data_6psi_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6psi _Structure_validation_residue.Date_analyzed 2019-09-13 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 113.409 0.892 . . . . 64.14 113.409 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.8 mmtp -68.07 107.27 2.66 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-N 115.239 -0.891 . . . . 74.32 108.725 168.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -72.83 88.77 1.34 Allowed 'General case' 0 C--O 1.241 0.637 0 N-CA-C 107.415 -1.328 . . . . 62.43 107.415 174.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -60.26 -30.64 69.57 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 114.827 -1.079 . . . . 73.34 111.678 -175.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -64.9 -53.53 45.13 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.958 -0.565 . . . . 73.33 110.357 176.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.16 -34.63 76.78 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 122.72 0.408 . . . . 70.01 111.3 -178.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 76.5 mt -59.96 -43.35 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 N-CA-C 109.865 -0.42 . . . . 74.23 109.865 172.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.425 ' O ' ' HB1' ' A' ' 25' ' ' ALA . 97.0 mt -75.71 -12.24 60.15 Favored 'General case' 0 CA--C 1.555 1.172 0 CA-C-N 116.042 -0.527 . . . . 73.11 112.3 175.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.52 36.56 33.41 Favored Glycine 0 C--N 1.349 1.302 0 CA-C-N 117.75 0.25 . . . . 73.42 113.686 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.8 m -131.34 159.8 70.07 Favored Pre-proline 0 N--CA 1.484 1.25 0 C-N-CA 124.935 1.294 . . . . 72.52 109.14 177.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -75.96 166.35 28.19 Favored 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 122.524 2.149 . . . . 50.12 112.846 177.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 43.3 mtm-85 -74.73 21.02 0.11 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 113.309 0.855 . . . . 75.43 113.309 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -122.15 6.67 9.72 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.184 0.993 . . . . 71.2 108.982 174.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.47 136.26 47.54 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.508 0.723 . . . . 74.14 111.936 -175.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.5 p -85.6 176.44 8.19 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.284 1.034 . . . . 75.03 110.691 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.3 tm0? -57.15 -37.65 72.38 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.384 0.674 . . . . 71.11 109.978 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.443 ' HB3' ' NH1' ' A' ' 24' ' ' ARG . 43.3 mm-40 -56.69 -54.33 47.34 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 123.772 0.67 . . . . 72.43 111.054 174.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -63.25 -38.82 92.66 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.994 0.518 . . . . 71.14 111.016 -177.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.6 mp -59.55 -39.52 79.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 124.52 1.128 . . . . 73.31 110.6 173.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -68.25 -56.07 9.96 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.414 -0.812 . . . . 75.22 111.056 -175.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.443 ' NH1' ' HB3' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -66.85 -28.84 68.67 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 122.976 0.172 . . . . 73.12 111.203 -179.204 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.425 ' HB1' ' O ' ' A' ' 11' ' ' LEU . . . -62.66 -51.09 68.63 Favored 'General case' 0 C--O 1.245 0.866 0 O-C-N 123.609 0.568 . . . . 72.43 110.754 173.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -58.75 -45.77 88.93 Favored 'General case' 0 C--O 1.215 -0.711 0 CA-C-N 114.73 -1.123 . . . . 73.1 110.469 178.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.426 ' O ' ' HG3' ' A' ' 31' ' ' ARG . 57.3 mtpt -63.14 -44.01 96.75 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 123.888 0.743 . . . . 74.22 111.128 -177.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.1 ttp85 -54.86 -48.25 73.17 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.609 0.763 . . . . 75.52 110.6 175.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.665 ' HB3' HD11 ' A' ' 50' ' ' ILE . 81.6 mt -77.39 -20.65 54.39 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 115.619 -0.719 . . . . 75.12 111.671 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.532 ' HA ' ' HE1' ' A' ' 47' ' ' PHE . . . -81.21 -22.32 38.92 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.615 0.766 . . . . 71.54 111.118 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.426 ' HG3' ' O ' ' A' ' 27' ' ' LYS . 58.1 mtm180 -91.75 -41.85 10.46 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 122.981 0.512 . . . . 72.33 110.047 174.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -69.45 -55.36 10.5 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.319 0.648 . . . . 73.31 111.191 -176.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -96.85 31.25 2.41 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 122.849 0.46 . . . . 72.41 110.27 179.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.469 ' HD2' HG21 ' A' ' 37' ' ' VAL . 44.2 t60 -60.26 101.6 0.26 Allowed Pre-proline 0 N--CA 1.477 0.904 0 C-N-CA 123.99 0.916 . . . . 73.54 110.234 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -70.11 -13.9 34.35 Favored 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 123.061 2.507 . . . . 75.51 113.216 -164.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.405 ' HB3' ' CD2' ' A' ' 34' ' ' HIS . 28.5 t70 -71.53 -35.12 70.58 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.477 0.711 . . . . 73.23 110.526 175.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.469 HG21 ' HD2' ' A' ' 34' ' ' HIS . 99.0 t -94.52 -48.97 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-O 121.309 0.576 . . . . 73.25 109.46 178.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -100.54 71.91 1.54 Allowed 'General case' 0 C--O 1.249 1.035 0 C-N-CA 124.104 0.961 . . . . 64.12 109.486 -177.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -74.36 81.34 1.88 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.049 -0.978 . . . . 73.11 108.873 176.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 67.4 m -138.83 108.67 7.71 Favored Pre-proline 0 C--O 1.24 0.571 0 CA-C-O 118.168 -0.92 . . . . 71.24 108.724 177.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -30.93 -52.43 0.25 Allowed 'Trans proline' 0 C--N 1.392 2.846 0 C-N-CA 125.284 3.989 . . . . 73.53 115.784 -175.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -51.3 -51.39 54.71 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.492 0.717 . . . . 64.43 111.743 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.24 -22.26 62.91 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 115.381 -0.827 . . . . 73.42 111.752 -177.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -88.91 -37.56 15.19 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.372 0.669 . . . . 63.35 110.514 -173.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.488 ' HA ' ' HE2' ' A' ' 48' ' ' LYS . 35.8 mm-40 -70.22 -41.48 73.56 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 108.807 -0.812 . . . . 62.44 108.807 175.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 15.4 tppt? -59.35 -45.54 91.1 Favored 'General case' 0 C--N 1.348 0.541 0 CA-C-N 114.641 -1.163 . . . . 74.03 110.011 173.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.578 ' HA ' HD12 ' A' ' 50' ' ' ILE . 71.3 t80 -58.09 -40.69 81.76 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 123.954 0.784 . . . . 73.32 110.984 176.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.51 ' HB3' ' CE1' ' A' ' 93' ' ' PHE . 43.4 mtmt -66.78 -32.83 74.38 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 119.414 -0.327 . . . . 75.14 111.858 178.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.85 -34.58 76.98 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 120.831 0.348 . . . . 71.44 110.439 172.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.665 HD11 ' HB3' ' A' ' 29' ' ' LEU . 73.3 mt -66.97 -30.27 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.049 0.939 . . . . 74.43 109.721 174.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.425 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 11.7 m-80 -83.29 -19.89 35.46 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.815 0.846 . . . . 73.43 112.125 174.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -70.98 -52.11 21.69 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 122.509 1.147 . . . . 75.34 108.389 171.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.66 -54.3 45.95 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 112.801 -1.999 . . . . 65.45 111.088 176.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -63.18 -37.84 88.81 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-N 115.262 -0.881 . . . . 73.53 111.176 177.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 51' ' ' ASN . . . -51.2 -53.53 34.17 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 122.98 0.512 . . . . 72.52 111.407 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 68.0 t -68.02 -44.11 85.0 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 CA-C-N 114.377 -1.283 . . . . 74.52 110.449 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.461 HD22 ' HD2' ' A' ' 63' ' ' ARG . 41.9 mt -91.48 5.8 48.02 Favored 'General case' 0 CA--C 1.563 1.457 0 N-CA-C 113.875 1.065 . . . . 74.35 113.875 -170.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.8 t -80.68 -47.89 13.37 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 123.218 0.607 . . . . 74.34 110.926 177.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -93.35 134.36 26.98 Favored Pre-proline 0 N--CA 1.474 0.768 0 CA-C-O 117.72 -1.133 . . . . 74.34 109.906 -173.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.51 ' O ' ' HG2' ' A' ' 64' ' ' ARG . 9.1 Cg_endo -49.7 -43.98 37.81 Favored 'Trans proline' 0 C--N 1.385 2.492 0 C-N-CA 124.014 3.142 . . . . 72.41 114.027 -177.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -67.88 -54.14 21.15 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 122.939 0.496 . . . . 72.3 111.635 -177.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.531 ' HA ' HD13 ' A' ' 65' ' ' ILE . 47.4 mtpt -61.52 -35.17 76.96 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.536 0.734 . . . . 74.54 110.787 -178.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.461 ' HD2' HD22 ' A' ' 57' ' ' LEU . 46.4 tpt85 -54.52 -58.27 8.13 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 114.311 -1.313 . . . . 74.11 108.891 171.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.51 ' HG2' ' O ' ' A' ' 60' ' ' PRO . 1.2 mmp_? -61.58 -28.7 69.53 Favored 'General case' 0 C--O 1.214 -0.801 0 CA-C-N 115.354 -0.839 . . . . 74.25 111.783 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.577 HG21 ' HD2' ' A' ' 76' ' ' PRO . 89.6 mt -61.69 -47.7 92.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 122.931 0.492 . . . . 74.41 109.677 176.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -60.79 -53.77 53.33 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 115.961 -0.563 . . . . 75.4 110.28 175.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -54.13 -44.73 71.61 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.533 0.733 . . . . 64.04 111.801 -176.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 53.7 p -73.77 -27.33 61.1 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.73 0.412 . . . . 75.44 111.332 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -73.37 119.49 17.67 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 109.105 -0.702 . . . . 75.32 109.105 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 101.19 16.22 25.88 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-N 115.964 -0.562 . . . . 64.23 111.964 -168.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 62.9 m -143.29 -59.27 0.42 Allowed 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 104.021 -2.585 . . . . 71.23 104.021 174.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.4 m -83.56 148.85 26.95 Favored 'General case' 0 C--O 1.249 1.061 0 N-CA-C 105.225 -2.139 . . . . 74.23 105.225 157.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.56 -30.15 9.21 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.273 1.029 . . . . 74.04 110.734 -176.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.17 139.9 61.03 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 123.321 0.648 . . . . 75.1 110.005 175.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -62.34 119.02 5.94 Favored 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 122.33 2.02 . . . . 75.41 111.111 175.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.577 ' HD2' HG21 ' A' ' 65' ' ' ILE . 78.6 Cg_exo -51.55 122.14 9.75 Favored 'Trans proline' 0 C--N 1.384 2.42 0 C-N-CA 123.357 2.705 . . . . 74.25 113.183 178.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -44.11 134.51 8.52 Favored 'Trans proline' 0 C--N 1.389 2.703 0 C-N-CA 124.504 3.469 . . . . 73.45 115.176 -168.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -63.15 135.03 48.64 Favored 'Trans proline' 0 C--N 1.386 2.545 0 C-N-CA 122.965 2.444 . . . . 73.2 112.456 -177.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.15 157.66 16.85 Favored 'Trans proline' 0 C--N 1.381 2.268 0 C-N-CA 122.953 2.436 . . . . 71.05 112.1 175.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -60.39 84.45 0.07 OUTLIER 'Trans proline' 0 C--N 1.38 2.222 0 C-N-CA 122.718 2.279 . . . . 74.31 112.185 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 155.01 -42.32 0.59 Allowed Glycine 0 CA--C 1.527 0.785 0 N-CA-C 109.873 -1.291 . . . . 62.41 109.873 -176.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 128.44 -160.5 22.13 Favored Glycine 0 C--N 1.351 1.414 0 CA-C-N 115.103 -0.548 . . . . 53.03 111.79 176.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -97.65 107.55 20.07 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 123.402 0.681 . . . . 74.41 109.166 176.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -54.91 155.09 4.65 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 115.632 -0.713 . . . . 71.31 111.849 170.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -155.98 60.16 0.59 Allowed 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 108.448 -0.945 . . . . 73.24 108.448 174.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 20.4 m -31.93 86.05 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 126.692 1.997 . . . . 74.44 116.39 -169.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 57.13 24.87 52.68 Favored Glycine 0 CA--C 1.536 1.347 0 N-CA-C 114.953 0.741 . . . . 70.11 114.953 176.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -96.58 154.38 17.31 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.412 0.685 . . . . 72.34 110.063 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -82.03 72.05 9.07 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 123.864 0.866 . . . . 71.44 111.476 -168.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.459 HG22 ' HE2' ' A' ' 97' ' ' PHE . 2.1 p -46.31 -50.37 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 C-N-CA 125.171 1.388 . . . . 75.21 113.537 -175.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.41 ' HG2' HG11 ' A' ' 90' ' ' VAL . 11.7 mm-40 -71.64 -4.04 24.99 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 113.55 0.944 . . . . 75.33 113.55 -171.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -107.42 -17.97 13.98 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.157 0.583 . . . . 61.35 111.27 178.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.51 ' CE1' ' HB3' ' A' ' 48' ' ' LYS . 7.6 m-30 -85.64 176.13 8.36 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 122.497 0.319 . . . . 73.34 111.134 -171.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 89.5 p -59.46 151.09 24.86 Favored 'General case' 0 C--O 1.247 0.926 0 N-CA-C 114.163 1.172 . . . . 74.5 114.163 -166.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.409 ' HG3' ' H ' ' A' ' 96' ' ' PHE . 3.4 pt-20 -53.34 -44.65 68.65 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 114.54 -1.209 . . . . 74.52 110.007 167.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.409 ' H ' ' HG3' ' A' ' 95' ' ' GLU . 73.8 t80 -49.79 -51.04 42.44 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.614 1.166 . . . . 75.03 111.331 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.459 ' HE2' HG22 ' A' ' 90' ' ' VAL . 3.5 t80 -58.78 -54.89 42.02 Favored 'General case' 0 CA--C 1.55 0.97 0 O-C-N 123.981 0.801 . . . . 72.32 110.28 174.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -70.8 -6.66 39.45 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 113.371 0.878 . . . . 74.14 113.371 -172.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -101.83 -38.8 7.68 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.275 0.63 . . . . 70.02 111.834 174.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 30.3 tp -69.01 -49.32 58.78 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 121.305 0.574 . . . . 74.33 109.798 177.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -92.04 -8.72 45.16 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 115.231 -0.895 . . . . 72.11 111.42 178.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -45.5 -59.07 4.94 Favored Glycine 0 N--CA 1.482 1.765 0 N-CA-C 115.579 0.991 . . . . 72.43 115.579 178.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -45.37 -23.1 1.12 Allowed 'Trans proline' 0 C--N 1.388 2.635 0 C-N-CA 124.45 3.433 . . . . 64.43 115.441 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -144.28 39.69 1.22 Allowed Glycine 0 C--N 1.354 1.53 0 CA-C-O 118.989 -0.895 . . . . 54.4 113.399 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 13.1 mt -66.02 38.03 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 114.79 1.404 . . . . 74.25 114.79 178.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.641 ' HB3' ' HA ' ' A' ' 169' ' ' ASN . 0.3 OUTLIER 55.78 -102.81 0.16 Allowed 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 123.888 0.875 . . . . 74.45 110.639 162.433 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 70.2 13.3 70.07 Favored Glycine 0 C--N 1.362 2.003 0 C-N-CA 122.776 0.227 . . . . 44.0 112.811 176.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.504 ' H ' ' HD1' ' A' ' 106' ' ' PHE . . . . . . . . 0 C--N 1.346 1.104 0 C-N-CA 123.522 0.582 . . . . 71.34 112.568 -173.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.483 ' HA ' ' HD2' ' A' ' 170' ' ' PRO . 27.1 tptp . . . . . 0 N--CA 1.475 0.808 0 CA-C-O 120.926 0.393 . . . . 73.31 111.331 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -87.46 144.39 19.06 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-N 115.603 -0.726 . . . . 73.4 112.364 172.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -86.92 160.59 18.64 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.156 0.583 . . . . 74.43 111.821 -177.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -60.26 139.22 57.72 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.147 0.579 . . . . 74.23 111.305 176.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.437 HD21 ' N ' ' A' ' 120' ' ' ARG . 4.8 tt -145.89 160.78 41.33 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 107.994 -1.113 . . . . 75.42 107.994 -179.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.437 ' N ' HD21 ' A' ' 119' ' ' LEU . 0.3 OUTLIER -124.77 123.89 40.96 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 109.501 -0.555 . . . . 74.51 109.501 176.794 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -129.89 164.95 23.05 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.479 0.712 . . . . 54.41 110.477 -177.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.427 ' O ' HD13 ' B' ' 8' ' ' LEU . 4.2 mm-40 -106.73 120.34 41.73 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 106.976 -1.49 . . . . 72.42 106.976 -172.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.411 HD22 HD11 ' A' ' 176' ' ' LEU . 47.4 tp -97.92 99.84 7.55 Favored Pre-proline 0 CA--C 1.54 0.594 0 N-CA-C 108.191 -1.04 . . . . 74.14 108.191 -176.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.576 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 93.3 Cg_endo -77.74 110.99 3.04 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 121.374 1.383 . . . . 75.33 109.407 177.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.621 ' HA ' HG21 ' B' ' 6' ' ' ILE . 44.2 tp -119.57 136.22 54.46 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.87 0.468 . . . . 72.43 110.862 -168.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 67.9 m -67.92 129.41 39.84 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.927 0.891 . . . . 71.34 110.221 -179.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.494 HD23 ' HB3' ' A' ' 180' ' ' LEU . 51.5 mt -55.11 -43.37 74.0 Favored 'General case' 0 N--CA 1.481 1.123 0 O-C-N 124.376 1.048 . . . . 75.21 111.163 -174.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -57.34 -46.44 83.28 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 114.76 -1.109 . . . . 75.32 110.442 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -72.39 -29.0 63.35 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 115.339 -0.846 . . . . 64.33 110.719 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -67.12 -33.25 75.04 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.199 0.6 . . . . 65.44 110.564 175.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -66.62 -56.22 11.7 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 123.754 0.659 . . . . 74.51 109.744 172.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -61.27 -50.25 73.77 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 114.895 -1.048 . . . . 75.25 112.162 -169.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.04 131.9 0.28 Allowed Glycine 0 C--N 1.344 0.988 0 O-C-N 123.595 0.559 . . . . 71.54 112.937 -178.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 153.93 -161.34 29.9 Favored Glycine 0 C--N 1.338 0.643 0 N-CA-C 111.693 -0.563 . . . . 70.42 111.693 -177.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -71.23 134.7 47.06 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 109.813 -0.44 . . . . 73.14 109.813 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.551 ' NE ' ' HA ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -120.45 124.68 46.05 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 120.759 0.314 . . . . 75.05 110.634 179.701 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.428 ' HB ' HG22 ' B' ' 5' ' ' THR . 92.6 t -77.9 103.63 5.15 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-N 115.118 -0.947 . . . . 75.04 109.452 175.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 57.4 t -115.98 112.51 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.679 1.191 . . . . 73.34 107.792 177.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -111.97 129.54 56.15 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 120.98 0.419 . . . . 71.3 110.675 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.412 HG13 HD22 ' B' ' 8' ' ' LEU . 7.9 p -169.65 149.94 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.99 0 C-N-CA 124.906 1.282 . . . . 75.1 108.388 -177.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 60.68 19.56 9.58 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 113.237 0.828 . . . . 74.24 113.237 174.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 98.68 -31.03 8.59 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 116.402 -0.363 . . . . 54.15 112.607 -178.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.566 ' NH1' ' SD ' ' A' ' 164' ' ' MET . 66.3 ttt180 -86.7 137.62 32.3 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 122.804 0.441 . . . . 72.43 110.811 -178.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 43.1 ttm105 -112.34 97.15 6.43 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 108.189 -1.041 . . . . 74.41 108.189 169.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.6 p -87.21 145.73 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 CA-C-N 115.457 -0.792 . . . . 73.53 111.405 -177.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 39.8 t -103.59 89.05 3.23 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 108.475 -0.935 . . . . 64.43 108.475 170.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 4.9 p -94.45 118.44 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 109.702 -0.481 . . . . 73.42 109.702 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 58.1 ttt85 -72.95 104.16 3.99 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.022 0.439 . . . . 74.32 110.142 177.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 23.6 pt -74.18 143.14 79.81 Favored Pre-proline 0 CA--C 1.554 1.123 0 CA-C-N 115.184 -0.916 . . . . 74.52 110.164 175.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -63.32 138.46 66.27 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.782 2.321 . . . . 74.22 112.315 175.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -62.78 106.38 0.51 Allowed 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.801 2.334 . . . . 74.15 111.837 174.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 90.71 46.68 3.9 Favored Glycine 0 C--N 1.342 0.904 0 CA-C-N 115.508 -0.769 . . . . 75.51 112.184 -176.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.484 HG23 HG12 ' A' ' 178' ' ' VAL . 4.6 p -81.04 126.85 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.314 0.646 . . . . 75.43 110.784 -174.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.675 ' HD2' ' HA ' ' A' ' 191' ' ' GLN . 12.9 mtm180 -108.71 156.98 18.97 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.422 1.089 . . . . 73.23 110.225 -166.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.518 ' HB3' ' HA ' ' A' ' 189' ' ' GLU . 12.9 tp10 -49.62 130.36 20.57 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.011 0.925 . . . . 72.32 112.376 -177.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 89.78 0.18 78.85 Favored Glycine 0 C--N 1.347 1.152 0 CA-C-N 115.483 -0.78 . . . . 74.33 114.008 177.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 58.2 m -67.39 115.31 6.89 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 117.717 0.758 . . . . 74.23 109.784 174.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.492 HG23 HG23 ' A' ' 177' ' ' VAL . 90.3 t -95.98 106.02 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 124.164 0.986 . . . . 74.02 110.209 -174.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.507 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 54.1 mt -87.73 100.67 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 108.243 -1.021 . . . . 75.24 108.243 172.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 65.2 ttt-85 -75.15 100.45 4.27 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 109.247 -0.649 . . . . 75.21 109.247 176.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 4.5 p -125.28 117.36 25.28 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 123.927 0.891 . . . . 71.41 109.348 -178.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.442 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 41.1 Cg_endo -67.19 147.54 79.09 Favored 'Trans proline' 0 C--N 1.371 1.759 0 C-N-CA 121.451 1.434 . . . . 74.53 110.435 169.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . 0.584 ' HA2' ' HD2' ' A' ' 171' ' ' PRO . . . 124.28 -19.72 7.16 Favored Glycine 0 C--N 1.341 0.838 0 N-CA-C 115.213 0.845 . . . . 70.43 115.213 174.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.566 ' SD ' ' NH1' ' A' ' 143' ' ' ARG . 3.6 mpp? -124.12 8.93 8.61 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 117.687 0.744 . . . . 64.15 111.675 -178.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -87.92 -126.14 2.37 Favored Glycine 0 N--CA 1.477 1.382 0 CA-C-N 117.926 0.33 . . . . 73.33 113.32 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -62.71 153.65 43.93 Favored Glycine 0 C--N 1.357 1.72 0 O-C-N 123.481 0.165 . . . . 74.5 112.698 175.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -70.29 123.02 20.67 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.14 0.576 . . . . 75.42 110.903 -173.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -174.48 167.27 39.53 Favored Glycine 0 C--N 1.345 1.066 0 CA-C-O 119.365 -0.686 . . . . 64.21 111.571 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . 0.641 ' HA ' ' HB3' ' A' ' 106' ' ' PHE . 2.9 t-20 -69.98 -50.78 15.96 Favored Pre-proline 0 N--CA 1.479 0.982 0 CA-C-N 118.281 1.04 . . . . 63.54 110.279 174.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.537 ' HD3' ' HB3' ' A' ' 169' ' ' ASN . 8.3 Cg_endo -90.45 84.69 0.4 Allowed 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 121.703 1.602 . . . . 73.02 108.237 160.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.584 ' HD2' ' HA2' ' A' ' 163' ' ' GLY . 2.7 Cg_exo -71.26 178.99 4.87 Favored 'Trans proline' 0 C--N 1.369 1.657 0 C-N-CA 122.525 2.15 . . . . 71.25 113.007 -163.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -62.85 146.46 50.22 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 117.494 1.758 . . . . 72.4 117.494 -162.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.442 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 3.7 m-20 -69.5 89.04 0.5 Allowed 'General case' 0 C--O 1.241 0.658 0 C-N-CA 124.872 1.269 . . . . 71.14 108.547 175.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 22.6 tp -83.14 149.18 27.03 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 114.994 -1.003 . . . . 74.2 111.332 -173.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 80.3 mt -110.56 95.93 5.87 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.037 0.935 . . . . 72.12 108.618 174.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.507 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 93.0 mt -71.21 92.25 1.0 Allowed 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 109.835 -0.431 . . . . 74.52 109.835 175.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.492 HG23 HG23 ' A' ' 158' ' ' VAL . 57.5 t -82.7 100.4 6.38 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 N-CA-C 106.923 -1.51 . . . . 71.11 106.923 173.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.484 HG12 HG23 ' A' ' 153' ' ' VAL . 9.9 p -65.87 113.45 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 CA-C-O 122.036 0.922 . . . . 74.13 110.922 -171.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.576 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 37.6 mmt180 -102.51 106.46 17.18 Favored 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 106.705 -1.591 . . . . 73.42 106.705 171.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.704 HD13 ' HB3' ' A' ' 188' ' ' LEU . 33.0 mt -70.09 143.29 52.46 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 118.921 0.782 . . . . 74.04 109.884 178.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 44.0 mt -54.08 158.07 3.91 Favored Pre-proline 0 N--CA 1.49 1.551 0 C-N-CA 124.314 1.046 . . . . 73.22 112.82 -167.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -75.92 44.01 1.22 Allowed 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 123.298 2.665 . . . . 74.32 111.022 163.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 62.0 t-80 -70.73 131.94 87.43 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 125.371 1.469 . . . . 73.35 107.178 177.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -64.34 12.3 0.1 OUTLIER 'Trans proline' 0 C--N 1.37 1.68 0 C-N-CA 123.557 2.838 . . . . 61.24 117.427 -162.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 4.1 t -112.03 -64.54 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.89 0 CA-C-N 120.455 1.479 . . . . 72.34 110.1 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . 0.529 ' CD1' ' HB3' ' A' ' 195' ' ' ALA . 39.2 m-85 -126.41 163.57 23.01 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 121.614 0.721 . . . . 72.31 111.869 -168.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 31.5 ttp-105 -141.35 96.07 2.93 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 107.102 -1.444 . . . . 75.51 107.102 161.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.704 ' HB3' HD13 ' A' ' 180' ' ' LEU . 54.5 tp -66.24 117.25 8.25 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.784 0.834 . . . . 74.21 110.465 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . 0.544 ' HB3' ' HE1' ' A' ' 194' ' ' TYR . 35.8 tt0 -138.36 132.76 32.02 Favored 'General case' 0 C--O 1.247 0.925 0 C-N-CA 124.164 0.986 . . . . 70.31 109.084 -177.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 78.0 -82.78 1.2 Allowed Glycine 0 C--N 1.343 0.924 0 CA-C-N 115.687 -0.688 . . . . 65.41 111.56 -177.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.675 ' HA ' ' HD2' ' A' ' 154' ' ' ARG . 4.7 pm0 -147.68 -4.79 0.49 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.978 0.911 . . . . 72.32 110.647 174.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -130.73 156.18 45.37 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 122.997 0.519 . . . . 72.32 112.087 -165.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.49 HD21 ' HE1' ' A' ' 240' ' ' PHE . 68.9 mt -90.4 144.49 25.76 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.999 0.92 . . . . 74.25 110.334 -174.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.544 ' HE1' ' HB3' ' A' ' 189' ' ' GLU . 63.7 m-85 -117.24 110.45 18.13 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 109.049 -0.723 . . . . 73.14 109.049 171.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.529 ' HB3' ' CD1' ' A' ' 186' ' ' PHE . . . -121.52 -175.02 2.99 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.827 0.851 . . . . 74.34 110.999 178.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 22.8 m -125.08 145.63 49.83 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.715 0.806 . . . . 70.21 109.184 175.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.533 HD23 HD12 ' A' ' 251' ' ' LEU . 21.9 tp -133.77 101.16 4.99 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.931 -0.396 . . . . 74.1 109.931 176.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -80.67 113.49 18.9 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.321 -0.992 . . . . 63.3 108.321 166.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 6.4 p -133.26 133.21 22.65 Favored Pre-proline 0 N--CA 1.481 1.089 0 C-N-CA 123.652 0.781 . . . . 74.33 109.097 -171.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.37 151.89 60.25 Favored 'Trans proline' 0 C--N 1.375 1.941 0 C-N-CA 121.386 1.391 . . . . 70.05 112.146 177.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -55.52 -45.81 99.81 Favored Pre-proline 0 CA--C 1.553 1.083 0 N-CA-C 114.507 1.299 . . . . 71.34 114.507 -171.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -57.73 -45.4 33.46 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 121.442 1.428 . . . . 73.32 112.734 175.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 41.9 mt -71.11 -27.67 30.44 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 CA-C-N 116.117 -0.492 . . . . 71.02 111.12 -178.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -72.38 -45.0 61.74 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.268 0.627 . . . . 74.14 111.428 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 73.7 t -71.5 -49.86 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 123.356 0.662 . . . . 64.22 111.52 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.474 HG22 ' HA ' ' C' ' 270' ' ' LYS . 47.8 t -83.67 -35.18 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.196 0.598 . . . . 74.41 110.907 -172.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 91.87 73.96 1.26 Allowed Glycine 0 C--N 1.348 1.202 0 CA-C-N 116.084 -0.507 . . . . 72.35 113.35 176.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -110.42 170.33 13.99 Favored Glycine 0 N--CA 1.473 1.134 0 C-N-CA 122.853 0.263 . . . . 73.32 112.646 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 49.7 mtmt -81.22 128.23 33.56 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.016 0.527 . . . . 73.34 111.921 -175.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.525 HG23 HD11 ' A' ' 197' ' ' LEU . 34.4 m -116.02 168.38 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.124 0.97 . . . . 63.11 108.705 169.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 37.9 ttp-105 -88.51 105.69 17.79 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.643 -0.873 . . . . 74.32 108.643 174.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -103.31 123.48 46.86 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.791 -0.818 . . . . 74.41 108.791 176.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' MET . . . . . 0.423 ' HA ' ' HA ' ' A' ' 218' ' ' PRO . 57.6 mtm -68.06 143.8 55.36 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 122.904 0.482 . . . . 74.15 110.72 -177.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 8.5 m -136.71 166.01 24.56 Favored 'General case' 0 CA--C 1.554 1.106 0 N-CA-C 108.762 -0.829 . . . . 74.1 108.762 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 52.6 mt -65.72 -12.85 57.21 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 114.495 1.294 . . . . 73.14 114.495 -170.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -128.2 31.3 5.08 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 109.355 -0.609 . . . . 64.44 109.355 178.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 112.9 160.71 14.61 Favored Glycine 0 C--N 1.351 1.408 0 CA-C-N 114.883 -1.053 . . . . 63.05 112.887 176.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . 0.423 ' HA ' ' HA ' ' A' ' 213' ' ' MET . 3.0 Cg_exo -74.44 142.56 29.93 Favored 'Trans proline' 0 C--N 1.372 1.783 0 C-N-CA 123.141 2.56 . . . . 74.13 111.917 -178.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 34.7 m -128.88 152.0 36.44 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 C-N-CA 124.026 0.93 . . . . 73.4 109.898 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -78.62 117.97 20.28 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-O 121.248 0.547 . . . . 75.04 110.476 176.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 66.2 t -118.11 114.52 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 123.774 0.83 . . . . 74.51 109.063 -177.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.404 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -67.78 101.97 1.15 Allowed 'General case' 0 C--N 1.349 0.556 0 N-CA-C 109.525 -0.546 . . . . 70.4 109.525 172.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 96.3 t -53.9 137.58 55.29 Favored Pre-proline 0 CA--C 1.554 1.105 0 C-N-CA 124.354 1.062 . . . . 71.22 109.823 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -56.22 156.31 21.34 Favored 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 122.522 2.148 . . . . 75.51 111.864 174.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -77.97 151.82 27.76 Favored 'Trans proline' 0 C--N 1.366 1.449 0 C-N-CA 121.616 1.544 . . . . 72.53 111.553 177.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 67.4 mtt-85 67.1 26.68 8.82 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 125.056 1.342 . . . . 75.13 111.498 174.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.42 HG22 HD23 ' A' ' 233' ' ' LEU . 28.8 m -64.16 109.01 1.71 Allowed 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 124.581 1.153 . . . . 64.32 111.468 177.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -101.53 146.56 27.5 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.324 1.05 . . . . 75.32 110.572 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -71.01 145.45 49.98 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.225 0.61 . . . . 65.12 112.367 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 95.19 -1.32 64.68 Favored Glycine 0 C--N 1.342 0.901 0 CA-C-N 115.241 -0.89 . . . . 75.54 112.368 -176.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -109.56 167.97 9.75 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.69 0.796 . . . . 74.44 111.449 -176.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -118.59 115.71 25.12 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.079 0.952 . . . . 72.22 109.919 -177.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.518 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 73.9 mt -80.51 110.19 15.74 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 122.76 0.424 . . . . 71.4 110.279 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . 0.488 ' HA ' ' O ' ' A' ' 249' ' ' LEU . 42.4 ttm180 -74.18 106.65 5.93 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 124.309 1.006 . . . . 73.41 110.392 175.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.434 HD12 HD23 ' A' ' 249' ' ' LEU . 5.0 mt -112.14 101.57 9.82 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 108.331 -0.988 . . . . 74.24 108.331 173.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -67.43 156.18 37.21 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.399 0.68 . . . . 71.01 111.89 -177.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 81.18 -6.81 62.1 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 116.512 -0.313 . . . . 74.2 113.627 177.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.19 -39.83 20.47 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.651 0.781 . . . . 74.1 109.968 176.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -78.98 173.84 55.34 Favored Glycine 0 C--N 1.347 1.153 0 O-C-N 123.676 0.61 . . . . 74.43 111.944 178.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . 0.49 ' HE1' HD21 ' A' ' 193' ' ' LEU . 63.2 m-85 -96.45 160.4 29.7 Favored Pre-proline 0 N--CA 1.473 0.703 0 C-N-CA 123.875 0.87 . . . . 73.41 111.472 -167.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -52.7 140.35 56.46 Favored 'Trans proline' 0 C--N 1.387 2.568 0 C-N-CA 122.79 2.327 . . . . 73.33 112.348 175.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 179.94 -153.04 11.45 Favored Glycine 0 C--N 1.341 0.821 0 CA-C-O 118.738 -1.035 . . . . 73.52 111.597 -176.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . 0.474 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 85.0 Cg_exo -50.0 -43.52 41.48 Favored 'Trans proline' 0 C--N 1.382 2.342 0 C-N-CA 123.955 3.103 . . . . 72.5 114.482 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -85.29 21.45 1.71 Allowed 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.544 0.738 . . . . 70.11 112.372 -175.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 81.1 -77.1 2.07 Favored Glycine 0 C--N 1.347 1.192 0 N-CA-C 109.253 -1.539 . . . . 62.24 109.253 -170.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 73.1 mtp180 -126.19 160.64 29.69 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.243 1.017 . . . . 75.41 108.537 163.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -92.18 172.03 34.57 Favored Glycine 0 C--O 1.25 1.124 0 CA-C-O 122.134 0.852 . . . . 70.31 113.589 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -101.2 -170.95 1.91 Allowed 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 114.105 -1.048 . . . . 75.44 110.238 -177.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.488 ' O ' ' HA ' ' A' ' 234' ' ' ARG . 22.3 tp -121.54 144.61 48.62 Favored 'General case' 0 C--O 1.216 -0.704 0 N-CA-C 107.041 -1.466 . . . . 73.32 107.041 164.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -124.84 106.24 9.87 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 108.471 -0.937 . . . . 71.3 108.471 173.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.533 HD12 HD23 ' A' ' 197' ' ' LEU . 83.1 mt -90.35 119.3 30.53 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 115.386 -0.825 . . . . 74.54 110.712 -179.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -77.21 104.0 7.47 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.011 -0.737 . . . . 75.41 109.011 177.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 38.8 t -73.15 123.53 28.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 115.254 -0.885 . . . . 71.34 111.582 -173.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -125.02 100.96 6.82 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 107.379 -1.341 . . . . 73.14 107.379 166.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.528 ' HB ' ' O ' ' C' ' 255' ' ' ILE . 64.0 mt -75.23 137.15 23.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 115.909 -0.587 . . . . 74.34 109.946 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 39.9 p -119.44 169.49 9.98 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.081 0.952 . . . . 74.52 108.667 173.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . 0.501 ' HB ' ' HD2' ' A' ' 258' ' ' PRO . 2.9 pp -134.38 157.0 78.43 Favored Pre-proline 0 CA--C 1.561 1.392 0 N-CA-C 108.547 -0.909 . . . . 73.4 108.547 175.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' PRO . . . . . 0.501 ' HD2' ' HB ' ' A' ' 257' ' ' ILE . 37.3 Cg_endo -58.81 -12.34 14.53 Favored 'Trans proline' 0 C--N 1.385 2.481 0 C-N-CA 123.617 2.878 . . . . 74.45 116.147 -162.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . 0.568 ' HA ' ' HB3' ' C' ' 226' ' ' ARG . 29.9 tt0 58.25 -70.26 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 125.352 1.461 . . . . 75.12 112.646 -172.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -74.01 131.01 40.96 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 109.285 -0.635 . . . . 75.12 109.285 172.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 19.6 mt -138.58 144.24 39.73 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.78 0.8 . . . . 72.32 111.587 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 24.5 p -96.92 148.9 35.07 Favored Pre-proline 0 CA--C 1.559 1.32 0 CA-C-N 114.167 -1.378 . . . . 74.31 108.954 173.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -39.87 -47.55 3.76 Favored 'Trans proline' 0 C--N 1.387 2.566 0 C-N-CA 125.114 3.876 . . . . 74.33 116.937 -168.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -67.92 -49.16 63.48 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 122.747 0.419 . . . . 71.44 111.417 -175.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -58.48 -44.57 89.39 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 109.91 -0.404 . . . . 73.22 109.91 177.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -62.65 -33.65 75.47 Favored 'General case' 0 CA--C 1.549 0.92 0 O-C-N 123.754 0.659 . . . . 73.45 111.278 178.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -66.63 -41.71 87.9 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 122.843 0.457 . . . . 64.12 110.782 176.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 10.9 mp -65.54 -47.73 74.87 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.13 0.572 . . . . 73.14 110.7 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 65.9 m95 -58.63 -43.97 89.87 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.925 0.89 . . . . 75.0 111.752 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . 0.485 ' O ' ' HG3' ' A' ' 274' ' ' GLU . 42.9 mttp -67.53 -42.78 82.17 Favored 'General case' 0 C--O 1.215 -0.736 0 CA-C-O 119.215 -0.422 . . . . 73.12 111.44 178.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . 0.429 ' HA ' ' HD3' ' A' ' 271' ' ' LYS . 32.2 mmtm -62.87 -35.62 80.59 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 117.884 0.311 . . . . 70.22 111.706 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' LEU . . . . . 0.621 HD23 ' HB2' ' C' ' 268' ' ' LEU . 86.7 mt -60.31 -50.81 72.14 Favored 'General case' 0 C--O 1.214 -0.768 0 O-C-N 123.909 0.755 . . . . 71.54 109.5 169.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . 0.497 ' HA ' ' HB2' ' C' ' 202' ' ' PRO . . . -65.41 -29.93 70.68 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.492 1.117 . . . . 72.23 113.721 -174.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . 0.485 ' HG3' ' O ' ' A' ' 270' ' ' LYS . 41.1 mt-10 -81.3 -49.09 11.15 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 123.27 0.628 . . . . 74.35 109.311 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -67.7 -18.81 65.05 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 115.605 -0.725 . . . . 72.24 111.156 177.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . 0.42 ' HE2' ' HG3' ' C' ' 258' ' ' PRO . 21.0 t80 -77.9 -76.66 0.18 Allowed 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 108.349 -0.982 . . . . 75.02 108.349 171.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -50.05 -60.63 2.76 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.673 1.189 . . . . 72.14 111.543 -171.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -61.63 -28.65 69.52 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 123.7 0.625 . . . . 75.41 111.795 -174.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . 0.454 ' HA ' ' HE ' ' A' ' 279' ' ' ARG . 4.6 mmp_? -117.84 32.48 6.13 Favored 'General case' 0 C--N 1.349 0.548 0 N-CA-C 109.507 -0.553 . . . . 75.15 109.507 -174.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.198 0 N-CA-C 108.709 -0.848 . . . . 72.5 108.709 171.524 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 68.4 mtm . . . . . 0 N--CA 1.483 1.185 0 N-CA-C 109.936 -0.394 . . . . 74.12 109.936 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -104.06 84.96 2.31 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.473 0.709 . . . . 62.45 109.354 -173.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -67.78 -72.34 0.18 Allowed 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 109.44 -0.578 . . . . 74.04 109.44 178.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 22.4 m 64.88 -65.87 0.14 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 125.132 1.373 . . . . 52.14 112.716 176.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' THR . . . . . 0.428 HG22 ' HB ' ' A' ' 137' ' ' VAL . 4.3 m -74.44 153.44 39.18 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 123.635 0.774 . . . . 74.34 111.254 177.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.621 HG21 ' HA ' ' A' ' 125' ' ' LEU . 41.6 pt -135.6 -179.84 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 123.173 0.589 . . . . 65.34 112.282 -169.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -130.35 -158.24 0.88 Allowed 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 124.258 1.023 . . . . 72.22 109.612 178.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . 0.427 HD13 ' O ' ' A' ' 122' ' ' GLU . 45.3 tp -141.4 149.75 41.47 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.735 0.814 . . . . 75.22 109.802 179.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.84 -51.25 8.81 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 122.747 0.419 . . . . 73.12 111.764 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 27.0 mt 74.71 -22.46 0.26 Allowed 'General case' 0 N--CA 1.499 2.013 0 C-N-CA 125.381 1.472 . . . . 74.1 113.788 -174.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 79.9 mt . . . . . 0 CA--C 1.565 1.549 0 C-N-CA 124.385 1.074 . . . . 72.11 111.877 -172.442 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.061 0 N-CA-C 109.506 -0.553 . . . . 74.35 109.506 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . -172.73 -56.06 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 114.527 -1.215 . . . . 75.32 108.482 170.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 181' ' ' LEU . . . . . 0.624 ' HB2' ' HB3' ' C' ' 136' ' ' ARG . 59.3 tp -105.9 -89.38 0.43 Allowed 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 107.602 -1.259 . . . . 74.44 107.602 169.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 182' ' ' VAL . . . . . 0.492 HG13 ' HB2' ' C' ' 123' ' ' LEU . 30.5 m -129.04 -173.04 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.932 0 C-N-CA 124.716 1.206 . . . . 72.43 108.477 170.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -171.94 95.99 0.16 Allowed 'General case' 0 CA--C 1.547 0.865 0 CA-C-O 118.414 -0.803 . . . . 65.24 112.394 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 11.1 p-80 164.56 159.19 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.724 0 C-N-CA 125.551 1.54 . . . . 75.32 112.396 160.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 185' ' ' VAL . . . . . . . . . . . . . 34.8 t . . . . . 0 N--CA 1.494 1.737 0 C-N-CA 124.901 1.28 . . . . 74.01 109.33 169.932 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 23.0 m . . . . . 0 CA--C 1.557 1.213 0 CA-C-O 120.796 0.331 . . . . 71.31 110.639 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 239' ' ' ALA . . . . . 0.555 ' HB1' ' H ' ' C' ' 222' ' ' ALA . . . -55.27 -78.63 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.184 0.994 . . . . 74.42 112.951 -175.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . 152.82 -114.32 0.62 Allowed Glycine 0 C--N 1.339 0.699 0 N-CA-C 110.623 -0.991 . . . . 71.23 110.623 -172.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -151.61 136.07 16.91 Favored 'General case' 0 C--O 1.245 0.855 0 C-N-CA 123.455 0.702 . . . . 71.23 110.012 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 242' ' ' TRP . . . . . 0.514 ' CD2' ' HG ' ' C' ' 233' ' ' LEU . 4.7 p-90 -172.21 138.24 0.96 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.809 0.843 . . . . 70.32 112.106 173.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 71.8 mm-40 62.99 -75.0 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.819 1.648 . . . . 74.22 111.765 175.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 178.96 58.9 0.07 OUTLIER Glycine 0 C--N 1.342 0.9 0 N-CA-C 112.226 -0.35 . . . . 71.54 112.226 177.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 245' ' ' LYS . . . . . 0.76 ' HE2' ' HB3' ' C' ' 222' ' ' ALA . 52.8 tptt . . . . . 0 CA--C 1.541 0.607 0 CA-C-O 120.883 0.373 . . . . 75.34 110.767 177.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.287 0 CA-C-O 120.889 0.376 . . . . 71.34 110.881 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -39.11 102.75 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.607 1.563 . . . . 70.52 113.548 177.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 5' ' ' LYS . . . . . 0.465 ' HB3' HD11 ' C' ' 10' ' ' ILE . 48.0 mtpt -84.47 125.44 32.37 Favored 'General case' 0 C--O 1.245 0.832 0 N-CA-C 109.402 -0.592 . . . . 72.32 109.402 173.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -77.16 100.98 5.96 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.627 -0.879 . . . . 65.15 108.627 177.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 7' ' ' TYR . . . . . 0.531 ' HD1' HD13 ' C' ' 10' ' ' ILE . 23.4 m-85 -63.27 -31.17 72.25 Favored 'General case' 0 C--O 1.252 1.185 0 C-N-CA 123.741 0.817 . . . . 73.43 112.158 -172.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -60.51 -47.77 84.71 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.828 -0.624 . . . . 74.23 109.846 174.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.7 -38.02 88.05 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.546 0.738 . . . . 63.34 111.102 -177.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 10' ' ' ILE . . . . . 0.531 HD13 ' HD1' ' C' ' 7' ' ' TYR . 72.0 mt -58.28 -39.93 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 123.225 0.61 . . . . 73.31 110.41 175.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 11' ' ' LEU . . . . . 0.518 ' O ' ' HB1' ' C' ' 25' ' ' ALA . 86.0 mt -86.3 -11.67 51.57 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 112.654 0.613 . . . . 75.53 112.654 175.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.69 24.15 65.58 Favored Glycine 0 CA--C 1.535 1.328 0 N-CA-C 114.347 0.499 . . . . 74.43 114.347 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 5.8 m -105.84 156.19 37.02 Favored Pre-proline 0 N--CA 1.486 1.374 0 C-N-CA 124.056 0.942 . . . . 71.34 109.955 171.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -78.4 168.29 21.71 Favored 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 122.825 2.35 . . . . 74.43 114.427 -178.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 80.2 mtt180 -75.01 72.2 2.13 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.766 0.827 . . . . 74.35 109.87 173.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 175.11 -19.94 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.99 1.316 . . . . 71.24 108.896 -175.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -46.49 133.47 9.98 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 125.484 1.513 . . . . 75.2 113.447 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 18.2 p -74.19 148.2 41.85 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 123.946 0.779 . . . . 74.41 109.074 175.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -51.51 -34.11 34.58 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 124.069 0.948 . . . . 74.45 112.131 -178.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.11 -44.98 67.86 Favored 'General case' 0 CA--C 1.556 1.201 0 CA-C-N 114.838 -1.074 . . . . 74.53 110.331 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -73.38 -27.27 61.39 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 123.023 0.529 . . . . 73.42 111.659 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 22' ' ' ILE . . . . . 0.527 HD11 HD12 ' C' ' 57' ' ' LEU . 76.5 mt -61.97 -44.29 98.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 123.94 0.896 . . . . 75.54 109.073 169.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 23' ' ' LYS . . . . . 0.567 ' HZ1' ' HB3' ' C' ' 23' ' ' LYS . 5.1 ttpm? -65.02 -32.64 74.46 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 114.922 -1.036 . . . . 74.13 111.388 175.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 24' ' ' ARG . . . . . 0.624 ' HA ' ' HE3' ' C' ' 27' ' ' LYS . 56.1 mtt180 -62.67 -46.91 85.98 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 120.961 0.41 . . . . 73.52 111.118 175.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . 0.518 ' HB1' ' O ' ' C' ' 11' ' ' LEU . . . -62.13 -39.17 91.69 Favored 'General case' 0 C--O 1.251 1.14 0 CA-C-N 114.814 -1.084 . . . . 75.32 111.389 177.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 26' ' ' TYR . . . . . 0.474 ' HD1' HG21 ' C' ' 50' ' ' ILE . 38.9 t80 -54.3 -54.7 36.66 Favored 'General case' 0 C--O 1.207 -1.147 0 CA-C-N 115.115 -0.948 . . . . 72.31 109.975 170.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . 0.624 ' HE3' ' HA ' ' C' ' 24' ' ' ARG . 10.3 mtmp? -56.85 -40.13 75.54 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 123.319 0.647 . . . . 75.33 111.452 -176.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 28' ' ' ARG . . . . . 0.465 ' HA ' ' NH2' ' C' ' 31' ' ' ARG . 34.8 ttp180 -57.9 -52.25 66.26 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 123.936 0.773 . . . . 75.55 110.606 177.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 80.6 mt -84.28 -9.72 58.25 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-N 114.905 -1.043 . . . . 71.43 111.756 -176.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -86.85 -23.5 25.26 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.991 0.917 . . . . 75.32 110.214 175.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . 0.465 ' NH2' ' HA ' ' C' ' 28' ' ' ARG . 54.7 mtm180 -80.4 -45.88 16.94 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.518 0.727 . . . . 73.5 109.108 167.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 59.4 tp60 -60.94 -50.97 71.26 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.245 1.018 . . . . 71.12 112.263 -175.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 33' ' ' TYR . . . . . 0.506 ' HB3' ' O ' ' C' ' 43' ' ' ALA . 31.2 m-85 -103.94 20.03 18.92 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.066 0.547 . . . . 72.14 111.843 -172.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 34' ' ' HIS . . . . . 0.49 ' HB3' ' HB ' ' C' ' 37' ' ' VAL . 5.7 t60 -63.87 114.34 13.22 Favored Pre-proline 0 N--CA 1.482 1.16 0 CA-C-O 118.526 -0.75 . . . . 74.34 111.023 -172.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 35' ' ' PRO . . . . . 0.501 ' HA ' ' HG2' ' C' ' 44' ' ' GLU . 34.7 Cg_exo -40.25 -50.43 3.58 Favored 'Trans proline' 0 C--N 1.385 2.488 0 C-N-CA 124.868 3.712 . . . . 72.22 116.111 -166.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -91.39 -23.7 19.97 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 111.797 0.295 . . . . 60.34 111.797 -173.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . 0.49 ' HB ' ' HB3' ' C' ' 34' ' ' HIS . 69.0 t -74.67 -41.94 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 108.658 -0.867 . . . . 75.33 108.658 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -112.8 96.12 5.79 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.399 -1.334 . . . . 65.41 107.399 175.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -70.61 76.44 0.59 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.801 0.841 . . . . 71.22 110.138 -175.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 62.5 m -152.04 104.62 2.81 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 123.659 0.784 . . . . 74.14 109.306 -176.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -44.64 -38.4 12.33 Favored 'Trans proline' 0 C--N 1.382 2.305 0 C-N-CA 123.882 3.054 . . . . 75.0 113.554 173.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -52.02 -49.94 62.38 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.647 0.779 . . . . 71.01 110.588 174.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 43' ' ' ALA . . . . . 0.506 ' O ' ' HB3' ' C' ' 33' ' ' TYR . . . -71.11 -21.72 62.18 Favored 'General case' 0 C--O 1.213 -0.831 0 CA-C-N 115.143 -0.935 . . . . 71.45 110.805 -178.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 44' ' ' GLU . . . . . 0.501 ' HG2' ' HA ' ' C' ' 35' ' ' PRO . 38.0 mt-10 -76.37 -36.06 58.34 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.481 -0.563 . . . . 74.04 109.481 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -73.27 -38.73 65.84 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.756 0.822 . . . . 75.44 110.382 176.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 46' ' ' LYS . . . . . 0.499 ' O ' HG12 ' C' ' 50' ' ' ILE . 0.4 OUTLIER -63.91 -39.16 93.53 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.751 -0.659 . . . . 72.32 109.355 172.711 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -63.52 -34.53 78.0 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.08 0.952 . . . . 71.12 110.317 176.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 48' ' ' LYS . . . . . 0.468 ' HG3' ' O ' ' C' ' 44' ' ' GLU . 94.6 mttt -63.28 -43.47 97.83 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.487 -0.324 . . . . 72.04 110.28 174.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -64.11 -33.88 76.77 Favored 'General case' 0 CA--C 1.555 1.148 0 O-C-N 122.928 0.142 . . . . 72.33 110.741 176.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 50' ' ' ILE . . . . . 0.499 HG12 ' O ' ' C' ' 46' ' ' LYS . 13.2 mm -65.11 -42.48 94.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 CA-C-O 121.571 0.701 . . . . 75.43 109.441 175.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 51' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -76.31 -18.18 59.07 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 114.454 -1.248 . . . . 74.04 111.972 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 52' ' ' GLU . . . . . 0.443 ' O ' HG21 ' C' ' 56' ' ' VAL . 33.6 tt0 -74.86 -56.52 4.68 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.323 1.049 . . . . 75.54 108.611 176.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.95 -44.37 78.37 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 113.823 -1.535 . . . . 63.1 110.781 177.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -67.45 -38.6 84.73 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.33 -0.85 . . . . 75.01 111.152 176.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.32 -36.57 68.87 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 117.891 0.314 . . . . 60.54 111.197 177.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 56' ' ' VAL . . . . . 0.461 HG11 ' HZ ' ' C' ' 101' ' ' PHE . 3.0 t -94.98 -11.82 8.73 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 CA-C-N 115.902 -0.59 . . . . 72.43 111.871 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 57' ' ' LEU . . . . . 0.527 HD12 HD11 ' C' ' 22' ' ' ILE . 86.5 mt -126.37 19.86 7.44 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.98 -1.075 . . . . 75.02 113.654 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 45.9 t -80.74 -56.52 4.09 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 123.22 0.608 . . . . 75.33 112.456 178.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 59' ' ' ASP . . . . . 0.618 ' HB2' ' HD3' ' C' ' 62' ' ' LYS . 3.6 m-20 -108.68 153.6 42.16 Favored Pre-proline 0 N--CA 1.487 1.414 0 CA-C-O 118.086 -0.959 . . . . 72.03 109.904 -168.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 60' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -44.09 -43.47 12.75 Favored 'Trans proline' 0 C--N 1.397 3.106 0 C-N-CA 124.453 3.436 . . . . 73.21 114.192 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -61.89 -60.4 3.7 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.637 -0.71 . . . . 62.13 111.491 -178.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 62' ' ' LYS . . . . . 0.618 ' HD3' ' HB2' ' C' ' 59' ' ' ASP . 0.1 OUTLIER -62.67 -40.12 96.08 Favored 'General case' 0 C--O 1.248 1.01 0 O-C-N 124.244 0.965 . . . . 75.43 109.419 -173.164 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 47.2 tpt85 -51.84 -55.79 17.84 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 114.06 -1.427 . . . . 74.14 109.993 176.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -74.93 -18.07 60.46 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.333 -0.849 . . . . 74.15 112.499 -177.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 69.2 mt -62.94 -48.85 86.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 108.645 -0.872 . . . . 71.5 108.645 170.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -65.7 -43.86 87.88 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.799 -0.637 . . . . 74.31 110.681 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -61.59 -36.13 79.8 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 122.765 0.426 . . . . 73.14 111.578 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 74.4 p -83.9 -15.49 47.84 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 119.144 -0.455 . . . . 74.43 111.165 175.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -71.33 136.25 47.75 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.42 -0.956 . . . . 75.22 108.42 175.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.64 19.21 55.0 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 111.296 -0.721 . . . . 62.51 111.296 -167.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 58.6 m -145.84 -59.07 0.32 Allowed 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 103.274 -2.862 . . . . 72.34 103.274 174.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 13.3 m -79.88 137.47 36.92 Favored 'General case' 0 C--O 1.251 1.168 0 N-CA-C 104.63 -2.359 . . . . 73.35 104.63 156.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.09 -30.9 5.53 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.957 0.903 . . . . 73.23 110.15 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.45 124.86 91.4 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 115.614 -0.721 . . . . 53.23 109.219 174.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -53.31 146.1 41.97 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 122.871 2.381 . . . . 75.14 112.293 173.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -51.89 139.59 50.1 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 123.01 2.473 . . . . 71.22 112.849 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.66 138.9 86.81 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 122.743 2.295 . . . . 74.4 111.705 172.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 78' ' ' PRO . . . . . 0.525 ' HB3' ' HB2' ' C' ' 103' ' ' PRO . 18.0 Cg_endo -59.22 116.45 3.28 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 122.85 2.366 . . . . 74.44 112.581 -176.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -64.21 124.05 12.82 Favored 'Trans proline' 0 C--N 1.376 2.023 0 C-N-CA 122.324 2.016 . . . . 70.12 109.729 171.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -55.32 83.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.392 2.824 0 C-N-CA 123.751 2.967 . . . . 74.31 112.697 -175.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 161.91 -59.99 0.29 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 109.245 -1.542 . . . . 75.2 109.245 -174.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . 0.414 ' HA3' ' HG3' ' C' ' 167' ' ' GLN . . . 143.61 172.69 14.61 Favored Glycine 0 C--N 1.358 1.795 0 C-N-CA 123.069 0.366 . . . . 75.13 112.761 -177.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -90.37 119.02 30.31 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.684 -0.858 . . . . 73.4 108.684 171.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 84' ' ' ASP . . . . . 0.593 ' HB2' ' HA ' ' C' ' 164' ' ' MET . 6.6 p-10 -70.29 133.21 46.76 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.509 0.724 . . . . 75.11 111.156 -178.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 85' ' ' PHE . . . . . 0.59 ' HB3' ' HB2' ' C' ' 88' ' ' PHE . 54.8 m-85 -139.43 69.81 1.37 Allowed 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.813 0.816 . . . . 74.41 110.796 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 16.7 m -61.5 96.07 0.06 Allowed 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 114.276 -1.329 . . . . 52.42 111.442 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.11 5.11 90.34 Favored Glycine 0 C--N 1.347 1.14 0 CA-C-N 115.807 -0.633 . . . . 74.34 113.317 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 88' ' ' PHE . . . . . 0.59 ' HB2' ' HB3' ' C' ' 85' ' ' PHE . 6.3 m-85 -103.78 118.07 35.83 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 108.154 -1.054 . . . . 74.44 108.154 -179.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -83.7 73.32 10.28 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 122.2 1.0 . . . . 72.23 110.766 -176.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 90' ' ' VAL . . . . . 0.491 HG22 ' HE2' ' C' ' 97' ' ' PHE . 2.4 p -41.32 -43.28 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 C-N-CA 126.551 1.94 . . . . 54.42 113.961 175.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -61.78 -32.01 72.26 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.831 0.852 . . . . 75.25 112.049 -175.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -101.26 4.18 41.55 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.482 0.313 . . . . 75.53 111.471 -176.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 93' ' ' PHE . . . . . 0.432 ' CD2' ' HA ' ' C' ' 90' ' ' VAL . 19.4 m-30 -78.04 177.5 8.26 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 110.23 -0.285 . . . . 72.45 110.23 174.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 77.4 p -62.18 158.63 16.49 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.829 0.852 . . . . 52.11 113.269 -173.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 95' ' ' GLU . . . . . 0.463 ' O ' ' HG3' ' C' ' 99' ' ' GLU . 0.0 OUTLIER -64.25 -25.69 68.17 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 123.51 0.507 . . . . 72.35 111.008 170.98 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -62.44 -45.41 93.19 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.694 0.798 . . . . 74.24 110.413 172.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 97' ' ' PHE . . . . . 0.491 ' HE2' HG22 ' C' ' 90' ' ' VAL . 32.5 t80 -64.93 -37.17 86.74 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 115.02 -0.991 . . . . 64.25 109.432 175.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 98' ' ' GLN . . . . . 0.422 ' HB2' ' HA ' ' C' ' 95' ' ' GLU . 70.3 mt-30 -71.12 -17.27 62.57 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.021 -0.99 . . . . 71.33 112.003 178.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 99' ' ' GLU . . . . . 0.463 ' HG3' ' O ' ' C' ' 95' ' ' GLU . 40.2 mt-10 -78.22 -57.9 3.54 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 109.602 -0.518 . . . . 74.43 109.602 167.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 26.6 tp -65.94 -31.26 72.08 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 114.369 -1.287 . . . . 73.23 112.336 -166.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 101' ' ' PHE . . . . . 0.461 ' HZ ' HG11 ' C' ' 56' ' ' VAL . 76.6 m-85 -120.34 13.37 11.88 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.377 0.671 . . . . 75.04 110.885 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -43.55 -63.8 2.05 Favored Glycine 0 C--N 1.352 1.437 0 N-CA-C 116.241 1.256 . . . . 74.41 116.241 -173.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . 0.525 ' HB2' ' HB3' ' C' ' 78' ' ' PRO . 38.8 Cg_exo -58.81 -6.3 3.31 Favored 'Trans proline' 0 C--N 1.373 1.837 0 C-N-CA 123.545 2.83 . . . . 64.35 115.225 -174.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -147.28 41.02 0.97 Allowed Glycine 0 C--N 1.351 1.407 0 CA-C-O 119.634 -0.537 . . . . 73.42 112.712 176.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 38.0 mt . . . . . 0 N--CA 1.495 1.813 0 N-CA-C 116.445 2.017 . . . . 75.43 116.445 -177.76 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 116' ' ' GLY . . . . . 0.581 ' HA2' ' HA3' ' C' ' 168' ' ' GLY . . . . . . . . 0 CA--C 1.51 -0.241 0 CA-C-O 120.064 -0.298 . . . . 54.4 113.302 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 117' ' ' ARG . . . . . 0.454 ' HB2' ' HA3' ' C' ' 166' ' ' GLY . 52.1 mmm-85 -70.03 97.9 1.23 Allowed 'General case' 0 C--O 1.249 1.027 0 N-CA-C 107.314 -1.365 . . . . 74.32 107.314 174.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.09 98.12 0.56 Allowed 'General case' 0 C--O 1.242 0.659 0 CA-C-N 114.767 -1.106 . . . . 75.42 108.166 -178.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 119' ' ' LEU . . . . . . . . . . . . . 56.0 tp -93.05 98.67 11.49 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 108.134 -1.061 . . . . 75.21 108.134 -168.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.413 HH12 HG22 ' C' ' 158' ' ' VAL . 40.8 ttm-85 -100.48 114.83 28.76 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.58 -0.896 . . . . 72.31 108.58 -177.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 121' ' ' ALA . . . . . 0.488 ' HB1' HD21 ' C' ' 176' ' ' LEU . . . -115.46 130.25 56.82 Favored 'General case' 0 C--O 1.219 -0.534 0 C-N-CA 123.644 0.777 . . . . 75.44 110.366 -174.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 122' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' C' ' 177' ' ' VAL . 11.5 pt-20 -90.06 147.63 23.53 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 109.413 -0.588 . . . . 74.12 109.413 174.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 123' ' ' LEU . . . . . 0.492 ' HB2' HG13 ' B' ' 182' ' ' VAL . 2.6 pt? -143.81 123.12 7.34 Favored Pre-proline 0 N--CA 1.482 1.173 0 N-CA-C 112.68 0.622 . . . . 73.3 112.68 -176.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . 0.42 ' HA ' ' O ' ' C' ' 179' ' ' ARG . 24.3 Cg_exo -65.7 117.67 4.83 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 122.739 2.293 . . . . 72.51 110.905 170.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 125' ' ' LEU . . . . . 0.493 HD22 HG13 ' C' ' 153' ' ' VAL . 44.7 tp -145.32 153.72 41.56 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.92 0.488 . . . . 75.32 110.311 -172.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 126' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.31 166.01 10.68 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.766 0.827 . . . . 61.53 109.873 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 127' ' ' LEU . . . . . 0.44 HD22 HD12 ' C' ' 180' ' ' LEU . 94.4 mt -78.13 -36.79 47.42 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.854 0.862 . . . . 62.25 111.333 -178.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 128' ' ' GLU . . . . . 0.422 ' HG3' ' HA ' ' C' ' 215' ' ' LEU . 18.0 mp0 -70.52 -32.18 69.54 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.987 -1.006 . . . . 75.24 109.542 173.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -87.4 -8.71 56.25 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.095 0.558 . . . . 75.51 111.416 176.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -76.56 -43.19 40.04 Favored 'General case' 0 C--O 1.22 -0.461 0 N-CA-C 108.191 -1.04 . . . . 73.14 108.191 164.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 131' ' ' PHE . . . . . 0.417 ' HB2' HD11 ' C' ' 215' ' ' LEU . 77.5 t80 -60.2 -37.99 81.94 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.781 1.233 . . . . 75.55 111.234 174.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 132' ' ' HIS . . . . . . . . . . . . . 65.7 m170 -78.68 -69.96 0.53 Allowed 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.831 -0.622 . . . . 70.15 110.669 177.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 49.46 -103.81 0.09 OUTLIER Glycine 0 C--N 1.353 1.52 0 O-C-N 124.047 0.842 . . . . 65.31 112.986 -178.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.98 -153.8 34.67 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 114.525 0.57 . . . . 73.12 114.525 170.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -93.42 93.86 8.39 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.152 -1.055 . . . . 73.03 108.152 -167.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 136' ' ' ARG . . . . . 0.624 ' HB3' ' HB2' ' B' ' 181' ' ' LEU . 0.9 OUTLIER -142.19 147.45 36.61 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 122.229 -0.295 . . . . 72.12 110.979 -167.977 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 137' ' ' VAL . . . . . 0.599 ' HA ' ' HA ' ' C' ' 146' ' ' SER . 7.7 p -95.07 129.99 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-O 121.493 0.664 . . . . 73.11 111.364 -177.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 138' ' ' VAL . . . . . . . . . . . . . 3.0 p -114.84 140.72 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.612 1.165 . . . . 72.14 108.953 178.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 139' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -108.0 111.59 23.74 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 107.8 -1.185 . . . . 74.31 107.8 172.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 140' ' ' VAL . . . . . 0.414 HG22 ' HB2' ' C' ' 121' ' ' ALA . 2.7 p -130.63 128.15 62.94 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 C-N-CA 123.896 0.878 . . . . 73.25 109.215 -179.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 65.37 33.36 9.03 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.803 0.841 . . . . 65.0 112.388 174.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 78.7 12.5 84.15 Favored Glycine 0 C--N 1.345 1.044 0 CA-C-N 116.399 -0.364 . . . . 52.4 112.302 -176.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 143' ' ' ARG . . . . . . . . . . . . . 29.1 tpt180 -126.32 100.83 6.45 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.445 0.698 . . . . 75.05 109.991 -168.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -83.99 129.33 34.92 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.181 -0.918 . . . . 71.51 109.225 176.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 145' ' ' VAL . . . . . . . . . . . . . 3.7 p -166.34 140.26 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 123.822 0.849 . . . . 75.03 109.854 -174.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 146' ' ' SER . . . . . 0.599 ' HA ' ' HA ' ' C' ' 137' ' ' VAL . 56.8 p -100.7 146.05 27.69 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.075 0.55 . . . . 73.22 111.998 -174.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 8.9 p -151.67 150.33 13.22 Favored 'Isoleucine or valine' 0 C--O 1.242 0.711 0 CA-C-N 115.716 -0.674 . . . . 72.53 109.838 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 20.3 ttt180 -105.36 94.67 5.34 Favored 'General case' 0 C--N 1.347 0.482 0 N-CA-C 107.971 -1.122 . . . . 74.22 107.971 168.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 149' ' ' ILE . . . . . 0.417 HD13 HD12 ' C' ' 159' ' ' ILE . 37.8 pt -75.97 146.68 79.44 Favored Pre-proline 0 CA--C 1.55 0.956 0 CA-C-O 118.603 -0.713 . . . . 74.42 109.513 176.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.37 115.75 2.8 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 122.408 2.072 . . . . 61.44 111.619 177.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -51.72 111.69 0.65 Allowed 'Trans proline' 0 C--N 1.384 2.424 0 C-N-CA 123.633 2.889 . . . . 73.2 114.081 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 152' ' ' GLY . . . . . . . . . . . . . . . 139.77 136.28 3.35 Favored Glycine 0 C--N 1.35 1.324 0 CA-C-N 115.373 -0.83 . . . . 63.11 113.175 -174.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 153' ' ' VAL . . . . . 0.493 HG13 HD22 ' C' ' 125' ' ' LEU . 1.7 p -160.38 160.72 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.777 0 CA-C-N 117.192 0.496 . . . . 74.01 112.2 177.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 154' ' ' ARG . . . . . 0.47 ' HD3' ' O ' ' C' ' 188' ' ' LEU . 43.9 ttp180 -128.2 139.68 52.33 Favored 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 125.052 1.341 . . . . 75.32 109.225 177.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 155' ' ' GLU . . . . . 0.59 ' HB2' HD13 ' C' ' 180' ' ' LEU . 21.8 tp10 -40.51 123.53 1.83 Allowed 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 125.464 1.506 . . . . 74.51 113.9 176.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 81.09 -13.46 32.02 Favored Glycine 0 C--N 1.353 1.486 0 CA-C-N 115.054 -0.976 . . . . 75.21 113.951 176.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 157' ' ' SER . . . . . . . . . . . . . 17.1 m -83.56 166.28 18.36 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.226 0.61 . . . . 75.43 111.203 -174.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 158' ' ' VAL . . . . . 0.524 HG21 HG23 ' C' ' 177' ' ' VAL . 21.5 t -111.66 136.44 47.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 CA-C-N 115.245 -0.889 . . . . 72.31 110.884 -163.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 159' ' ' ILE . . . . . 0.683 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 27.2 mt -105.99 122.13 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 107.136 -1.431 . . . . 72.31 107.136 172.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 16.8 ttm180 -83.8 141.22 31.54 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 117.947 0.339 . . . . 75.13 110.151 178.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 161' ' ' VAL . . . . . 0.491 ' HB ' ' HB3' ' C' ' 174' ' ' LEU . 39.8 t -128.74 97.65 26.74 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 107.24 -1.393 . . . . 75.24 107.24 164.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -62.92 127.67 21.05 Favored 'Trans proline' 0 C--N 1.377 2.038 0 C-N-CA 122.92 2.413 . . . . 75.23 113.489 -172.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 163' ' ' GLY . . . . . 0.641 ' H ' ' HB3' ' C' ' 173' ' ' ASP . . . 84.67 -18.39 25.61 Favored Glycine 0 CA--C 1.541 1.665 0 N-CA-C 115.135 0.814 . . . . 53.54 115.135 177.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 164' ' ' MET . . . . . 0.593 ' HA ' ' HB2' ' C' ' 84' ' ' ASP . 31.3 ttp -94.77 38.71 1.11 Allowed 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 117.94 0.87 . . . . 73.35 112.317 -167.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . -109.02 -147.01 11.96 Favored Glycine 0 N--CA 1.473 1.132 0 CA-C-N 115.718 -0.674 . . . . 73.32 112.649 174.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 166' ' ' GLY . . . . . 0.454 ' HA3' ' HB2' ' C' ' 117' ' ' ARG . . . -88.88 -177.22 46.53 Favored Glycine 0 C--N 1.351 1.405 0 CA-C-O 119.868 -0.407 . . . . 75.44 112.992 -179.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 167' ' ' GLN . . . . . 0.414 ' HG3' ' HA3' ' C' ' 82' ' ' GLY . 28.4 mt-30 -49.97 129.21 20.16 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.168 1.387 . . . . 74.2 112.894 -173.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 168' ' ' GLY . . . . . 0.581 ' HA3' ' HA2' ' C' ' 116' ' ' GLY . . . 165.71 158.07 10.47 Favored Glycine 0 C--N 1.351 1.412 0 N-CA-C 114.984 0.754 . . . . 13.44 114.984 173.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 169' ' ' ASN . . . . . 0.534 ' HB3' ' HD3' ' C' ' 170' ' ' PRO . 5.0 t30 -90.37 -55.43 0.28 Allowed Pre-proline 0 CA--C 1.557 1.213 0 CA-C-N 114.166 -1.017 . . . . 62.44 110.298 165.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 170' ' ' PRO . . . . . 0.534 ' HD3' ' HB3' ' C' ' 169' ' ' ASN . 20.9 Cg_exo -64.44 118.52 5.48 Favored 'Trans proline' 0 C--N 1.399 3.221 0 CA-C-N 120.883 1.351 . . . . 73.55 109.029 175.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 171' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -46.17 107.0 0.1 Allowed 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 123.335 2.69 . . . . 74.02 114.073 -167.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -82.62 -48.15 5.67 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-N 115.154 -0.93 . . . . 74.42 111.154 175.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 173' ' ' ASP . . . . . 0.641 ' HB3' ' H ' ' C' ' 163' ' ' GLY . 2.4 p30 50.84 173.11 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 115.709 1.744 . . . . 74.51 115.709 172.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 174' ' ' LEU . . . . . 0.491 ' HB3' ' HB ' ' C' ' 161' ' ' VAL . 49.5 tp -100.73 132.87 45.91 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 115.488 -0.778 . . . . 75.22 109.759 -177.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 90.0 mt -127.54 89.31 2.93 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.924 0.869 . . . . 72.15 110.316 -173.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 176' ' ' LEU . . . . . 0.683 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 96.0 mt -76.36 97.26 4.2 Favored 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 114.262 -1.336 . . . . 74.33 111.945 -175.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 177' ' ' VAL . . . . . 0.524 HG23 HG21 ' C' ' 158' ' ' VAL . 71.5 t -83.56 109.94 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 108.334 -0.987 . . . . 75.23 108.334 174.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 178' ' ' VAL . . . . . 0.408 ' HA ' HD22 ' C' ' 123' ' ' LEU . 8.2 p -75.14 136.03 25.96 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 CA-C-O 121.919 0.866 . . . . 74.01 111.707 -173.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 179' ' ' ARG . . . . . 0.42 ' O ' ' HA ' ' C' ' 124' ' ' PRO . 8.5 mmm180 -109.76 96.1 6.03 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 105.563 -2.014 . . . . 74.42 105.563 171.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 180' ' ' LEU . . . . . 0.59 HD13 ' HB2' ' C' ' 155' ' ' GLU . 77.0 mt -68.97 148.52 50.02 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-O 121.26 0.552 . . . . 73.43 111.046 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 181' ' ' LEU . . . . . . . . . . . . . 56.8 mt -68.97 171.49 6.37 Favored Pre-proline 0 N--CA 1.484 1.235 0 CA-C-N 114.217 -1.356 . . . . 74.24 110.494 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -60.98 67.37 0.09 OUTLIER 'Trans proline' 0 C--N 1.384 2.423 0 C-N-CA 122.543 2.162 . . . . 73.32 111.855 166.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 183' ' ' HIS . . . . . 0.578 ' H ' ' HD3' ' C' ' 184' ' ' PRO . 71.1 t60 -170.25 27.39 0.01 OUTLIER Pre-proline 0 CA--C 1.582 2.195 0 C-N-CA 126.726 2.01 . . . . 72.0 109.894 -177.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 184' ' ' PRO . . . . . 0.578 ' HD3' ' H ' ' C' ' 183' ' ' HIS . 12.2 Cg_endo -84.74 68.22 6.2 Favored 'Trans proline' 0 C--N 1.405 3.522 0 C-N-CA 122.542 2.161 . . . . 74.25 110.513 -173.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 185' ' ' VAL . . . . . 0.466 HG13 ' HB1' ' C' ' 195' ' ' ALA . 5.9 t -90.4 -40.95 13.21 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.573 0 N-CA-C 107.658 -1.238 . . . . 72.23 107.658 -172.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 186' ' ' PHE . . . . . 0.416 ' HB2' HD12 ' C' ' 127' ' ' LEU . 74.5 m-85 -99.24 104.56 16.5 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.687 0.795 . . . . 61.44 109.825 -172.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 187' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -94.41 113.3 25.15 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.292 1.437 . . . . 75.14 108.465 -177.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 188' ' ' LEU . . . . . 0.47 ' O ' ' HD3' ' C' ' 154' ' ' ARG . 64.7 tp -81.93 146.99 29.5 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 113.233 0.827 . . . . 74.14 113.233 -171.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -145.59 101.88 3.62 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.033 1.333 . . . . 73.21 107.55 164.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 74.73 -102.25 1.39 Allowed Glycine 0 C--N 1.346 1.115 0 N-CA-C 112.159 -0.376 . . . . 74.2 112.159 -175.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 191' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -112.24 -13.68 13.45 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.493 0.717 . . . . 75.25 110.363 170.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -87.72 141.06 28.89 Favored 'General case' 0 C--O 1.213 -0.835 0 C-N-CA 123.689 0.796 . . . . 65.13 110.685 -170.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 193' ' ' LEU . . . . . . . . . . . . . 85.6 mt -106.58 167.56 9.77 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 122.899 0.48 . . . . 65.15 110.871 -176.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 194' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -143.2 105.3 4.4 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.567 -0.531 . . . . 75.43 109.567 171.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 195' ' ' ALA . . . . . 0.49 ' HB2' HD22 ' C' ' 251' ' ' LEU . . . -119.52 -176.35 3.14 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.607 1.163 . . . . 65.11 109.324 177.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 30.1 m -123.78 133.58 53.8 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 109.306 -0.628 . . . . 53.42 109.306 176.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 197' ' ' LEU . . . . . 0.452 HD11 ' HB3' ' C' ' 212' ' ' ALA . 32.0 tp -107.2 122.73 47.11 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.403 0.681 . . . . 73.5 109.567 -178.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -82.56 98.16 8.83 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 108.566 -0.901 . . . . 64.33 108.566 176.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 199' ' ' VAL . . . . . . . . . . . . . 60.3 t -107.77 121.42 44.11 Favored Pre-proline 0 N--CA 1.478 0.964 0 C-N-CA 123.296 0.639 . . . . 73.12 109.335 -175.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 200' ' ' PRO . . . . . 0.541 ' HG2' HD11 ' C' ' 203' ' ' ILE . 15.9 Cg_exo -63.23 140.69 78.92 Favored 'Trans proline' 0 C--N 1.367 1.541 0 C-N-CA 121.839 1.693 . . . . 73.11 111.181 172.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 201' ' ' ALA . . . . . 0.458 ' HB1' ' HH2' ' C' ' 269' ' ' TRP . . . -53.5 -46.43 98.13 Favored Pre-proline 0 CA--C 1.554 1.107 0 N-CA-C 113.49 0.922 . . . . 74.35 113.49 178.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 202' ' ' PRO . . . . . 0.497 ' HB2' ' HA ' ' A' ' 273' ' ' ALA . 39.2 Cg_endo -62.06 -42.64 28.76 Favored 'Trans proline' 0 C--N 1.384 2.407 0 CA-C-N 120.722 1.294 . . . . 63.15 111.946 178.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 203' ' ' ILE . . . . . 0.541 HD11 ' HG2' ' C' ' 200' ' ' PRO . 24.8 mt -64.48 -34.68 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 122.839 0.456 . . . . 74.02 110.958 177.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 204' ' ' ALA . . . . . 0.489 ' HA ' HG11 ' C' ' 223' ' ' VAL . . . -68.13 -35.29 77.87 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.687 0.795 . . . . 75.02 111.913 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 205' ' ' VAL . . . . . 0.526 ' HA ' ' HA ' ' C' ' 226' ' ' ARG . 95.6 t -77.96 -42.09 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-N 115.836 -0.62 . . . . 74.52 112.498 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 206' ' ' VAL . . . . . 0.465 HG21 ' HE3' ' A' ' 270' ' ' LYS . 11.7 p -76.6 -32.73 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 CA-C-O 121.028 0.442 . . . . 74.12 110.009 -177.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 84.3 49.95 4.48 Favored Glycine 0 N--CA 1.44 -1.062 0 CA-C-N 115.095 -0.957 . . . . 63.21 111.846 -172.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -84.37 -136.92 3.44 Favored Glycine 0 C--N 1.347 1.187 0 CA-C-O 119.62 -0.545 . . . . 51.32 112.03 177.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 209' ' ' LYS . . . . . 0.501 ' HB3' ' HG2' ' C' ' 220' ' ' GLU . 9.2 mtmp? -139.02 140.89 38.27 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 117.649 0.724 . . . . 72.44 112.83 -178.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 210' ' ' VAL . . . . . . . . . . . . . 57.5 t -132.78 129.48 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 124.953 1.301 . . . . 71.52 108.614 178.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 211' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -80.28 125.57 30.04 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 118.16 0.436 . . . . 75.53 111.505 -177.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 212' ' ' ALA . . . . . 0.452 ' HB3' HD11 ' C' ' 197' ' ' LEU . . . -103.12 120.08 40.04 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 108.038 -1.097 . . . . 74.43 108.038 165.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 213' ' ' MET . . . . . . . . . . . . . 5.4 tmm? -79.12 108.53 12.68 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 108.331 -0.989 . . . . 63.12 108.331 -177.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.93 171.85 7.1 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 118.128 0.422 . . . . 72.34 110.772 -173.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 215' ' ' LEU . . . . . 0.422 ' HA ' ' HG3' ' C' ' 128' ' ' GLU . 25.2 mt -58.41 -37.84 76.15 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 125.302 1.441 . . . . 75.24 113.49 -165.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 216' ' ' GLU . . . . . 0.45 ' HG2' HH11 ' C' ' 246' ' ' ARG . 0.0 OUTLIER -110.1 -6.32 15.14 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.057 0.943 . . . . 71.0 111.483 -174.579 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 169.42 156.23 10.62 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-O 119.761 -0.466 . . . . 74.41 113.303 -177.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.74 111.17 3.08 Favored 'Trans proline' 0 CA--C 1.557 1.656 0 C-N-CA 122.933 2.422 . . . . 64.03 112.403 178.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 219' ' ' VAL . . . . . 0.514 ' HB ' ' HE3' ' C' ' 238' ' ' LYS . 9.0 p -84.21 140.16 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 O-C-N 122.07 -0.394 . . . . 52.53 110.019 176.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 220' ' ' GLU . . . . . 0.501 ' HG2' ' HB3' ' C' ' 209' ' ' LYS . 25.5 tt0 -101.23 108.02 19.56 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 107.657 -1.238 . . . . 72.32 107.657 176.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 221' ' ' VAL . . . . . 0.48 ' HA ' ' HB1' ' B' ' 239' ' ' ALA . 42.5 t -77.07 119.48 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 124.055 0.942 . . . . 74.03 111.897 -174.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 222' ' ' ALA . . . . . 0.76 ' HB3' ' HE2' ' B' ' 245' ' ' LYS . . . -80.69 112.71 18.31 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.537 0.735 . . . . 73.3 110.277 169.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 223' ' ' VAL . . . . . 0.489 HG11 ' HA ' ' C' ' 204' ' ' ALA . 63.8 t -89.19 138.89 28.65 Favored Pre-proline 0 CA--C 1.559 1.306 0 C-N-CA 124.719 1.208 . . . . 73.11 110.028 -178.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 224' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.62 154.38 64.36 Favored 'Trans proline' 0 C--N 1.389 2.705 0 C-N-CA 122.501 2.134 . . . . 73.11 112.147 172.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.31 114.21 1.83 Allowed 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 122.768 2.312 . . . . 74.4 111.906 174.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 226' ' ' ARG . . . . . 0.568 ' HB3' ' HA ' ' A' ' 259' ' ' GLU . 0.0 OUTLIER 70.69 97.91 0.07 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.879 1.672 . . . . 71.5 112.406 -178.186 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 227' ' ' THR . . . . . 0.441 HG21 HG12 ' C' ' 253' ' ' VAL . 50.5 m -120.29 129.28 53.95 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 124.726 1.21 . . . . 73.3 111.562 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 228' ' ' GLN . . . . . 0.43 ' NE2' ' HB2' ' A' ' 259' ' ' GLU . 27.0 mp0 -95.14 156.43 16.32 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 124.247 1.019 . . . . 74.32 111.635 175.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -75.72 131.32 39.77 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 114.84 -1.073 . . . . 65.31 109.742 177.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 110.95 -18.96 25.9 Favored Glycine 0 C--N 1.339 0.697 0 CA-C-N 115.711 -0.677 . . . . 62.04 112.085 -170.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 231' ' ' ARG . . . . . . . . . . . . . 56.4 mtt180 -62.35 161.86 10.9 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 116.754 0.277 . . . . 75.03 110.318 169.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 232' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -137.65 138.91 39.93 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.042 0.449 . . . . 74.05 110.76 -174.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 233' ' ' LEU . . . . . 0.643 ' O ' ' HA ' ' C' ' 250' ' ' TYR . 6.1 mp -97.11 153.01 18.22 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 114.366 -1.288 . . . . 74.22 109.431 176.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 17.3 ptt180 -130.78 91.33 3.05 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 107.855 -1.165 . . . . 72.34 107.855 162.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 235' ' ' LEU . . . . . 0.516 HD12 HD23 ' C' ' 249' ' ' LEU . 17.1 mt -71.4 106.41 3.9 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 114.29 -1.323 . . . . 74.34 109.061 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 26.2 mmmt -69.82 115.25 8.83 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 113.997 -1.456 . . . . 73.41 110.872 -171.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 81.39 33.15 29.18 Favored Glycine 0 C--N 1.346 1.1 0 CA-C-N 115.799 -0.637 . . . . 71.42 112.955 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 238' ' ' LYS . . . . . 0.514 ' HE3' ' HB ' ' C' ' 219' ' ' VAL . 64.6 mmtt -125.77 24.41 7.11 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.723 0.809 . . . . 75.11 111.364 177.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -102.32 -156.1 25.77 Favored Glycine 0 C--N 1.344 1.007 0 N-CA-C 111.652 -0.579 . . . . 75.2 111.652 171.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 240' ' ' PHE . . . . . 0.433 ' HD2' HD12 ' C' ' 188' ' ' LEU . 56.8 m-85 -81.67 153.38 70.49 Favored Pre-proline 0 CA--C 1.553 1.086 0 C-N-CA 122.868 0.467 . . . . 75.14 109.915 175.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 241' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -66.95 136.05 39.93 Favored 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 123.746 2.964 . . . . 71.53 114.806 -168.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -134.9 173.11 21.71 Favored Glycine 0 C--N 1.351 1.416 0 CA-C-N 115.487 -0.779 . . . . 70.14 112.869 175.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -60.91 -42.8 34.76 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 123.899 3.066 . . . . 71.42 112.796 -174.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -83.53 -17.36 42.1 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.725 0.81 . . . . 71.42 110.698 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 143.92 -179.19 21.46 Favored Glycine 0 C--N 1.346 1.108 0 CA-C-N 115.621 -0.718 . . . . 63.24 111.423 -176.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 246' ' ' ARG . . . . . 0.45 HH11 ' HG2' ' C' ' 216' ' ' GLU . 80.8 mtm180 -71.34 159.52 34.42 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.298 0.639 . . . . 71.32 111.192 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -70.42 -164.29 4.99 Favored Glycine 0 C--N 1.353 1.504 0 CA-C-N 116.074 -0.512 . . . . 63.23 113.463 178.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -117.17 124.46 49.18 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 108.803 -0.814 . . . . 73.54 108.803 -173.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 249' ' ' LEU . . . . . 0.516 HD23 HD12 ' C' ' 235' ' ' LEU . 11.0 tp -79.58 119.99 23.31 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.902 -0.777 . . . . 74.23 108.902 177.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 250' ' ' TYR . . . . . 0.643 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 20.0 m-85 -96.24 111.93 23.83 Favored 'General case' 0 C--O 1.221 -0.419 0 N-CA-C 108.205 -1.035 . . . . 71.43 108.205 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 251' ' ' LEU . . . . . 0.518 HD11 HD21 ' C' ' 233' ' ' LEU . 77.1 mt -105.32 123.02 47.16 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 109.218 -0.66 . . . . 72.0 109.218 -177.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -81.32 120.27 24.72 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.273 -1.01 . . . . 75.41 108.273 173.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 253' ' ' VAL . . . . . 0.441 HG12 HG21 ' C' ' 227' ' ' THR . 60.3 t -72.29 128.93 35.66 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 C-N-CA 123.018 0.527 . . . . 73.5 110.954 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 254' ' ' ARG . . . . . . . . . . . . . 39.4 mtm105 -112.38 129.77 56.2 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 107.462 -1.31 . . . . 75.13 107.462 162.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 255' ' ' ILE . . . . . 0.528 ' O ' ' HB ' ' A' ' 255' ' ' ILE . 37.9 mm -94.65 114.21 30.75 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.775 0 N-CA-C 106.14 -1.8 . . . . 75.24 106.14 173.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 256' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' C' ' 200' ' ' PRO . 0.1 OUTLIER -132.56 155.28 48.94 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 123.991 0.916 . . . . 70.25 108.93 -170.642 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 2.7 pp -124.0 151.07 64.58 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 109.086 -0.709 . . . . 75.21 109.086 -175.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 258' ' ' PRO . . . . . 0.42 ' HG3' ' HE2' ' A' ' 276' ' ' TYR . 68.9 Cg_endo -75.04 8.88 2.23 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.45 2.1 . . . . 74.41 113.025 -171.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 61.37 -79.25 0.02 OUTLIER 'General case' 0 C--N 1.359 0.987 0 C-N-CA 125.718 1.607 . . . . 72.3 110.268 -170.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 2.6 ptp85 -72.95 142.63 47.82 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.396 1.478 . . . . 73.41 110.671 -178.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 261' ' ' LEU . . . . . 0.461 HD22 ' HB3' ' C' ' 265' ' ' GLU . 85.6 mt -139.04 168.25 20.25 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.771 0.829 . . . . 74.53 110.579 -174.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 49.4 p -86.53 162.94 43.78 Favored Pre-proline 0 CA--C 1.553 1.063 0 N-CA-C 108.401 -0.963 . . . . 61.23 108.401 168.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -50.49 -40.99 53.85 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 122.738 2.292 . . . . 74.2 113.107 173.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -60.44 -59.21 5.77 Favored 'General case' 0 C--O 1.262 1.73 0 C-N-CA 124.011 0.924 . . . . 71.04 110.846 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 265' ' ' GLU . . . . . 0.461 ' HB3' HD22 ' C' ' 261' ' ' LEU . 49.3 mm-40 -51.04 -63.5 1.11 Allowed 'General case' 0 C--N 1.353 0.724 0 CA-C-N 114.416 -1.265 . . . . 71.03 110.538 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 266' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -55.58 -38.68 69.7 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.365 1.066 . . . . 73.1 111.58 -173.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -58.01 -51.31 70.18 Favored 'General case' 0 C--O 1.248 1.008 0 O-C-N 123.606 0.566 . . . . 71.12 111.427 177.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 268' ' ' LEU . . . . . 0.621 ' HB2' HD23 ' A' ' 272' ' ' LEU . 10.6 mp -64.68 -39.8 94.29 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 119.288 -0.387 . . . . 70.11 111.332 178.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 269' ' ' TRP . . . . . 0.458 ' HH2' ' HB1' ' C' ' 201' ' ' ALA . 86.0 m95 -58.88 -36.64 74.98 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 122.854 0.462 . . . . 63.11 111.683 176.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 270' ' ' LYS . . . . . 0.506 ' HZ3' ' HB3' ' C' ' 270' ' ' LYS . 9.5 mtpm? -72.71 -34.96 67.47 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.244 0.618 . . . . 75.43 111.352 178.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 271' ' ' LYS . . . . . 0.401 ' HA ' ' HD3' ' C' ' 271' ' ' LYS . 69.3 mmtt -68.17 -32.83 73.36 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 123.108 0.255 . . . . 75.33 111.627 175.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 272' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' C' ' 268' ' ' LEU . 68.6 mt -67.89 -41.56 82.57 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.202 0.601 . . . . 74.33 109.622 173.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -62.68 -38.61 91.03 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 115.732 -0.667 . . . . 43.22 111.227 176.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -66.22 -37.51 85.71 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.781 0.832 . . . . 63.21 110.756 176.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -62.9 -35.25 79.43 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.891 0.476 . . . . 70.04 111.046 173.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 276' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -69.97 -45.76 66.7 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.559 -0.746 . . . . 75.52 112.179 175.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -63.84 -33.98 76.89 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-O 121.066 0.46 . . . . 65.52 109.801 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -63.29 -17.21 62.28 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 114.882 -1.054 . . . . 72.22 112.659 178.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 279' ' ' ARG . . . . . . . . . . . . . 70.3 mtm180 -73.21 -24.46 60.52 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 122.486 0.314 . . . . 75.11 111.298 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.558 1.255 0 CA-C-O 118.459 -0.781 . . . . 75.14 109.771 -176.481 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.5 tmmm? . . . . . 0 N--CA 1.48 1.057 0 N-CA-C 112.63 0.604 . . . . 64.14 112.63 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.616 ' HB3' HD13 ' A' ' 10' ' ' ILE . 48.8 mtpt -97.92 109.32 22.1 Favored 'General case' 0 C--O 1.244 0.782 0 N-CA-C 107.882 -1.155 . . . . 74.32 107.882 172.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.522 ' HA ' ' OH ' ' A' ' 66' ' ' TYR . 24.9 t70 -70.98 109.33 5.03 Favored 'General case' 0 C--N 1.351 0.657 0 N-CA-C 108.101 -1.074 . . . . 62.43 108.101 173.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -65.65 -32.23 73.68 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-N 115.114 -0.948 . . . . 73.34 111.998 -170.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -63.25 -43.49 97.87 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 109.846 -0.427 . . . . 73.33 109.846 173.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.4 -45.86 90.31 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.52 0.728 . . . . 70.01 111.337 178.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.616 HD13 ' HB3' ' A' ' 5' ' ' LYS . 66.1 mt -56.09 -45.02 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 O-C-N 123.903 0.752 . . . . 74.23 110.613 177.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.526 HD12 HG22 ' A' ' 22' ' ' ILE . 69.1 mt -69.74 -23.19 63.35 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 115.644 -0.707 . . . . 73.11 112.207 176.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.78 44.4 7.24 Favored Glycine 0 C--N 1.349 1.253 0 O-C-N 123.182 0.301 . . . . 73.42 112.976 -176.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.0 m -138.17 152.62 72.07 Favored Pre-proline 0 N--CA 1.486 1.326 0 C-N-CA 124.658 1.183 . . . . 72.52 109.839 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -59.26 157.3 30.99 Favored 'Trans proline' 0 C--N 1.384 2.397 0 C-N-CA 122.799 2.333 . . . . 50.12 112.366 177.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 10.9 mtm105 -72.68 8.71 1.35 Allowed 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 113.676 0.991 . . . . 75.43 113.676 -167.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -129.45 14.66 6.06 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.073 0.949 . . . . 71.2 109.474 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.76 131.78 51.79 Favored 'General case' 0 C--N 1.35 0.61 0 C-N-CA 124.273 1.029 . . . . 74.14 111.361 -176.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.1 p -71.98 162.63 29.17 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.568 0.747 . . . . 75.03 110.594 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 8.6 tm0? -55.23 -31.57 61.6 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.096 0.958 . . . . 71.11 110.301 178.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -62.93 -51.11 68.21 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 125.033 1.333 . . . . 72.43 110.481 177.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -71.97 -32.36 67.18 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.613 0.765 . . . . 71.14 111.361 -178.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.557 HD13 ' HB3' ' A' ' 57' ' ' LEU . 61.4 mt -70.66 -30.71 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.269 1.427 . . . . 73.31 110.116 176.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.425 ' HG2' ' HE2' ' A' ' 27' ' ' LYS . 13.7 ttmm -69.74 -44.82 69.46 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.745 0.818 . . . . 75.22 109.114 174.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 71.4 mtp180 -59.62 -42.06 91.81 Favored 'General case' 0 N--CA 1.485 1.275 0 O-C-N 123.981 0.801 . . . . 73.12 111.008 176.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.25 -39.22 75.13 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.783 0.833 . . . . 72.43 111.297 -178.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -60.44 -54.78 41.46 Favored 'General case' 0 C--O 1.216 -0.662 0 CA-C-N 114.917 -1.038 . . . . 73.1 109.361 176.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.425 ' HE2' ' HG2' ' A' ' 23' ' ' LYS . 68.4 mttm -56.75 -42.17 78.86 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.892 0.877 . . . . 74.22 110.964 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -55.7 -55.96 26.03 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.672 0.789 . . . . 75.52 110.855 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.506 ' HB3' HD11 ' A' ' 50' ' ' ILE . 95.3 mt -79.25 -15.17 58.41 Favored 'General case' 0 CA--C 1.555 1.137 0 CA-C-N 115.471 -0.786 . . . . 75.12 111.579 -176.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.66 -20.5 33.46 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.983 0.913 . . . . 71.54 110.985 175.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 28.3 mtm180 -96.55 -25.36 15.65 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.591 0.757 . . . . 72.33 110.164 172.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -69.07 -65.75 0.67 Allowed 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 107.964 -1.124 . . . . 73.31 107.964 176.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -92.89 29.91 1.71 Allowed 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.061 0.544 . . . . 72.41 110.896 -177.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 -52.71 99.91 0.22 Allowed Pre-proline 0 N--CA 1.486 1.366 0 C-N-CA 125.52 1.528 . . . . 73.54 112.365 -170.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -60.95 -17.88 54.05 Favored 'Trans proline' 0 C--N 1.384 2.415 0 C-N-CA 123.336 2.691 . . . . 75.51 113.914 -171.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -66.98 -39.17 87.12 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.447 0.699 . . . . 73.23 111.862 176.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 82.2 t -102.28 -52.09 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 123.174 0.589 . . . . 73.25 109.624 -178.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -96.71 87.51 4.36 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 124.166 0.986 . . . . 64.12 109.568 -178.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -84.39 49.19 1.63 Allowed 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 115.439 -0.8 . . . . 73.11 110.653 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 74.0 m -91.94 115.62 64.96 Favored Pre-proline 0 N--CA 1.471 0.59 0 CA-C-O 118.054 -0.974 . . . . 71.24 108.548 176.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.406 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 85.2 Cg_exo -44.77 -49.6 9.34 Favored 'Trans proline' 0 C--N 1.384 2.439 0 C-N-CA 123.756 2.971 . . . . 73.53 113.295 -176.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -54.8 -43.32 72.78 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.963 0.905 . . . . 64.43 111.312 178.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.94 -27.68 64.95 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.513 -0.767 . . . . 73.42 110.926 -177.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.443 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 50.1 mt-10 -84.0 -29.98 26.54 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.173 0.589 . . . . 63.35 110.47 -175.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.406 ' HG3' ' O ' ' A' ' 41' ' ' PRO . 44.6 mt-10 -77.54 -38.45 48.67 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.186 0.595 . . . . 62.44 109.991 177.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -66.14 -34.24 77.59 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.855 -0.611 . . . . 74.03 109.766 170.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.784 ' HA ' HD12 ' A' ' 50' ' ' ILE . 88.0 t80 -62.04 -37.22 84.11 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 122.879 0.472 . . . . 73.32 110.475 172.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' A' ' 44' ' ' GLU . 97.7 mttt -64.89 -35.12 80.13 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.723 0.409 . . . . 75.14 111.327 174.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -69.88 -29.9 67.22 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 122.421 0.288 . . . . 71.44 111.753 175.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.784 HD12 ' HA ' ' A' ' 47' ' ' PHE . 47.3 mt -70.43 -40.91 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 123.405 0.682 . . . . 74.43 109.794 173.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.418 ' HB3' ' HD1' ' A' ' 88' ' ' PHE . 3.2 m-20 -74.25 -20.15 60.26 Favored 'General case' 0 C--O 1.21 -0.99 0 C-N-CA 123.747 0.819 . . . . 73.43 110.934 176.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -74.92 -48.59 23.82 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.682 1.193 . . . . 75.34 109.564 174.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.25 -47.18 87.22 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 113.674 -1.603 . . . . 65.45 110.691 177.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 45.4 t80 -73.92 -23.6 59.56 Favored 'General case' 0 C--O 1.216 -0.661 0 CA-C-N 114.9 -1.045 . . . . 73.53 110.249 176.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.445 ' HB1' ' HD2' ' A' ' 85' ' ' PHE . . . -56.35 -50.82 70.4 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 118.357 0.526 . . . . 72.52 110.272 172.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.403 HG11 ' HZ ' ' A' ' 101' ' ' PHE . 38.3 t -64.46 -51.77 63.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 O-C-N 124.588 1.18 . . . . 74.52 110.409 177.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.557 ' HB3' HD13 ' A' ' 22' ' ' ILE . 45.1 mt -94.05 13.07 24.15 Favored 'General case' 0 CA--C 1.565 1.555 0 N-CA-C 113.095 0.776 . . . . 74.35 113.095 -166.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.1 t -66.77 -63.05 1.15 Allowed 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 123.668 0.787 . . . . 74.34 112.135 175.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.61 ' HB2' ' HD3' ' A' ' 62' ' ' LYS . 9.0 m-20 -100.64 145.53 30.49 Favored Pre-proline 0 N--CA 1.475 0.816 0 CA-C-O 118.478 -0.773 . . . . 74.34 110.046 -173.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.413 ' O ' ' HG2' ' A' ' 64' ' ' ARG . 19.8 Cg_endo -56.65 -32.25 89.96 Favored 'Trans proline' 0 C--N 1.384 2.404 0 C-N-CA 123.427 2.751 . . . . 72.41 113.294 -175.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -66.12 -47.67 73.37 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.707 0.803 . . . . 72.3 111.855 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.61 ' HD3' ' HB2' ' A' ' 59' ' ' ASP . 32.1 mtpt -74.59 -33.49 62.65 Favored 'General case' 0 C--O 1.252 1.209 0 C-N-CA 123.958 0.903 . . . . 74.54 110.641 -176.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 22.2 tpt85 -52.9 -51.39 61.35 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 113.922 -1.49 . . . . 74.11 108.827 167.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.413 ' HG2' ' O ' ' A' ' 60' ' ' PRO . 4.7 mmp_? -59.7 -38.97 83.07 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 123.802 0.689 . . . . 74.25 111.644 176.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.568 HG22 ' HD2' ' A' ' 76' ' ' PRO . 87.2 mt -54.96 -45.34 76.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 C-N-CA 122.681 0.392 . . . . 74.41 110.512 178.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.522 ' OH ' ' HA ' ' A' ' 6' ' ' ASP . 5.2 t80 -65.44 -49.22 69.96 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 120.77 -0.372 . . . . 75.4 110.813 175.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -57.8 -35.52 70.94 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.347 0.659 . . . . 64.04 112.062 -176.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 61.0 p -75.82 -32.27 59.76 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.044 0.538 . . . . 75.44 110.213 177.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -69.31 110.15 4.5 Favored 'General case' 0 C--N 1.359 0.992 0 N-CA-C 108.865 -0.791 . . . . 75.32 108.865 176.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 108.39 15.4 14.0 Favored Glycine 0 C--N 1.342 0.908 0 CA-C-N 115.905 -0.589 . . . . 64.23 112.151 -171.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 43.7 m -142.83 -57.17 0.43 Allowed 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 104.95 -2.241 . . . . 71.23 104.95 176.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.9 m -89.79 146.72 24.27 Favored 'General case' 0 C--O 1.25 1.121 0 N-CA-C 104.438 -2.43 . . . . 74.23 104.438 156.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.54 -35.56 19.45 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 109.981 -0.377 . . . . 74.04 109.981 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -84.02 131.05 52.47 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 123.85 0.86 . . . . 75.1 110.373 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -64.99 133.48 36.0 Favored 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 122.465 2.11 . . . . 75.41 110.717 173.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.568 ' HD2' HG22 ' A' ' 65' ' ' ILE . 58.7 Cg_exo -44.97 143.89 4.15 Favored 'Trans proline' 0 C--N 1.382 2.298 0 C-N-CA 124.211 3.274 . . . . 74.25 114.404 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -42.97 130.35 5.76 Favored 'Trans proline' 0 C--N 1.387 2.554 0 C-N-CA 124.115 3.21 . . . . 73.45 113.383 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -49.06 119.75 4.76 Favored 'Trans proline' 0 C--N 1.386 2.512 0 C-N-CA 123.378 2.719 . . . . 73.2 112.559 -177.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -51.91 164.15 1.17 Allowed 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 123.648 2.899 . . . . 71.05 113.785 177.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -53.18 88.29 0.03 OUTLIER 'Trans proline' 0 C--N 1.384 2.397 0 C-N-CA 123.379 2.719 . . . . 74.31 113.498 178.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 133.92 -33.53 2.52 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-N 114.541 -1.209 . . . . 62.41 110.33 177.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 139.67 -171.41 23.8 Favored Glycine 0 C--N 1.34 0.752 0 N-CA-C 109.835 -1.306 . . . . 53.03 109.835 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -67.48 105.4 1.82 Allowed 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.274 -1.01 . . . . 74.41 108.274 167.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.459 ' HB3' ' HD2' ' A' ' 62' ' ' LYS . 9.4 t70 -63.87 144.69 56.87 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 122.951 0.5 . . . . 71.31 112.186 -176.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.445 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 67.7 m-85 -139.37 71.11 1.37 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.917 0.887 . . . . 73.24 109.886 174.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.502 ' HA ' ' O ' ' A' ' 162' ' ' PRO . 51.0 m -59.99 85.36 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.244 0 CA-C-N 114.787 -1.097 . . . . 74.44 112.863 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 95.73 11.63 54.84 Favored Glycine 0 C--N 1.35 1.349 0 CA-C-N 115.646 -0.706 . . . . 70.11 113.972 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.445 ' HB2' ' HB3' ' A' ' 85' ' ' PHE . 26.7 m-85 -123.65 114.05 19.47 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 117.951 0.876 . . . . 72.34 110.575 -170.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -80.37 83.25 6.24 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-O 121.401 0.619 . . . . 71.44 110.504 -174.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.748 HG22 HD21 ' A' ' 105' ' ' LEU . 1.6 p -49.21 -42.21 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 N-CA-C 114.543 1.312 . . . . 75.21 114.543 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -66.07 -18.63 65.47 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 120.897 0.379 . . . . 75.33 111.01 -176.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -95.38 -7.24 39.05 Favored 'General case' 0 CA--C 1.559 1.298 0 C-N-CA 123.659 0.783 . . . . 61.35 111.167 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 21.6 m-30 -87.77 -172.46 3.87 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 123.491 0.716 . . . . 73.34 111.87 -177.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 86.1 p -74.78 166.68 23.22 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 113.349 0.87 . . . . 74.5 113.349 -169.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.03 -49.42 77.46 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 114.96 -1.018 . . . . 74.52 111.789 178.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -58.94 -40.0 83.3 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.597 0.759 . . . . 75.03 110.718 -175.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -62.63 -49.5 74.94 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.423 -1.262 . . . . 72.32 110.195 176.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.534 ' HA ' HD11 ' A' ' 105' ' ' LEU . 46.3 mt-30 -77.86 -4.37 46.34 Favored 'General case' 0 CA--C 1.552 1.038 0 CA-C-N 115.482 -0.781 . . . . 74.14 112.735 -178.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -92.54 -50.24 5.71 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.628 0.771 . . . . 70.02 109.918 172.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 26.0 tp -58.94 -54.85 42.47 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.1 0.96 . . . . 74.33 110.581 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.403 ' HZ ' HG11 ' A' ' 56' ' ' VAL . 88.5 m-85 -87.48 -1.54 58.0 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 115.801 -0.636 . . . . 72.11 111.098 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -41.28 -58.37 2.87 Favored Glycine 0 N--CA 1.482 1.74 0 N-CA-C 115.879 1.112 . . . . 72.43 115.879 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -50.35 -20.15 5.49 Favored 'Trans proline' 0 C--N 1.385 2.467 0 C-N-CA 124.318 3.346 . . . . 64.43 115.216 -177.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -141.59 31.89 2.09 Favored Glycine 0 C--N 1.355 1.632 0 CA-C-O 119.239 -0.756 . . . . 54.4 113.901 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.748 HD21 HG22 ' A' ' 90' ' ' VAL . 39.8 mt -66.68 78.19 0.11 Allowed 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 117.746 0.773 . . . . 74.25 112.028 171.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.458 ' HB2' ' HA ' ' A' ' 169' ' ' ASN . 24.5 m-85 36.5 -108.68 0.05 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.202 1.401 . . . . 74.45 114.78 177.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 59.77 16.12 37.06 Favored Glycine 0 C--N 1.36 1.916 0 N-CA-C 111.256 -0.738 . . . . 44.0 111.256 -160.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.36 1.887 0 O-C-N 124.321 0.66 . . . . 71.34 112.612 -164.876 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 43.4 tttp . . . . . 0 N--CA 1.494 1.746 0 N-CA-C 113.01 0.745 . . . . 73.31 113.01 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -85.34 -177.76 50.65 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-N 115.566 -0.743 . . . . 73.4 113.725 178.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.501 ' H ' ' HA3' ' A' ' 166' ' ' GLY . 22.1 ttm180 -94.19 164.52 13.02 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.186 1.394 . . . . 74.43 110.362 176.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.419 ' N ' ' HG2' ' A' ' 117' ' ' ARG . 7.9 p-10 -82.95 124.8 30.72 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 108.221 -1.029 . . . . 74.23 108.221 164.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 10.5 tt -122.75 121.31 36.02 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.42 -1.326 . . . . 75.42 107.42 -172.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.534 ' HA ' ' HB2' ' A' ' 175' ' ' LEU . 3.7 tmt_? -92.21 110.62 22.01 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 109.001 -0.74 . . . . 74.51 109.001 -177.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -111.21 171.93 7.18 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.265 1.026 . . . . 54.41 109.564 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.46 ' HA ' ' O ' ' A' ' 177' ' ' VAL . 68.0 mt-10 -121.75 125.84 47.51 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 109.0 -0.741 . . . . 72.42 109.0 -177.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 46.2 tp -98.79 100.91 10.58 Favored Pre-proline 0 N--CA 1.471 0.614 0 N-CA-C 107.307 -1.368 . . . . 74.14 107.307 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.56 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 55.4 Cg_endo -71.37 113.45 3.62 Favored 'Trans proline' 0 C--N 1.373 1.839 0 N-CA-C 108.587 -1.351 . . . . 75.33 108.587 176.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.498 ' HB3' HD23 ' A' ' 180' ' ' LEU . 47.1 tp -122.85 134.57 54.39 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 119.021 0.828 . . . . 72.43 111.067 -171.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.541 ' HA ' HD12 ' A' ' 181' ' ' LEU . 22.8 m -64.81 134.67 54.59 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 114.275 -1.329 . . . . 71.34 110.333 176.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.574 HD13 ' HD1' ' A' ' 183' ' ' HIS . 47.3 mt -59.55 -38.46 81.13 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 122.927 0.491 . . . . 75.21 111.524 -174.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -59.17 -42.56 91.05 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.385 0.674 . . . . 75.32 109.558 177.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.559 ' HG2' ' HB3' ' B' ' 4' ' ' SER . 50.0 mm-40 -65.78 -37.36 86.1 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.926 0.89 . . . . 64.33 111.768 173.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -66.07 -30.22 70.7 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 121.088 0.47 . . . . 65.44 110.838 -177.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -78.58 -59.78 2.64 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 115.016 -0.993 . . . . 74.51 110.551 177.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 44.7 m80 -75.87 -44.55 40.12 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.33 0.652 . . . . 75.25 112.323 -167.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.422 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 85.7 -170.05 43.55 Favored Glycine 0 N--CA 1.477 1.377 0 N-CA-C 114.117 0.407 . . . . 71.54 114.117 176.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 108.16 -166.68 13.06 Favored Glycine 0 C--N 1.353 1.51 0 C-N-CA 123.077 0.37 . . . . 70.42 113.019 177.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -70.7 105.83 3.32 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 122.957 0.503 . . . . 73.14 110.598 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 3.1 tpp180 -94.26 120.12 34.04 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 109.124 -0.695 . . . . 75.05 109.124 171.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 58.1 t -84.07 115.02 25.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 N-CA-C 107.889 -1.152 . . . . 75.04 107.889 173.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.401 HG13 HG11 ' A' ' 145' ' ' VAL . 2.7 p -129.44 129.92 67.19 Favored 'Isoleucine or valine' 0 C--O 1.246 0.916 0 C-N-CA 123.593 0.757 . . . . 73.34 109.754 -177.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -92.86 144.5 25.22 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.223 1.009 . . . . 71.3 110.189 -177.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.595 ' HB ' ' HB3' ' B' ' 8' ' ' LEU . 6.6 p -162.68 105.79 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 120.933 0.397 . . . . 75.1 111.07 174.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 57.84 34.23 24.13 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.092 0.957 . . . . 74.24 111.473 178.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 95.41 -19.68 53.1 Favored Glycine 0 C--N 1.35 1.311 0 CA-C-N 115.796 -0.638 . . . . 54.15 113.29 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 18.3 tpt85 -76.26 103.26 6.2 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.878 0.871 . . . . 72.43 110.503 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -87.87 97.22 10.81 Favored 'General case' 0 C--O 1.243 0.732 0 C-N-CA 123.873 0.869 . . . . 74.41 109.386 173.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.401 HG11 HG13 ' A' ' 138' ' ' VAL . 3.6 p -102.47 125.3 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-O 121.209 0.528 . . . . 73.53 110.14 177.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 34.6 t -91.48 83.97 5.48 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 108.189 -1.041 . . . . 64.43 108.189 174.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.7 p -92.5 123.56 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 115.703 -0.681 . . . . 73.42 109.705 -176.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 24.2 ttm180 -71.52 107.31 4.35 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.158 0.504 . . . . 74.32 110.037 174.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.422 HG13 ' HA2' ' A' ' 133' ' ' GLY . 20.2 pt -76.96 126.03 86.13 Favored Pre-proline 0 CA--C 1.555 1.172 0 CA-C-N 114.9 -1.045 . . . . 74.52 109.073 170.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -64.12 132.11 32.99 Favored 'Trans proline' 0 C--N 1.37 1.706 0 C-N-CA 122.493 2.128 . . . . 74.22 112.169 176.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -56.91 109.78 0.5 Allowed 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 122.888 2.392 . . . . 74.15 111.499 172.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.427 ' HA3' ' HD2' ' A' ' 241' ' ' PRO . . . 97.2 48.78 1.98 Allowed Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.844 -0.503 . . . . 75.51 111.844 -174.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 4.5 p -96.61 137.85 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.564 0.745 . . . . 75.43 109.507 177.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.433 ' HG2' ' HA ' ' A' ' 191' ' ' GLN . 0.0 OUTLIER -116.48 168.18 10.39 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.613 0.765 . . . . 73.23 111.519 -169.528 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.524 ' HB3' ' HA ' ' A' ' 189' ' ' GLU . 15.9 tp10 -56.61 129.91 42.98 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.594 0.758 . . . . 72.32 111.165 177.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 78.08 10.96 85.83 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-N 115.548 -0.751 . . . . 74.33 114.235 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 10.7 t -75.18 129.85 38.2 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 118.015 0.908 . . . . 74.23 108.665 175.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 21.7 t -108.61 114.78 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 123.199 0.6 . . . . 74.02 110.7 -167.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.545 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 48.4 mt -93.93 92.35 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 107.212 -1.403 . . . . 75.24 107.212 169.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 31.5 ttt180 -74.2 100.39 3.67 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 109.422 -0.584 . . . . 75.21 109.422 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.2 p -126.35 99.35 30.82 Favored Pre-proline 0 CA--C 1.557 1.239 0 C-N-CA 124.129 0.972 . . . . 71.41 110.427 -176.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.546 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 65.1 Cg_exo -50.56 158.02 3.04 Favored 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 123.062 2.508 . . . . 74.53 114.186 172.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 108.96 -26.82 14.26 Favored Glycine 0 N--CA 1.48 1.571 0 N-CA-C 113.872 0.309 . . . . 70.43 113.872 169.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 63.7 mtm -118.67 -0.04 11.39 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 122.608 0.363 . . . . 64.15 110.891 -177.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -88.17 -106.9 0.99 Allowed Glycine 0 C--N 1.351 1.379 0 N-CA-C 111.025 -0.83 . . . . 73.33 111.025 175.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.501 ' HA3' ' H ' ' A' ' 117' ' ' ARG . . . -69.1 117.73 8.18 Favored Glycine 0 C--O 1.251 1.196 0 N-CA-C 111.589 -0.604 . . . . 74.5 111.589 171.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -75.17 104.78 5.88 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 109.218 -0.66 . . . . 75.42 109.218 -175.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -169.92 158.21 30.18 Favored Glycine 0 C--N 1.339 0.725 0 N-CA-C 110.826 -0.91 . . . . 64.21 110.826 -176.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . 0.512 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . 54.0 t30 -61.59 -62.82 5.15 Favored Pre-proline 0 N--CA 1.488 1.43 0 CA-C-O 117.438 -1.268 . . . . 63.54 110.619 -169.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.512 ' HD3' ' HB3' ' A' ' 169' ' ' ASN . 21.2 Cg_exo -63.1 109.32 0.92 Allowed 'Trans proline' 0 C--N 1.391 2.779 0 CA-C-N 122.487 1.924 . . . . 73.02 107.789 162.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -60.3 128.46 26.31 Favored 'Trans proline' 0 CA--C 1.55 1.301 0 C-N-CA 123.379 2.719 . . . . 71.25 113.622 -163.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -77.34 136.85 19.43 Favored Glycine 0 C--N 1.358 1.752 0 N-CA-C 111.377 -0.689 . . . . 72.4 111.377 175.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.546 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 15.1 m-20 -61.98 128.81 37.94 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.935 0.894 . . . . 71.14 112.034 -172.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 49.6 tp -102.69 107.84 18.88 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.887 -0.783 . . . . 74.2 108.887 169.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.534 ' HB2' ' HA ' ' A' ' 120' ' ' ARG . 42.7 mt -79.3 94.21 5.43 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 108.663 -0.866 . . . . 72.12 108.663 176.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.545 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 91.8 mt -74.22 82.13 1.83 Allowed 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 109.468 -0.567 . . . . 74.52 109.468 175.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 122' ' ' GLU . 11.8 t -87.87 103.7 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 N-CA-C 107.261 -1.385 . . . . 71.11 107.261 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 8.1 p -73.91 119.15 20.57 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.219 0 N-CA-C 113.39 0.885 . . . . 74.13 113.39 -165.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.56 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 20.8 mmt180 -92.71 102.23 14.64 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.195 0.998 . . . . 73.42 109.437 170.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.498 HD23 ' HB3' ' A' ' 125' ' ' LEU . 96.0 mt -72.91 136.12 45.18 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 122.052 -0.405 . . . . 74.04 110.757 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.541 HD12 ' HA ' ' A' ' 126' ' ' THR . 85.5 mt -55.71 156.25 9.57 Favored Pre-proline 0 N--CA 1.484 1.247 0 C-N-CA 124.649 1.18 . . . . 73.22 112.507 -174.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -82.47 40.72 1.0 Allowed 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 122.943 2.429 . . . . 74.32 111.515 171.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . 0.574 ' HD1' HD13 ' A' ' 127' ' ' LEU . 51.9 t-80 -62.24 125.44 85.57 Favored Pre-proline 0 CA--C 1.551 0.997 0 N-CA-C 107.615 -1.254 . . . . 73.35 107.615 172.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 183' ' ' HIS . 23.5 Cg_exo -66.17 23.85 0.09 OUTLIER 'Trans proline' 0 N--CA 1.502 2.014 0 C-N-CA 124.239 3.292 . . . . 61.24 118.289 -162.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 58.9 t -106.3 -59.32 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 120.294 1.406 . . . . 72.34 109.809 177.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . 0.483 ' CE1' ' HB2' ' A' ' 195' ' ' ALA . 21.6 m-85 -127.14 125.6 41.47 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.92 -0.582 . . . . 72.31 111.061 -172.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . 0.423 HH22 ' HG2' ' A' ' 155' ' ' GLU . 0.0 OUTLIER -102.31 71.56 1.24 Allowed 'General case' 0 C--O 1.237 0.399 0 N-CA-C 106.452 -1.684 . . . . 75.51 106.452 171.316 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.439 ' HB2' HD22 ' A' ' 193' ' ' LEU . 7.4 tp -64.27 132.95 51.75 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 113.348 -1.751 . . . . 74.21 110.516 -176.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . 0.524 ' HA ' ' HB3' ' A' ' 155' ' ' GLU . 11.9 tp10 -138.75 123.6 18.78 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.691 1.196 . . . . 70.31 109.643 -178.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 70.73 -75.04 0.58 Allowed Glycine 0 C--N 1.354 1.545 0 O-C-N 123.491 0.495 . . . . 65.41 113.694 175.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.433 ' HA ' ' HG2' ' A' ' 154' ' ' ARG . 2.9 pm0 -145.02 -14.29 0.53 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.669 1.188 . . . . 72.32 110.792 175.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -112.57 137.23 51.1 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.274 1.43 . . . . 72.32 112.708 -165.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.467 HD23 ' HB3' ' A' ' 186' ' ' PHE . 77.3 mt -88.84 159.85 17.51 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.836 1.254 . . . . 74.25 111.003 -173.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -130.78 101.59 5.72 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 108.256 -1.016 . . . . 73.14 108.256 169.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.483 ' HB2' ' CE1' ' A' ' 186' ' ' PHE . . . -104.75 148.14 26.93 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 108.806 -0.812 . . . . 74.34 108.806 175.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 26.1 m -86.87 141.45 28.77 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 109.601 -0.518 . . . . 70.21 109.601 175.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 56.4 tp -138.88 102.33 4.53 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.15 0.58 . . . . 74.1 109.548 -173.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -79.95 125.75 30.15 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 108.968 -0.753 . . . . 63.3 108.968 173.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 5.5 p -139.81 136.78 17.68 Favored Pre-proline 0 CA--C 1.55 0.956 0 C-N-CA 124.462 1.105 . . . . 74.33 108.626 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -77.58 155.32 31.57 Favored 'Trans proline' 0 C--N 1.368 1.595 0 C-N-CA 121.714 1.609 . . . . 70.05 112.483 173.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.402 ' HB2' ' HD3' ' A' ' 202' ' ' PRO . . . -58.1 -50.24 89.18 Favored Pre-proline 0 CA--C 1.552 1.038 0 N-CA-C 113.785 1.032 . . . . 71.34 113.785 -169.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.431 ' HG2' ' CE2' ' C' ' 276' ' ' TYR . 86.1 Cg_exo -55.02 -46.64 31.72 Favored 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 121.548 1.499 . . . . 73.32 113.426 176.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.437 HD13 ' HB3' ' C' ' 276' ' ' TYR . 40.5 mt -71.75 -24.03 22.83 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.28 0 C-N-CA 122.375 0.27 . . . . 71.02 110.492 -177.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -74.7 -47.03 33.81 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.121 0.569 . . . . 74.14 111.706 175.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 90.3 t -70.91 -38.43 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 C-N-CA 123.736 0.814 . . . . 64.22 111.075 -176.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 55.3 t -89.76 -41.21 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 124.173 0.989 . . . . 74.41 111.782 -175.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 95.45 148.6 24.46 Favored Glycine 0 C--N 1.339 0.739 0 CA-C-N 115.581 -0.736 . . . . 72.35 111.339 -168.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 177.44 -142.67 5.82 Favored Glycine 0 C--N 1.333 0.399 0 N-CA-C 111.235 -0.746 . . . . 73.32 111.235 -177.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -125.76 123.41 38.76 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 117.277 0.538 . . . . 73.34 110.666 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.453 HG13 HG21 ' A' ' 199' ' ' VAL . 22.5 m -124.02 -171.47 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 125.425 1.49 . . . . 63.11 109.207 174.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -126.6 131.9 51.4 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.336 0.654 . . . . 74.32 111.525 178.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -114.02 166.31 11.74 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.395 1.078 . . . . 74.41 109.043 167.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 27.9 ttt -111.49 145.01 39.79 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 122.757 0.423 . . . . 74.15 110.486 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 17.4 p -114.05 -171.07 1.84 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.139 0.976 . . . . 74.1 108.868 171.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 83.5 mt -80.3 -5.24 55.97 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.93 0.715 . . . . 73.14 112.93 -175.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -139.91 9.74 2.38 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 112.848 0.685 . . . . 64.44 112.848 -177.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 154.07 175.83 25.75 Favored Glycine 0 N--CA 1.472 1.046 0 CA-C-O 119.382 -0.677 . . . . 63.05 112.413 177.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -81.65 175.79 9.12 Favored 'Trans proline' 0 C--N 1.362 1.288 0 C-N-CA 122.29 1.993 . . . . 74.13 112.559 178.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 3.2 m -148.77 132.78 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.096 1.358 . . . . 73.4 108.425 178.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -86.72 104.45 16.13 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.418 -0.956 . . . . 75.04 108.418 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 41.1 t -99.78 134.47 39.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 123.968 0.907 . . . . 74.51 110.721 -169.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -83.08 105.24 13.9 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 122.847 0.459 . . . . 70.4 109.815 174.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.424 HG11 HG23 ' A' ' 203' ' ' ILE . 11.5 p -79.23 139.97 56.56 Favored Pre-proline 0 CA--C 1.563 1.469 0 C-N-CA 124.35 1.06 . . . . 71.22 109.811 -178.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -82.04 178.68 6.18 Favored 'Trans proline' 0 C--N 1.384 2.426 0 C-N-CA 123.094 2.529 . . . . 75.51 111.806 -175.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -80.8 150.99 18.8 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 121.6 1.533 . . . . 72.53 112.387 171.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . 0.512 HH21 ' HB2' ' C' ' 261' ' ' LEU . 79.1 mtt85 67.01 25.15 9.34 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 125.159 1.383 . . . . 75.13 112.45 175.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.442 HG22 HD23 ' A' ' 233' ' ' LEU . 37.7 m -61.52 117.11 5.3 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 124.7 1.2 . . . . 64.32 110.466 175.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -110.33 139.7 45.27 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.978 0.911 . . . . 75.32 112.161 -167.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -64.57 133.79 53.05 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.459 1.104 . . . . 65.12 111.772 -177.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . 0.502 ' HA3' HH12 ' C' ' 254' ' ' ARG . . . 93.19 -24.63 24.13 Favored Glycine 0 C--N 1.341 0.836 0 CA-C-N 115.85 -0.614 . . . . 75.54 112.803 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 67.6 mtt180 -72.32 147.28 46.49 Favored 'General case' 0 C--N 1.347 0.478 0 CA-C-O 121.41 0.624 . . . . 74.44 109.744 171.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.749 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 2.9 mptp? -106.29 119.34 39.0 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.254 -1.387 . . . . 72.22 107.254 174.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.499 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 70.6 mt -74.38 100.21 3.73 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.32 -0.993 . . . . 71.4 108.32 -177.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 66.1 ttt180 -76.6 104.61 7.19 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 124.07 0.856 . . . . 73.41 110.564 -172.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.613 ' HB3' ' HG3' ' A' ' 238' ' ' LYS . 49.2 mt -103.11 96.56 6.87 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.542 0.737 . . . . 74.24 110.694 -178.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 23.8 mtpp -74.52 138.26 43.01 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 122.707 0.403 . . . . 71.01 111.231 -177.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 82.81 16.73 69.55 Favored Glycine 0 C--N 1.346 1.086 0 CA-C-N 115.603 -0.726 . . . . 74.2 112.876 -174.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.627 ' HZ2' ' HA ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -121.05 -17.73 7.7 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.276 0.63 . . . . 74.1 112.572 -174.256 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -78.69 -167.42 32.2 Favored Glycine 0 C--N 1.339 0.722 0 N-CA-C 111.904 -0.478 . . . . 74.43 111.904 171.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -86.01 151.4 54.54 Favored Pre-proline 0 CA--C 1.557 1.239 0 CA-C-O 118.895 -0.574 . . . . 73.41 109.509 -172.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.427 ' HD2' ' HA3' ' A' ' 152' ' ' GLY . 29.7 Cg_exo -38.91 107.92 0.07 OUTLIER 'Trans proline' 0 C--N 1.389 2.673 0 C-N-CA 124.675 3.583 . . . . 73.33 115.52 -179.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -133.92 -158.15 8.5 Favored Glycine 0 C--N 1.35 1.354 0 CA-C-O 119.255 -0.747 . . . . 73.52 112.33 -176.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -59.8 -39.65 70.69 Favored 'Trans proline' 0 C--N 1.383 2.357 0 C-N-CA 123.695 2.93 . . . . 72.5 113.595 -174.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -89.25 21.62 3.19 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.417 0.687 . . . . 70.11 111.567 -176.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 97.29 -74.44 0.67 Allowed Glycine 0 C--N 1.346 1.121 0 N-CA-C 109.794 -1.322 . . . . 62.24 109.794 -173.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 17.1 mtp180 -122.55 157.91 31.04 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.124 0.97 . . . . 75.41 108.675 168.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -79.43 -158.54 14.52 Favored Glycine 0 C--N 1.344 0.995 0 O-C-N 123.315 0.384 . . . . 70.31 113.486 176.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -104.44 172.32 6.86 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.142 0.577 . . . . 75.44 110.019 -177.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.575 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 32.5 tp -136.65 97.5 3.56 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 107.831 -1.174 . . . . 73.32 107.831 175.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.749 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 62.2 m-85 -79.45 108.57 13.07 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.266 1.026 . . . . 71.3 110.091 178.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.499 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 88.6 mt -93.42 108.31 20.0 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 122.91 0.484 . . . . 74.54 110.061 176.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . 0.535 ' HG2' ' HG3' ' A' ' 232' ' ' LYS . 35.5 mt-10 -77.67 102.64 7.17 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.531 1.132 . . . . 75.41 109.708 -172.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 42.9 t -67.93 126.07 26.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 115.008 -0.997 . . . . 71.34 111.619 -172.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -124.2 92.25 3.63 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 107.275 -1.38 . . . . 73.14 107.275 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.477 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 63.5 mt -82.79 127.69 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 122.815 0.446 . . . . 74.34 111.41 -173.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 69.1 p -111.07 154.68 23.89 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.291 1.036 . . . . 74.52 109.675 175.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . 0.437 HD13 ' H ' ' A' ' 259' ' ' GLU . 2.5 pp -103.06 150.08 37.5 Favored Pre-proline 0 CA--C 1.558 1.263 0 C-N-CA 123.069 0.548 . . . . 73.4 109.653 175.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -51.7 -21.98 12.33 Favored 'Trans proline' 0 N--CA 1.509 2.394 0 C-N-CA 124.519 3.48 . . . . 74.45 115.133 -170.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . 0.682 ' HG2' HE21 ' C' ' 228' ' ' GLN . 29.3 mt-10 52.17 -78.46 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.991 1.317 . . . . 75.12 111.548 -167.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.9 132.19 46.88 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.566 0.746 . . . . 75.12 111.332 176.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.562 HD23 ' HB2' ' A' ' 265' ' ' GLU . 96.2 mt -143.44 150.54 39.17 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.312 1.045 . . . . 72.32 109.723 176.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 20.9 p -118.64 156.69 51.23 Favored Pre-proline 0 CA--C 1.555 1.167 0 CA-C-O 117.774 -1.108 . . . . 74.31 109.204 170.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -21.12 -50.2 0.03 OUTLIER 'Trans proline' 0 C--N 1.401 3.322 1 C-N-CA 126.871 5.047 . . . . 74.33 117.433 -172.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -56.56 -69.44 0.15 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.314 0.646 . . . . 71.44 111.289 178.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . 0.562 ' HB2' HD23 ' A' ' 261' ' ' LEU . 2.1 mp0 -71.32 -28.75 64.32 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.601 0.36 . . . . 73.22 110.062 -172.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' GLU . . . . . 0.406 ' HA ' HD11 ' A' ' 261' ' ' LEU . 18.8 tp10 -55.86 -60.97 2.7 Favored 'General case' 0 C--O 1.255 1.345 0 C-N-CA 124.22 1.008 . . . . 73.45 110.467 175.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -60.58 -38.01 83.22 Favored 'General case' 0 C--O 1.22 -0.472 0 CA-C-N 114.38 -1.282 . . . . 64.12 110.675 178.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . 0.467 HD23 ' HB2' ' C' ' 271' ' ' LYS . 11.8 tp -65.26 -40.1 93.52 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.106 0.962 . . . . 73.14 111.026 -174.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 44.4 m95 -69.41 -37.84 77.65 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.582 -0.736 . . . . 75.0 110.609 176.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . 0.663 ' HE2' ' HA ' ' C' ' 206' ' ' VAL . 1.1 mptm? -67.02 -39.47 87.05 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 123.473 0.483 . . . . 73.12 111.632 176.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -62.33 -48.83 78.07 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.089 0.556 . . . . 70.22 109.884 177.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 18.5 mt -54.36 -51.46 64.72 Favored 'General case' 0 C--O 1.203 -1.371 0 O-C-N 124.55 1.156 . . . . 71.54 110.446 173.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . 0.65 ' HA ' ' HB2' ' C' ' 202' ' ' PRO . . . -67.33 -39.95 85.89 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.697 0.999 . . . . 72.23 113.697 -168.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -86.86 -33.15 19.9 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.589 0.756 . . . . 74.35 110.996 -173.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -71.22 -33.21 69.69 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 109.916 -0.401 . . . . 72.24 109.916 169.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -67.35 -41.54 85.0 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.946 0.898 . . . . 75.02 109.453 174.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -62.62 -43.39 98.94 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 124.105 0.878 . . . . 72.14 108.783 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -66.55 -7.88 23.04 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-N 115.199 -0.909 . . . . 75.41 112.647 175.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 73.7 mmt-85 -127.79 13.95 6.91 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 123.885 0.874 . . . . 75.15 111.127 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.658 0 C-N-CA 122.847 0.459 . . . . 72.5 111.309 -173.864 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.0 ttt . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 109.577 -0.527 . . . . 74.12 109.577 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -101.06 -178.05 3.63 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.533 0.733 . . . . 62.45 111.038 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -59.85 103.17 0.19 Allowed 'General case' 0 C--N 1.354 0.777 0 C-N-CA 123.379 0.672 . . . . 74.04 109.375 176.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 4' ' ' SER . . . . . 0.559 ' HB3' ' HG2' ' A' ' 129' ' ' GLU . 50.5 m -83.5 27.25 0.61 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.443 1.097 . . . . 52.14 112.163 -173.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 6.4 m -123.06 145.95 48.1 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 109.011 -0.737 . . . . 74.34 109.011 177.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 29.4 pt -140.18 177.76 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 C-N-CA 123.356 0.662 . . . . 65.34 111.75 -158.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -147.03 127.28 13.86 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.847 0.859 . . . . 72.22 110.053 178.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . 0.595 ' HB3' ' HB ' ' A' ' 140' ' ' VAL . 19.3 tp -65.48 148.85 51.02 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.797 1.239 . . . . 75.22 112.196 -171.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.35 -49.56 33.27 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.522 0.729 . . . . 73.12 111.886 177.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 4.2 tt 60.48 102.6 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 124.594 1.158 . . . . 74.1 110.151 -173.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.41 ' HB2' ' O ' ' A' ' 120' ' ' ARG . 74.8 mt . . . . . 0 N--CA 1.481 1.086 0 CA-C-O 118.24 -0.886 . . . . 72.11 109.738 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.237 0 N-CA-C 109.263 -0.643 . . . . 74.35 109.263 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . 63.48 -74.98 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.909 1.284 . . . . 75.32 110.67 -164.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 16.8 tp -161.43 13.69 0.09 Allowed 'General case' 0 CA--C 1.56 1.365 0 N-CA-C 111.919 0.341 . . . . 74.44 111.919 -168.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 182' ' ' VAL . . . . . 0.657 ' HA ' ' HB2' ' C' ' 139' ' ' GLU . 12.4 p -117.7 150.09 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 CA-C-O 118.533 -0.746 . . . . 72.43 110.008 178.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -169.05 6.57 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 115.21 1.559 . . . . 65.24 115.21 -177.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 79.7 m80 76.4 161.49 0.23 Allowed 'General case' 0 N--CA 1.507 2.399 0 C-N-CA 124.548 1.139 . . . . 75.32 111.437 177.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 185' ' ' VAL . . . . . 0.576 HG23 ' HA ' ' C' ' 141' ' ' ALA . 92.7 t . . . . . 0 N--CA 1.479 0.995 0 C-N-CA 122.901 0.48 . . . . 74.01 111.407 -173.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 238' ' ' THR . . . . . 0.503 HG22 HG21 ' C' ' 219' ' ' VAL . 21.9 m . . . . . 0 N--CA 1.471 0.616 0 N-CA-C 110.132 -0.322 . . . . 71.31 110.132 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 239' ' ' ALA . . . . . 0.448 ' HA ' HG22 ' C' ' 219' ' ' VAL . . . -159.71 -82.8 0.04 OUTLIER 'General case' 0 C--O 1.24 0.593 0 O-C-N 123.837 0.711 . . . . 74.42 109.561 -178.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 240' ' ' GLY . . . . . 0.421 ' HA3' ' HA ' ' C' ' 235' ' ' LEU . . . 161.91 -108.67 0.36 Allowed Glycine 0 C--N 1.333 0.367 0 N-CA-C 109.678 -1.369 . . . . 71.23 109.678 -170.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -159.92 160.45 33.53 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.35 0.66 . . . . 71.23 111.125 178.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 26.7 m95 -123.77 -83.08 0.65 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.165 0.986 . . . . 70.32 108.715 168.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -154.49 -54.87 0.1 Allowed 'General case' 0 C--N 1.362 1.152 0 C-N-CA 125.985 1.714 . . . . 74.22 106.654 -168.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -147.34 -163.28 10.49 Favored Glycine 0 C--N 1.355 1.614 0 CA-C-N 113.843 -1.526 . . . . 71.54 110.628 173.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? . . . . . 0 N--CA 1.488 1.439 0 N-CA-C 108.89 -0.781 . . . . 75.34 108.89 175.878 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.976 0 N-CA-C 109.825 -0.435 . . . . 71.34 109.825 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 4' ' ' LYS . . . . . 0.451 ' HE2' ' HE2' ' C' ' 69' ' ' TYR . 38.7 ttmt -39.42 101.15 0.02 OUTLIER 'General case' 0 C--N 1.353 0.739 0 C-N-CA 125.421 1.488 . . . . 70.52 113.766 -177.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -66.32 95.62 0.31 Allowed 'General case' 0 C--O 1.244 0.807 0 N-CA-C 108.558 -0.905 . . . . 72.32 108.558 164.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 6' ' ' ASP . . . . . 0.407 ' HA ' ' HH ' ' C' ' 66' ' ' TYR . 10.0 t70 -74.7 94.71 2.74 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 106.758 -1.571 . . . . 65.15 106.758 173.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 7' ' ' TYR . . . . . 0.416 ' HB3' ' HA ' ' C' ' 53' ' ' ALA . 50.1 m-85 -56.53 -35.74 68.42 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 114.766 -1.107 . . . . 73.43 111.551 -170.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 8' ' ' TYR . . . . . 0.433 ' HD1' HG21 ' C' ' 13' ' ' VAL . 65.4 m-85 -65.9 -42.65 89.95 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.411 -1.268 . . . . 74.23 111.801 175.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.42 -39.52 94.0 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 122.643 0.377 . . . . 63.34 110.848 177.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 59.2 mt -56.88 -43.14 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.446 0.698 . . . . 73.31 109.939 175.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 11' ' ' LEU . . . . . 0.528 ' HB3' ' HB1' ' C' ' 25' ' ' ALA . 96.2 mt -76.94 -15.15 59.75 Favored 'General case' 0 CA--C 1.556 1.195 0 CA-C-N 115.268 -0.878 . . . . 75.53 113.205 177.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.67 18.86 80.04 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 113.797 0.279 . . . . 74.43 113.797 -176.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 13' ' ' VAL . . . . . 0.433 HG21 ' HD1' ' C' ' 8' ' ' TYR . 30.1 m -111.73 155.03 43.75 Favored Pre-proline 0 N--CA 1.483 1.206 0 C-N-CA 124.442 1.097 . . . . 71.34 110.015 179.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -60.59 156.53 41.67 Favored 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 123.155 2.57 . . . . 74.43 113.729 177.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 33.4 mtp-105 -69.95 7.12 1.0 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 113.804 1.038 . . . . 74.35 113.804 -174.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -127.6 9.07 6.47 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.305 1.042 . . . . 71.24 109.302 -177.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.09 130.28 45.45 Favored 'General case' 0 C--N 1.356 0.883 0 C-N-CA 123.97 0.908 . . . . 75.2 110.951 -175.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 71.5 p -68.47 166.86 15.99 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.56 0.744 . . . . 74.41 110.713 -177.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 62.4 tp60 -57.75 -33.62 68.67 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.784 0.833 . . . . 74.45 111.908 -172.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -70.1 -40.53 74.9 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.038 0.535 . . . . 74.53 111.288 177.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -65.64 -39.9 91.92 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 122.757 0.423 . . . . 73.42 110.748 179.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 22' ' ' ILE . . . . . 0.558 HD11 ' HB3' ' C' ' 57' ' ' LEU . 86.1 mt -64.75 -42.57 95.34 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 C-N-CA 124.054 0.942 . . . . 75.54 110.372 176.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -61.99 -47.13 86.17 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.367 1.067 . . . . 74.13 111.326 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 78.7 mtm180 -71.24 -35.53 71.47 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 115.987 -0.551 . . . . 73.52 110.758 -178.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . 0.528 ' HB1' ' HB3' ' C' ' 11' ' ' LEU . . . -64.11 -40.39 96.09 Favored 'General case' 0 C--O 1.249 1.031 0 C-N-CA 123.11 0.564 . . . . 75.32 110.457 176.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 26' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -57.91 -60.25 4.0 Favored 'General case' 0 C--O 1.214 -0.778 0 CA-C-N 114.77 -1.105 . . . . 72.31 109.873 175.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -60.49 -41.32 94.01 Favored 'General case' 0 N--CA 1.483 1.183 0 O-C-N 124.068 0.855 . . . . 75.33 111.653 -174.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -53.07 -58.67 6.22 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.456 1.103 . . . . 75.55 110.922 176.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 97.1 mt -80.79 -11.09 59.66 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.521 -0.763 . . . . 71.43 111.06 -176.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -80.43 -26.23 38.54 Favored 'General case' 0 C--O 1.216 -0.684 0 C-N-CA 122.906 0.482 . . . . 75.32 109.731 171.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -81.2 -39.81 24.85 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.929 0.892 . . . . 73.5 110.404 175.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -70.16 -51.15 33.53 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.171 0.588 . . . . 71.12 109.789 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 33' ' ' TYR . . . . . 0.433 ' HB3' ' O ' ' C' ' 43' ' ' ALA . 35.6 m-85 -89.73 14.65 11.27 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 115.739 -0.664 . . . . 72.14 111.798 -176.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 34' ' ' HIS . . . . . 0.485 ' HD2' ' HB3' ' C' ' 36' ' ' ASP . 6.7 t60 -62.15 103.55 0.4 Allowed Pre-proline 0 N--CA 1.487 1.397 0 C-N-CA 123.947 0.899 . . . . 74.34 110.76 -174.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 35' ' ' PRO . . . . . 0.59 ' HB3' ' HG2' ' C' ' 44' ' ' GLU . 31.7 Cg_exo -59.55 -26.88 83.48 Favored 'Trans proline' 0 C--N 1.381 2.274 0 C-N-CA 123.285 2.656 . . . . 72.22 113.12 -171.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 36' ' ' ASP . . . . . 0.485 ' HB3' ' HD2' ' C' ' 34' ' ' HIS . 25.2 t70 -64.87 -39.0 92.86 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.25 1.02 . . . . 60.34 111.833 177.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 43.5 t -94.1 -54.34 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-O 121.277 0.56 . . . . 75.33 109.677 -177.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -100.04 92.21 5.14 Favored 'General case' 0 C--O 1.243 0.732 0 C-N-CA 124.558 1.143 . . . . 65.41 109.219 178.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -79.39 76.51 5.96 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 109.346 -0.613 . . . . 71.22 109.346 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 49.5 m -129.27 118.07 19.11 Favored Pre-proline 0 CA--C 1.538 0.491 0 CA-C-O 118.091 -0.957 . . . . 74.14 108.787 177.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -45.04 -45.26 14.47 Favored 'Trans proline' 0 C--N 1.382 2.335 0 C-N-CA 123.917 3.078 . . . . 75.0 113.679 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -60.08 -39.85 87.51 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.482 -0.781 . . . . 71.01 110.94 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 43' ' ' ALA . . . . . 0.433 ' O ' ' HB3' ' C' ' 33' ' ' TYR . . . -74.42 -19.79 60.28 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.885 -0.598 . . . . 71.45 111.447 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 44' ' ' GLU . . . . . 0.59 ' HG2' ' HB3' ' C' ' 35' ' ' PRO . 39.4 mt-10 -78.35 -45.57 22.21 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 109.547 -0.538 . . . . 74.04 109.547 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -68.7 -39.68 80.37 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.258 -0.883 . . . . 75.44 109.915 177.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 46' ' ' LYS . . . . . 0.557 ' O ' HG12 ' C' ' 50' ' ' ILE . 23.1 mmtm -61.7 -42.77 99.39 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.069 -0.514 . . . . 72.32 110.836 174.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -55.93 -43.13 77.09 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.551 0.74 . . . . 71.12 110.027 175.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 48' ' ' LYS . . . . . 0.402 ' HA ' ' HB2' ' C' ' 51' ' ' ASN . 97.1 mttt -72.59 -23.32 60.94 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-N 115.641 -0.709 . . . . 72.04 112.091 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -78.05 -25.61 47.85 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 118.139 0.427 . . . . 72.33 110.342 172.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 50' ' ' ILE . . . . . 0.557 HG12 ' O ' ' C' ' 46' ' ' LYS . 18.2 mm -75.35 -36.13 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 N-CA-C 108.287 -1.005 . . . . 75.43 108.287 172.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 51' ' ' ASN . . . . . 0.402 ' HB2' ' HA ' ' C' ' 48' ' ' LYS . 0.9 OUTLIER -68.27 -36.61 79.66 Favored 'General case' 0 C--O 1.2 -1.548 0 CA-C-N 114.883 -1.053 . . . . 74.04 110.018 173.643 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -65.52 -47.05 77.26 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.902 1.281 . . . . 75.54 109.986 178.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . 0.416 ' HA ' ' HB3' ' C' ' 7' ' ' TYR . . . -57.85 -61.41 2.55 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 113.998 -1.455 . . . . 63.1 111.01 178.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 54' ' ' TYR . . . . . 0.522 ' HD1' HG23 ' C' ' 22' ' ' ILE . 76.6 t80 -71.17 -12.87 61.72 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.745 -0.661 . . . . 75.01 111.533 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.64 -57.69 7.51 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 108.95 -0.759 . . . . 60.54 108.95 171.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 48.4 t -69.04 -22.69 26.41 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 CA-C-N 114.543 -1.208 . . . . 72.43 110.814 -178.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 57' ' ' LEU . . . . . 0.558 ' HB3' HD11 ' C' ' 22' ' ' ILE . 64.7 mt -109.13 9.2 26.2 Favored 'General case' 0 CA--C 1.564 1.484 0 N-CA-C 112.772 0.656 . . . . 75.02 112.772 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 46.6 t -51.69 -45.55 63.54 Favored 'General case' 0 N--CA 1.503 2.215 0 C-N-CA 124.66 1.184 . . . . 75.33 113.292 176.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 59' ' ' ASP . . . . . 0.431 ' HB2' ' HG3' ' C' ' 62' ' ' LYS . 2.0 m-20 -114.85 148.78 41.19 Favored Pre-proline 0 C--O 1.241 0.608 0 CA-C-N 115.492 -0.776 . . . . 72.03 109.145 177.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 60' ' ' PRO . . . . . 0.498 ' O ' ' HG2' ' C' ' 64' ' ' ARG . 69.0 Cg_exo -55.75 -30.6 76.76 Favored 'Trans proline' 0 C--N 1.374 1.921 0 C-N-CA 122.636 2.224 . . . . 73.21 111.984 167.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -64.41 -49.48 71.38 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.925 0.89 . . . . 62.13 111.054 175.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 62' ' ' LYS . . . . . 0.431 ' HG3' ' HB2' ' C' ' 59' ' ' ASP . 28.1 mtpp -66.7 -30.92 71.28 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-O 121.259 0.552 . . . . 75.43 110.07 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 23.0 tpt180 -60.65 -41.68 95.44 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 115.272 -0.876 . . . . 74.14 110.145 168.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 64' ' ' ARG . . . . . 0.498 ' HG2' ' O ' ' C' ' 60' ' ' PRO . 30.5 mmm180 -65.68 -27.09 68.1 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-O 119.305 -0.379 . . . . 74.15 111.525 176.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 1.7 mp -63.46 -45.08 98.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 109.581 -0.526 . . . . 71.5 109.581 168.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 66' ' ' TYR . . . . . 0.407 ' HH ' ' HA ' ' C' ' 6' ' ' ASP . 7.0 t80 -58.46 -46.39 86.69 Favored 'General case' 0 CA--C 1.562 1.429 0 N-CA-C 109.312 -0.625 . . . . 74.31 109.312 174.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -61.85 -35.68 78.99 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 124.122 0.969 . . . . 73.14 112.009 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 40.7 p -73.99 -22.55 59.56 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 119.421 -0.323 . . . . 74.43 110.775 177.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 69' ' ' TYR . . . . . 0.451 ' HE2' ' HE2' ' C' ' 4' ' ' LYS . 79.9 t80 -76.11 108.05 8.76 Favored 'General case' 0 C--N 1.355 0.84 0 N-CA-C 107.648 -1.241 . . . . 75.22 107.648 168.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 102.64 27.71 6.63 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.202 -0.759 . . . . 62.51 111.202 -167.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 25.1 m -145.95 -57.64 0.31 Allowed 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 103.494 -2.78 . . . . 72.34 103.494 173.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 5.4 m -81.2 140.18 35.09 Favored 'General case' 0 C--O 1.254 1.32 0 N-CA-C 104.618 -2.364 . . . . 73.35 104.618 157.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.23 -32.63 15.69 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.647 0.779 . . . . 73.23 110.505 -178.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -92.98 159.06 36.47 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 124.056 0.942 . . . . 53.23 109.888 177.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -59.5 150.85 73.08 Favored 'Trans proline' 0 CA--C 1.56 1.786 0 C-N-CA 122.318 2.012 . . . . 75.14 112.141 168.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -68.0 164.16 32.96 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 122.729 2.286 . . . . 71.22 112.788 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -60.64 129.73 30.53 Favored 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 122.973 2.449 . . . . 74.4 111.97 173.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 78' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -59.61 115.17 2.42 Favored 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 123.158 2.572 . . . . 74.44 113.182 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.16 130.6 24.55 Favored 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 122.532 2.155 . . . . 70.12 111.332 175.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -62.0 88.66 0.1 Allowed 'Trans proline' 0 C--N 1.379 2.179 0 C-N-CA 122.733 2.289 . . . . 74.31 111.754 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 155.77 -33.51 0.62 Allowed Glycine 0 N--CA 1.465 0.63 0 N-CA-C 110.238 -1.145 . . . . 75.2 110.238 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 126.96 157.7 9.58 Favored Glycine 0 C--N 1.352 1.47 0 CA-C-N 114.837 -0.682 . . . . 75.13 113.462 173.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -67.69 107.89 2.72 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 107.636 -1.246 . . . . 73.4 107.636 164.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -67.21 130.19 42.31 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.396 0.617 . . . . 75.11 111.719 -169.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 85' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -132.57 52.53 2.07 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.565 1.146 . . . . 74.41 108.122 174.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 50.9 m -64.01 96.38 0.14 Allowed 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 113.295 -1.775 . . . . 52.42 111.862 -174.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 114.95 -13.95 19.56 Favored Glycine 0 C--N 1.348 1.243 0 CA-C-N 115.658 -0.701 . . . . 74.34 113.105 176.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 88' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -112.3 144.01 42.44 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 117.392 0.596 . . . . 74.44 110.376 -169.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 89' ' ' ASP . . . . . 0.543 ' HA ' ' HG2' ' C' ' 171' ' ' PRO . 46.0 t0 -77.11 74.46 3.69 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.861 0.839 . . . . 72.23 110.746 -175.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 90' ' ' VAL . . . . . 0.457 HG13 ' HG3' ' C' ' 171' ' ' PRO . 5.2 p -48.85 -47.46 16.23 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.003 0 C-N-CA 126.128 1.771 . . . . 54.42 113.063 -171.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -61.78 -27.2 68.58 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 112.836 0.68 . . . . 75.25 112.836 -173.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -83.74 -11.09 57.61 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 111.796 0.295 . . . . 75.53 111.796 -173.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 13.5 m-30 -74.6 171.29 14.12 Favored 'General case' 0 CA--C 1.557 1.233 0 CA-C-O 120.846 0.355 . . . . 72.45 111.581 -174.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 93.6 p -76.52 174.34 10.43 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 115.105 1.52 . . . . 52.11 115.105 -164.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -51.87 -47.93 64.29 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.34 1.456 . . . . 72.35 112.644 174.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -56.94 -45.67 82.6 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.547 0.739 . . . . 74.24 110.59 -177.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 97' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.33 -47.76 80.73 Favored 'General case' 0 CA--C 1.56 1.34 0 CA-C-N 114.359 -1.291 . . . . 64.25 110.208 172.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -66.79 -14.09 62.23 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.739 0.815 . . . . 71.33 112.29 -179.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -95.73 -39.2 9.99 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.085 0.554 . . . . 74.43 112.196 177.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 43.8 tp -83.13 -51.28 7.65 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-O 121.403 0.621 . . . . 73.23 110.929 -176.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -87.75 -18.79 28.63 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.001 0.921 . . . . 75.04 110.607 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -40.33 -56.24 2.89 Favored Glycine 0 C--N 1.358 1.781 0 CA-C-O 118.137 -1.369 . . . . 74.41 115.335 177.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 0.8 OUTLIER -28.9 -37.15 0.04 OUTLIER 'Trans proline' 0 C--N 1.389 2.695 1 C-N-CA 125.831 4.354 . . . . 64.35 116.663 174.281 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -149.44 47.3 0.63 Allowed Glycine 0 C--N 1.345 1.056 0 C-N-CA 121.266 -0.492 . . . . 73.42 112.621 -179.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 105' ' ' LEU . . . . . 0.507 ' HB3' HD21 ' C' ' 169' ' ' ASN . 37.1 mt . . . . . 0 N--CA 1.48 1.042 0 CA-C-O 121.266 0.555 . . . . 75.43 111.606 170.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 CA-C-O 121.297 0.387 . . . . 54.4 113.829 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -88.5 163.54 15.87 Favored 'General case' 0 C--O 1.244 0.769 0 C-N-CA 124.733 1.213 . . . . 74.32 110.694 178.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -68.87 144.63 54.18 Favored 'General case' 0 C--O 1.245 0.849 0 N-CA-C 108.47 -0.937 . . . . 75.42 108.47 168.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 119' ' ' LEU . . . . . 0.459 HD21 HG21 ' C' ' 140' ' ' VAL . 0.0 OUTLIER -133.53 152.72 51.95 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 121.266 0.555 . . . . 75.21 110.625 175.97 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -105.49 113.52 27.15 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.046 -0.979 . . . . 72.31 108.714 -173.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 121' ' ' ALA . . . . . 0.664 ' HB3' ' HG3' ' C' ' 139' ' ' GLU . . . -111.79 116.84 31.36 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.485 -1.672 . . . . 75.44 106.485 172.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 122' ' ' GLU . . . . . 0.593 ' HB2' ' HB ' ' C' ' 177' ' ' VAL . 20.7 tt0 -114.5 138.09 51.03 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 122.638 0.375 . . . . 74.12 110.429 -171.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -142.14 133.38 13.07 Favored Pre-proline 0 CA--C 1.544 0.72 0 CA-C-N 115.403 -0.817 . . . . 73.3 111.164 -168.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.93 128.55 18.97 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.383 2.056 . . . . 72.51 110.624 164.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 125' ' ' LEU . . . . . 0.473 ' O ' ' HA ' ' C' ' 180' ' ' LEU . 14.0 tp -153.56 165.48 35.76 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 106.763 -1.569 . . . . 75.32 106.763 -174.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 126' ' ' THR . . . . . 0.405 ' HB ' HD12 ' C' ' 181' ' ' LEU . 15.1 t -127.69 175.96 7.9 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 119.69 1.132 . . . . 61.53 110.278 173.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 127' ' ' LEU . . . . . 0.405 HD23 HD13 ' C' ' 180' ' ' LEU . 33.5 mt -58.89 -47.82 83.61 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.494 1.518 . . . . 62.25 110.876 -178.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 128' ' ' GLU . . . . . 0.477 ' HG3' ' HA ' ' C' ' 215' ' ' LEU . 11.4 mp0 -60.92 -36.73 80.07 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 114.904 -1.044 . . . . 75.24 110.281 177.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -78.77 -22.67 46.04 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.548 0.739 . . . . 75.51 112.519 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 130' ' ' ALA . . . . . 0.404 ' HB1' HG22 ' C' ' 153' ' ' VAL . . . -74.39 -33.16 62.97 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 108.92 -0.77 . . . . 73.14 108.92 174.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 131' ' ' PHE . . . . . 0.414 ' HB3' ' O ' ' C' ' 128' ' ' GLU . 54.8 t80 -65.64 -48.62 71.54 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 113.922 -1.49 . . . . 75.55 110.07 169.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 132' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -73.69 -12.88 60.87 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.331 0.652 . . . . 70.15 112.013 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -37.42 -84.87 0.01 OUTLIER Glycine 0 C--N 1.365 2.176 0 O-C-N 124.649 1.218 . . . . 65.31 114.606 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 134' ' ' GLY . . . . . 0.455 ' O ' ' HA ' ' C' ' 148' ' ' ARG . . . 49.36 -135.31 23.44 Favored Glycine 0 C--N 1.356 1.666 0 O-C-N 124.278 0.634 . . . . 73.12 114.237 174.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 135' ' ' GLU . . . . . 0.519 ' HG3' ' HB2' ' C' ' 148' ' ' ARG . 1.4 mp0 -89.92 91.96 8.81 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 108.044 -1.095 . . . . 73.03 108.044 177.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 136' ' ' ARG . . . . . . . . . . . . . 66.5 mtm180 -140.82 169.29 17.9 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 121.976 0.893 . . . . 72.12 110.751 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 137' ' ' VAL . . . . . 0.608 ' HB ' ' HG2' ' C' ' 144' ' ' ARG . 15.8 m -75.14 95.41 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 CA-C-N 113.769 -1.56 . . . . 73.11 111.122 -176.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 138' ' ' VAL . . . . . 0.508 HG13 ' HE3' ' C' ' 164' ' ' MET . 2.9 p -79.7 161.24 4.12 Favored 'Isoleucine or valine' 0 C--O 1.251 1.132 0 CA-C-N 114.176 -1.375 . . . . 72.14 112.48 -172.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 139' ' ' GLU . . . . . 0.664 ' HG3' ' HB3' ' C' ' 121' ' ' ALA . 7.7 tp10 -82.5 136.57 34.85 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 113.636 -1.62 . . . . 74.31 111.686 175.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 140' ' ' VAL . . . . . 0.459 HG21 HD21 ' C' ' 119' ' ' LEU . 5.5 p -169.76 99.52 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 124.534 1.133 . . . . 73.25 108.821 163.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 141' ' ' ALA . . . . . 0.576 ' HA ' HG23 ' B' ' 185' ' ' VAL . . . 66.32 22.64 10.83 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.247 1.019 . . . . 65.0 111.921 -178.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 86.93 -14.17 57.52 Favored Glycine 0 C--N 1.346 1.09 0 CA-C-N 116.208 -0.451 . . . . 52.4 112.726 -174.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 143' ' ' ARG . . . . . 0.604 HH12 HG23 ' C' ' 145' ' ' VAL . 0.0 OUTLIER -74.82 120.94 21.04 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 108.588 -0.893 . . . . 75.05 108.588 -178.688 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 144' ' ' ARG . . . . . 0.608 ' HG2' ' HB ' ' C' ' 137' ' ' VAL . 51.2 ttp180 -87.7 92.36 9.08 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 125.451 1.501 . . . . 71.51 109.918 -169.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 145' ' ' VAL . . . . . 0.604 HG23 HH12 ' C' ' 143' ' ' ARG . 65.5 t -98.27 121.03 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 C-N-CA 122.679 0.391 . . . . 75.03 111.067 -174.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 19.8 m -75.02 101.73 4.59 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.165 0.586 . . . . 73.22 109.819 177.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 7.5 p -152.36 158.99 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 122.337 0.255 . . . . 72.53 110.739 -174.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 148' ' ' ARG . . . . . 0.519 ' HB2' ' HG3' ' C' ' 135' ' ' GLU . 42.7 ttm180 -91.44 123.68 35.04 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 109.412 -0.588 . . . . 74.22 109.412 170.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 149' ' ' ILE . . . . . . . . . . . . . 34.2 pt -105.03 151.42 39.47 Favored Pre-proline 0 CA--C 1.548 0.904 0 N-CA-C 107.297 -1.371 . . . . 74.42 107.297 163.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -47.95 115.5 1.51 Allowed 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.852 2.368 . . . . 61.44 112.484 175.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 151' ' ' PRO . . . . . 0.52 ' HG2' ' HA2' ' C' ' 242' ' ' GLY . 28.9 Cg_endo -61.87 109.06 0.72 Allowed 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 122.613 2.209 . . . . 73.2 111.155 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 152' ' ' GLY . . . . . . . . . . . . . . . 124.5 122.96 2.7 Favored Glycine 0 C--N 1.343 0.925 0 CA-C-N 115.376 -0.829 . . . . 63.11 113.739 -173.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 153' ' ' VAL . . . . . 0.62 HG23 HG21 ' C' ' 178' ' ' VAL . 5.7 m -141.78 176.04 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 C-N-CA 123.586 0.754 . . . . 74.01 110.658 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 154' ' ' ARG . . . . . 0.697 ' HB2' ' HB2' ' C' ' 157' ' ' SER . 15.6 mtp180 -125.85 169.13 12.95 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 124.378 1.071 . . . . 75.32 109.877 -178.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 155' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -69.81 126.54 30.01 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.744 0.418 . . . . 74.51 110.814 175.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 67.9 11.7 61.14 Favored Glycine 0 C--N 1.349 1.288 0 CA-C-N 115.719 -0.673 . . . . 75.21 113.559 -178.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 157' ' ' SER . . . . . 0.697 ' HB2' ' HB2' ' C' ' 154' ' ' ARG . 33.0 t -74.07 132.8 42.67 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.131 0.572 . . . . 75.43 110.523 -174.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 158' ' ' VAL . . . . . 0.519 HG11 HG23 ' C' ' 177' ' ' VAL . 16.1 m -86.08 95.94 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 CA-C-N 115.527 -0.761 . . . . 72.31 109.192 171.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 159' ' ' ILE . . . . . 0.76 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 8.3 mt -68.55 90.53 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 107.468 -1.308 . . . . 72.31 107.468 171.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -83.59 100.19 10.65 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.404 -0.591 . . . . 75.13 109.404 -176.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 161' ' ' VAL . . . . . 0.496 HG11 ' HB3' ' C' ' 174' ' ' LEU . 2.6 p -102.84 103.98 36.51 Favored Pre-proline 0 CA--C 1.561 1.391 0 N-CA-C 108.477 -0.935 . . . . 75.24 108.477 175.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -62.54 142.55 90.51 Favored 'Trans proline' 0 C--N 1.386 2.534 0 C-N-CA 123.633 2.889 . . . . 75.23 113.805 -175.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 86.15 -24.98 7.32 Favored Glycine 0 C--N 1.347 1.188 0 CA-C-N 115.638 -0.71 . . . . 53.54 113.719 177.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 164' ' ' MET . . . . . 0.508 ' HE3' HG13 ' C' ' 138' ' ' VAL . 41.6 mtp -78.64 -6.47 55.77 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 113.403 0.89 . . . . 73.35 113.403 -174.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . -106.03 -151.5 19.43 Favored Glycine 0 C--N 1.334 0.465 0 N-CA-C 111.856 -0.497 . . . . 73.32 111.856 173.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . 109.27 73.36 0.77 Allowed Glycine 0 C--N 1.342 0.906 0 C-N-CA 121.562 -0.351 . . . . 75.44 112.392 -173.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 167' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -77.32 102.37 6.71 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 105.999 -1.852 . . . . 74.2 105.999 163.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . 115.51 153.1 10.21 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 108.109 -1.997 . . . . 13.44 108.109 -161.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 169' ' ' ASN . . . . . 0.507 HD21 ' HB3' ' C' ' 105' ' ' LEU . 25.0 t-20 -66.07 -66.66 1.22 Allowed Pre-proline 0 CA--C 1.583 2.245 0 CA-C-O 116.74 -1.6 . . . . 62.44 112.833 -168.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 170' ' ' PRO . . . . . 0.451 ' HD3' ' HB3' ' C' ' 169' ' ' ASN . 51.8 Cg_exo -51.08 111.94 0.67 Allowed 'Trans proline' 0 C--N 1.401 3.309 0 CA-C-N 123.076 2.134 . . . . 73.55 113.381 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 171' ' ' PRO . . . . . 0.543 ' HG2' ' HA ' ' C' ' 89' ' ' ASP . 71.6 Cg_exo -47.58 139.9 17.32 Favored 'Trans proline' 0 C--N 1.383 2.377 0 C-N-CA 124.465 3.443 . . . . 74.02 115.698 -164.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -108.69 -127.17 5.5 Favored Glycine 0 C--N 1.344 1.004 0 N-CA-C 111.329 -0.708 . . . . 74.42 111.329 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 173' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -151.88 156.47 40.19 Favored 'General case' 0 C--O 1.249 1.077 0 CA-C-O 121.606 0.717 . . . . 74.51 110.423 173.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 174' ' ' LEU . . . . . 0.496 ' HB3' HG11 ' C' ' 161' ' ' VAL . 39.4 tp -104.32 123.48 47.47 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.488 -0.778 . . . . 75.22 110.367 -177.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 175' ' ' LEU . . . . . 0.518 HD22 ' HB ' ' C' ' 158' ' ' VAL . 92.8 mt -101.95 94.87 6.01 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.619 1.167 . . . . 72.15 108.159 173.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 176' ' ' LEU . . . . . 0.76 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 44.2 mt -78.78 101.47 7.62 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.472 -0.566 . . . . 74.33 109.472 174.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 177' ' ' VAL . . . . . 0.593 ' HB ' ' HB2' ' C' ' 122' ' ' GLU . 39.5 t -84.32 94.13 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 107.172 -1.418 . . . . 75.23 107.172 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 178' ' ' VAL . . . . . 0.62 HG21 HG23 ' C' ' 153' ' ' VAL . 2.7 p -82.02 125.3 39.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.623 0.725 . . . . 74.01 110.68 -178.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 179' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -104.81 106.73 17.35 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 114.772 -1.104 . . . . 74.42 108.101 175.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 180' ' ' LEU . . . . . 0.473 ' HA ' ' O ' ' C' ' 125' ' ' LEU . 97.3 mt -70.37 148.93 47.85 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 123.677 0.611 . . . . 73.43 110.505 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 181' ' ' LEU . . . . . 0.405 HD12 ' HB ' ' C' ' 126' ' ' THR . 80.2 mt -72.62 166.58 41.12 Favored Pre-proline 0 N--CA 1.483 1.216 0 C-N-CA 123.443 0.697 . . . . 74.24 110.418 -174.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -55.57 78.74 0.03 OUTLIER 'Trans proline' 0 C--N 1.384 2.426 0 C-N-CA 122.837 2.358 . . . . 73.32 111.867 166.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 183' ' ' HIS . . . . . . . . . . . . . 76.3 t60 -173.11 57.21 0.21 Allowed Pre-proline 0 CA--C 1.559 1.297 0 CA-C-N 113.459 -1.7 . . . . 72.0 107.039 -171.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 184' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -86.16 66.73 5.12 Favored 'Trans proline' 0 C--N 1.385 2.454 0 C-N-CA 123.176 2.584 . . . . 74.25 111.323 -174.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 185' ' ' VAL . . . . . 0.508 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 21.2 t -92.66 -43.17 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 108.595 -0.891 . . . . 72.23 108.595 -173.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 186' ' ' PHE . . . . . 0.559 ' HB3' HD22 ' C' ' 193' ' ' LEU . 56.0 m-85 -119.75 119.85 34.83 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.307 0.643 . . . . 61.44 111.738 -171.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 187' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -96.58 109.7 22.25 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 107.03 -1.47 . . . . 75.14 107.03 171.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 188' ' ' LEU . . . . . 0.517 HD13 ' HD2' ' C' ' 240' ' ' PHE . 67.2 tp -82.21 151.25 26.96 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.654 0.74 . . . . 74.14 112.502 -177.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -142.02 101.92 4.03 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.252 1.421 . . . . 73.21 107.298 164.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 68.28 -89.53 0.21 Allowed Glycine 0 C--N 1.35 1.354 0 O-C-N 123.205 0.316 . . . . 74.2 113.188 -177.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 191' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -119.88 -22.91 6.59 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.61 1.164 . . . . 75.25 110.789 175.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -86.45 129.0 35.01 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.574 0.749 . . . . 65.13 110.934 -173.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 193' ' ' LEU . . . . . 0.559 HD22 ' HB3' ' C' ' 186' ' ' PHE . 62.6 mt -93.72 166.71 12.08 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.913 0.485 . . . . 65.15 111.106 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 194' ' ' TYR . . . . . 0.521 ' HA ' ' O ' ' C' ' 250' ' ' TYR . 4.1 t80 -137.82 103.65 5.06 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 109.049 -0.723 . . . . 75.43 109.049 169.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 195' ' ' ALA . . . . . 0.508 ' HA ' ' O ' ' C' ' 185' ' ' VAL . . . -101.77 -177.38 3.41 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 124.032 0.933 . . . . 65.11 110.093 176.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 56.3 m -132.56 130.17 39.96 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 108.113 -1.069 . . . . 53.42 108.113 168.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 197' ' ' LEU . . . . . . . . . . . . . 51.7 tp -106.54 135.24 48.39 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 123.769 0.828 . . . . 73.5 110.699 -171.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -78.98 101.7 7.92 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.395 0.678 . . . . 64.33 109.619 173.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 199' ' ' VAL . . . . . . . . . . . . . 40.8 t -119.11 109.94 38.54 Favored Pre-proline 0 N--CA 1.473 0.68 0 N-CA-C 108.052 -1.092 . . . . 73.12 108.052 175.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 200' ' ' PRO . . . . . 0.502 ' HA ' ' O ' ' C' ' 256' ' ' THR . 25.6 Cg_exo -60.7 147.2 95.65 Favored 'Trans proline' 0 C--N 1.363 1.325 0 C-N-CA 122.188 1.925 . . . . 73.11 111.546 175.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 201' ' ' ALA . . . . . . . . . . . . . . . -50.46 -48.39 81.6 Favored Pre-proline 0 CA--C 1.561 1.384 0 O-C-N 123.885 0.74 . . . . 74.35 112.6 176.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 202' ' ' PRO . . . . . 0.65 ' HB2' ' HA ' ' A' ' 273' ' ' ALA . 20.3 Cg_endo -58.34 -49.81 11.33 Favored 'Trans proline' 0 C--N 1.387 2.584 0 C-N-CA 121.572 1.515 . . . . 63.15 113.161 174.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 203' ' ' ILE . . . . . 0.48 HD12 ' HG2' ' C' ' 200' ' ' PRO . 37.6 mt -63.84 -29.32 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 C-N-CA 122.933 0.493 . . . . 74.02 111.22 -178.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.43 -46.02 67.76 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.166 0.986 . . . . 75.02 111.531 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 205' ' ' VAL . . . . . . . . . . . . . 72.6 t -68.52 -40.42 81.99 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 CA-C-N 115.466 -0.788 . . . . 74.52 111.617 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 206' ' ' VAL . . . . . 0.663 ' HA ' ' HE2' ' A' ' 270' ' ' LYS . 14.3 p -80.13 -38.25 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 112.787 0.662 . . . . 74.12 112.787 -173.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 85.05 71.56 1.31 Allowed Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 116.054 -0.521 . . . . 63.21 112.091 -167.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -98.62 -138.68 10.4 Favored Glycine 0 C--N 1.341 0.813 0 N-CA-C 111.294 -0.722 . . . . 51.32 111.294 176.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 209' ' ' LYS . . . . . 0.577 ' HG2' ' HA ' ' C' ' 222' ' ' ALA . 43.7 mtmt -139.7 146.3 39.45 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.451 0.7 . . . . 72.44 110.221 170.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 210' ' ' VAL . . . . . . . . . . . . . 19.9 m -138.15 137.17 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 107.923 -1.14 . . . . 71.52 107.923 173.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 211' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -75.7 127.79 33.8 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 120.685 0.278 . . . . 75.53 110.983 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -95.79 119.19 33.85 Favored 'General case' 0 C--O 1.245 0.854 0 N-CA-C 108.637 -0.875 . . . . 74.43 108.637 165.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 213' ' ' MET . . . . . . . . . . . . . 2.6 tmm? -72.08 121.69 19.66 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 107.583 -1.265 . . . . 63.12 107.583 176.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 214' ' ' THR . . . . . 0.416 ' OG1' HG11 ' C' ' 219' ' ' VAL . 0.2 OUTLIER -126.21 168.13 14.49 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 122.909 0.484 . . . . 72.34 110.568 -174.51 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 215' ' ' LEU . . . . . 0.477 ' HA ' ' HG3' ' C' ' 128' ' ' GLU . 17.0 mt -55.7 -45.27 77.9 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 125.398 1.479 . . . . 75.24 112.043 -176.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -78.64 -28.5 45.52 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 113.547 -1.66 . . . . 71.0 111.416 -176.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 154.98 -164.38 31.78 Favored Glycine 0 C--N 1.343 0.935 0 CA-C-O 119.575 -0.569 . . . . 74.41 112.018 -169.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -84.87 116.49 1.86 Allowed 'Trans proline' 0 CA--C 1.552 1.424 0 C-N-CA 122.691 2.261 . . . . 64.03 113.223 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 219' ' ' VAL . . . . . 0.503 HG21 HG22 ' B' ' 238' ' ' THR . 10.8 p -101.09 117.26 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 108.311 -0.996 . . . . 52.53 108.311 171.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 220' ' ' GLU . . . . . 0.459 ' HG2' ' HD2' ' C' ' 209' ' ' LYS . 27.4 tt0 -91.28 105.36 17.73 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 121.467 0.651 . . . . 72.32 109.986 -171.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 221' ' ' VAL . . . . . 0.409 HG13 HD22 ' C' ' 233' ' ' LEU . 64.4 t -70.23 119.92 17.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 114.846 -1.07 . . . . 74.03 112.019 -174.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 222' ' ' ALA . . . . . 0.577 ' HA ' ' HG2' ' C' ' 209' ' ' LYS . . . -76.76 99.13 5.01 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 124.149 0.906 . . . . 73.3 109.806 169.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 98.6 t -73.79 138.54 76.77 Favored Pre-proline 0 CA--C 1.555 1.161 0 C-N-CA 123.651 0.781 . . . . 73.11 109.126 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 224' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -92.35 172.86 2.32 Favored 'Trans proline' 0 C--N 1.368 1.605 0 C-N-CA 123.778 2.985 . . . . 73.11 111.787 174.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -72.85 154.24 53.52 Favored 'Trans proline' 0 C--N 1.371 1.714 0 C-N-CA 121.57 1.513 . . . . 74.4 110.837 174.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 226' ' ' ARG . . . . . 0.51 HH22 ' HB2' ' A' ' 261' ' ' LEU . 10.4 mpt_? 57.95 58.67 3.49 Favored 'General case' 0 N--CA 1.483 1.204 0 O-C-N 124.023 0.827 . . . . 71.5 111.651 177.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 227' ' ' THR . . . . . 0.567 HG21 HG11 ' C' ' 253' ' ' VAL . 90.0 m -97.28 112.23 24.13 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 122.29 -0.256 . . . . 73.3 110.625 178.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 228' ' ' GLN . . . . . 0.682 HE21 ' HG2' ' A' ' 259' ' ' GLU . 26.2 mp0 -89.03 163.41 15.53 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.941 0.897 . . . . 74.32 112.206 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -70.36 115.02 9.06 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 113.516 -1.674 . . . . 65.31 109.58 175.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 102.26 8.65 43.67 Favored Glycine 0 C--N 1.336 0.546 0 O-C-N 123.562 0.539 . . . . 62.04 113.449 -178.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 231' ' ' ARG . . . . . . . . . . . . . 41.4 mtp180 -67.89 169.87 9.11 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 117.502 0.651 . . . . 75.03 109.435 164.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 232' ' ' LYS . . . . . 0.436 ' HA ' ' O ' ' C' ' 251' ' ' LEU . 35.4 ttmt -142.06 142.96 32.88 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.794 0.807 . . . . 74.05 112.288 -173.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 233' ' ' LEU . . . . . 0.661 HD12 ' HB2' ' C' ' 251' ' ' LEU . 3.2 mp -106.72 154.45 20.95 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.766 1.626 . . . . 74.22 108.542 178.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 10.5 ptp85 -130.89 88.08 2.57 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 122.268 1.032 . . . . 72.34 108.77 165.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 235' ' ' LEU . . . . . 0.421 ' HA ' ' HA3' ' B' ' 240' ' ' GLY . 30.5 mt -77.59 118.07 19.64 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 114.874 -1.057 . . . . 74.34 109.624 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -81.03 124.71 29.4 Favored 'General case' 0 C--O 1.241 0.605 0 CA-C-N 115.081 -0.963 . . . . 73.41 111.547 -168.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 66.78 29.64 75.0 Favored Glycine 0 C--N 1.345 1.038 0 CA-C-N 115.219 -0.901 . . . . 71.42 112.442 -177.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 34.4 mmtm -118.24 4.42 11.93 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.722 0.809 . . . . 75.11 110.722 178.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 239' ' ' GLY . . . . . 0.423 ' HA2' HD12 ' C' ' 193' ' ' LEU . . . -88.67 -135.4 5.25 Favored Glycine 0 C--N 1.347 1.164 0 N-CA-C 110.625 -0.99 . . . . 75.2 110.625 170.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 240' ' ' PHE . . . . . 0.517 ' HD2' HD13 ' C' ' 188' ' ' LEU . 44.8 m-85 -101.57 108.01 53.8 Favored Pre-proline 0 C--O 1.25 1.093 0 CA-C-N 116.968 0.384 . . . . 75.14 110.092 171.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 241' ' ' PRO . . . . . 0.634 ' HA ' ' H ' ' C' ' 246' ' ' ARG . 40.5 Cg_endo -67.51 113.28 2.87 Favored 'Trans proline' 0 C--N 1.366 1.462 0 C-N-CA 122.027 1.818 . . . . 71.53 110.281 170.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 242' ' ' GLY . . . . . 0.52 ' HA2' ' HG2' ' C' ' 151' ' ' PRO . . . -90.45 -162.45 38.27 Favored Glycine 0 N--CA 1.483 1.773 0 CA-C-N 115.347 -0.842 . . . . 70.14 113.217 -169.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -58.95 -33.38 98.69 Favored 'Trans proline' 0 C--N 1.374 1.888 0 C-N-CA 122.677 2.251 . . . . 71.42 112.11 170.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -79.01 -24.43 43.7 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.127 0.571 . . . . 71.42 110.59 169.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 74.89 98.8 0.1 Allowed Glycine 0 C--N 1.343 0.959 0 CA-C-O 119.38 -0.678 . . . . 63.24 114.149 176.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 246' ' ' ARG . . . . . 0.634 ' H ' ' HA ' ' C' ' 241' ' ' PRO . 10.5 ptt180 -162.48 -72.81 0.05 OUTLIER 'General case' 0 CA--C 1.558 1.257 0 N-CA-C 114.187 1.18 . . . . 71.32 114.187 168.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 247' ' ' GLY . . . . . 0.475 ' N ' ' HG3' ' C' ' 246' ' ' ARG . . . 45.62 128.27 0.0 OUTLIER Glycine 0 C--N 1.358 1.758 0 N-CA-C 117.449 1.74 . . . . 63.23 117.449 -159.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -125.95 119.29 27.35 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 108.308 -0.997 . . . . 73.54 108.308 175.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 249' ' ' LEU . . . . . 0.448 ' HG ' HD12 ' C' ' 251' ' ' LEU . 15.4 tp -86.78 118.49 26.22 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.039 -0.982 . . . . 74.23 109.726 -173.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 250' ' ' TYR . . . . . 0.584 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 20.4 m-85 -98.46 119.88 37.93 Favored 'General case' 0 C--O 1.211 -0.948 0 N-CA-C 108.138 -1.06 . . . . 71.43 108.138 175.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 251' ' ' LEU . . . . . 0.661 ' HB2' HD12 ' C' ' 233' ' ' LEU . 2.6 mp -111.24 139.46 46.62 Favored 'General case' 0 N--CA 1.506 2.355 0 CA-C-N 118.706 0.684 . . . . 72.0 110.029 178.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -94.2 131.14 40.08 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.984 -0.747 . . . . 75.41 108.984 171.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 253' ' ' VAL . . . . . 0.567 HG11 HG21 ' C' ' 227' ' ' THR . 83.9 t -78.65 123.93 36.28 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 C-N-CA 123.619 0.768 . . . . 73.5 111.557 -175.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 254' ' ' ARG . . . . . 0.502 HH12 ' HA3' ' A' ' 230' ' ' GLY . 9.8 mmt85 -101.36 120.92 41.0 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 109.167 -0.679 . . . . 75.13 109.167 166.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 255' ' ' ILE . . . . . . . . . . . . . 36.0 mm -83.78 94.6 3.49 Favored 'Isoleucine or valine' 0 C--O 1.241 0.636 0 O-C-N 124.265 0.978 . . . . 75.24 108.801 170.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 256' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' C' ' 200' ' ' PRO . 0.0 OUTLIER -97.45 144.11 27.5 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 114.883 -1.053 . . . . 70.25 109.731 -179.799 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 2.8 pp -98.79 153.16 38.0 Favored Pre-proline 0 CA--C 1.558 1.267 0 C-N-CA 122.742 0.417 . . . . 75.21 111.227 -177.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -41.7 -24.34 0.26 Allowed 'Trans proline' 0 C--N 1.389 2.672 1 C-N-CA 125.369 4.046 . . . . 74.41 118.333 -170.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 59.88 -73.33 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 124.477 1.111 . . . . 72.3 111.08 -165.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.06 159.14 31.43 Favored 'General case' 0 C--N 1.352 0.674 0 N-CA-C 109.026 -0.731 . . . . 73.41 109.026 171.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 261' ' ' LEU . . . . . 0.512 ' HB2' HH21 ' A' ' 226' ' ' ARG . 75.7 mt -145.12 170.9 15.33 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.045 -1.095 . . . . 74.53 108.045 165.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 45.1 p -122.09 159.96 49.52 Favored Pre-proline 0 CA--C 1.547 0.844 0 N-CA-C 107.587 -1.264 . . . . 61.23 107.587 164.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -38.82 -47.65 2.74 Favored 'Trans proline' 0 C--N 1.387 2.554 0 C-N-CA 123.535 2.823 . . . . 74.2 113.982 175.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -68.82 -53.26 22.54 Favored 'General case' 0 C--N 1.351 0.639 0 CA-C-N 115.886 -0.597 . . . . 71.04 111.344 -178.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -48.24 -56.86 6.91 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 123.806 0.691 . . . . 71.03 109.474 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 266' ' ' GLU . . . . . 0.512 ' O ' ' HG2' ' C' ' 270' ' ' LYS . 33.9 tt0 -57.23 -41.53 79.71 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 114.908 -1.042 . . . . 73.1 111.364 -177.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -61.69 -41.81 98.09 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 123.424 0.69 . . . . 71.12 112.784 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 268' ' ' LEU . . . . . 0.412 ' HG ' HD13 ' A' ' 268' ' ' LEU . 10.8 mp -67.14 -40.31 86.71 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.783 0.433 . . . . 70.11 110.177 177.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -59.03 -36.51 75.11 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 116.353 -0.385 . . . . 63.11 110.761 172.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 270' ' ' LYS . . . . . 0.512 ' HG2' ' O ' ' C' ' 266' ' ' GLU . 25.3 mmtp -60.74 -50.65 72.62 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 122.859 0.464 . . . . 75.43 110.276 177.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 271' ' ' LYS . . . . . 0.467 ' HB2' HD23 ' A' ' 268' ' ' LEU . 47.2 mtpt -53.68 -41.37 66.83 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 124.112 0.883 . . . . 75.33 111.326 177.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 95.5 mt -60.96 -45.54 94.32 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 123.799 0.687 . . . . 74.33 111.135 176.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -64.13 -31.01 72.04 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.153 0.581 . . . . 43.22 111.98 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 274' ' ' GLU . . . . . 0.481 ' HG3' ' O ' ' C' ' 270' ' ' LYS . 30.7 mt-10 -77.66 -34.51 53.04 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.143 0.577 . . . . 63.21 110.402 177.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -67.06 -24.23 65.95 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 115.824 -0.625 . . . . 70.04 110.48 171.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 276' ' ' TYR . . . . . 0.437 ' HB3' HD13 ' A' ' 203' ' ' ILE . 4.1 m-85 -80.51 -35.87 34.0 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.281 -0.872 . . . . 75.52 112.077 175.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -66.98 -28.35 68.19 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 109.491 -0.559 . . . . 65.52 109.491 169.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -72.19 3.3 4.7 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 123.8 0.84 . . . . 72.22 112.878 173.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 279' ' ' ARG . . . . . 0.426 HH11 ' HD1' ' C' ' 276' ' ' TYR . 71.9 mtp180 -74.51 -18.85 60.55 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 118.15 0.432 . . . . 75.11 110.4 168.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.558 1.269 0 N-CA-C 109.602 -0.518 . . . . 75.14 109.602 175.826 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt . . . . . 0 N--CA 1.476 0.827 0 N-CA-C 115.37 1.618 . . . . 64.14 115.37 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.433 ' HD2' HD12 ' A' ' 10' ' ' ILE . 27.7 mmtp -72.26 105.2 3.95 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 108.84 -0.8 . . . . 74.32 108.84 164.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -72.99 96.06 2.09 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 105.905 -1.887 . . . . 62.43 105.905 165.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.408 ' HB2' HD13 ' A' ' 57' ' ' LEU . 67.6 m-85 -61.87 -31.18 71.43 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-N 114.96 -1.018 . . . . 73.34 111.503 -170.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -67.41 -40.23 85.57 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.408 -0.815 . . . . 73.33 109.884 176.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.85 -37.93 89.2 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 122.908 0.483 . . . . 70.01 110.921 177.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.433 HD12 ' HD2' ' A' ' 5' ' ' LYS . 65.3 mt -59.33 -41.46 84.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 123.1 0.56 . . . . 74.23 110.267 173.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.6 mt -80.49 -8.54 59.6 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 115.756 -0.656 . . . . 73.11 112.606 176.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 70.01 18.23 74.37 Favored Glycine 0 C--N 1.353 1.484 0 N-CA-C 114.239 0.455 . . . . 73.42 114.239 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.3 m -103.14 163.3 17.78 Favored Pre-proline 0 N--CA 1.486 1.347 0 C-N-CA 124.374 1.07 . . . . 72.52 110.709 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -47.54 146.75 7.24 Favored 'Trans proline' 0 C--N 1.387 2.577 0 C-N-CA 123.6 2.867 . . . . 50.12 114.043 174.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -71.36 15.78 0.12 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 114.284 1.216 . . . . 75.43 114.284 -170.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -159.8 33.56 0.18 Allowed 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 108.625 -0.88 . . . . 71.2 108.625 173.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.34 149.58 50.16 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.436 1.094 . . . . 74.14 111.834 -177.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 76.1 p -77.8 170.76 16.03 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.516 0.726 . . . . 75.03 111.88 -174.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -55.95 -41.28 74.46 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.673 1.189 . . . . 71.11 112.559 -172.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.36 -32.2 66.25 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 122.629 0.372 . . . . 72.43 110.581 -177.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.447 ' HG2' ' NH2' ' A' ' 24' ' ' ARG . 40.1 mt-10 -65.96 -40.97 91.75 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 121.101 0.476 . . . . 71.14 109.771 175.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.6 mp -65.04 -38.57 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-N 114.763 -1.108 . . . . 73.31 110.416 176.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -75.55 -33.36 60.66 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.567 0.747 . . . . 75.22 111.307 -175.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.546 ' HA ' ' HZ2' ' A' ' 27' ' ' LYS . 85.3 mtm-85 -72.78 -43.64 62.55 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 122.693 0.397 . . . . 73.12 110.566 175.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.04 -31.07 70.48 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.797 -0.638 . . . . 72.43 111.146 177.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -62.55 -58.65 6.79 Favored 'General case' 0 C--O 1.213 -0.856 0 CA-C-O 118.61 -0.709 . . . . 73.1 109.381 173.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.546 ' HZ2' ' HA ' ' A' ' 24' ' ' ARG . 35.5 mtmm -53.97 -39.43 65.98 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 123.949 0.781 . . . . 74.22 111.241 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -54.38 -58.3 7.98 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.182 0.993 . . . . 75.52 110.966 177.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.407 ' HA ' ' HB3' ' A' ' 32' ' ' GLN . 75.4 mt -86.38 -8.99 57.23 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 115.074 -0.967 . . . . 75.12 111.635 -173.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.12 -21.62 25.88 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.686 0.794 . . . . 71.54 109.95 174.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -90.87 -31.76 16.3 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.483 0.713 . . . . 72.33 110.509 170.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.407 ' HB3' ' HA ' ' A' ' 29' ' ' LEU . 35.1 tt0 -73.36 -49.06 29.3 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.999 0.52 . . . . 73.31 111.326 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -98.15 23.78 7.86 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.077 0.551 . . . . 72.41 110.796 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 51.1 t60 -63.2 101.38 0.26 Allowed Pre-proline 0 CA--C 1.554 1.101 0 C-N-CA 124.968 1.307 . . . . 73.54 112.195 -170.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -73.79 -5.44 17.05 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 123.561 2.841 . . . . 75.51 112.552 -172.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -73.73 -27.29 61.11 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 124.571 1.148 . . . . 73.23 111.479 174.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 60.5 t -123.47 -46.71 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 CA-C-O 121.561 0.696 . . . . 73.25 109.716 178.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -98.62 80.96 2.62 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.703 1.201 . . . . 64.12 109.883 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.48 69.4 10.05 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 115.806 -0.633 . . . . 73.11 109.649 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 24.2 m -108.86 134.46 20.34 Favored Pre-proline 0 N--CA 1.479 0.988 0 CA-C-O 118.518 -0.753 . . . . 71.24 109.822 -179.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -48.07 -52.24 8.6 Favored 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 123.88 3.054 . . . . 73.53 113.419 -178.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 8.2 tp10 -62.42 -32.61 73.48 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 122.85 0.46 . . . . 64.43 110.873 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -82.15 -14.75 55.21 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.928 0.491 . . . . 73.42 110.435 -179.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.422 ' O ' ' HD3' ' A' ' 48' ' ' LYS . 49.0 mm-40 -68.67 -58.9 3.57 Favored 'General case' 0 C--N 1.358 0.94 0 N-CA-C 107.21 -1.404 . . . . 63.35 107.21 170.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -53.23 -47.01 69.35 Favored 'General case' 0 C--N 1.352 0.705 0 CA-C-N 113.842 -1.527 . . . . 62.44 110.396 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.512 ' O ' HG12 ' A' ' 50' ' ' ILE . 0.1 OUTLIER -71.02 -48.9 50.39 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 114.747 -1.115 . . . . 74.03 111.193 -172.385 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -53.45 -46.54 69.91 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 123.849 0.718 . . . . 73.32 110.508 177.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.422 ' HD3' ' O ' ' A' ' 44' ' ' GLU . 2.1 mtpm? -63.3 -36.37 83.46 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 115.37 -0.832 . . . . 75.14 111.525 178.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -69.99 -30.26 67.55 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 122.62 0.368 . . . . 71.44 111.274 173.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.512 HG12 ' O ' ' A' ' 46' ' ' LYS . 18.3 mm -68.95 -36.87 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 108.843 -0.799 . . . . 74.43 108.843 175.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.427 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 11.5 m-80 -80.5 -20.09 44.41 Favored 'General case' 0 C--O 1.211 -0.955 0 CA-C-N 114.435 -1.257 . . . . 73.43 111.385 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -71.98 -50.38 29.28 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.328 1.051 . . . . 75.34 109.01 171.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.16 -50.78 71.77 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 113.494 -1.684 . . . . 65.45 111.076 176.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -64.51 -37.96 89.34 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-N 115.068 -0.969 . . . . 73.53 110.525 177.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 51' ' ' ASN . . . -54.23 -46.91 72.66 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.289 0.636 . . . . 72.52 112.169 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 67.9 t -72.94 -45.86 53.9 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.116 0 CA-C-N 115.955 -0.566 . . . . 74.52 110.996 177.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.408 HD13 ' HB2' ' A' ' 7' ' ' TYR . 64.2 mt -93.57 0.84 56.77 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 114.206 1.188 . . . . 74.35 114.206 -166.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.1 t -73.58 -52.79 12.25 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.464 0.649 . . . . 74.34 109.85 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -88.89 137.21 29.95 Favored Pre-proline 0 C--O 1.241 0.657 0 CA-C-N 114.737 -1.119 . . . . 74.34 109.745 -176.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.408 ' O ' ' HG2' ' A' ' 64' ' ' ARG . 48.0 Cg_exo -56.19 -26.9 63.14 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 123.346 2.697 . . . . 72.41 112.576 178.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -64.4 -59.88 3.83 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.814 0.846 . . . . 72.3 111.451 -176.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 42.0 mtmt -77.36 -23.62 50.82 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 115.842 -0.617 . . . . 74.54 111.275 -176.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 44.9 tpt85 -54.77 -54.64 39.49 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 108.919 -0.771 . . . . 74.11 108.919 166.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.458 ' HA ' ' HE ' ' A' ' 64' ' ' ARG . 2.2 mmp_? -63.27 -33.37 75.36 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.582 0.753 . . . . 74.25 112.168 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.67 HG23 ' HG3' ' A' ' 76' ' ' PRO . 89.2 mt -59.46 -45.59 93.54 Favored 'Isoleucine or valine' 0 C--O 1.253 1.24 0 C-N-CA 123.105 0.562 . . . . 74.41 110.783 174.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -66.74 -42.03 86.9 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 116.237 -0.438 . . . . 75.4 109.823 178.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -53.93 -45.82 71.32 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 123.161 0.585 . . . . 64.04 110.852 175.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 50.5 p -75.36 -19.3 59.66 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.224 -0.444 . . . . 75.44 112.013 -178.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -70.5 112.33 6.7 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 109.04 -0.726 . . . . 75.32 109.04 174.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 103.36 19.99 11.68 Favored Glycine 0 N--CA 1.474 1.171 0 N-CA-C 111.711 -0.556 . . . . 64.23 111.711 -172.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 97.6 m -142.05 -58.09 0.46 Allowed 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 103.623 -2.732 . . . . 71.23 103.623 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 29.4 m -77.8 134.37 38.03 Favored 'General case' 0 C--O 1.256 1.427 0 N-CA-C 104.399 -2.445 . . . . 74.23 104.399 155.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.18 -29.27 16.55 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.328 0.651 . . . . 74.04 111.15 -177.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -94.22 168.35 11.73 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 124.085 0.954 . . . . 75.1 109.929 177.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -53.32 140.36 62.7 Favored 'Trans proline' 0 C--N 1.378 2.108 0 C-N-CA 122.164 1.909 . . . . 75.41 112.621 165.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.67 ' HG3' HG23 ' A' ' 65' ' ' ILE . 91.4 Cg_endo -72.52 175.53 10.01 Favored 'Trans proline' 0 C--N 1.375 1.925 0 C-N-CA 123.644 2.896 . . . . 74.25 112.562 -177.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.46 121.15 9.31 Favored 'Trans proline' 0 C--N 1.38 2.2 0 C-N-CA 122.002 1.801 . . . . 73.45 111.186 171.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -63.32 130.2 27.84 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.594 2.196 . . . . 73.2 112.063 176.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -59.5 141.57 97.58 Favored 'Trans proline' 0 C--N 1.381 2.269 0 C-N-CA 122.64 2.227 . . . . 71.05 111.32 172.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.29 78.28 0.45 Allowed 'Trans proline' 0 C--N 1.382 2.298 0 C-N-CA 123.156 2.571 . . . . 74.31 112.694 -177.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 159.29 -35.38 0.48 Allowed Glycine 0 N--CA 1.467 0.713 0 N-CA-C 109.669 -1.372 . . . . 62.41 109.669 -174.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.477 ' HA3' ' HA ' ' A' ' 106' ' ' PHE . . . 130.04 167.22 12.01 Favored Glycine 0 C--N 1.351 1.375 0 CA-C-N 114.899 -0.651 . . . . 53.03 112.926 170.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -69.25 100.9 1.38 Allowed 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 108.175 -1.046 . . . . 74.41 108.175 166.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.454 ' O ' ' HD1' ' A' ' 85' ' ' PHE . 12.6 t70 -63.61 152.16 39.65 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.88 0.872 . . . . 71.31 112.969 -174.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.454 ' HD1' ' O ' ' A' ' 84' ' ' ASP . 0.3 OUTLIER -148.54 72.43 1.19 Allowed 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 124.699 1.199 . . . . 73.24 107.783 169.882 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.552 ' HA ' ' HA3' ' A' ' 163' ' ' GLY . 44.8 m -55.3 87.75 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 114.562 1.319 . . . . 74.44 114.562 -174.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.61 ' HA2' ' HB3' ' A' ' 171' ' ' PRO . . . 94.56 14.48 50.21 Favored Glycine 0 N--CA 1.47 0.942 0 CA-C-N 116.237 -0.438 . . . . 70.11 113.425 176.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -123.19 111.72 16.82 Favored 'General case' 0 C--O 1.245 0.835 0 C-N-CA 122.922 0.489 . . . . 72.34 110.133 -169.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -68.69 92.97 0.49 Allowed 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.077 0.551 . . . . 71.44 110.917 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.483 HG12 ' HG2' ' A' ' 91' ' ' GLU . 2.2 p -31.82 -49.21 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 125.521 1.529 . . . . 75.21 114.311 169.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.483 ' HG2' HG12 ' A' ' 90' ' ' VAL . 7.7 mm-40 -68.27 -14.88 63.31 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.992 0.738 . . . . 75.33 112.992 -169.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -78.54 -42.3 29.75 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.504 0.722 . . . . 61.35 111.228 171.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -77.59 178.85 6.94 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 113.46 0.911 . . . . 73.34 113.46 -165.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 67.4 p -58.18 144.4 40.76 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.777 1.231 . . . . 74.5 113.711 -166.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.452 ' O ' ' HG3' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -53.65 -43.02 68.45 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 114.401 -1.272 . . . . 74.52 110.973 172.516 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -51.18 -52.88 40.01 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.368 1.067 . . . . 75.03 111.479 176.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -57.62 -46.68 83.81 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 114.786 -1.097 . . . . 72.32 110.179 178.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.438 ' HA ' HD11 ' A' ' 105' ' ' LEU . 96.3 mt-30 -70.04 -13.01 62.02 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 115.757 -0.656 . . . . 74.14 112.527 -178.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' A' ' 95' ' ' GLU . 52.5 mt-10 -88.87 -52.63 5.01 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 122.982 0.513 . . . . 70.02 111.515 172.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 36.2 tp -65.14 -50.95 64.04 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.368 0.667 . . . . 74.33 111.014 -175.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -87.88 -6.0 58.3 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 115.606 -0.725 . . . . 72.11 110.74 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -42.68 -59.17 3.29 Favored Glycine 0 C--N 1.355 1.585 0 CA-C-O 118.625 -1.097 . . . . 72.43 114.859 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -39.83 -26.89 0.18 Allowed 'Trans proline' 0 C--N 1.393 2.877 0 C-N-CA 124.883 3.722 . . . . 64.43 116.365 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -152.03 37.63 0.81 Allowed Glycine 0 C--N 1.354 1.568 0 CA-C-O 118.975 -0.903 . . . . 54.4 113.427 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.438 HD11 ' HA ' ' A' ' 98' ' ' GLN . 33.9 mt -53.52 85.19 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 117.487 0.644 . . . . 74.25 112.232 174.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.477 ' HA ' ' HA3' ' A' ' 82' ' ' GLY . 0.6 OUTLIER 20.99 -110.88 0.01 OUTLIER 'General case' 0 CA--C 1.565 1.533 0 C-N-CA 127.348 2.259 . . . . 74.45 113.526 177.638 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.48 ' HA2' ' HA2' ' A' ' 168' ' ' GLY . . . 58.46 13.74 17.74 Favored Glycine 0 C--N 1.366 2.236 0 N-CA-C 114.388 0.515 . . . . 44.0 114.388 178.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.35 1.342 0 N-CA-C 110.753 -0.939 . . . . 71.34 110.753 -165.241 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.563 ' HZ1' ' HB3' ' A' ' 115' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.332 0 N-CA-C 113.374 0.879 . . . . 73.31 113.374 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -100.97 -164.13 27.81 Favored Glycine 0 CA--C 1.546 1.984 0 CA-C-N 115.573 -0.74 . . . . 73.4 113.304 -178.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -108.8 137.61 46.46 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 124.121 0.968 . . . . 74.43 112.257 176.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -57.87 99.04 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 122.194 0.997 . . . . 74.23 111.685 173.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 53.5 tp -103.92 157.54 17.02 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 114.45 -1.25 . . . . 75.42 110.698 -173.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 40.5 ttp180 -109.38 142.25 40.6 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 108.817 -0.809 . . . . 74.51 108.817 170.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.527 ' HB1' HD11 ' A' ' 174' ' ' LEU . . . -128.36 159.33 35.66 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.598 0.713 . . . . 54.41 111.113 177.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -116.47 109.73 17.68 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 105.944 -1.873 . . . . 72.42 105.944 -177.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.502 ' HB3' ' HA ' ' A' ' 178' ' ' VAL . 37.5 tp -98.86 96.58 4.11 Favored Pre-proline 0 N--CA 1.475 0.805 0 N-CA-C 108.228 -1.027 . . . . 74.14 108.228 -174.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.524 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 97.5 Cg_endo -78.75 107.72 2.31 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 121.065 1.176 . . . . 75.33 109.307 -176.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.438 ' HB3' HD23 ' A' ' 180' ' ' LEU . 43.1 tp -106.76 131.47 53.84 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 122.755 0.422 . . . . 72.43 110.238 -167.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 72.9 m -59.41 124.19 19.25 Favored 'General case' 0 CA--C 1.555 1.171 0 O-C-N 124.609 1.193 . . . . 71.34 109.037 173.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.569 ' HB3' HD22 ' A' ' 215' ' ' LEU . 61.1 mt -53.78 -40.02 65.91 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 124.16 0.984 . . . . 75.21 111.743 -171.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 16.0 mp0 -65.02 -35.42 81.14 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 114.228 -1.351 . . . . 75.32 109.683 -178.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -78.67 -22.45 46.77 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.657 0.783 . . . . 64.33 111.165 177.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -68.05 -33.73 75.13 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 109.952 -0.388 . . . . 65.44 109.952 171.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.425 ' HB2' HD13 ' A' ' 215' ' ' LEU . 82.3 t80 -74.75 -47.55 30.54 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 115.236 -0.893 . . . . 74.51 111.488 173.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 51.2 m170 -69.87 -53.82 16.28 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.416 0.686 . . . . 75.25 110.921 -173.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.91 -168.42 41.23 Favored Glycine 0 C--N 1.344 1.003 0 CA-C-N 115.78 -0.645 . . . . 71.54 112.84 -178.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 98.44 -164.62 21.17 Favored Glycine 0 C--N 1.349 1.28 0 C-N-CA 123.011 0.339 . . . . 70.42 113.512 175.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -72.06 110.59 6.64 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.535 0.734 . . . . 73.14 110.409 177.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -93.85 122.48 36.38 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 122.861 0.464 . . . . 75.05 110.604 177.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 57.4 t -78.18 113.93 18.08 Favored 'Isoleucine or valine' 0 C--O 1.243 0.728 0 N-CA-C 108.428 -0.953 . . . . 75.04 108.428 169.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.535 HG11 HG13 ' A' ' 145' ' ' VAL . 3.8 p -134.25 136.57 53.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 124.49 1.116 . . . . 73.34 108.683 178.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -123.78 133.32 53.85 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.312 0.645 . . . . 71.3 110.677 -167.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.534 HG11 HD23 ' B' ' 8' ' ' LEU . 12.4 p -166.04 135.34 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.128 0.971 . . . . 75.1 109.318 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 53.23 38.49 27.76 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.196 0.999 . . . . 74.24 112.774 173.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 86.52 -21.82 16.23 Favored Glycine 0 C--N 1.353 1.504 0 CA-C-N 116.551 -0.295 . . . . 54.15 113.323 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.563 HH12 ' HG2' ' A' ' 164' ' ' MET . 12.1 tpt180 -81.82 99.27 8.91 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.138 0.975 . . . . 72.43 111.019 -179.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 38.0 ttp180 -84.65 89.38 7.47 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 107.867 -1.16 . . . . 74.41 107.867 165.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.535 HG13 HG11 ' A' ' 138' ' ' VAL . 3.0 p -97.09 145.58 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 114.783 -1.099 . . . . 73.53 110.877 -175.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 34.2 t -106.04 85.38 2.2 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.425 -0.807 . . . . 64.43 109.1 177.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 35.7 m -84.58 121.88 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 N-CA-C 109.929 -0.397 . . . . 73.42 109.929 -177.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -74.44 97.16 3.02 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.101 0.477 . . . . 74.32 109.817 -178.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 26.9 pt -78.35 123.41 85.8 Favored Pre-proline 0 CA--C 1.557 1.219 0 CA-C-N 115.267 -0.878 . . . . 74.52 109.305 174.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -63.16 135.02 48.58 Favored 'Trans proline' 0 C--N 1.372 1.78 0 C-N-CA 122.642 2.228 . . . . 74.22 112.204 176.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -61.84 96.15 0.14 Allowed 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 122.373 2.048 . . . . 74.15 111.143 171.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.553 ' HA2' ' HD2' ' A' ' 240' ' ' PHE . . . 116.5 35.14 1.21 Allowed Glycine 0 C--N 1.342 0.896 0 CA-C-N 115.481 -0.782 . . . . 75.51 111.536 -172.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.509 HG22 HG13 ' A' ' 178' ' ' VAL . 4.7 p -89.26 135.47 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 123.39 0.676 . . . . 75.43 109.496 -178.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.765 ' HD2' ' HA ' ' A' ' 191' ' ' GLN . 7.9 mtm-85 -123.77 148.72 46.4 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 115.322 -0.854 . . . . 73.23 110.502 -162.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.434 ' HB3' ' O ' ' A' ' 188' ' ' LEU . 6.8 tp10 -52.58 118.82 3.89 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 124.357 1.063 . . . . 72.32 110.464 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 105.78 -2.54 38.86 Favored Glycine 0 C--N 1.344 1.006 0 CA-C-N 115.71 -0.677 . . . . 74.33 113.276 -176.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 26.6 t -72.34 104.31 3.69 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 108.915 -0.772 . . . . 74.23 108.915 177.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.462 HG21 HG23 ' A' ' 177' ' ' VAL . 55.6 t -86.03 95.88 4.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 123.689 0.795 . . . . 74.02 109.558 -178.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.52 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 47.7 mt -77.84 92.82 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 N-CA-C 107.809 -1.182 . . . . 75.24 107.809 169.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 65.5 ttt-85 -72.68 114.96 11.39 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 107.928 -1.138 . . . . 75.21 107.928 177.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.455 HG13 ' SD ' ' A' ' 164' ' ' MET . 7.1 p -125.46 129.51 24.4 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 123.523 0.729 . . . . 71.41 109.154 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -73.93 149.3 41.89 Favored 'Trans proline' 0 CA--C 1.552 1.413 0 C-N-CA 122.069 1.846 . . . . 74.53 111.949 177.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . 0.553 ' HA2' ' HA ' ' A' ' 171' ' ' PRO . . . 83.43 -25.51 4.98 Favored Glycine 0 N--CA 1.48 1.602 0 N-CA-C 116.244 1.258 . . . . 70.43 116.244 169.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.563 ' HG2' HH12 ' A' ' 143' ' ' ARG . 66.5 mtp -75.0 -23.67 58.28 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 117.679 0.74 . . . . 64.15 111.763 -178.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.453 ' HA2' HD12 ' A' ' 174' ' ' LEU . . . -82.37 -103.21 0.44 Allowed Glycine 0 C--N 1.35 1.35 0 CA-C-O 119.747 -0.474 . . . . 73.33 113.255 -175.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -54.99 115.61 5.8 Favored Glycine 0 C--O 1.278 2.861 0 O-C-N 124.005 0.473 . . . . 74.5 113.422 173.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -56.85 103.45 0.11 Allowed 'General case' 0 C--N 1.355 0.812 0 O-C-N 127.59 2.582 . . . . 75.42 109.088 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.48 ' HA2' ' HA2' ' A' ' 107' ' ' GLY . . . -176.85 139.12 4.29 Favored Glycine 0 N--CA 1.436 -1.32 0 CA-C-N 113.347 -1.751 . . . . 64.21 108.943 -170.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . 0.483 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . 0.1 OUTLIER -73.55 -49.46 6.49 Favored Pre-proline 0 CA--C 1.559 1.294 0 N-CA-C 109.04 -0.726 . . . . 63.54 109.04 -173.422 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.483 ' HD3' ' HB3' ' A' ' 169' ' ' ASN . 28.2 Cg_exo -68.58 146.3 67.08 Favored 'Trans proline' 0 C--N 1.379 2.132 0 N-CA-C 107.991 -1.58 . . . . 73.02 107.991 156.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.61 ' HB3' ' HA2' ' A' ' 87' ' ' GLY . 56.4 Cg_endo -64.17 120.99 8.49 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.878 2.385 . . . . 71.25 116.312 -161.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -62.93 -43.0 99.56 Favored Glycine 0 C--N 1.374 2.681 0 C-N-CA 119.169 -1.491 . . . . 72.4 111.927 161.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 95.31 147.74 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 127.396 2.279 . . . . 71.14 108.563 175.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.527 HD11 ' HB1' ' A' ' 121' ' ' ALA . 27.9 tp -140.17 143.94 36.38 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.09 0.471 . . . . 74.2 111.162 -171.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 54.0 mt -108.95 90.57 3.33 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 114.746 -1.115 . . . . 72.12 108.254 170.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.52 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 78.7 mt -69.37 87.43 0.44 Allowed 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 109.335 -0.617 . . . . 74.52 109.335 174.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.462 HG23 HG21 ' A' ' 158' ' ' VAL . 11.9 t -84.31 104.67 12.86 Favored 'Isoleucine or valine' 0 C--O 1.245 0.827 0 N-CA-C 106.182 -1.784 . . . . 71.11 106.182 174.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.509 HG13 HG22 ' A' ' 153' ' ' VAL . 9.9 p -67.51 125.67 25.55 Favored 'Isoleucine or valine' 0 C--N 1.349 0.566 0 CA-C-O 121.961 0.886 . . . . 74.13 109.381 -175.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.524 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 28.6 mmt180 -111.94 119.18 37.63 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 107.54 -1.281 . . . . 73.42 107.54 179.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.438 HD23 ' HB3' ' A' ' 125' ' ' LEU . 56.7 mt -83.38 144.02 29.92 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-N 118.348 0.522 . . . . 74.04 110.014 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 41.6 mt -54.22 153.54 9.41 Favored Pre-proline 0 N--CA 1.488 1.447 0 C-N-CA 123.898 0.879 . . . . 73.22 112.808 -169.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.93 16.79 0.41 Allowed 'Trans proline' 0 C--N 1.387 2.557 0 C-N-CA 122.97 2.447 . . . . 74.32 113.329 175.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -60.91 101.9 0.28 Allowed Pre-proline 0 CA--C 1.557 1.247 0 N-CA-C 107.213 -1.403 . . . . 73.35 107.213 164.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -78.55 25.87 0.53 Allowed 'Trans proline' 0 C--N 1.375 1.932 0 C-N-CA 124.066 3.177 . . . . 61.24 115.478 -161.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 82.3 t -96.88 -32.27 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 109.946 -0.39 . . . . 72.34 109.946 -176.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . 0.737 ' HE1' ' HA ' ' A' ' 214' ' ' THR . 35.3 m-85 -145.9 98.87 3.18 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 121.279 0.561 . . . . 72.31 111.935 178.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . 0.614 ' HB3' ' HB2' ' A' ' 194' ' ' TYR . 52.3 ttt180 -85.93 81.63 8.45 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 107.863 -1.162 . . . . 75.51 107.863 164.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.435 ' HB2' HD22 ' A' ' 193' ' ' LEU . 35.5 tp -78.1 94.52 4.7 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-N 115.228 -0.896 . . . . 74.21 108.671 175.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -114.26 129.98 56.64 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.185 0.594 . . . . 70.31 109.753 -176.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 77.11 -73.89 1.92 Allowed Glycine 0 C--N 1.351 1.389 0 O-C-N 123.85 0.719 . . . . 65.41 111.98 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.765 ' HA ' ' HD2' ' A' ' 154' ' ' ARG . 13.6 pt20 -154.78 -7.23 0.14 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.655 0.782 . . . . 72.32 111.173 172.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -123.05 152.87 40.57 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.472 -0.785 . . . . 72.32 110.671 -167.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.435 HD22 ' HB2' ' A' ' 188' ' ' LEU . 38.8 mt -95.33 152.52 18.31 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 114.642 -1.163 . . . . 74.25 111.032 -168.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.614 ' HB2' ' HB3' ' A' ' 187' ' ' ARG . 91.8 m-85 -132.61 103.93 6.39 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 107.633 -1.247 . . . . 73.14 107.633 171.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.424 ' HB2' HD22 ' A' ' 251' ' ' LEU . . . -129.9 112.6 13.7 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.472 1.109 . . . . 74.34 110.008 -172.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 86.0 m -68.72 122.56 18.81 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-O 120.944 0.402 . . . . 70.21 111.187 -179.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.477 HD22 HD13 ' A' ' 251' ' ' LEU . 44.7 tp -108.97 119.54 39.86 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.861 0.865 . . . . 74.1 110.337 -173.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -80.02 116.96 20.44 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 108.296 -1.001 . . . . 63.3 108.296 174.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 2.8 p -144.23 127.66 8.82 Favored Pre-proline 0 N--CA 1.478 0.951 0 C-N-CA 123.335 0.654 . . . . 74.33 110.282 -175.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -72.8 150.87 50.59 Favored 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 121.868 1.712 . . . . 70.05 111.88 176.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -42.24 -60.23 2.23 Favored Pre-proline 0 N--CA 1.487 1.406 0 N-CA-C 116.485 2.032 . . . . 71.34 116.485 -173.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -75.07 -18.96 18.15 Favored 'Trans proline' 0 C--N 1.382 2.339 0 CA-C-N 121.524 1.58 . . . . 73.32 113.081 -173.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 16.4 mt -73.37 -34.73 44.21 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 N-CA-C 109.257 -0.646 . . . . 71.02 109.257 172.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.54 -42.87 81.99 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 123.094 0.558 . . . . 74.14 111.482 173.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 71.6 t -72.96 -44.45 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 123.59 0.756 . . . . 64.22 112.513 -174.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 78.7 t -88.76 -37.08 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 122.759 0.424 . . . . 74.41 110.933 -176.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 98.53 77.55 1.33 Allowed Glycine 0 C--N 1.339 0.713 0 N-CA-C 111.651 -0.58 . . . . 72.35 111.651 -176.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -103.44 -144.35 13.73 Favored Glycine 0 C--N 1.34 0.763 0 CA-C-N 115.255 -0.472 . . . . 73.32 112.042 178.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.538 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 43.1 mtmt -127.55 147.03 50.33 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 122.863 0.465 . . . . 73.34 110.614 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 24.8 m -137.14 -177.07 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.634 1.174 . . . . 63.11 108.861 170.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 26.2 ttm180 -116.62 129.24 56.04 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.609 0.763 . . . . 74.32 108.998 171.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -109.03 149.37 29.36 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.444 -0.947 . . . . 74.41 108.444 173.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -88.78 145.95 25.3 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.059 -0.719 . . . . 74.15 109.059 174.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' THR . . . . . 0.737 ' HA ' ' HE1' ' A' ' 186' ' ' PHE . 41.0 p -127.94 174.27 9.32 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 123.914 0.886 . . . . 74.1 109.635 172.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . 0.569 HD22 ' HB3' ' A' ' 127' ' ' LEU . 24.6 mt -59.19 -36.56 75.56 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.001 0.92 . . . . 73.14 110.889 -176.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.419 ' HA ' ' NZ ' ' B' ' 2' ' ' LYS . 15.1 mm-40 -98.87 2.07 46.32 Favored 'General case' 0 CA--C 1.554 1.127 0 CA-C-N 114.714 -1.13 . . . . 64.44 112.539 -172.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 140.8 -173.53 23.12 Favored Glycine 0 N--CA 1.483 1.77 0 CA-C-O 119.253 -0.748 . . . . 63.05 112.785 176.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -79.28 155.67 25.41 Favored 'Trans proline' 0 C--N 1.369 1.643 0 C-N-CA 122.644 2.229 . . . . 74.13 111.8 176.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 18.4 m -148.26 157.08 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 C-N-CA 123.888 0.875 . . . . 73.4 111.066 -177.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -91.24 124.93 35.82 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.951 0.9 . . . . 75.04 109.809 178.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 97.1 t -136.13 123.3 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.22 1.008 . . . . 74.51 109.163 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.538 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -89.98 133.68 34.66 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 118.163 0.438 . . . . 70.4 111.207 178.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 44.5 t -78.61 145.42 67.17 Favored Pre-proline 0 CA--C 1.561 1.384 0 C-N-CA 125.571 1.548 . . . . 71.22 110.051 -178.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -78.93 172.12 15.45 Favored 'Trans proline' 0 C--N 1.386 2.509 0 C-N-CA 122.767 2.312 . . . . 75.51 111.51 172.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.42 150.74 28.73 Favored 'Trans proline' 0 C--N 1.373 1.829 0 C-N-CA 121.87 1.713 . . . . 72.53 113.274 175.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . 0.475 HH12 ' HB2' ' C' ' 261' ' ' LEU . 85.9 mtt-85 64.16 30.04 13.81 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 125.851 1.661 . . . . 75.13 111.477 172.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.539 HG22 HD22 ' A' ' 233' ' ' LEU . 43.7 m -66.15 106.27 1.6 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.516 1.526 . . . . 64.32 111.291 178.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . 0.444 ' HB3' ' HD2' ' A' ' 231' ' ' ARG . 6.4 tp-100 -93.16 140.39 29.57 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.021 0.928 . . . . 75.32 110.657 -176.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . 0.439 ' HA ' ' HB ' ' A' ' 253' ' ' VAL . . . -66.07 157.59 30.68 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.849 0.86 . . . . 65.12 111.782 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 82.96 -40.19 2.79 Favored Glycine 0 C--N 1.347 1.179 0 CA-C-N 116.189 -0.459 . . . . 75.54 112.043 -177.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.444 ' HD2' ' HB3' ' A' ' 228' ' ' GLN . 92.6 mtt180 -66.4 157.67 31.3 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 124.147 0.979 . . . . 74.44 111.437 175.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.743 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 3.3 mptp? -109.94 125.59 53.01 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 114.856 -1.065 . . . . 72.22 108.418 177.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.539 HD22 HG22 ' A' ' 227' ' ' THR . 87.4 mt -76.14 104.82 6.85 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.883 -0.784 . . . . 71.4 108.883 177.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 18.4 ttp180 -84.95 109.6 18.27 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.27 0.628 . . . . 73.41 110.324 178.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.472 ' HG ' ' HB3' ' A' ' 249' ' ' LEU . 0.4 OUTLIER -120.57 117.1 26.73 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.972 0.909 . . . . 74.24 109.75 175.127 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 30.8 mmtm -60.69 151.08 30.18 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.916 1.286 . . . . 71.01 113.277 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 71.23 32.21 65.63 Favored Glycine 0 C--N 1.356 1.656 0 CA-C-N 114.682 -1.145 . . . . 74.2 113.604 172.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.459 ' HG3' HD11 ' A' ' 235' ' ' LEU . 41.8 mmtm -130.32 -30.31 1.94 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.524 0.73 . . . . 74.1 110.565 -174.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -73.04 173.87 47.64 Favored Glycine 0 C--N 1.351 1.396 0 O-C-N 123.301 0.376 . . . . 74.43 112.451 171.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . 0.553 ' HD2' ' HA2' ' A' ' 152' ' ' GLY . 5.7 m-85 -91.78 158.15 40.51 Favored Pre-proline 0 N--CA 1.48 1.044 0 C-N-CA 123.204 0.602 . . . . 73.41 110.85 -169.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -61.09 111.05 0.97 Allowed 'Trans proline' 0 C--N 1.387 2.558 0 C-N-CA 123.054 2.503 . . . . 73.33 112.158 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -125.31 -150.34 7.73 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-O 119.337 -0.702 . . . . 73.52 112.212 179.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . 0.419 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 32.6 Cg_endo -63.33 -30.77 73.48 Favored 'Trans proline' 0 C--N 1.373 1.848 0 C-N-CA 122.895 2.397 . . . . 72.5 113.07 -177.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . 0.426 ' HB3' HE22 ' A' ' 191' ' ' GLN . . . -107.28 12.7 27.93 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.867 0.867 . . . . 70.11 111.4 178.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 87.66 -161.61 32.37 Favored Glycine 0 C--N 1.345 1.053 0 CA-C-N 116.327 -0.397 . . . . 62.24 112.158 -174.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 66.4 mtt85 -59.46 108.83 0.77 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.337 0.655 . . . . 75.41 110.676 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -70.5 -157.39 2.11 Favored Glycine 0 C--N 1.347 1.142 0 CA-C-N 115.605 -0.725 . . . . 70.31 113.758 -178.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -100.48 166.28 11.01 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.924 0.869 . . . . 75.44 110.641 178.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.472 ' HB3' ' HG ' ' A' ' 235' ' ' LEU . 14.5 tp -102.64 128.36 49.36 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 106.284 -1.746 . . . . 73.32 106.284 164.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.743 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 18.6 m-85 -108.77 105.1 14.54 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 107.609 -1.256 . . . . 71.3 107.609 173.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.533 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 40.1 mt -90.7 103.93 16.57 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 109.245 -0.65 . . . . 74.54 109.245 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . 0.488 ' HG2' ' HG3' ' A' ' 232' ' ' LYS . 22.3 mt-10 -76.7 101.69 5.89 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.146 0.978 . . . . 75.41 108.758 -170.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.439 ' HB ' ' HA ' ' A' ' 229' ' ' ALA . 27.0 t -64.31 122.96 16.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-N 114.849 -1.068 . . . . 71.34 112.504 -167.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 5.7 mmt180 -122.42 96.29 4.98 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.423 1.089 . . . . 73.14 108.604 169.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.442 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 73.1 mt -72.94 117.09 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 114.171 -1.377 . . . . 74.34 109.57 178.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 41.1 p -110.3 174.17 5.99 Favored 'General case' 0 C--O 1.255 1.348 0 C-N-CA 124.445 1.098 . . . . 74.52 110.092 178.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 26.1 pt -132.87 151.8 78.68 Favored Pre-proline 0 CA--C 1.554 1.135 0 CA-C-N 114.93 -1.032 . . . . 73.4 108.778 177.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -87.22 22.09 0.97 Allowed 'Trans proline' 0 C--N 1.365 1.429 0 C-N-CA 122.725 2.283 . . . . 74.45 112.962 -171.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 33.83 -87.89 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 125.303 1.441 . . . . 75.12 113.49 -165.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.47 132.52 47.14 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.775 0.83 . . . . 75.12 110.945 -170.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.508 HD13 HG11 ' C' ' 205' ' ' VAL . 86.0 mt -127.64 170.42 12.7 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.521 0.728 . . . . 72.32 111.094 -174.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 75.1 p -104.8 159.78 28.21 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-N 114.598 -1.183 . . . . 74.31 110.174 171.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_exo -32.7 -46.92 0.3 Allowed 'Trans proline' 0 C--N 1.383 2.346 0 C-N-CA 124.831 3.687 . . . . 74.33 116.044 172.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -57.62 -64.41 0.91 Allowed 'General case' 0 C--O 1.25 1.114 0 C-N-CA 123.987 0.915 . . . . 71.44 111.197 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -59.5 -48.3 82.17 Favored 'General case' 0 C--N 1.349 0.562 0 CA-C-N 114.54 -1.209 . . . . 73.22 110.2 -176.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' GLU . . . . . 0.523 ' O ' ' HG2' ' A' ' 270' ' ' LYS . 7.1 tp10 -53.03 -52.93 56.88 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 124.617 1.198 . . . . 73.45 111.099 -176.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -63.5 -45.19 91.84 Favored 'General case' 0 C--O 1.254 1.294 0 O-C-N 124.199 0.937 . . . . 64.12 111.94 -178.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 9.4 mp -63.38 -34.09 76.97 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-N 115.826 -0.624 . . . . 73.14 111.358 178.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' TRP . . . . . 0.406 ' O ' HG11 ' C' ' 206' ' ' VAL . 61.7 m95 -75.97 -30.51 58.63 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 118.677 -0.677 . . . . 75.0 111.349 177.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . 0.523 ' HG2' ' O ' ' A' ' 266' ' ' GLU . 0.0 OUTLIER -57.37 -60.73 3.2 Favored 'General case' 0 C--O 1.267 2.005 0 N-CA-C 108.214 -1.032 . . . . 73.12 108.214 175.103 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . 0.667 ' HZ1' ' HB3' ' A' ' 271' ' ' LYS . 9.9 mtpm? -55.67 -50.24 70.78 Favored 'General case' 0 C--N 1.357 0.928 0 CA-C-N 112.002 -2.363 . . . . 70.22 110.66 -178.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 2.1 tt -58.1 -58.93 6.28 Favored 'General case' 0 C--O 1.191 -2.026 0 O-C-N 124.298 0.999 . . . . 71.54 108.992 -177.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . 0.464 ' O ' ' HB3' ' A' ' 276' ' ' TYR . . . -56.21 -48.77 75.77 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 114.236 1.199 . . . . 72.23 114.236 -170.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -89.21 -21.85 23.06 Favored 'General case' 0 C--O 1.252 1.189 0 N-CA-C 112.68 0.622 . . . . 74.35 112.68 -172.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -80.47 -26.24 38.4 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.988 -0.445 . . . . 72.24 110.697 168.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . 0.464 ' HB3' ' O ' ' A' ' 273' ' ' ALA . 2.2 t80 -58.92 -55.81 30.28 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 125.79 1.636 . . . . 75.02 107.797 170.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -44.91 -66.1 0.44 Allowed 'General case' 0 C--O 1.249 1.077 0 O-C-N 125.538 1.774 . . . . 72.14 109.431 173.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -62.82 -14.24 43.11 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 114.76 -1.109 . . . . 75.41 113.841 -175.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 86.7 mtm180 -132.17 34.16 3.82 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 122.927 0.491 . . . . 75.15 110.228 -175.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.568 1.673 0 O-C-N 124.261 0.976 . . . . 72.5 113.134 175.712 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.443 ' SD ' ' N ' ' B' ' 1' ' ' MET . 1.6 mpt? . . . . . 0 N--CA 1.48 1.073 0 N-CA-C 110.338 -0.245 . . . . 74.12 110.338 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . 0.419 ' NZ ' ' HA ' ' A' ' 216' ' ' GLU . 13.3 mptt -75.16 116.93 16.43 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.668 0.787 . . . . 62.45 110.788 178.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -168.58 -38.15 0.02 OUTLIER 'General case' 0 C--O 1.242 0.701 0 C-N-CA 124.361 1.064 . . . . 74.04 109.358 174.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 23.3 t 65.39 -177.59 0.18 Allowed 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.567 1.147 . . . . 52.14 111.027 -179.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 94.6 m 68.69 131.76 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.561 1.144 . . . . 74.34 112.182 177.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 138' ' ' VAL . 42.8 pt -140.5 173.44 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.584 0.754 . . . . 65.34 110.565 -175.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -132.82 129.83 39.03 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.544 0.738 . . . . 72.22 110.269 177.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . 0.534 HD23 HG11 ' A' ' 140' ' ' VAL . 50.1 tp -78.51 155.56 29.72 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.036 0.934 . . . . 75.22 110.97 -174.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.31 -68.31 0.69 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 122.932 0.493 . . . . 73.12 111.437 176.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . 0.484 HD23 ' HB1' ' A' ' 121' ' ' ALA . 51.7 mt 68.32 2.98 3.51 Favored 'General case' 0 N--CA 1.501 2.094 0 C-N-CA 124.871 1.269 . . . . 74.1 111.844 -164.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 56.7 mt . . . . . 0 CA--C 1.555 1.169 0 C-N-CA 124.564 1.146 . . . . 72.11 112.137 -175.367 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.449 0 N-CA-C 107.346 -1.353 . . . . 74.35 107.346 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 180' ' ' ALA . . . . . 0.524 ' HB2' HG13 ' C' ' 137' ' ' VAL . . . -145.77 -63.0 0.33 Allowed 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 105.292 -2.114 . . . . 75.32 105.292 169.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 181' ' ' LEU . . . . . 0.579 ' HB3' HG13 ' C' ' 138' ' ' VAL . 37.0 tp -148.37 -32.44 0.25 Allowed 'General case' 0 CA--C 1.553 1.087 0 CA-C-N 114.22 -1.355 . . . . 74.44 108.837 160.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 182' ' ' VAL . . . . . 0.582 HG12 HD12 ' C' ' 123' ' ' LEU . 32.6 m -118.6 -176.88 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 C-N-CA 124.53 1.132 . . . . 72.43 111.499 177.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 183' ' ' ALA . . . . . 0.544 ' HB3' ' HD2' ' C' ' 124' ' ' PRO . . . -112.21 -95.44 0.44 Allowed 'General case' 0 C--N 1.357 0.92 0 C-N-CA 123.976 0.91 . . . . 65.24 110.163 167.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 35.9 m80 -157.58 -171.19 3.47 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 123.689 0.796 . . . . 75.32 110.881 -170.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 185' ' ' VAL . . . . . 0.549 HG22 HD21 ' C' ' 119' ' ' LEU . 25.1 t . . . . . 0 N--CA 1.499 1.98 0 C-N-CA 124.761 1.224 . . . . 74.01 112.853 -171.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 56.8 m . . . . . 0 N--CA 1.496 1.871 0 CA-C-O 118.359 -0.829 . . . . 71.31 110.495 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -173.92 -174.48 0.94 Allowed 'General case' 0 C--N 1.377 1.782 0 N-CA-C 114.028 1.121 . . . . 74.42 114.028 174.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . -116.62 -138.21 6.19 Favored Glycine 0 C--N 1.362 2.004 0 C-N-CA 125.348 1.451 . . . . 71.23 110.902 175.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 241' ' ' GLU . . . . . 0.43 ' HB3' ' HE3' ' B' ' 245' ' ' LYS . 11.6 pt-20 -156.65 177.05 11.92 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 117.452 0.626 . . . . 71.23 111.066 174.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 242' ' ' TRP . . . . . 0.464 ' CD2' ' HG ' ' C' ' 233' ' ' LEU . 0.0 OUTLIER -158.87 -39.46 0.06 Allowed 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.991 1.316 . . . . 70.32 108.944 179.483 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -126.36 -168.32 1.84 Allowed 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 107.484 -1.302 . . . . 74.22 107.484 162.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -71.87 91.42 0.51 Allowed Glycine 0 C--N 1.344 1.007 0 CA-C-N 116.611 -0.268 . . . . 71.54 112.529 171.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 245' ' ' LYS . . . . . 0.465 ' HA ' ' HA ' ' C' ' 224' ' ' PRO . 0.7 OUTLIER . . . . . 0 N--CA 1.482 1.158 0 C-N-CA 124.525 1.13 . . . . 75.34 110.592 176.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.95 0 CA-C-O 120.89 0.376 . . . . 71.34 110.576 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -38.52 110.12 0.12 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.129 1.772 . . . . 70.52 113.253 177.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 5' ' ' LYS . . . . . 0.514 ' HB3' HD13 ' C' ' 10' ' ' ILE . 37.7 mtpt -95.71 104.73 16.66 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 108.506 -0.924 . . . . 72.32 108.506 167.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -66.98 104.32 1.35 Allowed 'General case' 0 C--N 1.351 0.658 0 N-CA-C 109.08 -0.711 . . . . 65.15 109.08 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 7' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -63.92 -29.59 70.75 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 124.088 0.868 . . . . 73.43 112.443 -169.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -71.34 -40.43 70.71 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 122.516 0.326 . . . . 74.23 110.38 178.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.11 -37.82 88.69 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 122.825 0.45 . . . . 63.34 110.271 177.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 10' ' ' ILE . . . . . 0.514 HD13 ' HB3' ' C' ' 5' ' ' LYS . 69.4 mt -59.74 -40.25 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 123.186 0.594 . . . . 73.31 110.128 173.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 92.7 mt -82.08 -8.2 59.65 Favored 'General case' 0 CA--C 1.556 1.186 0 N-CA-C 112.935 0.717 . . . . 75.53 112.935 176.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 67.67 35.7 86.36 Favored Glycine 0 C--N 1.352 1.464 0 N-CA-C 113.845 0.298 . . . . 74.43 113.845 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 11.7 m -124.15 160.31 52.89 Favored Pre-proline 0 N--CA 1.486 1.372 0 C-N-CA 125.08 1.352 . . . . 71.34 110.175 178.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -56.91 152.24 44.41 Favored 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 122.933 2.422 . . . . 74.43 113.485 175.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -79.67 28.56 0.26 Allowed 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 113.746 1.017 . . . . 74.35 113.746 -171.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -154.83 27.73 0.43 Allowed 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 108.008 -1.108 . . . . 71.24 108.008 171.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.07 154.24 40.11 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.183 -0.917 . . . . 75.2 111.896 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 69.4 p -95.53 179.42 5.15 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.002 0.921 . . . . 74.41 111.912 -172.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -52.94 -45.0 67.47 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.46 1.104 . . . . 74.45 111.957 -177.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -70.41 -32.85 70.64 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 123.56 0.537 . . . . 74.53 111.746 -177.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -71.57 -43.04 67.05 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 122.907 0.483 . . . . 73.42 110.489 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 1.7 mp -64.86 -38.24 82.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 123.758 0.823 . . . . 75.54 110.221 175.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -64.43 -52.25 59.07 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.124 0.969 . . . . 74.13 111.031 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -69.8 -34.14 73.32 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.467 -0.788 . . . . 73.52 111.087 -177.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -72.38 -35.58 68.5 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.292 0.637 . . . . 75.32 110.979 178.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 26' ' ' TYR . . . . . 0.455 ' HD1' HG23 ' C' ' 50' ' ' ILE . 32.8 t80 -56.75 -61.35 2.49 Favored 'General case' 0 C--O 1.209 -1.065 0 O-C-N 124.261 0.976 . . . . 72.31 108.98 171.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -58.22 -41.67 84.57 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 124.15 0.906 . . . . 75.33 111.929 -177.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 45.7 ttt180 -50.75 -53.89 27.9 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.981 1.312 . . . . 75.55 110.699 176.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 87.1 mt -92.11 -6.2 51.32 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.228 -0.896 . . . . 71.43 111.743 -176.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.65 -4.7 47.18 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.694 0.798 . . . . 75.32 110.145 173.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 58.6 mtp180 -103.96 -35.2 8.21 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.92 0.888 . . . . 73.5 109.53 166.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.98 -55.15 15.73 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 109.506 -0.553 . . . . 71.12 109.506 178.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -89.9 7.22 38.39 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 112.046 0.387 . . . . 72.14 112.046 -177.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 34' ' ' HIS . . . . . . . . . . . . . 31.8 t60 -61.28 105.3 0.57 Allowed Pre-proline 0 N--CA 1.478 0.964 0 C-N-CA 124.241 1.016 . . . . 74.34 110.406 -176.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -53.87 -28.36 48.27 Favored 'Trans proline' 0 N--CA 1.507 2.29 0 C-N-CA 123.467 2.778 . . . . 72.22 115.393 -171.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -68.79 -31.81 71.08 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.534 0.734 . . . . 60.34 111.711 178.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 97.9 t -90.96 -50.7 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.402 0.681 . . . . 75.33 109.93 176.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -105.38 92.22 4.11 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.426 1.491 . . . . 65.41 108.605 -173.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -76.36 81.53 3.1 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 108.733 -0.839 . . . . 71.22 108.733 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 45.9 m -147.84 128.63 6.97 Favored Pre-proline 0 N--CA 1.48 1.06 0 C-N-CA 123.244 0.618 . . . . 74.14 110.342 177.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.8 -40.2 86.12 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 122.903 2.402 . . . . 75.0 111.002 174.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -53.0 -46.19 68.22 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 114.871 -1.059 . . . . 71.01 111.004 174.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.71 -16.9 56.69 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 122.616 0.367 . . . . 71.45 110.649 -175.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -73.97 -47.99 33.53 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 107.68 -1.23 . . . . 74.04 107.68 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -70.58 -38.06 74.0 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 114.055 -1.429 . . . . 75.44 111.465 178.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 46' ' ' LYS . . . . . 0.528 ' O ' HG12 ' C' ' 50' ' ' ILE . 34.0 mmtm -64.54 -37.34 87.22 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 116.224 -0.444 . . . . 72.32 110.577 175.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -62.2 -40.98 97.9 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.486 0.715 . . . . 71.12 109.665 175.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -60.3 -38.37 83.42 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 123.391 0.432 . . . . 72.04 111.554 173.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -68.48 -33.91 74.99 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 122.744 0.418 . . . . 72.33 111.473 177.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 50' ' ' ILE . . . . . 0.528 HG12 ' O ' ' C' ' 46' ' ' LYS . 26.6 mm -68.77 -32.82 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 N-CA-C 109.246 -0.65 . . . . 75.43 109.246 174.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 51' ' ' ASN . . . . . 0.41 ' HB3' ' HD1' ' C' ' 88' ' ' PHE . 0.9 OUTLIER -74.12 -32.1 63.04 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 114.998 -1.001 . . . . 74.04 111.05 177.761 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -66.35 -57.28 7.81 Favored 'General case' 0 C--O 1.248 0.992 0 C-N-CA 123.966 0.906 . . . . 75.54 109.903 175.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -52.15 -54.98 24.03 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 113.632 -1.622 . . . . 63.1 111.194 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -61.19 -46.11 91.84 Favored 'General case' 0 C--O 1.21 -1.024 0 CA-C-N 115.278 -0.874 . . . . 75.01 111.405 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.42 -47.55 72.66 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 122.841 0.456 . . . . 60.54 112.007 -176.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 90.5 t -63.93 -44.08 97.87 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 O-C-N 123.93 0.769 . . . . 72.43 110.331 177.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 57' ' ' LEU . . . . . . . . . . . . . 52.4 mt -88.17 0.17 56.37 Favored 'General case' 0 CA--C 1.564 1.482 0 N-CA-C 113.283 0.846 . . . . 75.02 113.283 -174.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 33.5 t -87.1 -51.31 6.07 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.142 0.977 . . . . 75.33 109.801 -178.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.44 123.06 84.56 Favored Pre-proline 0 C--O 1.217 -0.631 0 N-CA-C 107.845 -1.169 . . . . 72.03 107.845 172.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 60' ' ' PRO . . . . . 0.569 ' HD2' ' HA ' ' C' ' 145' ' ' VAL . 15.0 Cg_endo -55.95 -29.21 72.38 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 122.696 2.264 . . . . 73.21 111.216 170.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -65.39 -64.38 0.88 Allowed 'General case' 0 C--N 1.35 0.595 0 CA-C-N 115.626 -0.715 . . . . 62.13 110.825 176.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 62' ' ' LYS . . . . . 0.494 ' HD3' ' HB3' ' C' ' 83' ' ' TYR . 27.0 mtmm -64.69 -26.62 68.45 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.826 0.45 . . . . 75.43 111.414 -177.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 47.3 tpt85 -57.83 -58.49 8.13 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.642 1.177 . . . . 74.14 109.0 173.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -74.74 -16.79 60.72 Favored 'General case' 0 C--N 1.348 0.518 0 CA-C-N 115.182 -0.917 . . . . 74.15 112.215 -176.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 65' ' ' ILE . . . . . 0.613 HG22 ' HD2' ' C' ' 76' ' ' PRO . 65.2 mt -65.97 -48.26 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 N-CA-C 108.791 -0.818 . . . . 71.5 108.791 169.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -58.61 -51.77 68.49 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.311 -0.859 . . . . 74.31 110.181 176.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -54.44 -51.26 65.53 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.47 0.708 . . . . 73.14 111.643 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 68.0 p -76.0 -13.65 60.23 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 118.958 -0.544 . . . . 74.43 112.376 -177.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -67.52 107.09 2.36 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 109.004 -0.739 . . . . 75.22 109.004 176.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 114.29 17.78 7.01 Favored Glycine 0 C--N 1.343 0.945 0 CA-C-N 115.514 -0.766 . . . . 62.51 111.743 -167.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 98.8 m -148.89 -59.78 0.23 Allowed 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 104.064 -2.569 . . . . 72.34 104.064 176.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 12.4 m -77.9 138.95 39.18 Favored 'General case' 0 C--O 1.256 1.431 0 N-CA-C 104.571 -2.381 . . . . 73.35 104.571 158.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -100.05 -54.82 2.79 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 108.75 -0.833 . . . . 73.23 108.75 -173.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -72.12 151.63 92.54 Favored Pre-proline 0 CA--C 1.546 0.824 0 CA-C-N 114.688 -1.142 . . . . 53.23 109.765 173.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -56.29 123.51 14.01 Favored 'Trans proline' 0 C--N 1.369 1.63 0 C-N-CA 122.338 2.025 . . . . 75.14 110.921 169.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 76' ' ' PRO . . . . . 0.613 ' HD2' HG22 ' C' ' 65' ' ' ILE . 84.3 Cg_exo -50.98 145.79 23.71 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 123.004 2.469 . . . . 71.22 112.817 172.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -51.57 125.79 17.77 Favored 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 123.642 2.894 . . . . 74.4 112.587 -177.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 78' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -69.21 141.3 47.05 Favored 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 122.89 2.393 . . . . 74.44 111.95 -177.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 79' ' ' PRO . . . . . 0.412 ' HB2' ' O ' ' C' ' 142' ' ' GLY . 30.9 Cg_endo -61.83 152.68 73.08 Favored 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 122.522 2.148 . . . . 70.12 111.218 174.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -50.73 82.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.392 2.859 0 C-N-CA 124.242 3.295 . . . . 74.31 114.494 -169.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 153.36 -53.05 0.46 Allowed Glycine 0 C--N 1.335 0.481 0 N-CA-C 109.811 -1.315 . . . . 75.2 109.811 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 141.13 -150.76 22.05 Favored Glycine 0 C--N 1.353 1.528 0 CA-C-N 115.615 -0.292 . . . . 75.13 113.662 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 83' ' ' TYR . . . . . 0.494 ' HB3' ' HD3' ' C' ' 62' ' ' LYS . 29.4 m-85 -104.01 122.24 44.83 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.274 1.43 . . . . 73.4 108.855 -177.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 84' ' ' ASP . . . . . 0.491 ' HB2' ' NE ' ' C' ' 143' ' ' ARG . 5.5 t70 -80.82 128.38 33.59 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 112.367 0.506 . . . . 75.11 112.367 -169.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 85' ' ' PHE . . . . . 0.54 ' HA ' ' HD2' ' C' ' 88' ' ' PHE . 77.0 m-85 -139.46 29.99 2.15 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.263 1.025 . . . . 74.41 109.776 176.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 13.7 m -78.6 84.94 4.68 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 114.89 -1.05 . . . . 52.42 111.39 -173.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 87' ' ' GLY . . . . . 0.596 ' N ' ' HA ' ' C' ' 171' ' ' PRO . . . 130.59 -19.73 5.0 Favored Glycine 0 N--CA 1.47 0.959 0 N-CA-C 110.24 -1.144 . . . . 74.34 110.24 -174.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 88' ' ' PHE . . . . . 0.54 ' HD2' ' HA ' ' C' ' 85' ' ' PHE . 32.5 m-85 -100.0 129.89 46.1 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 107.921 -1.14 . . . . 74.44 107.921 178.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -75.75 78.88 2.69 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.548 0.689 . . . . 72.23 110.804 -175.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 90' ' ' VAL . . . . . 0.434 HG22 ' ND2' ' C' ' 169' ' ' ASN . 5.6 p -50.06 -35.93 11.79 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 C-N-CA 125.981 1.713 . . . . 54.42 113.482 -174.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -65.94 -26.05 67.41 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 123.499 0.72 . . . . 75.25 112.124 -175.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -78.17 -26.56 47.72 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 122.674 0.389 . . . . 75.53 111.88 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 9.3 m-30 -70.13 164.33 24.38 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 123.345 0.403 . . . . 72.45 111.343 -167.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 52.1 p -59.43 149.85 28.25 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 113.969 1.1 . . . . 52.11 113.969 -166.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.71 -35.71 75.07 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 114.738 -1.119 . . . . 72.35 110.525 171.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -53.73 -50.91 64.92 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.542 1.137 . . . . 74.24 110.858 172.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 97' ' ' PHE . . . . . 0.405 ' CZ ' HG23 ' C' ' 90' ' ' VAL . 1.1 t80 -58.96 -43.04 91.23 Favored 'General case' 0 CA--C 1.552 1.043 0 CA-C-N 114.511 -1.222 . . . . 64.25 110.767 175.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -69.31 -21.4 63.85 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.077 0.551 . . . . 71.33 112.026 -177.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -82.69 -50.0 9.19 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.293 0.637 . . . . 74.43 110.621 173.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 38.6 tp -67.45 -63.73 1.0 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.775 0.83 . . . . 73.23 110.553 -175.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -80.26 -0.71 37.63 Favored 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 123.091 0.556 . . . . 75.04 112.413 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -45.57 -58.84 5.1 Favored Glycine 0 CA--C 1.544 1.85 0 CA-C-O 118.933 -0.926 . . . . 74.41 115.411 178.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -62.65 -3.38 4.36 Favored 'Trans proline' 0 C--N 1.385 2.466 0 C-N-CA 123.535 2.824 . . . . 64.35 114.528 -176.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -141.71 38.28 1.52 Allowed Glycine 0 C--N 1.354 1.535 0 CA-C-O 119.118 -0.823 . . . . 73.42 112.62 174.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 43.0 mt . . . . . 0 N--CA 1.505 2.285 0 CA-C-N 118.58 1.19 . . . . 75.43 113.922 175.71 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 116' ' ' GLY . . . . . 0.427 ' HA2' ' HA3' ' C' ' 168' ' ' GLY . . . . . . . . 0 N--CA 1.47 0.948 0 N-CA-C 113.981 0.352 . . . . 54.4 113.981 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 117' ' ' ARG . . . . . 0.541 ' HB2' ' HB2' ' C' ' 167' ' ' GLN . 2.4 mmp_? -116.29 147.51 41.46 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 124.492 1.117 . . . . 74.32 111.498 177.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -68.9 113.66 6.52 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 108.322 -0.992 . . . . 75.42 108.322 174.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 119' ' ' LEU . . . . . 0.549 HD21 HG22 ' B' ' 185' ' ' VAL . 5.7 tt -92.12 119.34 31.69 Favored 'General case' 0 C--O 1.219 -0.512 0 N-CA-C 105.953 -1.869 . . . . 75.21 105.953 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.409 ' HG2' HD12 ' C' ' 175' ' ' LEU . 98.3 mtt180 -97.48 132.95 42.69 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 107.399 -1.334 . . . . 72.31 107.399 176.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 121' ' ' ALA . . . . . . . . . . . . . . . -143.02 117.37 9.63 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.294 -0.632 . . . . 75.44 109.294 -178.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 122' ' ' GLU . . . . . 0.447 ' HA ' ' O ' ' C' ' 177' ' ' VAL . 12.7 pt-20 -99.17 130.0 45.46 Favored 'General case' 0 C--N 1.348 0.529 0 CA-C-O 120.959 0.409 . . . . 74.12 109.913 177.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 123' ' ' LEU . . . . . 0.582 HD12 HG12 ' B' ' 182' ' ' VAL . 0.4 OUTLIER -122.96 120.9 27.41 Favored Pre-proline 0 N--CA 1.473 0.7 0 C-N-CA 123.447 0.699 . . . . 73.3 111.92 -166.132 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . 0.544 ' HD2' ' HB3' ' B' ' 183' ' ' ALA . 80.4 Cg_exo -51.19 116.96 3.0 Favored 'Trans proline' 0 C--N 1.37 1.68 0 C-N-CA 122.82 2.347 . . . . 72.51 111.298 162.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 125' ' ' LEU . . . . . . . . . . . . . 26.3 tp -138.64 140.26 38.83 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.373 1.069 . . . . 75.32 108.6 -175.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.4 156.24 21.91 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.069 0.461 . . . . 61.53 111.192 -177.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 127' ' ' LEU . . . . . 0.601 ' HB3' HD22 ' C' ' 215' ' ' LEU . 95.9 mt -63.72 -44.99 91.94 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.124 0.97 . . . . 62.25 110.776 177.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -52.84 -46.39 67.77 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 114.885 -1.052 . . . . 75.24 110.513 172.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -67.01 -33.84 76.42 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.092 0.957 . . . . 75.51 111.553 -176.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -72.44 -33.1 66.84 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 123.866 0.729 . . . . 73.14 110.344 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 131' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -68.09 -41.38 81.94 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.2 0.6 . . . . 75.55 110.361 172.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 132' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -66.72 -68.91 0.34 Allowed 'General case' 0 N--CA 1.481 1.118 0 O-C-N 123.653 0.595 . . . . 70.15 111.284 -175.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 62.93 93.25 0.02 OUTLIER Glycine 0 CA--C 1.541 1.678 0 O-C-N 123.735 0.647 . . . . 65.31 113.239 -176.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . -135.89 161.38 24.82 Favored Glycine 0 N--CA 1.479 1.516 0 CA-C-O 119.473 -0.626 . . . . 73.12 111.802 177.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -71.88 95.53 1.56 Allowed 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 108.727 -0.842 . . . . 73.03 108.727 176.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 136' ' ' ARG . . . . . 0.459 ' HB2' HD22 ' B' ' 181' ' ' LEU . 90.0 mtt180 -123.93 163.52 21.16 Favored 'General case' 0 C--O 1.248 1.006 0 C-N-CA 123.563 0.745 . . . . 72.12 109.733 -173.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 137' ' ' VAL . . . . . 0.524 HG13 ' HB2' ' B' ' 180' ' ' ALA . 7.8 p -79.84 125.34 38.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 121.553 0.692 . . . . 73.11 110.621 -169.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 138' ' ' VAL . . . . . 0.579 HG13 ' HB3' ' B' ' 181' ' ' LEU . 8.1 m -112.46 141.84 26.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 124.068 0.947 . . . . 72.14 108.554 173.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 139' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -124.76 100.61 6.7 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 107.742 -1.207 . . . . 74.31 107.742 170.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 140' ' ' VAL . . . . . 0.435 HG22 HD22 ' C' ' 174' ' ' LEU . 61.3 t -116.59 100.33 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 109.376 -0.601 . . . . 73.25 109.376 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 63.41 30.69 15.4 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.444 0.698 . . . . 65.0 111.151 177.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 142' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' C' ' 79' ' ' PRO . . . 101.86 -11.6 57.59 Favored Glycine 0 C--N 1.343 0.917 0 CA-C-N 115.713 -0.676 . . . . 52.4 112.409 -179.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 143' ' ' ARG . . . . . 0.491 ' NE ' ' HB2' ' C' ' 84' ' ' ASP . 6.0 tpp180 -76.63 92.87 3.54 Favored 'General case' 0 C--N 1.352 0.699 0 N-CA-C 109.573 -0.529 . . . . 75.05 109.573 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 144' ' ' ARG . . . . . 0.427 ' HA ' ' O ' ' C' ' 138' ' ' VAL . 39.3 ttp85 -96.66 94.62 7.42 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 115.083 -0.962 . . . . 71.51 108.778 178.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 145' ' ' VAL . . . . . 0.569 ' HA ' ' HD2' ' C' ' 60' ' ' PRO . 28.6 m -131.5 176.16 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-N 114.978 -1.01 . . . . 75.03 109.879 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 49.0 m -125.12 118.83 26.97 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 109.05 -0.722 . . . . 73.22 109.05 178.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 147' ' ' VAL . . . . . 0.458 HG13 ' HE1' ' C' ' 164' ' ' MET . 14.1 p -142.0 150.99 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.103 0.561 . . . . 72.53 110.101 -173.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 45.2 ttp180 -103.34 110.58 22.62 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 108.346 -0.983 . . . . 74.22 108.346 169.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 149' ' ' ILE . . . . . 0.558 ' HB ' HD12 ' C' ' 159' ' ' ILE . 38.0 pt -76.46 148.29 80.04 Favored Pre-proline 0 CA--C 1.557 1.245 0 N-CA-C 109.267 -0.642 . . . . 74.42 109.267 170.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -47.88 119.64 4.03 Favored 'Trans proline' 0 C--N 1.381 2.268 0 C-N-CA 124.033 3.156 . . . . 61.44 113.723 -174.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -63.26 132.72 37.36 Favored 'Trans proline' 0 C--N 1.383 2.364 0 C-N-CA 122.903 2.402 . . . . 73.2 110.969 174.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 152' ' ' GLY . . . . . 0.56 ' HA2' ' HB3' ' C' ' 240' ' ' PHE . . . 86.92 53.92 2.74 Favored Glycine 0 C--N 1.334 0.435 0 N-CA-C 111.338 -0.705 . . . . 63.11 111.338 -173.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 153' ' ' VAL . . . . . 0.528 HG23 HD11 ' C' ' 159' ' ' ILE . 12.5 p -101.99 143.84 14.17 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.245 0 C-N-CA 123.539 0.736 . . . . 74.01 110.531 -172.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 154' ' ' ARG . . . . . 0.648 ' HA ' ' HB3' ' C' ' 188' ' ' LEU . 49.9 mtp180 -96.82 155.2 16.88 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.698 0.799 . . . . 75.32 112.329 -167.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 155' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -53.42 108.82 0.37 Allowed 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 123.267 0.627 . . . . 74.51 110.064 162.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 89.25 18.13 53.92 Favored Glycine 0 C--N 1.343 0.959 0 CA-C-O 119.803 -0.443 . . . . 75.21 113.454 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 157' ' ' SER . . . . . . . . . . . . . 3.5 m -73.35 107.1 5.47 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 117.148 0.474 . . . . 75.43 110.314 172.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 158' ' ' VAL . . . . . 0.466 HG11 HD22 ' C' ' 175' ' ' LEU . 42.1 t -85.02 90.25 2.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-N 114.438 -1.255 . . . . 72.31 108.378 176.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 159' ' ' ILE . . . . . 0.558 HD12 ' HB ' ' C' ' 149' ' ' ILE . 53.0 mt -75.88 118.96 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 114.972 -1.013 . . . . 72.31 110.179 -178.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 53.1 ttt180 -78.06 119.71 21.87 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 109.918 -0.401 . . . . 75.13 109.918 173.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 161' ' ' VAL . . . . . 0.605 HG11 ' SD ' ' C' ' 164' ' ' MET . 21.2 t -125.97 95.47 39.48 Favored Pre-proline 0 CA--C 1.551 1.017 0 N-CA-C 109.062 -0.718 . . . . 75.24 109.062 176.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.43 119.63 5.85 Favored 'Trans proline' 0 C--N 1.368 1.59 0 C-N-CA 122.388 2.058 . . . . 75.23 111.253 172.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 113.24 23.32 5.23 Favored Glycine 0 C--N 1.341 0.815 0 CA-C-N 115.899 -0.591 . . . . 53.54 112.843 178.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 164' ' ' MET . . . . . 0.605 ' SD ' HG11 ' C' ' 161' ' ' VAL . 28.6 mtp -148.95 3.96 0.63 Allowed 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 112.884 0.698 . . . . 73.35 112.884 -178.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 165' ' ' GLY . . . . . 0.404 ' HA3' ' O ' ' C' ' 173' ' ' ASP . . . -126.37 -123.04 2.63 Favored Glycine 0 N--CA 1.48 1.603 0 CA-C-O 118.346 -1.252 . . . . 73.32 111.067 -177.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . 68.57 73.62 0.68 Allowed Glycine 0 C--N 1.363 2.041 0 CA-C-N 118.516 1.158 . . . . 75.44 113.501 165.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 167' ' ' GLN . . . . . 0.541 ' HB2' ' HB2' ' C' ' 117' ' ' ARG . 23.4 mm-40 -67.14 98.06 0.57 Allowed 'General case' 0 C--N 1.348 0.502 0 N-CA-C 107.033 -1.469 . . . . 74.2 107.033 170.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 168' ' ' GLY . . . . . 0.427 ' HA3' ' HA2' ' C' ' 116' ' ' GLY . . . 136.57 -140.55 11.58 Favored Glycine 0 C--O 1.217 -0.939 0 CA-C-N 112.745 -2.025 . . . . 13.44 108.881 -161.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 169' ' ' ASN . . . . . 0.434 ' ND2' HG22 ' C' ' 90' ' ' VAL . 62.6 t30 -153.3 -51.6 0.02 OUTLIER Pre-proline 0 N--CA 1.497 1.894 0 CA-C-N 119.918 1.859 . . . . 62.44 111.952 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 170' ' ' PRO . . . . . 0.419 ' HD3' ' HB3' ' C' ' 169' ' ' ASN . 86.3 Cg_exo -53.81 161.99 4.13 Favored 'Trans proline' 0 C--N 1.393 2.912 0 C-N-CA 122.559 2.173 . . . . 73.55 113.504 164.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 171' ' ' PRO . . . . . 0.596 ' HA ' ' N ' ' C' ' 87' ' ' GLY . 1.5 Cg_exo -28.63 104.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.39 2.759 1 C-N-CA 125.494 4.13 . . . . 74.02 117.854 -174.438 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -121.66 -146.61 7.42 Favored Glycine 0 C--N 1.341 0.819 0 N-CA-C 109.387 -1.485 . . . . 74.42 109.387 170.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 173' ' ' ASP . . . . . 0.404 ' O ' ' HA3' ' C' ' 165' ' ' GLY . 27.2 t70 -171.16 159.5 5.94 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 117.607 0.703 . . . . 74.51 111.053 -176.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 174' ' ' LEU . . . . . 0.472 HD23 ' HE3' ' C' ' 164' ' ' MET . 17.5 tp -124.89 115.4 20.56 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.727 0.811 . . . . 75.22 110.166 170.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 175' ' ' LEU . . . . . 0.466 HD22 HG11 ' C' ' 158' ' ' VAL . 76.7 mt -92.05 89.99 7.19 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.172 0.989 . . . . 72.15 110.291 174.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 176' ' ' LEU . . . . . 0.408 ' HG ' ' HG ' ' C' ' 174' ' ' LEU . 58.1 mt -76.66 93.78 3.69 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.48 0.712 . . . . 74.33 111.002 176.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 177' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' C' ' 122' ' ' GLU . 8.2 t -86.64 100.71 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 123.371 0.668 . . . . 75.23 109.69 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 178' ' ' VAL . . . . . 0.421 ' HA ' ' HG ' ' C' ' 123' ' ' LEU . 14.8 m -73.64 112.43 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.199 0 CA-C-O 122.336 1.065 . . . . 74.01 111.154 -174.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 179' ' ' ARG . . . . . . . . . . . . . 7.0 mmm180 -91.4 115.39 27.99 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 114.291 -1.322 . . . . 74.42 107.687 170.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 180' ' ' LEU . . . . . . . . . . . . . 77.4 mt -69.07 135.39 50.71 Favored 'General case' 0 CA--C 1.561 1.398 0 CA-C-N 118.3 0.5 . . . . 73.43 111.436 178.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 181' ' ' LEU . . . . . 0.413 HD23 ' HB3' ' C' ' 124' ' ' PRO . 16.4 mt -53.43 169.65 0.31 Allowed Pre-proline 0 N--CA 1.501 2.102 0 C-N-CA 126.896 2.078 . . . . 74.24 113.965 -175.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -60.86 62.22 0.09 OUTLIER 'Trans proline' 0 C--N 1.397 3.112 0 C-N-CA 123.936 3.09 . . . . 73.32 112.442 161.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 183' ' ' HIS . . . . . 0.521 ' N ' ' HD3' ' C' ' 184' ' ' PRO . 85.7 t60 -162.06 28.17 0.03 OUTLIER Pre-proline 0 CA--C 1.572 1.803 0 C-N-CA 127.82 2.448 . . . . 72.0 107.203 -179.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 184' ' ' PRO . . . . . 0.521 ' HD3' ' N ' ' C' ' 183' ' ' HIS . 44.2 Cg_endo -91.81 67.57 1.0 Allowed 'Trans proline' 0 C--N 1.396 3.061 0 C-N-CA 123.719 2.946 . . . . 74.25 111.731 -162.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 185' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 2.9 t -87.81 -23.28 6.56 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.788 0 N-CA-C 107.751 -1.203 . . . . 72.23 107.751 -176.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 186' ' ' PHE . . . . . 0.529 ' HD2' HD12 ' C' ' 127' ' ' LEU . 56.7 m-85 -125.57 100.55 6.5 Favored 'General case' 0 C--N 1.346 0.439 0 N-CA-C 108.931 -0.766 . . . . 61.44 108.931 -178.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 187' ' ' ARG . . . . . 0.419 ' NH2' ' HB2' ' C' ' 184' ' ' PRO . 32.1 ttm105 -99.89 107.82 19.91 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 107.477 -1.305 . . . . 75.14 107.477 -177.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 188' ' ' LEU . . . . . 0.648 ' HB3' ' HA ' ' C' ' 154' ' ' ARG . 53.3 tp -76.52 127.89 33.71 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.199 0.814 . . . . 74.14 113.199 -163.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -112.97 104.46 12.43 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.9 1.28 . . . . 73.21 108.082 169.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 68.2 -103.29 0.98 Allowed Glycine 0 CA--C 1.534 1.247 0 CA-C-N 116.437 -0.347 . . . . 74.2 112.533 -176.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 191' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -113.85 -16.4 12.24 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 124.226 1.01 . . . . 75.25 110.469 175.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -99.52 130.7 45.79 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.409 1.084 . . . . 65.13 110.126 -173.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 193' ' ' LEU . . . . . 0.438 HD21 HD12 ' C' ' 188' ' ' LEU . 71.1 mt -74.41 152.55 39.49 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.743 0.817 . . . . 65.15 111.501 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 194' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -120.09 106.66 12.19 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 107.531 -1.285 . . . . 75.43 107.531 167.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 195' ' ' ALA . . . . . 0.484 ' HA ' ' O ' ' C' ' 185' ' ' VAL . . . -109.38 -177.73 3.37 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.264 1.026 . . . . 65.11 110.315 -177.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 95.8 m -137.83 118.42 13.95 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.598 -0.89 . . . . 53.42 108.598 165.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 197' ' ' LEU . . . . . . . . . . . . . 62.3 tp -97.09 139.48 33.03 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.182 -0.917 . . . . 73.5 110.482 -175.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -93.53 100.87 13.07 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 109.015 -0.735 . . . . 64.33 109.015 -178.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 199' ' ' VAL . . . . . 0.482 HG21 HG21 ' C' ' 210' ' ' VAL . 94.7 t -114.41 119.35 40.22 Favored Pre-proline 0 N--CA 1.484 1.232 0 C-N-CA 124.068 0.947 . . . . 73.12 109.226 -178.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 200' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -72.68 145.78 42.1 Favored 'Trans proline' 0 C--N 1.366 1.469 0 C-N-CA 121.664 1.576 . . . . 73.11 110.75 174.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 201' ' ' ALA . . . . . 0.431 ' N ' ' HD2' ' C' ' 202' ' ' PRO . . . -58.26 -38.82 70.27 Favored Pre-proline 0 CA--C 1.552 1.037 0 N-CA-C 115.348 1.61 . . . . 74.35 115.348 -173.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 202' ' ' PRO . . . . . 0.514 ' O ' HG12 ' C' ' 206' ' ' VAL . 19.4 Cg_endo -58.45 -52.43 5.54 Favored 'Trans proline' 0 C--N 1.382 2.337 0 CA-C-N 121.547 1.588 . . . . 63.15 111.417 174.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 203' ' ' ILE . . . . . . . . . . . . . 41.7 mt -63.34 -27.6 43.37 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 123.887 0.875 . . . . 74.02 110.793 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.21 -41.59 76.87 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.567 -0.742 . . . . 75.02 112.229 175.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 205' ' ' VAL . . . . . 0.508 HG11 HD13 ' A' ' 261' ' ' LEU . 90.7 t -72.14 -43.65 66.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 122.578 0.351 . . . . 74.52 111.175 -178.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 206' ' ' VAL . . . . . 0.514 HG12 ' O ' ' C' ' 202' ' ' PRO . 0.6 OUTLIER -98.25 -38.08 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 N-CA-C 111.656 0.243 . . . . 74.12 111.656 -168.265 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 106.01 123.62 5.18 Favored Glycine 0 CA--C 1.529 0.914 0 O-C-N 123.122 0.264 . . . . 63.21 112.787 -173.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -158.38 -130.92 1.22 Allowed Glycine 0 C--N 1.34 0.797 0 N-CA-C 110.197 -1.161 . . . . 51.32 110.197 176.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 209' ' ' LYS . . . . . 0.556 ' HG2' ' HA ' ' C' ' 222' ' ' ALA . 8.6 mtmp? -147.65 146.86 29.48 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 117.673 0.737 . . . . 72.44 111.558 176.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 210' ' ' VAL . . . . . 0.482 HG21 HG21 ' C' ' 199' ' ' VAL . 31.1 m -141.84 142.59 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 124.417 1.087 . . . . 71.52 109.354 173.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 211' ' ' ARG . . . . . . . . . . . . . 45.2 ttm-85 -81.45 127.81 33.2 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.656 0.782 . . . . 75.53 111.801 -172.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -105.98 112.19 25.14 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 107.574 -1.269 . . . . 74.43 107.574 169.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 213' ' ' MET . . . . . 0.672 ' HA ' ' HA ' ' C' ' 218' ' ' PRO . 4.0 ttp -77.97 100.62 6.52 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.812 -0.81 . . . . 63.12 108.812 -176.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.68 177.63 8.8 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 118.02 0.373 . . . . 72.34 110.154 -174.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 215' ' ' LEU . . . . . 0.601 HD22 ' HB3' ' C' ' 127' ' ' LEU . 12.3 mt -51.26 -61.25 2.35 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.295 1.038 . . . . 75.24 111.109 -173.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -92.86 13.36 20.65 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.239 -0.891 . . . . 71.0 111.933 -173.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 144.35 154.86 6.25 Favored Glycine 0 C--N 1.346 1.112 0 CA-C-O 119.831 -0.427 . . . . 74.41 113.128 177.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 218' ' ' PRO . . . . . 0.672 ' HA ' ' HA ' ' C' ' 213' ' ' MET . 52.8 Cg_endo -69.1 125.76 12.89 Favored 'Trans proline' 0 C--N 1.365 1.403 0 C-N-CA 122.896 2.398 . . . . 64.03 114.878 179.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 219' ' ' VAL . . . . . . . . . . . . . 9.6 p -100.71 173.21 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.809 0 N-CA-C 106.103 -1.814 . . . . 52.53 106.103 168.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 220' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -118.36 158.18 25.74 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.703 -0.48 . . . . 72.32 109.703 174.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 221' ' ' VAL . . . . . . . . . . . . . 38.0 t -115.31 127.95 72.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 124.801 1.24 . . . . 74.03 109.592 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 222' ' ' ALA . . . . . 0.556 ' HA ' ' HG2' ' C' ' 209' ' ' LYS . . . -80.14 102.32 9.31 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 108.69 -0.856 . . . . 73.3 108.69 170.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 48.5 t -76.67 126.58 85.8 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-N 115.294 -0.866 . . . . 73.11 109.344 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 224' ' ' PRO . . . . . 0.465 ' HA ' ' HA ' ' B' ' 245' ' ' LYS . 6.1 Cg_exo -79.87 163.9 23.12 Favored 'Trans proline' 0 C--N 1.366 1.479 0 C-N-CA 123.715 2.943 . . . . 73.11 112.848 171.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -56.73 146.7 75.89 Favored 'Trans proline' 0 C--N 1.37 1.668 0 C-N-CA 122.128 1.885 . . . . 74.4 112.003 164.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 226' ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? 65.51 71.25 0.44 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.533 1.133 . . . . 71.5 110.929 171.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 227' ' ' THR . . . . . 0.489 HG21 HD12 ' C' ' 255' ' ' ILE . 8.0 m -116.95 125.85 52.05 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 124.287 1.035 . . . . 73.3 111.419 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 228' ' ' GLN . . . . . . . . . . . . . 24.9 mp0 -108.23 157.21 18.53 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.404 1.081 . . . . 74.32 111.017 -177.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -77.03 110.59 11.8 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 114.842 -1.072 . . . . 65.31 110.416 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 108.69 8.95 27.59 Favored Glycine 0 N--CA 1.475 1.25 0 CA-C-O 119.871 -0.405 . . . . 62.04 113.0 -169.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 231' ' ' ARG . . . . . . . . . . . . . 49.9 mtp85 -76.07 168.34 20.22 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 109.223 -0.658 . . . . 75.03 109.223 164.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 232' ' ' LYS . . . . . 0.616 ' HZ2' ' HB2' ' C' ' 232' ' ' LYS . 2.4 ttmp? -134.29 146.96 50.51 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-O 121.493 0.663 . . . . 74.05 112.452 178.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 233' ' ' LEU . . . . . 0.72 HD11 ' HB2' ' C' ' 251' ' ' LEU . 5.1 mp -111.27 155.61 22.75 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.323 1.449 . . . . 74.22 111.22 -173.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 29.5 ptt-85 -125.93 91.72 3.44 Favored 'General case' 0 CA--C 1.571 1.769 0 O-C-N 125.477 1.736 . . . . 72.34 110.87 175.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 235' ' ' LEU . . . . . 0.469 ' HB2' ' HB3' ' C' ' 249' ' ' LEU . 79.5 mt -90.96 103.72 16.4 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.876 -0.787 . . . . 74.34 108.876 170.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -69.71 129.63 40.13 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.525 0.73 . . . . 73.41 111.863 -175.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 75.13 25.9 67.7 Favored Glycine 0 C--N 1.353 1.507 0 O-C-N 123.882 0.739 . . . . 71.42 114.196 175.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 31.1 mmtm -115.14 13.34 16.79 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.172 0.589 . . . . 75.11 110.621 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 239' ' ' GLY . . . . . 0.436 ' HA2' ' HG ' ' C' ' 193' ' ' LEU . . . -91.3 -163.16 38.47 Favored Glycine 0 C--N 1.353 1.51 0 O-C-N 123.511 0.507 . . . . 75.2 113.323 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 240' ' ' PHE . . . . . 0.56 ' HB3' ' HA2' ' C' ' 152' ' ' GLY . 4.6 m-85 -87.05 154.09 54.78 Favored Pre-proline 0 CA--C 1.552 1.05 0 N-CA-C 110.005 -0.368 . . . . 75.14 110.005 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 241' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.33 113.59 1.67 Allowed 'Trans proline' 0 C--N 1.386 2.513 0 C-N-CA 122.915 2.41 . . . . 71.53 111.382 175.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -111.11 164.54 12.14 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-O 118.945 -0.92 . . . . 70.14 111.714 177.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -68.65 -20.7 40.22 Favored 'Trans proline' 0 C--N 1.37 1.692 0 C-N-CA 122.902 2.401 . . . . 71.42 112.536 -178.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -98.18 20.87 11.69 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.1 0.96 . . . . 71.42 110.489 176.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 97.01 177.94 34.79 Favored Glycine 0 C--N 1.348 1.197 0 N-CA-C 111.263 -0.735 . . . . 63.24 111.263 -171.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 246' ' ' ARG . . . . . . . . . . . . . 69.4 mtm180 -71.89 142.6 49.52 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 117.465 0.632 . . . . 71.32 110.593 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -79.42 -158.18 13.79 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 123.846 0.716 . . . . 63.23 112.723 177.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -116.89 -179.86 3.81 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.725 0.81 . . . . 73.54 108.896 -174.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 249' ' ' LEU . . . . . 0.469 ' HB3' ' HB2' ' C' ' 235' ' ' LEU . 10.3 tp -122.41 109.43 14.38 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.48 -0.933 . . . . 74.23 108.48 176.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 250' ' ' TYR . . . . . 0.625 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 23.5 m-85 -101.14 105.71 16.89 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.601 -0.727 . . . . 71.43 109.736 178.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 251' ' ' LEU . . . . . 0.72 ' HB2' HD11 ' C' ' 233' ' ' LEU . 2.0 mp -98.79 149.89 22.41 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 109.536 -0.542 . . . . 72.0 109.536 -173.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -104.61 128.93 52.76 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 108.16 -1.052 . . . . 75.41 108.16 175.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 253' ' ' VAL . . . . . . . . . . . . . 67.7 t -74.99 134.66 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 112.247 0.462 . . . . 73.5 112.247 -172.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 254' ' ' ARG . . . . . 0.408 ' CZ ' ' HB ' ' C' ' 256' ' ' THR . 1.5 tmm_? -121.69 93.94 4.16 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 107.293 -1.373 . . . . 75.13 107.293 177.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 255' ' ' ILE . . . . . 0.489 HD12 HG21 ' C' ' 227' ' ' THR . 46.1 mm -68.49 124.52 24.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 O-C-N 123.264 0.353 . . . . 75.24 110.077 176.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 256' ' ' THR . . . . . 0.408 ' HB ' ' CZ ' ' C' ' 254' ' ' ARG . 0.0 OUTLIER -133.27 170.33 15.6 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.855 1.262 . . . . 70.25 110.772 -174.596 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 257' ' ' ILE . . . . . 0.449 ' HB ' ' HD2' ' C' ' 258' ' ' PRO . 2.9 pp -130.19 157.6 76.67 Favored Pre-proline 0 CA--C 1.556 1.204 0 C-N-CA 124.025 0.93 . . . . 75.21 109.44 178.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 258' ' ' PRO . . . . . 0.449 ' HD2' ' HB ' ' C' ' 257' ' ' ILE . 74.3 Cg_endo -67.14 -8.56 22.24 Favored 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 122.817 2.345 . . . . 74.41 114.031 -166.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 56.94 -71.88 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 125.024 1.329 . . . . 72.3 111.246 -164.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -73.88 152.33 40.21 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.831 0.852 . . . . 73.41 111.483 177.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 261' ' ' LEU . . . . . 0.571 HD11 ' HA ' ' C' ' 266' ' ' GLU . 31.2 mt -146.41 141.04 26.77 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.07 0.548 . . . . 74.53 112.043 179.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 53.7 p -87.72 145.33 36.73 Favored Pre-proline 0 CA--C 1.551 0.983 0 CA-C-O 117.914 -1.041 . . . . 61.23 108.369 167.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -45.02 -31.3 5.4 Favored 'Trans proline' 0 C--N 1.382 2.34 0 C-N-CA 124.471 3.448 . . . . 74.2 114.906 -176.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -56.83 -72.45 0.08 Allowed 'General case' 0 C--O 1.257 1.465 0 C-N-CA 124.599 1.159 . . . . 71.04 111.482 174.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -68.36 -24.87 64.85 Favored 'General case' 0 C--O 1.212 -0.888 0 CA-C-N 115.068 -0.969 . . . . 71.03 110.339 -176.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 266' ' ' GLU . . . . . 0.571 ' HA ' HD11 ' C' ' 261' ' ' LEU . 11.3 tp10 -59.09 -48.31 82.08 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.689 0.795 . . . . 73.1 109.95 173.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -63.74 -35.58 81.05 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.18 0.592 . . . . 71.12 111.386 177.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 268' ' ' LEU . . . . . . . . . . . . . 11.2 mp -64.52 -50.88 65.64 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 112.279 0.474 . . . . 70.11 112.279 174.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 269' ' ' TRP . . . . . 0.475 ' HH2' ' HD3' ' C' ' 202' ' ' PRO . 89.6 m95 -60.95 -32.74 72.25 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.46 0.704 . . . . 63.11 110.774 178.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 270' ' ' LYS . . . . . 0.672 ' HZ3' ' HB3' ' C' ' 270' ' ' LYS . 3.7 mmmp? -62.42 -57.75 10.13 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.092 0.957 . . . . 75.43 111.241 175.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 31.1 mmtm -66.39 -24.8 66.54 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.476 0.711 . . . . 75.33 112.475 -177.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 55.4 mt -81.67 -32.46 31.77 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 122.981 0.512 . . . . 74.33 110.744 174.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -63.61 -40.19 96.29 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 109.613 -0.514 . . . . 43.22 109.613 172.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -64.23 -42.48 96.53 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.431 1.092 . . . . 63.21 110.355 175.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -62.17 -28.27 69.55 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.1 0.56 . . . . 70.04 111.316 173.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 276' ' ' TYR . . . . . 0.47 ' HA ' ' HD3' ' C' ' 279' ' ' ARG . 3.0 m-85 -85.05 -25.21 27.76 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.254 0.464 . . . . 75.52 112.254 178.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -68.73 -33.74 74.44 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 108.361 -0.977 . . . . 65.52 108.361 171.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -64.87 -15.63 62.17 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 115.127 -0.942 . . . . 72.22 112.491 172.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 279' ' ' ARG . . . . . 0.47 ' HD3' ' HA ' ' C' ' 276' ' ' TYR . 27.0 mtp-105 -82.15 -33.79 29.42 Favored 'General case' 0 C--N 1.357 0.906 0 N-CA-C 109.27 -0.641 . . . . 75.11 109.27 172.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.869 0 CA-C-O 118.329 -0.843 . . . . 75.14 109.502 -170.238 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt . . . . . 0 CA--C 1.54 0.588 0 N-CA-C 112.991 0.737 . . . . 64.14 112.991 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.559 ' HD2' HD13 ' A' ' 10' ' ' ILE . 29.0 mmtp -79.28 93.02 5.2 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 108.273 -1.01 . . . . 74.32 108.273 164.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -73.93 96.62 2.66 Favored 'General case' 0 C--N 1.352 0.686 0 N-CA-C 107.573 -1.269 . . . . 62.43 107.573 172.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.468 ' CD1' ' HA ' ' A' ' 53' ' ' ALA . 56.2 m-85 -64.39 -22.25 66.9 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 114.954 -1.021 . . . . 73.34 111.726 -171.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -63.48 -50.6 69.03 Favored 'General case' 0 C--N 1.353 0.72 0 O-C-N 123.484 0.49 . . . . 73.33 109.891 171.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.31 -40.25 96.82 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.392 0.677 . . . . 70.01 111.072 -178.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.559 HD13 ' HD2' ' A' ' 5' ' ' LYS . 68.5 mt -58.37 -43.66 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 123.284 0.633 . . . . 74.23 110.261 174.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 92.4 mt -83.26 -2.18 55.0 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 115.845 -0.616 . . . . 73.11 112.586 177.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 67.86 19.41 71.51 Favored Glycine 0 C--N 1.349 1.28 0 N-CA-C 114.639 0.616 . . . . 73.42 114.639 177.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.9 m -102.85 158.49 31.66 Favored Pre-proline 0 N--CA 1.481 1.1 0 C-N-CA 124.06 0.944 . . . . 72.52 110.874 178.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -60.81 158.26 34.1 Favored 'Trans proline' 0 C--N 1.387 2.553 0 C-N-CA 122.77 2.313 . . . . 50.12 112.156 177.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 27.8 mtp180 -74.88 10.85 1.25 Allowed 'General case' 0 CA--C 1.558 1.272 0 O-C-N 121.95 -0.469 . . . . 75.43 112.031 -178.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -119.19 5.63 11.25 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.777 1.631 . . . . 71.2 109.012 -178.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.33 138.53 55.5 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.717 0.807 . . . . 74.14 111.332 -176.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 33.9 p -90.26 -179.71 5.7 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.389 0.676 . . . . 75.03 110.1 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -52.43 -31.95 36.99 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.901 0.88 . . . . 71.11 112.683 179.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 19.3 tp10 -87.34 -28.51 22.19 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 112.055 0.391 . . . . 72.43 112.055 -173.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -66.12 -42.94 88.48 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 109.118 -0.697 . . . . 71.14 109.118 168.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.34 -39.85 84.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 O-C-N 124.332 1.02 . . . . 73.31 111.051 174.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -59.89 -56.0 27.2 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.935 0.894 . . . . 75.22 110.521 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 -69.56 -26.77 64.65 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 114.688 -1.142 . . . . 73.12 110.998 -176.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -75.3 -37.26 60.92 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.359 0.663 . . . . 72.43 111.079 178.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -60.06 -54.27 47.91 Favored 'General case' 0 C--O 1.216 -0.66 0 N-CA-C 108.947 -0.76 . . . . 73.1 108.947 173.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.9 mtpt -62.87 -38.02 89.2 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 124.287 0.992 . . . . 74.22 111.526 -178.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.9 ttt180 -53.14 -55.9 20.48 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.615 1.166 . . . . 75.52 110.119 174.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.633 ' HB3' HD12 ' A' ' 50' ' ' ILE . 96.5 mt -79.63 -16.22 56.2 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 115.035 -0.984 . . . . 75.12 111.613 -177.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -81.9 -19.92 39.85 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.717 0.807 . . . . 71.54 110.554 175.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 -89.7 -37.17 14.77 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.186 0.594 . . . . 72.33 110.323 171.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -69.47 -60.45 2.32 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.103 0.478 . . . . 73.31 110.391 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -93.42 34.24 1.18 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.552 0.741 . . . . 72.41 110.286 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.9 t-160 -61.58 102.5 0.31 Allowed Pre-proline 0 C--N 1.356 0.849 0 C-N-CA 124.051 0.94 . . . . 73.54 109.581 178.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -67.89 -19.66 46.16 Favored 'Trans proline' 0 C--N 1.371 1.751 0 C-N-CA 122.879 2.386 . . . . 75.51 112.279 -168.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -59.34 -39.08 82.03 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.453 1.101 . . . . 73.23 111.129 173.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.3 t -101.63 -46.63 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 123.494 0.717 . . . . 73.25 110.466 -176.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -100.51 85.63 2.99 Favored 'General case' 0 C--O 1.245 0.826 0 C-N-CA 124.482 1.113 . . . . 64.12 109.933 -177.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.72 69.94 9.6 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.316 0.646 . . . . 73.11 109.525 178.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.0 m -121.21 110.03 34.74 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-O 118.191 -0.909 . . . . 71.24 108.794 177.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -35.88 -61.9 0.26 Allowed 'Trans proline' 0 C--N 1.389 2.658 0 C-N-CA 125.157 3.904 . . . . 73.53 115.051 -171.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -67.49 -27.01 66.65 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 122.891 0.476 . . . . 64.43 111.957 -175.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.44 -30.46 67.3 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-O 121.001 0.429 . . . . 73.42 109.919 175.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.422 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 35.3 mt-10 -83.29 -28.6 28.98 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.166 -0.925 . . . . 63.35 109.337 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.446 ' HA ' ' HE3' ' A' ' 48' ' ' LYS . 50.7 mt-10 -66.81 -43.46 83.76 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.325 0.65 . . . . 62.44 109.977 173.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 35.0 mmtm -61.61 -42.25 98.61 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 115.057 -0.974 . . . . 74.03 109.939 173.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.561 ' HA ' HD13 ' A' ' 50' ' ' ILE . 91.1 t80 -57.41 -37.16 72.28 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 123.737 0.648 . . . . 73.32 111.112 176.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.569 ' HB2' ' HZ1' ' A' ' 48' ' ' LYS . 10.4 mtmp? -70.85 -33.59 70.79 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.947 0.499 . . . . 75.14 111.472 176.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -71.14 -23.64 62.11 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 122.741 0.416 . . . . 71.44 111.082 173.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.633 HD12 ' HB3' ' A' ' 29' ' ' LEU . 59.9 mt -79.53 -35.68 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.718 1.207 . . . . 74.43 109.331 174.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -65.38 -35.86 82.25 Favored 'General case' 0 C--O 1.209 -1.05 0 CA-C-N 115.628 -0.715 . . . . 73.43 109.827 171.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -65.61 -48.9 70.71 Favored 'General case' 0 C--O 1.247 0.946 0 C-N-CA 125.344 1.458 . . . . 75.34 110.542 177.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.468 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . . . -57.87 -48.28 80.27 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 114.265 -1.334 . . . . 65.45 111.243 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -79.19 -19.87 49.78 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 115.044 -0.98 . . . . 73.53 110.891 177.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.31 -45.72 87.49 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 118.404 0.547 . . . . 72.52 109.865 174.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.591 HG11 ' HZ ' ' A' ' 101' ' ' PHE . 22.7 t -71.43 -56.37 10.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 114.138 -1.392 . . . . 74.52 110.042 175.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.617 HD23 ' HD2' ' A' ' 63' ' ' ARG . 43.5 mt -91.93 15.73 12.53 Favored 'General case' 0 CA--C 1.56 1.346 0 N-CA-C 113.644 0.979 . . . . 74.35 113.644 -164.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.2 t -71.63 -71.54 0.26 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 122.813 0.445 . . . . 74.34 110.798 171.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -79.97 143.18 57.02 Favored Pre-proline 0 N--CA 1.471 0.619 0 CA-C-N 115.439 -0.801 . . . . 74.34 110.113 -176.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -58.47 -27.06 80.73 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 123.155 2.57 . . . . 72.41 112.932 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -67.31 -59.12 3.67 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.711 0.805 . . . . 72.3 111.002 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.499 ' HA ' HD12 ' A' ' 65' ' ' ILE . 27.9 mtpt -70.07 -28.92 65.83 Favored 'General case' 0 C--O 1.248 0.987 0 CA-C-N 114.893 -1.048 . . . . 74.54 110.829 -177.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.617 ' HD2' HD23 ' A' ' 57' ' ' LEU . 31.6 tpt85 -54.21 -55.61 26.28 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 114.635 -1.166 . . . . 74.11 109.401 168.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -65.2 -25.68 67.81 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 115.761 -0.654 . . . . 74.25 112.113 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.499 HD12 ' HA ' ' A' ' 62' ' ' LYS . 78.6 mt -59.38 -47.15 91.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 CA-C-N 118.231 0.469 . . . . 74.41 110.138 171.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -58.35 -52.97 63.35 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 116.033 -0.53 . . . . 75.4 110.255 173.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -56.67 -41.85 77.99 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.477 0.711 . . . . 64.04 112.599 -176.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.8 p -74.13 -23.02 59.23 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 122.844 0.458 . . . . 75.44 110.95 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -71.0 126.58 29.96 Favored 'General case' 0 C--N 1.357 0.909 0 N-CA-C 107.42 -1.326 . . . . 75.32 107.42 170.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.82 13.93 41.88 Favored Glycine 0 N--CA 1.471 1.027 0 N-CA-C 112.108 -0.397 . . . . 64.23 112.108 -169.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 42.6 m -140.79 -57.56 0.51 Allowed 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 103.786 -2.672 . . . . 71.23 103.786 173.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 46.7 m -83.82 140.55 31.96 Favored 'General case' 0 C--O 1.247 0.951 0 N-CA-C 104.832 -2.284 . . . . 74.23 104.832 155.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.41 -26.29 17.3 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.027 0.531 . . . . 74.04 110.889 178.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -88.82 163.16 36.19 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 123.911 0.884 . . . . 75.1 110.516 176.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -58.23 143.88 96.43 Favored 'Trans proline' 0 C--N 1.371 1.716 0 C-N-CA 122.268 1.979 . . . . 75.41 111.657 163.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.92 159.61 47.73 Favored 'Trans proline' 0 CA--C 1.557 1.665 0 C-N-CA 122.397 2.065 . . . . 74.25 111.341 174.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -51.41 114.57 1.62 Allowed 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 122.927 2.418 . . . . 73.45 112.911 173.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -61.04 140.31 89.13 Favored 'Trans proline' 0 C--N 1.384 2.4 0 C-N-CA 123.311 2.674 . . . . 73.2 112.556 177.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.52 163.86 37.37 Favored 'Trans proline' 0 C--N 1.374 1.896 0 C-N-CA 122.766 2.311 . . . . 71.05 112.445 177.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -58.18 87.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.38 2.186 0 C-N-CA 123.122 2.548 . . . . 74.31 112.648 174.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 150.96 -34.1 0.94 Allowed Glycine 0 C--N 1.338 0.645 0 CA-C-N 114.281 -1.327 . . . . 62.41 110.006 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 106.5 -160.39 14.49 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-N 114.754 -0.723 . . . . 53.03 111.722 178.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -90.89 103.5 16.2 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 123.478 0.711 . . . . 74.41 109.3 178.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -61.63 152.51 30.53 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.728 0.811 . . . . 71.31 111.658 171.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.565 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 70.8 m-85 -142.09 75.04 1.47 Allowed 'General case' 0 C--N 1.353 0.745 0 C-N-CA 124.582 1.153 . . . . 73.24 109.411 172.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' A' ' 162' ' ' PRO . 74.0 m -53.84 84.38 0.0 OUTLIER 'General case' 0 CA--C 1.562 1.405 0 C-N-CA 124.392 1.077 . . . . 74.44 113.316 -178.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 88.32 19.31 53.12 Favored Glycine 0 C--N 1.351 1.369 0 CA-C-N 115.691 -0.686 . . . . 70.11 113.992 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.565 ' HB2' ' HB3' ' A' ' 85' ' ' PHE . 37.4 m-85 -125.95 113.53 17.29 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 118.102 0.951 . . . . 72.34 110.402 -174.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -78.0 86.71 4.18 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.655 0.74 . . . . 71.44 111.008 -176.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.619 HG21 HD21 ' A' ' 105' ' ' LEU . 2.3 p -46.49 -36.31 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 124.926 1.291 . . . . 75.21 113.402 172.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.477 ' HB2' ' HG3' ' A' ' 170' ' ' PRO . 16.9 tp10 -54.32 -28.25 41.28 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.197 0.999 . . . . 75.33 111.563 -178.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -84.59 -39.53 18.61 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.654 0.781 . . . . 61.35 112.061 178.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 15.3 m-30 -66.15 162.58 19.46 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 113.404 0.89 . . . . 73.34 113.404 -162.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 92.2 p -65.03 164.55 12.63 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 114.025 1.12 . . . . 74.5 114.025 -165.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.88 -39.33 71.37 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 114.392 -1.276 . . . . 74.52 112.948 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -58.81 -45.59 89.59 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 121.654 0.74 . . . . 75.03 110.302 178.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -64.65 -41.0 96.42 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 113.995 -1.457 . . . . 72.32 110.109 178.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -73.35 -10.67 59.99 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 115.313 -0.858 . . . . 74.14 111.922 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -90.41 -54.48 3.99 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 118.267 0.485 . . . . 70.02 110.507 169.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 29.0 tp -60.47 -28.02 68.0 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.597 1.159 . . . . 74.33 111.786 -174.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.591 ' HZ ' HG11 ' A' ' 56' ' ' VAL . 95.4 m-85 -117.28 -3.97 11.42 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 123.072 0.549 . . . . 72.11 111.72 177.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -47.61 -60.63 5.21 Favored Glycine 0 CA--C 1.537 1.438 0 N-CA-C 116.035 1.174 . . . . 72.43 116.035 -175.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -66.1 5.53 0.65 Allowed 'Trans proline' 0 C--N 1.375 1.935 0 C-N-CA 123.303 2.669 . . . . 64.43 114.789 -175.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -150.58 30.92 1.03 Allowed Glycine 0 C--N 1.356 1.639 0 CA-C-O 118.79 -1.006 . . . . 54.4 112.755 170.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.619 HD21 HG21 ' A' ' 90' ' ' VAL . 17.2 mt -60.8 78.64 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 117.421 0.61 . . . . 74.25 112.502 176.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 38.48 -109.05 0.07 Allowed 'General case' 0 CA--C 1.563 1.464 0 C-N-CA 126.628 1.971 . . . . 74.45 113.069 -176.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 70.78 15.45 73.68 Favored Glycine 0 C--N 1.366 2.237 0 CA-C-O 119.165 -0.797 . . . . 44.0 114.323 -177.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.719 ' HA3' ' HB3' ' A' ' 167' ' ' GLN . . . . . . . . 0 C--N 1.366 2.202 0 C-N-CA 125.895 1.712 . . . . 71.34 115.63 166.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.584 ' HD2' ' HB2' ' A' ' 170' ' ' PRO . 24.3 tptp . . . . . 0 N--CA 1.493 1.696 0 N-CA-C 114.533 1.308 . . . . 73.31 114.533 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -83.64 175.79 52.22 Favored Glycine 0 CA--C 1.54 1.637 0 CA-C-N 115.844 -0.616 . . . . 73.4 112.592 175.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.731 ' H ' ' HA3' ' A' ' 166' ' ' GLY . 0.0 OUTLIER -116.72 174.0 6.32 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 124.118 0.967 . . . . 74.43 111.697 -178.359 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -78.46 101.66 7.43 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-O 122.02 0.914 . . . . 74.23 110.089 175.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 10.4 tt -112.2 139.84 47.4 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.938 0.895 . . . . 75.42 108.825 -174.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.412 ' HA ' ' HB2' ' A' ' 175' ' ' LEU . 58.3 ttt180 -94.42 139.02 31.66 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.33 0.652 . . . . 74.51 111.207 -178.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -134.77 169.43 17.37 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 123.981 0.912 . . . . 54.41 109.368 170.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.64 115.74 25.68 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 107.0 -1.482 . . . . 72.42 107.0 -174.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 50.5 tp -100.52 100.23 11.74 Favored Pre-proline 0 N--CA 1.476 0.846 0 N-CA-C 108.912 -0.773 . . . . 74.14 108.912 -175.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.534 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 77.4 Cg_endo -84.16 111.73 1.64 Allowed 'Trans proline' 0 C--N 1.374 1.909 0 C-N-CA 121.323 1.348 . . . . 75.33 110.049 176.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.602 ' HA ' HG23 ' B' ' 6' ' ' ILE . 52.3 tp -104.99 137.09 43.28 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.706 0.402 . . . . 72.43 110.338 -176.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 90.0 m -68.06 126.69 30.3 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.035 0.934 . . . . 71.34 109.638 177.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 53.9 mt -53.6 -51.88 61.61 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.625 1.17 . . . . 75.21 112.47 -171.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -58.77 -37.39 76.16 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 115.115 -0.948 . . . . 75.32 110.007 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.464 ' HB3' ' NH2' ' A' ' 136' ' ' ARG . 44.6 mm-40 -80.48 -14.81 57.95 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.048 -0.978 . . . . 64.33 112.34 -178.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -70.51 -52.18 23.62 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 107.823 -1.177 . . . . 65.44 107.823 167.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -53.98 -40.1 66.59 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 116.028 -0.533 . . . . 74.51 110.913 175.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 35.9 m170 -78.41 -29.57 47.23 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 122.838 0.455 . . . . 75.25 112.099 -178.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 64.04 -138.05 41.42 Favored Glycine 0 N--CA 1.479 1.531 0 O-C-N 123.271 0.357 . . . . 71.54 113.844 176.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.36 -161.09 46.5 Favored Glycine 0 C--N 1.357 1.696 0 O-C-N 123.781 0.342 . . . . 70.42 113.002 175.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -76.23 119.09 19.65 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 109.255 -0.646 . . . . 73.14 109.255 170.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.464 ' NH2' ' HB3' ' A' ' 129' ' ' GLU . 10.0 tpp180 -93.52 123.35 36.77 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 109.336 -0.616 . . . . 75.05 109.336 175.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 145' ' ' VAL . 98.2 t -88.37 104.07 14.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 109.018 -0.734 . . . . 75.04 109.018 175.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.422 HG23 HD13 ' B' ' 6' ' ' ILE . 15.3 t -102.64 125.36 56.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 CA-C-N 115.041 -0.981 . . . . 73.34 108.598 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -102.98 134.03 47.1 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.554 0.741 . . . . 71.3 109.968 -178.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.402 ' HB ' ' HB3' ' B' ' 8' ' ' LEU . 7.2 p -168.3 113.91 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 122.782 0.433 . . . . 75.1 111.547 178.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 61.26 24.78 14.84 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.396 1.078 . . . . 74.24 113.047 170.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 99.38 -11.25 61.59 Favored Glycine 0 C--N 1.349 1.286 0 CA-C-N 116.766 -0.197 . . . . 54.15 112.871 -178.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 -87.9 108.42 19.17 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.872 0.869 . . . . 72.43 109.959 175.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 -105.4 94.87 5.45 Favored 'General case' 0 C--O 1.244 0.794 0 C-N-CA 123.916 0.887 . . . . 74.41 108.864 175.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.412 HG23 HG13 ' A' ' 147' ' ' VAL . 11.5 p -95.58 143.67 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 123.205 0.602 . . . . 73.53 110.959 -176.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 33.3 t -118.16 85.6 2.38 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.82 0.848 . . . . 64.43 109.277 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.412 HG13 HG23 ' A' ' 145' ' ' VAL . 11.1 m -92.88 114.04 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 C-N-CA 123.364 0.666 . . . . 73.42 111.745 -173.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -71.32 105.56 3.54 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.449 -0.574 . . . . 74.32 109.449 173.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 21.2 pt -102.14 153.9 37.73 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 124.644 1.178 . . . . 74.52 109.772 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -57.6 -166.34 0.02 OUTLIER 'Trans proline' 0 N--CA 1.519 3.007 0 C-N-CA 124.305 3.337 . . . . 74.22 112.591 170.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -46.13 90.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.399 3.217 0 C-N-CA 121.621 1.547 . . . . 74.15 110.864 162.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 36.52 -94.58 0.01 OUTLIER Glycine 0 C--N 1.346 1.131 0 CA-C-N 113.011 -1.904 . . . . 75.51 114.521 -162.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.577 HG13 HG21 ' A' ' 178' ' ' VAL . 5.5 p 172.71 166.34 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 113.364 -1.418 . . . . 75.43 107.986 -162.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.93 146.64 50.57 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 108.59 -0.892 . . . . 73.23 108.59 177.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.567 ' HG2' ' NH1' ' A' ' 187' ' ' ARG . 14.9 tp10 -48.95 129.81 17.67 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.447 1.099 . . . . 72.32 112.263 -177.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 91.08 -4.9 81.58 Favored Glycine 0 C--N 1.346 1.114 0 CA-C-N 115.438 -0.801 . . . . 74.33 113.774 179.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 57.8 m -66.23 113.82 4.85 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 117.499 0.649 . . . . 74.23 110.409 179.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.404 HG23 HG21 ' A' ' 177' ' ' VAL . 61.1 t -90.13 94.93 5.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 C-N-CA 123.892 0.877 . . . . 74.02 108.949 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.582 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 60.1 mt -77.76 108.8 11.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 108.604 -0.887 . . . . 75.24 108.604 175.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 30.1 ttt180 -76.64 107.09 8.68 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.474 -0.565 . . . . 75.21 109.474 178.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.404 HG12 ' HB3' ' A' ' 174' ' ' LEU . 3.8 p -125.93 95.86 38.74 Favored Pre-proline 0 CA--C 1.55 0.958 0 N-CA-C 109.304 -0.628 . . . . 71.41 109.304 174.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.511 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 30.0 Cg_exo -62.25 142.04 90.04 Favored 'Trans proline' 0 C--N 1.369 1.636 0 C-N-CA 122.524 2.149 . . . . 74.53 111.597 174.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . 0.419 ' N ' ' HB3' ' A' ' 171' ' ' PRO . . . 121.04 -26.36 6.79 Favored Glycine 0 N--CA 1.475 1.299 0 CA-C-N 117.855 0.298 . . . . 70.43 112.759 175.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 68.4 mtm -116.36 2.74 13.24 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 122.761 0.424 . . . . 64.15 110.858 -178.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.426 ' HA2' HD12 ' A' ' 174' ' ' LEU . . . -83.39 -108.99 0.52 Allowed Glycine 0 C--N 1.353 1.505 0 N-CA-C 110.875 -0.89 . . . . 73.33 110.875 175.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.731 ' HA3' ' H ' ' A' ' 117' ' ' ARG . . . -57.69 108.62 1.44 Allowed Glycine 0 C--O 1.263 1.932 0 N-CA-C 110.902 -0.879 . . . . 74.5 110.902 164.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.719 ' HB3' ' HA3' ' A' ' 108' ' ' GLY . 27.1 mm-40 -67.47 105.2 1.75 Allowed 'General case' 0 N--CA 1.446 -0.63 0 O-C-N 125.453 1.325 . . . . 75.42 109.204 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -178.26 169.08 40.67 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 110.871 -0.891 . . . . 64.21 110.871 -176.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . 0.53 ' ND2' ' HB3' ' A' ' 105' ' ' LEU . 4.6 t-20 -63.03 -67.98 0.94 Allowed Pre-proline 0 CA--C 1.57 1.722 0 CA-C-O 117.026 -1.464 . . . . 63.54 111.639 -170.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.584 ' HB2' ' HD2' ' A' ' 115' ' ' LYS . 17.0 Cg_exo -66.23 116.01 3.8 Favored 'Trans proline' 0 C--N 1.396 3.066 0 CA-C-N 122.878 2.063 . . . . 73.02 109.922 167.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.419 ' HB3' ' N ' ' A' ' 163' ' ' GLY . 18.8 Cg_exo -40.5 127.27 2.32 Favored 'Trans proline' 0 C--N 1.368 1.592 0 C-N-CA 125.214 3.943 . . . . 71.25 117.131 -171.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -83.11 132.14 10.87 Favored Glycine 0 C--N 1.367 2.289 0 CA-C-O 119.159 -0.801 . . . . 72.4 111.987 164.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.511 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 22.8 m-20 -64.48 108.35 1.63 Allowed 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.166 0.586 . . . . 71.14 110.82 -175.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.426 HD12 ' HA2' ' A' ' 165' ' ' GLY . 38.3 tp -83.64 129.31 34.96 Favored 'General case' 0 C--N 1.349 0.545 0 N-CA-C 109.623 -0.51 . . . . 74.2 109.623 175.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.412 ' HB2' ' HA ' ' A' ' 120' ' ' ARG . 55.6 mt -99.1 88.45 3.95 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 107.999 -1.112 . . . . 72.12 107.999 178.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.582 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 75.1 mt -70.62 87.32 0.67 Allowed 'General case' 0 C--N 1.35 0.609 0 N-CA-C 109.06 -0.719 . . . . 74.52 109.06 174.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.404 HG21 HG23 ' A' ' 158' ' ' VAL . 19.7 t -82.62 102.15 8.22 Favored 'Isoleucine or valine' 0 C--O 1.248 1.017 0 N-CA-C 105.749 -1.945 . . . . 71.11 105.749 175.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.577 HG21 HG13 ' A' ' 153' ' ' VAL . 5.4 p -73.42 131.89 34.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 115.034 -0.985 . . . . 74.13 110.865 -169.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.534 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 28.9 mmt180 -112.72 127.27 56.09 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 106.261 -1.755 . . . . 73.42 106.261 167.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.425 HD22 ' HB3' ' A' ' 125' ' ' LEU . 27.7 mt -80.12 147.7 31.28 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.477 -0.935 . . . . 74.04 108.477 169.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 20.2 mt -53.28 152.49 8.17 Favored Pre-proline 0 N--CA 1.482 1.145 0 O-C-N 124.174 0.921 . . . . 73.22 113.021 -167.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -65.16 5.23 0.53 Allowed 'Trans proline' 0 C--N 1.383 2.354 0 C-N-CA 123.566 2.844 . . . . 74.32 113.425 175.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 61.2 t-80 -59.56 104.0 0.41 Allowed Pre-proline 0 CA--C 1.56 1.341 0 C-N-CA 124.894 1.278 . . . . 73.35 107.985 168.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -80.81 26.36 0.6 Allowed 'Trans proline' 0 C--N 1.372 1.773 0 C-N-CA 123.792 2.995 . . . . 61.24 115.537 -162.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 75.5 t -95.22 -61.03 2.28 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.901 0 CA-C-O 118.715 -0.659 . . . . 72.34 110.848 -175.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -138.11 92.57 2.67 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 119.064 0.847 . . . . 72.31 110.34 -176.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . 0.567 ' NH1' ' HG2' ' A' ' 155' ' ' GLU . 62.1 ttp85 -98.09 98.24 9.58 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.867 0.867 . . . . 75.51 109.391 176.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.508 ' HA ' ' HA ' ' A' ' 193' ' ' LEU . 61.9 tp -68.78 142.15 55.0 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.163 0.985 . . . . 74.21 110.864 178.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -152.7 129.03 10.56 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.792 1.237 . . . . 70.31 109.973 -174.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 68.51 -80.5 0.22 Allowed Glycine 0 C--N 1.351 1.412 0 N-CA-C 111.916 -0.474 . . . . 65.41 111.916 -177.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.534 ' HG3' ' HB3' ' A' ' 244' ' ' ALA . 14.6 mm100 -147.47 -11.18 0.41 Allowed 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 125.069 1.347 . . . . 72.32 110.533 166.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -103.7 148.81 25.61 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.492 1.117 . . . . 72.32 110.944 -174.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.508 ' HA ' ' HA ' ' A' ' 188' ' ' LEU . 11.6 mt -90.36 162.67 15.03 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.245 1.018 . . . . 74.25 111.02 -175.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -131.16 114.51 15.19 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.303 1.041 . . . . 73.14 109.142 173.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.483 ' HB1' HD21 ' A' ' 251' ' ' LEU . . . -135.68 174.92 10.08 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.64 1.176 . . . . 74.34 110.458 -176.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 27.9 m -120.72 144.87 48.02 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.818 0.847 . . . . 70.21 108.878 173.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.47 HD22 HG23 ' A' ' 210' ' ' VAL . 44.7 tp -129.4 115.92 18.26 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.621 0.768 . . . . 74.1 109.457 -175.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -90.24 121.05 31.92 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 108.092 -1.077 . . . . 63.3 108.092 173.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.5 p -139.5 131.02 14.85 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 124.054 0.942 . . . . 74.33 109.136 -173.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -72.35 148.58 49.23 Favored 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 121.602 1.535 . . . . 70.05 110.77 174.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -49.54 -47.4 78.17 Favored Pre-proline 0 CA--C 1.561 1.374 0 N-CA-C 114.131 1.16 . . . . 71.34 114.131 -174.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -51.66 -48.09 23.11 Favored 'Trans proline' 0 C--N 1.384 2.442 0 C-N-CA 122.022 1.815 . . . . 73.32 113.725 176.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 22.9 mt -73.12 -29.36 28.31 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 CA-C-N 115.74 -0.664 . . . . 71.02 110.514 -176.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.4 -41.71 76.06 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.979 0.512 . . . . 74.14 111.493 176.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 54.6 t -74.26 -46.88 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 123.867 0.867 . . . . 64.22 111.875 -175.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 91.5 t -90.56 -31.35 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 122.884 0.473 . . . . 74.41 111.569 -175.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 82.49 111.22 0.45 Allowed Glycine 0 C--N 1.343 0.928 0 N-CA-C 112.37 -0.292 . . . . 72.35 112.37 178.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.459 ' HA3' ' CE1' ' C' ' 277' ' ' TYR . . . -145.47 -132.61 2.47 Favored Glycine 0 C--O 1.217 -0.957 0 CA-C-O 119.178 -0.79 . . . . 73.32 111.719 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.501 ' HZ3' ' HB2' ' A' ' 209' ' ' LYS . 9.2 mtmp? -112.05 134.83 53.36 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 118.008 0.904 . . . . 73.34 110.377 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.47 HG23 HD22 ' A' ' 197' ' ' LEU . 12.2 m -132.88 162.34 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 124.796 1.238 . . . . 63.11 108.633 171.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 5.8 tpp180 -86.1 126.96 34.58 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 109.314 -0.624 . . . . 74.32 109.314 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.44 109.93 21.84 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.409 -0.96 . . . . 74.41 108.409 170.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 16.9 tpt -83.0 111.82 19.2 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 108.45 -0.944 . . . . 74.15 108.45 177.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 26.5 p -107.55 -174.47 2.54 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 109.502 -0.555 . . . . 74.1 109.502 -174.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 80.7 mt -63.94 -33.9 76.77 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.019 0.927 . . . . 73.14 111.942 -176.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -97.24 -6.63 34.14 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.421 0.688 . . . . 64.44 112.118 -177.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 135.06 -179.03 18.08 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-O 120.054 -0.303 . . . . 63.05 112.61 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -79.6 147.35 19.72 Favored 'Trans proline' 0 CA--C 1.549 1.238 0 C-N-CA 122.94 2.426 . . . . 74.13 113.455 -176.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 31.7 m -136.04 -177.91 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.624 1.569 . . . . 73.4 107.556 172.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -109.77 127.77 54.85 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 118.499 0.59 . . . . 75.04 109.745 169.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 7.0 m -107.52 132.25 55.54 Favored 'Isoleucine or valine' 0 C--O 1.242 0.683 0 C-N-CA 124.178 0.991 . . . . 74.51 108.512 168.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -80.24 97.3 6.89 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.572 -0.899 . . . . 70.4 108.572 178.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 14.9 p -65.62 137.39 96.36 Favored Pre-proline 0 N--CA 1.479 1.007 0 C-N-CA 124.186 0.994 . . . . 71.22 109.732 -175.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -72.04 165.93 31.12 Favored 'Trans proline' 0 C--N 1.374 1.9 0 C-N-CA 122.158 1.906 . . . . 75.51 111.931 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -73.58 164.11 35.75 Favored 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 122.214 1.942 . . . . 72.53 112.916 172.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 64.2 mtt-85 61.44 26.94 16.61 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 125.377 1.471 . . . . 75.13 111.812 169.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.503 HG23 HD21 ' A' ' 233' ' ' LEU . 94.6 m -72.06 103.87 3.4 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.19 1.396 . . . . 64.32 110.873 -176.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -87.08 138.11 31.77 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.636 1.174 . . . . 75.32 110.313 -175.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . 0.471 ' HA ' ' HB ' ' A' ' 253' ' ' VAL . . . -67.2 156.64 35.76 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.561 0.744 . . . . 65.12 111.973 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 83.51 -14.87 38.48 Favored Glycine 0 N--CA 1.471 0.99 0 CA-C-N 116.024 -0.535 . . . . 75.54 112.892 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -92.42 160.78 14.93 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 123.691 0.796 . . . . 74.44 110.4 177.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -113.49 113.5 25.22 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.783 0.833 . . . . 72.22 108.79 178.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.503 HD21 HG23 ' A' ' 227' ' ' THR . 64.7 mt -76.24 117.21 17.69 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.793 0.837 . . . . 71.4 109.683 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 27.8 ttm-85 -85.97 102.69 14.0 Favored 'General case' 0 CA--C 1.551 1.001 0 N-CA-C 108.679 -0.859 . . . . 73.41 108.679 172.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.494 HD13 HD22 ' A' ' 249' ' ' LEU . 3.1 mt -87.76 110.9 20.81 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 108.581 -0.896 . . . . 74.24 108.581 -178.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -59.38 127.84 34.1 Favored 'General case' 0 CA--C 1.555 1.135 0 O-C-N 124.098 0.874 . . . . 71.01 113.254 -177.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 82.59 6.37 88.63 Favored Glycine 0 C--N 1.353 1.5 0 N-CA-C 114.847 0.699 . . . . 74.2 114.847 170.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -95.31 -20.51 19.1 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 117.515 0.657 . . . . 74.1 112.714 -172.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -82.21 -173.01 48.42 Favored Glycine 0 N--CA 1.478 1.451 0 N-CA-C 113.717 0.247 . . . . 74.43 113.717 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -84.87 146.95 47.21 Favored Pre-proline 0 N--CA 1.483 1.213 0 C-N-CA 122.898 0.479 . . . . 73.41 111.811 -167.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -68.98 157.16 62.96 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 123.323 2.682 . . . . 73.33 113.326 173.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 169.84 -156.51 27.38 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 119.305 -0.719 . . . . 73.52 112.07 -178.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -61.99 -28.27 80.43 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 123.786 2.991 . . . . 72.5 113.286 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . 0.534 ' HB3' ' HG3' ' A' ' 191' ' ' GLN . . . -87.38 22.32 2.2 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.252 0.621 . . . . 70.11 111.416 176.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 75.01 -97.32 1.01 Allowed Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.47 -1.052 . . . . 62.24 110.47 -175.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 39.2 mtp180 -128.05 152.4 48.01 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.718 0.807 . . . . 75.41 110.167 166.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -91.57 -175.65 43.07 Favored Glycine 0 C--N 1.342 0.876 0 CA-C-N 116.082 -0.508 . . . . 70.31 112.031 171.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -112.62 -173.25 2.21 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.601 0.76 . . . . 75.44 110.588 178.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.494 HD22 HD13 ' A' ' 235' ' ' LEU . 19.1 tp -125.55 115.6 20.44 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 122.102 -0.374 . . . . 73.32 110.17 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.403 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 9.9 m-85 -80.44 123.08 27.74 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.545 -0.539 . . . . 71.3 109.545 172.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.483 HD21 ' HB1' ' A' ' 195' ' ' ALA . 57.8 mt -114.67 119.21 35.93 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.414 0.685 . . . . 74.54 109.415 171.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -77.46 116.94 18.45 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 106.579 -1.637 . . . . 75.41 106.579 176.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.471 ' HB ' ' HA ' ' A' ' 229' ' ' ALA . 24.3 t -75.71 109.68 9.6 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 CA-C-O 121.234 0.54 . . . . 71.34 110.569 -173.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.78 93.36 4.42 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.054 1.341 . . . . 73.14 107.625 177.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.407 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 58.6 mt -83.57 132.41 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-O 120.758 0.313 . . . . 74.34 110.308 -177.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 28.0 p -121.48 172.11 8.3 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.619 1.167 . . . . 74.52 109.889 174.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . 0.425 HD13 ' H ' ' A' ' 259' ' ' GLU . 2.1 pp -126.48 154.86 75.15 Favored Pre-proline 0 CA--C 1.562 1.429 0 N-CA-C 107.966 -1.124 . . . . 73.4 107.966 175.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' PRO . . . . . 0.527 ' HG3' ' HH ' ' C' ' 276' ' ' TYR . 61.2 Cg_endo -75.96 14.42 1.08 Allowed 'Trans proline' 0 N--CA 1.511 2.549 0 C-N-CA 123.36 2.707 . . . . 74.45 115.713 -164.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . 0.425 ' H ' HD13 ' A' ' 257' ' ' ILE . 5.6 mm-40 54.1 -125.12 2.28 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 124.142 0.977 . . . . 75.12 111.682 -170.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' ARG . . . . . 0.403 ' H ' ' HD3' ' A' ' 260' ' ' ARG . 0.0 OUTLIER -63.61 140.61 58.89 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 118.449 0.568 . . . . 75.12 110.904 -170.443 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.407 HD13 ' CG1' ' C' ' 205' ' ' VAL . 84.9 mt -110.34 160.6 16.42 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.248 0.619 . . . . 72.32 111.584 -171.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 21.3 p -103.92 146.85 33.32 Favored Pre-proline 0 CA--C 1.554 1.118 0 C-N-CA 124.652 1.181 . . . . 74.31 108.94 174.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' PRO . . . . . 0.46 ' O ' ' HB3' ' A' ' 266' ' ' GLU . 21.7 Cg_exo -29.46 -58.74 0.14 Allowed 'Trans proline' 0 C--N 1.389 2.692 1 C-N-CA 126.089 4.526 . . . . 74.33 117.948 -163.209 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -72.28 -45.41 60.22 Favored 'General case' 0 C--O 1.211 -0.949 0 CA-C-O 119.217 -0.42 . . . . 71.44 110.711 -176.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -60.17 -31.49 70.16 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 123.955 0.784 . . . . 73.22 109.819 178.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' GLU . . . . . 0.462 ' O ' ' HD3' ' A' ' 270' ' ' LYS . 8.3 tp10 -59.47 -60.58 3.62 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.925 0.89 . . . . 73.45 109.045 171.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -63.99 -21.58 66.56 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 115.235 -0.893 . . . . 64.12 112.198 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . 0.418 ' HA ' ' HE2' ' A' ' 271' ' ' LYS . 26.3 tp -79.7 -48.7 13.24 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.548 1.139 . . . . 73.14 110.24 -173.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 70.6 m95 -61.03 -39.07 88.37 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.336 -0.847 . . . . 75.0 110.401 172.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . 0.597 ' HG3' HG23 ' C' ' 206' ' ' VAL . 1.0 OUTLIER -63.08 -45.7 90.92 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 123.689 0.618 . . . . 73.12 111.676 176.09 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . 0.418 ' HE2' ' HA ' ' A' ' 268' ' ' LEU . 30.3 mtmm -56.63 -50.01 73.28 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 123.082 0.553 . . . . 70.22 110.813 176.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' LEU . . . . . 0.4 ' O ' ' HB2' ' A' ' 276' ' ' TYR . 57.8 mt -51.32 -50.97 58.36 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 124.444 1.09 . . . . 71.54 110.4 175.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -72.73 -34.1 66.84 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 114.158 1.17 . . . . 72.23 114.158 -168.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -78.06 -41.68 34.66 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 122.75 0.42 . . . . 74.35 110.105 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -67.39 -30.8 70.67 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 115.98 -0.555 . . . . 72.24 110.52 174.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . 0.4 ' HB2' ' O ' ' A' ' 272' ' ' LEU . 35.1 t80 -66.15 -62.76 1.31 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.326 1.051 . . . . 75.02 109.596 176.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -60.43 -44.04 96.19 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.525 1.13 . . . . 72.14 111.168 -172.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -63.13 -17.82 62.75 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 112.467 0.543 . . . . 75.41 112.467 -179.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 -128.27 19.62 6.37 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.668 0.787 . . . . 75.15 111.016 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.08 0 CA-C-O 118.786 -0.626 . . . . 72.5 110.552 -174.956 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.416 ' SD ' ' N ' ' B' ' 1' ' ' MET . 1.0 OUTLIER . . . . . 0 N--CA 1.482 1.167 0 N-CA-C 108.866 -0.79 . . . . 74.12 108.866 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . 0.57 ' HA ' ' HE3' ' B' ' 2' ' ' LYS . 0.5 OUTLIER -69.31 129.34 39.52 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 123.656 0.597 . . . . 62.45 110.046 -177.22 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 22.7 tm0? -144.71 145.01 31.5 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 108.462 -0.94 . . . . 74.04 108.462 -173.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 72.5 p 54.86 -85.21 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 125.859 1.663 . . . . 52.14 113.041 -178.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 11.3 m -75.01 157.63 34.58 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.018 0.527 . . . . 74.34 110.218 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.602 HG23 ' HA ' ' A' ' 125' ' ' LEU . 36.3 pt -131.43 170.26 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 123.158 0.583 . . . . 65.34 111.071 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -142.04 132.98 25.88 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.583 0.753 . . . . 72.22 109.955 -177.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . 0.402 ' HB3' ' HB ' ' A' ' 140' ' ' VAL . 48.5 tp -79.05 154.42 29.46 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.775 0.83 . . . . 75.22 111.338 -173.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -79.17 -63.56 1.39 Allowed 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.349 0.66 . . . . 73.12 112.153 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 86.5 mt 62.91 117.43 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 124.865 1.266 . . . . 74.1 110.566 -163.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 28.2 mt . . . . . 0 CA--C 1.584 2.278 0 N-CA-C 116.298 1.962 . . . . 72.11 116.298 -176.756 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.594 0 N-CA-C 109.441 -0.577 . . . . 74.35 109.441 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . -70.81 -36.91 73.19 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.182 0.593 . . . . 75.32 110.547 175.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 13.1 tp -159.72 18.77 0.16 Allowed 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 114.629 -1.169 . . . . 74.44 109.179 176.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 182' ' ' VAL . . . . . 0.59 HG21 ' HA ' ' C' ' 138' ' ' VAL . 55.9 t -76.86 107.0 7.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 116.089 -0.505 . . . . 72.43 111.119 -169.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 183' ' ' ALA . . . . . 0.401 ' HB3' ' HB3' ' C' ' 123' ' ' LEU . . . -86.62 -36.4 18.84 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.13 -0.941 . . . . 65.24 110.214 170.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 184' ' ' HIS . . . . . 0.518 ' HB2' HG11 ' B' ' 182' ' ' VAL . 6.3 t-80 58.42 28.88 17.46 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 125.259 1.424 . . . . 75.32 112.382 171.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 185' ' ' VAL . . . . . . . . . . . . . 53.5 t . . . . . 0 N--CA 1.481 1.123 0 C-N-CA 124.226 1.01 . . . . 74.01 109.443 -168.408 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 41.0 m . . . . . 0 N--CA 1.485 1.298 0 CA-C-O 122.986 1.374 . . . . 71.31 107.752 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 239' ' ' ALA . . . . . 0.703 ' HB2' ' H ' ' C' ' 222' ' ' ALA . . . -97.32 -173.67 2.73 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 114.329 -1.305 . . . . 74.42 111.945 -173.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . -117.1 -151.9 9.49 Favored Glycine 0 C--N 1.341 0.848 0 CA-C-N 114.799 -1.091 . . . . 71.23 111.06 178.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -110.39 141.68 43.12 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.941 0.896 . . . . 71.23 112.026 -165.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 242' ' ' TRP . . . . . 0.429 ' HB3' ' HA ' ' C' ' 233' ' ' LEU . 0.4 OUTLIER -171.09 -39.55 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.584 1.154 . . . . 70.32 109.577 174.231 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 243' ' ' GLN . . . . . 0.723 ' HG3' ' HG2' ' C' ' 224' ' ' PRO . 12.6 pt20 -157.36 162.93 39.08 Favored 'General case' 0 C--O 1.244 0.791 0 C-N-CA 124.47 1.108 . . . . 74.22 108.881 169.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -69.07 116.78 7.46 Favored Glycine 0 C--N 1.351 1.384 0 N-CA-C 111.896 -0.482 . . . . 71.54 111.896 -175.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 245' ' ' LYS . . . . . 0.548 ' HE2' ' HB3' ' C' ' 222' ' ' ALA . 9.2 tmtm? . . . . . 0 N--CA 1.476 0.839 0 CA-C-N 117.245 0.522 . . . . 75.34 110.474 -175.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.812 0 CA-C-O 120.668 0.27 . . . . 71.34 110.34 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -37.92 100.97 0.02 OUTLIER 'General case' 0 C--N 1.356 0.872 0 C-N-CA 125.778 1.631 . . . . 70.52 113.442 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 5' ' ' LYS . . . . . 0.609 ' HD2' HD11 ' C' ' 10' ' ' ILE . 25.0 mmtp -74.47 101.14 4.04 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 108.943 -0.762 . . . . 72.32 108.943 167.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 6' ' ' ASP . . . . . 0.42 ' HA ' ' OH ' ' C' ' 66' ' ' TYR . 13.5 t70 -73.73 93.12 2.06 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 106.261 -1.755 . . . . 65.15 106.261 168.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 7' ' ' TYR . . . . . 0.46 ' CD1' ' HA ' ' C' ' 53' ' ' ALA . 63.5 m-85 -61.13 -29.37 69.73 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.074 -0.966 . . . . 73.43 111.744 -171.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 8' ' ' TYR . . . . . 0.534 ' HH ' HD13 ' C' ' 22' ' ' ILE . 32.1 m-85 -64.05 -46.08 85.97 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.316 -0.856 . . . . 74.23 111.171 173.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.9 -39.39 94.08 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.103 0.561 . . . . 63.34 111.231 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 10' ' ' ILE . . . . . 0.609 HD11 ' HD2' ' C' ' 5' ' ' LYS . 62.2 mt -57.67 -43.81 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 C-N-CA 123.173 0.589 . . . . 73.31 110.042 174.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 11' ' ' LEU . . . . . 0.452 ' HB3' ' HB1' ' C' ' 25' ' ' ALA . 92.0 mt -82.72 -3.05 55.91 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 115.44 -0.8 . . . . 75.53 112.834 178.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 63.03 34.53 90.22 Favored Glycine 0 C--N 1.355 1.592 0 N-CA-C 114.088 0.395 . . . . 74.43 114.088 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 13' ' ' VAL . . . . . 0.5 HG23 ' HD1' ' C' ' 8' ' ' TYR . 8.3 m -129.38 154.33 80.68 Favored Pre-proline 0 N--CA 1.486 1.362 0 C-N-CA 124.776 1.23 . . . . 71.34 109.456 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -77.24 171.18 18.23 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 122.356 2.037 . . . . 74.43 112.778 -179.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 62.6 mtt180 -80.4 29.05 0.3 Allowed 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.518 0.727 . . . . 74.35 111.682 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -117.17 -15.94 10.43 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 125.659 1.583 . . . . 71.24 108.341 175.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.07 110.21 1.52 Allowed 'General case' 0 C--N 1.354 0.77 0 CA-C-N 114.918 -1.037 . . . . 75.2 110.655 -178.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 41.3 p -74.15 174.9 8.06 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 122.936 0.494 . . . . 74.41 109.857 172.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.93 -44.31 29.82 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 124.772 1.229 . . . . 74.45 111.745 -173.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 20' ' ' GLU . . . . . 0.63 ' HA ' ' HE3' ' C' ' 23' ' ' LYS . 2.3 tm-20 -65.08 -40.43 94.62 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.241 1.016 . . . . 74.53 110.851 -175.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . 0.481 ' HG2' ' NH2' ' C' ' 24' ' ' ARG . 33.6 mt-10 -70.57 -39.39 73.93 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.733 0.813 . . . . 73.42 110.837 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 22' ' ' ILE . . . . . 0.802 HD11 ' HB3' ' C' ' 57' ' ' LEU . 97.0 mt -64.07 -38.18 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.175 1.39 . . . . 75.54 110.368 175.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 23' ' ' LYS . . . . . 0.63 ' HE3' ' HA ' ' C' ' 20' ' ' GLU . 22.1 ttpp -67.76 -35.41 78.67 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.144 1.377 . . . . 74.13 110.438 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 24' ' ' ARG . . . . . 0.481 ' NH2' ' HG2' ' C' ' 21' ' ' GLU . 39.7 mtm180 -73.88 -33.04 63.89 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 115.848 -0.615 . . . . 73.52 112.361 172.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . 0.452 ' HB1' ' HB3' ' C' ' 11' ' ' LEU . . . -63.18 -38.4 91.04 Favored 'General case' 0 C--O 1.251 1.162 0 CA-C-O 121.465 0.65 . . . . 75.32 110.045 174.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 26' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -60.74 -58.46 8.38 Favored 'General case' 0 C--O 1.208 -1.1 0 CA-C-N 113.92 -1.491 . . . . 72.31 109.342 173.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . 0.416 ' HD3' ' HA ' ' C' ' 24' ' ' ARG . 27.5 mtpp -42.92 -52.3 5.2 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 124.042 0.839 . . . . 75.33 111.574 178.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -53.95 -62.65 1.52 Allowed 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.375 -1.284 . . . . 75.55 111.423 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 93.4 mt -84.65 -6.48 59.36 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 112.499 0.555 . . . . 71.43 112.499 -171.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' C' ' 34' ' ' HIS . . . -96.58 -17.07 20.68 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.134 0.574 . . . . 75.32 110.859 179.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 65.3 mtm180 -94.61 -33.08 13.14 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 123.324 0.39 . . . . 73.5 110.219 167.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -69.91 -52.77 21.83 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.042 0.537 . . . . 71.12 109.766 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 33' ' ' TYR . . . . . 0.433 ' HD1' ' HB1' ' C' ' 43' ' ' ALA . 51.2 m-85 -88.37 10.38 20.11 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 119.504 -0.284 . . . . 72.14 111.013 178.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 34' ' ' HIS . . . . . 0.401 ' HB2' ' O ' ' C' ' 30' ' ' ALA . 14.5 t60 -61.11 116.76 20.68 Favored Pre-proline 0 C--N 1.363 1.173 0 CA-C-O 118.325 -0.845 . . . . 74.34 109.788 -178.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -45.46 -53.43 5.5 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 123.901 3.067 . . . . 72.22 114.272 -172.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -56.14 -40.86 74.47 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.332 0.653 . . . . 60.34 112.63 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 62.1 t -80.13 -31.37 13.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 CA-C-N 115.542 -0.754 . . . . 75.33 110.442 -173.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -143.57 74.85 1.45 Allowed 'General case' 0 C--O 1.243 0.752 0 N-CA-C 108.245 -1.02 . . . . 65.41 108.245 -174.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -69.83 79.54 0.46 Allowed 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 114.919 -1.037 . . . . 71.22 109.975 178.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 16.1 m -136.17 102.17 10.03 Favored Pre-proline 0 CA--C 1.537 0.467 0 N-CA-C 107.486 -1.301 . . . . 74.14 107.486 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -32.83 -55.25 0.36 Allowed 'Trans proline' 0 C--N 1.389 2.703 0 C-N-CA 124.796 3.664 . . . . 75.0 115.256 -175.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.4 -40.57 91.43 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.299 0.64 . . . . 71.01 111.079 -178.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 43' ' ' ALA . . . . . 0.433 ' HB1' ' HD1' ' C' ' 33' ' ' TYR . . . -71.54 -24.0 61.86 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.368 0.667 . . . . 71.45 111.205 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -85.81 -28.71 24.31 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.4 -0.592 . . . . 74.04 109.4 -178.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -71.56 -40.87 69.68 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.728 0.811 . . . . 75.44 109.627 170.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 46' ' ' LYS . . . . . 0.523 ' O ' HG12 ' C' ' 50' ' ' ILE . 38.0 mmtm -67.05 -33.18 74.97 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 115.155 -0.93 . . . . 72.32 110.342 173.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -58.58 -46.96 85.84 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.608 0.763 . . . . 71.12 109.376 172.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 48' ' ' LYS . . . . . 0.637 ' HB3' ' HE1' ' C' ' 93' ' ' PHE . 55.4 mtpt -56.58 -42.61 78.95 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 123.894 0.746 . . . . 72.04 110.947 175.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -69.68 -24.58 63.62 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 122.936 0.494 . . . . 72.33 112.187 177.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 50' ' ' ILE . . . . . 0.523 HG12 ' O ' ' C' ' 46' ' ' LYS . 27.6 mm -69.71 -41.58 80.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.793 -0.818 . . . . 75.43 108.793 172.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 51' ' ' ASN . . . . . 0.495 ' HB3' ' CD1' ' C' ' 88' ' ' PHE . 58.7 m-80 -68.37 -32.75 73.05 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-N 114.79 -1.096 . . . . 74.04 111.18 177.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -65.84 -54.07 31.57 Favored 'General case' 0 C--O 1.248 0.988 0 C-N-CA 124.677 1.191 . . . . 75.54 110.317 176.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . 0.46 ' HA ' ' CD1' ' C' ' 7' ' ' TYR . . . -56.6 -51.04 70.17 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-N 113.627 -1.624 . . . . 63.1 111.297 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -64.35 -35.73 81.83 Favored 'General case' 0 C--O 1.197 -1.664 0 CA-C-N 114.874 -1.057 . . . . 75.01 110.528 177.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.97 -44.64 91.55 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 118.378 0.535 . . . . 60.54 111.706 -178.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 86.2 t -68.06 -42.5 85.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 CA-C-O 121.367 0.603 . . . . 72.43 110.432 174.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 57' ' ' LEU . . . . . 0.802 ' HB3' HD11 ' C' ' 22' ' ' ILE . 80.7 mt -93.35 5.13 52.6 Favored 'General case' 0 CA--C 1.563 1.467 0 N-CA-C 113.483 0.92 . . . . 75.02 113.483 -171.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 30.4 t -81.42 -44.24 17.78 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.419 0.688 . . . . 75.33 110.262 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -80.06 128.78 72.47 Favored Pre-proline 0 CA--C 1.515 -0.401 0 CA-C-O 118.246 -0.883 . . . . 72.03 109.08 175.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 60' ' ' PRO . . . . . 0.557 ' O ' ' HG2' ' C' ' 64' ' ' ARG . 87.7 Cg_exo -51.41 -33.11 45.26 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.026 1.817 . . . . 73.21 110.978 162.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . 0.455 ' HB2' ' HB3' ' C' ' 144' ' ' ARG . 8.6 tp10 -61.36 -63.97 1.1 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.424 0.689 . . . . 62.13 111.365 176.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -64.81 -23.92 67.39 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 122.886 0.474 . . . . 75.43 111.336 -177.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 63' ' ' ARG . . . . . 0.481 HH21 ' HB3' ' C' ' 66' ' ' TYR . 2.6 tpm_? -63.98 -50.57 68.04 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.827 0.851 . . . . 74.14 110.115 172.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 64' ' ' ARG . . . . . 0.557 ' HG2' ' O ' ' C' ' 60' ' ' PRO . 28.5 mmm180 -69.62 -25.02 63.74 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 122.369 0.268 . . . . 74.15 110.894 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 66.6 mt -62.97 -46.52 96.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 N-CA-C 109.46 -0.57 . . . . 71.5 109.46 169.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 66' ' ' TYR . . . . . 0.481 ' HB3' HH21 ' C' ' 63' ' ' ARG . 6.5 t80 -58.78 -46.94 86.36 Favored 'General case' 0 CA--C 1.555 1.142 0 CA-C-N 115.33 -0.85 . . . . 74.31 109.809 176.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -56.23 -46.99 79.34 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.869 0.868 . . . . 73.14 111.265 177.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 27.5 p -78.03 -11.85 59.94 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.144 -0.48 . . . . 74.43 111.809 -177.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -73.82 101.63 3.79 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 107.922 -1.14 . . . . 75.22 107.922 173.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 107.77 22.23 7.42 Favored Glycine 0 C--N 1.347 1.172 0 CA-C-N 116.054 -0.521 . . . . 62.51 111.989 -172.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 92.4 m -144.33 -56.72 0.36 Allowed 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 104.233 -2.506 . . . . 72.34 104.233 175.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 21.9 m -78.74 140.35 38.3 Favored 'General case' 0 C--O 1.256 1.437 0 N-CA-C 104.619 -2.363 . . . . 73.35 104.619 156.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.5 -22.95 15.75 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.63 0.772 . . . . 73.23 111.273 -176.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.64 154.69 38.38 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 123.423 0.689 . . . . 53.23 109.594 174.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -58.82 119.98 7.57 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.194 1.93 . . . . 75.14 110.774 168.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.43 121.25 9.7 Favored 'Trans proline' 0 C--N 1.383 2.376 0 C-N-CA 122.732 2.288 . . . . 71.22 110.918 177.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -41.28 127.54 3.02 Favored 'Trans proline' 0 C--N 1.393 2.887 0 C-N-CA 124.119 3.213 . . . . 74.4 114.091 -169.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 78' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -52.22 142.36 46.21 Favored 'Trans proline' 0 C--N 1.391 2.764 0 C-N-CA 123.8 3.0 . . . . 74.44 113.633 -175.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -54.67 162.87 4.36 Favored 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 123.551 2.834 . . . . 70.12 113.67 176.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -53.97 87.38 0.03 OUTLIER 'Trans proline' 0 C--N 1.387 2.567 0 C-N-CA 123.641 2.894 . . . . 74.31 113.007 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 144.58 -49.51 0.68 Allowed Glycine 0 CA--C 1.524 0.627 0 CA-C-N 113.54 -1.664 . . . . 75.2 109.332 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 142.69 -164.1 27.13 Favored Glycine 0 C--N 1.348 1.237 0 CA-C-N 114.807 -0.697 . . . . 75.13 111.669 -177.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -92.52 111.51 23.13 Favored 'General case' 0 C--O 1.245 0.866 0 C-N-CA 123.907 0.883 . . . . 73.4 108.896 171.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -89.38 -174.4 4.36 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 109.409 -0.589 . . . . 75.11 109.409 170.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 85' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -162.56 71.27 0.3 Allowed 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 107.644 -1.243 . . . . 74.41 107.644 176.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 86' ' ' SER . . . . . 0.416 ' OG ' ' HD3' ' C' ' 143' ' ' ARG . 50.5 m -33.73 96.71 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 118.042 2.608 . . . . 52.42 118.042 -166.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 68.16 12.71 63.5 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-N 116.093 -0.503 . . . . 74.34 113.695 173.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 88' ' ' PHE . . . . . 0.495 ' CD1' ' HB3' ' C' ' 51' ' ' ASN . 16.8 m-85 -103.74 150.85 23.67 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 124.271 1.028 . . . . 74.44 108.385 -178.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -83.54 69.31 10.06 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.061 0.458 . . . . 72.23 110.995 -173.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 90' ' ' VAL . . . . . 0.427 HG23 ' CE2' ' C' ' 97' ' ' PHE . 0.8 OUTLIER -43.55 -43.35 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 125.719 1.608 . . . . 54.42 111.945 173.007 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -60.8 -30.77 70.26 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 114.787 -1.097 . . . . 75.25 111.641 -172.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -110.85 4.86 20.16 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.107 0.563 . . . . 75.53 111.289 -176.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 93' ' ' PHE . . . . . 0.637 ' HE1' ' HB3' ' C' ' 48' ' ' LYS . 10.5 m-30 -79.84 -177.14 5.79 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.841 -0.537 . . . . 72.45 112.302 -178.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 96.6 p -67.15 161.18 25.23 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.631 0.975 . . . . 52.11 113.631 -165.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -57.81 -56.08 26.53 Favored 'General case' 0 C--O 1.217 -0.641 0 CA-C-N 113.902 -1.499 . . . . 72.35 110.356 176.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -50.88 -45.27 60.03 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.868 0.867 . . . . 74.24 112.226 -176.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 97' ' ' PHE . . . . . 0.427 ' CE2' HG23 ' C' ' 90' ' ' VAL . 7.5 t80 -58.17 -53.18 61.21 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 115.23 -0.895 . . . . 64.25 110.214 174.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -77.49 4.38 11.23 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 122.707 0.403 . . . . 71.33 112.047 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -98.47 -45.54 6.08 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.534 0.733 . . . . 74.43 110.663 170.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 22.9 tp -78.65 -56.34 4.5 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.169 0.588 . . . . 73.23 110.281 -178.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 101' ' ' PHE . . . . . 0.472 ' O ' ' HG ' ' C' ' 105' ' ' LEU . 90.4 m-85 -85.26 -15.52 43.19 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.346 -0.843 . . . . 75.04 111.257 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -46.49 -54.78 8.47 Favored Glycine 0 CA--C 1.545 1.932 0 CA-C-O 118.941 -0.922 . . . . 74.41 114.951 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_exo -45.01 -24.5 1.32 Allowed 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 124.681 3.587 . . . . 64.35 116.434 175.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -128.58 14.56 6.09 Favored Glycine 0 C--N 1.355 1.633 0 CA-C-O 118.605 -1.108 . . . . 73.42 114.237 -178.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 105' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' C' ' 101' ' ' PHE . 49.3 mt . . . . . 0 N--CA 1.492 1.671 0 CA-C-N 118.247 1.024 . . . . 75.43 112.246 177.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.478 0 CA-C-O 120.153 -0.248 . . . . 54.4 113.269 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 117' ' ' ARG . . . . . 0.451 ' HG2' ' H ' ' C' ' 118' ' ' ASP . 46.3 ttt-85 -82.98 174.67 10.69 Favored 'General case' 0 C--O 1.25 1.08 0 C-N-CA 123.459 0.704 . . . . 74.32 109.523 175.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 118' ' ' ASP . . . . . 0.451 ' H ' ' HG2' ' C' ' 117' ' ' ARG . 5.0 p-10 -64.52 151.76 43.62 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 121.59 0.709 . . . . 75.42 110.985 173.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 119' ' ' LEU . . . . . . . . . . . . . 61.1 tp -108.17 164.04 12.65 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 106.828 -1.545 . . . . 75.21 106.828 172.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 74.0 ttt-85 -138.69 120.94 15.85 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 118.665 0.666 . . . . 72.31 109.654 177.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 121' ' ' ALA . . . . . 0.419 ' HB1' HD11 ' C' ' 174' ' ' LEU . . . -140.84 118.81 11.85 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.28 1.032 . . . . 75.44 108.827 -178.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -102.05 147.6 26.39 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 110.317 -0.253 . . . . 74.12 110.317 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 123' ' ' LEU . . . . . 0.401 ' HB3' ' HB3' ' B' ' 183' ' ' ALA . 1.9 pt? -134.98 144.94 52.46 Favored Pre-proline 0 N--CA 1.478 0.954 0 C-N-CA 122.998 0.519 . . . . 73.3 111.237 -173.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.4 116.39 4.1 Favored 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 123.011 2.474 . . . . 72.51 110.076 165.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 125' ' ' LEU . . . . . 0.403 ' O ' ' HA ' ' C' ' 180' ' ' LEU . 38.4 tp -133.1 149.55 52.12 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.928 0.891 . . . . 75.32 108.687 -176.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 126' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.26 157.12 16.03 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 122.635 0.374 . . . . 61.53 110.775 -176.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 127' ' ' LEU . . . . . 0.54 HD11 ' CD2' ' C' ' 186' ' ' PHE . 17.9 mt -58.31 -47.02 85.03 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.809 1.244 . . . . 62.25 110.201 173.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 128' ' ' GLU . . . . . 0.428 ' HG3' ' HA ' ' C' ' 215' ' ' LEU . 1.8 mp0 -63.0 -38.08 89.77 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 114.267 -1.333 . . . . 75.24 110.903 178.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -79.54 -17.47 53.94 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 122.749 0.42 . . . . 75.51 111.707 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -75.37 -40.76 57.72 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 109.193 -0.669 . . . . 73.14 109.193 171.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 131' ' ' PHE . . . . . 0.533 ' HB2' HD11 ' C' ' 215' ' ' LEU . 69.2 t80 -62.38 -35.77 80.2 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.61 1.564 . . . . 75.55 111.91 172.007 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 132' ' ' HIS . . . . . . . . . . . . . 43.7 m170 -77.07 -51.31 11.27 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 110.318 -0.253 . . . . 70.15 110.318 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 50.55 -129.29 29.37 Favored Glycine 0 C--N 1.351 1.411 0 O-C-N 124.306 1.004 . . . . 65.31 113.894 177.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.29 -147.51 33.08 Favored Glycine 0 C--N 1.348 1.233 0 C-N-CA 123.128 0.394 . . . . 73.12 113.483 174.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -92.79 110.26 21.7 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.866 0.867 . . . . 73.03 109.898 -177.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 136' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -117.52 135.51 53.89 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.184 0.994 . . . . 72.12 110.152 -174.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 137' ' ' VAL . . . . . 0.467 HG12 ' HG ' ' C' ' 146' ' ' SER . 35.8 m -76.86 143.98 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 122.644 0.378 . . . . 73.11 111.574 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 138' ' ' VAL . . . . . 0.59 ' HA ' HG21 ' B' ' 182' ' ' VAL . 7.4 p -158.93 139.7 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.28 1.032 . . . . 72.14 108.981 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 139' ' ' GLU . . . . . 0.471 ' HA ' ' O ' ' C' ' 143' ' ' ARG . 0.0 OUTLIER -123.8 94.84 4.35 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.559 0.743 . . . . 74.31 110.621 176.112 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 140' ' ' VAL . . . . . . . . . . . . . 11.5 p -147.77 139.85 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 122.977 0.511 . . . . 73.25 111.154 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 61.36 15.58 6.68 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 125.001 1.32 . . . . 65.0 113.72 173.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 114.4 -26.64 9.5 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-N 116.489 -0.323 . . . . 52.4 112.602 -178.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 143' ' ' ARG . . . . . 0.471 ' O ' ' HA ' ' C' ' 139' ' ' GLU . 7.7 mmm180 -80.34 101.16 8.79 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.182 0.593 . . . . 75.05 111.593 178.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 144' ' ' ARG . . . . . 0.455 ' HB3' ' HB2' ' C' ' 61' ' ' GLU . 75.2 ttt180 -109.87 89.79 3.12 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 107.402 -1.333 . . . . 71.51 107.402 169.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 145' ' ' VAL . . . . . . . . . . . . . 12.6 p -161.05 163.8 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.904 0 C-N-CA 123.369 0.668 . . . . 75.03 111.26 -166.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 146' ' ' SER . . . . . 0.467 ' HG ' HG12 ' C' ' 137' ' ' VAL . 20.3 m -85.99 113.26 21.94 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 123.898 0.879 . . . . 73.22 109.972 168.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 3.9 p -89.18 129.45 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.477 0.711 . . . . 72.53 110.192 175.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 42.9 ttt180 -86.59 95.07 9.63 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.152 0.581 . . . . 74.22 109.846 178.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 149' ' ' ILE . . . . . . . . . . . . . 40.7 pt -116.53 107.02 47.53 Favored Pre-proline 0 CA--C 1.546 0.827 0 N-CA-C 108.209 -1.034 . . . . 74.42 108.209 165.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -54.2 167.4 1.25 Allowed 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 123.075 2.516 . . . . 61.44 114.005 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -47.69 115.06 1.27 Allowed 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 123.062 2.508 . . . . 73.2 113.063 171.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 152' ' ' GLY . . . . . . . . . . . . . . . 150.43 88.45 0.07 OUTLIER Glycine 0 C--N 1.344 1.021 0 C-N-CA 120.441 -0.885 . . . . 63.11 114.527 -178.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 153' ' ' VAL . . . . . 0.557 HG22 HG12 ' C' ' 178' ' ' VAL . 14.0 p -165.26 151.83 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.201 0 C-N-CA 122.885 0.474 . . . . 74.01 110.001 173.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 154' ' ' ARG . . . . . 0.539 ' HD2' ' HG2' ' C' ' 187' ' ' ARG . 37.4 ttp180 -150.55 149.18 29.59 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.182 0.993 . . . . 75.32 109.819 -170.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 155' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -42.3 129.8 3.81 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 125.288 1.435 . . . . 74.51 112.849 -177.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.87 -13.72 58.42 Favored Glycine 0 C--N 1.348 1.219 0 CA-C-N 115.753 -0.658 . . . . 75.21 113.238 177.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 157' ' ' SER . . . . . 0.505 ' O ' HG11 ' C' ' 178' ' ' VAL . 43.8 t -74.8 140.43 43.97 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 108.832 -0.803 . . . . 75.43 108.832 174.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 58.6 t -119.73 105.84 18.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.629 -0.714 . . . . 72.31 109.266 -173.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 159' ' ' ILE . . . . . 0.68 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 15.3 mt -72.06 97.16 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.66 0 CA-C-N 114.805 -1.089 . . . . 72.31 108.954 -177.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 7.2 ttt180 -78.96 97.61 6.11 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 107.673 -1.232 . . . . 75.13 107.673 175.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 161' ' ' VAL . . . . . . . . . . . . . 2.2 p -101.53 103.99 31.22 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 124.457 1.103 . . . . 75.24 108.734 -178.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -55.36 123.98 15.16 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 123.407 2.738 . . . . 75.23 114.207 -173.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 163' ' ' GLY . . . . . 0.655 ' H ' ' HA ' ' C' ' 173' ' ' ASP . . . 89.79 -10.13 74.8 Favored Glycine 0 N--CA 1.441 -1.003 0 N-CA-C 117.236 1.654 . . . . 53.54 117.236 169.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 164' ' ' MET . . . . . 0.493 ' SD ' HD22 ' C' ' 174' ' ' LEU . 46.9 ttm -75.12 -13.23 60.46 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 119.954 1.877 . . . . 73.35 111.028 -177.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . -102.75 -117.12 4.27 Favored Glycine 0 C--N 1.347 1.156 0 CA-C-O 119.368 -0.685 . . . . 73.32 111.691 173.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 166' ' ' GLY . . . . . 0.521 ' HA3' ' HA ' ' C' ' 171' ' ' PRO . . . 87.44 68.86 1.31 Allowed Glycine 0 C--N 1.358 1.766 0 CA-C-N 117.781 0.791 . . . . 75.44 113.7 176.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 167' ' ' GLN . . . . . . . . . . . . . 19.9 mm-40 -80.14 100.21 8.13 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 106.97 -1.493 . . . . 74.2 106.97 173.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . 150.51 -89.23 0.14 Allowed Glycine 0 C--O 1.213 -1.167 0 CA-C-O 118.295 -1.281 . . . . 13.44 110.014 -168.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 169' ' ' ASN . . . . . 0.533 ' HB3' ' HD3' ' C' ' 170' ' ' PRO . 2.9 t-20 -176.36 -59.95 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.706 0 CA-C-O 117.165 -1.398 . . . . 62.44 112.216 164.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 170' ' ' PRO . . . . . 0.533 ' HD3' ' HB3' ' C' ' 169' ' ' ASN . 32.4 Cg_exo -61.52 98.91 0.16 Allowed 'Trans proline' 0 C--N 1.402 3.345 0 CA-C-N 122.446 1.909 . . . . 73.55 110.418 165.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 171' ' ' PRO . . . . . 0.53 ' HB2' ' HA2' ' C' ' 163' ' ' GLY . 7.5 Cg_exo -72.33 120.55 6.83 Favored 'Trans proline' 0 C--N 1.362 1.289 0 C-N-CA 122.34 2.027 . . . . 74.02 113.118 -163.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -63.78 -73.3 0.56 Allowed Glycine 0 C--N 1.347 1.164 0 O-C-N 124.029 0.831 . . . . 74.42 111.701 175.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 173' ' ' ASP . . . . . 0.655 ' HA ' ' H ' ' C' ' 163' ' ' GLY . 5.4 p-10 -170.46 175.99 4.56 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.245 0.545 . . . . 74.51 111.828 -179.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 174' ' ' LEU . . . . . 0.493 HD22 ' SD ' ' C' ' 164' ' ' MET . 11.2 tp -120.87 136.16 55.0 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 114.633 -1.167 . . . . 75.22 108.254 168.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 81.7 mt -98.88 88.92 4.14 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.659 1.184 . . . . 72.15 109.449 176.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 176' ' ' LEU . . . . . 0.68 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 78.8 mt -75.3 94.73 3.06 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.303 0.641 . . . . 74.33 110.012 174.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 177' ' ' VAL . . . . . . . . . . . . . 23.5 t -84.62 114.72 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 108.597 -0.89 . . . . 75.23 108.597 -178.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 178' ' ' VAL . . . . . 0.557 HG12 HG22 ' C' ' 153' ' ' VAL . 8.4 p -82.12 126.04 39.88 Favored 'Isoleucine or valine' 0 C--O 1.251 1.15 0 CA-C-O 121.941 0.877 . . . . 74.01 110.822 -176.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 179' ' ' ARG . . . . . . . . . . . . . 24.3 mmt180 -113.82 111.09 21.18 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.188 -1.412 . . . . 74.42 107.188 170.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 180' ' ' LEU . . . . . 0.403 ' HA ' ' O ' ' C' ' 125' ' ' LEU . 93.1 mt -73.29 148.52 43.5 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.86 0.362 . . . . 73.43 110.906 -177.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 181' ' ' LEU . . . . . 0.42 ' HB3' ' HD2' ' C' ' 182' ' ' PRO . 24.9 mt -62.12 166.29 6.84 Favored Pre-proline 0 CA--C 1.564 1.483 0 C-N-CA 124.405 1.082 . . . . 74.24 111.899 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 182' ' ' PRO . . . . . 0.42 ' HD2' ' HB3' ' C' ' 181' ' ' LEU . 12.1 Cg_exo -33.95 -20.84 0.02 OUTLIER 'Trans proline' 0 C--N 1.396 3.068 1 C-N-CA 125.413 4.075 . . . . 73.32 118.26 179.329 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 183' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -104.85 96.8 11.34 Favored Pre-proline 0 CA--C 1.568 1.644 0 CA-C-N 119.14 0.882 . . . . 72.0 110.147 165.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 184' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -98.14 65.91 0.09 OUTLIER 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 123.658 2.905 . . . . 74.25 110.575 171.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 185' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 36.9 t -94.02 -43.44 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 CA-C-N 115.952 -0.567 . . . . 72.23 110.611 -164.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 186' ' ' PHE . . . . . 0.54 ' CD2' HD11 ' C' ' 127' ' ' LEU . 68.1 m-85 -99.9 116.55 32.23 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-O 121.205 0.526 . . . . 61.44 111.345 -167.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 187' ' ' ARG . . . . . 0.677 ' HB3' ' HB3' ' C' ' 194' ' ' TYR . 3.2 tmt_? -96.12 107.91 20.28 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.997 1.319 . . . . 75.14 108.919 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 188' ' ' LEU . . . . . . . . . . . . . 45.8 tp -84.16 140.92 31.42 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.445 0.535 . . . . 74.14 112.445 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -144.97 106.28 4.21 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 107.069 -1.456 . . . . 73.21 107.069 162.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 74.96 -96.43 0.96 Allowed Glycine 0 C--N 1.355 1.633 0 N-CA-C 112.022 -0.431 . . . . 74.2 112.022 -177.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 191' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -115.19 -31.28 6.06 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.108 0.963 . . . . 75.25 110.154 173.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -76.97 152.66 35.15 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 116.072 -0.513 . . . . 65.13 111.551 -170.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 193' ' ' LEU . . . . . 0.458 HD21 ' CD1' ' C' ' 240' ' ' PHE . 88.1 mt -119.82 165.59 14.38 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.735 0.814 . . . . 65.15 111.257 -176.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 194' ' ' TYR . . . . . 0.677 ' HB3' ' HB3' ' C' ' 187' ' ' ARG . 27.5 t80 -139.47 107.3 5.66 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.097 -0.956 . . . . 75.43 109.585 170.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 195' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' C' ' 185' ' ' VAL . . . -104.67 -174.99 2.67 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.22 1.008 . . . . 65.11 110.907 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 65.9 m -132.11 121.09 23.24 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 108.088 -1.079 . . . . 53.42 108.088 164.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 197' ' ' LEU . . . . . . . . . . . . . 41.0 tp -97.53 125.86 42.48 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.292 0.637 . . . . 73.5 111.183 -172.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -73.84 101.85 3.88 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.005 0.922 . . . . 64.33 108.87 176.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 199' ' ' VAL . . . . . 0.558 ' HA ' HG12 ' C' ' 210' ' ' VAL . 26.9 t -121.72 109.28 34.37 Favored Pre-proline 0 N--CA 1.475 0.812 0 N-CA-C 108.62 -0.881 . . . . 73.12 108.62 178.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 200' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -68.45 147.13 70.49 Favored 'Trans proline' 0 C--N 1.37 1.702 0 C-N-CA 121.588 1.526 . . . . 73.11 111.317 175.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 201' ' ' ALA . . . . . 0.473 ' O ' HG21 ' C' ' 205' ' ' VAL . . . -52.44 -49.24 86.65 Favored Pre-proline 0 CA--C 1.553 1.07 0 CA-C-O 118.02 -0.99 . . . . 74.35 112.958 -173.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 202' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -51.12 -47.27 26.58 Favored 'Trans proline' 0 C--N 1.387 2.6 0 C-N-CA 121.649 1.566 . . . . 63.15 112.891 176.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 203' ' ' ILE . . . . . 0.497 ' HA ' HG13 ' C' ' 206' ' ' VAL . 47.0 mt -68.56 -34.18 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 123.044 0.538 . . . . 74.02 111.139 -178.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -70.24 -28.45 65.26 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.659 0.783 . . . . 75.02 112.208 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 205' ' ' VAL . . . . . 0.473 HG21 ' O ' ' C' ' 201' ' ' ALA . 55.0 t -86.39 -40.1 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 116.084 -0.507 . . . . 74.52 111.374 178.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 206' ' ' VAL . . . . . 0.597 HG23 ' HG3' ' A' ' 270' ' ' LYS . 14.0 p -80.16 -37.83 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 O-C-N 123.375 0.422 . . . . 74.12 111.355 -171.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 88.08 61.6 1.48 Allowed Glycine 0 N--CA 1.438 -1.177 0 CA-C-N 115.741 -0.663 . . . . 63.21 112.257 -168.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -101.38 -136.65 9.39 Favored Glycine 0 C--O 1.246 0.882 0 N-CA-C 111.431 -0.668 . . . . 51.32 111.431 176.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 209' ' ' LYS . . . . . 0.557 ' HG2' ' HA ' ' C' ' 222' ' ' ALA . 8.3 mtmp? -140.28 136.3 33.15 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.395 0.617 . . . . 72.44 110.92 178.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 210' ' ' VAL . . . . . 0.558 HG12 ' HA ' ' C' ' 199' ' ' VAL . 34.3 m -119.24 -179.86 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.539 1.535 . . . . 71.52 107.272 169.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 211' ' ' ARG . . . . . 0.61 ' HD3' ' HB2' ' C' ' 218' ' ' PRO . 23.1 ttm105 -132.76 130.6 40.15 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 118.976 0.807 . . . . 75.53 112.095 -178.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -97.0 115.05 26.74 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.32 1.048 . . . . 74.43 108.492 168.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 213' ' ' MET . . . . . 0.456 ' HA ' ' HA ' ' C' ' 218' ' ' PRO . 4.2 tmm? -71.56 101.91 2.6 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 107.418 -1.327 . . . . 63.12 107.418 171.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.88 174.25 6.46 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.348 0.594 . . . . 72.34 110.234 -173.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 215' ' ' LEU . . . . . 0.533 HD11 ' HB2' ' C' ' 131' ' ' PHE . 30.7 mt -65.48 -33.89 77.0 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.309 1.444 . . . . 75.24 112.712 -169.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.23 10.71 23.7 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 114.94 -1.027 . . . . 71.0 111.472 -178.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 143.65 149.37 5.08 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-O 119.86 -0.411 . . . . 74.41 112.453 176.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 218' ' ' PRO . . . . . 0.61 ' HB2' ' HD3' ' C' ' 211' ' ' ARG . 73.3 Cg_endo -77.24 106.42 2.23 Favored 'Trans proline' 0 CA--C 1.557 1.634 0 C-N-CA 122.606 2.204 . . . . 64.03 113.081 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 219' ' ' VAL . . . . . . . . . . . . . 7.2 p -88.32 138.26 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 123.558 0.743 . . . . 52.53 109.903 -178.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 220' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -89.01 111.21 21.88 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 108.734 -0.839 . . . . 72.32 108.734 174.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 221' ' ' VAL . . . . . . . . . . . . . 58.7 t -78.97 128.09 38.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 114.539 -1.209 . . . . 74.03 110.627 -178.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 222' ' ' ALA . . . . . 0.703 ' H ' ' HB2' ' B' ' 239' ' ' ALA . . . -85.42 105.48 16.08 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 124.424 1.09 . . . . 73.3 109.678 176.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 59.1 t -85.71 126.73 65.33 Favored Pre-proline 0 C--O 1.213 -0.858 0 N-CA-C 108.105 -1.072 . . . . 73.11 108.105 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 224' ' ' PRO . . . . . 0.723 ' HG2' ' HG3' ' B' ' 243' ' ' GLN . 10.4 Cg_exo -79.09 156.77 26.48 Favored 'Trans proline' 0 CA--C 1.555 1.546 0 C-N-CA 123.847 3.031 . . . . 73.11 112.221 166.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.43 148.17 64.02 Favored 'Trans proline' 0 C--N 1.387 2.587 0 C-N-CA 123.208 2.605 . . . . 74.4 113.635 -178.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 226' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.5 91.64 0.08 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.229 1.011 . . . . 71.5 112.215 178.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 227' ' ' THR . . . . . 0.482 HG23 HG11 ' C' ' 253' ' ' VAL . 34.0 m -140.9 124.46 16.85 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 115.37 -0.832 . . . . 73.3 111.869 176.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 228' ' ' GLN . . . . . 0.419 HE21 HG13 ' A' ' 257' ' ' ILE . 27.1 mp0 -98.11 161.39 13.74 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-O 122.483 1.135 . . . . 74.32 111.024 170.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -67.85 150.04 49.08 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-N 113.729 -1.578 . . . . 65.31 109.375 173.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 86.46 -4.17 86.38 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.304 -0.474 . . . . 62.04 113.03 -174.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 231' ' ' ARG . . . . . 0.438 ' NH1' HE22 ' B' ' 243' ' ' GLN . 45.5 mtt180 -76.65 170.34 16.61 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 117.789 0.794 . . . . 75.03 109.334 163.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 232' ' ' LYS . . . . . 0.652 ' HB2' ' HZ1' ' C' ' 232' ' ' LYS . 3.9 ttmp? -146.55 139.68 25.58 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.205 0.457 . . . . 74.05 111.921 -173.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 233' ' ' LEU . . . . . 0.577 ' O ' ' HA ' ' C' ' 250' ' ' TYR . 2.4 mp -107.77 151.79 25.23 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.625 1.17 . . . . 74.22 109.89 -177.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -118.83 90.18 3.28 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.638 0.775 . . . . 72.34 109.255 171.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 235' ' ' LEU . . . . . 0.507 ' HB2' ' HB3' ' C' ' 249' ' ' LEU . 49.1 mt -74.25 108.39 7.01 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 109.13 -0.693 . . . . 74.34 109.13 172.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -71.08 125.57 27.25 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.879 0.872 . . . . 73.41 111.125 -175.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 71.44 37.14 62.66 Favored Glycine 0 C--N 1.349 1.251 0 O-C-N 123.532 0.52 . . . . 71.42 112.968 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 20.4 mmtm -126.07 14.95 7.9 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.913 0.885 . . . . 75.11 111.065 176.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -93.0 -167.48 38.91 Favored Glycine 0 C--N 1.352 1.449 0 N-CA-C 112.002 -0.439 . . . . 75.2 112.002 171.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 240' ' ' PHE . . . . . 0.458 ' CD1' HD21 ' C' ' 193' ' ' LEU . 3.6 m-85 -69.06 153.45 96.06 Favored Pre-proline 0 N--CA 1.478 0.96 0 C-N-CA 123.74 0.816 . . . . 75.14 111.529 176.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 241' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -65.91 118.86 5.85 Favored 'Trans proline' 0 C--N 1.377 2.054 0 C-N-CA 123.75 2.967 . . . . 71.53 112.411 -175.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -126.84 -169.52 12.74 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-N 115.719 -0.673 . . . . 70.14 112.548 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -72.14 -31.61 11.84 Favored 'Trans proline' 0 C--N 1.383 2.344 0 C-N-CA 123.049 2.5 . . . . 71.42 111.006 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -80.35 6.35 12.34 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.82 0.848 . . . . 71.42 111.807 176.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 111.04 -76.56 0.22 Allowed Glycine 0 C--N 1.349 1.285 0 N-CA-C 109.907 -1.277 . . . . 63.24 109.907 -178.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 246' ' ' ARG . . . . . . . . . . . . . 29.4 mtm180 -146.09 166.44 26.12 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.847 1.259 . . . . 71.32 109.468 174.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -80.57 -158.89 19.53 Favored Glycine 0 C--N 1.347 1.172 0 CA-C-N 116.345 -0.388 . . . . 63.23 112.241 172.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -123.82 135.24 53.65 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 117.085 0.443 . . . . 73.54 109.836 -177.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 249' ' ' LEU . . . . . 0.507 ' HB3' ' HB2' ' C' ' 235' ' ' LEU . 21.0 tp -88.33 116.15 26.35 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 114.97 -1.014 . . . . 74.23 110.133 -178.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 250' ' ' TYR . . . . . 0.577 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 16.0 m-85 -102.05 99.87 10.07 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 109.838 -0.431 . . . . 71.43 109.838 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 251' ' ' LEU . . . . . 0.552 ' HB2' HD13 ' C' ' 233' ' ' LEU . 1.6 mp -97.15 136.2 38.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.8 -0.563 . . . . 72.0 110.152 -174.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -88.14 118.71 27.91 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 108.047 -1.094 . . . . 75.41 108.047 174.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 253' ' ' VAL . . . . . 0.482 HG11 HG23 ' C' ' 227' ' ' THR . 94.0 t -60.14 131.14 24.66 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 123.348 0.659 . . . . 73.5 111.066 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 254' ' ' ARG . . . . . 0.468 ' CZ ' ' HB ' ' C' ' 256' ' ' THR . 2.1 tmm_? -124.02 98.32 5.74 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 107.507 -1.294 . . . . 75.13 107.507 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 255' ' ' ILE . . . . . 0.443 ' HA ' ' O ' ' C' ' 199' ' ' VAL . 52.0 mm -72.45 120.4 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 123.356 0.41 . . . . 75.24 109.903 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 256' ' ' THR . . . . . 0.468 ' HB ' ' CZ ' ' C' ' 254' ' ' ARG . 0.0 OUTLIER -125.39 164.46 20.38 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.012 0.925 . . . . 70.25 111.1 -176.131 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 2.8 pp -137.61 149.07 63.76 Favored Pre-proline 0 CA--C 1.554 1.099 0 C-N-CA 124.224 1.01 . . . . 75.21 108.328 175.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -80.11 16.52 1.49 Allowed 'Trans proline' 0 C--N 1.375 1.936 0 C-N-CA 122.599 2.2 . . . . 74.41 113.243 -171.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 57.83 -79.87 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.237 1.415 . . . . 72.3 111.635 -173.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -78.53 148.13 33.52 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.97 0.908 . . . . 73.41 109.901 -178.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 261' ' ' LEU . . . . . . . . . . . . . 82.1 mt -132.88 165.59 24.27 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 121.524 0.678 . . . . 74.53 111.329 -178.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 1.6 p -83.61 147.4 52.27 Favored Pre-proline 0 CA--C 1.552 1.035 0 CA-C-N 114.635 -1.166 . . . . 61.23 108.894 164.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -47.73 -31.63 15.1 Favored 'Trans proline' 0 C--N 1.387 2.558 0 C-N-CA 124.476 3.451 . . . . 74.2 114.988 -173.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -60.43 -65.76 0.63 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.88 0.872 . . . . 71.04 109.73 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -57.67 -42.56 83.82 Favored 'General case' 0 C--O 1.216 -0.697 0 CA-C-N 114.466 -1.243 . . . . 71.03 109.767 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 266' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -51.82 -46.12 64.19 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 123.992 0.917 . . . . 73.1 110.718 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -67.81 -43.67 79.08 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.5 0.72 . . . . 71.12 112.05 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 268' ' ' LEU . . . . . . . . . . . . . 10.6 mp -64.72 -37.35 87.29 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 120.765 0.317 . . . . 70.11 111.295 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 84.5 m95 -70.03 -32.26 70.31 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.536 0.735 . . . . 63.11 110.377 175.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 270' ' ' LYS . . . . . 0.56 ' HZ2' ' HB3' ' C' ' 270' ' ' LYS . 3.9 mmmp? -57.91 -50.65 72.61 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 122.852 0.461 . . . . 75.43 109.823 171.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 9.7 mmpt? -56.33 -52.53 64.2 Favored 'General case' 0 C--O 1.252 1.223 0 O-C-N 124.183 0.927 . . . . 75.33 111.191 -178.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 57.6 mt -51.99 -60.65 2.94 Favored 'General case' 0 C--N 1.355 0.845 0 CA-C-N 115.323 -0.853 . . . . 74.33 110.216 174.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -51.9 -44.77 63.94 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.927 0.891 . . . . 43.22 112.338 -173.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -62.21 -45.49 93.14 Favored 'General case' 0 C--O 1.252 1.235 0 C-N-CA 123.579 0.752 . . . . 63.21 110.818 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -58.54 -32.03 68.49 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 116.096 -0.502 . . . . 70.04 111.399 175.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 276' ' ' TYR . . . . . 0.698 ' HA ' ' HD3' ' C' ' 279' ' ' ARG . 1.4 m-85 -85.56 -23.09 27.8 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.09 0.556 . . . . 75.52 111.801 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 277' ' ' TYR . . . . . 0.459 ' CE1' ' HA3' ' A' ' 208' ' ' GLY . 20.4 m-30 -70.43 -30.74 67.67 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 109.424 -0.584 . . . . 65.52 109.424 174.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -59.72 -18.74 45.09 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-N 115.361 -0.836 . . . . 72.22 112.384 171.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 279' ' ' ARG . . . . . 0.698 ' HD3' ' HA ' ' C' ' 276' ' ' TYR . 17.5 mtp-105 -87.76 -26.91 22.65 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.784 0.834 . . . . 75.11 110.844 175.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.025 0 C-N-CA 123.243 0.617 . . . . 75.14 110.277 -172.654 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt . . . . . 0 N--CA 1.479 0.988 0 N-CA-C 114.165 1.172 . . . . 64.14 114.165 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -65.85 109.1 2.36 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 109.278 -0.638 . . . . 74.32 109.278 169.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -73.83 89.35 1.84 Allowed 'General case' 0 C--O 1.246 0.917 0 N-CA-C 107.165 -1.42 . . . . 62.43 107.165 170.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.431 ' CD1' ' HA ' ' A' ' 53' ' ' ALA . 67.1 m-85 -61.29 -27.94 68.83 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 113.9 -1.5 . . . . 73.34 111.565 -172.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -68.13 -41.7 81.27 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 122.962 0.505 . . . . 73.33 110.255 177.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.13 -41.77 97.07 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.045 0.538 . . . . 70.01 110.497 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 65.2 mt -58.93 -36.73 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 O-C-N 123.804 0.69 . . . . 74.23 110.29 174.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 91.2 mt -84.71 -10.49 57.21 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 113.303 0.853 . . . . 73.11 113.303 177.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 68.74 32.52 74.33 Favored Glycine 0 CA--C 1.537 1.427 0 N-CA-C 114.03 0.372 . . . . 73.42 114.03 -178.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.3 m -118.35 162.67 29.04 Favored Pre-proline 0 N--CA 1.484 1.226 0 C-N-CA 124.609 1.164 . . . . 72.52 109.554 174.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -54.79 152.35 28.83 Favored 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 122.772 2.315 . . . . 50.12 112.586 175.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 76.1 mtt-85 -74.84 19.43 0.14 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 113.648 0.981 . . . . 75.43 113.648 -172.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -148.79 12.68 0.89 Allowed 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 124.605 1.162 . . . . 71.2 109.128 -177.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.06 145.49 55.79 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.789 1.235 . . . . 74.14 113.457 -171.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.1 p -70.45 162.71 28.22 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.363 1.065 . . . . 75.03 111.658 -178.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -57.82 -30.18 65.53 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.145 0.978 . . . . 71.11 111.262 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.473 ' HA ' ' HE2' ' A' ' 23' ' ' LYS . 0.8 OUTLIER -69.07 -40.92 78.17 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.746 0.818 . . . . 72.43 109.899 178.949 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.504 ' HG2' ' NH2' ' A' ' 24' ' ' ARG . 42.7 mt-10 -67.98 -35.96 79.23 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.415 0.686 . . . . 71.14 110.833 176.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.81 -33.76 65.54 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 C-N-CA 124.592 1.157 . . . . 73.31 110.326 175.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.473 ' HE2' ' HA ' ' A' ' 20' ' ' GLU . 37.6 ttpt -76.19 -33.26 59.29 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.74 1.216 . . . . 75.22 110.483 179.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.504 ' NH2' ' HG2' ' A' ' 21' ' ' GLU . 50.2 mtm-85 -70.82 -40.97 72.14 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.156 0.583 . . . . 73.12 110.235 173.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.97 -33.88 75.5 Favored 'General case' 0 C--O 1.237 0.402 0 O-C-N 124.163 0.914 . . . . 72.43 110.719 176.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -60.33 -56.97 15.0 Favored 'General case' 0 C--O 1.215 -0.724 0 O-C-N 123.913 0.758 . . . . 73.1 109.9 176.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.489 ' NZ ' ' HA ' ' A' ' 24' ' ' ARG . 35.1 mtmm -60.32 -44.81 95.12 Favored 'General case' 0 N--CA 1.482 1.164 0 O-C-N 123.869 0.73 . . . . 74.22 111.132 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 46.1 ttt180 -47.25 -52.61 15.55 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 125.087 1.355 . . . . 75.52 111.945 176.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.447 HD11 HD13 ' A' ' 50' ' ' ILE . 62.7 mt -91.74 -13.94 30.78 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.559 -0.746 . . . . 75.12 111.656 -173.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -80.51 -18.51 48.3 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.259 0.624 . . . . 71.54 109.991 172.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 51.1 mtp180 -94.55 -39.11 10.56 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.04 0.936 . . . . 72.33 110.331 172.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -71.22 -40.24 71.24 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 122.537 0.335 . . . . 73.31 111.671 -177.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -106.97 24.62 12.5 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.879 0.472 . . . . 72.41 110.319 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 75.8 t60 -57.18 94.79 0.05 OUTLIER Pre-proline 0 N--CA 1.484 1.259 0 C-N-CA 124.73 1.212 . . . . 73.54 112.105 -171.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -72.02 -22.2 23.22 Favored 'Trans proline' 0 C--N 1.368 1.575 0 C-N-CA 122.652 2.235 . . . . 75.51 111.883 -164.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -53.57 -35.82 61.21 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.473 1.509 . . . . 73.23 111.615 176.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 89.4 t -115.42 -40.32 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 CA-C-O 120.905 0.383 . . . . 73.25 110.113 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -100.5 82.46 2.47 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.23 1.012 . . . . 64.12 110.045 -177.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.99 60.87 6.51 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.043 0.537 . . . . 73.11 110.189 -178.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 63.2 m -105.14 123.85 38.42 Favored Pre-proline 0 N--CA 1.481 1.096 0 CA-C-O 117.81 -1.09 . . . . 71.24 109.706 -177.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -40.88 -51.91 3.51 Favored 'Trans proline' 0 C--N 1.391 2.778 0 C-N-CA 124.767 3.645 . . . . 73.53 114.322 -175.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -51.94 -51.17 58.9 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.067 0.947 . . . . 64.43 110.849 175.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.04 -15.46 60.64 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.403 0.681 . . . . 73.42 111.81 -178.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.6 mm-40 -74.93 -60.77 2.14 Favored 'General case' 0 C--N 1.36 1.024 0 N-CA-C 108.236 -1.024 . . . . 63.35 108.236 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -56.59 -44.45 81.07 Favored 'General case' 0 C--N 1.354 0.793 0 CA-C-N 114.214 -1.357 . . . . 62.44 109.826 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.493 ' O ' HG12 ' A' ' 50' ' ' ILE . 9.6 tppt? -66.89 -43.77 82.61 Favored 'General case' 0 C--N 1.357 0.897 0 O-C-N 124.249 0.968 . . . . 74.03 111.078 -175.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -55.66 -44.39 77.21 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 123.765 0.665 . . . . 73.32 110.523 175.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.7 mtpm? -65.37 -35.64 81.58 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 115.54 -0.754 . . . . 75.14 111.578 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -67.96 -31.24 70.83 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 122.921 0.488 . . . . 71.44 110.747 173.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.493 HG12 ' O ' ' A' ' 46' ' ' LYS . 12.0 mm -67.01 -37.54 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 N-CA-C 109.099 -0.704 . . . . 74.43 109.099 173.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.439 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 53.2 m-80 -69.43 -31.54 69.94 Favored 'General case' 0 C--O 1.207 -1.137 0 CA-C-N 115.283 -0.871 . . . . 73.43 111.388 177.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -64.22 -53.77 43.92 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.788 0.804 . . . . 75.34 109.874 174.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.431 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . . . -56.8 -53.27 59.8 Favored 'General case' 0 C--O 1.25 1.096 0 CA-C-N 113.569 -1.651 . . . . 65.45 111.915 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -61.51 -40.35 94.3 Favored 'General case' 0 C--O 1.209 -1.054 0 CA-C-N 115.023 -0.989 . . . . 73.53 110.517 176.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 51' ' ' ASN . . . -54.8 -47.51 73.93 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.297 0.639 . . . . 72.52 112.123 -176.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 78.7 t -69.71 -45.36 77.79 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 O-C-N 123.738 0.649 . . . . 74.52 110.671 177.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.428 HD13 ' HB2' ' A' ' 7' ' ' TYR . 58.4 mt -90.84 6.47 44.24 Favored 'General case' 0 CA--C 1.563 1.455 0 N-CA-C 113.603 0.964 . . . . 74.35 113.603 -172.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 44.4 t -71.95 -51.87 19.95 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 124.409 1.084 . . . . 74.34 111.339 -178.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -102.29 140.05 20.8 Favored Pre-proline 0 C--O 1.243 0.763 0 CA-C-N 115.209 -0.905 . . . . 74.34 109.172 -176.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -53.25 -26.21 33.25 Favored 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 123.705 2.937 . . . . 72.41 113.142 177.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -61.69 -62.07 2.07 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 124.485 1.114 . . . . 72.3 111.054 -179.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.455 ' HA ' HD11 ' A' ' 65' ' ' ILE . 41.2 mtmt -76.04 -24.0 55.16 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 115.688 -0.687 . . . . 74.54 111.303 -176.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 42.1 tpt85 -55.76 -53.33 57.92 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 124.099 0.875 . . . . 74.11 109.005 168.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -64.19 -34.91 79.17 Favored 'General case' 0 C--N 1.36 1.05 0 C-N-CA 123.459 0.704 . . . . 74.25 112.172 178.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.455 HD11 ' HA ' ' A' ' 62' ' ' LYS . 94.7 mt -57.09 -44.93 83.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 CA-C-O 121.15 0.5 . . . . 74.41 110.811 174.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -63.97 -44.88 91.41 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 115.77 -0.65 . . . . 75.4 110.09 177.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -60.61 -32.58 71.71 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 123.075 0.55 . . . . 64.04 112.019 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 48.6 p -84.4 -15.33 46.67 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.576 0.35 . . . . 75.44 111.571 178.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -72.71 106.4 4.69 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 108.636 -0.876 . . . . 75.32 108.636 170.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 105.54 18.08 12.42 Favored Glycine 0 N--CA 1.472 1.091 0 N-CA-C 111.535 -0.626 . . . . 64.23 111.535 -171.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 85.0 m -137.55 -56.64 0.69 Allowed 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 103.733 -2.691 . . . . 71.23 103.733 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.7 m -82.54 141.32 32.71 Favored 'General case' 0 C--O 1.251 1.156 0 N-CA-C 104.385 -2.45 . . . . 74.23 104.385 155.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.54 -23.13 20.99 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.364 0.665 . . . . 74.04 111.736 -176.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -111.46 169.17 6.6 Favored Pre-proline 0 N--CA 1.478 0.936 0 C-N-CA 124.181 0.993 . . . . 75.1 110.029 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -52.11 135.79 52.66 Favored 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 122.253 1.969 . . . . 75.41 112.386 167.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.43 ' HG3' HG23 ' A' ' 65' ' ' ILE . 73.0 Cg_endo -70.17 173.0 11.98 Favored 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 123.127 2.551 . . . . 74.25 112.259 -178.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -62.58 119.82 7.07 Favored 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 121.759 1.639 . . . . 73.45 111.185 170.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -64.16 145.78 89.63 Favored 'Trans proline' 0 C--N 1.382 2.331 0 C-N-CA 122.848 2.366 . . . . 73.2 112.829 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -63.66 149.62 90.43 Favored 'Trans proline' 0 C--N 1.38 2.205 0 C-N-CA 122.946 2.43 . . . . 71.05 111.954 171.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -67.87 76.35 0.61 Allowed 'Trans proline' 0 C--N 1.382 2.322 0 C-N-CA 123.601 2.867 . . . . 74.31 112.711 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 159.33 -35.47 0.48 Allowed Glycine 0 N--CA 1.462 0.384 0 N-CA-C 109.288 -1.525 . . . . 62.41 109.288 -174.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 128.13 171.36 12.99 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-N 114.804 -0.698 . . . . 53.03 112.331 171.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -67.31 107.36 2.36 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 107.977 -1.119 . . . . 74.41 107.977 166.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.443 ' O ' ' HD1' ' A' ' 85' ' ' PHE . 23.6 t70 -61.86 153.22 29.54 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.802 0.841 . . . . 71.31 112.615 -175.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.443 ' HD1' ' O ' ' A' ' 84' ' ' ASP . 0.1 OUTLIER -153.52 70.77 0.86 Allowed 'General case' 0 CA--C 1.553 1.059 0 N-CA-C 107.761 -1.2 . . . . 73.24 107.761 170.428 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.573 ' HA ' ' HA3' ' A' ' 163' ' ' GLY . 41.5 m -57.9 86.76 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 125.006 1.322 . . . . 74.44 114.367 -174.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.576 ' HA2' ' HB3' ' A' ' 171' ' ' PRO . . . 98.16 12.22 46.48 Favored Glycine 0 N--CA 1.47 0.936 0 CA-C-N 116.368 -0.378 . . . . 70.11 113.721 176.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.408 ' CD1' ' HB3' ' A' ' 51' ' ' ASN . 30.2 m-85 -123.58 110.32 14.88 Favored 'General case' 0 C--O 1.245 0.846 0 C-N-CA 122.831 0.453 . . . . 72.34 110.16 -170.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -70.23 94.8 0.94 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 122.803 0.441 . . . . 71.44 110.066 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.56 HG12 ' HG2' ' A' ' 91' ' ' GLU . 2.3 p -27.41 -50.39 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 126.203 1.801 . . . . 75.21 114.961 166.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.56 ' HG2' HG12 ' A' ' 90' ' ' VAL . 9.7 mm-40 -67.86 -12.89 61.56 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.994 0.918 . . . . 75.33 112.854 -168.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -80.97 -39.17 26.45 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.127 0.971 . . . . 61.35 111.438 175.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.413 ' CD2' ' HE2' ' A' ' 85' ' ' PHE . 22.3 m-85 -83.28 179.73 7.62 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 115.429 -0.805 . . . . 73.34 112.357 -166.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 80.1 p -59.14 142.42 51.6 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.446 1.098 . . . . 74.5 112.598 -170.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.4 -28.53 69.85 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.024 -0.989 . . . . 74.52 111.343 174.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -52.32 -55.27 22.58 Favored 'General case' 0 C--N 1.367 1.333 0 C-N-CA 123.026 0.53 . . . . 75.03 110.607 169.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -56.77 -43.53 80.92 Favored 'General case' 0 CA--C 1.548 0.887 0 O-C-N 124.065 0.853 . . . . 72.32 109.586 178.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.559 ' HA ' HD11 ' A' ' 105' ' ' LEU . 92.7 mt-30 -70.87 -12.33 61.48 Favored 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 115.458 -0.792 . . . . 74.14 112.307 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -88.07 -57.71 2.83 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.83 0.852 . . . . 70.02 111.766 171.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 51.0 tp -64.39 -42.51 96.08 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.69 0.796 . . . . 74.33 111.506 -174.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -94.62 -4.75 47.19 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-N 115.811 -0.632 . . . . 72.11 110.331 178.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -43.48 -59.24 3.69 Favored Glycine 0 C--N 1.356 1.663 0 CA-C-O 118.49 -1.172 . . . . 72.43 114.882 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -43.42 -24.15 0.58 Allowed 'Trans proline' 0 C--N 1.392 2.834 0 C-N-CA 124.717 3.612 . . . . 64.43 116.143 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -150.79 36.8 0.9 Allowed Glycine 0 C--N 1.352 1.457 0 CA-C-O 119.241 -0.755 . . . . 54.4 113.016 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.559 HD11 ' HA ' ' A' ' 98' ' ' GLN . 18.1 mt -54.33 84.62 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.147 0.579 . . . . 74.25 111.997 173.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.408 ' CD2' ' HA ' ' A' ' 84' ' ' ASP . 0.4 OUTLIER 19.19 -110.18 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 127.938 2.495 . . . . 74.45 113.831 176.192 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 58.46 16.86 30.43 Favored Glycine 0 C--N 1.361 1.931 0 CA-C-O 119.771 -0.461 . . . . 44.0 113.869 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.356 1.664 0 N-CA-C 111.396 -0.682 . . . . 71.34 111.396 -167.702 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.569 ' HZ1' ' HB3' ' A' ' 115' ' ' LYS . 0.0 OUTLIER . . . . . 0 CA--C 1.543 0.697 0 N-CA-C 112.188 0.44 . . . . 73.31 112.188 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -77.86 -163.57 21.41 Favored Glycine 0 CA--C 1.543 1.803 0 CA-C-N 115.476 -0.784 . . . . 73.4 114.6 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -112.74 130.33 56.1 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 124.587 1.155 . . . . 74.43 111.751 178.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -52.23 120.56 5.61 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.622 0.725 . . . . 74.23 111.487 176.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 67.2 tp -129.1 157.33 42.06 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 115.138 -0.937 . . . . 75.42 110.287 -171.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 34.3 ttp180 -111.18 146.67 36.47 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 108.793 -0.817 . . . . 74.51 108.793 171.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.535 ' HB1' HD11 ' A' ' 174' ' ' LEU . . . -128.35 158.19 38.91 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.604 0.716 . . . . 54.41 110.762 177.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -112.76 108.1 16.99 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 105.262 -2.125 . . . . 72.42 105.262 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.554 ' HB3' ' HA ' ' A' ' 178' ' ' VAL . 41.9 tp -98.44 97.44 4.68 Favored Pre-proline 0 N--CA 1.476 0.841 0 N-CA-C 108.042 -1.096 . . . . 74.14 108.042 -175.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.559 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 98.5 Cg_endo -79.22 107.62 2.23 Favored 'Trans proline' 0 C--N 1.381 2.237 0 C-N-CA 121.005 1.137 . . . . 75.33 109.309 -177.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.505 ' HB3' HD23 ' A' ' 180' ' ' LEU . 54.2 tp -109.63 132.05 54.5 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 122.362 0.265 . . . . 72.43 110.637 -166.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 97.4 m -62.59 124.87 22.11 Favored 'General case' 0 CA--C 1.551 0.986 0 O-C-N 124.496 1.122 . . . . 71.34 109.165 176.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 73.7 mt -52.77 -43.39 65.8 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 124.266 1.027 . . . . 75.21 112.195 -170.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -60.12 -35.84 76.14 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 114.36 -1.291 . . . . 75.32 110.241 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -83.01 -20.54 34.86 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.998 0.919 . . . . 64.33 111.314 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -66.64 -35.58 80.52 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 109.86 -0.422 . . . . 65.44 109.86 168.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -74.51 -48.05 29.46 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 115.298 -0.864 . . . . 74.51 111.831 173.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 33.3 m170 -74.03 -40.17 63.05 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 123.221 0.608 . . . . 75.25 111.886 -171.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 74.11 -151.33 43.73 Favored Glycine 0 CA--C 1.531 1.084 0 O-C-N 123.618 0.574 . . . . 71.54 113.092 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 86.34 -167.63 39.51 Favored Glycine 0 N--CA 1.473 1.166 0 C-N-CA 123.117 0.389 . . . . 70.42 112.435 -178.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.429 ' HB3' ' OG ' ' A' ' 146' ' ' SER . 2.6 mp0 -76.65 118.84 19.7 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.908 0.483 . . . . 73.14 110.289 175.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -94.47 119.88 33.85 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.658 0.783 . . . . 75.05 110.083 177.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 77.2 t -75.83 111.56 12.42 Favored 'Isoleucine or valine' 0 C--O 1.244 0.788 0 N-CA-C 108.704 -0.85 . . . . 75.04 108.704 168.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.505 HG11 HG13 ' A' ' 145' ' ' VAL . 3.5 p -135.69 138.09 48.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 124.452 1.101 . . . . 73.34 108.444 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -124.27 141.98 51.63 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.185 0.594 . . . . 71.3 110.974 -170.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.526 HG11 HD23 ' B' ' 8' ' ' LEU . 12.3 p -169.11 137.07 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 124.571 1.149 . . . . 75.1 109.07 176.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 55.49 33.21 20.55 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.129 0.972 . . . . 74.24 112.394 174.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 87.25 -23.6 11.32 Favored Glycine 0 C--N 1.352 1.443 0 CA-C-N 116.092 -0.504 . . . . 54.15 113.255 -178.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.533 ' NH1' ' HG2' ' A' ' 164' ' ' MET . 11.5 tpt180 -74.41 100.09 3.71 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.211 1.005 . . . . 72.43 110.543 179.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 19.7 ttp180 -84.47 92.53 8.1 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 107.912 -1.144 . . . . 74.41 107.912 165.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.505 HG13 HG11 ' A' ' 138' ' ' VAL . 3.7 p -98.53 143.02 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 115.041 -0.981 . . . . 73.53 110.796 -175.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.429 ' OG ' ' HB3' ' A' ' 135' ' ' GLU . 17.3 t -105.53 84.96 2.16 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 108.46 -0.941 . . . . 64.43 108.46 177.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 34.8 m -83.17 115.4 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 CA-C-O 121.244 0.545 . . . . 73.42 110.192 -177.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 48.5 ttt180 -74.18 103.36 4.58 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 109.426 -0.583 . . . . 74.32 109.426 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.462 ' HB ' HG13 ' A' ' 153' ' ' VAL . 36.3 pt -94.05 139.22 22.51 Favored Pre-proline 0 CA--C 1.557 1.243 0 C-N-CA 123.818 0.847 . . . . 74.52 109.508 176.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -73.26 140.7 31.09 Favored 'Trans proline' 0 C--N 1.372 1.784 0 C-N-CA 122.345 2.03 . . . . 74.22 111.846 176.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -57.85 93.18 0.06 OUTLIER 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 122.653 2.235 . . . . 74.15 111.494 167.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.582 ' HA2' ' HD2' ' A' ' 240' ' ' PHE . . . 124.62 31.48 0.89 Allowed Glycine 0 C--N 1.341 0.847 0 CA-C-N 115.558 -0.746 . . . . 75.51 112.474 -176.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.462 HG13 ' HB ' ' A' ' 149' ' ' ILE . 3.4 p -86.36 137.23 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 123.391 0.676 . . . . 75.43 110.323 -178.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.812 ' HD2' ' HA ' ' A' ' 191' ' ' GLN . 2.7 mtm-85 -127.46 151.29 49.03 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.815 0.846 . . . . 73.23 110.908 -163.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -53.24 116.9 2.65 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 124.694 1.246 . . . . 72.32 110.477 178.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 107.16 2.26 35.89 Favored Glycine 0 C--N 1.345 1.081 0 CA-C-N 115.76 -0.654 . . . . 74.33 113.54 -175.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 28.1 t -78.03 104.32 8.53 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 108.091 -1.078 . . . . 74.23 108.091 172.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.426 HG21 HG23 ' A' ' 177' ' ' VAL . 41.8 t -87.06 91.89 3.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 C-N-CA 124.74 1.216 . . . . 74.02 109.585 -178.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.54 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 58.9 mt -76.02 97.04 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 N-CA-C 108.576 -0.898 . . . . 75.24 108.576 173.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 74.0 ttt-85 -75.28 103.91 5.63 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.563 -0.532 . . . . 75.21 109.563 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.446 HG13 ' SD ' ' A' ' 164' ' ' MET . 7.5 p -116.46 123.15 30.95 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 123.505 0.722 . . . . 71.41 109.431 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -65.28 148.68 88.74 Favored 'Trans proline' 0 C--N 1.364 1.359 0 C-N-CA 122.707 2.271 . . . . 74.53 113.113 174.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . 0.573 ' HA3' ' HA ' ' A' ' 86' ' ' SER . . . 83.5 -25.74 4.92 Favored Glycine 0 N--CA 1.479 1.516 0 N-CA-C 116.482 1.353 . . . . 70.43 116.482 166.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.533 ' HG2' ' NH1' ' A' ' 143' ' ' ARG . 66.7 mtp -75.11 -21.68 58.73 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 117.502 0.651 . . . . 64.15 111.691 -179.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.51 ' HA2' HD12 ' A' ' 174' ' ' LEU . . . -80.2 -106.62 0.28 Allowed Glycine 0 C--N 1.348 1.236 0 CA-C-O 119.346 -0.697 . . . . 73.33 113.107 -175.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -53.13 109.02 0.86 Allowed Glycine 0 C--O 1.275 2.658 0 O-C-N 123.85 0.382 . . . . 74.5 112.849 168.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -54.29 104.07 0.1 Allowed 'General case' 0 C--N 1.351 0.673 0 O-C-N 127.854 2.737 . . . . 75.42 108.676 177.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -173.26 143.98 7.51 Favored Glycine 0 N--CA 1.44 -1.066 0 N-CA-C 108.556 -1.818 . . . . 64.21 108.556 -171.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . 0.508 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . 0.2 OUTLIER -73.16 -49.58 7.04 Favored Pre-proline 0 CA--C 1.558 1.27 0 N-CA-C 109.396 -0.594 . . . . 63.54 109.396 -171.688 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.508 ' HD3' ' HB3' ' A' ' 169' ' ' ASN . 18.8 Cg_exo -71.76 149.76 54.92 Favored 'Trans proline' 0 C--N 1.375 1.965 0 N-CA-C 108.19 -1.504 . . . . 73.02 108.19 156.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.576 ' HB3' ' HA2' ' A' ' 87' ' ' GLY . 74.1 Cg_endo -69.61 124.12 10.82 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 122.716 2.278 . . . . 71.25 116.247 -162.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -62.26 -46.73 93.33 Favored Glycine 0 C--N 1.374 2.641 0 C-N-CA 119.41 -1.376 . . . . 72.4 111.117 161.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 101.8 147.71 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 128.49 2.716 . . . . 71.14 108.438 177.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.535 HD11 ' HB1' ' A' ' 121' ' ' ALA . 28.3 tp -137.14 138.51 40.35 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.115 0.483 . . . . 74.2 110.768 -175.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 48.0 mt -105.34 89.8 3.23 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 114.731 -1.122 . . . . 72.12 108.166 171.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.54 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 64.6 mt -68.39 88.27 0.32 Allowed 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 109.684 -0.487 . . . . 74.52 109.684 175.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.426 HG23 HG21 ' A' ' 158' ' ' VAL . 18.2 t -85.36 104.01 12.89 Favored 'Isoleucine or valine' 0 C--O 1.25 1.1 0 N-CA-C 106.384 -1.71 . . . . 71.11 106.384 174.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.554 ' HA ' ' HB3' ' A' ' 123' ' ' LEU . 8.2 p -67.49 119.55 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 CA-C-N 115.216 -0.902 . . . . 74.13 109.688 -175.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.559 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 36.7 mmt180 -103.07 109.08 20.51 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-N 114.18 -1.373 . . . . 73.42 107.868 176.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.505 HD23 ' HB3' ' A' ' 125' ' ' LEU . 59.6 mt -74.79 143.05 44.17 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.683 -0.636 . . . . 74.04 109.496 177.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 86.2 mt -52.86 154.72 4.72 Favored Pre-proline 0 N--CA 1.486 1.325 0 C-N-CA 123.94 0.896 . . . . 73.22 112.82 -168.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.25 21.43 0.39 Allowed 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 122.695 2.263 . . . . 74.32 112.783 171.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . 0.453 ' HA ' ' HD3' ' A' ' 184' ' ' PRO . 36.7 t-80 -61.64 106.7 0.87 Allowed Pre-proline 0 CA--C 1.557 1.215 0 C-N-CA 125.817 1.647 . . . . 73.35 108.114 168.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 183' ' ' HIS . 8.0 Cg_exo -73.95 25.04 0.34 Allowed 'Trans proline' 0 C--N 1.373 1.86 0 C-N-CA 124.137 3.225 . . . . 61.24 116.428 -162.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 69.1 t -97.25 -39.08 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 118.569 0.622 . . . . 72.34 109.672 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . 0.697 ' HE1' ' HA ' ' A' ' 214' ' ' THR . 35.4 m-85 -146.29 111.59 5.44 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.114 0.483 . . . . 72.31 112.069 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . 0.671 ' HB3' ' HB2' ' A' ' 194' ' ' TYR . 59.4 ttt180 -91.93 82.39 5.14 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 106.889 -1.523 . . . . 75.51 106.889 162.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.464 ' HB2' HD22 ' A' ' 193' ' ' LEU . 40.8 tp -79.5 95.39 5.8 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.438 -0.801 . . . . 74.21 108.872 177.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -118.74 131.12 56.12 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.609 0.764 . . . . 70.31 109.951 -174.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 77.62 -77.51 1.59 Allowed Glycine 0 C--N 1.353 1.48 0 N-CA-C 111.497 -0.641 . . . . 65.41 111.497 -178.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.812 ' HA ' ' HD2' ' A' ' 154' ' ' ARG . 13.2 pt20 -153.34 -6.03 0.18 Allowed 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.041 0.936 . . . . 72.32 111.061 173.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -122.18 150.43 42.25 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.459 0.704 . . . . 72.32 110.975 -167.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.464 HD22 ' HB2' ' A' ' 188' ' ' LEU . 38.5 mt -92.17 152.31 19.95 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.935 1.294 . . . . 74.25 111.089 -170.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.671 ' HB2' ' HB3' ' A' ' 187' ' ' ARG . 89.0 m-85 -131.34 103.09 6.25 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 107.964 -1.124 . . . . 73.14 107.964 169.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.456 ' HB2' HD22 ' A' ' 251' ' ' LEU . . . -122.93 115.95 22.78 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.464 1.106 . . . . 74.34 110.648 -173.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' THR . . . . . 0.47 ' HA ' ' HB2' ' A' ' 252' ' ' GLU . 93.6 m -71.43 111.63 6.9 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 121.082 0.468 . . . . 70.21 110.686 -177.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.472 HD22 HD13 ' A' ' 251' ' ' LEU . 37.5 tp -99.04 119.85 38.49 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.772 0.829 . . . . 74.1 110.809 -173.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -82.38 115.86 21.6 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 108.363 -0.977 . . . . 63.3 108.363 172.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.1 p -143.62 126.35 8.75 Favored Pre-proline 0 N--CA 1.479 1.022 0 C-N-CA 123.375 0.67 . . . . 74.33 110.138 -175.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -72.11 152.1 56.18 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 121.942 1.762 . . . . 70.05 112.095 176.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -44.22 -59.31 3.89 Favored Pre-proline 0 N--CA 1.484 1.268 0 N-CA-C 116.267 1.951 . . . . 71.34 116.267 -172.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -74.07 -19.82 19.88 Favored 'Trans proline' 0 C--N 1.384 2.411 0 CA-C-N 121.84 1.693 . . . . 73.32 112.76 -174.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 17.7 mt -75.11 -30.27 22.97 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 N-CA-C 109.521 -0.548 . . . . 71.02 109.521 172.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -72.22 -43.03 65.04 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-O 121.129 0.49 . . . . 74.14 111.23 173.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 54.5 t -71.94 -41.77 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 123.803 0.841 . . . . 64.22 112.375 -174.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 97.2 t -93.06 -32.61 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 122.546 0.338 . . . . 74.41 110.747 -178.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 89.83 77.19 1.32 Allowed Glycine 0 C--N 1.343 0.923 0 CA-C-N 116.312 -0.404 . . . . 72.35 112.137 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -96.03 -136.55 8.84 Favored Glycine 0 C--N 1.342 0.867 0 N-CA-C 112.056 -0.418 . . . . 73.32 112.056 178.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 46.0 mtmt -130.47 144.27 51.29 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.12 0.568 . . . . 73.34 110.013 178.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 16.8 m -136.32 176.71 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.533 1.133 . . . . 63.11 109.526 174.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 20.5 ttm180 -109.75 112.2 24.12 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.578 0.751 . . . . 74.32 109.529 175.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -104.6 126.62 51.86 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.721 -0.844 . . . . 74.41 108.721 176.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' MET . . . . . 0.685 ' HA ' ' HA ' ' A' ' 218' ' ' PRO . 3.5 mpp? -74.52 138.92 43.45 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.916 0.486 . . . . 74.15 110.245 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' THR . . . . . 0.697 ' HA ' ' HE1' ' A' ' 186' ' ' PHE . 69.0 p -117.95 179.29 4.13 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 122.999 0.52 . . . . 74.1 110.34 171.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 55.5 mt -67.33 -20.13 65.55 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 115.231 -0.895 . . . . 73.14 111.592 -178.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -109.24 19.71 19.12 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.619 0.767 . . . . 64.44 111.404 179.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 110.47 174.29 20.41 Favored Glycine 0 N--CA 1.474 1.224 0 CA-C-O 119.426 -0.652 . . . . 63.05 113.23 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . 0.685 ' HA ' ' HA ' ' A' ' 213' ' ' MET . 83.9 Cg_endo -76.43 145.98 27.26 Favored 'Trans proline' 0 C--N 1.368 1.581 0 C-N-CA 122.744 2.296 . . . . 74.13 112.622 -175.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 24.3 m -139.89 163.9 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 C-N-CA 123.777 0.831 . . . . 73.4 111.371 -176.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -91.28 117.54 29.73 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.154 0.982 . . . . 75.04 110.157 -178.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 57.9 t -128.81 126.59 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 124.269 1.027 . . . . 74.51 109.037 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.464 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -88.04 131.5 34.63 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.495 0.318 . . . . 70.4 111.372 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 38.4 t -73.5 146.81 86.65 Favored Pre-proline 0 CA--C 1.57 1.744 0 C-N-CA 125.749 1.62 . . . . 71.22 110.602 -178.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -78.91 171.69 16.12 Favored 'Trans proline' 0 C--N 1.388 2.613 0 C-N-CA 122.924 2.416 . . . . 75.51 111.308 169.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -81.06 150.48 17.94 Favored 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 121.92 1.746 . . . . 72.53 113.133 176.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 84.8 mtt-85 63.22 31.16 15.72 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 126.007 1.723 . . . . 75.13 111.527 174.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.55 HG22 HD22 ' A' ' 233' ' ' LEU . 50.2 m -63.26 105.75 0.78 Allowed 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 113.796 -1.547 . . . . 64.32 111.081 177.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -90.18 140.03 30.06 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.291 1.036 . . . . 75.32 110.197 -176.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -66.04 160.19 24.31 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.838 0.855 . . . . 65.12 111.461 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 81.02 -41.38 2.6 Favored Glycine 0 C--N 1.347 1.162 0 CA-C-N 116.382 -0.372 . . . . 75.54 112.405 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -67.19 156.19 36.88 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 124.339 1.056 . . . . 74.44 110.907 177.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.76 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 3.5 mptp? -106.93 124.59 49.84 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-N 114.686 -1.143 . . . . 72.22 108.492 176.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.55 HD22 HG22 ' A' ' 227' ' ' THR . 86.0 mt -74.72 106.43 6.27 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.417 -0.957 . . . . 71.4 108.417 176.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 20.6 ttp180 -87.93 110.92 20.93 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.043 0.537 . . . . 73.41 110.687 178.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.516 ' HG ' ' HB3' ' A' ' 249' ' ' LEU . 0.3 OUTLIER -120.26 117.94 29.15 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.101 0.96 . . . . 74.24 109.982 176.154 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 36.0 mmtm -59.68 151.16 25.62 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 125.155 1.382 . . . . 71.01 112.752 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 71.39 34.88 63.54 Favored Glycine 0 C--N 1.354 1.583 0 CA-C-N 114.985 -1.007 . . . . 74.2 113.757 171.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.439 ' HG3' HD11 ' A' ' 235' ' ' LEU . 41.2 mmtm -130.08 -38.87 1.4 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.16 0.584 . . . . 74.1 110.895 -176.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -71.38 168.9 50.43 Favored Glycine 0 C--N 1.35 1.318 0 CA-C-N 116.219 -0.446 . . . . 74.43 112.17 175.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . 0.582 ' HD2' ' HA2' ' A' ' 152' ' ' GLY . 4.4 m-85 -87.44 158.15 52.07 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 123.533 0.733 . . . . 73.41 111.067 -165.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -62.6 109.3 0.85 Allowed 'Trans proline' 0 C--N 1.385 2.452 0 C-N-CA 123.051 2.5 . . . . 73.33 111.994 177.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.422 ' HA3' ' HB3' ' A' ' 191' ' ' GLN . . . -122.38 -149.63 7.99 Favored Glycine 0 C--N 1.338 0.644 0 CA-C-O 119.174 -0.792 . . . . 73.52 112.696 -179.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . 0.45 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 26.1 Cg_endo -60.14 -45.71 22.17 Favored 'Trans proline' 0 C--N 1.375 1.932 0 C-N-CA 123.179 2.586 . . . . 72.5 112.845 -176.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -88.43 -19.51 26.45 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.256 0.622 . . . . 70.11 111.073 177.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 126.72 -158.46 20.76 Favored Glycine 0 C--N 1.347 1.166 0 N-CA-C 111.192 -0.763 . . . . 62.24 111.192 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 61.5 mtt180 -57.68 108.41 0.56 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.336 0.654 . . . . 75.41 110.612 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -72.21 -161.82 5.62 Favored Glycine 0 C--O 1.248 1.03 0 CA-C-O 121.977 0.765 . . . . 70.31 113.708 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -102.3 168.31 9.42 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.411 0.684 . . . . 75.44 110.549 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.516 ' HB3' ' HG ' ' A' ' 235' ' ' LEU . 16.0 tp -101.54 128.61 47.71 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 106.794 -1.558 . . . . 73.32 106.794 164.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.76 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 7.0 m-85 -108.93 104.83 14.14 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 107.763 -1.199 . . . . 71.3 107.763 174.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.543 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 46.3 mt -90.08 103.94 16.56 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 109.098 -0.705 . . . . 74.54 109.098 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . 0.494 ' HG2' ' HG3' ' A' ' 232' ' ' LYS . 23.2 mt-10 -75.91 100.09 4.72 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.229 1.012 . . . . 75.41 108.866 -171.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 38.4 t -64.97 120.43 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 CA-C-N 114.564 -1.198 . . . . 71.34 112.241 -168.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.8 mmt180 -118.33 94.72 4.59 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.489 1.115 . . . . 73.14 108.065 169.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.44 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 73.5 mt -70.76 115.67 10.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 114.706 -1.133 . . . . 74.34 109.234 176.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 40.0 p -111.41 173.12 6.5 Favored 'General case' 0 C--O 1.255 1.346 0 C-N-CA 124.248 1.019 . . . . 74.52 109.994 178.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 23.0 pt -134.25 151.72 76.89 Favored Pre-proline 0 CA--C 1.556 1.195 0 CA-C-N 114.918 -1.037 . . . . 73.4 108.523 176.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' PRO . . . . . 0.422 ' O ' ' HD2' ' A' ' 260' ' ' ARG . 11.1 Cg_endo -87.56 20.12 1.25 Allowed 'Trans proline' 0 C--N 1.37 1.667 0 C-N-CA 122.699 2.266 . . . . 74.45 113.426 -166.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . 0.444 ' HA ' ' HG3' ' C' ' 226' ' ' ARG . 3.4 mp0 40.52 -89.27 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.806 1.242 . . . . 75.12 112.18 -162.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' ARG . . . . . 0.422 ' HD2' ' O ' ' A' ' 258' ' ' PRO . 0.4 OUTLIER -69.62 138.77 53.37 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.072 0.949 . . . . 75.12 111.425 -168.012 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.522 HD13 HG11 ' C' ' 205' ' ' VAL . 98.2 mt -129.28 173.14 10.78 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.016 0.926 . . . . 72.32 110.108 -178.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 40.7 p -114.16 156.7 43.83 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 124.252 1.021 . . . . 74.31 109.644 171.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -33.07 -45.22 0.27 Allowed 'Trans proline' 0 C--N 1.396 3.034 1 C-N-CA 125.351 4.034 . . . . 74.33 116.505 -176.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -59.31 -61.27 2.75 Favored 'General case' 0 C--O 1.249 1.045 0 C-N-CA 123.926 0.89 . . . . 71.44 110.778 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -57.71 -47.57 82.02 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-N 114.901 -1.045 . . . . 73.22 110.581 -178.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' GLU . . . . . 0.522 ' O ' ' HG2' ' A' ' 270' ' ' LYS . 7.2 tp10 -55.05 -50.68 68.52 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 124.543 1.152 . . . . 73.45 110.866 -176.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -62.45 -46.68 87.4 Favored 'General case' 0 C--O 1.254 1.34 0 O-C-N 124.229 0.956 . . . . 64.12 112.151 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 10.0 mp -63.22 -34.81 78.46 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 116.053 -0.522 . . . . 73.14 111.472 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' TRP . . . . . 0.425 ' O ' HG11 ' C' ' 206' ' ' VAL . 68.6 m95 -74.59 -29.74 61.44 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 118.709 -0.662 . . . . 75.0 111.345 177.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . 0.522 ' HG2' ' O ' ' A' ' 266' ' ' GLU . 0.0 OUTLIER -58.53 -61.05 2.88 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.442 -0.947 . . . . 73.12 108.442 174.478 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . 0.65 ' HZ1' ' HB3' ' A' ' 271' ' ' LYS . 9.9 mtpm? -54.61 -48.97 71.56 Favored 'General case' 0 C--N 1.364 1.203 0 CA-C-N 112.636 -2.075 . . . . 70.22 110.562 -178.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' LEU . . . . . 0.418 HD12 HD11 ' C' ' 272' ' ' LEU . 1.8 tt -58.01 -66.03 0.54 Allowed 'General case' 0 C--O 1.186 -2.268 0 O-C-N 124.244 0.965 . . . . 71.54 108.846 -179.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . 0.512 ' HA ' ' HB2' ' C' ' 202' ' ' PRO . . . -50.24 -50.67 49.17 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 114.849 1.426 . . . . 72.23 114.849 -170.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -88.66 -24.52 22.75 Favored 'General case' 0 C--O 1.255 1.379 0 N-CA-C 112.727 0.64 . . . . 74.35 112.727 -170.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -77.7 -36.21 51.34 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 121.846 -0.534 . . . . 72.24 110.631 170.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . 0.402 ' HB3' ' O ' ' A' ' 273' ' ' ALA . 2.7 t80 -47.2 -57.47 5.12 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 126.567 1.947 . . . . 75.02 109.66 167.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -44.81 -66.1 0.44 Allowed 'General case' 0 C--O 1.248 1.019 0 O-C-N 125.515 1.759 . . . . 72.14 109.426 174.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -65.14 -9.54 23.78 Favored 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 114.598 -1.183 . . . . 75.41 114.087 -176.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . 0.472 ' NH2' ' HG2' ' C' ' 264' ' ' GLU . 77.7 mtm180 -132.92 31.95 3.84 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.308 0.643 . . . . 75.15 110.08 -176.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.566 1.587 0 C-N-CA 124.07 0.948 . . . . 72.5 113.177 177.332 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.433 ' SD ' ' N ' ' B' ' 1' ' ' MET . 1.3 mpt? . . . . . 0 N--CA 1.48 1.04 0 N-CA-C 109.814 -0.439 . . . . 74.12 109.814 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -72.5 101.04 2.86 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.548 0.739 . . . . 62.45 109.791 174.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -164.39 -40.98 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.312 1.045 . . . . 74.04 109.434 175.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 16.6 t 68.64 -173.45 0.19 Allowed 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.331 1.052 . . . . 52.14 111.225 176.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 17.9 m 70.46 135.62 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.992 1.317 . . . . 74.34 112.346 -178.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 38.7 pt -143.27 176.79 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.392 1.077 . . . . 65.34 109.629 -176.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -137.38 132.64 33.8 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.329 0.652 . . . . 72.22 110.307 177.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . 0.526 HD23 HG11 ' A' ' 140' ' ' VAL . 39.0 tp -81.07 157.02 25.54 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.319 1.048 . . . . 75.22 111.086 -171.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.62 -72.34 0.42 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 122.856 0.462 . . . . 73.12 111.287 176.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . 0.442 HD23 ' HB1' ' A' ' 121' ' ' ALA . 33.6 mt 72.35 -7.54 1.35 Allowed 'General case' 0 N--CA 1.503 2.193 0 C-N-CA 125.588 1.555 . . . . 74.1 112.46 -165.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 28.6 mt . . . . . 0 CA--C 1.563 1.473 0 C-N-CA 124.727 1.211 . . . . 72.11 112.257 -176.333 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.622 0 N-CA-C 107.436 -1.32 . . . . 74.35 107.436 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 180' ' ' ALA . . . . . 0.488 ' HB2' HG13 ' C' ' 137' ' ' VAL . . . -135.1 -63.14 0.7 Allowed 'General case' 0 C--O 1.238 0.473 0 N-CA-C 104.791 -2.299 . . . . 75.32 104.791 166.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 181' ' ' LEU . . . . . 0.539 HD22 ' HB2' ' C' ' 136' ' ' ARG . 21.8 tp -152.85 -6.72 0.19 Allowed 'General case' 0 CA--C 1.567 1.611 0 CA-C-N 114.613 -1.176 . . . . 74.44 110.689 158.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 182' ' ' VAL . . . . . 0.666 ' HA ' ' HB2' ' C' ' 123' ' ' LEU . 14.7 m -136.75 178.3 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 C-N-CA 124.583 1.153 . . . . 72.43 112.555 -175.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 183' ' ' ALA . . . . . 0.666 ' HB2' ' HD2' ' C' ' 124' ' ' PRO . . . -143.69 55.37 1.33 Allowed 'General case' 0 CA--C 1.552 1.049 0 CA-C-N 115.118 -0.946 . . . . 65.24 110.401 164.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 32.6 m170 70.3 -168.77 0.16 Allowed 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 114.959 1.466 . . . . 75.32 114.959 162.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 185' ' ' VAL . . . . . 0.54 HG22 HD21 ' C' ' 119' ' ' LEU . 45.9 t . . . . . 0 N--CA 1.496 1.866 0 C-N-CA 125.615 1.566 . . . . 74.01 113.263 -164.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 95.2 m . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 118.674 -0.679 . . . . 71.31 110.79 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -170.24 -179.35 3.06 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 113.44 0.904 . . . . 74.42 113.44 176.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . -114.89 -142.85 7.95 Favored Glycine 0 C--N 1.36 1.887 0 CA-C-N 114.678 -1.146 . . . . 71.23 111.757 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 241' ' ' GLU . . . . . 0.715 ' HB3' ' HZ2' ' B' ' 245' ' ' LYS . 11.9 pt-20 -167.31 156.92 10.56 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.753 0.821 . . . . 71.23 110.18 177.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 242' ' ' TRP . . . . . 0.486 ' CE2' ' HG ' ' C' ' 233' ' ' LEU . 0.0 OUTLIER -137.53 -35.19 0.67 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.176 1.391 . . . . 70.32 108.75 -172.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -123.72 -173.49 2.76 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 106.212 -1.773 . . . . 74.22 106.212 157.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -74.36 103.92 1.58 Allowed Glycine 0 C--N 1.335 0.483 0 C-N-CA 121.417 -0.421 . . . . 71.54 112.556 174.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 245' ' ' LYS . . . . . 0.715 ' HZ2' ' HB3' ' B' ' 241' ' ' GLU . 1.6 pptp? . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 122.039 0.923 . . . . 75.34 110.532 174.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.694 0 CA-C-O 121.33 0.586 . . . . 71.34 109.647 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -38.53 105.73 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.11 1.764 . . . . 70.52 113.589 177.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 5' ' ' LYS . . . . . 0.489 ' HB3' HD13 ' C' ' 10' ' ' ILE . 49.7 mtpt -88.47 104.15 16.53 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 107.425 -1.324 . . . . 72.32 107.425 164.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -67.8 108.35 2.94 Favored 'General case' 0 C--N 1.35 0.595 0 N-CA-C 108.401 -0.962 . . . . 65.15 108.401 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 7' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -64.96 -33.61 76.45 Favored 'General case' 0 C--O 1.244 0.81 0 O-C-N 124.162 0.914 . . . . 73.43 111.814 -169.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -68.11 -41.36 81.87 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.76 -0.654 . . . . 74.23 110.219 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.53 -39.73 94.31 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.274 0.629 . . . . 63.34 110.883 179.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 10' ' ' ILE . . . . . 0.489 HD13 ' HB3' ' C' ' 5' ' ' LYS . 81.7 mt -56.98 -43.17 80.39 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 123.686 0.795 . . . . 73.31 110.027 173.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 96.2 mt -76.59 -15.81 59.75 Favored 'General case' 0 CA--C 1.556 1.174 0 N-CA-C 112.952 0.723 . . . . 75.53 112.952 176.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.88 21.29 71.69 Favored Glycine 0 C--N 1.351 1.413 0 N-CA-C 114.021 0.368 . . . . 74.43 114.021 -177.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 23.8 m -112.52 160.26 31.07 Favored Pre-proline 0 N--CA 1.486 1.353 0 C-N-CA 124.463 1.105 . . . . 71.34 110.479 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -55.04 157.58 13.15 Favored 'Trans proline' 0 C--N 1.385 2.46 0 C-N-CA 123.582 2.855 . . . . 74.43 114.509 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 65.1 mtt85 -78.98 28.62 0.22 Allowed 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 124.113 0.965 . . . . 74.35 113.58 -176.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -158.59 15.35 0.19 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.508 1.123 . . . . 71.24 108.631 174.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.28 148.15 33.15 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.371 1.068 . . . . 75.2 112.605 -171.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 74.6 p -87.66 -175.79 5.31 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.831 0.853 . . . . 74.41 112.245 -171.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -53.11 -55.2 25.83 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.155 0.982 . . . . 74.45 111.741 -174.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -63.99 -31.37 72.53 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 123.833 0.708 . . . . 74.53 111.673 -176.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -67.59 -49.77 61.54 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 122.237 0.215 . . . . 73.42 110.516 179.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 1.7 mp -64.0 -42.51 95.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 C-N-CA 123.548 0.739 . . . . 75.54 110.932 177.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -64.41 -52.54 57.64 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.233 1.013 . . . . 74.13 111.008 -176.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -75.29 -26.84 59.04 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.662 -0.699 . . . . 73.52 111.433 -174.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -73.34 -36.49 66.17 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 122.583 0.353 . . . . 75.32 110.893 173.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 26' ' ' TYR . . . . . 0.551 ' HD1' HG23 ' C' ' 50' ' ' ILE . 51.3 t80 -58.63 -56.21 25.13 Favored 'General case' 0 C--O 1.211 -0.973 0 N-CA-C 109.031 -0.729 . . . . 72.31 109.031 173.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -56.23 -45.69 79.84 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 124.614 1.196 . . . . 75.33 111.593 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 44.7 ttt180 -50.47 -55.1 17.4 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.479 1.112 . . . . 75.55 111.245 177.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 84.4 mt -85.26 -12.01 53.47 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 114.929 -1.032 . . . . 71.43 111.558 -175.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -91.75 -4.89 54.47 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.637 0.775 . . . . 75.32 110.155 173.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 36.7 mtp-105 -95.95 -43.47 7.8 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.887 0.875 . . . . 73.5 109.741 166.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.52 -54.29 25.4 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 109.212 -0.662 . . . . 71.12 109.212 -178.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -90.5 13.5 15.59 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 116.222 -0.445 . . . . 72.14 111.722 -178.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 34' ' ' HIS . . . . . . . . . . . . . 40.3 t60 -60.61 106.69 0.82 Allowed Pre-proline 0 N--CA 1.479 1.023 0 CA-C-O 118.386 -0.816 . . . . 74.34 109.248 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.28 -36.58 47.48 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 123.687 2.925 . . . . 72.22 114.855 -171.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -66.07 -34.63 78.5 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.45 1.1 . . . . 60.34 111.894 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 80.0 t -89.15 -50.69 13.06 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 122.916 0.486 . . . . 75.33 110.429 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -102.63 104.0 14.33 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.746 1.219 . . . . 65.41 109.507 -173.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -83.86 35.16 0.51 Allowed 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 123.498 0.719 . . . . 71.22 111.973 -174.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 59.6 m -97.38 132.57 25.13 Favored Pre-proline 0 N--CA 1.488 1.434 0 CA-C-O 119.047 -0.501 . . . . 74.14 110.548 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -49.22 -42.49 39.82 Favored 'Trans proline' 0 C--N 1.384 2.413 0 C-N-CA 123.199 2.599 . . . . 75.0 112.15 168.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -58.32 -37.23 74.68 Favored 'General case' 0 C--N 1.353 0.75 0 CA-C-N 115.542 -0.754 . . . . 71.01 111.025 177.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.56 -21.79 59.33 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 119.431 -0.319 . . . . 71.45 110.768 -178.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -69.59 -51.01 39.13 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 108.987 -0.746 . . . . 74.04 108.987 174.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 45' ' ' GLU . . . . . 0.435 ' O ' ' HG3' ' C' ' 49' ' ' GLU . 42.1 mt-10 -67.88 -47.35 69.09 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 114.103 -1.408 . . . . 75.44 110.793 -175.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 46' ' ' LYS . . . . . 0.551 ' O ' HG12 ' C' ' 50' ' ' ILE . 35.8 mmtm -60.35 -43.11 96.81 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-N 115.329 -0.851 . . . . 72.32 111.097 175.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -58.22 -40.96 83.03 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 123.656 0.597 . . . . 71.12 110.546 178.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -64.68 -34.26 77.88 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 123.747 0.654 . . . . 72.04 111.601 175.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 49' ' ' GLU . . . . . 0.435 ' HG3' ' O ' ' C' ' 45' ' ' GLU . 41.6 mt-10 -69.42 -33.0 72.33 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 122.653 0.381 . . . . 72.33 111.139 174.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 50' ' ' ILE . . . . . 0.551 HG23 ' HD1' ' C' ' 26' ' ' TYR . 14.7 mm -71.66 -34.41 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 N-CA-C 108.903 -0.777 . . . . 75.43 108.903 176.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 51' ' ' ASN . . . . . 0.462 ' HB3' ' HD1' ' C' ' 88' ' ' PHE . 11.7 m120 -69.18 -36.71 77.62 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-N 114.642 -1.163 . . . . 74.04 110.662 176.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 62.2 tt0 -62.68 -54.34 40.89 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.9 0.88 . . . . 75.54 110.128 177.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -52.64 -60.88 2.71 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-N 113.467 -1.697 . . . . 63.1 111.224 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -61.19 -38.66 87.32 Favored 'General case' 0 C--O 1.21 -1.019 0 CA-C-N 115.072 -0.967 . . . . 75.01 111.895 -178.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.61 -51.26 70.58 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 122.827 0.451 . . . . 60.54 111.463 -177.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 56' ' ' VAL . . . . . 0.504 ' HA ' ' HE3' ' C' ' 62' ' ' LYS . 75.0 t -60.49 -40.63 84.92 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 O-C-N 124.307 1.004 . . . . 72.43 110.394 176.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 57' ' ' LEU . . . . . . . . . . . . . 46.9 mt -89.15 -0.8 57.74 Favored 'General case' 0 CA--C 1.565 1.544 0 N-CA-C 113.025 0.75 . . . . 75.02 113.025 -176.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 32.8 t -77.25 -57.39 3.86 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 124.339 1.056 . . . . 75.33 111.066 -178.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.83 122.83 82.81 Favored Pre-proline 0 C--N 1.354 0.796 0 N-CA-C 107.955 -1.128 . . . . 72.03 107.955 173.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 60' ' ' PRO . . . . . 0.532 ' HD2' ' HA ' ' C' ' 145' ' ' VAL . 19.1 Cg_endo -56.17 -27.78 67.34 Favored 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 123.066 2.51 . . . . 73.21 111.177 173.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . 0.655 ' HG2' ' HD3' ' C' ' 79' ' ' PRO . 3.2 tp10 -58.08 -66.06 0.54 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.249 1.02 . . . . 62.13 110.416 172.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 62' ' ' LYS . . . . . 0.504 ' HE3' ' HA ' ' C' ' 56' ' ' VAL . 17.7 mtmt -70.1 -22.99 62.97 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.426 0.69 . . . . 75.43 111.565 -173.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 48.8 tpt85 -61.18 -55.84 27.61 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.759 1.224 . . . . 74.14 109.233 172.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 -75.24 -19.15 59.9 Favored 'General case' 0 C--N 1.351 0.668 0 CA-C-N 115.26 -0.882 . . . . 74.15 111.523 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 65' ' ' ILE . . . . . 0.49 HG12 ' HB2' ' C' ' 76' ' ' PRO . 36.0 mt -66.03 -46.87 86.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.28 0.632 . . . . 71.5 109.55 171.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -61.46 -46.95 87.93 Favored 'General case' 0 C--N 1.353 0.727 0 O-C-N 123.803 0.689 . . . . 74.31 109.667 177.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -55.05 -48.6 73.22 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 123.675 0.609 . . . . 73.14 111.649 177.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 76.7 p -79.73 -9.15 59.61 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 112.568 0.581 . . . . 74.43 112.568 -178.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -72.38 100.37 2.65 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 108.229 -1.026 . . . . 75.22 108.229 174.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 125.05 10.83 4.54 Favored Glycine 0 N--CA 1.47 0.918 0 CA-C-N 115.348 -0.842 . . . . 62.51 111.704 -165.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 29.5 m -142.61 -55.53 0.43 Allowed 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 104.526 -2.398 . . . . 72.34 104.526 175.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 70.6 m -84.12 135.48 34.38 Favored 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 103.613 -2.736 . . . . 73.35 103.613 154.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.42 -31.09 8.31 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 118.987 0.812 . . . . 73.23 111.147 178.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -72.69 153.18 91.5 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 123.425 0.69 . . . . 53.23 109.254 171.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -54.3 113.55 1.41 Allowed 'Trans proline' 0 C--N 1.373 1.822 0 C-N-CA 122.56 2.173 . . . . 75.14 112.06 171.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 76' ' ' PRO . . . . . 0.49 ' HB2' HG12 ' C' ' 65' ' ' ILE . 45.8 Cg_exo -59.01 148.3 85.91 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 122.979 2.453 . . . . 71.22 111.525 175.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -57.82 124.43 16.0 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.985 2.457 . . . . 74.4 112.963 -169.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 78' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -63.33 153.25 75.61 Favored 'Trans proline' 0 C--N 1.38 2.221 0 C-N-CA 122.541 2.16 . . . . 74.44 111.904 175.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 79' ' ' PRO . . . . . 0.655 ' HD3' ' HG2' ' C' ' 61' ' ' GLU . 37.7 Cg_endo -66.36 147.44 82.94 Favored 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 122.128 1.885 . . . . 70.12 109.531 170.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -55.22 78.77 0.03 OUTLIER 'Trans proline' 0 C--N 1.384 2.436 0 C-N-CA 124.139 3.226 . . . . 74.31 114.646 -176.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 163.7 -51.89 0.3 Allowed Glycine 0 CA--C 1.519 0.283 0 N-CA-C 108.326 -1.909 . . . . 75.2 108.326 -174.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 134.14 -157.63 22.96 Favored Glycine 0 C--N 1.351 1.383 0 C-N-CA 123.09 0.376 . . . . 75.13 113.102 173.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -97.25 121.1 38.76 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.181 0.992 . . . . 73.4 109.007 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 84' ' ' ASP . . . . . 0.497 ' HB2' ' NE ' ' C' ' 143' ' ' ARG . 7.8 t70 -79.5 126.12 30.45 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 112.516 0.562 . . . . 75.11 112.516 -171.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 85' ' ' PHE . . . . . 0.405 ' HA ' ' HD2' ' C' ' 88' ' ' PHE . 87.0 m-85 -137.61 31.7 2.54 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.184 0.994 . . . . 74.41 109.288 173.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 15.5 m -81.07 85.24 6.33 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 114.657 -1.156 . . . . 52.42 110.869 -172.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 129.31 -15.85 5.76 Favored Glycine 0 N--CA 1.471 0.971 0 N-CA-C 110.626 -0.99 . . . . 74.34 110.626 -172.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 88' ' ' PHE . . . . . 0.462 ' HD1' ' HB3' ' C' ' 51' ' ' ASN . 33.2 m-85 -108.57 135.87 49.11 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 108.023 -1.102 . . . . 74.44 108.023 178.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -77.18 79.26 3.7 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.014 0.525 . . . . 72.23 110.271 -175.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 90' ' ' VAL . . . . . 0.521 HG23 ' HZ ' ' C' ' 97' ' ' PHE . 3.4 p -48.48 -40.85 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 C-N-CA 124.96 1.304 . . . . 54.42 112.574 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -62.92 -29.89 71.13 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.715 0.806 . . . . 75.25 111.42 -177.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -72.32 -33.42 67.34 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.057 0.543 . . . . 75.53 112.023 178.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 10.6 m-30 -70.38 166.22 20.76 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 122.72 0.408 . . . . 72.45 111.208 -166.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 75.5 p -57.32 149.65 19.84 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 113.306 0.854 . . . . 52.11 113.306 -168.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.4 -32.94 70.63 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 115.299 -0.864 . . . . 72.35 111.118 170.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -52.97 -52.06 59.43 Favored 'General case' 0 C--N 1.357 0.915 0 C-N-CA 125.016 1.327 . . . . 74.24 109.934 174.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 97' ' ' PHE . . . . . 0.521 ' HZ ' HG23 ' C' ' 90' ' ' VAL . 1.8 t80 -60.35 -44.12 95.86 Favored 'General case' 0 CA--C 1.557 1.22 0 CA-C-N 113.256 -1.793 . . . . 64.25 110.677 174.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -70.79 -12.82 61.78 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 112.568 0.581 . . . . 71.33 112.568 -177.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -93.25 -40.61 10.34 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.298 0.639 . . . . 74.43 110.818 173.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 23.7 tp -75.03 -63.57 1.24 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.021 0.528 . . . . 73.23 110.795 -178.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -80.65 -11.43 59.64 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 122.851 0.46 . . . . 75.04 111.841 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -41.03 -60.91 2.11 Favored Glycine 0 CA--C 1.541 1.715 0 CA-C-O 118.726 -1.041 . . . . 74.41 115.137 178.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -50.14 -28.13 18.91 Favored 'Trans proline' 0 C--N 1.386 2.551 0 C-N-CA 124.113 3.209 . . . . 64.35 114.693 -177.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -126.77 30.55 4.16 Favored Glycine 0 C--N 1.358 1.757 0 CA-C-O 118.516 -1.158 . . . . 73.42 113.145 -175.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 34.5 mt . . . . . 0 N--CA 1.496 1.839 0 CA-C-N 118.373 1.086 . . . . 75.43 112.688 177.628 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.667 0 N-CA-C 113.618 0.207 . . . . 54.4 113.618 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 117' ' ' ARG . . . . . 0.462 ' NE ' ' HA ' ' C' ' 117' ' ' ARG . 2.2 mmp_? -116.71 155.51 28.75 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.21 1.004 . . . . 74.32 112.156 178.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -66.89 108.61 2.62 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-O 121.756 0.789 . . . . 75.42 109.428 175.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 119' ' ' LEU . . . . . 0.54 HD21 HG22 ' B' ' 185' ' ' VAL . 3.9 tt -89.22 112.74 23.84 Favored 'General case' 0 C--O 1.224 -0.28 0 N-CA-C 105.814 -1.921 . . . . 75.21 105.814 -174.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -93.66 132.68 37.77 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.516 -1.29 . . . . 72.31 107.516 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 121' ' ' ALA . . . . . . . . . . . . . . . -143.52 117.0 9.12 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.161 -0.681 . . . . 75.44 109.161 -177.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 122' ' ' GLU . . . . . 0.531 ' HA ' ' O ' ' C' ' 177' ' ' VAL . 13.1 pt-20 -92.91 125.47 37.52 Favored 'General case' 0 C--N 1.353 0.754 0 N-CA-C 109.036 -0.727 . . . . 74.12 109.036 176.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 123' ' ' LEU . . . . . 0.666 ' HB2' ' HA ' ' B' ' 182' ' ' VAL . 0.8 OUTLIER -121.51 105.72 38.49 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 115.873 -0.603 . . . . 73.3 111.63 -170.048 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . 0.666 ' HD2' ' HB2' ' B' ' 183' ' ' ALA . 28.2 Cg_exo -42.33 113.77 0.34 Allowed 'Trans proline' 0 C--N 1.374 1.9 0 C-N-CA 123.314 2.676 . . . . 72.51 112.02 161.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 125' ' ' LEU . . . . . . . . . . . . . 42.9 tp -140.09 140.78 36.16 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.829 1.252 . . . . 75.32 108.401 -170.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.43 154.11 22.98 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 121.006 0.431 . . . . 61.53 111.156 -176.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 127' ' ' LEU . . . . . 0.65 ' HB3' HD22 ' C' ' 215' ' ' LEU . 96.2 mt -63.22 -44.28 95.72 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.519 1.128 . . . . 62.25 111.067 177.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -53.55 -49.03 68.55 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 114.964 -1.016 . . . . 75.24 110.302 172.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -66.19 -32.31 73.67 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.889 0.876 . . . . 75.51 111.484 -176.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -73.05 -31.54 64.48 Favored 'General case' 0 CA--C 1.541 0.596 0 O-C-N 124.087 0.867 . . . . 73.14 110.475 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 131' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -69.45 -43.16 73.85 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.448 0.699 . . . . 75.55 110.395 171.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 132' ' ' HIS . . . . . . . . . . . . . 38.2 m170 -67.11 -67.65 0.44 Allowed 'General case' 0 N--CA 1.485 1.28 0 O-C-N 124.007 0.817 . . . . 70.15 111.924 -172.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 67.52 99.28 0.03 OUTLIER Glycine 0 CA--C 1.542 1.734 0 O-C-N 123.423 0.452 . . . . 65.31 113.607 -178.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . -142.52 162.12 27.33 Favored Glycine 0 N--CA 1.476 1.311 0 CA-C-O 119.244 -0.753 . . . . 73.12 111.272 178.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 53.6 mp0 -71.45 92.81 1.12 Allowed 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 108.565 -0.902 . . . . 73.03 108.565 177.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 136' ' ' ARG . . . . . 0.539 ' HB2' HD22 ' B' ' 181' ' ' LEU . 99.0 mtt180 -124.75 154.71 40.47 Favored 'General case' 0 C--O 1.247 0.941 0 C-N-CA 124.084 0.954 . . . . 72.12 109.302 -173.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 137' ' ' VAL . . . . . 0.488 HG13 ' HB2' ' B' ' 180' ' ' ALA . 7.6 p -81.12 108.8 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-O 121.919 0.866 . . . . 73.11 111.828 -165.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 138' ' ' VAL . . . . . . . . . . . . . 20.8 m -87.78 133.98 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 108.012 -1.107 . . . . 72.14 108.012 165.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 139' ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' C' ' 143' ' ' ARG . 1.2 tm-20 -124.7 105.34 9.23 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 108.03 -1.1 . . . . 74.31 108.03 169.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 140' ' ' VAL . . . . . . . . . . . . . 67.1 t -127.81 110.41 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 123.796 0.838 . . . . 73.25 109.181 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 63.86 29.32 14.64 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.149 0.979 . . . . 65.0 110.976 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 97.76 -12.96 64.26 Favored Glycine 0 C--N 1.349 1.257 0 CA-C-N 115.003 -0.999 . . . . 52.4 112.738 -178.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 143' ' ' ARG . . . . . 0.497 ' NE ' ' HB2' ' C' ' 84' ' ' ASP . 5.9 tpp180 -75.26 93.92 2.93 Favored 'General case' 0 C--N 1.353 0.717 0 CA-C-N 117.253 0.527 . . . . 75.05 109.84 -177.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 28.8 ttp85 -104.73 96.68 6.74 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 124.373 1.069 . . . . 71.51 109.511 -176.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 145' ' ' VAL . . . . . 0.532 ' HA ' ' HD2' ' C' ' 60' ' ' PRO . 25.7 m -133.02 146.38 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.64 0.776 . . . . 75.03 110.615 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 46.4 m -89.79 92.48 9.06 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.949 -0.76 . . . . 73.22 108.949 174.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 147' ' ' VAL . . . . . 0.538 HG13 ' HE1' ' C' ' 164' ' ' MET . 10.8 p -113.16 145.37 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 122.942 0.497 . . . . 72.53 109.977 -174.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -101.16 101.81 12.61 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 108.499 -0.926 . . . . 74.22 108.499 170.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 149' ' ' ILE . . . . . . . . . . . . . 36.0 pt -73.57 137.1 77.49 Favored Pre-proline 0 CA--C 1.551 1.006 0 N-CA-C 107.734 -1.21 . . . . 74.42 107.734 165.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -63.76 142.66 83.9 Favored 'Trans proline' 0 C--N 1.37 1.702 0 C-N-CA 122.417 2.078 . . . . 61.44 113.136 -167.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -62.92 149.95 89.94 Favored 'Trans proline' 0 C--N 1.379 2.148 0 C-N-CA 122.843 2.362 . . . . 73.2 111.719 176.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 152' ' ' GLY . . . . . 0.689 ' HA2' ' HB3' ' C' ' 240' ' ' PHE . . . 80.59 52.79 4.29 Favored Glycine 0 C--N 1.336 0.557 0 CA-C-N 116.216 -0.447 . . . . 63.11 112.435 -176.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 153' ' ' VAL . . . . . 0.487 HG23 HD11 ' C' ' 159' ' ' ILE . 8.3 p -104.14 142.83 16.87 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.312 0 C-N-CA 123.009 0.524 . . . . 74.01 110.26 -177.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 154' ' ' ARG . . . . . 0.611 ' HA ' ' HB3' ' C' ' 188' ' ' LEU . 57.5 mtp180 -97.51 161.35 13.82 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.762 0.825 . . . . 75.32 112.094 -168.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 155' ' ' GLU . . . . . 0.454 ' HG2' ' HE ' ' C' ' 187' ' ' ARG . 8.3 tp10 -54.22 115.7 2.21 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.682 0.793 . . . . 74.51 110.102 162.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 78.1 19.67 74.34 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-O 119.536 -0.591 . . . . 75.21 113.862 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 157' ' ' SER . . . . . . . . . . . . . 3.4 m -70.62 108.53 4.41 Favored 'General case' 0 C--N 1.355 0.842 0 CA-C-N 117.365 0.583 . . . . 75.43 110.105 172.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 158' ' ' VAL . . . . . 0.477 HG13 HG21 ' C' ' 177' ' ' VAL . 22.0 t -84.43 88.46 2.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 114.698 -1.137 . . . . 72.31 108.437 176.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 159' ' ' ILE . . . . . 0.487 HD11 HG23 ' C' ' 153' ' ' VAL . 37.5 mt -72.14 118.02 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 115.184 -0.916 . . . . 72.31 109.587 -178.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -75.95 118.61 18.91 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 109.091 -0.707 . . . . 75.13 109.091 173.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 161' ' ' VAL . . . . . 0.452 HG11 ' SD ' ' C' ' 164' ' ' MET . 20.6 t -125.85 95.55 39.61 Favored Pre-proline 0 CA--C 1.55 0.96 0 N-CA-C 109.556 -0.535 . . . . 75.24 109.556 174.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.38 128.11 12.5 Favored 'Trans proline' 0 C--N 1.369 1.609 0 C-N-CA 122.264 1.976 . . . . 75.23 111.342 173.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 101.92 23.92 8.93 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-N 115.793 -0.64 . . . . 53.54 113.466 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 164' ' ' MET . . . . . 0.538 ' HE1' HG13 ' C' ' 147' ' ' VAL . 28.2 mtp -151.81 6.9 0.47 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 112.619 0.6 . . . . 73.35 112.619 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 165' ' ' GLY . . . . . 0.404 ' HA3' ' O ' ' C' ' 173' ' ' ASP . . . -121.92 -122.89 2.88 Favored Glycine 0 N--CA 1.478 1.458 0 CA-C-O 118.348 -1.251 . . . . 73.32 111.515 -177.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . 69.4 81.93 0.21 Allowed Glycine 0 C--N 1.359 1.816 0 CA-C-N 118.149 0.974 . . . . 75.44 113.823 165.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 167' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -69.23 99.41 1.16 Allowed 'General case' 0 C--N 1.348 0.512 0 N-CA-C 107.035 -1.469 . . . . 74.2 107.035 166.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . 131.51 -142.51 13.91 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 108.395 -1.882 . . . . 13.44 108.395 -161.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 169' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -145.74 -62.2 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.774 0 CA-C-N 120.226 2.013 . . . . 62.44 111.784 175.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 170' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -61.88 162.79 20.97 Favored 'Trans proline' 0 C--N 1.399 3.191 0 C-N-CA 122.174 1.916 . . . . 73.55 112.345 173.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 171' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -10.38 108.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.396 3.078 1 C-N-CA 127.079 5.186 . . . . 74.02 118.497 -165.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -140.32 -156.41 6.87 Favored Glycine 0 C--N 1.342 0.912 0 N-CA-C 109.311 -1.516 . . . . 74.42 109.311 170.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 173' ' ' ASP . . . . . 0.404 ' O ' ' HA3' ' C' ' 165' ' ' GLY . 14.5 t70 -166.3 158.29 13.85 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 117.843 0.822 . . . . 74.51 110.087 -177.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 174' ' ' LEU . . . . . 0.503 HD23 ' HE3' ' C' ' 164' ' ' MET . 45.2 tp -118.82 107.53 13.73 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.674 0.79 . . . . 75.22 109.758 175.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 175' ' ' LEU . . . . . 0.442 HD22 HG11 ' C' ' 158' ' ' VAL . 73.8 mt -86.44 85.85 7.33 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.962 0.905 . . . . 72.15 110.273 175.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 176' ' ' LEU . . . . . 0.445 ' HG ' ' HG ' ' C' ' 174' ' ' LEU . 47.9 mt -75.3 92.7 2.79 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.594 0.758 . . . . 74.33 110.543 177.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 177' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' C' ' 122' ' ' GLU . 6.5 t -84.92 94.13 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 C-N-CA 123.423 0.689 . . . . 75.23 109.921 179.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 178' ' ' VAL . . . . . . . . . . . . . 23.0 m -68.78 119.53 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 O-C-N 121.344 -0.848 . . . . 74.01 110.781 -176.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 179' ' ' ARG . . . . . 0.419 ' O ' ' HA ' ' C' ' 124' ' ' PRO . 7.0 mmm180 -100.93 119.7 39.09 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 107.023 -1.473 . . . . 74.42 107.023 171.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 180' ' ' LEU . . . . . 0.435 HD11 HD21 ' C' ' 127' ' ' LEU . 75.5 mt -68.6 134.99 50.78 Favored 'General case' 0 CA--C 1.559 1.29 0 CA-C-N 118.171 0.441 . . . . 73.43 111.397 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 181' ' ' LEU . . . . . 0.414 HD23 ' HB3' ' C' ' 124' ' ' PRO . 18.5 mt -53.12 169.64 0.29 Allowed Pre-proline 0 N--CA 1.502 2.148 0 C-N-CA 126.521 1.928 . . . . 74.24 113.538 -176.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -59.99 64.5 0.07 OUTLIER 'Trans proline' 0 C--N 1.405 3.543 0 C-N-CA 123.486 2.791 . . . . 73.32 112.268 161.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 183' ' ' HIS . . . . . 0.537 ' N ' ' HD3' ' C' ' 184' ' ' PRO . 76.4 t60 -162.37 26.15 0.02 OUTLIER Pre-proline 0 CA--C 1.576 1.957 0 C-N-CA 127.77 2.428 . . . . 72.0 107.705 -176.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 184' ' ' PRO . . . . . 0.537 ' HD3' ' N ' ' C' ' 183' ' ' HIS . 11.0 Cg_endo -88.49 67.67 3.0 Favored 'Trans proline' 0 C--N 1.401 3.341 0 C-N-CA 123.588 2.859 . . . . 74.25 111.377 -163.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 185' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 9.0 t -89.48 -23.93 6.05 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.492 0 N-CA-C 108.146 -1.057 . . . . 72.23 108.146 -177.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 186' ' ' PHE . . . . . 0.477 ' HD2' HD12 ' C' ' 127' ' ' LEU . 48.4 m-85 -127.85 101.82 6.51 Favored 'General case' 0 C--N 1.352 0.704 0 C-N-CA 123.737 0.815 . . . . 61.44 109.266 -178.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 187' ' ' ARG . . . . . 0.454 ' HE ' ' HG2' ' C' ' 155' ' ' GLU . 27.9 ttm105 -97.72 110.65 23.17 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 124.557 1.143 . . . . 75.14 108.182 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 188' ' ' LEU . . . . . 0.611 ' HB3' ' HA ' ' C' ' 154' ' ' ARG . 59.5 tp -76.77 131.94 38.99 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.387 0.613 . . . . 74.14 112.6 -166.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -116.08 106.3 13.59 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.147 1.379 . . . . 73.21 108.377 167.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 66.85 -99.8 0.51 Allowed Glycine 0 C--N 1.348 1.239 0 CA-C-N 116.053 -0.521 . . . . 74.2 112.454 -178.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 191' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -117.53 -14.21 10.28 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 124.262 1.025 . . . . 75.25 110.183 175.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -101.32 128.71 47.36 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.678 1.191 . . . . 65.13 110.401 -173.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 193' ' ' LEU . . . . . 0.43 ' HG ' ' HA2' ' C' ' 239' ' ' GLY . 77.8 mt -73.74 153.75 39.89 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.828 0.851 . . . . 65.15 111.883 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 194' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -123.83 106.72 10.7 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 107.266 -1.383 . . . . 75.43 107.266 169.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 195' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' C' ' 185' ' ' VAL . . . -110.76 -177.91 3.34 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.286 1.034 . . . . 65.11 110.38 -174.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 90.2 m -137.75 121.12 17.05 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 108.638 -0.875 . . . . 53.42 108.638 164.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 197' ' ' LEU . . . . . . . . . . . . . 63.2 tp -100.48 143.5 30.59 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.586 1.155 . . . . 73.5 110.232 -175.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -100.61 101.59 12.53 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 123.656 0.782 . . . . 64.33 109.004 -178.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 199' ' ' VAL . . . . . . . . . . . . . 94.9 t -114.51 125.58 29.0 Favored Pre-proline 0 N--CA 1.486 1.354 0 C-N-CA 124.404 1.081 . . . . 73.12 109.864 -176.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 200' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -74.06 145.05 34.83 Favored 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 121.675 1.583 . . . . 73.11 111.125 174.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 201' ' ' ALA . . . . . 0.437 ' O ' HG23 ' C' ' 205' ' ' VAL . . . -58.66 -38.89 70.25 Favored Pre-proline 0 CA--C 1.552 1.024 0 N-CA-C 115.263 1.579 . . . . 74.35 115.263 -173.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 202' ' ' PRO . . . . . 0.512 ' HB2' ' HA ' ' A' ' 273' ' ' ALA . 21.2 Cg_endo -59.13 -52.33 5.16 Favored 'Trans proline' 0 C--N 1.388 2.613 0 CA-C-N 121.711 1.647 . . . . 63.15 111.205 175.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 203' ' ' ILE . . . . . . . . . . . . . 43.4 mt -62.49 -28.25 44.36 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 C-N-CA 124.228 1.011 . . . . 74.02 110.737 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.62 -43.4 76.44 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.5 -0.773 . . . . 75.02 112.305 175.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 205' ' ' VAL . . . . . 0.522 HG11 HD13 ' A' ' 261' ' ' LEU . 65.2 t -69.39 -45.42 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 122.373 0.269 . . . . 74.52 110.964 -178.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 206' ' ' VAL . . . . . 0.505 HG12 ' O ' ' C' ' 202' ' ' PRO . 0.7 OUTLIER -96.58 -38.09 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 111.514 0.19 . . . . 74.12 111.514 -167.717 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 106.07 119.49 4.55 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 112.455 -0.258 . . . . 63.21 112.455 -173.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -156.44 -137.64 2.37 Favored Glycine 0 C--N 1.336 0.56 0 N-CA-C 109.79 -1.324 . . . . 51.32 109.79 176.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 209' ' ' LYS . . . . . 0.669 ' HG2' ' HA ' ' C' ' 222' ' ' ALA . 10.2 mtmp? -142.37 151.94 42.38 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 118.08 0.94 . . . . 72.44 111.712 177.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 210' ' ' VAL . . . . . . . . . . . . . 30.2 m -139.42 174.0 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 125.644 1.577 . . . . 71.52 108.516 174.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 211' ' ' ARG . . . . . 0.667 HH11 ' HB2' ' C' ' 218' ' ' PRO . 40.5 ttm-85 -109.66 127.64 54.7 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 118.431 0.56 . . . . 75.53 110.778 -176.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -107.97 113.14 26.11 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 107.335 -1.358 . . . . 74.43 107.335 169.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 213' ' ' MET . . . . . 0.809 ' HA ' ' HA ' ' C' ' 218' ' ' PRO . 4.2 ttp -80.28 98.95 7.63 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 108.954 -0.758 . . . . 63.12 108.954 -176.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.11 177.74 8.58 Favored 'General case' 0 C--O 1.244 0.798 0 O-C-N 123.342 0.401 . . . . 72.34 109.936 -174.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 215' ' ' LEU . . . . . 0.65 HD22 ' HB3' ' C' ' 127' ' ' LEU . 11.9 mt -52.68 -60.81 2.8 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.055 0.942 . . . . 75.24 110.506 -175.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -86.76 8.61 21.94 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.211 -0.904 . . . . 71.0 112.185 -174.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 142.07 157.03 7.0 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-O 119.925 -0.375 . . . . 74.41 113.307 177.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 218' ' ' PRO . . . . . 0.809 ' HA ' ' HA ' ' C' ' 213' ' ' MET . 31.8 Cg_endo -63.22 121.99 10.03 Favored 'Trans proline' 0 C--N 1.364 1.389 0 C-N-CA 122.95 2.433 . . . . 64.03 115.322 177.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 219' ' ' VAL . . . . . . . . . . . . . 8.0 p -98.77 167.84 1.8 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.928 0 N-CA-C 107.05 -1.463 . . . . 52.53 107.05 170.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 220' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -101.04 158.45 16.0 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 109.338 -0.616 . . . . 72.32 109.338 173.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 221' ' ' VAL . . . . . . . . . . . . . 33.3 t -121.97 123.22 68.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 125.2 1.4 . . . . 74.03 108.309 173.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 222' ' ' ALA . . . . . 0.669 ' HA ' ' HG2' ' C' ' 209' ' ' LYS . . . -84.15 101.92 12.19 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 123.118 0.567 . . . . 73.3 109.565 169.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 61.0 t -75.53 123.39 88.49 Favored Pre-proline 0 CA--C 1.549 0.91 0 CA-C-N 114.409 -1.269 . . . . 73.11 109.222 178.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 224' ' ' PRO . . . . . 0.403 ' HA ' ' HA ' ' B' ' 245' ' ' LYS . 11.0 Cg_exo -76.37 164.44 30.85 Favored 'Trans proline' 0 C--N 1.369 1.651 0 C-N-CA 123.552 2.835 . . . . 73.11 112.917 172.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -55.96 146.52 68.2 Favored 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 122.361 2.041 . . . . 74.4 112.684 165.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 226' ' ' ARG . . . . . 0.444 ' HG3' ' HA ' ' A' ' 259' ' ' GLU . 8.0 mpt_? 66.65 66.5 0.45 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.764 1.225 . . . . 71.5 110.814 171.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 227' ' ' THR . . . . . 0.494 ' HA ' ' HD3' ' C' ' 231' ' ' ARG . 16.7 m -114.89 121.79 44.29 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 114.697 -1.138 . . . . 73.3 110.779 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 228' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -111.27 163.01 14.4 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.922 0.889 . . . . 74.32 110.809 -178.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -77.18 111.43 12.79 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 114.403 -1.271 . . . . 65.31 109.965 -178.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 110.61 6.2 27.12 Favored Glycine 0 N--CA 1.476 1.311 0 CA-C-O 119.896 -0.391 . . . . 62.04 113.115 -169.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 231' ' ' ARG . . . . . 0.494 ' HD3' ' HA ' ' C' ' 227' ' ' THR . 39.4 mtp85 -77.84 169.78 17.71 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 109.623 -0.51 . . . . 75.03 109.623 164.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 232' ' ' LYS . . . . . 0.692 ' HZ2' ' HB2' ' C' ' 232' ' ' LYS . 2.1 ttmp? -135.08 151.02 50.36 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.424 0.63 . . . . 74.05 112.461 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 233' ' ' LEU . . . . . 0.697 HD11 ' HB2' ' C' ' 251' ' ' LEU . 5.6 mp -113.96 157.21 22.75 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.672 1.589 . . . . 74.22 110.874 -176.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 28.5 ptt-85 -134.57 97.12 3.71 Favored 'General case' 0 CA--C 1.559 1.324 0 O-C-N 125.327 1.642 . . . . 72.34 110.65 173.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 235' ' ' LEU . . . . . 0.472 ' HB2' ' HB3' ' C' ' 249' ' ' LEU . 87.5 mt -93.29 104.44 16.61 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.9 0.88 . . . . 74.34 108.819 171.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -68.89 132.28 46.48 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.756 0.822 . . . . 73.41 112.184 -174.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 74.37 22.58 77.32 Favored Glycine 0 C--N 1.357 1.711 0 O-C-N 123.925 0.766 . . . . 71.42 113.965 177.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 27.9 mmtm -115.79 17.96 15.88 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.462 0.705 . . . . 75.11 111.382 -178.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 239' ' ' GLY . . . . . 0.43 ' HA2' ' HG ' ' C' ' 193' ' ' LEU . . . -91.61 -159.04 35.13 Favored Glycine 0 C--N 1.349 1.252 0 O-C-N 123.421 0.45 . . . . 75.2 112.851 177.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 240' ' ' PHE . . . . . 0.689 ' HB3' ' HA2' ' C' ' 152' ' ' GLY . 4.4 m-85 -88.65 154.84 50.82 Favored Pre-proline 0 CA--C 1.551 0.997 0 CA-C-O 119.102 -0.475 . . . . 75.14 109.776 179.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 241' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -67.93 101.62 0.7 Allowed 'Trans proline' 0 C--N 1.387 2.596 0 C-N-CA 122.83 2.353 . . . . 71.53 110.66 177.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -94.12 167.86 28.14 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-N 115.623 -0.717 . . . . 70.14 112.152 177.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.02 -23.52 29.53 Favored 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 123.023 2.482 . . . . 71.42 111.412 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -99.0 27.34 5.09 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.318 1.047 . . . . 71.42 110.064 175.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 92.07 177.98 41.94 Favored Glycine 0 C--N 1.351 1.377 0 CA-C-N 115.918 -0.583 . . . . 63.24 112.186 -177.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 246' ' ' ARG . . . . . . . . . . . . . 80.1 mtm180 -72.48 138.21 46.87 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 122.699 0.399 . . . . 71.32 110.267 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -79.01 -155.54 9.07 Favored Glycine 0 C--N 1.344 1.025 0 O-C-N 123.857 0.723 . . . . 63.23 112.374 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -120.25 177.6 4.96 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 108.562 -0.903 . . . . 73.54 108.562 -175.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 249' ' ' LEU . . . . . 0.472 ' HB3' ' HB2' ' C' ' 235' ' ' LEU . 12.8 tp -119.7 109.28 15.45 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.877 -0.786 . . . . 74.23 108.877 177.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 250' ' ' TYR . . . . . 0.6 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 19.9 m-85 -101.5 105.57 16.58 Favored 'General case' 0 C--N 1.343 0.325 0 CA-C-N 115.901 -0.59 . . . . 71.43 109.605 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 251' ' ' LEU . . . . . 0.697 ' HB2' HD11 ' C' ' 233' ' ' LEU . 2.1 mp -99.71 149.47 23.29 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 109.595 -0.52 . . . . 72.0 109.595 -173.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -103.44 128.17 50.65 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.388 -0.967 . . . . 75.41 108.388 175.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 253' ' ' VAL . . . . . . . . . . . . . 95.1 t -74.15 133.28 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.172 0.589 . . . . 73.5 111.896 -172.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 254' ' ' ARG . . . . . 0.537 ' NH2' ' HB ' ' C' ' 256' ' ' THR . 1.3 tmm_? -122.27 94.98 4.47 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 107.321 -1.363 . . . . 75.13 107.321 176.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 255' ' ' ILE . . . . . 0.445 HD12 HG21 ' C' ' 227' ' ' THR . 46.6 mm -69.17 131.35 34.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 122.634 0.374 . . . . 75.24 110.459 177.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 256' ' ' THR . . . . . 0.537 ' HB ' ' NH2' ' C' ' 254' ' ' ARG . 0.0 OUTLIER -140.8 172.0 13.3 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.538 1.135 . . . . 70.25 111.153 -174.514 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 2.9 pp -130.96 154.18 81.94 Favored Pre-proline 0 CA--C 1.556 1.181 0 C-N-CA 124.351 1.06 . . . . 75.21 109.29 177.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -72.38 -2.62 11.99 Favored 'Trans proline' 0 C--N 1.377 2.065 0 C-N-CA 122.451 2.101 . . . . 74.41 113.631 -166.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 57.14 -72.12 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 125.229 1.412 . . . . 72.3 111.74 -166.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 -69.75 148.03 49.72 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.597 0.759 . . . . 73.41 111.103 177.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 261' ' ' LEU . . . . . 0.472 HD11 ' HA ' ' C' ' 266' ' ' GLU . 72.7 mt -138.35 141.47 39.69 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.243 0.617 . . . . 74.53 111.416 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 46.7 p -82.09 150.8 65.58 Favored Pre-proline 0 CA--C 1.545 0.771 0 N-CA-C 107.995 -1.113 . . . . 61.23 107.995 170.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -47.04 -39.46 25.43 Favored 'Trans proline' 0 N--CA 1.509 2.394 0 C-N-CA 123.77 2.98 . . . . 74.2 113.759 -177.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 264' ' ' GLU . . . . . 0.472 ' HG2' ' NH2' ' A' ' 279' ' ' ARG . 2.8 tp10 -55.89 -67.62 0.27 Allowed 'General case' 0 C--O 1.246 0.877 0 C-N-CA 124.578 1.151 . . . . 71.04 111.093 175.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -66.04 -28.63 69.0 Favored 'General case' 0 C--O 1.212 -0.885 0 CA-C-N 115.176 -0.92 . . . . 71.03 110.847 -173.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 266' ' ' GLU . . . . . 0.472 ' HA ' HD11 ' C' ' 261' ' ' LEU . 11.6 tp10 -57.88 -50.15 74.3 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.025 0.93 . . . . 73.1 109.575 174.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -60.4 -38.53 84.27 Favored 'General case' 0 CA--C 1.548 0.887 0 O-C-N 123.853 0.72 . . . . 71.12 111.592 176.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 268' ' ' LEU . . . . . . . . . . . . . 11.0 mp -65.06 -47.68 76.45 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 112.445 0.535 . . . . 70.11 112.445 177.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 269' ' ' TRP . . . . . 0.426 ' CH2' ' HD3' ' C' ' 202' ' ' PRO . 90.5 m95 -64.74 -33.42 75.92 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.302 0.641 . . . . 63.11 110.603 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 270' ' ' LYS . . . . . 0.531 ' HZ3' ' HB3' ' C' ' 270' ' ' LYS . 4.6 mmmp? -64.9 -48.64 73.47 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.739 0.816 . . . . 75.43 111.547 177.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 13.0 mmtm -65.74 -37.96 87.83 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.059 0.543 . . . . 75.33 111.917 179.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 272' ' ' LEU . . . . . 0.418 HD11 HD12 ' A' ' 272' ' ' LEU . 64.3 mt -76.53 -22.46 54.35 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.761 -0.654 . . . . 74.33 111.226 177.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -67.28 -47.04 71.82 Favored 'General case' 0 C--O 1.218 -0.572 0 N-CA-C 109.226 -0.657 . . . . 43.22 109.226 171.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -60.69 -37.36 81.38 Favored 'General case' 0 N--CA 1.483 1.215 0 O-C-N 124.291 0.994 . . . . 63.21 111.099 176.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -63.58 -37.2 86.43 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.625 0.77 . . . . 70.04 111.287 175.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 276' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -83.25 -22.33 33.09 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 116.311 -0.404 . . . . 75.52 112.077 178.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 20.8 m-30 -68.16 -35.93 78.84 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 108.408 -0.96 . . . . 65.52 108.408 172.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -59.39 -27.26 65.83 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 114.898 -1.047 . . . . 72.22 111.439 171.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 279' ' ' ARG . . . . . . . . . . . . . 25.3 mtp-105 -74.95 -31.54 61.52 Favored 'General case' 0 C--N 1.364 1.236 0 N-CA-C 109.648 -0.501 . . . . 75.11 109.648 175.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 N-CA-C 109.185 -0.672 . . . . 75.14 109.185 -175.233 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp . . . . . 0 CA--C 1.548 0.88 0 N-CA-C 112.955 0.724 . . . . 64.14 112.955 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -89.42 129.12 35.98 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.663 0.785 . . . . 74.32 110.269 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -84.07 86.55 7.19 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 107.007 -1.479 . . . . 62.43 107.007 170.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.444 ' CD1' ' HA ' ' A' ' 53' ' ' ALA . 69.9 m-85 -61.0 -25.96 67.26 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 114.988 -1.005 . . . . 73.34 112.024 -174.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.505 ' HE1' ' HE2' ' A' ' 66' ' ' TYR . 49.3 m-85 -66.69 -52.54 43.58 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.602 -0.726 . . . . 73.33 109.581 175.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.61 -36.54 76.51 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.592 0.757 . . . . 70.01 110.885 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 69.8 mt -59.43 -44.16 92.07 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.097 0 C-N-CA 123.91 0.884 . . . . 74.23 110.943 174.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.5 mt -77.18 -6.95 54.91 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 112.515 0.561 . . . . 73.11 112.515 175.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.92 17.83 76.29 Favored Glycine 0 C--N 1.352 1.434 0 C-N-CA 122.961 0.315 . . . . 73.42 113.561 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.6 m -108.83 152.24 42.22 Favored Pre-proline 0 CA--C 1.554 1.125 0 C-N-CA 124.055 0.942 . . . . 72.52 110.008 176.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -86.41 172.72 6.88 Favored 'Trans proline' 0 C--N 1.368 1.599 0 C-N-CA 122.366 2.044 . . . . 50.12 112.928 178.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 11.9 mmt85 -68.85 78.48 0.31 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.127 -0.942 . . . . 75.43 109.345 172.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -174.37 -31.82 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 114.335 -1.302 . . . . 71.2 108.431 -172.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.43 120.92 15.29 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.624 -0.716 . . . . 74.14 111.304 -178.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 76.2 p -82.62 175.25 10.31 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.989 0.916 . . . . 75.03 110.027 174.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -47.96 -39.81 20.43 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 124.728 1.211 . . . . 71.11 113.033 -176.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.445 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 0.5 OUTLIER -69.35 -44.82 70.83 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.521 0.729 . . . . 72.43 109.796 -175.689 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -67.39 -34.69 77.78 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 124.036 0.935 . . . . 71.14 111.455 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.559 HD12 HD13 ' A' ' 57' ' ' LEU . 77.9 mt -67.23 -36.6 77.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.98 1.312 . . . . 73.31 110.461 175.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -69.84 -38.64 76.56 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.233 -0.894 . . . . 75.22 109.672 178.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.445 ' HG3' ' O ' ' A' ' 20' ' ' GLU . 94.9 mtt180 -60.25 -48.56 81.22 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.509 0.723 . . . . 73.12 109.896 175.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.81 -43.71 98.31 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 124.541 1.151 . . . . 72.43 111.668 -177.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -61.55 -54.81 38.17 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.55 -0.75 . . . . 73.1 110.638 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -62.66 -32.73 73.84 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 124.119 0.887 . . . . 74.22 111.7 -177.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.403 ' HA ' ' NH2' ' A' ' 31' ' ' ARG . 14.9 ttt180 -57.99 -55.38 35.63 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.341 1.056 . . . . 75.52 110.058 174.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.603 ' HB3' HD11 ' A' ' 50' ' ' ILE . 78.8 mt -74.94 -15.13 60.7 Favored 'General case' 0 CA--C 1.552 1.026 0 CA-C-N 114.865 -1.061 . . . . 75.12 110.925 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.478 ' HA ' ' HE1' ' A' ' 47' ' ' PHE . . . -89.75 -12.0 40.6 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.032 0.933 . . . . 71.54 111.723 176.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.403 ' NH2' ' HA ' ' A' ' 28' ' ' ARG . 47.1 mtm105 -90.68 -42.93 10.45 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 109.714 -0.476 . . . . 72.33 109.714 167.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -68.68 -61.4 1.83 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.491 0.717 . . . . 73.31 111.345 -177.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -92.11 17.5 9.41 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.227 0.611 . . . . 72.41 112.211 -172.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 7.2 t-160 -57.38 101.85 0.28 Allowed Pre-proline 0 CA--C 1.555 1.156 0 C-N-CA 124.645 1.178 . . . . 73.54 111.654 -172.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.87 -32.03 75.78 Favored 'Trans proline' 0 C--N 1.388 2.65 0 C-N-CA 123.883 3.055 . . . . 75.51 113.71 -171.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -47.0 -43.68 19.61 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.609 1.164 . . . . 73.23 112.331 176.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 60.3 t -104.65 -24.77 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.665 0.786 . . . . 73.25 110.069 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -127.48 73.96 1.48 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.259 0.624 . . . . 64.12 110.474 -170.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -79.16 69.19 5.3 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 109.066 -0.716 . . . . 73.11 109.066 171.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.4 m -112.06 105.05 56.43 Favored Pre-proline 0 CA--C 1.535 0.38 0 N-CA-C 107.28 -1.378 . . . . 71.24 107.28 177.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -37.3 -49.38 1.72 Allowed 'Trans proline' 0 C--N 1.389 2.698 0 C-N-CA 124.689 3.593 . . . . 73.53 114.647 -173.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -51.95 -54.32 30.99 Favored 'General case' 0 N--CA 1.48 1.042 0 O-C-N 124.314 1.009 . . . . 64.43 111.086 177.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.09 -21.54 63.12 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 114.798 -1.092 . . . . 73.42 111.385 -177.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.457 ' O ' ' HD3' ' A' ' 48' ' ' LYS . 51.8 mt-10 -83.25 -38.69 21.88 Favored 'General case' 0 C--N 1.355 0.818 0 C-N-CA 122.824 0.45 . . . . 63.35 109.891 -176.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -65.73 -43.98 87.4 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.485 0.714 . . . . 62.44 109.445 175.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -58.62 -41.01 84.94 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 114.696 -1.138 . . . . 74.03 110.265 171.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.478 ' HE1' ' HA ' ' A' ' 30' ' ' ALA . 40.9 t80 -69.51 -25.32 63.99 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 123.407 0.442 . . . . 73.32 111.886 179.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.457 ' HD3' ' O ' ' A' ' 44' ' ' GLU . 2.0 mptm? -70.32 -39.13 74.95 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 109.944 -0.391 . . . . 75.14 109.944 174.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -63.43 -41.36 98.69 Favored 'General case' 0 CA--C 1.55 0.962 0 O-C-N 123.907 0.754 . . . . 71.44 110.568 174.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.603 HD11 ' HB3' ' A' ' 29' ' ' LEU . 69.4 mt -67.91 -40.53 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 124.621 1.168 . . . . 74.43 110.994 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -63.76 -41.03 98.05 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.261 -0.881 . . . . 73.43 110.379 174.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.411 ' HG3' ' CD1' ' A' ' 97' ' ' PHE . 33.4 tt0 -61.27 -48.85 79.52 Favored 'General case' 0 C--O 1.246 0.906 0 C-N-CA 124.62 1.168 . . . . 75.34 110.591 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.444 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . . . -58.01 -48.07 81.15 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 114.163 -1.38 . . . . 65.45 111.564 -178.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -82.8 -14.52 54.26 Favored 'General case' 0 C--O 1.212 -0.915 0 CA-C-N 115.774 -0.648 . . . . 73.53 111.649 178.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.11 -35.62 81.7 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.777 0.799 . . . . 72.52 109.661 173.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.436 HG21 ' HE1' ' A' ' 101' ' ' PHE . 34.4 t -73.05 -58.7 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 CA-C-N 113.748 -1.569 . . . . 74.52 110.264 170.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.559 HD13 HD12 ' A' ' 22' ' ' ILE . 51.8 mt -90.11 15.09 10.83 Favored 'General case' 0 CA--C 1.558 1.256 0 CA-C-N 115.215 -0.902 . . . . 74.35 113.109 -166.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 44.2 t -67.01 -68.07 0.4 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.283 0.633 . . . . 74.34 109.806 173.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -80.95 135.82 51.29 Favored Pre-proline 0 C--O 1.238 0.456 0 CA-C-N 114.799 -1.091 . . . . 74.34 108.792 176.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.453 ' O ' ' HG2' ' A' ' 64' ' ' ARG . 51.3 Cg_exo -56.43 -28.32 72.54 Favored 'Trans proline' 0 C--N 1.369 1.627 0 C-N-CA 123.016 2.477 . . . . 72.41 112.082 170.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -71.29 -48.31 51.52 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.438 0.695 . . . . 72.3 111.285 -178.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.502 ' HA ' HD11 ' A' ' 65' ' ' ILE . 37.6 mtpt -70.87 -27.25 63.68 Favored 'General case' 0 C--O 1.257 1.493 0 CA-C-O 121.36 0.6 . . . . 74.54 110.934 178.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.406 HH21 ' CD1' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -65.58 -41.76 92.5 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 115.382 -0.827 . . . . 74.11 109.436 171.159 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.453 ' HG2' ' O ' ' A' ' 60' ' ' PRO . 4.5 mmp_? -59.22 -41.68 89.22 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.572 0.749 . . . . 74.25 110.734 176.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.586 ' HA ' ' HG2' ' A' ' 76' ' ' PRO . 91.0 mt -53.34 -51.12 43.78 Favored 'Isoleucine or valine' 0 C--O 1.251 1.15 0 C-N-CA 124.037 0.935 . . . . 74.41 110.57 175.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.505 ' HE2' ' HE1' ' A' ' 8' ' ' TYR . 37.9 t80 -58.2 -52.16 66.73 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 115.826 -0.624 . . . . 75.4 111.653 173.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -56.91 -33.74 67.23 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.144 0.978 . . . . 64.04 112.041 -173.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 40.5 p -91.42 -14.91 29.76 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.133 0.573 . . . . 75.44 112.214 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -72.1 125.41 27.19 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 107.513 -1.291 . . . . 75.32 107.513 166.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.84 23.91 29.11 Favored Glycine 0 N--CA 1.47 0.918 0 N-CA-C 111.281 -0.728 . . . . 64.23 111.281 -171.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 60.0 m -144.88 -57.67 0.35 Allowed 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 103.321 -2.844 . . . . 71.23 103.321 175.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 34.2 m -78.91 134.48 36.88 Favored 'General case' 0 C--O 1.25 1.099 0 N-CA-C 104.348 -2.464 . . . . 74.23 104.348 155.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.27 -31.78 67.9 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.396 0.678 . . . . 74.04 110.733 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -92.17 161.33 33.35 Favored Pre-proline 0 C--O 1.244 0.769 0 C-N-CA 124.177 0.991 . . . . 75.1 110.561 177.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -63.85 138.65 64.35 Favored 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 121.822 1.681 . . . . 75.41 110.172 164.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.586 ' HG2' ' HA ' ' A' ' 65' ' ' ILE . 82.6 Cg_exo -52.99 156.98 8.81 Favored 'Trans proline' 0 N--CA 1.501 1.917 0 C-N-CA 124.062 3.175 . . . . 74.25 114.77 178.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -58.27 124.87 16.86 Favored 'Trans proline' 0 C--N 1.385 2.483 0 C-N-CA 123.065 2.51 . . . . 73.45 112.382 -178.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.427 ' HA ' ' HH ' ' A' ' 83' ' ' TYR . 16.1 Cg_exo -70.1 130.67 19.3 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 123.086 2.524 . . . . 73.2 112.245 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -60.91 142.64 98.2 Favored 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 122.827 2.351 . . . . 71.05 111.436 171.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.78 84.47 0.31 Allowed 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 122.83 2.353 . . . . 74.31 111.937 -177.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 165.85 -38.19 0.27 Allowed Glycine 0 C--N 1.333 0.383 0 CA-C-N 114.18 -1.373 . . . . 62.41 109.722 -177.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 113.29 -165.21 12.02 Favored Glycine 0 C--N 1.35 1.346 0 CA-C-N 115.212 -0.494 . . . . 53.03 112.921 176.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.427 ' HH ' ' HA ' ' A' ' 78' ' ' PRO . 25.4 m-85 -109.58 108.43 18.87 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.125 0.97 . . . . 74.41 109.882 -179.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -66.54 156.09 35.89 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.965 0.906 . . . . 71.31 111.369 173.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.554 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 59.9 m-85 -144.8 77.66 1.54 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.015 0.926 . . . . 73.24 110.491 -175.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.493 ' HB3' ' HG2' ' A' ' 162' ' ' PRO . 7.0 m -48.43 85.61 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.356 0 C-N-CA 125.596 1.558 . . . . 74.44 113.597 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.03 10.95 81.47 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-N 116.013 -0.539 . . . . 70.11 113.628 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.554 ' HB2' ' HB3' ' A' ' 85' ' ' PHE . 25.2 m-85 -104.25 103.57 13.35 Favored 'General case' 0 C--N 1.351 0.652 0 C-N-CA 123.211 0.604 . . . . 72.34 109.492 -175.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -82.55 83.29 7.63 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 121.469 0.652 . . . . 71.44 110.034 -174.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.3 p -44.56 -33.27 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 C-N-CA 126.058 1.743 . . . . 75.21 114.36 176.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -55.99 -30.91 62.51 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.369 1.068 . . . . 75.33 111.647 -177.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -100.04 -6.65 26.09 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 123.787 0.835 . . . . 61.35 111.334 -175.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 12.8 m-30 -86.41 176.83 7.67 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 123.632 0.773 . . . . 73.34 110.929 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 91.9 p -67.56 161.39 25.7 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 113.161 0.8 . . . . 74.5 113.161 -169.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.85 -39.09 90.64 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 114.788 -1.096 . . . . 74.52 111.437 174.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -61.64 -40.39 94.71 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 122.655 0.382 . . . . 75.03 110.343 177.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.411 ' CD1' ' HG3' ' A' ' 52' ' ' GLU . 61.0 t80 -62.0 -41.46 98.08 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-O 121.493 0.663 . . . . 72.32 109.624 176.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -80.54 -1.22 41.01 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 114.693 -1.139 . . . . 74.14 112.531 177.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -100.15 -44.35 6.01 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 123.682 0.793 . . . . 70.02 111.872 170.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 24.7 tp -64.58 -47.68 77.81 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.454 1.101 . . . . 74.33 109.803 178.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.436 ' HE1' HG21 ' A' ' 56' ' ' VAL . 98.5 m-85 -92.65 -7.04 48.03 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.375 -0.83 . . . . 72.11 111.272 177.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -45.7 -58.89 5.16 Favored Glycine 0 CA--C 1.538 1.492 0 C-N-CA 124.458 1.028 . . . . 72.43 115.668 -177.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -61.9 -8.7 12.22 Favored 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 123.042 2.495 . . . . 64.43 114.046 -176.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -139.85 32.77 2.18 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-O 119.658 -0.523 . . . . 54.4 112.74 175.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.1 mt -68.34 22.47 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 115.007 1.484 . . . . 74.25 115.007 -177.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.516 ' HB3' ' ND2' ' A' ' 169' ' ' ASN . 0.2 OUTLIER 55.83 -107.34 0.38 Allowed 'General case' 0 CA--C 1.566 1.56 0 C-N-CA 124.06 0.944 . . . . 74.45 110.779 164.583 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 67.26 16.68 67.29 Favored Glycine 0 C--N 1.361 1.925 0 CA-C-O 120.043 -0.309 . . . . 44.0 113.479 -179.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.411 ' H ' ' HD1' ' A' ' 106' ' ' PHE . . . . . . . . 0 C--N 1.352 1.438 0 N-CA-C 111.414 -0.674 . . . . 71.34 111.414 -171.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 170' ' ' PRO . 34.8 ttmt . . . . . 0 N--CA 1.477 0.905 0 N-CA-C 113.142 0.793 . . . . 73.31 113.142 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -97.77 -170.98 32.82 Favored Glycine 0 CA--C 1.544 1.867 0 CA-C-N 115.316 -0.856 . . . . 73.4 113.716 176.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -110.21 140.28 44.5 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.327 1.051 . . . . 74.43 111.049 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -44.09 104.11 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 125.393 1.477 . . . . 74.23 112.953 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.43 ' O ' HD13 ' A' ' 174' ' ' LEU . 5.3 tt -100.39 144.53 29.28 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.209 -0.905 . . . . 75.42 108.788 -171.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.537 ' HD2' ' HB2' ' A' ' 175' ' ' LEU . 16.4 tpt180 -96.67 142.64 28.47 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 108.58 -0.896 . . . . 74.51 108.58 -178.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.56 ' HB1' HD11 ' A' ' 174' ' ' LEU . . . -139.62 166.98 23.15 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 118.737 0.698 . . . . 54.41 111.279 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.405 ' HB2' ' HB2' ' B' ' 9' ' ' ALA . 8.1 mm-40 -120.45 101.31 7.69 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 106.193 -1.78 . . . . 72.42 106.193 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.507 HD23 HD12 ' A' ' 176' ' ' LEU . 15.3 tp -99.1 101.87 13.85 Favored Pre-proline 0 C--O 1.215 -0.732 0 N-CA-C 107.918 -1.142 . . . . 74.14 107.918 -177.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.457 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 41.8 Cg_endo -64.63 150.3 88.42 Favored 'Trans proline' 0 C--N 1.368 1.592 0 N-CA-C 108.972 -1.203 . . . . 75.33 108.972 171.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.618 ' HA ' HG23 ' B' ' 6' ' ' ILE . 16.7 tp -152.12 145.99 25.16 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 119.294 0.952 . . . . 72.43 112.152 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 49.2 m -77.47 126.76 31.42 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 114.669 -1.151 . . . . 71.34 109.307 175.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.659 ' HB3' HD23 ' A' ' 215' ' ' LEU . 3.1 mm? -43.86 -55.88 4.24 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 125.955 1.702 . . . . 75.21 112.973 -176.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 -59.52 -45.47 91.64 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 114.42 -1.264 . . . . 75.32 109.917 -176.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -77.19 -11.81 59.87 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.376 -0.829 . . . . 64.33 111.976 -177.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.532 ' HB1' ' O ' ' A' ' 153' ' ' VAL . . . -79.24 -41.81 27.39 Favored 'General case' 0 C--O 1.251 1.181 0 CA-C-O 122.0 0.905 . . . . 65.44 109.433 175.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -67.99 -40.04 83.14 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 114.204 -1.362 . . . . 74.51 110.813 172.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 38.9 m170 -77.86 -43.74 29.34 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.386 0.674 . . . . 75.25 111.92 -173.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.472 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 74.7 -163.61 54.38 Favored Glycine 0 CA--C 1.533 1.209 0 N-CA-C 114.386 0.514 . . . . 71.54 114.386 178.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 102.42 -168.01 18.31 Favored Glycine 0 N--CA 1.477 1.42 0 C-N-CA 123.612 0.625 . . . . 70.42 112.743 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 11.1 mp0 -68.56 102.82 1.54 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.368 0.667 . . . . 73.14 109.442 176.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 4.2 tpp180 -94.05 122.71 36.84 Favored 'General case' 0 C--O 1.245 0.819 0 C-N-CA 123.413 0.685 . . . . 75.05 109.616 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 59.4 t -78.35 109.45 13.0 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 N-CA-C 108.99 -0.744 . . . . 75.04 108.99 176.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.463 HG12 HG13 ' A' ' 145' ' ' VAL . 3.0 p -133.19 122.43 45.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 124.3 1.04 . . . . 73.34 108.673 178.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -107.56 136.93 46.5 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.262 0.625 . . . . 71.3 109.403 -175.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.573 ' HB ' ' HB3' ' B' ' 8' ' ' LEU . 7.6 p -152.29 132.34 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.445 0.698 . . . . 75.1 109.995 178.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 62.31 22.95 13.55 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.389 1.076 . . . . 74.24 112.091 176.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 87.42 10.78 70.16 Favored Glycine 0 C--N 1.346 1.115 0 CA-C-O 119.872 -0.404 . . . . 54.15 113.181 -178.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.13 99.17 6.44 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 108.359 -0.978 . . . . 72.43 108.359 -176.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 19.2 ttt180 -71.55 92.58 1.14 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.51 1.124 . . . . 74.41 109.969 176.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.463 HG13 HG12 ' A' ' 138' ' ' VAL . 7.7 p -92.94 133.74 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-O 121.065 0.459 . . . . 73.53 110.406 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 32.8 t -98.52 85.45 3.37 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 108.57 -0.9 . . . . 64.43 108.57 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 96.3 t -81.62 113.08 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 109.166 -0.679 . . . . 73.42 109.166 -176.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 60.5 ttt85 -68.41 93.7 0.5 Allowed 'General case' 0 C--O 1.241 0.655 0 N-CA-C 108.894 -0.78 . . . . 74.32 108.894 172.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.472 HG13 ' HA2' ' A' ' 133' ' ' GLY . 47.5 pt -78.68 135.72 59.81 Favored Pre-proline 0 CA--C 1.551 0.99 0 CA-C-N 115.035 -0.984 . . . . 74.52 108.933 178.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -58.92 128.7 28.88 Favored 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 122.445 2.097 . . . . 74.22 111.539 174.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.84 92.48 0.05 OUTLIER 'Trans proline' 0 C--N 1.382 2.294 0 C-N-CA 122.655 2.236 . . . . 74.15 110.979 170.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 125.92 66.84 0.17 Allowed Glycine 0 C--N 1.336 0.529 0 C-N-CA 121.127 -0.559 . . . . 75.51 111.851 -167.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.532 ' O ' ' HB1' ' A' ' 130' ' ' ALA . 7.5 p -140.78 139.88 33.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 N-CA-C 107.351 -1.352 . . . . 75.43 107.351 171.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.603 ' HG3' ' HE2' ' A' ' 240' ' ' PHE . 52.0 mtt85 -153.02 173.59 15.23 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.072 0.949 . . . . 73.23 109.194 174.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.539 ' HB3' ' H ' ' A' ' 188' ' ' LEU . 16.7 tp10 -35.38 122.31 0.61 Allowed 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 126.505 1.922 . . . . 72.32 114.975 -168.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 93.15 -13.38 67.78 Favored Glycine 0 C--N 1.342 0.871 0 CA-C-O 119.655 -0.525 . . . . 74.33 114.174 176.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' SER . . . . . 0.43 ' O ' HG11 ' A' ' 178' ' ' VAL . 17.9 t -71.39 139.29 49.72 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 109.274 -0.639 . . . . 74.23 109.274 175.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 71.2 t -105.55 119.53 54.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 123.565 0.746 . . . . 74.02 109.131 -178.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.531 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 60.4 mt -98.49 115.19 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 N-CA-C 108.394 -0.965 . . . . 75.24 108.394 174.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -78.3 106.0 9.93 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 109.068 -0.716 . . . . 75.21 109.068 173.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 13.3 p -113.6 113.01 48.09 Favored Pre-proline 0 CA--C 1.556 1.205 0 N-CA-C 109.417 -0.586 . . . . 71.41 109.417 173.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.493 ' HG2' ' HB3' ' A' ' 86' ' ' SER . 43.2 Cg_endo -68.88 139.73 44.15 Favored 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 122.672 2.248 . . . . 74.53 113.042 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . 0.431 ' N ' ' HB3' ' A' ' 171' ' ' PRO . . . 109.67 -26.68 13.75 Favored Glycine 0 N--CA 1.476 1.335 0 C-N-CA 123.442 0.544 . . . . 70.43 113.689 167.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.472 ' N ' ' SD ' ' A' ' 164' ' ' MET . 1.3 mpt? -95.67 -31.06 13.43 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.232 0.613 . . . . 64.15 109.9 -177.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.492 ' N ' ' HB2' ' A' ' 174' ' ' LEU . . . -94.32 153.39 21.03 Favored Glycine 0 CA--C 1.492 -1.4 0 N-CA-C 108.742 -1.743 . . . . 73.33 108.742 168.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.807 ' HA3' ' HA3' ' A' ' 172' ' ' GLY . . . 53.44 80.54 0.07 OUTLIER Glycine 0 CA--C 1.475 -2.407 0 CA-C-O 118.872 -0.96 . . . . 74.5 112.968 -162.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.525 ' HA ' HE21 ' A' ' 167' ' ' GLN . 0.0 OUTLIER -56.52 105.11 0.18 Allowed 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 128.149 2.911 . . . . 75.42 109.059 -178.574 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -176.89 -140.61 3.66 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.096 -1.602 . . . . 64.21 109.096 -172.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . 0.516 ' ND2' ' HB3' ' A' ' 106' ' ' PHE . 0.7 OUTLIER -133.04 -54.28 0.02 OUTLIER Pre-proline 0 N--CA 1.484 1.232 0 CA-C-N 117.613 0.707 . . . . 63.54 109.608 176.421 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.437 ' O ' ' HA ' ' A' ' 115' ' ' LYS . 19.1 Cg_exo -67.74 123.44 10.73 Favored 'Trans proline' 0 C--N 1.388 2.625 0 N-CA-C 106.44 -2.177 . . . . 73.02 106.44 159.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.431 ' HB3' ' N ' ' A' ' 163' ' ' GLY . 41.1 Cg_endo -63.43 141.24 80.19 Favored 'Trans proline' 0 N--CA 1.483 0.874 0 C-N-CA 122.508 2.139 . . . . 71.25 114.858 -164.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.807 ' HA3' ' HA3' ' A' ' 166' ' ' GLY . . . -79.52 -26.41 56.92 Favored Glycine 0 C--N 1.348 1.217 0 C-N-CA 119.553 -1.308 . . . . 72.4 111.924 159.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 89.24 137.37 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 127.385 2.274 . . . . 71.14 110.116 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.56 HD11 ' HB1' ' A' ' 121' ' ' ALA . 24.5 tp -111.21 136.89 49.62 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.26 0.624 . . . . 74.2 110.16 -174.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.537 ' HB2' ' HD2' ' A' ' 120' ' ' ARG . 59.2 mt -105.75 84.79 2.12 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.239 1.015 . . . . 72.12 109.102 -178.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.531 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 95.4 mt -69.03 100.38 1.22 Allowed 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 115.204 -0.907 . . . . 74.52 110.812 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 57.7 t -84.52 102.5 10.56 Favored 'Isoleucine or valine' 0 C--O 1.242 0.69 0 N-CA-C 107.726 -1.213 . . . . 71.11 107.726 173.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 9.1 p -69.37 122.53 21.03 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.211 0 CA-C-N 115.48 -0.782 . . . . 74.13 111.254 -173.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.457 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 23.6 mmt180 -112.44 93.58 4.51 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.449 1.5 . . . . 73.42 108.217 -178.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.559 HD13 HD13 ' A' ' 127' ' ' LEU . 22.4 mt -70.19 149.39 47.56 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.428 0.529 . . . . 74.04 112.428 -175.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 77.9 mt -59.44 159.68 15.95 Favored Pre-proline 0 CA--C 1.554 1.127 0 C-N-CA 124.49 1.116 . . . . 73.22 111.71 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -70.8 32.98 0.23 Allowed 'Trans proline' 0 C--N 1.384 2.439 0 C-N-CA 123.365 2.71 . . . . 74.32 114.7 175.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . 0.494 ' HB3' ' HG ' ' A' ' 127' ' ' LEU . 56.2 t-80 -67.39 106.53 1.26 Allowed Pre-proline 0 CA--C 1.553 1.091 0 C-N-CA 125.165 1.386 . . . . 73.35 107.533 165.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -75.39 24.51 0.4 Allowed 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 123.877 3.051 . . . . 61.24 115.683 -163.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 97.5 t -97.94 -61.76 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 122.595 0.358 . . . . 72.34 111.165 -173.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 14.6 m-30 -124.31 140.52 52.88 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 121.604 0.716 . . . . 72.31 111.937 -171.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -139.02 141.8 38.29 Favored 'General case' 0 C--O 1.215 -0.734 0 C-N-CA 125.883 1.673 . . . . 75.51 106.557 171.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.618 HD11 ' HA ' ' A' ' 193' ' ' LEU . 5.4 tp -106.36 176.3 5.21 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 107.211 -1.404 . . . . 74.21 107.211 178.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -163.16 128.08 3.05 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 109.019 -0.734 . . . . 70.31 109.019 168.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 69.0 -74.19 0.36 Allowed Glycine 0 C--N 1.349 1.256 0 N-CA-C 111.005 -0.838 . . . . 65.41 111.005 -169.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -163.81 -2.42 0.03 OUTLIER 'General case' 0 CA--C 1.564 1.495 0 C-N-CA 124.115 0.966 . . . . 72.32 110.996 173.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -98.62 150.88 21.29 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 122.818 0.447 . . . . 72.32 110.599 -178.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.618 ' HA ' HD11 ' A' ' 188' ' ' LEU . 0.4 OUTLIER -88.81 155.93 19.26 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.347 1.059 . . . . 74.25 110.796 -167.112 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -142.57 151.31 41.43 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.642 1.577 . . . . 73.14 108.134 173.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -152.72 136.68 16.33 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.168 0.987 . . . . 74.34 108.662 177.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 32.2 m -77.79 133.69 38.18 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 118.008 0.367 . . . . 70.21 110.026 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 32.3 tp -134.01 97.59 3.92 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.047 0.539 . . . . 74.1 110.262 -176.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -85.71 121.42 28.35 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 108.723 -0.843 . . . . 63.3 108.723 170.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 7.7 p -138.25 137.37 20.66 Favored Pre-proline 0 N--CA 1.482 1.164 0 C-N-CA 123.754 0.822 . . . . 74.33 109.179 -171.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -72.32 153.97 56.19 Favored 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 121.607 1.538 . . . . 70.05 111.386 177.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -50.98 -50.91 72.08 Favored Pre-proline 0 CA--C 1.553 1.076 0 N-CA-C 114.696 1.369 . . . . 71.34 114.696 -171.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.569 ' HG2' ' HE1' ' C' ' 276' ' ' TYR . 47.6 Cg_exo -61.2 -37.78 71.53 Favored 'Trans proline' 0 C--N 1.386 2.552 0 C-N-CA 121.851 1.7 . . . . 73.32 113.969 -179.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.525 HG22 ' HA3' ' A' ' 208' ' ' GLY . 34.9 mt -67.2 -37.64 79.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 N-CA-C 109.754 -0.462 . . . . 71.02 109.754 176.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.06 -42.83 88.94 Favored 'General case' 0 CA--C 1.554 1.127 0 CA-C-N 115.571 -0.741 . . . . 74.14 111.688 177.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 54.3 t -70.21 -48.49 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 124.081 0.952 . . . . 64.22 111.435 -176.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 57.7 t -85.14 -39.24 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-N 115.137 -0.938 . . . . 74.41 111.781 -170.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 97.67 90.08 1.9 Allowed Glycine 0 C--O 1.242 0.638 0 N-CA-C 110.873 -0.891 . . . . 72.35 110.873 -171.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.525 ' HA3' HG22 ' A' ' 203' ' ' ILE . . . -115.49 -151.48 9.91 Favored Glycine 0 C--N 1.339 0.735 0 CA-C-N 115.468 -0.366 . . . . 73.32 113.54 -175.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 27.1 mtmt -137.55 132.41 33.12 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.311 -0.625 . . . . 73.34 109.311 -176.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 30.9 m -134.39 149.84 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 108.512 -0.922 . . . . 63.11 108.512 173.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -87.12 113.3 22.75 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 109.019 -0.734 . . . . 74.32 109.019 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.55 165.57 11.17 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.02 0.928 . . . . 74.41 110.052 -176.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' MET . . . . . 0.464 ' N ' ' SD ' ' A' ' 213' ' ' MET . 0.0 OUTLIER -98.21 151.9 19.95 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 115.658 -0.701 . . . . 74.15 109.455 -175.712 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 63.8 p -133.13 -173.82 3.31 Favored 'General case' 0 C--O 1.242 0.697 0 C-N-CA 124.814 1.246 . . . . 74.1 107.721 167.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . 0.659 HD23 ' HB3' ' A' ' 127' ' ' LEU . 28.4 mt -81.12 -26.6 36.04 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.133 0.573 . . . . 73.14 109.901 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -87.64 -17.44 31.86 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 114.977 -1.01 . . . . 64.44 111.723 -176.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 149.34 -156.83 26.98 Favored Glycine 0 C--N 1.344 1.016 0 CA-C-O 119.35 -0.694 . . . . 63.05 111.687 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -87.61 139.92 5.03 Favored 'Trans proline' 0 C--N 1.365 1.395 0 C-N-CA 122.641 2.227 . . . . 74.13 112.055 173.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 35.1 m -132.14 169.66 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.791 1.236 . . . . 73.4 107.796 171.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -111.92 134.46 53.46 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 121.726 -0.609 . . . . 75.04 111.372 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 7.5 p -119.51 140.22 44.23 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 124.745 1.218 . . . . 74.51 109.352 -176.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -103.62 103.2 13.11 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.971 0.508 . . . . 70.4 110.05 -178.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 70.5 t -58.8 140.78 85.83 Favored Pre-proline 0 CA--C 1.567 1.614 0 C-N-CA 125.432 1.493 . . . . 71.22 110.7 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -84.72 170.47 10.12 Favored 'Trans proline' 0 C--N 1.387 2.604 0 C-N-CA 123.25 2.634 . . . . 75.51 111.549 177.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.16 148.08 30.51 Favored 'Trans proline' 0 C--N 1.368 1.558 0 C-N-CA 121.748 1.632 . . . . 72.53 113.155 174.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 63.3 mtt85 63.62 32.34 14.0 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 125.329 1.451 . . . . 75.13 111.978 175.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.455 HG22 HD21 ' A' ' 233' ' ' LEU . 90.8 m -62.31 106.68 0.78 Allowed 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 113.689 -1.596 . . . . 64.32 110.498 172.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -95.53 151.37 19.37 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.389 0.675 . . . . 75.32 110.888 -170.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -62.27 117.84 6.63 Favored 'General case' 0 C--N 1.351 0.669 0 C-N-CA 123.981 0.912 . . . . 65.12 110.774 177.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 105.51 -23.64 29.46 Favored Glycine 0 C--N 1.34 0.805 0 CA-C-N 115.903 -0.589 . . . . 75.54 112.885 178.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 231' ' ' ARG . 46.5 mtt180 -72.79 136.25 45.4 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-O 121.552 0.691 . . . . 74.44 110.944 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.699 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 39.3 mttm -101.14 112.0 24.36 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 114.09 -1.413 . . . . 72.22 109.299 -179.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.539 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 45.9 mt -75.86 100.94 4.95 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.068 0.947 . . . . 71.4 110.175 -172.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 57.1 ttt180 -73.26 125.22 27.28 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.529 1.132 . . . . 73.41 110.895 -172.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.499 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 76.7 mt -118.74 107.25 13.43 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.19 0.996 . . . . 74.24 109.614 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.62 ' HZ1' ' HB3' ' A' ' 236' ' ' LYS . 3.5 mmmp? -60.93 126.06 25.99 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 113.127 0.788 . . . . 71.01 113.127 -172.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 73.6 33.64 57.96 Favored Glycine 0 C--N 1.354 1.543 0 O-C-N 123.852 0.72 . . . . 74.2 114.05 173.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -114.58 -18.31 11.47 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.242 0.617 . . . . 74.1 111.387 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -81.9 -170.14 44.03 Favored Glycine 0 C--N 1.346 1.128 0 N-CA-C 112.004 -0.438 . . . . 74.43 112.004 170.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . 0.603 ' HE2' ' HG3' ' A' ' 154' ' ' ARG . 9.9 m-85 -94.69 154.92 39.9 Favored Pre-proline 0 N--CA 1.478 0.965 0 C-N-CA 122.844 0.457 . . . . 73.41 112.149 -170.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -66.65 123.06 10.58 Favored 'Trans proline' 0 C--N 1.387 2.595 0 C-N-CA 123.216 2.611 . . . . 73.33 112.831 -178.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -151.42 -150.03 5.22 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-O 119.368 -0.685 . . . . 73.52 112.426 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -65.06 -29.84 56.56 Favored 'Trans proline' 0 C--N 1.378 2.108 0 C-N-CA 123.249 2.633 . . . . 72.5 113.179 -175.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -87.59 20.77 2.79 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.8 0.84 . . . . 70.11 111.57 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 85.55 -89.76 1.63 Allowed Glycine 0 C--N 1.35 1.332 0 N-CA-C 109.736 -1.346 . . . . 62.24 109.736 -173.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 59.1 mtm180 -127.12 157.56 39.36 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.045 0.938 . . . . 75.41 109.109 165.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -81.38 179.78 53.35 Favored Glycine 0 C--O 1.241 0.561 0 CA-C-N 115.736 -0.665 . . . . 70.31 112.179 178.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -125.27 154.26 41.96 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.725 0.81 . . . . 75.44 109.085 -179.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.525 HD12 HD11 ' A' ' 193' ' ' LEU . 40.1 tp -96.64 112.22 24.05 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 109.466 -0.568 . . . . 73.32 109.466 -179.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.699 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 22.0 m-85 -97.79 105.84 18.05 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.577 1.151 . . . . 71.3 109.307 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.539 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 16.4 mt -79.6 98.8 7.04 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 109.67 -0.493 . . . . 74.54 109.67 175.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -77.34 103.52 7.32 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 108.465 -0.939 . . . . 75.41 108.465 -175.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.454 HG11 HG23 ' A' ' 227' ' ' THR . 56.6 t -87.73 144.07 9.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 N-CA-C 114.259 1.207 . . . . 71.34 114.259 -166.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 6.7 mmm180 -128.32 113.61 15.83 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.475 1.51 . . . . 73.14 107.619 165.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 62.1 mt -75.96 138.88 19.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 122.986 0.515 . . . . 74.34 109.747 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 46.7 p -124.11 175.82 6.76 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 124.709 1.204 . . . . 74.52 109.304 177.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . 0.481 ' HB ' ' HD2' ' A' ' 258' ' ' PRO . 28.6 pt -121.82 164.72 23.41 Favored Pre-proline 0 CA--C 1.556 1.189 0 C-N-CA 123.762 0.825 . . . . 73.4 109.286 175.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' PRO . . . . . 0.638 ' HB3' ' HH ' ' C' ' 276' ' ' TYR . 60.8 Cg_endo -69.65 6.53 1.24 Allowed 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 122.687 2.258 . . . . 74.45 114.851 177.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . 0.474 ' HG3' ' NE2' ' C' ' 228' ' ' GLN . 0.8 OUTLIER 49.35 -96.79 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.615 0.766 . . . . 75.12 109.494 -161.012 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.93 158.56 19.88 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.086 0.954 . . . . 75.12 110.778 -173.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.425 HD11 ' HA ' ' A' ' 266' ' ' GLU . 67.9 mt -135.64 -178.04 4.94 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.732 0.813 . . . . 72.32 110.719 -175.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 5.2 p -133.52 146.44 60.6 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 124.697 1.199 . . . . 74.31 109.033 176.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -17.69 -60.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.393 2.918 1 C-N-CA 127.402 5.401 . . . . 74.33 118.037 -168.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -65.03 -59.36 4.23 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.036 0.534 . . . . 71.44 111.197 -175.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -62.91 -29.69 70.97 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.712 0.805 . . . . 73.22 110.659 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' GLU . . . . . 0.436 ' O ' ' HD3' ' A' ' 270' ' ' LYS . 8.6 tp10 -57.71 -54.74 43.48 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 124.236 1.015 . . . . 73.45 109.433 175.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -64.34 -33.41 75.77 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 114.681 -1.145 . . . . 64.12 111.691 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 8.8 mp -61.42 -52.22 65.46 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.0 0.52 . . . . 73.14 111.429 177.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 61.2 m95 -61.7 -38.82 89.27 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.344 0.658 . . . . 75.0 111.805 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . 0.452 ' HE2' HG21 ' C' ' 206' ' ' VAL . 1.0 OUTLIER -67.55 -40.22 84.99 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.758 -0.655 . . . . 73.12 111.368 179.278 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -64.3 -41.93 96.61 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.071 0.548 . . . . 70.22 110.521 175.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' LEU . . . . . 0.481 ' O ' ' HB2' ' A' ' 276' ' ' TYR . 51.8 mt -55.5 -45.96 77.02 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 124.012 0.82 . . . . 71.54 110.574 175.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -77.13 -32.92 56.76 Favored 'General case' 0 C--O 1.246 0.874 0 O-C-N 124.389 1.055 . . . . 72.23 113.005 -173.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -72.47 -48.09 43.61 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.318 0.647 . . . . 74.35 110.061 177.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . 0.444 ' HB1' ' NH2' ' A' ' 279' ' ' ARG . . . -71.97 -20.77 61.68 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.51 0.724 . . . . 72.24 111.225 177.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . 0.481 ' HB2' ' O ' ' A' ' 272' ' ' LEU . 21.7 t80 -63.14 -64.96 0.76 Allowed 'General case' 0 C--N 1.356 0.884 0 C-N-CA 123.803 0.841 . . . . 75.02 108.847 171.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -63.32 -40.6 97.76 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.316 -0.856 . . . . 72.14 110.432 -172.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -59.35 -30.72 68.59 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.659 0.784 . . . . 75.41 111.834 176.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . 0.444 ' NH2' ' HB1' ' A' ' 275' ' ' ALA . 23.6 mtm180 -118.22 34.74 5.04 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.347 0.659 . . . . 75.15 109.855 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.386 0 N-CA-C 109.235 -0.654 . . . . 72.5 109.235 174.439 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.464 ' SD ' ' N ' ' B' ' 1' ' ' MET . 1.4 mpt? . . . . . 0 N--CA 1.478 0.974 0 N-CA-C 109.283 -0.636 . . . . 74.12 109.283 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 59.5 tttp 71.34 115.57 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.772 1.229 . . . . 62.45 112.052 -176.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 66.4 48.34 1.58 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.575 1.55 . . . . 74.04 111.533 170.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 25.5 m -67.5 -22.74 65.44 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 114.816 -1.084 . . . . 52.14 110.574 172.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 2.5 m 71.29 150.37 0.09 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.793 1.637 . . . . 74.34 111.469 176.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.618 HG23 ' HA ' ' A' ' 125' ' ' LEU . 36.5 pt -136.97 167.67 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 113.146 0.795 . . . . 65.34 113.146 -162.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -145.57 124.33 12.61 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.274 1.03 . . . . 72.22 109.647 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . 0.573 ' HB3' ' HB ' ' A' ' 140' ' ' VAL . 44.2 tp -74.26 150.47 40.23 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.168 0.987 . . . . 75.22 111.264 -172.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . 0.405 ' HB2' ' HB2' ' A' ' 122' ' ' GLU . . . -90.74 -50.32 5.97 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.192 0.597 . . . . 73.12 112.117 -178.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 84.8 mt 66.65 115.61 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 124.677 1.191 . . . . 74.1 111.678 -170.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 56.2 mt . . . . . 0 CA--C 1.553 1.062 0 N-CA-C 108.007 -1.108 . . . . 72.11 108.007 171.888 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.972 0 CA-C-O 121.242 0.544 . . . . 74.35 110.111 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 180' ' ' ALA . . . . . 0.464 ' HB3' ' HB ' ' C' ' 137' ' ' VAL . . . 70.94 -34.77 0.31 Allowed 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 126.438 1.895 . . . . 75.32 113.304 -173.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 181' ' ' LEU . . . . . 0.486 HD22 ' HB2' ' C' ' 136' ' ' ARG . 60.5 tp -161.29 -71.75 0.06 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.139 0.976 . . . . 74.44 108.928 170.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 182' ' ' VAL . . . . . . . . . . . . . 49.2 t -86.71 131.08 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 109.263 -0.643 . . . . 72.43 109.263 177.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -66.19 -56.83 9.39 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 123.908 0.755 . . . . 65.24 111.263 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -169.52 178.73 4.08 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-O 121.64 0.733 . . . . 75.32 111.173 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 185' ' ' VAL . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.469 0.487 0 N-CA-C 107.564 -1.273 . . . . 74.01 107.564 160.364 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 31.4 m . . . . . 0 N--CA 1.488 1.456 0 N-CA-C 110.07 -0.345 . . . . 71.31 110.07 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -172.47 -179.19 2.16 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.054 0.942 . . . . 74.42 109.815 173.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . -106.0 -125.38 5.49 Favored Glycine 0 C--N 1.346 1.123 0 N-CA-C 112.178 -0.369 . . . . 71.23 112.178 -178.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -104.69 -168.68 1.51 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.895 0.878 . . . . 71.23 110.844 -176.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 242' ' ' TRP . . . . . 0.554 ' HZ3' ' HD3' ' C' ' 231' ' ' ARG . 0.0 OUTLIER 92.43 -13.66 0.18 Allowed 'General case' 0 N--CA 1.508 2.452 0 C-N-CA 128.035 2.534 . . . . 70.32 111.867 176.968 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -124.89 119.34 28.52 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.434 0.635 . . . . 74.22 111.989 -164.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -69.54 -33.83 72.66 Favored Glycine 0 C--N 1.345 1.056 0 N-CA-C 110.16 -1.176 . . . . 71.54 110.16 162.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 8.2 ttpp . . . . . 0 CA--C 1.558 1.285 0 C-N-CA 124.597 1.159 . . . . 75.34 113.443 161.482 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.127 0 CA-C-O 119.464 -0.303 . . . . 71.34 111.814 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -37.38 94.95 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.489 1.516 . . . . 70.52 113.862 -175.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -66.49 104.36 1.24 Allowed 'General case' 0 C--O 1.239 0.514 0 N-CA-C 107.915 -1.142 . . . . 72.32 107.915 166.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -74.63 90.98 2.3 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 107.531 -1.285 . . . . 65.15 107.531 172.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 7' ' ' TYR . . . . . 0.436 ' CD1' ' HA ' ' C' ' 53' ' ' ALA . 72.4 m-85 -62.21 -26.01 68.12 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 114.387 -1.279 . . . . 73.43 111.99 -171.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -63.13 -47.86 80.96 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.54 0.736 . . . . 74.23 110.543 173.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.75 -39.58 93.87 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.06 0.544 . . . . 63.34 110.972 178.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 65.9 mt -59.26 -39.93 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 C-N-CA 123.374 0.669 . . . . 73.31 110.737 176.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 11' ' ' LEU . . . . . 0.417 ' O ' ' HB1' ' C' ' 25' ' ' ALA . 95.5 mt -90.14 -0.17 57.47 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 112.497 0.555 . . . . 75.53 112.497 177.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 59.59 37.92 92.93 Favored Glycine 0 C--N 1.352 1.459 0 N-CA-C 114.107 0.403 . . . . 74.43 114.107 178.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 7.2 m -126.03 139.41 34.28 Favored Pre-proline 0 N--CA 1.482 1.141 0 C-N-CA 124.775 1.23 . . . . 71.34 109.209 177.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -76.87 159.83 34.31 Favored 'Trans proline' 0 C--N 1.368 1.605 0 C-N-CA 122.192 1.928 . . . . 74.43 111.976 176.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 53.6 mtt180 -74.08 76.34 1.74 Allowed 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.329 -0.989 . . . . 74.35 108.329 171.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 176.39 -27.59 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.17 1.388 . . . . 71.24 108.487 -172.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.45 135.93 57.85 Favored 'General case' 0 C--N 1.351 0.664 0 CA-C-N 115.653 -0.703 . . . . 75.2 110.172 172.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 72.0 p -65.99 160.87 22.69 Favored 'General case' 0 C--O 1.246 0.899 0 O-C-N 123.668 0.605 . . . . 74.41 109.671 177.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 19' ' ' GLN . . . . . 0.553 ' HG2' ' HD3' ' C' ' 60' ' ' PRO . 24.8 tp60 -56.57 -33.67 66.38 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.233 0.613 . . . . 74.45 111.808 -176.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -75.0 -28.78 60.67 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 119.121 -0.466 . . . . 74.53 111.698 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . 0.511 ' HG2' HH21 ' C' ' 24' ' ' ARG . 46.3 mt-10 -69.36 -41.13 76.97 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 121.109 0.481 . . . . 73.42 110.161 174.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 22' ' ' ILE . . . . . 0.44 HG21 ' HB3' ' C' ' 57' ' ' LEU . 57.2 mt -66.44 -38.3 81.45 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 CA-C-N 114.735 -1.12 . . . . 75.54 110.12 176.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 23' ' ' LYS . . . . . 0.44 ' O ' ' HD3' ' C' ' 27' ' ' LYS . 4.5 ttpt -70.11 -40.49 74.86 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 114.69 -1.141 . . . . 74.13 109.617 179.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 24' ' ' ARG . . . . . 0.511 HH21 ' HG2' ' C' ' 21' ' ' GLU . 46.6 mtm105 -72.57 -22.39 61.0 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.276 0.63 . . . . 73.52 111.283 176.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . 0.417 ' HB1' ' O ' ' C' ' 11' ' ' LEU . . . -66.96 -45.2 78.46 Favored 'General case' 0 C--O 1.242 0.661 0 O-C-N 123.537 0.523 . . . . 75.32 109.603 171.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 26' ' ' TYR . . . . . 0.547 ' HD1' HG23 ' C' ' 50' ' ' ILE . 83.4 t80 -57.76 -52.95 63.35 Favored 'General case' 0 C--N 1.355 0.82 0 CA-C-N 115.5 -0.773 . . . . 72.31 110.698 171.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . 0.454 ' HE2' ' HA ' ' C' ' 24' ' ' ARG . 6.0 mppt? -60.69 -32.63 71.84 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.433 0.693 . . . . 75.33 111.62 -176.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -61.98 -48.81 78.7 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.974 0.91 . . . . 75.55 109.494 174.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . 0.524 HD11 HD13 ' C' ' 50' ' ' ILE . 76.6 mt -77.39 -13.4 59.94 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 114.781 -1.1 . . . . 71.43 111.664 178.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -86.93 -19.68 28.45 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.488 0.715 . . . . 75.32 110.02 176.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 60.4 mtm180 -91.92 -27.23 18.03 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.309 0.644 . . . . 73.5 110.364 169.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -72.84 -59.93 2.48 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.415 0.686 . . . . 71.12 109.218 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -90.25 22.31 3.39 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.92 0.888 . . . . 72.14 110.901 -178.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 34' ' ' HIS . . . . . 0.403 ' NE2' ' HB3' ' C' ' 36' ' ' ASP . 75.8 t60 -53.18 93.97 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.586 0 C-N-CA 125.565 1.546 . . . . 74.34 113.043 -166.007 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 35' ' ' PRO . . . . . 0.401 ' O ' ' HG2' ' C' ' 39' ' ' LYS . 53.3 Cg_endo -76.55 -6.05 16.64 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.901 2.401 . . . . 72.22 111.806 -168.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 36' ' ' ASP . . . . . 0.403 ' HB3' ' NE2' ' C' ' 34' ' ' HIS . 24.0 t70 -63.73 -35.91 82.15 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.442 1.097 . . . . 60.34 111.46 172.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 41.1 t -122.92 -46.9 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 CA-C-O 121.191 0.519 . . . . 75.33 109.753 -177.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -98.33 81.85 2.82 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.005 0.922 . . . . 65.41 109.678 -178.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 39' ' ' LYS . . . . . 0.559 ' HZ2' ' HB2' ' C' ' 39' ' ' LYS . 9.7 mtmp? -84.74 70.03 10.76 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 115.641 -0.709 . . . . 71.22 109.919 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 49.4 m -95.22 108.59 39.8 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-O 118.254 -0.879 . . . . 74.14 108.74 175.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -41.35 -53.01 3.33 Favored 'Trans proline' 0 C--N 1.386 2.542 0 C-N-CA 124.457 3.438 . . . . 75.0 115.157 -174.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -65.72 -31.6 72.69 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.302 0.641 . . . . 71.01 111.335 -178.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.46 -18.93 56.71 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.036 0.534 . . . . 71.45 110.546 176.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 44' ' ' GLU . . . . . 0.45 ' HA ' ' HB3' ' C' ' 47' ' ' PHE . 51.0 mt-10 -89.91 -19.39 24.61 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.797 0.839 . . . . 74.04 109.634 177.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -77.07 -39.82 48.42 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.069 0.947 . . . . 75.44 109.53 168.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 46' ' ' LYS . . . . . 0.526 ' O ' HG12 ' C' ' 50' ' ' ILE . 63.3 mttp -61.35 -48.04 83.11 Favored 'General case' 0 C--N 1.35 0.606 0 CA-C-N 115.094 -0.957 . . . . 72.32 108.847 169.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 47' ' ' PHE . . . . . 0.45 ' HB3' ' HA ' ' C' ' 44' ' ' GLU . 59.5 t80 -64.22 -27.97 69.42 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.179 0.991 . . . . 71.12 110.856 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 48' ' ' LYS . . . . . 0.498 ' HE2' ' HB3' ' C' ' 89' ' ' ASP . 2.9 tptm -62.82 -48.78 77.62 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 108.698 -0.853 . . . . 72.04 108.698 172.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -70.79 -19.68 62.67 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 112.557 0.577 . . . . 72.33 112.557 176.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 50' ' ' ILE . . . . . 0.547 HG23 ' HD1' ' C' ' 26' ' ' TYR . 23.6 mm -78.75 -34.43 17.39 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 N-CA-C 108.787 -0.82 . . . . 75.43 108.787 174.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 51' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -79.1 -18.23 53.66 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 124.069 0.947 . . . . 74.04 111.276 175.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 52' ' ' GLU . . . . . 0.417 ' O ' HG22 ' C' ' 56' ' ' VAL . 32.6 tt0 -76.18 -50.23 15.09 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.569 -0.9 . . . . 75.54 108.569 170.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . 0.436 ' HA ' ' CD1' ' C' ' 7' ' ' TYR . . . -60.57 -33.38 72.62 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 114.593 -1.185 . . . . 63.1 111.247 176.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 54' ' ' TYR . . . . . 0.435 ' O ' ' HB2' ' C' ' 58' ' ' SER . 20.8 t80 -81.92 -32.9 30.66 Favored 'General case' 0 C--O 1.214 -0.783 0 C-N-CA 123.788 0.835 . . . . 75.01 110.207 176.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.81 -34.37 67.63 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 120.915 0.388 . . . . 60.54 110.247 174.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 56' ' ' VAL . . . . . 0.417 HG22 ' O ' ' C' ' 52' ' ' GLU . 14.8 t -97.61 -24.62 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.26 0 CA-C-N 115.065 -0.97 . . . . 72.43 112.308 -178.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 57' ' ' LEU . . . . . 0.44 ' HB3' HG21 ' C' ' 22' ' ' ILE . 61.9 mt -125.46 29.77 5.94 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 119.242 0.928 . . . . 75.02 112.746 -177.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 58' ' ' SER . . . . . 0.435 ' HB2' ' O ' ' C' ' 54' ' ' TYR . 23.1 t -69.8 -56.44 7.13 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.238 0.542 . . . . 75.33 111.8 175.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -130.05 157.19 77.74 Favored Pre-proline 0 N--CA 1.479 0.981 0 C-N-CA 124.313 1.045 . . . . 72.03 109.303 -171.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 60' ' ' PRO . . . . . 0.553 ' HD3' ' HG2' ' C' ' 19' ' ' GLN . 18.2 Cg_endo -54.26 -21.05 21.42 Favored 'Trans proline' 0 C--N 1.391 2.797 0 C-N-CA 122.921 2.414 . . . . 73.21 112.992 -179.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -51.35 -75.62 0.03 OUTLIER 'General case' 0 CA--C 1.565 1.537 0 C-N-CA 124.554 1.142 . . . . 62.13 110.832 170.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.39 -28.68 67.32 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.592 0.757 . . . . 75.43 111.338 -176.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 10.1 ttp180 -66.14 -44.74 83.31 Favored 'General case' 0 C--N 1.351 0.644 0 N-CA-C 109.496 -0.557 . . . . 74.14 109.496 -177.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -71.0 -29.98 66.1 Favored 'General case' 0 C--N 1.359 1.003 0 O-C-N 123.876 0.735 . . . . 74.15 111.015 178.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 47.5 mm -57.19 -48.55 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 CA-C-O 121.196 0.522 . . . . 71.5 110.049 170.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -67.23 -40.72 86.39 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.773 -0.649 . . . . 74.31 111.012 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -59.42 -45.8 90.52 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 122.95 0.5 . . . . 73.14 110.565 178.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 74.2 p -73.14 -15.72 61.47 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.522 -0.763 . . . . 74.43 111.271 178.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -73.05 116.91 14.14 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 106.948 -1.501 . . . . 75.22 106.948 167.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 111.2 9.5 21.95 Favored Glycine 0 N--CA 1.472 1.073 0 N-CA-C 111.475 -0.65 . . . . 62.51 111.475 -165.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 88.3 m -141.57 -59.01 0.48 Allowed 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 103.755 -2.683 . . . . 72.34 103.755 176.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 34.4 m -73.96 134.16 43.09 Favored 'General case' 0 C--O 1.251 1.164 0 N-CA-C 103.88 -2.637 . . . . 73.35 103.88 155.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.03 -37.45 5.36 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.329 0.652 . . . . 73.23 110.8 -170.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -88.86 150.7 46.17 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 123.992 0.917 . . . . 53.23 109.098 174.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -52.37 117.66 3.85 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 122.838 2.359 . . . . 75.14 111.629 172.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.89 156.75 18.41 Favored 'Trans proline' 0 C--N 1.382 2.325 0 C-N-CA 123.494 2.796 . . . . 71.22 113.745 -176.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -66.53 121.38 8.62 Favored 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 122.209 1.939 . . . . 74.4 111.044 172.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 78' ' ' PRO . . . . . 0.408 ' HB3' ' HA3' ' C' ' 104' ' ' GLY . 32.0 Cg_endo -61.82 135.38 55.58 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 122.886 2.391 . . . . 74.44 113.414 -174.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.22 159.06 54.84 Favored 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 123.001 2.467 . . . . 70.12 112.455 176.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.49 85.9 0.04 OUTLIER 'Trans proline' 0 C--N 1.391 2.815 0 C-N-CA 123.553 2.835 . . . . 74.31 112.873 177.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 159.01 -45.33 0.45 Allowed Glycine 0 C--N 1.341 0.856 0 CA-C-N 114.967 -1.015 . . . . 75.2 111.358 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 111.55 175.23 20.02 Favored Glycine 0 C--N 1.351 1.37 0 C-N-CA 123.514 0.578 . . . . 75.13 112.053 -174.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -83.94 113.24 20.84 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.996 -0.742 . . . . 73.4 108.996 177.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -63.08 144.87 56.52 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 123.928 0.767 . . . . 75.11 112.639 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 85' ' ' PHE . . . . . 0.522 ' O ' ' HG3' ' C' ' 171' ' ' PRO . 78.3 m-85 -137.31 72.24 1.42 Allowed 'General case' 0 C--O 1.212 -0.88 0 C-N-CA 124.567 1.147 . . . . 74.41 109.348 171.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 50.7 m -47.49 86.61 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 124.31 1.044 . . . . 52.42 112.924 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 67.64 13.13 62.89 Favored Glycine 0 C--N 1.349 1.275 0 CA-C-N 115.513 -0.767 . . . . 74.34 114.611 -178.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 88' ' ' PHE . . . . . 0.494 ' HB2' ' HB3' ' C' ' 85' ' ' PHE . 18.6 m-85 -92.22 128.97 38.26 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 109.081 -0.711 . . . . 74.44 109.081 -177.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 89' ' ' ASP . . . . . 0.498 ' HB3' ' HE2' ' C' ' 48' ' ' LYS . 27.9 t70 -83.69 78.59 9.67 Favored 'General case' 0 C--O 1.246 0.898 0 CA-C-O 121.665 0.745 . . . . 72.23 110.509 -172.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 90' ' ' VAL . . . . . 0.712 HG21 HD22 ' C' ' 169' ' ' ASN . 1.3 p -43.44 -36.43 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.22 0 C-N-CA 125.934 1.694 . . . . 54.42 112.415 172.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -50.21 -36.53 31.16 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.648 1.579 . . . . 75.25 112.891 -178.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -119.26 21.41 12.26 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.524 0.729 . . . . 75.53 111.234 -170.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 21.5 m-30 -94.17 175.49 6.68 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.805 -0.559 . . . . 72.45 111.123 175.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 84.5 p -74.4 173.45 10.27 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 113.754 1.02 . . . . 52.11 113.754 -164.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 95' ' ' GLU . . . . . 0.453 ' O ' ' HG3' ' C' ' 99' ' ' GLU . 4.0 mp0 -73.21 -36.52 66.52 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 114.71 -1.132 . . . . 72.35 110.617 178.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -60.57 -42.56 96.88 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-O 121.535 0.683 . . . . 74.24 110.289 173.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 97' ' ' PHE . . . . . 0.701 ' HE2' HG22 ' C' ' 90' ' ' VAL . 48.9 t80 -58.46 -43.4 88.85 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 114.282 -1.326 . . . . 64.25 109.933 174.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -66.56 -29.21 69.24 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 122.664 0.386 . . . . 71.33 111.814 176.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 99' ' ' GLU . . . . . 0.453 ' HG3' ' O ' ' C' ' 95' ' ' GLU . 45.0 mt-10 -67.21 -56.15 11.09 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 122.752 0.421 . . . . 74.43 110.24 178.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 26.7 tp -75.33 -50.18 16.81 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.392 -0.822 . . . . 73.23 111.802 -172.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -91.66 -20.3 21.75 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.299 0.64 . . . . 75.04 112.555 -173.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -46.46 -58.18 6.07 Favored Glycine 0 CA--C 1.541 1.68 0 CA-C-O 118.933 -0.926 . . . . 74.41 115.107 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -63.43 -3.29 5.04 Favored 'Trans proline' 0 C--N 1.385 2.462 0 C-N-CA 123.186 2.591 . . . . 64.35 114.464 -177.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 104' ' ' GLY . . . . . 0.408 ' HA3' ' HB3' ' C' ' 78' ' ' PRO . . . -137.91 32.53 2.35 Favored Glycine 0 C--N 1.349 1.284 0 CA-C-O 119.953 -0.359 . . . . 73.42 113.14 176.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 105' ' ' LEU . . . . . 0.401 ' HB3' ' ND2' ' C' ' 169' ' ' ASN . 48.3 mt . . . . . 0 N--CA 1.486 1.337 0 C-N-CA 123.019 0.528 . . . . 75.43 111.733 173.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 116' ' ' GLY . . . . . 0.408 ' HA2' ' HA3' ' C' ' 168' ' ' GLY . . . . . . . . 0 CA--C 1.499 -0.921 0 CA-C-O 120.926 0.181 . . . . 54.4 113.182 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 17.1 mtm180 -116.4 171.88 7.56 Favored 'General case' 0 C--O 1.263 1.81 0 CA-C-O 122.369 1.081 . . . . 74.32 111.397 -173.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 118' ' ' ASP . . . . . 0.442 ' HA ' ' O ' ' C' ' 173' ' ' ASP . 3.4 m-20 -61.3 117.95 6.28 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 112.37 -2.195 . . . . 75.42 109.138 170.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 119' ' ' LEU . . . . . 0.631 ' HG ' ' HG2' ' C' ' 167' ' ' GLN . 3.0 tt -92.89 120.72 33.52 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 105.818 -1.919 . . . . 75.21 105.818 -178.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.538 ' HE ' HG22 ' C' ' 177' ' ' VAL . 57.0 ttt180 -117.56 114.19 23.07 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.625 -0.509 . . . . 72.31 109.625 -164.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 121' ' ' ALA . . . . . . . . . . . . . . . -108.66 169.95 8.33 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 122.812 0.445 . . . . 75.44 111.805 -171.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -131.86 114.49 14.74 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 123.88 0.872 . . . . 74.12 109.636 -176.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -140.03 115.43 7.88 Favored Pre-proline 0 N--CA 1.483 1.221 0 CA-C-N 117.992 0.36 . . . . 73.3 111.858 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -66.88 116.03 3.91 Favored 'Trans proline' 0 C--N 1.378 2.098 0 C-N-CA 122.229 1.952 . . . . 72.51 109.486 162.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 125' ' ' LEU . . . . . 0.454 ' O ' ' HA ' ' C' ' 180' ' ' LEU . 14.8 tp -139.58 166.87 23.43 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 107.392 -1.336 . . . . 75.32 107.392 -170.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 126' ' ' THR . . . . . 0.408 ' HB ' HD12 ' C' ' 181' ' ' LEU . 14.2 t -127.01 175.32 8.18 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 119.1 0.864 . . . . 61.53 110.976 175.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 127' ' ' LEU . . . . . . . . . . . . . 6.5 mt -59.86 -44.55 94.09 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 126.092 1.757 . . . . 62.25 110.011 -177.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -58.16 -45.25 87.77 Favored 'General case' 0 C--O 1.213 -0.848 0 CA-C-N 113.694 -1.593 . . . . 75.24 109.586 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 129' ' ' GLU . . . . . 0.527 ' HA ' ' HB2' ' C' ' 132' ' ' HIS . 20.0 mm-40 -77.74 -18.0 56.98 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 124.446 1.091 . . . . 75.51 111.659 -178.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 130' ' ' ALA . . . . . 0.464 ' HB2' ' HA2' ' C' ' 152' ' ' GLY . . . -71.86 -36.67 70.18 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.066 -0.716 . . . . 73.14 109.066 174.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 131' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -73.07 -46.71 49.98 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 114.753 -1.112 . . . . 75.55 111.176 167.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 132' ' ' HIS . . . . . 0.527 ' HB2' ' HA ' ' C' ' 129' ' ' GLU . 32.7 m170 -74.79 -7.57 53.81 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 118.998 -0.525 . . . . 70.15 111.24 -172.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -70.28 66.96 0.72 Allowed Glycine 0 C--N 1.354 1.537 0 O-C-N 123.712 0.632 . . . . 65.31 113.482 172.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . -88.45 -139.8 6.88 Favored Glycine 0 C--N 1.348 1.206 0 N-CA-C 109.657 -1.377 . . . . 73.12 109.657 169.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -72.73 93.62 1.67 Allowed 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 108.727 -0.842 . . . . 73.03 108.727 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 136' ' ' ARG . . . . . 0.486 ' HB2' HD22 ' B' ' 181' ' ' LEU . 57.2 mtp180 -141.91 163.11 33.77 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.722 0.809 . . . . 72.12 110.756 -171.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 137' ' ' VAL . . . . . 0.464 ' HB ' ' HB3' ' B' ' 180' ' ' ALA . 54.2 t -71.33 95.48 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 CA-C-N 115.019 -0.991 . . . . 73.11 110.9 -171.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 138' ' ' VAL . . . . . . . . . . . . . 97.9 t -79.01 112.22 16.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 107.055 -1.461 . . . . 72.14 107.055 165.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 139' ' ' GLU . . . . . . . . . . . . . 53.7 tt0 -121.48 78.44 1.43 Allowed 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 107.567 -1.272 . . . . 74.31 107.567 -167.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 140' ' ' VAL . . . . . 0.472 HG11 HD13 ' C' ' 174' ' ' LEU . 89.3 t -128.1 104.56 12.04 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 CA-C-N 114.31 -1.313 . . . . 73.25 110.755 -166.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 68.14 24.31 7.7 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.979 1.312 . . . . 65.0 113.045 168.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 107.5 -29.48 10.43 Favored Glycine 0 C--N 1.338 0.689 0 N-CA-C 111.273 -0.731 . . . . 52.4 111.273 -176.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 143' ' ' ARG . . . . . 0.44 ' CZ ' ' HB ' ' C' ' 145' ' ' VAL . 14.0 tpt180 -70.37 106.94 3.57 Favored 'General case' 0 C--N 1.363 1.192 0 N-CA-C 108.8 -0.815 . . . . 75.05 108.8 177.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 11.4 ttt-85 -113.83 96.74 6.0 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-N 114.864 -1.062 . . . . 71.51 108.773 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 145' ' ' VAL . . . . . 0.563 HG21 ' HB ' ' C' ' 147' ' ' VAL . 3.1 p -127.71 130.28 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 124.273 1.029 . . . . 75.03 110.085 -175.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 55.5 m -90.76 86.53 6.36 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 108.803 -0.814 . . . . 73.22 108.803 174.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 147' ' ' VAL . . . . . 0.563 ' HB ' HG21 ' C' ' 145' ' ' VAL . 9.7 p -131.51 159.34 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-N 114.981 -1.008 . . . . 72.53 110.473 -170.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 23.1 ttm180 -88.56 104.52 16.91 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 108.392 -0.966 . . . . 74.22 108.392 170.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 149' ' ' ILE . . . . . . . . . . . . . 30.5 pt -69.74 151.52 96.4 Favored Pre-proline 0 CA--C 1.548 0.88 0 CA-C-O 118.045 -0.979 . . . . 74.42 108.861 166.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 150' ' ' PRO . . . . . 0.461 ' HD2' HG22 ' C' ' 161' ' ' VAL . 34.8 Cg_exo -39.27 108.66 0.08 OUTLIER 'Trans proline' 0 C--N 1.39 2.74 0 C-N-CA 123.547 2.831 . . . . 61.44 112.864 176.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -66.6 122.09 9.45 Favored 'Trans proline' 0 C--N 1.382 2.302 0 C-N-CA 122.537 2.158 . . . . 73.2 111.447 -171.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 152' ' ' GLY . . . . . 0.603 ' HA3' HD22 ' C' ' 188' ' ' LEU . . . 99.47 122.72 4.84 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-N 115.52 -0.764 . . . . 63.11 113.386 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 153' ' ' VAL . . . . . 0.621 ' HB ' HG13 ' C' ' 178' ' ' VAL . 3.5 m -129.99 176.13 9.23 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 C-N-CA 123.745 0.818 . . . . 74.01 109.487 -174.014 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 154' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -133.66 160.05 38.68 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.375 0.67 . . . . 75.32 110.322 177.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 155' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -67.25 103.75 1.32 Allowed 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 124.786 1.234 . . . . 74.51 112.125 -176.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 97.89 -0.79 59.29 Favored Glycine 0 C--N 1.354 1.542 0 CA-C-N 115.583 -0.735 . . . . 75.21 113.163 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 157' ' ' SER . . . . . . . . . . . . . 55.6 m -90.39 170.34 10.32 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.082 0.553 . . . . 75.43 111.966 -172.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 158' ' ' VAL . . . . . 0.498 HG13 HG21 ' C' ' 177' ' ' VAL . 28.2 m -104.99 125.77 59.97 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 CA-C-N 115.488 -0.778 . . . . 72.31 111.086 178.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 159' ' ' ILE . . . . . 0.582 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 17.3 mt -76.04 98.66 1.7 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.6 0 N-CA-C 108.082 -1.081 . . . . 72.31 108.082 166.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 21.6 ttp180 -81.97 101.25 10.18 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.993 0.917 . . . . 75.13 110.012 -178.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 161' ' ' VAL . . . . . 0.539 ' HB ' ' HB3' ' C' ' 174' ' ' LEU . 16.1 t -100.19 112.87 64.92 Favored Pre-proline 0 CA--C 1.551 1.004 0 N-CA-C 107.83 -1.174 . . . . 75.24 107.83 175.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -50.48 99.11 0.04 OUTLIER 'Trans proline' 0 C--N 1.384 2.418 0 C-N-CA 124.034 3.156 . . . . 75.23 114.745 -172.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 67.29 23.6 73.32 Favored Glycine 0 C--N 1.347 1.143 0 N-CA-C 115.73 1.052 . . . . 53.54 115.73 169.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 164' ' ' MET . . . . . 0.4 ' HE2' HG13 ' C' ' 161' ' ' VAL . 43.6 ttp -98.0 18.67 15.47 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 117.582 0.691 . . . . 73.35 109.795 174.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . -74.94 -120.95 0.1 Allowed Glycine 0 C--N 1.357 1.727 0 CA-C-N 115.81 -0.632 . . . . 73.32 112.248 174.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . 153.03 -82.87 0.17 Allowed Glycine 0 C--N 1.35 1.354 0 C-N-CA 119.057 -1.544 . . . . 75.44 114.669 172.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 167' ' ' GLN . . . . . 0.631 ' HG2' ' HG ' ' C' ' 119' ' ' LEU . 26.2 mm-40 -14.99 102.49 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.479 0 C-N-CA 126.294 1.837 . . . . 74.2 113.933 -160.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 168' ' ' GLY . . . . . 0.408 ' HA3' ' HA2' ' C' ' 116' ' ' GLY . . . 108.88 145.3 11.22 Favored Glycine 0 CA--C 1.535 1.301 0 N-CA-C 108.996 -1.642 . . . . 13.44 108.996 -161.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 169' ' ' ASN . . . . . 0.712 HD22 HG21 ' C' ' 90' ' ' VAL . 3.1 t-20 -61.42 -59.61 13.02 Favored Pre-proline 0 CA--C 1.576 1.954 0 N-CA-C 114.687 1.365 . . . . 62.44 114.687 -164.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 170' ' ' PRO . . . . . 0.539 ' HD3' ' HB3' ' C' ' 169' ' ' ASN . 7.9 Cg_exo -71.41 104.55 1.59 Allowed 'Trans proline' 0 C--N 1.398 3.142 0 C-N-CA 122.303 2.002 . . . . 73.55 110.693 175.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 171' ' ' PRO . . . . . 0.522 ' HG3' ' O ' ' C' ' 85' ' ' PHE . 58.1 Cg_endo -61.35 126.83 20.25 Favored 'Trans proline' 0 N--CA 1.502 1.972 0 C-N-CA 123.736 2.957 . . . . 74.02 114.688 -161.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -80.49 -167.18 36.09 Favored Glycine 0 C--N 1.354 1.538 0 O-C-N 123.48 0.488 . . . . 74.42 112.269 172.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 173' ' ' ASP . . . . . 0.442 ' O ' ' HA ' ' C' ' 118' ' ' ASP . 13.0 t70 -86.62 155.62 20.35 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 123.54 0.736 . . . . 74.51 110.556 -174.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 174' ' ' LEU . . . . . 0.539 ' HB3' ' HB ' ' C' ' 161' ' ' VAL . 27.7 tp -98.24 114.86 27.26 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 121.496 -0.752 . . . . 75.22 110.198 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 175' ' ' LEU . . . . . 0.427 ' O ' ' HA ' ' C' ' 120' ' ' ARG . 79.6 mt -110.97 91.03 3.5 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.316 0.646 . . . . 72.15 109.867 176.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 176' ' ' LEU . . . . . 0.582 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 62.0 mt -81.02 105.88 12.58 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 109.178 -0.675 . . . . 74.33 109.178 178.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 177' ' ' VAL . . . . . 0.538 HG22 ' HE ' ' C' ' 120' ' ' ARG . 60.3 t -81.51 107.68 13.93 Favored 'Isoleucine or valine' 0 C--O 1.249 1.045 0 CA-C-O 121.901 0.857 . . . . 75.23 108.832 -178.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 178' ' ' VAL . . . . . 0.621 HG13 ' HB ' ' C' ' 153' ' ' VAL . 4.0 p -93.86 140.41 16.58 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 CA-C-N 114.113 -1.403 . . . . 74.01 110.464 -178.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 179' ' ' ARG . . . . . . . . . . . . . 50.9 mmm-85 -121.92 111.56 17.22 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 107.402 -1.333 . . . . 74.42 107.402 172.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 180' ' ' LEU . . . . . 0.454 ' HA ' ' O ' ' C' ' 125' ' ' LEU . 84.5 mt -70.52 145.88 50.57 Favored 'General case' 0 C--O 1.237 0.432 0 O-C-N 123.543 0.527 . . . . 73.43 111.299 -175.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 181' ' ' LEU . . . . . 0.408 HD12 ' HB ' ' C' ' 126' ' ' THR . 31.1 mt -60.01 168.53 2.06 Favored Pre-proline 0 CA--C 1.555 1.171 0 C-N-CA 124.914 1.286 . . . . 74.24 111.886 -178.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -42.0 -3.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.395 3.023 0 C-N-CA 124.834 3.69 . . . . 73.32 118.14 174.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 183' ' ' HIS . . . . . 0.409 ' HE1' ' HE1' ' C' ' 213' ' ' MET . 0.3 OUTLIER -125.3 83.39 61.16 Favored Pre-proline 0 CA--C 1.569 1.69 0 CA-C-N 118.865 0.757 . . . . 72.0 110.499 166.134 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 184' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -85.57 69.57 5.18 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 123.671 2.914 . . . . 74.25 110.311 173.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 185' ' ' VAL . . . . . . . . . . . . . 4.3 t -90.83 -43.77 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 N-CA-C 109.993 -0.373 . . . . 72.23 109.993 -166.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 186' ' ' PHE . . . . . 0.648 ' HB3' HD22 ' C' ' 193' ' ' LEU . 21.7 m-85 -99.75 113.0 25.21 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.708 0.766 . . . . 61.44 112.151 -170.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 187' ' ' ARG . . . . . 0.485 ' HB3' ' HB3' ' C' ' 194' ' ' TYR . 36.0 ttm180 -96.98 101.23 12.76 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 107.257 -1.386 . . . . 75.14 107.257 171.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 188' ' ' LEU . . . . . 0.603 HD22 ' HA3' ' C' ' 152' ' ' GLY . 41.1 tp -93.88 144.73 25.18 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 112.856 0.687 . . . . 74.14 112.856 -171.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -131.42 111.02 11.45 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 107.242 -1.392 . . . . 73.21 107.242 159.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 70.32 -86.37 0.33 Allowed Glycine 0 C--N 1.351 1.362 0 O-C-N 123.704 0.627 . . . . 74.2 113.141 177.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 191' ' ' GLN . . . . . 0.583 ' HA ' ' HB2' ' C' ' 240' ' ' PHE . 20.7 mt-30 -132.51 -10.76 3.18 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.289 0.636 . . . . 75.25 112.028 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -104.66 121.58 43.85 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 121.303 0.573 . . . . 65.13 110.839 -177.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 193' ' ' LEU . . . . . 0.648 HD22 ' HB3' ' C' ' 186' ' ' PHE . 56.7 mt -90.87 153.15 20.42 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.353 1.461 . . . . 65.15 111.034 -177.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 194' ' ' TYR . . . . . 0.485 ' HB3' ' HB3' ' C' ' 187' ' ' ARG . 46.7 t80 -112.05 148.79 33.13 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 106.983 -1.488 . . . . 75.43 106.983 162.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 195' ' ' ALA . . . . . . . . . . . . . . . -154.66 -175.24 5.32 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.253 0.621 . . . . 65.11 110.946 -177.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 58.3 m -130.74 145.9 52.07 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.072 0.949 . . . . 53.42 108.813 168.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 197' ' ' LEU . . . . . . . . . . . . . 36.3 tp -127.4 113.64 16.48 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.359 1.064 . . . . 73.5 108.861 -176.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 198' ' ' ASP . . . . . 0.458 ' HB3' HG21 ' C' ' 256' ' ' THR . 19.9 m-20 -86.11 101.76 13.26 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 109.778 -0.453 . . . . 64.33 109.778 -178.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 199' ' ' VAL . . . . . 0.545 ' HA ' HG11 ' C' ' 210' ' ' VAL . 88.8 t -105.58 123.22 40.13 Favored Pre-proline 0 N--CA 1.474 0.747 0 C-N-CA 123.775 0.83 . . . . 73.12 109.13 177.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 200' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.88 148.03 56.91 Favored 'Trans proline' 0 C--N 1.369 1.655 0 C-N-CA 121.896 1.731 . . . . 73.11 110.929 176.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 201' ' ' ALA . . . . . . . . . . . . . . . -55.0 -43.59 99.14 Favored Pre-proline 0 CA--C 1.553 1.069 0 N-CA-C 114.174 1.176 . . . . 74.35 114.174 -175.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 202' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -54.38 -52.78 7.44 Favored 'Trans proline' 0 C--N 1.394 2.971 0 C-N-CA 121.733 1.622 . . . . 63.15 112.666 175.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 203' ' ' ILE . . . . . . . . . . . . . 44.6 mt -65.18 -31.04 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 124.089 0.956 . . . . 74.02 111.269 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.34 -43.26 81.99 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.736 0.814 . . . . 75.02 111.817 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 205' ' ' VAL . . . . . . . . . . . . . 87.4 t -72.62 -47.81 49.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 115.866 -0.606 . . . . 74.52 111.22 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 206' ' ' VAL . . . . . 0.452 HG21 ' HE2' ' A' ' 270' ' ' LYS . 11.5 p -80.96 -34.12 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 112.842 0.682 . . . . 74.12 112.842 -171.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 89.86 111.77 1.4 Allowed Glycine 0 CA--C 1.531 1.04 0 N-CA-C 111.623 -0.591 . . . . 63.21 111.623 -169.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -153.24 -121.46 0.85 Allowed Glycine 0 C--N 1.348 1.217 0 CA-C-O 119.606 -0.552 . . . . 51.32 111.76 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 209' ' ' LYS . . . . . . . . . . . . . 31.7 mtmt -151.81 153.09 33.57 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.672 0.789 . . . . 72.44 111.6 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 210' ' ' VAL . . . . . 0.545 HG11 ' HA ' ' C' ' 199' ' ' VAL . 29.3 m -139.97 178.06 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 126.764 2.026 . . . . 71.52 108.393 174.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 211' ' ' ARG . . . . . 0.42 ' NE ' ' HB2' ' C' ' 218' ' ' PRO . 0.0 OUTLIER -111.84 147.93 34.7 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.018 0.527 . . . . 75.53 111.296 177.213 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -127.18 121.29 30.91 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 107.369 -1.345 . . . . 74.43 107.369 164.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 213' ' ' MET . . . . . 0.409 ' HE1' ' HE1' ' C' ' 183' ' ' HIS . 1.4 tmm? -76.02 112.99 13.03 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 108.281 -1.007 . . . . 63.12 108.281 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 214' ' ' THR . . . . . 0.409 HG22 ' H ' ' C' ' 215' ' ' LEU . 0.2 OUTLIER -117.99 175.39 5.69 Favored 'General case' 0 N--CA 1.485 1.325 0 CA-C-N 118.86 0.755 . . . . 72.34 111.962 -173.373 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 215' ' ' LEU . . . . . 0.409 ' H ' HG22 ' C' ' 214' ' ' THR . 35.7 mt -73.82 -33.49 64.18 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.247 1.419 . . . . 75.24 112.384 -171.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -83.41 -4.65 58.69 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 115.262 -0.881 . . . . 71.0 110.647 175.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 132.09 173.22 13.26 Favored Glycine 0 C--N 1.342 0.878 0 N-CA-C 110.898 -0.881 . . . . 74.41 110.898 -175.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 218' ' ' PRO . . . . . 0.42 ' HB2' ' NE ' ' C' ' 211' ' ' ARG . 93.5 Cg_endo -75.56 113.22 3.7 Favored 'Trans proline' 0 CA--C 1.55 1.316 0 C-N-CA 122.253 1.969 . . . . 64.03 112.0 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 219' ' ' VAL . . . . . . . . . . . . . 14.6 p -89.03 152.3 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 108.034 -1.099 . . . . 52.53 108.034 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 220' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -111.57 107.69 16.93 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.194 -1.039 . . . . 72.32 108.194 176.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 221' ' ' VAL . . . . . 0.41 HG22 HD12 ' C' ' 235' ' ' LEU . 53.9 t -75.86 129.08 37.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 114.281 -1.327 . . . . 74.03 111.415 -174.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -77.95 138.07 38.66 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.016 0.436 . . . . 73.3 110.507 169.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 57.5 t -118.25 124.17 28.82 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 124.066 0.946 . . . . 73.11 108.916 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 224' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -76.47 162.41 33.37 Favored 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 123.065 2.51 . . . . 73.11 111.067 169.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -60.71 156.14 44.52 Favored 'Trans proline' 0 C--N 1.369 1.632 0 C-N-CA 122.526 2.151 . . . . 74.4 113.333 176.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 226' ' ' ARG . . . . . 0.452 ' HD2' ' O ' ' A' ' 259' ' ' GLU . 11.8 mmt180 59.59 63.52 1.5 Allowed 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 125.269 1.428 . . . . 71.5 111.764 176.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 227' ' ' THR . . . . . . . . . . . . . 57.8 m -100.33 132.28 45.79 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.644 0.777 . . . . 73.3 111.51 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 228' ' ' GLN . . . . . 0.474 ' NE2' ' HG3' ' A' ' 259' ' ' GLU . 26.7 mp0 -111.17 150.6 29.27 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 124.562 1.145 . . . . 74.32 112.376 -179.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 229' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' C' ' 253' ' ' VAL . . . -75.1 118.85 18.49 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 114.551 -1.204 . . . . 65.31 109.606 177.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 116.58 -1.35 20.24 Favored Glycine 0 C--N 1.339 0.747 0 O-C-N 123.688 0.617 . . . . 62.04 112.287 -176.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 231' ' ' ARG . . . . . 0.554 ' HD3' ' HZ3' ' B' ' 242' ' ' TRP . 32.4 mtt180 -66.42 172.99 3.55 Favored 'General case' 0 C--N 1.355 0.819 0 CA-C-O 120.843 0.354 . . . . 75.03 110.691 167.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 232' ' ' LYS . . . . . 0.65 ' HZ2' ' HB2' ' C' ' 232' ' ' LYS . 3.6 ttmp? -142.88 146.29 33.94 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 109.582 -0.525 . . . . 74.05 109.582 175.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 233' ' ' LEU . . . . . 0.421 ' O ' ' HA ' ' C' ' 250' ' ' TYR . 3.5 tt -132.91 125.36 29.72 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.726 0.811 . . . . 74.22 108.838 -168.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 35.5 ttp180 -92.31 104.25 16.62 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.776 0.322 . . . . 72.34 110.397 170.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 235' ' ' LEU . . . . . 0.451 HD11 HD23 ' C' ' 249' ' ' LEU . 72.2 mt -81.56 116.41 21.31 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 107.903 -1.147 . . . . 74.34 107.903 164.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -80.27 134.08 36.05 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 123.328 0.651 . . . . 73.41 110.963 -176.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 70.9 26.97 73.02 Favored Glycine 0 C--N 1.349 1.269 0 O-C-N 123.933 0.77 . . . . 71.42 113.235 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 21.7 mmtm -120.62 12.15 11.42 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.958 0.903 . . . . 75.11 111.515 -177.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -90.44 -133.1 5.29 Favored Glycine 0 C--N 1.343 0.966 0 N-CA-C 111.316 -0.714 . . . . 75.2 111.316 172.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 240' ' ' PHE . . . . . 0.583 ' HB2' ' HA ' ' C' ' 191' ' ' GLN . 3.5 m-85 -97.35 118.49 64.42 Favored Pre-proline 0 C--O 1.237 0.436 0 C-N-CA 123.068 0.547 . . . . 75.14 109.907 174.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 241' ' ' PRO . . . . . 0.514 ' HA ' ' HG2' ' C' ' 246' ' ' ARG . 87.4 Cg_exo -50.94 103.88 0.07 OUTLIER 'Trans proline' 0 C--N 1.365 1.432 0 C-N-CA 123.557 2.838 . . . . 71.53 113.069 166.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -77.42 174.0 54.79 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-N 114.707 -1.133 . . . . 70.14 112.974 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -66.82 -11.08 30.61 Favored 'Trans proline' 0 C--N 1.368 1.559 0 C-N-CA 123.123 2.549 . . . . 71.42 114.038 -171.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -137.29 1.72 2.44 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.687 0.795 . . . . 71.42 111.735 179.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . -171.75 -138.38 2.54 Favored Glycine 0 C--N 1.348 1.238 0 CA-C-O 119.706 -0.497 . . . . 63.24 112.949 -177.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 246' ' ' ARG . . . . . 0.514 ' HG2' ' HA ' ' C' ' 241' ' ' PRO . 85.5 mtm180 -148.44 160.87 42.62 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.845 0.858 . . . . 71.32 111.004 -178.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -96.46 -169.3 34.32 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 114.879 -1.055 . . . . 63.23 112.173 173.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -126.33 169.94 12.41 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.104 0.562 . . . . 73.54 110.495 -173.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 249' ' ' LEU . . . . . 0.451 HD23 HD11 ' C' ' 235' ' ' LEU . 17.6 tp -129.25 127.14 40.63 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.945 0.898 . . . . 74.23 109.38 -176.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 250' ' ' TYR . . . . . 0.421 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 89.5 m-85 -117.06 101.17 8.26 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.695 0.798 . . . . 71.43 110.141 -178.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 251' ' ' LEU . . . . . 0.435 ' O ' ' HA ' ' C' ' 232' ' ' LYS . 0.9 OUTLIER -99.23 129.76 45.48 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 119.286 -0.388 . . . . 72.0 110.113 -176.039 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -73.11 108.45 6.0 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.076 -1.083 . . . . 75.41 108.076 166.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 253' ' ' VAL . . . . . 0.425 HG11 ' HH2' ' B' ' 242' ' ' TRP . 46.7 t -78.79 110.69 14.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.732 -0.667 . . . . 73.5 109.977 -176.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 254' ' ' ARG . . . . . . . . . . . . . 41.0 mtm180 -94.06 159.01 15.35 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.498 0.719 . . . . 75.13 111.321 175.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 255' ' ' ILE . . . . . . . . . . . . . 35.4 mm -105.82 127.23 60.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 114.235 -1.348 . . . . 75.24 107.983 169.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 256' ' ' THR . . . . . 0.458 HG21 ' HB3' ' C' ' 198' ' ' ASP . 0.3 OUTLIER -133.49 172.82 12.21 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.917 1.287 . . . . 70.25 108.775 -177.685 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 35.1 pt -127.02 145.55 54.4 Favored Pre-proline 0 N--CA 1.481 1.099 0 C-N-CA 123.434 0.694 . . . . 75.21 110.109 -178.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -63.33 -11.83 27.52 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.698 2.266 . . . . 74.41 113.72 -173.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 53.32 -67.25 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.961 1.704 . . . . 72.3 112.64 -165.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 8.1 ppt_? -59.77 133.65 56.29 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.33 0.652 . . . . 73.41 110.351 174.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 261' ' ' LEU . . . . . 0.545 HD23 ' HB3' ' C' ' 265' ' ' GLU . 91.2 mt -143.34 161.75 37.52 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.73 0.812 . . . . 74.53 110.488 -173.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 63.4 p -91.18 165.56 21.17 Favored Pre-proline 0 CA--C 1.55 0.954 0 N-CA-C 108.62 -0.882 . . . . 61.23 108.62 167.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -48.92 -42.13 38.37 Favored 'Trans proline' 0 C--N 1.381 2.281 0 C-N-CA 122.293 1.996 . . . . 74.2 111.988 169.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -64.18 -58.13 7.5 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 114.202 -1.363 . . . . 71.04 111.244 -178.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 265' ' ' GLU . . . . . 0.545 ' HB3' HD23 ' C' ' 261' ' ' LEU . 0.5 OUTLIER -48.85 -58.37 4.93 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.877 0.871 . . . . 71.03 110.924 177.793 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 266' ' ' GLU . . . . . 0.535 ' O ' ' HG2' ' C' ' 270' ' ' LYS . 33.6 tt0 -58.36 -39.49 79.67 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 124.17 0.919 . . . . 73.1 110.939 -175.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -60.2 -44.13 95.36 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.712 0.805 . . . . 71.12 112.408 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 268' ' ' LEU . . . . . . . . . . . . . 11.1 mp -65.65 -40.71 92.78 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 116.709 -0.223 . . . . 70.11 110.745 176.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -59.81 -36.37 76.62 Favored 'General case' 0 N--CA 1.483 1.177 0 O-C-N 123.558 0.536 . . . . 63.11 110.946 174.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 270' ' ' LYS . . . . . 0.535 ' HG2' ' O ' ' C' ' 266' ' ' GLU . 30.5 mmtp -63.9 -46.92 82.68 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.684 0.794 . . . . 75.43 110.368 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -61.68 -45.06 95.6 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.55 0.74 . . . . 75.33 111.708 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 92.7 mt -62.0 -43.75 98.18 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.236 -0.893 . . . . 74.33 110.315 177.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -59.39 -41.21 88.87 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.558 -0.746 . . . . 43.22 110.695 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -69.31 -31.91 70.69 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.185 0.594 . . . . 63.21 111.595 177.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -62.44 -31.95 72.74 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 122.531 0.332 . . . . 70.04 110.473 171.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 276' ' ' TYR . . . . . 0.638 ' HH ' ' HB3' ' A' ' 258' ' ' PRO . 79.2 m-85 -77.35 -34.56 55.15 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 122.887 0.475 . . . . 75.52 112.207 171.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 15.2 m-30 -66.27 -27.48 67.97 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.797 -0.446 . . . . 65.52 109.797 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -65.53 -1.96 3.01 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 124.413 1.085 . . . . 72.22 113.244 175.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 279' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -72.84 -22.89 60.72 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 122.697 0.399 . . . . 75.11 110.917 171.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.077 0 C-N-CA 123.581 0.752 . . . . 75.14 110.154 178.829 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt . . . . . 0 N--CA 1.472 0.668 0 N-CA-C 113.474 0.916 . . . . 64.14 113.474 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -70.74 88.92 0.73 Allowed 'General case' 0 C--O 1.241 0.62 0 N-CA-C 107.584 -1.265 . . . . 74.32 107.584 162.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.459 ' HA ' ' OH ' ' A' ' 66' ' ' TYR . 34.7 t70 -75.45 93.81 3.02 Favored 'General case' 0 C--N 1.354 0.782 0 N-CA-C 107.511 -1.292 . . . . 62.43 107.511 173.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.594 ' HB2' HD13 ' A' ' 57' ' ' LEU . 50.7 m-85 -60.17 -28.61 68.07 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 113.783 -1.553 . . . . 73.34 111.836 -169.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.439 ' HD1' HD12 ' A' ' 22' ' ' ILE . 50.3 m-85 -65.47 -47.63 75.45 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.035 0.534 . . . . 73.33 110.454 177.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.5 -38.69 91.9 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.871 -0.604 . . . . 70.01 111.427 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 69.6 mt -60.45 -38.98 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 123.733 0.646 . . . . 74.23 110.107 174.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.432 ' HB3' ' HB1' ' A' ' 25' ' ' ALA . 93.7 mt -86.31 2.81 45.98 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 115.36 -0.836 . . . . 73.11 112.505 178.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 63.83 18.23 61.65 Favored Glycine 0 C--N 1.356 1.64 0 N-CA-C 114.771 0.668 . . . . 73.42 114.771 177.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.6 m -107.48 155.35 39.75 Favored Pre-proline 0 N--CA 1.482 1.167 0 C-N-CA 124.389 1.075 . . . . 72.52 110.076 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.88 154.88 30.1 Favored 'Trans proline' 0 C--N 1.383 2.356 0 C-N-CA 123.0 2.466 . . . . 50.12 113.106 177.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 55.7 mtp180 -76.39 13.75 0.89 Allowed 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 112.763 0.653 . . . . 75.43 112.763 -173.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -119.96 -5.41 10.07 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 125.141 1.376 . . . . 71.2 109.402 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.449 ' HB1' ' HB2' ' A' ' 21' ' ' GLU . . . -58.34 127.28 31.35 Favored 'General case' 0 C--N 1.347 0.477 0 C-N-CA 124.75 1.22 . . . . 74.14 111.51 -175.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.548 ' HA ' HH21 ' A' ' 63' ' ' ARG . 79.8 p -84.17 177.05 8.37 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 122.881 0.473 . . . . 75.03 110.658 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -46.71 -32.65 3.72 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 124.982 1.313 . . . . 71.11 113.292 -175.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -81.59 -30.06 33.11 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 112.264 0.468 . . . . 72.43 112.264 -173.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.449 ' HB2' ' HB1' ' A' ' 17' ' ' ALA . 2.5 mp0 -72.92 -33.67 66.12 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 109.601 -0.518 . . . . 71.14 109.601 170.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.482 HG23 ' HB2' ' A' ' 57' ' ' LEU . 1.7 mp -67.29 -33.72 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.738 0.815 . . . . 73.31 110.265 173.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.421 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 4.6 tppp? -64.28 -53.5 47.96 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.824 0.85 . . . . 75.22 109.717 176.024 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -59.12 -44.43 92.01 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 124.166 0.916 . . . . 73.12 110.935 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.432 ' HB1' ' HB3' ' A' ' 11' ' ' LEU . . . -66.7 -35.54 80.37 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.792 0.837 . . . . 72.43 111.849 -177.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -64.12 -50.49 68.04 Favored 'General case' 0 C--O 1.215 -0.711 0 CA-C-N 115.403 -0.817 . . . . 73.1 109.784 175.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.421 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 54.8 mtpt -59.07 -42.82 91.27 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 123.947 0.779 . . . . 74.22 110.737 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.0 ttt180 -53.25 -55.55 23.6 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.283 1.433 . . . . 75.52 110.728 176.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.704 ' HB3' HD12 ' A' ' 50' ' ' ILE . 95.5 mt -79.28 -15.63 57.68 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.603 -0.726 . . . . 75.12 111.793 -176.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.21 -18.78 38.06 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.55 0.74 . . . . 71.54 110.595 175.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -86.07 -45.86 11.02 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 122.977 0.511 . . . . 72.33 110.37 169.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -63.86 -57.65 9.2 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.006 0.522 . . . . 73.31 110.434 -177.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -97.35 38.56 1.25 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.556 0.742 . . . . 72.41 110.025 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 7.7 t-160 -63.94 103.58 0.43 Allowed Pre-proline 0 C--N 1.354 0.782 0 C-N-CA 123.769 0.828 . . . . 73.54 109.478 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -68.38 -14.46 40.15 Favored 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 122.534 2.156 . . . . 75.51 112.86 -167.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -67.85 -39.93 83.75 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.502 1.121 . . . . 73.23 111.305 173.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 96.5 t -96.58 -51.18 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 123.291 0.636 . . . . 73.25 110.08 -177.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -102.16 89.86 3.74 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.174 0.989 . . . . 64.12 110.898 -176.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.22 44.83 1.17 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.426 0.69 . . . . 73.11 110.58 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 74.0 m -89.72 130.48 42.93 Favored Pre-proline 0 N--CA 1.474 0.766 0 CA-C-O 117.918 -1.039 . . . . 71.24 108.447 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -38.61 -70.35 0.07 OUTLIER 'Trans proline' 0 C--N 1.392 2.836 0 C-N-CA 124.76 3.64 . . . . 73.53 114.334 -172.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.487 ' HA ' ' HB2' ' A' ' 45' ' ' GLU . 30.9 tt0 -75.81 -7.21 53.89 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 116.61 -0.268 . . . . 64.43 111.642 -174.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.37 -35.62 68.53 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 108.929 -0.767 . . . . 73.42 108.929 172.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -86.56 -30.51 21.83 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-N 115.874 -0.603 . . . . 63.35 109.95 -178.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.487 ' HB2' ' HA ' ' A' ' 42' ' ' GLU . 41.2 mt-10 -67.17 -46.49 73.83 Favored 'General case' 0 C--O 1.244 0.792 0 C-N-CA 123.339 0.656 . . . . 62.44 110.285 174.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 32.3 mmtm -61.19 -39.38 89.97 Favored 'General case' 0 C--O 1.214 -0.785 0 CA-C-N 115.633 -0.712 . . . . 74.03 110.383 171.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.443 ' HA ' HD13 ' A' ' 50' ' ' ILE . 85.2 t80 -58.46 -36.69 74.09 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 123.376 0.423 . . . . 73.32 111.179 176.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.542 ' HB2' ' HZ1' ' A' ' 48' ' ' LYS . 10.5 mtmp? -69.68 -32.81 71.65 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.009 0.523 . . . . 75.14 111.607 175.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -77.59 -22.65 50.55 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 122.603 0.361 . . . . 71.44 111.873 175.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.704 HD12 ' HB3' ' A' ' 29' ' ' LEU . 60.3 mt -77.82 -34.02 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 124.321 1.048 . . . . 74.43 108.737 172.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -64.89 -39.65 93.87 Favored 'General case' 0 C--O 1.218 -0.582 0 CA-C-N 114.817 -1.083 . . . . 73.43 109.641 171.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -61.04 -51.27 69.9 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.349 1.06 . . . . 75.34 110.603 176.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.18 -55.81 27.03 Favored 'General case' 0 C--O 1.255 1.395 0 CA-C-N 114.465 -1.243 . . . . 65.45 112.105 -178.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -65.01 -38.48 91.05 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.069 -0.968 . . . . 73.53 110.978 178.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.56 ' HB1' ' HD2' ' A' ' 85' ' ' PHE . . . -54.0 -50.07 67.44 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.334 0.654 . . . . 72.52 111.399 -178.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 70.9 t -62.71 -53.15 50.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 CA-C-N 114.706 -1.134 . . . . 74.52 110.74 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.594 HD13 ' HB2' ' A' ' 7' ' ' TYR . 55.1 mt -90.76 6.77 42.8 Favored 'General case' 0 CA--C 1.559 1.318 0 N-CA-C 113.796 1.036 . . . . 74.35 113.796 -168.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.6 t -78.4 -54.15 6.5 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.202 0.601 . . . . 74.34 110.539 176.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -75.89 131.23 76.66 Favored Pre-proline 0 C--O 1.236 0.373 0 CA-C-N 115.322 -0.853 . . . . 74.34 109.393 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.415 ' O ' ' HG2' ' A' ' 64' ' ' ARG . 22.9 Cg_endo -58.35 -32.62 96.51 Favored 'Trans proline' 0 C--N 1.385 2.491 0 C-N-CA 123.201 2.601 . . . . 72.41 112.344 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -66.45 -51.56 55.56 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.557 0.743 . . . . 72.3 110.878 -178.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 36.5 mtpt -73.74 -26.67 60.79 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.042 0.937 . . . . 74.54 111.669 -177.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.548 HH21 ' HA ' ' A' ' 18' ' ' THR . 42.6 tpt85 -59.28 -53.64 55.99 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.959 0.904 . . . . 74.11 108.925 168.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.454 ' HA ' ' HE ' ' A' ' 64' ' ' ARG . 2.4 mmp_? -61.92 -31.89 72.25 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 124.163 0.914 . . . . 74.25 111.611 178.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 64.2 mt -60.16 -47.77 90.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.16 0.584 . . . . 74.41 110.373 174.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.459 ' OH ' ' HA ' ' A' ' 6' ' ' ASP . 21.3 t80 -60.26 -48.14 83.02 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 116.037 -0.529 . . . . 75.4 110.14 177.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -54.06 -47.89 71.18 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.044 0.537 . . . . 64.04 111.546 178.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 72.2 p -72.54 -17.78 61.69 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.799 -0.637 . . . . 75.44 111.824 -177.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -74.84 107.34 6.86 Favored 'General case' 0 C--N 1.361 1.079 0 N-CA-C 107.808 -1.182 . . . . 75.32 107.808 170.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 119.71 10.76 7.53 Favored Glycine 0 N--CA 1.469 0.874 0 N-CA-C 111.744 -0.543 . . . . 64.23 111.744 -167.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 90.6 m -145.13 -56.62 0.33 Allowed 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 105.11 -2.181 . . . . 71.23 105.11 177.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 22.0 m -88.0 143.73 26.93 Favored 'General case' 0 C--O 1.251 1.157 0 N-CA-C 104.421 -2.437 . . . . 74.23 104.421 156.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.22 -31.06 9.29 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.288 0.635 . . . . 74.04 110.728 -178.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -83.85 150.63 59.37 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 123.371 0.669 . . . . 75.1 109.483 173.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.446 ' HG2' ' HG2' ' A' ' 103' ' ' PRO . 55.7 Cg_exo -56.87 135.94 73.63 Favored 'Trans proline' 0 C--N 1.371 1.733 0 C-N-CA 122.864 2.376 . . . . 75.41 112.946 175.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.01 162.98 39.46 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 123.612 2.875 . . . . 74.25 112.801 178.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -50.42 115.62 2.03 Favored 'Trans proline' 0 C--N 1.385 2.449 0 C-N-CA 123.444 2.762 . . . . 73.45 113.678 176.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -68.97 134.17 28.95 Favored 'Trans proline' 0 C--N 1.381 2.251 0 C-N-CA 122.568 2.179 . . . . 73.2 111.895 177.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -61.41 154.46 58.73 Favored 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 122.883 2.388 . . . . 71.05 112.656 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.57 87.8 0.05 OUTLIER 'Trans proline' 0 C--N 1.382 2.326 0 C-N-CA 123.375 2.716 . . . . 74.31 112.943 178.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 148.28 -39.89 0.96 Allowed Glycine 0 N--CA 1.463 0.443 0 N-CA-C 109.492 -1.443 . . . . 62.41 109.492 179.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 117.28 -165.62 12.48 Favored Glycine 0 C--N 1.345 1.068 0 CA-C-N 114.607 -0.796 . . . . 53.03 111.991 178.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -90.99 106.09 18.28 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.629 0.772 . . . . 74.41 108.942 178.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -78.14 149.05 33.86 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.454 0.702 . . . . 71.31 111.725 177.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.56 ' HD2' ' HB1' ' A' ' 55' ' ' ALA . 75.9 m-85 -134.61 75.04 1.56 Allowed 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.311 1.044 . . . . 73.24 110.006 -176.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.9 m -49.72 85.59 0.0 OUTLIER 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 125.688 1.595 . . . . 74.44 113.479 -179.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 86.18 12.04 71.46 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-O 119.573 -0.57 . . . . 70.11 114.172 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.599 ' HB3' ' HZ ' ' A' ' 93' ' ' PHE . 45.9 m-85 -119.75 117.45 28.27 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 117.883 0.841 . . . . 72.34 110.334 -174.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -73.77 87.48 1.73 Allowed 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 121.528 0.68 . . . . 71.44 110.391 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.601 HG12 ' HD3' ' A' ' 171' ' ' PRO . 6.0 p -49.45 -32.16 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 125.51 1.524 . . . . 75.21 113.378 173.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -56.2 -24.22 40.5 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.45 1.1 . . . . 75.33 111.847 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -86.1 -30.63 22.41 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.932 0.893 . . . . 61.35 112.483 -178.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.599 ' HZ ' ' HB3' ' A' ' 88' ' ' PHE . 10.3 m-30 -65.75 153.27 42.25 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 112.903 0.705 . . . . 73.34 112.903 -165.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 84.8 p -64.74 171.1 3.59 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 115.667 1.729 . . . . 74.5 115.667 -165.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.56 -42.4 82.97 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 114.46 -1.246 . . . . 74.52 112.725 177.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -57.14 -46.02 83.06 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.984 0.914 . . . . 75.03 109.592 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.424 ' CE2' HG22 ' A' ' 90' ' ' VAL . 48.9 t80 -62.46 -43.52 98.61 Favored 'General case' 0 CA--C 1.553 1.084 0 CA-C-N 113.631 -1.622 . . . . 72.32 110.468 177.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -69.26 -13.21 62.27 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.064 0.546 . . . . 74.14 111.64 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -92.59 -30.8 15.44 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.238 0.615 . . . . 70.02 111.408 170.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 25.1 tp -82.25 -63.38 1.39 Allowed 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.491 0.716 . . . . 74.33 111.412 -177.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -93.77 -6.89 45.0 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.7 0.8 . . . . 72.11 112.727 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -43.74 -56.04 5.19 Favored Glycine 0 CA--C 1.545 1.964 0 N-CA-C 116.315 1.286 . . . . 72.43 116.315 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.446 ' HG2' ' HG2' ' A' ' 75' ' ' PRO . 33.4 Cg_exo -63.14 -3.67 5.25 Favored 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 123.625 2.884 . . . . 64.43 115.367 -176.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -139.42 26.96 2.65 Favored Glycine 0 C--N 1.352 1.468 0 CA-C-O 119.159 -0.801 . . . . 54.4 112.968 175.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.58 ' HB3' ' ND2' ' A' ' 169' ' ' ASN . 23.2 mt -65.38 81.07 0.05 Allowed 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 117.583 0.692 . . . . 74.25 111.708 176.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.429 ' HB3' ' H ' ' A' ' 107' ' ' GLY . 0.1 OUTLIER 43.62 -108.73 0.13 Allowed 'General case' 0 CA--C 1.56 1.327 0 C-N-CA 126.274 1.83 . . . . 74.45 113.072 -178.249 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.429 ' H ' ' HB3' ' A' ' 106' ' ' PHE . . . 74.1 5.63 71.57 Favored Glycine 0 C--N 1.368 2.314 0 CA-C-O 118.979 -0.9 . . . . 44.0 114.271 -174.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.669 ' HA3' ' HB3' ' A' ' 167' ' ' GLN . . . . . . . . 0 C--N 1.37 2.422 0 C-N-CA 125.781 1.658 . . . . 71.34 115.905 168.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 25.1 tptp . . . . . 0 N--CA 1.486 1.327 0 N-CA-C 113.32 0.859 . . . . 73.31 113.32 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -89.63 176.48 43.0 Favored Glycine 0 CA--C 1.541 1.712 0 O-C-N 123.691 0.619 . . . . 73.4 113.013 175.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.683 ' H ' ' HA3' ' A' ' 166' ' ' GLY . 0.0 OUTLIER -116.24 175.79 5.39 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.451 1.1 . . . . 74.43 111.211 179.537 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -86.84 95.93 10.03 Favored 'General case' 0 CA--C 1.565 1.521 0 CA-C-O 122.035 0.921 . . . . 74.23 111.025 178.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 9.2 tt -100.89 150.62 22.65 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.671 1.189 . . . . 75.42 109.3 -178.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -98.37 138.75 35.15 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.54 0.736 . . . . 74.51 111.376 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.532 ' HB3' HD11 ' A' ' 174' ' ' LEU . . . -128.74 170.5 13.23 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.939 0.895 . . . . 54.41 109.85 170.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -122.21 114.72 21.23 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 106.402 -1.703 . . . . 72.42 106.402 -178.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 53.4 tp -99.25 101.46 12.89 Favored Pre-proline 0 N--CA 1.475 0.796 0 N-CA-C 108.208 -1.034 . . . . 74.14 108.208 -175.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.536 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 7.1 Cg_endo -86.07 111.05 1.09 Allowed 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 121.403 1.402 . . . . 75.33 109.488 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.574 ' HA ' HG23 ' B' ' 6' ' ' ILE . 47.7 tp -106.48 136.95 45.35 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 110.058 -0.349 . . . . 72.43 110.058 -176.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.404 HG22 ' H ' ' B' ' 4' ' ' SER . 99.9 m -65.54 131.09 45.52 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.985 0.914 . . . . 71.34 110.049 175.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 69.3 mt -57.26 -50.81 71.71 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.908 0.883 . . . . 75.21 111.385 -175.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -59.94 -37.55 79.86 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 114.824 -1.08 . . . . 75.32 110.606 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.406 ' HB3' ' NH2' ' A' ' 136' ' ' ARG . 45.1 mm-40 -82.06 -12.71 58.11 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 115.425 -0.807 . . . . 64.33 112.056 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -71.29 -54.04 12.21 Favored 'General case' 0 C--N 1.347 0.471 0 N-CA-C 107.719 -1.215 . . . . 65.44 107.719 167.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -51.98 -44.41 64.02 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 116.138 -0.483 . . . . 74.51 110.984 174.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 50.8 m170 -73.51 -30.13 62.91 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 116.468 -0.333 . . . . 75.25 111.786 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 67.9 -129.05 26.72 Favored Glycine 0 C--N 1.349 1.26 0 O-C-N 123.216 0.323 . . . . 71.54 113.257 177.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.427 ' O ' HG12 ' A' ' 149' ' ' ILE . . . 83.24 -175.59 52.74 Favored Glycine 0 C--N 1.35 1.31 0 C-N-CA 123.007 0.337 . . . . 70.42 113.856 175.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.9 111.36 13.66 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 107.783 -1.191 . . . . 73.14 107.783 169.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.406 ' NH2' ' HB3' ' A' ' 129' ' ' GLU . 13.8 tpp180 -90.16 121.35 32.12 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 109.186 -0.672 . . . . 75.05 109.186 -175.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.449 HG11 ' HE ' ' A' ' 144' ' ' ARG . 97.6 t -86.68 108.33 17.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 CA-C-N 115.204 -0.907 . . . . 75.04 108.904 177.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.464 HG23 HD13 ' B' ' 6' ' ' ILE . 14.6 t -107.37 113.03 42.52 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 115.005 -0.998 . . . . 73.34 108.417 -178.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -99.05 133.21 43.65 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.586 0.754 . . . . 71.3 109.535 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.464 HG13 HD23 ' B' ' 8' ' ' LEU . 7.3 p -166.14 119.24 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.904 0 C-N-CA 123.595 0.758 . . . . 75.1 110.776 -179.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 61.51 19.29 10.2 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.052 1.341 . . . . 74.24 113.741 172.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 102.01 -2.73 51.66 Favored Glycine 0 C--N 1.351 1.376 0 CA-C-N 117.555 0.161 . . . . 54.15 112.993 -177.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 20.7 tpt180 -99.94 112.83 25.09 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.07 0.948 . . . . 72.43 109.589 175.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.449 ' HE ' HG11 ' A' ' 137' ' ' VAL . 74.9 ttt180 -108.02 93.89 4.78 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.122 0.969 . . . . 74.41 108.642 175.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.451 HG13 ' HE1' ' A' ' 164' ' ' MET . 15.0 p -94.59 149.99 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 123.318 0.647 . . . . 73.53 110.031 -178.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 32.4 t -120.85 98.55 6.06 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.734 0.814 . . . . 64.43 108.872 176.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 19.0 m -103.48 116.63 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.375 0.67 . . . . 73.42 110.951 -176.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -67.41 112.37 4.58 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 109.608 -0.516 . . . . 74.32 109.608 172.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.427 HG12 ' O ' ' A' ' 134' ' ' GLY . 23.7 pt -101.62 152.29 38.04 Favored Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 123.727 0.811 . . . . 74.52 110.283 178.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -58.85 -165.57 0.03 OUTLIER 'Trans proline' 0 N--CA 1.517 2.872 0 C-N-CA 124.568 3.512 . . . . 74.22 112.451 168.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_exo -48.9 89.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.398 3.148 0 CA-C-N 121.025 1.402 . . . . 74.15 109.867 159.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 40.17 -98.01 0.01 OUTLIER Glycine 0 CA--C 1.494 -1.267 0 CA-C-N 112.727 -2.033 . . . . 75.51 114.647 -162.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.541 HG13 HG21 ' A' ' 178' ' ' VAL . 5.5 p 173.43 161.67 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 113.116 -1.542 . . . . 75.43 107.938 -162.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.04 152.86 43.72 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.452 -0.944 . . . . 73.23 108.452 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.465 ' HG2' ' NH1' ' A' ' 187' ' ' ARG . 11.3 tp10 -50.76 130.81 25.42 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 124.008 0.923 . . . . 72.32 112.662 -174.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.83 9.35 85.07 Favored Glycine 0 C--N 1.346 1.1 0 CA-C-N 115.412 -0.813 . . . . 74.33 114.072 178.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 42.0 m -66.18 109.84 2.78 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-N 118.016 0.908 . . . . 74.23 109.087 173.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 46.7 t -88.65 90.47 3.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 123.801 0.84 . . . . 74.02 109.024 -178.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.541 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 59.6 mt -74.24 104.96 3.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 108.656 -0.868 . . . . 75.24 108.656 175.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 46.7 ttt180 -74.86 108.85 7.87 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 109.32 -0.622 . . . . 75.21 109.32 177.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.456 HG12 ' HB3' ' A' ' 174' ' ' LEU . 3.8 p -119.48 95.58 49.33 Favored Pre-proline 0 CA--C 1.554 1.114 0 C-N-CA 123.898 0.879 . . . . 71.41 108.825 174.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.691 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 51.4 Cg_exo -59.74 126.41 20.44 Favored 'Trans proline' 0 C--N 1.372 1.77 0 C-N-CA 122.495 2.13 . . . . 74.53 114.014 175.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 128.05 -30.4 3.92 Favored Glycine 0 N--CA 1.47 0.93 0 CA-C-N 114.852 -1.067 . . . . 70.43 113.774 169.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.451 ' HE1' HG13 ' A' ' 145' ' ' VAL . 69.8 mtm -95.27 3.52 54.44 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 117.191 0.495 . . . . 64.15 111.699 -178.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.516 ' HA2' HD12 ' A' ' 174' ' ' LEU . . . -90.11 -98.32 1.13 Allowed Glycine 0 C--N 1.348 1.227 0 N-CA-C 110.856 -0.898 . . . . 73.33 110.856 175.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.683 ' HA3' ' H ' ' A' ' 117' ' ' ARG . . . -61.01 101.4 0.31 Allowed Glycine 0 C--O 1.265 2.089 0 N-CA-C 111.277 -0.729 . . . . 74.5 111.277 164.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.669 ' HB3' ' HA3' ' A' ' 108' ' ' GLY . 23.4 mm-40 -64.93 105.87 1.12 Allowed 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 113.151 -1.525 . . . . 75.42 109.066 177.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 174.21 164.9 29.96 Favored Glycine 0 C--O 1.238 0.344 0 N-CA-C 110.393 -1.083 . . . . 64.21 110.393 -175.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . 0.58 ' ND2' ' HB3' ' A' ' 105' ' ' LEU . 2.4 t-20 -60.8 -72.01 0.3 Allowed Pre-proline 0 CA--C 1.563 1.457 0 CA-C-O 116.657 -1.639 . . . . 63.54 112.116 -164.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.524 ' HD3' ' HB3' ' A' ' 169' ' ' ASN . 22.4 Cg_exo -65.65 115.75 3.56 Favored 'Trans proline' 0 C--N 1.389 2.71 0 CA-C-N 123.569 2.31 . . . . 73.02 109.854 171.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.601 ' HD3' HG12 ' A' ' 90' ' ' VAL . 8.7 Cg_exo -38.45 123.0 0.66 Allowed 'Trans proline' 0 C--N 1.375 1.965 1 C-N-CA 125.671 4.247 . . . . 71.25 117.42 -166.48 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -88.0 127.25 8.45 Favored Glycine 0 C--N 1.366 2.225 0 N-CA-C 111.112 -0.795 . . . . 72.4 111.112 164.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.691 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 4.9 m-20 -61.3 136.85 58.19 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.994 0.917 . . . . 71.14 111.792 -169.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.532 HD11 ' HB3' ' A' ' 121' ' ' ALA . 32.3 tp -113.7 126.93 55.79 Favored 'General case' 0 C--N 1.343 0.292 0 N-CA-C 109.786 -0.449 . . . . 74.2 109.786 173.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 83.7 mt -95.36 90.06 5.67 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.296 -0.865 . . . . 72.12 108.879 178.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.541 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 81.9 mt -70.07 88.51 0.6 Allowed 'General case' 0 C--N 1.354 0.799 0 N-CA-C 109.282 -0.636 . . . . 74.52 109.282 174.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 17.1 t -82.22 101.32 6.86 Favored 'Isoleucine or valine' 0 C--O 1.246 0.895 0 N-CA-C 105.54 -2.022 . . . . 71.11 105.54 175.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.541 HG21 HG13 ' A' ' 153' ' ' VAL . 6.0 p -71.2 136.38 25.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 115.217 -0.901 . . . . 74.13 111.01 -171.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.536 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 30.7 mmt180 -119.7 120.78 37.6 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.745 -1.576 . . . . 73.42 106.745 169.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 32.7 mt -74.82 147.2 41.39 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 109.062 -0.718 . . . . 74.04 109.062 171.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.422 ' HA ' ' HD3' ' A' ' 182' ' ' PRO . 18.5 mt -53.73 150.46 13.65 Favored Pre-proline 0 N--CA 1.484 1.241 0 C-N-CA 123.662 0.785 . . . . 73.22 112.936 -167.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 181' ' ' LEU . 24.2 Cg_exo -66.95 8.8 0.31 Allowed 'Trans proline' 0 C--N 1.387 2.558 0 C-N-CA 124.312 3.342 . . . . 74.32 113.921 176.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -60.65 103.11 0.34 Allowed Pre-proline 0 CA--C 1.562 1.423 0 C-N-CA 125.377 1.471 . . . . 73.35 107.938 165.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -80.86 26.17 0.61 Allowed 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 123.636 2.89 . . . . 61.24 115.471 -162.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 77.3 t -96.08 -58.94 3.44 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.908 0 CA-C-O 118.644 -0.693 . . . . 72.34 111.15 -173.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -139.41 91.77 2.52 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 119.191 0.905 . . . . 72.31 110.575 -177.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . 0.465 ' NH1' ' HG2' ' A' ' 155' ' ' GLU . 44.8 ttp85 -101.26 103.8 14.82 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.073 0.949 . . . . 75.51 109.526 178.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.412 HD22 ' O ' ' A' ' 153' ' ' VAL . 51.2 tp -71.02 141.47 50.95 Favored 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 124.103 0.961 . . . . 74.21 111.218 179.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . 0.421 ' HG3' ' HB3' ' A' ' 155' ' ' GLU . 34.2 tt0 -151.8 126.1 9.33 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.822 1.249 . . . . 70.31 109.825 -175.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 70.15 -81.93 0.35 Allowed Glycine 0 C--N 1.352 1.424 0 N-CA-C 111.625 -0.59 . . . . 65.41 111.625 -176.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -147.88 -10.08 0.4 Allowed 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 125.349 1.46 . . . . 72.32 109.882 166.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -101.06 148.31 25.2 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.325 1.05 . . . . 72.32 111.205 -176.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 188' ' ' LEU . 14.4 mt -90.92 159.89 15.96 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.26 1.024 . . . . 74.25 110.782 -176.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.489 ' HA ' ' HB2' ' A' ' 250' ' ' TYR . 41.8 m-85 -126.95 110.46 13.02 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.375 1.07 . . . . 73.14 108.919 173.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.5 ' HB1' HD21 ' A' ' 251' ' ' LEU . . . -125.88 166.95 15.95 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.217 1.007 . . . . 74.34 110.796 -178.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 24.5 m -112.9 147.42 37.08 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 108.493 -0.928 . . . . 70.21 108.493 171.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.508 HD21 HD12 ' A' ' 251' ' ' LEU . 50.8 tp -139.55 113.37 8.64 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.423 0.689 . . . . 74.1 109.51 -173.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -89.03 124.76 34.59 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 108.402 -0.962 . . . . 63.3 108.402 174.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.9 p -140.47 131.3 13.85 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 124.276 1.031 . . . . 74.33 108.966 -174.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -72.74 150.24 49.85 Favored 'Trans proline' 0 C--N 1.379 2.139 0 C-N-CA 121.554 1.503 . . . . 70.05 110.973 173.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -50.94 -46.93 87.73 Favored Pre-proline 0 CA--C 1.558 1.278 0 N-CA-C 114.654 1.353 . . . . 71.34 114.654 -173.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -52.85 -46.58 32.7 Favored 'Trans proline' 0 C--N 1.383 2.394 0 C-N-CA 121.895 1.73 . . . . 73.32 113.754 176.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.408 HG22 ' HE1' ' C' ' 277' ' ' TYR . 20.3 mt -72.54 -30.28 33.65 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 CA-C-N 115.68 -0.691 . . . . 71.02 110.403 -176.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.3 -42.66 75.13 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.205 0.602 . . . . 74.14 111.909 175.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 50.1 t -71.47 -48.62 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 123.903 0.881 . . . . 64.22 111.847 -176.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 53.2 t -87.49 -34.38 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-N 115.731 -0.668 . . . . 74.41 111.472 -173.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 85.21 113.88 0.74 Allowed Glycine 0 C--N 1.337 0.637 0 N-CA-C 111.989 -0.445 . . . . 72.35 111.989 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.431 ' HA3' ' CE1' ' C' ' 277' ' ' TYR . . . -149.7 -136.52 2.62 Favored Glycine 0 C--O 1.219 -0.805 0 CA-C-O 119.386 -0.675 . . . . 73.32 111.747 -178.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.481 ' HZ3' ' HB2' ' A' ' 209' ' ' LYS . 8.4 mtmp? -114.92 129.98 56.82 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 117.684 0.742 . . . . 73.34 110.444 -177.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.449 HG23 HD22 ' A' ' 197' ' ' LEU . 7.1 m -128.31 157.72 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.711 1.205 . . . . 63.11 108.489 171.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . 0.476 HH11 ' HG2' ' A' ' 220' ' ' GLU . 7.6 tpp180 -87.98 122.09 31.17 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 109.307 -0.627 . . . . 74.32 109.307 -175.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -99.69 110.98 23.36 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.943 -0.762 . . . . 74.41 108.943 176.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 17.0 tpt -82.37 116.48 21.88 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.701 -0.852 . . . . 74.15 108.701 177.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 19.7 p -108.23 -172.29 2.03 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.024 0.53 . . . . 74.1 109.583 -176.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 81.3 mt -67.15 -26.14 66.51 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.861 0.864 . . . . 73.14 112.372 -176.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -105.26 -19.19 13.88 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.15 0.58 . . . . 64.44 111.989 -175.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 152.68 -178.83 29.61 Favored Glycine 0 C--N 1.343 0.933 0 CA-C-O 119.92 -0.378 . . . . 63.05 112.426 -177.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -82.85 149.86 14.12 Favored 'Trans proline' 0 CA--C 1.552 1.423 0 C-N-CA 122.749 2.3 . . . . 74.13 113.545 -176.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 27.9 m -136.22 -178.81 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 125.657 1.583 . . . . 73.4 108.008 172.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.476 ' HG2' HH11 ' A' ' 211' ' ' ARG . 50.2 mt-10 -107.2 131.2 54.43 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 109.483 -0.562 . . . . 75.04 109.483 168.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 7.0 m -111.65 128.82 67.95 Favored 'Isoleucine or valine' 0 C--O 1.243 0.738 0 N-CA-C 108.242 -1.022 . . . . 74.51 108.242 167.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -78.23 99.2 6.16 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 109.001 -0.74 . . . . 70.4 109.001 177.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 14.8 p -67.64 137.53 93.09 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 124.066 0.947 . . . . 71.22 109.276 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -76.3 170.86 19.18 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 122.242 1.961 . . . . 75.51 110.958 -177.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.75 161.17 45.96 Favored 'Trans proline' 0 C--N 1.371 1.728 0 C-N-CA 121.378 1.385 . . . . 72.53 112.226 172.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 57.7 mtt-85 64.4 24.19 13.15 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 125.188 1.395 . . . . 75.13 112.02 168.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.514 HG23 HD21 ' A' ' 233' ' ' LEU . 98.6 m -68.27 102.38 1.37 Allowed 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 125.238 1.415 . . . . 64.32 111.162 -178.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -87.72 139.16 30.81 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.981 1.312 . . . . 75.32 110.88 -176.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . 0.448 ' HA ' ' HB ' ' A' ' 253' ' ' VAL . . . -68.13 156.98 36.33 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.405 0.682 . . . . 65.12 112.197 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 84.42 -19.08 20.66 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-N 115.886 -0.597 . . . . 75.54 112.929 -179.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -90.92 160.96 15.4 Favored 'General case' 0 C--N 1.351 0.672 0 C-N-CA 123.762 0.825 . . . . 74.44 110.654 178.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -115.95 114.44 24.63 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.193 0.997 . . . . 72.22 108.615 -177.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.514 HD21 HG23 ' A' ' 227' ' ' THR . 84.9 mt -75.71 118.67 18.78 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.817 0.847 . . . . 71.4 110.64 -177.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 27.2 ttm-85 -90.48 103.13 15.85 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 109.492 -0.559 . . . . 73.41 109.492 172.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.599 HD13 ' HG3' ' A' ' 238' ' ' LYS . 0.1 OUTLIER -97.17 123.54 40.97 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.477 0.711 . . . . 74.24 109.174 173.968 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -69.98 132.09 45.4 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 114.592 -1.185 . . . . 71.01 113.48 -169.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 79.44 3.3 88.67 Favored Glycine 0 C--N 1.354 1.575 0 CA-C-N 115.774 -0.648 . . . . 74.2 114.433 171.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.599 ' HG3' HD13 ' A' ' 235' ' ' LEU . 0.0 OUTLIER -90.38 -7.26 53.66 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 112.536 0.569 . . . . 74.1 112.536 -172.406 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -85.91 -166.07 41.6 Favored Glycine 0 C--N 1.351 1.399 0 C-N-CA 123.101 0.382 . . . . 74.43 113.791 175.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -89.64 147.95 38.96 Favored Pre-proline 0 N--CA 1.485 1.308 0 C-N-CA 123.375 0.67 . . . . 73.41 111.429 -171.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -66.3 146.75 81.87 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 123.576 2.851 . . . . 73.33 113.28 174.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -177.87 -155.3 13.79 Favored Glycine 0 CA--C 1.534 1.278 0 CA-C-O 118.969 -0.906 . . . . 73.52 112.138 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -64.49 -33.52 56.8 Favored 'Trans proline' 0 C--N 1.385 2.472 0 C-N-CA 123.746 2.964 . . . . 72.5 113.522 -176.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -89.96 21.03 3.84 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.136 0.574 . . . . 70.11 111.165 176.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 72.38 -152.14 47.69 Favored Glycine 0 C--N 1.35 1.346 0 N-CA-C 110.803 -0.919 . . . . 62.24 110.803 -169.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 27.4 mtp180 -76.29 137.43 39.89 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 109.608 -0.516 . . . . 75.41 109.608 170.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -80.39 -161.5 24.8 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 112.155 -0.378 . . . . 70.31 112.155 173.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -110.92 -174.38 2.46 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 123.734 0.814 . . . . 75.44 110.138 -178.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.539 ' HB3' ' HG ' ' A' ' 235' ' ' LEU . 18.6 tp -127.68 133.22 49.6 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.381 -0.97 . . . . 73.32 108.381 175.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.489 ' HB2' ' HA ' ' A' ' 194' ' ' TYR . 3.1 m-85 -96.55 126.34 41.67 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 108.611 -0.885 . . . . 71.3 108.611 173.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.508 HD12 HD21 ' A' ' 197' ' ' LEU . 88.7 mt -115.52 108.66 16.74 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.691 -0.855 . . . . 74.54 108.691 172.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -76.65 115.87 16.8 Favored 'General case' 0 C--N 1.348 0.529 0 N-CA-C 106.817 -1.549 . . . . 75.41 106.817 -176.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.448 ' HB ' ' HA ' ' A' ' 229' ' ' ALA . 22.7 t -76.25 116.06 18.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 CA-C-N 115.548 -0.751 . . . . 71.34 110.68 -169.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -119.15 91.68 3.61 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 107.091 -1.448 . . . . 73.14 107.091 178.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.414 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 62.5 mt -81.23 129.89 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 116.469 -0.332 . . . . 74.34 110.292 -176.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 32.3 p -120.28 173.22 7.26 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.645 1.178 . . . . 74.52 109.618 173.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.1 pp -125.14 155.03 71.64 Favored Pre-proline 0 CA--C 1.562 1.433 0 N-CA-C 107.888 -1.152 . . . . 73.4 107.888 173.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' PRO . . . . . 0.638 ' HG3' ' HH ' ' C' ' 276' ' ' TYR . 37.9 Cg_endo -78.51 18.6 0.94 Allowed 'Trans proline' 0 N--CA 1.512 2.568 0 C-N-CA 123.382 2.721 . . . . 74.45 115.64 -164.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 51.67 -122.91 2.06 Favored 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 124.015 0.926 . . . . 75.12 111.959 -169.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' ARG . . . . . 0.45 ' H ' ' HD3' ' A' ' 260' ' ' ARG . 0.0 OUTLIER -67.34 149.54 50.19 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 118.679 0.672 . . . . 75.12 111.743 -169.162 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 69.8 mt -120.77 160.67 22.89 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.596 0.758 . . . . 72.32 111.657 -171.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 27.5 p -90.56 148.34 38.47 Favored Pre-proline 0 CA--C 1.556 1.183 0 CA-C-O 117.782 -1.104 . . . . 74.31 108.92 170.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' PRO . . . . . 0.506 ' O ' ' HB3' ' A' ' 266' ' ' GLU . 31.5 Cg_exo -35.23 -54.0 0.7 Allowed 'Trans proline' 0 C--N 1.394 2.932 1 C-N-CA 125.418 4.079 . . . . 74.33 117.298 -167.453 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -77.87 -38.29 46.31 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 121.962 -0.461 . . . . 71.44 111.439 -176.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -64.91 -26.54 68.36 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 122.912 0.485 . . . . 73.22 110.623 173.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' GLU . . . . . 0.506 ' HB3' ' O ' ' A' ' 263' ' ' PRO . 7.9 tp10 -63.14 -58.35 7.51 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 108.353 -0.98 . . . . 73.45 108.353 172.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -66.31 -18.31 65.28 Favored 'General case' 0 CA--C 1.553 1.086 0 CA-C-N 115.321 -0.854 . . . . 64.12 112.871 177.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 41.5 tp -78.27 -47.0 18.83 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.691 0.797 . . . . 73.14 110.412 -177.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 68.6 m95 -63.08 -38.13 89.95 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.478 -0.783 . . . . 75.0 110.495 173.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . 0.484 ' HG3' HG23 ' C' ' 206' ' ' VAL . 0.9 OUTLIER -63.45 -44.07 95.57 Favored 'General case' 0 CA--C 1.557 1.216 0 O-C-N 123.672 0.607 . . . . 73.12 111.778 175.311 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 29.8 mtmm -57.18 -49.89 74.56 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 123.124 0.57 . . . . 70.22 110.664 175.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 24.7 mt -51.73 -51.0 59.49 Favored 'General case' 0 C--O 1.216 -0.7 0 O-C-N 124.596 1.185 . . . . 71.54 110.862 175.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -68.19 -38.42 81.96 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 113.935 1.087 . . . . 72.23 113.935 -169.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -76.96 -42.79 37.68 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 123.467 0.48 . . . . 74.35 110.154 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -66.02 -30.1 70.58 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.82 -0.627 . . . . 72.24 110.899 175.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -67.71 -60.17 2.74 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.377 1.071 . . . . 75.02 109.636 177.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -60.35 -41.72 94.23 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.345 1.058 . . . . 72.14 111.017 -172.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -60.89 -20.59 62.21 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.337 0.655 . . . . 75.41 112.705 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 87.6 mtm180 -128.99 18.37 6.09 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.8 0.84 . . . . 75.15 111.005 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.022 0 CA-C-O 118.412 -0.804 . . . . 72.5 110.754 -175.734 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.476 ' SD ' ' N ' ' B' ' 1' ' ' MET . 1.0 OUTLIER . . . . . 0 N--CA 1.482 1.171 0 N-CA-C 108.775 -0.824 . . . . 74.12 108.775 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . 0.533 ' HA ' ' HE3' ' B' ' 2' ' ' LYS . 0.4 OUTLIER -70.77 90.03 0.77 Allowed 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 109.425 -0.583 . . . . 62.45 109.425 179.238 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 23.9 tm0? -113.11 160.36 18.27 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.253 1.021 . . . . 74.04 108.95 -173.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 4' ' ' SER . . . . . 0.404 ' H ' HG22 ' A' ' 126' ' ' THR . 80.7 p 59.25 -80.45 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 126.785 2.034 . . . . 52.14 111.655 -177.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 6.4 m -76.65 153.88 34.81 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 109.01 -0.737 . . . . 74.34 109.01 172.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.574 HG23 ' HA ' ' A' ' 125' ' ' LEU . 31.7 pt -128.74 173.76 13.14 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 CA-C-O 121.033 0.444 . . . . 65.34 111.207 -174.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -146.54 127.66 14.69 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.395 -0.821 . . . . 72.22 109.458 -177.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . 0.527 HD22 HD23 ' A' ' 174' ' ' LEU . 38.3 tp -73.1 150.73 42.02 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.419 0.688 . . . . 75.22 111.049 -176.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.68 -60.37 2.38 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 122.873 0.469 . . . . 73.12 111.027 176.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 67.3 mt 62.17 127.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 124.584 1.153 . . . . 74.1 110.114 -163.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 24.6 mt . . . . . 0 CA--C 1.561 1.383 0 O-C-N 121.706 -0.621 . . . . 72.11 110.318 178.389 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.638 0 N-CA-C 110.41 -0.218 . . . . 74.35 110.41 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.89 -39.57 93.74 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.449 0.699 . . . . 75.32 110.676 176.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 14.8 tp -163.08 27.85 0.09 Allowed 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 114.769 -1.105 . . . . 74.44 108.341 176.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 182' ' ' VAL . . . . . 0.68 HG21 ' HA ' ' C' ' 138' ' ' VAL . 53.9 t -80.58 113.78 20.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 115.768 -0.651 . . . . 72.43 110.892 -171.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -90.21 -40.58 12.1 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.507 -0.769 . . . . 65.24 110.231 170.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 52.65 35.86 19.36 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 124.813 1.245 . . . . 75.32 111.599 175.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 185' ' ' VAL . . . . . . . . . . . . . 48.9 t . . . . . 0 N--CA 1.483 1.178 0 C-N-CA 124.755 1.222 . . . . 74.01 110.326 -170.436 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 94.0 m . . . . . 0 N--CA 1.485 1.31 0 CA-C-O 123.722 1.725 . . . . 71.31 106.642 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 239' ' ' ALA . . . . . 0.56 ' HB2' ' H ' ' C' ' 222' ' ' ALA . . . -100.31 -178.73 3.91 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.171 -1.377 . . . . 74.42 112.592 -167.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 240' ' ' GLY . . . . . 0.429 ' HA3' ' HA ' ' C' ' 235' ' ' LEU . . . -107.34 -140.08 9.43 Favored Glycine 0 C--N 1.343 0.938 0 CA-C-N 114.589 -1.187 . . . . 71.23 110.629 176.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -133.95 147.93 51.11 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.403 0.681 . . . . 71.23 111.571 -170.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -167.95 -44.21 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.018 1.327 . . . . 70.32 109.193 176.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 243' ' ' GLN . . . . . 0.807 ' HG3' ' HG2' ' C' ' 224' ' ' PRO . 6.7 pt20 -159.45 164.1 34.82 Favored 'General case' 0 C--O 1.245 0.82 0 C-N-CA 123.969 0.908 . . . . 74.22 111.17 177.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -67.1 98.15 0.42 Allowed Glycine 0 C--N 1.355 1.633 0 O-C-N 124.179 0.924 . . . . 71.54 113.567 -169.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 245' ' ' LYS . . . . . 0.488 ' HE2' ' HB3' ' C' ' 222' ' ' ALA . 9.2 tmtm? . . . . . 0 N--CA 1.47 0.545 0 C-N-CA 123.589 0.756 . . . . 75.34 110.009 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.97 0 N-CA-C 110.542 -0.17 . . . . 71.34 110.542 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -38.3 110.38 0.13 Allowed 'General case' 0 C--N 1.363 1.183 0 C-N-CA 125.362 1.465 . . . . 70.52 114.698 -172.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 5' ' ' LYS . . . . . 0.694 ' HD2' HD11 ' C' ' 10' ' ' ILE . 23.2 mmtp -82.57 99.81 9.75 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 115.479 -0.782 . . . . 72.32 109.822 170.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -75.04 89.58 2.44 Favored 'General case' 0 C--O 1.246 0.875 0 N-CA-C 107.092 -1.447 . . . . 65.15 107.092 169.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 7' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -61.1 -28.36 69.03 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 114.917 -1.038 . . . . 73.43 112.145 -170.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 8' ' ' TYR . . . . . 0.424 ' HD1' HG23 ' C' ' 13' ' ' VAL . 64.1 m-85 -72.62 -41.44 65.54 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.356 0.662 . . . . 74.23 111.548 177.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.84 -43.05 99.62 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 123.386 0.429 . . . . 63.34 110.497 175.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 10' ' ' ILE . . . . . 0.694 HD11 ' HD2' ' C' ' 5' ' ' LYS . 73.1 mt -59.06 -44.55 91.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 O-C-N 123.956 0.785 . . . . 73.31 110.619 176.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 85.1 mt -78.69 -3.33 43.58 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 112.896 0.702 . . . . 75.53 112.896 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 61.29 39.79 97.71 Favored Glycine 0 C--N 1.356 1.655 0 O-C-N 123.302 0.376 . . . . 74.43 113.438 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 13' ' ' VAL . . . . . 0.424 HG23 ' HD1' ' C' ' 8' ' ' TYR . 11.8 m -135.69 158.49 74.09 Favored Pre-proline 0 N--CA 1.48 1.057 0 C-N-CA 125.084 1.354 . . . . 71.34 109.075 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.29 163.66 38.38 Favored 'Trans proline' 0 C--N 1.377 2.071 0 C-N-CA 122.125 1.884 . . . . 74.43 112.49 178.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 58.1 mtt180 -77.81 21.96 0.29 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.004 0.921 . . . . 74.35 111.876 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -117.33 -14.16 10.41 Favored 'General case' 0 C--O 1.243 0.749 0 C-N-CA 125.951 1.7 . . . . 71.24 108.37 178.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.15 114.97 1.34 Allowed 'General case' 0 C--N 1.356 0.879 0 C-N-CA 124.214 1.006 . . . . 75.2 110.538 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 54.4 p -74.21 167.02 22.43 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.596 0.758 . . . . 74.41 109.092 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.91 -40.68 57.44 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 124.014 0.926 . . . . 74.45 111.187 -173.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 20' ' ' GLU . . . . . 0.651 ' HA ' ' HE3' ' C' ' 23' ' ' LYS . 3.7 tm-20 -66.04 -40.79 91.27 Favored 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 124.467 1.107 . . . . 74.53 110.685 -178.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . 0.51 ' HG2' ' NH2' ' C' ' 24' ' ' ARG . 32.7 mt-10 -72.26 -34.44 68.24 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 115.651 -0.704 . . . . 73.42 111.258 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 22' ' ' ILE . . . . . 0.855 HD11 ' HB3' ' C' ' 57' ' ' LEU . 96.1 mt -68.61 -38.98 79.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 124.785 1.234 . . . . 75.54 110.16 176.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 23' ' ' LYS . . . . . 0.651 ' HE3' ' HA ' ' C' ' 20' ' ' GLU . 22.2 ttpp -62.98 -35.88 81.64 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 113.896 -1.502 . . . . 74.13 110.063 177.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 24' ' ' ARG . . . . . 0.51 ' NH2' ' HG2' ' C' ' 21' ' ' GLU . 45.6 mtm180 -77.35 -30.07 53.68 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 113.235 0.828 . . . . 73.52 113.235 173.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.03 -37.38 86.97 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 121.617 0.723 . . . . 75.32 109.918 171.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 26' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -68.52 -41.93 79.24 Favored 'General case' 0 C--O 1.209 -1.051 0 CA-C-N 113.869 -1.514 . . . . 72.31 110.474 175.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . 0.437 ' HD3' ' HG2' ' C' ' 24' ' ' ARG . 27.5 mtpp -50.89 -56.23 13.29 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 118.369 0.531 . . . . 75.33 110.385 173.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -55.61 -58.88 5.95 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 114.944 -1.026 . . . . 75.55 112.138 -177.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 87.1 mt -83.21 -21.28 33.48 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 112.894 0.702 . . . . 71.43 112.894 -169.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' C' ' 34' ' ' HIS . . . -78.97 -30.54 44.5 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 118.809 0.732 . . . . 75.32 110.406 176.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 65.1 mtm180 -73.59 -45.54 52.6 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 109.997 -0.371 . . . . 73.5 109.997 170.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.63 -46.61 84.89 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.617 0.767 . . . . 71.12 111.023 -174.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 33' ' ' TYR . . . . . 0.516 ' HD1' ' HB1' ' C' ' 43' ' ' ALA . 52.7 m-85 -90.76 4.72 50.84 Favored 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 123.466 0.706 . . . . 72.14 112.071 -178.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 34' ' ' HIS . . . . . 0.474 ' HB2' ' O ' ' C' ' 30' ' ' ALA . 41.8 t60 -60.64 113.35 7.4 Favored Pre-proline 0 N--CA 1.49 1.551 0 CA-C-O 118.206 -0.902 . . . . 74.34 110.959 -177.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -48.47 -36.65 31.61 Favored 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 124.283 3.322 . . . . 72.22 115.287 -171.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -69.99 -41.35 74.52 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 122.688 0.395 . . . . 60.34 111.324 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 45.3 t -85.03 -28.71 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-O 121.036 0.446 . . . . 75.33 110.123 -175.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -139.0 80.22 1.77 Allowed 'General case' 0 C--O 1.248 0.981 0 C-N-CA 124.204 1.002 . . . . 65.41 108.83 -174.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -70.31 84.8 0.57 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 114.778 -1.101 . . . . 71.22 109.402 176.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 40' ' ' SER . . . . . 0.523 ' HB2' ' HB2' ' C' ' 43' ' ' ALA . 16.4 m -138.68 103.75 7.65 Favored Pre-proline 0 CA--C 1.542 0.655 0 CA-C-O 117.836 -1.078 . . . . 74.14 108.117 175.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' C' ' 40' ' ' SER . 5.3 Cg_exo -37.33 -54.23 1.19 Allowed 'Trans proline' 0 C--N 1.393 2.874 0 C-N-CA 124.702 3.601 . . . . 75.0 114.183 -176.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.56 -36.49 83.96 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.973 0.509 . . . . 71.01 110.698 -177.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 43' ' ' ALA . . . . . 0.523 ' HB2' ' HB2' ' C' ' 40' ' ' SER . . . -75.17 -17.51 60.37 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.168 0.587 . . . . 71.45 111.313 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -86.2 -31.93 21.48 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.333 0.653 . . . . 74.04 109.491 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -70.1 -41.74 73.63 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.57 -0.741 . . . . 75.44 109.502 170.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 46' ' ' LYS . . . . . 0.531 ' O ' HG12 ' C' ' 50' ' ' ILE . 33.6 mmtm -63.32 -36.3 83.24 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-N 115.201 -0.908 . . . . 72.32 110.468 173.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -57.2 -49.0 77.38 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.604 0.762 . . . . 71.12 109.337 174.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 48' ' ' LYS . . . . . 0.553 ' HB3' ' HE1' ' C' ' 93' ' ' PHE . 52.0 mtpt -57.87 -38.23 75.36 Favored 'General case' 0 CA--C 1.551 1.009 0 O-C-N 123.762 0.663 . . . . 72.04 111.631 175.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -76.31 -19.39 58.29 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.203 0.601 . . . . 72.33 112.267 178.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 50' ' ' ILE . . . . . 0.531 HG12 ' O ' ' C' ' 46' ' ' LYS . 28.4 mm -76.0 -38.96 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 108.474 -0.936 . . . . 75.43 108.474 171.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 51' ' ' ASN . . . . . 0.472 ' HB3' ' CD1' ' C' ' 88' ' ' PHE . 55.7 m-80 -68.42 -30.76 69.73 Favored 'General case' 0 C--O 1.217 -0.645 0 CA-C-N 114.474 -1.239 . . . . 74.04 110.736 176.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -68.51 -55.15 12.69 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.845 1.258 . . . . 75.54 110.528 175.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.26 -50.41 69.55 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 114.035 -1.438 . . . . 63.1 111.162 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -63.56 -39.41 94.33 Favored 'General case' 0 C--O 1.198 -1.638 0 CA-C-N 115.023 -0.99 . . . . 75.01 110.775 176.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 55' ' ' ALA . . . . . 0.424 ' HB3' ' CD2' ' C' ' 88' ' ' PHE . . . -56.31 -45.04 80.43 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 118.531 0.605 . . . . 60.54 112.255 -178.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 56' ' ' VAL . . . . . 0.425 ' O ' ' HB2' ' C' ' 62' ' ' LYS . 96.1 t -65.7 -46.42 89.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 CA-C-O 121.752 0.786 . . . . 72.43 109.826 173.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 57' ' ' LEU . . . . . 0.855 ' HB3' HD11 ' C' ' 22' ' ' ILE . 81.6 mt -92.37 9.54 33.7 Favored 'General case' 0 CA--C 1.56 1.344 0 N-CA-C 113.365 0.876 . . . . 75.02 113.365 -169.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 21.9 t -86.16 -24.15 26.27 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.54 0.736 . . . . 75.33 110.491 179.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -101.61 131.54 22.82 Favored Pre-proline 0 C--O 1.241 0.633 0 N-CA-C 108.336 -0.987 . . . . 72.03 108.336 174.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 60' ' ' PRO . . . . . 0.488 ' O ' ' HG2' ' C' ' 64' ' ' ARG . 73.7 Cg_exo -53.48 -32.51 63.39 Favored 'Trans proline' 0 C--N 1.375 1.934 0 C-N-CA 122.833 2.356 . . . . 73.21 111.444 164.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -68.09 -49.44 61.26 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.078 0.951 . . . . 62.13 111.561 -177.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 62' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' C' ' 56' ' ' VAL . 62.1 mttp -73.27 -23.98 60.38 Favored 'General case' 0 CA--C 1.559 1.302 0 C-N-CA 122.386 0.274 . . . . 75.43 110.751 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 -61.38 -43.3 99.1 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 109.39 -0.596 . . . . 74.14 109.39 167.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 64' ' ' ARG . . . . . 0.488 ' HG2' ' O ' ' C' ' 60' ' ' PRO . 28.5 mmm180 -68.72 -32.07 71.6 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 119.272 -0.394 . . . . 74.15 111.56 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 65' ' ' ILE . . . . . 0.437 HG21 ' HD2' ' C' ' 76' ' ' PRO . 80.1 mt -62.29 -42.19 94.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 N-CA-C 109.716 -0.475 . . . . 71.5 109.716 171.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -63.25 -44.86 93.99 Favored 'General case' 0 CA--C 1.553 1.079 0 CA-C-N 115.573 -0.739 . . . . 74.31 109.756 176.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -58.11 -42.13 85.06 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.184 0.994 . . . . 73.14 111.064 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 68' ' ' THR . . . . . 0.405 ' OG1' ' HG2' ' C' ' 76' ' ' PRO . 39.9 p -83.93 -10.31 58.05 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.602 -0.726 . . . . 74.43 112.013 -178.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -71.81 96.7 1.68 Allowed 'General case' 0 C--N 1.36 1.037 0 N-CA-C 108.197 -1.038 . . . . 75.22 108.197 171.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 104.34 30.98 4.81 Favored Glycine 0 C--N 1.346 1.104 0 CA-C-N 116.075 -0.511 . . . . 62.51 111.94 -173.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 84.9 m -146.78 -54.16 0.24 Allowed 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 103.877 -2.638 . . . . 72.34 103.877 174.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 24.7 m -86.24 141.71 29.09 Favored 'General case' 0 C--O 1.256 1.406 0 N-CA-C 104.811 -2.292 . . . . 73.35 104.811 157.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.15 -27.62 20.58 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 123.752 0.821 . . . . 73.23 111.612 -177.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -97.24 155.77 37.03 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 123.911 0.884 . . . . 53.23 109.806 176.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_exo -60.12 114.74 2.23 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 122.65 2.234 . . . . 75.14 111.079 168.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 76' ' ' PRO . . . . . 0.437 ' HD2' HG21 ' C' ' 65' ' ' ILE . 50.0 Cg_exo -55.97 122.74 12.3 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 123.091 2.527 . . . . 71.22 111.596 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -43.63 139.85 4.74 Favored 'Trans proline' 0 C--N 1.39 2.725 0 C-N-CA 124.31 3.34 . . . . 74.4 114.849 -166.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 78' ' ' PRO . . . . . 0.501 ' HB2' ' HA2' ' C' ' 82' ' ' GLY . 25.9 Cg_endo -58.86 145.25 97.42 Favored 'Trans proline' 0 C--N 1.387 2.564 0 C-N-CA 123.483 2.788 . . . . 74.44 113.743 -172.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 79' ' ' PRO . . . . . 0.582 ' HB2' ' HA2' ' C' ' 142' ' ' GLY . 51.0 Cg_exo -55.93 163.24 6.03 Favored 'Trans proline' 0 C--N 1.385 2.458 0 C-N-CA 123.559 2.84 . . . . 70.12 112.923 176.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -55.12 87.07 0.04 OUTLIER 'Trans proline' 0 C--N 1.392 2.832 0 C-N-CA 123.569 2.846 . . . . 74.31 112.855 -177.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 145.65 -52.19 0.58 Allowed Glycine 0 C--N 1.339 0.742 0 CA-C-N 113.829 -1.532 . . . . 75.2 109.443 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . 0.501 ' HA2' ' HB2' ' C' ' 78' ' ' PRO . . . 144.34 -170.84 25.95 Favored Glycine 0 C--N 1.344 0.998 0 C-N-CA 123.526 0.584 . . . . 75.13 111.653 -177.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -86.93 104.18 16.01 Favored 'General case' 0 C--O 1.244 0.806 0 C-N-CA 123.653 0.781 . . . . 73.4 109.273 171.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -86.55 -176.21 5.75 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.384 -0.598 . . . . 75.11 109.384 170.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 85' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -161.1 70.98 0.39 Allowed 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 107.507 -1.294 . . . . 74.41 107.507 177.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 55.0 m -36.78 95.18 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 117.875 2.546 . . . . 52.42 117.875 -164.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 75.55 6.68 81.65 Favored Glycine 0 C--N 1.355 1.608 0 C-N-CA 123.044 0.354 . . . . 74.34 113.292 174.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 88' ' ' PHE . . . . . 0.472 ' CD1' ' HB3' ' C' ' 51' ' ' ASN . 11.9 m-85 -105.59 131.13 53.35 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 107.489 -1.3 . . . . 74.44 107.489 -177.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -80.99 81.97 7.09 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 120.966 0.412 . . . . 72.23 111.337 -170.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 90' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -43.58 -36.14 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 C-N-CA 125.405 1.482 . . . . 54.42 112.74 171.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -62.66 -20.09 64.47 Favored 'General case' 0 CA--C 1.561 1.394 0 C-N-CA 124.352 1.061 . . . . 75.25 112.884 -175.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -119.82 7.37 10.97 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 122.865 0.466 . . . . 75.53 111.008 178.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 93' ' ' PHE . . . . . 0.553 ' HE1' ' HB3' ' C' ' 48' ' ' LYS . 13.9 m-30 -83.9 -174.28 5.19 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.129 -0.982 . . . . 72.45 112.114 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 97.6 p -71.3 161.8 30.48 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.839 1.052 . . . . 52.11 113.839 -167.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 95' ' ' GLU . . . . . 0.401 ' O ' ' HG3' ' C' ' 99' ' ' GLU . 42.9 mt-10 -59.44 -56.34 23.25 Favored 'General case' 0 C--O 1.215 -0.745 0 CA-C-N 114.249 -1.342 . . . . 72.35 110.837 174.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -51.03 -46.56 61.63 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 124.169 0.918 . . . . 74.24 111.867 -174.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 97' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -58.98 -53.44 58.39 Favored 'General case' 0 CA--C 1.554 1.13 0 CA-C-N 115.406 -0.816 . . . . 64.25 110.158 174.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -74.18 0.84 12.75 Favored 'General case' 0 CA--C 1.56 1.339 0 N-CA-C 112.611 0.597 . . . . 71.33 112.611 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 99' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' C' ' 95' ' ' GLU . 50.1 mt-10 -98.27 -50.74 4.23 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.984 0.914 . . . . 74.43 110.393 172.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 31.3 tp -71.07 -52.83 17.17 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.892 0.877 . . . . 73.23 110.463 -177.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 101' ' ' PHE . . . . . 0.462 ' O ' ' HG ' ' C' ' 105' ' ' LEU . 87.4 m-85 -86.22 -10.02 55.43 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.435 -0.802 . . . . 75.04 110.781 179.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -43.04 -55.73 4.79 Favored Glycine 0 CA--C 1.545 1.924 0 CA-C-O 118.479 -1.178 . . . . 74.41 115.026 176.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -37.6 -35.61 0.33 Allowed 'Trans proline' 0 C--N 1.392 2.837 0 C-N-CA 125.136 3.891 . . . . 64.35 116.279 175.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -130.9 24.59 4.27 Favored Glycine 0 C--N 1.349 1.276 0 CA-C-O 118.798 -1.001 . . . . 73.42 113.837 -174.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 105' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' C' ' 101' ' ' PHE . 38.1 mt . . . . . 0 N--CA 1.489 1.521 0 CA-C-N 118.038 0.919 . . . . 75.43 111.72 173.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 116' ' ' GLY . . . . . 0.443 ' HA2' ' HA3' ' C' ' 168' ' ' GLY . . . . . . . . 0 CA--C 1.524 0.611 0 N-CA-C 113.963 0.345 . . . . 54.4 113.963 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 117' ' ' ARG . . . . . 0.438 ' HG2' ' H ' ' C' ' 118' ' ' ASP . 56.1 ttt-85 -80.3 175.06 10.99 Favored 'General case' 0 C--O 1.252 1.214 0 C-N-CA 123.615 0.766 . . . . 74.32 109.684 174.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 118' ' ' ASP . . . . . 0.438 ' H ' ' HG2' ' C' ' 117' ' ' ARG . 3.6 p30 -65.38 155.81 34.2 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 121.687 0.756 . . . . 75.42 111.201 172.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 119' ' ' LEU . . . . . . . . . . . . . 61.9 tp -109.01 161.67 14.95 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 107.189 -1.411 . . . . 75.21 107.189 172.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 38.8 ttt-85 -131.31 119.84 22.31 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 118.77 0.714 . . . . 72.31 109.322 175.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 121' ' ' ALA . . . . . 0.412 ' HB1' HD11 ' C' ' 174' ' ' LEU . . . -138.09 118.16 13.46 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 124.129 0.972 . . . . 75.44 108.68 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 122' ' ' GLU . . . . . 0.431 ' HB3' ' HB ' ' C' ' 177' ' ' VAL . 13.0 pt-20 -108.03 148.3 29.94 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 122.339 0.255 . . . . 74.12 110.457 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -140.71 145.89 42.08 Favored Pre-proline 0 N--CA 1.481 1.109 0 C-N-CA 122.833 0.453 . . . . 73.3 111.607 -170.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -75.88 130.11 12.13 Favored 'Trans proline' 0 C--N 1.377 2.038 0 C-N-CA 122.509 2.139 . . . . 72.51 110.559 166.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 125' ' ' LEU . . . . . . . . . . . . . 30.2 tp -145.14 148.58 33.76 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 108.668 -0.864 . . . . 75.32 108.668 -175.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 126' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -94.53 158.5 15.51 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 120.911 0.386 . . . . 61.53 110.488 -178.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 127' ' ' LEU . . . . . 0.523 HD11 ' HD2' ' C' ' 186' ' ' PHE . 56.9 mt -62.33 -42.56 99.48 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.656 1.182 . . . . 62.25 110.643 173.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -62.2 -38.05 87.66 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 114.495 -1.229 . . . . 75.24 110.725 173.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -79.01 -17.93 54.5 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 122.968 0.507 . . . . 75.51 111.592 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -76.63 -40.29 49.71 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-O 121.719 0.771 . . . . 73.14 109.428 172.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 131' ' ' PHE . . . . . 0.571 ' HB2' HD11 ' C' ' 215' ' ' LEU . 76.8 t80 -63.09 -34.89 78.56 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 126.065 1.746 . . . . 75.55 111.873 171.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 132' ' ' HIS . . . . . . . . . . . . . 36.6 m170 -78.35 -59.26 2.85 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 122.381 0.272 . . . . 70.15 110.345 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 53.03 -127.39 35.48 Favored Glycine 0 CA--C 1.537 1.426 0 O-C-N 124.077 0.86 . . . . 65.31 113.955 177.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.51 -146.33 38.72 Favored Glycine 0 C--N 1.349 1.303 0 C-N-CA 123.24 0.448 . . . . 73.12 113.646 177.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -92.01 112.79 24.86 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.337 1.055 . . . . 73.03 109.618 -177.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 136' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -126.64 133.36 51.01 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.389 0.675 . . . . 72.12 110.432 -175.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 137' ' ' VAL . . . . . . . . . . . . . 34.0 m -73.11 138.95 20.32 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 CA-C-O 120.976 0.417 . . . . 73.11 111.479 -176.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 138' ' ' VAL . . . . . 0.68 ' HA ' HG21 ' B' ' 182' ' ' VAL . 7.3 p -152.05 135.53 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.325 1.05 . . . . 72.14 108.986 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 139' ' ' GLU . . . . . 0.512 ' HA ' ' O ' ' C' ' 143' ' ' ARG . 0.0 OUTLIER -117.69 116.25 26.67 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.19 0.596 . . . . 74.31 109.927 170.742 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 140' ' ' VAL . . . . . . . . . . . . . 13.8 p -164.39 138.33 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.823 0.849 . . . . 73.25 110.12 174.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 62.58 13.94 6.68 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 124.869 1.268 . . . . 65.0 113.72 170.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 142' ' ' GLY . . . . . 0.582 ' HA2' ' HB2' ' C' ' 79' ' ' PRO . . . 120.18 -31.63 5.21 Favored Glycine 0 C--N 1.348 1.248 0 CA-C-O 120.103 -0.276 . . . . 52.4 112.814 -178.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 143' ' ' ARG . . . . . 0.512 ' O ' ' HA ' ' C' ' 139' ' ' GLU . 9.8 mmm180 -80.33 108.37 13.89 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.034 0.534 . . . . 75.05 111.954 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 48.6 ttt180 -113.62 91.31 3.6 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 107.635 -1.246 . . . . 71.51 107.635 166.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 145' ' ' VAL . . . . . . . . . . . . . 13.0 p -157.34 159.24 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.142 0.577 . . . . 75.03 111.174 -168.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 20.3 m -78.19 106.89 10.39 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.76 0.824 . . . . 73.22 110.146 168.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 147' ' ' VAL . . . . . 0.495 ' HB ' ' HE2' ' C' ' 164' ' ' MET . 2.6 p -80.52 119.8 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 CA-C-O 121.044 0.45 . . . . 72.53 110.137 174.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 48.0 ttt180 -83.82 95.15 8.37 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.595 -0.729 . . . . 74.22 110.068 177.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 149' ' ' ILE . . . . . . . . . . . . . 38.3 pt -118.71 105.19 46.06 Favored Pre-proline 0 CA--C 1.547 0.861 0 N-CA-C 107.647 -1.242 . . . . 74.42 107.647 164.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -53.88 166.78 1.31 Allowed 'Trans proline' 0 C--N 1.384 2.428 0 C-N-CA 123.459 2.772 . . . . 61.44 113.903 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -44.12 108.85 0.13 Allowed 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 123.305 2.67 . . . . 73.2 113.425 171.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 152' ' ' GLY . . . . . . . . . . . . . . . 154.21 87.98 0.06 OUTLIER Glycine 0 C--N 1.349 1.292 0 N-CA-C 114.8 0.68 . . . . 63.11 114.8 -176.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 153' ' ' VAL . . . . . 0.528 HG22 HG12 ' C' ' 178' ' ' VAL . 12.4 p -165.53 155.54 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.617 0 C-N-CA 123.249 0.62 . . . . 74.01 110.656 172.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 154' ' ' ARG . . . . . 0.463 ' HD2' ' HG2' ' C' ' 187' ' ' ARG . 30.3 ttp180 -155.64 150.86 26.8 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 124.071 0.948 . . . . 75.32 110.419 -172.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 155' ' ' GLU . . . . . 0.401 ' N ' ' HG2' ' C' ' 154' ' ' ARG . 10.3 tp10 -42.93 130.66 4.3 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 125.589 1.556 . . . . 74.51 113.263 -177.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 84.53 -5.79 79.85 Favored Glycine 0 C--N 1.348 1.199 0 CA-C-N 115.827 -0.624 . . . . 75.21 113.252 178.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 157' ' ' SER . . . . . 0.485 ' O ' HG11 ' C' ' 178' ' ' VAL . 37.6 t -78.58 129.5 34.87 Favored 'General case' 0 C--O 1.245 0.82 0 N-CA-C 108.622 -0.881 . . . . 75.43 108.622 173.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 97.9 t -105.99 100.44 10.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 N-CA-C 108.261 -1.015 . . . . 72.31 108.261 -177.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 159' ' ' ILE . . . . . 0.658 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 26.1 mt -71.25 96.67 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.672 0 CA-C-N 115.046 -0.979 . . . . 72.31 108.85 -175.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 4.6 ttt180 -79.75 96.58 6.31 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 107.551 -1.277 . . . . 75.13 107.551 175.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 161' ' ' VAL . . . . . . . . . . . . . 2.2 p -97.99 108.44 46.46 Favored Pre-proline 0 C--O 1.247 0.938 0 CA-C-N 114.804 -1.089 . . . . 75.24 108.588 -178.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -52.05 115.97 2.49 Favored 'Trans proline' 0 C--N 1.387 2.572 0 C-N-CA 123.483 2.788 . . . . 75.23 114.55 -173.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 163' ' ' GLY . . . . . 0.574 ' H ' ' HA ' ' C' ' 173' ' ' ASP . . . 91.49 -13.82 65.53 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 117.513 1.765 . . . . 53.54 117.513 168.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 164' ' ' MET . . . . . 0.495 ' HE2' ' HB ' ' C' ' 147' ' ' VAL . 47.7 ttm -68.13 -19.07 64.79 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-N 120.45 2.125 . . . . 73.35 112.659 -170.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . -94.77 -112.54 2.51 Favored Glycine 0 C--N 1.347 1.181 0 CA-C-O 119.332 -0.704 . . . . 73.32 111.886 175.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 166' ' ' GLY . . . . . 0.413 ' HA3' ' HB3' ' C' ' 171' ' ' PRO . . . 86.65 67.23 1.36 Allowed Glycine 0 C--N 1.362 2.007 0 CA-C-N 118.057 0.929 . . . . 75.44 113.866 176.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 167' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -79.65 99.88 7.58 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 107.124 -1.436 . . . . 74.2 107.124 172.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 168' ' ' GLY . . . . . 0.443 ' HA3' ' HA2' ' C' ' 116' ' ' GLY . . . 153.31 -85.61 0.14 Allowed Glycine 0 C--O 1.213 -1.164 0 CA-C-O 118.432 -1.205 . . . . 13.44 110.397 -169.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 169' ' ' ASN . . . . . 0.53 ' HB3' ' HD3' ' C' ' 170' ' ' PRO . 2.9 t-20 179.95 -59.78 0.0 OUTLIER Pre-proline 0 N--CA 1.499 1.985 0 CA-C-O 117.387 -1.292 . . . . 62.44 112.189 163.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 170' ' ' PRO . . . . . 0.53 ' HD3' ' HB3' ' C' ' 169' ' ' ASN . 19.4 Cg_exo -67.77 100.24 0.59 Allowed 'Trans proline' 0 C--N 1.399 3.208 0 CA-C-N 122.623 1.972 . . . . 73.55 109.688 165.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 171' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' C' ' 170' ' ' PRO . 14.2 Cg_exo -71.05 132.06 20.58 Favored 'Trans proline' 0 C--N 1.362 1.267 0 C-N-CA 122.901 2.401 . . . . 74.02 114.469 -162.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -71.44 -72.87 0.86 Allowed Glycine 0 C--N 1.347 1.178 0 O-C-N 124.176 0.922 . . . . 74.42 111.331 173.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 173' ' ' ASP . . . . . 0.574 ' HA ' ' H ' ' C' ' 163' ' ' GLY . 4.9 p-10 -172.67 178.32 2.7 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.201 0.6 . . . . 74.51 111.897 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 174' ' ' LEU . . . . . 0.484 ' HB3' ' HB3' ' C' ' 164' ' ' MET . 12.6 tp -122.09 139.17 54.04 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.169 0.988 . . . . 75.22 109.002 170.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 85.9 mt -101.39 87.11 3.12 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.67 1.188 . . . . 72.15 109.594 177.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 176' ' ' LEU . . . . . 0.658 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 83.9 mt -74.22 92.93 2.28 Favored 'General case' 0 C--N 1.351 0.671 0 C-N-CA 123.09 0.556 . . . . 74.33 109.557 173.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 177' ' ' VAL . . . . . 0.431 ' HB ' ' HB3' ' C' ' 122' ' ' GLU . 22.2 t -84.51 113.52 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 108.619 -0.882 . . . . 75.23 108.619 -177.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 178' ' ' VAL . . . . . 0.528 HG12 HG22 ' C' ' 153' ' ' VAL . 7.5 p -80.76 125.17 39.26 Favored 'Isoleucine or valine' 0 C--O 1.246 0.908 0 CA-C-O 121.798 0.809 . . . . 74.01 111.036 -176.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 179' ' ' ARG . . . . . . . . . . . . . 24.3 mmt180 -110.54 122.9 48.88 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 114.028 -1.442 . . . . 74.42 107.224 169.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 180' ' ' LEU . . . . . 0.477 HD13 HD23 ' C' ' 127' ' ' LEU . 92.5 mt -85.69 149.57 25.21 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 122.774 0.43 . . . . 73.43 111.431 -177.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 181' ' ' LEU . . . . . 0.406 ' HB3' ' HD2' ' C' ' 182' ' ' PRO . 26.4 mt -65.4 165.36 18.52 Favored Pre-proline 0 CA--C 1.565 1.551 0 C-N-CA 124.624 1.17 . . . . 74.24 111.711 -178.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 182' ' ' PRO . . . . . 0.406 ' HD2' ' HB3' ' C' ' 181' ' ' LEU . 12.7 Cg_exo -36.04 -20.88 0.04 OUTLIER 'Trans proline' 0 C--N 1.403 3.423 1 C-N-CA 125.642 4.228 . . . . 73.32 118.701 -177.357 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 183' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -104.94 99.54 19.66 Favored Pre-proline 0 CA--C 1.562 1.44 0 CA-C-N 119.495 1.043 . . . . 72.0 109.123 167.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 184' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -99.26 66.39 0.06 OUTLIER 'Trans proline' 0 C--N 1.38 2.221 0 C-N-CA 123.961 3.107 . . . . 74.25 110.713 174.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 185' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 21.6 t -92.63 -45.06 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-N 115.487 -0.779 . . . . 72.23 110.144 -165.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 186' ' ' PHE . . . . . 0.523 ' HD2' HD11 ' C' ' 127' ' ' LEU . 71.1 m-85 -100.16 114.57 28.05 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.506 0.67 . . . . 61.44 111.354 -167.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 187' ' ' ARG . . . . . 0.662 ' HB3' ' HB3' ' C' ' 194' ' ' TYR . 3.2 tmt_? -95.77 107.4 19.63 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.878 1.271 . . . . 75.14 108.72 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 188' ' ' LEU . . . . . . . . . . . . . 41.1 tp -82.32 141.78 32.59 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.835 0.68 . . . . 74.14 112.835 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -145.16 108.68 4.65 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 107.103 -1.443 . . . . 73.21 107.103 161.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 71.36 -92.5 0.5 Allowed Glycine 0 C--N 1.356 1.649 0 O-C-N 123.225 0.328 . . . . 74.2 112.534 -178.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 191' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -117.92 -26.53 6.43 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.874 0.87 . . . . 75.25 110.114 174.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -86.54 153.25 21.97 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.557 -0.747 . . . . 65.13 110.731 -166.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 193' ' ' LEU . . . . . 0.426 HD12 HD13 ' C' ' 215' ' ' LEU . 84.1 mt -120.3 163.7 17.42 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.6 -0.727 . . . . 65.15 111.172 -175.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 194' ' ' TYR . . . . . 0.662 ' HB3' ' HB3' ' C' ' 187' ' ' ARG . 33.8 t80 -136.64 107.56 6.67 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 114.723 -1.126 . . . . 75.43 108.884 169.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 195' ' ' ALA . . . . . 0.488 ' HA ' ' O ' ' C' ' 185' ' ' VAL . . . -105.01 -175.33 2.76 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.725 0.81 . . . . 65.11 110.822 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 59.1 m -128.31 124.05 35.54 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 107.912 -1.144 . . . . 53.42 107.912 164.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 197' ' ' LEU . . . . . 0.426 HD13 ' HB2' ' C' ' 212' ' ' ALA . 35.4 tp -98.99 126.74 44.75 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 122.889 0.476 . . . . 73.5 110.743 -176.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -79.15 101.54 7.98 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.038 0.935 . . . . 64.33 108.858 177.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 199' ' ' VAL . . . . . 0.545 ' HA ' HG12 ' C' ' 210' ' ' VAL . 40.3 t -119.38 106.99 41.8 Favored Pre-proline 0 N--CA 1.478 0.936 0 C-N-CA 123.667 0.787 . . . . 73.12 109.307 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 200' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.23 147.94 67.43 Favored 'Trans proline' 0 C--N 1.373 1.836 0 C-N-CA 121.683 1.589 . . . . 73.11 111.45 175.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 201' ' ' ALA . . . . . 0.418 ' O ' HG21 ' C' ' 205' ' ' VAL . . . -55.44 -45.66 99.83 Favored Pre-proline 0 CA--C 1.551 1.016 0 N-CA-C 113.998 1.11 . . . . 74.35 113.998 -171.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 202' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -52.35 -47.32 27.57 Favored 'Trans proline' 0 C--N 1.385 2.468 0 C-N-CA 121.411 1.407 . . . . 63.15 112.569 174.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 203' ' ' ILE . . . . . 0.513 ' HA ' HG13 ' C' ' 206' ' ' VAL . 51.3 mt -69.02 -32.59 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 123.15 0.58 . . . . 74.02 111.195 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.85 -33.84 75.54 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.688 0.795 . . . . 75.02 112.145 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 205' ' ' VAL . . . . . 0.418 HG21 ' O ' ' C' ' 201' ' ' ALA . 43.1 t -85.75 -38.35 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-N 116.072 -0.513 . . . . 74.52 111.693 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 206' ' ' VAL . . . . . 0.513 HG13 ' HA ' ' C' ' 203' ' ' ILE . 14.4 p -79.09 -35.67 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 CA-C-O 120.952 0.406 . . . . 74.12 111.175 -174.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 79.8 66.8 1.63 Allowed Glycine 0 N--CA 1.435 -1.406 0 CA-C-N 115.185 -0.916 . . . . 63.21 111.948 -167.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -98.08 -137.22 9.58 Favored Glycine 0 C--O 1.244 0.766 0 N-CA-C 111.176 -0.769 . . . . 51.32 111.176 174.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 209' ' ' LYS . . . . . 0.413 ' HG2' ' HA ' ' C' ' 222' ' ' ALA . 7.2 mtmp? -134.22 133.15 40.56 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.337 0.655 . . . . 72.44 110.25 174.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 210' ' ' VAL . . . . . 0.545 HG12 ' HA ' ' C' ' 199' ' ' VAL . 35.8 m -114.84 178.49 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.012 1.325 . . . . 71.52 107.936 169.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 211' ' ' ARG . . . . . 0.6 ' HD3' ' HB2' ' C' ' 218' ' ' PRO . 24.8 ttm105 -131.56 130.24 42.01 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 118.454 0.57 . . . . 75.53 112.204 -177.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 212' ' ' ALA . . . . . 0.426 ' HB2' HD13 ' C' ' 197' ' ' LEU . . . -98.59 115.35 28.45 Favored 'General case' 0 C--N 1.348 0.519 0 C-N-CA 124.356 1.062 . . . . 74.43 108.248 169.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 213' ' ' MET . . . . . 0.564 ' HA ' ' HA ' ' C' ' 218' ' ' PRO . 2.3 tmm? -71.68 101.59 2.58 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 107.185 -1.413 . . . . 63.12 107.185 172.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 214' ' ' THR . . . . . 0.427 HG22 ' H ' ' C' ' 215' ' ' LEU . 0.6 OUTLIER -101.74 174.63 5.87 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 120.991 0.424 . . . . 72.34 110.348 -171.037 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 215' ' ' LEU . . . . . 0.571 HD11 ' HB2' ' C' ' 131' ' ' PHE . 26.5 mt -61.49 -43.42 98.9 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.793 1.637 . . . . 75.24 112.755 -173.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.86 17.5 19.36 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 115.189 -0.914 . . . . 71.0 110.927 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 127.86 159.73 10.18 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-N 115.492 -0.776 . . . . 74.41 112.567 173.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 218' ' ' PRO . . . . . 0.6 ' HB2' ' HD3' ' C' ' 211' ' ' ARG . 70.3 Cg_endo -75.31 102.88 1.65 Allowed 'Trans proline' 0 CA--C 1.561 1.845 0 C-N-CA 122.764 2.309 . . . . 64.03 114.292 -178.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 219' ' ' VAL . . . . . . . . . . . . . 12.6 p -83.87 144.28 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 123.729 0.812 . . . . 52.53 110.097 -178.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 220' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -97.36 109.83 22.5 Favored 'General case' 0 C--O 1.246 0.872 0 CA-C-O 121.66 0.743 . . . . 72.32 109.636 174.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 221' ' ' VAL . . . . . 0.434 HG13 HD21 ' C' ' 233' ' ' LEU . 49.2 t -80.12 138.19 20.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 125.114 1.366 . . . . 74.03 111.136 -178.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 222' ' ' ALA . . . . . 0.56 ' H ' ' HB2' ' B' ' 239' ' ' ALA . . . -89.53 118.01 28.85 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.149 0.979 . . . . 73.3 110.309 173.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 49.0 t -92.72 130.72 35.84 Favored Pre-proline 0 CA--C 1.553 1.092 0 N-CA-C 108.18 -1.044 . . . . 73.11 108.18 174.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 224' ' ' PRO . . . . . 0.807 ' HG2' ' HG3' ' B' ' 243' ' ' GLN . 21.1 Cg_exo -72.48 157.66 52.52 Favored 'Trans proline' 0 C--N 1.37 1.697 0 C-N-CA 123.561 2.84 . . . . 73.11 111.894 164.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -58.67 142.88 98.91 Favored 'Trans proline' 0 C--N 1.382 2.337 0 C-N-CA 122.368 2.045 . . . . 74.4 111.209 174.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 226' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 67.57 95.57 0.06 Allowed 'General case' 0 N--CA 1.484 1.247 0 O-C-N 124.488 1.118 . . . . 71.5 111.331 -179.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 227' ' ' THR . . . . . 0.484 HG23 HG11 ' C' ' 253' ' ' VAL . 52.9 m -140.41 123.04 16.24 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 123.222 0.609 . . . . 73.3 112.14 175.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 228' ' ' GLN . . . . . . . . . . . . . 27.7 mp0 -97.74 158.55 15.45 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-O 122.392 1.091 . . . . 74.32 111.172 171.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -67.45 148.87 50.98 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-N 113.874 -1.512 . . . . 65.31 109.357 171.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 88.71 -5.44 84.62 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-O 119.689 -0.506 . . . . 62.04 112.93 -174.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 231' ' ' ARG . . . . . 0.422 ' NH1' HE22 ' B' ' 243' ' ' GLN . 57.1 mtt180 -76.85 168.97 19.18 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 109.053 -0.721 . . . . 75.03 109.053 163.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 232' ' ' LYS . . . . . 0.609 ' HB2' ' HZ1' ' C' ' 232' ' ' LYS . 3.9 ttmp? -143.47 139.82 30.05 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.96 0.41 . . . . 74.05 112.087 -175.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 233' ' ' LEU . . . . . 0.565 HD13 ' HB2' ' C' ' 251' ' ' LEU . 2.4 mp -105.7 155.75 18.95 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.808 1.243 . . . . 74.22 109.724 -179.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 41.1 ttp85 -128.01 89.93 3.01 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 109.095 -0.706 . . . . 72.34 109.095 172.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 235' ' ' LEU . . . . . 0.511 HD12 HD23 ' C' ' 249' ' ' LEU . 72.3 mt -73.43 114.14 11.32 Favored 'General case' 0 C--N 1.359 0.995 0 N-CA-C 109.497 -0.557 . . . . 74.34 109.497 174.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 24.7 mmmt -72.55 124.17 24.68 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.956 0.902 . . . . 73.41 111.236 -177.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 72.27 37.52 59.24 Favored Glycine 0 C--N 1.35 1.307 0 O-C-N 123.832 0.708 . . . . 71.42 113.118 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 29.8 mmtm -125.32 14.77 8.32 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.836 0.854 . . . . 75.11 111.322 177.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -96.32 -162.96 33.08 Favored Glycine 0 C--N 1.348 1.245 0 N-CA-C 111.972 -0.451 . . . . 75.2 111.972 172.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 240' ' ' PHE . . . . . 0.408 ' CD1' HD21 ' C' ' 193' ' ' LEU . 3.3 m-85 -72.51 149.59 91.08 Favored Pre-proline 0 N--CA 1.477 0.899 0 C-N-CA 123.588 0.755 . . . . 75.14 111.489 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 241' ' ' PRO . . . . . 0.435 ' HD3' ' CD2' ' C' ' 131' ' ' PHE . 31.6 Cg_exo -59.49 119.25 6.36 Favored 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 124.101 3.201 . . . . 71.53 112.572 -176.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -131.34 -172.76 13.17 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-N 115.488 -0.778 . . . . 70.14 112.822 -174.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.56 -40.48 30.18 Favored 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 123.781 2.988 . . . . 71.42 112.652 -178.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -84.56 10.81 10.05 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.097 0.559 . . . . 71.42 111.854 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 120.11 -75.45 0.32 Allowed Glycine 0 C--N 1.348 1.207 0 N-CA-C 110.601 -1.0 . . . . 63.24 110.601 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 246' ' ' ARG . . . . . . . . . . . . . 30.5 mtm180 -142.46 -179.97 6.6 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.845 1.258 . . . . 71.32 109.655 175.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -89.02 -161.86 37.93 Favored Glycine 0 C--N 1.346 1.137 0 N-CA-C 112.105 -0.398 . . . . 63.23 112.105 173.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -122.71 137.96 54.75 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 117.358 0.579 . . . . 73.54 109.736 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 249' ' ' LEU . . . . . 0.511 HD23 HD12 ' C' ' 235' ' ' LEU . 21.1 tp -95.04 115.11 27.01 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.198 0.999 . . . . 74.23 110.177 -175.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 250' ' ' TYR . . . . . 0.566 ' HB3' ' HD3' ' C' ' 232' ' ' LYS . 8.6 m-85 -100.91 100.13 10.72 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.253 -0.647 . . . . 71.43 109.253 -179.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 251' ' ' LEU . . . . . 0.565 ' HB2' HD13 ' C' ' 233' ' ' LEU . 1.8 mp -96.98 138.65 34.18 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.651 -0.656 . . . . 72.0 109.923 -174.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -89.89 118.83 29.76 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.358 -0.978 . . . . 75.41 108.358 173.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 253' ' ' VAL . . . . . 0.484 HG11 HG23 ' C' ' 227' ' ' THR . 91.7 t -60.27 130.61 24.26 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 123.45 0.7 . . . . 73.5 110.842 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 254' ' ' ARG . . . . . 0.464 ' CZ ' ' HB ' ' C' ' 256' ' ' THR . 2.1 tmm_? -126.27 101.0 6.54 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 107.122 -1.436 . . . . 75.13 107.122 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 255' ' ' ILE . . . . . 0.454 ' HA ' ' O ' ' C' ' 199' ' ' VAL . 46.2 mm -73.45 125.92 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 109.577 -0.527 . . . . 75.24 109.577 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 256' ' ' THR . . . . . 0.464 ' HB ' ' CZ ' ' C' ' 254' ' ' ARG . 0.1 OUTLIER -128.09 163.47 24.55 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.102 0.961 . . . . 70.25 111.003 -175.418 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 2.8 pp -137.08 147.97 60.8 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 124.751 1.221 . . . . 75.21 107.827 173.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -79.17 15.48 1.53 Allowed 'Trans proline' 0 N--CA 1.501 1.943 0 C-N-CA 122.566 2.178 . . . . 74.41 113.089 -170.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 57.59 -84.3 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.406 1.483 . . . . 72.3 111.017 -171.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -73.09 137.83 45.48 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.215 1.006 . . . . 73.41 110.138 -177.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 261' ' ' LEU . . . . . . . . . . . . . 77.3 mt -130.16 165.03 23.17 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.756 0.822 . . . . 74.53 111.361 -178.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 14.9 p -84.09 146.4 48.41 Favored Pre-proline 0 CA--C 1.549 0.918 0 CA-C-N 114.245 -1.343 . . . . 61.23 108.854 167.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -51.38 -26.0 19.95 Favored 'Trans proline' 0 C--N 1.39 2.732 0 C-N-CA 124.256 3.304 . . . . 74.2 114.649 -172.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -66.36 -65.4 0.68 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.753 0.821 . . . . 71.04 109.754 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -56.13 -44.02 78.76 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 114.647 -1.16 . . . . 71.03 109.85 177.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 266' ' ' GLU . . . . . 0.402 ' O ' ' HG2' ' C' ' 270' ' ' LYS . 5.2 tp10 -50.44 -48.42 56.41 Favored 'General case' 0 CA--C 1.548 0.891 0 O-C-N 124.549 1.156 . . . . 73.1 110.529 179.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 267' ' ' ALA . . . . . 0.464 ' O ' ' HG2' ' C' ' 271' ' ' LYS . . . -66.57 -41.0 89.27 Favored 'General case' 0 C--N 1.355 0.835 0 CA-C-N 115.481 -0.781 . . . . 71.12 112.22 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 268' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.98 -38.42 91.0 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 120.797 0.332 . . . . 70.11 111.112 176.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -68.01 -32.56 73.03 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.39 0.676 . . . . 63.11 110.43 175.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 270' ' ' LYS . . . . . 0.596 ' HZ2' ' HB3' ' C' ' 270' ' ' LYS . 4.0 mmmp? -58.99 -49.39 78.05 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.048 0.539 . . . . 75.43 109.721 173.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 271' ' ' LYS . . . . . 0.472 ' HE2' ' HA ' ' C' ' 271' ' ' LYS . 10.8 mmpt? -59.54 -48.76 80.41 Favored 'General case' 0 C--O 1.249 1.033 0 O-C-N 124.252 0.97 . . . . 75.33 111.106 -177.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 80.4 mt -54.14 -57.84 9.6 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 124.049 0.843 . . . . 74.33 110.193 173.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -52.95 -45.92 67.93 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.938 0.895 . . . . 43.22 112.339 -173.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -63.56 -43.54 96.76 Favored 'General case' 0 C--O 1.25 1.097 0 C-N-CA 123.789 0.835 . . . . 63.21 110.8 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -56.4 -34.37 66.66 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-O 121.001 0.429 . . . . 70.04 111.444 174.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 276' ' ' TYR . . . . . 0.705 ' HA ' ' HD3' ' C' ' 279' ' ' ARG . 1.0 OUTLIER -85.26 -25.65 27.14 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 115.743 -0.662 . . . . 75.52 111.596 -179.404 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 277' ' ' TYR . . . . . 0.431 ' CE1' ' HA3' ' A' ' 208' ' ' GLY . 22.1 m-30 -68.85 -32.36 71.99 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.938 -0.393 . . . . 65.52 109.938 176.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -55.57 -18.62 7.93 Favored 'General case' 0 CA--C 1.561 1.393 0 O-C-N 123.756 0.66 . . . . 72.22 112.515 173.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 279' ' ' ARG . . . . . 0.705 ' HD3' ' HA ' ' C' ' 276' ' ' TYR . 12.6 mtp-105 -89.87 -28.88 18.94 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.061 0.944 . . . . 75.11 111.833 176.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.963 0 C-N-CA 123.292 0.637 . . . . 75.14 110.671 -174.062 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt . . . . . 0 N--CA 1.476 0.864 0 N-CA-C 113.24 0.83 . . . . 64.14 113.24 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -72.13 112.02 7.86 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.587 -0.894 . . . . 74.32 108.587 166.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -75.98 84.3 2.88 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 107.242 -1.392 . . . . 62.43 107.242 178.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.488 ' CD1' ' HA ' ' A' ' 53' ' ' ALA . 41.7 m-85 -60.67 -29.98 69.63 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-N 114.59 -1.186 . . . . 73.34 111.996 -173.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -66.38 -42.34 88.09 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.833 -0.621 . . . . 73.33 110.432 176.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.09 -40.31 95.95 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.933 0.493 . . . . 70.01 111.19 176.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.483 HD11 ' HA ' ' A' ' 7' ' ' TYR . 62.9 mt -60.79 -39.17 80.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-N 115.807 -0.633 . . . . 74.23 110.727 178.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 92.1 mt -86.03 -7.59 58.52 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 112.287 0.477 . . . . 73.11 112.287 176.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.49 18.29 76.93 Favored Glycine 0 C--N 1.351 1.391 0 N-CA-C 114.501 0.56 . . . . 73.42 114.501 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.4 m -103.83 153.88 38.43 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 124.444 1.098 . . . . 72.52 110.041 177.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.23 165.11 20.52 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 122.785 2.323 . . . . 50.12 114.142 -176.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -81.63 61.05 4.86 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.4 1.08 . . . . 75.43 109.658 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -177.42 -26.83 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 114.073 -1.421 . . . . 71.2 108.286 -166.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -47.16 123.58 5.58 Favored 'General case' 0 C--N 1.349 0.579 0 C-N-CA 125.714 1.606 . . . . 74.14 113.137 -174.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 43.7 p -74.42 173.01 10.9 Favored 'General case' 0 C--O 1.243 0.733 0 O-C-N 124.226 0.954 . . . . 75.03 110.901 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.2 tm0? -55.81 -29.19 59.37 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.04 0.936 . . . . 71.11 110.178 179.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -57.22 -58.67 7.19 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.416 1.086 . . . . 72.43 110.845 173.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -66.03 -35.02 79.43 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.135 0.574 . . . . 71.14 111.484 -173.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.479 HG12 ' HB3' ' A' ' 57' ' ' LEU . 1.7 mp -61.76 -45.0 99.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 123.044 0.537 . . . . 73.31 110.296 173.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -61.69 -40.02 93.5 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.575 1.15 . . . . 75.22 111.035 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.628 ' HA ' ' HD3' ' A' ' 27' ' ' LYS . 18.5 mtp180 -77.15 -37.47 53.88 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.997 0.919 . . . . 73.12 111.41 -175.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.92 -37.99 89.43 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.652 -0.704 . . . . 72.43 110.161 173.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -74.97 -28.05 60.42 Favored 'General case' 0 C--O 1.215 -0.732 0 CA-C-N 115.006 -0.997 . . . . 73.1 110.964 176.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.628 ' HD3' ' HA ' ' A' ' 24' ' ' ARG . 22.6 mtpp -55.29 -53.54 54.76 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.414 -0.958 . . . . 74.22 108.414 171.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 -54.2 -67.06 0.29 Allowed 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 114.576 -1.193 . . . . 75.52 111.34 176.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 79.4 mt -70.21 -22.98 62.87 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.04 0.936 . . . . 75.12 112.952 -166.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.81 -54.79 6.66 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 109.252 -0.647 . . . . 71.54 109.252 173.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -64.11 -21.59 66.6 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 120.878 0.37 . . . . 72.33 111.509 -178.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -84.96 -44.33 13.2 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 124.721 1.209 . . . . 73.31 111.113 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -113.78 21.53 14.88 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 112.749 0.648 . . . . 72.41 112.749 -174.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -63.85 113.37 9.81 Favored Pre-proline 0 N--CA 1.484 1.263 0 CA-C-O 118.074 -0.965 . . . . 73.54 108.465 176.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.696 ' HB3' ' HG2' ' A' ' 44' ' ' GLU . 19.5 Cg_endo -57.87 -28.08 81.15 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 123.227 2.618 . . . . 75.51 113.647 -174.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -73.38 -30.55 63.36 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.881 0.873 . . . . 73.23 111.997 176.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 75.4 t -85.16 -39.23 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.017 0.527 . . . . 73.25 109.889 176.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -132.33 94.5 3.45 Favored 'General case' 0 C--O 1.244 0.793 0 C-N-CA 124.491 1.116 . . . . 64.12 109.088 -175.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.538 ' HE3' ' H ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -76.04 82.91 2.9 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 108.764 -0.828 . . . . 73.11 108.764 -179.581 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.5 m -140.08 116.22 7.99 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-O 117.998 -1.001 . . . . 71.24 108.666 177.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_exo -46.93 -42.22 25.33 Favored 'Trans proline' 0 C--N 1.387 2.579 0 C-N-CA 123.119 2.546 . . . . 73.53 112.419 175.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 34.3 tp10 -48.56 -51.29 28.47 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.05 1.34 . . . . 64.43 111.116 173.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.3 -25.6 65.22 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 115.113 -0.949 . . . . 73.42 111.031 -177.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.696 ' HG2' ' HB3' ' A' ' 35' ' ' PRO . 41.7 mt-10 -84.17 -33.94 24.11 Favored 'General case' 0 C--N 1.354 0.785 0 C-N-CA 123.324 0.65 . . . . 63.35 110.948 -174.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -76.47 -38.68 54.98 Favored 'General case' 0 C--O 1.246 0.905 0 CA-C-O 121.372 0.606 . . . . 62.44 109.459 178.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -66.35 -34.21 77.47 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.411 -0.813 . . . . 74.03 110.083 170.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -62.15 -39.74 93.63 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.361 0.665 . . . . 73.32 109.246 172.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.413 ' HG3' ' O ' ' A' ' 44' ' ' GLU . 67.1 mttm -58.14 -50.93 71.78 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 122.975 0.51 . . . . 75.14 110.688 176.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -60.29 -44.76 95.09 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.474 0.654 . . . . 71.44 111.579 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 96.6 mt -70.82 -26.91 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 124.422 1.089 . . . . 74.43 111.39 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.521 ' HA ' ' HB3' ' A' ' 54' ' ' TYR . 9.7 m-80 -94.82 -6.12 43.57 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.732 0.813 . . . . 73.43 111.474 178.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -75.94 -49.04 18.88 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 106.329 -1.73 . . . . 75.34 106.329 164.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.488 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . . . -57.27 -48.66 78.32 Favored 'General case' 0 C--N 1.349 0.573 0 CA-C-N 113.505 -1.679 . . . . 65.45 111.452 174.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.521 ' HB3' ' HA ' ' A' ' 51' ' ' ASN . 67.2 t80 -67.95 -41.31 82.66 Favored 'General case' 0 C--O 1.209 -1.07 0 CA-C-N 115.689 -0.687 . . . . 73.53 110.602 179.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.45 -51.19 60.54 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 118.42 0.554 . . . . 72.52 111.368 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.497 HG12 ' HZ ' ' A' ' 101' ' ' PHE . 47.5 t -73.65 -31.97 33.94 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 CA-C-N 115.122 -0.945 . . . . 74.52 111.204 -177.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.479 ' HB3' HG12 ' A' ' 22' ' ' ILE . 76.4 mt -103.75 3.66 34.36 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 113.961 1.097 . . . . 74.35 113.961 -175.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.3 t -63.06 -51.26 67.35 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 123.855 0.862 . . . . 74.34 111.804 -176.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -109.66 144.25 29.5 Favored Pre-proline 0 C--O 1.239 0.513 0 CA-C-N 114.439 -1.255 . . . . 74.34 108.924 -169.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.401 ' O ' ' HG2' ' A' ' 64' ' ' ARG . 48.3 Cg_exo -41.61 -51.09 4.49 Favored 'Trans proline' 0 C--N 1.383 2.379 0 C-N-CA 123.943 3.095 . . . . 72.41 114.983 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.455 ' O ' HG13 ' A' ' 65' ' ' ILE . 18.9 tp10 -79.8 -31.31 40.71 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 112.531 0.567 . . . . 72.3 112.531 -172.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.594 ' HZ3' ' HB3' ' A' ' 84' ' ' ASP . 3.0 mmmm -62.7 -42.2 99.52 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-O 122.084 0.945 . . . . 74.54 108.884 174.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.414 ' HG2' HD22 ' A' ' 57' ' ' LEU . 4.0 tmt_? -61.98 -42.65 99.37 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 113.72 -1.582 . . . . 74.11 108.443 175.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.401 ' HG2' ' O ' ' A' ' 60' ' ' PRO . 2.8 mmp_? -62.04 -34.51 76.37 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.615 0.766 . . . . 74.25 111.364 174.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 61' ' ' GLU . 62.4 mt -62.98 -44.24 99.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 109.217 -0.66 . . . . 74.41 109.217 178.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -57.79 -54.22 49.31 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.558 -0.747 . . . . 75.4 110.181 173.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -57.62 -42.52 83.47 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.703 0.801 . . . . 64.04 111.606 -175.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 40.4 p -69.68 -31.22 69.14 Favored 'General case' 0 C--N 1.348 0.535 0 CA-C-N 115.948 -0.569 . . . . 75.44 110.311 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -80.26 137.19 36.59 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 118.212 0.46 . . . . 75.32 110.335 -177.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.15 6.93 77.95 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-N 115.764 -0.653 . . . . 64.23 111.547 -174.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 95.0 m -130.37 -61.28 0.97 Allowed 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 103.671 -2.714 . . . . 71.23 103.671 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 92.0 m -87.72 150.09 23.82 Favored 'General case' 0 C--O 1.255 1.364 0 N-CA-C 105.274 -2.121 . . . . 74.23 105.274 156.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.57 -15.34 11.44 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.768 0.827 . . . . 74.04 111.136 178.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.1 123.99 87.71 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 123.695 0.798 . . . . 75.1 110.919 177.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -71.37 146.26 50.06 Favored 'Trans proline' 0 C--N 1.376 1.995 0 C-N-CA 122.413 2.075 . . . . 75.41 110.77 175.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -70.76 152.14 63.9 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 122.46 2.107 . . . . 74.25 110.982 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -58.63 148.5 81.77 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 122.809 2.34 . . . . 73.45 112.947 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -50.36 114.15 1.32 Allowed 'Trans proline' 0 C--N 1.391 2.812 0 C-N-CA 123.542 2.828 . . . . 73.2 112.782 177.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.4 ' HD2' ' HA3' ' A' ' 104' ' ' GLY . 85.8 Cg_endo -81.73 127.6 5.66 Favored 'Trans proline' 0 CA--C 1.557 1.648 0 C-N-CA 122.467 2.111 . . . . 71.05 112.192 -176.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -60.33 84.16 0.07 OUTLIER 'Trans proline' 0 C--N 1.384 2.434 0 C-N-CA 123.176 2.584 . . . . 74.31 112.854 -177.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 146.99 -44.32 0.82 Allowed Glycine 0 C--N 1.341 0.834 0 CA-C-N 114.656 -1.156 . . . . 62.41 110.549 -177.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 115.13 144.75 8.45 Favored Glycine 0 C--N 1.359 1.809 0 C-N-CA 123.282 0.468 . . . . 53.03 112.707 178.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -58.24 117.75 4.75 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.693 0.797 . . . . 74.41 109.646 174.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.594 ' HB3' ' HZ3' ' A' ' 62' ' ' LYS . 13.9 t70 -54.65 108.54 0.4 Allowed 'General case' 0 N--CA 1.476 0.852 0 O-C-N 124.339 1.024 . . . . 71.31 112.967 -171.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.569 ' HA ' ' HD2' ' A' ' 88' ' ' PHE . 14.1 m-85 -134.81 38.7 3.02 Favored 'General case' 0 C--O 1.245 0.862 0 C-N-CA 125.95 1.7 . . . . 73.24 108.068 173.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.3 m -67.18 117.75 9.64 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 113.256 -1.793 . . . . 74.44 110.732 177.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 85.24 -12.07 59.25 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-N 116.116 -0.493 . . . . 70.11 113.535 -176.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.569 ' HD2' ' HA ' ' A' ' 85' ' ' PHE . 12.2 m-85 -101.59 135.53 42.96 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 109.426 -0.583 . . . . 72.34 109.426 -172.016 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -79.45 80.41 5.82 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-O 120.909 0.385 . . . . 71.44 110.237 -174.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.4 HG22 ' HZ ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -42.14 -53.64 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 125.692 1.597 . . . . 75.21 112.996 176.841 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -73.85 -5.65 42.31 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 113.374 0.879 . . . . 75.33 113.374 -173.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -95.83 -18.71 20.17 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.209 0.604 . . . . 61.35 110.986 175.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.409 ' HE1' ' HB3' ' A' ' 48' ' ' LYS . 23.2 m-30 -83.62 179.12 7.7 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 113.068 0.766 . . . . 73.34 113.068 -171.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 68.2 p -68.14 151.95 46.23 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.892 1.277 . . . . 74.5 113.236 -170.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.6 -35.23 73.91 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 115.309 -0.86 . . . . 74.52 110.727 172.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -50.08 -51.36 43.33 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.132 1.373 . . . . 75.03 110.297 176.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.4 ' HZ ' HG22 ' A' ' 90' ' ' VAL . 0.3 OUTLIER -64.37 -46.08 84.94 Favored 'General case' 0 CA--C 1.556 1.205 0 CA-C-N 114.257 -1.338 . . . . 72.32 110.831 173.859 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.441 ' HA ' HD22 ' A' ' 105' ' ' LEU . 60.7 mt-30 -70.19 -9.9 57.18 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 112.98 0.733 . . . . 74.14 112.98 -173.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -101.96 -44.46 5.48 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.952 0.901 . . . . 70.02 110.929 173.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 17.8 tp -63.66 -56.9 12.21 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.646 0.778 . . . . 74.33 111.042 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.497 ' HZ ' HG12 ' A' ' 56' ' ' VAL . 86.5 m-85 -85.77 6.97 25.53 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 115.392 -0.822 . . . . 72.11 111.073 176.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.439 ' HA2' ' HG ' ' A' ' 105' ' ' LEU . . . -41.4 -63.16 1.67 Allowed Glycine 0 C--N 1.358 1.792 0 C-N-CA 124.867 1.223 . . . . 72.43 114.659 178.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -43.55 -23.12 0.47 Allowed 'Trans proline' 0 C--N 1.389 2.689 0 C-N-CA 124.793 3.662 . . . . 64.43 115.849 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.4 ' HA3' ' HD2' ' A' ' 79' ' ' PRO . . . -152.74 51.6 0.49 Allowed Glycine 0 C--N 1.346 1.138 0 O-C-N 121.888 -0.507 . . . . 54.4 112.035 177.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.441 HD22 ' HA ' ' A' ' 98' ' ' GLN . 25.9 mt -57.48 14.05 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.241 0 N-CA-C 116.067 1.877 . . . . 74.25 116.067 177.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER 61.76 -164.66 0.24 Allowed 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.855 0.862 . . . . 74.45 110.417 166.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 61.68 45.63 95.88 Favored Glycine 0 N--CA 1.442 -0.925 0 N-CA-C 115.678 1.031 . . . . 44.0 115.678 164.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.956 0 N-CA-C 118.692 2.237 . . . . 71.34 118.692 162.069 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.4 tmtt? . . . . . 0 N--CA 1.51 2.543 0 N-CA-C 114.093 1.146 . . . . 73.31 114.093 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.82 129.13 41.36 Favored Glycine 0 CA--C 1.543 1.835 0 CA-C-N 115.549 -0.751 . . . . 73.4 114.7 -175.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.522 ' N ' ' HA3' ' A' ' 166' ' ' GLY . 65.0 mtt180 -77.37 160.4 28.8 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 125.214 1.406 . . . . 74.43 111.576 172.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -85.14 84.86 7.55 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 107.321 -1.362 . . . . 74.23 107.321 163.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 9.5 tt -95.9 144.54 26.14 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.365 1.066 . . . . 75.42 109.45 -171.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.438 ' HA ' ' HB2' ' A' ' 175' ' ' LEU . 53.6 ttt-85 -102.98 143.37 32.64 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.045 0.938 . . . . 74.51 109.924 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.404 ' HB2' HD11 ' A' ' 174' ' ' LEU . . . -147.4 167.46 24.32 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.308 0.575 . . . . 54.41 112.123 -178.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.431 ' O ' HD11 ' B' ' 8' ' ' LEU . 5.7 mm-40 -103.38 107.93 18.96 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 114.49 -1.232 . . . . 72.42 107.741 -175.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 24.0 tp -99.24 100.25 9.88 Favored Pre-proline 0 N--CA 1.48 1.05 0 N-CA-C 107.888 -1.153 . . . . 74.14 107.888 177.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.566 ' HG2' ' HB ' ' B' ' 6' ' ' ILE . 43.9 Cg_endo -68.29 139.03 44.63 Favored 'Trans proline' 0 C--N 1.37 1.663 0 C-N-CA 121.323 1.348 . . . . 75.33 109.269 176.008 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.505 ' HB3' HD22 ' A' ' 180' ' ' LEU . 28.5 tp -142.56 138.7 31.02 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.151 0.887 . . . . 72.43 112.027 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 98.8 m -73.18 131.05 41.55 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 114.233 -1.349 . . . . 71.34 109.189 174.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.562 HD22 HD11 ' A' ' 180' ' ' LEU . 5.4 mt -53.48 -56.74 14.41 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 124.113 0.883 . . . . 75.21 111.085 -172.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.624 ' HG2' ' HD3' ' B' ' 2' ' ' LYS . 28.8 mp0 -41.41 -53.06 3.45 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 113.148 -1.842 . . . . 75.32 111.615 176.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -65.43 -37.42 86.84 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.454 0.702 . . . . 64.33 111.219 -178.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.538 ' HB1' ' O ' ' A' ' 153' ' ' VAL . . . -60.3 -34.66 74.08 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 124.421 1.075 . . . . 65.44 111.46 178.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -82.68 -37.69 24.46 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.563 0.745 . . . . 74.51 111.527 176.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 41.4 m170 -64.59 -40.12 94.96 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.254 0.622 . . . . 75.25 110.903 -175.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 67.34 77.84 0.3 Allowed Glycine 0 C--N 1.343 0.938 0 CA-C-N 115.452 -0.795 . . . . 71.54 112.804 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.405 ' O ' HG12 ' A' ' 149' ' ' ILE . . . -155.33 -158.99 9.05 Favored Glycine 0 C--N 1.334 0.427 0 N-CA-C 112.141 -0.384 . . . . 70.42 112.141 -179.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -68.87 123.89 22.2 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 125.001 1.32 . . . . 73.14 110.401 -175.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.589 HH11 HG22 ' B' ' 5' ' ' THR . 10.1 tpp180 -126.87 120.31 28.9 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.274 -1.01 . . . . 75.05 108.274 169.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.4 t -80.66 128.0 39.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 115.18 -0.918 . . . . 75.04 109.499 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.6 p -142.58 124.03 12.12 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 C-N-CA 124.327 1.051 . . . . 73.34 108.25 -178.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.402 ' HA ' ' HA ' ' A' ' 144' ' ' ARG . 37.4 tt0 -116.56 123.73 48.09 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.925 0.49 . . . . 71.3 111.695 -171.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.495 HG21 HD21 ' B' ' 8' ' ' LEU . 1.0 OUTLIER -153.69 149.4 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 125.406 1.483 . . . . 75.1 109.598 170.491 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 61.41 20.38 11.1 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.09 0.956 . . . . 74.24 112.33 176.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 85.89 -14.11 53.96 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-N 116.21 -0.45 . . . . 54.15 112.78 -175.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.586 ' HD3' ' SD ' ' A' ' 164' ' ' MET . 59.4 ttt180 -87.82 102.5 14.75 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 123.225 0.61 . . . . 72.43 109.579 177.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.431 ' HB3' ' HB2' ' A' ' 61' ' ' GLU . 41.9 ttt85 -92.41 89.79 6.94 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 107.926 -1.138 . . . . 74.41 107.926 171.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.3 p -96.86 142.95 13.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 115.34 -0.846 . . . . 73.53 109.508 -173.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 23.2 t -108.97 95.81 5.9 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 109.029 -0.73 . . . . 64.43 109.029 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 3.4 p -81.14 116.39 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.005 0.522 . . . . 73.42 110.041 -177.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 38.8 ttt85 -77.61 94.33 4.36 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 107.884 -1.154 . . . . 74.32 107.884 171.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.478 HD13 HD22 ' A' ' 125' ' ' LEU . 9.3 pt -70.45 150.69 95.69 Favored Pre-proline 0 CA--C 1.553 1.064 0 CA-C-N 114.494 -1.23 . . . . 74.52 110.805 -178.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.606 ' HB2' ' HZ ' ' A' ' 240' ' ' PHE . 92.9 Cg_endo -75.69 137.73 20.57 Favored 'Trans proline' 0 CA--C 1.566 2.098 0 C-N-CA 122.231 1.954 . . . . 74.22 111.997 178.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.24 101.64 0.36 Allowed 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 123.086 2.524 . . . . 74.15 114.119 -175.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 121.24 5.62 9.42 Favored Glycine 0 C--N 1.345 1.036 0 CA-C-N 115.006 -0.997 . . . . 75.51 112.914 178.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.538 ' O ' ' HB1' ' A' ' 130' ' ' ALA . 7.4 p -62.38 134.71 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 N-CA-C 109.314 -0.624 . . . . 75.43 109.314 175.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.71 ' HD3' ' HB3' ' A' ' 186' ' ' PHE . 70.0 mtt85 -139.17 174.68 10.26 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 122.761 0.424 . . . . 73.23 110.413 -173.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.544 ' HG3' ' HE ' ' A' ' 187' ' ' ARG . 4.2 tp10 -43.62 136.35 3.39 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 126.792 2.037 . . . . 72.32 113.297 -172.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.38 -15.33 46.03 Favored Glycine 0 CA--C 1.534 1.267 0 CA-C-O 118.885 -0.953 . . . . 74.33 114.627 177.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 22.8 t -63.23 151.76 39.53 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-N 118.648 1.224 . . . . 74.23 110.172 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.415 HG22 HG23 ' A' ' 177' ' ' VAL . 57.3 t -123.5 102.08 10.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 123.566 0.747 . . . . 74.02 109.431 -175.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.539 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 60.2 mt -83.43 108.57 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 108.282 -1.007 . . . . 75.24 108.282 172.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.439 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 78.1 ttt180 -82.39 110.07 17.2 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 109.381 -0.6 . . . . 75.21 109.381 177.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 3.5 p -121.66 106.52 37.22 Favored Pre-proline 0 CA--C 1.558 1.269 0 C-N-CA 123.164 0.586 . . . . 71.41 110.133 178.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.547 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 24.5 Cg_exo -64.98 129.9 24.41 Favored 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 122.938 2.425 . . . . 74.53 111.89 174.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 102.5 24.97 7.97 Favored Glycine 0 C--N 1.342 0.862 0 CA-C-O 119.713 -0.493 . . . . 70.43 114.055 177.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.586 ' SD ' ' HD3' ' A' ' 143' ' ' ARG . 18.6 tpp -138.77 -40.32 0.49 Allowed 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 117.489 0.645 . . . . 64.15 111.19 -175.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.456 ' N ' ' HB2' ' A' ' 174' ' ' LEU . . . -76.98 -85.54 0.43 Allowed Glycine 0 C--N 1.351 1.398 0 O-C-N 123.61 0.569 . . . . 73.33 112.493 -174.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.522 ' HA3' ' N ' ' A' ' 117' ' ' ARG . . . -62.33 105.04 0.86 Allowed Glycine 0 C--O 1.257 1.581 0 N-CA-C 111.697 -0.561 . . . . 74.5 111.697 171.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -60.01 124.46 20.28 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.257 -1.016 . . . . 75.42 108.257 169.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 176.47 152.92 10.09 Favored Glycine 0 CA--C 1.499 -0.967 0 O-C-N 123.758 0.661 . . . . 64.21 112.103 -176.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . 0.457 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . 3.6 t-20 -55.19 -45.45 99.85 Favored Pre-proline 0 CA--C 1.569 1.705 0 CA-C-O 118.702 -0.666 . . . . 63.54 110.903 169.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.457 ' HD3' ' HB3' ' A' ' 169' ' ' ASN . 15.1 Cg_exo -75.33 140.1 24.18 Favored 'Trans proline' 0 C--N 1.387 2.595 0 C-N-CA 121.911 1.74 . . . . 73.02 110.449 161.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.34 112.5 3.54 Favored 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 123.047 2.498 . . . . 71.25 113.159 -170.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -80.57 130.54 9.82 Favored Glycine 0 C--N 1.36 1.87 0 C-N-CA 121.004 -0.617 . . . . 72.4 113.369 177.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.547 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 22.5 m-20 -61.28 137.97 58.24 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.781 0.832 . . . . 71.14 110.392 178.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.456 ' HB2' ' N ' ' A' ' 165' ' ' GLY . 43.3 tp -113.3 138.51 49.92 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.766 -0.457 . . . . 74.2 109.766 175.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.438 ' HB2' ' HA ' ' A' ' 120' ' ' ARG . 60.3 mt -103.08 86.12 2.64 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 107.947 -1.131 . . . . 72.12 107.947 172.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.539 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 68.3 mt -66.77 89.75 0.16 Allowed 'General case' 0 C--N 1.354 0.792 0 CA-C-N 115.419 -0.81 . . . . 74.52 109.298 174.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.415 HG23 HG22 ' A' ' 158' ' ' VAL . 97.3 t -84.15 99.33 6.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 107.23 -1.396 . . . . 71.11 107.23 175.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.4 p -66.06 102.38 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 CA-C-O 122.294 1.045 . . . . 74.13 111.013 -174.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.513 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 8.1 mmm180 -85.28 96.23 9.45 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 114.137 -1.392 . . . . 73.42 107.797 174.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.562 HD11 HD22 ' A' ' 127' ' ' LEU . 19.1 mt -67.91 150.48 48.48 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 109.925 -0.398 . . . . 74.04 109.925 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 74.3 mt -52.75 144.77 24.22 Favored Pre-proline 0 N--CA 1.48 1.026 0 CA-C-O 118.067 -0.968 . . . . 73.22 110.531 178.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -56.2 81.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.388 2.615 0 C-N-CA 124.149 3.232 . . . . 74.32 112.932 -174.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . 0.438 ' HA ' ' HD3' ' A' ' 184' ' ' PRO . 12.1 t-80 -143.84 96.91 5.46 Favored Pre-proline 0 CA--C 1.547 0.829 0 N-CA-C 105.346 -2.094 . . . . 73.35 105.346 -177.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 183' ' ' HIS . 7.3 Cg_exo -72.67 27.83 0.28 Allowed 'Trans proline' 0 N--CA 1.498 1.779 0 C-N-CA 124.738 3.625 . . . . 61.24 116.733 -162.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.537 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 61.3 t -93.91 -61.17 2.18 Favored 'Isoleucine or valine' 0 C--N 1.352 0.709 0 CA-C-N 119.648 1.113 . . . . 72.34 110.283 -172.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . 0.71 ' HB3' ' HD3' ' A' ' 154' ' ' ARG . 11.7 m-85 -114.52 148.27 38.17 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 114.792 1.404 . . . . 72.31 114.792 -166.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . 0.544 ' HE ' ' HG3' ' A' ' 155' ' ' GLU . 28.5 ttm180 -148.0 134.0 19.21 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.661 1.584 . . . . 75.51 109.192 177.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.479 ' HB2' ' HB2' ' A' ' 154' ' ' ARG . 47.0 tp -97.26 110.27 22.85 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 109.334 -0.617 . . . . 74.21 109.334 174.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.42 92.57 4.75 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 106.983 -1.488 . . . . 70.31 106.983 174.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 68.82 -98.71 0.56 Allowed Glycine 0 C--N 1.346 1.095 0 CA-C-N 115.546 -0.752 . . . . 65.41 111.349 -174.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -115.66 -15.42 11.38 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.118 0.567 . . . . 72.32 110.702 172.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -79.2 163.58 24.89 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.226 0.61 . . . . 72.32 110.061 177.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.469 HD23 ' HD2' ' A' ' 154' ' ' ARG . 80.1 mt -125.44 141.12 52.23 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.027 0.931 . . . . 74.25 110.699 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.402 ' HB2' ' HB3' ' A' ' 187' ' ' ARG . 55.3 m-85 -102.26 140.67 36.24 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.862 -1.162 . . . . 73.14 107.862 163.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.537 ' HA ' ' O ' ' A' ' 185' ' ' VAL . . . -143.92 155.97 44.26 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.557 1.143 . . . . 74.34 109.314 -173.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 25.4 m -121.27 126.31 49.24 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 108.986 -0.746 . . . . 70.21 108.986 176.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.431 ' HB2' HD23 ' A' ' 251' ' ' LEU . 49.3 tp -117.73 117.89 30.58 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.301 0.641 . . . . 74.1 110.54 -174.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -92.68 113.91 26.31 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.683 -0.858 . . . . 63.3 108.683 169.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 7.4 p -130.46 133.33 24.75 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 124.118 0.967 . . . . 74.33 108.578 -179.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -79.8 157.29 24.36 Favored 'Trans proline' 0 C--N 1.366 1.478 0 C-N-CA 121.94 1.76 . . . . 70.05 112.076 171.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -59.3 -48.55 95.89 Favored Pre-proline 0 CA--C 1.558 1.252 0 N-CA-C 114.274 1.213 . . . . 71.34 114.274 -170.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -57.42 -42.64 59.58 Favored 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 121.897 1.731 . . . . 73.32 113.652 178.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 45.3 mt -75.21 -28.24 20.37 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 CA-C-N 116.442 -0.344 . . . . 71.02 110.485 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.44 -42.4 78.92 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.46 0.704 . . . . 74.14 111.101 176.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 42.3 t -71.72 -52.12 27.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 115.184 -0.916 . . . . 64.22 111.583 -178.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 72.5 t -77.29 -31.34 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 122.867 0.467 . . . . 74.41 111.455 -176.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 77.66 71.47 1.21 Allowed Glycine 0 C--N 1.338 0.686 0 CA-C-N 116.242 -0.436 . . . . 72.35 112.015 -177.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -101.19 -123.35 5.17 Favored Glycine 0 C--N 1.346 1.102 0 N-CA-C 111.52 -0.632 . . . . 73.32 111.52 177.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -133.92 139.95 46.48 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.686 0.795 . . . . 73.34 109.395 173.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.415 HG11 HG21 ' A' ' 199' ' ' VAL . 25.1 m -120.96 162.02 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-O 121.33 0.586 . . . . 63.11 110.32 169.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 6.8 ttp180 -85.11 114.42 22.23 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.645 -1.161 . . . . 74.32 108.738 171.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -106.26 164.55 11.92 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 109.226 -0.657 . . . . 74.41 109.226 169.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 71.6 mtp -103.94 139.42 39.11 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 108.729 -0.841 . . . . 74.15 108.729 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 77.8 p -111.42 -165.41 0.99 Allowed 'General case' 0 C--O 1.243 0.755 0 N-CA-C 108.929 -0.767 . . . . 74.1 108.929 174.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . 0.4 HD13 ' HG2' ' A' ' 154' ' ' ARG . 69.9 mt -76.23 -14.69 60.13 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.7 -0.682 . . . . 73.14 112.112 176.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -120.56 -16.61 8.27 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 118.718 0.69 . . . . 64.44 112.071 -175.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 156.82 -165.3 33.06 Favored Glycine 0 N--CA 1.475 1.293 0 CA-C-O 119.776 -0.458 . . . . 63.05 113.694 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -83.67 141.58 9.86 Favored 'Trans proline' 0 C--N 1.367 1.504 0 C-N-CA 122.926 2.417 . . . . 74.13 113.717 -174.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 34.9 m -134.29 169.57 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 124.353 1.061 . . . . 73.4 110.073 176.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -93.53 142.38 27.4 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.361 0.664 . . . . 75.04 110.416 174.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 59.3 t -130.67 119.2 45.02 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 C-N-CA 124.075 0.95 . . . . 74.51 108.452 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -73.02 102.31 3.47 Favored 'General case' 0 C--N 1.348 0.508 0 N-CA-C 109.181 -0.674 . . . . 70.4 109.181 177.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 48.2 t -67.36 141.2 95.64 Favored Pre-proline 0 CA--C 1.555 1.152 0 C-N-CA 124.689 1.196 . . . . 71.22 110.24 -176.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.8 150.86 39.81 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 122.168 1.912 . . . . 75.51 110.448 171.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -66.6 138.47 49.76 Favored 'Trans proline' 0 CA--C 1.55 1.291 0 C-N-CA 121.332 1.354 . . . . 72.53 112.021 170.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . 0.252 7.7 ptp180 52.43 58.77 5.05 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 127.054 2.142 . . . . 75.13 112.544 -177.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.423 ' O ' HD13 ' A' ' 255' ' ' ILE . 1.3 m -73.45 105.51 4.85 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 113.989 -1.46 . . . . 64.32 109.146 176.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . 0.411 ' HB3' ' HD2' ' A' ' 231' ' ' ARG . 5.9 tp-100 -84.41 132.34 34.59 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.275 0.63 . . . . 75.32 111.03 -174.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . 0.535 ' HB2' HG22 ' C' ' 256' ' ' THR . . . -66.81 142.04 57.49 Favored 'General case' 0 C--N 1.358 0.97 0 C-N-CA 123.815 0.846 . . . . 65.12 111.916 -177.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 88.3 -10.87 69.58 Favored Glycine 0 C--N 1.342 0.906 0 CA-C-N 115.323 -0.853 . . . . 75.54 113.192 -179.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.411 ' HD2' ' HB3' ' A' ' 228' ' ' GLN . 86.8 mtt180 -87.15 167.07 14.48 Favored 'General case' 0 C--O 1.249 1.062 0 N-CA-C 109.417 -0.586 . . . . 74.44 109.417 172.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.92 126.24 49.5 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.106 -0.952 . . . . 72.22 109.218 -178.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 16.7 mt -83.28 99.16 9.82 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 107.363 -1.347 . . . . 71.4 107.363 177.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 69.6 ttp85 -82.38 100.8 10.21 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.442 -0.947 . . . . 73.41 108.442 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.501 HD12 HD22 ' A' ' 249' ' ' LEU . 21.6 mt -98.41 92.24 5.58 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 108.975 -0.75 . . . . 74.24 108.975 -175.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? -60.99 128.51 36.8 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.243 0.617 . . . . 71.01 110.69 -175.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 83.16 6.11 88.39 Favored Glycine 0 C--N 1.346 1.103 0 CA-C-N 115.228 -0.896 . . . . 74.2 114.012 175.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.404 ' HA ' ' HE3' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -98.14 6.73 47.21 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 117.715 0.757 . . . . 74.1 111.066 178.759 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -93.92 -162.04 35.58 Favored Glycine 0 C--N 1.34 0.79 0 CA-C-N 115.662 -0.699 . . . . 74.43 112.095 174.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . 0.606 ' HZ ' ' HB2' ' A' ' 150' ' ' PRO . 18.3 t80 -78.07 137.1 61.27 Favored Pre-proline 0 CA--C 1.551 1.016 0 CA-C-O 118.904 -0.569 . . . . 73.41 109.967 -177.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -61.16 106.65 0.4 Allowed 'Trans proline' 0 C--N 1.382 2.336 0 C-N-CA 122.152 1.902 . . . . 73.33 112.1 171.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -137.06 -153.11 6.33 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-O 119.027 -0.874 . . . . 73.52 112.776 -175.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -54.32 -42.01 71.37 Favored 'Trans proline' 0 C--N 1.384 2.416 0 C-N-CA 123.455 2.77 . . . . 72.5 113.383 176.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -82.24 23.96 0.7 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.965 0.906 . . . . 70.11 112.452 -178.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 83.14 -93.07 1.68 Allowed Glycine 0 C--N 1.35 1.308 0 N-CA-C 109.612 -1.395 . . . . 62.24 109.612 -174.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 20.1 mtm180 -128.12 141.86 51.36 Favored 'General case' 0 C--O 1.247 0.936 0 N-CA-C 107.951 -1.129 . . . . 75.41 107.951 164.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -72.99 -173.51 24.88 Favored Glycine 0 C--N 1.349 1.26 0 O-C-N 123.352 0.408 . . . . 70.31 113.884 -177.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -112.85 135.7 53.31 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.505 0.722 . . . . 75.44 110.498 -174.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.501 HD22 HD12 ' A' ' 235' ' ' LEU . 64.6 tp -97.32 104.96 17.03 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.749 -0.834 . . . . 73.32 108.749 -178.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -90.12 105.98 18.18 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.515 0.726 . . . . 71.3 110.05 -177.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.431 HD23 ' HB2' ' A' ' 197' ' ' LEU . 41.5 mt -90.14 119.21 30.28 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 122.874 0.47 . . . . 74.54 109.942 177.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.11 116.44 19.4 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 107.973 -1.121 . . . . 75.41 107.973 178.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 21.8 t -78.21 102.4 4.46 Favored 'Isoleucine or valine' 0 C--O 1.245 0.841 0 CA-C-O 120.969 0.414 . . . . 71.34 111.402 -174.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -101.85 95.39 6.36 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.642 1.177 . . . . 73.14 109.066 168.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.497 ' HB ' ' O ' ' C' ' 255' ' ' ILE . 63.0 mt -77.18 141.06 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 109.879 -0.415 . . . . 74.34 109.879 175.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 21.6 p -130.03 176.68 7.87 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.777 1.231 . . . . 74.52 109.161 177.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.6 pp -137.71 158.41 71.75 Favored Pre-proline 0 CA--C 1.571 1.779 0 C-N-CA 123.625 0.77 . . . . 73.4 111.208 -175.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -55.96 -14.8 11.98 Favored 'Trans proline' 0 C--N 1.39 2.724 0 C-N-CA 123.843 3.028 . . . . 74.45 116.11 -167.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . 0.661 ' HG2' HE21 ' C' ' 228' ' ' GLN . 39.9 mt-10 56.52 -69.98 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 125.53 1.532 . . . . 75.12 113.396 -173.008 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.36 146.19 36.83 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 108.939 -0.763 . . . . 75.12 108.939 169.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.619 HD22 ' HB2' ' A' ' 265' ' ' GLU . 66.6 mt -138.12 167.97 20.71 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.495 0.718 . . . . 72.32 109.23 172.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 71.6 p -129.75 154.13 80.95 Favored Pre-proline 0 CA--C 1.555 1.149 0 N-CA-C 107.596 -1.261 . . . . 74.31 107.596 169.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -33.65 -37.2 0.1 OUTLIER 'Trans proline' 0 C--N 1.397 3.128 0 C-N-CA 125.041 3.828 . . . . 74.33 117.221 -169.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -62.51 -68.17 0.35 Allowed 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.377 0.671 . . . . 71.44 111.798 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . 0.619 ' HB2' HD22 ' A' ' 261' ' ' LEU . 2.5 mp0 -65.25 -30.29 71.15 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 109.478 -0.564 . . . . 73.22 109.478 -176.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' GLU . . . . . 0.493 ' HA ' HD11 ' A' ' 261' ' ' LEU . 5.8 tp10 -53.21 -52.52 58.63 Favored 'General case' 0 CA--C 1.551 0.998 0 O-C-N 124.043 0.839 . . . . 73.45 109.401 174.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -61.83 -49.52 75.97 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 115.28 -0.873 . . . . 64.12 111.714 177.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 9.3 mp -56.78 -54.32 47.7 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.804 0.842 . . . . 73.14 112.145 -176.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 72.5 m95 -56.7 -49.1 76.13 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.949 0.899 . . . . 75.0 111.404 177.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . 0.665 ' HG3' HG23 ' C' ' 206' ' ' VAL . 1.1 mptm? -60.48 -34.89 74.69 Favored 'General case' 0 CA--C 1.552 1.039 0 O-C-N 123.678 0.611 . . . . 73.12 111.359 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 7.4 mmpt? -69.91 -46.87 64.45 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 117.993 0.361 . . . . 70.22 111.213 178.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' LEU . . . . . 0.428 HD23 ' HB2' ' C' ' 268' ' ' LEU . 80.9 mt -54.24 -39.83 67.16 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.827 0.851 . . . . 71.54 110.7 174.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -80.38 -41.52 24.51 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.786 1.234 . . . . 72.23 113.974 -170.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -64.93 -43.98 90.99 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 108.937 -0.764 . . . . 74.35 108.937 175.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -63.81 -38.57 91.6 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 114.909 -1.041 . . . . 72.24 110.934 173.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -59.91 -56.24 24.22 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.462 0.705 . . . . 75.02 110.109 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -63.67 -37.62 88.03 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.019 0.928 . . . . 72.14 109.967 -175.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -60.12 -26.13 66.0 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 115.463 -0.79 . . . . 75.41 111.89 173.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 49.7 mtm180 -107.38 -1.17 21.83 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.832 0.853 . . . . 75.15 111.72 178.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.248 0 N-CA-C 109.001 -0.74 . . . . 72.5 109.001 -179.231 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 111.437 0.162 . . . . 74.12 111.437 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . 0.652 ' HZ1' ' HB3' ' B' ' 2' ' ' LYS . 0.4 OUTLIER -123.25 -1.85 8.64 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.377 0.671 . . . . 62.45 111.934 -178.734 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -93.2 0.62 57.18 Favored 'General case' 0 CA--C 1.559 1.307 0 N-CA-C 109.032 -0.729 . . . . 74.04 109.032 168.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 63.4 m -51.56 138.36 22.66 Favored 'General case' 0 C--N 1.357 0.903 0 C-N-CA 125.993 1.717 . . . . 52.14 113.165 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 5' ' ' THR . . . . . 0.589 HG22 HH11 ' A' ' 136' ' ' ARG . 0.3 OUTLIER -110.99 170.04 8.37 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.149 0.98 . . . . 74.34 110.108 -175.583 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.566 ' HB ' ' HG2' ' A' ' 124' ' ' PRO . 45.5 pt -132.64 173.49 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 N-CA-C 113.031 0.752 . . . . 65.34 113.031 -161.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -145.1 133.77 22.17 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.571 1.148 . . . . 72.22 108.875 171.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . 0.495 HD21 HG21 ' A' ' 140' ' ' VAL . 34.2 tp -72.83 150.77 42.42 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.868 0.867 . . . . 75.22 110.249 -176.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -79.35 -50.48 10.79 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 119.654 -0.212 . . . . 73.12 111.254 177.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 74.7 mt 62.93 109.2 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 124.338 1.055 . . . . 74.1 110.4 -167.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 85.5 mt . . . . . 0 N--CA 1.478 0.936 0 N-CA-C 109.201 -0.666 . . . . 72.11 109.201 177.986 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.993 0 CA-C-O 120.184 0.04 . . . . 74.35 110.97 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . -67.91 -46.38 71.74 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-O 121.347 0.594 . . . . 75.32 109.431 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 181' ' ' LEU . . . . . 0.566 ' HB2' ' HB3' ' C' ' 136' ' ' ARG . 33.3 tp -116.61 -96.57 0.46 Allowed 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 105.856 -1.905 . . . . 74.44 105.856 154.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 182' ' ' VAL . . . . . 0.567 HG12 ' HB2' ' C' ' 123' ' ' LEU . 7.4 p 156.74 138.6 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.245 0.857 0 C-N-CA 126.777 2.031 . . . . 72.43 105.688 -178.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 183' ' ' ALA . . . . . 0.725 ' HA ' ' HB3' ' C' ' 123' ' ' LEU . . . -160.76 -103.28 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 118.907 -0.568 . . . . 65.24 111.168 176.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 59.54 142.86 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 124.142 0.977 . . . . 75.32 111.372 -164.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 185' ' ' VAL . . . . . 0.506 ' HA ' ' HA ' ' C' ' 121' ' ' ALA . 50.8 t . . . . . 0 CA--C 1.57 1.733 0 C-N-CA 123.581 0.752 . . . . 74.01 112.707 -170.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 238' ' ' THR . . . . . 0.419 HG23 HG23 ' C' ' 219' ' ' VAL . 13.3 m . . . . . 0 N--CA 1.479 1.003 0 CA-C-O 121.488 0.661 . . . . 71.31 109.797 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -83.64 173.23 11.56 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 114.518 -1.219 . . . . 74.42 111.15 177.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . -83.17 -130.7 1.65 Allowed Glycine 0 C--N 1.346 1.126 0 CA-C-N 115.369 -0.832 . . . . 71.23 112.651 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -151.69 156.1 39.68 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.695 0.798 . . . . 71.23 108.96 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 242' ' ' TRP . . . . . 0.471 ' CD2' ' HG ' ' C' ' 233' ' ' LEU . 1.2 p-90 -168.04 115.85 0.73 Allowed 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 113.251 0.834 . . . . 70.32 113.251 -175.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 24.83 74.23 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 128.072 2.549 . . . . 74.22 115.307 166.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 126.58 -142.62 13.72 Favored Glycine 0 C--N 1.341 0.822 0 CA-C-N 115.49 -0.777 . . . . 71.54 112.396 178.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? . . . . . 0 N--CA 1.482 1.16 0 C-N-CA 127.159 2.183 . . . . 75.34 110.145 -175.066 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.772 0 N-CA-C 110.188 -0.301 . . . . 71.34 110.188 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -34.17 93.71 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 127.041 2.137 . . . . 70.52 112.894 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 5' ' ' LYS . . . . . 0.471 ' HE2' HD11 ' C' ' 10' ' ' ILE . 14.5 mmmm -92.84 93.29 8.33 Favored 'General case' 0 C--O 1.243 0.72 0 N-CA-C 107.812 -1.181 . . . . 72.32 107.812 169.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -73.67 97.36 2.66 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 107.193 -1.41 . . . . 65.15 107.193 175.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 7' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -61.54 -37.86 85.32 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.182 -0.917 . . . . 73.43 111.598 -171.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -60.97 -45.02 96.45 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 116.181 -0.463 . . . . 74.23 110.481 175.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.96 -40.95 99.25 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.051 0.54 . . . . 63.34 111.207 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 10' ' ' ILE . . . . . 0.471 HD11 ' HE2' ' C' ' 5' ' ' LYS . 64.6 mt -61.92 -36.07 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.213 0.605 . . . . 73.31 110.576 177.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 11' ' ' LEU . . . . . 0.598 HD11 HG23 ' C' ' 22' ' ' ILE . 68.7 mt -80.61 -13.85 58.69 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 112.46 0.541 . . . . 75.53 112.46 176.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.11 35.92 42.27 Favored Glycine 0 C--N 1.351 1.364 0 N-CA-C 113.689 0.235 . . . . 74.43 113.689 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 6.1 m -131.56 153.44 81.55 Favored Pre-proline 0 N--CA 1.482 1.151 0 C-N-CA 124.691 1.196 . . . . 71.34 109.184 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -76.51 161.08 34.7 Favored 'Trans proline' 0 C--N 1.373 1.83 0 C-N-CA 122.432 2.088 . . . . 74.43 112.293 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -67.85 80.53 0.2 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.339 0.655 . . . . 74.35 109.898 176.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -179.19 -30.03 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.673 1.189 . . . . 71.24 109.038 -174.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -47.58 119.72 2.9 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 124.744 1.277 . . . . 75.2 111.688 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 72.3 p -86.25 178.35 7.21 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.802 0.841 . . . . 74.41 110.14 177.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.45 -38.28 19.46 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 124.515 1.126 . . . . 74.45 112.195 -177.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 20' ' ' GLU . . . . . 0.405 ' O ' ' HG3' ' C' ' 24' ' ' ARG . 13.9 tp10 -66.72 -52.63 42.25 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.387 0.675 . . . . 74.53 110.953 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . 0.609 ' HA ' ' HE ' ' C' ' 24' ' ' ARG . 33.7 mt-10 -65.0 -34.37 78.27 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.636 0.775 . . . . 73.42 111.285 -176.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 22' ' ' ILE . . . . . 0.86 HD11 ' HB3' ' C' ' 57' ' ' LEU . 82.1 mt -75.56 -36.08 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.214 1.405 . . . . 75.54 111.268 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -62.87 -44.21 96.74 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.758 0.823 . . . . 74.13 109.77 175.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 24' ' ' ARG . . . . . 0.609 ' HE ' ' HA ' ' C' ' 21' ' ' GLU . 42.8 mtm180 -64.63 -46.05 84.19 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 115.332 -0.849 . . . . 73.52 110.829 178.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . 0.417 ' O ' ' HB3' ' C' ' 28' ' ' ARG . . . -61.5 -37.68 84.58 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.461 0.705 . . . . 75.32 111.682 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 26' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -62.97 -52.1 64.33 Favored 'General case' 0 C--O 1.212 -0.882 0 CA-C-N 115.121 -0.945 . . . . 72.31 109.998 176.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -58.02 -37.14 73.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 123.882 0.739 . . . . 75.33 111.369 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 28' ' ' ARG . . . . . 0.417 ' HB3' ' O ' ' C' ' 25' ' ' ALA . 20.8 ttt180 -53.15 -56.03 19.54 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.294 1.037 . . . . 75.55 110.45 172.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . 0.651 ' HB3' HD11 ' C' ' 50' ' ' ILE . 91.2 mt -80.9 -11.15 59.63 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 115.769 -0.65 . . . . 71.43 111.879 -177.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -91.31 -10.7 40.39 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.126 0.97 . . . . 75.32 110.535 177.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -93.89 -48.6 6.2 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.216 0.606 . . . . 73.5 110.342 165.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 20.6 tp60 -62.44 -48.52 79.31 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.452 0.701 . . . . 71.12 111.297 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 33' ' ' TYR . . . . . 0.41 ' HE2' HD22 ' C' ' 29' ' ' LEU . 29.4 m-85 -109.01 37.11 2.65 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.218 0.607 . . . . 72.14 109.969 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 34' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -67.89 111.48 7.81 Favored Pre-proline 0 N--CA 1.473 0.719 0 CA-C-O 118.373 -0.823 . . . . 74.34 109.378 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.74 -29.21 76.94 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 122.417 2.078 . . . . 72.22 111.318 -176.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -62.07 -33.03 73.65 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.364 1.466 . . . . 60.34 112.153 176.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 98.6 t -96.71 -62.62 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 N-CA-C 108.988 -0.745 . . . . 75.33 108.988 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -98.72 96.46 7.93 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.263 1.025 . . . . 65.41 110.604 -177.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -80.03 74.66 6.8 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 108.644 -0.873 . . . . 71.22 108.644 173.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 71.1 m -126.8 97.85 32.17 Favored Pre-proline 0 CA--C 1.538 0.506 0 N-CA-C 108.591 -0.892 . . . . 74.14 108.591 175.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -39.16 -44.19 2.64 Favored 'Trans proline' 0 C--N 1.388 2.655 0 C-N-CA 124.76 3.64 . . . . 75.0 114.545 -176.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -48.6 -55.51 10.98 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 124.811 1.244 . . . . 71.01 111.023 174.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.42 -21.21 63.77 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 115.476 -0.784 . . . . 71.45 111.272 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 44' ' ' GLU . . . . . 0.435 ' O ' ' HG3' ' C' ' 48' ' ' LYS . 43.0 mt-10 -88.76 -24.57 22.61 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.529 0.731 . . . . 74.04 110.748 -175.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -81.31 -36.54 29.65 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.615 0.766 . . . . 75.44 109.248 174.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 46' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -65.21 -36.64 84.81 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.05 -0.977 . . . . 72.32 109.167 169.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 47' ' ' PHE . . . . . 0.57 ' HA ' HD12 ' C' ' 50' ' ' ILE . 41.9 t80 -66.68 -32.62 74.06 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.449 0.7 . . . . 71.12 110.408 173.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 48' ' ' LYS . . . . . 0.44 ' HB3' ' CE1' ' C' ' 93' ' ' PHE . 95.7 mttt -64.14 -39.79 94.79 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 122.889 0.476 . . . . 72.04 110.808 172.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -69.15 -28.94 66.87 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.65 0.38 . . . . 72.33 110.774 176.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 50' ' ' ILE . . . . . 0.651 HD11 ' HB3' ' C' ' 29' ' ' LEU . 71.2 mt -73.07 -32.79 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 123.856 0.863 . . . . 75.43 110.381 173.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 51' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -77.38 -24.73 50.54 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.257 0.623 . . . . 74.04 110.62 175.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -71.09 -52.85 17.02 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 108.369 -0.974 . . . . 75.54 108.369 172.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.22 -44.41 79.53 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 113.533 -1.667 . . . . 63.1 111.467 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -74.18 -38.33 63.68 Favored 'General case' 0 C--O 1.208 -1.112 0 CA-C-N 115.425 -0.807 . . . . 75.01 110.384 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.89 -35.77 75.54 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-O 120.81 0.338 . . . . 60.54 111.469 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 47.5 t -77.84 -44.71 28.55 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 CA-C-N 115.906 -0.588 . . . . 72.43 109.875 175.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 57' ' ' LEU . . . . . 0.86 ' HB3' HD11 ' C' ' 22' ' ' ILE . 52.4 mt -98.74 0.65 44.93 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 115.428 1.64 . . . . 75.02 115.428 -166.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 30.9 t -75.56 -66.12 0.81 Allowed 'General case' 0 N--CA 1.484 1.233 0 CA-C-O 121.733 0.777 . . . . 75.33 109.686 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -86.83 132.36 42.39 Favored Pre-proline 0 C--O 1.255 1.376 0 CA-C-N 114.438 -1.255 . . . . 72.03 108.885 -169.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 60' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_exo -46.6 -30.5 8.9 Favored 'Trans proline' 0 C--N 1.388 2.626 0 C-N-CA 124.218 3.279 . . . . 73.21 114.796 -175.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -57.25 -69.74 0.15 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.572 0.749 . . . . 62.13 111.413 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.28 -25.54 63.39 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 122.773 0.429 . . . . 75.43 110.619 -173.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -61.93 -47.86 83.0 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 108.147 -1.057 . . . . 74.14 108.147 175.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -70.14 -29.34 66.23 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.156 0.582 . . . . 74.15 111.618 177.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 82.0 mt -62.08 -43.8 98.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 C-N-CA 122.72 0.408 . . . . 71.5 110.384 174.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -67.08 -46.55 73.93 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.771 -0.649 . . . . 74.31 109.797 177.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -55.1 -47.58 74.75 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.228 0.611 . . . . 73.14 110.758 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 70.4 p -70.39 -26.81 63.87 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.94 -0.573 . . . . 74.43 111.518 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -69.51 136.17 51.08 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 108.81 -0.811 . . . . 75.22 108.81 178.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.05 15.28 54.5 Favored Glycine 0 N--CA 1.473 1.107 0 N-CA-C 111.632 -0.587 . . . . 62.51 111.632 -169.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 58.2 m -148.4 -60.24 0.24 Allowed 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 103.698 -2.704 . . . . 72.34 103.698 175.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 56.8 m -75.04 140.53 43.61 Favored 'General case' 0 C--O 1.252 1.218 0 N-CA-C 105.147 -2.168 . . . . 73.35 105.147 156.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.87 -36.25 6.7 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.88 0.872 . . . . 73.23 110.873 -176.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -93.32 139.17 22.88 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 123.986 0.915 . . . . 53.23 110.096 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 75' ' ' PRO . . . . . 0.563 ' HB2' ' HH ' ' C' ' 83' ' ' TYR . 28.8 Cg_endo -61.7 144.48 97.29 Favored 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 122.691 2.261 . . . . 75.14 112.096 175.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -49.84 144.34 21.07 Favored 'Trans proline' 0 C--N 1.384 2.406 0 C-N-CA 123.826 3.017 . . . . 71.22 113.805 175.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -57.82 131.87 46.52 Favored 'Trans proline' 0 C--N 1.381 2.251 0 C-N-CA 122.697 2.265 . . . . 74.4 111.65 177.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 78' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.92 113.61 1.6 Allowed 'Trans proline' 0 C--N 1.388 2.657 0 C-N-CA 122.89 2.393 . . . . 74.44 112.221 -174.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -80.93 178.41 6.94 Favored 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 122.882 2.388 . . . . 70.12 111.902 -178.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -54.51 90.54 0.04 OUTLIER 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 122.279 1.986 . . . . 74.31 112.271 167.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 134.26 -1.64 4.14 Favored Glycine 0 N--CA 1.466 0.662 0 CA-C-N 114.937 -1.029 . . . . 75.2 112.399 175.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 67.01 -149.8 51.51 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 112.39 -0.284 . . . . 75.13 112.39 178.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 83' ' ' TYR . . . . . 0.563 ' HH ' ' HB2' ' C' ' 75' ' ' PRO . 41.1 m-85 -99.46 113.63 26.1 Favored 'General case' 0 C--O 1.244 0.803 0 N-CA-C 108.208 -1.034 . . . . 73.4 108.208 168.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 84' ' ' ASP . . . . . 0.418 ' HB3' ' HG3' ' C' ' 143' ' ' ARG . 4.8 p-10 -71.74 134.3 46.14 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-O 121.394 0.616 . . . . 75.11 110.009 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 85' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -159.25 22.24 0.19 Allowed 'General case' 0 C--O 1.248 0.999 0 CA-C-N 114.603 -1.181 . . . . 74.41 107.969 -177.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 19.0 m -62.79 128.27 35.14 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 113.141 -1.845 . . . . 52.42 111.273 -170.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 87' ' ' GLY . . . . . 0.461 ' HA2' ' HA ' ' C' ' 171' ' ' PRO . . . 99.25 -20.95 47.93 Favored Glycine 0 C--N 1.336 0.569 0 O-C-N 123.775 0.672 . . . . 74.34 112.938 178.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 88' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -93.79 150.64 20.22 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 117.457 0.628 . . . . 74.44 110.224 -178.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -82.56 73.69 9.58 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.113 0.565 . . . . 72.23 110.442 -174.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 90' ' ' VAL . . . . . . . . . . . . . 3.2 p -43.41 -41.72 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 C-N-CA 125.456 1.503 . . . . 54.42 112.486 177.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -56.76 -36.09 69.41 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.902 1.281 . . . . 75.25 111.945 -175.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -88.87 -21.02 23.88 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.02 0.528 . . . . 75.53 111.997 -175.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 93' ' ' PHE . . . . . 0.44 ' CE1' ' HB3' ' C' ' 48' ' ' LYS . 4.5 m-30 -81.75 164.74 21.51 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 122.326 0.251 . . . . 72.45 111.295 -168.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 94.5 p -60.19 152.08 25.51 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.586 1.154 . . . . 52.11 113.598 -165.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.55 -31.79 70.88 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 114.964 -1.016 . . . . 72.35 111.062 170.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -59.88 -44.51 94.14 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.175 0.99 . . . . 74.24 110.426 175.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 97' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -62.1 -43.33 99.07 Favored 'General case' 0 CA--C 1.558 1.28 0 CA-C-N 114.978 -1.01 . . . . 64.25 110.362 170.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -73.68 -1.46 19.13 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.184 0.593 . . . . 71.33 111.758 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -98.95 -41.32 7.64 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.559 0.743 . . . . 74.43 112.092 168.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 23.9 tp -82.02 -35.55 28.73 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.284 0.634 . . . . 73.23 111.83 -174.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -114.14 -17.76 11.82 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.673 0.789 . . . . 75.04 110.956 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -42.72 -58.73 3.47 Favored Glycine 0 CA--C 1.541 1.67 0 CA-C-O 118.689 -1.062 . . . . 74.41 115.466 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.0 -21.19 20.53 Favored 'Trans proline' 0 C--N 1.389 2.658 0 C-N-CA 123.645 2.896 . . . . 64.35 114.224 -176.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -127.68 8.72 6.88 Favored Glycine 0 C--N 1.357 1.7 0 CA-C-O 117.051 -1.972 . . . . 73.42 114.631 -175.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 28.5 mt . . . . . 0 N--CA 1.513 2.709 0 N-CA-C 114.623 1.342 . . . . 75.43 114.623 -175.677 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.413 0 N-CA-C 111.601 -0.6 . . . . 54.4 111.601 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 117' ' ' ARG . . . . . 0.675 ' HB2' ' HB2' ' C' ' 167' ' ' GLN . 50.3 mtm180 -115.46 180.0 3.8 Favored 'General case' 0 C--O 1.254 1.313 0 CA-C-O 122.056 0.931 . . . . 74.32 110.662 -174.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 118' ' ' ASP . . . . . 0.474 ' HA ' ' O ' ' C' ' 173' ' ' ASP . 0.8 OUTLIER -57.07 107.24 0.39 Allowed 'General case' 0 C--O 1.243 0.73 0 CA-C-N 112.278 -2.237 . . . . 75.42 110.193 172.124 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 119' ' ' LEU . . . . . 0.565 HD12 ' HA3' ' C' ' 166' ' ' GLY . 0.3 OUTLIER -94.91 113.89 25.67 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 107.647 -1.242 . . . . 75.21 107.647 174.619 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' C' ' 175' ' ' LEU . 0.0 OUTLIER -104.4 124.8 49.88 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 110.125 -0.324 . . . . 72.31 110.125 -173.797 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 121' ' ' ALA . . . . . 0.506 ' HA ' ' HA ' ' B' ' 185' ' ' VAL . . . -111.43 137.15 49.59 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.388 0.675 . . . . 75.44 111.231 -177.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -92.66 90.15 6.97 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 107.665 -1.235 . . . . 74.12 107.665 170.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 123' ' ' LEU . . . . . 0.725 ' HB3' ' HA ' ' B' ' 183' ' ' ALA . 1.1 pt? -105.36 114.28 63.49 Favored Pre-proline 0 N--CA 1.49 1.539 0 CA-C-N 118.474 0.579 . . . . 73.3 112.116 -174.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . 0.511 ' HA ' ' O ' ' C' ' 179' ' ' ARG . 36.2 Cg_exo -64.64 112.35 1.94 Allowed 'Trans proline' 0 C--N 1.386 2.528 0 C-N-CA 122.606 2.204 . . . . 72.51 110.489 164.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 125' ' ' LEU . . . . . 0.427 HD23 HG23 ' C' ' 153' ' ' VAL . 51.3 tp -131.79 147.3 52.48 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 122.552 0.341 . . . . 75.32 110.828 -169.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 126' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -92.08 151.47 20.42 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.302 0.641 . . . . 61.53 109.946 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 127' ' ' LEU . . . . . 0.408 ' CD2' HD12 ' C' ' 180' ' ' LEU . 25.2 mt -65.82 -50.99 62.66 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.425 1.09 . . . . 62.25 110.311 -177.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -53.69 -42.87 68.44 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 113.165 -1.834 . . . . 75.24 109.896 176.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 129' ' ' GLU . . . . . 0.5 ' HA ' ' HB2' ' C' ' 132' ' ' HIS . 15.1 mm-40 -82.33 -16.93 47.5 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.737 0.815 . . . . 75.51 111.821 -175.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -71.93 -31.53 66.44 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 109.014 -0.735 . . . . 73.14 109.014 172.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 131' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -73.11 -51.12 19.16 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 115.471 -0.786 . . . . 75.55 110.659 164.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 132' ' ' HIS . . . . . 0.5 ' HB2' ' HA ' ' C' ' 129' ' ' GLU . 38.3 m80 -76.32 3.82 10.16 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.005 0.522 . . . . 70.15 112.234 -171.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -58.83 88.26 0.02 OUTLIER Glycine 0 CA--C 1.539 1.544 0 N-CA-C 114.578 0.591 . . . . 65.31 114.578 171.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . -88.03 -143.9 9.12 Favored Glycine 0 C--N 1.355 1.631 0 N-CA-C 111.34 -0.704 . . . . 73.12 111.34 170.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 26.1 mp0 -70.48 93.83 0.92 Allowed 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 107.971 -1.122 . . . . 73.03 107.971 171.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 136' ' ' ARG . . . . . 0.566 ' HB3' ' HB2' ' B' ' 181' ' ' LEU . 78.7 mtt180 -115.58 138.19 51.31 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.024 0.529 . . . . 72.12 110.081 -173.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 137' ' ' VAL . . . . . 0.507 ' HA ' ' HA ' ' C' ' 146' ' ' SER . 21.5 t -76.7 103.57 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-N 116.099 -0.501 . . . . 73.11 109.877 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 138' ' ' VAL . . . . . 0.519 ' HB ' HD23 ' B' ' 181' ' ' LEU . 4.6 p -80.43 123.69 37.45 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 123.659 0.784 . . . . 72.14 109.22 174.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 139' ' ' GLU . . . . . 0.623 ' HG2' ' HG3' ' C' ' 144' ' ' ARG . 28.3 mt-10 -118.97 92.01 3.7 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.77 0.828 . . . . 74.31 109.175 -165.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 140' ' ' VAL . . . . . 0.41 HG22 ' HB3' ' C' ' 121' ' ' ALA . 7.1 p -143.53 147.39 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 C-N-CA 123.282 0.633 . . . . 73.25 111.435 -168.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 64.53 17.29 10.78 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 125.045 1.338 . . . . 65.0 111.908 -174.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 87.37 -8.64 76.29 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-N 115.568 -0.742 . . . . 52.4 112.947 -175.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 143' ' ' ARG . . . . . 0.429 ' HD3' ' HA ' ' C' ' 143' ' ' ARG . 6.7 mmt180 -101.47 139.94 36.45 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.446 0.641 . . . . 75.05 111.474 -177.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 144' ' ' ARG . . . . . 0.623 ' HG3' ' HG2' ' C' ' 139' ' ' GLU . 59.7 ttt180 -115.45 93.22 4.19 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-N 114.652 -1.158 . . . . 71.51 110.178 -165.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 145' ' ' VAL . . . . . . . . . . . . . 30.3 m -118.79 142.5 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 123.179 0.591 . . . . 75.03 112.001 -172.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 146' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' C' ' 137' ' ' VAL . 20.3 m -95.0 128.97 42.23 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.266 1.026 . . . . 73.22 111.054 -177.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 14.4 p -162.75 148.1 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 123.042 0.537 . . . . 72.53 110.663 175.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 29.8 ttm-85 -84.28 117.22 23.41 Favored 'General case' 0 C--N 1.349 0.571 0 N-CA-C 108.994 -0.743 . . . . 74.22 108.994 166.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 149' ' ' ILE . . . . . . . . . . . . . 42.2 pt -88.36 150.12 46.12 Favored Pre-proline 0 CA--C 1.548 0.878 0 N-CA-C 108.642 -0.873 . . . . 74.42 108.642 172.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -50.02 112.29 0.69 Allowed 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 123.183 2.589 . . . . 61.44 113.236 179.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -61.5 106.35 0.41 Allowed 'Trans proline' 0 C--N 1.383 2.376 0 C-N-CA 122.958 2.439 . . . . 73.2 112.117 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 152' ' ' GLY . . . . . . . . . . . . . . . 129.19 101.53 1.0 Allowed Glycine 0 C--N 1.343 0.922 0 CA-C-N 115.214 -0.903 . . . . 63.11 111.37 -171.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 153' ' ' VAL . . . . . 0.427 HG23 HD23 ' C' ' 125' ' ' LEU . 1.0 OUTLIER -122.77 159.84 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 CA-C-N 117.145 0.472 . . . . 74.01 110.398 -179.042 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 154' ' ' ARG . . . . . 0.618 ' HB2' ' HB2' ' C' ' 157' ' ' SER . 38.6 mtp180 -119.05 121.77 40.61 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.245 1.018 . . . . 75.32 109.105 -171.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 155' ' ' GLU . . . . . 0.683 ' HB3' ' HG2' ' C' ' 187' ' ' ARG . 9.4 tp10 -45.3 122.94 3.73 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.909 0.883 . . . . 74.51 112.45 174.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 87.52 -21.25 22.86 Favored Glycine 0 C--N 1.351 1.403 0 O-C-N 124.425 1.078 . . . . 75.21 113.276 176.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 157' ' ' SER . . . . . 0.618 ' HB2' ' HB2' ' C' ' 154' ' ' ARG . 33.8 m -88.97 -177.92 5.59 Favored 'General case' 0 C--O 1.247 0.962 0 CA-C-O 121.445 0.641 . . . . 75.43 110.733 -172.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 7.2 p -128.11 127.53 67.78 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 CA-C-N 115.48 -0.782 . . . . 72.31 111.587 -173.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 159' ' ' ILE . . . . . 0.598 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 47.9 mt -73.63 139.04 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.673 1.189 . . . . 72.31 109.194 168.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 30.1 ttt85 -117.38 111.02 18.76 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 109.098 -0.705 . . . . 75.13 109.098 175.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 161' ' ' VAL . . . . . 0.61 HG13 ' HB3' ' C' ' 174' ' ' LEU . 1.6 p -106.03 98.93 20.31 Favored Pre-proline 0 CA--C 1.555 1.166 0 N-CA-C 108.295 -1.002 . . . . 75.24 108.295 168.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -76.54 140.17 21.14 Favored 'Trans proline' 0 C--N 1.384 2.433 0 C-N-CA 123.07 2.513 . . . . 75.23 112.141 178.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 110.14 -7.84 30.99 Favored Glycine 0 C--N 1.347 1.157 0 CA-C-O 119.817 -0.435 . . . . 53.54 112.455 178.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 164' ' ' MET . . . . . 0.477 ' HE2' HD23 ' C' ' 174' ' ' LEU . 3.3 ppp? -158.13 124.17 4.65 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.959 0.904 . . . . 73.35 109.383 172.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . -125.68 -116.33 2.1 Favored Glycine 0 C--N 1.346 1.123 0 C-N-CA 123.854 0.74 . . . . 73.32 112.474 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 166' ' ' GLY . . . . . 0.565 ' HA3' HD12 ' C' ' 119' ' ' LEU . . . -169.87 -61.52 0.04 OUTLIER Glycine 0 C--N 1.346 1.103 0 C-N-CA 120.21 -0.995 . . . . 75.44 114.653 175.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 167' ' ' GLN . . . . . 0.675 ' HB2' ' HB2' ' C' ' 117' ' ' ARG . 14.1 mm100 -66.69 98.58 0.53 Allowed 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 117.09 0.445 . . . . 74.2 110.692 -165.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . 110.34 -144.25 17.01 Favored Glycine 0 C--O 1.213 -1.173 0 CA-C-O 118.352 -1.249 . . . . 13.44 111.72 -165.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 169' ' ' ASN . . . . . 0.424 ' HB3' ' HD3' ' C' ' 170' ' ' PRO . 17.9 t-20 -150.21 -51.39 0.02 OUTLIER Pre-proline 0 CA--C 1.594 2.659 0 CA-C-N 119.723 1.762 . . . . 62.44 113.291 -177.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 170' ' ' PRO . . . . . 0.424 ' HD3' ' HB3' ' C' ' 169' ' ' ASN . 49.5 Cg_exo -48.59 177.03 0.02 OUTLIER 'Trans proline' 0 N--CA 1.522 3.188 0 C-N-CA 124.359 3.373 . . . . 73.55 116.765 168.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 171' ' ' PRO . . . . . 0.461 ' HA ' ' HA2' ' C' ' 87' ' ' GLY . 1.1 Cg_exo -31.55 119.25 0.08 OUTLIER 'Trans proline' 0 C--N 1.404 3.483 1 C-N-CA 125.417 4.078 . . . . 74.02 117.272 172.969 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -160.56 -172.24 27.56 Favored Glycine 0 C--N 1.356 1.668 0 C-N-CA 124.276 0.941 . . . . 74.42 111.333 177.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 173' ' ' ASP . . . . . 0.474 ' O ' ' HA ' ' C' ' 118' ' ' ASP . 5.8 p-10 -140.79 147.68 39.44 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.718 0.771 . . . . 74.51 111.209 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 174' ' ' LEU . . . . . 0.61 ' HB3' HG13 ' C' ' 161' ' ' VAL . 43.9 tp -97.83 112.63 24.47 Favored 'General case' 0 C--O 1.245 0.849 0 N-CA-C 109.147 -0.686 . . . . 75.22 109.147 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 175' ' ' LEU . . . . . 0.47 ' O ' ' HA ' ' C' ' 120' ' ' ARG . 55.7 mt -87.18 112.25 21.78 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.245 -1.343 . . . . 72.15 109.664 174.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 176' ' ' LEU . . . . . 0.598 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 57.7 mt -100.41 97.26 8.02 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 109.355 -0.609 . . . . 74.33 109.355 174.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 177' ' ' VAL . . . . . . . . . . . . . 17.1 t -83.61 103.36 10.78 Favored 'Isoleucine or valine' 0 C--O 1.253 1.238 0 N-CA-C 107.904 -1.147 . . . . 75.23 107.904 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 178' ' ' VAL . . . . . . . . . . . . . 6.1 m -84.95 117.43 30.19 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 CA-C-N 114.397 -1.274 . . . . 74.01 112.086 -172.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 179' ' ' ARG . . . . . 0.511 ' O ' ' HA ' ' C' ' 124' ' ' PRO . 6.2 mmm180 -105.36 107.77 18.94 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 106.142 -1.799 . . . . 74.42 106.142 166.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 180' ' ' LEU . . . . . 0.603 HD13 ' HB2' ' C' ' 155' ' ' GLU . 58.4 mt -70.12 148.23 48.99 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 122.35 -0.219 . . . . 73.43 110.583 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 181' ' ' LEU . . . . . . . . . . . . . 67.5 mt -54.28 167.03 0.6 Allowed Pre-proline 0 N--CA 1.494 1.75 0 C-N-CA 125.261 1.425 . . . . 74.24 112.434 -176.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -56.64 71.43 0.04 OUTLIER 'Trans proline' 0 C--N 1.387 2.554 0 C-N-CA 123.029 2.486 . . . . 73.32 111.217 163.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 183' ' ' HIS . . . . . 0.415 ' N ' ' HD3' ' C' ' 184' ' ' PRO . 81.2 t60 -179.2 51.91 0.05 OUTLIER Pre-proline 0 CA--C 1.557 1.249 0 C-N-CA 126.768 2.027 . . . . 72.0 106.237 -164.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 184' ' ' PRO . . . . . 0.415 ' HD3' ' N ' ' C' ' 183' ' ' HIS . 61.5 Cg_endo -92.18 65.19 0.87 Allowed 'Trans proline' 0 C--N 1.386 2.537 0 C-N-CA 123.046 2.498 . . . . 74.25 110.662 -170.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 185' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 12.4 t -93.37 -33.86 5.52 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.41 0 CA-C-N 115.284 -0.871 . . . . 72.23 109.035 -171.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 186' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -127.79 106.0 8.83 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 118.809 0.732 . . . . 61.44 111.93 -175.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 187' ' ' ARG . . . . . 0.683 ' HG2' ' HB3' ' C' ' 155' ' ' GLU . 1.6 tmt_? -95.26 116.59 28.95 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 107.352 -1.351 . . . . 75.14 107.352 169.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 188' ' ' LEU . . . . . 0.48 HD12 ' HA ' ' C' ' 191' ' ' GLN . 65.3 tp -80.74 138.89 36.32 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 122.917 0.487 . . . . 74.14 111.762 -178.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -142.6 113.09 7.28 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 106.548 -1.649 . . . . 73.21 106.548 169.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 73.92 -109.44 2.8 Favored Glycine 0 N--CA 1.474 1.177 0 N-CA-C 111.413 -0.675 . . . . 74.2 111.413 -170.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 191' ' ' GLN . . . . . 0.48 ' HA ' HD12 ' C' ' 188' ' ' LEU . 28.1 mt-30 -123.85 7.0 8.7 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 123.564 0.745 . . . . 75.25 109.085 167.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 192' ' ' ASP . . . . . 0.486 ' HB3' ' HE1' ' C' ' 250' ' ' TYR . 3.8 m-20 -95.63 142.74 27.59 Favored 'General case' 0 C--N 1.344 0.351 0 C-N-CA 125.176 1.391 . . . . 65.13 109.188 -172.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 193' ' ' LEU . . . . . 0.461 HD22 ' CD2' ' C' ' 240' ' ' PHE . 86.7 mt -112.45 142.34 45.11 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.587 0.355 . . . . 65.15 110.777 -178.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 194' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -108.97 128.05 54.6 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 108.17 -1.048 . . . . 75.43 108.17 165.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 195' ' ' ALA . . . . . 0.547 ' HB2' ' HG ' ' C' ' 251' ' ' LEU . . . -127.03 -178.19 4.32 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.404 0.682 . . . . 65.11 110.768 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 33.0 m -135.54 111.03 9.14 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 107.675 -1.231 . . . . 53.42 107.675 169.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 197' ' ' LEU . . . . . 0.448 HD13 ' HB1' ' C' ' 212' ' ' ALA . 42.2 tp -88.92 136.89 32.77 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 123.436 0.694 . . . . 73.5 110.055 176.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -92.4 117.32 29.8 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 108.616 -0.883 . . . . 64.33 108.616 173.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 199' ' ' VAL . . . . . 0.562 ' HA ' HG12 ' C' ' 210' ' ' VAL . 21.4 t -125.6 106.57 26.7 Favored Pre-proline 0 CA--C 1.544 0.728 0 N-CA-C 108.09 -1.078 . . . . 73.12 108.09 176.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 200' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -67.76 141.69 55.29 Favored 'Trans proline' 0 C--N 1.369 1.613 0 C-N-CA 121.737 1.625 . . . . 73.11 111.33 176.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 201' ' ' ALA . . . . . . . . . . . . . . . -42.65 -49.16 13.3 Favored Pre-proline 0 CA--C 1.559 1.313 0 C-N-CA 125.498 1.519 . . . . 74.35 114.507 -176.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 202' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -55.34 -52.04 8.65 Favored 'Trans proline' 0 C--N 1.388 2.611 0 C-N-CA 121.558 1.505 . . . . 63.15 112.95 175.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 203' ' ' ILE . . . . . 0.445 ' HA ' HG11 ' C' ' 206' ' ' VAL . 53.0 mt -63.45 -34.57 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 122.885 0.474 . . . . 74.02 111.022 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -62.7 -43.27 99.24 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.79 0.836 . . . . 75.02 111.522 178.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 205' ' ' VAL . . . . . 0.418 HG13 ' HG3' ' C' ' 226' ' ' ARG . 88.5 t -79.29 -34.12 16.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 115.842 -0.617 . . . . 74.52 112.097 -176.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 206' ' ' VAL . . . . . 0.665 HG23 ' HG3' ' A' ' 270' ' ' LYS . 9.9 p -80.24 -32.05 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 122.183 0.193 . . . . 74.12 111.04 -177.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 79.48 56.32 3.42 Favored Glycine 0 C--N 1.336 0.582 0 N-CA-C 111.366 -0.694 . . . . 63.21 111.366 -171.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -92.84 -124.21 3.53 Favored Glycine 0 C--N 1.34 0.786 0 N-CA-C 111.104 -0.798 . . . . 51.32 111.104 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 209' ' ' LYS . . . . . 0.551 ' HB3' ' HG2' ' C' ' 220' ' ' GLU . 40.5 mtmt -148.0 149.35 31.99 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.399 0.679 . . . . 72.44 111.074 176.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 210' ' ' VAL . . . . . 0.562 HG12 ' HA ' ' C' ' 199' ' ' VAL . 15.8 m -137.76 141.68 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-N 114.546 -1.206 . . . . 71.52 108.753 174.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 211' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.73 110.54 19.4 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.264 0.626 . . . . 75.53 111.013 -176.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 212' ' ' ALA . . . . . 0.448 ' HB1' HD13 ' C' ' 197' ' ' LEU . . . -90.46 113.56 25.54 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 107.742 -1.207 . . . . 74.43 107.742 165.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 213' ' ' MET . . . . . 0.474 ' HA ' ' HA ' ' C' ' 218' ' ' PRO . 6.8 tmm? -71.62 132.45 44.64 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 107.79 -1.189 . . . . 63.12 107.79 176.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.19 175.18 8.34 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.008 0.523 . . . . 72.34 110.68 -176.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 215' ' ' LEU . . . . . . . . . . . . . 20.3 mt -68.17 -23.31 64.85 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.12 0.968 . . . . 75.24 112.074 -172.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -87.36 -26.83 23.16 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 114.684 -1.144 . . . . 71.0 109.735 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 141.47 179.44 18.64 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 109.403 -1.479 . . . . 74.41 109.403 -168.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 218' ' ' PRO . . . . . 0.474 ' HA ' ' HA ' ' C' ' 213' ' ' MET . 86.4 Cg_endo -75.15 119.11 5.47 Favored 'Trans proline' 0 CA--C 1.559 1.735 0 C-N-CA 122.561 2.174 . . . . 64.03 113.481 -175.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 219' ' ' VAL . . . . . 0.419 HG23 HG23 ' B' ' 238' ' ' THR . 8.6 p -91.66 125.32 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 N-CA-C 108.253 -1.018 . . . . 52.53 108.253 169.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 220' ' ' GLU . . . . . 0.551 ' HG2' ' HB3' ' C' ' 209' ' ' LYS . 15.6 tt0 -90.53 106.33 18.43 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.874 0.845 . . . . 72.32 108.757 177.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 221' ' ' VAL . . . . . . . . . . . . . 71.0 t -72.64 126.39 33.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 113.807 -1.542 . . . . 74.03 111.972 -174.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -72.6 117.33 14.15 Favored 'General case' 0 CA--C 1.549 0.919 0 O-C-N 124.314 1.009 . . . . 73.3 110.306 169.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 90.9 t -91.35 140.93 25.68 Favored Pre-proline 0 CA--C 1.555 1.157 0 C-N-CA 124.514 1.125 . . . . 73.11 109.794 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 224' ' ' PRO . . . . . 0.521 ' HG3' HH22 ' C' ' 231' ' ' ARG . 87.3 Cg_endo -81.03 147.54 16.66 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 123.172 2.581 . . . . 73.11 112.089 167.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -52.45 132.45 44.95 Favored 'Trans proline' 0 C--N 1.372 1.793 0 C-N-CA 122.417 2.078 . . . . 74.4 112.793 169.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 226' ' ' ARG . . . . . 0.442 ' HB3' ' HA ' ' A' ' 259' ' ' GLU . 0.0 OUTLIER 51.31 85.6 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 126.279 1.832 . . . . 71.5 112.583 -171.703 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 227' ' ' THR . . . . . 0.503 HG21 HG12 ' C' ' 253' ' ' VAL . 90.4 m -101.11 130.79 47.21 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 114.406 -1.27 . . . . 73.3 109.854 174.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 228' ' ' GLN . . . . . 0.661 HE21 ' HG2' ' A' ' 259' ' ' GLU . 25.2 mp0 -95.4 147.39 23.57 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.499 1.12 . . . . 74.32 111.978 -176.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -72.76 124.25 24.96 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 114.989 -1.005 . . . . 65.31 109.209 173.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 108.32 -9.76 36.03 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-O 119.641 -0.533 . . . . 62.04 112.526 -172.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 231' ' ' ARG . . . . . 0.521 HH22 ' HG3' ' C' ' 224' ' ' PRO . 34.3 mtp180 -64.35 169.92 4.27 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 117.616 0.708 . . . . 75.03 110.465 169.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 232' ' ' LYS . . . . . 0.429 ' HA ' ' O ' ' C' ' 251' ' ' LEU . 33.6 ttmt -142.92 136.96 29.11 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.226 0.536 . . . . 74.05 110.552 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 233' ' ' LEU . . . . . 0.698 HD12 ' HB2' ' C' ' 251' ' ' LEU . 4.0 mp -98.01 145.92 26.02 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 114.478 -1.237 . . . . 74.22 109.759 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 11.5 ptp85 -110.02 90.9 3.45 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 124.628 1.205 . . . . 72.34 108.183 163.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 235' ' ' LEU . . . . . 0.406 HD12 HD22 ' C' ' 249' ' ' LEU . 24.8 mt -78.25 95.95 5.12 Favored 'General case' 0 C--N 1.352 0.686 0 N-CA-C 107.407 -1.331 . . . . 74.34 107.407 169.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -70.75 125.71 27.57 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 114.516 -1.22 . . . . 73.41 111.594 -171.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 75.72 29.23 59.73 Favored Glycine 0 C--N 1.348 1.22 0 O-C-N 123.867 0.73 . . . . 71.42 112.423 -176.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -124.34 17.02 9.04 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.279 0.631 . . . . 75.11 110.535 176.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -77.53 -165.44 24.88 Favored Glycine 0 C--N 1.359 1.811 0 N-CA-C 110.893 -0.883 . . . . 75.2 110.893 167.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 240' ' ' PHE . . . . . 0.461 ' CD2' HD22 ' C' ' 193' ' ' LEU . 1.2 m-85 -70.67 127.29 92.05 Favored Pre-proline 0 C--O 1.257 1.472 0 CA-C-N 118.061 0.93 . . . . 75.14 108.959 176.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 241' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -61.47 94.94 0.12 Allowed 'Trans proline' 0 C--N 1.385 2.459 0 C-N-CA 123.553 2.836 . . . . 71.53 113.171 177.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 242' ' ' GLY . . . . . 0.441 ' H ' ' HA ' ' C' ' 246' ' ' ARG . . . -77.56 137.94 20.96 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-N 113.838 -1.528 . . . . 70.14 112.126 -179.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.47 -9.32 25.66 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 123.152 2.568 . . . . 71.42 113.804 -176.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -120.78 23.09 10.91 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.393 0.677 . . . . 71.42 110.576 176.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 115.31 143.85 8.14 Favored Glycine 0 C--N 1.341 0.83 0 N-CA-C 109.951 -1.26 . . . . 63.24 109.951 -171.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 246' ' ' ARG . . . . . 0.441 ' HA ' ' H ' ' C' ' 242' ' ' GLY . 15.3 ptp180 -99.42 170.84 8.34 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 118.01 0.905 . . . . 71.32 112.395 -171.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -92.38 -164.92 38.51 Favored Glycine 0 C--N 1.35 1.356 0 CA-C-N 114.932 -1.031 . . . . 63.23 113.581 177.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -130.35 148.11 52.14 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.08 0.952 . . . . 73.54 109.055 -172.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 249' ' ' LEU . . . . . 0.406 HD22 HD12 ' C' ' 235' ' ' LEU . 22.8 tp -101.24 137.16 39.95 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.903 0.881 . . . . 74.23 110.611 -175.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 250' ' ' TYR . . . . . 0.584 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 59.3 m-85 -127.46 101.56 6.49 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.443 1.097 . . . . 71.43 109.265 -176.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 251' ' ' LEU . . . . . 0.698 ' HB2' HD12 ' C' ' 233' ' ' LEU . 1.2 mp -101.33 139.13 37.42 Favored 'General case' 0 N--CA 1.508 2.442 0 CA-C-N 118.138 0.426 . . . . 72.0 110.923 -175.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -80.09 138.99 37.06 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 108.953 -0.758 . . . . 75.41 108.953 168.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 253' ' ' VAL . . . . . 0.503 HG12 HG21 ' C' ' 227' ' ' THR . 99.0 t -87.29 128.14 40.12 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 CA-C-O 121.079 0.466 . . . . 73.5 111.214 176.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 254' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 -110.18 111.67 23.16 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.465 1.106 . . . . 75.13 108.828 167.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 255' ' ' ILE . . . . . 0.497 ' O ' ' HB ' ' A' ' 255' ' ' ILE . 33.8 mm -80.84 120.51 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 N-CA-C 108.294 -1.002 . . . . 75.24 108.294 171.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 256' ' ' THR . . . . . 0.535 HG22 ' HB2' ' A' ' 229' ' ' ALA . 46.4 p -120.34 -172.78 2.43 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.672 0.789 . . . . 70.25 111.257 -173.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 2.7 pp -141.45 148.79 52.02 Favored Pre-proline 0 N--CA 1.489 1.477 0 C-N-CA 123.39 0.676 . . . . 75.21 110.196 178.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -61.26 -7.69 8.86 Favored 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 123.372 2.715 . . . . 74.41 114.684 -174.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 57.12 -78.35 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.908 1.283 . . . . 72.3 110.846 -166.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 22.5 ptt-85 -60.35 136.58 58.08 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 124.23 1.012 . . . . 73.41 110.26 177.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 261' ' ' LEU . . . . . 0.469 HD21 ' HB3' ' C' ' 265' ' ' GLU . 94.8 mt -143.34 148.21 35.91 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.58 0.752 . . . . 74.53 109.65 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 262' ' ' THR . . . . . 0.463 ' OG1' ' HG2' ' C' ' 265' ' ' GLU . 36.4 p -84.31 162.42 51.39 Favored Pre-proline 0 CA--C 1.548 0.898 0 N-CA-C 108.417 -0.957 . . . . 61.23 108.417 167.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -53.4 -35.84 76.94 Favored 'Trans proline' 0 C--N 1.374 1.881 0 C-N-CA 122.267 1.978 . . . . 74.2 114.202 175.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -66.43 -48.11 71.07 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 122.381 0.272 . . . . 71.04 110.514 178.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 265' ' ' GLU . . . . . 0.469 ' HB3' HD21 ' C' ' 261' ' ' LEU . 33.2 mm-40 -52.57 -51.33 60.27 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 123.612 0.57 . . . . 71.03 109.633 175.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 266' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -54.43 -41.57 69.54 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 114.354 -1.294 . . . . 73.1 110.627 -177.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 267' ' ' ALA . . . . . 0.446 ' O ' ' HG3' ' C' ' 271' ' ' LYS . . . -62.13 -46.0 90.95 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.731 -0.668 . . . . 71.12 111.573 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 268' ' ' LEU . . . . . 0.428 ' HB2' HD23 ' A' ' 272' ' ' LEU . 10.4 mp -66.33 -41.94 88.91 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 111.591 0.219 . . . . 70.11 111.591 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -63.48 -33.11 74.86 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 122.988 0.515 . . . . 63.11 111.141 176.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 270' ' ' LYS . . . . . 0.594 ' HZ2' ' HB3' ' C' ' 270' ' ' LYS . 4.2 mmmp? -61.04 -48.92 79.52 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.631 0.772 . . . . 75.43 110.076 173.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 271' ' ' LYS . . . . . 0.446 ' HG3' ' O ' ' C' ' 267' ' ' ALA . 63.2 mttm -58.55 -43.76 89.41 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.72 0.808 . . . . 75.33 111.568 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 91.2 mt -61.63 -40.36 94.59 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.368 -0.833 . . . . 74.33 110.404 176.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -64.38 -34.69 78.75 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 115.522 -0.763 . . . . 43.22 110.822 177.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 274' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' C' ' 270' ' ' LYS . 13.5 mm-40 -67.58 -40.3 84.85 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.127 0.571 . . . . 63.21 109.702 177.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -61.71 -30.84 71.02 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.457 0.703 . . . . 70.04 110.662 174.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 276' ' ' TYR . . . . . 0.545 ' HA ' ' HD3' ' C' ' 279' ' ' ARG . 9.6 m-85 -77.27 -31.6 55.0 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.069 -0.968 . . . . 75.52 112.733 172.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -76.3 -19.13 58.56 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 118.526 0.603 . . . . 65.52 110.198 175.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -69.13 -16.58 63.69 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.331 0.652 . . . . 72.22 110.538 169.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 279' ' ' ARG . . . . . 0.545 ' HD3' ' HA ' ' C' ' 276' ' ' TYR . 16.3 mtp-105 -83.52 -14.81 51.46 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.155 0.582 . . . . 75.11 110.978 173.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.085 -0.96 . . . . 75.14 110.338 -179.233 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.487 ' HZ2' ' HB2' ' A' ' 4' ' ' LYS . 4.9 ttmp? . . . . . 0 N--CA 1.483 1.219 0 N-CA-C 114.472 1.286 . . . . 64.14 114.472 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -100.26 114.49 27.98 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 123.546 0.739 . . . . 74.32 109.071 164.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.489 ' HA ' ' OH ' ' A' ' 66' ' ' TYR . 23.9 t70 -82.46 102.94 11.65 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 107.729 -1.211 . . . . 62.43 107.729 168.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.435 ' HD1' HD13 ' A' ' 10' ' ' ILE . 32.4 m-85 -64.08 -30.44 71.51 Favored 'General case' 0 C--O 1.244 0.811 0 CA-C-N 115.576 -0.738 . . . . 73.34 112.131 -171.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.417 ' CD1' HD12 ' A' ' 22' ' ' ILE . 64.9 m-85 -62.04 -44.34 96.89 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 122.851 0.46 . . . . 73.33 110.394 174.109 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.94 -41.84 97.49 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.285 0.634 . . . . 70.01 111.229 178.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.435 HD13 ' HD1' ' A' ' 7' ' ' TYR . 65.1 mt -55.77 -43.28 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 123.469 0.707 . . . . 74.23 110.976 176.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.6 mt -79.62 -14.12 59.03 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 112.936 0.717 . . . . 73.11 112.936 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.39 36.65 59.25 Favored Glycine 0 C--N 1.351 1.378 0 O-C-N 123.026 0.204 . . . . 73.42 113.485 -176.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.3 m -119.93 157.33 52.96 Favored Pre-proline 0 N--CA 1.482 1.175 0 C-N-CA 124.764 1.226 . . . . 72.52 109.164 175.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.472 ' HG2' ' HB3' ' A' ' 17' ' ' ALA . 12.2 Cg_endo -55.93 153.1 33.05 Favored 'Trans proline' 0 C--N 1.388 2.645 0 C-N-CA 122.771 2.314 . . . . 50.12 112.508 177.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 72.3 mtp180 -81.63 59.53 4.19 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.113 0.965 . . . . 75.43 111.411 -170.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 176.37 -27.96 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.643 1.177 . . . . 71.2 109.273 -168.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.472 ' HB3' ' HG2' ' A' ' 14' ' ' PRO . . . -37.64 138.01 0.4 Allowed 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 126.864 2.065 . . . . 74.14 114.897 -171.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.9 p -61.67 162.26 8.76 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 124.6 1.16 . . . . 75.03 112.455 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -56.05 -35.93 67.47 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.118 0.967 . . . . 71.11 112.279 -175.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.46 ' HA ' ' HZ2' ' A' ' 23' ' ' LYS . 0.4 OUTLIER -74.51 -29.49 61.43 Favored 'General case' 0 C--O 1.209 -1.058 0 CA-C-O 118.939 -0.553 . . . . 72.43 110.654 -177.246 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -69.67 -39.0 77.27 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 118.516 0.598 . . . . 71.14 110.005 173.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.417 HD12 ' CD1' ' A' ' 8' ' ' TYR . 1.6 mp -61.86 -40.91 88.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 C-N-CA 124.199 1.0 . . . . 73.31 110.345 172.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.46 ' HZ2' ' HA ' ' A' ' 20' ' ' GLU . 3.8 ttpm? -80.32 -25.76 39.15 Favored 'General case' 0 C--O 1.213 -0.844 0 CA-C-N 114.491 -1.231 . . . . 75.22 110.197 -174.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.428 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 73.5 mtp180 -78.07 -34.85 50.1 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.484 0.714 . . . . 73.12 109.918 173.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.78 -34.36 73.65 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 123.893 0.746 . . . . 72.43 109.982 173.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -63.96 -60.23 3.51 Favored 'General case' 0 C--O 1.209 -1.068 0 CA-C-N 115.672 -0.695 . . . . 73.1 109.533 172.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.428 ' HE3' ' HA ' ' A' ' 24' ' ' ARG . 51.6 mtmt -53.87 -38.2 64.48 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 124.31 1.044 . . . . 74.22 110.686 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.2 ttt180 -59.37 -57.91 10.93 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.521 1.128 . . . . 75.52 110.956 176.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.589 ' HB3' HD12 ' A' ' 50' ' ' ILE . 84.7 mt -76.81 -11.69 59.87 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.702 0.801 . . . . 75.12 111.18 -177.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.06 -20.44 24.36 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.909 0.884 . . . . 71.54 110.535 178.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 75.4 mtm180 -95.68 -31.9 13.02 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.052 0.541 . . . . 72.33 110.673 171.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -77.03 -55.0 5.83 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 108.981 -0.748 . . . . 73.31 108.981 -178.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.593 ' HA ' HD21 ' A' ' 38' ' ' ASN . 39.2 m-85 -93.47 33.55 1.24 Allowed 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 115.879 -0.601 . . . . 72.41 110.531 173.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 7.9 t-80 -61.28 107.75 1.23 Allowed Pre-proline 0 C--N 1.357 0.912 0 N-CA-C 108.564 -0.902 . . . . 73.54 108.564 177.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -57.87 -19.32 38.84 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 122.976 2.451 . . . . 75.51 113.086 -169.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -63.42 -42.69 98.73 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.685 1.194 . . . . 73.23 112.704 178.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.5 t -105.09 -37.46 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 123.173 0.589 . . . . 73.25 109.984 -177.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.593 HD21 ' HA ' ' A' ' 33' ' ' TYR . 63.1 t30 -98.09 68.13 1.95 Allowed 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 122.634 1.207 . . . . 64.12 108.51 178.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt -79.6 75.88 6.24 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 113.827 -1.533 . . . . 73.11 109.282 -178.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.8 m -135.55 108.29 10.12 Favored Pre-proline 0 N--CA 1.467 0.422 0 CA-C-O 118.124 -0.941 . . . . 71.24 108.622 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -39.31 -45.31 3.03 Favored 'Trans proline' 0 C--N 1.387 2.569 0 C-N-CA 124.23 3.287 . . . . 73.53 114.248 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -56.22 -46.93 79.33 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.408 0.683 . . . . 64.43 111.343 178.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.5 -16.96 61.78 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.527 0.731 . . . . 73.42 111.623 -178.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -92.07 -30.72 15.87 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.532 0.733 . . . . 63.35 110.428 -176.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -72.23 -36.62 69.16 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 109.417 -0.586 . . . . 62.44 109.417 168.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -62.84 -41.28 99.27 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 116.058 -0.519 . . . . 74.03 109.834 170.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.629 ' HA ' HD13 ' A' ' 50' ' ' ILE . 52.1 t80 -63.64 -31.56 72.77 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.583 0.753 . . . . 73.32 110.716 176.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -63.64 -45.14 91.56 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 122.567 0.347 . . . . 75.14 110.975 171.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -65.63 -25.87 67.57 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 111.821 0.304 . . . . 71.44 111.821 178.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.629 HD13 ' HA ' ' A' ' 47' ' ' PHE . 66.1 mt -74.78 -39.28 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 123.847 0.859 . . . . 74.43 110.103 172.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.444 ' HB3' ' HD1' ' A' ' 88' ' ' PHE . 94.4 m-20 -71.07 -23.56 62.16 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.684 0.793 . . . . 73.43 110.911 176.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -76.05 -53.35 8.49 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.593 1.557 . . . . 75.34 109.626 177.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.06 -47.19 78.4 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 113.928 -1.487 . . . . 65.45 110.417 176.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -68.87 -37.05 78.82 Favored 'General case' 0 C--O 1.207 -1.14 0 CA-C-N 114.64 -1.164 . . . . 73.53 110.928 176.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.407 ' HB1' ' HD2' ' A' ' 85' ' ' PHE . . . -51.93 -53.81 36.78 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 118.658 0.663 . . . . 72.52 110.462 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.474 HG11 ' HZ ' ' A' ' 101' ' ' PHE . 47.0 t -64.1 -55.93 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 113.866 -1.515 . . . . 74.52 110.273 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 78.1 mt -81.61 2.03 31.2 Favored 'General case' 0 CA--C 1.556 1.183 0 N-CA-C 113.745 1.017 . . . . 74.35 113.745 -169.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.0 t -80.19 -75.14 0.27 Allowed 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 109.215 -0.661 . . . . 74.34 109.215 174.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -68.86 116.95 46.5 Favored Pre-proline 0 C--O 1.239 0.549 0 CA-C-O 118.651 -0.69 . . . . 74.34 109.392 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -49.88 -28.0 17.27 Favored 'Trans proline' 0 C--N 1.388 2.621 0 C-N-CA 124.069 3.179 . . . . 72.41 114.294 -175.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -60.34 -62.73 1.65 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.704 0.802 . . . . 72.3 110.735 175.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.421 ' HA ' HD12 ' A' ' 65' ' ' ILE . 29.6 mtmm -64.28 -33.12 75.09 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.176 0.591 . . . . 74.54 110.737 -177.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 22.3 ttt85 -61.83 -45.76 92.45 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.065 -0.971 . . . . 74.11 110.703 176.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -70.65 -28.25 64.65 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 119.279 -0.391 . . . . 74.25 111.262 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' A' ' 62' ' ' LYS . 73.2 mt -53.24 -52.8 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 N-CA-C 108.86 -0.793 . . . . 74.41 108.86 168.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.489 ' OH ' ' HA ' ' A' ' 6' ' ' ASP . 55.9 t80 -61.97 -52.01 65.76 Favored 'General case' 0 CA--C 1.556 1.179 0 CA-C-N 114.561 -1.2 . . . . 75.4 112.004 178.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -56.37 -40.54 74.73 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.135 0.974 . . . . 64.04 111.848 -175.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 58.6 p -80.35 -22.55 41.31 Favored 'General case' 0 C--O 1.215 -0.728 0 CA-C-N 115.498 -0.774 . . . . 75.44 111.07 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -66.45 109.23 2.66 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 118.909 0.777 . . . . 75.32 108.934 176.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 113.18 13.29 10.98 Favored Glycine 0 CA--C 1.537 1.429 0 CA-C-N 115.337 -0.847 . . . . 64.23 111.565 -166.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 50.7 m -148.4 -61.08 0.25 Allowed 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 103.986 -2.598 . . . . 71.23 103.986 176.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 61.8 m -75.83 139.87 41.97 Favored 'General case' 0 C--O 1.248 1.005 0 N-CA-C 104.549 -2.389 . . . . 74.23 104.549 155.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.14 -25.8 7.94 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 122.792 0.437 . . . . 74.04 111.179 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.08 132.51 90.18 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 123.851 0.86 . . . . 75.1 110.597 176.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -55.51 141.95 81.88 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 122.74 2.294 . . . . 75.41 111.252 168.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -57.72 149.93 65.27 Favored 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 123.501 2.801 . . . . 74.25 113.009 -173.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -66.2 170.81 11.25 Favored 'Trans proline' 0 C--N 1.383 2.393 0 C-N-CA 124.095 3.197 . . . . 73.45 113.742 -173.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -33.71 127.58 0.16 Allowed 'Trans proline' 0 C--N 1.401 3.304 0 C-N-CA 124.818 3.679 . . . . 73.2 114.404 174.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.571 ' HG3' ' HA3' ' A' ' 104' ' ' GLY . 42.2 Cg_endo -77.92 119.8 4.84 Favored 'Trans proline' 0 CA--C 1.559 1.73 0 C-N-CA 123.277 2.651 . . . . 71.05 113.049 -165.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.09 76.23 2.63 Favored 'Trans proline' 0 CA--C 1.554 1.511 0 C-N-CA 122.592 2.195 . . . . 74.31 112.746 -178.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 115.22 0.96 22.25 Favored Glycine 0 C--N 1.347 1.152 0 CA-C-N 115.075 -0.966 . . . . 62.41 112.002 -176.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.74 147.14 12.31 Favored Glycine 0 C--N 1.352 1.436 0 N-CA-C 110.713 -0.955 . . . . 53.03 110.713 -167.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -65.53 100.62 0.52 Allowed 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 118.349 1.074 . . . . 74.41 109.029 172.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -54.1 139.75 34.14 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.496 1.118 . . . . 71.31 112.519 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.491 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 65.2 m-85 -143.48 72.85 1.37 Allowed 'General case' 0 N--CA 1.47 0.55 0 O-C-N 124.136 0.897 . . . . 73.24 109.682 171.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 18.2 m -52.7 86.7 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 125.509 1.524 . . . . 74.44 112.68 -179.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.703 ' H ' ' HA3' ' A' ' 163' ' ' GLY . . . 80.7 1.39 89.2 Favored Glycine 0 C--N 1.34 0.767 0 CA-C-N 115.858 -0.61 . . . . 70.11 112.853 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.491 ' HB2' ' HB3' ' A' ' 85' ' ' PHE . 17.4 m-85 -97.24 114.29 26.01 Favored 'General case' 0 C--N 1.344 0.365 0 N-CA-C 107.727 -1.212 . . . . 72.34 107.727 -176.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -80.22 80.92 6.58 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.245 0.545 . . . . 71.44 110.191 -174.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.63 HG23 HD23 ' A' ' 105' ' ' LEU . 1.6 p -42.31 -39.42 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 125.413 1.485 . . . . 75.21 112.936 174.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -57.23 -33.36 67.47 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.008 0.923 . . . . 75.33 112.714 -176.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -105.32 11.6 32.66 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.236 0.541 . . . . 61.35 111.69 -178.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 17.2 m-30 -90.33 173.84 7.9 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 121.967 -0.458 . . . . 73.34 109.881 174.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 86.0 p -65.72 157.89 28.96 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 113.631 0.974 . . . . 74.5 113.631 -167.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.45 -42.77 96.82 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.345 1.058 . . . . 74.52 111.633 176.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -55.63 -49.93 71.52 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.092 0.957 . . . . 75.03 111.2 177.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.508 ' HE2' HG21 ' A' ' 90' ' ' VAL . 37.7 t80 -60.01 -42.84 95.17 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.443 -1.253 . . . . 72.32 110.584 176.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -78.27 -4.35 47.42 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.325 -0.852 . . . . 74.14 112.415 -178.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -102.34 -34.05 9.34 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.038 0.535 . . . . 70.02 111.286 169.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 41.6 tp -65.81 -52.13 53.25 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.223 0.609 . . . . 74.33 109.56 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.474 ' HZ ' HG11 ' A' ' 56' ' ' VAL . 88.8 m-85 -92.86 -0.49 57.23 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.529 -0.76 . . . . 72.11 110.745 174.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.403 ' N ' ' HD2' ' A' ' 103' ' ' PRO . . . -42.78 -56.65 4.27 Favored Glycine 0 C--N 1.353 1.509 0 CA-C-O 118.213 -1.326 . . . . 72.43 115.188 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.403 ' HD2' ' N ' ' A' ' 102' ' ' GLY . 4.8 Cg_exo -34.76 -32.49 0.07 OUTLIER 'Trans proline' 0 C--N 1.395 3.024 1 C-N-CA 125.697 4.264 . . . . 64.43 115.263 177.17 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.571 ' HA3' ' HG3' ' A' ' 79' ' ' PRO . . . -152.94 49.21 0.52 Allowed Glycine 0 C--N 1.351 1.4 0 C-N-CA 120.547 -0.835 . . . . 54.4 113.786 179.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.63 HD23 HG23 ' A' ' 90' ' ' VAL . 29.7 mt -58.22 79.61 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 112.444 0.535 . . . . 74.25 112.444 171.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.451 ' HD1' ' H ' ' A' ' 108' ' ' GLY . 0.1 OUTLIER 42.27 -110.29 0.14 Allowed 'General case' 0 CA--C 1.559 1.326 0 C-N-CA 126.514 1.925 . . . . 74.45 112.819 -179.751 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.429 ' H ' ' HB3' ' A' ' 106' ' ' PHE . . . 70.24 -0.66 23.01 Favored Glycine 0 C--N 1.362 2.011 0 CA-C-N 118.27 0.486 . . . . 44.0 113.663 -172.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.451 ' H ' ' HD1' ' A' ' 106' ' ' PHE . . . . . . . . 0 C--N 1.352 1.417 0 N-CA-C 112.26 -0.336 . . . . 71.34 112.26 -172.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.528 ' HA ' ' HD2' ' A' ' 170' ' ' PRO . 8.0 tmtm? . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 107.226 -1.398 . . . . 73.31 107.226 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -73.71 148.71 40.51 Favored Glycine 0 CA--C 1.531 1.086 0 O-C-N 123.373 0.421 . . . . 73.4 113.335 -175.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 8.0 tmm_? -114.79 155.6 26.43 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 124.081 0.952 . . . . 74.43 110.349 -175.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -58.37 131.42 50.64 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 123.731 0.813 . . . . 74.23 111.694 -178.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.2 tt -145.63 164.77 30.69 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 108.566 -0.901 . . . . 75.42 108.566 -172.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.462 ' NH2' HH21 ' A' ' 179' ' ' ARG . 60.1 ttt180 -129.54 139.22 51.59 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.62 -0.881 . . . . 74.51 108.62 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -135.61 151.51 50.33 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.642 0.777 . . . . 54.41 108.994 177.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.415 ' H ' ' HB1' ' B' ' 9' ' ' ALA . 13.0 mm-40 -102.18 133.78 46.5 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 107.119 -1.437 . . . . 72.42 107.119 -177.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.447 ' HA ' HD13 ' B' ' 8' ' ' LEU . 39.7 tp -102.54 95.15 5.74 Favored Pre-proline 0 CA--C 1.544 0.743 0 N-CA-C 107.991 -1.114 . . . . 74.14 107.991 179.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.512 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 52.6 Cg_endo -72.39 112.73 3.52 Favored 'Trans proline' 0 C--N 1.384 2.42 0 C-N-CA 121.532 1.488 . . . . 75.33 109.085 174.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.663 ' HA ' HG23 ' B' ' 6' ' ' ILE . 42.0 tp -123.79 137.49 54.67 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.243 0.544 . . . . 72.43 110.862 -166.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 17.3 m -75.78 133.85 40.58 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 114.984 -1.007 . . . . 71.34 109.72 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 49.5 mt -49.69 -44.01 47.76 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 124.656 1.183 . . . . 75.21 112.103 -169.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -57.58 -54.07 50.97 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.009 -0.996 . . . . 75.32 110.518 -176.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -57.8 -40.29 79.55 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 115.719 -0.673 . . . . 64.33 110.788 177.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -58.76 -48.85 79.79 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 124.291 0.994 . . . . 65.44 112.246 -176.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -74.15 -41.02 62.19 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 123.274 0.359 . . . . 74.51 111.717 -177.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -68.53 -43.54 76.51 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 120.79 0.328 . . . . 75.25 110.87 -178.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.445 ' HA3' ' HA ' ' A' ' 151' ' ' PRO . . . 76.21 177.57 43.44 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-N 115.418 -0.81 . . . . 71.54 113.802 178.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 109.48 -152.41 17.14 Favored Glycine 0 C--N 1.34 0.783 0 C-N-CA 123.48 0.562 . . . . 70.42 112.178 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -77.31 111.52 13.05 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.653 0.781 . . . . 73.14 111.115 -178.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 4.4 tpm_? -101.09 124.12 46.31 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 123.919 0.888 . . . . 75.05 109.81 176.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.0 t -84.33 109.5 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 123.959 0.904 . . . . 75.04 109.308 177.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.9 p -129.56 131.07 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.335 1.054 . . . . 73.34 108.881 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.49 ' HA ' ' HA ' ' A' ' 144' ' ' ARG . 39.3 tt0 -113.93 142.45 46.11 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.035 0.445 . . . . 71.3 110.911 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.7 p -155.31 127.83 1.06 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.59 0 C-N-CA 124.4 1.08 . . . . 75.1 108.622 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 58.81 18.38 6.01 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.025 0.93 . . . . 74.24 112.536 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 103.12 -32.36 7.68 Favored Glycine 0 C--N 1.352 1.453 0 C-N-CA 122.903 0.287 . . . . 54.15 112.463 -176.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.35 105.26 4.02 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 108.898 -0.778 . . . . 72.43 108.898 178.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.49 ' HA ' ' HA ' ' A' ' 139' ' ' GLU . 16.1 ttm180 -94.9 98.81 10.98 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.755 0.822 . . . . 74.41 109.51 173.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 6.8 p -95.8 140.75 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.777 0.831 . . . . 73.53 111.303 -177.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 28.7 t -92.62 84.36 5.04 Favored 'General case' 0 C--O 1.243 0.742 0 N-CA-C 108.67 -0.863 . . . . 64.43 108.67 174.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 31.5 m -82.64 122.99 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 N-CA-C 110.257 -0.275 . . . . 73.42 110.257 -177.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -73.73 103.27 4.23 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.565 0.698 . . . . 74.32 109.525 174.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.421 HG13 ' HA2' ' A' ' 133' ' ' GLY . 18.1 pt -82.43 133.7 49.63 Favored Pre-proline 0 CA--C 1.554 1.112 0 CA-C-N 114.565 -1.198 . . . . 74.52 108.206 167.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -62.78 143.17 91.44 Favored 'Trans proline' 0 C--N 1.371 1.742 0 C-N-CA 121.939 1.759 . . . . 74.22 112.163 175.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.445 ' HA ' ' HA3' ' A' ' 133' ' ' GLY . 49.0 Cg_exo -57.47 92.14 0.05 OUTLIER 'Trans proline' 0 C--N 1.389 2.695 0 C-N-CA 123.22 2.614 . . . . 74.15 112.563 176.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.68 ' HA3' ' HD2' ' A' ' 241' ' ' PRO . . . 98.65 56.87 1.01 Allowed Glycine 0 C--N 1.335 0.474 0 CA-C-N 114.812 -1.085 . . . . 75.51 111.214 -169.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.45 HG22 HG13 ' A' ' 178' ' ' VAL . 5.4 p -78.38 131.29 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-O 121.73 0.776 . . . . 75.43 109.288 178.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.653 ' HA ' HD21 ' A' ' 188' ' ' LEU . 21.8 mtt85 -100.75 149.67 23.58 Favored 'General case' 0 C--O 1.21 -0.98 0 CA-C-N 114.587 -1.188 . . . . 73.23 110.873 -163.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -58.77 118.65 5.95 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.795 0.838 . . . . 72.32 110.916 -178.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 91.66 12.33 59.56 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-N 115.214 -0.903 . . . . 74.33 113.414 -176.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 24.0 t -70.94 113.97 8.53 Favored 'General case' 0 C--N 1.356 0.874 0 N-CA-C 108.319 -0.993 . . . . 74.23 108.319 173.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.48 HG22 HG23 ' A' ' 177' ' ' VAL . 47.2 t -85.57 90.33 2.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 C-N-CA 123.565 0.746 . . . . 74.02 109.09 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 61.6 mt -71.86 93.0 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 107.779 -1.193 . . . . 75.24 107.779 171.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -81.19 109.02 15.33 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.795 -0.639 . . . . 75.21 110.416 -174.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 3.7 p -114.63 108.17 49.73 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 123.606 0.763 . . . . 71.41 109.506 177.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.573 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 52.6 Cg_endo -68.33 155.37 69.49 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 121.95 1.766 . . . . 74.53 110.894 172.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . 0.703 ' HA3' ' H ' ' A' ' 87' ' ' GLY . . . 75.81 27.64 62.39 Favored Glycine 0 C--N 1.345 1.063 0 C-N-CA 121.44 -0.409 . . . . 70.43 114.022 176.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 36.6 tpp -134.65 -22.78 1.65 Allowed 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.031 0.532 . . . . 64.15 111.385 -178.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.58 ' HA2' HD11 ' A' ' 174' ' ' LEU . . . -68.65 -99.93 0.03 OUTLIER Glycine 0 C--N 1.354 1.54 0 N-CA-C 114.993 0.757 . . . . 73.33 114.993 -172.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -63.69 121.51 23.88 Favored Glycine 0 C--N 1.347 1.182 0 N-CA-C 111.888 -0.485 . . . . 74.5 111.888 178.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.537 ' HA ' HE21 ' A' ' 167' ' ' GLN . 0.0 OUTLIER -67.96 104.84 1.83 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.506 0.722 . . . . 75.42 110.596 -174.726 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -165.32 170.52 40.29 Favored Glycine 0 C--N 1.339 0.733 0 CA-C-O 118.785 -1.008 . . . . 64.21 111.242 -178.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . 0.503 ' ND2' ' HB3' ' A' ' 105' ' ' LEU . 24.4 t-20 -49.52 -65.88 0.74 Allowed Pre-proline 0 CA--C 1.561 1.399 0 CA-C-O 117.247 -1.359 . . . . 63.54 110.858 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.528 ' HD2' ' HA ' ' A' ' 115' ' ' LYS . 71.1 Cg_endo -93.83 94.06 0.13 Allowed 'Trans proline' 0 C--N 1.393 2.869 0 CA-C-N 122.645 1.98 . . . . 73.02 108.881 165.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -69.73 158.26 57.62 Favored 'Trans proline' 0 C--N 1.373 1.848 0 C-N-CA 122.475 2.117 . . . . 71.25 111.765 -164.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -70.1 171.74 42.04 Favored Glycine 0 C--N 1.34 0.802 0 CA-C-N 116.143 -0.48 . . . . 72.4 113.598 -174.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.573 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 31.0 t70 -67.63 142.75 56.31 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 109.329 -0.619 . . . . 71.14 109.329 172.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.58 HD11 ' HA2' ' A' ' 165' ' ' GLY . 23.4 tp -124.57 131.85 53.46 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 120.859 0.362 . . . . 74.2 110.291 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 47.1 mt -102.53 98.37 8.45 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.676 0.791 . . . . 72.12 109.271 176.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.562 HD22 HD11 ' B' ' 8' ' ' LEU . 80.2 mt -83.09 93.98 7.72 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 118.051 0.387 . . . . 74.52 110.577 178.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.48 HG23 HG22 ' A' ' 158' ' ' VAL . 24.2 t -85.47 107.43 16.18 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 N-CA-C 107.965 -1.124 . . . . 71.11 107.965 177.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.45 HG13 HG22 ' A' ' 153' ' ' VAL . 7.5 p -69.4 127.7 31.68 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 CA-C-O 121.386 0.613 . . . . 74.13 111.233 -174.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.512 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 37.0 mmt180 -116.77 101.7 8.78 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 125.193 1.397 . . . . 73.42 108.278 176.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 4.9 mt -69.92 143.14 52.81 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 118.559 0.618 . . . . 74.04 110.246 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 83.4 mt -61.32 155.47 57.21 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 123.995 0.918 . . . . 73.22 111.755 -175.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -76.95 53.59 4.23 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 122.892 2.395 . . . . 74.32 109.858 163.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 27.8 t-80 -79.19 131.3 66.49 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 125.014 1.326 . . . . 73.35 108.572 -171.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -9.06 -53.6 0.0 OUTLIER 'Trans proline' 0 C--N 1.383 2.379 1 C-N-CA 127.692 5.595 . . . . 61.24 119.748 -163.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.434 HG11 ' HB1' ' A' ' 195' ' ' ALA . 44.2 t -99.76 -59.32 3.35 Favored 'Isoleucine or valine' 0 C--N 1.356 0.855 0 CA-C-N 119.322 0.965 . . . . 72.34 109.993 -168.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . 0.624 ' HB3' HD23 ' A' ' 193' ' ' LEU . 51.8 m-85 -101.4 138.78 37.96 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 112.863 0.69 . . . . 72.31 112.863 -165.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 27.2 ttp-105 -116.58 98.51 6.58 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 106.02 -1.844 . . . . 75.51 106.02 164.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.653 HD21 ' HA ' ' A' ' 154' ' ' ARG . 56.0 tp -68.98 144.16 54.2 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.616 -0.513 . . . . 74.21 109.616 176.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -149.15 115.67 5.87 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 107.788 -1.19 . . . . 70.31 107.788 -176.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . 0.417 ' O ' ' HB3' ' A' ' 154' ' ' ARG . . . 73.29 -75.9 0.95 Allowed Glycine 0 C--N 1.349 1.29 0 CA-C-O 119.889 -0.395 . . . . 65.41 113.587 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -153.15 -2.98 0.22 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.976 0.911 . . . . 72.32 110.959 176.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -125.21 148.15 48.75 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.961 0.904 . . . . 72.32 110.446 -172.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.624 HD23 ' HB3' ' A' ' 186' ' ' PHE . 81.7 mt -90.83 149.88 21.78 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.856 0.862 . . . . 74.25 111.162 -171.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -128.58 99.59 5.43 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.312 1.045 . . . . 73.14 108.456 171.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.543 ' HB2' HD23 ' A' ' 251' ' ' LEU . . . -110.78 110.86 21.67 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.537 1.135 . . . . 74.34 111.055 -171.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 77.4 m -64.59 121.84 15.4 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 109.299 -0.63 . . . . 70.21 109.299 178.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 54.0 tp -122.62 105.73 10.36 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 123.722 0.809 . . . . 74.1 108.978 -166.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -70.35 126.2 28.96 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.144 0.497 . . . . 63.3 109.917 173.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 7.1 p -142.79 136.96 14.7 Favored Pre-proline 0 CA--C 1.548 0.894 0 N-CA-C 107.179 -1.415 . . . . 74.33 107.179 179.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.64 154.56 34.99 Favored 'Trans proline' 0 C--N 1.361 1.19 0 C-N-CA 121.55 1.5 . . . . 70.05 111.718 172.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -53.72 -47.25 97.28 Favored Pre-proline 0 CA--C 1.565 1.52 0 N-CA-C 114.718 1.377 . . . . 71.34 114.718 -174.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -59.11 -39.74 76.69 Favored 'Trans proline' 0 C--N 1.383 2.376 0 C-N-CA 122.088 1.859 . . . . 73.32 114.325 176.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 45.7 mt -75.43 -26.79 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 122.517 0.327 . . . . 71.02 110.609 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.09 -43.68 74.03 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.196 0.598 . . . . 74.14 111.158 173.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 11.1 t -69.23 -52.64 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 123.957 0.903 . . . . 64.22 112.017 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 85.3 t -85.28 -31.7 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 123.231 0.612 . . . . 74.41 111.262 -171.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 83.4 94.66 0.61 Allowed Glycine 0 CA--C 1.53 0.989 0 CA-C-N 116.308 -0.405 . . . . 72.35 113.035 -178.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -123.54 -178.15 15.34 Favored Glycine 0 N--CA 1.476 1.33 0 N-CA-C 111.487 -0.645 . . . . 73.32 111.487 174.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -81.28 134.15 35.55 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 117.963 0.882 . . . . 73.34 110.409 177.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 33.2 m -123.54 143.8 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 106.537 -1.653 . . . . 63.11 106.537 164.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -92.87 113.65 25.98 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 121.622 -0.674 . . . . 74.32 109.809 -176.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.03 128.8 46.07 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.265 1.026 . . . . 74.41 109.22 -177.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' MET . . . . . 0.454 ' HA ' ' HA ' ' A' ' 218' ' ' PRO . 1.6 mpt? -82.65 124.06 29.84 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.118 -0.697 . . . . 74.15 109.118 -177.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 77.2 p -109.3 -179.61 3.89 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 123.228 0.611 . . . . 74.1 109.784 178.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 49.3 mt -75.83 1.0 16.12 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.388 1.075 . . . . 73.14 111.987 -171.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -133.75 5.17 3.64 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 124.317 1.047 . . . . 64.44 111.592 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 137.49 170.6 11.93 Favored Glycine 0 N--CA 1.482 1.709 0 CA-C-O 119.802 -0.443 . . . . 63.05 113.545 176.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . 0.454 ' HA ' ' HA ' ' A' ' 213' ' ' MET . 85.2 Cg_endo -80.49 115.86 3.2 Favored 'Trans proline' 0 C--N 1.372 1.778 0 C-N-CA 122.955 2.437 . . . . 74.13 112.609 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 35.8 m -114.35 147.54 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.637 0.775 . . . . 73.4 109.834 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -73.85 147.18 43.54 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 109.566 -0.531 . . . . 75.04 109.566 175.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 10.1 p -137.24 116.52 15.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-O 121.544 0.688 . . . . 74.51 109.574 175.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -77.39 101.09 6.2 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 123.954 0.902 . . . . 70.4 109.522 -177.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 91.3 t -66.98 131.92 93.83 Favored Pre-proline 0 CA--C 1.556 1.205 0 CA-C-N 114.989 -1.005 . . . . 71.22 109.46 178.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.58 165.99 30.96 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.688 2.258 . . . . 75.51 110.922 175.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -69.47 158.62 56.66 Favored 'Trans proline' 0 C--N 1.37 1.695 0 C-N-CA 121.766 1.644 . . . . 72.53 111.857 175.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 15.3 mmt180 69.26 15.62 8.53 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 125.277 1.431 . . . . 75.13 112.046 175.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 4.0 m -59.89 104.65 0.31 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.188 0.995 . . . . 64.32 111.065 -179.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -92.11 139.55 30.52 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 114.418 -1.264 . . . . 75.32 111.671 -173.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -54.11 153.19 5.27 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.496 1.518 . . . . 65.12 112.337 174.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 79.36 -49.15 3.53 Favored Glycine 0 C--N 1.345 1.069 0 N-CA-C 112.269 -0.332 . . . . 75.54 112.269 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -63.73 163.44 11.55 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 124.276 1.03 . . . . 74.44 111.363 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.517 ' HG3' ' HG2' ' A' ' 252' ' ' GLU . 2.9 mppt? -112.12 129.5 56.21 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 114.838 -1.074 . . . . 72.22 110.355 -175.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.578 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 79.6 mt -77.59 104.3 8.04 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 108.323 -0.992 . . . . 71.4 108.323 170.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 42.1 ttm105 -82.25 109.3 16.4 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 122.643 0.377 . . . . 73.41 110.247 177.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.43 ' HG ' ' HB3' ' A' ' 249' ' ' LEU . 0.4 OUTLIER -120.83 106.31 11.54 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 108.055 -1.091 . . . . 74.24 108.055 169.866 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -74.56 159.87 31.62 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.069 0.948 . . . . 71.01 112.666 -169.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 73.35 9.51 77.51 Favored Glycine 0 C--N 1.349 1.294 0 CA-C-N 115.496 -0.774 . . . . 74.2 113.369 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.38 -11.63 15.15 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.295 0.638 . . . . 74.1 111.187 -176.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -79.53 -154.34 8.72 Favored Glycine 0 C--N 1.348 1.218 0 N-CA-C 112.515 -0.234 . . . . 74.43 112.515 177.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -92.41 137.69 24.47 Favored Pre-proline 0 N--CA 1.48 1.063 0 CA-C-O 118.918 -0.563 . . . . 73.41 110.132 -175.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.68 ' HD2' ' HA3' ' A' ' 152' ' ' GLY . 89.7 Cg_exo -46.78 107.99 0.14 Allowed 'Trans proline' 0 C--N 1.388 2.61 0 C-N-CA 123.973 3.115 . . . . 73.33 113.83 -178.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -134.56 -145.35 5.21 Favored Glycine 0 C--N 1.35 1.317 0 CA-C-O 119.073 -0.848 . . . . 73.52 112.585 -171.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -72.78 -26.93 15.37 Favored 'Trans proline' 0 C--N 1.385 2.475 0 C-N-CA 123.052 2.501 . . . . 72.5 112.655 -173.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -94.2 22.89 5.47 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.19 0.996 . . . . 70.11 111.066 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 90.13 -68.97 2.42 Favored Glycine 0 C--N 1.345 1.077 0 N-CA-C 109.579 -1.408 . . . . 62.24 109.579 -171.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.515 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 75.8 mtp180 -127.23 168.39 14.79 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.53 1.132 . . . . 75.41 109.306 166.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -84.95 -166.2 41.29 Favored Glycine 0 C--N 1.346 1.094 0 CA-C-N 116.171 -0.468 . . . . 70.31 111.973 172.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . 0.423 ' HB2' ' CE1' ' A' ' 250' ' ' TYR . 26.6 m-20 -104.39 158.99 16.09 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.371 0.669 . . . . 75.44 109.831 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.43 ' HB3' ' HG ' ' A' ' 235' ' ' LEU . 40.6 tp -106.57 122.74 46.91 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 107.619 -1.252 . . . . 73.32 107.619 167.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.423 ' CE1' ' HB2' ' A' ' 248' ' ' ASP . 42.4 m-85 -108.27 105.69 15.52 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.096 -1.076 . . . . 71.3 108.096 176.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.578 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 69.1 mt -84.41 102.83 13.06 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 108.75 -0.833 . . . . 74.54 108.75 176.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . 0.517 ' HG2' ' HG3' ' A' ' 232' ' ' LYS . 27.7 mt-10 -74.96 96.34 3.15 Favored 'General case' 0 C--N 1.356 0.855 0 C-N-CA 123.57 0.748 . . . . 75.41 109.091 -176.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 46.3 t -55.73 133.74 19.55 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 125.571 1.548 . . . . 71.34 112.222 -172.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -133.93 94.42 3.26 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 107.733 -1.21 . . . . 73.14 107.733 -179.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.443 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 77.6 mt -79.59 133.9 28.81 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-N 115.961 -0.563 . . . . 74.34 111.144 -176.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 31.1 p -129.87 176.22 8.22 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.548 1.139 . . . . 74.52 109.519 172.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.7 pp -133.23 153.03 80.51 Favored Pre-proline 0 CA--C 1.569 1.703 0 C-N-CA 123.803 0.841 . . . . 73.4 111.116 -174.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -59.18 -9.68 8.77 Favored 'Trans proline' 0 C--N 1.387 2.597 0 C-N-CA 123.999 3.133 . . . . 74.45 116.278 -166.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . 0.484 ' HA ' ' HB3' ' C' ' 226' ' ' ARG . 36.3 mt-10 56.67 -67.52 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.075 0 C-N-CA 125.415 1.486 . . . . 75.12 113.89 -174.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.03 132.59 39.02 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.55 -0.718 . . . . 75.12 109.66 172.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.608 HD22 ' HB2' ' A' ' 265' ' ' GLU . 56.2 mt -123.73 148.92 46.15 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.414 0.686 . . . . 72.32 110.453 173.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 21.7 p -127.9 155.09 78.12 Favored Pre-proline 0 CA--C 1.558 1.259 0 C-N-CA 125.06 1.344 . . . . 74.31 108.054 172.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -17.96 -52.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.403 3.44 1 C-N-CA 126.867 5.045 . . . . 74.33 117.989 -170.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . 0.431 ' O ' HD11 ' A' ' 268' ' ' LEU . 63.3 mm-40 -55.71 -74.68 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.012 0.525 . . . . 71.44 111.285 177.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . 0.608 ' HB2' HD22 ' A' ' 261' ' ' LEU . 1.5 mp0 -64.07 -30.31 71.39 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 122.858 0.463 . . . . 73.22 109.964 -172.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' GLU . . . . . 0.55 ' HA ' HD12 ' A' ' 261' ' ' LEU . 7.6 tp10 -55.51 -62.73 1.49 Allowed 'General case' 0 C--O 1.248 1.01 0 O-C-N 123.79 0.681 . . . . 73.45 109.69 176.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -60.63 -38.86 86.16 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 115.238 -0.892 . . . . 64.12 111.354 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . 0.431 HD11 ' O ' ' A' ' 264' ' ' GLU . 2.2 mp -63.46 -48.09 79.13 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.007 0.923 . . . . 73.14 111.921 -176.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 77.9 m95 -68.79 -33.44 73.87 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.315 0.646 . . . . 75.0 111.398 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' A' ' 266' ' ' GLU . 29.8 mmtp -70.43 -39.95 74.07 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 122.405 0.282 . . . . 73.12 111.504 175.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -73.44 -30.24 63.08 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.016 0.526 . . . . 70.22 110.574 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 24.0 mt -59.67 -54.4 46.84 Favored 'General case' 0 C--O 1.205 -1.252 0 N-CA-C 108.541 -0.911 . . . . 71.54 108.541 167.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -51.28 -48.57 62.22 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 124.107 0.879 . . . . 72.23 111.948 -177.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 270' ' ' LYS . 25.8 mt-10 -62.72 -56.96 12.87 Favored 'General case' 0 CA--C 1.551 0.989 0 O-C-N 123.371 0.419 . . . . 74.35 110.389 178.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -57.71 -65.85 0.57 Allowed 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.726 0.81 . . . . 72.24 111.761 -177.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . 0.485 ' HE2' ' HG3' ' C' ' 258' ' ' PRO . 81.9 t80 -45.61 -59.09 2.94 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.703 1.601 . . . . 75.02 112.826 178.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' TYR . . . . . 0.62 ' HA ' ' HB3' ' A' ' 280' ' ' ALA . 2.3 t80 -66.86 -35.01 79.07 Favored 'General case' 0 N--CA 1.482 1.132 0 O-C-N 123.59 0.556 . . . . 72.14 110.691 -170.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -61.38 -20.1 62.64 Favored 'General case' 0 CA--C 1.554 1.102 0 N-CA-C 112.761 0.652 . . . . 75.41 112.761 176.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.4 16.29 7.69 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-O 118.437 -0.792 . . . . 75.15 111.479 176.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . 0.62 ' HB3' ' HA ' ' A' ' 277' ' ' TYR . . . . . . . . 0 N--CA 1.495 1.802 0 N-CA-C 113.135 0.791 . . . . 72.5 113.135 -166.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.479 1.002 0 N-CA-C 109.167 -0.679 . . . . 74.12 109.167 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -63.43 108.25 1.3 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.491 0.716 . . . . 62.45 109.645 175.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 61.3 tp60 -82.7 73.92 9.7 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 109.126 -0.694 . . . . 74.04 109.126 177.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 61.4 p 45.65 -88.06 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 126.012 1.725 . . . . 52.14 114.062 172.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 59.4 m 56.95 133.5 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 126.18 1.792 . . . . 74.34 114.044 -178.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.663 HG23 ' HA ' ' A' ' 125' ' ' LEU . 37.5 pt -137.54 172.43 14.6 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 C-N-CA 122.991 0.517 . . . . 65.34 111.971 -175.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -124.97 -167.6 1.7 Allowed 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.616 1.167 . . . . 72.22 108.991 175.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . 0.562 HD11 HD22 ' A' ' 176' ' ' LEU . 11.0 tp -130.69 167.1 19.35 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 109.428 -0.582 . . . . 75.22 109.428 177.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . 0.415 ' HB1' ' H ' ' A' ' 122' ' ' GLU . . . -87.68 -67.11 0.85 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 122.804 0.441 . . . . 73.12 110.864 173.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 3.8 tt 64.05 94.27 0.05 Allowed 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.556 1.142 . . . . 74.1 108.834 -169.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 57.2 mt . . . . . 0 CA--C 1.553 1.08 0 CA-C-O 118.751 -0.642 . . . . 72.11 109.434 -176.515 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.475 0 N-CA-C 108.276 -1.009 . . . . 74.35 108.276 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . 60.79 -74.69 0.03 OUTLIER 'General case' 0 C--N 1.358 0.963 0 O-C-N 125.111 1.507 . . . . 75.32 113.407 169.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 181' ' ' LEU . . . . . 0.435 ' HG ' ' HB ' ' C' ' 138' ' ' VAL . 30.3 tp -63.06 -30.14 71.36 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.146 1.378 . . . . 74.44 112.176 -177.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 182' ' ' VAL . . . . . 0.605 HG23 ' HB3' ' C' ' 139' ' ' GLU . 2.8 p -99.11 133.93 39.97 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 CA-C-N 116.189 -0.459 . . . . 72.43 110.982 174.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 183' ' ' ALA . . . . . 0.418 ' HB1' ' HA ' ' C' ' 123' ' ' LEU . . . -159.11 39.47 0.21 Allowed 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 114.806 -1.088 . . . . 65.24 108.453 163.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 42.5 p-80 54.49 171.44 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 127.216 2.207 . . . . 75.32 114.731 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 185' ' ' VAL . . . . . 0.468 HG21 HD13 ' C' ' 119' ' ' LEU . 6.9 p . . . . . 0 N--CA 1.479 1.007 0 CA-C-N 115.638 -0.71 . . . . 74.01 110.469 177.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 4.4 m . . . . . 0 CA--C 1.557 1.214 0 CA-C-O 121.792 0.806 . . . . 71.31 110.753 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -83.29 153.29 24.72 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.678 0.791 . . . . 74.42 111.345 -176.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 240' ' ' GLY . . . . . 0.411 ' O ' ' HE3' ' B' ' 245' ' ' LYS . . . -86.86 -60.62 1.67 Allowed Glycine 0 C--N 1.349 1.288 0 CA-C-N 116.008 -0.542 . . . . 71.23 113.708 -164.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -112.18 -167.41 1.18 Allowed 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 117.49 0.645 . . . . 71.23 110.685 178.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . 0.259 0.0 OUTLIER 59.53 166.33 0.06 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 127.647 2.379 . . . . 70.32 114.567 177.496 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 243' ' ' GLN . . . . . 0.452 ' HG3' ' N ' ' B' ' 245' ' ' LYS . 1.9 pt20 51.99 -166.95 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 126.519 1.928 . . . . 74.22 114.584 170.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -78.98 -43.81 10.58 Favored Glycine 0 C--N 1.362 2.007 0 CA-C-N 115.773 -0.649 . . . . 71.54 112.246 173.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 245' ' ' LYS . . . . . 0.452 ' N ' ' HG3' ' B' ' 243' ' ' GLN . 22.9 pttm . . . . . 0 N--CA 1.497 1.888 0 C-N-CA 126.324 1.85 . . . . 75.34 112.734 -178.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 114.673 1.36 . . . . 71.34 114.673 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 4' ' ' LYS . . . . . 0.52 ' HB2' ' HZ2' ' C' ' 4' ' ' LYS . 4.4 ttmp? 46.36 78.46 0.07 Allowed 'General case' 0 C--O 1.244 0.773 0 C-N-CA 125.93 1.692 . . . . 70.52 113.385 178.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -78.42 111.1 14.08 Favored 'General case' 0 C--O 1.246 0.882 0 N-CA-C 107.614 -1.254 . . . . 72.32 107.614 165.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 6' ' ' ASP . . . . . 0.485 ' HA ' ' OH ' ' C' ' 66' ' ' TYR . 13.9 t70 -64.73 113.35 3.72 Favored 'General case' 0 C--N 1.345 0.41 0 O-C-N 123.679 0.612 . . . . 65.15 109.837 177.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 7' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -63.83 -31.6 72.84 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 114.893 -1.049 . . . . 73.43 111.535 -176.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -64.76 -39.71 94.08 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 116.322 -0.399 . . . . 74.23 110.462 174.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.93 -41.5 86.94 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.25 0.62 . . . . 63.34 111.166 176.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 61.3 mt -58.57 -40.15 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 122.988 0.515 . . . . 73.31 110.433 178.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 94.0 mt -83.8 -12.62 55.39 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 112.606 0.595 . . . . 75.53 112.606 177.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.36 22.67 78.8 Favored Glycine 0 CA--C 1.535 1.33 0 N-CA-C 114.196 0.438 . . . . 74.43 114.196 -178.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 14.1 m -104.47 152.76 39.39 Favored Pre-proline 0 N--CA 1.482 1.136 0 C-N-CA 123.916 0.886 . . . . 71.34 110.337 177.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -64.0 157.95 50.24 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.542 2.162 . . . . 74.43 112.436 173.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 71.0 mtt180 -77.47 22.3 0.24 Allowed 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 123.508 0.723 . . . . 74.35 112.262 -179.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -120.9 8.79 10.53 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.965 1.306 . . . . 71.24 108.333 173.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.41 133.92 50.47 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 123.671 0.788 . . . . 75.2 111.328 -178.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 53.0 p -104.24 -176.11 2.99 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.564 1.146 . . . . 74.41 109.993 -178.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -48.41 -52.3 22.64 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 124.623 1.169 . . . . 74.45 112.184 -171.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.79 -48.4 63.73 Favored 'General case' 0 C--O 1.212 -0.912 0 O-C-N 123.746 0.654 . . . . 74.53 109.943 -172.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -63.93 -38.98 93.07 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.003 0.921 . . . . 73.42 111.562 -174.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 22' ' ' ILE . . . . . 0.778 HD13 ' HB3' ' C' ' 57' ' ' LEU . 78.3 mt -67.9 -50.3 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 123.977 0.911 . . . . 75.54 110.325 175.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -66.3 -22.31 66.29 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.195 -0.912 . . . . 74.13 110.017 -178.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 -74.05 -48.4 30.19 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.088 1.355 . . . . 73.52 110.035 176.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.39 -38.35 80.28 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 123.925 0.765 . . . . 75.32 110.678 175.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 26' ' ' TYR . . . . . 0.475 ' HE1' ' ND2' ' C' ' 51' ' ' ASN . 54.4 t80 -58.96 -62.52 1.82 Allowed 'General case' 0 C--O 1.208 -1.098 0 CA-C-N 115.097 -0.956 . . . . 72.31 109.857 173.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -50.33 -38.59 42.74 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 124.089 0.868 . . . . 75.33 111.582 -177.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 28' ' ' ARG . . . . . 0.411 ' HA ' ' NH2' ' C' ' 31' ' ' ARG . 59.5 ttt180 -57.95 -59.84 4.64 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.138 0.975 . . . . 75.55 110.957 176.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . 0.556 HD21 ' HE2' ' C' ' 33' ' ' TYR . 75.9 mt -76.98 -11.9 59.87 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 114.982 -1.008 . . . . 71.43 110.933 -176.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -88.83 -24.56 22.55 Favored 'General case' 0 C--O 1.213 -0.858 0 C-N-CA 124.131 0.973 . . . . 75.32 110.219 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . 0.411 ' NH2' ' HA ' ' C' ' 28' ' ' ARG . 45.3 mtm105 -85.12 -39.07 18.34 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.208 0.603 . . . . 73.5 110.204 171.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.72 -56.62 5.45 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 122.871 0.468 . . . . 71.12 110.196 -177.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 33' ' ' TYR . . . . . 0.556 ' HE2' HD21 ' C' ' 29' ' ' LEU . 50.1 m-85 -90.48 23.22 3.07 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 122.986 0.514 . . . . 72.14 111.438 -176.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 34' ' ' HIS . . . . . 0.404 ' HD2' ' HB3' ' C' ' 36' ' ' ASP . 20.6 t60 -68.99 109.1 3.72 Favored Pre-proline 0 N--CA 1.477 0.915 0 CA-C-O 118.265 -0.874 . . . . 74.34 110.114 -178.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 35' ' ' PRO . . . . . 0.511 ' HG3' ' HG2' ' C' ' 44' ' ' GLU . 76.9 Cg_exo -53.12 -25.38 29.04 Favored 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 123.663 2.909 . . . . 72.22 114.932 -173.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 36' ' ' ASP . . . . . 0.404 ' HB3' ' HD2' ' C' ' 34' ' ' HIS . 30.4 t70 -74.49 -35.74 63.25 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.508 0.723 . . . . 60.34 111.687 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 58.0 t -92.29 -56.01 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 109.336 -0.616 . . . . 75.33 109.336 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -100.62 92.17 4.99 Favored 'General case' 0 C--O 1.244 0.795 0 C-N-CA 125.098 1.359 . . . . 65.41 109.616 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.84 76.13 6.53 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.109 0.564 . . . . 71.22 109.722 -178.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 40' ' ' SER . . . . . 0.459 ' O ' ' HG3' ' C' ' 44' ' ' GLU . 69.8 m -131.23 111.42 15.45 Favored Pre-proline 0 N--CA 1.475 0.777 0 CA-C-O 118.256 -0.878 . . . . 74.14 110.221 179.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -45.1 -40.88 16.1 Favored 'Trans proline' 0 C--N 1.383 2.388 0 C-N-CA 123.718 2.946 . . . . 75.0 113.397 174.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -53.41 -48.83 68.37 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.996 0.919 . . . . 71.01 110.229 175.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 43' ' ' ALA . . . . . 0.444 ' O ' ' HB2' ' C' ' 47' ' ' PHE . . . -72.01 -18.72 61.95 Favored 'General case' 0 C--O 1.212 -0.913 0 CA-C-N 113.655 -1.611 . . . . 71.45 111.393 -177.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 44' ' ' GLU . . . . . 0.511 ' HG2' ' HG3' ' C' ' 35' ' ' PRO . 44.1 mt-10 -88.43 -40.61 13.36 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.805 0.842 . . . . 74.04 111.139 -174.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -69.93 -40.85 75.27 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 109.974 -0.38 . . . . 75.44 109.974 173.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 46' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -66.43 -35.12 79.51 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.916 -0.584 . . . . 72.32 110.774 173.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 47' ' ' PHE . . . . . 0.444 ' HB2' ' O ' ' C' ' 43' ' ' ALA . 77.3 t80 -57.73 -44.63 86.13 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.364 0.666 . . . . 71.12 109.271 173.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -58.87 -46.46 87.76 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 122.878 0.471 . . . . 72.04 111.311 176.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -64.37 -32.27 73.81 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 120.719 0.295 . . . . 72.33 111.756 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 50' ' ' ILE . . . . . 0.524 HD13 ' HB3' ' C' ' 29' ' ' LEU . 80.5 mt -74.03 -31.81 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 124.148 0.979 . . . . 75.43 110.136 175.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 51' ' ' ASN . . . . . 0.475 ' ND2' ' HE1' ' C' ' 26' ' ' TYR . 0.9 OUTLIER -82.81 -14.65 54.0 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.04 0.936 . . . . 74.04 110.811 176.805 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -81.48 -50.32 9.55 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.288 1.435 . . . . 75.54 108.429 173.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.95 -40.35 76.26 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 113.276 -1.783 . . . . 63.1 110.567 174.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -77.61 -33.97 53.57 Favored 'General case' 0 C--O 1.215 -0.72 0 CA-C-N 115.544 -0.753 . . . . 75.01 111.356 174.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 55' ' ' ALA . . . . . 0.688 ' HB1' ' HB3' ' C' ' 85' ' ' PHE . . . -51.01 -46.49 61.54 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.916 0.865 . . . . 60.54 110.266 178.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 47.2 t -76.71 -58.6 4.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-N 113.453 -1.703 . . . . 72.43 110.605 177.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 57' ' ' LEU . . . . . 0.778 ' HB3' HD13 ' C' ' 22' ' ' ILE . 69.6 mt -82.03 1.95 33.28 Favored 'General case' 0 CA--C 1.563 1.45 0 N-CA-C 114.465 1.283 . . . . 75.02 114.465 -166.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 48.4 t -50.79 -56.45 12.05 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 124.262 1.025 . . . . 75.33 113.393 -173.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -123.79 150.42 62.05 Favored Pre-proline 0 C--O 1.252 1.207 0 CA-C-N 114.359 -1.291 . . . . 72.03 108.387 -171.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 60' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -47.19 -45.7 21.22 Favored 'Trans proline' 0 C--N 1.384 2.41 0 C-N-CA 123.761 2.974 . . . . 73.21 114.389 -169.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -58.15 -53.38 58.87 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.154 0.582 . . . . 62.13 112.365 -174.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -69.96 -37.24 75.76 Favored 'General case' 0 C--O 1.247 0.948 0 CA-C-N 115.602 -0.726 . . . . 75.43 110.821 -176.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 1.1 ppt_? -64.76 -35.85 82.4 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 115.847 -0.615 . . . . 74.14 109.601 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -73.82 -29.71 62.3 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.107 0.963 . . . . 74.15 111.198 177.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 82.6 mt -62.11 -43.68 98.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 109.57 -0.53 . . . . 71.5 109.57 172.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 66' ' ' TYR . . . . . 0.485 ' OH ' ' HA ' ' C' ' 6' ' ' ASP . 22.2 t80 -57.71 -50.82 71.93 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 116.145 -0.479 . . . . 74.31 110.094 173.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -58.45 -40.89 83.86 Favored 'General case' 0 N--CA 1.48 1.074 0 O-C-N 123.813 0.696 . . . . 73.14 112.182 -178.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 40.3 p -69.13 -22.27 63.96 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 119.604 -0.236 . . . . 74.43 110.722 178.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -81.69 142.17 32.94 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 108.678 -0.86 . . . . 75.22 108.678 166.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.72 22.05 62.62 Favored Glycine 0 C--N 1.345 1.071 0 N-CA-C 110.817 -0.913 . . . . 62.51 110.817 -174.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 61.5 m -145.54 -54.72 0.29 Allowed 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 103.045 -2.946 . . . . 72.34 103.045 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 47.3 m -83.41 142.26 31.12 Favored 'General case' 0 C--O 1.26 1.646 0 N-CA-C 105.214 -2.143 . . . . 73.35 105.214 157.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.32 -33.59 28.9 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.72 0.808 . . . . 73.23 111.022 177.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.16 152.89 71.63 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 123.741 0.817 . . . . 53.23 110.521 177.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -58.95 125.77 19.17 Favored 'Trans proline' 0 C--N 1.38 2.211 0 C-N-CA 122.638 2.226 . . . . 75.14 111.162 171.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -58.03 151.02 60.91 Favored 'Trans proline' 0 C--N 1.384 2.429 0 C-N-CA 123.323 2.682 . . . . 71.22 112.215 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -49.28 111.35 0.47 Allowed 'Trans proline' 0 C--N 1.387 2.556 0 C-N-CA 123.492 2.795 . . . . 74.4 113.347 -177.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 78' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.0 133.1 45.37 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.769 2.312 . . . . 74.44 112.493 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -50.16 124.45 12.88 Favored 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 122.399 2.066 . . . . 70.12 110.244 167.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -65.68 37.81 0.13 Allowed 'Trans proline' 0 C--N 1.383 2.385 0 C-N-CA 124.741 3.627 . . . . 74.31 116.746 -172.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -163.24 -10.46 0.03 OUTLIER Glycine 0 CA--C 1.524 0.619 0 C-N-CA 123.51 0.576 . . . . 75.2 112.265 168.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 144.99 168.93 13.11 Favored Glycine 0 C--N 1.35 1.345 0 N-CA-C 114.384 0.513 . . . . 75.13 114.384 173.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -98.5 135.03 40.64 Favored 'General case' 0 C--O 1.219 -0.545 0 N-CA-C 106.744 -1.576 . . . . 73.4 106.744 171.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 84' ' ' ASP . . . . . 0.431 ' HB2' ' NE ' ' C' ' 143' ' ' ARG . 14.2 t70 -72.49 137.18 46.19 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 118.8 0.727 . . . . 75.11 112.333 -178.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 85' ' ' PHE . . . . . 0.688 ' HB3' ' HB1' ' C' ' 55' ' ' ALA . 6.8 p90 -164.49 48.46 0.11 Allowed 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.413 1.485 . . . . 74.41 109.09 170.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 86' ' ' SER . . . . . 0.66 ' HA ' ' HG2' ' C' ' 171' ' ' PRO . 68.2 m -63.38 122.89 17.32 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 115.223 -0.898 . . . . 52.42 112.056 -176.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.01 4.52 88.42 Favored Glycine 0 C--N 1.351 1.385 0 CA-C-N 115.29 -0.868 . . . . 74.34 113.401 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 88' ' ' PHE . . . . . 0.485 ' HB3' ' HZ ' ' C' ' 93' ' ' PHE . 11.7 m-85 -108.17 137.67 45.75 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 117.481 0.641 . . . . 74.44 109.579 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -79.92 78.75 6.52 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.52 0.676 . . . . 72.23 111.376 -173.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 90' ' ' VAL . . . . . . . . . . . . . 3.4 p -49.21 -34.83 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 125.478 1.511 . . . . 54.42 113.952 176.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.21 -19.99 64.8 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 123.152 0.581 . . . . 75.25 110.529 -174.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -110.91 16.05 21.46 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-O 121.01 0.433 . . . . 75.53 111.469 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 93' ' ' PHE . . . . . 0.485 ' HZ ' ' HB3' ' C' ' 88' ' ' PHE . 16.7 m-30 -89.13 166.29 13.94 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 109.797 -0.445 . . . . 72.45 109.797 172.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 80.6 p -65.53 164.62 13.71 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.683 0.793 . . . . 52.11 112.91 -170.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.14 -36.81 78.34 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 114.951 -1.022 . . . . 72.35 110.831 170.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -58.71 -45.67 89.01 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.189 0.996 . . . . 74.24 110.466 177.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 97' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -62.2 -45.63 92.5 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.936 -0.575 . . . . 64.25 109.661 176.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -81.05 -0.3 39.19 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 115.747 -0.66 . . . . 71.33 112.716 -175.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -101.55 -63.85 1.11 Allowed 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.357 0.663 . . . . 74.43 110.786 168.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 51.3 tp -55.1 -45.08 75.43 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.551 0.74 . . . . 73.23 111.265 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -98.5 -6.1 30.95 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.572 -0.74 . . . . 75.04 111.271 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -45.28 -61.42 3.6 Favored Glycine 0 C--N 1.356 1.647 0 N-CA-C 115.793 1.077 . . . . 74.41 115.793 -176.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -55.37 -27.68 59.37 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 123.097 2.531 . . . . 64.35 112.826 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -115.45 28.2 8.0 Favored Glycine 0 C--N 1.359 1.843 0 CA-C-O 118.937 -0.924 . . . . 73.42 112.815 -177.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 105' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' C' ' 169' ' ' ASN . 72.2 mt . . . . . 0 N--CA 1.495 1.776 0 CA-C-N 119.594 1.697 . . . . 75.43 110.528 170.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.878 0 N-CA-C 115.233 0.853 . . . . 54.4 115.233 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.04 -175.38 2.78 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.147 1.379 . . . . 74.32 110.18 -177.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -72.44 131.84 43.11 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 109.281 -0.637 . . . . 75.42 109.281 167.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 119' ' ' LEU . . . . . 0.468 HD13 HG21 ' B' ' 185' ' ' VAL . 36.1 tp -110.73 142.21 42.99 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.246 1.018 . . . . 75.21 108.617 -175.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -117.73 104.45 11.0 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 108.719 -0.845 . . . . 72.31 108.719 -169.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 121' ' ' ALA . . . . . 0.435 ' HB1' HD21 ' C' ' 176' ' ' LEU . . . -113.41 116.2 29.26 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.077 -0.712 . . . . 75.44 109.077 176.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 122' ' ' GLU . . . . . 0.503 ' HA ' ' O ' ' C' ' 177' ' ' VAL . 44.5 mt-10 -89.03 110.95 21.58 Favored 'General case' 0 C--N 1.347 0.462 0 N-CA-C 108.26 -1.015 . . . . 74.12 108.26 172.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 123' ' ' LEU . . . . . 0.513 ' H ' HD23 ' C' ' 123' ' ' LEU . 1.1 pt? -106.31 113.71 63.03 Favored Pre-proline 0 C--O 1.248 0.976 0 O-C-N 123.781 0.676 . . . . 73.3 109.39 -177.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -58.33 114.45 1.98 Allowed 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 122.205 1.937 . . . . 72.51 110.2 162.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 125' ' ' LEU . . . . . 0.532 ' O ' ' HA ' ' C' ' 180' ' ' LEU . 53.7 tp -142.94 154.94 44.57 Favored 'General case' 0 C--O 1.219 -0.547 0 N-CA-C 106.967 -1.494 . . . . 75.32 106.967 -171.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 126' ' ' THR . . . . . 0.438 ' HB ' HD12 ' C' ' 181' ' ' LEU . 11.1 t -119.3 171.62 8.18 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 119.735 1.152 . . . . 61.53 110.795 177.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 127' ' ' LEU . . . . . 0.441 HD22 HD12 ' C' ' 180' ' ' LEU . 10.0 mt -62.86 -47.48 83.19 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 113.724 -1.58 . . . . 62.25 110.72 -171.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -58.32 -44.58 88.69 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 114.219 -1.355 . . . . 75.24 109.896 -177.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -75.25 -24.37 57.64 Favored 'General case' 0 C--O 1.216 -0.703 0 CA-C-N 114.975 -1.011 . . . . 75.51 111.445 178.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -71.76 -31.58 66.79 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 109.611 -0.514 . . . . 73.14 109.611 175.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 131' ' ' PHE . . . . . 0.536 ' HB2' HD11 ' C' ' 215' ' ' LEU . 75.5 t80 -70.35 -41.88 72.59 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.207 1.003 . . . . 75.55 109.855 172.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 132' ' ' HIS . . . . . . . . . . . . . 24.9 m170 -76.62 -8.23 56.83 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 115.19 -0.914 . . . . 70.15 110.99 176.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -54.02 134.1 44.52 Favored Glycine 0 C--N 1.356 1.661 0 O-C-N 123.973 0.796 . . . . 65.31 113.233 176.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . 173.17 -128.37 1.51 Allowed Glycine 0 C--O 1.24 0.526 0 N-CA-C 108.969 -1.652 . . . . 73.12 108.969 -177.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -72.0 95.54 1.61 Allowed 'General case' 0 C--N 1.35 0.587 0 N-CA-C 108.357 -0.979 . . . . 73.03 108.357 175.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 136' ' ' ARG . . . . . . . . . . . . . 19.5 mmt180 -126.1 162.48 25.24 Favored 'General case' 0 C--O 1.243 0.724 0 C-N-CA 123.522 0.729 . . . . 72.12 109.837 -178.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 137' ' ' VAL . . . . . . . . . . . . . 8.6 p -78.85 123.81 36.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 CA-C-N 115.374 -0.83 . . . . 73.11 110.119 177.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 138' ' ' VAL . . . . . 0.435 ' HB ' ' HG ' ' B' ' 181' ' ' LEU . 8.8 p -115.87 131.28 68.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 108.247 -1.02 . . . . 72.14 108.247 169.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 139' ' ' GLU . . . . . 0.605 ' HB3' HG23 ' B' ' 182' ' ' VAL . 9.9 tp10 -124.32 83.31 2.13 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 107.075 -1.454 . . . . 74.31 107.075 174.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 140' ' ' VAL . . . . . . . . . . . . . 54.6 t -140.9 148.67 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 107.214 -1.402 . . . . 73.25 107.214 178.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 68.67 23.39 7.13 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 124.14 0.976 . . . . 65.0 111.524 -177.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 67.14 40.62 92.74 Favored Glycine 0 C--N 1.347 1.167 0 O-C-N 123.931 0.769 . . . . 52.4 112.94 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 143' ' ' ARG . . . . . 0.605 ' NH2' ' HA ' ' C' ' 164' ' ' MET . 25.3 ttp-105 -153.07 124.18 7.49 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-O 120.82 0.343 . . . . 75.05 110.883 179.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 62.9 ttt-85 -88.34 124.0 33.48 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.239 -0.891 . . . . 71.51 109.269 167.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 145' ' ' VAL . . . . . . . . . . . . . 8.0 p -151.52 142.38 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.083 0.553 . . . . 75.03 109.587 173.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 52.9 p -84.33 105.36 15.1 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 109.196 -0.668 . . . . 73.22 109.196 174.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 14.5 p -123.2 146.73 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 N-CA-C 109.663 -0.495 . . . . 72.53 109.663 -178.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -91.16 114.93 27.59 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 122.933 0.493 . . . . 74.22 110.465 174.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 149' ' ' ILE . . . . . . . . . . . . . 31.5 pt -93.24 153.63 41.57 Favored Pre-proline 0 CA--C 1.55 0.953 0 N-CA-C 107.955 -1.128 . . . . 74.42 107.955 164.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -47.52 122.02 6.25 Favored 'Trans proline' 0 C--N 1.384 2.404 0 C-N-CA 123.029 2.486 . . . . 61.44 112.018 177.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -61.25 109.35 0.71 Allowed 'Trans proline' 0 C--N 1.385 2.498 0 C-N-CA 123.043 2.495 . . . . 73.2 111.536 -178.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 152' ' ' GLY . . . . . . . . . . . . . . . 110.58 109.78 3.19 Favored Glycine 0 C--N 1.338 0.673 0 CA-C-N 115.456 -0.793 . . . . 63.11 111.973 -170.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 153' ' ' VAL . . . . . 0.493 ' HB ' HG21 ' C' ' 178' ' ' VAL . 2.1 m -105.27 168.75 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 123.063 0.545 . . . . 74.01 109.647 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 154' ' ' ARG . . . . . 0.423 ' O ' HG22 ' C' ' 178' ' ' VAL . 18.2 mtp180 -115.78 116.26 27.73 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 122.905 0.482 . . . . 75.32 111.258 -174.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 155' ' ' GLU . . . . . 0.518 ' HG2' ' HE ' ' C' ' 187' ' ' ARG . 2.9 tp10 -22.7 115.95 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 126.733 2.013 . . . . 74.51 114.234 168.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 57.76 10.29 6.23 Favored Glycine 0 C--N 1.351 1.406 0 O-C-N 123.827 0.704 . . . . 75.21 114.752 171.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 157' ' ' SER . . . . . 0.402 ' HB2' ' HB2' ' C' ' 154' ' ' ARG . 49.5 m -106.74 167.28 9.98 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 121.572 0.701 . . . . 75.43 110.466 -173.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 18.4 t -103.31 104.75 17.13 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 CA-C-N 114.774 -1.103 . . . . 72.31 110.439 -169.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 159' ' ' ILE . . . . . 0.436 HD13 ' HB ' ' C' ' 153' ' ' VAL . 19.1 mt -72.23 145.87 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 109.287 -0.634 . . . . 72.31 109.287 167.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -109.82 108.4 18.71 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 109.148 -0.686 . . . . 75.13 109.148 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 161' ' ' VAL . . . . . 0.511 HG22 HD12 ' C' ' 176' ' ' LEU . 49.4 t -125.87 95.23 40.27 Favored Pre-proline 0 N--CA 1.485 1.283 0 C-N-CA 123.734 0.814 . . . . 75.24 110.967 -171.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -64.53 146.57 89.48 Favored 'Trans proline' 0 C--N 1.363 1.327 0 C-N-CA 121.805 1.67 . . . . 75.23 109.736 165.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 129.78 -16.87 5.54 Favored Glycine 0 N--CA 1.475 1.296 0 C-N-CA 121.715 -0.279 . . . . 53.54 113.569 -176.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 164' ' ' MET . . . . . 0.605 ' HA ' ' NH2' ' C' ' 143' ' ' ARG . 2.9 mpp? -121.58 -79.5 0.61 Allowed 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 109.434 -0.58 . . . . 73.35 109.434 170.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 165' ' ' GLY . . . . . 0.425 ' HA2' ' O ' ' C' ' 173' ' ' ASP . . . 68.9 174.18 9.37 Favored Glycine 0 C--N 1.349 1.28 0 N-CA-C 114.436 0.535 . . . . 73.32 114.436 -178.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . -71.11 165.14 53.43 Favored Glycine 0 C--N 1.343 0.934 0 N-CA-C 111.988 -0.445 . . . . 75.44 111.988 172.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 167' ' ' GLN . . . . . 0.407 ' HA ' HE21 ' C' ' 167' ' ' GLN . 0.0 OUTLIER -67.27 144.28 56.01 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 109.828 -0.434 . . . . 74.2 109.828 -179.655 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . 144.68 130.85 2.33 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-O 119.084 -0.842 . . . . 13.44 111.37 -174.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 169' ' ' ASN . . . . . 0.557 ' HB3' ' HD3' ' C' ' 170' ' ' PRO . 8.5 t30 -49.88 -49.82 71.74 Favored Pre-proline 0 CA--C 1.557 1.224 0 C-N-CA 124.468 1.107 . . . . 62.44 112.46 -172.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 170' ' ' PRO . . . . . 0.557 ' HD3' ' HB3' ' C' ' 169' ' ' ASN . 1.5 Cg_endo -86.87 104.71 0.64 Allowed 'Trans proline' 0 C--N 1.383 2.345 0 CA-C-N 121.522 1.579 . . . . 73.55 110.061 162.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 171' ' ' PRO . . . . . 0.66 ' HG2' ' HA ' ' C' ' 86' ' ' SER . 72.4 Cg_endo -72.83 173.09 14.05 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.906 2.404 . . . . 74.02 112.648 -175.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -117.21 -94.76 1.79 Allowed Glycine 0 C--N 1.346 1.09 0 CA-C-N 115.772 -0.649 . . . . 74.42 112.895 -177.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 173' ' ' ASP . . . . . 0.425 ' O ' ' HA2' ' C' ' 165' ' ' GLY . 6.8 t70 -166.26 151.32 8.21 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.906 0.882 . . . . 74.51 109.626 -164.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 174' ' ' LEU . . . . . 0.407 HD21 HD23 ' C' ' 176' ' ' LEU . 30.1 tp -117.84 105.15 11.64 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.554 0.741 . . . . 75.22 109.207 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 77.2 mt -74.81 96.18 3.04 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-N 114.523 -1.217 . . . . 72.15 109.744 172.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 176' ' ' LEU . . . . . 0.511 HD12 HG22 ' C' ' 161' ' ' VAL . 41.7 mt -85.77 96.87 9.88 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-N 115.313 -0.858 . . . . 74.33 109.945 178.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 177' ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' C' ' 122' ' ' GLU . 22.0 t -84.57 101.24 8.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 107.906 -1.146 . . . . 75.23 107.906 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 178' ' ' VAL . . . . . 0.493 HG21 ' HB ' ' C' ' 153' ' ' VAL . 0.8 OUTLIER -84.74 102.66 11.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.059 -0.973 . . . . 74.01 110.632 -171.995 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 179' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -87.95 104.08 16.28 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.291 -1.374 . . . . 74.42 107.291 175.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 180' ' ' LEU . . . . . 0.532 ' HA ' ' O ' ' C' ' 125' ' ' LEU . 96.5 mt -68.83 138.29 54.63 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 109.99 -0.374 . . . . 73.43 109.99 177.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 181' ' ' LEU . . . . . 0.438 HD12 ' HB ' ' C' ' 126' ' ' THR . 51.8 mt -56.87 167.6 1.02 Allowed Pre-proline 0 N--CA 1.493 1.679 0 C-N-CA 125.539 1.536 . . . . 74.24 112.045 -173.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -54.62 68.38 0.03 OUTLIER 'Trans proline' 0 C--N 1.388 2.654 0 C-N-CA 123.842 3.028 . . . . 73.32 112.58 164.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 183' ' ' HIS . . . . . 0.519 ' N ' ' HD3' ' C' ' 184' ' ' PRO . 84.3 t60 177.39 48.16 0.03 OUTLIER Pre-proline 0 CA--C 1.567 1.615 0 C-N-CA 128.466 2.707 . . . . 72.0 106.444 -169.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 184' ' ' PRO . . . . . 0.519 ' HD3' ' N ' ' C' ' 183' ' ' HIS . 4.3 Cg_endo -87.95 65.66 3.57 Favored 'Trans proline' 0 C--N 1.398 3.141 0 C-N-CA 123.318 2.679 . . . . 74.25 110.236 -175.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 185' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 11.1 t -94.63 -24.77 4.79 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.076 0 CA-C-N 115.0 -1.0 . . . . 72.23 109.938 -170.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 186' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -124.58 105.51 9.42 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.398 0.618 . . . . 61.44 110.759 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 187' ' ' ARG . . . . . 0.518 ' HE ' ' HG2' ' C' ' 155' ' ' GLU . 35.4 ttm105 -108.3 104.41 13.79 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.708 1.203 . . . . 75.14 108.9 -174.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 188' ' ' LEU . . . . . . . . . . . . . 58.7 tp -77.91 134.89 37.82 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.202 0.815 . . . . 74.14 113.202 -167.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -132.55 119.07 20.03 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 126.008 1.723 . . . . 73.21 107.277 164.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 64.44 -99.21 0.32 Allowed Glycine 0 C--N 1.343 0.954 0 CA-C-N 116.07 -0.514 . . . . 74.2 112.614 -175.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 191' ' ' GLN . . . . . 0.424 ' NE2' ' HA3' ' C' ' 242' ' ' GLY . 50.4 mt-30 -127.3 -12.94 5.63 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.106 0.962 . . . . 75.25 109.336 173.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -86.74 148.49 25.4 Favored 'General case' 0 C--N 1.362 1.111 0 C-N-CA 123.509 0.724 . . . . 65.13 109.516 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 193' ' ' LEU . . . . . 0.448 HD21 ' CD2' ' C' ' 240' ' ' PHE . 90.1 mt -103.48 161.84 13.53 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.325 0.65 . . . . 65.15 110.681 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 194' ' ' TYR . . . . . 0.403 ' HB3' ' HB3' ' C' ' 187' ' ' ARG . 10.5 t80 -125.29 106.73 10.07 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.707 -1.22 . . . . 75.43 107.707 170.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 195' ' ' ALA . . . . . 0.448 ' HB1' HD11 ' C' ' 249' ' ' LEU . . . -105.76 -176.81 3.18 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.211 1.004 . . . . 65.11 110.268 177.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 87.0 m -139.07 120.95 15.48 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 114.953 -1.021 . . . . 53.42 108.836 166.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 197' ' ' LEU . . . . . 0.408 HD12 HD21 ' C' ' 251' ' ' LEU . 27.3 tp -90.69 115.48 27.82 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.886 0.874 . . . . 73.5 110.628 -175.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -78.15 104.06 8.49 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.826 0.85 . . . . 64.33 109.76 -178.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 199' ' ' VAL . . . . . 0.443 HG21 HG22 ' C' ' 210' ' ' VAL . 39.4 t -120.35 115.64 32.63 Favored Pre-proline 0 N--CA 1.482 1.145 0 C-N-CA 124.388 1.075 . . . . 73.12 109.481 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 200' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -69.28 149.75 70.33 Favored 'Trans proline' 0 C--N 1.367 1.529 0 C-N-CA 121.71 1.606 . . . . 73.11 111.988 175.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 201' ' ' ALA . . . . . 0.404 ' HB1' ' HH2' ' C' ' 269' ' ' TRP . . . -54.73 -47.6 97.68 Favored Pre-proline 0 CA--C 1.562 1.42 0 N-CA-C 114.263 1.209 . . . . 74.35 114.263 -170.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 202' ' ' PRO . . . . . 0.424 ' O ' HG13 ' C' ' 206' ' ' VAL . 78.2 Cg_exo -53.3 -45.74 38.85 Favored 'Trans proline' 0 C--N 1.388 2.646 0 C-N-CA 121.763 1.642 . . . . 63.15 112.728 175.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 203' ' ' ILE . . . . . . . . . . . . . 38.7 mt -67.88 -33.86 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 124.048 0.939 . . . . 74.02 111.167 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 204' ' ' ALA . . . . . 0.424 ' HA ' HG13 ' C' ' 223' ' ' VAL . . . -68.73 -34.07 74.98 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.485 0.714 . . . . 75.02 111.654 178.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 205' ' ' VAL . . . . . 0.542 HG12 ' HG3' ' C' ' 226' ' ' ARG . 95.1 t -85.26 -40.42 14.82 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 N-CA-C 112.775 0.658 . . . . 74.52 112.775 -175.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 206' ' ' VAL . . . . . 0.424 HG13 ' O ' ' C' ' 202' ' ' PRO . 6.4 p -81.36 -39.35 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-N 118.959 0.799 . . . . 74.12 110.472 176.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 97.27 92.49 1.89 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.387 -0.685 . . . . 63.21 111.387 -166.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -113.98 -141.36 7.76 Favored Glycine 0 C--N 1.338 0.694 0 N-CA-C 111.734 -0.546 . . . . 51.32 111.734 176.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 209' ' ' LYS . . . . . 0.587 ' HG2' ' HA ' ' C' ' 222' ' ' ALA . 8.7 mtmp? -140.21 141.28 35.94 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.126 0.571 . . . . 72.44 110.557 171.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 210' ' ' VAL . . . . . 0.443 HG22 HG21 ' C' ' 199' ' ' VAL . 15.1 m -133.59 135.34 55.84 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 C-N-CA 124.912 1.285 . . . . 71.52 107.597 169.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 211' ' ' ARG . . . . . 0.51 ' HA ' ' HA ' ' C' ' 220' ' ' GLU . 0.5 OUTLIER -89.43 122.11 32.32 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 122.279 0.232 . . . . 75.53 110.761 -174.371 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 212' ' ' ALA . . . . . 0.416 ' HB1' HG13 ' C' ' 219' ' ' VAL . . . -81.16 116.35 21.02 Favored 'General case' 0 C--O 1.248 1.023 0 N-CA-C 107.678 -1.23 . . . . 74.43 107.678 173.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 213' ' ' MET . . . . . . . . . . . . . 4.8 tmm? -70.36 117.25 11.67 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 108.002 -1.11 . . . . 63.12 108.002 174.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 214' ' ' THR . . . . . 0.528 HG22 ' HD2' ' C' ' 238' ' ' LYS . 1.0 OUTLIER -115.57 168.12 10.3 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 122.043 0.925 . . . . 72.34 112.406 -176.954 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 215' ' ' LEU . . . . . 0.536 HD11 ' HB2' ' C' ' 131' ' ' PHE . 81.4 mt -65.98 -37.17 85.29 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 114.438 -1.256 . . . . 75.24 113.003 -169.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 216' ' ' GLU . . . . . 0.448 ' HG2' ' NH1' ' C' ' 246' ' ' ARG . 0.0 OUTLIER -105.23 9.84 33.89 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 114.492 -1.231 . . . . 71.0 110.951 -174.936 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 148.41 -144.81 12.74 Favored Glycine 0 C--N 1.353 1.484 0 CA-C-O 119.925 -0.375 . . . . 74.41 112.4 178.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -105.6 165.14 0.15 Allowed 'Trans proline' 0 CA--C 1.548 1.221 0 C-N-CA 123.61 2.873 . . . . 64.03 113.716 168.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 219' ' ' VAL . . . . . 0.473 ' HB ' ' HE3' ' C' ' 238' ' ' LYS . 4.5 p -145.7 116.54 1.83 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 107.154 -1.424 . . . . 52.53 107.154 163.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 220' ' ' GLU . . . . . 0.51 ' HA ' ' HA ' ' C' ' 211' ' ' ARG . 28.2 tt0 -82.78 110.74 18.07 Favored 'General case' 0 C--O 1.247 0.971 0 N-CA-C 108.893 -0.78 . . . . 72.32 108.893 -179.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 221' ' ' VAL . . . . . . . . . . . . . 62.1 t -88.38 126.12 41.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 CA-C-N 115.16 -0.927 . . . . 74.03 109.515 -176.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 222' ' ' ALA . . . . . 0.587 ' HA ' ' HG2' ' C' ' 209' ' ' LYS . . . -87.24 143.72 27.15 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.666 -0.697 . . . . 73.3 110.378 176.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 223' ' ' VAL . . . . . 0.424 HG13 ' HA ' ' C' ' 204' ' ' ALA . 56.0 t -112.22 139.41 22.46 Favored Pre-proline 0 CA--C 1.558 1.254 0 C-N-CA 125.155 1.382 . . . . 73.11 108.537 -174.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 224' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -87.76 168.34 6.98 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 123.213 2.609 . . . . 73.11 112.627 175.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -65.77 119.4 6.42 Favored 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 122.197 1.931 . . . . 74.4 112.358 174.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 226' ' ' ARG . . . . . 0.542 ' HG3' HG12 ' C' ' 205' ' ' VAL . 0.0 OUTLIER 66.48 89.81 0.1 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.211 1.804 . . . . 71.5 111.679 179.763 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 227' ' ' THR . . . . . . . . . . . . . 40.6 m -112.95 124.91 53.7 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 113.56 -1.654 . . . . 73.3 110.612 -174.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 228' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -90.52 152.02 21.1 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.946 0.898 . . . . 74.32 111.63 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 229' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' C' ' 253' ' ' VAL . . . -76.16 135.59 39.77 Favored 'General case' 0 C--O 1.243 0.745 0 CA-C-N 115.31 -0.859 . . . . 65.31 109.673 175.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 98.06 -2.38 59.75 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 115.774 -0.648 . . . . 62.04 113.339 -169.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 231' ' ' ARG . . . . . . . . . . . . . 68.8 mtt180 -66.35 172.06 4.31 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 117.75 0.775 . . . . 75.03 110.736 167.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 232' ' ' LYS . . . . . 0.556 ' HA ' ' O ' ' C' ' 251' ' ' LEU . 37.7 ttmt -154.32 143.89 21.53 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.243 0.831 . . . . 74.05 113.243 -173.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 233' ' ' LEU . . . . . 0.556 ' O ' ' HA ' ' C' ' 250' ' ' TYR . 3.4 mp -123.88 144.23 49.88 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 115.03 -0.987 . . . . 74.22 109.936 170.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -101.66 115.85 31.45 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 108.366 -0.976 . . . . 72.34 108.366 162.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 33.7 mt -98.2 119.37 36.74 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 107.913 -1.143 . . . . 74.34 107.913 176.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -67.93 128.78 37.76 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.739 0.815 . . . . 73.41 112.087 -172.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 78.8 3.69 87.63 Favored Glycine 0 C--N 1.352 1.448 0 CA-C-N 115.731 -0.668 . . . . 71.42 113.342 176.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 238' ' ' LYS . . . . . 0.528 ' HD2' HG22 ' C' ' 214' ' ' THR . 67.0 mmtt -96.17 8.34 44.07 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.161 0.584 . . . . 75.11 111.518 -177.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -87.42 -170.09 46.17 Favored Glycine 0 C--N 1.352 1.464 0 O-C-N 123.373 0.421 . . . . 75.2 112.802 174.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 240' ' ' PHE . . . . . 0.448 ' CD2' HD21 ' C' ' 193' ' ' LEU . 2.0 m-85 -81.47 150.47 67.09 Favored Pre-proline 0 N--CA 1.48 1.073 0 N-CA-C 110.001 -0.37 . . . . 75.14 110.001 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 241' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -62.08 139.79 80.54 Favored 'Trans proline' 0 C--N 1.385 2.494 0 C-N-CA 123.26 2.64 . . . . 71.53 113.92 -174.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 242' ' ' GLY . . . . . 0.424 ' HA3' ' NE2' ' C' ' 191' ' ' GLN . . . -132.07 177.28 18.81 Favored Glycine 0 CA--C 1.522 0.485 0 CA-C-N 114.852 -1.067 . . . . 70.14 111.501 177.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.97 -11.25 27.21 Favored 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 122.792 2.328 . . . . 71.42 112.716 -175.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -110.34 -4.83 15.43 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.655 0.782 . . . . 71.42 111.858 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 147.65 -104.86 0.3 Allowed Glycine 0 C--N 1.35 1.342 0 N-CA-C 111.814 -0.514 . . . . 63.24 111.814 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 246' ' ' ARG . . . . . 0.448 ' NH1' ' HG2' ' C' ' 216' ' ' GLU . 85.0 mtm180 -146.05 167.71 22.71 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 124.78 1.232 . . . . 71.32 109.248 176.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -87.67 -156.8 30.64 Favored Glycine 0 C--N 1.346 1.136 0 N-CA-C 112.21 -0.356 . . . . 63.23 112.21 172.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -115.51 170.01 8.74 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.177 0.591 . . . . 73.54 109.585 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 249' ' ' LEU . . . . . 0.448 HD11 ' HB1' ' C' ' 195' ' ' ALA . 28.4 tp -116.02 115.06 25.46 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.406 0.682 . . . . 74.23 110.857 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 250' ' ' TYR . . . . . 0.556 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 2.1 m-30 -100.83 98.15 8.69 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.231 0.612 . . . . 71.43 109.696 -178.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 251' ' ' LEU . . . . . 0.556 ' O ' ' HA ' ' C' ' 232' ' ' LYS . 1.8 mp -94.53 126.29 39.73 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 119.448 -0.31 . . . . 72.0 110.222 -177.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -80.29 113.16 18.26 Favored 'General case' 0 C--O 1.217 -0.619 0 O-C-N 124.887 1.367 . . . . 75.41 108.579 170.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 253' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' C' ' 229' ' ' ALA . 40.5 t -72.36 133.12 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 123.15 0.58 . . . . 73.5 110.335 -174.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 254' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -122.84 114.82 21.01 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.545 1.138 . . . . 75.13 108.918 -165.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 255' ' ' ILE . . . . . 0.402 HG12 ' HB2' ' C' ' 229' ' ' ALA . 20.8 mm -88.61 115.67 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 109.19 -0.67 . . . . 75.24 109.19 -179.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 256' ' ' THR . . . . . . . . . . . . . 1.4 t -124.09 151.43 43.88 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.973 0.909 . . . . 70.25 111.394 -174.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 2.4 pp -121.55 120.49 28.78 Favored Pre-proline 0 N--CA 1.482 1.173 0 N-CA-C 107.55 -1.278 . . . . 75.21 107.55 170.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 258' ' ' PRO . . . . . 0.485 ' HG3' ' HE2' ' A' ' 276' ' ' TYR . 26.6 Cg_endo -78.98 11.68 2.5 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 C-N-CA 122.845 2.364 . . . . 74.41 113.946 -161.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 69.21 -62.24 0.41 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.592 1.557 . . . . 72.3 111.025 -173.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.51 130.43 31.75 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.24 1.016 . . . . 73.41 111.098 176.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 261' ' ' LEU . . . . . . . . . . . . . 88.0 mt -156.68 143.78 18.8 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.188 1.395 . . . . 74.53 107.702 177.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 71.8 p -83.41 152.01 63.41 Favored Pre-proline 0 CA--C 1.549 0.936 0 CA-C-O 118.105 -0.95 . . . . 61.23 108.457 172.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_exo -45.6 -33.36 9.66 Favored 'Trans proline' 0 C--N 1.384 2.432 0 C-N-CA 123.486 2.79 . . . . 74.2 114.647 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -63.07 -62.01 2.0 Allowed 'General case' 0 C--O 1.251 1.148 0 C-N-CA 124.258 1.023 . . . . 71.04 110.695 175.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -50.55 -52.0 42.83 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 115.196 -0.911 . . . . 71.03 109.798 178.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 266' ' ' GLU . . . . . 0.462 ' O ' ' HG2' ' C' ' 270' ' ' LYS . 30.6 tt0 -57.75 -38.44 75.37 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.103 1.361 . . . . 73.1 111.249 -178.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -59.65 -42.92 93.89 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.386 0.674 . . . . 71.12 110.958 177.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 268' ' ' LEU . . . . . . . . . . . . . 8.2 mp -65.02 -39.13 92.95 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 115.744 -0.662 . . . . 70.11 110.791 175.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 269' ' ' TRP . . . . . 0.404 ' HH2' ' HB1' ' C' ' 201' ' ' ALA . 98.1 m95 -64.19 -29.81 70.9 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 122.582 0.353 . . . . 63.11 111.822 174.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 270' ' ' LYS . . . . . 0.462 ' HG2' ' O ' ' C' ' 266' ' ' GLU . 33.9 mmtp -68.91 -44.12 73.82 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 122.967 0.507 . . . . 75.43 109.927 176.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 11.0 mmmm -57.27 -45.98 83.52 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 123.92 0.762 . . . . 75.33 111.077 176.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 85.0 mt -62.52 -42.7 99.69 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 114.791 -1.095 . . . . 74.33 110.577 176.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -62.44 -39.16 92.44 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.491 0.716 . . . . 43.22 110.998 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -62.5 -47.82 82.28 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.542 0.737 . . . . 63.21 110.038 176.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -58.91 -30.85 68.13 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 115.319 -0.855 . . . . 70.04 111.368 176.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 276' ' ' TYR . . . . . 0.453 ' HD1' HH11 ' C' ' 279' ' ' ARG . 9.2 m-85 -80.55 -33.32 36.32 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.517 0.727 . . . . 75.52 112.662 178.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -73.36 -23.45 60.21 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 118.392 0.542 . . . . 65.52 109.822 177.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -66.79 -11.97 57.13 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 123.754 0.821 . . . . 72.22 112.289 171.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 279' ' ' ARG . . . . . 0.453 HH11 ' HD1' ' C' ' 276' ' ' TYR . 50.8 mtp180 -79.56 -12.8 59.84 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 122.845 0.458 . . . . 75.11 111.055 174.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.904 -0.57 . . . . 75.14 109.971 178.107 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 88.0 tttt . . . . . 0 N--CA 1.477 0.891 0 N-CA-C 113.76 1.022 . . . . 64.14 113.76 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.413 ' HG2' ' HB3' ' A' ' 96' ' ' PHE . 14.5 mmmm -79.7 94.58 5.75 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 107.544 -1.28 . . . . 74.32 107.544 168.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.427 ' O ' HG13 ' A' ' 10' ' ' ILE . 11.8 t70 -70.55 92.71 0.86 Allowed 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.154 -1.054 . . . . 62.43 108.154 177.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -58.84 -35.35 72.77 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.765 0.826 . . . . 73.34 112.89 -167.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -63.78 -45.22 90.73 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 116.501 -0.318 . . . . 73.33 110.515 176.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.34 -39.42 90.52 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 123.597 0.561 . . . . 70.01 110.964 178.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 6' ' ' ASP . 37.7 mt -65.46 -37.06 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 123.01 0.524 . . . . 74.23 110.55 179.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.488 ' HB2' HG21 ' A' ' 13' ' ' VAL . 81.5 mt -73.25 -16.17 61.4 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.114 0.566 . . . . 73.11 111.737 174.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.71 18.0 79.36 Favored Glycine 0 C--N 1.351 1.365 0 O-C-N 123.412 0.445 . . . . 73.42 112.782 -176.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.488 HG21 ' HB2' ' A' ' 11' ' ' LEU . 27.5 m -107.58 158.18 33.95 Favored Pre-proline 0 N--CA 1.479 0.991 0 C-N-CA 124.399 1.08 . . . . 72.52 109.57 179.001 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -64.09 158.15 49.54 Favored 'Trans proline' 0 C--N 1.378 2.117 0 C-N-CA 122.23 1.954 . . . . 50.12 111.998 178.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -72.61 11.78 0.58 Allowed 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 113.418 0.896 . . . . 75.43 113.418 -176.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -135.75 23.34 3.36 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.768 1.227 . . . . 71.2 108.017 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.55 134.22 49.7 Favored 'General case' 0 C--N 1.348 0.518 0 CA-C-N 115.233 -0.894 . . . . 74.14 110.03 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.6 p -68.84 155.93 39.32 Favored 'General case' 0 C--O 1.241 0.646 0 O-C-N 124.053 0.846 . . . . 75.03 109.362 173.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.432 ' HA ' ' HB ' ' A' ' 22' ' ' ILE . 52.1 tt0 -62.68 -19.34 63.77 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 123.026 0.53 . . . . 71.11 110.769 177.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -62.14 -53.55 53.7 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 125.019 1.328 . . . . 72.43 109.773 171.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -64.65 -32.97 74.88 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.846 0.858 . . . . 71.14 111.58 177.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.432 ' HB ' ' HA ' ' A' ' 19' ' ' GLN . 78.6 mt -69.68 -33.03 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.555 1.142 . . . . 73.31 110.846 177.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -72.99 -35.43 66.85 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.494 0.718 . . . . 75.22 110.263 175.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 52.8 mtp180 -66.55 -40.78 89.21 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.383 0.673 . . . . 73.12 110.649 173.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.81 -36.33 82.12 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.508 0.723 . . . . 72.43 110.47 178.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -59.98 -63.18 1.39 Allowed 'General case' 0 C--O 1.21 -0.985 0 CA-C-N 114.847 -1.07 . . . . 73.1 109.918 173.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -52.03 -48.37 64.56 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.066 0.547 . . . . 74.22 111.404 -177.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 50.5 ttt180 -56.38 -68.05 0.25 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.083 0.553 . . . . 75.52 111.784 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.417 ' HB3' HD13 ' A' ' 50' ' ' ILE . 93.8 mt -78.73 -43.38 25.89 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-N 115.74 -0.664 . . . . 75.12 111.753 -168.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.73 -25.35 63.8 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 118.015 -0.993 . . . . 71.54 112.814 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.582 ' HA ' ' HB2' ' A' ' 34' ' ' HIS . 81.7 mtp180 -85.02 -31.57 23.39 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 120.3 1.409 . . . . 72.33 110.969 171.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 48.0 tp60 -66.84 -32.57 73.93 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.607 0.363 . . . . 73.31 111.282 174.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -111.24 16.53 20.92 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.553 0.741 . . . . 72.41 110.493 -178.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.582 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 2.7 t-80 -67.86 116.65 40.49 Favored Pre-proline 0 C--N 1.354 0.781 0 CA-C-O 118.181 -0.914 . . . . 73.54 109.743 -175.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_exo -47.57 -31.94 14.94 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 123.317 2.678 . . . . 75.51 113.534 -178.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.408 ' HB3' ' HD1' ' A' ' 34' ' ' HIS . 18.7 t70 -59.91 -53.05 62.41 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.885 0.874 . . . . 73.23 111.493 176.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.6 t -90.44 -56.87 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 122.969 0.508 . . . . 73.25 109.737 -173.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -97.7 84.81 3.44 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 121.808 0.813 . . . . 64.12 108.816 -178.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -79.54 69.23 5.78 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 114.45 -1.25 . . . . 73.11 109.475 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.9 m -134.53 107.68 10.99 Favored Pre-proline 0 N--CA 1.473 0.703 0 CA-C-O 118.386 -0.816 . . . . 71.24 109.475 -177.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.441 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 24.5 Cg_exo -36.81 -56.11 0.78 Allowed 'Trans proline' 0 C--N 1.388 2.62 0 C-N-CA 124.713 3.609 . . . . 73.53 114.597 -177.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.475 ' HG2' ' HE3' ' A' ' 46' ' ' LYS . 28.3 tt0 -54.39 -43.48 71.47 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.088 0.955 . . . . 64.43 111.348 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.99 -31.48 69.19 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.023 -0.99 . . . . 73.42 110.375 -178.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.456 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 51.5 mt-10 -78.9 -23.13 44.98 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.224 0.61 . . . . 63.35 109.674 -178.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 41' ' ' PRO . 23.6 mm-40 -71.5 -47.9 52.43 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.366 0.666 . . . . 62.44 109.527 172.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.475 ' HE3' ' HG2' ' A' ' 42' ' ' GLU . 97.0 mttt -60.32 -37.02 79.3 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 115.0 -1.0 . . . . 74.03 110.251 175.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -57.72 -53.88 53.21 Favored 'General case' 0 C--O 1.215 -0.713 0 C-N-CA 124.115 0.966 . . . . 73.32 109.307 173.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 44' ' ' GLU . 91.2 mttt -52.41 -45.86 66.09 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.468 0.707 . . . . 75.14 111.582 -179.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -62.47 -51.76 66.17 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 123.575 0.547 . . . . 71.44 111.885 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.417 HD13 ' HB3' ' A' ' 29' ' ' LEU . 86.5 mt -64.13 -31.4 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 124.216 1.006 . . . . 74.43 110.712 -178.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -95.67 -7.78 36.54 Favored 'General case' 0 C--O 1.215 -0.735 0 C-N-CA 123.679 0.792 . . . . 73.43 111.731 -176.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -72.35 -50.25 28.12 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 106.616 -1.624 . . . . 75.34 106.616 163.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.13 -49.8 68.38 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 112.756 -2.02 . . . . 65.45 111.477 175.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -67.31 -43.93 80.44 Favored 'General case' 0 C--O 1.212 -0.883 0 CA-C-N 115.357 -0.838 . . . . 73.53 110.795 177.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.408 ' HB3' ' CD2' ' A' ' 88' ' ' PHE . . . -56.54 -33.1 65.78 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 112.446 0.536 . . . . 72.52 112.446 -176.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 95.4 t -74.06 -53.92 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 CA-C-N 115.809 -0.632 . . . . 74.52 109.894 171.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.414 ' HB3' HD12 ' A' ' 22' ' ' ILE . 82.4 mt -83.99 7.12 19.46 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 113.912 1.079 . . . . 74.35 113.912 -169.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.0 t -87.83 -41.25 13.38 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.104 0.961 . . . . 74.34 110.517 178.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -104.27 107.57 57.83 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 108.593 -0.892 . . . . 74.34 108.593 -174.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -33.75 -32.86 0.06 OUTLIER 'Trans proline' 0 C--N 1.388 2.655 1 C-N-CA 125.613 4.208 . . . . 72.41 116.953 -179.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.439 ' HB2' ' HB2' ' A' ' 144' ' ' ARG . 16.3 tp10 -63.61 -65.01 0.74 Allowed 'General case' 0 N--CA 1.485 1.316 0 CA-C-O 121.197 0.522 . . . . 72.3 110.596 179.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -65.67 -31.99 73.3 Favored 'General case' 0 C--O 1.247 0.929 0 CA-C-N 114.805 -1.089 . . . . 74.54 110.955 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.456 HH11 ' HG2' ' A' ' 63' ' ' ARG . 26.4 ttt-85 -58.27 -54.59 45.27 Favored 'General case' 0 C--N 1.344 0.345 0 CA-C-N 115.316 -0.856 . . . . 74.11 109.917 176.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -71.07 -21.26 62.26 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.527 -0.76 . . . . 74.25 111.787 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.428 HG23 ' HG2' ' A' ' 76' ' ' PRO . 50.9 mt -58.88 -50.13 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 N-CA-C 109.327 -0.62 . . . . 74.41 109.327 168.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.411 ' OH ' ' HA ' ' A' ' 6' ' ' ASP . 34.1 t80 -59.68 -49.98 75.63 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 123.68 0.613 . . . . 75.4 110.534 175.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -57.72 -34.93 69.99 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.457 0.703 . . . . 64.04 112.062 -178.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 69.7 p -89.81 -16.31 30.44 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 119.203 -0.427 . . . . 75.44 111.457 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -74.4 131.34 41.01 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 109.268 -0.642 . . . . 75.32 109.268 178.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 98.34 14.66 37.78 Favored Glycine 0 CA--C 1.53 0.982 0 N-CA-C 110.884 -0.886 . . . . 64.23 110.884 -164.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 37.6 m -146.97 -53.25 0.22 Allowed 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 103.622 -2.733 . . . . 71.23 103.622 177.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.5 m -75.45 135.58 40.71 Favored 'General case' 0 C--O 1.253 1.258 0 N-CA-C 104.408 -2.442 . . . . 74.23 104.408 155.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.23 -34.19 5.99 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.775 0.83 . . . . 74.04 110.917 -173.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -84.71 150.65 56.77 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 123.662 0.785 . . . . 75.1 109.625 176.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -60.28 133.12 47.62 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 122.393 2.062 . . . . 75.41 111.259 175.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.428 ' HG2' HG23 ' A' ' 65' ' ' ILE . 39.3 Cg_exo -60.43 153.86 57.48 Favored 'Trans proline' 0 C--N 1.375 1.934 0 C-N-CA 123.27 2.646 . . . . 74.25 113.174 -173.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.29 128.16 15.16 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.498 2.132 . . . . 73.45 111.415 175.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -62.92 116.02 3.3 Favored 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 123.043 2.495 . . . . 73.2 112.214 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -65.33 169.33 12.59 Favored 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 123.087 2.524 . . . . 71.05 111.979 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.83 86.23 0.03 OUTLIER 'Trans proline' 0 C--N 1.386 2.543 0 C-N-CA 123.394 2.729 . . . . 74.31 112.905 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.422 ' HA3' ' HA ' ' A' ' 141' ' ' ALA . . . 141.99 -37.44 1.58 Allowed Glycine 0 C--N 1.347 1.184 0 CA-C-N 115.021 -0.99 . . . . 62.41 111.411 178.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 114.14 -149.6 18.71 Favored Glycine 0 C--N 1.352 1.436 0 N-CA-C 112.274 -0.33 . . . . 53.03 112.274 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -110.98 73.62 0.83 Allowed 'General case' 0 C--O 1.242 0.66 0 C-N-CA 124.25 1.02 . . . . 74.41 108.283 175.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -57.38 125.11 21.34 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 115.511 -0.768 . . . . 71.31 110.914 177.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -121.92 24.28 9.67 Favored 'General case' 0 C--O 1.248 0.975 0 C-N-CA 123.737 0.815 . . . . 73.24 110.703 -175.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.411 ' OG ' ' HA2' ' A' ' 166' ' ' GLY . 74.0 m -50.61 124.9 11.75 Favored 'General case' 0 C--N 1.355 0.815 0 O-C-N 124.116 0.885 . . . . 74.44 111.814 176.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 129.0 -40.95 1.62 Allowed Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 109.012 -1.635 . . . . 70.11 109.012 -174.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.408 ' CD2' ' HB3' ' A' ' 55' ' ' ALA . 28.5 m-85 -137.18 143.31 42.32 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.78 0.432 . . . . 72.34 110.041 -170.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -75.37 89.37 2.62 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-O 121.515 0.674 . . . . 71.44 110.445 -177.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.551 HG21 ' ND2' ' A' ' 169' ' ' ASN . 2.8 p -38.01 -44.58 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 126.303 1.841 . . . . 75.21 114.068 172.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -70.28 -19.53 63.1 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.477 0.711 . . . . 75.33 111.789 -168.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -80.27 -24.8 39.83 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.102 0.561 . . . . 61.35 110.709 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -73.79 173.2 10.2 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 113.572 0.953 . . . . 73.34 113.572 -166.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 81.2 p -81.88 178.12 8.48 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 114.564 1.32 . . . . 74.5 114.564 -164.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -62.67 -52.52 62.99 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 113.181 -1.827 . . . . 74.52 112.307 -170.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.413 ' HB3' ' HG2' ' A' ' 5' ' ' LYS . 78.0 t80 -54.28 -41.97 69.47 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 123.501 0.72 . . . . 75.03 111.533 -178.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.475 ' CE2' HG22 ' A' ' 90' ' ' VAL . 36.9 t80 -64.9 -46.2 82.72 Favored 'General case' 0 CA--C 1.555 1.157 0 CA-C-N 114.763 -1.108 . . . . 72.32 110.513 176.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -67.05 -12.89 61.18 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.323 0.649 . . . . 74.14 112.371 178.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -89.82 -53.43 4.5 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.289 0.636 . . . . 70.02 111.36 173.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.2 tp -66.66 -52.78 41.02 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.059 0.944 . . . . 74.33 111.269 -171.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -96.21 -3.04 44.99 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.161 0.584 . . . . 72.11 111.174 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.417 ' N ' ' HD2' ' A' ' 103' ' ' PRO . . . -44.34 -55.83 5.72 Favored Glycine 0 C--N 1.354 1.551 0 CA-C-O 118.724 -1.042 . . . . 72.43 115.366 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.417 ' HD2' ' N ' ' A' ' 102' ' ' GLY . 9.5 Cg_endo -47.69 -28.11 8.93 Favored 'Trans proline' 0 C--N 1.388 2.655 0 C-N-CA 124.211 3.274 . . . . 64.43 114.941 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -134.69 35.08 2.25 Favored Glycine 0 C--N 1.346 1.134 0 CA-C-O 119.487 -0.618 . . . . 54.4 112.888 -176.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 17.6 mt -67.53 26.2 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 114.683 1.364 . . . . 74.25 114.683 176.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER 58.6 -107.39 0.35 Allowed 'General case' 0 CA--C 1.562 1.437 0 C-N-CA 124.46 1.104 . . . . 74.45 110.884 163.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.594 ' H ' ' HB2' ' A' ' 169' ' ' ASN . . . 74.92 8.64 82.92 Favored Glycine 0 C--N 1.354 1.539 0 C-N-CA 123.18 0.419 . . . . 44.0 112.709 -177.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.353 1.481 0 N-CA-C 111.854 -0.499 . . . . 71.34 111.854 -170.486 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 27.9 tptp . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 115.557 1.688 . . . . 73.31 115.557 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.444 ' HA2' ' HA3' ' A' ' 168' ' ' GLY . . . -84.4 167.88 43.57 Favored Glycine 0 C--N 1.343 0.935 0 N-CA-C 115.587 0.995 . . . . 73.4 115.587 -176.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.506 ' HB3' ' HB2' ' A' ' 167' ' ' GLN . 12.5 ttm180 -115.65 144.32 44.09 Favored 'General case' 0 C--O 1.26 1.628 0 C-N-CA 124.17 0.988 . . . . 74.43 111.31 -174.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.427 ' HA ' ' H ' ' A' ' 173' ' ' ASP . 9.3 p-10 -64.6 134.9 55.29 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 114.719 -1.128 . . . . 74.23 109.978 169.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.494 HD11 ' HB2' ' B' ' 11' ' ' LEU . 7.9 tp -144.12 143.67 31.23 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.08 -0.341 . . . . 75.42 110.08 -174.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 45.8 ttm180 -97.53 111.13 23.52 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.715 -0.846 . . . . 74.51 108.715 166.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -112.56 167.13 10.71 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 107.957 -1.127 . . . . 54.41 107.957 172.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.507 ' HG2' ' HB ' ' A' ' 177' ' ' VAL . 38.2 mt-10 -127.82 118.55 23.91 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 118.786 0.721 . . . . 72.42 109.648 -172.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.423 HD21 HD12 ' A' ' 176' ' ' LEU . 57.1 tp -100.13 104.62 30.5 Favored Pre-proline 0 N--CA 1.478 0.974 0 C-N-CA 123.985 0.914 . . . . 74.14 111.372 -164.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.673 ' HA ' ' HB2' ' A' ' 179' ' ' ARG . 24.6 Cg_exo -61.68 141.04 89.47 Favored 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 122.428 2.085 . . . . 75.33 110.511 176.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 13.4 tp -148.41 149.34 31.57 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.268 0.556 . . . . 72.43 111.975 177.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 97.8 m -85.5 140.26 30.82 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.708 1.203 . . . . 71.34 109.393 175.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.568 HD11 ' HB3' ' A' ' 183' ' ' HIS . 34.0 mt -54.79 -59.88 4.12 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 124.364 1.066 . . . . 75.21 113.359 -171.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -58.82 -39.1 80.18 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 114.961 -1.018 . . . . 75.32 110.644 -178.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -72.6 -21.83 61.06 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.06 0.944 . . . . 64.33 111.591 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.553 ' HB2' ' O ' ' A' ' 153' ' ' VAL . . . -74.87 -43.5 54.07 Favored 'General case' 0 C--O 1.247 0.947 0 C-N-CA 123.795 0.838 . . . . 65.44 110.915 178.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -72.05 -32.12 66.8 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 116.128 -0.487 . . . . 74.51 110.479 173.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 52.0 m170 -59.69 -48.13 82.88 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 123.4 0.438 . . . . 75.25 110.671 175.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.415 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 81.07 -136.08 15.65 Favored Glycine 0 CA--C 1.526 0.755 0 O-C-N 123.822 0.701 . . . . 71.54 111.583 -176.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 85.34 -172.04 46.6 Favored Glycine 0 C--N 1.344 0.983 0 O-C-N 123.632 0.254 . . . . 70.42 112.75 178.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.446 ' HB3' ' HB3' ' A' ' 146' ' ' SER . 1.8 mp0 -87.96 108.42 19.19 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 108.15 -1.056 . . . . 73.14 108.15 173.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 13.8 tpp180 -93.53 122.3 35.82 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 122.85 0.46 . . . . 75.05 110.003 -173.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 95.9 t -78.68 124.36 36.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 123.582 0.753 . . . . 75.04 109.782 -178.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.3 p -151.03 133.04 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 C-N-CA 123.82 0.848 . . . . 73.34 109.873 -174.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -84.93 135.25 34.13 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.196 0.998 . . . . 71.3 110.927 -176.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.635 HG21 ' HB2' ' B' ' 10' ' ' LEU . 2.6 p -166.4 111.56 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.201 0 C-N-CA 123.544 0.738 . . . . 75.1 111.168 -178.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.422 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . 60.25 37.71 20.33 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 113.796 1.035 . . . . 74.24 113.796 168.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 77.34 11.87 85.1 Favored Glycine 0 N--CA 1.475 1.298 0 CA-C-N 116.208 -0.451 . . . . 54.15 113.125 -178.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 26.6 ttm-85 -116.78 119.86 36.75 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.775 1.23 . . . . 72.43 108.197 174.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.439 ' HB2' ' HB2' ' A' ' 61' ' ' GLU . 14.1 tpp180 -93.34 89.62 6.44 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 106.707 -1.59 . . . . 74.41 106.707 170.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 11.6 p -89.53 140.16 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-O 121.368 0.604 . . . . 73.53 110.569 -170.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.446 ' HB3' ' HB3' ' A' ' 135' ' ' GLU . 25.2 m -106.01 90.14 3.28 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 107.768 -1.197 . . . . 64.43 107.768 174.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 3.3 p -77.35 112.56 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-O 121.335 0.588 . . . . 73.42 109.44 -174.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 5.8 tpm_? -67.06 92.12 0.24 Allowed 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 108.454 -0.943 . . . . 74.32 108.454 175.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.484 HG23 HD13 ' A' ' 159' ' ' ILE . 33.3 pt -93.44 131.74 31.88 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-N 115.203 -0.908 . . . . 74.52 109.089 -179.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -63.25 139.4 71.79 Favored 'Trans proline' 0 C--N 1.37 1.667 0 C-N-CA 122.414 2.076 . . . . 74.22 111.502 175.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -59.23 114.13 1.89 Allowed 'Trans proline' 0 C--N 1.383 2.393 0 C-N-CA 123.068 2.512 . . . . 74.15 111.855 -178.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 98.87 76.43 1.26 Allowed Glycine 0 C--N 1.345 1.066 0 N-CA-C 110.068 -1.213 . . . . 75.51 110.068 -175.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.553 ' O ' ' HB2' ' A' ' 130' ' ' ALA . 4.7 p -126.23 132.02 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 124.315 1.046 . . . . 75.43 108.453 172.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.637 ' HD2' HD11 ' A' ' 215' ' ' LEU . 0.0 OUTLIER -134.71 156.86 48.06 Favored 'General case' 0 N--CA 1.483 1.176 0 O-C-N 121.715 -0.616 . . . . 73.23 110.915 -169.92 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.404 ' O ' ' HB3' ' A' ' 188' ' ' LEU . 6.1 tp10 -51.66 117.09 2.45 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 125.222 1.409 . . . . 72.32 112.223 -172.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 114.55 -9.63 21.9 Favored Glycine 0 C--N 1.339 0.748 0 CA-C-N 115.596 -0.729 . . . . 74.33 112.708 -176.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 27.5 t -76.01 144.01 41.14 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.459 -0.941 . . . . 74.23 108.459 171.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 176' ' ' LEU . 18.6 t -113.75 102.44 13.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 N-CA-C 108.357 -0.979 . . . . 74.02 108.357 174.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.611 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 50.9 mt -70.65 84.48 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.831 0 N-CA-C 107.45 -1.315 . . . . 75.24 107.45 172.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 70.9 ttt-85 -75.56 100.63 4.63 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.076 -1.083 . . . . 75.21 108.076 176.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.506 HG11 ' HB3' ' A' ' 174' ' ' LEU . 2.4 p -105.9 102.78 40.99 Favored Pre-proline 0 CA--C 1.546 0.825 0 N-CA-C 108.175 -1.046 . . . . 71.41 108.175 175.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -61.97 140.84 86.92 Favored 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 122.613 2.208 . . . . 74.53 110.582 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 83.33 26.11 44.96 Favored Glycine 0 CA--C 1.523 0.544 0 CA-C-O 118.984 -0.898 . . . . 70.43 114.557 178.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.424 ' C ' ' HB2' ' A' ' 174' ' ' LEU . 44.0 ttm -139.06 -6.06 1.44 Allowed 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 118.768 1.284 . . . . 64.15 113.423 -177.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.498 ' HA2' HD13 ' A' ' 174' ' ' LEU . . . -49.25 -59.58 6.9 Favored Glycine 0 N--CA 1.499 2.87 0 CA-C-O 122.406 1.003 . . . . 73.33 111.111 -177.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.477 ' H ' ' HA3' ' A' ' 172' ' ' GLY . . . 132.74 -86.66 0.28 Allowed Glycine 0 CA--C 1.48 -2.1 0 CA-C-N 112.227 -1.987 . . . . 74.5 109.554 158.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.506 ' HB2' ' HB3' ' A' ' 117' ' ' ARG . 19.0 mm-40 -23.36 105.32 0.02 OUTLIER 'General case' 0 C--N 1.364 1.207 0 O-C-N 129.193 3.525 . . . . 75.42 115.947 -160.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.444 ' HA3' ' HA2' ' A' ' 116' ' ' GLY . . . 137.86 -118.74 1.71 Allowed Glycine 0 N--CA 1.44 -1.071 0 N-CA-C 105.668 -2.973 . . . . 64.21 105.668 -164.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . 0.594 ' HB2' ' H ' ' A' ' 107' ' ' GLY . 57.7 t30 -165.37 -43.12 0.0 OUTLIER Pre-proline 0 N--CA 1.481 1.101 0 CA-C-N 117.769 0.784 . . . . 63.54 110.912 165.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -61.21 165.32 12.89 Favored 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 121.872 1.715 . . . . 73.02 109.647 160.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -56.28 113.75 1.59 Allowed 'Trans proline' 0 CA--C 1.548 1.186 0 C-N-CA 122.811 2.34 . . . . 71.25 116.58 -168.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.477 ' HA3' ' H ' ' A' ' 166' ' ' GLY . . . -67.46 -142.06 0.07 OUTLIER Glycine 0 C--N 1.371 2.479 0 C-N-CA 118.593 -1.765 . . . . 72.4 113.534 153.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.427 ' H ' ' HA ' ' A' ' 118' ' ' ASP . 45.1 m-20 -152.27 108.53 3.41 Favored 'General case' 0 N--CA 1.51 2.569 0 CA-C-N 118.49 1.145 . . . . 71.14 108.916 176.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.506 ' HB3' HG11 ' A' ' 161' ' ' VAL . 7.8 tp -91.55 135.13 34.08 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 118.478 0.581 . . . . 74.2 112.019 -167.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 6.2 mt -115.99 93.94 4.46 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 106.029 -1.841 . . . . 72.12 106.029 177.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.611 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 82.2 mt -88.36 101.89 14.33 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.171 0.588 . . . . 74.52 111.519 -175.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.507 ' HB ' ' HG2' ' A' ' 122' ' ' GLU . 61.4 t -82.53 97.85 4.41 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 N-CA-C 107.378 -1.341 . . . . 71.11 107.378 174.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.489 HG12 HG23 ' A' ' 153' ' ' VAL . 10.5 p -64.84 124.01 18.84 Favored 'Isoleucine or valine' 0 C--O 1.251 1.158 0 CA-C-N 115.469 -0.787 . . . . 74.13 110.585 -174.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.673 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 8.4 mmt85 -87.94 148.17 24.71 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.03 -1.441 . . . . 73.42 108.526 167.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.496 HD12 ' HA ' ' A' ' 154' ' ' ARG . 29.2 mt -118.54 152.39 36.07 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.878 -0.786 . . . . 74.04 108.878 165.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 85.9 mt -53.09 153.87 5.97 Favored Pre-proline 0 CA--C 1.558 1.264 0 O-C-N 124.389 1.056 . . . . 73.22 111.111 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.28 11.66 0.1 Allowed 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 123.456 2.771 . . . . 74.32 115.372 -174.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . 0.568 ' HB3' HD11 ' A' ' 127' ' ' LEU . 4.0 t-80 -61.35 104.54 0.47 Allowed Pre-proline 0 CA--C 1.565 1.529 0 C-N-CA 125.166 1.386 . . . . 73.35 108.17 169.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -80.11 29.28 0.51 Allowed 'Trans proline' 0 C--N 1.368 1.571 0 C-N-CA 124.53 3.486 . . . . 61.24 117.229 -159.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.573 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 23.8 t -89.41 -51.39 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 120.379 1.445 . . . . 72.34 108.703 -172.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . 0.426 ' CZ ' ' HA ' ' A' ' 214' ' ' THR . 65.1 m-85 -114.2 129.38 56.63 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 112.267 0.469 . . . . 72.31 112.267 -169.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . 0.565 HH22 ' HB2' ' A' ' 189' ' ' GLU . 28.4 ttp85 -127.86 123.91 36.22 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.048 -1.093 . . . . 75.51 108.048 164.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.404 ' HB3' ' O ' ' A' ' 155' ' ' GLU . 9.1 tp -93.0 148.05 22.32 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 123.15 0.58 . . . . 74.21 110.475 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . 0.565 ' HB2' HH22 ' A' ' 187' ' ' ARG . 10.0 tp10 -123.5 90.58 3.31 Favored 'General case' 0 C--O 1.246 0.911 0 N-CA-C 107.583 -1.266 . . . . 70.31 107.583 163.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 64.83 -82.2 0.06 OUTLIER Glycine 0 C--N 1.353 1.506 0 CA-C-N 114.373 -1.285 . . . . 65.41 113.494 176.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 5.3 pm0 -93.18 -45.4 7.89 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.447 0.699 . . . . 72.32 111.362 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -111.09 144.85 39.56 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.38 -0.825 . . . . 72.32 113.009 -163.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.423 ' HB2' ' HA ' ' A' ' 249' ' ' LEU . 86.7 mt -91.46 157.41 17.07 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.491 1.116 . . . . 74.25 110.971 -177.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -131.1 105.22 7.56 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 107.777 -1.194 . . . . 73.14 107.777 170.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.573 ' HA ' ' O ' ' A' ' 185' ' ' VAL . . . -104.7 -175.77 2.89 Favored 'General case' 0 C--O 1.218 -0.567 0 C-N-CA 124.393 1.077 . . . . 74.34 110.67 178.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 34.7 m -125.18 128.66 48.71 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.672 -0.862 . . . . 70.21 108.672 173.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 48.3 tp -129.55 121.17 26.62 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 109.835 -0.432 . . . . 74.1 109.835 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -85.92 122.12 29.52 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 108.886 -0.783 . . . . 63.3 108.886 169.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 7.1 p -133.19 133.24 22.77 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 107.866 -1.161 . . . . 74.33 107.866 178.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.5 152.19 59.78 Favored 'Trans proline' 0 C--N 1.364 1.372 0 C-N-CA 121.378 1.385 . . . . 70.05 111.192 175.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.662 ' HB1' ' HH2' ' A' ' 269' ' ' TRP . . . -53.92 -44.5 98.29 Favored Pre-proline 0 CA--C 1.557 1.223 0 N-CA-C 114.782 1.401 . . . . 71.34 114.782 -175.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -64.2 -37.28 42.13 Favored 'Trans proline' 0 C--N 1.381 2.266 0 CA-C-N 121.677 1.635 . . . . 73.32 112.994 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 38.0 mt -73.59 -31.52 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.021 0.529 . . . . 71.02 110.21 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.15 -44.71 79.1 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.495 0.718 . . . . 74.14 110.999 177.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 69.5 t -68.32 -63.62 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 123.208 0.603 . . . . 64.22 110.273 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 96.4 t -72.56 -40.12 62.43 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 CA-C-N 115.466 -0.788 . . . . 74.41 111.899 -168.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 96.89 108.32 2.53 Favored Glycine 0 C--N 1.339 0.726 0 N-CA-C 111.1 -0.8 . . . . 72.35 111.1 -173.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -144.33 -157.44 7.2 Favored Glycine 0 C--N 1.342 0.871 0 CA-C-O 120.137 -0.257 . . . . 73.32 112.551 -177.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.468 ' HZ1' ' HB3' ' A' ' 209' ' ' LYS . 9.7 mtpm? -117.18 130.41 56.58 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 117.17 0.485 . . . . 73.34 110.897 -176.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 29.8 m -132.94 -172.39 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 N-CA-C 107.591 -1.263 . . . . 63.11 107.591 167.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . 0.5 ' HD3' ' HB2' ' A' ' 218' ' ' PRO . 25.7 ttm180 -113.55 126.49 55.35 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 121.897 -0.502 . . . . 74.32 110.663 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -104.57 116.74 32.59 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.868 0.867 . . . . 74.41 109.009 175.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' MET . . . . . 0.421 ' N ' ' SD ' ' A' ' 213' ' ' MET . 3.3 mpp? -82.75 104.72 13.21 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.836 -0.802 . . . . 74.15 108.836 178.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' THR . . . . . 0.426 ' HA ' ' CZ ' ' A' ' 186' ' ' PHE . 82.1 p -116.49 174.09 6.26 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 123.314 0.646 . . . . 74.1 110.364 -178.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . 0.637 HD11 ' HD2' ' A' ' 154' ' ' ARG . 14.6 mt -75.76 -17.64 59.82 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.131 0.573 . . . . 73.14 110.053 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -88.41 -5.21 58.41 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.772 1.229 . . . . 64.44 110.755 174.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 125.21 162.46 11.35 Favored Glycine 0 C--N 1.35 1.323 0 C-N-CA 123.579 0.609 . . . . 63.05 113.274 172.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . 0.5 ' HB2' ' HD3' ' A' ' 211' ' ' ARG . 60.5 Cg_endo -72.06 99.61 1.01 Allowed 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 122.463 2.109 . . . . 74.13 110.143 174.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 35.2 m -102.39 161.26 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.666 0.786 . . . . 73.4 111.466 -172.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -83.04 107.4 15.6 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 108.95 -0.759 . . . . 75.04 108.95 171.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 7.6 p -96.5 116.41 38.45 Favored 'Isoleucine or valine' 0 C--O 1.246 0.907 0 N-CA-C 109.161 -0.681 . . . . 74.51 109.161 178.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -81.97 97.32 8.04 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.646 -0.872 . . . . 70.4 108.646 175.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 97.5 t -58.22 121.82 54.44 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 124.454 1.101 . . . . 71.22 109.308 176.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.67 159.83 51.99 Favored 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 122.416 2.077 . . . . 75.51 111.453 176.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -65.04 156.35 63.19 Favored 'Trans proline' 0 C--N 1.365 1.417 0 C-N-CA 121.91 1.74 . . . . 72.53 111.711 171.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . 0.734 HH11 ' HA ' ' C' ' 260' ' ' ARG . 3.2 mmp_? 73.97 11.15 4.47 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.638 1.575 . . . . 75.13 111.89 176.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 13.2 m -59.69 120.78 10.14 Favored 'General case' 0 C--N 1.356 0.861 0 C-N-CA 124.002 0.921 . . . . 64.32 110.588 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . 0.504 ' HA ' HD13 ' A' ' 255' ' ' ILE . 48.0 tt0 -128.17 142.49 51.17 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.316 -0.402 . . . . 75.32 111.033 -166.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -60.95 133.85 56.51 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 124.1 0.875 . . . . 65.12 111.079 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 98.89 -38.67 3.01 Favored Glycine 0 C--N 1.34 0.792 0 O-C-N 123.553 0.533 . . . . 75.54 111.92 -177.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 28.5 mtm-85 -70.38 170.04 12.69 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-O 121.214 0.531 . . . . 74.44 111.053 173.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.647 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 2.9 mptp? -124.39 129.52 50.83 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.45 -0.795 . . . . 72.22 109.553 -176.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.456 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 54.7 mt -79.63 99.72 7.49 Favored 'General case' 0 C--N 1.346 0.455 0 N-CA-C 109.012 -0.736 . . . . 71.4 109.012 173.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 32.8 ttp180 -72.09 100.51 2.54 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.042 0.937 . . . . 73.41 110.014 178.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.514 HD12 HD11 ' A' ' 251' ' ' LEU . 5.0 mt -87.75 102.2 14.43 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 107.64 -1.245 . . . . 74.24 107.64 176.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -51.69 126.51 17.92 Favored 'General case' 0 CA--C 1.549 0.932 0 O-C-N 124.148 0.905 . . . . 71.01 113.219 -173.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 75.3 10.22 84.37 Favored Glycine 0 C--N 1.347 1.194 0 CA-C-N 115.051 -0.977 . . . . 74.2 115.47 168.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? -84.37 -11.17 56.78 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 117.615 0.707 . . . . 74.1 110.865 175.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -98.91 -164.94 30.17 Favored Glycine 0 C--N 1.348 1.215 0 N-CA-C 111.206 -0.758 . . . . 74.43 111.206 168.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . 0.403 ' N ' ' CD1' ' A' ' 240' ' ' PHE . 2.4 m-30 -96.06 131.6 28.58 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 123.895 0.878 . . . . 73.41 110.326 -168.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.13 153.91 62.35 Favored 'Trans proline' 0 CA--C 1.547 1.139 0 C-N-CA 122.742 2.295 . . . . 73.33 112.564 177.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -148.78 -178.14 23.6 Favored Glycine 0 C--N 1.347 1.149 0 CA-C-O 119.396 -0.669 . . . . 73.52 112.876 177.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -52.75 -53.36 6.96 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 123.63 2.886 . . . . 72.5 113.315 175.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -120.46 -28.26 5.01 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 122.963 0.505 . . . . 70.11 111.575 178.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -97.67 99.64 2.27 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 111.837 -0.505 . . . . 62.24 111.837 -176.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -86.03 121.83 29.2 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 108.959 -0.756 . . . . 75.41 108.959 173.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.63 130.1 10.03 Favored Glycine 0 C--O 1.246 0.852 0 N-CA-C 114.851 0.7 . . . . 70.31 114.851 -173.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -123.12 165.38 16.94 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.933 0.893 . . . . 75.44 108.961 176.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.445 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 38.0 tp -99.33 101.68 13.04 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 109.086 -0.709 . . . . 73.32 109.086 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.647 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 14.0 m-85 -87.04 103.58 15.51 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 109.155 -0.683 . . . . 71.3 109.155 -177.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.522 HD23 ' HB1' ' A' ' 195' ' ' ALA . 87.4 mt -83.22 108.63 16.59 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 108.777 -0.823 . . . . 74.54 108.777 177.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . 0.504 ' HG2' ' HG3' ' A' ' 232' ' ' LYS . 40.6 mt-10 -75.11 110.9 9.81 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 108.394 -0.965 . . . . 75.41 108.394 -175.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 59.5 t -67.16 125.57 24.91 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 CA-C-N 114.0 -1.454 . . . . 71.34 111.832 -170.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 3.3 mmm-85 -118.13 94.2 4.41 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 125.066 1.346 . . . . 73.14 107.626 170.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.504 HD13 ' HA ' ' A' ' 228' ' ' GLN . 57.5 mt -70.35 128.81 34.15 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 N-CA-C 109.02 -0.733 . . . . 74.34 109.02 174.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 51.9 p -122.59 146.66 47.23 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 124.434 1.094 . . . . 74.52 108.904 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . 0.484 HD13 HE21 ' C' ' 228' ' ' GLN . 2.7 pp -109.75 147.37 36.0 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 123.32 0.648 . . . . 73.4 109.458 175.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -50.49 -18.8 4.08 Favored 'Trans proline' 0 N--CA 1.505 2.16 0 C-N-CA 124.658 3.572 . . . . 74.45 115.906 -168.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 58.51 -80.33 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.761 1.225 . . . . 75.12 110.644 -168.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 12.1 ptm85 -73.93 139.43 44.91 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 109.227 -0.657 . . . . 75.12 109.227 173.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.649 ' HB3' ' HB2' ' A' ' 266' ' ' GLU . 9.3 mt -145.04 138.13 26.51 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.228 0.611 . . . . 72.32 111.403 -169.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 27.0 p -83.04 153.41 66.7 Favored Pre-proline 0 CA--C 1.555 1.15 0 C-N-CA 124.647 1.179 . . . . 74.31 109.572 175.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -39.14 -65.3 0.17 Allowed 'Trans proline' 0 C--N 1.384 2.396 0 C-N-CA 124.878 3.719 . . . . 74.33 116.798 -171.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -68.79 -40.69 79.51 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.016 0.526 . . . . 71.44 111.816 -172.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -68.13 -37.73 81.41 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.063 0.545 . . . . 73.22 110.974 -178.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' GLU . . . . . 0.649 ' HB2' ' HB3' ' A' ' 261' ' ' LEU . 41.3 tt0 -64.2 -48.07 77.29 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 121.487 0.661 . . . . 73.45 109.306 176.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . 0.404 ' HB1' ' HE3' ' A' ' 271' ' ' LYS . . . -54.66 -41.94 70.73 Favored 'General case' 0 C--O 1.208 -1.123 0 CA-C-N 113.8 -1.545 . . . . 64.12 109.81 175.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 12.4 tp -64.81 -46.47 81.87 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.234 1.014 . . . . 73.14 110.885 -175.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' TRP . . . . . 0.662 ' HH2' ' HB1' ' A' ' 201' ' ' ALA . 73.5 m95 -55.59 -44.94 77.4 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 115.232 -0.894 . . . . 75.0 111.331 173.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . 0.609 ' HE3' ' HA ' ' C' ' 206' ' ' VAL . 53.6 mtpt -90.27 -9.31 48.42 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 115.359 -0.837 . . . . 73.12 112.267 -171.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . 0.404 ' HE3' ' HB1' ' A' ' 267' ' ' ALA . 90.1 mttt -76.05 -45.09 36.0 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.55 -1.278 . . . . 70.22 107.55 166.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' LEU . . . . . 0.607 HD23 ' HB2' ' C' ' 268' ' ' LEU . 46.1 mt -55.57 -47.23 76.73 Favored 'General case' 0 C--O 1.213 -0.831 0 CA-C-N 114.4 -1.273 . . . . 71.54 110.185 169.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . 0.414 ' HA ' ' HB2' ' C' ' 202' ' ' PRO . . . -63.75 -47.27 81.7 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 124.258 0.974 . . . . 72.23 112.758 -174.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -65.8 -44.2 86.38 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 123.226 0.329 . . . . 74.35 110.909 177.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -67.27 -27.52 67.26 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 122.885 0.474 . . . . 72.24 111.598 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . 0.516 ' HE2' ' HG3' ' C' ' 258' ' ' PRO . 24.0 t80 -75.1 -74.95 0.18 Allowed 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 107.974 -1.121 . . . . 75.02 107.974 177.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -49.69 -60.5 2.83 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.307 1.843 . . . . 72.14 112.315 -175.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -70.23 -8.24 48.49 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 112.926 0.713 . . . . 75.41 112.926 -172.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . 0.438 ' HA ' ' HE ' ' A' ' 279' ' ' ARG . 1.0 OUTLIER -121.64 1.65 10.04 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-O 118.906 -0.569 . . . . 75.15 111.391 -178.971 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.416 0 O-C-N 124.392 1.058 . . . . 72.5 111.185 -172.514 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.405 ' SD ' ' N ' ' B' ' 1' ' ' MET . 3.8 mpp? . . . . . 0 N--CA 1.482 1.154 0 N-CA-C 109.302 -0.629 . . . . 74.12 109.302 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -67.33 116.88 8.59 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 108.999 -0.741 . . . . 62.45 108.999 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -86.15 68.9 10.42 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 122.344 1.068 . . . . 74.04 108.91 175.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 18.7 m -104.97 113.28 26.78 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-N 113.881 -1.509 . . . . 52.14 108.415 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.95 174.67 7.79 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 121.094 0.473 . . . . 74.34 110.524 -178.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 25.0 pt -138.93 160.13 29.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 123.357 0.663 . . . . 65.34 111.665 -163.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -136.17 143.43 44.44 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 107.09 -1.448 . . . . 72.22 107.09 166.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 35.4 tp -71.41 -89.01 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.579 0.752 . . . . 75.22 110.656 -170.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . 159.16 -61.36 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 126.188 1.795 . . . . 73.12 106.761 -175.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . 0.635 ' HB2' HG21 ' A' ' 140' ' ' VAL . 3.1 tt 53.49 115.65 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 113.561 -1.654 . . . . 74.1 110.024 -162.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.494 ' HB2' HD11 ' A' ' 119' ' ' LEU . 51.9 mt . . . . . 0 CA--C 1.546 0.819 0 N-CA-C 108.874 -0.787 . . . . 72.11 108.874 179.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.186 0 CA-C-O 121.671 0.748 . . . . 74.35 110.822 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 180' ' ' ALA . . . . . 0.401 ' HB1' HG21 ' C' ' 137' ' ' VAL . . . -174.38 -43.15 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.561 1.544 . . . . 75.32 107.385 -177.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 181' ' ' LEU . . . . . 0.719 HD21 ' HB ' ' C' ' 138' ' ' VAL . 41.8 tp -177.25 -63.87 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 126.48 1.912 . . . . 74.44 106.878 169.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 182' ' ' VAL . . . . . . . . . . . . . 15.0 p -107.2 149.18 10.83 Favored 'Isoleucine or valine' 0 C--O 1.244 0.787 0 CA-C-N 114.461 -1.245 . . . . 72.43 108.556 175.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -76.33 -62.72 1.52 Allowed 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 109.088 -0.708 . . . . 65.24 109.088 172.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 26.1 t-80 -171.42 -95.06 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.72 0 O-C-N 124.335 1.022 . . . . 75.32 108.437 173.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 185' ' ' VAL . . . . . 0.566 ' HA ' ' HB3' ' C' ' 121' ' ' ALA . 58.5 t . . . . . 0 N--CA 1.489 1.489 0 CA-C-N 118.844 0.747 . . . . 74.01 110.305 -179.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 30.7 m . . . . . 0 C--O 1.237 0.412 0 N-CA-C 108.16 -1.052 . . . . 71.31 108.16 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -168.05 -89.65 0.01 OUTLIER 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.059 0.944 . . . . 74.42 109.899 164.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . 159.11 -169.73 35.37 Favored Glycine 0 C--N 1.338 0.692 0 N-CA-C 111.404 -0.678 . . . . 71.23 111.404 -167.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 241' ' ' GLU . . . . . 0.453 ' HG3' ' HG3' ' C' ' 234' ' ' ARG . 9.7 pt-20 -93.04 -13.86 28.09 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 113.376 0.88 . . . . 71.23 113.376 -166.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 11.3 m95 55.9 -88.12 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 124.242 1.017 . . . . 70.32 111.706 -177.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 243' ' ' GLN . . . . . 0.499 ' HA ' ' NH2' ' C' ' 234' ' ' ARG . 9.9 pt20 173.67 -37.77 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 126.438 1.895 . . . . 74.22 108.059 -166.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -175.94 128.0 1.32 Allowed Glycine 0 C--N 1.348 1.247 0 N-CA-C 110.033 -1.227 . . . . 71.54 110.033 177.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 245' ' ' LYS . . . . . 0.606 ' HA ' ' HB3' ' C' ' 224' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.817 0 C-N-CA 123.582 0.753 . . . . 75.34 110.128 -172.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.542 0 N-CA-C 108.885 -0.783 . . . . 71.34 108.885 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -36.55 94.54 0.01 OUTLIER 'General case' 0 C--N 1.365 1.241 0 C-N-CA 125.232 1.413 . . . . 70.52 113.371 -175.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 5' ' ' LYS . . . . . 0.422 ' HB3' HD13 ' C' ' 10' ' ' ILE . 29.7 mmtp -65.76 95.84 0.26 Allowed 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.485 -1.234 . . . . 72.32 108.625 169.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 6' ' ' ASP . . . . . 0.465 ' HA ' ' OH ' ' C' ' 66' ' ' TYR . 16.2 t70 -73.14 97.25 2.35 Favored 'General case' 0 C--N 1.343 0.321 0 N-CA-C 106.975 -1.491 . . . . 65.15 106.975 169.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 7' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -63.6 -30.23 71.37 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 114.811 -1.086 . . . . 73.43 112.389 -169.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -61.56 -44.47 96.97 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.593 0.357 . . . . 74.23 110.16 172.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.47 -42.95 98.59 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.177 0.591 . . . . 63.34 110.934 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 10' ' ' ILE . . . . . 0.422 HD13 ' HB3' ' C' ' 5' ' ' LYS . 56.2 mt -59.98 -39.09 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 C-N-CA 123.407 0.683 . . . . 73.31 110.762 178.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 93.0 mt -76.98 -20.84 55.58 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 116.081 -0.509 . . . . 75.53 112.272 175.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.55 39.48 56.18 Favored Glycine 0 C--N 1.346 1.128 0 O-C-N 123.189 0.306 . . . . 74.43 112.549 -176.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 27.2 m -120.32 157.28 53.96 Favored Pre-proline 0 N--CA 1.479 0.976 0 C-N-CA 124.915 1.286 . . . . 71.34 109.097 176.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -51.16 145.76 25.19 Favored 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 122.849 2.366 . . . . 74.43 113.105 177.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 79.2 mtt180 -74.21 18.13 0.16 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 114.105 1.15 . . . . 74.35 114.105 -175.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -148.76 21.1 1.02 Allowed 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 124.985 1.314 . . . . 71.24 108.176 177.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.47 156.41 32.53 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.314 1.046 . . . . 75.2 112.883 -170.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 18' ' ' THR . . . . . 0.429 ' HG1' ' HG3' ' C' ' 21' ' ' GLU . 70.3 p -65.18 148.39 51.77 Favored 'General case' 0 C--N 1.348 0.534 0 CA-C-N 115.365 -0.834 . . . . 74.41 108.75 170.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 19' ' ' GLN . . . . . 0.438 ' OE1' ' HD2' ' C' ' 63' ' ' ARG . 1.2 mp0 -63.29 -20.01 65.09 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 122.954 0.502 . . . . 74.45 110.477 175.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -65.4 -44.7 86.64 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.261 -0.881 . . . . 74.53 111.408 168.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . 0.429 ' HG3' ' HG1' ' C' ' 18' ' ' THR . 36.5 mt-10 -63.71 -35.3 80.12 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.114 0.565 . . . . 73.42 110.657 176.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 22' ' ' ILE . . . . . 0.63 HG12 ' HB3' ' C' ' 57' ' ' LEU . 1.7 mp -59.72 -41.33 85.01 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 CA-C-N 115.664 -0.698 . . . . 75.54 109.833 170.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 23' ' ' LYS . . . . . 0.449 ' HA ' ' HB3' ' C' ' 26' ' ' TYR . 36.0 mtmm -77.94 -14.96 59.35 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.217 0.607 . . . . 74.13 112.631 175.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -75.18 -37.39 61.24 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 108.622 -0.881 . . . . 73.52 108.622 170.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -76.94 -25.21 52.6 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.246 -0.888 . . . . 75.32 110.936 175.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 26' ' ' TYR . . . . . 0.456 ' O ' ' HB2' ' C' ' 30' ' ' ALA . 87.5 t80 -66.73 -47.43 72.32 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 109.315 -0.624 . . . . 72.31 109.315 169.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . 0.435 ' HG3' ' O ' ' C' ' 23' ' ' LYS . 45.0 mtmt -59.04 -53.69 55.52 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 109.29 -0.633 . . . . 75.33 109.29 173.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 18.5 ttm180 -50.5 -69.34 0.12 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.9 1.28 . . . . 75.55 110.589 -175.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 94.3 mt -82.17 -35.59 28.23 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 114.799 -1.092 . . . . 71.43 112.862 -169.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . 0.456 ' HB2' ' O ' ' C' ' 26' ' ' TYR . . . -87.21 -5.78 58.84 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 118.345 0.521 . . . . 75.32 112.222 -176.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . 0.535 ' HA ' ' HB2' ' C' ' 34' ' ' HIS . 99.4 mtt180 -96.68 -37.37 10.35 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 118.323 0.51 . . . . 73.5 109.902 163.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -62.02 -43.17 99.4 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.344 0.658 . . . . 71.12 111.148 177.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 33' ' ' TYR . . . . . 0.507 ' HD2' HD11 ' C' ' 50' ' ' ILE . 19.3 m-85 -109.42 26.05 11.09 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.36 1.064 . . . . 72.14 110.044 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 34' ' ' HIS . . . . . 0.535 ' HB2' ' HA ' ' C' ' 31' ' ' ARG . 37.8 t60 -63.68 112.76 7.9 Favored Pre-proline 0 N--CA 1.475 0.79 0 CA-C-O 118.505 -0.76 . . . . 74.34 109.189 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.41 -18.81 15.62 Favored 'Trans proline' 0 N--CA 1.501 1.966 0 C-N-CA 123.392 2.728 . . . . 72.22 114.834 -170.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 36' ' ' ASP . . . . . 0.424 ' HB3' ' HD2' ' C' ' 34' ' ' HIS . 13.0 t70 -80.04 -46.72 16.07 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.041 0.936 . . . . 60.34 110.804 176.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 71.0 t -84.15 -54.49 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 123.361 0.664 . . . . 75.33 109.818 -175.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -98.45 83.83 3.09 Favored 'General case' 0 C--O 1.244 0.787 0 N-CA-C 107.991 -1.115 . . . . 65.41 107.991 176.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -79.03 78.09 5.48 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.011 -0.995 . . . . 71.22 109.895 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 71.0 m -139.37 118.55 9.09 Favored Pre-proline 0 CA--C 1.542 0.673 0 C-N-CA 123.882 0.873 . . . . 74.14 108.743 174.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_exo -47.05 -38.74 24.82 Favored 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 123.606 2.871 . . . . 75.0 113.207 176.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -58.05 -44.23 87.3 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.839 0.856 . . . . 71.01 110.211 177.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.47 -21.29 61.96 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.23 -0.896 . . . . 71.45 110.603 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 44' ' ' GLU . . . . . 0.406 ' O ' ' HG2' ' C' ' 48' ' ' LYS . 0.4 OUTLIER -81.54 -33.2 31.9 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.14 0.976 . . . . 74.04 109.2 -178.776 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -68.21 -45.39 73.49 Favored 'General case' 0 C--O 1.261 1.695 0 C-N-CA 124.013 0.925 . . . . 75.44 109.475 174.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 46' ' ' LYS . . . . . 0.421 ' HA ' ' HD3' ' C' ' 46' ' ' LYS . 68.3 mmtt -61.05 -38.61 86.78 Favored 'General case' 0 C--N 1.348 0.518 0 CA-C-N 114.588 -1.187 . . . . 72.32 110.33 172.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 47' ' ' PHE . . . . . 0.675 ' HA ' HD13 ' C' ' 50' ' ' ILE . 65.3 t80 -57.77 -41.13 81.35 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.177 0.991 . . . . 71.12 110.299 176.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 48' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' C' ' 44' ' ' GLU . 72.3 mmtt -59.01 -49.94 75.97 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 122.383 0.273 . . . . 72.04 110.59 175.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -58.93 -39.43 81.55 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 124.23 0.956 . . . . 72.33 112.097 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 50' ' ' ILE . . . . . 0.675 HD13 ' HA ' ' C' ' 47' ' ' PHE . 55.2 mt -62.76 -47.89 90.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 124.254 1.022 . . . . 75.43 109.628 177.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 51' ' ' ASN . . . . . 0.555 ' HA ' ' HB3' ' C' ' 54' ' ' TYR . 64.2 m-80 -79.85 -5.91 56.36 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 115.522 -0.763 . . . . 74.04 112.176 -178.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 52' ' ' GLU . . . . . 0.445 ' HA ' ' CE2' ' C' ' 93' ' ' PHE . 32.0 tt0 -75.3 -56.23 4.92 Favored 'General case' 0 C--O 1.249 1.027 0 CA-C-O 122.166 0.984 . . . . 75.54 108.844 167.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.86 -37.31 73.7 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 113.485 -1.689 . . . . 63.1 111.442 174.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 54' ' ' TYR . . . . . 0.555 ' HB3' ' HA ' ' C' ' 51' ' ' ASN . 70.0 t80 -75.84 -34.32 60.07 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.263 -0.88 . . . . 75.01 110.5 178.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.57 -40.71 75.68 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.099 0.476 . . . . 60.54 110.508 175.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 44.4 t -79.95 -37.23 17.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 114.737 -1.12 . . . . 72.43 112.578 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 57' ' ' LEU . . . . . 0.63 ' HB3' HG12 ' C' ' 22' ' ' ILE . 94.6 mt -111.14 12.38 21.89 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 114.033 1.123 . . . . 75.02 114.033 -170.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 47.4 t -57.94 -58.97 6.05 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.239 0.616 . . . . 75.33 111.073 178.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -99.73 150.93 37.26 Favored Pre-proline 0 N--CA 1.47 0.558 0 CA-C-N 114.786 -1.097 . . . . 72.03 110.236 -178.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 60' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -54.31 -34.63 80.94 Favored 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 123.659 2.906 . . . . 73.21 112.513 171.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -66.19 -47.17 74.79 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.912 0.885 . . . . 62.13 110.645 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -66.05 -33.59 76.15 Favored 'General case' 0 C--O 1.249 1.042 0 CA-C-N 115.093 -0.958 . . . . 75.43 111.049 178.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 63' ' ' ARG . . . . . 0.438 ' HD2' ' OE1' ' C' ' 19' ' ' GLN . 13.6 ttt180 -60.94 -47.27 87.21 Favored 'General case' 0 C--O 1.218 -0.585 0 CA-C-N 115.718 -0.674 . . . . 74.14 109.901 173.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -61.83 -34.42 75.92 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 123.603 0.564 . . . . 74.15 111.285 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 72.6 mt -54.2 -57.55 5.73 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.95 0 N-CA-C 108.522 -0.918 . . . . 71.5 108.522 169.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 66' ' ' TYR . . . . . 0.465 ' OH ' ' HA ' ' C' ' 6' ' ' ASP . 10.0 t80 -52.37 -51.52 58.47 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.253 0.621 . . . . 74.31 112.025 176.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -55.22 -36.33 65.87 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.899 0.88 . . . . 73.14 111.257 -174.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 54.8 p -102.37 -14.29 16.96 Favored 'General case' 0 CA--C 1.556 1.189 0 N-CA-C 112.782 0.66 . . . . 74.43 112.782 -178.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -122.05 125.02 45.32 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.023 0.529 . . . . 75.22 109.663 -173.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 74.61 18.93 80.02 Favored Glycine 0 N--CA 1.473 1.155 0 CA-C-O 121.539 0.522 . . . . 62.51 111.937 -175.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 47.8 m -141.31 -50.33 0.42 Allowed 'General case' 0 C--O 1.239 0.505 0 N-CA-C 103.898 -2.63 . . . . 72.34 103.898 178.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 19.2 m -106.62 163.61 12.76 Favored 'General case' 0 C--O 1.253 1.244 0 N-CA-C 105.192 -2.151 . . . . 73.35 105.192 156.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.09 13.06 27.84 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.511 1.124 . . . . 73.23 111.115 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.42 -152.25 0.0 OUTLIER Pre-proline 0 CA--C 1.607 3.15 0 CA-C-O 115.936 -1.983 . . . . 53.23 113.066 -175.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 0.8 OUTLIER 0.75 118.32 0.0 OUTLIER 'Trans proline' 1 C--N 1.427 4.684 1 C-N-CA 125.92 4.413 . . . . 75.14 119.796 -158.671 . . . . . . . . 4 3 . 1 . 010 nuclear orig core ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -63.39 178.22 1.3 Allowed 'Trans proline' 0 N--CA 1.51 2.472 0 C-N-CA 123.864 3.043 . . . . 71.22 112.745 176.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 77' ' ' PRO . . . . . 0.444 ' HA ' ' HD3' ' C' ' 78' ' ' PRO . 0.7 OUTLIER -26.41 116.96 0.03 OUTLIER 'Trans proline' 0 C--N 1.401 3.318 0 C-N-CA 124.929 3.753 . . . . 74.4 115.437 173.631 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 78' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' C' ' 77' ' ' PRO . 25.3 Cg_exo -65.68 167.92 16.19 Favored 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 124.111 3.207 . . . . 74.44 114.17 -171.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -54.16 132.91 52.88 Favored 'Trans proline' 0 C--N 1.39 2.712 0 C-N-CA 123.104 2.536 . . . . 70.12 113.227 175.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -58.47 83.76 0.05 OUTLIER 'Trans proline' 0 C--N 1.39 2.726 0 C-N-CA 123.65 2.9 . . . . 74.31 111.879 176.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.41 -34.08 0.04 OUTLIER Glycine 0 C--O 1.225 -0.442 0 N-CA-C 109.329 -1.508 . . . . 75.2 109.329 -176.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . 0.418 ' HA2' ' O ' ' C' ' 104' ' ' GLY . . . 95.09 165.15 35.29 Favored Glycine 0 C--N 1.35 1.339 0 N-CA-C 116.607 1.403 . . . . 75.13 116.607 166.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -69.58 135.84 50.51 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 124.258 1.023 . . . . 73.4 108.318 168.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 84' ' ' ASP . . . . . 0.413 ' HB2' ' HB2' ' C' ' 143' ' ' ARG . 35.6 t70 -66.94 129.22 39.18 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 118.273 0.488 . . . . 75.11 109.728 175.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 85' ' ' PHE . . . . . 0.493 ' HB3' ' HG3' ' C' ' 171' ' ' PRO . 23.5 t80 -116.68 34.77 4.89 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.688 0.795 . . . . 74.41 109.857 -165.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 52.8 m -5.74 78.99 0.0 OUTLIER 'General case' 0 CA--C 1.569 1.691 0 N-CA-C 116.836 2.161 . . . . 52.42 116.836 -170.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 53.06 31.71 41.04 Favored Glycine 0 CA--C 1.545 1.959 0 N-CA-C 116.399 1.32 . . . . 74.34 116.399 175.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 88' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -101.67 155.34 18.16 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 119.134 1.467 . . . . 74.44 113.643 -173.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -85.13 79.04 9.72 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.337 0.655 . . . . 72.23 111.128 -178.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 90' ' ' VAL . . . . . . . . . . . . . 2.0 p -42.17 -37.45 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 114.4 1.259 . . . . 54.42 114.4 177.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.11 -14.64 7.21 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 114.19 1.182 . . . . 75.25 114.19 -176.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -113.32 -3.49 13.81 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 112.757 0.651 . . . . 75.53 112.757 -175.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 93' ' ' PHE . . . . . 0.445 ' CE2' ' HA ' ' C' ' 52' ' ' GLU . 2.3 m-85 -77.13 153.33 34.33 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 122.741 0.417 . . . . 72.45 110.937 -176.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 97.0 p -82.94 -178.81 7.25 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.768 0.827 . . . . 52.11 113.013 -166.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.38 -61.81 2.33 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 114.552 -1.204 . . . . 72.35 112.911 -175.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -58.07 -38.98 77.38 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 118.753 0.706 . . . . 74.24 110.743 -171.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 97' ' ' PHE . . . . . 0.431 ' CE2' ' HE2' ' C' ' 85' ' ' PHE . 83.4 t80 -60.31 -54.75 41.94 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 114.43 -1.259 . . . . 64.25 110.009 175.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -81.69 5.18 19.19 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 112.478 0.547 . . . . 71.33 112.478 -177.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -100.05 -39.11 8.28 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.836 0.855 . . . . 74.43 109.942 170.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 45.6 tp -78.5 -52.51 8.41 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.892 0.853 . . . . 73.23 109.502 -178.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 101' ' ' PHE . . . . . 0.435 ' HB3' HD11 ' C' ' 105' ' ' LEU . 96.5 m-85 -86.31 -20.72 27.96 Favored 'General case' 0 C--O 1.214 -0.77 0 CA-C-N 113.952 -1.477 . . . . 75.04 111.347 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -49.26 -50.81 27.96 Favored Glycine 0 CA--C 1.549 2.217 0 CA-C-O 118.558 -1.135 . . . . 74.41 115.754 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -49.34 -25.33 9.89 Favored 'Trans proline' 0 C--N 1.387 2.596 0 C-N-CA 124.139 3.226 . . . . 64.35 115.09 175.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 104' ' ' GLY . . . . . 0.418 ' O ' ' HA2' ' C' ' 82' ' ' GLY . . . -137.72 31.68 2.46 Favored Glycine 0 C--N 1.353 1.485 0 CA-C-O 119.401 -0.666 . . . . 73.42 112.188 174.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 105' ' ' LEU . . . . . 0.435 HD11 ' HB3' ' C' ' 101' ' ' PHE . 13.1 tp . . . . . 0 N--CA 1.476 0.843 0 CA-C-N 118.103 0.951 . . . . 75.43 109.128 179.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 116' ' ' GLY . . . . . 0.459 ' HA3' ' HA ' ' C' ' 171' ' ' PRO . . . . . . . . 0 CA--C 1.486 -1.734 0 N-CA-C 109.768 -1.333 . . . . 54.4 109.768 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -90.5 161.42 15.51 Favored 'General case' 0 C--O 1.264 1.835 0 N-CA-C 108.076 -1.083 . . . . 74.32 108.076 172.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -62.6 155.35 26.3 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 115.031 -0.986 . . . . 75.42 109.416 168.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 119' ' ' LEU . . . . . 0.493 HD11 ' HA ' ' C' ' 174' ' ' LEU . 0.0 OUTLIER -119.64 144.57 47.08 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 108.247 -1.02 . . . . 75.21 108.247 171.562 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.414 ' HA ' ' O ' ' C' ' 175' ' ' LEU . 19.6 ttt180 -138.9 106.77 5.66 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 109.612 -0.514 . . . . 72.31 109.612 -162.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 121' ' ' ALA . . . . . 0.566 ' HB3' ' HA ' ' B' ' 185' ' ' VAL . . . -134.83 127.67 31.24 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 115.492 -0.776 . . . . 75.44 109.835 -172.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 122' ' ' GLU . . . . . 0.448 ' HA ' ' O ' ' C' ' 177' ' ' VAL . 13.2 pt-20 -85.54 141.16 30.07 Favored 'General case' 0 C--O 1.244 0.77 0 N-CA-C 110.13 -0.322 . . . . 74.12 110.13 176.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -142.71 144.28 29.31 Favored Pre-proline 0 N--CA 1.481 1.102 0 CA-C-N 116.182 -0.463 . . . . 73.3 110.937 -170.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -75.44 121.69 6.56 Favored 'Trans proline' 0 C--N 1.368 1.603 0 C-N-CA 123.147 2.565 . . . . 72.51 111.278 173.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 125' ' ' LEU . . . . . 0.423 ' HB3' HG21 ' C' ' 178' ' ' VAL . 55.7 tp -137.37 147.11 45.25 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.279 0.631 . . . . 75.32 110.058 -177.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.73 155.21 18.44 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 123.449 0.7 . . . . 61.53 110.308 -178.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 127' ' ' LEU . . . . . 0.477 HD21 HD13 ' C' ' 180' ' ' LEU . 96.2 mt -66.3 -44.74 82.62 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.373 1.069 . . . . 62.25 111.234 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 18.4 mp0 -65.09 -33.33 75.77 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.729 1.212 . . . . 75.24 109.733 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 53.3 mm-40 -77.83 -25.38 48.75 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.712 0.805 . . . . 75.51 112.116 177.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -74.3 -32.75 62.99 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 109.142 -0.688 . . . . 73.14 109.142 173.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 131' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -67.46 -44.89 77.51 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.407 1.083 . . . . 75.55 111.088 173.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 132' ' ' HIS . . . . . . . . . . . . . 54.2 m170 -70.72 -49.46 46.7 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 116.261 -0.427 . . . . 70.15 110.685 -176.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 68.39 -90.65 0.23 Allowed Glycine 0 C--N 1.345 1.069 0 N-CA-C 110.664 -0.974 . . . . 65.31 110.664 -170.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.28 161.83 5.7 Favored Glycine 0 C--N 1.353 1.509 0 O-C-N 123.876 0.398 . . . . 73.12 114.008 174.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -71.44 94.69 1.28 Allowed 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 109.105 -0.702 . . . . 73.03 109.105 174.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 136' ' ' ARG . . . . . 0.637 ' HB3' ' HB2' ' B' ' 181' ' ' LEU . 2.7 mpt_? -105.15 158.77 16.35 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.669 1.187 . . . . 72.12 109.051 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 137' ' ' VAL . . . . . 0.401 HG21 ' HB1' ' B' ' 180' ' ' ALA . 23.0 m -104.62 127.77 58.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 109.798 -0.445 . . . . 73.11 109.798 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 138' ' ' VAL . . . . . 0.719 ' HB ' HD21 ' B' ' 181' ' ' LEU . 6.1 p -113.12 114.61 47.44 Favored 'Isoleucine or valine' 0 C--O 1.248 0.986 0 C-N-CA 123.531 0.733 . . . . 72.14 110.052 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 139' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -120.68 93.15 3.94 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 124.829 1.252 . . . . 74.31 108.067 178.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 140' ' ' VAL . . . . . . . . . . . . . 12.7 p -147.61 149.04 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 108.877 -0.786 . . . . 73.25 108.877 -177.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 141' ' ' ALA . . . . . 0.404 ' HB2' ' NE2' ' C' ' 167' ' ' GLN . . . 65.2 19.47 11.74 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 124.75 1.22 . . . . 65.0 112.1 177.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 84.39 -4.03 84.92 Favored Glycine 0 C--N 1.344 0.991 0 CA-C-N 115.675 -0.693 . . . . 52.4 113.553 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 143' ' ' ARG . . . . . 0.528 ' NH2' ' HB3' ' C' ' 164' ' ' MET . 0.0 OUTLIER -111.41 124.37 52.12 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.41 0.684 . . . . 75.05 109.658 -176.722 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 12.9 ttt180 -114.3 121.61 44.18 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.656 1.182 . . . . 71.51 110.859 -171.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 145' ' ' VAL . . . . . 0.545 HG23 ' SD ' ' C' ' 164' ' ' MET . 21.9 m -143.25 177.1 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 C-N-CA 123.922 0.889 . . . . 75.03 110.581 172.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 23.0 t -119.36 129.79 55.01 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.761 0.825 . . . . 73.22 108.78 171.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 11.4 p -149.01 154.47 9.6 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 C-N-CA 123.489 0.716 . . . . 72.53 111.003 -178.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 22.0 ttm180 -96.06 116.19 28.58 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 108.082 -1.081 . . . . 74.22 108.082 164.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 149' ' ' ILE . . . . . 0.453 HD12 HD13 ' B' ' 181' ' ' LEU . 31.9 pt -73.22 147.41 87.86 Favored Pre-proline 0 CA--C 1.551 1.001 0 CA-C-O 118.597 -0.716 . . . . 74.42 109.302 172.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -43.07 115.07 0.51 Allowed 'Trans proline' 0 C--N 1.385 2.45 0 C-N-CA 123.698 2.932 . . . . 61.44 113.594 178.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -62.18 95.96 0.15 Allowed 'Trans proline' 0 C--N 1.386 2.533 0 C-N-CA 123.046 2.497 . . . . 73.2 111.636 178.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 152' ' ' GLY . . . . . . . . . . . . . . . 131.28 108.23 1.19 Allowed Glycine 0 C--N 1.343 0.943 0 CA-C-N 114.98 -1.009 . . . . 63.11 112.44 -174.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 153' ' ' VAL . . . . . 0.559 HG23 HG23 ' C' ' 178' ' ' VAL . 1.8 m -131.1 163.53 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 CA-C-N 117.121 0.46 . . . . 74.01 111.067 -179.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 154' ' ' ARG . . . . . . . . . . . . . 29.6 mtt85 -118.49 144.27 46.14 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.823 0.849 . . . . 75.32 109.443 -178.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 155' ' ' GLU . . . . . 0.476 ' HB2' HD11 ' C' ' 180' ' ' LEU . 4.6 tp10 -56.22 128.32 35.09 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.267 0.627 . . . . 74.51 111.974 173.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 68.29 14.66 66.79 Favored Glycine 0 C--N 1.344 1.024 0 O-C-N 123.882 0.739 . . . . 75.21 113.68 176.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 157' ' ' SER . . . . . . . . . . . . . 34.0 t -104.05 164.53 11.64 Favored 'General case' 0 C--N 1.349 0.566 0 C-N-CA 123.201 0.6 . . . . 75.43 109.534 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 158' ' ' VAL . . . . . 0.401 ' HA ' ' HA ' ' C' ' 177' ' ' VAL . 8.8 p -112.48 108.01 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.136 0 CA-C-O 121.738 0.78 . . . . 72.31 111.007 -170.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 159' ' ' ILE . . . . . . . . . . . . . 14.6 mt -71.38 117.2 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.588 1.155 . . . . 72.31 108.91 172.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 48.1 ttt-85 -95.44 119.73 34.45 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 118.532 0.605 . . . . 75.13 109.676 171.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 161' ' ' VAL . . . . . 0.609 ' HB ' ' HB3' ' C' ' 174' ' ' LEU . 92.9 t -99.0 99.02 7.1 Favored Pre-proline 0 C--O 1.246 0.892 0 N-CA-C 107.9 -1.148 . . . . 75.24 107.9 171.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -80.83 153.19 19.58 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.638 2.225 . . . . 75.23 112.002 -178.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 89.92 28.7 17.52 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-O 119.42 -0.656 . . . . 53.54 113.647 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 164' ' ' MET . . . . . 0.545 ' SD ' HG23 ' C' ' 145' ' ' VAL . 20.7 mtm -130.67 -88.14 0.49 Allowed 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 117.888 0.844 . . . . 73.35 111.717 178.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 165' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' C' ' 172' ' ' GLY . . . 131.91 147.93 6.02 Favored Glycine 0 N--CA 1.482 1.737 0 CA-C-N 118.686 0.676 . . . . 73.32 114.501 -172.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . -108.16 -105.95 3.04 Favored Glycine 0 C--N 1.371 2.494 0 N-CA-C 112.279 -0.328 . . . . 75.44 112.279 172.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 167' ' ' GLN . . . . . 0.404 ' NE2' ' HB2' ' C' ' 141' ' ' ALA . 22.7 mm-40 -105.38 107.0 17.76 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.515 0.726 . . . . 74.2 111.642 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . 129.9 159.54 9.81 Favored Glycine 0 C--N 1.357 1.702 0 CA-C-N 117.762 0.256 . . . . 13.44 113.108 171.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 169' ' ' ASN . . . . . 0.438 ' HB2' ' HD3' ' C' ' 170' ' ' PRO . 1.3 m-20 -61.72 -63.18 4.57 Favored Pre-proline 0 CA--C 1.572 1.795 0 C-N-CA 125.008 1.323 . . . . 62.44 114.01 -168.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 170' ' ' PRO . . . . . 0.438 ' HD3' ' HB2' ' C' ' 169' ' ' ASN . 73.2 Cg_endo -79.03 98.7 1.2 Allowed 'Trans proline' 0 C--N 1.406 3.569 0 CA-C-N 122.309 1.86 . . . . 73.55 110.335 173.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 171' ' ' PRO . . . . . 0.493 ' HG3' ' HB3' ' C' ' 85' ' ' PHE . 10.2 Cg_exo -69.74 142.47 48.13 Favored 'Trans proline' 0 C--N 1.369 1.658 0 C-N-CA 123.704 2.936 . . . . 74.02 116.557 -159.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 172' ' ' GLY . . . . . 0.405 ' O ' ' HA2' ' C' ' 165' ' ' GLY . . . -109.01 141.51 15.95 Favored Glycine 0 C--O 1.213 -1.208 0 N-CA-C 106.549 -2.62 . . . . 74.42 106.549 163.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 173' ' ' ASP . . . . . 0.43 ' HB3' ' O ' ' C' ' 161' ' ' VAL . 64.8 m-20 -81.12 -161.51 0.41 Allowed 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 115.349 1.611 . . . . 74.51 115.349 -159.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 174' ' ' LEU . . . . . 0.609 ' HB3' ' HB ' ' C' ' 161' ' ' VAL . 40.7 tp -94.34 141.95 27.98 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 121.504 -0.747 . . . . 75.22 110.896 -176.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 175' ' ' LEU . . . . . 0.414 ' O ' ' HA ' ' C' ' 120' ' ' ARG . 76.2 mt -130.06 84.78 2.23 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.416 1.486 . . . . 72.15 109.435 176.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 176' ' ' LEU . . . . . . . . . . . . . 69.5 mt -80.2 107.45 13.0 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.424 0.69 . . . . 74.33 109.644 175.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 177' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' C' ' 122' ' ' GLU . 58.2 t -83.06 95.48 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 107.553 -1.277 . . . . 75.23 107.553 175.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 178' ' ' VAL . . . . . 0.559 HG23 HG23 ' C' ' 153' ' ' VAL . 3.0 p -71.25 122.65 23.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.875 0.845 . . . . 74.01 111.334 -174.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 179' ' ' ARG . . . . . . . . . . . . . 17.1 mmm-85 -105.62 111.74 24.55 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 107.277 -1.379 . . . . 74.42 107.277 169.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 180' ' ' LEU . . . . . 0.477 HD13 HD21 ' C' ' 127' ' ' LEU . 97.3 mt -72.12 136.85 46.67 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.35 0.595 . . . . 73.43 111.101 -177.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 181' ' ' LEU . . . . . . . . . . . . . 60.3 mt -62.98 167.14 6.51 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 126.016 1.726 . . . . 74.24 113.857 -173.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -52.04 71.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.396 3.068 0 C-N-CA 124.208 3.272 . . . . 73.32 113.165 167.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 183' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -178.15 49.0 0.05 OUTLIER Pre-proline 0 CA--C 1.549 0.933 0 N-CA-C 105.153 -2.165 . . . . 72.0 105.153 -171.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 184' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -90.2 65.29 1.88 Allowed 'Trans proline' 0 C--N 1.387 2.586 0 C-N-CA 123.229 2.619 . . . . 74.25 111.655 -163.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 185' ' ' VAL . . . . . 0.558 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 21.2 t -95.73 -59.68 3.02 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.443 0 N-CA-C 108.223 -1.029 . . . . 72.23 108.223 -174.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 186' ' ' PHE . . . . . 0.46 ' HD2' HD11 ' C' ' 127' ' ' LEU . 53.8 m-85 -100.11 125.32 46.2 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.725 0.81 . . . . 61.44 110.787 -168.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.23 109.35 12.21 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 107.256 -1.387 . . . . 75.14 107.256 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 188' ' ' LEU . . . . . 0.444 HD13 ' HD2' ' C' ' 240' ' ' PHE . 52.3 tp -77.48 154.13 32.83 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.617 0.969 . . . . 74.14 113.617 -169.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -142.25 103.47 4.29 Favored 'General case' 0 C--O 1.248 1.01 0 N-CA-C 107.06 -1.459 . . . . 73.21 107.06 158.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 75.13 -88.39 0.79 Allowed Glycine 0 C--N 1.349 1.253 0 CA-C-N 115.471 -0.786 . . . . 74.2 112.526 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 191' ' ' GLN . . . . . 0.481 ' HB3' ' HA3' ' C' ' 247' ' ' GLY . 48.3 mt-30 -123.83 -23.05 4.75 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.659 1.184 . . . . 75.25 110.303 176.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -93.23 127.26 38.74 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 123.756 0.822 . . . . 65.13 110.79 -171.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 193' ' ' LEU . . . . . . . . . . . . . 84.3 mt -86.64 165.72 15.92 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.849 0.86 . . . . 65.15 111.316 -177.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 194' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -126.96 103.69 7.61 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.56 -1.274 . . . . 75.43 107.56 165.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 195' ' ' ALA . . . . . 0.558 ' HA ' ' O ' ' C' ' 185' ' ' VAL . . . -98.41 -177.08 3.58 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 124.024 0.93 . . . . 65.11 109.843 172.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 88.6 m -132.41 106.67 8.02 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 107.9 -1.148 . . . . 53.42 107.9 168.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 197' ' ' LEU . . . . . . . . . . . . . 43.3 tp -78.12 122.22 25.34 Favored 'General case' 0 C--N 1.35 0.596 0 N-CA-C 109.327 -0.62 . . . . 73.5 109.327 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -96.18 100.44 12.08 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 108.396 -0.965 . . . . 64.33 108.396 -177.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 199' ' ' VAL . . . . . . . . . . . . . 25.6 t -108.25 124.58 34.18 Favored Pre-proline 0 N--CA 1.481 1.11 0 C-N-CA 123.285 0.634 . . . . 73.12 109.649 -176.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 200' ' ' PRO . . . . . 0.494 ' HG2' HD11 ' C' ' 203' ' ' ILE . 4.5 Cg_exo -63.31 145.92 93.26 Favored 'Trans proline' 0 C--N 1.37 1.673 0 C-N-CA 121.961 1.774 . . . . 73.11 110.834 170.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 201' ' ' ALA . . . . . 0.453 ' HB3' ' HH2' ' C' ' 269' ' ' TRP . . . -53.37 -47.4 96.33 Favored Pre-proline 0 CA--C 1.558 1.262 0 N-CA-C 113.834 1.05 . . . . 74.35 113.834 -179.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 202' ' ' PRO . . . . . 0.414 ' HB2' ' HA ' ' A' ' 273' ' ' ALA . 44.3 Cg_endo -63.77 -41.88 22.44 Favored 'Trans proline' 0 C--N 1.384 2.444 0 C-N-CA 121.509 1.473 . . . . 63.15 112.523 -179.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 203' ' ' ILE . . . . . 0.494 HD11 ' HG2' ' C' ' 200' ' ' PRO . 39.5 mt -65.73 -36.04 76.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.009 0.524 . . . . 74.02 110.324 179.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 204' ' ' ALA . . . . . 0.46 ' HA ' HG13 ' C' ' 223' ' ' VAL . . . -62.05 -43.01 99.75 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.33 0.652 . . . . 75.02 110.897 176.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 205' ' ' VAL . . . . . . . . . . . . . 70.0 t -67.97 -45.35 83.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.659 0.784 . . . . 74.52 112.529 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 206' ' ' VAL . . . . . 0.609 ' HA ' ' HE3' ' A' ' 270' ' ' LYS . 14.8 p -78.9 -31.15 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 CA-C-O 121.021 0.438 . . . . 74.12 110.98 -176.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 82.12 52.06 4.2 Favored Glycine 0 C--N 1.336 0.546 0 CA-C-N 115.345 -0.843 . . . . 63.21 111.701 -172.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -84.22 -135.83 3.08 Favored Glycine 0 C--N 1.346 1.099 0 N-CA-C 111.868 -0.493 . . . . 51.32 111.868 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 209' ' ' LYS . . . . . 0.527 ' HG2' ' HA ' ' C' ' 222' ' ' ALA . 9.7 mtmp? -137.01 139.84 41.69 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 117.509 0.654 . . . . 72.44 111.397 175.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 210' ' ' VAL . . . . . 0.465 HG13 HG21 ' C' ' 203' ' ' ILE . 22.3 m -128.33 135.59 62.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.399 1.08 . . . . 71.52 109.216 175.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 211' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -84.62 112.51 20.51 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 120.852 0.358 . . . . 75.53 110.833 -176.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -81.69 114.58 20.46 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.07 0.948 . . . . 74.43 108.607 170.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 213' ' ' MET . . . . . . . . . . . . . 4.1 tmm? -74.87 116.08 15.19 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 107.311 -1.366 . . . . 63.12 107.311 178.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.96 174.4 6.11 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.286 0.565 . . . . 72.34 110.478 -174.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 215' ' ' LEU . . . . . . . . . . . . . 27.1 mt -64.47 -29.89 70.93 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.107 1.363 . . . . 75.24 112.067 -177.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -91.65 1.4 57.18 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 114.78 -1.1 . . . . 71.0 110.826 -177.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 110.77 -170.06 13.72 Favored Glycine 0 C--N 1.341 0.843 0 N-CA-C 110.693 -0.963 . . . . 74.41 110.693 -169.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -80.5 119.12 3.67 Favored 'Trans proline' 0 CA--C 1.554 1.524 0 C-N-CA 122.566 2.178 . . . . 64.03 113.506 -173.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 219' ' ' VAL . . . . . . . . . . . . . 14.8 p -97.82 148.05 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 N-CA-C 107.728 -1.212 . . . . 52.53 107.728 165.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 220' ' ' GLU . . . . . 0.483 ' HG2' ' HB3' ' C' ' 209' ' ' LYS . 13.3 tt0 -96.93 155.94 16.56 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 108.574 -0.899 . . . . 72.32 108.574 175.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 221' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' C' ' 209' ' ' LYS . 41.9 t -122.5 116.88 50.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 124.094 0.958 . . . . 74.03 110.154 -178.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 222' ' ' ALA . . . . . 0.527 ' HA ' ' HG2' ' C' ' 209' ' ' LYS . . . -78.74 102.64 8.2 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 108.965 -0.754 . . . . 73.3 108.965 171.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 223' ' ' VAL . . . . . 0.46 HG13 ' HA ' ' C' ' 204' ' ' ALA . 58.2 t -76.43 142.81 71.57 Favored Pre-proline 0 CA--C 1.566 1.574 0 C-N-CA 124.643 1.177 . . . . 73.11 110.372 -177.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 224' ' ' PRO . . . . . 0.606 ' HB3' ' HA ' ' B' ' 245' ' ' LYS . 71.7 Cg_endo -78.69 154.49 26.93 Favored 'Trans proline' 0 C--N 1.38 2.186 0 C-N-CA 122.957 2.438 . . . . 73.11 113.073 168.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -58.89 119.59 6.94 Favored 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 123.496 2.797 . . . . 74.4 112.674 175.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 226' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.0 82.92 0.13 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.275 1.43 . . . . 71.5 110.795 -175.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 227' ' ' THR . . . . . . . . . . . . . 97.8 m -93.31 133.08 36.92 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 114.295 -1.32 . . . . 73.3 109.482 174.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 228' ' ' GLN . . . . . 0.484 HE21 HD13 ' A' ' 257' ' ' ILE . 1.6 mp0 -100.09 147.75 25.32 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 121.24 0.543 . . . . 74.32 110.65 176.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -67.83 140.44 56.59 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 114.967 -1.015 . . . . 65.31 109.521 173.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 105.83 -18.37 40.45 Favored Glycine 0 C--N 1.333 0.37 0 N-CA-C 111.471 -0.652 . . . . 62.04 111.471 -171.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 231' ' ' ARG . . . . . . . . . . . . . 36.1 mtt85 -62.69 168.35 3.84 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 117.105 0.452 . . . . 75.03 111.697 169.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 232' ' ' LYS . . . . . 0.66 ' HD3' ' HB3' ' C' ' 250' ' ' TYR . 3.9 ttmp? -150.18 131.76 14.86 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.33 0.586 . . . . 74.05 111.117 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 233' ' ' LEU . . . . . 0.588 ' O ' ' HA ' ' C' ' 250' ' ' TYR . 4.7 mp -88.03 158.44 18.61 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.65 1.18 . . . . 74.22 110.214 178.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 234' ' ' ARG . . . . . 0.499 ' NH2' ' HA ' ' B' ' 243' ' ' GLN . 3.1 ptt85 -128.17 87.89 2.67 Favored 'General case' 0 CA--C 1.55 0.96 0 O-C-N 125.171 1.544 . . . . 72.34 108.19 164.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 54.4 mt -77.29 120.46 22.36 Favored 'General case' 0 C--N 1.361 1.071 0 CA-C-N 115.468 -0.787 . . . . 74.34 109.008 174.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -80.94 127.28 32.39 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.686 0.795 . . . . 73.41 111.48 -172.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 72.95 36.17 57.49 Favored Glycine 0 C--N 1.347 1.154 0 O-C-N 123.853 0.721 . . . . 71.42 113.028 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 24.0 mmtm -129.01 21.52 5.8 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.561 0.745 . . . . 75.11 110.987 176.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -92.78 -164.08 37.74 Favored Glycine 0 C--N 1.353 1.505 0 O-C-N 123.559 0.537 . . . . 75.2 112.975 175.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 240' ' ' PHE . . . . . 0.444 ' HD2' HD13 ' C' ' 188' ' ' LEU . 2.5 m-85 -80.89 157.58 71.43 Favored Pre-proline 0 CA--C 1.557 1.244 0 CA-C-O 119.352 -0.356 . . . . 75.14 110.065 177.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 241' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -59.26 114.52 2.06 Favored 'Trans proline' 0 C--N 1.387 2.565 0 C-N-CA 123.415 2.744 . . . . 71.53 112.786 -177.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 242' ' ' GLY . . . . . 0.433 ' HA3' ' NE2' ' C' ' 191' ' ' GLN . . . -99.53 168.3 21.65 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-N 115.217 -0.901 . . . . 70.14 112.812 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -67.46 -23.0 44.32 Favored 'Trans proline' 0 C--N 1.374 1.89 0 C-N-CA 123.116 2.544 . . . . 71.42 112.302 176.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -95.33 -4.18 45.93 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.837 0.855 . . . . 71.42 111.3 177.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 141.55 -85.55 0.2 Allowed Glycine 0 C--N 1.349 1.274 0 N-CA-C 111.311 -0.716 . . . . 63.24 111.311 -178.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 246' ' ' ARG . . . . . . . . . . . . . 85.6 mtm180 -138.61 175.26 9.71 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.657 1.183 . . . . 71.32 110.119 178.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 247' ' ' GLY . . . . . 0.481 ' HA3' ' HB3' ' C' ' 191' ' ' GLN . . . -104.08 -158.46 24.25 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 115.201 -0.909 . . . . 63.23 111.926 165.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -118.79 174.66 6.15 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.295 0.638 . . . . 73.54 109.492 -178.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 249' ' ' LEU . . . . . 0.459 ' HG ' HD11 ' C' ' 251' ' ' LEU . 20.6 tp -126.93 118.03 23.71 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.576 0.751 . . . . 74.23 110.841 -173.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 250' ' ' TYR . . . . . 0.66 ' HB3' ' HD3' ' C' ' 232' ' ' LYS . 22.3 m-30 -100.89 106.47 17.83 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.47 0.708 . . . . 71.43 110.715 178.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 251' ' ' LEU . . . . . 0.583 ' HB2' HD11 ' C' ' 233' ' ' LEU . 2.9 mp -105.3 124.32 49.34 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-N 118.836 0.744 . . . . 72.0 111.2 -174.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -76.7 120.2 21.55 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 109.068 -0.716 . . . . 75.41 109.068 174.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 253' ' ' VAL . . . . . . . . . . . . . 72.1 t -77.16 128.16 38.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 C-N-CA 123.235 0.614 . . . . 73.5 111.289 -176.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 254' ' ' ARG . . . . . . . . . . . . . 28.2 mtm180 -107.04 137.22 45.52 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.391 -0.966 . . . . 75.13 108.391 164.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 255' ' ' ILE . . . . . 0.483 ' O ' ' HB ' ' A' ' 255' ' ' ILE . 30.2 mm -98.64 109.61 24.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 105.843 -1.91 . . . . 75.24 105.843 165.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 256' ' ' THR . . . . . . . . . . . . . 7.5 t -131.15 176.87 7.9 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 124.09 0.956 . . . . 70.25 109.793 -170.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 49.6 pt -126.81 155.65 75.01 Favored Pre-proline 0 CA--C 1.557 1.226 0 C-N-CA 123.356 0.662 . . . . 75.21 110.254 -177.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 258' ' ' PRO . . . . . 0.516 ' HG3' ' HE2' ' A' ' 276' ' ' TYR . 49.6 Cg_endo -80.86 41.4 1.14 Allowed 'Trans proline' 0 C--N 1.377 2.051 0 C-N-CA 123.625 2.883 . . . . 74.41 113.945 -175.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 60.51 -93.63 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.882 1.273 . . . . 72.3 110.015 -171.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 260' ' ' ARG . . . . . 0.734 ' HA ' HH11 ' A' ' 226' ' ' ARG . 0.0 OUTLIER -115.03 164.1 14.66 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.514 1.126 . . . . 73.41 110.197 -178.16 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 261' ' ' LEU . . . . . . . . . . . . . 45.6 mt -126.96 173.15 9.85 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.023 0.929 . . . . 74.53 111.398 -171.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 73.4 p -84.27 148.6 53.32 Favored Pre-proline 0 CA--C 1.552 1.051 0 CA-C-N 114.942 -1.026 . . . . 61.23 108.801 168.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -43.34 -36.78 6.75 Favored 'Trans proline' 0 C--N 1.382 2.324 0 C-N-CA 124.478 3.452 . . . . 74.2 115.114 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -64.23 -60.94 2.6 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.251 0.62 . . . . 71.04 110.905 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -53.32 -51.1 63.44 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.448 -0.796 . . . . 71.03 109.874 178.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 266' ' ' GLU . . . . . 0.45 ' HG3' ' HZ1' ' C' ' 270' ' ' LYS . 22.1 tp10 -55.99 -36.17 67.6 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 114.547 -1.206 . . . . 73.1 111.706 -178.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -63.76 -48.89 75.13 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.2 0.6 . . . . 71.12 111.259 176.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 268' ' ' LEU . . . . . 0.607 ' HB2' HD23 ' A' ' 272' ' ' LEU . 8.0 mp -63.94 -38.17 90.09 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 123.033 0.208 . . . . 70.11 111.379 178.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 269' ' ' TRP . . . . . 0.453 ' HH2' ' HB3' ' C' ' 201' ' ' ALA . 77.1 m95 -64.78 -33.36 75.79 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.054 0.542 . . . . 63.11 111.017 175.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 270' ' ' LYS . . . . . 0.45 ' HZ1' ' HG3' ' C' ' 266' ' ' GLU . 52.5 mttp -70.87 -31.78 68.56 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.109 0.564 . . . . 75.43 111.74 175.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -69.76 -38.79 76.88 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 120.567 0.223 . . . . 75.33 110.903 175.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 92.9 mt -60.63 -44.91 95.81 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 115.723 -0.671 . . . . 74.33 109.581 170.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -62.12 -41.69 98.48 Favored 'General case' 0 C--O 1.216 -0.709 0 CA-C-N 115.42 -0.809 . . . . 43.22 111.401 -178.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -69.54 -33.71 73.19 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.386 0.675 . . . . 63.21 111.021 178.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -60.55 -33.77 73.16 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 121.243 0.544 . . . . 70.04 110.398 171.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 276' ' ' TYR . . . . . 0.697 ' HA ' ' HD3' ' C' ' 279' ' ' ARG . 16.4 m-85 -80.91 -31.39 35.13 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.251 -0.886 . . . . 75.52 112.839 174.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 18.6 m-30 -73.17 -22.2 60.53 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 118.391 0.541 . . . . 65.52 109.886 178.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -64.94 -23.43 67.22 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.474 0.71 . . . . 72.22 111.109 171.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 279' ' ' ARG . . . . . 0.697 ' HD3' ' HA ' ' C' ' 276' ' ' TYR . 17.2 mtp-105 -78.63 -21.37 48.51 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.498 0.719 . . . . 75.11 110.515 174.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.137 0 C-N-CA 123.507 0.723 . . . . 75.14 109.231 -178.857 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.8 ttpp . . . . . 0 N--CA 1.486 1.328 0 N-CA-C 114.103 1.149 . . . . 64.14 114.103 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -77.57 131.18 37.71 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.205 1.002 . . . . 74.32 110.427 177.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -83.76 86.84 7.08 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 107.022 -1.474 . . . . 62.43 107.022 166.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.472 ' CD1' ' HA ' ' A' ' 53' ' ' ALA . 66.6 m-85 -61.2 -31.11 70.87 Favored 'General case' 0 C--O 1.249 1.063 0 CA-C-N 115.094 -0.957 . . . . 73.34 112.144 -174.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -57.37 -55.38 35.51 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.241 0.617 . . . . 73.33 109.494 172.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.73 -33.66 74.43 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.816 0.847 . . . . 70.01 111.764 -177.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 78.1 mt -62.89 -40.14 87.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.287 0.635 . . . . 74.23 110.477 175.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 93.3 mt -80.03 -2.81 45.82 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 112.49 0.552 . . . . 73.11 112.49 173.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.26 18.03 72.63 Favored Glycine 0 C--N 1.351 1.394 0 O-C-N 123.3 0.375 . . . . 73.42 113.67 177.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.591 HG22 HG12 ' A' ' 22' ' ' ILE . 22.8 m -111.55 142.06 25.79 Favored Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 123.209 0.604 . . . . 72.52 110.185 177.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -82.94 169.78 12.89 Favored 'Trans proline' 0 C--N 1.366 1.453 0 C-N-CA 122.255 1.97 . . . . 50.12 112.048 174.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.6 mmt85 -67.92 80.43 0.21 Allowed 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 114.969 -1.014 . . . . 75.43 110.422 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -174.96 -32.75 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.166 1.387 . . . . 71.2 108.399 -177.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.28 122.07 17.08 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.831 -0.622 . . . . 74.14 110.56 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 72.8 p -76.58 175.13 9.57 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.14 0.976 . . . . 75.03 110.236 178.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -50.41 -38.63 43.99 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 124.424 1.09 . . . . 71.11 112.484 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.443 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 1.8 tm-20 -74.05 -41.76 61.26 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.397 1.079 . . . . 72.43 110.265 -175.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -67.86 -37.51 81.92 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 123.871 0.869 . . . . 71.14 110.623 177.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.67 HD12 HD13 ' A' ' 57' ' ' LEU . 45.0 mt -68.06 -33.06 58.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 C-N-CA 125.342 1.457 . . . . 73.31 110.612 175.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.2 ttmm -69.76 -38.99 76.98 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.733 0.813 . . . . 75.22 109.63 177.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.443 ' HG3' ' O ' ' A' ' 20' ' ' GLU . 48.9 mtt180 -61.36 -45.67 93.41 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 123.582 0.551 . . . . 73.12 109.97 174.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.72 -46.02 84.98 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 124.262 0.976 . . . . 72.43 111.302 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -60.6 -49.81 76.02 Favored 'General case' 0 C--N 1.348 0.534 0 O-C-N 123.693 0.621 . . . . 73.1 111.02 177.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -61.43 -35.95 78.99 Favored 'General case' 0 N--CA 1.484 1.229 0 O-C-N 124.078 0.861 . . . . 74.22 111.601 -178.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.8 ttt180 -58.52 -51.11 71.27 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.642 1.177 . . . . 75.52 110.355 174.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.678 ' HB3' HD11 ' A' ' 50' ' ' ILE . 54.2 mt -73.94 -21.07 60.17 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 114.843 -1.071 . . . . 75.12 110.708 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -88.4 -9.57 52.17 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.361 1.064 . . . . 71.54 111.392 179.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 48.4 mtm105 -93.5 -46.68 7.2 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.08 0.552 . . . . 72.33 109.967 166.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -69.75 -60.12 2.51 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.451 0.7 . . . . 73.31 111.423 -174.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.423 ' HE2' HD22 ' A' ' 29' ' ' LEU . 26.4 m-85 -92.97 19.52 7.68 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.371 0.668 . . . . 72.41 111.541 -174.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 -57.52 102.91 0.33 Allowed Pre-proline 0 N--CA 1.48 1.025 0 C-N-CA 125.147 1.379 . . . . 73.54 111.323 -172.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -62.17 -25.08 76.81 Favored 'Trans proline' 0 C--N 1.375 1.935 0 C-N-CA 123.164 2.576 . . . . 75.51 113.367 -177.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -59.66 -31.11 69.25 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.446 0.698 . . . . 73.23 111.416 175.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.9 t -102.2 -63.18 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 N-CA-C 109.254 -0.647 . . . . 73.25 109.254 176.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -97.95 86.07 3.65 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.397 1.079 . . . . 64.12 109.869 -174.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -77.13 71.46 3.63 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 115.382 -0.826 . . . . 73.11 109.707 174.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 43.7 m -118.19 117.57 34.9 Favored Pre-proline 0 N--CA 1.471 0.606 0 N-CA-C 108.287 -1.005 . . . . 71.24 108.287 178.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -41.22 -50.47 4.37 Favored 'Trans proline' 0 C--N 1.388 2.637 0 C-N-CA 124.291 3.327 . . . . 73.53 113.955 -171.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -53.98 -48.51 70.29 Favored 'General case' 0 CA--C 1.549 0.922 0 O-C-N 124.583 1.177 . . . . 64.43 111.323 -179.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.3 -28.74 67.44 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.384 -0.826 . . . . 73.42 111.237 -178.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.441 ' O ' ' HD3' ' A' ' 48' ' ' LYS . 49.2 mt-10 -84.84 -36.74 21.39 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.334 0.654 . . . . 63.35 110.321 -172.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -70.29 -42.68 71.73 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.842 0.857 . . . . 62.44 109.336 177.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -57.73 -41.48 81.91 Favored 'General case' 0 C--N 1.35 0.593 0 CA-C-N 114.857 -1.065 . . . . 74.03 109.689 169.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.415 ' HA ' HD12 ' A' ' 50' ' ' ILE . 35.1 t80 -70.47 -23.2 62.65 Favored 'General case' 0 CA--C 1.547 0.845 0 O-C-N 123.468 0.48 . . . . 73.32 111.836 179.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.441 ' HD3' ' O ' ' A' ' 44' ' ' GLU . 1.9 mptm? -68.98 -41.22 78.16 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 109.702 -0.481 . . . . 75.14 109.702 171.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -65.25 -37.37 87.01 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 123.629 0.58 . . . . 71.44 110.537 176.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.678 HD11 ' HB3' ' A' ' 29' ' ' LEU . 79.9 mt -69.14 -39.43 79.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.783 1.233 . . . . 74.43 110.565 177.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -67.95 -36.14 79.61 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.606 -0.724 . . . . 73.43 110.396 175.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.427 ' O ' HG23 ' A' ' 56' ' ' VAL . 32.4 tt0 -63.78 -53.39 51.57 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.551 1.141 . . . . 75.34 110.138 179.142 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.472 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . . . -60.41 -44.15 96.02 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 113.372 -1.74 . . . . 65.45 112.063 -177.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -82.54 -18.28 42.02 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 115.994 -0.548 . . . . 73.53 111.629 177.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.427 ' HB1' ' CD2' ' A' ' 85' ' ' PHE . . . -61.55 -36.62 81.1 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.8 0.809 . . . . 72.52 109.663 172.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.469 HG21 ' HE1' ' A' ' 101' ' ' PHE . 38.0 t -69.77 -61.73 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 CA-C-N 113.439 -1.709 . . . . 74.52 110.433 170.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.67 HD13 HD12 ' A' ' 22' ' ' ILE . 52.8 mt -86.45 12.78 9.52 Favored 'General case' 0 CA--C 1.559 1.322 0 CA-C-N 114.864 -1.062 . . . . 74.35 113.166 -165.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.6 t -67.88 -56.24 9.86 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.774 0.83 . . . . 74.34 110.664 174.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -95.04 148.05 34.04 Favored Pre-proline 0 N--CA 1.47 0.547 0 CA-C-N 115.095 -0.957 . . . . 74.34 110.286 -177.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.75 -41.15 57.65 Favored 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 123.266 2.644 . . . . 72.41 111.207 169.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -60.57 -54.69 42.35 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 123.97 0.908 . . . . 72.3 111.527 -178.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.435 ' HA ' HD11 ' A' ' 65' ' ' ILE . 37.6 mtpt -73.39 -32.04 64.24 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.625 0.77 . . . . 74.54 112.386 -174.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.435 HH21 HD13 ' A' ' 22' ' ' ILE . 7.6 ptm180 -67.31 -38.94 85.78 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.636 -0.505 . . . . 74.11 109.636 175.292 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -65.05 -35.91 82.68 Favored 'General case' 0 C--N 1.362 1.134 0 O-C-N 123.593 0.558 . . . . 74.25 110.904 174.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.435 HD11 ' HA ' ' A' ' 62' ' ' LYS . 83.4 mt -55.58 -47.14 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 C-N-CA 123.366 0.666 . . . . 74.41 110.469 174.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -58.04 -55.61 32.68 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 115.578 -0.737 . . . . 75.4 111.274 170.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -58.75 -31.8 68.67 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.467 0.707 . . . . 64.04 112.135 -173.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 67.8 p -86.98 -18.3 31.02 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.301 0.64 . . . . 75.44 111.338 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -72.47 134.64 45.42 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 106.839 -1.541 . . . . 75.32 106.839 164.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.63 26.77 49.52 Favored Glycine 0 N--CA 1.471 1.0 0 N-CA-C 111.201 -0.76 . . . . 64.23 111.201 -171.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 52.8 m -144.42 -56.45 0.36 Allowed 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 102.587 -3.116 . . . . 71.23 102.587 172.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.5 m -84.2 140.95 31.37 Favored 'General case' 0 C--O 1.25 1.098 0 N-CA-C 104.782 -2.303 . . . . 74.23 104.782 157.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.23 -41.84 63.27 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.08 0.552 . . . . 74.04 110.539 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.78 151.8 53.04 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 123.731 0.812 . . . . 75.1 110.134 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -63.0 133.8 43.11 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.214 1.943 . . . . 75.41 110.58 172.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_exo -47.26 150.44 3.3 Favored 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 124.373 3.382 . . . . 74.25 115.207 -178.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -55.82 113.35 1.39 Allowed 'Trans proline' 0 C--N 1.389 2.662 0 C-N-CA 123.302 2.668 . . . . 73.45 112.46 -178.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -62.58 146.45 95.39 Favored 'Trans proline' 0 C--N 1.382 2.297 0 C-N-CA 123.397 2.731 . . . . 73.2 113.283 -178.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -66.21 150.24 84.98 Favored 'Trans proline' 0 C--N 1.373 1.844 0 C-N-CA 122.819 2.346 . . . . 71.05 111.566 174.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.476 ' HD2' ' HA3' ' A' ' 142' ' ' GLY . 74.1 Cg_endo -72.75 64.89 3.94 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 123.576 2.851 . . . . 74.31 112.124 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -178.51 -31.98 0.05 OUTLIER Glycine 0 CA--C 1.522 0.484 0 CA-C-N 114.502 -1.227 . . . . 62.41 110.047 -170.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.77 -169.03 18.8 Favored Glycine 0 C--N 1.356 1.674 0 C-N-CA 122.993 0.33 . . . . 53.03 113.115 176.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -108.0 111.76 24.0 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.326 1.05 . . . . 74.41 110.165 -178.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -67.76 155.5 39.14 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.76 1.224 . . . . 71.31 110.944 172.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.531 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 64.8 m-85 -144.39 77.64 1.55 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.894 0.878 . . . . 73.24 110.517 -177.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.463 ' HB3' ' HG2' ' A' ' 162' ' ' PRO . 6.0 m -49.42 85.06 0.0 OUTLIER 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 125.446 1.499 . . . . 74.44 113.667 -179.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.33 20.71 79.96 Favored Glycine 0 CA--C 1.535 1.299 0 CA-C-N 116.118 -0.492 . . . . 70.11 113.772 -179.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.531 ' HB2' ' HB3' ' A' ' 85' ' ' PHE . 24.2 m-85 -114.09 106.86 14.89 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 117.41 0.605 . . . . 72.34 109.502 -176.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -83.73 80.52 9.11 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 121.686 0.755 . . . . 71.44 109.907 -177.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.41 HG13 ' OD1' ' A' ' 169' ' ' ASN . 3.4 p -39.94 -32.94 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 C-N-CA 126.635 1.974 . . . . 75.21 114.688 174.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -53.47 -38.55 63.73 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.557 1.143 . . . . 75.33 111.783 -176.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -97.18 0.68 48.74 Favored 'General case' 0 CA--C 1.554 1.126 0 CA-C-N 115.332 -0.849 . . . . 61.35 111.495 -173.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.409 ' CD2' ' HA ' ' A' ' 90' ' ' VAL . 10.3 m-30 -88.68 -178.12 5.72 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.588 0.755 . . . . 73.34 110.555 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 89.6 p -77.47 163.74 26.07 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 113.595 0.961 . . . . 74.5 113.595 -168.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.413 ' O ' ' HG3' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -61.57 -40.34 94.38 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 114.312 -1.313 . . . . 74.52 112.123 175.889 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -63.33 -39.31 94.2 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 110.085 -0.339 . . . . 75.03 110.085 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -62.14 -40.33 95.61 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.529 -0.759 . . . . 72.32 109.654 176.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -81.16 -1.61 45.24 Favored 'General case' 0 CA--C 1.558 1.272 0 CA-C-N 114.801 -1.091 . . . . 74.14 112.288 177.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 95' ' ' GLU . 51.8 mt-10 -96.6 -46.46 6.31 Favored 'General case' 0 N--CA 1.503 2.224 0 C-N-CA 123.278 0.631 . . . . 70.02 111.62 167.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 33.5 tp -65.41 -45.55 83.5 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.678 1.191 . . . . 74.33 110.215 -177.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.469 ' HE1' HG21 ' A' ' 56' ' ' VAL . 97.5 m-85 -95.71 -7.97 35.89 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.544 -0.753 . . . . 72.11 111.033 176.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -45.16 -58.58 4.98 Favored Glycine 0 CA--C 1.541 1.67 0 CA-C-O 118.656 -1.08 . . . . 72.43 115.625 -177.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -62.3 -8.21 12.01 Favored 'Trans proline' 0 C--N 1.386 2.512 0 C-N-CA 123.169 2.58 . . . . 64.43 113.86 -175.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -142.01 33.49 1.93 Allowed Glycine 0 C--N 1.357 1.731 0 CA-C-O 119.551 -0.583 . . . . 54.4 112.771 175.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.5 mt -66.79 20.92 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.305 0 N-CA-C 114.864 1.431 . . . . 74.25 114.864 -178.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.545 ' HB3' ' ND2' ' A' ' 169' ' ' ASN . 0.2 OUTLIER 57.06 -107.26 0.37 Allowed 'General case' 0 CA--C 1.564 1.486 0 C-N-CA 124.182 0.993 . . . . 74.45 110.541 165.123 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 66.22 15.36 63.11 Favored Glycine 0 C--N 1.362 1.975 0 CA-C-N 118.044 0.384 . . . . 44.0 113.414 -176.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.497 ' H ' ' HD1' ' A' ' 106' ' ' PHE . . . . . . . . 0 C--N 1.353 1.5 0 N-CA-C 111.482 -0.647 . . . . 71.34 111.482 -170.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 170' ' ' PRO . 39.2 ttmt . . . . . 0 N--CA 1.476 0.855 0 N-CA-C 112.365 0.506 . . . . 73.31 112.365 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -97.18 -168.21 33.07 Favored Glycine 0 CA--C 1.549 2.196 0 CA-C-N 115.643 -0.708 . . . . 73.4 113.29 179.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -112.95 139.06 48.92 Favored 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 124.374 1.07 . . . . 74.43 109.766 177.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -50.61 113.92 1.02 Allowed 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.962 0.887 . . . . 74.23 112.724 -176.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.422 ' O ' HD13 ' A' ' 174' ' ' LEU . 5.4 tt -105.81 148.65 27.28 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 114.652 -1.158 . . . . 75.42 108.795 -168.041 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.418 ' HD2' ' HB2' ' A' ' 175' ' ' LEU . 14.8 tpt180 -98.21 143.13 29.04 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 108.586 -0.894 . . . . 74.51 108.586 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.559 ' HB1' HD11 ' A' ' 174' ' ' LEU . . . -138.93 166.19 25.12 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 118.768 0.713 . . . . 54.41 111.45 -178.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.507 ' HB2' ' HB2' ' B' ' 9' ' ' ALA . 18.0 mm-40 -116.61 98.4 6.52 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 106.874 -1.528 . . . . 72.42 106.874 179.024 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.481 ' HB2' HD21 ' A' ' 176' ' ' LEU . 11.7 tp -98.25 103.57 18.65 Favored Pre-proline 0 C--O 1.213 -0.86 0 N-CA-C 107.392 -1.336 . . . . 74.14 107.392 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.451 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 55.2 Cg_endo -66.81 151.22 82.83 Favored 'Trans proline' 0 C--N 1.362 1.276 0 C-N-CA 121.253 1.302 . . . . 75.33 108.847 169.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.649 ' HA ' HG23 ' B' ' 6' ' ' ILE . 17.9 tp -150.91 148.2 28.14 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 119.283 0.947 . . . . 72.43 112.016 177.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 33.8 m -76.21 127.05 32.13 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 114.436 -1.256 . . . . 71.34 109.341 175.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.591 ' HB3' HD23 ' A' ' 215' ' ' LEU . 3.5 mm? -44.61 -57.73 3.46 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 125.516 1.526 . . . . 75.21 112.452 -178.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 17.5 mp0 -59.13 -44.56 92.05 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 114.33 -1.304 . . . . 75.32 109.632 -176.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -76.63 -12.28 59.99 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 115.185 -0.916 . . . . 64.33 111.856 -178.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.556 ' HB1' ' O ' ' A' ' 153' ' ' VAL . . . -79.45 -38.5 34.48 Favored 'General case' 0 C--O 1.252 1.223 0 CA-C-O 121.772 0.796 . . . . 65.44 109.206 176.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.454 ' HB2' HH21 ' A' ' 154' ' ' ARG . 89.2 t80 -70.57 -41.87 71.85 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 114.564 -1.198 . . . . 74.51 110.762 171.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 33.6 m170 -77.22 -36.46 54.68 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.149 0.579 . . . . 75.25 112.065 -172.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.512 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 70.21 -150.35 48.58 Favored Glycine 0 CA--C 1.531 1.087 0 O-C-N 123.411 0.444 . . . . 71.54 114.009 -179.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 91.57 -174.29 37.87 Favored Glycine 0 C--N 1.352 1.461 0 C-N-CA 123.483 0.563 . . . . 70.42 112.571 178.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 21.5 mp0 -67.95 113.16 5.42 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.823 0.849 . . . . 73.14 109.231 179.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 13.1 tpp180 -108.67 122.77 47.81 Favored 'General case' 0 C--O 1.244 0.806 0 C-N-CA 123.626 0.771 . . . . 75.05 109.626 -175.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 48.7 t -73.45 114.86 13.57 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 O-C-N 124.01 0.819 . . . . 75.04 109.156 175.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.44 HG12 HG13 ' A' ' 145' ' ' VAL . 5.5 p -142.39 134.64 26.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 124.65 1.18 . . . . 73.34 107.889 177.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -123.43 144.38 49.54 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 121.973 -0.454 . . . . 71.3 110.732 -175.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.503 ' HB ' ' HB3' ' B' ' 8' ' ' LEU . 11.9 p -159.32 141.09 4.69 Favored 'Isoleucine or valine' 0 C--O 1.243 0.715 0 C-N-CA 124.646 1.178 . . . . 75.1 108.111 173.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 58.92 31.71 21.57 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.911 0.885 . . . . 74.24 110.795 -177.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.476 ' HA3' ' HD2' ' A' ' 80' ' ' PRO . . . 73.05 0.15 50.09 Favored Glycine 0 C--N 1.355 1.598 0 CA-C-N 115.399 -0.818 . . . . 54.15 114.282 -178.378 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.75 99.08 10.41 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.317 1.047 . . . . 72.43 108.311 -174.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 27.1 ttt-85 -74.82 92.38 2.51 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.464 1.106 . . . . 74.41 109.702 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.468 HG23 ' HE1' ' A' ' 164' ' ' MET . 7.5 p -95.62 136.76 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 123.217 0.607 . . . . 73.53 110.899 -177.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 40.3 t -102.02 85.2 2.64 Favored 'General case' 0 C--O 1.243 0.718 0 N-CA-C 108.523 -0.917 . . . . 64.43 108.523 177.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 89.0 t -81.16 113.17 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 108.598 -0.89 . . . . 73.42 108.598 -176.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 40.4 ttt85 -68.79 93.04 0.51 Allowed 'General case' 0 C--O 1.242 0.692 0 N-CA-C 108.552 -0.907 . . . . 74.32 108.552 173.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.512 HG13 ' HA2' ' A' ' 133' ' ' GLY . 41.2 pt -72.91 133.16 82.24 Favored Pre-proline 0 CA--C 1.553 1.084 0 CA-C-N 114.481 -1.236 . . . . 74.52 108.832 177.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -59.87 128.52 27.03 Favored 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 122.527 2.152 . . . . 74.22 111.701 177.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.09 92.78 0.09 OUTLIER 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 122.5 2.134 . . . . 74.15 110.519 172.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 126.29 60.59 0.15 Allowed Glycine 0 C--N 1.339 0.698 0 CA-C-O 121.721 0.623 . . . . 75.51 111.709 -168.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.556 ' O ' ' HB1' ' A' ' 130' ' ' ALA . 7.5 p -137.46 138.02 45.26 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.754 0 N-CA-C 107.068 -1.456 . . . . 75.43 107.068 169.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.587 HH21 HD11 ' A' ' 215' ' ' LEU . 57.6 mtt180 -151.13 175.12 12.44 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.627 0.771 . . . . 73.23 109.102 173.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.516 ' HB3' ' H ' ' A' ' 188' ' ' LEU . 17.3 tp10 -34.7 128.16 0.47 Allowed 'General case' 0 N--CA 1.502 2.162 0 C-N-CA 126.442 1.897 . . . . 72.32 114.852 -166.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.72 -9.98 66.51 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 114.823 0.689 . . . . 74.33 114.823 175.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 15.3 t -73.18 153.56 40.65 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 117.329 0.564 . . . . 74.23 109.562 174.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 85.6 t -119.94 108.16 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.749 0.82 . . . . 74.02 109.846 -175.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.551 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 59.5 mt -86.7 113.85 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 N-CA-C 108.718 -0.845 . . . . 75.24 108.718 174.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -76.27 107.08 8.27 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 108.691 -0.855 . . . . 75.21 108.691 171.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 15.0 p -117.14 114.9 38.62 Favored Pre-proline 0 CA--C 1.554 1.106 0 N-CA-C 109.281 -0.637 . . . . 71.41 109.281 174.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.463 ' HG2' ' HB3' ' A' ' 86' ' ' SER . 50.4 Cg_endo -69.22 140.83 45.72 Favored 'Trans proline' 0 C--N 1.369 1.633 0 C-N-CA 122.368 2.045 . . . . 74.53 112.62 178.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . 0.504 ' N ' ' HB3' ' A' ' 171' ' ' PRO . . . 116.2 -26.52 8.66 Favored Glycine 0 N--CA 1.477 1.409 0 C-N-CA 123.519 0.58 . . . . 70.43 113.355 166.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.487 ' N ' ' SD ' ' A' ' 164' ' ' MET . 1.0 OUTLIER -102.37 -33.25 9.63 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.213 0.605 . . . . 64.15 110.245 -174.798 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.468 ' N ' ' HB2' ' A' ' 174' ' ' LEU . . . -89.86 151.97 22.06 Favored Glycine 0 CA--C 1.493 -1.343 0 N-CA-C 108.801 -1.72 . . . . 73.33 108.801 170.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.703 ' HA3' ' HA3' ' A' ' 172' ' ' GLY . . . 53.13 79.16 0.09 OUTLIER Glycine 0 CA--C 1.48 -2.129 0 CA-C-O 118.67 -1.072 . . . . 74.5 112.335 -161.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.499 ' HA ' HE21 ' A' ' 167' ' ' GLN . 0.0 OUTLIER -55.59 104.09 0.12 Allowed 'General case' 0 C--N 1.353 0.725 0 O-C-N 128.275 2.986 . . . . 75.42 109.27 -177.4 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -174.46 -135.95 2.15 Favored Glycine 0 N--CA 1.435 -1.414 0 N-CA-C 109.32 -1.512 . . . . 64.21 109.32 -172.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . 0.545 ' ND2' ' HB3' ' A' ' 106' ' ' PHE . 0.5 OUTLIER -134.31 -57.01 0.02 OUTLIER Pre-proline 0 CA--C 1.552 1.039 0 CA-C-O 118.518 -0.753 . . . . 63.54 109.204 176.344 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.455 ' O ' ' HA ' ' A' ' 115' ' ' LYS . 17.2 Cg_exo -67.98 124.1 11.43 Favored 'Trans proline' 0 C--N 1.39 2.751 0 N-CA-C 106.461 -2.169 . . . . 73.02 106.461 160.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.504 ' HB3' ' N ' ' A' ' 163' ' ' GLY . 57.2 Cg_endo -67.46 143.08 61.85 Favored 'Trans proline' 0 C--O 1.244 0.777 0 C-N-CA 122.067 1.845 . . . . 71.25 114.612 -164.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.703 ' HA3' ' HA3' ' A' ' 166' ' ' GLY . . . -74.68 -29.54 61.24 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 119.597 -1.287 . . . . 72.4 110.872 158.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 92.58 138.79 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 127.975 2.51 . . . . 71.14 109.635 -177.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.559 HD11 ' HB1' ' A' ' 121' ' ' ALA . 26.4 tp -109.05 141.02 41.8 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 122.678 0.391 . . . . 74.2 110.343 -173.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.418 ' HB2' ' HD2' ' A' ' 120' ' ' ARG . 65.8 mt -107.98 83.2 1.75 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.332 1.053 . . . . 72.12 108.686 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.551 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 92.1 mt -66.62 101.33 0.77 Allowed 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.174 -0.921 . . . . 74.52 110.283 179.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 64.0 t -84.29 102.81 10.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 N-CA-C 107.677 -1.231 . . . . 71.11 107.677 173.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 7.3 p -66.88 128.43 30.05 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 CA-C-N 115.358 -0.837 . . . . 74.13 110.592 -177.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.451 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 33.3 mmt180 -124.09 91.82 3.54 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.255 1.422 . . . . 73.42 107.272 -174.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.581 HD13 HD13 ' A' ' 127' ' ' LEU . 27.9 mt -70.17 147.52 49.77 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.597 -0.729 . . . . 74.04 112.181 -171.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 61.9 mt -58.95 149.14 67.33 Favored Pre-proline 0 N--CA 1.479 1.024 0 C-N-CA 124.362 1.065 . . . . 73.22 110.814 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -58.86 79.42 0.05 OUTLIER 'Trans proline' 0 C--N 1.383 2.381 0 C-N-CA 123.413 2.742 . . . . 74.32 112.703 176.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 66.5 t-80 -129.39 103.5 18.01 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 105.917 -1.882 . . . . 73.35 105.917 -175.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -73.58 25.39 0.32 Allowed 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 123.638 2.892 . . . . 61.24 116.227 -163.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 71.5 t -97.57 -61.21 2.32 Favored 'Isoleucine or valine' 0 C--N 1.351 0.669 0 CA-C-N 118.425 0.557 . . . . 72.34 110.465 -177.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 15.5 m-30 -124.34 147.92 47.85 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-O 121.829 0.823 . . . . 72.31 112.714 -171.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -144.8 150.28 36.89 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.328 1.851 . . . . 75.51 106.665 172.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.639 HD11 ' HA ' ' A' ' 193' ' ' LEU . 6.3 tp -121.17 173.43 7.31 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 107.177 -1.416 . . . . 74.21 107.177 178.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -159.56 128.98 5.34 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 109.076 -0.713 . . . . 70.31 109.076 165.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 68.6 -74.55 0.31 Allowed Glycine 0 C--N 1.347 1.169 0 N-CA-C 110.979 -0.848 . . . . 65.41 110.979 -170.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -164.17 -0.68 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 123.758 0.823 . . . . 72.32 111.547 172.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -95.89 146.49 24.54 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.914 -0.491 . . . . 72.32 109.685 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.639 ' HA ' HD11 ' A' ' 188' ' ' LEU . 0.8 OUTLIER -89.69 157.2 18.1 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.473 1.109 . . . . 74.25 111.486 -165.765 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -142.96 154.9 44.51 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.648 1.579 . . . . 73.14 107.631 175.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -158.84 127.16 5.21 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.902 0.881 . . . . 74.34 109.122 -176.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 31.1 m -75.66 127.23 32.62 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 118.163 0.438 . . . . 70.21 110.128 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 38.5 tp -130.7 104.32 7.12 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.522 0.729 . . . . 74.1 110.032 -175.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -89.85 124.59 34.82 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 109.261 -0.644 . . . . 63.3 109.261 171.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 8.9 p -138.06 137.62 21.53 Favored Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 123.874 0.869 . . . . 74.33 109.16 -174.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.85 155.16 53.69 Favored 'Trans proline' 0 C--N 1.378 2.086 0 C-N-CA 121.765 1.643 . . . . 70.05 111.327 174.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -52.2 -49.66 83.5 Favored Pre-proline 0 CA--C 1.552 1.043 0 N-CA-C 114.633 1.346 . . . . 71.34 114.633 -172.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.456 ' HG2' ' HE1' ' C' ' 276' ' ' TYR . 54.3 Cg_exo -58.75 -41.28 64.83 Favored 'Trans proline' 0 C--N 1.386 2.541 0 C-N-CA 121.912 1.741 . . . . 73.32 113.997 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.476 HD12 ' HB3' ' C' ' 276' ' ' TYR . 44.0 mt -68.29 -35.57 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 109.907 -0.405 . . . . 71.02 109.907 178.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.16 -45.82 79.59 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.46 0.704 . . . . 74.14 111.751 176.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 53.0 t -68.26 -48.75 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 124.194 0.998 . . . . 64.22 111.522 -176.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 54.7 t -83.13 -37.59 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.042 0.937 . . . . 74.41 111.613 -172.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 92.22 70.61 1.17 Allowed Glycine 0 C--O 1.24 0.48 0 CA-C-N 115.765 -0.652 . . . . 72.35 111.493 -174.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -92.18 -154.23 30.7 Favored Glycine 0 C--N 1.34 0.793 0 CA-C-N 115.055 -0.572 . . . . 73.32 113.312 -177.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 36.3 mtmt -130.02 132.84 46.39 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.327 -0.62 . . . . 73.34 109.327 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 29.0 m -132.52 160.37 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 N-CA-C 108.678 -0.86 . . . . 63.11 108.678 172.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -97.68 115.36 27.8 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.358 -0.979 . . . . 74.32 108.358 177.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.89 165.65 11.24 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.936 0.894 . . . . 74.41 110.326 -174.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' MET . . . . . 0.456 ' N ' ' SD ' ' A' ' 213' ' ' MET . 0.0 OUTLIER -98.98 137.04 38.08 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.241 -0.89 . . . . 74.15 109.211 -174.941 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 67.6 p -124.53 177.51 5.89 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 107.934 -1.135 . . . . 74.1 107.934 163.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . 0.591 HD23 ' HB3' ' A' ' 127' ' ' LEU . 33.0 mt -78.26 -23.14 47.42 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.81 -0.632 . . . . 73.14 110.395 -177.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -83.62 -12.84 55.49 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.148 0.979 . . . . 64.44 111.175 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 138.28 -164.62 25.6 Favored Glycine 0 C--N 1.346 1.137 0 N-CA-C 111.564 -0.614 . . . . 63.05 111.564 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -79.09 134.8 11.87 Favored 'Trans proline' 0 C--N 1.363 1.303 0 C-N-CA 122.262 1.974 . . . . 74.13 111.693 175.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 34.8 m -130.89 168.14 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 107.681 -1.229 . . . . 73.4 107.681 171.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -106.54 152.84 23.17 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 121.856 -0.528 . . . . 75.04 111.894 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 10.2 p -142.63 141.65 27.41 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 CA-C-N 114.868 -1.06 . . . . 74.51 109.319 -173.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -106.83 104.77 14.53 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 109.608 -0.515 . . . . 70.4 109.608 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 66.7 t -58.53 142.78 82.27 Favored Pre-proline 0 CA--C 1.569 1.68 0 C-N-CA 125.262 1.425 . . . . 71.22 110.472 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -84.31 167.36 12.13 Favored 'Trans proline' 0 C--N 1.386 2.515 0 C-N-CA 122.863 2.375 . . . . 75.51 111.195 175.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.12 145.91 28.26 Favored 'Trans proline' 0 C--N 1.367 1.546 0 C-N-CA 121.495 1.463 . . . . 72.53 112.681 174.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 71.9 mtt85 65.76 34.18 7.66 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 125.341 1.456 . . . . 75.13 111.642 175.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.492 HG23 HG11 ' A' ' 253' ' ' VAL . 89.3 m -63.15 108.67 1.31 Allowed 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 113.657 -1.611 . . . . 64.32 110.705 174.109 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -98.71 150.89 21.34 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.597 0.759 . . . . 75.32 110.824 -169.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -63.86 128.04 34.05 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.896 0.879 . . . . 65.12 110.742 177.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 97.0 -26.18 23.71 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-N 116.377 -0.374 . . . . 75.54 112.53 -178.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 55.8 mtt180 -74.36 135.3 42.47 Favored 'General case' 0 C--N 1.36 1.057 0 CA-C-O 121.623 0.725 . . . . 74.44 111.094 -178.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.604 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 33.6 mttm -102.71 112.37 25.12 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 114.219 -1.355 . . . . 72.22 109.03 -178.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.549 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 45.6 mt -75.33 99.5 4.12 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.031 0.932 . . . . 71.4 109.755 -172.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 58.9 ttt180 -73.64 123.89 24.91 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.59 1.156 . . . . 73.41 110.958 -173.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.473 HD12 HD23 ' A' ' 249' ' ' LEU . 67.3 mt -116.64 109.41 17.16 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.964 0.905 . . . . 74.24 109.889 -179.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.483 ' HZ1' ' HB3' ' A' ' 236' ' ' LYS . 3.0 mmmp? -62.5 125.31 23.5 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 123.668 0.787 . . . . 71.01 112.767 -173.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 73.08 30.65 62.79 Favored Glycine 0 C--N 1.352 1.43 0 O-C-N 124.036 0.835 . . . . 74.2 113.881 174.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -115.77 -12.38 11.49 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.333 0.653 . . . . 74.1 111.65 -178.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -87.17 -168.77 45.14 Favored Glycine 0 C--N 1.348 1.205 0 O-C-N 123.311 0.382 . . . . 74.43 112.323 171.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . 0.504 ' HE2' ' HG3' ' A' ' 154' ' ' ARG . 13.2 m-30 -95.0 154.29 39.69 Favored Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 123.039 0.536 . . . . 73.41 111.903 -169.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.474 ' HA ' ' HA ' ' A' ' 246' ' ' ARG . 59.5 Cg_endo -70.16 120.54 7.25 Favored 'Trans proline' 0 C--N 1.386 2.544 0 C-N-CA 123.339 2.692 . . . . 73.33 113.62 -176.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -157.05 -138.78 2.58 Favored Glycine 0 C--N 1.35 1.327 0 CA-C-O 119.208 -0.773 . . . . 73.52 112.645 -178.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -70.57 -16.31 34.12 Favored 'Trans proline' 0 C--N 1.385 2.493 0 C-N-CA 123.24 2.627 . . . . 72.5 113.549 -173.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -100.18 20.43 14.62 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.737 0.815 . . . . 70.11 110.643 177.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 79.09 -80.19 1.53 Allowed Glycine 0 C--N 1.351 1.398 0 N-CA-C 109.503 -1.439 . . . . 62.24 109.503 -171.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.474 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 44.8 mtm180 -125.6 159.36 32.33 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.476 1.11 . . . . 75.41 108.514 164.374 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -87.64 -176.81 48.3 Favored Glycine 0 C--N 1.339 0.696 0 CA-C-N 116.14 -0.482 . . . . 70.31 112.285 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -123.2 151.6 42.07 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.027 0.931 . . . . 75.44 109.648 178.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.473 HD23 HD12 ' A' ' 235' ' ' LEU . 53.8 tp -96.84 111.31 23.55 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 109.434 -0.58 . . . . 73.32 109.434 -178.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.604 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 18.7 m-85 -96.82 105.91 18.12 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.323 1.049 . . . . 71.3 109.539 -179.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.549 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 12.1 mt -81.63 97.4 7.86 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.949 0.5 . . . . 74.54 109.739 176.021 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -77.47 105.74 8.79 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.988 0.915 . . . . 75.41 108.726 -174.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.492 HG11 HG23 ' A' ' 227' ' ' THR . 55.0 t -88.79 144.35 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 N-CA-C 114.192 1.182 . . . . 71.34 114.192 -165.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -128.65 111.47 13.23 Favored 'General case' 0 C--N 1.351 0.666 0 C-N-CA 125.838 1.655 . . . . 73.14 108.01 168.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.405 HD12 ' HA ' ' C' ' 256' ' ' THR . 58.2 mt -76.8 138.6 20.28 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 122.955 0.502 . . . . 74.34 109.769 178.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 48.2 p -122.87 173.48 7.75 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.588 1.155 . . . . 74.52 109.307 176.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 27.3 pt -117.82 162.18 30.42 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 123.301 0.64 . . . . 73.4 109.68 175.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -66.65 5.98 0.65 Allowed 'Trans proline' 0 N--CA 1.502 1.979 0 C-N-CA 123.263 2.642 . . . . 74.45 115.609 176.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . 0.469 ' HG3' ' NE2' ' C' ' 228' ' ' GLN . 2.4 mp0 48.52 -97.68 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.692 0.797 . . . . 75.12 109.659 -161.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.7 160.95 17.9 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.062 0.945 . . . . 75.12 111.003 -172.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 79.7 mt -138.51 157.38 46.29 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.673 0.789 . . . . 72.32 110.446 -175.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 78.4 p -102.67 151.19 38.24 Favored Pre-proline 0 CA--C 1.554 1.133 0 N-CA-C 108.394 -0.965 . . . . 74.31 108.394 169.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -25.79 -46.29 0.06 OUTLIER 'Trans proline' 0 C--N 1.394 2.958 1 C-N-CA 126.58 4.854 . . . . 74.33 117.932 -170.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -66.64 -62.73 1.3 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 122.935 0.494 . . . . 71.44 111.445 -176.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -66.12 -25.81 67.16 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 122.509 0.324 . . . . 73.22 110.5 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -56.75 -52.12 66.22 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 124.179 0.924 . . . . 73.45 109.455 173.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -62.39 -42.42 99.41 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.698 -1.137 . . . . 64.12 111.653 176.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 10.4 mp -58.04 -55.46 34.63 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 122.971 0.508 . . . . 73.14 111.955 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 66.4 m95 -60.12 -39.79 87.46 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.487 0.715 . . . . 75.0 111.647 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . 0.571 ' HE2' HG21 ' C' ' 206' ' ' VAL . 1.1 mptm? -64.34 -44.03 92.78 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 123.62 0.575 . . . . 73.12 111.585 177.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -63.72 -43.02 97.78 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 122.993 0.517 . . . . 70.22 110.608 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 272' ' ' LEU . . . . . 0.478 ' O ' ' HB2' ' A' ' 276' ' ' TYR . 75.6 mt -56.53 -46.01 80.83 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 124.422 1.076 . . . . 71.54 110.57 174.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -74.69 -37.99 62.49 Favored 'General case' 0 C--O 1.244 0.797 0 O-C-N 124.468 1.105 . . . . 72.23 113.63 -171.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -77.3 -39.11 49.1 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.072 0.549 . . . . 74.35 109.566 -179.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . 0.408 ' HB1' ' NH2' ' A' ' 279' ' ' ARG . . . -74.19 -20.49 60.18 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.162 0.585 . . . . 72.24 111.034 174.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . 0.478 ' HB2' ' O ' ' A' ' 272' ' ' LEU . 14.7 t80 -65.16 -63.63 1.06 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.079 0.951 . . . . 75.02 108.762 172.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -64.94 -38.64 91.64 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 114.987 -1.006 . . . . 72.14 110.406 -173.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -62.85 -26.15 68.62 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.236 0.614 . . . . 75.41 112.093 176.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . 0.408 ' NH2' ' HB1' ' A' ' 275' ' ' ALA . 27.5 mtm180 -117.4 31.2 6.86 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.477 0.711 . . . . 75.15 109.938 179.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.393 0 N-CA-C 109.087 -0.708 . . . . 72.5 109.087 171.984 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.481 1.081 0 N-CA-C 109.872 -0.418 . . . . 74.12 109.872 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 57.6 tttp 70.97 135.11 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.931 1.292 . . . . 62.45 113.594 176.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 63.08 30.14 16.21 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 125.62 1.568 . . . . 74.04 112.168 171.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 11.9 m -66.63 -34.96 79.04 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.769 0.428 . . . . 52.14 110.448 175.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 1.8 m 69.14 152.03 0.09 Allowed 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 125.593 1.557 . . . . 74.34 112.167 177.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.649 HG23 ' HA ' ' A' ' 125' ' ' LEU . 31.4 pt -136.83 171.2 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 N-CA-C 113.044 0.757 . . . . 65.34 113.044 -158.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -146.05 123.58 11.75 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.169 0.988 . . . . 72.22 110.187 -178.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . 0.503 ' HB3' ' HB ' ' A' ' 140' ' ' VAL . 36.3 tp -77.75 145.37 36.53 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.119 0.968 . . . . 75.22 110.908 -173.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . 0.507 ' HB2' ' HB2' ' A' ' 122' ' ' GLU . . . -88.79 -50.39 6.26 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.052 0.541 . . . . 73.12 111.828 178.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 86.9 mt 68.0 122.57 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 124.872 1.269 . . . . 74.1 111.283 -166.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 N--CA 1.481 1.078 0 N-CA-C 108.046 -1.094 . . . . 72.11 108.046 171.664 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.879 0 N-CA-C 108.97 -0.752 . . . . 74.35 108.97 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . -162.14 -28.84 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 115.127 -0.942 . . . . 75.32 110.292 175.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 181' ' ' LEU . . . . . 0.538 HD22 ' HB2' ' C' ' 136' ' ' ARG . 29.3 tp -153.45 -68.7 0.15 Allowed 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 107.636 -1.246 . . . . 74.44 107.636 168.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 182' ' ' VAL . . . . . . . . . . . . . 62.6 t -76.43 131.81 34.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 108.123 -1.066 . . . . 72.43 108.123 168.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.1 -48.79 74.77 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 123.726 0.641 . . . . 65.24 110.695 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 179.9 -170.44 0.14 Allowed 'General case' 0 N--CA 1.485 1.301 0 O-C-N 124.2 0.938 . . . . 75.32 110.738 173.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 185' ' ' VAL . . . . . 0.456 HG22 ' HA ' ' C' ' 121' ' ' ALA . 1.8 p . . . . . 0 N--CA 1.47 0.548 0 N-CA-C 106.557 -1.645 . . . . 74.01 106.557 160.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 238' ' ' THR . . . . . 0.458 HG22 HG22 ' C' ' 219' ' ' VAL . 6.2 m . . . . . 0 CA--C 1.545 0.753 0 N-CA-C 109.946 -0.391 . . . . 71.31 109.946 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -165.63 -98.84 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 123.337 0.655 . . . . 74.42 110.44 171.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . 173.32 -148.52 10.36 Favored Glycine 0 C--N 1.35 1.334 0 N-CA-C 111.615 -0.594 . . . . 71.23 111.615 -176.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -86.38 -167.96 2.06 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.516 0.726 . . . . 71.23 111.144 -176.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 242' ' ' TRP . . . . . 0.576 ' HZ3' ' HD3' ' C' ' 231' ' ' ARG . 0.0 OUTLIER 86.59 -26.82 0.08 Allowed 'General case' 0 N--CA 1.504 2.231 0 C-N-CA 127.191 2.197 . . . . 70.32 111.66 175.872 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -102.24 120.69 40.89 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 124.054 0.942 . . . . 74.22 110.676 -168.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -60.35 -40.73 97.91 Favored Glycine 0 C--N 1.353 1.49 0 N-CA-C 110.458 -1.057 . . . . 71.54 110.458 165.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 5.5 ttpp . . . . . 0 N--CA 1.478 0.934 0 C-N-CA 125.148 1.379 . . . . 75.34 112.755 162.928 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.809 0 CA-C-O 120.267 0.079 . . . . 71.34 111.055 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -37.47 95.1 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 125.693 1.597 . . . . 70.52 114.197 -176.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -67.19 107.73 2.44 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 108.288 -1.004 . . . . 72.32 108.288 166.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -77.74 92.73 4.2 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 106.739 -1.578 . . . . 65.15 106.739 171.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 7' ' ' TYR . . . . . 0.453 ' CD1' ' HA ' ' C' ' 53' ' ' ALA . 75.8 m-85 -62.73 -25.9 68.42 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 114.51 -1.223 . . . . 73.43 112.128 -172.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -64.91 -46.49 81.46 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.382 0.673 . . . . 74.23 110.408 174.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.64 -39.44 94.36 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.266 0.626 . . . . 63.34 111.011 178.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 66.7 mt -59.75 -41.1 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 123.797 0.686 . . . . 73.31 110.475 175.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 98.0 mt -85.57 -3.55 58.9 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 112.265 0.469 . . . . 75.53 112.265 176.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 61.27 44.6 97.89 Favored Glycine 0 C--N 1.354 1.54 0 N-CA-C 114.063 0.385 . . . . 74.43 114.063 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 11.0 m -133.13 148.56 69.71 Favored Pre-proline 0 N--CA 1.487 1.423 0 C-N-CA 124.795 1.238 . . . . 71.34 109.823 177.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -75.29 161.36 38.03 Favored 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 122.721 2.281 . . . . 74.43 111.844 170.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 -77.07 20.17 0.27 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.806 0.842 . . . . 74.35 112.518 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -119.0 -15.39 9.29 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.243 1.017 . . . . 71.24 109.079 177.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.08 131.98 51.36 Favored 'General case' 0 C--N 1.355 0.828 0 C-N-CA 123.246 0.618 . . . . 75.2 109.595 175.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 59.8 p -65.59 161.8 19.57 Favored 'General case' 0 C--O 1.246 0.872 0 C-N-CA 123.047 0.539 . . . . 74.41 109.866 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 19' ' ' GLN . . . . . 0.515 ' HG2' ' HD3' ' C' ' 60' ' ' PRO . 25.1 tp60 -54.26 -38.82 66.25 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.586 0.754 . . . . 74.45 111.978 -173.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 20' ' ' GLU . . . . . 0.448 ' O ' ' HG3' ' C' ' 24' ' ' ARG . 0.4 OUTLIER -68.72 -35.6 77.35 Favored 'General case' 0 C--O 1.211 -0.933 0 CA-C-O 119.182 -0.437 . . . . 74.53 111.128 -179.058 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . 0.735 ' HG2' HH21 ' C' ' 24' ' ' ARG . 37.4 mt-10 -68.92 -38.11 79.32 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-O 121.006 0.431 . . . . 73.42 110.76 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 66.6 mt -66.15 -38.58 82.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 124.188 0.995 . . . . 75.54 109.889 174.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 23' ' ' LYS . . . . . 0.438 ' O ' ' HD3' ' C' ' 27' ' ' LYS . 6.6 ttpt -71.4 -33.85 69.85 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 114.68 -1.145 . . . . 74.13 109.972 178.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 24' ' ' ARG . . . . . 0.735 HH21 ' HG2' ' C' ' 21' ' ' GLU . 40.8 mtm180 -75.84 -24.21 55.8 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.305 0.642 . . . . 73.52 110.478 176.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.67 -43.96 87.73 Favored 'General case' 0 C--N 1.345 0.41 0 O-C-N 123.711 0.632 . . . . 75.32 109.636 170.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 26' ' ' TYR . . . . . 0.458 ' HD1' HG23 ' C' ' 50' ' ' ILE . 81.6 t80 -58.01 -52.42 65.58 Favored 'General case' 0 C--N 1.36 1.04 0 O-C-N 123.624 0.578 . . . . 72.31 110.865 171.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . 0.444 ' HE2' ' HA ' ' C' ' 24' ' ' ARG . 4.8 mppt? -61.0 -31.8 71.41 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 122.878 0.471 . . . . 75.33 111.487 -177.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 28' ' ' ARG . . . . . 0.505 HH21 HD21 ' C' ' 29' ' ' LEU . 38.9 ttp180 -62.28 -48.19 81.01 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.908 0.883 . . . . 75.55 109.602 174.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . 0.662 HD11 HD13 ' C' ' 50' ' ' ILE . 49.9 mt -74.55 -19.09 60.47 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 114.738 -1.119 . . . . 71.43 111.487 178.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.11 -22.49 33.37 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.409 0.684 . . . . 75.32 110.197 178.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . 0.402 ' HG3' ' O ' ' C' ' 27' ' ' LYS . 58.6 mtm180 -86.85 -31.78 20.61 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.252 0.621 . . . . 73.5 110.318 170.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -70.27 -60.58 2.19 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.827 0.851 . . . . 71.12 109.493 -178.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -90.61 24.52 2.63 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.028 0.931 . . . . 72.14 110.934 -177.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 34' ' ' HIS . . . . . 0.467 ' NE2' ' HB3' ' C' ' 36' ' ' ASP . 55.0 t60 -55.12 96.42 0.09 OUTLIER Pre-proline 0 N--CA 1.486 1.345 0 C-N-CA 124.963 1.305 . . . . 74.34 112.84 -164.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 35' ' ' PRO . . . . . 0.496 ' O ' ' HG2' ' C' ' 39' ' ' LYS . 57.9 Cg_endo -76.55 -2.24 12.42 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 123.429 2.753 . . . . 72.22 112.758 -167.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 36' ' ' ASP . . . . . 0.467 ' HB3' ' NE2' ' C' ' 34' ' ' HIS . 32.7 t70 -75.88 -38.03 58.28 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.949 0.899 . . . . 60.34 110.81 173.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 59.6 t -117.32 -52.69 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 122.89 0.476 . . . . 75.33 109.835 -174.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -97.51 79.29 2.73 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.701 0.762 . . . . 65.41 108.945 178.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 39' ' ' LYS . . . . . 0.582 ' HZ2' ' HB2' ' C' ' 39' ' ' LYS . 9.8 mtmp? -81.14 69.37 7.73 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 115.189 -0.914 . . . . 71.22 109.815 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 40' ' ' SER . . . . . 0.503 ' HB2' ' HB2' ' C' ' 43' ' ' ALA . 49.6 m -92.5 111.66 51.77 Favored Pre-proline 0 CA--C 1.546 0.81 0 CA-C-O 118.317 -0.849 . . . . 74.14 108.99 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -38.93 -61.09 0.42 Allowed 'Trans proline' 0 C--N 1.387 2.596 0 C-N-CA 124.571 3.514 . . . . 75.0 114.905 -174.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -61.18 -33.94 74.27 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.857 0.863 . . . . 71.01 111.397 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 43' ' ' ALA . . . . . 0.503 ' HB2' ' HB2' ' C' ' 40' ' ' SER . . . -77.35 -20.52 54.7 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.248 0.619 . . . . 71.45 110.659 -178.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -84.06 -28.44 27.6 Favored 'General case' 0 C--N 1.351 0.659 0 N-CA-C 109.127 -0.694 . . . . 74.04 109.127 176.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -70.62 -42.19 71.24 Favored 'General case' 0 C--O 1.25 1.125 0 C-N-CA 123.676 0.79 . . . . 75.44 109.602 173.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 46' ' ' LYS . . . . . 0.519 ' O ' HG12 ' C' ' 50' ' ' ILE . 63.5 mttp -58.12 -45.65 86.96 Favored 'General case' 0 C--N 1.355 0.832 0 CA-C-N 114.789 -1.096 . . . . 72.32 109.429 168.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -62.66 -30.31 71.29 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.926 0.89 . . . . 71.12 110.963 -178.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 2.7 mptm? -63.54 -50.37 69.82 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 109.07 -0.715 . . . . 72.04 109.07 171.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -67.57 -17.34 64.6 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 112.791 0.663 . . . . 72.33 112.791 176.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 50' ' ' ILE . . . . . 0.662 HD13 HD11 ' C' ' 29' ' ' LEU . 28.2 mm -78.36 -38.03 22.51 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 N-CA-C 108.832 -0.803 . . . . 75.43 108.832 173.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 51' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -78.85 -11.87 60.01 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.799 0.84 . . . . 74.04 111.399 174.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 52' ' ' GLU . . . . . 0.432 ' O ' HG22 ' C' ' 56' ' ' VAL . 30.0 tt0 -77.83 -53.07 7.92 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 108.064 -1.088 . . . . 75.54 108.064 169.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . 0.453 ' HA ' ' CD1' ' C' ' 7' ' ' TYR . . . -57.8 -34.14 69.31 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 114.432 -1.258 . . . . 63.1 111.399 175.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 54' ' ' TYR . . . . . 0.448 ' O ' ' HB2' ' C' ' 58' ' ' SER . 22.9 t80 -82.9 -32.45 27.28 Favored 'General case' 0 C--O 1.216 -0.68 0 C-N-CA 123.79 0.836 . . . . 75.01 110.378 177.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.39 -31.66 66.03 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 118.277 0.489 . . . . 60.54 110.537 173.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 56' ' ' VAL . . . . . 0.461 HG12 ' HB2' ' C' ' 66' ' ' TYR . 10.1 t -100.06 -21.3 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.245 0 CA-C-N 115.129 -0.941 . . . . 72.43 112.598 -179.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 57' ' ' LEU . . . . . 0.524 HD22 ' HG3' ' C' ' 63' ' ' ARG . 71.0 mt -127.4 29.3 5.56 Favored 'General case' 0 N--CA 1.501 2.122 0 CA-C-N 119.424 1.011 . . . . 75.02 112.655 -179.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 58' ' ' SER . . . . . 0.448 ' HB2' ' O ' ' C' ' 54' ' ' TYR . 21.4 t -68.62 -60.81 2.15 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.297 0.57 . . . . 75.33 112.221 177.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -125.9 158.98 63.8 Favored Pre-proline 0 N--CA 1.481 1.097 0 C-N-CA 124.393 1.077 . . . . 72.03 109.117 -171.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 60' ' ' PRO . . . . . 0.515 ' HD3' ' HG2' ' C' ' 19' ' ' GLN . 10.3 Cg_endo -48.89 -30.46 17.53 Favored 'Trans proline' 0 C--N 1.388 2.631 0 C-N-CA 123.162 2.574 . . . . 73.21 113.299 178.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . 0.423 ' O ' HG12 ' C' ' 65' ' ' ILE . 18.4 tt0 -50.79 -69.34 0.11 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.306 1.042 . . . . 62.13 110.625 170.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -60.22 -44.81 94.86 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-N 114.724 -1.125 . . . . 75.43 111.357 -174.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 63' ' ' ARG . . . . . 0.524 ' HG3' HD22 ' C' ' 57' ' ' LEU . 31.7 ttp-105 -62.77 -46.14 89.41 Favored 'General case' 0 C--N 1.349 0.544 0 CA-C-N 114.865 -1.062 . . . . 74.14 110.595 -174.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -72.57 -25.95 61.54 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 123.744 0.652 . . . . 74.15 111.552 -178.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 65' ' ' ILE . . . . . 0.423 HG12 ' O ' ' C' ' 61' ' ' GLU . 46.1 mm -60.13 -46.61 94.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 109.351 -0.611 . . . . 71.5 109.351 168.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 66' ' ' TYR . . . . . 0.461 ' HB2' HG12 ' C' ' 56' ' ' VAL . 18.3 t80 -63.63 -46.26 86.51 Favored 'General case' 0 C--N 1.353 0.723 0 CA-C-N 115.664 -0.698 . . . . 74.31 110.677 176.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -62.44 -33.67 75.28 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.219 0.607 . . . . 73.14 111.461 -176.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 44.5 p -78.14 -20.27 52.41 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.362 -0.381 . . . . 74.43 111.001 175.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -75.02 133.65 41.6 Favored 'General case' 0 CA--C 1.556 1.181 0 N-CA-C 108.415 -0.957 . . . . 75.22 108.415 165.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 91.28 15.6 55.25 Favored Glycine 0 N--CA 1.476 1.345 0 N-CA-C 111.225 -0.75 . . . . 62.51 111.225 -167.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 99.9 m -141.27 -60.34 0.49 Allowed 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 103.601 -2.74 . . . . 72.34 103.601 175.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 91.0 m -78.15 139.09 39.0 Favored 'General case' 0 C--O 1.251 1.155 0 N-CA-C 104.268 -2.493 . . . . 73.35 104.268 155.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.38 -45.93 4.34 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.62 0.768 . . . . 73.23 109.659 -172.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -73.87 144.32 82.5 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 123.435 0.694 . . . . 53.23 109.979 178.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.82 120.78 8.69 Favored 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 122.738 2.292 . . . . 75.14 110.989 173.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -54.27 159.59 7.79 Favored 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 123.685 2.924 . . . . 71.22 114.444 -176.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.57 127.75 14.37 Favored 'Trans proline' 0 C--N 1.381 2.242 0 C-N-CA 122.249 1.966 . . . . 74.4 110.839 172.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 78' ' ' PRO . . . . . 0.431 ' HB3' ' HA3' ' C' ' 104' ' ' GLY . 18.1 Cg_endo -59.02 129.91 34.06 Favored 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 122.609 2.206 . . . . 74.44 112.75 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.07 156.02 66.43 Favored 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 122.749 2.299 . . . . 70.12 111.45 174.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_exo -53.78 87.47 0.03 OUTLIER 'Trans proline' 0 C--N 1.385 2.494 0 C-N-CA 123.314 2.676 . . . . 74.31 112.707 176.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 159.55 -45.45 0.43 Allowed Glycine 0 C--N 1.342 0.894 0 CA-C-N 114.673 -1.149 . . . . 75.2 111.179 178.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 109.45 167.87 20.27 Favored Glycine 0 C--N 1.352 1.433 0 C-N-CA 123.669 0.652 . . . . 75.13 111.987 -175.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -78.03 112.15 14.65 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 109.293 -0.632 . . . . 73.4 109.293 176.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -63.56 146.22 54.13 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.808 0.843 . . . . 75.11 112.801 -178.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 85' ' ' PHE . . . . . 0.467 ' O ' ' HB3' ' C' ' 171' ' ' PRO . 75.9 m-85 -138.62 71.33 1.39 Allowed 'General case' 0 C--N 1.356 0.878 0 C-N-CA 124.299 1.039 . . . . 74.41 110.207 171.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 37.0 m -51.0 86.75 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 125.05 1.34 . . . . 52.42 112.744 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 75.68 -5.54 37.66 Favored Glycine 0 CA--C 1.535 1.294 0 CA-C-N 116.067 -0.515 . . . . 74.34 113.493 -176.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 88' ' ' PHE . . . . . 0.451 ' HB2' ' HB3' ' C' ' 85' ' ' PHE . 12.8 m-85 -81.19 118.52 22.64 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.829 -0.804 . . . . 74.44 108.829 -171.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -76.86 81.4 3.44 Favored 'General case' 0 C--O 1.243 0.745 0 CA-C-O 121.204 0.526 . . . . 72.23 110.483 -173.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 90' ' ' VAL . . . . . 0.651 HG21 HD22 ' C' ' 169' ' ' ASN . 1.5 p -44.41 -40.96 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 125.46 1.504 . . . . 54.42 111.852 175.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -48.12 -40.0 22.2 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.716 1.606 . . . . 75.25 112.961 -178.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -85.1 -29.37 24.91 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.583 0.753 . . . . 75.53 112.165 -173.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 17.1 m-30 -68.98 170.39 9.9 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 113.143 0.794 . . . . 72.45 113.143 -164.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 81.0 p -71.95 172.77 9.37 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 124.77 1.228 . . . . 52.11 113.779 -164.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 95' ' ' GLU . . . . . 0.484 ' O ' ' HG3' ' C' ' 99' ' ' GLU . 4.7 mp0 -71.6 -34.0 69.5 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 115.275 -0.875 . . . . 72.35 110.953 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -61.19 -44.2 97.67 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-O 121.494 0.664 . . . . 74.24 110.33 174.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 97' ' ' PHE . . . . . 0.647 ' HE2' HG22 ' C' ' 90' ' ' VAL . 47.9 t80 -56.93 -43.77 81.8 Favored 'General case' 0 CA--C 1.554 1.103 0 CA-C-N 114.148 -1.387 . . . . 64.25 109.884 172.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -70.6 -18.97 62.88 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.055 0.542 . . . . 71.33 112.459 177.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 99' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' C' ' 95' ' ' GLU . 43.2 mt-10 -74.27 -55.35 6.13 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.127 0.489 . . . . 74.43 110.015 173.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 27.3 tp -74.91 -45.22 44.17 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.819 -1.082 . . . . 73.23 111.643 -170.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -97.24 -19.1 18.82 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.599 0.76 . . . . 75.04 112.257 -175.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -47.42 -57.96 6.93 Favored Glycine 0 CA--C 1.545 1.913 0 CA-C-O 118.947 -0.918 . . . . 74.41 115.119 -178.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -59.07 -9.41 7.97 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 123.788 2.992 . . . . 64.35 114.621 -179.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 104' ' ' GLY . . . . . 0.431 ' HA3' ' HB3' ' C' ' 78' ' ' PRO . . . -136.8 34.29 2.23 Favored Glycine 0 C--N 1.351 1.414 0 CA-C-O 119.985 -0.342 . . . . 73.42 113.116 178.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 105' ' ' LEU . . . . . 0.553 ' HB3' ' ND2' ' C' ' 169' ' ' ASN . 43.1 mt . . . . . 0 N--CA 1.485 1.282 0 C-N-CA 123.314 0.645 . . . . 75.43 111.474 172.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 116' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' C' ' 170' ' ' PRO . . . . . . . . 0 C--O 1.239 0.42 0 CA-C-O 120.399 -0.112 . . . . 54.4 113.102 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 117' ' ' ARG . . . . . 0.533 HH21 ' HB3' ' C' ' 167' ' ' GLN . 69.4 mtm180 -110.41 163.86 13.26 Favored 'General case' 0 C--O 1.265 1.891 0 CA-C-O 122.154 0.978 . . . . 74.32 110.534 -177.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.09 117.74 5.06 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 112.589 -2.096 . . . . 75.42 108.353 165.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 119' ' ' LEU . . . . . 0.504 ' HG ' ' HG2' ' C' ' 167' ' ' GLN . 3.3 tt -92.23 116.18 28.73 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 104.59 -2.374 . . . . 75.21 104.59 178.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 63.0 ttt180 -117.98 118.84 33.04 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.35 -0.982 . . . . 72.31 108.35 -164.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 121' ' ' ALA . . . . . 0.456 ' HA ' HG22 ' B' ' 185' ' ' VAL . . . -108.58 170.03 8.28 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 113.847 1.055 . . . . 75.44 113.847 -164.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -127.79 108.14 10.47 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 114.16 -1.382 . . . . 74.12 110.288 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -139.12 111.68 7.94 Favored Pre-proline 0 N--CA 1.487 1.42 0 CA-C-N 118.535 0.607 . . . . 73.3 112.431 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -65.74 121.59 9.0 Favored 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 122.037 1.824 . . . . 72.51 109.692 162.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 125' ' ' LEU . . . . . 0.47 ' O ' ' HA ' ' C' ' 180' ' ' LEU . 12.7 tp -145.56 167.93 21.85 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 107.585 -1.265 . . . . 75.32 107.585 -169.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 126' ' ' THR . . . . . . . . . . . . . 14.5 t -128.26 176.99 7.25 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 119.366 0.985 . . . . 61.53 110.911 173.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 127' ' ' LEU . . . . . . . . . . . . . 6.3 mt -60.73 -43.54 97.76 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.485 1.514 . . . . 62.25 109.696 -177.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -60.96 -39.67 90.43 Favored 'General case' 0 C--O 1.213 -0.836 0 CA-C-N 114.133 -1.394 . . . . 75.24 110.031 179.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 129' ' ' GLU . . . . . 0.532 ' HA ' ' HB2' ' C' ' 132' ' ' HIS . 50.3 mm-40 -77.2 -22.85 51.74 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.783 0.833 . . . . 75.51 111.225 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 130' ' ' ALA . . . . . 0.457 ' HB2' ' HA2' ' C' ' 152' ' ' GLY . . . -72.26 -35.26 68.73 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 109.297 -0.631 . . . . 73.14 109.297 175.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 131' ' ' PHE . . . . . 0.497 ' HB2' HD12 ' C' ' 215' ' ' LEU . 10.5 t80 -71.09 -43.56 67.47 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 114.131 -1.395 . . . . 75.55 110.855 168.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 132' ' ' HIS . . . . . 0.532 ' HB2' ' HA ' ' C' ' 129' ' ' GLU . 32.4 m170 -75.32 -6.82 51.88 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.854 0.461 . . . . 70.15 110.378 -178.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -59.57 77.81 0.01 OUTLIER Glycine 0 C--N 1.356 1.648 0 C-N-CA 123.815 0.721 . . . . 65.31 112.904 168.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . -113.94 -152.61 10.78 Favored Glycine 0 C--N 1.342 0.884 0 N-CA-C 109.417 -1.473 . . . . 73.12 109.417 174.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -71.55 92.99 1.17 Allowed 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 108.409 -0.96 . . . . 73.03 108.409 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 136' ' ' ARG . . . . . 0.538 ' HB2' HD22 ' B' ' 181' ' ' LEU . 78.3 mtp180 -139.55 159.48 42.06 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.116 0.966 . . . . 72.12 109.589 -173.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 137' ' ' VAL . . . . . . . . . . . . . 93.5 t -70.78 98.87 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.887 0 CA-C-O 121.978 0.894 . . . . 73.11 110.664 -175.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 138' ' ' VAL . . . . . . . . . . . . . 72.9 t -79.17 112.16 16.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 CA-C-N 113.853 -1.521 . . . . 72.14 107.831 169.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 139' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -115.69 82.22 1.72 Allowed 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 108.092 -1.077 . . . . 74.31 108.092 -170.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 140' ' ' VAL . . . . . 0.464 HG11 HD13 ' C' ' 174' ' ' LEU . 67.4 t -122.86 104.65 14.82 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 C-N-CA 124.292 1.037 . . . . 73.25 110.833 -169.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 69.21 15.01 8.64 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 125.145 1.378 . . . . 65.0 113.388 168.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 116.8 -30.15 6.51 Favored Glycine 0 C--N 1.339 0.746 0 N-CA-C 110.987 -0.845 . . . . 52.4 110.987 -175.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 143' ' ' ARG . . . . . 0.481 ' CZ ' ' HB ' ' C' ' 145' ' ' VAL . 13.0 tpt180 -70.73 114.32 8.7 Favored 'General case' 0 C--N 1.361 1.092 0 N-CA-C 109.055 -0.72 . . . . 75.05 109.055 177.005 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 7.5 ttt-85 -114.27 99.26 7.47 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 115.339 -0.846 . . . . 71.51 108.95 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 145' ' ' VAL . . . . . 0.564 HG21 ' HB ' ' C' ' 147' ' ' VAL . 3.1 p -124.85 124.41 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.473 1.109 . . . . 75.03 110.028 -178.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 29.2 m -87.13 86.41 7.29 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 108.906 -0.775 . . . . 73.22 108.906 177.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 147' ' ' VAL . . . . . 0.564 ' HB ' HG21 ' C' ' 145' ' ' VAL . 7.3 p -134.81 160.56 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 124.114 0.966 . . . . 72.53 110.59 -169.214 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 28.5 ttm-85 -90.18 104.89 17.41 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 108.11 -1.071 . . . . 74.22 108.11 168.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 149' ' ' ILE . . . . . 0.403 HG12 HD23 ' B' ' 181' ' ' LEU . 29.6 pt -69.34 150.73 97.09 Favored Pre-proline 0 CA--C 1.548 0.872 0 CA-C-O 117.755 -1.117 . . . . 74.42 108.438 165.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 150' ' ' PRO . . . . . 0.516 ' HD2' HG22 ' C' ' 161' ' ' VAL . 28.4 Cg_exo -38.68 107.97 0.07 OUTLIER 'Trans proline' 0 C--N 1.393 2.88 0 C-N-CA 123.415 2.743 . . . . 61.44 113.124 178.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -69.71 130.66 19.79 Favored 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 122.671 2.247 . . . . 73.2 111.541 -171.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 152' ' ' GLY . . . . . 0.539 ' HA3' HD22 ' C' ' 188' ' ' LEU . . . 91.71 112.01 1.8 Allowed Glycine 0 C--N 1.342 0.905 0 CA-C-N 115.645 -0.707 . . . . 63.11 113.091 -177.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 153' ' ' VAL . . . . . 0.599 HG21 HG22 ' C' ' 178' ' ' VAL . 3.0 m -123.64 177.66 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 C-N-CA 123.745 0.818 . . . . 74.01 109.595 -173.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 154' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -135.03 155.48 50.69 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 123.429 0.692 . . . . 75.32 110.775 -178.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 155' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -67.88 102.53 1.27 Allowed 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.911 1.284 . . . . 74.51 112.036 -176.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 97.36 3.5 58.66 Favored Glycine 0 C--N 1.348 1.236 0 CA-C-N 115.354 -0.839 . . . . 75.21 113.009 179.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 157' ' ' SER . . . . . . . . . . . . . 52.0 m -95.75 169.82 9.74 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 117.205 0.502 . . . . 75.43 111.394 -175.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 158' ' ' VAL . . . . . 0.414 HG13 HG21 ' C' ' 177' ' ' VAL . 27.6 m -105.68 127.87 60.27 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 CA-C-O 121.604 0.716 . . . . 72.31 111.038 178.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 159' ' ' ILE . . . . . 0.583 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 15.2 mt -78.07 98.21 2.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 107.995 -1.113 . . . . 72.31 107.995 168.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 36.5 ttp180 -78.74 99.64 6.74 Favored 'General case' 0 C--O 1.239 0.51 0 O-C-N 123.794 0.684 . . . . 75.13 109.683 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 161' ' ' VAL . . . . . 0.598 ' HB ' ' HB3' ' C' ' 174' ' ' LEU . 19.3 t -95.99 113.11 61.52 Favored Pre-proline 0 C--O 1.251 1.15 0 N-CA-C 108.223 -1.028 . . . . 75.24 108.223 175.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -53.31 106.95 0.17 Allowed 'Trans proline' 0 C--N 1.381 2.277 0 C-N-CA 123.848 3.032 . . . . 75.23 114.476 -174.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 71.44 16.4 75.61 Favored Glycine 0 C--N 1.347 1.189 0 N-CA-C 115.694 1.038 . . . . 53.54 115.694 168.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 164' ' ' MET . . . . . 0.425 ' HE2' HG13 ' C' ' 161' ' ' VAL . 37.5 ttp -105.28 21.76 16.58 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 118.143 0.972 . . . . 73.35 110.939 -178.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . -78.12 -121.81 0.26 Allowed Glycine 0 C--N 1.35 1.345 0 CA-C-O 119.42 -0.656 . . . . 73.32 112.311 174.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . 150.98 -80.1 0.2 Allowed Glycine 0 C--N 1.356 1.639 0 C-N-CA 118.909 -1.615 . . . . 75.44 114.442 170.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 167' ' ' GLN . . . . . 0.533 ' HB3' HH21 ' C' ' 117' ' ' ARG . 31.6 mm-40 -14.91 101.18 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.491 0 C-N-CA 126.244 1.818 . . . . 74.2 114.043 -161.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . 115.1 143.57 8.11 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 109.078 -1.609 . . . . 13.44 109.078 -162.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 169' ' ' ASN . . . . . 0.651 HD22 HG21 ' C' ' 90' ' ' VAL . 2.7 t-20 -54.76 -57.61 18.36 Favored Pre-proline 0 CA--C 1.572 1.812 0 N-CA-C 114.597 1.332 . . . . 62.44 114.597 -164.041 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 170' ' ' PRO . . . . . 0.447 ' HD3' ' HB3' ' C' ' 169' ' ' ASN . 33.1 Cg_exo -62.18 154.16 64.72 Favored 'Trans proline' 0 C--N 1.393 2.905 0 CA-C-N 121.93 1.725 . . . . 73.55 112.208 172.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 171' ' ' PRO . . . . . 0.467 ' HB3' ' O ' ' C' ' 85' ' ' PHE . 22.7 Cg_endo -62.08 129.88 28.75 Favored 'Trans proline' 0 C--N 1.368 1.553 0 C-N-CA 122.234 1.956 . . . . 74.02 112.828 175.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -99.39 -175.23 31.37 Favored Glycine 0 N--CA 1.474 1.174 0 N-CA-C 110.51 -1.036 . . . . 74.42 110.51 166.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 173' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -98.91 152.97 19.19 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 117.993 0.896 . . . . 74.51 109.302 178.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 174' ' ' LEU . . . . . 0.598 ' HB3' ' HB ' ' C' ' 161' ' ' VAL . 26.5 tp -99.25 121.74 41.47 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 121.946 -0.472 . . . . 75.22 110.585 -176.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 81.3 mt -117.74 87.71 2.77 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.281 0.632 . . . . 72.15 109.9 176.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 176' ' ' LEU . . . . . 0.583 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 48.6 mt -76.22 108.46 9.17 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 116.232 -0.44 . . . . 74.33 109.949 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 177' ' ' VAL . . . . . 0.414 HG21 HG13 ' C' ' 158' ' ' VAL . 61.5 t -81.82 106.46 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 N-CA-C 108.256 -1.016 . . . . 75.23 108.256 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 178' ' ' VAL . . . . . 0.599 HG22 HG21 ' C' ' 153' ' ' VAL . 4.0 p -95.64 138.83 20.24 Favored 'Isoleucine or valine' 0 C--O 1.242 0.69 0 CA-C-N 114.344 -1.298 . . . . 74.01 110.344 -177.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 179' ' ' ARG . . . . . . . . . . . . . 52.4 mmm-85 -121.68 109.9 15.31 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 107.73 -1.211 . . . . 74.42 107.73 175.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 180' ' ' LEU . . . . . 0.47 ' HA ' ' O ' ' C' ' 125' ' ' LEU . 87.6 mt -71.11 147.87 48.02 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.199 0.6 . . . . 73.43 111.843 -176.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 181' ' ' LEU . . . . . . . . . . . . . 30.5 mt -62.01 167.83 4.42 Favored Pre-proline 0 CA--C 1.559 1.316 0 C-N-CA 124.892 1.277 . . . . 74.24 112.106 -179.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -42.43 -1.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.398 3.157 1 C-N-CA 125.364 4.043 . . . . 73.32 118.557 175.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 183' ' ' HIS . . . . . 0.482 ' HE1' ' HE1' ' C' ' 213' ' ' MET . 0.9 OUTLIER -127.2 81.2 70.42 Favored Pre-proline 0 CA--C 1.562 1.438 0 CA-C-N 118.971 0.805 . . . . 72.0 109.792 166.017 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' C' C ' 184' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -85.51 69.6 5.23 Favored 'Trans proline' 0 C--N 1.371 1.713 0 C-N-CA 123.628 2.886 . . . . 74.25 110.485 174.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 185' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 3.9 t -89.89 -42.37 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 109.843 -0.429 . . . . 72.23 109.843 -165.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 186' ' ' PHE . . . . . 0.592 ' HB3' HD22 ' C' ' 193' ' ' LEU . 20.9 m-85 -99.38 116.05 30.65 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.369 0.604 . . . . 61.44 112.425 -170.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 187' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -102.51 101.77 11.99 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.312 1.445 . . . . 75.14 107.339 171.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 188' ' ' LEU . . . . . 0.539 HD22 ' HA3' ' C' ' 152' ' ' GLY . 57.8 tp -92.55 141.16 28.8 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 113.301 0.852 . . . . 74.14 113.301 -169.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -125.23 101.25 6.9 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 107.857 -1.164 . . . . 73.21 107.857 160.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 72.2 -81.12 0.59 Allowed Glycine 0 C--N 1.353 1.504 0 CA-C-N 115.18 -0.918 . . . . 74.2 113.51 176.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 191' ' ' GLN . . . . . 0.582 ' HA ' ' HB2' ' C' ' 240' ' ' PHE . 19.4 mt-30 -132.64 -9.94 3.16 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.318 0.647 . . . . 75.25 111.746 178.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -105.49 115.38 30.16 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 121.23 0.538 . . . . 65.13 110.587 -176.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 193' ' ' LEU . . . . . 0.592 HD22 ' HB3' ' C' ' 186' ' ' PHE . 72.2 mt -86.0 152.27 23.06 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.932 1.293 . . . . 65.15 111.132 -178.061 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 194' ' ' TYR . . . . . 0.455 ' O ' ' HA ' ' C' ' 186' ' ' PHE . 49.7 t80 -111.98 148.96 32.68 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 107.25 -1.389 . . . . 75.43 107.25 162.211 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 195' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' C' ' 185' ' ' VAL . . . -154.42 -176.95 6.14 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.078 0.551 . . . . 65.11 111.177 -177.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 40.2 m -128.36 139.05 52.59 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.049 -0.978 . . . . 53.42 108.893 168.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 197' ' ' LEU . . . . . 0.412 HD12 HD22 ' C' ' 251' ' ' LEU . 35.9 tp -115.53 143.46 45.28 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.522 1.129 . . . . 73.5 108.473 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -113.04 102.1 10.09 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.388 -0.597 . . . . 64.33 109.388 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 199' ' ' VAL . . . . . 0.584 ' HA ' HG11 ' C' ' 210' ' ' VAL . 95.2 t -108.08 119.36 50.17 Favored Pre-proline 0 N--CA 1.473 0.698 0 C-N-CA 123.901 0.88 . . . . 73.12 109.005 176.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 200' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.94 149.54 65.91 Favored 'Trans proline' 0 C--N 1.371 1.751 0 C-N-CA 121.858 1.705 . . . . 73.11 110.934 175.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 201' ' ' ALA . . . . . . . . . . . . . . . -56.02 -43.44 99.23 Favored Pre-proline 0 CA--C 1.553 1.093 0 N-CA-C 114.093 1.145 . . . . 74.35 114.093 -174.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 202' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -54.18 -53.44 6.31 Favored 'Trans proline' 0 C--N 1.398 3.156 0 C-N-CA 121.752 1.635 . . . . 63.15 112.286 175.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 203' ' ' ILE . . . . . . . . . . . . . 41.0 mt -62.73 -32.99 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 124.554 1.142 . . . . 74.02 111.209 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.96 -43.9 81.92 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.756 0.822 . . . . 75.02 112.013 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 205' ' ' VAL . . . . . . . . . . . . . 87.9 t -71.7 -47.95 54.38 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 123.256 0.622 . . . . 74.52 111.199 -179.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 206' ' ' VAL . . . . . 0.571 HG21 ' HE2' ' A' ' 270' ' ' LYS . 14.7 p -80.1 -34.74 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 112.761 0.652 . . . . 74.12 112.761 -171.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 90.57 104.5 1.25 Allowed Glycine 0 C--N 1.343 0.92 0 N-CA-C 111.069 -0.812 . . . . 63.21 111.069 -167.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -143.44 -126.71 2.03 Favored Glycine 0 C--N 1.343 0.927 0 N-CA-C 111.679 -0.568 . . . . 51.32 111.679 -176.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 209' ' ' LYS . . . . . 0.473 ' HG2' ' HG2' ' C' ' 220' ' ' GLU . 34.1 ttmt -157.21 137.18 12.53 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 117.633 0.717 . . . . 72.44 110.85 -176.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 210' ' ' VAL . . . . . 0.584 HG11 ' HA ' ' C' ' 199' ' ' VAL . 23.4 m -129.95 177.03 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 125.501 1.52 . . . . 71.52 109.526 174.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 211' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.46 149.99 28.76 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 118.436 0.562 . . . . 75.53 111.204 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -129.5 118.55 22.26 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 107.45 -1.315 . . . . 74.43 107.45 166.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 213' ' ' MET . . . . . 0.482 ' HE1' ' HE1' ' C' ' 183' ' ' HIS . 1.4 tmm? -73.82 117.79 16.02 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.344 -0.984 . . . . 63.12 108.344 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 214' ' ' THR . . . . . 0.4 HG22 ' H ' ' C' ' 215' ' ' LEU . 0.2 OUTLIER -122.8 175.76 6.36 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 119.014 0.824 . . . . 72.34 112.095 -173.521 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' C' C ' 215' ' ' LEU . . . . . 0.497 HD12 ' HB2' ' C' ' 131' ' ' PHE . 41.7 mt -75.82 -29.8 58.78 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.459 1.503 . . . . 75.24 112.012 -171.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -87.11 3.28 46.86 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 114.803 -1.09 . . . . 71.0 110.272 176.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 118.26 -178.22 16.75 Favored Glycine 0 C--N 1.348 1.208 0 N-CA-C 110.433 -1.067 . . . . 74.41 110.433 -172.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -75.26 125.2 9.0 Favored 'Trans proline' 0 CA--C 1.554 1.477 0 C-N-CA 121.954 1.769 . . . . 64.03 111.97 178.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 219' ' ' VAL . . . . . 0.458 HG22 HG22 ' B' ' 238' ' ' THR . 14.0 p -100.56 157.51 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 N-CA-C 106.865 -1.531 . . . . 52.53 106.865 171.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 220' ' ' GLU . . . . . 0.473 ' HG2' ' HG2' ' C' ' 209' ' ' LYS . 16.5 tt0 -126.63 108.33 11.01 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.859 -0.793 . . . . 72.32 108.859 -177.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 221' ' ' VAL . . . . . 0.404 HG22 HD21 ' C' ' 235' ' ' LEU . 32.1 t -68.9 123.99 23.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 125.858 1.663 . . . . 74.03 111.2 -174.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -84.67 108.49 17.42 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 109.413 -0.588 . . . . 73.3 109.413 172.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 61.1 t -84.25 127.64 65.54 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 123.744 0.818 . . . . 73.11 110.508 -176.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 224' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -79.76 161.83 24.33 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 123.233 2.622 . . . . 73.11 111.082 168.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -63.12 159.05 40.7 Favored 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 122.427 2.084 . . . . 74.4 113.483 177.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 226' ' ' ARG . . . . . 0.428 ' HD2' ' O ' ' A' ' 259' ' ' GLU . 9.5 mmt180 55.3 63.0 2.24 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.514 1.526 . . . . 71.5 111.894 177.078 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 227' ' ' THR . . . . . . . . . . . . . 52.4 m -96.92 128.93 44.36 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 123.815 0.846 . . . . 73.3 110.97 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 228' ' ' GLN . . . . . 0.469 ' NE2' ' HG3' ' A' ' 259' ' ' GLU . 27.8 mp0 -105.23 147.67 27.8 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 124.545 1.138 . . . . 74.32 111.893 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -73.28 123.4 23.65 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 115.43 -0.805 . . . . 65.31 109.264 177.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 116.12 -7.41 18.99 Favored Glycine 0 C--N 1.337 0.599 0 O-C-N 123.522 0.514 . . . . 62.04 112.064 -176.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 231' ' ' ARG . . . . . 0.576 ' HD3' ' HZ3' ' B' ' 242' ' ' TRP . 36.0 mtt180 -63.02 169.57 3.27 Favored 'General case' 0 C--N 1.354 0.79 0 CA-C-N 116.846 0.323 . . . . 75.03 110.925 171.072 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 232' ' ' LYS . . . . . 0.627 ' HZ2' ' HB2' ' C' ' 232' ' ' LYS . 3.7 ttmp? -139.29 147.06 41.13 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.567 -0.531 . . . . 74.05 109.567 176.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 233' ' ' LEU . . . . . 0.467 ' O ' ' HA ' ' C' ' 250' ' ' TYR . 1.7 tt -133.01 125.01 28.77 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.693 0.797 . . . . 74.22 109.308 -166.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -93.19 104.22 16.43 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-O 121.065 0.459 . . . . 72.34 110.614 170.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 235' ' ' LEU . . . . . 0.404 HD21 HG22 ' C' ' 221' ' ' VAL . 75.8 mt -85.11 123.88 31.14 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.391 -0.966 . . . . 74.34 108.391 166.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -85.32 131.75 34.36 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 123.349 0.66 . . . . 73.41 111.541 -171.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 80.83 -1.28 84.45 Favored Glycine 0 C--N 1.351 1.402 0 O-C-N 124.033 0.833 . . . . 71.42 113.687 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 14.0 mmtm -95.11 9.05 41.03 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.19 0.996 . . . . 75.11 112.019 -172.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -86.29 -133.01 3.27 Favored Glycine 0 C--N 1.346 1.085 0 N-CA-C 111.723 -0.551 . . . . 75.2 111.723 172.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 240' ' ' PHE . . . . . 0.582 ' HB2' ' HA ' ' C' ' 191' ' ' GLN . 1.9 m-85 -103.37 128.45 27.48 Favored Pre-proline 0 N--CA 1.47 0.558 0 C-N-CA 123.105 0.562 . . . . 75.14 110.132 177.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 241' ' ' PRO . . . . . 0.509 ' HA ' ' HG2' ' C' ' 246' ' ' ARG . 31.4 Cg_exo -61.98 105.21 0.37 Allowed 'Trans proline' 0 C--N 1.37 1.688 0 C-N-CA 123.405 2.736 . . . . 71.53 112.916 173.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -75.67 173.16 53.58 Favored Glycine 0 CA--C 1.531 1.081 0 CA-C-N 115.195 -0.911 . . . . 70.14 112.798 174.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -64.86 -17.17 58.69 Favored 'Trans proline' 0 C--N 1.367 1.545 0 C-N-CA 123.184 2.589 . . . . 71.42 113.955 -170.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -130.84 1.07 4.34 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.631 0.773 . . . . 71.42 111.907 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . -173.19 -136.66 2.22 Favored Glycine 0 C--N 1.35 1.349 0 CA-C-O 119.648 -0.529 . . . . 63.24 113.09 -178.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 246' ' ' ARG . . . . . 0.509 ' HG2' ' HA ' ' C' ' 241' ' ' PRO . 77.8 mtm180 -150.04 165.06 33.89 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.826 0.851 . . . . 71.32 110.891 -176.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -102.35 -166.66 26.63 Favored Glycine 0 C--N 1.35 1.322 0 CA-C-N 114.801 -1.091 . . . . 63.23 111.951 174.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -129.44 164.12 24.36 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 121.114 0.483 . . . . 73.54 110.359 -171.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 249' ' ' LEU . . . . . . . . . . . . . 17.7 tp -120.18 127.62 52.63 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.167 0.987 . . . . 74.23 109.401 -174.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 250' ' ' TYR . . . . . 0.467 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 79.0 m-85 -117.24 100.78 7.93 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.704 0.802 . . . . 71.43 110.323 -177.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 251' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' C' ' 232' ' ' LYS . 0.6 OUTLIER -100.97 134.29 44.19 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 109.932 -0.395 . . . . 72.0 109.932 -176.133 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -76.68 107.73 9.19 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.145 -1.057 . . . . 75.41 108.145 168.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 253' ' ' VAL . . . . . . . . . . . . . 46.2 t -75.07 113.78 14.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 115.199 -0.91 . . . . 73.5 110.2 -176.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 254' ' ' ARG . . . . . . . . . . . . . 39.1 mtm180 -97.13 155.46 16.81 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.297 0.639 . . . . 75.13 110.882 177.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 255' ' ' ILE . . . . . . . . . . . . . 36.9 mm -101.56 124.88 55.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 114.764 -1.107 . . . . 75.24 108.052 166.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 256' ' ' THR . . . . . 0.405 ' HA ' HD12 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -130.07 175.97 8.46 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.138 1.375 . . . . 70.25 108.536 -178.775 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 35.4 pt -131.16 147.88 67.99 Favored Pre-proline 0 N--CA 1.484 1.243 0 C-N-CA 123.491 0.716 . . . . 75.21 110.047 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -62.56 -12.89 30.3 Favored 'Trans proline' 0 C--N 1.377 2.07 0 C-N-CA 122.862 2.375 . . . . 74.41 113.858 -172.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 54.24 -67.58 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 125.481 1.512 . . . . 72.3 112.194 -164.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 8.0 ppt_? -60.07 132.7 54.76 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.264 0.626 . . . . 73.41 110.433 174.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 261' ' ' LEU . . . . . . . . . . . . . 92.4 mt -139.9 147.86 41.2 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.728 0.811 . . . . 74.53 109.978 -174.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 74.4 p -81.89 160.45 63.56 Favored Pre-proline 0 CA--C 1.553 1.084 0 N-CA-C 107.97 -1.122 . . . . 61.23 107.97 168.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -45.84 -44.08 18.67 Favored 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 122.782 2.322 . . . . 74.2 112.538 172.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -60.97 -54.18 48.14 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-N 114.18 -1.373 . . . . 71.04 111.514 176.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -50.02 -58.45 5.46 Favored 'General case' 0 C--N 1.359 0.994 0 O-C-N 124.284 0.99 . . . . 71.03 109.992 -177.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 266' ' ' GLU . . . . . 0.461 ' O ' ' HG2' ' C' ' 270' ' ' LYS . 26.8 tt0 -61.34 -38.21 86.09 Favored 'General case' 0 C--N 1.349 0.574 0 CA-C-N 114.719 -1.128 . . . . 73.1 111.336 -175.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -57.28 -46.43 83.11 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.201 0.6 . . . . 71.12 112.351 177.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 268' ' ' LEU . . . . . 0.47 ' HB2' HD21 ' A' ' 272' ' ' LEU . 10.4 mp -66.15 -39.97 90.21 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 116.407 -0.36 . . . . 70.11 110.89 177.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -60.44 -36.0 77.17 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 123.266 0.354 . . . . 63.11 111.277 174.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 270' ' ' LYS . . . . . 0.461 ' HG2' ' O ' ' C' ' 266' ' ' GLU . 34.2 mmtp -64.08 -45.94 86.49 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.397 0.679 . . . . 75.43 110.439 178.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -56.29 -47.42 78.69 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 124.036 0.835 . . . . 75.33 111.577 176.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 91.3 mt -61.42 -42.09 98.19 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 114.834 -1.075 . . . . 74.33 110.803 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -61.47 -40.4 94.39 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.373 0.669 . . . . 43.22 111.046 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -68.16 -34.06 75.62 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.715 0.806 . . . . 63.21 111.634 177.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -62.67 -31.43 72.32 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 115.838 -0.619 . . . . 70.04 110.331 172.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 276' ' ' TYR . . . . . 0.476 ' HB3' HD12 ' A' ' 203' ' ' ILE . 53.6 m-85 -79.82 -30.99 40.61 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.084 0.554 . . . . 75.52 112.437 171.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 19.0 m-30 -68.11 -24.23 65.0 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 118.517 0.599 . . . . 65.52 110.205 178.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -61.32 -8.3 3.74 Favored 'General case' 0 CA--C 1.559 1.326 0 C-N-CA 124.193 0.997 . . . . 72.22 113.425 172.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 279' ' ' ARG . . . . . . . . . . . . . 81.3 mtt180 -73.59 -24.07 60.01 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 122.739 0.416 . . . . 75.11 112.005 174.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.556 1.186 0 O-C-N 124.417 1.073 . . . . 75.14 112.781 -167.514 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp . . . . . 0 CA--C 1.553 1.07 0 N-CA-C 113.789 1.033 . . . . 64.14 113.789 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.409 ' HB3' HD13 ' A' ' 10' ' ' ILE . 51.3 mtmt -87.96 128.18 35.38 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 108.565 -0.902 . . . . 74.32 108.565 169.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.504 ' HA ' ' OH ' ' A' ' 66' ' ' TYR . 10.7 t70 -76.48 105.81 7.75 Favored 'General case' 0 C--N 1.347 0.491 0 N-CA-C 109.187 -0.672 . . . . 62.43 109.187 -177.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -68.44 -33.31 73.98 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.692 0.797 . . . . 73.34 112.531 -170.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -64.12 -45.62 87.77 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 109.634 -0.506 . . . . 73.33 109.634 174.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.48 -42.1 95.59 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.632 -0.713 . . . . 70.01 111.375 178.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.409 HD13 ' HB3' ' A' ' 5' ' ' LYS . 81.4 mt -58.79 -42.22 84.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 123.676 0.79 . . . . 74.23 110.231 176.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.2 mt -76.14 -11.81 60.0 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 112.912 0.708 . . . . 73.11 112.912 178.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.56 35.09 56.12 Favored Glycine 0 C--N 1.351 1.385 0 O-C-N 122.972 0.17 . . . . 73.42 112.709 -178.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.5 m -127.1 154.5 76.67 Favored Pre-proline 0 CA--C 1.552 1.028 0 C-N-CA 124.916 1.286 . . . . 72.52 109.608 178.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -74.57 168.56 24.52 Favored 'Trans proline' 0 C--N 1.374 1.914 0 C-N-CA 122.282 1.988 . . . . 50.12 112.25 177.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 83.7 mtt180 -75.12 17.36 0.24 Allowed 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 113.142 0.793 . . . . 75.43 113.142 -178.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -124.78 15.42 8.67 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.101 0.96 . . . . 71.2 108.974 173.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.11 112.08 2.84 Favored 'General case' 0 C--N 1.349 0.566 0 CA-C-N 115.069 -0.969 . . . . 74.14 110.437 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 62.1 p -72.31 169.76 15.57 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.59 0.756 . . . . 75.03 109.708 176.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -54.03 -41.06 67.62 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.954 0.902 . . . . 71.11 112.07 -177.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -65.69 -41.28 92.6 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.187 0.595 . . . . 72.43 110.598 -177.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -69.29 -40.81 77.51 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.36 0.664 . . . . 71.14 111.014 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.507 HD11 ' HB3' ' A' ' 57' ' ' LEU . 60.9 mt -68.68 -32.86 56.74 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 C-N-CA 124.271 1.028 . . . . 73.31 110.721 178.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp -73.49 -37.88 65.57 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.177 0.991 . . . . 75.22 110.341 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -75.72 -29.25 58.86 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.044 0.538 . . . . 73.12 110.909 175.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.87 -33.85 71.01 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.351 0.66 . . . . 72.43 110.073 174.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -64.96 -53.05 52.36 Favored 'General case' 0 C--O 1.201 -1.466 0 CA-C-N 114.916 -1.038 . . . . 73.1 109.369 173.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -54.08 -40.14 66.96 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.643 0.777 . . . . 74.22 111.703 178.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.406 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 61.0 ttt180 -55.08 -68.19 0.21 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.174 1.39 . . . . 75.52 110.79 177.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.712 ' HB3' HD12 ' A' ' 50' ' ' ILE . 96.2 mt -74.43 -16.71 60.86 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.411 -0.813 . . . . 75.12 111.745 -174.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.21 -56.71 8.75 Favored 'General case' 0 C--O 1.204 -1.306 0 N-CA-C 108.177 -1.046 . . . . 71.54 108.177 174.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 69.2 mtp180 -55.22 -51.88 65.17 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 124.127 0.892 . . . . 72.33 110.768 177.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.406 ' HG2' ' O ' ' A' ' 28' ' ' ARG . 14.5 mm100 -54.28 -47.13 72.68 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 124.303 1.002 . . . . 73.31 111.728 -178.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.41 ' HE2' HD23 ' A' ' 29' ' ' LEU . 27.7 m-85 -117.82 29.54 7.77 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.36 0.664 . . . . 72.41 111.775 -168.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -75.84 111.79 16.56 Favored Pre-proline 0 N--CA 1.485 1.281 0 CA-C-O 117.795 -1.098 . . . . 73.54 109.705 -179.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.4 -26.86 83.71 Favored 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 122.516 2.144 . . . . 75.51 111.759 176.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -59.81 -37.39 79.04 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.126 1.37 . . . . 73.23 111.572 175.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 73.5 t -101.97 -58.66 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 CA-C-O 121.478 0.656 . . . . 73.25 109.74 -178.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -97.0 98.96 10.51 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.122 1.369 . . . . 64.12 109.739 -177.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -74.36 82.76 1.91 Allowed 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.953 -0.758 . . . . 73.11 108.953 177.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 53.7 m -139.64 113.52 7.87 Favored Pre-proline 0 N--CA 1.474 0.753 0 CA-C-O 118.492 -0.765 . . . . 71.24 109.281 177.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -48.19 -40.95 34.97 Favored 'Trans proline' 0 C--N 1.385 2.48 0 C-N-CA 123.606 2.87 . . . . 73.53 113.437 178.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -55.15 -47.03 75.68 Favored 'General case' 0 C--O 1.248 0.999 0 C-N-CA 124.578 1.151 . . . . 64.43 110.696 175.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.64 -23.04 63.43 Favored 'General case' 0 C--N 1.354 0.787 0 CA-C-N 115.077 -0.965 . . . . 73.42 110.782 -178.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.521 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 33.5 mt-10 -76.31 -49.11 17.8 Favored 'General case' 0 C--N 1.358 0.957 0 O-C-N 123.511 0.507 . . . . 63.35 109.781 -176.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -67.95 -39.68 83.38 Favored 'General case' 0 C--O 1.251 1.166 0 O-C-N 123.801 0.688 . . . . 62.44 110.927 -179.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 42.8 mttp -56.94 -48.95 77.1 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 116.168 -0.469 . . . . 74.03 110.177 170.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -59.71 -32.91 70.97 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.101 0.96 . . . . 73.32 110.84 179.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.521 ' HG2' ' O ' ' A' ' 44' ' ' GLU . 33.5 mmtp -66.66 -43.41 84.63 Favored 'General case' 0 C--N 1.349 0.548 0 CA-C-O 119.245 -0.407 . . . . 75.14 110.662 177.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -68.17 -26.56 65.81 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 123.706 0.629 . . . . 71.44 112.278 176.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.712 HD12 ' HB3' ' A' ' 29' ' ' LEU . 59.5 mt -76.76 -35.2 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 124.106 0.962 . . . . 74.43 110.242 175.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -79.3 -21.61 45.73 Favored 'General case' 0 C--O 1.212 -0.891 0 C-N-CA 123.889 0.875 . . . . 73.43 110.621 175.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -77.27 -45.64 25.71 Favored 'General case' 0 C--O 1.247 0.924 0 C-N-CA 124.977 1.311 . . . . 75.34 108.726 176.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.78 -47.45 82.51 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-N 113.672 -1.604 . . . . 65.45 110.184 174.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.487 ' HD2' ' HZ ' ' A' ' 88' ' ' PHE . 16.6 t80 -76.48 -23.27 53.8 Favored 'General case' 0 C--O 1.207 -1.166 0 CA-C-N 115.435 -0.802 . . . . 73.53 110.713 177.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.412 ' HB1' ' HD2' ' A' ' 85' ' ' PHE . . . -60.97 -36.16 78.69 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 118.833 0.742 . . . . 72.52 110.875 175.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.541 HG13 ' HB2' ' A' ' 66' ' ' TYR . 19.2 t -76.04 -57.66 5.79 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 CA-C-N 115.363 -0.835 . . . . 74.52 110.099 171.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.507 ' HB3' HD11 ' A' ' 22' ' ' ILE . 49.2 mt -87.31 12.0 12.99 Favored 'General case' 0 CA--C 1.561 1.397 0 CA-C-N 115.003 -0.999 . . . . 74.35 112.964 -164.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.438 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 26.0 t -69.06 -38.61 79.17 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 123.933 0.893 . . . . 74.34 111.228 176.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.486 ' HB2' ' HD3' ' A' ' 62' ' ' LYS . 8.8 m-20 -124.6 142.07 39.57 Favored Pre-proline 0 N--CA 1.475 0.813 0 N-CA-C 108.96 -0.755 . . . . 74.34 108.96 -177.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.412 ' O ' ' HG2' ' A' ' 64' ' ' ARG . 40.0 Cg_exo -58.04 -27.45 79.57 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 122.972 2.448 . . . . 72.41 113.115 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -59.43 -58.72 7.39 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.012 0.925 . . . . 72.3 110.817 176.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.486 ' HD3' ' HB2' ' A' ' 59' ' ' ASP . 20.8 mtpt -73.07 -29.56 63.04 Favored 'General case' 0 C--O 1.249 1.078 0 CA-C-N 114.53 -1.214 . . . . 74.54 111.029 -175.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.416 ' HG3' HD22 ' A' ' 57' ' ' LEU . 61.6 ttt-85 -60.05 -43.92 95.05 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.204 -0.907 . . . . 74.11 109.462 172.215 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.412 ' HG2' ' O ' ' A' ' 60' ' ' PRO . 22.8 mmt180 -68.93 -31.34 70.17 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 123.736 0.648 . . . . 74.25 112.029 177.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.444 HD11 ' HA ' ' A' ' 62' ' ' LYS . 87.3 mt -54.38 -46.5 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 CA-C-O 121.255 0.55 . . . . 74.41 109.653 169.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.541 ' HB2' HG13 ' A' ' 56' ' ' VAL . 7.7 t80 -63.82 -49.99 70.7 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 115.532 -0.758 . . . . 75.4 111.377 175.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -57.68 -36.07 71.43 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.997 0.919 . . . . 64.04 111.323 -176.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 60.8 p -79.31 -28.08 42.18 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 119.054 -0.498 . . . . 75.44 110.922 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -67.88 102.78 1.32 Allowed 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 109.455 -0.572 . . . . 75.32 109.455 176.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 119.68 17.63 4.64 Favored Glycine 0 N--CA 1.473 1.124 0 C-N-CA 124.053 0.835 . . . . 64.23 111.346 -170.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 67.8 m -150.61 -55.75 0.16 Allowed 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 104.208 -2.516 . . . . 71.23 104.208 177.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 34.0 m -78.98 138.45 38.06 Favored 'General case' 0 C--O 1.251 1.146 0 N-CA-C 104.466 -2.42 . . . . 74.23 104.466 156.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.75 -31.58 12.17 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.015 0.526 . . . . 74.04 110.122 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.72 152.15 87.04 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 123.923 0.889 . . . . 75.1 110.314 175.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -62.32 116.58 3.59 Favored 'Trans proline' 0 C--N 1.375 1.934 0 C-N-CA 122.262 1.975 . . . . 75.41 109.952 168.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -51.02 144.99 26.33 Favored 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 123.653 2.902 . . . . 74.25 114.07 -177.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -50.54 124.46 13.36 Favored 'Trans proline' 0 C--N 1.389 2.705 0 C-N-CA 123.828 3.019 . . . . 73.45 113.279 -174.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -63.87 135.33 47.59 Favored 'Trans proline' 0 C--N 1.379 2.152 0 C-N-CA 122.627 2.218 . . . . 73.2 112.227 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -51.16 149.91 15.07 Favored 'Trans proline' 0 C--N 1.378 2.091 0 C-N-CA 122.932 2.422 . . . . 71.05 112.281 168.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -61.3 85.23 0.09 OUTLIER 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 123.183 2.589 . . . . 74.31 113.266 -175.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 150.03 -34.29 1.02 Allowed Glycine 0 N--CA 1.466 0.674 0 N-CA-C 109.963 -1.255 . . . . 62.41 109.963 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 140.76 -152.73 23.27 Favored Glycine 0 C--N 1.35 1.32 0 C-N-CA 124.151 0.882 . . . . 53.03 110.955 175.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -99.01 113.22 25.29 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.152 0.981 . . . . 74.41 108.897 175.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -55.1 141.76 33.32 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.638 1.175 . . . . 71.31 111.47 174.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.429 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 55.8 m-85 -140.58 77.99 1.63 Allowed 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 124.429 1.092 . . . . 73.24 110.215 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.56 ' HA ' ' HA3' ' A' ' 163' ' ' GLY . 1.7 m -45.62 82.86 0.0 OUTLIER 'General case' 0 CA--C 1.561 1.392 0 C-N-CA 125.892 1.677 . . . . 74.44 113.225 -177.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 62.4 28.48 71.15 Favored Glycine 0 C--N 1.349 1.282 0 CA-C-N 116.044 -0.525 . . . . 70.11 114.306 -176.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.487 ' HZ ' ' HD2' ' A' ' 54' ' ' TYR . 30.1 m-85 -112.23 117.66 33.16 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.034 0.534 . . . . 72.34 110.031 -176.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.512 ' HA ' ' HB3' ' A' ' 170' ' ' PRO . 5.7 m-20 -82.89 74.75 9.83 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 122.405 1.097 . . . . 71.44 110.225 178.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.429 HG21 HD22 ' A' ' 105' ' ' LEU . 1.6 p -50.13 -30.0 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 126.613 1.965 . . . . 75.21 113.11 171.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -63.59 -4.99 3.33 Favored 'General case' 0 CA--C 1.566 1.595 0 C-N-CA 124.651 1.18 . . . . 75.33 111.989 177.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -119.03 -15.49 9.27 Favored 'General case' 0 CA--C 1.562 1.433 0 C-N-CA 124.652 1.181 . . . . 61.35 111.559 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.403 ' CD2' ' HA ' ' A' ' 90' ' ' VAL . 18.7 m-30 -74.94 -170.06 1.03 Allowed 'General case' 0 N--CA 1.503 2.212 0 C-N-CA 123.75 0.82 . . . . 73.34 112.625 -173.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 82.5 p -77.76 167.3 21.77 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 113.693 0.997 . . . . 74.5 113.693 -169.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.02 -49.02 77.72 Favored 'General case' 0 C--N 1.365 1.276 0 CA-C-N 115.455 -0.793 . . . . 74.52 111.665 179.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -56.35 -40.87 75.2 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.592 0.757 . . . . 75.03 110.258 -177.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -65.27 -45.88 82.74 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 114.606 -1.179 . . . . 72.32 110.228 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.502 ' HA ' HD12 ' A' ' 105' ' ' LEU . 41.1 mt-30 -80.82 1.73 29.35 Favored 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 114.994 -1.003 . . . . 74.14 111.868 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -99.64 -51.09 3.85 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 124.074 0.95 . . . . 70.02 111.748 170.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 43.0 tp -66.61 -46.92 74.31 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.548 0.739 . . . . 74.33 110.382 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -90.76 -5.05 56.19 Favored 'General case' 0 CA--C 1.55 0.981 0 CA-C-N 115.766 -0.652 . . . . 72.11 110.694 176.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -44.99 -59.39 4.47 Favored Glycine 0 CA--C 1.541 1.681 0 CA-C-O 118.651 -1.083 . . . . 72.43 114.975 178.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -59.6 -1.72 1.18 Allowed 'Trans proline' 0 C--N 1.387 2.564 0 C-N-CA 123.711 2.941 . . . . 64.43 115.126 -177.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -149.49 36.32 1.01 Allowed Glycine 0 C--N 1.354 1.574 0 CA-C-N 118.549 0.613 . . . . 54.4 112.82 173.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.502 HD12 ' HA ' ' A' ' 98' ' ' GLN . 18.3 mt -71.94 62.51 0.45 Allowed 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 117.705 0.753 . . . . 74.25 112.348 172.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 35.47 -112.07 0.07 Allowed 'General case' 0 CA--C 1.561 1.378 0 C-N-CA 126.403 1.881 . . . . 74.45 114.214 173.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 56.86 18.88 27.24 Favored Glycine 0 C--N 1.369 2.397 0 N-CA-C 111.77 -0.532 . . . . 44.0 111.77 -163.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.361 1.972 0 O-C-N 124.604 0.826 . . . . 71.34 111.96 -166.583 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.586 ' HA ' ' HD2' ' A' ' 170' ' ' PRO . 37.4 tttp . . . . . 0 N--CA 1.482 1.169 0 N-CA-C 112.637 0.606 . . . . 73.31 112.637 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -80.47 165.75 48.64 Favored Glycine 0 C--N 1.348 1.239 0 O-C-N 124.108 0.88 . . . . 73.4 115.094 -168.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.439 ' O ' ' HA3' ' A' ' 172' ' ' GLY . 24.3 ttt180 -59.99 143.93 50.54 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.819 1.248 . . . . 74.43 111.495 176.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -78.68 126.92 31.38 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 108.733 -0.84 . . . . 74.23 108.733 166.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 53.9 tp -119.25 132.56 55.94 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 109.386 -0.598 . . . . 75.42 109.386 -176.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 67.9 ttp85 -90.8 110.97 22.17 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 108.36 -0.978 . . . . 74.51 108.36 171.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -114.72 150.97 34.47 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.637 0.775 . . . . 54.41 109.131 178.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -106.95 118.63 37.21 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 107.134 -1.432 . . . . 72.42 107.134 -170.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 13.2 tp -99.79 100.14 10.48 Favored Pre-proline 0 N--CA 1.472 0.67 0 N-CA-C 108.892 -0.781 . . . . 74.14 108.892 -176.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.612 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 50.8 Cg_endo -71.75 111.05 3.05 Favored 'Trans proline' 0 C--N 1.374 1.891 0 N-CA-C 108.544 -1.368 . . . . 75.33 108.544 172.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.476 ' HB3' HD22 ' A' ' 180' ' ' LEU . 60.6 tp -115.78 140.22 49.43 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.438 0.637 . . . . 72.43 110.263 -171.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 93.3 m -74.87 134.4 41.66 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 114.068 -1.423 . . . . 71.34 111.078 179.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.402 HD11 ' HB2' ' A' ' 186' ' ' PHE . 91.0 mt -57.96 -38.36 75.87 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.939 0.895 . . . . 75.21 111.134 -177.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -56.2 -42.6 77.44 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 114.492 -1.231 . . . . 75.32 110.045 176.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -73.26 -34.61 65.91 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.583 0.753 . . . . 64.33 111.412 178.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -67.23 -25.94 66.35 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 121.128 0.49 . . . . 65.44 110.326 178.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -78.49 -42.75 28.78 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 114.657 -1.156 . . . . 74.51 110.538 173.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 36.6 m170 -68.32 -66.69 0.54 Allowed 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.14 0.576 . . . . 75.25 111.055 -177.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.584 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 81.97 56.48 2.89 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-N 116.068 -0.515 . . . . 71.54 112.789 177.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -126.42 -170.11 12.89 Favored Glycine 0 N--CA 1.471 1.017 0 N-CA-C 111.584 -0.606 . . . . 70.42 111.584 178.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 30.1 mp0 -71.37 104.71 3.27 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.447 0.699 . . . . 73.14 109.69 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.707 HH22 HD12 ' A' ' 159' ' ' ILE . 0.0 OUTLIER -90.93 147.08 23.37 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.298 -1.001 . . . . 75.05 108.298 174.843 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 62.3 t -102.68 132.44 48.78 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 N-CA-C 107.923 -1.139 . . . . 75.04 107.923 171.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.459 HG13 HG11 ' A' ' 145' ' ' VAL . 2.2 p -139.08 113.0 6.98 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 124.362 1.065 . . . . 73.34 108.389 -177.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -95.97 142.6 28.0 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 115.599 -0.728 . . . . 71.3 109.76 -176.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.2 p -168.97 138.59 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 123.617 0.767 . . . . 75.1 109.939 173.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 57.2 32.07 21.11 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 124.404 1.082 . . . . 74.24 112.548 175.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 78.41 0.37 78.27 Favored Glycine 0 C--N 1.35 1.349 0 CA-C-N 116.538 -0.301 . . . . 54.15 113.333 -178.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.92 104.39 14.36 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 124.266 1.026 . . . . 72.43 108.233 178.153 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 27.9 ttp-105 -92.67 104.4 16.68 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 125.135 1.374 . . . . 74.41 108.775 175.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.459 HG11 HG13 ' A' ' 138' ' ' VAL . 3.4 p -107.23 131.69 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 CA-C-O 120.935 0.398 . . . . 73.53 112.045 -175.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 37.6 t -100.4 110.55 22.76 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 108.249 -1.019 . . . . 64.43 108.249 170.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -136.37 140.53 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.8 1.24 . . . . 73.42 108.593 -178.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.497 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 52.7 ttt85 -83.41 144.55 29.54 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.354 0.662 . . . . 74.32 110.9 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.584 HG13 ' HA2' ' A' ' 133' ' ' GLY . 6.3 pt -106.56 145.62 31.41 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 124.609 1.164 . . . . 74.52 108.359 167.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -70.95 143.12 44.27 Favored 'Trans proline' 0 C--N 1.369 1.647 0 C-N-CA 122.272 1.981 . . . . 74.22 111.428 170.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.4 97.5 0.12 Allowed 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 122.606 2.204 . . . . 74.15 110.485 170.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 106.03 66.21 0.66 Allowed Glycine 0 C--N 1.339 0.74 0 CA-C-N 115.675 -0.693 . . . . 75.51 111.837 -168.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.414 HG23 HG11 ' A' ' 178' ' ' VAL . 2.1 p -111.89 110.91 33.94 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 N-CA-C 107.999 -1.112 . . . . 75.43 107.999 175.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.514 ' HG3' ' HG ' ' A' ' 188' ' ' LEU . 0.0 OUTLIER -93.87 159.5 15.16 Favored 'General case' 0 C--O 1.205 -1.278 0 C-N-CA 124.09 0.956 . . . . 73.23 110.704 -165.633 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -50.89 119.01 3.52 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.934 1.294 . . . . 72.32 110.357 175.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 93.46 1.19 66.56 Favored Glycine 0 CA--C 1.534 1.252 0 CA-C-O 119.296 -0.725 . . . . 74.33 113.875 -179.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 12.7 t -72.19 126.53 30.02 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 108.458 -0.941 . . . . 74.23 108.458 178.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.524 HG21 HG23 ' A' ' 177' ' ' VAL . 48.4 t -102.38 105.46 18.14 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 C-N-CA 123.552 0.741 . . . . 74.02 110.416 -172.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.707 HD12 HH22 ' A' ' 136' ' ' ARG . 57.2 mt -76.3 102.23 3.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 107.777 -1.194 . . . . 75.24 107.777 166.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 58.1 ttt180 -74.42 101.06 3.99 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 107.798 -1.186 . . . . 75.21 107.798 172.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 6.2 p -124.41 95.57 42.98 Favored Pre-proline 0 CA--C 1.547 0.856 0 N-CA-C 109.448 -0.575 . . . . 71.41 109.448 177.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.556 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 28.9 Cg_endo -63.91 152.55 80.27 Favored 'Trans proline' 0 C--N 1.369 1.616 0 C-N-CA 121.963 1.776 . . . . 74.53 111.667 172.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . 0.56 ' HA3' ' HA ' ' A' ' 86' ' ' SER . . . 105.12 -25.9 23.73 Favored Glycine 0 C--N 1.335 0.514 0 CA-C-N 116.043 -0.526 . . . . 70.43 113.628 176.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -103.61 0.05 30.28 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 117.331 0.566 . . . . 64.15 110.949 178.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.58 ' HA2' HD11 ' A' ' 174' ' ' LEU . . . -82.71 -129.65 1.36 Allowed Glycine 0 C--N 1.35 1.315 0 O-C-N 123.286 0.366 . . . . 73.33 113.904 -174.077 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -73.95 158.27 52.0 Favored Glycine 0 C--N 1.338 0.683 0 CA-C-N 115.507 -0.346 . . . . 74.5 113.089 -176.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -71.7 111.53 7.06 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.955 1.302 . . . . 75.42 112.09 -169.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -174.7 159.56 28.34 Favored Glycine 0 C--O 1.221 -0.661 0 CA-C-O 118.327 -1.263 . . . . 64.21 110.723 176.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . 0.579 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . 55.3 t30 -55.35 -56.64 26.69 Favored Pre-proline 0 N--CA 1.496 1.872 0 CA-C-N 118.262 1.031 . . . . 63.54 111.36 -169.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.586 ' HD2' ' HA ' ' A' ' 115' ' ' LYS . 3.3 Cg_endo -88.55 94.4 0.38 Allowed 'Trans proline' 0 C--N 1.386 2.545 0 N-CA-C 107.403 -1.807 . . . . 73.02 107.403 157.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -65.45 154.5 73.39 Favored 'Trans proline' 0 C--N 1.378 2.086 0 C-N-CA 122.111 1.874 . . . . 71.25 111.805 -167.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.439 ' HA3' ' O ' ' A' ' 117' ' ' ARG . . . -74.28 -179.55 41.08 Favored Glycine 0 C--O 1.241 0.559 0 N-CA-C 115.372 0.909 . . . . 72.4 115.372 -164.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.556 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 7.0 m-20 -74.59 108.58 7.44 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.105 0.962 . . . . 71.14 110.425 -173.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.58 HD11 ' HA2' ' A' ' 165' ' ' GLY . 21.9 tp -82.9 99.84 10.01 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 108.759 -0.83 . . . . 74.2 108.759 176.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 77.0 mt -74.77 89.15 2.28 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.206 -0.906 . . . . 72.12 109.188 174.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.464 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 65.9 mt -75.46 90.17 2.7 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.474 -0.784 . . . . 74.52 110.025 177.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.524 HG23 HG21 ' A' ' 158' ' ' VAL . 46.3 t -84.33 103.71 11.83 Favored 'Isoleucine or valine' 0 C--O 1.244 0.809 0 N-CA-C 107.234 -1.395 . . . . 71.11 107.234 175.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.414 HG11 HG23 ' A' ' 153' ' ' VAL . 11.6 p -70.27 118.63 15.06 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 CA-C-N 115.136 -0.938 . . . . 74.13 111.396 -173.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.612 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 35.4 mmt180 -98.94 104.52 16.57 Favored 'General case' 0 C--O 1.216 -0.706 0 N-CA-C 108.263 -1.014 . . . . 73.42 108.263 170.109 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.476 HD22 ' HB3' ' A' ' 125' ' ' LEU . 77.1 mt -69.23 142.48 54.19 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 118.7 0.682 . . . . 74.04 109.534 178.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 82.9 mt -54.17 161.56 1.86 Allowed Pre-proline 0 N--CA 1.486 1.348 0 C-N-CA 124.19 0.996 . . . . 73.22 112.939 -170.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -76.34 30.72 0.4 Allowed 'Trans proline' 0 C--N 1.383 2.382 0 C-N-CA 122.791 2.327 . . . . 74.32 111.982 164.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -64.59 115.49 20.73 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 125.976 1.71 . . . . 73.35 107.283 175.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -76.5 24.73 0.45 Allowed 'Trans proline' 0 N--CA 1.497 1.709 0 C-N-CA 123.474 2.783 . . . . 61.24 115.832 -161.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.408 HG11 ' CD1' ' A' ' 186' ' ' PHE . 51.0 t -106.99 -61.01 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 122.841 0.457 . . . . 72.34 110.446 -176.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . 0.549 ' HE2' HD13 ' A' ' 193' ' ' LEU . 2.9 m-30 -131.42 165.78 22.75 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.939 0.895 . . . . 72.31 110.792 -172.051 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 22.8 ttp85 -150.4 87.73 1.46 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 114.362 -1.29 . . . . 75.51 108.338 169.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.514 ' HG ' ' HG3' ' A' ' 154' ' ' ARG . 51.5 tp -62.23 104.81 0.52 Allowed 'General case' 0 C--O 1.207 -1.157 0 CA-C-N 115.141 -0.936 . . . . 74.21 108.776 174.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -136.44 132.93 36.08 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.068 1.347 . . . . 70.31 109.02 -171.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 82.72 -84.81 1.52 Allowed Glycine 0 C--N 1.35 1.32 0 N-CA-C 110.757 -0.937 . . . . 65.41 110.757 -177.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.598 ' HG2' ' HD2' ' A' ' 243' ' ' PRO . 0.9 OUTLIER -153.89 3.73 0.27 Allowed 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 125.158 1.383 . . . . 72.32 109.962 165.917 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -118.74 175.29 5.81 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.246 1.419 . . . . 72.32 109.809 -169.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.549 HD13 ' HE2' ' A' ' 186' ' ' PHE . 41.3 mt -114.75 126.16 54.53 Favored 'General case' 0 C--O 1.215 -0.762 0 C-N-CA 123.276 0.63 . . . . 74.25 110.544 -171.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -105.21 102.23 11.73 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.469 0.707 . . . . 73.14 109.437 174.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.549 ' HB1' HD21 ' A' ' 251' ' ' LEU . . . -108.28 156.46 19.35 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.946 -0.761 . . . . 74.34 108.946 172.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 57.0 m -93.6 123.57 37.01 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 109.036 -0.727 . . . . 70.21 109.036 178.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.503 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 32.5 tp -113.09 94.62 4.98 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 108.662 -0.866 . . . . 74.1 108.662 178.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -79.5 122.09 26.02 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 107.026 -1.472 . . . . 63.3 107.026 169.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.532 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 9.2 p -133.48 137.47 29.06 Favored Pre-proline 0 CA--C 1.545 0.765 0 N-CA-C 108.156 -1.053 . . . . 74.33 108.156 -177.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.75 159.51 48.34 Favored 'Trans proline' 0 C--N 1.36 1.183 0 C-N-CA 121.796 1.664 . . . . 70.05 111.5 173.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.401 ' HB1' ' HD3' ' A' ' 202' ' ' PRO . . . -56.32 -52.94 69.08 Favored Pre-proline 0 CA--C 1.555 1.146 0 CA-C-O 117.715 -1.136 . . . . 71.34 113.242 -172.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.401 ' HD3' ' HB1' ' A' ' 201' ' ' ALA . 51.8 Cg_exo -59.3 -40.97 63.34 Favored 'Trans proline' 0 C--N 1.391 2.804 0 C-N-CA 122.03 1.82 . . . . 73.32 113.417 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.536 HD13 ' HB3' ' C' ' 276' ' ' TYR . 36.0 mt -71.93 -31.42 40.65 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.962 0 C-N-CA 122.782 0.433 . . . . 71.02 110.368 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.71 -40.73 84.26 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-O 121.155 0.502 . . . . 74.14 110.606 174.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.474 HG13 HD11 ' C' ' 261' ' ' LEU . 48.4 t -71.21 -46.92 63.45 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 C-N-CA 124.189 0.995 . . . . 64.22 112.167 -176.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.469 HG23 ' HA ' ' C' ' 270' ' ' LYS . 94.6 t -98.92 -26.38 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 123.698 0.799 . . . . 74.41 111.574 -170.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 99.03 160.29 29.46 Favored Glycine 0 C--O 1.241 0.554 0 N-CA-C 110.941 -0.864 . . . . 72.35 110.941 -170.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.462 ' O ' HG13 ' A' ' 223' ' ' VAL . . . 162.18 168.37 23.99 Favored Glycine 0 N--CA 1.467 0.73 0 N-CA-C 111.84 -0.504 . . . . 73.32 111.84 177.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -99.62 117.65 34.46 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 117.068 0.434 . . . . 73.34 110.519 -175.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 35.9 m -121.71 162.46 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 124.136 0.974 . . . . 63.11 109.055 177.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -70.39 115.29 9.41 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 120.635 0.255 . . . . 74.32 110.96 -177.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -103.12 112.54 25.44 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 108.176 -1.046 . . . . 74.41 108.176 168.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -76.48 116.57 17.29 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 107.382 -1.34 . . . . 74.15 107.382 173.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' THR . . . . . 0.404 ' HA ' ' CE1' ' A' ' 186' ' ' PHE . 72.8 p -118.79 167.92 11.24 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.804 0.442 . . . . 74.1 110.354 178.172 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 72.1 mt -66.2 -20.77 66.23 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.278 0.631 . . . . 73.14 111.595 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -91.29 -18.31 24.55 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 123.555 0.742 . . . . 64.44 111.562 177.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 147.34 170.63 15.73 Favored Glycine 0 C--N 1.36 1.909 0 CA-C-O 119.97 -0.35 . . . . 63.05 113.594 174.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.79 103.98 1.67 Allowed 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 122.482 2.122 . . . . 74.13 111.404 176.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 33.6 m -106.9 179.83 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 124.25 1.02 . . . . 73.4 110.444 -177.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -110.99 119.54 39.4 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.357 0.663 . . . . 75.04 109.248 173.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 7.2 p -96.85 121.0 46.91 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 N-CA-C 108.979 -0.749 . . . . 74.51 108.979 175.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -80.09 96.68 6.57 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.662 -0.866 . . . . 70.4 108.662 172.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.462 HG13 ' O ' ' A' ' 208' ' ' GLY . 10.7 p -68.35 132.72 91.4 Favored Pre-proline 0 CA--C 1.554 1.102 0 N-CA-C 108.916 -0.772 . . . . 71.22 108.916 178.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.39 163.55 26.3 Favored 'Trans proline' 0 C--N 1.374 1.875 0 C-N-CA 122.483 2.122 . . . . 75.51 112.455 174.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -64.77 163.9 26.21 Favored 'Trans proline' 0 C--N 1.37 1.664 0 C-N-CA 121.993 1.795 . . . . 72.53 112.95 169.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 41.25 67.78 0.5 Allowed 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 126.057 1.743 . . . . 75.13 112.824 -173.207 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.513 HG21 HD22 ' A' ' 233' ' ' LEU . 95.0 m -101.68 103.01 13.77 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 114.407 -1.27 . . . . 64.32 109.224 177.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . 0.787 ' HB3' ' HD3' ' A' ' 231' ' ' ARG . 5.5 tp-100 -87.18 145.96 26.2 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.166 0.986 . . . . 75.32 111.784 -172.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -73.15 143.42 47.29 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.975 0.91 . . . . 65.12 111.267 179.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 85.26 -0.59 88.73 Favored Glycine 0 C--N 1.348 1.233 0 CA-C-N 115.787 -0.642 . . . . 75.54 113.103 -178.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.787 ' HD3' ' HB3' ' A' ' 228' ' ' GLN . 78.7 mtp180 -112.03 162.49 15.33 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.536 1.134 . . . . 74.44 108.949 176.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 49.6 pttt -129.63 136.31 49.6 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 122.902 0.481 . . . . 72.22 110.389 -171.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.513 HD22 HG21 ' A' ' 227' ' ' THR . 26.3 mt -86.72 110.97 20.26 Favored 'General case' 0 C--O 1.212 -0.882 0 CA-C-N 115.281 -0.872 . . . . 71.4 110.133 -172.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -77.22 106.94 9.26 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.01 0.524 . . . . 73.41 110.25 175.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.483 HD13 HD22 ' A' ' 249' ' ' LEU . 8.5 mt -101.68 93.54 5.39 Favored 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 108.454 -0.943 . . . . 74.24 108.454 172.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 4.5 tmtm? -73.67 117.97 16.06 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.437 0.695 . . . . 71.01 111.939 -164.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 101.45 32.16 5.27 Favored Glycine 0 C--N 1.347 1.157 0 CA-C-N 115.813 -0.63 . . . . 74.2 112.614 175.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 2.8 mmmt -117.26 -28.19 6.23 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.941 0.896 . . . . 74.1 111.229 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -79.0 -166.87 32.04 Favored Glycine 0 C--N 1.342 0.915 0 O-C-N 123.663 0.602 . . . . 74.43 113.256 174.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -97.59 158.97 32.15 Favored Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 123.565 0.746 . . . . 73.41 110.333 -173.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -58.64 151.92 59.57 Favored 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 122.656 2.237 . . . . 73.33 113.322 -173.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -173.88 -163.42 27.32 Favored Glycine 0 C--N 1.341 0.816 0 CA-C-N 115.65 -0.705 . . . . 73.52 113.761 177.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . 0.598 ' HD2' ' HG2' ' A' ' 191' ' ' GLN . 73.4 Cg_endo -70.8 -5.86 17.81 Favored 'Trans proline' 0 C--N 1.373 1.862 0 C-N-CA 123.708 2.939 . . . . 72.5 113.613 -179.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -103.94 23.12 13.38 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.74 0.816 . . . . 70.11 109.954 171.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 82.37 -84.44 1.51 Allowed Glycine 0 C--N 1.351 1.4 0 N-CA-C 110.78 -0.928 . . . . 62.24 110.78 -177.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 50.2 mtm180 -125.68 144.64 50.51 Favored 'General case' 0 C--O 1.246 0.871 0 N-CA-C 108.348 -0.982 . . . . 75.41 108.348 171.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -65.79 166.82 35.11 Favored Glycine 0 N--CA 1.448 -0.552 0 O-C-N 123.979 0.799 . . . . 70.31 113.457 176.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -110.91 -178.31 3.44 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 123.776 0.831 . . . . 75.44 108.89 -179.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.483 HD22 HD13 ' A' ' 235' ' ' LEU . 31.1 tp -118.63 96.53 5.32 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 107.875 -1.157 . . . . 73.32 107.875 169.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -79.69 109.52 14.17 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.285 1.034 . . . . 71.3 109.79 175.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.549 HD21 ' HB1' ' A' ' 195' ' ' ALA . 89.7 mt -97.88 97.86 9.31 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.5 -0.773 . . . . 74.54 109.483 177.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -75.61 115.97 15.84 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.374 0.67 . . . . 75.41 109.611 -176.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 91.7 t -86.43 132.89 31.11 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 C-N-CA 125.468 1.507 . . . . 71.34 113.06 -163.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -130.07 107.04 9.03 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.19 1.396 . . . . 73.14 108.565 173.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.532 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 73.4 mt -84.01 130.74 35.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 123.257 0.623 . . . . 74.34 111.016 -176.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 20.3 p -119.1 174.15 6.49 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.497 1.119 . . . . 74.52 109.844 173.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . 0.41 ' HB ' ' HD2' ' A' ' 258' ' ' PRO . 2.9 pp -136.13 154.91 77.72 Favored Pre-proline 0 CA--C 1.566 1.576 0 C-N-CA 123.696 0.798 . . . . 73.4 109.938 -179.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 258' ' ' PRO . . . . . 0.41 ' HD2' ' HB ' ' A' ' 257' ' ' ILE . 49.1 Cg_endo -64.67 -5.56 10.53 Favored 'Trans proline' 0 C--N 1.385 2.493 0 C-N-CA 123.457 2.771 . . . . 74.45 116.1 -163.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . 0.501 ' HG2' ' NE2' ' C' ' 228' ' ' GLN . 31.4 mt-10 52.42 -87.37 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.422 0 C-N-CA 124.122 0.969 . . . . 75.12 112.728 -170.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.27 132.84 47.83 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 109.935 -0.394 . . . . 75.12 109.935 -177.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 97.5 mt -130.93 134.62 46.91 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.702 0.801 . . . . 72.32 110.575 -177.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 19.1 p -84.16 146.26 47.87 Favored Pre-proline 0 CA--C 1.545 0.788 0 CA-C-O 117.874 -1.06 . . . . 74.31 108.841 169.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -30.94 -42.98 0.11 Allowed 'Trans proline' 0 C--N 1.39 2.731 1 C-N-CA 126.062 4.508 . . . . 74.33 116.569 -172.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -64.59 -64.3 0.91 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.25 0.62 . . . . 71.44 110.99 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -61.48 -32.49 72.5 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.086 0.954 . . . . 73.22 110.866 -178.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -53.48 -52.95 57.89 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.779 1.231 . . . . 73.45 109.847 174.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . 0.415 ' O ' ' HG3' ' A' ' 271' ' ' LYS . . . -65.69 -41.72 92.07 Favored 'General case' 0 C--O 1.214 -0.795 0 CA-C-N 114.923 -1.035 . . . . 64.12 111.585 178.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 10.9 mp -57.24 -47.0 82.47 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 123.071 0.548 . . . . 73.14 111.544 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -64.89 -40.76 95.6 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 123.755 0.659 . . . . 75.0 111.091 178.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . 0.465 ' HE2' ' HA ' ' C' ' 206' ' ' VAL . 1.5 mptm? -71.68 -25.33 62.06 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.093 0.557 . . . . 73.12 111.98 178.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . 0.415 ' HG3' ' O ' ' A' ' 267' ' ' ALA . 97.1 mttt -73.75 -48.82 28.99 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.873 -0.788 . . . . 70.22 108.873 176.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 72.6 mt -55.28 -40.96 71.62 Favored 'General case' 0 C--O 1.198 -1.641 0 O-C-N 124.774 1.296 . . . . 71.54 109.992 172.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -65.79 -55.51 16.8 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.056 0.942 . . . . 72.23 113.105 -174.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -66.57 -43.75 84.16 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 123.787 0.679 . . . . 74.35 110.76 -176.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -62.59 -47.95 81.59 Favored 'General case' 0 C--N 1.355 0.82 0 O-C-N 123.944 0.778 . . . . 72.24 110.285 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -62.75 -45.77 91.14 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.729 0.812 . . . . 75.02 110.945 -177.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -66.82 -40.04 87.89 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 123.519 0.512 . . . . 72.14 110.103 -176.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -66.62 -17.86 65.06 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 115.824 -0.625 . . . . 75.41 111.579 174.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 82.6 mtt180 -117.76 20.05 13.56 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.134 0.974 . . . . 75.15 109.733 178.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.845 0 N-CA-C 109.173 -0.677 . . . . 72.5 109.173 179.193 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 63.7 mtt . . . . . 0 N--CA 1.483 1.182 0 N-CA-C 109.104 -0.702 . . . . 74.12 109.104 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -82.06 126.65 32.25 Favored 'General case' 0 C--N 1.353 0.733 0 N-CA-C 108.649 -0.871 . . . . 62.45 108.649 172.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -106.34 37.49 2.28 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.137 0.575 . . . . 74.04 110.095 -176.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 55.2 m -53.89 -3.51 0.04 OUTLIER 'General case' 0 CA--C 1.565 1.535 0 N-CA-C 117.31 2.337 . . . . 52.14 117.31 -162.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 16.9 m -132.27 147.6 52.41 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 119.316 0.962 . . . . 74.34 110.291 171.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 15.1 pt -138.23 169.59 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 123.85 0.86 . . . . 65.34 112.384 -164.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -131.51 147.68 52.56 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 124.21 1.004 . . . . 72.22 109.672 176.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 15.2 tp -85.51 157.0 20.54 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.863 0.865 . . . . 75.22 110.918 -172.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.44 -59.52 2.67 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.322 0.649 . . . . 73.12 111.81 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 66.1 mt 61.12 18.1 8.72 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.863 1.265 . . . . 74.1 111.911 -165.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 64.5 mt . . . . . 0 N--CA 1.485 1.309 0 C-N-CA 124.771 1.228 . . . . 72.11 112.116 179.477 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.776 0 N-CA-C 108.843 -0.799 . . . . 74.35 108.843 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . -66.11 -35.22 79.91 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 109.368 -0.604 . . . . 75.32 109.368 166.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 181' ' ' LEU . . . . . 0.529 ' HB2' ' HB3' ' C' ' 136' ' ' ARG . 58.0 tp -159.79 -69.95 0.08 Allowed 'General case' 0 C--N 1.353 0.726 0 CA-C-N 115.816 -0.629 . . . . 74.44 111.186 -176.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 182' ' ' VAL . . . . . 0.475 HG13 ' H ' ' C' ' 139' ' ' GLU . 8.2 p -79.93 150.43 4.96 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 CA-C-N 115.355 -0.839 . . . . 72.43 112.711 -163.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -119.67 38.17 3.98 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.909 0.883 . . . . 65.24 109.278 171.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 35.7 m80 56.85 -87.11 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.723 1.209 . . . . 75.32 110.589 -171.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 185' ' ' VAL . . . . . 0.55 HG23 ' HA ' ' C' ' 121' ' ' ALA . 1.5 p . . . . . 0 N--CA 1.469 0.489 0 C-N-CA 124.382 1.073 . . . . 74.01 108.71 173.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 238' ' ' THR . . . . . 0.429 HG21 ' H ' ' C' ' 220' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 113.599 0.962 . . . . 71.31 113.599 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -163.81 174.38 11.64 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.803 0.729 . . . . 74.42 111.113 -165.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . -79.51 -106.29 0.24 Allowed Glycine 0 C--N 1.345 1.051 0 CA-C-N 115.409 -0.814 . . . . 71.23 111.804 174.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.29 -179.52 5.62 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.41 0.684 . . . . 71.23 111.132 -178.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 242' ' ' TRP . . . . . 0.428 ' CZ3' HG23 ' C' ' 253' ' ' VAL . 7.8 m0 -94.18 -60.54 1.71 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.198 0.999 . . . . 70.32 109.375 -175.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -172.25 -33.16 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 113.472 -1.694 . . . . 74.22 109.097 -167.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -162.15 101.7 0.2 Allowed Glycine 0 C--N 1.347 1.185 0 N-CA-C 111.375 -0.69 . . . . 71.54 111.375 174.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 39.1 tptt . . . . . 0 N--CA 1.476 0.867 0 C-N-CA 124.13 0.972 . . . . 75.34 109.976 179.301 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.835 0 CA-C-O 120.632 0.253 . . . . 71.34 110.534 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -36.89 117.52 0.52 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.891 1.676 . . . . 70.52 114.288 -176.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 5' ' ' LYS . . . . . 0.466 ' HB3' HD12 ' C' ' 10' ' ' ILE . 14.1 mmmm -93.93 108.59 20.37 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 108.355 -0.98 . . . . 72.32 108.355 167.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -71.94 93.97 1.41 Allowed 'General case' 0 C--O 1.238 0.487 0 N-CA-C 107.583 -1.265 . . . . 65.15 107.583 175.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 7' ' ' TYR . . . . . 0.467 ' HA ' HD11 ' C' ' 10' ' ' ILE . 30.9 m-85 -60.41 -30.36 69.56 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 115.004 -0.998 . . . . 73.43 112.158 -171.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -66.76 -45.04 79.78 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.572 -0.74 . . . . 74.23 110.521 177.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.9 -42.58 99.25 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.088 0.555 . . . . 63.34 110.685 177.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 10' ' ' ILE . . . . . 0.467 HD11 ' HA ' ' C' ' 7' ' ' TYR . 69.5 mt -55.3 -50.95 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 123.72 0.808 . . . . 73.31 111.144 178.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 83.4 mt -74.48 -12.0 60.37 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.528 -0.76 . . . . 75.53 112.371 -179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 69.99 33.82 70.35 Favored Glycine 0 C--N 1.351 1.384 0 O-C-N 123.045 0.216 . . . . 74.43 112.754 -176.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 13' ' ' VAL . . . . . 0.455 ' HB ' ' HD2' ' C' ' 14' ' ' PRO . 11.6 m -108.46 164.39 14.86 Favored Pre-proline 0 N--CA 1.479 1.021 0 C-N-CA 124.46 1.104 . . . . 71.34 109.615 174.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 14' ' ' PRO . . . . . 0.455 ' HD2' ' HB ' ' C' ' 13' ' ' VAL . 35.5 Cg_endo -60.12 162.79 15.76 Favored 'Trans proline' 0 C--N 1.384 2.4 0 C-N-CA 122.095 1.863 . . . . 74.43 112.596 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 8.8 mmm180 -77.18 14.31 0.94 Allowed 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.042 0.937 . . . . 74.35 112.413 -170.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -148.99 14.75 0.92 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.692 1.197 . . . . 71.24 108.716 -176.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.04 137.5 56.81 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 123.923 0.889 . . . . 75.2 112.914 -170.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 78.8 p -70.77 161.87 30.13 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.798 0.839 . . . . 74.41 110.649 178.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -57.52 -29.34 64.26 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.519 0.728 . . . . 74.45 111.541 -177.204 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -65.68 -47.92 73.84 Favored 'General case' 0 C--O 1.215 -0.733 0 CA-C-O 119.33 -0.367 . . . . 74.53 110.486 176.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -61.24 -35.62 77.73 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 123.711 0.632 . . . . 73.42 110.821 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.46 -44.04 97.85 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.928 0 C-N-CA 123.671 0.788 . . . . 75.54 110.756 173.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 6.5 ttpm? -73.02 -31.43 64.46 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.539 0.736 . . . . 74.13 111.304 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 40.0 mtt180 -69.08 -45.47 70.21 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.124 0.97 . . . . 73.52 110.083 178.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -71.77 -31.81 67.01 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 124.522 1.139 . . . . 75.32 111.183 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 26' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -58.0 -60.3 3.94 Favored 'General case' 0 C--O 1.21 -0.995 0 O-C-N 124.191 0.932 . . . . 72.31 109.323 171.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . 0.43 ' O ' ' HG3' ' C' ' 31' ' ' ARG . 53.4 mtmt -63.07 -35.08 79.04 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 124.366 1.041 . . . . 75.33 111.336 -178.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 28' ' ' ARG . . . . . 0.582 ' HA ' HH21 ' C' ' 31' ' ' ARG . 63.7 ttt180 -58.11 -51.88 67.86 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.071 0.948 . . . . 75.55 110.244 177.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . 0.477 ' HA ' ' HB3' ' C' ' 32' ' ' GLN . 83.2 mt -90.62 -0.02 57.54 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 113.983 -1.462 . . . . 71.43 111.195 -177.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.15 -10.96 29.05 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.778 0.831 . . . . 75.32 110.003 169.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . 0.582 HH21 ' HA ' ' C' ' 28' ' ' ARG . 32.7 mtm105 -93.66 -35.81 12.66 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.261 0.624 . . . . 73.5 109.454 165.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 32' ' ' GLN . . . . . 0.477 ' HB3' ' HA ' ' C' ' 29' ' ' LEU . 8.3 tt0 -67.69 -60.55 2.45 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 122.489 0.316 . . . . 71.12 110.386 176.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -92.38 31.71 1.28 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.287 0.635 . . . . 72.14 109.781 178.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 34' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -58.91 106.46 0.72 Allowed Pre-proline 0 N--CA 1.481 1.078 0 C-N-CA 124.184 0.993 . . . . 74.34 109.059 -179.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -58.37 -29.45 88.25 Favored 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 123.041 2.494 . . . . 72.22 113.146 -165.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -72.28 -33.15 67.22 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.042 0.937 . . . . 60.34 112.442 178.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 61.8 t -97.73 -23.15 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 123.457 0.703 . . . . 75.33 110.689 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -128.86 83.61 2.17 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.74 0.816 . . . . 65.41 109.504 -168.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -81.85 36.05 0.44 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.134 0.973 . . . . 71.22 111.374 178.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 40' ' ' SER . . . . . 0.424 ' HB2' ' HB2' ' C' ' 43' ' ' ALA . 20.0 m -93.02 107.71 26.97 Favored Pre-proline 0 CA--C 1.544 0.742 0 N-CA-C 108.63 -0.878 . . . . 74.14 108.63 -178.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -43.39 -54.67 3.4 Favored 'Trans proline' 0 C--N 1.386 2.507 0 C-N-CA 124.437 3.425 . . . . 75.0 114.439 -171.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -67.29 -31.14 71.25 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.974 0.91 . . . . 71.01 110.777 -176.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 43' ' ' ALA . . . . . 0.424 ' HB2' ' HB2' ' C' ' 40' ' ' SER . . . -77.31 -19.13 56.84 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.021 0.528 . . . . 71.45 110.68 177.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -82.9 -28.06 30.23 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.11 0.564 . . . . 74.04 109.504 176.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -75.63 -32.74 60.36 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.542 0.737 . . . . 75.44 109.832 173.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 46' ' ' LYS . . . . . . . . . . . . . 41.1 mmtm -65.17 -44.02 89.87 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.73 -0.668 . . . . 72.32 109.992 168.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -56.71 -37.01 70.32 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.529 0.732 . . . . 71.12 110.171 174.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -62.41 -44.33 96.71 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 123.745 0.653 . . . . 72.04 111.72 174.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -66.35 -33.87 76.69 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 122.334 0.253 . . . . 72.33 111.628 176.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 50' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.56 -39.44 85.05 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 C-N-CA 123.77 0.828 . . . . 75.43 109.751 173.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 51' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -72.08 -29.29 63.97 Favored 'General case' 0 C--O 1.212 -0.88 0 C-N-CA 124.034 0.934 . . . . 74.04 110.785 177.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -67.51 -57.53 6.33 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.566 1.146 . . . . 75.54 109.966 177.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.57 -47.12 85.32 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-N 113.158 -1.837 . . . . 63.1 111.629 -176.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -60.22 -57.76 11.4 Favored 'General case' 0 C--O 1.203 -1.362 0 CA-C-N 115.051 -0.977 . . . . 75.01 110.567 174.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.97 -30.77 64.38 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 113.174 0.805 . . . . 60.54 113.174 -170.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 94.3 t -73.78 -60.06 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 N-CA-C 109.843 -0.429 . . . . 72.43 109.843 170.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 57' ' ' LEU . . . . . 0.415 HD11 ' HB2' ' C' ' 7' ' ' TYR . 79.7 mt -81.64 4.6 21.06 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 113.454 0.909 . . . . 75.02 113.454 -169.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 41.8 t -74.62 -36.53 62.92 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.447 1.099 . . . . 75.33 109.717 177.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -82.96 127.78 68.16 Favored Pre-proline 0 C--N 1.331 -0.206 0 N-CA-C 108.399 -0.963 . . . . 72.03 108.399 174.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 60' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -54.71 -32.91 78.05 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.571 2.181 . . . . 73.21 111.073 165.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -55.4 -64.64 0.78 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.957 1.303 . . . . 62.13 110.864 174.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 62' ' ' LYS . . . . . 0.404 ' HA ' HD12 ' C' ' 65' ' ' ILE . 36.8 mtpt -76.45 -16.0 59.78 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.13 0.972 . . . . 75.43 112.197 -173.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -71.37 -45.15 63.57 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 107.816 -1.179 . . . . 74.14 107.816 171.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -72.13 -24.06 61.41 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.199 0.599 . . . . 74.15 111.861 175.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 65' ' ' ILE . . . . . 0.404 HD12 ' HA ' ' C' ' 62' ' ' LYS . 90.3 mt -66.06 -42.93 92.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 N-CA-C 109.204 -0.665 . . . . 71.5 109.204 171.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -60.58 -48.89 79.77 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 115.486 -0.779 . . . . 74.31 109.5 174.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -57.39 -42.73 82.76 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.801 0.84 . . . . 73.14 112.112 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 35.8 p -74.13 -23.18 59.25 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.659 0.384 . . . . 74.43 111.431 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -74.11 142.93 45.56 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 109.133 -0.692 . . . . 75.22 109.133 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.64 11.99 65.18 Favored Glycine 0 N--CA 1.476 1.351 0 N-CA-C 112.072 -0.411 . . . . 62.51 112.072 -171.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 36.2 m -144.75 -54.26 0.32 Allowed 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 104.259 -2.497 . . . . 72.34 104.259 175.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 55.0 m -88.73 151.98 22.08 Favored 'General case' 0 C--O 1.246 0.88 0 N-CA-C 104.949 -2.241 . . . . 73.35 104.949 156.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.56 -17.33 2.27 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.872 0.869 . . . . 73.23 110.29 -176.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.88 132.55 77.28 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 123.572 0.749 . . . . 53.23 110.466 174.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -61.46 156.87 44.17 Favored 'Trans proline' 0 C--N 1.377 2.071 0 C-N-CA 123.413 2.742 . . . . 75.14 112.48 175.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -63.21 169.08 9.87 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 123.421 2.748 . . . . 71.22 112.81 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.85 122.58 5.92 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 121.86 1.707 . . . . 74.4 111.305 171.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 78' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.81 122.8 7.53 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 122.51 2.14 . . . . 74.44 112.043 175.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -82.72 159.55 16.4 Favored 'Trans proline' 0 CA--C 1.557 1.672 0 C-N-CA 122.72 2.28 . . . . 70.12 112.109 173.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.27 84.77 0.04 OUTLIER 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 123.123 2.549 . . . . 74.31 112.18 169.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . 0.515 ' HA3' ' HB1' ' C' ' 141' ' ' ALA . . . 160.21 -30.18 0.37 Allowed Glycine 0 C--O 1.239 0.43 0 CA-C-N 114.559 -1.2 . . . . 75.2 110.316 -178.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 92.14 178.86 41.58 Favored Glycine 0 C--N 1.35 1.311 0 CA-C-N 115.196 -0.502 . . . . 75.13 112.314 173.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -80.68 102.16 9.71 Favored 'General case' 0 C--O 1.243 0.761 0 N-CA-C 106.927 -1.508 . . . . 73.4 106.927 168.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -53.73 132.69 41.56 Favored 'General case' 0 C--O 1.248 0.978 0 O-C-N 124.769 1.293 . . . . 75.11 111.42 -174.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 85' ' ' PHE . . . . . 0.483 ' CD1' ' HB ' ' C' ' 90' ' ' VAL . 2.1 t80 -156.18 24.02 0.36 Allowed 'General case' 0 C--O 1.243 0.761 0 CA-C-N 114.624 -1.171 . . . . 74.41 110.697 -173.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 52.3 m -58.45 128.38 36.85 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.274 -0.876 . . . . 52.42 111.01 -176.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 91.47 -30.31 6.55 Favored Glycine 0 C--N 1.342 0.906 0 CA-C-O 119.591 -0.561 . . . . 74.34 113.175 -179.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 88' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -94.44 137.74 33.22 Favored 'General case' 0 C--N 1.355 0.823 0 N-CA-C 108.443 -0.947 . . . . 74.44 108.443 -177.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -86.64 70.45 10.41 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.244 0.618 . . . . 72.23 111.142 -169.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 90' ' ' VAL . . . . . 0.483 ' HB ' ' CD1' ' C' ' 85' ' ' PHE . 1.3 p -39.59 -47.13 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 C-N-CA 125.138 1.375 . . . . 54.42 113.446 178.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -69.93 -23.38 63.2 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 114.695 -1.139 . . . . 75.25 111.753 -167.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -100.77 -7.18 23.96 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.293 0.637 . . . . 75.53 111.1 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 8.1 m-30 -78.73 -172.12 2.85 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 109.869 -0.419 . . . . 72.45 109.869 176.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 88.0 p -68.27 148.81 50.26 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 112.332 0.493 . . . . 52.11 112.332 -170.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.63 -38.26 89.55 Favored 'General case' 0 CA--C 1.551 1.009 0 CA-C-N 114.871 -1.059 . . . . 72.35 110.869 175.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -49.05 -52.45 25.38 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.658 1.183 . . . . 74.24 111.375 171.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 97' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -62.37 -43.68 98.25 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 114.409 -1.268 . . . . 64.25 110.626 178.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -73.3 -5.06 37.15 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.428 0.691 . . . . 71.33 112.341 -178.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -100.08 -41.96 6.93 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.267 0.627 . . . . 74.43 111.712 167.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 26.6 tp -67.24 -42.86 83.28 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.329 0.652 . . . . 73.23 111.573 -173.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -109.91 5.13 22.18 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-O 121.062 0.458 . . . . 75.04 109.875 173.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -44.96 -52.56 7.87 Favored Glycine 0 CA--C 1.538 1.514 0 CA-C-O 118.416 -1.213 . . . . 74.41 115.153 -177.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -35.03 -29.05 0.05 OUTLIER 'Trans proline' 0 C--N 1.389 2.658 0 C-N-CA 125.045 3.83 . . . . 64.35 117.142 175.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -145.73 21.79 1.82 Allowed Glycine 0 C--N 1.36 1.91 0 CA-C-N 118.552 0.615 . . . . 73.42 113.891 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 6.9 mt . . . . . 0 N--CA 1.48 1.039 0 N-CA-C 113.284 0.846 . . . . 75.43 113.284 -179.859 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.401 0 CA-C-O 120.084 -0.287 . . . . 54.4 113.573 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 16.2 mtm180 -58.21 124.53 19.73 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.43 0.692 . . . . 74.32 109.25 174.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -57.92 135.22 56.87 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 123.836 0.71 . . . . 75.42 109.249 176.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 119' ' ' LEU . . . . . . . . . . . . . 4.9 tt -95.28 121.34 36.83 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 107.57 -1.27 . . . . 75.21 107.57 -172.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.76 94.78 5.26 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 107.668 -1.234 . . . . 72.31 107.668 -168.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 121' ' ' ALA . . . . . 0.55 ' HA ' HG23 ' B' ' 185' ' ' VAL . . . -108.58 113.0 25.65 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 108.308 -0.997 . . . . 75.44 108.308 -176.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 122' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' C' ' 177' ' ' VAL . 0.0 OUTLIER -94.15 110.52 22.23 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 106.959 -1.497 . . . . 74.12 106.959 -178.649 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -129.82 133.32 24.89 Favored Pre-proline 0 N--CA 1.48 1.031 0 C-N-CA 122.481 0.313 . . . . 73.3 111.801 -165.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' C' ' 179' ' ' ARG . 10.7 Cg_exo -73.53 119.57 6.01 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 123.077 2.518 . . . . 72.51 111.172 170.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 125' ' ' LEU . . . . . . . . . . . . . 47.1 tp -128.97 165.32 21.34 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.187 0.995 . . . . 75.32 108.631 -177.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.61 170.9 7.62 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 121.541 0.686 . . . . 61.53 111.686 179.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 127' ' ' LEU . . . . . 0.424 HD23 ' CD2' ' C' ' 183' ' ' HIS . 2.4 mt -81.46 -56.69 3.87 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 114.583 -1.189 . . . . 62.25 109.698 -162.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -49.07 -47.13 45.27 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 112.756 -2.02 . . . . 75.24 110.33 170.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -67.88 -33.0 73.88 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 115.707 -0.679 . . . . 75.51 111.456 -177.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 130' ' ' ALA . . . . . 0.441 ' HB3' HG22 ' C' ' 153' ' ' VAL . . . -68.17 -31.95 71.87 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 123.698 0.623 . . . . 73.14 110.721 173.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 131' ' ' PHE . . . . . 0.403 ' HB2' HD12 ' C' ' 215' ' ' LEU . 74.0 t80 -75.28 -31.85 60.85 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 124.029 0.932 . . . . 75.55 111.37 174.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 132' ' ' HIS . . . . . . . . . . . . . 34.6 m170 -79.62 -55.64 4.88 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 112.335 0.495 . . . . 70.15 112.335 -173.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.07 -111.41 3.34 Favored Glycine 0 C--N 1.345 1.068 0 N-CA-C 110.253 -1.139 . . . . 65.31 110.253 -167.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.41 168.2 35.53 Favored Glycine 0 C--N 1.356 1.645 0 CA-C-N 117.426 0.613 . . . . 73.12 113.511 177.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -71.05 93.65 1.04 Allowed 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 108.932 -0.766 . . . . 73.03 108.932 175.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 136' ' ' ARG . . . . . 0.529 ' HB3' ' HB2' ' B' ' 181' ' ' LEU . 9.6 mpt_? -117.47 133.5 55.9 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.452 1.101 . . . . 72.12 109.493 -174.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 137' ' ' VAL . . . . . . . . . . . . . 27.8 m -71.91 131.12 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-O 121.346 0.593 . . . . 73.11 111.616 -176.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 138' ' ' VAL . . . . . 0.485 HG11 ' SD ' ' C' ' 164' ' ' MET . 13.2 p -115.3 130.12 70.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 C-N-CA 124.684 1.194 . . . . 72.14 107.808 170.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 139' ' ' GLU . . . . . 0.475 ' H ' HG13 ' B' ' 182' ' ' VAL . 42.4 mt-10 -126.61 86.52 2.52 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 108.117 -1.068 . . . . 74.31 108.117 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 140' ' ' VAL . . . . . . . . . . . . . 11.0 m -125.39 107.59 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 123.25 0.62 . . . . 73.25 111.319 -175.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 141' ' ' ALA . . . . . 0.515 ' HB1' ' HA3' ' C' ' 81' ' ' GLY . . . 56.31 28.74 13.84 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.812 1.245 . . . . 65.0 113.27 173.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 119.49 -24.3 8.13 Favored Glycine 0 C--N 1.353 1.475 0 CA-C-N 116.5 -0.318 . . . . 52.4 113.663 177.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 143' ' ' ARG . . . . . 0.547 ' HG2' ' HG3' ' C' ' 164' ' ' MET . 0.3 OUTLIER -76.44 97.63 4.35 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.511 0.724 . . . . 75.05 109.059 178.838 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 40.9 ttp180 -113.42 95.45 5.37 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 109.17 -0.678 . . . . 71.51 109.17 176.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 145' ' ' VAL . . . . . . . . . . . . . 7.6 p -142.31 141.62 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 123.438 0.695 . . . . 75.03 111.254 -176.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 28.0 t -80.4 101.4 8.99 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 108.754 -0.832 . . . . 73.22 108.754 170.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 12.4 p -122.79 152.58 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.102 0.961 . . . . 72.53 110.014 -176.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -99.98 98.86 9.57 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 107.488 -1.301 . . . . 74.22 107.488 171.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 149' ' ' ILE . . . . . 0.642 HD13 HG21 ' C' ' 159' ' ' ILE . 45.9 pt -68.72 151.39 97.27 Favored Pre-proline 0 CA--C 1.55 0.961 0 N-CA-C 108.873 -0.788 . . . . 74.42 108.873 173.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -43.09 110.53 0.17 Allowed 'Trans proline' 0 C--N 1.387 2.604 0 C-N-CA 123.451 2.767 . . . . 61.44 113.543 -178.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -62.3 131.3 33.61 Favored 'Trans proline' 0 C--N 1.386 2.53 0 C-N-CA 122.786 2.324 . . . . 73.2 110.992 178.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 152' ' ' GLY . . . . . . . . . . . . . . . 102.13 61.57 0.74 Allowed Glycine 0 C--N 1.334 0.422 0 N-CA-C 110.396 -1.082 . . . . 63.11 110.396 -171.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 153' ' ' VAL . . . . . 0.523 ' HB ' HG12 ' C' ' 159' ' ' ILE . 0.9 OUTLIER -77.98 158.64 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 108.679 -0.86 . . . . 74.01 108.679 -179.691 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 154' ' ' ARG . . . . . 0.71 ' HG2' HD22 ' C' ' 188' ' ' LEU . 33.8 mtp180 -110.52 111.69 23.1 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 118.757 -0.639 . . . . 75.32 110.179 -170.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 155' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -43.29 120.29 1.84 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.735 1.214 . . . . 74.51 112.853 173.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.12 -7.8 20.47 Favored Glycine 0 C--N 1.354 1.551 0 C-N-CA 124.395 0.997 . . . . 75.21 114.182 177.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 157' ' ' SER . . . . . 0.479 ' HB2' ' HB2' ' C' ' 154' ' ' ARG . 69.4 m -109.91 -172.78 2.11 Favored 'General case' 0 C--O 1.246 0.905 0 C-N-CA 124.461 1.105 . . . . 75.43 110.735 -175.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 158' ' ' VAL . . . . . 0.446 HG22 HD22 ' C' ' 175' ' ' LEU . 12.1 p -88.25 138.99 18.07 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 CA-C-N 114.346 -1.297 . . . . 72.31 112.894 -170.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 159' ' ' ILE . . . . . 0.665 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 8.7 mt -108.31 93.25 2.41 Favored 'Isoleucine or valine' 0 C--O 1.245 0.819 0 N-CA-C 105.428 -2.064 . . . . 72.31 105.428 161.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -82.27 123.65 29.24 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 108.951 -0.759 . . . . 75.13 108.951 178.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 161' ' ' VAL . . . . . 0.613 HG12 ' HB3' ' C' ' 174' ' ' LEU . 2.0 p -126.47 95.9 37.22 Favored Pre-proline 0 C--O 1.247 0.966 0 N-CA-C 107.694 -1.225 . . . . 75.24 107.694 170.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.26 147.75 88.12 Favored 'Trans proline' 0 C--N 1.381 2.268 0 C-N-CA 122.499 2.133 . . . . 75.23 110.836 175.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 87.64 25.73 31.88 Favored Glycine 0 C--N 1.338 0.686 0 CA-C-O 119.372 -0.682 . . . . 53.54 112.039 -171.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 164' ' ' MET . . . . . 0.547 ' HG3' ' HG2' ' C' ' 143' ' ' ARG . 34.4 ttm -156.44 23.26 0.35 Allowed 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 117.373 0.586 . . . . 73.35 112.144 -177.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . -86.77 -160.94 35.46 Favored Glycine 0 N--CA 1.48 1.604 0 N-CA-C 114.36 0.504 . . . . 73.32 114.36 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . -96.63 -175.46 35.45 Favored Glycine 0 C--N 1.357 1.733 0 C-N-CA 123.02 0.343 . . . . 75.44 113.514 -177.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 167' ' ' GLN . . . . . 0.442 ' HA ' HE21 ' C' ' 167' ' ' GLN . 0.0 OUTLIER -43.42 122.01 2.46 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 126.036 1.734 . . . . 74.2 113.334 -176.941 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . 177.07 -126.46 1.11 Allowed Glycine 0 C--N 1.349 1.288 0 CA-C-O 118.889 -0.951 . . . . 13.44 112.003 -175.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 169' ' ' ASN . . . . . 0.554 ' HB3' ' HD3' ' C' ' 170' ' ' PRO . 2.2 t-20 -174.53 -66.57 0.0 OUTLIER Pre-proline 0 CA--C 1.565 1.532 0 CA-C-O 117.759 -1.115 . . . . 62.44 110.731 163.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 170' ' ' PRO . . . . . 0.554 ' HD3' ' HB3' ' C' ' 169' ' ' ASN . 6.9 Cg_exo -69.31 -70.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.403 3.439 0 CA-C-N 122.015 1.755 . . . . 73.55 113.685 -177.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 171' ' ' PRO . . . . . 0.528 ' HD3' ' HB2' ' C' ' 170' ' ' PRO . 85.0 Cg_endo -93.85 126.08 0.53 Allowed 'Trans proline' 0 C--N 1.405 3.542 0 CA-C-N 123.901 2.429 . . . . 74.02 111.521 178.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -154.43 107.79 0.34 Allowed Glycine 0 C--N 1.331 0.25 0 N-CA-C 109.293 -1.523 . . . . 74.42 109.293 176.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 173' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -126.06 121.99 34.53 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 123.447 0.699 . . . . 74.51 109.473 -166.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 174' ' ' LEU . . . . . 0.613 ' HB3' HG12 ' C' ' 161' ' ' VAL . 61.8 tp -81.96 107.3 14.57 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 109.467 -0.568 . . . . 75.22 109.467 177.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 175' ' ' LEU . . . . . 0.446 HD22 HG22 ' C' ' 158' ' ' VAL . 11.4 mt -89.76 87.91 7.16 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 115.632 -0.713 . . . . 72.15 109.641 174.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 176' ' ' LEU . . . . . 0.665 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 98.5 mt -73.8 98.12 2.89 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 108.431 -0.951 . . . . 74.33 108.431 171.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 177' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' C' ' 122' ' ' GLU . 23.7 t -81.24 97.96 3.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 106.585 -1.635 . . . . 75.23 106.585 178.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 178' ' ' VAL . . . . . . . . . . . . . 3.5 p -87.86 129.95 38.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.012 -0.994 . . . . 74.01 110.756 -169.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 179' ' ' ARG . . . . . 0.405 ' O ' ' HA ' ' C' ' 124' ' ' PRO . 7.4 mmm180 -115.26 107.05 14.76 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 106.216 -1.772 . . . . 74.42 106.216 169.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 180' ' ' LEU . . . . . . . . . . . . . 80.8 mt -68.38 138.51 55.42 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 109.147 -0.686 . . . . 73.43 109.147 175.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 181' ' ' LEU . . . . . . . . . . . . . 86.7 mt -50.55 129.76 26.36 Favored Pre-proline 0 N--CA 1.495 1.817 0 CA-C-O 117.848 -1.072 . . . . 74.24 108.672 -173.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER 11.42 -67.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.39 2.723 1 C-N-CA 126.135 4.557 . . . . 73.32 116.329 -153.024 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 183' ' ' HIS . . . . . 0.424 ' CD2' HD23 ' C' ' 127' ' ' LEU . 37.7 t-80 57.29 73.33 0.79 Allowed Pre-proline 0 N--CA 1.479 0.992 0 C-N-CA 124.18 0.992 . . . . 72.0 111.964 168.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 184' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -93.22 59.22 0.44 Allowed 'Trans proline' 0 C--N 1.358 1.042 0 N-CA-C 107.678 -1.701 . . . . 74.25 107.678 163.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 185' ' ' VAL . . . . . 0.601 HG12 ' SD ' ' C' ' 213' ' ' MET . 2.2 t -119.5 -59.01 2.95 Favored 'Isoleucine or valine' 0 C--N 1.362 1.133 0 N-CA-C 108.652 -0.87 . . . . 72.23 108.652 178.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 186' ' ' PHE . . . . . 0.483 ' HZ ' ' HA ' ' C' ' 214' ' ' THR . 40.8 m-85 -128.82 173.02 10.73 Favored 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 113.564 0.95 . . . . 61.44 113.564 -172.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 187' ' ' ARG . . . . . 0.443 ' NH1' ' HB2' ' C' ' 189' ' ' GLU . 2.1 tmt_? -152.61 120.92 6.3 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.983 1.313 . . . . 75.14 108.138 167.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 188' ' ' LEU . . . . . 0.71 HD22 ' HG2' ' C' ' 154' ' ' ARG . 48.7 tp -85.59 129.9 34.7 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 118.765 0.711 . . . . 74.14 112.797 -175.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 189' ' ' GLU . . . . . 0.443 ' HB2' ' NH1' ' C' ' 187' ' ' ARG . 14.6 tp10 -133.8 122.41 23.24 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 107.618 -1.253 . . . . 73.21 107.618 165.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 67.27 -107.98 2.25 Favored Glycine 0 C--N 1.344 1.025 0 N-CA-C 111.473 -0.651 . . . . 74.2 111.473 -172.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 191' ' ' GLN . . . . . 0.416 ' NE2' ' HA3' ' C' ' 242' ' ' GLY . 24.7 mt-30 -122.93 -16.93 6.92 Favored 'General case' 0 C--O 1.258 1.513 0 C-N-CA 124.506 1.123 . . . . 75.25 109.446 174.247 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -81.37 135.8 35.69 Favored 'General case' 0 C--N 1.355 0.816 0 C-N-CA 124.76 1.224 . . . . 65.13 110.295 -178.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 193' ' ' LEU . . . . . 0.505 HD23 ' CD2' ' C' ' 240' ' ' PHE . 95.4 mt -92.9 154.04 18.44 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.771 0.428 . . . . 65.15 110.67 177.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 194' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -116.64 105.75 12.77 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.076 -1.453 . . . . 75.43 107.076 167.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 195' ' ' ALA . . . . . 0.51 ' HB1' ' HG ' ' C' ' 251' ' ' LEU . . . -103.07 -177.5 3.39 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 124.017 0.927 . . . . 65.11 110.536 177.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 46.7 m -134.64 110.83 9.55 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 108.702 -0.851 . . . . 53.42 108.702 168.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 197' ' ' LEU . . . . . . . . . . . . . 47.9 tp -85.22 146.13 27.23 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 109.139 -0.689 . . . . 73.5 109.139 174.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 198' ' ' ASP . . . . . 0.498 ' HA ' ' HB2' ' C' ' 254' ' ' ARG . 28.4 t70 -117.89 105.88 12.39 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 108.661 -0.866 . . . . 64.33 108.661 -179.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 199' ' ' VAL . . . . . . . . . . . . . 44.7 t -115.05 122.12 33.99 Favored Pre-proline 0 N--CA 1.48 1.046 0 C-N-CA 124.095 0.958 . . . . 73.12 109.435 -176.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 200' ' ' PRO . . . . . 0.412 ' HA ' ' O ' ' C' ' 256' ' ' THR . 55.3 Cg_endo -70.36 148.91 62.24 Favored 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 122.021 1.814 . . . . 73.11 111.341 175.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 201' ' ' ALA . . . . . . . . . . . . . . . -53.9 -45.41 98.92 Favored Pre-proline 0 CA--C 1.559 1.318 0 C-N-CA 124.844 1.258 . . . . 74.35 113.763 -172.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 202' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -55.49 -49.27 16.63 Favored 'Trans proline' 0 C--N 1.396 3.064 0 C-N-CA 121.879 1.719 . . . . 63.15 112.847 175.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 203' ' ' ILE . . . . . . . . . . . . . 58.0 mt -68.12 -33.14 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.721 0.808 . . . . 74.02 110.869 -178.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 204' ' ' ALA . . . . . 0.413 ' HA ' HG12 ' C' ' 223' ' ' VAL . . . -64.25 -44.07 92.93 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.653 0.781 . . . . 75.02 110.856 178.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 205' ' ' VAL . . . . . 0.515 ' HA ' ' HA ' ' C' ' 226' ' ' ARG . 87.0 t -75.4 -39.16 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 115.508 -0.769 . . . . 74.52 112.131 -176.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 206' ' ' VAL . . . . . 0.465 ' HA ' ' HE2' ' A' ' 270' ' ' LYS . 14.6 p -77.34 -37.04 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 CA-C-N 118.078 0.399 . . . . 74.12 110.635 -178.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 86.57 57.68 2.05 Favored Glycine 0 C--N 1.337 0.631 0 N-CA-C 111.384 -0.687 . . . . 63.21 111.384 -168.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -89.49 -131.61 4.36 Favored Glycine 0 C--N 1.345 1.075 0 N-CA-C 110.915 -0.874 . . . . 51.32 110.915 177.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 209' ' ' LYS . . . . . 0.534 ' HZ2' ' HB2' ' C' ' 209' ' ' LYS . 4.6 ttmp? -150.44 143.35 24.72 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.345 0.658 . . . . 72.44 110.123 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 210' ' ' VAL . . . . . . . . . . . . . 30.4 m -134.34 167.98 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 C-N-CA 124.824 1.25 . . . . 71.52 109.486 177.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 211' ' ' ARG . . . . . 0.463 ' HA ' ' HA ' ' C' ' 220' ' ' GLU . 36.2 ttm180 -92.24 127.77 37.85 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 122.608 0.363 . . . . 75.53 111.027 179.247 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -102.47 122.99 45.41 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 107.817 -1.179 . . . . 74.43 107.817 164.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 213' ' ' MET . . . . . 0.601 ' SD ' HG12 ' C' ' 185' ' ' VAL . 1.3 tmt? -77.63 136.63 38.26 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.757 -0.831 . . . . 63.12 108.757 175.195 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 214' ' ' THR . . . . . 0.483 ' HA ' ' HZ ' ' C' ' 186' ' ' PHE . 0.1 OUTLIER -134.32 166.8 21.98 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.014 0.526 . . . . 72.34 110.932 178.15 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 215' ' ' LEU . . . . . 0.403 HD12 ' HB2' ' C' ' 131' ' ' PHE . 52.1 mt -60.12 -38.77 84.03 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.752 1.221 . . . . 75.24 112.851 -171.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.41 14.64 22.55 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.044 0.938 . . . . 71.0 111.844 -174.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 148.77 169.2 15.28 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-O 119.645 -0.531 . . . . 74.41 112.735 176.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -91.73 118.3 0.49 Allowed 'Trans proline' 0 CA--C 1.56 1.815 0 C-N-CA 122.829 2.353 . . . . 64.03 113.004 176.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 219' ' ' VAL . . . . . 0.438 HG11 ' OG1' ' C' ' 214' ' ' THR . 2.9 p -100.01 115.26 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.13 0.572 . . . . 52.53 110.174 178.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 220' ' ' GLU . . . . . 0.498 ' HG2' ' HG2' ' C' ' 209' ' ' LYS . 24.8 tt0 -82.93 103.79 12.66 Favored 'General case' 0 CA--C 1.556 1.173 0 N-CA-C 108.015 -1.106 . . . . 72.32 108.015 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 221' ' ' VAL . . . . . . . . . . . . . 7.6 p -101.79 138.87 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.648 0.779 . . . . 74.03 112.513 -168.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -81.45 117.58 21.99 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.839 1.256 . . . . 73.3 112.424 -173.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 223' ' ' VAL . . . . . 0.413 HG12 ' HA ' ' C' ' 204' ' ' ALA . 59.7 t -77.7 142.09 65.39 Favored Pre-proline 0 CA--C 1.564 1.491 0 C-N-CA 125.801 1.64 . . . . 73.11 110.423 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 224' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -84.47 155.26 12.26 Favored 'Trans proline' 0 C--N 1.384 2.444 0 C-N-CA 123.408 2.739 . . . . 73.11 113.188 174.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.88 117.67 4.33 Favored 'Trans proline' 0 C--N 1.382 2.306 0 C-N-CA 123.49 2.793 . . . . 74.4 113.3 176.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 226' ' ' ARG . . . . . 0.515 ' HA ' ' HA ' ' C' ' 205' ' ' VAL . 0.0 OUTLIER 65.35 88.69 0.1 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.652 1.581 . . . . 71.5 112.224 -177.917 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 227' ' ' THR . . . . . . . . . . . . . 58.4 m -106.5 131.57 53.53 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 114.337 -1.301 . . . . 73.3 110.345 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 228' ' ' GLN . . . . . 0.501 ' NE2' ' HG2' ' A' ' 259' ' ' GLU . 22.8 mp0 -103.81 152.68 21.61 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.833 0.853 . . . . 74.32 110.816 177.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -69.27 140.71 54.46 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.032 -0.985 . . . . 65.31 109.523 177.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 93.28 -3.88 73.14 Favored Glycine 0 C--N 1.338 0.654 0 CA-C-O 119.639 -0.534 . . . . 62.04 112.942 -174.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 231' ' ' ARG . . . . . 0.407 ' HD2' ' H ' ' C' ' 228' ' ' GLN . 54.3 mtt180 -64.81 174.51 1.82 Allowed 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 117.564 0.682 . . . . 75.03 111.376 168.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 232' ' ' LYS . . . . . 0.638 ' HB2' ' HZ1' ' C' ' 232' ' ' LYS . 2.6 ttmp? -143.29 151.43 40.51 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.641 0.734 . . . . 74.05 111.064 179.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 233' ' ' LEU . . . . . 0.524 HD12 HD12 ' C' ' 251' ' ' LEU . 1.9 tt -127.97 142.35 51.27 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.049 1.74 . . . . 74.22 107.873 -169.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 234' ' ' ARG . . . . . 0.425 ' HA ' ' O ' ' C' ' 249' ' ' LEU . 36.3 ptt180 -115.22 116.78 28.91 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 121.577 0.703 . . . . 72.34 111.379 173.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 235' ' ' LEU . . . . . 0.456 ' HB2' ' HB3' ' C' ' 249' ' ' LEU . 67.9 mt -109.63 99.42 8.61 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 108.839 -0.8 . . . . 74.34 108.839 171.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -69.4 126.19 28.99 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 114.335 -1.302 . . . . 73.41 110.949 -172.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 87.56 7.06 76.2 Favored Glycine 0 C--N 1.349 1.269 0 O-C-N 123.749 0.656 . . . . 71.42 113.956 -177.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 238' ' ' LYS . . . . . 0.42 ' HD2' HG21 ' C' ' 214' ' ' THR . 74.5 mmtt -109.91 17.16 21.43 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.469 0.708 . . . . 75.11 111.412 -178.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 239' ' ' GLY . . . . . 0.416 ' HA2' ' HG ' ' C' ' 193' ' ' LEU . . . -86.78 -166.11 42.06 Favored Glycine 0 C--N 1.348 1.239 0 N-CA-C 112.081 -0.408 . . . . 75.2 112.081 174.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 240' ' ' PHE . . . . . 0.505 ' CD2' HD23 ' C' ' 193' ' ' LEU . 2.2 m-85 -86.79 152.61 54.23 Favored Pre-proline 0 CA--C 1.558 1.261 0 N-CA-C 108.845 -0.798 . . . . 75.14 108.845 175.092 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 241' ' ' PRO . . . . . 0.43 ' HA ' ' HG2' ' C' ' 246' ' ' ARG . 31.5 Cg_exo -43.34 141.07 3.49 Favored 'Trans proline' 0 C--N 1.382 2.309 0 C-N-CA 124.622 3.548 . . . . 71.53 115.674 178.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 242' ' ' GLY . . . . . 0.416 ' HA3' ' NE2' ' C' ' 191' ' ' GLN . . . -133.88 148.95 19.61 Favored Glycine 0 C--N 1.348 1.217 0 CA-C-O 119.097 -0.835 . . . . 70.14 112.422 -176.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -60.09 -40.36 61.48 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 123.729 2.953 . . . . 71.42 113.462 -169.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -118.45 19.46 13.34 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.865 0.866 . . . . 71.42 110.787 -175.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 142.16 136.3 3.21 Favored Glycine 0 C--N 1.344 1.022 0 N-CA-C 110.063 -1.215 . . . . 63.24 110.063 -175.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 246' ' ' ARG . . . . . 0.43 ' HG2' ' HA ' ' C' ' 241' ' ' PRO . 90.5 mtt180 -78.25 150.72 33.37 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 117.349 0.575 . . . . 71.32 110.918 -172.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -72.76 -170.47 17.03 Favored Glycine 0 C--N 1.35 1.311 0 O-C-N 124.29 0.993 . . . . 63.23 114.831 -171.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -129.9 155.1 46.59 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.761 0.824 . . . . 73.54 109.017 -170.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 249' ' ' LEU . . . . . 0.489 HD11 ' HB2' ' C' ' 195' ' ' ALA . 24.0 tp -100.27 133.37 44.77 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.934 0.894 . . . . 74.23 110.89 -171.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 250' ' ' TYR . . . . . 0.477 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 1.0 OUTLIER -122.7 100.56 6.98 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.236 1.014 . . . . 71.43 111.084 178.662 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 251' ' ' LEU . . . . . 0.524 HD12 HD12 ' C' ' 233' ' ' LEU . 1.6 mp -97.0 125.69 41.6 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 118.9 -0.572 . . . . 72.0 110.586 -176.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -82.6 136.22 34.86 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 108.852 -0.795 . . . . 75.41 108.852 167.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 253' ' ' VAL . . . . . 0.428 HG23 ' CZ3' ' B' ' 242' ' ' TRP . 47.0 t -92.71 138.03 20.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 123.887 0.875 . . . . 73.5 112.82 -168.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 254' ' ' ARG . . . . . 0.498 ' HB2' ' HA ' ' C' ' 198' ' ' ASP . 20.6 mmt85 -102.65 136.07 43.15 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.2 1.4 . . . . 75.13 108.49 168.106 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 255' ' ' ILE . . . . . . . . . . . . . 32.7 mm -102.14 104.45 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 107.188 -1.412 . . . . 75.24 107.188 163.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 256' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' C' ' 200' ' ' PRO . 1.7 t -107.82 148.25 29.79 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.365 1.066 . . . . 70.25 109.902 -175.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 2.9 pp -111.9 145.73 33.31 Favored Pre-proline 0 N--CA 1.476 0.853 0 N-CA-C 109.393 -0.595 . . . . 75.21 109.393 176.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -60.4 -8.41 8.66 Favored 'Trans proline' 0 N--CA 1.507 2.268 0 C-N-CA 123.036 2.49 . . . . 74.41 115.36 -169.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 58.61 -68.5 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.572 1.549 . . . . 72.3 112.38 -168.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.17 149.68 44.75 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.771 0.829 . . . . 73.41 109.377 170.33 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 261' ' ' LEU . . . . . 0.474 HD11 HG13 ' A' ' 205' ' ' VAL . 77.6 mt -141.41 148.39 39.52 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.077 0.465 . . . . 74.53 111.089 -178.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 69.2 p -94.28 154.66 40.38 Favored Pre-proline 0 CA--C 1.554 1.129 0 N-CA-C 108.544 -0.91 . . . . 61.23 108.544 168.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -45.27 -45.06 15.52 Favored 'Trans proline' 0 C--N 1.391 2.798 0 C-N-CA 123.553 2.836 . . . . 74.2 114.188 -176.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -61.37 -52.59 64.01 Favored 'General case' 0 C--O 1.249 1.045 0 CA-C-N 115.1 -0.955 . . . . 71.04 110.856 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -52.06 -60.32 3.33 Favored 'General case' 0 C--N 1.362 1.129 0 O-C-N 124.537 1.148 . . . . 71.03 110.373 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 266' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -61.43 -33.82 74.35 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 124.179 0.924 . . . . 73.1 111.732 -172.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -59.63 -51.52 69.44 Favored 'General case' 0 CA--C 1.552 1.042 0 O-C-N 123.273 0.358 . . . . 71.12 111.359 173.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 268' ' ' LEU . . . . . . . . . . . . . 11.1 mp -66.61 -41.74 87.92 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 119.327 -0.368 . . . . 70.11 111.766 179.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -58.76 -38.57 78.74 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.654 0.782 . . . . 63.11 110.716 177.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 270' ' ' LYS . . . . . 0.611 ' HZ3' ' HB3' ' C' ' 270' ' ' LYS . 9.6 mtpm? -66.51 -46.38 76.4 Favored 'General case' 0 C--N 1.361 1.091 0 C-N-CA 122.997 0.519 . . . . 75.43 111.139 176.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.83 -37.59 74.11 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 123.66 0.6 . . . . 75.33 111.405 178.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 82.5 mt -68.35 -42.48 79.16 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.537 -0.756 . . . . 74.33 110.356 174.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -67.58 -25.6 65.86 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.408 0.683 . . . . 43.22 111.369 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -81.31 -36.34 29.91 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.252 1.021 . . . . 63.21 109.879 176.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -61.02 -28.36 68.99 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.522 -0.763 . . . . 70.04 110.327 168.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 276' ' ' TYR . . . . . 0.536 ' HB3' HD13 ' A' ' 203' ' ' ILE . 7.9 m-85 -82.08 -32.4 30.32 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.419 1.088 . . . . 75.52 111.863 175.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 23.0 m-30 -64.68 -30.16 71.17 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 109.483 -0.562 . . . . 65.52 109.483 172.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -66.38 -15.48 63.32 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 123.784 0.834 . . . . 72.22 112.41 175.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 279' ' ' ARG . . . . . . . . . . . . . 26.3 mtp-105 -82.47 -15.67 51.66 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.1 0.56 . . . . 75.11 111.091 175.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.065 0 C-N-CA 122.938 0.495 . . . . 75.14 109.718 178.317 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 76.6 tttt . . . . . 0 N--CA 1.485 1.293 0 N-CA-C 114.312 1.227 . . . . 64.14 114.312 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -87.9 102.77 15.04 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 107.479 -1.304 . . . . 74.32 107.479 163.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.484 ' HA ' ' OH ' ' A' ' 66' ' ' TYR . 7.3 t0 -71.37 92.7 1.08 Allowed 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 108.455 -0.943 . . . . 62.43 108.455 178.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -62.93 -36.28 82.89 Favored 'General case' 0 C--O 1.244 0.796 0 C-N-CA 123.613 0.765 . . . . 73.34 111.979 -171.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.405 ' HE1' HD13 ' A' ' 22' ' ' ILE . 77.7 m-85 -62.98 -44.49 95.9 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.595 -0.73 . . . . 73.33 110.674 175.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.91 -36.91 83.33 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.965 0.506 . . . . 70.01 111.431 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.404 HG13 ' O ' ' A' ' 6' ' ' ASP . 76.3 mt -61.61 -41.69 91.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.134 0.574 . . . . 74.23 110.086 176.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.1 mt -75.28 -14.12 60.48 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-N 116.145 -0.48 . . . . 73.11 111.955 175.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.49 24.13 76.77 Favored Glycine 0 C--N 1.353 1.476 0 CA-C-N 116.745 -0.207 . . . . 73.42 113.256 -177.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.5 m -108.48 152.38 42.04 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 124.128 0.971 . . . . 72.52 110.008 178.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -58.87 152.51 57.08 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.904 2.402 . . . . 50.12 112.602 174.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -69.49 7.34 0.84 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 112.664 0.616 . . . . 75.43 112.664 178.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -128.44 28.5 5.44 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.025 1.33 . . . . 71.2 107.786 177.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.6 168.7 2.75 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.96 0.904 . . . . 74.14 111.436 176.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 67.2 p -114.08 172.91 6.71 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.275 0.63 . . . . 75.03 109.642 175.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -58.02 -36.53 72.82 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.327 0.651 . . . . 71.11 110.393 176.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -66.59 -43.96 83.48 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.474 0.709 . . . . 72.43 111.433 177.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -67.42 -40.2 85.54 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.204 0.602 . . . . 71.14 111.743 -178.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.548 HD11 ' HB3' ' A' ' 57' ' ' LEU . 69.0 mt -71.59 -38.78 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.135 0.974 . . . . 73.31 110.748 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -65.25 -50.94 63.85 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.198 -0.91 . . . . 75.22 110.295 177.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 31.9 mtm180 -67.52 -33.12 74.42 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.352 0.661 . . . . 73.12 111.565 -178.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.32 -49.91 73.74 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 123.902 0.751 . . . . 72.43 109.588 174.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -60.58 -44.02 96.68 Favored 'General case' 0 C--O 1.206 -1.19 0 O-C-N 124.088 0.868 . . . . 73.1 110.589 178.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -58.69 -46.74 86.58 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.846 0.859 . . . . 74.22 110.833 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 47.4 ttt180 -57.14 -53.85 53.42 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.134 0.974 . . . . 75.52 110.671 177.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.623 ' HB3' HD11 ' A' ' 50' ' ' ILE . 73.6 mt -77.35 -21.66 53.01 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 115.274 -0.875 . . . . 75.12 111.368 -172.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -80.29 -32.09 38.17 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.443 0.697 . . . . 71.54 110.785 178.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 78.3 mtp180 -81.08 -39.99 24.83 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 122.938 0.495 . . . . 72.33 110.245 174.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.521 HE21 ' HA ' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -70.12 -50.13 43.75 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.297 0.639 . . . . 73.31 111.34 -175.288 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.496 ' HE2' HD23 ' A' ' 29' ' ' LEU . 15.6 m-85 -100.21 30.19 3.94 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.153 0.581 . . . . 72.41 109.628 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -65.71 111.44 6.32 Favored Pre-proline 0 C--N 1.354 0.763 0 N-CA-C 108.59 -0.893 . . . . 73.54 108.59 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -53.87 -38.37 85.79 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 123.186 2.591 . . . . 75.51 113.778 -168.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -70.24 -28.94 65.65 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.055 0.942 . . . . 73.23 112.3 -179.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 46.9 t -88.51 -61.58 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 N-CA-C 109.122 -0.696 . . . . 73.25 109.122 177.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -100.13 90.26 4.31 Favored 'General case' 0 C--O 1.243 0.759 0 C-N-CA 124.384 1.074 . . . . 64.12 108.881 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -81.04 69.93 7.75 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 108.67 -0.863 . . . . 73.11 108.67 178.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.2 m -125.03 106.04 28.8 Favored Pre-proline 0 C--O 1.237 0.4 0 N-CA-C 107.883 -1.154 . . . . 71.24 107.883 178.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_exo -43.89 -44.7 11.78 Favored 'Trans proline' 0 C--N 1.388 2.626 0 C-N-CA 123.749 2.966 . . . . 73.53 112.979 -177.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -50.81 -52.43 41.24 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.395 1.078 . . . . 64.43 111.31 176.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.7 -28.45 69.08 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 114.434 -1.257 . . . . 73.42 110.426 -177.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -82.19 -33.6 29.37 Favored 'General case' 0 C--O 1.219 -0.55 0 O-C-N 123.936 0.772 . . . . 63.35 110.293 -175.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.648 ' HA ' ' HD3' ' A' ' 48' ' ' LYS . 44.0 mt-10 -66.89 -46.35 75.19 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.961 0.905 . . . . 62.44 109.983 176.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -62.22 -42.64 99.49 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 114.224 -1.353 . . . . 74.03 109.875 174.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -56.99 -40.53 76.73 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.302 1.041 . . . . 73.32 110.725 176.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.648 ' HD3' ' HA ' ' A' ' 45' ' ' GLU . 24.0 mtpp -60.68 -48.75 80.38 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.703 0.801 . . . . 75.14 109.982 177.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -65.57 -26.5 67.89 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 123.38 0.425 . . . . 71.44 111.848 177.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.623 HD11 ' HB3' ' A' ' 29' ' ' LEU . 72.7 mt -74.5 -29.49 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 124.241 1.016 . . . . 74.43 110.058 175.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -73.27 -35.08 66.12 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.126 0.57 . . . . 73.43 110.444 172.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -67.86 -45.31 74.93 Favored 'General case' 0 C--O 1.256 1.443 0 C-N-CA 124.76 1.224 . . . . 75.34 110.302 175.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.13 -51.31 70.15 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 113.762 -1.563 . . . . 65.45 110.186 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 92.5 t80 -63.26 -35.26 79.75 Favored 'General case' 0 C--O 1.205 -1.267 0 CA-C-N 114.7 -1.136 . . . . 73.53 110.691 174.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.04 -51.34 66.61 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.298 0.639 . . . . 72.52 111.838 -177.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 94.4 t -75.39 -38.78 40.7 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 CA-C-N 115.121 -0.945 . . . . 74.52 110.893 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.548 ' HB3' HD11 ' A' ' 22' ' ' ILE . 73.1 mt -89.02 3.97 49.88 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 113.43 0.9 . . . . 74.35 113.43 -174.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.2 t -68.18 -73.12 0.15 Allowed 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.751 0.821 . . . . 74.34 110.497 -179.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -83.41 120.54 75.75 Favored Pre-proline 0 C--O 1.25 1.095 0 N-CA-C 108.346 -0.983 . . . . 74.34 108.346 178.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.547 ' O ' ' HG3' ' A' ' 64' ' ' ARG . 9.5 Cg_endo -53.82 -19.76 15.76 Favored 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 123.582 2.855 . . . . 72.41 115.187 -172.179 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -72.63 -53.14 12.63 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 119.397 0.999 . . . . 72.3 111.183 178.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -56.25 -41.16 75.32 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 122.417 1.103 . . . . 74.54 110.112 173.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.439 ' HG3' HD22 ' A' ' 57' ' ' LEU . 32.6 ttt180 -60.12 -43.09 95.91 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 113.273 -1.785 . . . . 74.11 111.142 175.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.547 ' HG3' ' O ' ' A' ' 60' ' ' PRO . 42.1 mtm180 -62.04 -37.23 84.16 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-O 118.974 -0.536 . . . . 74.25 110.314 177.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 84.9 mt -57.65 -44.55 85.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 O-C-N 123.982 0.801 . . . . 74.41 109.655 176.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.484 ' OH ' ' HA ' ' A' ' 6' ' ' ASP . 35.1 t80 -61.13 -50.51 72.89 Favored 'General case' 0 CA--C 1.558 1.25 0 CA-C-N 115.912 -0.585 . . . . 75.4 111.163 175.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -65.26 -23.85 67.16 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.857 0.863 . . . . 64.04 112.425 -179.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 81.5 p -97.0 -7.3 33.32 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 122.855 0.462 . . . . 75.44 110.601 176.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -73.28 103.76 4.09 Favored 'General case' 0 C--N 1.353 0.737 0 N-CA-C 106.997 -1.483 . . . . 75.32 106.997 168.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 110.15 23.95 5.9 Favored Glycine 0 CA--C 1.531 1.055 0 N-CA-C 110.947 -0.861 . . . . 64.23 110.947 -164.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 94.3 m -145.69 -56.33 0.3 Allowed 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 104.633 -2.358 . . . . 71.23 104.633 172.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 85.8 m -89.85 148.22 23.31 Favored 'General case' 0 C--O 1.252 1.235 0 N-CA-C 105.23 -2.137 . . . . 74.23 105.23 157.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.78 -42.32 4.53 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 123.405 0.682 . . . . 74.04 110.895 -178.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.25 134.98 51.13 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 123.346 0.658 . . . . 75.1 109.315 177.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -52.28 126.16 19.7 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.718 2.279 . . . . 75.41 111.749 175.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_exo -57.51 160.99 12.76 Favored 'Trans proline' 0 C--N 1.375 1.974 0 C-N-CA 123.305 2.67 . . . . 74.25 113.562 -177.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -64.48 121.25 8.78 Favored 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 122.195 1.93 . . . . 73.45 111.523 173.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.475 ' HG3' ' HA3' ' A' ' 104' ' ' GLY . 35.9 Cg_endo -63.25 136.43 55.63 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 122.871 2.38 . . . . 73.2 111.702 177.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -57.89 157.07 25.61 Favored 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 123.183 2.589 . . . . 71.05 112.626 175.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -60.37 84.46 0.07 OUTLIER 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 122.801 2.334 . . . . 74.31 111.411 172.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.21 -32.3 0.32 Allowed Glycine 0 CA--C 1.525 0.672 0 CA-C-N 114.312 -1.313 . . . . 62.41 109.824 -176.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.92 156.32 31.37 Favored Glycine 0 C--N 1.351 1.366 0 C-N-CA 123.413 0.53 . . . . 53.03 113.072 171.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -63.06 94.47 0.07 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.809 0.843 . . . . 74.41 110.169 170.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -76.78 157.89 31.28 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 109.002 -0.74 . . . . 71.31 109.002 169.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.521 ' HE2' ' HD2' ' A' ' 93' ' ' PHE . 16.1 t80 -127.49 50.46 2.01 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.567 0.699 . . . . 73.24 109.563 -178.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 57.8 m -0.41 83.69 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.484 0 C-N-CA 127.288 2.235 . . . . 74.44 116.475 -174.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.86 -13.94 2.94 Favored Glycine 0 N--CA 1.482 1.748 0 N-CA-C 116.655 1.422 . . . . 70.11 116.655 168.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.492 ' HB3' ' HE2' ' A' ' 93' ' ' PHE . 63.5 m-85 -90.34 136.98 32.72 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 118.158 0.979 . . . . 72.34 110.179 -174.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -66.17 92.51 0.18 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.091 0.556 . . . . 71.44 110.695 -170.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.561 HG11 ' HG3' ' A' ' 91' ' ' GLU . 2.3 p -40.9 -51.49 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 125.12 1.368 . . . . 75.21 113.0 171.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.561 ' HG3' HG11 ' A' ' 90' ' ' VAL . 40.3 mt-10 -71.87 -12.1 61.11 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.614 0.766 . . . . 75.33 111.528 -173.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -87.09 -34.35 19.17 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.518 0.727 . . . . 61.35 110.632 174.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.521 ' HD2' ' HE2' ' A' ' 85' ' ' PHE . 26.5 m-85 -91.49 174.14 7.53 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.158 0.799 . . . . 73.34 113.158 -168.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 88.5 p -58.76 151.39 21.32 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 115.395 1.628 . . . . 74.5 115.395 -162.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.91 -42.87 80.72 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.028 -1.442 . . . . 74.52 110.877 170.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -50.61 -50.99 52.76 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.185 0.994 . . . . 75.03 111.042 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.502 ' HE2' HG21 ' A' ' 90' ' ' VAL . 1.4 t80 -59.69 -50.56 73.35 Favored 'General case' 0 CA--C 1.555 1.172 0 O-C-N 124.226 0.954 . . . . 72.32 109.829 174.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -66.56 -6.6 15.71 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.207 0.603 . . . . 74.14 112.249 -176.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -103.0 -30.95 10.47 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.168 0.987 . . . . 70.02 111.831 170.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 26.3 tp -73.59 -56.19 5.33 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.341 0.657 . . . . 74.33 110.842 -177.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -93.51 -6.55 46.54 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.115 0.566 . . . . 72.11 110.662 174.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -47.48 -55.75 8.93 Favored Glycine 0 C--N 1.351 1.394 0 CA-C-O 118.767 -1.018 . . . . 72.43 115.579 -177.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -46.4 -13.83 0.11 Allowed 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 124.792 3.661 . . . . 64.43 116.746 176.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.475 ' HA3' ' HG3' ' A' ' 78' ' ' PRO . . . -149.93 29.03 1.14 Allowed Glycine 0 C--N 1.355 1.585 0 CA-C-O 118.599 -1.112 . . . . 54.4 114.215 174.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.504 ' HB3' ' ND2' ' A' ' 169' ' ' ASN . 15.1 mt -60.99 79.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 113.005 0.743 . . . . 74.25 113.005 177.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.763 ' HB3' ' HA ' ' A' ' 169' ' ' ASN . 0.5 OUTLIER 24.72 -100.9 0.01 OUTLIER 'General case' 0 CA--C 1.569 1.7 0 C-N-CA 127.249 2.219 . . . . 74.45 113.956 170.175 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 80.06 6.28 89.23 Favored Glycine 0 C--N 1.363 2.046 0 CA-C-N 117.896 0.317 . . . . 44.0 113.431 -176.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.348 1.231 0 N-CA-C 111.317 -0.713 . . . . 71.34 111.317 -172.436 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 88.3 tttt . . . . . 0 CA--C 1.554 1.102 0 N-CA-C 111.756 0.28 . . . . 73.31 111.756 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -88.65 169.98 37.87 Favored Glycine 0 C--N 1.353 1.478 0 CA-C-N 116.337 -0.392 . . . . 73.4 112.961 178.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.95 -178.25 3.33 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.523 0.729 . . . . 74.43 110.353 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -77.07 142.54 39.77 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 109.04 -0.726 . . . . 74.23 109.04 170.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.454 HD11 ' HB3' ' B' ' 10' ' ' LEU . 7.7 tt -144.18 125.75 14.98 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 107.658 -1.238 . . . . 75.42 107.658 -175.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.495 ' NH2' ' HB ' ' A' ' 177' ' ' VAL . 0.0 OUTLIER -97.58 126.44 42.88 Favored 'General case' 0 C--O 1.217 -0.625 0 N-CA-C 107.293 -1.373 . . . . 74.51 107.293 175.903 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.472 ' HB3' HD21 ' A' ' 176' ' ' LEU . . . -120.42 155.7 32.93 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-N 118.39 0.541 . . . . 54.41 111.534 -177.07 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.536 ' HB2' ' HB2' ' B' ' 9' ' ' ALA . 1.2 mm-40 -92.8 111.7 23.41 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 106.244 -1.761 . . . . 72.42 106.244 175.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.525 ' HB3' ' HA ' ' A' ' 178' ' ' VAL . 61.1 tp -101.35 96.17 5.79 Favored Pre-proline 0 N--CA 1.476 0.854 0 N-CA-C 108.29 -1.004 . . . . 74.14 108.29 177.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.609 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 58.5 Cg_endo -73.23 112.37 3.51 Favored 'Trans proline' 0 C--N 1.376 2.016 0 C-N-CA 121.406 1.404 . . . . 75.33 110.001 178.198 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.506 ' HB3' HD22 ' A' ' 180' ' ' LEU . 52.8 tp -116.73 138.9 51.13 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.413 0.625 . . . . 72.43 111.536 -168.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.597 ' HB ' ' HG2' ' A' ' 129' ' ' GLU . 93.3 m -72.3 125.73 28.06 Favored 'General case' 0 CA--C 1.553 1.072 0 CA-C-N 113.856 -1.52 . . . . 71.34 109.369 174.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.415 ' HB3' HD22 ' A' ' 215' ' ' LEU . 48.9 mt -53.4 -39.7 64.48 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 124.032 0.933 . . . . 75.21 112.249 -171.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.469 ' HB2' ' H2 ' ' B' ' 1' ' ' MET . 3.8 mp0 -69.03 -33.85 74.28 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 115.465 -0.789 . . . . 75.32 110.628 -177.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.597 ' HG2' ' HB ' ' A' ' 126' ' ' THR . 12.2 mm-40 -72.99 -26.42 61.33 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 109.949 -0.389 . . . . 64.33 109.949 175.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.429 ' HB1' ' O ' ' A' ' 153' ' ' VAL . . . -66.7 -37.62 85.08 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 123.393 0.433 . . . . 65.44 110.54 174.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -65.38 -50.52 65.22 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 115.025 -0.989 . . . . 74.51 111.287 173.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 30.9 m170 -70.74 -45.19 65.29 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.183 0.593 . . . . 75.25 111.624 -171.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.07 -163.27 54.11 Favored Glycine 0 C--N 1.339 0.742 0 O-C-N 123.465 0.478 . . . . 71.54 112.834 -175.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 96.93 -173.84 29.64 Favored Glycine 0 C--N 1.345 1.051 0 N-CA-C 112.554 -0.219 . . . . 70.42 112.554 179.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 2.0 mp0 -78.88 109.53 13.24 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 122.655 -0.321 . . . . 73.14 110.357 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -90.97 126.46 36.08 Favored 'General case' 0 C--O 1.248 1.022 0 N-CA-C 109.317 -0.623 . . . . 75.05 109.317 173.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 76.3 t -80.31 116.31 24.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 114.742 -1.117 . . . . 75.04 108.483 168.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.637 ' HB ' HG12 ' A' ' 145' ' ' VAL . 62.2 t -124.75 129.21 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.08 0.952 . . . . 73.34 109.042 -175.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -98.03 142.92 29.15 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 122.996 0.518 . . . . 71.3 110.941 -177.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.528 ' HB ' ' HB3' ' B' ' 8' ' ' LEU . 8.1 p -160.67 121.86 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 C-N-CA 123.515 0.726 . . . . 75.1 111.023 174.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 65.51 14.3 9.4 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.471 1.108 . . . . 74.24 113.911 169.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 84.6 28.04 33.69 Favored Glycine 0 N--CA 1.479 1.518 0 N-CA-C 111.9 -0.48 . . . . 54.15 111.9 -174.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 17.9 tpt85 -152.62 97.31 2.23 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 107.737 -1.208 . . . . 72.43 107.737 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.534 ' NH1' ' HB2' ' A' ' 146' ' ' SER . 0.0 OUTLIER -64.54 129.96 41.86 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 114.908 -1.042 . . . . 74.41 111.424 179.375 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.637 HG12 ' HB ' ' A' ' 138' ' ' VAL . 1.4 p -91.79 130.09 41.46 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 C-N-CA 124.346 1.058 . . . . 73.53 109.223 165.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.534 ' HB2' ' NH1' ' A' ' 144' ' ' ARG . 47.5 t -92.96 132.03 37.43 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 108.317 -0.994 . . . . 64.43 108.317 167.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 2.1 p -139.81 118.01 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 O-C-N 123.65 0.594 . . . . 73.42 109.919 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.464 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 47.8 ttt85 -74.37 93.41 2.41 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 107.864 -1.162 . . . . 74.32 107.864 167.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.544 ' HB ' HG13 ' A' ' 153' ' ' VAL . 34.2 pt -71.75 125.23 91.7 Favored Pre-proline 0 CA--C 1.55 0.956 0 N-CA-C 108.408 -0.96 . . . . 74.52 108.408 175.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -59.39 138.28 83.3 Favored 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 122.371 2.048 . . . . 74.22 111.951 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -62.84 93.02 0.14 Allowed 'Trans proline' 0 C--N 1.374 1.877 0 C-N-CA 121.996 1.797 . . . . 74.15 110.116 171.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.471 ' HA2' ' CD2' ' A' ' 240' ' ' PHE . . . 125.02 24.21 1.69 Allowed Glycine 0 C--N 1.345 1.046 0 CA-C-N 115.1 -0.954 . . . . 75.51 113.084 -173.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.565 HG21 HD13 ' A' ' 159' ' ' ILE . 2.6 p -75.38 149.67 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 123.626 0.77 . . . . 75.43 110.366 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.474 ' O ' HG11 ' A' ' 178' ' ' VAL . 0.1 OUTLIER -119.24 -165.35 1.14 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.507 0.723 . . . . 73.23 112.099 -161.043 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.535 ' HB3' ' O ' ' A' ' 188' ' ' LEU . 3.0 tp10 -86.6 141.36 29.06 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 105.481 -2.044 . . . . 72.32 105.481 160.252 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 65.71 9.03 43.46 Favored Glycine 0 CA--C 1.535 1.311 0 N-CA-C 115.322 0.889 . . . . 74.33 115.322 177.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' SER . . . . . 0.484 ' O ' HG12 ' A' ' 178' ' ' VAL . 23.2 t -74.64 117.89 16.98 Favored 'General case' 0 C--N 1.355 0.833 0 N-CA-C 107.949 -1.13 . . . . 74.23 107.949 175.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.487 HG23 HG22 ' A' ' 177' ' ' VAL . 41.7 t -84.84 88.63 2.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.577 -0.898 . . . . 74.02 108.577 -178.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.565 HD13 HG21 ' A' ' 153' ' ' VAL . 30.0 mt -72.3 98.82 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 107.704 -1.221 . . . . 75.24 107.704 174.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -79.61 98.19 6.81 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 114.581 -1.19 . . . . 75.21 108.687 -176.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.402 ' HA ' ' HD2' ' A' ' 162' ' ' PRO . 3.4 p -123.51 94.92 45.81 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 123.649 0.78 . . . . 71.41 109.473 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.592 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 10.8 Cg_endo -56.65 143.67 88.47 Favored 'Trans proline' 0 C--N 1.363 1.336 0 C-N-CA 123.025 2.483 . . . . 74.53 112.874 167.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 95.51 20.37 27.27 Favored Glycine 0 N--CA 1.445 -0.764 0 CA-C-N 114.658 -1.155 . . . . 70.43 115.056 172.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.463 ' HG3' HG23 ' A' ' 145' ' ' VAL . 24.9 mmt -143.99 7.96 1.43 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.16 0.584 . . . . 64.15 110.433 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.574 ' HA2' HD11 ' A' ' 174' ' ' LEU . . . -90.55 -121.13 2.31 Favored Glycine 0 C--N 1.346 1.115 0 CA-C-N 115.672 -0.694 . . . . 73.33 114.436 -168.129 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 171' ' ' PRO . . . -60.94 115.71 8.25 Favored Glycine 0 C--N 1.362 2.007 0 CA-C-O 119.493 -0.615 . . . . 74.5 113.494 -169.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -59.59 146.25 41.5 Favored 'General case' 0 C--N 1.35 0.615 0 O-C-N 125.087 1.11 . . . . 75.42 111.034 -175.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 169.18 -125.25 1.24 Allowed Glycine 0 CA--C 1.495 -1.197 0 N-CA-C 106.816 -2.514 . . . . 64.21 106.816 -174.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . 0.763 ' HA ' ' HB3' ' A' ' 106' ' ' PHE . 43.4 t-20 -98.31 -57.09 0.17 Allowed Pre-proline 0 CA--C 1.55 0.981 0 N-CA-C 107.415 -1.328 . . . . 63.54 107.415 170.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.653 ' HD3' ' HB3' ' A' ' 169' ' ' ASN . 59.5 Cg_endo -95.03 109.18 0.13 Allowed 'Trans proline' 0 C--N 1.382 2.341 0 C-N-CA 122.033 1.822 . . . . 73.02 110.937 165.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.468 ' HA ' ' O ' ' A' ' 166' ' ' GLY . 29.6 Cg_endo -61.59 113.58 1.87 Allowed 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 121.74 1.627 . . . . 71.25 108.936 174.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -63.94 -142.06 0.02 OUTLIER Glycine 0 N--CA 1.484 1.841 0 N-CA-C 116.096 1.198 . . . . 72.4 116.096 -166.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.592 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 38.9 t70 -80.85 124.71 29.32 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 122.177 -0.602 . . . . 71.14 109.427 -177.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.574 HD11 ' HA2' ' A' ' 165' ' ' GLY . 26.9 tp -106.88 118.36 36.48 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.148 0.499 . . . . 74.2 110.5 -174.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.455 ' HB2' ' HA ' ' A' ' 120' ' ' ARG . 47.5 mt -94.58 85.53 4.54 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 124.061 0.944 . . . . 72.12 108.764 176.175 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.527 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 43.1 mt -72.73 84.37 1.19 Allowed 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.025 -0.534 . . . . 74.52 109.852 178.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.495 ' HB ' ' NH2' ' A' ' 120' ' ' ARG . 46.6 t -82.9 98.71 5.13 Favored 'Isoleucine or valine' 0 C--O 1.248 1.026 0 N-CA-C 104.917 -2.253 . . . . 71.11 104.917 176.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.525 ' HA ' ' HB3' ' A' ' 123' ' ' LEU . 10.0 p -76.27 113.29 15.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 112.108 -2.315 . . . . 74.13 111.001 -166.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.609 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 30.8 mmm-85 -90.16 106.45 18.49 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-N 115.499 -0.773 . . . . 73.42 108.989 178.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.506 HD22 ' HB3' ' A' ' 125' ' ' LEU . 23.3 mt -68.66 147.36 51.98 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 118.76 0.709 . . . . 74.04 110.29 177.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 83.9 mt -55.37 159.1 4.8 Favored Pre-proline 0 N--CA 1.484 1.261 0 C-N-CA 124.17 0.988 . . . . 73.22 112.289 -176.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -74.87 24.01 0.39 Allowed 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 122.991 2.46 . . . . 74.32 112.689 170.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . 0.403 ' ND1' HD11 ' A' ' 127' ' ' LEU . 65.5 t-80 -61.62 116.09 18.67 Favored Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 125.231 1.412 . . . . 73.35 108.327 174.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -75.51 24.89 0.4 Allowed 'Trans proline' 0 C--N 1.371 1.727 0 C-N-CA 124.146 3.23 . . . . 61.24 116.902 -160.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 97.0 t -97.24 -57.82 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 119.168 0.895 . . . . 72.34 109.695 -179.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . 0.475 ' CE1' ' HB1' ' A' ' 195' ' ' ALA . 19.1 m-85 -132.87 143.61 49.63 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 112.551 0.574 . . . . 72.31 112.551 -171.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . 0.668 ' HB3' ' HB2' ' A' ' 194' ' ' TYR . 0.0 OUTLIER -114.12 83.33 1.85 Allowed 'General case' 0 C--O 1.239 0.508 0 N-CA-C 106.735 -1.58 . . . . 75.51 106.735 163.389 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.535 ' O ' ' HB3' ' A' ' 155' ' ' GLU . 48.1 tp -75.07 131.1 40.32 Favored 'General case' 0 C--O 1.202 -1.395 0 CA-C-N 114.465 -1.243 . . . . 74.21 109.367 177.076 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -147.2 129.89 16.05 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.089 -1.078 . . . . 70.31 108.089 171.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 66.26 -81.86 0.1 Allowed Glycine 0 C--N 1.344 0.98 0 O-C-N 124.352 1.032 . . . . 65.41 112.564 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.503 ' HB2' ' HA2' ' A' ' 247' ' ' GLY . 0.7 OUTLIER -129.97 -32.63 1.83 Allowed 'General case' 0 C--O 1.249 1.071 0 C-N-CA 123.834 0.853 . . . . 72.32 109.867 179.268 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -88.26 149.38 23.85 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.625 -0.716 . . . . 72.32 111.776 -166.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.462 HD21 ' HB2' ' A' ' 188' ' ' LEU . 88.6 mt -103.25 158.99 15.94 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.532 1.133 . . . . 74.25 108.97 173.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.668 ' HB2' ' HB3' ' A' ' 187' ' ' ARG . 28.5 m-85 -131.35 101.33 5.5 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 108.707 -0.849 . . . . 73.14 108.707 168.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.476 ' HB3' HD21 ' A' ' 251' ' ' LEU . . . -105.4 131.48 52.78 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 109.145 -0.687 . . . . 74.34 109.145 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' THR . . . . . 0.581 ' HA ' ' HB2' ' A' ' 252' ' ' GLU . 30.4 m -71.72 110.75 6.47 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 109.308 -0.627 . . . . 70.21 109.308 177.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.516 HD22 HD12 ' A' ' 251' ' ' LEU . 50.1 tp -103.15 101.14 11.09 Favored 'General case' 0 C--N 1.347 0.487 0 N-CA-C 110.111 -0.329 . . . . 74.1 110.111 -178.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -73.6 127.7 33.47 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.562 -1.273 . . . . 63.3 107.562 164.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.577 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 7.1 p -142.18 135.35 14.14 Favored Pre-proline 0 CA--C 1.539 0.545 0 N-CA-C 107.889 -1.152 . . . . 74.33 107.889 178.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.3 158.72 37.0 Favored 'Trans proline' 0 C--N 1.361 1.222 0 C-N-CA 121.475 1.45 . . . . 70.05 112.196 172.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.406 ' HB2' ' HD3' ' A' ' 202' ' ' PRO . . . -56.83 -49.66 92.57 Favored Pre-proline 0 N--CA 1.481 1.109 0 N-CA-C 113.233 0.827 . . . . 71.34 113.233 -178.08 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.406 ' HD3' ' HB2' ' A' ' 201' ' ' ALA . 57.1 Cg_exo -57.28 -45.42 35.14 Favored 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 121.953 1.768 . . . . 73.32 113.802 178.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 55.4 mt -71.39 -29.69 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 122.953 0.501 . . . . 71.02 110.86 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.89 -42.2 85.92 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.715 0.406 . . . . 74.14 110.391 175.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 46.0 t -68.85 -55.66 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.593 0.757 . . . . 64.22 111.292 -178.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.641 HG22 ' HA ' ' C' ' 270' ' ' LYS . 61.4 t -83.06 -41.69 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-O 120.872 0.367 . . . . 74.41 111.173 -172.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 88.96 168.89 44.27 Favored Glycine 0 C--N 1.338 0.692 0 CA-C-N 115.968 -0.56 . . . . 72.35 111.973 -174.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 161.32 -125.34 1.43 Allowed Glycine 0 C--O 1.224 -0.495 0 N-CA-C 110.149 -1.18 . . . . 73.32 110.149 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -137.97 135.74 36.29 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 118.099 0.95 . . . . 73.34 110.882 175.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 28.4 m -129.34 -176.71 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 124.181 0.993 . . . . 63.11 109.276 170.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -80.86 133.24 35.55 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.32 0.648 . . . . 74.32 110.765 176.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -119.92 111.94 18.57 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.542 -1.281 . . . . 74.41 107.542 165.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -71.81 129.16 37.96 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.055 -0.72 . . . . 74.15 109.055 177.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 43.4 p -109.27 179.82 4.05 Favored 'General case' 0 C--O 1.243 0.763 0 N-CA-C 107.744 -1.206 . . . . 74.1 107.744 171.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . 0.415 HD22 ' HB3' ' A' ' 127' ' ' LEU . 72.2 mt -61.21 -22.11 64.46 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 114.021 1.119 . . . . 73.14 114.021 -170.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -142.64 28.7 1.6 Allowed 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 112.705 0.632 . . . . 64.44 112.705 -177.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 155.89 159.67 9.51 Favored Glycine 0 N--CA 1.477 1.419 0 N-CA-C 114.28 0.472 . . . . 63.05 114.28 173.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -87.69 130.39 2.7 Favored 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 123.199 2.599 . . . . 74.13 113.305 178.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 30.9 m -110.99 175.59 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 123.749 0.82 . . . . 73.4 110.262 175.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -101.82 111.22 23.4 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.803 0.841 . . . . 75.04 109.355 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 14.7 p -100.15 133.81 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 123.156 0.582 . . . . 74.51 109.584 177.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -86.64 104.47 16.08 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 122.955 0.502 . . . . 70.4 110.49 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 60.2 t -71.24 128.74 89.95 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 123.914 0.886 . . . . 71.22 109.857 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -74.62 167.02 28.07 Favored 'Trans proline' 0 C--N 1.373 1.835 0 C-N-CA 122.743 2.295 . . . . 75.51 111.636 172.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . 0.448 ' HB2' ' HE ' ' A' ' 226' ' ' ARG . 58.8 Cg_endo -70.35 159.99 51.07 Favored 'Trans proline' 0 C--N 1.365 1.418 0 C-N-CA 122.712 2.274 . . . . 72.53 113.441 171.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . 0.448 ' HE ' ' HB2' ' A' ' 225' ' ' PRO 0.266 0.0 OUTLIER 38.03 55.96 1.64 Allowed 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 126.428 1.891 . . . . 75.13 113.378 -175.913 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.495 HG22 HD21 ' A' ' 233' ' ' LEU . 64.2 m -84.2 90.44 7.51 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 113.06 -1.882 . . . . 64.32 108.953 173.198 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -86.15 146.45 26.58 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.766 0.826 . . . . 75.32 111.545 -171.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -64.8 148.45 51.23 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.846 0.858 . . . . 65.12 112.333 -176.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . 0.402 ' HA3' ' NH2' ' C' ' 254' ' ' ARG . . . 90.78 -21.16 34.71 Favored Glycine 0 C--N 1.345 1.041 0 CA-C-N 115.434 -0.803 . . . . 75.54 113.311 -178.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -81.2 170.81 15.64 Favored 'General case' 0 C--O 1.245 0.821 0 C-N-CA 123.757 0.823 . . . . 74.44 110.993 -179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.419 ' HG3' ' HB3' ' A' ' 250' ' ' TYR . 0.3 OUTLIER -129.02 117.28 20.65 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 114.601 -1.181 . . . . 72.22 109.03 -178.892 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.495 HD21 HG22 ' A' ' 227' ' ' THR . 58.2 mt -78.33 110.86 13.73 Favored 'General case' 0 C--O 1.218 -0.558 0 N-CA-C 108.034 -1.098 . . . . 71.4 108.034 175.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -80.99 106.51 13.05 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.974 0.909 . . . . 73.41 109.974 175.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.595 HD13 ' HG3' ' A' ' 238' ' ' LYS . 0.2 OUTLIER -118.68 107.22 13.43 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.229 0.537 . . . . 74.24 109.757 171.912 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 248' ' ' ASP . 25.6 mtpp -76.52 159.75 30.08 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.36 1.064 . . . . 71.01 111.079 -177.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 66.37 18.56 67.63 Favored Glycine 0 C--N 1.348 1.207 0 CA-C-N 115.688 -0.687 . . . . 74.2 113.279 -176.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.595 ' HG3' HD13 ' A' ' 235' ' ' LEU . 45.5 mmtm -114.32 -29.93 6.76 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.229 1.011 . . . . 74.1 109.805 -179.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -79.04 -154.98 8.56 Favored Glycine 0 C--N 1.343 0.95 0 CA-C-N 115.001 -1.0 . . . . 74.43 111.107 169.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . 0.471 ' CD2' ' HA2' ' A' ' 152' ' ' GLY . 35.3 m-85 -95.35 123.44 56.72 Favored Pre-proline 0 C--O 1.239 0.504 0 N-CA-C 109.519 -0.548 . . . . 73.41 109.519 -173.383 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.681 ' HA ' ' HA ' ' A' ' 246' ' ' ARG . 73.8 Cg_endo -73.24 132.16 17.52 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 122.721 2.281 . . . . 73.33 113.116 -170.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -101.65 -167.48 27.44 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 110.757 -0.937 . . . . 73.52 110.757 167.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -60.07 -62.54 0.15 Allowed 'Trans proline' 0 C--N 1.377 2.037 0 C-N-CA 122.915 2.41 . . . . 72.5 111.649 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -106.34 -25.31 11.98 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.449 0.7 . . . . 70.11 110.104 170.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -89.84 67.42 2.7 Favored Glycine 0 C--N 1.352 1.447 0 CA-C-N 115.759 -0.655 . . . . 62.24 112.457 -175.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.681 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 52.3 mtm-85 -69.92 118.24 12.51 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 123.529 0.732 . . . . 75.41 109.853 175.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . 0.503 ' HA2' ' HB2' ' A' ' 191' ' ' GLN . . . -52.85 149.86 10.4 Favored Glycine 0 C--N 1.351 1.376 0 N-CA-C 117.346 1.698 . . . . 70.31 117.346 -167.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . 0.473 ' HA ' ' HA ' ' A' ' 236' ' ' LYS . 0.8 OUTLIER -98.46 172.87 7.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 113.858 -1.171 . . . . 75.44 109.173 -179.228 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.506 ' HB3' ' HG ' ' A' ' 235' ' ' LEU . 17.5 tp -137.06 101.78 4.65 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 106.21 -1.774 . . . . 73.32 106.21 170.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.419 ' HB3' ' HG3' ' A' ' 232' ' ' LYS . 84.6 m-85 -85.98 112.14 20.93 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 123.553 0.741 . . . . 71.3 109.219 174.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.516 HD12 HD22 ' A' ' 197' ' ' LEU . 94.0 mt -88.92 121.12 30.96 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.152 -0.931 . . . . 74.54 110.065 178.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . 0.581 ' HB2' ' HA ' ' A' ' 196' ' ' THR . 45.9 mm-40 -75.15 91.49 2.6 Favored 'General case' 0 C--N 1.352 0.711 0 N-CA-C 108.132 -1.062 . . . . 75.41 108.132 177.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 42.0 t -65.41 115.59 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 O-C-N 123.705 0.628 . . . . 71.34 110.239 -178.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . 0.448 ' HD3' ' HA ' ' A' ' 254' ' ' ARG . 7.2 mmt180 -129.23 102.22 6.36 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.703 0.801 . . . . 73.14 108.921 172.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.577 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 60.9 mt -77.38 134.04 29.4 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-N 114.174 -1.375 . . . . 74.34 110.706 -179.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 28.4 p -127.7 174.5 9.05 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.638 1.175 . . . . 74.52 109.503 173.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.9 pp -134.98 152.89 78.08 Favored Pre-proline 0 CA--C 1.567 1.625 0 C-N-CA 123.583 0.753 . . . . 73.4 110.768 -177.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -65.95 -6.77 15.06 Favored 'Trans proline' 0 N--CA 1.51 2.448 0 C-N-CA 123.854 3.036 . . . . 74.45 115.58 -166.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . 0.436 ' O ' ' HG2' ' C' ' 226' ' ' ARG . 39.1 mt-10 48.16 -83.62 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.751 1.221 . . . . 75.12 112.368 -164.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 7.1 ppt_? -61.02 137.86 58.21 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.388 0.675 . . . . 75.12 110.115 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.443 HD13 ' HA ' ' A' ' 266' ' ' GLU . 74.1 mt -137.86 140.92 40.68 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.321 0.581 . . . . 72.32 111.1 -172.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 37.0 p -83.4 138.74 41.57 Favored Pre-proline 0 CA--C 1.554 1.097 0 CA-C-O 117.683 -1.151 . . . . 74.31 108.745 175.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -24.79 -56.02 0.07 OUTLIER 'Trans proline' 0 C--N 1.386 2.55 1 C-N-CA 126.309 4.673 . . . . 74.33 117.382 -169.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -80.94 -33.22 34.14 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 112.481 0.548 . . . . 71.44 112.481 -173.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -69.95 -35.61 74.64 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 122.833 0.453 . . . . 73.22 110.066 174.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 266' ' ' GLU . . . . . 0.443 ' HA ' HD13 ' A' ' 261' ' ' LEU . 8.1 tp10 -54.36 -52.98 59.9 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 124.119 0.968 . . . . 73.45 109.091 169.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . 0.535 ' O ' ' HG3' ' A' ' 271' ' ' LYS . . . -57.42 -43.96 84.24 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 114.291 -1.322 . . . . 64.12 111.486 177.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 4.7 mp -59.55 -53.23 60.53 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 123.983 0.913 . . . . 73.14 111.286 -176.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -53.88 -48.15 70.35 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 124.198 0.937 . . . . 75.0 110.608 175.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . 0.501 ' HG3' HG22 ' C' ' 206' ' ' VAL . 1.0 OUTLIER -62.76 -34.82 78.03 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 123.875 0.735 . . . . 73.12 112.715 -179.327 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . 0.535 ' HG3' ' O ' ' A' ' 267' ' ' ALA . 64.2 mttm -62.33 -59.03 5.58 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.814 -0.81 . . . . 70.22 108.814 177.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 272' ' ' LEU . . . . . 0.517 ' O ' ' HB2' ' A' ' 276' ' ' TYR . 82.2 mt -49.2 -46.19 45.35 Favored 'General case' 0 C--N 1.358 0.963 0 O-C-N 125.564 1.79 . . . . 71.54 110.366 178.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . 0.546 ' HA ' ' HB2' ' C' ' 202' ' ' PRO . . . -79.12 -47.73 15.57 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 114.556 1.317 . . . . 72.23 114.556 -165.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -74.48 -31.4 62.2 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 110.123 -0.325 . . . . 74.35 110.123 -178.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . 0.452 ' O ' ' HG3' ' A' ' 279' ' ' ARG . . . -68.19 -42.04 80.51 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 109.756 -0.461 . . . . 72.24 109.756 169.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . 0.517 ' HB2' ' O ' ' A' ' 272' ' ' LEU . 32.7 t80 -56.26 -49.99 72.64 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 124.906 1.283 . . . . 75.02 110.683 178.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -64.18 -41.57 97.05 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 114.556 -1.202 . . . . 72.14 109.54 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -68.99 -10.42 57.39 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 123.432 0.693 . . . . 75.41 112.599 176.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 275' ' ' ALA . 74.4 mtt180 -89.51 -11.28 43.34 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.377 0.671 . . . . 75.15 111.23 175.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.302 0 N-CA-C 109.206 -0.664 . . . . 72.5 109.206 177.851 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.469 ' H2 ' ' HB2' ' A' ' 128' ' ' GLU . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.407 0 N-CA-C 108.683 -0.858 . . . . 74.12 108.683 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -81.16 -46.96 14.11 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 108.352 -0.981 . . . . 62.45 108.352 170.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 20.6 mm-40 -138.43 91.38 2.54 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.395 1.478 . . . . 74.04 108.531 173.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 4' ' ' SER . . . . . 0.405 ' HB2' ' HB2' ' B' ' 1' ' ' MET . 47.6 t -108.35 151.69 25.66 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 123.991 0.916 . . . . 52.14 108.774 174.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 4.5 m -123.87 156.19 36.68 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 123.121 0.568 . . . . 74.34 110.813 -172.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.437 HG21 ' HA ' ' A' ' 125' ' ' LEU . 25.8 pt -139.32 174.21 9.81 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 C-N-CA 124.325 1.05 . . . . 65.34 111.449 -165.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -115.15 -163.31 0.87 Allowed 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.113 0.965 . . . . 72.22 110.295 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . 0.545 HD21 HG11 ' A' ' 145' ' ' VAL . 14.9 tp -148.09 178.89 8.16 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.129 0.571 . . . . 75.22 110.66 -178.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . 0.536 ' HB2' ' HB2' ' A' ' 122' ' ' GLU . . . -156.91 105.51 2.18 Favored 'General case' 0 C--N 1.358 0.937 0 C-N-CA 124.576 1.15 . . . . 73.12 108.389 178.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . 0.454 ' HB3' HD11 ' A' ' 119' ' ' LEU . 93.6 mt -79.59 121.27 25.05 Favored 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 123.997 0.919 . . . . 74.1 111.522 -173.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.444 ' O ' ' HG ' ' A' ' 119' ' ' LEU . 2.9 mt . . . . . 0 N--CA 1.506 2.357 0 C-N-CA 124.679 1.191 . . . . 72.11 109.195 -178.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.823 0 N-CA-C 109.618 -0.512 . . . . 74.35 109.618 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 180' ' ' ALA . . . . . 0.531 ' HB1' ' HB ' ' C' ' 137' ' ' VAL . . . 61.5 -79.19 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 124.461 1.104 . . . . 75.32 109.881 -165.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 181' ' ' LEU . . . . . 0.562 HD22 ' HB ' ' C' ' 138' ' ' VAL . 15.4 tp -168.29 21.48 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.315 0 C-N-CA 123.587 0.755 . . . . 74.44 110.364 172.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 182' ' ' VAL . . . . . . . . . . . . . 26.2 t -136.16 148.98 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.403 -0.81 . . . . 72.43 110.701 -173.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -149.07 -72.38 0.19 Allowed 'General case' 0 C--N 1.359 0.999 0 C-N-CA 123.376 0.67 . . . . 65.24 110.933 169.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 56.0 p-80 -150.52 161.37 42.67 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 122.402 0.281 . . . . 75.32 111.548 -174.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 185' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 CA--C 1.561 1.379 0 C-N-CA 124.389 1.076 . . . . 74.01 109.065 175.844 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 20.8 m . . . . . 0 CA--C 1.553 1.081 0 CA-C-O 120.974 0.416 . . . . 71.31 111.206 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -75.86 145.57 40.46 Favored 'General case' 0 C--N 1.348 0.532 0 C-N-CA 123.833 0.853 . . . . 74.42 112.262 -177.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 240' ' ' GLY . . . . . 0.428 ' H ' HD23 ' C' ' 235' ' ' LEU . . . -74.93 -138.78 0.59 Allowed Glycine 0 CA--C 1.533 1.158 0 CA-C-N 114.656 -1.157 . . . . 71.23 111.984 168.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 241' ' ' GLU . . . . . 0.539 ' HB3' ' HZ2' ' B' ' 245' ' ' LYS . 10.5 pt-20 -158.93 172.65 17.82 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.068 0.547 . . . . 71.23 111.221 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 242' ' ' TRP . . . . . 0.493 ' HH2' HG21 ' C' ' 227' ' ' THR . 0.0 OUTLIER -157.2 -46.65 0.07 Allowed 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.247 1.419 . . . . 70.32 108.514 -172.147 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 243' ' ' GLN . . . . . 0.589 ' HB2' ' HG2' ' C' ' 224' ' ' PRO . 35.8 mt-30 -117.76 -170.06 1.8 Allowed 'General case' 0 C--O 1.247 0.928 0 N-CA-C 107.71 -1.218 . . . . 74.22 107.71 166.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -78.37 89.4 1.11 Allowed Glycine 0 C--N 1.345 1.036 0 N-CA-C 111.147 -0.781 . . . . 71.54 111.147 171.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 245' ' ' LYS . . . . . 0.539 ' HZ2' ' HB3' ' B' ' 241' ' ' GLU . 1.7 pptp? . . . . . 0 N--CA 1.478 0.971 0 C-N-CA 123.05 0.54 . . . . 75.34 111.513 -177.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.916 0 N-CA-C 110.257 -0.275 . . . . 71.34 110.257 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' C' C ' 4' ' ' LYS . . . . . 0.418 ' HZ3' ' HB2' ' C' ' 4' ' ' LYS . 5.0 ttmp? -38.33 99.43 0.02 OUTLIER 'General case' 0 C--N 1.364 1.2 0 C-N-CA 124.691 1.196 . . . . 70.52 113.536 -176.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 5' ' ' LYS . . . . . 0.445 ' HG3' ' OG ' ' C' ' 94' ' ' SER . 1.3 mmmp? -67.64 96.87 0.57 Allowed 'General case' 0 C--O 1.241 0.651 0 N-CA-C 107.319 -1.363 . . . . 72.32 107.319 165.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 6' ' ' ASP . . . . . 0.484 ' HA ' ' OH ' ' C' ' 66' ' ' TYR . 38.4 t70 -70.42 96.56 1.16 Allowed 'General case' 0 C--N 1.348 0.539 0 N-CA-C 108.453 -0.943 . . . . 65.15 108.453 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 7' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -58.36 -34.32 70.54 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 113.835 -1.53 . . . . 73.43 111.737 -173.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -62.0 -47.22 85.76 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 115.777 -0.647 . . . . 74.23 110.42 175.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.99 -40.32 93.0 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.252 0.621 . . . . 63.34 111.288 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 58.6 mt -60.93 -39.59 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.079 0.552 . . . . 73.31 110.227 176.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 87.0 mt -80.26 -6.97 58.77 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 112.785 0.661 . . . . 75.53 112.785 177.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 69.2 31.39 71.85 Favored Glycine 0 C--N 1.353 1.5 0 O-C-N 123.055 0.222 . . . . 74.43 113.189 -178.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 26.9 m -126.34 154.67 74.78 Favored Pre-proline 0 N--CA 1.481 1.107 0 C-N-CA 124.932 1.293 . . . . 71.34 109.268 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -80.36 167.56 19.23 Favored 'Trans proline' 0 C--N 1.371 1.743 0 C-N-CA 122.401 2.067 . . . . 74.43 112.754 178.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -72.85 74.29 1.14 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.12 0.968 . . . . 74.35 109.652 173.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -178.3 -19.3 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.164 1.386 . . . . 71.24 108.538 -176.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -49.42 112.04 0.58 Allowed 'General case' 0 C--N 1.354 0.782 0 C-N-CA 125.176 1.391 . . . . 75.2 112.345 175.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 77.9 p -73.62 -177.94 2.91 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.011 0.925 . . . . 74.41 111.429 -178.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -51.74 -52.25 50.06 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.307 0.643 . . . . 74.45 111.846 -176.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -67.18 -32.01 72.81 Favored 'General case' 0 C--O 1.206 -1.227 0 CA-C-O 118.679 -0.677 . . . . 74.53 112.107 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -68.92 -40.77 78.87 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 119.014 0.824 . . . . 73.42 110.767 -179.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 22' ' ' ILE . . . . . 0.833 HD13 ' HB3' ' C' ' 57' ' ' LEU . 96.6 mt -69.62 -37.77 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.553 1.141 . . . . 75.54 110.199 174.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 23' ' ' LYS . . . . . 0.477 ' O ' ' HG3' ' C' ' 27' ' ' LYS . 10.4 tppt? -65.41 -42.86 92.08 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 114.942 -1.026 . . . . 74.13 109.636 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 24' ' ' ARG . . . . . 0.438 ' HA ' ' HD2' ' C' ' 27' ' ' LYS . 97.3 mtt180 -77.71 -28.23 50.84 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 124.607 1.163 . . . . 73.52 110.669 -177.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.72 -43.65 95.9 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 123.895 0.747 . . . . 75.32 109.065 172.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 26' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -65.08 -45.36 85.55 Favored 'General case' 0 C--O 1.213 -0.818 0 CA-C-N 114.939 -1.028 . . . . 72.31 110.886 176.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' C' ' 23' ' ' LYS . 83.9 mttt -55.57 -46.19 77.22 Favored 'General case' 0 N--CA 1.502 2.14 0 C-N-CA 123.824 0.85 . . . . 75.33 110.143 178.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 25.0 ttm180 -56.07 -56.58 19.1 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 114.338 -1.301 . . . . 75.55 110.203 178.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . 0.51 HD11 HD11 ' C' ' 50' ' ' ILE . 66.1 mt -80.46 -9.61 59.76 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 114.543 -1.208 . . . . 71.43 111.636 -172.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.77 -27.52 26.83 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.702 0.801 . . . . 75.32 110.248 173.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 81.9 mtm180 -90.9 -21.71 21.26 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 123.56 0.537 . . . . 73.5 111.107 171.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -82.55 -55.67 4.33 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.363 0.665 . . . . 71.12 110.187 -178.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -89.63 17.08 6.8 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.221 0.609 . . . . 72.14 110.984 178.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 34' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -47.14 94.8 0.08 OUTLIER Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 125.151 1.38 . . . . 74.34 112.365 -169.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -75.35 -8.87 20.02 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 123.313 2.675 . . . . 72.22 112.817 -164.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -65.05 -41.32 95.26 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.62 1.168 . . . . 60.34 110.107 171.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 88.5 t -97.06 -48.11 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 115.683 -0.69 . . . . 75.33 109.868 -178.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -97.0 75.02 2.62 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 108.152 -1.055 . . . . 65.41 108.152 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 39' ' ' LYS . . . . . 0.533 ' HZ2' ' HB2' ' C' ' 39' ' ' LYS . 10.5 mtmp? -75.8 75.83 2.75 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 114.377 -1.283 . . . . 71.22 109.247 177.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 49.7 m -139.42 132.72 15.59 Favored Pre-proline 0 C--O 1.245 0.831 0 CA-C-N 115.027 -0.988 . . . . 74.14 109.847 -176.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . 0.469 ' HA ' ' HB2' ' C' ' 44' ' ' GLU . 81.7 Cg_exo -47.37 -33.16 16.22 Favored 'Trans proline' 0 C--N 1.389 2.709 0 C-N-CA 124.049 3.166 . . . . 75.0 113.059 174.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -45.17 -59.62 2.54 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.418 1.087 . . . . 71.01 110.494 171.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.6 -7.93 59.65 Favored 'General case' 0 C--O 1.211 -0.923 0 CA-C-N 114.339 -1.301 . . . . 71.45 110.646 -177.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 44' ' ' GLU . . . . . 0.469 ' HB2' ' HA ' ' C' ' 41' ' ' PRO . 22.0 mm-40 -78.26 -60.57 2.32 Favored 'General case' 0 C--O 1.213 -0.825 0 N-CA-C 108.422 -0.955 . . . . 74.04 108.422 175.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -53.28 -47.89 68.79 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.147 0.979 . . . . 75.44 110.925 176.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 46' ' ' LYS . . . . . 0.504 ' O ' HG12 ' C' ' 50' ' ' ILE . 49.4 mttp -65.48 -52.28 53.99 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.301 -0.863 . . . . 72.32 112.32 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -68.98 -23.1 64.08 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 118.511 0.596 . . . . 71.12 111.624 -178.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 48' ' ' LYS . . . . . 0.429 ' HD3' ' O ' ' C' ' 44' ' ' GLU . 13.1 mptt -75.85 -35.89 59.78 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 122.59 0.356 . . . . 72.04 110.27 177.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -67.28 -33.23 74.87 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 117.763 0.256 . . . . 72.33 110.351 170.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 50' ' ' ILE . . . . . 0.51 HD11 HD11 ' C' ' 29' ' ' LEU . 22.8 mm -66.34 -38.88 82.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 N-CA-C 109.538 -0.542 . . . . 75.43 109.538 173.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 51' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -65.3 -42.29 93.2 Favored 'General case' 0 C--O 1.204 -1.335 0 C-N-CA 123.637 0.775 . . . . 74.04 110.08 178.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -61.82 -52.73 62.97 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.329 1.052 . . . . 75.54 110.097 177.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.13 -56.56 19.41 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-N 113.582 -1.644 . . . . 63.1 111.571 -176.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -64.51 -35.82 82.2 Favored 'General case' 0 C--O 1.204 -1.318 0 CA-C-N 114.19 -1.368 . . . . 75.01 111.226 177.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.78 -39.72 92.66 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 118.779 0.718 . . . . 60.54 111.747 -176.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 78.8 t -72.94 -50.34 33.27 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 O-C-N 123.597 0.56 . . . . 72.43 109.715 174.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 57' ' ' LEU . . . . . 0.833 ' HB3' HD13 ' C' ' 22' ' ' ILE . 60.9 mt -88.12 1.43 54.36 Favored 'General case' 0 CA--C 1.56 1.362 0 N-CA-C 114.582 1.327 . . . . 75.02 114.582 -168.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 41.5 t -55.8 -38.08 69.47 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 124.599 1.16 . . . . 75.33 112.719 -173.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -121.41 137.91 27.54 Favored Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 107.409 -1.33 . . . . 72.03 107.409 -168.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 60' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -48.9 -36.64 34.75 Favored 'Trans proline' 0 C--N 1.381 2.261 0 C-N-CA 123.839 3.026 . . . . 73.21 113.441 -177.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -58.12 -66.76 0.43 Allowed 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 114.261 -1.336 . . . . 62.13 111.398 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 1.8 mtpm? -72.4 -23.31 61.08 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.54 0.736 . . . . 75.43 111.7 -174.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 -57.24 -50.13 73.85 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.276 -0.874 . . . . 74.14 109.153 169.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 64' ' ' ARG . . . . . 0.51 ' HA ' ' HB2' ' C' ' 67' ' ' ASP . 27.4 mmt180 -72.7 -21.81 60.99 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.636 -0.711 . . . . 74.15 112.117 178.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 1.6 mp -58.86 -46.92 90.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-N 118.556 0.616 . . . . 71.5 109.417 167.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 66' ' ' TYR . . . . . 0.484 ' OH ' ' HA ' ' C' ' 6' ' ' ASP . 37.0 t80 -62.41 -51.41 67.65 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 115.78 -0.646 . . . . 74.31 110.52 174.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 67' ' ' ASP . . . . . 0.51 ' HB2' ' HA ' ' C' ' 64' ' ' ARG . 27.4 m-20 -59.83 -31.14 69.46 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.704 0.802 . . . . 73.14 112.021 -176.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 39.9 p -81.31 -26.93 35.26 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 119.269 -0.396 . . . . 74.43 110.986 176.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 69' ' ' TYR . . . . . 0.403 ' HE2' ' HE1' ' C' ' 96' ' ' PHE . 71.2 t80 -72.6 133.52 44.73 Favored 'General case' 0 C--N 1.359 1.019 0 N-CA-C 108.518 -0.919 . . . . 75.22 108.518 173.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.46 16.94 41.11 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.286 -0.726 . . . . 62.51 111.286 -164.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 63.1 m -146.76 -61.42 0.3 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 103.497 -2.779 . . . . 72.34 103.497 172.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 28.3 m -76.5 142.08 41.04 Favored 'General case' 0 C--O 1.25 1.099 0 N-CA-C 104.997 -2.223 . . . . 73.35 104.997 157.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.46 -10.74 8.39 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.342 0.657 . . . . 73.23 110.82 177.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -77.5 138.61 63.26 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 123.242 0.617 . . . . 53.23 109.529 171.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -63.16 136.66 57.2 Favored 'Trans proline' 0 C--N 1.373 1.836 0 C-N-CA 122.602 2.201 . . . . 75.14 111.808 174.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.04 159.37 53.31 Favored 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 123.323 2.682 . . . . 71.22 112.229 -178.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -59.51 116.38 3.25 Favored 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 122.693 2.262 . . . . 74.4 112.637 174.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 78' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -68.48 136.5 36.8 Favored 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 122.675 2.25 . . . . 74.44 111.82 175.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 79' ' ' PRO . . . . . 0.618 ' HB3' ' HA3' ' C' ' 142' ' ' GLY . 38.5 Cg_exo -45.77 159.46 0.21 Allowed 'Trans proline' 0 CA--C 1.567 2.134 0 C-N-CA 123.955 3.103 . . . . 70.12 114.303 166.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -66.02 84.21 0.25 Allowed 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 123.075 2.516 . . . . 74.31 111.892 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 146.67 -28.19 1.62 Allowed Glycine 0 C--N 1.336 0.567 0 CA-C-N 114.668 -1.151 . . . . 75.2 110.799 -178.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 146.93 173.77 18.43 Favored Glycine 0 C--N 1.344 1.026 0 C-N-CA 123.857 0.741 . . . . 75.13 112.004 172.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 83' ' ' TYR . . . . . 0.461 ' HA ' ' HD2' ' C' ' 79' ' ' PRO . 76.5 m-85 -52.05 120.34 5.29 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.009 0.924 . . . . 73.4 110.591 176.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 84' ' ' ASP . . . . . 0.578 ' HB2' ' HG2' ' C' ' 79' ' ' PRO . 44.3 t0 -60.65 124.83 21.55 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 124.502 1.126 . . . . 75.11 110.385 -176.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 85' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -169.34 17.94 0.02 OUTLIER 'General case' 0 C--O 1.257 1.492 0 CA-C-N 114.185 -1.37 . . . . 74.41 107.493 -167.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 19.6 m -59.08 116.44 3.84 Favored 'General case' 0 C--N 1.361 1.09 0 CA-C-N 113.755 -1.566 . . . . 52.42 110.781 -166.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 87' ' ' GLY . . . . . 0.572 ' HA2' ' HA ' ' C' ' 171' ' ' PRO . . . 124.1 -20.57 7.1 Favored Glycine 0 C--N 1.342 0.867 0 O-C-N 123.732 0.645 . . . . 74.34 112.936 179.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 88' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -123.32 131.96 53.84 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 117.599 0.7 . . . . 74.44 111.804 -169.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -75.42 86.16 2.56 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.553 0.741 . . . . 72.23 111.154 -171.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 90' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -39.8 -43.72 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 C-N-CA 125.901 1.68 . . . . 54.42 114.74 174.228 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -65.07 -18.52 65.37 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.327 0.651 . . . . 75.25 112.149 -174.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -79.3 -30.44 42.89 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 122.848 0.459 . . . . 75.53 110.693 177.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -85.47 174.64 9.36 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.484 0.714 . . . . 72.45 112.908 -164.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 94' ' ' SER . . . . . 0.445 ' OG ' ' HG3' ' C' ' 5' ' ' LYS . 93.7 p -78.88 178.24 8.11 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 114.363 1.246 . . . . 52.11 114.363 -163.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -62.61 -54.02 45.91 Favored 'General case' 0 C--N 1.355 0.818 0 CA-C-N 113.888 -1.505 . . . . 72.35 111.2 -176.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 96' ' ' PHE . . . . . 0.403 ' HE1' ' HE2' ' C' ' 69' ' ' TYR . 48.6 t80 -48.44 -50.19 32.28 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 123.629 0.772 . . . . 74.24 111.626 -176.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 97' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -60.14 -52.01 67.14 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 114.592 -1.186 . . . . 64.25 110.116 175.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 98' ' ' GLN . . . . . 0.618 ' HA ' HD11 ' C' ' 105' ' ' LEU . 22.2 mt-30 -73.13 3.78 5.18 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 112.753 0.649 . . . . 71.33 112.753 -178.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -100.47 -54.5 2.83 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.879 0.872 . . . . 74.43 111.796 168.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 28.9 tp -63.84 -44.76 92.19 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.215 0.606 . . . . 73.23 110.809 -176.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 101' ' ' PHE . . . . . 0.447 ' O ' ' HG ' ' C' ' 105' ' ' LEU . 42.3 m-85 -94.78 -5.76 44.53 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.387 -0.824 . . . . 75.04 110.152 177.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -42.61 -60.97 2.67 Favored Glycine 0 CA--C 1.541 1.669 0 CA-C-O 118.553 -1.137 . . . . 74.41 115.076 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -41.42 -24.49 0.23 Allowed 'Trans proline' 0 C--N 1.391 2.785 0 C-N-CA 125.05 3.833 . . . . 64.35 116.584 -179.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -149.29 38.92 0.94 Allowed Glycine 0 C--N 1.35 1.352 0 CA-C-O 119.226 -0.763 . . . . 73.42 112.706 -176.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 105' ' ' LEU . . . . . 0.618 HD11 ' HA ' ' C' ' 98' ' ' GLN . 38.5 mt . . . . . 0 N--CA 1.496 1.863 0 N-CA-C 114.647 1.351 . . . . 75.43 114.647 176.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 116' ' ' GLY . . . . . 0.423 ' HA2' ' HA3' ' C' ' 168' ' ' GLY . . . . . . . . 0 C--O 1.241 0.585 0 CA-C-O 118.822 -0.988 . . . . 54.4 110.653 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 37.8 ttp180 -57.24 101.99 0.08 Allowed 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.401 -0.963 . . . . 74.32 108.401 -177.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -47.05 100.55 0.02 OUTLIER 'General case' 0 C--N 1.351 0.653 0 O-C-N 124.739 1.274 . . . . 75.42 107.734 172.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 119' ' ' LEU . . . . . . . . . . . . . 23.3 tp -91.15 119.21 31.07 Favored 'General case' 0 C--N 1.338 0.095 0 CA-C-N 114.466 -1.243 . . . . 75.21 109.441 -161.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 10.6 mtt180 -112.22 88.56 2.84 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 114.312 -1.313 . . . . 72.31 107.734 -169.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 121' ' ' ALA . . . . . 0.474 ' HB2' HD21 ' C' ' 176' ' ' LEU . . . -109.46 142.38 40.55 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 109.363 -0.606 . . . . 75.44 109.363 -174.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -126.97 127.81 45.4 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 107.152 -1.425 . . . . 74.12 107.152 178.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -138.51 147.32 54.6 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 123.249 0.62 . . . . 73.3 110.992 -167.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . 0.439 ' HA ' ' O ' ' C' ' 179' ' ' ARG . 6.1 Cg_exo -80.78 122.73 4.47 Favored 'Trans proline' 0 C--N 1.368 1.576 0 C-N-CA 123.184 2.59 . . . . 72.51 110.445 166.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 125' ' ' LEU . . . . . 0.44 ' O ' ' HA ' ' C' ' 180' ' ' LEU . 18.1 tp -132.23 151.97 51.56 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 108.995 -0.743 . . . . 75.32 108.995 -177.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 126' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -95.04 152.61 18.18 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-O 120.734 0.302 . . . . 61.53 110.47 -178.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 127' ' ' LEU . . . . . 0.518 HD11 ' HD2' ' C' ' 186' ' ' PHE . 89.4 mt -60.51 -49.16 78.67 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.272 1.029 . . . . 62.25 111.029 177.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 22.1 mp0 -66.32 -33.45 75.76 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 115.564 -0.743 . . . . 75.24 110.564 179.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -68.83 -29.09 67.35 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.423 0.689 . . . . 75.51 111.363 176.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -75.18 -40.95 59.01 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 109.256 -0.646 . . . . 73.14 109.256 176.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 131' ' ' PHE . . . . . 0.555 ' HB2' HD12 ' C' ' 215' ' ' LEU . 84.6 t80 -55.06 -40.12 69.95 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.044 0.937 . . . . 75.55 110.744 174.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 132' ' ' HIS . . . . . . . . . . . . . 35.4 m170 -64.75 -59.52 4.14 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 115.545 -0.752 . . . . 70.15 109.676 174.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 62.77 -132.59 43.82 Favored Glycine 0 C--N 1.352 1.434 0 CA-C-N 115.719 -0.673 . . . . 65.31 111.925 -176.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 134' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' C' ' 148' ' ' ARG . . . 63.52 -151.65 48.52 Favored Glycine 0 C--N 1.351 1.41 0 O-C-N 123.956 0.445 . . . . 73.12 112.905 175.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -70.82 107.96 4.25 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.268 0.627 . . . . 73.03 109.784 178.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 136' ' ' ARG . . . . . 0.559 ' HB2' HD23 ' B' ' 181' ' ' LEU . 5.6 mmp_? -106.48 145.51 31.72 Favored 'General case' 0 C--O 1.249 1.029 0 C-N-CA 123.942 0.897 . . . . 72.12 109.185 171.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 137' ' ' VAL . . . . . 0.531 ' HB ' ' HB1' ' B' ' 180' ' ' ALA . 82.9 t -72.07 106.57 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.175 0.99 . . . . 73.11 110.412 -178.168 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 138' ' ' VAL . . . . . 0.562 ' HB ' HD22 ' B' ' 181' ' ' LEU . 12.1 p -119.54 111.73 34.26 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 CA-C-O 121.534 0.683 . . . . 72.14 110.173 176.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 139' ' ' GLU . . . . . 0.473 ' HA ' ' O ' ' C' ' 143' ' ' ARG . 1.4 tm-20 -119.32 99.85 6.95 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 106.882 -1.525 . . . . 74.31 106.882 169.289 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 140' ' ' VAL . . . . . . . . . . . . . 7.3 p -139.03 134.83 42.15 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 109.128 -0.693 . . . . 73.25 109.128 -179.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 141' ' ' ALA . . . . . 0.518 ' HB1' ' HG2' ' C' ' 167' ' ' GLN . . . 68.7 6.81 5.72 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.759 1.223 . . . . 65.0 112.713 -179.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 142' ' ' GLY . . . . . 0.618 ' HA3' ' HB3' ' C' ' 79' ' ' PRO . . . 105.49 -8.1 43.64 Favored Glycine 0 C--N 1.349 1.304 0 N-CA-C 112.611 -0.196 . . . . 52.4 112.611 -176.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 143' ' ' ARG . . . . . 0.473 ' O ' ' HA ' ' C' ' 139' ' ' GLU . 23.9 ttt85 -86.42 104.21 15.7 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.403 0.681 . . . . 75.05 110.615 179.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 39.8 ttt180 -98.18 107.76 20.31 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.684 0.794 . . . . 71.51 109.9 177.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 145' ' ' VAL . . . . . . . . . . . . . 7.2 p -150.94 157.14 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 123.914 0.886 . . . . 75.03 109.787 177.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 41.3 m -100.83 105.1 16.37 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.106 -1.072 . . . . 73.22 108.106 168.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 147' ' ' VAL . . . . . 0.427 HG22 HG13 ' C' ' 161' ' ' VAL . 7.6 p -104.67 146.26 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 N-CA-C 110.311 -0.255 . . . . 72.53 110.311 -173.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 148' ' ' ARG . . . . . 0.411 ' HA ' ' O ' ' C' ' 134' ' ' GLY . 12.6 ttm180 -85.78 109.73 18.86 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 116.224 -0.444 . . . . 74.22 110.318 177.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 149' ' ' ILE . . . . . . . . . . . . . 31.3 pt -91.99 150.08 39.94 Favored Pre-proline 0 C--O 1.245 0.846 0 CA-C-N 114.971 -1.013 . . . . 74.42 108.334 169.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 150' ' ' PRO . . . . . 0.503 ' HD2' HG22 ' C' ' 159' ' ' ILE . 19.3 Cg_endo -56.04 125.76 20.13 Favored 'Trans proline' 0 C--N 1.383 2.359 0 C-N-CA 122.744 2.296 . . . . 61.44 110.974 178.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -57.07 93.77 0.05 OUTLIER 'Trans proline' 0 C--N 1.383 2.346 0 C-N-CA 123.187 2.592 . . . . 73.2 111.971 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 152' ' ' GLY . . . . . . . . . . . . . . . 114.25 131.44 5.21 Favored Glycine 0 C--N 1.342 0.9 0 CA-C-N 115.259 -0.882 . . . . 63.11 112.633 -174.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 p -145.66 158.95 12.5 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.11 0 C-N-CA 123.694 0.797 . . . . 74.01 110.664 -177.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 154' ' ' ARG . . . . . . . . . . . . . 16.7 mtt85 -101.98 153.19 20.11 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 124.399 1.08 . . . . 75.32 110.335 -173.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 155' ' ' GLU . . . . . 0.414 ' HB2' HD12 ' C' ' 180' ' ' LEU . 12.7 tp10 -65.59 127.25 31.14 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.891 0.877 . . . . 74.51 110.372 169.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 76.18 6.08 82.4 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-N 115.576 -0.738 . . . . 75.21 114.566 178.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 157' ' ' SER . . . . . . . . . . . . . 26.7 t -107.38 156.41 18.96 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 117.337 0.569 . . . . 75.43 111.229 -175.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 158' ' ' VAL . . . . . 0.425 ' HB ' ' HB3' ' C' ' 175' ' ' LEU . 18.4 m -93.31 134.25 31.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-N 114.83 -1.077 . . . . 72.31 111.772 -176.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 159' ' ' ILE . . . . . 0.557 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 80.9 mt -86.88 132.04 33.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 C-N-CA 124.187 0.995 . . . . 72.31 108.53 166.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 21.3 ttm180 -82.49 99.97 9.8 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 109.084 -0.71 . . . . 75.13 109.084 171.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 161' ' ' VAL . . . . . 0.427 HG13 HG22 ' C' ' 147' ' ' VAL . 63.5 t -96.24 95.37 1.96 Allowed Pre-proline 0 CA--C 1.548 0.866 0 N-CA-C 106.432 -1.692 . . . . 75.24 106.432 169.016 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -94.86 165.68 1.7 Allowed 'Trans proline' 0 C--N 1.361 1.232 0 C-N-CA 123.05 2.5 . . . . 75.23 115.226 -162.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 65.83 13.41 59.18 Favored Glycine 0 C--N 1.345 1.044 0 CA-C-N 114.114 -1.403 . . . . 53.54 114.829 172.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 164' ' ' MET . . . . . 0.432 ' SD ' ' NH2' ' C' ' 143' ' ' ARG . 35.1 mtm -136.81 -88.68 0.29 Allowed 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 117.468 0.634 . . . . 73.35 110.067 -175.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . 79.85 -152.56 35.24 Favored Glycine 0 C--N 1.351 1.412 0 CA-C-N 116.762 -0.199 . . . . 73.32 113.369 -172.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . -98.77 -159.64 29.68 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-N 115.307 -0.447 . . . . 75.44 112.819 -178.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 167' ' ' GLN . . . . . 0.518 ' HG2' ' HB1' ' C' ' 141' ' ' ALA . 27.4 mm-40 -70.66 118.91 14.05 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.899 0.88 . . . . 74.2 111.533 -174.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 168' ' ' GLY . . . . . 0.423 ' HA3' ' HA2' ' C' ' 116' ' ' GLY . . . 161.77 162.48 13.13 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 109.929 -1.269 . . . . 13.44 109.929 178.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 169' ' ' ASN . . . . . 0.683 ' HB2' ' HD3' ' C' ' 170' ' ' PRO . 1.7 m-20 -73.57 -68.41 0.36 Allowed Pre-proline 0 CA--C 1.578 2.051 0 CA-C-O 117.846 -1.073 . . . . 62.44 112.97 -166.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 170' ' ' PRO . . . . . 0.683 ' HD3' ' HB2' ' C' ' 169' ' ' ASN . 34.1 Cg_exo -63.73 176.17 2.48 Favored 'Trans proline' 0 C--N 1.401 3.298 0 C-N-CA 122.475 2.117 . . . . 73.55 113.281 172.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 171' ' ' PRO . . . . . 0.572 ' HA ' ' HA2' ' C' ' 87' ' ' GLY . 29.7 Cg_endo -62.28 139.23 76.35 Favored 'Trans proline' 0 C--N 1.389 2.666 0 C-N-CA 122.551 2.167 . . . . 74.02 111.76 172.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -116.18 -34.03 1.41 Allowed Glycine 0 C--N 1.336 0.574 0 CA-C-N 116.089 -0.505 . . . . 74.42 112.56 177.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 173' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 71.04 147.97 0.08 Allowed 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 125.089 1.355 . . . . 74.51 111.273 -179.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 174' ' ' LEU . . . . . . . . . . . . . 11.0 tp -121.97 128.55 51.61 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.904 0.882 . . . . 75.22 108.853 -174.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 175' ' ' LEU . . . . . 0.439 ' HA ' ' O ' ' C' ' 159' ' ' ILE . 71.8 mt -110.49 130.58 55.53 Favored 'General case' 0 C--O 1.243 0.721 0 C-N-CA 123.597 0.759 . . . . 72.15 109.23 172.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 176' ' ' LEU . . . . . 0.557 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 95.7 mt -108.33 107.97 18.77 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.373 0.669 . . . . 74.33 110.884 178.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 177' ' ' VAL . . . . . . . . . . . . . 56.0 t -81.53 101.12 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 107.147 -1.427 . . . . 75.23 107.147 173.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 178' ' ' VAL . . . . . 0.416 HG12 ' HB3' ' C' ' 125' ' ' LEU . 39.7 t -76.65 128.87 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 114.599 -1.182 . . . . 74.01 110.755 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 179' ' ' ARG . . . . . 0.439 ' O ' ' HA ' ' C' ' 124' ' ' PRO . 36.6 mmt180 -111.94 101.03 9.36 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 105.325 -2.102 . . . . 74.42 105.325 171.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 180' ' ' LEU . . . . . 0.44 ' HA ' ' O ' ' C' ' 125' ' ' LEU . 28.9 mt -68.93 133.03 47.65 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 108.922 -0.77 . . . . 73.43 108.922 -176.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 181' ' ' LEU . . . . . . . . . . . . . 85.0 mt -54.05 163.01 1.29 Allowed Pre-proline 0 N--CA 1.493 1.717 0 C-N-CA 125.31 1.444 . . . . 74.24 113.317 -167.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -51.52 77.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.391 2.813 0 C-N-CA 123.744 2.963 . . . . 73.32 111.982 164.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 183' ' ' HIS . . . . . . . . . . . . . 75.3 t60 -174.08 53.92 0.15 Allowed Pre-proline 0 CA--C 1.553 1.059 0 N-CA-C 104.112 -2.551 . . . . 72.0 104.112 -170.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 184' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -86.67 65.79 4.68 Favored 'Trans proline' 0 C--N 1.388 2.65 0 C-N-CA 123.535 2.823 . . . . 74.25 112.079 -164.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 185' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 11.7 t -95.89 -50.24 11.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 108.047 -1.094 . . . . 72.23 108.047 -178.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 186' ' ' PHE . . . . . 0.518 ' HD2' HD11 ' C' ' 127' ' ' LEU . 34.0 m-85 -117.67 156.39 28.28 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.488 0.715 . . . . 61.44 111.956 -174.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 187' ' ' ARG . . . . . 0.478 ' O ' ' HB3' ' C' ' 194' ' ' TYR . 33.8 ttp180 -153.64 112.11 3.64 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.476 1.51 . . . . 75.14 107.742 177.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 188' ' ' LEU . . . . . 0.419 HD22 ' O ' ' C' ' 190' ' ' GLY . 47.9 tp -80.73 153.1 28.02 Favored 'General case' 0 CA--C 1.558 1.263 0 N-CA-C 115.392 1.627 . . . . 74.14 115.392 -163.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -126.92 99.59 5.8 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.889 1.675 . . . . 73.21 107.182 159.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 190' ' ' GLY . . . . . 0.419 ' O ' HD22 ' C' ' 188' ' ' LEU . . . 63.61 -80.09 0.04 OUTLIER Glycine 0 CA--C 1.539 1.575 0 N-CA-C 114.194 0.438 . . . . 74.2 114.194 175.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 191' ' ' GLN . . . . . 0.414 HE21 ' HA3' ' C' ' 242' ' ' GLY . 42.8 mt-30 -122.42 -34.86 3.2 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.877 1.271 . . . . 75.25 109.635 177.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -83.63 125.12 31.5 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.189 0.995 . . . . 65.13 110.983 -174.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 193' ' ' LEU . . . . . 0.426 ' HG ' ' HA2' ' C' ' 239' ' ' GLY . 91.7 mt -80.65 159.09 25.44 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.253 0.621 . . . . 65.15 112.017 -179.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 194' ' ' TYR . . . . . 0.478 ' HB3' ' O ' ' C' ' 187' ' ' ARG . 43.7 t80 -119.12 106.94 12.88 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 108.112 -1.07 . . . . 75.43 108.112 165.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 195' ' ' ALA . . . . . 0.474 ' HB1' HD13 ' C' ' 249' ' ' LEU . . . -108.2 -174.9 2.63 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.553 0.741 . . . . 65.11 110.099 175.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 29.3 m -138.47 119.06 13.93 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.586 -0.733 . . . . 53.42 109.604 174.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 197' ' ' LEU . . . . . 0.489 HD11 ' HB3' ' C' ' 212' ' ' ALA . 53.5 tp -98.78 118.21 35.01 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.292 0.637 . . . . 73.5 109.375 -179.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 198' ' ' ASP . . . . . 0.575 ' HA ' ' HB2' ' C' ' 254' ' ' ARG . 26.4 t70 -85.69 99.97 11.67 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.501 0.721 . . . . 64.33 109.087 -178.102 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 199' ' ' VAL . . . . . 0.446 HG21 HG21 ' C' ' 210' ' ' VAL . 21.4 t -110.59 123.6 35.26 Favored Pre-proline 0 N--CA 1.479 0.989 0 N-CA-C 108.661 -0.866 . . . . 73.12 108.661 -178.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 200' ' ' PRO . . . . . 0.412 ' HD2' HG13 ' C' ' 210' ' ' VAL . 46.2 Cg_endo -69.09 147.22 66.72 Favored 'Trans proline' 0 C--N 1.367 1.546 0 C-N-CA 121.565 1.51 . . . . 73.11 110.553 173.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 201' ' ' ALA . . . . . 0.523 ' HB3' ' HH2' ' C' ' 269' ' ' TRP . . . -52.59 -45.46 96.06 Favored Pre-proline 0 CA--C 1.555 1.158 0 C-N-CA 124.638 1.175 . . . . 74.35 113.467 -176.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 202' ' ' PRO . . . . . 0.546 ' HB2' ' HA ' ' A' ' 273' ' ' ALA . 23.7 Cg_endo -57.99 -49.71 12.09 Favored 'Trans proline' 0 C--N 1.391 2.774 0 C-N-CA 121.384 1.389 . . . . 63.15 112.304 177.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 203' ' ' ILE . . . . . . . . . . . . . 29.2 mt -64.42 -32.34 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 123.218 0.607 . . . . 74.02 111.145 178.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.8 -37.6 84.87 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.134 0.574 . . . . 75.02 111.512 179.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 205' ' ' VAL . . . . . 0.45 ' HA ' ' HA ' ' C' ' 226' ' ' ARG . 91.2 t -82.09 -37.24 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 123.233 0.613 . . . . 74.52 111.972 -178.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 206' ' ' VAL . . . . . 0.501 HG22 ' HG3' ' A' ' 270' ' ' LYS . 8.3 p -87.61 -33.58 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 N-CA-C 111.975 0.361 . . . . 74.12 111.975 -175.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 90.33 126.44 3.22 Favored Glycine 0 C--N 1.344 0.98 0 N-CA-C 111.076 -0.81 . . . . 63.21 111.076 -167.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -159.93 -137.3 2.2 Favored Glycine 0 C--N 1.336 0.57 0 CA-C-N 117.81 0.805 . . . . 51.32 111.466 179.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 209' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' C' ' 221' ' ' VAL . 7.6 mtmp? -139.26 134.75 33.06 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 123.43 0.692 . . . . 72.44 110.603 171.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 210' ' ' VAL . . . . . 0.446 HG21 HG21 ' C' ' 199' ' ' VAL . 27.7 m -134.3 140.57 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 107.754 -1.202 . . . . 71.52 107.754 169.021 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 211' ' ' ARG . . . . . 0.538 ' HA ' ' HA ' ' C' ' 220' ' ' GLU . 32.4 ttm105 -80.5 133.12 35.78 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 122.975 0.51 . . . . 75.53 111.66 -175.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 212' ' ' ALA . . . . . 0.489 ' HB3' HD11 ' C' ' 197' ' ' LEU . . . -104.18 130.36 51.94 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.785 1.234 . . . . 74.43 107.704 164.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 213' ' ' MET . . . . . . . . . . . . . 6.6 ttt -70.39 149.49 47.24 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 109.264 -0.643 . . . . 63.12 109.264 168.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 214' ' ' THR . . . . . 0.508 HG23 ' HD2' ' C' ' 238' ' ' LYS . 0.1 OUTLIER -139.92 169.14 18.26 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.173 0.511 . . . . 72.34 110.415 168.101 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 215' ' ' LEU . . . . . 0.555 HD12 ' HB2' ' C' ' 131' ' ' PHE . 54.4 mt -61.82 -36.05 80.02 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.144 1.378 . . . . 75.24 112.667 -172.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.78 -2.67 27.63 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.396 0.679 . . . . 71.0 112.11 -177.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 155.69 171.41 22.14 Favored Glycine 0 C--O 1.212 -1.274 0 CA-C-O 119.556 -0.58 . . . . 74.41 112.492 -178.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -88.26 126.01 1.91 Allowed 'Trans proline' 0 CA--C 1.556 1.618 0 C-N-CA 122.998 2.465 . . . . 64.03 112.748 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 219' ' ' VAL . . . . . 0.413 HG13 ' HB2' ' C' ' 212' ' ' ALA . 3.3 p -103.2 115.12 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 123.925 0.89 . . . . 52.53 109.696 177.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 220' ' ' GLU . . . . . 0.538 ' HA ' ' HA ' ' C' ' 211' ' ' ARG . 23.6 tt0 -84.43 109.38 17.83 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 109.491 -0.559 . . . . 72.32 109.491 -179.012 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 221' ' ' VAL . . . . . 0.439 HG11 HD23 ' C' ' 233' ' ' LEU . 47.7 t -74.13 127.88 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 124.491 1.116 . . . . 74.03 111.957 -174.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 222' ' ' ALA . . . . . 0.424 ' HA ' ' HG2' ' C' ' 209' ' ' LYS . . . -80.97 103.52 10.85 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 124.199 0.937 . . . . 73.3 109.05 167.162 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 62.1 t -79.04 129.47 72.91 Favored Pre-proline 0 CA--C 1.553 1.079 0 C-N-CA 123.744 0.818 . . . . 73.11 109.721 176.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 224' ' ' PRO . . . . . 0.589 ' HG2' ' HB2' ' B' ' 243' ' ' GLN . 3.1 Cg_exo -78.68 160.64 28.01 Favored 'Trans proline' 0 C--N 1.371 1.722 0 C-N-CA 123.925 3.084 . . . . 73.11 112.103 169.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.51 143.49 98.02 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 122.944 2.429 . . . . 74.4 112.93 176.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 226' ' ' ARG . . . . . 0.45 ' HA ' ' HA ' ' C' ' 205' ' ' VAL . 0.6 OUTLIER 55.18 86.02 0.06 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.468 1.907 . . . . 71.5 113.79 173.748 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 227' ' ' THR . . . . . 0.493 HG21 ' HH2' ' B' ' 242' ' ' TRP . 82.1 m -123.93 133.36 53.74 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 114.828 -1.078 . . . . 73.3 111.143 -178.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 228' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -104.77 155.71 18.65 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.712 0.768 . . . . 74.32 110.702 176.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -72.23 145.59 47.86 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.328 -0.851 . . . . 65.31 109.936 176.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 95.42 -9.34 69.36 Favored Glycine 0 N--CA 1.464 0.561 0 CA-C-N 115.746 -0.661 . . . . 62.04 112.118 -171.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 231' ' ' ARG . . . . . 0.415 ' NH1' ' HA ' ' C' ' 227' ' ' THR . 81.8 mtt180 -69.55 178.34 2.54 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 117.339 0.569 . . . . 75.03 110.761 167.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 232' ' ' LYS . . . . . 0.578 ' HD3' ' HB3' ' C' ' 250' ' ' TYR . 1.9 ttmp? -153.93 126.86 8.29 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 112.258 0.466 . . . . 74.05 112.258 -174.295 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 233' ' ' LEU . . . . . 0.608 ' O ' ' HA ' ' C' ' 250' ' ' TYR . 5.1 mp -86.39 158.66 19.57 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.488 1.115 . . . . 74.22 110.437 175.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 19.1 ptt-85 -128.92 88.46 2.72 Favored 'General case' 0 CA--C 1.556 1.204 0 O-C-N 124.712 1.257 . . . . 72.34 109.513 170.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 235' ' ' LEU . . . . . 0.468 ' HB2' ' HB3' ' C' ' 249' ' ' LEU . 56.9 mt -86.55 105.99 17.22 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 108.213 -1.032 . . . . 74.34 108.213 174.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -67.71 132.75 48.05 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.36 0.664 . . . . 73.41 111.639 -168.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 80.95 1.38 89.79 Favored Glycine 0 C--N 1.349 1.254 0 N-CA-C 115.018 0.767 . . . . 71.42 115.018 174.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 238' ' ' LYS . . . . . 0.508 ' HD2' HG23 ' C' ' 214' ' ' THR . 73.8 mmtt -92.8 13.18 21.09 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 123.588 0.755 . . . . 75.11 111.116 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 239' ' ' GLY . . . . . 0.426 ' HA2' ' HG ' ' C' ' 193' ' ' LEU . . . -95.17 -169.6 36.3 Favored Glycine 0 C--N 1.358 1.772 0 C-N-CA 122.977 0.322 . . . . 75.2 113.205 177.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 240' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -78.73 148.28 72.49 Favored Pre-proline 0 N--CA 1.481 1.102 0 C-N-CA 123.027 0.531 . . . . 75.14 110.397 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 241' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -63.64 137.31 58.5 Favored 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 123.43 2.753 . . . . 71.53 112.103 -178.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 242' ' ' GLY . . . . . 0.414 ' HA3' HE21 ' C' ' 191' ' ' GLN . . . -131.71 168.6 22.26 Favored Glycine 0 C--N 1.342 0.911 0 CA-C-O 120.169 -0.24 . . . . 70.14 113.678 -175.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -73.91 -2.38 12.17 Favored 'Trans proline' 0 C--N 1.38 2.206 0 C-N-CA 123.642 2.894 . . . . 71.42 114.553 -173.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -137.62 11.8 2.95 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.655 0.782 . . . . 71.42 111.118 178.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 137.43 167.79 11.17 Favored Glycine 0 C--N 1.348 1.214 0 N-CA-C 111.111 -0.795 . . . . 63.24 111.111 -176.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 246' ' ' ARG . . . . . . . . . . . . . 26.8 mtm-85 -81.85 151.32 27.38 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-N 117.275 0.537 . . . . 71.32 109.914 176.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -78.13 -169.93 35.31 Favored Glycine 0 C--N 1.34 0.798 0 O-C-N 123.872 0.733 . . . . 63.23 113.48 -178.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -123.79 142.66 50.89 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.122 -1.066 . . . . 73.54 108.122 -173.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 249' ' ' LEU . . . . . 0.474 HD13 ' HB1' ' C' ' 195' ' ' ALA . 25.6 tp -83.89 109.52 17.65 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.95 -0.568 . . . . 74.23 109.797 -179.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 250' ' ' TYR . . . . . 0.608 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 22.0 m-30 -101.02 100.53 11.15 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 109.498 -0.556 . . . . 71.43 109.498 179.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 251' ' ' LEU . . . . . 0.546 ' HB2' HD12 ' C' ' 233' ' ' LEU . 2.2 mp -100.39 121.91 42.29 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 119.166 -0.445 . . . . 72.0 110.338 -172.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 252' ' ' GLU . . . . . 0.435 ' HB2' ' HE1' ' C' ' 194' ' ' TYR . 25.3 tt0 -75.07 129.7 38.04 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-O 121.129 0.49 . . . . 75.41 109.681 170.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 253' ' ' VAL . . . . . 0.483 HG11 HG23 ' C' ' 227' ' ' THR . 60.4 t -76.23 135.19 27.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 115.166 -0.925 . . . . 73.5 111.012 -175.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 254' ' ' ARG . . . . . 0.575 ' HB2' ' HA ' ' C' ' 198' ' ' ASP . 11.4 mmt85 -103.8 135.19 45.8 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.321 1.448 . . . . 75.13 108.32 165.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 255' ' ' ILE . . . . . . . . . . . . . 33.0 mm -106.94 105.34 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 107.028 -1.471 . . . . 75.24 107.028 165.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 256' ' ' THR . . . . . . . . . . . . . 3.5 t -115.76 171.72 7.58 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.037 0.935 . . . . 70.25 110.067 -173.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 10.7 pt -134.95 152.93 78.18 Favored Pre-proline 0 CA--C 1.552 1.037 0 C-N-CA 123.987 0.915 . . . . 75.21 109.876 -173.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -80.79 20.98 0.91 Allowed 'Trans proline' 0 C--N 1.381 2.274 0 C-N-CA 123.372 2.715 . . . . 74.41 113.737 -168.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 57.3 -89.81 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.778 1.231 . . . . 72.3 111.18 -174.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 260' ' ' ARG . . . . . 0.518 ' H ' ' HD2' ' C' ' 260' ' ' ARG . 0.0 OUTLIER -80.39 145.86 31.78 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 123.214 0.606 . . . . 73.41 109.473 -179.317 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 261' ' ' LEU . . . . . . . . . . . . . 96.4 mt -128.73 154.69 46.1 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.89 0.876 . . . . 74.53 109.566 176.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 45.1 p -84.92 155.72 61.11 Favored Pre-proline 0 CA--C 1.555 1.142 0 N-CA-C 109.252 -0.647 . . . . 61.23 109.252 170.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -34.35 -51.81 0.62 Allowed 'Trans proline' 0 C--N 1.382 2.302 1 C-N-CA 125.684 4.256 . . . . 74.2 115.836 -178.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -62.94 -55.05 29.33 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.954 0.501 . . . . 71.04 110.259 -177.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -49.31 -55.14 13.77 Favored 'General case' 0 C--N 1.356 0.866 0 O-C-N 124.451 1.094 . . . . 71.03 109.675 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 266' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' C' ' 270' ' ' LYS . 15.4 tp10 -54.62 -43.27 72.09 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 124.655 1.222 . . . . 73.1 110.997 -177.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -60.6 -45.42 94.07 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.508 0.723 . . . . 71.12 112.217 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 268' ' ' LEU . . . . . 0.5 ' HB2' HD21 ' A' ' 272' ' ' LEU . 10.3 mp -66.35 -50.99 61.69 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 116.729 -0.214 . . . . 70.11 110.93 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 269' ' ' TRP . . . . . 0.523 ' HH2' ' HB3' ' C' ' 201' ' ' ALA . 92.5 m95 -56.95 -32.41 65.99 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.292 0.637 . . . . 63.11 111.039 177.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 270' ' ' LYS . . . . . 0.641 ' HA ' HG22 ' A' ' 206' ' ' VAL . 10.2 tmtt? -67.76 -46.46 72.02 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.987 0.915 . . . . 75.43 110.336 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -63.2 -37.21 86.32 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 122.73 0.412 . . . . 75.33 111.486 177.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 272' ' ' LEU . . . . . 0.401 HD12 ' HA ' ' C' ' 269' ' ' TRP . 75.1 mt -64.9 -37.11 86.54 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.295 0.638 . . . . 74.33 110.125 176.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -63.43 -45.39 91.16 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.438 0.695 . . . . 43.22 111.055 177.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -65.72 -36.71 84.38 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.289 0.636 . . . . 63.21 111.036 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -62.7 -33.07 74.33 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 115.596 -0.729 . . . . 70.04 110.584 174.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 276' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -73.46 -42.34 62.06 Favored 'General case' 0 CA--C 1.554 1.114 0 CA-C-N 115.36 -0.836 . . . . 75.52 111.939 174.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -68.05 -22.61 64.94 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.949 -0.469 . . . . 65.52 111.403 178.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -59.77 -22.53 62.26 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.504 0.722 . . . . 72.22 112.131 174.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 279' ' ' ARG . . . . . . . . . . . . . 39.0 mtm180 -72.66 -29.84 63.77 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 122.743 0.417 . . . . 75.11 110.738 178.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.044 0 C-N-CA 123.7 0.8 . . . . 75.14 109.378 -173.402 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.484 1.245 0 N-CA-C 113.039 0.755 . . . . 64.14 113.039 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -77.68 109.34 11.57 Favored 'General case' 0 C--O 1.245 0.863 0 C-N-CA 124.031 0.932 . . . . 74.32 109.413 171.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.53 ' HA ' ' HH ' ' A' ' 66' ' ' TYR . 7.3 t70 -82.34 94.53 7.39 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 108.459 -0.941 . . . . 62.43 108.459 177.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -60.54 -37.46 81.3 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.191 0.997 . . . . 73.34 111.672 -174.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.49 ' HB3' ' O ' ' A' ' 13' ' ' VAL . 95.1 m-85 -67.28 -35.74 80.12 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 114.609 -1.178 . . . . 73.33 111.324 178.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.86 -40.13 72.51 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 122.897 0.479 . . . . 70.01 111.014 177.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 77.0 mt -56.0 -42.75 72.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 123.613 0.765 . . . . 74.23 109.455 174.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 87.7 mt -81.06 -17.47 50.0 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 115.212 -0.903 . . . . 73.11 112.392 176.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.09 18.74 78.06 Favored Glycine 0 CA--C 1.536 1.398 0 N-CA-C 114.71 0.644 . . . . 73.42 114.71 -178.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.49 ' O ' ' HB3' ' A' ' 8' ' ' TYR . 19.6 m -103.89 144.07 27.94 Favored Pre-proline 0 N--CA 1.484 1.228 0 C-N-CA 123.666 0.787 . . . . 72.52 109.252 173.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -54.58 151.01 32.81 Favored 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 122.889 2.393 . . . . 50.12 113.282 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.33 69.48 1.61 Allowed 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.692 0.797 . . . . 75.43 110.561 179.253 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 170.92 -24.36 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.805 1.242 . . . . 71.2 109.422 -173.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.09 138.85 19.12 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.283 1.033 . . . . 74.14 111.761 -177.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 67.2 p -63.49 166.08 7.1 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.17 0.988 . . . . 75.03 111.033 -175.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -56.64 -33.37 66.25 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.985 0.914 . . . . 71.11 111.384 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -69.72 -36.1 75.6 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 122.89 0.476 . . . . 72.43 111.062 -178.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -72.02 -42.06 66.83 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.629 0.772 . . . . 71.14 110.664 177.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 73.7 mt -58.59 -39.53 76.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 124.558 1.143 . . . . 73.31 110.241 173.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.73 ' HG2' ' HE3' ' A' ' 27' ' ' LYS . 33.9 ttmt -71.67 -37.94 70.71 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 114.555 -1.202 . . . . 75.22 110.259 -177.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 49.1 mtp180 -57.36 -52.46 65.25 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.503 0.721 . . . . 73.12 110.319 173.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.33 -38.47 91.14 Favored 'General case' 0 C--O 1.246 0.899 0 CA-C-N 114.435 -1.257 . . . . 72.43 111.653 -177.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -61.87 -60.75 3.18 Favored 'General case' 0 C--O 1.209 -1.067 0 CA-C-N 115.433 -0.803 . . . . 73.1 109.487 177.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.73 ' HE3' ' HG2' ' A' ' 23' ' ' LYS . 10.1 mtmp? -58.71 -33.58 70.36 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 124.266 0.979 . . . . 74.22 111.913 -177.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 14.6 ttt180 -52.74 -58.72 5.94 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.299 1.04 . . . . 75.52 109.856 171.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.615 ' HB3' HD11 ' A' ' 50' ' ' ILE . 88.1 mt -81.21 -10.28 59.64 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 115.172 -0.922 . . . . 75.12 111.991 -178.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.492 ' HA ' ' HE1' ' A' ' 47' ' ' PHE . . . -94.53 -14.59 24.92 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.772 0.829 . . . . 71.54 111.34 -178.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.4 mtm105 -97.96 -38.09 9.53 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.957 -0.757 . . . . 72.33 108.957 168.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -65.43 -47.36 76.48 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.26 0.624 . . . . 73.31 111.092 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -107.4 29.21 7.37 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.515 0.726 . . . . 72.41 110.734 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -68.23 101.51 0.31 Allowed Pre-proline 0 N--CA 1.483 1.204 0 C-N-CA 123.979 0.911 . . . . 73.54 110.547 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.517 ' O ' ' HG3' ' A' ' 39' ' ' LYS . 46.6 Cg_exo -55.07 -39.82 89.0 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 123.073 2.516 . . . . 75.51 113.306 -169.176 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -46.89 -36.94 8.11 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.799 1.239 . . . . 73.23 112.786 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 48.7 t -101.79 -49.25 10.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 C-N-CA 123.657 0.783 . . . . 73.25 109.28 178.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -107.27 75.26 1.01 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 125.121 1.368 . . . . 64.12 110.665 -176.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.585 ' HB2' ' HZ3' ' A' ' 39' ' ' LYS . 9.0 mtmp? -78.02 72.47 4.56 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 109.636 -0.505 . . . . 73.11 109.636 172.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 70.4 m -116.9 113.31 39.85 Favored Pre-proline 0 N--CA 1.471 0.621 0 N-CA-C 107.906 -1.146 . . . . 71.24 107.906 176.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -42.8 -53.29 4.01 Favored 'Trans proline' 0 C--N 1.387 2.591 0 C-N-CA 124.58 3.52 . . . . 73.53 114.191 -170.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -52.12 -46.82 65.49 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.221 1.009 . . . . 64.43 111.817 176.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.82 -29.16 69.01 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.597 0.759 . . . . 73.42 110.982 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.501 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 46.1 mt-10 -84.47 -29.7 25.83 Favored 'General case' 0 C--N 1.352 0.707 0 C-N-CA 123.423 0.689 . . . . 63.35 110.461 -175.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -72.31 -43.45 64.16 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.929 0.892 . . . . 62.44 109.791 176.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 40.2 mmtm -62.65 -39.7 94.72 Favored 'General case' 0 C--N 1.345 0.405 0 CA-C-N 115.038 -0.983 . . . . 74.03 109.631 171.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.492 ' HE1' ' HA ' ' A' ' 30' ' ' ALA . 60.0 t80 -63.08 -30.14 71.36 Favored 'General case' 0 C--N 1.356 0.866 0 O-C-N 123.867 0.729 . . . . 73.32 110.656 176.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' A' ' 44' ' ' GLU . 34.3 mmtp -62.98 -47.36 83.49 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 109.893 -0.41 . . . . 75.14 109.893 171.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -67.95 -25.88 65.67 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 112.384 0.513 . . . . 71.44 112.384 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.615 HD11 ' HB3' ' A' ' 29' ' ' LEU . 63.0 mt -79.47 -33.46 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 C-N-CA 124.515 1.126 . . . . 74.43 110.102 176.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -70.22 -39.14 75.29 Favored 'General case' 0 C--O 1.208 -1.08 0 CA-C-N 115.265 -0.879 . . . . 73.43 109.81 173.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -61.01 -48.75 80.37 Favored 'General case' 0 C--O 1.247 0.952 0 C-N-CA 124.986 1.314 . . . . 75.34 109.541 176.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.32 -60.42 3.36 Favored 'General case' 0 C--N 1.352 0.69 0 CA-C-N 113.52 -1.673 . . . . 65.45 111.188 177.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -63.92 -35.73 81.62 Favored 'General case' 0 C--O 1.214 -0.771 0 CA-C-N 115.686 -0.688 . . . . 73.53 111.412 -179.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.14 -53.34 58.29 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.579 0.752 . . . . 72.52 110.831 -177.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 66.4 t -62.84 -50.86 78.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 114.533 -1.212 . . . . 74.52 110.352 177.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 67.2 mt -76.07 -8.3 56.67 Favored 'General case' 0 CA--C 1.557 1.242 0 N-CA-C 113.152 0.797 . . . . 74.35 113.152 -172.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.2 t -65.42 -58.46 5.8 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.405 1.082 . . . . 74.34 111.853 -176.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.488 ' HB2' ' HD3' ' A' ' 62' ' ' LYS . 13.4 m-20 -99.31 142.33 24.41 Favored Pre-proline 0 C--O 1.244 0.778 0 C-N-CA 123.419 0.688 . . . . 74.34 109.432 -174.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.503 ' O ' ' HG2' ' A' ' 64' ' ' ARG . 48.7 Cg_exo -54.55 -47.23 27.92 Favored 'Trans proline' 0 C--N 1.385 2.447 0 C-N-CA 123.167 2.578 . . . . 72.41 112.941 -172.114 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.467 ' O ' HG12 ' A' ' 65' ' ' ILE . 3.1 mp0 -58.78 -58.2 9.64 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.505 0.722 . . . . 72.3 111.213 -174.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.488 ' HD3' ' HB2' ' A' ' 59' ' ' ASP . 37.9 mtpt -58.28 -43.52 88.05 Favored 'General case' 0 C--O 1.257 1.492 0 C-N-CA 124.29 1.036 . . . . 74.54 111.135 -178.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -59.04 -46.81 87.3 Favored 'General case' 0 C--N 1.349 0.581 0 CA-C-N 114.667 -1.152 . . . . 74.11 110.793 178.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.503 ' HG2' ' O ' ' A' ' 60' ' ' PRO . 30.2 mmm180 -77.6 -18.66 56.61 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 123.677 0.61 . . . . 74.25 111.305 -175.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 61' ' ' GLU . 28.3 mm -62.29 -50.93 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 N-CA-C 108.081 -1.081 . . . . 74.41 108.081 168.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.53 ' HH ' ' HA ' ' A' ' 6' ' ' ASP . 54.0 t80 -60.35 -52.25 66.07 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 114.908 -1.042 . . . . 75.4 111.001 175.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -63.31 -31.22 72.31 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.457 0.703 . . . . 64.04 112.059 -172.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.3 p -76.65 -31.55 57.41 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 119.166 -0.445 . . . . 75.44 110.773 173.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -64.06 115.12 4.63 Favored 'General case' 0 CA--C 1.556 1.2 0 N-CA-C 109.492 -0.559 . . . . 75.32 109.492 178.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 115.38 5.66 18.82 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 123.562 0.601 . . . . 64.23 111.969 -169.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 86.2 m -147.59 -56.62 0.24 Allowed 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 104.823 -2.288 . . . . 71.23 104.823 178.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.4 m -82.79 141.92 31.95 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 104.446 -2.427 . . . . 74.23 104.446 156.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.79 -35.08 10.25 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 118.617 0.644 . . . . 74.04 111.145 -179.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -93.24 134.18 27.41 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 123.393 0.677 . . . . 75.1 109.412 179.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.92 116.93 3.61 Favored 'Trans proline' 0 C--N 1.373 1.833 0 C-N-CA 122.299 1.999 . . . . 75.41 110.532 171.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -52.14 142.32 45.58 Favored 'Trans proline' 0 C--N 1.38 2.19 0 C-N-CA 123.035 2.49 . . . . 74.25 112.611 177.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -43.4 129.86 6.58 Favored 'Trans proline' 0 C--N 1.388 2.642 0 C-N-CA 123.969 3.113 . . . . 73.45 113.424 -174.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.41 ' HG3' ' HA3' ' A' ' 104' ' ' GLY . 28.2 Cg_endo -58.41 144.02 96.98 Favored 'Trans proline' 0 C--N 1.387 2.579 0 C-N-CA 122.84 2.36 . . . . 73.2 112.705 -171.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -65.89 167.49 17.59 Favored 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 122.876 2.384 . . . . 71.05 112.59 -177.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.84 88.45 0.07 OUTLIER 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 122.665 2.244 . . . . 74.31 111.694 176.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 149.91 -40.88 0.84 Allowed Glycine 0 CA--C 1.524 0.611 0 CA-C-N 113.728 -1.578 . . . . 62.41 109.525 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 110.63 -169.51 13.46 Favored Glycine 0 C--N 1.351 1.383 0 C-N-CA 123.594 0.616 . . . . 53.03 111.686 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -84.72 88.36 7.37 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 123.431 0.692 . . . . 74.41 109.867 176.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -58.11 157.96 7.49 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 114.407 -1.269 . . . . 71.31 111.828 175.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -154.56 72.44 0.86 Allowed 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 108.597 -0.89 . . . . 73.24 108.597 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.441 ' HG ' ' HE2' ' A' ' 164' ' ' MET . 2.4 m -43.58 84.99 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 126.134 1.774 . . . . 74.44 115.218 -165.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.461 ' N ' ' HA3' ' A' ' 163' ' ' GLY . . . 67.78 10.81 59.23 Favored Glycine 0 C--N 1.352 1.449 0 CA-C-N 115.815 -0.629 . . . . 70.11 114.008 175.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -93.23 122.95 36.15 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.231 -1.396 . . . . 72.34 107.231 178.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -69.74 90.39 0.59 Allowed 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 110.177 -0.305 . . . . 71.44 110.177 -173.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.465 HG23 ' HE2' ' A' ' 97' ' ' PHE . 2.4 p -34.81 -50.31 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 125.578 1.551 . . . . 75.21 114.084 175.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -59.84 -34.22 72.81 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.255 1.022 . . . . 75.33 111.297 -173.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -78.08 -30.84 49.87 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.218 1.007 . . . . 61.35 111.753 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -82.14 172.19 13.48 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 122.746 0.419 . . . . 73.34 110.161 -173.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 83.8 p -57.56 150.06 19.94 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 114.093 1.145 . . . . 74.5 114.093 -164.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.96 -41.8 71.58 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 114.568 -1.196 . . . . 74.52 110.881 170.135 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -59.76 -43.06 94.5 Favored 'General case' 0 C--N 1.354 0.769 0 C-N-CA 123.226 0.61 . . . . 75.03 110.755 -177.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.465 ' HE2' HG23 ' A' ' 90' ' ' VAL . 26.5 t80 -58.58 -49.99 75.42 Favored 'General case' 0 CA--C 1.548 0.895 0 O-C-N 123.761 0.663 . . . . 72.32 109.242 173.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.51 ' HA ' HD13 ' A' ' 105' ' ' LEU . 46.4 mt-30 -71.97 -5.6 36.04 Favored 'General case' 0 CA--C 1.557 1.237 0 CA-C-N 115.347 -0.842 . . . . 74.14 112.291 -178.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -97.65 -47.61 5.55 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 124.239 1.015 . . . . 70.02 111.903 173.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 37.2 tp -70.86 -52.75 18.34 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.655 0.782 . . . . 74.33 109.739 -176.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -86.16 -11.64 52.01 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 115.718 -0.674 . . . . 72.11 110.745 178.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -39.27 -58.82 1.94 Allowed Glycine 0 CA--C 1.543 1.792 0 CA-C-O 118.623 -1.098 . . . . 72.43 114.742 177.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -35.02 -36.92 0.13 Allowed 'Trans proline' 0 C--N 1.394 2.937 0 C-N-CA 125.289 3.993 . . . . 64.43 116.362 176.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.41 ' HA3' ' HG3' ' A' ' 78' ' ' PRO . . . -145.77 42.38 0.97 Allowed Glycine 0 C--N 1.354 1.53 0 CA-C-O 119.224 -0.764 . . . . 54.4 112.117 -178.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.51 HD13 ' HA ' ' A' ' 98' ' ' GLN . 8.1 mt -63.2 71.73 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.071 0.948 . . . . 74.25 112.867 177.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.739 ' HB3' ' HA ' ' A' ' 169' ' ' ASN . 1.5 t80 32.4 -105.13 0.02 OUTLIER 'General case' 0 CA--C 1.562 1.413 0 C-N-CA 126.3 1.84 . . . . 74.45 111.738 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 80.48 -40.03 2.38 Favored Glycine 0 C--N 1.359 1.844 0 CA-C-O 119.213 -0.77 . . . . 44.0 113.204 179.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.669 ' HA3' ' HB3' ' A' ' 167' ' ' GLN . . . . . . . . 0 C--N 1.359 1.839 0 C-N-CA 123.514 0.578 . . . . 71.34 113.519 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.594 ' HA ' ' HD2' ' A' ' 170' ' ' PRO . 21.9 ttmm . . . . . 0 CA--C 1.548 0.886 0 N-CA-C 109.842 -0.429 . . . . 73.31 109.842 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -89.36 161.18 29.86 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-N 116.65 -0.25 . . . . 73.4 113.7 -177.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -100.97 145.59 28.47 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.797 1.239 . . . . 74.43 108.174 175.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -58.6 144.95 41.25 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 118.717 0.69 . . . . 74.23 112.014 -175.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.8 tt -144.5 137.13 26.68 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 109.049 -0.723 . . . . 75.42 109.049 -173.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -93.19 130.56 38.83 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.306 0.642 . . . . 74.51 109.364 174.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.51 ' HB2' HD12 ' B' ' 8' ' ' LEU . . . -141.31 140.86 33.9 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.415 -0.957 . . . . 54.41 108.415 176.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.461 ' HG3' HD13 ' B' ' 11' ' ' LEU . 42.6 mt-10 -123.11 109.27 13.83 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 108.704 -0.85 . . . . 72.42 108.704 -166.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.768 HD23 HD23 ' A' ' 176' ' ' LEU . 3.8 pp -101.27 114.84 65.71 Favored Pre-proline 0 N--CA 1.484 1.252 0 N-CA-C 110.293 -0.262 . . . . 74.14 110.293 -169.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.613 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 40.4 Cg_endo -67.24 109.56 1.79 Allowed 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 120.7 0.933 . . . . 75.33 110.309 173.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.713 ' HA ' HG23 ' B' ' 6' ' ' ILE . 57.7 tp -110.25 144.25 39.21 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 123.555 0.742 . . . . 72.43 110.829 -171.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 40.5 m -71.43 136.71 47.8 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 114.908 -1.042 . . . . 71.34 110.892 178.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.863 ' HB3' HD23 ' A' ' 215' ' ' LEU . 59.4 mt -54.37 -49.5 69.68 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.109 0.963 . . . . 75.21 111.688 -177.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -54.99 -46.51 75.14 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 114.646 -1.161 . . . . 75.32 111.452 175.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -65.66 -29.43 69.99 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 122.743 0.417 . . . . 64.33 111.451 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -66.75 -47.54 71.91 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.878 0.471 . . . . 65.44 110.503 178.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -63.96 -44.51 92.55 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 114.762 -1.108 . . . . 74.51 111.518 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 30.8 m170 -76.64 -45.58 29.39 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 115.709 -0.678 . . . . 75.25 111.404 -174.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.476 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 74.49 -153.25 45.85 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 123.54 0.525 . . . . 71.54 112.689 -177.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 81.72 -153.12 32.66 Favored Glycine 0 C--N 1.348 1.245 0 C-N-CA 123.223 0.439 . . . . 70.42 112.935 178.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -72.22 97.4 1.97 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.286 0.635 . . . . 73.14 110.09 -177.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.66 HH11 HD11 ' A' ' 125' ' ' LEU . 5.2 tmm_? -96.05 120.4 36.28 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 107.365 -1.346 . . . . 75.05 107.365 173.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 59.6 t -85.75 134.61 26.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 108.945 -0.761 . . . . 75.04 108.945 178.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.491 ' HB ' HG13 ' A' ' 145' ' ' VAL . 85.9 t -116.41 133.44 62.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 C-N-CA 124.007 0.923 . . . . 73.34 108.627 176.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -106.81 114.16 28.09 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 107.719 -1.215 . . . . 71.3 107.719 171.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.554 ' HB ' ' HB3' ' B' ' 8' ' ' LEU . 3.1 p -147.09 108.44 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 122.81 0.444 . . . . 75.1 111.845 -170.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 62.5 20.67 12.1 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.31 1.044 . . . . 74.24 112.198 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 92.64 4.87 65.31 Favored Glycine 0 C--N 1.352 1.428 0 CA-C-N 116.257 -0.429 . . . . 54.15 112.782 -175.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.455 ' HA ' ' NE ' ' A' ' 143' ' ' ARG . 3.7 tpm_? -98.59 106.67 18.97 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.567 0.747 . . . . 72.43 109.998 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 49.5 ttp180 -85.32 98.75 10.71 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.716 0.806 . . . . 74.41 109.252 174.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.491 HG13 ' HB ' ' A' ' 138' ' ' VAL . 2.5 p -110.8 131.93 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 123.458 0.703 . . . . 73.53 110.906 -177.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 48.3 t -89.35 93.28 9.48 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.705 0.802 . . . . 64.43 109.501 177.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 43.4 t -93.95 111.17 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 109.353 -0.61 . . . . 73.42 109.353 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 58.9 ttt85 -77.84 105.18 8.86 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 109.432 -0.581 . . . . 74.32 109.432 175.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.476 HG13 ' HA2' ' A' ' 133' ' ' GLY . 33.2 pt -90.71 149.17 40.04 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 123.766 0.826 . . . . 74.52 110.409 177.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -63.73 132.14 33.97 Favored 'Trans proline' 0 C--N 1.379 2.158 0 C-N-CA 122.843 2.362 . . . . 74.22 111.794 175.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.409 ' HA ' ' HA3' ' A' ' 133' ' ' GLY . 50.5 Cg_exo -56.24 95.54 0.06 OUTLIER 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 123.155 2.57 . . . . 74.15 112.184 171.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 107.81 47.32 0.97 Allowed Glycine 0 C--N 1.341 0.828 0 N-CA-C 111.255 -0.738 . . . . 75.51 111.255 -172.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 5.2 p -86.25 141.39 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 108.219 -1.03 . . . . 75.43 108.219 175.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.515 ' HG2' ' HA ' ' A' ' 191' ' ' GLN . 0.0 OUTLIER -118.97 135.76 54.44 Favored 'General case' 0 C--O 1.198 -1.62 0 CA-C-O 117.116 -1.421 . . . . 73.23 110.146 -160.839 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.448 ' HB3' ' HB3' ' A' ' 188' ' ' LEU . 5.0 tp10 -43.62 129.94 5.35 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 119.386 0.994 . . . . 72.32 111.381 174.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 88.3 -7.47 81.49 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-O 119.062 -0.855 . . . . 74.33 113.594 -175.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 8.2 t -66.26 113.53 4.65 Favored 'General case' 0 C--N 1.362 1.129 0 N-CA-C 107.247 -1.39 . . . . 74.23 107.247 176.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 58.9 t -85.12 91.27 3.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 107.696 -1.224 . . . . 74.02 107.696 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.579 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 32.8 mt -70.71 82.82 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 107.3 -1.37 . . . . 75.24 107.3 174.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 63.2 ttt-85 -74.57 97.93 3.26 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 107.804 -1.184 . . . . 75.21 107.804 179.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.402 ' HA ' ' HD2' ' A' ' 162' ' ' PRO . 2.5 p -106.82 104.71 52.67 Favored Pre-proline 0 C--O 1.242 0.707 0 N-CA-C 108.834 -0.802 . . . . 71.41 108.834 -178.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 161' ' ' VAL . 29.0 Cg_endo -62.03 104.16 0.32 Allowed 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 122.055 1.836 . . . . 74.53 109.956 173.132 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . 0.461 ' HA3' ' N ' ' A' ' 87' ' ' GLY . . . 124.56 26.82 1.38 Allowed Glycine 0 C--N 1.341 0.843 0 N-CA-C 115.759 1.063 . . . . 70.43 115.759 174.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.441 ' HE2' ' HG ' ' A' ' 86' ' ' SER . 22.5 mmt -138.63 1.75 2.15 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 117.999 0.899 . . . . 64.15 111.33 172.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.639 ' HA2' HD12 ' A' ' 174' ' ' LEU . . . -84.01 -123.09 0.98 Allowed Glycine 0 C--N 1.351 1.38 0 N-CA-C 114.252 0.461 . . . . 73.33 114.252 -171.004 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -58.54 143.95 43.96 Favored Glycine 0 C--N 1.351 1.37 0 O-C-N 124.122 0.542 . . . . 74.5 111.864 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.669 ' HB3' ' HA3' ' A' ' 108' ' ' GLY . 27.1 mm-40 -68.47 103.98 1.8 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.956 0.902 . . . . 75.42 111.937 -164.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -156.05 168.62 33.52 Favored Glycine 0 C--N 1.338 0.69 0 N-CA-C 109.759 -1.337 . . . . 64.21 109.759 177.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . 0.739 ' HA ' ' HB3' ' A' ' 106' ' ' PHE . 0.3 OUTLIER -62.14 -53.62 57.32 Favored Pre-proline 0 N--CA 1.485 1.289 0 CA-C-N 118.401 1.1 . . . . 63.54 110.032 -179.198 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.631 ' HD3' ' HB3' ' A' ' 169' ' ' ASN . 24.4 Cg_endo -95.99 90.79 0.09 OUTLIER 'Trans proline' 0 C--N 1.387 2.558 0 C-N-CA 122.089 1.86 . . . . 73.02 108.079 159.303 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 169' ' ' ASN . 25.3 Cg_exo -60.58 174.82 1.42 Allowed 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 122.786 2.324 . . . . 71.25 113.857 -171.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -66.35 175.15 21.01 Favored Glycine 0 N--CA 1.472 1.052 0 N-CA-C 115.397 0.919 . . . . 72.4 115.397 -175.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -69.79 97.43 1.09 Allowed 'General case' 0 C--O 1.242 0.693 0 N-CA-C 108.225 -1.028 . . . . 71.14 108.225 172.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.639 HD12 ' HA2' ' A' ' 165' ' ' GLY . 21.4 tp -78.47 104.0 8.78 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 109.518 -0.549 . . . . 74.2 109.518 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 68.4 mt -71.67 81.58 0.85 Allowed 'General case' 0 C--O 1.242 0.67 0 C-N-CA 124.1 0.96 . . . . 72.12 109.07 173.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.768 HD23 HD23 ' A' ' 123' ' ' LEU . 34.8 mt -76.02 90.06 3.01 Favored 'General case' 0 C--N 1.35 0.627 0 CA-C-N 115.978 -0.556 . . . . 74.52 110.133 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.437 ' HB ' ' HG2' ' A' ' 122' ' ' GLU . 17.4 t -82.22 105.04 11.65 Favored 'Isoleucine or valine' 0 C--O 1.246 0.886 0 N-CA-C 106.954 -1.498 . . . . 71.11 106.954 179.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.21 106.42 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.037 0 CA-C-N 114.924 -1.034 . . . . 74.13 110.963 -174.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.613 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 33.7 mmt180 -91.89 94.46 9.32 Favored 'General case' 0 C--O 1.208 -1.089 0 C-N-CA 123.233 0.613 . . . . 73.42 110.215 179.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.537 HD21 ' HB3' ' A' ' 125' ' ' LEU . 17.6 mt -67.12 143.73 56.48 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 121.379 -0.826 . . . . 74.04 110.564 -177.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 82.5 mt -54.37 144.62 41.01 Favored Pre-proline 0 N--CA 1.476 0.835 0 O-C-N 124.367 1.042 . . . . 73.22 111.329 -172.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -75.17 36.52 0.45 Allowed 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 123.041 2.494 . . . . 74.32 113.073 176.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . 0.52 ' HB3' HD11 ' A' ' 127' ' ' LEU . 24.1 t-80 -61.45 126.26 86.16 Favored Pre-proline 0 CA--C 1.549 0.929 0 N-CA-C 107.636 -1.246 . . . . 73.35 107.636 171.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 183' ' ' HIS . 21.2 Cg_exo -66.16 24.06 0.1 OUTLIER 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 124.078 3.185 . . . . 61.24 118.689 -160.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 16.2 t -102.93 -59.99 3.1 Favored 'Isoleucine or valine' 0 C--N 1.367 1.366 0 CA-C-N 121.23 1.832 . . . . 72.34 109.362 175.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . 0.532 ' CD1' ' HB1' ' A' ' 195' ' ' ALA . 49.0 m-85 -120.09 140.6 50.8 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.006 0.743 . . . . 72.31 113.006 -168.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -117.49 92.18 3.78 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 104.604 -2.369 . . . . 75.51 104.604 162.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.605 ' HA ' ' HA ' ' A' ' 193' ' ' LEU . 13.9 tp -73.33 162.14 29.68 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.468 1.107 . . . . 74.21 109.897 -177.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . 0.422 ' H ' HD13 ' A' ' 188' ' ' LEU . 11.4 tp10 -163.99 129.53 2.95 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.766 0.827 . . . . 70.31 109.464 171.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 75.25 -77.99 1.15 Allowed Glycine 0 C--N 1.348 1.237 0 O-C-N 123.388 0.43 . . . . 65.41 112.986 175.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.515 ' HA ' ' HG2' ' A' ' 154' ' ' ARG . 0.5 OUTLIER -153.26 -0.8 0.24 Allowed 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 124.708 1.203 . . . . 72.32 110.364 170.28 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 6.4 p-10 -117.95 133.19 56.16 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.998 1.319 . . . . 72.32 111.566 -172.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.605 ' HA ' ' HA ' ' A' ' 188' ' ' LEU . 18.2 mt -88.43 155.11 19.86 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.611 1.165 . . . . 74.25 110.126 -171.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -126.2 99.13 5.75 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 108.489 -0.93 . . . . 73.14 108.489 167.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.532 ' HB1' ' CD1' ' A' ' 186' ' ' PHE . . . -103.02 173.19 6.42 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.021 0.929 . . . . 74.34 109.325 175.005 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 30.7 m -110.88 149.06 31.15 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 108.457 -0.942 . . . . 70.21 108.457 171.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.407 HD21 HD13 ' A' ' 251' ' ' LEU . 49.5 tp -142.44 109.53 5.55 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 109.248 -0.649 . . . . 74.1 109.248 -176.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -86.35 121.93 29.61 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 108.296 -1.002 . . . . 63.3 108.296 173.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 7.5 p -140.36 133.25 14.8 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 123.987 0.915 . . . . 74.33 108.588 -176.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.69 156.55 48.93 Favored 'Trans proline' 0 C--N 1.369 1.645 0 C-N-CA 121.858 1.705 . . . . 70.05 111.911 175.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -57.51 -46.64 99.77 Favored Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 124.725 1.21 . . . . 71.34 114.038 -170.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -57.86 -45.04 35.28 Favored 'Trans proline' 0 C--N 1.39 2.75 0 C-N-CA 121.643 1.562 . . . . 73.32 113.082 175.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.485 HD13 ' HB3' ' C' ' 276' ' ' TYR . 33.8 mt -71.33 -27.19 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.087 0.555 . . . . 71.02 110.273 -179.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -71.52 -47.33 55.93 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.359 0.663 . . . . 74.14 111.08 177.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 53.0 t -65.71 -49.94 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 123.629 0.772 . . . . 64.22 111.309 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 59.0 t -88.74 -43.47 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.588 0.755 . . . . 74.41 111.509 -170.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 96.19 121.75 3.98 Favored Glycine 0 C--N 1.338 0.666 0 CA-C-N 115.947 -0.569 . . . . 72.35 112.683 -174.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.4 ' H ' ' HB ' ' A' ' 223' ' ' VAL . . . -141.98 -137.2 3.34 Favored Glycine 0 C--N 1.341 0.827 0 N-CA-C 111.095 -0.802 . . . . 73.32 111.095 178.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -136.24 137.71 41.07 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 118.006 0.903 . . . . 73.34 109.739 174.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 26.9 m -133.74 149.47 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 N-CA-C 108.59 -0.893 . . . . 63.11 108.59 172.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 21.3 ttm105 -75.36 107.58 7.57 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 121.101 0.477 . . . . 74.32 110.12 177.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -105.78 144.81 31.99 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.348 1.059 . . . . 74.41 109.181 175.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' MET . . . . . 0.514 ' N ' ' SD ' ' A' ' 213' ' ' MET . 0.5 OUTLIER -87.02 151.82 22.92 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 123.07 0.548 . . . . 74.15 109.898 -177.998 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 81.3 p -122.05 -162.67 1.01 Allowed 'General case' 0 C--O 1.243 0.732 0 N-CA-C 108.36 -0.978 . . . . 74.1 108.36 170.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . 0.863 HD23 ' HB3' ' A' ' 127' ' ' LEU . 34.1 mt -65.36 -42.63 92.57 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.159 0.584 . . . . 73.14 110.781 177.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -129.3 30.35 5.0 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 115.331 -0.85 . . . . 64.44 112.351 -165.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 155.45 158.2 8.65 Favored Glycine 0 C--N 1.352 1.457 0 CA-C-O 119.75 -0.472 . . . . 63.05 113.888 173.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . 0.437 ' HA ' ' HA ' ' A' ' 213' ' ' MET . 42.4 Cg_endo -94.25 101.67 0.13 Allowed 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 123.277 2.651 . . . . 74.13 112.716 178.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 29.7 m -90.63 173.67 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 123.822 0.849 . . . . 73.4 109.771 -176.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 25.9 pt-20 -100.74 124.01 45.76 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 108.47 -0.937 . . . . 75.04 108.47 169.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 14.4 p -100.22 129.21 51.29 Favored 'Isoleucine or valine' 0 C--O 1.245 0.867 0 N-CA-C 108.493 -0.928 . . . . 74.51 108.493 173.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -84.43 101.24 11.87 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 109.379 -0.6 . . . . 70.4 109.379 178.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.4 ' HB ' ' H ' ' A' ' 208' ' ' GLY . 62.4 t -58.33 136.49 85.16 Favored Pre-proline 0 CA--C 1.553 1.067 0 CA-C-N 113.677 -1.601 . . . . 71.22 110.064 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -81.8 176.32 8.5 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 122.987 2.458 . . . . 75.51 110.716 177.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -71.53 159.09 52.27 Favored 'Trans proline' 0 C--N 1.359 1.131 0 C-N-CA 120.607 0.871 . . . . 72.53 110.844 165.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . 0.552 ' HD2' ' O ' ' C' ' 259' ' ' GLU . 11.1 mmt180 65.81 26.95 11.16 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 124.56 1.144 . . . . 75.13 113.195 168.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.501 HG21 HD23 ' A' ' 233' ' ' LEU . 31.4 m -65.1 84.43 0.05 OUTLIER 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 124.969 1.308 . . . . 64.32 109.568 175.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -86.39 138.89 31.44 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.291 1.036 . . . . 75.32 110.713 -171.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -50.11 127.26 16.42 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.39 1.476 . . . . 65.12 112.112 -176.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 88.29 -25.06 9.6 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-N 115.543 -0.753 . . . . 75.54 114.462 172.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.408 ' O ' HG23 ' A' ' 253' ' ' VAL . 70.8 mtt180 -67.5 156.01 37.69 Favored 'General case' 0 C--N 1.345 0.408 0 N-CA-C 109.323 -0.621 . . . . 74.44 109.323 172.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.4 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 2.5 mppt? -110.46 123.29 49.63 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.558 -0.904 . . . . 72.22 108.558 -176.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.526 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 80.7 mt -72.42 111.53 7.69 Favored 'General case' 0 C--O 1.217 -0.645 0 N-CA-C 107.525 -1.287 . . . . 71.4 107.525 179.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -95.21 100.28 12.11 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 123.462 0.476 . . . . 73.41 110.185 -178.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.562 HD13 ' HG3' ' A' ' 238' ' ' LYS . 0.2 OUTLIER -107.31 107.02 17.74 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.547 0.739 . . . . 74.24 109.455 -179.659 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.594 ' HA ' ' HB3' ' A' ' 248' ' ' ASP . 14.2 mmmm -67.54 148.91 50.84 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.702 0.801 . . . . 71.01 111.73 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.445 ' HA2' ' HB2' ' A' ' 246' ' ' ARG . . . 73.55 23.79 76.2 Favored Glycine 0 C--N 1.352 1.45 0 CA-C-N 116.164 -0.471 . . . . 74.2 113.566 177.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.562 ' HG3' HD13 ' A' ' 235' ' ' LEU . 46.6 mmtm -123.05 -26.23 4.4 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.873 0.869 . . . . 74.1 110.985 -174.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -80.19 -155.19 10.58 Favored Glycine 0 C--N 1.345 1.079 0 CA-C-N 115.948 -0.569 . . . . 74.43 113.009 171.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . 0.472 ' HZ ' HD11 ' A' ' 215' ' ' LEU . 3.9 m-85 -94.92 139.03 21.98 Favored Pre-proline 0 N--CA 1.478 0.95 0 CA-C-O 118.893 -0.575 . . . . 73.41 111.175 -168.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.56 ' HA ' ' HA ' ' A' ' 246' ' ' ARG . 59.6 Cg_exo -42.4 129.04 4.75 Favored 'Trans proline' 0 C--N 1.391 2.79 0 C-N-CA 124.437 3.425 . . . . 73.33 114.585 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -165.23 -147.15 5.04 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-O 119.334 -0.703 . . . . 73.52 112.586 -176.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . 0.437 ' HD2' ' HG2' ' A' ' 191' ' ' GLN . 28.1 Cg_exo -62.71 -28.42 76.51 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 123.761 2.974 . . . . 72.5 113.138 -177.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -90.82 21.28 4.2 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.964 0.906 . . . . 70.11 111.524 -179.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 78.28 -70.11 2.65 Favored Glycine 0 C--N 1.35 1.346 0 N-CA-C 109.762 -1.335 . . . . 62.24 109.762 -170.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.56 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 64.0 mtm180 -122.65 144.82 48.88 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 107.154 -1.425 . . . . 75.41 107.154 164.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -69.55 -165.81 4.81 Favored Glycine 0 C--N 1.335 0.514 0 CA-C-O 121.435 0.464 . . . . 70.31 113.919 172.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . 0.594 ' HB3' ' HA ' ' A' ' 236' ' ' LYS . 0.9 OUTLIER -121.0 173.53 7.2 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.589 0.755 . . . . 75.44 111.492 -174.049 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.457 ' HB3' ' HG ' ' A' ' 235' ' ' LEU . 16.2 tp -126.56 136.25 52.32 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.297 -1.001 . . . . 73.32 108.297 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.453 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 56.5 m-85 -111.78 113.94 26.61 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.352 1.061 . . . . 71.3 109.112 176.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.526 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 78.2 mt -102.39 106.85 17.67 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 109.262 -0.644 . . . . 74.54 109.262 178.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -76.79 117.94 18.9 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 109.435 -0.58 . . . . 75.41 109.435 -178.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 231' ' ' ARG . 49.2 t -71.61 134.19 30.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-N 114.477 -1.238 . . . . 71.34 111.31 -171.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -130.94 91.23 3.02 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 106.82 -1.548 . . . . 73.14 106.82 177.113 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.494 HD13 HG23 ' C' ' 257' ' ' ILE . 62.0 mt -77.52 127.88 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 122.767 0.427 . . . . 74.34 111.243 -173.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 25.6 p -116.11 165.16 13.46 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.738 1.215 . . . . 74.52 110.263 175.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . 0.479 ' HB ' ' HD2' ' A' ' 258' ' ' PRO . 2.9 pp -134.17 154.54 80.13 Favored Pre-proline 0 N--CA 1.486 1.363 0 C-N-CA 123.519 0.728 . . . . 73.4 109.079 174.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 258' ' ' PRO . . . . . 0.479 ' HD2' ' HB ' ' A' ' 257' ' ' ILE . 18.4 Cg_endo -54.28 -17.84 12.89 Favored 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 123.705 2.937 . . . . 74.45 116.336 -164.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 59.18 -64.49 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 125.234 1.414 . . . . 75.12 113.119 -167.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -79.24 129.68 34.7 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.792 -0.568 . . . . 75.12 111.013 178.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.405 HD13 ' HD2' ' C' ' 226' ' ' ARG . 67.4 mt -143.29 154.59 43.94 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.412 1.085 . . . . 72.32 109.852 177.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 262' ' ' THR . . . . . 0.416 ' HB ' ' HD2' ' A' ' 263' ' ' PRO . 18.0 p -132.33 159.3 72.84 Favored Pre-proline 0 CA--C 1.564 1.515 0 C-N-CA 124.791 1.236 . . . . 74.31 108.787 174.066 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 263' ' ' PRO . . . . . 0.416 ' HD2' ' HB ' ' A' ' 262' ' ' THR . 39.2 Cg_exo -17.21 -58.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.398 3.155 1 C-N-CA 127.317 5.344 . . . . 74.33 119.167 -170.921 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -70.9 -47.51 58.76 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 118.056 0.389 . . . . 71.44 111.861 -173.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -66.05 -36.97 84.67 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 109.506 -0.553 . . . . 73.22 109.506 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 266' ' ' GLU . . . . . 0.461 ' O ' ' HG3' ' A' ' 270' ' ' LYS . 4.2 tp10 -52.55 -48.97 65.81 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 124.509 1.131 . . . . 73.45 109.238 172.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -58.65 -51.16 71.11 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.697 1.199 . . . . 64.12 112.835 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 11.0 mp -59.94 -46.62 88.81 Favored 'General case' 0 N--CA 1.483 1.223 0 O-C-N 123.717 0.636 . . . . 73.14 110.689 -178.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -65.61 -34.93 79.37 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 123.58 0.752 . . . . 75.0 112.385 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . 0.643 ' HB3' ' HZ1' ' A' ' 270' ' ' LYS . 9.1 mtpm? -63.06 -55.31 26.6 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 122.961 0.504 . . . . 73.12 110.793 176.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 30.7 mmtm -62.98 -27.99 69.78 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 124.085 0.865 . . . . 70.22 111.634 -178.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 272' ' ' LEU . . . . . 0.414 ' O ' ' HB2' ' A' ' 276' ' ' TYR . 40.9 mt -60.12 -55.42 34.05 Favored 'General case' 0 C--O 1.207 -1.158 0 O-C-N 123.836 0.71 . . . . 71.54 109.887 167.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -63.34 -33.42 75.48 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.874 0.87 . . . . 72.23 113.184 -176.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -69.57 -55.34 10.39 Favored 'General case' 0 C--O 1.252 1.203 0 C-N-CA 123.957 0.903 . . . . 74.35 109.736 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -77.26 -2.86 36.86 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-N 115.032 -0.985 . . . . 72.24 111.668 178.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . 0.434 ' CE2' ' HB3' ' C' ' 258' ' ' PRO . 33.4 t80 -79.53 -61.79 1.89 Allowed 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.236 -1.024 . . . . 75.02 108.236 171.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 277' ' ' TYR . . . . . 0.518 ' HA ' ' HB3' ' A' ' 280' ' ' ALA . 2.6 t80 -58.03 -38.76 76.84 Favored 'General case' 0 C--N 1.356 0.877 0 O-C-N 124.988 1.43 . . . . 72.14 109.53 -175.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -48.03 -38.05 16.31 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.67 1.188 . . . . 75.41 113.7 175.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.55 37.85 3.47 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 109.319 -0.623 . . . . 75.15 109.319 179.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . 0.518 ' HB3' ' HA ' ' A' ' 277' ' ' TYR . . . . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 118.89 -0.576 . . . . 72.5 112.102 -175.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 61.1 mtm . . . . . 0 N--CA 1.483 1.18 0 N-CA-C 109.488 -0.56 . . . . 74.12 109.488 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt 67.09 -77.42 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 125.335 1.454 . . . . 62.45 111.552 177.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 36.6 tp60 -154.51 128.01 8.57 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 107.258 -1.386 . . . . 74.04 107.258 -177.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 39.4 m -141.75 100.65 3.8 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 108.763 -0.828 . . . . 52.14 108.763 -178.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 8.6 m -64.09 153.34 37.86 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.353 0.661 . . . . 74.34 112.428 -168.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.713 HG23 ' HA ' ' A' ' 125' ' ' LEU . 19.1 pt -117.55 -177.64 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 N-CA-C 113.12 0.785 . . . . 65.34 113.12 -167.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -135.76 143.66 45.39 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 114.572 -1.194 . . . . 72.22 110.322 177.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . 0.554 ' HB3' ' HB ' ' A' ' 140' ' ' VAL . 36.9 tp -115.76 157.72 23.91 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.842 1.257 . . . . 75.22 108.494 173.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -103.73 -35.66 8.14 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.016 0.526 . . . . 73.12 111.926 178.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . 0.405 ' HG ' HG23 ' A' ' 140' ' ' VAL . 88.4 mt 76.68 2.58 3.4 Favored 'General case' 0 N--CA 1.502 2.145 0 C-N-CA 125.556 1.543 . . . . 74.1 110.726 -162.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.461 HD13 ' HG3' ' A' ' 122' ' ' GLU . 65.0 mt . . . . . 0 CA--C 1.578 2.043 0 N-CA-C 116.383 1.994 . . . . 72.11 116.383 177.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.214 0 N-CA-C 109.042 -0.725 . . . . 74.35 109.042 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 180' ' ' ALA . . . . . 0.608 ' HB3' HG21 ' C' ' 137' ' ' VAL . . . -161.77 -69.81 0.06 Allowed 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 108.505 -0.924 . . . . 75.32 108.505 172.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 20.1 tp -88.35 -68.72 0.75 Allowed 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 107.171 -1.418 . . . . 74.44 107.171 160.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 182' ' ' VAL . . . . . . . . . . . . . 78.4 t -135.64 -70.95 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.705 0.802 . . . . 72.43 109.644 175.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -171.64 -89.44 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.257 0.623 . . . . 65.24 110.537 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 26.7 p-80 -168.01 -167.58 0.85 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.481 0.712 . . . . 75.32 110.869 -173.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 185' ' ' VAL . . . . . . . . . . . . . 89.6 t . . . . . 0 N--CA 1.482 1.165 0 C-N-CA 124.1 0.96 . . . . 74.01 111.011 -179.267 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 33.0 m . . . . . 0 CA--C 1.544 0.713 0 CA-C-O 121.48 0.657 . . . . 71.31 110.016 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 239' ' ' ALA . . . . . 0.416 ' HA ' HD21 ' C' ' 235' ' ' LEU . . . -68.96 137.96 54.18 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 114.671 -1.15 . . . . 74.42 111.16 172.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . -70.34 -101.57 0.04 OUTLIER Glycine 0 C--N 1.355 1.586 0 N-CA-C 110.923 -0.871 . . . . 71.23 110.923 172.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 241' ' ' GLU . . . . . 0.467 ' HB3' ' HG3' ' B' ' 245' ' ' LYS . 24.0 pt-20 -175.31 171.58 2.87 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.847 0.859 . . . . 71.23 111.462 169.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -98.27 -66.11 0.92 Allowed 'General case' 0 C--O 1.237 0.408 0 N-CA-C 107.094 -1.447 . . . . 70.32 107.094 -175.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -141.72 19.49 2.17 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 112.586 -2.097 . . . . 74.22 106.974 -175.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 114.41 164.88 15.09 Favored Glycine 0 CA--C 1.535 1.341 0 N-CA-C 109.75 -1.34 . . . . 71.54 109.75 -156.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 245' ' ' LYS . . . . . 0.467 ' HG3' ' HB3' ' B' ' 241' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.374 0 C-N-CA 123.727 0.811 . . . . 75.34 111.019 177.223 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.838 0 N-CA-C 110.308 -0.256 . . . . 71.34 110.308 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' C' C ' 4' ' ' LYS . . . . . 0.641 ' HZ2' ' HB3' ' C' ' 4' ' ' LYS . 5.5 ttpm? -37.64 96.2 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 125.616 1.566 . . . . 70.52 113.179 178.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 5' ' ' LYS . . . . . 0.51 ' HB3' HD12 ' C' ' 10' ' ' ILE . 97.4 mttt -96.86 106.93 19.34 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.72 0.808 . . . . 72.32 109.561 174.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -73.83 97.62 2.79 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 107.076 -1.453 . . . . 65.15 107.076 166.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 7' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -61.16 -26.04 67.42 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 114.451 -1.249 . . . . 73.43 112.257 -172.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -68.67 -46.77 68.22 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.851 0.461 . . . . 74.23 109.792 176.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.3 -42.88 92.35 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.366 0.666 . . . . 63.34 110.678 178.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 10' ' ' ILE . . . . . 0.51 HD12 ' HB3' ' C' ' 5' ' ' LYS . 83.3 mt -54.17 -47.39 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 C-N-CA 124.023 0.929 . . . . 73.31 110.615 174.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 85.8 mt -75.79 -13.6 60.29 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 115.397 -0.82 . . . . 75.53 112.787 179.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.66 21.29 75.06 Favored Glycine 0 C--N 1.351 1.393 0 CA-C-N 117.903 0.32 . . . . 74.43 113.655 -177.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 12.5 m -106.19 160.58 25.7 Favored Pre-proline 0 N--CA 1.483 1.187 0 C-N-CA 124.291 1.036 . . . . 71.34 110.271 176.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -56.82 153.37 37.47 Favored 'Trans proline' 0 C--N 1.388 2.65 0 C-N-CA 122.714 2.276 . . . . 74.43 112.152 177.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 63.6 mtp180 -70.67 7.21 1.16 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 113.661 0.985 . . . . 74.35 113.661 -174.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -135.93 21.94 3.29 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.276 1.031 . . . . 71.24 108.594 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.04 128.07 34.99 Favored 'General case' 0 C--N 1.35 0.608 0 CA-C-N 114.684 -1.144 . . . . 75.2 111.089 -176.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 70.8 p -71.44 169.22 15.84 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 123.662 0.785 . . . . 74.41 110.252 177.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -50.98 -38.59 51.89 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.052 0.941 . . . . 74.45 111.615 -178.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 20' ' ' GLU . . . . . 0.432 ' O ' ' HG3' ' C' ' 24' ' ' ARG . 0.3 OUTLIER -69.68 -45.56 68.04 Favored 'General case' 0 CA--C 1.553 1.061 0 O-C-N 123.952 0.783 . . . . 74.53 110.539 -176.14 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -63.47 -43.41 97.42 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.724 0.773 . . . . 73.42 110.741 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 22' ' ' ILE . . . . . 0.69 HD12 ' HB3' ' C' ' 57' ' ' LEU . 89.8 mt -63.13 -34.3 65.88 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 CA-C-N 114.044 -1.435 . . . . 75.54 110.75 175.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -72.67 -29.95 63.86 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.928 0.891 . . . . 74.13 111.223 176.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 24' ' ' ARG . . . . . 0.432 ' HG3' ' O ' ' C' ' 20' ' ' GLU . 94.6 mtt180 -64.81 -53.05 52.94 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.142 0.577 . . . . 73.52 109.541 175.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.93 -40.96 97.32 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 114.704 -1.135 . . . . 75.32 111.24 178.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 26' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -52.48 -64.43 0.82 Allowed 'General case' 0 C--O 1.212 -0.877 0 O-C-N 124.789 1.306 . . . . 72.31 110.309 176.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -59.01 -38.73 79.9 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 124.339 1.025 . . . . 75.33 111.45 -174.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 -55.03 -53.68 52.67 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 123.715 0.634 . . . . 75.55 110.588 177.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . 0.508 ' HB3' HD11 ' C' ' 50' ' ' ILE . 72.4 mt -82.65 -17.14 45.66 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 115.009 -0.996 . . . . 71.43 111.941 -176.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -85.84 -16.6 38.17 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.738 0.815 . . . . 75.32 110.472 179.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -95.19 -37.7 10.92 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.525 0.73 . . . . 73.5 109.954 170.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 25.8 tp60 -65.07 -47.76 76.17 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.393 0.677 . . . . 71.12 111.187 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -108.69 22.7 15.57 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.333 0.653 . . . . 72.14 111.069 -175.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 34' ' ' HIS . . . . . 0.519 ' CD2' ' HB3' ' C' ' 36' ' ' ASP . 54.3 t60 -60.51 99.39 0.18 Allowed Pre-proline 0 N--CA 1.487 1.412 0 C-N-CA 124.913 1.285 . . . . 74.34 111.547 -174.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -61.97 -22.37 74.15 Favored 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 123.51 2.806 . . . . 72.22 113.916 -167.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 36' ' ' ASP . . . . . 0.519 ' HB3' ' CD2' ' C' ' 34' ' ' HIS . 9.4 t70 -56.44 -43.88 79.91 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.38 1.072 . . . . 60.34 111.603 174.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . 0.406 HG22 ' HD2' ' C' ' 34' ' ' HIS . 51.7 t -99.94 -46.24 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-O 121.762 0.791 . . . . 75.33 109.754 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -100.93 84.5 2.7 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.391 1.476 . . . . 65.41 109.921 -175.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -83.37 54.88 2.96 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.402 0.681 . . . . 71.22 110.663 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 44.3 m -104.37 108.33 60.14 Favored Pre-proline 0 N--CA 1.475 0.791 0 CA-C-O 118.572 -0.728 . . . . 74.14 109.136 -178.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -40.75 -52.12 3.34 Favored 'Trans proline' 0 C--N 1.387 2.6 0 C-N-CA 124.655 3.57 . . . . 75.0 114.707 -174.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 42' ' ' GLU . . . . . 0.466 ' HG3' ' HZ3' ' C' ' 46' ' ' LYS . 41.8 tt0 -56.81 -47.39 80.35 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 124.043 0.839 . . . . 71.01 110.813 178.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.05 -20.87 66.32 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 115.966 -0.561 . . . . 71.45 110.901 -178.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -86.29 -28.87 23.47 Favored 'General case' 0 C--N 1.355 0.814 0 C-N-CA 123.21 0.604 . . . . 74.04 109.995 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -60.85 -50.26 74.17 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.753 -0.832 . . . . 75.44 108.753 171.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 46' ' ' LYS . . . . . 0.466 ' HZ3' ' HG3' ' C' ' 42' ' ' GLU . 12.3 mptt -62.5 -48.79 78.04 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 113.811 -1.541 . . . . 72.32 110.07 179.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -56.25 -39.19 72.18 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.809 0.844 . . . . 71.12 110.79 178.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -62.02 -49.19 77.01 Favored 'General case' 0 C--O 1.214 -0.794 0 O-C-N 123.841 0.713 . . . . 72.04 109.97 179.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -70.68 -22.02 62.53 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 112.557 0.577 . . . . 72.33 112.557 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 50' ' ' ILE . . . . . 0.508 HD11 ' HB3' ' C' ' 29' ' ' LEU . 73.2 mt -80.11 -36.78 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 124.423 1.089 . . . . 75.43 110.69 176.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 51' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -89.63 -8.64 52.07 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.031 0.932 . . . . 74.04 110.521 177.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 52' ' ' GLU . . . . . 0.407 ' O ' HG23 ' C' ' 56' ' ' VAL . 29.4 tt0 -79.0 -47.19 16.71 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.93 1.292 . . . . 75.54 107.928 166.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.42 -44.34 80.29 Favored 'General case' 0 C--N 1.346 0.431 0 CA-C-N 114.243 -1.344 . . . . 63.1 110.684 173.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -80.93 -22.84 39.31 Favored 'General case' 0 CA--C 1.553 1.06 0 CA-C-N 115.501 -0.772 . . . . 75.01 111.125 178.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.85 -38.24 78.28 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 118.839 0.745 . . . . 60.54 110.22 171.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 56' ' ' VAL . . . . . 0.407 HG23 ' O ' ' C' ' 52' ' ' GLU . 26.1 t -77.34 -47.69 26.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-N 114.891 -1.049 . . . . 72.43 110.501 174.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 57' ' ' LEU . . . . . 0.69 ' HB3' HD12 ' C' ' 22' ' ' ILE . 85.1 mt -103.72 20.8 17.36 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 113.569 0.952 . . . . 75.02 113.569 -166.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 33.6 t -55.89 -43.1 76.92 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 124.161 0.984 . . . . 75.33 113.275 177.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -140.71 156.91 68.82 Favored Pre-proline 0 N--CA 1.472 0.664 0 C-N-CA 124.379 1.072 . . . . 72.03 109.559 -170.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 60' ' ' PRO . . . . . 0.465 ' O ' ' HG2' ' C' ' 64' ' ' ARG . 19.6 Cg_endo -54.62 -29.21 59.8 Favored 'Trans proline' 0 C--N 1.394 2.959 0 C-N-CA 123.408 2.739 . . . . 73.21 112.454 179.176 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -54.04 -63.16 1.24 Allowed 'General case' 0 C--O 1.252 1.199 0 C-N-CA 124.823 1.249 . . . . 62.13 111.801 177.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 44.0 mtpt -81.55 -24.64 36.45 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 113.94 -1.482 . . . . 75.43 110.152 -171.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -54.3 -50.13 68.05 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.763 1.225 . . . . 74.14 109.595 166.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 64' ' ' ARG . . . . . 0.465 ' HG2' ' O ' ' C' ' 60' ' ' PRO . 20.9 mmt180 -71.11 -29.02 64.74 Favored 'General case' 0 C--N 1.358 0.967 0 CA-C-O 119.13 -0.462 . . . . 74.15 111.801 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 69.4 mt -56.86 -44.92 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-O 121.296 0.57 . . . . 71.5 110.317 168.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -63.19 -48.15 79.6 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.994 -0.548 . . . . 74.31 110.969 176.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -58.84 -41.4 86.86 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 123.581 0.551 . . . . 73.14 111.725 -177.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 64.9 p -67.8 -28.99 68.06 Favored 'General case' 0 C--N 1.349 0.574 0 O-C-N 123.341 0.4 . . . . 74.43 110.671 176.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -77.26 142.71 39.36 Favored 'General case' 0 C--N 1.359 0.989 0 N-CA-C 109.052 -0.721 . . . . 75.22 109.052 171.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.69 13.3 82.6 Favored Glycine 0 C--N 1.346 1.102 0 N-CA-C 112.009 -0.436 . . . . 62.51 112.009 -177.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 28.8 m -136.93 -54.5 0.71 Allowed 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 103.749 -2.686 . . . . 72.34 103.749 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 82.2 m -97.51 150.17 21.37 Favored 'General case' 0 C--O 1.255 1.354 0 N-CA-C 104.532 -2.395 . . . . 73.35 104.532 156.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.12 -34.16 11.8 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.844 0.858 . . . . 73.23 110.258 -178.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -70.64 128.1 91.31 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 123.742 0.817 . . . . 53.23 110.732 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -67.13 150.38 82.12 Favored 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 122.647 2.231 . . . . 75.14 111.176 172.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -58.75 147.39 88.44 Favored 'Trans proline' 0 C--N 1.373 1.856 0 C-N-CA 122.645 2.23 . . . . 71.22 112.123 173.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.43 147.42 68.55 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 122.388 2.059 . . . . 74.4 112.113 171.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 78' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -59.05 123.05 12.63 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.975 2.45 . . . . 74.44 112.618 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -71.91 170.68 18.25 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 122.872 2.382 . . . . 70.12 112.178 178.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 80' ' ' PRO . . . . . 0.522 ' HB2' ' HB3' ' C' ' 141' ' ' ALA . 82.4 Cg_exo -48.8 89.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.393 2.911 0 C-N-CA 123.468 2.779 . . . . 74.31 113.607 178.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 118.29 -40.1 2.4 Favored Glycine 0 C--O 1.225 -0.464 0 CA-C-N 114.651 -1.158 . . . . 75.2 110.255 177.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 126.5 -176.04 17.68 Favored Glycine 0 C--N 1.347 1.18 0 N-CA-C 111.249 -0.741 . . . . 75.13 111.249 -172.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -73.98 124.13 25.63 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.839 0.856 . . . . 73.4 111.152 -176.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 84' ' ' ASP . . . . . 0.64 ' HB3' HH21 ' C' ' 143' ' ' ARG . 6.9 p-10 -70.77 149.15 47.18 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.616 0.766 . . . . 75.11 110.506 177.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 85' ' ' PHE . . . . . 0.529 ' HB3' ' HB2' ' C' ' 88' ' ' PHE . 53.6 m-85 -148.37 74.86 1.3 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.641 0.777 . . . . 74.41 110.056 -179.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 16.5 m -54.98 86.57 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 125.131 1.373 . . . . 52.42 113.645 -175.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 85.49 13.45 70.45 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-N 115.686 -0.688 . . . . 74.34 112.829 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 88' ' ' PHE . . . . . 0.529 ' HB2' ' HB3' ' C' ' 85' ' ' PHE . 18.5 m-85 -115.34 108.15 16.16 Favored 'General case' 0 C--N 1.355 0.815 0 C-N-CA 123.135 0.574 . . . . 74.44 109.641 -174.071 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -74.46 88.13 2.1 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 108.042 -1.095 . . . . 72.23 108.042 177.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 90' ' ' VAL . . . . . 0.616 HG23 HD22 ' C' ' 105' ' ' LEU . 2.1 p -47.35 -40.65 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 CA-C-N 114.317 -1.311 . . . . 54.42 113.151 176.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 91' ' ' GLU . . . . . 0.446 ' HB2' ' ND2' ' C' ' 169' ' ' ASN . 33.7 tt0 -65.99 -21.3 66.4 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.863 0.865 . . . . 75.25 111.43 -175.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -86.42 -21.59 27.03 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 123.728 0.811 . . . . 75.53 111.239 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -77.24 -177.72 4.72 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.339 0.656 . . . . 72.45 112.338 -175.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 92.4 p -78.14 173.31 12.38 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 113.307 0.854 . . . . 52.11 113.307 -168.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.21 -51.07 71.59 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 114.333 -1.303 . . . . 72.35 111.557 178.038 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -56.17 -40.51 74.0 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.984 0.914 . . . . 74.24 111.087 -175.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 97' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -64.72 -50.36 67.22 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 114.519 -1.219 . . . . 64.25 110.04 177.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -80.06 2.69 22.89 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 115.213 -0.903 . . . . 71.33 112.56 -177.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -100.07 -45.12 5.77 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.568 0.747 . . . . 74.43 110.507 170.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 13.2 tp -62.74 -58.29 7.96 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.242 0.617 . . . . 73.23 110.127 176.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -81.87 -11.36 58.97 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 115.71 -0.677 . . . . 75.04 111.408 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -37.38 -63.18 0.84 Allowed Glycine 0 C--N 1.358 1.767 0 C-N-CA 124.807 1.194 . . . . 74.41 115.679 -177.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_exo -46.21 -34.13 13.08 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 123.841 3.028 . . . . 64.35 115.282 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -119.05 27.88 6.87 Favored Glycine 0 C--N 1.356 1.647 0 CA-C-O 119.318 -0.712 . . . . 73.42 113.823 -175.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 105' ' ' LEU . . . . . 0.616 HD22 HG23 ' C' ' 90' ' ' VAL . 29.0 mt . . . . . 0 N--CA 1.482 1.17 0 CA-C-N 117.761 0.78 . . . . 75.43 112.706 176.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 116' ' ' GLY . . . . . 0.5 ' HA2' ' HA3' ' C' ' 168' ' ' GLY . . . . . . . . 0 CA--C 1.516 0.121 0 N-CA-C 113.902 0.321 . . . . 54.4 113.902 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.09 -176.82 2.99 Favored 'General case' 0 C--O 1.26 1.621 0 C-N-CA 124.301 1.041 . . . . 74.32 108.907 168.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 118' ' ' ASP . . . . . 0.469 ' HA ' ' O ' ' C' ' 173' ' ' ASP . 4.8 p-10 -60.62 152.99 24.9 Favored 'General case' 0 C--O 1.244 0.764 0 CA-C-N 115.127 -0.942 . . . . 75.42 112.828 -171.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 119' ' ' LEU . . . . . 0.457 ' O ' HD12 ' C' ' 174' ' ' LEU . 20.0 tp -110.85 118.28 35.71 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 106.57 -1.641 . . . . 75.21 106.57 173.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 21.8 ttm180 -112.37 106.03 14.45 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 121.207 0.527 . . . . 72.31 110.761 -167.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 121' ' ' ALA . . . . . . . . . . . . . . . -124.13 117.28 24.3 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.445 -0.798 . . . . 75.44 109.314 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -82.14 125.44 30.89 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 108.478 -0.934 . . . . 74.12 108.478 170.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 123' ' ' LEU . . . . . 0.414 HD12 HD22 ' C' ' 176' ' ' LEU . 2.2 pt? -130.33 115.3 17.34 Favored Pre-proline 0 CA--C 1.554 1.134 0 C-N-CA 123.03 0.532 . . . . 73.3 110.461 -171.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' C' ' 179' ' ' ARG . 53.6 Cg_exo -62.78 115.69 3.08 Favored 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 123.301 2.667 . . . . 72.51 113.707 170.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 125' ' ' LEU . . . . . 0.565 HD22 HG13 ' C' ' 153' ' ' VAL . 19.0 tp -131.32 166.52 21.05 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 106.308 -1.738 . . . . 75.32 106.308 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 126' ' ' THR . . . . . . . . . . . . . 11.7 t -129.54 176.03 8.31 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 120.833 1.651 . . . . 61.53 112.1 175.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 127' ' ' LEU . . . . . 0.445 HD22 HD11 ' C' ' 180' ' ' LEU . 7.4 mt -60.79 -41.67 96.07 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.003 1.721 . . . . 62.25 110.069 -177.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -65.02 -43.63 91.83 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 113.867 -1.515 . . . . 75.24 110.716 176.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -72.59 -21.17 61.17 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-N 115.47 -0.786 . . . . 75.51 111.224 -179.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 130' ' ' ALA . . . . . 0.459 ' HB1' HG12 ' C' ' 153' ' ' VAL . . . -78.57 -46.25 19.84 Favored 'General case' 0 C--O 1.22 -0.456 0 O-C-N 124.139 0.899 . . . . 73.14 109.194 174.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 131' ' ' PHE . . . . . 0.529 ' HB2' HD11 ' C' ' 215' ' ' LEU . 88.1 t80 -50.68 -42.99 57.42 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.709 1.204 . . . . 75.55 110.796 173.074 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 132' ' ' HIS . . . . . . . . . . . . . 28.0 m170 -67.44 -67.43 0.46 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.187 -0.915 . . . . 70.15 108.754 175.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 50.51 -139.28 22.04 Favored Glycine 0 C--N 1.358 1.791 0 O-C-N 124.198 0.936 . . . . 65.31 113.662 175.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.86 -152.97 37.58 Favored Glycine 0 C--N 1.342 0.913 0 O-C-N 123.958 0.446 . . . . 73.12 113.27 177.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -79.15 94.4 5.37 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 108.554 -0.906 . . . . 73.03 108.554 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 136' ' ' ARG . . . . . . . . . . . . . 28.1 mmm-85 -103.39 125.35 49.95 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.778 0.831 . . . . 72.12 109.382 -177.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 137' ' ' VAL . . . . . 0.608 HG21 ' HB3' ' B' ' 180' ' ' ALA . 31.6 m -77.43 135.96 25.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 N-CA-C 109.361 -0.607 . . . . 73.11 109.361 174.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 138' ' ' VAL . . . . . . . . . . . . . 7.3 p -136.28 126.42 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.607 0.763 . . . . 72.14 109.35 -176.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 139' ' ' GLU . . . . . 0.487 ' HG3' ' HB2' ' C' ' 144' ' ' ARG . 1.6 mp0 -86.72 75.81 9.6 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.543 -0.539 . . . . 74.31 109.543 -176.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 140' ' ' VAL . . . . . . . . . . . . . 87.0 t -86.04 113.02 23.41 Favored 'Isoleucine or valine' 0 C--O 1.246 0.891 0 N-CA-C 108.396 -0.964 . . . . 73.25 108.396 -178.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 141' ' ' ALA . . . . . 0.522 ' HB3' ' HB2' ' C' ' 80' ' ' PRO . . . 62.78 37.01 12.75 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 124.565 1.165 . . . . 65.0 110.914 176.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 101.55 -34.81 5.36 Favored Glycine 0 C--N 1.351 1.363 0 CA-C-N 114.856 -1.065 . . . . 52.4 112.803 177.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 143' ' ' ARG . . . . . 0.64 HH21 ' HB3' ' C' ' 84' ' ' ASP . 0.2 OUTLIER -92.4 118.96 31.47 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 117.179 0.489 . . . . 75.05 111.324 -171.508 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 144' ' ' ARG . . . . . 0.507 ' HG3' ' HB ' ' C' ' 137' ' ' VAL . 35.4 ttm180 -73.92 115.95 13.97 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.194 -0.912 . . . . 71.51 109.638 171.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 145' ' ' VAL . . . . . . . . . . . . . 4.2 p -131.51 128.87 61.46 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 C-N-CA 124.049 0.94 . . . . 75.03 109.775 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 36.1 t -75.45 93.02 2.9 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 123.977 0.911 . . . . 73.22 110.582 -177.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 8.8 p -88.15 119.12 35.04 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 N-CA-C 109.241 -0.652 . . . . 72.53 109.241 175.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -75.53 104.33 6.04 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 109.513 -0.551 . . . . 74.22 109.513 174.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 149' ' ' ILE . . . . . 0.445 HG21 HG21 ' C' ' 159' ' ' ILE . 36.0 pt -120.29 95.46 49.07 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 107.133 -1.432 . . . . 74.42 107.133 165.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -49.78 161.14 0.96 Allowed 'Trans proline' 0 C--N 1.395 2.994 0 C-N-CA 124.271 3.314 . . . . 61.44 114.205 -174.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -43.56 94.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.389 2.7 0 C-N-CA 123.345 2.697 . . . . 73.2 112.247 174.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 152' ' ' GLY . . . . . 0.427 ' HA2' ' CD2' ' C' ' 240' ' ' PHE . . . 151.44 132.76 1.93 Allowed Glycine 0 C--N 1.348 1.222 0 CA-C-N 115.073 -0.967 . . . . 63.11 113.637 -174.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 153' ' ' VAL . . . . . 0.589 HG22 HG12 ' C' ' 178' ' ' VAL . 0.6 OUTLIER -153.59 160.23 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.028 0 CA-C-N 116.745 0.273 . . . . 74.01 110.948 169.696 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 154' ' ' ARG . . . . . 0.439 ' HG2' ' HB3' ' C' ' 188' ' ' LEU . 22.1 mtp180 -121.36 123.49 42.26 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.206 1.002 . . . . 75.32 110.447 -170.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 155' ' ' GLU . . . . . 0.456 ' HB2' HD12 ' C' ' 180' ' ' LEU . 13.3 tp10 -51.18 124.74 12.26 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.439 0.696 . . . . 74.51 112.241 171.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 76.28 12.39 84.23 Favored Glycine 0 C--N 1.348 1.241 0 O-C-N 124.394 1.059 . . . . 75.21 114.008 170.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 157' ' ' SER . . . . . . . . . . . . . 55.4 m -101.94 156.1 17.74 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.202 0.525 . . . . 75.43 110.829 -178.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 158' ' ' VAL . . . . . 0.599 HG13 HG22 ' C' ' 177' ' ' VAL . 27.1 m -96.56 111.71 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 CA-C-N 115.103 -0.953 . . . . 72.31 109.161 175.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 159' ' ' ILE . . . . . 0.702 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 57.1 mt -71.39 94.95 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 107.903 -1.147 . . . . 72.31 107.903 170.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 12.1 ttp180 -86.87 100.75 12.78 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 109.336 -0.616 . . . . 75.13 109.336 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 161' ' ' VAL . . . . . 0.585 HG11 ' HB3' ' C' ' 174' ' ' LEU . 2.1 p -101.03 102.46 20.19 Favored Pre-proline 0 CA--C 1.553 1.076 0 N-CA-C 108.866 -0.79 . . . . 75.24 108.866 172.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -63.76 136.34 53.07 Favored 'Trans proline' 0 C--N 1.386 2.52 0 C-N-CA 122.921 2.414 . . . . 75.23 112.855 -175.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 163' ' ' GLY . . . . . 0.407 ' O ' ' HB2' ' C' ' 171' ' ' PRO . . . 98.29 -6.82 61.69 Favored Glycine 0 C--N 1.341 0.847 0 CA-C-N 115.317 -0.856 . . . . 53.54 113.512 177.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 164' ' ' MET . . . . . . . . . . . . . 82.7 mtp -103.26 30.68 4.74 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 118.016 0.908 . . . . 73.35 110.883 178.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 165' ' ' GLY . . . . . 0.485 ' HA2' ' O ' ' C' ' 173' ' ' ASP . . . -57.34 162.8 7.73 Favored Glycine 0 C--N 1.351 1.393 0 CA-C-N 114.932 -1.031 . . . . 73.32 114.82 177.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . -117.85 -59.55 0.29 Allowed Glycine 0 C--N 1.346 1.101 0 C-N-CA 121.532 -0.366 . . . . 75.44 112.764 -170.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 167' ' ' GLN . . . . . 0.411 ' O ' ' HA2' ' C' ' 116' ' ' GLY . 29.9 mm-40 -88.46 99.07 12.0 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 110.164 -0.31 . . . . 74.2 110.164 -173.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 168' ' ' GLY . . . . . 0.5 ' HA3' ' HA2' ' C' ' 116' ' ' GLY . . . 123.04 147.96 7.5 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-O 119.564 -0.575 . . . . 13.44 112.9 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 169' ' ' ASN . . . . . 0.458 ' OD1' ' HB3' ' C' ' 105' ' ' LEU . 7.3 t30 -61.04 -59.41 13.91 Favored Pre-proline 0 N--CA 1.491 1.607 0 CA-C-O 117.621 -1.18 . . . . 62.44 113.781 -169.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 170' ' ' PRO . . . . . 0.446 ' HD3' ' HB3' ' C' ' 169' ' ' ASN . 6.6 Cg_exo -75.12 106.08 2.21 Favored 'Trans proline' 0 C--N 1.39 2.76 0 C-N-CA 122.01 1.807 . . . . 73.55 109.792 170.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 171' ' ' PRO . . . . . 0.407 ' HB2' ' O ' ' C' ' 163' ' ' GLY . 17.0 Cg_exo -66.58 126.02 14.79 Favored 'Trans proline' 0 C--N 1.372 1.798 0 C-N-CA 122.75 2.3 . . . . 74.02 113.229 -167.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -71.37 -74.94 0.68 Allowed Glycine 0 C--N 1.355 1.619 0 O-C-N 123.797 0.686 . . . . 74.42 113.464 -177.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 173' ' ' ASP . . . . . 0.485 ' O ' ' HA2' ' C' ' 165' ' ' GLY . 4.6 p-10 -164.05 166.64 21.21 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.04 0.936 . . . . 74.51 109.746 175.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 174' ' ' LEU . . . . . 0.585 ' HB3' HG11 ' C' ' 161' ' ' VAL . 31.6 tp -113.48 113.76 25.6 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.901 -0.778 . . . . 75.22 108.901 176.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 175' ' ' LEU . . . . . 0.436 HD22 ' HB ' ' C' ' 158' ' ' VAL . 70.4 mt -87.72 93.54 9.47 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 123.882 0.873 . . . . 72.15 109.879 170.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 176' ' ' LEU . . . . . 0.702 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 82.3 mt -82.92 100.44 10.4 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 108.989 -0.745 . . . . 74.33 108.989 170.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 177' ' ' VAL . . . . . 0.599 HG22 HG13 ' C' ' 158' ' ' VAL . 41.4 t -81.49 93.35 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 108.49 -0.93 . . . . 75.23 108.49 -178.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 178' ' ' VAL . . . . . 0.589 HG12 HG22 ' C' ' 153' ' ' VAL . 2.1 p -76.77 125.29 36.43 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 CA-C-N 115.329 -0.85 . . . . 74.01 110.996 -172.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 179' ' ' ARG . . . . . 0.417 ' O ' ' HA ' ' C' ' 124' ' ' PRO . 34.8 mmt180 -120.29 112.9 19.62 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 114.355 -1.293 . . . . 74.42 108.308 178.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 180' ' ' LEU . . . . . 0.524 ' HA ' ' O ' ' C' ' 125' ' ' LEU . 80.5 mt -69.48 143.32 53.54 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 116.561 -0.291 . . . . 73.43 111.579 -178.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 181' ' ' LEU . . . . . . . . . . . . . 36.6 mt -60.94 156.49 47.07 Favored Pre-proline 0 N--CA 1.482 1.17 0 CA-C-O 117.731 -1.128 . . . . 74.24 109.92 -179.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -49.02 79.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.395 2.987 0 C-N-CA 124.205 3.27 . . . . 73.32 115.516 -174.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 183' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 171.87 76.78 0.04 OUTLIER Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 128.456 2.702 . . . . 72.0 106.82 172.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 184' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.22 68.86 4.99 Favored 'Trans proline' 0 C--N 1.38 2.19 0 C-N-CA 123.686 2.924 . . . . 74.25 111.533 178.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 185' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 13.1 t -90.48 -41.16 13.32 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.702 0 N-CA-C 109.326 -0.62 . . . . 72.23 109.326 -168.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 186' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -122.25 111.03 16.44 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 120.9 0.381 . . . . 61.44 111.718 -172.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 187' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -95.98 112.9 24.51 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 106.562 -1.644 . . . . 75.14 106.562 170.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 188' ' ' LEU . . . . . 0.439 ' HB3' ' HG2' ' C' ' 154' ' ' ARG . 62.0 tp -80.75 144.8 31.88 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-O 121.272 0.558 . . . . 74.14 112.465 -175.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -136.9 101.52 4.6 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.634 1.574 . . . . 73.21 107.124 169.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 72.41 -97.27 0.77 Allowed Glycine 0 C--N 1.349 1.263 0 N-CA-C 112.084 -0.406 . . . . 74.2 112.084 -175.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 191' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -119.86 -18.57 8.21 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 124.323 1.049 . . . . 75.25 110.321 175.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -94.53 140.94 29.18 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.168 0.987 . . . . 65.13 110.467 -172.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 193' ' ' LEU . . . . . 0.534 HD22 ' CE2' ' C' ' 240' ' ' PHE . 88.5 mt -100.25 170.18 8.62 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 113.119 0.785 . . . . 65.15 113.119 -169.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 194' ' ' TYR . . . . . 0.423 ' HA ' ' O ' ' C' ' 250' ' ' TYR . 52.1 t80 -127.97 108.42 10.66 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.787 0.835 . . . . 75.43 110.197 167.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 195' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' C' ' 185' ' ' VAL . . . -110.68 -175.85 2.82 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.823 0.849 . . . . 65.11 109.125 168.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 17.9 m -121.8 132.15 54.44 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 108.432 -0.951 . . . . 53.42 108.432 167.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 197' ' ' LEU . . . . . 0.471 HD23 HD13 ' C' ' 233' ' ' LEU . 53.7 tp -102.1 145.68 29.01 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.459 0.704 . . . . 73.5 110.444 -177.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -116.61 101.61 8.75 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.274 -1.01 . . . . 64.33 108.274 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 199' ' ' VAL . . . . . . . . . . . . . 39.5 t -115.13 126.29 27.98 Favored Pre-proline 0 N--CA 1.476 0.872 0 N-CA-C 108.826 -0.805 . . . . 73.12 108.826 177.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 200' ' ' PRO . . . . . 0.572 ' HG2' HD11 ' C' ' 203' ' ' ILE . 24.0 Cg_exo -60.73 150.01 84.81 Favored 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 122.588 2.192 . . . . 73.11 112.204 168.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 201' ' ' ALA . . . . . 0.432 ' HA ' HG21 ' C' ' 255' ' ' ILE . . . -51.84 -57.92 13.02 Favored Pre-proline 0 CA--C 1.56 1.358 0 C-N-CA 124.756 1.222 . . . . 74.35 113.409 177.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 202' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -71.46 -30.68 14.9 Favored 'Trans proline' 0 C--N 1.389 2.71 0 CA-C-N 121.585 1.602 . . . . 63.15 112.544 -174.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 203' ' ' ILE . . . . . 0.572 HD11 ' HG2' ' C' ' 200' ' ' PRO . 20.4 mt -64.43 -40.48 89.21 Favored 'Isoleucine or valine' 0 C--N 1.361 1.085 0 N-CA-C 109.307 -0.627 . . . . 74.02 109.307 172.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 204' ' ' ALA . . . . . 0.524 ' HB1' ' HB ' ' C' ' 227' ' ' THR . . . -62.06 -39.06 91.1 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.24 -0.891 . . . . 75.02 110.816 176.447 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 205' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' C' ' 226' ' ' ARG . 53.4 t -74.06 -48.86 36.27 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 N-CA-C 114.027 1.121 . . . . 74.52 114.027 -173.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 206' ' ' VAL . . . . . . . . . . . . . 9.0 p -92.73 -33.55 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 CA-C-N 119.551 1.069 . . . . 74.12 111.453 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 105.58 121.69 4.9 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.399 -0.68 . . . . 63.21 111.399 -173.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -145.41 -136.22 2.95 Favored Glycine 0 C--N 1.339 0.709 0 N-CA-C 110.833 -0.907 . . . . 51.32 110.833 178.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 209' ' ' LYS . . . . . . . . . . . . . 20.2 ttpp -151.7 118.48 5.78 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 117.523 0.661 . . . . 72.44 109.903 175.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 210' ' ' VAL . . . . . . . . . . . . . 19.1 m -111.35 170.0 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 124.829 1.252 . . . . 71.52 109.671 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 211' ' ' ARG . . . . . . . . . . . . . 8.1 tmm_? -103.25 125.35 49.87 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 120.922 0.391 . . . . 75.53 110.909 -179.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 212' ' ' ALA . . . . . 0.425 ' HB3' HG12 ' C' ' 219' ' ' VAL . . . -105.72 152.36 23.27 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.849 1.26 . . . . 74.43 109.728 168.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 213' ' ' MET . . . . . . . . . . . . . 17.8 mmm -85.15 142.06 29.74 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.439 0.695 . . . . 63.12 110.017 174.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 214' ' ' THR . . . . . 0.51 HG21 ' HD3' ' C' ' 238' ' ' LYS . 0.2 OUTLIER -141.23 175.05 9.96 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.114 0.566 . . . . 72.34 111.204 172.619 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 215' ' ' LEU . . . . . 0.529 HD11 ' HB2' ' C' ' 131' ' ' PHE . 23.9 mt -61.92 -48.46 80.33 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.246 1.018 . . . . 75.24 111.394 -173.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -91.21 13.62 16.61 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 114.399 -1.273 . . . . 71.0 111.416 -176.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 124.39 -171.21 16.56 Favored Glycine 0 C--N 1.351 1.392 0 N-CA-C 111.824 -0.51 . . . . 74.41 111.824 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -81.7 129.55 6.44 Favored 'Trans proline' 0 CA--C 1.558 1.719 0 C-N-CA 122.675 2.25 . . . . 64.03 113.848 -178.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 219' ' ' VAL . . . . . 0.425 HG12 ' HB3' ' C' ' 212' ' ' ALA . 5.1 p -97.5 140.32 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 N-CA-C 108.361 -0.978 . . . . 52.53 108.361 172.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 220' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -98.44 107.98 20.56 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 118.583 0.629 . . . . 72.32 109.651 179.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 221' ' ' VAL . . . . . . . . . . . . . 37.9 t -69.8 116.04 10.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 126.058 1.743 . . . . 74.03 112.708 -179.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -76.01 113.67 13.78 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.493 0.717 . . . . 73.3 109.146 168.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 47.0 t -92.17 138.08 24.61 Favored Pre-proline 0 CA--C 1.561 1.371 0 C-N-CA 124.136 0.975 . . . . 73.11 110.646 -174.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 224' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -86.22 164.19 9.86 Favored 'Trans proline' 0 C--N 1.387 2.6 0 C-N-CA 123.377 2.718 . . . . 73.11 112.103 173.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.07 128.48 21.87 Favored 'Trans proline' 0 C--N 1.377 2.079 0 C-N-CA 122.751 2.3 . . . . 74.4 113.705 177.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 226' ' ' ARG . . . . . 0.471 ' HA ' ' HA ' ' C' ' 205' ' ' VAL . 0.0 OUTLIER 59.43 89.09 0.07 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.814 2.045 . . . . 71.5 110.988 179.886 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 227' ' ' THR . . . . . 0.524 ' HB ' ' HB1' ' C' ' 204' ' ' ALA . 24.7 m -106.63 135.68 47.73 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 113.789 -1.551 . . . . 73.3 110.221 178.058 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 228' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -110.35 142.83 41.47 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 124.291 1.036 . . . . 74.32 110.479 -175.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -71.23 137.46 48.67 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.677 -0.86 . . . . 65.31 108.677 174.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 100.99 0.68 54.97 Favored Glycine 0 CA--C 1.521 0.411 0 CA-C-N 116.08 -0.509 . . . . 62.04 112.286 -170.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 231' ' ' ARG . . . . . 0.459 ' HD2' HG21 ' C' ' 227' ' ' THR . 86.2 mtt180 -76.08 172.4 12.85 Favored 'General case' 0 C--N 1.359 1.018 0 CA-C-N 117.115 0.458 . . . . 75.03 110.142 164.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 232' ' ' LYS . . . . . 0.657 ' HD3' ' HB3' ' C' ' 250' ' ' TYR . 4.0 ttmp? -148.07 109.4 4.35 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.394 0.616 . . . . 74.05 110.164 175.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 233' ' ' LEU . . . . . 0.603 ' O ' ' HA ' ' C' ' 250' ' ' TYR . 0.5 OUTLIER -72.14 144.75 48.5 Favored 'General case' 0 C--O 1.209 -1.075 0 C-N-CA 125.781 1.632 . . . . 74.22 109.429 -178.02 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 10.1 ptt180 -118.37 90.48 3.34 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 124.912 1.285 . . . . 72.34 110.108 173.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 235' ' ' LEU . . . . . 0.545 ' HB2' ' HB3' ' C' ' 249' ' ' LEU . 66.4 mt -77.79 116.41 18.29 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.509 0.723 . . . . 74.34 111.057 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -63.02 117.03 5.88 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.089 0.956 . . . . 73.41 112.65 -176.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 77.78 11.79 85.08 Favored Glycine 0 C--N 1.351 1.399 0 CA-C-N 115.223 -0.899 . . . . 71.42 114.688 175.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 238' ' ' LYS . . . . . 0.749 ' HA ' ' HZ3' ' C' ' 238' ' ' LYS . 0.1 OUTLIER -99.96 8.53 43.99 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.008 0.523 . . . . 75.11 111.053 178.447 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -86.44 -151.25 18.26 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 110.852 -0.899 . . . . 75.2 110.852 164.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 240' ' ' PHE . . . . . 0.534 ' CE2' HD22 ' C' ' 193' ' ' LEU . 48.3 m-85 -90.57 137.02 27.46 Favored Pre-proline 0 N--CA 1.476 0.856 0 CA-C-N 117.036 0.418 . . . . 75.14 110.65 175.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 241' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -57.39 120.98 9.25 Favored 'Trans proline' 0 C--N 1.383 2.382 0 C-N-CA 123.254 2.636 . . . . 71.53 111.353 175.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -100.28 157.77 19.48 Favored Glycine 0 C--N 1.348 1.246 0 CA-C-O 119.612 -0.549 . . . . 70.14 113.096 -173.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -65.62 -21.98 58.61 Favored 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 123.036 2.491 . . . . 71.42 113.61 -176.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -132.06 25.56 4.58 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.778 0.831 . . . . 71.42 110.57 178.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 164.25 -137.78 4.92 Favored Glycine 0 C--N 1.346 1.124 0 N-CA-C 111.549 -0.62 . . . . 63.24 111.549 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 246' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.12 163.07 39.33 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.037 0.935 . . . . 71.32 109.664 173.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -86.87 170.53 41.84 Favored Glycine 0 C--O 1.242 0.613 0 CA-C-N 116.088 -0.506 . . . . 63.23 111.986 178.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -124.32 136.42 54.09 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 107.763 -1.199 . . . . 73.54 107.763 -178.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 249' ' ' LEU . . . . . 0.545 ' HB3' ' HB2' ' C' ' 235' ' ' LEU . 19.4 tp -81.57 117.86 22.3 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.18 0.592 . . . . 74.23 109.877 -176.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 250' ' ' TYR . . . . . 0.657 ' HB3' ' HD3' ' C' ' 232' ' ' LYS . 19.4 m-30 -99.68 101.76 13.05 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 122.799 0.439 . . . . 71.43 109.915 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 251' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' C' ' 232' ' ' LYS . 2.0 mp -101.44 124.4 47.05 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 119.375 -0.345 . . . . 72.0 110.303 -175.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -70.97 109.31 5.0 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.544 -0.91 . . . . 75.41 108.544 173.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 253' ' ' VAL . . . . . . . . . . . . . 57.0 t -77.52 128.96 37.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 123.427 0.691 . . . . 73.5 111.655 -169.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 254' ' ' ARG . . . . . . . . . . . . . 20.9 mtm180 -108.64 147.26 32.13 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.125 0.97 . . . . 75.13 109.568 170.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 255' ' ' ILE . . . . . 0.432 HG21 ' HA ' ' C' ' 201' ' ' ALA . 36.5 mm -107.05 125.56 63.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 C-N-CA 124.452 1.101 . . . . 75.24 108.065 171.002 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 256' ' ' THR . . . . . . . . . . . . . 60.2 p -122.94 -175.59 3.21 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.855 0.862 . . . . 70.25 111.69 -171.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 257' ' ' ILE . . . . . 0.533 ' HB ' ' HD2' ' C' ' 258' ' ' PRO . 44.9 pt -135.48 161.58 62.32 Favored Pre-proline 0 CA--C 1.571 1.756 0 C-N-CA 123.53 0.732 . . . . 75.21 111.233 -179.081 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 258' ' ' PRO . . . . . 0.533 ' HD2' ' HB ' ' C' ' 257' ' ' ILE . 61.3 Cg_endo -69.43 11.26 0.37 Allowed 'Trans proline' 0 C--N 1.395 3.021 0 C-N-CA 123.733 2.956 . . . . 74.41 116.696 -170.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 259' ' ' GLU . . . . . 0.552 ' O ' ' HD2' ' A' ' 226' ' ' ARG . 5.5 mm-40 60.85 -84.29 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.607 0.763 . . . . 72.3 109.775 -170.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.47 172.02 8.66 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.45 0.7 . . . . 73.41 110.771 175.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 261' ' ' LEU . . . . . 0.464 ' HB2' HH12 ' A' ' 226' ' ' ARG . 11.3 mt -149.47 163.33 38.08 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 121.604 0.716 . . . . 74.53 111.919 176.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 1.2 p -104.36 147.62 34.66 Favored Pre-proline 0 CA--C 1.562 1.404 0 CA-C-N 113.494 -1.685 . . . . 61.23 108.997 171.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -45.51 -48.8 11.37 Favored 'Trans proline' 0 C--N 1.39 2.758 0 C-N-CA 125.038 3.825 . . . . 74.2 115.868 -166.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -64.62 -51.2 63.91 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-O 121.303 0.573 . . . . 71.04 111.242 -173.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 11.4 mp0 -60.98 -45.53 94.4 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 114.502 -1.226 . . . . 71.03 109.44 -177.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 266' ' ' GLU . . . . . 0.423 ' HG2' ' HE3' ' C' ' 270' ' ' LYS . 42.4 tt0 -61.42 -37.44 83.5 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 114.934 -1.03 . . . . 73.1 111.076 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -63.71 -38.55 91.54 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.591 0.756 . . . . 71.12 111.52 177.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 268' ' ' LEU . . . . . . . . . . . . . 11.1 mp -62.23 -43.38 98.96 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 123.242 0.339 . . . . 70.11 110.72 172.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 92.9 m95 -58.34 -36.11 72.94 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 122.904 0.482 . . . . 63.11 111.104 174.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 270' ' ' LYS . . . . . 0.423 ' HE3' ' HG2' ' C' ' 266' ' ' GLU . 99.5 mttt -70.75 -39.35 73.32 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.543 0.737 . . . . 75.43 111.442 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.64 -38.35 89.11 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.954 0.502 . . . . 75.33 110.611 178.009 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 88.8 mt -73.49 -31.31 63.68 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.618 0.767 . . . . 74.33 110.891 176.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -66.24 -40.93 90.57 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.295 0.638 . . . . 43.22 110.021 175.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -69.3 -37.84 77.99 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.13 0.972 . . . . 63.21 110.97 178.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -62.85 -30.76 71.75 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.298 0.639 . . . . 70.04 110.43 172.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 276' ' ' TYR . . . . . 0.485 ' HB3' HD13 ' A' ' 203' ' ' ILE . 1.6 m-85 -75.25 -38.04 60.73 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.705 0.802 . . . . 75.52 111.492 173.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -69.56 -24.26 63.68 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 122.456 0.302 . . . . 65.52 110.254 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -63.45 -20.1 65.28 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.922 0.889 . . . . 72.22 112.176 173.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 279' ' ' ARG . . . . . 0.437 ' HD3' ' HA ' ' C' ' 276' ' ' TYR . 14.9 mtp-105 -75.22 -9.64 58.74 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.251 0.62 . . . . 75.11 111.8 176.098 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.151 0 CA-C-O 118.252 -0.88 . . . . 75.14 108.673 174.149 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt . . . . . 0 N--CA 1.472 0.672 0 N-CA-C 113.357 0.873 . . . . 64.14 113.357 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.512 ' HB3' HD13 ' A' ' 10' ' ' ILE . 14.3 mmmm -63.4 110.86 2.07 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.29 -1.004 . . . . 74.32 108.29 170.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -73.39 93.64 1.97 Allowed 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 107.638 -1.245 . . . . 62.43 107.638 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.432 ' CD1' ' HA ' ' A' ' 53' ' ' ALA . 62.4 m-85 -63.82 -30.13 71.26 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 114.88 -1.055 . . . . 73.34 112.291 -168.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -66.4 -44.47 82.92 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 116.215 -0.448 . . . . 73.33 109.961 173.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.47 -37.58 87.85 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.943 0.497 . . . . 70.01 111.421 178.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.512 HD13 ' HB3' ' A' ' 5' ' ' LYS . 72.9 mt -64.13 -36.22 76.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 123.452 0.701 . . . . 74.23 110.462 176.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.0 mt -81.05 -10.36 59.7 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 112.331 0.493 . . . . 73.11 112.331 173.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.02 32.4 60.71 Favored Glycine 0 C--N 1.35 1.352 0 N-CA-C 113.888 0.315 . . . . 73.42 113.888 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.4 m -126.07 155.21 73.77 Favored Pre-proline 0 N--CA 1.482 1.148 0 C-N-CA 124.346 1.058 . . . . 72.52 110.377 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.2 158.98 55.16 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 122.491 2.128 . . . . 50.12 112.335 173.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 35.3 mtm180 -82.02 64.37 6.67 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.068 0.947 . . . . 75.43 110.347 -177.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -179.7 -14.81 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.257 1.423 . . . . 71.2 109.032 -175.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.52 131.15 29.1 Favored 'General case' 0 C--N 1.36 1.061 0 C-N-CA 123.604 0.762 . . . . 74.14 111.325 176.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 58.1 p -63.37 164.6 8.85 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 123.867 0.729 . . . . 75.03 111.148 -175.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 47.6 tp60 -61.32 -27.39 68.45 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.376 0.671 . . . . 71.11 111.538 -176.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -67.97 -46.29 71.78 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.47 -0.786 . . . . 72.43 109.771 175.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -67.24 -35.96 80.65 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.209 0.604 . . . . 71.14 111.012 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.423 HG23 ' HB3' ' A' ' 57' ' ' LEU . 70.9 mt -66.06 -47.13 86.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.361 1.064 . . . . 73.31 110.586 178.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 51.4 tttt -55.65 -48.43 75.02 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.597 1.159 . . . . 75.22 110.533 173.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 63.9 mtt180 -75.94 -15.97 60.08 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 115.805 -0.634 . . . . 73.12 111.763 -177.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -77.26 -40.13 45.8 Favored 'General case' 0 C--O 1.251 1.17 0 C-N-CA 123.356 0.663 . . . . 72.43 110.262 173.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.515 ' HD1' HG23 ' A' ' 50' ' ' ILE . 64.6 t80 -55.45 -56.79 16.09 Favored 'General case' 0 C--N 1.352 0.702 0 CA-C-N 114.83 -1.077 . . . . 73.1 108.984 169.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.426 ' O ' ' HG3' ' A' ' 31' ' ' ARG . 55.5 mtpt -60.7 -38.98 86.84 Favored 'General case' 0 N--CA 1.483 1.208 0 O-C-N 124.248 0.967 . . . . 74.22 111.701 -177.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 45.6 ttt180 -52.04 -60.23 3.44 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 125.122 1.369 . . . . 75.52 110.913 175.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 95.9 mt -79.22 -13.5 59.65 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 114.876 -1.056 . . . . 75.12 111.314 -178.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.89 -14.72 46.93 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.309 0.643 . . . . 71.54 110.934 175.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.426 ' HG3' ' O ' ' A' ' 27' ' ' LYS . 82.7 mtm180 -89.63 -39.55 13.16 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.248 0.619 . . . . 72.33 109.734 168.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -67.28 -59.73 3.18 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.272 0.558 . . . . 73.31 111.447 178.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.678 ' HD2' HD11 ' A' ' 50' ' ' ILE . 21.3 m-85 -91.0 25.83 2.31 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.958 0.903 . . . . 72.41 110.718 -178.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 40.1 t60 -62.61 108.57 1.73 Allowed Pre-proline 0 C--N 1.358 0.955 0 CA-C-O 118.439 -0.791 . . . . 73.54 110.215 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.462 ' HB3' ' HG2' ' A' ' 44' ' ' GLU . 16.5 Cg_endo -53.64 -40.17 80.41 Favored 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 123.281 2.654 . . . . 75.51 113.447 -167.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -60.65 -40.7 93.01 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.553 0.741 . . . . 73.23 112.551 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 64.8 t -89.8 -30.08 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 CA-C-O 121.184 0.516 . . . . 73.25 110.28 -175.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 53.6 t-20 -108.44 97.29 6.98 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 124.397 1.079 . . . . 64.12 108.845 -172.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -81.1 71.11 8.07 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.618 0.767 . . . . 73.11 109.795 -177.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 62.2 m -152.07 112.55 2.88 Favored Pre-proline 0 N--CA 1.476 0.86 0 C-N-CA 123.88 0.872 . . . . 71.24 109.156 178.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -51.31 -36.02 55.76 Favored 'Trans proline' 0 C--N 1.388 2.633 0 C-N-CA 123.347 2.698 . . . . 73.53 111.662 176.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -47.34 -51.15 20.3 Favored 'General case' 0 C--N 1.35 0.596 0 C-N-CA 124.993 1.317 . . . . 64.43 111.339 174.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.79 -20.05 61.23 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.004 -0.998 . . . . 73.42 111.307 -175.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.462 ' HG2' ' HB3' ' A' ' 35' ' ' PRO . 40.4 mt-10 -86.03 -33.34 21.05 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.594 0.758 . . . . 63.35 110.777 -177.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -70.62 -42.7 70.57 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.831 -0.803 . . . . 62.44 108.831 174.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.523 ' O ' HG13 ' A' ' 50' ' ' ILE . 13.2 mptt -65.55 -32.87 74.7 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 114.76 -1.109 . . . . 74.03 110.685 171.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.667 ' HA ' HD13 ' A' ' 50' ' ' ILE . 86.9 t80 -62.86 -40.3 97.06 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.402 0.681 . . . . 73.32 110.453 175.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.475 ' HB3' ' HE1' ' A' ' 93' ' ' PHE . 48.2 mtmt -69.11 -33.43 73.48 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.929 -0.578 . . . . 75.14 110.799 176.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -65.37 -30.79 71.66 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-N 117.734 0.243 . . . . 71.44 111.577 172.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.678 HD11 ' HD2' ' A' ' 33' ' ' TYR . 31.1 mt -65.18 -43.48 95.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 109.012 -0.736 . . . . 74.43 109.012 172.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.443 ' HB3' ' HD1' ' A' ' 88' ' ' PHE . 43.7 m-80 -69.11 -21.53 64.03 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 115.282 -0.872 . . . . 73.43 111.716 175.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -73.37 -51.79 16.11 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-O 122.244 1.021 . . . . 75.34 108.974 175.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.432 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . . . -57.24 -41.75 80.15 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 113.35 -1.75 . . . . 65.45 111.032 175.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.426 ' O ' ' HB2' ' A' ' 58' ' ' SER . 13.0 t80 -79.15 -22.93 44.38 Favored 'General case' 0 C--O 1.212 -0.887 0 CA-C-N 114.887 -1.051 . . . . 73.53 110.279 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.93 -26.54 65.13 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.815 -0.553 . . . . 72.52 110.789 173.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.566 HG22 ' HE1' ' A' ' 101' ' ' PHE . 20.6 t -95.68 -23.12 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 115.8 -0.636 . . . . 74.52 111.778 173.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.474 HD22 ' HG2' ' A' ' 63' ' ' ARG . 62.3 mt -123.72 26.07 7.86 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.575 -0.703 . . . . 74.35 112.292 -174.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.426 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 16.5 t -66.24 -48.24 71.17 Favored 'General case' 0 N--CA 1.502 2.16 0 CA-C-O 121.45 0.643 . . . . 74.34 111.801 176.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -110.28 154.32 42.94 Favored Pre-proline 0 N--CA 1.475 0.798 0 CA-C-N 114.697 -1.138 . . . . 74.34 109.109 -176.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.12 -28.26 83.07 Favored 'Trans proline' 0 C--N 1.382 2.333 0 C-N-CA 122.637 2.225 . . . . 72.41 111.818 173.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -70.68 -53.73 14.59 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.269 1.028 . . . . 72.3 111.534 -179.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -58.48 -40.15 81.93 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 121.692 0.758 . . . . 74.54 110.475 175.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.474 ' HG2' HD22 ' A' ' 57' ' ' LEU . 4.5 tmt_? -58.39 -42.19 86.55 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 113.92 -1.491 . . . . 74.11 109.762 178.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -72.19 -27.28 62.46 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 118.601 -0.714 . . . . 74.25 112.721 175.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 78.9 mt -62.66 -45.97 97.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 CA-C-N 118.754 0.706 . . . . 74.41 109.456 174.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -64.87 -45.39 86.22 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 115.688 -0.687 . . . . 75.4 110.503 176.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -54.61 -42.8 71.58 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 122.892 0.477 . . . . 64.04 111.194 176.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 80.8 p -82.28 -12.68 57.88 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 118.889 -0.577 . . . . 75.44 111.58 -178.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -65.72 120.46 13.03 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 108.305 -0.998 . . . . 75.32 108.305 172.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 109.14 8.3 27.58 Favored Glycine 0 C--N 1.344 1.021 0 CA-C-N 115.948 -0.569 . . . . 64.23 111.929 -164.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 85.9 m -147.27 -57.94 0.26 Allowed 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 103.862 -2.644 . . . . 71.23 103.862 176.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 27.1 m -71.37 123.83 23.2 Favored 'General case' 0 C--O 1.246 0.874 0 N-CA-C 103.402 -2.814 . . . . 74.23 103.402 154.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.32 -35.0 6.19 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 117.934 0.334 . . . . 74.04 110.628 -178.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.35 138.91 74.88 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 123.232 0.613 . . . . 75.1 109.832 173.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -57.0 149.9 59.27 Favored 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 122.769 2.312 . . . . 75.41 110.994 171.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -57.3 136.18 74.7 Favored 'Trans proline' 0 CA--C 1.564 1.984 0 C-N-CA 122.695 2.263 . . . . 74.25 112.249 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.43 123.24 13.32 Favored 'Trans proline' 0 C--N 1.386 2.538 0 C-N-CA 123.668 2.912 . . . . 73.45 113.916 -173.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -67.39 120.15 7.19 Favored 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 122.766 2.311 . . . . 73.2 112.842 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -78.97 167.12 22.46 Favored 'Trans proline' 0 C--N 1.378 2.108 0 C-N-CA 122.826 2.351 . . . . 71.05 111.621 173.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.24 82.89 0.05 OUTLIER 'Trans proline' 0 C--N 1.388 2.605 0 C-N-CA 123.415 2.743 . . . . 74.31 112.131 175.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 147.37 -44.8 0.79 Allowed Glycine 0 C--N 1.337 0.637 0 CA-C-N 114.74 -1.118 . . . . 62.41 110.331 -176.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.414 ' HA3' ' HA ' ' A' ' 106' ' ' PHE . . . 104.39 -160.52 15.73 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 116.478 0.139 . . . . 53.03 113.134 -176.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -106.77 128.68 54.44 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.993 0.917 . . . . 74.41 111.486 -175.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.434 ' HA ' ' HD2' ' A' ' 106' ' ' PHE . 13.2 t70 -70.14 144.58 51.98 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.017 1.327 . . . . 71.31 112.811 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.589 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 54.0 m-85 -136.54 72.18 1.43 Allowed 'General case' 0 C--N 1.358 0.977 0 CA-C-O 121.998 0.904 . . . . 73.24 111.453 -178.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 51.3 m -52.93 105.59 0.13 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 113.398 -1.728 . . . . 74.44 113.314 177.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.639 ' H ' ' HA3' ' A' ' 163' ' ' GLY . . . 67.9 2.3 23.02 Favored Glycine 0 C--N 1.343 0.938 0 C-N-CA 123.187 0.423 . . . . 70.11 113.976 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.589 ' HB2' ' HB3' ' A' ' 85' ' ' PHE . 19.0 m-85 -95.78 121.77 37.86 Favored 'General case' 0 C--N 1.349 0.569 0 N-CA-C 108.948 -0.76 . . . . 72.34 108.948 -174.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -82.85 60.06 5.16 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 122.119 0.962 . . . . 71.44 109.899 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.499 ' HA ' ' CD2' ' A' ' 93' ' ' PHE . 1.3 p -47.97 -38.69 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 126.532 1.933 . . . . 75.21 113.531 -179.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -55.61 -31.66 62.45 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 124.048 0.939 . . . . 75.33 112.236 -178.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -108.7 0.64 20.66 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.39 0.676 . . . . 61.35 112.111 -176.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.499 ' CD2' ' HA ' ' A' ' 90' ' ' VAL . 20.9 m-30 -72.05 178.97 3.48 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.907 -0.495 . . . . 73.34 110.697 177.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 77.5 p -58.94 155.72 12.84 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.637 0.775 . . . . 74.5 113.007 -173.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.46 ' O ' ' HG3' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -58.85 -41.67 87.52 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.165 -0.925 . . . . 74.52 110.631 173.381 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -57.92 -44.18 86.68 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.79 0.436 . . . . 75.03 111.286 175.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -59.92 -44.39 94.34 Favored 'General case' 0 C--O 1.244 0.805 0 CA-C-O 121.424 0.631 . . . . 72.32 109.814 177.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -75.44 -2.6 29.45 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 114.314 -1.312 . . . . 74.14 111.753 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.46 ' HG3' ' O ' ' A' ' 95' ' ' GLU . 48.8 mt-10 -93.88 -47.61 6.66 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 123.011 0.525 . . . . 70.02 110.949 163.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 48.8 tp -63.45 -32.16 73.52 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.54 1.136 . . . . 74.33 111.679 -171.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.566 ' HE1' HG22 ' A' ' 56' ' ' VAL . 93.7 m-85 -120.13 9.24 11.08 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.979 0.512 . . . . 72.11 110.477 173.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.42 ' HA2' ' HG ' ' A' ' 105' ' ' LEU . . . -48.47 -62.2 4.56 Favored Glycine 0 C--N 1.352 1.458 0 C-N-CA 124.702 1.144 . . . . 72.43 115.894 -172.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -56.63 -17.34 22.14 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 123.366 2.711 . . . . 64.43 113.474 178.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -129.57 43.22 1.33 Allowed Glycine 0 C--N 1.35 1.329 0 CA-C-O 119.679 -0.512 . . . . 54.4 112.287 178.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.469 HD22 HG23 ' A' ' 90' ' ' VAL . 33.7 mt -78.95 56.98 2.06 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 117.855 0.827 . . . . 74.25 111.065 170.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.658 ' HB3' ' HA ' ' A' ' 169' ' ' ASN . 0.2 OUTLIER 35.05 -108.55 0.04 OUTLIER 'General case' 0 CA--C 1.568 1.651 0 C-N-CA 126.29 1.836 . . . . 74.45 112.565 178.215 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 72.06 12.2 75.34 Favored Glycine 0 C--N 1.357 1.701 0 CA-C-N 118.485 0.584 . . . . 44.0 112.722 -173.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.599 ' H ' ' HD1' ' A' ' 106' ' ' PHE . . . . . . . . 0 C--N 1.342 0.865 0 C-N-CA 124.058 0.837 . . . . 71.34 113.446 -178.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.446 ' HG3' ' O ' ' A' ' 170' ' ' PRO . 87.1 tttt . . . . . 0 N--CA 1.493 1.676 0 N-CA-C 112.789 0.663 . . . . 73.31 112.789 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -81.31 171.94 53.55 Favored Glycine 0 C--N 1.345 1.05 0 CA-C-N 115.438 -0.801 . . . . 73.4 113.371 174.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.8 tmm_? -87.19 140.43 29.55 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 108.568 -0.901 . . . . 74.43 108.568 176.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -53.68 116.9 2.74 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.949 0.9 . . . . 74.23 111.383 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.0 tt -109.86 140.99 43.18 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 121.833 -0.542 . . . . 75.42 109.953 -167.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 29.6 ttt-85 -99.01 107.52 19.97 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.992 0.917 . . . . 74.51 108.755 -178.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.413 ' HB1' HD12 ' A' ' 174' ' ' LEU . . . -111.14 165.14 12.15 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.275 0.63 . . . . 54.41 109.425 178.065 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.438 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 19.4 mm-40 -123.78 111.41 16.1 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 107.49 -1.3 . . . . 72.42 107.49 -174.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.416 ' O ' ' HA ' ' A' ' 178' ' ' VAL . 60.0 tp -99.71 96.66 4.85 Favored Pre-proline 0 N--CA 1.487 1.398 0 CA-C-N 118.869 0.759 . . . . 74.14 109.55 -172.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.438 ' HD3' ' O ' ' A' ' 122' ' ' GLU . 39.3 Cg_endo -74.92 112.19 3.5 Favored 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 121.189 1.259 . . . . 75.33 110.067 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.627 ' HA ' HG23 ' B' ' 6' ' ' ILE . 38.2 tp -117.26 141.71 47.96 Favored 'General case' 0 C--N 1.338 0.08 0 C-N-CA 123.856 0.863 . . . . 72.43 110.113 -169.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.408 ' HB ' ' HG2' ' A' ' 129' ' ' GLU . 27.0 m -74.78 130.17 38.98 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.177 0.991 . . . . 71.34 110.199 178.298 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 64.9 mt -53.84 -52.87 58.99 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.225 1.01 . . . . 75.21 111.852 -177.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.439 ' HA ' ' HB3' ' A' ' 215' ' ' LEU . 5.7 mp0 -58.83 -38.17 78.06 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.938 0.895 . . . . 75.32 110.377 -176.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.415 ' HB3' ' CZ ' ' A' ' 136' ' ' ARG . 16.0 mm-40 -74.95 -28.4 60.56 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 114.925 -1.034 . . . . 64.33 110.837 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -68.79 -35.64 77.29 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.969 0.508 . . . . 65.44 111.182 176.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.414 ' HB2' HD12 ' A' ' 215' ' ' LEU . 77.6 t80 -67.19 -49.56 64.18 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 123.481 0.488 . . . . 74.51 110.815 173.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 34.6 m170 -70.35 -36.49 74.23 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 123.526 0.516 . . . . 75.25 111.789 -175.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.452 ' HA3' ' HG3' ' A' ' 151' ' ' PRO . . . 72.7 -171.37 50.13 Favored Glycine 0 CA--C 1.528 0.889 0 O-C-N 123.451 0.469 . . . . 71.54 113.574 -176.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.15 172.95 25.25 Favored Glycine 0 N--CA 1.476 1.347 0 C-N-CA 122.704 0.193 . . . . 70.42 112.788 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.42 ' HG3' ' HB2' ' A' ' 148' ' ' ARG . 1.8 mp0 -71.68 108.82 5.21 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.362 0.665 . . . . 73.14 111.112 -174.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.415 ' CZ ' ' HB3' ' A' ' 129' ' ' GLU . 6.5 tpp180 -92.84 122.11 34.89 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 108.628 -0.878 . . . . 75.05 108.628 -177.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 94.6 t -78.39 96.71 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 109.237 -0.653 . . . . 75.04 109.237 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.579 ' HB ' HG13 ' B' ' 6' ' ' ILE . 0.2 OUTLIER -112.27 118.37 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 108.294 -1.002 . . . . 73.34 108.294 176.388 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 144' ' ' ARG . 30.5 mt-10 -101.29 133.99 45.04 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.092 0.557 . . . . 71.3 111.152 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.472 HG12 HD21 ' B' ' 8' ' ' LEU . 15.0 p -170.64 139.08 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.039 0 O-C-N 123.628 0.58 . . . . 75.1 111.613 -178.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 55.43 26.28 8.67 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 115.696 1.739 . . . . 74.24 115.696 163.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 98.22 10.15 52.08 Favored Glycine 0 N--CA 1.476 1.301 0 C-N-CA 121.694 -0.289 . . . . 54.15 113.02 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 34.0 ttm105 -144.07 106.58 4.42 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 123.343 0.657 . . . . 72.43 110.958 -171.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 139' ' ' GLU . 32.4 ttm180 -78.48 93.57 4.79 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 107.173 -1.418 . . . . 74.41 107.173 162.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 1.5 p -84.83 107.82 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 108.306 -0.998 . . . . 73.53 108.306 175.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 26.9 t -84.53 83.03 8.15 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 107.586 -1.265 . . . . 64.43 107.586 172.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.6 p -87.86 109.65 19.87 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 CA-C-O 121.422 0.629 . . . . 73.42 110.343 -173.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.42 ' HB2' ' HG3' ' A' ' 135' ' ' GLU . 20.3 ttm180 -57.47 93.42 0.01 OUTLIER 'General case' 0 C--O 1.24 0.565 0 CA-C-N 115.232 -0.895 . . . . 74.32 108.924 166.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.635 ' HB ' HG13 ' A' ' 153' ' ' VAL . 28.8 pt -72.88 118.64 70.01 Favored Pre-proline 0 CA--C 1.547 0.85 0 CA-C-N 114.068 -1.424 . . . . 74.52 108.192 173.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -63.52 128.69 23.02 Favored 'Trans proline' 0 C--N 1.368 1.578 0 C-N-CA 122.248 1.965 . . . . 74.22 110.723 177.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.452 ' HG3' ' HA3' ' A' ' 133' ' ' GLY . 52.1 Cg_exo -53.36 100.37 0.06 OUTLIER 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 122.579 2.186 . . . . 74.15 111.272 177.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.422 ' HA2' ' CD2' ' A' ' 240' ' ' PHE . . . 116.75 36.44 1.06 Allowed Glycine 0 C--N 1.342 0.914 0 CA-C-N 115.532 -0.758 . . . . 75.51 112.647 -173.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.635 HG13 ' HB ' ' A' ' 149' ' ' ILE . 2.1 p -91.66 132.8 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 123.843 0.857 . . . . 75.43 108.737 176.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.402 ' HB3' ' HA ' ' A' ' 189' ' ' GLU . 0.1 OUTLIER -101.97 168.1 9.62 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.983 0.913 . . . . 73.23 113.047 -161.09 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.57 ' HB3' ' O ' ' A' ' 188' ' ' LEU . 9.0 tp10 -68.37 127.1 31.75 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 108.747 -0.835 . . . . 72.32 108.747 167.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 73.07 14.59 78.81 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-N 115.378 -0.828 . . . . 74.33 113.362 -174.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 46.5 t -66.34 109.76 2.82 Favored 'General case' 0 C--N 1.359 0.999 0 N-CA-C 107.721 -1.214 . . . . 74.23 107.721 171.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.451 HG11 ' HB3' ' A' ' 175' ' ' LEU . 58.6 t -84.86 87.13 2.37 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 N-CA-C 108.59 -0.893 . . . . 74.02 108.59 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.634 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 54.6 mt -74.01 91.89 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.642 0 N-CA-C 107.763 -1.199 . . . . 75.24 107.763 174.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -74.87 105.25 5.82 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 115.566 -0.743 . . . . 75.21 109.528 179.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 4.3 p -115.05 110.36 45.97 Favored Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 123.68 0.792 . . . . 71.41 108.94 173.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.467 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 46.5 Cg_endo -66.61 153.8 76.69 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 122.698 2.265 . . . . 74.53 111.684 177.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . 0.639 ' HA3' ' H ' ' A' ' 87' ' ' GLY . . . 76.93 15.9 81.25 Favored Glycine 0 C--N 1.34 0.756 0 CA-C-N 115.827 -0.624 . . . . 70.43 113.892 178.241 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 49.2 mtt -125.46 -3.13 7.37 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 117.954 0.877 . . . . 64.15 111.465 177.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.501 ' HA2' HD13 ' A' ' 174' ' ' LEU . . . -85.15 -124.12 1.29 Allowed Glycine 0 C--N 1.343 0.956 0 N-CA-C 113.739 0.256 . . . . 73.33 113.739 -168.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -65.13 164.54 36.36 Favored Glycine 0 C--N 1.348 1.225 0 O-C-N 123.97 0.453 . . . . 74.5 113.422 -176.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.404 ' HB3' ' CA ' ' A' ' 108' ' ' GLY . 29.3 mm-40 -65.47 105.65 1.23 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.47 1.108 . . . . 75.42 111.581 -171.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -169.96 167.21 40.34 Favored Glycine 0 C--N 1.354 1.563 0 CA-C-O 118.96 -0.911 . . . . 64.21 112.124 -178.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . 0.658 ' HA ' ' HB3' ' A' ' 106' ' ' PHE . 48.3 t30 -63.74 -59.04 12.57 Favored Pre-proline 0 N--CA 1.493 1.694 0 CA-C-N 118.077 0.938 . . . . 63.54 110.752 -173.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.512 ' HD3' ' HB3' ' A' ' 169' ' ' ASN . 27.1 Cg_endo -94.64 95.13 0.11 Allowed 'Trans proline' 0 C--N 1.381 2.247 0 N-CA-C 106.181 -2.276 . . . . 73.02 106.181 156.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_exo -51.9 175.73 0.06 OUTLIER 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 123.391 2.727 . . . . 71.25 115.205 -170.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -62.72 -178.6 4.01 Favored Glycine 0 N--CA 1.474 1.229 0 CA-C-O 121.844 0.691 . . . . 72.4 114.499 -176.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.467 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 3.5 m-20 -79.9 104.76 10.7 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.441 -0.948 . . . . 71.14 108.441 171.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.501 HD13 ' HA2' ' A' ' 165' ' ' GLY . 18.2 tp -78.95 124.64 28.44 Favored 'General case' 0 C--N 1.346 0.421 0 N-CA-C 109.29 -0.633 . . . . 74.2 109.29 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.451 ' HB3' HG11 ' A' ' 158' ' ' VAL . 42.8 mt -101.28 88.88 3.59 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 106.661 -1.607 . . . . 72.12 106.661 -177.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.634 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 91.2 mt -72.66 83.18 1.15 Allowed 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 109.357 -0.608 . . . . 74.52 109.357 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.431 HG21 HG23 ' A' ' 158' ' ' VAL . 23.3 t -84.36 98.89 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 107.97 -1.122 . . . . 71.11 107.97 -176.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 98.6 t -56.58 140.46 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 N-CA-C 113.046 0.758 . . . . 74.13 113.046 -172.318 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.409 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 62.5 mmt-85 -114.52 89.92 3.21 Favored 'General case' 0 C--N 1.343 0.296 0 N-CA-C 107.463 -1.31 . . . . 73.42 107.463 163.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.402 HD21 ' HA ' ' A' ' 180' ' ' LEU . 10.7 mt -66.63 125.01 24.43 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 107.675 -1.232 . . . . 74.04 107.675 178.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 44.4 mt -51.85 152.9 4.82 Favored Pre-proline 0 N--CA 1.485 1.279 0 O-C-N 124.639 1.212 . . . . 73.22 113.628 -162.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -72.36 23.41 0.27 Allowed 'Trans proline' 0 C--N 1.382 2.321 0 C-N-CA 123.311 2.674 . . . . 74.32 113.366 178.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . 0.449 ' HA ' ' HD3' ' A' ' 184' ' ' PRO . 59.7 t-80 -59.84 105.49 0.57 Allowed Pre-proline 0 CA--C 1.556 1.179 0 N-CA-C 106.399 -1.704 . . . . 73.35 106.399 164.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 183' ' ' HIS . 13.7 Cg_exo -69.2 25.31 0.16 Allowed 'Trans proline' 0 C--N 1.375 1.921 0 C-N-CA 124.049 3.166 . . . . 61.24 117.534 -161.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 87.5 t -97.02 -58.92 3.49 Favored 'Isoleucine or valine' 0 C--N 1.35 0.623 0 CA-C-N 119.524 1.056 . . . . 72.34 110.422 -175.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . 0.416 ' HB3' HD23 ' A' ' 193' ' ' LEU . 46.7 m-85 -121.51 121.4 37.41 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 118.373 0.533 . . . . 72.31 112.22 -174.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.57 92.15 4.99 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 107.215 -1.402 . . . . 75.51 107.215 165.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.57 ' O ' ' HB3' ' A' ' 155' ' ' GLU . 53.7 tp -87.91 139.97 29.97 Favored 'General case' 0 C--O 1.207 -1.157 0 C-N-CA 123.769 0.828 . . . . 74.21 109.855 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . 0.402 ' HA ' ' HB3' ' A' ' 154' ' ' ARG . 40.0 tt0 -162.22 125.47 3.0 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 118.482 0.583 . . . . 70.31 110.003 177.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 73.59 -65.37 1.74 Allowed Glycine 0 C--N 1.356 1.691 0 O-C-N 123.586 0.554 . . . . 65.41 112.223 -173.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.41 ' HB3' ' HA3' ' A' ' 242' ' ' GLY . 4.3 pm0 -164.45 -19.42 0.03 OUTLIER 'General case' 0 C--O 1.249 1.037 0 C-N-CA 125.694 1.598 . . . . 72.32 109.104 177.073 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -94.65 134.81 36.83 Favored 'General case' 0 C--N 1.358 0.968 0 C-N-CA 123.908 0.883 . . . . 72.32 112.005 -169.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.552 ' HB2' ' HA ' ' A' ' 249' ' ' LEU . 66.8 mt -95.91 150.12 20.79 Favored 'General case' 0 C--O 1.22 -0.463 0 C-N-CA 125.788 1.635 . . . . 74.25 110.368 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -133.74 105.27 6.72 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 106.944 -1.502 . . . . 73.14 106.944 169.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.481 ' HB2' HD22 ' A' ' 251' ' ' LEU . . . -118.6 119.33 34.16 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.658 1.183 . . . . 74.34 109.906 -172.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 31.8 m -69.83 129.41 39.47 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 123.358 0.411 . . . . 70.21 109.912 -175.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 54.6 tp -128.79 99.99 5.53 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 109.001 -0.74 . . . . 74.1 109.001 -170.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -80.21 121.43 25.6 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.955 -0.757 . . . . 63.3 108.955 176.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 6.3 p -138.68 135.58 18.02 Favored Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 124.714 1.206 . . . . 74.33 108.374 -175.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -74.12 152.73 45.86 Favored 'Trans proline' 0 C--N 1.368 1.553 0 C-N-CA 121.923 1.748 . . . . 70.05 111.081 173.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -53.35 -50.57 82.0 Favored Pre-proline 0 CA--C 1.553 1.07 0 N-CA-C 113.93 1.085 . . . . 71.34 113.93 -173.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -55.52 -46.25 33.58 Favored 'Trans proline' 0 C--N 1.38 2.19 0 C-N-CA 121.902 1.735 . . . . 73.32 113.581 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 19.6 mt -70.32 -32.32 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 CA-C-N 116.141 -0.481 . . . . 71.02 110.927 -176.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.89 -42.4 85.58 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.004 0.522 . . . . 74.14 111.301 175.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.404 ' CG1' HD13 ' C' ' 261' ' ' LEU . 53.9 t -73.17 -40.85 58.43 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.037 0 C-N-CA 124.082 0.953 . . . . 64.22 112.577 -174.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 65.0 t -95.58 -34.77 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 122.614 0.366 . . . . 74.41 111.694 -175.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 93.42 108.84 1.94 Allowed Glycine 0 C--N 1.335 0.508 0 CA-C-N 116.354 -0.384 . . . . 72.35 112.166 -178.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -141.45 -161.94 8.93 Favored Glycine 0 N--CA 1.469 0.841 0 N-CA-C 110.741 -0.943 . . . . 73.32 110.741 177.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 44.5 mtmt -100.43 124.11 45.52 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 118.426 1.113 . . . . 73.34 110.814 176.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 31.4 m -108.89 166.07 4.75 Favored 'Isoleucine or valine' 0 C--O 1.247 0.924 0 C-N-CA 125.014 1.326 . . . . 63.11 108.973 170.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . 0.634 HH21 ' HA ' ' A' ' 220' ' ' GLU . 0.0 OUTLIER -95.16 117.41 30.18 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.022 -0.733 . . . . 74.32 109.022 174.501 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -119.71 130.97 55.27 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 107.481 -1.303 . . . . 74.41 107.481 172.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' MET . . . . . 0.593 ' HA ' ' HA ' ' A' ' 218' ' ' PRO . 0.8 OUTLIER -80.27 148.62 30.69 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 122.46 0.304 . . . . 74.15 110.505 -176.497 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 71.5 p -117.67 -177.81 3.33 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 108.808 -0.812 . . . . 74.1 108.808 168.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . 0.439 ' HB3' ' HA ' ' A' ' 128' ' ' GLU . 86.0 mt -76.89 -1.98 31.23 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.642 -0.708 . . . . 73.14 112.098 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -126.89 -2.17 6.56 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.145 0.578 . . . . 64.44 111.805 177.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 149.17 167.31 13.82 Favored Glycine 0 N--CA 1.481 1.635 0 N-CA-C 114.626 0.61 . . . . 63.05 114.626 173.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . 0.593 ' HA ' ' HA ' ' A' ' 213' ' ' MET . 2.7 Cg_exo -76.19 116.59 4.4 Favored 'Trans proline' 0 C--N 1.374 1.888 0 C-N-CA 123.662 2.908 . . . . 74.13 111.968 -177.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 34.7 m -106.42 162.29 5.32 Favored 'Isoleucine or valine' 0 C--O 1.254 1.317 0 C-N-CA 123.98 0.912 . . . . 73.4 112.03 -172.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.634 ' HA ' HH21 ' A' ' 211' ' ' ARG . 29.4 mt-10 -86.49 103.12 14.72 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 114.213 -1.358 . . . . 75.04 109.889 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 39.7 t -106.93 116.9 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.172 0.589 . . . . 74.51 109.48 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -77.88 99.36 5.95 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 109.255 -0.646 . . . . 70.4 109.255 174.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 14.3 p -64.9 134.0 95.93 Favored Pre-proline 0 CA--C 1.559 1.326 0 N-CA-C 109.491 -0.559 . . . . 71.22 109.491 177.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -61.44 168.71 7.64 Favored 'Trans proline' 0 C--N 1.38 2.227 0 C-N-CA 122.735 2.29 . . . . 75.51 112.654 176.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.77 150.96 31.34 Favored 'Trans proline' 0 C--N 1.374 1.904 0 C-N-CA 121.624 1.549 . . . . 72.53 112.474 172.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 45.3 mtt-85 66.29 27.34 10.17 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 125.692 1.597 . . . . 75.13 110.963 169.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.547 HG21 HD22 ' A' ' 233' ' ' LEU . 80.6 m -63.59 104.87 0.7 Allowed 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 113.06 -1.882 . . . . 64.32 110.843 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -85.14 139.83 31.4 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 123.945 0.898 . . . . 75.32 110.647 -176.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -62.24 157.4 19.59 Favored 'General case' 0 C--N 1.356 0.863 0 C-N-CA 124.152 0.981 . . . . 65.12 111.082 177.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 81.1 -38.74 2.41 Favored Glycine 0 C--N 1.346 1.088 0 CA-C-N 116.637 -0.256 . . . . 75.54 112.606 177.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -69.07 166.94 17.06 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 123.686 0.794 . . . . 74.44 110.26 173.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.7 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 2.7 mptp? -124.85 131.87 53.39 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 115.13 -0.941 . . . . 72.22 108.772 -178.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.547 HD22 HG21 ' A' ' 227' ' ' THR . 59.4 mt -76.62 97.54 4.44 Favored 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 107.903 -1.147 . . . . 71.4 107.903 176.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . 0.408 ' HG3' ' HB3' ' A' ' 248' ' ' ASP . 40.7 ttp180 -78.73 103.52 8.73 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 123.599 0.562 . . . . 73.41 109.737 -176.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.466 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 10.7 mt -100.04 89.33 4.0 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.217 -1.031 . . . . 74.24 108.217 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -71.0 139.08 50.42 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.751 0.42 . . . . 71.01 110.977 -173.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 79.32 2.6 87.76 Favored Glycine 0 CA--C 1.536 1.346 0 O-C-N 123.533 0.521 . . . . 74.2 113.271 -174.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.496 ' HA ' ' HE3' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -105.83 -16.45 14.66 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 117.47 0.635 . . . . 74.1 111.73 -179.395 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -72.32 -163.29 6.63 Favored Glycine 0 CA--C 1.534 1.238 0 O-C-N 123.412 0.445 . . . . 74.43 112.87 173.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . 0.422 ' CD2' ' HA2' ' A' ' 152' ' ' GLY . 58.6 m-85 -95.01 166.26 15.29 Favored Pre-proline 0 N--CA 1.485 1.284 0 CA-C-O 118.282 -0.866 . . . . 73.41 109.869 -177.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' ' 240' ' ' PHE . 10.2 Cg_endo -49.69 146.26 15.86 Favored 'Trans proline' 0 C--N 1.392 2.868 0 C-N-CA 123.399 2.733 . . . . 73.33 113.943 -177.062 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.41 ' HA3' ' HB3' ' A' ' 191' ' ' GLN . . . -168.65 -158.68 12.91 Favored Glycine 0 C--N 1.338 0.657 0 CA-C-N 114.928 -1.033 . . . . 73.52 112.002 -178.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -78.46 -5.52 14.95 Favored 'Trans proline' 0 C--N 1.369 1.626 0 C-N-CA 123.284 2.656 . . . . 72.5 112.749 -173.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -113.51 22.0 14.57 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.003 0.921 . . . . 70.11 110.309 177.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 90.84 -75.28 1.63 Allowed Glycine 0 C--N 1.345 1.031 0 N-CA-C 109.996 -1.241 . . . . 62.24 109.996 -174.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 73.9 mtp180 -119.94 175.29 5.98 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.994 0.918 . . . . 75.41 109.279 168.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -105.58 -161.03 23.14 Favored Glycine 0 C--N 1.341 0.85 0 CA-C-N 115.988 -0.551 . . . . 70.31 114.306 -177.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . 0.408 ' HB3' ' HG3' ' A' ' 234' ' ' ARG . 19.3 m-20 -110.7 134.75 52.18 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 124.032 0.933 . . . . 75.44 108.813 -174.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.552 ' HA ' ' HB2' ' A' ' 193' ' ' LEU . 12.3 tp -98.95 95.51 7.21 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.0 -1.111 . . . . 73.32 108.0 176.21 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.7 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 84.4 m-85 -82.27 108.28 15.6 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 109.523 -0.547 . . . . 71.3 109.523 178.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.517 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 86.7 mt -86.8 105.7 17.19 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 109.298 -0.63 . . . . 74.54 109.298 172.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -76.54 106.99 8.5 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.358 0.663 . . . . 75.41 109.504 -174.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 23.9 t -69.27 127.93 31.91 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 124.252 1.021 . . . . 71.34 112.089 -170.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -127.5 93.93 3.85 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 107.365 -1.346 . . . . 73.14 107.365 178.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.408 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 69.6 mt -83.25 136.11 23.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 C-N-CA 122.641 0.377 . . . . 74.34 110.762 -177.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 22.5 p -124.93 169.57 11.95 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.594 1.157 . . . . 74.52 109.497 172.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . 0.468 HD12 ' H ' ' A' ' 259' ' ' GLU . 2.3 pp -109.58 141.18 23.07 Favored Pre-proline 0 N--CA 1.484 1.25 0 C-N-CA 122.928 0.491 . . . . 73.4 109.92 178.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 258' ' ' PRO . . . . . 0.531 ' HB3' ' HE1' ' C' ' 276' ' ' TYR . 12.7 Cg_endo -52.53 -20.95 13.03 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 124.598 3.532 . . . . 74.45 115.615 -170.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . 0.468 ' H ' HD12 ' A' ' 257' ' ' ILE . 23.2 mt-10 50.85 -78.93 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.561 1.144 . . . . 75.12 110.576 -160.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.59 129.34 16.26 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.271 1.029 . . . . 75.12 111.713 176.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.416 HD22 ' HB3' ' A' ' 265' ' ' GLU . 89.1 mt -154.99 144.85 21.6 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.555 1.142 . . . . 72.32 109.096 -179.073 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 64.2 p -93.86 156.72 39.06 Favored Pre-proline 0 CA--C 1.555 1.151 0 CA-C-O 118.06 -0.971 . . . . 74.31 109.101 171.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -34.98 -48.07 0.69 Allowed 'Trans proline' 0 C--N 1.388 2.639 0 C-N-CA 124.843 3.695 . . . . 74.33 116.532 -177.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -68.46 -49.47 59.6 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.05 0.54 . . . . 71.44 111.406 -178.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . 0.416 ' HB3' HD22 ' A' ' 261' ' ' LEU . 49.9 mt-10 -56.95 -43.77 81.91 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.077 0.551 . . . . 73.22 110.344 178.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -57.12 -45.81 83.18 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 114.483 -1.235 . . . . 73.45 110.513 177.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -60.93 -41.67 96.65 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.162 -0.926 . . . . 64.12 111.685 178.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . 0.402 ' HG ' ' HG ' ' C' ' 268' ' ' LEU . 9.7 mp -64.78 -48.53 74.17 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.296 0.638 . . . . 73.14 111.193 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 68.5 m95 -57.86 -45.58 86.08 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.142 0.577 . . . . 75.0 111.583 178.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . 0.636 ' HE3' HG21 ' C' ' 206' ' ' VAL . 44.9 mttp -65.16 -42.95 93.22 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-N 115.536 -0.756 . . . . 73.12 111.547 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 34.4 mmtm -63.31 -42.94 99.05 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 122.88 0.472 . . . . 70.22 111.789 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 272' ' ' LEU . . . . . 0.428 ' O ' ' HB2' ' A' ' 276' ' ' TYR . 67.5 mt -54.93 -49.28 71.69 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 124.251 0.97 . . . . 71.54 109.435 172.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -70.06 -33.22 71.66 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.076 1.139 . . . . 72.23 114.076 -175.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 270' ' ' LYS . 40.6 mt-10 -65.08 -53.94 37.81 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.373 -0.973 . . . . 74.35 108.373 176.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -69.87 -20.83 63.38 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 113.567 -1.651 . . . . 72.24 112.161 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . 0.571 ' HE2' ' HB3' ' C' ' 258' ' ' PRO . 23.8 t80 -75.49 -64.07 1.15 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.188 0.995 . . . . 75.02 109.4 178.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -72.09 -23.06 61.28 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 114.799 -1.091 . . . . 72.14 111.848 -170.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -59.24 -26.99 65.37 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 112.762 0.653 . . . . 75.41 112.762 172.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -77.58 -15.14 59.42 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 116.429 -0.351 . . . . 75.15 110.497 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.131 0 C-N-CA 123.857 0.863 . . . . 72.5 109.042 175.507 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 14.6 tpt . . . . . 0 N--CA 1.479 0.979 0 N-CA-C 109.391 -0.596 . . . . 74.12 109.391 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt 59.86 33.94 21.69 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 124.568 1.147 . . . . 62.45 112.126 175.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 59.22 72.94 0.5 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.736 1.214 . . . . 74.04 109.814 -173.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 11.1 p -82.87 -17.51 43.57 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 115.029 -0.987 . . . . 52.14 111.864 -176.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 4.5 m 68.94 158.72 0.16 Allowed 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 125.234 1.413 . . . . 74.34 113.252 174.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.627 HG23 ' HA ' ' A' ' 125' ' ' LEU . 14.5 pt -138.57 175.08 8.93 Favored 'Isoleucine or valine' 0 C--N 1.364 1.199 0 C-N-CA 123.316 0.646 . . . . 65.34 111.117 -172.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -150.38 141.81 23.39 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.074 0.95 . . . . 72.22 109.017 172.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . 0.472 HD21 HG12 ' A' ' 140' ' ' VAL . 52.7 tp -75.76 143.03 42.22 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.263 1.025 . . . . 75.22 109.91 -174.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.93 -68.1 0.35 Allowed 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 109.513 -0.551 . . . . 73.12 109.513 172.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 6.6 tt 53.39 101.23 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 125.365 1.466 . . . . 74.1 110.527 -176.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 31.0 mt . . . . . 0 CA--C 1.556 1.209 0 C-N-CA 124.732 1.213 . . . . 72.11 110.769 -179.6 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.023 0 N-CA-C 109.57 -0.53 . . . . 74.35 109.57 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . 58.37 -79.24 0.02 OUTLIER 'General case' 0 C--N 1.359 1.0 0 C-N-CA 124.953 1.301 . . . . 75.32 110.472 -164.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 181' ' ' LEU . . . . . 0.451 HD21 ' HB3' ' C' ' 136' ' ' ARG . 12.8 tp -162.94 26.61 0.09 Allowed 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.699 0.762 . . . . 74.44 109.505 174.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 182' ' ' VAL . . . . . 0.482 HG13 ' HB3' ' C' ' 139' ' ' GLU . 76.7 t -83.44 147.45 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.505 1.122 . . . . 72.43 110.761 -174.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 183' ' ' ALA . . . . . 0.421 ' HB1' HD13 ' C' ' 123' ' ' LEU . . . -134.05 -13.69 2.43 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.54 0.736 . . . . 65.24 112.222 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 55.53 -138.77 1.02 Allowed 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.995 0.918 . . . . 75.32 108.836 -174.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 185' ' ' VAL . . . . . . . . . . . . . 61.0 t . . . . . 0 N--CA 1.47 0.554 0 N-CA-C 106.997 -1.483 . . . . 74.01 106.997 158.528 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 238' ' ' THR . . . . . 0.451 HG21 HG23 ' C' ' 219' ' ' VAL . 6.9 m . . . . . 0 CA--C 1.553 1.081 0 CA-C-O 121.046 0.45 . . . . 71.31 110.197 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 239' ' ' ALA . . . . . 0.625 ' HB2' ' HA ' ' C' ' 221' ' ' VAL . . . -60.79 -177.09 0.07 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.032 1.333 . . . . 74.42 114.117 -178.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . -103.21 -95.48 2.33 Favored Glycine 0 C--N 1.341 0.837 0 N-CA-C 110.32 -1.112 . . . . 71.23 110.32 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -166.07 157.12 13.29 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.506 0.723 . . . . 71.23 110.789 -179.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -170.58 -69.37 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.17 0.988 . . . . 70.32 109.971 174.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -136.74 -6.97 1.91 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.389 1.076 . . . . 74.22 110.505 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 142.74 -163.79 27.21 Favored Glycine 0 C--N 1.352 1.468 0 N-CA-C 113.472 0.149 . . . . 71.54 113.472 174.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.544 0.748 0 C-N-CA 124.322 1.049 . . . . 75.34 109.526 -174.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.783 0 N-CA-C 109.693 -0.484 . . . . 71.34 109.693 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -37.72 101.63 0.02 OUTLIER 'General case' 0 C--N 1.354 0.773 0 C-N-CA 125.765 1.626 . . . . 70.52 113.756 -176.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 5' ' ' LYS . . . . . 0.468 ' HE2' HD11 ' C' ' 10' ' ' ILE . 14.6 mmmm -73.32 98.94 2.78 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.46 -1.311 . . . . 72.32 107.46 164.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -71.15 92.78 1.01 Allowed 'General case' 0 C--O 1.234 0.258 0 N-CA-C 107.759 -1.2 . . . . 65.15 107.759 177.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 7' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -58.64 -29.96 66.94 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 114.668 -1.151 . . . . 73.43 112.17 -170.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -67.33 -48.75 66.63 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.112 -0.949 . . . . 74.23 110.002 176.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.12 -38.52 86.66 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.978 0.511 . . . . 63.34 110.941 178.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 10' ' ' ILE . . . . . 0.468 HD11 ' HE2' ' C' ' 5' ' ' LYS . 59.5 mt -61.79 -39.36 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.335 0.654 . . . . 73.31 110.185 176.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 96.0 mt -80.44 -7.47 59.16 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 112.586 0.587 . . . . 75.53 112.586 176.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.37 35.84 51.41 Favored Glycine 0 C--N 1.352 1.454 0 CA-C-N 117.917 0.326 . . . . 74.43 113.636 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 6.3 m -133.55 155.89 80.15 Favored Pre-proline 0 N--CA 1.483 1.206 0 C-N-CA 125.109 1.364 . . . . 71.34 109.576 177.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -81.98 155.42 17.49 Favored 'Trans proline' 0 C--N 1.371 1.714 0 C-N-CA 122.195 1.93 . . . . 74.43 112.306 174.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 90.1 mtm-85 -67.35 75.98 0.16 Allowed 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.747 0.819 . . . . 74.35 110.311 174.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -177.48 -31.63 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.572 1.149 . . . . 71.24 108.779 -175.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.68 134.22 56.52 Favored 'General case' 0 C--N 1.353 0.748 0 CA-C-N 115.578 -0.737 . . . . 75.2 110.401 177.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 75.0 p -71.36 173.46 7.8 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.319 0.648 . . . . 74.41 111.671 -175.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 19' ' ' GLN . . . . . 0.454 HE22 ' HE2' ' C' ' 23' ' ' LYS . 0.1 OUTLIER -60.24 -39.55 87.09 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.347 1.059 . . . . 74.45 110.376 -176.005 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 20' ' ' GLU . . . . . 0.41 ' O ' ' HG3' ' C' ' 24' ' ' ARG . 7.8 tm-20 -66.64 -34.94 78.98 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 123.148 0.579 . . . . 74.53 110.015 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -70.97 -36.95 72.73 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 122.734 0.414 . . . . 73.42 110.773 176.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 1.4 mp -63.87 -34.52 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.333 1.053 . . . . 75.54 110.078 173.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 23' ' ' LYS . . . . . 0.524 ' O ' ' HG3' ' C' ' 27' ' ' LYS . 13.7 tppt? -66.55 -45.18 80.22 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.295 0.638 . . . . 74.13 109.305 178.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 24' ' ' ARG . . . . . 0.41 ' HG3' ' O ' ' C' ' 20' ' ' GLU . 63.1 mtm-85 -63.49 -41.99 98.55 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 123.459 0.475 . . . . 73.52 110.839 178.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.95 -38.45 86.14 Favored 'General case' 0 C--O 1.253 1.251 0 CA-C-N 115.257 -0.883 . . . . 75.32 110.987 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 26' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -57.14 -55.78 30.25 Favored 'General case' 0 C--O 1.216 -0.685 0 CA-C-N 114.541 -1.208 . . . . 72.31 109.13 173.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . 0.524 ' HG3' ' O ' ' C' ' 23' ' ' LYS . 33.2 mtmt -57.39 -41.56 80.47 Favored 'General case' 0 N--CA 1.483 1.186 0 O-C-N 124.424 1.078 . . . . 75.33 110.824 -177.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -55.32 -51.45 66.69 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.004 0.921 . . . . 75.55 110.961 178.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 82.3 mt -86.07 -6.02 59.1 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.724 -0.671 . . . . 71.43 111.498 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.41 -0.09 49.75 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.934 0.893 . . . . 75.32 110.011 171.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . 0.406 ' HG3' ' O ' ' C' ' 27' ' ' LYS . 95.7 mtt180 -100.94 -41.89 6.64 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.26 1.024 . . . . 73.5 109.208 165.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.33 -50.16 49.07 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 115.637 -0.71 . . . . 71.12 109.629 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 33' ' ' TYR . . . . . 0.425 ' HB3' ' O ' ' C' ' 43' ' ' ALA . 37.2 m-85 -95.4 14.94 20.9 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.924 0.49 . . . . 72.14 111.52 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 34' ' ' HIS . . . . . . . . . . . . . 12.4 t60 -61.4 107.82 1.27 Allowed Pre-proline 0 N--CA 1.489 1.48 0 C-N-CA 124.36 1.064 . . . . 74.34 110.792 -177.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -61.74 -21.31 71.87 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 123.018 2.479 . . . . 72.22 114.16 -172.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.05 -26.31 36.44 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.951 0.9 . . . . 60.34 111.668 178.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 90.2 t -97.39 -58.33 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 109.046 -0.724 . . . . 75.33 109.046 176.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -98.12 84.21 3.24 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 114.801 -1.09 . . . . 65.41 108.907 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.26 79.21 0.99 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 114.866 -1.061 . . . . 71.22 108.635 175.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 67.1 m -140.38 114.9 7.53 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-O 118.301 -0.857 . . . . 74.14 109.387 -178.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -52.12 -41.85 62.61 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 123.326 2.684 . . . . 75.0 112.774 -176.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -48.62 -50.62 31.94 Favored 'General case' 0 N--CA 1.483 1.18 0 O-C-N 124.078 0.861 . . . . 71.01 110.85 173.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 43' ' ' ALA . . . . . 0.425 ' O ' ' HB3' ' C' ' 33' ' ' TYR . . . -71.55 -23.55 61.78 Favored 'General case' 0 C--O 1.216 -0.679 0 CA-C-N 114.768 -1.105 . . . . 71.45 110.931 -176.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 44' ' ' GLU . . . . . 0.469 ' O ' ' HG3' ' C' ' 48' ' ' LYS . 47.9 mt-10 -80.72 -33.48 35.22 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 122.992 0.517 . . . . 74.04 110.672 -176.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 45' ' ' GLU . . . . . 0.411 ' HA ' ' HD2' ' C' ' 48' ' ' LYS . 40.3 mt-10 -76.36 -39.4 53.95 Favored 'General case' 0 C--O 1.244 0.763 0 C-N-CA 123.316 0.647 . . . . 75.44 109.643 178.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 46' ' ' LYS . . . . . 0.527 ' O ' HG12 ' C' ' 50' ' ' ILE . 99.6 mttt -64.26 -34.7 78.71 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.008 -0.997 . . . . 72.32 110.131 170.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -66.34 -35.87 81.45 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.919 0.888 . . . . 71.12 110.297 175.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 48' ' ' LYS . . . . . 0.469 ' HG3' ' O ' ' C' ' 44' ' ' GLU . 95.1 mttt -60.67 -42.32 96.83 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 109.773 -0.454 . . . . 72.04 109.773 173.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -66.67 -33.8 76.45 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 123.653 0.596 . . . . 72.33 111.578 174.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 50' ' ' ILE . . . . . 0.527 HG12 ' O ' ' C' ' 46' ' ' LYS . 32.8 mm -65.72 -33.93 66.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 109.005 -0.739 . . . . 75.43 109.005 175.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 51' ' ' ASN . . . . . 0.55 ' HA ' ' HB3' ' C' ' 54' ' ' TYR . 36.3 m-80 -93.0 -3.98 53.46 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.123 0.969 . . . . 74.04 112.333 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -81.53 -51.45 8.25 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 107.243 -1.391 . . . . 75.54 107.243 165.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.14 -37.29 71.82 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 112.503 -2.135 . . . . 63.1 111.304 173.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 54' ' ' TYR . . . . . 0.55 ' HB3' ' HA ' ' C' ' 51' ' ' ASN . 58.1 t80 -78.18 -39.21 41.51 Favored 'General case' 0 C--O 1.215 -0.724 0 CA-C-N 115.5 -0.773 . . . . 75.01 110.411 174.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.52 -28.32 44.46 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 118.751 0.705 . . . . 60.54 111.56 177.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 56' ' ' VAL . . . . . 0.455 ' O ' ' HB2' ' C' ' 62' ' ' LYS . 47.3 t -83.28 -67.09 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 CA-C-O 121.288 0.566 . . . . 72.43 110.443 169.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 57' ' ' LEU . . . . . . . . . . . . . 52.1 mt -84.47 15.5 3.67 Favored 'General case' 0 CA--C 1.565 1.538 0 N-CA-C 113.066 0.765 . . . . 75.02 113.066 -164.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 45.5 t -61.2 -45.8 93.09 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 124.188 0.995 . . . . 75.33 112.291 -178.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -123.31 149.83 58.82 Favored Pre-proline 0 C--O 1.242 0.69 0 CA-C-N 114.897 -1.047 . . . . 72.03 108.639 -173.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 60' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -51.43 -26.97 22.9 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 123.299 2.666 . . . . 73.21 113.088 174.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -62.56 -70.28 0.21 Allowed 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.439 -0.8 . . . . 62.13 111.272 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 62' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' C' ' 56' ' ' VAL . 0.0 OUTLIER -70.64 -20.66 62.71 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 122.117 0.167 . . . . 75.43 110.857 -175.568 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -53.59 -62.11 1.87 Allowed 'General case' 0 C--N 1.354 0.776 0 O-C-N 124.002 0.814 . . . . 74.14 109.864 168.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -70.1 -27.56 64.69 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 112.249 0.463 . . . . 74.15 112.249 -176.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 88.5 mt -57.71 -50.27 78.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 109.68 -0.489 . . . . 71.5 109.68 172.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -61.74 -47.61 84.45 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.112 0.565 . . . . 74.31 111.691 174.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -53.94 -32.16 52.75 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.119 0.568 . . . . 73.14 111.979 -178.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 68' ' ' THR . . . . . 0.427 ' O ' ' HB ' ' C' ' 72' ' ' THR . 40.1 p -97.02 -24.09 15.96 Favored 'General case' 0 CA--C 1.553 1.069 0 N-CA-C 112.512 0.56 . . . . 74.43 112.512 176.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 69' ' ' TYR . . . . . 0.439 ' HE2' ' HD3' ' C' ' 78' ' ' PRO . 3.4 t80 -118.25 120.29 37.22 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.31 -0.869 . . . . 75.22 110.763 -172.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.94 23.58 66.25 Favored Glycine 0 C--N 1.346 1.136 0 N-CA-C 111.616 -0.594 . . . . 62.51 111.616 -173.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 54.8 m -142.18 -53.58 0.42 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 103.745 -2.687 . . . . 72.34 103.745 175.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 72' ' ' THR . . . . . 0.427 ' HB ' ' O ' ' C' ' 68' ' ' THR . 21.1 m -105.25 173.3 6.36 Favored 'General case' 0 CA--C 1.564 1.498 0 N-CA-C 104.969 -2.234 . . . . 73.35 104.969 158.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -90.85 11.41 22.67 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 118.999 0.818 . . . . 73.23 111.081 173.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.12 -163.35 0.0 OUTLIER Pre-proline 0 CA--C 1.594 2.646 0 C-N-CA 125.728 1.611 . . . . 53.23 112.305 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER 8.2 109.24 0.0 OUTLIER 'Trans proline' 1 C--N 1.419 4.25 0 C-N-CA 125.153 3.902 . . . . 75.14 118.512 -156.134 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -62.12 165.96 13.59 Favored 'Trans proline' 0 C--N 1.387 2.556 0 C-N-CA 123.52 2.813 . . . . 71.22 113.321 -179.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -21.39 106.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.405 3.517 1 C-N-CA 126.157 4.572 . . . . 74.4 116.029 178.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 78' ' ' PRO . . . . . 0.585 ' HG2' ' HA ' ' C' ' 101' ' ' PHE . 1.3 Cg_exo -37.59 146.45 0.11 Allowed 'Trans proline' 0 C--N 1.379 2.133 1 C-N-CA 126.277 4.651 . . . . 74.44 117.639 -171.781 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -58.87 119.43 6.68 Favored 'Trans proline' 0 C--N 1.391 2.813 0 C-N-CA 123.555 2.837 . . . . 70.12 113.411 -178.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -62.12 75.49 0.1 OUTLIER 'Trans proline' 0 C--N 1.391 2.811 0 C-N-CA 123.56 2.84 . . . . 74.31 110.321 169.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -167.48 -24.89 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 113.704 -1.589 . . . . 75.2 110.281 -166.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . 0.413 ' HA2' ' O ' ' C' ' 104' ' ' GLY . . . 118.21 141.73 6.81 Favored Glycine 0 C--N 1.361 1.969 0 N-CA-C 116.377 1.311 . . . . 75.13 116.377 163.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 83' ' ' TYR . . . . . 0.494 ' CE1' ' HB3' ' C' ' 78' ' ' PRO . 22.7 m-85 -110.03 92.93 4.24 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 107.311 -1.366 . . . . 73.4 107.311 165.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -27.67 135.29 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 127.471 2.308 . . . . 75.11 116.157 -175.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 85' ' ' PHE . . . . . 0.522 ' CZ ' HD22 ' C' ' 105' ' ' LEU . 16.0 m-85 -135.49 74.21 1.5 Allowed 'General case' 0 C--N 1.346 0.451 0 CA-C-N 115.167 -0.924 . . . . 74.41 110.999 -177.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 86' ' ' SER . . . . . 0.518 ' OG ' ' HA2' ' C' ' 163' ' ' GLY . 1.4 m -55.82 83.21 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 123.715 0.806 . . . . 52.42 110.523 177.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 62.65 16.0 54.92 Favored Glycine 0 CA--C 1.54 1.637 0 CA-C-O 119.007 -0.885 . . . . 74.34 114.624 -170.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 88' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -86.46 120.81 28.19 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 118.536 1.168 . . . . 74.44 109.772 -174.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -76.56 88.67 3.28 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 120.856 0.36 . . . . 72.23 110.604 -174.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 90' ' ' VAL . . . . . . . . . . . . . 6.0 p -45.43 -43.96 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 124.333 1.053 . . . . 54.42 113.06 175.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -61.48 -31.2 71.17 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.745 0.818 . . . . 75.25 111.381 -176.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -79.08 -24.89 43.18 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.275 -0.875 . . . . 75.53 111.083 -176.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 19.1 m-30 -73.83 165.51 24.98 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 122.637 0.375 . . . . 72.45 110.787 -175.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 86.3 p -67.62 163.45 21.33 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 113.509 0.929 . . . . 52.11 113.509 -167.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.11 -42.91 95.72 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.027 -0.988 . . . . 72.35 110.645 172.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -58.44 -43.53 88.82 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.161 0.584 . . . . 74.24 110.653 178.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 97' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -61.51 -43.67 98.45 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.203 -0.908 . . . . 64.25 109.691 177.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 98' ' ' GLN . . . . . 0.526 ' HA ' HD13 ' C' ' 105' ' ' LEU . 48.6 mt-30 -82.58 -5.21 58.65 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 115.091 -0.958 . . . . 71.33 113.306 -177.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -101.4 -35.95 9.03 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.412 0.685 . . . . 74.43 110.947 172.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 46.3 tp -74.2 -61.4 1.87 Allowed 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 109.067 -0.716 . . . . 73.23 109.067 -178.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 101' ' ' PHE . . . . . 0.585 ' HA ' ' HG2' ' C' ' 78' ' ' PRO . 65.6 m-85 -92.08 8.72 36.54 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 115.389 -0.823 . . . . 75.04 111.55 -177.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -46.52 -58.28 6.05 Favored Glycine 0 CA--C 1.544 1.895 0 N-CA-C 117.629 1.811 . . . . 74.41 117.629 -169.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . 0.449 ' HD2' ' HD2' ' C' ' 78' ' ' PRO . 52.9 Cg_exo -58.49 -18.55 39.84 Favored 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 123.359 2.706 . . . . 64.35 114.41 179.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 104' ' ' GLY . . . . . 0.413 ' O ' ' HA2' ' C' ' 82' ' ' GLY . . . -105.35 -1.71 41.05 Favored Glycine 0 C--N 1.348 1.197 0 CA-C-O 119.501 -0.61 . . . . 73.42 113.814 179.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 105' ' ' LEU . . . . . 0.526 HD13 ' HA ' ' C' ' 98' ' ' GLN . 15.3 mt . . . . . 0 N--CA 1.494 1.761 0 CA-C-N 119.284 1.542 . . . . 75.43 113.595 -175.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.518 0 N-CA-C 111.965 -0.454 . . . . 54.4 111.965 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 60.4 mtt180 -80.26 174.91 11.13 Favored 'General case' 0 C--O 1.247 0.947 0 N-CA-C 108.963 -0.755 . . . . 74.32 108.963 175.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 118' ' ' ASP . . . . . 0.402 ' HA ' ' O ' ' C' ' 172' ' ' GLY . 1.0 OUTLIER -70.39 130.91 43.19 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-O 120.865 0.364 . . . . 75.42 110.293 174.667 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 119' ' ' LEU . . . . . . . . . . . . . 5.1 tt -90.47 137.35 32.43 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 105.15 -2.167 . . . . 75.21 105.15 -179.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.48 148.88 50.31 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 110.14 -0.318 . . . . 72.31 110.14 -172.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.27 118.56 6.84 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.525 -0.761 . . . . 75.44 109.45 177.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -83.93 132.54 34.76 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 109.772 -0.455 . . . . 74.12 109.772 178.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 123' ' ' LEU . . . . . 0.421 HD13 ' HB1' ' B' ' 183' ' ' ALA . 2.6 pt? -144.69 129.88 9.38 Favored Pre-proline 0 N--CA 1.481 1.1 0 C-N-CA 122.646 0.378 . . . . 73.3 110.185 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . 0.457 ' HA ' ' O ' ' C' ' 179' ' ' ARG . 17.3 Cg_exo -72.14 124.83 10.33 Favored 'Trans proline' 0 C--N 1.366 1.452 0 C-N-CA 122.218 1.945 . . . . 72.51 111.281 165.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 125' ' ' LEU . . . . . . . . . . . . . 38.0 tp -142.64 155.05 44.89 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.199 1.0 . . . . 75.32 109.015 -170.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 126' ' ' THR . . . . . 0.615 ' HB ' ' HG2' ' C' ' 129' ' ' GLU . 1.8 m -101.45 158.04 16.36 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 122.965 0.506 . . . . 61.53 110.289 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 127' ' ' LEU . . . . . 0.489 HD22 HD11 ' C' ' 180' ' ' LEU . 56.1 mt -64.45 -44.69 90.33 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.581 1.153 . . . . 62.25 110.92 178.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -59.93 -36.98 78.19 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 114.954 -1.021 . . . . 75.24 110.505 175.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 129' ' ' GLU . . . . . 0.615 ' HG2' ' HB ' ' C' ' 126' ' ' THR . 6.8 mm-40 -78.54 -22.08 47.81 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.105 0.562 . . . . 75.51 111.401 -179.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -73.79 -31.68 63.39 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 121.118 0.485 . . . . 73.14 109.935 174.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 131' ' ' PHE . . . . . 0.417 ' CZ ' ' HB3' ' C' ' 216' ' ' GLU . 49.4 t80 -69.19 -46.84 66.5 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 114.575 -1.193 . . . . 75.55 110.186 167.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 132' ' ' HIS . . . . . . . . . . . . . 28.1 m170 -78.03 -6.32 54.17 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.152 0.581 . . . . 70.15 111.608 -176.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -55.45 -94.29 0.01 OUTLIER Glycine 0 C--N 1.355 1.631 0 O-C-N 123.977 0.798 . . . . 65.31 113.259 175.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . 55.06 -137.0 45.1 Favored Glycine 0 C--N 1.355 1.636 0 CA-C-N 117.306 0.553 . . . . 73.12 112.799 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 135' ' ' GLU . . . . . 0.496 ' HG3' ' HB2' ' C' ' 148' ' ' ARG . 2.5 mp0 -76.29 96.4 3.96 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 108.839 -0.8 . . . . 73.03 108.839 172.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 136' ' ' ARG . . . . . 0.483 ' HA ' ' HE ' ' C' ' 136' ' ' ARG . 2.4 tpm_? -140.43 160.2 40.52 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-O 120.842 0.353 . . . . 72.12 110.296 -175.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 137' ' ' VAL . . . . . . . . . . . . . 19.9 m -74.73 96.19 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.191 0 CA-C-O 122.249 1.023 . . . . 73.11 111.741 -177.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 138' ' ' VAL . . . . . . . . . . . . . 42.8 t -90.36 136.54 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 114.621 -1.172 . . . . 72.14 108.758 172.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 139' ' ' GLU . . . . . 0.496 ' HA ' ' O ' ' C' ' 143' ' ' ARG . 1.4 tm-20 -124.09 115.89 21.89 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 108.165 -1.05 . . . . 74.31 108.165 174.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 140' ' ' VAL . . . . . . . . . . . . . 66.8 t -137.64 109.13 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 124.187 0.995 . . . . 73.25 109.148 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 63.59 25.75 14.45 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.265 1.026 . . . . 65.0 113.186 173.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 108.68 -8.24 34.29 Favored Glycine 0 N--CA 1.473 1.153 0 CA-C-N 116.666 -0.243 . . . . 52.4 113.006 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 143' ' ' ARG . . . . . 0.681 HH12 ' HA ' ' C' ' 164' ' ' MET . 27.4 mmm-85 -87.85 95.98 10.3 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.135 0.574 . . . . 75.05 110.718 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 47.1 ttp180 -96.9 98.84 10.44 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 108.631 -0.878 . . . . 71.51 108.631 175.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 145' ' ' VAL . . . . . 0.522 HG22 ' NH2' ' C' ' 143' ' ' ARG . 69.8 t -132.38 133.09 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.061 0.944 . . . . 75.03 110.525 -169.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 15.7 m -85.59 85.03 7.44 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 108.455 -0.943 . . . . 73.22 108.455 170.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 10.4 p -118.54 145.35 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 123.232 0.613 . . . . 72.53 110.428 -171.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 148' ' ' ARG . . . . . 0.496 ' HB2' ' HG3' ' C' ' 135' ' ' GLU . 42.3 ttm180 -78.25 105.76 9.7 Favored 'General case' 0 C--N 1.348 0.518 0 N-CA-C 108.468 -0.938 . . . . 74.22 108.468 169.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 149' ' ' ILE . . . . . 0.612 HD11 HG21 ' C' ' 159' ' ' ILE . 6.9 pt -80.82 152.71 72.33 Favored Pre-proline 0 C--O 1.246 0.869 0 N-CA-C 107.299 -1.371 . . . . 74.42 107.299 165.048 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -39.79 108.91 0.08 OUTLIER 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 122.828 2.352 . . . . 61.44 112.12 168.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -63.98 107.91 0.85 Allowed 'Trans proline' 0 C--N 1.382 2.32 0 C-N-CA 122.928 2.419 . . . . 73.2 110.662 -176.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 152' ' ' GLY . . . . . . . . . . . . . . . 105.11 137.61 9.11 Favored Glycine 0 C--N 1.34 0.803 0 CA-C-N 115.837 -0.62 . . . . 63.11 113.955 -170.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 153' ' ' VAL . . . . . 0.576 HG21 HG22 ' C' ' 178' ' ' VAL . 1.9 m -134.57 171.84 17.13 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.192 0 C-N-CA 123.029 0.532 . . . . 74.01 110.922 -175.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 154' ' ' ARG . . . . . . . . . . . . . 8.7 mtp180 -135.34 145.06 47.03 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.176 0.99 . . . . 75.32 108.906 -174.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 155' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -56.17 126.07 24.51 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 118.601 0.637 . . . . 74.51 111.766 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 60.84 24.04 62.01 Favored Glycine 0 C--N 1.351 1.364 0 CA-C-N 115.305 -0.861 . . . . 75.21 114.01 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 157' ' ' SER . . . . . . . . . . . . . 37.7 m -107.91 163.59 13.0 Favored 'General case' 0 C--O 1.246 0.87 0 CA-C-O 121.209 0.528 . . . . 75.43 110.275 178.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 20.7 m -102.67 110.42 29.3 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 CA-C-N 114.997 -1.001 . . . . 72.31 110.528 -174.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 159' ' ' ILE . . . . . 0.612 HG21 HD11 ' C' ' 149' ' ' ILE . 7.4 mt -71.51 97.9 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.791 0 N-CA-C 108.251 -1.018 . . . . 72.31 108.251 172.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 160' ' ' ARG . . . . . 0.442 ' HA ' ' O ' ' C' ' 174' ' ' LEU . 15.3 ttp180 -79.62 102.63 9.02 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.591 -0.732 . . . . 75.13 110.572 -177.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 161' ' ' VAL . . . . . 0.644 HG23 ' HB3' ' C' ' 174' ' ' LEU . 0.7 OUTLIER -109.2 130.34 22.86 Favored Pre-proline 0 CA--C 1.548 0.892 0 N-CA-C 108.221 -1.029 . . . . 75.24 108.221 178.05 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -76.67 147.35 27.81 Favored 'Trans proline' 0 C--N 1.369 1.617 0 C-N-CA 122.528 2.152 . . . . 75.23 111.014 169.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 163' ' ' GLY . . . . . 0.518 ' HA2' ' OG ' ' C' ' 86' ' ' SER . . . 112.53 24.88 4.84 Favored Glycine 0 N--CA 1.47 0.917 0 CA-C-O 119.38 -0.678 . . . . 53.54 114.015 174.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 164' ' ' MET . . . . . 0.681 ' HA ' HH12 ' C' ' 143' ' ' ARG . 26.4 mmt -130.2 -79.75 0.54 Allowed 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 118.002 0.901 . . . . 73.35 110.769 -179.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 165' ' ' GLY . . . . . 0.526 ' H ' ' HA ' ' C' ' 173' ' ' ASP . . . 84.13 139.36 4.12 Favored Glycine 0 C--N 1.349 1.3 0 N-CA-C 114.033 0.373 . . . . 73.32 114.033 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . -76.37 -170.93 31.9 Favored Glycine 0 C--N 1.363 2.045 0 CA-C-N 117.213 0.507 . . . . 75.44 112.5 167.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 167' ' ' GLN . . . . . 0.556 ' HA ' HE21 ' C' ' 167' ' ' GLN . 0.0 OUTLIER -77.08 105.78 8.38 Favored 'General case' 0 N--CA 1.479 0.982 0 O-C-N 122.18 -0.6 . . . . 74.2 111.841 -174.192 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . 149.85 171.38 18.25 Favored Glycine 0 C--N 1.346 1.138 0 CA-C-O 121.492 0.496 . . . . 13.44 113.713 177.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 169' ' ' ASN . . . . . 0.489 ' HB3' ' HD2' ' C' ' 170' ' ' PRO . 1.0 OUTLIER -60.2 158.98 24.33 Favored Pre-proline 0 CA--C 1.559 1.317 0 C-N-CA 126.642 1.977 . . . . 62.44 109.498 175.537 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 170' ' ' PRO . . . . . 0.489 ' HD2' ' HB3' ' C' ' 169' ' ' ASN . 6.5 Cg_exo -0.05 75.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.403 3.415 1 C-N-CA 126.326 4.684 . . . . 73.55 115.511 -162.054 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 171' ' ' PRO . . . . . 0.504 ' HD2' ' O ' ' C' ' 85' ' ' PHE . 93.9 Cg_endo -81.97 176.54 8.18 Favored 'Trans proline' 0 C--N 1.37 1.708 0 C-N-CA 123.065 2.51 . . . . 74.02 114.965 -165.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 172' ' ' GLY . . . . . 0.433 ' O ' ' HA2' ' C' ' 165' ' ' GLY . . . -95.49 127.82 9.29 Favored Glycine 0 C--N 1.342 0.882 0 CA-C-N 114.247 -1.342 . . . . 74.42 110.118 -178.038 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 173' ' ' ASP . . . . . 0.526 ' HA ' ' H ' ' C' ' 165' ' ' GLY . 50.0 m-20 -72.85 -162.05 0.1 Allowed 'General case' 0 CA--C 1.555 1.15 0 N-CA-C 114.038 1.125 . . . . 74.51 114.038 -169.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 174' ' ' LEU . . . . . 0.644 ' HB3' HG23 ' C' ' 161' ' ' VAL . 38.2 tp -87.99 142.29 27.91 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 112.621 0.6 . . . . 75.22 112.621 -164.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 49.8 mt -129.21 95.23 3.99 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.681 1.592 . . . . 72.15 107.95 177.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 176' ' ' LEU . . . . . 0.574 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 95.4 mt -82.24 109.04 16.16 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 110.037 -0.357 . . . . 74.33 110.037 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 177' ' ' VAL . . . . . . . . . . . . . 57.8 t -83.52 95.63 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 107.657 -1.238 . . . . 75.23 107.657 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 178' ' ' VAL . . . . . 0.576 HG22 HG21 ' C' ' 153' ' ' VAL . 3.3 p -87.26 140.19 16.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 121.342 0.591 . . . . 74.01 112.117 -172.129 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 179' ' ' ARG . . . . . 0.457 ' O ' ' HA ' ' C' ' 124' ' ' PRO . 36.7 mmt180 -117.65 105.5 12.1 Favored 'General case' 0 C--N 1.342 0.276 0 C-N-CA 124.939 1.296 . . . . 74.42 107.872 177.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 180' ' ' LEU . . . . . 0.489 HD11 HD22 ' C' ' 127' ' ' LEU . 96.2 mt -73.45 143.02 46.84 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 122.547 0.339 . . . . 73.43 111.47 -175.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 181' ' ' LEU . . . . . . . . . . . . . 16.8 mt -61.19 166.86 4.47 Favored Pre-proline 0 CA--C 1.56 1.359 0 C-N-CA 124.66 1.184 . . . . 74.24 112.27 -178.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 99.4 Cg_exo -52.71 12.59 0.02 OUTLIER 'Trans proline' 0 C--N 1.39 2.755 0 C-N-CA 124.305 3.337 . . . . 73.32 118.361 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 183' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -129.38 74.24 81.08 Favored Pre-proline 0 CA--C 1.564 1.51 0 CA-C-N 119.069 0.85 . . . . 72.0 108.779 163.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 184' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -86.43 66.08 4.9 Favored 'Trans proline' 0 C--N 1.378 2.091 0 C-N-CA 123.099 2.532 . . . . 74.25 110.484 178.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 185' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 26.2 t -91.47 -45.25 14.53 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.552 0 CA-C-N 115.623 -0.717 . . . . 72.23 109.331 -166.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 186' ' ' PHE . . . . . 0.486 ' HB3' HD12 ' C' ' 193' ' ' LEU . 42.8 m-85 -103.95 101.45 11.23 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.534 0.734 . . . . 61.44 110.058 -173.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 187' ' ' ARG . . . . . . . . . . . . . 18.1 ttt180 -103.61 129.51 50.89 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.403 0.681 . . . . 75.14 109.298 -177.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 188' ' ' LEU . . . . . 0.527 HD12 ' HD2' ' C' ' 240' ' ' PHE . 53.7 tp -79.93 144.73 33.1 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 112.421 0.526 . . . . 74.14 112.421 -173.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -143.75 116.75 8.86 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 107.176 -1.416 . . . . 73.21 107.176 163.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 63.1 -97.08 0.18 Allowed Glycine 0 C--N 1.345 1.075 0 N-CA-C 111.436 -0.666 . . . . 74.2 111.436 -172.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 191' ' ' GLN . . . . . 0.432 ' HA ' HD11 ' C' ' 188' ' ' LEU . 45.8 mt-30 -129.01 -10.34 4.82 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.992 0.917 . . . . 75.25 110.675 171.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 192' ' ' ASP . . . . . 0.404 ' O ' HD13 ' C' ' 188' ' ' LEU . 22.2 m-20 -82.86 161.91 21.77 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.706 0.802 . . . . 65.13 110.448 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 193' ' ' LEU . . . . . 0.601 HD21 ' CD2' ' C' ' 240' ' ' PHE . 79.6 mt -123.03 161.33 24.5 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 122.885 0.474 . . . . 65.15 111.901 -176.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 194' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -124.27 128.99 49.98 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 107.824 -1.176 . . . . 75.43 107.824 168.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 195' ' ' ALA . . . . . 0.485 ' HA ' ' O ' ' C' ' 185' ' ' VAL . . . -136.33 -176.65 4.4 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.576 1.15 . . . . 65.11 109.305 -177.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 87.9 m -137.98 119.93 15.42 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 108.594 -0.891 . . . . 53.42 108.594 171.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 197' ' ' LEU . . . . . . . . . . . . . 55.8 tp -96.66 124.1 40.55 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.066 0.546 . . . . 73.5 110.606 -175.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -77.75 104.59 8.39 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.42 1.088 . . . . 64.33 109.64 179.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 199' ' ' VAL . . . . . 0.519 HG22 HG22 ' C' ' 210' ' ' VAL . 41.1 t -121.53 120.4 28.84 Favored Pre-proline 0 N--CA 1.481 1.105 0 C-N-CA 124.413 1.085 . . . . 73.12 109.196 -178.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 200' ' ' PRO . . . . . 0.45 ' HG2' HD12 ' C' ' 203' ' ' ILE . 12.9 Cg_exo -66.3 150.53 84.6 Favored 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 122.534 2.156 . . . . 73.11 112.12 173.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 201' ' ' ALA . . . . . . . . . . . . . . . -57.09 -48.42 97.44 Favored Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 123.746 0.819 . . . . 74.35 113.068 178.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 202' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -57.13 -49.34 14.42 Favored 'Trans proline' 0 C--N 1.383 2.369 0 C-N-CA 121.631 1.554 . . . . 63.15 112.856 175.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 203' ' ' ILE . . . . . 0.45 HD12 ' HG2' ' C' ' 200' ' ' PRO . 27.2 mt -63.11 -29.53 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 123.276 0.631 . . . . 74.02 111.055 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -74.45 -36.59 63.36 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.612 0.765 . . . . 75.02 112.217 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 205' ' ' VAL . . . . . . . . . . . . . 69.1 t -76.73 -41.15 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 122.909 0.483 . . . . 74.52 111.984 -179.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 206' ' ' VAL . . . . . 0.636 HG21 ' HE3' ' A' ' 270' ' ' LYS . 12.4 p -90.88 -34.61 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 112.218 0.451 . . . . 74.12 112.218 -176.202 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 94.03 127.65 4.86 Favored Glycine 0 C--N 1.344 0.999 0 N-CA-C 111.644 -0.582 . . . . 63.21 111.644 -167.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -156.81 -131.18 1.32 Allowed Glycine 0 C--N 1.346 1.108 0 N-CA-C 111.042 -0.823 . . . . 51.32 111.042 177.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 209' ' ' LYS . . . . . 0.511 ' HG2' ' HA ' ' C' ' 222' ' ' ALA . 8.2 mtmp? -147.07 140.77 25.71 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.486 0.714 . . . . 72.44 111.072 173.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 210' ' ' VAL . . . . . 0.519 HG22 HG22 ' C' ' 199' ' ' VAL . 17.8 m -136.6 138.92 45.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 125.216 1.406 . . . . 71.52 108.32 172.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 211' ' ' ARG . . . . . 0.423 ' HA ' ' HA ' ' C' ' 220' ' ' GLU . 36.0 ttm180 -86.82 126.82 34.88 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.376 0.51 . . . . 75.53 112.376 -173.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 212' ' ' ALA . . . . . 0.463 ' HB3' HG11 ' C' ' 219' ' ' VAL . . . -92.56 114.84 27.5 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 123.97 0.908 . . . . 74.43 108.568 164.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 213' ' ' MET . . . . . . . . . . . . . 5.4 tmm? -77.31 105.8 8.65 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 107.895 -1.15 . . . . 63.12 107.895 175.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 214' ' ' THR . . . . . 0.465 ' OG1' HG12 ' C' ' 219' ' ' VAL . 0.2 OUTLIER -100.75 173.09 6.68 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.49 0.662 . . . . 72.34 110.594 -176.269 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 215' ' ' LEU . . . . . 0.412 HD11 ' CE1' ' C' ' 240' ' ' PHE . 25.9 mt -69.91 -26.72 64.29 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 114.488 -1.233 . . . . 75.24 112.836 -169.358 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 216' ' ' GLU . . . . . 0.417 ' HB3' ' CZ ' ' C' ' 131' ' ' PHE . 0.0 OUTLIER -111.52 8.69 21.13 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.206 1.002 . . . . 71.0 111.614 -178.985 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 137.92 172.67 12.63 Favored Glycine 0 C--N 1.341 0.833 0 CA-C-O 119.803 -0.443 . . . . 74.41 112.607 179.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -87.62 119.48 1.36 Allowed 'Trans proline' 0 CA--C 1.555 1.562 0 C-N-CA 123.178 2.586 . . . . 64.03 113.099 -174.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 219' ' ' VAL . . . . . 0.465 HG12 ' OG1' ' C' ' 214' ' ' THR . 3.8 p -98.71 115.4 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 108.961 -0.755 . . . . 52.53 108.961 173.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 220' ' ' GLU . . . . . 0.423 ' HA ' ' HA ' ' C' ' 211' ' ' ARG . 46.1 tt0 -80.99 106.6 13.12 Favored 'General case' 0 C--O 1.244 0.77 0 N-CA-C 108.716 -0.846 . . . . 72.32 108.716 178.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 221' ' ' VAL . . . . . 0.625 ' HA ' ' HB2' ' B' ' 239' ' ' ALA . 88.3 t -77.85 127.34 38.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 114.786 -1.097 . . . . 74.03 110.589 -176.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 222' ' ' ALA . . . . . 0.511 ' HA ' ' HG2' ' C' ' 209' ' ' LYS . . . -95.58 130.51 42.41 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.585 0.754 . . . . 73.3 111.099 177.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 94.8 t -108.35 140.31 21.62 Favored Pre-proline 0 CA--C 1.558 1.28 0 C-N-CA 125.328 1.451 . . . . 73.11 110.065 -173.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 224' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -89.47 168.59 5.0 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 123.556 2.838 . . . . 73.11 111.958 169.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -58.35 142.66 97.82 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.386 2.057 . . . . 74.4 112.428 170.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 226' ' ' ARG . . . . . 0.406 ' HD2' ' HA ' ' A' ' 259' ' ' GLU . 30.8 mmt-85 66.44 95.12 0.06 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.531 1.533 . . . . 71.5 111.073 -176.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 227' ' ' THR . . . . . 0.415 ' O ' HG12 ' A' ' 257' ' ' ILE . 25.7 m -137.29 116.78 12.84 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.637 0.775 . . . . 73.3 111.32 173.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 228' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -101.8 155.88 17.86 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.842 0.857 . . . . 74.32 111.17 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -70.37 144.0 51.75 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 115.197 -0.91 . . . . 65.31 109.986 175.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 97.02 -11.85 65.75 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-O 119.2 -0.778 . . . . 62.04 113.024 -172.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 231' ' ' ARG . . . . . . . . . . . . . 54.9 mtt180 -69.37 174.34 4.93 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 118.348 1.074 . . . . 75.03 111.04 170.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 232' ' ' LYS . . . . . 0.419 ' HD3' ' HB3' ' C' ' 250' ' ' TYR . 28.0 ttmt -147.75 141.95 26.15 Favored 'General case' 0 C--N 1.355 0.819 0 CA-C-O 121.371 0.605 . . . . 74.05 112.222 -176.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 233' ' ' LEU . . . . . 0.555 ' O ' ' HA ' ' C' ' 250' ' ' TYR . 3.3 mp -114.63 154.53 28.21 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.945 1.298 . . . . 74.22 109.519 -179.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -122.95 120.72 34.23 Favored 'General case' 0 C--O 1.243 0.744 0 N-CA-C 109.19 -0.67 . . . . 72.34 109.19 167.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 44.5 mt -107.54 125.35 51.19 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.418 -0.956 . . . . 74.34 108.418 177.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -74.3 130.11 39.08 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.848 0.859 . . . . 73.41 112.192 -171.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 77.87 -0.69 71.03 Favored Glycine 0 C--N 1.35 1.336 0 CA-C-N 115.16 -0.927 . . . . 71.42 114.013 178.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 238' ' ' LYS . . . . . 0.419 ' HE3' ' HB ' ' C' ' 219' ' ' VAL . 75.1 mmtt -92.11 8.6 37.11 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.361 0.664 . . . . 75.11 112.06 -173.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -81.63 -168.29 40.5 Favored Glycine 0 C--N 1.349 1.303 0 N-CA-C 111.367 -0.693 . . . . 75.2 111.367 167.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 240' ' ' PHE . . . . . 0.601 ' CD2' HD21 ' C' ' 193' ' ' LEU . 18.4 m-85 -78.86 149.59 74.16 Favored Pre-proline 0 CA--C 1.558 1.287 0 CA-C-N 117.105 0.452 . . . . 75.14 110.249 178.019 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 241' ' ' PRO . . . . . 0.433 ' HA ' ' HG2' ' C' ' 246' ' ' ARG . 83.5 Cg_endo -82.65 142.18 11.38 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 123.492 2.794 . . . . 71.53 112.501 -173.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -132.63 165.06 23.91 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-O 119.422 -0.654 . . . . 70.14 112.69 -178.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -67.79 -1.81 7.48 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 123.527 2.818 . . . . 71.42 113.768 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -121.82 -15.45 7.88 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.657 0.783 . . . . 71.42 111.299 174.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 154.7 174.7 24.99 Favored Glycine 0 C--N 1.357 1.703 0 CA-C-O 120.16 -0.244 . . . . 63.24 113.474 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 246' ' ' ARG . . . . . 0.433 ' HG2' ' HA ' ' C' ' 241' ' ' PRO . 59.3 mtm180 -91.94 157.32 16.89 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 123.983 0.913 . . . . 71.32 111.049 179.049 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -85.38 -161.19 34.14 Favored Glycine 0 C--N 1.353 1.493 0 CA-C-O 120.137 -0.257 . . . . 63.23 113.705 176.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -127.41 136.47 51.89 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 117.458 0.629 . . . . 73.54 109.906 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 249' ' ' LEU . . . . . 0.422 HD13 ' HB3' ' C' ' 195' ' ' ALA . 31.0 tp -86.22 119.87 26.97 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.6 0.76 . . . . 74.23 110.59 -177.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 250' ' ' TYR . . . . . 0.555 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 14.3 m-85 -100.84 102.79 13.93 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 109.372 -0.603 . . . . 71.43 109.372 176.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 251' ' ' LEU . . . . . 0.43 ' HB2' HD13 ' C' ' 233' ' ' LEU . 1.3 mp -97.52 135.93 38.66 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.58 -0.896 . . . . 72.0 108.58 -178.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -98.17 121.07 39.64 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 108.906 -0.776 . . . . 75.41 108.906 175.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 253' ' ' VAL . . . . . 0.401 HG11 HG21 ' C' ' 227' ' ' THR . 92.0 t -58.48 138.32 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 124.403 1.081 . . . . 73.5 111.897 -176.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 254' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -131.72 109.06 9.9 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.22 1.008 . . . . 75.13 108.295 -178.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 255' ' ' ILE . . . . . . . . . . . . . 41.4 mm -81.34 123.05 37.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 122.759 0.423 . . . . 75.24 110.186 179.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 256' ' ' THR . . . . . 0.407 ' O ' ' HA ' ' C' ' 200' ' ' PRO . 0.0 OUTLIER -125.79 151.78 46.29 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.157 1.383 . . . . 70.25 109.177 -179.565 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 2.8 pp -114.77 153.14 46.9 Favored Pre-proline 0 N--CA 1.49 1.532 0 C-N-CA 122.883 0.473 . . . . 75.21 111.137 -176.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 258' ' ' PRO . . . . . 0.571 ' HB3' ' HE2' ' A' ' 276' ' ' TYR . 37.7 Cg_endo -62.01 -2.9 3.28 Favored 'Trans proline' 0 C--N 1.385 2.46 0 C-N-CA 123.451 2.767 . . . . 74.41 115.119 -173.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 58.38 -83.33 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.111 1.364 . . . . 72.3 111.567 -173.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 260' ' ' ARG . . . . . 0.461 HH21 ' HB2' ' C' ' 258' ' ' PRO . 0.0 OUTLIER -66.41 158.09 30.24 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 122.878 0.471 . . . . 73.41 110.631 -177.178 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 261' ' ' LEU . . . . . 0.668 HD11 ' HA ' ' C' ' 266' ' ' GLU . 95.7 mt -145.96 130.86 18.15 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.542 -0.54 . . . . 74.53 109.542 175.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 58.3 p -82.84 154.69 67.97 Favored Pre-proline 0 N--CA 1.479 0.988 0 CA-C-O 117.264 -1.351 . . . . 61.23 107.729 170.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -34.66 -40.59 0.23 Allowed 'Trans proline' 0 N--CA 1.508 2.353 0 C-N-CA 124.314 3.343 . . . . 74.2 116.52 -175.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -76.58 -54.95 5.99 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.83 0.452 . . . . 71.04 110.963 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 265' ' ' GLU . . . . . 0.451 ' HB3' HD21 ' C' ' 261' ' ' LEU . 16.0 mm-40 -44.56 -51.88 8.55 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 124.1 0.875 . . . . 71.03 109.84 173.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 266' ' ' GLU . . . . . 0.668 ' HA ' HD11 ' C' ' 261' ' ' LEU . 7.9 tp10 -48.82 -60.29 2.86 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 112.856 -1.974 . . . . 73.1 111.007 176.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -53.23 -43.43 67.29 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 124.131 0.894 . . . . 71.12 112.92 -175.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 268' ' ' LEU . . . . . 0.409 ' O ' ' HG ' ' C' ' 272' ' ' LEU . 10.5 mp -65.13 -54.12 34.63 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 116.564 -0.289 . . . . 70.11 111.123 179.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 93.3 m95 -60.36 -31.51 70.41 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 111.76 0.281 . . . . 63.11 111.76 178.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 270' ' ' LYS . . . . . 0.521 ' HZ1' ' HB3' ' C' ' 270' ' ' LYS . 4.5 mmmp? -61.4 -52.63 63.81 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.483 0.713 . . . . 75.43 109.801 176.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 42.3 mtpt -59.8 -38.9 83.25 Favored 'General case' 0 N--CA 1.481 1.102 0 O-C-N 123.858 0.724 . . . . 75.33 111.848 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 272' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' C' ' 268' ' ' LEU . 78.1 mt -63.0 -41.88 99.7 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 123.823 0.702 . . . . 74.33 111.174 178.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -71.81 -41.13 68.61 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 115.599 -0.728 . . . . 43.22 112.257 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -67.84 -34.07 76.0 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.263 0.625 . . . . 63.21 110.084 179.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -62.87 -37.53 87.24 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 114.974 -1.012 . . . . 70.04 110.451 172.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 276' ' ' TYR . . . . . 0.531 ' HE1' ' HB3' ' A' ' 258' ' ' PRO . 0.2 OUTLIER -66.72 -44.84 80.54 Favored 'General case' 0 CA--C 1.554 1.107 0 CA-C-N 115.184 -0.916 . . . . 75.52 111.612 173.903 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -69.04 -22.61 64.04 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 122.707 0.403 . . . . 65.52 110.15 -178.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -69.49 0.34 5.4 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.982 0.913 . . . . 72.22 113.012 175.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 279' ' ' ARG . . . . . . . . . . . . . 73.3 mtm180 -82.24 -31.25 30.31 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 117.945 0.339 . . . . 75.11 110.335 168.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.98 0 C-N-CA 123.763 0.825 . . . . 75.14 109.246 -177.252 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.404 ' HE2' ' HD2' ' A' ' 69' ' ' TYR . 40.9 ttmt . . . . . 0 N--CA 1.483 1.224 0 N-CA-C 113.255 0.835 . . . . 64.14 113.255 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 49.5 mtpt -80.93 120.17 24.4 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 108.061 -1.088 . . . . 74.32 108.061 168.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -71.22 94.92 1.21 Allowed 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 108.23 -1.026 . . . . 62.43 108.23 178.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -63.39 -28.7 70.17 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 114.513 -1.221 . . . . 73.34 112.016 -172.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -67.01 -43.48 82.79 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 122.888 0.475 . . . . 73.33 110.14 176.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.05 -43.66 98.0 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 123.65 0.594 . . . . 70.01 110.467 177.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 65.8 mt -57.4 -40.62 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 123.917 0.761 . . . . 74.23 110.662 176.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 87.2 mt -79.4 -21.09 46.11 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 112.448 0.536 . . . . 73.11 112.448 177.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.62 49.59 8.91 Favored Glycine 0 CA--C 1.539 1.56 0 CA-C-N 117.688 0.222 . . . . 73.42 113.35 -175.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.53 HG13 ' HB3' ' A' ' 25' ' ' ALA . 3.4 m -134.25 161.45 63.64 Favored Pre-proline 0 N--CA 1.491 1.602 0 C-N-CA 125.226 1.41 . . . . 72.52 109.581 175.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -46.73 147.76 4.31 Favored 'Trans proline' 0 C--N 1.392 2.862 0 C-N-CA 123.104 2.536 . . . . 50.12 113.032 173.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 61.7 mtp180 -80.88 27.32 0.39 Allowed 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 113.359 0.874 . . . . 75.43 113.359 -166.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -161.08 20.74 0.13 Allowed 'General case' 0 CA--C 1.559 1.319 0 C-N-CA 124.894 1.278 . . . . 71.2 108.646 172.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.58 147.25 51.95 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.762 1.225 . . . . 74.14 112.731 -171.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.2 p -79.89 176.95 9.27 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.806 0.843 . . . . 75.03 112.658 -175.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -52.2 -47.09 65.79 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.492 1.517 . . . . 71.11 113.09 -172.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.455 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 17.2 tp10 -75.42 -28.16 59.27 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 111.656 0.243 . . . . 72.43 111.656 -174.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -65.81 -46.78 77.36 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 121.031 0.443 . . . . 71.14 109.973 174.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.597 HG12 ' HB3' ' A' ' 57' ' ' LEU . 1.7 mp -61.33 -36.39 72.57 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 CA-C-N 114.632 -1.167 . . . . 73.31 110.912 174.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.495 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 1.6 tppp? -63.12 -47.98 80.48 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.937 0.895 . . . . 75.22 109.639 179.376 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.455 ' HG3' ' O ' ' A' ' 20' ' ' GLU . 52.8 mtm180 -67.76 -38.22 83.16 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.166 0.987 . . . . 73.12 111.424 -177.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.53 ' HB3' HG13 ' A' ' 13' ' ' VAL . . . -61.72 -43.88 98.01 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.725 0.81 . . . . 72.43 110.49 176.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -59.07 -49.24 78.65 Favored 'General case' 0 C--O 1.202 -1.404 0 CA-C-N 114.335 -1.302 . . . . 73.1 110.238 174.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.495 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 88.2 mttt -52.63 -50.33 63.35 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.732 0.813 . . . . 74.22 110.854 -178.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 54.1 ttp180 -55.8 -55.88 27.11 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 114.501 -1.227 . . . . 75.52 111.571 178.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.604 ' HB3' HD12 ' A' ' 50' ' ' ILE . 96.8 mt -76.64 -18.97 58.28 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.476 0.711 . . . . 75.12 112.527 -174.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -86.33 -29.16 23.21 Favored 'General case' 0 C--O 1.211 -0.93 0 C-N-CA 123.134 0.574 . . . . 71.54 110.153 -178.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 45.7 mtp180 -83.94 -35.01 24.33 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 122.446 0.298 . . . . 72.33 110.397 173.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -71.79 -45.49 61.42 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.332 0.653 . . . . 73.31 110.72 -179.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.429 ' HA ' HD21 ' A' ' 38' ' ' ASN . 22.4 m-85 -107.56 35.98 2.89 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.516 0.726 . . . . 72.41 109.829 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -66.11 114.72 17.88 Favored Pre-proline 0 N--CA 1.476 0.866 0 N-CA-C 108.63 -0.878 . . . . 73.54 108.63 178.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.04 -15.2 21.64 Favored 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 123.249 2.633 . . . . 75.51 114.564 -168.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -94.66 -32.1 13.54 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.814 0.846 . . . . 73.23 111.882 177.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 99.3 t -85.46 -59.97 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 CA-C-O 121.679 0.752 . . . . 73.25 109.084 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.429 HD21 ' HA ' ' A' ' 33' ' ' TYR . 37.4 t30 -98.7 75.64 2.15 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 114.507 -1.224 . . . . 64.12 108.745 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -78.04 79.6 4.49 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 114.538 -1.21 . . . . 73.11 108.891 177.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.2 m -131.59 125.62 20.66 Favored Pre-proline 0 N--CA 1.471 0.623 0 N-CA-C 108.812 -0.811 . . . . 71.24 108.812 176.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -43.09 -45.73 9.33 Favored 'Trans proline' 0 C--N 1.383 2.392 0 C-N-CA 123.498 2.798 . . . . 73.53 113.281 171.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -51.27 -47.53 62.47 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.893 1.277 . . . . 64.43 111.194 174.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.23 -23.67 62.05 Favored 'General case' 0 C--N 1.35 0.623 0 CA-C-N 114.498 -1.228 . . . . 73.42 111.13 -177.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.45 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 46.9 mt-10 -78.82 -41.27 30.64 Favored 'General case' 0 C--N 1.359 0.989 0 O-C-N 123.623 0.577 . . . . 63.35 109.651 -178.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -64.58 -46.89 80.79 Favored 'General case' 0 C--O 1.251 1.174 0 C-N-CA 124.25 1.02 . . . . 62.44 110.622 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -61.9 -44.0 97.69 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 114.951 -1.022 . . . . 74.03 110.087 173.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -61.56 -31.36 71.39 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.717 0.807 . . . . 73.32 110.867 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.45 ' HG2' ' O ' ' A' ' 44' ' ' GLU . 33.0 mmtp -65.16 -50.64 65.18 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.072 0.549 . . . . 75.14 109.993 175.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -64.51 -29.88 70.91 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 123.247 0.342 . . . . 71.44 111.56 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.604 HD12 ' HB3' ' A' ' 29' ' ' LEU . 84.6 mt -74.1 -31.89 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.577 1.151 . . . . 74.43 110.208 175.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -72.59 -36.64 68.19 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.579 0.752 . . . . 73.43 110.522 175.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -66.88 -49.46 65.58 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.286 1.034 . . . . 75.34 109.976 176.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.1 -52.06 66.98 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 114.558 -1.201 . . . . 65.45 111.138 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.441 ' HH ' ' HD3' ' A' ' 23' ' ' LYS . 59.1 t80 -63.52 -33.65 76.04 Favored 'General case' 0 C--O 1.209 -1.026 0 CA-C-N 115.166 -0.924 . . . . 73.53 110.615 178.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.54 -56.46 20.99 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.798 0.439 . . . . 72.52 110.861 177.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.404 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 48.5 t -66.28 -33.42 63.43 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 CA-C-N 114.595 -1.184 . . . . 74.52 111.303 -176.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.597 ' HB3' HG12 ' A' ' 22' ' ' ILE . 75.4 mt -102.38 -5.02 24.63 Favored 'General case' 0 CA--C 1.555 1.163 0 N-CA-C 114.416 1.265 . . . . 74.35 114.416 -172.295 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 34.8 t -75.03 -56.82 4.36 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 118.497 0.59 . . . . 74.34 109.916 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.502 ' HB2' ' HE3' ' A' ' 62' ' ' LYS . 12.9 m-20 -80.62 127.38 75.67 Favored Pre-proline 0 C--O 1.255 1.35 0 CA-C-N 115.372 -0.831 . . . . 74.34 110.041 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.45 ' O ' ' HG2' ' A' ' 64' ' ' ARG . 64.6 Cg_exo -53.11 -26.43 32.93 Favored 'Trans proline' 0 C--N 1.387 2.575 0 C-N-CA 123.57 2.847 . . . . 72.41 113.02 177.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -54.13 -65.72 0.52 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.006 1.322 . . . . 72.3 111.688 174.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.572 ' HE2' ' HB3' ' A' ' 84' ' ' ASP . 21.9 mttt -72.08 -26.14 62.04 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 115.667 -0.697 . . . . 74.54 110.117 -173.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.6 tpt180 -55.34 -51.34 67.1 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 124.015 0.822 . . . . 74.11 109.802 168.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.45 ' HG2' ' O ' ' A' ' 60' ' ' PRO . 1.7 mmp_? -63.67 -36.56 84.24 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.889 0.476 . . . . 74.25 111.392 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.623 HD11 ' HG3' ' A' ' 79' ' ' PRO . 79.5 mt -60.73 -40.19 84.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 123.753 0.658 . . . . 74.41 110.535 175.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -69.18 -41.83 76.66 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.827 -0.624 . . . . 75.4 109.462 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -61.36 -43.09 99.46 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.222 0.609 . . . . 64.04 110.899 177.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 50.9 p -72.07 -20.44 61.66 Favored 'General case' 0 C--N 1.348 0.537 0 CA-C-N 115.701 -0.682 . . . . 75.44 110.653 177.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.404 ' HD2' ' HE2' ' A' ' 4' ' ' LYS . 46.2 t80 -86.01 101.18 12.69 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 108.243 -1.021 . . . . 75.32 108.243 173.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 115.2 17.63 6.63 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.894 -0.882 . . . . 64.23 110.894 -166.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 90.6 m -142.17 -61.39 0.45 Allowed 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 103.822 -2.659 . . . . 71.23 103.822 173.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 50.9 m -79.92 146.35 32.17 Favored 'General case' 0 C--O 1.251 1.178 0 N-CA-C 105.032 -2.211 . . . . 74.23 105.032 157.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.36 -39.85 10.26 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.025 0.53 . . . . 74.04 111.375 -177.163 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.47 155.9 56.65 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 123.633 0.773 . . . . 75.1 110.528 -176.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -57.08 119.71 7.14 Favored 'Trans proline' 0 C--N 1.384 2.4 0 C-N-CA 122.673 2.249 . . . . 75.41 111.266 175.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.45 155.99 23.53 Favored 'Trans proline' 0 C--N 1.384 2.431 0 C-N-CA 122.909 2.406 . . . . 74.25 112.841 178.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -56.12 135.45 69.93 Favored 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 122.512 2.141 . . . . 73.45 111.123 174.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -42.61 118.69 1.2 Allowed 'Trans proline' 0 C--N 1.383 2.36 0 C-N-CA 123.687 2.925 . . . . 73.2 113.821 177.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.623 ' HG3' HD11 ' A' ' 65' ' ' ILE . 52.2 Cg_endo -62.31 166.58 12.7 Favored 'Trans proline' 0 C--N 1.383 2.391 0 C-N-CA 123.723 2.949 . . . . 71.05 112.342 -176.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -49.45 83.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.398 3.155 0 C-N-CA 124.095 3.197 . . . . 74.31 114.007 -175.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 136.26 -61.81 0.61 Allowed Glycine 0 N--CA 1.445 -0.701 0 CA-C-N 113.905 -1.498 . . . . 62.41 109.551 -176.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.4 ' O ' ' HG2' ' A' ' 79' ' ' PRO . . . 144.86 -157.75 27.39 Favored Glycine 0 N--CA 1.468 0.812 0 N-CA-C 110.579 -1.008 . . . . 53.03 110.579 -169.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.409 ' HB3' ' HD1' ' A' ' 101' ' ' PHE . 96.3 m-85 -105.1 106.54 17.08 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.489 0.716 . . . . 74.41 109.884 -177.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.572 ' HB3' ' HE2' ' A' ' 62' ' ' LYS . 5.0 t70 -78.98 138.59 38.12 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.298 1.039 . . . . 71.31 112.313 -177.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -136.59 68.98 1.42 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.802 0.841 . . . . 73.24 109.812 170.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 59.0 m -53.32 94.71 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 125.104 1.362 . . . . 74.44 113.766 -176.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.34 9.14 63.76 Favored Glycine 0 C--N 1.352 1.436 0 CA-C-N 115.901 -0.591 . . . . 70.11 114.144 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -96.23 130.59 43.27 Favored 'General case' 0 C--O 1.241 0.63 0 N-CA-C 107.71 -1.218 . . . . 72.34 107.71 -179.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -75.32 81.56 2.42 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 121.668 0.747 . . . . 71.44 111.134 -171.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.502 HG21 ' CZ ' ' A' ' 97' ' ' PHE . 0.9 OUTLIER -40.02 -41.19 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 126.633 1.973 . . . . 75.21 112.4 171.66 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -69.51 -5.85 26.84 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.328 1.051 . . . . 75.33 113.167 -172.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -115.45 -12.08 11.74 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.997 0.519 . . . . 61.35 111.753 -177.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 20.8 m-30 -85.53 168.57 14.39 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 112.919 0.711 . . . . 73.34 112.919 -167.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 98.7 p -65.69 168.51 7.59 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 124.919 1.288 . . . . 74.5 114.233 -164.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.24 -35.9 82.34 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 115.308 -0.86 . . . . 74.52 111.148 174.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -58.29 -47.08 84.79 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.96 0.904 . . . . 75.03 109.901 177.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.502 ' CZ ' HG21 ' A' ' 90' ' ' VAL . 5.3 t80 -56.94 -52.28 65.83 Favored 'General case' 0 CA--C 1.554 1.126 0 O-C-N 124.348 1.03 . . . . 72.32 110.114 172.226 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -65.59 -17.23 64.43 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 112.81 0.67 . . . . 74.14 112.81 -173.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -99.9 -36.5 9.38 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 112.93 0.715 . . . . 70.02 112.93 178.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 50.6 tp -78.23 -41.91 32.82 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-O 121.392 0.615 . . . . 74.33 110.355 -179.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.409 ' HD1' ' HB3' ' A' ' 83' ' ' TYR . 43.3 m-85 -97.18 -24.88 15.51 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.213 1.005 . . . . 72.11 111.278 -175.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -44.17 -56.13 5.47 Favored Glycine 0 CA--C 1.545 1.958 0 CA-C-O 118.807 -0.996 . . . . 72.43 115.193 -178.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_exo -47.32 -25.8 5.13 Favored 'Trans proline' 0 C--N 1.391 2.769 0 C-N-CA 124.039 3.16 . . . . 64.43 115.53 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -133.11 28.96 3.27 Favored Glycine 0 C--N 1.354 1.581 0 CA-C-O 119.53 -0.594 . . . . 54.4 113.427 -177.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 44.6 mt -72.19 72.25 0.9 Allowed 'General case' 0 CA--C 1.563 1.477 0 CA-C-N 117.316 0.558 . . . . 74.25 112.151 170.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 11.8 p90 32.4 -130.76 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 127.27 2.228 . . . . 74.45 116.199 163.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.436 ' HA2' ' H ' ' A' ' 169' ' ' ASN . . . 92.2 36.36 6.32 Favored Glycine 0 C--N 1.354 1.541 0 N-CA-C 111.49 -0.644 . . . . 44.0 111.49 -165.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.359 1.838 0 CA-C-O 121.434 0.463 . . . . 71.34 112.847 167.84 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 48.6 tptt . . . . . 0 N--CA 1.505 2.284 0 N-CA-C 115.85 1.796 . . . . 73.31 115.85 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.614 ' H ' ' HA3' ' A' ' 172' ' ' GLY . . . -121.29 -155.56 9.53 Favored Glycine 0 CA--C 1.548 2.152 0 C-N-CA 127.317 2.389 . . . . 73.4 112.76 162.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.06 143.46 56.7 Favored 'General case' 0 C--O 1.285 2.97 0 N-CA-C 116.361 1.985 . . . . 74.43 116.361 178.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.577 ' HA ' ' O ' ' A' ' 173' ' ' ASP . 14.8 p-10 -76.16 104.57 6.75 Favored 'General case' 0 CA--C 1.552 1.052 0 CA-C-N 112.175 -2.284 . . . . 74.23 113.151 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.466 ' O ' HD13 ' A' ' 174' ' ' LEU . 6.4 tt -93.37 165.36 12.82 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.1 1.36 . . . . 75.42 107.556 174.122 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 30.4 ttp85 -112.66 130.82 55.91 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 118.503 0.592 . . . . 74.51 110.127 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.442 ' HB1' HD11 ' A' ' 174' ' ' LEU . . . -146.33 176.54 9.69 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.998 0.919 . . . . 54.41 110.886 -175.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -107.89 139.88 41.83 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-N 114.533 -1.212 . . . . 72.42 109.197 -171.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.561 ' HB2' HD13 ' A' ' 176' ' ' LEU . 45.7 tp -100.18 96.97 5.55 Favored Pre-proline 0 N--CA 1.473 0.71 0 N-CA-C 107.368 -1.345 . . . . 74.14 107.368 170.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.505 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 53.0 Cg_endo -75.54 107.31 2.44 Favored 'Trans proline' 0 C--N 1.37 1.704 0 N-CA-C 106.923 -1.991 . . . . 75.33 106.923 171.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.506 ' HB3' HD22 ' A' ' 180' ' ' LEU . 59.5 tp -116.54 127.47 54.55 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 109.241 -0.651 . . . . 72.43 109.241 -167.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.616 HG22 ' HB2' ' B' ' 4' ' ' SER . 50.6 m -57.03 130.55 46.58 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 124.66 1.225 . . . . 71.34 110.965 -178.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.42 HD11 ' HD1' ' A' ' 183' ' ' HIS . 35.4 mt -47.62 -47.22 29.01 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.358 1.063 . . . . 75.21 111.232 -178.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -56.23 -49.53 73.87 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 114.391 -1.277 . . . . 75.32 110.695 178.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -64.26 -33.71 76.45 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.298 0.639 . . . . 64.33 111.7 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.412 ' HB2' HD23 ' A' ' 180' ' ' LEU . . . -62.46 -38.68 90.76 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.459 0.704 . . . . 65.44 110.825 177.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -66.33 -46.02 78.26 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 114.874 -1.057 . . . . 74.51 111.071 173.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.508 ' HE1' ' HA ' ' B' ' 2' ' ' LYS . 24.0 m170 -66.55 -65.52 0.67 Allowed 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.282 0.633 . . . . 75.25 111.378 -173.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.511 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 90.82 179.76 43.15 Favored Glycine 0 C--N 1.346 1.117 0 CA-C-N 116.14 -0.482 . . . . 71.54 112.421 -177.029 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.59 -157.45 27.67 Favored Glycine 0 C--N 1.345 1.038 0 C-N-CA 123.298 0.475 . . . . 70.42 112.313 179.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 13.7 mp0 -70.98 98.77 1.67 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.929 0.892 . . . . 73.14 111.091 -176.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 7.1 tpp180 -94.01 119.95 33.59 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.872 0.869 . . . . 75.05 109.295 172.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.481 ' O ' HG21 ' B' ' 5' ' ' THR . 76.2 t -79.44 106.01 9.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 114.749 -1.114 . . . . 75.04 109.218 172.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.6 p -111.32 125.1 68.63 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 N-CA-C 108.86 -0.793 . . . . 73.34 108.86 172.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.538 ' HB3' ' HG3' ' A' ' 144' ' ' ARG . 6.4 pt-20 -124.97 116.46 22.19 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.547 0.739 . . . . 71.3 111.426 -166.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.498 HG12 ' HB2' ' B' ' 8' ' ' LEU . 9.2 p -159.92 155.19 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.166 0.986 . . . . 75.1 108.963 177.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 61.63 22.68 13.13 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 124.274 1.03 . . . . 74.24 112.757 174.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 87.42 -13.05 61.15 Favored Glycine 0 C--N 1.353 1.486 0 CA-C-N 116.369 -0.378 . . . . 54.15 113.285 -177.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 22.7 tpt180 -95.81 115.09 26.92 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.395 0.678 . . . . 72.43 110.251 178.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.538 ' HG3' ' HB3' ' A' ' 139' ' ' GLU . 13.1 ttt180 -100.55 88.22 3.57 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.081 0.952 . . . . 74.41 108.726 173.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 11.2 p -94.88 144.99 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 123.083 0.553 . . . . 73.53 110.909 -173.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 22.9 t -107.64 86.97 2.39 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 109.226 -0.657 . . . . 64.43 109.226 176.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.7 p -85.02 124.17 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 123.305 0.642 . . . . 73.42 110.003 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 61.6 ttt85 -75.88 95.74 3.58 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.311 0.577 . . . . 74.32 109.652 177.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.511 HG13 ' HA2' ' A' ' 133' ' ' GLY . 33.6 pt -77.37 140.2 64.76 Favored Pre-proline 0 CA--C 1.557 1.225 0 CA-C-N 115.255 -0.884 . . . . 74.52 109.977 175.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -61.86 130.83 32.54 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.547 2.164 . . . . 74.22 112.301 174.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -61.96 112.11 1.42 Allowed 'Trans proline' 0 C--N 1.377 2.065 0 C-N-CA 122.389 2.059 . . . . 74.15 111.45 170.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 84.37 46.3 5.87 Favored Glycine 0 C--N 1.343 0.951 0 N-CA-C 111.128 -0.789 . . . . 75.51 111.128 -171.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -80.36 153.1 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 N-CA-C 109.525 -0.546 . . . . 75.43 109.525 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.543 ' HG2' ' HA ' ' A' ' 191' ' ' GLN . 0.0 OUTLIER -124.91 159.46 31.09 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 123.448 0.699 . . . . 73.23 110.926 -174.629 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.425 ' HB2' ' HB3' ' A' ' 188' ' ' LEU . 10.4 tp10 -57.73 126.29 26.71 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.222 1.409 . . . . 72.32 110.998 -179.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 103.52 -10.32 53.46 Favored Glycine 0 C--N 1.347 1.148 0 CA-C-O 119.175 -0.792 . . . . 74.33 113.993 178.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 33.6 t -63.63 112.18 2.71 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 117.693 0.746 . . . . 74.23 109.962 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.455 HG23 HG21 ' A' ' 177' ' ' VAL . 41.8 t -89.51 115.96 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.156 0.582 . . . . 74.02 110.672 -176.32 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 55.2 mt -108.22 108.14 24.54 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 123.967 0.907 . . . . 75.24 108.684 175.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -75.39 101.17 4.67 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 108.68 -0.859 . . . . 75.21 108.68 174.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.524 HG21 ' HE3' ' A' ' 164' ' ' MET . 7.6 p -124.15 113.58 27.99 Favored Pre-proline 0 CA--C 1.541 0.62 0 N-CA-C 108.26 -1.015 . . . . 71.41 108.26 -173.095 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.412 ' HA ' ' H ' ' A' ' 174' ' ' LEU . 10.1 Cg_exo -71.66 146.43 48.94 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 121.106 1.204 . . . . 74.53 111.839 178.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . 0.497 ' H ' ' HA ' ' A' ' 173' ' ' ASP . . . 131.36 -23.91 4.24 Favored Glycine 0 C--N 1.344 0.977 0 N-CA-C 116.646 1.418 . . . . 70.43 116.646 170.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.524 ' HE3' HG21 ' A' ' 161' ' ' VAL . 3.1 mpp? -124.47 -3.8 7.84 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 113.498 0.925 . . . . 64.15 113.498 -165.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.595 ' HA2' HD12 ' A' ' 174' ' ' LEU . . . -74.7 -100.23 0.1 OUTLIER Glycine 0 N--CA 1.474 1.202 0 CA-C-O 118.653 -1.082 . . . . 73.33 113.836 -174.299 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.631 ' HA3' ' HB2' ' A' ' 171' ' ' PRO . . . -70.04 167.17 49.19 Favored Glycine 0 C--N 1.377 2.808 0 C-N-CA 118.079 -2.01 . . . . 74.5 111.333 172.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.504 ' HA ' HE21 ' A' ' 167' ' ' GLN . 0.0 OUTLIER -104.32 102.85 12.52 Favored 'General case' 0 CA--C 1.56 1.359 0 CA-C-N 118.675 1.238 . . . . 75.42 114.095 -177.434 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 122.1 -161.64 16.17 Favored Glycine 0 C--N 1.369 2.392 0 N-CA-C 115.653 1.021 . . . . 64.21 115.653 164.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . 0.436 ' H ' ' HA2' ' A' ' 107' ' ' GLY . 20.4 m120 -63.88 -45.91 81.27 Favored Pre-proline 0 CA--C 1.576 1.953 0 CA-C-O 118.494 -0.765 . . . . 63.54 111.023 174.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.492 ' HB2' ' HD3' ' A' ' 171' ' ' PRO . 12.6 Cg_exo -72.67 -56.7 0.09 OUTLIER 'Trans proline' 0 CA--C 1.593 3.451 0 CA-C-N 121.973 1.74 . . . . 73.02 116.001 175.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.631 ' HB2' ' HA3' ' A' ' 166' ' ' GLY . 18.8 Cg_endo -98.75 155.27 0.7 Allowed 'Trans proline' 0 C--N 1.399 3.189 0 C-N-CA 122.647 2.231 . . . . 71.25 111.24 167.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.614 ' HA3' ' H ' ' A' ' 116' ' ' GLY . . . -170.13 -80.04 0.05 OUTLIER Glycine 0 C--N 1.379 2.951 0 N-CA-C 120.489 2.956 . . . . 72.4 120.489 -164.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.577 ' O ' ' HA ' ' A' ' 118' ' ' ASP . 59.0 m-20 -63.08 162.96 10.71 Favored 'General case' 0 N--CA 1.509 2.476 0 CA-C-N 118.054 0.927 . . . . 71.14 112.179 -168.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.595 HD12 ' HA2' ' A' ' 165' ' ' GLY . 20.1 tp -128.42 147.85 50.68 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 120.132 1.333 . . . . 74.2 113.608 -177.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 8.4 mt -111.09 92.75 4.17 Favored 'General case' 0 CA--C 1.555 1.145 0 N-CA-C 106.774 -1.565 . . . . 72.12 106.774 168.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.561 HD13 ' HB2' ' A' ' 123' ' ' LEU . 15.0 mt -76.19 138.51 40.71 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 118.132 0.424 . . . . 74.52 111.607 178.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.455 HG21 HG23 ' A' ' 158' ' ' VAL . 47.4 t -119.71 116.0 49.25 Favored 'Isoleucine or valine' 0 C--O 1.242 0.677 0 N-CA-C 106.017 -1.846 . . . . 71.11 106.017 164.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.457 ' HA ' ' HB3' ' A' ' 123' ' ' LEU . 10.1 p -72.12 120.32 20.3 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 CA-C-O 121.848 0.832 . . . . 74.13 111.314 -171.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.505 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 32.3 mmt180 -106.82 99.53 9.09 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 107.849 -1.167 . . . . 73.42 107.849 172.109 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.746 HD11 ' HG ' ' A' ' 188' ' ' LEU . 80.4 mt -70.12 131.22 43.96 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 109.162 -0.681 . . . . 74.04 109.162 179.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.469 HD11 ' HA ' ' A' ' 126' ' ' THR . 54.7 mt -53.38 150.5 11.92 Favored Pre-proline 0 N--CA 1.481 1.084 0 O-C-N 124.606 1.191 . . . . 73.22 113.666 -163.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -83.21 49.1 2.9 Favored 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 122.796 2.331 . . . . 74.32 108.488 160.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . 0.42 ' HD1' HD11 ' A' ' 127' ' ' LEU . 26.6 t-80 -69.97 131.5 89.08 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 107.254 -1.387 . . . . 73.35 107.254 178.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_exo -16.84 -34.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.386 2.522 1 C-N-CA 127.977 5.784 . . . . 61.24 120.623 -164.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 4.8 t -95.06 -59.57 3.05 Favored 'Isoleucine or valine' 0 C--N 1.353 0.744 0 CA-C-N 120.011 1.278 . . . . 72.34 108.728 -172.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . 0.453 ' CD1' ' HB1' ' A' ' 195' ' ' ALA . 49.2 m-85 -115.76 154.62 29.28 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 121.177 0.513 . . . . 72.31 111.333 -169.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 26.6 ttp180 -138.6 129.57 26.77 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 107.032 -1.47 . . . . 75.51 107.032 165.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.746 ' HG ' HD11 ' A' ' 180' ' ' LEU . 4.5 mm? -79.51 166.16 22.24 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.96 0.886 . . . . 74.21 112.3 -176.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -163.83 96.86 0.83 Allowed 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 105.663 -1.976 . . . . 70.31 105.663 174.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 62.02 -122.6 29.11 Favored Glycine 0 CA--C 1.531 1.075 0 N-CA-C 111.413 -0.675 . . . . 65.41 111.413 -168.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.543 ' HA ' ' HG2' ' A' ' 154' ' ' ARG . 2.2 mp0 -86.39 -13.89 45.0 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.793 0.837 . . . . 72.32 111.512 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -107.98 156.57 19.08 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 121.718 0.771 . . . . 72.32 112.684 -168.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.526 HD21 ' HE1' ' A' ' 240' ' ' PHE . 59.5 mt -103.61 155.7 18.35 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.781 1.633 . . . . 74.25 111.06 -170.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -132.04 100.13 4.95 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 107.845 -1.168 . . . . 73.14 107.845 169.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.568 ' HB3' HD21 ' A' ' 251' ' ' LEU . . . -105.32 116.0 31.2 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.429 1.091 . . . . 74.34 110.656 -176.463 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 38.3 m -71.4 102.62 2.68 Favored 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 109.409 -0.589 . . . . 70.21 109.409 176.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.546 HD21 HD13 ' A' ' 251' ' ' LEU . 33.2 tp -101.26 104.42 15.45 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 108.727 -0.842 . . . . 74.1 108.727 -174.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -84.4 108.68 17.35 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.891 -0.781 . . . . 63.3 108.891 175.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 6.2 p -120.76 137.27 26.2 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 124.71 1.204 . . . . 74.33 108.316 -177.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.29 156.84 33.28 Favored 'Trans proline' 0 C--N 1.363 1.327 0 C-N-CA 121.485 1.457 . . . . 70.05 111.605 173.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.455 ' HB2' ' HH2' ' A' ' 269' ' ' TRP . . . -56.46 -48.82 96.35 Favored Pre-proline 0 CA--C 1.557 1.227 0 N-CA-C 114.701 1.371 . . . . 71.34 114.701 -168.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -57.5 -42.71 58.25 Favored 'Trans proline' 0 C--N 1.395 2.995 0 CA-C-N 121.526 1.581 . . . . 73.32 112.079 178.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.433 HG12 ' HE1' ' C' ' 277' ' ' TYR . 20.2 mt -73.21 -28.74 26.51 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 CA-C-N 115.262 -0.881 . . . . 71.02 110.634 -176.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -72.05 -48.64 42.89 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.348 0.659 . . . . 74.14 111.371 178.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.472 HG13 HD13 ' C' ' 261' ' ' LEU . 95.6 t -72.03 -41.54 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.469 0.708 . . . . 64.22 111.747 -175.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 70.3 t -87.32 -41.9 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 116.07 -0.513 . . . . 74.41 111.384 -176.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 91.73 83.81 1.46 Allowed Glycine 0 CA--C 1.525 0.711 0 CA-C-N 116.097 -0.501 . . . . 72.35 112.83 -177.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -126.22 -172.42 13.35 Favored Glycine 0 N--CA 1.473 1.149 0 N-CA-C 111.363 -0.695 . . . . 73.32 111.363 173.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 221' ' ' VAL . 50.2 mtmt -85.06 133.16 34.24 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 117.75 0.775 . . . . 73.34 112.522 -174.281 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 34.8 m -121.55 170.55 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 124.253 1.021 . . . . 63.11 108.726 166.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 22.2 ttm180 -82.43 109.36 16.6 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 109.473 -0.566 . . . . 74.32 109.473 172.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -103.18 132.32 49.52 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 108.426 -0.953 . . . . 74.41 108.426 173.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' MET . . . . . 0.444 ' N ' ' SD ' ' A' ' 213' ' ' MET . 1.5 mpt? -92.38 135.75 33.77 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.494 -0.558 . . . . 74.15 109.494 -175.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 55.8 p -111.79 -176.45 2.94 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.379 0.672 . . . . 74.1 109.517 174.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 58.5 mt -80.41 -4.17 52.59 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.658 0.783 . . . . 73.14 111.949 -177.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.417 ' HA ' ' HE2' ' B' ' 2' ' ' LYS . 56.3 mm-40 -115.65 -17.93 10.99 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.356 0.662 . . . . 64.44 111.507 176.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 156.16 175.35 27.04 Favored Glycine 0 C--N 1.354 1.536 0 C-N-CA 121.465 -0.398 . . . . 63.05 114.012 176.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -77.93 124.41 6.76 Favored 'Trans proline' 0 C--N 1.372 1.795 0 C-N-CA 122.934 2.423 . . . . 74.13 112.349 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 30.9 m -121.11 179.92 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 124.451 1.1 . . . . 73.4 109.429 177.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -102.58 150.27 23.58 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.356 0.662 . . . . 75.04 109.584 172.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 209' ' ' LYS . 2.8 p -145.98 141.36 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 N-CA-C 108.972 -0.751 . . . . 74.51 108.972 176.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -86.45 100.81 12.62 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.045 0.538 . . . . 70.4 110.47 -178.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 91.8 t -53.9 143.29 41.88 Favored Pre-proline 0 N--CA 1.494 1.734 0 C-N-CA 125.204 1.402 . . . . 71.22 111.136 -179.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -62.11 162.83 21.59 Favored 'Trans proline' 0 C--N 1.386 2.534 0 C-N-CA 122.627 2.218 . . . . 75.51 112.406 172.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.54 155.47 35.92 Favored 'Trans proline' 0 C--N 1.367 1.521 0 C-N-CA 121.408 1.405 . . . . 72.53 111.134 166.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 65.33 20.59 11.87 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 125.305 1.442 . . . . 75.13 112.244 173.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.428 HG23 HD21 ' A' ' 233' ' ' LEU . 96.5 m -59.19 104.52 0.25 Allowed 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 124.715 1.206 . . . . 64.32 111.202 -176.028 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 5.3 tp60 -98.11 133.97 41.83 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.689 1.196 . . . . 75.32 111.994 -168.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -62.48 140.32 58.6 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.833 1.253 . . . . 65.12 112.892 -173.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 92.37 -35.69 3.94 Favored Glycine 0 C--N 1.349 1.291 0 O-C-N 123.877 0.736 . . . . 75.54 112.005 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -74.04 161.76 29.71 Favored 'General case' 0 C--N 1.349 0.555 0 C-N-CA 123.867 0.867 . . . . 74.44 111.352 -177.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.718 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 3.4 mptp? -113.34 118.46 34.65 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.909 0.884 . . . . 72.22 109.065 -175.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.489 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 39.0 mt -76.79 100.25 5.41 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.764 -0.828 . . . . 71.4 108.764 178.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 54.3 ttm-85 -71.86 105.86 3.97 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 110.245 -0.279 . . . . 73.41 110.245 179.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.501 HD13 HD23 ' A' ' 249' ' ' LEU . 9.1 mt -95.31 104.06 15.94 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 107.508 -1.293 . . . . 74.24 107.508 173.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 18.0 tptp -71.47 118.82 14.76 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.353 0.661 . . . . 71.01 111.181 -172.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 85.47 32.21 19.92 Favored Glycine 0 C--N 1.35 1.347 0 O-C-N 123.418 0.449 . . . . 74.2 113.251 177.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -125.62 5.69 7.52 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.68 0.792 . . . . 74.1 112.443 -175.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -93.86 -157.5 33.15 Favored Glycine 0 N--CA 1.469 0.868 0 C-N-CA 123.378 0.513 . . . . 74.43 112.451 171.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . 0.526 ' HE1' HD21 ' A' ' 193' ' ' LEU . 27.2 m-85 -83.38 140.44 41.9 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 122.954 0.502 . . . . 73.41 111.136 -175.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 240' ' ' PHE . 3.6 Cg_exo -77.41 138.09 17.26 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 123.558 2.839 . . . . 73.33 112.587 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 178.19 -138.52 3.75 Favored Glycine 0 CA--C 1.534 1.275 0 CA-C-O 119.056 -0.858 . . . . 73.52 112.449 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -67.69 -12.52 35.8 Favored 'Trans proline' 0 C--N 1.382 2.337 0 C-N-CA 123.844 3.03 . . . . 72.5 114.086 -177.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -103.96 21.77 15.78 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.744 0.418 . . . . 70.11 110.37 175.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 71.88 -93.74 0.58 Allowed Glycine 0 C--N 1.353 1.483 0 N-CA-C 110.329 -1.108 . . . . 62.24 110.329 -173.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 -126.18 131.46 52.0 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 107.626 -1.25 . . . . 75.41 107.626 167.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -70.35 -168.0 7.0 Favored Glycine 0 C--N 1.352 1.419 0 O-C-N 123.266 0.354 . . . . 70.31 112.871 178.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -111.55 173.34 6.4 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 117.513 0.656 . . . . 75.44 111.112 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.501 HD23 HD13 ' A' ' 235' ' ' LEU . 23.5 tp -128.9 104.07 7.39 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.556 -0.905 . . . . 73.32 108.556 176.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.718 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 0.4 OUTLIER -89.81 105.65 17.94 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.701 -0.852 . . . . 71.3 108.701 -178.881 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.568 HD21 ' HB3' ' A' ' 195' ' ' ALA . 66.3 mt -84.93 101.95 12.75 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.906 -0.775 . . . . 74.54 108.906 177.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . 0.576 ' HG2' ' HG3' ' A' ' 232' ' ' LYS . 26.0 mt-10 -76.36 104.47 6.89 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.025 0.93 . . . . 75.41 108.743 -177.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 40.6 t -67.11 127.68 29.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 114.316 -1.311 . . . . 71.34 112.145 -167.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.49 91.93 3.4 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 107.516 -1.291 . . . . 73.14 107.516 175.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.531 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 66.7 mt -79.4 133.55 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 109.777 -0.453 . . . . 74.34 109.777 -178.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 19.6 p -130.52 175.26 9.13 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.144 0.978 . . . . 74.52 110.481 174.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . 0.417 HD12 ' H ' ' A' ' 259' ' ' GLU . 2.7 pp -132.38 152.45 80.09 Favored Pre-proline 0 CA--C 1.558 1.26 0 C-N-CA 123.843 0.857 . . . . 73.4 109.557 -178.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -76.55 8.63 2.91 Favored 'Trans proline' 0 N--CA 1.507 2.301 0 C-N-CA 123.157 2.571 . . . . 74.45 115.03 -165.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . 0.571 ' HG2' ' NE2' ' C' ' 228' ' ' GLN . 33.3 mt-10 53.11 -85.53 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.616 1.166 . . . . 75.12 111.219 -163.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.83 158.93 5.86 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.163 0.985 . . . . 75.12 111.878 179.135 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.598 HD21 ' HB3' ' A' ' 265' ' ' GLU . 74.7 mt -143.39 151.22 40.15 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.416 0.686 . . . . 72.32 110.558 178.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 58.3 p -83.67 161.57 55.74 Favored Pre-proline 0 CA--C 1.559 1.303 0 N-CA-C 108.689 -0.856 . . . . 74.31 108.689 166.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -42.06 -47.03 6.95 Favored 'Trans proline' 0 C--N 1.385 2.45 0 C-N-CA 123.779 2.986 . . . . 74.33 115.217 177.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -67.14 -47.42 71.15 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.017 0.527 . . . . 71.44 109.856 -179.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . 0.598 ' HB3' HD21 ' A' ' 261' ' ' LEU . 43.6 mt-10 -56.83 -42.46 79.67 Favored 'General case' 0 C--N 1.352 0.693 0 O-C-N 123.873 0.733 . . . . 73.22 110.866 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -62.58 -50.13 72.53 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 123.195 0.31 . . . . 73.45 110.292 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -54.97 -51.61 65.65 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 124.158 0.912 . . . . 64.12 111.569 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . 0.46 ' HB2' HD22 ' C' ' 272' ' ' LEU . 10.1 mp -73.67 -43.62 58.89 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.291 0.637 . . . . 73.14 111.935 -173.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 269' ' ' TRP . . . . . 0.455 ' HH2' ' HB2' ' A' ' 201' ' ' ALA . 62.5 m95 -58.68 -45.79 88.66 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 123.358 0.663 . . . . 75.0 111.086 177.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . 0.714 ' HB3' ' HZ1' ' A' ' 270' ' ' LYS . 8.7 mtpm? -63.34 -50.06 71.48 Favored 'General case' 0 C--N 1.352 0.693 0 CA-C-N 115.842 -0.617 . . . . 73.12 111.012 178.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -64.38 -29.66 70.72 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.045 0.538 . . . . 70.22 111.979 -179.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 272' ' ' LEU . . . . . 0.4 ' O ' ' HB2' ' A' ' 276' ' ' TYR . 31.5 mt -61.62 -52.41 64.48 Favored 'General case' 0 C--O 1.211 -0.943 0 N-CA-C 109.377 -0.601 . . . . 71.54 109.377 172.238 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -64.68 -37.04 86.23 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 123.904 0.752 . . . . 72.23 112.824 -178.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -67.18 -47.65 70.3 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.823 0.849 . . . . 74.35 110.485 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . 0.508 ' O ' ' HG2' ' A' ' 279' ' ' ARG . . . -59.68 -60.13 4.34 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.546 0.738 . . . . 72.24 109.767 175.32 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . 0.4 ' HB2' ' O ' ' A' ' 272' ' ' LEU . 24.5 t80 -39.24 -58.96 1.1 Allowed 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 127.45 2.3 . . . . 75.02 111.939 178.072 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -62.45 -46.02 90.44 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 114.572 -1.195 . . . . 72.14 109.963 -176.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -69.81 -8.9 52.24 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.005 0.742 . . . . 75.41 113.005 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . 0.508 ' HG2' ' O ' ' A' ' 275' ' ' ALA . 8.7 mmm180 -93.26 -7.45 45.02 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 117.902 0.319 . . . . 75.15 111.63 177.164 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 1.163 0 CA-C-O 118.309 -0.853 . . . . 72.5 109.811 179.676 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.2 mmt . . . . . 0 N--CA 1.475 0.796 0 N-CA-C 110.135 -0.321 . . . . 74.12 110.135 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . 0.508 ' HA ' ' HE1' ' A' ' 132' ' ' HIS . 0.2 OUTLIER -78.68 1.45 22.86 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.934 0.894 . . . . 62.45 113.286 -165.996 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.62 10.04 4.71 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.811 0.845 . . . . 74.04 111.118 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 4' ' ' SER . . . . . 0.616 ' HB2' HG22 ' A' ' 126' ' ' THR . 60.8 m -70.81 101.11 2.04 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-O 121.599 0.714 . . . . 52.14 110.703 -176.172 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 5' ' ' THR . . . . . 0.481 HG21 ' O ' ' A' ' 137' ' ' VAL . 92.9 m -85.85 154.78 21.3 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 114.337 -1.301 . . . . 74.34 110.986 -179.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.443 HD13 ' HA ' ' A' ' 125' ' ' LEU . 21.9 pt -126.61 178.44 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 C-N-CA 124.509 1.124 . . . . 65.34 111.487 -167.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -147.19 134.5 20.66 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.805 1.242 . . . . 72.22 108.448 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . 0.498 ' HB2' HG12 ' A' ' 140' ' ' VAL . 1.5 mm? -63.59 150.9 43.04 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 118.575 0.625 . . . . 75.22 111.569 -178.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.04 -43.17 79.33 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 114.787 -1.097 . . . . 73.12 110.054 173.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 29.9 mt 74.34 -40.76 0.46 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 126.477 1.911 . . . . 74.1 113.525 -179.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 53.1 mt . . . . . 0 CA--C 1.565 1.533 0 C-N-CA 124.566 1.146 . . . . 72.11 110.714 -173.121 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.849 0 CA-C-O 120.787 0.327 . . . . 74.35 110.726 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 180' ' ' ALA . . . . . 0.482 ' HB3' HG22 ' C' ' 137' ' ' VAL . . . -63.71 -63.68 1.1 Allowed 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 109.16 -0.681 . . . . 75.32 109.16 170.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 181' ' ' LEU . . . . . 0.541 HD11 ' HB2' ' C' ' 136' ' ' ARG . 45.1 tp -143.85 -67.28 0.34 Allowed 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 106.727 -1.582 . . . . 74.44 106.727 167.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 182' ' ' VAL . . . . . 0.551 HG22 ' HB2' ' C' ' 125' ' ' LEU . 14.7 p -151.4 153.78 9.34 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 N-CA-C 107.185 -1.413 . . . . 72.43 107.185 -177.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -83.08 63.97 7.41 Favored 'General case' 0 CA--C 1.562 1.438 0 N-CA-C 115.266 1.58 . . . . 65.24 115.266 -158.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 12.3 m170 60.79 -176.16 0.11 Allowed 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 114.379 1.252 . . . . 75.32 114.379 161.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 185' ' ' VAL . . . . . . . . . . . . . 2.6 p . . . . . 0 N--CA 1.476 0.869 0 C-N-CA 122.816 0.446 . . . . 74.01 110.509 173.238 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 238' ' ' THR . . . . . 0.544 HG23 HG23 ' C' ' 219' ' ' VAL . 3.0 m . . . . . 0 N--CA 1.474 0.736 0 N-CA-C 107.527 -1.286 . . . . 71.31 107.527 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -84.09 169.13 15.21 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.746 -0.661 . . . . 74.42 110.204 175.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 240' ' ' GLY . . . . . 0.426 ' H ' HD23 ' C' ' 235' ' ' LEU . . . -109.91 -93.08 2.22 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 110.778 -0.929 . . . . 71.23 110.778 -173.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -165.34 161.2 18.89 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.7 0.8 . . . . 71.23 110.097 -179.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 13.8 m95 -108.19 -82.08 0.56 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.655 0.782 . . . . 70.32 108.944 177.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -153.12 -162.21 1.44 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.765 1.626 . . . . 74.22 107.772 -171.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -73.7 79.53 0.83 Allowed Glycine 0 C--N 1.349 1.274 0 N-CA-C 111.199 -0.76 . . . . 71.54 111.199 170.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 2.1 pptp? . . . . . 0 N--CA 1.479 0.993 0 C-N-CA 123.946 0.898 . . . . 75.34 111.55 -174.685 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.903 0 CA-C-O 121.006 0.431 . . . . 71.34 111.304 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -36.86 117.51 0.51 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.974 1.71 . . . . 70.52 114.133 173.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -76.07 102.58 5.75 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.849 -0.796 . . . . 72.32 108.849 165.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 6' ' ' ASP . . . . . 0.438 ' HA ' ' OH ' ' C' ' 66' ' ' TYR . 8.6 t70 -75.01 94.24 2.83 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.184 -1.043 . . . . 65.15 108.184 176.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 7' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -61.44 -35.51 77.78 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-N 115.264 -0.88 . . . . 73.43 112.361 -171.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -60.12 -50.24 74.49 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 116.121 -0.49 . . . . 74.23 110.179 175.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.7 -39.16 93.62 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.899 -0.591 . . . . 63.34 111.506 -178.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 81.5 mt -58.14 -42.13 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 C-N-CA 123.665 0.786 . . . . 73.31 110.163 176.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 95.9 mt -74.35 -24.01 59.11 Favored 'General case' 0 N--CA 1.48 1.075 0 CA-C-N 116.19 -0.459 . . . . 75.53 112.025 175.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.99 38.31 10.44 Favored Glycine 0 C--N 1.345 1.079 0 CA-C-N 116.93 -0.123 . . . . 74.43 113.187 -176.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 6.0 m -125.78 157.14 69.87 Favored Pre-proline 0 N--CA 1.481 1.116 0 C-N-CA 124.786 1.235 . . . . 71.34 110.226 176.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -67.77 165.38 27.95 Favored 'Trans proline' 0 C--N 1.383 2.386 0 C-N-CA 122.782 2.321 . . . . 74.43 112.423 177.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -77.54 16.38 0.66 Allowed 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 123.18 0.592 . . . . 74.35 111.982 -179.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -119.18 -0.15 11.1 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.786 1.635 . . . . 71.24 108.406 178.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.46 133.01 47.99 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.406 0.682 . . . . 75.2 111.94 -171.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 68.4 p -87.69 175.47 7.86 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.452 1.101 . . . . 74.41 110.862 -178.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -51.5 -39.14 57.01 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.183 0.993 . . . . 74.45 111.527 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -62.59 -47.46 83.72 Favored 'General case' 0 C--N 1.349 0.584 0 O-C-N 123.811 0.694 . . . . 74.53 111.258 178.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -66.77 -37.99 85.69 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.659 0.784 . . . . 73.42 111.322 -177.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 22' ' ' ILE . . . . . 0.603 HG12 ' HB3' ' C' ' 57' ' ' LEU . 1.7 mp -62.28 -42.56 95.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.323 1.049 . . . . 75.54 110.439 175.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -69.24 -39.65 78.37 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 114.853 -1.067 . . . . 74.13 110.891 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -70.27 -33.63 71.81 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.737 0.815 . . . . 73.52 110.572 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -74.65 -36.26 62.85 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.777 0.831 . . . . 75.32 110.624 177.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 26' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -60.03 -48.28 82.35 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 115.447 -0.797 . . . . 72.31 108.988 172.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -60.1 -44.76 94.6 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.317 1.047 . . . . 75.33 111.203 178.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 22.6 ttt180 -51.25 -52.16 47.38 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.744 1.217 . . . . 75.55 110.963 177.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . 0.439 HD22 ' HE2' ' C' ' 33' ' ' TYR . 83.3 mt -83.6 -12.47 56.02 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 114.585 -1.189 . . . . 71.43 111.506 -178.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.19 -2.65 55.01 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.684 0.793 . . . . 75.32 110.41 173.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 76.6 mtp180 -95.89 -45.35 6.99 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.6 0.76 . . . . 73.5 109.045 166.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -68.31 -52.84 29.08 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 115.343 -0.844 . . . . 71.12 111.188 -178.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 33' ' ' TYR . . . . . 0.439 ' HE2' HD22 ' C' ' 29' ' ' LEU . 37.3 m-85 -100.97 26.26 7.16 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.577 0.751 . . . . 72.14 110.464 -178.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 34' ' ' HIS . . . . . . . . . . . . . 13.0 t60 -55.12 99.16 0.19 Allowed Pre-proline 0 N--CA 1.488 1.46 0 C-N-CA 124.765 1.226 . . . . 74.34 110.738 -177.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -59.58 -27.88 86.05 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 123.088 2.525 . . . . 72.22 113.97 -167.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -72.1 -25.86 61.92 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.357 0.663 . . . . 60.34 111.929 -177.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 67.2 t -113.22 -25.59 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 CA-C-O 121.352 0.596 . . . . 75.33 110.783 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -105.43 83.98 2.03 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 106.807 -1.553 . . . . 65.41 106.807 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.96 76.5 7.9 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.89 -0.782 . . . . 71.22 108.89 -178.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 67.4 m -143.08 108.43 5.37 Favored Pre-proline 0 C--O 1.235 0.329 0 N-CA-C 107.004 -1.48 . . . . 74.14 107.004 172.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . 0.44 ' O ' ' HG2' ' C' ' 45' ' ' GLU . 76.9 Cg_exo -46.79 -30.59 9.53 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 123.548 2.832 . . . . 75.0 114.161 175.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -57.14 -45.53 83.48 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.752 0.821 . . . . 71.01 111.216 175.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.54 -19.19 62.91 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.508 -0.769 . . . . 71.45 110.84 178.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 44' ' ' GLU . . . . . 0.411 ' O ' ' HG3' ' C' ' 48' ' ' LYS . 36.5 mt-10 -87.6 -30.36 20.54 Favored 'General case' 0 C--N 1.358 0.95 0 C-N-CA 123.184 0.594 . . . . 74.04 110.409 -178.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 45' ' ' GLU . . . . . 0.44 ' HG2' ' O ' ' C' ' 41' ' ' PRO . 11.8 mm-40 -72.39 -40.09 67.51 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 108.895 -0.78 . . . . 75.44 108.895 174.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 46' ' ' LYS . . . . . 0.426 ' O ' HG13 ' C' ' 50' ' ' ILE . 48.4 mttp -63.25 -38.11 89.88 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-N 114.587 -1.188 . . . . 72.32 110.413 170.217 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 47' ' ' PHE . . . . . 0.801 ' HA ' HD12 ' C' ' 50' ' ' ILE . 26.8 t80 -62.45 -35.28 78.81 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 123.526 0.516 . . . . 71.12 110.387 175.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 48' ' ' LYS . . . . . 0.432 ' HB3' ' CE1' ' C' ' 93' ' ' PHE . 98.3 mttt -63.16 -44.74 94.64 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.099 0.56 . . . . 72.04 111.009 174.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -61.13 -36.38 79.6 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 120.997 0.427 . . . . 72.33 111.407 177.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 50' ' ' ILE . . . . . 0.801 HD12 ' HA ' ' C' ' 47' ' ' PHE . 52.5 mt -65.89 -40.28 87.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 124.051 0.94 . . . . 75.43 109.887 174.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 51' ' ' ASN . . . . . 0.418 ' HB3' ' CD1' ' C' ' 88' ' ' PHE . 28.5 m-80 -75.93 -16.68 59.98 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.067 0.947 . . . . 74.04 111.757 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -73.18 -53.39 11.08 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 108.939 -0.763 . . . . 75.54 108.939 170.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.29 -42.88 82.57 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 113.852 -1.522 . . . . 63.1 111.051 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -68.44 -40.67 81.06 Favored 'General case' 0 C--O 1.204 -1.307 0 CA-C-N 114.655 -1.157 . . . . 75.01 110.129 175.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.55 -35.04 73.46 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 112.373 0.508 . . . . 60.54 112.373 -179.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 56' ' ' VAL . . . . . 0.402 HG11 ' HZ ' ' C' ' 101' ' ' PHE . 15.6 t -96.39 -16.48 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 O-C-N 123.47 0.482 . . . . 72.43 111.882 -177.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 57' ' ' LEU . . . . . 0.603 ' HB3' HG12 ' C' ' 22' ' ' ILE . 92.9 mt -118.81 11.01 12.52 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.086 -1.009 . . . . 75.02 113.153 177.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 58' ' ' SER . . . . . 0.463 ' HB3' ' HD2' ' C' ' 62' ' ' LYS . 43.1 t -52.7 -34.21 51.2 Favored 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 124.749 1.219 . . . . 75.33 113.315 -176.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -134.28 155.93 79.45 Favored Pre-proline 0 N--CA 1.474 0.763 0 C-N-CA 124.803 1.241 . . . . 72.03 108.891 -174.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 60' ' ' PRO . . . . . 0.4 ' O ' ' HG2' ' C' ' 64' ' ' ARG . 50.3 Cg_exo -55.5 -29.73 70.61 Favored 'Trans proline' 0 C--N 1.383 2.347 0 C-N-CA 122.79 2.327 . . . . 73.21 112.354 169.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -56.8 -61.84 2.15 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.738 0.815 . . . . 62.13 110.278 174.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 62' ' ' LYS . . . . . 0.463 ' HD2' ' HB3' ' C' ' 58' ' ' SER . 56.1 mttp -64.31 -37.79 88.75 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 114.527 -1.215 . . . . 75.43 110.785 -176.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -56.28 -49.61 73.75 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 114.072 -1.422 . . . . 74.14 110.389 178.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 64' ' ' ARG . . . . . 0.4 ' HG2' ' O ' ' C' ' 60' ' ' PRO . 29.9 mmt180 -73.1 -27.54 61.77 Favored 'General case' 0 C--N 1.35 0.595 0 CA-C-O 118.591 -0.718 . . . . 74.15 111.755 -177.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 81.3 mt -58.73 -47.29 89.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-O 121.215 0.531 . . . . 71.5 109.585 170.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 66' ' ' TYR . . . . . 0.438 ' OH ' ' HA ' ' C' ' 6' ' ' ASP . 25.2 t80 -60.17 -52.75 63.98 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.028 -0.987 . . . . 74.31 110.323 175.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -62.05 -34.38 76.15 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.356 0.662 . . . . 73.14 111.831 -175.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 72.0 p -77.24 -24.97 51.12 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 119.223 -0.418 . . . . 74.43 110.634 176.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -66.7 128.95 38.23 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 108.816 -0.809 . . . . 75.22 108.816 173.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 93.79 15.55 48.91 Favored Glycine 0 C--N 1.344 1.021 0 N-CA-C 111.498 -0.641 . . . . 62.51 111.498 -168.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 86.3 m -143.95 -62.46 0.39 Allowed 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 102.959 -2.978 . . . . 72.34 102.959 174.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 27.1 m -70.41 132.93 46.35 Favored 'General case' 0 C--O 1.25 1.115 0 N-CA-C 104.615 -2.365 . . . . 73.35 104.615 155.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.16 -43.83 6.18 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 122.853 0.461 . . . . 73.23 111.316 -173.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -90.89 136.95 27.05 Favored Pre-proline 0 N--CA 1.477 0.886 0 C-N-CA 123.653 0.781 . . . . 53.23 109.834 -179.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.33 138.43 86.19 Favored 'Trans proline' 0 C--N 1.376 2.02 0 C-N-CA 122.761 2.308 . . . . 75.14 111.856 171.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -59.73 152.63 61.78 Favored 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 122.604 2.202 . . . . 71.22 112.417 176.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -51.67 136.77 50.3 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 122.98 2.454 . . . . 74.4 111.848 178.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 78' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.87 124.03 15.28 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 123.052 2.501 . . . . 74.44 112.565 -176.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.87 173.91 2.02 Favored 'Trans proline' 0 N--CA 1.51 2.46 0 C-N-CA 123.727 2.951 . . . . 70.12 114.447 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -57.11 88.62 0.04 OUTLIER 'Trans proline' 0 C--N 1.392 2.856 0 C-N-CA 122.857 2.372 . . . . 74.31 112.628 171.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 130.34 -23.93 4.51 Favored Glycine 0 N--CA 1.467 0.738 0 CA-C-N 114.442 -1.254 . . . . 75.2 110.729 178.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 107.75 -171.1 15.92 Favored Glycine 0 C--N 1.349 1.289 0 C-N-CA 124.852 1.215 . . . . 75.13 111.006 176.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -65.0 90.18 0.08 Allowed 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.59 -0.893 . . . . 73.4 108.59 165.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 84' ' ' ASP . . . . . 0.61 ' HB3' ' HG3' ' C' ' 143' ' ' ARG . 18.4 t0 -62.36 139.79 58.54 Favored 'General case' 0 C--O 1.241 0.652 0 O-C-N 124.1 0.875 . . . . 75.11 109.624 178.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 85' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -153.74 6.49 0.33 Allowed 'General case' 0 C--O 1.243 0.73 0 CA-C-N 115.447 -0.797 . . . . 74.41 110.273 -175.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 86' ' ' SER . . . . . 0.472 ' HB3' ' O ' ' C' ' 163' ' ' GLY . 74.8 m -64.41 146.75 53.99 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.315 -0.857 . . . . 52.42 110.859 -177.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 97.9 -28.03 16.35 Favored Glycine 0 C--N 1.339 0.719 0 N-CA-C 110.765 -0.934 . . . . 74.34 110.765 -165.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 88' ' ' PHE . . . . . 0.418 ' CD1' ' HB3' ' C' ' 51' ' ' ASN . 23.2 m-85 -116.07 138.03 51.59 Favored 'General case' 0 C--N 1.356 0.882 0 N-CA-C 108.684 -0.858 . . . . 74.44 108.684 -178.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -74.73 81.85 2.08 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.638 0.775 . . . . 72.23 110.589 -174.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 90' ' ' VAL . . . . . 0.456 HG13 ' HA ' ' C' ' 170' ' ' PRO . 6.5 p -41.54 -43.69 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 C-N-CA 125.119 1.368 . . . . 54.42 112.845 177.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 91' ' ' GLU . . . . . 0.424 ' HG2' HG11 ' C' ' 90' ' ' VAL . 51.5 mm-40 -74.97 8.09 2.76 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.653 1.181 . . . . 75.25 113.288 -172.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -120.38 -27.35 5.23 Favored 'General case' 0 C--O 1.243 0.753 0 C-N-CA 123.811 0.844 . . . . 75.53 110.929 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 93' ' ' PHE . . . . . 0.432 ' CE1' ' HB3' ' C' ' 48' ' ' LYS . 2.3 m-30 -77.73 170.95 15.7 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 120.864 0.364 . . . . 72.45 111.726 -165.022 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 87.1 p -63.02 164.21 8.65 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 114.964 1.468 . . . . 52.11 114.964 -162.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 95' ' ' GLU . . . . . 0.454 ' O ' ' HG3' ' C' ' 99' ' ' GLU . 0.0 OUTLIER -66.59 -33.02 74.74 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 113.749 -1.568 . . . . 72.35 111.401 173.767 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -66.61 -40.08 88.67 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 120.938 0.399 . . . . 74.24 110.469 176.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 97' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -58.85 -44.13 90.92 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 115.415 -0.811 . . . . 64.25 109.73 170.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 98' ' ' GLN . . . . . 0.423 ' O ' ' HA3' ' C' ' 102' ' ' GLY . 69.4 mt-30 -66.78 -18.62 65.46 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 123.463 0.705 . . . . 71.33 112.05 177.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 99' ' ' GLU . . . . . 0.454 ' HG3' ' O ' ' C' ' 95' ' ' GLU . 47.5 mt-10 -81.14 -48.15 12.52 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.156 0.583 . . . . 74.43 112.123 171.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 19.3 tp -82.14 -49.42 10.17 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 116.149 -0.478 . . . . 73.23 111.517 -168.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 101' ' ' PHE . . . . . 0.402 ' HZ ' HG11 ' C' ' 56' ' ' VAL . 93.2 m-85 -100.12 -25.11 14.4 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.117 0.567 . . . . 75.04 111.474 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 102' ' ' GLY . . . . . 0.423 ' HA3' ' O ' ' C' ' 98' ' ' GLN . . . -43.08 -58.27 3.83 Favored Glycine 0 CA--C 1.546 2.02 0 CA-C-O 118.961 -0.911 . . . . 74.41 115.325 -178.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -54.68 -22.35 28.5 Favored 'Trans proline' 0 C--N 1.387 2.583 0 C-N-CA 123.843 3.029 . . . . 64.35 113.957 -177.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -126.29 16.17 6.74 Favored Glycine 0 C--N 1.356 1.658 0 CA-C-O 118.756 -1.024 . . . . 73.42 113.95 -177.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 34.4 mt . . . . . 0 N--CA 1.487 1.402 0 CA-C-N 117.829 0.814 . . . . 75.43 111.607 176.849 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.625 0 CA-C-O 120.034 -0.315 . . . . 54.4 112.473 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 74.9 mtt85 -89.86 173.17 8.39 Favored 'General case' 0 C--O 1.253 1.261 0 C-N-CA 123.422 0.689 . . . . 74.32 111.51 -178.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -66.93 133.93 50.99 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 107.69 -1.226 . . . . 75.42 107.69 169.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 119' ' ' LEU . . . . . 0.429 HD11 ' HB2' ' C' ' 141' ' ' ALA . 3.9 tt -93.61 137.49 32.82 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 106.607 -1.627 . . . . 75.21 106.607 -177.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 6.0 mmm-85 -128.0 104.02 7.56 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.194 0.521 . . . . 72.31 109.682 -172.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 121' ' ' ALA . . . . . 0.462 ' HB2' HD22 ' C' ' 176' ' ' LEU . . . -109.29 115.52 30.15 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.206 -1.405 . . . . 75.44 107.206 172.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -104.42 88.93 3.08 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 105.174 -2.158 . . . . 74.12 105.174 174.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 123' ' ' LEU . . . . . 0.455 ' HG ' HG23 ' B' ' 182' ' ' VAL . 1.7 pt? -125.52 136.21 27.98 Favored Pre-proline 0 N--CA 1.485 1.294 0 N-CA-C 114.252 1.204 . . . . 73.3 114.252 -158.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . 0.473 ' HA ' ' O ' ' C' ' 179' ' ' ARG . 53.2 Cg_exo -57.42 140.41 93.06 Favored 'Trans proline' 0 C--N 1.39 2.753 0 C-N-CA 123.816 3.01 . . . . 72.51 114.519 175.127 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 125' ' ' LEU . . . . . 0.551 ' HB2' HG22 ' B' ' 182' ' ' VAL . 54.3 tp -158.38 155.56 28.9 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.071 0.948 . . . . 75.32 109.791 176.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 126' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -102.49 153.7 19.8 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.122 0.569 . . . . 61.53 110.427 178.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 127' ' ' LEU . . . . . 0.647 HD12 ' HD2' ' C' ' 186' ' ' PHE . 98.0 mt -63.15 -44.46 95.46 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.237 1.015 . . . . 62.25 111.353 176.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 12.2 mp0 -62.04 -37.27 84.29 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 114.729 -1.123 . . . . 75.24 110.553 177.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -67.95 -37.82 82.06 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.68 0.792 . . . . 75.51 111.283 177.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -68.27 -33.58 74.62 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 123.748 0.655 . . . . 73.14 109.972 178.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 131' ' ' PHE . . . . . 0.415 ' HB2' HD13 ' C' ' 215' ' ' LEU . 83.0 t80 -67.21 -42.46 84.05 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.412 1.085 . . . . 75.55 111.007 174.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 132' ' ' HIS . . . . . . . . . . . . . 35.3 m170 -61.89 -40.96 97.23 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 123.585 0.553 . . . . 70.15 110.076 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 64.09 -108.37 2.22 Favored Glycine 0 C--N 1.355 1.588 0 N-CA-C 111.04 -0.824 . . . . 65.31 111.04 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . 70.49 147.09 0.37 Allowed Glycine 0 C--N 1.354 1.568 0 O-C-N 124.23 0.606 . . . . 73.12 114.535 173.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -80.19 92.94 5.76 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 107.359 -1.349 . . . . 73.03 107.359 176.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 136' ' ' ARG . . . . . 0.541 ' HB2' HD11 ' B' ' 181' ' ' LEU . 72.7 mtp180 -123.82 155.89 37.16 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 124.08 0.952 . . . . 72.12 109.501 -168.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 137' ' ' VAL . . . . . 0.482 HG22 ' HB3' ' B' ' 180' ' ' ALA . 31.3 m -78.97 122.52 34.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 CA-C-O 121.242 0.544 . . . . 73.11 111.893 -172.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 138' ' ' VAL . . . . . 0.524 ' HB ' HD22 ' B' ' 181' ' ' LEU . 12.9 p -111.56 140.8 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 107.681 -1.229 . . . . 72.14 107.681 169.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 139' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -109.83 100.77 9.7 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 108.131 -1.063 . . . . 74.31 108.131 179.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 140' ' ' VAL . . . . . . . . . . . . . 11.7 p -143.62 134.88 22.65 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.111 0 C-N-CA 123.484 0.714 . . . . 73.25 109.579 -173.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 141' ' ' ALA . . . . . 0.429 ' HB2' HD11 ' C' ' 119' ' ' LEU . . . 67.26 -1.67 1.43 Allowed 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 125.301 1.44 . . . . 65.0 114.173 178.263 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 119.55 -2.13 13.86 Favored Glycine 0 C--N 1.348 1.238 0 CA-C-O 119.23 -0.761 . . . . 52.4 114.231 179.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 143' ' ' ARG . . . . . 0.61 ' HG3' ' HB3' ' C' ' 84' ' ' ASP . 64.2 mtm180 -119.41 130.7 55.42 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 118.367 1.083 . . . . 75.05 111.744 175.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -83.76 103.61 13.19 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 107.709 -1.219 . . . . 71.51 107.709 164.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 145' ' ' VAL . . . . . . . . . . . . . 7.3 p -125.18 130.41 73.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.162 0.585 . . . . 75.03 111.733 -174.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 46.2 m -74.5 95.94 2.84 Favored 'General case' 0 C--N 1.353 0.736 0 C-N-CA 123.602 0.761 . . . . 73.22 110.369 176.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 35.1 m -123.42 152.29 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.538 0.735 . . . . 72.53 109.564 177.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 45.5 ttp180 -107.1 105.7 15.84 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 107.594 -1.262 . . . . 74.22 107.594 170.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 149' ' ' ILE . . . . . . . . . . . . . 31.6 pt -69.52 147.43 96.76 Favored Pre-proline 0 CA--C 1.55 0.946 0 CA-C-O 118.235 -0.888 . . . . 74.42 108.647 170.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -35.9 115.75 0.12 Allowed 'Trans proline' 0 C--N 1.394 2.925 0 C-N-CA 124.185 3.256 . . . . 61.44 113.578 -178.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -57.21 95.58 0.06 OUTLIER 'Trans proline' 0 C--N 1.39 2.715 0 C-N-CA 123.052 2.501 . . . . 73.2 111.886 -176.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 152' ' ' GLY . . . . . . . . . . . . . . . 109.64 136.11 7.4 Favored Glycine 0 C--N 1.345 1.08 0 CA-C-N 114.785 -1.098 . . . . 63.11 114.873 -174.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 153' ' ' VAL . . . . . 0.422 HG13 HD11 ' C' ' 159' ' ' ILE . 7.0 m -146.61 174.47 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 124.613 1.165 . . . . 74.01 111.077 172.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 154' ' ' ARG . . . . . 0.499 ' HB3' ' H ' ' C' ' 188' ' ' LEU . 11.7 ptt180 -124.72 168.74 12.77 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.495 1.118 . . . . 75.32 109.11 174.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 155' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -60.03 119.88 8.62 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.319 0.648 . . . . 74.51 111.104 176.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 82.27 15.05 75.26 Favored Glycine 0 C--N 1.351 1.368 0 CA-C-N 115.649 -0.705 . . . . 75.21 113.476 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 157' ' ' SER . . . . . . . . . . . . . 34.1 t -75.63 125.59 29.34 Favored 'General case' 0 C--N 1.353 0.736 0 N-CA-C 109.162 -0.681 . . . . 75.43 109.162 176.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 6.0 p -98.5 97.06 5.62 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 CA-C-O 121.844 0.83 . . . . 72.31 109.714 -177.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 159' ' ' ILE . . . . . 0.662 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 58.0 mt -70.71 113.17 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-N 115.179 -0.919 . . . . 72.31 109.678 175.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 160' ' ' ARG . . . . . 0.421 ' HA ' ' O ' ' C' ' 174' ' ' LEU . 61.8 ttt180 -99.22 101.25 12.51 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 109.696 -0.483 . . . . 75.13 109.696 179.006 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 161' ' ' VAL . . . . . 0.676 ' HB ' ' HB3' ' C' ' 174' ' ' LEU . 97.7 t -82.95 119.7 74.79 Favored Pre-proline 0 C--O 1.25 1.116 0 N-CA-C 108.455 -0.943 . . . . 75.24 108.455 174.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -60.64 106.04 0.34 Allowed 'Trans proline' 0 C--N 1.384 2.42 0 C-N-CA 123.335 2.69 . . . . 75.23 113.163 -173.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 163' ' ' GLY . . . . . 0.472 ' O ' ' HB3' ' C' ' 86' ' ' SER . . . 91.06 -25.34 14.5 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 118.581 -1.122 . . . . 53.54 114.927 169.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 164' ' ' MET . . . . . 0.475 ' HE2' HG13 ' C' ' 161' ' ' VAL . 39.6 ttp -87.39 50.66 2.05 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 118.536 1.168 . . . . 73.35 112.783 -165.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . -125.69 -96.11 1.03 Allowed Glycine 0 N--CA 1.472 1.041 0 N-CA-C 110.665 -0.974 . . . . 73.32 110.665 171.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . 61.98 40.29 98.69 Favored Glycine 0 C--N 1.353 1.475 0 N-CA-C 115.61 1.004 . . . . 75.44 115.61 162.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 167' ' ' GLN . . . . . 0.613 ' HA ' HE21 ' C' ' 167' ' ' GLN . 0.0 OUTLIER -64.96 105.26 0.99 Allowed 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 117.155 0.477 . . . . 74.2 110.126 177.689 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . 159.0 -67.91 0.27 Allowed Glycine 0 C--O 1.219 -0.827 0 N-CA-C 110.867 -0.893 . . . . 13.44 110.867 -178.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 169' ' ' ASN . . . . . 0.598 ' HB3' ' HD3' ' C' ' 170' ' ' PRO . 26.6 t-20 -173.7 -62.21 0.0 OUTLIER Pre-proline 0 CA--C 1.575 1.916 0 C-N-CA 124.172 0.989 . . . . 62.44 111.569 172.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 170' ' ' PRO . . . . . 0.598 ' HD3' ' HB3' ' C' ' 169' ' ' ASN . 13.4 Cg_exo -72.63 160.34 46.7 Favored 'Trans proline' 0 C--N 1.4 3.259 0 C-N-CA 121.802 1.668 . . . . 73.55 111.618 172.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 171' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.79 152.47 78.4 Favored 'Trans proline' 0 C--N 1.374 1.875 0 C-N-CA 122.163 1.909 . . . . 74.02 113.073 177.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -130.96 -103.48 0.97 Allowed Glycine 0 C--N 1.341 0.855 0 N-CA-C 109.29 -1.524 . . . . 74.42 109.29 174.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 173' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -170.68 162.91 7.98 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 124.72 1.208 . . . . 74.51 109.474 165.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 174' ' ' LEU . . . . . 0.676 ' HB3' ' HB ' ' C' ' 161' ' ' VAL . 28.3 tp -104.86 137.47 42.58 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.425 0.69 . . . . 75.22 110.523 -175.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 96.8 mt -124.08 92.02 3.58 Favored 'General case' 0 C--O 1.246 0.88 0 C-N-CA 124.62 1.168 . . . . 72.15 109.538 177.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 176' ' ' LEU . . . . . 0.662 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 74.3 mt -83.21 92.38 7.45 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 108.817 -0.808 . . . . 74.33 108.817 173.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 177' ' ' VAL . . . . . . . . . . . . . 96.0 t -83.45 102.24 9.16 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 N-CA-C 107.642 -1.244 . . . . 75.23 107.642 174.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 178' ' ' VAL . . . . . . . . . . . . . 5.9 p -74.83 132.14 33.84 Favored 'Isoleucine or valine' 0 C--O 1.249 1.039 0 CA-C-N 114.433 -1.258 . . . . 74.01 111.693 -173.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 179' ' ' ARG . . . . . 0.473 ' O ' ' HA ' ' C' ' 124' ' ' PRO . 23.0 mmt180 -110.74 103.27 11.79 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 106.844 -1.539 . . . . 74.42 106.844 170.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 180' ' ' LEU . . . . . 0.501 HD12 HD22 ' C' ' 127' ' ' LEU . 83.9 mt -69.92 148.33 49.11 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 116.006 -0.543 . . . . 73.43 111.059 -179.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 181' ' ' LEU . . . . . . . . . . . . . 63.5 mt -66.83 166.91 15.77 Favored Pre-proline 0 CA--C 1.552 1.045 0 CA-C-N 115.083 -0.962 . . . . 74.24 111.299 -175.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -57.33 78.1 0.04 OUTLIER 'Trans proline' 0 C--N 1.394 2.936 0 C-N-CA 122.99 2.46 . . . . 73.32 111.815 170.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 183' ' ' HIS . . . . . 0.424 ' N ' ' HD3' ' C' ' 184' ' ' PRO . 62.6 t60 176.68 51.65 0.03 OUTLIER Pre-proline 0 CA--C 1.556 1.202 0 C-N-CA 127.772 2.429 . . . . 72.0 105.591 -173.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 184' ' ' PRO . . . . . 0.424 ' HD3' ' N ' ' C' ' 183' ' ' HIS . 79.8 Cg_endo -94.47 65.12 0.31 Allowed 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 122.919 2.413 . . . . 74.25 110.903 -169.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 185' ' ' VAL . . . . . 0.529 HG12 ' HB3' ' C' ' 195' ' ' ALA . 6.7 t -94.09 -52.64 9.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 108.951 -0.759 . . . . 72.23 108.951 -167.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 186' ' ' PHE . . . . . 0.647 ' HD2' HD12 ' C' ' 127' ' ' LEU . 67.1 m-85 -99.79 121.35 41.15 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.437 0.695 . . . . 61.44 110.288 -169.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 187' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -114.99 107.59 15.58 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.066 0.946 . . . . 75.14 108.699 179.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 188' ' ' LEU . . . . . 0.499 ' H ' ' HB3' ' C' ' 154' ' ' ARG . 58.8 tp -77.12 140.69 40.31 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.479 1.112 . . . . 74.14 112.964 -171.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -142.0 123.58 15.02 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 106.925 -1.509 . . . . 73.21 106.925 163.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 68.02 -111.54 4.1 Favored Glycine 0 CA--C 1.536 1.377 0 N-CA-C 111.526 -0.629 . . . . 74.2 111.526 -172.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 191' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -113.89 -10.95 12.89 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 124.086 0.954 . . . . 75.25 110.057 172.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -95.96 147.45 23.68 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.029 0.932 . . . . 65.13 109.98 -168.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 193' ' ' LEU . . . . . 0.489 HD23 ' CD2' ' C' ' 240' ' ' PHE . 84.6 mt -104.21 158.25 16.57 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.018 0.527 . . . . 65.15 111.115 -176.15 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 194' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -131.46 106.67 8.38 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 108.119 -1.067 . . . . 75.43 108.119 165.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 195' ' ' ALA . . . . . 0.529 ' HB3' HG12 ' C' ' 185' ' ' VAL . . . -116.15 -177.75 3.24 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.159 0.984 . . . . 65.11 109.549 176.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 25.2 m -128.73 111.42 13.13 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 109.32 -0.622 . . . . 53.42 109.32 178.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 197' ' ' LEU . . . . . 0.498 HD13 ' HB1' ' C' ' 212' ' ' ALA . 55.2 tp -85.18 130.88 34.52 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.289 1.036 . . . . 73.5 110.497 -179.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -89.8 112.14 23.37 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.359 0.663 . . . . 64.33 109.386 174.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 199' ' ' VAL . . . . . 0.542 ' HA ' HG11 ' C' ' 210' ' ' VAL . 59.3 t -117.77 113.55 38.04 Favored Pre-proline 0 N--CA 1.471 0.612 0 C-N-CA 124.347 1.059 . . . . 73.12 108.621 177.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 200' ' ' PRO . . . . . 0.451 ' HA ' ' O ' ' C' ' 256' ' ' THR . 39.7 Cg_endo -68.3 146.25 68.57 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 121.788 1.659 . . . . 73.11 110.907 176.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 201' ' ' ALA . . . . . 0.405 ' HB2' ' HH2' ' C' ' 269' ' ' TRP . . . -53.23 -46.18 97.98 Favored Pre-proline 0 CA--C 1.56 1.357 0 C-N-CA 124.917 1.287 . . . . 74.35 114.271 -172.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 202' ' ' PRO . . . . . 0.4 ' HA ' ' HE3' ' A' ' 269' ' ' TRP . 28.5 Cg_endo -59.3 -45.51 26.63 Favored 'Trans proline' 0 C--N 1.397 3.09 0 CA-C-N 121.212 1.469 . . . . 63.15 111.977 178.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 203' ' ' ILE . . . . . . . . . . . . . 42.4 mt -66.1 -30.54 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 123.84 0.856 . . . . 74.02 110.675 178.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.32 -42.69 79.01 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.332 0.653 . . . . 75.02 111.799 178.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 205' ' ' VAL . . . . . 0.502 HG13 HD12 ' A' ' 261' ' ' LEU . 57.5 t -75.71 -46.84 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 116.016 -0.538 . . . . 74.52 111.942 -176.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 206' ' ' VAL . . . . . . . . . . . . . 14.1 p -81.14 -28.9 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 CA-C-O 120.743 0.306 . . . . 74.12 111.118 -179.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 80.12 83.13 0.71 Allowed Glycine 0 C--N 1.337 0.624 0 N-CA-C 111.431 -0.668 . . . . 63.21 111.431 -174.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -105.92 -127.83 5.98 Favored Glycine 0 C--N 1.34 0.78 0 N-CA-C 110.365 -1.094 . . . . 51.32 110.365 176.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 209' ' ' LYS . . . . . 0.494 ' HG2' ' HA ' ' C' ' 222' ' ' ALA . 8.2 mtmp? -139.19 145.32 39.17 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.494 0.664 . . . . 72.44 110.545 172.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 210' ' ' VAL . . . . . 0.542 HG11 ' HA ' ' C' ' 199' ' ' VAL . 34.1 m -126.87 178.6 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.299 1.44 . . . . 71.52 107.671 173.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 211' ' ' ARG . . . . . 0.49 ' HD3' ' HB2' ' C' ' 218' ' ' PRO . 33.6 ttm-85 -128.65 124.01 34.65 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 118.522 0.601 . . . . 75.53 112.167 -178.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 212' ' ' ALA . . . . . 0.498 ' HB1' HD13 ' C' ' 197' ' ' LEU . . . -97.81 114.24 26.23 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 107.756 -1.202 . . . . 74.43 107.756 166.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 213' ' ' MET . . . . . 0.445 ' HA ' ' HA ' ' C' ' 218' ' ' PRO . 2.3 tmm? -77.06 98.53 5.03 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 107.112 -1.44 . . . . 63.12 107.112 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 214' ' ' THR . . . . . 0.461 ' OG1' HG11 ' C' ' 219' ' ' VAL . 1.0 OUTLIER -100.98 170.67 8.13 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.359 0.599 . . . . 72.34 109.746 -172.991 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' C' C ' 215' ' ' LEU . . . . . 0.415 HD13 ' HB2' ' C' ' 131' ' ' PHE . 8.4 mt -61.94 -43.55 98.61 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.24 1.416 . . . . 75.24 110.956 -173.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -93.35 17.83 10.65 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 113.824 -1.535 . . . . 71.0 111.627 -177.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 125.44 152.86 8.32 Favored Glycine 0 C--N 1.344 0.982 0 CA-C-N 116.006 -0.543 . . . . 74.41 111.744 178.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 218' ' ' PRO . . . . . 0.49 ' HB2' ' HD3' ' C' ' 211' ' ' ARG . 68.8 Cg_endo -74.98 103.29 1.7 Allowed 'Trans proline' 0 CA--C 1.554 1.507 0 C-N-CA 122.377 2.051 . . . . 64.03 112.517 175.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 219' ' ' VAL . . . . . 0.544 HG23 HG23 ' B' ' 238' ' ' THR . 1.5 p -75.43 127.4 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 122.938 0.495 . . . . 52.53 109.667 178.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 220' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -87.0 104.62 16.48 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 107.383 -1.339 . . . . 72.32 107.383 171.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 221' ' ' VAL . . . . . . . . . . . . . 47.6 t -71.22 125.96 30.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 125.733 1.613 . . . . 74.03 111.631 -177.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 222' ' ' ALA . . . . . 0.494 ' HA ' ' HG2' ' C' ' 209' ' ' LYS . . . -78.55 106.94 10.85 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.174 0.59 . . . . 73.3 109.821 171.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 60.4 t -83.05 132.69 49.95 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 123.906 0.882 . . . . 73.11 109.179 178.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 224' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -83.13 156.76 15.0 Favored 'Trans proline' 0 C--N 1.379 2.179 0 C-N-CA 123.271 2.647 . . . . 73.11 110.979 172.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -57.64 134.52 63.63 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 122.309 2.006 . . . . 74.4 112.012 174.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 226' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? 70.97 82.16 0.15 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.617 1.167 . . . . 71.5 110.374 177.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 227' ' ' THR . . . . . . . . . . . . . 53.2 m -115.91 123.23 47.58 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.775 0.83 . . . . 73.3 110.612 179.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 228' ' ' GLN . . . . . 0.571 ' NE2' ' HG2' ' A' ' 259' ' ' GLU . 24.7 mp0 -102.33 150.8 22.96 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.307 1.043 . . . . 74.32 111.197 -179.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -72.47 134.11 45.16 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 114.559 -1.2 . . . . 65.31 109.563 176.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 102.88 -6.45 51.75 Favored Glycine 0 C--N 1.339 0.712 0 O-C-N 123.681 0.613 . . . . 62.04 112.375 -173.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 231' ' ' ARG . . . . . . . . . . . . . 59.6 mtt180 -65.38 171.97 3.54 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 117.266 0.533 . . . . 75.03 110.85 167.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 232' ' ' LYS . . . . . 0.438 ' HA ' ' O ' ' C' ' 251' ' ' LEU . 37.1 ttmt -148.51 124.74 10.83 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.2 -0.455 . . . . 74.05 110.849 -177.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 233' ' ' LEU . . . . . 0.568 ' O ' ' HA ' ' C' ' 250' ' ' TYR . 6.3 mp -84.66 156.9 21.3 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.444 1.098 . . . . 74.22 110.254 174.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 18.2 ptt-85 -128.0 85.2 2.32 Favored 'General case' 0 CA--C 1.553 1.08 0 O-C-N 124.966 1.416 . . . . 72.34 108.527 166.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 235' ' ' LEU . . . . . 0.471 HD11 HD23 ' C' ' 249' ' ' LEU . 49.8 mt -79.0 116.02 19.04 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.434 -0.803 . . . . 74.34 108.849 176.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -77.28 129.62 36.12 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 123.219 0.607 . . . . 73.41 111.835 -169.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 76.18 14.74 82.0 Favored Glycine 0 C--N 1.346 1.088 0 O-C-N 124.451 1.095 . . . . 71.42 114.731 177.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 14.2 mmtm -98.87 9.65 43.0 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.386 0.674 . . . . 75.11 111.493 -179.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 239' ' ' GLY . . . . . 0.413 ' HA2' ' HG ' ' C' ' 193' ' ' LEU . . . -86.88 -169.55 46.0 Favored Glycine 0 C--N 1.346 1.113 0 O-C-N 123.447 0.467 . . . . 75.2 112.763 177.298 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 240' ' ' PHE . . . . . 0.489 ' CD2' HD23 ' C' ' 193' ' ' LEU . 12.8 m-85 -81.35 150.7 67.99 Favored Pre-proline 0 C--O 1.247 0.968 0 CA-C-O 119.167 -0.444 . . . . 75.14 110.005 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 241' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_exo -71.44 96.14 0.72 Allowed 'Trans proline' 0 C--N 1.388 2.647 0 C-N-CA 123.418 2.745 . . . . 71.53 112.341 -175.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -83.03 177.52 53.2 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 115.255 -0.884 . . . . 70.14 113.278 178.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -69.82 -18.93 36.46 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 123.134 2.556 . . . . 71.42 112.602 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -111.21 15.51 21.46 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.052 0.941 . . . . 71.42 110.563 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 109.42 177.26 21.33 Favored Glycine 0 C--N 1.354 1.534 0 N-CA-C 111.712 -0.555 . . . . 63.24 111.712 -175.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 246' ' ' ARG . . . . . . . . . . . . . 34.2 mtm180 -71.72 147.81 47.02 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.124 0.569 . . . . 71.32 111.393 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -78.64 -159.0 12.97 Favored Glycine 0 N--CA 1.48 1.59 0 O-C-N 123.43 0.456 . . . . 63.23 113.329 176.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -124.47 135.96 53.64 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 108.944 -0.761 . . . . 73.54 108.944 -175.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 249' ' ' LEU . . . . . 0.471 HD23 HD11 ' C' ' 235' ' ' LEU . 18.7 tp -83.89 121.9 27.98 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.0 0.92 . . . . 74.23 110.397 -179.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 250' ' ' TYR . . . . . 0.568 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 23.1 m-85 -101.64 109.94 21.83 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.221 -0.659 . . . . 71.43 109.221 175.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 251' ' ' LEU . . . . . 0.487 ' HB2' ' HB2' ' C' ' 233' ' ' LEU . 68.5 mt -102.64 112.85 25.8 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 116.402 -0.363 . . . . 72.0 110.917 -175.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -70.4 128.46 36.27 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 108.537 -0.912 . . . . 75.41 108.537 168.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 253' ' ' VAL . . . . . . . . . . . . . 84.6 t -82.01 122.53 36.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.014 -0.539 . . . . 73.5 110.944 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 254' ' ' ARG . . . . . . . . . . . . . 13.8 mmt180 -102.1 114.42 28.54 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 107.853 -1.166 . . . . 75.13 107.853 164.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 255' ' ' ILE . . . . . 0.507 ' O ' ' HB ' ' A' ' 255' ' ' ILE . 34.2 mm -76.7 119.16 24.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 106.455 -1.683 . . . . 75.24 106.455 164.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 256' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' C' ' 200' ' ' PRO . 2.3 t -134.4 172.32 13.06 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.594 1.158 . . . . 70.25 109.416 -171.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 2.9 pp -135.2 156.11 78.38 Favored Pre-proline 0 N--CA 1.482 1.137 0 C-N-CA 123.273 0.629 . . . . 75.21 109.793 -176.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -77.43 22.31 0.59 Allowed 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 122.835 2.357 . . . . 74.41 114.952 -170.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 61.55 -78.49 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.98 1.312 . . . . 72.3 111.098 -174.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.11 178.23 8.2 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.389 0.675 . . . . 73.41 110.026 179.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 261' ' ' LEU . . . . . 0.539 HD23 ' HB3' ' C' ' 265' ' ' GLU . 85.6 mt -142.57 151.36 41.48 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.888 0.875 . . . . 74.53 109.504 169.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 66.2 p -82.76 155.36 68.21 Favored Pre-proline 0 N--CA 1.479 0.981 0 N-CA-C 107.689 -1.226 . . . . 61.23 107.689 166.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -39.21 -44.27 2.71 Favored 'Trans proline' 0 C--N 1.381 2.285 0 C-N-CA 123.814 3.009 . . . . 74.2 115.592 178.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -67.43 -50.4 59.55 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.298 0.639 . . . . 71.04 110.826 -178.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 265' ' ' GLU . . . . . 0.539 ' HB3' HD23 ' C' ' 261' ' ' LEU . 47.8 mt-10 -55.31 -52.08 64.64 Favored 'General case' 0 C--N 1.358 0.968 0 O-C-N 123.927 0.767 . . . . 71.03 109.943 176.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 266' ' ' GLU . . . . . 0.433 ' O ' ' HG2' ' C' ' 270' ' ' LYS . 3.7 tp10 -43.98 -56.08 4.2 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.596 1.558 . . . . 73.1 111.209 176.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -59.97 -48.85 80.01 Favored 'General case' 0 CA--C 1.549 0.93 0 O-C-N 124.217 0.948 . . . . 71.12 112.503 -176.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 268' ' ' LEU . . . . . . . . . . . . . 11.1 mp -65.37 -44.19 88.41 Favored 'General case' 0 N--CA 1.481 1.12 0 O-C-N 123.392 0.433 . . . . 70.11 111.319 -178.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 269' ' ' TRP . . . . . 0.405 ' HH2' ' HB2' ' C' ' 201' ' ' ALA . 78.3 m95 -61.26 -37.68 83.99 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.558 0.743 . . . . 63.11 111.221 177.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 270' ' ' LYS . . . . . 0.433 ' HG2' ' O ' ' C' ' 266' ' ' GLU . 31.1 mmtp -64.73 -47.23 79.03 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.142 0.577 . . . . 75.43 110.695 178.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 271' ' ' LYS . . . . . 0.645 ' HB3' ' HZ2' ' C' ' 271' ' ' LYS . 9.1 mtpm? -64.15 -41.46 97.16 Favored 'General case' 0 N--CA 1.484 1.234 0 O-C-N 123.534 0.521 . . . . 75.33 111.486 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 272' ' ' LEU . . . . . 0.46 HD22 ' HB2' ' A' ' 268' ' ' LEU . 69.2 mt -57.92 -45.85 85.88 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 123.92 0.763 . . . . 74.33 110.146 174.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -60.67 -44.2 96.74 Favored 'General case' 0 C--O 1.209 -1.063 0 O-C-N 124.4 1.062 . . . . 43.22 111.718 -176.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -63.13 -49.92 72.48 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-O 121.437 0.637 . . . . 63.21 110.428 178.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -61.17 -23.25 65.43 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 114.493 -1.231 . . . . 70.04 111.342 176.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 276' ' ' TYR . . . . . 0.434 ' HB2' ' O ' ' C' ' 272' ' ' LEU . 6.7 t80 -89.46 -31.69 17.57 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.416 1.086 . . . . 75.52 110.665 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 277' ' ' TYR . . . . . 0.433 ' HE1' HG12 ' A' ' 203' ' ' ILE . 22.7 m-85 -68.24 -25.61 65.27 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 109.176 -0.676 . . . . 65.52 109.176 176.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -53.48 -26.61 21.25 Favored 'General case' 0 CA--C 1.554 1.13 0 O-C-N 124.331 1.019 . . . . 72.22 112.954 171.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 279' ' ' ARG . . . . . . . . . . . . . 26.4 mtm180 -73.5 -16.45 61.28 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 117.898 0.317 . . . . 75.11 111.726 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.087 0 C-N-CA 123.289 0.636 . . . . 75.14 109.764 -177.231 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 114.869 1.433 . . . . 64.14 114.869 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.522 ' HB3' HD11 ' A' ' 10' ' ' ILE . 99.5 mttt -81.21 123.23 28.29 Favored 'General case' 0 C--O 1.245 0.85 0 N-CA-C 108.924 -0.769 . . . . 74.32 108.924 167.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.463 ' HA ' ' OH ' ' A' ' 66' ' ' TYR . 37.2 t70 -75.53 103.97 5.89 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 107.58 -1.267 . . . . 62.43 107.58 167.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -61.83 -27.57 68.86 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 114.876 -1.056 . . . . 73.34 111.873 -173.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.485 ' HE1' HD13 ' A' ' 22' ' ' ILE . 30.7 m-85 -68.12 -42.26 80.5 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 116.355 -0.384 . . . . 73.33 110.038 175.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.21 -45.58 92.69 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.13 0.572 . . . . 70.01 110.403 177.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.522 HD11 ' HB3' ' A' ' 5' ' ' LYS . 64.0 mt -52.91 -47.78 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 123.236 0.614 . . . . 74.23 110.41 175.144 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.433 ' HB3' ' HB1' ' A' ' 25' ' ' ALA . 88.6 mt -81.16 -9.47 59.79 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 115.159 -0.928 . . . . 73.11 113.16 -178.164 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.71 27.7 68.66 Favored Glycine 0 CA--C 1.543 1.824 0 N-CA-C 114.412 0.525 . . . . 73.42 114.412 179.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.9 m -114.49 162.08 25.28 Favored Pre-proline 0 N--CA 1.486 1.345 0 C-N-CA 124.507 1.123 . . . . 72.52 110.087 176.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -64.3 163.72 25.43 Favored 'Trans proline' 0 C--N 1.389 2.688 0 C-N-CA 122.38 2.053 . . . . 50.12 112.769 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 41.1 mtp180 -83.23 41.43 0.76 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.065 0.946 . . . . 75.43 112.135 -170.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -172.86 -5.24 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.053 1.341 . . . . 71.2 109.355 -171.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -40.8 131.43 2.42 Favored 'General case' 0 C--N 1.364 1.229 0 C-N-CA 125.879 1.672 . . . . 74.14 112.674 178.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 63.2 p -78.29 -178.94 5.96 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.2 0.6 . . . . 75.03 112.249 -174.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -46.44 -58.72 3.49 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 124.915 1.286 . . . . 71.11 112.778 -177.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -71.1 -33.36 70.1 Favored 'General case' 0 C--O 1.211 -0.966 0 CA-C-O 119.111 -0.471 . . . . 72.43 111.114 -174.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -62.12 -49.29 76.48 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.137 0.494 . . . . 71.14 110.959 179.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.497 HD11 HD11 ' A' ' 57' ' ' LEU . 71.9 mt -61.76 -42.41 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.123 0.969 . . . . 73.31 110.518 177.205 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -70.85 -28.17 64.38 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.121 -0.945 . . . . 75.22 111.624 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -73.06 -36.94 66.97 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.331 0.653 . . . . 73.12 110.12 175.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.433 ' HB1' ' HB3' ' A' ' 11' ' ' LEU . . . -66.95 -39.95 87.42 Favored 'General case' 0 C--O 1.246 0.909 0 O-C-N 124.028 0.83 . . . . 72.43 110.874 175.006 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.473 ' HD1' HG23 ' A' ' 50' ' ' ILE . 48.8 t80 -57.03 -66.87 0.38 Allowed 'General case' 0 C--O 1.203 -1.391 0 CA-C-N 114.398 -1.273 . . . . 73.1 109.08 172.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -50.74 -40.93 55.88 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.567 1.147 . . . . 74.22 111.888 -178.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.8 ttt180 -57.5 -67.54 0.32 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.247 0.619 . . . . 75.52 110.59 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 83.9 mt -71.72 -22.79 61.58 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.499 -0.773 . . . . 75.12 111.577 -173.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.9 -26.14 29.62 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.466 0.707 . . . . 71.54 110.782 -178.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 85.0 mtt180 -83.82 -26.48 29.5 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 122.951 0.501 . . . . 72.33 110.551 172.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -70.58 -52.18 23.32 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 121.004 0.431 . . . . 73.31 110.393 173.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.448 ' HD2' HD12 ' A' ' 50' ' ' ILE . 14.4 m-85 -97.97 35.51 1.71 Allowed 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.988 0.915 . . . . 72.41 109.843 -177.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.48 ' CD2' ' HB3' ' A' ' 36' ' ' ASP . 18.3 t60 -76.63 109.91 10.07 Favored Pre-proline 0 N--CA 1.473 0.695 0 C-N-CA 124.763 1.225 . . . . 73.54 110.156 -172.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -52.21 -37.22 69.73 Favored 'Trans proline' 0 C--N 1.379 2.148 0 C-N-CA 123.584 2.856 . . . . 75.51 113.274 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.48 ' HB3' ' CD2' ' A' ' 34' ' ' HIS . 15.9 t70 -64.28 -31.49 72.71 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.93 0.892 . . . . 73.23 111.778 178.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 85.3 t -84.79 -54.25 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 122.868 0.467 . . . . 73.25 109.876 176.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -133.9 110.05 9.46 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.319 1.048 . . . . 64.12 109.762 -174.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -85.97 63.7 8.18 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.376 0.671 . . . . 73.11 109.983 -178.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 66.9 m -99.8 112.56 64.0 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-O 117.654 -1.165 . . . . 71.24 108.459 174.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -38.61 -53.54 1.79 Allowed 'Trans proline' 0 C--N 1.39 2.732 0 C-N-CA 124.411 3.408 . . . . 73.53 114.044 -177.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -63.12 -35.04 78.96 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.671 0.788 . . . . 64.43 111.816 -178.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.438 ' O ' ' HB3' ' A' ' 33' ' ' TYR . . . -71.2 -29.78 65.58 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 122.829 0.452 . . . . 73.42 110.157 176.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -82.54 -26.74 32.16 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 109.422 -0.585 . . . . 63.35 109.422 -178.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -69.01 -41.83 77.25 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.913 0.885 . . . . 62.44 109.653 172.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 9.7 mptt -64.66 -41.02 96.39 Favored 'General case' 0 C--O 1.212 -0.903 0 CA-C-N 115.315 -0.857 . . . . 74.03 110.271 174.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.494 ' HA ' HD11 ' A' ' 50' ' ' ILE . 90.7 t80 -55.78 -45.42 78.18 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.794 0.838 . . . . 73.32 109.684 174.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.456 ' HB3' ' HE1' ' A' ' 93' ' ' PHE . 52.4 mtpt -60.25 -41.26 92.84 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.866 0.866 . . . . 75.14 111.435 176.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -67.61 -34.47 77.07 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.479 0.712 . . . . 71.44 111.717 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.494 HD11 ' HA ' ' A' ' 47' ' ' PHE . 53.8 mt -69.33 -35.93 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.496 1.118 . . . . 74.43 109.499 174.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.415 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 26.9 m-80 -83.43 -13.55 54.54 Favored 'General case' 0 C--O 1.206 -1.222 0 C-N-CA 124.224 1.01 . . . . 73.43 111.401 178.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -74.27 -56.8 4.47 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 107.646 -1.242 . . . . 75.34 107.646 169.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -52.94 -50.64 63.6 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-N 113.152 -1.84 . . . . 65.45 110.515 177.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -66.35 -41.91 88.86 Favored 'General case' 0 C--O 1.205 -1.247 0 CA-C-N 115.296 -0.865 . . . . 73.53 110.857 178.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 51' ' ' ASN . . . -53.62 -39.65 65.11 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 118.76 0.709 . . . . 72.52 111.986 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 61.1 t -70.8 -51.06 39.31 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 CA-C-N 115.794 -0.639 . . . . 74.52 110.748 174.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.497 HD11 HD11 ' A' ' 22' ' ' ILE . 48.6 mt -89.81 -0.1 57.34 Favored 'General case' 0 CA--C 1.568 1.657 0 N-CA-C 113.806 1.039 . . . . 74.35 113.806 -167.069 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 48.0 t -71.07 -51.15 26.89 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 124.091 0.956 . . . . 74.34 111.411 -173.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -86.59 125.19 68.07 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 114.613 -1.176 . . . . 74.34 107.87 177.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -53.21 -26.01 32.21 Favored 'Trans proline' 0 C--N 1.374 1.921 0 C-N-CA 123.322 2.681 . . . . 72.41 113.335 178.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -70.93 -56.26 6.61 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.957 0.903 . . . . 72.3 110.911 177.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.451 ' HA ' HD13 ' A' ' 65' ' ' ILE . 46.4 mtpt -66.96 -27.7 67.67 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 123.829 0.852 . . . . 74.54 111.477 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -60.92 -55.5 32.17 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 114.48 -1.236 . . . . 74.11 109.713 171.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -54.21 -40.61 67.78 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 124.165 0.916 . . . . 74.25 111.159 177.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.65 HD12 ' HE1' ' A' ' 83' ' ' TYR . 77.3 mt -51.92 -63.78 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.025 0 O-C-N 124.404 1.065 . . . . 74.41 109.265 174.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.463 ' OH ' ' HA ' ' A' ' 6' ' ' ASP . 32.6 t80 -50.19 -54.66 19.41 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 119.024 -0.512 . . . . 75.4 112.071 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -43.27 -55.22 4.13 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 124.433 1.083 . . . . 64.04 110.585 -178.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.44 ' HB ' ' HB2' ' A' ' 74' ' ' ALA . 69.1 p -98.47 -2.53 38.73 Favored 'General case' 0 CA--C 1.551 1.019 0 CA-C-N 115.071 -0.968 . . . . 75.44 113.258 -171.271 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -117.78 118.72 32.82 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 118.754 0.706 . . . . 75.32 109.428 -178.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.08 21.81 72.81 Favored Glycine 0 C--N 1.344 0.991 0 CA-C-O 121.6 0.556 . . . . 64.23 112.781 177.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 90.6 m -146.67 -51.81 0.22 Allowed 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 103.969 -2.604 . . . . 71.23 103.969 178.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 60.6 m -102.2 161.43 13.7 Favored 'General case' 0 C--O 1.258 1.533 0 CA-C-N 112.198 -2.273 . . . . 74.23 105.165 158.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.89 12.3 17.77 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.409 0.683 . . . . 74.04 112.203 179.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.44 ' HB2' ' HB ' ' A' ' 68' ' ' THR . . . -70.3 -152.05 0.0 OUTLIER Pre-proline 0 CA--C 1.589 2.456 0 CA-C-O 116.775 -1.583 . . . . 75.1 111.333 176.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.479 ' HA ' ' HD2' ' A' ' 76' ' ' PRO . 6.2 Cg_exo 7.76 107.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.412 3.909 0 C-N-CA 124.384 3.39 . . . . 75.41 117.835 -153.026 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.479 ' HD2' ' HA ' ' A' ' 75' ' ' PRO . 28.9 Cg_endo -57.98 -177.44 0.09 OUTLIER 'Trans proline' 0 N--CA 1.518 2.961 0 C-N-CA 124.519 3.48 . . . . 74.25 113.217 174.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -39.11 131.49 1.36 Allowed 'Trans proline' 0 C--N 1.402 3.351 0 C-N-CA 123.111 2.54 . . . . 73.45 114.056 173.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.466 ' HG3' ' HE2' ' A' ' 83' ' ' TYR . 0.5 OUTLIER -29.03 123.31 0.05 OUTLIER 'Trans proline' 0 C--N 1.382 2.324 1 C-N-CA 126.105 4.537 . . . . 73.2 117.314 -172.433 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -78.39 156.45 28.96 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 123.137 2.558 . . . . 71.05 114.07 -176.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -56.35 80.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.393 2.915 0 C-N-CA 124.384 3.389 . . . . 74.31 113.191 175.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -178.15 -34.85 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 N-CA-C 109.903 -1.279 . . . . 62.41 109.903 -177.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 75.63 168.82 25.41 Favored Glycine 0 C--N 1.353 1.52 0 N-CA-C 115.194 0.838 . . . . 53.03 115.194 171.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.65 ' HE1' HD12 ' A' ' 65' ' ' ILE . 27.0 m-85 -111.06 102.25 10.72 Favored 'General case' 0 C--O 1.243 0.731 0 C-N-CA 124.789 1.236 . . . . 74.41 109.406 178.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -89.49 152.79 21.26 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.148 0.579 . . . . 71.31 110.819 175.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -127.65 77.89 1.78 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.386 1.074 . . . . 73.24 108.367 175.153 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 9.0 m -38.37 86.67 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 126.982 2.113 . . . . 74.44 115.505 -172.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 76.03 -7.27 29.8 Favored Glycine 0 C--N 1.35 1.32 0 CA-C-N 116.041 -0.527 . . . . 70.11 113.789 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -89.71 125.29 35.22 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.609 1.164 . . . . 72.34 108.208 -178.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -71.71 88.68 0.99 Allowed 'General case' 0 N--CA 1.482 1.139 0 CA-C-O 121.52 0.676 . . . . 71.44 110.082 -175.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -47.13 -43.05 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 126.112 1.765 . . . . 75.21 111.949 177.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -73.88 -6.5 47.55 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 115.214 -0.903 . . . . 75.33 111.889 -173.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -91.64 -27.93 17.81 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.976 0.911 . . . . 61.35 110.787 172.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.456 ' HE1' ' HB3' ' A' ' 48' ' ' LYS . 23.8 m-85 -76.78 -176.2 3.76 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 112.802 0.667 . . . . 73.34 112.802 -170.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 67.8 p -56.86 145.28 30.22 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.194 0.998 . . . . 74.5 112.944 -167.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.63 -41.26 85.55 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.0 -1.0 . . . . 74.52 111.428 177.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -58.91 -44.3 91.25 Favored 'General case' 0 C--N 1.355 0.812 0 C-N-CA 123.038 0.535 . . . . 75.03 110.145 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -58.08 -49.64 76.21 Favored 'General case' 0 CA--C 1.555 1.16 0 CA-C-N 116.077 -0.51 . . . . 72.32 109.963 174.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -73.98 -3.92 32.08 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 112.428 0.529 . . . . 74.14 112.428 -178.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -95.73 -60.15 1.71 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.427 0.691 . . . . 70.02 110.398 171.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 24.2 tp -58.5 -56.77 17.9 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.916 1.286 . . . . 74.33 110.785 -177.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -84.25 -8.13 59.13 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 114.251 -1.341 . . . . 72.11 111.043 178.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -40.65 -66.28 0.88 Allowed Glycine 0 C--N 1.351 1.376 0 N-CA-C 116.114 1.206 . . . . 72.43 116.114 -174.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.466 ' HB2' ' HG2' ' A' ' 78' ' ' PRO . 23.7 Cg_exo -62.6 -14.86 42.43 Favored 'Trans proline' 0 C--N 1.373 1.864 0 C-N-CA 122.749 2.299 . . . . 64.43 114.06 -175.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -103.36 -2.23 47.58 Favored Glycine 0 C--N 1.358 1.773 0 CA-C-O 118.91 -0.939 . . . . 54.4 113.825 -177.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.427 ' HB3' ' OD1' ' A' ' 169' ' ' ASN . 86.6 mt -63.32 77.11 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 124.065 0.946 . . . . 74.25 113.007 -177.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 19.65 -105.14 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.256 0 C-N-CA 127.9 2.48 . . . . 74.45 116.36 174.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 71.85 2.88 53.59 Favored Glycine 0 C--N 1.35 1.353 0 CA-C-O 119.576 -0.569 . . . . 44.0 112.664 -164.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.355 1.584 0 O-C-N 123.923 0.425 . . . . 71.34 112.763 -172.631 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 51.7 tttm . . . . . 0 N--CA 1.484 1.228 0 N-CA-C 112.906 0.706 . . . . 73.31 112.906 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -85.99 -178.3 50.0 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 115.7 -0.682 . . . . 73.4 113.646 177.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.44 ' O ' ' HA3' ' A' ' 172' ' ' GLY . 13.4 ptt180 -96.05 173.43 7.43 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.796 0.838 . . . . 74.43 111.061 179.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -78.82 138.76 38.33 Favored 'General case' 0 CA--C 1.549 0.941 0 N-CA-C 109.267 -0.642 . . . . 74.23 109.267 166.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 9.3 tt -144.95 139.33 27.48 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 107.966 -1.124 . . . . 75.42 107.966 -173.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.53 ' HA ' ' HB2' ' A' ' 175' ' ' LEU . 2.8 tmm_? -100.26 119.04 37.78 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 108.891 -0.781 . . . . 74.51 108.891 175.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.465 ' HB2' HD12 ' A' ' 174' ' ' LEU . . . -111.73 169.87 8.53 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-O 121.7 0.762 . . . . 54.41 110.41 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -120.26 113.42 20.39 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 106.497 -1.668 . . . . 72.42 106.497 -176.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 51.1 tp -98.64 98.02 5.53 Favored Pre-proline 0 N--CA 1.473 0.682 0 N-CA-C 108.194 -1.039 . . . . 74.14 108.194 -178.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.619 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 73.4 Cg_endo -77.05 114.24 3.77 Favored 'Trans proline' 0 C--N 1.372 1.789 0 C-N-CA 121.32 1.347 . . . . 75.33 108.958 177.194 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.523 ' HA ' HG23 ' B' ' 6' ' ' ILE . 61.6 tp -123.06 139.56 53.95 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.075 0.55 . . . . 72.43 110.687 -169.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 27.2 m -68.56 128.86 38.14 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.861 0.864 . . . . 71.34 109.99 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.537 HD21 ' HB3' ' A' ' 180' ' ' LEU . 75.7 mt -50.93 -49.88 58.8 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 124.187 0.995 . . . . 75.21 111.21 -174.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -55.93 -49.4 73.59 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.239 -1.346 . . . . 75.32 109.911 -178.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -75.06 -19.84 59.82 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 114.631 -1.168 . . . . 64.33 111.677 -176.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -68.86 -43.69 74.88 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.334 0.653 . . . . 65.44 109.723 174.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -70.8 -35.51 72.57 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 115.126 -0.943 . . . . 74.51 111.364 176.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -73.65 -39.95 64.09 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 116.202 -0.453 . . . . 75.25 111.885 -178.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.581 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 77.29 -166.44 53.67 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-N 116.513 -0.312 . . . . 71.54 113.42 -176.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 100.08 179.04 30.32 Favored Glycine 0 C--N 1.35 1.311 0 C-N-CA 122.828 0.251 . . . . 70.42 113.161 176.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.623 ' HB3' ' HG ' ' A' ' 146' ' ' SER . 2.1 mp0 -74.75 100.63 4.07 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 122.96 0.504 . . . . 73.14 110.2 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -90.57 123.99 34.67 Favored 'General case' 0 C--O 1.244 0.8 0 N-CA-C 109.307 -0.627 . . . . 75.05 109.307 -177.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 98.3 t -72.39 108.41 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 N-CA-C 109.043 -0.725 . . . . 75.04 109.043 173.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.521 HG12 HG12 ' A' ' 145' ' ' VAL . 3.1 p -121.57 133.16 68.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 124.752 1.221 . . . . 73.34 108.312 175.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -122.42 146.59 47.22 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.037 0.535 . . . . 71.3 110.243 -170.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 10.7 p -163.89 135.03 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 123.26 0.624 . . . . 75.1 110.06 175.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 61.9 19.89 11.05 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.727 1.211 . . . . 74.24 112.871 176.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 96.87 -19.91 52.84 Favored Glycine 0 C--N 1.348 1.226 0 CA-C-N 116.386 -0.37 . . . . 54.15 112.844 -176.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.515 ' NH2' ' HE3' ' A' ' 164' ' ' MET . 1.0 OUTLIER -80.31 115.8 20.04 Favored 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 108.58 -0.896 . . . . 72.43 108.58 -179.213 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 42.2 ttt180 -98.38 99.53 10.73 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.187 0.995 . . . . 74.41 109.781 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.521 HG12 HG12 ' A' ' 138' ' ' VAL . 6.7 p -104.37 153.01 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 C-N-CA 123.231 0.612 . . . . 73.53 110.446 -177.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.623 ' HG ' ' HB3' ' A' ' 135' ' ' GLU . 32.0 t -124.61 103.99 8.44 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.599 0.759 . . . . 64.43 109.6 -179.057 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 4.8 p -101.38 121.99 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 123.169 0.588 . . . . 73.42 110.646 -175.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -73.84 99.36 3.19 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.422 0.629 . . . . 74.32 109.969 173.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.581 HG13 ' HA2' ' A' ' 133' ' ' GLY . 24.1 pt -80.96 142.89 52.48 Favored Pre-proline 0 CA--C 1.558 1.25 0 CA-C-N 114.608 -1.178 . . . . 74.52 109.622 173.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -66.43 136.28 42.63 Favored 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 122.538 2.159 . . . . 74.22 113.24 174.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -56.36 96.9 0.06 OUTLIER 'Trans proline' 0 C--N 1.385 2.45 0 C-N-CA 123.084 2.523 . . . . 74.15 112.409 168.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 104.57 39.63 2.35 Favored Glycine 0 C--N 1.339 0.713 0 CA-C-N 115.298 -0.865 . . . . 75.51 111.675 -174.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 11.6 p -78.56 140.94 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 N-CA-C 109.158 -0.682 . . . . 75.43 109.158 177.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 9.5 mtm105 -115.23 147.15 40.7 Favored 'General case' 0 C--O 1.205 -1.264 0 CA-C-N 115.937 -0.574 . . . . 73.23 111.77 -164.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -53.77 120.01 5.7 Favored 'General case' 0 CA--C 1.551 0.984 0 O-C-N 124.266 0.979 . . . . 72.32 110.355 175.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 105.09 -8.34 45.23 Favored Glycine 0 C--N 1.347 1.14 0 CA-C-N 115.536 -0.757 . . . . 74.33 113.425 -176.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 44.1 m -68.32 105.09 2.03 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 117.447 0.623 . . . . 74.23 110.253 177.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.409 HG21 HG21 ' A' ' 177' ' ' VAL . 41.5 t -85.17 90.81 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-N 115.117 -0.947 . . . . 74.02 109.31 -178.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.583 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 56.9 mt -70.44 91.64 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 108.404 -0.961 . . . . 75.24 108.404 175.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 67.9 ttt-85 -78.38 100.05 6.62 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.778 -0.647 . . . . 75.21 109.273 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.6 p -106.6 105.39 54.56 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 123.662 0.785 . . . . 71.41 109.266 177.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.459 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 23.8 Cg_exo -65.25 104.18 0.59 Allowed 'Trans proline' 0 C--N 1.377 2.058 0 C-N-CA 122.551 2.168 . . . . 74.53 111.283 175.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . 0.43 ' HA2' ' O ' ' A' ' 171' ' ' PRO . . . 126.99 25.77 1.18 Allowed Glycine 0 C--N 1.342 0.873 0 N-CA-C 115.801 1.081 . . . . 70.43 115.801 175.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.515 ' HE3' ' NH2' ' A' ' 143' ' ' ARG . 24.7 mmt -137.57 0.44 2.26 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 119.013 1.406 . . . . 64.15 112.057 177.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.7 ' HA2' HD13 ' A' ' 174' ' ' LEU . . . -75.85 -108.22 0.12 Allowed Glycine 0 N--CA 1.477 1.404 0 C-N-CA 123.685 0.66 . . . . 73.33 114.274 -170.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -58.22 119.05 15.25 Favored Glycine 0 C--N 1.344 0.992 0 N-CA-C 110.051 -1.22 . . . . 74.5 110.051 168.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -64.45 109.09 1.83 Allowed 'General case' 0 CA--C 1.538 0.503 0 O-C-N 124.67 0.865 . . . . 75.42 110.056 -175.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -146.77 174.14 26.71 Favored Glycine 0 C--N 1.339 0.739 0 N-CA-C 110.1 -1.2 . . . . 64.21 110.1 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . 0.427 ' OD1' ' HB3' ' A' ' 105' ' ' LEU . 50.4 t30 -59.61 -61.05 8.66 Favored Pre-proline 0 CA--C 1.565 1.525 0 CA-C-O 118.629 -0.7 . . . . 63.54 109.742 -176.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.427 ' HD3' ' HB3' ' A' ' 169' ' ' ASN . 19.6 Cg_endo -94.81 96.16 0.11 Allowed 'Trans proline' 0 C--N 1.382 2.314 0 CA-C-N 121.44 1.55 . . . . 73.02 108.16 154.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.43 ' O ' ' HA2' ' A' ' 163' ' ' GLY . 18.1 Cg_exo -61.59 167.41 9.95 Favored 'Trans proline' 0 C--N 1.385 2.473 0 C-N-CA 122.361 2.041 . . . . 71.25 112.638 -169.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.44 ' HA3' ' O ' ' A' ' 117' ' ' ARG . . . -85.81 -168.83 45.25 Favored Glycine 0 C--O 1.216 -0.989 0 C-N-CA 121.172 -0.537 . . . . 72.4 113.247 -177.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.459 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 13.6 m-20 -72.59 138.69 46.99 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 122.94 0.496 . . . . 71.14 110.467 -176.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.7 HD13 ' HA2' ' A' ' 165' ' ' GLY . 25.6 tp -119.21 132.05 55.9 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 110.0 -0.37 . . . . 74.2 110.0 177.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.53 ' HB2' ' HA ' ' A' ' 120' ' ' ARG . 44.6 mt -102.09 85.74 2.73 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 107.999 -1.112 . . . . 72.12 107.999 176.083 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.583 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 79.8 mt -71.72 85.83 0.92 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 109.543 -0.539 . . . . 74.52 109.543 176.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.409 HG21 HG21 ' A' ' 158' ' ' VAL . 18.9 t -82.64 102.22 8.33 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 N-CA-C 106.787 -1.56 . . . . 71.11 106.787 178.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 8.2 p -67.92 107.7 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.961 0 CA-C-O 122.516 1.151 . . . . 74.13 110.705 -171.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.619 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 36.0 mmt180 -95.18 100.08 11.95 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.116 -1.402 . . . . 73.42 108.953 175.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.537 ' HB3' HD21 ' A' ' 127' ' ' LEU . 26.3 mt -68.98 142.91 54.53 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 109.753 -0.462 . . . . 74.04 109.753 -179.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 55.2 mt -53.97 159.06 3.02 Favored Pre-proline 0 N--CA 1.486 1.336 0 C-N-CA 124.281 1.032 . . . . 73.22 113.142 -168.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -74.8 28.72 0.35 Allowed 'Trans proline' 0 C--N 1.38 2.215 0 C-N-CA 123.488 2.792 . . . . 74.32 112.485 167.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 64.8 t-80 -60.1 104.83 0.48 Allowed Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 125.722 1.609 . . . . 73.35 106.881 169.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -70.03 24.53 0.18 Allowed 'Trans proline' 0 C--N 1.382 2.34 0 C-N-CA 124.513 3.475 . . . . 61.24 116.801 -160.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 49.1 t -98.92 -50.94 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 118.721 0.691 . . . . 72.34 109.349 178.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . 0.474 ' HB3' HD22 ' A' ' 193' ' ' LEU . 82.9 m-85 -127.74 124.8 38.65 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.045 0.538 . . . . 72.31 110.864 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 52.1 ttp85 -103.5 87.96 2.98 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 107.007 -1.479 . . . . 75.51 107.007 164.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 193' ' ' LEU . 16.3 tp -66.9 155.84 37.37 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.29 0.636 . . . . 74.21 109.601 177.089 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -163.92 121.07 1.73 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.236 0.614 . . . . 70.31 109.384 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 74.62 -79.23 0.97 Allowed Glycine 0 C--N 1.348 1.238 0 N-CA-C 112.239 -0.344 . . . . 65.41 112.239 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.519 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 3.8 pm0 -146.25 -13.3 0.46 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.567 1.147 . . . . 72.32 110.251 173.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -112.03 140.31 46.81 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.285 1.034 . . . . 72.32 111.503 -169.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.474 HD22 ' HB3' ' A' ' 186' ' ' PHE . 35.5 mt -90.2 153.88 20.17 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.312 1.445 . . . . 74.25 111.027 -172.354 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -128.2 98.89 5.24 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 107.738 -1.208 . . . . 73.14 107.738 170.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.435 ' HB2' HD22 ' A' ' 251' ' ' LEU . . . -113.08 130.1 56.28 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.755 0.822 . . . . 74.34 109.932 -176.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 41.2 m -77.25 131.43 38.18 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 109.579 -0.526 . . . . 70.21 109.579 -176.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.427 HD22 HD13 ' A' ' 251' ' ' LEU . 57.1 tp -124.91 108.03 11.47 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 123.216 0.606 . . . . 74.1 109.704 -170.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -80.72 107.74 13.79 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 108.513 -0.921 . . . . 63.3 108.513 173.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 6.7 p -126.51 130.59 23.85 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 124.055 0.942 . . . . 74.33 108.58 -179.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.45 157.44 40.88 Favored 'Trans proline' 0 C--N 1.365 1.409 0 C-N-CA 121.627 1.551 . . . . 70.05 111.96 173.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.43 ' HB1' ' HD3' ' A' ' 202' ' ' PRO . . . -54.09 -53.29 60.21 Favored Pre-proline 0 CA--C 1.559 1.295 0 N-CA-C 114.177 1.177 . . . . 71.34 114.177 -169.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.43 ' HD3' ' HB1' ' A' ' 201' ' ' ALA . 50.4 Cg_exo -58.5 -35.63 98.43 Favored 'Trans proline' 0 C--N 1.382 2.292 0 C-N-CA 122.02 1.813 . . . . 73.32 113.682 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 46.2 mt -74.51 -33.89 34.03 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 N-CA-C 109.966 -0.383 . . . . 71.02 109.966 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . 0.51 ' HA ' HG12 ' A' ' 223' ' ' VAL . . . -67.92 -41.32 82.78 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.303 0.641 . . . . 74.14 111.275 175.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.496 HG12 HD13 ' C' ' 261' ' ' LEU . 55.1 t -78.94 -42.16 24.02 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 C-N-CA 123.865 0.866 . . . . 64.22 112.466 -172.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 84.6 t -84.17 -33.0 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 122.793 0.437 . . . . 74.41 110.288 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 88.04 48.5 4.08 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-N 115.551 -0.749 . . . . 72.35 111.796 -177.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -76.93 173.86 54.62 Favored Glycine 0 C--N 1.341 0.853 0 N-CA-C 111.334 -0.706 . . . . 73.32 111.334 173.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.531 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 46.8 mtmt -84.76 129.92 34.76 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 117.694 0.747 . . . . 73.34 111.915 -178.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 30.2 m -111.56 -172.12 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.961 0 N-CA-C 106.237 -1.764 . . . . 63.11 106.237 161.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . 0.502 ' HD3' ' HB2' ' A' ' 218' ' ' PRO . 15.5 ttm180 -127.39 132.16 50.2 Favored 'General case' 0 C--O 1.237 0.432 0 O-C-N 121.954 -0.466 . . . . 74.32 110.353 177.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -99.51 111.75 24.05 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 108.29 -1.004 . . . . 74.41 108.29 174.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' MET . . . . . 0.577 ' HA ' ' HA ' ' A' ' 218' ' ' PRO . 3.5 mpp? -71.93 123.78 23.46 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 108.602 -0.888 . . . . 74.15 108.602 173.584 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' THR . . . . . 0.464 ' HA ' ' HE1' ' A' ' 186' ' ' PHE . 24.5 p -108.81 -177.74 3.4 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 109.405 -0.591 . . . . 74.1 109.405 179.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . 0.434 HD13 ' HZ ' ' A' ' 240' ' ' PHE . 61.5 mt -58.82 -27.21 64.88 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.661 1.184 . . . . 73.14 113.141 -171.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -142.34 28.84 1.64 Allowed 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 116.323 -0.399 . . . . 64.44 111.222 -175.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 155.72 146.59 4.48 Favored Glycine 0 C--N 1.35 1.346 0 O-C-N 121.513 -0.742 . . . . 63.05 114.612 171.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . 0.577 ' HA ' ' HA ' ' A' ' 213' ' ' MET . 72.9 Cg_endo -85.94 108.82 0.98 Allowed 'Trans proline' 0 C--N 1.369 1.613 0 C-N-CA 122.962 2.441 . . . . 74.13 112.567 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 30.1 m -103.05 150.28 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 123.592 0.757 . . . . 73.4 109.648 -178.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -79.36 142.32 36.14 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 117.802 0.273 . . . . 75.04 110.613 -177.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 3.9 m -134.1 110.87 14.34 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 C-N-CA 124.163 0.985 . . . . 74.51 108.578 174.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.531 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -72.61 114.53 10.85 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 109.145 -0.687 . . . . 70.4 109.145 174.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.51 HG12 ' HA ' ' A' ' 204' ' ' ALA . 50.5 t -59.53 146.63 79.46 Favored Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 124.357 1.063 . . . . 71.22 109.425 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -70.75 158.9 54.36 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 121.592 1.528 . . . . 75.51 109.316 169.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -72.34 151.46 54.14 Favored 'Trans proline' 0 CA--C 1.549 1.25 0 CA-C-N 119.925 1.009 . . . . 72.53 111.969 171.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 46.1 mtt180 64.82 39.26 6.22 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 125.331 1.452 . . . . 75.13 110.894 169.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.564 HG21 HD21 ' A' ' 233' ' ' LEU . 53.2 m -74.42 109.58 8.01 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 112.989 -1.914 . . . . 64.32 111.716 -177.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . 0.407 ' HB3' ' HD2' ' A' ' 231' ' ' ARG . 5.8 tp60 -84.86 140.96 30.78 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.618 1.167 . . . . 75.32 111.521 -177.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -63.31 145.56 55.29 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.061 0.944 . . . . 65.12 112.184 -179.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 86.29 -24.89 7.58 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-N 116.334 -0.394 . . . . 75.54 113.355 178.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.407 ' HD2' ' HB3' ' A' ' 228' ' ' GLN . 93.7 mtt180 -69.15 160.83 30.37 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-O 121.46 0.648 . . . . 74.44 110.905 176.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.628 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 2.8 mppt? -115.16 114.87 25.85 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.112 -1.07 . . . . 72.22 108.112 178.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.564 HD21 HG21 ' A' ' 227' ' ' THR . 87.9 mt -76.16 103.44 6.2 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 115.46 -0.791 . . . . 71.4 109.905 -175.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -76.14 105.09 6.99 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 123.712 0.632 . . . . 73.41 109.982 177.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.515 ' HG ' ' HB3' ' A' ' 249' ' ' LEU . 0.4 OUTLIER -108.45 115.45 30.13 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.006 -1.109 . . . . 74.24 108.006 167.772 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -69.73 141.44 53.46 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 114.651 -1.159 . . . . 71.01 111.978 -167.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 69.98 17.42 73.58 Favored Glycine 0 C--N 1.348 1.221 0 O-C-N 123.936 0.773 . . . . 74.2 113.922 174.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.444 ' HG3' HD11 ' A' ' 235' ' ' LEU . 33.7 mmtp -107.62 5.15 26.65 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.225 0.61 . . . . 74.1 111.086 -176.075 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -101.74 -156.3 26.42 Favored Glycine 0 C--N 1.347 1.19 0 C-N-CA 123.194 0.426 . . . . 74.43 112.659 173.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . 0.434 ' HZ ' HD13 ' A' ' 215' ' ' LEU . 3.4 m-85 -94.23 145.18 29.28 Favored Pre-proline 0 N--CA 1.481 1.079 0 C-N-CA 123.136 0.575 . . . . 73.41 111.065 -172.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -60.56 119.09 6.07 Favored 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 123.52 2.813 . . . . 73.33 112.85 178.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -156.42 -148.19 4.99 Favored Glycine 0 C--N 1.35 1.323 0 CA-C-O 118.548 -1.14 . . . . 73.52 113.746 -173.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . 0.519 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 74.2 Cg_exo -51.92 -38.52 68.82 Favored 'Trans proline' 0 C--N 1.39 2.747 0 C-N-CA 124.138 3.225 . . . . 72.5 113.84 -176.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -82.98 15.33 2.8 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.821 0.848 . . . . 70.11 112.207 -178.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 81.16 -71.57 2.89 Favored Glycine 0 C--N 1.345 1.048 0 N-CA-C 109.814 -1.314 . . . . 62.24 109.814 -169.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 23.1 mtp180 -122.12 147.49 46.08 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.491 1.117 . . . . 75.41 108.723 168.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -86.14 -177.44 49.89 Favored Glycine 0 C--N 1.339 0.706 0 CA-C-N 116.303 -0.408 . . . . 70.31 112.346 175.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -111.45 170.93 7.79 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.29 0.636 . . . . 75.44 110.072 -179.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.515 ' HB3' ' HG ' ' A' ' 235' ' ' LEU . 34.0 tp -114.91 134.39 55.19 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.361 -1.348 . . . . 73.32 107.361 170.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.628 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 62.0 m-85 -116.38 106.28 13.45 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 107.945 -1.131 . . . . 71.3 107.945 175.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.435 HD22 ' HB2' ' A' ' 195' ' ' ALA . 49.5 mt -90.23 108.2 19.61 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 109.51 -0.552 . . . . 74.54 109.51 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . 0.504 ' HG2' ' HG3' ' A' ' 232' ' ' LYS . 30.6 mt-10 -76.33 111.5 11.84 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.663 1.185 . . . . 75.41 109.068 -172.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 27.5 t -69.81 119.24 15.49 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 C-N-CA 123.827 0.851 . . . . 71.34 111.902 -168.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.28 91.67 3.59 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 107.433 -1.321 . . . . 73.14 107.433 174.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.478 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 62.4 mt -78.61 129.68 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 O-C-N 123.204 0.315 . . . . 74.34 110.305 -177.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 51.9 p -113.94 166.46 11.57 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.939 0.895 . . . . 74.52 109.703 173.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . 0.596 HG23 HG23 ' C' ' 255' ' ' ILE . 2.6 pp -118.17 157.52 48.67 Favored Pre-proline 0 CA--C 1.56 1.329 0 C-N-CA 123.735 0.814 . . . . 73.4 110.378 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 258' ' ' PRO . . . . . 0.512 ' HD2' ' HB ' ' A' ' 257' ' ' ILE . 25.7 Cg_endo -56.23 -17.2 19.65 Favored 'Trans proline' 0 N--CA 1.513 2.631 0 C-N-CA 124.42 3.413 . . . . 74.45 115.165 -168.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . 0.646 ' HG2' HE21 ' C' ' 228' ' ' GLN . 40.5 mt-10 50.01 -81.61 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 124.859 1.264 . . . . 75.12 111.659 -166.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.6 161.49 29.52 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 120.114 1.325 . . . . 75.12 109.806 173.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.678 HD22 ' HB3' ' A' ' 265' ' ' GLU . 54.6 mt -147.47 146.5 29.55 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.37 0.668 . . . . 72.32 109.936 173.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 72.5 p -83.97 161.35 55.67 Favored Pre-proline 0 CA--C 1.551 1.011 0 N-CA-C 107.958 -1.127 . . . . 74.31 107.958 165.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -50.24 -40.25 52.08 Favored 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 123.279 2.653 . . . . 74.33 113.562 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -63.1 -56.99 12.16 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.745 -0.661 . . . . 71.44 110.53 177.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . 0.678 ' HB3' HD22 ' A' ' 261' ' ' LEU . 53.0 mt-10 -57.38 -35.97 70.66 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 123.626 0.579 . . . . 73.22 111.102 -179.032 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 266' ' ' GLU . . . . . 0.556 ' HA ' HD12 ' A' ' 261' ' ' LEU . 7.3 tp10 -59.69 -50.41 73.96 Favored 'General case' 0 C--O 1.248 0.984 0 C-N-CA 123.985 0.914 . . . . 73.45 109.519 178.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -60.71 -41.54 95.45 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 114.627 -1.169 . . . . 64.12 111.814 177.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 10.1 mp -69.85 -45.28 68.11 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.42 0.688 . . . . 73.14 111.786 -176.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 63.1 m95 -66.68 -35.38 80.02 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.563 0.745 . . . . 75.0 111.62 -179.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . 0.462 ' HE2' HG21 ' C' ' 206' ' ' VAL . 96.2 mttt -85.22 -16.79 39.09 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 116.216 -0.447 . . . . 73.12 112.142 177.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . 0.401 ' HB3' ' HZ2' ' A' ' 271' ' ' LYS . 4.0 mmmp? -74.47 -32.79 62.69 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 110.029 -0.36 . . . . 70.22 110.029 166.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 91.6 mt -61.87 -58.24 8.7 Favored 'General case' 0 C--O 1.212 -0.892 0 N-CA-C 108.338 -0.986 . . . . 71.54 108.338 170.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -57.5 -32.59 67.16 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.52 1.128 . . . . 72.23 112.793 -177.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -65.17 -62.68 1.4 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.443 0.697 . . . . 74.35 109.35 172.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -70.6 -6.35 36.02 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.276 0.631 . . . . 72.24 112.564 -175.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -93.64 -80.51 0.39 Allowed 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 107.612 -1.255 . . . . 75.02 107.612 174.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -73.27 -38.1 66.06 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.33 -0.85 . . . . 72.14 112.005 -166.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -73.37 -4.54 34.05 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 122.345 -0.222 . . . . 75.41 111.1 178.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -120.96 10.74 10.88 Favored 'General case' 0 C--N 1.358 0.961 0 C-N-CA 123.451 0.7 . . . . 75.15 110.059 176.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.142 0 C-N-CA 123.603 0.761 . . . . 72.5 111.314 -178.502 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.436 ' HB3' ' HB3' ' B' ' 4' ' ' SER . 1.5 mpt? . . . . . 0 N--CA 1.477 0.898 0 N-CA-C 110.238 -0.282 . . . . 74.12 110.238 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -79.77 -49.43 12.04 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.189 0.596 . . . . 62.45 110.608 176.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -93.88 19.89 8.37 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.312 0.645 . . . . 74.04 112.3 -171.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 4' ' ' SER . . . . . 0.436 ' HB3' ' HB3' ' B' ' 1' ' ' MET . 13.9 p -65.97 -56.31 12.33 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-O 120.945 0.403 . . . . 52.14 110.156 178.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 4.1 m 67.78 151.8 0.08 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.501 1.52 . . . . 74.34 112.328 174.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.523 HG23 ' HA ' ' A' ' 125' ' ' LEU . 46.2 pt -130.93 159.99 42.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 123.019 0.527 . . . . 65.34 111.645 -162.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -131.93 134.74 45.99 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.828 0.851 . . . . 72.22 110.104 178.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 32.7 tp -73.15 144.69 46.81 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.429 0.691 . . . . 75.22 110.378 -176.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.39 -50.03 10.67 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 122.477 0.311 . . . . 73.12 111.345 178.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 31.4 mt 71.22 -25.09 0.17 Allowed 'General case' 0 N--CA 1.504 2.251 0 C-N-CA 125.295 1.438 . . . . 74.1 113.282 -172.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 61.0 mt . . . . . 0 CA--C 1.558 1.278 0 C-N-CA 124.468 1.107 . . . . 72.11 109.649 -168.391 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.13 0 CA-C-O 121.378 0.608 . . . . 74.35 109.979 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . -176.92 -57.57 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 105.869 -1.9 . . . . 75.32 105.869 170.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 46.1 tp -142.75 123.18 13.95 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 106.35 -1.722 . . . . 74.44 106.35 163.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 182' ' ' VAL . . . . . 0.685 ' HB ' ' HB2' ' C' ' 123' ' ' LEU . 69.5 t -68.67 131.94 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.064 0.546 . . . . 72.43 110.817 -172.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -119.54 16.78 12.91 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.767 0.827 . . . . 65.24 112.264 -172.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 28.5 m-70 -62.18 100.39 0.17 Allowed 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 122.789 0.436 . . . . 75.32 111.138 -178.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 185' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' C' ' 121' ' ' ALA . 60.6 t . . . . . 0 N--CA 1.48 1.048 0 C-N-CA 123.826 0.851 . . . . 74.01 110.102 177.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 90.8 m . . . . . 0 CA--C 1.56 1.348 0 N-CA-C 110.148 -0.316 . . . . 71.31 110.148 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -88.95 168.1 12.66 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 113.88 1.067 . . . . 74.42 113.88 -176.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 240' ' ' GLY . . . . . 0.487 ' H ' HD21 ' C' ' 235' ' ' LEU . . . -102.44 -118.79 4.48 Favored Glycine 0 C--N 1.34 0.766 0 CA-C-N 112.94 -1.936 . . . . 71.23 110.543 176.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -161.11 -179.49 7.53 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-O 121.705 0.764 . . . . 71.23 110.334 174.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 242' ' ' TRP . . . . . 0.401 ' CZ3' HG23 ' C' ' 253' ' ' VAL . 2.6 m0 -106.17 -52.57 2.78 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 106.468 -1.678 . . . . 70.32 106.468 174.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 179.76 -152.13 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.139 0 CA-C-N 112.987 -1.915 . . . . 74.22 107.802 -167.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -62.02 116.31 9.18 Favored Glycine 0 CA--C 1.542 1.751 0 CA-C-N 117.785 0.266 . . . . 71.54 113.629 175.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? . . . . . 0 CA--C 1.55 0.98 0 C-N-CA 124.052 0.941 . . . . 75.34 108.886 179.181 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.808 0 CA-C-O 121.185 0.517 . . . . 71.34 109.798 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -37.91 123.8 1.1 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.237 1.815 . . . . 70.52 114.951 -174.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 22.3 mmtp -93.53 122.68 36.22 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.6 -0.727 . . . . 72.32 109.591 166.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -82.65 86.18 6.89 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 107.48 -1.304 . . . . 65.15 107.48 170.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 7' ' ' TYR . . . . . 0.421 ' HB3' ' HA ' ' C' ' 53' ' ' ALA . 73.9 m-85 -61.61 -35.12 76.95 Favored 'General case' 0 C--O 1.244 0.764 0 CA-C-N 114.341 -1.299 . . . . 73.43 111.198 -176.164 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -60.26 -46.86 88.34 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.584 -0.735 . . . . 74.23 110.113 175.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.55 -39.19 92.83 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.888 0.475 . . . . 63.34 111.27 179.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 69.0 mt -57.86 -39.79 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 122.984 0.513 . . . . 73.31 110.704 174.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 11' ' ' LEU . . . . . 0.496 HD13 HG21 ' C' ' 22' ' ' ILE . 67.9 mt -79.92 -17.13 53.85 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 122.898 0.479 . . . . 75.53 112.068 176.059 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.66 26.7 45.22 Favored Glycine 0 CA--C 1.537 1.445 0 N-CA-C 113.887 0.315 . . . . 74.43 113.887 -178.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 12.3 m -120.0 156.83 54.11 Favored Pre-proline 0 CA--C 1.555 1.167 0 C-N-CA 124.76 1.224 . . . . 71.34 110.069 178.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.62 164.03 36.79 Favored 'Trans proline' 0 C--N 1.383 2.357 0 C-N-CA 122.85 2.366 . . . . 74.43 112.283 177.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -70.03 8.06 0.82 Allowed 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 114.068 1.136 . . . . 74.35 114.068 -174.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -128.01 16.13 6.79 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.508 0.723 . . . . 71.24 109.432 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.5 123.44 19.23 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.354 1.062 . . . . 75.2 110.788 178.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 76.0 p -74.0 177.18 5.83 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.303 0.641 . . . . 74.41 111.003 -177.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.46 -55.44 21.92 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 124.269 1.028 . . . . 74.45 111.191 -171.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -67.9 -29.11 68.12 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.393 0.677 . . . . 74.53 112.008 -174.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -71.16 -47.37 58.14 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-O 121.12 0.486 . . . . 73.42 110.682 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 22' ' ' ILE . . . . . 0.771 HD12 ' HB3' ' C' ' 57' ' ' LEU . 82.3 mt -57.89 -44.01 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 124.447 1.099 . . . . 75.54 110.27 172.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 23' ' ' LYS . . . . . 0.456 ' HG2' ' HE2' ' C' ' 27' ' ' LYS . 79.1 tttt -66.35 -35.86 81.43 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 113.723 -1.58 . . . . 74.13 111.257 -176.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 27.2 mtm180 -78.95 -33.84 44.96 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 123.323 0.649 . . . . 73.52 111.463 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.98 -44.61 95.56 Favored 'General case' 0 C--O 1.257 1.482 0 CA-C-O 121.812 0.815 . . . . 75.32 110.032 173.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 26' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -60.95 -57.89 10.72 Favored 'General case' 0 C--O 1.201 -1.48 0 CA-C-N 113.797 -1.547 . . . . 72.31 110.125 175.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . 0.456 ' HE2' ' HG2' ' C' ' 23' ' ' LYS . 49.9 mtmt -54.8 -35.55 64.0 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 123.698 0.799 . . . . 75.33 111.142 -176.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 39.7 ttp180 -57.13 -57.77 11.14 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.026 0.531 . . . . 75.55 109.75 172.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . 0.611 ' HB3' HD12 ' C' ' 50' ' ' ILE . 95.5 mt -74.71 -14.84 60.78 Favored 'General case' 0 CA--C 1.557 1.229 0 CA-C-N 115.686 -0.688 . . . . 71.43 112.586 -177.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.32 -23.46 19.26 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.376 1.07 . . . . 75.32 111.129 -176.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -88.86 -35.98 16.25 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 109.041 -0.726 . . . . 73.5 109.041 171.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.45 -50.1 55.01 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 122.996 0.518 . . . . 71.12 109.759 -178.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -97.43 25.8 5.39 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.886 0.474 . . . . 72.14 111.178 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 34' ' ' HIS . . . . . . . . . . . . . 13.2 t-160 -59.92 106.87 0.83 Allowed Pre-proline 0 N--CA 1.487 1.406 0 CA-C-O 118.708 -0.663 . . . . 74.34 111.324 -173.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.06 -22.49 69.7 Favored 'Trans proline' 0 C--N 1.383 2.355 0 C-N-CA 123.351 2.701 . . . . 72.22 113.233 -172.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -70.08 -36.48 74.95 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.782 0.833 . . . . 60.34 111.094 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 62.1 t -98.81 -57.54 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 CA-C-O 121.676 0.75 . . . . 75.33 109.266 -179.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -94.0 79.49 4.1 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 124.836 1.254 . . . . 65.41 107.979 -178.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -75.59 78.85 2.59 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-N 113.738 -1.574 . . . . 71.22 109.196 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 26.7 m -132.54 107.09 13.1 Favored Pre-proline 0 C--O 1.236 0.352 0 N-CA-C 108.35 -0.981 . . . . 74.14 108.35 178.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . 0.43 ' O ' ' HG2' ' C' ' 45' ' ' GLU . 48.0 Cg_exo -42.02 -45.7 7.13 Favored 'Trans proline' 0 C--N 1.386 2.512 0 C-N-CA 123.814 3.009 . . . . 75.0 113.308 178.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -59.92 -41.16 91.14 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.672 0.789 . . . . 71.01 111.481 -179.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.89 -27.34 65.7 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 115.678 -0.692 . . . . 71.45 109.956 178.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 44' ' ' GLU . . . . . 0.475 ' O ' ' HG3' ' C' ' 48' ' ' LYS . 38.5 mt-10 -79.2 -27.72 42.58 Favored 'General case' 0 C--O 1.215 -0.759 0 O-C-N 123.827 0.704 . . . . 74.04 109.508 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 45' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' C' ' 41' ' ' PRO . 29.6 mm-40 -70.78 -48.08 56.16 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.636 0.774 . . . . 75.44 110.344 177.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 46' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -57.89 -42.77 85.32 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 114.8 -1.091 . . . . 72.32 109.484 172.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -65.62 -30.15 70.82 Favored 'General case' 0 C--O 1.213 -0.834 0 CA-C-N 115.04 -0.982 . . . . 71.12 111.202 178.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 48' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' C' ' 44' ' ' GLU . 92.8 mttt -64.89 -43.42 92.94 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.057 0.543 . . . . 72.04 110.384 174.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -61.9 -39.69 92.86 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.595 0.712 . . . . 72.33 111.221 177.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 50' ' ' ILE . . . . . 0.611 HD12 ' HB3' ' C' ' 29' ' ' LEU . 79.0 mt -67.35 -34.1 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 CA-C-N 115.018 -0.992 . . . . 75.43 110.468 173.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 51' ' ' ASN . . . . . 0.509 ' HB3' ' CD1' ' C' ' 88' ' ' PHE . 70.8 m-20 -76.92 -17.06 59.17 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.586 1.154 . . . . 74.04 111.408 177.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -75.48 -51.27 13.39 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 108.103 -1.073 . . . . 75.54 108.103 171.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . 0.421 ' HA ' ' HB3' ' C' ' 7' ' ' TYR . . . -55.3 -38.15 68.29 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 113.752 -1.567 . . . . 63.1 111.518 174.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -80.9 -29.87 35.55 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.132 0.973 . . . . 75.01 110.454 178.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.56 -28.21 66.93 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 123.17 0.588 . . . . 60.54 110.559 174.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 21.1 t -92.02 -45.31 14.34 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.166 0 CA-C-N 115.285 -0.871 . . . . 72.43 112.023 175.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 57' ' ' LEU . . . . . 0.771 ' HB3' HD12 ' C' ' 22' ' ' ILE . 87.3 mt -104.52 4.58 33.19 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 115.584 1.698 . . . . 75.02 115.584 -163.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 38.6 t -66.71 -74.55 0.11 Allowed 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 118.56 0.618 . . . . 75.33 112.414 -177.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -66.6 140.97 96.72 Favored Pre-proline 0 C--N 1.349 0.571 0 N-CA-C 108.7 -0.852 . . . . 72.03 108.7 176.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 60' ' ' PRO . . . . . 0.451 ' O ' ' HG2' ' C' ' 64' ' ' ARG . 18.1 Cg_endo -58.29 -27.75 82.05 Favored 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 122.067 1.845 . . . . 73.21 111.013 174.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -65.01 -52.23 57.24 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.541 0.736 . . . . 62.13 111.418 175.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 62' ' ' LYS . . . . . 0.537 ' HD3' ' HB3' ' C' ' 84' ' ' ASP . 46.4 mtmt -66.06 -36.49 83.35 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 121.163 0.506 . . . . 75.43 110.72 -178.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 45.0 ttt-85 -57.44 -46.06 84.0 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.14 -0.936 . . . . 74.14 108.74 175.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 64' ' ' ARG . . . . . 0.451 ' HG2' ' O ' ' C' ' 60' ' ' PRO . 24.0 mmt180 -68.75 -24.65 64.47 Favored 'General case' 0 C--O 1.213 -0.823 0 CA-C-N 115.442 -0.799 . . . . 74.15 111.999 177.046 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 65' ' ' ILE . . . . . 0.518 HG12 ' HG2' ' C' ' 76' ' ' PRO . 78.4 mt -60.89 -45.28 98.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 108.906 -0.776 . . . . 71.5 108.906 171.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -60.86 -51.38 69.57 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 115.146 -0.933 . . . . 74.31 109.95 174.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -58.01 -40.0 79.69 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.605 0.762 . . . . 73.14 111.862 -177.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 63.5 p -74.64 -24.83 58.89 Favored 'General case' 0 C--O 1.217 -0.615 0 CA-C-O 119.288 -0.387 . . . . 74.43 110.339 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -75.28 120.12 20.32 Favored 'General case' 0 C--N 1.356 0.868 0 N-CA-C 108.653 -0.869 . . . . 75.22 108.653 174.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.55 24.87 22.59 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.293 -0.723 . . . . 62.51 111.293 -169.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 56.8 m -145.62 -62.49 0.33 Allowed 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 103.269 -2.863 . . . . 72.34 103.269 171.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 23.6 m -85.1 148.67 26.02 Favored 'General case' 0 C--O 1.254 1.29 0 N-CA-C 105.458 -2.052 . . . . 73.35 105.458 157.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.94 -28.56 15.11 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.273 0.629 . . . . 73.23 110.703 176.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -87.56 136.97 32.43 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 123.594 0.757 . . . . 53.23 110.253 178.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -68.51 127.59 15.85 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.435 2.09 . . . . 75.14 110.495 175.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 76' ' ' PRO . . . . . 0.518 ' HG2' HG12 ' C' ' 65' ' ' ILE . 9.8 Cg_endo -51.87 132.87 43.8 Favored 'Trans proline' 0 C--N 1.387 2.602 0 C-N-CA 123.058 2.505 . . . . 71.22 111.741 177.469 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -48.08 128.54 16.94 Favored 'Trans proline' 0 C--N 1.387 2.585 0 C-N-CA 123.877 3.051 . . . . 74.4 114.101 -169.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 78' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -67.95 154.72 72.08 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 122.383 2.055 . . . . 74.44 111.574 178.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.97 156.39 39.14 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.398 2.065 . . . . 70.12 111.439 170.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -54.75 85.56 0.03 OUTLIER 'Trans proline' 0 C--N 1.388 2.645 0 C-N-CA 123.367 2.712 . . . . 74.31 113.13 177.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 153.17 -42.11 0.66 Allowed Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 114.032 -1.44 . . . . 75.2 110.492 -179.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 137.54 169.44 11.63 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-N 115.151 -0.525 . . . . 75.13 112.1 178.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -57.93 148.81 24.52 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.008 0.923 . . . . 73.4 110.36 172.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 84' ' ' ASP . . . . . 0.537 ' HB3' ' HD3' ' C' ' 62' ' ' LYS . 18.0 t0 -57.32 130.82 47.95 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 123.739 0.649 . . . . 75.11 111.88 -179.114 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 85' ' ' PHE . . . . . 0.483 ' CD1' ' HB2' ' C' ' 88' ' ' PHE . 0.3 OUTLIER -148.91 32.97 0.76 Allowed 'General case' 0 C--O 1.241 0.624 0 O-C-N 123.625 0.578 . . . . 74.41 111.543 -170.808 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' C' C ' 86' ' ' SER . . . . . 0.565 ' HA ' ' O ' ' C' ' 169' ' ' ASN . 18.3 m -70.89 93.75 1.0 Allowed 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.286 -0.87 . . . . 52.42 112.721 -169.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 86.62 10.02 74.01 Favored Glycine 0 C--N 1.346 1.112 0 CA-C-N 114.796 -1.093 . . . . 74.34 113.306 177.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 88' ' ' PHE . . . . . 0.509 ' CD1' ' HB3' ' C' ' 51' ' ' ASN . 10.2 m-85 -92.62 138.18 31.72 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 108.384 -0.969 . . . . 74.44 108.384 -176.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -84.32 76.63 10.1 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 122.029 -0.42 . . . . 72.23 110.799 -168.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 90' ' ' VAL . . . . . . . . . . . . . 4.2 p -43.46 -55.53 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 C-N-CA 125.177 1.391 . . . . 54.42 114.594 -176.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -70.76 -19.71 62.69 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.52 0.328 . . . . 75.25 111.813 -173.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -87.64 -23.0 24.38 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 110.221 -0.289 . . . . 75.53 110.221 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 93' ' ' PHE . . . . . 0.509 ' HE2' ' HB3' ' C' ' 88' ' ' PHE . 11.9 m-30 -72.35 171.86 11.42 Favored 'General case' 0 C--N 1.352 0.683 0 N-CA-C 113.314 0.857 . . . . 72.45 113.314 -168.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 49.7 m -60.24 150.51 29.93 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 114.288 -1.324 . . . . 52.11 112.463 -172.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 95' ' ' GLU . . . . . 0.428 ' O ' ' HG3' ' C' ' 99' ' ' GLU . 0.0 OUTLIER -66.38 -45.05 81.37 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.448 0.699 . . . . 72.35 110.854 -178.542 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -52.09 -44.41 64.38 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.556 1.142 . . . . 74.24 110.946 172.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 97' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -66.56 -39.7 88.65 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 114.118 -1.401 . . . . 64.25 110.605 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -76.66 -9.7 58.85 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.644 0.778 . . . . 71.33 112.037 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 99' ' ' GLU . . . . . 0.428 ' HG3' ' O ' ' C' ' 95' ' ' GLU . 51.1 mt-10 -90.28 -47.02 8.03 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.916 0.486 . . . . 74.43 111.102 169.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 25.6 tp -66.6 -50.0 64.48 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.844 0.858 . . . . 73.23 110.808 -176.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -92.54 -1.23 57.09 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.664 -0.698 . . . . 75.04 111.257 177.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -45.47 -61.42 3.69 Favored Glycine 0 C--N 1.356 1.68 0 CA-C-O 118.769 -1.017 . . . . 74.41 114.704 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -46.66 -18.8 0.57 Allowed 'Trans proline' 0 C--N 1.391 2.808 0 C-N-CA 124.511 3.474 . . . . 64.35 114.735 179.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -150.62 53.32 0.5 Allowed Glycine 0 C--N 1.347 1.163 0 CA-C-O 119.894 -0.392 . . . . 73.42 112.728 177.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 32.6 mt . . . . . 0 N--CA 1.504 2.268 0 N-CA-C 113.94 1.089 . . . . 75.43 113.94 172.752 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.887 0 N-CA-C 110.197 -1.161 . . . . 54.4 110.197 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' C' C ' 117' ' ' ARG . . . . . 0.436 ' O ' ' HA2' ' C' ' 166' ' ' GLY . 49.8 ttp180 -88.19 116.62 26.52 Favored 'General case' 0 C--O 1.253 1.246 0 N-CA-C 108.96 -0.755 . . . . 74.32 108.96 177.02 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -40.8 120.58 1.32 Allowed 'General case' 0 N--CA 1.483 1.189 0 O-C-N 124.465 1.103 . . . . 75.42 109.908 175.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 119' ' ' LEU . . . . . . . . . . . . . 13.5 tp -94.81 154.36 17.3 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 118.687 -1.205 . . . . 75.21 108.289 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.403 ' HD3' ' N ' ' C' ' 120' ' ' ARG . 0.0 OUTLIER -143.49 112.71 6.77 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 105.823 -1.917 . . . . 72.31 105.823 -175.403 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' C' C ' 121' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' B' ' 185' ' ' VAL . . . -132.38 116.52 16.95 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 109.002 -0.74 . . . . 75.44 109.002 -177.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 122' ' ' GLU . . . . . 0.476 ' HA ' ' O ' ' C' ' 177' ' ' VAL . 13.8 pt-20 -88.91 131.44 35.13 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 109.357 -0.609 . . . . 74.12 109.357 178.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 123' ' ' LEU . . . . . 0.685 ' HB2' ' HB ' ' B' ' 182' ' ' VAL . 2.6 pt? -134.86 124.37 16.63 Favored Pre-proline 0 N--CA 1.478 0.964 0 N-CA-C 111.89 0.33 . . . . 73.3 111.89 -170.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . 0.416 ' HD2' HG12 ' B' ' 182' ' ' VAL . 16.2 Cg_exo -68.95 117.84 5.29 Favored 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 122.924 2.416 . . . . 72.51 110.314 170.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 125' ' ' LEU . . . . . 0.513 HD22 HG13 ' C' ' 153' ' ' VAL . 42.9 tp -143.68 146.77 33.46 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 122.896 0.479 . . . . 75.32 109.785 -169.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 126' ' ' THR . . . . . 0.457 HG21 HD13 ' C' ' 181' ' ' LEU . 34.0 p -93.93 166.75 12.02 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.753 0.787 . . . . 61.53 110.379 171.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 127' ' ' LEU . . . . . 0.488 HD21 HD11 ' C' ' 180' ' ' LEU . 15.2 mt -71.25 -37.7 71.94 Favored 'General case' 0 C--O 1.249 1.065 0 CA-C-N 114.04 -1.436 . . . . 62.25 109.358 178.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 11.2 mp0 -61.36 -49.87 75.19 Favored 'General case' 0 C--O 1.216 -0.696 0 CA-C-N 113.085 -1.871 . . . . 75.24 109.134 178.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 129' ' ' GLU . . . . . 0.683 ' HA ' ' HB2' ' C' ' 132' ' ' HIS . 28.7 mm-40 -81.52 -7.48 59.59 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 123.848 0.717 . . . . 75.51 111.562 178.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -68.6 -46.34 69.58 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 109.478 -0.564 . . . . 73.14 109.478 166.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 131' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -67.11 -51.27 56.31 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 115.719 -0.673 . . . . 75.55 110.426 169.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 132' ' ' HIS . . . . . 0.683 ' HB2' ' HA ' ' C' ' 129' ' ' GLU . 30.6 m170 -74.06 -1.17 18.95 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.694 0.798 . . . . 70.15 111.604 -174.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -63.3 -101.37 0.01 OUTLIER Glycine 0 C--N 1.352 1.453 0 N-CA-C 111.365 -0.694 . . . . 65.31 111.365 165.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 134' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' C' ' 148' ' ' ARG . . . 53.74 -108.49 0.83 Allowed Glycine 0 C--N 1.349 1.253 0 N-CA-C 111.61 -0.596 . . . . 73.12 111.61 -177.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -77.13 95.99 4.38 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.173 -1.047 . . . . 73.03 108.173 174.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 136' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.29 138.53 47.88 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 123.755 0.822 . . . . 72.12 109.291 -174.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 137' ' ' VAL . . . . . 0.513 HG13 ' HG ' ' C' ' 146' ' ' SER . 34.0 m -86.61 131.54 34.51 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 N-CA-C 109.181 -0.674 . . . . 73.11 109.181 174.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 138' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' C' ' 144' ' ' ARG . 7.6 p -133.96 143.74 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.22 1.008 . . . . 72.14 108.464 -176.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 139' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -123.47 82.99 2.07 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.237 0.541 . . . . 74.31 109.813 176.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 140' ' ' VAL . . . . . 0.55 HG11 ' HG2' ' C' ' 164' ' ' MET . 6.9 p -96.34 137.21 24.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 115.299 -0.864 . . . . 73.25 109.226 176.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 55.93 28.27 12.37 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 123.978 0.911 . . . . 65.0 111.701 -177.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 72.2 31.19 64.12 Favored Glycine 0 C--N 1.35 1.338 0 CA-C-N 116.343 -0.39 . . . . 52.4 113.394 -179.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 143' ' ' ARG . . . . . . . . . . . . . 55.5 ttt180 -128.03 104.3 7.71 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.561 0.744 . . . . 75.05 109.632 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 144' ' ' ARG . . . . . 0.406 ' HA ' ' O ' ' C' ' 138' ' ' VAL . 49.1 ttt180 -85.35 107.42 17.34 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.618 0.767 . . . . 71.51 110.845 -178.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 145' ' ' VAL . . . . . . . . . . . . . 22.7 t -123.05 140.98 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.534 0.734 . . . . 75.03 110.187 178.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 146' ' ' SER . . . . . 0.513 ' HG ' HG13 ' C' ' 137' ' ' VAL . 20.0 m -83.13 96.0 8.26 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 108.88 -0.785 . . . . 73.22 108.88 168.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 147' ' ' VAL . . . . . 0.472 HG23 ' HE3' ' C' ' 164' ' ' MET . 29.4 m -98.73 157.93 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 123.528 0.731 . . . . 72.53 109.839 -178.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 148' ' ' ARG . . . . . 0.451 HH22 ' HB3' ' C' ' 243' ' ' PRO . 62.8 ttt180 -116.73 94.5 4.63 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 108.638 -0.875 . . . . 74.22 108.638 167.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 149' ' ' ILE . . . . . . . . . . . . . 19.4 pt -79.03 150.94 75.54 Favored Pre-proline 0 N--CA 1.476 0.863 0 N-CA-C 107.818 -1.179 . . . . 74.42 107.818 170.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -53.82 120.85 8.56 Favored 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 122.092 1.861 . . . . 61.44 110.875 176.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -60.04 98.39 0.12 Allowed 'Trans proline' 0 C--N 1.386 2.515 0 C-N-CA 122.509 2.139 . . . . 73.2 110.204 177.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 152' ' ' GLY . . . . . 0.412 ' HA2' ' CZ ' ' C' ' 240' ' ' PHE . . . 147.63 145.34 4.16 Favored Glycine 0 C--N 1.347 1.18 0 CA-C-N 115.943 -0.572 . . . . 63.11 113.35 -172.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 153' ' ' VAL . . . . . 0.513 HG13 HD22 ' C' ' 125' ' ' LEU . 2.9 p -159.99 155.07 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.314 0 N-CA-C 112.708 0.633 . . . . 74.01 112.708 172.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 154' ' ' ARG . . . . . . . . . . . . . 16.7 ttm180 -120.72 132.07 54.87 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.626 1.57 . . . . 75.32 109.089 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 155' ' ' GLU . . . . . 0.571 ' HB2' HD12 ' C' ' 180' ' ' LEU . 8.3 tp10 -41.61 127.65 3.14 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 124.779 1.232 . . . . 74.51 112.887 175.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 74.04 0.76 57.6 Favored Glycine 0 C--N 1.352 1.429 0 N-CA-C 114.44 0.536 . . . . 75.21 114.44 173.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 157' ' ' SER . . . . . . . . . . . . . 36.1 t -92.71 155.52 17.65 Favored 'General case' 0 C--O 1.255 1.365 0 CA-C-O 121.519 0.676 . . . . 75.43 109.877 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 158' ' ' VAL . . . . . 0.534 HG11 HG21 ' C' ' 177' ' ' VAL . 29.7 m -99.54 122.0 50.84 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 CA-C-N 114.209 -1.36 . . . . 72.31 110.086 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 159' ' ' ILE . . . . . 0.651 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 31.7 mt -80.22 105.14 9.46 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 N-CA-C 107.198 -1.408 . . . . 72.31 107.198 170.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 62.0 ttm-85 -74.33 99.25 3.43 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 107.658 -1.238 . . . . 75.13 107.658 173.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 161' ' ' VAL . . . . . . . . . . . . . 2.4 p -117.48 101.97 52.28 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 124.301 1.041 . . . . 75.24 109.736 -178.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.69 145.46 81.41 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.106 1.87 . . . . 75.23 110.144 168.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 99.36 4.05 56.34 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-O 119.468 -0.629 . . . . 53.54 113.857 -176.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 164' ' ' MET . . . . . 0.58 ' SD ' HD22 ' C' ' 174' ' ' LEU . 19.1 ttm -144.42 5.75 1.25 Allowed 'General case' 0 CA--C 1.559 1.293 0 CA-C-N 117.668 0.734 . . . . 73.35 112.698 -174.236 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . -129.43 177.56 17.93 Favored Glycine 0 N--CA 1.488 2.143 0 CA-C-O 118.421 -1.211 . . . . 73.32 113.203 177.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 166' ' ' GLY . . . . . 0.436 ' HA2' ' O ' ' C' ' 117' ' ' ARG . . . 98.28 106.11 2.54 Favored Glycine 0 C--N 1.364 2.087 0 CA-C-N 119.636 1.718 . . . . 75.44 116.366 176.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 167' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -99.98 100.18 11.04 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 105.87 -1.9 . . . . 74.2 105.87 160.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . 163.12 -139.11 5.7 Favored Glycine 0 C--O 1.208 -1.521 0 CA-C-O 119.188 -0.784 . . . . 13.44 112.521 -169.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 169' ' ' ASN . . . . . 0.594 ' HB3' ' HD3' ' C' ' 170' ' ' PRO . 2.1 t30 -145.3 -66.05 0.02 OUTLIER Pre-proline 0 CA--C 1.574 1.87 0 CA-C-O 116.846 -1.55 . . . . 62.44 111.254 -176.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 170' ' ' PRO . . . . . 0.594 ' HD3' ' HB3' ' C' ' 169' ' ' ASN . 73.9 Cg_exo -54.12 142.45 66.43 Favored 'Trans proline' 0 C--N 1.405 3.528 0 CA-C-N 124.046 2.481 . . . . 73.55 112.897 174.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 171' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -85.18 150.55 10.7 Favored 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 123.424 2.749 . . . . 74.02 115.22 -161.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -160.96 -109.3 0.24 Allowed Glycine 0 C--N 1.357 1.71 0 CA-C-O 118.629 -1.095 . . . . 74.42 113.495 177.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 173' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -173.56 171.94 3.76 Favored 'General case' 0 C--O 1.263 1.785 0 CA-C-O 123.782 1.753 . . . . 74.51 115.19 -168.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 174' ' ' LEU . . . . . 0.58 HD22 ' SD ' ' C' ' 164' ' ' MET . 9.9 tp -110.89 143.25 41.81 Favored 'General case' 0 C--N 1.353 0.723 0 CA-C-N 112.008 -2.36 . . . . 75.22 108.934 170.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 175' ' ' LEU . . . . . 0.472 ' HB3' ' HB ' ' C' ' 158' ' ' VAL . 72.1 mt -106.97 95.68 5.89 Favored 'General case' 0 C--O 1.249 1.036 0 N-CA-C 108.054 -1.091 . . . . 72.15 108.054 171.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 176' ' ' LEU . . . . . 0.651 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 67.5 mt -72.61 101.14 2.95 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.767 -0.651 . . . . 74.33 109.913 175.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 177' ' ' VAL . . . . . 0.534 HG21 HG11 ' C' ' 158' ' ' VAL . 25.3 t -82.67 96.94 3.95 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 N-CA-C 107.701 -1.222 . . . . 75.23 107.701 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 178' ' ' VAL . . . . . 0.419 HG22 HG13 ' C' ' 153' ' ' VAL . 8.5 p -72.99 135.45 27.68 Favored 'Isoleucine or valine' 0 C--O 1.248 1.003 0 CA-C-O 121.938 0.875 . . . . 74.01 111.62 -172.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 179' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -110.57 94.55 5.06 Favored 'General case' 0 C--O 1.243 0.717 0 N-CA-C 106.596 -1.631 . . . . 74.42 106.596 171.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 180' ' ' LEU . . . . . 0.571 HD12 ' HB2' ' C' ' 155' ' ' GLU . 80.0 mt -69.17 136.5 52.2 Favored 'General case' 0 C--N 1.351 0.631 0 CA-C-O 120.981 0.419 . . . . 73.43 110.462 178.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 181' ' ' LEU . . . . . 0.457 HD13 HG21 ' C' ' 126' ' ' THR . 98.7 mt -72.88 165.21 54.51 Favored Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 123.806 0.842 . . . . 74.24 111.234 -173.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -53.84 80.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.391 2.78 0 C-N-CA 123.154 2.569 . . . . 73.32 112.478 169.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 183' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -172.93 60.72 0.26 Allowed Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 126.165 1.786 . . . . 72.0 106.373 -175.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 184' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -82.51 65.38 8.21 Favored 'Trans proline' 0 C--N 1.384 2.397 0 C-N-CA 123.066 2.511 . . . . 74.25 111.293 -176.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 185' ' ' VAL . . . . . . . . . . . . . 17.8 t -95.45 -36.75 6.94 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.593 0 CA-C-N 115.705 -0.68 . . . . 72.23 109.248 -177.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 186' ' ' PHE . . . . . 0.401 ' HD1' ' HB3' ' C' ' 195' ' ' ALA . 38.0 m-85 -133.38 157.39 45.66 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.287 1.035 . . . . 61.44 110.825 -178.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 187' ' ' ARG . . . . . 0.424 ' HE ' ' HB3' ' C' ' 155' ' ' GLU . 35.8 ttt180 -150.73 131.82 14.37 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 108.967 -0.753 . . . . 75.14 108.967 168.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 188' ' ' LEU . . . . . 0.459 HD13 ' HD2' ' C' ' 240' ' ' PHE . 39.5 tp -79.93 146.83 31.9 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 114.266 1.21 . . . . 74.14 114.266 -168.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -139.79 100.6 3.99 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 126.157 1.783 . . . . 73.21 106.907 165.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 70.88 -95.9 0.57 Allowed Glycine 0 N--CA 1.477 1.375 0 CA-C-N 116.495 -0.32 . . . . 74.2 112.597 -176.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 191' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -124.4 -14.08 6.99 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.423 1.089 . . . . 75.25 109.805 169.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -84.38 153.53 23.39 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.397 0.679 . . . . 65.13 109.456 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 193' ' ' LEU . . . . . 0.512 HD21 ' CE2' ' C' ' 240' ' ' PHE . 89.1 mt -117.32 156.27 28.11 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.26 0.553 . . . . 65.15 111.636 -173.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 194' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -121.44 109.45 14.87 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 107.199 -1.408 . . . . 75.43 107.199 168.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 195' ' ' ALA . . . . . 0.601 ' HB2' ' HG ' ' C' ' 251' ' ' LEU . . . -111.42 -177.56 3.23 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 123.576 0.75 . . . . 65.11 111.578 -175.142 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 38.8 m -136.05 118.48 15.77 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.293 -0.867 . . . . 53.42 109.572 170.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 197' ' ' LEU . . . . . 0.437 HD11 ' HB1' ' C' ' 212' ' ' ALA . 51.4 tp -98.25 136.38 38.53 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.428 0.691 . . . . 73.5 109.758 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 198' ' ' ASP . . . . . 0.463 ' HB3' HG22 ' C' ' 256' ' ' THR . 66.9 m-20 -101.83 102.0 12.54 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 109.122 -0.696 . . . . 64.33 109.122 179.229 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 199' ' ' VAL . . . . . . . . . . . . . 21.4 t -107.05 117.15 57.17 Favored Pre-proline 0 N--CA 1.473 0.72 0 N-CA-C 108.41 -0.959 . . . . 73.12 108.41 178.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 200' ' ' PRO . . . . . 0.472 ' HD2' HG13 ' C' ' 210' ' ' VAL . 45.4 Cg_endo -69.49 151.76 70.66 Favored 'Trans proline' 0 C--N 1.371 1.718 0 C-N-CA 122.001 1.801 . . . . 73.11 111.81 175.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 201' ' ' ALA . . . . . . . . . . . . . . . -54.65 -47.16 98.74 Favored Pre-proline 0 CA--C 1.564 1.489 0 N-CA-C 114.425 1.268 . . . . 74.35 114.425 -171.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 202' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -54.49 -51.37 10.65 Favored 'Trans proline' 0 C--N 1.384 2.41 0 C-N-CA 121.813 1.675 . . . . 63.15 112.916 175.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 203' ' ' ILE . . . . . 0.452 HG21 HG11 ' C' ' 210' ' ' VAL . 53.9 mt -64.92 -32.86 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.303 0.641 . . . . 74.02 111.032 -178.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -63.72 -48.07 78.55 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.737 0.815 . . . . 75.02 111.187 178.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 205' ' ' VAL . . . . . . . . . . . . . 79.5 t -69.35 -43.26 81.19 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 CA-C-N 115.125 -0.943 . . . . 74.52 112.315 -176.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 206' ' ' VAL . . . . . 0.462 HG21 ' HE2' ' A' ' 270' ' ' LYS . 9.1 p -79.26 -36.19 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 123.248 0.343 . . . . 74.12 111.715 -176.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 82.21 71.77 1.29 Allowed Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.773 -0.649 . . . . 63.21 111.912 -168.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -100.81 -128.32 6.33 Favored Glycine 0 C--N 1.342 0.907 0 N-CA-C 111.249 -0.74 . . . . 51.32 111.249 176.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 209' ' ' LYS . . . . . 0.482 ' HG2' ' HA ' ' C' ' 222' ' ' ALA . 8.5 mtmp? -140.7 143.62 35.15 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.207 0.603 . . . . 72.44 110.424 174.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 210' ' ' VAL . . . . . 0.472 HG13 ' HD2' ' C' ' 200' ' ' PRO . 30.4 m -135.18 149.93 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 124.453 1.101 . . . . 71.52 108.207 172.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 211' ' ' ARG . . . . . . . . . . . . . 8.1 tmm_? -94.94 126.63 40.41 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 122.74 0.416 . . . . 75.53 111.033 -175.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 212' ' ' ALA . . . . . 0.437 ' HB1' HD11 ' C' ' 197' ' ' LEU . . . -96.92 118.73 33.98 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 107.201 -1.407 . . . . 74.43 107.201 167.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 213' ' ' MET . . . . . . . . . . . . . 4.3 tmm? -76.68 104.96 7.46 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 108.445 -0.946 . . . . 63.12 108.445 -178.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.49 168.74 10.0 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.857 0.837 . . . . 72.34 110.561 -176.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 215' ' ' LEU . . . . . . . . . . . . . 14.6 mt -71.53 -32.34 68.05 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 113.636 -1.62 . . . . 75.24 111.66 -168.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.28 17.75 19.93 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 114.813 -1.085 . . . . 71.0 111.366 -177.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 144.92 164.51 10.65 Favored Glycine 0 C--N 1.355 1.587 0 CA-C-O 119.685 -0.509 . . . . 74.41 112.521 176.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -84.12 113.37 1.8 Allowed 'Trans proline' 0 CA--C 1.552 1.397 0 C-N-CA 122.633 2.222 . . . . 64.03 112.027 177.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 219' ' ' VAL . . . . . . . . . . . . . 12.1 p -93.62 130.65 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 109.941 -0.392 . . . . 52.53 109.941 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 220' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -98.33 105.74 17.93 Favored 'General case' 0 C--N 1.349 0.559 0 N-CA-C 109.184 -0.673 . . . . 72.32 109.184 176.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 221' ' ' VAL . . . . . 0.491 HG11 HD23 ' C' ' 233' ' ' LEU . 70.7 t -73.14 131.74 34.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 125.236 1.414 . . . . 74.03 112.35 -177.033 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 222' ' ' ALA . . . . . 0.482 ' HA ' ' HG2' ' C' ' 209' ' ' LYS . . . -81.19 108.1 14.55 Favored 'General case' 0 CA--C 1.548 0.887 0 O-C-N 123.91 0.756 . . . . 73.3 110.247 169.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 83.7 t -81.85 136.19 48.0 Favored Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 124.87 1.268 . . . . 73.11 109.697 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 224' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -83.81 160.2 14.09 Favored 'Trans proline' 0 C--N 1.383 2.366 0 C-N-CA 123.019 2.479 . . . . 73.11 111.8 172.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -62.09 140.3 83.29 Favored 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 122.292 1.995 . . . . 74.4 111.4 174.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 226' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? 63.31 68.14 0.62 Allowed 'General case' 0 N--CA 1.477 0.883 0 O-C-N 124.243 0.964 . . . . 71.5 110.635 -178.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 227' ' ' THR . . . . . 0.438 ' O ' HG12 ' A' ' 257' ' ' ILE . 16.8 m -93.44 115.17 27.7 Favored 'General case' 0 C--O 1.219 -0.521 0 C-N-CA 123.051 0.54 . . . . 73.3 109.729 176.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 228' ' ' GLN . . . . . 0.646 HE21 ' HG2' ' A' ' 259' ' ' GLU . 27.4 mp0 -89.57 151.36 21.97 Favored 'General case' 0 C--O 1.246 0.895 0 C-N-CA 124.521 1.128 . . . . 74.32 111.94 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -72.17 108.42 5.34 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 113.914 -1.494 . . . . 65.31 109.016 174.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 121.0 1.22 11.53 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 119.215 -0.77 . . . . 62.04 113.569 -176.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 231' ' ' ARG . . . . . 0.454 ' HD2' ' H ' ' C' ' 228' ' ' GLN . 19.3 mtp180 -71.53 -179.78 2.68 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 118.107 0.953 . . . . 75.03 110.872 172.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 232' ' ' LYS . . . . . 0.432 ' HA ' ' O ' ' C' ' 251' ' ' LEU . 31.7 ttmt -143.27 144.88 32.31 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.38 0.609 . . . . 74.05 111.76 -176.115 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 233' ' ' LEU . . . . . 0.664 HD13 ' HB2' ' C' ' 251' ' ' LEU . 5.3 mp -114.05 156.98 23.14 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.198 1.399 . . . . 74.22 109.986 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 20.9 ptt180 -129.92 86.11 2.37 Favored 'General case' 0 CA--C 1.553 1.081 0 O-C-N 124.948 1.405 . . . . 72.34 109.19 170.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 235' ' ' LEU . . . . . 0.543 ' HB2' ' HB3' ' C' ' 249' ' ' LEU . 59.6 mt -83.36 98.62 9.56 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 108.464 -0.939 . . . . 74.34 108.464 173.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -65.71 133.38 50.94 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.805 0.842 . . . . 73.41 111.273 -175.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 237' ' ' GLY . . . . . 0.402 ' O ' ' HD3' ' C' ' 246' ' ' ARG . . . 77.24 7.29 86.85 Favored Glycine 0 C--N 1.348 1.207 0 O-C-N 123.444 0.465 . . . . 71.42 114.058 179.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -105.95 16.3 25.31 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.279 0.632 . . . . 75.11 111.603 -177.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -78.6 -135.06 0.95 Allowed Glycine 0 C--N 1.348 1.214 0 N-CA-C 111.285 -0.726 . . . . 75.2 111.285 170.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 240' ' ' PHE . . . . . 0.512 ' CE2' HD21 ' C' ' 193' ' ' LEU . 48.2 m-85 -97.59 116.53 65.82 Favored Pre-proline 0 C--O 1.247 0.964 0 N-CA-C 109.201 -0.666 . . . . 75.14 109.201 168.237 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 241' ' ' PRO . . . . . 0.49 ' HA ' ' HG2' ' C' ' 246' ' ' ARG . 48.9 Cg_exo -59.13 99.99 0.12 Allowed 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 123.446 2.764 . . . . 71.53 113.071 169.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -82.82 159.32 37.87 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-N 114.428 -1.26 . . . . 70.14 111.927 175.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 243' ' ' PRO . . . . . 0.451 ' HB3' HH22 ' C' ' 148' ' ' ARG . 59.4 Cg_endo -70.16 -1.71 9.25 Favored 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 122.89 2.394 . . . . 71.42 113.688 -179.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -119.47 -10.98 9.56 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.549 0.74 . . . . 71.42 111.425 176.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 158.22 157.86 8.69 Favored Glycine 0 C--N 1.346 1.116 0 N-CA-C 112.147 -0.381 . . . . 63.24 112.147 -178.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 246' ' ' ARG . . . . . 0.49 ' HG2' ' HA ' ' C' ' 241' ' ' PRO . 41.8 mtt180 -85.89 146.47 26.7 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.733 0.813 . . . . 71.32 111.576 -179.074 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -82.78 -172.23 48.1 Favored Glycine 0 C--N 1.35 1.349 0 N-CA-C 111.573 -0.611 . . . . 63.23 111.573 165.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -115.7 164.54 14.21 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 117.567 0.683 . . . . 73.54 109.886 -176.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 249' ' ' LEU . . . . . 0.543 ' HB3' ' HB2' ' C' ' 235' ' ' LEU . 34.2 tp -113.12 109.19 18.39 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 123.734 0.814 . . . . 74.23 109.08 177.145 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 250' ' ' TYR . . . . . 0.534 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 39.1 m-85 -102.0 103.14 13.74 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 108.97 -0.752 . . . . 71.43 108.97 177.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 251' ' ' LEU . . . . . 0.664 ' HB2' HD13 ' C' ' 233' ' ' LEU . 2.8 mp -96.78 147.56 23.8 Favored 'General case' 0 N--CA 1.505 2.275 0 N-CA-C 109.903 -0.406 . . . . 72.0 109.903 -173.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -107.53 137.67 45.14 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 108.883 -0.784 . . . . 75.41 108.883 169.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 253' ' ' VAL . . . . . 0.401 HG23 ' CZ3' ' B' ' 242' ' ' TRP . 45.8 t -89.68 142.59 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 113.377 0.88 . . . . 73.5 113.377 -169.132 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 254' ' ' ARG . . . . . . . . . . . . . 42.8 mtm180 -119.78 145.27 46.75 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.405 1.082 . . . . 75.13 108.255 163.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 255' ' ' ILE . . . . . 0.596 HG23 HG23 ' A' ' 257' ' ' ILE . 29.6 mm -98.32 123.46 50.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 107.958 -1.127 . . . . 75.24 107.958 169.199 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 256' ' ' THR . . . . . 0.463 HG22 ' HB3' ' C' ' 198' ' ' ASP . 0.5 OUTLIER -127.3 172.71 10.37 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.524 1.13 . . . . 70.25 109.215 -173.569 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 2.8 pp -136.91 157.53 74.6 Favored Pre-proline 0 CA--C 1.567 1.621 0 C-N-CA 124.124 0.969 . . . . 75.21 109.529 177.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -80.98 17.01 1.51 Allowed 'Trans proline' 0 C--N 1.384 2.404 0 C-N-CA 122.775 2.317 . . . . 74.41 114.209 -167.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 55.32 -83.45 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.507 1.123 . . . . 72.3 110.547 -164.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 2.4 ptp85 -78.68 134.75 37.09 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 124.312 1.045 . . . . 73.41 110.812 -174.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 261' ' ' LEU . . . . . 0.496 HD13 HG12 ' A' ' 205' ' ' VAL . 65.3 mt -113.54 154.17 27.56 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 115.065 -0.971 . . . . 74.53 111.347 -170.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 52.7 p -83.74 164.05 46.38 Favored Pre-proline 0 CA--C 1.555 1.14 0 N-CA-C 108.31 -0.996 . . . . 61.23 108.31 169.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -51.05 -42.31 53.36 Favored 'Trans proline' 0 C--N 1.382 2.298 0 C-N-CA 122.417 2.078 . . . . 74.2 112.933 173.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -57.82 -58.14 9.68 Favored 'General case' 0 C--O 1.252 1.213 0 C-N-CA 124.058 0.943 . . . . 71.04 110.316 178.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -48.01 -67.22 0.29 Allowed 'General case' 0 C--N 1.357 0.91 0 O-C-N 125.056 1.473 . . . . 71.03 109.999 177.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 266' ' ' GLU . . . . . 0.507 ' HG3' ' HE2' ' C' ' 270' ' ' LYS . 8.3 tp10 -49.18 -51.33 33.29 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.2 1.4 . . . . 73.1 111.838 -171.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -60.7 -49.11 78.84 Favored 'General case' 0 C--O 1.257 1.479 0 CA-C-N 115.582 -0.736 . . . . 71.12 112.012 -177.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 268' ' ' LEU . . . . . 0.411 ' O ' ' HG ' ' C' ' 272' ' ' LEU . 7.6 mp -65.39 -38.3 89.58 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.428 -0.806 . . . . 70.11 110.906 -178.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 73.1 m95 -58.41 -41.72 85.58 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.103 0.561 . . . . 63.11 110.693 175.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 270' ' ' LYS . . . . . 0.507 ' HE2' ' HG3' ' C' ' 266' ' ' GLU . 68.3 mmtt -56.08 -51.53 67.53 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 123.327 0.392 . . . . 75.43 110.134 176.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -56.45 -43.63 79.69 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 114.872 -1.058 . . . . 75.33 111.541 -178.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 272' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' C' ' 268' ' ' LEU . 82.8 mt -65.83 -41.1 92.2 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.14 -0.937 . . . . 74.33 110.656 -179.065 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -59.17 -42.68 91.37 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.758 0.423 . . . . 43.22 110.431 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -63.26 -38.99 93.32 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.23 0.612 . . . . 63.21 111.28 176.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -61.69 -30.04 70.49 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.037 0.535 . . . . 70.04 111.366 174.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 276' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -78.68 -33.86 46.63 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.04 0.536 . . . . 75.52 112.042 176.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -63.14 -32.53 73.94 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 120.993 0.425 . . . . 65.52 109.955 170.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -68.48 -14.21 62.85 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 123.587 0.755 . . . . 72.22 112.066 175.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 279' ' ' ARG . . . . . . . . . . . . . 42.4 mtm180 -83.86 -16.26 45.11 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 122.749 0.419 . . . . 75.11 110.394 174.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.628 0 N-CA-C 108.268 -1.012 . . . . 75.14 108.268 173.582 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? . . . . . 0 N--CA 1.486 1.371 0 N-CA-C 114.135 1.161 . . . . 64.14 114.135 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.456 ' HG2' ' HB3' ' A' ' 96' ' ' PHE . 70.5 mmtt -93.44 94.32 8.63 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 107.907 -1.145 . . . . 74.32 107.907 171.158 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.409 ' O ' HG13 ' A' ' 10' ' ' ILE . 49.3 t0 -69.37 95.71 0.82 Allowed 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 107.305 -1.368 . . . . 62.43 107.305 173.09 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -61.82 -35.32 77.89 Favored 'General case' 0 C--O 1.244 0.803 0 O-C-N 124.121 0.888 . . . . 73.34 112.252 -171.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -65.04 -45.91 83.47 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.079 -0.51 . . . . 73.33 110.045 177.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.01 -37.86 84.02 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 123.435 0.459 . . . . 70.01 111.119 179.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 6' ' ' ASP . 68.3 mt -61.7 -39.58 83.73 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 C-N-CA 123.367 0.667 . . . . 74.23 110.318 175.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 92.9 mt -80.3 -5.52 56.42 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 112.543 0.572 . . . . 73.11 112.543 176.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.23 34.24 58.23 Favored Glycine 0 C--N 1.354 1.577 0 O-C-N 123.146 0.279 . . . . 73.42 113.396 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 23.8 m -133.23 158.77 74.91 Favored Pre-proline 0 CA--C 1.559 1.295 0 C-N-CA 124.853 1.261 . . . . 72.52 109.622 -177.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -75.3 166.55 28.63 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 122.417 2.078 . . . . 50.12 112.145 176.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -70.49 9.84 0.57 Allowed 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 113.706 1.002 . . . . 75.43 113.706 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -116.86 -1.19 12.07 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.493 1.117 . . . . 71.2 108.897 -177.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.63 121.73 14.62 Favored 'General case' 0 C--N 1.347 0.492 0 C-N-CA 124.477 1.111 . . . . 74.14 110.133 176.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.7 p -75.07 173.0 11.35 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.543 0.737 . . . . 75.03 110.931 -176.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -58.02 -33.11 68.61 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.796 0.839 . . . . 71.11 110.801 178.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.447 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 16.9 tp10 -58.0 -49.57 76.37 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.149 0.98 . . . . 72.43 110.567 171.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -70.68 -30.01 66.47 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.477 0.711 . . . . 71.14 111.85 -176.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.4 mp -69.25 -39.93 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 123.718 0.807 . . . . 73.31 109.213 174.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -64.0 -42.52 97.13 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 124.122 0.889 . . . . 75.22 110.357 178.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.514 ' HA ' ' HD3' ' A' ' 27' ' ' LYS . 66.2 mtm180 -68.69 -44.72 73.38 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.087 0.555 . . . . 73.12 110.849 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.2 -40.31 89.6 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.434 -0.803 . . . . 72.43 110.243 177.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -64.92 -47.73 76.67 Favored 'General case' 0 C--O 1.201 -1.486 0 CA-C-N 115.164 -0.926 . . . . 73.1 110.6 177.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.514 ' HD3' ' HA ' ' A' ' 24' ' ' ARG . 25.4 mtpp -50.07 -47.74 53.47 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 123.674 0.789 . . . . 74.22 110.428 178.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.451 ' HA ' ' NH2' ' A' ' 31' ' ' ARG . 8.1 tpt180 -56.52 -56.19 24.39 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 114.326 -1.306 . . . . 75.52 111.285 176.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.602 HD21 ' HE2' ' A' ' 33' ' ' TYR . 64.5 mt -82.62 -12.06 57.94 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.594 0.758 . . . . 75.12 112.297 -171.132 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 34' ' ' HIS . . . -93.37 -18.79 21.99 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.733 0.813 . . . . 71.54 110.015 179.106 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.451 ' NH2' ' HA ' ' A' ' 28' ' ' ARG . 48.8 mtm180 -84.96 -44.98 12.62 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 123.311 0.382 . . . . 72.33 110.204 165.088 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -67.5 -48.29 67.51 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.43 0.692 . . . . 73.31 111.03 -174.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.602 ' HE2' HD21 ' A' ' 29' ' ' LEU . 60.6 m-85 -102.9 24.82 10.11 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.169 0.588 . . . . 72.41 111.308 -176.01 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.482 ' CD2' ' HB3' ' A' ' 36' ' ' ASP . 48.8 t60 -71.09 102.05 0.44 Allowed Pre-proline 0 N--CA 1.482 1.141 0 C-N-CA 124.362 1.065 . . . . 73.54 110.726 -177.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.521 ' HB3' ' HG2' ' A' ' 44' ' ' GLU . 23.6 Cg_exo -62.06 -25.8 77.78 Favored 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 123.066 2.511 . . . . 75.51 113.29 -168.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.482 ' HB3' ' CD2' ' A' ' 34' ' ' HIS . 8.0 t70 -62.92 -40.18 96.83 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.117 1.367 . . . . 73.23 112.208 179.109 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 98.5 t -103.83 -44.7 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-O 121.431 0.634 . . . . 73.25 109.684 -177.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -98.44 83.1 2.97 Favored 'General case' 0 C--O 1.243 0.721 0 C-N-CA 124.344 1.057 . . . . 64.12 108.333 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -78.26 79.22 4.71 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.146 -0.934 . . . . 73.11 108.616 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 74.3 m -138.71 115.62 8.9 Favored Pre-proline 0 CA--C 1.542 0.671 0 CA-C-N 115.297 -0.865 . . . . 71.24 108.985 178.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_exo -46.15 -42.83 21.34 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 124.213 3.275 . . . . 73.53 114.353 -178.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -51.33 -49.82 60.64 Favored 'General case' 0 N--CA 1.482 1.161 0 O-C-N 124.245 0.966 . . . . 64.43 110.49 175.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.26 -26.85 67.54 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-N 114.676 -1.147 . . . . 73.42 111.602 -177.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.521 ' HG2' ' HB3' ' A' ' 35' ' ' PRO . 39.8 mt-10 -81.68 -34.48 30.67 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 122.86 0.464 . . . . 63.35 110.964 -173.041 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -82.3 -32.44 29.48 Favored 'General case' 0 C--O 1.246 0.897 0 N-CA-C 110.305 -0.257 . . . . 62.44 110.305 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 36.5 mmtm -62.54 -40.63 97.4 Favored 'General case' 0 C--N 1.348 0.502 0 CA-C-N 115.715 -0.675 . . . . 74.03 109.369 167.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -60.16 -38.63 83.74 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.555 0.742 . . . . 73.32 110.489 175.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -56.74 -57.49 12.2 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 120.793 0.33 . . . . 75.14 110.341 174.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -58.61 -41.43 85.85 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 115.151 -0.931 . . . . 71.44 111.786 -176.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.444 HD11 ' HB3' ' A' ' 29' ' ' LEU . 77.3 mt -74.33 -33.1 32.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.777 1.231 . . . . 74.43 111.217 -176.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -88.31 -10.58 49.04 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 119.237 -0.411 . . . . 73.43 111.28 179.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -75.89 -49.19 18.59 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 108.06 -1.089 . . . . 75.34 108.06 166.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -53.5 -46.9 70.21 Favored 'General case' 0 C--N 1.35 0.623 0 CA-C-N 113.625 -1.625 . . . . 65.45 111.307 174.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -69.05 -44.66 72.21 Favored 'General case' 0 C--O 1.216 -0.662 0 CA-C-N 115.026 -0.988 . . . . 73.53 110.618 177.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -50.1 -37.74 35.32 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.41 0.684 . . . . 72.52 112.224 -179.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 88.3 t -76.86 -57.74 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.971 0 CA-C-N 115.267 -0.878 . . . . 74.52 110.943 175.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 65.9 mt -87.22 6.04 35.12 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 113.619 0.97 . . . . 74.35 113.619 -166.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 37.2 t -73.03 -42.15 63.46 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 124.154 0.981 . . . . 74.34 111.349 -178.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -116.25 138.22 24.09 Favored Pre-proline 0 N--CA 1.471 0.579 0 CA-C-N 115.112 -0.949 . . . . 74.34 108.483 -171.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -58.61 -20.95 52.81 Favored 'Trans proline' 0 C--N 1.383 2.375 0 C-N-CA 123.844 3.029 . . . . 72.41 113.416 -172.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -66.6 -70.01 0.27 Allowed 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.622 0.769 . . . . 72.3 110.867 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt -67.22 -25.28 66.03 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.698 0.799 . . . . 74.54 110.894 -178.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -54.97 -56.92 14.34 Favored 'General case' 0 C--N 1.35 0.614 0 CA-C-N 114.791 -1.095 . . . . 74.11 109.702 169.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -58.13 -37.91 75.5 Favored 'General case' 0 C--N 1.364 1.236 0 O-C-N 123.784 0.677 . . . . 74.25 111.362 178.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.53 HG23 ' HG2' ' A' ' 76' ' ' PRO . 1.7 mp -54.31 -48.64 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 123.521 0.513 . . . . 74.41 110.997 175.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -69.72 -43.13 73.0 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 119.43 -0.319 . . . . 75.4 110.88 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -57.68 -39.95 78.3 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.156 0.582 . . . . 64.04 111.344 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 63.1 p -74.17 -25.5 59.76 Favored 'General case' 0 C--N 1.347 0.495 0 CA-C-N 115.617 -0.72 . . . . 75.44 110.6 177.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -72.86 136.41 45.32 Favored 'General case' 0 CA--C 1.551 0.983 0 N-CA-C 108.752 -0.833 . . . . 75.32 108.752 169.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.95 18.0 56.88 Favored Glycine 0 N--CA 1.471 1.007 0 N-CA-C 111.513 -0.635 . . . . 64.23 111.513 -171.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 34.9 m -144.33 -58.81 0.38 Allowed 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 103.415 -2.809 . . . . 71.23 103.415 176.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 51.3 m -80.93 142.82 33.14 Favored 'General case' 0 C--O 1.25 1.127 0 N-CA-C 105.411 -2.07 . . . . 74.23 105.411 156.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.67 -25.22 13.23 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.66 0.784 . . . . 74.04 110.637 178.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.98 143.19 77.29 Favored Pre-proline 0 C--O 1.245 0.843 0 C-N-CA 123.71 0.804 . . . . 75.1 110.094 175.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -62.55 143.56 93.06 Favored 'Trans proline' 0 C--N 1.371 1.761 0 C-N-CA 122.224 1.95 . . . . 75.41 109.921 170.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.53 ' HG2' HG23 ' A' ' 65' ' ' ILE . 31.6 Cg_exo -59.98 144.37 99.47 Favored 'Trans proline' 0 C--N 1.371 1.741 0 C-N-CA 122.831 2.354 . . . . 74.25 112.293 -179.132 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.53 119.21 6.27 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 122.647 2.231 . . . . 73.45 111.421 176.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -65.74 134.35 37.45 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 122.76 2.307 . . . . 73.2 112.78 -173.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -72.92 145.49 40.34 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.387 2.058 . . . . 71.05 111.201 174.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -59.88 87.01 0.07 OUTLIER 'Trans proline' 0 C--N 1.384 2.402 0 C-N-CA 122.924 2.416 . . . . 74.31 111.605 178.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 155.26 -46.67 0.52 Allowed Glycine 0 C--N 1.332 0.308 0 N-CA-C 109.141 -1.584 . . . . 62.41 109.141 -176.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.515 ' HA3' ' HA ' ' A' ' 106' ' ' PHE . . . 117.01 -174.01 14.99 Favored Glycine 0 C--N 1.346 1.102 0 CA-C-N 115.575 -0.313 . . . . 53.03 113.55 174.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -92.78 130.45 38.39 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.825 0.85 . . . . 74.41 110.655 -178.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.65 158.19 30.63 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 124.464 1.103 . . . . 71.31 110.432 174.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -153.35 75.33 1.06 Allowed 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 107.93 -1.137 . . . . 73.24 107.93 177.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.401 ' HA ' ' HE2' ' A' ' 164' ' ' MET . 12.9 m -38.4 84.87 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 127.229 2.212 . . . . 74.44 116.536 -164.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 71.69 20.17 78.42 Favored Glycine 0 C--N 1.342 0.88 0 N-CA-C 114.791 0.676 . . . . 70.11 114.791 174.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -122.04 135.87 54.87 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 123.62 0.768 . . . . 72.34 109.454 -174.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -74.9 88.47 2.32 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 115.842 -0.617 . . . . 71.44 111.22 -171.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.6 p -33.11 -47.9 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.562 1.426 0 C-N-CA 126.34 1.856 . . . . 75.21 113.529 169.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -64.76 -22.85 67.07 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.048 0.939 . . . . 75.33 111.984 -170.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -89.38 -27.74 20.24 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.216 0.606 . . . . 61.35 112.437 -178.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -75.7 173.93 10.45 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 113.288 0.847 . . . . 73.34 113.288 -166.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 53.2 p -71.56 175.43 5.58 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 114.655 1.354 . . . . 74.5 114.655 -161.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -67.23 -50.64 59.95 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 113.562 -1.654 . . . . 74.52 110.374 -174.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.456 ' HB3' ' HG2' ' A' ' 5' ' ' LYS . 72.5 t80 -54.01 -41.06 67.55 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 124.48 1.113 . . . . 75.03 111.729 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -60.46 -51.97 67.2 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 115.384 -0.825 . . . . 72.32 110.121 172.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.524 ' HA ' HD12 ' A' ' 105' ' ' LEU . 46.8 mt-30 -70.04 -3.14 14.99 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.609 0.763 . . . . 74.14 112.281 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -98.29 -47.98 5.24 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.191 0.996 . . . . 70.02 111.684 170.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 52.8 tp -73.4 -50.77 20.05 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.394 0.678 . . . . 74.33 110.531 -172.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -90.11 -7.44 53.75 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.363 -0.835 . . . . 72.11 110.067 175.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.42 ' HA2' ' HG ' ' A' ' 105' ' ' LEU . . . -44.64 -59.1 4.42 Favored Glycine 0 C--N 1.364 2.096 0 CA-C-O 118.058 -1.412 . . . . 72.43 115.078 -178.078 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -40.56 -25.8 0.2 Allowed 'Trans proline' 0 C--N 1.391 2.809 0 C-N-CA 124.687 3.591 . . . . 64.43 115.739 178.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -149.11 54.79 0.5 Allowed Glycine 0 C--N 1.348 1.216 0 N-CA-C 111.461 -0.656 . . . . 54.4 111.461 177.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.524 HD12 ' HA ' ' A' ' 98' ' ' GLN . 13.4 mt -69.0 73.3 0.27 Allowed 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 117.468 0.634 . . . . 74.25 110.998 171.142 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.594 ' CG ' ' HA3' ' A' ' 168' ' ' GLY . 0.1 OUTLIER 43.97 -115.02 0.39 Allowed 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 125.639 1.576 . . . . 74.45 113.152 177.769 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.48 ' H ' ' HB3' ' A' ' 106' ' ' PHE . . . 60.8 20.86 57.65 Favored Glycine 0 C--N 1.36 1.863 0 CA-C-O 119.712 -0.493 . . . . 44.0 112.965 -168.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.36 1.903 0 N-CA-C 111.577 -0.609 . . . . 71.34 111.577 -171.89 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 22.5 tptm . . . . . 0 N--CA 1.479 1.011 0 CA-C-O 120.498 0.189 . . . . 73.31 110.953 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.575 ' HA2' ' HA ' ' A' ' 170' ' ' PRO . . . -106.37 177.42 22.19 Favored Glycine 0 CA--C 1.5 -0.886 0 N-CA-C 122.751 3.86 . . . . 73.4 122.751 -162.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -120.97 150.18 41.51 Favored 'General case' 0 C--O 1.266 1.926 0 CA-C-N 111.197 -2.501 . . . . 74.43 110.034 175.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -66.21 149.95 49.54 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.837 1.255 . . . . 74.23 112.466 -174.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 10.0 tt -149.32 147.05 27.87 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.881 -0.785 . . . . 75.42 108.881 178.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.477 HH21 HG22 ' A' ' 177' ' ' VAL . 33.8 mtp-105 -94.26 122.76 37.13 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.011 0.524 . . . . 74.51 109.961 176.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.438 ' HB1' HD11 ' A' ' 174' ' ' LEU . . . -113.57 166.63 11.33 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.549 -0.908 . . . . 54.41 108.549 171.115 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -127.59 118.9 24.79 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.666 -1.235 . . . . 72.42 107.666 -174.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 25.4 tp -99.92 99.76 9.84 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 108.611 -0.885 . . . . 74.14 108.611 -169.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 56.3 Cg_endo -73.61 113.55 3.81 Favored 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 121.69 1.594 . . . . 75.33 108.637 176.04 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.552 ' HA ' HG22 ' B' ' 6' ' ' ILE . 28.0 tp -120.82 138.43 54.05 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 123.44 0.696 . . . . 72.43 109.848 -169.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 96.6 m -67.79 128.85 38.01 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 114.408 -1.269 . . . . 71.34 110.062 176.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.817 ' HB3' HD21 ' A' ' 215' ' ' LEU . 8.2 mt -54.8 -47.63 73.78 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 122.264 1.031 . . . . 75.21 111.914 -173.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 16.7 mp0 -62.28 -44.04 97.45 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 113.292 -1.776 . . . . 75.32 109.997 -177.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -76.57 -20.09 57.2 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 115.577 -0.738 . . . . 64.33 111.798 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 153' ' ' VAL . . . -69.26 -39.98 78.1 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.523 0.729 . . . . 65.44 109.636 175.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.435 ' HB2' HD11 ' A' ' 215' ' ' LEU . 47.8 t80 -75.78 -38.91 57.86 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 115.06 -0.973 . . . . 74.51 111.564 176.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 54.4 m170 -71.25 -35.51 71.45 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 122.565 0.346 . . . . 75.25 111.188 -178.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.401 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 75.94 -141.15 26.83 Favored Glycine 0 C--N 1.344 1.012 0 CA-C-N 116.069 -0.514 . . . . 71.54 113.039 -179.317 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 84.09 -175.48 51.5 Favored Glycine 0 C--N 1.348 1.249 0 C-N-CA 123.254 0.454 . . . . 70.42 113.036 178.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.447 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 1.2 mp0 -72.29 111.87 7.87 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.249 0.62 . . . . 73.14 109.588 174.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 8.3 tpp180 -93.65 119.32 32.52 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.246 0.618 . . . . 75.05 109.611 -178.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 74.9 t -81.65 105.37 11.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 108.326 -0.99 . . . . 75.04 108.326 175.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.0 p -124.99 123.33 65.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 C-N-CA 124.396 1.078 . . . . 73.34 108.44 176.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -121.2 146.63 46.58 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.119 0.568 . . . . 71.3 109.971 -177.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 11.0 p -160.4 131.66 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-N 115.5 -0.773 . . . . 75.1 109.509 -177.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 59.93 24.64 13.75 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 124.319 1.048 . . . . 74.24 112.007 -177.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 92.85 -24.65 23.17 Favored Glycine 0 C--N 1.355 1.627 0 CA-C-N 116.13 -0.486 . . . . 54.15 112.387 -176.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 66.1 ttp85 -74.52 99.81 3.7 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.772 0.829 . . . . 72.43 110.489 -177.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -89.97 116.13 27.79 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 123.674 0.79 . . . . 74.41 109.977 178.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.476 HG21 ' HE1' ' A' ' 164' ' ' MET . 7.3 p -121.5 148.39 24.93 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 C-N-CA 123.993 0.917 . . . . 73.53 109.506 177.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.446 ' OG ' ' HB3' ' A' ' 135' ' ' GLU . 34.6 t -113.48 87.56 2.64 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.109 0.963 . . . . 64.43 109.035 179.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 29.6 m -83.83 112.51 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-N 116.093 -0.503 . . . . 73.42 109.729 -176.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.447 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 57.4 ttt85 -68.46 95.01 0.59 Allowed 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.329 0.585 . . . . 74.32 109.461 177.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.613 ' HB ' HG13 ' A' ' 153' ' ' VAL . 44.6 pt -81.45 138.13 48.16 Favored Pre-proline 0 CA--C 1.554 1.108 0 CA-C-N 114.896 -1.047 . . . . 74.52 109.506 178.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.48 140.38 43.59 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 122.282 1.988 . . . . 74.22 111.525 177.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.07 93.53 0.11 Allowed 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 123.076 2.518 . . . . 74.15 111.913 174.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 138.59 -5.74 3.19 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-O 118.946 -0.919 . . . . 75.51 113.22 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.613 HG13 ' HB ' ' A' ' 149' ' ' ILE . 7.5 p -58.8 123.22 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 C-N-CA 123.767 0.827 . . . . 75.43 110.969 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.748 ' HD3' HD23 ' A' ' 193' ' ' LEU . 95.4 mtt180 -140.67 167.97 20.91 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 121.704 -0.622 . . . . 73.23 111.271 -173.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.461 ' HB3' ' H ' ' A' ' 188' ' ' LEU . 10.3 tp10 -35.62 118.46 0.48 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 126.977 2.111 . . . . 72.32 114.119 -172.115 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 107.95 -27.25 15.0 Favored Glycine 0 C--N 1.342 0.867 0 CA-C-O 119.398 -0.668 . . . . 74.33 112.92 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 30.7 t -59.6 112.51 1.82 Allowed 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.533 0.733 . . . . 74.23 110.133 -178.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 48.4 t -86.67 96.88 5.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 115.633 -0.712 . . . . 74.02 109.266 -179.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.578 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 65.8 mt -72.91 102.5 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 N-CA-C 108.409 -0.96 . . . . 75.24 108.409 171.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 51.9 ttt-85 -85.53 103.36 14.32 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.929 -0.578 . . . . 75.21 109.991 -175.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.448 HG11 ' HB3' ' A' ' 174' ' ' LEU . 4.4 p -120.64 116.81 31.64 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 122.895 0.478 . . . . 71.41 109.999 178.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.559 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 48.3 Cg_endo -68.86 175.77 6.92 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.573 2.182 . . . . 74.53 112.809 178.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 65.05 6.37 25.03 Favored Glycine 0 C--N 1.351 1.404 0 N-CA-C 115.787 1.075 . . . . 70.43 115.787 173.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.476 ' HE1' HG21 ' A' ' 145' ' ' VAL . 64.1 mtt -131.44 -1.7 3.91 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 117.776 0.788 . . . . 64.15 112.796 -173.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -54.63 -89.11 0.01 OUTLIER Glycine 0 N--CA 1.487 2.091 0 N-CA-C 110.54 -1.024 . . . . 73.33 110.54 -176.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.562 ' O ' ' HA ' ' A' ' 171' ' ' PRO . . . -74.89 161.49 53.43 Favored Glycine 0 CA--C 1.541 1.689 0 N-CA-C 106.185 -2.766 . . . . 74.5 106.185 155.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.52 ' HA ' HE21 ' A' ' 167' ' ' GLN . 0.0 OUTLIER -102.7 99.67 9.67 Favored 'General case' 0 CA--C 1.56 1.339 0 CA-C-N 120.153 1.977 . . . . 75.42 113.61 -174.162 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.594 ' HA3' ' CG ' ' A' ' 106' ' ' PHE . . . 75.06 -19.68 2.13 Favored Glycine 0 C--N 1.363 2.076 0 N-CA-C 119.471 2.548 . . . . 64.21 119.471 158.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . 0.541 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . 10.8 t30 -107.8 -43.88 0.12 Allowed Pre-proline 0 C--N 1.319 -0.757 0 N-CA-C 105.111 -2.181 . . . . 63.54 105.111 164.122 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.575 ' HA ' ' HA2' ' A' ' 116' ' ' GLY . 97.2 Cg_endo -106.64 52.28 0.02 OUTLIER 'Trans proline' 0 CA--C 1.587 3.126 0 C-N-CA 122.361 2.041 . . . . 73.02 114.687 158.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.562 ' HA ' ' O ' ' A' ' 166' ' ' GLY . 59.0 Cg_endo -63.89 102.61 0.37 Allowed 'Trans proline' 1 C--N 1.43 4.855 0 C-N-CA 122.746 2.297 . . . . 71.25 110.997 -177.771 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -116.75 -169.63 15.24 Favored Glycine 0 N--CA 1.482 1.761 0 C-N-CA 120.665 -0.779 . . . . 72.4 114.677 -169.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.559 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 33.5 m-20 -79.33 105.84 10.93 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 108.725 -0.842 . . . . 71.14 108.725 169.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.448 ' HB3' HG11 ' A' ' 161' ' ' VAL . 20.8 tp -82.73 108.67 16.26 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.416 -0.811 . . . . 74.2 110.004 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 82.4 mt -85.93 93.68 9.0 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.764 -0.828 . . . . 72.12 108.764 175.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.578 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 92.2 mt -78.02 93.88 4.55 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-N 115.794 -0.639 . . . . 74.52 109.958 178.3 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.477 HG22 HH21 ' A' ' 120' ' ' ARG . 41.9 t -81.99 98.21 4.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 106.137 -1.801 . . . . 71.11 106.137 174.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 12.8 p -65.39 110.77 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-O 121.797 0.808 . . . . 74.13 110.101 -174.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.477 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 11.9 mmm-85 -91.32 127.45 36.75 Favored 'General case' 0 C--O 1.219 -0.509 0 N-CA-C 107.636 -1.246 . . . . 73.42 107.636 173.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.426 HD12 HD21 ' A' ' 127' ' ' LEU . 15.5 mt -91.16 147.33 23.13 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.806 -0.442 . . . . 74.04 109.806 176.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 89.3 mt -55.88 162.77 2.49 Favored Pre-proline 0 N--CA 1.487 1.395 0 C-N-CA 124.979 1.312 . . . . 73.22 113.841 -169.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.23 14.55 0.29 Allowed 'Trans proline' 0 C--N 1.395 2.987 0 C-N-CA 123.052 2.501 . . . . 74.32 113.696 173.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 184' ' ' PRO . 66.2 t-80 -60.85 105.36 0.57 Allowed Pre-proline 0 CA--C 1.563 1.47 0 N-CA-C 106.317 -1.734 . . . . 73.35 106.317 165.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 183' ' ' HIS . 6.6 Cg_exo -72.13 28.24 0.26 Allowed 'Trans proline' 0 N--CA 1.506 2.222 0 C-N-CA 124.764 3.643 . . . . 61.24 118.161 -158.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 21.6 t -93.97 -57.95 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-N 119.583 1.083 . . . . 72.34 110.303 -172.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . 0.553 ' HB3' HD22 ' A' ' 193' ' ' LEU . 26.8 m-85 -124.81 155.82 38.79 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 112.815 0.672 . . . . 72.31 112.815 -169.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -147.39 99.18 3.1 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 106.076 -1.824 . . . . 75.51 106.076 171.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.461 ' H ' ' HB3' ' A' ' 155' ' ' GLU . 0.7 OUTLIER -78.83 158.03 28.25 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 122.736 0.415 . . . . 74.21 111.429 -175.356 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -148.61 128.64 13.58 Favored 'General case' 0 C--O 1.247 0.937 0 N-CA-C 107.439 -1.319 . . . . 70.31 107.439 166.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 70.85 -82.38 0.41 Allowed Glycine 0 C--N 1.349 1.267 0 O-C-N 123.653 0.596 . . . . 65.41 112.716 -178.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.409 ' OE1' ' HD2' ' A' ' 243' ' ' PRO . 0.1 OUTLIER -147.63 -5.8 0.47 Allowed 'General case' 0 C--O 1.252 1.222 0 C-N-CA 123.19 0.596 . . . . 72.32 111.776 179.856 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -111.23 147.84 34.13 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 122.886 0.474 . . . . 72.32 111.262 -175.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.748 HD23 ' HD3' ' A' ' 154' ' ' ARG . 83.8 mt -93.54 137.25 33.01 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.191 0.996 . . . . 74.25 111.035 -177.149 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -105.74 103.37 12.86 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 108.063 -1.088 . . . . 73.14 108.063 165.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.492 ' HB1' HD23 ' A' ' 251' ' ' LEU . . . -103.15 172.55 6.75 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.285 1.034 . . . . 74.34 110.759 179.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 91.1 m -119.81 131.84 55.43 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.625 0.77 . . . . 70.21 108.956 171.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.42 HD13 HG22 ' A' ' 210' ' ' VAL . 38.2 tp -113.86 129.05 56.63 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.358 0.663 . . . . 74.1 110.793 -176.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -88.15 120.64 29.69 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 107.411 -1.329 . . . . 63.3 107.411 167.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.2 p -142.88 120.65 7.11 Favored Pre-proline 0 CA--C 1.544 0.747 0 N-CA-C 109.404 -0.591 . . . . 74.33 109.404 179.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.72 151.22 74.69 Favored 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 121.763 1.642 . . . . 70.05 111.038 174.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -51.05 -45.54 88.34 Favored Pre-proline 0 CA--C 1.552 1.021 0 N-CA-C 114.756 1.391 . . . . 71.34 114.756 -173.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -55.96 -45.79 35.99 Favored 'Trans proline' 0 C--N 1.388 2.616 0 C-N-CA 122.013 1.809 . . . . 73.32 113.584 175.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.568 HD13 ' HB3' ' C' ' 276' ' ' TYR . 27.8 mt -71.4 -28.27 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 123.082 0.553 . . . . 71.02 110.645 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.95 -41.86 77.47 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.043 0.537 . . . . 74.14 110.761 177.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 34.1 t -71.18 -48.19 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.602 0.761 . . . . 64.22 111.828 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 86.8 t -94.26 -35.5 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.059 0.544 . . . . 74.41 112.1 -169.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 88.68 111.7 1.17 Allowed Glycine 0 CA--C 1.53 0.977 0 CA-C-N 116.366 -0.379 . . . . 72.35 113.569 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -173.62 -158.7 18.54 Favored Glycine 0 C--N 1.351 1.402 0 CA-C-O 120.174 -0.237 . . . . 73.32 112.763 177.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -80.31 119.2 22.73 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.343 0.868 . . . . 73.34 113.343 -167.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.42 HG22 HD13 ' A' ' 197' ' ' LEU . 29.2 m -110.84 -172.74 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 114.158 -1.383 . . . . 63.11 107.665 162.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . 0.461 ' HD2' ' HB2' ' A' ' 218' ' ' PRO . 60.2 ttp180 -126.4 115.93 20.38 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 109.823 -0.436 . . . . 74.32 109.823 172.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -105.68 160.06 15.5 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.94 -0.763 . . . . 74.41 108.94 172.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 54.1 ttm -97.09 147.86 23.62 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 109.164 -0.68 . . . . 74.15 109.164 176.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 81.4 p -124.86 -173.3 2.77 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 108.455 -0.943 . . . . 74.1 108.455 169.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . 0.817 HD21 ' HB3' ' A' ' 127' ' ' LEU . 22.5 mt -72.64 -19.78 61.38 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.044 0.538 . . . . 73.14 110.699 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -110.6 25.95 11.22 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.978 0.911 . . . . 64.44 110.506 178.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 98.94 -175.26 28.53 Favored Glycine 0 C--N 1.351 1.373 0 N-CA-C 114.839 0.696 . . . . 63.05 114.839 173.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . 0.461 ' HB2' ' HD2' ' A' ' 211' ' ' ARG . 83.8 Cg_endo -76.58 132.07 13.05 Favored 'Trans proline' 0 CA--C 1.557 1.671 0 C-N-CA 123.399 2.733 . . . . 74.13 113.719 -174.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 27.2 m -125.7 153.93 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 124.891 1.276 . . . . 73.4 110.257 177.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -79.79 130.08 35.02 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.947 -0.39 . . . . 75.04 109.947 173.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 88.9 t -119.96 121.73 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 123.6 0.76 . . . . 74.51 110.269 -176.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -81.33 103.5 11.14 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.184 0.593 . . . . 70.4 109.812 177.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 92.9 t -67.64 146.58 98.58 Favored Pre-proline 0 CA--C 1.56 1.328 0 C-N-CA 125.497 1.519 . . . . 71.22 110.609 177.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -83.04 161.82 15.66 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 122.434 2.09 . . . . 75.51 111.268 172.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -70.47 148.4 60.37 Favored 'Trans proline' 0 C--N 1.365 1.44 0 C-N-CA 122.23 1.953 . . . . 72.53 112.647 176.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 57.6 mtt-85 69.32 28.41 4.82 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.578 1.551 . . . . 75.13 111.575 171.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.439 HG21 HD23 ' A' ' 233' ' ' LEU . 19.6 m -69.27 104.45 2.23 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.665 1.586 . . . . 64.32 110.512 174.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . 0.401 HE21 ' HG3' ' C' ' 259' ' ' GLU . 6.0 tt0 -101.21 151.61 21.65 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.712 0.805 . . . . 75.32 110.475 -177.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . 0.426 ' HA ' ' HB ' ' A' ' 253' ' ' VAL . . . -75.01 152.01 38.74 Favored 'General case' 0 C--N 1.355 0.847 0 N-CA-C 113.19 0.811 . . . . 65.12 113.19 -169.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 85.73 -3.34 87.28 Favored Glycine 0 C--N 1.348 1.209 0 CA-C-N 114.719 -1.128 . . . . 75.54 112.988 -176.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -98.02 156.74 16.5 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.671 0.788 . . . . 74.44 110.563 -178.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -104.82 112.39 25.48 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.936 0.895 . . . . 72.22 108.683 176.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.439 HD23 HG21 ' A' ' 227' ' ' THR . 65.9 mt -75.8 99.83 4.56 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 107.906 -1.146 . . . . 71.4 107.906 174.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -83.58 100.46 10.82 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 109.578 -0.527 . . . . 73.41 109.578 176.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.516 ' HG ' ' HB3' ' A' ' 249' ' ' LEU . 0.3 OUTLIER -95.94 115.48 27.49 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 107.838 -1.171 . . . . 74.24 107.838 172.118 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.537 ' HZ1' ' HB3' ' A' ' 236' ' ' LYS . 1.5 mmmp? -68.09 136.66 54.1 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 114.577 -1.192 . . . . 71.01 112.203 -171.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 84.99 35.82 12.08 Favored Glycine 0 C--N 1.349 1.282 0 O-C-N 123.807 0.692 . . . . 74.2 114.375 169.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -116.04 -23.2 8.62 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.787 0.435 . . . . 74.1 111.68 -177.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -89.06 -173.64 46.47 Favored Glycine 0 C--N 1.348 1.211 0 N-CA-C 111.063 -0.815 . . . . 74.43 111.063 171.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -96.27 164.24 18.89 Favored Pre-proline 0 N--CA 1.49 1.563 0 CA-C-N 117.794 0.797 . . . . 73.41 111.398 -173.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 246' ' ' ARG . 96.4 Cg_exo -48.75 135.57 28.03 Favored 'Trans proline' 0 C--N 1.388 2.655 0 C-N-CA 123.356 2.704 . . . . 73.33 114.949 175.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -161.42 -162.42 12.87 Favored Glycine 0 C--N 1.347 1.144 0 CA-C-O 119.253 -0.749 . . . . 73.52 112.601 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . 0.409 ' HD2' ' OE1' ' A' ' 191' ' ' GLN . 32.0 Cg_exo -58.15 -23.65 62.6 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 123.399 2.733 . . . . 72.5 113.164 177.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -88.09 19.06 3.84 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.777 0.831 . . . . 70.11 111.716 176.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 81.44 -82.41 1.57 Allowed Glycine 0 C--N 1.349 1.26 0 N-CA-C 110.269 -1.132 . . . . 62.24 110.269 -174.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.493 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 70.2 mtm180 -126.51 151.86 47.27 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.709 1.203 . . . . 75.41 108.032 169.149 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -83.74 175.96 52.13 Favored Glycine 0 C--N 1.347 1.185 0 N-CA-C 114.192 0.437 . . . . 70.31 114.192 -174.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -122.83 -175.68 3.22 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.113 0.965 . . . . 75.44 110.906 -174.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.516 ' HB3' ' HG ' ' A' ' 235' ' ' LEU . 50.9 tp -127.58 130.44 49.07 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.048 -1.093 . . . . 73.32 108.048 169.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -113.24 105.33 13.29 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 107.429 -1.323 . . . . 71.3 107.429 178.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.492 HD23 ' HB1' ' A' ' 195' ' ' ALA . 36.8 mt -93.6 110.92 22.5 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.129 0.571 . . . . 74.54 110.016 -176.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -77.69 109.72 11.92 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.256 0.623 . . . . 75.41 109.491 -177.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.426 ' HB ' ' HA ' ' A' ' 229' ' ' ALA . 31.9 t -68.99 111.25 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 CA-C-N 114.669 -1.151 . . . . 71.34 111.691 -170.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -110.8 99.93 8.76 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 107.803 -1.184 . . . . 73.14 107.803 167.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.55 HD13 ' HA ' ' C' ' 256' ' ' THR . 72.4 mt -76.9 122.18 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 114.853 -1.067 . . . . 74.34 109.985 179.261 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 61.8 p -107.46 165.36 11.46 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 124.164 0.986 . . . . 74.52 109.667 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . 0.717 HD13 HE21 ' C' ' 228' ' ' GLN . 2.8 pp -130.86 152.24 80.26 Favored Pre-proline 0 CA--C 1.557 1.231 0 C-N-CA 123.517 0.727 . . . . 73.4 110.285 -176.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_exo -53.44 -16.4 7.43 Favored 'Trans proline' 0 C--N 1.383 2.344 0 C-N-CA 123.891 3.061 . . . . 74.45 116.744 -169.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . 0.424 ' HA ' ' HB3' ' C' ' 226' ' ' ARG . 64.8 mt-10 50.54 -74.22 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 124.581 1.152 . . . . 75.12 112.947 -167.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.51 139.71 42.35 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 109.814 -0.439 . . . . 75.12 109.814 174.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.63 HD21 ' HB2' ' A' ' 265' ' ' GLU . 83.4 mt -134.99 152.25 51.56 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.436 0.694 . . . . 72.32 109.949 174.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.0 155.6 39.74 Favored Pre-proline 0 CA--C 1.552 1.039 0 N-CA-C 106.513 -1.662 . . . . 74.31 106.513 164.137 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -42.95 -27.92 1.06 Allowed 'Trans proline' 0 C--N 1.39 2.74 0 C-N-CA 124.325 3.35 . . . . 74.33 115.515 -174.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -60.51 -71.49 0.13 Allowed 'General case' 0 C--O 1.252 1.194 0 C-N-CA 124.28 1.032 . . . . 71.44 111.842 178.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . 0.63 ' HB2' HD21 ' A' ' 261' ' ' LEU . 2.1 mp0 -65.83 -30.92 71.62 Favored 'General case' 0 C--N 1.356 0.871 0 N-CA-C 109.265 -0.643 . . . . 73.22 109.265 -177.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 266' ' ' GLU . . . . . 0.575 ' HA ' HD12 ' A' ' 261' ' ' LEU . 4.7 tp10 -51.58 -54.77 24.08 Favored 'General case' 0 C--N 1.355 0.815 0 O-C-N 124.294 0.996 . . . . 73.45 109.678 174.122 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -65.71 -37.41 86.36 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.214 0.606 . . . . 64.12 112.108 -177.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . 0.481 HD22 ' HE3' ' C' ' 271' ' ' LYS . 9.3 mp -59.47 -60.33 4.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 123.452 0.47 . . . . 73.14 110.982 175.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -55.65 -38.43 69.54 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.359 1.064 . . . . 75.0 112.465 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . 0.627 ' HE2' ' HA ' ' C' ' 206' ' ' VAL . 0.0 OUTLIER -65.47 -50.17 66.33 Favored 'General case' 0 N--CA 1.478 0.969 0 O-C-N 123.52 0.512 . . . . 73.12 110.181 -179.784 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . 0.453 ' HZ3' HD23 ' C' ' 268' ' ' LEU . 3.2 tmpt? -57.64 -48.9 78.18 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 123.68 0.612 . . . . 70.22 109.89 179.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 272' ' ' LEU . . . . . 0.482 ' O ' ' HB2' ' A' ' 276' ' ' TYR . 83.9 mt -52.43 -50.5 62.43 Favored 'General case' 0 C--N 1.357 0.916 0 O-C-N 124.413 1.07 . . . . 71.54 110.586 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -72.33 -43.49 64.05 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.019 1.118 . . . . 72.23 114.019 -171.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -75.39 -36.16 60.92 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.038 0.535 . . . . 74.35 110.13 -175.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -72.33 -32.91 66.92 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 116.293 -0.412 . . . . 72.24 110.414 171.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . 0.521 ' HE2' ' HG3' ' C' ' 258' ' ' PRO . 51.4 t80 -55.93 -53.01 62.08 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.344 1.058 . . . . 75.02 109.37 176.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.37 -34.75 75.02 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 115.401 -0.818 . . . . 72.14 110.391 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -63.0 -10.54 14.23 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 112.757 0.651 . . . . 75.41 112.757 173.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . 0.443 HH22 ' CD ' ' C' ' 265' ' ' GLU . 49.7 mtm180 -122.95 3.65 9.39 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.777 0.831 . . . . 75.15 111.033 174.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.465 0 C-N-CA 123.576 0.75 . . . . 72.5 109.775 176.501 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.297 0 N-CA-C 111.394 0.146 . . . . 74.12 111.394 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -89.62 120.22 30.72 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.727 0.811 . . . . 62.45 110.056 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -82.05 -10.94 59.05 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.743 -0.598 . . . . 74.04 112.154 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 19.5 m 58.97 -84.11 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 125.384 1.474 . . . . 52.14 112.838 177.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 11.8 m -95.49 150.8 19.92 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.277 0.631 . . . . 74.34 110.139 -175.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.552 HG22 ' HA ' ' A' ' 125' ' ' LEU . 38.2 pt -134.13 169.92 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 123.388 0.675 . . . . 65.34 112.329 -163.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -139.44 134.38 32.27 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.314 1.046 . . . . 72.22 109.582 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 52.9 tp -74.32 147.87 41.88 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.213 1.005 . . . . 75.22 111.705 -171.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.35 -57.73 3.96 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.075 0.55 . . . . 73.12 111.559 178.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 21.8 mt 67.43 -13.31 0.23 Allowed 'General case' 0 N--CA 1.506 2.367 0 C-N-CA 124.961 1.304 . . . . 74.1 113.449 -169.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 83.9 mt . . . . . 0 CA--C 1.551 1.015 0 C-N-CA 125.155 1.382 . . . . 72.11 112.305 -176.315 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.805 0 N-CA-C 112.669 0.618 . . . . 74.35 112.669 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . 68.3 -67.26 0.2 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.329 1.452 . . . . 75.32 110.541 -169.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 35.1 tp -154.63 114.86 3.86 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 109.109 -0.7 . . . . 74.44 109.109 -178.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 182' ' ' VAL . . . . . . . . . . . . . 14.4 p 44.53 111.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 C-N-CA 127.033 2.133 . . . . 72.43 116.196 178.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -103.61 84.61 2.31 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 107.579 -1.267 . . . . 65.24 107.579 167.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 23.7 p-80 64.85 165.3 0.16 Allowed 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 126.871 2.068 . . . . 75.32 113.841 174.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 185' ' ' VAL . . . . . 0.636 HG23 ' HA ' ' C' ' 121' ' ' ALA . 7.7 p . . . . . 0 CA--C 1.55 0.969 0 CA-C-N 115.02 -0.991 . . . . 74.01 111.875 -170.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 238' ' ' THR . . . . . 0.528 HG23 HG23 ' C' ' 219' ' ' VAL . 59.3 m . . . . . 0 N--CA 1.465 0.314 0 N-CA-C 107.072 -1.455 . . . . 71.31 107.072 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -162.78 -88.56 0.02 OUTLIER 'General case' 0 C--O 1.236 0.387 0 N-CA-C 109.42 -0.585 . . . . 74.42 109.42 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 240' ' ' GLY . . . . . 0.572 ' HA3' ' HA ' ' C' ' 235' ' ' LEU . . . 162.55 -128.9 1.95 Allowed Glycine 0 C--N 1.339 0.705 0 N-CA-C 110.628 -0.989 . . . . 71.23 110.628 -169.04 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 241' ' ' GLU . . . . . 0.659 ' HG3' ' HG3' ' C' ' 234' ' ' ARG . 6.4 pt-20 -150.24 138.08 20.05 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.412 0.685 . . . . 71.23 109.784 -175.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 242' ' ' TRP . . . . . 0.409 ' CD2' ' HG ' ' C' ' 233' ' ' LEU . 1.0 OUTLIER -173.16 117.24 0.29 Allowed 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 107.155 -1.424 . . . . 70.32 107.155 170.628 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 59.69 -82.56 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 124.104 0.962 . . . . 74.22 109.081 -168.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 179.83 88.22 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 107.362 -2.295 . . . . 71.54 107.362 177.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 245' ' ' LYS . . . . . 0.437 ' HD3' ' HB3' ' C' ' 222' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.931 0 N-CA-C 112.337 0.495 . . . . 75.34 112.337 -172.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.101 0 CA-C-O 120.808 0.337 . . . . 71.34 110.588 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' C' C ' 4' ' ' LYS . . . . . 0.612 ' HB3' ' HZ1' ' C' ' 4' ' ' LYS . 6.7 ttpm? -39.42 100.76 0.02 OUTLIER 'General case' 0 C--N 1.351 0.674 0 C-N-CA 125.301 1.44 . . . . 70.52 112.996 171.245 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -76.42 123.18 25.6 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 106.445 -1.687 . . . . 72.32 106.445 166.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -72.4 96.0 1.83 Allowed 'General case' 0 C--O 1.245 0.818 0 N-CA-C 108.705 -0.85 . . . . 65.15 108.705 -176.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 7' ' ' TYR . . . . . 0.441 ' CD1' ' HA ' ' C' ' 53' ' ' ALA . 50.2 m-85 -66.89 -24.2 66.08 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 113.893 -1.503 . . . . 73.43 112.083 -169.099 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -66.36 -49.11 68.0 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.803 -0.443 . . . . 74.23 109.803 174.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.09 -41.87 97.47 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 123.635 0.584 . . . . 63.34 110.986 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 58.3 mt -59.05 -41.83 84.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 123.645 0.591 . . . . 73.31 110.715 176.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 11' ' ' LEU . . . . . 0.408 ' HB2' HG23 ' C' ' 13' ' ' VAL . 78.4 mt -69.97 -26.24 64.0 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 115.994 -0.548 . . . . 75.53 111.869 174.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.95 22.31 55.52 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-N 116.694 -0.23 . . . . 74.43 112.953 -173.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 13' ' ' VAL . . . . . 0.408 HG23 ' HB2' ' C' ' 11' ' ' LEU . 19.0 m -107.23 150.5 40.02 Favored Pre-proline 0 N--CA 1.481 1.077 0 C-N-CA 124.184 0.994 . . . . 71.34 109.588 174.156 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -66.38 163.15 33.33 Favored 'Trans proline' 0 C--N 1.371 1.738 0 C-N-CA 122.455 2.103 . . . . 74.43 111.809 178.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -77.27 21.59 0.24 Allowed 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 123.175 0.59 . . . . 74.35 112.326 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -131.49 18.3 4.81 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.1 1.36 . . . . 71.24 107.691 173.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.23 123.72 18.07 Favored 'General case' 0 C--N 1.353 0.74 0 C-N-CA 124.166 0.986 . . . . 75.2 111.322 -178.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 44.0 p -66.72 170.29 6.65 Favored 'General case' 0 C--O 1.251 1.168 0 N-CA-C 109.059 -0.719 . . . . 74.41 109.059 170.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 59.4 tp60 -61.43 -36.42 80.31 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.538 -0.301 . . . . 74.45 111.081 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 20' ' ' GLU . . . . . 0.442 ' HB3' ' NH1' ' C' ' 24' ' ' ARG . 0.1 OUTLIER -73.27 -36.59 66.38 Favored 'General case' 0 C--O 1.212 -0.91 0 CA-C-O 118.869 -0.586 . . . . 74.53 110.171 179.773 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -55.93 -48.79 75.07 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.383 0.611 . . . . 73.42 111.188 174.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 22' ' ' ILE . . . . . 0.501 HD13 ' HB3' ' C' ' 57' ' ' LEU . 71.7 mt -61.6 -43.05 96.36 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-N 114.743 -1.117 . . . . 75.54 110.964 176.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 23' ' ' LYS . . . . . 0.536 ' O ' ' HG3' ' C' ' 27' ' ' LYS . 13.1 tppt? -68.76 -25.45 64.73 Favored 'General case' 0 CA--C 1.558 1.287 0 CA-C-N 115.34 -0.845 . . . . 74.13 110.158 179.214 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 24' ' ' ARG . . . . . 0.442 ' NH1' ' HB3' ' C' ' 20' ' ' GLU . 68.5 mtt85 -71.94 -50.95 24.66 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.775 0.83 . . . . 73.52 110.283 178.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.87 -37.73 74.45 Favored 'General case' 0 C--O 1.246 0.917 0 O-C-N 124.296 0.997 . . . . 75.32 110.293 177.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 26' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -56.31 -71.37 0.09 Allowed 'General case' 0 C--N 1.358 0.968 0 CA-C-O 117.642 -1.171 . . . . 72.31 110.487 172.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . 0.536 ' HG3' ' O ' ' C' ' 23' ' ' LYS . 39.0 mttp -50.24 -39.59 45.17 Favored 'General case' 0 N--CA 1.504 2.237 0 C-N-CA 123.633 0.773 . . . . 75.33 112.259 -173.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -54.75 -62.7 1.49 Allowed 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.691 1.197 . . . . 75.55 110.852 176.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . 0.486 HD12 HD12 ' C' ' 50' ' ' ILE . 42.3 mt -81.66 -8.81 59.75 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 115.25 -0.886 . . . . 71.43 111.256 -175.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . 0.475 ' HA ' ' HE1' ' C' ' 47' ' ' PHE . . . -93.36 -14.51 26.79 Favored 'General case' 0 C--O 1.215 -0.763 0 C-N-CA 124.23 1.012 . . . . 75.32 110.579 179.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 54.1 mtm180 -92.4 -41.67 10.19 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 109.245 -0.65 . . . . 73.5 109.245 164.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 23.9 tp60 -63.78 -50.61 68.35 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.764 0.826 . . . . 71.12 111.564 -175.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 33' ' ' TYR . . . . . 0.415 ' HE2' HD22 ' C' ' 29' ' ' LEU . 32.6 m-85 -104.26 20.16 18.87 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.235 0.614 . . . . 72.14 110.846 -177.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 34' ' ' HIS . . . . . 0.422 ' CD2' ' HB3' ' C' ' 36' ' ' ASP . 5.8 t60 -62.57 114.48 12.17 Favored Pre-proline 0 N--CA 1.475 0.819 0 CA-C-O 118.405 -0.807 . . . . 74.34 109.461 -179.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -51.15 -33.47 44.09 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 123.345 2.696 . . . . 72.22 114.414 -173.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 36' ' ' ASP . . . . . 0.422 ' HB3' ' CD2' ' C' ' 34' ' ' HIS . 15.7 t70 -68.51 -44.13 75.32 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.745 0.818 . . . . 60.34 111.639 177.404 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 61.5 t -80.51 -51.14 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 CA-C-O 121.495 0.664 . . . . 75.33 110.05 -173.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -112.67 96.79 6.17 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 114.809 -1.087 . . . . 65.41 108.939 177.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -84.08 67.03 9.53 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.899 0.479 . . . . 71.22 109.961 178.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 49.4 m -124.41 109.77 28.73 Favored Pre-proline 0 N--CA 1.477 0.878 0 C-N-CA 123.645 0.778 . . . . 74.14 108.933 177.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -43.82 -47.21 10.09 Favored 'Trans proline' 0 C--N 1.386 2.547 0 C-N-CA 124.197 3.265 . . . . 75.0 113.775 -177.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -55.25 -42.36 73.4 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.913 0.885 . . . . 71.01 111.299 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.68 -27.37 61.19 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 114.972 -1.013 . . . . 71.45 110.754 -178.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -81.51 -24.69 36.51 Favored 'General case' 0 C--N 1.352 0.689 0 O-C-N 123.774 0.671 . . . . 74.04 109.955 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -73.32 -45.07 57.5 Favored 'General case' 0 C--O 1.244 0.774 0 C-N-CA 123.709 0.804 . . . . 75.44 109.688 173.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 46' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -60.83 -41.03 94.99 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 115.605 -0.725 . . . . 72.32 110.36 171.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 47' ' ' PHE . . . . . 0.475 ' HE1' ' HA ' ' C' ' 30' ' ' ALA . 84.6 t80 -57.09 -45.99 82.92 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 124.149 0.906 . . . . 71.12 109.933 176.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 48' ' ' LYS . . . . . 0.476 ' HE3' ' HB3' ' C' ' 89' ' ' ASP . 48.5 mtpt -58.98 -46.26 88.54 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 123.965 0.791 . . . . 72.04 111.555 178.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -60.56 -43.15 97.56 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.303 0.573 . . . . 72.33 112.099 178.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 50' ' ' ILE . . . . . 0.486 HD12 HD12 ' C' ' 29' ' ' LEU . 82.8 mt -70.56 -29.35 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 124.187 0.995 . . . . 75.43 110.526 178.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 51' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -90.21 -5.58 56.23 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.802 0.841 . . . . 74.04 111.212 178.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -78.0 -48.49 16.06 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 107.319 -1.363 . . . . 75.54 107.319 164.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . 0.441 ' HA ' ' CD1' ' C' ' 7' ' ' TYR . . . -53.87 -43.6 69.7 Favored 'General case' 0 C--N 1.344 0.331 0 CA-C-N 113.236 -1.802 . . . . 63.1 111.29 174.235 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -79.32 -30.37 42.75 Favored 'General case' 0 C--O 1.214 -0.8 0 CA-C-N 114.934 -1.03 . . . . 75.01 111.111 176.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.82 -36.92 68.01 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 119.01 0.823 . . . . 60.54 111.172 176.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 56' ' ' VAL . . . . . 0.426 HG13 ' HZ ' ' C' ' 101' ' ' PHE . 35.3 t -78.78 -55.02 10.82 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 CA-C-N 114.894 -1.048 . . . . 72.43 110.445 174.024 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 57' ' ' LEU . . . . . 0.501 ' HB3' HD13 ' C' ' 22' ' ' ILE . 79.4 mt -92.56 19.18 7.59 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 113.021 0.749 . . . . 75.02 113.021 -168.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 29.9 t -51.31 -61.48 2.21 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.852 1.261 . . . . 75.33 113.657 -177.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -133.03 151.59 78.2 Favored Pre-proline 0 N--CA 1.476 0.846 0 N-CA-C 108.422 -0.955 . . . . 72.03 108.422 -172.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 60' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -41.01 -31.53 0.77 Allowed 'Trans proline' 0 C--N 1.386 2.528 0 C-N-CA 124.997 3.798 . . . . 73.21 116.417 -175.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -70.13 -58.97 3.2 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 118.078 0.399 . . . . 62.13 111.242 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -65.23 -28.63 69.5 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.028 0.442 . . . . 75.43 111.544 179.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 45.0 tpt85 -54.71 -53.46 54.68 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.371 1.069 . . . . 74.14 110.001 168.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -73.11 -19.16 61.2 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 115.806 -0.634 . . . . 74.15 112.386 -179.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 68.0 mt -65.34 -44.46 94.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 N-CA-C 108.869 -0.789 . . . . 71.5 108.869 170.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -60.54 -47.76 84.77 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.725 -0.67 . . . . 74.31 110.334 173.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -56.62 -45.79 81.3 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.312 0.645 . . . . 73.14 111.814 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 67.2 p -71.62 -25.48 62.18 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.197 -0.456 . . . . 74.43 110.829 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 69' ' ' TYR . . . . . 0.404 ' CD1' HD11 ' C' ' 100' ' ' LEU . 5.6 t80 -79.68 137.07 36.95 Favored 'General case' 0 C--N 1.358 0.953 0 N-CA-C 109.728 -0.471 . . . . 75.22 109.728 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.48 17.89 53.82 Favored Glycine 0 N--CA 1.473 1.144 0 N-CA-C 111.339 -0.704 . . . . 62.51 111.339 -170.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 87.7 m -147.32 -58.98 0.27 Allowed 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 103.615 -2.735 . . . . 72.34 103.615 176.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 34.7 m -84.48 148.96 26.26 Favored 'General case' 0 C--O 1.249 1.048 0 N-CA-C 105.403 -2.073 . . . . 73.35 105.403 156.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.96 -16.13 7.65 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.929 0.892 . . . . 73.23 110.202 -176.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.92 125.88 87.64 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 123.086 0.554 . . . . 53.23 109.781 174.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -61.57 148.49 92.89 Favored 'Trans proline' 0 C--N 1.372 1.804 0 C-N-CA 122.684 2.256 . . . . 75.14 111.373 169.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -65.83 165.24 24.13 Favored 'Trans proline' 0 CA--C 1.56 1.806 0 C-N-CA 122.735 2.29 . . . . 71.22 112.725 -179.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -67.37 158.54 56.56 Favored 'Trans proline' 0 C--N 1.374 1.918 0 C-N-CA 122.868 2.379 . . . . 74.4 111.427 167.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 78' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.27 116.83 3.5 Favored 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 122.498 2.132 . . . . 74.44 111.758 175.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -66.7 155.67 69.37 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 122.469 2.112 . . . . 70.12 110.087 177.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 80' ' ' PRO . . . . . 0.416 ' HB2' ' HA ' ' C' ' 141' ' ' ALA . 97.9 Cg_exo -46.52 76.27 0.01 OUTLIER 'Trans proline' 0 N--CA 1.509 2.428 0 C-N-CA 124.819 3.68 . . . . 74.31 116.309 -172.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 137.51 -47.06 0.97 Allowed Glycine 0 CA--C 1.53 1.01 0 CA-C-N 115.879 -0.6 . . . . 75.2 112.266 -178.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 141.25 164.61 10.03 Favored Glycine 0 N--CA 1.473 1.151 0 N-CA-C 109.799 -1.32 . . . . 75.13 109.799 -174.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 83' ' ' TYR . . . . . 0.444 ' HH ' ' HG2' ' C' ' 103' ' ' PRO . 89.9 m-85 -70.18 115.15 9.05 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 122.945 0.498 . . . . 73.4 110.028 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -52.09 121.99 7.74 Favored 'General case' 0 C--O 1.242 0.662 0 O-C-N 124.698 1.249 . . . . 75.11 111.661 176.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 85' ' ' PHE . . . . . 0.507 ' HA ' ' HD2' ' C' ' 88' ' ' PHE . 56.3 m-85 -135.39 59.23 1.73 Allowed 'General case' 0 N--CA 1.475 0.789 0 O-C-N 124.074 0.859 . . . . 74.41 110.444 169.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 25.0 m -61.0 89.59 0.02 OUTLIER 'General case' 0 C--N 1.354 0.783 0 CA-C-N 114.311 -1.313 . . . . 52.42 113.326 179.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 79.74 13.45 82.35 Favored Glycine 0 C--N 1.35 1.36 0 CA-C-N 115.271 -0.877 . . . . 74.34 112.967 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 88' ' ' PHE . . . . . 0.507 ' HD2' ' HA ' ' C' ' 85' ' ' PHE . 5.7 m-85 -100.8 119.77 39.13 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 107.657 -1.238 . . . . 74.44 107.657 -178.05 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 89' ' ' ASP . . . . . 0.476 ' HB3' ' HE3' ' C' ' 48' ' ' LYS . 62.7 t0 -80.19 72.21 6.99 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-O 121.647 0.737 . . . . 72.23 110.622 -176.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 90' ' ' VAL . . . . . 0.557 HG23 ' HE2' ' C' ' 97' ' ' PHE . 5.3 p -49.91 -42.53 18.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 125.416 1.486 . . . . 54.42 113.261 -176.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -66.39 -23.07 66.26 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.512 0.725 . . . . 75.25 111.575 -173.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -90.38 -19.54 23.86 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.429 0.691 . . . . 75.53 111.112 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 20.1 m-30 -77.81 178.02 7.72 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.138 0.575 . . . . 72.45 111.778 -174.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 94' ' ' SER . . . . . 0.411 ' O ' ' HB3' ' C' ' 97' ' ' PHE . 78.4 p -62.16 153.87 28.94 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.607 0.763 . . . . 52.11 112.323 -171.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 95' ' ' GLU . . . . . 0.461 ' O ' ' HG3' ' C' ' 99' ' ' GLU . 0.0 OUTLIER -68.49 -32.14 71.9 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.723 -0.671 . . . . 72.35 111.199 178.582 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -51.38 -53.1 39.84 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.131 0.972 . . . . 74.24 110.556 169.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 97' ' ' PHE . . . . . 0.557 ' HE2' HG23 ' C' ' 90' ' ' VAL . 48.6 t80 -56.6 -47.51 79.46 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-N 113.775 -1.557 . . . . 64.25 110.327 178.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -76.58 -9.21 58.49 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 114.753 -1.112 . . . . 71.33 112.988 -176.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 99' ' ' GLU . . . . . 0.461 ' HG3' ' O ' ' C' ' 95' ' ' GLU . 61.7 mt-10 -82.61 -51.31 7.87 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.211 0.604 . . . . 74.43 109.563 166.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 100' ' ' LEU . . . . . 0.404 HD11 ' CD1' ' C' ' 69' ' ' TYR . 18.7 tp -59.35 -44.84 92.62 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 114.438 -1.256 . . . . 73.23 111.911 -171.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 101' ' ' PHE . . . . . 0.426 ' HZ ' HG13 ' C' ' 56' ' ' VAL . 48.2 m-85 -105.38 11.47 32.69 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.375 0.27 . . . . 75.04 111.03 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -42.23 -64.63 1.48 Allowed Glycine 0 C--N 1.357 1.745 0 C-N-CA 124.823 1.201 . . . . 74.41 114.538 -171.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . 0.444 ' HG2' ' HH ' ' C' ' 83' ' ' TYR . 15.0 Cg_exo -29.93 -31.44 0.02 OUTLIER 'Trans proline' 0 C--N 1.389 2.69 1 C-N-CA 126.299 4.666 . . . . 64.35 117.266 176.599 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -156.83 52.67 0.41 Allowed Glycine 0 C--N 1.354 1.538 0 C-N-CA 120.934 -0.651 . . . . 73.42 113.024 179.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 105' ' ' LEU . . . . . 0.483 ' HB3' HG22 ' C' ' 90' ' ' VAL . 92.7 mt . . . . . 0 CA--C 1.579 2.065 0 N-CA-C 117.218 2.303 . . . . 75.43 117.218 177.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.637 0 N-CA-C 109.813 -1.315 . . . . 54.4 109.813 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 67.0 mtt180 -97.49 113.13 24.76 Favored 'General case' 0 C--O 1.257 1.463 0 CA-C-O 122.304 1.049 . . . . 74.32 110.903 -172.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -74.36 109.28 7.72 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 111.612 -2.54 . . . . 75.42 105.647 162.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 119' ' ' LEU . . . . . 0.566 HD12 ' HA2' ' C' ' 165' ' ' GLY . 70.0 mt -91.01 106.84 18.8 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.341 -0.391 . . . . 75.21 110.445 -162.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -90.01 94.45 9.8 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 106.604 -1.628 . . . . 72.31 106.604 -178.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 121' ' ' ALA . . . . . 0.636 ' HA ' HG23 ' B' ' 185' ' ' VAL . . . -105.44 113.8 27.6 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 109.104 -0.702 . . . . 75.44 109.104 -171.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -73.31 107.74 5.79 Favored 'General case' 0 C--O 1.244 0.775 0 N-CA-C 106.981 -1.489 . . . . 74.12 106.981 171.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -116.13 137.27 23.31 Favored Pre-proline 0 N--CA 1.474 0.756 0 CA-C-O 120.48 0.181 . . . . 73.3 111.465 -179.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.13 116.84 4.54 Favored 'Trans proline' 0 C--N 1.371 1.734 0 C-N-CA 122.984 2.456 . . . . 72.51 110.802 168.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 125' ' ' LEU . . . . . 0.497 HD21 HG11 ' C' ' 153' ' ' VAL . 13.6 tp -152.63 161.28 42.78 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 109.479 -0.563 . . . . 75.32 109.479 -178.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 126' ' ' THR . . . . . 0.511 ' HB ' ' HG ' ' C' ' 181' ' ' LEU . 6.2 t -125.98 175.25 7.84 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.56 0.695 . . . . 61.53 109.96 171.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 127' ' ' LEU . . . . . 0.478 HD21 HD12 ' C' ' 180' ' ' LEU . 13.6 mt -60.4 -48.52 81.41 Favored 'General case' 0 C--O 1.245 0.821 0 C-N-CA 125.55 1.54 . . . . 62.25 110.303 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 128' ' ' GLU . . . . . 0.512 ' HG3' ' HA ' ' C' ' 215' ' ' LEU . 8.5 mp0 -63.55 -33.06 74.75 Favored 'General case' 0 C--O 1.215 -0.723 0 CA-C-N 114.009 -1.45 . . . . 75.24 110.748 178.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 129' ' ' GLU . . . . . 0.416 ' HA ' ' HB2' ' C' ' 132' ' ' HIS . 19.4 mm-40 -84.65 -13.65 50.89 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.779 0.832 . . . . 75.51 111.771 178.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 130' ' ' ALA . . . . . 0.459 ' HB1' HG13 ' C' ' 153' ' ' VAL . . . -76.33 -34.61 59.0 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.876 -0.787 . . . . 73.14 108.876 170.115 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 131' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -70.54 -46.28 63.89 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 113.993 -1.458 . . . . 75.55 111.512 168.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 132' ' ' HIS . . . . . 0.416 ' HB2' ' HA ' ' C' ' 129' ' ' GLU . 35.8 m170 -80.65 -9.71 59.77 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 123.365 0.666 . . . . 70.15 111.02 -178.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -66.44 -120.16 0.01 OUTLIER Glycine 0 C--N 1.354 1.528 0 O-C-N 123.921 0.763 . . . . 65.31 113.371 177.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . 64.85 -103.69 0.81 Allowed Glycine 0 C--N 1.342 0.91 0 N-CA-C 110.852 -0.899 . . . . 73.12 110.852 -173.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 135' ' ' GLU . . . . . 0.704 ' HG3' ' HB2' ' C' ' 148' ' ' ARG . 2.7 mp0 -87.94 94.06 9.66 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.03 0.932 . . . . 73.03 109.277 -177.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 136' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -142.41 166.95 23.28 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.502 0.721 . . . . 72.12 110.263 -177.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 137' ' ' VAL . . . . . . . . . . . . . 17.7 m -73.89 88.66 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.1 0 CA-C-N 115.251 -0.886 . . . . 73.11 111.202 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 138' ' ' VAL . . . . . 0.527 ' O ' ' HA ' ' C' ' 144' ' ' ARG . 37.4 t -80.21 129.76 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.912 0.885 . . . . 72.14 109.819 175.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 139' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -124.95 113.73 18.21 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 108.3 -1.0 . . . . 74.31 108.3 169.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 140' ' ' VAL . . . . . 0.608 HG12 ' HB ' ' B' ' 185' ' ' VAL . 30.7 t -150.02 126.88 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.215 1.006 . . . . 73.25 108.341 167.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 141' ' ' ALA . . . . . 0.416 ' HA ' ' HB2' ' C' ' 80' ' ' PRO . . . 65.04 32.4 10.43 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.172 0.989 . . . . 65.0 112.895 172.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 73.03 26.94 69.64 Favored Glycine 0 C--N 1.344 0.991 0 N-CA-C 111.722 -0.551 . . . . 52.4 111.722 -178.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 143' ' ' ARG . . . . . . . . . . . . . 45.2 mtp180 -115.74 96.27 5.53 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 107.539 -1.282 . . . . 75.05 107.539 171.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 144' ' ' ARG . . . . . 0.527 ' HA ' ' O ' ' C' ' 138' ' ' VAL . 29.2 ttp-105 -114.25 104.22 11.87 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 123.491 0.716 . . . . 71.51 109.539 -178.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 145' ' ' VAL . . . . . . . . . . . . . 7.7 p -150.47 146.21 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.34 0.656 . . . . 75.03 110.639 -175.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 24.7 m -77.62 88.29 3.92 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 108.601 -0.889 . . . . 73.22 108.601 171.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 11.2 p -117.18 154.44 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.656 0.782 . . . . 72.53 109.91 -173.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 148' ' ' ARG . . . . . 0.704 ' HB2' ' HG3' ' C' ' 135' ' ' GLU . 31.5 ttt85 -92.54 114.27 26.77 Favored 'General case' 0 C--O 1.242 0.669 0 O-C-N 123.801 0.688 . . . . 74.22 111.02 177.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 149' ' ' ILE . . . . . 0.438 HD13 HD12 ' C' ' 159' ' ' ILE . 26.2 pt -94.47 154.26 40.24 Favored Pre-proline 0 CA--C 1.552 1.028 0 N-CA-C 107.493 -1.299 . . . . 74.42 107.493 163.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -51.15 115.6 2.15 Favored 'Trans proline' 0 CA--C 1.565 2.038 0 C-N-CA 122.311 2.007 . . . . 61.44 111.378 174.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -61.36 113.45 1.78 Allowed 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 123.359 2.706 . . . . 73.2 111.169 -178.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 152' ' ' GLY . . . . . . . . . . . . . . . 129.28 142.15 5.24 Favored Glycine 0 C--N 1.34 0.779 0 O-C-N 123.449 0.468 . . . . 63.11 114.13 -172.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 153' ' ' VAL . . . . . 0.497 HG11 HD21 ' C' ' 125' ' ' LEU . 3.0 p -164.69 168.36 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.39 0 N-CA-C 112.524 0.564 . . . . 74.01 112.524 174.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 154' ' ' ARG . . . . . 0.46 ' HB3' ' HB2' ' C' ' 157' ' ' SER . 0.8 OUTLIER -125.81 169.48 12.57 Favored 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 125.806 1.642 . . . . 75.32 108.563 176.96 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' C' C ' 155' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -65.06 128.45 35.83 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.158 0.583 . . . . 74.51 110.289 169.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 71.82 12.0 74.19 Favored Glycine 0 C--N 1.348 1.215 0 O-C-N 123.891 0.744 . . . . 75.21 113.478 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 157' ' ' SER . . . . . 0.46 ' HB2' ' HB3' ' C' ' 154' ' ' ARG . 43.6 t -78.82 140.98 38.1 Favored 'General case' 0 C--O 1.252 1.206 0 C-N-CA 123.117 0.567 . . . . 75.43 109.903 -179.073 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 158' ' ' VAL . . . . . 0.475 HG21 ' HB3' ' C' ' 175' ' ' LEU . 5.4 p -108.78 96.94 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 O-C-N 125.077 1.485 . . . . 72.31 108.956 -174.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 159' ' ' ILE . . . . . 0.614 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 56.4 mt -78.41 111.45 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 108.687 -0.857 . . . . 72.31 108.687 178.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 26.4 ttt180 -85.58 107.94 17.73 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 108.826 -0.805 . . . . 75.13 108.826 173.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 161' ' ' VAL . . . . . . . . . . . . . 2.2 t -98.17 105.66 30.0 Favored Pre-proline 0 CA--C 1.557 1.228 0 N-CA-C 106.219 -1.771 . . . . 75.24 106.219 171.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -64.68 132.02 31.43 Favored 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 123.512 2.808 . . . . 75.23 113.042 -171.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 64.83 19.57 65.52 Favored Glycine 0 C--N 1.347 1.194 0 O-C-N 124.01 0.819 . . . . 53.54 113.348 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 164' ' ' MET . . . . . . . . . . . . . 31.8 mmm -110.08 -2.48 16.96 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.583 0.753 . . . . 73.35 111.753 -178.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 165' ' ' GLY . . . . . 0.566 ' HA2' HD12 ' C' ' 119' ' ' LEU . . . -89.5 -111.87 1.33 Allowed Glycine 0 C--N 1.347 1.162 0 N-CA-C 108.293 -1.923 . . . . 73.32 108.293 164.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . -156.78 118.11 0.82 Allowed Glycine 0 C--N 1.335 0.498 0 C-N-CA 120.692 -0.766 . . . . 75.44 111.831 161.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 167' ' ' GLN . . . . . 0.535 ' HA ' ' H ' ' C' ' 172' ' ' GLY . 15.0 mm-40 -71.23 101.9 2.42 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 107.792 -1.188 . . . . 74.2 107.792 175.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . -115.77 -125.5 3.88 Favored Glycine 0 N--CA 1.467 0.758 0 N-CA-C 110.275 -1.13 . . . . 13.44 110.275 178.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 169' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -61.41 -67.19 1.15 Allowed Pre-proline 0 CA--C 1.574 1.865 0 CA-C-N 117.956 0.878 . . . . 62.44 110.562 175.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 170' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -93.94 113.82 0.22 Allowed 'Trans proline' 0 C--N 1.393 2.878 0 CA-C-N 122.107 1.788 . . . . 73.55 109.143 163.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 171' ' ' PRO . . . . . 0.485 ' HA ' ' HA ' ' C' ' 167' ' ' GLN . 6.5 Cg_exo -33.87 131.78 0.15 Allowed 'Trans proline' 0 C--N 1.372 1.763 0 C-N-CA 124.609 3.54 . . . . 74.02 115.514 -178.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 172' ' ' GLY . . . . . 0.535 ' H ' ' HA ' ' C' ' 167' ' ' GLN . . . -120.85 115.93 3.04 Favored Glycine 0 C--N 1.341 0.828 0 N-CA-C 110.968 -0.853 . . . . 74.42 110.968 -171.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 173' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -107.75 158.9 16.91 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 108.512 -0.921 . . . . 74.51 108.512 175.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 174' ' ' LEU . . . . . . . . . . . . . 9.8 tp -81.41 107.56 14.29 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 109.739 -0.467 . . . . 75.22 109.739 -177.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 175' ' ' LEU . . . . . 0.475 ' HB3' HG21 ' C' ' 158' ' ' VAL . 78.6 mt -95.12 82.22 3.75 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.43 1.092 . . . . 72.15 110.084 179.505 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 176' ' ' LEU . . . . . 0.614 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 75.7 mt -68.4 100.76 1.12 Allowed 'General case' 0 CA--C 1.546 0.804 0 CA-C-O 121.022 0.439 . . . . 74.33 110.86 178.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 177' ' ' VAL . . . . . . . . . . . . . 61.0 t -85.53 101.57 10.11 Favored 'Isoleucine or valine' 0 C--O 1.244 0.784 0 C-N-CA 124.147 0.979 . . . . 75.23 108.398 176.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 178' ' ' VAL . . . . . 0.45 HG22 HG21 ' C' ' 153' ' ' VAL . 52.1 t -84.93 135.82 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 N-CA-C 112.538 0.57 . . . . 74.01 112.538 -174.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 179' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -110.76 113.27 25.73 Favored 'General case' 0 C--O 1.254 1.33 0 C-N-CA 124.981 1.312 . . . . 74.42 108.436 169.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 180' ' ' LEU . . . . . 0.478 HD12 HD21 ' C' ' 127' ' ' LEU . 91.8 mt -76.53 153.76 35.15 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 124.572 1.149 . . . . 73.43 111.445 178.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 181' ' ' LEU . . . . . 0.511 ' HG ' ' HB ' ' C' ' 126' ' ' THR . 8.2 mt -65.73 168.4 8.75 Favored Pre-proline 0 N--CA 1.49 1.553 0 C-N-CA 123.105 0.562 . . . . 74.24 110.892 -179.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -60.45 70.07 0.07 OUTLIER 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 122.482 2.121 . . . . 73.32 110.793 160.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 183' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -160.44 62.39 1.73 Allowed Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 106.753 -1.573 . . . . 72.0 106.753 -167.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 184' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -85.34 64.53 5.97 Favored 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 123.03 2.486 . . . . 74.25 111.217 -170.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 185' ' ' VAL . . . . . 0.612 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 18.1 t -95.55 -56.42 5.22 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.905 0 N-CA-C 107.826 -1.176 . . . . 72.23 107.826 -173.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 186' ' ' PHE . . . . . 0.44 ' HD1' ' HB3' ' C' ' 195' ' ' ALA . 33.9 m-85 -114.8 153.66 29.99 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.56 0.744 . . . . 61.44 110.832 -174.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 187' ' ' ARG . . . . . . . . . . . . . 7.5 mtm180 -143.42 115.74 8.5 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.569 1.148 . . . . 75.14 108.772 175.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 188' ' ' LEU . . . . . 0.429 HD13 ' HD2' ' C' ' 240' ' ' PHE . 55.6 tp -77.48 143.27 38.63 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.973 0.731 . . . . 74.14 112.973 -171.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -141.76 105.22 4.67 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 107.14 -1.429 . . . . 73.21 107.14 166.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 74.32 -101.06 1.21 Allowed Glycine 0 CA--C 1.536 1.37 0 N-CA-C 111.885 -0.486 . . . . 74.2 111.885 -175.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 191' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -123.14 -5.13 8.41 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 124.246 1.018 . . . . 75.25 110.744 172.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -101.92 140.14 36.61 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.299 0.64 . . . . 65.13 110.088 -174.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 193' ' ' LEU . . . . . 0.424 HD22 ' CE2' ' C' ' 240' ' ' PHE . 82.0 mt -99.39 153.24 19.14 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.558 0.743 . . . . 65.15 111.273 -174.134 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 194' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -113.73 107.27 15.52 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 107.418 -1.327 . . . . 75.43 107.418 168.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 195' ' ' ALA . . . . . 0.612 ' HA ' ' O ' ' C' ' 185' ' ' VAL . . . -105.09 -178.59 3.7 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.164 0.586 . . . . 65.11 110.119 175.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 26.0 m -142.35 99.33 3.48 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 107.457 -1.312 . . . . 53.42 107.457 171.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 197' ' ' LEU . . . . . 0.438 HD11 ' HB1' ' C' ' 212' ' ' ALA . 25.7 tp -80.44 121.31 25.58 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.773 -0.649 . . . . 73.5 111.013 -171.115 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -74.51 100.1 3.78 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 108.166 -1.05 . . . . 64.33 108.166 175.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 199' ' ' VAL . . . . . . . . . . . . . 58.5 t -111.32 117.69 48.97 Favored Pre-proline 0 N--CA 1.474 0.731 0 N-CA-C 108.23 -1.026 . . . . 73.12 108.23 178.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 200' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -72.17 143.96 40.95 Favored 'Trans proline' 0 C--N 1.369 1.625 0 C-N-CA 121.727 1.618 . . . . 73.11 109.81 174.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 201' ' ' ALA . . . . . 0.425 ' N ' ' HD2' ' C' ' 202' ' ' PRO . . . -55.0 -44.28 99.52 Favored Pre-proline 0 CA--C 1.552 1.058 0 N-CA-C 114.119 1.155 . . . . 74.35 114.119 -173.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 202' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' C' ' 201' ' ' ALA . 17.3 Cg_endo -55.29 -46.99 28.51 Favored 'Trans proline' 0 C--N 1.393 2.906 0 C-N-CA 121.883 1.722 . . . . 63.15 112.67 176.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 203' ' ' ILE . . . . . 0.453 ' HA ' HG13 ' C' ' 206' ' ' VAL . 48.0 mt -68.18 -37.52 78.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.14 0.576 . . . . 74.02 110.871 -178.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 204' ' ' ALA . . . . . 0.423 ' HA ' HG12 ' C' ' 223' ' ' VAL . . . -58.53 -44.13 89.44 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.477 0.711 . . . . 75.02 111.338 176.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 205' ' ' VAL . . . . . 0.509 ' HA ' ' HA ' ' C' ' 226' ' ' ARG . 81.7 t -72.74 -42.65 61.87 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 115.156 -0.929 . . . . 74.52 111.786 -177.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 206' ' ' VAL . . . . . 0.627 ' HA ' ' HE2' ' A' ' 270' ' ' LYS . 11.3 p -77.05 -29.38 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 CA-C-O 120.676 0.274 . . . . 74.12 110.74 -174.185 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 77.18 51.91 5.93 Favored Glycine 0 C--N 1.341 0.826 0 N-CA-C 110.634 -0.987 . . . . 63.21 110.634 -171.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -91.78 -120.37 2.55 Favored Glycine 0 C--N 1.344 1.026 0 N-CA-C 111.246 -0.741 . . . . 51.32 111.246 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 209' ' ' LYS . . . . . 0.575 ' HG2' ' HG2' ' C' ' 220' ' ' GLU . 34.6 ttmt -151.72 133.17 14.64 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.619 0.723 . . . . 72.44 111.208 -178.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 210' ' ' VAL . . . . . . . . . . . . . 26.8 m -115.16 -175.28 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 126.596 1.958 . . . . 71.52 108.091 174.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 211' ' ' ARG . . . . . 0.467 ' HD3' ' HB2' ' C' ' 218' ' ' PRO . 36.9 ttm105 -142.85 127.99 18.61 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 118.236 0.471 . . . . 75.53 111.908 -178.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 212' ' ' ALA . . . . . 0.438 ' HB1' HD11 ' C' ' 197' ' ' LEU . . . -101.68 113.49 26.7 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 108.039 -1.097 . . . . 74.43 108.039 168.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 213' ' ' MET . . . . . 0.55 ' HA ' ' HA ' ' C' ' 218' ' ' PRO . 2.9 ttp -69.73 105.87 2.89 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 107.86 -1.163 . . . . 63.12 107.86 174.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 214' ' ' THR . . . . . 0.47 ' OG1' HG12 ' C' ' 219' ' ' VAL . 0.2 OUTLIER -101.02 175.63 5.53 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.506 0.669 . . . . 72.34 110.243 -173.144 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' C' C ' 215' ' ' LEU . . . . . 0.512 ' HA ' ' HG3' ' C' ' 128' ' ' GLU . 9.2 mt -63.0 -41.14 99.5 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.711 1.604 . . . . 75.24 111.326 -175.179 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -92.77 0.33 57.4 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 114.32 -1.309 . . . . 71.0 111.15 -177.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 134.36 162.65 9.98 Favored Glycine 0 C--N 1.343 0.931 0 N-CA-C 111.669 -0.572 . . . . 74.41 111.669 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 218' ' ' PRO . . . . . 0.55 ' HA ' ' HA ' ' C' ' 213' ' ' MET . 59.9 Cg_endo -70.04 107.88 2.01 Favored 'Trans proline' 0 CA--C 1.555 1.575 0 C-N-CA 122.708 2.272 . . . . 64.03 112.952 -178.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 219' ' ' VAL . . . . . 0.528 HG23 HG23 ' B' ' 238' ' ' THR . 7.3 p -80.71 120.85 33.12 Favored 'Isoleucine or valine' 0 C--N 1.355 0.832 0 N-CA-C 107.664 -1.236 . . . . 52.53 107.664 174.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 220' ' ' GLU . . . . . 0.575 ' HG2' ' HG2' ' C' ' 209' ' ' LYS . 16.3 tt0 -92.75 103.79 16.12 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 107.583 -1.266 . . . . 72.32 107.583 -179.059 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 221' ' ' VAL . . . . . . . . . . . . . 60.8 t -85.88 123.29 39.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 113.534 -1.666 . . . . 74.03 112.319 -165.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 222' ' ' ALA . . . . . 0.437 ' HB3' ' HD3' ' B' ' 245' ' ' LYS . . . -74.84 143.56 43.85 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.311 0.644 . . . . 73.3 110.508 173.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 223' ' ' VAL . . . . . 0.423 HG12 ' HA ' ' C' ' 204' ' ' ALA . 98.0 t -116.62 138.11 24.22 Favored Pre-proline 0 N--CA 1.485 1.299 0 C-N-CA 124.316 1.047 . . . . 73.11 109.512 -174.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 224' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -78.74 156.02 27.43 Favored 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 123.279 2.653 . . . . 73.11 111.488 170.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.48 124.46 16.31 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 123.346 2.697 . . . . 74.4 113.137 -175.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 226' ' ' ARG . . . . . 0.509 ' HA ' ' HA ' ' C' ' 205' ' ' VAL . 0.0 OUTLIER 58.53 90.87 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.62 1.568 . . . . 71.5 112.378 -179.495 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' C' C ' 227' ' ' THR . . . . . 0.554 ' HA ' ' NH1' ' C' ' 231' ' ' ARG . 21.6 m -110.03 127.96 55.13 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 114.817 -1.083 . . . . 73.3 111.378 179.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 228' ' ' GLN . . . . . 0.717 HE21 HD13 ' A' ' 257' ' ' ILE . 0.8 OUTLIER -96.54 153.52 17.8 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.11 0.964 . . . . 74.32 111.859 -179.596 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -70.45 134.01 47.38 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 114.681 -1.145 . . . . 65.31 109.69 173.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 110.45 -19.28 26.77 Favored Glycine 0 C--N 1.339 0.702 0 O-C-N 123.613 0.571 . . . . 62.04 112.088 -173.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 231' ' ' ARG . . . . . 0.554 ' NH1' ' HA ' ' C' ' 227' ' ' THR . 71.3 mtt180 -65.78 174.9 2.13 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 117.138 0.469 . . . . 75.03 111.46 173.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 232' ' ' LYS . . . . . 0.452 ' HD3' ' HB3' ' C' ' 250' ' ' TYR . 30.2 ttmt -142.85 145.71 33.42 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 121.206 0.527 . . . . 74.05 111.525 -178.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 233' ' ' LEU . . . . . 0.702 HD12 ' HB2' ' C' ' 251' ' ' LEU . 1.7 mp -113.26 145.33 41.2 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.815 1.246 . . . . 74.22 108.412 178.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 234' ' ' ARG . . . . . 0.659 ' HG3' ' HG3' ' B' ' 241' ' ' GLU . 9.2 ptp85 -120.29 95.06 4.59 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 121.957 0.884 . . . . 72.34 109.432 169.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 235' ' ' LEU . . . . . 0.572 ' HA ' ' HA3' ' B' ' 240' ' ' GLY . 26.0 mt -84.67 107.66 16.99 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.611 -0.722 . . . . 74.34 109.324 178.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -69.07 122.99 19.85 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 123.627 0.771 . . . . 73.41 111.483 -174.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 76.54 32.56 50.6 Favored Glycine 0 C--N 1.344 0.994 0 O-C-N 124.199 0.937 . . . . 71.42 113.192 178.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 33.5 mmtm -123.83 14.99 9.34 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.821 0.848 . . . . 75.11 111.209 175.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -91.62 -147.39 20.02 Favored Glycine 0 C--N 1.353 1.477 0 N-CA-C 111.178 -0.769 . . . . 75.2 111.178 170.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 240' ' ' PHE . . . . . 0.437 ' CE1' HD13 ' C' ' 215' ' ' LEU . 39.9 m-85 -94.56 142.12 24.36 Favored Pre-proline 0 N--CA 1.482 1.141 0 CA-C-N 117.572 0.686 . . . . 75.14 111.302 178.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 241' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' C' ' 240' ' ' PHE . 3.3 Cg_exo -76.65 113.99 3.76 Favored 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 123.837 3.025 . . . . 71.53 113.69 -172.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -96.78 159.96 21.65 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-O 119.015 -0.88 . . . . 70.14 111.396 170.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.58 -13.43 37.27 Favored 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 122.781 2.32 . . . . 71.42 112.857 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -103.25 -16.71 15.6 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.515 0.726 . . . . 71.42 110.935 174.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 157.88 158.41 8.96 Favored Glycine 0 C--N 1.356 1.641 0 O-C-N 123.119 0.262 . . . . 63.24 113.702 177.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 246' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -73.65 152.62 40.44 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.804 0.842 . . . . 71.32 110.22 174.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.44 -164.69 22.9 Favored Glycine 0 C--N 1.346 1.112 0 O-C-N 123.702 0.626 . . . . 63.23 112.004 173.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -119.72 154.48 34.06 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 108.877 -0.786 . . . . 73.54 108.877 -178.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 249' ' ' LEU . . . . . 0.534 ' HB3' ' HB2' ' C' ' 235' ' ' LEU . 19.0 tp -99.61 109.24 21.76 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.637 -0.71 . . . . 74.23 109.284 175.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 250' ' ' TYR . . . . . 0.591 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 20.2 m-85 -99.44 100.36 11.39 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 109.236 -0.653 . . . . 71.43 109.236 178.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 251' ' ' LEU . . . . . 0.702 ' HB2' HD12 ' C' ' 233' ' ' LEU . 0.8 OUTLIER -100.4 140.37 34.74 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.232 -0.655 . . . . 72.0 109.232 -176.716 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -89.54 128.43 36.01 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 108.225 -1.028 . . . . 75.41 108.225 168.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 253' ' ' VAL . . . . . 0.514 HG13 HG21 ' C' ' 227' ' ' THR . 80.0 t -67.97 131.97 32.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 123.641 0.776 . . . . 73.5 110.25 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 254' ' ' ARG . . . . . 0.402 HH11 ' HB3' ' C' ' 254' ' ' ARG . 0.0 OUTLIER -126.72 93.06 3.67 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.354 -1.351 . . . . 75.13 107.354 179.226 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' C' C ' 255' ' ' ILE . . . . . . . . . . . . . 49.8 mm -73.11 127.49 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 O-C-N 123.853 0.721 . . . . 75.24 109.788 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 256' ' ' THR . . . . . 0.55 ' HA ' HD13 ' A' ' 255' ' ' ILE . 1.7 t -144.73 171.04 14.97 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 124.412 1.07 . . . . 70.25 110.396 -171.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 2.7 pp -132.59 148.31 69.06 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 123.735 0.814 . . . . 75.21 109.398 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 258' ' ' PRO . . . . . 0.521 ' HG3' ' HE2' ' A' ' 276' ' ' TYR . 98.5 Cg_endo -74.53 11.14 1.37 Allowed 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 123.323 2.682 . . . . 74.41 114.277 -172.179 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 259' ' ' GLU . . . . . 0.401 ' HG3' HE21 ' A' ' 228' ' ' GLN . 18.0 mt-10 62.1 -80.64 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 125.194 1.398 . . . . 72.3 111.101 -171.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 2.8 ptp85 -77.87 143.89 37.41 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.518 1.527 . . . . 73.41 110.928 -173.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 261' ' ' LEU . . . . . . . . . . . . . 75.3 mt -141.7 169.98 16.58 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.046 0.938 . . . . 74.53 110.107 -177.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 23.9 p -84.04 152.02 61.37 Favored Pre-proline 0 CA--C 1.552 1.024 0 N-CA-C 107.765 -1.198 . . . . 61.23 107.765 169.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -48.12 -34.64 24.24 Favored 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 123.173 2.582 . . . . 74.2 113.9 176.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.52 -56.14 9.36 Favored 'General case' 0 C--O 1.268 2.037 0 C-N-CA 124.249 1.019 . . . . 71.04 110.624 -178.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 265' ' ' GLU . . . . . 0.443 ' CD ' HH22 ' A' ' 279' ' ' ARG . 40.7 mm-40 -51.16 -55.09 19.66 Favored 'General case' 0 C--N 1.359 1.002 0 CA-C-N 114.953 -1.021 . . . . 71.03 110.359 175.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 266' ' ' GLU . . . . . 0.479 ' O ' ' HG2' ' C' ' 270' ' ' LYS . 30.8 tt0 -61.15 -31.46 71.18 Favored 'General case' 0 C--O 1.217 -0.652 0 CA-C-N 114.186 -1.37 . . . . 73.1 111.39 -175.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -60.76 -45.15 95.46 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 123.461 0.475 . . . . 71.12 110.866 174.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 268' ' ' LEU . . . . . 0.514 ' HA ' ' HE2' ' C' ' 271' ' ' LYS . 11.2 mp -64.18 -42.32 96.74 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 116.202 -0.454 . . . . 70.11 111.465 174.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -65.12 -25.36 67.73 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 122.797 0.439 . . . . 63.11 111.296 175.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 270' ' ' LYS . . . . . 0.479 ' HG2' ' O ' ' C' ' 266' ' ' GLU . 13.2 mmmm -67.93 -49.66 60.53 Favored 'General case' 0 C--N 1.363 1.175 0 C-N-CA 122.837 0.455 . . . . 75.43 109.867 175.235 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 271' ' ' LYS . . . . . 0.514 ' HE2' ' HA ' ' C' ' 268' ' ' LEU . 52.7 mtmt -57.62 -44.72 85.72 Favored 'General case' 0 N--CA 1.484 1.243 0 O-C-N 123.688 0.618 . . . . 75.33 111.294 178.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 88.3 mt -62.08 -41.41 98.16 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.237 0.615 . . . . 74.33 111.189 175.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -64.83 -45.35 86.56 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 115.573 -0.74 . . . . 43.22 111.545 -177.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -70.26 -32.42 70.24 Favored 'General case' 0 C--O 1.242 0.667 0 O-C-N 124.142 0.901 . . . . 63.21 110.62 -178.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -61.82 -34.13 75.39 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.684 -0.689 . . . . 70.04 110.678 170.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 276' ' ' TYR . . . . . 0.568 ' HB3' HD13 ' A' ' 203' ' ' ILE . 10.0 m-85 -83.49 -25.48 31.07 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 113.047 0.758 . . . . 75.52 113.047 174.212 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 20.3 m-30 -72.81 -21.23 61.01 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 118.524 0.602 . . . . 65.52 109.933 176.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -61.81 -3.6 1.2 Allowed 'General case' 0 CA--C 1.558 1.266 0 CA-C-N 115.02 -0.991 . . . . 72.22 112.821 169.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 279' ' ' ARG . . . . . . . . . . . . . 81.7 mtt180 -72.7 -14.12 61.5 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.255 0.622 . . . . 75.11 112.441 171.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.257 0 C-N-CA 124.452 1.101 . . . . 75.14 112.683 -175.924 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt . . . . . 0 N--CA 1.472 0.627 0 N-CA-C 113.072 0.768 . . . . 64.14 113.072 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.469 ' HE3' ' HB3' ' A' ' 94' ' ' SER . 94.6 mttt -70.84 133.08 46.19 Favored 'General case' 0 C--O 1.244 0.766 0 N-CA-C 108.917 -0.772 . . . . 74.32 108.917 166.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -75.44 86.74 2.58 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 106.388 -1.708 . . . . 62.43 106.388 168.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -60.62 -34.67 74.59 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-N 115.002 -0.999 . . . . 73.34 111.231 -173.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -62.56 -45.02 94.87 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.517 -0.765 . . . . 73.33 110.713 175.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.81 -42.84 99.52 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.871 0.468 . . . . 70.01 111.254 178.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.421 HD13 ' HB3' ' A' ' 5' ' ' LYS . 71.3 mt -55.88 -45.13 79.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 C-N-CA 123.508 0.723 . . . . 74.23 110.311 177.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.663 HD11 HG23 ' A' ' 22' ' ' ILE . 83.1 mt -69.43 -29.87 67.68 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 115.898 -0.592 . . . . 73.11 111.674 175.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.3 46.54 5.24 Favored Glycine 0 C--N 1.344 0.995 0 CA-C-O 120.946 0.192 . . . . 73.42 112.737 -173.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.512 HG12 ' HB3' ' A' ' 25' ' ' ALA . 3.1 m -141.5 154.76 67.06 Favored Pre-proline 0 N--CA 1.483 1.204 0 C-N-CA 125.166 1.387 . . . . 72.52 109.615 178.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -69.07 165.7 29.26 Favored 'Trans proline' 0 N--CA 1.502 1.994 0 C-N-CA 123.239 2.626 . . . . 50.12 113.328 178.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -73.68 14.23 0.39 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 113.855 1.057 . . . . 75.43 113.855 -172.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -135.74 19.97 3.3 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 108.954 -0.758 . . . . 71.2 108.954 175.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.36 121.96 15.56 Favored 'General case' 0 C--N 1.343 0.291 0 CA-C-N 115.095 -0.957 . . . . 74.14 110.137 178.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 39.9 p -76.88 171.13 15.25 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.554 -0.748 . . . . 75.03 110.166 175.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 15.9 mp0 -53.54 -28.98 34.57 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 124.399 1.08 . . . . 71.11 112.359 -177.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -71.95 -48.0 48.37 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.017 0.927 . . . . 72.43 110.869 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -63.88 -41.97 97.6 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 121.742 0.782 . . . . 71.14 110.493 178.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.663 HG23 HD11 ' A' ' 11' ' ' LEU . 74.9 mt -68.07 -32.07 54.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 114.093 -1.412 . . . . 73.31 111.174 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -70.53 -35.97 73.46 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.463 0.705 . . . . 75.22 110.907 175.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 45.9 mtm105 -61.94 -50.85 70.48 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 109.68 -0.489 . . . . 73.12 109.68 173.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.512 ' HB3' HG12 ' A' ' 13' ' ' VAL . . . -62.08 -37.66 85.88 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 114.891 -1.05 . . . . 72.43 111.764 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -60.26 -64.21 1.03 Allowed 'General case' 0 C--O 1.207 -1.142 0 CA-C-N 114.831 -1.077 . . . . 73.1 109.362 176.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -55.15 -30.5 59.97 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 124.167 0.917 . . . . 74.22 112.021 -177.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.461 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 50.2 ttp180 -59.46 -67.98 0.32 Allowed 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.567 -0.531 . . . . 75.52 109.567 172.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.612 ' HB3' HD12 ' A' ' 50' ' ' ILE . 91.8 mt -70.9 -14.34 62.35 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.171 0.588 . . . . 75.12 112.171 -175.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.631 ' HA ' ' HE1' ' A' ' 47' ' ' PHE . . . -82.96 -38.66 22.43 Favored 'General case' 0 C--O 1.206 -1.229 0 C-N-CA 123.695 0.798 . . . . 71.54 109.864 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.0 mtm180 -78.98 -33.41 45.11 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 122.497 0.319 . . . . 72.33 110.692 176.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' A' ' 28' ' ' ARG . 15.1 mm100 -67.46 -62.44 1.42 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 122.962 0.505 . . . . 73.31 110.44 177.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.448 ' HE2' HD21 ' A' ' 29' ' ' LEU . 21.7 m-85 -94.83 31.39 1.84 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.288 0.635 . . . . 72.41 110.941 -176.027 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -61.5 105.65 0.65 Allowed Pre-proline 0 N--CA 1.482 1.16 0 C-N-CA 123.877 0.871 . . . . 73.54 109.983 -178.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.65 -14.53 36.56 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.423 2.082 . . . . 75.51 111.444 -172.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -62.65 -37.48 86.53 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.399 1.08 . . . . 73.23 111.065 173.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 46.7 t -104.58 -51.64 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 CA-C-O 121.356 0.598 . . . . 73.25 109.862 -178.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -99.12 86.13 3.38 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.552 1.141 . . . . 64.12 110.72 -177.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.589 ' HB2' ' HZ3' ' A' ' 39' ' ' LYS . 10.4 mtmp? -85.78 61.06 6.61 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.352 0.596 . . . . 73.11 110.402 176.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 66.4 m -107.13 110.58 63.46 Favored Pre-proline 0 N--CA 1.476 0.845 0 CA-C-O 118.176 -0.916 . . . . 71.24 109.202 176.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.417 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 2.8 Cg_endo -38.07 -53.62 1.57 Allowed 'Trans proline' 0 C--N 1.393 2.911 0 C-N-CA 124.941 3.761 . . . . 73.53 114.151 -172.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -47.43 -52.9 15.54 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 124.657 1.183 . . . . 64.43 112.005 177.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.58 -24.89 63.75 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 114.599 -1.182 . . . . 73.42 111.244 -176.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -85.03 -36.46 21.24 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.753 0.821 . . . . 63.35 110.84 -175.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.417 ' HG2' ' O ' ' A' ' 41' ' ' PRO . 28.0 mm-40 -68.74 -47.73 65.53 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 108.854 -0.795 . . . . 62.44 108.854 177.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 49.4 mttp -65.87 -33.15 75.18 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 114.856 -1.065 . . . . 74.03 111.38 175.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.631 ' HE1' ' HA ' ' A' ' 30' ' ' ALA . 88.2 t80 -58.6 -44.64 89.94 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.051 0.54 . . . . 73.32 110.292 173.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.521 ' HB3' ' HE1' ' A' ' 93' ' ' PHE . 48.5 mtmt -62.45 -39.54 93.7 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.258 -0.428 . . . . 75.14 111.055 177.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -65.4 -28.7 69.44 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.044 0.45 . . . . 71.44 111.926 176.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.612 HD12 ' HB3' ' A' ' 29' ' ' LEU . 68.2 mt -73.86 -32.9 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.516 0.726 . . . . 74.43 109.834 173.088 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.416 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 25.9 m-80 -81.19 -14.7 57.3 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.541 0.736 . . . . 73.43 111.3 174.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -73.68 -55.56 6.11 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.82 1.248 . . . . 75.34 108.484 170.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.76 -51.47 65.6 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 113.448 -1.705 . . . . 65.45 110.707 175.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -60.82 -45.91 92.59 Favored 'General case' 0 C--O 1.21 -0.984 0 CA-C-N 114.936 -1.029 . . . . 73.53 110.649 177.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 51' ' ' ASN . . . -52.64 -52.58 54.93 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.355 0.662 . . . . 72.52 112.246 -177.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 97.3 t -61.11 -49.44 84.64 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 O-C-N 124.201 0.938 . . . . 74.52 109.782 178.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.54 ' HB3' HD13 ' A' ' 22' ' ' ILE . 69.5 mt -87.75 -6.82 58.0 Favored 'General case' 0 CA--C 1.56 1.335 0 N-CA-C 114.6 1.333 . . . . 74.35 114.6 -168.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.2 t -79.83 -32.63 40.65 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 123.268 0.627 . . . . 74.34 110.694 -177.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -100.55 129.43 27.78 Favored Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 108.296 -1.002 . . . . 74.34 108.296 -176.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.82 -40.18 86.33 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 123.297 2.665 . . . . 72.41 113.499 -172.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.415 ' O ' HG13 ' A' ' 65' ' ' ILE . 13.0 mp0 -64.77 -56.09 15.71 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.055 0.942 . . . . 72.3 110.067 -178.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.449 ' HA ' HD11 ' A' ' 65' ' ' ILE . 44.3 mtpt -65.11 -36.49 84.44 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.838 0.855 . . . . 74.54 111.65 -176.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 54.2 ttt180 -56.91 -49.98 73.93 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 124.051 0.844 . . . . 74.11 108.967 174.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -69.73 -25.27 63.76 Favored 'General case' 0 C--O 1.214 -0.814 0 CA-C-N 115.091 -0.959 . . . . 74.25 112.354 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.556 HG12 ' HG2' ' A' ' 76' ' ' PRO . 85.1 mt -61.14 -48.08 90.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 108.763 -0.828 . . . . 74.41 108.763 172.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -58.03 -58.26 9.22 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 115.414 -0.812 . . . . 75.4 110.774 173.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -58.13 -38.47 76.6 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.415 1.086 . . . . 64.04 112.381 -172.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 73.1 p -76.14 -33.1 59.4 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 118.935 -0.555 . . . . 75.44 110.459 178.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -63.46 120.71 12.2 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-N 118.535 0.607 . . . . 75.32 109.915 -176.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 107.61 5.61 33.79 Favored Glycine 0 CA--C 1.54 1.597 0 C-N-CA 123.443 0.544 . . . . 64.23 112.034 -166.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 91.4 m -146.53 -57.7 0.28 Allowed 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 104.583 -2.377 . . . . 71.23 104.583 175.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 96.4 m -79.14 149.14 32.11 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 105.277 -2.12 . . . . 74.23 105.277 155.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.58 -17.77 3.23 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 122.863 0.465 . . . . 74.04 111.942 -171.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -101.98 140.96 21.63 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 123.42 0.688 . . . . 75.1 109.666 177.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.13 126.85 13.53 Favored 'Trans proline' 0 C--N 1.374 1.884 0 C-N-CA 122.803 2.335 . . . . 75.41 112.322 177.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.556 ' HG2' HG12 ' A' ' 65' ' ' ILE . 71.4 Cg_exo -53.7 149.28 32.92 Favored 'Trans proline' 0 C--N 1.385 2.495 0 C-N-CA 123.751 2.967 . . . . 74.25 113.419 177.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -55.36 136.83 75.42 Favored 'Trans proline' 0 C--N 1.383 2.39 0 C-N-CA 122.941 2.427 . . . . 73.45 112.181 -176.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -61.27 126.02 18.34 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.907 2.404 . . . . 73.2 112.796 -178.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -58.09 157.95 23.41 Favored 'Trans proline' 0 C--N 1.382 2.328 0 C-N-CA 123.415 2.743 . . . . 71.05 113.038 173.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.534 ' HD2' ' HA3' ' A' ' 142' ' ' GLY . 79.8 Cg_exo -48.78 82.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.388 2.64 0 C-N-CA 124.648 3.565 . . . . 74.31 115.42 178.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 136.84 -39.55 1.62 Allowed Glycine 0 N--CA 1.467 0.766 0 N-CA-C 109.881 -1.287 . . . . 62.41 109.881 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 144.61 -176.89 23.5 Favored Glycine 0 C--N 1.344 0.982 0 C-N-CA 124.237 0.922 . . . . 53.03 110.969 176.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -58.79 98.47 0.04 OUTLIER 'General case' 0 C--O 1.243 0.738 0 N-CA-C 107.604 -1.258 . . . . 74.41 107.604 164.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -64.8 110.68 2.49 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.51 0.671 . . . . 71.31 109.307 -173.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -133.05 23.9 4.2 Favored 'General case' 0 C--O 1.259 1.567 0 C-N-CA 124.862 1.265 . . . . 73.24 108.664 -168.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.432 ' O ' ' HA2' ' A' ' 163' ' ' GLY . 73.4 m -58.5 146.28 36.0 Favored 'General case' 0 C--N 1.349 0.559 0 CA-C-N 113.986 -1.461 . . . . 74.44 112.279 -171.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.414 ' H ' ' HG2' ' A' ' 171' ' ' PRO . . . 79.73 -9.08 45.97 Favored Glycine 0 CA--C 1.536 1.382 0 CA-C-O 118.803 -0.998 . . . . 70.11 114.629 -176.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.419 ' HB3' ' HE2' ' A' ' 93' ' ' PHE . 51.8 m-85 -112.74 142.63 45.13 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 119.383 1.591 . . . . 72.34 112.575 -176.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -82.42 75.89 9.31 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 124.149 0.98 . . . . 71.44 111.126 -172.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.593 HG21 ' HE2' ' A' ' 97' ' ' PHE . 2.5 p -39.4 -48.55 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.62 0 C-N-CA 125.787 1.635 . . . . 75.21 113.904 176.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.17 -36.52 70.88 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 124.157 0.983 . . . . 75.33 112.195 -176.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -72.69 -31.7 65.23 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.949 -0.568 . . . . 61.35 110.902 -175.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.521 ' HE1' ' HB3' ' A' ' 48' ' ' LYS . 15.4 m-30 -80.05 174.71 11.32 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.905 -0.589 . . . . 73.34 111.939 -164.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.469 ' HB3' ' HE3' ' A' ' 5' ' ' LYS . 78.7 p -57.1 149.41 19.47 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.808 0.843 . . . . 74.5 113.129 -168.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.16 -39.61 72.59 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 114.839 -1.073 . . . . 74.52 110.084 168.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -54.49 -47.25 73.26 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.384 1.074 . . . . 75.03 110.896 176.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.593 ' HE2' HG21 ' A' ' 90' ' ' VAL . 44.3 t80 -59.42 -50.07 75.35 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 115.338 -0.847 . . . . 72.32 110.092 175.315 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -76.31 -2.18 30.36 Favored 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 112.403 0.52 . . . . 74.14 112.403 -175.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -93.94 -59.3 2.01 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.652 0.781 . . . . 70.02 110.191 169.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 33.4 tp -62.46 -46.18 89.68 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.979 0.912 . . . . 74.33 111.24 -176.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -92.75 -3.65 54.44 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.104 0.562 . . . . 72.11 111.477 177.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -46.35 -57.73 6.28 Favored Glycine 0 CA--C 1.544 1.87 0 CA-C-O 118.988 -0.895 . . . . 72.43 115.195 177.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -68.21 11.51 0.26 Allowed 'Trans proline' 0 C--N 1.382 2.317 0 C-N-CA 123.637 2.891 . . . . 64.43 114.635 -178.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -147.05 16.5 1.54 Allowed Glycine 0 C--N 1.348 1.228 0 CA-C-O 119.078 -0.845 . . . . 54.4 113.077 171.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 35.5 mt -66.65 79.81 0.11 Allowed 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 118.01 0.905 . . . . 74.25 111.61 174.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 38.55 -113.27 0.12 Allowed 'General case' 0 CA--C 1.56 1.34 0 C-N-CA 126.632 1.973 . . . . 74.45 115.813 172.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 70.31 0.49 29.96 Favored Glycine 0 C--N 1.368 2.311 0 N-CA-C 112.29 -0.324 . . . . 44.0 112.29 -162.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.355 1.604 0 C-N-CA 123.198 0.428 . . . . 71.34 113.284 -171.805 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? . . . . . 0 CA--C 1.55 0.974 0 N-CA-C 109.181 -0.674 . . . . 73.31 109.181 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.402 ' HA2' HH11 ' A' ' 117' ' ' ARG . . . -64.53 160.52 40.4 Favored Glycine 0 C--N 1.343 0.954 0 CA-C-O 121.664 0.591 . . . . 73.4 113.471 178.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.461 ' H ' ' HA3' ' A' ' 166' ' ' GLY . 2.7 mpt_? -102.87 165.43 11.05 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.424 1.09 . . . . 74.43 110.923 -168.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -76.44 115.75 16.48 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 106.698 -1.593 . . . . 74.23 106.698 163.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.53 HD13 ' HA2' ' A' ' 166' ' ' GLY . 3.6 tt -114.99 136.85 52.67 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 107.756 -1.201 . . . . 75.42 107.756 -174.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 29.8 ttt-85 -117.02 135.94 53.33 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 108.554 -0.906 . . . . 74.51 108.554 174.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.97 168.7 23.06 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 121.192 0.52 . . . . 54.41 111.407 -177.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -111.66 112.77 24.7 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.324 1.05 . . . . 72.42 109.439 -169.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 37.5 tp -100.92 96.2 5.39 Favored Pre-proline 0 CA--C 1.549 0.909 0 N-CA-C 108.796 -0.816 . . . . 74.14 108.796 -178.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -83.53 114.27 2.07 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 122.695 2.263 . . . . 75.33 110.61 -173.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.52 ' HB3' HD21 ' A' ' 180' ' ' LEU . 46.3 tp -117.41 141.55 48.19 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.152 0.501 . . . . 72.43 111.134 -169.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 24.0 m -69.41 142.05 53.96 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 114.908 -1.042 . . . . 71.34 110.277 173.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.577 HD13 ' HB2' ' A' ' 186' ' ' PHE . 84.5 mt -57.65 -46.53 84.1 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.245 0.618 . . . . 75.21 110.389 179.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -62.67 -37.51 86.7 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 115.071 -0.968 . . . . 75.32 110.519 -177.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -76.6 -21.4 55.63 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.256 0.622 . . . . 64.33 111.574 178.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -71.71 -40.9 69.18 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.023 0.529 . . . . 65.44 110.166 171.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -65.02 -42.43 94.38 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.477 1.111 . . . . 74.51 110.547 177.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 41.7 m170 -69.16 -48.3 62.66 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.384 -0.826 . . . . 75.25 111.273 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.465 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 71.3 -141.96 33.36 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 115.941 -0.572 . . . . 71.54 112.496 -175.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 71.97 -161.2 54.25 Favored Glycine 0 C--N 1.349 1.297 0 C-N-CA 122.987 0.327 . . . . 70.42 113.141 178.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.662 ' HB3' ' HB2' ' A' ' 146' ' ' SER . 26.2 mp0 -69.54 118.46 12.44 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 122.949 0.5 . . . . 73.14 110.146 178.354 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 11.1 tpp180 -101.21 118.91 37.92 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.794 -0.817 . . . . 75.05 108.794 176.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.513 ' HB ' HG23 ' B' ' 5' ' ' THR . 97.2 t -81.74 96.0 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 121.413 0.625 . . . . 75.04 109.465 -178.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.1 p -115.47 124.11 71.65 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-N 114.985 -1.007 . . . . 73.34 108.435 173.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 144' ' ' ARG . 32.1 mt-10 -85.13 115.11 22.73 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 114.792 -1.095 . . . . 71.3 110.246 178.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 33.9 m -122.58 127.65 75.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 124.226 1.011 . . . . 75.1 110.684 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 63.17 21.26 12.76 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.105 0.962 . . . . 74.24 112.575 177.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.534 ' HA3' ' HD2' ' A' ' 80' ' ' PRO . . . 90.2 -17.95 51.04 Favored Glycine 0 C--N 1.35 1.33 0 C-N-CA 122.689 0.185 . . . . 54.15 113.075 -175.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -87.83 118.64 27.49 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.201 1.001 . . . . 72.43 108.831 176.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.407 ' HA ' ' HA ' ' A' ' 139' ' ' GLU . 45.4 ttm105 -82.4 115.46 21.44 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.592 0.757 . . . . 74.41 109.05 178.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 14.7 p -125.47 149.54 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-O 121.4 0.619 . . . . 73.53 110.607 -177.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.662 ' HB2' ' HB3' ' A' ' 135' ' ' GLU . 35.9 p -107.55 93.27 4.45 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 124.382 1.073 . . . . 64.43 110.45 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 3.4 p -80.57 112.68 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 123.108 0.563 . . . . 73.42 109.564 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -67.02 95.28 0.38 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.658 0.742 . . . . 74.32 110.378 176.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.465 HG13 ' HA2' ' A' ' 133' ' ' GLY . 44.5 pt -78.15 140.58 61.63 Favored Pre-proline 0 CA--C 1.556 1.186 0 CA-C-N 114.42 -1.264 . . . . 74.52 108.713 170.047 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -66.31 138.48 51.19 Favored 'Trans proline' 0 C--N 1.373 1.833 0 C-N-CA 121.995 1.797 . . . . 74.22 112.187 176.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -63.82 92.63 0.17 Allowed 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 122.424 2.083 . . . . 74.15 110.749 171.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 123.4 27.35 1.49 Allowed Glycine 0 CA--C 1.526 0.736 0 CA-C-N 114.756 -1.111 . . . . 75.51 110.993 -171.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 5.7 p -73.67 137.45 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 123.294 0.637 . . . . 75.43 109.552 179.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.548 HH21 ' HG2' ' A' ' 241' ' ' PRO . 0.0 OUTLIER -112.36 154.61 25.47 Favored 'General case' 0 C--O 1.211 -0.941 0 CA-C-N 116.372 -0.376 . . . . 73.23 111.816 -163.704 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -54.0 124.26 15.02 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 124.049 0.843 . . . . 72.32 110.248 171.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.46 4.88 70.13 Favored Glycine 0 C--N 1.342 0.9 0 CA-C-O 119.159 -0.8 . . . . 74.33 113.747 -178.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 58.3 m -67.78 102.09 1.17 Allowed 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 118.157 0.979 . . . . 74.23 108.857 170.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 53.9 t -83.94 91.4 2.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 107.34 -1.356 . . . . 74.02 107.34 177.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.624 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 53.0 mt -71.99 85.12 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.801 0 N-CA-C 107.618 -1.253 . . . . 75.24 107.618 174.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -74.17 99.52 3.42 Favored 'General case' 0 C--N 1.353 0.76 0 N-CA-C 107.378 -1.342 . . . . 75.21 107.378 175.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.0 p -110.13 118.75 48.87 Favored Pre-proline 0 CA--C 1.548 0.903 0 CA-C-N 115.076 -0.966 . . . . 71.41 110.872 -169.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -79.06 125.3 6.45 Favored 'Trans proline' 0 C--N 1.369 1.626 0 C-N-CA 122.386 2.057 . . . . 74.53 106.841 160.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . 0.432 ' HA2' ' O ' ' A' ' 86' ' ' SER . . . 130.0 -23.75 4.63 Favored Glycine 0 N--CA 1.469 0.9 0 N-CA-C 111.303 -0.719 . . . . 70.43 111.303 -165.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -134.22 144.55 48.5 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 106.152 -1.795 . . . . 64.15 106.152 163.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -175.85 -160.95 24.27 Favored Glycine 0 CA--C 1.498 -0.993 0 N-CA-C 114.596 0.598 . . . . 73.33 114.596 171.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.53 ' HA2' HD13 ' A' ' 119' ' ' LEU . . . -57.79 135.64 51.56 Favored Glycine 0 C--N 1.356 1.691 0 O-C-N 124.476 0.75 . . . . 74.5 112.322 175.059 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -70.38 105.11 2.91 Favored 'General case' 0 CA--C 1.548 0.899 0 O-C-N 125.686 1.462 . . . . 75.42 110.105 -172.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -170.39 155.7 25.51 Favored Glycine 0 C--N 1.339 0.727 0 CA-C-O 118.887 -0.952 . . . . 64.21 111.253 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . 0.485 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . 7.3 t30 -64.74 -56.26 22.99 Favored Pre-proline 0 N--CA 1.488 1.438 0 CA-C-O 117.826 -1.083 . . . . 63.54 111.41 -170.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.485 ' HD3' ' HB3' ' A' ' 169' ' ' ASN . 1.7 Cg_endo -82.68 91.74 0.96 Allowed 'Trans proline' 0 C--N 1.388 2.649 0 N-CA-C 106.965 -1.975 . . . . 73.02 106.965 162.137 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.424 ' CG ' ' HA ' ' A' ' 86' ' ' SER . 56.0 Cg_endo -76.6 174.58 12.61 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 123.479 2.786 . . . . 71.25 117.232 -156.017 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -95.48 -158.86 32.73 Favored Glycine 0 C--N 1.363 2.05 0 CA-C-N 114.724 -1.125 . . . . 72.4 114.736 -177.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -133.52 146.08 50.73 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 125.386 1.474 . . . . 71.14 108.147 -177.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 41.8 tp -118.26 141.63 48.31 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 120.966 0.412 . . . . 74.2 112.015 -172.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 68.9 mt -97.2 91.67 5.65 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 124.268 1.027 . . . . 72.12 108.284 171.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.624 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 85.4 mt -74.28 85.61 1.93 Allowed 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.392 -0.966 . . . . 74.52 108.392 170.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 46.5 t -83.34 97.82 4.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 107.037 -1.468 . . . . 71.11 107.037 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 8.9 p -68.41 125.88 27.1 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 CA-C-N 115.558 -0.746 . . . . 74.13 110.144 -173.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 40.4 mmm-85 -116.94 97.61 6.04 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.497 1.119 . . . . 73.42 108.215 -176.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.52 HD21 ' HB3' ' A' ' 125' ' ' LEU . 45.3 mt -69.34 141.11 54.31 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 110.067 -0.346 . . . . 74.04 110.067 -179.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 79.6 mt -57.52 148.2 56.51 Favored Pre-proline 0 CA--C 1.549 0.929 0 O-C-N 124.066 0.854 . . . . 73.22 111.202 -177.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -77.43 48.19 2.49 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 123.084 2.523 . . . . 74.32 110.441 167.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -70.28 136.94 86.54 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 125.27 1.428 . . . . 73.35 109.051 -172.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -58.32 12.09 0.04 OUTLIER 'Trans proline' 0 C--N 1.381 2.253 0 C-N-CA 124.202 3.268 . . . . 61.24 118.127 -168.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 40.2 t -106.63 -55.2 5.61 Favored 'Isoleucine or valine' 0 C--N 1.352 0.702 0 CA-C-N 119.43 1.014 . . . . 72.34 109.181 172.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . 0.577 ' HB2' HD13 ' A' ' 127' ' ' LEU . 23.1 m-85 -134.49 147.11 50.3 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 115.061 -0.972 . . . . 72.31 111.681 -168.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -133.79 90.96 2.77 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 106.177 -1.786 . . . . 75.51 106.177 165.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.473 HD12 ' HG ' ' A' ' 193' ' ' LEU . 60.0 tp -71.47 161.33 31.21 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 124.48 1.112 . . . . 74.21 111.652 -177.129 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -154.28 107.54 2.89 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 122.905 0.482 . . . . 70.31 110.59 174.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 82.22 -53.37 4.76 Favored Glycine 0 C--N 1.36 1.861 0 C-N-CA 123.375 0.512 . . . . 65.41 114.216 174.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -178.97 -21.43 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 126.917 2.087 . . . . 72.32 107.789 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -85.31 120.37 26.72 Favored 'General case' 0 C--N 1.357 0.923 0 CA-C-N 114.405 -1.271 . . . . 72.32 109.509 -178.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.523 HD12 HD13 ' A' ' 249' ' ' LEU . 0.6 OUTLIER -89.97 142.7 27.46 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.06 0.944 . . . . 74.25 110.112 -170.23 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -119.3 145.18 46.35 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 107.878 -1.156 . . . . 73.14 107.878 166.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.434 ' HB2' HD21 ' A' ' 251' ' ' LEU . . . -144.63 175.84 9.85 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.609 1.164 . . . . 74.34 109.485 -171.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 2.9 m -118.41 139.84 50.77 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.643 -0.873 . . . . 70.21 108.643 172.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.566 HD22 HD11 ' A' ' 251' ' ' LEU . 34.5 tp -145.61 105.87 4.05 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 110.127 -0.323 . . . . 74.1 110.127 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -73.62 133.38 43.46 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 109.285 -0.635 . . . . 63.3 109.285 167.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 7.3 p -143.59 133.03 11.63 Favored Pre-proline 0 CA--C 1.548 0.879 0 N-CA-C 107.781 -1.192 . . . . 74.33 107.781 178.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.28 146.15 35.46 Favored 'Trans proline' 0 C--N 1.368 1.586 0 C-N-CA 121.313 1.342 . . . . 70.05 110.404 169.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.484 ' HB3' ' HH2' ' A' ' 269' ' ' TRP . . . -44.13 -52.0 17.16 Favored Pre-proline 0 CA--C 1.568 1.669 0 N-CA-C 115.644 1.72 . . . . 71.34 115.644 -173.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.423 ' HD3' ' HB3' ' A' ' 201' ' ' ALA . 50.5 Cg_exo -60.07 -38.55 76.86 Favored 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 121.809 1.673 . . . . 73.32 113.845 -179.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 46.3 mt -70.17 -29.4 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 110.016 -0.364 . . . . 71.02 110.016 179.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.18 -48.83 61.1 Favored 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 123.069 0.548 . . . . 74.14 111.941 172.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 201' ' ' ALA . 93.4 t -65.54 -43.04 94.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 C-N-CA 123.837 0.855 . . . . 64.22 111.859 -175.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.496 HG21 ' HB3' ' C' ' 273' ' ' ALA . 70.4 t -92.55 -34.68 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.594 0.757 . . . . 74.41 111.458 -173.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 88.09 89.21 1.12 Allowed Glycine 0 C--N 1.341 0.845 0 N-CA-C 111.319 -0.712 . . . . 72.35 111.319 -175.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -107.4 -139.28 9.1 Favored Glycine 0 C--N 1.34 0.798 0 CA-C-O 120.277 -0.18 . . . . 73.32 112.67 -177.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -130.85 128.21 40.16 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.175 0.99 . . . . 73.34 108.917 177.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 29.3 m -129.83 159.24 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 109.038 -0.727 . . . . 63.11 109.038 175.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 55.2 ttm-85 -93.93 107.24 19.16 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 109.494 -0.558 . . . . 74.32 109.494 178.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -102.25 124.35 47.69 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 124.111 0.964 . . . . 74.41 109.436 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' MET . . . . . 0.421 ' HA ' ' HA ' ' A' ' 218' ' ' PRO . 1.0 OUTLIER -75.08 126.08 30.27 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.202 0.601 . . . . 74.15 109.747 175.922 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 72.7 p -116.1 -178.01 3.3 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 123.876 0.87 . . . . 74.1 108.726 173.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . 0.418 ' HG ' ' HE2' ' A' ' 186' ' ' PHE . 63.8 mt -77.01 -7.6 55.93 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 122.778 0.431 . . . . 73.14 110.727 174.521 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -99.98 -19.66 16.46 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.225 1.01 . . . . 64.44 110.553 176.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 139.53 172.84 12.86 Favored Glycine 0 C--N 1.353 1.504 0 CA-C-O 119.858 -0.412 . . . . 63.05 113.451 175.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . 0.421 ' HA ' ' HA ' ' A' ' 213' ' ' MET . 4.0 Cg_exo -75.9 99.32 1.27 Allowed 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 122.93 2.42 . . . . 74.13 111.285 178.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 32.5 m -103.2 159.34 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.208 1.003 . . . . 73.4 110.619 -174.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -93.8 105.07 17.12 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.152 -0.684 . . . . 75.04 109.152 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 8.7 p -101.64 137.52 29.09 Favored 'Isoleucine or valine' 0 C--O 1.253 1.273 0 C-N-CA 123.832 0.853 . . . . 74.51 110.021 -174.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -86.42 102.75 14.34 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.784 0.834 . . . . 70.4 110.744 -178.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 48.8 t -63.48 137.76 97.17 Favored Pre-proline 0 CA--C 1.56 1.353 0 C-N-CA 124.458 1.103 . . . . 71.22 110.304 179.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -79.98 164.01 22.76 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 122.673 2.249 . . . . 75.51 110.612 174.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.99 152.4 46.11 Favored 'Trans proline' 0 C--N 1.369 1.63 0 C-N-CA 121.786 1.657 . . . . 72.53 112.814 178.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . 0.56 HH12 ' HG ' ' C' ' 261' ' ' LEU . 63.5 mtt-85 67.54 26.06 8.22 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 125.533 1.533 . . . . 75.13 111.873 172.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.472 HG23 HD21 ' A' ' 233' ' ' LEU . 10.5 m -61.17 104.01 0.34 Allowed 'General case' 0 CA--C 1.559 1.323 0 C-N-CA 125.699 1.6 . . . . 64.32 111.026 175.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . 0.565 ' HB3' ' HD2' ' A' ' 231' ' ' ARG . 4.8 tp-100 -97.38 143.89 27.67 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.085 0.954 . . . . 75.32 111.263 -173.252 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -63.57 150.91 42.94 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.588 0.755 . . . . 65.12 112.462 -177.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 83.71 -28.27 4.03 Favored Glycine 0 C--N 1.349 1.271 0 O-C-N 123.684 0.615 . . . . 75.54 112.523 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.565 ' HD2' ' HB3' ' A' ' 228' ' ' GLN . 76.6 mtt180 -77.63 167.11 22.12 Favored 'General case' 0 C--N 1.347 0.492 0 C-N-CA 123.971 0.908 . . . . 74.44 110.469 178.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.449 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 12.5 mptt -121.82 120.55 34.89 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 115.067 -0.97 . . . . 72.22 108.571 -178.078 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.472 HD21 HG23 ' A' ' 227' ' ' THR . 81.8 mt -74.59 110.3 8.77 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 108.595 -0.891 . . . . 71.4 108.595 177.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . 0.545 ' HG3' ' HB3' ' A' ' 248' ' ' ASP . 39.9 ttp180 -87.63 100.77 13.05 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 122.622 0.369 . . . . 73.41 110.121 178.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.492 HD12 ' HG3' ' A' ' 238' ' ' LYS . 0.2 OUTLIER -100.84 106.84 18.25 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 106.466 -1.679 . . . . 74.24 106.466 170.662 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -76.18 143.95 40.81 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 115.045 -0.979 . . . . 71.01 111.708 -169.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 71.35 32.62 64.97 Favored Glycine 0 C--N 1.348 1.2 0 O-C-N 123.704 0.627 . . . . 74.2 112.536 -178.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.492 ' HG3' HD12 ' A' ' 235' ' ' LEU . 43.9 mmtm -125.32 -17.18 5.71 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.985 0.914 . . . . 74.1 110.453 178.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . 0.511 ' HA2' HD13 ' A' ' 193' ' ' LEU . . . -79.6 -151.86 6.85 Favored Glycine 0 C--N 1.353 1.474 0 CA-C-N 116.298 -0.41 . . . . 74.43 112.655 176.354 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -96.72 146.06 30.65 Favored Pre-proline 0 N--CA 1.482 1.169 0 C-N-CA 122.882 0.473 . . . . 73.41 109.857 -179.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.719 ' HA ' ' HA ' ' A' ' 246' ' ' ARG . 33.1 Cg_endo -61.27 167.26 9.66 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 123.203 2.602 . . . . 73.33 114.195 -175.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -175.2 -176.35 43.4 Favored Glycine 0 CA--C 1.535 1.335 0 CA-C-N 115.213 -0.903 . . . . 73.52 112.18 177.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -62.44 -19.31 67.05 Favored 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 123.68 2.92 . . . . 72.5 113.961 -175.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -102.53 22.52 13.4 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 124.027 0.931 . . . . 70.11 110.855 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 90.18 -164.38 30.9 Favored Glycine 0 C--N 1.35 1.338 0 N-CA-C 111.471 -0.651 . . . . 62.24 111.471 -174.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.719 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 25.1 ttm180 -73.08 139.37 46.45 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 117.664 0.732 . . . . 75.41 110.383 177.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -70.06 179.11 28.58 Favored Glycine 0 C--N 1.34 0.775 0 CA-C-N 115.709 -0.678 . . . . 70.31 113.379 -176.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . 0.545 ' HB3' ' HG3' ' A' ' 234' ' ' ARG . 55.7 m-20 -106.12 140.57 38.89 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.52 0.728 . . . . 75.44 109.493 -173.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.523 HD13 HD12 ' A' ' 193' ' ' LEU . 34.4 tp -97.61 120.0 37.19 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.349 -0.982 . . . . 73.32 108.349 178.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.449 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 2.9 m-85 -100.93 106.18 17.49 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.363 1.065 . . . . 71.3 108.66 177.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.566 HD11 HD22 ' A' ' 197' ' ' LEU . 47.1 mt -87.03 121.45 29.51 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.392 0.677 . . . . 74.54 109.659 177.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . 0.446 ' HG2' ' HE3' ' A' ' 232' ' ' LYS . 2.8 tm-20 -74.38 107.3 6.45 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 107.45 -1.315 . . . . 75.41 107.45 -178.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.489 HG13 HG13 ' A' ' 255' ' ' ILE . 42.6 t -67.36 99.67 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.687 0 O-C-N 124.117 0.886 . . . . 71.34 110.223 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.25 92.16 4.39 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 107.181 -1.414 . . . . 73.14 107.181 177.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.489 HG13 HG13 ' A' ' 253' ' ' VAL . 70.2 mt -83.8 130.95 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-O 120.779 0.323 . . . . 74.34 110.583 -177.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 51.8 p -128.99 169.38 14.75 Favored 'General case' 0 C--O 1.253 1.265 0 C-N-CA 123.942 0.897 . . . . 74.52 109.585 172.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . 0.545 HD12 HG22 ' C' ' 205' ' ' VAL . 2.1 pp -119.14 155.95 52.91 Favored Pre-proline 0 CA--C 1.564 1.513 0 N-CA-C 108.121 -1.066 . . . . 73.4 108.121 173.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 258' ' ' PRO . . . . . 0.624 ' HG3' ' HH ' ' C' ' 276' ' ' TYR . 42.8 Cg_endo -76.27 9.21 2.56 Favored 'Trans proline' 0 N--CA 1.512 2.564 0 C-N-CA 123.027 2.485 . . . . 74.45 115.328 -162.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 56.72 -90.72 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 123.858 0.863 . . . . 75.12 109.925 -164.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 260' ' ' ARG . . . . . 0.448 HH22 HG21 ' A' ' 262' ' ' THR . 0.0 OUTLIER -74.33 144.32 44.53 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.589 0.756 . . . . 75.12 111.521 -175.029 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.435 HD11 HG11 ' C' ' 205' ' ' VAL . 49.5 mt -123.41 178.67 5.05 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.046 0.938 . . . . 72.32 111.165 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 262' ' ' THR . . . . . 0.448 HG21 HH22 ' A' ' 260' ' ' ARG . 1.2 p -128.16 143.88 49.61 Favored Pre-proline 0 CA--C 1.556 1.181 0 CA-C-N 114.007 -1.451 . . . . 74.31 108.43 176.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -28.26 -53.91 0.14 Allowed 'Trans proline' 0 C--N 1.39 2.757 1 C-N-CA 126.166 4.577 . . . . 74.33 117.734 -167.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -70.25 -47.52 60.98 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 122.589 0.356 . . . . 71.44 110.68 -174.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -64.51 -29.22 70.26 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.284 1.034 . . . . 73.22 110.319 178.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 266' ' ' GLU . . . . . 0.425 ' HA ' HD12 ' A' ' 261' ' ' LEU . 8.1 tp10 -62.76 -50.53 70.69 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.736 0.814 . . . . 73.45 109.047 175.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -62.76 -37.13 85.4 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 114.991 -1.004 . . . . 64.12 112.097 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . 0.491 HD21 ' HB3' ' C' ' 271' ' ' LYS . 6.7 mp -64.73 -56.05 16.08 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.704 0.802 . . . . 73.14 111.396 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 269' ' ' TRP . . . . . 0.484 ' HH2' ' HB3' ' A' ' 201' ' ' ALA . 68.1 m95 -58.62 -41.73 86.57 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.431 0.693 . . . . 75.0 111.279 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -60.25 -58.54 8.07 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 123.828 0.705 . . . . 73.12 111.516 178.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 30.8 mmtm -66.34 -33.64 76.18 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 112.418 0.525 . . . . 70.22 112.418 -175.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 13.7 mt -54.25 -53.54 52.3 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 109.224 -0.658 . . . . 71.54 109.224 169.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . 0.487 ' HA ' ' HB2' ' C' ' 202' ' ' PRO . . . -67.41 -37.84 83.68 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.671 1.188 . . . . 72.23 113.664 -172.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -67.81 -53.81 24.08 Favored 'General case' 0 C--O 1.243 0.733 0 C-N-CA 123.956 0.902 . . . . 74.35 109.398 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -66.29 -30.41 70.82 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 115.538 -0.755 . . . . 72.24 111.145 178.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -68.57 -44.65 74.0 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.474 0.71 . . . . 75.02 109.945 178.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 277' ' ' TYR . . . . . 0.437 ' HA ' ' HB2' ' A' ' 280' ' ' ALA . 70.3 t80 -65.12 -37.53 87.75 Favored 'General case' 0 C--O 1.242 0.674 0 O-C-N 124.06 0.85 . . . . 72.14 110.245 -178.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -57.79 -23.83 54.3 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 115.571 -0.74 . . . . 75.41 111.683 173.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 67.7 mtm-85 -102.89 -15.76 16.08 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 124.026 0.93 . . . . 75.15 111.398 176.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . 0.437 ' HB2' ' HA ' ' A' ' 277' ' ' TYR . . . . . . . . 0 C--O 1.259 1.561 0 C-N-CA 123.851 0.86 . . . . 72.5 110.275 -176.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 62.9 mtm . . . . . 0 N--CA 1.482 1.148 0 N-CA-C 109.25 -0.648 . . . . 74.12 109.25 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 61.93 -158.23 0.33 Allowed 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.766 0.826 . . . . 62.45 109.777 -177.221 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -90.47 67.5 6.58 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 108.108 -1.071 . . . . 74.04 108.108 169.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 21.8 p -69.94 97.57 1.15 Allowed 'General case' 0 C--O 1.244 0.776 0 CA-C-N 115.53 -0.759 . . . . 52.14 110.543 -177.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 5' ' ' THR . . . . . 0.513 HG23 ' HB ' ' A' ' 137' ' ' VAL . 0.0 OUTLIER -97.07 166.17 11.72 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.475 -0.784 . . . . 74.34 111.71 -174.59 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 19.7 pt -133.78 166.57 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 115.248 -0.887 . . . . 65.34 112.385 -157.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -128.59 155.31 45.15 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.878 1.271 . . . . 72.22 108.625 173.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 45.7 tp -89.36 -98.55 0.1 Allowed 'General case' 0 CA--C 1.55 0.961 0 CA-C-O 119.131 -0.461 . . . . 75.22 110.574 -173.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . 166.31 -55.0 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 125.126 1.371 . . . . 73.12 109.065 -173.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 93.0 mt 57.95 91.29 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.983 1.313 . . . . 74.1 110.459 -168.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 78.7 mt . . . . . 0 CA--C 1.546 0.792 0 C-N-CA 123.526 0.73 . . . . 72.11 109.434 -177.069 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.89 0 N-CA-C 108.46 -0.941 . . . . 74.35 108.46 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 180' ' ' ALA . . . . . 0.542 ' HB1' HG21 ' C' ' 137' ' ' VAL . . . -170.03 -76.97 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.197 1.399 . . . . 75.32 107.553 177.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 181' ' ' LEU . . . . . 0.653 HD22 ' HB2' ' C' ' 136' ' ' ARG . 33.9 tp -132.46 -58.01 0.94 Allowed 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 107.518 -1.289 . . . . 74.44 107.518 163.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 182' ' ' VAL . . . . . 0.43 HG11 HG11 ' C' ' 138' ' ' VAL . 11.5 p -74.04 160.51 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-N 114.883 -1.053 . . . . 72.43 110.812 178.163 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -90.33 22.75 3.21 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.888 0.875 . . . . 65.24 111.305 173.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 77.1 t60 64.98 -83.65 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.138 1.375 . . . . 75.32 107.885 -166.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 185' ' ' VAL . . . . . 0.446 HG22 ' HA ' ' C' ' 121' ' ' ALA . 1.7 p . . . . . 0 N--CA 1.475 0.813 0 C-N-CA 123.921 0.888 . . . . 74.01 109.002 168.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 238' ' ' THR . . . . . 0.467 ' HB ' ' HA ' ' C' ' 219' ' ' VAL . 6.3 m . . . . . 0 CA--C 1.555 1.159 0 CA-C-O 120.599 0.238 . . . . 71.31 110.826 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 239' ' ' ALA . . . . . 0.447 ' HB2' ' HA ' ' C' ' 221' ' ' VAL . . . -77.14 172.95 12.42 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.867 1.062 . . . . 74.42 113.867 -167.125 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 240' ' ' GLY . . . . . 0.405 ' H ' HD21 ' C' ' 235' ' ' LEU . . . -113.05 -101.3 2.5 Favored Glycine 0 C--N 1.339 0.723 0 CA-C-N 114.015 -1.448 . . . . 71.23 109.634 177.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -157.51 162.16 38.84 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.588 0.709 . . . . 71.23 111.562 -175.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 242' ' ' TRP . . . . . 0.548 ' HH2' HG21 ' C' ' 199' ' ' VAL . 5.4 m95 -107.04 -47.36 3.71 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 114.106 -1.406 . . . . 70.32 107.478 172.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 177.69 -35.78 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 111.532 -2.576 . . . . 74.22 105.504 -166.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -156.5 -176.0 28.1 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 113.487 -1.688 . . . . 71.54 109.459 166.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.476 0.874 0 C-N-CA 123.661 0.784 . . . . 75.34 110.303 175.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.701 0 N-CA-C 109.56 -0.533 . . . . 71.34 109.56 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -40.5 95.67 0.01 OUTLIER 'General case' 0 C--N 1.359 0.99 0 C-N-CA 125.564 1.546 . . . . 70.52 114.045 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -87.72 124.52 33.67 Favored 'General case' 0 C--O 1.247 0.942 0 N-CA-C 108.899 -0.778 . . . . 72.32 108.899 170.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -75.84 112.88 12.7 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.629 -0.878 . . . . 65.15 108.629 175.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 7' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -64.47 -26.16 68.32 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.713 0.805 . . . . 73.43 112.711 -171.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -70.89 -45.07 65.0 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 109.319 -0.623 . . . . 74.23 109.319 178.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.57 -36.91 84.16 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.973 -1.012 . . . . 63.34 110.762 176.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 56.6 mt -59.46 -46.57 92.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 122.908 0.483 . . . . 73.31 110.06 174.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 11' ' ' LEU . . . . . 0.595 ' HB3' ' HB1' ' C' ' 25' ' ' ALA . 56.6 mt -71.39 -6.73 42.36 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 112.639 0.607 . . . . 75.53 112.639 176.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.84 21.09 79.66 Favored Glycine 0 C--N 1.355 1.629 0 C-N-CA 122.812 0.244 . . . . 74.43 113.62 178.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 31.3 m -113.98 161.51 27.57 Favored Pre-proline 0 N--CA 1.477 0.885 0 C-N-CA 124.111 0.964 . . . . 71.34 110.259 -177.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -54.89 148.52 46.32 Favored 'Trans proline' 0 C--N 1.382 2.294 0 C-N-CA 122.617 2.211 . . . . 74.43 113.05 174.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 68.4 mtm180 -76.94 19.9 0.28 Allowed 'General case' 0 CA--C 1.559 1.296 0 C-N-CA 123.757 0.823 . . . . 74.35 112.969 -172.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -136.97 8.17 2.97 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 125.076 1.35 . . . . 71.24 109.344 179.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.07 141.13 58.84 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.851 0.86 . . . . 75.2 112.242 -174.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 47.7 p -93.24 176.44 6.4 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.276 1.03 . . . . 74.41 112.335 -174.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -53.41 -36.34 61.39 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 125.288 1.435 . . . . 74.45 112.585 -175.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -57.95 -47.98 81.31 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.55 1.14 . . . . 74.53 111.405 175.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -76.89 -29.98 56.0 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.042 -1.436 . . . . 73.42 111.194 -174.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 22' ' ' ILE . . . . . 0.425 HG12 ' HB3' ' C' ' 57' ' ' LEU . 1.7 mp -72.28 -34.11 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 C-N-CA 124.119 0.968 . . . . 75.54 110.058 175.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 23' ' ' LYS . . . . . 0.524 ' HD3' ' NH2' ' C' ' 148' ' ' ARG . 34.1 ttpt -61.5 -50.64 71.9 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.694 0.798 . . . . 74.13 109.973 173.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 50.1 mtm180 -75.5 -20.23 58.89 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 115.582 -0.736 . . . . 73.52 112.423 -178.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . 0.595 ' HB1' ' HB3' ' C' ' 11' ' ' LEU . . . -74.23 -38.75 63.45 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.098 0.559 . . . . 75.32 110.238 172.364 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 26' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -63.8 -43.69 95.57 Favored 'General case' 0 C--O 1.216 -0.7 0 CA-C-N 114.846 -1.07 . . . . 72.31 109.524 174.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -55.48 -55.14 35.21 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.886 0.474 . . . . 75.33 109.994 175.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -46.5 -62.39 1.39 Allowed 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.047 1.339 . . . . 75.55 111.956 -179.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 62.7 mt -74.46 -38.83 62.85 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.385 -0.825 . . . . 71.43 112.168 -173.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.01 2.96 32.25 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 122.573 0.349 . . . . 75.32 111.742 -178.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -95.94 -44.99 7.12 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 108.944 -0.761 . . . . 73.5 108.944 163.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 21.3 tp60 -67.65 -55.86 11.63 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 123.501 0.5 . . . . 71.12 112.216 -176.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 33' ' ' TYR . . . . . 0.471 ' HD2' HD11 ' C' ' 50' ' ' ILE . 11.1 m-85 -95.66 25.5 4.54 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.699 0.8 . . . . 72.14 110.942 -178.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 34' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 -64.9 114.86 16.44 Favored Pre-proline 0 CA--C 1.546 0.813 0 CA-C-O 118.251 -0.881 . . . . 74.34 109.691 -177.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -55.62 -16.14 14.02 Favored 'Trans proline' 0 C--N 1.38 2.211 0 C-N-CA 123.216 2.611 . . . . 72.22 114.314 -177.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -67.75 -53.26 28.79 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.486 0.714 . . . . 60.34 110.391 169.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 77.1 t -77.07 -50.67 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.801 0.84 . . . . 75.33 110.508 -173.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -114.26 86.58 2.45 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.775 1.23 . . . . 65.41 109.011 -178.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -75.96 77.21 2.84 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 116.056 -0.52 . . . . 71.22 109.786 178.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 22.5 m -135.37 121.06 14.01 Favored Pre-proline 0 N--CA 1.471 0.608 0 CA-C-O 118.284 -0.865 . . . . 74.14 109.278 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -47.99 -37.16 29.22 Favored 'Trans proline' 0 C--N 1.384 2.443 0 C-N-CA 123.346 2.697 . . . . 75.0 112.694 174.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -59.94 -41.84 92.69 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.16 0.984 . . . . 71.01 110.246 177.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.7 -17.98 61.06 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 116.2 -0.455 . . . . 71.45 110.521 177.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 44' ' ' GLU . . . . . 0.539 ' HA ' ' HB3' ' C' ' 47' ' ' PHE . 50.1 mt-10 -86.22 -14.88 42.6 Favored 'General case' 0 C--N 1.358 0.953 0 C-N-CA 123.045 0.538 . . . . 74.04 110.371 177.137 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 45' ' ' GLU . . . . . 0.425 ' O ' ' HB2' ' C' ' 48' ' ' LYS . 32.6 mt-10 -82.72 -38.29 23.52 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.924 -0.769 . . . . 75.44 108.924 169.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 46' ' ' LYS . . . . . 0.5 ' O ' HG13 ' C' ' 50' ' ' ILE . 59.0 mttp -64.13 -32.04 73.46 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.597 -0.729 . . . . 72.32 110.115 166.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 47' ' ' PHE . . . . . 0.539 ' HB3' ' HA ' ' C' ' 44' ' ' GLU . 46.3 t80 -78.29 -21.98 48.91 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.582 0.753 . . . . 71.12 110.533 177.141 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 48' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' C' ' 45' ' ' GLU . 50.6 mttp -60.35 -53.13 61.29 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 107.961 -1.125 . . . . 72.04 107.961 164.033 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -56.81 -40.19 75.53 Favored 'General case' 0 CA--C 1.55 0.954 0 O-C-N 124.447 1.092 . . . . 72.33 112.132 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 50' ' ' ILE . . . . . 0.5 HG13 ' O ' ' C' ' 46' ' ' LYS . 69.9 mt -62.75 -55.13 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 C-N-CA 123.312 0.645 . . . . 75.43 110.082 176.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 51' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -71.67 -20.91 61.87 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 114.823 -1.08 . . . . 74.04 112.174 -173.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -79.52 -54.29 6.05 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.279 1.032 . . . . 75.54 108.548 178.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.71 -33.74 72.0 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 114.125 -1.398 . . . . 63.1 111.732 176.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -81.66 -33.74 31.13 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 119.138 -0.458 . . . . 75.01 110.452 177.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 55' ' ' ALA . . . . . 0.434 ' HB1' ' HD2' ' C' ' 85' ' ' PHE . . . -56.6 -35.33 68.12 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 118.023 0.374 . . . . 60.54 110.535 174.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 56' ' ' VAL . . . . . 0.447 ' O ' ' HB2' ' C' ' 62' ' ' LYS . 46.2 t -81.02 -62.2 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 CA-C-N 115.559 -0.746 . . . . 72.43 110.986 176.087 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 57' ' ' LEU . . . . . 0.425 ' HB3' HG12 ' C' ' 22' ' ' ILE . 39.4 mt -79.84 -7.88 58.96 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 114.169 1.174 . . . . 75.02 114.169 -164.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 32.6 t -59.92 -51.9 67.69 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.335 0.588 . . . . 75.33 110.433 178.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.86 126.39 80.14 Favored Pre-proline 0 C--O 1.246 0.891 0 CA-C-N 114.787 -1.097 . . . . 72.03 108.805 172.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 60' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -59.12 -23.77 70.61 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.095 1.863 . . . . 73.21 111.231 168.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -64.8 -54.74 26.49 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 124.568 1.147 . . . . 62.13 110.905 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 62' ' ' LYS . . . . . 0.447 ' HB2' ' O ' ' C' ' 56' ' ' VAL . 70.3 mttt -69.77 -30.85 68.51 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 115.873 -0.603 . . . . 75.43 110.804 178.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 1.3 ttp180 -57.91 -43.6 86.3 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.62 -0.882 . . . . 74.14 108.62 175.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -72.13 -28.4 63.24 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 115.053 -0.976 . . . . 74.15 112.32 177.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 65' ' ' ILE . . . . . 0.466 HD12 ' HE1' ' C' ' 83' ' ' TYR . 78.6 mt -59.82 -44.54 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 109.878 -0.416 . . . . 71.5 109.878 170.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -67.58 -42.65 82.2 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 116.169 -0.469 . . . . 74.31 110.207 176.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -58.91 -39.96 83.06 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.329 0.652 . . . . 73.14 111.423 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 71.6 p -77.1 -19.33 57.13 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 122.948 0.499 . . . . 74.43 110.983 177.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -74.08 114.29 12.23 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 108.517 -0.92 . . . . 75.22 108.517 170.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 112.26 11.92 14.69 Favored Glycine 0 N--CA 1.472 1.084 0 N-CA-C 111.699 -0.561 . . . . 62.51 111.699 -166.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 95.2 m -144.38 -50.39 0.29 Allowed 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 105.05 -2.204 . . . . 72.34 105.05 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 33.1 m -93.8 137.3 33.19 Favored 'General case' 0 C--O 1.249 1.078 0 N-CA-C 103.527 -2.768 . . . . 73.35 103.527 156.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.06 -31.75 13.44 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 118.384 0.538 . . . . 73.23 110.687 177.191 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.94 140.91 74.39 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 123.582 0.753 . . . . 53.23 109.968 176.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -53.03 115.87 2.56 Favored 'Trans proline' 0 C--N 1.376 2.016 0 C-N-CA 123.173 2.582 . . . . 75.14 112.306 176.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -53.44 148.9 32.18 Favored 'Trans proline' 0 C--N 1.391 2.772 0 C-N-CA 123.911 3.074 . . . . 71.22 113.276 -178.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -50.87 118.62 4.37 Favored 'Trans proline' 0 C--N 1.389 2.663 0 C-N-CA 123.24 2.627 . . . . 74.4 113.521 -178.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 78' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.11 139.48 80.31 Favored 'Trans proline' 0 C--N 1.386 2.511 0 C-N-CA 123.343 2.695 . . . . 74.44 112.943 -178.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.58 158.02 17.31 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 123.078 2.519 . . . . 70.12 112.591 177.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -74.91 42.48 0.84 Allowed 'Trans proline' 0 C--N 1.382 2.312 0 C-N-CA 123.678 2.918 . . . . 74.31 112.735 174.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -159.46 16.86 0.23 Allowed Glycine 0 CA--C 1.529 0.951 0 N-CA-C 108.585 -1.806 . . . . 75.2 108.585 177.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 67.6 -171.93 32.86 Favored Glycine 0 C--N 1.365 2.179 0 C-N-CA 124.439 1.019 . . . . 75.13 111.959 -175.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 83' ' ' TYR . . . . . 0.466 ' HE1' HD12 ' C' ' 65' ' ' ILE . 58.8 m-85 -83.58 98.15 9.44 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 105.991 -1.855 . . . . 73.4 105.991 162.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 84' ' ' ASP . . . . . 0.478 ' OD1' ' HA3' ' C' ' 163' ' ' GLY . 0.3 OUTLIER -56.32 137.18 52.88 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 112.015 0.376 . . . . 75.11 112.015 -175.114 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' C' C ' 85' ' ' PHE . . . . . 0.458 ' HB3' ' HB2' ' C' ' 88' ' ' PHE . 30.7 m-85 -133.06 73.1 1.5 Allowed 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.523 1.129 . . . . 74.41 108.325 177.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 50.4 m -51.64 85.72 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 124.308 1.043 . . . . 52.42 112.345 178.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 65.61 19.11 66.7 Favored Glycine 0 CA--C 1.534 1.273 0 CA-C-N 115.566 -0.743 . . . . 74.34 113.672 -175.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 88' ' ' PHE . . . . . 0.458 ' HB2' ' HB3' ' C' ' 85' ' ' PHE . 23.0 m-85 -101.81 118.55 37.16 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 109.411 -0.588 . . . . 74.44 109.411 -176.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -75.74 90.23 2.86 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.216 0.531 . . . . 72.23 109.686 -178.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 90' ' ' VAL . . . . . . . . . . . . . 1.6 p -41.12 -47.99 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 CA-C-N 113.96 -1.473 . . . . 54.42 113.326 171.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -68.78 -19.32 64.31 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.275 0.63 . . . . 75.25 111.635 -175.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -93.06 -2.89 55.16 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.354 0.662 . . . . 75.53 111.583 -178.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -95.21 174.77 6.89 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 122.714 0.405 . . . . 72.45 111.803 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 90.0 p -66.23 167.15 10.71 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 114.643 1.349 . . . . 52.11 114.643 -168.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 95' ' ' GLU . . . . . 0.409 ' O ' ' HG3' ' C' ' 99' ' ' GLU . 0.0 OUTLIER -59.49 -50.89 72.19 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 114.962 -1.017 . . . . 72.35 112.026 178.744 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -57.13 -46.44 82.66 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.608 0.763 . . . . 74.24 110.502 -176.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 97' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -54.64 -52.29 62.77 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 114.756 -1.111 . . . . 64.25 110.634 175.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 98' ' ' GLN . . . . . 0.517 ' HA ' HD22 ' C' ' 105' ' ' LEU . 98.0 mt-30 -69.0 -18.29 64.03 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.617 -0.719 . . . . 71.33 112.558 -175.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 99' ' ' GLU . . . . . 0.409 ' HG3' ' O ' ' C' ' 95' ' ' GLU . 44.3 mt-10 -86.65 -52.42 5.55 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.729 0.411 . . . . 74.43 111.087 176.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 54.5 tp -62.09 -39.58 92.94 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.528 0.731 . . . . 73.23 111.012 -178.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -96.57 7.49 46.41 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.987 -0.551 . . . . 75.04 110.839 178.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 102' ' ' GLY . . . . . 0.494 ' HA2' ' HG ' ' C' ' 105' ' ' LEU . . . -43.38 -62.34 2.49 Favored Glycine 0 C--N 1.356 1.672 0 C-N-CA 124.906 1.241 . . . . 74.41 114.916 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -49.6 -21.22 5.07 Favored 'Trans proline' 0 C--N 1.384 2.431 0 C-N-CA 123.985 3.123 . . . . 64.35 115.105 -177.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -146.97 41.26 0.97 Allowed Glycine 0 C--N 1.36 1.909 0 CA-C-O 119.576 -0.569 . . . . 73.42 112.823 178.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 105' ' ' LEU . . . . . 0.517 HD22 ' HA ' ' C' ' 98' ' ' GLN . 13.2 mt . . . . . 0 N--CA 1.511 2.59 0 N-CA-C 115.717 1.747 . . . . 75.43 115.717 177.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.732 0 CA-C-O 120.09 -0.283 . . . . 54.4 112.901 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 4.6 ppt_? -116.51 137.25 52.32 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.714 -0.847 . . . . 74.32 108.714 167.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 118' ' ' ASP . . . . . 0.871 ' HA ' ' HA2' ' C' ' 166' ' ' GLY . 8.7 p-10 -61.3 134.85 57.41 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 123.851 0.861 . . . . 75.42 111.517 -172.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 119' ' ' LEU . . . . . 0.527 ' HB2' ' O ' ' C' ' 165' ' ' GLY . 0.2 OUTLIER -92.81 143.62 26.1 Favored 'General case' 0 N--CA 1.504 2.252 0 C-N-CA 119.293 -0.963 . . . . 75.21 109.697 -176.979 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -128.87 95.44 4.09 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 107.947 -1.131 . . . . 72.31 107.947 175.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 121' ' ' ALA . . . . . 0.446 ' HA ' HG22 ' B' ' 185' ' ' VAL . . . -108.33 114.1 27.7 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 108.542 -0.911 . . . . 75.44 108.542 -177.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 122' ' ' GLU . . . . . 0.486 ' HA ' ' O ' ' C' ' 177' ' ' VAL . 37.4 mt-10 -95.27 101.44 13.17 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 107.114 -1.439 . . . . 74.12 107.114 172.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 123' ' ' LEU . . . . . 0.536 ' H ' HD22 ' C' ' 123' ' ' LEU . 1.7 pt? -105.57 115.52 61.63 Favored Pre-proline 0 N--CA 1.478 0.942 0 CA-C-N 115.702 -0.681 . . . . 73.3 110.896 -168.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . 0.507 ' HA ' ' O ' ' C' ' 179' ' ' ARG . 85.8 Cg_exo -52.76 113.46 1.26 Allowed 'Trans proline' 0 C--N 1.384 2.426 0 C-N-CA 122.506 2.138 . . . . 72.51 111.121 164.276 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 125' ' ' LEU . . . . . 0.545 HD21 HG12 ' C' ' 153' ' ' VAL . 37.8 tp -129.99 143.84 51.01 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.648 0.379 . . . . 75.32 110.106 -175.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 126' ' ' THR . . . . . 0.409 ' HB ' ' HG2' ' C' ' 129' ' ' GLU . 2.5 m -85.37 149.49 25.4 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 116.033 -0.531 . . . . 61.53 110.917 -177.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 127' ' ' LEU . . . . . . . . . . . . . 9.8 mt -70.61 -52.14 23.47 Favored 'General case' 0 C--O 1.247 0.962 0 C-N-CA 124.198 0.999 . . . . 62.25 109.038 -178.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 128' ' ' GLU . . . . . 0.528 ' HG3' ' HA ' ' C' ' 215' ' ' LEU . 1.7 mp0 -59.49 -34.72 72.93 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 113.88 -1.509 . . . . 75.24 111.227 178.026 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 129' ' ' GLU . . . . . 0.531 ' HA ' ' HB2' ' C' ' 132' ' ' HIS . 17.7 mm-40 -84.47 -19.55 33.18 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.616 0.366 . . . . 75.51 111.544 -179.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -70.5 -33.68 71.49 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 108.882 -0.785 . . . . 73.14 108.882 171.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 131' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -65.46 -49.06 70.53 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 115.482 -0.781 . . . . 75.55 109.91 167.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 132' ' ' HIS . . . . . 0.531 ' HB2' ' HA ' ' C' ' 129' ' ' GLU . 32.8 m170 -72.18 -3.82 25.62 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 112.704 0.631 . . . . 70.15 112.704 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -54.41 165.13 2.83 Favored Glycine 0 CA--C 1.547 2.047 0 N-CA-C 115.715 1.046 . . . . 65.31 115.715 174.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . 158.52 -130.44 2.53 Favored Glycine 0 C--N 1.348 1.218 0 N-CA-C 110.269 -1.133 . . . . 73.12 110.269 -174.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 17.0 mp0 -81.2 95.53 6.95 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 108.263 -1.014 . . . . 73.03 108.263 169.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 136' ' ' ARG . . . . . 0.653 ' HB2' HD22 ' B' ' 181' ' ' LEU . 26.9 mmt180 -121.83 147.04 46.48 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 122.897 0.479 . . . . 72.12 110.662 -172.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 137' ' ' VAL . . . . . 0.542 HG21 ' HB1' ' B' ' 180' ' ' ALA . 8.0 m -74.42 132.55 33.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 121.69 0.757 . . . . 73.11 110.72 -175.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 138' ' ' VAL . . . . . 0.469 HG13 ' HE2' ' C' ' 164' ' ' MET . 2.3 t -139.02 133.31 40.64 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 C-N-CA 124.656 1.183 . . . . 72.14 109.269 -175.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 139' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' C' ' 143' ' ' ARG . 1.6 tm-20 -125.28 109.17 12.49 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 107.898 -1.149 . . . . 74.31 107.898 171.075 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 140' ' ' VAL . . . . . . . . . . . . . 3.2 p -143.32 134.03 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.022 0.929 . . . . 73.25 109.174 178.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 64.42 8.17 4.1 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.613 1.165 . . . . 65.0 113.329 177.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 105.29 1.46 41.17 Favored Glycine 0 C--N 1.351 1.37 0 CA-C-O 119.63 -0.539 . . . . 52.4 113.817 -178.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 143' ' ' ARG . . . . . 0.404 ' O ' ' HA ' ' C' ' 139' ' ' GLU . 77.2 ttt180 -100.14 124.98 46.17 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 118.037 0.918 . . . . 75.05 110.708 -179.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 49.2 ttt-85 -96.22 116.57 29.22 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.163 0.985 . . . . 71.51 108.944 170.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 145' ' ' VAL . . . . . 0.447 HG12 ' SD ' ' C' ' 164' ' ' MET . 7.7 p -151.74 147.4 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 122.714 0.405 . . . . 75.03 111.104 -177.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 50.8 m -85.39 93.47 8.74 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 108.044 -1.095 . . . . 73.22 108.044 166.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 6.2 p -81.33 154.41 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-O 120.853 0.359 . . . . 72.53 110.414 -175.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 148' ' ' ARG . . . . . 0.524 ' NH2' ' HD3' ' C' ' 23' ' ' LYS . 53.5 ttm-85 -113.77 95.79 5.51 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 108.275 -1.009 . . . . 74.22 108.275 172.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 149' ' ' ILE . . . . . . . . . . . . . 34.8 pt -106.91 150.99 40.45 Favored Pre-proline 0 CA--C 1.548 0.898 0 N-CA-C 108.49 -0.93 . . . . 74.42 108.49 171.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -40.24 111.73 0.15 Allowed 'Trans proline' 0 C--N 1.384 2.409 0 C-N-CA 124.311 3.341 . . . . 61.44 115.042 -179.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -64.09 93.78 0.19 Allowed 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.996 2.464 . . . . 73.2 109.856 166.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 152' ' ' GLY . . . . . . . . . . . . . . . 113.17 90.6 1.87 Allowed Glycine 0 C--N 1.341 0.816 0 N-CA-C 110.004 -1.238 . . . . 63.11 110.004 -165.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 153' ' ' VAL . . . . . 0.545 HG12 HD21 ' C' ' 125' ' ' LEU . 2.0 p -115.51 156.74 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 C-N-CA 123.051 0.54 . . . . 74.01 110.152 -174.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 154' ' ' ARG . . . . . 0.513 ' HB2' ' HB3' ' C' ' 157' ' ' SER . 56.7 mtp180 -107.54 135.26 49.3 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.68 0.792 . . . . 75.32 110.675 -174.192 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 155' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -47.04 120.91 3.33 Favored 'General case' 0 CA--C 1.553 1.059 0 CA-C-N 118.663 0.665 . . . . 74.51 111.588 166.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.59 -0.49 88.23 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-O 119.263 -0.743 . . . . 75.21 114.496 176.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 157' ' ' SER . . . . . 0.513 ' HB3' ' HB2' ' C' ' 154' ' ' ARG . 91.5 p -77.83 147.96 34.93 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 118.183 0.991 . . . . 75.43 109.93 177.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 6.1 p -119.63 109.58 26.69 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 CA-C-O 121.668 0.746 . . . . 72.31 109.902 -173.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 159' ' ' ILE . . . . . 0.577 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 17.3 mt -88.24 116.01 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.613 1.165 . . . . 72.31 109.078 -178.127 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -91.01 111.84 23.48 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.521 -0.548 . . . . 75.13 109.521 177.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 161' ' ' VAL . . . . . . . . . . . . . 1.9 p -122.21 96.4 46.39 Favored Pre-proline 0 CA--C 1.558 1.286 0 C-N-CA 124.254 1.022 . . . . 75.24 108.964 177.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 162' ' ' PRO . . . . . 0.741 ' HA ' ' HA ' ' C' ' 173' ' ' ASP . 10.6 Cg_endo -57.05 128.03 28.18 Favored 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 122.847 2.364 . . . . 75.23 113.329 176.023 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 163' ' ' GLY . . . . . 0.478 ' HA3' ' OD1' ' C' ' 84' ' ' ASP . . . 107.31 13.03 22.12 Favored Glycine 0 C--N 1.348 1.209 0 N-CA-C 115.179 0.832 . . . . 53.54 115.179 172.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 164' ' ' MET . . . . . 0.469 ' HE2' HG13 ' C' ' 138' ' ' VAL . 5.7 mtm -126.67 32.0 5.23 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 117.991 0.896 . . . . 73.35 112.216 -176.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 165' ' ' GLY . . . . . 0.598 ' H ' ' HA2' ' C' ' 172' ' ' GLY . . . 112.35 122.49 4.07 Favored Glycine 0 C--O 1.192 -2.483 0 CA-C-O 115.526 -2.819 . . . . 73.32 107.48 -176.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 166' ' ' GLY . . . . . 0.871 ' HA2' ' HA ' ' C' ' 118' ' ' ASP . . . 144.5 -143.57 12.23 Favored Glycine 0 C--O 1.199 -2.035 0 CA-C-N 122.379 3.089 . . . . 75.44 113.239 -161.18 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 167' ' ' GLN . . . . . 0.528 ' H ' ' HB3' ' C' ' 173' ' ' ASP . 22.2 mm-40 -90.07 114.33 26.21 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 118.968 1.384 . . . . 74.2 110.539 177.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . -167.59 -150.97 6.74 Favored Glycine 0 N--CA 1.479 1.502 0 CA-C-O 119.654 -0.526 . . . . 13.44 113.118 -175.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 169' ' ' ASN . . . . . 0.581 ' HB3' ' HD3' ' C' ' 170' ' ' PRO . 25.1 t-20 -72.33 -56.23 4.31 Favored Pre-proline 0 C--N 1.358 0.973 0 N-CA-C 108.354 -0.98 . . . . 62.44 108.354 168.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 170' ' ' PRO . . . . . 0.581 ' HD3' ' HB3' ' C' ' 169' ' ' ASN . 57.7 Cg_endo -98.83 -160.11 0.05 OUTLIER 'Trans proline' 0 C--N 1.365 1.409 0 N-CA-C 105.292 -2.619 . . . . 73.55 105.292 159.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 171' ' ' PRO . . . . . 0.46 ' HA ' ' O ' ' C' ' 166' ' ' GLY . 22.3 Cg_exo -47.17 119.47 3.52 Favored 'Trans proline' 0 CA--C 1.587 3.13 0 CA-C-N 121.543 1.587 . . . . 74.02 114.733 160.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 172' ' ' GLY . . . . . 0.598 ' HA2' ' H ' ' C' ' 165' ' ' GLY . . . -150.96 84.45 0.16 Allowed Glycine 1 CA--C 1.587 4.575 0 N-CA-C 117.169 1.628 . . . . 74.42 117.169 168.999 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' C' C ' 173' ' ' ASP . . . . . 0.741 ' HA ' ' HA ' ' C' ' 162' ' ' PRO . 29.0 t70 163.05 93.21 0.0 OUTLIER 'General case' 0 N--CA 1.535 3.817 0 C-N-CA 127.58 2.352 . . . . 74.51 108.231 -178.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 174' ' ' LEU . . . . . 0.455 HD23 ' HE3' ' C' ' 164' ' ' MET . 15.1 tp -104.45 139.79 38.87 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 114.724 -1.125 . . . . 75.22 113.035 -162.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 66.9 mt -110.26 92.26 3.98 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.462 1.105 . . . . 72.15 109.398 172.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 176' ' ' LEU . . . . . 0.577 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 68.1 mt -75.29 93.6 2.89 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-N 114.796 -1.093 . . . . 74.33 110.953 175.222 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 177' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' C' ' 122' ' ' GLU . 59.4 t -84.53 101.33 8.91 Favored 'Isoleucine or valine' 0 C--O 1.244 0.777 0 N-CA-C 107.28 -1.378 . . . . 75.23 107.28 172.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 178' ' ' VAL . . . . . . . . . . . . . 28.9 m -76.92 122.05 30.58 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 CA-C-O 121.927 0.87 . . . . 74.01 110.18 -176.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 179' ' ' ARG . . . . . 0.507 ' O ' ' HA ' ' C' ' 124' ' ' PRO . 9.9 mmm180 -113.71 111.87 22.52 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 106.376 -1.713 . . . . 74.42 106.376 174.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 180' ' ' LEU . . . . . . . . . . . . . 53.2 mt -67.8 148.19 51.56 Favored 'General case' 0 CA--C 1.558 1.253 0 CA-C-N 117.619 0.191 . . . . 73.43 111.026 -176.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 181' ' ' LEU . . . . . . . . . . . . . 41.1 mt -53.23 167.75 0.41 Allowed Pre-proline 0 N--CA 1.5 2.068 0 C-N-CA 125.671 1.588 . . . . 74.24 113.827 -171.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -61.66 68.7 0.1 Allowed 'Trans proline' 0 C--N 1.393 2.9 0 C-N-CA 122.861 2.374 . . . . 73.32 110.252 161.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 183' ' ' HIS . . . . . 0.418 ' N ' ' HD3' ' C' ' 184' ' ' PRO . 81.6 t60 172.85 47.52 0.01 OUTLIER Pre-proline 0 CA--C 1.562 1.404 0 C-N-CA 129.031 2.932 . . . . 72.0 104.503 -167.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 184' ' ' PRO . . . . . 0.418 ' HD3' ' N ' ' C' ' 183' ' ' HIS . 85.8 Cg_endo -95.05 63.89 0.23 Allowed 'Trans proline' 0 C--N 1.387 2.573 0 C-N-CA 122.395 2.064 . . . . 74.25 109.713 -167.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 185' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 9.8 t -92.85 -23.02 5.66 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.476 0 CA-C-N 114.748 -1.114 . . . . 72.23 109.271 -168.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 186' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -130.68 101.03 5.51 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 118.746 0.703 . . . . 61.44 110.945 -175.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 187' ' ' ARG . . . . . . . . . . . . . 40.7 ttt85 -94.57 117.27 29.86 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 114.494 -1.23 . . . . 75.14 108.066 171.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 188' ' ' LEU . . . . . 0.494 HD13 ' HA ' ' C' ' 191' ' ' GLN . 61.5 tp -82.03 145.95 29.95 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 121.489 0.661 . . . . 74.14 111.824 -179.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 189' ' ' GLU . . . . . 0.431 ' HA ' ' NE ' ' C' ' 154' ' ' ARG . 31.2 tt0 -143.71 111.98 6.32 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 107.064 -1.458 . . . . 73.21 107.064 164.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 67.49 -100.51 0.61 Allowed Glycine 0 C--N 1.35 1.316 0 N-CA-C 111.271 -0.732 . . . . 74.2 111.271 -171.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 191' ' ' GLN . . . . . 0.494 ' HA ' HD13 ' C' ' 188' ' ' LEU . 48.9 mt-30 -125.61 -6.27 6.93 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.531 0.732 . . . . 75.25 111.136 171.185 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -84.8 138.99 32.26 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 122.892 0.477 . . . . 65.13 110.475 179.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 193' ' ' LEU . . . . . 0.476 HD21 ' CD2' ' C' ' 240' ' ' PHE . 90.4 mt -101.49 163.61 12.18 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.408 0.623 . . . . 65.15 111.142 178.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 194' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -129.82 115.4 17.19 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 114.59 -1.186 . . . . 75.43 108.915 172.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 195' ' ' ALA . . . . . 0.529 ' HA ' ' O ' ' C' ' 185' ' ' VAL . . . -114.59 -178.32 3.34 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.73 0.812 . . . . 65.11 111.242 176.208 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 196' ' ' THR . . . . . 0.434 ' HA ' ' O ' ' C' ' 252' ' ' GLU . 78.1 m -136.32 114.53 11.57 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 108.27 -1.011 . . . . 53.42 108.27 164.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 197' ' ' LEU . . . . . . . . . . . . . 45.7 tp -88.85 132.57 34.6 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 123.814 0.846 . . . . 73.5 110.542 -176.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -88.22 105.32 17.46 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 108.551 -0.907 . . . . 64.33 108.551 175.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 199' ' ' VAL . . . . . 0.548 HG21 ' HH2' ' B' ' 242' ' ' TRP . 51.2 t -115.22 118.5 39.92 Favored Pre-proline 0 N--CA 1.469 0.504 0 N-CA-C 108.019 -1.104 . . . . 73.12 108.019 177.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 200' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.69 138.36 31.8 Favored 'Trans proline' 0 C--N 1.372 1.785 0 C-N-CA 121.76 1.64 . . . . 73.11 110.612 175.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 201' ' ' ALA . . . . . . . . . . . . . . . -41.47 -48.14 9.19 Favored Pre-proline 0 CA--C 1.562 1.411 0 N-CA-C 115.363 1.616 . . . . 74.35 115.363 178.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 202' ' ' PRO . . . . . 0.487 ' HB2' ' HA ' ' A' ' 273' ' ' ALA . 11.9 Cg_endo -53.36 -54.46 4.92 Favored 'Trans proline' 0 C--N 1.386 2.548 0 CA-C-N 121.281 1.493 . . . . 63.15 112.638 176.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 203' ' ' ILE . . . . . . . . . . . . . 63.9 mt -63.74 -29.88 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 123.197 0.599 . . . . 74.02 110.703 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.96 -35.79 78.98 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.995 0.918 . . . . 75.02 112.377 179.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 205' ' ' VAL . . . . . 0.545 HG22 HD12 ' A' ' 257' ' ' ILE . 46.3 t -80.04 -42.8 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 CA-C-O 119.355 -0.355 . . . . 74.52 111.675 179.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 206' ' ' VAL . . . . . . . . . . . . . 10.9 p -80.18 -36.84 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 112.558 0.577 . . . . 74.12 112.558 -172.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 83.31 89.45 0.73 Allowed Glycine 0 C--N 1.344 1.024 0 N-CA-C 111.755 -0.538 . . . . 63.21 111.755 -166.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -127.8 -129.55 3.23 Favored Glycine 0 C--N 1.344 1.006 0 N-CA-C 111.03 -0.828 . . . . 51.32 111.03 177.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 209' ' ' LYS . . . . . 0.576 ' HG2' ' HA ' ' C' ' 222' ' ' ALA . 5.9 mtmp? -136.3 146.95 47.19 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 117.711 0.756 . . . . 72.44 111.71 170.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 210' ' ' VAL . . . . . 0.407 HG21 HG23 ' C' ' 199' ' ' VAL . 33.4 m -128.67 168.22 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 125.225 1.41 . . . . 71.52 107.678 169.075 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 211' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -106.19 136.43 45.91 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 118.117 0.417 . . . . 75.53 111.391 -177.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 212' ' ' ALA . . . . . 0.498 ' HB1' HG12 ' C' ' 219' ' ' VAL . . . -120.56 120.72 36.64 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 107.6 -1.259 . . . . 74.43 107.6 171.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 213' ' ' MET . . . . . 0.426 ' SD ' ' N ' ' C' ' 214' ' ' THR . 8.7 tmm? -71.98 146.38 47.77 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.431 -0.951 . . . . 63.12 108.431 173.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 214' ' ' THR . . . . . 0.538 HG23 ' HD2' ' C' ' 238' ' ' LYS . 0.1 OUTLIER -141.79 168.85 18.78 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 119.035 0.834 . . . . 72.34 112.333 178.165 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' C' C ' 215' ' ' LEU . . . . . 0.528 ' HA ' ' HG3' ' C' ' 128' ' ' GLU . 30.8 mt -62.8 -35.78 80.99 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 124.566 1.146 . . . . 75.24 113.444 -166.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.48 -2.21 15.61 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 114.546 -1.207 . . . . 71.0 111.495 -171.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 164.37 -168.16 38.61 Favored Glycine 0 C--O 1.21 -1.363 0 CA-C-O 119.6 -0.556 . . . . 74.41 111.786 -174.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -94.41 165.42 1.91 Allowed 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 122.302 2.001 . . . . 64.03 112.554 171.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 219' ' ' VAL . . . . . 0.637 ' HB ' ' HE3' ' C' ' 238' ' ' LYS . 2.2 p -142.96 112.9 2.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 108.073 -1.084 . . . . 52.53 108.073 168.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 220' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -90.78 108.12 19.62 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 108.277 -1.009 . . . . 72.32 108.277 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 221' ' ' VAL . . . . . 0.447 ' HA ' ' HB2' ' B' ' 239' ' ' ALA . 39.4 t -71.33 127.15 32.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 114.012 -1.449 . . . . 74.03 112.767 -171.163 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 222' ' ' ALA . . . . . 0.576 ' HA ' ' HG2' ' C' ' 209' ' ' LYS . . . -81.41 109.09 15.57 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 123.713 0.633 . . . . 73.3 109.346 169.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 58.1 t -82.02 139.6 46.13 Favored Pre-proline 0 CA--C 1.558 1.263 0 C-N-CA 124.282 1.033 . . . . 73.11 110.116 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 224' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -84.93 160.81 11.86 Favored 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 122.929 2.419 . . . . 73.11 111.938 170.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -63.36 140.57 77.33 Favored 'Trans proline' 0 C--N 1.372 1.779 0 C-N-CA 122.247 1.965 . . . . 74.4 110.828 169.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 226' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? 70.0 83.62 0.15 Allowed 'General case' 0 N--CA 1.483 1.189 0 O-C-N 124.403 1.065 . . . . 71.5 111.174 177.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 227' ' ' THR . . . . . 0.584 HG21 HD12 ' C' ' 255' ' ' ILE . 52.7 m -128.1 122.05 31.11 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.874 -0.603 . . . . 73.3 112.404 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 228' ' ' GLN . . . . . 0.469 HE21 HG13 ' A' ' 257' ' ' ILE . 26.1 mp0 -108.89 162.28 14.35 Favored 'General case' 0 C--O 1.253 1.259 0 CA-C-O 122.615 1.197 . . . . 74.32 111.152 168.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -65.64 138.29 57.91 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 112.934 -1.939 . . . . 65.31 109.32 175.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 101.56 -4.79 54.21 Favored Glycine 0 CA--C 1.523 0.574 0 CA-C-O 119.616 -0.547 . . . . 62.04 113.012 -174.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 231' ' ' ARG . . . . . . . . . . . . . 43.1 mtt85 -70.19 171.3 9.97 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 108.567 -0.901 . . . . 75.03 108.567 162.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 232' ' ' LYS . . . . . 0.481 ' HA ' ' O ' ' C' ' 251' ' ' LEU . 32.6 ttmt -155.48 126.18 6.92 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.274 0.559 . . . . 74.05 111.744 -178.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 233' ' ' LEU . . . . . 0.612 HD11 ' HB2' ' C' ' 251' ' ' LEU . 4.5 mp -84.92 155.03 21.84 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 114.762 -1.108 . . . . 74.22 110.712 -178.077 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -122.78 100.62 7.0 Favored 'General case' 0 CA--C 1.55 0.953 0 O-C-N 125.099 1.5 . . . . 72.34 108.941 165.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 235' ' ' LEU . . . . . 0.405 HD21 ' H ' ' B' ' 240' ' ' GLY . 61.3 mt -95.22 114.88 26.72 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.495 0.718 . . . . 74.34 109.165 176.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -71.83 130.82 42.0 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.795 0.838 . . . . 73.41 111.899 -174.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 85.01 -12.81 57.0 Favored Glycine 0 C--N 1.352 1.426 0 CA-C-N 116.029 -0.532 . . . . 71.42 113.123 178.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 238' ' ' LYS . . . . . 0.637 ' HE3' ' HB ' ' C' ' 219' ' ' VAL . 68.5 mmtt -92.25 13.13 20.1 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.743 0.817 . . . . 75.11 112.279 -172.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -80.16 -163.25 27.77 Favored Glycine 0 C--N 1.352 1.462 0 N-CA-C 110.992 -0.843 . . . . 75.2 110.992 164.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 240' ' ' PHE . . . . . 0.487 ' HD2' HD11 ' C' ' 188' ' ' LEU . 1.9 m-85 -73.21 124.23 90.36 Favored Pre-proline 0 C--O 1.249 1.036 0 CA-C-N 118.167 0.983 . . . . 75.14 109.141 175.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 241' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' C' ' 240' ' ' PHE . 39.4 Cg_exo -63.51 107.28 0.69 Allowed 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 123.353 2.702 . . . . 71.53 114.381 178.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -79.41 158.3 43.44 Favored Glycine 0 C--N 1.341 0.834 0 CA-C-O 118.904 -0.942 . . . . 70.14 111.371 168.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -57.31 -30.1 86.43 Favored 'Trans proline' 0 C--N 1.374 1.89 0 C-N-CA 123.53 2.82 . . . . 71.42 113.826 -170.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -134.27 17.55 3.72 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.023 0.529 . . . . 71.42 111.439 -177.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 175.77 115.29 0.41 Allowed Glycine 0 C--N 1.346 1.116 0 N-CA-C 111.761 -0.535 . . . . 63.24 111.761 -178.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 246' ' ' ARG . . . . . . . . . . . . . 52.4 mtm180 -82.21 156.33 24.46 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.508 0.723 . . . . 71.32 110.264 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -82.24 -160.93 28.17 Favored Glycine 0 N--CA 1.479 1.509 0 N-CA-C 113.825 0.29 . . . . 63.23 113.825 178.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -133.41 133.31 42.2 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 121.539 0.685 . . . . 73.54 110.647 -175.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 249' ' ' LEU . . . . . . . . . . . . . 19.2 tp -88.96 129.5 35.62 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.108 0.963 . . . . 74.23 110.85 -175.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 250' ' ' TYR . . . . . 0.579 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 26.8 m-85 -112.38 101.62 9.81 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.856 0.863 . . . . 71.43 110.092 177.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 251' ' ' LEU . . . . . 0.612 ' HB2' HD11 ' C' ' 233' ' ' LEU . 3.3 mp -96.94 117.1 30.4 Favored 'General case' 0 N--CA 1.504 2.249 0 C-N-CA 120.845 -0.342 . . . . 72.0 110.59 -175.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 252' ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' C' ' 196' ' ' THR . 6.3 tp10 -70.55 128.94 37.86 Favored 'General case' 0 C--O 1.218 -0.578 0 N-CA-C 108.522 -0.918 . . . . 75.41 108.522 170.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 253' ' ' VAL . . . . . . . . . . . . . 78.1 t -85.41 140.27 16.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 O-C-N 121.815 -0.553 . . . . 73.5 111.306 -174.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 254' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 -128.81 121.57 28.59 Favored 'General case' 0 C--N 1.346 0.456 0 C-N-CA 124.337 1.055 . . . . 75.13 108.899 169.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 255' ' ' ILE . . . . . 0.584 HD12 HG21 ' C' ' 227' ' ' THR . 38.7 mm -87.7 125.97 41.28 Favored 'Isoleucine or valine' 0 C--N 1.344 0.328 0 CA-C-N 115.854 -0.612 . . . . 75.24 109.775 178.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 256' ' ' THR . . . . . . . . . . . . . 43.9 p -121.61 -174.8 2.94 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.024 0.93 . . . . 70.25 111.027 -173.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 257' ' ' ILE . . . . . 0.412 ' HB ' HG21 ' A' ' 205' ' ' VAL . 2.8 pp -140.0 156.45 70.43 Favored Pre-proline 0 CA--C 1.561 1.381 0 C-N-CA 123.408 0.683 . . . . 75.21 110.815 -176.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -56.5 -10.86 5.56 Favored 'Trans proline' 0 C--N 1.387 2.576 0 C-N-CA 124.046 3.164 . . . . 74.41 115.795 -174.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 53.87 -84.62 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 124.772 1.229 . . . . 72.3 110.006 -163.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.28 155.68 39.24 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.012 0.925 . . . . 73.41 110.827 176.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 261' ' ' LEU . . . . . 0.56 ' HG ' HH12 ' A' ' 226' ' ' ARG . 85.2 mt -130.97 141.36 50.25 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.297 0.639 . . . . 74.53 110.161 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 80.6 p -84.65 164.66 41.57 Favored Pre-proline 0 CA--C 1.558 1.279 0 N-CA-C 107.812 -1.181 . . . . 61.23 107.812 166.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -45.61 -41.87 18.82 Favored 'Trans proline' 0 C--N 1.387 2.574 0 C-N-CA 122.783 2.322 . . . . 74.2 113.776 176.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -55.25 -63.37 1.18 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.037 1.335 . . . . 71.04 111.056 175.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -58.4 -41.46 84.95 Favored 'General case' 0 C--N 1.348 0.525 0 CA-C-N 114.442 -1.253 . . . . 71.03 110.719 -176.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 266' ' ' GLU . . . . . 0.54 ' HA ' HD11 ' C' ' 261' ' ' LEU . 11.0 tp10 -56.31 -51.64 67.47 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.908 0.883 . . . . 73.1 110.43 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -59.44 -49.99 75.68 Favored 'General case' 0 CA--C 1.553 1.085 0 CA-C-N 115.747 -0.66 . . . . 71.12 112.114 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 268' ' ' LEU . . . . . . . . . . . . . 10.3 mp -71.4 -38.31 71.47 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 112.536 0.569 . . . . 70.11 112.536 -174.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -70.98 -30.21 66.41 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 122.629 0.371 . . . . 63.11 111.09 177.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 26.8 mmtp -68.14 -40.45 82.44 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 122.913 0.485 . . . . 75.43 111.172 173.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 271' ' ' LYS . . . . . 0.491 ' HB3' HD21 ' A' ' 268' ' ' LEU . 3.4 mmtm -64.14 -41.3 97.25 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 121.048 0.451 . . . . 75.33 111.256 175.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 72.7 mt -61.41 -42.31 98.54 Favored 'General case' 0 C--O 1.217 -0.649 0 CA-C-N 115.728 -0.669 . . . . 74.33 110.177 172.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 273' ' ' ALA . . . . . 0.496 ' HB3' HG21 ' A' ' 206' ' ' VAL . . . -56.51 -43.09 79.41 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.07 0.548 . . . . 43.22 110.899 -179.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -58.66 -52.15 66.9 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.177 0.991 . . . . 63.21 110.845 174.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -57.88 -28.92 64.62 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 115.05 -0.977 . . . . 70.04 112.09 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 276' ' ' TYR . . . . . 0.624 ' HH ' ' HG3' ' A' ' 258' ' ' PRO . 2.6 m-85 -95.87 -17.23 21.27 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.532 0.733 . . . . 75.52 111.943 -179.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 19.5 m-30 -67.41 -33.88 76.1 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.544 -0.91 . . . . 65.52 108.544 168.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -71.66 -1.05 12.37 Favored 'General case' 0 CA--C 1.557 1.228 0 CA-C-N 114.671 -1.15 . . . . 72.22 112.737 173.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 279' ' ' ARG . . . . . . . . . . . . . 30.2 mtp-105 -99.63 -1.71 37.37 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.403 0.681 . . . . 75.11 110.973 171.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.051 0 CA-C-O 118.551 -0.738 . . . . 75.14 109.722 175.671 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 88.0 tttt . . . . . 0 N--CA 1.479 1.011 0 N-CA-C 114.288 1.218 . . . . 64.14 114.288 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.407 ' NZ ' ' HB3' ' A' ' 94' ' ' SER . 29.3 mmtp -73.18 97.66 2.46 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 107.766 -1.198 . . . . 74.32 107.766 164.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.495 ' HA ' ' OH ' ' A' ' 66' ' ' TYR . 14.3 t70 -74.06 90.55 2.01 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.562 -1.273 . . . . 62.43 107.562 174.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -58.16 -31.69 67.49 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 113.919 -1.491 . . . . 73.34 112.264 -170.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -66.22 -44.56 83.48 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 122.822 0.449 . . . . 73.33 110.736 177.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.73 -41.83 99.36 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 122.992 0.517 . . . . 70.01 110.828 178.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 65.6 mt -58.73 -41.19 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 O-C-N 124.071 0.857 . . . . 74.23 110.683 177.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 87.6 mt -80.11 -12.21 59.69 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 112.681 0.622 . . . . 73.11 112.681 177.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.86 17.85 78.61 Favored Glycine 0 C--N 1.349 1.267 0 O-C-N 122.958 0.161 . . . . 73.42 113.403 -176.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.9 m -101.34 154.4 37.24 Favored Pre-proline 0 N--CA 1.482 1.144 0 C-N-CA 124.075 0.95 . . . . 72.52 109.623 174.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -58.5 154.56 41.21 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 122.695 2.263 . . . . 50.12 113.534 176.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 79.0 mtt180 -77.02 66.7 2.89 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.184 0.994 . . . . 75.43 109.797 177.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -178.86 -25.24 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 114.629 -1.169 . . . . 71.2 109.088 -168.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.21 133.32 39.48 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 125.098 1.359 . . . . 74.14 113.338 -174.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 51.1 p -78.44 172.98 12.85 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.768 0.827 . . . . 75.03 111.16 179.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 22.7 tm0? -50.4 -37.26 36.69 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.814 1.246 . . . . 71.11 111.016 176.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.44 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 0.3 OUTLIER -61.47 -47.56 85.09 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 124.502 1.121 . . . . 72.43 110.217 -179.522 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -70.32 -34.52 72.78 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.308 1.043 . . . . 71.14 111.211 -178.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.5 mp -64.6 -36.96 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.375 1.07 . . . . 73.31 110.04 174.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -73.42 -30.47 63.26 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.766 0.826 . . . . 75.22 110.42 179.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.44 ' HG3' ' O ' ' A' ' 20' ' ' GLU . 95.3 mtt180 -62.02 -54.67 38.24 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.296 0.57 . . . . 73.12 110.031 172.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.8 -34.29 72.84 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 114.541 -1.208 . . . . 72.43 111.61 178.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -62.82 -49.95 72.92 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.957 0.903 . . . . 73.1 111.12 176.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.418 ' HE2' ' HA ' ' A' ' 24' ' ' ARG . 49.5 mtmt -57.57 -55.15 38.55 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 109.799 -0.445 . . . . 74.22 109.799 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.7 ttp-105 -52.57 -65.89 0.48 Allowed 'General case' 0 N--CA 1.479 1.022 0 O-C-N 123.825 0.703 . . . . 75.52 111.523 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.71 ' HB3' HD12 ' A' ' 50' ' ' ILE . 95.4 mt -72.23 -48.7 40.85 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.186 -0.915 . . . . 75.12 112.434 -170.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.75 -15.54 59.73 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 112.872 0.693 . . . . 71.54 112.872 -173.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -81.3 -40.24 23.96 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 119.187 0.903 . . . . 72.33 109.57 165.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -63.43 -33.94 76.65 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 115.46 -0.791 . . . . 73.31 111.84 -179.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.438 ' HB3' ' O ' ' A' ' 43' ' ' ALA . 21.7 m-85 -111.6 15.97 20.85 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.89 0.876 . . . . 72.41 110.474 -175.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -69.8 119.35 70.72 Favored Pre-proline 0 C--N 1.352 0.685 0 C-N-CA 123.492 0.717 . . . . 73.54 109.332 -176.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.468 ' HG3' ' HG2' ' A' ' 44' ' ' GLU . 32.6 Cg_exo -60.51 -8.66 9.34 Favored 'Trans proline' 0 C--N 1.373 1.829 0 C-N-CA 123.12 2.547 . . . . 75.51 114.369 -178.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -73.56 -43.74 59.1 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.965 0.506 . . . . 73.23 110.601 170.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 52.3 t -95.75 -63.66 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 123.286 0.634 . . . . 73.25 110.168 -177.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -98.28 80.58 2.67 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 122.303 1.049 . . . . 64.12 109.223 -173.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -76.43 81.45 3.15 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 114.205 -1.361 . . . . 73.11 109.638 178.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 69.8 m -140.43 113.94 7.38 Favored Pre-proline 0 N--CA 1.475 0.78 0 C-N-CA 124.152 0.981 . . . . 71.24 108.439 174.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -40.82 -46.17 4.86 Favored 'Trans proline' 0 C--N 1.387 2.568 0 C-N-CA 124.31 3.34 . . . . 73.53 114.05 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -54.37 -50.43 67.52 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.679 1.192 . . . . 64.43 109.924 177.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.438 ' O ' ' HB3' ' A' ' 33' ' ' TYR . . . -62.55 -31.86 72.73 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 115.121 -0.945 . . . . 73.42 110.691 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.627 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 47.9 mt-10 -77.4 -34.4 54.82 Favored 'General case' 0 C--O 1.217 -0.626 0 O-C-N 123.75 0.656 . . . . 63.35 109.945 -173.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -65.59 -44.22 87.32 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.533 0.733 . . . . 62.44 109.932 174.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -58.13 -44.94 88.07 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 123.772 0.67 . . . . 74.03 109.869 174.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -58.96 -38.97 80.29 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.085 1.354 . . . . 73.32 110.968 178.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.627 ' HG2' ' O ' ' A' ' 44' ' ' GLU . 32.9 mmtp -66.55 -43.45 85.04 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 122.688 0.395 . . . . 75.14 110.925 179.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -58.59 -42.54 88.3 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 123.855 0.722 . . . . 71.44 111.184 175.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.71 HD12 ' HB3' ' A' ' 29' ' ' LEU . 62.3 mt -76.1 -28.68 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 124.935 1.294 . . . . 74.43 111.321 -176.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.416 ' HA ' ' HB3' ' A' ' 54' ' ' TYR . 13.7 m-80 -93.61 -5.65 48.31 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.587 0.755 . . . . 73.43 111.421 175.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -77.01 -53.47 7.77 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 107.49 -1.3 . . . . 75.34 107.49 164.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.18 -37.09 76.53 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 112.962 -1.927 . . . . 65.45 111.133 176.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.416 ' HB3' ' HA ' ' A' ' 51' ' ' ASN . 61.4 t80 -73.43 -47.27 43.04 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-O 118.811 -0.614 . . . . 73.53 110.537 173.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -50.27 -36.18 30.31 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 123.231 0.613 . . . . 72.52 112.368 -178.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.517 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 61.3 t -78.74 -67.48 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 CA-C-N 114.697 -1.138 . . . . 74.52 110.025 175.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.443 HD22 ' HG2' ' A' ' 63' ' ' ARG . 46.3 mt -80.09 4.59 16.74 Favored 'General case' 0 CA--C 1.564 1.483 0 N-CA-C 113.484 0.92 . . . . 74.35 113.484 -165.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.5 t -76.24 -25.0 54.57 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 123.875 0.87 . . . . 74.34 110.275 174.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -109.99 117.47 51.87 Favored Pre-proline 0 N--CA 1.449 -0.524 0 N-CA-C 107.142 -1.429 . . . . 74.34 107.142 176.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.434 ' O ' ' HG2' ' A' ' 64' ' ' ARG . 84.0 Cg_exo -46.96 -26.47 4.89 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 123.147 2.565 . . . . 72.41 113.318 171.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -63.62 -61.21 2.47 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 122.962 0.505 . . . . 72.3 111.274 175.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.517 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 34.8 mttp -66.79 -26.72 67.09 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 122.375 0.27 . . . . 74.54 111.029 -178.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.443 ' HG2' HD22 ' A' ' 57' ' ' LEU . 4.2 tmt_? -61.58 -48.17 82.2 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.845 1.258 . . . . 74.11 108.826 176.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.434 ' HG2' ' O ' ' A' ' 60' ' ' PRO . 19.7 mmm180 -67.1 -33.84 76.33 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.516 -0.765 . . . . 74.25 111.717 176.325 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.412 HD11 ' HA ' ' A' ' 62' ' ' LYS . 84.5 mt -60.49 -42.87 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 C-N-CA 123.077 0.551 . . . . 74.41 110.169 176.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.495 ' OH ' ' HA ' ' A' ' 6' ' ' ASP . 32.5 t80 -62.76 -51.92 65.23 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.623 -0.717 . . . . 75.4 110.068 175.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -54.17 -41.48 68.57 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 123.826 0.704 . . . . 64.04 111.271 -178.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 68.7 p -79.07 -22.39 45.37 Favored 'General case' 0 C--N 1.348 0.506 0 CA-C-N 115.637 -0.711 . . . . 75.44 111.931 -178.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -70.9 112.46 7.1 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 109.186 -0.672 . . . . 75.32 109.186 177.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 111.34 9.34 21.95 Favored Glycine 0 N--CA 1.473 1.109 0 CA-C-N 115.832 -0.622 . . . . 64.23 111.638 -170.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.8 m -141.44 -59.4 0.48 Allowed 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 104.177 -2.527 . . . . 71.23 104.177 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.5 m -76.64 141.81 40.87 Favored 'General case' 0 C--O 1.252 1.232 0 N-CA-C 104.472 -2.418 . . . . 74.23 104.472 155.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.66 -49.38 6.32 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.243 0.617 . . . . 74.04 111.219 -178.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -97.08 142.49 24.61 Favored Pre-proline 0 N--CA 1.477 0.893 0 C-N-CA 123.037 0.535 . . . . 75.1 110.441 -174.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.403 ' HB2' ' HG3' ' A' ' 103' ' ' PRO . 37.2 Cg_exo -59.34 151.85 65.03 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 123.114 2.543 . . . . 75.41 112.697 174.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.05 158.86 45.52 Favored 'Trans proline' 0 C--N 1.377 2.053 0 C-N-CA 123.216 2.611 . . . . 74.25 114.36 -175.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.96 120.26 7.96 Favored 'Trans proline' 0 C--N 1.386 2.54 0 C-N-CA 123.221 2.614 . . . . 73.45 112.198 171.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.18 118.31 5.6 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 122.859 2.372 . . . . 73.2 112.087 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.58 ' HB2' ' HA3' ' A' ' 142' ' ' GLY . 6.5 Cg_exo -74.16 165.62 31.52 Favored 'Trans proline' 0 CA--C 1.566 2.115 0 C-N-CA 122.868 2.378 . . . . 71.05 111.726 178.151 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_exo -51.91 85.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.393 2.913 0 C-N-CA 123.921 3.081 . . . . 74.31 114.428 -176.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 141.29 -44.89 0.99 Allowed Glycine 0 C--N 1.338 0.69 0 N-CA-C 109.767 -1.333 . . . . 62.41 109.767 178.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.42 -168.19 33.27 Favored Glycine 0 C--N 1.351 1.399 0 C-N-CA 123.38 0.514 . . . . 53.03 113.535 176.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -70.14 100.48 1.66 Allowed 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.476 1.11 . . . . 74.41 110.215 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.475 ' HA ' ' HD2' ' A' ' 106' ' ' PHE . 32.6 t0 -60.84 115.82 3.97 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.84 0.856 . . . . 71.31 109.783 173.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -112.9 70.24 0.71 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.458 1.103 . . . . 73.24 108.374 -174.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 16.1 m -44.57 86.56 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 126.232 1.813 . . . . 74.44 115.479 -164.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 65.44 23.39 70.21 Favored Glycine 0 C--N 1.353 1.489 0 CA-C-N 115.496 -0.774 . . . . 70.11 114.741 173.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -102.4 136.25 42.56 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 109.617 -0.512 . . . . 72.34 109.617 -178.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -77.37 91.16 3.83 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 122.111 -0.368 . . . . 71.44 110.033 -175.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.4 p -34.69 -56.65 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 115.019 1.488 . . . . 75.21 115.019 175.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -64.4 -26.32 68.41 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 118.363 0.529 . . . . 75.33 112.369 -178.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -79.85 -21.04 44.6 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.614 0.765 . . . . 61.35 111.006 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -94.82 170.33 9.51 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 107.974 -1.121 . . . . 73.34 107.974 177.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.407 ' HB3' ' NZ ' ' A' ' 5' ' ' LYS . 80.4 p -60.3 149.65 32.84 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 113.826 1.047 . . . . 74.5 113.826 -165.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.424 ' O ' ' HG3' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -61.06 -30.16 70.16 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 114.893 -1.049 . . . . 74.52 110.486 168.127 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -57.83 -45.07 86.7 Favored 'General case' 0 C--N 1.355 0.812 0 C-N-CA 124.002 0.921 . . . . 75.03 110.838 172.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -63.5 -44.54 94.02 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 115.311 -0.859 . . . . 72.32 109.729 175.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -68.47 -9.8 51.26 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 115.963 -0.562 . . . . 74.14 111.917 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.424 ' HG3' ' O ' ' A' ' 95' ' ' GLU . 38.7 mt-10 -88.78 -59.29 2.27 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 124.119 0.968 . . . . 70.02 111.208 165.099 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 33.8 tp -60.83 -35.67 77.13 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.943 1.297 . . . . 74.33 112.474 -167.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -116.14 6.43 13.95 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.117 0.567 . . . . 72.11 110.67 176.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -42.84 -57.99 3.81 Favored Glycine 0 C--N 1.357 1.721 0 C-N-CA 124.629 1.109 . . . . 72.43 115.131 177.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.403 ' HG3' ' HB2' ' A' ' 75' ' ' PRO . 28.3 Cg_endo -56.88 -19.08 30.17 Favored 'Trans proline' 0 C--N 1.39 2.752 0 C-N-CA 123.264 2.643 . . . . 64.43 113.377 -173.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -142.1 39.89 1.34 Allowed Glycine 0 C--N 1.354 1.563 0 CA-C-O 119.718 -0.49 . . . . 54.4 112.426 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.461 ' HB3' ' ND2' ' A' ' 169' ' ' ASN . 48.6 mt -61.72 72.61 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 123.026 0.53 . . . . 74.25 111.487 169.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.635 ' HB3' ' HA ' ' A' ' 169' ' ' ASN . 2.2 t80 21.09 -106.12 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.432 0 C-N-CA 127.109 2.163 . . . . 74.45 112.774 -170.12 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 58.99 41.41 96.37 Favored Glycine 0 C--N 1.364 2.11 0 CA-C-O 119.744 -0.475 . . . . 44.0 112.644 178.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.82 ' HA3' ' HB3' ' A' ' 167' ' ' GLN . . . . . . . . 0 C--N 1.367 2.269 0 C-N-CA 124.896 1.236 . . . . 71.34 114.887 165.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 82.4 tttt . . . . . 0 N--CA 1.479 1.008 0 N-CA-C 114.907 1.447 . . . . 73.31 114.907 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -90.22 -173.47 44.89 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-N 115.129 -0.941 . . . . 73.4 113.601 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -93.86 164.07 13.26 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 124.926 1.29 . . . . 74.43 109.572 -177.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -74.25 99.67 3.51 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 121.216 -0.927 . . . . 74.23 109.887 174.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 38.3 tp -95.5 141.19 29.32 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 121.039 0.447 . . . . 75.42 111.484 -167.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -93.0 122.18 35.09 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 107.184 -1.413 . . . . 74.51 107.184 169.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -129.9 168.99 15.77 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.399 -0.593 . . . . 54.41 109.399 176.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -128.91 115.4 17.8 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.482 -0.933 . . . . 72.42 108.482 -175.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 65.3 tp -99.59 100.39 10.71 Favored Pre-proline 0 N--CA 1.472 0.659 0 N-CA-C 108.432 -0.951 . . . . 74.14 108.432 -173.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.52 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 46.4 Cg_endo -67.41 135.86 37.96 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 121.587 1.525 . . . . 75.33 109.535 178.047 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.636 ' HA ' HG23 ' B' ' 6' ' ' ILE . 57.1 tp -146.66 154.93 42.03 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 118.467 0.576 . . . . 72.43 110.311 -176.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 48.5 m -84.67 145.24 28.07 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 124.536 1.134 . . . . 71.34 110.337 178.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.704 ' HB3' HD23 ' A' ' 215' ' ' LEU . 18.7 mt -55.83 -60.55 3.3 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.927 0.891 . . . . 75.21 112.233 -175.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -51.33 -46.37 62.6 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 114.447 -1.252 . . . . 75.32 110.836 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -70.48 -23.94 62.77 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.138 0.975 . . . . 64.33 111.997 -177.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -67.91 -48.01 67.17 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 123.198 0.599 . . . . 65.44 109.596 176.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.424 ' HA ' ' HA2' ' A' ' 152' ' ' GLY . 61.0 t80 -71.85 -28.92 63.88 Favored 'General case' 0 CA--C 1.556 1.199 0 O-C-N 124.015 0.822 . . . . 74.51 111.702 178.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 49.6 m170 -69.61 -53.43 18.85 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 122.663 0.385 . . . . 75.25 111.039 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.556 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 81.19 -167.7 49.65 Favored Glycine 0 CA--C 1.538 1.474 0 CA-C-N 116.266 -0.425 . . . . 71.54 113.199 -178.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.82 -175.75 23.46 Favored Glycine 0 N--CA 1.477 1.41 0 C-N-CA 123.563 0.601 . . . . 70.42 112.205 -179.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.445 ' HB3' ' HB3' ' A' ' 146' ' ' SER . 2.5 mp0 -72.16 108.8 5.53 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.696 -0.853 . . . . 73.14 108.696 176.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 17.8 tpt180 -91.47 127.05 36.76 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.625 -0.88 . . . . 75.05 108.625 -177.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.412 ' HB ' HG22 ' B' ' 5' ' ' THR . 61.6 t -72.7 118.04 17.2 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 N-CA-C 108.779 -0.822 . . . . 75.04 108.779 176.139 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.494 ' HB ' HG12 ' A' ' 145' ' ' VAL . 59.2 t -132.23 115.8 27.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 124.056 0.942 . . . . 73.34 109.236 -175.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -79.62 124.73 28.8 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 109.04 -0.726 . . . . 71.3 109.04 170.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.475 HG22 HD22 ' B' ' 8' ' ' LEU . 12.2 p -167.68 138.13 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 122.899 0.48 . . . . 75.1 110.57 172.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 64.66 12.3 7.45 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.933 1.293 . . . . 74.24 112.205 -178.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.58 ' HA3' ' HB2' ' A' ' 79' ' ' PRO . . . 76.05 20.41 77.6 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-N 116.562 -0.29 . . . . 54.15 113.132 -172.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.469 ' NE ' ' HB3' ' A' ' 84' ' ' ASP . 1.0 OUTLIER -123.85 114.32 19.71 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 107.926 -1.138 . . . . 72.43 107.926 175.866 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 55.0 ttt-85 -73.16 87.57 1.43 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.3 1.04 . . . . 74.41 109.357 176.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.494 HG12 ' HB ' ' A' ' 138' ' ' VAL . 5.7 p -86.06 134.48 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 123.572 0.749 . . . . 73.53 111.136 -176.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.445 ' HB3' ' HB3' ' A' ' 135' ' ' GLU . 15.2 m -94.41 84.86 4.43 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 114.879 -1.055 . . . . 64.43 108.515 174.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 90.0 t -79.92 108.84 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 N-CA-C 108.207 -1.034 . . . . 73.42 108.207 -177.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.415 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 50.5 ttt180 -76.23 92.87 3.32 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 109.116 -0.698 . . . . 74.32 109.116 -177.045 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.63 ' HB ' HG13 ' A' ' 153' ' ' VAL . 42.2 pt -80.1 137.96 53.04 Favored Pre-proline 0 CA--C 1.555 1.163 0 CA-C-N 114.481 -1.236 . . . . 74.52 109.266 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -62.56 141.58 86.74 Favored 'Trans proline' 0 C--N 1.374 1.888 0 C-N-CA 122.519 2.146 . . . . 74.22 112.245 176.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -58.88 93.79 0.08 OUTLIER 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 122.659 2.24 . . . . 74.15 111.045 170.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.424 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . 104.85 77.19 1.13 Allowed Glycine 0 C--N 1.335 0.524 0 CA-C-N 115.032 -0.986 . . . . 75.51 110.85 -172.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.63 HG13 ' HB ' ' A' ' 149' ' ' ILE . 5.8 p -135.01 103.37 4.3 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.239 0 C-N-CA 123.899 0.88 . . . . 75.43 109.248 174.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.608 ' HD2' HD12 ' A' ' 193' ' ' LEU . 60.5 mtt180 -113.32 173.74 6.25 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 113.3 0.852 . . . . 73.23 113.3 -166.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.523 ' HB2' ' HB2' ' A' ' 180' ' ' LEU . 8.6 tp10 -47.65 94.06 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 127.222 2.209 . . . . 72.32 113.965 -167.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 121.49 8.57 7.59 Favored Glycine 0 N--CA 1.478 1.471 0 CA-C-O 119.82 -0.433 . . . . 74.33 114.065 178.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 21.8 t -80.9 147.76 30.18 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 109.048 -0.723 . . . . 74.23 109.048 171.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 61.2 t -114.49 94.15 2.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 C-N-CA 123.584 0.754 . . . . 74.02 109.072 -178.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.579 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 51.7 mt -74.95 95.13 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 N-CA-C 108.212 -1.033 . . . . 75.24 108.212 173.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -79.94 118.01 21.3 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.395 -0.366 . . . . 75.21 110.127 179.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.5 p -118.08 108.89 41.6 Favored Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 123.653 0.781 . . . . 71.41 109.594 175.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -76.37 115.3 4.07 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 123.103 2.536 . . . . 74.53 111.141 175.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 125.56 -28.07 5.08 Favored Glycine 0 CA--C 1.507 -0.458 0 N-CA-C 111.205 -0.758 . . . . 70.43 111.205 176.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 87.9 mtp -94.77 144.21 25.82 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 105.229 -2.137 . . . . 64.15 105.229 162.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 171.4 -124.79 1.14 Allowed Glycine 0 CA--C 1.498 -0.995 0 C-N-CA 121.724 -0.274 . . . . 73.33 112.434 175.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -68.93 160.98 52.11 Favored Glycine 0 C--O 1.245 0.787 0 O-C-N 124.508 0.769 . . . . 74.5 111.967 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.82 ' HB3' ' HA3' ' A' ' 108' ' ' GLY . 31.9 mm-40 -68.87 104.58 2.09 Favored 'General case' 0 CA--C 1.55 0.972 0 O-C-N 125.142 1.143 . . . . 75.42 111.706 -169.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -171.33 162.57 35.24 Favored Glycine 0 C--N 1.344 1.016 0 CA-C-O 118.762 -1.021 . . . . 64.21 112.182 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . 0.635 ' HA ' ' HB3' ' A' ' 106' ' ' PHE . 49.5 t-20 -56.54 -58.69 15.43 Favored Pre-proline 0 N--CA 1.503 2.214 0 CA-C-O 118.288 -0.863 . . . . 63.54 110.571 -171.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.594 ' HD3' ' HB3' ' A' ' 169' ' ' ASN . 12.8 Cg_endo -91.6 97.21 0.21 Allowed 'Trans proline' 0 C--N 1.383 2.376 0 N-CA-C 107.779 -1.662 . . . . 73.02 107.779 157.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.43 165.3 3.32 Favored 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 122.502 2.134 . . . . 71.25 113.861 -170.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -69.0 -118.34 0.03 OUTLIER Glycine 0 N--CA 1.484 1.881 0 N-CA-C 115.401 0.92 . . . . 72.4 115.401 -170.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -135.7 118.89 16.56 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 107.667 -1.234 . . . . 71.14 107.667 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 11.2 tp -105.58 132.46 51.71 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.082 0.467 . . . . 74.2 111.303 -166.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 58.9 mt -108.37 94.69 5.2 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 114.915 -1.039 . . . . 72.12 108.445 176.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.579 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 72.2 mt -78.5 93.84 4.85 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.564 -0.744 . . . . 74.52 109.732 -179.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.0 t -83.4 96.76 4.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 107.498 -1.297 . . . . 71.11 107.498 176.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 12.8 p -65.76 110.37 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.083 0 CA-C-N 115.009 -0.996 . . . . 74.13 111.032 -172.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.52 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 38.8 mmm-85 -96.88 96.14 8.33 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 114.817 -1.083 . . . . 73.42 109.677 179.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.523 ' HB2' ' HB2' ' A' ' 155' ' ' GLU . 29.3 mt -69.59 151.21 46.23 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 122.423 -0.173 . . . . 74.04 110.895 178.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 99.3 mt -51.63 143.08 21.64 Favored Pre-proline 0 N--CA 1.481 1.076 0 C-N-CA 124.173 0.989 . . . . 73.22 111.489 -175.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.2 86.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.387 2.582 0 C-N-CA 123.475 2.784 . . . . 74.32 112.407 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . 0.508 ' HA ' ' HD3' ' A' ' 184' ' ' PRO . 16.3 t-80 -136.96 112.69 9.64 Favored Pre-proline 0 CA--C 1.546 0.823 0 N-CA-C 107.0 -1.482 . . . . 73.35 107.0 -178.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . 0.508 ' HD3' ' HA ' ' A' ' 183' ' ' HIS . 14.2 Cg_exo -70.35 27.05 0.19 Allowed 'Trans proline' 0 CA--C 1.556 1.611 0 C-N-CA 124.42 3.413 . . . . 61.24 117.916 -162.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 14.5 t -94.66 -60.08 2.76 Favored 'Isoleucine or valine' 0 C--N 1.364 1.225 0 CA-C-N 121.102 1.774 . . . . 72.34 109.13 177.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . 0.428 ' HB3' HD22 ' A' ' 193' ' ' LEU . 48.7 m-85 -109.29 140.92 42.33 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 114.765 1.394 . . . . 72.31 114.765 -164.041 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 7.9 tpp180 -145.13 94.38 2.52 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 126.592 1.957 . . . . 75.51 106.839 172.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.513 ' HA ' ' HA ' ' A' ' 193' ' ' LEU . 22.5 tp -75.0 150.24 39.03 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.056 0.942 . . . . 74.21 110.556 173.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -131.25 100.15 5.09 Favored 'General case' 0 C--O 1.244 0.805 0 N-CA-C 107.879 -1.156 . . . . 70.31 107.879 167.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 65.92 -87.51 0.11 Allowed Glycine 0 C--N 1.352 1.448 0 CA-C-N 115.522 -0.763 . . . . 65.41 113.412 176.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.533 HE21 ' HA3' ' A' ' 242' ' ' GLY . 33.3 tt0 -107.04 -35.13 6.96 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.078 0.951 . . . . 72.32 110.931 -175.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.446 ' HB2' ' HE1' ' A' ' 250' ' ' TYR . 10.6 p-10 -108.02 125.13 51.19 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-O 121.699 0.762 . . . . 72.32 110.598 -168.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.608 HD12 ' HD2' ' A' ' 154' ' ' ARG . 0.4 OUTLIER -91.9 125.7 36.7 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.12 -0.946 . . . . 74.25 108.628 -169.985 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.43 ' HA ' ' HB2' ' A' ' 250' ' ' TYR . 39.3 m-85 -95.97 158.25 15.53 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.837 -0.801 . . . . 73.14 108.837 170.113 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 185' ' ' VAL . . . -156.05 176.17 13.01 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 123.155 0.582 . . . . 74.34 109.581 -173.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 35.6 m -130.51 142.08 50.48 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.824 0.849 . . . . 70.21 108.792 172.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 47.6 tp -135.47 125.21 25.41 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 123.796 0.838 . . . . 74.1 109.526 -174.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -82.99 126.2 32.26 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 109.186 -0.672 . . . . 63.3 109.186 170.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 7.5 p -141.19 134.08 14.34 Favored Pre-proline 0 CA--C 1.542 0.662 0 N-CA-C 107.508 -1.293 . . . . 74.33 107.508 175.031 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -78.65 161.22 27.91 Favored 'Trans proline' 0 CA--C 1.545 1.047 0 C-N-CA 121.537 1.491 . . . . 70.05 111.377 169.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.498 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -55.55 -53.89 57.35 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 124.621 1.169 . . . . 71.34 113.899 -171.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -67.53 -28.98 37.78 Favored 'Trans proline' 0 C--N 1.384 2.421 0 CA-C-N 120.769 1.31 . . . . 73.32 112.032 -173.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 17.8 mt -73.74 -34.06 39.75 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 C-N-CA 123.632 0.773 . . . . 71.02 110.318 176.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.79 -38.61 80.12 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 122.858 0.463 . . . . 74.14 111.389 176.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 201' ' ' ALA . 39.9 t -78.43 -42.93 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 123.096 0.558 . . . . 64.22 111.941 -175.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.416 HG11 ' HD2' ' C' ' 270' ' ' LYS . 56.0 t -89.38 -37.81 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 122.507 0.323 . . . . 74.41 111.45 -177.006 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 101.0 105.45 2.8 Favored Glycine 0 C--N 1.337 0.604 0 CA-C-N 116.413 -0.358 . . . . 72.35 112.421 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.422 ' HA3' ' CE1' ' C' ' 277' ' ' TYR . . . -158.69 178.46 34.88 Favored Glycine 0 C--N 1.347 1.152 0 CA-C-N 116.631 0.215 . . . . 73.32 113.163 -178.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.42 ' HE3' ' HB2' ' A' ' 209' ' ' LYS . 38.1 mtmt -79.98 137.38 36.83 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.945 0.498 . . . . 73.34 111.63 -172.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.425 HG12 ' HA ' ' A' ' 199' ' ' VAL . 27.5 m -130.45 151.74 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.83 1.252 . . . . 63.11 108.0 167.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 43.3 ttp180 -84.18 115.13 22.26 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 110.054 -0.35 . . . . 74.32 110.054 -179.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.29 132.09 47.0 Favored 'General case' 0 C--O 1.245 0.832 0 C-N-CA 123.502 0.721 . . . . 74.41 109.415 174.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' MET . . . . . 0.509 ' N ' ' SD ' ' A' ' 213' ' ' MET . 1.0 OUTLIER -86.37 101.79 13.43 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 107.64 -1.244 . . . . 74.15 107.64 178.931 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 60.2 p -111.23 168.99 9.09 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 108.896 -0.779 . . . . 74.1 108.896 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . 0.704 HD23 ' HB3' ' A' ' 127' ' ' LEU . 7.2 mt -79.14 -6.76 57.28 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 120.865 0.364 . . . . 73.14 111.183 -172.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -100.31 -4.36 29.39 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.697 1.199 . . . . 64.44 110.92 173.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 132.67 -175.36 20.02 Favored Glycine 0 C--N 1.351 1.37 0 CA-C-O 120.038 -0.312 . . . . 63.05 113.312 174.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -83.68 101.36 0.92 Allowed 'Trans proline' 0 C--N 1.369 1.628 0 C-N-CA 122.754 2.302 . . . . 74.13 111.155 175.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 34.9 m -101.37 162.2 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 123.151 0.58 . . . . 73.4 109.836 -177.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -100.82 112.63 25.09 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 109.397 -0.594 . . . . 75.04 109.397 176.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 76.6 t -93.84 106.3 17.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 107.985 -1.117 . . . . 74.51 107.985 177.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -71.91 99.65 2.27 Favored 'General case' 0 C--N 1.347 0.495 0 N-CA-C 107.923 -1.14 . . . . 70.4 107.923 172.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 90.6 t -62.77 133.33 95.04 Favored Pre-proline 0 CA--C 1.543 0.705 0 CA-C-N 114.015 -1.448 . . . . 71.22 109.569 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -58.03 155.63 32.89 Favored 'Trans proline' 0 C--N 1.376 1.986 0 C-N-CA 122.493 2.129 . . . . 75.51 112.614 171.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.33 156.77 64.81 Favored 'Trans proline' 0 C--N 1.372 1.771 0 C-N-CA 121.798 1.665 . . . . 72.53 112.33 172.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . 0.416 HH21 ' HG ' ' C' ' 261' ' ' LEU . 1.5 ptp85 43.53 48.45 6.3 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 126.484 1.914 . . . . 75.13 113.047 -178.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 20.1 m -86.63 115.68 24.25 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 113.053 -1.885 . . . . 64.32 109.815 175.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -87.13 147.3 25.7 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.652 0.781 . . . . 75.32 111.291 -175.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -63.65 132.92 52.61 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.884 0.874 . . . . 65.12 110.9 175.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 99.29 -19.82 52.39 Favored Glycine 0 C--N 1.343 0.924 0 CA-C-O 119.612 -0.549 . . . . 75.54 112.902 177.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 30.1 mtm-85 -77.35 158.93 29.87 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 117.289 0.544 . . . . 74.44 110.424 175.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -108.97 123.46 49.15 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.122 0.969 . . . . 72.22 109.883 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.446 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 57.5 mt -77.9 108.3 11.05 Favored 'General case' 0 C--N 1.348 0.542 0 N-CA-C 108.489 -0.93 . . . . 71.4 108.489 173.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -88.07 109.37 19.8 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 122.96 0.504 . . . . 73.41 110.927 -178.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.539 ' HG ' ' HB3' ' A' ' 249' ' ' LEU . 0.6 OUTLIER -121.85 111.79 17.55 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.15 0.58 . . . . 74.24 111.577 -179.194 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.442 ' HE3' ' HB3' ' A' ' 248' ' ' ASP . 4.2 mmpt? -52.87 147.92 8.36 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.862 1.265 . . . . 71.01 113.096 174.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 101.56 -17.32 55.36 Favored Glycine 0 C--N 1.351 1.377 0 CA-C-N 115.562 -0.745 . . . . 74.2 114.315 173.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -104.91 5.75 33.12 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 112.567 0.58 . . . . 74.1 112.567 -175.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -100.23 174.81 26.59 Favored Glycine 0 C--N 1.349 1.27 0 N-CA-C 112.383 -0.287 . . . . 74.43 112.383 166.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -100.53 163.92 17.24 Favored Pre-proline 0 N--CA 1.48 1.074 0 C-N-CA 125.155 1.382 . . . . 73.41 112.584 -163.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -46.94 140.63 13.07 Favored 'Trans proline' 0 C--N 1.394 2.952 0 C-N-CA 124.23 3.286 . . . . 73.33 114.563 174.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.533 ' HA3' HE21 ' A' ' 191' ' ' GLN . . . 175.75 -167.48 39.33 Favored Glycine 0 CA--C 1.534 1.271 0 CA-C-N 115.422 -0.808 . . . . 73.52 112.122 179.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -56.32 -28.81 73.96 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 123.733 2.956 . . . . 72.5 114.439 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -92.83 22.43 4.85 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.562 0.745 . . . . 70.11 111.843 -178.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 78.18 -93.1 1.19 Allowed Glycine 0 C--N 1.348 1.233 0 N-CA-C 109.762 -1.335 . . . . 62.24 109.762 -172.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 30.3 mtp180 -127.19 148.09 50.19 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.88 0.872 . . . . 75.41 108.904 166.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -78.32 -157.03 9.64 Favored Glycine 0 CA--C 1.535 1.33 0 CA-C-O 121.637 0.576 . . . . 70.31 113.902 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . 0.442 ' HB3' ' HE3' ' A' ' 236' ' ' LYS . 0.4 OUTLIER -134.49 165.0 26.2 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.404 1.081 . . . . 75.44 111.223 -174.96 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.539 ' HB3' ' HG ' ' A' ' 235' ' ' LEU . 61.6 tp -100.39 153.31 19.44 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.493 1.117 . . . . 73.32 109.756 178.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.446 ' HE1' ' HB2' ' A' ' 192' ' ' ASP . 62.9 m-85 -128.65 103.6 7.18 Favored 'General case' 0 C--O 1.219 -0.536 0 N-CA-C 108.873 -0.788 . . . . 71.3 108.873 177.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.446 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 32.8 mt -90.09 104.16 16.76 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.122 -0.696 . . . . 74.54 109.122 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -77.36 125.27 29.07 Favored 'General case' 0 C--N 1.362 1.141 0 CA-C-O 121.64 0.734 . . . . 75.41 109.933 -176.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 61.1 t -78.76 117.61 24.6 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-N 114.271 -1.331 . . . . 71.34 111.701 -169.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 15.8 mmm-85 -114.49 96.17 5.63 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.126 -1.064 . . . . 73.14 108.126 170.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.496 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 69.8 mt -75.44 133.95 30.27 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 CA-C-N 114.86 -1.064 . . . . 74.34 110.12 178.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 22.6 p -126.09 -177.95 4.13 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.865 1.266 . . . . 74.52 110.144 178.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . 0.539 HG23 HG21 ' C' ' 255' ' ' ILE . 2.4 pp -139.01 159.66 65.93 Favored Pre-proline 0 N--CA 1.491 1.589 0 C-N-CA 123.803 0.841 . . . . 73.4 110.655 -177.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -60.96 -9.44 12.06 Favored 'Trans proline' 0 C--N 1.393 2.903 0 C-N-CA 123.112 2.541 . . . . 74.45 115.519 -167.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . 0.724 ' HG2' HE21 ' C' ' 228' ' ' GLN . 42.4 mt-10 57.0 -64.92 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 125.824 1.649 . . . . 75.12 114.288 -174.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.15 157.16 16.87 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 109.326 -0.62 . . . . 75.12 109.326 168.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.594 HD11 ' HA ' ' A' ' 266' ' ' GLU . 64.2 mt -141.9 131.47 23.95 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 118.287 0.494 . . . . 72.32 111.237 -178.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.46 148.35 52.1 Favored Pre-proline 0 CA--C 1.555 1.143 0 N-CA-C 107.702 -1.222 . . . . 74.31 107.702 167.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -40.8 -31.82 0.76 Allowed 'Trans proline' 0 C--N 1.392 2.838 0 C-N-CA 124.939 3.76 . . . . 74.33 116.58 -167.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -61.38 -68.08 0.35 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.448 0.699 . . . . 71.44 110.758 176.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . 0.533 ' HB2' HD22 ' A' ' 261' ' ' LEU . 1.7 mp0 -67.17 -28.28 67.98 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 123.487 0.492 . . . . 73.22 110.28 -175.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 266' ' ' GLU . . . . . 0.594 ' HA ' HD11 ' A' ' 261' ' ' LEU . 8.3 tp10 -50.38 -58.46 5.65 Favored 'General case' 0 C--O 1.253 1.249 0 C-N-CA 124.258 1.023 . . . . 73.45 109.459 171.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . 0.447 ' O ' ' HG2' ' A' ' 271' ' ' LYS . . . -59.13 -58.43 8.67 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 114.702 -1.135 . . . . 64.12 111.15 177.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 10.2 mp -57.6 -45.92 84.69 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 123.852 0.861 . . . . 73.14 112.854 -170.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 63.3 m95 -60.23 -46.92 88.1 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 123.749 0.655 . . . . 75.0 110.805 175.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . 0.614 ' HE2' ' HA ' ' C' ' 206' ' ' VAL . 2.2 mptm? -63.05 -34.33 77.35 Favored 'General case' 0 CA--C 1.548 0.874 0 O-C-N 123.727 0.642 . . . . 73.12 112.03 178.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' A' ' 267' ' ' ALA . 26.4 mmmt -73.96 -40.31 63.12 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 118.084 0.402 . . . . 70.22 110.366 -177.558 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 39.5 mt -57.72 -39.38 77.11 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 123.467 0.707 . . . . 71.54 110.204 170.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -65.97 -45.1 82.92 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 124.129 0.893 . . . . 72.23 112.644 -177.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -67.35 -42.85 82.83 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.811 0.844 . . . . 74.35 110.763 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -62.53 -44.13 97.1 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.38 -0.827 . . . . 72.24 110.231 177.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -63.69 -44.25 94.25 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.415 1.086 . . . . 75.02 109.909 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -62.71 -43.6 98.4 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.82 1.248 . . . . 72.14 109.492 -177.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -75.02 -5.03 41.83 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 115.236 -0.893 . . . . 75.41 112.563 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 43.7 mtm180 -115.38 -0.88 13.01 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.808 0.843 . . . . 75.15 110.08 173.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.1 0 N-CA-C 108.546 -0.909 . . . . 72.5 108.546 178.975 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.425 ' SD ' ' N ' ' B' ' 1' ' ' MET . 1.6 mpt? . . . . . 0 N--CA 1.476 0.874 0 N-CA-C 109.627 -0.509 . . . . 74.12 109.627 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 85.1 tttt 65.43 143.89 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 125.483 1.513 . . . . 62.45 111.906 -176.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 64.64 1.66 1.43 Allowed 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 125.164 1.386 . . . . 74.04 113.479 -178.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 43.3 m -72.57 95.28 1.8 Allowed 'General case' 0 C--N 1.354 0.797 0 C-N-CA 123.468 0.707 . . . . 52.14 109.111 -179.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 5' ' ' THR . . . . . 0.412 HG22 ' HB ' ' A' ' 137' ' ' VAL . 0.1 OUTLIER -83.39 160.85 21.53 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.418 -0.81 . . . . 74.34 111.102 -171.879 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.636 HG23 ' HA ' ' A' ' 125' ' ' LEU . 38.5 pt -130.34 168.89 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 112.943 0.72 . . . . 65.34 112.943 -154.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -145.25 124.78 13.17 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.82 0.848 . . . . 72.22 108.975 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . 0.475 HD22 HG22 ' A' ' 140' ' ' VAL . 60.7 tp -63.53 138.3 58.46 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.066 0.946 . . . . 75.22 110.894 -174.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.52 -48.63 80.9 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 124.183 0.927 . . . . 73.12 111.074 177.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 6.1 tt 53.67 89.79 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.155 0 O-C-N 124.53 1.144 . . . . 74.1 108.957 -172.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 91.7 mt . . . . . 0 CA--C 1.547 0.833 0 N-CA-C 110.045 -0.354 . . . . 72.11 110.045 -176.05 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.319 0 N-CA-C 114.308 1.225 . . . . 74.35 114.308 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . 54.54 48.45 20.41 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.838 0.828 . . . . 75.32 109.088 -168.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 31.2 tp 62.25 -77.56 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.28 0 CA-C-N 113.277 -1.783 . . . . 74.44 111.584 -166.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 182' ' ' VAL . . . . . 0.658 ' HA ' ' HB3' ' C' ' 123' ' ' LEU . 91.3 t -96.5 141.3 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 123.839 0.856 . . . . 72.43 111.364 -175.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -134.8 8.05 3.52 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.5 0.72 . . . . 65.24 112.708 -176.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 184' ' ' HIS . . . . . 0.428 ' CD2' ' HB3' ' C' ' 122' ' ' GLU . 80.0 t60 -145.44 152.33 39.64 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 118.104 0.411 . . . . 75.32 110.371 179.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 185' ' ' VAL . . . . . . . . . . . . . 71.4 t . . . . . 0 N--CA 1.501 2.087 0 C-N-CA 126.124 1.77 . . . . 74.01 110.439 -170.83 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 8.9 m . . . . . 0 CA--C 1.555 1.149 0 N-CA-C 109.562 -0.533 . . . . 71.31 109.562 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 239' ' ' ALA . . . . . 0.493 ' HB3' ' HA ' ' C' ' 221' ' ' VAL . . . -67.91 -179.36 1.17 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.345 1.058 . . . . 74.42 111.964 176.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 240' ' ' GLY . . . . . 0.455 ' HA3' ' O ' ' C' ' 234' ' ' ARG . . . -103.38 -114.09 3.89 Favored Glycine 0 C--N 1.343 0.956 0 CA-C-O 119.718 -0.49 . . . . 71.23 111.903 -176.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -149.99 142.55 24.47 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.217 0.607 . . . . 71.23 111.087 -178.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -179.63 117.25 0.06 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 125.279 1.432 . . . . 70.32 108.971 173.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 243' ' ' GLN . . . . . 0.568 HE21 ' HG2' ' C' ' 224' ' ' PRO . 26.2 mt-30 65.36 -79.48 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 125.068 1.347 . . . . 74.22 113.004 176.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 152.63 100.13 0.19 Allowed Glycine 0 C--N 1.347 1.177 0 N-CA-C 111.699 -0.561 . . . . 71.54 111.699 -177.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 245' ' ' LYS . . . . . 0.461 ' HA ' ' HA ' ' C' ' 224' ' ' PRO . 0.0 OUTLIER . . . . . 0 CA--C 1.552 1.058 0 C-N-CA 123.835 0.854 . . . . 75.34 111.48 -178.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.656 0 N-CA-C 110.008 -0.367 . . . . 71.34 110.008 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -38.72 104.96 0.04 OUTLIER 'General case' 0 C--N 1.358 0.939 0 C-N-CA 125.504 1.522 . . . . 70.52 112.779 178.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 5' ' ' LYS . . . . . 0.425 ' HE2' HD11 ' C' ' 10' ' ' ILE . 47.6 mtpt -97.34 112.37 24.22 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.625 -0.88 . . . . 72.32 108.625 173.083 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -71.07 105.01 3.19 Favored 'General case' 0 C--O 1.244 0.788 0 N-CA-C 108.806 -0.813 . . . . 65.15 108.806 174.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 7' ' ' TYR . . . . . 0.411 ' HA ' HD13 ' C' ' 10' ' ' ILE . 75.5 m-85 -63.42 -26.54 68.78 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 114.544 -1.207 . . . . 73.43 112.074 -173.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -63.58 -48.23 78.25 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 109.578 -0.527 . . . . 74.23 109.578 173.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.95 -37.84 83.77 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.102 0.561 . . . . 63.34 111.544 179.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 10' ' ' ILE . . . . . 0.425 HD11 ' HE2' ' C' ' 5' ' ' LYS . 63.8 mt -58.78 -43.9 89.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 C-N-CA 123.225 0.61 . . . . 73.31 110.465 174.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 73.4 mt -76.32 -11.83 59.97 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 115.77 -0.65 . . . . 75.53 112.698 177.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.32 40.22 55.7 Favored Glycine 0 C--N 1.35 1.353 0 N-CA-C 112.821 -0.112 . . . . 74.43 112.821 -176.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 14.6 m -131.78 156.66 79.83 Favored Pre-proline 0 N--CA 1.485 1.295 0 C-N-CA 124.927 1.291 . . . . 71.34 109.826 178.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -80.97 177.16 8.23 Favored 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 122.452 2.101 . . . . 74.43 112.421 176.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 90.5 mtt180 -83.78 36.99 0.57 Allowed 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 122.485 1.136 . . . . 74.35 111.297 176.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -117.34 -15.59 10.35 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.702 2.001 . . . . 71.24 107.417 172.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.79 104.69 0.56 Allowed 'General case' 0 C--N 1.35 0.621 0 CA-C-N 114.383 -1.28 . . . . 75.2 112.834 -169.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 76.7 p -71.28 -170.13 0.46 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.894 1.278 . . . . 74.41 110.841 174.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.83 -42.89 90.34 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 124.276 1.03 . . . . 74.45 110.152 177.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 20' ' ' GLU . . . . . 0.485 ' O ' ' HG3' ' C' ' 24' ' ' ARG . 0.9 OUTLIER -75.58 -35.74 60.52 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 116.235 -0.438 . . . . 74.53 110.326 -175.582 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -68.52 -38.85 81.26 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-O 121.223 0.535 . . . . 73.42 110.55 178.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 1.1 mp -60.14 -39.53 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.397 1.079 . . . . 75.54 109.796 169.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -70.01 -31.39 69.04 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.297 -0.865 . . . . 74.13 110.812 178.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 24' ' ' ARG . . . . . 0.485 ' HG3' ' O ' ' C' ' 20' ' ' GLU . 89.0 mtt180 -65.81 -44.87 84.35 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 109.398 -0.593 . . . . 73.52 109.398 177.435 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.09 -34.9 79.11 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 114.57 -1.196 . . . . 75.32 111.562 176.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 26' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -67.9 -48.15 66.8 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 123.816 0.698 . . . . 72.31 110.631 177.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -59.37 -56.11 26.18 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.381 -0.6 . . . . 75.33 109.381 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 32.3 ttt180 -50.49 -70.76 0.08 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.947 0.899 . . . . 75.55 111.489 177.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 86.7 mt -75.0 -50.31 16.98 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.42 -0.809 . . . . 71.43 112.04 -168.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' C' ' 34' ' ' HIS . . . -67.57 -28.52 67.85 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-O 117.714 -1.136 . . . . 75.32 112.239 -176.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . 0.47 ' HA ' ' HB2' ' C' ' 34' ' ' HIS . 74.5 mtm180 -80.9 -28.24 35.95 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 120.051 1.296 . . . . 73.5 110.842 173.117 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -65.34 -31.33 72.4 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.212 0.605 . . . . 71.12 110.367 171.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 33' ' ' TYR . . . . . 0.449 ' HB3' ' O ' ' C' ' 43' ' ' ALA . 21.7 m-85 -111.02 8.13 21.8 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.884 0.873 . . . . 72.14 112.056 -174.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 34' ' ' HIS . . . . . 0.47 ' HB2' ' HA ' ' C' ' 31' ' ' ARG . 9.4 t-160 -75.43 114.33 34.79 Favored Pre-proline 0 N--CA 1.479 1.003 0 CA-C-O 118.26 -0.876 . . . . 74.34 110.152 -174.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.52 -20.53 49.9 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 122.423 2.082 . . . . 72.22 112.882 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -53.5 -43.69 68.45 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.773 1.229 . . . . 60.34 112.181 173.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 86.5 t -107.53 -52.49 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 123.109 0.564 . . . . 75.33 109.955 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -98.37 90.68 4.88 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.128 0.971 . . . . 65.41 109.898 -176.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -74.84 81.4 2.12 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 109.113 -0.699 . . . . 71.22 109.113 176.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 70.8 m -137.37 117.02 10.31 Favored Pre-proline 0 N--CA 1.48 1.037 0 C-N-CA 123.459 0.704 . . . . 74.14 109.756 176.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -50.52 -43.33 45.52 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 123.882 3.055 . . . . 75.0 114.005 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -58.06 -40.3 80.66 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.406 0.682 . . . . 71.01 110.549 175.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 43' ' ' ALA . . . . . 0.449 ' O ' ' HB3' ' C' ' 33' ' ' TYR . . . -73.41 -17.93 61.21 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 115.661 -0.7 . . . . 71.45 110.259 -178.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 44' ' ' GLU . . . . . 0.434 ' O ' ' HD3' ' C' ' 48' ' ' LYS . 44.1 mt-10 -74.87 -43.9 51.9 Favored 'General case' 0 C--N 1.358 0.947 0 N-CA-C 109.217 -0.66 . . . . 74.04 109.217 175.01 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -57.69 -46.03 84.87 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 121.672 0.748 . . . . 75.44 110.048 175.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 46' ' ' LYS . . . . . 0.551 ' O ' HG12 ' C' ' 50' ' ' ILE . 99.9 mttt -63.6 -39.56 94.67 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 114.237 -1.347 . . . . 72.32 110.802 176.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -62.94 -32.53 73.86 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.869 0.868 . . . . 71.12 110.476 177.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 48' ' ' LYS . . . . . 0.434 ' HD3' ' O ' ' C' ' 44' ' ' GLU . 2.5 mptm? -65.81 -47.32 75.48 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 122.959 0.504 . . . . 72.04 109.702 173.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -58.57 -44.59 89.81 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.13 0.572 . . . . 72.33 111.304 178.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 50' ' ' ILE . . . . . 0.551 HG12 ' O ' ' C' ' 46' ' ' LYS . 20.3 mm -63.21 -49.31 83.7 Favored 'Isoleucine or valine' 0 C--N 1.361 1.078 0 CA-C-N 115.686 -0.688 . . . . 75.43 109.733 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 51' ' ' ASN . . . . . 0.501 ' HA ' ' HB3' ' C' ' 54' ' ' TYR . 22.0 m-80 -79.9 -9.18 59.65 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.703 0.801 . . . . 74.04 112.169 -176.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -71.26 -61.37 1.79 Allowed 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 107.842 -1.17 . . . . 75.54 107.842 167.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.65 -41.72 86.71 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 113.626 -1.624 . . . . 63.1 112.216 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 54' ' ' TYR . . . . . 0.501 ' HB3' ' HA ' ' C' ' 51' ' ' ASN . 67.2 t80 -65.1 -52.68 54.04 Favored 'General case' 0 C--O 1.213 -0.837 0 CA-C-N 115.148 -0.933 . . . . 75.01 109.884 177.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.68 -38.2 63.95 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 112.199 0.444 . . . . 60.54 112.199 -177.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 98.2 t -64.61 -55.61 20.39 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 O-C-N 123.99 0.807 . . . . 72.43 110.887 173.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 57' ' ' LEU . . . . . . . . . . . . . 68.0 mt -94.27 7.58 44.86 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 113.616 0.969 . . . . 75.02 113.616 -168.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 43.8 t -69.65 -81.03 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.719 0.807 . . . . 75.33 110.919 -175.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -83.8 145.4 47.0 Favored Pre-proline 0 C--O 1.248 1.021 0 N-CA-C 109.37 -0.604 . . . . 72.03 109.37 -174.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 60' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -47.13 -33.92 16.4 Favored 'Trans proline' 0 C--N 1.387 2.588 0 C-N-CA 124.546 3.497 . . . . 73.21 113.634 -176.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -56.11 -71.03 0.1 Allowed 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 124.492 1.117 . . . . 62.13 111.62 178.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 33.8 mtmt -66.01 -29.08 69.39 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.74 0.816 . . . . 75.43 111.185 -174.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 23.8 tpt85 -54.19 -52.47 61.1 Favored 'General case' 0 C--N 1.356 0.876 0 O-C-N 124.277 0.986 . . . . 74.14 109.583 170.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -63.33 -35.99 82.21 Favored 'General case' 0 C--N 1.357 0.896 0 CA-C-O 118.613 -0.708 . . . . 74.15 111.915 178.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 1.5 mp -55.98 -45.31 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-N 118.281 0.492 . . . . 71.5 110.363 175.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -61.59 -55.17 33.7 Favored 'General case' 0 C--N 1.358 0.957 0 N-CA-C 109.937 -0.394 . . . . 74.31 109.937 176.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -56.48 -36.48 69.15 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.646 0.778 . . . . 73.14 112.586 -176.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 45.5 p -77.35 -30.65 54.0 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 119.085 -0.484 . . . . 74.43 110.92 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -66.82 128.39 36.13 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 118.425 0.557 . . . . 75.22 110.471 -179.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.19 14.85 55.4 Favored Glycine 0 C--N 1.345 1.059 0 N-CA-C 111.582 -0.607 . . . . 62.51 111.582 -176.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 29.8 m -142.48 -57.44 0.44 Allowed 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 103.942 -2.614 . . . . 72.34 103.942 177.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 49.5 m -79.73 141.15 36.61 Favored 'General case' 0 C--O 1.257 1.494 0 N-CA-C 104.871 -2.27 . . . . 73.35 104.871 154.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.4 -40.07 10.12 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.486 0.714 . . . . 73.23 109.833 178.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -77.88 128.28 79.56 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 123.886 0.874 . . . . 53.23 110.619 -175.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -62.48 121.28 9.18 Favored 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 122.642 2.228 . . . . 75.14 110.746 174.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -52.23 131.19 38.67 Favored 'Trans proline' 0 C--N 1.38 2.193 0 C-N-CA 123.328 2.685 . . . . 71.22 113.001 -179.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -53.03 126.79 22.62 Favored 'Trans proline' 0 C--N 1.39 2.743 0 C-N-CA 123.392 2.728 . . . . 74.4 112.232 -175.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 78' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -64.09 148.53 91.39 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 122.738 2.292 . . . . 74.44 112.317 -172.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -57.34 158.1 19.81 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 122.512 2.141 . . . . 70.12 111.251 171.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -53.42 80.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.386 2.52 0 C-N-CA 124.069 3.179 . . . . 74.31 115.259 -171.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 149.75 -41.91 0.81 Allowed Glycine 0 C--N 1.341 0.826 0 N-CA-C 110.773 -0.931 . . . . 75.2 110.773 -178.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 145.86 174.86 18.42 Favored Glycine 0 C--N 1.343 0.921 0 C-N-CA 123.472 0.558 . . . . 75.13 111.881 177.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -53.56 124.32 14.64 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.209 1.004 . . . . 73.4 109.799 169.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -58.1 110.85 1.01 Allowed 'General case' 0 N--CA 1.479 0.984 0 O-C-N 123.88 0.737 . . . . 75.11 111.179 175.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 85' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -142.86 31.62 1.42 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.371 1.469 . . . . 74.41 108.736 170.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 86' ' ' SER . . . . . 0.459 ' OG ' ' HD2' ' C' ' 143' ' ' ARG . 7.4 m -71.04 106.88 3.86 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 114.216 -1.356 . . . . 52.42 110.191 -173.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 100.84 -21.8 42.21 Favored Glycine 0 C--N 1.337 0.626 0 CA-C-N 116.107 -0.497 . . . . 74.34 112.811 -176.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 88' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -88.0 130.65 34.9 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 108.203 -1.036 . . . . 74.44 108.203 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -75.68 69.55 2.39 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.964 0.905 . . . . 72.23 110.664 -170.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 90' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -48.34 -43.27 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 125.679 1.592 . . . . 54.42 112.114 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -62.76 -30.78 71.7 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.267 0.627 . . . . 75.25 111.91 -176.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -81.53 -26.02 35.43 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.511 0.324 . . . . 75.53 110.607 177.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 15.1 m-30 -68.95 166.75 17.24 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.499 0.319 . . . . 72.45 110.855 -174.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 65.1 p -63.68 162.2 13.6 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 114.3 1.222 . . . . 52.11 114.3 -165.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 95' ' ' GLU . . . . . 0.429 ' O ' ' HG3' ' C' ' 99' ' ' GLU . 0.0 OUTLIER -63.39 -44.17 95.47 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 114.988 -1.006 . . . . 72.35 111.931 178.245 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -55.79 -46.95 77.85 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.313 0.645 . . . . 74.24 110.545 177.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 97' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -56.58 -46.85 80.59 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 113.77 -1.559 . . . . 64.25 110.271 175.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 98' ' ' GLN . . . . . 0.479 ' HA ' ' CD1' ' C' ' 105' ' ' LEU . 93.1 mt-30 -73.89 -12.71 60.75 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.183 0.808 . . . . 71.33 113.183 -176.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 99' ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' C' ' 95' ' ' GLU . 46.8 mt-10 -87.1 -48.43 8.08 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.19 0.596 . . . . 74.43 111.211 172.195 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 13.3 tp -66.6 -60.1 3.01 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.588 0.755 . . . . 73.23 111.313 -175.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -85.23 -8.98 58.29 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 116.205 -0.452 . . . . 75.04 110.994 -177.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -39.0 -55.24 2.34 Favored Glycine 0 C--N 1.365 2.157 0 CA-C-O 118.407 -1.218 . . . . 74.41 114.943 -176.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -29.24 -37.47 0.04 OUTLIER 'Trans proline' 0 C--N 1.391 2.782 1 C-N-CA 125.731 4.287 . . . . 64.35 116.888 173.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -147.52 36.45 1.17 Allowed Glycine 0 C--N 1.352 1.454 0 C-N-CA 121.559 -0.353 . . . . 73.42 112.982 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 105' ' ' LEU . . . . . 0.479 ' CD1' ' HA ' ' C' ' 98' ' ' GLN . 4.1 mt . . . . . 0 N--CA 1.488 1.436 0 N-CA-C 115.629 1.714 . . . . 75.43 115.629 -174.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.969 0 N-CA-C 111.252 -0.739 . . . . 54.4 111.252 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 67.7 mtp180 -93.91 163.55 13.45 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.545 0.738 . . . . 74.32 109.977 177.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 118' ' ' ASP . . . . . 0.42 ' HA ' ' O ' ' C' ' 173' ' ' ASP . 9.6 p-10 -73.33 93.52 1.92 Allowed 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 108.57 -0.9 . . . . 75.42 108.57 174.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 119' ' ' LEU . . . . . 0.467 HD11 ' HA ' ' C' ' 174' ' ' LEU . 0.0 OUTLIER -95.33 157.08 16.05 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 108.233 -1.025 . . . . 75.21 108.233 -178.544 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.64 126.41 48.97 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.94 -0.392 . . . . 72.31 109.94 -174.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 121' ' ' ALA . . . . . . . . . . . . . . . -125.19 118.71 26.65 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 108.747 -0.834 . . . . 75.44 108.747 -178.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 122' ' ' GLU . . . . . 0.428 ' HB3' ' CD2' ' B' ' 184' ' ' HIS . 37.2 tt0 -94.88 148.16 22.6 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 122.676 0.39 . . . . 74.12 110.839 -171.116 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 123' ' ' LEU . . . . . 0.658 ' HB3' ' HA ' ' B' ' 182' ' ' VAL . 1.0 OUTLIER -144.61 114.82 5.19 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 122.862 0.465 . . . . 73.3 111.137 -177.318 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -66.18 114.45 3.03 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 121.862 1.708 . . . . 72.51 108.964 162.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 125' ' ' LEU . . . . . 0.548 HD21 HG13 ' C' ' 153' ' ' VAL . 18.4 tp -138.15 155.52 48.64 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.579 0.351 . . . . 75.32 110.846 -164.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 126' ' ' THR . . . . . . . . . . . . . 15.0 p -100.09 160.6 14.19 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-O 121.871 0.843 . . . . 61.53 111.218 173.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 127' ' ' LEU . . . . . 0.451 HD22 HD13 ' C' ' 180' ' ' LEU . 8.4 mt -67.13 -35.46 79.77 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 113.46 -1.7 . . . . 62.25 108.479 174.127 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -62.88 -47.23 84.2 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 113.145 -1.843 . . . . 75.24 109.605 176.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -66.46 -28.82 68.89 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 122.854 0.462 . . . . 75.51 111.732 176.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.85 -41.23 97.85 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 123.463 0.477 . . . . 73.14 110.51 175.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 131' ' ' PHE . . . . . 0.405 ' HB2' HD13 ' C' ' 215' ' ' LEU . 52.3 t80 -65.31 -43.0 92.46 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.965 0.906 . . . . 75.55 110.292 172.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 132' ' ' HIS . . . . . 0.467 ' O ' ' HD3' ' C' ' 136' ' ' ARG . 23.5 m170 -80.01 -1.8 41.35 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.206 -0.906 . . . . 70.15 110.781 -176.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -69.15 65.47 0.52 Allowed Glycine 0 C--N 1.358 1.8 0 C-N-CA 123.977 0.799 . . . . 65.31 114.447 174.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . -93.47 -126.23 4.25 Favored Glycine 0 C--N 1.343 0.936 0 N-CA-C 109.442 -1.463 . . . . 73.12 109.442 165.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 13.8 mp0 -71.97 94.79 1.5 Allowed 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 117.667 0.734 . . . . 73.03 109.119 175.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 136' ' ' ARG . . . . . 0.467 ' HD3' ' O ' ' C' ' 132' ' ' HIS . 17.9 mmm180 -110.82 147.64 34.07 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.45 0.7 . . . . 72.12 110.313 -175.081 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 137' ' ' VAL . . . . . . . . . . . . . 35.8 m -91.73 144.19 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 108.823 -0.806 . . . . 73.11 108.823 178.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 138' ' ' VAL . . . . . 0.438 HG21 HG21 ' C' ' 140' ' ' VAL . 14.7 p -160.64 151.0 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 O-C-N 123.211 0.32 . . . . 72.14 110.936 -177.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 139' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -120.1 113.27 20.22 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 107.561 -1.274 . . . . 74.31 107.561 171.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 140' ' ' VAL . . . . . 0.438 HG21 HG21 ' C' ' 138' ' ' VAL . 90.0 t -130.14 101.61 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 123.759 0.824 . . . . 73.25 110.794 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 141' ' ' ALA . . . . . 0.661 ' HB2' HH21 ' C' ' 143' ' ' ARG . . . 55.45 44.65 26.69 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.576 1.551 . . . . 65.0 112.562 168.04 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 103.08 6.26 45.72 Favored Glycine 0 C--N 1.347 1.175 0 CA-C-N 115.46 -0.791 . . . . 52.4 113.183 178.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 143' ' ' ARG . . . . . 0.661 HH21 ' HB2' ' C' ' 141' ' ' ALA . 0.0 OUTLIER -120.82 95.39 4.69 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 117.452 0.626 . . . . 75.05 110.19 -176.95 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 52.9 ttt180 -90.49 87.25 6.69 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 107.767 -1.197 . . . . 71.51 107.767 168.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 145' ' ' VAL . . . . . . . . . . . . . 27.4 m -119.66 148.77 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 115.4 -0.818 . . . . 75.03 111.574 -176.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 16.0 p -99.11 96.9 8.1 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 124.492 1.117 . . . . 73.22 108.433 168.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 14.8 p -124.83 151.52 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.753 0.821 . . . . 72.53 110.471 -173.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 24.2 ttm180 -98.24 110.15 22.78 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 109.952 -0.388 . . . . 74.22 109.952 169.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 149' ' ' ILE . . . . . 0.428 HD11 HD13 ' C' ' 159' ' ' ILE . 39.8 pt -78.82 153.88 78.04 Favored Pre-proline 0 CA--C 1.552 1.038 0 N-CA-C 108.085 -1.08 . . . . 74.42 108.085 164.297 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -43.03 111.73 0.24 Allowed 'Trans proline' 0 C--N 1.385 2.45 0 C-N-CA 122.989 2.459 . . . . 61.44 112.879 175.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.95 102.6 0.13 Allowed 'Trans proline' 0 C--N 1.389 2.708 0 C-N-CA 123.507 2.805 . . . . 73.2 111.257 -178.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 152' ' ' GLY . . . . . 0.496 ' HA3' HD21 ' C' ' 188' ' ' LEU . . . 132.06 140.33 4.49 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 116.025 -0.534 . . . . 63.11 112.635 -171.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 153' ' ' VAL . . . . . 0.622 HG21 HG11 ' C' ' 178' ' ' VAL . 0.3 OUTLIER -152.59 167.26 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 N-CA-C 112.267 0.469 . . . . 74.01 112.267 -174.899 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' C' C ' 154' ' ' ARG . . . . . 0.448 ' HB2' ' OG ' ' C' ' 157' ' ' SER . 19.2 mtt180 -138.61 162.89 33.47 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.529 1.131 . . . . 75.32 109.28 -173.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 155' ' ' GLU . . . . . 0.443 ' HB2' HD11 ' C' ' 180' ' ' LEU . 10.2 tp10 -72.76 132.65 43.89 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 123.98 0.912 . . . . 74.51 111.953 178.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 65.17 19.73 66.41 Favored Glycine 0 C--N 1.359 1.839 0 O-C-N 123.745 0.653 . . . . 75.21 113.601 173.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 157' ' ' SER . . . . . 0.448 ' OG ' ' HB2' ' C' ' 154' ' ' ARG . 53.4 m -98.18 172.19 7.75 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.241 0.616 . . . . 75.43 111.018 -172.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 7.7 p -127.13 118.55 50.46 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.987 0 CA-C-N 115.173 -0.921 . . . . 72.31 110.062 -173.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 159' ' ' ILE . . . . . 0.682 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 25.4 mt -94.58 103.56 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 108.281 -1.007 . . . . 72.31 108.281 178.019 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 160' ' ' ARG . . . . . 0.471 HH12 ' HB3' ' C' ' 162' ' ' PRO . 64.4 ttp85 -83.55 100.92 11.09 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 109.819 -0.437 . . . . 75.13 109.819 -179.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 161' ' ' VAL . . . . . 0.604 ' HB ' ' HB3' ' C' ' 174' ' ' LEU . 58.2 t -94.59 103.37 11.02 Favored Pre-proline 0 CA--C 1.554 1.13 0 N-CA-C 108.404 -0.961 . . . . 75.24 108.404 175.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 162' ' ' PRO . . . . . 0.471 ' HB3' HH12 ' C' ' 160' ' ' ARG . 90.9 Cg_endo -73.87 164.19 35.2 Favored 'Trans proline' 0 C--N 1.373 1.843 0 C-N-CA 122.924 2.416 . . . . 75.23 113.879 -172.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.46 -25.14 6.58 Favored Glycine 0 C--N 1.345 1.055 0 CA-C-N 114.886 -1.052 . . . . 53.54 114.294 172.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 164' ' ' MET . . . . . 0.407 ' SD ' ' HG2' ' C' ' 143' ' ' ARG . 23.9 ttp -83.5 -77.7 0.24 Allowed 'General case' 0 C--N 1.356 0.853 0 CA-C-N 117.779 0.789 . . . . 73.35 110.071 -172.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . 87.21 -173.27 44.32 Favored Glycine 0 C--N 1.342 0.887 0 CA-C-O 120.116 -0.269 . . . . 73.32 113.664 179.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . -83.2 -125.53 1.03 Allowed Glycine 0 C--N 1.345 1.048 0 CA-C-O 119.98 -0.344 . . . . 75.44 112.826 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 167' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -79.64 146.64 32.39 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 117.037 0.419 . . . . 74.2 110.851 -177.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . 78.11 -166.48 52.8 Favored Glycine 0 C--N 1.348 1.216 0 O-C-N 123.876 0.735 . . . . 13.44 112.934 -175.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 169' ' ' ASN . . . . . . . . . . . . . 23.0 t30 -104.6 -64.35 0.04 OUTLIER Pre-proline 0 CA--C 1.558 1.275 0 CA-C-O 117.214 -1.374 . . . . 62.44 114.421 -164.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 170' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -42.67 117.4 0.86 Allowed 'Trans proline' 0 C--N 1.408 3.679 0 C-N-CA 123.3 2.667 . . . . 73.55 114.216 -162.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 171' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -36.27 115.72 0.13 Allowed 'Trans proline' 0 C--N 1.397 3.099 1 C-N-CA 125.614 4.21 . . . . 74.02 115.876 -163.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -118.87 -150.51 8.8 Favored Glycine 0 C--N 1.345 1.03 0 CA-C-N 115.863 -0.608 . . . . 74.42 112.358 178.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 173' ' ' ASP . . . . . 0.42 ' O ' ' HA ' ' C' ' 118' ' ' ASP . 11.6 m-20 -136.43 147.12 47.09 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-O 121.794 0.807 . . . . 74.51 111.189 -178.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 174' ' ' LEU . . . . . 0.604 ' HB3' ' HB ' ' C' ' 161' ' ' VAL . 19.0 tp -103.06 136.72 42.34 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 114.194 -1.366 . . . . 75.22 107.71 168.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 66.5 mt -123.44 85.87 2.49 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.321 1.049 . . . . 72.15 108.97 -178.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 176' ' ' LEU . . . . . 0.682 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 82.0 mt -71.43 108.15 4.71 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.156 -0.475 . . . . 74.33 110.352 179.384 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 177' ' ' VAL . . . . . . . . . . . . . 25.1 t -84.96 93.46 3.57 Favored 'Isoleucine or valine' 0 C--N 1.347 0.472 0 N-CA-C 108.253 -1.017 . . . . 75.23 108.253 178.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 178' ' ' VAL . . . . . 0.622 HG11 HG21 ' C' ' 153' ' ' VAL . 2.4 p -84.11 117.15 29.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.292 -0.867 . . . . 74.01 110.525 -175.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 179' ' ' ARG . . . . . . . . . . . . . 6.1 mmm180 -108.2 116.0 31.16 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 107.8 -1.185 . . . . 74.42 107.8 172.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 180' ' ' LEU . . . . . 0.451 HD13 HD22 ' C' ' 127' ' ' LEU . 92.9 mt -74.59 148.33 40.89 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 120.854 0.359 . . . . 73.43 110.499 178.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 181' ' ' LEU . . . . . . . . . . . . . 80.9 mt -70.14 166.09 37.12 Favored Pre-proline 0 CA--C 1.552 1.049 0 CA-C-O 118.236 -0.888 . . . . 74.24 109.348 177.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -54.2 76.15 0.03 OUTLIER 'Trans proline' 0 C--N 1.393 2.869 0 C-N-CA 123.224 2.616 . . . . 73.32 112.58 170.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 183' ' ' HIS . . . . . 0.441 ' N ' ' HD3' ' C' ' 184' ' ' PRO . 74.5 t60 174.88 54.48 0.03 OUTLIER Pre-proline 0 CA--C 1.561 1.384 0 C-N-CA 126.895 2.078 . . . . 72.0 106.384 -167.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 184' ' ' PRO . . . . . 0.441 ' HD3' ' N ' ' C' ' 183' ' ' HIS . 66.3 Cg_endo -93.83 65.1 0.41 Allowed 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.409 2.739 . . . . 74.25 110.628 -174.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 185' ' ' VAL . . . . . 0.515 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 16.4 t -93.28 -58.04 3.93 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.559 0 N-CA-C 108.946 -0.761 . . . . 72.23 108.946 -167.249 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 186' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -101.23 104.31 15.35 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 121.201 0.524 . . . . 61.44 111.052 -169.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 187' ' ' ARG . . . . . 0.435 ' NH1' ' HB2' ' C' ' 189' ' ' GLU . 4.0 tmt_? -95.63 122.37 38.32 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 107.79 -1.189 . . . . 75.14 107.79 174.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 188' ' ' LEU . . . . . 0.538 HD13 ' HD2' ' C' ' 240' ' ' PHE . 59.2 tp -80.34 147.94 30.87 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.689 0.396 . . . . 74.14 111.861 -177.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 189' ' ' GLU . . . . . 0.435 ' HB2' ' NH1' ' C' ' 187' ' ' ARG . 8.8 tp10 -144.93 110.54 5.33 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 107.756 -1.202 . . . . 73.21 107.756 161.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 67.88 -93.12 0.26 Allowed Glycine 0 C--N 1.35 1.345 0 N-CA-C 111.58 -0.608 . . . . 74.2 111.58 -172.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 191' ' ' GLN . . . . . 0.508 ' NE2' ' HA3' ' C' ' 242' ' ' GLY . 51.0 mt-30 -128.37 -16.39 4.42 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.383 1.073 . . . . 75.25 110.553 173.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -91.63 134.86 34.33 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.09 0.956 . . . . 65.13 110.249 -173.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 193' ' ' LEU . . . . . 0.631 ' HG ' ' HA2' ' C' ' 239' ' ' GLY . 17.4 mt -98.27 173.13 7.15 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 122.878 0.471 . . . . 65.15 112.043 -171.062 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 194' ' ' TYR . . . . . 0.509 ' HA ' ' O ' ' C' ' 250' ' ' TYR . 35.4 t80 -139.05 107.04 5.69 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 114.824 -1.08 . . . . 75.43 108.843 171.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 195' ' ' ALA . . . . . 0.515 ' HA ' ' O ' ' C' ' 185' ' ' VAL . . . -106.72 -176.16 3.0 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.322 1.049 . . . . 65.11 109.871 175.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 41.0 m -132.31 110.66 10.75 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 108.909 -0.774 . . . . 53.42 108.909 167.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 197' ' ' LEU . . . . . 0.437 ' HB2' HD21 ' C' ' 251' ' ' LEU . 35.6 tp -97.7 109.38 22.14 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.835 0.854 . . . . 73.5 109.169 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -88.94 104.5 17.01 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-O 121.917 0.865 . . . . 64.33 110.071 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 199' ' ' VAL . . . . . 0.403 ' HA ' HG11 ' C' ' 210' ' ' VAL . 42.3 t -92.35 123.22 62.92 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 124.958 1.303 . . . . 73.12 109.148 179.215 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 200' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.48 149.44 68.66 Favored 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 121.95 1.767 . . . . 73.11 110.826 176.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 201' ' ' ALA . . . . . 0.423 ' HB3' ' HH2' ' C' ' 269' ' ' TRP . . . -54.89 -46.84 99.47 Favored Pre-proline 0 CA--C 1.553 1.061 0 CA-C-O 117.579 -1.2 . . . . 74.35 113.909 -169.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 202' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -54.08 -47.16 28.57 Favored 'Trans proline' 0 C--N 1.395 3.006 0 C-N-CA 121.926 1.751 . . . . 63.15 112.625 176.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 203' ' ' ILE . . . . . . . . . . . . . 48.6 mt -69.77 -37.75 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.152 0.981 . . . . 74.02 111.156 -177.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -61.71 -43.95 97.87 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.507 0.723 . . . . 75.02 110.87 178.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 205' ' ' VAL . . . . . 0.409 ' HA ' ' HA ' ' C' ' 226' ' ' ARG . 78.7 t -74.16 -40.99 51.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 115.024 -0.989 . . . . 74.52 112.378 -176.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 206' ' ' VAL . . . . . 0.614 ' HA ' ' HE2' ' A' ' 270' ' ' LYS . 11.1 p -78.15 -33.99 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 CA-C-N 118.047 0.385 . . . . 74.12 110.839 -177.189 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 85.13 52.64 3.37 Favored Glycine 0 C--N 1.338 0.652 0 CA-C-N 115.779 -0.646 . . . . 63.21 111.518 -170.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -90.13 -123.49 2.56 Favored Glycine 0 C--N 1.345 1.055 0 CA-C-N 115.104 -0.548 . . . . 51.32 111.778 -177.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 209' ' ' LYS . . . . . 0.517 ' HG2' ' HA ' ' C' ' 222' ' ' ALA . 6.5 mtmp? -147.2 144.13 28.7 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.53 0.681 . . . . 72.44 111.103 175.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 210' ' ' VAL . . . . . 0.403 HG11 ' HA ' ' C' ' 199' ' ' VAL . 16.2 m -122.67 178.66 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 113.6 -1.637 . . . . 71.52 107.468 167.073 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 211' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -132.3 130.29 40.64 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.922 0.392 . . . . 75.53 110.542 -178.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 212' ' ' ALA . . . . . 0.529 ' HB2' HG11 ' C' ' 219' ' ' VAL . . . -104.85 113.98 27.91 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 107.171 -1.418 . . . . 74.43 107.171 173.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 213' ' ' MET . . . . . . . . . . . . . 5.4 tmm? -67.38 135.51 53.31 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 107.84 -1.17 . . . . 63.12 107.84 171.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 214' ' ' THR . . . . . 0.516 HG22 ' HD2' ' C' ' 238' ' ' LYS . 0.1 OUTLIER -134.46 171.42 14.33 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-O 122.088 0.947 . . . . 72.34 111.962 -174.896 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' C' C ' 215' ' ' LEU . . . . . 0.405 HD13 ' HB2' ' C' ' 131' ' ' PHE . 27.4 mt -73.24 -31.16 63.96 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 114.151 -1.386 . . . . 75.24 113.08 -163.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.92 8.04 21.97 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.956 -1.02 . . . . 71.0 111.362 -178.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 149.37 -163.11 29.18 Favored Glycine 0 C--N 1.351 1.381 0 CA-C-O 119.479 -0.623 . . . . 74.41 111.938 -177.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -96.44 163.89 1.19 Allowed 'Trans proline' 0 C--N 1.362 1.269 0 C-N-CA 122.984 2.456 . . . . 64.03 113.415 173.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 219' ' ' VAL . . . . . 0.755 ' HB ' ' HE3' ' C' ' 238' ' ' LYS . 1.7 p -142.44 114.64 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.099 0 N-CA-C 108.154 -1.054 . . . . 52.53 108.154 166.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 220' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -90.84 107.74 19.38 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.081 -1.081 . . . . 72.32 108.081 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 221' ' ' VAL . . . . . 0.493 ' HA ' ' HB3' ' B' ' 239' ' ' ALA . 56.0 t -76.07 129.77 36.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 125.124 1.37 . . . . 74.03 111.798 -172.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 222' ' ' ALA . . . . . 0.517 ' HA ' ' HG2' ' C' ' 209' ' ' LYS . . . -90.99 123.77 34.72 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.59 0.756 . . . . 73.3 109.848 173.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 58.4 t -99.17 142.0 23.84 Favored Pre-proline 0 CA--C 1.561 1.389 0 C-N-CA 125.149 1.38 . . . . 73.11 110.168 -172.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 224' ' ' PRO . . . . . 0.568 ' HG2' HE21 ' B' ' 243' ' ' GLN . 5.1 Cg_exo -85.6 158.9 10.73 Favored 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 123.958 3.105 . . . . 73.11 112.923 168.388 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -55.95 128.52 30.59 Favored 'Trans proline' 0 C--N 1.385 2.497 0 C-N-CA 123.462 2.775 . . . . 74.4 113.448 178.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 226' ' ' ARG . . . . . 0.53 HH11 HD12 ' A' ' 261' ' ' LEU . 0.0 OUTLIER 52.45 81.14 0.09 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.756 1.622 . . . . 71.5 112.141 -178.82 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' C' C ' 227' ' ' THR . . . . . 0.529 HG21 HG13 ' C' ' 253' ' ' VAL . 54.7 m -93.64 142.27 27.54 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 114.869 -1.06 . . . . 73.3 110.204 176.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 228' ' ' GLN . . . . . 0.724 HE21 ' HG2' ' A' ' 259' ' ' GLU . 27.3 mp0 -101.94 146.56 27.69 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.733 0.813 . . . . 74.32 112.271 -173.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -69.56 118.14 12.05 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 114.647 -1.16 . . . . 65.31 108.519 169.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 113.12 -2.3 25.47 Favored Glycine 0 C--N 1.339 0.717 0 CA-C-O 119.6 -0.556 . . . . 62.04 112.205 -175.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 231' ' ' ARG . . . . . . . . . . . . . 60.0 mtp85 -73.79 -179.49 3.68 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 117.126 0.463 . . . . 75.03 111.273 171.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 232' ' ' LYS . . . . . 0.578 ' HD3' ' HB3' ' C' ' 250' ' ' TYR . 34.4 ttmt -148.61 146.43 28.22 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.891 -0.595 . . . . 74.05 111.225 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 233' ' ' LEU . . . . . 0.635 HD12 ' HB2' ' C' ' 251' ' ' LEU . 0.9 OUTLIER -117.26 155.61 29.17 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.998 1.319 . . . . 74.22 108.495 177.349 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' C' C ' 234' ' ' ARG . . . . . 0.455 ' O ' ' HA3' ' B' ' 240' ' ' GLY . 16.8 ptt180 -127.07 109.6 12.05 Favored 'General case' 0 N--CA 1.475 0.775 0 O-C-N 123.702 0.626 . . . . 72.34 109.583 166.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 235' ' ' LEU . . . . . 0.433 HD13 HD23 ' C' ' 249' ' ' LEU . 26.8 mt -95.82 128.08 42.39 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.614 0.765 . . . . 74.34 109.185 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -79.87 125.76 30.13 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.25 0.62 . . . . 73.41 112.284 -168.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 77.77 13.71 83.16 Favored Glycine 0 C--N 1.353 1.481 0 O-C-N 124.124 0.89 . . . . 71.42 113.458 178.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 238' ' ' LYS . . . . . 0.755 ' HE3' ' HB ' ' C' ' 219' ' ' VAL . 69.6 mmtt -105.05 19.85 19.88 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.592 0.757 . . . . 75.11 111.446 -178.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 239' ' ' GLY . . . . . 0.631 ' HA2' ' HG ' ' C' ' 193' ' ' LEU . . . -92.53 -171.08 40.86 Favored Glycine 0 C--N 1.345 1.071 0 CA-C-N 116.217 -0.447 . . . . 75.2 112.749 171.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 240' ' ' PHE . . . . . 0.538 ' HD2' HD13 ' C' ' 188' ' ' LEU . 11.9 m-85 -79.04 154.68 77.61 Favored Pre-proline 0 CA--C 1.563 1.447 0 C-N-CA 122.965 0.506 . . . . 75.14 110.221 177.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 241' ' ' PRO . . . . . 0.626 ' HA ' ' HG2' ' C' ' 246' ' ' ARG . 18.6 Cg_exo -67.55 136.73 40.4 Favored 'Trans proline' 0 C--N 1.396 3.05 0 C-N-CA 124.183 3.255 . . . . 71.53 114.355 -172.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 242' ' ' GLY . . . . . 0.508 ' HA3' ' NE2' ' C' ' 191' ' ' GLN . . . -134.2 171.96 21.97 Favored Glycine 0 C--N 1.35 1.344 0 CA-C-N 115.514 -0.767 . . . . 70.14 113.041 178.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.01 -25.06 38.53 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 123.764 2.976 . . . . 71.42 113.321 -177.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -112.7 14.52 20.02 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.894 0.878 . . . . 71.42 111.008 178.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 119.45 177.09 16.3 Favored Glycine 0 C--N 1.349 1.299 0 N-CA-C 112.078 -0.409 . . . . 63.24 112.078 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 246' ' ' ARG . . . . . 0.626 ' HG2' ' HA ' ' C' ' 241' ' ' PRO . 72.4 mtm-85 -85.09 158.77 20.33 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.856 0.862 . . . . 71.32 111.005 -177.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.82 -155.03 6.18 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 114.045 0.378 . . . . 63.23 114.045 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -124.96 139.11 54.12 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.363 0.665 . . . . 73.54 109.578 -179.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 249' ' ' LEU . . . . . 0.464 HD13 ' HB1' ' C' ' 195' ' ' ALA . 28.8 tp -85.2 115.27 22.88 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.927 0.891 . . . . 74.23 110.836 -177.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 250' ' ' TYR . . . . . 0.585 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 16.0 m-30 -99.91 101.7 12.89 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 110.022 -0.362 . . . . 71.43 110.022 179.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 251' ' ' LEU . . . . . 0.635 ' HB2' HD12 ' C' ' 233' ' ' LEU . 0.8 OUTLIER -100.62 138.41 37.72 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.632 -0.668 . . . . 72.0 109.802 -175.716 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -87.57 125.44 34.35 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.895 -0.78 . . . . 75.41 108.895 171.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 253' ' ' VAL . . . . . 0.529 HG13 HG21 ' C' ' 227' ' ' THR . 59.3 t -74.5 136.84 24.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 123.213 0.605 . . . . 73.5 110.899 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 254' ' ' ARG . . . . . . . . . . . . . 40.8 mtm180 -116.12 147.11 41.67 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 107.63 -1.248 . . . . 75.13 107.63 163.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 255' ' ' ILE . . . . . 0.539 HG21 HG23 ' A' ' 257' ' ' ILE . 33.4 mm -97.89 119.07 45.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 106.757 -1.571 . . . . 75.24 106.757 164.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 256' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.4 173.59 7.89 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.031 1.333 . . . . 70.25 108.461 -178.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 2.3 pp -144.12 153.27 56.36 Favored Pre-proline 0 N--CA 1.477 0.888 0 C-N-CA 123.181 0.592 . . . . 75.21 110.569 -174.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.51 6.1 1.35 Allowed 'Trans proline' 0 C--N 1.385 2.495 0 C-N-CA 122.812 2.341 . . . . 74.41 114.278 -175.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 52.43 -84.29 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.858 1.663 . . . . 72.3 112.825 -174.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.14 140.1 58.83 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.908 0.883 . . . . 73.41 110.718 -177.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 261' ' ' LEU . . . . . 0.495 HD21 ' HB3' ' C' ' 265' ' ' GLU . 65.1 mt -124.7 152.97 43.04 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.363 0.665 . . . . 74.53 111.101 -176.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 67.6 p -85.05 168.35 21.15 Favored Pre-proline 0 CA--C 1.556 1.202 0 N-CA-C 107.572 -1.27 . . . . 61.23 107.572 164.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -51.16 -37.44 58.61 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 122.799 2.333 . . . . 74.2 112.863 171.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -58.71 -64.08 1.06 Allowed 'General case' 0 C--O 1.251 1.138 0 C-N-CA 124.762 1.225 . . . . 71.04 110.845 175.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 265' ' ' GLU . . . . . 0.495 ' HB3' HD21 ' C' ' 261' ' ' LEU . 32.1 mm-40 -53.21 -44.06 67.72 Favored 'General case' 0 C--N 1.352 0.704 0 O-C-N 124.375 1.047 . . . . 71.03 110.493 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 266' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -58.72 -43.02 90.01 Favored 'General case' 0 C--O 1.214 -0.791 0 C-N-CA 123.462 0.705 . . . . 73.1 110.374 -178.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -62.22 -51.84 66.17 Favored 'General case' 0 CA--C 1.555 1.157 0 O-C-N 123.726 0.641 . . . . 71.12 111.764 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 268' ' ' LEU . . . . . . . . . . . . . 8.7 mp -66.75 -48.69 68.33 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 116.498 -0.319 . . . . 70.11 111.238 -176.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 269' ' ' TRP . . . . . 0.423 ' HH2' ' HB3' ' C' ' 201' ' ' ALA . 94.6 m95 -61.22 -32.53 72.31 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.511 0.724 . . . . 63.11 111.281 176.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 270' ' ' LYS . . . . . 0.416 ' HD2' HG11 ' A' ' 206' ' ' VAL . 1.2 mmmm -61.35 -52.34 65.07 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 123.433 0.693 . . . . 75.43 110.872 176.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -63.48 -37.57 87.82 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 123.686 0.616 . . . . 75.33 111.233 -178.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 95.5 mt -67.14 -35.1 79.0 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 122.744 0.418 . . . . 74.33 111.586 173.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -64.3 -45.53 87.55 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.35 0.66 . . . . 43.22 110.479 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -69.27 -38.72 78.53 Favored 'General case' 0 C--O 1.245 0.845 0 O-C-N 124.38 1.05 . . . . 63.21 110.931 -179.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -60.91 -30.7 70.34 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.768 -0.651 . . . . 70.04 110.554 172.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 276' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -94.05 -13.73 26.58 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 122.984 0.514 . . . . 75.52 112.304 177.374 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 277' ' ' TYR . . . . . 0.422 ' CE1' ' HA3' ' A' ' 208' ' ' GLY . 22.6 m-30 -70.3 -30.65 67.7 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.001 -1.111 . . . . 65.52 108.001 169.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -63.79 2.61 0.46 Allowed 'General case' 0 CA--C 1.557 1.249 0 CA-C-N 114.177 -1.374 . . . . 72.22 113.07 169.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 279' ' ' ARG . . . . . . . . . . . . . 51.9 ttt180 -73.91 -33.54 64.01 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.043 0.537 . . . . 75.11 110.882 171.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 1.168 0 O-C-N 123.333 0.396 . . . . 75.14 110.725 -169.499 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.6 mtm . . . . . 0 CA--C 1.545 0.778 0 N-CA-C 109.648 -0.501 . . . . 64.12 109.648 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 66.0 43.29 3.02 Favored 'General case' 0 C--N 1.364 1.197 0 C-N-CA 124.907 1.283 . . . . 74.44 112.55 177.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -66.78 78.55 0.12 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.628 0.771 . . . . 74.04 111.368 175.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -35.99 92.89 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 125.703 1.601 . . . . 64.14 113.409 -178.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.8 mmtp -68.07 107.27 2.66 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-N 115.239 -0.891 . . . . 74.32 108.725 168.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -72.83 88.77 1.34 Allowed 'General case' 0 C--O 1.241 0.637 0 N-CA-C 107.415 -1.328 . . . . 62.43 107.415 174.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -60.26 -30.64 69.57 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 114.827 -1.079 . . . . 73.34 111.678 -175.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -64.9 -53.53 45.13 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.958 -0.565 . . . . 73.33 110.357 176.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.16 -34.63 76.78 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 122.72 0.408 . . . . 70.01 111.3 -178.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 76.5 mt -59.96 -43.35 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 N-CA-C 109.865 -0.42 . . . . 74.23 109.865 172.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.425 ' O ' ' HB1' ' A' ' 25' ' ' ALA . 97.0 mt -75.71 -12.24 60.15 Favored 'General case' 0 CA--C 1.555 1.172 0 CA-C-N 116.042 -0.527 . . . . 73.11 112.3 175.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.52 36.56 33.41 Favored Glycine 0 C--N 1.349 1.302 0 CA-C-N 117.75 0.25 . . . . 73.42 113.686 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.8 m -131.34 159.8 70.07 Favored Pre-proline 0 N--CA 1.484 1.25 0 C-N-CA 124.935 1.294 . . . . 72.52 109.14 177.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -75.96 166.35 28.19 Favored 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 122.524 2.149 . . . . 50.12 112.846 177.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 43.3 mtm-85 -74.73 21.02 0.11 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 113.309 0.855 . . . . 75.43 113.309 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -122.15 6.67 9.72 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.184 0.993 . . . . 71.2 108.982 174.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.47 136.26 47.54 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.508 0.723 . . . . 74.14 111.936 -175.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.5 p -85.6 176.44 8.19 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.284 1.034 . . . . 75.03 110.691 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.3 tm0? -57.15 -37.65 72.38 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.384 0.674 . . . . 71.11 109.978 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.443 ' HB3' ' NH1' ' A' ' 24' ' ' ARG . 43.3 mm-40 -56.69 -54.33 47.34 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 123.772 0.67 . . . . 72.43 111.054 174.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -63.25 -38.82 92.66 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.994 0.518 . . . . 71.14 111.016 -177.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.6 mp -59.55 -39.52 79.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 124.52 1.128 . . . . 73.31 110.6 173.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -68.25 -56.07 9.96 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.414 -0.812 . . . . 75.22 111.056 -175.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.443 ' NH1' ' HB3' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -66.85 -28.84 68.67 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 122.976 0.172 . . . . 73.12 111.203 -179.204 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.425 ' HB1' ' O ' ' A' ' 11' ' ' LEU . . . -62.66 -51.09 68.63 Favored 'General case' 0 C--O 1.245 0.866 0 O-C-N 123.609 0.568 . . . . 72.43 110.754 173.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -58.75 -45.77 88.93 Favored 'General case' 0 C--O 1.215 -0.711 0 CA-C-N 114.73 -1.123 . . . . 73.1 110.469 178.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.426 ' O ' ' HG3' ' A' ' 31' ' ' ARG . 57.3 mtpt -63.14 -44.01 96.75 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 123.888 0.743 . . . . 74.22 111.128 -177.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.1 ttp85 -54.86 -48.25 73.17 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.609 0.763 . . . . 75.52 110.6 175.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.665 ' HB3' HD11 ' A' ' 50' ' ' ILE . 81.6 mt -77.39 -20.65 54.39 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 115.619 -0.719 . . . . 75.12 111.671 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.532 ' HA ' ' HE1' ' A' ' 47' ' ' PHE . . . -81.21 -22.32 38.92 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.615 0.766 . . . . 71.54 111.118 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.426 ' HG3' ' O ' ' A' ' 27' ' ' LYS . 58.1 mtm180 -91.75 -41.85 10.46 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 122.981 0.512 . . . . 72.33 110.047 174.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -69.45 -55.36 10.5 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.319 0.648 . . . . 73.31 111.191 -176.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -96.85 31.25 2.41 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 122.849 0.46 . . . . 72.41 110.27 179.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.469 ' HD2' HG21 ' A' ' 37' ' ' VAL . 44.2 t60 -60.26 101.6 0.26 Allowed Pre-proline 0 N--CA 1.477 0.904 0 C-N-CA 123.99 0.916 . . . . 73.54 110.234 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -70.11 -13.9 34.35 Favored 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 123.061 2.507 . . . . 75.51 113.216 -164.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.405 ' HB3' ' CD2' ' A' ' 34' ' ' HIS . 28.5 t70 -71.53 -35.12 70.58 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.477 0.711 . . . . 73.23 110.526 175.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.469 HG21 ' HD2' ' A' ' 34' ' ' HIS . 99.0 t -94.52 -48.97 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-O 121.309 0.576 . . . . 73.25 109.46 178.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -100.54 71.91 1.54 Allowed 'General case' 0 C--O 1.249 1.035 0 C-N-CA 124.104 0.961 . . . . 64.12 109.486 -177.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -74.36 81.34 1.88 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.049 -0.978 . . . . 73.11 108.873 176.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 67.4 m -138.83 108.67 7.71 Favored Pre-proline 0 C--O 1.24 0.571 0 CA-C-O 118.168 -0.92 . . . . 71.24 108.724 177.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -30.93 -52.43 0.25 Allowed 'Trans proline' 0 C--N 1.392 2.846 0 C-N-CA 125.284 3.989 . . . . 73.53 115.784 -175.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -51.3 -51.39 54.71 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.492 0.717 . . . . 64.43 111.743 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.24 -22.26 62.91 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 115.381 -0.827 . . . . 73.42 111.752 -177.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -88.91 -37.56 15.19 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.372 0.669 . . . . 63.35 110.514 -173.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.488 ' HA ' ' HE2' ' A' ' 48' ' ' LYS . 35.8 mm-40 -70.22 -41.48 73.56 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 108.807 -0.812 . . . . 62.44 108.807 175.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 15.4 tppt? -59.35 -45.54 91.1 Favored 'General case' 0 C--N 1.348 0.541 0 CA-C-N 114.641 -1.163 . . . . 74.03 110.011 173.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.578 ' HA ' HD12 ' A' ' 50' ' ' ILE . 71.3 t80 -58.09 -40.69 81.76 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 123.954 0.784 . . . . 73.32 110.984 176.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.51 ' HB3' ' CE1' ' A' ' 93' ' ' PHE . 43.4 mtmt -66.78 -32.83 74.38 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 119.414 -0.327 . . . . 75.14 111.858 178.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.85 -34.58 76.98 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 120.831 0.348 . . . . 71.44 110.439 172.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.665 HD11 ' HB3' ' A' ' 29' ' ' LEU . 73.3 mt -66.97 -30.27 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.049 0.939 . . . . 74.43 109.721 174.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.425 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 11.7 m-80 -83.29 -19.89 35.46 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.815 0.846 . . . . 73.43 112.125 174.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -70.98 -52.11 21.69 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 122.509 1.147 . . . . 75.34 108.389 171.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.66 -54.3 45.95 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 112.801 -1.999 . . . . 65.45 111.088 176.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -63.18 -37.84 88.81 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-N 115.262 -0.881 . . . . 73.53 111.176 177.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 51' ' ' ASN . . . -51.2 -53.53 34.17 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 122.98 0.512 . . . . 72.52 111.407 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 68.0 t -68.02 -44.11 85.0 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 CA-C-N 114.377 -1.283 . . . . 74.52 110.449 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.461 HD22 ' HD2' ' A' ' 63' ' ' ARG . 41.9 mt -91.48 5.8 48.02 Favored 'General case' 0 CA--C 1.563 1.457 0 N-CA-C 113.875 1.065 . . . . 74.35 113.875 -170.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.8 t -80.68 -47.89 13.37 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 123.218 0.607 . . . . 74.34 110.926 177.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -93.35 134.36 26.98 Favored Pre-proline 0 N--CA 1.474 0.768 0 CA-C-O 117.72 -1.133 . . . . 74.34 109.906 -173.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.51 ' O ' ' HG2' ' A' ' 64' ' ' ARG . 9.1 Cg_endo -49.7 -43.98 37.81 Favored 'Trans proline' 0 C--N 1.385 2.492 0 C-N-CA 124.014 3.142 . . . . 72.41 114.027 -177.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -67.88 -54.14 21.15 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 122.939 0.496 . . . . 72.3 111.635 -177.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.531 ' HA ' HD13 ' A' ' 65' ' ' ILE . 47.4 mtpt -61.52 -35.17 76.96 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.536 0.734 . . . . 74.54 110.787 -178.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.461 ' HD2' HD22 ' A' ' 57' ' ' LEU . 46.4 tpt85 -54.52 -58.27 8.13 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 114.311 -1.313 . . . . 74.11 108.891 171.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.51 ' HG2' ' O ' ' A' ' 60' ' ' PRO . 1.2 mmp_? -61.58 -28.7 69.53 Favored 'General case' 0 C--O 1.214 -0.801 0 CA-C-N 115.354 -0.839 . . . . 74.25 111.783 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.577 HG21 ' HD2' ' A' ' 76' ' ' PRO . 89.6 mt -61.69 -47.7 92.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 122.931 0.492 . . . . 74.41 109.677 176.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -60.79 -53.77 53.33 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 115.961 -0.563 . . . . 75.4 110.28 175.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -54.13 -44.73 71.61 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.533 0.733 . . . . 64.04 111.801 -176.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 53.7 p -73.77 -27.33 61.1 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.73 0.412 . . . . 75.44 111.332 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -73.37 119.49 17.67 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 109.105 -0.702 . . . . 75.32 109.105 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 101.19 16.22 25.88 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-N 115.964 -0.562 . . . . 64.23 111.964 -168.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 62.9 m -143.29 -59.27 0.42 Allowed 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 104.021 -2.585 . . . . 71.23 104.021 174.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.4 m -83.56 148.85 26.95 Favored 'General case' 0 C--O 1.249 1.061 0 N-CA-C 105.225 -2.139 . . . . 74.23 105.225 157.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.56 -30.15 9.21 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.273 1.029 . . . . 74.04 110.734 -176.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.17 139.9 61.03 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 123.321 0.648 . . . . 75.1 110.005 175.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -62.34 119.02 5.94 Favored 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 122.33 2.02 . . . . 75.41 111.111 175.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.577 ' HD2' HG21 ' A' ' 65' ' ' ILE . 78.6 Cg_exo -51.55 122.14 9.75 Favored 'Trans proline' 0 C--N 1.384 2.42 0 C-N-CA 123.357 2.705 . . . . 74.25 113.183 178.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -44.11 134.51 8.52 Favored 'Trans proline' 0 C--N 1.389 2.703 0 C-N-CA 124.504 3.469 . . . . 73.45 115.176 -168.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -63.15 135.03 48.64 Favored 'Trans proline' 0 C--N 1.386 2.545 0 C-N-CA 122.965 2.444 . . . . 73.2 112.456 -177.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.15 157.66 16.85 Favored 'Trans proline' 0 C--N 1.381 2.268 0 C-N-CA 122.953 2.436 . . . . 71.05 112.1 175.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -60.39 84.45 0.07 OUTLIER 'Trans proline' 0 C--N 1.38 2.222 0 C-N-CA 122.718 2.279 . . . . 74.31 112.185 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 155.01 -42.32 0.59 Allowed Glycine 0 CA--C 1.527 0.785 0 N-CA-C 109.873 -1.291 . . . . 62.41 109.873 -176.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 128.44 -160.5 22.13 Favored Glycine 0 C--N 1.351 1.414 0 CA-C-N 115.103 -0.548 . . . . 53.03 111.79 176.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -97.65 107.55 20.07 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 123.402 0.681 . . . . 74.41 109.166 176.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -54.91 155.09 4.65 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 115.632 -0.713 . . . . 71.31 111.849 170.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -155.98 60.16 0.59 Allowed 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 108.448 -0.945 . . . . 73.24 108.448 174.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 20.4 m -31.93 86.05 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 126.692 1.997 . . . . 74.44 116.39 -169.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 57.13 24.87 52.68 Favored Glycine 0 CA--C 1.536 1.347 0 N-CA-C 114.953 0.741 . . . . 70.11 114.953 176.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -96.58 154.38 17.31 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.412 0.685 . . . . 72.34 110.063 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -82.03 72.05 9.07 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 123.864 0.866 . . . . 71.44 111.476 -168.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.459 HG22 ' HE2' ' A' ' 97' ' ' PHE . 2.1 p -46.31 -50.37 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 C-N-CA 125.171 1.388 . . . . 75.21 113.537 -175.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.41 ' HG2' HG11 ' A' ' 90' ' ' VAL . 11.7 mm-40 -71.64 -4.04 24.99 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 113.55 0.944 . . . . 75.33 113.55 -171.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -107.42 -17.97 13.98 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.157 0.583 . . . . 61.35 111.27 178.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.51 ' CE1' ' HB3' ' A' ' 48' ' ' LYS . 7.6 m-30 -85.64 176.13 8.36 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 122.497 0.319 . . . . 73.34 111.134 -171.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 89.5 p -59.46 151.09 24.86 Favored 'General case' 0 C--O 1.247 0.926 0 N-CA-C 114.163 1.172 . . . . 74.5 114.163 -166.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.409 ' HG3' ' H ' ' A' ' 96' ' ' PHE . 3.4 pt-20 -53.34 -44.65 68.65 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 114.54 -1.209 . . . . 74.52 110.007 167.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.409 ' H ' ' HG3' ' A' ' 95' ' ' GLU . 73.8 t80 -49.79 -51.04 42.44 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.614 1.166 . . . . 75.03 111.331 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.459 ' HE2' HG22 ' A' ' 90' ' ' VAL . 3.5 t80 -58.78 -54.89 42.02 Favored 'General case' 0 CA--C 1.55 0.97 0 O-C-N 123.981 0.801 . . . . 72.32 110.28 174.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -70.8 -6.66 39.45 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 113.371 0.878 . . . . 74.14 113.371 -172.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -101.83 -38.8 7.68 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.275 0.63 . . . . 70.02 111.834 174.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 30.3 tp -69.01 -49.32 58.78 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 121.305 0.574 . . . . 74.33 109.798 177.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -92.04 -8.72 45.16 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 115.231 -0.895 . . . . 72.11 111.42 178.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -45.5 -59.07 4.94 Favored Glycine 0 N--CA 1.482 1.765 0 N-CA-C 115.579 0.991 . . . . 72.43 115.579 178.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -45.37 -23.1 1.12 Allowed 'Trans proline' 0 C--N 1.388 2.635 0 C-N-CA 124.45 3.433 . . . . 64.43 115.441 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.519 ' HA2' ' NH2' ' A' ' 111' ' ' ARG . . . -144.28 39.69 1.22 Allowed Glycine 0 C--N 1.354 1.53 0 CA-C-O 118.989 -0.895 . . . . 54.4 113.399 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 13.1 mt -66.02 38.03 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 114.79 1.404 . . . . 74.25 114.79 178.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.641 ' HB3' ' HA ' ' A' ' 169' ' ' ASN . 0.3 OUTLIER 55.78 -102.81 0.16 Allowed 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 123.888 0.875 . . . . 74.45 110.639 162.433 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 70.2 13.3 70.07 Favored Glycine 0 C--N 1.362 2.003 0 C-N-CA 122.776 0.227 . . . . 44.0 112.811 176.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.504 ' H ' ' HD1' ' A' ' 106' ' ' PHE . . . 61.22 -110.19 2.93 Favored Glycine 0 C--N 1.346 1.104 0 C-N-CA 123.522 0.582 . . . . 71.34 112.568 -173.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -107.64 -5.72 17.31 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.651 0.781 . . . . 74.55 110.351 176.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -81.26 -39.2 13.05 Favored Glycine 0 C--N 1.346 1.121 0 CA-C-N 115.901 -0.59 . . . . 55.25 111.912 174.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.519 ' NH2' ' HA2' ' A' ' 104' ' ' GLY . 11.9 tpt180 75.8 -31.46 0.2 Allowed 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 126.18 1.792 . . . . 75.52 113.415 176.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 17.2 ttt180 -84.71 51.56 2.17 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.08 0.952 . . . . 75.13 110.834 -177.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 70.8 m 58.39 33.0 22.75 Favored 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 114.383 1.253 . . . . 74.21 114.383 169.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -71.44 155.76 40.24 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.305 0.242 . . . . 74.52 110.617 176.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.483 ' HA ' ' HD2' ' A' ' 170' ' ' PRO . 27.1 tptp -80.57 146.7 31.13 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.665 1.186 . . . . 73.31 111.331 -175.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -87.46 144.39 19.06 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-N 115.603 -0.726 . . . . 73.4 112.364 172.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -86.92 160.59 18.64 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.156 0.583 . . . . 74.43 111.821 -177.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -60.26 139.22 57.72 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.147 0.579 . . . . 74.23 111.305 176.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.437 HD21 ' N ' ' A' ' 120' ' ' ARG . 4.8 tt -145.89 160.78 41.33 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 107.994 -1.113 . . . . 75.42 107.994 -179.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.437 ' N ' HD21 ' A' ' 119' ' ' LEU . 0.3 OUTLIER -124.77 123.89 40.96 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 109.501 -0.555 . . . . 74.51 109.501 176.794 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -129.89 164.95 23.05 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.479 0.712 . . . . 54.41 110.477 -177.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.427 ' O ' HD13 ' B' ' 8' ' ' LEU . 4.2 mm-40 -106.73 120.34 41.73 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 106.976 -1.49 . . . . 72.42 106.976 -172.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.411 HD22 HD11 ' A' ' 176' ' ' LEU . 47.4 tp -97.92 99.84 7.55 Favored Pre-proline 0 CA--C 1.54 0.594 0 N-CA-C 108.191 -1.04 . . . . 74.14 108.191 -176.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.576 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 93.3 Cg_endo -77.74 110.99 3.04 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 121.374 1.383 . . . . 75.33 109.407 177.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.621 ' HA ' HG21 ' B' ' 6' ' ' ILE . 44.2 tp -119.57 136.22 54.46 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.87 0.468 . . . . 72.43 110.862 -168.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 67.9 m -67.92 129.41 39.84 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.927 0.891 . . . . 71.34 110.221 -179.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.494 HD23 ' HB3' ' A' ' 180' ' ' LEU . 51.5 mt -55.11 -43.37 74.0 Favored 'General case' 0 N--CA 1.481 1.123 0 O-C-N 124.376 1.048 . . . . 75.21 111.163 -174.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -57.34 -46.44 83.28 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 114.76 -1.109 . . . . 75.32 110.442 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -72.39 -29.0 63.35 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 115.339 -0.846 . . . . 64.33 110.719 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -67.12 -33.25 75.04 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.199 0.6 . . . . 65.44 110.564 175.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -66.62 -56.22 11.7 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 123.754 0.659 . . . . 74.51 109.744 172.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -61.27 -50.25 73.77 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 114.895 -1.048 . . . . 75.25 112.162 -169.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.04 131.9 0.28 Allowed Glycine 0 C--N 1.344 0.988 0 O-C-N 123.595 0.559 . . . . 71.54 112.937 -178.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 153.93 -161.34 29.9 Favored Glycine 0 C--N 1.338 0.643 0 N-CA-C 111.693 -0.563 . . . . 70.42 111.693 -177.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -71.23 134.7 47.06 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 109.813 -0.44 . . . . 73.14 109.813 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.551 ' NE ' ' HA ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -120.45 124.68 46.05 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 120.759 0.314 . . . . 75.05 110.634 179.701 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.428 ' HB ' HG22 ' B' ' 5' ' ' THR . 92.6 t -77.9 103.63 5.15 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-N 115.118 -0.947 . . . . 75.04 109.452 175.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 57.4 t -115.98 112.51 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.679 1.191 . . . . 73.34 107.792 177.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -111.97 129.54 56.15 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 120.98 0.419 . . . . 71.3 110.675 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.412 HG13 HD22 ' B' ' 8' ' ' LEU . 7.9 p -169.65 149.94 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.99 0 C-N-CA 124.906 1.282 . . . . 75.1 108.388 -177.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 60.68 19.56 9.58 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 113.237 0.828 . . . . 74.24 113.237 174.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 98.68 -31.03 8.59 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 116.402 -0.363 . . . . 54.15 112.607 -178.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.566 ' NH1' ' SD ' ' A' ' 164' ' ' MET . 66.3 ttt180 -86.7 137.62 32.3 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 122.804 0.441 . . . . 72.43 110.811 -178.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 43.1 ttm105 -112.34 97.15 6.43 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 108.189 -1.041 . . . . 74.41 108.189 169.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.6 p -87.21 145.73 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 CA-C-N 115.457 -0.792 . . . . 73.53 111.405 -177.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 39.8 t -103.59 89.05 3.23 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 108.475 -0.935 . . . . 64.43 108.475 170.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 4.9 p -94.45 118.44 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 109.702 -0.481 . . . . 73.42 109.702 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 58.1 ttt85 -72.95 104.16 3.99 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.022 0.439 . . . . 74.32 110.142 177.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 23.6 pt -74.18 143.14 79.81 Favored Pre-proline 0 CA--C 1.554 1.123 0 CA-C-N 115.184 -0.916 . . . . 74.52 110.164 175.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -63.32 138.46 66.27 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.782 2.321 . . . . 74.22 112.315 175.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -62.78 106.38 0.51 Allowed 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.801 2.334 . . . . 74.15 111.837 174.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 90.71 46.68 3.9 Favored Glycine 0 C--N 1.342 0.904 0 CA-C-N 115.508 -0.769 . . . . 75.51 112.184 -176.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.484 HG23 HG12 ' A' ' 178' ' ' VAL . 4.6 p -81.04 126.85 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.314 0.646 . . . . 75.43 110.784 -174.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.675 ' HD2' ' HA ' ' A' ' 191' ' ' GLN . 12.9 mtm180 -108.71 156.98 18.97 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.422 1.089 . . . . 73.23 110.225 -166.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.518 ' HB3' ' HA ' ' A' ' 189' ' ' GLU . 12.9 tp10 -49.62 130.36 20.57 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.011 0.925 . . . . 72.32 112.376 -177.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 89.78 0.18 78.85 Favored Glycine 0 C--N 1.347 1.152 0 CA-C-N 115.483 -0.78 . . . . 74.33 114.008 177.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 58.2 m -67.39 115.31 6.89 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 117.717 0.758 . . . . 74.23 109.784 174.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.492 HG23 HG23 ' A' ' 177' ' ' VAL . 90.3 t -95.98 106.02 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 124.164 0.986 . . . . 74.02 110.209 -174.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.507 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 54.1 mt -87.73 100.67 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 108.243 -1.021 . . . . 75.24 108.243 172.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 65.2 ttt-85 -75.15 100.45 4.27 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 109.247 -0.649 . . . . 75.21 109.247 176.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 4.5 p -125.28 117.36 25.28 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 123.927 0.891 . . . . 71.41 109.348 -178.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.442 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 41.1 Cg_endo -67.19 147.54 79.09 Favored 'Trans proline' 0 C--N 1.371 1.759 0 C-N-CA 121.451 1.434 . . . . 74.53 110.435 169.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . 0.584 ' HA2' ' HD2' ' A' ' 171' ' ' PRO . . . 124.28 -19.72 7.16 Favored Glycine 0 C--N 1.341 0.838 0 N-CA-C 115.213 0.845 . . . . 70.43 115.213 174.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.566 ' SD ' ' NH1' ' A' ' 143' ' ' ARG . 3.6 mpp? -124.12 8.93 8.61 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 117.687 0.744 . . . . 64.15 111.675 -178.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -87.92 -126.14 2.37 Favored Glycine 0 N--CA 1.477 1.382 0 CA-C-N 117.926 0.33 . . . . 73.33 113.32 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -62.71 153.65 43.93 Favored Glycine 0 C--N 1.357 1.72 0 O-C-N 123.481 0.165 . . . . 74.5 112.698 175.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -70.29 123.02 20.67 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.14 0.576 . . . . 75.42 110.903 -173.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -174.48 167.27 39.53 Favored Glycine 0 C--N 1.345 1.066 0 CA-C-O 119.365 -0.686 . . . . 64.21 111.571 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . 0.641 ' HA ' ' HB3' ' A' ' 106' ' ' PHE . 2.9 t-20 -69.98 -50.78 15.96 Favored Pre-proline 0 N--CA 1.479 0.982 0 CA-C-N 118.281 1.04 . . . . 63.54 110.279 174.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.537 ' HD3' ' HB3' ' A' ' 169' ' ' ASN . 8.3 Cg_endo -90.45 84.69 0.4 Allowed 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 121.703 1.602 . . . . 73.02 108.237 160.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.584 ' HD2' ' HA2' ' A' ' 163' ' ' GLY . 2.7 Cg_exo -71.26 178.99 4.87 Favored 'Trans proline' 0 C--N 1.369 1.657 0 C-N-CA 122.525 2.15 . . . . 71.25 113.007 -163.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -62.85 146.46 50.22 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 117.494 1.758 . . . . 72.4 117.494 -162.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.442 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 3.7 m-20 -69.5 89.04 0.5 Allowed 'General case' 0 C--O 1.241 0.658 0 C-N-CA 124.872 1.269 . . . . 71.14 108.547 175.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 22.6 tp -83.14 149.18 27.03 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 114.994 -1.003 . . . . 74.2 111.332 -173.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 80.3 mt -110.56 95.93 5.87 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.037 0.935 . . . . 72.12 108.618 174.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.507 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 93.0 mt -71.21 92.25 1.0 Allowed 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 109.835 -0.431 . . . . 74.52 109.835 175.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.492 HG23 HG23 ' A' ' 158' ' ' VAL . 57.5 t -82.7 100.4 6.38 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 N-CA-C 106.923 -1.51 . . . . 71.11 106.923 173.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.484 HG12 HG23 ' A' ' 153' ' ' VAL . 9.9 p -65.87 113.45 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 CA-C-O 122.036 0.922 . . . . 74.13 110.922 -171.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.576 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 37.6 mmt180 -102.51 106.46 17.18 Favored 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 106.705 -1.591 . . . . 73.42 106.705 171.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.704 HD13 ' HB3' ' A' ' 188' ' ' LEU . 33.0 mt -70.09 143.29 52.46 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 118.921 0.782 . . . . 74.04 109.884 178.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 44.0 mt -54.08 158.07 3.91 Favored Pre-proline 0 N--CA 1.49 1.551 0 C-N-CA 124.314 1.046 . . . . 73.22 112.82 -167.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -75.92 44.01 1.22 Allowed 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 123.298 2.665 . . . . 74.32 111.022 163.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 62.0 t-80 -70.73 131.94 87.43 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 125.371 1.469 . . . . 73.35 107.178 177.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . 0.409 ' HB3' ' HG1' ' B' ' 389' ' ' THR . 24.4 Cg_exo -64.34 12.3 0.1 OUTLIER 'Trans proline' 0 C--N 1.37 1.68 0 C-N-CA 123.557 2.838 . . . . 61.24 117.427 -162.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 4.1 t -112.03 -64.54 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.89 0 CA-C-N 120.455 1.479 . . . . 72.34 110.1 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . 0.529 ' CD1' ' HB3' ' A' ' 195' ' ' ALA . 39.2 m-85 -126.41 163.57 23.01 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 121.614 0.721 . . . . 72.31 111.869 -168.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 31.5 ttp-105 -141.35 96.07 2.93 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 107.102 -1.444 . . . . 75.51 107.102 161.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.704 ' HB3' HD13 ' A' ' 180' ' ' LEU . 54.5 tp -66.24 117.25 8.25 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.784 0.834 . . . . 74.21 110.465 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . 0.544 ' HB3' ' HE1' ' A' ' 194' ' ' TYR . 35.8 tt0 -138.36 132.76 32.02 Favored 'General case' 0 C--O 1.247 0.925 0 C-N-CA 124.164 0.986 . . . . 70.31 109.084 -177.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 78.0 -82.78 1.2 Allowed Glycine 0 C--N 1.343 0.924 0 CA-C-N 115.687 -0.688 . . . . 65.41 111.56 -177.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.675 ' HA ' ' HD2' ' A' ' 154' ' ' ARG . 4.7 pm0 -147.68 -4.79 0.49 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.978 0.911 . . . . 72.32 110.647 174.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -130.73 156.18 45.37 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 122.997 0.519 . . . . 72.32 112.087 -165.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.49 HD21 ' HE1' ' A' ' 240' ' ' PHE . 68.9 mt -90.4 144.49 25.76 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.999 0.92 . . . . 74.25 110.334 -174.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.544 ' HE1' ' HB3' ' A' ' 189' ' ' GLU . 63.7 m-85 -117.24 110.45 18.13 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 109.049 -0.723 . . . . 73.14 109.049 171.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.529 ' HB3' ' CD1' ' A' ' 186' ' ' PHE . . . -121.52 -175.02 2.99 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.827 0.851 . . . . 74.34 110.999 178.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 22.8 m -125.08 145.63 49.83 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.715 0.806 . . . . 70.21 109.184 175.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.533 HD23 HD12 ' A' ' 251' ' ' LEU . 21.9 tp -133.77 101.16 4.99 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.931 -0.396 . . . . 74.1 109.931 176.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -80.67 113.49 18.9 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.321 -0.992 . . . . 63.3 108.321 166.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 6.4 p -133.26 133.21 22.65 Favored Pre-proline 0 N--CA 1.481 1.089 0 C-N-CA 123.652 0.781 . . . . 74.33 109.097 -171.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.37 151.89 60.25 Favored 'Trans proline' 0 C--N 1.375 1.941 0 C-N-CA 121.386 1.391 . . . . 70.05 112.146 177.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -55.52 -45.81 99.81 Favored Pre-proline 0 CA--C 1.553 1.083 0 N-CA-C 114.507 1.299 . . . . 71.34 114.507 -171.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -57.73 -45.4 33.46 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 121.442 1.428 . . . . 73.32 112.734 175.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 41.9 mt -71.11 -27.67 30.44 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 CA-C-N 116.117 -0.492 . . . . 71.02 111.12 -178.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -72.38 -45.0 61.74 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.268 0.627 . . . . 74.14 111.428 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 73.7 t -71.5 -49.86 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 123.356 0.662 . . . . 64.22 111.52 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.474 HG22 ' HA ' ' C' ' 270' ' ' LYS . 47.8 t -83.67 -35.18 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.196 0.598 . . . . 74.41 110.907 -172.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 91.87 73.96 1.26 Allowed Glycine 0 C--N 1.348 1.202 0 CA-C-N 116.084 -0.507 . . . . 72.35 113.35 176.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -110.42 170.33 13.99 Favored Glycine 0 N--CA 1.473 1.134 0 C-N-CA 122.853 0.263 . . . . 73.32 112.646 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 49.7 mtmt -81.22 128.23 33.56 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.016 0.527 . . . . 73.34 111.921 -175.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.525 HG23 HD11 ' A' ' 197' ' ' LEU . 34.4 m -116.02 168.38 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.124 0.97 . . . . 63.11 108.705 169.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 37.9 ttp-105 -88.51 105.69 17.79 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.643 -0.873 . . . . 74.32 108.643 174.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -103.31 123.48 46.86 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.791 -0.818 . . . . 74.41 108.791 176.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' MET . . . . . 0.423 ' HA ' ' HA ' ' A' ' 218' ' ' PRO . 57.6 mtm -68.06 143.8 55.36 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 122.904 0.482 . . . . 74.15 110.72 -177.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 8.5 m -136.71 166.01 24.56 Favored 'General case' 0 CA--C 1.554 1.106 0 N-CA-C 108.762 -0.829 . . . . 74.1 108.762 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 52.6 mt -65.72 -12.85 57.21 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 114.495 1.294 . . . . 73.14 114.495 -170.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -128.2 31.3 5.08 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 109.355 -0.609 . . . . 64.44 109.355 178.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 112.9 160.71 14.61 Favored Glycine 0 C--N 1.351 1.408 0 CA-C-N 114.883 -1.053 . . . . 63.05 112.887 176.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . 0.423 ' HA ' ' HA ' ' A' ' 213' ' ' MET . 3.0 Cg_exo -74.44 142.56 29.93 Favored 'Trans proline' 0 C--N 1.372 1.783 0 C-N-CA 123.141 2.56 . . . . 74.13 111.917 -178.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 34.7 m -128.88 152.0 36.44 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 C-N-CA 124.026 0.93 . . . . 73.4 109.898 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -78.62 117.97 20.28 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-O 121.248 0.547 . . . . 75.04 110.476 176.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 66.2 t -118.11 114.52 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 123.774 0.83 . . . . 74.51 109.063 -177.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.404 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -67.78 101.97 1.15 Allowed 'General case' 0 C--N 1.349 0.556 0 N-CA-C 109.525 -0.546 . . . . 70.4 109.525 172.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 96.3 t -53.9 137.58 55.29 Favored Pre-proline 0 CA--C 1.554 1.105 0 C-N-CA 124.354 1.062 . . . . 71.22 109.823 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -56.22 156.31 21.34 Favored 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 122.522 2.148 . . . . 75.51 111.864 174.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -77.97 151.82 27.76 Favored 'Trans proline' 0 C--N 1.366 1.449 0 C-N-CA 121.616 1.544 . . . . 72.53 111.553 177.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 67.4 mtt-85 67.1 26.68 8.82 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 125.056 1.342 . . . . 75.13 111.498 174.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.42 HG22 HD23 ' A' ' 233' ' ' LEU . 28.8 m -64.16 109.01 1.71 Allowed 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 124.581 1.153 . . . . 64.32 111.468 177.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -101.53 146.56 27.5 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.324 1.05 . . . . 75.32 110.572 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -71.01 145.45 49.98 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.225 0.61 . . . . 65.12 112.367 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 95.19 -1.32 64.68 Favored Glycine 0 C--N 1.342 0.901 0 CA-C-N 115.241 -0.89 . . . . 75.54 112.368 -176.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -109.56 167.97 9.75 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.69 0.796 . . . . 74.44 111.449 -176.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -118.59 115.71 25.12 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.079 0.952 . . . . 72.22 109.919 -177.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.518 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 73.9 mt -80.51 110.19 15.74 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 122.76 0.424 . . . . 71.4 110.279 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . 0.488 ' HA ' ' O ' ' A' ' 249' ' ' LEU . 42.4 ttm180 -74.18 106.65 5.93 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 124.309 1.006 . . . . 73.41 110.392 175.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.512 HD21 HG12 ' B' ' 441' ' ' ILE . 5.0 mt -112.14 101.57 9.82 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 108.331 -0.988 . . . . 74.24 108.331 173.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -67.43 156.18 37.21 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.399 0.68 . . . . 71.01 111.89 -177.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 81.18 -6.81 62.1 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 116.512 -0.313 . . . . 74.2 113.627 177.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.19 -39.83 20.47 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.651 0.781 . . . . 74.1 109.968 176.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -78.98 173.84 55.34 Favored Glycine 0 C--N 1.347 1.153 0 O-C-N 123.676 0.61 . . . . 74.43 111.944 178.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . 0.49 ' HE1' HD21 ' A' ' 193' ' ' LEU . 63.2 m-85 -96.45 160.4 29.7 Favored Pre-proline 0 N--CA 1.473 0.703 0 C-N-CA 123.875 0.87 . . . . 73.41 111.472 -167.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -52.7 140.35 56.46 Favored 'Trans proline' 0 C--N 1.387 2.568 0 C-N-CA 122.79 2.327 . . . . 73.33 112.348 175.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 179.94 -153.04 11.45 Favored Glycine 0 C--N 1.341 0.821 0 CA-C-O 118.738 -1.035 . . . . 73.52 111.597 -176.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . 0.474 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 85.0 Cg_exo -50.0 -43.52 41.48 Favored 'Trans proline' 0 C--N 1.382 2.342 0 C-N-CA 123.955 3.103 . . . . 72.5 114.482 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -85.29 21.45 1.71 Allowed 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.544 0.738 . . . . 70.11 112.372 -175.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 81.1 -77.1 2.07 Favored Glycine 0 C--N 1.347 1.192 0 N-CA-C 109.253 -1.539 . . . . 62.24 109.253 -170.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 73.1 mtp180 -126.19 160.64 29.69 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.243 1.017 . . . . 75.41 108.537 163.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -92.18 172.03 34.57 Favored Glycine 0 C--O 1.25 1.124 0 CA-C-O 122.134 0.852 . . . . 70.31 113.589 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -101.2 -170.95 1.91 Allowed 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 114.105 -1.048 . . . . 75.44 110.238 -177.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.488 ' O ' ' HA ' ' A' ' 234' ' ' ARG . 22.3 tp -121.54 144.61 48.62 Favored 'General case' 0 C--O 1.216 -0.704 0 N-CA-C 107.041 -1.466 . . . . 73.32 107.041 164.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -124.84 106.24 9.87 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 108.471 -0.937 . . . . 71.3 108.471 173.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.533 HD12 HD23 ' A' ' 197' ' ' LEU . 83.1 mt -90.35 119.3 30.53 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 115.386 -0.825 . . . . 74.54 110.712 -179.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -77.21 104.0 7.47 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.011 -0.737 . . . . 75.41 109.011 177.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 38.8 t -73.15 123.53 28.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 115.254 -0.885 . . . . 71.34 111.582 -173.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -125.02 100.96 6.82 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 107.379 -1.341 . . . . 73.14 107.379 166.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.528 ' HB ' ' O ' ' C' ' 255' ' ' ILE . 64.0 mt -75.23 137.15 23.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 115.909 -0.587 . . . . 74.34 109.946 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 39.9 p -119.44 169.49 9.98 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.081 0.952 . . . . 74.52 108.667 173.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . 0.501 ' HB ' ' HD2' ' A' ' 258' ' ' PRO . 2.9 pp -134.38 157.0 78.43 Favored Pre-proline 0 CA--C 1.561 1.392 0 N-CA-C 108.547 -0.909 . . . . 73.4 108.547 175.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . 0.501 ' HD2' ' HB ' ' A' ' 257' ' ' ILE . 37.3 Cg_endo -58.81 -12.34 14.53 Favored 'Trans proline' 0 C--N 1.385 2.481 0 C-N-CA 123.617 2.878 . . . . 74.45 116.147 -162.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.568 ' HA ' ' HB3' ' C' ' 226' ' ' ARG . 29.9 tt0 58.25 -70.26 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 125.352 1.461 . . . . 75.12 112.646 -172.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -74.01 131.01 40.96 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 109.285 -0.635 . . . . 75.12 109.285 172.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 19.6 mt -138.58 144.24 39.73 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.78 0.8 . . . . 72.32 111.587 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 24.5 p -96.92 148.9 35.07 Favored Pre-proline 0 CA--C 1.559 1.32 0 CA-C-N 114.167 -1.378 . . . . 74.31 108.954 173.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -39.87 -47.55 3.76 Favored 'Trans proline' 0 C--N 1.387 2.566 0 C-N-CA 125.114 3.876 . . . . 74.33 116.937 -168.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -67.92 -49.16 63.48 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 122.747 0.419 . . . . 71.44 111.417 -175.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -58.48 -44.57 89.39 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 109.91 -0.404 . . . . 73.22 109.91 177.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -62.65 -33.65 75.47 Favored 'General case' 0 CA--C 1.549 0.92 0 O-C-N 123.754 0.659 . . . . 73.45 111.278 178.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -66.63 -41.71 87.9 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 122.843 0.457 . . . . 64.12 110.782 176.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 10.9 mp -65.54 -47.73 74.87 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.13 0.572 . . . . 73.14 110.7 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 65.9 m95 -58.63 -43.97 89.87 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.925 0.89 . . . . 75.0 111.752 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . 0.485 ' O ' ' HG3' ' A' ' 274' ' ' GLU . 42.9 mttp -67.53 -42.78 82.17 Favored 'General case' 0 C--O 1.215 -0.736 0 CA-C-O 119.215 -0.422 . . . . 73.12 111.44 178.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . 0.429 ' HA ' ' HD3' ' A' ' 271' ' ' LYS . 32.2 mmtm -62.87 -35.62 80.59 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 117.884 0.311 . . . . 70.22 111.706 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' LEU . . . . . 0.621 HD23 ' HB2' ' C' ' 268' ' ' LEU . 86.7 mt -60.31 -50.81 72.14 Favored 'General case' 0 C--O 1.214 -0.768 0 O-C-N 123.909 0.755 . . . . 71.54 109.5 169.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . 0.497 ' HA ' ' HB2' ' C' ' 202' ' ' PRO . . . -65.41 -29.93 70.68 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.492 1.117 . . . . 72.23 113.721 -174.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.756 ' HG2' ' HA ' ' B' ' 251' ' ' ALA . 41.1 mt-10 -81.3 -49.09 11.15 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 123.27 0.628 . . . . 74.35 109.311 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -67.7 -18.81 65.05 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 115.605 -0.725 . . . . 72.24 111.156 177.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . 0.42 ' HE2' ' HG3' ' C' ' 258' ' ' PRO . 21.0 t80 -77.9 -76.66 0.18 Allowed 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 108.349 -0.982 . . . . 75.02 108.349 171.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -50.05 -60.63 2.76 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.673 1.189 . . . . 72.14 111.543 -171.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' B' ' 277' ' ' LEU . . . -61.63 -28.65 69.52 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 123.7 0.625 . . . . 75.41 111.795 -174.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . 0.454 ' HE ' ' HA ' ' A' ' 279' ' ' ARG . 4.6 mmp_? -117.84 32.48 6.13 Favored 'General case' 0 C--N 1.349 0.548 0 N-CA-C 109.507 -0.553 . . . . 75.15 109.507 -174.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.198 0 N-CA-C 108.709 -0.848 . . . . 72.5 108.709 171.524 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 68.4 mtm . . . . . 0 N--CA 1.483 1.185 0 N-CA-C 109.936 -0.394 . . . . 74.12 109.936 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -104.06 84.96 2.31 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.473 0.709 . . . . 62.45 109.354 -173.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -67.78 -72.34 0.18 Allowed 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 109.44 -0.578 . . . . 74.04 109.44 178.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 22.4 m 64.88 -65.87 0.14 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 125.132 1.373 . . . . 52.14 112.716 176.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' THR . . . . . 0.428 HG22 ' HB ' ' A' ' 137' ' ' VAL . 4.3 m -74.44 153.44 39.18 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 123.635 0.774 . . . . 74.34 111.254 177.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.621 HG21 ' HA ' ' A' ' 125' ' ' LEU . 41.6 pt -135.6 -179.84 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 123.173 0.589 . . . . 65.34 112.282 -169.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -130.35 -158.24 0.88 Allowed 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 124.258 1.023 . . . . 72.22 109.612 178.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . 0.427 HD13 ' O ' ' A' ' 122' ' ' GLU . 45.3 tp -141.4 149.75 41.47 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.735 0.814 . . . . 75.22 109.802 179.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.84 -51.25 8.81 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 122.747 0.419 . . . . 73.12 111.764 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 27.0 mt 74.71 -22.46 0.26 Allowed 'General case' 0 N--CA 1.499 2.013 0 C-N-CA 125.381 1.472 . . . . 74.1 113.788 -174.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.424 ' N ' ' HD3' ' B' ' 12' ' ' PRO . 79.9 mt 53.38 58.12 13.74 Favored Pre-proline 0 CA--C 1.565 1.549 0 C-N-CA 124.385 1.074 . . . . 72.11 111.877 -172.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.424 ' HD3' ' N ' ' B' ' 11' ' ' LEU . 4.6 Cg_exo -81.51 -26.08 3.41 Favored 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 122.791 2.327 . . . . 71.41 111.868 176.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -159.97 171.34 19.54 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 124.558 1.143 . . . . 75.11 108.251 -174.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 52.3 tp -104.3 117.99 35.55 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.316 -0.994 . . . . 64.54 108.316 172.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -64.89 115.26 5.17 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.257 0.623 . . . . 74.01 109.871 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 47.1 p -82.49 143.38 47.63 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 123.564 0.746 . . . . 71.11 110.133 176.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -76.81 169.01 22.53 Favored 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 122.816 2.344 . . . . 71.22 113.213 178.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 7.3 p -105.93 135.86 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 123.914 0.886 . . . . 63.3 110.347 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 29.3 p -67.29 144.35 55.95 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.137 0.975 . . . . 71.22 112.035 -178.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -123.24 176.51 6.06 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.463 1.105 . . . . 74.33 109.967 -179.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.97 109.99 2.74 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 122.996 0.518 . . . . 75.34 110.036 175.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . 0.454 ' NH2' ' HA ' ' B' ' 377' ' ' PHE . 41.1 ttt180 -159.06 153.82 24.66 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.808 0.843 . . . . 73.31 110.027 -171.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' THR . . . . . 0.685 ' HA ' ' HG3' ' B' ' 376' ' ' GLU . 85.1 m 70.69 83.65 0.15 Allowed Pre-proline 0 N--CA 1.478 0.967 0 C-N-CA 124.748 1.219 . . . . 72.54 112.185 174.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -91.08 33.47 0.31 Allowed 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 123.418 2.745 . . . . 74.55 111.373 166.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -84.07 75.22 10.18 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 123.976 0.91 . . . . 74.53 110.079 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' MET . . . . . 0.528 ' HB3' ' HD3' ' B' ' 27' ' ' PRO . 1.4 tpt -164.33 -48.24 0.0 OUTLIER Pre-proline 0 CA--C 1.554 1.103 0 CA-C-N 114.808 -1.087 . . . . 75.13 108.931 175.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' PRO . . . . . 0.528 ' HD3' ' HB3' ' B' ' 26' ' ' MET . 2.7 Cg_endo -85.92 96.22 0.57 Allowed 'Trans proline' 0 C--N 1.388 2.618 0 C-N-CA 121.687 1.591 . . . . 73.04 108.776 159.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.438 HG23 ' HB2' ' B' ' 139' ' ' ASN . 7.2 p -58.93 122.75 9.67 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 CA-C-N 116.147 -0.478 . . . . 75.25 110.784 -178.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -104.54 115.82 31.02 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 106.401 -1.703 . . . . 73.34 106.401 172.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -64.34 -32.83 74.59 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.026 0.931 . . . . 71.25 112.226 -172.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 65.5 t30 70.38 13.89 7.49 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 124.873 1.269 . . . . 74.34 111.983 175.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' ARG . . . . . 0.421 ' HB3' ' HB1' ' C' ' 244' ' ' ALA . 4.3 ppt_? -85.99 -1.28 57.19 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.559 0.744 . . . . 72.22 112.603 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.1 118.48 11.32 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 122.975 0.51 . . . . 73.31 110.066 174.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . 59.09 29.7 19.32 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 124.468 1.107 . . . . 53.33 112.182 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . 0.637 ' HA ' ' HB3' ' C' ' 236' ' ' LYS . 28.1 tt0 -78.27 -30.9 48.76 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.02 0.928 . . . . 73.13 112.305 -173.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.02 -83.33 0.23 Allowed Glycine 0 CA--C 1.531 1.07 0 N-CA-C 111.647 -0.581 . . . . 74.33 111.647 -173.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . 0.485 ' HB2' ' HG2' ' B' ' 35' ' ' GLN . 31.5 t70 60.51 -83.26 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 125.564 1.546 . . . . 61.44 111.995 170.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 7.5 tt -96.78 85.04 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 CA-C-O 122.375 1.083 . . . . 75.44 108.47 173.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 43.7 m -110.51 -43.08 3.93 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 114.856 -1.066 . . . . 73.32 109.108 177.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.08 119.01 72.14 Favored Pre-proline 0 CA--C 1.549 0.911 0 CA-C-N 115.655 -0.702 . . . . 73.24 109.372 172.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -65.97 89.1 0.24 Allowed 'Trans proline' 0 C--N 1.381 2.277 0 C-N-CA 123.107 2.538 . . . . 72.44 112.457 -177.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.78 -80.17 1.08 Allowed Glycine 0 C--N 1.345 1.055 0 CA-C-N 115.529 -0.76 . . . . 61.22 111.642 -176.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.88 -66.62 3.87 Favored Glycine 0 C--N 1.346 1.119 0 N-CA-C 112.044 -0.423 . . . . 64.32 112.044 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . 58.26 -168.99 0.13 Allowed 'General case' 0 C--N 1.36 1.056 0 C-N-CA 124.696 1.198 . . . . 63.2 111.216 -176.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.516 ' HB2' ' HB3' ' B' ' 127' ' ' SER . 0.0 OUTLIER -92.21 128.96 38.25 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 107.467 -1.309 . . . . 74.21 107.467 169.531 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -86.15 81.07 8.57 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 107.637 -1.246 . . . . 75.02 107.637 178.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.409 HD22 ' HA3' ' B' ' 229' ' ' GLY . 2.8 tm? -124.16 101.41 7.19 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 108.021 -1.103 . . . . 72.13 108.021 175.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 10.3 t -179.69 171.76 1.17 Allowed 'General case' 0 C--O 1.245 0.853 0 O-C-N 124.816 1.323 . . . . 73.12 108.104 169.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 145.53 157.96 7.49 Favored Glycine 0 C--N 1.345 1.08 0 N-CA-C 111.841 -0.503 . . . . 74.15 111.841 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -82.73 54.55 2.72 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.997 0.919 . . . . 64.2 110.429 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' GLN . . . . . 0.583 ' HG2' HD22 ' B' ' 55' ' ' LEU . 9.5 tp-100 66.8 128.85 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 125.723 1.609 . . . . 75.3 111.48 -173.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 95.1 m -147.31 103.02 3.53 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 123.298 0.639 . . . . 73.31 109.294 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . 63.65 169.31 0.16 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.932 1.293 . . . . 73.24 113.049 177.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . 72.76 -16.82 0.43 Allowed 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.168 1.387 . . . . 75.51 113.795 176.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . 0.583 HD22 ' HG2' ' B' ' 51' ' ' GLN . 40.5 tp -62.82 128.69 37.08 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 118.772 0.715 . . . . 72.35 109.713 176.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 26.5 mmm180 78.1 -45.49 0.42 Allowed 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 125.76 1.624 . . . . 74.21 112.072 -174.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -69.38 -72.21 0.2 Allowed 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.42 0.688 . . . . 75.31 109.974 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 20.0 m 66.18 4.98 3.36 Favored 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 125.007 1.323 . . . . 62.01 114.028 169.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 60.8 tp 57.94 95.17 0.03 OUTLIER 'General case' 0 C--N 1.36 1.03 0 C-N-CA 124.647 1.179 . . . . 72.44 110.401 -170.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 41.3 m -78.26 90.88 4.35 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 122.869 0.467 . . . . 71.31 109.831 177.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -114.75 148.81 37.84 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.196 0.598 . . . . 71.45 109.79 172.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' LYS . . . . . 0.568 ' HE2' ' HA ' ' B' ' 62' ' ' LYS . 10.8 mmpt? 75.11 141.38 0.08 OUTLIER Pre-proline 0 N--CA 1.484 1.241 0 C-N-CA 125.747 1.619 . . . . 72.42 111.737 -177.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -69.09 90.76 0.45 Allowed 'Trans proline' 0 C--N 1.383 2.344 0 C-N-CA 123.262 2.641 . . . . 72.24 111.641 -177.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 76.32 -48.19 0.56 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 125.647 1.579 . . . . 72.04 111.559 -171.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.571 ' HZ2' ' HE2' ' B' ' 117' ' ' LYS . 37.4 ttmt 71.89 -73.28 0.1 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.417 1.487 . . . . 73.42 109.258 -174.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 45.4 t30 54.05 -102.03 0.13 Allowed 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 124.301 1.041 . . . . 72.41 110.589 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 17.3 mm -90.71 95.2 5.34 Favored 'Isoleucine or valine' 0 C--N 1.355 0.843 0 N-CA-C 107.794 -1.188 . . . . 74.04 107.794 177.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 6.4 tp -60.1 117.02 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.23 0 C-N-CA 124.094 0.958 . . . . 73.4 111.94 -175.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 58.6 tp 72.3 -62.89 0.45 Allowed 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 125.868 1.667 . . . . 74.34 112.136 176.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.19 47.86 1.4 Allowed 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 123.915 0.886 . . . . 65.22 111.018 -174.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 9.2 tt -61.41 -43.77 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 123.047 0.539 . . . . 75.5 109.872 172.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.53 -67.61 2.54 Favored Glycine 0 C--N 1.35 1.345 0 CA-C-N 115.798 -0.637 . . . . 71.15 112.157 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 11.5 t70 79.0 -62.5 0.31 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 126.765 2.026 . . . . 74.12 110.789 176.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.8 -63.94 0.27 Allowed Glycine 0 C--N 1.343 0.961 0 N-CA-C 112.362 -0.295 . . . . 72.45 112.362 176.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 21.2 ptp -87.15 -24.61 24.43 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 122.866 0.466 . . . . 74.01 111.23 -176.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . -111.54 14.04 27.57 Favored Glycine 0 C--N 1.346 1.117 0 N-CA-C 111.54 -0.624 . . . . 71.52 111.54 174.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -62.68 135.4 57.35 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.686 1.194 . . . . 74.35 111.927 -178.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 22.8 t -166.29 158.39 13.95 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.369 0.668 . . . . 55.34 110.309 178.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 68.55 -71.05 0.12 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 125.678 1.591 . . . . 74.44 112.181 176.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 12.3 tt -53.38 -23.65 7.32 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.295 0 C-N-CA 124.764 1.226 . . . . 72.52 112.936 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -56.71 -47.42 79.99 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.006 0.922 . . . . 74.52 110.958 177.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . 0.404 ' HA ' ' HB2' ' B' ' 86' ' ' TYR . . . -66.59 -23.47 66.2 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 114.975 -1.011 . . . . 75.12 112.498 -175.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.9 -41.56 86.92 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.378 0.671 . . . . 74.13 111.229 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 18.4 tpp180 -160.64 140.37 10.97 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.214 0.606 . . . . 73.0 110.363 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 67.46 30.35 6.86 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.493 1.117 . . . . 72.23 112.001 177.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 86' ' ' TYR . . . . . 0.404 ' HB2' ' HA ' ' B' ' 82' ' ' ALA . 50.7 t80 -77.38 77.54 3.91 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 109.198 -0.667 . . . . 74.21 109.198 172.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . 164.03 -34.93 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 126.851 2.061 . . . . 52.24 108.877 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 66.26 -78.04 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 124.806 1.242 . . . . 74.14 108.194 -167.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . 0.652 ' HA3' ' HG2' ' B' ' 95' ' ' LYS . . . 151.7 -58.7 0.42 Allowed Glycine 0 C--N 1.343 0.928 0 N-CA-C 110.878 -0.889 . . . . 54.33 110.878 176.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . 0.443 ' HB1' ' HB3' ' B' ' 95' ' ' LYS . . . -176.73 113.18 0.1 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.522 1.129 . . . . 75.53 108.836 177.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -66.92 86.87 0.13 Allowed Glycine 0 C--N 1.35 1.352 0 N-CA-C 110.96 -0.856 . . . . 70.11 110.96 174.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . 0.468 ' H ' ' HA3' ' B' ' 96' ' ' GLY . . . 92.04 -138.99 14.49 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.961 -0.856 . . . . 73.42 110.961 -167.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 62.73 -75.95 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.911 1.285 . . . . 74.22 111.501 177.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -143.66 -48.78 0.3 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.519 1.128 . . . . 72.14 109.427 176.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . 0.652 ' HG2' ' HA3' ' B' ' 89' ' ' GLY . 28.0 tptp -61.95 -47.67 83.82 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.682 0.793 . . . . 74.44 111.31 -177.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 96' ' ' GLY . . . . . 0.468 ' HA3' ' H ' ' B' ' 92' ' ' GLY . . . -65.75 82.44 0.09 OUTLIER Glycine 0 C--N 1.345 1.054 0 O-C-N 123.954 0.784 . . . . 75.21 112.638 178.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 31.8 pt -84.96 -20.78 8.21 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 124.035 0.934 . . . . 73.0 109.586 176.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -139.67 172.56 12.62 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 125.087 1.355 . . . . 75.21 108.497 168.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -142.84 -40.4 0.33 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.612 0.365 . . . . 61.12 110.629 -177.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 93.5 mt -124.94 81.11 62.71 Favored Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 123.375 0.67 . . . . 74.2 110.767 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -85.09 -8.33 8.96 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 122.345 2.03 . . . . 74.43 112.936 170.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . 0.522 ' HB3' ' HA ' ' B' ' 105' ' ' GLN . 3.5 mm? -77.56 -45.03 26.58 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.597 0.759 . . . . 73.12 109.811 177.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 14.5 m 65.35 78.47 0.28 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.621 1.169 . . . . 75.52 110.537 178.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 66.96 22.43 72.23 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-N 114.606 -1.179 . . . . 51.35 112.732 -176.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 105' ' ' GLN . . . . . 0.522 ' HA ' ' HB3' ' B' ' 102' ' ' LEU . 8.9 tp-100 57.37 76.36 0.32 Allowed 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 124.462 1.105 . . . . 75.22 109.699 -169.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 64.37 107.62 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 125.682 1.593 . . . . 74.44 113.804 175.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 50.2 p -78.18 -173.63 3.3 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 123.529 0.732 . . . . 75.34 110.497 171.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -79.7 80.34 6.09 Favored 'General case' 0 CA--C 1.558 1.272 0 CA-C-O 122.042 0.925 . . . . 73.44 109.895 177.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -74.28 -41.92 60.43 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 121.785 -0.572 . . . . 74.1 109.86 176.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -169.53 -46.69 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.702 1.201 . . . . 75.22 108.396 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 5.7 tt -170.97 -51.72 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 106.311 -1.737 . . . . 70.25 106.311 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 65.36 -133.73 0.23 Allowed 'General case' 0 CA--C 1.555 1.155 0 CA-C-N 114.149 -1.387 . . . . 73.2 109.474 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 113' ' ' LYS . . . . . 0.544 ' HA ' ' HE2' ' B' ' 113' ' ' LYS . 11.5 mmpt? 69.74 -3.31 1.72 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.115 1.366 . . . . 75.13 113.621 175.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 13.3 mptt 51.2 -92.18 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.525 1.13 . . . . 74.21 110.888 -173.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 115' ' ' THR . . . . . 0.522 HG21 ' HD3' ' B' ' 117' ' ' LYS . 12.1 m 58.13 -74.56 0.02 OUTLIER 'General case' 0 CA--C 1.562 1.408 0 C-N-CA 125.33 1.452 . . . . 73.23 112.755 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.16 47.42 4.7 Favored Glycine 0 C--N 1.354 1.572 0 N-CA-C 111.625 -0.59 . . . . 55.33 111.625 -178.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . 0.571 ' HE2' ' HZ2' ' B' ' 65' ' ' LYS . 5.1 mptp? -119.68 -52.08 0.04 OUTLIER Pre-proline 0 CA--C 1.569 1.681 0 CA-C-O 117.786 -1.102 . . . . 75.35 112.861 -173.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 118' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -61.72 106.09 0.41 Allowed 'Trans proline' 0 C--N 1.39 2.76 0 C-N-CA 121.985 1.79 . . . . 63.21 113.162 -176.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 119' ' ' ASP . . . . . . . . . . . . . 31.0 t70 76.24 161.6 0.23 Allowed 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 125.207 1.403 . . . . 75.33 112.924 173.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 120' ' ' TYR . . . . . 0.494 ' HA ' ' HB2' ' B' ' 221' ' ' ARG . 0.8 OUTLIER -152.57 -2.77 0.25 Allowed 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 124.36 1.064 . . . . 70.1 111.483 176.1 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 15.9 m -126.94 -31.14 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 113.419 0.896 . . . . 74.32 113.419 -170.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 45.1 m -77.26 91.13 3.75 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.126 0.571 . . . . 75.25 110.284 -174.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -154.5 162.03 41.36 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.146 0.578 . . . . 70.53 109.886 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 46.1 m -101.44 12.93 36.48 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.395 0.678 . . . . 61.03 111.987 -176.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.67 130.35 42.99 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.503 0.721 . . . . 74.53 110.641 177.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.96 -22.73 67.05 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.825 -0.625 . . . . 74.13 110.697 176.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 127' ' ' SER . . . . . 0.516 ' HB3' ' HB2' ' B' ' 45' ' ' ARG . 53.6 m 67.78 26.06 7.83 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.811 1.245 . . . . 70.01 111.906 171.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -104.66 -25.79 12.57 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.55 0.74 . . . . 74.33 110.768 176.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 41.1 p -76.99 89.35 3.54 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 121.105 0.479 . . . . 74.41 110.675 178.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . -85.75 69.58 10.61 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 109.481 -0.562 . . . . 61.42 109.481 175.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 131' ' ' TRP . . . . . 0.428 ' CD1' ' HB3' ' C' ' 132' ' ' HIS . 66.8 t-105 66.23 -76.17 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 125.193 1.397 . . . . 73.51 110.801 -177.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 36.4 t -162.88 162.01 26.14 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.102 0.961 . . . . 74.11 109.303 176.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 63.6 m -153.81 141.18 19.67 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 108.993 -0.743 . . . . 74.52 108.993 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . -148.13 135.69 5.63 Favored Glycine 0 C--N 1.343 0.96 0 N-CA-C 111.465 -0.654 . . . . 55.15 111.465 177.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 135' ' ' VAL . . . . . . . . . . . . . 18.9 m -90.76 178.27 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 123.451 0.7 . . . . 73.24 109.857 175.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 136' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' B' ' 371' ' ' VAL . 18.8 pttp -88.86 47.72 1.54 Allowed 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 121.079 0.466 . . . . 74.24 109.839 173.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 45.3 m 56.69 -83.68 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.237 0 C-N-CA 125.381 1.472 . . . . 75.31 113.07 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -134.82 174.43 10.59 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.166 0.987 . . . . 75.52 108.995 -169.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . 0.438 ' HB2' HG23 ' B' ' 28' ' ' VAL . 30.0 p-10 -78.5 -41.66 31.79 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 121.747 -0.596 . . . . 73.24 110.638 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 140' ' ' GLY . . . . . 0.802 ' HA3' HG22 ' B' ' 371' ' ' VAL . . . 58.07 -136.41 50.92 Favored Glycine 0 C--N 1.35 1.359 0 N-CA-C 115.068 0.787 . . . . 75.54 115.068 171.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -110.17 -38.38 5.3 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.821 0.849 . . . . 75.34 111.354 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 23.4 mt 73.97 171.57 0.29 Allowed 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 126.103 1.761 . . . . 74.24 111.598 -176.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.63 -172.08 53.18 Favored Glycine 0 C--N 1.346 1.113 0 CA-C-N 115.542 -0.754 . . . . 61.25 113.615 178.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 43.3 t 75.5 -33.98 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 C-N-CA 125.738 1.615 . . . . 75.31 112.183 -178.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -60.96 106.15 0.55 Allowed 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 123.87 0.868 . . . . 75.32 111.215 178.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 82.4 mt -128.05 -74.0 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 107.85 -1.167 . . . . 72.52 107.85 172.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 147' ' ' HIS . . . . . 0.568 ' HA ' HG22 ' B' ' 306' ' ' VAL . 34.1 t-80 72.44 -56.32 0.65 Allowed 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 125.444 1.498 . . . . 72.43 114.678 173.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . 0.422 ' HG3' ' O ' ' B' ' 197' ' ' SER . 6.7 mm-40 -46.17 138.88 4.99 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 115.64 1.719 . . . . 75.05 115.64 -155.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 149' ' ' LYS . . . . . 0.448 ' HE2' ' CE1' ' B' ' 147' ' ' HIS . 33.2 mtmt -123.48 -93.34 0.51 Allowed 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 114.279 -1.328 . . . . 74.13 109.599 -173.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 38.7 t70 178.45 -123.85 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 125.175 1.39 . . . . 74.11 107.592 172.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 151' ' ' HIS . . . . . 0.406 ' HA ' ' HB2' ' C' ' 118' ' ' ASP . 10.4 p-80 -176.43 113.96 0.26 Allowed Pre-proline 0 C--N 1.356 0.886 0 C-N-CA 124.629 1.171 . . . . 74.43 109.122 -176.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -77.58 -17.9 14.03 Favored 'Trans proline' 0 C--N 1.366 1.499 0 C-N-CA 122.186 1.924 . . . . 64.13 110.862 169.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 21.9 m -111.11 131.55 55.0 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.457 1.103 . . . . 74.2 109.29 -176.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 15.8 tt -142.57 160.77 19.01 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 C-N-CA 124.478 1.111 . . . . 74.25 108.108 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 155' ' ' LEU . . . . . 0.423 HD21 ' HA ' ' B' ' 187' ' ' SER . 58.7 mt 70.47 172.8 0.31 Allowed 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 124.872 1.269 . . . . 73.12 112.628 177.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -172.69 -154.22 0.08 Allowed 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 124.698 1.199 . . . . 72.23 108.639 172.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 157' ' ' MET . . . . . . . . . . . . . 60.2 mtt -52.55 -74.83 0.03 OUTLIER 'General case' 0 C--N 1.365 1.27 0 C-N-CA 123.823 0.849 . . . . 61.13 110.994 173.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 158' ' ' ALA . . . . . . . . . . . . . . . 172.17 -71.0 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.561 1.144 . . . . 65.11 108.996 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 32.5 mtmm 46.27 69.07 0.51 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.548 1.539 . . . . 73.24 112.668 -175.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -86.61 59.28 5.54 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.103 0.561 . . . . 74.34 109.578 174.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -69.87 121.66 17.75 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.794 0.837 . . . . 71.1 111.26 -173.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 83.68 -73.64 2.64 Favored Glycine 0 C--N 1.347 1.175 0 N-CA-C 111.718 -0.553 . . . . 73.4 111.718 -177.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 25.4 tp 62.7 8.38 2.98 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 125.173 1.389 . . . . 75.25 112.393 175.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 164' ' ' ALA . . . . . . . . . . . . . . . -170.4 -46.37 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.843 1.257 . . . . 75.34 107.715 -174.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 48.4 p -103.5 -174.55 2.57 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 114.304 -1.316 . . . . 73.14 109.211 169.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . 113.34 -136.02 13.07 Favored Glycine 0 C--N 1.344 0.983 0 N-CA-C 111.111 -0.796 . . . . 74.53 111.111 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 167' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -83.01 68.45 9.51 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 108.742 -0.836 . . . . 74.33 108.742 176.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . 0.495 HG21 ' H ' ' B' ' 169' ' ' SER . 17.4 m -108.0 -62.8 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 CA-C-N 115.216 -0.902 . . . . 75.53 110.503 -176.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 169' ' ' SER . . . . . 0.723 ' HA ' ' HB2' ' B' ' 174' ' ' GLN . 20.1 m 49.62 -176.96 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.412 0 N-CA-C 115.427 1.64 . . . . 65.53 115.427 177.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 48.0 m -150.25 98.87 2.73 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.692 -0.855 . . . . 73.13 108.692 176.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . 0.441 ' H ' ' HG2' ' C' ' 128' ' ' GLU . . . 72.46 -64.8 0.38 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 125.28 1.432 . . . . 73.41 111.209 -178.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 172' ' ' GLU . . . . . . . . . . . . . 15.6 mp0 -105.3 170.89 7.62 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.151 0.981 . . . . 75.25 109.055 168.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 173' ' ' LEU . . . . . 0.455 ' H ' HD13 ' B' ' 173' ' ' LEU . 0.0 OUTLIER -57.25 131.1 49.0 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 123.511 0.724 . . . . 74.44 111.721 178.658 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 174' ' ' GLN . . . . . 0.723 ' HB2' ' HA ' ' B' ' 169' ' ' SER . 8.2 mm100 -131.63 -26.68 2.0 Allowed 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.129 0.972 . . . . 74.45 110.731 -178.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 175' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -153.99 149.51 27.3 Favored 'General case' 0 C--O 1.245 0.831 0 O-C-N 123.477 0.485 . . . . 74.1 110.241 174.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -148.27 81.02 1.47 Allowed 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.124 0.97 . . . . 74.11 108.823 172.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 177' ' ' THR . . . . . 0.461 ' N ' ' HD3' ' B' ' 178' ' ' PRO . 2.8 m -130.25 47.5 2.93 Favored Pre-proline 0 CA--C 1.582 2.178 0 CA-C-N 115.951 -0.568 . . . . 74.15 112.248 175.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 178' ' ' PRO . . . . . 0.461 ' HD3' ' N ' ' B' ' 177' ' ' THR . 91.4 Cg_endo -99.1 -152.39 0.03 OUTLIER 'Trans proline' 0 C--N 1.393 2.915 0 C-N-CA 122.319 2.012 . . . . 74.53 110.338 168.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -64.41 -47.21 80.01 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 109.506 -0.553 . . . . 74.35 109.506 167.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . -172.73 -56.06 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 114.527 -1.215 . . . . 75.32 108.482 170.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 181' ' ' LEU . . . . . 0.624 ' HB2' ' HB3' ' C' ' 136' ' ' ARG . 59.3 tp -105.9 -89.38 0.43 Allowed 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 107.602 -1.259 . . . . 74.44 107.602 169.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 182' ' ' VAL . . . . . 0.492 HG13 ' HB2' ' C' ' 123' ' ' LEU . 30.5 m -129.04 -173.04 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.932 0 C-N-CA 124.716 1.206 . . . . 72.43 108.477 170.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -171.94 95.99 0.16 Allowed 'General case' 0 CA--C 1.547 0.865 0 CA-C-O 118.414 -0.803 . . . . 65.24 112.394 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 11.1 p-80 164.56 159.19 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.724 0 C-N-CA 125.551 1.54 . . . . 75.32 112.396 160.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 185' ' ' VAL . . . . . . . . . . . . . 34.8 t -77.45 171.77 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 C-N-CA 124.901 1.28 . . . . 74.01 109.33 169.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 186' ' ' THR . . . . . 0.427 HG22 ' HB3' ' C' ' 122' ' ' GLU . 17.9 p -56.07 86.88 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.461 0.704 . . . . 60.24 110.625 170.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 187' ' ' SER . . . . . 0.423 ' HA ' HD21 ' B' ' 155' ' ' LEU . 10.3 t -111.63 12.65 21.21 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.948 0.899 . . . . 62.14 111.377 -170.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 2.4 tpm_? -131.96 -54.8 0.99 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.527 0.731 . . . . 72.32 109.395 177.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -170.55 174.1 5.23 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.788 0.835 . . . . 72.52 111.402 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 190' ' ' CYS . . . . . . . . . . . . . 42.4 t -161.27 124.05 3.15 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.751 0.82 . . . . 70.33 109.511 175.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -64.16 -67.95 0.39 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.238 0.615 . . . . 74.04 111.213 -176.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 179.75 157.5 20.11 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-O 119.142 -0.81 . . . . 64.22 111.215 -177.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 193' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.43 -72.96 0.02 OUTLIER 'Trans proline' 0 C--N 1.366 1.496 0 C-N-CA 122.534 2.156 . . . . 73.22 112.397 -177.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 194' ' ' SER . . . . . 0.439 ' HB2' ' HB3' ' B' ' 300' ' ' ASN . 19.8 m -81.0 -4.76 56.25 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.037 0.935 . . . . 63.44 111.68 -179.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 195' ' ' ALA . . . . . . . . . . . . . . . -67.45 -53.41 29.2 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 122.901 0.48 . . . . 74.32 110.254 174.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 68.9 p -93.27 -23.57 18.46 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.331 -0.85 . . . . 73.32 111.59 -177.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 197' ' ' SER . . . . . 0.437 ' O ' ' HA ' ' B' ' 194' ' ' SER . 22.0 m -146.75 96.32 2.73 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.201 0.6 . . . . 75.11 110.377 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 198' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -70.61 -16.4 62.84 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-O 121.176 0.512 . . . . 65.14 110.718 171.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.93 91.85 1.76 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.672 1.189 . . . . 75.14 109.334 -173.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 200' ' ' CYS . . . . . 0.407 ' SG ' ' HG2' ' B' ' 148' ' ' GLU . 23.8 p -94.24 112.88 59.21 Favored Pre-proline 0 N--CA 1.476 0.826 0 N-CA-C 109.568 -0.53 . . . . 73.31 109.568 177.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 201' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -78.02 162.64 28.93 Favored 'Trans proline' 0 C--N 1.37 1.658 0 C-N-CA 122.385 2.056 . . . . 74.02 111.808 174.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . -165.2 -37.65 0.02 OUTLIER Glycine 0 C--N 1.339 0.72 0 CA-C-N 116.275 -0.42 . . . . 73.41 112.574 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -79.14 78.19 5.61 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.605 -0.887 . . . . 71.33 108.605 174.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -168.86 82.39 0.14 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.854 0.862 . . . . 74.01 109.096 178.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 205' ' ' LEU . . . . . 0.504 HD23 ' H ' ' B' ' 205' ' ' LEU . 1.4 pt? -115.27 21.6 14.0 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.213 0.605 . . . . 72.44 110.585 -178.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 206' ' ' GLU . . . . . 0.481 ' HB3' ' NH1' ' C' ' 148' ' ' ARG . 16.6 tt0 56.01 -94.42 0.04 OUTLIER 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 125.415 1.486 . . . . 70.3 112.752 172.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 48.3 tttm -179.66 -64.27 0.01 OUTLIER 'General case' 0 C--N 1.354 0.776 0 C-N-CA 123.553 0.741 . . . . 74.32 109.5 -169.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 75.92 165.01 17.45 Favored Glycine 0 C--N 1.35 1.311 0 CA-C-N 115.704 -0.68 . . . . 71.52 111.911 -169.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 158.17 174.36 27.78 Favored Glycine 0 N--CA 1.468 0.796 0 O-C-N 122.217 -0.578 . . . . 63.34 112.777 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 210' ' ' LYS . . . . . 0.455 ' HG3' ' HB2' ' B' ' 326' ' ' ASP . 53.9 mtpt 65.37 6.25 3.57 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 125.047 1.339 . . . . 74.51 112.238 -178.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . -84.49 -100.25 0.62 Allowed Glycine 0 C--N 1.348 1.206 0 N-CA-C 110.859 -0.896 . . . . 74.43 110.859 -177.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 19.7 m 61.21 10.3 2.92 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.039 0.936 . . . . 74.04 112.294 -175.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 9.7 tp -160.96 131.08 0.79 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.855 0 N-CA-C 107.404 -1.332 . . . . 70.12 107.404 -175.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 15.0 t -159.76 12.63 0.13 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 122.911 0.484 . . . . 75.43 110.698 -174.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 215' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -70.49 -29.23 65.71 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 122.909 0.483 . . . . 73.31 110.514 -171.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -80.77 84.23 6.35 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 109.412 -0.588 . . . . 61.42 109.412 175.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -78.53 -33.45 47.93 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 108.622 -0.881 . . . . 75.4 108.622 173.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 6.1 mp -68.22 97.31 0.71 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.627 0.771 . . . . 71.43 110.178 -178.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -75.26 -43.85 49.16 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 109.928 -0.397 . . . . 71.24 109.928 174.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -113.27 -72.31 0.71 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.158 0.583 . . . . 74.3 111.496 -178.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 221' ' ' ARG . . . . . 0.494 ' HB2' ' HA ' ' B' ' 120' ' ' TYR . 1.0 OUTLIER -155.72 -81.62 0.07 Allowed 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 119.53 -0.271 . . . . 73.55 111.205 -179.644 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -169.51 138.99 2.01 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.688 0.395 . . . . 75.21 111.559 -173.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 31.2 t70 50.89 -81.88 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 125.982 1.713 . . . . 72.13 114.352 168.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 7.1 p -61.22 -39.65 83.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.605 0.762 . . . . 75.32 110.885 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 18.5 m -145.05 84.63 1.72 Allowed 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 107.99 -1.115 . . . . 73.55 107.99 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . 0.555 ' HB3' ' HA ' ' B' ' 174' ' ' GLN . 58.1 tp -103.81 -14.17 16.15 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.614 0.766 . . . . 74.43 110.212 178.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . -151.74 178.79 28.83 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-N 116.32 -0.4 . . . . 71.24 112.539 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 78.11 -72.77 2.25 Favored Glycine 0 C--N 1.346 1.135 0 C-N-CA 122.871 0.272 . . . . 72.41 112.662 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 229' ' ' GLY . . . . . 0.409 ' HA3' HD22 ' B' ' 47' ' ' LEU . . . 77.16 -76.68 1.61 Allowed Glycine 0 C--N 1.344 1.027 0 CA-C-N 115.684 -0.258 . . . . 71.04 112.742 177.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -152.31 113.43 4.23 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.641 0.776 . . . . 70.23 109.944 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 231' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -135.99 84.55 2.09 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.697 0.799 . . . . 73.24 109.269 176.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 41.5 p -76.14 155.77 34.34 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 122.95 0.5 . . . . 74.24 111.11 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -134.88 124.77 25.53 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.659 0.783 . . . . 71.44 109.513 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -171.39 98.6 0.19 Allowed 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 108.138 -1.06 . . . . 72.31 108.138 176.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -154.24 148.9 26.41 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 109.161 -0.681 . . . . 64.41 109.161 -172.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 236' ' ' THR . . . . . . . . . . . . . 5.5 m -50.73 -54.36 23.89 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.638 1.575 . . . . 73.34 113.016 -176.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -161.5 83.45 0.62 Allowed 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.724 -0.671 . . . . 73.03 110.273 -175.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 23.0 m -88.61 -5.76 57.96 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 123.253 0.621 . . . . 71.31 110.639 174.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 239' ' ' ALA . . . . . 0.555 ' HB1' ' H ' ' C' ' 222' ' ' ALA . . . -55.27 -78.63 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.184 0.994 . . . . 74.42 112.951 -175.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . 152.82 -114.32 0.62 Allowed Glycine 0 C--N 1.339 0.699 0 N-CA-C 110.623 -0.991 . . . . 71.23 110.623 -172.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -151.61 136.07 16.91 Favored 'General case' 0 C--O 1.245 0.855 0 C-N-CA 123.455 0.702 . . . . 71.23 110.012 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 242' ' ' TRP . . . . . 0.514 ' CD2' ' HG ' ' C' ' 233' ' ' LEU . 4.7 p-90 -172.21 138.24 0.96 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.809 0.843 . . . . 70.32 112.106 173.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 71.8 mm-40 62.99 -75.0 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.819 1.648 . . . . 74.22 111.765 175.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 178.96 58.9 0.07 OUTLIER Glycine 0 C--N 1.342 0.9 0 N-CA-C 112.226 -0.35 . . . . 71.54 112.226 177.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 245' ' ' LYS . . . . . 0.76 ' HE2' ' HB3' ' C' ' 222' ' ' ALA . 52.8 tptt -69.23 96.28 0.83 Allowed 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 120.883 0.373 . . . . 75.34 110.767 177.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 4.8 t -68.51 131.88 46.01 Favored 'General case' 0 C--O 1.244 0.815 0 N-CA-C 108.399 -0.963 . . . . 71.14 108.399 164.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 247' ' ' LEU . . . . . . . . . . . . . 46.9 tp -62.45 88.29 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.752 0.821 . . . . 72.51 110.478 -174.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 248' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -141.61 121.55 13.64 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.611 1.165 . . . . 75.15 108.574 -178.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.65 -55.17 5.75 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 122.608 0.363 . . . . 71.33 110.414 -178.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 250' ' ' GLN . . . . . 0.441 ' N ' HE21 ' B' ' 250' ' ' GLN . 0.0 OUTLIER 53.17 -171.62 0.04 OUTLIER 'General case' 0 CA--C 1.561 1.374 0 C-N-CA 125.264 1.426 . . . . 70.14 112.933 -177.444 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 251' ' ' ALA . . . . . 0.756 ' HA ' ' HG2' ' A' ' 274' ' ' GLU . . . 61.03 74.38 0.45 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.548 1.139 . . . . 64.21 112.438 173.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -119.46 -41.19 2.72 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-N 115.791 -0.64 . . . . 73.12 110.934 -177.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . 80.02 -36.31 0.15 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 125.679 1.592 . . . . 51.41 113.144 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -52.58 98.59 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.238 1.015 . . . . 72.51 112.509 -171.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -142.44 -38.97 0.07 OUTLIER Glycine 0 C--N 1.34 0.77 0 CA-C-N 114.579 -1.191 . . . . 63.32 110.877 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 256' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -161.03 -56.73 0.05 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.157 0.583 . . . . 71.2 110.586 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 14.7 mp0 54.44 36.38 25.44 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.531 1.132 . . . . 74.31 112.416 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 258' ' ' LEU . . . . . . . . . . . . . 8.0 mp 67.73 -73.48 0.08 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.856 1.263 . . . . 75.13 110.896 178.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 57.4 t -109.3 -53.91 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 123.204 0.601 . . . . 63.31 110.298 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 260' ' ' SER . . . . . . . . . . . . . 58.4 p -157.12 164.96 37.29 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.07 0.548 . . . . 73.11 110.577 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -87.29 -39.14 15.64 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.376 0.67 . . . . 65.51 111.846 -172.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 262' ' ' ALA . . . . . . . . . . . . . . . -73.68 88.27 1.71 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.286 0.634 . . . . 75.22 110.373 -177.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . 67.34 -74.26 0.07 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 125.225 1.41 . . . . 70.44 111.929 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 31.3 t 69.56 -73.26 0.09 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.569 1.548 . . . . 51.14 111.963 175.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 265' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -66.13 -21.83 66.36 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.939 0.896 . . . . 73.31 111.15 -177.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 266' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -121.91 144.65 48.73 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.749 0.82 . . . . 71.52 109.559 173.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 30.7 t -96.15 -53.28 3.7 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.608 0.763 . . . . 73.13 109.675 177.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 11.9 p -164.3 146.36 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 115.956 -0.566 . . . . 74.44 110.132 -176.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 269' ' ' THR . . . . . . . . . . . . . 33.6 m -142.1 96.07 2.9 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 107.986 -1.116 . . . . 74.31 107.986 173.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 270' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 56.64 -85.81 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 125.423 1.489 . . . . 72.41 112.054 177.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 271' ' ' ALA . . . . . . . . . . . . . . . -141.65 -65.61 0.42 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 106.681 -1.6 . . . . 75.3 106.681 171.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 272' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 60.2 -70.1 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 125.948 1.699 . . . . 73.11 113.559 172.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 65.37 50.99 1.63 Allowed 'General case' 0 C--N 1.355 0.828 0 C-N-CA 125.013 1.325 . . . . 73.43 109.789 -175.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -106.63 157.5 17.65 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 114.04 -1.436 . . . . 71.44 108.923 173.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 275' ' ' LYS . . . . . 0.565 ' N ' ' HD3' ' B' ' 276' ' ' PRO . 3.4 mptp? 60.65 42.58 0.61 Allowed Pre-proline 0 CA--C 1.58 2.099 0 C-N-CA 124.799 1.24 . . . . 72.14 112.412 -168.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 276' ' ' PRO . . . . . 0.565 ' HD3' ' N ' ' B' ' 275' ' ' LYS . 43.7 Cg_endo -109.41 42.35 0.02 OUTLIER 'Trans proline' 0 C--N 1.392 2.866 0 C-N-CA 124.459 3.439 . . . . 73.04 112.112 -177.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 277' ' ' LEU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 278' ' ' ALA . 91.4 mt 81.4 -23.87 0.21 Allowed 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 126.351 1.861 . . . . 74.52 112.5 -174.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -173.22 132.63 0.5 Allowed 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 124.549 1.14 . . . . 72.2 108.725 168.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . 174.52 -103.89 0.19 Allowed Glycine 0 C--N 1.345 1.032 0 CA-C-O 119.875 -0.403 . . . . 75.43 113.04 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 1.5 tm? 56.69 -90.81 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 125.12 1.368 . . . . 74.31 108.912 -170.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -149.11 -63.49 0.23 Allowed 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 106.356 -1.72 . . . . 75.31 106.356 171.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . 54.84 -165.85 0.1 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.684 1.193 . . . . 65.41 112.838 172.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 34.3 t70 61.08 87.99 0.09 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.841 1.256 . . . . 72.33 112.103 174.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . -74.93 -163.32 10.63 Favored Glycine 0 CA--C 1.533 1.187 0 CA-C-N 115.581 -0.736 . . . . 72.13 112.49 171.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 70.06 -75.37 0.07 Allowed 'General case' 0 CA--C 1.558 1.288 0 C-N-CA 124.829 1.251 . . . . 73.03 110.552 -176.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 286' ' ' MET . . . . . . . . . . . . 0.285 58.2 mtt 41.42 -90.04 0.0 OUTLIER Pre-proline 0 CA--C 1.585 2.296 0 C-N-CA 127.328 2.251 . . . . 74.22 114.562 -177.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 287' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -75.91 -26.98 8.99 Favored 'Trans proline' 1 C--N 1.423 4.472 0 CA-C-N 124.905 2.788 . . . . 74.24 112.827 178.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 288' ' ' VAL . . . . . . . . . . . . . 41.4 t 50.91 -91.47 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.564 1.486 0 C-N-CA 124.817 1.247 . . . . 74.32 110.759 -173.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 289' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? 51.55 95.78 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 126.27 1.828 . . . . 74.32 112.715 176.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 290' ' ' TRP . . . . . . . . . . . . . 45.1 p90 -77.64 137.61 38.64 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.132 0.573 . . . . 75.34 110.451 173.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 291' ' ' LEU . . . . . . . . . . . . . 2.8 pp -88.79 -17.9 28.83 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.98 0.512 . . . . 73.52 110.747 175.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . -93.77 103.46 3.04 Favored Glycine 0 C--N 1.35 1.327 0 CA-C-N 115.619 -0.719 . . . . 71.42 111.414 -179.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -85.65 17.6 1.73 Allowed 'Trans proline' 0 C--N 1.374 1.891 0 C-N-CA 123.411 2.741 . . . . 75.13 113.593 -172.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 11.0 mmpt? 63.25 -83.25 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.494 1.518 . . . . 74.44 110.135 -174.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -147.17 157.66 43.68 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.621 0.768 . . . . 71.35 110.128 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 24.9 p -88.86 -59.11 2.32 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.2 0.6 . . . . 71.52 109.638 176.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 73.6 t80 60.27 93.88 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 125.05 1.34 . . . . 75.44 111.596 176.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 41.0 m80 -99.2 71.27 1.8 Allowed 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.696 0.76 . . . . 73.43 109.15 177.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . -139.48 175.32 21.78 Favored Glycine 0 C--N 1.342 0.88 0 CA-C-N 114.466 -1.243 . . . . 72.35 111.898 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 300' ' ' ASN . . . . . 0.439 ' HB3' ' HB2' ' B' ' 194' ' ' SER . 10.9 t-20 62.43 32.95 16.53 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.619 1.168 . . . . 72.23 109.011 -174.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 301' ' ' ILE . . . . . . . . . . . . . 2.0 pp -67.26 160.17 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 CA-C-N 113.26 -1.791 . . . . 75.13 112.807 -173.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 302' ' ' ASP . . . . . 0.447 ' O ' ' HA ' ' B' ' 149' ' ' LYS 0.275 6.1 p-10 34.25 -88.91 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 126.128 1.771 . . . . 74.32 113.148 -168.663 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 303' ' ' LYS . . . . . 0.691 ' HB3' ' HZ1' ' B' ' 303' ' ' LYS . 4.7 ttpm? 54.99 70.98 1.41 Allowed Pre-proline 0 CA--C 1.565 1.526 0 CA-C-N 118.332 0.514 . . . . 74.11 109.803 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 304' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -83.77 35.68 0.57 Allowed 'Trans proline' 0 C--N 1.374 1.887 0 C-N-CA 123.162 2.575 . . . . 75.12 111.851 -178.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -74.54 -11.85 60.32 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.66 1.184 . . . . 72.13 112.07 -178.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . 0.568 HG22 ' HA ' ' B' ' 147' ' ' HIS . 40.4 t -71.99 95.26 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 C-N-CA 123.342 0.657 . . . . 72.33 109.32 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 23.7 p -69.68 -59.58 2.86 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 114.871 -1.059 . . . . 74.23 110.688 -178.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 308' ' ' CYS . . . . . . . . . . . . . 52.4 t -81.42 119.72 24.08 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 122.925 0.49 . . . . 74.22 110.123 177.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 309' ' ' THR . . . . . 0.403 ' HA ' HD22 ' B' ' 367' ' ' LEU . 13.5 t 177.06 -36.64 0.0 OUTLIER Pre-proline 0 CA--C 1.568 1.645 0 C-N-CA 125.689 1.596 . . . . 72.2 112.366 177.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -95.13 20.98 0.53 Allowed 'Trans proline' 0 C--N 1.408 3.699 0 CA-C-N 122.728 2.01 . . . . 64.44 112.949 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 311' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -97.27 109.86 51.73 Favored Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 123.73 0.812 . . . . 73.13 109.674 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 312' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -87.04 80.63 1.46 Allowed 'Trans proline' 0 C--N 1.372 1.772 0 C-N-CA 122.898 2.399 . . . . 70.14 111.935 176.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 313' ' ' GLN . . . . . 0.425 HE21 ' HB2' ' B' ' 316' ' ' ASP . 22.7 tm0? 70.3 138.42 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 125.232 1.413 . . . . 75.13 111.472 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 314' ' ' ARG . . . . . . . . . . . . . 44.4 ttp180 -153.41 -79.09 0.1 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.47 0.708 . . . . 74.53 110.354 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 315' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -112.21 75.41 0.92 Allowed 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 122.13 0.967 . . . . 75.34 109.302 -175.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 316' ' ' ASP . . . . . 0.425 ' HB2' HE21 ' B' ' 313' ' ' GLN . 2.5 m-20 -111.45 -178.15 3.38 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 114.528 -1.214 . . . . 74.4 111.08 -173.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 3.8 m -83.4 -67.41 0.79 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.528 -0.76 . . . . 75.41 108.973 -179.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 318' ' ' VAL . . . . . 0.419 ' O ' ' HG3' ' B' ' 363' ' ' GLU . 12.7 p 177.1 137.86 0.22 Allowed Pre-proline 0 CA--C 1.556 1.18 0 C-N-CA 124.861 1.265 . . . . 73.13 109.049 -179.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 319' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -73.96 45.06 1.06 Allowed 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 122.581 2.187 . . . . 65.1 113.557 173.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 320' ' ' THR . . . . . . . . . . . . . 11.1 m -144.48 28.79 1.3 Allowed 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 124.764 1.226 . . . . 73.24 108.128 176.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 321' ' ' LEU . . . . . . . . . . . . . 66.3 tp -83.32 -59.64 2.39 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 121.876 -0.515 . . . . 74.43 110.233 176.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 322' ' ' ALA . . . . . . . . . . . . . . . -63.65 100.4 0.28 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.701 0.801 . . . . 64.54 110.726 -177.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 323' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 71.77 -12.49 0.65 Allowed 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 124.934 1.294 . . . . 74.02 112.789 177.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 324' ' ' MET . . . . . . . . . . . . . 91.9 mtp 62.87 -76.04 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 125.065 1.346 . . . . 74.22 110.743 -170.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 325' ' ' THR . . . . . . . . . . . . . 52.5 m -137.09 124.26 21.71 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.444 -0.947 . . . . 72.33 108.444 174.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 326' ' ' ASP . . . . . 0.455 ' HB2' ' HG3' ' B' ' 210' ' ' LYS . 4.8 p-10 -75.75 -37.8 58.99 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.906 0.482 . . . . 72.01 110.8 -178.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -161.13 -69.9 0.06 Allowed 'General case' 0 C--N 1.345 0.402 0 C-N-CA 124.235 1.014 . . . . 75.41 109.306 178.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 328' ' ' ALA . . . . . . . . . . . . . . . -171.0 -70.06 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 108.625 -0.88 . . . . 72.03 108.625 -176.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 329' ' ' ILE . . . . . . . . . . . . . 29.9 mm 65.08 -64.42 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.429 0 C-N-CA 126.003 1.721 . . . . 73.5 112.532 174.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 330' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -55.09 -53.06 60.63 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.176 0.99 . . . . 74.44 111.154 175.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 331' ' ' LEU . . . . . . . . . . . . . 85.2 mt -110.76 90.06 3.22 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.251 -1.018 . . . . 64.42 108.251 172.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 44.5 tp -85.6 -21.96 28.23 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.082 0.553 . . . . 74.41 111.366 -174.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 333' ' ' SER . . . . . . . . . . . . . 36.7 m 52.04 41.3 29.74 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.081 0.952 . . . . 65.04 111.714 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 6.9 tmtm? -73.42 -50.35 22.22 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.405 -0.816 . . . . 65.35 109.935 -174.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 335' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -139.0 149.38 44.62 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.507 0.723 . . . . 74.12 109.745 -176.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -64.92 -27.33 68.78 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.98 0.912 . . . . 73.55 111.64 -176.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 337' ' ' LYS . . . . . 0.423 ' HZ1' ' HB2' ' B' ' 337' ' ' LYS . 0.1 OUTLIER -125.1 168.19 13.73 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 124.005 0.922 . . . . 71.1 109.737 -177.241 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 338' ' ' GLY . . . . . . . . . . . . . . . -80.26 62.36 4.28 Favored Glycine 0 C--N 1.349 1.29 0 N-CA-C 111.971 -0.452 . . . . 73.12 111.971 177.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 339' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 61.9 -173.19 0.14 Allowed 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 125.254 1.422 . . . . 74.33 112.243 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 340' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -86.75 -49.2 7.62 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 109.792 -0.448 . . . . 75.24 109.792 174.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 341' ' ' LEU . . . . . 0.495 HD12 ' HG2' ' B' ' 344' ' ' GLU . 54.6 tp 35.66 86.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 126.326 1.85 . . . . 75.34 113.379 178.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 342' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -94.8 -68.82 0.78 Allowed 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 109.06 -0.718 . . . . 74.32 109.06 177.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 343' ' ' VAL . . . . . . . . . . . . . 4.4 p -160.43 87.68 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 107.688 -1.227 . . . . 65.15 107.688 178.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 344' ' ' GLU . . . . . 0.495 ' HG2' HD12 ' B' ' 341' ' ' LEU . 11.8 mm-40 -97.33 32.57 2.19 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-N 115.571 -0.74 . . . . 74.33 109.147 -176.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 345' ' ' GLY . . . . . . . . . . . . . . . 84.43 -65.91 3.99 Favored Glycine 0 C--N 1.345 1.066 0 N-CA-C 109.674 -1.37 . . . . 63.14 109.674 -165.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 346' ' ' ALA . . . . . . . . . . . . . . . -134.33 -171.06 2.66 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.552 1.141 . . . . 72.51 108.756 172.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 80.1 p -74.15 165.75 24.62 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 109.49 -0.559 . . . . 72.21 109.49 166.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 8.8 tt -82.1 57.18 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.551 0 CA-C-O 121.945 0.879 . . . . 73.42 109.849 178.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 349' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -62.29 -60.84 2.99 Favored 'General case' 0 C--N 1.359 1.001 0 N-CA-C 108.987 -0.746 . . . . 71.13 108.987 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 350' ' ' LYS . . . . . . . . . . . . . 71.1 tttt 67.14 -12.25 0.25 Allowed 'General case' 0 CA--C 1.56 1.348 0 C-N-CA 124.747 1.219 . . . . 74.52 114.286 164.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 72.03 5.68 5.39 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 124.856 1.262 . . . . 71.32 110.951 -160.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -156.21 155.01 31.67 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.501 0.72 . . . . 74.35 110.585 -174.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 353' ' ' HIS . . . . . 0.502 ' HB3' ' HB3' ' C' ' 20' ' ' GLU . 19.5 t-80 -150.17 -41.48 0.13 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.805 1.242 . . . . 74.33 108.338 179.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 354' ' ' ALA . . . . . 0.561 ' HB3' HH21 ' C' ' 24' ' ' ARG . . . -161.19 16.04 0.11 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.43 0.692 . . . . 72.23 111.499 176.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 355' ' ' ALA . . . . . . . . . . . . . . . 64.59 -78.2 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 125.222 1.409 . . . . 75.44 110.989 -174.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 356' ' ' ASN . . . . . 0.465 HD21 ' HG2' ' C' ' 24' ' ' ARG . 61.8 t30 62.46 106.96 0.03 OUTLIER Pre-proline 0 CA--C 1.556 1.209 0 C-N-CA 125.566 1.546 . . . . 74.32 112.875 172.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 357' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.19 139.83 86.43 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 123.679 2.919 . . . . 74.21 113.84 -173.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 358' ' ' CYS . . . . . 0.54 ' HA ' ' HD3' ' C' ' 27' ' ' LYS . 74.9 m -67.1 165.3 16.15 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.119 0.968 . . . . 75.21 112.271 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 359' ' ' GLY . . . . . . . . . . . . . . . -68.79 113.67 5.4 Favored Glycine 0 C--N 1.35 1.343 0 CA-C-O 119.422 -0.654 . . . . 72.04 112.07 177.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 360' ' ' GLN . . . . . . . . . . . . . 25.3 tp60 65.59 35.54 7.05 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 124.723 1.209 . . . . 53.34 110.018 -177.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 361' ' ' ILE . . . . . 0.41 HD11 ' H ' ' B' ' 358' ' ' CYS . 19.3 tt -57.91 -32.64 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 C-N-CA 124.337 1.055 . . . . 64.41 112.222 -176.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 362' ' ' GLY . . . . . . . . . . . . . . . -159.82 98.11 0.17 Allowed Glycine 0 C--O 1.243 0.686 0 N-CA-C 110.704 -0.958 . . . . 72.35 110.704 176.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 363' ' ' GLU . . . . . 0.419 ' HG3' ' O ' ' B' ' 318' ' ' VAL . 1.9 tm-20 -175.52 86.82 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 107.443 -1.317 . . . . 73.13 107.443 175.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 364' ' ' THR . . . . . . . . . . . . . 89.7 m 65.09 -69.48 0.1 Allowed 'General case' 0 CA--C 1.57 1.741 0 C-N-CA 124.314 1.045 . . . . 74.04 112.537 177.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 22.0 t 64.39 42.52 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 126.195 1.798 . . . . 74.51 109.198 -178.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 34.0 t70 69.62 -60.17 0.48 Allowed 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 126.495 1.918 . . . . 52.52 112.043 179.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 367' ' ' LEU . . . . . 0.403 HD22 ' HA ' ' B' ' 309' ' ' THR . 49.8 tp -54.13 -26.59 28.4 Favored 'General case' 0 CA--C 1.564 1.485 0 C-N-CA 125.4 1.48 . . . . 75.05 113.161 176.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 368' ' ' ASP . . . . . 0.57 ' O ' HG21 ' B' ' 371' ' ' VAL . 19.4 t70 80.21 -14.79 0.81 Allowed 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 126.25 1.82 . . . . 73.23 112.154 -178.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 369' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -62.39 -16.04 52.41 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.665 0.786 . . . . 74.11 112.96 -175.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 370' ' ' ALA . . . . . . . . . . . . . . . -58.33 -23.76 57.61 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 122.687 0.395 . . . . 74.25 111.806 175.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 371' ' ' VAL . . . . . 0.802 HG22 ' HA3' ' B' ' 140' ' ' GLY . 11.2 m -107.98 11.97 8.82 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.226 0 C-N-CA 123.83 0.852 . . . . 74.12 111.568 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 372' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -135.13 151.03 50.33 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.993 0.917 . . . . 63.2 110.933 -176.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 373' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -146.91 49.02 1.14 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.264 0.626 . . . . 72.2 109.967 174.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . 66.17 179.21 0.21 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 124.89 1.276 . . . . 71.45 111.872 -173.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 375' ' ' LEU . . . . . 0.44 ' HA ' ' HA3' ' C' ' 190' ' ' GLY . 47.0 tp -163.5 -37.41 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.844 0.458 . . . . 72.22 110.768 175.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 376' ' ' GLU . . . . . 0.685 ' HG3' ' HA ' ' B' ' 23' ' ' THR . 12.9 mm-40 -114.89 153.75 29.93 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.496 0.718 . . . . 73.13 112.442 -176.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 377' ' ' PHE . . . . . 0.454 ' HA ' ' NH2' ' B' ' 22' ' ' ARG . 74.6 t80 -168.73 -63.2 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.023 -0.989 . . . . 73.31 108.412 178.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 378' ' ' ALA . . . . . . . . . . . . . . . -174.07 84.89 0.04 OUTLIER 'General case' 0 C--O 1.245 0.819 0 C-N-CA 124.942 1.297 . . . . 73.45 109.003 -178.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm -61.43 -20.51 63.17 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.084 0.553 . . . . 73.22 111.44 176.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 380' ' ' LYS . . . . . . . . . . . . . 65.1 mttm 80.47 -52.13 0.34 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 126.223 1.809 . . . . 72.4 111.474 176.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 381' ' ' GLU . . . . . 0.436 ' HG2' ' H ' ' B' ' 383' ' ' ASN . 25.8 tt0 66.03 -76.59 0.04 OUTLIER 'General case' 0 C--N 1.359 1.0 0 C-N-CA 124.348 1.059 . . . . 74.34 110.243 -176.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . 100.92 -18.72 54.39 Favored Glycine 0 C--N 1.349 1.266 0 CA-C-N 116.043 -0.526 . . . . 73.1 113.567 176.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 383' ' ' ASN . . . . . 0.436 ' H ' ' HG2' ' B' ' 381' ' ' GLU . 2.8 t-20 -67.71 -11.73 58.98 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 123.51 0.724 . . . . 73.1 111.94 -176.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 384' ' ' THR . . . . . . . . . . . . . 40.1 p -63.58 -15.51 58.28 Favored 'General case' 0 CA--C 1.56 1.348 0 C-N-CA 123.71 0.804 . . . . 71.44 112.317 172.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 82.6 mt -75.67 -176.11 3.17 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.615 0.766 . . . . 75.43 111.815 174.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 386' ' ' VAL . . . . . . . . . . . . . 94.2 t 77.91 -41.14 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 C-N-CA 125.595 1.558 . . . . 75.23 112.091 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 387' ' ' ILE . . . . . . . . . . . . . 33.5 mm -76.51 75.38 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 C-N-CA 123.686 0.794 . . . . 74.12 110.766 -174.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 388' ' ' VAL . . . . . 0.48 HG11 ' H ' ' B' ' 391' ' ' ASP . 21.7 t 43.6 91.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 126.444 1.898 . . . . 74.43 112.674 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 389' ' ' THR . . . . . 0.409 ' HG1' ' HB3' ' A' ' 184' ' ' PRO . 34.6 p -75.87 3.56 9.83 Favored 'General case' 0 CA--C 1.559 1.326 0 N-CA-C 112.328 0.492 . . . . 71.25 112.328 -175.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . -94.8 -69.52 0.75 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.564 0.746 . . . . 73.41 110.677 171.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 391' ' ' ASP . . . . . 0.48 ' H ' HG11 ' B' ' 388' ' ' VAL . 13.2 m-20 -92.11 -12.76 32.11 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.026 0.931 . . . . 64.12 111.566 -169.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 392' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 64.94 18.57 11.55 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 125.114 1.365 . . . . 72.42 111.474 -174.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 393' ' ' ALA . . . . . 0.444 ' HA ' ' OE1' ' B' ' 397' ' ' GLN . . . 66.19 -73.65 0.07 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 125.387 1.475 . . . . 61.53 112.203 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 19.4 t60 56.67 66.56 1.15 Allowed 'General case' 0 C--N 1.359 0.997 0 C-N-CA 124.31 1.044 . . . . 73.31 108.91 -175.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . 60.95 -158.64 0.33 Allowed 'General case' 0 CA--C 1.559 1.32 0 CA-C-N 115.106 -0.952 . . . . 75.42 110.734 -172.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 33.3 t 63.31 -80.43 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.357 1.063 . . . . 75.55 112.497 173.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 397' ' ' GLN . . . . . 0.444 ' OE1' ' HA ' ' B' ' 393' ' ' ALA . 92.2 mt-30 -60.95 -40.3 92.82 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.356 1.062 . . . . 75.54 110.498 178.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 12.6 tt -156.52 116.2 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 N-CA-C 108.216 -1.031 . . . . 75.44 108.216 173.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 399' ' ' VAL . . . . . . . . . . . . . 3.3 p -113.67 -46.47 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 123.354 0.662 . . . . 73.32 112.65 -169.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 400' ' ' ALA . . . . . 0.532 ' HB3' ' HD3' ' B' ' 401' ' ' PRO . . . -69.12 -54.57 11.68 Favored Pre-proline 0 CA--C 1.56 1.338 0 CA-C-O 118.8 -0.619 . . . . 74.52 112.521 -173.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 401' ' ' PRO . . . . . 0.532 ' HD3' ' HB3' ' B' ' 400' ' ' ALA . 59.7 Cg_endo -98.16 112.5 0.09 OUTLIER 'Trans proline' 0 C--N 1.383 2.37 0 C-N-CA 122.03 1.82 . . . . 71.34 112.698 173.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -72.9 -39.77 66.1 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 109.052 -0.721 . . . . 74.34 109.052 172.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 403' ' ' THR . . . . . . . . . . . . . 7.7 t 173.44 172.65 0.15 Allowed 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 126.019 1.728 . . . . 73.2 108.248 170.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 404' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm 74.89 -47.24 0.62 Allowed 'General case' 0 N--CA 1.507 2.404 0 C-N-CA 125.465 1.506 . . . . 71.14 112.514 -176.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 405' ' ' ALA . . . . . . . . . . . . . . . -58.54 -38.62 67.5 Favored Pre-proline 0 CA--C 1.566 1.559 0 N-CA-C 115.008 1.484 . . . . 71.24 115.008 177.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 406' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -44.12 91.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.396 3.048 0 C-N-CA 122.922 2.414 . . . . 64.23 114.85 174.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . -133.77 -40.8 0.18 Allowed Glycine 0 C--N 1.338 0.642 0 CA-C-N 114.762 -1.108 . . . . 74.04 110.715 -178.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 408' ' ' LEU . . . . . . . . . . . . . 61.7 tp -63.75 -39.75 95.05 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.385 0.674 . . . . 72.55 109.616 170.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 70.8 p -72.8 -16.77 61.61 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.04 -0.982 . . . . 73.52 111.057 174.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 410' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 67.37 -144.97 0.14 Allowed 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 125.315 1.446 . . . . 70.42 108.944 -176.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . 79.37 -28.71 0.15 Allowed 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 124.978 1.311 . . . . 74.33 113.091 177.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 1.5 tt 50.9 78.49 0.11 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 125.864 1.665 . . . . 75.21 111.83 172.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 77.43 -54.59 0.54 Allowed 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 125.496 1.518 . . . . 71.14 112.119 177.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 414' ' ' THR . . . . . . . . . . . . . 13.0 m 72.87 -69.02 0.2 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 126.077 1.751 . . . . 73.24 112.089 176.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 415' ' ' LYS . . . . . . . . . . . . 0.269 12.8 ptmm? 59.36 -57.4 0.06 Allowed 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 127.653 2.381 . . . . 75.21 114.145 -175.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -79.15 94.38 5.37 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 121.498 -0.751 . . . . 75.33 110.391 175.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 417' ' ' GLY . . . . . . . . . . . . . . . -160.12 67.25 0.26 Allowed Glycine 0 C--N 1.347 1.173 0 CA-C-N 114.323 -1.308 . . . . 62.31 109.853 177.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 418' ' ' ALA . . . . . . . . . . . . . . . -70.65 -31.9 69.0 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.856 0.862 . . . . 70.25 110.647 -177.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 419' ' ' VAL . . . . . . . . . . . . . 46.2 t -101.41 -91.4 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 N-CA-C 107.29 -1.374 . . . . 73.31 107.29 170.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 420' ' ' MET . . . . . . . . . . . . . 26.8 ttt 48.81 -82.49 0.01 OUTLIER 'General case' 0 C--N 1.37 1.477 0 C-N-CA 123.929 0.892 . . . . 73.34 110.385 -167.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 421' ' ' VAL . . . . . . . . . . . . . 69.0 t -110.25 -78.73 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.209 0 N-CA-C 107.035 -1.468 . . . . 72.42 107.035 167.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 422' ' ' MET . . . . . . . . . . . . . 49.1 tpp 55.88 -73.82 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 126.327 1.851 . . . . 74.1 113.215 177.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 423' ' ' SER . . . . . . . . . . . . . 21.2 p -53.4 150.9 6.0 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.112 0.965 . . . . 63.45 112.67 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 424' ' ' TYR . . . . . . . . . . . . . 44.9 t80 74.58 -65.78 0.33 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 125.747 1.619 . . . . 74.22 110.474 -174.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . 58.33 43.3 95.71 Favored Glycine 0 C--N 1.351 1.373 0 N-CA-C 114.181 0.432 . . . . 75.12 114.181 173.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 426' ' ' ASN . . . . . . . . . . . . . 18.8 m120 58.59 23.84 11.34 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 124.064 0.946 . . . . 75.43 112.086 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 427' ' ' SER . . . . . . . . . . . . . 28.5 t -132.46 168.15 18.69 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.84 0.856 . . . . 75.14 109.458 -178.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -77.98 87.95 4.15 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-O 121.338 0.589 . . . . 73.23 110.617 -176.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 429' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -93.57 101.07 13.23 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 106.219 -1.771 . . . . 63.42 106.219 166.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -58.11 -53.91 52.89 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.252 1.021 . . . . 62.42 111.104 -172.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 17.7 m 65.67 -96.29 0.04 OUTLIER 'General case' 0 CA--C 1.561 1.389 0 O-C-N 124.941 1.401 . . . . 75.05 111.867 -177.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 432' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 58.16 176.03 0.06 Allowed 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 124.897 1.279 . . . . 71.1 113.001 -170.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 433' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -81.46 103.06 10.94 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.49 1.116 . . . . 73.43 108.562 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 434' ' ' HIS . . . . . . . . . . . . . 10.5 m170 -126.87 170.07 12.6 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.68 0.792 . . . . 73.42 111.277 -172.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 435' ' ' THR . . . . . . . . . . . . . 15.8 m -71.31 -20.86 62.14 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.109 0.964 . . . . 73.42 112.115 -175.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . -59.18 -20.87 51.82 Favored Glycine 0 N--CA 1.475 1.267 0 N-CA-C 114.599 0.599 . . . . 61.51 114.599 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 72.3 p -55.22 -40.96 71.43 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.978 1.311 . . . . 72.35 112.957 -178.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 438' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -34.13 114.37 0.2 Allowed 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 125.94 1.696 . . . . 71.55 113.976 -172.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 439' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -149.86 152.45 35.13 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.128 0.571 . . . . 74.24 110.793 -176.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 440' ' ' ARG . . . . . . . . . . . . . 7.1 tpp180 -156.81 98.34 1.77 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.518 1.127 . . . . 74.1 108.225 177.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 441' ' ' ILE . . . . . 0.512 HG12 HD21 ' A' ' 235' ' ' LEU . 22.2 mt -69.52 118.83 14.49 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 CA-C-N 115.586 -0.734 . . . . 74.15 111.358 -173.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 442' ' ' ALA . . . . . . . . . . . . . . . -130.75 38.08 3.74 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 114.951 -1.022 . . . . 73.33 109.593 178.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . -80.94 170.18 16.58 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.455 -0.793 . . . . 74.21 110.024 173.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -55.02 142.02 31.83 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.843 0.857 . . . . 71.31 112.123 -178.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . 120.34 -78.69 0.32 Allowed Glycine 0 C--N 1.345 1.079 0 N-CA-C 110.744 -0.943 . . . . 74.34 110.744 -176.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 446' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -77.19 71.62 6.24 Favored 'Trans proline' 0 C--N 1.379 2.15 0 C-N-CA 122.8 2.334 . . . . 72.44 112.144 175.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 447' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -138.75 128.17 24.45 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 124.49 1.116 . . . . 63.45 109.503 175.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . 61.83 -176.07 0.13 Allowed 'General case' 0 CA--C 1.549 0.939 0 O-C-N 124.346 1.029 . . . . 74.31 112.986 175.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 449' ' ' ALA . . . . . 0.634 ' HB1' ' SD ' ' B' ' 464' ' ' MET . . . 62.57 -82.63 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 124.834 1.254 . . . . 74.42 112.753 171.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 450' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -79.98 -34.35 38.69 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.067 0.947 . . . . 63.22 111.382 -176.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 61.6 t -62.8 -76.73 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 123.964 0.906 . . . . 74.44 111.746 -170.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 452' ' ' VAL . . . . . . . . . . . . . 4.7 m -137.69 42.74 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 124.193 0.997 . . . . 74.24 108.823 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 72.22 -161.59 54.35 Favored Glycine 0 C--N 1.34 0.768 0 CA-C-N 114.736 -1.12 . . . . 73.44 110.449 -166.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 454' ' ' LEU . . . . . 0.461 ' HG ' ' H ' ' B' ' 461' ' ' PHE . 3.5 mm? -73.31 -64.29 1.01 Allowed 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 117.3 0.55 . . . . 73.13 110.629 -178.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 14.0 t -169.06 176.28 5.39 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 122.806 0.442 . . . . 72.1 110.81 174.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -84.87 63.32 7.98 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-O 122.029 0.919 . . . . 74.3 109.713 178.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 457' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -169.55 166.74 10.0 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 114.948 -1.024 . . . . 65.21 108.46 -177.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 34.1 p -70.25 -5.31 26.76 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.064 0.546 . . . . 72.13 111.578 172.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 459' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -67.86 89.19 0.27 Allowed 'General case' 0 C--N 1.353 0.728 0 N-CA-C 109.054 -0.721 . . . . 73.31 109.054 169.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 2.6 pp -145.47 144.5 30.63 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.05 -0.977 . . . . 65.42 108.864 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 461' ' ' PHE . . . . . 0.461 ' H ' ' HG ' ' B' ' 454' ' ' LEU . 96.6 m-85 -137.92 149.62 46.36 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.612 0.765 . . . . 75.0 109.521 -178.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 24.8 p90 -89.2 12.62 15.39 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.178 0.591 . . . . 72.53 111.207 177.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 41.1 p -74.72 85.05 2.13 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.204 1.002 . . . . 71.14 111.772 -172.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 464' ' ' MET . . . . . 0.634 ' SD ' ' HB1' ' B' ' 449' ' ' ALA . 83.5 mtp -147.98 101.15 3.27 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.3 1.04 . . . . 75.31 108.839 176.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -88.17 134.76 33.7 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 109.261 -0.644 . . . . 72.15 109.261 174.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -100.82 -48.87 4.33 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.25 0.62 . . . . 65.13 112.031 -174.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . -71.14 -30.39 66.42 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.894 0.878 . . . . 75.3 112.009 -175.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 90.7 mt -129.41 142.09 50.88 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 107.678 -1.23 . . . . 74.32 107.678 175.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 469' ' ' GLY . . . . . 0.512 ' HA3' ' HB2' ' C' ' 260' ' ' ARG . . . -72.98 99.41 0.94 Allowed Glycine 0 CA--C 1.527 0.843 0 N-CA-C 111.022 -0.831 . . . . 62.03 111.022 172.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 470' ' ' LEU . . . . . 0.401 HD11 ' N ' ' B' ' 471' ' ' LYS . 0.5 OUTLIER -150.05 147.82 28.28 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 108.113 -1.069 . . . . 75.32 108.113 -179.563 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 471' ' ' LYS . . . . . 0.401 ' N ' HD11 ' B' ' 470' ' ' LEU . 1.2 tmtp? . . . . . 0 C--O 1.247 0.97 0 N-CA-C 108.703 -0.851 . . . . 74.2 108.703 177.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 1' ' ' MET . . . . . 0.444 ' N ' ' SD ' ' C' ' 1' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.482 1.146 0 N-CA-C 109.883 -0.414 . . . . 70.43 109.883 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 60.08 19.32 8.54 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 125.357 1.463 . . . . 70.41 114.776 170.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -88.83 49.01 1.71 Allowed 'General case' 0 N--CA 1.485 1.287 0 O-C-N 121.662 -0.649 . . . . 71.34 110.881 178.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -39.11 102.75 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.607 1.563 . . . . 70.52 113.548 177.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 5' ' ' LYS . . . . . 0.465 ' HB3' HD11 ' C' ' 10' ' ' ILE . 48.0 mtpt -84.47 125.44 32.37 Favored 'General case' 0 C--O 1.245 0.832 0 N-CA-C 109.402 -0.592 . . . . 72.32 109.402 173.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -77.16 100.98 5.96 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.627 -0.879 . . . . 65.15 108.627 177.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 7' ' ' TYR . . . . . 0.531 ' HD1' HD13 ' C' ' 10' ' ' ILE . 23.4 m-85 -63.27 -31.17 72.25 Favored 'General case' 0 C--O 1.252 1.185 0 C-N-CA 123.741 0.817 . . . . 73.43 112.158 -172.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -60.51 -47.77 84.71 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.828 -0.624 . . . . 74.23 109.846 174.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.7 -38.02 88.05 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.546 0.738 . . . . 63.34 111.102 -177.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 10' ' ' ILE . . . . . 0.531 HD13 ' HD1' ' C' ' 7' ' ' TYR . 72.0 mt -58.28 -39.93 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 123.225 0.61 . . . . 73.31 110.41 175.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 11' ' ' LEU . . . . . 0.518 ' O ' ' HB1' ' C' ' 25' ' ' ALA . 86.0 mt -86.3 -11.67 51.57 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 112.654 0.613 . . . . 75.53 112.654 175.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.69 24.15 65.58 Favored Glycine 0 CA--C 1.535 1.328 0 N-CA-C 114.347 0.499 . . . . 74.43 114.347 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 5.8 m -105.84 156.19 37.02 Favored Pre-proline 0 N--CA 1.486 1.374 0 C-N-CA 124.056 0.942 . . . . 71.34 109.955 171.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -78.4 168.29 21.71 Favored 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 122.825 2.35 . . . . 74.43 114.427 -178.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 80.2 mtt180 -75.01 72.2 2.13 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.766 0.827 . . . . 74.35 109.87 173.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 175.11 -19.94 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.99 1.316 . . . . 71.24 108.896 -175.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -46.49 133.47 9.98 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 125.484 1.513 . . . . 75.2 113.447 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 18.2 p -74.19 148.2 41.85 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 123.946 0.779 . . . . 74.41 109.074 175.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -51.51 -34.11 34.58 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 124.069 0.948 . . . . 74.45 112.131 -178.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 20' ' ' GLU . . . . . 0.502 ' HB3' ' HB3' ' B' ' 353' ' ' HIS . 0.9 OUTLIER -70.11 -44.98 67.86 Favored 'General case' 0 CA--C 1.556 1.201 0 CA-C-N 114.838 -1.074 . . . . 74.53 110.331 -179.461 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -73.38 -27.27 61.39 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 123.023 0.529 . . . . 73.42 111.659 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 22' ' ' ILE . . . . . 0.527 HD11 HD12 ' C' ' 57' ' ' LEU . 76.5 mt -61.97 -44.29 98.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 123.94 0.896 . . . . 75.54 109.073 169.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 23' ' ' LYS . . . . . 0.567 ' HB3' ' HZ1' ' C' ' 23' ' ' LYS . 5.1 ttpm? -65.02 -32.64 74.46 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 114.922 -1.036 . . . . 74.13 111.388 175.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 24' ' ' ARG . . . . . 0.624 ' HA ' ' HE3' ' C' ' 27' ' ' LYS . 56.1 mtt180 -62.67 -46.91 85.98 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 120.961 0.41 . . . . 73.52 111.118 175.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . 0.518 ' HB1' ' O ' ' C' ' 11' ' ' LEU . . . -62.13 -39.17 91.69 Favored 'General case' 0 C--O 1.251 1.14 0 CA-C-N 114.814 -1.084 . . . . 75.32 111.389 177.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 26' ' ' TYR . . . . . 0.474 ' HD1' HG21 ' C' ' 50' ' ' ILE . 38.9 t80 -54.3 -54.7 36.66 Favored 'General case' 0 C--O 1.207 -1.147 0 CA-C-N 115.115 -0.948 . . . . 72.31 109.975 170.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . 0.624 ' HE3' ' HA ' ' C' ' 24' ' ' ARG . 10.3 mtmp? -56.85 -40.13 75.54 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 123.319 0.647 . . . . 75.33 111.452 -176.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 28' ' ' ARG . . . . . 0.465 ' HA ' ' NH2' ' C' ' 31' ' ' ARG . 34.8 ttp180 -57.9 -52.25 66.26 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 123.936 0.773 . . . . 75.55 110.606 177.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 80.6 mt -84.28 -9.72 58.25 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-N 114.905 -1.043 . . . . 71.43 111.756 -176.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -86.85 -23.5 25.26 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.991 0.917 . . . . 75.32 110.214 175.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . 0.465 ' NH2' ' HA ' ' C' ' 28' ' ' ARG . 54.7 mtm180 -80.4 -45.88 16.94 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.518 0.727 . . . . 73.5 109.108 167.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 59.4 tp60 -60.94 -50.97 71.26 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.245 1.018 . . . . 71.12 112.263 -175.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 33' ' ' TYR . . . . . 0.506 ' HB3' ' O ' ' C' ' 43' ' ' ALA . 31.2 m-85 -103.94 20.03 18.92 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.066 0.547 . . . . 72.14 111.843 -172.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 34' ' ' HIS . . . . . 0.49 ' HB3' ' HB ' ' C' ' 37' ' ' VAL . 5.7 t60 -63.87 114.34 13.22 Favored Pre-proline 0 N--CA 1.482 1.16 0 CA-C-O 118.526 -0.75 . . . . 74.34 111.023 -172.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 35' ' ' PRO . . . . . 0.501 ' HA ' ' HG2' ' C' ' 44' ' ' GLU . 34.7 Cg_exo -40.25 -50.43 3.58 Favored 'Trans proline' 0 C--N 1.385 2.488 0 C-N-CA 124.868 3.712 . . . . 72.22 116.111 -166.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -91.39 -23.7 19.97 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 111.797 0.295 . . . . 60.34 111.797 -173.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . 0.49 ' HB ' ' HB3' ' C' ' 34' ' ' HIS . 69.0 t -74.67 -41.94 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 108.658 -0.867 . . . . 75.33 108.658 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -112.8 96.12 5.79 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.399 -1.334 . . . . 65.41 107.399 175.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -70.61 76.44 0.59 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.801 0.841 . . . . 71.22 110.138 -175.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 62.5 m -152.04 104.62 2.81 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 123.659 0.784 . . . . 74.14 109.306 -176.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -44.64 -38.4 12.33 Favored 'Trans proline' 0 C--N 1.382 2.305 0 C-N-CA 123.882 3.054 . . . . 75.0 113.554 173.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -52.02 -49.94 62.38 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.647 0.779 . . . . 71.01 110.588 174.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 43' ' ' ALA . . . . . 0.506 ' O ' ' HB3' ' C' ' 33' ' ' TYR . . . -71.11 -21.72 62.18 Favored 'General case' 0 C--O 1.213 -0.831 0 CA-C-N 115.143 -0.935 . . . . 71.45 110.805 -178.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 44' ' ' GLU . . . . . 0.501 ' HG2' ' HA ' ' C' ' 35' ' ' PRO . 38.0 mt-10 -76.37 -36.06 58.34 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.481 -0.563 . . . . 74.04 109.481 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -73.27 -38.73 65.84 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.756 0.822 . . . . 75.44 110.382 176.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 46' ' ' LYS . . . . . 0.499 ' O ' HG12 ' C' ' 50' ' ' ILE . 0.4 OUTLIER -63.91 -39.16 93.53 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.751 -0.659 . . . . 72.32 109.355 172.711 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -63.52 -34.53 78.0 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.08 0.952 . . . . 71.12 110.317 176.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 48' ' ' LYS . . . . . 0.468 ' HG3' ' O ' ' C' ' 44' ' ' GLU . 94.6 mttt -63.28 -43.47 97.83 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.487 -0.324 . . . . 72.04 110.28 174.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -64.11 -33.88 76.77 Favored 'General case' 0 CA--C 1.555 1.148 0 O-C-N 122.928 0.142 . . . . 72.33 110.741 176.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 50' ' ' ILE . . . . . 0.499 HG12 ' O ' ' C' ' 46' ' ' LYS . 13.2 mm -65.11 -42.48 94.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 CA-C-O 121.571 0.701 . . . . 75.43 109.441 175.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 51' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -76.31 -18.18 59.07 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 114.454 -1.248 . . . . 74.04 111.972 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 52' ' ' GLU . . . . . 0.443 ' O ' HG21 ' C' ' 56' ' ' VAL . 33.6 tt0 -74.86 -56.52 4.68 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.323 1.049 . . . . 75.54 108.611 176.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.95 -44.37 78.37 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 113.823 -1.535 . . . . 63.1 110.781 177.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -67.45 -38.6 84.73 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.33 -0.85 . . . . 75.01 111.152 176.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.32 -36.57 68.87 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 117.891 0.314 . . . . 60.54 111.197 177.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 56' ' ' VAL . . . . . 0.461 HG11 ' HZ ' ' C' ' 101' ' ' PHE . 3.0 t -94.98 -11.82 8.73 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 CA-C-N 115.902 -0.59 . . . . 72.43 111.871 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 57' ' ' LEU . . . . . 0.527 HD12 HD11 ' C' ' 22' ' ' ILE . 86.5 mt -126.37 19.86 7.44 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.98 -1.075 . . . . 75.02 113.654 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 45.9 t -80.74 -56.52 4.09 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 123.22 0.608 . . . . 75.33 112.456 178.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . 0.618 ' HB2' ' HD3' ' C' ' 62' ' ' LYS . 3.6 m-20 -108.68 153.6 42.16 Favored Pre-proline 0 N--CA 1.487 1.414 0 CA-C-O 118.086 -0.959 . . . . 72.03 109.904 -168.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 60' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -44.09 -43.47 12.75 Favored 'Trans proline' 0 C--N 1.397 3.106 0 C-N-CA 124.453 3.436 . . . . 73.21 114.192 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -61.89 -60.4 3.7 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.637 -0.71 . . . . 62.13 111.491 -178.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 62' ' ' LYS . . . . . 0.618 ' HD3' ' HB2' ' C' ' 59' ' ' ASP . 0.1 OUTLIER -62.67 -40.12 96.08 Favored 'General case' 0 C--O 1.248 1.01 0 O-C-N 124.244 0.965 . . . . 75.43 109.419 -173.164 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 47.2 tpt85 -51.84 -55.79 17.84 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 114.06 -1.427 . . . . 74.14 109.993 176.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -74.93 -18.07 60.46 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.333 -0.849 . . . . 74.15 112.499 -177.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 69.2 mt -62.94 -48.85 86.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 108.645 -0.872 . . . . 71.5 108.645 170.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -65.7 -43.86 87.88 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.799 -0.637 . . . . 74.31 110.681 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -61.59 -36.13 79.8 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 122.765 0.426 . . . . 73.14 111.578 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 74.4 p -83.9 -15.49 47.84 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 119.144 -0.455 . . . . 74.43 111.165 175.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -71.33 136.25 47.75 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.42 -0.956 . . . . 75.22 108.42 175.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.64 19.21 55.0 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 111.296 -0.721 . . . . 62.51 111.296 -167.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 58.6 m -145.84 -59.07 0.32 Allowed 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 103.274 -2.862 . . . . 72.34 103.274 174.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 13.3 m -79.88 137.47 36.92 Favored 'General case' 0 C--O 1.251 1.168 0 N-CA-C 104.63 -2.359 . . . . 73.35 104.63 156.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.09 -30.9 5.53 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.957 0.903 . . . . 73.23 110.15 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.45 124.86 91.4 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 115.614 -0.721 . . . . 53.23 109.219 174.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -53.31 146.1 41.97 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 122.871 2.381 . . . . 75.14 112.293 173.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -51.89 139.59 50.1 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 123.01 2.473 . . . . 71.22 112.849 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.66 138.9 86.81 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 122.743 2.295 . . . . 74.4 111.705 172.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 78' ' ' PRO . . . . . 0.525 ' HB3' ' HB2' ' C' ' 103' ' ' PRO . 18.0 Cg_endo -59.22 116.45 3.28 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 122.85 2.366 . . . . 74.44 112.581 -176.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -64.21 124.05 12.82 Favored 'Trans proline' 0 C--N 1.376 2.023 0 C-N-CA 122.324 2.016 . . . . 70.12 109.729 171.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -55.32 83.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.392 2.824 0 C-N-CA 123.751 2.967 . . . . 74.31 112.697 -175.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 161.91 -59.99 0.29 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 109.245 -1.542 . . . . 75.2 109.245 -174.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . 0.414 ' HA3' ' HG3' ' C' ' 167' ' ' GLN . . . 143.61 172.69 14.61 Favored Glycine 0 C--N 1.358 1.795 0 C-N-CA 123.069 0.366 . . . . 75.13 112.761 -177.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -90.37 119.02 30.31 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.684 -0.858 . . . . 73.4 108.684 171.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 84' ' ' ASP . . . . . 0.593 ' HB2' ' HA ' ' C' ' 164' ' ' MET . 6.6 p-10 -70.29 133.21 46.76 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.509 0.724 . . . . 75.11 111.156 -178.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 85' ' ' PHE . . . . . 0.59 ' HB3' ' HB2' ' C' ' 88' ' ' PHE . 54.8 m-85 -139.43 69.81 1.37 Allowed 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.813 0.816 . . . . 74.41 110.796 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 16.7 m -61.5 96.07 0.06 Allowed 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 114.276 -1.329 . . . . 52.42 111.442 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.11 5.11 90.34 Favored Glycine 0 C--N 1.347 1.14 0 CA-C-N 115.807 -0.633 . . . . 74.34 113.317 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 88' ' ' PHE . . . . . 0.59 ' HB2' ' HB3' ' C' ' 85' ' ' PHE . 6.3 m-85 -103.78 118.07 35.83 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 108.154 -1.054 . . . . 74.44 108.154 -179.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -83.7 73.32 10.28 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 122.2 1.0 . . . . 72.23 110.766 -176.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 90' ' ' VAL . . . . . 0.651 HG13 ' HB3' ' C' ' 106' ' ' PHE . 2.4 p -41.32 -43.28 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 C-N-CA 126.551 1.94 . . . . 54.42 113.961 175.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -61.78 -32.01 72.26 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.831 0.852 . . . . 75.25 112.049 -175.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -101.26 4.18 41.55 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.482 0.313 . . . . 75.53 111.471 -176.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 93' ' ' PHE . . . . . 0.432 ' CD2' ' HA ' ' C' ' 90' ' ' VAL . 19.4 m-30 -78.04 177.5 8.26 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 110.23 -0.285 . . . . 72.45 110.23 174.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 77.4 p -62.18 158.63 16.49 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.829 0.852 . . . . 52.11 113.269 -173.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 95' ' ' GLU . . . . . 0.463 ' O ' ' HG3' ' C' ' 99' ' ' GLU . 0.0 OUTLIER -64.25 -25.69 68.17 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 123.51 0.507 . . . . 72.35 111.008 170.98 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -62.44 -45.41 93.19 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.694 0.798 . . . . 74.24 110.413 172.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 97' ' ' PHE . . . . . 0.491 ' HE2' HG22 ' C' ' 90' ' ' VAL . 32.5 t80 -64.93 -37.17 86.74 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 115.02 -0.991 . . . . 64.25 109.432 175.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 98' ' ' GLN . . . . . 0.422 ' HB2' ' HA ' ' C' ' 95' ' ' GLU . 70.3 mt-30 -71.12 -17.27 62.57 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.021 -0.99 . . . . 71.33 112.003 178.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . 0.463 ' HG3' ' O ' ' C' ' 95' ' ' GLU . 40.2 mt-10 -78.22 -57.9 3.54 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 109.602 -0.518 . . . . 74.43 109.602 167.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 26.6 tp -65.94 -31.26 72.08 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 114.369 -1.287 . . . . 73.23 112.336 -166.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 101' ' ' PHE . . . . . 0.461 ' HZ ' HG11 ' C' ' 56' ' ' VAL . 76.6 m-85 -120.34 13.37 11.88 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.377 0.671 . . . . 75.04 110.885 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -43.55 -63.8 2.05 Favored Glycine 0 C--N 1.352 1.437 0 N-CA-C 116.241 1.256 . . . . 74.41 116.241 -173.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . 0.525 ' HB2' ' HB3' ' C' ' 78' ' ' PRO . 38.8 Cg_exo -58.81 -6.3 3.31 Favored 'Trans proline' 0 C--N 1.373 1.837 0 C-N-CA 123.545 2.83 . . . . 64.35 115.225 -174.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -147.28 41.02 0.97 Allowed Glycine 0 C--N 1.351 1.407 0 CA-C-O 119.634 -0.537 . . . . 73.42 112.712 176.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 38.0 mt -62.88 21.59 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 116.445 2.017 . . . . 75.43 116.445 -177.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 106' ' ' PHE . . . . . 0.661 ' HA ' ' HA ' ' C' ' 167' ' ' GLN . 17.2 t80 57.9 -94.34 0.05 OUTLIER 'General case' 0 CA--C 1.568 1.658 0 CA-C-N 120.252 1.387 . . . . 64.24 111.583 164.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 107' ' ' GLY . . . . . 0.673 ' HA3' ' HB2' ' C' ' 113' ' ' SER . . . 113.97 17.81 7.16 Favored Glycine 0 C--N 1.344 1.026 0 C-N-CA 125.393 1.473 . . . . 51.05 113.861 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . -9.49 -70.7 0.01 OUTLIER Glycine 0 N--CA 1.479 1.538 0 C-N-CA 127.035 2.255 . . . . 74.41 118.262 172.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 109' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -123.78 25.15 8.17 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.028 0.531 . . . . 74.45 110.274 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 110' ' ' GLY . . . . . . . . . . . . . . . -76.27 -1.78 70.87 Favored Glycine 0 C--N 1.35 1.317 0 CA-C-N 115.593 -0.731 . . . . 73.14 113.11 173.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 9.2 tpp180 81.9 -41.17 0.13 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 127.074 2.15 . . . . 75.25 112.481 171.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 112' ' ' ARG . . . . . 0.468 ' O ' ' N ' ' C' ' 114' ' ' ARG . 9.8 tpp180 -126.88 -39.62 1.95 Allowed 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 117.273 -1.346 . . . . 75.43 113.308 170.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 113' ' ' SER . . . . . 0.673 ' HB2' ' HA3' ' C' ' 107' ' ' GLY . 12.7 m -5.63 -33.75 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.469 0 N-CA-C 120.206 3.41 . . . . 72.53 120.206 -168.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 114' ' ' ARG . . . . . 0.51 ' HB3' ' HA2' ' C' ' 168' ' ' GLY . 1.5 tpp180 -159.9 161.96 34.43 Favored 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 107.683 -1.229 . . . . 74.05 107.683 164.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 115' ' ' LYS . . . . . . . . . . . . . 23.4 tptp -85.07 130.12 34.67 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 108.155 -1.054 . . . . 74.15 108.155 165.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 116' ' ' GLY . . . . . 0.581 ' HA2' ' HA3' ' C' ' 168' ' ' GLY . . . -51.92 111.54 1.52 Allowed Glycine 0 C--N 1.358 1.754 0 O-C-N 124.68 1.237 . . . . 54.4 113.302 -178.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 117' ' ' ARG . . . . . 0.454 ' HB2' ' HA3' ' C' ' 166' ' ' GLY . 52.1 mmm-85 -70.03 97.9 1.23 Allowed 'General case' 0 C--O 1.249 1.027 0 N-CA-C 107.314 -1.365 . . . . 74.32 107.314 174.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 118' ' ' ASP . . . . . 0.406 ' HB2' ' HA ' ' B' ' 151' ' ' HIS . 4.5 m-20 -67.09 98.12 0.56 Allowed 'General case' 0 C--O 1.242 0.659 0 CA-C-N 114.767 -1.106 . . . . 75.42 108.166 -178.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 119' ' ' LEU . . . . . . . . . . . . . 56.0 tp -93.05 98.67 11.49 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 108.134 -1.061 . . . . 75.21 108.134 -168.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.413 HH12 HG22 ' C' ' 158' ' ' VAL . 40.8 ttm-85 -100.48 114.83 28.76 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.58 -0.896 . . . . 72.31 108.58 -177.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 121' ' ' ALA . . . . . 0.488 ' HB1' HD21 ' C' ' 176' ' ' LEU . . . -115.46 130.25 56.82 Favored 'General case' 0 C--O 1.219 -0.534 0 C-N-CA 123.644 0.777 . . . . 75.44 110.366 -174.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 122' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' C' ' 177' ' ' VAL . 11.5 pt-20 -90.06 147.63 23.53 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 109.413 -0.588 . . . . 74.12 109.413 174.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 123' ' ' LEU . . . . . 0.492 ' HB2' HG13 ' B' ' 182' ' ' VAL . 2.6 pt? -143.81 123.12 7.34 Favored Pre-proline 0 N--CA 1.482 1.173 0 N-CA-C 112.68 0.622 . . . . 73.3 112.68 -176.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . 0.42 ' HA ' ' O ' ' C' ' 179' ' ' ARG . 24.3 Cg_exo -65.7 117.67 4.83 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 122.739 2.293 . . . . 72.51 110.905 170.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 125' ' ' LEU . . . . . 0.493 HD22 HG13 ' C' ' 153' ' ' VAL . 44.7 tp -145.32 153.72 41.56 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.92 0.488 . . . . 75.32 110.311 -172.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 126' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.31 166.01 10.68 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.766 0.827 . . . . 61.53 109.873 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 127' ' ' LEU . . . . . 0.44 HD22 HD12 ' C' ' 180' ' ' LEU . 94.4 mt -78.13 -36.79 47.42 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.854 0.862 . . . . 62.25 111.333 -178.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 128' ' ' GLU . . . . . 0.441 ' HG2' ' H ' ' B' ' 171' ' ' ALA . 18.0 mp0 -70.52 -32.18 69.54 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.987 -1.006 . . . . 75.24 109.542 173.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -87.4 -8.71 56.25 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.095 0.558 . . . . 75.51 111.416 176.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -76.56 -43.19 40.04 Favored 'General case' 0 C--O 1.22 -0.461 0 N-CA-C 108.191 -1.04 . . . . 73.14 108.191 164.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 131' ' ' PHE . . . . . 0.417 ' HB2' HD11 ' C' ' 215' ' ' LEU . 77.5 t80 -60.2 -37.99 81.94 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.781 1.233 . . . . 75.55 111.234 174.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 132' ' ' HIS . . . . . 0.428 ' HB3' ' CD1' ' B' ' 131' ' ' TRP . 65.7 m170 -78.68 -69.96 0.53 Allowed 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.831 -0.622 . . . . 70.15 110.669 177.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 49.46 -103.81 0.09 OUTLIER Glycine 0 C--N 1.353 1.52 0 O-C-N 124.047 0.842 . . . . 65.31 112.986 -178.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.98 -153.8 34.67 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 114.525 0.57 . . . . 73.12 114.525 170.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -93.42 93.86 8.39 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.152 -1.055 . . . . 73.03 108.152 -167.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 136' ' ' ARG . . . . . 0.624 ' HB3' ' HB2' ' B' ' 181' ' ' LEU . 0.9 OUTLIER -142.19 147.45 36.61 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 122.229 -0.295 . . . . 72.12 110.979 -167.977 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 137' ' ' VAL . . . . . 0.599 ' HA ' ' HA ' ' C' ' 146' ' ' SER . 7.7 p -95.07 129.99 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-O 121.493 0.664 . . . . 73.11 111.364 -177.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 138' ' ' VAL . . . . . . . . . . . . . 3.0 p -114.84 140.72 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.612 1.165 . . . . 72.14 108.953 178.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 139' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -108.0 111.59 23.74 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 107.8 -1.185 . . . . 74.31 107.8 172.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 140' ' ' VAL . . . . . 0.414 HG22 ' HB2' ' C' ' 121' ' ' ALA . 2.7 p -130.63 128.15 62.94 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 C-N-CA 123.896 0.878 . . . . 73.25 109.215 -179.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 65.37 33.36 9.03 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.803 0.841 . . . . 65.0 112.388 174.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 78.7 12.5 84.15 Favored Glycine 0 C--N 1.345 1.044 0 CA-C-N 116.399 -0.364 . . . . 52.4 112.302 -176.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 143' ' ' ARG . . . . . . . . . . . . . 29.1 tpt180 -126.32 100.83 6.45 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.445 0.698 . . . . 75.05 109.991 -168.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -83.99 129.33 34.92 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.181 -0.918 . . . . 71.51 109.225 176.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 145' ' ' VAL . . . . . . . . . . . . . 3.7 p -166.34 140.26 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 123.822 0.849 . . . . 75.03 109.854 -174.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 146' ' ' SER . . . . . 0.599 ' HA ' ' HA ' ' C' ' 137' ' ' VAL . 56.8 p -100.7 146.05 27.69 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.075 0.55 . . . . 73.22 111.998 -174.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 8.9 p -151.67 150.33 13.22 Favored 'Isoleucine or valine' 0 C--O 1.242 0.711 0 CA-C-N 115.716 -0.674 . . . . 72.53 109.838 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 148' ' ' ARG . . . . . 0.481 ' NH1' ' HB3' ' B' ' 206' ' ' GLU . 20.3 ttt180 -105.36 94.67 5.34 Favored 'General case' 0 C--N 1.347 0.482 0 N-CA-C 107.971 -1.122 . . . . 74.22 107.971 168.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 149' ' ' ILE . . . . . 0.417 HD13 HD12 ' C' ' 159' ' ' ILE . 37.8 pt -75.97 146.68 79.44 Favored Pre-proline 0 CA--C 1.55 0.956 0 CA-C-O 118.603 -0.713 . . . . 74.42 109.513 176.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.37 115.75 2.8 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 122.408 2.072 . . . . 61.44 111.619 177.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -51.72 111.69 0.65 Allowed 'Trans proline' 0 C--N 1.384 2.424 0 C-N-CA 123.633 2.889 . . . . 73.2 114.081 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 152' ' ' GLY . . . . . . . . . . . . . . . 139.77 136.28 3.35 Favored Glycine 0 C--N 1.35 1.324 0 CA-C-N 115.373 -0.83 . . . . 63.11 113.175 -174.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 153' ' ' VAL . . . . . 0.493 HG13 HD22 ' C' ' 125' ' ' LEU . 1.7 p -160.38 160.72 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.777 0 CA-C-N 117.192 0.496 . . . . 74.01 112.2 177.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 154' ' ' ARG . . . . . 0.47 ' HD3' ' O ' ' C' ' 188' ' ' LEU . 43.9 ttp180 -128.2 139.68 52.33 Favored 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 125.052 1.341 . . . . 75.32 109.225 177.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 155' ' ' GLU . . . . . 0.59 ' HB2' HD13 ' C' ' 180' ' ' LEU . 21.8 tp10 -40.51 123.53 1.83 Allowed 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 125.464 1.506 . . . . 74.51 113.9 176.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 81.09 -13.46 32.02 Favored Glycine 0 C--N 1.353 1.486 0 CA-C-N 115.054 -0.976 . . . . 75.21 113.951 176.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 157' ' ' SER . . . . . . . . . . . . . 17.1 m -83.56 166.28 18.36 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.226 0.61 . . . . 75.43 111.203 -174.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 158' ' ' VAL . . . . . 0.524 HG21 HG23 ' C' ' 177' ' ' VAL . 21.5 t -111.66 136.44 47.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 CA-C-N 115.245 -0.889 . . . . 72.31 110.884 -163.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 159' ' ' ILE . . . . . 0.683 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 27.2 mt -105.99 122.13 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 107.136 -1.431 . . . . 72.31 107.136 172.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 16.8 ttm180 -83.8 141.22 31.54 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 117.947 0.339 . . . . 75.13 110.151 178.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 161' ' ' VAL . . . . . 0.491 ' HB ' ' HB3' ' C' ' 174' ' ' LEU . 39.8 t -128.74 97.65 26.74 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 107.24 -1.393 . . . . 75.24 107.24 164.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -62.92 127.67 21.05 Favored 'Trans proline' 0 C--N 1.377 2.038 0 C-N-CA 122.92 2.413 . . . . 75.23 113.489 -172.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 163' ' ' GLY . . . . . 0.641 ' H ' ' HB3' ' C' ' 173' ' ' ASP . . . 84.67 -18.39 25.61 Favored Glycine 0 CA--C 1.541 1.665 0 N-CA-C 115.135 0.814 . . . . 53.54 115.135 177.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 164' ' ' MET . . . . . 0.593 ' HA ' ' HB2' ' C' ' 84' ' ' ASP . 31.3 ttp -94.77 38.71 1.11 Allowed 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 117.94 0.87 . . . . 73.35 112.317 -167.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . -109.02 -147.01 11.96 Favored Glycine 0 N--CA 1.473 1.132 0 CA-C-N 115.718 -0.674 . . . . 73.32 112.649 174.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 166' ' ' GLY . . . . . 0.454 ' HA3' ' HB2' ' C' ' 117' ' ' ARG . . . -88.88 -177.22 46.53 Favored Glycine 0 C--N 1.351 1.405 0 CA-C-O 119.868 -0.407 . . . . 75.44 112.992 -179.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 167' ' ' GLN . . . . . 0.661 ' HA ' ' HA ' ' C' ' 106' ' ' PHE . 28.4 mt-30 -49.97 129.21 20.16 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.168 1.387 . . . . 74.2 112.894 -173.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 168' ' ' GLY . . . . . 0.581 ' HA3' ' HA2' ' C' ' 116' ' ' GLY . . . 165.71 158.07 10.47 Favored Glycine 0 C--N 1.351 1.412 0 N-CA-C 114.984 0.754 . . . . 13.44 114.984 173.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 169' ' ' ASN . . . . . 0.534 ' HB3' ' HD3' ' C' ' 170' ' ' PRO . 5.0 t30 -90.37 -55.43 0.28 Allowed Pre-proline 0 CA--C 1.557 1.213 0 CA-C-N 114.166 -1.017 . . . . 62.44 110.298 165.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 170' ' ' PRO . . . . . 0.534 ' HD3' ' HB3' ' C' ' 169' ' ' ASN . 20.9 Cg_exo -64.44 118.52 5.48 Favored 'Trans proline' 0 C--N 1.399 3.221 0 CA-C-N 120.883 1.351 . . . . 73.55 109.029 175.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 171' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -46.17 107.0 0.1 Allowed 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 123.335 2.69 . . . . 74.02 114.073 -167.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -82.62 -48.15 5.67 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-N 115.154 -0.93 . . . . 74.42 111.154 175.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 173' ' ' ASP . . . . . 0.641 ' HB3' ' H ' ' C' ' 163' ' ' GLY . 2.4 p30 50.84 173.11 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 115.709 1.744 . . . . 74.51 115.709 172.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 174' ' ' LEU . . . . . 0.491 ' HB3' ' HB ' ' C' ' 161' ' ' VAL . 49.5 tp -100.73 132.87 45.91 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 115.488 -0.778 . . . . 75.22 109.759 -177.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 175' ' ' LEU . . . . . 0.457 HD23 ' CE1' ' B' ' 147' ' ' HIS . 90.0 mt -127.54 89.31 2.93 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.924 0.869 . . . . 72.15 110.316 -173.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 176' ' ' LEU . . . . . 0.683 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 96.0 mt -76.36 97.26 4.2 Favored 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 114.262 -1.336 . . . . 74.33 111.945 -175.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 177' ' ' VAL . . . . . 0.524 HG23 HG21 ' C' ' 158' ' ' VAL . 71.5 t -83.56 109.94 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 108.334 -0.987 . . . . 75.23 108.334 174.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 178' ' ' VAL . . . . . 0.408 ' HA ' HD22 ' C' ' 123' ' ' LEU . 8.2 p -75.14 136.03 25.96 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 CA-C-O 121.919 0.866 . . . . 74.01 111.707 -173.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 179' ' ' ARG . . . . . 0.42 ' O ' ' HA ' ' C' ' 124' ' ' PRO . 8.5 mmm180 -109.76 96.1 6.03 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 105.563 -2.014 . . . . 74.42 105.563 171.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 180' ' ' LEU . . . . . 0.59 HD13 ' HB2' ' C' ' 155' ' ' GLU . 77.0 mt -68.97 148.52 50.02 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-O 121.26 0.552 . . . . 73.43 111.046 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 181' ' ' LEU . . . . . . . . . . . . . 56.8 mt -68.97 171.49 6.37 Favored Pre-proline 0 N--CA 1.484 1.235 0 CA-C-N 114.217 -1.356 . . . . 74.24 110.494 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -60.98 67.37 0.09 OUTLIER 'Trans proline' 0 C--N 1.384 2.423 0 C-N-CA 122.543 2.162 . . . . 73.32 111.855 166.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 183' ' ' HIS . . . . . 0.578 ' H ' ' HD3' ' C' ' 184' ' ' PRO . 71.1 t60 -170.25 27.39 0.01 OUTLIER Pre-proline 0 CA--C 1.582 2.195 0 C-N-CA 126.726 2.01 . . . . 72.0 109.894 -177.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 184' ' ' PRO . . . . . 0.578 ' HD3' ' H ' ' C' ' 183' ' ' HIS . 12.2 Cg_endo -84.74 68.22 6.2 Favored 'Trans proline' 0 C--N 1.405 3.522 0 C-N-CA 122.542 2.161 . . . . 74.25 110.513 -173.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 185' ' ' VAL . . . . . 0.466 HG13 ' HB1' ' C' ' 195' ' ' ALA . 5.9 t -90.4 -40.95 13.21 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.573 0 N-CA-C 107.658 -1.238 . . . . 72.23 107.658 -172.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 186' ' ' PHE . . . . . 0.416 ' HB2' HD12 ' C' ' 127' ' ' LEU . 74.5 m-85 -99.24 104.56 16.5 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.687 0.795 . . . . 61.44 109.825 -172.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 187' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -94.41 113.3 25.15 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.292 1.437 . . . . 75.14 108.465 -177.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 188' ' ' LEU . . . . . 0.47 ' O ' ' HD3' ' C' ' 154' ' ' ARG . 64.7 tp -81.93 146.99 29.5 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 113.233 0.827 . . . . 74.14 113.233 -171.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 189' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' B' ' 375' ' ' LEU . 32.8 tt0 -145.59 101.88 3.62 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.033 1.333 . . . . 73.21 107.55 164.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 190' ' ' GLY . . . . . 0.44 ' HA3' ' HA ' ' B' ' 375' ' ' LEU . . . 74.73 -102.25 1.39 Allowed Glycine 0 C--N 1.346 1.115 0 N-CA-C 112.159 -0.376 . . . . 74.2 112.159 -175.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 191' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -112.24 -13.68 13.45 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.493 0.717 . . . . 75.25 110.363 170.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -87.72 141.06 28.89 Favored 'General case' 0 C--O 1.213 -0.835 0 C-N-CA 123.689 0.796 . . . . 65.13 110.685 -170.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 193' ' ' LEU . . . . . . . . . . . . . 85.6 mt -106.58 167.56 9.77 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 122.899 0.48 . . . . 65.15 110.871 -176.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 194' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -143.2 105.3 4.4 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.567 -0.531 . . . . 75.43 109.567 171.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 195' ' ' ALA . . . . . 0.49 ' HB2' HD22 ' C' ' 251' ' ' LEU . . . -119.52 -176.35 3.14 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.607 1.163 . . . . 65.11 109.324 177.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 30.1 m -123.78 133.58 53.8 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 109.306 -0.628 . . . . 53.42 109.306 176.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 197' ' ' LEU . . . . . 0.452 HD11 ' HB3' ' C' ' 212' ' ' ALA . 32.0 tp -107.2 122.73 47.11 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.403 0.681 . . . . 73.5 109.567 -178.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -82.56 98.16 8.83 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 108.566 -0.901 . . . . 64.33 108.566 176.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 199' ' ' VAL . . . . . . . . . . . . . 60.3 t -107.77 121.42 44.11 Favored Pre-proline 0 N--CA 1.478 0.964 0 C-N-CA 123.296 0.639 . . . . 73.12 109.335 -175.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 200' ' ' PRO . . . . . 0.541 ' HG2' HD11 ' C' ' 203' ' ' ILE . 15.9 Cg_exo -63.23 140.69 78.92 Favored 'Trans proline' 0 C--N 1.367 1.541 0 C-N-CA 121.839 1.693 . . . . 73.11 111.181 172.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 201' ' ' ALA . . . . . 0.458 ' HB1' ' HH2' ' C' ' 269' ' ' TRP . . . -53.5 -46.43 98.13 Favored Pre-proline 0 CA--C 1.554 1.107 0 N-CA-C 113.49 0.922 . . . . 74.35 113.49 178.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 202' ' ' PRO . . . . . 0.497 ' HB2' ' HA ' ' A' ' 273' ' ' ALA . 39.2 Cg_endo -62.06 -42.64 28.76 Favored 'Trans proline' 0 C--N 1.384 2.407 0 CA-C-N 120.722 1.294 . . . . 63.15 111.946 178.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 203' ' ' ILE . . . . . 0.541 HD11 ' HG2' ' C' ' 200' ' ' PRO . 24.8 mt -64.48 -34.68 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 122.839 0.456 . . . . 74.02 110.958 177.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 204' ' ' ALA . . . . . 0.489 ' HA ' HG11 ' C' ' 223' ' ' VAL . . . -68.13 -35.29 77.87 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.687 0.795 . . . . 75.02 111.913 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 205' ' ' VAL . . . . . 0.526 ' HA ' ' HA ' ' C' ' 226' ' ' ARG . 95.6 t -77.96 -42.09 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-N 115.836 -0.62 . . . . 74.52 112.498 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 206' ' ' VAL . . . . . 0.465 HG21 ' HE3' ' A' ' 270' ' ' LYS . 11.7 p -76.6 -32.73 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 CA-C-O 121.028 0.442 . . . . 74.12 110.009 -177.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 84.3 49.95 4.48 Favored Glycine 0 N--CA 1.44 -1.062 0 CA-C-N 115.095 -0.957 . . . . 63.21 111.846 -172.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -84.37 -136.92 3.44 Favored Glycine 0 C--N 1.347 1.187 0 CA-C-O 119.62 -0.545 . . . . 51.32 112.03 177.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 209' ' ' LYS . . . . . 0.501 ' HB3' ' HG2' ' C' ' 220' ' ' GLU . 9.2 mtmp? -139.02 140.89 38.27 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 117.649 0.724 . . . . 72.44 112.83 -178.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 210' ' ' VAL . . . . . . . . . . . . . 57.5 t -132.78 129.48 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 124.953 1.301 . . . . 71.52 108.614 178.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 211' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -80.28 125.57 30.04 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 118.16 0.436 . . . . 75.53 111.505 -177.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 212' ' ' ALA . . . . . 0.452 ' HB3' HD11 ' C' ' 197' ' ' LEU . . . -103.12 120.08 40.04 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 108.038 -1.097 . . . . 74.43 108.038 165.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 213' ' ' MET . . . . . . . . . . . . . 5.4 tmm? -79.12 108.53 12.68 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 108.331 -0.989 . . . . 63.12 108.331 -177.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.93 171.85 7.1 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 118.128 0.422 . . . . 72.34 110.772 -173.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 215' ' ' LEU . . . . . 0.422 ' HA ' ' HG3' ' C' ' 128' ' ' GLU . 25.2 mt -58.41 -37.84 76.15 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 125.302 1.441 . . . . 75.24 113.49 -165.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 216' ' ' GLU . . . . . 0.45 ' HG2' HH11 ' C' ' 246' ' ' ARG . 0.0 OUTLIER -110.1 -6.32 15.14 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.057 0.943 . . . . 71.0 111.483 -174.579 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 169.42 156.23 10.62 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-O 119.761 -0.466 . . . . 74.41 113.303 -177.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.74 111.17 3.08 Favored 'Trans proline' 0 CA--C 1.557 1.656 0 C-N-CA 122.933 2.422 . . . . 64.03 112.403 178.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 219' ' ' VAL . . . . . 0.514 ' HB ' ' HE3' ' C' ' 238' ' ' LYS . 9.0 p -84.21 140.16 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 O-C-N 122.07 -0.394 . . . . 52.53 110.019 176.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 220' ' ' GLU . . . . . 0.501 ' HG2' ' HB3' ' C' ' 209' ' ' LYS . 25.5 tt0 -101.23 108.02 19.56 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 107.657 -1.238 . . . . 72.32 107.657 176.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 221' ' ' VAL . . . . . 0.48 ' HA ' ' HB1' ' B' ' 239' ' ' ALA . 42.5 t -77.07 119.48 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 124.055 0.942 . . . . 74.03 111.897 -174.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 222' ' ' ALA . . . . . 0.76 ' HB3' ' HE2' ' B' ' 245' ' ' LYS . . . -80.69 112.71 18.31 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.537 0.735 . . . . 73.3 110.277 169.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . 0.489 HG11 ' HA ' ' C' ' 204' ' ' ALA . 63.8 t -89.19 138.89 28.65 Favored Pre-proline 0 CA--C 1.559 1.306 0 C-N-CA 124.719 1.208 . . . . 73.11 110.028 -178.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 224' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.62 154.38 64.36 Favored 'Trans proline' 0 C--N 1.389 2.705 0 C-N-CA 122.501 2.134 . . . . 73.11 112.147 172.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.31 114.21 1.83 Allowed 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 122.768 2.312 . . . . 74.4 111.906 174.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 226' ' ' ARG . . . . . 0.568 ' HB3' ' HA ' ' A' ' 259' ' ' GLU . 0.0 OUTLIER 70.69 97.91 0.07 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.879 1.672 . . . . 71.5 112.406 -178.186 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 227' ' ' THR . . . . . 0.441 HG21 HG12 ' C' ' 253' ' ' VAL . 50.5 m -120.29 129.28 53.95 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 124.726 1.21 . . . . 73.3 111.562 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 228' ' ' GLN . . . . . 0.43 ' NE2' ' HB2' ' A' ' 259' ' ' GLU . 27.0 mp0 -95.14 156.43 16.32 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 124.247 1.019 . . . . 74.32 111.635 175.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -75.72 131.32 39.77 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 114.84 -1.073 . . . . 65.31 109.742 177.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 110.95 -18.96 25.9 Favored Glycine 0 C--N 1.339 0.697 0 CA-C-N 115.711 -0.677 . . . . 62.04 112.085 -170.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 231' ' ' ARG . . . . . . . . . . . . . 56.4 mtt180 -62.35 161.86 10.9 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 116.754 0.277 . . . . 75.03 110.318 169.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 232' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -137.65 138.91 39.93 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.042 0.449 . . . . 74.05 110.76 -174.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 233' ' ' LEU . . . . . 0.643 ' O ' ' HA ' ' C' ' 250' ' ' TYR . 6.1 mp -97.11 153.01 18.22 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 114.366 -1.288 . . . . 74.22 109.431 176.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 17.3 ptt180 -130.78 91.33 3.05 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 107.855 -1.165 . . . . 72.34 107.855 162.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 235' ' ' LEU . . . . . 0.516 HD12 HD23 ' C' ' 249' ' ' LEU . 17.1 mt -71.4 106.41 3.9 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 114.29 -1.323 . . . . 74.34 109.061 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 236' ' ' LYS . . . . . 0.637 ' HB3' ' HA ' ' B' ' 35' ' ' GLN . 26.2 mmmt -69.82 115.25 8.83 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 113.997 -1.456 . . . . 73.41 110.872 -171.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 81.39 33.15 29.18 Favored Glycine 0 C--N 1.346 1.1 0 CA-C-N 115.799 -0.637 . . . . 71.42 112.955 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 238' ' ' LYS . . . . . 0.514 ' HE3' ' HB ' ' C' ' 219' ' ' VAL . 64.6 mmtt -125.77 24.41 7.11 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.723 0.809 . . . . 75.11 111.364 177.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -102.32 -156.1 25.77 Favored Glycine 0 C--N 1.344 1.007 0 N-CA-C 111.652 -0.579 . . . . 75.2 111.652 171.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 240' ' ' PHE . . . . . 0.433 ' HD2' HD12 ' C' ' 188' ' ' LEU . 56.8 m-85 -81.67 153.38 70.49 Favored Pre-proline 0 CA--C 1.553 1.086 0 C-N-CA 122.868 0.467 . . . . 75.14 109.915 175.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 241' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -66.95 136.05 39.93 Favored 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 123.746 2.964 . . . . 71.53 114.806 -168.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -134.9 173.11 21.71 Favored Glycine 0 C--N 1.351 1.416 0 CA-C-N 115.487 -0.779 . . . . 70.14 112.869 175.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -60.91 -42.8 34.76 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 123.899 3.066 . . . . 71.42 112.796 -174.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 244' ' ' ALA . . . . . 0.421 ' HB1' ' HB3' ' B' ' 32' ' ' ARG . . . -83.53 -17.36 42.1 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.725 0.81 . . . . 71.42 110.698 178.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 143.92 -179.19 21.46 Favored Glycine 0 C--N 1.346 1.108 0 CA-C-N 115.621 -0.718 . . . . 63.24 111.423 -176.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 246' ' ' ARG . . . . . 0.45 HH11 ' HG2' ' C' ' 216' ' ' GLU . 80.8 mtm180 -71.34 159.52 34.42 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.298 0.639 . . . . 71.32 111.192 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -70.42 -164.29 4.99 Favored Glycine 0 C--N 1.353 1.504 0 CA-C-N 116.074 -0.512 . . . . 63.23 113.463 178.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -117.17 124.46 49.18 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 108.803 -0.814 . . . . 73.54 108.803 -173.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 249' ' ' LEU . . . . . 0.516 HD23 HD12 ' C' ' 235' ' ' LEU . 11.0 tp -79.58 119.99 23.31 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.902 -0.777 . . . . 74.23 108.902 177.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 250' ' ' TYR . . . . . 0.643 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 20.0 m-85 -96.24 111.93 23.83 Favored 'General case' 0 C--O 1.221 -0.419 0 N-CA-C 108.205 -1.035 . . . . 71.43 108.205 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 251' ' ' LEU . . . . . 0.518 HD11 HD21 ' C' ' 233' ' ' LEU . 77.1 mt -105.32 123.02 47.16 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 109.218 -0.66 . . . . 72.0 109.218 -177.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -81.32 120.27 24.72 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.273 -1.01 . . . . 75.41 108.273 173.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 253' ' ' VAL . . . . . 0.441 HG12 HG21 ' C' ' 227' ' ' THR . 60.3 t -72.29 128.93 35.66 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 C-N-CA 123.018 0.527 . . . . 73.5 110.954 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 254' ' ' ARG . . . . . . . . . . . . . 39.4 mtm105 -112.38 129.77 56.2 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 107.462 -1.31 . . . . 75.13 107.462 162.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 255' ' ' ILE . . . . . 0.528 ' O ' ' HB ' ' A' ' 255' ' ' ILE . 37.9 mm -94.65 114.21 30.75 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.775 0 N-CA-C 106.14 -1.8 . . . . 75.24 106.14 173.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 256' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' C' ' 200' ' ' PRO . 0.1 OUTLIER -132.56 155.28 48.94 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 123.991 0.916 . . . . 70.25 108.93 -170.642 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 2.7 pp -124.0 151.07 64.58 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 109.086 -0.709 . . . . 75.21 109.086 -175.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 258' ' ' PRO . . . . . 0.42 ' HG3' ' HE2' ' A' ' 276' ' ' TYR . 68.9 Cg_endo -75.04 8.88 2.23 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.45 2.1 . . . . 74.41 113.025 -171.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 61.37 -79.25 0.02 OUTLIER 'General case' 0 C--N 1.359 0.987 0 C-N-CA 125.718 1.607 . . . . 72.3 110.268 -170.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 260' ' ' ARG . . . . . 0.512 ' HB2' ' HA3' ' B' ' 469' ' ' GLY . 2.6 ptp85 -72.95 142.63 47.82 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.396 1.478 . . . . 73.41 110.671 -178.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 261' ' ' LEU . . . . . 0.461 HD22 ' HB3' ' C' ' 265' ' ' GLU . 85.6 mt -139.04 168.25 20.25 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.771 0.829 . . . . 74.53 110.579 -174.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 49.4 p -86.53 162.94 43.78 Favored Pre-proline 0 CA--C 1.553 1.063 0 N-CA-C 108.401 -0.963 . . . . 61.23 108.401 168.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -50.49 -40.99 53.85 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 122.738 2.292 . . . . 74.2 113.107 173.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -60.44 -59.21 5.77 Favored 'General case' 0 C--O 1.262 1.73 0 C-N-CA 124.011 0.924 . . . . 71.04 110.846 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 265' ' ' GLU . . . . . 0.461 ' HB3' HD22 ' C' ' 261' ' ' LEU . 49.3 mm-40 -51.04 -63.5 1.11 Allowed 'General case' 0 C--N 1.353 0.724 0 CA-C-N 114.416 -1.265 . . . . 71.03 110.538 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 266' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -55.58 -38.68 69.7 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.365 1.066 . . . . 73.1 111.58 -173.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -58.01 -51.31 70.18 Favored 'General case' 0 C--O 1.248 1.008 0 O-C-N 123.606 0.566 . . . . 71.12 111.427 177.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 268' ' ' LEU . . . . . 0.621 ' HB2' HD23 ' A' ' 272' ' ' LEU . 10.6 mp -64.68 -39.8 94.29 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 119.288 -0.387 . . . . 70.11 111.332 178.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 269' ' ' TRP . . . . . 0.458 ' HH2' ' HB1' ' C' ' 201' ' ' ALA . 86.0 m95 -58.88 -36.64 74.98 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 122.854 0.462 . . . . 63.11 111.683 176.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 270' ' ' LYS . . . . . 0.506 ' HB3' ' HZ3' ' C' ' 270' ' ' LYS . 9.5 mtpm? -72.71 -34.96 67.47 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.244 0.618 . . . . 75.43 111.352 178.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 271' ' ' LYS . . . . . 0.401 ' HA ' ' HD3' ' C' ' 271' ' ' LYS . 69.3 mmtt -68.17 -32.83 73.36 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 123.108 0.255 . . . . 75.33 111.627 175.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 272' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' C' ' 268' ' ' LEU . 68.6 mt -67.89 -41.56 82.57 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.202 0.601 . . . . 74.33 109.622 173.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -62.68 -38.61 91.03 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 115.732 -0.667 . . . . 43.22 111.227 176.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -66.22 -37.51 85.71 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.781 0.832 . . . . 63.21 110.756 176.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -62.9 -35.25 79.43 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.891 0.476 . . . . 70.04 111.046 173.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 276' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -69.97 -45.76 66.7 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.559 -0.746 . . . . 75.52 112.179 175.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -63.84 -33.98 76.89 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-O 121.066 0.46 . . . . 65.52 109.801 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -63.29 -17.21 62.28 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 114.882 -1.054 . . . . 72.22 112.659 178.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 279' ' ' ARG . . . . . . . . . . . . . 70.3 mtm180 -73.21 -24.46 60.52 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 122.486 0.314 . . . . 75.11 111.298 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.558 1.255 0 CA-C-O 118.459 -0.781 . . . . 75.14 109.771 -176.481 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.574 ' SD ' ' HG2' ' A' ' 95' ' ' GLU . 1.3 mpt? . . . . . 0 N--CA 1.488 1.451 0 N-CA-C 111.108 0.04 . . . . 64.12 111.108 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 54.23 29.12 10.07 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.318 1.447 . . . . 74.44 112.938 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.32 77.49 4.81 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.13 0.572 . . . . 74.04 110.105 -176.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.5 tmmm? -38.14 105.35 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.93 1.692 . . . . 64.14 112.63 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.616 ' HB3' HD13 ' A' ' 10' ' ' ILE . 48.8 mtpt -97.92 109.32 22.1 Favored 'General case' 0 C--O 1.244 0.782 0 N-CA-C 107.882 -1.155 . . . . 74.32 107.882 172.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.522 ' HA ' ' OH ' ' A' ' 66' ' ' TYR . 24.9 t70 -70.98 109.33 5.03 Favored 'General case' 0 C--N 1.351 0.657 0 N-CA-C 108.101 -1.074 . . . . 62.43 108.101 173.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -65.65 -32.23 73.68 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-N 115.114 -0.948 . . . . 73.34 111.998 -170.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -63.25 -43.49 97.87 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 109.846 -0.427 . . . . 73.33 109.846 173.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.4 -45.86 90.31 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.52 0.728 . . . . 70.01 111.337 178.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.616 HD13 ' HB3' ' A' ' 5' ' ' LYS . 66.1 mt -56.09 -45.02 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 O-C-N 123.903 0.752 . . . . 74.23 110.613 177.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.526 HD12 HG22 ' A' ' 22' ' ' ILE . 69.1 mt -69.74 -23.19 63.35 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 115.644 -0.707 . . . . 73.11 112.207 176.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.78 44.4 7.24 Favored Glycine 0 C--N 1.349 1.253 0 O-C-N 123.182 0.301 . . . . 73.42 112.976 -176.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.0 m -138.17 152.62 72.07 Favored Pre-proline 0 N--CA 1.486 1.326 0 C-N-CA 124.658 1.183 . . . . 72.52 109.839 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -59.26 157.3 30.99 Favored 'Trans proline' 0 C--N 1.384 2.397 0 C-N-CA 122.799 2.333 . . . . 50.12 112.366 177.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 10.9 mtm105 -72.68 8.71 1.35 Allowed 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 113.676 0.991 . . . . 75.43 113.676 -167.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -129.45 14.66 6.06 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.073 0.949 . . . . 71.2 109.474 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.76 131.78 51.79 Favored 'General case' 0 C--N 1.35 0.61 0 C-N-CA 124.273 1.029 . . . . 74.14 111.361 -176.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.1 p -71.98 162.63 29.17 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.568 0.747 . . . . 75.03 110.594 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 8.6 tm0? -55.23 -31.57 61.6 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.096 0.958 . . . . 71.11 110.301 178.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -62.93 -51.11 68.21 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 125.033 1.333 . . . . 72.43 110.481 177.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -71.97 -32.36 67.18 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.613 0.765 . . . . 71.14 111.361 -178.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.557 HD13 ' HB3' ' A' ' 57' ' ' LEU . 61.4 mt -70.66 -30.71 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.269 1.427 . . . . 73.31 110.116 176.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.425 ' HG2' ' HE2' ' A' ' 27' ' ' LYS . 13.7 ttmm -69.74 -44.82 69.46 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.745 0.818 . . . . 75.22 109.114 174.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 71.4 mtp180 -59.62 -42.06 91.81 Favored 'General case' 0 N--CA 1.485 1.275 0 O-C-N 123.981 0.801 . . . . 73.12 111.008 176.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.25 -39.22 75.13 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.783 0.833 . . . . 72.43 111.297 -178.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -60.44 -54.78 41.46 Favored 'General case' 0 C--O 1.216 -0.662 0 CA-C-N 114.917 -1.038 . . . . 73.1 109.361 176.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.425 ' HE2' ' HG2' ' A' ' 23' ' ' LYS . 68.4 mttm -56.75 -42.17 78.86 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.892 0.877 . . . . 74.22 110.964 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -55.7 -55.96 26.03 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.672 0.789 . . . . 75.52 110.855 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.506 ' HB3' HD11 ' A' ' 50' ' ' ILE . 95.3 mt -79.25 -15.17 58.41 Favored 'General case' 0 CA--C 1.555 1.137 0 CA-C-N 115.471 -0.786 . . . . 75.12 111.579 -176.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.66 -20.5 33.46 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.983 0.913 . . . . 71.54 110.985 175.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 28.3 mtm180 -96.55 -25.36 15.65 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.591 0.757 . . . . 72.33 110.164 172.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -69.07 -65.75 0.67 Allowed 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 107.964 -1.124 . . . . 73.31 107.964 176.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -92.89 29.91 1.71 Allowed 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.061 0.544 . . . . 72.41 110.896 -177.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 -52.71 99.91 0.22 Allowed Pre-proline 0 N--CA 1.486 1.366 0 C-N-CA 125.52 1.528 . . . . 73.54 112.365 -170.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -60.95 -17.88 54.05 Favored 'Trans proline' 0 C--N 1.384 2.415 0 C-N-CA 123.336 2.691 . . . . 75.51 113.914 -171.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -66.98 -39.17 87.12 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.447 0.699 . . . . 73.23 111.862 176.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 82.2 t -102.28 -52.09 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 123.174 0.589 . . . . 73.25 109.624 -178.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -96.71 87.51 4.36 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 124.166 0.986 . . . . 64.12 109.568 -178.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -84.39 49.19 1.63 Allowed 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 115.439 -0.8 . . . . 73.11 110.653 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 74.0 m -91.94 115.62 64.96 Favored Pre-proline 0 N--CA 1.471 0.59 0 CA-C-O 118.054 -0.974 . . . . 71.24 108.548 176.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.406 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 85.2 Cg_exo -44.77 -49.6 9.34 Favored 'Trans proline' 0 C--N 1.384 2.439 0 C-N-CA 123.756 2.971 . . . . 73.53 113.295 -176.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -54.8 -43.32 72.78 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.963 0.905 . . . . 64.43 111.312 178.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.94 -27.68 64.95 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.513 -0.767 . . . . 73.42 110.926 -177.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.443 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 50.1 mt-10 -84.0 -29.98 26.54 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.173 0.589 . . . . 63.35 110.47 -175.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.406 ' HG3' ' O ' ' A' ' 41' ' ' PRO . 44.6 mt-10 -77.54 -38.45 48.67 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.186 0.595 . . . . 62.44 109.991 177.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -66.14 -34.24 77.59 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.855 -0.611 . . . . 74.03 109.766 170.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.784 ' HA ' HD12 ' A' ' 50' ' ' ILE . 88.0 t80 -62.04 -37.22 84.11 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 122.879 0.472 . . . . 73.32 110.475 172.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' A' ' 44' ' ' GLU . 97.7 mttt -64.89 -35.12 80.13 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.723 0.409 . . . . 75.14 111.327 174.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -69.88 -29.9 67.22 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 122.421 0.288 . . . . 71.44 111.753 175.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.784 HD12 ' HA ' ' A' ' 47' ' ' PHE . 47.3 mt -70.43 -40.91 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 123.405 0.682 . . . . 74.43 109.794 173.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.418 ' HB3' ' HD1' ' A' ' 88' ' ' PHE . 3.2 m-20 -74.25 -20.15 60.26 Favored 'General case' 0 C--O 1.21 -0.99 0 C-N-CA 123.747 0.819 . . . . 73.43 110.934 176.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -74.92 -48.59 23.82 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.682 1.193 . . . . 75.34 109.564 174.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.25 -47.18 87.22 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 113.674 -1.603 . . . . 65.45 110.691 177.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 45.4 t80 -73.92 -23.6 59.56 Favored 'General case' 0 C--O 1.216 -0.661 0 CA-C-N 114.9 -1.045 . . . . 73.53 110.249 176.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.445 ' HB1' ' HD2' ' A' ' 85' ' ' PHE . . . -56.35 -50.82 70.4 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 118.357 0.526 . . . . 72.52 110.272 172.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.403 HG11 ' HZ ' ' A' ' 101' ' ' PHE . 38.3 t -64.46 -51.77 63.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 O-C-N 124.588 1.18 . . . . 74.52 110.409 177.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.557 ' HB3' HD13 ' A' ' 22' ' ' ILE . 45.1 mt -94.05 13.07 24.15 Favored 'General case' 0 CA--C 1.565 1.555 0 N-CA-C 113.095 0.776 . . . . 74.35 113.095 -166.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.1 t -66.77 -63.05 1.15 Allowed 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 123.668 0.787 . . . . 74.34 112.135 175.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.61 ' HB2' ' HD3' ' A' ' 62' ' ' LYS . 9.0 m-20 -100.64 145.53 30.49 Favored Pre-proline 0 N--CA 1.475 0.816 0 CA-C-O 118.478 -0.773 . . . . 74.34 110.046 -173.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.413 ' O ' ' HG2' ' A' ' 64' ' ' ARG . 19.8 Cg_endo -56.65 -32.25 89.96 Favored 'Trans proline' 0 C--N 1.384 2.404 0 C-N-CA 123.427 2.751 . . . . 72.41 113.294 -175.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -66.12 -47.67 73.37 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.707 0.803 . . . . 72.3 111.855 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.61 ' HD3' ' HB2' ' A' ' 59' ' ' ASP . 32.1 mtpt -74.59 -33.49 62.65 Favored 'General case' 0 C--O 1.252 1.209 0 C-N-CA 123.958 0.903 . . . . 74.54 110.641 -176.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 22.2 tpt85 -52.9 -51.39 61.35 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 113.922 -1.49 . . . . 74.11 108.827 167.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.413 ' HG2' ' O ' ' A' ' 60' ' ' PRO . 4.7 mmp_? -59.7 -38.97 83.07 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 123.802 0.689 . . . . 74.25 111.644 176.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.568 HG22 ' HD2' ' A' ' 76' ' ' PRO . 87.2 mt -54.96 -45.34 76.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 C-N-CA 122.681 0.392 . . . . 74.41 110.512 178.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.522 ' OH ' ' HA ' ' A' ' 6' ' ' ASP . 5.2 t80 -65.44 -49.22 69.96 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 120.77 -0.372 . . . . 75.4 110.813 175.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -57.8 -35.52 70.94 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.347 0.659 . . . . 64.04 112.062 -176.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 61.0 p -75.82 -32.27 59.76 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.044 0.538 . . . . 75.44 110.213 177.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -69.31 110.15 4.5 Favored 'General case' 0 C--N 1.359 0.992 0 N-CA-C 108.865 -0.791 . . . . 75.32 108.865 176.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 108.39 15.4 14.0 Favored Glycine 0 C--N 1.342 0.908 0 CA-C-N 115.905 -0.589 . . . . 64.23 112.151 -171.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 43.7 m -142.83 -57.17 0.43 Allowed 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 104.95 -2.241 . . . . 71.23 104.95 176.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.9 m -89.79 146.72 24.27 Favored 'General case' 0 C--O 1.25 1.121 0 N-CA-C 104.438 -2.43 . . . . 74.23 104.438 156.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.54 -35.56 19.45 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 109.981 -0.377 . . . . 74.04 109.981 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -84.02 131.05 52.47 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 123.85 0.86 . . . . 75.1 110.373 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -64.99 133.48 36.0 Favored 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 122.465 2.11 . . . . 75.41 110.717 173.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.568 ' HD2' HG22 ' A' ' 65' ' ' ILE . 58.7 Cg_exo -44.97 143.89 4.15 Favored 'Trans proline' 0 C--N 1.382 2.298 0 C-N-CA 124.211 3.274 . . . . 74.25 114.404 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -42.97 130.35 5.76 Favored 'Trans proline' 0 C--N 1.387 2.554 0 C-N-CA 124.115 3.21 . . . . 73.45 113.383 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -49.06 119.75 4.76 Favored 'Trans proline' 0 C--N 1.386 2.512 0 C-N-CA 123.378 2.719 . . . . 73.2 112.559 -177.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -51.91 164.15 1.17 Allowed 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 123.648 2.899 . . . . 71.05 113.785 177.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -53.18 88.29 0.03 OUTLIER 'Trans proline' 0 C--N 1.384 2.397 0 C-N-CA 123.379 2.719 . . . . 74.31 113.498 178.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 133.92 -33.53 2.52 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-N 114.541 -1.209 . . . . 62.41 110.33 177.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 139.67 -171.41 23.8 Favored Glycine 0 C--N 1.34 0.752 0 N-CA-C 109.835 -1.306 . . . . 53.03 109.835 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -67.48 105.4 1.82 Allowed 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.274 -1.01 . . . . 74.41 108.274 167.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.459 ' HB3' ' HD2' ' A' ' 62' ' ' LYS . 9.4 t70 -63.87 144.69 56.87 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 122.951 0.5 . . . . 71.31 112.186 -176.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.445 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 67.7 m-85 -139.37 71.11 1.37 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.917 0.887 . . . . 73.24 109.886 174.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.502 ' HA ' ' O ' ' A' ' 162' ' ' PRO . 51.0 m -59.99 85.36 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.244 0 CA-C-N 114.787 -1.097 . . . . 74.44 112.863 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 95.73 11.63 54.84 Favored Glycine 0 C--N 1.35 1.349 0 CA-C-N 115.646 -0.706 . . . . 70.11 113.972 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.445 ' HB2' ' HB3' ' A' ' 85' ' ' PHE . 26.7 m-85 -123.65 114.05 19.47 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 117.951 0.876 . . . . 72.34 110.575 -170.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -80.37 83.25 6.24 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-O 121.401 0.619 . . . . 71.44 110.504 -174.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.748 HG22 HD21 ' A' ' 105' ' ' LEU . 1.6 p -49.21 -42.21 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 N-CA-C 114.543 1.312 . . . . 75.21 114.543 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -66.07 -18.63 65.47 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 120.897 0.379 . . . . 75.33 111.01 -176.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -95.38 -7.24 39.05 Favored 'General case' 0 CA--C 1.559 1.298 0 C-N-CA 123.659 0.783 . . . . 61.35 111.167 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 21.6 m-30 -87.77 -172.46 3.87 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 123.491 0.716 . . . . 73.34 111.87 -177.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 86.1 p -74.78 166.68 23.22 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 113.349 0.87 . . . . 74.5 113.349 -169.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.574 ' HG2' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -61.03 -49.42 77.46 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 114.96 -1.018 . . . . 74.52 111.789 178.097 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -58.94 -40.0 83.3 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.597 0.759 . . . . 75.03 110.718 -175.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -62.63 -49.5 74.94 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.423 -1.262 . . . . 72.32 110.195 176.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.534 ' HA ' HD11 ' A' ' 105' ' ' LEU . 46.3 mt-30 -77.86 -4.37 46.34 Favored 'General case' 0 CA--C 1.552 1.038 0 CA-C-N 115.482 -0.781 . . . . 74.14 112.735 -178.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -92.54 -50.24 5.71 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.628 0.771 . . . . 70.02 109.918 172.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 26.0 tp -58.94 -54.85 42.47 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.1 0.96 . . . . 74.33 110.581 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.403 ' HZ ' HG11 ' A' ' 56' ' ' VAL . 88.5 m-85 -87.48 -1.54 58.0 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 115.801 -0.636 . . . . 72.11 111.098 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -41.28 -58.37 2.87 Favored Glycine 0 N--CA 1.482 1.74 0 N-CA-C 115.879 1.112 . . . . 72.43 115.879 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -50.35 -20.15 5.49 Favored 'Trans proline' 0 C--N 1.385 2.467 0 C-N-CA 124.318 3.346 . . . . 64.43 115.216 -177.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -141.59 31.89 2.09 Favored Glycine 0 C--N 1.355 1.632 0 CA-C-O 119.239 -0.756 . . . . 54.4 113.901 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.748 HD21 HG22 ' A' ' 90' ' ' VAL . 39.8 mt -66.68 78.19 0.11 Allowed 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 117.746 0.773 . . . . 74.25 112.028 171.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.458 ' HB2' ' HA ' ' A' ' 169' ' ' ASN . 24.5 m-85 36.5 -108.68 0.05 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.202 1.401 . . . . 74.45 114.78 177.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 59.77 16.12 37.06 Favored Glycine 0 C--N 1.36 1.916 0 N-CA-C 111.256 -0.738 . . . . 44.0 111.256 -160.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 52.61 -123.27 22.55 Favored Glycine 0 C--N 1.36 1.887 0 O-C-N 124.321 0.66 . . . . 71.34 112.612 -164.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -98.69 -1.84 39.71 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.95 0.9 . . . . 74.55 110.599 176.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.12 -30.14 26.36 Favored Glycine 0 C--N 1.346 1.127 0 CA-C-N 116.376 -0.374 . . . . 55.25 112.317 177.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 65.3 -4.0 0.58 Allowed 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 114.704 1.372 . . . . 75.52 114.704 173.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.33 -30.11 68.13 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.946 0.899 . . . . 75.13 110.918 172.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 70.1 m 78.83 68.9 0.04 OUTLIER 'General case' 0 C--N 1.354 0.763 0 C-N-CA 125.102 1.361 . . . . 74.21 111.657 177.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -133.18 161.73 33.65 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 115.464 -0.789 . . . . 74.52 109.887 177.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 43.4 tttp -63.66 145.19 56.19 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 123.902 0.881 . . . . 73.31 113.01 -165.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -85.34 -177.76 50.65 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-N 115.566 -0.743 . . . . 73.4 113.725 178.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.519 ' HD3' HD11 ' B' ' 13' ' ' LEU . 22.1 ttm180 -94.19 164.52 13.02 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.186 1.394 . . . . 74.43 110.362 176.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.419 ' N ' ' HG2' ' A' ' 117' ' ' ARG . 7.9 p-10 -82.95 124.8 30.72 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 108.221 -1.029 . . . . 74.23 108.221 164.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 10.5 tt -122.75 121.31 36.02 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.42 -1.326 . . . . 75.42 107.42 -172.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.534 ' HA ' ' HB2' ' A' ' 175' ' ' LEU . 3.7 tmt_? -92.21 110.62 22.01 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 109.001 -0.74 . . . . 74.51 109.001 -177.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -111.21 171.93 7.18 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.265 1.026 . . . . 54.41 109.564 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.46 ' HA ' ' O ' ' A' ' 177' ' ' VAL . 68.0 mt-10 -121.75 125.84 47.51 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 109.0 -0.741 . . . . 72.42 109.0 -177.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 46.2 tp -98.79 100.91 10.58 Favored Pre-proline 0 N--CA 1.471 0.614 0 N-CA-C 107.307 -1.368 . . . . 74.14 107.307 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.56 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 55.4 Cg_endo -71.37 113.45 3.62 Favored 'Trans proline' 0 C--N 1.373 1.839 0 N-CA-C 108.587 -1.351 . . . . 75.33 108.587 176.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.498 ' HB3' HD23 ' A' ' 180' ' ' LEU . 47.1 tp -122.85 134.57 54.39 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 119.021 0.828 . . . . 72.43 111.067 -171.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.541 ' HA ' HD12 ' A' ' 181' ' ' LEU . 22.8 m -64.81 134.67 54.59 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 114.275 -1.329 . . . . 71.34 110.333 176.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.574 HD13 ' HD1' ' A' ' 183' ' ' HIS . 47.3 mt -59.55 -38.46 81.13 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 122.927 0.491 . . . . 75.21 111.524 -174.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -59.17 -42.56 91.05 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.385 0.674 . . . . 75.32 109.558 177.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.559 ' HG2' ' HB3' ' B' ' 4' ' ' SER . 50.0 mm-40 -65.78 -37.36 86.1 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.926 0.89 . . . . 64.33 111.768 173.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -66.07 -30.22 70.7 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 121.088 0.47 . . . . 65.44 110.838 -177.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -78.58 -59.78 2.64 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 115.016 -0.993 . . . . 74.51 110.551 177.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 44.7 m80 -75.87 -44.55 40.12 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.33 0.652 . . . . 75.25 112.323 -167.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.422 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 85.7 -170.05 43.55 Favored Glycine 0 N--CA 1.477 1.377 0 N-CA-C 114.117 0.407 . . . . 71.54 114.117 176.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 108.16 -166.68 13.06 Favored Glycine 0 C--N 1.353 1.51 0 C-N-CA 123.077 0.37 . . . . 70.42 113.019 177.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -70.7 105.83 3.32 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 122.957 0.503 . . . . 73.14 110.598 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 3.1 tpp180 -94.26 120.12 34.04 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 109.124 -0.695 . . . . 75.05 109.124 171.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 58.1 t -84.07 115.02 25.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 N-CA-C 107.889 -1.152 . . . . 75.04 107.889 173.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.401 HG13 HG11 ' A' ' 145' ' ' VAL . 2.7 p -129.44 129.92 67.19 Favored 'Isoleucine or valine' 0 C--O 1.246 0.916 0 C-N-CA 123.593 0.757 . . . . 73.34 109.754 -177.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -92.86 144.5 25.22 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.223 1.009 . . . . 71.3 110.189 -177.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.595 ' HB ' ' HB3' ' B' ' 8' ' ' LEU . 6.6 p -162.68 105.79 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 120.933 0.397 . . . . 75.1 111.07 174.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 57.84 34.23 24.13 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.092 0.957 . . . . 74.24 111.473 178.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 95.41 -19.68 53.1 Favored Glycine 0 C--N 1.35 1.311 0 CA-C-N 115.796 -0.638 . . . . 54.15 113.29 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 18.3 tpt85 -76.26 103.26 6.2 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.878 0.871 . . . . 72.43 110.503 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -87.87 97.22 10.81 Favored 'General case' 0 C--O 1.243 0.732 0 C-N-CA 123.873 0.869 . . . . 74.41 109.386 173.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.401 HG11 HG13 ' A' ' 138' ' ' VAL . 3.6 p -102.47 125.3 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-O 121.209 0.528 . . . . 73.53 110.14 177.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 34.6 t -91.48 83.97 5.48 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 108.189 -1.041 . . . . 64.43 108.189 174.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.7 p -92.5 123.56 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 115.703 -0.681 . . . . 73.42 109.705 -176.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 24.2 ttm180 -71.52 107.31 4.35 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.158 0.504 . . . . 74.32 110.037 174.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.422 HG13 ' HA2' ' A' ' 133' ' ' GLY . 20.2 pt -76.96 126.03 86.13 Favored Pre-proline 0 CA--C 1.555 1.172 0 CA-C-N 114.9 -1.045 . . . . 74.52 109.073 170.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -64.12 132.11 32.99 Favored 'Trans proline' 0 C--N 1.37 1.706 0 C-N-CA 122.493 2.128 . . . . 74.22 112.169 176.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -56.91 109.78 0.5 Allowed 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 122.888 2.392 . . . . 74.15 111.499 172.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.427 ' HA3' ' HD2' ' A' ' 241' ' ' PRO . . . 97.2 48.78 1.98 Allowed Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.844 -0.503 . . . . 75.51 111.844 -174.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 4.5 p -96.61 137.85 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.564 0.745 . . . . 75.43 109.507 177.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.433 ' HG2' ' HA ' ' A' ' 191' ' ' GLN . 0.0 OUTLIER -116.48 168.18 10.39 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.613 0.765 . . . . 73.23 111.519 -169.528 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.524 ' HB3' ' HA ' ' A' ' 189' ' ' GLU . 15.9 tp10 -56.61 129.91 42.98 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.594 0.758 . . . . 72.32 111.165 177.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 78.08 10.96 85.83 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-N 115.548 -0.751 . . . . 74.33 114.235 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 10.7 t -75.18 129.85 38.2 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 118.015 0.908 . . . . 74.23 108.665 175.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 21.7 t -108.61 114.78 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 123.199 0.6 . . . . 74.02 110.7 -167.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.545 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 48.4 mt -93.93 92.35 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 107.212 -1.403 . . . . 75.24 107.212 169.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 31.5 ttt180 -74.2 100.39 3.67 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 109.422 -0.584 . . . . 75.21 109.422 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.2 p -126.35 99.35 30.82 Favored Pre-proline 0 CA--C 1.557 1.239 0 C-N-CA 124.129 0.972 . . . . 71.41 110.427 -176.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.546 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 65.1 Cg_exo -50.56 158.02 3.04 Favored 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 123.062 2.508 . . . . 74.53 114.186 172.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 108.96 -26.82 14.26 Favored Glycine 0 N--CA 1.48 1.571 0 N-CA-C 113.872 0.309 . . . . 70.43 113.872 169.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 63.7 mtm -118.67 -0.04 11.39 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 122.608 0.363 . . . . 64.15 110.891 -177.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -88.17 -106.9 0.99 Allowed Glycine 0 C--N 1.351 1.379 0 N-CA-C 111.025 -0.83 . . . . 73.33 111.025 175.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.501 ' HA3' ' H ' ' A' ' 117' ' ' ARG . . . -69.1 117.73 8.18 Favored Glycine 0 C--O 1.251 1.196 0 N-CA-C 111.589 -0.604 . . . . 74.5 111.589 171.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -75.17 104.78 5.88 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 109.218 -0.66 . . . . 75.42 109.218 -175.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -169.92 158.21 30.18 Favored Glycine 0 C--N 1.339 0.725 0 N-CA-C 110.826 -0.91 . . . . 64.21 110.826 -176.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . 0.512 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . 54.0 t30 -61.59 -62.82 5.15 Favored Pre-proline 0 N--CA 1.488 1.43 0 CA-C-O 117.438 -1.268 . . . . 63.54 110.619 -169.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.512 ' HD3' ' HB3' ' A' ' 169' ' ' ASN . 21.2 Cg_exo -63.1 109.32 0.92 Allowed 'Trans proline' 0 C--N 1.391 2.779 0 CA-C-N 122.487 1.924 . . . . 73.02 107.789 162.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -60.3 128.46 26.31 Favored 'Trans proline' 0 CA--C 1.55 1.301 0 C-N-CA 123.379 2.719 . . . . 71.25 113.622 -163.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -77.34 136.85 19.43 Favored Glycine 0 C--N 1.358 1.752 0 N-CA-C 111.377 -0.689 . . . . 72.4 111.377 175.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.546 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 15.1 m-20 -61.98 128.81 37.94 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.935 0.894 . . . . 71.14 112.034 -172.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 49.6 tp -102.69 107.84 18.88 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.887 -0.783 . . . . 74.2 108.887 169.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.534 ' HB2' ' HA ' ' A' ' 120' ' ' ARG . 42.7 mt -79.3 94.21 5.43 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 108.663 -0.866 . . . . 72.12 108.663 176.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.545 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 91.8 mt -74.22 82.13 1.83 Allowed 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 109.468 -0.567 . . . . 74.52 109.468 175.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 122' ' ' GLU . 11.8 t -87.87 103.7 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 N-CA-C 107.261 -1.385 . . . . 71.11 107.261 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 8.1 p -73.91 119.15 20.57 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.219 0 N-CA-C 113.39 0.885 . . . . 74.13 113.39 -165.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.56 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 20.8 mmt180 -92.71 102.23 14.64 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.195 0.998 . . . . 73.42 109.437 170.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.498 HD23 ' HB3' ' A' ' 125' ' ' LEU . 96.0 mt -72.91 136.12 45.18 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 122.052 -0.405 . . . . 74.04 110.757 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.541 HD12 ' HA ' ' A' ' 126' ' ' THR . 85.5 mt -55.71 156.25 9.57 Favored Pre-proline 0 N--CA 1.484 1.247 0 C-N-CA 124.649 1.18 . . . . 73.22 112.507 -174.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -82.47 40.72 1.0 Allowed 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 122.943 2.429 . . . . 74.32 111.515 171.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.574 ' HD1' HD13 ' A' ' 127' ' ' LEU . 51.9 t-80 -62.24 125.44 85.57 Favored Pre-proline 0 CA--C 1.551 0.997 0 N-CA-C 107.615 -1.254 . . . . 73.35 107.615 172.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 183' ' ' HIS . 23.5 Cg_exo -66.17 23.85 0.09 OUTLIER 'Trans proline' 0 N--CA 1.502 2.014 0 C-N-CA 124.239 3.292 . . . . 61.24 118.289 -162.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 58.9 t -106.3 -59.32 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 120.294 1.406 . . . . 72.34 109.809 177.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . 0.483 ' CE1' ' HB2' ' A' ' 195' ' ' ALA . 21.6 m-85 -127.14 125.6 41.47 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.92 -0.582 . . . . 72.31 111.061 -172.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . 0.423 HH22 ' HG2' ' A' ' 155' ' ' GLU . 0.0 OUTLIER -102.31 71.56 1.24 Allowed 'General case' 0 C--O 1.237 0.399 0 N-CA-C 106.452 -1.684 . . . . 75.51 106.452 171.316 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.439 ' HB2' HD22 ' A' ' 193' ' ' LEU . 7.4 tp -64.27 132.95 51.75 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 113.348 -1.751 . . . . 74.21 110.516 -176.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . 0.524 ' HA ' ' HB3' ' A' ' 155' ' ' GLU . 11.9 tp10 -138.75 123.6 18.78 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.691 1.196 . . . . 70.31 109.643 -178.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 70.73 -75.04 0.58 Allowed Glycine 0 C--N 1.354 1.545 0 O-C-N 123.491 0.495 . . . . 65.41 113.694 175.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.433 ' HA ' ' HG2' ' A' ' 154' ' ' ARG . 2.9 pm0 -145.02 -14.29 0.53 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.669 1.188 . . . . 72.32 110.792 175.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -112.57 137.23 51.1 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.274 1.43 . . . . 72.32 112.708 -165.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.467 HD23 ' HB3' ' A' ' 186' ' ' PHE . 77.3 mt -88.84 159.85 17.51 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.836 1.254 . . . . 74.25 111.003 -173.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -130.78 101.59 5.72 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 108.256 -1.016 . . . . 73.14 108.256 169.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.483 ' HB2' ' CE1' ' A' ' 186' ' ' PHE . . . -104.75 148.14 26.93 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 108.806 -0.812 . . . . 74.34 108.806 175.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 26.1 m -86.87 141.45 28.77 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 109.601 -0.518 . . . . 70.21 109.601 175.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 56.4 tp -138.88 102.33 4.53 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.15 0.58 . . . . 74.1 109.548 -173.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -79.95 125.75 30.15 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 108.968 -0.753 . . . . 63.3 108.968 173.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 5.5 p -139.81 136.78 17.68 Favored Pre-proline 0 CA--C 1.55 0.956 0 C-N-CA 124.462 1.105 . . . . 74.33 108.626 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -77.58 155.32 31.57 Favored 'Trans proline' 0 C--N 1.368 1.595 0 C-N-CA 121.714 1.609 . . . . 70.05 112.483 173.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.402 ' HB2' ' HD3' ' A' ' 202' ' ' PRO . . . -58.1 -50.24 89.18 Favored Pre-proline 0 CA--C 1.552 1.038 0 N-CA-C 113.785 1.032 . . . . 71.34 113.785 -169.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.431 ' HG2' ' CE2' ' C' ' 276' ' ' TYR . 86.1 Cg_exo -55.02 -46.64 31.72 Favored 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 121.548 1.499 . . . . 73.32 113.426 176.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.437 HD13 ' HB3' ' C' ' 276' ' ' TYR . 40.5 mt -71.75 -24.03 22.83 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.28 0 C-N-CA 122.375 0.27 . . . . 71.02 110.492 -177.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -74.7 -47.03 33.81 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.121 0.569 . . . . 74.14 111.706 175.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 90.3 t -70.91 -38.43 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 C-N-CA 123.736 0.814 . . . . 64.22 111.075 -176.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 55.3 t -89.76 -41.21 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 124.173 0.989 . . . . 74.41 111.782 -175.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 95.45 148.6 24.46 Favored Glycine 0 C--N 1.339 0.739 0 CA-C-N 115.581 -0.736 . . . . 72.35 111.339 -168.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 177.44 -142.67 5.82 Favored Glycine 0 C--N 1.333 0.399 0 N-CA-C 111.235 -0.746 . . . . 73.32 111.235 -177.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.538 ' HZ3' HG23 ' B' ' 455' ' ' THR . 37.5 mtmm -125.76 123.41 38.76 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 117.277 0.538 . . . . 73.34 110.666 179.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.453 HG13 HG21 ' A' ' 199' ' ' VAL . 22.5 m -124.02 -171.47 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 125.425 1.49 . . . . 63.11 109.207 174.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -126.6 131.9 51.4 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.336 0.654 . . . . 74.32 111.525 178.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -114.02 166.31 11.74 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.395 1.078 . . . . 74.41 109.043 167.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 27.9 ttt -111.49 145.01 39.79 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 122.757 0.423 . . . . 74.15 110.486 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 17.4 p -114.05 -171.07 1.84 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.139 0.976 . . . . 74.1 108.868 171.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 83.5 mt -80.3 -5.24 55.97 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.93 0.715 . . . . 73.14 112.93 -175.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -139.91 9.74 2.38 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 112.848 0.685 . . . . 64.44 112.848 -177.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 154.07 175.83 25.75 Favored Glycine 0 N--CA 1.472 1.046 0 CA-C-O 119.382 -0.677 . . . . 63.05 112.413 177.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -81.65 175.79 9.12 Favored 'Trans proline' 0 C--N 1.362 1.288 0 C-N-CA 122.29 1.993 . . . . 74.13 112.559 178.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 3.2 m -148.77 132.78 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.096 1.358 . . . . 73.4 108.425 178.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.493 ' HB2' ' HA2' ' B' ' 436' ' ' GLY . 6.4 mm-40 -86.72 104.45 16.13 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.418 -0.956 . . . . 75.04 108.418 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 41.1 t -99.78 134.47 39.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 123.968 0.907 . . . . 74.51 110.721 -169.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -83.08 105.24 13.9 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 122.847 0.459 . . . . 70.4 109.815 174.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.58 ' HA ' HD11 ' B' ' 441' ' ' ILE . 11.5 p -79.23 139.97 56.56 Favored Pre-proline 0 CA--C 1.563 1.469 0 C-N-CA 124.35 1.06 . . . . 71.22 109.811 -178.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -82.04 178.68 6.18 Favored 'Trans proline' 0 C--N 1.384 2.426 0 C-N-CA 123.094 2.529 . . . . 75.51 111.806 -175.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -80.8 150.99 18.8 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 121.6 1.533 . . . . 72.53 112.387 171.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . 0.512 HH21 ' HB2' ' C' ' 261' ' ' LEU . 79.1 mtt85 67.01 25.15 9.34 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 125.159 1.383 . . . . 75.13 112.45 175.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.442 HG22 HD23 ' A' ' 233' ' ' LEU . 37.7 m -61.52 117.11 5.3 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 124.7 1.2 . . . . 64.32 110.466 175.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . 0.569 ' HG2' HH12 ' B' ' 221' ' ' ARG . 6.3 tp-100 -110.33 139.7 45.27 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.978 0.911 . . . . 75.32 112.161 -167.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -64.57 133.79 53.05 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.459 1.104 . . . . 65.12 111.772 -177.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . 0.502 ' HA3' HH12 ' C' ' 254' ' ' ARG . . . 93.19 -24.63 24.13 Favored Glycine 0 C--N 1.341 0.836 0 CA-C-N 115.85 -0.614 . . . . 75.54 112.803 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 67.6 mtt180 -72.32 147.28 46.49 Favored 'General case' 0 C--N 1.347 0.478 0 CA-C-O 121.41 0.624 . . . . 74.44 109.744 171.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.749 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 2.9 mptp? -106.29 119.34 39.0 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.254 -1.387 . . . . 72.22 107.254 174.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.499 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 70.6 mt -74.38 100.21 3.73 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.32 -0.993 . . . . 71.4 108.32 -177.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 66.1 ttt180 -76.6 104.61 7.19 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 124.07 0.856 . . . . 73.41 110.564 -172.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.631 HD23 HG23 ' B' ' 441' ' ' ILE . 49.2 mt -103.11 96.56 6.87 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.542 0.737 . . . . 74.24 110.694 -178.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 23.8 mtpp -74.52 138.26 43.01 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 122.707 0.403 . . . . 71.01 111.231 -177.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 82.81 16.73 69.55 Favored Glycine 0 C--N 1.346 1.086 0 CA-C-N 115.603 -0.726 . . . . 74.2 112.876 -174.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.627 ' HA ' ' HZ2' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -121.05 -17.73 7.7 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.276 0.63 . . . . 74.1 112.572 -174.256 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -78.69 -167.42 32.2 Favored Glycine 0 C--N 1.339 0.722 0 N-CA-C 111.904 -0.478 . . . . 74.43 111.904 171.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -86.01 151.4 54.54 Favored Pre-proline 0 CA--C 1.557 1.239 0 CA-C-O 118.895 -0.574 . . . . 73.41 109.509 -172.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.427 ' HD2' ' HA3' ' A' ' 152' ' ' GLY . 29.7 Cg_exo -38.91 107.92 0.07 OUTLIER 'Trans proline' 0 C--N 1.389 2.673 0 C-N-CA 124.675 3.583 . . . . 73.33 115.52 -179.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -133.92 -158.15 8.5 Favored Glycine 0 C--N 1.35 1.354 0 CA-C-O 119.255 -0.747 . . . . 73.52 112.33 -176.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -59.8 -39.65 70.69 Favored 'Trans proline' 0 C--N 1.383 2.357 0 C-N-CA 123.695 2.93 . . . . 72.5 113.595 -174.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -89.25 21.62 3.19 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.417 0.687 . . . . 70.11 111.567 -176.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 97.29 -74.44 0.67 Allowed Glycine 0 C--N 1.346 1.121 0 N-CA-C 109.794 -1.322 . . . . 62.24 109.794 -173.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 17.1 mtp180 -122.55 157.91 31.04 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.124 0.97 . . . . 75.41 108.675 168.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -79.43 -158.54 14.52 Favored Glycine 0 C--N 1.344 0.995 0 O-C-N 123.315 0.384 . . . . 70.31 113.486 176.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -104.44 172.32 6.86 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.142 0.577 . . . . 75.44 110.019 -177.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.575 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 32.5 tp -136.65 97.5 3.56 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 107.831 -1.174 . . . . 73.32 107.831 175.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.749 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 62.2 m-85 -79.45 108.57 13.07 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.266 1.026 . . . . 71.3 110.091 178.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.499 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 88.6 mt -93.42 108.31 20.0 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 122.91 0.484 . . . . 74.54 110.061 176.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.535 ' HG2' ' HG3' ' A' ' 232' ' ' LYS . 35.5 mt-10 -77.67 102.64 7.17 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.531 1.132 . . . . 75.41 109.708 -172.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 42.9 t -67.93 126.07 26.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 115.008 -0.997 . . . . 71.34 111.619 -172.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -124.2 92.25 3.63 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 107.275 -1.38 . . . . 73.14 107.275 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.477 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 63.5 mt -82.79 127.69 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 122.815 0.446 . . . . 74.34 111.41 -173.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 69.1 p -111.07 154.68 23.89 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.291 1.036 . . . . 74.52 109.675 175.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . 0.437 HD13 ' H ' ' A' ' 259' ' ' GLU . 2.5 pp -103.06 150.08 37.5 Favored Pre-proline 0 CA--C 1.558 1.263 0 C-N-CA 123.069 0.548 . . . . 73.4 109.653 175.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -51.7 -21.98 12.33 Favored 'Trans proline' 0 N--CA 1.509 2.394 0 C-N-CA 124.519 3.48 . . . . 74.45 115.133 -170.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.682 ' HG2' HE21 ' C' ' 228' ' ' GLN . 29.3 mt-10 52.17 -78.46 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.991 1.317 . . . . 75.12 111.548 -167.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.9 132.19 46.88 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.566 0.746 . . . . 75.12 111.332 176.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.562 HD23 ' HB2' ' A' ' 265' ' ' GLU . 96.2 mt -143.44 150.54 39.17 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.312 1.045 . . . . 72.32 109.723 176.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 20.9 p -118.64 156.69 51.23 Favored Pre-proline 0 CA--C 1.555 1.167 0 CA-C-O 117.774 -1.108 . . . . 74.31 109.204 170.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -21.12 -50.2 0.03 OUTLIER 'Trans proline' 0 C--N 1.401 3.322 1 C-N-CA 126.871 5.047 . . . . 74.33 117.433 -172.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -56.56 -69.44 0.15 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.314 0.646 . . . . 71.44 111.289 178.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . 0.562 ' HB2' HD23 ' A' ' 261' ' ' LEU . 2.1 mp0 -71.32 -28.75 64.32 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.601 0.36 . . . . 73.22 110.062 -172.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' GLU . . . . . 0.406 ' HA ' HD11 ' A' ' 261' ' ' LEU . 18.8 tp10 -55.86 -60.97 2.7 Favored 'General case' 0 C--O 1.255 1.345 0 C-N-CA 124.22 1.008 . . . . 73.45 110.467 175.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -60.58 -38.01 83.22 Favored 'General case' 0 C--O 1.22 -0.472 0 CA-C-N 114.38 -1.282 . . . . 64.12 110.675 178.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . 0.467 HD23 ' HB2' ' C' ' 271' ' ' LYS . 11.8 tp -65.26 -40.1 93.52 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.106 0.962 . . . . 73.14 111.026 -174.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 44.4 m95 -69.41 -37.84 77.65 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.582 -0.736 . . . . 75.0 110.609 176.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . 0.663 ' HE2' ' HA ' ' C' ' 206' ' ' VAL . 1.1 mptm? -67.02 -39.47 87.05 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 123.473 0.483 . . . . 73.12 111.632 176.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -62.33 -48.83 78.07 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.089 0.556 . . . . 70.22 109.884 177.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 18.5 mt -54.36 -51.46 64.72 Favored 'General case' 0 C--O 1.203 -1.371 0 O-C-N 124.55 1.156 . . . . 71.54 110.446 173.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . 0.65 ' HA ' ' HB2' ' C' ' 202' ' ' PRO . . . -67.33 -39.95 85.89 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.697 0.999 . . . . 72.23 113.697 -168.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.468 ' HB3' HE21 ' B' ' 250' ' ' GLN . 41.6 mt-10 -86.86 -33.15 19.9 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.589 0.756 . . . . 74.35 110.996 -173.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -71.22 -33.21 69.69 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 109.916 -0.401 . . . . 72.24 109.916 169.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -67.35 -41.54 85.0 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.946 0.898 . . . . 75.02 109.453 174.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -62.62 -43.39 98.94 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 124.105 0.878 . . . . 72.14 108.783 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -66.55 -7.88 23.04 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-N 115.199 -0.909 . . . . 75.41 112.647 175.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 73.7 mmt-85 -127.79 13.95 6.91 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 123.885 0.874 . . . . 75.15 111.127 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.658 0 C-N-CA 122.847 0.459 . . . . 72.5 111.309 -173.864 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.0 ttt . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 109.577 -0.527 . . . . 74.12 109.577 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -101.06 -178.05 3.63 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.533 0.733 . . . . 62.45 111.038 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -59.85 103.17 0.19 Allowed 'General case' 0 C--N 1.354 0.777 0 C-N-CA 123.379 0.672 . . . . 74.04 109.375 176.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' SER . . . . . 0.559 ' HB3' ' HG2' ' A' ' 129' ' ' GLU . 50.5 m -83.5 27.25 0.61 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.443 1.097 . . . . 52.14 112.163 -173.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 6.4 m -123.06 145.95 48.1 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 109.011 -0.737 . . . . 74.34 109.011 177.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 29.4 pt -140.18 177.76 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 C-N-CA 123.356 0.662 . . . . 65.34 111.75 -158.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -147.03 127.28 13.86 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.847 0.859 . . . . 72.22 110.053 178.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . 0.595 ' HB3' ' HB ' ' A' ' 140' ' ' VAL . 19.3 tp -65.48 148.85 51.02 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.797 1.239 . . . . 75.22 112.196 -171.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.35 -49.56 33.27 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.522 0.729 . . . . 73.12 111.886 177.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 4.2 tt 60.48 102.6 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 124.594 1.158 . . . . 74.1 110.151 -173.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.41 ' HB2' ' O ' ' A' ' 120' ' ' ARG . 74.8 mt -121.93 122.32 27.75 Favored Pre-proline 0 N--CA 1.481 1.086 0 CA-C-O 118.24 -0.886 . . . . 72.11 109.738 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -37.53 -58.8 0.57 Allowed 'Trans proline' 0 C--N 1.387 2.56 0 C-N-CA 125.268 3.979 . . . . 71.41 114.728 -173.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . 0.519 HD11 ' HD3' ' A' ' 117' ' ' ARG . 2.2 pt? -177.44 121.34 0.12 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.853 0.861 . . . . 75.11 109.464 172.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -160.69 137.41 8.83 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.122 0.969 . . . . 64.54 109.905 177.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 34.0 p90 30.91 86.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 126.843 2.057 . . . . 74.01 114.623 -176.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 81.3 m -70.07 123.06 88.04 Favored Pre-proline 0 CA--C 1.554 1.105 0 CA-C-N 115.272 -0.876 . . . . 71.11 110.629 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -60.15 137.72 77.07 Favored 'Trans proline' 0 C--N 1.372 1.79 0 C-N-CA 123.201 2.601 . . . . 71.22 112.689 177.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 48.2 t -120.74 -44.66 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 123.422 0.689 . . . . 63.3 110.91 -175.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 46.3 p -70.79 116.0 10.59 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-O 121.004 0.431 . . . . 71.22 111.196 -176.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -79.53 -14.13 59.08 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.799 0.839 . . . . 74.33 110.758 177.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 63.44 68.72 0.59 Allowed 'General case' 0 C--N 1.358 0.968 0 C-N-CA 125.114 1.366 . . . . 75.34 110.967 176.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -91.91 165.53 13.18 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.15 -0.932 . . . . 73.31 109.438 176.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' THR . . . . . . . . . . . . . 48.4 m -66.6 116.8 38.14 Favored Pre-proline 0 CA--C 1.554 1.128 0 C-N-CA 123.036 0.534 . . . . 72.54 111.024 -178.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -90.12 -170.28 0.4 Allowed 'Trans proline' 0 C--N 1.373 1.818 0 C-N-CA 122.772 2.315 . . . . 74.55 111.935 176.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -78.3 154.52 30.83 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 109.395 -0.594 . . . . 74.53 109.395 175.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 61.3 mtt -111.77 98.07 39.97 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 123.229 0.612 . . . . 75.13 109.382 178.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -64.11 154.16 72.13 Favored 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 123.172 2.582 . . . . 73.04 112.796 176.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 14.0 p -65.7 -36.78 78.39 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 C-N-CA 122.756 0.422 . . . . 75.25 109.868 174.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . 0.413 HD23 ' HB2' ' B' ' 32' ' ' ARG . 2.8 tt 59.53 -77.75 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 126.413 1.885 . . . . 73.34 111.726 170.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.462 ' HG2' ' HD2' ' B' ' 337' ' ' LYS . 42.3 mt-10 68.24 78.82 0.22 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.824 1.65 . . . . 71.25 112.39 178.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' ASN . . . . . 0.675 ' HB3' ' HA ' ' B' ' 34' ' ' ALA . 6.1 m120 55.88 97.66 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 125.656 1.582 . . . . 74.34 113.35 176.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' ARG . . . . . 0.421 ' NH2' ' HB3' ' B' ' 215' ' ' GLU . 33.6 ttt180 -64.98 99.14 0.33 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.466 1.106 . . . . 72.22 110.355 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . 0.583 ' HA ' ' HA2' ' B' ' 211' ' ' GLY . . . 64.25 13.11 7.69 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 125.073 1.349 . . . . 73.31 111.995 -175.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . 0.675 ' HA ' ' HB3' ' B' ' 31' ' ' ASN . . . 58.68 -77.18 0.02 OUTLIER 'General case' 0 C--N 1.36 1.043 0 C-N-CA 125.576 1.55 . . . . 53.33 111.698 -168.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . 0.466 HE22 ' HB3' ' A' ' 226' ' ' ARG . 18.0 pt20 -164.44 -46.5 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.152 0.981 . . . . 73.13 109.082 -178.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 138.04 -179.81 17.89 Favored Glycine 0 C--N 1.346 1.121 0 N-CA-C 110.977 -0.849 . . . . 74.33 110.977 -171.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -164.81 157.83 16.82 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.081 0.553 . . . . 61.44 110.668 -175.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . 0.527 HG12 ' HB2' ' C' ' 259' ' ' GLU . 36.6 mm -118.81 15.4 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 C-N-CA 123.803 0.841 . . . . 75.44 110.814 -175.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 29.8 p -120.55 -77.55 0.58 Allowed 'General case' 0 N--CA 1.484 1.254 0 O-C-N 120.719 -1.238 . . . . 73.32 109.9 171.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.419 ' HB2' ' HD3' ' B' ' 41' ' ' PRO . . . -176.97 -57.75 0.0 OUTLIER Pre-proline 0 CA--C 1.555 1.147 0 C-N-CA 124.725 1.21 . . . . 73.24 110.762 177.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . 0.419 ' HD3' ' HB2' ' B' ' 40' ' ' ALA . 25.4 Cg_endo -89.25 -17.64 1.87 Allowed 'Trans proline' 0 C--N 1.391 2.776 0 C-N-CA 121.714 1.609 . . . . 72.44 113.852 -172.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 130.89 -38.8 1.88 Allowed Glycine 0 C--N 1.342 0.917 0 N-CA-C 110.491 -1.044 . . . . 61.22 110.491 -167.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.42 -175.54 53.57 Favored Glycine 0 C--N 1.342 0.866 0 N-CA-C 112.174 -0.37 . . . . 64.32 112.174 -177.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . 0.411 ' HB2' ' HA ' ' C' ' 262' ' ' THR . . . -83.52 65.17 8.28 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.11 0.564 . . . . 63.2 110.953 -173.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -73.73 -4.99 37.86 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.357 0.663 . . . . 74.21 112.726 -172.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' ARG . . . . . 0.461 HH11 ' N ' ' B' ' 46' ' ' ARG . 0.0 OUTLIER -130.18 -179.1 5.04 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.086 0.954 . . . . 75.02 108.605 174.319 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -131.9 175.69 9.0 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.844 0.458 . . . . 72.13 111.199 -177.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 4.4 m -74.37 -28.99 61.36 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.106 -0.952 . . . . 73.12 111.033 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . 0.434 ' HA3' ' HB3' ' B' ' 267' ' ' SER . . . 65.76 -103.48 0.84 Allowed Glycine 0 C--N 1.349 1.295 0 CA-C-N 115.537 -0.756 . . . . 74.15 111.861 -176.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -167.98 -78.05 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.77 0.428 . . . . 64.2 110.317 173.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 8.3 tp60 -121.16 -49.69 2.17 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.224 0.61 . . . . 75.3 110.844 -174.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' THR . . . . . 0.451 ' HA ' ' HB3' ' B' ' 287' ' ' PRO . 14.3 t -143.51 170.08 16.5 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.068 0.461 . . . . 73.31 111.591 -176.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -101.28 110.22 22.2 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.973 0.909 . . . . 73.24 109.527 178.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.2 158.02 32.07 Favored 'General case' 0 C--O 1.245 0.847 0 C-N-CA 123.452 0.701 . . . . 75.51 111.161 177.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . 0.55 HD11 ' HB2' ' B' ' 113' ' ' LYS . 24.7 tp -102.88 31.61 4.1 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.813 1.245 . . . . 72.35 108.381 -179.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . 0.714 HH21 ' HA ' ' B' ' 464' ' ' MET . 25.7 ttm180 67.6 164.1 0.21 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.724 1.21 . . . . 74.21 108.561 -155.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . 0.492 ' N ' ' HG2' ' B' ' 56' ' ' ARG . 3.9 m-20 -65.1 89.58 0.08 Allowed 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 124.061 0.945 . . . . 75.31 111.542 -177.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' SER . . . . . 0.647 ' HA ' ' HB2' ' B' ' 313' ' ' GLN . 19.3 m -82.57 -52.7 6.58 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.971 0.908 . . . . 62.01 111.311 -174.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . 0.427 ' HB3' HG21 ' B' ' 306' ' ' VAL . 62.2 tp -75.42 -33.58 60.95 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.988 -0.551 . . . . 72.44 109.987 176.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 22.0 m 58.6 -152.17 0.41 Allowed 'General case' 0 CA--C 1.557 1.25 0 C-N-CA 124.199 1.0 . . . . 71.31 111.201 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -84.19 -68.67 0.7 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.534 0.734 . . . . 71.45 109.134 168.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' LYS . . . . . . . . . . . . . 8.1 mtmp? -124.8 105.4 29.77 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 124.247 1.019 . . . . 72.42 108.314 174.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.25 159.12 54.15 Favored 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 122.742 2.295 . . . . 72.24 111.25 177.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.11 -154.27 0.37 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.537 0.735 . . . . 72.04 110.437 -174.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 42.4 mttp 63.99 92.05 0.07 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 124.132 0.973 . . . . 73.42 110.731 172.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 50.3 t30 72.9 -55.84 0.67 Allowed 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 124.906 1.282 . . . . 72.41 109.583 -170.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . 0.486 HG21 HD13 ' B' ' 68' ' ' ILE . 23.6 mm -58.81 141.13 16.19 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.105 0 C-N-CA 124.558 1.143 . . . . 74.04 109.067 168.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . 0.486 HD13 HG21 ' B' ' 67' ' ' ILE . 2.2 mp 69.51 132.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 C-N-CA 124.513 1.125 . . . . 73.4 108.587 -163.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.432 ' HB3' ' O ' ' B' ' 96' ' ' GLY . 68.3 mt 66.37 9.75 6.69 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 125.284 1.434 . . . . 74.34 111.86 -169.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 7.1 tt -83.15 -44.34 15.18 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 109.482 -0.562 . . . . 65.22 109.482 -176.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 47.1 mm 65.14 -77.12 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.067 0 C-N-CA 124.824 1.25 . . . . 75.5 109.893 -174.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 64.46 31.92 82.49 Favored Glycine 0 C--N 1.355 1.613 0 C-N-CA 122.949 0.309 . . . . 71.15 113.65 177.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -96.32 161.2 14.04 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.532 0.733 . . . . 74.12 110.127 -176.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -70.73 -12.83 71.14 Favored Glycine 0 C--N 1.347 1.174 0 CA-C-N 116.086 -0.506 . . . . 72.45 113.039 176.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 45.0 mtm 65.41 16.82 10.72 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 125.232 1.413 . . . . 74.01 112.126 173.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 66.7 62.74 4.33 Favored Glycine 0 C--N 1.343 0.961 0 CA-C-N 115.961 -0.563 . . . . 71.52 112.89 -178.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 9.3 t70 68.81 -82.04 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.352 1.061 . . . . 74.35 110.811 175.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 78' ' ' SER . . . . . 0.407 ' H ' ' HE1' ' B' ' 424' ' ' TYR . 12.0 t 56.29 50.45 13.3 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 125.089 1.356 . . . . 55.34 112.241 176.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . 0.429 ' HG3' ' HH ' ' B' ' 424' ' ' TYR . 0.0 OUTLIER -67.34 -3.55 8.46 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 123.693 0.797 . . . . 74.44 113.122 178.496 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 38.8 mm -44.21 -42.66 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 125.509 1.524 . . . . 72.52 111.581 177.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 35.6 m -131.68 94.17 3.47 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-N 115.377 -0.829 . . . . 74.52 109.032 172.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.43 84.16 2.53 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 115.493 -0.776 . . . . 75.12 108.996 172.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.54 84.9 0.61 Allowed 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.254 -0.885 . . . . 74.13 109.556 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 65.0 -75.25 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.531 1.532 . . . . 73.0 109.967 -168.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -133.36 -55.43 0.91 Allowed 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 106.806 -1.553 . . . . 72.23 106.806 170.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -159.44 108.25 1.83 Allowed 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.438 1.495 . . . . 74.21 107.285 174.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -131.98 -75.27 0.51 Allowed 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 108.594 -0.891 . . . . 52.24 108.594 178.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -73.95 141.47 45.93 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 108.719 -0.845 . . . . 74.14 108.719 172.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . 0.533 ' HA3' ' HB2' ' B' ' 93' ' ' PHE . . . -89.72 45.91 3.1 Favored Glycine 0 C--N 1.342 0.905 0 CA-C-O 119.4 -0.666 . . . . 54.33 114.005 -171.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . 47.24 -87.13 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 125.69 1.596 . . . . 75.53 113.088 172.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -133.22 -31.96 0.41 Allowed Glycine 0 C--N 1.348 1.211 0 N-CA-C 111.337 -0.705 . . . . 70.11 111.337 175.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -63.45 -29.16 73.75 Favored Glycine 0 C--N 1.35 1.343 0 N-CA-C 114.421 0.528 . . . . 73.42 114.421 -174.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . 0.533 ' HB2' ' HA3' ' B' ' 89' ' ' GLY . 93.5 t80 -61.97 -37.66 85.61 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.543 0.737 . . . . 74.22 111.351 177.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -70.84 -13.42 62.03 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.373 -0.831 . . . . 72.14 112.169 -174.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . 0.486 ' HG3' HD11 ' B' ' 100' ' ' LEU . 0.8 OUTLIER -75.12 -29.88 60.67 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.77 0.828 . . . . 74.44 110.13 174.539 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 96' ' ' GLY . . . . . 0.432 ' O ' ' HB3' ' B' ' 69' ' ' LEU . . . -75.82 -7.81 84.01 Favored Glycine 0 C--N 1.35 1.314 0 CA-C-N 115.507 -0.769 . . . . 75.21 113.848 177.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 71.1 mt -64.77 -56.27 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 117.302 0.551 . . . . 73.0 110.31 176.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -87.9 -84.96 0.19 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.012 0.525 . . . . 75.21 110.511 -178.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . 168.07 -37.07 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.701 1.2 . . . . 61.12 110.106 -172.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . 0.486 HD11 ' HG3' ' B' ' 95' ' ' LYS . 83.2 mt 54.6 59.22 11.35 Favored Pre-proline 0 N--CA 1.483 1.198 0 C-N-CA 124.825 1.25 . . . . 74.2 109.911 -167.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 101' ' ' PRO . . . . . 0.574 ' HA ' ' HB2' ' B' ' 105' ' ' GLN . 77.6 Cg_endo -85.24 139.14 6.91 Favored 'Trans proline' 0 C--N 1.369 1.632 0 C-N-CA 122.01 1.807 . . . . 74.43 114.138 -164.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 6.6 tt -68.04 -69.06 0.34 Allowed 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 106.809 -1.552 . . . . 73.12 106.809 167.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 88.2 m -159.46 99.35 1.45 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.598 1.159 . . . . 75.52 107.937 173.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 60.65 59.03 10.94 Favored Glycine 0 C--N 1.353 1.486 0 N-CA-C 111.521 -0.631 . . . . 51.35 111.521 -173.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 105' ' ' GLN . . . . . 0.574 ' HB2' ' HA ' ' B' ' 101' ' ' PRO . 55.0 tp60 -58.19 -27.01 63.47 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.776 0.831 . . . . 75.22 112.776 -170.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -56.97 -31.2 64.79 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 125.04 1.336 . . . . 74.44 112.471 -176.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 7.3 m -129.18 4.03 5.24 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.579 0.752 . . . . 75.34 110.857 -179.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 27.9 t60 -74.02 81.93 1.73 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.219 0.608 . . . . 73.44 111.146 -173.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 72.56 -43.54 0.57 Allowed 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 126.213 1.805 . . . . 74.1 112.692 -177.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . 0.583 ' HB1' ' HB3' ' B' ' 317' ' ' SER . . . -76.53 75.51 3.25 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.536 1.135 . . . . 75.22 111.398 -178.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 46.4 tp -173.4 -81.71 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 107.229 -1.397 . . . . 70.25 107.229 174.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -81.75 130.61 35.12 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 109.139 -0.689 . . . . 73.2 109.139 176.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 113' ' ' LYS . . . . . 0.55 ' HB2' HD11 ' B' ' 55' ' ' LEU . 44.3 mttm -93.97 85.02 4.63 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 122.917 0.487 . . . . 75.13 111.011 -170.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 4.5 tmtt? 69.76 -76.98 0.06 Allowed 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 125.85 1.66 . . . . 74.21 112.026 171.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 115' ' ' THR . . . . . 0.662 HG23 ' HB3' ' B' ' 300' ' ' ASN . 54.0 m 71.51 92.19 0.09 Allowed 'General case' 0 C--N 1.361 1.085 0 C-N-CA 125.329 1.452 . . . . 73.23 111.459 -176.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 163.57 -174.92 39.83 Favored Glycine 0 C--N 1.353 1.509 0 N-CA-C 114.375 0.51 . . . . 55.33 114.375 174.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp 57.3 81.5 0.25 Allowed Pre-proline 0 N--CA 1.488 1.439 0 C-N-CA 125.775 1.63 . . . . 75.35 111.949 -178.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 118' ' ' PRO . . . . . 0.465 ' HG3' ' HG3' ' B' ' 294' ' ' LYS . 55.6 Cg_endo -86.16 83.2 1.29 Allowed 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 123.399 2.733 . . . . 63.21 111.927 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 119' ' ' ASP . . . . . 0.474 ' HB2' ' NH2' ' B' ' 289' ' ' ARG . 5.6 m-20 -67.3 127.23 31.88 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.636 -0.711 . . . . 75.33 110.65 -174.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 120' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -68.11 150.38 48.46 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.971 0.908 . . . . 70.1 112.363 178.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 121' ' ' VAL . . . . . 0.435 HG12 HD13 ' B' ' 265' ' ' LEU . 30.2 m -110.85 15.38 8.28 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 CA-C-N 114.714 -1.13 . . . . 74.32 110.782 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 11.1 p -105.85 5.86 31.08 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.389 1.076 . . . . 75.25 112.123 -173.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -91.49 -178.78 5.2 Favored 'General case' 0 CA--C 1.561 1.374 0 C-N-CA 123.955 0.902 . . . . 70.53 110.316 -178.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 124' ' ' SER . . . . . 0.667 ' HB2' ' HB3' ' B' ' 207' ' ' LYS . 23.0 t -58.81 124.98 21.63 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.132 0.973 . . . . 61.03 112.538 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . 0.447 ' HA ' ' HG2' ' B' ' 342' ' ' GLN . . . -62.64 137.69 58.32 Favored 'General case' 0 C--N 1.352 0.692 0 C-N-CA 123.512 0.725 . . . . 74.53 110.208 172.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . 0.583 ' HA ' ' HA3' ' B' ' 211' ' ' GLY . . . -75.37 -67.8 0.62 Allowed 'General case' 0 N--CA 1.471 0.615 0 O-C-N 123.051 0.219 . . . . 74.13 111.091 -176.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 19.8 m 61.68 -167.64 0.2 Allowed 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 124.223 1.009 . . . . 70.01 112.489 176.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -146.85 138.09 24.13 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.41 0.684 . . . . 74.33 109.794 169.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 27.7 p -134.37 145.8 49.31 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.402 1.081 . . . . 74.41 108.961 178.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 130' ' ' ALA . . . . . 0.595 ' HB2' ' HZ2' ' B' ' 136' ' ' LYS . . . 63.19 82.95 0.17 Allowed 'General case' 0 C--O 1.243 0.76 0 C-N-CA 124.48 1.112 . . . . 61.42 113.578 171.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 24.1 m-90 -75.38 141.24 43.3 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 115.147 -0.933 . . . . 73.51 109.061 172.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 22.7 m -90.8 31.62 1.05 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.669 0.788 . . . . 74.11 111.741 -173.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 81.4 m -58.55 -49.33 77.8 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.64 1.176 . . . . 74.52 111.981 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . -138.77 72.22 0.43 Allowed Glycine 0 C--N 1.34 0.783 0 CA-C-N 115.434 -0.803 . . . . 55.15 112.266 -174.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 135' ' ' VAL . . . . . . . . . . . . . 10.0 m 51.02 -168.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 C-N-CA 125.867 1.667 . . . . 73.24 113.358 176.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 136' ' ' LYS . . . . . 0.595 ' HZ2' ' HB2' ' B' ' 130' ' ' ALA . 75.0 mmtt -127.47 -155.92 0.72 Allowed 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 108.77 -0.826 . . . . 74.24 108.77 176.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 23.3 m 82.61 -40.65 0.11 Allowed 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 125.421 1.488 . . . . 75.31 113.447 173.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -84.93 43.76 1.02 Allowed 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.549 0.74 . . . . 75.52 112.688 -171.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . 0.507 ' HB3' ' HA ' ' B' ' 164' ' ' ALA . 37.9 p30 -75.68 -5.67 46.73 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.266 0.626 . . . . 73.24 112.319 178.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -83.64 2.15 87.74 Favored Glycine 0 C--N 1.345 1.063 0 CA-C-O 120.172 -0.238 . . . . 75.54 113.202 173.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -85.41 133.87 34.1 Favored 'General case' 0 C--N 1.349 0.567 0 C-N-CA 123.156 0.582 . . . . 75.34 110.432 176.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 6.4 mp -72.96 147.89 44.78 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 108.722 -0.844 . . . . 74.24 108.722 172.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 128.4 -140.56 11.86 Favored Glycine 0 C--N 1.34 0.788 0 N-CA-C 111.151 -0.78 . . . . 61.25 111.151 -177.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 84.6 t 76.32 -39.0 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 C-N-CA 124.985 1.314 . . . . 75.31 112.55 177.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 22.0 t70 66.09 -83.48 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.389 1.476 . . . . 75.32 109.865 -171.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 8.0 tp 45.25 23.61 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 C-N-CA 126.452 1.901 . . . . 72.52 112.959 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 26.8 t-80 -75.28 -30.96 60.57 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.65 -0.704 . . . . 72.43 110.301 -175.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . 0.408 ' HB3' ' HG2' ' B' ' 152' ' ' PRO . 0.8 OUTLIER 70.56 -72.82 0.1 Allowed 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 125.477 1.511 . . . . 75.05 109.87 169.691 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 149' ' ' LYS . . . . . 0.617 ' HE2' ' HA ' ' B' ' 260' ' ' SER . 63.7 mttp -132.82 -63.19 0.79 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.528 0.731 . . . . 74.13 110.428 172.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -159.71 -66.73 0.08 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.812 0.445 . . . . 74.11 110.43 -170.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 -71.69 -37.88 5.73 Favored Pre-proline 0 CA--C 1.561 1.375 0 CA-C-O 117.767 -1.111 . . . . 74.43 113.886 -174.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 152' ' ' PRO . . . . . 0.408 ' HG2' ' HB3' ' B' ' 148' ' ' GLU . 76.0 Cg_exo -53.79 111.44 0.69 Allowed 'Trans proline' 0 C--N 1.385 2.462 0 C-N-CA 121.814 1.676 . . . . 64.13 112.788 172.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 46.2 m -101.8 151.7 21.75 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.603 1.161 . . . . 74.2 110.295 -175.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 14.6 tt -82.94 115.29 25.17 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 CA-C-O 121.028 0.442 . . . . 74.25 110.106 176.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 155' ' ' LEU . . . . . 0.652 ' HB2' ' HB1' ' B' ' 158' ' ' ALA . 5.4 mp -116.43 138.92 50.98 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 108.627 -0.879 . . . . 73.12 108.627 173.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -71.85 -19.86 61.9 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.467 0.707 . . . . 72.23 112.785 -172.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 157' ' ' MET . . . . . 0.497 ' HA ' ' HA ' ' B' ' 161' ' ' ALA . 95.0 mmm -118.72 11.75 12.83 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-O 119.09 -0.481 . . . . 61.13 111.61 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 158' ' ' ALA . . . . . 0.652 ' HB1' ' HB2' ' B' ' 155' ' ' LEU . . . -53.94 95.53 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.829 0.852 . . . . 65.11 112.551 -174.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 94.5 mttt 65.54 -76.13 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 125.635 1.574 . . . . 73.24 112.059 175.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -105.95 23.33 14.14 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.633 0.773 . . . . 74.34 110.532 177.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . 0.497 ' HA ' ' HA ' ' B' ' 157' ' ' MET . . . 82.74 24.07 0.17 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 126.023 1.729 . . . . 71.1 112.806 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 76.95 -68.15 2.61 Favored Glycine 0 C--N 1.353 1.522 0 CA-C-N 116.224 -0.444 . . . . 73.4 113.061 170.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . 0.57 ' HA ' ' HA ' ' B' ' 130' ' ' ALA . 0.2 OUTLIER -141.98 -40.18 0.36 Allowed 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 107.35 -1.352 . . . . 75.25 107.35 171.537 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 164' ' ' ALA . . . . . 0.509 ' HB2' ' HD2' ' B' ' 136' ' ' LYS . . . 71.24 0.84 3.59 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.453 1.501 . . . . 75.34 112.997 175.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 15.3 t -152.87 169.0 23.91 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 123.406 0.683 . . . . 73.14 109.985 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . -178.08 -49.94 0.07 OUTLIER Glycine 0 C--N 1.339 0.747 0 N-CA-C 109.846 -1.302 . . . . 74.53 109.846 -178.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 167' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -75.58 150.48 38.05 Favored 'General case' 0 C--O 1.245 0.816 0 N-CA-C 108.424 -0.954 . . . . 74.33 108.424 170.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . 0.478 HG23 ' HB2' ' B' ' 175' ' ' ASP . 97.0 t 64.23 -87.24 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 C-N-CA 123.809 0.844 . . . . 75.53 108.82 -170.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 58.3 p 44.13 -90.51 0.01 OUTLIER 'General case' 0 CA--C 1.565 1.525 0 C-N-CA 125.311 1.445 . . . . 65.53 114.046 -177.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 28.6 m -82.9 87.33 6.84 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 109.189 -0.671 . . . . 73.13 109.189 -177.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . 60.91 -160.88 0.3 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.615 1.166 . . . . 73.41 109.762 -168.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 172' ' ' GLU . . . . . 0.433 ' HB3' HG13 ' B' ' 168' ' ' VAL . 0.1 OUTLIER -132.29 150.75 52.09 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.953 -0.758 . . . . 75.25 108.953 169.585 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 173' ' ' LEU . . . . . . . . . . . . . 27.2 tp -88.88 -53.71 4.48 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 108.533 -0.914 . . . . 74.44 108.533 178.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 174' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -165.2 41.82 0.07 Allowed 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 107.724 -1.213 . . . . 74.45 107.724 173.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 175' ' ' ASP . . . . . 0.478 ' HB2' HG23 ' B' ' 168' ' ' VAL . 6.3 m-20 -113.34 -37.29 4.73 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 114.959 -1.019 . . . . 74.1 112.585 -164.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -113.89 114.81 26.75 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 112.932 0.716 . . . . 74.11 112.932 -166.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 8.0 t -156.36 127.94 3.81 Favored Pre-proline 0 CA--C 1.556 1.202 0 C-N-CA 124.21 1.004 . . . . 74.15 109.287 168.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 178' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.88 -61.96 0.04 OUTLIER 'Trans proline' 0 C--N 1.383 2.345 0 C-N-CA 122.475 2.117 . . . . 74.53 112.845 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -152.76 33.03 0.49 Allowed 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.021 0.928 . . . . 74.35 109.263 -178.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . 63.48 -74.98 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.909 1.284 . . . . 75.32 110.67 -164.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 16.8 tp -161.43 13.69 0.09 Allowed 'General case' 0 CA--C 1.56 1.365 0 N-CA-C 111.919 0.341 . . . . 74.44 111.919 -168.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 182' ' ' VAL . . . . . 0.657 ' HA ' ' HB2' ' C' ' 139' ' ' GLU . 12.4 p -117.7 150.09 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 CA-C-O 118.533 -0.746 . . . . 72.43 110.008 178.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -169.05 6.57 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 115.21 1.559 . . . . 65.24 115.21 -177.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 79.7 m80 76.4 161.49 0.23 Allowed 'General case' 0 N--CA 1.507 2.399 0 C-N-CA 124.548 1.139 . . . . 75.32 111.437 177.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 185' ' ' VAL . . . . . 0.576 HG23 ' HA ' ' C' ' 141' ' ' ALA . 92.7 t -64.41 106.82 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 122.901 0.48 . . . . 74.01 111.407 -173.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 186' ' ' THR . . . . . 0.794 ' HA ' ' HB3' ' C' ' 122' ' ' GLU . 65.2 p 66.43 105.48 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.872 1.669 . . . . 60.24 114.392 163.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 187' ' ' SER . . . . . . . . . . . . . 51.5 p -171.82 97.58 0.17 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.658 1.183 . . . . 62.14 109.573 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 188' ' ' ARG . . . . . 0.439 ' HG2' ' HB3' ' C' ' 179' ' ' ARG . 0.0 OUTLIER -73.83 113.22 10.73 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 107.346 -1.353 . . . . 72.32 107.346 173.171 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -69.74 98.27 1.18 Allowed 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 109.19 -0.67 . . . . 72.52 109.19 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 190' ' ' CYS . . . . . . . . . . . . . 6.4 p -76.98 112.64 13.83 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-N 115.302 -0.863 . . . . 70.33 109.909 176.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -79.84 124.81 28.97 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.08 0.552 . . . . 74.04 110.621 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -89.83 112.36 4.02 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-O 118.458 -1.19 . . . . 64.22 110.74 168.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 193' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.14 -41.05 82.42 Favored 'Trans proline' 0 C--N 1.385 2.449 0 C-N-CA 122.917 2.412 . . . . 73.22 112.82 177.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 194' ' ' SER . . . . . . . . . . . . . 21.4 t 62.85 20.26 12.07 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 124.839 1.256 . . . . 63.44 111.652 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 195' ' ' ALA . . . . . . . . . . . . . . . -83.7 77.64 9.83 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.538 0.735 . . . . 74.32 111.377 -173.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 72.1 m -70.65 130.3 41.42 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.272 -0.876 . . . . 73.32 108.763 169.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 45.5 m -69.47 83.12 0.4 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.612 0.765 . . . . 75.11 112.765 -169.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 198' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 55.05 -91.1 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 126.072 1.749 . . . . 65.14 110.728 178.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 199' ' ' LYS . . . . . 0.501 ' HB3' ' HZ2' ' B' ' 199' ' ' LYS . 6.6 ttpm? -155.96 61.23 0.58 Allowed 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 105.762 -1.94 . . . . 75.14 105.762 -178.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 200' ' ' CYS . . . . . . . . . . . . . 54.0 t -59.12 -39.4 73.23 Favored Pre-proline 0 CA--C 1.559 1.293 0 CA-C-N 113.314 -1.766 . . . . 73.31 112.818 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 201' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -63.94 -10.11 21.64 Favored 'Trans proline' 0 C--N 1.39 2.754 0 C-N-CA 121.509 1.472 . . . . 74.02 114.113 171.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . -125.89 67.91 0.53 Allowed Glycine 0 C--N 1.353 1.497 0 C-N-CA 123.002 0.334 . . . . 73.41 112.509 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -120.84 16.23 11.8 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.916 0.886 . . . . 71.33 110.036 177.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . 64.78 17.4 10.95 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.796 1.238 . . . . 74.01 112.163 -174.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 205' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 54.61 78.04 0.18 Allowed 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 125.664 1.586 . . . . 72.44 110.946 175.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -171.92 -54.87 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.608 0.763 . . . . 70.3 109.893 -174.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 207' ' ' LYS . . . . . 0.667 ' HB3' ' HB2' ' B' ' 124' ' ' SER . 13.2 mptt -65.6 -36.0 82.47 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 114.992 -1.003 . . . . 74.32 110.821 -178.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 79.27 -78.79 1.69 Allowed Glycine 0 C--N 1.345 1.034 0 CA-C-N 115.788 -0.642 . . . . 71.52 111.96 -178.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 171.42 -65.77 0.14 Allowed Glycine 0 C--N 1.345 1.043 0 N-CA-C 110.296 -1.122 . . . . 63.34 110.296 -177.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 63.92 -78.34 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 125.318 1.447 . . . . 74.51 111.835 169.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 211' ' ' GLY . . . . . 0.583 ' HA3' ' HA ' ' B' ' 126' ' ' ALA . . . -83.88 52.76 4.77 Favored Glycine 0 C--N 1.35 1.346 0 N-CA-C 111.72 -0.552 . . . . 74.43 111.72 173.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 70.9 m -149.85 177.27 9.97 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.657 1.183 . . . . 74.04 109.79 -174.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 72.1 mt 71.77 -69.29 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 C-N-CA 125.516 1.526 . . . . 70.12 111.592 178.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 40.7 m 70.51 -67.88 0.23 Allowed 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 125.705 1.602 . . . . 75.43 110.685 -175.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 215' ' ' GLU . . . . . 0.421 ' HB3' ' NH2' ' B' ' 32' ' ' ARG . 33.5 tt0 64.31 107.02 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.183 1.393 . . . . 73.31 112.747 173.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 59.7 81.99 0.16 Allowed 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.0 1.32 . . . . 61.42 112.688 171.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.34 117.18 5.48 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 107.801 -1.185 . . . . 75.4 107.801 173.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -72.52 113.66 9.8 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 108.431 -0.951 . . . . 71.43 108.431 178.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 61.8 t30 75.89 -69.65 0.16 Allowed 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 125.526 1.53 . . . . 71.24 112.615 175.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . 70.71 -73.11 0.1 Allowed 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 125.351 1.461 . . . . 74.3 111.87 -175.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 221' ' ' ARG . . . . . 0.569 HH12 ' HG2' ' A' ' 228' ' ' GLN . 0.8 OUTLIER -134.38 131.18 37.94 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.472 1.109 . . . . 73.55 108.486 -178.22 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -157.81 26.19 0.27 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.415 0.686 . . . . 75.21 110.451 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -64.17 100.78 0.35 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.175 0.99 . . . . 72.13 110.26 -171.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . 0.418 ' O ' ' HB3' ' C' ' 211' ' ' ARG . 11.3 p -109.74 41.05 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 C-N-CA 124.827 1.251 . . . . 75.32 108.817 -173.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 73.6 p -51.56 -46.92 63.57 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 113.818 -1.537 . . . . 73.55 111.719 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 2.4 tm? 60.85 95.37 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.08 1.352 . . . . 74.43 109.601 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . -107.73 150.0 16.82 Favored Glycine 0 C--N 1.334 0.464 0 CA-C-N 115.819 -0.628 . . . . 71.24 112.859 -177.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . -79.9 101.2 1.92 Allowed Glycine 0 C--N 1.343 0.92 0 N-CA-C 111.207 -0.757 . . . . 72.41 111.207 175.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -62.87 -7.21 15.01 Favored Glycine 0 C--N 1.351 1.411 0 N-CA-C 115.034 0.774 . . . . 71.04 115.034 -178.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . 0.412 ' HA ' HE21 ' B' ' 252' ' ' GLN . . . -130.53 147.75 52.26 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 124.775 1.23 . . . . 70.23 108.892 171.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 231' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -61.84 120.92 11.67 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.6 0.36 . . . . 73.24 110.521 177.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 8.6 t -158.04 162.43 38.12 Favored 'General case' 0 C--O 1.246 0.884 0 C-N-CA 124.101 0.961 . . . . 74.24 108.423 174.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -72.71 113.35 9.65 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.939 -1.134 . . . . 71.44 107.939 171.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -74.94 82.23 2.19 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 121.186 0.517 . . . . 72.31 109.946 178.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -76.97 172.29 13.42 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 124.067 0.947 . . . . 64.41 110.148 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 236' ' ' THR . . . . . . . . . . . . . 43.2 m 74.54 86.32 0.1 Allowed 'General case' 0 C--N 1.354 0.768 0 C-N-CA 124.865 1.266 . . . . 73.34 109.524 -176.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -94.37 25.59 3.8 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 114.697 -1.138 . . . . 73.03 110.775 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 238' ' ' THR . . . . . 0.503 HG22 HG21 ' C' ' 219' ' ' VAL . 21.9 m -55.75 105.72 0.2 Allowed 'General case' 0 C--N 1.361 1.108 0 C-N-CA 123.624 0.77 . . . . 71.31 110.132 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 239' ' ' ALA . . . . . 0.448 ' HA ' HG22 ' C' ' 219' ' ' VAL . . . -159.71 -82.8 0.04 OUTLIER 'General case' 0 C--O 1.24 0.593 0 O-C-N 123.837 0.711 . . . . 74.42 109.561 -178.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 240' ' ' GLY . . . . . 0.421 ' HA3' ' HA ' ' C' ' 235' ' ' LEU . . . 161.91 -108.67 0.36 Allowed Glycine 0 C--N 1.333 0.367 0 N-CA-C 109.678 -1.369 . . . . 71.23 109.678 -170.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -159.92 160.45 33.53 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.35 0.66 . . . . 71.23 111.125 178.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 26.7 m95 -123.77 -83.08 0.65 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.165 0.986 . . . . 70.32 108.715 168.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -154.49 -54.87 0.1 Allowed 'General case' 0 C--N 1.362 1.152 0 C-N-CA 125.985 1.714 . . . . 74.22 106.654 -168.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -147.34 -163.28 10.49 Favored Glycine 0 C--N 1.355 1.614 0 CA-C-N 113.843 -1.526 . . . . 71.54 110.628 173.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? -171.69 133.41 0.77 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.89 -0.781 . . . . 75.34 108.89 175.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 246' ' ' THR . . . . . 0.598 HG23 HG13 ' B' ' 371' ' ' VAL . 91.6 m -133.53 151.46 51.75 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.572 1.149 . . . . 71.14 108.759 176.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 247' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -132.44 -178.83 5.1 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.458 0.703 . . . . 72.51 110.017 176.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 248' ' ' ARG . . . . . 0.655 ' HD2' ' HA ' ' B' ' 370' ' ' ALA . 2.4 tpm_? -161.68 157.34 24.32 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.975 0.91 . . . . 75.15 109.422 -178.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 249' ' ' GLU . . . . . 0.439 ' HG2' ' NH2' ' B' ' 248' ' ' ARG . 13.4 pt-20 -114.88 160.68 19.21 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.589 0.756 . . . . 71.33 109.274 170.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 250' ' ' GLN . . . . . 0.468 HE21 ' HB3' ' A' ' 274' ' ' GLU . 0.0 OUTLIER -146.41 177.22 9.19 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.454 0.702 . . . . 70.14 109.692 -173.563 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 251' ' ' ALA . . . . . . . . . . . . . . . -88.37 -7.15 57.12 Favored 'General case' 0 N--CA 1.483 1.223 0 O-C-N 122.292 -0.255 . . . . 64.21 111.507 174.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . 0.422 ' H ' ' HG2' ' B' ' 250' ' ' GLN . 1.4 tm0? 70.0 -68.73 0.19 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.954 1.701 . . . . 73.12 111.563 172.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -76.44 74.21 3.19 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.012 0.925 . . . . 51.41 110.608 176.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -86.32 -77.84 0.3 Allowed 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 114.667 -1.151 . . . . 72.51 108.106 175.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -84.62 -28.66 31.81 Favored Glycine 0 N--CA 1.47 0.931 0 CA-C-N 117.998 0.363 . . . . 63.32 112.244 169.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 256' ' ' TYR . . . . . . . . . . . . . 78.0 t80 67.4 -76.45 0.05 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.254 1.421 . . . . 71.2 109.616 -171.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 257' ' ' GLN . . . . . 0.531 ' HA ' ' HB2' ' B' ' 355' ' ' ALA . 78.2 mt-30 38.45 88.49 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 126.189 1.796 . . . . 74.31 114.309 171.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 258' ' ' LEU . . . . . . . . . . . . . 2.6 tt -86.0 64.89 8.83 Favored 'General case' 0 CA--C 1.556 1.208 0 N-CA-C 109.243 -0.651 . . . . 75.13 109.243 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 33.4 m 38.2 31.69 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 C-N-CA 127.248 2.219 . . . . 63.31 115.899 172.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 260' ' ' SER . . . . . 0.617 ' HA ' ' HE2' ' B' ' 149' ' ' LYS . 32.4 m -76.96 -29.64 55.65 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 112.425 0.528 . . . . 73.11 112.425 -175.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 28.3 t0 69.31 176.01 0.28 Allowed 'General case' 0 N--CA 1.483 1.193 0 O-C-N 124.36 1.038 . . . . 65.51 111.733 169.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 262' ' ' ALA . . . . . . . . . . . . . . . -137.97 134.97 35.55 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 123.581 0.752 . . . . 75.22 110.062 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 263' ' ' ALA . . . . . 0.412 ' HB1' ' HB ' ' B' ' 348' ' ' ILE . . . -80.65 62.46 4.72 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.566 0.746 . . . . 70.44 111.076 176.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 50.7 m -123.12 -9.45 8.18 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.942 0.897 . . . . 51.14 110.564 176.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 265' ' ' LEU . . . . . 0.435 HD13 HG12 ' B' ' 121' ' ' VAL . 68.9 mt 54.04 58.73 4.77 Favored 'General case' 0 C--N 1.363 1.166 0 C-N-CA 124.446 1.099 . . . . 73.31 110.439 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 266' ' ' ASN . . . . . 0.422 ' H ' ' HB3' ' B' ' 46' ' ' ARG . 29.3 m120 78.13 -63.94 0.3 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 126.574 1.95 . . . . 71.52 111.13 -172.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 267' ' ' SER . . . . . 0.434 ' HB3' ' HA3' ' B' ' 49' ' ' GLY . 32.6 t 56.63 55.82 6.07 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.49 0.716 . . . . 73.13 109.074 -171.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 39.0 t -63.88 102.54 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 115.362 -0.835 . . . . 74.44 110.828 -172.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 269' ' ' THR . . . . . . . . . . . . . 14.2 t -159.83 -40.52 0.05 Allowed 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 111.932 0.345 . . . . 74.31 111.932 -175.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 270' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -123.04 132.54 54.16 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 123.414 0.686 . . . . 72.41 110.4 -167.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 271' ' ' ALA . . . . . 0.453 ' HB2' ' HB1' ' B' ' 467' ' ' ALA . . . -174.45 -28.9 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 O-C-N 123.913 0.758 . . . . 75.3 111.937 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 272' ' ' ASN . . . . . 0.549 HD21 HD13 ' B' ' 468' ' ' LEU . 65.5 t30 -90.9 61.83 4.79 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-O 121.367 0.603 . . . . 73.11 111.803 -170.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 63.47 -0.51 0.69 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 116.061 1.874 . . . . 73.43 116.061 165.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -68.51 -44.85 73.78 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 118.725 0.693 . . . . 71.44 109.279 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 275' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -105.34 99.04 18.4 Favored Pre-proline 0 N--CA 1.478 0.944 0 N-CA-C 107.24 -1.392 . . . . 72.14 107.24 169.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -61.76 85.94 0.1 OUTLIER 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 123.101 2.534 . . . . 73.04 114.257 -169.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 277' ' ' LEU . . . . . . . . . . . . . 9.7 mp 60.17 -72.47 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 126.977 2.111 . . . . 74.52 114.482 169.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 278' ' ' LEU . . . . . 0.585 HD12 ' H ' ' B' ' 278' ' ' LEU . 0.0 OUTLIER -103.82 0.76 30.73 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.761 0.825 . . . . 72.2 111.78 -175.271 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . -72.28 -78.06 0.52 Allowed Glycine 0 C--N 1.352 1.46 0 O-C-N 123.416 0.448 . . . . 75.43 112.722 179.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 69.51 152.91 0.1 Allowed 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 125.188 1.395 . . . . 74.31 113.728 178.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -114.4 37.45 3.38 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 106.294 -1.743 . . . . 75.31 106.294 165.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -64.59 87.68 0.06 Allowed 'General case' 0 C--N 1.357 0.926 0 CA-C-N 114.561 -1.199 . . . . 65.41 111.856 -171.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -107.34 -13.95 14.99 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.862 1.265 . . . . 72.33 109.442 175.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . -61.94 97.71 0.16 Allowed Glycine 0 C--N 1.345 1.052 0 CA-C-N 115.672 -0.695 . . . . 72.13 113.505 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -67.23 -48.13 68.73 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.021 0.928 . . . . 73.03 110.09 177.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 286' ' ' MET . . . . . . . . . . . . . 44.4 tpp -163.21 108.9 1.0 Allowed Pre-proline 0 CA--C 1.543 0.705 0 N-CA-C 108.729 -0.841 . . . . 74.22 108.729 178.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 287' ' ' PRO . . . . . 0.451 ' HB3' ' HA ' ' B' ' 52' ' ' THR . 28.2 Cg_exo -65.1 78.81 0.21 Allowed 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 123.53 2.82 . . . . 74.24 112.585 178.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 288' ' ' VAL . . . . . 0.535 HG21 ' H ' ' B' ' 289' ' ' ARG 0.269 6.2 m 35.69 -96.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 C-N-CA 125.504 1.521 . . . . 74.32 112.448 -170.071 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 289' ' ' ARG . . . . . 0.535 ' H ' HG21 ' B' ' 288' ' ' VAL . 24.6 tpt180 62.25 -82.5 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.638 1.175 . . . . 74.32 111.152 176.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 290' ' ' TRP . . . . . . . . . . . . . 31.9 t90 -107.01 -31.42 8.3 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.303 1.041 . . . . 75.34 109.221 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 291' ' ' LEU . . . . . . . . . . . . . 47.9 tp -67.66 126.36 29.12 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.469 1.107 . . . . 73.52 110.617 177.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . 90.86 -161.29 28.08 Favored Glycine 0 C--N 1.348 1.213 0 O-C-N 123.633 0.583 . . . . 71.42 112.581 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.84 162.58 41.53 Favored 'Trans proline' 0 C--N 1.371 1.743 0 C-N-CA 122.761 2.308 . . . . 75.13 112.647 176.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 294' ' ' LYS . . . . . 0.602 ' HZ2' ' HB3' ' B' ' 294' ' ' LYS . 5.6 ttpm? -57.56 91.28 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.885 1.274 . . . . 74.44 111.384 -177.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . 59.09 13.36 2.88 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.863 1.265 . . . . 71.35 112.334 -178.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 296' ' ' THR . . . . . 0.419 ' HB ' ' HA3' ' B' ' 299' ' ' GLY . 6.9 m 51.14 47.69 24.4 Favored 'General case' 0 C--N 1.364 1.221 0 C-N-CA 124.687 1.195 . . . . 71.52 110.103 -169.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 62.68 -78.49 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.431 1.493 . . . . 75.44 110.325 -171.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 298' ' ' HIS . . . . . 0.421 ' HA ' HG22 ' B' ' 115' ' ' THR . 54.6 t-80 -136.7 38.21 2.63 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 108.418 -0.956 . . . . 73.43 108.418 177.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 299' ' ' GLY . . . . . 0.419 ' HA3' ' HB ' ' B' ' 296' ' ' THR . . . -67.04 -29.25 74.31 Favored Glycine 0 C--N 1.349 1.283 0 CA-C-N 115.107 -0.951 . . . . 72.35 112.603 177.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 300' ' ' ASN . . . . . 0.662 ' HB3' HG23 ' B' ' 115' ' ' THR . 7.1 t30 -71.92 91.77 1.22 Allowed 'General case' 0 CA--C 1.549 0.911 0 CA-C-O 121.682 0.753 . . . . 72.23 109.132 171.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 301' ' ' ILE . . . . . . . . . . . . . 12.7 tt -133.7 -21.26 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 CA-C-N 114.703 -1.135 . . . . 75.13 109.561 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 10.5 t70 71.16 108.1 0.06 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 125.252 1.421 . . . . 74.32 111.688 -178.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 303' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -147.75 -53.78 0.02 OUTLIER Pre-proline 0 CA--C 1.56 1.36 0 C-N-CA 125.155 1.382 . . . . 74.11 110.409 176.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 304' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -72.42 -3.32 13.19 Favored 'Trans proline' 0 C--N 1.401 3.307 0 C-N-CA 122.345 2.03 . . . . 75.12 113.61 -176.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -85.56 -78.03 0.28 Allowed 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 109.703 -0.48 . . . . 72.13 109.703 175.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . 0.427 HG21 ' HB3' ' B' ' 59' ' ' LEU . 17.3 m -43.56 -51.0 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 114.918 1.451 . . . . 72.33 114.918 -168.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 21.4 m 62.72 -70.02 0.06 Allowed 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 124.784 1.234 . . . . 74.23 111.057 -170.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 308' ' ' CYS . . . . . . . . . . . . . 18.8 p -156.13 96.55 1.71 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.035 0.934 . . . . 74.22 109.901 177.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 30.0 p -131.04 135.27 27.03 Favored Pre-proline 0 N--CA 1.484 1.275 0 C-N-CA 123.684 0.794 . . . . 72.2 111.67 -174.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -80.35 -0.98 11.04 Favored 'Trans proline' 0 C--N 1.379 2.157 0 C-N-CA 122.831 2.354 . . . . 64.44 114.454 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 311' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -80.58 122.33 82.27 Favored Pre-proline 0 N--CA 1.481 1.12 0 N-CA-C 109.387 -0.598 . . . . 73.13 109.387 177.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 312' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -83.59 144.18 11.17 Favored 'Trans proline' 0 C--N 1.37 1.692 0 C-N-CA 121.996 1.797 . . . . 70.14 113.503 176.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 313' ' ' GLN . . . . . 0.647 ' HB2' ' HA ' ' B' ' 58' ' ' SER . 6.8 tp60 -62.51 -37.02 84.41 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 115.202 -0.908 . . . . 75.13 110.207 167.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 314' ' ' ARG . . . . . 0.409 HH22 ' HG3' ' B' ' 105' ' ' GLN . 32.6 ttt180 -144.77 118.48 9.22 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 113.839 -1.528 . . . . 74.53 109.047 -173.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 315' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -76.62 -50.85 12.77 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 107.36 -1.348 . . . . 75.34 107.36 170.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 316' ' ' ASP . . . . . . . . . . . . . 32.5 t70 176.13 108.19 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.648 1.579 . . . . 74.4 108.817 158.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 317' ' ' SER . . . . . 0.583 ' HB3' ' HB1' ' B' ' 110' ' ' ALA . 35.1 t -92.73 91.29 7.43 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 121.513 0.673 . . . . 75.41 109.754 175.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 318' ' ' VAL . . . . . . . . . . . . . 14.0 p -91.12 -24.43 0.27 Allowed Pre-proline 0 CA--C 1.583 2.229 0 N-CA-C 114.117 1.154 . . . . 73.13 114.117 173.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 319' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -76.92 25.05 0.46 Allowed 'Trans proline' 0 C--N 1.414 3.986 0 CA-C-N 123.343 2.229 . . . . 65.1 114.883 -170.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 320' ' ' THR . . . . . . . . . . . . . 72.6 m -60.03 -51.71 68.48 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.789 0.836 . . . . 73.24 109.758 170.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 321' ' ' LEU . . . . . 0.57 ' HB3' ' HB3' ' B' ' 434' ' ' HIS . 2.4 tm? 61.19 -78.8 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 125.601 1.561 . . . . 74.43 110.884 176.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 322' ' ' ALA . . . . . . . . . . . . . . . -139.64 108.24 5.9 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.857 0.863 . . . . 64.54 109.461 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 323' ' ' GLN . . . . . . . . . . . . . 5.4 pp0? -82.63 7.47 14.64 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.414 0.686 . . . . 74.02 111.731 -178.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 324' ' ' MET . . . . . . . . . . . . . 9.5 ptt? -56.07 -26.16 48.26 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 124.15 0.98 . . . . 74.22 112.057 -177.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 325' ' ' THR . . . . . . . . . . . . . 19.8 m -56.94 154.21 9.89 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 124.438 1.095 . . . . 72.33 110.708 174.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 326' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -57.69 159.22 5.37 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.932 0.893 . . . . 72.01 111.696 -179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . 0.479 ' H ' ' HG ' ' B' ' 331' ' ' LEU . 3.2 mptp? -102.41 3.84 38.23 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.316 0.647 . . . . 75.41 110.426 -179.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 328' ' ' ALA . . . . . . . . . . . . . . . 58.81 -85.0 0.02 OUTLIER 'General case' 0 C--N 1.363 1.195 0 C-N-CA 125.293 1.437 . . . . 72.03 109.987 -172.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 329' ' ' ILE . . . . . . . . . . . . . 2.7 pp -61.25 141.96 16.76 Favored 'Isoleucine or valine' 0 C--O 1.244 0.793 0 C-N-CA 123.587 0.755 . . . . 73.5 111.326 176.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 330' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 65.34 4.27 2.62 Favored 'General case' 0 CA--C 1.566 1.592 0 C-N-CA 124.054 0.942 . . . . 74.44 112.166 177.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 331' ' ' LEU . . . . . 0.479 ' HG ' ' H ' ' B' ' 327' ' ' LYS . 2.2 tm? -112.55 89.17 3.0 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 108.966 -0.753 . . . . 64.42 108.966 -174.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 51.44 -85.82 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 125.868 1.667 . . . . 74.41 113.493 171.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 333' ' ' SER . . . . . . . . . . . . . 15.3 m -61.1 -58.08 9.84 Favored 'General case' 0 C--N 1.354 0.773 0 C-N-CA 124.253 1.021 . . . . 65.04 109.512 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 23.2 pttm 41.28 -169.92 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 126.618 1.967 . . . . 65.35 115.415 176.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 335' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -124.53 172.15 9.44 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 123.621 0.768 . . . . 74.12 109.203 171.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.75 -47.19 80.62 Favored 'General case' 0 CA--C 1.556 1.194 0 C-N-CA 124.041 0.936 . . . . 73.55 113.264 -173.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 337' ' ' LYS . . . . . 0.462 ' HD2' ' HG2' ' B' ' 30' ' ' GLU . 20.0 ptmt -173.77 -27.07 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.935 0.894 . . . . 71.1 110.26 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 338' ' ' GLY . . . . . . . . . . . . . . . 90.62 -55.39 3.45 Favored Glycine 0 C--N 1.354 1.572 0 O-C-N 123.558 0.537 . . . . 73.12 111.798 177.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 339' ' ' PHE . . . . . 0.468 ' HB2' ' HA ' ' B' ' 446' ' ' PRO . 22.6 p90 -120.12 115.98 24.75 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.624 0.77 . . . . 74.33 109.284 177.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 340' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -66.77 -51.11 59.58 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.451 0.7 . . . . 75.24 110.968 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 341' ' ' LEU . . . . . 0.502 HD21 HH21 ' B' ' 289' ' ' ARG . 29.4 tp 51.04 77.85 0.12 Allowed 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.906 1.282 . . . . 75.34 110.679 178.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 342' ' ' GLN . . . . . 0.447 ' HG2' ' HA ' ' B' ' 125' ' ' ALA . 3.3 tp-100 -109.53 -69.95 0.83 Allowed 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 115.714 -0.675 . . . . 74.32 111.049 -166.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 343' ' ' VAL . . . . . . . . . . . . . 12.0 p -160.21 -35.66 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.827 0 C-N-CA 123.317 0.647 . . . . 65.15 109.792 -173.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 54.07 -78.41 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 125.56 1.544 . . . . 74.33 113.277 174.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 345' ' ' GLY . . . . . . . . . . . . . . . -70.39 -8.5 62.68 Favored Glycine 0 N--CA 1.484 1.881 0 CA-C-N 118.614 0.643 . . . . 63.14 114.626 -178.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 346' ' ' ALA . . . . . . . . . . . . . . . 77.42 -61.54 0.41 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.69 1.596 . . . . 72.51 112.562 172.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 48.4 p -70.18 -28.75 65.57 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.348 0.659 . . . . 72.21 111.747 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 348' ' ' ILE . . . . . 0.412 ' HB ' ' HB1' ' B' ' 263' ' ' ALA . 2.6 pp 42.02 28.29 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 C-N-CA 126.714 2.005 . . . . 73.42 115.055 177.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 349' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -85.8 122.38 29.8 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.786 -0.643 . . . . 71.13 110.437 -171.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 350' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -121.18 26.25 9.07 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.213 1.005 . . . . 74.52 109.764 178.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -143.73 90.25 2.13 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.407 1.083 . . . . 71.32 109.91 -170.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 26.9 t70 83.59 -47.21 0.12 Allowed 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 125.384 1.474 . . . . 74.35 112.828 178.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 353' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -99.24 29.47 3.92 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 123.213 0.605 . . . . 74.33 109.542 -177.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 354' ' ' ALA . . . . . . . . . . . . . . . -82.82 63.7 7.06 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.131 0.972 . . . . 72.23 112.723 -168.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 355' ' ' ALA . . . . . 0.531 ' HB2' ' HA ' ' B' ' 257' ' ' GLN . . . 60.52 11.51 3.06 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.994 1.318 . . . . 75.44 113.445 175.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 356' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 66.7 146.0 0.1 Allowed Pre-proline 0 N--CA 1.487 1.383 0 C-N-CA 125.672 1.589 . . . . 74.32 111.271 -168.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 357' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -62.36 133.72 44.7 Favored 'Trans proline' 0 C--N 1.382 2.32 0 C-N-CA 122.051 1.834 . . . . 74.21 110.698 175.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 358' ' ' CYS . . . . . . . . . . . . . 56.2 m -53.97 127.83 27.92 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 124.075 0.859 . . . . 75.21 111.35 -176.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 359' ' ' GLY . . . . . . . . . . . . . . . -60.14 -27.95 65.84 Favored Glycine 0 C--N 1.353 1.505 0 O-C-N 123.45 0.469 . . . . 72.04 113.004 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 360' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 59.03 -79.14 0.02 OUTLIER 'General case' 0 C--N 1.356 0.857 0 C-N-CA 125.961 1.704 . . . . 53.34 113.023 176.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 361' ' ' ILE . . . . . . . . . . . . . 51.7 mt -59.32 96.97 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 C-N-CA 124.152 0.981 . . . . 64.41 110.076 -174.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 362' ' ' GLY . . . . . . . . . . . . . . . -162.56 22.27 0.19 Allowed Glycine 0 C--N 1.342 0.898 0 CA-C-N 115.216 -0.902 . . . . 72.35 112.656 -173.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 363' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -115.39 131.02 57.06 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.121 0.969 . . . . 73.13 108.633 176.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 364' ' ' THR . . . . . . . . . . . . . 13.7 m -74.2 -29.53 61.78 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 122.925 0.49 . . . . 74.04 111.092 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 21.9 t 65.74 117.93 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 125.402 1.481 . . . . 74.51 110.067 -177.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 73.28 -64.95 0.38 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 125.702 1.601 . . . . 52.52 111.133 -176.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 367' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -67.87 -4.17 11.96 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.564 1.146 . . . . 75.05 112.566 -175.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 368' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -83.08 38.76 0.61 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.698 0.799 . . . . 73.23 109.636 171.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 369' ' ' GLU . . . . . 0.44 ' HB3' ' HA ' ' B' ' 372' ' ' GLN . 35.4 mt-10 -54.0 -28.09 35.85 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 126.023 1.729 . . . . 74.11 112.969 -163.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 370' ' ' ALA . . . . . 0.655 ' HA ' ' HD2' ' B' ' 248' ' ' ARG . . . 77.43 -68.29 0.17 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.603 1.561 . . . . 74.25 111.78 171.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 371' ' ' VAL . . . . . 0.598 HG13 HG23 ' B' ' 246' ' ' THR . 29.1 m -130.36 15.84 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 C-N-CA 123.662 0.785 . . . . 74.12 110.078 171.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 372' ' ' GLN . . . . . 0.44 ' HA ' ' HB3' ' B' ' 369' ' ' GLU . 8.9 tp-100 79.99 147.57 0.09 Allowed 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 125.809 1.644 . . . . 63.2 109.71 -166.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 373' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -145.94 171.92 14.12 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.052 0.941 . . . . 72.2 109.627 -173.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . 74.43 -48.55 0.65 Allowed 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 125.248 1.419 . . . . 71.45 112.63 177.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 375' ' ' LEU . . . . . . . . . . . . . 67.8 mt -81.88 55.41 2.74 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.652 1.181 . . . . 72.22 110.036 176.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 53.08 -122.88 2.11 Favored 'General case' 0 CA--C 1.566 1.584 0 C-N-CA 124.603 1.161 . . . . 73.13 110.028 -172.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 377' ' ' PHE . . . . . . . . . . . . . 5.7 t80 56.24 -178.1 0.05 OUTLIER 'General case' 0 CA--C 1.566 1.564 0 C-N-CA 125.165 1.386 . . . . 73.31 111.969 -178.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 378' ' ' ALA . . . . . . . . . . . . . . . 64.84 24.46 12.78 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.077 0.951 . . . . 73.45 111.389 173.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -150.26 155.52 39.85 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.478 -0.783 . . . . 73.22 110.067 -167.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 380' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.29 -177.57 3.38 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.819 0.848 . . . . 72.4 108.955 170.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 381' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -82.68 111.71 18.88 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 109.027 -0.731 . . . . 74.34 109.027 175.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . 131.86 151.7 6.94 Favored Glycine 0 N--CA 1.473 1.128 0 N-CA-C 111.949 -0.46 . . . . 73.1 111.949 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 383' ' ' ASN . . . . . . . . . . . . . 32.4 p-10 -165.29 -161.4 0.53 Allowed 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 123.607 0.763 . . . . 73.1 109.88 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 384' ' ' THR . . . . . . . . . . . . . 24.4 m -65.76 153.55 41.49 Favored 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 123.74 0.816 . . . . 71.44 111.998 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 385' ' ' LEU . . . . . 0.418 HD12 ' H ' ' B' ' 392' ' ' HIS . 97.4 mt 79.27 163.52 0.2 Allowed 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 126.16 1.784 . . . . 75.43 111.951 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 386' ' ' VAL . . . . . . . . . . . . . 26.8 m -104.72 -170.2 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 123.678 0.791 . . . . 75.23 111.618 -169.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 387' ' ' ILE . . . . . 0.605 HG22 ' HA ' ' B' ' 405' ' ' ALA . 3.1 mp -70.91 -49.75 47.93 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.962 0 C-N-CA 122.902 0.481 . . . . 74.12 110.137 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 388' ' ' VAL . . . . . . . . . . . . . 96.5 t -68.05 -60.72 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 122.95 0.5 . . . . 74.43 110.687 -177.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 389' ' ' THR . . . . . . . . . . . . . 36.4 m -75.35 90.29 2.64 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.07 -1.085 . . . . 71.25 108.07 169.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . -72.42 -112.84 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.025 0 CA-C-N 114.99 -1.005 . . . . 73.41 111.679 -172.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 391' ' ' ASP . . . . . . . . . . . . . 34.5 t70 58.9 -74.62 0.02 OUTLIER 'General case' 0 CA--C 1.565 1.521 0 C-N-CA 124.624 1.17 . . . . 64.12 111.923 -178.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 392' ' ' HIS . . . . . 0.418 ' H ' HD12 ' B' ' 385' ' ' LEU . 89.5 m-70 67.59 78.3 0.24 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.356 1.462 . . . . 72.42 111.386 175.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . 57.12 40.8 28.08 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.187 0.995 . . . . 61.53 110.682 178.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 25.8 m170 74.03 121.15 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.984 1.713 . . . . 73.31 110.299 -174.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . -51.14 103.87 0.07 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.725 1.21 . . . . 75.42 113.149 -172.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 38.5 m -143.5 -164.19 1.81 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.631 1.172 . . . . 75.55 109.505 -179.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 397' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -93.82 32.74 1.39 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.93 0.892 . . . . 75.54 109.872 175.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 7.3 tp -64.23 -33.64 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 124.552 1.141 . . . . 75.44 112.316 -173.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 399' ' ' VAL . . . . . . . . . . . . . 36.9 t -122.45 4.95 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 N-CA-C 108.75 -0.833 . . . . 73.32 108.75 174.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 400' ' ' ALA . . . . . 0.469 ' HB3' ' HD2' ' B' ' 401' ' ' PRO . . . 66.63 170.52 0.1 Allowed Pre-proline 0 CA--C 1.567 1.626 0 C-N-CA 124.412 1.085 . . . . 74.52 110.164 -169.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 401' ' ' PRO . . . . . 0.469 ' HD2' ' HB3' ' B' ' 400' ' ' ALA . 36.4 Cg_endo -64.87 -1.78 4.63 Favored 'Trans proline' 0 C--N 1.384 2.443 0 C-N-CA 121.507 1.471 . . . . 71.34 114.681 176.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -72.37 90.5 1.29 Allowed 'General case' 0 N--CA 1.481 1.124 0 CA-C-O 121.253 0.549 . . . . 74.34 109.935 174.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 403' ' ' THR . . . . . . . . . . . . . 4.9 t -156.02 122.56 5.18 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.36 1.064 . . . . 73.2 108.563 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 404' ' ' LYS . . . . . . . . . . . . . 7.6 mtmt -137.74 155.33 49.19 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.66 0.784 . . . . 71.14 110.941 -172.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 405' ' ' ALA . . . . . 0.605 ' HA ' HG22 ' B' ' 387' ' ' ILE . . . -70.64 -54.94 7.72 Favored Pre-proline 0 CA--C 1.555 1.15 0 C-N-CA 123.539 0.736 . . . . 71.24 112.552 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 406' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -79.73 8.85 3.76 Favored 'Trans proline' 0 C--N 1.388 2.607 0 C-N-CA 121.438 1.425 . . . . 64.23 113.252 -176.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . 172.28 97.16 0.11 Allowed Glycine 0 C--N 1.34 0.756 0 N-CA-C 110.419 -1.072 . . . . 74.04 110.419 178.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 408' ' ' LEU . . . . . . . . . . . . . 62.3 tp -48.49 -68.1 0.21 Allowed 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 124.775 1.23 . . . . 72.55 111.832 -169.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 50.8 m -113.17 74.76 0.88 Allowed 'General case' 0 C--O 1.237 0.405 0 N-CA-C 107.45 -1.315 . . . . 73.52 107.45 169.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 410' ' ' GLN . . . . . . . . . . . . . 10.4 mm-40 67.85 -70.2 0.13 Allowed 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 125.558 1.543 . . . . 70.42 110.232 -176.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . -72.07 178.86 3.56 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 124.284 1.034 . . . . 74.33 111.278 170.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 1.7 tm? 66.72 83.02 0.17 Allowed 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.765 1.226 . . . . 75.21 109.136 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -77.61 74.57 4.17 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.658 0.783 . . . . 71.14 110.8 -176.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 414' ' ' THR . . . . . . . . . . . . . 15.8 m 76.12 -53.97 0.61 Allowed 'General case' 0 CA--C 1.56 1.341 0 C-N-CA 125.978 1.711 . . . . 73.24 113.28 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 415' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm 74.75 150.65 0.11 Allowed 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 125.177 1.391 . . . . 75.21 110.712 -171.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -57.74 119.88 7.42 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.891 0.476 . . . . 75.33 109.74 171.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 417' ' ' GLY . . . . . . . . . . . . . . . -82.31 62.76 4.53 Favored Glycine 0 C--N 1.342 0.872 0 O-C-N 123.477 0.485 . . . . 62.31 112.653 -178.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 418' ' ' ALA . . . . . . . . . . . . . . . -70.77 -31.56 68.39 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.481 0.712 . . . . 70.25 110.034 173.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 419' ' ' VAL . . . . . . . . . . . . . 27.8 m -87.69 -10.71 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 CA-C-N 115.118 -0.946 . . . . 73.31 111.341 175.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 420' ' ' MET . . . . . . . . . . . . . 22.1 ttt -82.9 -51.92 7.18 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.445 0.698 . . . . 73.34 109.613 175.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 421' ' ' VAL . . . . . . . . . . . . . 11.4 p -64.41 140.36 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 123.047 0.539 . . . . 72.42 111.132 -177.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 422' ' ' MET . . . . . 0.517 ' HG3' HG21 ' B' ' 435' ' ' THR . 6.0 tmm? 63.46 80.99 0.22 Allowed 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 125.123 1.369 . . . . 74.1 109.526 -172.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 423' ' ' SER . . . . . . . . . . . . . 28.3 p 177.39 -72.27 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.636 1.174 . . . . 63.45 110.395 173.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 424' ' ' TYR . . . . . 0.429 ' HH ' ' HG3' ' B' ' 79' ' ' GLU . 15.5 t80 -78.92 -36.24 42.17 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.342 0.657 . . . . 74.22 111.24 -168.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . -90.04 12.46 67.59 Favored Glycine 0 N--CA 1.472 1.081 0 CA-C-O 119.513 -0.604 . . . . 75.12 113.569 178.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 426' ' ' ASN . . . . . . . . . . . . . 15.0 m120 65.45 97.3 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.826 1.251 . . . . 75.43 112.115 173.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 427' ' ' SER . . . . . 0.501 ' O ' ' HG2' ' B' ' 422' ' ' MET . 21.0 t 72.92 -62.09 0.48 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 125.661 1.584 . . . . 75.14 112.65 175.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 56.27 -90.93 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 124.008 0.923 . . . . 73.23 112.856 173.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 429' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -111.17 84.31 1.91 Allowed 'General case' 0 C--N 1.356 0.861 0 C-N-CA 124.162 0.985 . . . . 63.42 108.631 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -94.1 109.66 21.42 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 109.19 -0.67 . . . . 62.42 109.19 -178.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 21.1 m -64.16 108.8 1.65 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.674 0.79 . . . . 75.05 111.357 -176.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 432' ' ' GLN . . . . . 0.406 ' HB2' ' NE2' ' B' ' 438' ' ' GLN . 1.4 mp0 57.92 -87.54 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.429 1.492 . . . . 71.1 111.033 -175.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 433' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -144.67 126.02 14.82 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.751 1.221 . . . . 73.43 108.355 -178.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 434' ' ' HIS . . . . . 0.57 ' HB3' ' HB3' ' B' ' 321' ' ' LEU . 13.5 p-80 51.92 100.85 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 126.501 1.92 . . . . 73.42 113.22 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 435' ' ' THR . . . . . 0.517 HG21 ' HG3' ' B' ' 422' ' ' MET . 15.9 p -64.25 -43.07 96.02 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.211 0.604 . . . . 73.42 111.088 174.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 436' ' ' GLY . . . . . 0.493 ' HA2' ' HB2' ' A' ' 220' ' ' GLU . . . -61.68 103.12 0.52 Allowed Glycine 0 C--N 1.35 1.32 0 CA-C-N 115.391 -0.822 . . . . 61.51 112.409 178.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 83.5 p 61.84 43.5 9.36 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.798 1.639 . . . . 72.35 111.679 -174.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 438' ' ' GLN . . . . . 0.406 ' NE2' ' HB2' ' B' ' 432' ' ' GLN . 5.6 tp60 -63.59 -42.5 98.25 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 115.468 -0.787 . . . . 71.55 110.448 171.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 439' ' ' LEU . . . . . 0.409 ' HB2' ' HD3' ' A' ' 238' ' ' LYS . 3.8 pp -134.02 133.61 41.45 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 109.039 -0.726 . . . . 74.24 109.039 176.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 440' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.37 152.13 34.54 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.823 0.849 . . . . 74.1 109.651 -177.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 441' ' ' ILE . . . . . 0.631 HG23 HD23 ' A' ' 235' ' ' LEU . 62.6 mt -105.06 134.69 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.314 0.646 . . . . 74.15 111.348 -175.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 442' ' ' ALA . . . . . . . . . . . . . . . -107.2 -78.83 0.58 Allowed 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 108.522 -0.918 . . . . 73.33 108.522 166.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . 56.83 -83.26 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 125.166 1.386 . . . . 74.21 113.11 176.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -152.25 -177.48 6.21 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.932 0.893 . . . . 71.31 110.207 -178.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . 99.07 103.73 2.45 Favored Glycine 0 C--N 1.349 1.277 0 CA-C-O 118.566 -1.13 . . . . 74.34 110.394 -174.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 446' ' ' PRO . . . . . 0.468 ' HA ' ' HB2' ' B' ' 339' ' ' PHE . 95.4 Cg_endo -74.06 71.35 4.32 Favored 'Trans proline' 0 C--N 1.382 2.327 0 C-N-CA 123.174 2.583 . . . . 72.44 113.593 -173.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 447' ' ' HIS . . . . . . . . . . . . . 13.2 t60 67.38 -67.84 0.17 Allowed 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 125.965 1.706 . . . . 63.45 112.812 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . 68.6 164.69 0.24 Allowed 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 125.154 1.382 . . . . 74.31 111.077 -173.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 449' ' ' ALA . . . . . . . . . . . . . . . -82.1 63.46 6.32 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 120.841 0.353 . . . . 74.42 110.705 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 450' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -168.79 -75.68 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.824 0.85 . . . . 63.22 109.934 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 61.2 t -71.65 92.57 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 123.531 0.732 . . . . 74.44 111.296 -166.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 452' ' ' VAL . . . . . . . . . . . . . 14.9 p -102.1 -9.78 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.15 0 CA-C-N 114.655 -1.157 . . . . 74.24 109.873 175.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 113.99 -81.3 0.29 Allowed Glycine 0 C--N 1.355 1.62 0 CA-C-N 116.296 -0.411 . . . . 73.44 113.611 169.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 454' ' ' LEU . . . . . 0.52 HD13 ' HA ' ' B' ' 110' ' ' ALA . 3.4 tm? -64.71 106.27 1.15 Allowed 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.539 0.736 . . . . 73.13 109.731 -174.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 455' ' ' THR . . . . . 0.538 HG23 ' HZ3' ' A' ' 209' ' ' LYS . 30.2 m -94.43 152.74 18.37 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 114.716 -1.129 . . . . 72.1 109.411 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -83.21 -86.37 0.11 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 122.493 0.317 . . . . 74.3 110.401 177.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 457' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 178.62 -68.49 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 108.372 -0.973 . . . . 65.21 108.372 -168.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 35.4 p -101.76 75.74 1.59 Allowed 'General case' 0 C--N 1.35 0.599 0 CA-C-O 122.631 1.205 . . . . 72.13 108.995 178.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 459' ' ' ASP . . . . . 0.45 ' HB3' ' O ' ' B' ' 463' ' ' THR . 9.1 m-20 -87.35 23.62 1.83 Allowed 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 114.195 -1.366 . . . . 73.31 111.144 -173.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 1.8 pp -67.4 -12.67 60.81 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 124.306 1.042 . . . . 65.42 112.863 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -75.32 -56.95 4.21 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 122.679 0.392 . . . . 75.0 110.756 -177.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -148.24 29.04 0.89 Allowed 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 123.109 0.563 . . . . 72.53 112.307 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 463' ' ' THR . . . . . 0.45 ' O ' ' HB3' ' B' ' 459' ' ' ASP . 6.1 p 54.16 -71.24 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 126.015 1.726 . . . . 71.14 114.144 -177.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 464' ' ' MET . . . . . 0.714 ' HA ' HH21 ' B' ' 56' ' ' ARG . 41.9 ttm -155.22 -44.58 0.08 Allowed 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.734 -0.604 . . . . 75.31 110.414 178.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.33 138.9 51.83 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 123.529 0.518 . . . . 72.15 110.4 175.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -64.81 -67.84 0.41 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.168 0.587 . . . . 65.13 110.492 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 467' ' ' ALA . . . . . 0.453 ' HB1' ' HB2' ' B' ' 271' ' ' ALA . . . 69.52 -11.56 0.5 Allowed 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 115.027 1.492 . . . . 75.3 115.027 168.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 468' ' ' LEU . . . . . 0.549 HD13 HD21 ' B' ' 272' ' ' ASN . 53.2 tp -65.66 -30.52 71.23 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.913 0.885 . . . . 74.32 112.07 -172.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 469' ' ' GLY . . . . . . . . . . . . . . . 119.89 56.36 0.25 Allowed Glycine 0 C--N 1.343 0.97 0 N-CA-C 111.232 -0.747 . . . . 62.03 111.232 -178.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 470' ' ' LEU . . . . . . . . . . . . . 6.8 mp -79.33 -27.98 42.08 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.172 0.589 . . . . 75.32 110.947 -173.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 471' ' ' LYS . . . . . 0.441 ' NZ ' ' HB3' ' B' ' 471' ' ' LYS . 0.2 OUTLIER . . . . . 0 CA--C 1.56 1.346 0 C-N-CA 124.287 1.035 . . . . 74.2 109.219 -172.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 1' ' ' MET . . . . . 0.452 ' SD ' ' N ' ' C' ' 1' ' ' MET . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 110.085 -0.339 . . . . 70.43 110.085 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.42 36.44 17.3 Favored 'General case' 0 C--N 1.351 0.671 0 C-N-CA 125.389 1.476 . . . . 70.41 112.473 176.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.8 73.11 4.37 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 109.825 -0.435 . . . . 71.34 109.825 175.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 4' ' ' LYS . . . . . 0.451 ' HE2' ' HE2' ' C' ' 69' ' ' TYR . 38.7 ttmt -39.42 101.15 0.02 OUTLIER 'General case' 0 C--N 1.353 0.739 0 C-N-CA 125.421 1.488 . . . . 70.52 113.766 -177.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -66.32 95.62 0.31 Allowed 'General case' 0 C--O 1.244 0.807 0 N-CA-C 108.558 -0.905 . . . . 72.32 108.558 164.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 6' ' ' ASP . . . . . 0.407 ' HA ' ' HH ' ' C' ' 66' ' ' TYR . 10.0 t70 -74.7 94.71 2.74 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 106.758 -1.571 . . . . 65.15 106.758 173.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 7' ' ' TYR . . . . . 0.416 ' HB3' ' HA ' ' C' ' 53' ' ' ALA . 50.1 m-85 -56.53 -35.74 68.42 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 114.766 -1.107 . . . . 73.43 111.551 -170.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 8' ' ' TYR . . . . . 0.433 ' HD1' HG21 ' C' ' 13' ' ' VAL . 65.4 m-85 -65.9 -42.65 89.95 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.411 -1.268 . . . . 74.23 111.801 175.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.42 -39.52 94.0 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 122.643 0.377 . . . . 63.34 110.848 177.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 59.2 mt -56.88 -43.14 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.446 0.698 . . . . 73.31 109.939 175.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 11' ' ' LEU . . . . . 0.528 ' HB3' ' HB1' ' C' ' 25' ' ' ALA . 96.2 mt -76.94 -15.15 59.75 Favored 'General case' 0 CA--C 1.556 1.195 0 CA-C-N 115.268 -0.878 . . . . 75.53 113.205 177.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.67 18.86 80.04 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 113.797 0.279 . . . . 74.43 113.797 -176.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 13' ' ' VAL . . . . . 0.433 HG21 ' HD1' ' C' ' 8' ' ' TYR . 30.1 m -111.73 155.03 43.75 Favored Pre-proline 0 N--CA 1.483 1.206 0 C-N-CA 124.442 1.097 . . . . 71.34 110.015 179.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -60.59 156.53 41.67 Favored 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 123.155 2.57 . . . . 74.43 113.729 177.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 33.4 mtp-105 -69.95 7.12 1.0 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 113.804 1.038 . . . . 74.35 113.804 -174.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -127.6 9.07 6.47 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.305 1.042 . . . . 71.24 109.302 -177.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.09 130.28 45.45 Favored 'General case' 0 C--N 1.356 0.883 0 C-N-CA 123.97 0.908 . . . . 75.2 110.951 -175.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 71.5 p -68.47 166.86 15.99 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.56 0.744 . . . . 74.41 110.713 -177.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 62.4 tp60 -57.75 -33.62 68.67 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.784 0.833 . . . . 74.45 111.908 -172.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -70.1 -40.53 74.9 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.038 0.535 . . . . 74.53 111.288 177.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -65.64 -39.9 91.92 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 122.757 0.423 . . . . 73.42 110.748 179.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 22' ' ' ILE . . . . . 0.558 HD11 ' HB3' ' C' ' 57' ' ' LEU . 86.1 mt -64.75 -42.57 95.34 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 C-N-CA 124.054 0.942 . . . . 75.54 110.372 176.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -61.99 -47.13 86.17 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.367 1.067 . . . . 74.13 111.326 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 78.7 mtm180 -71.24 -35.53 71.47 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 115.987 -0.551 . . . . 73.52 110.758 -178.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . 0.528 ' HB1' ' HB3' ' C' ' 11' ' ' LEU . . . -64.11 -40.39 96.09 Favored 'General case' 0 C--O 1.249 1.031 0 C-N-CA 123.11 0.564 . . . . 75.32 110.457 176.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 26' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -57.91 -60.25 4.0 Favored 'General case' 0 C--O 1.214 -0.778 0 CA-C-N 114.77 -1.105 . . . . 72.31 109.873 175.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -60.49 -41.32 94.01 Favored 'General case' 0 N--CA 1.483 1.183 0 O-C-N 124.068 0.855 . . . . 75.33 111.653 -174.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -53.07 -58.67 6.22 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.456 1.103 . . . . 75.55 110.922 176.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 97.1 mt -80.79 -11.09 59.66 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.521 -0.763 . . . . 71.43 111.06 -176.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -80.43 -26.23 38.54 Favored 'General case' 0 C--O 1.216 -0.684 0 C-N-CA 122.906 0.482 . . . . 75.32 109.731 171.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -81.2 -39.81 24.85 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.929 0.892 . . . . 73.5 110.404 175.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -70.16 -51.15 33.53 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.171 0.588 . . . . 71.12 109.789 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 33' ' ' TYR . . . . . 0.433 ' HB3' ' O ' ' C' ' 43' ' ' ALA . 35.6 m-85 -89.73 14.65 11.27 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 115.739 -0.664 . . . . 72.14 111.798 -176.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 34' ' ' HIS . . . . . 0.485 ' HD2' ' HB3' ' C' ' 36' ' ' ASP . 6.7 t60 -62.15 103.55 0.4 Allowed Pre-proline 0 N--CA 1.487 1.397 0 C-N-CA 123.947 0.899 . . . . 74.34 110.76 -174.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 35' ' ' PRO . . . . . 0.59 ' HB3' ' HG2' ' C' ' 44' ' ' GLU . 31.7 Cg_exo -59.55 -26.88 83.48 Favored 'Trans proline' 0 C--N 1.381 2.274 0 C-N-CA 123.285 2.656 . . . . 72.22 113.12 -171.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 36' ' ' ASP . . . . . 0.485 ' HB3' ' HD2' ' C' ' 34' ' ' HIS . 25.2 t70 -64.87 -39.0 92.86 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.25 1.02 . . . . 60.34 111.833 177.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 43.5 t -94.1 -54.34 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-O 121.277 0.56 . . . . 75.33 109.677 -177.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -100.04 92.21 5.14 Favored 'General case' 0 C--O 1.243 0.732 0 C-N-CA 124.558 1.143 . . . . 65.41 109.219 178.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -79.39 76.51 5.96 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 109.346 -0.613 . . . . 71.22 109.346 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 49.5 m -129.27 118.07 19.11 Favored Pre-proline 0 CA--C 1.538 0.491 0 CA-C-O 118.091 -0.957 . . . . 74.14 108.787 177.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -45.04 -45.26 14.47 Favored 'Trans proline' 0 C--N 1.382 2.335 0 C-N-CA 123.917 3.078 . . . . 75.0 113.679 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -60.08 -39.85 87.51 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.482 -0.781 . . . . 71.01 110.94 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 43' ' ' ALA . . . . . 0.433 ' O ' ' HB3' ' C' ' 33' ' ' TYR . . . -74.42 -19.79 60.28 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.885 -0.598 . . . . 71.45 111.447 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 44' ' ' GLU . . . . . 0.59 ' HG2' ' HB3' ' C' ' 35' ' ' PRO . 39.4 mt-10 -78.35 -45.57 22.21 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 109.547 -0.538 . . . . 74.04 109.547 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -68.7 -39.68 80.37 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.258 -0.883 . . . . 75.44 109.915 177.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 46' ' ' LYS . . . . . 0.557 ' O ' HG12 ' C' ' 50' ' ' ILE . 23.1 mmtm -61.7 -42.77 99.39 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.069 -0.514 . . . . 72.32 110.836 174.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -55.93 -43.13 77.09 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.551 0.74 . . . . 71.12 110.027 175.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 48' ' ' LYS . . . . . 0.402 ' HA ' ' HB2' ' C' ' 51' ' ' ASN . 97.1 mttt -72.59 -23.32 60.94 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-N 115.641 -0.709 . . . . 72.04 112.091 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -78.05 -25.61 47.85 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 118.139 0.427 . . . . 72.33 110.342 172.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 50' ' ' ILE . . . . . 0.557 HG12 ' O ' ' C' ' 46' ' ' LYS . 18.2 mm -75.35 -36.13 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 N-CA-C 108.287 -1.005 . . . . 75.43 108.287 172.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 51' ' ' ASN . . . . . 0.402 ' HB2' ' HA ' ' C' ' 48' ' ' LYS . 0.9 OUTLIER -68.27 -36.61 79.66 Favored 'General case' 0 C--O 1.2 -1.548 0 CA-C-N 114.883 -1.053 . . . . 74.04 110.018 173.643 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -65.52 -47.05 77.26 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.902 1.281 . . . . 75.54 109.986 178.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . 0.416 ' HA ' ' HB3' ' C' ' 7' ' ' TYR . . . -57.85 -61.41 2.55 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 113.998 -1.455 . . . . 63.1 111.01 178.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 54' ' ' TYR . . . . . 0.522 ' HD1' HG23 ' C' ' 22' ' ' ILE . 76.6 t80 -71.17 -12.87 61.72 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.745 -0.661 . . . . 75.01 111.533 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.64 -57.69 7.51 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 108.95 -0.759 . . . . 60.54 108.95 171.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 48.4 t -69.04 -22.69 26.41 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 CA-C-N 114.543 -1.208 . . . . 72.43 110.814 -178.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 57' ' ' LEU . . . . . 0.558 ' HB3' HD11 ' C' ' 22' ' ' ILE . 64.7 mt -109.13 9.2 26.2 Favored 'General case' 0 CA--C 1.564 1.484 0 N-CA-C 112.772 0.656 . . . . 75.02 112.772 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 46.6 t -51.69 -45.55 63.54 Favored 'General case' 0 N--CA 1.503 2.215 0 C-N-CA 124.66 1.184 . . . . 75.33 113.292 176.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . 0.431 ' HB2' ' HG3' ' C' ' 62' ' ' LYS . 2.0 m-20 -114.85 148.78 41.19 Favored Pre-proline 0 C--O 1.241 0.608 0 CA-C-N 115.492 -0.776 . . . . 72.03 109.145 177.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 60' ' ' PRO . . . . . 0.498 ' O ' ' HG2' ' C' ' 64' ' ' ARG . 69.0 Cg_exo -55.75 -30.6 76.76 Favored 'Trans proline' 0 C--N 1.374 1.921 0 C-N-CA 122.636 2.224 . . . . 73.21 111.984 167.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -64.41 -49.48 71.38 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.925 0.89 . . . . 62.13 111.054 175.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 62' ' ' LYS . . . . . 0.431 ' HG3' ' HB2' ' C' ' 59' ' ' ASP . 28.1 mtpp -66.7 -30.92 71.28 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-O 121.259 0.552 . . . . 75.43 110.07 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 23.0 tpt180 -60.65 -41.68 95.44 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 115.272 -0.876 . . . . 74.14 110.145 168.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 64' ' ' ARG . . . . . 0.498 ' HG2' ' O ' ' C' ' 60' ' ' PRO . 30.5 mmm180 -65.68 -27.09 68.1 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-O 119.305 -0.379 . . . . 74.15 111.525 176.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 1.7 mp -63.46 -45.08 98.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 109.581 -0.526 . . . . 71.5 109.581 168.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 66' ' ' TYR . . . . . 0.407 ' HH ' ' HA ' ' C' ' 6' ' ' ASP . 7.0 t80 -58.46 -46.39 86.69 Favored 'General case' 0 CA--C 1.562 1.429 0 N-CA-C 109.312 -0.625 . . . . 74.31 109.312 174.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -61.85 -35.68 78.99 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 124.122 0.969 . . . . 73.14 112.009 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 40.7 p -73.99 -22.55 59.56 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 119.421 -0.323 . . . . 74.43 110.775 177.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 69' ' ' TYR . . . . . 0.451 ' HE2' ' HE2' ' C' ' 4' ' ' LYS . 79.9 t80 -76.11 108.05 8.76 Favored 'General case' 0 C--N 1.355 0.84 0 N-CA-C 107.648 -1.241 . . . . 75.22 107.648 168.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 102.64 27.71 6.63 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.202 -0.759 . . . . 62.51 111.202 -167.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 25.1 m -145.95 -57.64 0.31 Allowed 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 103.494 -2.78 . . . . 72.34 103.494 173.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 5.4 m -81.2 140.18 35.09 Favored 'General case' 0 C--O 1.254 1.32 0 N-CA-C 104.618 -2.364 . . . . 73.35 104.618 157.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.23 -32.63 15.69 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.647 0.779 . . . . 73.23 110.505 -178.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -92.98 159.06 36.47 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 124.056 0.942 . . . . 53.23 109.888 177.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -59.5 150.85 73.08 Favored 'Trans proline' 0 CA--C 1.56 1.786 0 C-N-CA 122.318 2.012 . . . . 75.14 112.141 168.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -68.0 164.16 32.96 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 122.729 2.286 . . . . 71.22 112.788 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -60.64 129.73 30.53 Favored 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 122.973 2.449 . . . . 74.4 111.97 173.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 78' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -59.61 115.17 2.42 Favored 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 123.158 2.572 . . . . 74.44 113.182 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.16 130.6 24.55 Favored 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 122.532 2.155 . . . . 70.12 111.332 175.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -62.0 88.66 0.1 Allowed 'Trans proline' 0 C--N 1.379 2.179 0 C-N-CA 122.733 2.289 . . . . 74.31 111.754 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 155.77 -33.51 0.62 Allowed Glycine 0 N--CA 1.465 0.63 0 N-CA-C 110.238 -1.145 . . . . 75.2 110.238 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 126.96 157.7 9.58 Favored Glycine 0 C--N 1.352 1.47 0 CA-C-N 114.837 -0.682 . . . . 75.13 113.462 173.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -67.69 107.89 2.72 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 107.636 -1.246 . . . . 73.4 107.636 164.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -67.21 130.19 42.31 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.396 0.617 . . . . 75.11 111.719 -169.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 85' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -132.57 52.53 2.07 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.565 1.146 . . . . 74.41 108.122 174.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 50.9 m -64.01 96.38 0.14 Allowed 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 113.295 -1.775 . . . . 52.42 111.862 -174.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 114.95 -13.95 19.56 Favored Glycine 0 C--N 1.348 1.243 0 CA-C-N 115.658 -0.701 . . . . 74.34 113.105 176.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 88' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -112.3 144.01 42.44 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 117.392 0.596 . . . . 74.44 110.376 -169.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 89' ' ' ASP . . . . . 0.543 ' HA ' ' HG2' ' C' ' 171' ' ' PRO . 46.0 t0 -77.11 74.46 3.69 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.861 0.839 . . . . 72.23 110.746 -175.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 90' ' ' VAL . . . . . 0.457 HG13 ' HG3' ' C' ' 171' ' ' PRO . 5.2 p -48.85 -47.46 16.23 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.003 0 C-N-CA 126.128 1.771 . . . . 54.42 113.063 -171.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -61.78 -27.2 68.58 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 112.836 0.68 . . . . 75.25 112.836 -173.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -83.74 -11.09 57.61 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 111.796 0.295 . . . . 75.53 111.796 -173.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 13.5 m-30 -74.6 171.29 14.12 Favored 'General case' 0 CA--C 1.557 1.233 0 CA-C-O 120.846 0.355 . . . . 72.45 111.581 -174.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 93.6 p -76.52 174.34 10.43 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 115.105 1.52 . . . . 52.11 115.105 -164.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -51.87 -47.93 64.29 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.34 1.456 . . . . 72.35 112.644 174.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -56.94 -45.67 82.6 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.547 0.739 . . . . 74.24 110.59 -177.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 97' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.33 -47.76 80.73 Favored 'General case' 0 CA--C 1.56 1.34 0 CA-C-N 114.359 -1.291 . . . . 64.25 110.208 172.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -66.79 -14.09 62.23 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.739 0.815 . . . . 71.33 112.29 -179.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -95.73 -39.2 9.99 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.085 0.554 . . . . 74.43 112.196 177.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 43.8 tp -83.13 -51.28 7.65 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-O 121.403 0.621 . . . . 73.23 110.929 -176.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -87.75 -18.79 28.63 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.001 0.921 . . . . 75.04 110.607 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -40.33 -56.24 2.89 Favored Glycine 0 C--N 1.358 1.781 0 CA-C-O 118.137 -1.369 . . . . 74.41 115.335 177.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 0.8 OUTLIER -28.9 -37.15 0.04 OUTLIER 'Trans proline' 0 C--N 1.389 2.695 1 C-N-CA 125.831 4.354 . . . . 64.35 116.663 174.281 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -149.44 47.3 0.63 Allowed Glycine 0 C--N 1.345 1.056 0 C-N-CA 121.266 -0.492 . . . . 73.42 112.621 -179.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 105' ' ' LEU . . . . . 0.507 ' HB3' HD21 ' C' ' 169' ' ' ASN . 37.1 mt -61.19 80.55 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 121.266 0.555 . . . . 75.43 111.606 170.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 106' ' ' PHE . . . . . 0.445 ' HB3' ' H ' ' C' ' 168' ' ' GLY . 87.0 m-85 45.22 -110.25 0.21 Allowed 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 125.796 1.638 . . . . 64.24 114.159 -178.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . 66.17 15.0 62.48 Favored Glycine 0 C--N 1.362 1.981 0 C-N-CA 121.016 -0.611 . . . . 51.05 112.723 -162.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 59.48 -122.02 28.68 Favored Glycine 0 C--N 1.349 1.294 0 N-CA-C 111.072 -0.811 . . . . 74.41 111.072 -167.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 109' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -100.46 -7.77 23.9 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 122.919 0.488 . . . . 74.45 109.961 173.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 110' ' ' GLY . . . . . . . . . . . . . . . -93.11 -6.32 63.26 Favored Glycine 0 C--N 1.353 1.49 0 CA-C-O 119.293 -0.726 . . . . 73.14 114.322 -173.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 51.55 16.78 0.48 Allowed 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 125.016 1.327 . . . . 75.25 112.371 178.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 112' ' ' ARG . . . . . 0.413 ' HD2' ' HB2' ' C' ' 114' ' ' ARG . 1.5 tmt_? -58.27 -33.52 69.49 Favored 'General case' 0 CA--C 1.56 1.346 0 C-N-CA 124.165 0.986 . . . . 75.43 110.045 172.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 113' ' ' SER . . . . . . . . . . . . . 55.4 m 60.5 34.53 20.4 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.824 1.65 . . . . 72.53 112.382 176.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 114' ' ' ARG . . . . . 0.537 ' NE ' ' HA ' ' C' ' 114' ' ' ARG . 1.1 tpm_? -105.9 -159.32 0.7 Allowed 'General case' 0 C--O 1.209 -1.027 0 CA-C-O 117.847 -1.073 . . . . 74.05 111.023 176.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 115' ' ' LYS . . . . . 0.48 ' H ' ' HG3' ' C' ' 114' ' ' ARG . 5.5 tmtt? -58.24 125.37 22.94 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 120.146 1.339 . . . . 74.15 112.172 -163.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 116' ' ' GLY . . . . . 0.428 ' N ' ' HD3' ' C' ' 115' ' ' LYS . . . -63.48 118.96 14.92 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-N 114.667 -1.151 . . . . 54.4 113.829 177.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -88.5 163.54 15.87 Favored 'General case' 0 C--O 1.244 0.769 0 C-N-CA 124.733 1.213 . . . . 74.32 110.694 178.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -68.87 144.63 54.18 Favored 'General case' 0 C--O 1.245 0.849 0 N-CA-C 108.47 -0.937 . . . . 75.42 108.47 168.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 119' ' ' LEU . . . . . 0.459 HD21 HG21 ' C' ' 140' ' ' VAL . 0.0 OUTLIER -133.53 152.72 51.95 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 121.266 0.555 . . . . 75.21 110.625 175.97 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -105.49 113.52 27.15 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.046 -0.979 . . . . 72.31 108.714 -173.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 121' ' ' ALA . . . . . 0.664 ' HB3' ' HG3' ' C' ' 139' ' ' GLU . . . -111.79 116.84 31.36 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.485 -1.672 . . . . 75.44 106.485 172.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 122' ' ' GLU . . . . . 0.794 ' HB3' ' HA ' ' B' ' 186' ' ' THR . 20.7 tt0 -114.5 138.09 51.03 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 122.638 0.375 . . . . 74.12 110.429 -171.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -142.14 133.38 13.07 Favored Pre-proline 0 CA--C 1.544 0.72 0 CA-C-N 115.403 -0.817 . . . . 73.3 111.164 -168.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.93 128.55 18.97 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.383 2.056 . . . . 72.51 110.624 164.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 125' ' ' LEU . . . . . 0.473 ' O ' ' HA ' ' C' ' 180' ' ' LEU . 14.0 tp -153.56 165.48 35.76 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 106.763 -1.569 . . . . 75.32 106.763 -174.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 126' ' ' THR . . . . . 0.405 ' HB ' HD12 ' C' ' 181' ' ' LEU . 15.1 t -127.69 175.96 7.9 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 119.69 1.132 . . . . 61.53 110.278 173.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 127' ' ' LEU . . . . . 0.405 HD23 HD13 ' C' ' 180' ' ' LEU . 33.5 mt -58.89 -47.82 83.61 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.494 1.518 . . . . 62.25 110.876 -178.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 128' ' ' GLU . . . . . 0.477 ' HG3' ' HA ' ' C' ' 215' ' ' LEU . 11.4 mp0 -60.92 -36.73 80.07 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 114.904 -1.044 . . . . 75.24 110.281 177.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -78.77 -22.67 46.04 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.548 0.739 . . . . 75.51 112.519 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 130' ' ' ALA . . . . . 0.404 ' HB1' HG22 ' C' ' 153' ' ' VAL . . . -74.39 -33.16 62.97 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 108.92 -0.77 . . . . 73.14 108.92 174.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 131' ' ' PHE . . . . . 0.414 ' HB3' ' O ' ' C' ' 128' ' ' GLU . 54.8 t80 -65.64 -48.62 71.54 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 113.922 -1.49 . . . . 75.55 110.07 169.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 132' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -73.69 -12.88 60.87 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.331 0.652 . . . . 70.15 112.013 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -37.42 -84.87 0.01 OUTLIER Glycine 0 C--N 1.365 2.176 0 O-C-N 124.649 1.218 . . . . 65.31 114.606 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 134' ' ' GLY . . . . . 0.455 ' O ' ' HA ' ' C' ' 148' ' ' ARG . . . 49.36 -135.31 23.44 Favored Glycine 0 C--N 1.356 1.666 0 O-C-N 124.278 0.634 . . . . 73.12 114.237 174.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 135' ' ' GLU . . . . . 0.519 ' HG3' ' HB2' ' C' ' 148' ' ' ARG . 1.4 mp0 -89.92 91.96 8.81 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 108.044 -1.095 . . . . 73.03 108.044 177.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 136' ' ' ARG . . . . . . . . . . . . . 66.5 mtm180 -140.82 169.29 17.9 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 121.976 0.893 . . . . 72.12 110.751 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 137' ' ' VAL . . . . . 0.608 ' HB ' ' HG2' ' C' ' 144' ' ' ARG . 15.8 m -75.14 95.41 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 CA-C-N 113.769 -1.56 . . . . 73.11 111.122 -176.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 138' ' ' VAL . . . . . 0.508 HG13 ' HE3' ' C' ' 164' ' ' MET . 2.9 p -79.7 161.24 4.12 Favored 'Isoleucine or valine' 0 C--O 1.251 1.132 0 CA-C-N 114.176 -1.375 . . . . 72.14 112.48 -172.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 139' ' ' GLU . . . . . 0.664 ' HG3' ' HB3' ' C' ' 121' ' ' ALA . 7.7 tp10 -82.5 136.57 34.85 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 113.636 -1.62 . . . . 74.31 111.686 175.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 140' ' ' VAL . . . . . 0.459 HG21 HD21 ' C' ' 119' ' ' LEU . 5.5 p -169.76 99.52 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 124.534 1.133 . . . . 73.25 108.821 163.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 141' ' ' ALA . . . . . 0.576 ' HA ' HG23 ' B' ' 185' ' ' VAL . . . 66.32 22.64 10.83 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.247 1.019 . . . . 65.0 111.921 -178.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 86.93 -14.17 57.52 Favored Glycine 0 C--N 1.346 1.09 0 CA-C-N 116.208 -0.451 . . . . 52.4 112.726 -174.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 143' ' ' ARG . . . . . 0.604 HH12 HG23 ' C' ' 145' ' ' VAL . 0.0 OUTLIER -74.82 120.94 21.04 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 108.588 -0.893 . . . . 75.05 108.588 -178.688 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 144' ' ' ARG . . . . . 0.608 ' HG2' ' HB ' ' C' ' 137' ' ' VAL . 51.2 ttp180 -87.7 92.36 9.08 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 125.451 1.501 . . . . 71.51 109.918 -169.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 145' ' ' VAL . . . . . 0.604 HG23 HH12 ' C' ' 143' ' ' ARG . 65.5 t -98.27 121.03 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 C-N-CA 122.679 0.391 . . . . 75.03 111.067 -174.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 19.8 m -75.02 101.73 4.59 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.165 0.586 . . . . 73.22 109.819 177.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 7.5 p -152.36 158.99 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 122.337 0.255 . . . . 72.53 110.739 -174.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 148' ' ' ARG . . . . . 0.519 ' HB2' ' HG3' ' C' ' 135' ' ' GLU . 42.7 ttm180 -91.44 123.68 35.04 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 109.412 -0.588 . . . . 74.22 109.412 170.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 149' ' ' ILE . . . . . . . . . . . . . 34.2 pt -105.03 151.42 39.47 Favored Pre-proline 0 CA--C 1.548 0.904 0 N-CA-C 107.297 -1.371 . . . . 74.42 107.297 163.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -47.95 115.5 1.51 Allowed 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.852 2.368 . . . . 61.44 112.484 175.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 151' ' ' PRO . . . . . 0.52 ' HG2' ' HA2' ' C' ' 242' ' ' GLY . 28.9 Cg_endo -61.87 109.06 0.72 Allowed 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 122.613 2.209 . . . . 73.2 111.155 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 152' ' ' GLY . . . . . . . . . . . . . . . 124.5 122.96 2.7 Favored Glycine 0 C--N 1.343 0.925 0 CA-C-N 115.376 -0.829 . . . . 63.11 113.739 -173.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 153' ' ' VAL . . . . . 0.62 HG23 HG21 ' C' ' 178' ' ' VAL . 5.7 m -141.78 176.04 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 C-N-CA 123.586 0.754 . . . . 74.01 110.658 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 154' ' ' ARG . . . . . 0.697 ' HB2' ' HB2' ' C' ' 157' ' ' SER . 15.6 mtp180 -125.85 169.13 12.95 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 124.378 1.071 . . . . 75.32 109.877 -178.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 155' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -69.81 126.54 30.01 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.744 0.418 . . . . 74.51 110.814 175.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 67.9 11.7 61.14 Favored Glycine 0 C--N 1.349 1.288 0 CA-C-N 115.719 -0.673 . . . . 75.21 113.559 -178.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 157' ' ' SER . . . . . 0.697 ' HB2' ' HB2' ' C' ' 154' ' ' ARG . 33.0 t -74.07 132.8 42.67 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.131 0.572 . . . . 75.43 110.523 -174.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 158' ' ' VAL . . . . . 0.519 HG11 HG23 ' C' ' 177' ' ' VAL . 16.1 m -86.08 95.94 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 CA-C-N 115.527 -0.761 . . . . 72.31 109.192 171.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 159' ' ' ILE . . . . . 0.76 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 8.3 mt -68.55 90.53 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 107.468 -1.308 . . . . 72.31 107.468 171.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -83.59 100.19 10.65 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.404 -0.591 . . . . 75.13 109.404 -176.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 161' ' ' VAL . . . . . 0.496 HG11 ' HB3' ' C' ' 174' ' ' LEU . 2.6 p -102.84 103.98 36.51 Favored Pre-proline 0 CA--C 1.561 1.391 0 N-CA-C 108.477 -0.935 . . . . 75.24 108.477 175.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -62.54 142.55 90.51 Favored 'Trans proline' 0 C--N 1.386 2.534 0 C-N-CA 123.633 2.889 . . . . 75.23 113.805 -175.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 86.15 -24.98 7.32 Favored Glycine 0 C--N 1.347 1.188 0 CA-C-N 115.638 -0.71 . . . . 53.54 113.719 177.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 164' ' ' MET . . . . . 0.508 ' HE3' HG13 ' C' ' 138' ' ' VAL . 41.6 mtp -78.64 -6.47 55.77 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 113.403 0.89 . . . . 73.35 113.403 -174.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . -106.03 -151.5 19.43 Favored Glycine 0 C--N 1.334 0.465 0 N-CA-C 111.856 -0.497 . . . . 73.32 111.856 173.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . 109.27 73.36 0.77 Allowed Glycine 0 C--N 1.342 0.906 0 C-N-CA 121.562 -0.351 . . . . 75.44 112.392 -173.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 167' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -77.32 102.37 6.71 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 105.999 -1.852 . . . . 74.2 105.999 163.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 168' ' ' GLY . . . . . 0.445 ' H ' ' HB3' ' C' ' 106' ' ' PHE . . . 115.51 153.1 10.21 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 108.109 -1.997 . . . . 13.44 108.109 -161.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 169' ' ' ASN . . . . . 0.507 HD21 ' HB3' ' C' ' 105' ' ' LEU . 25.0 t-20 -66.07 -66.66 1.22 Allowed Pre-proline 0 CA--C 1.583 2.245 0 CA-C-O 116.74 -1.6 . . . . 62.44 112.833 -168.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 170' ' ' PRO . . . . . 0.451 ' HD3' ' HB3' ' C' ' 169' ' ' ASN . 51.8 Cg_exo -51.08 111.94 0.67 Allowed 'Trans proline' 0 C--N 1.401 3.309 0 CA-C-N 123.076 2.134 . . . . 73.55 113.381 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 171' ' ' PRO . . . . . 0.543 ' HG2' ' HA ' ' C' ' 89' ' ' ASP . 71.6 Cg_exo -47.58 139.9 17.32 Favored 'Trans proline' 0 C--N 1.383 2.377 0 C-N-CA 124.465 3.443 . . . . 74.02 115.698 -164.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -108.69 -127.17 5.5 Favored Glycine 0 C--N 1.344 1.004 0 N-CA-C 111.329 -0.708 . . . . 74.42 111.329 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 173' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -151.88 156.47 40.19 Favored 'General case' 0 C--O 1.249 1.077 0 CA-C-O 121.606 0.717 . . . . 74.51 110.423 173.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 174' ' ' LEU . . . . . 0.496 ' HB3' HG11 ' C' ' 161' ' ' VAL . 39.4 tp -104.32 123.48 47.47 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.488 -0.778 . . . . 75.22 110.367 -177.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 175' ' ' LEU . . . . . 0.518 HD22 ' HB ' ' C' ' 158' ' ' VAL . 92.8 mt -101.95 94.87 6.01 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.619 1.167 . . . . 72.15 108.159 173.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 176' ' ' LEU . . . . . 0.76 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 44.2 mt -78.78 101.47 7.62 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.472 -0.566 . . . . 74.33 109.472 174.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 177' ' ' VAL . . . . . 0.593 ' HB ' ' HB2' ' C' ' 122' ' ' GLU . 39.5 t -84.32 94.13 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 107.172 -1.418 . . . . 75.23 107.172 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 178' ' ' VAL . . . . . 0.62 HG21 HG23 ' C' ' 153' ' ' VAL . 2.7 p -82.02 125.3 39.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.623 0.725 . . . . 74.01 110.68 -178.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 179' ' ' ARG . . . . . 0.439 ' HB3' ' HG2' ' B' ' 188' ' ' ARG . 39.6 mmt180 -104.81 106.73 17.35 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 114.772 -1.104 . . . . 74.42 108.101 175.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 180' ' ' LEU . . . . . 0.473 ' HA ' ' O ' ' C' ' 125' ' ' LEU . 97.3 mt -70.37 148.93 47.85 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 123.677 0.611 . . . . 73.43 110.505 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 181' ' ' LEU . . . . . 0.405 HD12 ' HB ' ' C' ' 126' ' ' THR . 80.2 mt -72.62 166.58 41.12 Favored Pre-proline 0 N--CA 1.483 1.216 0 C-N-CA 123.443 0.697 . . . . 74.24 110.418 -174.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -55.57 78.74 0.03 OUTLIER 'Trans proline' 0 C--N 1.384 2.426 0 C-N-CA 122.837 2.358 . . . . 73.32 111.867 166.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 183' ' ' HIS . . . . . . . . . . . . . 76.3 t60 -173.11 57.21 0.21 Allowed Pre-proline 0 CA--C 1.559 1.297 0 CA-C-N 113.459 -1.7 . . . . 72.0 107.039 -171.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 184' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -86.16 66.73 5.12 Favored 'Trans proline' 0 C--N 1.385 2.454 0 C-N-CA 123.176 2.584 . . . . 74.25 111.323 -174.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 185' ' ' VAL . . . . . 0.508 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 21.2 t -92.66 -43.17 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 108.595 -0.891 . . . . 72.23 108.595 -173.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 186' ' ' PHE . . . . . 0.559 ' HB3' HD22 ' C' ' 193' ' ' LEU . 56.0 m-85 -119.75 119.85 34.83 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.307 0.643 . . . . 61.44 111.738 -171.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 187' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -96.58 109.7 22.25 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 107.03 -1.47 . . . . 75.14 107.03 171.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 188' ' ' LEU . . . . . 0.517 HD13 ' HD2' ' C' ' 240' ' ' PHE . 67.2 tp -82.21 151.25 26.96 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.654 0.74 . . . . 74.14 112.502 -177.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -142.02 101.92 4.03 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.252 1.421 . . . . 73.21 107.298 164.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 68.28 -89.53 0.21 Allowed Glycine 0 C--N 1.35 1.354 0 O-C-N 123.205 0.316 . . . . 74.2 113.188 -177.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 191' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -119.88 -22.91 6.59 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.61 1.164 . . . . 75.25 110.789 175.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -86.45 129.0 35.01 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.574 0.749 . . . . 65.13 110.934 -173.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 193' ' ' LEU . . . . . 0.559 HD22 ' HB3' ' C' ' 186' ' ' PHE . 62.6 mt -93.72 166.71 12.08 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.913 0.485 . . . . 65.15 111.106 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 194' ' ' TYR . . . . . 0.521 ' HA ' ' O ' ' C' ' 250' ' ' TYR . 4.1 t80 -137.82 103.65 5.06 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 109.049 -0.723 . . . . 75.43 109.049 169.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 195' ' ' ALA . . . . . 0.508 ' HA ' ' O ' ' C' ' 185' ' ' VAL . . . -101.77 -177.38 3.41 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 124.032 0.933 . . . . 65.11 110.093 176.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 56.3 m -132.56 130.17 39.96 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 108.113 -1.069 . . . . 53.42 108.113 168.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 197' ' ' LEU . . . . . . . . . . . . . 51.7 tp -106.54 135.24 48.39 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 123.769 0.828 . . . . 73.5 110.699 -171.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -78.98 101.7 7.92 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.395 0.678 . . . . 64.33 109.619 173.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 199' ' ' VAL . . . . . . . . . . . . . 40.8 t -119.11 109.94 38.54 Favored Pre-proline 0 N--CA 1.473 0.68 0 N-CA-C 108.052 -1.092 . . . . 73.12 108.052 175.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 200' ' ' PRO . . . . . 0.502 ' HA ' ' O ' ' C' ' 256' ' ' THR . 25.6 Cg_exo -60.7 147.2 95.65 Favored 'Trans proline' 0 C--N 1.363 1.325 0 C-N-CA 122.188 1.925 . . . . 73.11 111.546 175.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 201' ' ' ALA . . . . . . . . . . . . . . . -50.46 -48.39 81.6 Favored Pre-proline 0 CA--C 1.561 1.384 0 O-C-N 123.885 0.74 . . . . 74.35 112.6 176.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 202' ' ' PRO . . . . . 0.65 ' HB2' ' HA ' ' A' ' 273' ' ' ALA . 20.3 Cg_endo -58.34 -49.81 11.33 Favored 'Trans proline' 0 C--N 1.387 2.584 0 C-N-CA 121.572 1.515 . . . . 63.15 113.161 174.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 203' ' ' ILE . . . . . 0.48 HD12 ' HG2' ' C' ' 200' ' ' PRO . 37.6 mt -63.84 -29.32 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 C-N-CA 122.933 0.493 . . . . 74.02 111.22 -178.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.43 -46.02 67.76 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.166 0.986 . . . . 75.02 111.531 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 205' ' ' VAL . . . . . . . . . . . . . 72.6 t -68.52 -40.42 81.99 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 CA-C-N 115.466 -0.788 . . . . 74.52 111.617 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 206' ' ' VAL . . . . . 0.663 ' HA ' ' HE2' ' A' ' 270' ' ' LYS . 14.3 p -80.13 -38.25 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 112.787 0.662 . . . . 74.12 112.787 -173.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 85.05 71.56 1.31 Allowed Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 116.054 -0.521 . . . . 63.21 112.091 -167.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -98.62 -138.68 10.4 Favored Glycine 0 C--N 1.341 0.813 0 N-CA-C 111.294 -0.722 . . . . 51.32 111.294 176.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 209' ' ' LYS . . . . . 0.577 ' HG2' ' HA ' ' C' ' 222' ' ' ALA . 43.7 mtmt -139.7 146.3 39.45 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.451 0.7 . . . . 72.44 110.221 170.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 210' ' ' VAL . . . . . . . . . . . . . 19.9 m -138.15 137.17 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 107.923 -1.14 . . . . 71.52 107.923 173.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 211' ' ' ARG . . . . . 0.418 ' HB3' ' O ' ' B' ' 224' ' ' VAL . 37.2 ttm180 -75.7 127.79 33.8 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 120.685 0.278 . . . . 75.53 110.983 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -95.79 119.19 33.85 Favored 'General case' 0 C--O 1.245 0.854 0 N-CA-C 108.637 -0.875 . . . . 74.43 108.637 165.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 213' ' ' MET . . . . . . . . . . . . . 2.6 tmm? -72.08 121.69 19.66 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 107.583 -1.265 . . . . 63.12 107.583 176.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 214' ' ' THR . . . . . 0.416 ' OG1' HG11 ' C' ' 219' ' ' VAL . 0.2 OUTLIER -126.21 168.13 14.49 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 122.909 0.484 . . . . 72.34 110.568 -174.51 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 215' ' ' LEU . . . . . 0.477 ' HA ' ' HG3' ' C' ' 128' ' ' GLU . 17.0 mt -55.7 -45.27 77.9 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 125.398 1.479 . . . . 75.24 112.043 -176.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -78.64 -28.5 45.52 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 113.547 -1.66 . . . . 71.0 111.416 -176.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 154.98 -164.38 31.78 Favored Glycine 0 C--N 1.343 0.935 0 CA-C-O 119.575 -0.569 . . . . 74.41 112.018 -169.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -84.87 116.49 1.86 Allowed 'Trans proline' 0 CA--C 1.552 1.424 0 C-N-CA 122.691 2.261 . . . . 64.03 113.223 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 219' ' ' VAL . . . . . 0.503 HG21 HG22 ' B' ' 238' ' ' THR . 10.8 p -101.09 117.26 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 108.311 -0.996 . . . . 52.53 108.311 171.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 220' ' ' GLU . . . . . 0.459 ' HG2' ' HD2' ' C' ' 209' ' ' LYS . 27.4 tt0 -91.28 105.36 17.73 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 121.467 0.651 . . . . 72.32 109.986 -171.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 221' ' ' VAL . . . . . 0.409 HG13 HD22 ' C' ' 233' ' ' LEU . 64.4 t -70.23 119.92 17.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 114.846 -1.07 . . . . 74.03 112.019 -174.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 222' ' ' ALA . . . . . 0.577 ' HA ' ' HG2' ' C' ' 209' ' ' LYS . . . -76.76 99.13 5.01 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 124.149 0.906 . . . . 73.3 109.806 169.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 98.6 t -73.79 138.54 76.77 Favored Pre-proline 0 CA--C 1.555 1.161 0 C-N-CA 123.651 0.781 . . . . 73.11 109.126 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 224' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -92.35 172.86 2.32 Favored 'Trans proline' 0 C--N 1.368 1.605 0 C-N-CA 123.778 2.985 . . . . 73.11 111.787 174.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -72.85 154.24 53.52 Favored 'Trans proline' 0 C--N 1.371 1.714 0 C-N-CA 121.57 1.513 . . . . 74.4 110.837 174.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 226' ' ' ARG . . . . . 0.51 HH22 ' HB2' ' A' ' 261' ' ' LEU . 10.4 mpt_? 57.95 58.67 3.49 Favored 'General case' 0 N--CA 1.483 1.204 0 O-C-N 124.023 0.827 . . . . 71.5 111.651 177.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 227' ' ' THR . . . . . 0.567 HG21 HG11 ' C' ' 253' ' ' VAL . 90.0 m -97.28 112.23 24.13 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 122.29 -0.256 . . . . 73.3 110.625 178.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 228' ' ' GLN . . . . . 0.682 HE21 ' HG2' ' A' ' 259' ' ' GLU . 26.2 mp0 -89.03 163.41 15.53 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.941 0.897 . . . . 74.32 112.206 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -70.36 115.02 9.06 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 113.516 -1.674 . . . . 65.31 109.58 175.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 102.26 8.65 43.67 Favored Glycine 0 C--N 1.336 0.546 0 O-C-N 123.562 0.539 . . . . 62.04 113.449 -178.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 231' ' ' ARG . . . . . . . . . . . . . 41.4 mtp180 -67.89 169.87 9.11 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 117.502 0.651 . . . . 75.03 109.435 164.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 232' ' ' LYS . . . . . 0.436 ' HA ' ' O ' ' C' ' 251' ' ' LEU . 35.4 ttmt -142.06 142.96 32.88 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.794 0.807 . . . . 74.05 112.288 -173.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 233' ' ' LEU . . . . . 0.661 HD12 ' HB2' ' C' ' 251' ' ' LEU . 3.2 mp -106.72 154.45 20.95 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.766 1.626 . . . . 74.22 108.542 178.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 10.5 ptp85 -130.89 88.08 2.57 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 122.268 1.032 . . . . 72.34 108.77 165.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 235' ' ' LEU . . . . . 0.421 ' HA ' ' HA3' ' B' ' 240' ' ' GLY . 30.5 mt -77.59 118.07 19.64 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 114.874 -1.057 . . . . 74.34 109.624 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -81.03 124.71 29.4 Favored 'General case' 0 C--O 1.241 0.605 0 CA-C-N 115.081 -0.963 . . . . 73.41 111.547 -168.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 66.78 29.64 75.0 Favored Glycine 0 C--N 1.345 1.038 0 CA-C-N 115.219 -0.901 . . . . 71.42 112.442 -177.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 34.4 mmtm -118.24 4.42 11.93 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.722 0.809 . . . . 75.11 110.722 178.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 239' ' ' GLY . . . . . 0.423 ' HA2' HD12 ' C' ' 193' ' ' LEU . . . -88.67 -135.4 5.25 Favored Glycine 0 C--N 1.347 1.164 0 N-CA-C 110.625 -0.99 . . . . 75.2 110.625 170.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 240' ' ' PHE . . . . . 0.517 ' HD2' HD13 ' C' ' 188' ' ' LEU . 44.8 m-85 -101.57 108.01 53.8 Favored Pre-proline 0 C--O 1.25 1.093 0 CA-C-N 116.968 0.384 . . . . 75.14 110.092 171.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 241' ' ' PRO . . . . . 0.634 ' HA ' ' H ' ' C' ' 246' ' ' ARG . 40.5 Cg_endo -67.51 113.28 2.87 Favored 'Trans proline' 0 C--N 1.366 1.462 0 C-N-CA 122.027 1.818 . . . . 71.53 110.281 170.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 242' ' ' GLY . . . . . 0.52 ' HA2' ' HG2' ' C' ' 151' ' ' PRO . . . -90.45 -162.45 38.27 Favored Glycine 0 N--CA 1.483 1.773 0 CA-C-N 115.347 -0.842 . . . . 70.14 113.217 -169.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -58.95 -33.38 98.69 Favored 'Trans proline' 0 C--N 1.374 1.888 0 C-N-CA 122.677 2.251 . . . . 71.42 112.11 170.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -79.01 -24.43 43.7 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.127 0.571 . . . . 71.42 110.59 169.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 74.89 98.8 0.1 Allowed Glycine 0 C--N 1.343 0.959 0 CA-C-O 119.38 -0.678 . . . . 63.24 114.149 176.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 246' ' ' ARG . . . . . 0.634 ' H ' ' HA ' ' C' ' 241' ' ' PRO . 10.5 ptt180 -162.48 -72.81 0.05 OUTLIER 'General case' 0 CA--C 1.558 1.257 0 N-CA-C 114.187 1.18 . . . . 71.32 114.187 168.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 247' ' ' GLY . . . . . 0.475 ' N ' ' HG3' ' C' ' 246' ' ' ARG . . . 45.62 128.27 0.0 OUTLIER Glycine 0 C--N 1.358 1.758 0 N-CA-C 117.449 1.74 . . . . 63.23 117.449 -159.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -125.95 119.29 27.35 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 108.308 -0.997 . . . . 73.54 108.308 175.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 249' ' ' LEU . . . . . 0.448 ' HG ' HD12 ' C' ' 251' ' ' LEU . 15.4 tp -86.78 118.49 26.22 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.039 -0.982 . . . . 74.23 109.726 -173.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 250' ' ' TYR . . . . . 0.584 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 20.4 m-85 -98.46 119.88 37.93 Favored 'General case' 0 C--O 1.211 -0.948 0 N-CA-C 108.138 -1.06 . . . . 71.43 108.138 175.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 251' ' ' LEU . . . . . 0.661 ' HB2' HD12 ' C' ' 233' ' ' LEU . 2.6 mp -111.24 139.46 46.62 Favored 'General case' 0 N--CA 1.506 2.355 0 CA-C-N 118.706 0.684 . . . . 72.0 110.029 178.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -94.2 131.14 40.08 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.984 -0.747 . . . . 75.41 108.984 171.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 253' ' ' VAL . . . . . 0.567 HG11 HG21 ' C' ' 227' ' ' THR . 83.9 t -78.65 123.93 36.28 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 C-N-CA 123.619 0.768 . . . . 73.5 111.557 -175.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 254' ' ' ARG . . . . . 0.502 HH12 ' HA3' ' A' ' 230' ' ' GLY . 9.8 mmt85 -101.36 120.92 41.0 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 109.167 -0.679 . . . . 75.13 109.167 166.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 255' ' ' ILE . . . . . . . . . . . . . 36.0 mm -83.78 94.6 3.49 Favored 'Isoleucine or valine' 0 C--O 1.241 0.636 0 O-C-N 124.265 0.978 . . . . 75.24 108.801 170.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 256' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' C' ' 200' ' ' PRO . 0.0 OUTLIER -97.45 144.11 27.5 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 114.883 -1.053 . . . . 70.25 109.731 -179.799 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 2.8 pp -98.79 153.16 38.0 Favored Pre-proline 0 CA--C 1.558 1.267 0 C-N-CA 122.742 0.417 . . . . 75.21 111.227 -177.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -41.7 -24.34 0.26 Allowed 'Trans proline' 0 C--N 1.389 2.672 1 C-N-CA 125.369 4.046 . . . . 74.41 118.333 -170.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 259' ' ' GLU . . . . . 0.527 ' HB2' HG12 ' B' ' 38' ' ' ILE . 58.1 mm-40 59.88 -73.33 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 124.477 1.111 . . . . 72.3 111.08 -165.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.06 159.14 31.43 Favored 'General case' 0 C--N 1.352 0.674 0 N-CA-C 109.026 -0.731 . . . . 73.41 109.026 171.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 261' ' ' LEU . . . . . 0.512 ' HB2' HH21 ' A' ' 226' ' ' ARG . 75.7 mt -145.12 170.9 15.33 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.045 -1.095 . . . . 74.53 108.045 165.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 262' ' ' THR . . . . . 0.411 ' HA ' ' HB2' ' B' ' 44' ' ' ALA . 45.1 p -122.09 159.96 49.52 Favored Pre-proline 0 CA--C 1.547 0.844 0 N-CA-C 107.587 -1.264 . . . . 61.23 107.587 164.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -38.82 -47.65 2.74 Favored 'Trans proline' 0 C--N 1.387 2.554 0 C-N-CA 123.535 2.823 . . . . 74.2 113.982 175.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -68.82 -53.26 22.54 Favored 'General case' 0 C--N 1.351 0.639 0 CA-C-N 115.886 -0.597 . . . . 71.04 111.344 -178.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -48.24 -56.86 6.91 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 123.806 0.691 . . . . 71.03 109.474 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 266' ' ' GLU . . . . . 0.512 ' O ' ' HG2' ' C' ' 270' ' ' LYS . 33.9 tt0 -57.23 -41.53 79.71 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 114.908 -1.042 . . . . 73.1 111.364 -177.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -61.69 -41.81 98.09 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 123.424 0.69 . . . . 71.12 112.784 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 268' ' ' LEU . . . . . 0.412 ' HG ' HD13 ' A' ' 268' ' ' LEU . 10.8 mp -67.14 -40.31 86.71 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.783 0.433 . . . . 70.11 110.177 177.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -59.03 -36.51 75.11 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 116.353 -0.385 . . . . 63.11 110.761 172.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 270' ' ' LYS . . . . . 0.512 ' HG2' ' O ' ' C' ' 266' ' ' GLU . 25.3 mmtp -60.74 -50.65 72.62 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 122.859 0.464 . . . . 75.43 110.276 177.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 271' ' ' LYS . . . . . 0.467 ' HB2' HD23 ' A' ' 268' ' ' LEU . 47.2 mtpt -53.68 -41.37 66.83 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 124.112 0.883 . . . . 75.33 111.326 177.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 95.5 mt -60.96 -45.54 94.32 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 123.799 0.687 . . . . 74.33 111.135 176.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -64.13 -31.01 72.04 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.153 0.581 . . . . 43.22 111.98 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 274' ' ' GLU . . . . . 0.481 ' HG3' ' O ' ' C' ' 270' ' ' LYS . 30.7 mt-10 -77.66 -34.51 53.04 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.143 0.577 . . . . 63.21 110.402 177.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -67.06 -24.23 65.95 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 115.824 -0.625 . . . . 70.04 110.48 171.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 276' ' ' TYR . . . . . 0.437 ' HB3' HD13 ' A' ' 203' ' ' ILE . 4.1 m-85 -80.51 -35.87 34.0 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.281 -0.872 . . . . 75.52 112.077 175.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -66.98 -28.35 68.19 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 109.491 -0.559 . . . . 65.52 109.491 169.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -72.19 3.3 4.7 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 123.8 0.84 . . . . 72.22 112.878 173.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 279' ' ' ARG . . . . . 0.426 HH11 ' HD1' ' C' ' 276' ' ' TYR . 71.9 mtp180 -74.51 -18.85 60.55 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 118.15 0.432 . . . . 75.11 110.4 168.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.558 1.269 0 N-CA-C 109.602 -0.518 . . . . 75.14 109.602 175.826 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.4 mtp . . . . . 0 N--CA 1.472 0.631 0 N-CA-C 110.222 -0.288 . . . . 64.12 110.222 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.4 33.55 22.41 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 113.979 1.103 . . . . 74.44 113.979 164.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -85.27 48.36 1.56 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 122.789 0.435 . . . . 74.04 110.193 176.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -38.09 108.85 0.09 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.021 1.728 . . . . 64.14 115.37 -172.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.433 ' HD2' HD12 ' A' ' 10' ' ' ILE . 27.7 mmtp -72.26 105.2 3.95 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 108.84 -0.8 . . . . 74.32 108.84 164.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -72.99 96.06 2.09 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 105.905 -1.887 . . . . 62.43 105.905 165.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.408 ' HB2' HD13 ' A' ' 57' ' ' LEU . 67.6 m-85 -61.87 -31.18 71.43 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-N 114.96 -1.018 . . . . 73.34 111.503 -170.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -67.41 -40.23 85.57 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.408 -0.815 . . . . 73.33 109.884 176.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.85 -37.93 89.2 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 122.908 0.483 . . . . 70.01 110.921 177.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.433 HD12 ' HD2' ' A' ' 5' ' ' LYS . 65.3 mt -59.33 -41.46 84.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 123.1 0.56 . . . . 74.23 110.267 173.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.6 mt -80.49 -8.54 59.6 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 115.756 -0.656 . . . . 73.11 112.606 176.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 70.01 18.23 74.37 Favored Glycine 0 C--N 1.353 1.484 0 N-CA-C 114.239 0.455 . . . . 73.42 114.239 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.3 m -103.14 163.3 17.78 Favored Pre-proline 0 N--CA 1.486 1.347 0 C-N-CA 124.374 1.07 . . . . 72.52 110.709 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -47.54 146.75 7.24 Favored 'Trans proline' 0 C--N 1.387 2.577 0 C-N-CA 123.6 2.867 . . . . 50.12 114.043 174.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -71.36 15.78 0.12 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 114.284 1.216 . . . . 75.43 114.284 -170.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -159.8 33.56 0.18 Allowed 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 108.625 -0.88 . . . . 71.2 108.625 173.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.34 149.58 50.16 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.436 1.094 . . . . 74.14 111.834 -177.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 76.1 p -77.8 170.76 16.03 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.516 0.726 . . . . 75.03 111.88 -174.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -55.95 -41.28 74.46 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.673 1.189 . . . . 71.11 112.559 -172.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.36 -32.2 66.25 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 122.629 0.372 . . . . 72.43 110.581 -177.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.447 ' HG2' ' NH2' ' A' ' 24' ' ' ARG . 40.1 mt-10 -65.96 -40.97 91.75 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 121.101 0.476 . . . . 71.14 109.771 175.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.6 mp -65.04 -38.57 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-N 114.763 -1.108 . . . . 73.31 110.416 176.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -75.55 -33.36 60.66 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.567 0.747 . . . . 75.22 111.307 -175.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.546 ' HA ' ' HZ2' ' A' ' 27' ' ' LYS . 85.3 mtm-85 -72.78 -43.64 62.55 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 122.693 0.397 . . . . 73.12 110.566 175.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.04 -31.07 70.48 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.797 -0.638 . . . . 72.43 111.146 177.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -62.55 -58.65 6.79 Favored 'General case' 0 C--O 1.213 -0.856 0 CA-C-O 118.61 -0.709 . . . . 73.1 109.381 173.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.546 ' HZ2' ' HA ' ' A' ' 24' ' ' ARG . 35.5 mtmm -53.97 -39.43 65.98 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 123.949 0.781 . . . . 74.22 111.241 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -54.38 -58.3 7.98 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.182 0.993 . . . . 75.52 110.966 177.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.407 ' HA ' ' HB3' ' A' ' 32' ' ' GLN . 75.4 mt -86.38 -8.99 57.23 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 115.074 -0.967 . . . . 75.12 111.635 -173.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.12 -21.62 25.88 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.686 0.794 . . . . 71.54 109.95 174.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -90.87 -31.76 16.3 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.483 0.713 . . . . 72.33 110.509 170.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.407 ' HB3' ' HA ' ' A' ' 29' ' ' LEU . 35.1 tt0 -73.36 -49.06 29.3 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.999 0.52 . . . . 73.31 111.326 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -98.15 23.78 7.86 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.077 0.551 . . . . 72.41 110.796 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 51.1 t60 -63.2 101.38 0.26 Allowed Pre-proline 0 CA--C 1.554 1.101 0 C-N-CA 124.968 1.307 . . . . 73.54 112.195 -170.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -73.79 -5.44 17.05 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 123.561 2.841 . . . . 75.51 112.552 -172.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -73.73 -27.29 61.11 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 124.571 1.148 . . . . 73.23 111.479 174.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 60.5 t -123.47 -46.71 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 CA-C-O 121.561 0.696 . . . . 73.25 109.716 178.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -98.62 80.96 2.62 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.703 1.201 . . . . 64.12 109.883 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.48 69.4 10.05 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 115.806 -0.633 . . . . 73.11 109.649 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 24.2 m -108.86 134.46 20.34 Favored Pre-proline 0 N--CA 1.479 0.988 0 CA-C-O 118.518 -0.753 . . . . 71.24 109.822 -179.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -48.07 -52.24 8.6 Favored 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 123.88 3.054 . . . . 73.53 113.419 -178.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 8.2 tp10 -62.42 -32.61 73.48 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 122.85 0.46 . . . . 64.43 110.873 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -82.15 -14.75 55.21 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.928 0.491 . . . . 73.42 110.435 -179.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.422 ' O ' ' HD3' ' A' ' 48' ' ' LYS . 49.0 mm-40 -68.67 -58.9 3.57 Favored 'General case' 0 C--N 1.358 0.94 0 N-CA-C 107.21 -1.404 . . . . 63.35 107.21 170.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -53.23 -47.01 69.35 Favored 'General case' 0 C--N 1.352 0.705 0 CA-C-N 113.842 -1.527 . . . . 62.44 110.396 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.512 ' O ' HG12 ' A' ' 50' ' ' ILE . 0.1 OUTLIER -71.02 -48.9 50.39 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 114.747 -1.115 . . . . 74.03 111.193 -172.385 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -53.45 -46.54 69.91 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 123.849 0.718 . . . . 73.32 110.508 177.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.422 ' HD3' ' O ' ' A' ' 44' ' ' GLU . 2.1 mtpm? -63.3 -36.37 83.46 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 115.37 -0.832 . . . . 75.14 111.525 178.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -69.99 -30.26 67.55 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 122.62 0.368 . . . . 71.44 111.274 173.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.512 HG12 ' O ' ' A' ' 46' ' ' LYS . 18.3 mm -68.95 -36.87 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 108.843 -0.799 . . . . 74.43 108.843 175.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.427 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 11.5 m-80 -80.5 -20.09 44.41 Favored 'General case' 0 C--O 1.211 -0.955 0 CA-C-N 114.435 -1.257 . . . . 73.43 111.385 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -71.98 -50.38 29.28 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.328 1.051 . . . . 75.34 109.01 171.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.16 -50.78 71.77 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 113.494 -1.684 . . . . 65.45 111.076 176.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -64.51 -37.96 89.34 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-N 115.068 -0.969 . . . . 73.53 110.525 177.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 51' ' ' ASN . . . -54.23 -46.91 72.66 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.289 0.636 . . . . 72.52 112.169 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 67.9 t -72.94 -45.86 53.9 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.116 0 CA-C-N 115.955 -0.566 . . . . 74.52 110.996 177.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.408 HD13 ' HB2' ' A' ' 7' ' ' TYR . 64.2 mt -93.57 0.84 56.77 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 114.206 1.188 . . . . 74.35 114.206 -166.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.1 t -73.58 -52.79 12.25 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.464 0.649 . . . . 74.34 109.85 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -88.89 137.21 29.95 Favored Pre-proline 0 C--O 1.241 0.657 0 CA-C-N 114.737 -1.119 . . . . 74.34 109.745 -176.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.408 ' O ' ' HG2' ' A' ' 64' ' ' ARG . 48.0 Cg_exo -56.19 -26.9 63.14 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 123.346 2.697 . . . . 72.41 112.576 178.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -64.4 -59.88 3.83 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.814 0.846 . . . . 72.3 111.451 -176.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 42.0 mtmt -77.36 -23.62 50.82 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 115.842 -0.617 . . . . 74.54 111.275 -176.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 44.9 tpt85 -54.77 -54.64 39.49 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 108.919 -0.771 . . . . 74.11 108.919 166.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.458 ' HE ' ' HA ' ' A' ' 64' ' ' ARG . 2.2 mmp_? -63.27 -33.37 75.36 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.582 0.753 . . . . 74.25 112.168 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.67 HG23 ' HG3' ' A' ' 76' ' ' PRO . 89.2 mt -59.46 -45.59 93.54 Favored 'Isoleucine or valine' 0 C--O 1.253 1.24 0 C-N-CA 123.105 0.562 . . . . 74.41 110.783 174.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -66.74 -42.03 86.9 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 116.237 -0.438 . . . . 75.4 109.823 178.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -53.93 -45.82 71.32 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 123.161 0.585 . . . . 64.04 110.852 175.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 50.5 p -75.36 -19.3 59.66 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.224 -0.444 . . . . 75.44 112.013 -178.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -70.5 112.33 6.7 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 109.04 -0.726 . . . . 75.32 109.04 174.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 103.36 19.99 11.68 Favored Glycine 0 N--CA 1.474 1.171 0 N-CA-C 111.711 -0.556 . . . . 64.23 111.711 -172.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 97.6 m -142.05 -58.09 0.46 Allowed 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 103.623 -2.732 . . . . 71.23 103.623 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 29.4 m -77.8 134.37 38.03 Favored 'General case' 0 C--O 1.256 1.427 0 N-CA-C 104.399 -2.445 . . . . 74.23 104.399 155.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.18 -29.27 16.55 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.328 0.651 . . . . 74.04 111.15 -177.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -94.22 168.35 11.73 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 124.085 0.954 . . . . 75.1 109.929 177.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -53.32 140.36 62.7 Favored 'Trans proline' 0 C--N 1.378 2.108 0 C-N-CA 122.164 1.909 . . . . 75.41 112.621 165.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.67 ' HG3' HG23 ' A' ' 65' ' ' ILE . 91.4 Cg_endo -72.52 175.53 10.01 Favored 'Trans proline' 0 C--N 1.375 1.925 0 C-N-CA 123.644 2.896 . . . . 74.25 112.562 -177.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.46 121.15 9.31 Favored 'Trans proline' 0 C--N 1.38 2.2 0 C-N-CA 122.002 1.801 . . . . 73.45 111.186 171.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -63.32 130.2 27.84 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.594 2.196 . . . . 73.2 112.063 176.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -59.5 141.57 97.58 Favored 'Trans proline' 0 C--N 1.381 2.269 0 C-N-CA 122.64 2.227 . . . . 71.05 111.32 172.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.29 78.28 0.45 Allowed 'Trans proline' 0 C--N 1.382 2.298 0 C-N-CA 123.156 2.571 . . . . 74.31 112.694 -177.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 159.29 -35.38 0.48 Allowed Glycine 0 N--CA 1.467 0.713 0 N-CA-C 109.669 -1.372 . . . . 62.41 109.669 -174.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.477 ' HA3' ' HA ' ' A' ' 106' ' ' PHE . . . 130.04 167.22 12.01 Favored Glycine 0 C--N 1.351 1.375 0 CA-C-N 114.899 -0.651 . . . . 53.03 112.926 170.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -69.25 100.9 1.38 Allowed 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 108.175 -1.046 . . . . 74.41 108.175 166.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.454 ' O ' ' HD1' ' A' ' 85' ' ' PHE . 12.6 t70 -63.61 152.16 39.65 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.88 0.872 . . . . 71.31 112.969 -174.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.454 ' HD1' ' O ' ' A' ' 84' ' ' ASP . 0.3 OUTLIER -148.54 72.43 1.19 Allowed 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 124.699 1.199 . . . . 73.24 107.783 169.882 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.552 ' HA ' ' HA3' ' A' ' 163' ' ' GLY . 44.8 m -55.3 87.75 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 114.562 1.319 . . . . 74.44 114.562 -174.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.61 ' HA2' ' HB3' ' A' ' 171' ' ' PRO . . . 94.56 14.48 50.21 Favored Glycine 0 N--CA 1.47 0.942 0 CA-C-N 116.237 -0.438 . . . . 70.11 113.425 176.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -123.19 111.72 16.82 Favored 'General case' 0 C--O 1.245 0.835 0 C-N-CA 122.922 0.489 . . . . 72.34 110.133 -169.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -68.69 92.97 0.49 Allowed 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.077 0.551 . . . . 71.44 110.917 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.483 HG12 ' HG2' ' A' ' 91' ' ' GLU . 2.2 p -31.82 -49.21 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 125.521 1.529 . . . . 75.21 114.311 169.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.483 ' HG2' HG12 ' A' ' 90' ' ' VAL . 7.7 mm-40 -68.27 -14.88 63.31 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.992 0.738 . . . . 75.33 112.992 -169.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -78.54 -42.3 29.75 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.504 0.722 . . . . 61.35 111.228 171.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -77.59 178.85 6.94 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 113.46 0.911 . . . . 73.34 113.46 -165.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 67.4 p -58.18 144.4 40.76 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.777 1.231 . . . . 74.5 113.711 -166.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.452 ' O ' ' HG3' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -53.65 -43.02 68.45 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 114.401 -1.272 . . . . 74.52 110.973 172.516 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -51.18 -52.88 40.01 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.368 1.067 . . . . 75.03 111.479 176.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -57.62 -46.68 83.81 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 114.786 -1.097 . . . . 72.32 110.179 178.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.438 ' HA ' HD11 ' A' ' 105' ' ' LEU . 96.3 mt-30 -70.04 -13.01 62.02 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 115.757 -0.656 . . . . 74.14 112.527 -178.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' A' ' 95' ' ' GLU . 52.5 mt-10 -88.87 -52.63 5.01 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 122.982 0.513 . . . . 70.02 111.515 172.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 36.2 tp -65.14 -50.95 64.04 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.368 0.667 . . . . 74.33 111.014 -175.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -87.88 -6.0 58.3 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 115.606 -0.725 . . . . 72.11 110.74 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -42.68 -59.17 3.29 Favored Glycine 0 C--N 1.355 1.585 0 CA-C-O 118.625 -1.097 . . . . 72.43 114.859 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -39.83 -26.89 0.18 Allowed 'Trans proline' 0 C--N 1.393 2.877 0 C-N-CA 124.883 3.722 . . . . 64.43 116.365 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -152.03 37.63 0.81 Allowed Glycine 0 C--N 1.354 1.568 0 CA-C-O 118.975 -0.903 . . . . 54.4 113.427 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.438 HD11 ' HA ' ' A' ' 98' ' ' GLN . 33.9 mt -53.52 85.19 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 117.487 0.644 . . . . 74.25 112.232 174.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.477 ' HA ' ' HA3' ' A' ' 82' ' ' GLY . 0.6 OUTLIER 20.99 -110.88 0.01 OUTLIER 'General case' 0 CA--C 1.565 1.533 0 C-N-CA 127.348 2.259 . . . . 74.45 113.526 177.638 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.48 ' HA2' ' HA2' ' A' ' 168' ' ' GLY . . . 58.46 13.74 17.74 Favored Glycine 0 C--N 1.366 2.236 0 N-CA-C 114.388 0.515 . . . . 44.0 114.388 178.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 70.62 -94.22 0.49 Allowed Glycine 0 C--N 1.35 1.342 0 N-CA-C 110.753 -0.939 . . . . 71.34 110.753 -165.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -140.02 17.57 2.46 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.716 1.207 . . . . 74.55 108.853 170.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -62.63 -23.61 65.25 Favored Glycine 0 C--N 1.356 1.667 0 CA-C-N 115.78 -0.645 . . . . 55.25 114.324 -175.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 77.22 -39.19 0.31 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 125.313 1.445 . . . . 75.52 112.982 174.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.32 -15.06 59.1 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.176 0.591 . . . . 75.13 110.463 174.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 2.5 m 73.46 68.6 0.11 Allowed 'General case' 0 C--N 1.36 1.038 0 C-N-CA 124.668 1.187 . . . . 74.21 110.776 172.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.463 ' HD2' ' HA ' ' A' ' 114' ' ' ARG . 0.2 OUTLIER -124.62 170.46 10.92 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 112.379 0.511 . . . . 74.52 112.379 -172.178 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.563 ' HZ1' ' HB3' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -57.95 149.39 23.1 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 125.981 1.712 . . . . 73.31 113.374 -164.462 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -100.97 -164.13 27.81 Favored Glycine 0 CA--C 1.546 1.984 0 CA-C-N 115.573 -0.74 . . . . 73.4 113.304 -178.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -108.8 137.61 46.46 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 124.121 0.968 . . . . 74.43 112.257 176.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -57.87 99.04 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 122.194 0.997 . . . . 74.23 111.685 173.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 53.5 tp -103.92 157.54 17.02 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 114.45 -1.25 . . . . 75.42 110.698 -173.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 40.5 ttp180 -109.38 142.25 40.6 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 108.817 -0.809 . . . . 74.51 108.817 170.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.527 ' HB1' HD11 ' A' ' 174' ' ' LEU . . . -128.36 159.33 35.66 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.598 0.713 . . . . 54.41 111.113 177.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -116.47 109.73 17.68 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 105.944 -1.873 . . . . 72.42 105.944 -177.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.502 ' HB3' ' HA ' ' A' ' 178' ' ' VAL . 37.5 tp -98.86 96.58 4.11 Favored Pre-proline 0 N--CA 1.475 0.805 0 N-CA-C 108.228 -1.027 . . . . 74.14 108.228 -174.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.524 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 97.5 Cg_endo -78.75 107.72 2.31 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 121.065 1.176 . . . . 75.33 109.307 -176.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.438 ' HB3' HD23 ' A' ' 180' ' ' LEU . 43.1 tp -106.76 131.47 53.84 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 122.755 0.422 . . . . 72.43 110.238 -167.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 72.9 m -59.41 124.19 19.25 Favored 'General case' 0 CA--C 1.555 1.171 0 O-C-N 124.609 1.193 . . . . 71.34 109.037 173.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.569 ' HB3' HD22 ' A' ' 215' ' ' LEU . 61.1 mt -53.78 -40.02 65.91 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 124.16 0.984 . . . . 75.21 111.743 -171.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 16.0 mp0 -65.02 -35.42 81.14 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 114.228 -1.351 . . . . 75.32 109.683 -178.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -78.67 -22.45 46.77 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.657 0.783 . . . . 64.33 111.165 177.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -68.05 -33.73 75.13 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 109.952 -0.388 . . . . 65.44 109.952 171.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.425 ' HB2' HD13 ' A' ' 215' ' ' LEU . 82.3 t80 -74.75 -47.55 30.54 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 115.236 -0.893 . . . . 74.51 111.488 173.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 51.2 m170 -69.87 -53.82 16.28 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.416 0.686 . . . . 75.25 110.921 -173.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.91 -168.42 41.23 Favored Glycine 0 C--N 1.344 1.003 0 CA-C-N 115.78 -0.645 . . . . 71.54 112.84 -178.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 98.44 -164.62 21.17 Favored Glycine 0 C--N 1.349 1.28 0 C-N-CA 123.011 0.339 . . . . 70.42 113.512 175.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -72.06 110.59 6.64 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.535 0.734 . . . . 73.14 110.409 177.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -93.85 122.48 36.38 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 122.861 0.464 . . . . 75.05 110.604 177.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 57.4 t -78.18 113.93 18.08 Favored 'Isoleucine or valine' 0 C--O 1.243 0.728 0 N-CA-C 108.428 -0.953 . . . . 75.04 108.428 169.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.535 HG11 HG13 ' A' ' 145' ' ' VAL . 3.8 p -134.25 136.57 53.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 124.49 1.116 . . . . 73.34 108.683 178.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -123.78 133.32 53.85 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.312 0.645 . . . . 71.3 110.677 -167.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.534 HG11 HD23 ' B' ' 8' ' ' LEU . 12.4 p -166.04 135.34 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.128 0.971 . . . . 75.1 109.318 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 53.23 38.49 27.76 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.196 0.999 . . . . 74.24 112.774 173.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 86.52 -21.82 16.23 Favored Glycine 0 C--N 1.353 1.504 0 CA-C-N 116.551 -0.295 . . . . 54.15 113.323 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.563 HH12 ' HG2' ' A' ' 164' ' ' MET . 12.1 tpt180 -81.82 99.27 8.91 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.138 0.975 . . . . 72.43 111.019 -179.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 38.0 ttp180 -84.65 89.38 7.47 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 107.867 -1.16 . . . . 74.41 107.867 165.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.535 HG13 HG11 ' A' ' 138' ' ' VAL . 3.0 p -97.09 145.58 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 114.783 -1.099 . . . . 73.53 110.877 -175.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 34.2 t -106.04 85.38 2.2 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.425 -0.807 . . . . 64.43 109.1 177.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 35.7 m -84.58 121.88 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 N-CA-C 109.929 -0.397 . . . . 73.42 109.929 -177.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -74.44 97.16 3.02 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.101 0.477 . . . . 74.32 109.817 -178.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 26.9 pt -78.35 123.41 85.8 Favored Pre-proline 0 CA--C 1.557 1.219 0 CA-C-N 115.267 -0.878 . . . . 74.52 109.305 174.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -63.16 135.02 48.58 Favored 'Trans proline' 0 C--N 1.372 1.78 0 C-N-CA 122.642 2.228 . . . . 74.22 112.204 176.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -61.84 96.15 0.14 Allowed 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 122.373 2.048 . . . . 74.15 111.143 171.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.553 ' HA2' ' HD2' ' A' ' 240' ' ' PHE . . . 116.5 35.14 1.21 Allowed Glycine 0 C--N 1.342 0.896 0 CA-C-N 115.481 -0.782 . . . . 75.51 111.536 -172.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.509 HG22 HG13 ' A' ' 178' ' ' VAL . 4.7 p -89.26 135.47 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 123.39 0.676 . . . . 75.43 109.496 -178.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.765 ' HD2' ' HA ' ' A' ' 191' ' ' GLN . 7.9 mtm-85 -123.77 148.72 46.4 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 115.322 -0.854 . . . . 73.23 110.502 -162.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.434 ' HB3' ' O ' ' A' ' 188' ' ' LEU . 6.8 tp10 -52.58 118.82 3.89 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 124.357 1.063 . . . . 72.32 110.464 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 105.78 -2.54 38.86 Favored Glycine 0 C--N 1.344 1.006 0 CA-C-N 115.71 -0.677 . . . . 74.33 113.276 -176.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 26.6 t -72.34 104.31 3.69 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 108.915 -0.772 . . . . 74.23 108.915 177.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.462 HG21 HG23 ' A' ' 177' ' ' VAL . 55.6 t -86.03 95.88 4.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 123.689 0.795 . . . . 74.02 109.558 -178.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.52 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 47.7 mt -77.84 92.82 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 N-CA-C 107.809 -1.182 . . . . 75.24 107.809 169.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 65.5 ttt-85 -72.68 114.96 11.39 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 107.928 -1.138 . . . . 75.21 107.928 177.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.455 HG13 ' SD ' ' A' ' 164' ' ' MET . 7.1 p -125.46 129.51 24.4 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 123.523 0.729 . . . . 71.41 109.154 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -73.93 149.3 41.89 Favored 'Trans proline' 0 CA--C 1.552 1.413 0 C-N-CA 122.069 1.846 . . . . 74.53 111.949 177.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . 0.553 ' HA2' ' HA ' ' A' ' 171' ' ' PRO . . . 83.43 -25.51 4.98 Favored Glycine 0 N--CA 1.48 1.602 0 N-CA-C 116.244 1.258 . . . . 70.43 116.244 169.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.563 ' HG2' HH12 ' A' ' 143' ' ' ARG . 66.5 mtp -75.0 -23.67 58.28 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 117.679 0.74 . . . . 64.15 111.763 -178.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.453 ' HA2' HD12 ' A' ' 174' ' ' LEU . . . -82.37 -103.21 0.44 Allowed Glycine 0 C--N 1.35 1.35 0 CA-C-O 119.747 -0.474 . . . . 73.33 113.255 -175.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -54.99 115.61 5.8 Favored Glycine 0 C--O 1.278 2.861 0 O-C-N 124.005 0.473 . . . . 74.5 113.422 173.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -56.85 103.45 0.11 Allowed 'General case' 0 C--N 1.355 0.812 0 O-C-N 127.59 2.582 . . . . 75.42 109.088 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.48 ' HA2' ' HA2' ' A' ' 107' ' ' GLY . . . -176.85 139.12 4.29 Favored Glycine 0 N--CA 1.436 -1.32 0 CA-C-N 113.347 -1.751 . . . . 64.21 108.943 -170.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . 0.483 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . 0.1 OUTLIER -73.55 -49.46 6.49 Favored Pre-proline 0 CA--C 1.559 1.294 0 N-CA-C 109.04 -0.726 . . . . 63.54 109.04 -173.422 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.483 ' HD3' ' HB3' ' A' ' 169' ' ' ASN . 28.2 Cg_exo -68.58 146.3 67.08 Favored 'Trans proline' 0 C--N 1.379 2.132 0 N-CA-C 107.991 -1.58 . . . . 73.02 107.991 156.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.61 ' HB3' ' HA2' ' A' ' 87' ' ' GLY . 56.4 Cg_endo -64.17 120.99 8.49 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.878 2.385 . . . . 71.25 116.312 -161.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -62.93 -43.0 99.56 Favored Glycine 0 C--N 1.374 2.681 0 C-N-CA 119.169 -1.491 . . . . 72.4 111.927 161.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 95.31 147.74 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 127.396 2.279 . . . . 71.14 108.563 175.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.527 HD11 ' HB1' ' A' ' 121' ' ' ALA . 27.9 tp -140.17 143.94 36.38 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.09 0.471 . . . . 74.2 111.162 -171.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 54.0 mt -108.95 90.57 3.33 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 114.746 -1.115 . . . . 72.12 108.254 170.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.52 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 78.7 mt -69.37 87.43 0.44 Allowed 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 109.335 -0.617 . . . . 74.52 109.335 174.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.462 HG23 HG21 ' A' ' 158' ' ' VAL . 11.9 t -84.31 104.67 12.86 Favored 'Isoleucine or valine' 0 C--O 1.245 0.827 0 N-CA-C 106.182 -1.784 . . . . 71.11 106.182 174.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.509 HG13 HG22 ' A' ' 153' ' ' VAL . 9.9 p -67.51 125.67 25.55 Favored 'Isoleucine or valine' 0 C--N 1.349 0.566 0 CA-C-O 121.961 0.886 . . . . 74.13 109.381 -175.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.527 ' HD2' HG12 ' B' ' 18' ' ' VAL . 28.6 mmt180 -111.94 119.18 37.63 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 107.54 -1.281 . . . . 73.42 107.54 179.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.438 HD23 ' HB3' ' A' ' 125' ' ' LEU . 56.7 mt -83.38 144.02 29.92 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-N 118.348 0.522 . . . . 74.04 110.014 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 41.6 mt -54.22 153.54 9.41 Favored Pre-proline 0 N--CA 1.488 1.447 0 C-N-CA 123.898 0.879 . . . . 73.22 112.808 -169.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.93 16.79 0.41 Allowed 'Trans proline' 0 C--N 1.387 2.557 0 C-N-CA 122.97 2.447 . . . . 74.32 113.329 175.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -60.91 101.9 0.28 Allowed Pre-proline 0 CA--C 1.557 1.247 0 N-CA-C 107.213 -1.403 . . . . 73.35 107.213 164.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -78.55 25.87 0.53 Allowed 'Trans proline' 0 C--N 1.375 1.932 0 C-N-CA 124.066 3.177 . . . . 61.24 115.478 -161.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 82.3 t -96.88 -32.27 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 109.946 -0.39 . . . . 72.34 109.946 -176.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . 0.737 ' HE1' ' HA ' ' A' ' 214' ' ' THR . 35.3 m-85 -145.9 98.87 3.18 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 121.279 0.561 . . . . 72.31 111.935 178.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . 0.614 ' HB3' ' HB2' ' A' ' 194' ' ' TYR . 52.3 ttt180 -85.93 81.63 8.45 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 107.863 -1.162 . . . . 75.51 107.863 164.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.435 ' HB2' HD22 ' A' ' 193' ' ' LEU . 35.5 tp -78.1 94.52 4.7 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-N 115.228 -0.896 . . . . 74.21 108.671 175.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -114.26 129.98 56.64 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.185 0.594 . . . . 70.31 109.753 -176.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 77.11 -73.89 1.92 Allowed Glycine 0 C--N 1.351 1.389 0 O-C-N 123.85 0.719 . . . . 65.41 111.98 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.765 ' HA ' ' HD2' ' A' ' 154' ' ' ARG . 13.6 pt20 -154.78 -7.23 0.14 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.655 0.782 . . . . 72.32 111.173 172.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -123.05 152.87 40.57 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.472 -0.785 . . . . 72.32 110.671 -167.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.435 HD22 ' HB2' ' A' ' 188' ' ' LEU . 38.8 mt -95.33 152.52 18.31 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 114.642 -1.163 . . . . 74.25 111.032 -168.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.614 ' HB2' ' HB3' ' A' ' 187' ' ' ARG . 91.8 m-85 -132.61 103.93 6.39 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 107.633 -1.247 . . . . 73.14 107.633 171.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.424 ' HB2' HD22 ' A' ' 251' ' ' LEU . . . -129.9 112.6 13.7 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.472 1.109 . . . . 74.34 110.008 -172.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 86.0 m -68.72 122.56 18.81 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-O 120.944 0.402 . . . . 70.21 111.187 -179.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.477 HD22 HD13 ' A' ' 251' ' ' LEU . 44.7 tp -108.97 119.54 39.86 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.861 0.865 . . . . 74.1 110.337 -173.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -80.02 116.96 20.44 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 108.296 -1.001 . . . . 63.3 108.296 174.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 2.8 p -144.23 127.66 8.82 Favored Pre-proline 0 N--CA 1.478 0.951 0 C-N-CA 123.335 0.654 . . . . 74.33 110.282 -175.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -72.8 150.87 50.59 Favored 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 121.868 1.712 . . . . 70.05 111.88 176.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -42.24 -60.23 2.23 Favored Pre-proline 0 N--CA 1.487 1.406 0 N-CA-C 116.485 2.032 . . . . 71.34 116.485 -173.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -75.07 -18.96 18.15 Favored 'Trans proline' 0 C--N 1.382 2.339 0 CA-C-N 121.524 1.58 . . . . 73.32 113.081 -173.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 16.4 mt -73.37 -34.73 44.21 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 N-CA-C 109.257 -0.646 . . . . 71.02 109.257 172.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.54 -42.87 81.99 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 123.094 0.558 . . . . 74.14 111.482 173.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 71.6 t -72.96 -44.45 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 123.59 0.756 . . . . 64.22 112.513 -174.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 78.7 t -88.76 -37.08 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 122.759 0.424 . . . . 74.41 110.933 -176.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 98.53 77.55 1.33 Allowed Glycine 0 C--N 1.339 0.713 0 N-CA-C 111.651 -0.58 . . . . 72.35 111.651 -176.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -103.44 -144.35 13.73 Favored Glycine 0 C--N 1.34 0.763 0 CA-C-N 115.255 -0.472 . . . . 73.32 112.042 178.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.538 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 43.1 mtmt -127.55 147.03 50.33 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 122.863 0.465 . . . . 73.34 110.614 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 24.8 m -137.14 -177.07 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.634 1.174 . . . . 63.11 108.861 170.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 26.2 ttm180 -116.62 129.24 56.04 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.609 0.763 . . . . 74.32 108.998 171.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -109.03 149.37 29.36 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.444 -0.947 . . . . 74.41 108.444 173.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -88.78 145.95 25.3 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.059 -0.719 . . . . 74.15 109.059 174.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' THR . . . . . 0.737 ' HA ' ' HE1' ' A' ' 186' ' ' PHE . 41.0 p -127.94 174.27 9.32 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 123.914 0.886 . . . . 74.1 109.635 172.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.569 HD22 ' HB3' ' A' ' 127' ' ' LEU . 24.6 mt -59.19 -36.56 75.56 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.001 0.92 . . . . 73.14 110.889 -176.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.419 ' HA ' ' NZ ' ' B' ' 2' ' ' LYS . 15.1 mm-40 -98.87 2.07 46.32 Favored 'General case' 0 CA--C 1.554 1.127 0 CA-C-N 114.714 -1.13 . . . . 64.44 112.539 -172.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 140.8 -173.53 23.12 Favored Glycine 0 N--CA 1.483 1.77 0 CA-C-O 119.253 -0.748 . . . . 63.05 112.785 176.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -79.28 155.67 25.41 Favored 'Trans proline' 0 C--N 1.369 1.643 0 C-N-CA 122.644 2.229 . . . . 74.13 111.8 176.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 18.4 m -148.26 157.08 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 C-N-CA 123.888 0.875 . . . . 73.4 111.066 -177.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -91.24 124.93 35.82 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.951 0.9 . . . . 75.04 109.809 178.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 97.1 t -136.13 123.3 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.22 1.008 . . . . 74.51 109.163 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.538 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -89.98 133.68 34.66 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 118.163 0.438 . . . . 70.4 111.207 178.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.552 ' HA ' HD11 ' B' ' 441' ' ' ILE . 44.5 t -78.61 145.42 67.17 Favored Pre-proline 0 CA--C 1.561 1.384 0 C-N-CA 125.571 1.548 . . . . 71.22 110.051 -178.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -78.93 172.12 15.45 Favored 'Trans proline' 0 C--N 1.386 2.509 0 C-N-CA 122.767 2.312 . . . . 75.51 111.51 172.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.42 150.74 28.73 Favored 'Trans proline' 0 C--N 1.373 1.829 0 C-N-CA 121.87 1.713 . . . . 72.53 113.274 175.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . 0.475 HH12 ' HB2' ' C' ' 261' ' ' LEU . 85.9 mtt-85 64.16 30.04 13.81 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 125.851 1.661 . . . . 75.13 111.477 172.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.539 HG22 HD22 ' A' ' 233' ' ' LEU . 43.7 m -66.15 106.27 1.6 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.516 1.526 . . . . 64.32 111.291 178.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . 0.444 ' HB3' ' HD2' ' A' ' 231' ' ' ARG . 6.4 tp-100 -93.16 140.39 29.57 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.021 0.928 . . . . 75.32 110.657 -176.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . 0.439 ' HA ' ' HB ' ' A' ' 253' ' ' VAL . . . -66.07 157.59 30.68 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.849 0.86 . . . . 65.12 111.782 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 82.96 -40.19 2.79 Favored Glycine 0 C--N 1.347 1.179 0 CA-C-N 116.189 -0.459 . . . . 75.54 112.043 -177.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.444 ' HD2' ' HB3' ' A' ' 228' ' ' GLN . 92.6 mtt180 -66.4 157.67 31.3 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 124.147 0.979 . . . . 74.44 111.437 175.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.743 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 3.3 mptp? -109.94 125.59 53.01 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 114.856 -1.065 . . . . 72.22 108.418 177.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.539 HD22 HG22 ' A' ' 227' ' ' THR . 87.4 mt -76.14 104.82 6.85 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.883 -0.784 . . . . 71.4 108.883 177.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 18.4 ttp180 -84.95 109.6 18.27 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.27 0.628 . . . . 73.41 110.324 178.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.531 HD23 HG21 ' B' ' 441' ' ' ILE . 0.4 OUTLIER -120.57 117.1 26.73 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.972 0.909 . . . . 74.24 109.75 175.127 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 30.8 mmtm -60.69 151.08 30.18 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.916 1.286 . . . . 71.01 113.277 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 71.23 32.21 65.63 Favored Glycine 0 C--N 1.356 1.656 0 CA-C-N 114.682 -1.145 . . . . 74.2 113.604 172.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.459 ' HG3' HD11 ' A' ' 235' ' ' LEU . 41.8 mmtm -130.32 -30.31 1.94 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.524 0.73 . . . . 74.1 110.565 -174.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -73.04 173.87 47.64 Favored Glycine 0 C--N 1.351 1.396 0 O-C-N 123.301 0.376 . . . . 74.43 112.451 171.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . 0.553 ' HD2' ' HA2' ' A' ' 152' ' ' GLY . 5.7 m-85 -91.78 158.15 40.51 Favored Pre-proline 0 N--CA 1.48 1.044 0 C-N-CA 123.204 0.602 . . . . 73.41 110.85 -169.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -61.09 111.05 0.97 Allowed 'Trans proline' 0 C--N 1.387 2.558 0 C-N-CA 123.054 2.503 . . . . 73.33 112.158 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -125.31 -150.34 7.73 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-O 119.337 -0.702 . . . . 73.52 112.212 179.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . 0.419 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 32.6 Cg_endo -63.33 -30.77 73.48 Favored 'Trans proline' 0 C--N 1.373 1.848 0 C-N-CA 122.895 2.397 . . . . 72.5 113.07 -177.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . 0.426 ' HB3' HE22 ' A' ' 191' ' ' GLN . . . -107.28 12.7 27.93 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.867 0.867 . . . . 70.11 111.4 178.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 87.66 -161.61 32.37 Favored Glycine 0 C--N 1.345 1.053 0 CA-C-N 116.327 -0.397 . . . . 62.24 112.158 -174.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 66.4 mtt85 -59.46 108.83 0.77 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.337 0.655 . . . . 75.41 110.676 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -70.5 -157.39 2.11 Favored Glycine 0 C--N 1.347 1.142 0 CA-C-N 115.605 -0.725 . . . . 70.31 113.758 -178.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -100.48 166.28 11.01 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.924 0.869 . . . . 75.44 110.641 178.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.472 ' HB3' ' HG ' ' A' ' 235' ' ' LEU . 14.5 tp -102.64 128.36 49.36 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 106.284 -1.746 . . . . 73.32 106.284 164.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.743 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 18.6 m-85 -108.77 105.1 14.54 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 107.609 -1.256 . . . . 71.3 107.609 173.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.533 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 40.1 mt -90.7 103.93 16.57 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 109.245 -0.65 . . . . 74.54 109.245 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.488 ' HG2' ' HG3' ' A' ' 232' ' ' LYS . 22.3 mt-10 -76.7 101.69 5.89 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.146 0.978 . . . . 75.41 108.758 -170.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.439 ' HB ' ' HA ' ' A' ' 229' ' ' ALA . 27.0 t -64.31 122.96 16.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-N 114.849 -1.068 . . . . 71.34 112.504 -167.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . 0.521 ' HD2' ' SD ' ' B' ' 26' ' ' MET . 5.7 mmt180 -122.42 96.29 4.98 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.423 1.089 . . . . 73.14 108.604 169.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.442 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 73.1 mt -72.94 117.09 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 114.171 -1.377 . . . . 74.34 109.57 178.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 41.1 p -110.3 174.17 5.99 Favored 'General case' 0 C--O 1.255 1.348 0 C-N-CA 124.445 1.098 . . . . 74.52 110.092 178.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 26.1 pt -132.87 151.8 78.68 Favored Pre-proline 0 CA--C 1.554 1.135 0 CA-C-N 114.93 -1.032 . . . . 73.4 108.778 177.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -87.22 22.09 0.97 Allowed 'Trans proline' 0 C--N 1.365 1.429 0 C-N-CA 122.725 2.283 . . . . 74.45 112.962 -171.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 33.83 -87.89 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 125.303 1.441 . . . . 75.12 113.49 -165.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.47 132.52 47.14 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.775 0.83 . . . . 75.12 110.945 -170.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.508 HD13 HG11 ' C' ' 205' ' ' VAL . 86.0 mt -127.64 170.42 12.7 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.521 0.728 . . . . 72.32 111.094 -174.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 75.1 p -104.8 159.78 28.21 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-N 114.598 -1.183 . . . . 74.31 110.174 171.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_exo -32.7 -46.92 0.3 Allowed 'Trans proline' 0 C--N 1.383 2.346 0 C-N-CA 124.831 3.687 . . . . 74.33 116.044 172.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -57.62 -64.41 0.91 Allowed 'General case' 0 C--O 1.25 1.114 0 C-N-CA 123.987 0.915 . . . . 71.44 111.197 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -59.5 -48.3 82.17 Favored 'General case' 0 C--N 1.349 0.562 0 CA-C-N 114.54 -1.209 . . . . 73.22 110.2 -176.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' GLU . . . . . 0.523 ' O ' ' HG2' ' A' ' 270' ' ' LYS . 7.1 tp10 -53.03 -52.93 56.88 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 124.617 1.198 . . . . 73.45 111.099 -176.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -63.5 -45.19 91.84 Favored 'General case' 0 C--O 1.254 1.294 0 O-C-N 124.199 0.937 . . . . 64.12 111.94 -178.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 9.4 mp -63.38 -34.09 76.97 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-N 115.826 -0.624 . . . . 73.14 111.358 178.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' TRP . . . . . 0.406 ' O ' HG11 ' C' ' 206' ' ' VAL . 61.7 m95 -75.97 -30.51 58.63 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 118.677 -0.677 . . . . 75.0 111.349 177.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . 0.523 ' HG2' ' O ' ' A' ' 266' ' ' GLU . 0.0 OUTLIER -57.37 -60.73 3.2 Favored 'General case' 0 C--O 1.267 2.005 0 N-CA-C 108.214 -1.032 . . . . 73.12 108.214 175.103 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . 0.667 ' HZ1' ' HB3' ' A' ' 271' ' ' LYS . 9.9 mtpm? -55.67 -50.24 70.78 Favored 'General case' 0 C--N 1.357 0.928 0 CA-C-N 112.002 -2.363 . . . . 70.22 110.66 -178.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 2.1 tt -58.1 -58.93 6.28 Favored 'General case' 0 C--O 1.191 -2.026 0 O-C-N 124.298 0.999 . . . . 71.54 108.992 -177.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . 0.464 ' O ' ' HB3' ' A' ' 276' ' ' TYR . . . -56.21 -48.77 75.77 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 114.236 1.199 . . . . 72.23 114.236 -170.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -89.21 -21.85 23.06 Favored 'General case' 0 C--O 1.252 1.189 0 N-CA-C 112.68 0.622 . . . . 74.35 112.68 -172.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -80.47 -26.24 38.4 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.988 -0.445 . . . . 72.24 110.697 168.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . 0.464 ' HB3' ' O ' ' A' ' 273' ' ' ALA . 2.2 t80 -58.92 -55.81 30.28 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 125.79 1.636 . . . . 75.02 107.797 170.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' TYR . . . . . 0.426 ' HH ' ' HA ' ' B' ' 235' ' ' GLU . 0.8 OUTLIER -44.91 -66.1 0.44 Allowed 'General case' 0 C--O 1.249 1.077 0 O-C-N 125.538 1.774 . . . . 72.14 109.431 173.593 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -62.82 -14.24 43.11 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 114.76 -1.109 . . . . 75.41 113.841 -175.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 86.7 mtm180 -132.17 34.16 3.82 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 122.927 0.491 . . . . 75.15 110.228 -175.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.568 1.673 0 O-C-N 124.261 0.976 . . . . 72.5 113.134 175.712 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.443 ' N ' ' SD ' ' B' ' 1' ' ' MET . 1.6 mpt? . . . . . 0 N--CA 1.48 1.073 0 N-CA-C 110.338 -0.245 . . . . 74.12 110.338 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.419 ' NZ ' ' HA ' ' A' ' 216' ' ' GLU . 13.3 mptt -75.16 116.93 16.43 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.668 0.787 . . . . 62.45 110.788 178.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -168.58 -38.15 0.02 OUTLIER 'General case' 0 C--O 1.242 0.701 0 C-N-CA 124.361 1.064 . . . . 74.04 109.358 174.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 23.3 t 65.39 -177.59 0.18 Allowed 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.567 1.147 . . . . 52.14 111.027 -179.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 94.6 m 68.69 131.76 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.561 1.144 . . . . 74.34 112.182 177.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 138' ' ' VAL . 42.8 pt -140.5 173.44 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.584 0.754 . . . . 65.34 110.565 -175.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -132.82 129.83 39.03 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.544 0.738 . . . . 72.22 110.269 177.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . 0.534 HD23 HG11 ' A' ' 140' ' ' VAL . 50.1 tp -78.51 155.56 29.72 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.036 0.934 . . . . 75.22 110.97 -174.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.31 -68.31 0.69 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 122.932 0.493 . . . . 73.12 111.437 176.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . 0.484 HD23 ' HB1' ' A' ' 121' ' ' ALA . 51.7 mt 68.32 2.98 3.51 Favored 'General case' 0 N--CA 1.501 2.094 0 C-N-CA 124.871 1.269 . . . . 74.1 111.844 -164.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 56.7 mt 55.36 71.07 1.35 Allowed Pre-proline 0 CA--C 1.555 1.169 0 C-N-CA 124.564 1.146 . . . . 72.11 112.137 -175.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -98.66 -145.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 123.922 3.082 . . . . 71.41 111.053 173.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 76.1 mt -59.84 -38.85 83.25 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.444 0.698 . . . . 75.11 111.478 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 3.2 pp -139.55 151.6 46.21 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.561 0.744 . . . . 64.54 110.349 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -144.78 176.51 9.39 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.263 0.625 . . . . 74.01 110.566 -178.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 6.2 t -71.55 135.22 83.91 Favored Pre-proline 0 CA--C 1.556 1.199 0 C-N-CA 123.934 0.894 . . . . 71.11 110.841 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.63 85.55 1.29 Allowed 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 122.167 1.911 . . . . 71.22 112.141 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.527 HG12 ' HD2' ' A' ' 179' ' ' ARG . 35.7 t -80.0 86.13 1.34 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.605 0 N-CA-C 108.607 -0.886 . . . . 63.3 108.607 177.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' THR . . . . . 0.452 HG23 ' HD3' ' B' ' 117' ' ' LYS . 1.1 m -85.0 -27.16 26.62 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.405 -0.816 . . . . 71.22 110.587 -175.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 59.5 mttm 67.08 -79.51 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.665 1.186 . . . . 74.33 111.334 -174.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -101.65 75.2 1.56 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.516 0.727 . . . . 75.34 111.683 -169.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 -137.29 118.24 14.26 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 107.786 -1.19 . . . . 73.31 107.786 161.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' THR . . . . . . . . . . . . . 19.7 p -135.2 61.87 48.02 Favored Pre-proline 0 CA--C 1.555 1.139 0 C-N-CA 123.689 0.796 . . . . 72.54 110.12 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -89.92 24.82 0.61 Allowed 'Trans proline' 0 C--N 1.382 2.303 0 C-N-CA 122.809 2.339 . . . . 74.55 112.329 -177.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -84.19 71.83 10.57 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.992 0.917 . . . . 74.53 109.287 -175.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' MET . . . . . 0.521 ' SD ' ' HD2' ' A' ' 254' ' ' ARG . 59.1 mtm -128.41 157.56 74.31 Favored Pre-proline 0 CA--C 1.549 0.93 0 CA-C-N 114.792 -1.094 . . . . 75.13 108.511 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -74.69 65.31 5.77 Favored 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 122.739 2.292 . . . . 73.04 115.418 -173.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.434 HG11 ' HE3' ' B' ' 75' ' ' MET . 54.4 t 70.43 -49.52 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 C-N-CA 126.504 1.922 . . . . 75.25 114.599 169.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . 0.556 HD13 ' HB3' ' C' ' 228' ' ' GLN . 1.9 mm? 74.31 -64.42 0.39 Allowed 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 125.816 1.646 . . . . 73.34 112.213 170.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -56.59 -65.38 0.62 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.238 0.615 . . . . 71.25 110.383 176.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' ASN . . . . . 0.4 ' HB2' HG13 ' B' ' 28' ' ' VAL . 12.3 m120 -80.95 8.49 8.27 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 112.032 0.382 . . . . 74.34 112.032 -179.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 15.9 ttt85 -77.28 -26.07 52.04 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 109.466 -0.568 . . . . 72.22 109.466 170.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -125.7 -86.2 0.62 Allowed 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 123.606 0.763 . . . . 73.31 109.381 168.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . 61.67 11.28 3.84 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 124.562 1.145 . . . . 53.33 113.848 176.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -142.71 144.13 32.57 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 122.825 0.45 . . . . 73.13 110.475 -168.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.78 98.19 0.12 Allowed Glycine 0 C--N 1.341 0.814 0 N-CA-C 109.669 -1.372 . . . . 74.33 109.669 176.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 12.7 t70 62.67 -175.26 0.14 Allowed 'General case' 0 CA--C 1.565 1.551 0 C-N-CA 124.431 1.092 . . . . 61.44 111.21 176.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 36.8 pt -92.72 -12.49 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.575 -0.703 . . . . 75.44 110.692 170.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' THR . . . . . 0.458 ' O ' ' HB2' ' B' ' 155' ' ' LEU . 76.1 p 56.38 -71.09 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 126.795 2.038 . . . . 73.32 113.216 -172.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . 69.05 160.29 0.15 Allowed Pre-proline 0 N--CA 1.491 1.593 0 C-N-CA 124.271 1.028 . . . . 73.24 112.234 177.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.66 138.69 35.48 Favored 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 122.188 1.925 . . . . 72.44 112.484 173.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.1 -80.68 0.06 OUTLIER Glycine 0 C--N 1.347 1.14 0 N-CA-C 111.931 -0.468 . . . . 61.22 111.931 177.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . 0.627 ' HA2' ' HB2' ' B' ' 159' ' ' LYS . . . -170.88 -170.61 35.29 Favored Glycine 0 C--N 1.343 0.97 0 O-C-N 123.372 0.101 . . . . 64.32 113.075 -176.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . 0.584 ' HA ' HG12 ' B' ' 154' ' ' ILE . . . -141.54 -171.0 3.22 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.59 0.756 . . . . 63.2 110.773 -176.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -68.86 85.49 0.33 Allowed 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 108.958 -0.756 . . . . 74.21 108.958 173.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 30.6 ttm-85 -57.6 100.5 0.05 Allowed 'General case' 0 C--N 1.359 1.005 0 C-N-CA 124.235 1.014 . . . . 75.02 110.512 -176.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.558 HD13 ' HG3' ' B' ' 148' ' ' GLU . 86.6 mt 52.64 32.23 11.49 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.004 0.922 . . . . 72.13 111.702 177.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 42.5 m -118.24 86.43 2.53 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 115.08 -0.963 . . . . 73.12 108.596 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -62.51 -54.18 36.05 Favored Glycine 0 C--N 1.349 1.294 0 N-CA-C 110.274 -1.13 . . . . 74.15 110.274 172.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -165.97 104.12 0.67 Allowed 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 106.752 -1.573 . . . . 64.2 106.752 162.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 73.03 -67.22 0.28 Allowed 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 125.748 1.619 . . . . 75.3 110.211 -163.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 49.1 p -106.32 163.25 12.98 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.854 0.862 . . . . 73.31 110.272 177.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.07 113.3 2.76 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 108.775 -0.824 . . . . 73.24 108.775 169.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.42 ' HB2' ' HE2' ' B' ' 138' ' ' TYR . . . 58.75 -156.94 0.32 Allowed 'General case' 0 N--CA 1.485 1.309 0 O-C-N 124.123 0.889 . . . . 75.51 110.612 -171.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . 0.417 ' HB3' ' HG2' ' B' ' 235' ' ' GLU . 63.0 tp -156.4 -76.64 0.09 Allowed 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.134 -0.691 . . . . 72.35 109.134 173.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . 0.517 ' NH1' ' HA ' ' B' ' 290' ' ' TRP . 48.4 ttp85 -168.2 106.58 0.5 Allowed 'General case' 0 C--O 1.24 0.565 0 C-N-CA 124.122 0.969 . . . . 74.21 108.729 -173.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -49.08 -73.4 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 125.302 1.441 . . . . 75.31 112.288 -171.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 9.8 m 75.14 -36.59 0.32 Allowed 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 125.334 1.454 . . . . 62.01 114.2 169.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 51.4 tp -65.71 -34.36 78.02 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.474 1.109 . . . . 72.44 110.819 -176.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' SER . . . . . 0.485 ' HB3' ' HB3' ' B' ' 297' ' ' TYR . 8.0 m 73.57 -67.49 0.26 Allowed 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 125.644 1.578 . . . . 71.31 112.175 171.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . 0.415 ' HB2' ' H ' ' B' ' 298' ' ' HIS . 21.3 t70 -108.03 130.84 55.05 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.979 0.912 . . . . 71.45 110.077 -177.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' LYS . . . . . . . . . . . . . 8.8 mptt -126.64 77.29 73.87 Favored Pre-proline 0 N--CA 1.493 1.725 0 C-N-CA 123.623 0.769 . . . . 72.42 109.691 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -98.49 -0.09 1.18 Allowed 'Trans proline' 0 C--N 1.37 1.683 0 C-N-CA 123.103 2.536 . . . . 72.24 114.221 178.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 63.04 88.26 0.1 Allowed 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.506 1.122 . . . . 72.04 109.852 -166.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -85.4 22.95 1.41 Allowed 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.541 0.736 . . . . 73.42 111.888 -174.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -85.48 6.17 28.05 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.763 0.825 . . . . 72.41 111.214 -178.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 50.8 mm 74.42 -72.5 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 C-N-CA 125.885 1.674 . . . . 74.04 111.186 177.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . 0.419 HG22 ' HG1' ' B' ' 122' ' ' THR . 3.9 pt -122.25 125.92 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 123.61 0.764 . . . . 73.4 110.178 -176.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.429 ' HG ' ' HB1' ' B' ' 230' ' ' ALA . 2.8 mm? -112.68 -168.4 1.31 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.494 1.118 . . . . 74.34 109.431 -177.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . 0.453 ' HB3' ' H ' ' B' ' 71' ' ' ILE . 3.5 mm? 56.31 -146.67 0.55 Allowed 'General case' 0 CA--C 1.562 1.438 0 C-N-CA 124.115 0.966 . . . . 65.22 111.42 178.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . 0.489 HG22 ' NZ ' ' A' ' 232' ' ' LYS . 11.3 tp 58.03 111.2 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 C-N-CA 127.082 2.153 . . . . 75.5 113.192 176.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 115.9 -24.34 10.22 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-N 115.43 -0.805 . . . . 71.15 111.801 -175.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -57.07 142.96 40.39 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 124.247 1.019 . . . . 74.12 112.139 -175.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 129.14 -156.38 21.2 Favored Glycine 0 C--N 1.341 0.842 0 N-CA-C 110.781 -0.928 . . . . 72.45 110.781 -177.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 75' ' ' MET . . . . . 0.434 ' HE3' HG11 ' B' ' 28' ' ' VAL . 19.7 ptm -154.37 132.94 12.08 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 122.967 0.507 . . . . 74.01 109.919 -177.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . -129.42 -92.69 0.68 Allowed Glycine 0 C--N 1.342 0.862 0 N-CA-C 110.582 -1.007 . . . . 71.52 110.582 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . 0.491 ' HB2' ' HB ' ' B' ' 80' ' ' ILE . 6.5 p-10 -71.05 169.63 14.56 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.301 0.64 . . . . 74.35 112.083 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 78' ' ' SER . . . . . 0.453 ' O ' ' HA2' ' B' ' 104' ' ' GLY . 21.4 m -118.88 93.74 4.2 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 108.095 -1.076 . . . . 55.34 108.095 172.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 66.53 3.47 2.9 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 125.343 1.457 . . . . 74.44 113.249 178.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . 0.491 ' HB ' ' HB2' ' B' ' 77' ' ' ASP . 40.0 mm -75.58 -18.42 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 123.605 0.762 . . . . 72.52 111.058 -172.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 62.1 m -88.37 -64.24 1.18 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 122.854 0.462 . . . . 74.52 110.61 173.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -80.45 -67.04 0.81 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.484 0.714 . . . . 75.12 112.372 -167.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . 0.493 ' HB2' HD22 ' B' ' 102' ' ' LEU . . . -92.6 31.32 1.37 Allowed 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.966 0.906 . . . . 74.13 112.523 -165.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -86.87 13.85 8.26 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 113.739 1.014 . . . . 73.0 113.739 -168.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . 0.475 ' HA ' HD12 ' B' ' 385' ' ' LEU . 28.7 t-20 -162.46 -58.33 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 119.045 0.838 . . . . 72.23 111.359 -177.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -89.18 164.88 14.8 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.943 0.497 . . . . 74.21 111.312 -173.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . 0.626 ' HB2' ' H ' ' B' ' 100' ' ' LEU . . . -91.17 128.73 37.11 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 115.969 -0.56 . . . . 52.24 109.72 174.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -82.35 80.44 8.53 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 121.542 0.687 . . . . 74.14 110.447 -178.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . 0.487 ' N ' ' HG2' ' C' ' 279' ' ' ARG . . . 171.96 136.28 2.11 Favored Glycine 0 C--N 1.342 0.906 0 N-CA-C 109.83 -1.308 . . . . 54.33 109.83 175.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -53.58 -44.84 69.7 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.011 0.924 . . . . 75.53 111.401 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -118.36 31.19 5.71 Favored Glycine 0 C--N 1.342 0.908 0 CA-C-N 114.746 -1.116 . . . . 70.11 111.279 172.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -79.04 2.0 71.94 Favored Glycine 0 C--N 1.352 1.457 0 C-N-CA 123.127 0.394 . . . . 73.42 113.168 -175.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -92.65 155.22 17.88 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.179 1.392 . . . . 74.22 108.568 179.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 94' ' ' PHE . . . . . 0.814 ' HB2' ' HB2' ' B' ' 98' ' ' ASP . 25.1 m-85 -68.41 136.06 52.71 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 108.696 -0.853 . . . . 72.14 108.696 169.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . 0.413 ' N ' ' HD2' ' B' ' 95' ' ' LYS . 10.4 mptt -71.06 84.67 0.71 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.556 1.143 . . . . 74.44 112.0 -164.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 178.25 -59.34 0.09 OUTLIER Glycine 0 C--N 1.341 0.825 0 CA-C-N 114.181 -1.372 . . . . 75.21 109.953 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 16.2 tt -172.54 -26.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 C-N-CA 124.23 1.012 . . . . 73.0 110.103 175.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . 0.814 ' HB2' ' HB2' ' B' ' 94' ' ' PHE . 4.3 m-20 -56.61 112.58 1.32 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.017 1.327 . . . . 75.21 111.792 -169.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.92 159.99 31.15 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.041 0.448 . . . . 61.12 111.024 177.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . 0.626 ' H ' ' HB2' ' B' ' 87' ' ' ALA . 4.4 mm? -112.17 77.83 2.25 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 124.217 1.007 . . . . 74.2 108.69 169.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 101' ' ' PRO . . . . . 0.525 ' HB2' HD13 ' B' ' 385' ' ' LEU . 83.7 Cg_endo -81.3 107.78 1.9 Allowed 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 122.072 1.848 . . . . 74.43 110.699 -179.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . 0.493 HD22 ' HB2' ' B' ' 83' ' ' ALA . 3.0 mm? -56.05 -41.16 74.6 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 122.959 0.504 . . . . 73.12 110.158 -177.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 34.3 m 65.6 -70.09 0.1 Allowed 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 125.706 1.602 . . . . 75.52 112.089 173.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 104' ' ' GLY . . . . . 0.453 ' HA2' ' O ' ' B' ' 78' ' ' SER . . . -144.41 -29.54 0.1 Allowed Glycine 0 C--N 1.338 0.674 0 CA-C-N 114.904 -1.043 . . . . 51.35 111.719 174.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 40.09 -74.51 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 126.966 2.106 . . . . 75.22 114.312 -174.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 27.0 p90 -94.29 32.64 1.5 Allowed 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 124.167 0.987 . . . . 74.44 111.625 -178.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 63.1 m -66.97 116.72 8.11 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 122.129 -0.357 . . . . 75.34 110.89 178.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 42.3 p-80 -165.81 87.25 0.38 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.763 1.225 . . . . 73.44 108.052 170.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 67.1 t80 65.74 -84.54 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.622 1.169 . . . . 74.1 110.203 -175.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . 75.16 -54.74 0.65 Allowed 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 125.55 1.54 . . . . 75.22 114.179 171.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 1.7 pp -52.21 123.43 10.66 Favored 'General case' 0 CA--C 1.555 1.149 0 N-CA-C 114.042 1.127 . . . . 70.25 114.042 -172.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -129.11 89.42 2.86 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 107.577 -1.268 . . . . 73.2 107.577 172.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 113' ' ' LYS . . . . . 0.552 ' HA ' HG22 ' B' ' 224' ' ' VAL . 56.0 pttt -144.63 30.32 1.22 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 114.166 -1.379 . . . . 75.13 108.925 -176.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -54.8 -69.27 0.13 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 125.16 1.384 . . . . 74.21 110.876 -171.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 7.8 p -147.2 128.06 14.43 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 125.048 1.339 . . . . 73.23 107.451 173.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 177.39 153.91 11.54 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 110.974 -0.851 . . . . 55.33 110.974 -177.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . 0.452 ' HD3' HG23 ' B' ' 19' ' ' THR . 27.1 ttpp -162.45 127.45 2.1 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 123.021 0.528 . . . . 75.35 109.893 -178.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 118' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.57 -35.17 17.85 Favored 'Trans proline' 0 C--N 1.381 2.268 0 C-N-CA 122.658 2.239 . . . . 63.21 111.283 167.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 119' ' ' ASP . . . . . 0.421 ' HB2' ' HZ2' ' B' ' 117' ' ' LYS . 27.3 t70 66.23 -81.07 0.03 OUTLIER 'General case' 0 C--N 1.361 1.089 0 C-N-CA 125.589 1.556 . . . . 75.33 111.676 177.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 120' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -59.27 -26.11 64.66 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.73 1.212 . . . . 70.1 112.746 -175.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 121' ' ' VAL . . . . . 0.431 ' O ' ' HB2' ' B' ' 70' ' ' LEU . 51.9 t 67.85 -72.7 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.365 1.269 0 C-N-CA 125.164 1.386 . . . . 74.32 110.881 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 122' ' ' THR . . . . . 0.419 ' HG1' HG22 ' B' ' 68' ' ' ILE . 16.5 m -45.9 -60.49 2.22 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.582 1.553 . . . . 75.25 113.067 -177.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 14.9 t0 57.64 -85.13 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 125.19 1.396 . . . . 70.53 110.043 -174.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 30.9 m 60.73 -177.46 0.11 Allowed 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 124.901 1.28 . . . . 61.03 113.4 172.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -170.31 110.29 0.39 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.699 0.8 . . . . 74.53 109.751 172.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -71.28 154.35 41.7 Favored 'General case' 0 C--O 1.246 0.895 0 O-C-N 123.879 0.737 . . . . 74.13 110.826 177.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 17.0 t 67.65 -174.22 0.19 Allowed 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 124.775 1.23 . . . . 70.01 111.586 177.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . 0.524 ' HA ' ' SD ' ' C' ' 213' ' ' MET . . . -147.32 152.61 38.52 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.806 0.842 . . . . 74.33 109.695 177.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 33.9 m -76.77 85.34 3.38 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 122.915 0.486 . . . . 74.41 110.351 178.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . 54.92 -149.21 0.45 Allowed 'General case' 0 CA--C 1.561 1.37 0 C-N-CA 124.521 1.128 . . . . 61.42 112.483 171.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 23.5 m95 58.71 -114.86 0.77 Allowed 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 124.572 1.149 . . . . 73.51 110.841 176.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 49.9 m 51.18 19.45 0.72 Allowed 'General case' 0 C--N 1.372 1.549 0 C-N-CA 124.69 1.196 . . . . 74.11 112.509 -171.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 133' ' ' THR . . . . . 0.428 HG22 HG23 ' B' ' 137' ' ' THR . 68.0 p 48.98 18.45 0.21 Allowed 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 126.197 1.799 . . . . 74.52 113.836 -172.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 61.36 22.88 61.67 Favored Glycine 0 C--N 1.359 1.859 0 CA-C-O 119.342 -0.699 . . . . 55.15 114.022 -176.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 135' ' ' VAL . . . . . . . . . . . . . 89.2 t 74.92 -48.52 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 C-N-CA 125.687 1.595 . . . . 73.24 111.198 -174.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -76.37 91.2 3.25 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.43 1.092 . . . . 74.24 109.557 173.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 137' ' ' THR . . . . . 0.428 HG23 HG22 ' B' ' 133' ' ' THR . 16.6 m -83.04 117.27 22.71 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 123.926 0.89 . . . . 75.31 111.294 -169.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 138' ' ' TYR . . . . . 0.42 ' HE2' ' HB2' ' B' ' 54' ' ' ALA . 74.2 m-85 74.58 -47.76 0.64 Allowed 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 125.888 1.675 . . . . 75.52 112.92 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 7.0 t30 74.03 -56.19 0.65 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 125.267 1.427 . . . . 73.24 111.195 -177.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -60.25 -64.55 4.05 Favored Glycine 0 C--N 1.348 1.22 0 CA-C-O 119.678 -0.512 . . . . 75.54 112.14 172.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . 64.79 -64.91 0.15 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 125.735 1.614 . . . . 75.34 111.102 -175.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 7.3 mp -52.91 113.11 0.99 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.378 1.471 . . . . 74.24 110.862 173.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 149.31 132.84 2.13 Favored Glycine 0 C--N 1.336 0.542 0 N-CA-C 111.245 -0.742 . . . . 61.25 111.245 178.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 25.8 t 61.08 32.41 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.564 1.494 0 CA-C-O 122.515 1.15 . . . . 75.31 110.112 -178.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -63.48 -43.62 96.76 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 115.011 -0.995 . . . . 75.32 110.58 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 39.8 mm -73.81 118.93 20.05 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-N 115.247 -0.888 . . . . 72.52 108.785 175.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 60.48 -167.99 0.17 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.301 1.04 . . . . 72.43 113.796 176.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . 0.558 ' HG3' HD13 ' B' ' 47' ' ' LEU . 8.9 tp10 67.16 29.95 7.52 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 125.737 1.615 . . . . 75.05 110.404 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 149' ' ' LYS . . . . . . . . . . . . . 8.3 pttm -158.08 -63.74 0.09 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 114.03 -1.441 . . . . 74.13 107.898 171.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 69.99 0.71 3.19 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 114.226 1.195 . . . . 74.11 114.226 164.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 54.6 p-80 43.21 66.33 4.63 Favored Pre-proline 0 N--CA 1.492 1.644 0 C-N-CA 124.794 1.237 . . . . 74.43 111.438 -168.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -90.36 29.0 0.4 Allowed 'Trans proline' 0 C--N 1.369 1.636 0 C-N-CA 122.86 2.373 . . . . 64.13 111.913 -164.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 1.6 m 54.23 -144.07 0.69 Allowed 'General case' 0 CA--C 1.569 1.678 0 C-N-CA 124.912 1.285 . . . . 74.2 109.236 -167.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 154' ' ' ILE . . . . . 0.584 HG12 ' HA ' ' B' ' 44' ' ' ALA . 0.0 OUTLIER -173.0 139.3 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 N-CA-C 107.746 -1.205 . . . . 74.25 107.746 -177.098 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 155' ' ' LEU . . . . . 0.458 ' HB2' ' O ' ' B' ' 39' ' ' THR . 1.4 pt? -145.28 -59.69 0.34 Allowed 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 122.646 0.378 . . . . 73.12 111.228 176.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 61.6 tt0 -81.24 168.15 18.79 Favored 'General case' 0 CA--C 1.561 1.379 0 C-N-CA 123.705 0.802 . . . . 72.23 111.238 -176.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 157' ' ' MET . . . . . 0.599 ' HG3' ' HG2' ' B' ' 241' ' ' GLU . 4.5 mpp? -45.02 -68.45 0.2 Allowed 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 125.524 1.529 . . . . 61.13 111.932 177.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 158' ' ' ALA . . . . . . . . . . . . . . . -156.29 14.96 0.32 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.969 0.908 . . . . 65.11 110.48 -178.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . 0.627 ' HB2' ' HA2' ' B' ' 43' ' ' GLY . 34.0 ttpt 64.52 -77.41 0.04 OUTLIER 'General case' 0 C--N 1.358 0.974 0 C-N-CA 125.074 1.349 . . . . 73.24 111.575 -173.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -163.43 35.39 0.09 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.536 1.134 . . . . 74.34 108.705 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -112.21 152.98 27.77 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.786 0.834 . . . . 71.1 110.097 178.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 84.04 -80.7 1.8 Allowed Glycine 0 C--N 1.347 1.177 0 CA-C-N 116.166 -0.47 . . . . 73.4 111.942 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 8.2 mp 60.75 -80.82 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 125.126 1.371 . . . . 75.25 111.793 -175.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 164' ' ' ALA . . . . . . . . . . . . . . . -69.84 -68.39 0.42 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.264 0.626 . . . . 75.34 111.214 -175.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 26.4 p -138.95 -70.18 0.42 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.417 0.687 . . . . 73.14 110.304 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . -178.86 71.29 0.07 OUTLIER Glycine 0 C--N 1.342 0.868 0 N-CA-C 110.459 -1.057 . . . . 74.53 110.459 -174.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 167' ' ' ASN . . . . . . . . . . . . . 61.7 t30 72.98 -61.92 0.49 Allowed 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 126.302 1.841 . . . . 74.33 111.221 -175.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 7.2 p -138.82 139.29 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.668 0.787 . . . . 75.53 110.304 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 14.3 m -85.33 71.4 10.83 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.868 0.867 . . . . 65.53 109.517 -177.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 35.9 m -70.81 86.08 0.68 Allowed 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 124.282 1.033 . . . . 73.13 110.846 -173.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -133.21 -31.78 1.23 Allowed 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.058 0.543 . . . . 73.41 112.134 -172.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 172' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -83.1 62.7 6.74 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-O 122.381 1.086 . . . . 75.25 110.608 -176.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 173' ' ' LEU . . . . . . . . . . . . . 5.4 mp -109.91 -25.46 10.28 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.569 1.148 . . . . 74.44 108.117 169.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 174' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -132.54 175.65 9.12 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 124.923 1.289 . . . . 74.45 109.189 -178.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 175' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -116.49 160.37 20.7 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.649 0.78 . . . . 74.1 109.972 173.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -118.45 144.2 46.15 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.926 -0.768 . . . . 74.11 108.926 173.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 57.7 m -138.87 103.32 7.53 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 123.689 0.795 . . . . 74.15 109.301 -178.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 178' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.93 -38.73 12.47 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.715 2.277 . . . . 74.53 111.447 175.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -166.98 -63.39 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 107.346 -1.353 . . . . 74.35 107.346 178.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 180' ' ' ALA . . . . . 0.524 ' HB2' HG13 ' C' ' 137' ' ' VAL . . . -145.77 -63.0 0.33 Allowed 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 105.292 -2.114 . . . . 75.32 105.292 169.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 181' ' ' LEU . . . . . 0.579 ' HB3' HG13 ' C' ' 138' ' ' VAL . 37.0 tp -148.37 -32.44 0.25 Allowed 'General case' 0 CA--C 1.553 1.087 0 CA-C-N 114.22 -1.355 . . . . 74.44 108.837 160.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 182' ' ' VAL . . . . . 0.582 HG12 HD12 ' C' ' 123' ' ' LEU . 32.6 m -118.6 -176.88 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 C-N-CA 124.53 1.132 . . . . 72.43 111.499 177.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 183' ' ' ALA . . . . . 0.544 ' HB3' ' HD2' ' C' ' 124' ' ' PRO . . . -112.21 -95.44 0.44 Allowed 'General case' 0 C--N 1.357 0.92 0 C-N-CA 123.976 0.91 . . . . 65.24 110.163 167.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 35.9 m80 -157.58 -171.19 3.47 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 123.689 0.796 . . . . 75.32 110.881 -170.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 185' ' ' VAL . . . . . 0.549 HG22 HD21 ' C' ' 119' ' ' LEU . 25.1 t -68.82 159.78 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 C-N-CA 124.761 1.224 . . . . 74.01 112.853 -171.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 6.7 t -149.6 -171.35 3.87 Favored 'General case' 0 CA--C 1.56 1.364 0 C-N-CA 125.776 1.63 . . . . 60.24 108.583 171.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 187' ' ' SER . . . . . . . . . . . . . 55.6 m -137.41 12.82 3.01 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.271 0.628 . . . . 62.14 111.521 177.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -117.9 153.58 33.32 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 122.688 0.395 . . . . 72.32 110.803 -172.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 189' ' ' LYS . . . . . 0.414 ' HE2' HG12 ' C' ' 177' ' ' VAL . 33.5 mtmm 70.47 125.64 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.487 1.515 . . . . 72.52 113.392 171.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 190' ' ' CYS . . . . . 0.52 ' HA ' HG12 ' C' ' 158' ' ' VAL . 26.0 p -147.98 103.74 3.51 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.301 1.04 . . . . 70.33 109.218 178.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -143.86 -172.29 3.72 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.643 1.577 . . . . 74.04 108.025 -176.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -152.4 65.18 0.35 Allowed Glycine 0 CA--C 1.536 1.386 0 CA-C-O 119.467 -0.63 . . . . 64.22 113.164 173.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 193' ' ' PRO . . . . . 0.558 ' HG2' ' HA ' ' C' ' 157' ' ' SER . 27.7 Cg_endo -98.42 83.84 0.06 OUTLIER 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 123.674 2.916 . . . . 73.22 111.943 175.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 194' ' ' SER . . . . . . . . . . . . . 45.8 t -102.97 146.97 27.53 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.735 0.814 . . . . 63.44 109.844 178.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 195' ' ' ALA . . . . . . . . . . . . . . . -150.42 136.64 18.67 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.417 0.687 . . . . 74.32 110.967 -177.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 8.4 m 71.14 160.82 0.22 Allowed 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 124.922 1.289 . . . . 73.32 112.254 175.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 18.7 m -116.47 -62.0 1.65 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.561 0.744 . . . . 75.11 109.74 176.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 198' ' ' GLU . . . . . 0.45 ' HG3' ' HG2' ' B' ' 199' ' ' LYS . 6.7 pt-20 -166.23 -59.01 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.886 0.875 . . . . 65.14 110.116 -178.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 199' ' ' LYS . . . . . 0.45 ' HG2' ' HG3' ' B' ' 198' ' ' GLU . 75.0 mmtt -90.27 87.68 6.92 Favored 'General case' 0 C--N 1.345 0.374 0 C-N-CA 123.646 0.778 . . . . 75.14 109.105 -173.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 200' ' ' CYS . . . . . 0.401 ' SG ' ' O ' ' C' ' 242' ' ' GLY . 46.2 t -159.93 79.4 2.59 Favored Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 114.824 -1.08 . . . . 73.31 108.49 175.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 201' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -64.01 -45.84 9.52 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 122.807 2.338 . . . . 74.02 112.576 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 78.65 52.48 5.05 Favored Glycine 0 C--N 1.346 1.131 0 N-CA-C 111.624 -0.591 . . . . 73.41 111.624 -174.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -70.23 -47.8 59.82 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.033 0.933 . . . . 71.33 110.934 -176.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -70.52 89.28 0.7 Allowed 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.868 -0.605 . . . . 74.01 109.635 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 205' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -102.27 118.41 36.81 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-N 115.703 -0.681 . . . . 72.44 109.609 -174.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -76.77 132.65 39.38 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.658 -0.701 . . . . 70.3 109.604 173.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -92.4 -23.94 19.03 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.892 0.877 . . . . 74.32 110.824 177.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 103.67 120.24 4.74 Favored Glycine 0 C--N 1.347 1.172 0 CA-C-N 115.816 -0.629 . . . . 71.52 112.352 175.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . -76.75 -5.53 83.82 Favored Glycine 0 C--N 1.351 1.385 0 CA-C-O 119.874 -0.404 . . . . 63.34 113.148 174.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt 57.53 -67.38 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 127.582 2.353 . . . . 74.51 114.935 171.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . -68.48 99.32 0.58 Allowed Glycine 0 C--N 1.348 1.237 0 CA-C-O 119.557 -0.58 . . . . 74.43 112.528 -178.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 25.9 t 83.02 -10.81 1.0 Allowed 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 126.228 1.811 . . . . 74.04 111.69 -175.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 2.8 mp -92.69 88.49 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 N-CA-C 107.444 -1.317 . . . . 70.12 107.444 176.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 34.2 p -139.24 80.51 1.78 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.74 0.816 . . . . 75.43 109.682 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 215' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -118.77 159.17 24.18 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 109.059 -0.719 . . . . 73.31 109.059 172.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 67.69 116.57 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.09 1.356 . . . . 61.42 111.713 -175.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . 0.789 HD13 ' HG2' ' B' ' 221' ' ' ARG . 2.6 mm? 58.78 44.03 17.59 Favored 'General case' 0 C--N 1.36 1.048 0 C-N-CA 124.801 1.241 . . . . 75.4 109.874 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 10.2 tt -61.41 139.51 58.19 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 113.806 -1.543 . . . . 71.43 111.309 -174.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 60.7 26.01 15.78 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 124.836 1.254 . . . . 71.24 112.309 -173.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . 0.416 ' O ' ' HG3' ' B' ' 221' ' ' ARG . . . 74.5 -1.98 2.94 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 125.295 1.438 . . . . 74.3 113.177 175.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 221' ' ' ARG . . . . . 0.789 ' HG2' HD13 ' B' ' 217' ' ' LEU 0.251 0.0 OUTLIER 61.61 -21.59 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.337 0 C-N-CA 127.603 2.361 . . . . 73.55 116.734 175.973 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . 71.6 104.86 0.07 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 125.37 1.468 . . . . 75.21 112.521 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -103.14 158.23 16.45 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.036 0.935 . . . . 72.13 110.325 177.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . 0.552 HG22 ' HA ' ' B' ' 113' ' ' LYS . 10.7 p -167.15 9.67 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.54 0 C-N-CA 123.848 0.859 . . . . 75.32 110.539 178.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 37.1 p -122.63 146.48 47.41 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.273 0.629 . . . . 73.55 111.922 -169.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 63.64 -88.94 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.655 1.182 . . . . 74.43 113.19 169.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . 121.35 -155.57 16.43 Favored Glycine 0 N--CA 1.475 1.289 0 N-CA-C 110.875 -0.89 . . . . 71.24 110.875 -167.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . -172.61 51.51 0.17 Allowed Glycine 0 C--N 1.345 1.08 0 CA-C-N 117.569 0.685 . . . . 72.41 112.872 178.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . 65.45 -143.14 45.3 Favored Glycine 0 C--N 1.344 1.016 0 CA-C-O 119.901 -0.388 . . . . 71.04 113.818 172.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . 0.429 ' HB1' ' HG ' ' B' ' 69' ' ' LEU . . . 178.54 161.54 0.66 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.361 1.465 . . . . 70.23 109.406 172.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 231' ' ' LYS . . . . . 0.47 ' HE3' ' SD ' ' C' ' 213' ' ' MET . 4.0 mptp? -135.02 -153.86 0.54 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.135 0.974 . . . . 73.24 108.575 178.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 6.1 m -144.1 152.68 41.28 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 109.575 -0.528 . . . . 74.24 109.575 176.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -83.46 170.32 14.59 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 113.748 1.018 . . . . 71.44 113.748 -169.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . 0.543 ' HB2' ' HE ' ' C' ' 211' ' ' ARG . . . -166.07 -148.0 0.09 Allowed 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 125.353 1.461 . . . . 72.31 108.093 173.004 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . 0.426 ' HA ' ' HH ' ' A' ' 277' ' ' TYR . 0.0 OUTLIER -126.43 134.27 51.03 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.797 0.839 . . . . 64.41 111.136 -179.891 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 236' ' ' THR . . . . . 0.501 HG23 ' H ' ' B' ' 237' ' ' ALA . 3.5 m -156.18 177.73 11.1 Favored 'General case' 0 CA--C 1.564 1.489 0 C-N-CA 126.545 1.938 . . . . 73.34 107.188 176.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . 0.501 ' H ' HG23 ' B' ' 236' ' ' THR . . . -130.31 42.42 3.26 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 119.07 0.85 . . . . 73.03 111.873 -179.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 56.8 m -140.98 134.32 29.72 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 118.359 -0.829 . . . . 71.31 110.495 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -173.92 -174.48 0.94 Allowed 'General case' 0 C--N 1.377 1.782 0 N-CA-C 114.028 1.121 . . . . 74.42 114.028 174.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . -116.62 -138.21 6.19 Favored Glycine 0 C--N 1.362 2.004 0 C-N-CA 125.348 1.451 . . . . 71.23 110.902 175.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 241' ' ' GLU . . . . . 0.599 ' HG2' ' HG3' ' B' ' 157' ' ' MET . 11.6 pt-20 -156.65 177.05 11.92 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 117.452 0.626 . . . . 71.23 111.066 174.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 242' ' ' TRP . . . . . 0.464 ' CD2' ' HG ' ' C' ' 233' ' ' LEU . 0.0 OUTLIER -158.87 -39.46 0.06 Allowed 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.991 1.316 . . . . 70.32 108.944 179.483 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -126.36 -168.32 1.84 Allowed 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 107.484 -1.302 . . . . 74.22 107.484 162.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -71.87 91.42 0.51 Allowed Glycine 0 C--N 1.344 1.007 0 CA-C-N 116.611 -0.268 . . . . 71.54 112.529 171.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 245' ' ' LYS . . . . . 0.465 ' HA ' ' HA ' ' C' ' 224' ' ' PRO . 0.7 OUTLIER -80.55 51.08 1.4 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.525 1.13 . . . . 75.34 110.592 176.122 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 246' ' ' THR . . . . . 0.572 ' HA ' HG21 ' B' ' 154' ' ' ILE . 55.9 p -112.92 67.25 0.66 Allowed 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.053 -1.43 . . . . 71.14 110.062 -168.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 247' ' ' LEU . . . . . 0.412 HD11 ' N ' ' B' ' 248' ' ' ARG . 2.1 tm? -156.12 140.13 16.35 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.123 -0.695 . . . . 72.51 109.123 -176.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 248' ' ' ARG . . . . . 0.461 ' HD3' ' N ' ' B' ' 249' ' ' GLU . 1.1 tmt_? -159.94 143.34 14.07 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 107.767 -1.197 . . . . 75.15 107.767 169.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 249' ' ' GLU . . . . . 0.461 ' N ' ' HD3' ' B' ' 248' ' ' ARG . 0.3 OUTLIER -144.41 149.5 36.17 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 123.993 0.917 . . . . 71.33 109.437 -179.179 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -142.3 -38.55 0.37 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.947 0.899 . . . . 70.14 111.821 178.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 251' ' ' ALA . . . . . 0.429 ' HB2' ' HB3' ' B' ' 358' ' ' CYS . . . -160.83 54.9 0.31 Allowed 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 112.56 0.578 . . . . 64.21 112.56 -166.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . 0.529 ' HA ' ' HA ' ' B' ' 363' ' ' GLU . 33.0 tt0 -73.21 -50.54 21.89 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.705 0.802 . . . . 73.12 109.566 174.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -76.17 71.84 2.93 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 114.687 -1.142 . . . . 51.41 108.26 170.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 23.3 tpt180 -82.02 -5.97 58.78 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 114.49 -1.232 . . . . 72.51 110.649 -172.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -59.32 -60.89 7.99 Favored Glycine 0 C--N 1.356 1.646 0 O-C-N 123.511 0.507 . . . . 63.32 111.89 175.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 256' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 72.52 -44.73 0.6 Allowed 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 125.813 1.645 . . . . 71.2 113.115 177.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -63.42 95.44 0.1 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.493 0.717 . . . . 74.31 110.312 177.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 258' ' ' LEU . . . . . . . . . . . . . 31.5 tp -96.62 4.13 52.13 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.129 0.972 . . . . 75.13 109.96 176.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 81.12 -26.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 C-N-CA 126.684 1.994 . . . . 63.31 111.474 -176.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 260' ' ' SER . . . . . . . . . . . . . 14.1 m -68.73 120.61 14.97 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.261 1.024 . . . . 73.11 109.947 173.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 10.0 t70 71.14 -72.06 0.12 Allowed 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 125.068 1.347 . . . . 65.51 112.812 175.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 262' ' ' ALA . . . . . . . . . . . . . . . -60.39 -10.96 5.49 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 114.696 1.369 . . . . 75.22 114.696 -170.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -77.77 -21.29 51.96 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 112.54 0.571 . . . . 70.44 112.54 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 34.0 t -153.78 -51.0 0.1 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 122.665 0.386 . . . . 51.14 110.944 -173.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 265' ' ' LEU . . . . . . . . . . . . . 38.6 tp -72.82 -57.82 3.8 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.383 0.673 . . . . 73.31 111.048 -175.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 266' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 71.87 106.36 0.07 Allowed 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 124.948 1.299 . . . . 71.52 112.273 173.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 94.4 p 56.35 17.4 2.86 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 126.378 1.871 . . . . 73.13 113.774 177.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 46.6 t 56.56 -73.11 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 126.136 1.775 . . . . 74.44 113.425 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 269' ' ' THR . . . . . . . . . . . . . 10.7 m 58.4 52.39 7.25 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.381 1.072 . . . . 74.31 110.238 174.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 270' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -81.13 73.26 8.17 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 114.994 -1.003 . . . . 72.41 109.501 -175.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 271' ' ' ALA . . . . . . . . . . . . . . . 64.65 -70.62 0.08 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 125.38 1.472 . . . . 75.3 111.937 -175.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 272' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -127.28 -34.24 2.31 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.598 1.159 . . . . 73.11 109.864 173.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -66.53 112.97 4.38 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.216 1.006 . . . . 73.43 111.434 -175.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 62.16 104.58 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.75 1.22 . . . . 71.44 112.592 173.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 275' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -155.85 90.9 2.76 Favored Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 123.751 0.821 . . . . 72.14 109.66 175.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -49.47 -61.71 0.53 Allowed 'Trans proline' 0 C--N 1.387 2.589 0 C-N-CA 123.767 2.978 . . . . 73.04 112.714 176.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 277' ' ' LEU . . . . . . . . . . . . . 82.2 mt 50.6 93.1 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 125.192 1.397 . . . . 74.52 113.268 173.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 1.1 pp -80.96 2.91 24.8 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 113.331 0.863 . . . . 72.2 113.331 -171.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . -92.98 48.31 2.47 Favored Glycine 0 C--N 1.348 1.229 0 CA-C-O 120.024 -0.32 . . . . 75.43 113.29 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 4.8 tt 64.48 -88.94 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.083 1.353 . . . . 74.31 110.374 -177.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 63.57 -75.48 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.996 1.318 . . . . 75.31 112.718 -176.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . 63.33 -114.48 0.44 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.987 1.315 . . . . 65.41 111.303 -175.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -61.93 106.58 0.72 Allowed 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.64 0.776 . . . . 72.33 112.503 -169.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . 129.34 -48.43 0.97 Allowed Glycine 0 N--CA 1.47 0.959 0 N-CA-C 110.815 -0.914 . . . . 72.13 110.815 -175.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -100.63 12.29 37.71 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.549 0.74 . . . . 73.03 110.501 173.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 286' ' ' MET . . . . . 0.528 ' HB2' ' HE2' ' B' ' 350' ' ' LYS . 17.0 tpt -161.27 142.13 8.45 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 126.76 2.024 . . . . 74.22 105.795 178.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 287' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -42.98 -52.1 4.99 Favored 'Trans proline' 0 C--N 1.384 2.426 0 C-N-CA 123.532 2.821 . . . . 74.24 113.248 175.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 288' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -145.35 -100.33 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.215 0 C-N-CA 124.489 1.116 . . . . 74.32 108.415 170.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 289' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.58 -30.56 0.76 Allowed 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 106.762 -1.57 . . . . 74.32 106.762 169.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 290' ' ' TRP . . . . . 0.517 ' HA ' ' NH1' ' B' ' 56' ' ' ARG . 30.9 m-90 -67.03 167.74 11.3 Favored 'General case' 0 C--N 1.357 0.911 0 CA-C-N 115.289 -0.869 . . . . 75.34 110.889 164.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 291' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -44.51 -32.33 1.38 Allowed 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 125.288 1.435 . . . . 73.52 113.354 172.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . 174.03 -156.0 22.76 Favored Glycine 0 C--N 1.344 0.991 0 N-CA-C 111.322 -0.711 . . . . 71.42 111.322 177.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 293' ' ' PRO . . . . . 0.415 ' HD2' HE22 ' B' ' 342' ' ' GLN . 57.5 Cg_endo -68.9 3.73 2.21 Favored 'Trans proline' 0 CA--C 1.557 1.626 0 C-N-CA 123.294 2.663 . . . . 75.13 113.913 172.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 294' ' ' LYS . . . . . 0.531 ' HA ' ' HE3' ' B' ' 334' ' ' LYS . 13.7 tmtt? -63.23 113.4 3.16 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.0 0.92 . . . . 74.44 110.721 176.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -126.44 18.59 7.52 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 124.161 0.985 . . . . 71.35 109.734 170.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 32.1 m -67.43 101.88 1.03 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.007 0.923 . . . . 71.52 112.339 -172.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 297' ' ' TYR . . . . . 0.485 ' HB3' ' HB3' ' B' ' 60' ' ' SER . 38.4 p90 -100.82 154.7 18.42 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.685 0.794 . . . . 75.44 108.988 165.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 298' ' ' HIS . . . . . 0.415 ' H ' ' HB2' ' B' ' 61' ' ' ASP . 67.2 t60 66.4 111.77 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.581 1.152 . . . . 73.43 109.768 -171.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . -58.88 110.96 2.93 Favored Glycine 0 C--N 1.347 1.15 0 CA-C-N 115.824 -0.626 . . . . 72.35 113.624 -178.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 24.5 p30 -70.49 -33.48 71.27 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.933 0.893 . . . . 72.23 111.975 -177.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 301' ' ' ILE . . . . . . . . . . . . . 15.2 tt -90.69 -19.77 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 C-N-CA 123.539 0.735 . . . . 75.13 110.67 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -71.64 -30.69 66.03 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.946 0.899 . . . . 74.32 110.408 177.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 303' ' ' LYS . . . . . 0.493 ' HA ' ' HE2' ' B' ' 303' ' ' LYS . 0.6 OUTLIER -64.24 -54.3 40.12 Favored Pre-proline 0 CA--C 1.562 1.437 0 CA-C-O 118.534 -0.746 . . . . 74.11 111.453 -177.892 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 304' ' ' PRO . . . . . 0.424 ' HA ' ' SG ' ' B' ' 308' ' ' CYS . 91.6 Cg_endo -79.77 165.94 21.91 Favored 'Trans proline' 0 C--N 1.38 2.2 0 CA-C-N 121.443 1.551 . . . . 75.12 111.304 166.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . 66.17 -75.52 0.05 Allowed 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.923 1.289 . . . . 72.13 112.993 177.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 41.3 t -57.88 -55.68 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.864 1.265 . . . . 72.33 111.711 -171.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 80.9 p -89.56 -4.42 57.88 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.58 0.352 . . . . 74.23 111.884 -179.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 308' ' ' CYS . . . . . 0.424 ' SG ' ' HA ' ' B' ' 304' ' ' PRO . 75.3 m -72.82 -31.86 65.11 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.252 0.548 . . . . 74.22 110.322 173.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 39.3 p -90.21 146.95 35.83 Favored Pre-proline 0 CA--C 1.554 1.104 0 CA-C-N 115.202 -0.908 . . . . 72.2 109.285 171.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.34 161.43 40.75 Favored 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 122.764 2.309 . . . . 64.44 112.865 -178.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 311' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -59.96 -39.14 67.23 Favored Pre-proline 0 N--CA 1.491 1.611 0 C-N-CA 123.596 0.758 . . . . 73.13 112.801 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 312' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -74.54 72.33 4.38 Favored 'Trans proline' 0 C--N 1.385 2.474 0 CA-C-N 121.079 1.421 . . . . 70.14 112.056 164.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 313' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -72.03 -45.07 62.24 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 108.426 -0.953 . . . . 75.13 108.426 170.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 314' ' ' ARG . . . . . . . . . . . . . 59.5 mtt85 65.29 -79.0 0.03 OUTLIER 'General case' 0 C--N 1.359 1.0 0 C-N-CA 125.717 1.607 . . . . 74.53 111.29 -178.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 315' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -161.75 -162.61 0.88 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.92 1.288 . . . . 75.34 108.343 -172.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 316' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 70.76 146.09 0.07 Allowed 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 124.434 1.094 . . . . 74.4 112.541 -178.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 61.2 m -142.35 144.98 33.43 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.488 -0.778 . . . . 75.41 109.609 177.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 318' ' ' VAL . . . . . . . . . . . . . 17.0 m -124.82 149.53 63.0 Favored Pre-proline 0 N--CA 1.478 0.945 0 C-N-CA 124.151 0.98 . . . . 73.13 109.168 176.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 319' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -65.67 153.39 78.37 Favored 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 122.209 1.939 . . . . 65.1 111.027 172.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 320' ' ' THR . . . . . 0.431 HG22 ' NE2' ' B' ' 323' ' ' GLN . 6.8 m 68.92 11.44 8.34 Favored 'General case' 0 CA--C 1.561 1.381 0 C-N-CA 123.941 0.897 . . . . 73.24 111.415 177.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 321' ' ' LEU . . . . . . . . . . . . . 52.4 tp -62.33 114.19 3.34 Favored 'General case' 0 C--N 1.359 0.998 0 N-CA-C 109.509 -0.552 . . . . 74.43 109.509 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 322' ' ' ALA . . . . . . . . . . . . . . . 75.39 -66.41 0.29 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.403 1.481 . . . . 64.54 111.34 -175.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 323' ' ' GLN . . . . . 0.431 ' NE2' HG22 ' B' ' 320' ' ' THR . 32.1 tt0 57.59 56.25 5.06 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 124.432 1.093 . . . . 74.02 109.689 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 324' ' ' MET . . . . . . . . . . . . . 55.7 ttp 77.12 -38.68 0.3 Allowed 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 125.513 1.525 . . . . 74.22 112.189 -176.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 325' ' ' THR . . . . . . . . . . . . . 3.0 m 63.37 20.13 12.08 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 125.03 1.332 . . . . 72.33 110.902 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 326' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 62.21 -174.54 0.14 Allowed 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.386 1.074 . . . . 72.01 111.718 -172.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? 68.34 156.68 0.13 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 124.931 1.293 . . . . 75.41 112.414 -178.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 328' ' ' ALA . . . . . 0.478 ' HB1' ' HA ' ' B' ' 332' ' ' LEU . . . 68.2 -73.08 0.09 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.461 1.505 . . . . 72.03 111.07 -171.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 329' ' ' ILE . . . . . . . . . . . . . 2.0 mp 66.86 125.19 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 C-N-CA 125.218 1.407 . . . . 73.5 111.575 -178.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 330' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 64.51 -74.0 0.05 Allowed 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 125.366 1.466 . . . . 74.44 112.598 168.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 331' ' ' LEU . . . . . . . . . . . . . 61.3 mt -57.36 -45.27 84.58 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.032 1.333 . . . . 64.42 111.285 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 332' ' ' LEU . . . . . 0.478 ' HA ' ' HB1' ' B' ' 328' ' ' ALA . 95.7 mt 59.97 -82.55 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.981 1.312 . . . . 74.41 111.853 179.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 333' ' ' SER . . . . . . . . . . . . . 37.9 t -92.31 58.38 3.22 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.86 0.864 . . . . 65.04 109.354 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 334' ' ' LYS . . . . . 0.531 ' HE3' ' HA ' ' B' ' 294' ' ' LYS . 23.9 ttmm 68.42 165.32 0.24 Allowed 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 124.647 1.179 . . . . 65.35 110.949 -175.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 335' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -67.44 96.15 0.49 Allowed 'General case' 0 C--N 1.355 0.819 0 N-CA-C 109.213 -0.662 . . . . 74.12 109.213 169.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -77.92 -58.15 3.42 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 114.642 -1.163 . . . . 73.55 109.447 176.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 337' ' ' LYS . . . . . . . . . . . . . 28.7 tptp 63.13 -72.87 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 125.378 1.471 . . . . 71.1 109.929 -171.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 338' ' ' GLY . . . . . . . . . . . . . . . -110.68 156.05 15.77 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 111.401 -0.68 . . . . 73.12 111.401 172.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 339' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 67.58 112.53 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 125.109 1.364 . . . . 74.33 112.369 177.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 340' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -56.02 97.39 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.921 1.289 . . . . 75.24 112.049 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 341' ' ' LEU . . . . . . . . . . . . . 7.1 mp 61.76 8.7 2.51 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 125.043 1.337 . . . . 75.34 112.721 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 342' ' ' GLN . . . . . 0.415 HE22 ' HD2' ' B' ' 293' ' ' PRO . 75.5 mt-30 61.42 146.87 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 125.889 1.675 . . . . 74.32 112.203 -174.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 343' ' ' VAL . . . . . 0.605 HG23 ' H ' ' B' ' 345' ' ' GLY . 9.9 p -137.86 147.63 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 O-C-N 121.771 -0.581 . . . . 65.15 110.222 -171.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -70.19 -14.62 62.71 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.197 0.599 . . . . 74.33 111.603 178.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 345' ' ' GLY . . . . . 0.605 ' H ' HG23 ' B' ' 343' ' ' VAL . . . -84.19 44.49 3.34 Favored Glycine 0 C--N 1.347 1.139 0 CA-C-N 116.472 -0.331 . . . . 63.14 113.618 174.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 346' ' ' ALA . . . . . . . . . . . . . . . -90.96 -13.36 33.57 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.747 0.819 . . . . 72.51 110.799 176.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 74.8 m -147.01 152.37 38.49 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.477 1.111 . . . . 72.21 109.185 173.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 35.0 mm -86.09 91.8 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 109.36 -0.608 . . . . 73.42 109.36 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 349' ' ' ASP . . . . . . . . . . . . . 15.2 t70 71.59 -66.32 0.3 Allowed 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 125.805 1.642 . . . . 71.13 111.042 178.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 350' ' ' LYS . . . . . 0.528 ' HE2' ' HB2' ' B' ' 286' ' ' MET . 25.0 tttp 76.98 -70.33 0.13 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 126.311 1.844 . . . . 74.52 110.562 171.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -174.02 -30.36 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.91 0.884 . . . . 71.32 109.499 177.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -78.83 66.56 4.33 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.917 0.887 . . . . 74.35 109.18 177.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 353' ' ' HIS . . . . . . . . . . . . . 10.2 t-80 164.85 -46.79 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 126.924 2.09 . . . . 74.33 108.176 176.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 354' ' ' ALA . . . . . . . . . . . . . . . 64.71 30.84 12.31 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.835 1.254 . . . . 72.23 112.94 170.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 355' ' ' ALA . . . . . . . . . . . . . . . -91.02 -1.28 57.83 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.37 0.668 . . . . 75.44 111.4 176.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 356' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -58.17 -42.73 96.52 Favored Pre-proline 0 CA--C 1.565 1.549 0 C-N-CA 123.826 0.85 . . . . 74.32 111.915 175.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 357' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -72.83 118.57 5.63 Favored 'Trans proline' 0 C--N 1.39 2.73 0 C-N-CA 121.987 1.791 . . . . 74.21 111.884 166.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 358' ' ' CYS . . . . . 0.429 ' HB3' ' HB2' ' B' ' 251' ' ' ALA . 26.4 p -78.26 138.4 38.6 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.58 0.752 . . . . 75.21 110.014 176.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 359' ' ' GLY . . . . . . . . . . . . . . . -138.54 67.18 0.52 Allowed Glycine 0 C--N 1.339 0.701 0 CA-C-O 119.8 -0.444 . . . . 72.04 112.294 -177.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 360' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 74.15 -61.77 0.48 Allowed 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 125.157 1.383 . . . . 53.34 113.15 170.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 361' ' ' ILE . . . . . . . . . . . . . 45.1 mm -59.45 129.04 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.588 1.155 . . . . 64.41 111.471 -175.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 362' ' ' GLY . . . . . . . . . . . . . . . 84.81 -55.18 4.98 Favored Glycine 0 C--N 1.343 0.93 0 CA-C-N 115.384 -0.826 . . . . 72.35 113.371 -173.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 363' ' ' GLU . . . . . 0.529 ' HA ' ' HA ' ' B' ' 252' ' ' GLN . 35.4 tt0 -59.05 -70.21 0.16 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 125.064 1.346 . . . . 73.13 112.893 -174.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 364' ' ' THR . . . . . 0.453 HG23 ' HG2' ' B' ' 363' ' ' GLU . 2.0 p -105.27 0.01 26.74 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.874 0.869 . . . . 74.04 112.815 -167.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 4.8 p -92.95 88.49 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 CA-C-O 121.7 0.762 . . . . 74.51 109.9 177.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 73.74 -19.05 0.36 Allowed 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 125.67 1.588 . . . . 52.52 114.229 175.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 367' ' ' LEU . . . . . . . . . . . . . 5.7 mp 58.08 -83.62 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.979 1.312 . . . . 75.05 110.277 -175.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 368' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -142.31 -64.48 0.42 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.41 1.084 . . . . 73.23 109.026 178.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 369' ' ' GLU . . . . . . . . . . . . . 55.7 tt0 47.39 -85.53 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 125.723 1.609 . . . . 74.11 112.315 -173.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 370' ' ' ALA . . . . . . . . . . . . . . . -167.77 124.11 1.09 Allowed 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.648 1.179 . . . . 74.25 107.964 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 371' ' ' VAL . . . . . . . . . . . . . 58.5 t -68.95 109.08 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 109.064 -0.717 . . . . 74.12 109.064 177.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 372' ' ' GLN . . . . . 0.416 ' HB3' HD22 ' B' ' 375' ' ' LEU . 21.6 tm0? 85.77 -28.55 0.07 Allowed 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 125.897 1.679 . . . . 63.2 111.709 177.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 373' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? 78.63 -55.03 0.47 Allowed 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 125.75 1.62 . . . . 72.2 113.277 176.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -88.68 74.51 8.38 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.021 0.528 . . . . 71.45 111.625 -172.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 375' ' ' LEU . . . . . 0.416 HD22 ' HB3' ' B' ' 372' ' ' GLN . 2.9 mm? -117.99 89.4 3.11 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.243 0.617 . . . . 72.22 110.083 179.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -119.27 86.85 2.62 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.664 0.745 . . . . 73.13 108.994 173.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 377' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -125.15 176.16 6.9 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 108.049 -1.093 . . . . 73.31 108.049 177.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 378' ' ' ALA . . . . . . . . . . . . . . . 64.48 14.76 9.12 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 113.199 0.814 . . . . 73.45 113.199 173.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -84.01 86.54 7.18 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.102 0.961 . . . . 73.22 109.423 -171.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 380' ' ' LYS . . . . . . . . . . . . . 47.4 mttp 58.52 22.29 9.51 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 124.903 1.281 . . . . 72.4 112.117 -168.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 381' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -92.38 16.88 10.78 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.656 0.782 . . . . 74.34 111.015 -178.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -79.05 -75.3 1.01 Allowed Glycine 0 C--N 1.35 1.358 0 CA-C-N 115.968 -0.56 . . . . 73.1 112.006 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 383' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 62.7 14.48 7.26 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 124.937 1.295 . . . . 73.1 113.566 174.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 384' ' ' THR . . . . . . . . . . . . . 9.9 p -149.38 -75.86 0.16 Allowed 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.348 1.059 . . . . 71.44 108.981 178.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 385' ' ' LEU . . . . . 0.525 HD13 ' HB2' ' B' ' 101' ' ' PRO . 2.8 mm? 50.58 -84.86 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 125.922 1.689 . . . . 75.43 112.746 -175.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 386' ' ' VAL . . . . . . . . . . . . . 9.2 p -160.21 134.32 1.39 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.666 0 N-CA-C 106.808 -1.553 . . . . 75.23 106.808 177.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 387' ' ' ILE . . . . . 0.574 HG21 HG22 ' B' ' 389' ' ' THR . 31.4 mm 62.81 86.11 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 123.937 0.895 . . . . 74.12 108.664 -170.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 388' ' ' VAL . . . . . . . . . . . . . 18.9 m -73.58 72.22 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.291 0 C-N-CA 124.221 1.009 . . . . 74.43 112.662 -169.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 389' ' ' THR . . . . . 0.574 HG22 HG21 ' B' ' 387' ' ' ILE . 10.1 t -156.77 144.76 19.41 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 123.794 0.838 . . . . 71.25 109.175 -178.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . 68.18 -73.64 0.08 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.234 1.413 . . . . 73.41 112.353 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 391' ' ' ASP . . . . . . . . . . . . . 38.0 t70 58.85 45.16 15.74 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.524 1.13 . . . . 64.12 109.9 -174.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 392' ' ' HIS . . . . . . . . . . . . . 20.3 t-160 71.4 143.07 0.06 Allowed 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 114.576 -1.193 . . . . 72.42 110.116 -175.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -56.49 93.57 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.856 0.862 . . . . 61.53 111.005 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 27.4 m170 -72.6 -59.08 2.89 Favored 'General case' 0 C--N 1.351 0.655 0 N-CA-C 108.361 -0.977 . . . . 73.31 108.361 177.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . 57.34 45.61 19.8 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 124.604 1.19 . . . . 75.42 110.394 -175.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 18.8 m 65.74 11.78 7.82 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.101 1.361 . . . . 75.55 112.303 -176.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 397' ' ' GLN . . . . . . . . . . . . . 21.1 tp60 57.01 99.79 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.378 1.471 . . . . 75.54 111.637 -176.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 2.2 mp -70.81 91.58 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 N-CA-C 108.372 -0.973 . . . . 75.44 108.372 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 399' ' ' VAL . . . . . . . . . . . . . 44.6 t 55.45 -88.0 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.158 0 C-N-CA 125.205 1.402 . . . . 73.32 110.657 -173.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 400' ' ' ALA . . . . . . . . . . . . . . . -176.85 88.81 0.26 Allowed Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 124.602 1.161 . . . . 74.52 109.088 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 401' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -66.74 -15.81 48.47 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.704 2.269 . . . . 71.34 111.795 168.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -60.48 -46.58 89.57 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.919 1.288 . . . . 74.34 110.074 172.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 403' ' ' THR . . . . . . . . . . . . . 30.4 p 48.49 -88.05 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.035 1.734 . . . . 73.2 112.574 -173.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 404' ' ' LYS . . . . . 0.495 ' H ' ' HD2' ' B' ' 404' ' ' LYS . 7.0 mptt -74.7 -48.75 24.22 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.545 -0.909 . . . . 71.14 108.545 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 405' ' ' ALA . . . . . . . . . . . . . . . -171.67 -55.51 0.0 OUTLIER Pre-proline 0 CA--C 1.561 1.38 0 CA-C-N 114.644 -1.162 . . . . 71.24 112.374 -169.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 406' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -70.85 105.51 1.68 Allowed 'Trans proline' 0 C--N 1.396 3.032 0 C-N-CA 122.329 2.019 . . . . 64.23 112.917 -171.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . -163.99 -2.53 0.04 OUTLIER Glycine 0 N--CA 1.468 0.803 0 CA-C-N 115.715 -0.675 . . . . 74.04 112.511 178.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 408' ' ' LEU . . . . . . . . . . . . . 5.3 mp -85.99 3.9 40.15 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 124.901 1.281 . . . . 72.55 110.536 176.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 76.4 p -62.53 -164.65 0.01 OUTLIER 'General case' 0 CA--C 1.566 1.567 0 C-N-CA 125.875 1.67 . . . . 73.52 113.684 -178.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 410' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 74.88 -75.38 0.07 Allowed 'General case' 0 C--N 1.367 1.34 0 C-N-CA 125.661 1.584 . . . . 70.42 110.694 175.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . -167.51 134.66 2.29 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.639 0.775 . . . . 74.33 109.21 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 8.1 mp 72.61 168.84 0.32 Allowed 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 125.245 1.418 . . . . 75.21 111.485 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 13.6 m120 70.77 -55.23 0.64 Allowed 'General case' 0 N--CA 1.501 2.089 0 C-N-CA 125.462 1.505 . . . . 71.14 109.633 -164.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 414' ' ' THR . . . . . 0.448 HG21 ' HA ' ' B' ' 98' ' ' ASP . 55.0 p -65.14 170.43 4.55 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.415 1.086 . . . . 73.24 111.079 164.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 415' ' ' LYS . . . . . 0.688 ' HE3' HG23 ' B' ' 419' ' ' VAL . 84.4 tttt -74.7 77.64 2.05 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 108.663 -0.866 . . . . 75.21 108.663 171.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -88.79 -61.22 1.76 Allowed 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 107.927 -1.138 . . . . 75.33 107.927 176.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 417' ' ' GLY . . . . . . . . . . . . . . . -69.63 88.05 0.28 Allowed Glycine 0 C--N 1.35 1.35 0 N-CA-C 109.897 -1.281 . . . . 62.31 109.897 165.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 418' ' ' ALA . . . . . 0.46 ' HB3' ' HE2' ' B' ' 415' ' ' LYS . . . -77.32 89.07 3.73 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.662 0.785 . . . . 70.25 112.166 -168.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 419' ' ' VAL . . . . . 0.688 HG23 ' HE3' ' B' ' 415' ' ' LYS . 72.8 t 47.62 -80.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 126.155 1.782 . . . . 73.31 113.176 178.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 420' ' ' MET . . . . . . . . . . . . . 25.6 ttt -27.89 105.62 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 126.627 1.971 . . . . 73.34 113.86 -171.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 421' ' ' VAL . . . . . . . . . . . . . 7.5 p -60.61 -36.1 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.594 0.757 . . . . 72.42 111.176 -175.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 422' ' ' MET . . . . . 0.401 ' HA ' ' HE1' ' B' ' 422' ' ' MET . 5.0 tpt -73.19 89.88 1.55 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.831 0.852 . . . . 74.1 110.458 -175.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 423' ' ' SER . . . . . . . . . . . . . 22.7 t 67.15 -3.23 1.02 Allowed 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 125.006 1.322 . . . . 63.45 113.338 174.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 424' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 54.66 79.58 0.14 Allowed 'General case' 0 C--N 1.365 1.259 0 C-N-CA 124.367 1.067 . . . . 74.22 110.457 -170.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . -65.85 90.09 0.13 Allowed Glycine 0 C--N 1.348 1.232 0 CA-C-N 114.64 -1.164 . . . . 75.12 113.892 -171.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 426' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 61.72 -83.65 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 125.217 1.407 . . . . 75.43 111.378 177.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 427' ' ' SER . . . . . . . . . . . . . 26.9 t -141.46 63.86 1.42 Allowed 'General case' 0 C--O 1.239 0.53 0 N-CA-C 106.877 -1.527 . . . . 75.14 106.877 174.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 71.82 -67.45 0.26 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.761 1.624 . . . . 73.23 110.661 -176.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 429' ' ' GLU . . . . . 0.431 ' HB2' ' CE1' ' B' ' 434' ' ' HIS . 34.4 mm-40 60.74 20.49 10.55 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.379 1.472 . . . . 63.42 112.129 177.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -102.46 145.75 29.1 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.513 0.725 . . . . 62.42 109.984 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 30.2 t -142.36 -50.43 0.38 Allowed 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.696 -0.853 . . . . 75.05 108.696 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 432' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -139.63 -25.15 0.83 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.27 0.628 . . . . 71.1 110.708 176.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 433' ' ' GLU . . . . . 0.597 ' HG2' ' HB2' ' B' ' 438' ' ' GLN . 0.3 OUTLIER -165.3 125.5 1.86 Allowed 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 108.904 -0.776 . . . . 73.43 108.904 176.051 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 434' ' ' HIS . . . . . 0.431 ' CE1' ' HB2' ' B' ' 429' ' ' GLU . 11.8 t-160 -148.76 91.74 1.91 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.361 0.664 . . . . 73.42 109.254 172.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 435' ' ' THR . . . . . . . . . . . . . 5.2 m 61.69 69.55 0.64 Allowed 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 124.541 1.136 . . . . 73.42 111.169 172.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . 70.88 22.8 78.36 Favored Glycine 0 C--N 1.348 1.223 0 CA-C-N 115.61 -0.723 . . . . 61.51 114.18 175.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 98.8 p -107.97 29.26 7.44 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.294 0.638 . . . . 72.35 110.183 177.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 438' ' ' GLN . . . . . 0.597 ' HB2' ' HG2' ' B' ' 433' ' ' GLU . 29.5 tt0 -70.12 -95.38 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 122.802 0.441 . . . . 71.55 110.036 175.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 439' ' ' LEU . . . . . . . . . . . . . 80.6 mt 47.94 31.0 2.17 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 124.36 1.064 . . . . 74.24 112.688 -175.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 440' ' ' ARG . . . . . . . . . . . . . 6.9 mmt180 -72.98 127.9 33.9 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.836 0.854 . . . . 74.1 109.867 -172.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 441' ' ' ILE . . . . . 0.552 HD11 ' HA ' ' A' ' 223' ' ' VAL . 76.7 mt -69.44 110.63 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 O-C-N 123.924 0.765 . . . . 74.15 111.513 -173.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 442' ' ' ALA . . . . . . . . . . . . . . . -91.06 76.84 6.12 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 109.077 -0.712 . . . . 73.33 109.077 171.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . -122.03 -160.2 0.86 Allowed 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.179 0.991 . . . . 74.21 109.313 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -59.89 103.03 0.18 Allowed 'General case' 0 CA--C 1.555 1.157 0 CA-C-O 121.678 0.751 . . . . 71.31 111.521 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . -167.9 84.79 0.1 OUTLIER Glycine 0 C--N 1.344 0.992 0 N-CA-C 109.38 -1.488 . . . . 74.34 109.38 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 446' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.63 90.38 0.06 OUTLIER 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 123.671 2.914 . . . . 72.44 114.189 -171.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 447' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 58.73 -90.1 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.285 0 C-N-CA 125.662 1.585 . . . . 63.45 111.755 174.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . 51.78 -84.65 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 125.547 1.539 . . . . 74.31 114.792 173.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 449' ' ' ALA . . . . . . . . . . . . . . . -69.51 88.78 0.5 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.045 0.938 . . . . 74.42 112.506 -167.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 450' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -142.18 -72.06 0.32 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.49 1.116 . . . . 63.22 108.396 172.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 7.3 m -128.71 -43.32 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 123.654 0.782 . . . . 74.44 110.359 177.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 452' ' ' VAL . . . . . . . . . . . . . 4.8 t 56.71 30.59 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.412 0 C-N-CA 124.658 1.183 . . . . 74.24 110.37 -176.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 164.32 171.43 30.56 Favored Glycine 0 C--N 1.351 1.399 0 CA-C-N 115.87 -0.605 . . . . 73.44 112.693 -178.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 454' ' ' LEU . . . . . 0.597 ' HA ' ' HB2' ' B' ' 461' ' ' PHE . 3.5 pp -92.79 153.77 18.68 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.377 0.671 . . . . 73.13 111.126 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 30.2 m -112.21 75.87 0.94 Allowed 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 107.221 -1.4 . . . . 72.1 107.221 175.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 456' ' ' ASP . . . . . 0.464 ' HB2' HD13 ' B' ' 454' ' ' LEU . 26.5 t70 -63.22 85.54 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.87 0.868 . . . . 74.3 111.722 -170.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 457' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -136.07 43.16 2.55 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 106.993 -1.484 . . . . 65.21 106.993 177.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 17.3 m 71.85 74.49 0.17 Allowed 'General case' 0 C--N 1.355 0.839 0 C-N-CA 125.225 1.41 . . . . 72.13 107.267 -159.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 459' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -170.08 149.75 3.63 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 114.322 -1.308 . . . . 73.31 109.255 -170.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 37.7 tp -150.46 66.91 0.95 Allowed 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 109.23 -0.656 . . . . 65.42 109.23 178.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 461' ' ' PHE . . . . . 0.597 ' HB2' ' HA ' ' B' ' 454' ' ' LEU . 22.9 m-85 -66.11 102.51 0.83 Allowed 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 108.846 -0.798 . . . . 75.0 108.846 168.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -59.59 -51.85 68.06 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.186 0.594 . . . . 72.53 109.856 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 10.4 m 70.16 -8.87 0.79 Allowed 'General case' 0 CA--C 1.568 1.643 0 C-N-CA 125.341 1.457 . . . . 71.14 112.43 175.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 464' ' ' MET . . . . . . . . . . . . . 3.8 mpp? 50.52 48.34 22.69 Favored 'General case' 0 C--N 1.363 1.172 0 C-N-CA 125.505 1.522 . . . . 75.31 111.797 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -72.98 159.13 34.17 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.704 -1.135 . . . . 72.15 110.871 177.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -154.23 175.4 13.53 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 124.347 1.059 . . . . 65.13 108.897 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . -85.62 44.63 1.12 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.42 0.688 . . . . 75.3 110.757 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 47.5 tp -165.96 -40.47 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.281 1.033 . . . . 74.32 109.597 -176.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 469' ' ' GLY . . . . . . . . . . . . . . . -175.84 -153.51 10.5 Favored Glycine 0 C--N 1.351 1.375 0 CA-C-N 116.412 -0.358 . . . . 62.03 112.454 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 470' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -148.17 161.84 40.65 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.034 0.933 . . . . 75.32 109.298 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 471' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? . . . . . 0 CA--C 1.551 0.987 0 N-CA-C 106.985 -1.487 . . . . 74.2 106.985 174.255 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 67.3 mtm . . . . . 0 N--CA 1.476 0.86 0 N-CA-C 110.485 -0.191 . . . . 70.43 110.485 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 68.11 44.07 1.5 Allowed 'General case' 0 C--N 1.36 1.041 0 C-N-CA 124.306 1.043 . . . . 70.41 111.519 172.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.5 61.66 2.32 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 115.45 -0.795 . . . . 71.34 110.576 176.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -38.52 110.12 0.12 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.129 1.772 . . . . 70.52 113.253 177.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 5' ' ' LYS . . . . . 0.514 ' HB3' HD13 ' C' ' 10' ' ' ILE . 37.7 mtpt -95.71 104.73 16.66 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 108.506 -0.924 . . . . 72.32 108.506 167.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -66.98 104.32 1.35 Allowed 'General case' 0 C--N 1.351 0.658 0 N-CA-C 109.08 -0.711 . . . . 65.15 109.08 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 7' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -63.92 -29.59 70.75 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 124.088 0.868 . . . . 73.43 112.443 -169.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -71.34 -40.43 70.71 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 122.516 0.326 . . . . 74.23 110.38 178.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.11 -37.82 88.69 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 122.825 0.45 . . . . 63.34 110.271 177.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 10' ' ' ILE . . . . . 0.514 HD13 ' HB3' ' C' ' 5' ' ' LYS . 69.4 mt -59.74 -40.25 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 123.186 0.594 . . . . 73.31 110.128 173.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 92.7 mt -82.08 -8.2 59.65 Favored 'General case' 0 CA--C 1.556 1.186 0 N-CA-C 112.935 0.717 . . . . 75.53 112.935 176.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 67.67 35.7 86.36 Favored Glycine 0 C--N 1.352 1.464 0 N-CA-C 113.845 0.298 . . . . 74.43 113.845 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 11.7 m -124.15 160.31 52.89 Favored Pre-proline 0 N--CA 1.486 1.372 0 C-N-CA 125.08 1.352 . . . . 71.34 110.175 178.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -56.91 152.24 44.41 Favored 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 122.933 2.422 . . . . 74.43 113.485 175.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -79.67 28.56 0.26 Allowed 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 113.746 1.017 . . . . 74.35 113.746 -171.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -154.83 27.73 0.43 Allowed 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 108.008 -1.108 . . . . 71.24 108.008 171.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.07 154.24 40.11 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.183 -0.917 . . . . 75.2 111.896 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 69.4 p -95.53 179.42 5.15 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.002 0.921 . . . . 74.41 111.912 -172.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -52.94 -45.0 67.47 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.46 1.104 . . . . 74.45 111.957 -177.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -70.41 -32.85 70.64 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 123.56 0.537 . . . . 74.53 111.746 -177.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -71.57 -43.04 67.05 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 122.907 0.483 . . . . 73.42 110.489 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 1.7 mp -64.86 -38.24 82.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 123.758 0.823 . . . . 75.54 110.221 175.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -64.43 -52.25 59.07 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.124 0.969 . . . . 74.13 111.031 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -69.8 -34.14 73.32 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.467 -0.788 . . . . 73.52 111.087 -177.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -72.38 -35.58 68.5 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.292 0.637 . . . . 75.32 110.979 178.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 26' ' ' TYR . . . . . 0.455 ' HD1' HG23 ' C' ' 50' ' ' ILE . 32.8 t80 -56.75 -61.35 2.49 Favored 'General case' 0 C--O 1.209 -1.065 0 O-C-N 124.261 0.976 . . . . 72.31 108.98 171.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -58.22 -41.67 84.57 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 124.15 0.906 . . . . 75.33 111.929 -177.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 45.7 ttt180 -50.75 -53.89 27.9 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.981 1.312 . . . . 75.55 110.699 176.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 87.1 mt -92.11 -6.2 51.32 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.228 -0.896 . . . . 71.43 111.743 -176.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.65 -4.7 47.18 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.694 0.798 . . . . 75.32 110.145 173.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 58.6 mtp180 -103.96 -35.2 8.21 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.92 0.888 . . . . 73.5 109.53 166.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.98 -55.15 15.73 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 109.506 -0.553 . . . . 71.12 109.506 178.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -89.9 7.22 38.39 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 112.046 0.387 . . . . 72.14 112.046 -177.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 34' ' ' HIS . . . . . . . . . . . . . 31.8 t60 -61.28 105.3 0.57 Allowed Pre-proline 0 N--CA 1.478 0.964 0 C-N-CA 124.241 1.016 . . . . 74.34 110.406 -176.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -53.87 -28.36 48.27 Favored 'Trans proline' 0 N--CA 1.507 2.29 0 C-N-CA 123.467 2.778 . . . . 72.22 115.393 -171.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -68.79 -31.81 71.08 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.534 0.734 . . . . 60.34 111.711 178.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 97.9 t -90.96 -50.7 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.402 0.681 . . . . 75.33 109.93 176.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -105.38 92.22 4.11 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.426 1.491 . . . . 65.41 108.605 -173.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -76.36 81.53 3.1 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 108.733 -0.839 . . . . 71.22 108.733 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 45.9 m -147.84 128.63 6.97 Favored Pre-proline 0 N--CA 1.48 1.06 0 C-N-CA 123.244 0.618 . . . . 74.14 110.342 177.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.8 -40.2 86.12 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 122.903 2.402 . . . . 75.0 111.002 174.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -53.0 -46.19 68.22 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 114.871 -1.059 . . . . 71.01 111.004 174.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.71 -16.9 56.69 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 122.616 0.367 . . . . 71.45 110.649 -175.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -73.97 -47.99 33.53 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 107.68 -1.23 . . . . 74.04 107.68 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -70.58 -38.06 74.0 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 114.055 -1.429 . . . . 75.44 111.465 178.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 46' ' ' LYS . . . . . 0.528 ' O ' HG12 ' C' ' 50' ' ' ILE . 34.0 mmtm -64.54 -37.34 87.22 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 116.224 -0.444 . . . . 72.32 110.577 175.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -62.2 -40.98 97.9 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.486 0.715 . . . . 71.12 109.665 175.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -60.3 -38.37 83.42 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 123.391 0.432 . . . . 72.04 111.554 173.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -68.48 -33.91 74.99 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 122.744 0.418 . . . . 72.33 111.473 177.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 50' ' ' ILE . . . . . 0.528 HG12 ' O ' ' C' ' 46' ' ' LYS . 26.6 mm -68.77 -32.82 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 N-CA-C 109.246 -0.65 . . . . 75.43 109.246 174.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 51' ' ' ASN . . . . . 0.41 ' HB3' ' HD1' ' C' ' 88' ' ' PHE . 0.9 OUTLIER -74.12 -32.1 63.04 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 114.998 -1.001 . . . . 74.04 111.05 177.761 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -66.35 -57.28 7.81 Favored 'General case' 0 C--O 1.248 0.992 0 C-N-CA 123.966 0.906 . . . . 75.54 109.903 175.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -52.15 -54.98 24.03 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 113.632 -1.622 . . . . 63.1 111.194 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -61.19 -46.11 91.84 Favored 'General case' 0 C--O 1.21 -1.024 0 CA-C-N 115.278 -0.874 . . . . 75.01 111.405 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.42 -47.55 72.66 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 122.841 0.456 . . . . 60.54 112.007 -176.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 90.5 t -63.93 -44.08 97.87 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 O-C-N 123.93 0.769 . . . . 72.43 110.331 177.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 57' ' ' LEU . . . . . . . . . . . . . 52.4 mt -88.17 0.17 56.37 Favored 'General case' 0 CA--C 1.564 1.482 0 N-CA-C 113.283 0.846 . . . . 75.02 113.283 -174.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 33.5 t -87.1 -51.31 6.07 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.142 0.977 . . . . 75.33 109.801 -178.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.44 123.06 84.56 Favored Pre-proline 0 C--O 1.217 -0.631 0 N-CA-C 107.845 -1.169 . . . . 72.03 107.845 172.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 60' ' ' PRO . . . . . 0.569 ' HD2' ' HA ' ' C' ' 145' ' ' VAL . 15.0 Cg_endo -55.95 -29.21 72.38 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 122.696 2.264 . . . . 73.21 111.216 170.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -65.39 -64.38 0.88 Allowed 'General case' 0 C--N 1.35 0.595 0 CA-C-N 115.626 -0.715 . . . . 62.13 110.825 176.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 62' ' ' LYS . . . . . 0.494 ' HD3' ' HB3' ' C' ' 83' ' ' TYR . 27.0 mtmm -64.69 -26.62 68.45 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.826 0.45 . . . . 75.43 111.414 -177.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 47.3 tpt85 -57.83 -58.49 8.13 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.642 1.177 . . . . 74.14 109.0 173.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -74.74 -16.79 60.72 Favored 'General case' 0 C--N 1.348 0.518 0 CA-C-N 115.182 -0.917 . . . . 74.15 112.215 -176.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 65' ' ' ILE . . . . . 0.613 HG22 ' HD2' ' C' ' 76' ' ' PRO . 65.2 mt -65.97 -48.26 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 N-CA-C 108.791 -0.818 . . . . 71.5 108.791 169.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -58.61 -51.77 68.49 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.311 -0.859 . . . . 74.31 110.181 176.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -54.44 -51.26 65.53 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.47 0.708 . . . . 73.14 111.643 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 68.0 p -76.0 -13.65 60.23 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 118.958 -0.544 . . . . 74.43 112.376 -177.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -67.52 107.09 2.36 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 109.004 -0.739 . . . . 75.22 109.004 176.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 114.29 17.78 7.01 Favored Glycine 0 C--N 1.343 0.945 0 CA-C-N 115.514 -0.766 . . . . 62.51 111.743 -167.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 98.8 m -148.89 -59.78 0.23 Allowed 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 104.064 -2.569 . . . . 72.34 104.064 176.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 12.4 m -77.9 138.95 39.18 Favored 'General case' 0 C--O 1.256 1.431 0 N-CA-C 104.571 -2.381 . . . . 73.35 104.571 158.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -100.05 -54.82 2.79 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 108.75 -0.833 . . . . 73.23 108.75 -173.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -72.12 151.63 92.54 Favored Pre-proline 0 CA--C 1.546 0.824 0 CA-C-N 114.688 -1.142 . . . . 53.23 109.765 173.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -56.29 123.51 14.01 Favored 'Trans proline' 0 C--N 1.369 1.63 0 C-N-CA 122.338 2.025 . . . . 75.14 110.921 169.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 76' ' ' PRO . . . . . 0.613 ' HD2' HG22 ' C' ' 65' ' ' ILE . 84.3 Cg_exo -50.98 145.79 23.71 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 123.004 2.469 . . . . 71.22 112.817 172.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -51.57 125.79 17.77 Favored 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 123.642 2.894 . . . . 74.4 112.587 -177.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 78' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -69.21 141.3 47.05 Favored 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 122.89 2.393 . . . . 74.44 111.95 -177.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 79' ' ' PRO . . . . . 0.412 ' HB2' ' O ' ' C' ' 142' ' ' GLY . 30.9 Cg_endo -61.83 152.68 73.08 Favored 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 122.522 2.148 . . . . 70.12 111.218 174.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -50.73 82.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.392 2.859 0 C-N-CA 124.242 3.295 . . . . 74.31 114.494 -169.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 153.36 -53.05 0.46 Allowed Glycine 0 C--N 1.335 0.481 0 N-CA-C 109.811 -1.315 . . . . 75.2 109.811 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 141.13 -150.76 22.05 Favored Glycine 0 C--N 1.353 1.528 0 CA-C-N 115.615 -0.292 . . . . 75.13 113.662 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 83' ' ' TYR . . . . . 0.494 ' HB3' ' HD3' ' C' ' 62' ' ' LYS . 29.4 m-85 -104.01 122.24 44.83 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.274 1.43 . . . . 73.4 108.855 -177.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 84' ' ' ASP . . . . . 0.491 ' HB2' ' NE ' ' C' ' 143' ' ' ARG . 5.5 t70 -80.82 128.38 33.59 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 112.367 0.506 . . . . 75.11 112.367 -169.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 85' ' ' PHE . . . . . 0.54 ' HA ' ' HD2' ' C' ' 88' ' ' PHE . 77.0 m-85 -139.46 29.99 2.15 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.263 1.025 . . . . 74.41 109.776 176.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 13.7 m -78.6 84.94 4.68 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 114.89 -1.05 . . . . 52.42 111.39 -173.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 87' ' ' GLY . . . . . 0.596 ' N ' ' HA ' ' C' ' 171' ' ' PRO . . . 130.59 -19.73 5.0 Favored Glycine 0 N--CA 1.47 0.959 0 N-CA-C 110.24 -1.144 . . . . 74.34 110.24 -174.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 88' ' ' PHE . . . . . 0.54 ' HD2' ' HA ' ' C' ' 85' ' ' PHE . 32.5 m-85 -100.0 129.89 46.1 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 107.921 -1.14 . . . . 74.44 107.921 178.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -75.75 78.88 2.69 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.548 0.689 . . . . 72.23 110.804 -175.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 90' ' ' VAL . . . . . 0.434 HG22 ' ND2' ' C' ' 169' ' ' ASN . 5.6 p -50.06 -35.93 11.79 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 C-N-CA 125.981 1.713 . . . . 54.42 113.482 -174.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -65.94 -26.05 67.41 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 123.499 0.72 . . . . 75.25 112.124 -175.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -78.17 -26.56 47.72 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 122.674 0.389 . . . . 75.53 111.88 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 9.3 m-30 -70.13 164.33 24.38 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 123.345 0.403 . . . . 72.45 111.343 -167.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 52.1 p -59.43 149.85 28.25 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 113.969 1.1 . . . . 52.11 113.969 -166.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.71 -35.71 75.07 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 114.738 -1.119 . . . . 72.35 110.525 171.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -53.73 -50.91 64.92 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.542 1.137 . . . . 74.24 110.858 172.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 97' ' ' PHE . . . . . 0.405 ' CZ ' HG23 ' C' ' 90' ' ' VAL . 1.1 t80 -58.96 -43.04 91.23 Favored 'General case' 0 CA--C 1.552 1.043 0 CA-C-N 114.511 -1.222 . . . . 64.25 110.767 175.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -69.31 -21.4 63.85 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.077 0.551 . . . . 71.33 112.026 -177.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -82.69 -50.0 9.19 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.293 0.637 . . . . 74.43 110.621 173.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 38.6 tp -67.45 -63.73 1.0 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.775 0.83 . . . . 73.23 110.553 -175.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -80.26 -0.71 37.63 Favored 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 123.091 0.556 . . . . 75.04 112.413 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -45.57 -58.84 5.1 Favored Glycine 0 CA--C 1.544 1.85 0 CA-C-O 118.933 -0.926 . . . . 74.41 115.411 178.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -62.65 -3.38 4.36 Favored 'Trans proline' 0 C--N 1.385 2.466 0 C-N-CA 123.535 2.824 . . . . 64.35 114.528 -176.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -141.71 38.28 1.52 Allowed Glycine 0 C--N 1.354 1.535 0 CA-C-O 119.118 -0.823 . . . . 73.42 112.62 174.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 43.0 mt -70.86 41.24 0.06 Allowed 'General case' 0 N--CA 1.505 2.285 0 CA-C-N 118.58 1.19 . . . . 75.43 113.922 175.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 106' ' ' PHE . . . . . 0.513 ' O ' ' HA ' ' C' ' 111' ' ' ARG . 0.3 OUTLIER 68.59 -108.39 0.09 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.44 1.496 . . . . 64.24 111.926 163.09 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 107' ' ' GLY . . . . . 0.526 ' HA3' ' H ' ' C' ' 113' ' ' SER . . . 65.09 29.75 76.15 Favored Glycine 0 C--N 1.353 1.511 0 CA-C-N 118.534 0.606 . . . . 51.05 113.086 -168.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 60.86 -123.27 32.25 Favored Glycine 0 C--N 1.351 1.375 0 N-CA-C 111.505 -0.638 . . . . 74.41 111.505 -173.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 109' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -99.95 -7.14 25.54 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.443 0.697 . . . . 74.45 110.686 171.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.83 -12.41 66.41 Favored Glycine 0 C--N 1.348 1.224 0 O-C-N 123.603 0.564 . . . . 73.14 112.749 -178.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . 0.513 ' HA ' ' O ' ' C' ' 106' ' ' PHE . 77.6 mtm180 56.89 11.79 1.03 Allowed 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 124.539 1.135 . . . . 75.25 113.887 176.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 112' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -48.72 -29.53 4.56 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 126.649 1.98 . . . . 75.43 112.891 173.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 113' ' ' SER . . . . . 0.526 ' H ' ' HA3' ' C' ' 107' ' ' GLY . 38.0 m 63.6 15.54 8.96 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.244 1.418 . . . . 72.53 112.383 -177.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 114' ' ' ARG . . . . . 0.511 ' HG3' ' H ' ' C' ' 115' ' ' LYS . 12.9 tpt180 -117.88 -169.19 1.64 Allowed 'General case' 0 C--O 1.21 -1.01 0 CA-C-O 118.314 -0.851 . . . . 74.05 110.777 -174.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 115' ' ' LYS . . . . . 0.511 ' H ' ' HG3' ' C' ' 114' ' ' ARG . 57.7 tttp -35.82 126.27 0.7 Allowed 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 126.53 1.932 . . . . 74.15 116.123 -161.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 116' ' ' GLY . . . . . 0.427 ' HA2' ' HA3' ' C' ' 168' ' ' GLY . . . -79.94 153.96 36.86 Favored Glycine 0 C--N 1.36 1.9 0 CA-C-N 115.634 -0.712 . . . . 54.4 113.981 -177.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 117' ' ' ARG . . . . . 0.541 ' HB2' ' HB2' ' C' ' 167' ' ' GLN . 2.4 mmp_? -116.29 147.51 41.46 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 124.492 1.117 . . . . 74.32 111.498 177.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -68.9 113.66 6.52 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 108.322 -0.992 . . . . 75.42 108.322 174.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 119' ' ' LEU . . . . . 0.549 HD21 HG22 ' B' ' 185' ' ' VAL . 5.7 tt -92.12 119.34 31.69 Favored 'General case' 0 C--O 1.219 -0.512 0 N-CA-C 105.953 -1.869 . . . . 75.21 105.953 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.409 ' HG2' HD12 ' C' ' 175' ' ' LEU . 98.3 mtt180 -97.48 132.95 42.69 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 107.399 -1.334 . . . . 72.31 107.399 176.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 121' ' ' ALA . . . . . . . . . . . . . . . -143.02 117.37 9.63 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.294 -0.632 . . . . 75.44 109.294 -178.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 122' ' ' GLU . . . . . 0.447 ' HA ' ' O ' ' C' ' 177' ' ' VAL . 12.7 pt-20 -99.17 130.0 45.46 Favored 'General case' 0 C--N 1.348 0.529 0 CA-C-O 120.959 0.409 . . . . 74.12 109.913 177.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 123' ' ' LEU . . . . . 0.582 HD12 HG12 ' B' ' 182' ' ' VAL . 0.4 OUTLIER -122.96 120.9 27.41 Favored Pre-proline 0 N--CA 1.473 0.7 0 C-N-CA 123.447 0.699 . . . . 73.3 111.92 -166.132 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . 0.544 ' HD2' ' HB3' ' B' ' 183' ' ' ALA . 80.4 Cg_exo -51.19 116.96 3.0 Favored 'Trans proline' 0 C--N 1.37 1.68 0 C-N-CA 122.82 2.347 . . . . 72.51 111.298 162.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 125' ' ' LEU . . . . . . . . . . . . . 26.3 tp -138.64 140.26 38.83 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.373 1.069 . . . . 75.32 108.6 -175.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.4 156.24 21.91 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.069 0.461 . . . . 61.53 111.192 -177.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 127' ' ' LEU . . . . . 0.601 ' HB3' HD22 ' C' ' 215' ' ' LEU . 95.9 mt -63.72 -44.99 91.94 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.124 0.97 . . . . 62.25 110.776 177.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -52.84 -46.39 67.77 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 114.885 -1.052 . . . . 75.24 110.513 172.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -67.01 -33.84 76.42 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.092 0.957 . . . . 75.51 111.553 -176.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -72.44 -33.1 66.84 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 123.866 0.729 . . . . 73.14 110.344 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 131' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -68.09 -41.38 81.94 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.2 0.6 . . . . 75.55 110.361 172.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 132' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -66.72 -68.91 0.34 Allowed 'General case' 0 N--CA 1.481 1.118 0 O-C-N 123.653 0.595 . . . . 70.15 111.284 -175.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 62.93 93.25 0.02 OUTLIER Glycine 0 CA--C 1.541 1.678 0 O-C-N 123.735 0.647 . . . . 65.31 113.239 -176.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . -135.89 161.38 24.82 Favored Glycine 0 N--CA 1.479 1.516 0 CA-C-O 119.473 -0.626 . . . . 73.12 111.802 177.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -71.88 95.53 1.56 Allowed 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 108.727 -0.842 . . . . 73.03 108.727 176.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 136' ' ' ARG . . . . . 0.459 ' HB2' HD22 ' B' ' 181' ' ' LEU . 90.0 mtt180 -123.93 163.52 21.16 Favored 'General case' 0 C--O 1.248 1.006 0 C-N-CA 123.563 0.745 . . . . 72.12 109.733 -173.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 137' ' ' VAL . . . . . 0.524 HG13 ' HB2' ' B' ' 180' ' ' ALA . 7.8 p -79.84 125.34 38.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 121.553 0.692 . . . . 73.11 110.621 -169.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 138' ' ' VAL . . . . . 0.579 HG13 ' HB3' ' B' ' 181' ' ' LEU . 8.1 m -112.46 141.84 26.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 124.068 0.947 . . . . 72.14 108.554 173.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 139' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -124.76 100.61 6.7 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 107.742 -1.207 . . . . 74.31 107.742 170.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 140' ' ' VAL . . . . . 0.435 HG22 HD22 ' C' ' 174' ' ' LEU . 61.3 t -116.59 100.33 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 109.376 -0.601 . . . . 73.25 109.376 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 63.41 30.69 15.4 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.444 0.698 . . . . 65.0 111.151 177.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 142' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' C' ' 79' ' ' PRO . . . 101.86 -11.6 57.59 Favored Glycine 0 C--N 1.343 0.917 0 CA-C-N 115.713 -0.676 . . . . 52.4 112.409 -179.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 143' ' ' ARG . . . . . 0.491 ' NE ' ' HB2' ' C' ' 84' ' ' ASP . 6.0 tpp180 -76.63 92.87 3.54 Favored 'General case' 0 C--N 1.352 0.699 0 N-CA-C 109.573 -0.529 . . . . 75.05 109.573 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 144' ' ' ARG . . . . . 0.427 ' HA ' ' O ' ' C' ' 138' ' ' VAL . 39.3 ttp85 -96.66 94.62 7.42 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 115.083 -0.962 . . . . 71.51 108.778 178.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 145' ' ' VAL . . . . . 0.569 ' HA ' ' HD2' ' C' ' 60' ' ' PRO . 28.6 m -131.5 176.16 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-N 114.978 -1.01 . . . . 75.03 109.879 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 49.0 m -125.12 118.83 26.97 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 109.05 -0.722 . . . . 73.22 109.05 178.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 147' ' ' VAL . . . . . 0.458 HG13 ' HE1' ' C' ' 164' ' ' MET . 14.1 p -142.0 150.99 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.103 0.561 . . . . 72.53 110.101 -173.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 45.2 ttp180 -103.34 110.58 22.62 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 108.346 -0.983 . . . . 74.22 108.346 169.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 149' ' ' ILE . . . . . 0.558 ' HB ' HD12 ' C' ' 159' ' ' ILE . 38.0 pt -76.46 148.29 80.04 Favored Pre-proline 0 CA--C 1.557 1.245 0 N-CA-C 109.267 -0.642 . . . . 74.42 109.267 170.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -47.88 119.64 4.03 Favored 'Trans proline' 0 C--N 1.381 2.268 0 C-N-CA 124.033 3.156 . . . . 61.44 113.723 -174.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -63.26 132.72 37.36 Favored 'Trans proline' 0 C--N 1.383 2.364 0 C-N-CA 122.903 2.402 . . . . 73.2 110.969 174.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 152' ' ' GLY . . . . . 0.56 ' HA2' ' HB3' ' C' ' 240' ' ' PHE . . . 86.92 53.92 2.74 Favored Glycine 0 C--N 1.334 0.435 0 N-CA-C 111.338 -0.705 . . . . 63.11 111.338 -173.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 153' ' ' VAL . . . . . 0.528 HG23 HD11 ' C' ' 159' ' ' ILE . 12.5 p -101.99 143.84 14.17 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.245 0 C-N-CA 123.539 0.736 . . . . 74.01 110.531 -172.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 154' ' ' ARG . . . . . 0.648 ' HA ' ' HB3' ' C' ' 188' ' ' LEU . 49.9 mtp180 -96.82 155.2 16.88 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.698 0.799 . . . . 75.32 112.329 -167.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 155' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -53.42 108.82 0.37 Allowed 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 123.267 0.627 . . . . 74.51 110.064 162.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 89.25 18.13 53.92 Favored Glycine 0 C--N 1.343 0.959 0 CA-C-O 119.803 -0.443 . . . . 75.21 113.454 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 157' ' ' SER . . . . . 0.558 ' HA ' ' HG2' ' B' ' 193' ' ' PRO . 3.5 m -73.35 107.1 5.47 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 117.148 0.474 . . . . 75.43 110.314 172.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 158' ' ' VAL . . . . . 0.52 HG12 ' HA ' ' B' ' 190' ' ' CYS . 42.1 t -85.02 90.25 2.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-N 114.438 -1.255 . . . . 72.31 108.378 176.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 159' ' ' ILE . . . . . 0.558 HD12 ' HB ' ' C' ' 149' ' ' ILE . 53.0 mt -75.88 118.96 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 114.972 -1.013 . . . . 72.31 110.179 -178.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 53.1 ttt180 -78.06 119.71 21.87 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 109.918 -0.401 . . . . 75.13 109.918 173.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 161' ' ' VAL . . . . . 0.605 HG11 ' SD ' ' C' ' 164' ' ' MET . 21.2 t -125.97 95.47 39.48 Favored Pre-proline 0 CA--C 1.551 1.017 0 N-CA-C 109.062 -0.718 . . . . 75.24 109.062 176.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.43 119.63 5.85 Favored 'Trans proline' 0 C--N 1.368 1.59 0 C-N-CA 122.388 2.058 . . . . 75.23 111.253 172.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 113.24 23.32 5.23 Favored Glycine 0 C--N 1.341 0.815 0 CA-C-N 115.899 -0.591 . . . . 53.54 112.843 178.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 164' ' ' MET . . . . . 0.605 ' SD ' HG11 ' C' ' 161' ' ' VAL . 28.6 mtp -148.95 3.96 0.63 Allowed 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 112.884 0.698 . . . . 73.35 112.884 -178.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 165' ' ' GLY . . . . . 0.404 ' HA3' ' O ' ' C' ' 173' ' ' ASP . . . -126.37 -123.04 2.63 Favored Glycine 0 N--CA 1.48 1.603 0 CA-C-O 118.346 -1.252 . . . . 73.32 111.067 -177.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . 68.57 73.62 0.68 Allowed Glycine 0 C--N 1.363 2.041 0 CA-C-N 118.516 1.158 . . . . 75.44 113.501 165.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 167' ' ' GLN . . . . . 0.541 ' HB2' ' HB2' ' C' ' 117' ' ' ARG . 23.4 mm-40 -67.14 98.06 0.57 Allowed 'General case' 0 C--N 1.348 0.502 0 N-CA-C 107.033 -1.469 . . . . 74.2 107.033 170.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 168' ' ' GLY . . . . . 0.427 ' HA3' ' HA2' ' C' ' 116' ' ' GLY . . . 136.57 -140.55 11.58 Favored Glycine 0 C--O 1.217 -0.939 0 CA-C-N 112.745 -2.025 . . . . 13.44 108.881 -161.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 169' ' ' ASN . . . . . 0.434 ' ND2' HG22 ' C' ' 90' ' ' VAL . 62.6 t30 -153.3 -51.6 0.02 OUTLIER Pre-proline 0 N--CA 1.497 1.894 0 CA-C-N 119.918 1.859 . . . . 62.44 111.952 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 170' ' ' PRO . . . . . 0.419 ' HD3' ' HB3' ' C' ' 169' ' ' ASN . 86.3 Cg_exo -53.81 161.99 4.13 Favored 'Trans proline' 0 C--N 1.393 2.912 0 C-N-CA 122.559 2.173 . . . . 73.55 113.504 164.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 171' ' ' PRO . . . . . 0.596 ' HA ' ' N ' ' C' ' 87' ' ' GLY . 1.5 Cg_exo -28.63 104.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.39 2.759 1 C-N-CA 125.494 4.13 . . . . 74.02 117.854 -174.438 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -121.66 -146.61 7.42 Favored Glycine 0 C--N 1.341 0.819 0 N-CA-C 109.387 -1.485 . . . . 74.42 109.387 170.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 173' ' ' ASP . . . . . 0.404 ' O ' ' HA3' ' C' ' 165' ' ' GLY . 27.2 t70 -171.16 159.5 5.94 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 117.607 0.703 . . . . 74.51 111.053 -176.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 174' ' ' LEU . . . . . 0.472 HD23 ' HE3' ' C' ' 164' ' ' MET . 17.5 tp -124.89 115.4 20.56 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.727 0.811 . . . . 75.22 110.166 170.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 175' ' ' LEU . . . . . 0.466 HD22 HG11 ' C' ' 158' ' ' VAL . 76.7 mt -92.05 89.99 7.19 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.172 0.989 . . . . 72.15 110.291 174.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 176' ' ' LEU . . . . . 0.408 ' HG ' ' HG ' ' C' ' 174' ' ' LEU . 58.1 mt -76.66 93.78 3.69 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.48 0.712 . . . . 74.33 111.002 176.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 177' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' C' ' 122' ' ' GLU . 8.2 t -86.64 100.71 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 123.371 0.668 . . . . 75.23 109.69 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 178' ' ' VAL . . . . . 0.421 ' HA ' ' HG ' ' C' ' 123' ' ' LEU . 14.8 m -73.64 112.43 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.199 0 CA-C-O 122.336 1.065 . . . . 74.01 111.154 -174.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 179' ' ' ARG . . . . . . . . . . . . . 7.0 mmm180 -91.4 115.39 27.99 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 114.291 -1.322 . . . . 74.42 107.687 170.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 180' ' ' LEU . . . . . . . . . . . . . 77.4 mt -69.07 135.39 50.71 Favored 'General case' 0 CA--C 1.561 1.398 0 CA-C-N 118.3 0.5 . . . . 73.43 111.436 178.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 181' ' ' LEU . . . . . 0.413 HD23 ' HB3' ' C' ' 124' ' ' PRO . 16.4 mt -53.43 169.65 0.31 Allowed Pre-proline 0 N--CA 1.501 2.102 0 C-N-CA 126.896 2.078 . . . . 74.24 113.965 -175.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -60.86 62.22 0.09 OUTLIER 'Trans proline' 0 C--N 1.397 3.112 0 C-N-CA 123.936 3.09 . . . . 73.32 112.442 161.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 183' ' ' HIS . . . . . 0.521 ' N ' ' HD3' ' C' ' 184' ' ' PRO . 85.7 t60 -162.06 28.17 0.03 OUTLIER Pre-proline 0 CA--C 1.572 1.803 0 C-N-CA 127.82 2.448 . . . . 72.0 107.203 -179.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 184' ' ' PRO . . . . . 0.521 ' HD3' ' N ' ' C' ' 183' ' ' HIS . 44.2 Cg_endo -91.81 67.57 1.0 Allowed 'Trans proline' 0 C--N 1.396 3.061 0 C-N-CA 123.719 2.946 . . . . 74.25 111.731 -162.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 185' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 2.9 t -87.81 -23.28 6.56 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.788 0 N-CA-C 107.751 -1.203 . . . . 72.23 107.751 -176.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 186' ' ' PHE . . . . . 0.529 ' HD2' HD12 ' C' ' 127' ' ' LEU . 56.7 m-85 -125.57 100.55 6.5 Favored 'General case' 0 C--N 1.346 0.439 0 N-CA-C 108.931 -0.766 . . . . 61.44 108.931 -178.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 187' ' ' ARG . . . . . 0.419 ' NH2' ' HB2' ' C' ' 184' ' ' PRO . 32.1 ttm105 -99.89 107.82 19.91 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 107.477 -1.305 . . . . 75.14 107.477 -177.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 188' ' ' LEU . . . . . 0.648 ' HB3' ' HA ' ' C' ' 154' ' ' ARG . 53.3 tp -76.52 127.89 33.71 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.199 0.814 . . . . 74.14 113.199 -163.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -112.97 104.46 12.43 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.9 1.28 . . . . 73.21 108.082 169.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 68.2 -103.29 0.98 Allowed Glycine 0 CA--C 1.534 1.247 0 CA-C-N 116.437 -0.347 . . . . 74.2 112.533 -176.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 191' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -113.85 -16.4 12.24 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 124.226 1.01 . . . . 75.25 110.469 175.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -99.52 130.7 45.79 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.409 1.084 . . . . 65.13 110.126 -173.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 193' ' ' LEU . . . . . 0.438 HD21 HD12 ' C' ' 188' ' ' LEU . 71.1 mt -74.41 152.55 39.49 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.743 0.817 . . . . 65.15 111.501 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 194' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -120.09 106.66 12.19 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 107.531 -1.285 . . . . 75.43 107.531 167.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 195' ' ' ALA . . . . . 0.484 ' HA ' ' O ' ' C' ' 185' ' ' VAL . . . -109.38 -177.73 3.37 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.264 1.026 . . . . 65.11 110.315 -177.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 95.8 m -137.83 118.42 13.95 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.598 -0.89 . . . . 53.42 108.598 165.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 197' ' ' LEU . . . . . . . . . . . . . 62.3 tp -97.09 139.48 33.03 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.182 -0.917 . . . . 73.5 110.482 -175.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -93.53 100.87 13.07 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 109.015 -0.735 . . . . 64.33 109.015 -178.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 199' ' ' VAL . . . . . 0.482 HG21 HG21 ' C' ' 210' ' ' VAL . 94.7 t -114.41 119.35 40.22 Favored Pre-proline 0 N--CA 1.484 1.232 0 C-N-CA 124.068 0.947 . . . . 73.12 109.226 -178.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 200' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -72.68 145.78 42.1 Favored 'Trans proline' 0 C--N 1.366 1.469 0 C-N-CA 121.664 1.576 . . . . 73.11 110.75 174.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 201' ' ' ALA . . . . . 0.431 ' N ' ' HD2' ' C' ' 202' ' ' PRO . . . -58.26 -38.82 70.27 Favored Pre-proline 0 CA--C 1.552 1.037 0 N-CA-C 115.348 1.61 . . . . 74.35 115.348 -173.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 202' ' ' PRO . . . . . 0.514 ' O ' HG12 ' C' ' 206' ' ' VAL . 19.4 Cg_endo -58.45 -52.43 5.54 Favored 'Trans proline' 0 C--N 1.382 2.337 0 CA-C-N 121.547 1.588 . . . . 63.15 111.417 174.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 203' ' ' ILE . . . . . . . . . . . . . 41.7 mt -63.34 -27.6 43.37 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 123.887 0.875 . . . . 74.02 110.793 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.21 -41.59 76.87 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.567 -0.742 . . . . 75.02 112.229 175.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 205' ' ' VAL . . . . . 0.508 HG11 HD13 ' A' ' 261' ' ' LEU . 90.7 t -72.14 -43.65 66.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 122.578 0.351 . . . . 74.52 111.175 -178.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 206' ' ' VAL . . . . . 0.514 HG12 ' O ' ' C' ' 202' ' ' PRO . 0.6 OUTLIER -98.25 -38.08 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 N-CA-C 111.656 0.243 . . . . 74.12 111.656 -168.265 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 106.01 123.62 5.18 Favored Glycine 0 CA--C 1.529 0.914 0 O-C-N 123.122 0.264 . . . . 63.21 112.787 -173.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -158.38 -130.92 1.22 Allowed Glycine 0 C--N 1.34 0.797 0 N-CA-C 110.197 -1.161 . . . . 51.32 110.197 176.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 209' ' ' LYS . . . . . 0.556 ' HG2' ' HA ' ' C' ' 222' ' ' ALA . 8.6 mtmp? -147.65 146.86 29.48 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 117.673 0.737 . . . . 72.44 111.558 176.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 210' ' ' VAL . . . . . 0.482 HG21 HG21 ' C' ' 199' ' ' VAL . 31.1 m -141.84 142.59 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 124.417 1.087 . . . . 71.52 109.354 173.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 211' ' ' ARG . . . . . 0.543 ' HE ' ' HB2' ' B' ' 234' ' ' ALA . 45.2 ttm-85 -81.45 127.81 33.2 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.656 0.782 . . . . 75.53 111.801 -172.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -105.98 112.19 25.14 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 107.574 -1.269 . . . . 74.43 107.574 169.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 213' ' ' MET . . . . . 0.672 ' HA ' ' HA ' ' C' ' 218' ' ' PRO . 4.0 ttp -77.97 100.62 6.52 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.812 -0.81 . . . . 63.12 108.812 -176.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.68 177.63 8.8 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 118.02 0.373 . . . . 72.34 110.154 -174.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 215' ' ' LEU . . . . . 0.601 HD22 ' HB3' ' C' ' 127' ' ' LEU . 12.3 mt -51.26 -61.25 2.35 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.295 1.038 . . . . 75.24 111.109 -173.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -92.86 13.36 20.65 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.239 -0.891 . . . . 71.0 111.933 -173.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 144.35 154.86 6.25 Favored Glycine 0 C--N 1.346 1.112 0 CA-C-O 119.831 -0.427 . . . . 74.41 113.128 177.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 218' ' ' PRO . . . . . 0.672 ' HA ' ' HA ' ' C' ' 213' ' ' MET . 52.8 Cg_endo -69.1 125.76 12.89 Favored 'Trans proline' 0 C--N 1.365 1.403 0 C-N-CA 122.896 2.398 . . . . 64.03 114.878 179.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 219' ' ' VAL . . . . . . . . . . . . . 9.6 p -100.71 173.21 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.809 0 N-CA-C 106.103 -1.814 . . . . 52.53 106.103 168.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 220' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -118.36 158.18 25.74 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.703 -0.48 . . . . 72.32 109.703 174.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 221' ' ' VAL . . . . . . . . . . . . . 38.0 t -115.31 127.95 72.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 124.801 1.24 . . . . 74.03 109.592 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 222' ' ' ALA . . . . . 0.556 ' HA ' ' HG2' ' C' ' 209' ' ' LYS . . . -80.14 102.32 9.31 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 108.69 -0.856 . . . . 73.3 108.69 170.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 48.5 t -76.67 126.58 85.8 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-N 115.294 -0.866 . . . . 73.11 109.344 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 224' ' ' PRO . . . . . 0.465 ' HA ' ' HA ' ' B' ' 245' ' ' LYS . 6.1 Cg_exo -79.87 163.9 23.12 Favored 'Trans proline' 0 C--N 1.366 1.479 0 C-N-CA 123.715 2.943 . . . . 73.11 112.848 171.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -56.73 146.7 75.89 Favored 'Trans proline' 0 C--N 1.37 1.668 0 C-N-CA 122.128 1.885 . . . . 74.4 112.003 164.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 226' ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? 65.51 71.25 0.44 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.533 1.133 . . . . 71.5 110.929 171.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 227' ' ' THR . . . . . 0.489 HG21 HD12 ' C' ' 255' ' ' ILE . 8.0 m -116.95 125.85 52.05 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 124.287 1.035 . . . . 73.3 111.419 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 228' ' ' GLN . . . . . 0.556 ' HB3' HD13 ' B' ' 29' ' ' LEU . 24.9 mp0 -108.23 157.21 18.53 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.404 1.081 . . . . 74.32 111.017 -177.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 229' ' ' ALA . . . . . 0.521 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -77.03 110.59 11.8 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 114.842 -1.072 . . . . 65.31 110.416 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 108.69 8.95 27.59 Favored Glycine 0 N--CA 1.475 1.25 0 CA-C-O 119.871 -0.405 . . . . 62.04 113.0 -169.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 231' ' ' ARG . . . . . . . . . . . . . 49.9 mtp85 -76.07 168.34 20.22 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 109.223 -0.658 . . . . 75.03 109.223 164.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 232' ' ' LYS . . . . . 0.616 ' HB2' ' HZ2' ' C' ' 232' ' ' LYS . 2.4 ttmp? -134.29 146.96 50.51 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-O 121.493 0.663 . . . . 74.05 112.452 178.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 233' ' ' LEU . . . . . 0.72 HD11 ' HB2' ' C' ' 251' ' ' LEU . 5.1 mp -111.27 155.61 22.75 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.323 1.449 . . . . 74.22 111.22 -173.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 29.5 ptt-85 -125.93 91.72 3.44 Favored 'General case' 0 CA--C 1.571 1.769 0 O-C-N 125.477 1.736 . . . . 72.34 110.87 175.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 235' ' ' LEU . . . . . 0.469 ' HB2' ' HB3' ' C' ' 249' ' ' LEU . 79.5 mt -90.96 103.72 16.4 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.876 -0.787 . . . . 74.34 108.876 170.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -69.71 129.63 40.13 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.525 0.73 . . . . 73.41 111.863 -175.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 75.13 25.9 67.7 Favored Glycine 0 C--N 1.353 1.507 0 O-C-N 123.882 0.739 . . . . 71.42 114.196 175.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 31.1 mmtm -115.14 13.34 16.79 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.172 0.589 . . . . 75.11 110.621 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 239' ' ' GLY . . . . . 0.436 ' HA2' ' HG ' ' C' ' 193' ' ' LEU . . . -91.3 -163.16 38.47 Favored Glycine 0 C--N 1.353 1.51 0 O-C-N 123.511 0.507 . . . . 75.2 113.323 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 240' ' ' PHE . . . . . 0.56 ' HB3' ' HA2' ' C' ' 152' ' ' GLY . 4.6 m-85 -87.05 154.09 54.78 Favored Pre-proline 0 CA--C 1.552 1.05 0 N-CA-C 110.005 -0.368 . . . . 75.14 110.005 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 241' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.33 113.59 1.67 Allowed 'Trans proline' 0 C--N 1.386 2.513 0 C-N-CA 122.915 2.41 . . . . 71.53 111.382 175.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 242' ' ' GLY . . . . . 0.401 ' O ' ' SG ' ' B' ' 200' ' ' CYS . . . -111.11 164.54 12.14 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-O 118.945 -0.92 . . . . 70.14 111.714 177.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -68.65 -20.7 40.22 Favored 'Trans proline' 0 C--N 1.37 1.692 0 C-N-CA 122.902 2.401 . . . . 71.42 112.536 -178.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -98.18 20.87 11.69 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.1 0.96 . . . . 71.42 110.489 176.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 97.01 177.94 34.79 Favored Glycine 0 C--N 1.348 1.197 0 N-CA-C 111.263 -0.735 . . . . 63.24 111.263 -171.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 246' ' ' ARG . . . . . . . . . . . . . 69.4 mtm180 -71.89 142.6 49.52 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 117.465 0.632 . . . . 71.32 110.593 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -79.42 -158.18 13.79 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 123.846 0.716 . . . . 63.23 112.723 177.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -116.89 -179.86 3.81 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.725 0.81 . . . . 73.54 108.896 -174.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 249' ' ' LEU . . . . . 0.469 ' HB3' ' HB2' ' C' ' 235' ' ' LEU . 10.3 tp -122.41 109.43 14.38 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.48 -0.933 . . . . 74.23 108.48 176.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 250' ' ' TYR . . . . . 0.625 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 23.5 m-85 -101.14 105.71 16.89 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.601 -0.727 . . . . 71.43 109.736 178.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 251' ' ' LEU . . . . . 0.72 ' HB2' HD11 ' C' ' 233' ' ' LEU . 2.0 mp -98.79 149.89 22.41 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 109.536 -0.542 . . . . 72.0 109.536 -173.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -104.61 128.93 52.76 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 108.16 -1.052 . . . . 75.41 108.16 175.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 253' ' ' VAL . . . . . . . . . . . . . 67.7 t -74.99 134.66 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 112.247 0.462 . . . . 73.5 112.247 -172.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 254' ' ' ARG . . . . . 0.408 ' CZ ' ' HB ' ' C' ' 256' ' ' THR . 1.5 tmm_? -121.69 93.94 4.16 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 107.293 -1.373 . . . . 75.13 107.293 177.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 255' ' ' ILE . . . . . 0.489 HD12 HG21 ' C' ' 227' ' ' THR . 46.1 mm -68.49 124.52 24.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 O-C-N 123.264 0.353 . . . . 75.24 110.077 176.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 256' ' ' THR . . . . . 0.408 ' HB ' ' CZ ' ' C' ' 254' ' ' ARG . 0.0 OUTLIER -133.27 170.33 15.6 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.855 1.262 . . . . 70.25 110.772 -174.596 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 257' ' ' ILE . . . . . 0.449 ' HB ' ' HD2' ' C' ' 258' ' ' PRO . 2.9 pp -130.19 157.6 76.67 Favored Pre-proline 0 CA--C 1.556 1.204 0 C-N-CA 124.025 0.93 . . . . 75.21 109.44 178.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 258' ' ' PRO . . . . . 0.449 ' HD2' ' HB ' ' C' ' 257' ' ' ILE . 74.3 Cg_endo -67.14 -8.56 22.24 Favored 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 122.817 2.345 . . . . 74.41 114.031 -166.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 56.94 -71.88 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 125.024 1.329 . . . . 72.3 111.246 -164.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -73.88 152.33 40.21 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.831 0.852 . . . . 73.41 111.483 177.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 261' ' ' LEU . . . . . 0.571 HD11 ' HA ' ' C' ' 266' ' ' GLU . 31.2 mt -146.41 141.04 26.77 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.07 0.548 . . . . 74.53 112.043 179.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 53.7 p -87.72 145.33 36.73 Favored Pre-proline 0 CA--C 1.551 0.983 0 CA-C-O 117.914 -1.041 . . . . 61.23 108.369 167.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -45.02 -31.3 5.4 Favored 'Trans proline' 0 C--N 1.382 2.34 0 C-N-CA 124.471 3.448 . . . . 74.2 114.906 -176.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -56.83 -72.45 0.08 Allowed 'General case' 0 C--O 1.257 1.465 0 C-N-CA 124.599 1.159 . . . . 71.04 111.482 174.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -68.36 -24.87 64.85 Favored 'General case' 0 C--O 1.212 -0.888 0 CA-C-N 115.068 -0.969 . . . . 71.03 110.339 -176.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 266' ' ' GLU . . . . . 0.571 ' HA ' HD11 ' C' ' 261' ' ' LEU . 11.3 tp10 -59.09 -48.31 82.08 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.689 0.795 . . . . 73.1 109.95 173.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -63.74 -35.58 81.05 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.18 0.592 . . . . 71.12 111.386 177.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 268' ' ' LEU . . . . . . . . . . . . . 11.2 mp -64.52 -50.88 65.64 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 112.279 0.474 . . . . 70.11 112.279 174.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 269' ' ' TRP . . . . . 0.475 ' HH2' ' HD3' ' C' ' 202' ' ' PRO . 89.6 m95 -60.95 -32.74 72.25 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.46 0.704 . . . . 63.11 110.774 178.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 270' ' ' LYS . . . . . 0.672 ' HB3' ' HZ3' ' C' ' 270' ' ' LYS . 3.7 mmmp? -62.42 -57.75 10.13 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.092 0.957 . . . . 75.43 111.241 175.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 31.1 mmtm -66.39 -24.8 66.54 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.476 0.711 . . . . 75.33 112.475 -177.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 55.4 mt -81.67 -32.46 31.77 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 122.981 0.512 . . . . 74.33 110.744 174.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -63.61 -40.19 96.29 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 109.613 -0.514 . . . . 43.22 109.613 172.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -64.23 -42.48 96.53 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.431 1.092 . . . . 63.21 110.355 175.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -62.17 -28.27 69.55 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.1 0.56 . . . . 70.04 111.316 173.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 276' ' ' TYR . . . . . 0.47 ' HA ' ' HD3' ' C' ' 279' ' ' ARG . 3.0 m-85 -85.05 -25.21 27.76 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.254 0.464 . . . . 75.52 112.254 178.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -68.73 -33.74 74.44 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 108.361 -0.977 . . . . 65.52 108.361 171.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -64.87 -15.63 62.17 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 115.127 -0.942 . . . . 72.22 112.491 172.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 279' ' ' ARG . . . . . 0.487 ' HG2' ' N ' ' B' ' 89' ' ' GLY . 27.0 mtp-105 -82.15 -33.79 29.42 Favored 'General case' 0 C--N 1.357 0.906 0 N-CA-C 109.27 -0.641 . . . . 75.11 109.27 172.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.869 0 CA-C-O 118.329 -0.843 . . . . 75.14 109.502 -170.238 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.0 mtt . . . . . 0 N--CA 1.474 0.735 0 N-CA-C 107.716 -1.216 . . . . 64.12 107.716 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 78.54 -39.97 0.26 Allowed 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 125.809 1.644 . . . . 74.44 112.036 -178.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.02 76.28 4.54 Favored 'General case' 0 C--N 1.353 0.74 0 C-N-CA 123.948 0.899 . . . . 74.04 110.641 176.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -40.51 121.11 1.36 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.389 1.076 . . . . 64.14 112.991 166.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.559 ' HD2' HD13 ' A' ' 10' ' ' ILE . 29.0 mmtp -79.28 93.02 5.2 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 108.273 -1.01 . . . . 74.32 108.273 164.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -73.93 96.62 2.66 Favored 'General case' 0 C--N 1.352 0.686 0 N-CA-C 107.573 -1.269 . . . . 62.43 107.573 172.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.468 ' CD1' ' HA ' ' A' ' 53' ' ' ALA . 56.2 m-85 -64.39 -22.25 66.9 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 114.954 -1.021 . . . . 73.34 111.726 -171.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -63.48 -50.6 69.03 Favored 'General case' 0 C--N 1.353 0.72 0 O-C-N 123.484 0.49 . . . . 73.33 109.891 171.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.31 -40.25 96.82 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.392 0.677 . . . . 70.01 111.072 -178.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.559 HD13 ' HD2' ' A' ' 5' ' ' LYS . 68.5 mt -58.37 -43.66 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 123.284 0.633 . . . . 74.23 110.261 174.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 92.4 mt -83.26 -2.18 55.0 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 115.845 -0.616 . . . . 73.11 112.586 177.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 67.86 19.41 71.51 Favored Glycine 0 C--N 1.349 1.28 0 N-CA-C 114.639 0.616 . . . . 73.42 114.639 177.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.9 m -102.85 158.49 31.66 Favored Pre-proline 0 N--CA 1.481 1.1 0 C-N-CA 124.06 0.944 . . . . 72.52 110.874 178.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -60.81 158.26 34.1 Favored 'Trans proline' 0 C--N 1.387 2.553 0 C-N-CA 122.77 2.313 . . . . 50.12 112.156 177.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 27.8 mtp180 -74.88 10.85 1.25 Allowed 'General case' 0 CA--C 1.558 1.272 0 O-C-N 121.95 -0.469 . . . . 75.43 112.031 -178.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -119.19 5.63 11.25 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.777 1.631 . . . . 71.2 109.012 -178.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.33 138.53 55.5 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.717 0.807 . . . . 74.14 111.332 -176.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 33.9 p -90.26 -179.71 5.7 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.389 0.676 . . . . 75.03 110.1 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -52.43 -31.95 36.99 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.901 0.88 . . . . 71.11 112.683 179.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 19.3 tp10 -87.34 -28.51 22.19 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 112.055 0.391 . . . . 72.43 112.055 -173.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -66.12 -42.94 88.48 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 109.118 -0.697 . . . . 71.14 109.118 168.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.34 -39.85 84.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 O-C-N 124.332 1.02 . . . . 73.31 111.051 174.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -59.89 -56.0 27.2 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.935 0.894 . . . . 75.22 110.521 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 -69.56 -26.77 64.65 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 114.688 -1.142 . . . . 73.12 110.998 -176.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -75.3 -37.26 60.92 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.359 0.663 . . . . 72.43 111.079 178.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -60.06 -54.27 47.91 Favored 'General case' 0 C--O 1.216 -0.66 0 N-CA-C 108.947 -0.76 . . . . 73.1 108.947 173.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.9 mtpt -62.87 -38.02 89.2 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 124.287 0.992 . . . . 74.22 111.526 -178.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.9 ttt180 -53.14 -55.9 20.48 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.615 1.166 . . . . 75.52 110.119 174.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.633 ' HB3' HD12 ' A' ' 50' ' ' ILE . 96.5 mt -79.63 -16.22 56.2 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 115.035 -0.984 . . . . 75.12 111.613 -177.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -81.9 -19.92 39.85 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.717 0.807 . . . . 71.54 110.554 175.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 -89.7 -37.17 14.77 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.186 0.594 . . . . 72.33 110.323 171.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -69.47 -60.45 2.32 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.103 0.478 . . . . 73.31 110.391 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -93.42 34.24 1.18 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.552 0.741 . . . . 72.41 110.286 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.9 t-160 -61.58 102.5 0.31 Allowed Pre-proline 0 C--N 1.356 0.849 0 C-N-CA 124.051 0.94 . . . . 73.54 109.581 178.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -67.89 -19.66 46.16 Favored 'Trans proline' 0 C--N 1.371 1.751 0 C-N-CA 122.879 2.386 . . . . 75.51 112.279 -168.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -59.34 -39.08 82.03 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.453 1.101 . . . . 73.23 111.129 173.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.3 t -101.63 -46.63 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 123.494 0.717 . . . . 73.25 110.466 -176.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -100.51 85.63 2.99 Favored 'General case' 0 C--O 1.245 0.826 0 C-N-CA 124.482 1.113 . . . . 64.12 109.933 -177.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.72 69.94 9.6 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.316 0.646 . . . . 73.11 109.525 178.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.0 m -121.21 110.03 34.74 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-O 118.191 -0.909 . . . . 71.24 108.794 177.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -35.88 -61.9 0.26 Allowed 'Trans proline' 0 C--N 1.389 2.658 0 C-N-CA 125.157 3.904 . . . . 73.53 115.051 -171.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -67.49 -27.01 66.65 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 122.891 0.476 . . . . 64.43 111.957 -175.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.44 -30.46 67.3 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-O 121.001 0.429 . . . . 73.42 109.919 175.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.422 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 35.3 mt-10 -83.29 -28.6 28.98 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.166 -0.925 . . . . 63.35 109.337 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.446 ' HA ' ' HE3' ' A' ' 48' ' ' LYS . 50.7 mt-10 -66.81 -43.46 83.76 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.325 0.65 . . . . 62.44 109.977 173.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 35.0 mmtm -61.61 -42.25 98.61 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 115.057 -0.974 . . . . 74.03 109.939 173.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.561 ' HA ' HD13 ' A' ' 50' ' ' ILE . 91.1 t80 -57.41 -37.16 72.28 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 123.737 0.648 . . . . 73.32 111.112 176.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.569 ' HZ1' ' HB2' ' A' ' 48' ' ' LYS . 10.4 mtmp? -70.85 -33.59 70.79 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.947 0.499 . . . . 75.14 111.472 176.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -71.14 -23.64 62.11 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 122.741 0.416 . . . . 71.44 111.082 173.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.633 HD12 ' HB3' ' A' ' 29' ' ' LEU . 59.9 mt -79.53 -35.68 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.718 1.207 . . . . 74.43 109.331 174.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -65.38 -35.86 82.25 Favored 'General case' 0 C--O 1.209 -1.05 0 CA-C-N 115.628 -0.715 . . . . 73.43 109.827 171.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -65.61 -48.9 70.71 Favored 'General case' 0 C--O 1.247 0.946 0 C-N-CA 125.344 1.458 . . . . 75.34 110.542 177.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.468 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . . . -57.87 -48.28 80.27 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 114.265 -1.334 . . . . 65.45 111.243 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -79.19 -19.87 49.78 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 115.044 -0.98 . . . . 73.53 110.891 177.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.31 -45.72 87.49 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 118.404 0.547 . . . . 72.52 109.865 174.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.591 HG11 ' HZ ' ' A' ' 101' ' ' PHE . 22.7 t -71.43 -56.37 10.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 114.138 -1.392 . . . . 74.52 110.042 175.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.617 HD23 ' HD2' ' A' ' 63' ' ' ARG . 43.5 mt -91.93 15.73 12.53 Favored 'General case' 0 CA--C 1.56 1.346 0 N-CA-C 113.644 0.979 . . . . 74.35 113.644 -164.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.2 t -71.63 -71.54 0.26 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 122.813 0.445 . . . . 74.34 110.798 171.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -79.97 143.18 57.02 Favored Pre-proline 0 N--CA 1.471 0.619 0 CA-C-N 115.439 -0.801 . . . . 74.34 110.113 -176.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -58.47 -27.06 80.73 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 123.155 2.57 . . . . 72.41 112.932 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -67.31 -59.12 3.67 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.711 0.805 . . . . 72.3 111.002 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.499 ' HA ' HD12 ' A' ' 65' ' ' ILE . 27.9 mtpt -70.07 -28.92 65.83 Favored 'General case' 0 C--O 1.248 0.987 0 CA-C-N 114.893 -1.048 . . . . 74.54 110.829 -177.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.617 ' HD2' HD23 ' A' ' 57' ' ' LEU . 31.6 tpt85 -54.21 -55.61 26.28 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 114.635 -1.166 . . . . 74.11 109.401 168.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -65.2 -25.68 67.81 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 115.761 -0.654 . . . . 74.25 112.113 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.499 HD12 ' HA ' ' A' ' 62' ' ' LYS . 78.6 mt -59.38 -47.15 91.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 CA-C-N 118.231 0.469 . . . . 74.41 110.138 171.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -58.35 -52.97 63.35 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 116.033 -0.53 . . . . 75.4 110.255 173.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -56.67 -41.85 77.99 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.477 0.711 . . . . 64.04 112.599 -176.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.8 p -74.13 -23.02 59.23 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 122.844 0.458 . . . . 75.44 110.95 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -71.0 126.58 29.96 Favored 'General case' 0 C--N 1.357 0.909 0 N-CA-C 107.42 -1.326 . . . . 75.32 107.42 170.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.82 13.93 41.88 Favored Glycine 0 N--CA 1.471 1.027 0 N-CA-C 112.108 -0.397 . . . . 64.23 112.108 -169.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 42.6 m -140.79 -57.56 0.51 Allowed 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 103.786 -2.672 . . . . 71.23 103.786 173.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 46.7 m -83.82 140.55 31.96 Favored 'General case' 0 C--O 1.247 0.951 0 N-CA-C 104.832 -2.284 . . . . 74.23 104.832 155.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.41 -26.29 17.3 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.027 0.531 . . . . 74.04 110.889 178.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -88.82 163.16 36.19 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 123.911 0.884 . . . . 75.1 110.516 176.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -58.23 143.88 96.43 Favored 'Trans proline' 0 C--N 1.371 1.716 0 C-N-CA 122.268 1.979 . . . . 75.41 111.657 163.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.92 159.61 47.73 Favored 'Trans proline' 0 CA--C 1.557 1.665 0 C-N-CA 122.397 2.065 . . . . 74.25 111.341 174.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -51.41 114.57 1.62 Allowed 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 122.927 2.418 . . . . 73.45 112.911 173.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -61.04 140.31 89.13 Favored 'Trans proline' 0 C--N 1.384 2.4 0 C-N-CA 123.311 2.674 . . . . 73.2 112.556 177.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.52 163.86 37.37 Favored 'Trans proline' 0 C--N 1.374 1.896 0 C-N-CA 122.766 2.311 . . . . 71.05 112.445 177.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -58.18 87.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.38 2.186 0 C-N-CA 123.122 2.548 . . . . 74.31 112.648 174.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 150.96 -34.1 0.94 Allowed Glycine 0 C--N 1.338 0.645 0 CA-C-N 114.281 -1.327 . . . . 62.41 110.006 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 106.5 -160.39 14.49 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-N 114.754 -0.723 . . . . 53.03 111.722 178.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -90.89 103.5 16.2 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 123.478 0.711 . . . . 74.41 109.3 178.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -61.63 152.51 30.53 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.728 0.811 . . . . 71.31 111.658 171.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.565 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 70.8 m-85 -142.09 75.04 1.47 Allowed 'General case' 0 C--N 1.353 0.745 0 C-N-CA 124.582 1.153 . . . . 73.24 109.411 172.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' A' ' 162' ' ' PRO . 74.0 m -53.84 84.38 0.0 OUTLIER 'General case' 0 CA--C 1.562 1.405 0 C-N-CA 124.392 1.077 . . . . 74.44 113.316 -178.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 88.32 19.31 53.12 Favored Glycine 0 C--N 1.351 1.369 0 CA-C-N 115.691 -0.686 . . . . 70.11 113.992 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.565 ' HB2' ' HB3' ' A' ' 85' ' ' PHE . 37.4 m-85 -125.95 113.53 17.29 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 118.102 0.951 . . . . 72.34 110.402 -174.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -78.0 86.71 4.18 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.655 0.74 . . . . 71.44 111.008 -176.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.619 HG21 HD21 ' A' ' 105' ' ' LEU . 2.3 p -46.49 -36.31 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 124.926 1.291 . . . . 75.21 113.402 172.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.477 ' HB2' ' HG3' ' A' ' 170' ' ' PRO . 16.9 tp10 -54.32 -28.25 41.28 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.197 0.999 . . . . 75.33 111.563 -178.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -84.59 -39.53 18.61 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.654 0.781 . . . . 61.35 112.061 178.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 15.3 m-30 -66.15 162.58 19.46 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 113.404 0.89 . . . . 73.34 113.404 -162.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 92.2 p -65.03 164.55 12.63 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 114.025 1.12 . . . . 74.5 114.025 -165.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.88 -39.33 71.37 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 114.392 -1.276 . . . . 74.52 112.948 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -58.81 -45.59 89.59 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 121.654 0.74 . . . . 75.03 110.302 178.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -64.65 -41.0 96.42 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 113.995 -1.457 . . . . 72.32 110.109 178.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -73.35 -10.67 59.99 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 115.313 -0.858 . . . . 74.14 111.922 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -90.41 -54.48 3.99 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 118.267 0.485 . . . . 70.02 110.507 169.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 29.0 tp -60.47 -28.02 68.0 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.597 1.159 . . . . 74.33 111.786 -174.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.591 ' HZ ' HG11 ' A' ' 56' ' ' VAL . 95.4 m-85 -117.28 -3.97 11.42 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 123.072 0.549 . . . . 72.11 111.72 177.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -47.61 -60.63 5.21 Favored Glycine 0 CA--C 1.537 1.438 0 N-CA-C 116.035 1.174 . . . . 72.43 116.035 -175.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -66.1 5.53 0.65 Allowed 'Trans proline' 0 C--N 1.375 1.935 0 C-N-CA 123.303 2.669 . . . . 64.43 114.789 -175.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -150.58 30.92 1.03 Allowed Glycine 0 C--N 1.356 1.639 0 CA-C-O 118.79 -1.006 . . . . 54.4 112.755 170.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.619 HD21 HG21 ' A' ' 90' ' ' VAL . 17.2 mt -60.8 78.64 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 117.421 0.61 . . . . 74.25 112.502 176.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 38.48 -109.05 0.07 Allowed 'General case' 0 CA--C 1.563 1.464 0 C-N-CA 126.628 1.971 . . . . 74.45 113.069 -176.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 70.78 15.45 73.68 Favored Glycine 0 C--N 1.366 2.237 0 CA-C-O 119.165 -0.797 . . . . 44.0 114.323 -177.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.719 ' HA3' ' HB3' ' A' ' 167' ' ' GLN . . . -12.76 -69.55 0.01 OUTLIER Glycine 0 C--N 1.366 2.202 0 C-N-CA 125.895 1.712 . . . . 71.34 115.63 166.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -86.04 70.08 10.57 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 109.418 -0.586 . . . . 74.55 109.418 171.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -10.43 -74.28 0.01 OUTLIER Glycine 0 C--N 1.361 1.938 0 C-N-CA 126.534 2.016 . . . . 55.25 116.09 167.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 20.3 ttp180 -5.83 -42.16 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.481 0 C-N-CA 127.379 2.272 . . . . 75.52 116.852 166.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 -122.57 -35.41 3.08 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.194 0.998 . . . . 75.13 110.195 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 49.9 m 64.21 2.29 1.44 Allowed 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 124.775 1.23 . . . . 74.21 113.233 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 39.4 ttt180 -131.43 -148.94 0.37 Allowed 'General case' 0 CA--C 1.555 1.155 0 CA-C-O 118.219 -0.895 . . . . 74.52 109.168 -169.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.584 ' HD2' ' HB2' ' A' ' 170' ' ' PRO . 24.3 tptp -41.23 122.33 1.81 Allowed 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 125.724 1.61 . . . . 73.31 114.533 -163.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -83.64 175.79 52.22 Favored Glycine 0 CA--C 1.54 1.637 0 CA-C-N 115.844 -0.616 . . . . 73.4 112.592 175.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.731 ' H ' ' HA3' ' A' ' 166' ' ' GLY . 0.0 OUTLIER -116.72 174.0 6.32 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 124.118 0.967 . . . . 74.43 111.697 -178.359 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -78.46 101.66 7.43 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-O 122.02 0.914 . . . . 74.23 110.089 175.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.504 HD21 ' HD3' ' B' ' 12' ' ' PRO . 10.4 tt -112.2 139.84 47.4 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.938 0.895 . . . . 75.42 108.825 -174.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.412 ' HA ' ' HB2' ' A' ' 175' ' ' LEU . 58.3 ttt180 -94.42 139.02 31.66 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.33 0.652 . . . . 74.51 111.207 -178.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -134.77 169.43 17.37 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 123.981 0.912 . . . . 54.41 109.368 170.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.64 115.74 25.68 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 107.0 -1.482 . . . . 72.42 107.0 -174.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 50.5 tp -100.52 100.23 11.74 Favored Pre-proline 0 N--CA 1.476 0.846 0 N-CA-C 108.912 -0.773 . . . . 74.14 108.912 -175.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.534 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 77.4 Cg_endo -84.16 111.73 1.64 Allowed 'Trans proline' 0 C--N 1.374 1.909 0 C-N-CA 121.323 1.348 . . . . 75.33 110.049 176.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.602 ' HA ' HG23 ' B' ' 6' ' ' ILE . 52.3 tp -104.99 137.09 43.28 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.706 0.402 . . . . 72.43 110.338 -176.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 90.0 m -68.06 126.69 30.3 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.035 0.934 . . . . 71.34 109.638 177.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 53.9 mt -53.6 -51.88 61.61 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.625 1.17 . . . . 75.21 112.47 -171.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -58.77 -37.39 76.16 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 115.115 -0.948 . . . . 75.32 110.007 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.464 ' HB3' ' NH2' ' A' ' 136' ' ' ARG . 44.6 mm-40 -80.48 -14.81 57.95 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.048 -0.978 . . . . 64.33 112.34 -178.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -70.51 -52.18 23.62 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 107.823 -1.177 . . . . 65.44 107.823 167.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -53.98 -40.1 66.59 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 116.028 -0.533 . . . . 74.51 110.913 175.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 35.9 m170 -78.41 -29.57 47.23 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 122.838 0.455 . . . . 75.25 112.099 -178.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 64.04 -138.05 41.42 Favored Glycine 0 N--CA 1.479 1.531 0 O-C-N 123.271 0.357 . . . . 71.54 113.844 176.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.36 -161.09 46.5 Favored Glycine 0 C--N 1.357 1.696 0 O-C-N 123.781 0.342 . . . . 70.42 113.002 175.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -76.23 119.09 19.65 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 109.255 -0.646 . . . . 73.14 109.255 170.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.464 ' NH2' ' HB3' ' A' ' 129' ' ' GLU . 10.0 tpp180 -93.52 123.35 36.77 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 109.336 -0.616 . . . . 75.05 109.336 175.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 145' ' ' VAL . 98.2 t -88.37 104.07 14.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 109.018 -0.734 . . . . 75.04 109.018 175.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.422 HG23 HD13 ' B' ' 6' ' ' ILE . 15.3 t -102.64 125.36 56.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 CA-C-N 115.041 -0.981 . . . . 73.34 108.598 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -102.98 134.03 47.1 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.554 0.741 . . . . 71.3 109.968 -178.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.402 ' HB ' ' HB3' ' B' ' 8' ' ' LEU . 7.2 p -168.3 113.91 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 122.782 0.433 . . . . 75.1 111.547 178.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 61.26 24.78 14.84 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.396 1.078 . . . . 74.24 113.047 170.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 99.38 -11.25 61.59 Favored Glycine 0 C--N 1.349 1.286 0 CA-C-N 116.766 -0.197 . . . . 54.15 112.871 -178.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 -87.9 108.42 19.17 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.872 0.869 . . . . 72.43 109.959 175.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 -105.4 94.87 5.45 Favored 'General case' 0 C--O 1.244 0.794 0 C-N-CA 123.916 0.887 . . . . 74.41 108.864 175.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.412 HG23 HG13 ' A' ' 147' ' ' VAL . 11.5 p -95.58 143.67 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 123.205 0.602 . . . . 73.53 110.959 -176.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 33.3 t -118.16 85.6 2.38 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.82 0.848 . . . . 64.43 109.277 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.412 HG13 HG23 ' A' ' 145' ' ' VAL . 11.1 m -92.88 114.04 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 C-N-CA 123.364 0.666 . . . . 73.42 111.745 -173.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -71.32 105.56 3.54 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.449 -0.574 . . . . 74.32 109.449 173.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 21.2 pt -102.14 153.9 37.73 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 124.644 1.178 . . . . 74.52 109.772 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -57.6 -166.34 0.02 OUTLIER 'Trans proline' 0 N--CA 1.519 3.007 0 C-N-CA 124.305 3.337 . . . . 74.22 112.591 170.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -46.13 90.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.399 3.217 0 C-N-CA 121.621 1.547 . . . . 74.15 110.864 162.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 36.52 -94.58 0.01 OUTLIER Glycine 0 C--N 1.346 1.131 0 CA-C-N 113.011 -1.904 . . . . 75.51 114.521 -162.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.577 HG13 HG21 ' A' ' 178' ' ' VAL . 5.5 p 172.71 166.34 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 113.364 -1.418 . . . . 75.43 107.986 -162.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.93 146.64 50.57 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 108.59 -0.892 . . . . 73.23 108.59 177.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.567 ' HG2' ' NH1' ' A' ' 187' ' ' ARG . 14.9 tp10 -48.95 129.81 17.67 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.447 1.099 . . . . 72.32 112.263 -177.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 91.08 -4.9 81.58 Favored Glycine 0 C--N 1.346 1.114 0 CA-C-N 115.438 -0.801 . . . . 74.33 113.774 179.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 57.8 m -66.23 113.82 4.85 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 117.499 0.649 . . . . 74.23 110.409 179.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.404 HG23 HG21 ' A' ' 177' ' ' VAL . 61.1 t -90.13 94.93 5.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 C-N-CA 123.892 0.877 . . . . 74.02 108.949 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.582 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 60.1 mt -77.76 108.8 11.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 108.604 -0.887 . . . . 75.24 108.604 175.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 30.1 ttt180 -76.64 107.09 8.68 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.474 -0.565 . . . . 75.21 109.474 178.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.404 HG12 ' HB3' ' A' ' 174' ' ' LEU . 3.8 p -125.93 95.86 38.74 Favored Pre-proline 0 CA--C 1.55 0.958 0 N-CA-C 109.304 -0.628 . . . . 71.41 109.304 174.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.511 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 30.0 Cg_exo -62.25 142.04 90.04 Favored 'Trans proline' 0 C--N 1.369 1.636 0 C-N-CA 122.524 2.149 . . . . 74.53 111.597 174.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . 0.419 ' N ' ' HB3' ' A' ' 171' ' ' PRO . . . 121.04 -26.36 6.79 Favored Glycine 0 N--CA 1.475 1.299 0 CA-C-N 117.855 0.298 . . . . 70.43 112.759 175.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 68.4 mtm -116.36 2.74 13.24 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 122.761 0.424 . . . . 64.15 110.858 -178.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.426 ' HA2' HD12 ' A' ' 174' ' ' LEU . . . -83.39 -108.99 0.52 Allowed Glycine 0 C--N 1.353 1.505 0 N-CA-C 110.875 -0.89 . . . . 73.33 110.875 175.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.731 ' HA3' ' H ' ' A' ' 117' ' ' ARG . . . -57.69 108.62 1.44 Allowed Glycine 0 C--O 1.263 1.932 0 N-CA-C 110.902 -0.879 . . . . 74.5 110.902 164.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.719 ' HB3' ' HA3' ' A' ' 108' ' ' GLY . 27.1 mm-40 -67.47 105.2 1.75 Allowed 'General case' 0 N--CA 1.446 -0.63 0 O-C-N 125.453 1.325 . . . . 75.42 109.204 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -178.26 169.08 40.67 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 110.871 -0.891 . . . . 64.21 110.871 -176.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . 0.53 ' ND2' ' HB3' ' A' ' 105' ' ' LEU . 4.6 t-20 -63.03 -67.98 0.94 Allowed Pre-proline 0 CA--C 1.57 1.722 0 CA-C-O 117.026 -1.464 . . . . 63.54 111.639 -170.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.584 ' HB2' ' HD2' ' A' ' 115' ' ' LYS . 17.0 Cg_exo -66.23 116.01 3.8 Favored 'Trans proline' 0 C--N 1.396 3.066 0 CA-C-N 122.878 2.063 . . . . 73.02 109.922 167.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.419 ' HB3' ' N ' ' A' ' 163' ' ' GLY . 18.8 Cg_exo -40.5 127.27 2.32 Favored 'Trans proline' 0 C--N 1.368 1.592 0 C-N-CA 125.214 3.943 . . . . 71.25 117.131 -171.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -83.11 132.14 10.87 Favored Glycine 0 C--N 1.367 2.289 0 CA-C-O 119.159 -0.801 . . . . 72.4 111.987 164.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.511 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 22.8 m-20 -64.48 108.35 1.63 Allowed 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.166 0.586 . . . . 71.14 110.82 -175.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.426 HD12 ' HA2' ' A' ' 165' ' ' GLY . 38.3 tp -83.64 129.31 34.96 Favored 'General case' 0 C--N 1.349 0.545 0 N-CA-C 109.623 -0.51 . . . . 74.2 109.623 175.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.412 ' HB2' ' HA ' ' A' ' 120' ' ' ARG . 55.6 mt -99.1 88.45 3.95 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 107.999 -1.112 . . . . 72.12 107.999 178.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.582 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 75.1 mt -70.62 87.32 0.67 Allowed 'General case' 0 C--N 1.35 0.609 0 N-CA-C 109.06 -0.719 . . . . 74.52 109.06 174.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.404 HG21 HG23 ' A' ' 158' ' ' VAL . 19.7 t -82.62 102.15 8.22 Favored 'Isoleucine or valine' 0 C--O 1.248 1.017 0 N-CA-C 105.749 -1.945 . . . . 71.11 105.749 175.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.577 HG21 HG13 ' A' ' 153' ' ' VAL . 5.4 p -73.42 131.89 34.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 115.034 -0.985 . . . . 74.13 110.865 -169.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.534 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 28.9 mmt180 -112.72 127.27 56.09 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 106.261 -1.755 . . . . 73.42 106.261 167.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.425 HD22 ' HB3' ' A' ' 125' ' ' LEU . 27.7 mt -80.12 147.7 31.28 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.477 -0.935 . . . . 74.04 108.477 169.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 20.2 mt -53.28 152.49 8.17 Favored Pre-proline 0 N--CA 1.482 1.145 0 O-C-N 124.174 0.921 . . . . 73.22 113.021 -167.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . 0.41 ' HB3' ' HG2' ' B' ' 149' ' ' LYS . 24.6 Cg_exo -65.16 5.23 0.53 Allowed 'Trans proline' 0 C--N 1.383 2.354 0 C-N-CA 123.566 2.844 . . . . 74.32 113.425 175.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 61.2 t-80 -59.56 104.0 0.41 Allowed Pre-proline 0 CA--C 1.56 1.341 0 C-N-CA 124.894 1.278 . . . . 73.35 107.985 168.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -80.81 26.36 0.6 Allowed 'Trans proline' 0 C--N 1.372 1.773 0 C-N-CA 123.792 2.995 . . . . 61.24 115.537 -162.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 75.5 t -95.22 -61.03 2.28 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.901 0 CA-C-O 118.715 -0.659 . . . . 72.34 110.848 -175.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -138.11 92.57 2.67 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 119.064 0.847 . . . . 72.31 110.34 -176.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . 0.567 ' NH1' ' HG2' ' A' ' 155' ' ' GLU . 62.1 ttp85 -98.09 98.24 9.58 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.867 0.867 . . . . 75.51 109.391 176.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.508 ' HA ' ' HA ' ' A' ' 193' ' ' LEU . 61.9 tp -68.78 142.15 55.0 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.163 0.985 . . . . 74.21 110.864 178.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -152.7 129.03 10.56 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.792 1.237 . . . . 70.31 109.973 -174.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 68.51 -80.5 0.22 Allowed Glycine 0 C--N 1.351 1.412 0 N-CA-C 111.916 -0.474 . . . . 65.41 111.916 -177.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.534 ' HG3' ' HB3' ' A' ' 244' ' ' ALA . 14.6 mm100 -147.47 -11.18 0.41 Allowed 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 125.069 1.347 . . . . 72.32 110.533 166.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -103.7 148.81 25.61 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.492 1.117 . . . . 72.32 110.944 -174.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.508 ' HA ' ' HA ' ' A' ' 188' ' ' LEU . 11.6 mt -90.36 162.67 15.03 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.245 1.018 . . . . 74.25 111.02 -175.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -131.16 114.51 15.19 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.303 1.041 . . . . 73.14 109.142 173.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.483 ' HB1' HD21 ' A' ' 251' ' ' LEU . . . -135.68 174.92 10.08 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.64 1.176 . . . . 74.34 110.458 -176.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 27.9 m -120.72 144.87 48.02 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.818 0.847 . . . . 70.21 108.878 173.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.47 HD22 HG23 ' A' ' 210' ' ' VAL . 44.7 tp -129.4 115.92 18.26 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.621 0.768 . . . . 74.1 109.457 -175.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -90.24 121.05 31.92 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 108.092 -1.077 . . . . 63.3 108.092 173.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.5 p -139.5 131.02 14.85 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 124.054 0.942 . . . . 74.33 109.136 -173.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -72.35 148.58 49.23 Favored 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 121.602 1.535 . . . . 70.05 110.77 174.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -49.54 -47.4 78.17 Favored Pre-proline 0 CA--C 1.561 1.374 0 N-CA-C 114.131 1.16 . . . . 71.34 114.131 -174.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -51.66 -48.09 23.11 Favored 'Trans proline' 0 C--N 1.384 2.442 0 C-N-CA 122.022 1.815 . . . . 73.32 113.725 176.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 22.9 mt -73.12 -29.36 28.31 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 CA-C-N 115.74 -0.664 . . . . 71.02 110.514 -176.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.4 -41.71 76.06 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.979 0.512 . . . . 74.14 111.493 176.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 54.6 t -74.26 -46.88 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 123.867 0.867 . . . . 64.22 111.875 -175.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 91.5 t -90.56 -31.35 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 122.884 0.473 . . . . 74.41 111.569 -175.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 82.49 111.22 0.45 Allowed Glycine 0 C--N 1.343 0.928 0 N-CA-C 112.37 -0.292 . . . . 72.35 112.37 178.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.459 ' HA3' ' CE1' ' C' ' 277' ' ' TYR . . . -145.47 -132.61 2.47 Favored Glycine 0 C--O 1.217 -0.957 0 CA-C-O 119.178 -0.79 . . . . 73.32 111.719 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.501 ' HZ3' ' HB2' ' A' ' 209' ' ' LYS . 9.2 mtmp? -112.05 134.83 53.36 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 118.008 0.904 . . . . 73.34 110.377 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.47 HG23 HD22 ' A' ' 197' ' ' LEU . 12.2 m -132.88 162.34 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 124.796 1.238 . . . . 63.11 108.633 171.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . 0.454 ' HG2' HG13 ' B' ' 421' ' ' VAL . 5.8 tpp180 -86.1 126.96 34.58 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 109.314 -0.624 . . . . 74.32 109.314 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.44 109.93 21.84 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.409 -0.96 . . . . 74.41 108.409 170.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 16.9 tpt -83.0 111.82 19.2 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 108.45 -0.944 . . . . 74.15 108.45 177.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 26.5 p -107.55 -174.47 2.54 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 109.502 -0.555 . . . . 74.1 109.502 -174.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 80.7 mt -63.94 -33.9 76.77 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.019 0.927 . . . . 73.14 111.942 -176.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -97.24 -6.63 34.14 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.421 0.688 . . . . 64.44 112.118 -177.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 135.06 -179.03 18.08 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-O 120.054 -0.303 . . . . 63.05 112.61 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -79.6 147.35 19.72 Favored 'Trans proline' 0 CA--C 1.549 1.238 0 C-N-CA 122.94 2.426 . . . . 74.13 113.455 -176.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 31.7 m -136.04 -177.91 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.624 1.569 . . . . 73.4 107.556 172.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.534 ' HB2' ' H ' ' B' ' 437' ' ' SER . 55.5 mt-10 -109.77 127.77 54.85 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 118.499 0.59 . . . . 75.04 109.745 169.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.431 ' HB ' HD11 ' B' ' 441' ' ' ILE . 7.0 m -107.52 132.25 55.54 Favored 'Isoleucine or valine' 0 C--O 1.242 0.683 0 C-N-CA 124.178 0.991 . . . . 74.51 108.512 168.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -80.24 97.3 6.89 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.572 -0.899 . . . . 70.4 108.572 178.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 14.9 p -65.62 137.39 96.36 Favored Pre-proline 0 N--CA 1.479 1.007 0 C-N-CA 124.186 0.994 . . . . 71.22 109.732 -175.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -72.04 165.93 31.12 Favored 'Trans proline' 0 C--N 1.374 1.9 0 C-N-CA 122.158 1.906 . . . . 75.51 111.931 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -73.58 164.11 35.75 Favored 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 122.214 1.942 . . . . 72.53 112.916 172.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 64.2 mtt-85 61.44 26.94 16.61 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 125.377 1.471 . . . . 75.13 111.812 169.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.503 HG23 HD21 ' A' ' 233' ' ' LEU . 94.6 m -72.06 103.87 3.4 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.19 1.396 . . . . 64.32 110.873 -176.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -87.08 138.11 31.77 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.636 1.174 . . . . 75.32 110.313 -175.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . 0.471 ' HA ' ' HB ' ' A' ' 253' ' ' VAL . . . -67.2 156.64 35.76 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.561 0.744 . . . . 65.12 111.973 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 83.51 -14.87 38.48 Favored Glycine 0 N--CA 1.471 0.99 0 CA-C-N 116.024 -0.535 . . . . 75.54 112.892 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -92.42 160.78 14.93 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 123.691 0.796 . . . . 74.44 110.4 177.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -113.49 113.5 25.22 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.783 0.833 . . . . 72.22 108.79 178.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.503 HD21 HG23 ' A' ' 227' ' ' THR . 64.7 mt -76.24 117.21 17.69 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.793 0.837 . . . . 71.4 109.683 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 27.8 ttm-85 -85.97 102.69 14.0 Favored 'General case' 0 CA--C 1.551 1.001 0 N-CA-C 108.679 -0.859 . . . . 73.41 108.679 172.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.494 HD13 HD22 ' A' ' 249' ' ' LEU . 3.1 mt -87.76 110.9 20.81 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 108.581 -0.896 . . . . 74.24 108.581 -178.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -59.38 127.84 34.1 Favored 'General case' 0 CA--C 1.555 1.135 0 O-C-N 124.098 0.874 . . . . 71.01 113.254 -177.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 82.59 6.37 88.63 Favored Glycine 0 C--N 1.353 1.5 0 N-CA-C 114.847 0.699 . . . . 74.2 114.847 170.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -95.31 -20.51 19.1 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 117.515 0.657 . . . . 74.1 112.714 -172.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -82.21 -173.01 48.42 Favored Glycine 0 N--CA 1.478 1.451 0 N-CA-C 113.717 0.247 . . . . 74.43 113.717 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -84.87 146.95 47.21 Favored Pre-proline 0 N--CA 1.483 1.213 0 C-N-CA 122.898 0.479 . . . . 73.41 111.811 -167.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -68.98 157.16 62.96 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 123.323 2.682 . . . . 73.33 113.326 173.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 169.84 -156.51 27.38 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 119.305 -0.719 . . . . 73.52 112.07 -178.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -61.99 -28.27 80.43 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 123.786 2.991 . . . . 72.5 113.286 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . 0.534 ' HB3' ' HG3' ' A' ' 191' ' ' GLN . . . -87.38 22.32 2.2 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.252 0.621 . . . . 70.11 111.416 176.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 75.01 -97.32 1.01 Allowed Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.47 -1.052 . . . . 62.24 110.47 -175.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 39.2 mtp180 -128.05 152.4 48.01 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.718 0.807 . . . . 75.41 110.167 166.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -91.57 -175.65 43.07 Favored Glycine 0 C--N 1.342 0.876 0 CA-C-N 116.082 -0.508 . . . . 70.31 112.031 171.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -112.62 -173.25 2.21 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.601 0.76 . . . . 75.44 110.588 178.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.494 HD22 HD13 ' A' ' 235' ' ' LEU . 19.1 tp -125.55 115.6 20.44 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 122.102 -0.374 . . . . 73.32 110.17 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.403 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 9.9 m-85 -80.44 123.08 27.74 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.545 -0.539 . . . . 71.3 109.545 172.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.483 HD21 ' HB1' ' A' ' 195' ' ' ALA . 57.8 mt -114.67 119.21 35.93 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.414 0.685 . . . . 74.54 109.415 171.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -77.46 116.94 18.45 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 106.579 -1.637 . . . . 75.41 106.579 176.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.471 ' HB ' ' HA ' ' A' ' 229' ' ' ALA . 24.3 t -75.71 109.68 9.6 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 CA-C-O 121.234 0.54 . . . . 71.34 110.569 -173.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.78 93.36 4.42 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.054 1.341 . . . . 73.14 107.625 177.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.407 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 58.6 mt -83.57 132.41 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-O 120.758 0.313 . . . . 74.34 110.308 -177.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 28.0 p -121.48 172.11 8.3 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.619 1.167 . . . . 74.52 109.889 174.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . 0.425 HD13 ' H ' ' A' ' 259' ' ' GLU . 2.1 pp -126.48 154.86 75.15 Favored Pre-proline 0 CA--C 1.562 1.429 0 N-CA-C 107.966 -1.124 . . . . 73.4 107.966 175.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . 0.527 ' HG3' ' HH ' ' C' ' 276' ' ' TYR . 61.2 Cg_endo -75.96 14.42 1.08 Allowed 'Trans proline' 0 N--CA 1.511 2.549 0 C-N-CA 123.36 2.707 . . . . 74.45 115.713 -164.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.425 ' H ' HD13 ' A' ' 257' ' ' ILE . 5.6 mm-40 54.1 -125.12 2.28 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 124.142 0.977 . . . . 75.12 111.682 -170.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' ARG . . . . . 0.403 ' H ' ' HD3' ' A' ' 260' ' ' ARG . 0.0 OUTLIER -63.61 140.61 58.89 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 118.449 0.568 . . . . 75.12 110.904 -170.443 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.407 HD13 ' CG1' ' C' ' 205' ' ' VAL . 84.9 mt -110.34 160.6 16.42 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.248 0.619 . . . . 72.32 111.584 -171.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 21.3 p -103.92 146.85 33.32 Favored Pre-proline 0 CA--C 1.554 1.118 0 C-N-CA 124.652 1.181 . . . . 74.31 108.94 174.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' PRO . . . . . 0.46 ' O ' ' HB3' ' A' ' 266' ' ' GLU . 21.7 Cg_exo -29.46 -58.74 0.14 Allowed 'Trans proline' 0 C--N 1.389 2.692 1 C-N-CA 126.089 4.526 . . . . 74.33 117.948 -163.209 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -72.28 -45.41 60.22 Favored 'General case' 0 C--O 1.211 -0.949 0 CA-C-O 119.217 -0.42 . . . . 71.44 110.711 -176.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -60.17 -31.49 70.16 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 123.955 0.784 . . . . 73.22 109.819 178.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' GLU . . . . . 0.462 ' O ' ' HD3' ' A' ' 270' ' ' LYS . 8.3 tp10 -59.47 -60.58 3.62 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.925 0.89 . . . . 73.45 109.045 171.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -63.99 -21.58 66.56 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 115.235 -0.893 . . . . 64.12 112.198 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . 0.418 ' HA ' ' HE2' ' A' ' 271' ' ' LYS . 26.3 tp -79.7 -48.7 13.24 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.548 1.139 . . . . 73.14 110.24 -173.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 70.6 m95 -61.03 -39.07 88.37 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.336 -0.847 . . . . 75.0 110.401 172.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . 0.597 ' HG3' HG23 ' C' ' 206' ' ' VAL . 1.0 OUTLIER -63.08 -45.7 90.92 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 123.689 0.618 . . . . 73.12 111.676 176.09 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . 0.418 ' HE2' ' HA ' ' A' ' 268' ' ' LEU . 30.3 mtmm -56.63 -50.01 73.28 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 123.082 0.553 . . . . 70.22 110.813 176.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' LEU . . . . . 0.4 ' O ' ' HB2' ' A' ' 276' ' ' TYR . 57.8 mt -51.32 -50.97 58.36 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 124.444 1.09 . . . . 71.54 110.4 175.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -72.73 -34.1 66.84 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 114.158 1.17 . . . . 72.23 114.158 -168.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -78.06 -41.68 34.66 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 122.75 0.42 . . . . 74.35 110.105 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -67.39 -30.8 70.67 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 115.98 -0.555 . . . . 72.24 110.52 174.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . 0.4 ' HB2' ' O ' ' A' ' 272' ' ' LEU . 35.1 t80 -66.15 -62.76 1.31 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.326 1.051 . . . . 75.02 109.596 176.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -60.43 -44.04 96.19 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.525 1.13 . . . . 72.14 111.168 -172.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -63.13 -17.82 62.75 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 112.467 0.543 . . . . 75.41 112.467 -179.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 -128.27 19.62 6.37 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.668 0.787 . . . . 75.15 111.016 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.08 0 CA-C-O 118.786 -0.626 . . . . 72.5 110.552 -174.956 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.416 ' SD ' ' N ' ' B' ' 1' ' ' MET . 1.0 OUTLIER . . . . . 0 N--CA 1.482 1.167 0 N-CA-C 108.866 -0.79 . . . . 74.12 108.866 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.57 ' HE3' ' HA ' ' B' ' 2' ' ' LYS . 0.5 OUTLIER -69.31 129.34 39.52 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 123.656 0.597 . . . . 62.45 110.046 -177.22 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 22.7 tm0? -144.71 145.01 31.5 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 108.462 -0.94 . . . . 74.04 108.462 -173.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 72.5 p 54.86 -85.21 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 125.859 1.663 . . . . 52.14 113.041 -178.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 11.3 m -75.01 157.63 34.58 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.018 0.527 . . . . 74.34 110.218 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.602 HG23 ' HA ' ' A' ' 125' ' ' LEU . 36.3 pt -131.43 170.26 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 123.158 0.583 . . . . 65.34 111.071 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -142.04 132.98 25.88 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.583 0.753 . . . . 72.22 109.955 -177.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . 0.402 ' HB3' ' HB ' ' A' ' 140' ' ' VAL . 48.5 tp -79.05 154.42 29.46 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.775 0.83 . . . . 75.22 111.338 -173.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -79.17 -63.56 1.39 Allowed 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.349 0.66 . . . . 73.12 112.153 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 86.5 mt 62.91 117.43 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 124.865 1.266 . . . . 74.1 110.566 -163.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 28.2 mt -89.63 -15.89 0.21 Allowed Pre-proline 0 CA--C 1.584 2.278 0 N-CA-C 116.298 1.962 . . . . 72.11 116.298 -176.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.504 ' HD3' HD21 ' A' ' 119' ' ' LEU . 63.8 Cg_endo -67.11 -4.13 11.02 Favored 'Trans proline' 0 C--N 1.406 3.563 0 CA-C-N 124.068 2.489 . . . . 71.41 114.653 -175.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . 0.476 HD23 ' H ' ' B' ' 13' ' ' LEU . 2.1 pt? -128.94 6.54 5.48 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.986 0.915 . . . . 75.11 110.644 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 18.2 tp -102.64 167.49 9.87 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 108.582 -0.896 . . . . 64.54 108.582 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -64.26 115.17 4.78 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 122.677 0.391 . . . . 74.01 110.516 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 63.2 p -128.39 176.94 2.37 Favored Pre-proline 0 CA--C 1.559 1.326 0 C-N-CA 124.746 1.218 . . . . 71.11 108.46 176.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_exo -47.07 149.01 3.79 Favored 'Trans proline' 0 C--N 1.384 2.437 0 C-N-CA 122.604 2.202 . . . . 71.22 113.563 166.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 15.4 m -76.28 78.63 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 CA-C-O 122.473 1.13 . . . . 63.3 111.522 -174.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 27.3 p -76.64 91.98 3.47 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 114.663 -1.153 . . . . 71.22 110.403 -177.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp 75.21 -51.21 0.66 Allowed 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 126.075 1.75 . . . . 74.33 112.345 177.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.28 100.47 1.05 Allowed 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.954 -0.758 . . . . 75.34 108.954 167.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 -153.25 9.28 0.42 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.241 0.616 . . . . 73.31 112.036 -172.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' THR . . . . . 0.4 ' HB ' ' HD2' ' B' ' 24' ' ' PRO . 26.9 p 59.58 -176.33 0.03 OUTLIER Pre-proline 0 CA--C 1.576 1.946 0 C-N-CA 124.736 1.215 . . . . 72.54 111.279 177.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . 0.4 ' HD2' ' HB ' ' B' ' 23' ' ' THR . 81.4 Cg_exo -54.19 -10.64 2.17 Favored 'Trans proline' 0 C--N 1.392 2.844 0 C-N-CA 122.19 1.927 . . . . 74.55 114.822 165.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 78.83 -32.35 0.15 Allowed 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 126.299 1.84 . . . . 74.53 112.218 174.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -124.04 50.45 3.57 Favored Pre-proline 0 CA--C 1.573 1.834 0 C-N-CA 123.547 0.739 . . . . 75.13 112.097 169.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -85.12 -2.23 9.46 Favored 'Trans proline' 0 C--N 1.397 3.087 0 C-N-CA 121.653 1.569 . . . . 73.04 111.215 169.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 16.8 m -125.15 -152.9 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 C-N-CA 125.749 1.62 . . . . 75.25 108.511 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . 0.457 ' O ' ' HG3' ' B' ' 337' ' ' LYS . 83.5 mt 81.72 -49.8 0.24 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 125.938 1.695 . . . . 73.34 111.325 177.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.432 ' HG3' ' H ' ' B' ' 32' ' ' ARG . 8.7 tp10 68.83 141.65 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.562 1.145 . . . . 71.25 111.841 177.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -87.81 25.1 1.59 Allowed 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.671 0.788 . . . . 74.34 111.704 -179.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' ARG . . . . . 0.432 ' H ' ' HG3' ' B' ' 30' ' ' GLU . 11.1 ptm180 -65.76 -14.14 60.76 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.799 0.84 . . . . 72.22 111.958 174.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . 0.424 ' HB3' ' HG2' ' C' ' 162' ' ' PRO . . . -79.71 18.88 0.71 Allowed 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 124.254 1.021 . . . . 73.31 113.476 -174.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -155.24 92.1 1.4 Allowed 'General case' 0 C--O 1.242 0.683 0 C-N-CA 123.666 0.786 . . . . 53.33 109.679 173.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -76.99 -41.8 41.4 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 116.35 -0.386 . . . . 73.13 109.992 173.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 141.97 -31.68 2.07 Favored Glycine 0 C--N 1.342 0.889 0 CA-C-N 115.515 -0.766 . . . . 74.33 112.212 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . 0.484 ' HA ' ' HG2' ' C' ' 27' ' ' LYS . 24.2 m-20 -70.71 103.58 2.6 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.417 0.687 . . . . 61.44 111.819 -176.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . 0.46 HG23 ' HD2' ' C' ' 23' ' ' LYS . 31.6 mt -129.52 80.44 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 N-CA-C 107.61 -1.256 . . . . 75.44 107.61 172.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 59.3 p 56.13 129.89 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 126.93 2.092 . . . . 73.32 114.95 178.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -87.49 -177.35 0.86 Allowed Pre-proline 0 CA--C 1.573 1.841 0 CA-C-O 117.456 -1.259 . . . . 73.24 108.581 175.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -77.72 -168.18 0.57 Allowed 'Trans proline' 0 C--N 1.4 3.279 0 CA-C-N 122.965 2.095 . . . . 72.44 112.986 -168.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 178.79 -139.98 4.26 Favored Glycine 0 C--N 1.339 0.744 0 N-CA-C 110.501 -1.039 . . . . 61.22 110.501 177.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -81.38 72.56 2.74 Favored Glycine 0 C--N 1.342 0.874 0 N-CA-C 111.893 -0.483 . . . . 64.32 111.893 176.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -83.78 59.23 5.07 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.713 0.805 . . . . 63.2 109.462 177.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.656 ' HG2' ' HA ' ' B' ' 48' ' ' THR . 75.8 ttt180 -73.12 84.06 1.32 Allowed 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.304 1.041 . . . . 74.21 110.46 -169.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 29.1 ttm180 -65.46 129.11 38.56 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.731 1.212 . . . . 75.02 110.042 -178.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 10.4 tt 74.52 -14.81 0.68 Allowed 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 124.991 1.317 . . . . 72.13 111.738 -177.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' THR . . . . . 0.656 ' HA ' ' HG2' ' B' ' 45' ' ' ARG . 41.2 m 62.44 -78.25 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.247 1.419 . . . . 73.12 111.988 -171.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.37 69.96 1.12 Allowed Glycine 0 C--N 1.343 0.956 0 N-CA-C 111.395 -0.682 . . . . 74.15 111.395 -173.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 68.78 -79.24 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 125.273 1.429 . . . . 64.2 113.181 173.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 15.9 tp60 57.49 -88.83 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 124.696 1.198 . . . . 75.3 111.842 -172.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 5.6 m -109.04 49.21 0.83 Allowed 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 122.517 1.151 . . . . 73.31 109.244 -175.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -94.43 37.04 1.12 Allowed 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 114.988 -1.006 . . . . 73.24 110.197 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . 66.11 29.9 9.68 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.669 1.188 . . . . 75.51 111.697 175.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 59.4 tp -67.24 -65.47 0.68 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.581 0.753 . . . . 72.35 110.005 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -132.11 14.43 4.69 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.34 1.056 . . . . 74.21 109.725 177.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -83.18 81.27 8.77 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 124.235 1.014 . . . . 75.31 110.094 -170.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 22.6 m -83.31 77.64 9.76 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.252 -0.885 . . . . 62.01 110.179 -177.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . 0.663 ' HG ' ' HA ' ' B' ' 63' ' ' PRO . 2.9 tt 62.74 72.24 0.5 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.804 1.242 . . . . 72.44 109.924 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 18.5 m -73.9 -35.47 64.65 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-N 115.418 -0.81 . . . . 71.31 109.965 174.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -166.86 -56.57 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.88 1.672 . . . . 71.45 106.5 175.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -55.79 120.63 34.3 Favored Pre-proline 0 CA--C 1.547 0.862 0 CA-C-N 113.767 -1.56 . . . . 72.42 109.947 168.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . 0.663 ' HA ' ' HG ' ' B' ' 59' ' ' LEU . 26.5 Cg_endo -61.02 -46.53 15.51 Favored 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 122.765 2.31 . . . . 72.24 111.86 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 67.46 -8.15 0.5 Allowed 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 125.114 1.365 . . . . 72.04 113.574 177.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm 66.44 5.89 4.03 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 125.326 1.45 . . . . 73.42 111.936 -176.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -85.13 108.28 17.61 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 123.864 0.866 . . . . 72.41 110.847 -171.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 4.3 tt -157.94 100.85 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 124.364 1.065 . . . . 74.04 108.706 176.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 57.8 mt 65.84 -76.47 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 125.716 1.607 . . . . 73.4 111.232 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -145.85 -169.23 3.19 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.042 0.937 . . . . 74.34 108.875 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . 0.497 HD22 ' H ' ' B' ' 70' ' ' LEU . 1.5 pt? -55.33 92.04 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.128 0 CA-C-O 121.995 0.902 . . . . 65.22 109.685 167.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 8.3 tp -79.9 -39.09 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 115.115 -0.948 . . . . 75.5 111.087 -172.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.36 106.75 0.43 Allowed Glycine 0 C--O 1.241 0.579 0 N-CA-C 111.309 -0.717 . . . . 71.15 111.309 -169.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -66.98 96.25 0.42 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.761 0.824 . . . . 74.12 109.439 -178.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.85 44.77 60.86 Favored Glycine 0 C--N 1.349 1.301 0 N-CA-C 111.533 -0.627 . . . . 72.45 111.533 -172.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 50.6 mtt 71.01 -63.78 0.41 Allowed 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 125.688 1.595 . . . . 74.01 111.29 -168.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 59.06 38.61 93.25 Favored Glycine 0 C--N 1.355 1.633 0 N-CA-C 112.136 -0.386 . . . . 71.52 112.136 177.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -58.12 -27.64 63.92 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.106 1.363 . . . . 74.35 113.118 -169.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 23.1 t 69.25 59.84 0.32 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.711 1.204 . . . . 55.34 109.263 -175.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -96.6 144.45 26.65 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 114.614 -1.176 . . . . 74.44 111.166 -172.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . 0.449 HG23 ' H ' ' B' ' 81' ' ' THR 0.283 0.0 OUTLIER 49.22 -75.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 C-N-CA 127.242 2.217 . . . . 72.52 114.027 178.634 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' B' B ' 81' ' ' THR . . . . . 0.449 ' H ' HG23 ' B' ' 80' ' ' ILE . 8.7 t -80.63 -21.13 41.78 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.79 0.836 . . . . 74.52 110.23 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 73.15 153.86 0.14 Allowed 'General case' 0 C--N 1.354 0.786 0 C-N-CA 125.611 1.564 . . . . 75.12 111.965 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -87.07 67.36 9.7 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.543 0.737 . . . . 74.13 109.749 -176.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 83.2 mtm180 -79.53 95.82 5.94 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 114.935 -1.029 . . . . 73.0 110.39 -178.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -95.34 130.16 42.21 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 123.839 0.856 . . . . 72.23 109.696 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -73.56 118.6 16.71 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.919 -0.771 . . . . 74.21 108.919 174.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.84 87.54 0.53 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.037 0.935 . . . . 52.24 111.911 -171.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -107.27 -41.86 5.0 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.068 0.947 . . . . 74.14 109.414 176.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -146.94 65.67 0.42 Allowed Glycine 0 C--N 1.341 0.858 0 CA-C-N 115.017 -0.992 . . . . 54.33 110.754 -177.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.21 -172.91 2.6 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 123.69 0.796 . . . . 75.53 110.968 178.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -70.53 6.37 6.11 Favored Glycine 0 C--N 1.351 1.384 0 N-CA-C 115.453 0.941 . . . . 70.11 115.453 -172.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -81.92 31.11 2.84 Favored Glycine 0 C--N 1.356 1.642 0 CA-C-N 117.542 0.671 . . . . 73.42 113.804 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -71.94 100.47 2.46 Favored 'General case' 0 C--N 1.351 0.665 0 N-CA-C 109.59 -0.522 . . . . 74.22 109.59 174.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -153.59 94.29 1.77 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.171 -0.677 . . . . 72.14 109.171 173.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . 0.689 ' HG2' ' HB3' ' B' ' 98' ' ' ASP . 24.4 tptm -84.77 -58.41 2.73 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.88 -0.785 . . . . 74.44 108.88 173.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.44 15.91 77.34 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-N 115.707 -0.679 . . . . 75.21 114.076 173.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 10.2 tp -156.1 11.62 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.559 1.311 0 CA-C-O 122.046 0.927 . . . . 73.0 109.535 -178.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . 0.689 ' HB3' ' HG2' ' B' ' 95' ' ' LYS . 6.8 p-10 -80.85 114.38 19.7 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 123.465 0.706 . . . . 75.21 110.134 -178.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -91.44 65.9 5.36 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.528 -0.76 . . . . 61.12 109.098 174.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . 0.472 ' HG ' ' HB2' ' B' ' 98' ' ' ASP . 95.7 mt -98.85 123.84 47.98 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 115.619 -0.719 . . . . 74.2 110.135 -176.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 101' ' ' PRO . . . . . 0.503 ' HA ' ' HG2' ' B' ' 324' ' ' MET . 89.1 Cg_endo -78.42 133.08 11.6 Favored 'Trans proline' 0 C--N 1.375 1.945 0 C-N-CA 122.98 2.453 . . . . 74.43 112.488 178.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . 0.491 HD21 ' HB1' ' B' ' 322' ' ' ALA . 2.5 mm? -90.45 -38.41 13.29 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.341 0.656 . . . . 73.12 109.748 176.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 15.3 t -151.76 -172.36 4.2 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 115.206 -0.906 . . . . 75.52 109.582 -175.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . -71.34 86.26 0.41 Allowed Glycine 0 C--N 1.351 1.401 0 N-CA-C 112.345 -0.302 . . . . 51.35 112.345 177.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 105' ' ' GLN . . . . . 0.52 ' NE2' ' HA ' ' B' ' 326' ' ' ASP . 24.2 tm0? -68.46 113.72 6.25 Favored 'General case' 0 C--N 1.35 0.625 0 N-CA-C 108.828 -0.804 . . . . 75.22 108.828 176.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 14.5 m-30 60.06 -179.73 0.09 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.678 1.191 . . . . 74.44 113.247 -178.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 71.0 p -96.3 34.02 1.67 Allowed 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.696 0.799 . . . . 75.34 112.063 -174.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 26.5 p80 -90.21 38.13 0.92 Allowed 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.584 0.706 . . . . 73.44 110.552 175.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -120.76 -60.9 1.62 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.71 1.204 . . . . 74.1 107.958 -176.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.75 164.92 20.33 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-N 115.198 -0.91 . . . . 75.22 108.731 166.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . 0.73 ' HA ' ' HA ' ' C' ' 243' ' ' PRO . 84.1 mt 64.87 21.58 12.37 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.755 0.822 . . . . 70.25 110.97 -175.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 33.9 t-20 -78.7 135.35 37.15 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.46 0.704 . . . . 73.2 110.258 -170.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 113' ' ' LYS . . . . . 0.494 ' HG2' ' H ' ' B' ' 114' ' ' LYS 0.279 0.0 OUTLIER 32.44 -76.02 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 127.493 2.317 . . . . 75.13 114.129 -166.712 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' B' B ' 114' ' ' LYS . . . . . 0.494 ' H ' ' HG2' ' B' ' 113' ' ' LYS . 1.5 tpmt? -179.45 -162.18 0.04 OUTLIER 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 125.332 1.453 . . . . 74.21 107.232 -174.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 32.0 p -58.82 -63.73 1.19 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.098 0.959 . . . . 73.23 110.496 171.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -94.82 -136.85 8.61 Favored Glycine 0 C--N 1.347 1.141 0 CA-C-N 115.801 -0.636 . . . . 55.33 111.562 175.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . 0.49 ' H ' ' HD2' ' B' ' 118' ' ' PRO . 9.5 mtpm? -147.03 -54.14 0.02 OUTLIER Pre-proline 0 CA--C 1.562 1.436 0 C-N-CA 124.85 1.26 . . . . 75.35 110.771 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 118' ' ' PRO . . . . . 0.506 ' HA ' ' HB2' ' B' ' 336' ' ' GLU . 73.3 Cg_endo -73.95 -51.71 0.14 Allowed 'Trans proline' 0 C--N 1.396 3.058 0 C-N-CA 121.37 1.38 . . . . 63.21 114.036 -174.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 119' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -154.47 156.01 35.95 Favored 'General case' 0 C--O 1.243 0.751 0 C-N-CA 124.5 1.12 . . . . 75.33 108.202 -173.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 120' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -131.86 3.81 4.13 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 122.907 0.483 . . . . 70.1 111.215 -169.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 121' ' ' VAL . . . . . 0.43 HG22 ' H ' ' B' ' 122' ' ' THR . 3.7 m -137.49 -63.77 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 C-N-CA 123.287 0.635 . . . . 74.32 112.571 -173.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 122' ' ' THR . . . . . 0.43 ' H ' HG22 ' B' ' 121' ' ' VAL . 67.4 m -80.92 -66.35 0.9 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.646 0.778 . . . . 75.25 111.539 -171.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -87.66 -52.01 5.56 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 124.155 0.982 . . . . 70.53 110.676 -174.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 28.8 m 62.01 -107.94 0.27 Allowed 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 125.237 1.415 . . . . 61.03 112.2 177.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . 175.91 138.57 0.06 Allowed 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.196 0.998 . . . . 74.53 109.987 -174.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . 0.401 ' HB1' ' HB3' ' B' ' 141' ' ' ALA . . . -155.52 143.14 19.64 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.916 0.886 . . . . 74.13 109.471 177.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 73.7 p -156.35 179.49 9.2 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 112.485 0.55 . . . . 70.01 112.485 -176.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -76.9 145.94 37.94 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.917 0.887 . . . . 74.33 110.552 172.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 129' ' ' THR . . . . . 0.412 ' HB ' HD23 ' B' ' 155' ' ' LEU . 15.5 m -70.5 -16.5 62.91 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 123.345 0.658 . . . . 74.41 111.958 -179.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . -66.83 153.49 43.28 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.039 0.535 . . . . 61.42 111.297 176.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 131' ' ' TRP . . . . . 0.487 ' HA ' ' HB2' ' C' ' 187' ' ' ARG . 15.8 p90 -57.31 -29.56 64.03 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.527 1.131 . . . . 73.51 112.812 -172.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 132' ' ' SER . . . . . 0.652 ' HB3' HG22 ' B' ' 135' ' ' VAL . 35.6 t -118.56 150.21 40.04 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 123.423 0.689 . . . . 74.11 110.646 178.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 7.3 m -68.92 -29.66 67.97 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 115.623 -0.717 . . . . 74.52 109.315 168.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . -72.38 -5.45 63.12 Favored Glycine 0 C--N 1.355 1.634 0 CA-C-N 114.919 -1.037 . . . . 55.15 114.652 -178.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 135' ' ' VAL . . . . . 0.652 HG22 ' HB3' ' B' ' 132' ' ' SER . 47.6 t -74.44 -37.39 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 CA-C-N 117.554 0.677 . . . . 73.24 109.628 174.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt 68.87 10.37 7.88 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 124.76 1.224 . . . . 74.24 113.108 168.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 10.4 p -68.57 106.23 2.51 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 121.783 -0.573 . . . . 75.31 111.095 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 138' ' ' TYR . . . . . 0.589 ' HB2' ' HG3' ' B' ' 148' ' ' GLU . 49.6 t80 65.11 -75.95 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 125.901 1.681 . . . . 75.52 111.177 -176.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . 0.539 HD22 HD13 ' B' ' 341' ' ' LEU . 63.3 t30 71.94 155.61 0.15 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 125.367 1.467 . . . . 73.24 112.369 176.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . 90.58 50.45 2.93 Favored Glycine 0 C--N 1.348 1.213 0 CA-C-N 116.289 -0.414 . . . . 75.54 113.307 175.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 141' ' ' ALA . . . . . 0.401 ' HB3' ' HB1' ' B' ' 126' ' ' ALA . . . 75.44 -27.89 0.19 Allowed 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 125.338 1.455 . . . . 75.34 114.781 169.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . 0.261 0.3 OUTLIER 44.56 -81.57 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 125.897 1.679 . . . . 74.24 114.241 -172.369 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 96.23 -44.61 1.99 Allowed Glycine 0 C--N 1.352 1.47 0 N-CA-C 111.87 -0.492 . . . . 61.25 111.87 -175.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 26.1 t -101.18 153.38 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 108.295 -1.002 . . . . 75.31 108.295 173.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 145' ' ' ASP . . . . . 0.454 ' HB3' HE22 ' B' ' 397' ' ' GLN . 3.5 p-10 -63.43 -49.05 75.26 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 109.683 -0.488 . . . . 75.32 109.683 176.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 68.0 mt 66.28 -12.32 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.56 1.345 0 C-N-CA 125.696 1.599 . . . . 72.52 112.366 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 19.0 p-80 32.88 74.62 0.05 Allowed 'General case' 0 C--N 1.372 1.586 0 C-N-CA 125.482 1.513 . . . . 72.43 111.169 -163.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . 0.589 ' HG3' ' HB2' ' B' ' 138' ' ' TYR . 4.4 tm-20 -54.31 132.97 44.89 Favored 'General case' 0 C--N 1.358 0.953 0 CA-C-N 113.875 -1.511 . . . . 75.05 109.56 -172.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 149' ' ' LYS . . . . . 0.41 ' HG2' ' HB3' ' A' ' 182' ' ' PRO . 36.0 mtmm 73.54 -77.47 0.05 Allowed 'General case' 0 N--CA 1.478 0.935 0 O-C-N 125.188 1.555 . . . . 74.13 109.388 -163.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 25.4 t0 171.84 163.9 0.1 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 125.857 1.663 . . . . 74.11 108.509 174.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 151' ' ' HIS . . . . . 0.437 ' HB3' ' HD2' ' B' ' 152' ' ' PRO . 98.6 m-70 69.92 171.82 0.1 Allowed Pre-proline 0 CA--C 1.565 1.544 0 C-N-CA 124.366 1.066 . . . . 74.43 111.981 173.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 152' ' ' PRO . . . . . 0.437 ' HD2' ' HB3' ' B' ' 151' ' ' HIS . 25.0 Cg_endo -62.47 -177.18 0.28 Allowed 'Trans proline' 0 C--N 1.389 2.692 0 C-N-CA 122.509 2.14 . . . . 64.13 113.47 169.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 62.2 m 77.98 -52.37 0.51 Allowed 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 125.668 1.587 . . . . 74.2 110.552 -174.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 60.6 mt 61.58 -83.6 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 125.005 1.322 . . . . 74.25 111.946 170.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 155' ' ' LEU . . . . . 0.412 HD23 ' HB ' ' B' ' 129' ' ' THR . 1.0 OUTLIER -114.68 38.57 3.08 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.807 0.843 . . . . 73.12 110.851 -175.257 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 78.06 -27.32 0.17 Allowed 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 125.701 1.6 . . . . 72.23 112.127 -177.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 157' ' ' MET . . . . . 0.592 ' HB3' ' HG2' ' C' ' 252' ' ' GLU . 53.0 mtt 65.26 23.92 12.2 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.094 0.957 . . . . 61.13 111.394 -174.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 158' ' ' ALA . . . . . . . . . . . . . . . 70.34 -65.34 0.33 Allowed 'General case' 0 C--N 1.362 1.145 0 C-N-CA 125.788 1.635 . . . . 65.11 111.582 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . 0.417 ' HA ' HG21 ' C' ' 196' ' ' THR . 87.7 mttt 61.46 61.4 1.51 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.023 1.329 . . . . 73.24 111.179 177.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -72.17 153.24 41.74 Favored 'General case' 0 C--O 1.247 0.97 0 CA-C-N 114.338 -1.301 . . . . 74.34 108.9 167.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . 75.6 145.15 0.08 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.87 1.268 . . . . 71.1 112.619 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 162' ' ' GLY . . . . . 0.452 ' H ' ' HB2' ' B' ' 356' ' ' ASN . . . 159.39 -45.59 0.44 Allowed Glycine 0 C--N 1.352 1.449 0 CA-C-N 115.918 -0.583 . . . . 73.4 111.908 -176.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 1.6 pp -130.01 141.24 50.77 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.111 0.964 . . . . 75.25 109.739 175.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 164' ' ' ALA . . . . . . . . . . . . . . . -70.97 102.69 2.47 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.468 0.707 . . . . 75.34 111.183 -172.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 11.8 p -88.0 96.25 10.43 Favored 'General case' 0 C--O 1.244 0.769 0 C-N-CA 123.288 0.635 . . . . 73.14 109.857 174.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . -81.44 54.62 4.79 Favored Glycine 0 C--N 1.349 1.303 0 CA-C-N 115.703 -0.68 . . . . 74.53 112.666 178.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 167' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -148.44 2.04 0.63 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.601 1.16 . . . . 74.33 108.765 178.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 10.3 p -166.63 40.12 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.114 0 CA-C-O 122.596 1.189 . . . . 75.53 108.592 -173.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 13.3 m -56.91 -26.46 59.28 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 114.076 -1.42 . . . . 65.53 112.84 -173.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 3.8 m -144.8 -72.31 0.26 Allowed 'General case' 0 C--O 1.24 0.601 0 N-CA-C 107.704 -1.221 . . . . 73.13 107.704 176.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . 0.433 ' HB3' ' HE2' ' C' ' 213' ' ' MET . . . 174.72 58.19 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.788 1.635 . . . . 73.41 107.193 -174.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 172' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -61.61 97.47 0.07 Allowed 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.636 -0.711 . . . . 75.25 111.002 -175.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 173' ' ' LEU . . . . . . . . . . . . . 1.7 pp -83.24 6.5 19.31 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.957 0.903 . . . . 74.44 111.75 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 174' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -73.12 77.34 1.25 Allowed 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.821 0.848 . . . . 74.45 108.801 173.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 175' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -153.86 158.66 41.12 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-N 114.581 -1.19 . . . . 74.1 108.888 -171.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -151.74 35.06 0.55 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.782 0.833 . . . . 74.11 110.673 -176.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 97.4 m -64.42 126.28 90.22 Favored Pre-proline 0 CA--C 1.555 1.155 0 CA-C-N 115.701 -0.681 . . . . 74.15 109.621 172.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 178' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -81.79 51.38 3.82 Favored 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 123.308 2.672 . . . . 74.53 112.989 -176.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -135.38 96.95 3.57 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.623 0.769 . . . . 74.35 109.441 177.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . -70.81 -36.91 73.19 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.182 0.593 . . . . 75.32 110.547 175.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 13.1 tp -159.72 18.77 0.16 Allowed 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 114.629 -1.169 . . . . 74.44 109.179 176.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 182' ' ' VAL . . . . . 0.59 HG21 ' HA ' ' C' ' 138' ' ' VAL . 55.9 t -76.86 107.0 7.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 116.089 -0.505 . . . . 72.43 111.119 -169.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 183' ' ' ALA . . . . . 0.401 ' HB3' ' HB3' ' C' ' 123' ' ' LEU . . . -86.62 -36.4 18.84 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.13 -0.941 . . . . 65.24 110.214 170.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 184' ' ' HIS . . . . . 0.518 ' HB2' HG11 ' B' ' 182' ' ' VAL . 6.3 t-80 58.42 28.88 17.46 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 125.259 1.424 . . . . 75.32 112.382 171.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 185' ' ' VAL . . . . . . . . . . . . . 53.5 t 59.92 76.83 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 124.226 1.01 . . . . 74.01 109.443 -168.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 186' ' ' THR . . . . . 0.668 HG22 ' HG2' ' C' ' 122' ' ' GLU . 59.6 p 52.64 76.74 0.18 Allowed 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 125.452 1.501 . . . . 60.24 112.422 176.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 187' ' ' SER . . . . . 0.482 ' HB3' ' HB3' ' B' ' 184' ' ' HIS . 32.6 t -148.58 133.46 18.04 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 123.465 0.706 . . . . 62.14 109.4 -177.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -133.14 124.65 27.91 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.659 0.784 . . . . 72.32 110.363 -177.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -109.47 161.05 15.69 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 108.67 -0.863 . . . . 72.52 108.67 164.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 190' ' ' CYS . . . . . . . . . . . . . 77.8 m -148.05 132.83 17.95 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.529 0.732 . . . . 70.33 109.85 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -87.14 130.83 34.36 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 109.376 -0.602 . . . . 74.04 109.376 175.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . 0.545 ' H ' ' HG2' ' B' ' 312' ' ' PRO . . . -71.2 127.62 14.91 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-O 117.778 -1.568 . . . . 64.22 110.463 174.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 193' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -47.18 -30.11 10.13 Favored 'Trans proline' 0 C--N 1.388 2.656 0 C-N-CA 124.235 3.29 . . . . 73.22 114.993 -169.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 194' ' ' SER . . . . . . . . . . . . . 37.1 m 72.27 -66.48 0.3 Allowed 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.729 1.612 . . . . 63.44 111.547 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 195' ' ' ALA . . . . . . . . . . . . . . . -86.21 154.52 21.24 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 123.256 0.623 . . . . 74.32 109.694 173.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 59.3 m -73.36 -66.04 0.74 Allowed 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.701 0.8 . . . . 73.32 110.2 178.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 42.4 t -170.25 99.74 0.27 Allowed 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 109.045 -0.724 . . . . 75.11 109.045 177.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 198' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -92.47 6.49 46.91 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.324 0.649 . . . . 65.14 111.373 178.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 63.6 mttm 74.11 -63.13 0.44 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 125.9 1.68 . . . . 75.14 109.937 -173.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 200' ' ' CYS . . . . . . . . . . . . . 70.9 m 72.66 108.08 0.03 OUTLIER Pre-proline 0 N--CA 1.481 1.118 0 C-N-CA 125.595 1.558 . . . . 73.31 111.213 178.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 201' ' ' PRO . . . . . 0.551 ' HA ' ' HG2' ' B' ' 363' ' ' GLU . 31.7 Cg_exo -59.86 99.32 0.13 Allowed 'Trans proline' 0 C--N 1.38 2.205 0 C-N-CA 122.769 2.312 . . . . 74.02 112.804 175.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 153.07 26.17 0.04 OUTLIER Glycine 0 C--N 1.351 1.41 0 CA-C-N 115.91 -0.586 . . . . 73.41 113.525 178.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -79.82 -31.78 40.65 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 117.343 0.571 . . . . 71.33 110.663 175.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -146.17 132.04 19.09 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 123.129 0.572 . . . . 74.01 110.212 178.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 205' ' ' LEU . . . . . . . . . . . . . 47.2 tp -71.0 -48.58 52.37 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.766 0.827 . . . . 72.44 109.166 173.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.1 -127.22 0.14 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.468 1.107 . . . . 70.3 109.042 175.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 12.7 mptt 64.5 -75.99 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 124.473 1.109 . . . . 74.32 110.336 -167.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 111.08 147.44 10.99 Favored Glycine 0 C--N 1.349 1.283 0 N-CA-C 111.484 -0.646 . . . . 71.52 111.484 -177.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . -78.6 -31.23 46.0 Favored Glycine 0 N--CA 1.466 0.675 0 N-CA-C 111.774 -0.53 . . . . 63.34 111.774 175.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 210' ' ' LYS . . . . . 0.652 ' HB3' ' HG2' ' B' ' 235' ' ' GLU . 60.5 mttm 60.04 -85.81 0.02 OUTLIER 'General case' 0 C--N 1.365 1.259 0 C-N-CA 124.891 1.277 . . . . 74.51 112.134 168.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . -80.17 73.06 2.53 Favored Glycine 0 C--N 1.353 1.519 0 N-CA-C 108.975 -1.65 . . . . 74.43 108.975 167.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 23.1 t -78.12 71.87 4.61 Favored 'General case' 0 C--N 1.357 0.902 0 C-N-CA 124.278 1.031 . . . . 74.04 110.559 -173.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 18.9 pt -112.14 33.02 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.625 1.57 . . . . 70.12 107.976 177.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 76.4 p -70.34 -27.0 64.01 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.905 1.282 . . . . 75.43 112.346 -169.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 215' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -77.79 -24.85 48.73 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 115.799 -0.637 . . . . 73.31 110.176 174.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 19.5 tm0? 77.24 -63.62 0.35 Allowed 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 125.814 1.645 . . . . 61.42 112.667 168.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . 0.429 HD21 HD11 ' B' ' 218' ' ' LEU . 3.6 tt -72.19 82.42 1.0 Allowed 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.327 1.051 . . . . 75.4 110.914 -169.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . 0.429 HD11 HD21 ' B' ' 217' ' ' LEU . 9.2 mp 63.65 -70.98 0.06 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.833 1.653 . . . . 71.43 113.932 167.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 77.24 -35.06 0.21 Allowed 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 126.053 1.741 . . . . 71.24 111.488 -178.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . 0.59 ' HA ' HD21 ' B' ' 226' ' ' LEU . . . -68.68 -7.87 37.32 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.366 0.666 . . . . 74.3 111.382 164.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 221' ' ' ARG . . . . . . . . . . . . . 44.7 mtp180 70.99 -80.07 0.04 OUTLIER 'General case' 0 C--N 1.364 1.216 0 C-N-CA 125.814 1.646 . . . . 73.55 110.973 172.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -150.45 0.32 0.43 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.699 0.799 . . . . 75.21 110.487 175.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -73.84 -19.31 60.77 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.827 1.251 . . . . 72.13 111.445 -177.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 58.8 t 66.55 -73.07 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 125.441 1.496 . . . . 75.32 111.253 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 4.3 t -69.8 -43.17 72.64 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.931 0.892 . . . . 73.55 110.947 175.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . 0.59 HD21 ' HA ' ' B' ' 220' ' ' ALA . 22.3 tp 58.86 -75.32 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.506 1.522 . . . . 74.43 111.91 -175.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . -170.63 30.57 0.13 Allowed Glycine 0 C--N 1.338 0.659 0 N-CA-C 111.446 -0.662 . . . . 71.24 111.446 176.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 84.62 -46.43 3.67 Favored Glycine 0 C--N 1.348 1.217 0 N-CA-C 112.139 -0.384 . . . . 72.41 112.139 -172.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . 70.21 -91.2 0.37 Allowed Glycine 0 C--N 1.356 1.66 0 C-N-CA 123.175 0.417 . . . . 71.04 112.634 174.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -69.34 -43.63 73.29 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.065 0.546 . . . . 70.23 110.132 174.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 231' ' ' LYS . . . . . . . . . . . . . 45.3 mttp 62.44 -75.87 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 125.893 1.677 . . . . 73.24 111.638 178.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 33.2 m -65.1 98.12 0.28 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.322 1.049 . . . . 74.24 110.789 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -72.66 112.98 9.2 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 115.327 -0.851 . . . . 71.44 108.853 172.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -139.81 -169.95 2.83 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.415 0.686 . . . . 72.31 110.679 -174.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . 0.665 ' HG3' ' HE2' ' C' ' 209' ' ' LYS . 17.5 tp10 78.79 134.13 0.06 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.847 1.659 . . . . 64.41 111.517 178.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 236' ' ' THR . . . . . 0.58 HG22 HD22 ' B' ' 247' ' ' LEU . 88.9 m -118.27 -62.78 1.5 Allowed 'General case' 0 C--O 1.241 0.64 0 CA-C-N 115.13 -0.941 . . . . 73.34 110.527 -174.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -170.32 155.08 5.08 Favored 'General case' 0 C--N 1.351 0.652 0 O-C-N 123.538 0.524 . . . . 73.03 111.389 -171.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 41.0 m -146.31 27.72 1.13 Allowed 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 122.986 1.374 . . . . 71.31 107.752 166.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 239' ' ' ALA . . . . . 0.703 ' HB2' ' H ' ' C' ' 222' ' ' ALA . . . -97.32 -173.67 2.73 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 114.329 -1.305 . . . . 74.42 111.945 -173.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . -117.1 -151.9 9.49 Favored Glycine 0 C--N 1.341 0.848 0 CA-C-N 114.799 -1.091 . . . . 71.23 111.06 178.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -110.39 141.68 43.12 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.941 0.896 . . . . 71.23 112.026 -165.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 242' ' ' TRP . . . . . 0.429 ' HB3' ' HA ' ' C' ' 233' ' ' LEU . 0.4 OUTLIER -171.09 -39.55 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.584 1.154 . . . . 70.32 109.577 174.231 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 243' ' ' GLN . . . . . 0.79 ' HA ' ' HA ' ' B' ' 378' ' ' ALA . 12.6 pt20 -157.36 162.93 39.08 Favored 'General case' 0 C--O 1.244 0.791 0 C-N-CA 124.47 1.108 . . . . 74.22 108.881 169.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -69.07 116.78 7.46 Favored Glycine 0 C--N 1.351 1.384 0 N-CA-C 111.896 -0.482 . . . . 71.54 111.896 -175.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 245' ' ' LYS . . . . . 0.548 ' HE2' ' HB3' ' C' ' 222' ' ' ALA . 9.2 tmtm? -85.1 112.28 20.52 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 117.245 0.522 . . . . 75.34 110.474 -175.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 60.7 p -95.78 149.95 20.94 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.556 0.742 . . . . 71.14 109.005 167.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 247' ' ' LEU . . . . . 0.58 HD22 HG22 ' B' ' 236' ' ' THR . 97.8 mt -83.46 -177.06 6.6 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.845 0.858 . . . . 72.51 112.574 -172.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 248' ' ' ARG . . . . . 0.419 ' HA ' ' HE ' ' B' ' 248' ' ' ARG . 1.5 tpm_? -105.92 148.97 27.03 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.37 1.068 . . . . 75.15 109.035 173.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -130.05 137.32 50.17 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 107.495 -1.298 . . . . 71.33 107.495 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -88.95 40.28 0.97 Allowed 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 124.248 1.019 . . . . 70.14 111.488 -171.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 251' ' ' ALA . . . . . . . . . . . . . . . -59.56 -53.54 56.92 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.047 0.939 . . . . 64.21 111.876 -178.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -101.49 -15.64 17.07 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 124.271 1.028 . . . . 73.12 111.359 -178.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -68.87 -32.99 73.04 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.872 0.469 . . . . 51.41 111.066 174.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -72.09 92.48 1.33 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 122.953 0.501 . . . . 72.51 109.85 175.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . 59.24 -96.45 0.08 OUTLIER Glycine 0 C--N 1.353 1.495 0 O-C-N 123.745 0.653 . . . . 63.32 112.474 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 256' ' ' TYR . . . . . . . . . . . . . 22.9 t80 61.5 -74.7 0.03 OUTLIER 'General case' 0 C--N 1.363 1.156 0 C-N-CA 126.247 1.819 . . . . 71.2 111.16 178.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -64.06 -62.11 1.84 Allowed 'General case' 0 C--N 1.35 0.605 0 C-N-CA 124.163 0.985 . . . . 74.31 108.537 176.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 258' ' ' LEU . . . . . . . . . . . . . 1.5 tt 56.11 -84.75 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 125.603 1.561 . . . . 75.13 110.708 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . 0.518 ' HA ' ' HB3' ' B' ' 262' ' ' ALA . 62.2 t -85.21 97.23 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 123.199 0.6 . . . . 63.31 109.491 178.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 260' ' ' SER . . . . . . . . . . . . . 22.2 m -134.4 96.16 3.53 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 107.159 -1.422 . . . . 73.11 107.159 173.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 61.33 32.28 19.2 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.118 0.967 . . . . 65.51 110.333 -168.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 262' ' ' ALA . . . . . 0.518 ' HB3' ' HA ' ' B' ' 259' ' ' VAL . . . -128.47 39.96 3.73 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.213 1.005 . . . . 75.22 110.536 -174.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -63.22 -38.93 93.11 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 116.047 -0.524 . . . . 70.44 110.214 173.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 33.4 t -88.23 168.45 12.72 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 114.8 -1.091 . . . . 51.14 110.168 175.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 265' ' ' LEU . . . . . . . . . . . . . 90.9 mt -90.13 32.03 0.95 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.788 0.835 . . . . 73.31 111.337 -177.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 266' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 69.82 -65.91 0.29 Allowed 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 125.962 1.705 . . . . 71.52 111.25 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 33.5 m -139.8 -63.82 0.5 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.216 1.006 . . . . 73.13 108.4 173.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 11.4 p -174.12 -32.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 124.209 1.003 . . . . 74.44 110.038 -178.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 269' ' ' THR . . . . . . . . . . . . . 35.0 m -68.51 91.24 0.4 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.777 0.831 . . . . 74.31 111.515 -173.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 270' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.48 -175.78 4.98 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.004 1.322 . . . . 72.41 108.436 175.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 271' ' ' ALA . . . . . 0.523 ' HB2' ' HB3' ' B' ' 275' ' ' LYS . . . -120.8 53.49 1.12 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 122.893 0.477 . . . . 75.3 110.786 -175.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 272' ' ' ASN . . . . . 0.522 ' O ' ' HG3' ' B' ' 275' ' ' LYS . 42.7 m-80 61.14 -157.91 0.33 Allowed 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.25 1.02 . . . . 73.11 111.303 176.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -70.14 -7.42 41.54 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.774 -0.579 . . . . 73.43 111.433 170.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -85.09 4.93 31.85 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.094 0.958 . . . . 71.44 112.278 -176.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 275' ' ' LYS . . . . . 0.523 ' HB3' ' HB2' ' B' ' 271' ' ' ALA . 2.2 pptp? -94.82 109.42 43.81 Favored Pre-proline 0 CA--C 1.555 1.137 0 CA-C-N 118.31 0.505 . . . . 72.14 111.134 177.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -89.12 151.44 5.67 Favored 'Trans proline' 0 C--N 1.377 2.028 0 C-N-CA 122.683 2.256 . . . . 73.04 111.564 170.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 277' ' ' LEU . . . . . . . . . . . . . 4.2 tt -90.78 99.94 12.88 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 107.222 -1.399 . . . . 74.52 107.222 176.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -64.75 -36.09 83.19 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.657 0.783 . . . . 72.2 111.725 -175.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . 92.3 36.03 6.4 Favored Glycine 0 C--N 1.346 1.118 0 CA-C-N 116.263 -0.426 . . . . 75.43 114.05 174.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -155.93 178.49 10.21 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.284 0.634 . . . . 74.31 110.029 172.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -65.47 107.98 1.85 Allowed 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 108.9 -0.778 . . . . 75.31 108.9 176.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -84.41 35.7 0.56 Allowed 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.433 0.901 . . . . 65.41 113.433 -167.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -160.71 -97.08 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 122.785 0.434 . . . . 72.33 110.501 175.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . 144.8 -90.29 0.16 Allowed Glycine 0 C--N 1.355 1.594 0 N-CA-C 111.374 -0.691 . . . . 72.13 111.374 -172.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -146.28 5.92 0.97 Allowed 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 124.15 0.98 . . . . 73.03 111.221 -175.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 286' ' ' MET . . . . . . . . . . . . . 14.8 tpt -60.14 -56.93 30.62 Favored Pre-proline 0 CA--C 1.566 1.576 0 N-CA-C 114.787 1.403 . . . . 74.22 114.787 -165.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 287' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -90.58 35.39 0.32 Allowed 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 122.28 1.987 . . . . 74.24 111.622 -173.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 288' ' ' VAL . . . . . 0.562 HG11 ' H ' ' B' ' 289' ' ' ARG 0.288 7.2 p 41.07 -86.3 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.282 0 C-N-CA 125.941 1.697 . . . . 74.32 111.936 -163.887 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 289' ' ' ARG . . . . . 0.562 ' H ' HG11 ' B' ' 288' ' ' VAL . 7.0 tpm_? 53.41 37.7 26.16 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 122.451 1.119 . . . . 74.32 111.321 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 290' ' ' TRP . . . . . . . . . . . . . 64.7 t90 -63.25 114.72 3.96 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 114.451 -1.25 . . . . 75.34 111.395 -175.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 291' ' ' LEU . . . . . . . . . . . . . 53.9 mt 56.02 -78.25 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 126.799 2.04 . . . . 73.52 113.804 175.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . -176.83 -98.92 0.11 Allowed Glycine 0 CA--C 1.525 0.689 0 CA-C-O 118.741 -1.033 . . . . 71.42 110.777 -178.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.08 87.75 0.24 Allowed 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 122.843 2.362 . . . . 75.13 111.419 172.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 294' ' ' LYS . . . . . 0.568 ' HZ3' ' HB3' ' B' ' 294' ' ' LYS . 8.2 mtpm? -65.42 -32.33 73.89 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 114.799 -1.091 . . . . 74.44 111.287 -177.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -125.29 113.08 17.13 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 123.869 0.867 . . . . 71.35 109.015 171.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 6.4 t -72.57 150.94 42.68 Favored 'General case' 0 C--O 1.244 0.815 0 N-CA-C 109.336 -0.616 . . . . 71.52 109.336 171.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -73.11 -85.26 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 108.805 -0.813 . . . . 75.44 108.805 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 164.53 -158.15 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 126.786 2.034 . . . . 73.43 107.054 -179.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . 98.42 -73.29 0.58 Allowed Glycine 0 C--N 1.337 0.633 0 N-CA-C 111.705 -0.558 . . . . 72.35 111.705 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -98.48 11.37 38.46 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.303 0.641 . . . . 72.23 111.667 -172.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 301' ' ' ILE . . . . . . . . . . . . . 42.8 pt -119.68 12.3 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 C-N-CA 123.131 0.572 . . . . 75.13 111.058 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -91.95 27.2 2.19 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.737 0.815 . . . . 74.32 111.82 -174.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 303' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -66.2 142.81 98.06 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 124.164 0.985 . . . . 74.11 110.364 177.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 304' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -49.04 -23.89 6.84 Favored 'Trans proline' 0 C--N 1.388 2.606 0 C-N-CA 124.787 3.658 . . . . 75.12 116.032 -171.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -59.55 -43.02 93.66 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.612 0.765 . . . . 72.13 112.0 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 28.1 m -111.97 -33.38 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 123.271 0.628 . . . . 72.33 111.24 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 9.8 m 66.74 -74.3 0.07 Allowed 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 126.325 1.85 . . . . 74.23 110.727 -174.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 308' ' ' CYS . . . . . . . . . . . . . 40.9 m -122.34 -20.39 6.15 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.439 0.695 . . . . 74.22 110.281 175.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 309' ' ' THR . . . . . . . . . . . . 0.25 73.5 m 112.9 -59.43 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.14 0 C-N-CA 128.558 2.743 . . . . 72.2 112.021 177.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -90.92 35.77 0.3 Allowed 'Trans proline' 0 C--N 1.394 2.923 0 C-N-CA 122.614 2.21 . . . . 64.44 113.378 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 311' ' ' ASN . . . . . 0.43 ' HB2' ' HD3' ' B' ' 312' ' ' PRO . 11.7 m120 -76.82 -53.79 1.78 Allowed Pre-proline 0 CA--C 1.561 1.37 0 C-N-CA 123.437 0.695 . . . . 73.13 112.014 -178.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 312' ' ' PRO . . . . . 0.545 ' HG2' ' H ' ' B' ' 192' ' ' GLY . 69.6 Cg_endo -95.47 59.06 0.19 Allowed 'Trans proline' 0 C--N 1.385 2.462 0 C-N-CA 122.204 1.936 . . . . 70.14 112.341 -178.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 313' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -71.58 84.4 0.86 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.182 0.593 . . . . 75.13 111.223 178.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 314' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -111.66 75.32 0.91 Allowed 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 107.592 -1.262 . . . . 74.53 107.592 168.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 315' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -155.06 102.55 2.33 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.066 -0.97 . . . . 75.34 108.603 -176.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 316' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -87.49 -49.89 6.9 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.518 -0.919 . . . . 74.4 108.518 172.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 85.0 p 54.64 -74.29 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 126.146 1.778 . . . . 75.41 111.551 -173.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 318' ' ' VAL . . . . . 0.433 HG21 ' HB2' ' B' ' 95' ' ' LYS . 26.5 m 39.79 55.76 6.43 Favored Pre-proline 0 N--CA 1.488 1.448 0 C-N-CA 126.58 1.952 . . . . 73.13 113.724 177.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 319' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -62.81 138.69 70.33 Favored 'Trans proline' 0 C--N 1.387 2.574 0 C-N-CA 122.76 2.307 . . . . 65.1 111.972 -168.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 320' ' ' THR . . . . . . . . . . . . . 52.9 m -149.06 -60.78 0.22 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.411 0.684 . . . . 73.24 110.215 -172.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 321' ' ' LEU . . . . . 0.756 HD13 ' HB2' ' B' ' 323' ' ' GLN . 0.1 OUTLIER -70.26 -56.69 6.14 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.923 0.889 . . . . 74.43 110.305 -171.568 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 322' ' ' ALA . . . . . 0.491 ' HB1' HD21 ' B' ' 102' ' ' LEU . . . 60.16 36.28 21.06 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 124.274 1.03 . . . . 64.54 111.639 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 323' ' ' GLN . . . . . 0.756 ' HB2' HD13 ' B' ' 321' ' ' LEU . 24.2 tp60 -73.91 110.88 8.55 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 108.553 -0.906 . . . . 74.02 108.553 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 324' ' ' MET . . . . . 0.503 ' HG2' ' HA ' ' B' ' 101' ' ' PRO . 76.0 mtm -85.55 41.65 0.91 Allowed 'General case' 0 CA--C 1.556 1.174 0 N-CA-C 113.278 0.844 . . . . 74.22 113.278 -164.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 325' ' ' THR . . . . . . . . . . . . . 57.7 m 70.67 -59.17 0.54 Allowed 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 126.24 1.816 . . . . 72.33 111.654 177.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 326' ' ' ASP . . . . . 0.52 ' HA ' ' NE2' ' B' ' 105' ' ' GLN . 19.7 m-20 75.0 17.33 2.73 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.118 1.367 . . . . 72.01 112.461 171.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -105.1 126.56 52.21 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 108.483 -0.932 . . . . 75.41 108.483 173.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 328' ' ' ALA . . . . . . . . . . . . . . . -142.0 0.15 1.36 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.373 0.669 . . . . 72.03 111.517 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 329' ' ' ILE . . . . . . . . . . . . . 3.0 mp -85.17 106.89 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 N-CA-C 108.96 -0.756 . . . . 73.5 108.96 -170.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 330' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 69.94 130.94 0.03 OUTLIER 'General case' 0 CA--C 1.561 1.387 0 C-N-CA 126.896 2.078 . . . . 74.44 111.826 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 331' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -140.85 18.38 2.32 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.345 1.058 . . . . 64.42 110.861 -172.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -146.12 -163.82 1.82 Allowed 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.324 0.649 . . . . 74.41 111.267 -170.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 333' ' ' SER . . . . . . . . . . . . . 16.0 t 68.1 5.66 4.76 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.291 1.036 . . . . 65.04 113.323 164.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 12.6 ptmt -70.16 -40.55 74.65 Favored 'General case' 0 C--N 1.354 0.796 0 C-N-CA 122.691 0.396 . . . . 65.35 110.448 177.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 335' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 68.32 139.28 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 125.56 1.544 . . . . 74.12 111.686 -177.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 336' ' ' GLU . . . . . 0.506 ' HB2' ' HA ' ' B' ' 118' ' ' PRO . 46.7 mt-10 -135.75 -164.37 1.53 Allowed 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.477 1.111 . . . . 73.55 108.542 176.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 337' ' ' LYS . . . . . 0.457 ' HG3' ' O ' ' B' ' 29' ' ' LEU . 7.8 tmtt? -130.32 132.6 45.94 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 107.201 -1.407 . . . . 71.1 107.201 169.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 338' ' ' GLY . . . . . . . . . . . . . . . -82.36 48.15 3.89 Favored Glycine 0 C--N 1.35 1.308 0 O-C-N 123.302 0.376 . . . . 73.12 113.722 -175.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 339' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -89.68 20.81 3.8 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.897 0.879 . . . . 74.33 109.147 173.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 340' ' ' PHE . . . . . 0.404 ' HA ' ' O ' ' C' ' 158' ' ' VAL . 21.9 m-85 -72.0 -2.11 17.03 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.53 1.132 . . . . 75.24 112.06 -177.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 341' ' ' LEU . . . . . 0.539 HD13 HD22 ' B' ' 139' ' ' ASN . 1.8 tm? -73.52 -51.33 17.41 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.824 0.85 . . . . 75.34 109.08 175.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 342' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 60.35 -130.78 0.9 Allowed 'General case' 0 CA--C 1.565 1.548 0 C-N-CA 124.381 1.072 . . . . 74.32 109.44 -178.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 343' ' ' VAL . . . . . . . . . . . . . 11.6 p -158.78 41.1 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.243 0 CA-C-O 122.425 1.107 . . . . 65.15 108.895 178.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -63.84 143.58 57.73 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 115.042 -0.981 . . . . 74.33 110.96 177.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 345' ' ' GLY . . . . . . . . . . . . . . . -157.68 47.2 0.46 Allowed Glycine 0 C--N 1.345 1.069 0 CA-C-N 115.821 -0.627 . . . . 63.14 111.77 -178.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 346' ' ' ALA . . . . . . . . . . . . . . . -152.04 -81.66 0.1 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.389 0.676 . . . . 72.51 109.52 176.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 62.1 m 59.06 -80.76 0.02 OUTLIER 'General case' 0 C--N 1.365 1.277 0 C-N-CA 124.795 1.238 . . . . 72.21 112.362 -177.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 348' ' ' ILE . . . . . 0.414 ' O ' ' HG2' ' B' ' 351' ' ' GLN . 2.0 pp -102.56 -3.99 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 123.994 0.917 . . . . 73.42 111.847 -176.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 349' ' ' ASP . . . . . . . . . . . . . 31.7 t70 69.54 -78.44 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.698 1.199 . . . . 71.13 109.642 -175.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 350' ' ' LYS . . . . . . . . . . . . . 9.3 mptt -134.17 -67.68 0.58 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.652 -0.869 . . . . 74.52 108.652 167.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 351' ' ' GLN . . . . . 0.414 ' HG2' ' O ' ' B' ' 348' ' ' ILE . 86.7 mm-40 63.4 167.98 0.14 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 125.041 1.336 . . . . 71.32 111.985 -174.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -87.47 -23.32 24.49 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.138 -0.69 . . . . 74.35 109.138 174.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 353' ' ' HIS . . . . . . . . . . . . . 14.5 p80 52.54 18.35 0.95 Allowed 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 126.984 2.114 . . . . 74.33 114.017 173.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 354' ' ' ALA . . . . . 0.448 ' HB2' ' HA3' ' B' ' 162' ' ' GLY . . . -101.32 49.43 0.87 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.796 0.838 . . . . 72.23 110.364 -177.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 355' ' ' ALA . . . . . . . . . . . . . . . -71.6 107.45 4.47 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.135 0.574 . . . . 75.44 110.214 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 356' ' ' ASN . . . . . 0.452 ' HB2' ' H ' ' B' ' 162' ' ' GLY . 0.2 OUTLIER -101.16 120.54 54.8 Favored Pre-proline 0 N--CA 1.48 1.068 0 C-N-CA 123.192 0.597 . . . . 74.32 109.474 -173.571 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 357' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -67.07 150.54 82.43 Favored 'Trans proline' 0 C--N 1.372 1.813 0 C-N-CA 122.817 2.344 . . . . 74.21 111.588 171.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 358' ' ' CYS . . . . . . . . . . . . . 66.0 m -136.05 11.51 3.33 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.561 0.744 . . . . 75.21 111.54 -177.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 359' ' ' GLY . . . . . . . . . . . . . . . -139.43 156.82 24.82 Favored Glycine 0 C--N 1.347 1.186 0 N-CA-C 111.749 -0.54 . . . . 72.04 111.749 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 360' ' ' GLN . . . . . 0.459 ' HB2' ' HD2' ' C' ' 211' ' ' ARG . 23.5 pt20 -164.68 79.79 0.36 Allowed 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 122.791 0.436 . . . . 53.34 111.705 -175.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 361' ' ' ILE . . . . . . . . . . . . . 66.0 mt 69.07 148.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 C-N-CA 124.659 1.183 . . . . 64.41 111.208 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 362' ' ' GLY . . . . . . . . . . . . . . . -119.3 -20.7 3.91 Favored Glycine 0 N--CA 1.472 1.067 0 O-C-N 122.066 -0.396 . . . . 72.35 113.083 172.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 363' ' ' GLU . . . . . 0.551 ' HG2' ' HA ' ' B' ' 201' ' ' PRO . 1.6 mp0 -84.77 -4.2 58.95 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.072 0.949 . . . . 73.13 111.899 -173.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 364' ' ' THR . . . . . . . . . . . . . 61.6 m 73.59 -63.86 0.42 Allowed 'General case' 0 C--N 1.358 0.956 0 C-N-CA 125.602 1.561 . . . . 74.04 109.93 -169.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 76.7 t 70.18 142.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 C-N-CA 124.865 1.266 . . . . 74.51 110.932 -177.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -58.52 141.69 51.18 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.109 0.964 . . . . 52.52 111.459 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 367' ' ' LEU . . . . . . . . . . . . . 7.7 mp -59.95 -27.0 66.43 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.418 1.087 . . . . 75.05 111.455 -177.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 368' ' ' ASP . . . . . . . . . . . . . 31.8 t70 68.3 -75.92 0.06 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.503 1.521 . . . . 73.23 111.312 176.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 369' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 70.42 143.11 0.05 Allowed 'General case' 0 CA--C 1.56 1.346 0 C-N-CA 125.133 1.373 . . . . 74.11 112.06 174.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 370' ' ' ALA . . . . . . . . . . . . . . . -136.06 -174.5 3.69 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.019 0.928 . . . . 74.25 110.02 -177.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 371' ' ' VAL . . . . . . . . . . . . . 47.7 t -64.21 -37.68 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 C-N-CA 123.687 0.795 . . . . 74.12 110.909 -177.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 372' ' ' GLN . . . . . . . . . . . . . 59.9 mm-40 65.97 89.07 0.1 Allowed 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 125.277 1.431 . . . . 63.2 111.115 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 373' ' ' ARG . . . . . 0.64 ' HG3' ' HE2' ' B' ' 377' ' ' PHE . 0.2 OUTLIER -96.06 76.61 3.09 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.591 -0.732 . . . . 72.2 109.605 -177.087 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -160.45 11.18 0.1 Allowed 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.488 -0.778 . . . . 71.45 112.106 -175.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 375' ' ' LEU . . . . . . . . . . . . . 81.9 mt -91.76 9.35 32.99 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.233 0.613 . . . . 72.22 111.341 -174.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -143.86 -22.78 0.57 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.29 1.036 . . . . 73.13 110.362 -178.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 377' ' ' PHE . . . . . 0.64 ' HE2' ' HG3' ' B' ' 373' ' ' ARG . 97.6 m-85 -76.1 91.79 3.15 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 109.274 -0.639 . . . . 73.31 109.274 172.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 378' ' ' ALA . . . . . 0.79 ' HA ' ' HA ' ' B' ' 243' ' ' GLN . . . -129.29 -88.97 0.51 Allowed 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 116.174 -0.466 . . . . 73.45 111.845 -177.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt 60.21 93.46 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.126 0.97 . . . . 73.22 109.194 -168.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 380' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 70.83 171.96 0.31 Allowed 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.774 1.23 . . . . 72.4 110.853 -173.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 381' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -161.07 -53.7 0.05 OUTLIER 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.846 -0.615 . . . . 74.34 111.124 -175.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -166.47 86.89 0.1 OUTLIER Glycine 0 C--N 1.355 1.593 0 C-N-CA 121.596 -0.335 . . . . 73.1 113.872 -175.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 383' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -159.89 -12.27 0.06 Allowed 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 113.615 0.968 . . . . 73.1 113.615 -175.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 384' ' ' THR . . . . . . . . . . . . . 7.0 t -89.53 114.96 26.57 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 118.815 0.734 . . . . 71.44 112.064 -173.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 56.3 mt -93.17 47.51 1.27 Allowed 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.548 0.739 . . . . 75.43 110.093 173.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 386' ' ' VAL . . . . . . . . . . . . . 87.6 t 72.76 -62.64 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 125.44 1.496 . . . . 75.23 111.305 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 387' ' ' ILE . . . . . . . . . . . . . 8.0 tp -55.62 -30.13 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 125.128 1.371 . . . . 74.12 112.613 -177.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 388' ' ' VAL . . . . . . . . . . . . . 57.6 t -62.92 -43.89 99.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.421 0.688 . . . . 74.43 110.922 -177.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 389' ' ' THR . . . . . 0.431 ' HB ' ' HB3' ' B' ' 395' ' ' ALA . 35.4 p -97.38 -11.56 23.83 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.476 0.71 . . . . 71.25 111.677 177.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . 55.13 32.1 17.68 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 125.258 1.423 . . . . 73.41 112.471 178.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 391' ' ' ASP . . . . . . . . . . . . . 20.1 t70 65.87 -78.62 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 125.113 1.365 . . . . 64.12 110.725 -171.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 392' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -139.05 179.52 6.45 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 123.892 0.877 . . . . 72.42 109.883 -177.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . 61.32 23.0 13.29 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 124.211 1.004 . . . . 61.53 111.641 -178.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -166.23 -43.18 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.428 1.091 . . . . 73.31 108.792 -170.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 395' ' ' ALA . . . . . 0.431 ' HB3' ' HB ' ' B' ' 389' ' ' THR . . . -66.17 173.97 2.84 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.934 0.893 . . . . 75.42 112.093 178.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 49.7 m -65.94 -32.39 73.86 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.068 0.547 . . . . 75.55 111.399 176.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 397' ' ' GLN . . . . . 0.454 HE22 ' HB3' ' B' ' 145' ' ' ASP . 0.3 OUTLIER -93.35 107.36 19.2 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 108.26 -1.015 . . . . 75.54 108.26 176.71 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 62.3 mt -134.67 -75.23 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 N-CA-C 107.585 -1.265 . . . . 75.44 107.585 172.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 399' ' ' VAL . . . . . . . . . . . . . 29.2 m -105.39 176.93 0.99 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.699 0 C-N-CA 124.062 0.945 . . . . 73.32 110.046 -177.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 400' ' ' ALA . . . . . . . . . . . . . . . -62.76 -46.27 88.16 Favored Pre-proline 0 CA--C 1.562 1.41 0 CA-C-O 118.285 -0.864 . . . . 74.52 111.327 178.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 401' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.57 53.07 3.86 Favored 'Trans proline' 0 C--N 1.387 2.579 0 C-N-CA 121.939 1.759 . . . . 71.34 112.935 165.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 62.1 -82.06 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 125.644 1.578 . . . . 74.34 112.807 177.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 403' ' ' THR . . . . . . . . . . . . . 18.8 p -129.38 168.44 16.28 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.944 0.898 . . . . 73.2 111.284 -169.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 404' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.32 143.49 42.04 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 114.614 -1.176 . . . . 71.14 108.62 167.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 405' ' ' ALA . . . . . . . . . . . . . . . -69.44 -54.68 10.74 Favored Pre-proline 0 CA--C 1.564 1.508 0 CA-C-O 118.532 -0.747 . . . . 71.24 112.241 -177.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 406' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -83.82 113.91 1.94 Allowed 'Trans proline' 0 C--N 1.393 2.896 0 C-N-CA 122.237 1.958 . . . . 64.23 111.081 -176.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . -54.61 -81.75 0.06 OUTLIER Glycine 0 N--CA 1.478 1.462 0 O-C-N 123.628 0.58 . . . . 74.04 113.825 -174.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 408' ' ' LEU . . . . . . . . . . . . . 29.8 tp -176.06 153.69 1.34 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.082 0.953 . . . . 72.55 108.461 176.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 18.6 p -57.96 -38.03 75.28 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.643 0.777 . . . . 73.52 111.297 178.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 410' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 -132.72 101.96 5.49 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 109.156 -0.683 . . . . 70.42 109.156 169.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . -79.78 -59.85 2.57 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.441 -0.578 . . . . 74.33 109.441 177.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 99.2 mt 58.01 -87.68 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.236 1.414 . . . . 75.21 111.38 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 49.35 80.3 0.07 Allowed 'General case' 0 C--N 1.358 0.943 0 C-N-CA 124.769 1.228 . . . . 71.14 111.396 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 414' ' ' THR . . . . . . . . . . . . . 46.7 m -77.82 79.92 4.29 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 109.018 -0.734 . . . . 73.24 109.018 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 415' ' ' LYS . . . . . . . . . . . . . 57.2 mttp 52.46 46.66 26.26 Favored 'General case' 0 C--N 1.362 1.128 0 CA-C-N 114.389 -1.278 . . . . 75.21 110.816 -177.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 18.0 t70 75.03 -58.08 0.59 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 125.587 1.555 . . . . 75.33 111.266 -173.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 417' ' ' GLY . . . . . . . . . . . . . . . 144.94 -38.66 1.25 Allowed Glycine 0 C--O 1.246 0.889 0 N-CA-C 110.619 -0.992 . . . . 62.31 110.619 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 418' ' ' ALA . . . . . . . . . . . . . . . -72.67 127.44 32.56 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 123.212 0.605 . . . . 70.25 109.723 175.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 419' ' ' VAL . . . . . . . . . . . . . 14.1 m 48.99 35.36 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 C-N-CA 126.013 1.725 . . . . 73.31 112.768 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 420' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.42 -35.64 70.31 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.035 0.934 . . . . 73.34 112.496 -175.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 421' ' ' VAL . . . . . 0.454 HG13 ' HG2' ' A' ' 211' ' ' ARG . 3.4 p -83.65 82.33 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 CA-C-O 122.533 1.159 . . . . 72.42 108.319 170.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 422' ' ' MET . . . . . . . . . . . . . 15.3 ptp -86.61 -14.4 42.85 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 114.436 -1.256 . . . . 74.1 110.75 177.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 423' ' ' SER . . . . . . . . . . . . . 50.0 m 70.29 -71.33 0.13 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 126.081 1.752 . . . . 63.45 112.393 173.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 424' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 56.41 40.21 29.77 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.012 0.925 . . . . 74.22 109.45 -171.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . 87.91 -79.72 1.71 Allowed Glycine 0 C--N 1.346 1.101 0 CA-C-N 114.577 -1.192 . . . . 75.12 110.95 -171.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 426' ' ' ASN . . . . . . . . . . . . . 6.3 t30 64.34 -69.29 0.09 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 125.299 1.44 . . . . 75.43 110.583 -172.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 427' ' ' SER . . . . . 0.467 ' HB2' ' HB3' ' B' ' 432' ' ' GLN . 19.8 m -90.69 150.3 21.71 Favored 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 108.66 -0.867 . . . . 75.14 108.66 170.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -79.72 -52.05 8.44 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 113.729 1.011 . . . . 73.23 113.729 -162.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 429' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -61.15 83.82 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 123.539 0.736 . . . . 63.42 112.52 -169.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 36.9 t70 47.03 58.33 4.89 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 124.953 1.301 . . . . 62.42 110.819 -177.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 40.5 t 76.77 -46.1 0.5 Allowed 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 125.497 1.519 . . . . 75.05 111.324 -173.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 432' ' ' GLN . . . . . 0.467 ' HB3' ' HB2' ' B' ' 427' ' ' SER . 49.5 tp60 76.08 -49.75 0.6 Allowed 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 126.323 1.849 . . . . 71.1 112.112 178.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 433' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -84.1 61.32 6.42 Favored 'General case' 0 C--O 1.243 0.759 0 C-N-CA 123.922 0.889 . . . . 73.43 110.676 -179.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 434' ' ' HIS . . . . . . . . . . . . . 19.9 m170 -74.61 108.18 7.2 Favored 'General case' 0 C--N 1.34 0.193 0 N-CA-C 108.57 -0.9 . . . . 73.42 108.57 175.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 435' ' ' THR . . . . . . . . . . . . . 1.3 m -82.85 1.43 39.3 Favored 'General case' 0 CA--C 1.556 1.182 0 CA-C-N 115.037 -0.983 . . . . 73.42 111.67 -168.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . -176.36 -96.95 0.1 Allowed Glycine 0 C--N 1.352 1.435 0 CA-C-O 119.525 -0.597 . . . . 61.51 111.684 175.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 437' ' ' SER . . . . . 0.534 ' H ' ' HB2' ' A' ' 220' ' ' GLU . 31.1 t 76.48 -9.11 1.54 Allowed 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 125.541 1.536 . . . . 72.35 112.478 178.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 438' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -83.06 -27.9 29.95 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.763 0.825 . . . . 71.55 109.955 178.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 439' ' ' LEU . . . . . . . . . . . . . 5.1 mp -76.85 87.68 3.43 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.516 -0.765 . . . . 74.24 109.457 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 440' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -86.5 162.33 18.13 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.205 0.526 . . . . 74.1 110.632 178.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 441' ' ' ILE . . . . . 0.431 HD11 ' HB ' ' A' ' 221' ' ' VAL . 82.3 mt -133.64 149.38 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 124.276 1.031 . . . . 74.15 110.001 -172.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 442' ' ' ALA . . . . . . . . . . . . . . . -104.94 -77.35 0.58 Allowed 'General case' 0 CA--C 1.553 1.07 0 N-CA-C 109.251 -0.648 . . . . 73.33 109.251 168.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . 56.14 -88.01 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 125.179 1.392 . . . . 74.21 112.221 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -164.14 170.9 15.8 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.187 1.395 . . . . 71.31 108.375 173.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . 134.82 -61.05 0.64 Allowed Glycine 0 N--CA 1.469 0.881 0 N-CA-C 111.759 -0.537 . . . . 74.34 111.759 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 446' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -58.33 105.8 0.23 Allowed 'Trans proline' 0 C--N 1.382 2.311 0 C-N-CA 122.091 1.86 . . . . 72.44 108.886 164.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 447' ' ' HIS . . . . . . . . . . . . . 11.5 t60 -87.31 -29.03 21.91 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 116.229 -0.442 . . . . 63.45 110.258 -173.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . -153.72 25.17 0.51 Allowed 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.247 1.019 . . . . 74.31 109.555 169.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 449' ' ' ALA . . . . . . . . . . . . . . . -107.91 19.02 20.59 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.69 0.796 . . . . 74.42 110.253 178.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 450' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -80.31 89.43 5.52 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.338 -0.846 . . . . 63.22 109.716 -170.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 30.0 m 39.15 70.28 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 C-N-CA 125.807 1.643 . . . . 74.44 113.06 -177.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 452' ' ' VAL . . . . . . . . . . . . . 34.1 m -68.47 -17.73 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 CA-C-N 115.317 -0.856 . . . . 74.24 111.694 -176.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 81.26 60.94 2.16 Favored Glycine 0 C--N 1.348 1.194 0 N-CA-C 110.483 -1.047 . . . . 73.44 110.483 -178.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 454' ' ' LEU . . . . . . . . . . . . . 20.8 tp -94.13 12.27 27.09 Favored 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 123.679 0.792 . . . . 73.13 110.642 -175.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 3.2 m 60.02 21.27 10.39 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 124.592 1.157 . . . . 72.1 110.118 -175.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -78.39 149.27 33.38 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 114.674 -1.148 . . . . 74.3 110.813 -173.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 457' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -143.91 -74.82 0.25 Allowed 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.483 -0.781 . . . . 65.21 109.201 -172.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 17.9 p -147.37 -76.68 0.18 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.523 0.729 . . . . 72.13 111.473 -177.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 459' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -51.5 -93.2 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 125.616 1.566 . . . . 73.31 115.065 -160.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 8.0 mp -89.27 27.14 1.47 Allowed 'General case' 0 N--CA 1.481 1.114 0 O-C-N 121.423 -0.798 . . . . 65.42 109.976 -177.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -101.17 13.07 36.3 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.737 0.815 . . . . 75.0 110.773 -177.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -76.51 87.0 3.22 Favored 'General case' 0 C--N 1.355 0.835 0 N-CA-C 107.958 -1.127 . . . . 72.53 107.958 170.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 34.3 p -106.82 109.58 21.52 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 123.545 0.738 . . . . 71.14 109.835 -178.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 464' ' ' MET . . . . . . . . . . . . . 56.3 ttp -83.82 -59.14 2.52 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 108.717 -0.846 . . . . 75.31 108.717 175.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt 55.31 -83.74 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 125.279 1.432 . . . . 72.15 112.317 178.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -150.17 176.75 10.56 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.657 1.183 . . . . 65.13 109.523 -178.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . -81.31 95.07 6.87 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 109.22 -0.659 . . . . 75.3 109.22 174.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -65.63 92.62 0.15 Allowed 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.072 0.549 . . . . 74.32 109.702 175.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 469' ' ' GLY . . . . . . . . . . . . . . . -155.87 64.76 0.32 Allowed Glycine 0 C--N 1.342 0.897 0 N-CA-C 110.232 -1.147 . . . . 62.03 110.232 -178.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 470' ' ' LEU . . . . . . . . . . . . . 5.6 mp -83.88 63.28 7.45 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.111 0.964 . . . . 75.32 110.5 -175.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 471' ' ' LYS . . . . . . . . . . . . . 88.1 tttt . . . . . 0 CA--C 1.547 0.855 0 N-CA-C 107.97 -1.122 . . . . 74.2 107.97 -178.871 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtm . . . . . 0 N--CA 1.469 0.52 0 N-CA-C 109.029 -0.73 . . . . 70.43 109.029 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 58.02 26.73 13.87 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.482 1.113 . . . . 70.41 112.143 -177.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -89.04 56.25 3.64 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.883 0.873 . . . . 71.34 110.34 -174.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -37.92 100.97 0.02 OUTLIER 'General case' 0 C--N 1.356 0.872 0 C-N-CA 125.778 1.631 . . . . 70.52 113.442 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 5' ' ' LYS . . . . . 0.609 ' HD2' HD11 ' C' ' 10' ' ' ILE . 25.0 mmtp -74.47 101.14 4.04 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 108.943 -0.762 . . . . 72.32 108.943 167.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 6' ' ' ASP . . . . . 0.42 ' HA ' ' OH ' ' C' ' 66' ' ' TYR . 13.5 t70 -73.73 93.12 2.06 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 106.261 -1.755 . . . . 65.15 106.261 168.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 7' ' ' TYR . . . . . 0.46 ' CD1' ' HA ' ' C' ' 53' ' ' ALA . 63.5 m-85 -61.13 -29.37 69.73 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.074 -0.966 . . . . 73.43 111.744 -171.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 8' ' ' TYR . . . . . 0.534 ' HH ' HD13 ' C' ' 22' ' ' ILE . 32.1 m-85 -64.05 -46.08 85.97 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.316 -0.856 . . . . 74.23 111.171 173.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.9 -39.39 94.08 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.103 0.561 . . . . 63.34 111.231 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 10' ' ' ILE . . . . . 0.609 HD11 ' HD2' ' C' ' 5' ' ' LYS . 62.2 mt -57.67 -43.81 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 C-N-CA 123.173 0.589 . . . . 73.31 110.042 174.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 11' ' ' LEU . . . . . 0.452 ' HB3' ' HB1' ' C' ' 25' ' ' ALA . 92.0 mt -82.72 -3.05 55.91 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 115.44 -0.8 . . . . 75.53 112.834 178.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 63.03 34.53 90.22 Favored Glycine 0 C--N 1.355 1.592 0 N-CA-C 114.088 0.395 . . . . 74.43 114.088 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 13' ' ' VAL . . . . . 0.5 HG23 ' HD1' ' C' ' 8' ' ' TYR . 8.3 m -129.38 154.33 80.68 Favored Pre-proline 0 N--CA 1.486 1.362 0 C-N-CA 124.776 1.23 . . . . 71.34 109.456 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -77.24 171.18 18.23 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 122.356 2.037 . . . . 74.43 112.778 -179.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 62.6 mtt180 -80.4 29.05 0.3 Allowed 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.518 0.727 . . . . 74.35 111.682 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -117.17 -15.94 10.43 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 125.659 1.583 . . . . 71.24 108.341 175.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.07 110.21 1.52 Allowed 'General case' 0 C--N 1.354 0.77 0 CA-C-N 114.918 -1.037 . . . . 75.2 110.655 -178.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 41.3 p -74.15 174.9 8.06 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 122.936 0.494 . . . . 74.41 109.857 172.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.93 -44.31 29.82 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 124.772 1.229 . . . . 74.45 111.745 -173.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 20' ' ' GLU . . . . . 0.63 ' HA ' ' HE3' ' C' ' 23' ' ' LYS . 2.3 tm-20 -65.08 -40.43 94.62 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.241 1.016 . . . . 74.53 110.851 -175.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . 0.481 ' HG2' ' NH2' ' C' ' 24' ' ' ARG . 33.6 mt-10 -70.57 -39.39 73.93 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.733 0.813 . . . . 73.42 110.837 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 22' ' ' ILE . . . . . 0.802 HD11 ' HB3' ' C' ' 57' ' ' LEU . 97.0 mt -64.07 -38.18 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.175 1.39 . . . . 75.54 110.368 175.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 23' ' ' LYS . . . . . 0.63 ' HE3' ' HA ' ' C' ' 20' ' ' GLU . 22.1 ttpp -67.76 -35.41 78.67 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.144 1.377 . . . . 74.13 110.438 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 24' ' ' ARG . . . . . 0.481 ' NH2' ' HG2' ' C' ' 21' ' ' GLU . 39.7 mtm180 -73.88 -33.04 63.89 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 115.848 -0.615 . . . . 73.52 112.361 172.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . 0.452 ' HB1' ' HB3' ' C' ' 11' ' ' LEU . . . -63.18 -38.4 91.04 Favored 'General case' 0 C--O 1.251 1.162 0 CA-C-O 121.465 0.65 . . . . 75.32 110.045 174.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 26' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -60.74 -58.46 8.38 Favored 'General case' 0 C--O 1.208 -1.1 0 CA-C-N 113.92 -1.491 . . . . 72.31 109.342 173.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . 0.484 ' HG2' ' HA ' ' B' ' 37' ' ' ASP . 27.5 mtpp -42.92 -52.3 5.2 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 124.042 0.839 . . . . 75.33 111.574 178.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -53.95 -62.65 1.52 Allowed 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.375 -1.284 . . . . 75.55 111.423 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 93.4 mt -84.65 -6.48 59.36 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 112.499 0.555 . . . . 71.43 112.499 -171.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' C' ' 34' ' ' HIS . . . -96.58 -17.07 20.68 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.134 0.574 . . . . 75.32 110.859 179.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 65.3 mtm180 -94.61 -33.08 13.14 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 123.324 0.39 . . . . 73.5 110.219 167.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -69.91 -52.77 21.83 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.042 0.537 . . . . 71.12 109.766 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 33' ' ' TYR . . . . . 0.433 ' HD1' ' HB1' ' C' ' 43' ' ' ALA . 51.2 m-85 -88.37 10.38 20.11 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 119.504 -0.284 . . . . 72.14 111.013 178.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 34' ' ' HIS . . . . . 0.401 ' HB2' ' O ' ' C' ' 30' ' ' ALA . 14.5 t60 -61.11 116.76 20.68 Favored Pre-proline 0 C--N 1.363 1.173 0 CA-C-O 118.325 -0.845 . . . . 74.34 109.788 -178.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -45.46 -53.43 5.5 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 123.901 3.067 . . . . 72.22 114.272 -172.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -56.14 -40.86 74.47 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.332 0.653 . . . . 60.34 112.63 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 62.1 t -80.13 -31.37 13.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 CA-C-N 115.542 -0.754 . . . . 75.33 110.442 -173.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -143.57 74.85 1.45 Allowed 'General case' 0 C--O 1.243 0.752 0 N-CA-C 108.245 -1.02 . . . . 65.41 108.245 -174.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -69.83 79.54 0.46 Allowed 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 114.919 -1.037 . . . . 71.22 109.975 178.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 16.1 m -136.17 102.17 10.03 Favored Pre-proline 0 CA--C 1.537 0.467 0 N-CA-C 107.486 -1.301 . . . . 74.14 107.486 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -32.83 -55.25 0.36 Allowed 'Trans proline' 0 C--N 1.389 2.703 0 C-N-CA 124.796 3.664 . . . . 75.0 115.256 -175.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.4 -40.57 91.43 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.299 0.64 . . . . 71.01 111.079 -178.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 43' ' ' ALA . . . . . 0.433 ' HB1' ' HD1' ' C' ' 33' ' ' TYR . . . -71.54 -24.0 61.86 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.368 0.667 . . . . 71.45 111.205 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -85.81 -28.71 24.31 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.4 -0.592 . . . . 74.04 109.4 -178.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -71.56 -40.87 69.68 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.728 0.811 . . . . 75.44 109.627 170.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 46' ' ' LYS . . . . . 0.523 ' O ' HG12 ' C' ' 50' ' ' ILE . 38.0 mmtm -67.05 -33.18 74.97 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 115.155 -0.93 . . . . 72.32 110.342 173.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -58.58 -46.96 85.84 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.608 0.763 . . . . 71.12 109.376 172.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 48' ' ' LYS . . . . . 0.637 ' HB3' ' HE1' ' C' ' 93' ' ' PHE . 55.4 mtpt -56.58 -42.61 78.95 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 123.894 0.746 . . . . 72.04 110.947 175.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -69.68 -24.58 63.62 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 122.936 0.494 . . . . 72.33 112.187 177.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 50' ' ' ILE . . . . . 0.523 HG12 ' O ' ' C' ' 46' ' ' LYS . 27.6 mm -69.71 -41.58 80.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.793 -0.818 . . . . 75.43 108.793 172.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 51' ' ' ASN . . . . . 0.495 ' HB3' ' CD1' ' C' ' 88' ' ' PHE . 58.7 m-80 -68.37 -32.75 73.05 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-N 114.79 -1.096 . . . . 74.04 111.18 177.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -65.84 -54.07 31.57 Favored 'General case' 0 C--O 1.248 0.988 0 C-N-CA 124.677 1.191 . . . . 75.54 110.317 176.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . 0.46 ' HA ' ' CD1' ' C' ' 7' ' ' TYR . . . -56.6 -51.04 70.17 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-N 113.627 -1.624 . . . . 63.1 111.297 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -64.35 -35.73 81.83 Favored 'General case' 0 C--O 1.197 -1.664 0 CA-C-N 114.874 -1.057 . . . . 75.01 110.528 177.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.97 -44.64 91.55 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 118.378 0.535 . . . . 60.54 111.706 -178.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 86.2 t -68.06 -42.5 85.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 CA-C-O 121.367 0.603 . . . . 72.43 110.432 174.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 57' ' ' LEU . . . . . 0.802 ' HB3' HD11 ' C' ' 22' ' ' ILE . 80.7 mt -93.35 5.13 52.6 Favored 'General case' 0 CA--C 1.563 1.467 0 N-CA-C 113.483 0.92 . . . . 75.02 113.483 -171.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 30.4 t -81.42 -44.24 17.78 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.419 0.688 . . . . 75.33 110.262 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -80.06 128.78 72.47 Favored Pre-proline 0 CA--C 1.515 -0.401 0 CA-C-O 118.246 -0.883 . . . . 72.03 109.08 175.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 60' ' ' PRO . . . . . 0.557 ' O ' ' HG2' ' C' ' 64' ' ' ARG . 87.7 Cg_exo -51.41 -33.11 45.26 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.026 1.817 . . . . 73.21 110.978 162.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . 0.455 ' HB2' ' HB3' ' C' ' 144' ' ' ARG . 8.6 tp10 -61.36 -63.97 1.1 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.424 0.689 . . . . 62.13 111.365 176.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -64.81 -23.92 67.39 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 122.886 0.474 . . . . 75.43 111.336 -177.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 63' ' ' ARG . . . . . 0.481 HH21 ' HB3' ' C' ' 66' ' ' TYR . 2.6 tpm_? -63.98 -50.57 68.04 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.827 0.851 . . . . 74.14 110.115 172.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 64' ' ' ARG . . . . . 0.557 ' HG2' ' O ' ' C' ' 60' ' ' PRO . 28.5 mmm180 -69.62 -25.02 63.74 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 122.369 0.268 . . . . 74.15 110.894 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 66.6 mt -62.97 -46.52 96.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 N-CA-C 109.46 -0.57 . . . . 71.5 109.46 169.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 66' ' ' TYR . . . . . 0.481 ' HB3' HH21 ' C' ' 63' ' ' ARG . 6.5 t80 -58.78 -46.94 86.36 Favored 'General case' 0 CA--C 1.555 1.142 0 CA-C-N 115.33 -0.85 . . . . 74.31 109.809 176.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -56.23 -46.99 79.34 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.869 0.868 . . . . 73.14 111.265 177.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 27.5 p -78.03 -11.85 59.94 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.144 -0.48 . . . . 74.43 111.809 -177.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -73.82 101.63 3.79 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 107.922 -1.14 . . . . 75.22 107.922 173.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 107.77 22.23 7.42 Favored Glycine 0 C--N 1.347 1.172 0 CA-C-N 116.054 -0.521 . . . . 62.51 111.989 -172.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 92.4 m -144.33 -56.72 0.36 Allowed 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 104.233 -2.506 . . . . 72.34 104.233 175.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 21.9 m -78.74 140.35 38.3 Favored 'General case' 0 C--O 1.256 1.437 0 N-CA-C 104.619 -2.363 . . . . 73.35 104.619 156.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.5 -22.95 15.75 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.63 0.772 . . . . 73.23 111.273 -176.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.64 154.69 38.38 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 123.423 0.689 . . . . 53.23 109.594 174.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -58.82 119.98 7.57 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.194 1.93 . . . . 75.14 110.774 168.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.43 121.25 9.7 Favored 'Trans proline' 0 C--N 1.383 2.376 0 C-N-CA 122.732 2.288 . . . . 71.22 110.918 177.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -41.28 127.54 3.02 Favored 'Trans proline' 0 C--N 1.393 2.887 0 C-N-CA 124.119 3.213 . . . . 74.4 114.091 -169.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 78' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -52.22 142.36 46.21 Favored 'Trans proline' 0 C--N 1.391 2.764 0 C-N-CA 123.8 3.0 . . . . 74.44 113.633 -175.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -54.67 162.87 4.36 Favored 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 123.551 2.834 . . . . 70.12 113.67 176.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -53.97 87.38 0.03 OUTLIER 'Trans proline' 0 C--N 1.387 2.567 0 C-N-CA 123.641 2.894 . . . . 74.31 113.007 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 144.58 -49.51 0.68 Allowed Glycine 0 CA--C 1.524 0.627 0 CA-C-N 113.54 -1.664 . . . . 75.2 109.332 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 142.69 -164.1 27.13 Favored Glycine 0 C--N 1.348 1.237 0 CA-C-N 114.807 -0.697 . . . . 75.13 111.669 -177.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -92.52 111.51 23.13 Favored 'General case' 0 C--O 1.245 0.866 0 C-N-CA 123.907 0.883 . . . . 73.4 108.896 171.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -89.38 -174.4 4.36 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 109.409 -0.589 . . . . 75.11 109.409 170.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 85' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -162.56 71.27 0.3 Allowed 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 107.644 -1.243 . . . . 74.41 107.644 176.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 86' ' ' SER . . . . . 0.416 ' OG ' ' HD3' ' C' ' 143' ' ' ARG . 50.5 m -33.73 96.71 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 118.042 2.608 . . . . 52.42 118.042 -166.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 68.16 12.71 63.5 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-N 116.093 -0.503 . . . . 74.34 113.695 173.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 88' ' ' PHE . . . . . 0.495 ' CD1' ' HB3' ' C' ' 51' ' ' ASN . 16.8 m-85 -103.74 150.85 23.67 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 124.271 1.028 . . . . 74.44 108.385 -178.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -83.54 69.31 10.06 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.061 0.458 . . . . 72.23 110.995 -173.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 90' ' ' VAL . . . . . 0.427 HG23 ' CE2' ' C' ' 97' ' ' PHE . 0.8 OUTLIER -43.55 -43.35 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 125.719 1.608 . . . . 54.42 111.945 173.007 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -60.8 -30.77 70.26 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 114.787 -1.097 . . . . 75.25 111.641 -172.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -110.85 4.86 20.16 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.107 0.563 . . . . 75.53 111.289 -176.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 93' ' ' PHE . . . . . 0.637 ' HE1' ' HB3' ' C' ' 48' ' ' LYS . 10.5 m-30 -79.84 -177.14 5.79 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.841 -0.537 . . . . 72.45 112.302 -178.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 96.6 p -67.15 161.18 25.23 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.631 0.975 . . . . 52.11 113.631 -165.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -57.81 -56.08 26.53 Favored 'General case' 0 C--O 1.217 -0.641 0 CA-C-N 113.902 -1.499 . . . . 72.35 110.356 176.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -50.88 -45.27 60.03 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.868 0.867 . . . . 74.24 112.226 -176.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 97' ' ' PHE . . . . . 0.427 ' CE2' HG23 ' C' ' 90' ' ' VAL . 7.5 t80 -58.17 -53.18 61.21 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 115.23 -0.895 . . . . 64.25 110.214 174.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -77.49 4.38 11.23 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 122.707 0.403 . . . . 71.33 112.047 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -98.47 -45.54 6.08 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.534 0.733 . . . . 74.43 110.663 170.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 22.9 tp -78.65 -56.34 4.5 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.169 0.588 . . . . 73.23 110.281 -178.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 101' ' ' PHE . . . . . 0.472 ' O ' ' HG ' ' C' ' 105' ' ' LEU . 90.4 m-85 -85.26 -15.52 43.19 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.346 -0.843 . . . . 75.04 111.257 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -46.49 -54.78 8.47 Favored Glycine 0 CA--C 1.545 1.932 0 CA-C-O 118.941 -0.922 . . . . 74.41 114.951 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_exo -45.01 -24.5 1.32 Allowed 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 124.681 3.587 . . . . 64.35 116.434 175.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -128.58 14.56 6.09 Favored Glycine 0 C--N 1.355 1.633 0 CA-C-O 118.605 -1.108 . . . . 73.42 114.237 -178.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 105' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' C' ' 101' ' ' PHE . 49.3 mt -70.54 74.03 0.54 Allowed 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 118.247 1.024 . . . . 75.43 112.246 177.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 106' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 35.41 -103.93 0.03 OUTLIER 'General case' 0 CA--C 1.563 1.473 0 C-N-CA 125.496 1.519 . . . . 64.24 114.788 174.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . 61.16 28.74 69.56 Favored Glycine 0 C--N 1.363 2.056 0 N-CA-C 111.266 -0.734 . . . . 51.05 111.266 -163.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 68.44 -94.34 0.33 Allowed Glycine 0 C--N 1.348 1.247 0 N-CA-C 108.842 -1.703 . . . . 74.41 108.842 -163.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 109' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -136.47 5.21 2.93 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 124.165 0.986 . . . . 74.45 110.056 168.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 110' ' ' GLY . . . . . . . . . . . . . . . -92.91 -6.3 63.62 Favored Glycine 0 C--N 1.347 1.159 0 CA-C-N 115.857 -0.611 . . . . 73.14 113.449 175.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 52.77 18.47 1.04 Allowed 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 124.962 1.305 . . . . 75.25 113.441 174.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.84 -35.86 71.49 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.534 0.734 . . . . 75.43 110.378 167.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 113' ' ' SER . . . . . . . . . . . . . 50.7 m 75.69 48.85 0.08 Allowed 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 125.976 1.711 . . . . 72.53 110.993 -170.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 114' ' ' ARG . . . . . 0.424 ' HG2' ' N ' ' C' ' 115' ' ' LYS . 64.5 ttt-85 -69.86 159.56 33.42 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 115.565 -0.743 . . . . 74.05 109.733 176.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 115' ' ' LYS . . . . . 0.564 ' HA ' ' HD2' ' C' ' 170' ' ' PRO . 3.9 ttmt -61.15 135.87 57.89 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 118.971 0.805 . . . . 74.15 111.836 -177.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -84.18 128.18 8.49 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-N 114.962 -1.017 . . . . 54.4 113.269 -176.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 117' ' ' ARG . . . . . 0.451 ' HG2' ' H ' ' C' ' 118' ' ' ASP . 46.3 ttt-85 -82.98 174.67 10.69 Favored 'General case' 0 C--O 1.25 1.08 0 C-N-CA 123.459 0.704 . . . . 74.32 109.523 175.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 118' ' ' ASP . . . . . 0.451 ' H ' ' HG2' ' C' ' 117' ' ' ARG . 5.0 p-10 -64.52 151.76 43.62 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 121.59 0.709 . . . . 75.42 110.985 173.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 119' ' ' LEU . . . . . . . . . . . . . 61.1 tp -108.17 164.04 12.65 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 106.828 -1.545 . . . . 75.21 106.828 172.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 74.0 ttt-85 -138.69 120.94 15.85 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 118.665 0.666 . . . . 72.31 109.654 177.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 121' ' ' ALA . . . . . 0.419 ' HB1' HD11 ' C' ' 174' ' ' LEU . . . -140.84 118.81 11.85 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.28 1.032 . . . . 75.44 108.827 -178.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 122' ' ' GLU . . . . . 0.668 ' HG2' HG22 ' B' ' 186' ' ' THR . 13.6 pt-20 -102.05 147.6 26.39 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 110.317 -0.253 . . . . 74.12 110.317 178.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 123' ' ' LEU . . . . . 0.401 ' HB3' ' HB3' ' B' ' 183' ' ' ALA . 1.9 pt? -134.98 144.94 52.46 Favored Pre-proline 0 N--CA 1.478 0.954 0 C-N-CA 122.998 0.519 . . . . 73.3 111.237 -173.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.4 116.39 4.1 Favored 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 123.011 2.474 . . . . 72.51 110.076 165.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 125' ' ' LEU . . . . . 0.403 ' O ' ' HA ' ' C' ' 180' ' ' LEU . 38.4 tp -133.1 149.55 52.12 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.928 0.891 . . . . 75.32 108.687 -176.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 126' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.26 157.12 16.03 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 122.635 0.374 . . . . 61.53 110.775 -176.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 127' ' ' LEU . . . . . 0.54 HD11 ' CD2' ' C' ' 186' ' ' PHE . 17.9 mt -58.31 -47.02 85.03 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.809 1.244 . . . . 62.25 110.201 173.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 128' ' ' GLU . . . . . 0.428 ' HG3' ' HA ' ' C' ' 215' ' ' LEU . 1.8 mp0 -63.0 -38.08 89.77 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 114.267 -1.333 . . . . 75.24 110.903 178.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -79.54 -17.47 53.94 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 122.749 0.42 . . . . 75.51 111.707 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -75.37 -40.76 57.72 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 109.193 -0.669 . . . . 73.14 109.193 171.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 131' ' ' PHE . . . . . 0.533 ' HB2' HD11 ' C' ' 215' ' ' LEU . 69.2 t80 -62.38 -35.77 80.2 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.61 1.564 . . . . 75.55 111.91 172.007 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 132' ' ' HIS . . . . . . . . . . . . . 43.7 m170 -77.07 -51.31 11.27 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 110.318 -0.253 . . . . 70.15 110.318 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 50.55 -129.29 29.37 Favored Glycine 0 C--N 1.351 1.411 0 O-C-N 124.306 1.004 . . . . 65.31 113.894 177.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.29 -147.51 33.08 Favored Glycine 0 C--N 1.348 1.233 0 C-N-CA 123.128 0.394 . . . . 73.12 113.483 174.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -92.79 110.26 21.7 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.866 0.867 . . . . 73.03 109.898 -177.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 136' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -117.52 135.51 53.89 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.184 0.994 . . . . 72.12 110.152 -174.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 137' ' ' VAL . . . . . 0.467 HG12 ' HG ' ' C' ' 146' ' ' SER . 35.8 m -76.86 143.98 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 122.644 0.378 . . . . 73.11 111.574 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 138' ' ' VAL . . . . . 0.59 ' HA ' HG21 ' B' ' 182' ' ' VAL . 7.4 p -158.93 139.7 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.28 1.032 . . . . 72.14 108.981 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 139' ' ' GLU . . . . . 0.471 ' HA ' ' O ' ' C' ' 143' ' ' ARG . 0.0 OUTLIER -123.8 94.84 4.35 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.559 0.743 . . . . 74.31 110.621 176.112 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 140' ' ' VAL . . . . . . . . . . . . . 11.5 p -147.77 139.85 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 122.977 0.511 . . . . 73.25 111.154 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 61.36 15.58 6.68 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 125.001 1.32 . . . . 65.0 113.72 173.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 114.4 -26.64 9.5 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-N 116.489 -0.323 . . . . 52.4 112.602 -178.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 143' ' ' ARG . . . . . 0.471 ' O ' ' HA ' ' C' ' 139' ' ' GLU . 7.7 mmm180 -80.34 101.16 8.79 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.182 0.593 . . . . 75.05 111.593 178.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 144' ' ' ARG . . . . . 0.455 ' HB3' ' HB2' ' C' ' 61' ' ' GLU . 75.2 ttt180 -109.87 89.79 3.12 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 107.402 -1.333 . . . . 71.51 107.402 169.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 145' ' ' VAL . . . . . . . . . . . . . 12.6 p -161.05 163.8 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.904 0 C-N-CA 123.369 0.668 . . . . 75.03 111.26 -166.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 146' ' ' SER . . . . . 0.467 ' HG ' HG12 ' C' ' 137' ' ' VAL . 20.3 m -85.99 113.26 21.94 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 123.898 0.879 . . . . 73.22 109.972 168.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 3.9 p -89.18 129.45 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.477 0.711 . . . . 72.53 110.192 175.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 42.9 ttt180 -86.59 95.07 9.63 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.152 0.581 . . . . 74.22 109.846 178.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 149' ' ' ILE . . . . . . . . . . . . . 40.7 pt -116.53 107.02 47.53 Favored Pre-proline 0 CA--C 1.546 0.827 0 N-CA-C 108.209 -1.034 . . . . 74.42 108.209 165.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -54.2 167.4 1.25 Allowed 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 123.075 2.516 . . . . 61.44 114.005 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -47.69 115.06 1.27 Allowed 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 123.062 2.508 . . . . 73.2 113.063 171.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 152' ' ' GLY . . . . . . . . . . . . . . . 150.43 88.45 0.07 OUTLIER Glycine 0 C--N 1.344 1.021 0 C-N-CA 120.441 -0.885 . . . . 63.11 114.527 -178.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 153' ' ' VAL . . . . . 0.557 HG22 HG12 ' C' ' 178' ' ' VAL . 14.0 p -165.26 151.83 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.201 0 C-N-CA 122.885 0.474 . . . . 74.01 110.001 173.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 154' ' ' ARG . . . . . 0.539 ' HD2' ' HG2' ' C' ' 187' ' ' ARG . 37.4 ttp180 -150.55 149.18 29.59 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.182 0.993 . . . . 75.32 109.819 -170.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 155' ' ' GLU . . . . . 0.54 ' HG3' ' HG ' ' B' ' 132' ' ' SER . 10.4 tp10 -42.3 129.8 3.81 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 125.288 1.435 . . . . 74.51 112.849 -177.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.87 -13.72 58.42 Favored Glycine 0 C--N 1.348 1.219 0 CA-C-N 115.753 -0.658 . . . . 75.21 113.238 177.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 157' ' ' SER . . . . . 0.505 ' O ' HG11 ' C' ' 178' ' ' VAL . 43.8 t -74.8 140.43 43.97 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 108.832 -0.803 . . . . 75.43 108.832 174.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 158' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' B' ' 340' ' ' PHE . 58.6 t -119.73 105.84 18.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.629 -0.714 . . . . 72.31 109.266 -173.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 159' ' ' ILE . . . . . 0.68 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 15.3 mt -72.06 97.16 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.66 0 CA-C-N 114.805 -1.089 . . . . 72.31 108.954 -177.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 7.2 ttt180 -78.96 97.61 6.11 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 107.673 -1.232 . . . . 75.13 107.673 175.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 161' ' ' VAL . . . . . . . . . . . . . 2.2 p -101.53 103.99 31.22 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 124.457 1.103 . . . . 75.24 108.734 -178.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 162' ' ' PRO . . . . . 0.424 ' HG2' ' HB3' ' B' ' 33' ' ' ALA . 54.1 Cg_exo -55.36 123.98 15.16 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 123.407 2.738 . . . . 75.23 114.207 -173.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 163' ' ' GLY . . . . . 0.655 ' H ' ' HA ' ' C' ' 173' ' ' ASP . . . 89.79 -10.13 74.8 Favored Glycine 0 N--CA 1.441 -1.003 0 N-CA-C 117.236 1.654 . . . . 53.54 117.236 169.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 164' ' ' MET . . . . . 0.493 ' SD ' HD22 ' C' ' 174' ' ' LEU . 46.9 ttm -75.12 -13.23 60.46 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 119.954 1.877 . . . . 73.35 111.028 -177.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . -102.75 -117.12 4.27 Favored Glycine 0 C--N 1.347 1.156 0 CA-C-O 119.368 -0.685 . . . . 73.32 111.691 173.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 166' ' ' GLY . . . . . 0.521 ' HA3' ' HA ' ' C' ' 171' ' ' PRO . . . 87.44 68.86 1.31 Allowed Glycine 0 C--N 1.358 1.766 0 CA-C-N 117.781 0.791 . . . . 75.44 113.7 176.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 167' ' ' GLN . . . . . . . . . . . . . 19.9 mm-40 -80.14 100.21 8.13 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 106.97 -1.493 . . . . 74.2 106.97 173.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . 150.51 -89.23 0.14 Allowed Glycine 0 C--O 1.213 -1.167 0 CA-C-O 118.295 -1.281 . . . . 13.44 110.014 -168.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 169' ' ' ASN . . . . . 0.533 ' HB3' ' HD3' ' C' ' 170' ' ' PRO . 2.9 t-20 -176.36 -59.95 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.706 0 CA-C-O 117.165 -1.398 . . . . 62.44 112.216 164.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 170' ' ' PRO . . . . . 0.564 ' HD2' ' HA ' ' C' ' 115' ' ' LYS . 32.4 Cg_exo -61.52 98.91 0.16 Allowed 'Trans proline' 0 C--N 1.402 3.345 0 CA-C-N 122.446 1.909 . . . . 73.55 110.418 165.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 171' ' ' PRO . . . . . 0.53 ' HB2' ' HA2' ' C' ' 163' ' ' GLY . 7.5 Cg_exo -72.33 120.55 6.83 Favored 'Trans proline' 0 C--N 1.362 1.289 0 C-N-CA 122.34 2.027 . . . . 74.02 113.118 -163.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -63.78 -73.3 0.56 Allowed Glycine 0 C--N 1.347 1.164 0 O-C-N 124.029 0.831 . . . . 74.42 111.701 175.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 173' ' ' ASP . . . . . 0.655 ' HA ' ' H ' ' C' ' 163' ' ' GLY . 5.4 p-10 -170.46 175.99 4.56 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.245 0.545 . . . . 74.51 111.828 -179.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 174' ' ' LEU . . . . . 0.493 HD22 ' SD ' ' C' ' 164' ' ' MET . 11.2 tp -120.87 136.16 55.0 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 114.633 -1.167 . . . . 75.22 108.254 168.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 81.7 mt -98.88 88.92 4.14 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.659 1.184 . . . . 72.15 109.449 176.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 176' ' ' LEU . . . . . 0.68 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 78.8 mt -75.3 94.73 3.06 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.303 0.641 . . . . 74.33 110.012 174.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 177' ' ' VAL . . . . . . . . . . . . . 23.5 t -84.62 114.72 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 108.597 -0.89 . . . . 75.23 108.597 -178.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 178' ' ' VAL . . . . . 0.557 HG12 HG22 ' C' ' 153' ' ' VAL . 8.4 p -82.12 126.04 39.88 Favored 'Isoleucine or valine' 0 C--O 1.251 1.15 0 CA-C-O 121.941 0.877 . . . . 74.01 110.822 -176.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 179' ' ' ARG . . . . . . . . . . . . . 24.3 mmt180 -113.82 111.09 21.18 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.188 -1.412 . . . . 74.42 107.188 170.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 180' ' ' LEU . . . . . 0.403 ' HA ' ' O ' ' C' ' 125' ' ' LEU . 93.1 mt -73.29 148.52 43.5 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.86 0.362 . . . . 73.43 110.906 -177.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 181' ' ' LEU . . . . . 0.42 ' HB3' ' HD2' ' C' ' 182' ' ' PRO . 24.9 mt -62.12 166.29 6.84 Favored Pre-proline 0 CA--C 1.564 1.483 0 C-N-CA 124.405 1.082 . . . . 74.24 111.899 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 182' ' ' PRO . . . . . 0.42 ' HD2' ' HB3' ' C' ' 181' ' ' LEU . 12.1 Cg_exo -33.95 -20.84 0.02 OUTLIER 'Trans proline' 0 C--N 1.396 3.068 1 C-N-CA 125.413 4.075 . . . . 73.32 118.26 179.329 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 183' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -104.85 96.8 11.34 Favored Pre-proline 0 CA--C 1.568 1.644 0 CA-C-N 119.14 0.882 . . . . 72.0 110.147 165.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 184' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -98.14 65.91 0.09 OUTLIER 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 123.658 2.905 . . . . 74.25 110.575 171.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 185' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 36.9 t -94.02 -43.44 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 CA-C-N 115.952 -0.567 . . . . 72.23 110.611 -164.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 186' ' ' PHE . . . . . 0.54 ' CD2' HD11 ' C' ' 127' ' ' LEU . 68.1 m-85 -99.9 116.55 32.23 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-O 121.205 0.526 . . . . 61.44 111.345 -167.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 187' ' ' ARG . . . . . 0.677 ' HB3' ' HB3' ' C' ' 194' ' ' TYR . 3.2 tmt_? -96.12 107.91 20.28 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.997 1.319 . . . . 75.14 108.919 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 188' ' ' LEU . . . . . . . . . . . . . 45.8 tp -84.16 140.92 31.42 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.445 0.535 . . . . 74.14 112.445 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -144.97 106.28 4.21 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 107.069 -1.456 . . . . 73.21 107.069 162.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 74.96 -96.43 0.96 Allowed Glycine 0 C--N 1.355 1.633 0 N-CA-C 112.022 -0.431 . . . . 74.2 112.022 -177.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 191' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -115.19 -31.28 6.06 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.108 0.963 . . . . 75.25 110.154 173.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -76.97 152.66 35.15 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 116.072 -0.513 . . . . 65.13 111.551 -170.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 193' ' ' LEU . . . . . 0.458 HD21 ' CD1' ' C' ' 240' ' ' PHE . 88.1 mt -119.82 165.59 14.38 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.735 0.814 . . . . 65.15 111.257 -176.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 194' ' ' TYR . . . . . 0.677 ' HB3' ' HB3' ' C' ' 187' ' ' ARG . 27.5 t80 -139.47 107.3 5.66 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.097 -0.956 . . . . 75.43 109.585 170.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 195' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' C' ' 185' ' ' VAL . . . -104.67 -174.99 2.67 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.22 1.008 . . . . 65.11 110.907 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 196' ' ' THR . . . . . 0.417 HG21 ' HA ' ' B' ' 159' ' ' LYS . 65.9 m -132.11 121.09 23.24 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 108.088 -1.079 . . . . 53.42 108.088 164.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 197' ' ' LEU . . . . . . . . . . . . . 41.0 tp -97.53 125.86 42.48 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.292 0.637 . . . . 73.5 111.183 -172.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -73.84 101.85 3.88 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.005 0.922 . . . . 64.33 108.87 176.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 199' ' ' VAL . . . . . 0.558 ' HA ' HG12 ' C' ' 210' ' ' VAL . 26.9 t -121.72 109.28 34.37 Favored Pre-proline 0 N--CA 1.475 0.812 0 N-CA-C 108.62 -0.881 . . . . 73.12 108.62 178.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 200' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -68.45 147.13 70.49 Favored 'Trans proline' 0 C--N 1.37 1.702 0 C-N-CA 121.588 1.526 . . . . 73.11 111.317 175.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 201' ' ' ALA . . . . . 0.473 ' O ' HG21 ' C' ' 205' ' ' VAL . . . -52.44 -49.24 86.65 Favored Pre-proline 0 CA--C 1.553 1.07 0 CA-C-O 118.02 -0.99 . . . . 74.35 112.958 -173.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 202' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -51.12 -47.27 26.58 Favored 'Trans proline' 0 C--N 1.387 2.6 0 C-N-CA 121.649 1.566 . . . . 63.15 112.891 176.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 203' ' ' ILE . . . . . 0.497 ' HA ' HG13 ' C' ' 206' ' ' VAL . 47.0 mt -68.56 -34.18 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 123.044 0.538 . . . . 74.02 111.139 -178.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -70.24 -28.45 65.26 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.659 0.783 . . . . 75.02 112.208 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 205' ' ' VAL . . . . . 0.473 HG21 ' O ' ' C' ' 201' ' ' ALA . 55.0 t -86.39 -40.1 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 116.084 -0.507 . . . . 74.52 111.374 178.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 206' ' ' VAL . . . . . 0.597 HG23 ' HG3' ' A' ' 270' ' ' LYS . 14.0 p -80.16 -37.83 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 O-C-N 123.375 0.422 . . . . 74.12 111.355 -171.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 88.08 61.6 1.48 Allowed Glycine 0 N--CA 1.438 -1.177 0 CA-C-N 115.741 -0.663 . . . . 63.21 112.257 -168.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -101.38 -136.65 9.39 Favored Glycine 0 C--O 1.246 0.882 0 N-CA-C 111.431 -0.668 . . . . 51.32 111.431 176.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 209' ' ' LYS . . . . . 0.665 ' HE2' ' HG3' ' B' ' 235' ' ' GLU . 8.3 mtmp? -140.28 136.3 33.15 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.395 0.617 . . . . 72.44 110.92 178.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 210' ' ' VAL . . . . . 0.558 HG12 ' HA ' ' C' ' 199' ' ' VAL . 34.3 m -119.24 -179.86 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.539 1.535 . . . . 71.52 107.272 169.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 211' ' ' ARG . . . . . 0.61 ' HD3' ' HB2' ' C' ' 218' ' ' PRO . 23.1 ttm105 -132.76 130.6 40.15 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 118.976 0.807 . . . . 75.53 112.095 -178.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -97.0 115.05 26.74 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.32 1.048 . . . . 74.43 108.492 168.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 213' ' ' MET . . . . . 0.456 ' HA ' ' HA ' ' C' ' 218' ' ' PRO . 4.2 tmm? -71.56 101.91 2.6 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 107.418 -1.327 . . . . 63.12 107.418 171.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.88 174.25 6.46 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.348 0.594 . . . . 72.34 110.234 -173.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 215' ' ' LEU . . . . . 0.533 HD11 ' HB2' ' C' ' 131' ' ' PHE . 30.7 mt -65.48 -33.89 77.0 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.309 1.444 . . . . 75.24 112.712 -169.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.23 10.71 23.7 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 114.94 -1.027 . . . . 71.0 111.472 -178.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 143.65 149.37 5.08 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-O 119.86 -0.411 . . . . 74.41 112.453 176.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 218' ' ' PRO . . . . . 0.61 ' HB2' ' HD3' ' C' ' 211' ' ' ARG . 73.3 Cg_endo -77.24 106.42 2.23 Favored 'Trans proline' 0 CA--C 1.557 1.634 0 C-N-CA 122.606 2.204 . . . . 64.03 113.081 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 219' ' ' VAL . . . . . . . . . . . . . 7.2 p -88.32 138.26 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 123.558 0.743 . . . . 52.53 109.903 -178.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 220' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -89.01 111.21 21.88 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 108.734 -0.839 . . . . 72.32 108.734 174.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 221' ' ' VAL . . . . . . . . . . . . . 58.7 t -78.97 128.09 38.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 114.539 -1.209 . . . . 74.03 110.627 -178.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 222' ' ' ALA . . . . . 0.703 ' H ' ' HB2' ' B' ' 239' ' ' ALA . . . -85.42 105.48 16.08 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 124.424 1.09 . . . . 73.3 109.678 176.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 59.1 t -85.71 126.73 65.33 Favored Pre-proline 0 C--O 1.213 -0.858 0 N-CA-C 108.105 -1.072 . . . . 73.11 108.105 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 224' ' ' PRO . . . . . 0.723 ' HG2' ' HG3' ' B' ' 243' ' ' GLN . 10.4 Cg_exo -79.09 156.77 26.48 Favored 'Trans proline' 0 CA--C 1.555 1.546 0 C-N-CA 123.847 3.031 . . . . 73.11 112.221 166.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.43 148.17 64.02 Favored 'Trans proline' 0 C--N 1.387 2.587 0 C-N-CA 123.208 2.605 . . . . 74.4 113.635 -178.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 226' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.5 91.64 0.08 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.229 1.011 . . . . 71.5 112.215 178.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 227' ' ' THR . . . . . 0.482 HG23 HG11 ' C' ' 253' ' ' VAL . 34.0 m -140.9 124.46 16.85 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 115.37 -0.832 . . . . 73.3 111.869 176.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 228' ' ' GLN . . . . . 0.419 HE21 HG13 ' A' ' 257' ' ' ILE . 27.1 mp0 -98.11 161.39 13.74 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-O 122.483 1.135 . . . . 74.32 111.024 170.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -67.85 150.04 49.08 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-N 113.729 -1.578 . . . . 65.31 109.375 173.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 86.46 -4.17 86.38 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.304 -0.474 . . . . 62.04 113.03 -174.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 231' ' ' ARG . . . . . 0.438 ' NH1' HE22 ' B' ' 243' ' ' GLN . 45.5 mtt180 -76.65 170.34 16.61 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 117.789 0.794 . . . . 75.03 109.334 163.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 232' ' ' LYS . . . . . 0.652 ' HZ1' ' HB2' ' C' ' 232' ' ' LYS . 3.9 ttmp? -146.55 139.68 25.58 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.205 0.457 . . . . 74.05 111.921 -173.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 233' ' ' LEU . . . . . 0.577 ' O ' ' HA ' ' C' ' 250' ' ' TYR . 2.4 mp -107.77 151.79 25.23 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.625 1.17 . . . . 74.22 109.89 -177.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -118.83 90.18 3.28 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.638 0.775 . . . . 72.34 109.255 171.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 235' ' ' LEU . . . . . 0.507 ' HB2' ' HB3' ' C' ' 249' ' ' LEU . 49.1 mt -74.25 108.39 7.01 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 109.13 -0.693 . . . . 74.34 109.13 172.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -71.08 125.57 27.25 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.879 0.872 . . . . 73.41 111.125 -175.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 71.44 37.14 62.66 Favored Glycine 0 C--N 1.349 1.251 0 O-C-N 123.532 0.52 . . . . 71.42 112.968 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 20.4 mmtm -126.07 14.95 7.9 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.913 0.885 . . . . 75.11 111.065 176.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -93.0 -167.48 38.91 Favored Glycine 0 C--N 1.352 1.449 0 N-CA-C 112.002 -0.439 . . . . 75.2 112.002 171.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 240' ' ' PHE . . . . . 0.458 ' CD1' HD21 ' C' ' 193' ' ' LEU . 3.6 m-85 -69.06 153.45 96.06 Favored Pre-proline 0 N--CA 1.478 0.96 0 C-N-CA 123.74 0.816 . . . . 75.14 111.529 176.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 241' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -65.91 118.86 5.85 Favored 'Trans proline' 0 C--N 1.377 2.054 0 C-N-CA 123.75 2.967 . . . . 71.53 112.411 -175.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -126.84 -169.52 12.74 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-N 115.719 -0.673 . . . . 70.14 112.548 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 243' ' ' PRO . . . . . 0.73 ' HA ' ' HA ' ' B' ' 111' ' ' LEU . 2.0 Cg_endo -72.14 -31.61 11.84 Favored 'Trans proline' 0 C--N 1.383 2.344 0 C-N-CA 123.049 2.5 . . . . 71.42 111.006 -178.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -80.35 6.35 12.34 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.82 0.848 . . . . 71.42 111.807 176.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 111.04 -76.56 0.22 Allowed Glycine 0 C--N 1.349 1.285 0 N-CA-C 109.907 -1.277 . . . . 63.24 109.907 -178.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 246' ' ' ARG . . . . . . . . . . . . . 29.4 mtm180 -146.09 166.44 26.12 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.847 1.259 . . . . 71.32 109.468 174.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -80.57 -158.89 19.53 Favored Glycine 0 C--N 1.347 1.172 0 CA-C-N 116.345 -0.388 . . . . 63.23 112.241 172.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -123.82 135.24 53.65 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 117.085 0.443 . . . . 73.54 109.836 -177.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 249' ' ' LEU . . . . . 0.507 ' HB3' ' HB2' ' C' ' 235' ' ' LEU . 21.0 tp -88.33 116.15 26.35 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 114.97 -1.014 . . . . 74.23 110.133 -178.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 250' ' ' TYR . . . . . 0.577 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 16.0 m-85 -102.05 99.87 10.07 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 109.838 -0.431 . . . . 71.43 109.838 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 251' ' ' LEU . . . . . 0.552 ' HB2' HD13 ' C' ' 233' ' ' LEU . 1.6 mp -97.15 136.2 38.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.8 -0.563 . . . . 72.0 110.152 -174.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 252' ' ' GLU . . . . . 0.592 ' HG2' ' HB3' ' B' ' 157' ' ' MET . 4.9 tp10 -88.14 118.71 27.91 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 108.047 -1.094 . . . . 75.41 108.047 174.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 253' ' ' VAL . . . . . 0.482 HG11 HG23 ' C' ' 227' ' ' THR . 94.0 t -60.14 131.14 24.66 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 123.348 0.659 . . . . 73.5 111.066 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 254' ' ' ARG . . . . . 0.468 ' CZ ' ' HB ' ' C' ' 256' ' ' THR . 2.1 tmm_? -124.02 98.32 5.74 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 107.507 -1.294 . . . . 75.13 107.507 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 255' ' ' ILE . . . . . 0.443 ' HA ' ' O ' ' C' ' 199' ' ' VAL . 52.0 mm -72.45 120.4 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 123.356 0.41 . . . . 75.24 109.903 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 256' ' ' THR . . . . . 0.468 ' HB ' ' CZ ' ' C' ' 254' ' ' ARG . 0.0 OUTLIER -125.39 164.46 20.38 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.012 0.925 . . . . 70.25 111.1 -176.131 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 2.8 pp -137.61 149.07 63.76 Favored Pre-proline 0 CA--C 1.554 1.099 0 C-N-CA 124.224 1.01 . . . . 75.21 108.328 175.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -80.11 16.52 1.49 Allowed 'Trans proline' 0 C--N 1.375 1.936 0 C-N-CA 122.599 2.2 . . . . 74.41 113.243 -171.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 57.83 -79.87 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.237 1.415 . . . . 72.3 111.635 -173.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -78.53 148.13 33.52 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.97 0.908 . . . . 73.41 109.901 -178.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 261' ' ' LEU . . . . . . . . . . . . . 82.1 mt -132.88 165.59 24.27 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 121.524 0.678 . . . . 74.53 111.329 -178.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 1.6 p -83.61 147.4 52.27 Favored Pre-proline 0 CA--C 1.552 1.035 0 CA-C-N 114.635 -1.166 . . . . 61.23 108.894 164.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -47.73 -31.63 15.1 Favored 'Trans proline' 0 C--N 1.387 2.558 0 C-N-CA 124.476 3.451 . . . . 74.2 114.988 -173.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -60.43 -65.76 0.63 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.88 0.872 . . . . 71.04 109.73 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -57.67 -42.56 83.82 Favored 'General case' 0 C--O 1.216 -0.697 0 CA-C-N 114.466 -1.243 . . . . 71.03 109.767 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 266' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -51.82 -46.12 64.19 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 123.992 0.917 . . . . 73.1 110.718 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -67.81 -43.67 79.08 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.5 0.72 . . . . 71.12 112.05 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 268' ' ' LEU . . . . . . . . . . . . . 10.6 mp -64.72 -37.35 87.29 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 120.765 0.317 . . . . 70.11 111.295 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 84.5 m95 -70.03 -32.26 70.31 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.536 0.735 . . . . 63.11 110.377 175.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 270' ' ' LYS . . . . . 0.56 ' HZ2' ' HB3' ' C' ' 270' ' ' LYS . 3.9 mmmp? -57.91 -50.65 72.61 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 122.852 0.461 . . . . 75.43 109.823 171.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 9.7 mmpt? -56.33 -52.53 64.2 Favored 'General case' 0 C--O 1.252 1.223 0 O-C-N 124.183 0.927 . . . . 75.33 111.191 -178.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 57.6 mt -51.99 -60.65 2.94 Favored 'General case' 0 C--N 1.355 0.845 0 CA-C-N 115.323 -0.853 . . . . 74.33 110.216 174.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -51.9 -44.77 63.94 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.927 0.891 . . . . 43.22 112.338 -173.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -62.21 -45.49 93.14 Favored 'General case' 0 C--O 1.252 1.235 0 C-N-CA 123.579 0.752 . . . . 63.21 110.818 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -58.54 -32.03 68.49 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 116.096 -0.502 . . . . 70.04 111.399 175.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 276' ' ' TYR . . . . . 0.698 ' HA ' ' HD3' ' C' ' 279' ' ' ARG . 1.4 m-85 -85.56 -23.09 27.8 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.09 0.556 . . . . 75.52 111.801 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 277' ' ' TYR . . . . . 0.459 ' CE1' ' HA3' ' A' ' 208' ' ' GLY . 20.4 m-30 -70.43 -30.74 67.67 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 109.424 -0.584 . . . . 65.52 109.424 174.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -59.72 -18.74 45.09 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-N 115.361 -0.836 . . . . 72.22 112.384 171.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 279' ' ' ARG . . . . . 0.698 ' HD3' ' HA ' ' C' ' 276' ' ' TYR . 17.5 mtp-105 -87.76 -26.91 22.65 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.784 0.834 . . . . 75.11 110.844 175.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.025 0 C-N-CA 123.243 0.617 . . . . 75.14 110.277 -172.654 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.2 mtp . . . . . 0 N--CA 1.47 0.555 0 N-CA-C 108.463 -0.94 . . . . 64.12 108.463 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.67 30.99 19.73 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.29 1.036 . . . . 74.44 111.999 -179.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.0 64.75 6.83 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.828 0.851 . . . . 74.04 110.458 -175.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -39.3 100.74 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.499 1.52 . . . . 64.14 114.165 -175.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -65.85 109.1 2.36 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 109.278 -0.638 . . . . 74.32 109.278 169.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -73.83 89.35 1.84 Allowed 'General case' 0 C--O 1.246 0.917 0 N-CA-C 107.165 -1.42 . . . . 62.43 107.165 170.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.431 ' CD1' ' HA ' ' A' ' 53' ' ' ALA . 67.1 m-85 -61.29 -27.94 68.83 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 113.9 -1.5 . . . . 73.34 111.565 -172.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -68.13 -41.7 81.27 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 122.962 0.505 . . . . 73.33 110.255 177.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.13 -41.77 97.07 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.045 0.538 . . . . 70.01 110.497 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 65.2 mt -58.93 -36.73 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 O-C-N 123.804 0.69 . . . . 74.23 110.29 174.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 91.2 mt -84.71 -10.49 57.21 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 113.303 0.853 . . . . 73.11 113.303 177.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 68.74 32.52 74.33 Favored Glycine 0 CA--C 1.537 1.427 0 N-CA-C 114.03 0.372 . . . . 73.42 114.03 -178.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.3 m -118.35 162.67 29.04 Favored Pre-proline 0 N--CA 1.484 1.226 0 C-N-CA 124.609 1.164 . . . . 72.52 109.554 174.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -54.79 152.35 28.83 Favored 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 122.772 2.315 . . . . 50.12 112.586 175.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 76.1 mtt-85 -74.84 19.43 0.14 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 113.648 0.981 . . . . 75.43 113.648 -172.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -148.79 12.68 0.89 Allowed 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 124.605 1.162 . . . . 71.2 109.128 -177.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.06 145.49 55.79 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.789 1.235 . . . . 74.14 113.457 -171.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.1 p -70.45 162.71 28.22 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.363 1.065 . . . . 75.03 111.658 -178.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -57.82 -30.18 65.53 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.145 0.978 . . . . 71.11 111.262 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.473 ' HA ' ' HE2' ' A' ' 23' ' ' LYS . 0.8 OUTLIER -69.07 -40.92 78.17 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.746 0.818 . . . . 72.43 109.899 178.949 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.504 ' HG2' ' NH2' ' A' ' 24' ' ' ARG . 42.7 mt-10 -67.98 -35.96 79.23 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.415 0.686 . . . . 71.14 110.833 176.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.81 -33.76 65.54 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 C-N-CA 124.592 1.157 . . . . 73.31 110.326 175.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.473 ' HE2' ' HA ' ' A' ' 20' ' ' GLU . 37.6 ttpt -76.19 -33.26 59.29 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.74 1.216 . . . . 75.22 110.483 179.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.504 ' NH2' ' HG2' ' A' ' 21' ' ' GLU . 50.2 mtm-85 -70.82 -40.97 72.14 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.156 0.583 . . . . 73.12 110.235 173.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.97 -33.88 75.5 Favored 'General case' 0 C--O 1.237 0.402 0 O-C-N 124.163 0.914 . . . . 72.43 110.719 176.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -60.33 -56.97 15.0 Favored 'General case' 0 C--O 1.215 -0.724 0 O-C-N 123.913 0.758 . . . . 73.1 109.9 176.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.489 ' NZ ' ' HA ' ' A' ' 24' ' ' ARG . 35.1 mtmm -60.32 -44.81 95.12 Favored 'General case' 0 N--CA 1.482 1.164 0 O-C-N 123.869 0.73 . . . . 74.22 111.132 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 46.1 ttt180 -47.25 -52.61 15.55 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 125.087 1.355 . . . . 75.52 111.945 176.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.447 HD11 HD13 ' A' ' 50' ' ' ILE . 62.7 mt -91.74 -13.94 30.78 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.559 -0.746 . . . . 75.12 111.656 -173.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -80.51 -18.51 48.3 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.259 0.624 . . . . 71.54 109.991 172.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 51.1 mtp180 -94.55 -39.11 10.56 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.04 0.936 . . . . 72.33 110.331 172.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -71.22 -40.24 71.24 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 122.537 0.335 . . . . 73.31 111.671 -177.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -106.97 24.62 12.5 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.879 0.472 . . . . 72.41 110.319 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 75.8 t60 -57.18 94.79 0.05 OUTLIER Pre-proline 0 N--CA 1.484 1.259 0 C-N-CA 124.73 1.212 . . . . 73.54 112.105 -171.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -72.02 -22.2 23.22 Favored 'Trans proline' 0 C--N 1.368 1.575 0 C-N-CA 122.652 2.235 . . . . 75.51 111.883 -164.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -53.57 -35.82 61.21 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.473 1.509 . . . . 73.23 111.615 176.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 89.4 t -115.42 -40.32 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 CA-C-O 120.905 0.383 . . . . 73.25 110.113 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -100.5 82.46 2.47 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.23 1.012 . . . . 64.12 110.045 -177.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.99 60.87 6.51 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.043 0.537 . . . . 73.11 110.189 -178.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 63.2 m -105.14 123.85 38.42 Favored Pre-proline 0 N--CA 1.481 1.096 0 CA-C-O 117.81 -1.09 . . . . 71.24 109.706 -177.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -40.88 -51.91 3.51 Favored 'Trans proline' 0 C--N 1.391 2.778 0 C-N-CA 124.767 3.645 . . . . 73.53 114.322 -175.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -51.94 -51.17 58.9 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.067 0.947 . . . . 64.43 110.849 175.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.04 -15.46 60.64 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.403 0.681 . . . . 73.42 111.81 -178.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.6 mm-40 -74.93 -60.77 2.14 Favored 'General case' 0 C--N 1.36 1.024 0 N-CA-C 108.236 -1.024 . . . . 63.35 108.236 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -56.59 -44.45 81.07 Favored 'General case' 0 C--N 1.354 0.793 0 CA-C-N 114.214 -1.357 . . . . 62.44 109.826 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.493 ' O ' HG12 ' A' ' 50' ' ' ILE . 9.6 tppt? -66.89 -43.77 82.61 Favored 'General case' 0 C--N 1.357 0.897 0 O-C-N 124.249 0.968 . . . . 74.03 111.078 -175.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -55.66 -44.39 77.21 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 123.765 0.665 . . . . 73.32 110.523 175.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.7 mtpm? -65.37 -35.64 81.58 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 115.54 -0.754 . . . . 75.14 111.578 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -67.96 -31.24 70.83 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 122.921 0.488 . . . . 71.44 110.747 173.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.493 HG12 ' O ' ' A' ' 46' ' ' LYS . 12.0 mm -67.01 -37.54 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 N-CA-C 109.099 -0.704 . . . . 74.43 109.099 173.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.439 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 53.2 m-80 -69.43 -31.54 69.94 Favored 'General case' 0 C--O 1.207 -1.137 0 CA-C-N 115.283 -0.871 . . . . 73.43 111.388 177.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -64.22 -53.77 43.92 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.788 0.804 . . . . 75.34 109.874 174.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.431 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . . . -56.8 -53.27 59.8 Favored 'General case' 0 C--O 1.25 1.096 0 CA-C-N 113.569 -1.651 . . . . 65.45 111.915 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -61.51 -40.35 94.3 Favored 'General case' 0 C--O 1.209 -1.054 0 CA-C-N 115.023 -0.989 . . . . 73.53 110.517 176.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 51' ' ' ASN . . . -54.8 -47.51 73.93 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.297 0.639 . . . . 72.52 112.123 -176.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 78.7 t -69.71 -45.36 77.79 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 O-C-N 123.738 0.649 . . . . 74.52 110.671 177.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.428 HD13 ' HB2' ' A' ' 7' ' ' TYR . 58.4 mt -90.84 6.47 44.24 Favored 'General case' 0 CA--C 1.563 1.455 0 N-CA-C 113.603 0.964 . . . . 74.35 113.603 -172.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 44.4 t -71.95 -51.87 19.95 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 124.409 1.084 . . . . 74.34 111.339 -178.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -102.29 140.05 20.8 Favored Pre-proline 0 C--O 1.243 0.763 0 CA-C-N 115.209 -0.905 . . . . 74.34 109.172 -176.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -53.25 -26.21 33.25 Favored 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 123.705 2.937 . . . . 72.41 113.142 177.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -61.69 -62.07 2.07 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 124.485 1.114 . . . . 72.3 111.054 -179.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.455 ' HA ' HD11 ' A' ' 65' ' ' ILE . 41.2 mtmt -76.04 -24.0 55.16 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 115.688 -0.687 . . . . 74.54 111.303 -176.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 42.1 tpt85 -55.76 -53.33 57.92 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 124.099 0.875 . . . . 74.11 109.005 168.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -64.19 -34.91 79.17 Favored 'General case' 0 C--N 1.36 1.05 0 C-N-CA 123.459 0.704 . . . . 74.25 112.172 178.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.455 HD11 ' HA ' ' A' ' 62' ' ' LYS . 94.7 mt -57.09 -44.93 83.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 CA-C-O 121.15 0.5 . . . . 74.41 110.811 174.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -63.97 -44.88 91.41 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 115.77 -0.65 . . . . 75.4 110.09 177.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -60.61 -32.58 71.71 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 123.075 0.55 . . . . 64.04 112.019 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 48.6 p -84.4 -15.33 46.67 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.576 0.35 . . . . 75.44 111.571 178.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -72.71 106.4 4.69 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 108.636 -0.876 . . . . 75.32 108.636 170.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 105.54 18.08 12.42 Favored Glycine 0 N--CA 1.472 1.091 0 N-CA-C 111.535 -0.626 . . . . 64.23 111.535 -171.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 85.0 m -137.55 -56.64 0.69 Allowed 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 103.733 -2.691 . . . . 71.23 103.733 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.7 m -82.54 141.32 32.71 Favored 'General case' 0 C--O 1.251 1.156 0 N-CA-C 104.385 -2.45 . . . . 74.23 104.385 155.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.54 -23.13 20.99 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.364 0.665 . . . . 74.04 111.736 -176.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -111.46 169.17 6.6 Favored Pre-proline 0 N--CA 1.478 0.936 0 C-N-CA 124.181 0.993 . . . . 75.1 110.029 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -52.11 135.79 52.66 Favored 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 122.253 1.969 . . . . 75.41 112.386 167.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.43 ' HG3' HG23 ' A' ' 65' ' ' ILE . 73.0 Cg_endo -70.17 173.0 11.98 Favored 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 123.127 2.551 . . . . 74.25 112.259 -178.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -62.58 119.82 7.07 Favored 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 121.759 1.639 . . . . 73.45 111.185 170.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -64.16 145.78 89.63 Favored 'Trans proline' 0 C--N 1.382 2.331 0 C-N-CA 122.848 2.366 . . . . 73.2 112.829 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -63.66 149.62 90.43 Favored 'Trans proline' 0 C--N 1.38 2.205 0 C-N-CA 122.946 2.43 . . . . 71.05 111.954 171.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -67.87 76.35 0.61 Allowed 'Trans proline' 0 C--N 1.382 2.322 0 C-N-CA 123.601 2.867 . . . . 74.31 112.711 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 159.33 -35.47 0.48 Allowed Glycine 0 N--CA 1.462 0.384 0 N-CA-C 109.288 -1.525 . . . . 62.41 109.288 -174.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 128.13 171.36 12.99 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-N 114.804 -0.698 . . . . 53.03 112.331 171.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -67.31 107.36 2.36 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 107.977 -1.119 . . . . 74.41 107.977 166.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.443 ' O ' ' HD1' ' A' ' 85' ' ' PHE . 23.6 t70 -61.86 153.22 29.54 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.802 0.841 . . . . 71.31 112.615 -175.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.443 ' HD1' ' O ' ' A' ' 84' ' ' ASP . 0.1 OUTLIER -153.52 70.77 0.86 Allowed 'General case' 0 CA--C 1.553 1.059 0 N-CA-C 107.761 -1.2 . . . . 73.24 107.761 170.428 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.573 ' HA ' ' HA3' ' A' ' 163' ' ' GLY . 41.5 m -57.9 86.76 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 125.006 1.322 . . . . 74.44 114.367 -174.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.576 ' HA2' ' HB3' ' A' ' 171' ' ' PRO . . . 98.16 12.22 46.48 Favored Glycine 0 N--CA 1.47 0.936 0 CA-C-N 116.368 -0.378 . . . . 70.11 113.721 176.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.408 ' CD1' ' HB3' ' A' ' 51' ' ' ASN . 30.2 m-85 -123.58 110.32 14.88 Favored 'General case' 0 C--O 1.245 0.846 0 C-N-CA 122.831 0.453 . . . . 72.34 110.16 -170.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -70.23 94.8 0.94 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 122.803 0.441 . . . . 71.44 110.066 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.56 HG12 ' HG2' ' A' ' 91' ' ' GLU . 2.3 p -27.41 -50.39 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 126.203 1.801 . . . . 75.21 114.961 166.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.56 ' HG2' HG12 ' A' ' 90' ' ' VAL . 9.7 mm-40 -67.86 -12.89 61.56 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.994 0.918 . . . . 75.33 112.854 -168.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -80.97 -39.17 26.45 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.127 0.971 . . . . 61.35 111.438 175.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.413 ' CD2' ' HE2' ' A' ' 85' ' ' PHE . 22.3 m-85 -83.28 179.73 7.62 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 115.429 -0.805 . . . . 73.34 112.357 -166.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 80.1 p -59.14 142.42 51.6 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.446 1.098 . . . . 74.5 112.598 -170.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.4 -28.53 69.85 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.024 -0.989 . . . . 74.52 111.343 174.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -52.32 -55.27 22.58 Favored 'General case' 0 C--N 1.367 1.333 0 C-N-CA 123.026 0.53 . . . . 75.03 110.607 169.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -56.77 -43.53 80.92 Favored 'General case' 0 CA--C 1.548 0.887 0 O-C-N 124.065 0.853 . . . . 72.32 109.586 178.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.559 ' HA ' HD11 ' A' ' 105' ' ' LEU . 92.7 mt-30 -70.87 -12.33 61.48 Favored 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 115.458 -0.792 . . . . 74.14 112.307 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -88.07 -57.71 2.83 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.83 0.852 . . . . 70.02 111.766 171.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 51.0 tp -64.39 -42.51 96.08 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.69 0.796 . . . . 74.33 111.506 -174.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -94.62 -4.75 47.19 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-N 115.811 -0.632 . . . . 72.11 110.331 178.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -43.48 -59.24 3.69 Favored Glycine 0 C--N 1.356 1.663 0 CA-C-O 118.49 -1.172 . . . . 72.43 114.882 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -43.42 -24.15 0.58 Allowed 'Trans proline' 0 C--N 1.392 2.834 0 C-N-CA 124.717 3.612 . . . . 64.43 116.143 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -150.79 36.8 0.9 Allowed Glycine 0 C--N 1.352 1.457 0 CA-C-O 119.241 -0.755 . . . . 54.4 113.016 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.559 HD11 ' HA ' ' A' ' 98' ' ' GLN . 18.1 mt -54.33 84.62 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.147 0.579 . . . . 74.25 111.997 173.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.408 ' CD2' ' HA ' ' A' ' 84' ' ' ASP . 0.4 OUTLIER 19.19 -110.18 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 127.938 2.495 . . . . 74.45 113.831 176.192 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 58.46 16.86 30.43 Favored Glycine 0 C--N 1.361 1.931 0 CA-C-O 119.771 -0.461 . . . . 44.0 113.869 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 64.86 -100.04 0.41 Allowed Glycine 0 C--N 1.356 1.664 0 N-CA-C 111.396 -0.682 . . . . 71.34 111.396 -167.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -132.69 7.84 4.13 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.356 1.062 . . . . 74.55 109.842 177.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -69.07 -30.3 72.08 Favored Glycine 0 C--N 1.355 1.633 0 CA-C-N 115.509 -0.769 . . . . 55.25 113.037 178.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 74.52 -30.79 0.21 Allowed 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 124.758 1.223 . . . . 75.52 113.773 176.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.72 -11.7 58.93 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.483 0.713 . . . . 75.13 110.443 175.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 2.9 m 69.69 58.29 0.31 Allowed 'General case' 0 C--N 1.357 0.897 0 C-N-CA 124.218 1.007 . . . . 74.21 109.285 174.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -119.62 169.01 10.46 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.832 -0.622 . . . . 74.52 111.924 -174.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.569 ' HZ1' ' HB3' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -66.09 132.0 47.5 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.337 1.455 . . . . 73.31 112.188 -164.058 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -77.86 -163.57 21.41 Favored Glycine 0 CA--C 1.543 1.803 0 CA-C-N 115.476 -0.784 . . . . 73.4 114.6 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -112.74 130.33 56.1 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 124.587 1.155 . . . . 74.43 111.751 178.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -52.23 120.56 5.61 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.622 0.725 . . . . 74.23 111.487 176.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 67.2 tp -129.1 157.33 42.06 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 115.138 -0.937 . . . . 75.42 110.287 -171.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 34.3 ttp180 -111.18 146.67 36.47 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 108.793 -0.817 . . . . 74.51 108.793 171.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.535 ' HB1' HD11 ' A' ' 174' ' ' LEU . . . -128.35 158.19 38.91 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.604 0.716 . . . . 54.41 110.762 177.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -112.76 108.1 16.99 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 105.262 -2.125 . . . . 72.42 105.262 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.554 ' HB3' ' HA ' ' A' ' 178' ' ' VAL . 41.9 tp -98.44 97.44 4.68 Favored Pre-proline 0 N--CA 1.476 0.841 0 N-CA-C 108.042 -1.096 . . . . 74.14 108.042 -175.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.559 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 98.5 Cg_endo -79.22 107.62 2.23 Favored 'Trans proline' 0 C--N 1.381 2.237 0 C-N-CA 121.005 1.137 . . . . 75.33 109.309 -177.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.505 ' HB3' HD23 ' A' ' 180' ' ' LEU . 54.2 tp -109.63 132.05 54.5 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 122.362 0.265 . . . . 72.43 110.637 -166.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 97.4 m -62.59 124.87 22.11 Favored 'General case' 0 CA--C 1.551 0.986 0 O-C-N 124.496 1.122 . . . . 71.34 109.165 176.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 73.7 mt -52.77 -43.39 65.8 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 124.266 1.027 . . . . 75.21 112.195 -170.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -60.12 -35.84 76.14 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 114.36 -1.291 . . . . 75.32 110.241 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -83.01 -20.54 34.86 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.998 0.919 . . . . 64.33 111.314 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -66.64 -35.58 80.52 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 109.86 -0.422 . . . . 65.44 109.86 168.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -74.51 -48.05 29.46 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 115.298 -0.864 . . . . 74.51 111.831 173.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 33.3 m170 -74.03 -40.17 63.05 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 123.221 0.608 . . . . 75.25 111.886 -171.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 74.11 -151.33 43.73 Favored Glycine 0 CA--C 1.531 1.084 0 O-C-N 123.618 0.574 . . . . 71.54 113.092 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 86.34 -167.63 39.51 Favored Glycine 0 N--CA 1.473 1.166 0 C-N-CA 123.117 0.389 . . . . 70.42 112.435 -178.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.429 ' HB3' ' OG ' ' A' ' 146' ' ' SER . 2.6 mp0 -76.65 118.84 19.7 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.908 0.483 . . . . 73.14 110.289 175.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -94.47 119.88 33.85 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.658 0.783 . . . . 75.05 110.083 177.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 77.2 t -75.83 111.56 12.42 Favored 'Isoleucine or valine' 0 C--O 1.244 0.788 0 N-CA-C 108.704 -0.85 . . . . 75.04 108.704 168.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.505 HG11 HG13 ' A' ' 145' ' ' VAL . 3.5 p -135.69 138.09 48.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 124.452 1.101 . . . . 73.34 108.444 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -124.27 141.98 51.63 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.185 0.594 . . . . 71.3 110.974 -170.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.526 HG11 HD23 ' B' ' 8' ' ' LEU . 12.3 p -169.11 137.07 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 124.571 1.149 . . . . 75.1 109.07 176.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 55.49 33.21 20.55 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.129 0.972 . . . . 74.24 112.394 174.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 87.25 -23.6 11.32 Favored Glycine 0 C--N 1.352 1.443 0 CA-C-N 116.092 -0.504 . . . . 54.15 113.255 -178.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.533 ' NH1' ' HG2' ' A' ' 164' ' ' MET . 11.5 tpt180 -74.41 100.09 3.71 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.211 1.005 . . . . 72.43 110.543 179.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 19.7 ttp180 -84.47 92.53 8.1 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 107.912 -1.144 . . . . 74.41 107.912 165.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.505 HG13 HG11 ' A' ' 138' ' ' VAL . 3.7 p -98.53 143.02 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 115.041 -0.981 . . . . 73.53 110.796 -175.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.429 ' OG ' ' HB3' ' A' ' 135' ' ' GLU . 17.3 t -105.53 84.96 2.16 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 108.46 -0.941 . . . . 64.43 108.46 177.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 34.8 m -83.17 115.4 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 CA-C-O 121.244 0.545 . . . . 73.42 110.192 -177.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 48.5 ttt180 -74.18 103.36 4.58 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 109.426 -0.583 . . . . 74.32 109.426 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.462 ' HB ' HG13 ' A' ' 153' ' ' VAL . 36.3 pt -94.05 139.22 22.51 Favored Pre-proline 0 CA--C 1.557 1.243 0 C-N-CA 123.818 0.847 . . . . 74.52 109.508 176.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -73.26 140.7 31.09 Favored 'Trans proline' 0 C--N 1.372 1.784 0 C-N-CA 122.345 2.03 . . . . 74.22 111.846 176.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -57.85 93.18 0.06 OUTLIER 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 122.653 2.235 . . . . 74.15 111.494 167.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.582 ' HA2' ' HD2' ' A' ' 240' ' ' PHE . . . 124.62 31.48 0.89 Allowed Glycine 0 C--N 1.341 0.847 0 CA-C-N 115.558 -0.746 . . . . 75.51 112.474 -176.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.462 HG13 ' HB ' ' A' ' 149' ' ' ILE . 3.4 p -86.36 137.23 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 123.391 0.676 . . . . 75.43 110.323 -178.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.812 ' HD2' ' HA ' ' A' ' 191' ' ' GLN . 2.7 mtm-85 -127.46 151.29 49.03 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.815 0.846 . . . . 73.23 110.908 -163.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -53.24 116.9 2.65 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 124.694 1.246 . . . . 72.32 110.477 178.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 107.16 2.26 35.89 Favored Glycine 0 C--N 1.345 1.081 0 CA-C-N 115.76 -0.654 . . . . 74.33 113.54 -175.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 28.1 t -78.03 104.32 8.53 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 108.091 -1.078 . . . . 74.23 108.091 172.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.426 HG21 HG23 ' A' ' 177' ' ' VAL . 41.8 t -87.06 91.89 3.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 C-N-CA 124.74 1.216 . . . . 74.02 109.585 -178.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.54 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 58.9 mt -76.02 97.04 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 N-CA-C 108.576 -0.898 . . . . 75.24 108.576 173.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 74.0 ttt-85 -75.28 103.91 5.63 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.563 -0.532 . . . . 75.21 109.563 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.446 HG13 ' SD ' ' A' ' 164' ' ' MET . 7.5 p -116.46 123.15 30.95 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 123.505 0.722 . . . . 71.41 109.431 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -65.28 148.68 88.74 Favored 'Trans proline' 0 C--N 1.364 1.359 0 C-N-CA 122.707 2.271 . . . . 74.53 113.113 174.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . 0.573 ' HA3' ' HA ' ' A' ' 86' ' ' SER . . . 83.5 -25.74 4.92 Favored Glycine 0 N--CA 1.479 1.516 0 N-CA-C 116.482 1.353 . . . . 70.43 116.482 166.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.533 ' HG2' ' NH1' ' A' ' 143' ' ' ARG . 66.7 mtp -75.11 -21.68 58.73 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 117.502 0.651 . . . . 64.15 111.691 -179.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.51 ' HA2' HD12 ' A' ' 174' ' ' LEU . . . -80.2 -106.62 0.28 Allowed Glycine 0 C--N 1.348 1.236 0 CA-C-O 119.346 -0.697 . . . . 73.33 113.107 -175.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -53.13 109.02 0.86 Allowed Glycine 0 C--O 1.275 2.658 0 O-C-N 123.85 0.382 . . . . 74.5 112.849 168.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -54.29 104.07 0.1 Allowed 'General case' 0 C--N 1.351 0.673 0 O-C-N 127.854 2.737 . . . . 75.42 108.676 177.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -173.26 143.98 7.51 Favored Glycine 0 N--CA 1.44 -1.066 0 N-CA-C 108.556 -1.818 . . . . 64.21 108.556 -171.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . 0.508 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . 0.2 OUTLIER -73.16 -49.58 7.04 Favored Pre-proline 0 CA--C 1.558 1.27 0 N-CA-C 109.396 -0.594 . . . . 63.54 109.396 -171.688 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.508 ' HD3' ' HB3' ' A' ' 169' ' ' ASN . 18.8 Cg_exo -71.76 149.76 54.92 Favored 'Trans proline' 0 C--N 1.375 1.965 0 N-CA-C 108.19 -1.504 . . . . 73.02 108.19 156.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.576 ' HB3' ' HA2' ' A' ' 87' ' ' GLY . 74.1 Cg_endo -69.61 124.12 10.82 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 122.716 2.278 . . . . 71.25 116.247 -162.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -62.26 -46.73 93.33 Favored Glycine 0 C--N 1.374 2.641 0 C-N-CA 119.41 -1.376 . . . . 72.4 111.117 161.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 101.8 147.71 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 128.49 2.716 . . . . 71.14 108.438 177.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.535 HD11 ' HB1' ' A' ' 121' ' ' ALA . 28.3 tp -137.14 138.51 40.35 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.115 0.483 . . . . 74.2 110.768 -175.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 48.0 mt -105.34 89.8 3.23 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 114.731 -1.122 . . . . 72.12 108.166 171.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.54 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 64.6 mt -68.39 88.27 0.32 Allowed 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 109.684 -0.487 . . . . 74.52 109.684 175.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.426 HG23 HG21 ' A' ' 158' ' ' VAL . 18.2 t -85.36 104.01 12.89 Favored 'Isoleucine or valine' 0 C--O 1.25 1.1 0 N-CA-C 106.384 -1.71 . . . . 71.11 106.384 174.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.554 ' HA ' ' HB3' ' A' ' 123' ' ' LEU . 8.2 p -67.49 119.55 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 CA-C-N 115.216 -0.902 . . . . 74.13 109.688 -175.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.559 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 36.7 mmt180 -103.07 109.08 20.51 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-N 114.18 -1.373 . . . . 73.42 107.868 176.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.505 HD23 ' HB3' ' A' ' 125' ' ' LEU . 59.6 mt -74.79 143.05 44.17 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.683 -0.636 . . . . 74.04 109.496 177.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 86.2 mt -52.86 154.72 4.72 Favored Pre-proline 0 N--CA 1.486 1.325 0 C-N-CA 123.94 0.896 . . . . 73.22 112.82 -168.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . 0.405 ' HD3' HG22 ' B' ' 18' ' ' VAL . 72.2 Cg_endo -74.25 21.43 0.39 Allowed 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 122.695 2.263 . . . . 74.32 112.783 171.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.453 ' HA ' ' HD3' ' A' ' 184' ' ' PRO . 36.7 t-80 -61.64 106.7 0.87 Allowed Pre-proline 0 CA--C 1.557 1.215 0 C-N-CA 125.817 1.647 . . . . 73.35 108.114 168.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 183' ' ' HIS . 8.0 Cg_exo -73.95 25.04 0.34 Allowed 'Trans proline' 0 C--N 1.373 1.86 0 C-N-CA 124.137 3.225 . . . . 61.24 116.428 -162.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 69.1 t -97.25 -39.08 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 118.569 0.622 . . . . 72.34 109.672 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . 0.697 ' HE1' ' HA ' ' A' ' 214' ' ' THR . 35.4 m-85 -146.29 111.59 5.44 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.114 0.483 . . . . 72.31 112.069 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . 0.671 ' HB3' ' HB2' ' A' ' 194' ' ' TYR . 59.4 ttt180 -91.93 82.39 5.14 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 106.889 -1.523 . . . . 75.51 106.889 162.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.464 ' HB2' HD22 ' A' ' 193' ' ' LEU . 40.8 tp -79.5 95.39 5.8 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.438 -0.801 . . . . 74.21 108.872 177.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -118.74 131.12 56.12 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.609 0.764 . . . . 70.31 109.951 -174.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 77.62 -77.51 1.59 Allowed Glycine 0 C--N 1.353 1.48 0 N-CA-C 111.497 -0.641 . . . . 65.41 111.497 -178.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.812 ' HA ' ' HD2' ' A' ' 154' ' ' ARG . 13.2 pt20 -153.34 -6.03 0.18 Allowed 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.041 0.936 . . . . 72.32 111.061 173.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -122.18 150.43 42.25 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.459 0.704 . . . . 72.32 110.975 -167.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.464 HD22 ' HB2' ' A' ' 188' ' ' LEU . 38.5 mt -92.17 152.31 19.95 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.935 1.294 . . . . 74.25 111.089 -170.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.671 ' HB2' ' HB3' ' A' ' 187' ' ' ARG . 89.0 m-85 -131.34 103.09 6.25 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 107.964 -1.124 . . . . 73.14 107.964 169.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.456 ' HB2' HD22 ' A' ' 251' ' ' LEU . . . -122.93 115.95 22.78 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.464 1.106 . . . . 74.34 110.648 -173.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' THR . . . . . 0.47 ' HA ' ' HB2' ' A' ' 252' ' ' GLU . 93.6 m -71.43 111.63 6.9 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 121.082 0.468 . . . . 70.21 110.686 -177.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.472 HD22 HD13 ' A' ' 251' ' ' LEU . 37.5 tp -99.04 119.85 38.49 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.772 0.829 . . . . 74.1 110.809 -173.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -82.38 115.86 21.6 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 108.363 -0.977 . . . . 63.3 108.363 172.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.1 p -143.62 126.35 8.75 Favored Pre-proline 0 N--CA 1.479 1.022 0 C-N-CA 123.375 0.67 . . . . 74.33 110.138 -175.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -72.11 152.1 56.18 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 121.942 1.762 . . . . 70.05 112.095 176.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -44.22 -59.31 3.89 Favored Pre-proline 0 N--CA 1.484 1.268 0 N-CA-C 116.267 1.951 . . . . 71.34 116.267 -172.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -74.07 -19.82 19.88 Favored 'Trans proline' 0 C--N 1.384 2.411 0 CA-C-N 121.84 1.693 . . . . 73.32 112.76 -174.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 17.7 mt -75.11 -30.27 22.97 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 N-CA-C 109.521 -0.548 . . . . 71.02 109.521 172.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -72.22 -43.03 65.04 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-O 121.129 0.49 . . . . 74.14 111.23 173.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 54.5 t -71.94 -41.77 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 123.803 0.841 . . . . 64.22 112.375 -174.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 97.2 t -93.06 -32.61 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 122.546 0.338 . . . . 74.41 110.747 -178.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 89.83 77.19 1.32 Allowed Glycine 0 C--N 1.343 0.923 0 CA-C-N 116.312 -0.404 . . . . 72.35 112.137 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -96.03 -136.55 8.84 Favored Glycine 0 C--N 1.342 0.867 0 N-CA-C 112.056 -0.418 . . . . 73.32 112.056 178.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 46.0 mtmt -130.47 144.27 51.29 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.12 0.568 . . . . 73.34 110.013 178.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 16.8 m -136.32 176.71 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.533 1.133 . . . . 63.11 109.526 174.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 20.5 ttm180 -109.75 112.2 24.12 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.578 0.751 . . . . 74.32 109.529 175.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -104.6 126.62 51.86 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.721 -0.844 . . . . 74.41 108.721 176.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' MET . . . . . 0.685 ' HA ' ' HA ' ' A' ' 218' ' ' PRO . 3.5 mpp? -74.52 138.92 43.45 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.916 0.486 . . . . 74.15 110.245 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' THR . . . . . 0.697 ' HA ' ' HE1' ' A' ' 186' ' ' PHE . 69.0 p -117.95 179.29 4.13 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 122.999 0.52 . . . . 74.1 110.34 171.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 55.5 mt -67.33 -20.13 65.55 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 115.231 -0.895 . . . . 73.14 111.592 -178.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -109.24 19.71 19.12 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.619 0.767 . . . . 64.44 111.404 179.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 110.47 174.29 20.41 Favored Glycine 0 N--CA 1.474 1.224 0 CA-C-O 119.426 -0.652 . . . . 63.05 113.23 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . 0.685 ' HA ' ' HA ' ' A' ' 213' ' ' MET . 83.9 Cg_endo -76.43 145.98 27.26 Favored 'Trans proline' 0 C--N 1.368 1.581 0 C-N-CA 122.744 2.296 . . . . 74.13 112.622 -175.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 24.3 m -139.89 163.9 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 C-N-CA 123.777 0.831 . . . . 73.4 111.371 -176.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -91.28 117.54 29.73 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.154 0.982 . . . . 75.04 110.157 -178.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 57.9 t -128.81 126.59 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 124.269 1.027 . . . . 74.51 109.037 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.464 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -88.04 131.5 34.63 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.495 0.318 . . . . 70.4 111.372 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.459 ' HA ' HD11 ' B' ' 441' ' ' ILE . 38.4 t -73.5 146.81 86.65 Favored Pre-proline 0 CA--C 1.57 1.744 0 C-N-CA 125.749 1.62 . . . . 71.22 110.602 -178.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -78.91 171.69 16.12 Favored 'Trans proline' 0 C--N 1.388 2.613 0 C-N-CA 122.924 2.416 . . . . 75.51 111.308 169.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -81.06 150.48 17.94 Favored 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 121.92 1.746 . . . . 72.53 113.133 176.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 84.8 mtt-85 63.22 31.16 15.72 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 126.007 1.723 . . . . 75.13 111.527 174.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.55 HG22 HD22 ' A' ' 233' ' ' LEU . 50.2 m -63.26 105.75 0.78 Allowed 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 113.796 -1.547 . . . . 64.32 111.081 177.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -90.18 140.03 30.06 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.291 1.036 . . . . 75.32 110.197 -176.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -66.04 160.19 24.31 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.838 0.855 . . . . 65.12 111.461 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 81.02 -41.38 2.6 Favored Glycine 0 C--N 1.347 1.162 0 CA-C-N 116.382 -0.372 . . . . 75.54 112.405 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -67.19 156.19 36.88 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 124.339 1.056 . . . . 74.44 110.907 177.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.76 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 3.5 mptp? -106.93 124.59 49.84 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-N 114.686 -1.143 . . . . 72.22 108.492 176.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.55 HD22 HG22 ' A' ' 227' ' ' THR . 86.0 mt -74.72 106.43 6.27 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.417 -0.957 . . . . 71.4 108.417 176.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 20.6 ttp180 -87.93 110.92 20.93 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.043 0.537 . . . . 73.41 110.687 178.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.559 HD13 HG12 ' B' ' 441' ' ' ILE . 0.3 OUTLIER -120.26 117.94 29.15 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.101 0.96 . . . . 74.24 109.982 176.154 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 36.0 mmtm -59.68 151.16 25.62 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 125.155 1.382 . . . . 71.01 112.752 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 71.39 34.88 63.54 Favored Glycine 0 C--N 1.354 1.583 0 CA-C-N 114.985 -1.007 . . . . 74.2 113.757 171.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.439 ' HG3' HD11 ' A' ' 235' ' ' LEU . 41.2 mmtm -130.08 -38.87 1.4 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.16 0.584 . . . . 74.1 110.895 -176.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -71.38 168.9 50.43 Favored Glycine 0 C--N 1.35 1.318 0 CA-C-N 116.219 -0.446 . . . . 74.43 112.17 175.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . 0.582 ' HD2' ' HA2' ' A' ' 152' ' ' GLY . 4.4 m-85 -87.44 158.15 52.07 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 123.533 0.733 . . . . 73.41 111.067 -165.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -62.6 109.3 0.85 Allowed 'Trans proline' 0 C--N 1.385 2.452 0 C-N-CA 123.051 2.5 . . . . 73.33 111.994 177.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.422 ' HA3' ' HB3' ' A' ' 191' ' ' GLN . . . -122.38 -149.63 7.99 Favored Glycine 0 C--N 1.338 0.644 0 CA-C-O 119.174 -0.792 . . . . 73.52 112.696 -179.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . 0.45 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 26.1 Cg_endo -60.14 -45.71 22.17 Favored 'Trans proline' 0 C--N 1.375 1.932 0 C-N-CA 123.179 2.586 . . . . 72.5 112.845 -176.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -88.43 -19.51 26.45 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.256 0.622 . . . . 70.11 111.073 177.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 126.72 -158.46 20.76 Favored Glycine 0 C--N 1.347 1.166 0 N-CA-C 111.192 -0.763 . . . . 62.24 111.192 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 61.5 mtt180 -57.68 108.41 0.56 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.336 0.654 . . . . 75.41 110.612 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -72.21 -161.82 5.62 Favored Glycine 0 C--O 1.248 1.03 0 CA-C-O 121.977 0.765 . . . . 70.31 113.708 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -102.3 168.31 9.42 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.411 0.684 . . . . 75.44 110.549 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.516 ' HB3' ' HG ' ' A' ' 235' ' ' LEU . 16.0 tp -101.54 128.61 47.71 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 106.794 -1.558 . . . . 73.32 106.794 164.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.76 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 7.0 m-85 -108.93 104.83 14.14 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 107.763 -1.199 . . . . 71.3 107.763 174.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.543 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 46.3 mt -90.08 103.94 16.56 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 109.098 -0.705 . . . . 74.54 109.098 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.494 ' HG2' ' HG3' ' A' ' 232' ' ' LYS . 23.2 mt-10 -75.91 100.09 4.72 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.229 1.012 . . . . 75.41 108.866 -171.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 38.4 t -64.97 120.43 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 CA-C-N 114.564 -1.198 . . . . 71.34 112.241 -168.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . 0.477 ' HD2' ' SD ' ' B' ' 26' ' ' MET . 10.8 mmt180 -118.33 94.72 4.59 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.489 1.115 . . . . 73.14 108.065 169.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.44 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 73.5 mt -70.76 115.67 10.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 114.706 -1.133 . . . . 74.34 109.234 176.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 40.0 p -111.41 173.12 6.5 Favored 'General case' 0 C--O 1.255 1.346 0 C-N-CA 124.248 1.019 . . . . 74.52 109.994 178.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 23.0 pt -134.25 151.72 76.89 Favored Pre-proline 0 CA--C 1.556 1.195 0 CA-C-N 114.918 -1.037 . . . . 73.4 108.523 176.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . 0.5 ' HB2' ' HB3' ' B' ' 88' ' ' GLU . 11.1 Cg_endo -87.56 20.12 1.25 Allowed 'Trans proline' 0 C--N 1.37 1.667 0 C-N-CA 122.699 2.266 . . . . 74.45 113.426 -166.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.444 ' HA ' ' HG3' ' C' ' 226' ' ' ARG . 3.4 mp0 40.52 -89.27 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.806 1.242 . . . . 75.12 112.18 -162.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' ARG . . . . . 0.422 ' HD2' ' O ' ' A' ' 258' ' ' PRO . 0.4 OUTLIER -69.62 138.77 53.37 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.072 0.949 . . . . 75.12 111.425 -168.012 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.522 HD13 HG11 ' C' ' 205' ' ' VAL . 98.2 mt -129.28 173.14 10.78 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.016 0.926 . . . . 72.32 110.108 -178.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 40.7 p -114.16 156.7 43.83 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 124.252 1.021 . . . . 74.31 109.644 171.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -33.07 -45.22 0.27 Allowed 'Trans proline' 0 C--N 1.396 3.034 1 C-N-CA 125.351 4.034 . . . . 74.33 116.505 -176.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -59.31 -61.27 2.75 Favored 'General case' 0 C--O 1.249 1.045 0 C-N-CA 123.926 0.89 . . . . 71.44 110.778 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -57.71 -47.57 82.02 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-N 114.901 -1.045 . . . . 73.22 110.581 -178.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' GLU . . . . . 0.522 ' O ' ' HG2' ' A' ' 270' ' ' LYS . 7.2 tp10 -55.05 -50.68 68.52 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 124.543 1.152 . . . . 73.45 110.866 -176.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -62.45 -46.68 87.4 Favored 'General case' 0 C--O 1.254 1.34 0 O-C-N 124.229 0.956 . . . . 64.12 112.151 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 10.0 mp -63.22 -34.81 78.46 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 116.053 -0.522 . . . . 73.14 111.472 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' TRP . . . . . 0.425 ' O ' HG11 ' C' ' 206' ' ' VAL . 68.6 m95 -74.59 -29.74 61.44 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 118.709 -0.662 . . . . 75.0 111.345 177.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . 0.522 ' HG2' ' O ' ' A' ' 266' ' ' GLU . 0.0 OUTLIER -58.53 -61.05 2.88 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.442 -0.947 . . . . 73.12 108.442 174.478 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . 0.65 ' HZ1' ' HB3' ' A' ' 271' ' ' LYS . 9.9 mtpm? -54.61 -48.97 71.56 Favored 'General case' 0 C--N 1.364 1.203 0 CA-C-N 112.636 -2.075 . . . . 70.22 110.562 -178.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' LEU . . . . . 0.418 HD12 HD11 ' C' ' 272' ' ' LEU . 1.8 tt -58.01 -66.03 0.54 Allowed 'General case' 0 C--O 1.186 -2.268 0 O-C-N 124.244 0.965 . . . . 71.54 108.846 -179.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . 0.512 ' HA ' ' HB2' ' C' ' 202' ' ' PRO . . . -50.24 -50.67 49.17 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 114.849 1.426 . . . . 72.23 114.849 -170.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -88.66 -24.52 22.75 Favored 'General case' 0 C--O 1.255 1.379 0 N-CA-C 112.727 0.64 . . . . 74.35 112.727 -170.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -77.7 -36.21 51.34 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 121.846 -0.534 . . . . 72.24 110.631 170.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . 0.402 ' HB3' ' O ' ' A' ' 273' ' ' ALA . 2.7 t80 -47.2 -57.47 5.12 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 126.567 1.947 . . . . 75.02 109.66 167.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -44.81 -66.1 0.44 Allowed 'General case' 0 C--O 1.248 1.019 0 O-C-N 125.515 1.759 . . . . 72.14 109.426 174.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -65.14 -9.54 23.78 Favored 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 114.598 -1.183 . . . . 75.41 114.087 -176.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . 0.472 ' NH2' ' HG2' ' C' ' 264' ' ' GLU . 77.7 mtm180 -132.92 31.95 3.84 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.308 0.643 . . . . 75.15 110.08 -176.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.566 1.587 0 C-N-CA 124.07 0.948 . . . . 72.5 113.177 177.332 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.433 ' SD ' ' N ' ' B' ' 1' ' ' MET . 1.3 mpt? . . . . . 0 N--CA 1.48 1.04 0 N-CA-C 109.814 -0.439 . . . . 74.12 109.814 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -72.5 101.04 2.86 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.548 0.739 . . . . 62.45 109.791 174.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -164.39 -40.98 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.312 1.045 . . . . 74.04 109.434 175.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 16.6 t 68.64 -173.45 0.19 Allowed 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.331 1.052 . . . . 52.14 111.225 176.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 17.9 m 70.46 135.62 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.992 1.317 . . . . 74.34 112.346 -178.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 38.7 pt -143.27 176.79 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.392 1.077 . . . . 65.34 109.629 -176.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -137.38 132.64 33.8 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.329 0.652 . . . . 72.22 110.307 177.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . 0.526 HD23 HG11 ' A' ' 140' ' ' VAL . 39.0 tp -81.07 157.02 25.54 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.319 1.048 . . . . 75.22 111.086 -171.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.62 -72.34 0.42 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 122.856 0.462 . . . . 73.12 111.287 176.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . 0.442 HD23 ' HB1' ' A' ' 121' ' ' ALA . 33.6 mt 72.35 -7.54 1.35 Allowed 'General case' 0 N--CA 1.503 2.193 0 C-N-CA 125.588 1.555 . . . . 74.1 112.46 -165.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.407 ' N ' ' HD3' ' B' ' 12' ' ' PRO . 28.6 mt 55.87 56.97 10.04 Favored Pre-proline 0 CA--C 1.563 1.473 0 C-N-CA 124.727 1.211 . . . . 72.11 112.257 -176.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.407 ' HD3' ' N ' ' B' ' 11' ' ' LEU . 2.8 Cg_endo -88.78 -67.1 0.01 OUTLIER 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 123.14 2.56 . . . . 71.41 111.926 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 75.7 mt -119.21 -41.83 2.71 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.05 0.94 . . . . 75.11 109.6 177.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 3.4 pp -134.92 -176.94 4.41 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.905 0.882 . . . . 64.54 110.187 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -156.77 -176.13 5.81 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.717 0.807 . . . . 74.01 110.551 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 7.6 t -86.73 141.19 33.63 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 124.02 0.928 . . . . 71.11 110.814 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -83.2 42.68 1.32 Allowed 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 122.896 2.397 . . . . 71.22 113.518 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.492 HG12 ' HB3' ' A' ' 179' ' ' ARG . 98.7 t -74.76 108.7 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 108.842 -0.799 . . . . 63.3 108.842 171.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 2.9 m -101.97 1.21 36.43 Favored 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 123.597 0.759 . . . . 71.22 111.053 -174.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 51.2 mttm 66.11 -81.68 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.803 1.241 . . . . 74.33 111.243 -174.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -100.13 75.84 1.87 Allowed 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.297 0.639 . . . . 75.34 111.883 -169.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -144.89 120.6 10.5 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.368 -0.975 . . . . 73.31 108.368 164.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' THR . . . . . 0.439 ' HA ' ' HB3' ' A' ' 184' ' ' PRO . 17.2 p -135.71 62.49 48.31 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 123.966 0.906 . . . . 72.54 109.935 -177.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -87.06 34.23 0.44 Allowed 'Trans proline' 0 C--N 1.382 2.294 0 C-N-CA 123.273 2.649 . . . . 74.55 112.186 -175.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -93.4 29.42 1.96 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 123.899 0.88 . . . . 74.53 110.504 -173.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' MET . . . . . 0.619 ' HB3' HD23 ' B' ' 29' ' ' LEU . 51.7 mtm -80.4 155.83 73.93 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 123.757 0.823 . . . . 75.13 109.747 177.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -75.37 59.68 5.5 Favored 'Trans proline' 0 C--N 1.384 2.436 0 C-N-CA 123.041 2.494 . . . . 73.04 114.611 -177.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.514 HG13 ' HB2' ' B' ' 31' ' ' ASN . 71.9 t 68.03 -61.58 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 125.977 1.711 . . . . 75.25 113.54 172.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . 0.619 HD23 ' HB3' ' B' ' 26' ' ' MET . 2.1 mm? 77.35 -54.83 0.54 Allowed 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 126.164 1.786 . . . . 73.34 112.543 172.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.588 ' HA ' ' HG2' ' C' ' 231' ' ' ARG . 13.3 tp10 -58.68 -68.57 0.25 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 122.777 0.431 . . . . 71.25 110.35 174.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' ASN . . . . . 0.514 ' HB2' HG13 ' B' ' 28' ' ' VAL . 10.8 m120 -71.12 -19.14 62.48 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 122.668 0.387 . . . . 74.34 111.427 -177.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 18.3 ttt85 -61.03 -31.88 71.5 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.736 0.814 . . . . 72.22 111.028 175.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -109.11 -88.7 0.48 Allowed 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 109.119 -0.697 . . . . 73.31 109.119 168.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . 58.66 15.04 3.44 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 125.014 1.326 . . . . 53.33 113.674 176.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -133.51 141.16 47.63 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 122.902 0.481 . . . . 73.13 110.752 -169.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -176.98 61.68 0.1 OUTLIER Glycine 0 C--N 1.341 0.819 0 N-CA-C 110.543 -1.023 . . . . 74.33 110.543 175.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 37.8 t70 68.97 172.82 0.3 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 124.325 1.05 . . . . 61.44 111.116 178.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 45.2 pt -70.99 -18.5 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 123.217 0.607 . . . . 75.44 111.56 173.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' THR . . . . . 0.526 ' O ' ' HB2' ' B' ' 155' ' ' LEU . 69.9 p 62.31 -69.05 0.06 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 126.408 1.883 . . . . 73.32 112.155 -172.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . 74.2 161.78 0.15 Allowed Pre-proline 0 N--CA 1.495 1.817 0 C-N-CA 124.394 1.077 . . . . 73.24 112.397 174.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.0 145.29 35.41 Favored 'Trans proline' 0 C--N 1.385 2.457 0 C-N-CA 122.351 2.034 . . . . 72.44 113.02 178.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 178.35 -76.48 0.07 OUTLIER Glycine 0 C--N 1.352 1.459 0 CA-C-N 116.182 -0.463 . . . . 61.22 112.648 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 176.66 -166.77 37.83 Favored Glycine 0 C--N 1.347 1.165 0 N-CA-C 112.314 -0.314 . . . . 64.32 112.314 -176.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . 0.553 ' HA ' HG12 ' B' ' 154' ' ' ILE . . . -141.21 178.73 7.2 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 112.598 0.592 . . . . 63.2 112.598 -173.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.572 ' HG3' ' HB ' ' B' ' 154' ' ' ILE . 29.9 mtp180 -69.47 78.9 0.4 Allowed 'General case' 0 C--N 1.357 0.926 0 C-N-CA 123.83 0.852 . . . . 74.21 109.217 175.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -63.79 107.87 1.31 Allowed 'General case' 0 C--N 1.353 0.737 0 C-N-CA 124.227 1.011 . . . . 75.02 109.65 -177.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.431 HD13 ' HG3' ' B' ' 148' ' ' GLU . 81.4 mt 52.46 33.44 13.19 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.212 1.005 . . . . 72.13 111.896 177.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 25.8 m -128.11 76.13 1.67 Allowed 'General case' 0 C--O 1.246 0.874 0 C-N-CA 124.07 0.948 . . . . 73.12 108.831 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -67.64 -45.07 79.36 Favored Glycine 0 C--N 1.35 1.349 0 N-CA-C 110.742 -0.943 . . . . 74.15 110.742 173.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -168.96 105.82 0.42 Allowed 'General case' 0 C--O 1.24 0.58 0 N-CA-C 105.54 -2.022 . . . . 64.2 105.54 164.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 67.41 -72.07 0.09 Allowed 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 124.967 1.307 . . . . 75.3 110.381 -166.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 52.6 p -99.21 167.04 10.93 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.331 1.052 . . . . 73.31 110.465 176.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.16 120.49 13.3 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.606 -0.887 . . . . 73.24 108.606 169.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . 57.68 -160.27 0.25 Allowed 'General case' 0 N--CA 1.484 1.25 0 O-C-N 124.031 0.832 . . . . 75.51 111.241 -175.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' B' ' 353' ' ' HIS . 60.4 tp -148.47 -82.82 0.11 Allowed 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.842 -0.799 . . . . 72.35 108.842 169.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . 0.452 ' NH1' ' HA ' ' B' ' 290' ' ' TRP . 48.9 ttp85 -165.85 106.86 0.73 Allowed 'General case' 0 C--N 1.345 0.389 0 N-CA-C 108.969 -0.752 . . . . 74.21 108.969 -173.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -46.66 -71.28 0.07 Allowed 'General case' 0 N--CA 1.479 0.987 0 O-C-N 125.306 1.629 . . . . 75.31 111.9 -171.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 15.1 m 73.44 -35.87 0.33 Allowed 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 125.524 1.53 . . . . 62.01 114.657 169.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 56.9 tp -65.71 -31.51 72.56 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.137 0.975 . . . . 72.44 110.812 -177.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 1.8 m 71.23 -72.45 0.11 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.283 1.433 . . . . 71.31 111.666 172.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . 0.417 ' HB2' ' H ' ' B' ' 298' ' ' HIS . 30.8 t70 -101.87 126.28 48.73 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.028 1.331 . . . . 71.45 110.283 -174.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -124.55 78.41 62.73 Favored Pre-proline 0 N--CA 1.49 1.565 0 C-N-CA 123.606 0.763 . . . . 72.42 109.407 177.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -93.43 -2.76 3.23 Favored 'Trans proline' 0 C--N 1.371 1.736 0 C-N-CA 122.915 2.41 . . . . 72.24 113.17 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 63.54 89.7 0.09 Allowed 'General case' 0 C--N 1.36 1.047 0 O-C-N 124.798 1.311 . . . . 72.04 109.971 -164.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -86.99 30.14 0.78 Allowed 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.742 0.817 . . . . 73.42 110.235 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' ASN . . . . . 0.404 HD21 ' NH2' ' C' ' 254' ' ' ARG . 2.0 m-20 -91.76 -3.85 55.69 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.978 1.311 . . . . 72.41 110.87 -169.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 50.4 mm 75.81 -69.14 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 126.189 1.795 . . . . 74.04 112.013 176.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 3.2 pt -135.77 131.49 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 123.545 0.738 . . . . 73.4 110.072 -177.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.467 ' HG ' ' HB2' ' B' ' 230' ' ' ALA . 3.1 mm? -121.49 -175.09 3.0 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.454 1.102 . . . . 74.34 110.097 -173.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . 0.436 ' HB3' ' H ' ' B' ' 71' ' ' ILE . 3.8 mm? 54.2 -144.28 0.68 Allowed 'General case' 0 CA--C 1.562 1.427 0 O-C-N 123.987 0.804 . . . . 65.22 111.204 178.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . 0.501 ' HA ' ' HG2' ' B' ' 118' ' ' PRO 0.279 10.4 tp 55.66 105.15 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 C-N-CA 127.076 2.15 . . . . 75.5 112.982 177.942 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 119.8 -11.78 10.97 Favored Glycine 0 C--N 1.353 1.506 0 CA-C-N 115.098 -0.956 . . . . 71.15 111.984 -174.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -64.94 149.58 49.43 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 124.218 1.007 . . . . 74.12 111.809 -173.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 123.76 -167.34 16.05 Favored Glycine 0 C--N 1.339 0.73 0 CA-C-N 115.416 -0.811 . . . . 72.45 111.65 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 75' ' ' MET . . . . . 0.413 ' HE3' HG11 ' B' ' 28' ' ' VAL . 17.7 ptm -137.58 130.49 30.25 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.925 -0.769 . . . . 74.01 108.925 -177.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . -147.32 -60.65 0.01 OUTLIER Glycine 0 C--N 1.34 0.755 0 N-CA-C 110.372 -1.091 . . . . 71.52 110.372 -177.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -74.0 156.2 37.8 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.401 0.68 . . . . 74.35 110.812 177.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 52.9 m -135.0 79.67 1.8 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.917 0.887 . . . . 55.34 108.714 172.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . 0.418 ' HB2' ' HA2' ' B' ' 104' ' ' GLY . 12.1 mm-40 73.54 -8.94 1.26 Allowed 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 125.922 1.689 . . . . 74.44 113.965 174.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 24.5 mm -72.41 -24.27 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 123.202 0.601 . . . . 72.52 110.463 -173.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 84.4 m -86.6 -47.06 9.53 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.808 0.443 . . . . 74.52 110.254 173.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.1 -89.87 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 115.638 -0.71 . . . . 75.12 112.09 -171.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -100.02 51.36 0.91 Allowed 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.398 0.679 . . . . 74.13 111.123 -169.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -78.49 9.76 3.72 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 113.798 1.036 . . . . 73.0 113.798 -171.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . 0.498 ' HA ' HD12 ' B' ' 385' ' ' LEU . 29.4 t-20 -167.95 -45.94 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 118.346 0.521 . . . . 72.23 110.889 -178.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -87.74 158.86 18.69 Favored 'General case' 0 C--O 1.244 0.816 0 CA-C-N 116.092 -0.504 . . . . 74.21 111.983 -173.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.76 131.29 34.35 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-N 115.359 -0.837 . . . . 52.24 109.503 171.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 88' ' ' GLU . . . . . 0.5 ' HB3' ' HB2' ' A' ' 258' ' ' PRO . 32.1 mt-10 -83.44 77.29 9.84 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.402 0.62 . . . . 74.14 110.049 178.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . 0.437 ' H ' ' HG2' ' C' ' 279' ' ' ARG . . . 172.19 137.07 2.26 Favored Glycine 0 C--N 1.342 0.888 0 N-CA-C 110.263 -1.135 . . . . 54.33 110.263 177.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.2 -47.2 84.2 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.239 1.015 . . . . 75.53 111.43 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -98.36 31.46 8.02 Favored Glycine 0 C--N 1.345 1.071 0 CA-C-N 115.646 -0.707 . . . . 70.11 112.24 177.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -91.54 25.95 13.85 Favored Glycine 0 C--N 1.355 1.63 0 CA-C-N 116.885 0.342 . . . . 73.42 112.769 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -126.1 116.49 21.46 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.449 1.1 . . . . 74.22 108.953 -175.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 94' ' ' PHE . . . . . 0.503 ' HB2' ' HB2' ' B' ' 98' ' ' ASP . 81.9 m-85 -72.94 171.11 13.39 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 122.612 0.365 . . . . 72.14 110.442 175.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -66.26 -6.55 14.23 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.847 0.859 . . . . 74.44 113.146 -170.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . -80.44 -88.53 0.55 Allowed Glycine 0 C--N 1.348 1.21 0 N-CA-C 110.602 -0.999 . . . . 75.21 110.602 167.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 12.9 tt -163.22 19.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 C-N-CA 124.77 1.228 . . . . 73.0 108.073 174.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . 0.518 ' HA ' HG22 ' B' ' 414' ' ' THR . 6.6 m-20 -72.29 82.66 1.03 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.814 0.845 . . . . 75.21 112.904 -160.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -81.8 107.64 14.7 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.898 -1.149 . . . . 61.12 107.898 165.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . 0.453 HD22 ' HE1' ' B' ' 94' ' ' PHE . 3.4 mm? -66.88 107.46 1.68 Allowed Pre-proline 0 CA--C 1.55 0.959 0 O-C-N 123.866 0.729 . . . . 74.2 110.321 -178.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -83.02 104.81 1.29 Allowed 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 122.449 2.099 . . . . 74.43 111.257 -178.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -56.63 -42.42 78.8 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.062 0.545 . . . . 73.12 109.743 178.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 27.0 m 62.43 -69.81 0.06 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 126.228 1.811 . . . . 75.52 113.341 169.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 104' ' ' GLY . . . . . 0.418 ' HA2' ' HB2' ' B' ' 79' ' ' GLU . . . -142.36 -35.04 0.09 OUTLIER Glycine 0 C--N 1.341 0.826 0 CA-C-O 119.737 -0.48 . . . . 51.35 112.039 175.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 105' ' ' GLN . . . . . 0.422 ' HG3' ' H ' ' B' ' 106' ' ' TYR . 20.9 pt20 41.87 -75.75 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 127.041 2.136 . . . . 75.22 114.29 -177.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 106' ' ' TYR . . . . . 0.422 ' H ' ' HG3' ' B' ' 105' ' ' GLN . 51.6 p90 -90.42 33.74 0.9 Allowed 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 123.699 0.8 . . . . 74.44 111.243 -178.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 91.5 m -69.64 107.51 3.46 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 121.155 0.503 . . . . 75.34 110.59 177.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 8.1 p-80 -154.55 63.28 0.67 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.603 1.161 . . . . 73.44 108.726 178.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 92.1 t80 68.68 -82.11 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 124.821 1.248 . . . . 74.1 110.003 -174.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . 71.06 -41.01 0.49 Allowed 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 125.569 1.548 . . . . 75.22 114.821 172.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 3.6 pp -63.69 132.76 52.07 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.624 0.77 . . . . 70.25 112.624 -168.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 13.2 t30 -142.63 91.22 2.29 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 107.431 -1.322 . . . . 73.2 107.431 173.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 113' ' ' LYS . . . . . 0.655 ' HA ' HG22 ' B' ' 224' ' ' VAL . 54.9 pttt -137.14 35.07 2.55 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.544 1.538 . . . . 75.13 108.541 -175.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -55.1 -65.06 0.65 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.45 1.5 . . . . 74.21 111.54 -169.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 2.9 p -152.08 164.86 36.38 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.258 1.423 . . . . 73.23 108.652 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 129.97 162.48 10.81 Favored Glycine 0 C--N 1.338 0.653 0 N-CA-C 111.176 -0.77 . . . . 55.33 111.176 -177.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 22.6 ttpp -166.62 121.57 0.89 Allowed Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 123.711 0.804 . . . . 75.35 109.159 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 118' ' ' PRO . . . . . 0.501 ' HG2' ' HA ' ' B' ' 71' ' ' ILE . 14.7 Cg_exo -70.18 79.14 1.1 Allowed 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 122.433 2.089 . . . . 63.21 109.324 165.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 119' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -67.69 -46.56 71.95 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 114.678 -1.146 . . . . 75.33 110.401 -174.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 120' ' ' TYR . . . . . 0.467 ' HA ' ' HB3' ' B' ' 312' ' ' PRO . 0.5 OUTLIER -70.44 -23.85 62.8 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 114.251 -1.341 . . . . 70.1 112.254 177.977 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 121' ' ' VAL . . . . . 0.491 HG21 ' HA ' ' B' ' 314' ' ' ARG . 98.9 t 62.01 -78.38 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 125.009 1.324 . . . . 74.32 112.043 177.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 32.9 m -65.18 -60.56 2.87 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.517 1.127 . . . . 75.25 112.735 -175.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 55.82 -87.86 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.483 1.113 . . . . 70.53 111.42 -166.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 28.5 m 55.77 -158.09 0.23 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.293 1.037 . . . . 61.03 111.992 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . 0.635 ' HB1' ' HE2' ' B' ' 231' ' ' LYS . . . -168.11 121.81 0.91 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.344 0.658 . . . . 74.53 109.281 170.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.51 139.58 58.78 Favored 'General case' 0 C--O 1.245 0.817 0 O-C-N 124.183 0.927 . . . . 74.13 110.423 177.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 10.3 t 64.56 -168.97 0.2 Allowed 'General case' 0 CA--C 1.558 1.269 0 C-N-CA 124.902 1.281 . . . . 70.01 111.136 -178.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . 0.491 ' HA ' ' SD ' ' C' ' 213' ' ' MET . . . -137.95 149.38 46.11 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.565 0.746 . . . . 74.33 109.495 177.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 23.8 m -75.49 82.56 2.55 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.399 0.68 . . . . 74.41 110.224 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . 55.17 -151.08 0.4 Allowed 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 125.195 1.398 . . . . 61.42 112.284 176.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 40.4 m95 58.34 -131.78 1.22 Allowed 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 124.441 1.097 . . . . 73.51 110.149 -178.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 32.2 m 60.3 14.22 4.5 Favored 'General case' 0 C--N 1.374 1.671 0 C-N-CA 124.633 1.173 . . . . 74.11 111.718 -177.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 133' ' ' THR . . . . . 0.401 HG22 HG23 ' B' ' 137' ' ' THR . 70.3 p 48.32 18.15 0.15 Allowed 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 126.128 1.771 . . . . 74.52 114.068 -173.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 53.72 34.42 50.52 Favored Glycine 0 C--N 1.357 1.725 0 CA-C-O 119.283 -0.732 . . . . 55.15 113.572 -174.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 135' ' ' VAL . . . . . . . . . . . . . 59.5 t 76.46 -47.09 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 C-N-CA 125.562 1.545 . . . . 73.24 111.639 -175.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -73.95 89.21 1.88 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.894 1.278 . . . . 74.24 109.887 177.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 137' ' ' THR . . . . . 0.401 HG23 HG22 ' B' ' 133' ' ' THR . 12.1 m -83.25 119.76 24.97 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 123.269 0.627 . . . . 75.31 111.455 -170.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 75.3 -52.31 0.66 Allowed 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 126.122 1.769 . . . . 75.52 112.744 -178.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 8.2 t30 73.99 -56.86 0.64 Allowed 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 125.447 1.499 . . . . 73.24 110.867 -176.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -64.12 -70.69 1.0 Allowed Glycine 0 C--N 1.353 1.473 0 CA-C-O 119.795 -0.447 . . . . 75.54 112.018 170.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . 71.97 -60.93 0.51 Allowed 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 125.421 1.489 . . . . 75.34 112.646 176.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 7.1 mp -64.85 110.35 2.39 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.869 0.868 . . . . 74.24 109.904 177.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 162.62 132.31 1.32 Allowed Glycine 0 C--N 1.338 0.659 0 N-CA-C 111.021 -0.832 . . . . 61.25 111.021 -178.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 5.1 t 58.48 36.24 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.425 0 C-N-CA 124.641 1.176 . . . . 75.31 109.846 -178.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -66.55 -37.36 84.82 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 114.355 -1.293 . . . . 75.32 110.291 -178.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 44.4 mm -78.16 121.77 31.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 115.03 -0.987 . . . . 72.52 109.231 176.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 58.99 -163.39 0.22 Allowed 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 124.261 1.024 . . . . 72.43 112.307 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . 0.431 ' HG3' HD13 ' B' ' 47' ' ' LEU . 11.3 tp10 70.13 23.77 5.16 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 125.131 1.372 . . . . 75.05 110.824 175.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 149' ' ' LYS . . . . . 0.408 ' HG3' ' H ' ' B' ' 150' ' ' ASP . 10.3 pttm -157.86 -71.74 0.09 Allowed 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 107.546 -1.279 . . . . 74.13 107.546 174.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 150' ' ' ASP . . . . . 0.408 ' H ' ' HG3' ' B' ' 149' ' ' LYS . 20.9 m-20 66.25 21.32 11.05 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.244 1.018 . . . . 74.11 113.617 165.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 56.4 p-80 42.32 60.75 9.38 Favored Pre-proline 0 N--CA 1.496 1.861 0 C-N-CA 125.607 1.563 . . . . 74.43 112.443 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -86.51 12.56 2.97 Favored 'Trans proline' 0 C--N 1.37 1.681 0 C-N-CA 122.711 2.274 . . . . 64.13 113.347 -162.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 153' ' ' THR . . . . . 0.546 HG23 ' H ' ' B' ' 154' ' ' ILE . 1.6 m 61.62 -155.46 0.35 Allowed 'General case' 0 CA--C 1.568 1.663 0 C-N-CA 124.487 1.115 . . . . 74.2 109.013 -173.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 154' ' ' ILE . . . . . 0.572 ' HB ' ' HG3' ' B' ' 45' ' ' ARG . 0.0 OUTLIER -160.58 148.97 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 N-CA-C 107.82 -1.178 . . . . 74.25 107.82 178.316 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 155' ' ' LEU . . . . . 0.531 ' N ' HD11 ' B' ' 154' ' ' ILE . 2.0 pt? -158.41 -22.95 0.08 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.425 0.69 . . . . 73.12 111.132 173.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -122.89 94.29 4.23 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.723 0.809 . . . . 72.23 110.805 -178.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 157' ' ' MET . . . . . 0.564 ' HG3' ' HG2' ' B' ' 241' ' ' GLU . 3.8 mpp? 30.31 -87.95 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.418 0 C-N-CA 127.051 2.141 . . . . 61.13 114.412 174.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 158' ' ' ALA . . . . . 0.515 ' HB2' ' HB2' ' B' ' 161' ' ' ALA . . . -141.31 -3.07 1.21 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.539 1.536 . . . . 65.11 109.605 178.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt 55.95 -83.29 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 126.043 1.737 . . . . 73.24 112.074 -171.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -123.19 7.06 9.13 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.787 0.835 . . . . 74.34 111.699 -174.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . 0.515 ' HB2' ' HB2' ' B' ' 158' ' ' ALA . . . -89.58 119.39 29.97 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.19 0.596 . . . . 71.1 110.208 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 82.36 -90.48 1.5 Allowed Glycine 0 C--N 1.349 1.271 0 CA-C-O 119.792 -0.449 . . . . 73.4 112.561 177.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 10.6 mp 66.28 -71.99 0.08 Allowed 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 125.324 1.45 . . . . 75.25 111.525 -174.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 164' ' ' ALA . . . . . . . . . . . . . . . -65.3 -64.18 0.92 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.218 0.607 . . . . 75.34 111.215 -177.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 165' ' ' THR . . . . . 0.416 ' O ' ' HE3' ' C' ' 238' ' ' LYS . 25.9 p -136.66 -71.55 0.45 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.358 0.663 . . . . 73.14 110.774 -178.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . 163.99 74.2 0.03 OUTLIER Glycine 0 C--N 1.338 0.646 0 N-CA-C 111.343 -0.703 . . . . 74.53 111.343 -178.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 167' ' ' ASN . . . . . . . . . . . . . 48.2 t30 74.17 -65.04 0.37 Allowed 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 125.643 1.577 . . . . 74.33 111.323 -178.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 7.3 p -149.54 137.03 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 124.083 0.953 . . . . 75.53 110.101 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 19.2 m -83.08 90.04 7.0 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.642 0.777 . . . . 65.53 109.198 178.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 19.3 m -85.28 73.6 10.55 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.17 0.988 . . . . 73.13 109.448 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -120.68 -49.95 2.21 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 112.666 0.617 . . . . 73.41 112.666 -169.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 172' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -82.63 22.04 0.93 Allowed 'General case' 0 CA--C 1.559 1.296 0 CA-C-O 121.654 0.74 . . . . 75.25 112.139 -169.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 173' ' ' LEU . . . . . . . . . . . . . 7.6 mp -71.29 -23.46 61.96 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.247 0.619 . . . . 74.44 109.622 170.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 174' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -131.85 159.09 39.59 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.811 1.244 . . . . 74.45 108.605 173.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 175' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -100.26 165.8 11.3 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 109.465 -0.568 . . . . 74.1 109.465 172.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -121.56 149.5 43.03 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.781 0.833 . . . . 74.11 108.832 172.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 57.5 m -141.8 106.94 5.87 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 123.3 0.64 . . . . 74.15 109.412 -178.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 178' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -66.05 -44.38 7.48 Favored 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 122.669 2.246 . . . . 74.53 111.465 173.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -168.29 -71.56 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 107.436 -1.32 . . . . 74.35 107.436 -178.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 180' ' ' ALA . . . . . 0.488 ' HB2' HG13 ' C' ' 137' ' ' VAL . . . -135.1 -63.14 0.7 Allowed 'General case' 0 C--O 1.238 0.473 0 N-CA-C 104.791 -2.299 . . . . 75.32 104.791 166.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 181' ' ' LEU . . . . . 0.539 HD22 ' HB2' ' C' ' 136' ' ' ARG . 21.8 tp -152.85 -6.72 0.19 Allowed 'General case' 0 CA--C 1.567 1.611 0 CA-C-N 114.613 -1.176 . . . . 74.44 110.689 158.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 182' ' ' VAL . . . . . 0.666 ' HA ' ' HB2' ' C' ' 123' ' ' LEU . 14.7 m -136.75 178.3 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 C-N-CA 124.583 1.153 . . . . 72.43 112.555 -175.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 183' ' ' ALA . . . . . 0.666 ' HB2' ' HD2' ' C' ' 124' ' ' PRO . . . -143.69 55.37 1.33 Allowed 'General case' 0 CA--C 1.552 1.049 0 CA-C-N 115.118 -0.946 . . . . 65.24 110.401 164.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 32.6 m170 70.3 -168.77 0.16 Allowed 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 114.959 1.466 . . . . 75.32 114.959 162.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 185' ' ' VAL . . . . . 0.54 HG22 HD21 ' C' ' 119' ' ' LEU . 45.9 t -79.23 147.34 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 C-N-CA 125.615 1.566 . . . . 74.01 113.263 -164.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 186' ' ' THR . . . . . 0.503 ' HB ' ' HG2' ' C' ' 122' ' ' GLU . 15.2 t -126.02 174.24 8.58 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 125.325 1.45 . . . . 60.24 109.383 166.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 187' ' ' SER . . . . . . . . . . . . . 51.8 m -111.75 -16.85 13.11 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.634 0.774 . . . . 62.14 111.046 173.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -99.96 160.87 13.98 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.425 0.69 . . . . 72.32 111.388 -171.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 31.3 mtmm 70.96 120.42 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 125.48 1.512 . . . . 72.52 112.512 172.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 190' ' ' CYS . . . . . 0.528 ' HA ' HG12 ' C' ' 158' ' ' VAL . 11.6 p -151.82 108.14 3.44 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.507 0.723 . . . . 70.33 109.874 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -148.48 -165.73 2.35 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 126.273 1.829 . . . . 74.04 108.073 -177.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -150.54 62.04 0.41 Allowed Glycine 0 CA--C 1.539 1.553 0 CA-C-O 119.418 -0.657 . . . . 64.22 113.122 170.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 193' ' ' PRO . . . . . 0.565 ' HG2' ' HA ' ' C' ' 157' ' ' SER . 37.4 Cg_endo -94.82 91.05 0.11 Allowed 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 123.458 2.772 . . . . 73.22 111.339 175.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 194' ' ' SER . . . . . . . . . . . . . 35.0 t -128.72 141.65 51.26 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.821 0.849 . . . . 63.44 109.319 -178.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 195' ' ' ALA . . . . . 0.427 ' HB1' ' HD3' ' C' ' 243' ' ' PRO . . . -149.54 156.66 42.33 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.645 0.778 . . . . 74.32 110.445 -176.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 4.4 m 72.6 159.93 0.22 Allowed 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 125.135 1.374 . . . . 73.32 111.772 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 18.9 m -119.52 -68.18 0.93 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.574 0.75 . . . . 75.11 109.598 177.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 198' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -168.86 -55.89 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.96 0.904 . . . . 65.14 109.605 -176.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -93.67 90.13 6.49 Favored 'General case' 0 C--N 1.349 0.544 0 C-N-CA 123.6 0.76 . . . . 75.14 109.266 -178.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 200' ' ' CYS . . . . . . . . . . . . . 53.4 t -164.62 81.84 1.27 Allowed Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 124.013 0.925 . . . . 73.31 108.955 175.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 201' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -73.92 -39.8 1.62 Allowed 'Trans proline' 0 C--N 1.374 1.871 0 C-N-CA 122.457 2.105 . . . . 74.02 113.099 -177.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 69.65 57.79 6.96 Favored Glycine 0 C--N 1.351 1.369 0 N-CA-C 111.724 -0.55 . . . . 73.41 111.724 -173.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -69.82 -49.02 56.73 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.944 0.898 . . . . 71.33 111.483 -174.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.57 124.16 23.21 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.834 -0.432 . . . . 74.01 109.834 176.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 205' ' ' LEU . . . . . 0.438 HD11 ' HB3' ' C' ' 236' ' ' LYS . 3.1 tm? -141.99 130.52 22.56 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 108.503 -0.925 . . . . 72.44 108.503 -176.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -77.67 116.76 18.47 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.601 0.76 . . . . 70.3 109.283 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -63.24 -29.83 71.09 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.76 0.824 . . . . 74.32 111.447 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 131.88 96.32 0.67 Allowed Glycine 0 C--N 1.348 1.247 0 N-CA-C 111.796 -0.521 . . . . 71.52 111.796 174.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . -66.03 -18.91 67.34 Favored Glycine 0 C--N 1.352 1.436 0 CA-C-O 119.623 -0.543 . . . . 63.34 114.045 177.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt 52.09 -75.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 126.772 2.029 . . . . 74.51 115.07 171.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . -67.17 96.47 0.33 Allowed Glycine 0 C--N 1.355 1.6 0 CA-C-O 119.7 -0.5 . . . . 74.43 113.26 -173.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 23.0 t 80.79 -8.06 1.49 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 126.018 1.727 . . . . 74.04 112.326 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 2.6 mp -88.54 87.01 2.7 Favored 'Isoleucine or valine' 0 C--N 1.355 0.805 0 N-CA-C 107.497 -1.297 . . . . 70.12 107.497 172.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 29.5 p -131.68 84.41 2.17 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.815 0.846 . . . . 75.43 109.29 178.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 215' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -125.57 145.29 50.19 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 109.178 -0.675 . . . . 73.31 109.178 178.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 19.3 mm100 68.78 132.22 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 125.544 1.538 . . . . 61.42 111.425 -172.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 3.0 mm? 61.4 44.99 8.95 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.613 1.165 . . . . 75.4 110.092 -178.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 10.2 tt -59.8 125.81 25.12 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.965 1.306 . . . . 71.43 110.57 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 62.37 24.43 14.54 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 124.467 1.107 . . . . 71.24 112.491 -176.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . 62.47 14.11 6.7 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 124.73 1.212 . . . . 74.3 113.024 177.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 221' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 47.7 7.09 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.135 0 C-N-CA 127.195 2.198 . . . . 73.55 116.817 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . 57.23 91.79 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 124.702 1.201 . . . . 75.21 112.27 -178.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -83.77 154.07 23.77 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.648 0.779 . . . . 72.13 110.524 177.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . 0.655 HG22 ' HA ' ' B' ' 113' ' ' LYS . 7.3 p -173.81 -35.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 124.862 1.265 . . . . 75.32 110.091 -178.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 40.4 p -74.57 125.22 28.16 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 114.909 -1.041 . . . . 73.55 112.245 -172.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . 0.452 ' HB3' ' OH ' ' B' ' 120' ' ' TYR . 4.3 mm? 70.95 -74.79 0.08 Allowed 'General case' 0 CA--C 1.56 1.329 0 C-N-CA 124.812 1.245 . . . . 74.43 113.154 165.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . 86.53 -133.9 12.14 Favored Glycine 0 N--CA 1.474 1.194 0 N-CA-C 111.542 -0.623 . . . . 71.24 111.542 -174.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 228' ' ' GLY . . . . . 0.441 ' HA3' HH12 ' C' ' 187' ' ' ARG . . . 110.86 128.41 5.35 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-N 117.016 0.408 . . . . 72.41 113.898 169.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 229' ' ' GLY . . . . . 0.416 ' HA2' ' HA ' ' C' ' 185' ' ' VAL . . . 126.45 161.86 11.05 Favored Glycine 0 C--N 1.348 1.233 0 CA-C-O 119.738 -0.479 . . . . 71.04 113.193 174.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . 0.467 ' HB2' ' HG ' ' B' ' 69' ' ' LEU . . . 175.3 145.8 0.07 Allowed 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.635 1.174 . . . . 70.23 110.119 174.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 231' ' ' LYS . . . . . 0.635 ' HE2' ' HB1' ' B' ' 125' ' ' ALA . 4.8 tptp -148.53 -158.09 0.88 Allowed 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.128 0.971 . . . . 73.24 108.457 177.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 3.9 m -143.91 156.09 44.31 Favored 'General case' 0 CA--C 1.56 1.34 0 N-CA-C 109.231 -0.655 . . . . 74.24 109.231 175.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -88.04 155.26 19.9 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 114.07 1.137 . . . . 71.44 114.07 -167.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . 0.67 ' HB2' ' HE ' ' C' ' 211' ' ' ARG . . . -174.84 167.05 3.68 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 125.411 1.485 . . . . 72.31 109.839 171.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -76.79 140.91 40.88 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 114.033 1.123 . . . . 64.41 114.033 -168.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 236' ' ' THR . . . . . 0.65 ' HB ' ' HB2' ' C' ' 220' ' ' GLU . 1.7 m -149.29 -150.79 0.36 Allowed 'General case' 0 CA--C 1.577 1.992 0 C-N-CA 125.697 1.599 . . . . 73.34 107.095 174.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . 0.472 ' H ' HG23 ' B' ' 236' ' ' THR . . . -155.94 32.21 0.35 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 120.173 1.351 . . . . 73.03 112.084 178.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 95.2 m -146.92 128.33 14.93 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 118.674 -0.679 . . . . 71.31 110.79 -176.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -170.24 -179.35 3.06 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 113.44 0.904 . . . . 74.42 113.44 176.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . -114.89 -142.85 7.95 Favored Glycine 0 C--N 1.36 1.887 0 CA-C-N 114.678 -1.146 . . . . 71.23 111.757 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 241' ' ' GLU . . . . . 0.715 ' HB3' ' HZ2' ' B' ' 245' ' ' LYS . 11.9 pt-20 -167.31 156.92 10.56 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.753 0.821 . . . . 71.23 110.18 177.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 242' ' ' TRP . . . . . 0.486 ' CE2' ' HG ' ' C' ' 233' ' ' LEU . 0.0 OUTLIER -137.53 -35.19 0.67 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.176 1.391 . . . . 70.32 108.75 -172.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -123.72 -173.49 2.76 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 106.212 -1.773 . . . . 74.22 106.212 157.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -74.36 103.92 1.58 Allowed Glycine 0 C--N 1.335 0.483 0 C-N-CA 121.417 -0.421 . . . . 71.54 112.556 174.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 245' ' ' LYS . . . . . 0.715 ' HZ2' ' HB3' ' B' ' 241' ' ' GLU . 1.6 pptp? -85.37 41.67 0.9 Allowed 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 122.039 0.923 . . . . 75.34 110.532 174.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 246' ' ' THR . . . . . 0.417 ' HA ' HG21 ' B' ' 154' ' ' ILE . 81.9 p -94.12 55.08 2.0 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.003 1.321 . . . . 71.14 110.062 -173.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 247' ' ' LEU . . . . . 0.434 HD13 ' HE2' ' A' ' 270' ' ' LYS . 2.3 tm? -143.91 139.72 29.34 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 108.217 -1.031 . . . . 72.51 108.217 -175.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 248' ' ' ARG . . . . . 0.409 ' N ' HD11 ' B' ' 247' ' ' LEU . 1.6 tmt_? -161.29 149.33 15.49 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 107.526 -1.287 . . . . 75.15 107.526 171.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 249' ' ' GLU . . . . . 0.43 ' HA ' ' HA3' ' B' ' 362' ' ' GLY . 0.4 OUTLIER -151.62 153.42 34.43 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 123.489 0.716 . . . . 71.33 109.854 -179.253 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -149.28 -34.03 0.2 Allowed 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 123.985 0.914 . . . . 70.14 112.18 176.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 251' ' ' ALA . . . . . . . . . . . . . . . -158.24 38.4 0.25 Allowed 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 114.383 1.253 . . . . 64.21 114.383 -163.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -67.56 -47.43 69.82 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.273 0.629 . . . . 73.12 109.728 175.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -79.21 76.99 5.74 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 108.317 -0.994 . . . . 51.41 108.317 168.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 24.0 tpt180 -85.41 -5.17 59.32 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 114.967 -1.015 . . . . 72.51 111.284 -171.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -59.22 -61.01 7.8 Favored Glycine 0 C--N 1.354 1.568 0 N-CA-C 111.914 -0.474 . . . . 63.32 111.914 177.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 256' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 71.94 -50.77 0.7 Allowed 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 125.836 1.655 . . . . 71.2 113.002 178.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -61.5 99.24 0.1 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.957 0.903 . . . . 74.31 110.903 177.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 258' ' ' LEU . . . . . . . . . . . . . 30.1 tp -96.05 23.42 6.48 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 124.081 0.952 . . . . 75.13 109.301 176.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 4.3 p 50.65 21.8 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 C-N-CA 126.537 1.935 . . . . 63.31 112.71 -174.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 260' ' ' SER . . . . . . . . . . . . . 44.8 m -124.68 131.18 53.48 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 107.896 -1.15 . . . . 73.11 107.896 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 15.9 t70 67.68 -73.98 0.08 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.34 1.456 . . . . 65.51 111.704 -176.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 262' ' ' ALA . . . . . 0.466 ' HA ' ' HA ' ' B' ' 266' ' ' ASN . . . -58.05 -13.48 4.81 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.325 1.05 . . . . 75.22 113.114 -178.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -59.41 -32.12 69.89 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 124.07 0.948 . . . . 70.44 112.524 174.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 27.2 t -158.2 -41.39 0.06 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.86 0.464 . . . . 51.14 112.227 -178.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 265' ' ' LEU . . . . . . . . . . . . . 40.2 tp -72.64 -47.32 48.55 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.347 0.659 . . . . 73.31 110.823 -176.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 266' ' ' ASN . . . . . 0.466 ' HA ' ' HA ' ' B' ' 262' ' ' ALA . 51.4 m-80 64.71 111.2 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 125.306 1.442 . . . . 71.52 112.655 172.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 95.5 p 55.28 25.1 7.05 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 125.266 1.426 . . . . 73.13 112.333 178.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 54.2 t 52.3 -82.32 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 C-N-CA 125.853 1.661 . . . . 74.44 112.464 -177.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 269' ' ' THR . . . . . 0.543 HG22 ' HE2' ' B' ' 275' ' ' LYS . 10.9 m 58.24 59.7 2.94 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.502 1.121 . . . . 74.31 109.97 -177.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 270' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -83.54 75.65 10.01 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 115.403 -0.817 . . . . 72.41 108.864 -177.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 271' ' ' ALA . . . . . . . . . . . . . . . 65.36 -75.01 0.05 OUTLIER 'General case' 0 CA--C 1.558 1.271 0 C-N-CA 125.072 1.349 . . . . 75.3 111.402 -175.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 272' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -124.55 -31.76 3.2 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.351 1.06 . . . . 73.11 109.689 175.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -73.19 121.88 21.0 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.209 1.003 . . . . 73.43 111.714 -174.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 58.56 102.32 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 125.329 1.452 . . . . 71.44 112.847 173.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 275' ' ' LYS . . . . . 0.543 ' HE2' HG22 ' B' ' 269' ' ' THR . 16.6 ptpt -153.41 95.17 2.94 Favored Pre-proline 0 CA--C 1.553 1.091 0 C-N-CA 123.165 0.586 . . . . 72.14 110.305 178.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 276' ' ' PRO . . . . . 0.442 ' HB3' ' HB ' ' B' ' 348' ' ' ILE . 88.7 Cg_exo -49.49 -67.9 0.1 OUTLIER 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 123.442 2.761 . . . . 73.04 112.219 168.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 277' ' ' LEU . . . . . . . . . . . . . 87.8 mt 49.98 89.97 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 125.0 1.32 . . . . 74.52 113.087 176.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 1.8 pp -75.77 6.48 4.9 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 113.665 0.987 . . . . 72.2 113.665 -174.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . -88.46 45.92 3.3 Favored Glycine 0 C--N 1.349 1.25 0 CA-C-O 119.612 -0.549 . . . . 75.43 113.339 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 4.9 tt 61.23 -87.59 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.093 1.357 . . . . 74.31 109.782 -175.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 58.48 -77.52 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 125.15 1.38 . . . . 75.31 112.441 -176.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . 60.75 -98.42 0.08 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.867 1.267 . . . . 65.41 110.732 -176.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -68.44 99.58 0.97 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.229 0.612 . . . . 72.33 109.962 -175.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . 135.9 -38.74 1.74 Allowed Glycine 0 N--CA 1.475 1.28 0 CA-C-N 115.746 -0.661 . . . . 72.13 111.568 -176.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -116.03 12.73 15.72 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 124.113 0.965 . . . . 73.03 110.484 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 286' ' ' MET . . . . . 0.48 ' HE3' ' HB1' ' B' ' 346' ' ' ALA . 15.7 tpt -161.92 139.2 6.45 Favored Pre-proline 0 C--O 1.247 0.948 0 N-CA-C 105.582 -2.007 . . . . 74.22 105.582 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 287' ' ' PRO . . . . . 0.419 ' HD2' ' SD ' ' B' ' 286' ' ' MET . 55.3 Cg_exo -40.47 -41.82 3.67 Favored 'Trans proline' 0 C--N 1.388 2.637 0 C-N-CA 124.092 3.195 . . . . 74.24 114.152 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 288' ' ' VAL . . . . . 0.485 HG21 ' H ' ' B' ' 289' ' ' ARG . 0.0 OUTLIER -151.25 -86.11 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.233 0 C-N-CA 125.106 1.363 . . . . 74.32 107.81 169.295 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 289' ' ' ARG . . . . . 0.485 ' H ' HG21 ' B' ' 288' ' ' VAL . 0.0 OUTLIER -159.95 -26.64 0.06 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.032 1.733 . . . . 74.32 107.1 170.791 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 290' ' ' TRP . . . . . 0.452 ' HA ' ' NH1' ' B' ' 56' ' ' ARG . 31.8 m-90 -64.44 165.89 9.16 Favored 'General case' 0 C--N 1.357 0.925 0 CA-C-N 115.348 -0.842 . . . . 75.34 110.396 160.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 291' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -44.92 -32.26 1.55 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 125.659 1.584 . . . . 73.52 113.471 175.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . 170.03 -152.8 20.12 Favored Glycine 0 C--N 1.348 1.219 0 CA-C-O 119.547 -0.585 . . . . 71.42 112.094 176.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.14 6.39 1.46 Allowed 'Trans proline' 0 C--N 1.369 1.63 0 C-N-CA 123.366 2.711 . . . . 75.13 113.79 172.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -68.18 106.34 2.39 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.666 0.786 . . . . 74.44 109.849 174.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -119.46 17.69 12.92 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.31 1.044 . . . . 71.35 109.589 167.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 22.5 m -69.95 109.89 4.75 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.041 0.936 . . . . 71.52 112.512 -171.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -107.19 159.03 16.64 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.518 1.127 . . . . 75.44 108.663 165.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 298' ' ' HIS . . . . . 0.417 ' H ' ' HB2' ' B' ' 61' ' ' ASP . 80.1 t60 64.85 113.79 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.496 1.118 . . . . 73.43 110.334 -173.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . -60.98 94.99 0.08 OUTLIER Glycine 0 C--N 1.347 1.191 0 CA-C-N 116.232 -0.44 . . . . 72.35 113.092 177.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -71.03 -28.94 64.76 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.106 0.962 . . . . 72.23 111.186 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 301' ' ' ILE . . . . . . . . . . . . . 12.7 tt -87.41 -21.16 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 123.903 0.881 . . . . 75.13 110.622 176.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.54 -29.45 61.38 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.843 0.857 . . . . 74.32 110.652 177.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 303' ' ' LYS . . . . . 0.445 ' HA ' ' HE2' ' B' ' 303' ' ' LYS . 0.6 OUTLIER -62.31 -47.63 89.15 Favored Pre-proline 0 CA--C 1.567 1.598 0 C-N-CA 123.722 0.809 . . . . 74.11 111.551 -178.056 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 304' ' ' PRO . . . . . 0.469 ' HA ' ' SG ' ' B' ' 308' ' ' CYS . 92.2 Cg_endo -79.21 164.12 24.67 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 121.798 1.666 . . . . 75.12 111.452 160.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . 67.55 -78.01 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 124.906 1.282 . . . . 72.13 113.05 177.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 56.2 t -61.76 -58.27 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 124.32 1.048 . . . . 72.33 111.636 -170.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 82.7 p -88.1 4.76 44.17 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.642 0.377 . . . . 74.23 111.723 -177.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 308' ' ' CYS . . . . . 0.469 ' SG ' ' HA ' ' B' ' 304' ' ' PRO . 77.8 m -77.49 -43.35 32.5 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 109.233 -0.655 . . . . 74.22 109.233 171.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 41.2 p -83.52 144.14 45.52 Favored Pre-proline 0 CA--C 1.548 0.898 0 CA-C-N 114.775 -1.102 . . . . 72.2 109.59 174.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.36 146.04 89.21 Favored 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 122.738 2.292 . . . . 64.44 111.712 178.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 311' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -57.11 -39.51 78.24 Favored Pre-proline 0 N--CA 1.486 1.375 0 C-N-CA 124.282 1.033 . . . . 73.13 112.582 -178.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 312' ' ' PRO . . . . . 0.467 ' HB3' ' HA ' ' B' ' 120' ' ' TYR . 60.2 Cg_endo -70.76 66.29 2.37 Favored 'Trans proline' 0 C--N 1.399 3.191 0 C-N-CA 122.091 1.861 . . . . 70.14 112.592 164.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 313' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -66.08 -38.99 89.66 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 109.509 -0.552 . . . . 75.13 109.509 174.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 314' ' ' ARG . . . . . 0.491 ' HA ' HG21 ' B' ' 121' ' ' VAL . 91.8 mtt180 67.88 -76.33 0.06 Allowed 'General case' 0 C--N 1.362 1.133 0 C-N-CA 125.526 1.53 . . . . 74.53 111.186 -178.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 315' ' ' ASN . . . . . 0.421 ' HB2' ' CZ ' ' A' ' 194' ' ' TYR . 7.5 p-10 -164.49 -165.47 0.95 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.477 1.111 . . . . 75.34 108.872 -172.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 316' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 68.7 158.79 0.16 Allowed 'General case' 0 N--CA 1.499 2.023 0 C-N-CA 124.345 1.058 . . . . 74.4 112.573 -176.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 67.2 m -152.73 136.73 16.35 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.031 0.932 . . . . 75.41 109.458 175.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 318' ' ' VAL . . . . . . . . . . . . . 30.9 m -113.13 148.13 38.8 Favored Pre-proline 0 N--CA 1.48 1.032 0 C-N-CA 123.978 0.911 . . . . 73.13 109.984 178.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 319' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -69.1 147.83 67.99 Favored 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 122.457 2.105 . . . . 65.1 111.108 173.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 320' ' ' THR . . . . . . . . . . . . . 8.7 m 69.77 15.12 8.04 Favored 'General case' 0 CA--C 1.562 1.405 0 C-N-CA 124.53 1.132 . . . . 73.24 111.162 -179.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 321' ' ' LEU . . . . . . . . . . . . . 56.2 tp -59.35 113.7 2.3 Favored 'General case' 0 C--N 1.358 0.939 0 C-N-CA 123.188 0.595 . . . . 74.43 109.758 177.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 322' ' ' ALA . . . . . . . . . . . . . . . 77.2 -67.06 0.22 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.314 1.446 . . . . 64.54 112.015 -177.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 323' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 60.97 40.96 14.73 Favored 'General case' 0 CA--C 1.561 1.391 0 C-N-CA 124.069 0.948 . . . . 74.02 109.43 -177.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 324' ' ' MET . . . . . . . . . . . . . 63.6 ttp 77.36 -30.98 0.17 Allowed 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 125.684 1.594 . . . . 74.22 112.093 -175.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 325' ' ' THR . . . . . . . . . . . . . 3.2 m 63.5 30.98 15.14 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 124.956 1.302 . . . . 72.33 110.799 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 326' ' ' ASP . . . . . 0.47 ' HB2' ' HZ1' ' B' ' 327' ' ' LYS . 17.3 m-20 66.04 -176.47 0.19 Allowed 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.941 1.297 . . . . 72.01 112.028 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . 0.47 ' HZ1' ' HB2' ' B' ' 326' ' ' ASP . 3.8 mppt? 65.85 162.2 0.15 Allowed 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 125.424 1.489 . . . . 75.41 112.65 -178.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 328' ' ' ALA . . . . . 0.421 ' HB1' ' HA ' ' B' ' 332' ' ' LEU . . . 72.28 -66.15 0.32 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.731 1.612 . . . . 72.03 111.442 -178.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 329' ' ' ILE . . . . . . . . . . . . . 2.0 mp 60.51 112.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 C-N-CA 125.009 1.324 . . . . 73.5 111.546 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 330' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 72.21 -66.8 0.29 Allowed 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.281 1.432 . . . . 74.44 112.69 174.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 331' ' ' LEU . . . . . 0.428 HD22 ' HA ' ' B' ' 335' ' ' ASN . 39.7 mt -62.78 -48.81 77.52 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.196 0.998 . . . . 64.42 111.858 -173.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 332' ' ' LEU . . . . . 0.421 ' HA ' ' HB1' ' B' ' 328' ' ' ALA . 89.4 mt 62.18 -76.05 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 125.272 1.429 . . . . 74.41 112.451 177.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 333' ' ' SER . . . . . . . . . . . . . 38.9 t -100.88 59.0 0.92 Allowed 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.942 0.897 . . . . 65.04 109.081 178.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm 69.83 162.53 0.23 Allowed 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 125.014 1.325 . . . . 65.35 111.29 -175.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 335' ' ' ASN . . . . . 0.428 ' HA ' HD22 ' B' ' 331' ' ' LEU . 27.1 t-20 -63.26 91.52 0.05 Allowed 'General case' 0 C--N 1.361 1.074 0 N-CA-C 107.948 -1.13 . . . . 74.12 107.948 167.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -71.29 -50.0 37.08 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 114.901 -1.045 . . . . 73.55 108.914 176.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 337' ' ' LYS . . . . . . . . . . . . . 26.9 tptp 63.34 -71.97 0.05 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.812 1.645 . . . . 71.1 110.19 -175.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 338' ' ' GLY . . . . . . . . . . . . . . . -125.95 167.58 18.31 Favored Glycine 0 C--N 1.338 0.678 0 N-CA-C 111.385 -0.686 . . . . 73.12 111.385 171.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 339' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 67.11 113.78 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 125.188 1.395 . . . . 74.33 111.318 -178.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 340' ' ' PHE . . . . . 0.514 ' HD1' ' HD2' ' C' ' 260' ' ' ARG . 9.8 p90 -50.9 93.95 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 125.702 1.601 . . . . 75.24 112.917 -179.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 341' ' ' LEU . . . . . . . . . . . . . 6.7 mp 61.31 8.45 2.11 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 124.886 1.274 . . . . 75.34 112.861 -178.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 342' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 61.98 137.44 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 125.893 1.677 . . . . 74.32 111.525 -174.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 343' ' ' VAL . . . . . 0.571 HG23 ' H ' ' B' ' 345' ' ' GLY . 12.7 p -134.49 147.12 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 O-C-N 121.652 -0.655 . . . . 65.15 111.147 -169.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -67.32 -20.18 65.57 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.783 0.833 . . . . 74.33 111.441 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 345' ' ' GLY . . . . . 0.571 ' H ' HG23 ' B' ' 343' ' ' VAL . . . -80.32 24.97 3.35 Favored Glycine 0 C--N 1.348 1.223 0 N-CA-C 114.845 0.698 . . . . 63.14 114.845 177.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 346' ' ' ALA . . . . . 0.48 ' HB1' ' HE3' ' B' ' 286' ' ' MET . . . -79.04 -19.8 50.5 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.335 0.654 . . . . 72.51 110.792 173.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 73.4 m -128.68 130.38 47.12 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.857 0.863 . . . . 72.21 109.295 173.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 348' ' ' ILE . . . . . 0.442 ' HB ' ' HB3' ' B' ' 276' ' ' PRO . 40.3 mm -77.8 89.15 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.071 0 N-CA-C 109.011 -0.737 . . . . 73.42 109.011 175.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 349' ' ' ASP . . . . . . . . . . . . . 14.5 t70 72.59 -66.23 0.32 Allowed 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 126.002 1.721 . . . . 71.13 112.074 178.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 350' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' B' ' 276' ' ' PRO . 8.2 tttp 72.47 -75.17 0.08 Allowed 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 125.866 1.666 . . . . 74.52 110.027 177.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -175.05 -20.88 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.083 1.353 . . . . 71.32 109.627 177.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -81.79 56.22 2.98 Favored 'General case' 0 CA--C 1.558 1.287 0 C-N-CA 123.795 0.838 . . . . 74.35 109.472 178.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 353' ' ' HIS . . . . . 0.4 ' HA ' HD12 ' B' ' 55' ' ' LEU . 11.4 t-80 173.41 -49.04 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 126.091 1.756 . . . . 74.33 108.684 179.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 354' ' ' ALA . . . . . . . . . . . . . . . 62.39 37.16 13.87 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.533 1.133 . . . . 72.23 112.743 171.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 355' ' ' ALA . . . . . . . . . . . . . . . -91.84 -0.07 57.5 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.461 0.704 . . . . 75.44 111.729 173.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 356' ' ' ASN . . . . . 0.431 ' HB3' ' HD3' ' B' ' 357' ' ' PRO . 24.3 t-20 -60.98 -45.79 96.6 Favored Pre-proline 0 CA--C 1.565 1.545 0 CA-C-O 118.789 -0.624 . . . . 74.32 111.026 172.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 357' ' ' PRO . . . . . 0.431 ' HD3' ' HB3' ' B' ' 356' ' ' ASN . 24.3 Cg_exo -67.89 114.12 3.25 Favored 'Trans proline' 0 C--N 1.393 2.878 0 C-N-CA 121.972 1.781 . . . . 74.21 112.097 167.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 358' ' ' CYS . . . . . . . . . . . . . 6.8 p -78.02 144.95 36.24 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.629 0.771 . . . . 75.21 110.881 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 359' ' ' GLY . . . . . . . . . . . . . . . -139.35 53.79 0.69 Allowed Glycine 0 C--N 1.35 1.315 0 CA-C-O 119.52 -0.6 . . . . 72.04 113.515 -171.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 360' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 70.49 -63.68 0.4 Allowed 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 125.744 1.618 . . . . 53.34 113.003 176.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 361' ' ' ILE . . . . . . . . . . . . . 39.6 mm -57.46 108.27 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 124.802 1.241 . . . . 64.41 111.053 -173.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 362' ' ' GLY . . . . . 0.43 ' HA3' ' HA ' ' B' ' 249' ' ' GLU . . . 109.56 -55.15 0.52 Allowed Glycine 0 C--N 1.338 0.651 0 CA-C-N 114.649 -1.159 . . . . 72.35 112.395 -176.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 363' ' ' GLU . . . . . 0.549 ' HG2' HG23 ' B' ' 364' ' ' THR . 38.4 tt0 -68.38 -68.93 0.36 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.264 1.026 . . . . 73.13 111.486 -174.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 364' ' ' THR . . . . . 0.549 HG23 ' HG2' ' B' ' 363' ' ' GLU . 40.1 p -110.08 68.13 0.66 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.62 0.768 . . . . 74.04 110.576 -174.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 4.5 p -161.12 87.5 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.135 0 CA-C-O 121.635 0.731 . . . . 74.51 110.075 174.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 23.8 t70 76.73 -26.54 0.19 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 126.242 1.817 . . . . 52.52 113.124 177.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 367' ' ' LEU . . . . . . . . . . . . . 7.4 mp 71.0 -97.21 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.37 1.468 . . . . 75.05 111.717 174.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 368' ' ' ASP . . . . . . . . . . . . . 33.4 p-10 -153.41 -2.03 0.22 Allowed 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 113.96 1.096 . . . . 73.23 113.96 -162.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 369' ' ' GLU . . . . . 0.41 ' HB3' ' NH2' ' B' ' 373' ' ' ARG . 36.0 tt0 -53.94 -62.34 1.72 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.419 0.688 . . . . 74.11 112.832 -171.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 370' ' ' ALA . . . . . . . . . . . . . . . -169.61 169.9 8.41 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.248 0.619 . . . . 74.25 110.633 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 371' ' ' VAL . . . . . . . . . . . . . 59.7 t -110.46 122.05 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 108.099 -1.074 . . . . 74.12 108.099 173.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 372' ' ' GLN . . . . . 0.407 ' HB3' HD22 ' B' ' 375' ' ' LEU . 17.9 tm0? 81.46 -33.53 0.1 Allowed 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 125.667 1.587 . . . . 63.2 112.824 172.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 373' ' ' ARG . . . . . 0.41 ' NH2' ' HB3' ' B' ' 369' ' ' GLU . 7.0 mpt_? 80.43 -54.53 0.35 Allowed 'General case' 0 N--CA 1.507 2.391 0 C-N-CA 125.448 1.499 . . . . 72.2 113.561 173.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -83.26 69.86 10.02 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.051 0.541 . . . . 71.45 110.894 -174.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 375' ' ' LEU . . . . . 0.407 HD22 ' HB3' ' B' ' 372' ' ' GLN . 3.2 mm? -115.84 101.43 8.79 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.7 0.8 . . . . 72.22 109.365 178.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -122.74 92.76 3.78 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.591 -0.892 . . . . 73.13 108.591 172.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 377' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -132.86 162.17 32.26 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.381 1.072 . . . . 73.31 108.897 178.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 378' ' ' ALA . . . . . . . . . . . . . . . 67.87 16.87 9.68 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 124.496 1.119 . . . . 73.45 112.552 176.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -77.6 86.45 3.92 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.058 0.943 . . . . 73.22 109.586 -175.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 380' ' ' LYS . . . . . 0.411 ' H ' HD22 ' B' ' 408' ' ' LEU . 56.3 mttp 59.36 19.57 7.82 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 124.959 1.303 . . . . 72.4 112.037 -169.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 381' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -90.18 18.05 6.39 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.32 0.648 . . . . 74.34 111.265 -176.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -66.16 -69.01 1.46 Allowed Glycine 0 C--N 1.348 1.242 0 N-CA-C 110.996 -0.841 . . . . 73.1 110.996 173.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 383' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 69.31 -20.44 0.17 Allowed 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 125.707 1.603 . . . . 73.1 113.73 175.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 384' ' ' THR . . . . . . . . . . . . . 22.0 p -132.68 -64.93 0.73 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.902 0.881 . . . . 71.44 110.04 -171.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 385' ' ' LEU . . . . . 0.498 HD12 ' HA ' ' B' ' 85' ' ' ASN . 2.1 mm? 53.89 -86.29 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 125.801 1.64 . . . . 75.43 112.177 -178.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 386' ' ' VAL . . . . . . . . . . . . . 8.2 p -161.75 139.24 2.13 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 N-CA-C 106.773 -1.566 . . . . 75.23 106.773 178.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 387' ' ' ILE . . . . . . . . . . . . . 29.8 mm 58.91 75.44 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 N-CA-C 107.796 -1.187 . . . . 74.12 107.796 -166.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 388' ' ' VAL . . . . . . . . . . . . . 17.3 m -61.72 88.84 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.259 0 CA-C-N 114.537 -1.211 . . . . 74.43 112.658 -169.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 389' ' ' THR . . . . . . . . . . . . . 11.3 t -173.51 159.62 3.68 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.306 1.042 . . . . 71.25 110.049 178.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . 64.71 -76.61 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 125.572 1.549 . . . . 73.41 113.01 177.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 391' ' ' ASP . . . . . . . . . . . . . 34.3 t70 58.04 51.23 9.05 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 124.536 1.134 . . . . 64.12 109.892 -174.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 392' ' ' HIS . . . . . . . . . . . . . 10.4 t60 70.62 137.36 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 115.274 -0.875 . . . . 72.42 108.852 -172.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -60.5 92.75 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 122.878 0.471 . . . . 61.53 110.09 176.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 29.6 m170 -71.07 -58.9 3.11 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.956 0.903 . . . . 73.31 109.988 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . 60.01 43.47 14.53 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.081 0.952 . . . . 75.42 110.022 -169.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 36.4 m 68.65 4.71 4.5 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 125.782 1.633 . . . . 75.55 112.459 -174.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 397' ' ' GLN . . . . . 0.407 ' NE2' ' HD3' ' B' ' 401' ' ' PRO . 18.8 tp60 62.43 105.31 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.444 1.498 . . . . 75.54 112.26 -178.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 2.1 mp -69.82 99.46 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 N-CA-C 107.6 -1.259 . . . . 75.44 107.6 174.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 399' ' ' VAL . . . . . . . . . . . . . 39.4 t 54.08 -95.21 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 C-N-CA 125.176 1.39 . . . . 73.32 110.55 -170.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 400' ' ' ALA . . . . . . . . . . . . . . . 172.94 98.04 0.05 OUTLIER Pre-proline 0 C--N 1.364 1.226 0 C-N-CA 124.757 1.223 . . . . 74.52 109.327 178.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 401' ' ' PRO . . . . . 0.407 ' HD3' ' NE2' ' B' ' 397' ' ' GLN . 32.4 Cg_exo -61.12 -17.05 49.93 Favored 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 123.393 2.728 . . . . 71.34 112.55 174.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -51.5 -48.5 62.91 Favored 'General case' 0 C--N 1.348 0.517 0 C-N-CA 125.301 1.44 . . . . 74.34 110.071 173.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 403' ' ' THR . . . . . . . . . . . . . 55.1 p 52.09 -83.41 0.01 OUTLIER 'General case' 0 C--N 1.36 1.036 0 C-N-CA 126.107 1.763 . . . . 73.2 111.695 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 404' ' ' LYS . . . . . . . . . . . . . 10.1 mptt -75.96 -55.36 5.69 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.352 -0.981 . . . . 71.14 108.352 175.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 405' ' ' ALA . . . . . . . . . . . . . . . -172.79 -47.39 0.0 OUTLIER Pre-proline 0 CA--C 1.561 1.394 0 CA-C-N 114.643 -1.162 . . . . 71.24 111.838 -176.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 406' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -62.06 108.33 0.65 Allowed 'Trans proline' 0 C--N 1.4 3.288 0 C-N-CA 122.201 1.934 . . . . 64.23 113.118 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . -171.2 -10.18 0.02 OUTLIER Glycine 0 N--CA 1.467 0.751 0 CA-C-N 115.549 -0.751 . . . . 74.04 112.555 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 408' ' ' LEU . . . . . 0.411 HD22 ' H ' ' B' ' 380' ' ' LYS . 5.8 mp -81.02 15.12 1.96 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.741 1.217 . . . . 72.55 111.728 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 78.3 p -76.19 -165.17 0.45 Allowed 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 125.181 1.392 . . . . 73.52 112.681 -173.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 410' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 67.83 -85.0 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 125.331 1.452 . . . . 70.42 111.163 175.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . -138.27 138.23 38.24 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.184 0.593 . . . . 74.33 110.505 -174.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 7.0 mp 58.04 -165.5 0.17 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 125.411 1.485 . . . . 75.21 112.353 178.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 14.5 m120 67.2 -71.51 0.1 Allowed 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 125.033 1.333 . . . . 71.14 109.948 -169.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 414' ' ' THR . . . . . 0.518 HG22 ' HA ' ' B' ' 98' ' ' ASP . 81.4 p -84.03 -162.15 0.62 Allowed 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.573 1.549 . . . . 73.24 111.442 -178.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 415' ' ' LYS . . . . . 0.575 ' HE3' HG23 ' B' ' 419' ' ' VAL . 68.8 tttt -79.79 34.37 0.28 Allowed 'General case' 0 CA--C 1.571 1.769 0 C-N-CA 123.67 0.788 . . . . 75.21 112.238 -178.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -65.02 -46.61 80.6 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 108.651 -0.87 . . . . 75.33 108.651 168.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 417' ' ' GLY . . . . . . . . . . . . . . . -78.09 79.62 1.45 Allowed Glycine 0 C--N 1.351 1.386 0 N-CA-C 109.182 -1.567 . . . . 62.31 109.182 163.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 418' ' ' ALA . . . . . 0.524 ' HA ' ' HG2' ' B' ' 415' ' ' LYS . . . -78.18 86.57 4.3 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.352 0.871 . . . . 70.25 113.352 -163.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 419' ' ' VAL . . . . . 0.575 HG23 ' HE3' ' B' ' 415' ' ' LYS . 66.2 t 52.28 -77.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 C-N-CA 126.392 1.877 . . . . 73.31 113.983 171.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 420' ' ' MET . . . . . 0.601 ' HE2' ' HB3' ' B' ' 422' ' ' MET . 23.3 ttt -44.71 122.0 2.96 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.934 1.294 . . . . 73.34 113.652 -167.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 421' ' ' VAL . . . . . . . . . . . . . 13.1 p -64.58 -30.98 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 O-C-N 124.371 1.044 . . . . 72.42 112.361 -174.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 422' ' ' MET . . . . . 0.601 ' HB3' ' HE2' ' B' ' 420' ' ' MET . 3.5 tpt -68.03 85.39 0.24 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.308 0.643 . . . . 74.1 109.731 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 423' ' ' SER . . . . . . . . . . . . . 9.5 t 66.49 -5.43 0.61 Allowed 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 125.425 1.49 . . . . 63.45 114.121 173.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 424' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 55.31 30.91 15.63 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 124.493 1.117 . . . . 74.22 110.988 -173.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . -68.13 142.67 39.91 Favored Glycine 0 C--N 1.354 1.54 0 CA-C-N 114.796 -1.093 . . . . 75.12 113.817 -171.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 426' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 55.6 -91.53 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.972 1.309 . . . . 75.43 110.46 -173.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 427' ' ' SER . . . . . . . . . . . . . 36.1 t -170.03 78.26 0.09 Allowed 'General case' 0 C--N 1.353 0.749 0 C-N-CA 123.885 0.874 . . . . 75.14 109.228 176.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 73.56 -68.16 0.23 Allowed 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 125.148 1.379 . . . . 73.23 111.241 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 429' ' ' GLU . . . . . 0.454 ' HB2' ' CE1' ' B' ' 434' ' ' HIS . 15.5 mm-40 62.45 18.95 10.8 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 125.053 1.341 . . . . 63.42 112.779 174.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -108.14 138.55 44.22 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.824 0.85 . . . . 62.42 110.778 -176.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 46.3 t -125.97 -78.03 0.59 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 108.63 -0.878 . . . . 75.05 108.63 178.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 432' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -116.85 -11.39 10.88 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.44 0.696 . . . . 71.1 110.198 173.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 433' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -170.78 139.22 1.47 Allowed 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 107.993 -1.114 . . . . 73.43 107.993 178.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 434' ' ' HIS . . . . . 0.454 ' CE1' ' HB2' ' B' ' 429' ' ' GLU . 11.2 t-160 -151.35 88.18 1.42 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 122.945 0.498 . . . . 73.42 109.768 172.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 435' ' ' THR . . . . . . . . . . . . . 4.1 m 60.24 23.98 13.37 Favored 'General case' 0 CA--C 1.562 1.441 0 C-N-CA 123.957 0.903 . . . . 73.42 112.542 164.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . 144.05 -26.44 2.04 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-O 119.79 -0.45 . . . . 61.51 113.161 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 47.5 p -83.25 70.02 10.05 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-O 121.75 0.786 . . . . 72.35 110.574 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 438' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -101.78 -97.14 0.28 Allowed 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 107.592 -1.262 . . . . 71.55 107.592 175.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 439' ' ' LEU . . . . . . . . . . . . . 95.9 mt 49.89 27.56 2.42 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 124.303 1.041 . . . . 74.24 113.093 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 440' ' ' ARG . . . . . 0.423 ' NH1' ' HB2' ' A' ' 222' ' ' ALA . 8.1 mmt180 -70.34 123.49 21.84 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.699 0.8 . . . . 74.1 109.891 -172.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 441' ' ' ILE . . . . . 0.559 HG12 HD13 ' A' ' 235' ' ' LEU . 71.8 mt -66.6 134.01 30.54 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 124.18 0.992 . . . . 74.15 112.129 -168.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 442' ' ' ALA . . . . . . . . . . . . . . . -107.12 34.04 3.67 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.032 1.333 . . . . 73.33 110.867 -178.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 443' ' ' ALA . . . . . 0.537 ' H ' HG22 ' B' ' 441' ' ' ILE . . . -84.78 -167.48 1.83 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.309 0.644 . . . . 74.21 110.932 177.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -57.34 105.16 0.21 Allowed 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 123.624 0.77 . . . . 71.31 111.923 -177.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . -165.55 83.08 0.1 Allowed Glycine 0 C--N 1.342 0.911 0 N-CA-C 109.616 -1.394 . . . . 74.34 109.616 178.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 446' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -58.15 92.35 0.06 OUTLIER 'Trans proline' 0 C--N 1.383 2.343 0 C-N-CA 123.748 2.965 . . . . 72.44 114.002 -173.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 447' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 57.15 -92.93 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 125.369 1.468 . . . . 63.45 111.169 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 448' ' ' ALA . . . . . 0.675 ' HA ' HD23 ' B' ' 470' ' ' LEU . . . 49.2 -83.89 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.638 1.575 . . . . 74.31 114.394 178.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 449' ' ' ALA . . . . . . . . . . . . . . . -71.83 89.57 1.07 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.345 1.058 . . . . 74.42 112.826 -166.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 450' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -138.35 -68.33 0.45 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.13 0.972 . . . . 63.22 108.443 167.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 7.8 m -137.14 -42.86 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 123.843 0.857 . . . . 74.44 110.834 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 452' ' ' VAL . . . . . . . . . . . . . 6.4 t 57.55 33.72 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.702 0 C-N-CA 124.529 1.132 . . . . 74.24 110.505 -178.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 174.34 170.89 38.1 Favored Glycine 0 C--N 1.346 1.138 0 CA-C-N 115.447 -0.797 . . . . 73.44 112.152 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 454' ' ' LEU . . . . . 0.672 HD23 HD12 ' B' ' 460' ' ' LEU . 3.1 pp -105.38 138.45 41.56 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.164 0.586 . . . . 73.13 111.13 -178.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 13.4 m -96.19 87.46 4.52 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 107.695 -1.224 . . . . 72.1 107.695 172.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -74.2 89.8 2.04 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.376 0.608 . . . . 74.3 111.236 -175.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 457' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -124.18 45.1 2.57 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 107.382 -1.34 . . . . 65.21 107.382 170.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 21.8 m 72.26 71.47 0.15 Allowed 'General case' 0 C--N 1.352 0.684 0 C-N-CA 125.231 1.412 . . . . 72.13 107.926 -159.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 459' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -167.05 153.55 8.35 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 114.496 -1.229 . . . . 73.31 109.296 -172.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 460' ' ' LEU . . . . . 0.672 HD12 HD23 ' B' ' 454' ' ' LEU . 34.3 tp -149.0 73.61 1.22 Allowed 'General case' 0 C--O 1.24 0.576 0 N-CA-C 109.112 -0.699 . . . . 65.42 109.112 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -63.72 99.88 0.25 Allowed 'General case' 0 C--N 1.359 0.994 0 N-CA-C 107.159 -1.423 . . . . 75.0 107.159 165.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -54.96 -49.47 71.33 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 123.923 0.764 . . . . 72.53 109.697 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 21.5 m 71.9 -24.93 0.18 Allowed 'General case' 0 CA--C 1.564 1.518 0 C-N-CA 125.547 1.539 . . . . 71.14 113.192 174.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 464' ' ' MET . . . . . . . . . . . . . 3.9 mpp? 55.17 61.24 3.0 Favored 'General case' 0 C--N 1.361 1.103 0 C-N-CA 125.352 1.461 . . . . 75.31 110.722 -177.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -83.22 136.51 34.38 Favored 'General case' 0 C--N 1.35 0.597 0 CA-C-N 114.998 -1.001 . . . . 72.15 110.288 177.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -125.22 166.87 15.69 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 124.737 1.215 . . . . 65.13 108.533 173.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . -83.58 51.35 1.99 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.643 0.777 . . . . 75.3 110.813 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 52.0 tp -168.66 -44.67 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.623 1.169 . . . . 74.32 108.757 -175.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 469' ' ' GLY . . . . . . . . . . . . . . . -178.56 -144.35 5.6 Favored Glycine 0 C--N 1.347 1.194 0 CA-C-N 115.367 -0.833 . . . . 62.03 111.662 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 470' ' ' LEU . . . . . 0.675 HD23 ' HA ' ' B' ' 448' ' ' ALA . 2.6 pt? -156.62 164.35 38.27 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.821 0.849 . . . . 75.32 109.529 178.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 471' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? . . . . . 0 CA--C 1.553 1.08 0 N-CA-C 107.556 -1.276 . . . . 74.2 107.556 173.128 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 69.2 mtm . . . . . 0 N--CA 1.482 1.169 0 CA-C-O 120.261 0.077 . . . . 70.43 111.192 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 69.29 41.67 1.31 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.546 1.138 . . . . 70.41 112.206 169.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.55 69.94 9.42 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.787 -0.642 . . . . 71.34 109.647 175.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -38.53 105.73 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.11 1.764 . . . . 70.52 113.589 177.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 5' ' ' LYS . . . . . 0.489 ' HB3' HD13 ' C' ' 10' ' ' ILE . 49.7 mtpt -88.47 104.15 16.53 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 107.425 -1.324 . . . . 72.32 107.425 164.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -67.8 108.35 2.94 Favored 'General case' 0 C--N 1.35 0.595 0 N-CA-C 108.401 -0.962 . . . . 65.15 108.401 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 7' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -64.96 -33.61 76.45 Favored 'General case' 0 C--O 1.244 0.81 0 O-C-N 124.162 0.914 . . . . 73.43 111.814 -169.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -68.11 -41.36 81.87 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.76 -0.654 . . . . 74.23 110.219 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.53 -39.73 94.31 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.274 0.629 . . . . 63.34 110.883 179.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 10' ' ' ILE . . . . . 0.489 HD13 ' HB3' ' C' ' 5' ' ' LYS . 81.7 mt -56.98 -43.17 80.39 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 123.686 0.795 . . . . 73.31 110.027 173.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 96.2 mt -76.59 -15.81 59.75 Favored 'General case' 0 CA--C 1.556 1.174 0 N-CA-C 112.952 0.723 . . . . 75.53 112.952 176.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.88 21.29 71.69 Favored Glycine 0 C--N 1.351 1.413 0 N-CA-C 114.021 0.368 . . . . 74.43 114.021 -177.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 23.8 m -112.52 160.26 31.07 Favored Pre-proline 0 N--CA 1.486 1.353 0 C-N-CA 124.463 1.105 . . . . 71.34 110.479 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -55.04 157.58 13.15 Favored 'Trans proline' 0 C--N 1.385 2.46 0 C-N-CA 123.582 2.855 . . . . 74.43 114.509 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 65.1 mtt85 -78.98 28.62 0.22 Allowed 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 124.113 0.965 . . . . 74.35 113.58 -176.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -158.59 15.35 0.19 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.508 1.123 . . . . 71.24 108.631 174.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.28 148.15 33.15 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.371 1.068 . . . . 75.2 112.605 -171.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 74.6 p -87.66 -175.79 5.31 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.831 0.853 . . . . 74.41 112.245 -171.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -53.11 -55.2 25.83 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.155 0.982 . . . . 74.45 111.741 -174.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -63.99 -31.37 72.53 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 123.833 0.708 . . . . 74.53 111.673 -176.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -67.59 -49.77 61.54 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 122.237 0.215 . . . . 73.42 110.516 179.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 1.7 mp -64.0 -42.51 95.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 C-N-CA 123.548 0.739 . . . . 75.54 110.932 177.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -64.41 -52.54 57.64 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.233 1.013 . . . . 74.13 111.008 -176.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -75.29 -26.84 59.04 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.662 -0.699 . . . . 73.52 111.433 -174.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -73.34 -36.49 66.17 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 122.583 0.353 . . . . 75.32 110.893 173.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 26' ' ' TYR . . . . . 0.551 ' HD1' HG23 ' C' ' 50' ' ' ILE . 51.3 t80 -58.63 -56.21 25.13 Favored 'General case' 0 C--O 1.211 -0.973 0 N-CA-C 109.031 -0.729 . . . . 72.31 109.031 173.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -56.23 -45.69 79.84 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 124.614 1.196 . . . . 75.33 111.593 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 44.7 ttt180 -50.47 -55.1 17.4 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.479 1.112 . . . . 75.55 111.245 177.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 84.4 mt -85.26 -12.01 53.47 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 114.929 -1.032 . . . . 71.43 111.558 -175.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -91.75 -4.89 54.47 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.637 0.775 . . . . 75.32 110.155 173.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 36.7 mtp-105 -95.95 -43.47 7.8 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.887 0.875 . . . . 73.5 109.741 166.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.52 -54.29 25.4 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 109.212 -0.662 . . . . 71.12 109.212 -178.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -90.5 13.5 15.59 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 116.222 -0.445 . . . . 72.14 111.722 -178.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 34' ' ' HIS . . . . . . . . . . . . . 40.3 t60 -60.61 106.69 0.82 Allowed Pre-proline 0 N--CA 1.479 1.023 0 CA-C-O 118.386 -0.816 . . . . 74.34 109.248 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.28 -36.58 47.48 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 123.687 2.925 . . . . 72.22 114.855 -171.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -66.07 -34.63 78.5 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.45 1.1 . . . . 60.34 111.894 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 80.0 t -89.15 -50.69 13.06 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 122.916 0.486 . . . . 75.33 110.429 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -102.63 104.0 14.33 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.746 1.219 . . . . 65.41 109.507 -173.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -83.86 35.16 0.51 Allowed 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 123.498 0.719 . . . . 71.22 111.973 -174.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 59.6 m -97.38 132.57 25.13 Favored Pre-proline 0 N--CA 1.488 1.434 0 CA-C-O 119.047 -0.501 . . . . 74.14 110.548 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -49.22 -42.49 39.82 Favored 'Trans proline' 0 C--N 1.384 2.413 0 C-N-CA 123.199 2.599 . . . . 75.0 112.15 168.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -58.32 -37.23 74.68 Favored 'General case' 0 C--N 1.353 0.75 0 CA-C-N 115.542 -0.754 . . . . 71.01 111.025 177.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.56 -21.79 59.33 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 119.431 -0.319 . . . . 71.45 110.768 -178.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -69.59 -51.01 39.13 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 108.987 -0.746 . . . . 74.04 108.987 174.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 45' ' ' GLU . . . . . 0.435 ' O ' ' HG3' ' C' ' 49' ' ' GLU . 42.1 mt-10 -67.88 -47.35 69.09 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 114.103 -1.408 . . . . 75.44 110.793 -175.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 46' ' ' LYS . . . . . 0.551 ' O ' HG12 ' C' ' 50' ' ' ILE . 35.8 mmtm -60.35 -43.11 96.81 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-N 115.329 -0.851 . . . . 72.32 111.097 175.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -58.22 -40.96 83.03 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 123.656 0.597 . . . . 71.12 110.546 178.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -64.68 -34.26 77.88 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 123.747 0.654 . . . . 72.04 111.601 175.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 49' ' ' GLU . . . . . 0.435 ' HG3' ' O ' ' C' ' 45' ' ' GLU . 41.6 mt-10 -69.42 -33.0 72.33 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 122.653 0.381 . . . . 72.33 111.139 174.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 50' ' ' ILE . . . . . 0.551 HG12 ' O ' ' C' ' 46' ' ' LYS . 14.7 mm -71.66 -34.41 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 N-CA-C 108.903 -0.777 . . . . 75.43 108.903 176.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 51' ' ' ASN . . . . . 0.462 ' HB3' ' HD1' ' C' ' 88' ' ' PHE . 11.7 m120 -69.18 -36.71 77.62 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-N 114.642 -1.163 . . . . 74.04 110.662 176.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 62.2 tt0 -62.68 -54.34 40.89 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.9 0.88 . . . . 75.54 110.128 177.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -52.64 -60.88 2.71 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-N 113.467 -1.697 . . . . 63.1 111.224 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -61.19 -38.66 87.32 Favored 'General case' 0 C--O 1.21 -1.019 0 CA-C-N 115.072 -0.967 . . . . 75.01 111.895 -178.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.61 -51.26 70.58 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 122.827 0.451 . . . . 60.54 111.463 -177.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 56' ' ' VAL . . . . . 0.504 ' HA ' ' HE3' ' C' ' 62' ' ' LYS . 75.0 t -60.49 -40.63 84.92 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 O-C-N 124.307 1.004 . . . . 72.43 110.394 176.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 57' ' ' LEU . . . . . . . . . . . . . 46.9 mt -89.15 -0.8 57.74 Favored 'General case' 0 CA--C 1.565 1.544 0 N-CA-C 113.025 0.75 . . . . 75.02 113.025 -176.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 32.8 t -77.25 -57.39 3.86 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 124.339 1.056 . . . . 75.33 111.066 -178.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.83 122.83 82.81 Favored Pre-proline 0 C--N 1.354 0.796 0 N-CA-C 107.955 -1.128 . . . . 72.03 107.955 173.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 60' ' ' PRO . . . . . 0.532 ' HD2' ' HA ' ' C' ' 145' ' ' VAL . 19.1 Cg_endo -56.17 -27.78 67.34 Favored 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 123.066 2.51 . . . . 73.21 111.177 173.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . 0.655 ' HG2' ' HD3' ' C' ' 79' ' ' PRO . 3.2 tp10 -58.08 -66.06 0.54 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.249 1.02 . . . . 62.13 110.416 172.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 62' ' ' LYS . . . . . 0.504 ' HE3' ' HA ' ' C' ' 56' ' ' VAL . 17.7 mtmt -70.1 -22.99 62.97 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.426 0.69 . . . . 75.43 111.565 -173.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 48.8 tpt85 -61.18 -55.84 27.61 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.759 1.224 . . . . 74.14 109.233 172.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 -75.24 -19.15 59.9 Favored 'General case' 0 C--N 1.351 0.668 0 CA-C-N 115.26 -0.882 . . . . 74.15 111.523 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 65' ' ' ILE . . . . . 0.49 HG12 ' HB2' ' C' ' 76' ' ' PRO . 36.0 mt -66.03 -46.87 86.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.28 0.632 . . . . 71.5 109.55 171.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -61.46 -46.95 87.93 Favored 'General case' 0 C--N 1.353 0.727 0 O-C-N 123.803 0.689 . . . . 74.31 109.667 177.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -55.05 -48.6 73.22 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 123.675 0.609 . . . . 73.14 111.649 177.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 76.7 p -79.73 -9.15 59.61 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 112.568 0.581 . . . . 74.43 112.568 -178.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -72.38 100.37 2.65 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 108.229 -1.026 . . . . 75.22 108.229 174.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 125.05 10.83 4.54 Favored Glycine 0 N--CA 1.47 0.918 0 CA-C-N 115.348 -0.842 . . . . 62.51 111.704 -165.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 29.5 m -142.61 -55.53 0.43 Allowed 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 104.526 -2.398 . . . . 72.34 104.526 175.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 70.6 m -84.12 135.48 34.38 Favored 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 103.613 -2.736 . . . . 73.35 103.613 154.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.42 -31.09 8.31 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 118.987 0.812 . . . . 73.23 111.147 178.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -72.69 153.18 91.5 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 123.425 0.69 . . . . 53.23 109.254 171.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -54.3 113.55 1.41 Allowed 'Trans proline' 0 C--N 1.373 1.822 0 C-N-CA 122.56 2.173 . . . . 75.14 112.06 171.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 76' ' ' PRO . . . . . 0.49 ' HB2' HG12 ' C' ' 65' ' ' ILE . 45.8 Cg_exo -59.01 148.3 85.91 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 122.979 2.453 . . . . 71.22 111.525 175.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -57.82 124.43 16.0 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.985 2.457 . . . . 74.4 112.963 -169.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 78' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -63.33 153.25 75.61 Favored 'Trans proline' 0 C--N 1.38 2.221 0 C-N-CA 122.541 2.16 . . . . 74.44 111.904 175.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 79' ' ' PRO . . . . . 0.655 ' HD3' ' HG2' ' C' ' 61' ' ' GLU . 37.7 Cg_endo -66.36 147.44 82.94 Favored 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 122.128 1.885 . . . . 70.12 109.531 170.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -55.22 78.77 0.03 OUTLIER 'Trans proline' 0 C--N 1.384 2.436 0 C-N-CA 124.139 3.226 . . . . 74.31 114.646 -176.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 163.7 -51.89 0.3 Allowed Glycine 0 CA--C 1.519 0.283 0 N-CA-C 108.326 -1.909 . . . . 75.2 108.326 -174.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 134.14 -157.63 22.96 Favored Glycine 0 C--N 1.351 1.383 0 C-N-CA 123.09 0.376 . . . . 75.13 113.102 173.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -97.25 121.1 38.76 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.181 0.992 . . . . 73.4 109.007 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 84' ' ' ASP . . . . . 0.497 ' HB2' ' NE ' ' C' ' 143' ' ' ARG . 7.8 t70 -79.5 126.12 30.45 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 112.516 0.562 . . . . 75.11 112.516 -171.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 85' ' ' PHE . . . . . 0.405 ' HA ' ' HD2' ' C' ' 88' ' ' PHE . 87.0 m-85 -137.61 31.7 2.54 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.184 0.994 . . . . 74.41 109.288 173.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 15.5 m -81.07 85.24 6.33 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 114.657 -1.156 . . . . 52.42 110.869 -172.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 129.31 -15.85 5.76 Favored Glycine 0 N--CA 1.471 0.971 0 N-CA-C 110.626 -0.99 . . . . 74.34 110.626 -172.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 88' ' ' PHE . . . . . 0.462 ' HD1' ' HB3' ' C' ' 51' ' ' ASN . 33.2 m-85 -108.57 135.87 49.11 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 108.023 -1.102 . . . . 74.44 108.023 178.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -77.18 79.26 3.7 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.014 0.525 . . . . 72.23 110.271 -175.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 90' ' ' VAL . . . . . 0.521 HG23 ' HZ ' ' C' ' 97' ' ' PHE . 3.4 p -48.48 -40.85 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 C-N-CA 124.96 1.304 . . . . 54.42 112.574 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -62.92 -29.89 71.13 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.715 0.806 . . . . 75.25 111.42 -177.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -72.32 -33.42 67.34 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.057 0.543 . . . . 75.53 112.023 178.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 10.6 m-30 -70.38 166.22 20.76 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 122.72 0.408 . . . . 72.45 111.208 -166.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 75.5 p -57.32 149.65 19.84 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 113.306 0.854 . . . . 52.11 113.306 -168.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.4 -32.94 70.63 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 115.299 -0.864 . . . . 72.35 111.118 170.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -52.97 -52.06 59.43 Favored 'General case' 0 C--N 1.357 0.915 0 C-N-CA 125.016 1.327 . . . . 74.24 109.934 174.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 97' ' ' PHE . . . . . 0.521 ' HZ ' HG23 ' C' ' 90' ' ' VAL . 1.8 t80 -60.35 -44.12 95.86 Favored 'General case' 0 CA--C 1.557 1.22 0 CA-C-N 113.256 -1.793 . . . . 64.25 110.677 174.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -70.79 -12.82 61.78 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 112.568 0.581 . . . . 71.33 112.568 -177.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -93.25 -40.61 10.34 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.298 0.639 . . . . 74.43 110.818 173.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 23.7 tp -75.03 -63.57 1.24 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.021 0.528 . . . . 73.23 110.795 -178.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -80.65 -11.43 59.64 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 122.851 0.46 . . . . 75.04 111.841 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -41.03 -60.91 2.11 Favored Glycine 0 CA--C 1.541 1.715 0 CA-C-O 118.726 -1.041 . . . . 74.41 115.137 178.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -50.14 -28.13 18.91 Favored 'Trans proline' 0 C--N 1.386 2.551 0 C-N-CA 124.113 3.209 . . . . 64.35 114.693 -177.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -126.77 30.55 4.16 Favored Glycine 0 C--N 1.358 1.757 0 CA-C-O 118.516 -1.158 . . . . 73.42 113.145 -175.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 34.5 mt -68.28 72.17 0.19 Allowed 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 118.373 1.086 . . . . 75.43 112.688 177.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 106' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 43.53 -107.99 0.11 Allowed 'General case' 0 CA--C 1.562 1.441 0 C-N-CA 126.494 1.918 . . . . 64.24 113.874 170.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . 70.46 23.4 77.57 Favored Glycine 0 C--N 1.357 1.698 0 CA-C-O 120.002 -0.332 . . . . 51.05 112.943 -169.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 62.2 -104.14 0.7 Allowed Glycine 0 C--N 1.36 1.878 0 N-CA-C 111.668 -0.573 . . . . 74.41 111.668 -174.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 109' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -122.46 -7.28 8.67 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.571 1.148 . . . . 74.45 110.118 172.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 110' ' ' GLY . . . . . . . . . . . . . . . -88.83 -10.05 67.45 Favored Glycine 0 C--N 1.349 1.259 0 C-N-CA 123.48 0.562 . . . . 73.14 113.044 179.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 53.7 mtm-85 58.33 8.11 0.78 Allowed 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 124.642 1.177 . . . . 75.25 113.891 173.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 112' ' ' ARG . . . . . 0.638 ' HE ' ' HB3' ' C' ' 114' ' ' ARG . 44.3 ttp180 -55.7 -23.3 28.02 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 125.192 1.397 . . . . 75.43 112.544 176.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 113' ' ' SER . . . . . . . . . . . . . 27.4 m 65.14 17.5 11.07 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.963 1.305 . . . . 72.53 112.156 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 114' ' ' ARG . . . . . 0.638 ' HB3' ' HE ' ' C' ' 112' ' ' ARG . 14.4 tpt180 -119.57 177.59 4.88 Favored 'General case' 0 CA--C 1.555 1.142 0 CA-C-O 118.509 -0.757 . . . . 74.05 110.829 -170.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 115' ' ' LYS . . . . . 0.485 ' H ' ' HG3' ' C' ' 114' ' ' ARG . 53.9 tttp -25.16 129.24 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.362 0 C-N-CA 127.218 2.207 . . . . 74.15 116.262 -164.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -93.41 158.6 23.71 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-N 115.046 -0.979 . . . . 54.4 113.618 -173.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 117' ' ' ARG . . . . . 0.462 ' HA ' ' NE ' ' C' ' 117' ' ' ARG . 2.2 mmp_? -116.71 155.51 28.75 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.21 1.004 . . . . 74.32 112.156 178.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -66.89 108.61 2.62 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-O 121.756 0.789 . . . . 75.42 109.428 175.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 119' ' ' LEU . . . . . 0.54 HD21 HG22 ' B' ' 185' ' ' VAL . 3.9 tt -89.22 112.74 23.84 Favored 'General case' 0 C--O 1.224 -0.28 0 N-CA-C 105.814 -1.921 . . . . 75.21 105.814 -174.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -93.66 132.68 37.77 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.516 -1.29 . . . . 72.31 107.516 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 121' ' ' ALA . . . . . . . . . . . . . . . -143.52 117.0 9.12 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.161 -0.681 . . . . 75.44 109.161 -177.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 122' ' ' GLU . . . . . 0.531 ' HA ' ' O ' ' C' ' 177' ' ' VAL . 13.1 pt-20 -92.91 125.47 37.52 Favored 'General case' 0 C--N 1.353 0.754 0 N-CA-C 109.036 -0.727 . . . . 74.12 109.036 176.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 123' ' ' LEU . . . . . 0.666 ' HB2' ' HA ' ' B' ' 182' ' ' VAL . 0.8 OUTLIER -121.51 105.72 38.49 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 115.873 -0.603 . . . . 73.3 111.63 -170.048 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . 0.666 ' HD2' ' HB2' ' B' ' 183' ' ' ALA . 28.2 Cg_exo -42.33 113.77 0.34 Allowed 'Trans proline' 0 C--N 1.374 1.9 0 C-N-CA 123.314 2.676 . . . . 72.51 112.02 161.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 125' ' ' LEU . . . . . . . . . . . . . 42.9 tp -140.09 140.78 36.16 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.829 1.252 . . . . 75.32 108.401 -170.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.43 154.11 22.98 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 121.006 0.431 . . . . 61.53 111.156 -176.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 127' ' ' LEU . . . . . 0.65 ' HB3' HD22 ' C' ' 215' ' ' LEU . 96.2 mt -63.22 -44.28 95.72 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.519 1.128 . . . . 62.25 111.067 177.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -53.55 -49.03 68.55 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 114.964 -1.016 . . . . 75.24 110.302 172.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -66.19 -32.31 73.67 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.889 0.876 . . . . 75.51 111.484 -176.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -73.05 -31.54 64.48 Favored 'General case' 0 CA--C 1.541 0.596 0 O-C-N 124.087 0.867 . . . . 73.14 110.475 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 131' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -69.45 -43.16 73.85 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.448 0.699 . . . . 75.55 110.395 171.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 132' ' ' HIS . . . . . . . . . . . . . 38.2 m170 -67.11 -67.65 0.44 Allowed 'General case' 0 N--CA 1.485 1.28 0 O-C-N 124.007 0.817 . . . . 70.15 111.924 -172.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 67.52 99.28 0.03 OUTLIER Glycine 0 CA--C 1.542 1.734 0 O-C-N 123.423 0.452 . . . . 65.31 113.607 -178.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . -142.52 162.12 27.33 Favored Glycine 0 N--CA 1.476 1.311 0 CA-C-O 119.244 -0.753 . . . . 73.12 111.272 178.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 53.6 mp0 -71.45 92.81 1.12 Allowed 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 108.565 -0.902 . . . . 73.03 108.565 177.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 136' ' ' ARG . . . . . 0.539 ' HB2' HD22 ' B' ' 181' ' ' LEU . 99.0 mtt180 -124.75 154.71 40.47 Favored 'General case' 0 C--O 1.247 0.941 0 C-N-CA 124.084 0.954 . . . . 72.12 109.302 -173.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 137' ' ' VAL . . . . . 0.488 HG13 ' HB2' ' B' ' 180' ' ' ALA . 7.6 p -81.12 108.8 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-O 121.919 0.866 . . . . 73.11 111.828 -165.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 138' ' ' VAL . . . . . . . . . . . . . 20.8 m -87.78 133.98 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 108.012 -1.107 . . . . 72.14 108.012 165.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 139' ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' C' ' 143' ' ' ARG . 1.2 tm-20 -124.7 105.34 9.23 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 108.03 -1.1 . . . . 74.31 108.03 169.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 140' ' ' VAL . . . . . . . . . . . . . 67.1 t -127.81 110.41 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 123.796 0.838 . . . . 73.25 109.181 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 63.86 29.32 14.64 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.149 0.979 . . . . 65.0 110.976 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 97.76 -12.96 64.26 Favored Glycine 0 C--N 1.349 1.257 0 CA-C-N 115.003 -0.999 . . . . 52.4 112.738 -178.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 143' ' ' ARG . . . . . 0.497 ' NE ' ' HB2' ' C' ' 84' ' ' ASP . 5.9 tpp180 -75.26 93.92 2.93 Favored 'General case' 0 C--N 1.353 0.717 0 CA-C-N 117.253 0.527 . . . . 75.05 109.84 -177.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 28.8 ttp85 -104.73 96.68 6.74 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 124.373 1.069 . . . . 71.51 109.511 -176.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 145' ' ' VAL . . . . . 0.532 ' HA ' ' HD2' ' C' ' 60' ' ' PRO . 25.7 m -133.02 146.38 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.64 0.776 . . . . 75.03 110.615 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 46.4 m -89.79 92.48 9.06 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.949 -0.76 . . . . 73.22 108.949 174.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 147' ' ' VAL . . . . . 0.538 HG13 ' HE1' ' C' ' 164' ' ' MET . 10.8 p -113.16 145.37 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 122.942 0.497 . . . . 72.53 109.977 -174.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -101.16 101.81 12.61 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 108.499 -0.926 . . . . 74.22 108.499 170.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 149' ' ' ILE . . . . . . . . . . . . . 36.0 pt -73.57 137.1 77.49 Favored Pre-proline 0 CA--C 1.551 1.006 0 N-CA-C 107.734 -1.21 . . . . 74.42 107.734 165.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -63.76 142.66 83.9 Favored 'Trans proline' 0 C--N 1.37 1.702 0 C-N-CA 122.417 2.078 . . . . 61.44 113.136 -167.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -62.92 149.95 89.94 Favored 'Trans proline' 0 C--N 1.379 2.148 0 C-N-CA 122.843 2.362 . . . . 73.2 111.719 176.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 152' ' ' GLY . . . . . 0.689 ' HA2' ' HB3' ' C' ' 240' ' ' PHE . . . 80.59 52.79 4.29 Favored Glycine 0 C--N 1.336 0.557 0 CA-C-N 116.216 -0.447 . . . . 63.11 112.435 -176.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 153' ' ' VAL . . . . . 0.487 HG23 HD11 ' C' ' 159' ' ' ILE . 8.3 p -104.14 142.83 16.87 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.312 0 C-N-CA 123.009 0.524 . . . . 74.01 110.26 -177.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 154' ' ' ARG . . . . . 0.611 ' HA ' ' HB3' ' C' ' 188' ' ' LEU . 57.5 mtp180 -97.51 161.35 13.82 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.762 0.825 . . . . 75.32 112.094 -168.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 155' ' ' GLU . . . . . 0.454 ' HG2' ' HE ' ' C' ' 187' ' ' ARG . 8.3 tp10 -54.22 115.7 2.21 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.682 0.793 . . . . 74.51 110.102 162.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 78.1 19.67 74.34 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-O 119.536 -0.591 . . . . 75.21 113.862 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 157' ' ' SER . . . . . 0.565 ' HA ' ' HG2' ' B' ' 193' ' ' PRO . 3.4 m -70.62 108.53 4.41 Favored 'General case' 0 C--N 1.355 0.842 0 CA-C-N 117.365 0.583 . . . . 75.43 110.105 172.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 158' ' ' VAL . . . . . 0.528 HG12 ' HA ' ' B' ' 190' ' ' CYS . 22.0 t -84.43 88.46 2.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 114.698 -1.137 . . . . 72.31 108.437 176.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 159' ' ' ILE . . . . . 0.487 HD11 HG23 ' C' ' 153' ' ' VAL . 37.5 mt -72.14 118.02 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 115.184 -0.916 . . . . 72.31 109.587 -178.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -75.95 118.61 18.91 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 109.091 -0.707 . . . . 75.13 109.091 173.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 161' ' ' VAL . . . . . 0.452 HG11 ' SD ' ' C' ' 164' ' ' MET . 20.6 t -125.85 95.55 39.61 Favored Pre-proline 0 CA--C 1.55 0.96 0 N-CA-C 109.556 -0.535 . . . . 75.24 109.556 174.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.38 128.11 12.5 Favored 'Trans proline' 0 C--N 1.369 1.609 0 C-N-CA 122.264 1.976 . . . . 75.23 111.342 173.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 101.92 23.92 8.93 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-N 115.793 -0.64 . . . . 53.54 113.466 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 164' ' ' MET . . . . . 0.538 ' HE1' HG13 ' C' ' 147' ' ' VAL . 28.2 mtp -151.81 6.9 0.47 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 112.619 0.6 . . . . 73.35 112.619 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 165' ' ' GLY . . . . . 0.404 ' HA3' ' O ' ' C' ' 173' ' ' ASP . . . -121.92 -122.89 2.88 Favored Glycine 0 N--CA 1.478 1.458 0 CA-C-O 118.348 -1.251 . . . . 73.32 111.515 -177.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . 69.4 81.93 0.21 Allowed Glycine 0 C--N 1.359 1.816 0 CA-C-N 118.149 0.974 . . . . 75.44 113.823 165.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 167' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -69.23 99.41 1.16 Allowed 'General case' 0 C--N 1.348 0.512 0 N-CA-C 107.035 -1.469 . . . . 74.2 107.035 166.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . 131.51 -142.51 13.91 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 108.395 -1.882 . . . . 13.44 108.395 -161.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 169' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -145.74 -62.2 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.774 0 CA-C-N 120.226 2.013 . . . . 62.44 111.784 175.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 170' ' ' PRO . . . . . 0.452 ' HG2' ' HA ' ' C' ' 115' ' ' LYS . 26.6 Cg_endo -61.88 162.79 20.97 Favored 'Trans proline' 0 C--N 1.399 3.191 0 C-N-CA 122.174 1.916 . . . . 73.55 112.345 173.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 171' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -10.38 108.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.396 3.078 1 C-N-CA 127.079 5.186 . . . . 74.02 118.497 -165.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -140.32 -156.41 6.87 Favored Glycine 0 C--N 1.342 0.912 0 N-CA-C 109.311 -1.516 . . . . 74.42 109.311 170.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 173' ' ' ASP . . . . . 0.404 ' O ' ' HA3' ' C' ' 165' ' ' GLY . 14.5 t70 -166.3 158.29 13.85 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 117.843 0.822 . . . . 74.51 110.087 -177.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 174' ' ' LEU . . . . . 0.503 HD23 ' HE3' ' C' ' 164' ' ' MET . 45.2 tp -118.82 107.53 13.73 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.674 0.79 . . . . 75.22 109.758 175.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 175' ' ' LEU . . . . . 0.442 HD22 HG11 ' C' ' 158' ' ' VAL . 73.8 mt -86.44 85.85 7.33 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.962 0.905 . . . . 72.15 110.273 175.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 176' ' ' LEU . . . . . 0.445 ' HG ' ' HG ' ' C' ' 174' ' ' LEU . 47.9 mt -75.3 92.7 2.79 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.594 0.758 . . . . 74.33 110.543 177.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 177' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' C' ' 122' ' ' GLU . 6.5 t -84.92 94.13 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 C-N-CA 123.423 0.689 . . . . 75.23 109.921 179.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 178' ' ' VAL . . . . . . . . . . . . . 23.0 m -68.78 119.53 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 O-C-N 121.344 -0.848 . . . . 74.01 110.781 -176.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 179' ' ' ARG . . . . . 0.419 ' O ' ' HA ' ' C' ' 124' ' ' PRO . 7.0 mmm180 -100.93 119.7 39.09 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 107.023 -1.473 . . . . 74.42 107.023 171.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 180' ' ' LEU . . . . . 0.435 HD11 HD21 ' C' ' 127' ' ' LEU . 75.5 mt -68.6 134.99 50.78 Favored 'General case' 0 CA--C 1.559 1.29 0 CA-C-N 118.171 0.441 . . . . 73.43 111.397 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 181' ' ' LEU . . . . . 0.414 HD23 ' HB3' ' C' ' 124' ' ' PRO . 18.5 mt -53.12 169.64 0.29 Allowed Pre-proline 0 N--CA 1.502 2.148 0 C-N-CA 126.521 1.928 . . . . 74.24 113.538 -176.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -59.99 64.5 0.07 OUTLIER 'Trans proline' 0 C--N 1.405 3.543 0 C-N-CA 123.486 2.791 . . . . 73.32 112.268 161.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 183' ' ' HIS . . . . . 0.537 ' N ' ' HD3' ' C' ' 184' ' ' PRO . 76.4 t60 -162.37 26.15 0.02 OUTLIER Pre-proline 0 CA--C 1.576 1.957 0 C-N-CA 127.77 2.428 . . . . 72.0 107.705 -176.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 184' ' ' PRO . . . . . 0.537 ' HD3' ' N ' ' C' ' 183' ' ' HIS . 11.0 Cg_endo -88.49 67.67 3.0 Favored 'Trans proline' 0 C--N 1.401 3.341 0 C-N-CA 123.588 2.859 . . . . 74.25 111.377 -163.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 185' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 9.0 t -89.48 -23.93 6.05 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.492 0 N-CA-C 108.146 -1.057 . . . . 72.23 108.146 -177.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 186' ' ' PHE . . . . . 0.477 ' HD2' HD12 ' C' ' 127' ' ' LEU . 48.4 m-85 -127.85 101.82 6.51 Favored 'General case' 0 C--N 1.352 0.704 0 C-N-CA 123.737 0.815 . . . . 61.44 109.266 -178.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 187' ' ' ARG . . . . . 0.454 ' HE ' ' HG2' ' C' ' 155' ' ' GLU . 27.9 ttm105 -97.72 110.65 23.17 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 124.557 1.143 . . . . 75.14 108.182 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 188' ' ' LEU . . . . . 0.611 ' HB3' ' HA ' ' C' ' 154' ' ' ARG . 59.5 tp -76.77 131.94 38.99 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.387 0.613 . . . . 74.14 112.6 -166.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -116.08 106.3 13.59 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.147 1.379 . . . . 73.21 108.377 167.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 66.85 -99.8 0.51 Allowed Glycine 0 C--N 1.348 1.239 0 CA-C-N 116.053 -0.521 . . . . 74.2 112.454 -178.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 191' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -117.53 -14.21 10.28 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 124.262 1.025 . . . . 75.25 110.183 175.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -101.32 128.71 47.36 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.678 1.191 . . . . 65.13 110.401 -173.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 193' ' ' LEU . . . . . 0.43 ' HG ' ' HA2' ' C' ' 239' ' ' GLY . 77.8 mt -73.74 153.75 39.89 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.828 0.851 . . . . 65.15 111.883 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 194' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -123.83 106.72 10.7 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 107.266 -1.383 . . . . 75.43 107.266 169.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 195' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' C' ' 185' ' ' VAL . . . -110.76 -177.91 3.34 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.286 1.034 . . . . 65.11 110.38 -174.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 90.2 m -137.75 121.12 17.05 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 108.638 -0.875 . . . . 53.42 108.638 164.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 197' ' ' LEU . . . . . . . . . . . . . 63.2 tp -100.48 143.5 30.59 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.586 1.155 . . . . 73.5 110.232 -175.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -100.61 101.59 12.53 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 123.656 0.782 . . . . 64.33 109.004 -178.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 199' ' ' VAL . . . . . . . . . . . . . 94.9 t -114.51 125.58 29.0 Favored Pre-proline 0 N--CA 1.486 1.354 0 C-N-CA 124.404 1.081 . . . . 73.12 109.864 -176.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 200' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -74.06 145.05 34.83 Favored 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 121.675 1.583 . . . . 73.11 111.125 174.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 201' ' ' ALA . . . . . 0.437 ' O ' HG23 ' C' ' 205' ' ' VAL . . . -58.66 -38.89 70.25 Favored Pre-proline 0 CA--C 1.552 1.024 0 N-CA-C 115.263 1.579 . . . . 74.35 115.263 -173.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 202' ' ' PRO . . . . . 0.512 ' HB2' ' HA ' ' A' ' 273' ' ' ALA . 21.2 Cg_endo -59.13 -52.33 5.16 Favored 'Trans proline' 0 C--N 1.388 2.613 0 CA-C-N 121.711 1.647 . . . . 63.15 111.205 175.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 203' ' ' ILE . . . . . . . . . . . . . 43.4 mt -62.49 -28.25 44.36 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 C-N-CA 124.228 1.011 . . . . 74.02 110.737 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.62 -43.4 76.44 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.5 -0.773 . . . . 75.02 112.305 175.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 205' ' ' VAL . . . . . 0.522 HG11 HD13 ' A' ' 261' ' ' LEU . 65.2 t -69.39 -45.42 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 122.373 0.269 . . . . 74.52 110.964 -178.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 206' ' ' VAL . . . . . 0.505 HG12 ' O ' ' C' ' 202' ' ' PRO . 0.7 OUTLIER -96.58 -38.09 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 111.514 0.19 . . . . 74.12 111.514 -167.717 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 106.07 119.49 4.55 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 112.455 -0.258 . . . . 63.21 112.455 -173.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -156.44 -137.64 2.37 Favored Glycine 0 C--N 1.336 0.56 0 N-CA-C 109.79 -1.324 . . . . 51.32 109.79 176.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 209' ' ' LYS . . . . . 0.669 ' HG2' ' HA ' ' C' ' 222' ' ' ALA . 10.2 mtmp? -142.37 151.94 42.38 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 118.08 0.94 . . . . 72.44 111.712 177.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 210' ' ' VAL . . . . . . . . . . . . . 30.2 m -139.42 174.0 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 125.644 1.577 . . . . 71.52 108.516 174.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 211' ' ' ARG . . . . . 0.67 ' HE ' ' HB2' ' B' ' 234' ' ' ALA . 40.5 ttm-85 -109.66 127.64 54.7 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 118.431 0.56 . . . . 75.53 110.778 -176.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -107.97 113.14 26.11 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 107.335 -1.358 . . . . 74.43 107.335 169.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 213' ' ' MET . . . . . 0.809 ' HA ' ' HA ' ' C' ' 218' ' ' PRO . 4.2 ttp -80.28 98.95 7.63 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 108.954 -0.758 . . . . 63.12 108.954 -176.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.11 177.74 8.58 Favored 'General case' 0 C--O 1.244 0.798 0 O-C-N 123.342 0.401 . . . . 72.34 109.936 -174.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 215' ' ' LEU . . . . . 0.65 HD22 ' HB3' ' C' ' 127' ' ' LEU . 11.9 mt -52.68 -60.81 2.8 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.055 0.942 . . . . 75.24 110.506 -175.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -86.76 8.61 21.94 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.211 -0.904 . . . . 71.0 112.185 -174.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 142.07 157.03 7.0 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-O 119.925 -0.375 . . . . 74.41 113.307 177.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 218' ' ' PRO . . . . . 0.809 ' HA ' ' HA ' ' C' ' 213' ' ' MET . 31.8 Cg_endo -63.22 121.99 10.03 Favored 'Trans proline' 0 C--N 1.364 1.389 0 C-N-CA 122.95 2.433 . . . . 64.03 115.322 177.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 219' ' ' VAL . . . . . . . . . . . . . 8.0 p -98.77 167.84 1.8 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.928 0 N-CA-C 107.05 -1.463 . . . . 52.53 107.05 170.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 220' ' ' GLU . . . . . 0.65 ' HB2' ' HB ' ' B' ' 236' ' ' THR . 3.0 tt0 -101.04 158.45 16.0 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 109.338 -0.616 . . . . 72.32 109.338 173.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 221' ' ' VAL . . . . . . . . . . . . . 33.3 t -121.97 123.22 68.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 125.2 1.4 . . . . 74.03 108.309 173.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 222' ' ' ALA . . . . . 0.669 ' HA ' ' HG2' ' C' ' 209' ' ' LYS . . . -84.15 101.92 12.19 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 123.118 0.567 . . . . 73.3 109.565 169.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 61.0 t -75.53 123.39 88.49 Favored Pre-proline 0 CA--C 1.549 0.91 0 CA-C-N 114.409 -1.269 . . . . 73.11 109.222 178.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 224' ' ' PRO . . . . . 0.403 ' HA ' ' HA ' ' B' ' 245' ' ' LYS . 11.0 Cg_exo -76.37 164.44 30.85 Favored 'Trans proline' 0 C--N 1.369 1.651 0 C-N-CA 123.552 2.835 . . . . 73.11 112.917 172.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -55.96 146.52 68.2 Favored 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 122.361 2.041 . . . . 74.4 112.684 165.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 226' ' ' ARG . . . . . 0.444 ' HG3' ' HA ' ' A' ' 259' ' ' GLU . 8.0 mpt_? 66.65 66.5 0.45 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.764 1.225 . . . . 71.5 110.814 171.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 227' ' ' THR . . . . . 0.494 ' HA ' ' HD3' ' C' ' 231' ' ' ARG . 16.7 m -114.89 121.79 44.29 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 114.697 -1.138 . . . . 73.3 110.779 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 228' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -111.27 163.01 14.4 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.922 0.889 . . . . 74.32 110.809 -178.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -77.18 111.43 12.79 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 114.403 -1.271 . . . . 65.31 109.965 -178.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 110.61 6.2 27.12 Favored Glycine 0 N--CA 1.476 1.311 0 CA-C-O 119.896 -0.391 . . . . 62.04 113.115 -169.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 231' ' ' ARG . . . . . 0.588 ' HG2' ' HA ' ' B' ' 30' ' ' GLU . 39.4 mtp85 -77.84 169.78 17.71 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 109.623 -0.51 . . . . 75.03 109.623 164.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 232' ' ' LYS . . . . . 0.692 ' HB2' ' HZ2' ' C' ' 232' ' ' LYS . 2.1 ttmp? -135.08 151.02 50.36 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.424 0.63 . . . . 74.05 112.461 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 233' ' ' LEU . . . . . 0.697 HD11 ' HB2' ' C' ' 251' ' ' LEU . 5.6 mp -113.96 157.21 22.75 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.672 1.589 . . . . 74.22 110.874 -176.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 28.5 ptt-85 -134.57 97.12 3.71 Favored 'General case' 0 CA--C 1.559 1.324 0 O-C-N 125.327 1.642 . . . . 72.34 110.65 173.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 235' ' ' LEU . . . . . 0.472 ' HB2' ' HB3' ' C' ' 249' ' ' LEU . 87.5 mt -93.29 104.44 16.61 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.9 0.88 . . . . 74.34 108.819 171.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 236' ' ' LYS . . . . . 0.438 ' HB3' HD11 ' B' ' 205' ' ' LEU . 29.3 mmmt -68.89 132.28 46.48 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.756 0.822 . . . . 73.41 112.184 -174.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 74.37 22.58 77.32 Favored Glycine 0 C--N 1.357 1.711 0 O-C-N 123.925 0.766 . . . . 71.42 113.965 177.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 238' ' ' LYS . . . . . 0.416 ' HE3' ' O ' ' B' ' 165' ' ' THR . 27.9 mmtm -115.79 17.96 15.88 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.462 0.705 . . . . 75.11 111.382 -178.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 239' ' ' GLY . . . . . 0.43 ' HA2' ' HG ' ' C' ' 193' ' ' LEU . . . -91.61 -159.04 35.13 Favored Glycine 0 C--N 1.349 1.252 0 O-C-N 123.421 0.45 . . . . 75.2 112.851 177.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 240' ' ' PHE . . . . . 0.689 ' HB3' ' HA2' ' C' ' 152' ' ' GLY . 4.4 m-85 -88.65 154.84 50.82 Favored Pre-proline 0 CA--C 1.551 0.997 0 CA-C-O 119.102 -0.475 . . . . 75.14 109.776 179.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 241' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -67.93 101.62 0.7 Allowed 'Trans proline' 0 C--N 1.387 2.596 0 C-N-CA 122.83 2.353 . . . . 71.53 110.66 177.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -94.12 167.86 28.14 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-N 115.623 -0.717 . . . . 70.14 112.152 177.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 243' ' ' PRO . . . . . 0.427 ' HD3' ' HB1' ' B' ' 195' ' ' ALA . 73.8 Cg_endo -70.02 -23.52 29.53 Favored 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 123.023 2.482 . . . . 71.42 111.412 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -99.0 27.34 5.09 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.318 1.047 . . . . 71.42 110.064 175.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 92.07 177.98 41.94 Favored Glycine 0 C--N 1.351 1.377 0 CA-C-N 115.918 -0.583 . . . . 63.24 112.186 -177.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 246' ' ' ARG . . . . . . . . . . . . . 80.1 mtm180 -72.48 138.21 46.87 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 122.699 0.399 . . . . 71.32 110.267 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -79.01 -155.54 9.07 Favored Glycine 0 C--N 1.344 1.025 0 O-C-N 123.857 0.723 . . . . 63.23 112.374 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -120.25 177.6 4.96 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 108.562 -0.903 . . . . 73.54 108.562 -175.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 249' ' ' LEU . . . . . 0.472 ' HB3' ' HB2' ' C' ' 235' ' ' LEU . 12.8 tp -119.7 109.28 15.45 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.877 -0.786 . . . . 74.23 108.877 177.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 250' ' ' TYR . . . . . 0.6 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 19.9 m-85 -101.5 105.57 16.58 Favored 'General case' 0 C--N 1.343 0.325 0 CA-C-N 115.901 -0.59 . . . . 71.43 109.605 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 251' ' ' LEU . . . . . 0.697 ' HB2' HD11 ' C' ' 233' ' ' LEU . 2.1 mp -99.71 149.47 23.29 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 109.595 -0.52 . . . . 72.0 109.595 -173.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -103.44 128.17 50.65 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.388 -0.967 . . . . 75.41 108.388 175.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 253' ' ' VAL . . . . . . . . . . . . . 95.1 t -74.15 133.28 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.172 0.589 . . . . 73.5 111.896 -172.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 254' ' ' ARG . . . . . 0.537 ' NH2' ' HB ' ' C' ' 256' ' ' THR . 1.3 tmm_? -122.27 94.98 4.47 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 107.321 -1.363 . . . . 75.13 107.321 176.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 255' ' ' ILE . . . . . 0.445 HD12 HG21 ' C' ' 227' ' ' THR . 46.6 mm -69.17 131.35 34.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 122.634 0.374 . . . . 75.24 110.459 177.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 256' ' ' THR . . . . . 0.537 ' HB ' ' NH2' ' C' ' 254' ' ' ARG . 0.0 OUTLIER -140.8 172.0 13.3 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.538 1.135 . . . . 70.25 111.153 -174.514 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 2.9 pp -130.96 154.18 81.94 Favored Pre-proline 0 CA--C 1.556 1.181 0 C-N-CA 124.351 1.06 . . . . 75.21 109.29 177.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -72.38 -2.62 11.99 Favored 'Trans proline' 0 C--N 1.377 2.065 0 C-N-CA 122.451 2.101 . . . . 74.41 113.631 -166.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 57.14 -72.12 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 125.229 1.412 . . . . 72.3 111.74 -166.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 260' ' ' ARG . . . . . 0.514 ' HD2' ' HD1' ' B' ' 340' ' ' PHE . 27.4 ptt180 -69.75 148.03 49.72 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.597 0.759 . . . . 73.41 111.103 177.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 261' ' ' LEU . . . . . 0.472 HD11 ' HA ' ' C' ' 266' ' ' GLU . 72.7 mt -138.35 141.47 39.69 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.243 0.617 . . . . 74.53 111.416 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 46.7 p -82.09 150.8 65.58 Favored Pre-proline 0 CA--C 1.545 0.771 0 N-CA-C 107.995 -1.113 . . . . 61.23 107.995 170.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -47.04 -39.46 25.43 Favored 'Trans proline' 0 N--CA 1.509 2.394 0 C-N-CA 123.77 2.98 . . . . 74.2 113.759 -177.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 264' ' ' GLU . . . . . 0.472 ' HG2' ' NH2' ' A' ' 279' ' ' ARG . 2.8 tp10 -55.89 -67.62 0.27 Allowed 'General case' 0 C--O 1.246 0.877 0 C-N-CA 124.578 1.151 . . . . 71.04 111.093 175.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -66.04 -28.63 69.0 Favored 'General case' 0 C--O 1.212 -0.885 0 CA-C-N 115.176 -0.92 . . . . 71.03 110.847 -173.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 266' ' ' GLU . . . . . 0.472 ' HA ' HD11 ' C' ' 261' ' ' LEU . 11.6 tp10 -57.88 -50.15 74.3 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.025 0.93 . . . . 73.1 109.575 174.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -60.4 -38.53 84.27 Favored 'General case' 0 CA--C 1.548 0.887 0 O-C-N 123.853 0.72 . . . . 71.12 111.592 176.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 268' ' ' LEU . . . . . . . . . . . . . 11.0 mp -65.06 -47.68 76.45 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 112.445 0.535 . . . . 70.11 112.445 177.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 269' ' ' TRP . . . . . 0.426 ' CH2' ' HD3' ' C' ' 202' ' ' PRO . 90.5 m95 -64.74 -33.42 75.92 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.302 0.641 . . . . 63.11 110.603 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 270' ' ' LYS . . . . . 0.531 ' HB3' ' HZ3' ' C' ' 270' ' ' LYS . 4.6 mmmp? -64.9 -48.64 73.47 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.739 0.816 . . . . 75.43 111.547 177.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 13.0 mmtm -65.74 -37.96 87.83 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.059 0.543 . . . . 75.33 111.917 179.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 272' ' ' LEU . . . . . 0.418 HD11 HD12 ' A' ' 272' ' ' LEU . 64.3 mt -76.53 -22.46 54.35 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.761 -0.654 . . . . 74.33 111.226 177.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -67.28 -47.04 71.82 Favored 'General case' 0 C--O 1.218 -0.572 0 N-CA-C 109.226 -0.657 . . . . 43.22 109.226 171.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -60.69 -37.36 81.38 Favored 'General case' 0 N--CA 1.483 1.215 0 O-C-N 124.291 0.994 . . . . 63.21 111.099 176.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -63.58 -37.2 86.43 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.625 0.77 . . . . 70.04 111.287 175.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 276' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -83.25 -22.33 33.09 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 116.311 -0.404 . . . . 75.52 112.077 178.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 20.8 m-30 -68.16 -35.93 78.84 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 108.408 -0.96 . . . . 65.52 108.408 172.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -59.39 -27.26 65.83 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 114.898 -1.047 . . . . 72.22 111.439 171.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 279' ' ' ARG . . . . . 0.437 ' HG2' ' H ' ' B' ' 89' ' ' GLY . 25.3 mtp-105 -74.95 -31.54 61.52 Favored 'General case' 0 C--N 1.364 1.236 0 N-CA-C 109.648 -0.501 . . . . 75.11 109.648 175.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 N-CA-C 109.185 -0.672 . . . . 75.14 109.185 -175.233 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.0 mtp . . . . . 0 N--CA 1.473 0.701 0 N-CA-C 109.711 -0.477 . . . . 64.12 109.711 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.93 40.95 28.49 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.904 1.282 . . . . 74.44 112.612 174.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.6 61.47 5.74 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 122.986 0.515 . . . . 74.04 110.146 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -38.49 113.37 0.29 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.88 1.672 . . . . 64.14 112.955 -177.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -89.42 129.12 35.98 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.663 0.785 . . . . 74.32 110.269 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -84.07 86.55 7.19 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 107.007 -1.479 . . . . 62.43 107.007 170.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.444 ' CD1' ' HA ' ' A' ' 53' ' ' ALA . 69.9 m-85 -61.0 -25.96 67.26 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 114.988 -1.005 . . . . 73.34 112.024 -174.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.505 ' HE1' ' HE2' ' A' ' 66' ' ' TYR . 49.3 m-85 -66.69 -52.54 43.58 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.602 -0.726 . . . . 73.33 109.581 175.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.61 -36.54 76.51 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.592 0.757 . . . . 70.01 110.885 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 69.8 mt -59.43 -44.16 92.07 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.097 0 C-N-CA 123.91 0.884 . . . . 74.23 110.943 174.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.5 mt -77.18 -6.95 54.91 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 112.515 0.561 . . . . 73.11 112.515 175.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.92 17.83 76.29 Favored Glycine 0 C--N 1.352 1.434 0 C-N-CA 122.961 0.315 . . . . 73.42 113.561 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.6 m -108.83 152.24 42.22 Favored Pre-proline 0 CA--C 1.554 1.125 0 C-N-CA 124.055 0.942 . . . . 72.52 110.008 176.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -86.41 172.72 6.88 Favored 'Trans proline' 0 C--N 1.368 1.599 0 C-N-CA 122.366 2.044 . . . . 50.12 112.928 178.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 11.9 mmt85 -68.85 78.48 0.31 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.127 -0.942 . . . . 75.43 109.345 172.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -174.37 -31.82 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 114.335 -1.302 . . . . 71.2 108.431 -172.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.43 120.92 15.29 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.624 -0.716 . . . . 74.14 111.304 -178.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 76.2 p -82.62 175.25 10.31 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.989 0.916 . . . . 75.03 110.027 174.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -47.96 -39.81 20.43 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 124.728 1.211 . . . . 71.11 113.033 -176.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.445 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 0.5 OUTLIER -69.35 -44.82 70.83 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.521 0.729 . . . . 72.43 109.796 -175.689 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -67.39 -34.69 77.78 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 124.036 0.935 . . . . 71.14 111.455 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.559 HD12 HD13 ' A' ' 57' ' ' LEU . 77.9 mt -67.23 -36.6 77.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.98 1.312 . . . . 73.31 110.461 175.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -69.84 -38.64 76.56 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.233 -0.894 . . . . 75.22 109.672 178.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.445 ' HG3' ' O ' ' A' ' 20' ' ' GLU . 94.9 mtt180 -60.25 -48.56 81.22 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.509 0.723 . . . . 73.12 109.896 175.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.81 -43.71 98.31 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 124.541 1.151 . . . . 72.43 111.668 -177.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -61.55 -54.81 38.17 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.55 -0.75 . . . . 73.1 110.638 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -62.66 -32.73 73.84 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 124.119 0.887 . . . . 74.22 111.7 -177.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.403 ' HA ' ' NH2' ' A' ' 31' ' ' ARG . 14.9 ttt180 -57.99 -55.38 35.63 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.341 1.056 . . . . 75.52 110.058 174.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.603 ' HB3' HD11 ' A' ' 50' ' ' ILE . 78.8 mt -74.94 -15.13 60.7 Favored 'General case' 0 CA--C 1.552 1.026 0 CA-C-N 114.865 -1.061 . . . . 75.12 110.925 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.478 ' HA ' ' HE1' ' A' ' 47' ' ' PHE . . . -89.75 -12.0 40.6 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.032 0.933 . . . . 71.54 111.723 176.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.403 ' NH2' ' HA ' ' A' ' 28' ' ' ARG . 47.1 mtm105 -90.68 -42.93 10.45 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 109.714 -0.476 . . . . 72.33 109.714 167.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -68.68 -61.4 1.83 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.491 0.717 . . . . 73.31 111.345 -177.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -92.11 17.5 9.41 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.227 0.611 . . . . 72.41 112.211 -172.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 7.2 t-160 -57.38 101.85 0.28 Allowed Pre-proline 0 CA--C 1.555 1.156 0 C-N-CA 124.645 1.178 . . . . 73.54 111.654 -172.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.87 -32.03 75.78 Favored 'Trans proline' 0 C--N 1.388 2.65 0 C-N-CA 123.883 3.055 . . . . 75.51 113.71 -171.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -47.0 -43.68 19.61 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.609 1.164 . . . . 73.23 112.331 176.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 60.3 t -104.65 -24.77 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.665 0.786 . . . . 73.25 110.069 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -127.48 73.96 1.48 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.259 0.624 . . . . 64.12 110.474 -170.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -79.16 69.19 5.3 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 109.066 -0.716 . . . . 73.11 109.066 171.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.4 m -112.06 105.05 56.43 Favored Pre-proline 0 CA--C 1.535 0.38 0 N-CA-C 107.28 -1.378 . . . . 71.24 107.28 177.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -37.3 -49.38 1.72 Allowed 'Trans proline' 0 C--N 1.389 2.698 0 C-N-CA 124.689 3.593 . . . . 73.53 114.647 -173.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -51.95 -54.32 30.99 Favored 'General case' 0 N--CA 1.48 1.042 0 O-C-N 124.314 1.009 . . . . 64.43 111.086 177.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.09 -21.54 63.12 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 114.798 -1.092 . . . . 73.42 111.385 -177.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.457 ' O ' ' HD3' ' A' ' 48' ' ' LYS . 51.8 mt-10 -83.25 -38.69 21.88 Favored 'General case' 0 C--N 1.355 0.818 0 C-N-CA 122.824 0.45 . . . . 63.35 109.891 -176.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -65.73 -43.98 87.4 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.485 0.714 . . . . 62.44 109.445 175.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -58.62 -41.01 84.94 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 114.696 -1.138 . . . . 74.03 110.265 171.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.478 ' HE1' ' HA ' ' A' ' 30' ' ' ALA . 40.9 t80 -69.51 -25.32 63.99 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 123.407 0.442 . . . . 73.32 111.886 179.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.457 ' HD3' ' O ' ' A' ' 44' ' ' GLU . 2.0 mptm? -70.32 -39.13 74.95 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 109.944 -0.391 . . . . 75.14 109.944 174.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -63.43 -41.36 98.69 Favored 'General case' 0 CA--C 1.55 0.962 0 O-C-N 123.907 0.754 . . . . 71.44 110.568 174.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.603 HD11 ' HB3' ' A' ' 29' ' ' LEU . 69.4 mt -67.91 -40.53 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 124.621 1.168 . . . . 74.43 110.994 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -63.76 -41.03 98.05 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.261 -0.881 . . . . 73.43 110.379 174.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.411 ' HG3' ' CD1' ' A' ' 97' ' ' PHE . 33.4 tt0 -61.27 -48.85 79.52 Favored 'General case' 0 C--O 1.246 0.906 0 C-N-CA 124.62 1.168 . . . . 75.34 110.591 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.444 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . . . -58.01 -48.07 81.15 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 114.163 -1.38 . . . . 65.45 111.564 -178.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -82.8 -14.52 54.26 Favored 'General case' 0 C--O 1.212 -0.915 0 CA-C-N 115.774 -0.648 . . . . 73.53 111.649 178.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.11 -35.62 81.7 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.777 0.799 . . . . 72.52 109.661 173.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.436 HG21 ' HE1' ' A' ' 101' ' ' PHE . 34.4 t -73.05 -58.7 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 CA-C-N 113.748 -1.569 . . . . 74.52 110.264 170.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.559 HD13 HD12 ' A' ' 22' ' ' ILE . 51.8 mt -90.11 15.09 10.83 Favored 'General case' 0 CA--C 1.558 1.256 0 CA-C-N 115.215 -0.902 . . . . 74.35 113.109 -166.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 44.2 t -67.01 -68.07 0.4 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.283 0.633 . . . . 74.34 109.806 173.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -80.95 135.82 51.29 Favored Pre-proline 0 C--O 1.238 0.456 0 CA-C-N 114.799 -1.091 . . . . 74.34 108.792 176.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.453 ' O ' ' HG2' ' A' ' 64' ' ' ARG . 51.3 Cg_exo -56.43 -28.32 72.54 Favored 'Trans proline' 0 C--N 1.369 1.627 0 C-N-CA 123.016 2.477 . . . . 72.41 112.082 170.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -71.29 -48.31 51.52 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.438 0.695 . . . . 72.3 111.285 -178.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.502 ' HA ' HD11 ' A' ' 65' ' ' ILE . 37.6 mtpt -70.87 -27.25 63.68 Favored 'General case' 0 C--O 1.257 1.493 0 CA-C-O 121.36 0.6 . . . . 74.54 110.934 178.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.406 HH21 ' CD1' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -65.58 -41.76 92.5 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 115.382 -0.827 . . . . 74.11 109.436 171.159 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.453 ' HG2' ' O ' ' A' ' 60' ' ' PRO . 4.5 mmp_? -59.22 -41.68 89.22 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.572 0.749 . . . . 74.25 110.734 176.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.586 ' HA ' ' HG2' ' A' ' 76' ' ' PRO . 91.0 mt -53.34 -51.12 43.78 Favored 'Isoleucine or valine' 0 C--O 1.251 1.15 0 C-N-CA 124.037 0.935 . . . . 74.41 110.57 175.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.505 ' HE2' ' HE1' ' A' ' 8' ' ' TYR . 37.9 t80 -58.2 -52.16 66.73 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 115.826 -0.624 . . . . 75.4 111.653 173.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -56.91 -33.74 67.23 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.144 0.978 . . . . 64.04 112.041 -173.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 40.5 p -91.42 -14.91 29.76 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.133 0.573 . . . . 75.44 112.214 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -72.1 125.41 27.19 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 107.513 -1.291 . . . . 75.32 107.513 166.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.84 23.91 29.11 Favored Glycine 0 N--CA 1.47 0.918 0 N-CA-C 111.281 -0.728 . . . . 64.23 111.281 -171.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 60.0 m -144.88 -57.67 0.35 Allowed 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 103.321 -2.844 . . . . 71.23 103.321 175.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 34.2 m -78.91 134.48 36.88 Favored 'General case' 0 C--O 1.25 1.099 0 N-CA-C 104.348 -2.464 . . . . 74.23 104.348 155.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.27 -31.78 67.9 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.396 0.678 . . . . 74.04 110.733 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -92.17 161.33 33.35 Favored Pre-proline 0 C--O 1.244 0.769 0 C-N-CA 124.177 0.991 . . . . 75.1 110.561 177.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -63.85 138.65 64.35 Favored 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 121.822 1.681 . . . . 75.41 110.172 164.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.586 ' HG2' ' HA ' ' A' ' 65' ' ' ILE . 82.6 Cg_exo -52.99 156.98 8.81 Favored 'Trans proline' 0 N--CA 1.501 1.917 0 C-N-CA 124.062 3.175 . . . . 74.25 114.77 178.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -58.27 124.87 16.86 Favored 'Trans proline' 0 C--N 1.385 2.483 0 C-N-CA 123.065 2.51 . . . . 73.45 112.382 -178.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.427 ' HA ' ' HH ' ' A' ' 83' ' ' TYR . 16.1 Cg_exo -70.1 130.67 19.3 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 123.086 2.524 . . . . 73.2 112.245 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -60.91 142.64 98.2 Favored 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 122.827 2.351 . . . . 71.05 111.436 171.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.78 84.47 0.31 Allowed 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 122.83 2.353 . . . . 74.31 111.937 -177.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 165.85 -38.19 0.27 Allowed Glycine 0 C--N 1.333 0.383 0 CA-C-N 114.18 -1.373 . . . . 62.41 109.722 -177.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 113.29 -165.21 12.02 Favored Glycine 0 C--N 1.35 1.346 0 CA-C-N 115.212 -0.494 . . . . 53.03 112.921 176.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.427 ' HH ' ' HA ' ' A' ' 78' ' ' PRO . 25.4 m-85 -109.58 108.43 18.87 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.125 0.97 . . . . 74.41 109.882 -179.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -66.54 156.09 35.89 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.965 0.906 . . . . 71.31 111.369 173.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.554 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 59.9 m-85 -144.8 77.66 1.54 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.015 0.926 . . . . 73.24 110.491 -175.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.493 ' HB3' ' HG2' ' A' ' 162' ' ' PRO . 7.0 m -48.43 85.61 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.356 0 C-N-CA 125.596 1.558 . . . . 74.44 113.597 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.03 10.95 81.47 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-N 116.013 -0.539 . . . . 70.11 113.628 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.554 ' HB2' ' HB3' ' A' ' 85' ' ' PHE . 25.2 m-85 -104.25 103.57 13.35 Favored 'General case' 0 C--N 1.351 0.652 0 C-N-CA 123.211 0.604 . . . . 72.34 109.492 -175.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -82.55 83.29 7.63 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 121.469 0.652 . . . . 71.44 110.034 -174.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.3 p -44.56 -33.27 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 C-N-CA 126.058 1.743 . . . . 75.21 114.36 176.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.471 ' HB2' ' NH2' ' A' ' 114' ' ' ARG . 20.8 tp10 -55.99 -30.91 62.51 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.369 1.068 . . . . 75.33 111.647 -177.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -100.04 -6.65 26.09 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 123.787 0.835 . . . . 61.35 111.334 -175.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 12.8 m-30 -86.41 176.83 7.67 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 123.632 0.773 . . . . 73.34 110.929 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 91.9 p -67.56 161.39 25.7 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 113.161 0.8 . . . . 74.5 113.161 -169.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.85 -39.09 90.64 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 114.788 -1.096 . . . . 74.52 111.437 174.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -61.64 -40.39 94.71 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 122.655 0.382 . . . . 75.03 110.343 177.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.411 ' CD1' ' HG3' ' A' ' 52' ' ' GLU . 61.0 t80 -62.0 -41.46 98.08 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-O 121.493 0.663 . . . . 72.32 109.624 176.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -80.54 -1.22 41.01 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 114.693 -1.139 . . . . 74.14 112.531 177.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -100.15 -44.35 6.01 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 123.682 0.793 . . . . 70.02 111.872 170.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 24.7 tp -64.58 -47.68 77.81 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.454 1.101 . . . . 74.33 109.803 178.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.436 ' HE1' HG21 ' A' ' 56' ' ' VAL . 98.5 m-85 -92.65 -7.04 48.03 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.375 -0.83 . . . . 72.11 111.272 177.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -45.7 -58.89 5.16 Favored Glycine 0 CA--C 1.538 1.492 0 C-N-CA 124.458 1.028 . . . . 72.43 115.668 -177.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -61.9 -8.7 12.22 Favored 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 123.042 2.495 . . . . 64.43 114.046 -176.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -139.85 32.77 2.18 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-O 119.658 -0.523 . . . . 54.4 112.74 175.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.417 ' HB3' ' HG ' ' A' ' 113' ' ' SER . 7.1 mt -68.34 22.47 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 115.007 1.484 . . . . 74.25 115.007 -177.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.516 ' HB3' ' ND2' ' A' ' 169' ' ' ASN . 0.2 OUTLIER 55.83 -107.34 0.38 Allowed 'General case' 0 CA--C 1.566 1.56 0 C-N-CA 124.06 0.944 . . . . 74.45 110.779 164.583 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 67.26 16.68 67.29 Favored Glycine 0 C--N 1.361 1.925 0 CA-C-O 120.043 -0.309 . . . . 44.0 113.479 -179.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.411 ' H ' ' HD1' ' A' ' 106' ' ' PHE . . . 62.35 -98.62 0.21 Allowed Glycine 0 C--N 1.352 1.438 0 N-CA-C 111.414 -0.674 . . . . 71.34 111.414 -171.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -134.34 4.83 3.46 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.973 0.909 . . . . 74.55 110.326 176.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -81.19 -13.86 80.06 Favored Glycine 0 C--N 1.352 1.466 0 CA-C-O 119.914 -0.381 . . . . 55.25 113.128 176.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 52.3 mtt180 75.02 -43.26 0.51 Allowed 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 126.666 1.986 . . . . 75.52 113.655 175.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 43.0 ttt180 -87.94 44.75 1.22 Allowed 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.223 0.609 . . . . 75.13 110.533 -172.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.417 ' HG ' ' HB3' ' A' ' 105' ' ' LEU . 36.5 m 46.9 57.03 6.0 Favored 'General case' 0 C--N 1.359 1.021 0 C-N-CA 124.648 1.179 . . . . 74.21 112.244 167.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.471 ' NH2' ' HB2' ' A' ' 91' ' ' GLU . 0.0 OUTLIER -116.76 161.83 18.64 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 111.812 0.301 . . . . 74.52 111.812 -168.443 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 170' ' ' PRO . 34.8 ttmt -68.9 138.03 54.32 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.687 0.795 . . . . 73.31 113.142 -164.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -97.77 -170.98 32.82 Favored Glycine 0 CA--C 1.544 1.867 0 CA-C-N 115.316 -0.856 . . . . 73.4 113.716 176.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.54 ' NH2' ' HB3' ' B' ' 13' ' ' LEU . 7.2 tmm_? -110.21 140.28 44.5 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.327 1.051 . . . . 74.43 111.049 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -44.09 104.11 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 125.393 1.477 . . . . 74.23 112.953 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.43 ' O ' HD13 ' A' ' 174' ' ' LEU . 5.3 tt -100.39 144.53 29.28 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.209 -0.905 . . . . 75.42 108.788 -171.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.537 ' HD2' ' HB2' ' A' ' 175' ' ' LEU . 16.4 tpt180 -96.67 142.64 28.47 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 108.58 -0.896 . . . . 74.51 108.58 -178.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.56 ' HB1' HD11 ' A' ' 174' ' ' LEU . . . -139.62 166.98 23.15 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 118.737 0.698 . . . . 54.41 111.279 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.405 ' HB2' ' HB2' ' B' ' 9' ' ' ALA . 8.1 mm-40 -120.45 101.31 7.69 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 106.193 -1.78 . . . . 72.42 106.193 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.507 HD23 HD12 ' A' ' 176' ' ' LEU . 15.3 tp -99.1 101.87 13.85 Favored Pre-proline 0 C--O 1.215 -0.732 0 N-CA-C 107.918 -1.142 . . . . 74.14 107.918 -177.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.457 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 41.8 Cg_endo -64.63 150.3 88.42 Favored 'Trans proline' 0 C--N 1.368 1.592 0 N-CA-C 108.972 -1.203 . . . . 75.33 108.972 171.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.618 ' HA ' HG23 ' B' ' 6' ' ' ILE . 16.7 tp -152.12 145.99 25.16 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 119.294 0.952 . . . . 72.43 112.152 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 49.2 m -77.47 126.76 31.42 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 114.669 -1.151 . . . . 71.34 109.307 175.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.659 ' HB3' HD23 ' A' ' 215' ' ' LEU . 3.1 mm? -43.86 -55.88 4.24 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 125.955 1.702 . . . . 75.21 112.973 -176.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 -59.52 -45.47 91.64 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 114.42 -1.264 . . . . 75.32 109.917 -176.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -77.19 -11.81 59.87 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.376 -0.829 . . . . 64.33 111.976 -177.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.532 ' HB1' ' O ' ' A' ' 153' ' ' VAL . . . -79.24 -41.81 27.39 Favored 'General case' 0 C--O 1.251 1.181 0 CA-C-O 122.0 0.905 . . . . 65.44 109.433 175.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -67.99 -40.04 83.14 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 114.204 -1.362 . . . . 74.51 110.813 172.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 38.9 m170 -77.86 -43.74 29.34 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.386 0.674 . . . . 75.25 111.92 -173.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.472 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 74.7 -163.61 54.38 Favored Glycine 0 CA--C 1.533 1.209 0 N-CA-C 114.386 0.514 . . . . 71.54 114.386 178.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 102.42 -168.01 18.31 Favored Glycine 0 N--CA 1.477 1.42 0 C-N-CA 123.612 0.625 . . . . 70.42 112.743 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 11.1 mp0 -68.56 102.82 1.54 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.368 0.667 . . . . 73.14 109.442 176.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 4.2 tpp180 -94.05 122.71 36.84 Favored 'General case' 0 C--O 1.245 0.819 0 C-N-CA 123.413 0.685 . . . . 75.05 109.616 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 59.4 t -78.35 109.45 13.0 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 N-CA-C 108.99 -0.744 . . . . 75.04 108.99 176.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.463 HG12 HG13 ' A' ' 145' ' ' VAL . 3.0 p -133.19 122.43 45.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 124.3 1.04 . . . . 73.34 108.673 178.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -107.56 136.93 46.5 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.262 0.625 . . . . 71.3 109.403 -175.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.573 ' HB ' ' HB3' ' B' ' 8' ' ' LEU . 7.6 p -152.29 132.34 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.445 0.698 . . . . 75.1 109.995 178.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 62.31 22.95 13.55 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.389 1.076 . . . . 74.24 112.091 176.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 87.42 10.78 70.16 Favored Glycine 0 C--N 1.346 1.115 0 CA-C-O 119.872 -0.404 . . . . 54.15 113.181 -178.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.13 99.17 6.44 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 108.359 -0.978 . . . . 72.43 108.359 -176.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 19.2 ttt180 -71.55 92.58 1.14 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.51 1.124 . . . . 74.41 109.969 176.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.463 HG13 HG12 ' A' ' 138' ' ' VAL . 7.7 p -92.94 133.74 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-O 121.065 0.459 . . . . 73.53 110.406 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 32.8 t -98.52 85.45 3.37 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 108.57 -0.9 . . . . 64.43 108.57 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 96.3 t -81.62 113.08 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 109.166 -0.679 . . . . 73.42 109.166 -176.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 60.5 ttt85 -68.41 93.7 0.5 Allowed 'General case' 0 C--O 1.241 0.655 0 N-CA-C 108.894 -0.78 . . . . 74.32 108.894 172.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.472 HG13 ' HA2' ' A' ' 133' ' ' GLY . 47.5 pt -78.68 135.72 59.81 Favored Pre-proline 0 CA--C 1.551 0.99 0 CA-C-N 115.035 -0.984 . . . . 74.52 108.933 178.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -58.92 128.7 28.88 Favored 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 122.445 2.097 . . . . 74.22 111.539 174.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.84 92.48 0.05 OUTLIER 'Trans proline' 0 C--N 1.382 2.294 0 C-N-CA 122.655 2.236 . . . . 74.15 110.979 170.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 125.92 66.84 0.17 Allowed Glycine 0 C--N 1.336 0.529 0 C-N-CA 121.127 -0.559 . . . . 75.51 111.851 -167.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.532 ' O ' ' HB1' ' A' ' 130' ' ' ALA . 7.5 p -140.78 139.88 33.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 N-CA-C 107.351 -1.352 . . . . 75.43 107.351 171.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.603 ' HG3' ' HE2' ' A' ' 240' ' ' PHE . 52.0 mtt85 -153.02 173.59 15.23 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.072 0.949 . . . . 73.23 109.194 174.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.539 ' HB3' ' H ' ' A' ' 188' ' ' LEU . 16.7 tp10 -35.38 122.31 0.61 Allowed 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 126.505 1.922 . . . . 72.32 114.975 -168.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 93.15 -13.38 67.78 Favored Glycine 0 C--N 1.342 0.871 0 CA-C-O 119.655 -0.525 . . . . 74.33 114.174 176.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.43 ' O ' HG11 ' A' ' 178' ' ' VAL . 17.9 t -71.39 139.29 49.72 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 109.274 -0.639 . . . . 74.23 109.274 175.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 71.2 t -105.55 119.53 54.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 123.565 0.746 . . . . 74.02 109.131 -178.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.531 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 60.4 mt -98.49 115.19 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 N-CA-C 108.394 -0.965 . . . . 75.24 108.394 174.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -78.3 106.0 9.93 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 109.068 -0.716 . . . . 75.21 109.068 173.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 13.3 p -113.6 113.01 48.09 Favored Pre-proline 0 CA--C 1.556 1.205 0 N-CA-C 109.417 -0.586 . . . . 71.41 109.417 173.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.493 ' HG2' ' HB3' ' A' ' 86' ' ' SER . 43.2 Cg_endo -68.88 139.73 44.15 Favored 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 122.672 2.248 . . . . 74.53 113.042 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . 0.431 ' N ' ' HB3' ' A' ' 171' ' ' PRO . . . 109.67 -26.68 13.75 Favored Glycine 0 N--CA 1.476 1.335 0 C-N-CA 123.442 0.544 . . . . 70.43 113.689 167.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.472 ' SD ' ' N ' ' A' ' 164' ' ' MET . 1.3 mpt? -95.67 -31.06 13.43 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.232 0.613 . . . . 64.15 109.9 -177.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.492 ' N ' ' HB2' ' A' ' 174' ' ' LEU . . . -94.32 153.39 21.03 Favored Glycine 0 CA--C 1.492 -1.4 0 N-CA-C 108.742 -1.743 . . . . 73.33 108.742 168.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.807 ' HA3' ' HA3' ' A' ' 172' ' ' GLY . . . 53.44 80.54 0.07 OUTLIER Glycine 0 CA--C 1.475 -2.407 0 CA-C-O 118.872 -0.96 . . . . 74.5 112.968 -162.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.525 HE21 ' HA ' ' A' ' 167' ' ' GLN . 0.0 OUTLIER -56.52 105.11 0.18 Allowed 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 128.149 2.911 . . . . 75.42 109.059 -178.574 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -176.89 -140.61 3.66 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.096 -1.602 . . . . 64.21 109.096 -172.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . 0.516 ' ND2' ' HB3' ' A' ' 106' ' ' PHE . 0.7 OUTLIER -133.04 -54.28 0.02 OUTLIER Pre-proline 0 N--CA 1.484 1.232 0 CA-C-N 117.613 0.707 . . . . 63.54 109.608 176.421 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.437 ' O ' ' HA ' ' A' ' 115' ' ' LYS . 19.1 Cg_exo -67.74 123.44 10.73 Favored 'Trans proline' 0 C--N 1.388 2.625 0 N-CA-C 106.44 -2.177 . . . . 73.02 106.44 159.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.431 ' HB3' ' N ' ' A' ' 163' ' ' GLY . 41.1 Cg_endo -63.43 141.24 80.19 Favored 'Trans proline' 0 N--CA 1.483 0.874 0 C-N-CA 122.508 2.139 . . . . 71.25 114.858 -164.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.807 ' HA3' ' HA3' ' A' ' 166' ' ' GLY . . . -79.52 -26.41 56.92 Favored Glycine 0 C--N 1.348 1.217 0 C-N-CA 119.553 -1.308 . . . . 72.4 111.924 159.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 89.24 137.37 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 127.385 2.274 . . . . 71.14 110.116 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.56 HD11 ' HB1' ' A' ' 121' ' ' ALA . 24.5 tp -111.21 136.89 49.62 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.26 0.624 . . . . 74.2 110.16 -174.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.537 ' HB2' ' HD2' ' A' ' 120' ' ' ARG . 59.2 mt -105.75 84.79 2.12 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.239 1.015 . . . . 72.12 109.102 -178.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.531 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 95.4 mt -69.03 100.38 1.22 Allowed 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 115.204 -0.907 . . . . 74.52 110.812 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 57.7 t -84.52 102.5 10.56 Favored 'Isoleucine or valine' 0 C--O 1.242 0.69 0 N-CA-C 107.726 -1.213 . . . . 71.11 107.726 173.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 9.1 p -69.37 122.53 21.03 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.211 0 CA-C-N 115.48 -0.782 . . . . 74.13 111.254 -173.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.457 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 23.6 mmt180 -112.44 93.58 4.51 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.449 1.5 . . . . 73.42 108.217 -178.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.559 HD13 HD13 ' A' ' 127' ' ' LEU . 22.4 mt -70.19 149.39 47.56 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.428 0.529 . . . . 74.04 112.428 -175.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 77.9 mt -59.44 159.68 15.95 Favored Pre-proline 0 CA--C 1.554 1.127 0 C-N-CA 124.49 1.116 . . . . 73.22 111.71 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -70.8 32.98 0.23 Allowed 'Trans proline' 0 C--N 1.384 2.439 0 C-N-CA 123.365 2.71 . . . . 74.32 114.7 175.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.494 ' HB3' ' HG ' ' A' ' 127' ' ' LEU . 56.2 t-80 -67.39 106.53 1.26 Allowed Pre-proline 0 CA--C 1.553 1.091 0 C-N-CA 125.165 1.386 . . . . 73.35 107.533 165.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -75.39 24.51 0.4 Allowed 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 123.877 3.051 . . . . 61.24 115.683 -163.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 97.5 t -97.94 -61.76 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 122.595 0.358 . . . . 72.34 111.165 -173.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 14.6 m-30 -124.31 140.52 52.88 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 121.604 0.716 . . . . 72.31 111.937 -171.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -139.02 141.8 38.29 Favored 'General case' 0 C--O 1.215 -0.734 0 C-N-CA 125.883 1.673 . . . . 75.51 106.557 171.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.618 HD11 ' HA ' ' A' ' 193' ' ' LEU . 5.4 tp -106.36 176.3 5.21 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 107.211 -1.404 . . . . 74.21 107.211 178.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . 0.509 ' HG3' ' H ' ' B' ' 302' ' ' ASP . 6.9 tp10 -163.16 128.08 3.05 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 109.019 -0.734 . . . . 70.31 109.019 168.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 69.0 -74.19 0.36 Allowed Glycine 0 C--N 1.349 1.256 0 N-CA-C 111.005 -0.838 . . . . 65.41 111.005 -169.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.436 ' N ' HD22 ' B' ' 300' ' ' ASN . 4.6 tp-100 -163.81 -2.42 0.03 OUTLIER 'General case' 0 CA--C 1.564 1.495 0 C-N-CA 124.115 0.966 . . . . 72.32 110.996 173.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -98.62 150.88 21.29 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 122.818 0.447 . . . . 72.32 110.599 -178.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.618 ' HA ' HD11 ' A' ' 188' ' ' LEU . 0.4 OUTLIER -88.81 155.93 19.26 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.347 1.059 . . . . 74.25 110.796 -167.112 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -142.57 151.31 41.43 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.642 1.577 . . . . 73.14 108.134 173.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -152.72 136.68 16.33 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.168 0.987 . . . . 74.34 108.662 177.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 32.2 m -77.79 133.69 38.18 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 118.008 0.367 . . . . 70.21 110.026 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 32.3 tp -134.01 97.59 3.92 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.047 0.539 . . . . 74.1 110.262 -176.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -85.71 121.42 28.35 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 108.723 -0.843 . . . . 63.3 108.723 170.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 7.7 p -138.25 137.37 20.66 Favored Pre-proline 0 N--CA 1.482 1.164 0 C-N-CA 123.754 0.822 . . . . 74.33 109.179 -171.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -72.32 153.97 56.19 Favored 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 121.607 1.538 . . . . 70.05 111.386 177.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -50.98 -50.91 72.08 Favored Pre-proline 0 CA--C 1.553 1.076 0 N-CA-C 114.696 1.369 . . . . 71.34 114.696 -171.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.569 ' HG2' ' HE1' ' C' ' 276' ' ' TYR . 47.6 Cg_exo -61.2 -37.78 71.53 Favored 'Trans proline' 0 C--N 1.386 2.552 0 C-N-CA 121.851 1.7 . . . . 73.32 113.969 -179.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.525 HG22 ' HA3' ' A' ' 208' ' ' GLY . 34.9 mt -67.2 -37.64 79.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 N-CA-C 109.754 -0.462 . . . . 71.02 109.754 176.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.06 -42.83 88.94 Favored 'General case' 0 CA--C 1.554 1.127 0 CA-C-N 115.571 -0.741 . . . . 74.14 111.688 177.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 54.3 t -70.21 -48.49 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 124.081 0.952 . . . . 64.22 111.435 -176.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 57.7 t -85.14 -39.24 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-N 115.137 -0.938 . . . . 74.41 111.781 -170.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 97.67 90.08 1.9 Allowed Glycine 0 C--O 1.242 0.638 0 N-CA-C 110.873 -0.891 . . . . 72.35 110.873 -171.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.525 ' HA3' HG22 ' A' ' 203' ' ' ILE . . . -115.49 -151.48 9.91 Favored Glycine 0 C--N 1.339 0.735 0 CA-C-N 115.468 -0.366 . . . . 73.32 113.54 -175.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.558 ' HZ1' ' HA ' ' B' ' 427' ' ' SER . 27.1 mtmt -137.55 132.41 33.12 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.311 -0.625 . . . . 73.34 109.311 -176.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 30.9 m -134.39 149.84 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 108.512 -0.922 . . . . 63.11 108.512 173.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . 0.563 ' HD2' ' HA ' ' B' ' 385' ' ' LEU . 30.7 ttm180 -87.12 113.3 22.75 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 109.019 -0.734 . . . . 74.32 109.019 178.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.55 165.57 11.17 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.02 0.928 . . . . 74.41 110.052 -176.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' MET . . . . . 0.464 ' SD ' ' N ' ' A' ' 213' ' ' MET . 0.0 OUTLIER -98.21 151.9 19.95 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 115.658 -0.701 . . . . 74.15 109.455 -175.712 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 63.8 p -133.13 -173.82 3.31 Favored 'General case' 0 C--O 1.242 0.697 0 C-N-CA 124.814 1.246 . . . . 74.1 107.721 167.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.659 HD23 ' HB3' ' A' ' 127' ' ' LEU . 28.4 mt -81.12 -26.6 36.04 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.133 0.573 . . . . 73.14 109.901 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -87.64 -17.44 31.86 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 114.977 -1.01 . . . . 64.44 111.723 -176.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 149.34 -156.83 26.98 Favored Glycine 0 C--N 1.344 1.016 0 CA-C-O 119.35 -0.694 . . . . 63.05 111.687 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -87.61 139.92 5.03 Favored 'Trans proline' 0 C--N 1.365 1.395 0 C-N-CA 122.641 2.227 . . . . 74.13 112.055 173.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 35.1 m -132.14 169.66 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.791 1.236 . . . . 73.4 107.796 171.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -111.92 134.46 53.46 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 121.726 -0.609 . . . . 75.04 111.372 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 7.5 p -119.51 140.22 44.23 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 124.745 1.218 . . . . 74.51 109.352 -176.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.479 ' HB2' ' HA ' ' B' ' 440' ' ' ARG . . . -103.62 103.2 13.11 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.971 0.508 . . . . 70.4 110.05 -178.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.58 ' HA ' HD13 ' B' ' 441' ' ' ILE . 70.5 t -58.8 140.78 85.83 Favored Pre-proline 0 CA--C 1.567 1.614 0 C-N-CA 125.432 1.493 . . . . 71.22 110.7 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -84.72 170.47 10.12 Favored 'Trans proline' 0 C--N 1.387 2.604 0 C-N-CA 123.25 2.634 . . . . 75.51 111.549 177.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.16 148.08 30.51 Favored 'Trans proline' 0 C--N 1.368 1.558 0 C-N-CA 121.748 1.632 . . . . 72.53 113.155 174.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 63.3 mtt85 63.62 32.34 14.0 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 125.329 1.451 . . . . 75.13 111.978 175.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.455 HG22 HD21 ' A' ' 233' ' ' LEU . 90.8 m -62.31 106.68 0.78 Allowed 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 113.689 -1.596 . . . . 64.32 110.498 172.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -95.53 151.37 19.37 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.389 0.675 . . . . 75.32 110.888 -170.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -62.27 117.84 6.63 Favored 'General case' 0 C--N 1.351 0.669 0 C-N-CA 123.981 0.912 . . . . 65.12 110.774 177.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 105.51 -23.64 29.46 Favored Glycine 0 C--N 1.34 0.805 0 CA-C-N 115.903 -0.589 . . . . 75.54 112.885 178.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 231' ' ' ARG . 46.5 mtt180 -72.79 136.25 45.4 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-O 121.552 0.691 . . . . 74.44 110.944 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.699 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 39.3 mttm -101.14 112.0 24.36 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 114.09 -1.413 . . . . 72.22 109.299 -179.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.539 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 45.9 mt -75.86 100.94 4.95 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.068 0.947 . . . . 71.4 110.175 -172.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 57.1 ttt180 -73.26 125.22 27.28 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.529 1.132 . . . . 73.41 110.895 -172.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.499 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 76.7 mt -118.74 107.25 13.43 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.19 0.996 . . . . 74.24 109.614 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.62 ' HB3' ' HZ1' ' A' ' 236' ' ' LYS . 3.5 mmmp? -60.93 126.06 25.99 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 113.127 0.788 . . . . 71.01 113.127 -172.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 73.6 33.64 57.96 Favored Glycine 0 C--N 1.354 1.543 0 O-C-N 123.852 0.72 . . . . 74.2 114.05 173.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -114.58 -18.31 11.47 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.242 0.617 . . . . 74.1 111.387 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -81.9 -170.14 44.03 Favored Glycine 0 C--N 1.346 1.128 0 N-CA-C 112.004 -0.438 . . . . 74.43 112.004 170.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . 0.603 ' HE2' ' HG3' ' A' ' 154' ' ' ARG . 9.9 m-85 -94.69 154.92 39.9 Favored Pre-proline 0 N--CA 1.478 0.965 0 C-N-CA 122.844 0.457 . . . . 73.41 112.149 -170.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -66.65 123.06 10.58 Favored 'Trans proline' 0 C--N 1.387 2.595 0 C-N-CA 123.216 2.611 . . . . 73.33 112.831 -178.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -151.42 -150.03 5.22 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-O 119.368 -0.685 . . . . 73.52 112.426 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -65.06 -29.84 56.56 Favored 'Trans proline' 0 C--N 1.378 2.108 0 C-N-CA 123.249 2.633 . . . . 72.5 113.179 -175.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -87.59 20.77 2.79 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.8 0.84 . . . . 70.11 111.57 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 85.55 -89.76 1.63 Allowed Glycine 0 C--N 1.35 1.332 0 N-CA-C 109.736 -1.346 . . . . 62.24 109.736 -173.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 59.1 mtm180 -127.12 157.56 39.36 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.045 0.938 . . . . 75.41 109.109 165.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -81.38 179.78 53.35 Favored Glycine 0 C--O 1.241 0.561 0 CA-C-N 115.736 -0.665 . . . . 70.31 112.179 178.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -125.27 154.26 41.96 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.725 0.81 . . . . 75.44 109.085 -179.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.525 HD12 HD11 ' A' ' 193' ' ' LEU . 40.1 tp -96.64 112.22 24.05 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 109.466 -0.568 . . . . 73.32 109.466 -179.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.699 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 22.0 m-85 -97.79 105.84 18.05 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.577 1.151 . . . . 71.3 109.307 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.539 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 16.4 mt -79.6 98.8 7.04 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 109.67 -0.493 . . . . 74.54 109.67 175.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -77.34 103.52 7.32 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 108.465 -0.939 . . . . 75.41 108.465 -175.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.454 HG11 HG23 ' A' ' 227' ' ' THR . 56.6 t -87.73 144.07 9.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 N-CA-C 114.259 1.207 . . . . 71.34 114.259 -166.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 6.7 mmm180 -128.32 113.61 15.83 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.475 1.51 . . . . 73.14 107.619 165.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 62.1 mt -75.96 138.88 19.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 122.986 0.515 . . . . 74.34 109.747 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 46.7 p -124.11 175.82 6.76 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 124.709 1.204 . . . . 74.52 109.304 177.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . 0.481 ' HB ' ' HD2' ' A' ' 258' ' ' PRO . 28.6 pt -121.82 164.72 23.41 Favored Pre-proline 0 CA--C 1.556 1.189 0 C-N-CA 123.762 0.825 . . . . 73.4 109.286 175.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . 0.638 ' HB3' ' HH ' ' C' ' 276' ' ' TYR . 60.8 Cg_endo -69.65 6.53 1.24 Allowed 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 122.687 2.258 . . . . 74.45 114.851 177.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.474 ' HG3' ' NE2' ' C' ' 228' ' ' GLN . 0.8 OUTLIER 49.35 -96.79 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.615 0.766 . . . . 75.12 109.494 -161.012 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.93 158.56 19.88 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.086 0.954 . . . . 75.12 110.778 -173.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.425 HD11 ' HA ' ' A' ' 266' ' ' GLU . 67.9 mt -135.64 -178.04 4.94 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.732 0.813 . . . . 72.32 110.719 -175.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 5.2 p -133.52 146.44 60.6 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 124.697 1.199 . . . . 74.31 109.033 176.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -17.69 -60.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.393 2.918 1 C-N-CA 127.402 5.401 . . . . 74.33 118.037 -168.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -65.03 -59.36 4.23 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.036 0.534 . . . . 71.44 111.197 -175.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -62.91 -29.69 70.97 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.712 0.805 . . . . 73.22 110.659 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' GLU . . . . . 0.436 ' O ' ' HD3' ' A' ' 270' ' ' LYS . 8.6 tp10 -57.71 -54.74 43.48 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 124.236 1.015 . . . . 73.45 109.433 175.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -64.34 -33.41 75.77 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 114.681 -1.145 . . . . 64.12 111.691 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 8.8 mp -61.42 -52.22 65.46 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.0 0.52 . . . . 73.14 111.429 177.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 61.2 m95 -61.7 -38.82 89.27 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.344 0.658 . . . . 75.0 111.805 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . 0.452 ' HE2' HG21 ' C' ' 206' ' ' VAL . 1.0 OUTLIER -67.55 -40.22 84.99 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.758 -0.655 . . . . 73.12 111.368 179.278 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -64.3 -41.93 96.61 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.071 0.548 . . . . 70.22 110.521 175.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' LEU . . . . . 0.481 ' O ' ' HB2' ' A' ' 276' ' ' TYR . 51.8 mt -55.5 -45.96 77.02 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 124.012 0.82 . . . . 71.54 110.574 175.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -77.13 -32.92 56.76 Favored 'General case' 0 C--O 1.246 0.874 0 O-C-N 124.389 1.055 . . . . 72.23 113.005 -173.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -72.47 -48.09 43.61 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.318 0.647 . . . . 74.35 110.061 177.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . 0.444 ' HB1' ' NH2' ' A' ' 279' ' ' ARG . . . -71.97 -20.77 61.68 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.51 0.724 . . . . 72.24 111.225 177.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . 0.481 ' HB2' ' O ' ' A' ' 272' ' ' LEU . 21.7 t80 -63.14 -64.96 0.76 Allowed 'General case' 0 C--N 1.356 0.884 0 C-N-CA 123.803 0.841 . . . . 75.02 108.847 171.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -63.32 -40.6 97.76 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.316 -0.856 . . . . 72.14 110.432 -172.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . 0.449 ' HB1' ' HG2' ' B' ' 275' ' ' LYS . . . -59.35 -30.72 68.59 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.659 0.784 . . . . 75.41 111.834 176.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . 0.444 ' NH2' ' HB1' ' A' ' 275' ' ' ALA . 23.6 mtm180 -118.22 34.74 5.04 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.347 0.659 . . . . 75.15 109.855 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.386 0 N-CA-C 109.235 -0.654 . . . . 72.5 109.235 174.439 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.464 ' N ' ' SD ' ' B' ' 1' ' ' MET . 1.4 mpt? . . . . . 0 N--CA 1.478 0.974 0 N-CA-C 109.283 -0.636 . . . . 74.12 109.283 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 59.5 tttp 71.34 115.57 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.772 1.229 . . . . 62.45 112.052 -176.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 66.4 48.34 1.58 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.575 1.55 . . . . 74.04 111.533 170.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 25.5 m -67.5 -22.74 65.44 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 114.816 -1.084 . . . . 52.14 110.574 172.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 2.5 m 71.29 150.37 0.09 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.793 1.637 . . . . 74.34 111.469 176.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.618 HG23 ' HA ' ' A' ' 125' ' ' LEU . 36.5 pt -136.97 167.67 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 113.146 0.795 . . . . 65.34 113.146 -162.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -145.57 124.33 12.61 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.274 1.03 . . . . 72.22 109.647 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . 0.573 ' HB3' ' HB ' ' A' ' 140' ' ' VAL . 44.2 tp -74.26 150.47 40.23 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.168 0.987 . . . . 75.22 111.264 -172.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . 0.405 ' HB2' ' HB2' ' A' ' 122' ' ' GLU . . . -90.74 -50.32 5.97 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.192 0.597 . . . . 73.12 112.117 -178.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 84.8 mt 66.65 115.61 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 124.677 1.191 . . . . 74.1 111.678 -170.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 56.2 mt -109.01 102.28 48.07 Favored Pre-proline 0 CA--C 1.553 1.062 0 N-CA-C 108.007 -1.108 . . . . 72.11 108.007 171.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -52.39 -69.21 0.06 OUTLIER 'Trans proline' 0 C--N 1.382 2.301 0 C-N-CA 123.283 2.655 . . . . 71.41 112.461 -175.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . 0.54 ' HB3' ' NH2' ' A' ' 117' ' ' ARG . 2.1 pt? -162.59 140.78 8.56 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.93 -0.766 . . . . 75.11 108.93 175.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 94.4 mt 69.96 -16.38 0.29 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.854 1.262 . . . . 64.54 113.981 175.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -80.15 87.66 5.48 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-O 121.612 0.72 . . . . 74.01 109.478 -177.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 61.4 m -134.7 125.22 17.33 Favored Pre-proline 0 CA--C 1.542 0.64 0 N-CA-C 107.549 -1.278 . . . . 71.11 107.549 178.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.12 76.44 0.12 Allowed 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 123.242 2.628 . . . . 71.22 113.986 -176.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 62.0 t -137.55 87.7 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.2 1.0 . . . . 63.3 109.351 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 5.5 m 61.68 12.76 4.81 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 124.665 1.186 . . . . 71.22 113.31 167.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' LYS . . . . . 0.577 ' HB2' ' HZ2' ' B' ' 20' ' ' LYS . 0.1 OUTLIER -160.2 -72.0 0.07 Allowed 'General case' 0 N--CA 1.474 0.748 0 O-C-N 121.502 -0.749 . . . . 74.33 111.026 -174.564 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.26 77.8 3.79 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.22 0.608 . . . . 75.34 111.279 -171.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? 56.25 93.62 0.03 OUTLIER 'General case' 0 C--N 1.356 0.868 0 C-N-CA 125.328 1.451 . . . . 73.31 110.175 -172.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' THR . . . . . 0.612 HG23 HD12 ' B' ' 218' ' ' LEU . 26.8 m -95.95 114.33 63.92 Favored Pre-proline 0 CA--C 1.546 0.824 0 N-CA-C 108.938 -0.764 . . . . 72.54 108.938 176.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -61.26 -38.52 65.1 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 123.091 2.528 . . . . 74.55 112.394 178.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . 0.479 ' HG2' ' HB2' ' B' ' 219' ' ' ASN . 10.9 tp10 -72.39 116.03 12.34 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.664 -0.698 . . . . 74.53 109.726 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 27.0 ttt -172.89 -48.23 0.0 OUTLIER Pre-proline 0 CA--C 1.561 1.402 0 C-N-CA 124.461 1.105 . . . . 75.13 110.407 -174.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -70.07 163.1 39.77 Favored 'Trans proline' 0 C--N 1.395 3.026 0 C-N-CA 121.938 1.759 . . . . 73.04 111.957 173.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 61.8 t 76.98 -34.41 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 C-N-CA 125.867 1.667 . . . . 75.25 110.741 -174.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 50.8 mt -68.62 167.92 14.14 Favored 'General case' 0 C--O 1.246 0.912 0 C-N-CA 124.421 1.088 . . . . 73.34 111.517 171.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 62.51 35.23 14.75 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.324 1.049 . . . . 71.25 111.066 -176.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -66.75 108.65 2.58 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.616 0.767 . . . . 74.34 110.905 -177.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 2.9 mpp_? -87.45 -10.33 52.18 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 123.837 0.855 . . . . 72.22 111.666 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -73.14 -72.37 0.26 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.418 0.687 . . . . 73.31 111.204 -174.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -116.99 109.44 17.01 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.834 0.854 . . . . 53.33 109.163 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -165.63 71.36 0.15 Allowed 'General case' 0 C--N 1.356 0.868 0 CA-C-O 121.75 0.786 . . . . 73.13 110.251 -178.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . 0.472 ' HA2' ' HA2' ' C' ' 247' ' ' GLY . . . 64.14 -120.61 20.38 Favored Glycine 0 C--N 1.345 1.07 0 CA-C-N 114.753 -1.112 . . . . 74.33 114.195 177.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -62.17 -28.21 69.5 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.016 0.926 . . . . 61.44 113.365 -175.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 11.3 tt -65.87 -27.63 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 CA-C-O 120.74 0.305 . . . . 75.44 111.054 -175.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 12.1 t -103.41 -32.78 9.35 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.532 0.733 . . . . 73.32 110.946 178.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -166.85 105.25 0.64 Allowed Pre-proline 0 N--CA 1.476 0.842 0 C-N-CA 123.839 0.856 . . . . 73.24 109.53 -178.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -71.35 71.5 2.37 Favored 'Trans proline' 0 C--N 1.376 2.001 0 C-N-CA 123.135 2.557 . . . . 72.44 112.348 175.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 63.55 -89.61 0.07 OUTLIER Glycine 0 C--N 1.351 1.381 0 CA-C-N 115.571 -0.74 . . . . 61.22 112.835 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 178.37 21.05 0.03 OUTLIER Glycine 0 CA--C 1.527 0.813 0 C-N-CA 123.356 0.503 . . . . 64.32 112.037 177.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . 61.18 -78.78 0.02 OUTLIER 'General case' 0 C--N 1.363 1.159 0 C-N-CA 125.067 1.347 . . . . 63.2 110.351 -169.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -68.47 127.7 33.95 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.398 0.679 . . . . 74.21 109.207 170.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 5.1 tmm_? -76.78 -28.03 55.51 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 108.629 -0.878 . . . . 75.02 108.629 174.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 29.5 tp 79.63 -35.83 0.15 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 126.377 1.871 . . . . 72.13 112.956 168.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 3.8 m 68.72 9.67 7.47 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 124.329 1.052 . . . . 73.12 111.262 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.58 24.27 63.14 Favored Glycine 0 C--N 1.349 1.281 0 CA-C-N 115.94 -0.573 . . . . 74.15 112.287 -173.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -77.49 146.08 36.65 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.42 0.688 . . . . 64.2 110.764 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -135.2 4.55 3.21 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.998 0.919 . . . . 75.3 110.032 178.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 5.0 m 57.7 30.15 18.44 Favored 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 124.771 1.228 . . . . 73.31 111.514 177.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.42 107.11 2.32 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 122.904 0.481 . . . . 73.24 110.615 -177.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . 68.12 6.26 5.13 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.005 1.322 . . . . 75.51 112.02 -176.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 25.9 tp 57.08 25.18 10.49 Favored 'General case' 0 CA--C 1.564 1.49 0 C-N-CA 124.748 1.219 . . . . 72.35 110.302 -172.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 83.0 mtt85 -134.37 177.53 7.68 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.248 1.019 . . . . 74.21 110.957 -173.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -65.69 -8.63 21.79 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 125.224 1.41 . . . . 75.31 113.058 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 34.9 t -55.37 -22.54 19.99 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 124.602 1.161 . . . . 62.01 113.074 178.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -67.94 -33.78 75.33 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-O 121.02 0.438 . . . . 72.44 111.439 178.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 2.7 t -94.98 114.59 26.43 Favored 'General case' 0 C--O 1.244 0.773 0 N-CA-C 108.255 -1.017 . . . . 71.31 108.255 -171.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -72.28 147.58 46.27 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.777 0.831 . . . . 71.45 111.698 -170.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm 57.69 75.85 0.52 Allowed Pre-proline 0 CA--C 1.552 1.031 0 C-N-CA 125.476 1.51 . . . . 72.42 112.614 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -70.94 -0.38 7.8 Favored 'Trans proline' 0 C--N 1.38 2.197 0 C-N-CA 123.418 2.745 . . . . 72.24 112.904 168.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 73.33 -76.91 0.06 Allowed 'General case' 0 C--N 1.362 1.135 0 C-N-CA 126.041 1.736 . . . . 72.04 111.66 174.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -112.37 -10.74 13.75 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.546 0.738 . . . . 73.42 111.039 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 71.61 151.51 0.11 Allowed 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 124.758 1.223 . . . . 72.41 111.446 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 12.2 tt 44.59 41.73 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 C-N-CA 126.821 2.048 . . . . 74.04 112.873 176.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 20.2 pt -81.8 67.58 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.111 0 CA-C-N 114.695 -1.139 . . . . 73.4 111.175 -176.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 85.4 mt -77.68 119.88 21.83 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.225 -0.898 . . . . 74.34 109.863 -176.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mp 67.43 -74.81 0.07 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 125.586 1.554 . . . . 65.22 110.663 -178.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 12.9 tt -143.61 102.63 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 124.289 1.036 . . . . 75.5 108.615 177.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -88.32 27.08 7.19 Favored Glycine 0 C--N 1.348 1.232 0 CA-C-N 115.978 -0.555 . . . . 71.15 112.319 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -113.22 -1.73 14.26 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.95 1.3 . . . . 74.12 110.239 -175.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 105.08 169.82 24.11 Favored Glycine 0 C--N 1.352 1.46 0 N-CA-C 111.446 -0.662 . . . . 72.45 111.446 -174.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 75' ' ' MET . . . . . 0.433 ' N ' ' SD ' ' B' ' 75' ' ' MET . 0.4 OUTLIER -91.38 65.35 5.3 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 122.256 1.027 . . . . 74.01 110.459 -177.352 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . -128.99 49.9 0.91 Allowed Glycine 0 C--N 1.334 0.417 0 N-CA-C 109.014 -1.634 . . . . 71.52 109.014 171.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -50.45 -63.19 1.2 Allowed 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.488 1.515 . . . . 74.35 111.977 -170.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 38.7 p 50.98 -74.07 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 125.939 1.695 . . . . 55.34 113.42 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . 0.44 ' HG3' HG12 ' B' ' 80' ' ' ILE . 14.2 tp10 71.29 -86.54 0.03 OUTLIER 'General case' 0 C--N 1.357 0.895 0 C-N-CA 125.157 1.383 . . . . 74.44 110.131 176.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . 0.44 HG12 ' HG3' ' B' ' 79' ' ' GLU . 35.8 pt -145.52 -162.78 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 124.708 1.203 . . . . 72.52 107.839 179.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 50.0 m -56.96 140.63 48.14 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 108.969 -0.752 . . . . 74.52 108.969 165.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -49.91 93.26 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.175 0.99 . . . . 75.12 111.817 -175.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -159.29 -62.53 0.07 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.723 1.209 . . . . 74.13 108.783 -175.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -84.9 75.78 10.33 Favored 'General case' 0 C--N 1.355 0.837 0 N-CA-C 108.657 -0.868 . . . . 73.0 108.657 172.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -113.73 -68.33 0.93 Allowed 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 107.087 -1.449 . . . . 72.23 107.087 176.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 27.6 t80 63.78 151.88 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 125.19 1.396 . . . . 74.21 112.944 173.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . 62.31 -163.85 0.26 Allowed 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.595 1.158 . . . . 52.24 110.744 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 72.82 -69.79 0.18 Allowed 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 125.156 1.382 . . . . 74.14 110.001 177.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 166.11 -38.36 0.26 Allowed Glycine 0 C--N 1.336 0.538 0 N-CA-C 110.542 -1.023 . . . . 54.33 110.542 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.15 -34.09 73.07 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.767 0.827 . . . . 75.53 111.953 178.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -131.83 77.44 0.39 Allowed Glycine 0 C--N 1.348 1.224 0 N-CA-C 111.776 -0.529 . . . . 70.11 111.776 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.26 -59.71 9.53 Favored Glycine 0 C--N 1.35 1.33 0 CA-C-N 116.761 0.281 . . . . 73.42 112.598 178.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 32.0 t80 50.63 68.74 0.72 Allowed 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.534 1.534 . . . . 74.22 111.274 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -78.12 -9.41 59.15 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 114.479 -1.237 . . . . 72.14 111.357 -178.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 46.9 mttp 75.38 -24.94 0.21 Allowed 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 126.077 1.751 . . . . 74.44 113.281 169.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 80.53 -2.41 78.34 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-O 119.431 -0.649 . . . . 75.21 112.805 -171.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 97' ' ' ILE . . . . . 0.5 ' HA ' HD13 ' B' ' 100' ' ' LEU . 14.0 tt -62.67 -24.83 36.58 Favored 'Isoleucine or valine' 0 C--N 1.362 1.137 0 C-N-CA 124.334 1.053 . . . . 73.0 111.596 -172.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -59.42 132.25 53.42 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.683 0.793 . . . . 75.21 110.357 173.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . 71.88 2.97 4.5 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 124.73 1.212 . . . . 61.12 113.393 175.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . 0.5 HD13 ' HA ' ' B' ' 97' ' ' ILE . 79.6 mt -82.41 -41.1 0.93 Allowed Pre-proline 0 CA--C 1.56 1.363 0 CA-C-O 118.079 -0.962 . . . . 74.2 112.268 173.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -59.78 108.75 0.5 Allowed 'Trans proline' 0 C--N 1.398 3.134 0 C-N-CA 121.9 1.733 . . . . 74.43 111.861 171.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 59.1 tp -63.92 138.63 58.56 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 115.56 -0.746 . . . . 73.12 109.855 176.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 40.0 m -69.63 91.84 0.62 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.198 0.599 . . . . 75.52 110.148 178.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . -73.85 127.49 10.38 Favored Glycine 0 C--N 1.343 0.953 0 CA-C-N 114.803 -1.089 . . . . 51.35 111.293 176.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 26.3 mp0 -69.06 -29.41 67.53 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.124 0.97 . . . . 75.22 110.427 178.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 85.3 t80 78.11 -36.85 0.22 Allowed 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 125.626 1.571 . . . . 74.44 112.868 171.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 58.7 p -78.91 84.19 4.96 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 124.397 1.079 . . . . 75.34 111.764 -173.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 63.2 m80 68.17 125.58 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.886 1.674 . . . . 73.44 113.298 173.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.456 ' HD2' ' HA3' ' B' ' 202' ' ' GLY . 89.2 m-85 -127.58 40.98 3.6 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.195 0.998 . . . . 74.1 108.859 173.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -73.81 90.41 1.88 Allowed 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 114.562 -1.199 . . . . 75.22 110.779 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 4.4 pp -82.54 137.64 34.53 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.112 0.565 . . . . 70.25 110.72 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 67.75 -67.94 0.17 Allowed 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 126.137 1.775 . . . . 73.2 111.792 178.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 113' ' ' LYS . . . . . 0.727 ' HG2' ' HB2' ' C' ' 36' ' ' ASP . 18.5 tppt? 80.69 -63.97 0.19 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.236 1.814 . . . . 75.13 112.542 173.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.93 94.2 2.68 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-O 121.994 0.902 . . . . 74.21 112.105 -174.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 25.5 m -150.31 89.64 1.59 Allowed 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 108.345 -0.983 . . . . 73.23 108.345 174.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 62.06 -114.88 7.22 Favored Glycine 0 C--N 1.362 2.025 0 CA-C-O 118.584 -1.12 . . . . 55.33 110.568 -173.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 107.69 -69.95 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.814 0 C-N-CA 126.766 2.026 . . . . 75.35 115.426 156.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 118' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -56.94 -64.04 0.14 Allowed 'Trans proline' 0 C--N 1.402 3.389 0 C-N-CA 122.635 2.223 . . . . 63.21 114.743 -166.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 119' ' ' ASP . . . . . . . . . . . . . 37.9 t70 64.64 -75.88 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.895 1.278 . . . . 75.33 110.73 -173.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 120' ' ' TYR . . . . . 0.4 ' OH ' ' HD2' ' C' ' 160' ' ' ARG . 33.4 m-85 56.81 79.97 0.17 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 125.176 1.39 . . . . 70.1 112.245 177.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 24.9 m -100.86 -20.43 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 CA-C-N 115.427 -0.806 . . . . 74.32 110.182 170.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 33.1 m 55.42 77.13 0.23 Allowed 'General case' 0 C--N 1.358 0.95 0 C-N-CA 125.014 1.326 . . . . 75.25 110.082 -172.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -82.48 152.74 25.95 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 114.642 -1.163 . . . . 70.53 110.997 -175.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 92.4 p 53.32 -160.11 0.13 Allowed 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 125.967 1.707 . . . . 61.03 112.73 176.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -143.98 -67.62 0.34 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.588 0.755 . . . . 74.53 110.165 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -169.57 -168.08 0.75 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.936 0.894 . . . . 74.13 109.888 -179.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 66.9 m -134.33 -64.52 0.68 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.179 0.992 . . . . 70.01 109.232 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -140.86 65.63 1.39 Allowed 'General case' 0 C--O 1.238 0.45 0 N-CA-C 108.295 -1.002 . . . . 74.33 108.295 177.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 9.0 t -63.26 130.9 46.5 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 115.282 -0.872 . . . . 74.41 111.012 -172.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . 74.85 124.64 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 126.032 1.733 . . . . 61.42 110.214 -165.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 23.3 t90 76.33 -60.15 0.49 Allowed 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 125.546 1.539 . . . . 73.51 111.993 177.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 36.6 m 76.58 -61.82 0.43 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 125.501 1.52 . . . . 74.11 113.996 169.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 26.5 m -68.92 89.57 0.41 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.323 1.049 . . . . 74.52 111.644 -172.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 119.29 -11.93 11.38 Favored Glycine 0 N--CA 1.476 1.334 0 CA-C-N 115.991 -0.55 . . . . 55.15 113.004 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 135' ' ' VAL . . . . . . . . . . . . . 36.2 t 69.25 -79.3 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 125.553 1.541 . . . . 73.24 112.529 174.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 136' ' ' LYS . . . . . 0.408 ' HE3' HG21 ' B' ' 153' ' ' THR . 24.3 ttmm 57.99 47.12 15.39 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.416 1.087 . . . . 74.24 110.76 178.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 68.4 p 61.62 -3.23 0.22 Allowed 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 126.274 1.83 . . . . 75.31 115.127 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 36.1 p90 39.41 -64.4 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.32 0 C-N-CA 127.932 2.493 . . . . 75.52 116.366 -177.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 13.3 m120 66.89 24.43 9.7 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 125.275 1.43 . . . . 73.24 112.093 177.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . 84.72 -63.23 4.44 Favored Glycine 0 C--N 1.341 0.833 0 CA-C-N 115.544 -0.753 . . . . 75.54 112.494 174.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . 66.62 101.51 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.969 1.307 . . . . 75.34 110.263 -174.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -143.53 -167.44 2.57 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.756 0.822 . . . . 74.24 109.23 -175.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 167.86 -47.8 0.24 Allowed Glycine 0 C--N 1.348 1.206 0 N-CA-C 111.928 -0.469 . . . . 61.25 111.928 176.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 72.0 t 76.68 -50.29 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 C-N-CA 125.705 1.602 . . . . 75.31 111.16 178.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -83.11 -34.54 26.07 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.054 0.941 . . . . 75.32 109.775 169.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 2.8 pp -128.95 -169.72 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 124.38 1.072 . . . . 72.52 109.625 175.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 35.3 p-80 -149.72 145.28 26.59 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.213 0.605 . . . . 72.43 110.409 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 63.24 -78.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 125.508 1.523 . . . . 75.05 112.903 170.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 149' ' ' LYS . . . . . . . . . . . . . 56.4 tttm 70.27 -85.29 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 125.71 1.604 . . . . 74.13 113.361 173.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -100.67 -51.92 3.46 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 113.197 0.814 . . . . 74.11 113.197 -165.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -79.36 -55.25 0.91 Allowed Pre-proline 0 CA--C 1.567 1.617 0 N-CA-C 114.605 1.335 . . . . 74.43 114.605 -165.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -57.16 89.93 0.05 OUTLIER 'Trans proline' 0 C--N 1.393 2.885 0 C-N-CA 123.042 2.495 . . . . 64.13 115.014 -166.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 153' ' ' THR . . . . . 0.408 HG21 ' HE3' ' B' ' 136' ' ' LYS . 3.4 m 56.18 27.38 11.53 Favored 'General case' 0 CA--C 1.559 1.3 0 C-N-CA 125.561 1.544 . . . . 74.2 113.38 167.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 50.3 mm -71.87 -33.87 49.39 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 CA-C-N 115.543 -0.753 . . . . 74.25 109.591 176.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 1.8 tt -89.0 54.51 3.02 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 124.362 1.065 . . . . 73.12 108.964 175.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -165.63 -110.26 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.056 0 CA-C-O 119.045 -0.502 . . . . 72.23 109.689 173.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 157' ' ' MET . . . . . . . . . . . . . 24.3 ptt? -172.26 -43.14 0.02 OUTLIER 'General case' 0 C--N 1.363 1.183 0 C-N-CA 123.493 0.717 . . . . 61.13 110.508 -172.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 158' ' ' ALA . . . . . . . . . . . . . . . -83.53 75.24 10.04 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 121.517 0.675 . . . . 65.11 109.462 -176.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . 0.538 ' HZ1' ' HG3' ' C' ' 182' ' ' PRO . 12.3 tmtt? -121.8 -71.13 0.74 Allowed 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 106.951 -1.5 . . . . 73.24 106.951 -174.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . 176.77 97.68 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.398 1.479 . . . . 74.34 107.471 177.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -168.31 25.32 0.03 OUTLIER 'General case' 0 C--O 1.246 0.887 0 O-C-N 123.622 0.576 . . . . 71.1 111.08 -171.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . -65.18 -48.03 74.54 Favored Glycine 0 C--N 1.35 1.327 0 N-CA-C 111.409 -0.677 . . . . 73.4 111.409 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . 0.456 HD12 ' HB3' ' B' ' 173' ' ' LEU . 49.7 tp 68.21 -78.24 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 124.728 1.211 . . . . 75.25 111.963 166.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 164' ' ' ALA . . . . . . . . . . . . . . . -89.26 -12.86 39.51 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.483 0.713 . . . . 75.34 111.229 177.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 15.2 t -129.41 165.9 20.64 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.661 0.784 . . . . 73.14 110.194 -177.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . 134.17 164.35 10.6 Favored Glycine 0 C--N 1.345 1.078 0 N-CA-C 111.425 -0.67 . . . . 74.53 111.425 -177.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 167' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -80.51 119.05 22.67 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.151 0.581 . . . . 74.33 109.89 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 77.8 t 72.75 -69.76 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 125.915 1.686 . . . . 75.53 111.386 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 34.4 t 63.13 -88.74 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 125.024 1.33 . . . . 65.53 110.036 -178.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 42.7 m 71.03 -55.02 0.66 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 125.637 1.575 . . . . 73.13 113.868 174.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -64.37 171.25 3.24 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.758 0.823 . . . . 73.41 111.615 176.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 172' ' ' GLU . . . . . 0.522 ' HB3' ' HG2' ' C' ' 213' ' ' MET . 10.8 tp10 -60.79 87.96 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.058 0.943 . . . . 75.25 111.532 -173.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 173' ' ' LEU . . . . . 0.456 ' HB3' HD12 ' B' ' 163' ' ' LEU . 84.2 mt 62.4 14.4 6.86 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.107 1.363 . . . . 74.44 112.964 177.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 174' ' ' GLN . . . . . 0.427 ' NE2' ' SD ' ' B' ' 286' ' ' MET . 27.1 mm-40 -91.97 101.33 13.89 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.367 0.667 . . . . 74.45 109.97 -175.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 175' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -93.06 159.03 15.48 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.861 0.865 . . . . 74.1 111.045 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -169.85 166.28 9.56 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.463 1.105 . . . . 74.11 109.937 175.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 33.5 p -132.54 78.34 67.57 Favored Pre-proline 0 CA--C 1.559 1.323 0 C-N-CA 123.847 0.859 . . . . 74.15 109.862 172.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 178' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -79.46 148.41 20.75 Favored 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 122.425 2.083 . . . . 74.53 111.696 174.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 179' ' ' ALA . . . . . 0.533 ' HB2' ' HZ2' ' B' ' 337' ' ' LYS . . . -83.72 65.43 8.52 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.116 0.566 . . . . 74.35 110.111 -179.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 180' ' ' ALA . . . . . 0.464 ' HB3' ' HB ' ' C' ' 137' ' ' VAL . . . 70.94 -34.77 0.31 Allowed 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 126.438 1.895 . . . . 75.32 113.304 -173.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 181' ' ' LEU . . . . . 0.486 HD22 ' HB2' ' C' ' 136' ' ' ARG . 60.5 tp -161.29 -71.75 0.06 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.139 0.976 . . . . 74.44 108.928 170.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 182' ' ' VAL . . . . . . . . . . . . . 49.2 t -86.71 131.08 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 109.263 -0.643 . . . . 72.43 109.263 177.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -66.19 -56.83 9.39 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 123.908 0.755 . . . . 65.24 111.263 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -169.52 178.73 4.08 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-O 121.64 0.733 . . . . 75.32 111.173 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 185' ' ' VAL . . . . . 0.421 ' O ' ' HG2' ' B' ' 188' ' ' ARG . 1.9 p -130.19 122.03 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 107.564 -1.273 . . . . 74.01 107.564 160.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 50.0 p 49.04 -96.26 0.03 OUTLIER 'General case' 0 CA--C 1.565 1.526 0 C-N-CA 124.941 1.296 . . . . 60.24 113.389 172.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 187' ' ' SER . . . . . . . . . . . . . 56.7 m -140.51 88.58 2.21 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.592 0.757 . . . . 62.14 109.793 -177.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 188' ' ' ARG . . . . . 0.421 ' HG2' ' O ' ' B' ' 185' ' ' VAL . 13.7 mmt180 -132.34 -178.39 4.89 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.126 0.97 . . . . 72.32 109.571 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -96.98 178.85 5.14 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.879 0.872 . . . . 72.52 110.202 171.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 190' ' ' CYS . . . . . 0.534 ' SG ' ' NZ ' ' B' ' 337' ' ' LYS . 45.6 t -153.52 165.0 37.25 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.899 0.88 . . . . 70.33 109.69 178.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -148.31 168.07 23.52 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.888 0.875 . . . . 74.04 109.746 -170.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -68.78 153.65 53.0 Favored Glycine 0 C--N 1.352 1.439 0 CA-C-O 118.889 -0.95 . . . . 64.22 112.429 174.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 193' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -57.24 150.61 56.9 Favored 'Trans proline' 0 N--CA 1.504 2.13 0 C-N-CA 123.817 3.011 . . . . 73.22 113.896 -169.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 194' ' ' SER . . . . . . . . . . . . . 21.8 m -151.37 118.72 5.98 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.719 0.808 . . . . 63.44 109.821 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 195' ' ' ALA . . . . . . . . . . . . . . . -162.53 164.76 26.73 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.794 0.838 . . . . 74.32 110.093 177.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 99.4 m -106.88 -67.5 0.94 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.353 0.661 . . . . 73.32 110.087 177.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 49.5 m -153.7 -48.85 0.09 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.134 0.974 . . . . 75.11 108.61 -177.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 198' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 60.19 -81.9 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 125.969 1.708 . . . . 65.14 110.237 178.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 199' ' ' LYS . . . . . 0.489 ' HE2' ' HA ' ' B' ' 199' ' ' LYS . 0.6 OUTLIER 70.88 -19.02 0.24 Allowed 'General case' 0 CA--C 1.562 1.411 0 N-CA-C 115.144 1.535 . . . . 75.14 115.144 163.211 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 200' ' ' CYS . . . . . . . . . . . . . 69.2 m -67.09 105.6 0.91 Allowed Pre-proline 0 CA--C 1.56 1.34 0 C-N-CA 124.062 0.945 . . . . 73.31 112.43 -171.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 201' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -105.01 10.3 0.24 Allowed 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 123.591 2.861 . . . . 74.02 114.053 -178.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 202' ' ' GLY . . . . . 0.456 ' HA3' ' HD2' ' B' ' 109' ' ' TYR . . . -79.23 -7.44 88.47 Favored Glycine 0 C--N 1.353 1.492 0 CA-C-O 119.14 -0.811 . . . . 73.41 114.539 -170.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 64.6 t30 66.84 173.18 0.25 Allowed 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.312 1.045 . . . . 71.33 111.766 173.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -61.4 -53.6 54.52 Favored 'General case' 0 C--N 1.351 0.65 0 C-N-CA 123.336 0.654 . . . . 74.01 109.622 167.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 205' ' ' LEU . . . . . . . . . . . . . 4.5 tt 54.5 92.47 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.936 1.294 . . . . 72.44 110.666 173.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.54 -88.41 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.332 0 CA-C-O 119.386 -0.34 . . . . 70.3 110.424 175.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 35.0 mmtm -145.48 -41.88 0.22 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.427 0.691 . . . . 74.32 110.471 177.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . -78.31 -31.1 47.87 Favored Glycine 0 C--N 1.346 1.102 0 O-C-N 123.137 0.273 . . . . 71.52 113.242 -178.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 114.96 -21.37 13.57 Favored Glycine 0 N--CA 1.474 1.184 0 N-CA-C 111.622 -0.591 . . . . 63.34 111.622 -176.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 49.9 tttm -172.12 118.6 0.4 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.306 1.442 . . . . 74.51 107.709 178.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . -156.63 147.68 16.48 Favored Glycine 0 C--N 1.344 0.992 0 CA-C-O 119.535 -0.592 . . . . 74.43 111.739 -179.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 40.6 t 55.93 94.59 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 125.331 1.453 . . . . 74.04 111.918 -176.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 10.1 tp -72.46 -28.64 28.83 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 CA-C-N 116.109 -0.496 . . . . 70.12 110.388 177.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 24.2 m 61.66 -80.79 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 125.509 1.524 . . . . 75.43 111.53 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 215' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -152.12 4.11 0.39 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.692 0.797 . . . . 73.31 111.209 -178.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -70.05 141.91 52.78 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.6 0.76 . . . . 61.42 110.008 176.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . 0.536 HD13 ' H ' ' B' ' 218' ' ' LEU 0.324 4.0 pp 51.53 -71.53 0.01 OUTLIER 'General case' 0 CA--C 1.57 1.73 0 C-N-CA 126.772 2.029 . . . . 75.4 114.421 -178.662 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . 0.612 HD12 HG23 ' B' ' 23' ' ' THR . 88.8 mt 61.13 -77.75 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 125.857 1.663 . . . . 71.43 111.824 -177.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 219' ' ' ASN . . . . . 0.479 ' HB2' ' HG2' ' B' ' 25' ' ' GLU . 21.7 t-20 -160.47 154.12 22.43 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 108.148 -1.056 . . . . 71.24 108.148 174.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -134.89 -171.27 2.75 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.975 0.91 . . . . 74.3 110.214 -175.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 221' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -68.36 -71.01 0.23 Allowed 'General case' 0 C--N 1.351 0.638 0 N-CA-C 107.416 -1.327 . . . . 73.55 107.416 171.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . 0.625 ' HB2' ' HE ' ' C' ' 187' ' ' ARG . . . 39.87 66.05 0.64 Allowed 'General case' 0 C--N 1.368 1.39 0 C-N-CA 124.952 1.301 . . . . 75.21 111.228 178.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -86.35 -166.18 1.47 Allowed 'General case' 0 C--O 1.243 0.717 0 CA-C-N 114.09 -1.414 . . . . 72.13 111.948 -163.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 33.6 m -61.73 -31.23 50.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 115.477 -0.783 . . . . 75.32 112.529 -177.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 225' ' ' THR . . . . . 0.414 HG23 HG21 ' C' ' 185' ' ' VAL . 63.1 m 76.22 -53.44 0.61 Allowed 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.896 1.678 . . . . 73.55 113.215 177.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 1.4 tm? 68.38 83.89 0.16 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.205 1.402 . . . . 74.43 107.619 -168.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . -160.65 24.52 0.27 Allowed Glycine 0 C--N 1.344 1.014 0 CA-C-N 115.784 -0.643 . . . . 71.24 112.535 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . -86.98 -106.35 0.84 Allowed Glycine 0 C--N 1.353 1.482 0 N-CA-C 111.535 -0.626 . . . . 72.41 111.535 174.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . 63.8 -130.62 39.74 Favored Glycine 0 C--N 1.355 1.59 0 CA-C-O 119.9 -0.389 . . . . 71.04 113.38 176.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -148.2 153.09 38.3 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.167 0.987 . . . . 70.23 109.106 178.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 231' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -169.45 161.59 9.83 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.13 0.572 . . . . 73.24 110.2 -172.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 232' ' ' THR . . . . . 0.49 HG23 ' HA ' ' B' ' 280' ' ' LEU . 66.0 p -49.54 102.2 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.655 1.582 . . . . 74.24 113.042 -178.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 233' ' ' PHE . . . . . 0.715 ' HB2' HH22 ' C' ' 211' ' ' ARG . 18.6 t80 -156.26 -49.88 0.08 Allowed 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.338 -0.616 . . . . 71.44 109.338 173.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . 79.01 -40.42 0.25 Allowed 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 125.638 1.575 . . . . 72.31 112.338 177.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . 0.408 ' CG ' ' HB3' ' C' ' 220' ' ' GLU . 0.3 OUTLIER 73.09 132.31 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.34 1.456 . . . . 64.41 112.386 168.071 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 236' ' ' THR . . . . . 0.464 ' HB ' ' O ' ' B' ' 348' ' ' ILE . 39.7 m -138.54 79.41 1.73 Allowed 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.149 0.98 . . . . 73.34 108.658 172.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . 0.485 ' HB2' ' H ' ' B' ' 355' ' ' ALA . . . 70.49 79.94 0.17 Allowed 'General case' 0 CA--C 1.56 1.339 0 CA-C-N 113.921 -1.49 . . . . 73.03 112.681 170.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 238' ' ' THR . . . . . 0.454 ' OG1' ' HB2' ' B' ' 351' ' ' GLN . 31.4 m -154.1 99.0 2.21 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.877 1.271 . . . . 71.31 110.07 176.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -172.47 -179.19 2.16 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.054 0.942 . . . . 74.42 109.815 173.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . -106.0 -125.38 5.49 Favored Glycine 0 C--N 1.346 1.123 0 N-CA-C 112.178 -0.369 . . . . 71.23 112.178 -178.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -104.69 -168.68 1.51 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.895 0.878 . . . . 71.23 110.844 -176.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 242' ' ' TRP . . . . . 0.554 ' HZ3' ' HD3' ' C' ' 231' ' ' ARG . 0.0 OUTLIER 92.43 -13.66 0.18 Allowed 'General case' 0 N--CA 1.508 2.452 0 C-N-CA 128.035 2.534 . . . . 70.32 111.867 176.968 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -124.89 119.34 28.52 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.434 0.635 . . . . 74.22 111.989 -164.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -69.54 -33.83 72.66 Favored Glycine 0 C--N 1.345 1.056 0 N-CA-C 110.16 -1.176 . . . . 71.54 110.16 162.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 8.2 ttpp 61.97 9.33 2.97 Favored 'General case' 0 CA--C 1.558 1.285 0 C-N-CA 124.597 1.159 . . . . 75.34 113.443 161.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 34.0 p -102.42 -8.61 20.98 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.633 0.773 . . . . 71.14 111.092 -177.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 247' ' ' LEU . . . . . 0.556 HD11 ' HG2' ' C' ' 225' ' ' PRO . 4.0 tt -84.55 101.74 12.33 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 109.446 -0.575 . . . . 72.51 109.446 -173.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 248' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 72.44 -75.34 0.08 Allowed 'General case' 0 CA--C 1.558 1.261 0 C-N-CA 125.86 1.664 . . . . 75.15 112.206 174.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 61.54 21.29 11.96 Favored 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 124.672 1.189 . . . . 71.33 111.495 -171.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 250' ' ' GLN . . . . . 0.462 ' OE1' ' HA ' ' B' ' 250' ' ' GLN . 9.2 mm-40 67.24 155.47 0.1 Allowed 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 126.069 1.748 . . . . 70.14 114.57 -178.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 251' ' ' ALA . . . . . . . . . . . . . . . -69.78 138.22 52.55 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 114.546 -1.206 . . . . 64.21 109.537 175.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 -77.36 89.23 3.76 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 109.121 -0.696 . . . . 73.12 109.121 -176.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -60.38 136.73 58.13 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-N 115.31 -0.859 . . . . 51.41 110.112 176.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 68.78 87.56 0.12 Allowed 'General case' 0 N--CA 1.476 0.868 0 O-C-N 124.716 1.26 . . . . 72.51 109.526 -173.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 255' ' ' GLY . . . . . 0.588 ' HA2' ' HA ' ' B' ' 259' ' ' VAL . . . -150.3 54.78 0.48 Allowed Glycine 0 C--N 1.346 1.1 0 CA-C-N 115.597 -0.729 . . . . 63.32 112.83 -173.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 256' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -65.18 99.82 0.41 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.636 0.774 . . . . 71.2 109.597 174.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 15.0 tm0? 58.89 -82.27 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.57 1.548 . . . . 74.31 109.553 -174.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 258' ' ' LEU . . . . . . . . . . . . . 5.1 tt -117.68 85.6 2.37 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 107.633 -1.247 . . . . 75.13 107.633 173.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . 0.588 ' HA ' ' HA2' ' B' ' 255' ' ' GLY . 73.4 t 63.77 -74.4 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 C-N-CA 125.711 1.604 . . . . 63.31 112.514 177.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 260' ' ' SER . . . . . . . . . . . . . 22.1 p -174.41 -35.38 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 125.662 1.585 . . . . 73.11 107.464 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -167.39 156.99 10.49 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.545 1.138 . . . . 65.51 109.717 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 262' ' ' ALA . . . . . . . . . . . . . . . -80.14 -62.82 1.56 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.561 0.744 . . . . 75.22 109.316 171.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -177.18 101.36 0.05 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.421 1.089 . . . . 70.44 108.685 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 10.9 m 59.42 11.42 2.23 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 125.19 1.396 . . . . 51.14 113.38 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 265' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -75.81 -40.64 54.62 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 108.889 -0.782 . . . . 73.31 108.889 -173.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 266' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -66.09 -16.0 63.56 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 123.567 0.747 . . . . 71.52 110.124 176.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 18.2 m 79.0 -54.87 0.45 Allowed 'General case' 0 C--N 1.365 1.263 0 C-N-CA 126.348 1.859 . . . . 73.13 111.933 171.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 39.7 t -58.88 -48.18 87.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 C-N-CA 124.227 1.011 . . . . 74.44 111.063 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 269' ' ' THR . . . . . . . . . . . . . 26.6 m 50.25 74.5 0.21 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.938 1.295 . . . . 74.31 110.328 -172.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 270' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -66.15 -31.69 72.68 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 113.744 -1.571 . . . . 72.41 111.933 -173.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 271' ' ' ALA . . . . . . . . . . . . . . . 58.49 39.03 25.44 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 124.311 1.007 . . . . 75.3 110.682 -175.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 272' ' ' ASN . . . . . . . . . . . . . 44.5 t-20 -60.62 132.5 54.08 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.167 -0.924 . . . . 73.11 110.922 -173.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.06 93.02 0.99 Allowed 'General case' 0 CA--C 1.54 0.563 0 O-C-N 124.141 0.901 . . . . 73.43 108.959 -177.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 -136.02 79.81 1.79 Allowed 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 107.211 -1.403 . . . . 71.44 107.211 171.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 275' ' ' LYS . . . . . 0.454 ' N ' ' HD2' ' B' ' 275' ' ' LYS . 9.8 mptt 52.06 68.17 3.41 Favored Pre-proline 0 CA--C 1.552 1.037 0 CA-C-N 114.122 -1.399 . . . . 72.14 111.896 -178.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -83.81 17.96 1.61 Allowed 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 122.699 2.266 . . . . 73.04 111.954 174.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 277' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 279' ' ' ARG . 5.4 mp -81.41 -99.21 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 108.392 -0.966 . . . . 74.52 108.392 175.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 78.3 mt 59.5 22.51 11.08 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 118.918 0.781 . . . . 72.2 112.397 178.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . 108.05 -15.49 36.66 Favored Glycine 0 C--N 1.354 1.545 0 C-N-CA 123.086 0.374 . . . . 75.43 113.177 -176.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 280' ' ' LEU . . . . . 0.49 ' HA ' HG23 ' B' ' 232' ' ' THR . 2.2 tm? -63.77 -43.84 95.21 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.948 0.899 . . . . 74.31 109.622 177.075 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -78.18 -49.76 13.21 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 109.339 -0.615 . . . . 75.31 109.339 174.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . 78.31 -38.83 0.25 Allowed 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 126.063 1.745 . . . . 65.41 112.681 176.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 19.1 t70 66.92 -71.18 0.1 Allowed 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 126.326 1.85 . . . . 72.33 111.429 -176.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . -78.57 66.62 3.26 Favored Glycine 0 C--N 1.347 1.144 0 N-CA-C 111.794 -0.523 . . . . 72.13 111.794 175.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -77.77 88.84 4.0 Favored 'General case' 0 C--O 1.245 0.858 0 N-CA-C 108.08 -1.082 . . . . 73.03 108.08 177.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 286' ' ' MET . . . . . 0.551 ' HB3' ' HD2' ' B' ' 287' ' ' PRO . 65.5 mtm 70.0 176.9 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.533 0 C-N-CA 124.488 1.115 . . . . 74.22 110.611 -175.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 287' ' ' PRO . . . . . 0.551 ' HD2' ' HB3' ' B' ' 286' ' ' MET . 37.9 Cg_endo -65.73 5.37 0.61 Allowed 'Trans proline' 0 C--N 1.389 2.702 0 C-N-CA 121.897 1.731 . . . . 74.24 114.081 172.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 288' ' ' VAL . . . . . . . . . . . . . 26.1 t -74.28 80.29 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 CA-C-O 121.629 0.728 . . . . 74.32 109.206 171.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 289' ' ' ARG . . . . . . . . . . . . . 53.6 ttt180 -116.8 -7.77 11.44 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 124.478 1.111 . . . . 74.32 109.779 177.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 290' ' ' TRP . . . . . . . . . . . . . 72.2 t-105 69.22 116.41 0.04 OUTLIER 'General case' 0 C--N 1.362 1.118 0 C-N-CA 125.02 1.328 . . . . 75.34 110.157 -173.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 291' ' ' LEU . . . . . . . . . . . . . 30.8 tp 72.8 149.99 0.1 Allowed 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 125.712 1.605 . . . . 73.52 111.064 -172.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . 159.07 -65.06 0.29 Allowed Glycine 0 C--N 1.348 1.245 0 CA-C-N 116.007 -0.542 . . . . 71.42 111.907 -179.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -83.96 40.09 0.86 Allowed 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 123.394 2.729 . . . . 75.13 113.201 -178.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -71.44 120.54 17.16 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.383 1.073 . . . . 74.44 111.198 -175.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -163.59 -62.54 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.451 1.1 . . . . 71.35 108.751 169.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 24.8 m 68.79 149.9 0.07 Allowed 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 125.661 1.584 . . . . 71.52 112.417 176.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 84.5 t80 66.2 -82.38 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 124.847 1.259 . . . . 75.44 111.852 175.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 21.5 p80 39.75 85.24 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 125.966 1.707 . . . . 73.43 113.765 -176.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . -79.07 62.86 3.95 Favored Glycine 0 C--N 1.352 1.444 0 CA-C-N 115.934 -0.576 . . . . 72.35 112.841 179.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 300' ' ' ASN . . . . . 0.476 ' ND2' ' H ' ' B' ' 301' ' ' ILE . 11.0 t30 -171.45 -151.04 0.07 Allowed 'General case' 0 CA--C 1.551 0.999 0 N-CA-C 106.131 -1.803 . . . . 72.23 106.131 -175.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 301' ' ' ILE . . . . . 0.476 ' H ' ' ND2' ' B' ' 300' ' ' ASN . 29.7 mm 74.87 142.15 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.562 1.407 0 C-N-CA 124.907 1.283 . . . . 75.13 111.582 174.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 302' ' ' ASP . . . . . 0.509 ' H ' ' HG3' ' A' ' 189' ' ' GLU . 18.5 t0 78.83 161.27 0.2 Allowed 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 125.885 1.674 . . . . 74.32 112.737 171.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 303' ' ' LYS . . . . . 0.5 ' HB2' ' HZ3' ' B' ' 303' ' ' LYS . 0.1 OUTLIER -63.51 -36.71 24.3 Favored Pre-proline 0 CA--C 1.571 1.778 0 N-CA-C 115.255 1.576 . . . . 74.11 115.255 -165.35 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 304' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -49.83 -33.79 34.2 Favored 'Trans proline' 0 C--N 1.394 2.944 0 C-N-CA 122.624 2.216 . . . . 75.12 114.13 169.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . 68.53 -72.74 0.1 Allowed 'General case' 0 C--N 1.362 1.142 0 C-N-CA 125.353 1.461 . . . . 72.13 110.558 -175.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 6.9 p -124.28 139.46 50.56 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 C-N-CA 123.799 0.84 . . . . 72.33 109.372 172.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 24.4 m -61.17 -27.71 68.6 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.677 1.191 . . . . 74.23 112.475 -175.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 308' ' ' CYS . . . . . . . . . . . . . 20.2 p -70.1 -10.22 58.04 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.309 0.644 . . . . 74.22 111.735 -178.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 65.6 p -130.3 88.32 48.08 Favored Pre-proline 0 CA--C 1.554 1.134 0 C-N-CA 123.7 0.8 . . . . 72.2 109.36 174.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -79.68 162.75 24.25 Favored 'Trans proline' 0 C--N 1.376 2.023 0 C-N-CA 122.676 2.251 . . . . 64.44 112.266 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 311' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -83.86 -46.64 0.76 Allowed Pre-proline 0 CA--C 1.564 1.507 0 CA-C-O 119.04 -0.505 . . . . 73.13 111.317 178.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 312' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -92.63 -157.19 0.05 OUTLIER 'Trans proline' 0 C--N 1.386 2.538 0 C-N-CA 122.095 1.863 . . . . 70.14 110.543 166.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 313' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -89.3 9.69 25.07 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.563 0.345 . . . . 75.13 110.78 174.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 314' ' ' ARG . . . . . . . . . . . . . 37.9 ttp-105 72.99 -71.01 0.14 Allowed 'General case' 0 C--N 1.364 1.201 0 C-N-CA 125.922 1.689 . . . . 74.53 111.04 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 315' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 62.44 -81.02 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.921 1.289 . . . . 75.34 112.091 -179.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 316' ' ' ASP . . . . . . . . . . . . . 33.1 t70 64.35 -75.9 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.499 1.52 . . . . 74.4 112.394 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 317' ' ' SER . . . . . 0.628 ' HA ' HG23 ' B' ' 325' ' ' THR . 69.7 m -96.65 -6.95 35.4 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.787 0.835 . . . . 75.41 112.437 -177.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 318' ' ' VAL . . . . . 0.662 HG12 ' HA ' ' B' ' 322' ' ' ALA . 29.7 m -118.97 92.11 44.48 Favored Pre-proline 0 CA--C 1.557 1.242 0 C-N-CA 123.181 0.593 . . . . 73.13 110.752 -178.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 319' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -67.98 -37.63 14.73 Favored 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 122.572 2.181 . . . . 65.1 111.312 173.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 320' ' ' THR . . . . . . . . . . . . . 88.5 m -144.08 -58.0 0.38 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.482 1.113 . . . . 73.24 108.292 174.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 321' ' ' LEU . . . . . . . . . . . . . 93.9 mt -112.05 169.58 8.75 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-N 115.325 -0.852 . . . . 74.43 110.016 178.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 322' ' ' ALA . . . . . 0.662 ' HA ' HG12 ' B' ' 318' ' ' VAL . . . -79.63 72.09 6.29 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.61 0.764 . . . . 64.54 110.278 177.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 323' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -88.85 -25.15 22.33 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 115.175 -0.921 . . . . 74.02 109.497 175.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 324' ' ' MET . . . . . 0.419 ' HA ' ' HB3' ' B' ' 317' ' ' SER . 43.1 tpp 73.18 125.65 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.357 1.463 . . . . 74.22 113.441 166.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 325' ' ' THR . . . . . 0.628 HG23 ' HA ' ' B' ' 317' ' ' SER . 4.4 t -104.78 103.39 13.0 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 107.312 -1.366 . . . . 72.33 107.312 163.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 326' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -60.63 147.05 43.25 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.312 0.645 . . . . 72.01 110.019 -177.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . 0.433 ' HD2' ' N ' ' B' ' 327' ' ' LYS . 2.9 mptp? -83.45 22.9 0.98 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.685 0.794 . . . . 75.41 113.021 -170.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 328' ' ' ALA . . . . . . . . . . . . . . . 77.71 164.28 0.23 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.127 1.371 . . . . 72.03 113.193 167.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 329' ' ' ILE . . . . . . . . . . . . . 13.6 tt -144.7 173.24 4.51 Favored 'Isoleucine or valine' 0 C--O 1.251 1.144 0 CA-C-N 113.242 -1.799 . . . . 73.5 106.334 175.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 330' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -66.74 -81.33 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 108.134 -1.061 . . . . 74.44 108.134 164.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 331' ' ' LEU . . . . . . . . . . . . . 60.2 tp 48.31 -93.89 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 124.318 1.047 . . . . 64.42 110.585 -174.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 96.9 mt 30.69 -90.62 0.01 OUTLIER 'General case' 0 C--N 1.368 1.382 0 C-N-CA 126.739 2.016 . . . . 74.41 113.84 178.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 333' ' ' SER . . . . . . . . . . . . . 16.5 p -176.64 -66.44 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.491 1.516 . . . . 65.04 107.119 -178.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt 75.21 -45.08 0.55 Allowed 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 125.988 1.715 . . . . 65.35 113.047 172.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 335' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -53.41 109.37 0.43 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.982 1.313 . . . . 74.12 112.426 -176.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 55.73 32.33 19.21 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.865 1.266 . . . . 73.55 113.61 166.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 337' ' ' LYS . . . . . 0.534 ' NZ ' ' SG ' ' B' ' 190' ' ' CYS . 30.8 mtpt -75.94 79.62 2.83 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 121.391 0.615 . . . . 71.1 109.565 173.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 338' ' ' GLY . . . . . . . . . . . . . . . 110.63 157.12 15.27 Favored Glycine 0 C--N 1.342 0.874 0 CA-C-N 114.861 -1.063 . . . . 73.12 110.786 -169.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 339' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -140.4 178.81 7.05 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.623 0.769 . . . . 74.33 109.689 -178.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 340' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -65.36 163.53 15.41 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.672 0.789 . . . . 75.24 112.065 -176.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 341' ' ' LEU . . . . . . . . . . . . . 6.3 tt -146.94 117.59 7.54 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 107.751 -1.203 . . . . 75.34 107.751 176.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 342' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -91.11 127.37 36.51 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 122.944 0.498 . . . . 74.32 110.158 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 343' ' ' VAL . . . . . . . . . . . . . 7.5 p -96.11 -32.59 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.486 0.714 . . . . 65.15 109.618 173.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 63.43 -77.54 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 126.351 1.86 . . . . 74.33 111.384 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 345' ' ' GLY . . . . . . . . . . . . . . . -117.49 148.56 18.72 Favored Glycine 0 C--N 1.342 0.886 0 N-CA-C 112.332 -0.307 . . . . 63.14 112.332 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 346' ' ' ALA . . . . . . . . . . . . . . . -87.84 178.17 6.78 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.956 0.902 . . . . 72.51 110.157 173.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 46.8 t -66.63 -61.7 1.84 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.076 0.55 . . . . 72.21 109.979 177.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 348' ' ' ILE . . . . . 0.464 ' O ' ' HB ' ' B' ' 236' ' ' THR . 61.0 mt 68.02 -62.02 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 125.977 1.711 . . . . 73.42 112.247 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 349' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -52.28 92.35 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 125.41 1.484 . . . . 71.13 112.106 -178.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 350' ' ' LYS . . . . . 0.568 ' HZ2' ' HB3' ' B' ' 350' ' ' LYS . 6.9 ttpm? 48.09 73.72 0.2 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 125.317 1.447 . . . . 74.52 111.419 173.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 351' ' ' GLN . . . . . 0.454 ' HB2' ' OG1' ' B' ' 238' ' ' THR . 23.2 mt-30 -78.7 158.08 28.42 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.215 -0.902 . . . . 71.32 112.199 -170.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 7.7 t0 62.0 -99.9 0.09 Allowed 'General case' 0 CA--C 1.563 1.445 0 C-N-CA 124.993 1.317 . . . . 74.35 111.626 169.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 353' ' ' HIS . . . . . . . . . . . . . 44.6 p-80 -135.42 13.04 3.51 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.439 0.695 . . . . 74.33 109.494 -177.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 354' ' ' ALA . . . . . . . . . . . . . . . 72.21 177.07 0.26 Allowed 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 125.522 1.529 . . . . 72.23 110.821 -162.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 355' ' ' ALA . . . . . 0.485 ' H ' ' HB2' ' B' ' 237' ' ' ALA . . . -90.79 168.55 11.65 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.168 0.587 . . . . 75.44 109.591 177.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 356' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -111.52 98.79 42.0 Favored Pre-proline 0 N--CA 1.476 0.873 0 C-N-CA 123.347 0.659 . . . . 74.32 109.538 174.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 357' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -88.12 0.21 6.87 Favored 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 122.97 2.447 . . . . 74.21 111.8 166.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 358' ' ' CYS . . . . . . . . . . . . . 8.9 p -162.96 115.58 1.58 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.435 1.094 . . . . 75.21 108.272 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 359' ' ' GLY . . . . . . . . . . . . . . . -75.73 76.09 1.4 Allowed Glycine 0 C--N 1.349 1.254 0 N-CA-C 110.484 -1.046 . . . . 72.04 110.484 176.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 360' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 69.89 -67.92 0.22 Allowed 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 125.763 1.625 . . . . 53.34 108.75 -165.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 361' ' ' ILE . . . . . 0.426 HG23 ' H ' ' B' ' 363' ' ' GLU . 45.0 mt -96.38 147.82 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 123.745 0.818 . . . . 64.41 109.208 174.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 362' ' ' GLY . . . . . . . . . . . . . . . -65.36 -37.4 93.83 Favored Glycine 0 C--N 1.352 1.45 0 O-C-N 123.323 0.39 . . . . 72.35 113.053 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 363' ' ' GLU . . . . . 0.426 ' H ' HG23 ' B' ' 361' ' ' ILE . 4.1 mp0 -71.85 -23.31 61.51 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.953 0.901 . . . . 73.13 112.181 -178.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 364' ' ' THR . . . . . . . . . . . . . 69.3 m -59.66 -37.41 78.66 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.445 0.698 . . . . 74.04 111.592 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 17.0 m -108.82 -58.29 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.245 0 CA-C-O 118.751 -0.642 . . . . 74.51 110.504 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 32.4 t70 38.43 -94.23 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 126.024 1.73 . . . . 52.52 113.141 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 367' ' ' LEU . . . . . . . . . . . . . 7.6 mp -133.89 131.35 39.02 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 106.802 -1.555 . . . . 75.05 106.802 167.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 368' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -81.43 177.98 8.64 Favored 'General case' 0 CA--C 1.553 1.069 0 N-CA-C 110.172 -0.307 . . . . 73.23 110.172 177.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 369' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 68.83 -82.38 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 124.86 1.264 . . . . 74.11 111.004 -172.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 370' ' ' ALA . . . . . . . . . . . . . . . 59.12 -83.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 125.01 1.324 . . . . 74.25 111.931 -174.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 371' ' ' VAL . . . . . . . . . . . . . 43.3 t 61.17 -84.43 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 125.807 1.643 . . . . 74.12 112.133 178.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 372' ' ' GLN . . . . . . . . . . . . . 22.0 tp60 -151.18 5.52 0.48 Allowed 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.788 0.835 . . . . 63.2 110.362 -172.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 373' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 61.85 94.1 0.04 OUTLIER 'General case' 0 C--N 1.36 1.028 0 C-N-CA 124.517 1.127 . . . . 72.2 109.66 -171.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -62.35 115.6 4.33 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.523 -0.762 . . . . 71.45 111.468 -172.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 375' ' ' LEU . . . . . . . . . . . . . 53.5 tp -73.99 117.6 15.97 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 108.732 -0.84 . . . . 72.22 108.732 174.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 376' ' ' GLU . . . . . 0.458 ' HB3' ' HA ' ' A' ' 258' ' ' PRO . 0.0 OUTLIER -61.81 -31.09 71.29 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.164 0.985 . . . . 73.13 112.717 -177.98 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 377' ' ' PHE . . . . . 0.501 ' HZ ' ' HB3' ' B' ' 394' ' ' HIS . 79.5 t80 -62.44 -34.88 77.66 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.119 0.968 . . . . 73.31 111.009 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 378' ' ' ALA . . . . . . . . . . . . . . . -66.07 -37.35 85.59 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.446 -0.797 . . . . 73.45 110.158 176.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . 0.41 ' HB3' ' HB2' ' B' ' 383' ' ' ASN . 12.5 tmtt? 78.42 -28.08 0.16 Allowed 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 125.743 1.617 . . . . 73.22 111.938 170.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 380' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt 72.26 -82.59 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 125.931 1.692 . . . . 72.4 111.927 169.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 381' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -84.83 101.08 11.99 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.088 0.555 . . . . 74.34 111.297 -176.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . 67.35 65.83 2.59 Favored Glycine 0 C--N 1.349 1.303 0 CA-C-N 115.209 -0.905 . . . . 73.1 113.236 175.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 383' ' ' ASN . . . . . 0.41 ' HB2' ' HB3' ' B' ' 379' ' ' LYS . 60.6 t30 -89.82 -61.54 1.67 Allowed 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 109.555 -0.535 . . . . 73.1 109.555 175.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 384' ' ' THR . . . . . . . . . . . . . 26.2 m 62.88 -79.61 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 125.498 1.519 . . . . 71.44 111.028 -173.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 385' ' ' LEU . . . . . 0.563 ' HA ' ' HD2' ' A' ' 211' ' ' ARG . 96.9 mt 56.95 -89.96 0.03 OUTLIER 'General case' 0 C--N 1.355 0.813 0 C-N-CA 124.604 1.162 . . . . 75.43 109.533 -168.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 386' ' ' VAL . . . . . 0.432 ' HB ' ' HB3' ' B' ' 391' ' ' ASP . 2.9 t -124.87 45.94 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 107.66 -1.237 . . . . 75.23 107.66 174.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 387' ' ' ILE . . . . . . . . . . . . . 1.9 mp 69.96 -65.04 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 C-N-CA 125.664 1.586 . . . . 74.12 109.306 -172.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 388' ' ' VAL . . . . . 0.494 HG22 ' HB2' ' B' ' 391' ' ' ASP . 10.7 m -86.54 135.98 23.91 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 C-N-CA 123.502 0.721 . . . . 74.43 109.584 169.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 389' ' ' THR . . . . . . . . . . . . . 14.9 t -79.28 -16.26 56.69 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.364 0.665 . . . . 71.25 111.74 -175.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . -73.78 -20.76 60.39 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.324 0.649 . . . . 73.41 112.098 178.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 391' ' ' ASP . . . . . 0.494 ' HB2' HG22 ' B' ' 388' ' ' VAL . 7.1 t70 -80.79 170.61 16.07 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.298 0.639 . . . . 64.12 111.147 -175.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 392' ' ' HIS . . . . . . . . . . . . . 81.2 t60 66.12 35.81 5.98 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.849 1.26 . . . . 72.42 108.445 -169.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . 67.39 22.66 9.38 Favored 'General case' 0 C--N 1.357 0.915 0 CA-C-N 113.938 -1.483 . . . . 61.53 113.069 173.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 394' ' ' HIS . . . . . 0.501 ' HB3' ' HZ ' ' B' ' 377' ' ' PHE . 64.8 m170 -75.46 -11.03 59.95 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 112.25 0.463 . . . . 73.31 112.25 -177.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . -66.01 99.18 0.48 Allowed 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 109.134 -0.691 . . . . 75.42 109.134 166.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 32.0 p -72.59 81.5 1.1 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.975 0.91 . . . . 75.55 110.601 -177.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 397' ' ' GLN . . . . . . . . . . . . . 87.5 mm-40 -141.01 88.08 2.15 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.181 0.992 . . . . 75.54 108.875 -176.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 398' ' ' ILE . . . . . 0.623 ' HB ' HG23 ' B' ' 409' ' ' THR . 14.3 tt -111.25 89.57 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 CA-C-O 121.601 0.715 . . . . 75.44 109.508 178.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 399' ' ' VAL . . . . . . . . . . . . . 45.4 t -68.9 -75.12 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 CA-C-N 115.792 -0.64 . . . . 73.32 110.222 -174.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 400' ' ' ALA . . . . . . . . . . . . . . . -162.96 80.88 1.64 Allowed Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 123.352 0.661 . . . . 74.52 109.733 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 401' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -81.95 47.04 2.38 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 123.562 2.842 . . . . 71.34 111.712 173.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -64.16 -37.78 88.68 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.387 1.075 . . . . 74.34 111.895 -168.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 403' ' ' THR . . . . . . . . . . . . . 9.3 t -136.39 138.76 41.9 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 108.353 -0.98 . . . . 73.2 108.353 172.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 404' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? 55.8 86.0 0.06 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.364 1.066 . . . . 71.14 110.431 -173.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 405' ' ' ALA . . . . . . . . . . . . . . . -109.65 96.46 23.66 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 123.847 0.859 . . . . 71.24 110.786 -176.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 406' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -83.48 11.9 3.15 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 123.063 2.509 . . . . 64.23 112.852 173.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . 83.18 -84.14 1.57 Allowed Glycine 0 C--N 1.346 1.099 0 CA-C-O 119.693 -0.504 . . . . 74.04 112.058 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 408' ' ' LEU . . . . . . . . . . . . . 82.0 mt 61.54 5.74 1.31 Allowed 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 124.881 1.272 . . . . 72.55 112.814 -178.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 409' ' ' THR . . . . . 0.623 HG23 ' HB ' ' B' ' 398' ' ' ILE . 14.6 t -158.06 157.79 33.56 Favored 'General case' 0 C--O 1.244 0.766 0 C-N-CA 125.14 1.376 . . . . 73.52 107.582 -176.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 410' ' ' GLN . . . . . . . . . . . . . 27.0 pt20 43.69 78.75 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 125.481 1.512 . . . . 70.42 113.391 -178.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . 77.7 -53.92 0.52 Allowed 'General case' 0 N--CA 1.498 1.925 0 C-N-CA 125.55 1.54 . . . . 74.33 113.791 176.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 39.0 tp -73.81 96.35 2.55 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.736 0.814 . . . . 75.21 111.813 -171.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -164.13 -70.9 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 124.435 1.094 . . . . 71.14 108.702 170.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 414' ' ' THR . . . . . . . . . . . . . 36.9 p -112.1 159.45 18.5 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.066 0.946 . . . . 73.24 110.194 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 415' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -104.78 -18.81 14.12 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.066 0.946 . . . . 75.21 111.069 -176.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -78.08 169.37 18.38 Favored 'General case' 0 C--O 1.245 0.852 0 C-N-CA 124.438 1.095 . . . . 75.33 111.841 -171.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 417' ' ' GLY . . . . . . . . . . . . . . . 137.94 -23.42 3.06 Favored Glycine 0 C--N 1.341 0.814 0 CA-C-N 115.127 -0.942 . . . . 62.31 113.308 176.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 418' ' ' ALA . . . . . . . . . . . . . . . -150.22 147.54 27.81 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 117.49 0.645 . . . . 70.25 111.03 -177.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 419' ' ' VAL . . . . . . . . . . . . . 50.2 t -59.04 -43.75 89.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.202 1.001 . . . . 73.31 109.649 172.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 420' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -123.7 115.18 20.99 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 107.512 -1.292 . . . . 73.34 107.512 173.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 421' ' ' VAL . . . . . . . . . . . . . 6.3 p -123.65 121.83 63.41 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 C-N-CA 123.657 0.783 . . . . 72.42 110.056 -177.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 422' ' ' MET . . . . . 0.518 ' SD ' ' HD2' ' A' ' 209' ' ' LYS . 0.0 OUTLIER -122.1 10.58 10.08 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.03 0.932 . . . . 74.1 111.117 175.888 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 423' ' ' SER . . . . . . . . . . . . . 19.9 m -108.89 18.76 20.37 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.333 1.053 . . . . 63.45 109.818 169.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 424' ' ' TYR . . . . . 0.416 ' HB3' ' HG2' ' B' ' 429' ' ' GLU . 14.7 t80 -54.16 -58.45 7.31 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.06 1.344 . . . . 74.22 109.709 172.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . -105.15 51.01 0.8 Allowed Glycine 0 C--N 1.347 1.148 0 CA-C-N 114.945 -1.025 . . . . 75.12 111.0 172.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 426' ' ' ASN . . . . . . . . . . . . . 21.1 m120 71.79 -66.66 0.29 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.441 1.497 . . . . 75.43 112.534 175.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 427' ' ' SER . . . . . 0.558 ' HA ' ' HZ1' ' A' ' 209' ' ' LYS . 72.9 m -147.53 151.94 37.16 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.49 0.716 . . . . 75.14 111.269 175.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 51.76 93.04 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 125.773 1.629 . . . . 73.23 112.013 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 429' ' ' GLU . . . . . 0.638 ' HG3' ' H ' ' B' ' 431' ' ' SER . 17.0 tp10 -110.9 152.83 26.27 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.864 -0.607 . . . . 63.42 111.589 -171.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -56.86 -35.23 68.65 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.985 1.314 . . . . 62.42 111.009 171.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 431' ' ' SER . . . . . 0.638 ' H ' ' HG3' ' B' ' 429' ' ' GLU . 18.4 m -64.39 81.84 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.092 0.957 . . . . 75.05 110.797 177.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 432' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -120.58 26.79 8.93 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.264 1.025 . . . . 71.1 108.989 175.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 433' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -64.17 112.42 3.01 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 115.206 -0.906 . . . . 73.43 109.192 177.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 434' ' ' HIS . . . . . . . . . . . . . 50.3 t60 66.01 34.94 6.67 Favored 'General case' 0 CA--C 1.566 1.558 0 O-C-N 124.409 1.068 . . . . 73.42 110.387 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 435' ' ' THR . . . . . . . . . . . . . 10.6 t -73.31 -8.79 57.36 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.395 0.678 . . . . 73.42 111.622 177.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . -56.2 -31.4 59.2 Favored Glycine 0 C--N 1.357 1.737 0 O-C-N 123.576 0.547 . . . . 61.51 112.187 170.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 68.9 m -70.08 83.08 0.51 Allowed 'General case' 0 C--N 1.354 0.782 0 N-CA-C 107.544 -1.28 . . . . 72.35 107.544 161.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 438' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -66.34 93.94 0.24 Allowed 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 114.44 -1.255 . . . . 71.55 111.762 -170.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 439' ' ' LEU . . . . . . . . . . . . . 86.0 mt -83.21 -5.53 59.16 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 114.943 -1.026 . . . . 74.24 110.604 171.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 440' ' ' ARG . . . . . 0.479 ' HA ' ' HB2' ' A' ' 222' ' ' ALA . 13.1 mtp180 -89.52 108.55 19.72 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.449 -0.945 . . . . 74.1 108.449 177.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 441' ' ' ILE . . . . . 0.58 HD13 ' HA ' ' A' ' 223' ' ' VAL . 57.0 mt -69.25 124.03 24.16 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 C-N-CA 123.353 0.661 . . . . 74.15 112.315 -167.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 442' ' ' ALA . . . . . . . . . . . . . . . -115.27 32.41 6.07 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.071 0.948 . . . . 73.33 110.15 175.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 443' ' ' ALA . . . . . 0.486 ' H ' HG21 ' B' ' 441' ' ' ILE . . . -68.77 163.64 23.61 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.351 0.66 . . . . 74.21 111.425 178.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 15.3 m-30 78.3 -24.72 0.21 Allowed 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 125.744 1.617 . . . . 71.31 111.912 -174.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . 66.89 69.52 1.34 Allowed Glycine 0 C--N 1.352 1.424 0 N-CA-C 110.403 -1.079 . . . . 74.34 110.403 -168.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 446' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -49.08 98.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 124.246 3.297 . . . . 72.44 114.237 -165.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 447' ' ' HIS . . . . . 0.534 ' HD1' HD13 ' B' ' 454' ' ' LEU . 7.8 p-80 -121.4 95.26 4.61 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.937 0.895 . . . . 63.45 109.429 177.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . -90.64 -170.72 2.81 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.658 -0.701 . . . . 74.31 109.978 176.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 449' ' ' ALA . . . . . . . . . . . . . . . 63.24 30.82 15.78 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.081 0.952 . . . . 74.42 111.619 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 450' ' ' ASN . . . . . . . . . . . . . 10.8 t30 65.33 15.66 10.13 Favored 'General case' 0 CA--C 1.56 1.355 0 C-N-CA 124.601 1.161 . . . . 63.22 112.153 174.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 40.5 t -78.93 76.91 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 CA-C-O 122.01 0.909 . . . . 74.44 108.756 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 452' ' ' VAL . . . . . . . . . . . . . 8.0 p -75.8 -29.49 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-N 114.334 -1.303 . . . . 74.24 111.68 -172.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . -80.03 67.07 3.49 Favored Glycine 0 C--N 1.349 1.304 0 CA-C-N 115.745 -0.661 . . . . 73.44 112.056 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 454' ' ' LEU . . . . . 0.534 HD13 ' HD1' ' B' ' 447' ' ' HIS . 3.1 tm? -153.55 123.52 6.89 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 106.625 -1.62 . . . . 73.13 106.625 -178.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 58.7 m -79.33 -82.71 0.1 Allowed 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 108.991 -0.744 . . . . 72.1 108.991 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -140.02 155.17 47.2 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.731 0.812 . . . . 74.3 109.057 178.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 457' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 63.26 98.28 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.711 1.204 . . . . 65.21 110.551 -173.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 3.7 m -90.49 3.76 53.01 Favored 'General case' 0 CA--C 1.56 1.344 0 C-N-CA 123.714 0.806 . . . . 72.13 110.738 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 459' ' ' ASP . . . . . . . . . . . . . 28.5 t70 66.5 113.62 0.03 OUTLIER 'General case' 0 C--N 1.362 1.114 0 C-N-CA 125.775 1.63 . . . . 73.31 110.054 -172.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 1.3 tt 66.07 99.69 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 124.845 1.258 . . . . 65.42 108.801 -177.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -73.9 70.55 1.48 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.712 0.805 . . . . 75.0 111.029 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 41.2 t80 -152.66 17.62 0.6 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.231 1.412 . . . . 72.53 107.934 177.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 24.3 p -84.66 54.56 3.08 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.227 1.411 . . . . 71.14 109.978 178.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 464' ' ' MET . . . . . . . . . . . . . 24.6 ptt? -95.03 32.74 1.62 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.959 1.303 . . . . 75.31 110.09 -176.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.15 82.17 0.71 Allowed 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.326 1.05 . . . . 72.15 110.89 -173.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -105.17 -172.05 2.03 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.386 1.074 . . . . 65.13 109.368 177.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . -81.46 12.9 3.32 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 123.376 0.67 . . . . 75.3 111.868 178.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 1.4 pp -53.17 151.76 4.84 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.713 1.205 . . . . 74.32 112.675 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 469' ' ' GLY . . . . . . . . . . . . . . . 76.22 -80.46 1.12 Allowed Glycine 0 C--N 1.341 0.825 0 N-CA-C 110.437 -1.065 . . . . 62.03 110.437 -168.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 470' ' ' LEU . . . . . . . . . . . . . 53.1 tp -170.28 -44.25 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.457 1.103 . . . . 75.32 108.813 177.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 471' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? . . . . . 0 CA--C 1.56 1.353 0 C-N-CA 125.351 1.46 . . . . 74.2 109.681 -176.461 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 63.2 mtt . . . . . 0 N--CA 1.475 0.816 0 N-CA-C 109.184 -0.673 . . . . 70.43 109.184 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 63.61 31.55 14.52 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.805 1.242 . . . . 70.41 111.411 -176.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -85.61 35.11 0.6 Allowed 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.334 0.654 . . . . 71.34 111.814 -175.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -37.38 94.95 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.489 1.516 . . . . 70.52 113.862 -175.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -66.49 104.36 1.24 Allowed 'General case' 0 C--O 1.239 0.514 0 N-CA-C 107.915 -1.142 . . . . 72.32 107.915 166.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -74.63 90.98 2.3 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 107.531 -1.285 . . . . 65.15 107.531 172.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 7' ' ' TYR . . . . . 0.436 ' CD1' ' HA ' ' C' ' 53' ' ' ALA . 72.4 m-85 -62.21 -26.01 68.12 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 114.387 -1.279 . . . . 73.43 111.99 -171.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -63.13 -47.86 80.96 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.54 0.736 . . . . 74.23 110.543 173.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.75 -39.58 93.87 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.06 0.544 . . . . 63.34 110.972 178.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 65.9 mt -59.26 -39.93 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 C-N-CA 123.374 0.669 . . . . 73.31 110.737 176.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 11' ' ' LEU . . . . . 0.417 ' O ' ' HB1' ' C' ' 25' ' ' ALA . 95.5 mt -90.14 -0.17 57.47 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 112.497 0.555 . . . . 75.53 112.497 177.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 59.59 37.92 92.93 Favored Glycine 0 C--N 1.352 1.459 0 N-CA-C 114.107 0.403 . . . . 74.43 114.107 178.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 7.2 m -126.03 139.41 34.28 Favored Pre-proline 0 N--CA 1.482 1.141 0 C-N-CA 124.775 1.23 . . . . 71.34 109.209 177.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -76.87 159.83 34.31 Favored 'Trans proline' 0 C--N 1.368 1.605 0 C-N-CA 122.192 1.928 . . . . 74.43 111.976 176.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 53.6 mtt180 -74.08 76.34 1.74 Allowed 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.329 -0.989 . . . . 74.35 108.329 171.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 176.39 -27.59 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.17 1.388 . . . . 71.24 108.487 -172.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.45 135.93 57.85 Favored 'General case' 0 C--N 1.351 0.664 0 CA-C-N 115.653 -0.703 . . . . 75.2 110.172 172.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 72.0 p -65.99 160.87 22.69 Favored 'General case' 0 C--O 1.246 0.899 0 O-C-N 123.668 0.605 . . . . 74.41 109.671 177.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 19' ' ' GLN . . . . . 0.553 ' HG2' ' HD3' ' C' ' 60' ' ' PRO . 24.8 tp60 -56.57 -33.67 66.38 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.233 0.613 . . . . 74.45 111.808 -176.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -75.0 -28.78 60.67 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 119.121 -0.466 . . . . 74.53 111.698 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . 0.511 ' HG2' HH21 ' C' ' 24' ' ' ARG . 46.3 mt-10 -69.36 -41.13 76.97 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 121.109 0.481 . . . . 73.42 110.161 174.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 22' ' ' ILE . . . . . 0.44 HG21 ' HB3' ' C' ' 57' ' ' LEU . 57.2 mt -66.44 -38.3 81.45 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 CA-C-N 114.735 -1.12 . . . . 75.54 110.12 176.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 23' ' ' LYS . . . . . 0.44 ' O ' ' HD3' ' C' ' 27' ' ' LYS . 4.5 ttpt -70.11 -40.49 74.86 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 114.69 -1.141 . . . . 74.13 109.617 179.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 24' ' ' ARG . . . . . 0.511 HH21 ' HG2' ' C' ' 21' ' ' GLU . 46.6 mtm105 -72.57 -22.39 61.0 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.276 0.63 . . . . 73.52 111.283 176.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . 0.417 ' HB1' ' O ' ' C' ' 11' ' ' LEU . . . -66.96 -45.2 78.46 Favored 'General case' 0 C--O 1.242 0.661 0 O-C-N 123.537 0.523 . . . . 75.32 109.603 171.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 26' ' ' TYR . . . . . 0.547 ' HD1' HG23 ' C' ' 50' ' ' ILE . 83.4 t80 -57.76 -52.95 63.35 Favored 'General case' 0 C--N 1.355 0.82 0 CA-C-N 115.5 -0.773 . . . . 72.31 110.698 171.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . 0.454 ' HE2' ' HA ' ' C' ' 24' ' ' ARG . 6.0 mppt? -60.69 -32.63 71.84 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.433 0.693 . . . . 75.33 111.62 -176.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -61.98 -48.81 78.7 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.974 0.91 . . . . 75.55 109.494 174.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . 0.524 HD11 HD13 ' C' ' 50' ' ' ILE . 76.6 mt -77.39 -13.4 59.94 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 114.781 -1.1 . . . . 71.43 111.664 178.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -86.93 -19.68 28.45 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.488 0.715 . . . . 75.32 110.02 176.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 60.4 mtm180 -91.92 -27.23 18.03 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.309 0.644 . . . . 73.5 110.364 169.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -72.84 -59.93 2.48 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.415 0.686 . . . . 71.12 109.218 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -90.25 22.31 3.39 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.92 0.888 . . . . 72.14 110.901 -178.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 34' ' ' HIS . . . . . 0.403 ' NE2' ' HB3' ' C' ' 36' ' ' ASP . 75.8 t60 -53.18 93.97 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.586 0 C-N-CA 125.565 1.546 . . . . 74.34 113.043 -166.007 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 35' ' ' PRO . . . . . 0.401 ' O ' ' HG2' ' C' ' 39' ' ' LYS . 53.3 Cg_endo -76.55 -6.05 16.64 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.901 2.401 . . . . 72.22 111.806 -168.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 36' ' ' ASP . . . . . 0.727 ' HB2' ' HG2' ' B' ' 113' ' ' LYS . 24.0 t70 -63.73 -35.91 82.15 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.442 1.097 . . . . 60.34 111.46 172.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 41.1 t -122.92 -46.9 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 CA-C-O 121.191 0.519 . . . . 75.33 109.753 -177.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -98.33 81.85 2.82 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.005 0.922 . . . . 65.41 109.678 -178.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 39' ' ' LYS . . . . . 0.559 ' HB2' ' HZ2' ' C' ' 39' ' ' LYS . 9.7 mtmp? -84.74 70.03 10.76 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 115.641 -0.709 . . . . 71.22 109.919 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 49.4 m -95.22 108.59 39.8 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-O 118.254 -0.879 . . . . 74.14 108.74 175.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -41.35 -53.01 3.33 Favored 'Trans proline' 0 C--N 1.386 2.542 0 C-N-CA 124.457 3.438 . . . . 75.0 115.157 -174.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -65.72 -31.6 72.69 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.302 0.641 . . . . 71.01 111.335 -178.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.46 -18.93 56.71 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.036 0.534 . . . . 71.45 110.546 176.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 44' ' ' GLU . . . . . 0.45 ' HA ' ' HB3' ' C' ' 47' ' ' PHE . 51.0 mt-10 -89.91 -19.39 24.61 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.797 0.839 . . . . 74.04 109.634 177.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -77.07 -39.82 48.42 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.069 0.947 . . . . 75.44 109.53 168.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 46' ' ' LYS . . . . . 0.526 ' O ' HG12 ' C' ' 50' ' ' ILE . 63.3 mttp -61.35 -48.04 83.11 Favored 'General case' 0 C--N 1.35 0.606 0 CA-C-N 115.094 -0.957 . . . . 72.32 108.847 169.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 47' ' ' PHE . . . . . 0.45 ' HB3' ' HA ' ' C' ' 44' ' ' GLU . 59.5 t80 -64.22 -27.97 69.42 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.179 0.991 . . . . 71.12 110.856 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 48' ' ' LYS . . . . . 0.498 ' HE2' ' HB3' ' C' ' 89' ' ' ASP . 2.9 tptm -62.82 -48.78 77.62 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 108.698 -0.853 . . . . 72.04 108.698 172.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -70.79 -19.68 62.67 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 112.557 0.577 . . . . 72.33 112.557 176.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 50' ' ' ILE . . . . . 0.547 HG23 ' HD1' ' C' ' 26' ' ' TYR . 23.6 mm -78.75 -34.43 17.39 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 N-CA-C 108.787 -0.82 . . . . 75.43 108.787 174.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 51' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -79.1 -18.23 53.66 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 124.069 0.947 . . . . 74.04 111.276 175.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 52' ' ' GLU . . . . . 0.417 ' O ' HG22 ' C' ' 56' ' ' VAL . 32.6 tt0 -76.18 -50.23 15.09 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.569 -0.9 . . . . 75.54 108.569 170.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . 0.436 ' HA ' ' CD1' ' C' ' 7' ' ' TYR . . . -60.57 -33.38 72.62 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 114.593 -1.185 . . . . 63.1 111.247 176.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 54' ' ' TYR . . . . . 0.435 ' O ' ' HB2' ' C' ' 58' ' ' SER . 20.8 t80 -81.92 -32.9 30.66 Favored 'General case' 0 C--O 1.214 -0.783 0 C-N-CA 123.788 0.835 . . . . 75.01 110.207 176.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.81 -34.37 67.63 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 120.915 0.388 . . . . 60.54 110.247 174.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 56' ' ' VAL . . . . . 0.417 HG22 ' O ' ' C' ' 52' ' ' GLU . 14.8 t -97.61 -24.62 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.26 0 CA-C-N 115.065 -0.97 . . . . 72.43 112.308 -178.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 57' ' ' LEU . . . . . 0.44 ' HB3' HG21 ' C' ' 22' ' ' ILE . 61.9 mt -125.46 29.77 5.94 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 119.242 0.928 . . . . 75.02 112.746 -177.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 58' ' ' SER . . . . . 0.435 ' HB2' ' O ' ' C' ' 54' ' ' TYR . 23.1 t -69.8 -56.44 7.13 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.238 0.542 . . . . 75.33 111.8 175.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -130.05 157.19 77.74 Favored Pre-proline 0 N--CA 1.479 0.981 0 C-N-CA 124.313 1.045 . . . . 72.03 109.303 -171.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 60' ' ' PRO . . . . . 0.553 ' HD3' ' HG2' ' C' ' 19' ' ' GLN . 18.2 Cg_endo -54.26 -21.05 21.42 Favored 'Trans proline' 0 C--N 1.391 2.797 0 C-N-CA 122.921 2.414 . . . . 73.21 112.992 -179.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -51.35 -75.62 0.03 OUTLIER 'General case' 0 CA--C 1.565 1.537 0 C-N-CA 124.554 1.142 . . . . 62.13 110.832 170.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.39 -28.68 67.32 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.592 0.757 . . . . 75.43 111.338 -176.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 10.1 ttp180 -66.14 -44.74 83.31 Favored 'General case' 0 C--N 1.351 0.644 0 N-CA-C 109.496 -0.557 . . . . 74.14 109.496 -177.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -71.0 -29.98 66.1 Favored 'General case' 0 C--N 1.359 1.003 0 O-C-N 123.876 0.735 . . . . 74.15 111.015 178.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 47.5 mm -57.19 -48.55 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 CA-C-O 121.196 0.522 . . . . 71.5 110.049 170.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -67.23 -40.72 86.39 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.773 -0.649 . . . . 74.31 111.012 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -59.42 -45.8 90.52 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 122.95 0.5 . . . . 73.14 110.565 178.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 74.2 p -73.14 -15.72 61.47 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.522 -0.763 . . . . 74.43 111.271 178.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -73.05 116.91 14.14 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 106.948 -1.501 . . . . 75.22 106.948 167.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 111.2 9.5 21.95 Favored Glycine 0 N--CA 1.472 1.073 0 N-CA-C 111.475 -0.65 . . . . 62.51 111.475 -165.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 88.3 m -141.57 -59.01 0.48 Allowed 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 103.755 -2.683 . . . . 72.34 103.755 176.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 34.4 m -73.96 134.16 43.09 Favored 'General case' 0 C--O 1.251 1.164 0 N-CA-C 103.88 -2.637 . . . . 73.35 103.88 155.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.03 -37.45 5.36 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.329 0.652 . . . . 73.23 110.8 -170.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -88.86 150.7 46.17 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 123.992 0.917 . . . . 53.23 109.098 174.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -52.37 117.66 3.85 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 122.838 2.359 . . . . 75.14 111.629 172.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.89 156.75 18.41 Favored 'Trans proline' 0 C--N 1.382 2.325 0 C-N-CA 123.494 2.796 . . . . 71.22 113.745 -176.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -66.53 121.38 8.62 Favored 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 122.209 1.939 . . . . 74.4 111.044 172.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 78' ' ' PRO . . . . . 0.408 ' HB3' ' HA3' ' C' ' 104' ' ' GLY . 32.0 Cg_endo -61.82 135.38 55.58 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 122.886 2.391 . . . . 74.44 113.414 -174.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.22 159.06 54.84 Favored 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 123.001 2.467 . . . . 70.12 112.455 176.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.49 85.9 0.04 OUTLIER 'Trans proline' 0 C--N 1.391 2.815 0 C-N-CA 123.553 2.835 . . . . 74.31 112.873 177.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 159.01 -45.33 0.45 Allowed Glycine 0 C--N 1.341 0.856 0 CA-C-N 114.967 -1.015 . . . . 75.2 111.358 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 111.55 175.23 20.02 Favored Glycine 0 C--N 1.351 1.37 0 C-N-CA 123.514 0.578 . . . . 75.13 112.053 -174.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -83.94 113.24 20.84 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.996 -0.742 . . . . 73.4 108.996 177.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 84' ' ' ASP . . . . . 0.419 ' HA ' ' CZ ' ' C' ' 106' ' ' PHE . 2.0 t70 -63.08 144.87 56.52 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 123.928 0.767 . . . . 75.11 112.639 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 85' ' ' PHE . . . . . 0.522 ' O ' ' HG3' ' C' ' 171' ' ' PRO . 78.3 m-85 -137.31 72.24 1.42 Allowed 'General case' 0 C--O 1.212 -0.88 0 C-N-CA 124.567 1.147 . . . . 74.41 109.348 171.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 50.7 m -47.49 86.61 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 124.31 1.044 . . . . 52.42 112.924 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 67.64 13.13 62.89 Favored Glycine 0 C--N 1.349 1.275 0 CA-C-N 115.513 -0.767 . . . . 74.34 114.611 -178.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 88' ' ' PHE . . . . . 0.494 ' HB2' ' HB3' ' C' ' 85' ' ' PHE . 18.6 m-85 -92.22 128.97 38.26 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 109.081 -0.711 . . . . 74.44 109.081 -177.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 89' ' ' ASP . . . . . 0.498 ' HB3' ' HE2' ' C' ' 48' ' ' LYS . 27.9 t70 -83.69 78.59 9.67 Favored 'General case' 0 C--O 1.246 0.898 0 CA-C-O 121.665 0.745 . . . . 72.23 110.509 -172.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 90' ' ' VAL . . . . . 0.712 HG21 HD22 ' C' ' 169' ' ' ASN . 1.3 p -43.44 -36.43 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.22 0 C-N-CA 125.934 1.694 . . . . 54.42 112.415 172.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -50.21 -36.53 31.16 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.648 1.579 . . . . 75.25 112.891 -178.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -119.26 21.41 12.26 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.524 0.729 . . . . 75.53 111.234 -170.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 21.5 m-30 -94.17 175.49 6.68 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.805 -0.559 . . . . 72.45 111.123 175.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 84.5 p -74.4 173.45 10.27 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 113.754 1.02 . . . . 52.11 113.754 -164.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 95' ' ' GLU . . . . . 0.453 ' O ' ' HG3' ' C' ' 99' ' ' GLU . 4.0 mp0 -73.21 -36.52 66.52 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 114.71 -1.132 . . . . 72.35 110.617 178.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -60.57 -42.56 96.88 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-O 121.535 0.683 . . . . 74.24 110.289 173.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 97' ' ' PHE . . . . . 0.701 ' HE2' HG22 ' C' ' 90' ' ' VAL . 48.9 t80 -58.46 -43.4 88.85 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 114.282 -1.326 . . . . 64.25 109.933 174.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -66.56 -29.21 69.24 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 122.664 0.386 . . . . 71.33 111.814 176.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . 0.453 ' HG3' ' O ' ' C' ' 95' ' ' GLU . 45.0 mt-10 -67.21 -56.15 11.09 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 122.752 0.421 . . . . 74.43 110.24 178.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 26.7 tp -75.33 -50.18 16.81 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.392 -0.822 . . . . 73.23 111.802 -172.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -91.66 -20.3 21.75 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.299 0.64 . . . . 75.04 112.555 -173.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -46.46 -58.18 6.07 Favored Glycine 0 CA--C 1.541 1.68 0 CA-C-O 118.933 -0.926 . . . . 74.41 115.107 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -63.43 -3.29 5.04 Favored 'Trans proline' 0 C--N 1.385 2.462 0 C-N-CA 123.186 2.591 . . . . 64.35 114.464 -177.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 104' ' ' GLY . . . . . 0.408 ' HA3' ' HB3' ' C' ' 78' ' ' PRO . . . -137.91 32.53 2.35 Favored Glycine 0 C--N 1.349 1.284 0 CA-C-O 119.953 -0.359 . . . . 73.42 113.14 176.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 105' ' ' LEU . . . . . 0.401 ' HB3' ' ND2' ' C' ' 169' ' ' ASN . 48.3 mt -73.81 71.2 1.47 Allowed 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.019 0.528 . . . . 75.43 111.733 173.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 106' ' ' PHE . . . . . 0.493 ' HB3' ' H ' ' C' ' 168' ' ' GLY . 34.3 m-85 48.41 -109.3 0.3 Allowed 'General case' 0 CA--C 1.56 1.356 0 C-N-CA 125.05 1.34 . . . . 64.24 113.688 177.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . 66.22 6.58 33.8 Favored Glycine 0 C--N 1.369 2.393 0 CA-C-O 119.757 -0.468 . . . . 51.05 114.103 -165.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 56.36 -128.71 46.84 Favored Glycine 0 C--N 1.361 1.929 0 N-CA-C 111.798 -0.521 . . . . 74.41 111.798 -171.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 109' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -107.49 5.61 27.32 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.798 0.839 . . . . 74.45 110.037 168.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 110' ' ' GLY . . . . . . . . . . . . . . . -92.57 -7.93 62.84 Favored Glycine 0 C--N 1.352 1.418 0 O-C-N 123.642 0.588 . . . . 73.14 112.943 -175.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? 57.47 9.2 0.73 Allowed 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 114.246 1.202 . . . . 75.25 114.246 176.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 112' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -55.9 -33.67 64.85 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.628 1.171 . . . . 75.43 111.066 171.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 113' ' ' SER . . . . . . . . . . . . . 20.4 m 55.85 25.67 8.79 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.73 1.212 . . . . 72.53 112.086 175.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 114' ' ' ARG . . . . . 0.405 ' HG3' ' H ' ' C' ' 115' ' ' LYS . 4.6 tpt180 -137.77 -164.13 1.56 Allowed 'General case' 0 CA--C 1.555 1.138 0 CA-C-O 117.415 -1.279 . . . . 74.05 109.684 -173.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 115' ' ' LYS . . . . . 0.405 ' H ' ' HG3' ' C' ' 114' ' ' ARG . 11.1 ttpp -22.5 117.96 0.03 OUTLIER 'General case' 0 N--CA 1.509 2.485 0 N-CA-C 115.946 1.832 . . . . 74.15 115.946 -162.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 116' ' ' GLY . . . . . 0.408 ' HA2' ' HA3' ' C' ' 168' ' ' GLY . . . -77.91 147.72 32.42 Favored Glycine 0 C--N 1.343 0.936 0 CA-C-N 115.197 -0.91 . . . . 54.4 113.182 -177.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 17.1 mtm180 -116.4 171.88 7.56 Favored 'General case' 0 C--O 1.263 1.81 0 CA-C-O 122.369 1.081 . . . . 74.32 111.397 -173.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 118' ' ' ASP . . . . . 0.442 ' HA ' ' O ' ' C' ' 173' ' ' ASP . 3.4 m-20 -61.3 117.95 6.28 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 112.37 -2.195 . . . . 75.42 109.138 170.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 119' ' ' LEU . . . . . 0.631 ' HG ' ' HG2' ' C' ' 167' ' ' GLN . 3.0 tt -92.89 120.72 33.52 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 105.818 -1.919 . . . . 75.21 105.818 -178.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.538 ' HE ' HG22 ' C' ' 177' ' ' VAL . 57.0 ttt180 -117.56 114.19 23.07 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.625 -0.509 . . . . 72.31 109.625 -164.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 121' ' ' ALA . . . . . . . . . . . . . . . -108.66 169.95 8.33 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 122.812 0.445 . . . . 75.44 111.805 -171.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -131.86 114.49 14.74 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 123.88 0.872 . . . . 74.12 109.636 -176.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -140.03 115.43 7.88 Favored Pre-proline 0 N--CA 1.483 1.221 0 CA-C-N 117.992 0.36 . . . . 73.3 111.858 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -66.88 116.03 3.91 Favored 'Trans proline' 0 C--N 1.378 2.098 0 C-N-CA 122.229 1.952 . . . . 72.51 109.486 162.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 125' ' ' LEU . . . . . 0.454 ' O ' ' HA ' ' C' ' 180' ' ' LEU . 14.8 tp -139.58 166.87 23.43 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 107.392 -1.336 . . . . 75.32 107.392 -170.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 126' ' ' THR . . . . . 0.408 ' HB ' HD12 ' C' ' 181' ' ' LEU . 14.2 t -127.01 175.32 8.18 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 119.1 0.864 . . . . 61.53 110.976 175.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 127' ' ' LEU . . . . . . . . . . . . . 6.5 mt -59.86 -44.55 94.09 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 126.092 1.757 . . . . 62.25 110.011 -177.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -58.16 -45.25 87.77 Favored 'General case' 0 C--O 1.213 -0.848 0 CA-C-N 113.694 -1.593 . . . . 75.24 109.586 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 129' ' ' GLU . . . . . 0.527 ' HA ' ' HB2' ' C' ' 132' ' ' HIS . 20.0 mm-40 -77.74 -18.0 56.98 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 124.446 1.091 . . . . 75.51 111.659 -178.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 130' ' ' ALA . . . . . 0.464 ' HB2' ' HA2' ' C' ' 152' ' ' GLY . . . -71.86 -36.67 70.18 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.066 -0.716 . . . . 73.14 109.066 174.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 131' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -73.07 -46.71 49.98 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 114.753 -1.112 . . . . 75.55 111.176 167.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 132' ' ' HIS . . . . . 0.527 ' HB2' ' HA ' ' C' ' 129' ' ' GLU . 32.7 m170 -74.79 -7.57 53.81 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 118.998 -0.525 . . . . 70.15 111.24 -172.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -70.28 66.96 0.72 Allowed Glycine 0 C--N 1.354 1.537 0 O-C-N 123.712 0.632 . . . . 65.31 113.482 172.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . -88.45 -139.8 6.88 Favored Glycine 0 C--N 1.348 1.206 0 N-CA-C 109.657 -1.377 . . . . 73.12 109.657 169.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -72.73 93.62 1.67 Allowed 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 108.727 -0.842 . . . . 73.03 108.727 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 136' ' ' ARG . . . . . 0.486 ' HB2' HD22 ' B' ' 181' ' ' LEU . 57.2 mtp180 -141.91 163.11 33.77 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.722 0.809 . . . . 72.12 110.756 -171.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 137' ' ' VAL . . . . . 0.464 ' HB ' ' HB3' ' B' ' 180' ' ' ALA . 54.2 t -71.33 95.48 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 CA-C-N 115.019 -0.991 . . . . 73.11 110.9 -171.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 138' ' ' VAL . . . . . . . . . . . . . 97.9 t -79.01 112.22 16.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 107.055 -1.461 . . . . 72.14 107.055 165.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 139' ' ' GLU . . . . . . . . . . . . . 53.7 tt0 -121.48 78.44 1.43 Allowed 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 107.567 -1.272 . . . . 74.31 107.567 -167.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 140' ' ' VAL . . . . . 0.472 HG11 HD13 ' C' ' 174' ' ' LEU . 89.3 t -128.1 104.56 12.04 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 CA-C-N 114.31 -1.313 . . . . 73.25 110.755 -166.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 68.14 24.31 7.7 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.979 1.312 . . . . 65.0 113.045 168.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 107.5 -29.48 10.43 Favored Glycine 0 C--N 1.338 0.689 0 N-CA-C 111.273 -0.731 . . . . 52.4 111.273 -176.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 143' ' ' ARG . . . . . 0.44 ' CZ ' ' HB ' ' C' ' 145' ' ' VAL . 14.0 tpt180 -70.37 106.94 3.57 Favored 'General case' 0 C--N 1.363 1.192 0 N-CA-C 108.8 -0.815 . . . . 75.05 108.8 177.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 11.4 ttt-85 -113.83 96.74 6.0 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-N 114.864 -1.062 . . . . 71.51 108.773 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 145' ' ' VAL . . . . . 0.563 HG21 ' HB ' ' C' ' 147' ' ' VAL . 3.1 p -127.71 130.28 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 124.273 1.029 . . . . 75.03 110.085 -175.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 55.5 m -90.76 86.53 6.36 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 108.803 -0.814 . . . . 73.22 108.803 174.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 147' ' ' VAL . . . . . 0.563 ' HB ' HG21 ' C' ' 145' ' ' VAL . 9.7 p -131.51 159.34 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-N 114.981 -1.008 . . . . 72.53 110.473 -170.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 23.1 ttm180 -88.56 104.52 16.91 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 108.392 -0.966 . . . . 74.22 108.392 170.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 149' ' ' ILE . . . . . . . . . . . . . 30.5 pt -69.74 151.52 96.4 Favored Pre-proline 0 CA--C 1.548 0.88 0 CA-C-O 118.045 -0.979 . . . . 74.42 108.861 166.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 150' ' ' PRO . . . . . 0.461 ' HD2' HG22 ' C' ' 161' ' ' VAL . 34.8 Cg_exo -39.27 108.66 0.08 OUTLIER 'Trans proline' 0 C--N 1.39 2.74 0 C-N-CA 123.547 2.831 . . . . 61.44 112.864 176.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -66.6 122.09 9.45 Favored 'Trans proline' 0 C--N 1.382 2.302 0 C-N-CA 122.537 2.158 . . . . 73.2 111.447 -171.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 152' ' ' GLY . . . . . 0.603 ' HA3' HD22 ' C' ' 188' ' ' LEU . . . 99.47 122.72 4.84 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-N 115.52 -0.764 . . . . 63.11 113.386 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 153' ' ' VAL . . . . . 0.621 ' HB ' HG13 ' C' ' 178' ' ' VAL . 3.5 m -129.99 176.13 9.23 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 C-N-CA 123.745 0.818 . . . . 74.01 109.487 -174.014 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 154' ' ' ARG . . . . . 0.492 ' HD2' ' HB2' ' B' ' 217' ' ' LEU . 98.3 mtt180 -133.66 160.05 38.68 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.375 0.67 . . . . 75.32 110.322 177.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 155' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -67.25 103.75 1.32 Allowed 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 124.786 1.234 . . . . 74.51 112.125 -176.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 97.89 -0.79 59.29 Favored Glycine 0 C--N 1.354 1.542 0 CA-C-N 115.583 -0.735 . . . . 75.21 113.163 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 157' ' ' SER . . . . . 0.463 ' HB3' ' HA ' ' B' ' 217' ' ' LEU . 55.6 m -90.39 170.34 10.32 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.082 0.553 . . . . 75.43 111.966 -172.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 158' ' ' VAL . . . . . 0.498 HG13 HG21 ' C' ' 177' ' ' VAL . 28.2 m -104.99 125.77 59.97 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 CA-C-N 115.488 -0.778 . . . . 72.31 111.086 178.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 159' ' ' ILE . . . . . 0.582 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 17.3 mt -76.04 98.66 1.7 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.6 0 N-CA-C 108.082 -1.081 . . . . 72.31 108.082 166.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 160' ' ' ARG . . . . . 0.4 ' HD2' ' OH ' ' B' ' 120' ' ' TYR . 21.6 ttp180 -81.97 101.25 10.18 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.993 0.917 . . . . 75.13 110.012 -178.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 161' ' ' VAL . . . . . 0.539 ' HB ' ' HB3' ' C' ' 174' ' ' LEU . 16.1 t -100.19 112.87 64.92 Favored Pre-proline 0 CA--C 1.551 1.004 0 N-CA-C 107.83 -1.174 . . . . 75.24 107.83 175.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -50.48 99.11 0.04 OUTLIER 'Trans proline' 0 C--N 1.384 2.418 0 C-N-CA 124.034 3.156 . . . . 75.23 114.745 -172.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 67.29 23.6 73.32 Favored Glycine 0 C--N 1.347 1.143 0 N-CA-C 115.73 1.052 . . . . 53.54 115.73 169.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 164' ' ' MET . . . . . 0.4 ' HE2' HG13 ' C' ' 161' ' ' VAL . 43.6 ttp -98.0 18.67 15.47 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 117.582 0.691 . . . . 73.35 109.795 174.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . -74.94 -120.95 0.1 Allowed Glycine 0 C--N 1.357 1.727 0 CA-C-N 115.81 -0.632 . . . . 73.32 112.248 174.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . 153.03 -82.87 0.17 Allowed Glycine 0 C--N 1.35 1.354 0 C-N-CA 119.057 -1.544 . . . . 75.44 114.669 172.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 167' ' ' GLN . . . . . 0.631 ' HG2' ' HG ' ' C' ' 119' ' ' LEU . 26.2 mm-40 -14.99 102.49 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.479 0 C-N-CA 126.294 1.837 . . . . 74.2 113.933 -160.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 168' ' ' GLY . . . . . 0.493 ' H ' ' HB3' ' C' ' 106' ' ' PHE . . . 108.88 145.3 11.22 Favored Glycine 0 CA--C 1.535 1.301 0 N-CA-C 108.996 -1.642 . . . . 13.44 108.996 -161.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 169' ' ' ASN . . . . . 0.712 HD22 HG21 ' C' ' 90' ' ' VAL . 3.1 t-20 -61.42 -59.61 13.02 Favored Pre-proline 0 CA--C 1.576 1.954 0 N-CA-C 114.687 1.365 . . . . 62.44 114.687 -164.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 170' ' ' PRO . . . . . 0.539 ' HD3' ' HB3' ' C' ' 169' ' ' ASN . 7.9 Cg_exo -71.41 104.55 1.59 Allowed 'Trans proline' 0 C--N 1.398 3.142 0 C-N-CA 122.303 2.002 . . . . 73.55 110.693 175.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 171' ' ' PRO . . . . . 0.522 ' HG3' ' O ' ' C' ' 85' ' ' PHE . 58.1 Cg_endo -61.35 126.83 20.25 Favored 'Trans proline' 0 N--CA 1.502 1.972 0 C-N-CA 123.736 2.957 . . . . 74.02 114.688 -161.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -80.49 -167.18 36.09 Favored Glycine 0 C--N 1.354 1.538 0 O-C-N 123.48 0.488 . . . . 74.42 112.269 172.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 173' ' ' ASP . . . . . 0.442 ' O ' ' HA ' ' C' ' 118' ' ' ASP . 13.0 t70 -86.62 155.62 20.35 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 123.54 0.736 . . . . 74.51 110.556 -174.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 174' ' ' LEU . . . . . 0.539 ' HB3' ' HB ' ' C' ' 161' ' ' VAL . 27.7 tp -98.24 114.86 27.26 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 121.496 -0.752 . . . . 75.22 110.198 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 175' ' ' LEU . . . . . 0.427 ' O ' ' HA ' ' C' ' 120' ' ' ARG . 79.6 mt -110.97 91.03 3.5 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.316 0.646 . . . . 72.15 109.867 176.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 176' ' ' LEU . . . . . 0.582 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 62.0 mt -81.02 105.88 12.58 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 109.178 -0.675 . . . . 74.33 109.178 178.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 177' ' ' VAL . . . . . 0.538 HG22 ' HE ' ' C' ' 120' ' ' ARG . 60.3 t -81.51 107.68 13.93 Favored 'Isoleucine or valine' 0 C--O 1.249 1.045 0 CA-C-O 121.901 0.857 . . . . 75.23 108.832 -178.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 178' ' ' VAL . . . . . 0.621 HG13 ' HB ' ' C' ' 153' ' ' VAL . 4.0 p -93.86 140.41 16.58 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 CA-C-N 114.113 -1.403 . . . . 74.01 110.464 -178.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 179' ' ' ARG . . . . . . . . . . . . . 50.9 mmm-85 -121.92 111.56 17.22 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 107.402 -1.333 . . . . 74.42 107.402 172.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 180' ' ' LEU . . . . . 0.454 ' HA ' ' O ' ' C' ' 125' ' ' LEU . 84.5 mt -70.52 145.88 50.57 Favored 'General case' 0 C--O 1.237 0.432 0 O-C-N 123.543 0.527 . . . . 73.43 111.299 -175.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 181' ' ' LEU . . . . . 0.408 HD12 ' HB ' ' C' ' 126' ' ' THR . 31.1 mt -60.01 168.53 2.06 Favored Pre-proline 0 CA--C 1.555 1.171 0 C-N-CA 124.914 1.286 . . . . 74.24 111.886 -178.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 182' ' ' PRO . . . . . 0.538 ' HG3' ' HZ1' ' B' ' 159' ' ' LYS . 30.8 Cg_exo -42.0 -3.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.395 3.023 0 C-N-CA 124.834 3.69 . . . . 73.32 118.14 174.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 183' ' ' HIS . . . . . 0.409 ' HE1' ' HE1' ' C' ' 213' ' ' MET . 0.3 OUTLIER -125.3 83.39 61.16 Favored Pre-proline 0 CA--C 1.569 1.69 0 CA-C-N 118.865 0.757 . . . . 72.0 110.499 166.134 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 184' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -85.57 69.57 5.18 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 123.671 2.914 . . . . 74.25 110.311 173.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 185' ' ' VAL . . . . . 0.414 HG21 HG23 ' B' ' 225' ' ' THR . 4.3 t -90.83 -43.77 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 N-CA-C 109.993 -0.373 . . . . 72.23 109.993 -166.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 186' ' ' PHE . . . . . 0.648 ' HB3' HD22 ' C' ' 193' ' ' LEU . 21.7 m-85 -99.75 113.0 25.21 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.708 0.766 . . . . 61.44 112.151 -170.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 187' ' ' ARG . . . . . 0.625 ' HE ' ' HB2' ' B' ' 222' ' ' ALA . 36.0 ttm180 -96.98 101.23 12.76 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 107.257 -1.386 . . . . 75.14 107.257 171.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 188' ' ' LEU . . . . . 0.603 HD22 ' HA3' ' C' ' 152' ' ' GLY . 41.1 tp -93.88 144.73 25.18 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 112.856 0.687 . . . . 74.14 112.856 -171.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -131.42 111.02 11.45 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 107.242 -1.392 . . . . 73.21 107.242 159.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 70.32 -86.37 0.33 Allowed Glycine 0 C--N 1.351 1.362 0 O-C-N 123.704 0.627 . . . . 74.2 113.141 177.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 191' ' ' GLN . . . . . 0.583 ' HA ' ' HB2' ' C' ' 240' ' ' PHE . 20.7 mt-30 -132.51 -10.76 3.18 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.289 0.636 . . . . 75.25 112.028 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -104.66 121.58 43.85 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 121.303 0.573 . . . . 65.13 110.839 -177.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 193' ' ' LEU . . . . . 0.648 HD22 ' HB3' ' C' ' 186' ' ' PHE . 56.7 mt -90.87 153.15 20.42 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.353 1.461 . . . . 65.15 111.034 -177.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 194' ' ' TYR . . . . . 0.485 ' HB3' ' HB3' ' C' ' 187' ' ' ARG . 46.7 t80 -112.05 148.79 33.13 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 106.983 -1.488 . . . . 75.43 106.983 162.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 195' ' ' ALA . . . . . . . . . . . . . . . -154.66 -175.24 5.32 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.253 0.621 . . . . 65.11 110.946 -177.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 58.3 m -130.74 145.9 52.07 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.072 0.949 . . . . 53.42 108.813 168.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 197' ' ' LEU . . . . . . . . . . . . . 36.3 tp -127.4 113.64 16.48 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.359 1.064 . . . . 73.5 108.861 -176.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 198' ' ' ASP . . . . . 0.458 ' HB3' HG21 ' C' ' 256' ' ' THR . 19.9 m-20 -86.11 101.76 13.26 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 109.778 -0.453 . . . . 64.33 109.778 -178.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 199' ' ' VAL . . . . . 0.545 ' HA ' HG11 ' C' ' 210' ' ' VAL . 88.8 t -105.58 123.22 40.13 Favored Pre-proline 0 N--CA 1.474 0.747 0 C-N-CA 123.775 0.83 . . . . 73.12 109.13 177.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 200' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.88 148.03 56.91 Favored 'Trans proline' 0 C--N 1.369 1.655 0 C-N-CA 121.896 1.731 . . . . 73.11 110.929 176.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 201' ' ' ALA . . . . . . . . . . . . . . . -55.0 -43.59 99.14 Favored Pre-proline 0 CA--C 1.553 1.069 0 N-CA-C 114.174 1.176 . . . . 74.35 114.174 -175.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 202' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -54.38 -52.78 7.44 Favored 'Trans proline' 0 C--N 1.394 2.971 0 C-N-CA 121.733 1.622 . . . . 63.15 112.666 175.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 203' ' ' ILE . . . . . . . . . . . . . 44.6 mt -65.18 -31.04 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 124.089 0.956 . . . . 74.02 111.269 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.34 -43.26 81.99 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.736 0.814 . . . . 75.02 111.817 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 205' ' ' VAL . . . . . . . . . . . . . 87.4 t -72.62 -47.81 49.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 115.866 -0.606 . . . . 74.52 111.22 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 206' ' ' VAL . . . . . 0.452 HG21 ' HE2' ' A' ' 270' ' ' LYS . 11.5 p -80.96 -34.12 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 112.842 0.682 . . . . 74.12 112.842 -171.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 89.86 111.77 1.4 Allowed Glycine 0 CA--C 1.531 1.04 0 N-CA-C 111.623 -0.591 . . . . 63.21 111.623 -169.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -153.24 -121.46 0.85 Allowed Glycine 0 C--N 1.348 1.217 0 CA-C-O 119.606 -0.552 . . . . 51.32 111.76 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 209' ' ' LYS . . . . . . . . . . . . . 31.7 mtmt -151.81 153.09 33.57 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.672 0.789 . . . . 72.44 111.6 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 210' ' ' VAL . . . . . 0.545 HG11 ' HA ' ' C' ' 199' ' ' VAL . 29.3 m -139.97 178.06 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 126.764 2.026 . . . . 71.52 108.393 174.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 211' ' ' ARG . . . . . 0.715 HH22 ' HB2' ' B' ' 233' ' ' PHE . 0.0 OUTLIER -111.84 147.93 34.7 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.018 0.527 . . . . 75.53 111.296 177.213 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -127.18 121.29 30.91 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 107.369 -1.345 . . . . 74.43 107.369 164.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 213' ' ' MET . . . . . 0.522 ' HG2' ' HB3' ' B' ' 172' ' ' GLU . 1.4 tmm? -76.02 112.99 13.03 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 108.281 -1.007 . . . . 63.12 108.281 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 214' ' ' THR . . . . . 0.409 HG22 ' H ' ' C' ' 215' ' ' LEU . 0.2 OUTLIER -117.99 175.39 5.69 Favored 'General case' 0 N--CA 1.485 1.325 0 CA-C-N 118.86 0.755 . . . . 72.34 111.962 -173.373 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 215' ' ' LEU . . . . . 0.409 ' H ' HG22 ' C' ' 214' ' ' THR . 35.7 mt -73.82 -33.49 64.18 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.247 1.419 . . . . 75.24 112.384 -171.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -83.41 -4.65 58.69 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 115.262 -0.881 . . . . 71.0 110.647 175.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 132.09 173.22 13.26 Favored Glycine 0 C--N 1.342 0.878 0 N-CA-C 110.898 -0.881 . . . . 74.41 110.898 -175.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 218' ' ' PRO . . . . . 0.42 ' HB2' ' NE ' ' C' ' 211' ' ' ARG . 93.5 Cg_endo -75.56 113.22 3.7 Favored 'Trans proline' 0 CA--C 1.55 1.316 0 C-N-CA 122.253 1.969 . . . . 64.03 112.0 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 219' ' ' VAL . . . . . . . . . . . . . 14.6 p -89.03 152.3 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 108.034 -1.099 . . . . 52.53 108.034 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 220' ' ' GLU . . . . . 0.408 ' HB3' ' CG ' ' B' ' 235' ' ' GLU . 18.1 tt0 -111.57 107.69 16.93 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.194 -1.039 . . . . 72.32 108.194 176.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 221' ' ' VAL . . . . . 0.41 HG22 HD12 ' C' ' 235' ' ' LEU . 53.9 t -75.86 129.08 37.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 114.281 -1.327 . . . . 74.03 111.415 -174.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -77.95 138.07 38.66 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.016 0.436 . . . . 73.3 110.507 169.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 57.5 t -118.25 124.17 28.82 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 124.066 0.946 . . . . 73.11 108.916 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 224' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -76.47 162.41 33.37 Favored 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 123.065 2.51 . . . . 73.11 111.067 169.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 225' ' ' PRO . . . . . 0.556 ' HG2' HD11 ' B' ' 247' ' ' LEU . 41.7 Cg_exo -60.71 156.14 44.52 Favored 'Trans proline' 0 C--N 1.369 1.632 0 C-N-CA 122.526 2.151 . . . . 74.4 113.333 176.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 226' ' ' ARG . . . . . 0.452 ' HD2' ' O ' ' A' ' 259' ' ' GLU . 11.8 mmt180 59.59 63.52 1.5 Allowed 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 125.269 1.428 . . . . 71.5 111.764 176.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 227' ' ' THR . . . . . . . . . . . . . 57.8 m -100.33 132.28 45.79 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.644 0.777 . . . . 73.3 111.51 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 228' ' ' GLN . . . . . 0.474 ' NE2' ' HG3' ' A' ' 259' ' ' GLU . 26.7 mp0 -111.17 150.6 29.27 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 124.562 1.145 . . . . 74.32 112.376 -179.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 229' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' C' ' 253' ' ' VAL . . . -75.1 118.85 18.49 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 114.551 -1.204 . . . . 65.31 109.606 177.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 116.58 -1.35 20.24 Favored Glycine 0 C--N 1.339 0.747 0 O-C-N 123.688 0.617 . . . . 62.04 112.287 -176.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 231' ' ' ARG . . . . . 0.554 ' HD3' ' HZ3' ' B' ' 242' ' ' TRP . 32.4 mtt180 -66.42 172.99 3.55 Favored 'General case' 0 C--N 1.355 0.819 0 CA-C-O 120.843 0.354 . . . . 75.03 110.691 167.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 232' ' ' LYS . . . . . 0.65 ' HB2' ' HZ2' ' C' ' 232' ' ' LYS . 3.6 ttmp? -142.88 146.29 33.94 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 109.582 -0.525 . . . . 74.05 109.582 175.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 233' ' ' LEU . . . . . 0.421 ' O ' ' HA ' ' C' ' 250' ' ' TYR . 3.5 tt -132.91 125.36 29.72 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.726 0.811 . . . . 74.22 108.838 -168.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 35.5 ttp180 -92.31 104.25 16.62 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.776 0.322 . . . . 72.34 110.397 170.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 235' ' ' LEU . . . . . 0.451 HD11 HD23 ' C' ' 249' ' ' LEU . 72.2 mt -81.56 116.41 21.31 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 107.903 -1.147 . . . . 74.34 107.903 164.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -80.27 134.08 36.05 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 123.328 0.651 . . . . 73.41 110.963 -176.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 70.9 26.97 73.02 Favored Glycine 0 C--N 1.349 1.269 0 O-C-N 123.933 0.77 . . . . 71.42 113.235 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 21.7 mmtm -120.62 12.15 11.42 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.958 0.903 . . . . 75.11 111.515 -177.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -90.44 -133.1 5.29 Favored Glycine 0 C--N 1.343 0.966 0 N-CA-C 111.316 -0.714 . . . . 75.2 111.316 172.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 240' ' ' PHE . . . . . 0.583 ' HB2' ' HA ' ' C' ' 191' ' ' GLN . 3.5 m-85 -97.35 118.49 64.42 Favored Pre-proline 0 C--O 1.237 0.436 0 C-N-CA 123.068 0.547 . . . . 75.14 109.907 174.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 241' ' ' PRO . . . . . 0.514 ' HA ' ' HG2' ' C' ' 246' ' ' ARG . 87.4 Cg_exo -50.94 103.88 0.07 OUTLIER 'Trans proline' 0 C--N 1.365 1.432 0 C-N-CA 123.557 2.838 . . . . 71.53 113.069 166.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -77.42 174.0 54.79 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-N 114.707 -1.133 . . . . 70.14 112.974 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -66.82 -11.08 30.61 Favored 'Trans proline' 0 C--N 1.368 1.559 0 C-N-CA 123.123 2.549 . . . . 71.42 114.038 -171.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -137.29 1.72 2.44 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.687 0.795 . . . . 71.42 111.735 179.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . -171.75 -138.38 2.54 Favored Glycine 0 C--N 1.348 1.238 0 CA-C-O 119.706 -0.497 . . . . 63.24 112.949 -177.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 246' ' ' ARG . . . . . 0.514 ' HG2' ' HA ' ' C' ' 241' ' ' PRO . 85.5 mtm180 -148.44 160.87 42.62 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.845 0.858 . . . . 71.32 111.004 -178.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 247' ' ' GLY . . . . . 0.472 ' HA2' ' HA2' ' B' ' 36' ' ' GLY . . . -96.46 -169.3 34.32 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 114.879 -1.055 . . . . 63.23 112.173 173.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -126.33 169.94 12.41 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.104 0.562 . . . . 73.54 110.495 -173.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 249' ' ' LEU . . . . . 0.451 HD23 HD11 ' C' ' 235' ' ' LEU . 17.6 tp -129.25 127.14 40.63 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.945 0.898 . . . . 74.23 109.38 -176.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 250' ' ' TYR . . . . . 0.421 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 89.5 m-85 -117.06 101.17 8.26 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.695 0.798 . . . . 71.43 110.141 -178.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 251' ' ' LEU . . . . . 0.435 ' O ' ' HA ' ' C' ' 232' ' ' LYS . 0.9 OUTLIER -99.23 129.76 45.48 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 119.286 -0.388 . . . . 72.0 110.113 -176.039 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -73.11 108.45 6.0 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.076 -1.083 . . . . 75.41 108.076 166.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 253' ' ' VAL . . . . . 0.425 HG11 ' HH2' ' B' ' 242' ' ' TRP . 46.7 t -78.79 110.69 14.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.732 -0.667 . . . . 73.5 109.977 -176.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 254' ' ' ARG . . . . . . . . . . . . . 41.0 mtm180 -94.06 159.01 15.35 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.498 0.719 . . . . 75.13 111.321 175.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 255' ' ' ILE . . . . . . . . . . . . . 35.4 mm -105.82 127.23 60.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 114.235 -1.348 . . . . 75.24 107.983 169.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 256' ' ' THR . . . . . 0.458 HG21 ' HB3' ' C' ' 198' ' ' ASP . 0.3 OUTLIER -133.49 172.82 12.21 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.917 1.287 . . . . 70.25 108.775 -177.685 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 35.1 pt -127.02 145.55 54.4 Favored Pre-proline 0 N--CA 1.481 1.099 0 C-N-CA 123.434 0.694 . . . . 75.21 110.109 -178.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -63.33 -11.83 27.52 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.698 2.266 . . . . 74.41 113.72 -173.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 53.32 -67.25 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.961 1.704 . . . . 72.3 112.64 -165.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 8.1 ppt_? -59.77 133.65 56.29 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.33 0.652 . . . . 73.41 110.351 174.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 261' ' ' LEU . . . . . 0.545 HD23 ' HB3' ' C' ' 265' ' ' GLU . 91.2 mt -143.34 161.75 37.52 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.73 0.812 . . . . 74.53 110.488 -173.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 63.4 p -91.18 165.56 21.17 Favored Pre-proline 0 CA--C 1.55 0.954 0 N-CA-C 108.62 -0.882 . . . . 61.23 108.62 167.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -48.92 -42.13 38.37 Favored 'Trans proline' 0 C--N 1.381 2.281 0 C-N-CA 122.293 1.996 . . . . 74.2 111.988 169.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -64.18 -58.13 7.5 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 114.202 -1.363 . . . . 71.04 111.244 -178.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 265' ' ' GLU . . . . . 0.545 ' HB3' HD23 ' C' ' 261' ' ' LEU . 0.5 OUTLIER -48.85 -58.37 4.93 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.877 0.871 . . . . 71.03 110.924 177.793 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 266' ' ' GLU . . . . . 0.535 ' O ' ' HG2' ' C' ' 270' ' ' LYS . 33.6 tt0 -58.36 -39.49 79.67 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 124.17 0.919 . . . . 73.1 110.939 -175.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -60.2 -44.13 95.36 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.712 0.805 . . . . 71.12 112.408 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 268' ' ' LEU . . . . . . . . . . . . . 11.1 mp -65.65 -40.71 92.78 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 116.709 -0.223 . . . . 70.11 110.745 176.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -59.81 -36.37 76.62 Favored 'General case' 0 N--CA 1.483 1.177 0 O-C-N 123.558 0.536 . . . . 63.11 110.946 174.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 270' ' ' LYS . . . . . 0.535 ' HG2' ' O ' ' C' ' 266' ' ' GLU . 30.5 mmtp -63.9 -46.92 82.68 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.684 0.794 . . . . 75.43 110.368 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -61.68 -45.06 95.6 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.55 0.74 . . . . 75.33 111.708 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 92.7 mt -62.0 -43.75 98.18 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.236 -0.893 . . . . 74.33 110.315 177.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -59.39 -41.21 88.87 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.558 -0.746 . . . . 43.22 110.695 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -69.31 -31.91 70.69 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.185 0.594 . . . . 63.21 111.595 177.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -62.44 -31.95 72.74 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 122.531 0.332 . . . . 70.04 110.473 171.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 276' ' ' TYR . . . . . 0.638 ' HH ' ' HB3' ' A' ' 258' ' ' PRO . 79.2 m-85 -77.35 -34.56 55.15 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 122.887 0.475 . . . . 75.52 112.207 171.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 15.2 m-30 -66.27 -27.48 67.97 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.797 -0.446 . . . . 65.52 109.797 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -65.53 -1.96 3.01 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 124.413 1.085 . . . . 72.22 113.244 175.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 279' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -72.84 -22.89 60.72 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 122.697 0.399 . . . . 75.11 110.917 171.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.077 0 C-N-CA 123.581 0.752 . . . . 75.14 110.154 178.829 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.8 mtt . . . . . 0 N--CA 1.477 0.916 0 N-CA-C 107.625 -1.25 . . . . 64.12 107.625 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 69.12 -9.01 0.63 Allowed 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 125.092 1.357 . . . . 74.44 113.234 -176.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -90.18 64.53 6.13 Favored 'General case' 0 C--N 1.351 0.666 0 C-N-CA 123.843 0.857 . . . . 74.04 109.974 -174.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -41.46 107.67 0.08 Allowed 'General case' 0 C--N 1.352 0.7 0 N-CA-C 113.474 0.916 . . . . 64.14 113.474 172.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -70.74 88.92 0.73 Allowed 'General case' 0 C--O 1.241 0.62 0 N-CA-C 107.584 -1.265 . . . . 74.32 107.584 162.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.459 ' HA ' ' OH ' ' A' ' 66' ' ' TYR . 34.7 t70 -75.45 93.81 3.02 Favored 'General case' 0 C--N 1.354 0.782 0 N-CA-C 107.511 -1.292 . . . . 62.43 107.511 173.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.594 ' HB2' HD13 ' A' ' 57' ' ' LEU . 50.7 m-85 -60.17 -28.61 68.07 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 113.783 -1.553 . . . . 73.34 111.836 -169.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.439 ' HD1' HD12 ' A' ' 22' ' ' ILE . 50.3 m-85 -65.47 -47.63 75.45 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.035 0.534 . . . . 73.33 110.454 177.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.5 -38.69 91.9 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.871 -0.604 . . . . 70.01 111.427 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 69.6 mt -60.45 -38.98 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 123.733 0.646 . . . . 74.23 110.107 174.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.432 ' HB3' ' HB1' ' A' ' 25' ' ' ALA . 93.7 mt -86.31 2.81 45.98 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 115.36 -0.836 . . . . 73.11 112.505 178.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 63.83 18.23 61.65 Favored Glycine 0 C--N 1.356 1.64 0 N-CA-C 114.771 0.668 . . . . 73.42 114.771 177.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.6 m -107.48 155.35 39.75 Favored Pre-proline 0 N--CA 1.482 1.167 0 C-N-CA 124.389 1.075 . . . . 72.52 110.076 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.88 154.88 30.1 Favored 'Trans proline' 0 C--N 1.383 2.356 0 C-N-CA 123.0 2.466 . . . . 50.12 113.106 177.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 55.7 mtp180 -76.39 13.75 0.89 Allowed 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 112.763 0.653 . . . . 75.43 112.763 -173.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -119.96 -5.41 10.07 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 125.141 1.376 . . . . 71.2 109.402 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.449 ' HB1' ' HB2' ' A' ' 21' ' ' GLU . . . -58.34 127.28 31.35 Favored 'General case' 0 C--N 1.347 0.477 0 C-N-CA 124.75 1.22 . . . . 74.14 111.51 -175.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.548 ' HA ' HH21 ' A' ' 63' ' ' ARG . 79.8 p -84.17 177.05 8.37 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 122.881 0.473 . . . . 75.03 110.658 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -46.71 -32.65 3.72 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 124.982 1.313 . . . . 71.11 113.292 -175.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -81.59 -30.06 33.11 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 112.264 0.468 . . . . 72.43 112.264 -173.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.449 ' HB2' ' HB1' ' A' ' 17' ' ' ALA . 2.5 mp0 -72.92 -33.67 66.12 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 109.601 -0.518 . . . . 71.14 109.601 170.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.482 HG23 ' HB2' ' A' ' 57' ' ' LEU . 1.7 mp -67.29 -33.72 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.738 0.815 . . . . 73.31 110.265 173.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.421 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 4.6 tppp? -64.28 -53.5 47.96 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.824 0.85 . . . . 75.22 109.717 176.024 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -59.12 -44.43 92.01 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 124.166 0.916 . . . . 73.12 110.935 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.432 ' HB1' ' HB3' ' A' ' 11' ' ' LEU . . . -66.7 -35.54 80.37 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.792 0.837 . . . . 72.43 111.849 -177.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -64.12 -50.49 68.04 Favored 'General case' 0 C--O 1.215 -0.711 0 CA-C-N 115.403 -0.817 . . . . 73.1 109.784 175.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.421 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 54.8 mtpt -59.07 -42.82 91.27 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 123.947 0.779 . . . . 74.22 110.737 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.0 ttt180 -53.25 -55.55 23.6 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.283 1.433 . . . . 75.52 110.728 176.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.704 ' HB3' HD12 ' A' ' 50' ' ' ILE . 95.5 mt -79.28 -15.63 57.68 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.603 -0.726 . . . . 75.12 111.793 -176.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.21 -18.78 38.06 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.55 0.74 . . . . 71.54 110.595 175.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -86.07 -45.86 11.02 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 122.977 0.511 . . . . 72.33 110.37 169.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -63.86 -57.65 9.2 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.006 0.522 . . . . 73.31 110.434 -177.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -97.35 38.56 1.25 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.556 0.742 . . . . 72.41 110.025 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 7.7 t-160 -63.94 103.58 0.43 Allowed Pre-proline 0 C--N 1.354 0.782 0 C-N-CA 123.769 0.828 . . . . 73.54 109.478 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -68.38 -14.46 40.15 Favored 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 122.534 2.156 . . . . 75.51 112.86 -167.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -67.85 -39.93 83.75 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.502 1.121 . . . . 73.23 111.305 173.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 96.5 t -96.58 -51.18 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 123.291 0.636 . . . . 73.25 110.08 -177.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -102.16 89.86 3.74 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.174 0.989 . . . . 64.12 110.898 -176.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.22 44.83 1.17 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.426 0.69 . . . . 73.11 110.58 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 74.0 m -89.72 130.48 42.93 Favored Pre-proline 0 N--CA 1.474 0.766 0 CA-C-O 117.918 -1.039 . . . . 71.24 108.447 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -38.61 -70.35 0.07 OUTLIER 'Trans proline' 0 C--N 1.392 2.836 0 C-N-CA 124.76 3.64 . . . . 73.53 114.334 -172.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.487 ' HA ' ' HB2' ' A' ' 45' ' ' GLU . 30.9 tt0 -75.81 -7.21 53.89 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 116.61 -0.268 . . . . 64.43 111.642 -174.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.37 -35.62 68.53 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 108.929 -0.767 . . . . 73.42 108.929 172.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -86.56 -30.51 21.83 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-N 115.874 -0.603 . . . . 63.35 109.95 -178.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.487 ' HB2' ' HA ' ' A' ' 42' ' ' GLU . 41.2 mt-10 -67.17 -46.49 73.83 Favored 'General case' 0 C--O 1.244 0.792 0 C-N-CA 123.339 0.656 . . . . 62.44 110.285 174.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 32.3 mmtm -61.19 -39.38 89.97 Favored 'General case' 0 C--O 1.214 -0.785 0 CA-C-N 115.633 -0.712 . . . . 74.03 110.383 171.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.443 ' HA ' HD13 ' A' ' 50' ' ' ILE . 85.2 t80 -58.46 -36.69 74.09 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 123.376 0.423 . . . . 73.32 111.179 176.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.542 ' HZ1' ' HB2' ' A' ' 48' ' ' LYS . 10.5 mtmp? -69.68 -32.81 71.65 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.009 0.523 . . . . 75.14 111.607 175.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -77.59 -22.65 50.55 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 122.603 0.361 . . . . 71.44 111.873 175.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.704 HD12 ' HB3' ' A' ' 29' ' ' LEU . 60.3 mt -77.82 -34.02 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 124.321 1.048 . . . . 74.43 108.737 172.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -64.89 -39.65 93.87 Favored 'General case' 0 C--O 1.218 -0.582 0 CA-C-N 114.817 -1.083 . . . . 73.43 109.641 171.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -61.04 -51.27 69.9 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.349 1.06 . . . . 75.34 110.603 176.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.18 -55.81 27.03 Favored 'General case' 0 C--O 1.255 1.395 0 CA-C-N 114.465 -1.243 . . . . 65.45 112.105 -178.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -65.01 -38.48 91.05 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.069 -0.968 . . . . 73.53 110.978 178.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.56 ' HB1' ' HD2' ' A' ' 85' ' ' PHE . . . -54.0 -50.07 67.44 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.334 0.654 . . . . 72.52 111.399 -178.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 70.9 t -62.71 -53.15 50.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 CA-C-N 114.706 -1.134 . . . . 74.52 110.74 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.594 HD13 ' HB2' ' A' ' 7' ' ' TYR . 55.1 mt -90.76 6.77 42.8 Favored 'General case' 0 CA--C 1.559 1.318 0 N-CA-C 113.796 1.036 . . . . 74.35 113.796 -168.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.6 t -78.4 -54.15 6.5 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.202 0.601 . . . . 74.34 110.539 176.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -75.89 131.23 76.66 Favored Pre-proline 0 C--O 1.236 0.373 0 CA-C-N 115.322 -0.853 . . . . 74.34 109.393 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.415 ' O ' ' HG2' ' A' ' 64' ' ' ARG . 22.9 Cg_endo -58.35 -32.62 96.51 Favored 'Trans proline' 0 C--N 1.385 2.491 0 C-N-CA 123.201 2.601 . . . . 72.41 112.344 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -66.45 -51.56 55.56 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.557 0.743 . . . . 72.3 110.878 -178.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 36.5 mtpt -73.74 -26.67 60.79 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.042 0.937 . . . . 74.54 111.669 -177.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.548 HH21 ' HA ' ' A' ' 18' ' ' THR . 42.6 tpt85 -59.28 -53.64 55.99 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.959 0.904 . . . . 74.11 108.925 168.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.454 ' HE ' ' HA ' ' A' ' 64' ' ' ARG . 2.4 mmp_? -61.92 -31.89 72.25 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 124.163 0.914 . . . . 74.25 111.611 178.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 64.2 mt -60.16 -47.77 90.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.16 0.584 . . . . 74.41 110.373 174.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.459 ' OH ' ' HA ' ' A' ' 6' ' ' ASP . 21.3 t80 -60.26 -48.14 83.02 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 116.037 -0.529 . . . . 75.4 110.14 177.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -54.06 -47.89 71.18 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.044 0.537 . . . . 64.04 111.546 178.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 72.2 p -72.54 -17.78 61.69 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.799 -0.637 . . . . 75.44 111.824 -177.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -74.84 107.34 6.86 Favored 'General case' 0 C--N 1.361 1.079 0 N-CA-C 107.808 -1.182 . . . . 75.32 107.808 170.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 119.71 10.76 7.53 Favored Glycine 0 N--CA 1.469 0.874 0 N-CA-C 111.744 -0.543 . . . . 64.23 111.744 -167.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 90.6 m -145.13 -56.62 0.33 Allowed 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 105.11 -2.181 . . . . 71.23 105.11 177.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 22.0 m -88.0 143.73 26.93 Favored 'General case' 0 C--O 1.251 1.157 0 N-CA-C 104.421 -2.437 . . . . 74.23 104.421 156.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.22 -31.06 9.29 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.288 0.635 . . . . 74.04 110.728 -178.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -83.85 150.63 59.37 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 123.371 0.669 . . . . 75.1 109.483 173.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.446 ' HG2' ' HG2' ' A' ' 103' ' ' PRO . 55.7 Cg_exo -56.87 135.94 73.63 Favored 'Trans proline' 0 C--N 1.371 1.733 0 C-N-CA 122.864 2.376 . . . . 75.41 112.946 175.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.01 162.98 39.46 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 123.612 2.875 . . . . 74.25 112.801 178.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -50.42 115.62 2.03 Favored 'Trans proline' 0 C--N 1.385 2.449 0 C-N-CA 123.444 2.762 . . . . 73.45 113.678 176.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -68.97 134.17 28.95 Favored 'Trans proline' 0 C--N 1.381 2.251 0 C-N-CA 122.568 2.179 . . . . 73.2 111.895 177.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -61.41 154.46 58.73 Favored 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 122.883 2.388 . . . . 71.05 112.656 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.57 87.8 0.05 OUTLIER 'Trans proline' 0 C--N 1.382 2.326 0 C-N-CA 123.375 2.716 . . . . 74.31 112.943 178.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 148.28 -39.89 0.96 Allowed Glycine 0 N--CA 1.463 0.443 0 N-CA-C 109.492 -1.443 . . . . 62.41 109.492 179.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 117.28 -165.62 12.48 Favored Glycine 0 C--N 1.345 1.068 0 CA-C-N 114.607 -0.796 . . . . 53.03 111.991 178.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -90.99 106.09 18.28 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.629 0.772 . . . . 74.41 108.942 178.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -78.14 149.05 33.86 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.454 0.702 . . . . 71.31 111.725 177.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.56 ' HD2' ' HB1' ' A' ' 55' ' ' ALA . 75.9 m-85 -134.61 75.04 1.56 Allowed 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.311 1.044 . . . . 73.24 110.006 -176.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.9 m -49.72 85.59 0.0 OUTLIER 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 125.688 1.595 . . . . 74.44 113.479 -179.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 86.18 12.04 71.46 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-O 119.573 -0.57 . . . . 70.11 114.172 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.599 ' HB3' ' HZ ' ' A' ' 93' ' ' PHE . 45.9 m-85 -119.75 117.45 28.27 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 117.883 0.841 . . . . 72.34 110.334 -174.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -73.77 87.48 1.73 Allowed 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 121.528 0.68 . . . . 71.44 110.391 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.601 HG12 ' HD3' ' A' ' 171' ' ' PRO . 6.0 p -49.45 -32.16 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 125.51 1.524 . . . . 75.21 113.378 173.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -56.2 -24.22 40.5 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.45 1.1 . . . . 75.33 111.847 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -86.1 -30.63 22.41 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.932 0.893 . . . . 61.35 112.483 -178.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.599 ' HZ ' ' HB3' ' A' ' 88' ' ' PHE . 10.3 m-30 -65.75 153.27 42.25 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 112.903 0.705 . . . . 73.34 112.903 -165.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 84.8 p -64.74 171.1 3.59 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 115.667 1.729 . . . . 74.5 115.667 -165.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.56 -42.4 82.97 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 114.46 -1.246 . . . . 74.52 112.725 177.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -57.14 -46.02 83.06 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.984 0.914 . . . . 75.03 109.592 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.424 ' CE2' HG22 ' A' ' 90' ' ' VAL . 48.9 t80 -62.46 -43.52 98.61 Favored 'General case' 0 CA--C 1.553 1.084 0 CA-C-N 113.631 -1.622 . . . . 72.32 110.468 177.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -69.26 -13.21 62.27 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.064 0.546 . . . . 74.14 111.64 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -92.59 -30.8 15.44 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.238 0.615 . . . . 70.02 111.408 170.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 25.1 tp -82.25 -63.38 1.39 Allowed 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.491 0.716 . . . . 74.33 111.412 -177.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -93.77 -6.89 45.0 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.7 0.8 . . . . 72.11 112.727 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -43.74 -56.04 5.19 Favored Glycine 0 CA--C 1.545 1.964 0 N-CA-C 116.315 1.286 . . . . 72.43 116.315 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.446 ' HG2' ' HG2' ' A' ' 75' ' ' PRO . 33.4 Cg_exo -63.14 -3.67 5.25 Favored 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 123.625 2.884 . . . . 64.43 115.367 -176.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -139.42 26.96 2.65 Favored Glycine 0 C--N 1.352 1.468 0 CA-C-O 119.159 -0.801 . . . . 54.4 112.968 175.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.58 ' HB3' ' ND2' ' A' ' 169' ' ' ASN . 23.2 mt -65.38 81.07 0.05 Allowed 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 117.583 0.692 . . . . 74.25 111.708 176.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.429 ' HB3' ' H ' ' A' ' 107' ' ' GLY . 0.1 OUTLIER 43.62 -108.73 0.13 Allowed 'General case' 0 CA--C 1.56 1.327 0 C-N-CA 126.274 1.83 . . . . 74.45 113.072 -178.249 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.429 ' H ' ' HB3' ' A' ' 106' ' ' PHE . . . 74.1 5.63 71.57 Favored Glycine 0 C--N 1.368 2.314 0 CA-C-O 118.979 -0.9 . . . . 44.0 114.271 -174.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.669 ' HA3' ' HB3' ' A' ' 167' ' ' GLN . . . -13.08 -70.15 0.01 OUTLIER Glycine 0 C--N 1.37 2.422 0 C-N-CA 125.781 1.658 . . . . 71.34 115.905 168.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -85.1 65.58 9.31 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.738 0.815 . . . . 74.55 109.741 172.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -10.62 -75.72 0.01 OUTLIER Glycine 0 C--N 1.369 2.37 0 C-N-CA 126.888 2.185 . . . . 55.25 116.914 169.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 24.4 ttp180 -7.05 -43.64 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.604 0 N-CA-C 116.837 2.162 . . . . 75.52 116.837 166.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 51.6 ttp180 -124.28 -36.14 2.7 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.279 1.032 . . . . 75.13 110.289 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.419 ' HA ' ' HA2' ' A' ' 107' ' ' GLY . 75.6 m 65.75 -11.42 0.19 Allowed 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 125.398 1.479 . . . . 74.21 114.81 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 59.3 ttt180 -109.35 -136.23 0.36 Allowed 'General case' 0 CA--C 1.558 1.265 0 CA-C-O 117.776 -1.107 . . . . 74.52 109.287 -171.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -49.7 128.97 19.02 Favored 'General case' 0 C--N 1.367 1.334 0 C-N-CA 124.666 1.187 . . . . 73.31 113.32 -164.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -89.63 176.48 43.0 Favored Glycine 0 CA--C 1.541 1.712 0 O-C-N 123.691 0.619 . . . . 73.4 113.013 175.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.683 ' H ' ' HA3' ' A' ' 166' ' ' GLY . 0.0 OUTLIER -116.24 175.79 5.39 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.451 1.1 . . . . 74.43 111.211 179.537 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -86.84 95.93 10.03 Favored 'General case' 0 CA--C 1.565 1.521 0 CA-C-O 122.035 0.921 . . . . 74.23 111.025 178.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 9.2 tt -100.89 150.62 22.65 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.671 1.189 . . . . 75.42 109.3 -178.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -98.37 138.75 35.15 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.54 0.736 . . . . 74.51 111.376 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.532 ' HB3' HD11 ' A' ' 174' ' ' LEU . . . -128.74 170.5 13.23 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.939 0.895 . . . . 54.41 109.85 170.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -122.21 114.72 21.23 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 106.402 -1.703 . . . . 72.42 106.402 -178.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 53.4 tp -99.25 101.46 12.89 Favored Pre-proline 0 N--CA 1.475 0.796 0 N-CA-C 108.208 -1.034 . . . . 74.14 108.208 -175.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.536 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 7.1 Cg_endo -86.07 111.05 1.09 Allowed 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 121.403 1.402 . . . . 75.33 109.488 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.574 ' HA ' HG23 ' B' ' 6' ' ' ILE . 47.7 tp -106.48 136.95 45.35 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 110.058 -0.349 . . . . 72.43 110.058 -176.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.404 HG22 ' H ' ' B' ' 4' ' ' SER . 99.9 m -65.54 131.09 45.52 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.985 0.914 . . . . 71.34 110.049 175.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 69.3 mt -57.26 -50.81 71.71 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.908 0.883 . . . . 75.21 111.385 -175.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -59.94 -37.55 79.86 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 114.824 -1.08 . . . . 75.32 110.606 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.406 ' HB3' ' NH2' ' A' ' 136' ' ' ARG . 45.1 mm-40 -82.06 -12.71 58.11 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 115.425 -0.807 . . . . 64.33 112.056 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -71.29 -54.04 12.21 Favored 'General case' 0 C--N 1.347 0.471 0 N-CA-C 107.719 -1.215 . . . . 65.44 107.719 167.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -51.98 -44.41 64.02 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 116.138 -0.483 . . . . 74.51 110.984 174.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 50.8 m170 -73.51 -30.13 62.91 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 116.468 -0.333 . . . . 75.25 111.786 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 67.9 -129.05 26.72 Favored Glycine 0 C--N 1.349 1.26 0 O-C-N 123.216 0.323 . . . . 71.54 113.257 177.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.427 ' O ' HG12 ' A' ' 149' ' ' ILE . . . 83.24 -175.59 52.74 Favored Glycine 0 C--N 1.35 1.31 0 C-N-CA 123.007 0.337 . . . . 70.42 113.856 175.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.9 111.36 13.66 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 107.783 -1.191 . . . . 73.14 107.783 169.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.406 ' NH2' ' HB3' ' A' ' 129' ' ' GLU . 13.8 tpp180 -90.16 121.35 32.12 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 109.186 -0.672 . . . . 75.05 109.186 -175.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.449 HG11 ' HE ' ' A' ' 144' ' ' ARG . 97.6 t -86.68 108.33 17.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 CA-C-N 115.204 -0.907 . . . . 75.04 108.904 177.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.464 HG23 HD13 ' B' ' 6' ' ' ILE . 14.6 t -107.37 113.03 42.52 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 115.005 -0.998 . . . . 73.34 108.417 -178.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -99.05 133.21 43.65 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.586 0.754 . . . . 71.3 109.535 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.464 HG13 HD23 ' B' ' 8' ' ' LEU . 7.3 p -166.14 119.24 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.904 0 C-N-CA 123.595 0.758 . . . . 75.1 110.776 -179.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 61.51 19.29 10.2 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.052 1.341 . . . . 74.24 113.741 172.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 102.01 -2.73 51.66 Favored Glycine 0 C--N 1.351 1.376 0 CA-C-N 117.555 0.161 . . . . 54.15 112.993 -177.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 20.7 tpt180 -99.94 112.83 25.09 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.07 0.948 . . . . 72.43 109.589 175.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.449 ' HE ' HG11 ' A' ' 137' ' ' VAL . 74.9 ttt180 -108.02 93.89 4.78 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.122 0.969 . . . . 74.41 108.642 175.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.451 HG13 ' HE1' ' A' ' 164' ' ' MET . 15.0 p -94.59 149.99 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 123.318 0.647 . . . . 73.53 110.031 -178.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 32.4 t -120.85 98.55 6.06 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.734 0.814 . . . . 64.43 108.872 176.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 19.0 m -103.48 116.63 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.375 0.67 . . . . 73.42 110.951 -176.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -67.41 112.37 4.58 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 109.608 -0.516 . . . . 74.32 109.608 172.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.427 HG12 ' O ' ' A' ' 134' ' ' GLY . 23.7 pt -101.62 152.29 38.04 Favored Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 123.727 0.811 . . . . 74.52 110.283 178.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -58.85 -165.57 0.03 OUTLIER 'Trans proline' 0 N--CA 1.517 2.872 0 C-N-CA 124.568 3.512 . . . . 74.22 112.451 168.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_exo -48.9 89.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.398 3.148 0 CA-C-N 121.025 1.402 . . . . 74.15 109.867 159.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 40.17 -98.01 0.01 OUTLIER Glycine 0 CA--C 1.494 -1.267 0 CA-C-N 112.727 -2.033 . . . . 75.51 114.647 -162.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.541 HG13 HG21 ' A' ' 178' ' ' VAL . 5.5 p 173.43 161.67 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 113.116 -1.542 . . . . 75.43 107.938 -162.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.04 152.86 43.72 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.452 -0.944 . . . . 73.23 108.452 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.465 ' HG2' ' NH1' ' A' ' 187' ' ' ARG . 11.3 tp10 -50.76 130.81 25.42 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 124.008 0.923 . . . . 72.32 112.662 -174.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.83 9.35 85.07 Favored Glycine 0 C--N 1.346 1.1 0 CA-C-N 115.412 -0.813 . . . . 74.33 114.072 178.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 42.0 m -66.18 109.84 2.78 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-N 118.016 0.908 . . . . 74.23 109.087 173.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 46.7 t -88.65 90.47 3.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 123.801 0.84 . . . . 74.02 109.024 -178.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.541 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 59.6 mt -74.24 104.96 3.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 108.656 -0.868 . . . . 75.24 108.656 175.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 46.7 ttt180 -74.86 108.85 7.87 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 109.32 -0.622 . . . . 75.21 109.32 177.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.456 HG12 ' HB3' ' A' ' 174' ' ' LEU . 3.8 p -119.48 95.58 49.33 Favored Pre-proline 0 CA--C 1.554 1.114 0 C-N-CA 123.898 0.879 . . . . 71.41 108.825 174.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.691 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 51.4 Cg_exo -59.74 126.41 20.44 Favored 'Trans proline' 0 C--N 1.372 1.77 0 C-N-CA 122.495 2.13 . . . . 74.53 114.014 175.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 128.05 -30.4 3.92 Favored Glycine 0 N--CA 1.47 0.93 0 CA-C-N 114.852 -1.067 . . . . 70.43 113.774 169.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.451 ' HE1' HG13 ' A' ' 145' ' ' VAL . 69.8 mtm -95.27 3.52 54.44 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 117.191 0.495 . . . . 64.15 111.699 -178.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.516 ' HA2' HD12 ' A' ' 174' ' ' LEU . . . -90.11 -98.32 1.13 Allowed Glycine 0 C--N 1.348 1.227 0 N-CA-C 110.856 -0.898 . . . . 73.33 110.856 175.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.683 ' HA3' ' H ' ' A' ' 117' ' ' ARG . . . -61.01 101.4 0.31 Allowed Glycine 0 C--O 1.265 2.089 0 N-CA-C 111.277 -0.729 . . . . 74.5 111.277 164.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.669 ' HB3' ' HA3' ' A' ' 108' ' ' GLY . 23.4 mm-40 -64.93 105.87 1.12 Allowed 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 113.151 -1.525 . . . . 75.42 109.066 177.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 174.21 164.9 29.96 Favored Glycine 0 C--O 1.238 0.344 0 N-CA-C 110.393 -1.083 . . . . 64.21 110.393 -175.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . 0.58 ' ND2' ' HB3' ' A' ' 105' ' ' LEU . 2.4 t-20 -60.8 -72.01 0.3 Allowed Pre-proline 0 CA--C 1.563 1.457 0 CA-C-O 116.657 -1.639 . . . . 63.54 112.116 -164.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.524 ' HD3' ' HB3' ' A' ' 169' ' ' ASN . 22.4 Cg_exo -65.65 115.75 3.56 Favored 'Trans proline' 0 C--N 1.389 2.71 0 CA-C-N 123.569 2.31 . . . . 73.02 109.854 171.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.601 ' HD3' HG12 ' A' ' 90' ' ' VAL . 8.7 Cg_exo -38.45 123.0 0.66 Allowed 'Trans proline' 0 C--N 1.375 1.965 1 C-N-CA 125.671 4.247 . . . . 71.25 117.42 -166.48 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -88.0 127.25 8.45 Favored Glycine 0 C--N 1.366 2.225 0 N-CA-C 111.112 -0.795 . . . . 72.4 111.112 164.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.691 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 4.9 m-20 -61.3 136.85 58.19 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.994 0.917 . . . . 71.14 111.792 -169.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.532 HD11 ' HB3' ' A' ' 121' ' ' ALA . 32.3 tp -113.7 126.93 55.79 Favored 'General case' 0 C--N 1.343 0.292 0 N-CA-C 109.786 -0.449 . . . . 74.2 109.786 173.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 83.7 mt -95.36 90.06 5.67 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.296 -0.865 . . . . 72.12 108.879 178.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.541 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 81.9 mt -70.07 88.51 0.6 Allowed 'General case' 0 C--N 1.354 0.799 0 N-CA-C 109.282 -0.636 . . . . 74.52 109.282 174.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 17.1 t -82.22 101.32 6.86 Favored 'Isoleucine or valine' 0 C--O 1.246 0.895 0 N-CA-C 105.54 -2.022 . . . . 71.11 105.54 175.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.541 HG21 HG13 ' A' ' 153' ' ' VAL . 6.0 p -71.2 136.38 25.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 115.217 -0.901 . . . . 74.13 111.01 -171.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.536 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 30.7 mmt180 -119.7 120.78 37.6 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.745 -1.576 . . . . 73.42 106.745 169.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 32.7 mt -74.82 147.2 41.39 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 109.062 -0.718 . . . . 74.04 109.062 171.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.422 ' HA ' ' HD3' ' A' ' 182' ' ' PRO . 18.5 mt -53.73 150.46 13.65 Favored Pre-proline 0 N--CA 1.484 1.241 0 C-N-CA 123.662 0.785 . . . . 73.22 112.936 -167.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 181' ' ' LEU . 24.2 Cg_exo -66.95 8.8 0.31 Allowed 'Trans proline' 0 C--N 1.387 2.558 0 C-N-CA 124.312 3.342 . . . . 74.32 113.921 176.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -60.65 103.11 0.34 Allowed Pre-proline 0 CA--C 1.562 1.423 0 C-N-CA 125.377 1.471 . . . . 73.35 107.938 165.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -80.86 26.17 0.61 Allowed 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 123.636 2.89 . . . . 61.24 115.471 -162.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 77.3 t -96.08 -58.94 3.44 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.908 0 CA-C-O 118.644 -0.693 . . . . 72.34 111.15 -173.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -139.41 91.77 2.52 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 119.191 0.905 . . . . 72.31 110.575 -177.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . 0.465 ' NH1' ' HG2' ' A' ' 155' ' ' GLU . 44.8 ttp85 -101.26 103.8 14.82 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.073 0.949 . . . . 75.51 109.526 178.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.412 HD22 ' O ' ' A' ' 153' ' ' VAL . 51.2 tp -71.02 141.47 50.95 Favored 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 124.103 0.961 . . . . 74.21 111.218 179.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . 0.421 ' HG3' ' HB3' ' A' ' 155' ' ' GLU . 34.2 tt0 -151.8 126.1 9.33 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.822 1.249 . . . . 70.31 109.825 -175.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 70.15 -81.93 0.35 Allowed Glycine 0 C--N 1.352 1.424 0 N-CA-C 111.625 -0.59 . . . . 65.41 111.625 -176.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -147.88 -10.08 0.4 Allowed 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 125.349 1.46 . . . . 72.32 109.882 166.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -101.06 148.31 25.2 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.325 1.05 . . . . 72.32 111.205 -176.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 188' ' ' LEU . 14.4 mt -90.92 159.89 15.96 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.26 1.024 . . . . 74.25 110.782 -176.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.489 ' HA ' ' HB2' ' A' ' 250' ' ' TYR . 41.8 m-85 -126.95 110.46 13.02 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.375 1.07 . . . . 73.14 108.919 173.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.5 ' HB1' HD21 ' A' ' 251' ' ' LEU . . . -125.88 166.95 15.95 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.217 1.007 . . . . 74.34 110.796 -178.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 24.5 m -112.9 147.42 37.08 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 108.493 -0.928 . . . . 70.21 108.493 171.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.508 HD21 HD12 ' A' ' 251' ' ' LEU . 50.8 tp -139.55 113.37 8.64 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.423 0.689 . . . . 74.1 109.51 -173.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -89.03 124.76 34.59 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 108.402 -0.962 . . . . 63.3 108.402 174.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.9 p -140.47 131.3 13.85 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 124.276 1.031 . . . . 74.33 108.966 -174.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -72.74 150.24 49.85 Favored 'Trans proline' 0 C--N 1.379 2.139 0 C-N-CA 121.554 1.503 . . . . 70.05 110.973 173.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -50.94 -46.93 87.73 Favored Pre-proline 0 CA--C 1.558 1.278 0 N-CA-C 114.654 1.353 . . . . 71.34 114.654 -173.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -52.85 -46.58 32.7 Favored 'Trans proline' 0 C--N 1.383 2.394 0 C-N-CA 121.895 1.73 . . . . 73.32 113.754 176.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.408 HG22 ' HE1' ' C' ' 277' ' ' TYR . 20.3 mt -72.54 -30.28 33.65 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 CA-C-N 115.68 -0.691 . . . . 71.02 110.403 -176.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.3 -42.66 75.13 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.205 0.602 . . . . 74.14 111.909 175.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 50.1 t -71.47 -48.62 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 123.903 0.881 . . . . 64.22 111.847 -176.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 53.2 t -87.49 -34.38 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-N 115.731 -0.668 . . . . 74.41 111.472 -173.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 85.21 113.88 0.74 Allowed Glycine 0 C--N 1.337 0.637 0 N-CA-C 111.989 -0.445 . . . . 72.35 111.989 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.431 ' HA3' ' CE1' ' C' ' 277' ' ' TYR . . . -149.7 -136.52 2.62 Favored Glycine 0 C--O 1.219 -0.805 0 CA-C-O 119.386 -0.675 . . . . 73.32 111.747 -178.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.481 ' HZ3' ' HB2' ' A' ' 209' ' ' LYS . 8.4 mtmp? -114.92 129.98 56.82 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 117.684 0.742 . . . . 73.34 110.444 -177.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.449 HG23 HD22 ' A' ' 197' ' ' LEU . 7.1 m -128.31 157.72 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.711 1.205 . . . . 63.11 108.489 171.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . 0.607 ' HG2' HG13 ' B' ' 421' ' ' VAL . 7.6 tpp180 -87.98 122.09 31.17 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 109.307 -0.627 . . . . 74.32 109.307 -175.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -99.69 110.98 23.36 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.943 -0.762 . . . . 74.41 108.943 176.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 17.0 tpt -82.37 116.48 21.88 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.701 -0.852 . . . . 74.15 108.701 177.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 19.7 p -108.23 -172.29 2.03 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.024 0.53 . . . . 74.1 109.583 -176.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 81.3 mt -67.15 -26.14 66.51 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.861 0.864 . . . . 73.14 112.372 -176.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -105.26 -19.19 13.88 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.15 0.58 . . . . 64.44 111.989 -175.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 152.68 -178.83 29.61 Favored Glycine 0 C--N 1.343 0.933 0 CA-C-O 119.92 -0.378 . . . . 63.05 112.426 -177.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -82.85 149.86 14.12 Favored 'Trans proline' 0 CA--C 1.552 1.423 0 C-N-CA 122.749 2.3 . . . . 74.13 113.545 -176.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 27.9 m -136.22 -178.81 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 125.657 1.583 . . . . 73.4 108.008 172.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.48 ' HB2' ' N ' ' B' ' 437' ' ' SER . 50.2 mt-10 -107.2 131.2 54.43 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 109.483 -0.562 . . . . 75.04 109.483 168.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 7.0 m -111.65 128.82 67.95 Favored 'Isoleucine or valine' 0 C--O 1.243 0.738 0 N-CA-C 108.242 -1.022 . . . . 74.51 108.242 167.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -78.23 99.2 6.16 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 109.001 -0.74 . . . . 70.4 109.001 177.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.737 ' HA ' HD13 ' B' ' 441' ' ' ILE . 14.8 p -67.64 137.53 93.09 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 124.066 0.947 . . . . 71.22 109.276 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -76.3 170.86 19.18 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 122.242 1.961 . . . . 75.51 110.958 -177.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.75 161.17 45.96 Favored 'Trans proline' 0 C--N 1.371 1.728 0 C-N-CA 121.378 1.385 . . . . 72.53 112.226 172.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 57.7 mtt-85 64.4 24.19 13.15 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 125.188 1.395 . . . . 75.13 112.02 168.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.514 HG23 HD21 ' A' ' 233' ' ' LEU . 98.6 m -68.27 102.38 1.37 Allowed 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 125.238 1.415 . . . . 64.32 111.162 -178.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -87.72 139.16 30.81 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.981 1.312 . . . . 75.32 110.88 -176.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . 0.448 ' HA ' ' HB ' ' A' ' 253' ' ' VAL . . . -68.13 156.98 36.33 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.405 0.682 . . . . 65.12 112.197 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 84.42 -19.08 20.66 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-N 115.886 -0.597 . . . . 75.54 112.929 -179.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -90.92 160.96 15.4 Favored 'General case' 0 C--N 1.351 0.672 0 C-N-CA 123.762 0.825 . . . . 74.44 110.654 178.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -115.95 114.44 24.63 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.193 0.997 . . . . 72.22 108.615 -177.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.514 HD21 HG23 ' A' ' 227' ' ' THR . 84.9 mt -75.71 118.67 18.78 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.817 0.847 . . . . 71.4 110.64 -177.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 27.2 ttm-85 -90.48 103.13 15.85 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 109.492 -0.559 . . . . 73.41 109.492 172.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.655 HD12 HG12 ' B' ' 441' ' ' ILE . 0.1 OUTLIER -97.17 123.54 40.97 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.477 0.711 . . . . 74.24 109.174 173.968 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -69.98 132.09 45.4 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 114.592 -1.185 . . . . 71.01 113.48 -169.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 79.44 3.3 88.67 Favored Glycine 0 C--N 1.354 1.575 0 CA-C-N 115.774 -0.648 . . . . 74.2 114.433 171.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.599 ' HG3' HD13 ' A' ' 235' ' ' LEU . 0.0 OUTLIER -90.38 -7.26 53.66 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 112.536 0.569 . . . . 74.1 112.536 -172.406 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -85.91 -166.07 41.6 Favored Glycine 0 C--N 1.351 1.399 0 C-N-CA 123.101 0.382 . . . . 74.43 113.791 175.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -89.64 147.95 38.96 Favored Pre-proline 0 N--CA 1.485 1.308 0 C-N-CA 123.375 0.67 . . . . 73.41 111.429 -171.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -66.3 146.75 81.87 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 123.576 2.851 . . . . 73.33 113.28 174.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -177.87 -155.3 13.79 Favored Glycine 0 CA--C 1.534 1.278 0 CA-C-O 118.969 -0.906 . . . . 73.52 112.138 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -64.49 -33.52 56.8 Favored 'Trans proline' 0 C--N 1.385 2.472 0 C-N-CA 123.746 2.964 . . . . 72.5 113.522 -176.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -89.96 21.03 3.84 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.136 0.574 . . . . 70.11 111.165 176.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 72.38 -152.14 47.69 Favored Glycine 0 C--N 1.35 1.346 0 N-CA-C 110.803 -0.919 . . . . 62.24 110.803 -169.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 27.4 mtp180 -76.29 137.43 39.89 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 109.608 -0.516 . . . . 75.41 109.608 170.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -80.39 -161.5 24.8 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 112.155 -0.378 . . . . 70.31 112.155 173.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -110.92 -174.38 2.46 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 123.734 0.814 . . . . 75.44 110.138 -178.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.539 ' HB3' ' HG ' ' A' ' 235' ' ' LEU . 18.6 tp -127.68 133.22 49.6 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.381 -0.97 . . . . 73.32 108.381 175.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.489 ' HB2' ' HA ' ' A' ' 194' ' ' TYR . 3.1 m-85 -96.55 126.34 41.67 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 108.611 -0.885 . . . . 71.3 108.611 173.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.508 HD12 HD21 ' A' ' 197' ' ' LEU . 88.7 mt -115.52 108.66 16.74 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.691 -0.855 . . . . 74.54 108.691 172.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -76.65 115.87 16.8 Favored 'General case' 0 C--N 1.348 0.529 0 N-CA-C 106.817 -1.549 . . . . 75.41 106.817 -176.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.448 ' HB ' ' HA ' ' A' ' 229' ' ' ALA . 22.7 t -76.25 116.06 18.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 CA-C-N 115.548 -0.751 . . . . 71.34 110.68 -169.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -119.15 91.68 3.61 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 107.091 -1.448 . . . . 73.14 107.091 178.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.414 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 62.5 mt -81.23 129.89 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 116.469 -0.332 . . . . 74.34 110.292 -176.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 32.3 p -120.28 173.22 7.26 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.645 1.178 . . . . 74.52 109.618 173.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.1 pp -125.14 155.03 71.64 Favored Pre-proline 0 CA--C 1.562 1.433 0 N-CA-C 107.888 -1.152 . . . . 73.4 107.888 173.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . 0.638 ' HG3' ' HH ' ' C' ' 276' ' ' TYR . 37.9 Cg_endo -78.51 18.6 0.94 Allowed 'Trans proline' 0 N--CA 1.512 2.568 0 C-N-CA 123.382 2.721 . . . . 74.45 115.64 -164.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 51.67 -122.91 2.06 Favored 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 124.015 0.926 . . . . 75.12 111.959 -169.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' ARG . . . . . 0.45 ' HD3' ' H ' ' A' ' 260' ' ' ARG . 0.0 OUTLIER -67.34 149.54 50.19 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 118.679 0.672 . . . . 75.12 111.743 -169.162 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 69.8 mt -120.77 160.67 22.89 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.596 0.758 . . . . 72.32 111.657 -171.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 27.5 p -90.56 148.34 38.47 Favored Pre-proline 0 CA--C 1.556 1.183 0 CA-C-O 117.782 -1.104 . . . . 74.31 108.92 170.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' PRO . . . . . 0.506 ' O ' ' HB3' ' A' ' 266' ' ' GLU . 31.5 Cg_exo -35.23 -54.0 0.7 Allowed 'Trans proline' 0 C--N 1.394 2.932 1 C-N-CA 125.418 4.079 . . . . 74.33 117.298 -167.453 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -77.87 -38.29 46.31 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 121.962 -0.461 . . . . 71.44 111.439 -176.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -64.91 -26.54 68.36 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 122.912 0.485 . . . . 73.22 110.623 173.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' GLU . . . . . 0.506 ' HB3' ' O ' ' A' ' 263' ' ' PRO . 7.9 tp10 -63.14 -58.35 7.51 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 108.353 -0.98 . . . . 73.45 108.353 172.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -66.31 -18.31 65.28 Favored 'General case' 0 CA--C 1.553 1.086 0 CA-C-N 115.321 -0.854 . . . . 64.12 112.871 177.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 41.5 tp -78.27 -47.0 18.83 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.691 0.797 . . . . 73.14 110.412 -177.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 68.6 m95 -63.08 -38.13 89.95 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.478 -0.783 . . . . 75.0 110.495 173.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . 0.484 ' HG3' HG23 ' C' ' 206' ' ' VAL . 0.9 OUTLIER -63.45 -44.07 95.57 Favored 'General case' 0 CA--C 1.557 1.216 0 O-C-N 123.672 0.607 . . . . 73.12 111.778 175.311 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . 0.401 ' HZ2' HE22 ' B' ' 252' ' ' GLN . 29.8 mtmm -57.18 -49.89 74.56 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 123.124 0.57 . . . . 70.22 110.664 175.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 24.7 mt -51.73 -51.0 59.49 Favored 'General case' 0 C--O 1.216 -0.7 0 O-C-N 124.596 1.185 . . . . 71.54 110.862 175.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -68.19 -38.42 81.96 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 113.935 1.087 . . . . 72.23 113.935 -169.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -76.96 -42.79 37.68 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 123.467 0.48 . . . . 74.35 110.154 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -66.02 -30.1 70.58 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.82 -0.627 . . . . 72.24 110.899 175.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -67.71 -60.17 2.74 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.377 1.071 . . . . 75.02 109.636 177.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -60.35 -41.72 94.23 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.345 1.058 . . . . 72.14 111.017 -172.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -60.89 -20.59 62.21 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.337 0.655 . . . . 75.41 112.705 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 87.6 mtm180 -128.99 18.37 6.09 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.8 0.84 . . . . 75.15 111.005 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.022 0 CA-C-O 118.412 -0.804 . . . . 72.5 110.754 -175.734 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.476 ' N ' ' SD ' ' B' ' 1' ' ' MET . 1.0 OUTLIER . . . . . 0 N--CA 1.482 1.171 0 N-CA-C 108.775 -0.824 . . . . 74.12 108.775 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.533 ' HE3' ' HA ' ' B' ' 2' ' ' LYS . 0.4 OUTLIER -70.77 90.03 0.77 Allowed 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 109.425 -0.583 . . . . 62.45 109.425 179.238 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 23.9 tm0? -113.11 160.36 18.27 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.253 1.021 . . . . 74.04 108.95 -173.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' SER . . . . . 0.404 ' H ' HG22 ' A' ' 126' ' ' THR . 80.7 p 59.25 -80.45 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 126.785 2.034 . . . . 52.14 111.655 -177.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 6.4 m -76.65 153.88 34.81 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 109.01 -0.737 . . . . 74.34 109.01 172.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.574 HG23 ' HA ' ' A' ' 125' ' ' LEU . 31.7 pt -128.74 173.76 13.14 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 CA-C-O 121.033 0.444 . . . . 65.34 111.207 -174.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -146.54 127.66 14.69 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.395 -0.821 . . . . 72.22 109.458 -177.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . 0.527 HD22 HD23 ' A' ' 174' ' ' LEU . 38.3 tp -73.1 150.73 42.02 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.419 0.688 . . . . 75.22 111.049 -176.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.68 -60.37 2.38 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 122.873 0.469 . . . . 73.12 111.027 176.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 67.3 mt 62.17 127.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 124.584 1.153 . . . . 74.1 110.114 -163.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 24.6 mt -118.35 71.7 9.37 Favored Pre-proline 0 CA--C 1.561 1.383 0 O-C-N 121.706 -0.621 . . . . 72.11 110.318 178.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -91.07 -24.4 0.42 Allowed 'Trans proline' 0 C--N 1.385 2.484 0 C-N-CA 122.44 2.093 . . . . 71.41 113.041 174.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -158.27 13.86 0.2 Allowed 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 112.07 0.396 . . . . 75.11 112.07 -173.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 37.7 tp -63.81 160.5 17.23 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.81 -0.441 . . . . 64.54 109.81 175.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' PHE . . . . . 0.403 ' HE2' HG23 ' B' ' 343' ' ' VAL . 78.3 t80 -53.29 96.57 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 124.203 1.001 . . . . 74.01 111.82 -178.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 54.2 p -116.59 -177.87 0.48 Allowed Pre-proline 0 CA--C 1.556 1.176 0 C-N-CA 125.308 1.443 . . . . 71.11 108.428 176.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -49.25 143.05 20.36 Favored 'Trans proline' 0 C--N 1.383 2.354 0 C-N-CA 121.944 1.762 . . . . 71.22 112.711 162.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 10.7 m -72.21 86.24 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.348 0 CA-C-O 122.205 1.003 . . . . 63.3 112.013 -171.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 37.6 p -89.72 114.02 25.63 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.27 -0.877 . . . . 71.22 111.328 -177.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp 68.66 -68.65 0.17 Allowed 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 126.153 1.781 . . . . 74.33 111.93 174.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.57 93.08 0.48 Allowed 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 107.845 -1.169 . . . . 75.34 107.845 166.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 16.6 ptt180 -146.71 13.86 1.19 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.739 0.815 . . . . 73.31 111.131 -176.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' THR . . . . . 0.607 ' HB ' ' HD2' ' B' ' 24' ' ' PRO . 28.2 p 57.72 -173.89 0.02 OUTLIER Pre-proline 0 CA--C 1.577 2.012 0 C-N-CA 125.195 1.398 . . . . 72.54 111.391 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . 0.607 ' HD2' ' HB ' ' B' ' 23' ' ' THR . 26.5 Cg_endo -65.08 -2.01 5.12 Favored 'Trans proline' 0 C--N 1.398 3.166 0 CA-C-N 121.569 1.596 . . . . 74.55 114.075 165.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 78.72 -32.87 0.15 Allowed 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 126.004 1.722 . . . . 74.53 113.601 168.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -113.83 27.35 0.1 OUTLIER Pre-proline 0 CA--C 1.582 2.205 0 N-CA-C 114.806 1.41 . . . . 75.13 114.806 176.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -77.69 -10.57 17.07 Favored 'Trans proline' 0 C--N 1.411 3.842 0 CA-C-N 123.508 2.288 . . . . 73.04 110.848 168.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 30.0 m -100.63 -157.72 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 C-N-CA 125.191 1.397 . . . . 75.25 108.967 173.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 76.3 mt 81.98 -50.3 0.23 Allowed 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 126.054 1.742 . . . . 73.34 111.93 174.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 65.63 112.86 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 125.146 1.379 . . . . 71.25 112.152 -178.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 21.3 p-10 -93.28 35.09 1.1 Allowed 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 125.017 1.327 . . . . 74.34 111.278 -177.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' ARG . . . . . 0.608 HH22 ' HB2' ' B' ' 119' ' ' ASP . 27.8 ptt180 -63.39 -20.8 65.85 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.785 0.834 . . . . 72.22 112.221 179.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.22 80.86 0.72 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.989 0.916 . . . . 73.31 110.381 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -164.23 35.97 0.08 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.102 0.961 . . . . 53.33 110.238 -175.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -76.87 -44.82 30.58 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 116.407 -0.36 . . . . 73.13 110.187 177.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 126.26 -28.36 4.82 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-O 119.403 -0.665 . . . . 74.33 114.311 171.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . 0.539 ' HA ' ' HG2' ' C' ' 27' ' ' LYS . 18.9 m-20 -64.02 94.46 0.1 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.025 0.53 . . . . 61.44 111.839 -174.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . 0.434 HG22 ' HD2' ' C' ' 148' ' ' ARG . 39.4 mt -125.12 80.52 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.044 0 N-CA-C 107.583 -1.266 . . . . 75.44 107.583 173.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 75.5 p 56.15 131.79 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 126.931 2.092 . . . . 73.32 115.698 178.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.5 177.65 2.37 Favored Pre-proline 0 CA--C 1.569 1.705 0 CA-C-O 117.482 -1.247 . . . . 73.24 108.494 172.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -82.98 -159.14 0.1 OUTLIER 'Trans proline' 0 C--N 1.4 3.258 0 CA-C-N 122.824 2.044 . . . . 72.44 113.035 -168.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . 0.554 ' HA3' ' HA ' ' B' ' 327' ' ' LYS . . . 174.7 -112.81 0.42 Allowed Glycine 0 C--N 1.349 1.285 0 N-CA-C 111.222 -0.751 . . . . 61.22 111.222 179.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . 0.425 ' HA3' ' HB2' ' B' ' 326' ' ' ASP . . . -97.41 59.09 1.12 Allowed Glycine 0 C--N 1.344 1.02 0 N-CA-C 111.876 -0.49 . . . . 64.32 111.876 178.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.65 75.02 4.21 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.698 0.799 . . . . 63.2 109.39 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.465 ' HG2' ' HA ' ' B' ' 48' ' ' THR . 49.8 ttt180 -84.13 82.62 8.28 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 114.785 -1.098 . . . . 74.21 110.728 -168.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 17.6 ttm180 -64.88 134.46 54.08 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.712 0.805 . . . . 75.02 109.688 175.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 9.6 tt 78.83 -30.33 0.15 Allowed 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 125.657 1.583 . . . . 72.13 111.782 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' THR . . . . . 0.465 ' HA ' ' HG2' ' B' ' 45' ' ' ARG . 70.9 m 72.4 -63.14 0.44 Allowed 'General case' 0 C--N 1.36 1.028 0 C-N-CA 125.903 1.681 . . . . 73.12 111.362 -176.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.66 47.28 4.89 Favored Glycine 0 C--N 1.342 0.863 0 CA-C-O 120.099 -0.279 . . . . 74.15 112.536 178.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . 0.672 ' HB3' ' HB3' ' B' ' 53' ' ' ALA . 10.8 m-20 71.28 -69.51 0.18 Allowed 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 125.567 1.547 . . . . 64.2 111.801 175.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 22.8 tp60 63.27 -82.84 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.159 1.383 . . . . 75.3 111.493 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 5.2 m -93.26 52.03 1.72 Allowed 'General case' 0 CA--C 1.55 0.973 0 CA-C-O 121.808 0.813 . . . . 73.31 109.443 -175.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . 0.672 ' HB3' ' HB3' ' B' ' 50' ' ' ASP . . . -87.06 22.44 2.04 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.334 0.654 . . . . 73.24 112.697 -172.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.488 ' HA ' ' HB2' ' B' ' 57' ' ' ASP . . . 67.64 25.17 8.28 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 124.869 1.268 . . . . 75.51 110.243 -174.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 50.0 tp -68.53 -67.7 0.45 Allowed 'General case' 0 C--N 1.348 0.533 0 CA-C-N 114.756 -1.111 . . . . 72.35 108.8 -176.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -117.47 12.17 14.08 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.975 0.91 . . . . 74.21 109.709 173.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . 0.488 ' HB2' ' HA ' ' B' ' 54' ' ' ALA . 9.6 m-20 -86.07 72.0 10.49 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.588 1.155 . . . . 75.31 110.747 -170.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 47.1 m -88.54 81.95 7.03 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.269 -0.878 . . . . 62.01 108.985 178.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 2.5 tt 60.07 70.88 0.6 Allowed 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.871 1.268 . . . . 72.44 110.304 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 18.6 m -74.55 -36.68 63.11 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 121.788 0.804 . . . . 71.31 109.822 173.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -164.81 -56.0 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 105.888 -1.893 . . . . 71.45 105.888 176.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -49.79 135.97 19.71 Favored Pre-proline 0 CA--C 1.551 0.984 0 CA-C-N 113.156 -1.838 . . . . 72.42 111.067 166.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -49.53 -47.89 21.02 Favored 'Trans proline' 0 C--N 1.394 2.95 0 C-N-CA 123.882 3.054 . . . . 72.24 112.958 -176.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 71.5 -54.89 0.67 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 125.585 1.554 . . . . 72.04 112.587 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm 69.81 15.87 7.89 Favored 'General case' 0 CA--C 1.56 1.346 0 C-N-CA 124.984 1.314 . . . . 73.42 110.327 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -94.12 99.35 11.65 Favored 'General case' 0 C--N 1.351 0.666 0 C-N-CA 124.679 1.191 . . . . 72.41 108.979 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 4.9 tt -151.12 96.04 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 C-N-CA 123.574 0.75 . . . . 74.04 109.13 177.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 61.4 mt 64.4 -76.34 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 C-N-CA 125.434 1.494 . . . . 73.4 110.623 -174.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -144.84 -167.7 2.73 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.065 0.946 . . . . 74.34 109.255 178.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . 0.471 HD22 ' H ' ' B' ' 70' ' ' LEU . 2.1 pt? -64.59 83.07 0.04 OUTLIER 'General case' 0 CA--C 1.561 1.392 0 CA-C-O 122.047 0.927 . . . . 65.22 110.387 171.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 8.7 tp -67.12 -29.82 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 123.696 0.798 . . . . 75.5 111.129 -178.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.26 108.92 0.13 Allowed Glycine 0 C--N 1.345 1.074 0 CA-C-N 116.05 -0.523 . . . . 71.15 112.109 -175.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -61.0 102.71 0.22 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.735 0.814 . . . . 74.12 110.152 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.45 55.97 26.01 Favored Glycine 0 C--N 1.356 1.645 0 O-C-N 123.976 0.798 . . . . 72.45 111.934 -177.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 66.9 mtt 67.84 -69.0 0.15 Allowed 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 125.329 1.452 . . . . 74.01 110.085 -166.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 60.07 32.79 76.88 Favored Glycine 0 C--N 1.36 1.916 0 N-CA-C 111.845 -0.502 . . . . 71.52 111.845 -178.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -58.9 -32.96 70.0 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.564 1.145 . . . . 74.35 112.072 -171.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 48.2 t 68.36 47.18 0.98 Allowed 'General case' 0 CA--C 1.55 0.963 0 O-C-N 124.739 1.274 . . . . 55.34 109.335 -177.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -85.66 150.58 24.52 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.45 1.1 . . . . 74.44 111.62 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . 0.467 HG23 ' H ' ' B' ' 81' ' ' THR 0.291 0.0 OUTLIER 50.65 -77.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 C-N-CA 127.631 2.372 . . . . 72.52 113.079 176.02 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' B' B ' 81' ' ' THR . . . . . 0.467 ' H ' HG23 ' B' ' 80' ' ' ILE . 9.4 t -75.88 -18.22 59.49 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.829 0.852 . . . . 74.52 110.627 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 69.02 178.39 0.25 Allowed 'General case' 0 C--N 1.356 0.855 0 C-N-CA 125.052 1.341 . . . . 75.12 111.394 -172.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -100.52 54.7 0.88 Allowed 'General case' 0 C--O 1.243 0.756 0 N-CA-C 108.675 -0.861 . . . . 74.13 108.675 175.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 -69.0 85.7 0.34 Allowed 'General case' 0 C--N 1.353 0.745 0 CA-C-N 115.15 -0.932 . . . . 73.0 109.941 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -116.04 137.16 52.36 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.099 1.359 . . . . 72.23 108.745 -178.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -66.48 116.06 7.05 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 109.239 -0.652 . . . . 74.21 109.239 177.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.83 86.37 0.51 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.549 0.74 . . . . 52.24 111.122 -174.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -109.86 -56.02 2.37 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.803 1.241 . . . . 74.14 108.337 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -88.39 56.69 4.22 Favored Glycine 0 C--N 1.349 1.261 0 CA-C-N 115.154 -0.93 . . . . 54.33 111.224 171.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.88 166.25 22.48 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.591 0.757 . . . . 75.53 110.904 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.2 26.57 1.81 Allowed Glycine 0 CA--C 1.536 1.373 0 N-CA-C 114.448 0.539 . . . . 70.11 114.448 -177.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -97.09 29.89 9.96 Favored Glycine 0 C--N 1.352 1.458 0 C-N-CA 123.493 0.568 . . . . 73.42 112.619 178.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . 0.433 ' HA ' ' HB ' ' B' ' 318' ' ' VAL . 87.1 m-85 -68.51 94.82 0.59 Allowed 'General case' 0 C--N 1.352 0.677 0 N-CA-C 109.4 -0.593 . . . . 74.22 109.4 175.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 94' ' ' PHE . . . . . 0.414 ' H ' ' HB ' ' B' ' 318' ' ' VAL . 72.8 t80 -169.69 102.96 0.32 Allowed 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.551 -0.907 . . . . 72.14 108.551 174.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -95.44 -47.93 6.07 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 109.486 -0.561 . . . . 74.44 109.486 174.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.94 -39.54 3.07 Favored Glycine 0 C--N 1.348 1.236 0 CA-C-N 116.142 -0.481 . . . . 75.21 112.718 176.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 9.2 tp -102.79 20.74 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.373 0 CA-C-O 122.036 0.922 . . . . 73.0 109.47 176.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -87.14 155.29 20.18 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 121.83 -0.544 . . . . 75.21 110.925 177.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -142.15 123.86 15.1 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.099 0.96 . . . . 61.12 109.317 -178.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 94.9 mt -127.37 140.82 39.01 Favored Pre-proline 0 N--CA 1.474 0.766 0 C-N-CA 124.122 0.969 . . . . 74.2 108.773 178.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -80.39 98.44 1.09 Allowed 'Trans proline' 0 C--N 1.371 1.728 0 C-N-CA 122.189 1.926 . . . . 74.43 111.001 172.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -68.41 -45.18 73.32 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 109.407 -0.59 . . . . 73.12 109.407 175.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 13.0 t -151.57 -179.17 7.18 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-N 115.117 -0.947 . . . . 75.52 109.723 -176.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . -68.66 90.86 0.25 Allowed Glycine 0 C--N 1.349 1.279 0 N-CA-C 111.313 -0.715 . . . . 51.35 111.313 171.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 12.9 tm0? -65.18 99.24 0.36 Allowed 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 108.407 -0.96 . . . . 75.22 108.407 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 56.78 -170.45 0.09 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.345 1.058 . . . . 74.44 113.078 -177.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 70.5 p -96.82 24.77 5.8 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 112.878 0.696 . . . . 75.34 112.878 -172.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 31.5 p80 -81.16 69.22 7.72 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-O 122.492 1.139 . . . . 73.44 109.698 173.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -162.74 -62.71 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 106.928 -1.508 . . . . 74.1 106.928 -172.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -79.24 163.41 24.99 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 114.838 -1.074 . . . . 75.22 108.501 164.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . 0.544 ' HA ' ' HA ' ' C' ' 243' ' ' PRO . 38.3 mt 62.28 23.94 14.21 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 123.641 0.777 . . . . 70.25 110.874 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 37.0 t-20 -79.32 141.09 37.29 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.749 0.82 . . . . 73.2 110.657 -168.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 113' ' ' LYS . . . . . 0.471 ' HG2' ' H ' ' B' ' 114' ' ' LYS 0.292 0.0 OUTLIER 31.54 -77.64 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 127.802 2.441 . . . . 75.13 114.258 -169.853 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' B' B ' 114' ' ' LYS . . . . . 0.471 ' H ' ' HG2' ' B' ' 113' ' ' LYS . 0.6 OUTLIER -174.83 -165.08 0.18 Allowed 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 107.039 -1.467 . . . . 74.21 107.039 -175.062 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 115' ' ' THR . . . . . 0.43 ' H ' ' HG3' ' B' ' 114' ' ' LYS . 17.1 p -56.1 -70.81 0.1 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.358 0.663 . . . . 73.23 110.324 172.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -90.34 -140.0 8.15 Favored Glycine 0 C--N 1.343 0.944 0 N-CA-C 111.458 -0.657 . . . . 55.33 111.458 173.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . 0.466 ' H ' ' HD2' ' B' ' 118' ' ' PRO . 10.2 mtpm? -142.0 -58.06 0.02 OUTLIER Pre-proline 0 N--CA 1.485 1.3 0 C-N-CA 124.343 1.057 . . . . 75.35 110.993 176.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 118' ' ' PRO . . . . . 0.813 ' HA ' ' HB2' ' B' ' 336' ' ' GLU . 62.7 Cg_endo -70.37 -49.57 0.46 Allowed 'Trans proline' 0 C--N 1.397 3.129 0 C-N-CA 121.217 1.278 . . . . 63.21 113.27 -172.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 119' ' ' ASP . . . . . 0.608 ' HB2' HH22 ' B' ' 32' ' ' ARG . 15.3 t70 -161.07 153.92 20.99 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 124.56 1.144 . . . . 75.33 107.958 -175.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 120' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -122.14 -15.89 7.62 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.126 0.57 . . . . 70.1 111.309 -168.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 6.0 m -134.22 -57.31 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 113.606 0.965 . . . . 74.32 113.606 -170.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 53.6 m -79.96 -67.85 0.73 Allowed 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.17 0.51 . . . . 75.25 111.515 -170.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -88.37 -60.99 1.81 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.85 1.26 . . . . 70.53 111.028 -172.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 124' ' ' SER . . . . . 0.477 ' H ' ' HB3' ' B' ' 119' ' ' ASP . 39.2 m 56.92 -159.36 0.24 Allowed 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 125.329 1.452 . . . . 61.03 112.259 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -157.29 149.41 22.67 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.303 0.641 . . . . 74.53 110.733 178.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -153.08 160.6 42.95 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.269 1.028 . . . . 74.13 109.51 177.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 59.4 p -156.02 -178.22 7.15 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 112.652 0.612 . . . . 70.01 112.652 -171.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -76.85 146.58 37.65 Favored 'General case' 0 C--N 1.354 0.785 0 C-N-CA 123.896 0.878 . . . . 74.33 109.963 171.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 129' ' ' THR . . . . . 0.476 ' HB ' HD23 ' B' ' 155' ' ' LEU . 7.5 m -71.46 -11.27 60.79 Favored 'General case' 0 CA--C 1.556 1.173 0 C-N-CA 123.097 0.559 . . . . 74.41 111.464 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.88 147.98 50.57 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.126 0.57 . . . . 61.42 111.133 172.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 131' ' ' TRP . . . . . 0.425 ' HA ' ' HB2' ' C' ' 187' ' ' ARG . 20.7 p90 -55.43 -25.55 36.72 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 125.045 1.338 . . . . 73.51 113.201 -174.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 132' ' ' SER . . . . . 0.617 ' HB3' HG22 ' B' ' 135' ' ' VAL . 39.1 t -122.73 149.12 44.51 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 123.648 0.779 . . . . 74.11 110.557 178.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 6.5 m -68.92 -28.52 66.73 Favored 'General case' 0 CA--C 1.551 0.995 0 N-CA-C 109.194 -0.669 . . . . 74.52 109.194 167.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . -68.86 -8.14 56.94 Favored Glycine 0 C--N 1.357 1.716 0 CA-C-N 114.727 -1.124 . . . . 55.15 115.173 -178.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 135' ' ' VAL . . . . . 0.617 HG22 ' HB3' ' B' ' 132' ' ' SER . 39.6 t -77.36 -32.81 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 CA-C-N 117.568 0.684 . . . . 73.24 109.722 174.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt 66.41 15.25 10.04 Favored 'General case' 0 CA--C 1.572 1.789 0 C-N-CA 125.024 1.33 . . . . 74.24 112.833 170.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 137' ' ' THR . . . . . 0.455 HG23 HG13 ' B' ' 135' ' ' VAL . 11.5 p -69.93 100.7 1.62 Allowed 'General case' 0 N--CA 1.481 1.093 0 O-C-N 121.842 -0.536 . . . . 75.31 111.257 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 55.6 t80 68.08 -80.26 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.553 1.541 . . . . 75.52 110.345 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 4.7 t30 61.56 93.7 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.984 1.314 . . . . 73.24 112.085 176.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . 170.66 42.37 0.03 OUTLIER Glycine 0 C--N 1.354 1.542 0 CA-C-O 119.625 -0.541 . . . . 75.54 114.065 176.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . 76.12 -35.2 0.25 Allowed 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 125.278 1.431 . . . . 75.34 114.114 174.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . 0.265 0.3 OUTLIER 42.85 -86.64 0.01 OUTLIER 'General case' 0 CA--C 1.567 1.622 0 C-N-CA 126.11 1.764 . . . . 74.24 114.026 -176.901 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.32 -35.03 4.83 Favored Glycine 0 C--N 1.356 1.668 0 N-CA-C 112.141 -0.384 . . . . 61.25 112.141 -176.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 42.4 t -102.59 164.12 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 107.581 -1.266 . . . . 75.31 107.581 171.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 145' ' ' ASP . . . . . 0.476 ' HB3' HE22 ' B' ' 397' ' ' GLN . 6.3 p-10 -64.28 -43.87 93.46 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 118.325 0.511 . . . . 75.32 111.66 -178.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 1.7 mp 72.05 -29.07 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.568 1.654 0 C-N-CA 125.323 1.449 . . . . 72.52 112.308 -176.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 36.6 p-80 37.73 71.86 0.14 Allowed 'General case' 0 C--N 1.373 1.613 0 C-N-CA 125.277 1.431 . . . . 72.43 110.926 -163.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -54.1 131.85 41.71 Favored 'General case' 0 C--N 1.359 0.999 0 CA-C-N 114.163 -1.381 . . . . 75.05 110.763 -168.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 149' ' ' LYS . . . . . . . . . . . . . 31.6 mtmm 71.16 -80.26 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.859 1.664 . . . . 74.13 109.152 -164.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 34.5 t0 178.65 160.48 0.62 Allowed 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.637 1.175 . . . . 74.11 109.127 177.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 69.85 171.66 0.1 Allowed Pre-proline 0 N--CA 1.491 1.598 0 C-N-CA 124.724 1.21 . . . . 74.43 112.073 177.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.86 -173.43 0.2 Allowed 'Trans proline' 0 C--N 1.389 2.677 0 C-N-CA 122.618 2.212 . . . . 64.13 113.721 167.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 47.5 m 76.96 -53.3 0.57 Allowed 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 125.772 1.629 . . . . 74.2 110.391 -172.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 65.2 mt 64.67 -80.72 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.227 0 C-N-CA 125.132 1.373 . . . . 74.25 112.186 169.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 155' ' ' LEU . . . . . 0.476 HD23 ' HB ' ' B' ' 129' ' ' THR . 0.9 OUTLIER -121.63 41.4 3.37 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.894 0.878 . . . . 73.12 111.04 -174.331 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 79.91 -31.14 0.13 Allowed 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 125.77 1.628 . . . . 72.23 112.327 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 157' ' ' MET . . . . . 0.542 ' HB3' ' HG2' ' C' ' 252' ' ' GLU . 51.6 mtt 69.09 25.03 5.93 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.731 1.212 . . . . 61.13 111.618 -173.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 158' ' ' ALA . . . . . . . . . . . . . . . 68.71 -66.7 0.23 Allowed 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 125.931 1.693 . . . . 65.11 112.528 178.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . 0.58 ' HA ' HG21 ' C' ' 196' ' ' THR . 89.0 mttt 60.83 61.43 1.66 Allowed 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.833 1.253 . . . . 73.24 110.686 178.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -84.31 54.21 2.9 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 114.878 -1.055 . . . . 74.34 109.657 174.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . 0.444 ' HA ' ' HA ' ' B' ' 356' ' ' ASN . . . -175.9 132.31 0.26 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.655 1.182 . . . . 71.1 109.495 -174.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 162' ' ' GLY . . . . . 0.471 ' H ' ' HB2' ' B' ' 356' ' ' ASN . . . 170.56 -53.59 0.19 Allowed Glycine 0 C--N 1.354 1.566 0 N-CA-C 112.139 -0.384 . . . . 73.4 112.139 178.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 1.5 pp -129.15 138.3 51.7 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.952 0.901 . . . . 75.25 110.642 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 164' ' ' ALA . . . . . . . . . . . . . . . -71.09 102.13 2.4 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.845 0.858 . . . . 75.34 111.854 -171.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 21.5 p -90.03 100.14 13.02 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.345 0.658 . . . . 73.14 110.243 174.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . -84.41 59.39 4.93 Favored Glycine 0 C--N 1.351 1.396 0 CA-C-N 115.965 -0.561 . . . . 74.53 112.596 -177.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 167' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -150.79 -0.93 0.38 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.381 1.072 . . . . 74.33 108.968 178.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 8.1 p -161.85 34.28 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.219 0 CA-C-O 122.254 1.026 . . . . 75.53 108.72 -173.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 10.3 m -55.48 -46.29 76.88 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 114.154 -1.384 . . . . 65.53 111.552 -174.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 6.5 m -112.5 -77.37 0.58 Allowed 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.061 -1.089 . . . . 73.13 108.061 174.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . 0.488 ' HB3' ' HE2' ' C' ' 213' ' ' MET . . . 174.89 55.36 0.0 OUTLIER 'General case' 0 C--O 1.242 0.665 0 N-CA-C 106.453 -1.684 . . . . 73.41 106.453 -172.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 172' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -54.99 97.7 0.02 OUTLIER 'General case' 0 C--N 1.357 0.903 0 CA-C-N 115.306 -0.861 . . . . 75.25 111.814 -173.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 173' ' ' LEU . . . . . . . . . . . . . 1.2 pp -87.89 21.23 2.74 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.354 1.062 . . . . 74.44 111.413 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 174' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -76.99 -6.78 53.98 Favored 'General case' 0 CA--C 1.562 1.42 0 C-N-CA 124.738 1.215 . . . . 74.45 110.312 178.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 175' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -68.4 154.14 42.38 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.675 1.19 . . . . 74.1 110.015 168.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -141.41 26.56 1.96 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.293 0.637 . . . . 74.11 111.911 -174.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 92.5 m -60.52 123.66 74.94 Favored Pre-proline 0 CA--C 1.559 1.308 0 C-N-CA 123.158 0.583 . . . . 74.15 110.267 175.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 178' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.44 -3.38 12.9 Favored 'Trans proline' 0 C--N 1.387 2.575 0 C-N-CA 123.241 2.627 . . . . 74.53 113.887 -173.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -70.21 95.89 1.04 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.245 0.618 . . . . 74.35 110.41 176.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.89 -39.57 93.74 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.449 0.699 . . . . 75.32 110.676 176.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 14.8 tp -163.08 27.85 0.09 Allowed 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 114.769 -1.105 . . . . 74.44 108.341 176.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 182' ' ' VAL . . . . . 0.68 HG21 ' HA ' ' C' ' 138' ' ' VAL . 53.9 t -80.58 113.78 20.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 115.768 -0.651 . . . . 72.43 110.892 -171.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -90.21 -40.58 12.1 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.507 -0.769 . . . . 65.24 110.231 170.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 184' ' ' HIS . . . . . 0.651 ' HB3' ' HB3' ' B' ' 187' ' ' SER . 49.7 t-80 52.65 35.86 19.36 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 124.813 1.245 . . . . 75.32 111.599 175.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 185' ' ' VAL . . . . . . . . . . . . . 48.9 t 56.71 82.37 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 124.755 1.222 . . . . 74.01 110.326 -170.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 186' ' ' THR . . . . . 0.658 HG22 ' HG2' ' C' ' 122' ' ' GLU . 38.1 p 61.79 11.88 4.34 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 125.738 1.615 . . . . 60.24 114.059 172.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 187' ' ' SER . . . . . 0.651 ' HB3' ' HB3' ' B' ' 184' ' ' HIS . 35.4 t -83.92 143.39 29.88 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.491 0.716 . . . . 62.14 110.328 178.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 188' ' ' ARG . . . . . 0.433 ' HG3' ' HG3' ' C' ' 124' ' ' PRO . 35.9 ttt180 -149.66 137.65 20.39 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.859 0.864 . . . . 72.32 110.291 -174.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -127.43 158.43 37.34 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.946 0.898 . . . . 72.52 109.114 169.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 190' ' ' CYS . . . . . . . . . . . . . 74.8 m -144.2 127.82 17.11 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.732 0.813 . . . . 70.33 109.681 178.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 94.0 t80 -85.49 132.34 34.22 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.134 0.974 . . . . 74.04 109.701 178.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -67.11 134.99 31.74 Favored Glycine 0 C--N 1.349 1.297 0 CA-C-O 118.221 -1.321 . . . . 64.22 111.664 176.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 193' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -50.15 -29.23 21.8 Favored 'Trans proline' 0 C--N 1.388 2.61 0 C-N-CA 124.154 3.236 . . . . 73.22 114.964 -169.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 194' ' ' SER . . . . . . . . . . . . . 31.7 m 71.62 -65.77 0.33 Allowed 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 125.378 1.471 . . . . 63.44 112.107 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 195' ' ' ALA . . . . . . . . . . . . . . . -89.39 166.83 13.48 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.438 0.695 . . . . 74.32 110.613 174.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 31.8 m -86.66 -67.12 0.84 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.693 0.797 . . . . 73.32 109.792 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 39.8 t -167.56 102.63 0.5 Allowed 'General case' 0 C--N 1.35 0.605 0 N-CA-C 108.63 -0.878 . . . . 75.11 108.63 178.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 198' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -106.09 17.84 22.95 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.731 -0.668 . . . . 65.14 111.189 -175.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 64.1 mttm 68.51 -69.2 0.16 Allowed 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 125.24 1.416 . . . . 75.14 110.685 -177.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 200' ' ' CYS . . . . . . . . . . . . . 59.4 m 74.68 96.0 0.04 OUTLIER Pre-proline 0 N--CA 1.482 1.144 0 C-N-CA 125.398 1.479 . . . . 73.31 111.453 173.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 201' ' ' PRO . . . . . 0.615 ' HA ' ' HG2' ' B' ' 363' ' ' GLU . 32.1 Cg_exo -58.72 89.63 0.06 OUTLIER 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 123.317 2.678 . . . . 74.02 112.895 178.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 160.63 24.06 0.02 OUTLIER Glycine 0 C--N 1.345 1.07 0 CA-C-N 115.645 -0.707 . . . . 73.41 113.678 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -84.71 -19.24 33.06 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 117.647 0.724 . . . . 71.33 110.553 172.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -147.83 139.82 24.14 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.532 0.733 . . . . 74.01 110.162 176.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 205' ' ' LEU . . . . . . . . . . . . . 59.3 tp -76.41 -54.92 6.06 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.011 -0.737 . . . . 72.44 109.011 173.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.17 -91.04 0.56 Allowed 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.317 1.047 . . . . 70.3 108.983 175.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 207' ' ' LYS . . . . . 0.535 ' HD3' ' HA3' ' C' ' 217' ' ' GLY . 0.2 OUTLIER 61.9 -82.23 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 124.415 1.086 . . . . 74.32 111.442 -178.782 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 112.09 127.0 4.82 Favored Glycine 0 C--N 1.346 1.117 0 N-CA-C 110.604 -0.998 . . . . 71.52 110.604 -172.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 209' ' ' GLY . . . . . 0.521 ' HA3' HG21 ' B' ' 364' ' ' THR . . . -66.41 -48.01 66.48 Favored Glycine 0 C--N 1.352 1.422 0 N-CA-C 111.391 -0.684 . . . . 63.34 111.391 174.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 62.1 mttm 62.59 -81.22 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.547 1.139 . . . . 74.51 111.128 170.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . -72.61 80.3 0.66 Allowed Glycine 0 C--N 1.348 1.219 0 N-CA-C 108.665 -1.774 . . . . 74.43 108.665 159.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 18.4 t -83.39 31.64 0.46 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.685 1.194 . . . . 74.04 111.078 -172.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 19.8 pt -90.16 29.95 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 C-N-CA 125.413 1.485 . . . . 70.12 110.019 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 79.5 p -63.55 -23.16 67.27 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.429 1.092 . . . . 75.43 112.323 -171.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 215' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -80.12 -26.59 39.41 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.656 0.782 . . . . 73.31 111.013 176.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 16.4 tm0? 81.09 -55.26 0.3 Allowed 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 125.936 1.694 . . . . 61.42 113.369 167.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 1.8 tt -84.21 62.97 7.45 Favored 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 123.392 0.677 . . . . 75.4 111.412 -166.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 8.3 mp 74.93 -52.76 0.67 Allowed 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 125.61 1.564 . . . . 71.43 113.755 168.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 73.66 -41.77 0.5 Allowed 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 125.866 1.666 . . . . 71.24 111.698 -174.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . 0.586 ' HA ' HD21 ' B' ' 226' ' ' LEU . . . -63.24 -17.77 62.82 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.685 0.794 . . . . 74.3 111.908 166.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 221' ' ' ARG . . . . . . . . . . . . . 38.4 mtp-105 70.1 -81.17 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 125.54 1.536 . . . . 73.55 111.275 172.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -135.98 -9.72 2.05 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.845 0.858 . . . . 75.21 111.099 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.02 -35.37 78.16 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.88 1.272 . . . . 72.13 110.326 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 86.0 t 69.0 -68.54 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 125.455 1.502 . . . . 75.32 111.051 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 8.5 t -65.2 -41.95 94.03 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 123.916 0.887 . . . . 73.55 110.94 174.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . 0.586 HD21 ' HA ' ' B' ' 220' ' ' ALA . 37.8 tp 50.88 -80.76 0.01 OUTLIER 'General case' 0 C--N 1.366 1.321 0 C-N-CA 125.949 1.7 . . . . 74.43 112.203 -176.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . -167.96 12.03 0.06 OUTLIER Glycine 0 C--N 1.341 0.85 0 CA-C-N 116.485 -0.325 . . . . 71.24 112.476 176.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 88.7 -32.61 4.46 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-O 119.875 -0.403 . . . . 72.41 112.701 -173.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 229' ' ' GLY . . . . . 0.547 ' HA3' ' HA ' ' B' ' 283' ' ' ASP . . . 69.26 -104.05 1.2 Allowed Glycine 0 C--N 1.352 1.456 0 N-CA-C 112.511 -0.236 . . . . 71.04 112.511 175.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -64.7 -37.41 87.49 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.489 0.716 . . . . 70.23 110.243 172.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 231' ' ' LYS . . . . . . . . . . . . . 49.1 mttp 63.26 10.86 4.95 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 125.511 1.524 . . . . 73.24 112.169 178.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 86.6 m -121.34 110.59 16.29 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.151 0.581 . . . . 74.24 110.951 -168.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -95.11 95.63 8.69 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 108.408 -0.96 . . . . 71.44 108.408 173.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -144.76 -162.08 1.42 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.186 0.594 . . . . 72.31 110.095 -174.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . 0.508 ' HG3' ' HE2' ' C' ' 209' ' ' LYS . 17.9 tp10 76.76 121.27 0.05 OUTLIER 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 125.069 1.348 . . . . 64.41 112.087 173.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 236' ' ' THR . . . . . 0.654 HG22 HD22 ' B' ' 247' ' ' LEU . 49.3 m -96.25 -61.82 1.38 Allowed 'General case' 0 C--O 1.24 0.557 0 C-N-CA 125.614 1.565 . . . . 73.34 110.695 -173.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . 0.496 ' HA ' ' HD3' ' C' ' 209' ' ' LYS . . . 179.54 -178.3 0.37 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.574 0.75 . . . . 73.03 111.617 -171.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 238' ' ' THR . . . . . 0.506 ' HA ' HE22 ' B' ' 372' ' ' GLN . 94.0 m -152.7 38.46 0.53 Allowed 'General case' 0 N--CA 1.485 1.31 0 CA-C-O 123.722 1.725 . . . . 71.31 106.642 162.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 239' ' ' ALA . . . . . 0.56 ' HB2' ' H ' ' C' ' 222' ' ' ALA . . . -100.31 -178.73 3.91 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.171 -1.377 . . . . 74.42 112.592 -167.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 240' ' ' GLY . . . . . 0.429 ' HA3' ' HA ' ' C' ' 235' ' ' LEU . . . -107.34 -140.08 9.43 Favored Glycine 0 C--N 1.343 0.938 0 CA-C-N 114.589 -1.187 . . . . 71.23 110.629 176.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -133.95 147.93 51.11 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.403 0.681 . . . . 71.23 111.571 -170.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -167.95 -44.21 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.018 1.327 . . . . 70.32 109.193 176.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 243' ' ' GLN . . . . . 0.807 ' HG3' ' HG2' ' C' ' 224' ' ' PRO . 6.7 pt20 -159.45 164.1 34.82 Favored 'General case' 0 C--O 1.245 0.82 0 C-N-CA 123.969 0.908 . . . . 74.22 111.17 177.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -67.1 98.15 0.42 Allowed Glycine 0 C--N 1.355 1.633 0 O-C-N 124.179 0.924 . . . . 71.54 113.567 -169.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 245' ' ' LYS . . . . . 0.488 ' HE2' ' HB3' ' C' ' 222' ' ' ALA . 9.2 tmtm? -75.92 130.55 38.66 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.589 0.756 . . . . 75.34 110.009 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 35.1 p -116.25 139.31 50.49 Favored 'General case' 0 C--O 1.244 0.777 0 C-N-CA 124.095 0.958 . . . . 71.14 109.371 174.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 247' ' ' LEU . . . . . 0.654 HD22 HG22 ' B' ' 236' ' ' THR . 89.3 mt -72.71 158.64 35.21 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.839 0.856 . . . . 72.51 112.425 -175.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 248' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -82.88 145.51 29.4 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.069 0.947 . . . . 75.15 110.268 178.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -125.11 133.97 52.65 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 107.434 -1.321 . . . . 71.33 107.434 175.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -93.91 36.48 1.11 Allowed 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.818 0.847 . . . . 70.14 111.654 -170.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.96 -33.51 70.72 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 123.96 0.904 . . . . 64.21 113.301 -177.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . 0.401 HE22 ' HZ2' ' A' ' 271' ' ' LYS . 50.4 tt0 -113.63 -23.61 9.65 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.682 0.793 . . . . 73.12 111.173 -176.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -64.08 -36.06 82.77 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.047 0.539 . . . . 51.41 110.872 173.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -70.73 87.51 0.69 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.752 0.821 . . . . 72.51 110.085 176.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 255' ' ' GLY . . . . . 0.488 ' HA2' HD12 ' B' ' 277' ' ' LEU . . . 59.04 -97.17 0.08 OUTLIER Glycine 0 C--N 1.353 1.52 0 O-C-N 123.968 0.793 . . . . 63.32 112.568 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 256' ' ' TYR . . . . . . . . . . . . . 23.0 t80 63.03 -73.78 0.04 OUTLIER 'General case' 0 C--N 1.367 1.364 0 C-N-CA 125.667 1.587 . . . . 71.2 110.547 175.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -62.03 -64.46 0.93 Allowed 'General case' 0 C--N 1.35 0.588 0 C-N-CA 124.436 1.095 . . . . 74.31 108.514 169.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 258' ' ' LEU . . . . . . . . . . . . . 2.0 tt 57.35 -81.75 0.02 OUTLIER 'General case' 0 C--N 1.362 1.147 0 C-N-CA 125.775 1.63 . . . . 75.13 110.51 -178.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 45.2 t -90.85 99.32 9.47 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 N-CA-C 108.91 -0.774 . . . . 63.31 108.91 175.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 260' ' ' SER . . . . . . . . . . . . . 56.7 m -138.58 104.32 5.1 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.446 1.098 . . . . 73.11 108.198 176.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 62.3 23.26 13.75 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.59 1.156 . . . . 65.51 111.049 -170.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 262' ' ' ALA . . . . . . . . . . . . . . . -113.49 59.52 0.66 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.897 0.879 . . . . 75.22 109.773 -177.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -68.75 -32.2 71.79 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 115.746 -0.661 . . . . 70.44 110.469 175.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 34.6 t -98.55 161.75 13.5 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.939 0.896 . . . . 51.14 110.03 174.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 265' ' ' LEU . . . . . . . . . . . . . 85.8 mt -93.25 40.21 1.06 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.285 1.034 . . . . 73.31 110.644 -178.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 266' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 70.03 -67.0 0.25 Allowed 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 125.411 1.485 . . . . 71.52 109.999 -173.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 59.6 m -145.63 -57.84 0.32 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.578 1.151 . . . . 73.13 108.224 170.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 12.3 p -176.17 -23.18 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 C-N-CA 124.025 0.93 . . . . 74.44 110.28 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 269' ' ' THR . . . . . . . . . . . . . 12.5 m -66.17 85.05 0.09 Allowed 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.007 0.923 . . . . 74.31 111.822 -174.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 270' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -167.04 173.59 9.09 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.463 1.505 . . . . 72.41 108.749 178.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 271' ' ' ALA . . . . . 0.529 ' HB2' ' HB3' ' B' ' 275' ' ' LYS . . . -109.92 62.36 0.6 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 122.949 0.5 . . . . 75.3 110.688 -176.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 272' ' ' ASN . . . . . 0.492 ' O ' ' HG3' ' B' ' 275' ' ' LYS . 34.3 m-80 61.21 -167.91 0.19 Allowed 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 124.536 1.134 . . . . 73.11 111.398 174.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 5.6 pm0 -66.7 -15.92 63.86 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 122.882 0.473 . . . . 73.43 111.103 170.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -62.17 -35.66 79.48 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.515 1.126 . . . . 71.44 112.728 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 275' ' ' LYS . . . . . 0.529 ' HB3' ' HB2' ' B' ' 271' ' ' ALA . 2.2 pptp? -67.1 130.31 93.79 Favored Pre-proline 0 CA--C 1.555 1.172 0 N-CA-C 112.139 0.422 . . . . 72.14 112.139 -176.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -95.12 178.03 0.79 Allowed 'Trans proline' 0 C--N 1.371 1.739 0 C-N-CA 122.831 2.354 . . . . 73.04 112.297 171.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 277' ' ' LEU . . . . . 0.488 HD12 ' HA2' ' B' ' 255' ' ' GLY . 4.8 tt -107.0 110.33 22.44 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 106.804 -1.554 . . . . 74.52 106.804 174.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -68.13 -28.43 67.31 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.975 0.91 . . . . 72.2 112.386 -172.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . 84.22 17.98 63.64 Favored Glycine 0 N--CA 1.475 1.277 0 N-CA-C 114.401 0.52 . . . . 75.43 114.401 173.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -150.07 -179.65 7.34 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.468 0.707 . . . . 74.31 109.324 174.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -64.98 109.79 2.24 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 108.772 -0.825 . . . . 75.31 108.772 176.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -83.66 31.78 0.47 Allowed 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.568 0.951 . . . . 65.41 113.568 -166.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 283' ' ' ASP . . . . . 0.547 ' HA ' ' HA3' ' B' ' 229' ' ' GLY . 24.2 t70 -157.35 -93.59 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 122.682 0.393 . . . . 72.33 111.108 176.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . 138.68 -89.82 0.2 Allowed Glycine 0 C--N 1.352 1.446 0 N-CA-C 110.999 -0.84 . . . . 72.13 110.999 -170.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -145.94 3.21 0.93 Allowed 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 123.794 0.838 . . . . 73.03 111.984 -176.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 286' ' ' MET . . . . . . . . . . . . . 17.2 tpt -56.12 -57.29 23.23 Favored Pre-proline 0 CA--C 1.572 1.817 0 N-CA-C 115.424 1.638 . . . . 74.22 115.424 -165.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 287' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -92.65 36.63 0.23 Allowed 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 122.336 2.024 . . . . 74.24 111.633 -171.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 288' ' ' VAL . . . . . 0.546 HG11 ' H ' ' B' ' 289' ' ' ARG 0.299 7.3 p 41.96 -86.99 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.56 1.329 0 C-N-CA 126.005 1.722 . . . . 74.32 111.915 -161.783 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 289' ' ' ARG . . . . . 0.546 ' H ' HG11 ' B' ' 288' ' ' VAL . 6.2 tpm_? 55.14 49.49 17.27 Favored 'General case' 0 CA--C 1.56 1.357 0 CA-C-O 122.382 1.087 . . . . 74.32 110.564 -175.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 290' ' ' TRP . . . . . . . . . . . . . 75.7 t90 -64.7 114.59 4.54 Favored 'General case' 0 CA--C 1.552 1.04 0 CA-C-N 114.273 -1.33 . . . . 75.34 111.045 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 291' ' ' LEU . . . . . . . . . . . . . 74.1 mt 50.02 -81.37 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 126.747 2.019 . . . . 73.52 114.505 172.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . -177.0 -90.56 0.08 OUTLIER Glycine 0 C--N 1.338 0.666 0 N-CA-C 110.616 -0.994 . . . . 71.42 110.616 -177.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -64.44 101.27 0.35 Allowed 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.603 2.202 . . . . 75.13 110.802 173.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -72.67 -1.96 18.31 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.03 0.932 . . . . 74.44 112.026 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -148.52 175.15 11.39 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.072 0.949 . . . . 71.35 110.744 174.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 4.6 t -129.83 133.74 47.12 Favored 'General case' 0 C--O 1.243 0.759 0 N-CA-C 107.834 -1.173 . . . . 71.52 107.834 165.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -82.68 -10.95 58.69 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 122.838 0.455 . . . . 75.44 111.762 -174.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 50.5 m-70 63.64 -156.75 0.32 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.017 0.927 . . . . 73.43 110.388 -173.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . 77.11 18.25 78.74 Favored Glycine 0 C--N 1.35 1.315 0 CA-C-O 120.146 -0.252 . . . . 72.35 112.629 -175.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -162.87 -51.33 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.635 0.774 . . . . 72.23 110.271 -175.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 301' ' ' ILE . . . . . . . . . . . . . 37.3 pt -82.54 7.2 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 N-CA-C 112.829 0.678 . . . . 75.13 112.829 -174.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -80.43 74.37 7.3 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.642 0.777 . . . . 74.32 109.377 -174.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 303' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -95.95 136.36 22.23 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 107.629 -1.249 . . . . 74.11 107.629 178.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 304' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -34.1 -37.83 0.12 Allowed 'Trans proline' 0 C--N 1.387 2.579 1 C-N-CA 125.715 4.277 . . . . 75.12 116.946 -170.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -58.52 -54.28 48.87 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.821 0.848 . . . . 72.13 111.974 178.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 23.0 m -93.16 -51.07 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 122.859 0.464 . . . . 72.33 111.129 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 52.9 m 56.75 -90.39 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 125.1 1.36 . . . . 74.23 110.98 -175.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 308' ' ' CYS . . . . . . . . . . . . . 34.3 m -92.99 -31.48 14.87 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.437 0.695 . . . . 74.22 110.23 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 309' ' ' THR . . . . . . . . . . . . 0.254 60.5 m 107.84 -59.1 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.773 0 C-N-CA 128.56 2.744 . . . . 72.2 111.757 -178.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -93.19 51.11 0.4 Allowed 'Trans proline' 0 C--N 1.392 2.818 0 CA-C-N 122.018 1.756 . . . . 64.44 112.794 174.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 311' ' ' ASN . . . . . 0.427 ' HB2' ' HD3' ' B' ' 312' ' ' PRO . 13.7 m120 -74.17 -58.3 2.03 Favored Pre-proline 0 CA--C 1.561 1.387 0 CA-C-O 118.823 -0.608 . . . . 73.13 111.586 177.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 312' ' ' PRO . . . . . 0.427 ' HD3' ' HB2' ' B' ' 311' ' ' ASN . 55.9 Cg_endo -97.86 63.44 0.09 OUTLIER 'Trans proline' 0 C--N 1.388 2.611 0 C-N-CA 122.398 2.065 . . . . 70.14 111.943 -172.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 313' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -70.35 78.14 0.54 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.606 0.763 . . . . 75.13 111.186 -176.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 314' ' ' ARG . . . . . . . . . . . . . 4.6 mpt_? -124.04 69.46 1.06 Allowed 'General case' 0 C--O 1.238 0.491 0 N-CA-C 106.827 -1.546 . . . . 74.53 106.827 174.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 315' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -160.27 92.44 0.99 Allowed 'General case' 0 C--O 1.242 0.662 0 CA-C-N 114.311 -1.313 . . . . 75.34 107.671 176.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 316' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -74.2 -32.22 62.97 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.23 -0.895 . . . . 74.4 109.365 175.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 85.7 p 56.38 -74.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 126.12 1.768 . . . . 75.41 111.847 -173.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 318' ' ' VAL . . . . . 0.433 ' HB ' ' HA ' ' B' ' 93' ' ' PHE . 21.5 m 38.51 58.05 5.32 Favored Pre-proline 0 N--CA 1.493 1.702 0 C-N-CA 126.333 1.853 . . . . 73.13 114.066 175.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 319' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -79.77 148.01 19.77 Favored 'Trans proline' 0 C--N 1.373 1.84 0 C-N-CA 122.02 1.814 . . . . 65.1 112.363 -172.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 320' ' ' THR . . . . . . . . . . . . . 33.8 m -151.56 -62.77 0.18 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.257 1.023 . . . . 73.24 110.071 -176.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 321' ' ' LEU . . . . . 0.584 HD13 ' HB2' ' B' ' 323' ' ' GLN . 0.1 OUTLIER -61.42 -55.58 29.78 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 124.14 0.9 . . . . 74.43 110.478 -168.576 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 322' ' ' ALA . . . . . . . . . . . . . . . 63.04 28.86 16.31 Favored 'General case' 0 CA--C 1.55 0.952 0 O-C-N 124.717 1.26 . . . . 64.54 111.696 175.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 323' ' ' GLN . . . . . 0.584 ' HB2' HD13 ' B' ' 321' ' ' LEU . 28.7 tp60 -66.79 114.67 5.84 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 123.387 0.675 . . . . 74.02 109.798 -177.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 324' ' ' MET . . . . . . . . . . . . . 76.9 mtm -80.99 15.52 1.81 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.609 0.763 . . . . 74.22 113.007 -170.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 325' ' ' THR . . . . . . . . . . . . . 31.7 m 77.1 -43.96 0.45 Allowed 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 126.139 1.776 . . . . 72.33 111.4 177.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 326' ' ' ASP . . . . . 0.425 ' HB2' ' HA3' ' B' ' 43' ' ' GLY . 1.5 m-20 69.63 18.4 7.64 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.736 1.214 . . . . 72.01 112.409 166.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . 0.554 ' HA ' ' HA3' ' B' ' 42' ' ' GLY . 39.9 ttpt -89.41 116.01 27.28 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.49 -0.93 . . . . 75.41 108.49 173.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 328' ' ' ALA . . . . . . . . . . . . . . . -127.42 -9.62 5.74 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.246 0.618 . . . . 72.03 112.541 -172.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 329' ' ' ILE . . . . . . . . . . . . . 3.4 mp -89.41 112.4 24.31 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.177 0 C-N-CA 122.729 0.412 . . . . 73.5 109.985 -169.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 330' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 68.85 135.17 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 127.292 2.237 . . . . 74.44 112.202 178.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 331' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.85 20.45 1.8 Allowed 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.43 1.092 . . . . 64.42 110.918 -172.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -144.79 -164.95 2.04 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.348 0.659 . . . . 74.41 111.806 -172.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 333' ' ' SER . . . . . . . . . . . . . 16.5 t 67.18 12.36 8.9 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 124.503 1.121 . . . . 65.04 113.671 164.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 15.5 ptmt -67.87 -32.29 72.69 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 122.84 0.456 . . . . 65.35 110.985 176.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 335' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 69.1 127.85 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 125.349 1.46 . . . . 74.12 111.374 -175.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 336' ' ' GLU . . . . . 0.813 ' HB2' ' HA ' ' B' ' 118' ' ' PRO . 62.5 mt-10 -130.27 -164.4 1.42 Allowed 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.405 1.082 . . . . 73.55 109.025 172.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 337' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -147.88 131.89 17.22 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 107.756 -1.202 . . . . 71.1 107.756 174.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 338' ' ' GLY . . . . . . . . . . . . . . . -75.07 81.11 0.93 Allowed Glycine 0 C--N 1.347 1.166 0 O-C-N 123.535 0.522 . . . . 73.12 112.6 -178.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 339' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -126.55 23.12 6.88 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 107.618 -1.253 . . . . 74.33 107.618 171.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 340' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -78.32 -0.09 27.52 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.04 -0.982 . . . . 75.24 111.989 -176.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 341' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -78.31 -57.29 3.86 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.183 0.993 . . . . 75.34 109.327 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 342' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 60.14 -132.27 0.87 Allowed 'General case' 0 CA--C 1.566 1.589 0 C-N-CA 124.326 1.05 . . . . 74.32 108.536 -177.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 343' ' ' VAL . . . . . 0.403 HG23 ' HE2' ' B' ' 15' ' ' PHE . 6.7 p -163.97 74.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.677 0 N-CA-C 107.161 -1.422 . . . . 65.15 107.161 173.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -79.25 157.79 27.71 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 114.234 -1.348 . . . . 74.33 109.968 176.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 345' ' ' GLY . . . . . . . . . . . . . . . -163.4 50.67 0.3 Allowed Glycine 0 C--N 1.336 0.565 0 CA-C-N 115.472 -0.786 . . . . 63.14 112.114 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 346' ' ' ALA . . . . . . . . . . . . . . . -159.93 -88.38 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 109.164 -0.68 . . . . 72.51 109.164 175.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 70.3 m 61.01 -80.27 0.02 OUTLIER 'General case' 0 C--N 1.366 1.299 0 C-N-CA 124.541 1.136 . . . . 72.21 111.94 -178.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 348' ' ' ILE . . . . . 0.434 ' O ' ' HG2' ' B' ' 351' ' ' GLN . 2.4 pp -98.2 -6.96 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 123.959 0.904 . . . . 73.42 111.211 178.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 349' ' ' ASP . . . . . . . . . . . . . 29.3 t70 66.74 -82.36 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.632 1.573 . . . . 71.13 109.642 -174.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 350' ' ' LYS . . . . . . . . . . . . . 8.4 mptt -135.45 -76.46 0.44 Allowed 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.496 -0.927 . . . . 74.52 108.496 167.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 351' ' ' GLN . . . . . 0.434 ' HG2' ' O ' ' B' ' 348' ' ' ILE . 67.1 mm-40 59.73 176.36 0.08 Allowed 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 125.797 1.639 . . . . 71.32 112.843 -175.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -82.43 -28.23 31.46 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.676 -0.693 . . . . 74.35 109.521 175.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 353' ' ' HIS . . . . . . . . . . . . . 13.0 p80 52.54 12.67 0.26 Allowed 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 127.433 2.293 . . . . 74.33 114.706 174.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 354' ' ' ALA . . . . . 0.458 ' HB2' ' HA3' ' B' ' 162' ' ' GLY . . . -96.42 43.52 1.08 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.574 0.75 . . . . 72.23 110.594 -176.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 355' ' ' ALA . . . . . . . . . . . . . . . -66.34 99.96 0.59 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.543 0.737 . . . . 75.44 110.179 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 356' ' ' ASN . . . . . 0.471 ' HB2' ' H ' ' B' ' 162' ' ' GLY . 0.2 OUTLIER -85.14 113.38 49.88 Favored Pre-proline 0 N--CA 1.479 0.994 0 C-N-CA 124.164 0.986 . . . . 74.32 109.951 -171.958 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 357' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -83.73 149.55 12.67 Favored 'Trans proline' 0 C--N 1.373 1.852 0 C-N-CA 123.134 2.556 . . . . 74.21 111.107 173.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 358' ' ' CYS . . . . . . . . . . . . . 86.1 m -138.05 21.97 2.82 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.903 0.881 . . . . 75.21 109.554 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 359' ' ' GLY . . . . . . . . . . . . . . . -73.81 127.79 10.64 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 115.237 -0.892 . . . . 72.04 113.461 -174.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 360' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -143.36 52.67 1.35 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.96 0.904 . . . . 53.34 110.479 -171.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 361' ' ' ILE . . . . . . . . . . . . . 51.4 mt 68.23 -79.09 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 125.24 1.416 . . . . 64.41 110.568 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 362' ' ' GLY . . . . . . . . . . . . . . . 118.4 -43.55 1.58 Allowed Glycine 0 C--N 1.346 1.117 0 N-CA-C 111.605 -0.598 . . . . 72.35 111.605 -176.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 363' ' ' GLU . . . . . 0.615 ' HG2' ' HA ' ' B' ' 201' ' ' PRO . 1.7 mp0 -86.84 -8.66 57.1 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.634 0.774 . . . . 73.13 111.245 179.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 364' ' ' THR . . . . . 0.521 HG21 ' HA3' ' B' ' 209' ' ' GLY . 72.9 m 74.81 -63.44 0.42 Allowed 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.754 1.622 . . . . 74.04 110.955 -173.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 39.5 t 66.02 160.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 C-N-CA 124.401 1.08 . . . . 74.51 110.804 -178.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -52.04 130.45 29.9 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.404 0.682 . . . . 52.52 111.995 178.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 367' ' ' LEU . . . . . . . . . . . . . 8.2 mp -60.73 -32.89 72.13 Favored 'General case' 0 C--N 1.352 0.693 0 O-C-N 124.404 1.065 . . . . 75.05 110.449 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 368' ' ' ASP . . . . . . . . . . . . . 32.5 t70 69.38 -66.54 0.25 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.747 1.619 . . . . 73.23 111.718 173.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 369' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 74.0 117.32 0.05 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.487 1.515 . . . . 74.11 111.861 169.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 370' ' ' ALA . . . . . 0.504 ' HB1' ' NE2' ' B' ' 372' ' ' GLN . . . -92.27 -179.31 5.2 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.755 0.822 . . . . 74.25 111.347 -176.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 371' ' ' VAL . . . . . . . . . . . . . 85.5 t -74.19 -30.46 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.029 0.932 . . . . 74.12 111.187 -178.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 372' ' ' GLN . . . . . 0.506 HE22 ' HA ' ' B' ' 238' ' ' THR . 51.0 mm-40 64.24 83.45 0.16 Allowed 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 125.092 1.357 . . . . 63.2 111.122 179.036 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 373' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -95.35 68.14 3.0 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.424 -0.807 . . . . 72.2 109.486 -176.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 374' ' ' ALA . . . . . 0.481 ' HA ' ' HD2' ' B' ' 377' ' ' PHE . . . -151.92 13.89 0.62 Allowed 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 115.068 -0.969 . . . . 71.45 111.383 -177.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 375' ' ' LEU . . . . . . . . . . . . . 76.6 mt -81.74 -12.59 58.53 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.208 0.603 . . . . 72.22 111.646 -175.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -111.93 -31.15 7.01 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.272 1.029 . . . . 73.13 110.386 178.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 377' ' ' PHE . . . . . 0.481 ' HD2' ' HA ' ' B' ' 374' ' ' ALA . 71.7 m-85 -72.18 92.29 1.35 Allowed 'General case' 0 C--N 1.352 0.687 0 C-N-CA 123.341 0.656 . . . . 73.31 109.787 -178.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 378' ' ' ALA . . . . . . . . . . . . . . . -107.12 -83.64 0.53 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.485 0.714 . . . . 73.45 110.65 -177.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 40.8 mtmt 56.25 72.92 0.47 Allowed 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.728 0.811 . . . . 73.22 109.461 -172.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 380' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 66.21 -173.02 0.19 Allowed 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 124.682 1.193 . . . . 72.4 110.655 -170.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 381' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -165.0 -46.43 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.321 0.649 . . . . 74.34 110.248 -177.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -176.97 93.35 0.09 OUTLIER Glycine 0 C--N 1.346 1.115 0 CA-C-N 116.041 -0.527 . . . . 73.1 112.09 -172.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 383' ' ' ASN . . . . . . . . . . . . . 25.5 p30 -164.88 -10.44 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 112.849 0.685 . . . . 73.1 112.849 -172.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 384' ' ' THR . . . . . . . . . . . . . 6.5 t -97.93 108.56 21.29 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.435 0.636 . . . . 71.44 112.316 -174.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 68.3 mt -88.31 59.34 5.18 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 109.411 -0.589 . . . . 75.43 109.411 171.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 386' ' ' VAL . . . . . . . . . . . . . 98.0 t 70.67 -67.1 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 125.855 1.662 . . . . 75.23 111.929 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 387' ' ' ILE . . . . . . . . . . . . . 8.7 tp -57.91 -29.42 35.8 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.165 0 C-N-CA 125.078 1.351 . . . . 74.12 113.338 -172.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 388' ' ' VAL . . . . . . . . . . . . . 58.1 t -62.9 -48.57 87.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 123.09 0.556 . . . . 74.43 110.965 -177.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 389' ' ' THR . . . . . . . . . . . . . 29.8 p -84.59 -24.37 29.22 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 122.626 0.37 . . . . 71.25 111.182 174.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . 58.99 32.17 22.03 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 124.991 1.317 . . . . 73.41 112.137 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 391' ' ' ASP . . . . . . . . . . . . . 16.9 t70 67.6 -76.69 0.05 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 125.01 1.324 . . . . 64.12 111.112 -176.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 392' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -138.22 177.14 8.1 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.774 0.83 . . . . 72.42 109.185 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . 64.15 15.86 9.62 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 124.345 1.058 . . . . 61.53 112.56 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -164.59 -34.21 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.045 0.938 . . . . 73.31 109.838 -176.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . -65.03 165.46 10.99 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.888 0.875 . . . . 75.42 112.105 176.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 28.8 m -59.94 -32.61 70.95 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.384 0.674 . . . . 75.55 111.231 174.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 397' ' ' GLN . . . . . 0.476 HE22 ' HB3' ' B' ' 145' ' ' ASP . 0.4 OUTLIER -95.28 108.96 21.14 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 108.628 -0.878 . . . . 75.54 108.628 177.179 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 59.3 mt -136.96 -75.24 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 N-CA-C 106.973 -1.491 . . . . 75.44 106.973 171.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 399' ' ' VAL . . . . . . . . . . . . . 27.5 m -102.2 -178.85 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.322 1.049 . . . . 73.32 110.28 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 400' ' ' ALA . . . . . . . . . . . . . . . -70.04 -40.82 13.45 Favored Pre-proline 0 CA--C 1.56 1.35 0 C-N-CA 123.021 0.529 . . . . 74.52 112.386 178.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 401' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -74.61 39.55 0.57 Allowed 'Trans proline' 0 C--N 1.384 2.431 0 C-N-CA 122.234 1.956 . . . . 71.34 113.713 160.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 69.25 -80.06 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 126.14 1.776 . . . . 74.34 112.585 173.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 403' ' ' THR . . . . . . . . . . . . . 40.9 p -122.2 -176.92 3.47 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.111 0.564 . . . . 73.2 111.814 -173.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 404' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.88 142.62 42.77 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.484 1.114 . . . . 71.14 109.101 173.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 405' ' ' ALA . . . . . . . . . . . . . . . -72.99 -50.62 6.68 Favored Pre-proline 0 CA--C 1.557 1.228 0 CA-C-O 118.466 -0.778 . . . . 71.24 112.481 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 406' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -75.04 100.08 1.32 Allowed 'Trans proline' 0 C--N 1.39 2.76 0 CA-C-N 120.925 1.366 . . . . 64.23 111.166 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . -55.26 -87.82 0.01 OUTLIER Glycine 0 C--N 1.352 1.444 0 O-C-N 124.036 0.835 . . . . 74.04 113.995 -172.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 408' ' ' LEU . . . . . . . . . . . . . 21.7 tp -171.81 159.31 5.18 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.352 0.661 . . . . 72.55 109.642 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 16.6 p -64.67 -53.85 41.03 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.133 0.973 . . . . 73.52 111.134 174.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 410' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -139.11 108.01 5.98 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-O 121.456 0.646 . . . . 70.42 109.685 174.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . -94.94 -54.28 3.52 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.42 0.688 . . . . 74.33 110.135 178.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 95.2 mt 63.81 -77.85 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.451 1.5 . . . . 75.21 110.989 -177.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 42.1 t-20 48.52 75.23 0.15 Allowed 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 125.42 1.488 . . . . 71.14 111.863 175.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 414' ' ' THR . . . . . . . . . . . . . 45.4 m -84.76 78.14 9.93 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 109.443 -0.577 . . . . 73.24 109.443 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 415' ' ' LYS . . . . . . . . . . . . . 58.1 mttp 58.04 46.39 16.4 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.562 1.145 . . . . 75.21 111.136 -178.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 21.7 t70 72.04 -74.72 0.08 Allowed 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 125.058 1.343 . . . . 75.33 111.664 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 417' ' ' GLY . . . . . . . . . . . . . . . 163.94 -42.07 0.32 Allowed Glycine 0 C--N 1.339 0.745 0 N-CA-C 110.666 -0.974 . . . . 62.31 110.666 -176.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 418' ' ' ALA . . . . . . . . . . . . . . . -72.02 127.37 32.34 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.428 0.691 . . . . 70.25 109.437 173.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 419' ' ' VAL . . . . . . . . . . . . . 14.1 m 48.52 34.18 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 C-N-CA 126.02 1.728 . . . . 73.31 112.951 -178.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 420' ' ' MET . . . . . 0.402 ' SD ' ' N ' ' B' ' 421' ' ' VAL . 0.0 OUTLIER -58.19 -37.76 75.4 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.725 0.81 . . . . 73.34 111.699 -179.055 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 421' ' ' VAL . . . . . 0.607 HG13 ' HG2' ' A' ' 211' ' ' ARG . 3.9 p -90.23 74.65 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 CA-C-O 122.717 1.246 . . . . 72.42 108.463 168.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 422' ' ' MET . . . . . . . . . . . . . 17.8 ptp -80.15 -18.44 49.74 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 114.469 -1.241 . . . . 74.1 110.294 174.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 423' ' ' SER . . . . . . . . . . . . . 37.3 m 74.08 -60.63 0.52 Allowed 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 126.433 1.893 . . . . 63.45 113.237 170.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 424' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 59.03 34.65 23.63 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.066 0.946 . . . . 74.22 110.14 -172.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . 99.05 -64.03 0.72 Allowed Glycine 0 C--N 1.349 1.277 0 CA-C-N 114.23 -1.35 . . . . 75.12 110.862 -172.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 426' ' ' ASN . . . . . . . . . . . . . 6.5 t30 63.81 -67.51 0.1 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 126.259 1.824 . . . . 75.43 111.251 -174.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 427' ' ' SER . . . . . 0.524 ' HB2' ' HB3' ' B' ' 432' ' ' GLN . 20.0 m -90.4 138.85 31.21 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 108.905 -0.776 . . . . 75.14 108.905 171.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -88.14 11.53 16.03 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.163 0.585 . . . . 73.23 112.064 -164.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 429' ' ' GLU . . . . . 0.546 ' HB2' ' HB2' ' B' ' 432' ' ' GLN . 11.2 mp0 -95.38 33.22 1.62 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.596 0.758 . . . . 63.42 110.173 178.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 31.9 t70 58.61 93.62 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.848 1.259 . . . . 62.42 110.763 -176.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 44.8 t 66.36 -73.28 0.07 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.963 1.305 . . . . 75.05 110.099 -172.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 432' ' ' GLN . . . . . 0.546 ' HB2' ' HB2' ' B' ' 429' ' ' GLU . 52.7 tp60 73.01 -65.29 0.36 Allowed 'General case' 0 C--N 1.361 1.088 0 C-N-CA 125.866 1.666 . . . . 71.1 111.583 175.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 433' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -73.45 72.61 1.36 Allowed 'General case' 0 C--O 1.242 0.702 0 N-CA-C 108.345 -0.983 . . . . 73.43 108.345 174.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 434' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -82.55 93.8 7.36 Favored 'General case' 0 C--N 1.345 0.382 0 CA-C-N 114.751 -1.113 . . . . 73.42 108.292 -168.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 435' ' ' THR . . . . . 0.411 ' HB ' ' HG3' ' A' ' 220' ' ' GLU . 0.6 OUTLIER -69.56 -10.63 58.96 Favored 'General case' 0 CA--C 1.557 1.244 0 CA-C-N 114.999 -1.0 . . . . 73.42 112.56 -163.595 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . 176.5 -112.18 0.38 Allowed Glycine 0 C--N 1.353 1.525 0 CA-C-O 119.5 -0.611 . . . . 61.51 112.56 175.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 437' ' ' SER . . . . . 0.48 ' N ' ' HB2' ' A' ' 220' ' ' GLU . 16.4 t 84.33 -13.02 0.74 Allowed 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 126.69 1.996 . . . . 72.35 112.141 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 438' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -65.58 -28.81 69.41 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.103 0.561 . . . . 71.55 109.766 169.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 439' ' ' LEU . . . . . . . . . . . . . 4.9 mp -76.68 96.19 4.14 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.151 0.98 . . . . 74.24 109.323 175.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 440' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -90.28 161.41 15.67 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.509 0.724 . . . . 74.1 110.614 176.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 441' ' ' ILE . . . . . 0.737 HD13 ' HA ' ' A' ' 223' ' ' VAL . 44.7 mt -120.66 135.04 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 123.542 0.737 . . . . 74.15 110.564 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 442' ' ' ALA . . . . . . . . . . . . . . . -88.33 -87.08 0.16 Allowed 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 109.542 -0.54 . . . . 73.33 109.542 173.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . 55.99 -86.33 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.239 0 C-N-CA 125.232 1.413 . . . . 74.21 112.801 177.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -170.58 167.31 8.02 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.68 1.592 . . . . 71.31 107.871 178.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . 139.53 -64.33 0.54 Allowed Glycine 0 N--CA 1.469 0.839 0 N-CA-C 111.494 -0.642 . . . . 74.34 111.494 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 446' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -63.14 101.02 0.27 Allowed 'Trans proline' 0 C--N 1.382 2.342 0 C-N-CA 122.345 2.03 . . . . 72.44 108.874 166.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 447' ' ' HIS . . . . . 0.504 ' HB3' ' HA2' ' B' ' 469' ' ' GLY . 12.4 t60 -85.04 -23.97 28.36 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 115.639 -0.71 . . . . 63.45 110.227 -173.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . -156.56 26.86 0.34 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.986 0.914 . . . . 74.31 110.224 174.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 449' ' ' ALA . . . . . 0.465 ' HB2' ' HB2' ' B' ' 468' ' ' LEU . . . -120.93 21.29 11.42 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.305 0.642 . . . . 74.42 111.497 -175.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 450' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -78.44 89.08 4.41 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.477 0.711 . . . . 63.22 110.065 -174.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 27.2 m 41.28 81.4 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 C-N-CA 126.227 1.811 . . . . 74.44 113.164 -178.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 452' ' ' VAL . . . . . . . . . . . . . 34.9 m -80.14 5.66 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 CA-C-N 115.582 -0.736 . . . . 74.24 112.454 -176.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 67.61 47.62 61.01 Favored Glycine 0 C--N 1.352 1.45 0 N-CA-C 111.289 -0.724 . . . . 73.44 111.289 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 454' ' ' LEU . . . . . . . . . . . . . 32.1 tp -69.87 -6.62 33.92 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 124.444 1.098 . . . . 73.13 112.714 -170.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 6.1 m 65.45 30.92 10.61 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 122.548 1.166 . . . . 72.1 108.782 -171.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -91.16 174.95 7.13 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 114.417 -1.265 . . . . 74.3 110.966 -175.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 457' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -157.62 -79.77 0.07 Allowed 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.83 -0.623 . . . . 65.21 110.096 179.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 9.1 p -149.85 -48.95 0.14 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.212 0.605 . . . . 72.13 111.416 -170.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 459' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -80.74 -130.22 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 124.561 1.144 . . . . 73.31 112.19 -167.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 6.7 mp -68.44 85.02 0.27 Allowed 'General case' 0 C--N 1.366 1.293 0 CA-C-N 119.044 0.838 . . . . 65.42 110.22 -177.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -147.12 22.94 1.2 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.462 1.505 . . . . 75.0 108.945 177.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 21.9 t80 -69.49 90.35 0.54 Allowed 'General case' 0 C--N 1.359 1.006 0 C-N-CA 123.836 0.854 . . . . 72.53 109.916 -175.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 37.6 p -106.97 89.13 2.91 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.749 0.82 . . . . 71.14 109.569 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 464' ' ' MET . . . . . . . . . . . . . 48.3 ttp -72.22 -60.0 2.45 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.52 -0.919 . . . . 75.31 108.52 173.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt 56.6 -83.43 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 125.955 1.702 . . . . 72.15 112.23 173.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -162.63 173.9 13.3 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.146 1.378 . . . . 65.13 109.398 -177.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . -83.03 99.25 9.73 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 109.502 -0.555 . . . . 75.3 109.502 175.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 468' ' ' LEU . . . . . 0.465 ' HB2' ' HB2' ' B' ' 449' ' ' ALA . 3.4 mm? -66.27 100.33 0.62 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.229 0.612 . . . . 74.32 109.933 177.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 469' ' ' GLY . . . . . 0.504 ' HA2' ' HB3' ' B' ' 447' ' ' HIS . . . -157.1 61.41 0.33 Allowed Glycine 0 C--N 1.34 0.796 0 N-CA-C 110.913 -0.875 . . . . 62.03 110.913 -178.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 470' ' ' LEU . . . . . . . . . . . . . 5.7 mp -80.81 69.52 7.38 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 123.779 0.832 . . . . 75.32 110.619 -174.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 471' ' ' LYS . . . . . . . . . . . . . 88.2 tttt . . . . . 0 CA--C 1.556 1.179 0 C-N-CA 125.152 1.381 . . . . 74.2 107.947 177.335 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 73.1 mtm . . . . . 0 N--CA 1.474 0.736 0 N-CA-C 109.29 -0.633 . . . . 70.43 109.29 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 60.28 33.55 20.91 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.316 1.047 . . . . 70.41 111.442 -175.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -88.5 51.44 2.18 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.055 0.942 . . . . 71.34 110.542 -175.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -38.3 110.38 0.13 Allowed 'General case' 0 C--N 1.363 1.183 0 C-N-CA 125.362 1.465 . . . . 70.52 114.698 -172.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 5' ' ' LYS . . . . . 0.694 ' HD2' HD11 ' C' ' 10' ' ' ILE . 23.2 mmtp -82.57 99.81 9.75 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 115.479 -0.782 . . . . 72.32 109.822 170.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -75.04 89.58 2.44 Favored 'General case' 0 C--O 1.246 0.875 0 N-CA-C 107.092 -1.447 . . . . 65.15 107.092 169.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 7' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -61.1 -28.36 69.03 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 114.917 -1.038 . . . . 73.43 112.145 -170.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 8' ' ' TYR . . . . . 0.424 ' HD1' HG23 ' C' ' 13' ' ' VAL . 64.1 m-85 -72.62 -41.44 65.54 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.356 0.662 . . . . 74.23 111.548 177.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.84 -43.05 99.62 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 123.386 0.429 . . . . 63.34 110.497 175.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 10' ' ' ILE . . . . . 0.694 HD11 ' HD2' ' C' ' 5' ' ' LYS . 73.1 mt -59.06 -44.55 91.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 O-C-N 123.956 0.785 . . . . 73.31 110.619 176.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 85.1 mt -78.69 -3.33 43.58 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 112.896 0.702 . . . . 75.53 112.896 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 61.29 39.79 97.71 Favored Glycine 0 C--N 1.356 1.655 0 O-C-N 123.302 0.376 . . . . 74.43 113.438 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 13' ' ' VAL . . . . . 0.424 HG23 ' HD1' ' C' ' 8' ' ' TYR . 11.8 m -135.69 158.49 74.09 Favored Pre-proline 0 N--CA 1.48 1.057 0 C-N-CA 125.084 1.354 . . . . 71.34 109.075 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.29 163.66 38.38 Favored 'Trans proline' 0 C--N 1.377 2.071 0 C-N-CA 122.125 1.884 . . . . 74.43 112.49 178.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 58.1 mtt180 -77.81 21.96 0.29 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.004 0.921 . . . . 74.35 111.876 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -117.33 -14.16 10.41 Favored 'General case' 0 C--O 1.243 0.749 0 C-N-CA 125.951 1.7 . . . . 71.24 108.37 178.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.15 114.97 1.34 Allowed 'General case' 0 C--N 1.356 0.879 0 C-N-CA 124.214 1.006 . . . . 75.2 110.538 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 54.4 p -74.21 167.02 22.43 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.596 0.758 . . . . 74.41 109.092 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.91 -40.68 57.44 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 124.014 0.926 . . . . 74.45 111.187 -173.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 20' ' ' GLU . . . . . 0.651 ' HA ' ' HE3' ' C' ' 23' ' ' LYS . 3.7 tm-20 -66.04 -40.79 91.27 Favored 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 124.467 1.107 . . . . 74.53 110.685 -178.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . 0.51 ' HG2' ' NH2' ' C' ' 24' ' ' ARG . 32.7 mt-10 -72.26 -34.44 68.24 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 115.651 -0.704 . . . . 73.42 111.258 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 22' ' ' ILE . . . . . 0.855 HD11 ' HB3' ' C' ' 57' ' ' LEU . 96.1 mt -68.61 -38.98 79.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 124.785 1.234 . . . . 75.54 110.16 176.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 23' ' ' LYS . . . . . 0.651 ' HE3' ' HA ' ' C' ' 20' ' ' GLU . 22.2 ttpp -62.98 -35.88 81.64 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 113.896 -1.502 . . . . 74.13 110.063 177.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 24' ' ' ARG . . . . . 0.51 ' NH2' ' HG2' ' C' ' 21' ' ' GLU . 45.6 mtm180 -77.35 -30.07 53.68 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 113.235 0.828 . . . . 73.52 113.235 173.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.03 -37.38 86.97 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 121.617 0.723 . . . . 75.32 109.918 171.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 26' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -68.52 -41.93 79.24 Favored 'General case' 0 C--O 1.209 -1.051 0 CA-C-N 113.869 -1.514 . . . . 72.31 110.474 175.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . 0.539 ' HG2' ' HA ' ' B' ' 37' ' ' ASP . 27.5 mtpp -50.89 -56.23 13.29 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 118.369 0.531 . . . . 75.33 110.385 173.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -55.61 -58.88 5.95 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 114.944 -1.026 . . . . 75.55 112.138 -177.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 87.1 mt -83.21 -21.28 33.48 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 112.894 0.702 . . . . 71.43 112.894 -169.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' C' ' 34' ' ' HIS . . . -78.97 -30.54 44.5 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 118.809 0.732 . . . . 75.32 110.406 176.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 65.1 mtm180 -73.59 -45.54 52.6 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 109.997 -0.371 . . . . 73.5 109.997 170.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.63 -46.61 84.89 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.617 0.767 . . . . 71.12 111.023 -174.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 33' ' ' TYR . . . . . 0.516 ' HD1' ' HB1' ' C' ' 43' ' ' ALA . 52.7 m-85 -90.76 4.72 50.84 Favored 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 123.466 0.706 . . . . 72.14 112.071 -178.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 34' ' ' HIS . . . . . 0.474 ' HB2' ' O ' ' C' ' 30' ' ' ALA . 41.8 t60 -60.64 113.35 7.4 Favored Pre-proline 0 N--CA 1.49 1.551 0 CA-C-O 118.206 -0.902 . . . . 74.34 110.959 -177.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -48.47 -36.65 31.61 Favored 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 124.283 3.322 . . . . 72.22 115.287 -171.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -69.99 -41.35 74.52 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 122.688 0.395 . . . . 60.34 111.324 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 45.3 t -85.03 -28.71 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-O 121.036 0.446 . . . . 75.33 110.123 -175.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -139.0 80.22 1.77 Allowed 'General case' 0 C--O 1.248 0.981 0 C-N-CA 124.204 1.002 . . . . 65.41 108.83 -174.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -70.31 84.8 0.57 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 114.778 -1.101 . . . . 71.22 109.402 176.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 40' ' ' SER . . . . . 0.523 ' HB2' ' HB2' ' C' ' 43' ' ' ALA . 16.4 m -138.68 103.75 7.65 Favored Pre-proline 0 CA--C 1.542 0.655 0 CA-C-O 117.836 -1.078 . . . . 74.14 108.117 175.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' C' ' 40' ' ' SER . 5.3 Cg_exo -37.33 -54.23 1.19 Allowed 'Trans proline' 0 C--N 1.393 2.874 0 C-N-CA 124.702 3.601 . . . . 75.0 114.183 -176.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.56 -36.49 83.96 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.973 0.509 . . . . 71.01 110.698 -177.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 43' ' ' ALA . . . . . 0.523 ' HB2' ' HB2' ' C' ' 40' ' ' SER . . . -75.17 -17.51 60.37 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.168 0.587 . . . . 71.45 111.313 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -86.2 -31.93 21.48 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.333 0.653 . . . . 74.04 109.491 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -70.1 -41.74 73.63 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.57 -0.741 . . . . 75.44 109.502 170.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 46' ' ' LYS . . . . . 0.531 ' O ' HG12 ' C' ' 50' ' ' ILE . 33.6 mmtm -63.32 -36.3 83.24 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-N 115.201 -0.908 . . . . 72.32 110.468 173.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -57.2 -49.0 77.38 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.604 0.762 . . . . 71.12 109.337 174.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 48' ' ' LYS . . . . . 0.553 ' HB3' ' HE1' ' C' ' 93' ' ' PHE . 52.0 mtpt -57.87 -38.23 75.36 Favored 'General case' 0 CA--C 1.551 1.009 0 O-C-N 123.762 0.663 . . . . 72.04 111.631 175.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -76.31 -19.39 58.29 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.203 0.601 . . . . 72.33 112.267 178.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 50' ' ' ILE . . . . . 0.531 HG12 ' O ' ' C' ' 46' ' ' LYS . 28.4 mm -76.0 -38.96 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 108.474 -0.936 . . . . 75.43 108.474 171.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 51' ' ' ASN . . . . . 0.472 ' HB3' ' CD1' ' C' ' 88' ' ' PHE . 55.7 m-80 -68.42 -30.76 69.73 Favored 'General case' 0 C--O 1.217 -0.645 0 CA-C-N 114.474 -1.239 . . . . 74.04 110.736 176.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -68.51 -55.15 12.69 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.845 1.258 . . . . 75.54 110.528 175.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.26 -50.41 69.55 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 114.035 -1.438 . . . . 63.1 111.162 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -63.56 -39.41 94.33 Favored 'General case' 0 C--O 1.198 -1.638 0 CA-C-N 115.023 -0.99 . . . . 75.01 110.775 176.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 55' ' ' ALA . . . . . 0.424 ' HB3' ' CD2' ' C' ' 88' ' ' PHE . . . -56.31 -45.04 80.43 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 118.531 0.605 . . . . 60.54 112.255 -178.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 56' ' ' VAL . . . . . 0.425 ' O ' ' HB2' ' C' ' 62' ' ' LYS . 96.1 t -65.7 -46.42 89.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 CA-C-O 121.752 0.786 . . . . 72.43 109.826 173.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 57' ' ' LEU . . . . . 0.855 ' HB3' HD11 ' C' ' 22' ' ' ILE . 81.6 mt -92.37 9.54 33.7 Favored 'General case' 0 CA--C 1.56 1.344 0 N-CA-C 113.365 0.876 . . . . 75.02 113.365 -169.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 21.9 t -86.16 -24.15 26.27 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.54 0.736 . . . . 75.33 110.491 179.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -101.61 131.54 22.82 Favored Pre-proline 0 C--O 1.241 0.633 0 N-CA-C 108.336 -0.987 . . . . 72.03 108.336 174.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 60' ' ' PRO . . . . . 0.488 ' O ' ' HG2' ' C' ' 64' ' ' ARG . 73.7 Cg_exo -53.48 -32.51 63.39 Favored 'Trans proline' 0 C--N 1.375 1.934 0 C-N-CA 122.833 2.356 . . . . 73.21 111.444 164.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -68.09 -49.44 61.26 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.078 0.951 . . . . 62.13 111.561 -177.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 62' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' C' ' 56' ' ' VAL . 62.1 mttp -73.27 -23.98 60.38 Favored 'General case' 0 CA--C 1.559 1.302 0 C-N-CA 122.386 0.274 . . . . 75.43 110.751 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 -61.38 -43.3 99.1 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 109.39 -0.596 . . . . 74.14 109.39 167.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 64' ' ' ARG . . . . . 0.488 ' HG2' ' O ' ' C' ' 60' ' ' PRO . 28.5 mmm180 -68.72 -32.07 71.6 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 119.272 -0.394 . . . . 74.15 111.56 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 65' ' ' ILE . . . . . 0.437 HG21 ' HD2' ' C' ' 76' ' ' PRO . 80.1 mt -62.29 -42.19 94.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 N-CA-C 109.716 -0.475 . . . . 71.5 109.716 171.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -63.25 -44.86 93.99 Favored 'General case' 0 CA--C 1.553 1.079 0 CA-C-N 115.573 -0.739 . . . . 74.31 109.756 176.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -58.11 -42.13 85.06 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.184 0.994 . . . . 73.14 111.064 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 68' ' ' THR . . . . . 0.405 ' OG1' ' HG2' ' C' ' 76' ' ' PRO . 39.9 p -83.93 -10.31 58.05 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.602 -0.726 . . . . 74.43 112.013 -178.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -71.81 96.7 1.68 Allowed 'General case' 0 C--N 1.36 1.037 0 N-CA-C 108.197 -1.038 . . . . 75.22 108.197 171.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 104.34 30.98 4.81 Favored Glycine 0 C--N 1.346 1.104 0 CA-C-N 116.075 -0.511 . . . . 62.51 111.94 -173.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 84.9 m -146.78 -54.16 0.24 Allowed 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 103.877 -2.638 . . . . 72.34 103.877 174.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 24.7 m -86.24 141.71 29.09 Favored 'General case' 0 C--O 1.256 1.406 0 N-CA-C 104.811 -2.292 . . . . 73.35 104.811 157.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.15 -27.62 20.58 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 123.752 0.821 . . . . 73.23 111.612 -177.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -97.24 155.77 37.03 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 123.911 0.884 . . . . 53.23 109.806 176.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_exo -60.12 114.74 2.23 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 122.65 2.234 . . . . 75.14 111.079 168.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 76' ' ' PRO . . . . . 0.437 ' HD2' HG21 ' C' ' 65' ' ' ILE . 50.0 Cg_exo -55.97 122.74 12.3 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 123.091 2.527 . . . . 71.22 111.596 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -43.63 139.85 4.74 Favored 'Trans proline' 0 C--N 1.39 2.725 0 C-N-CA 124.31 3.34 . . . . 74.4 114.849 -166.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 78' ' ' PRO . . . . . 0.501 ' HB2' ' HA2' ' C' ' 82' ' ' GLY . 25.9 Cg_endo -58.86 145.25 97.42 Favored 'Trans proline' 0 C--N 1.387 2.564 0 C-N-CA 123.483 2.788 . . . . 74.44 113.743 -172.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 79' ' ' PRO . . . . . 0.582 ' HB2' ' HA2' ' C' ' 142' ' ' GLY . 51.0 Cg_exo -55.93 163.24 6.03 Favored 'Trans proline' 0 C--N 1.385 2.458 0 C-N-CA 123.559 2.84 . . . . 70.12 112.923 176.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -55.12 87.07 0.04 OUTLIER 'Trans proline' 0 C--N 1.392 2.832 0 C-N-CA 123.569 2.846 . . . . 74.31 112.855 -177.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 145.65 -52.19 0.58 Allowed Glycine 0 C--N 1.339 0.742 0 CA-C-N 113.829 -1.532 . . . . 75.2 109.443 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . 0.501 ' HA2' ' HB2' ' C' ' 78' ' ' PRO . . . 144.34 -170.84 25.95 Favored Glycine 0 C--N 1.344 0.998 0 C-N-CA 123.526 0.584 . . . . 75.13 111.653 -177.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -86.93 104.18 16.01 Favored 'General case' 0 C--O 1.244 0.806 0 C-N-CA 123.653 0.781 . . . . 73.4 109.273 171.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -86.55 -176.21 5.75 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.384 -0.598 . . . . 75.11 109.384 170.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 85' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -161.1 70.98 0.39 Allowed 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 107.507 -1.294 . . . . 74.41 107.507 177.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 55.0 m -36.78 95.18 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 117.875 2.546 . . . . 52.42 117.875 -164.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 75.55 6.68 81.65 Favored Glycine 0 C--N 1.355 1.608 0 C-N-CA 123.044 0.354 . . . . 74.34 113.292 174.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 88' ' ' PHE . . . . . 0.472 ' CD1' ' HB3' ' C' ' 51' ' ' ASN . 11.9 m-85 -105.59 131.13 53.35 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 107.489 -1.3 . . . . 74.44 107.489 -177.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -80.99 81.97 7.09 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 120.966 0.412 . . . . 72.23 111.337 -170.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 90' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -43.58 -36.14 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 C-N-CA 125.405 1.482 . . . . 54.42 112.74 171.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -62.66 -20.09 64.47 Favored 'General case' 0 CA--C 1.561 1.394 0 C-N-CA 124.352 1.061 . . . . 75.25 112.884 -175.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -119.82 7.37 10.97 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 122.865 0.466 . . . . 75.53 111.008 178.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 93' ' ' PHE . . . . . 0.553 ' HE1' ' HB3' ' C' ' 48' ' ' LYS . 13.9 m-30 -83.9 -174.28 5.19 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.129 -0.982 . . . . 72.45 112.114 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 97.6 p -71.3 161.8 30.48 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.839 1.052 . . . . 52.11 113.839 -167.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 95' ' ' GLU . . . . . 0.401 ' O ' ' HG3' ' C' ' 99' ' ' GLU . 42.9 mt-10 -59.44 -56.34 23.25 Favored 'General case' 0 C--O 1.215 -0.745 0 CA-C-N 114.249 -1.342 . . . . 72.35 110.837 174.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -51.03 -46.56 61.63 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 124.169 0.918 . . . . 74.24 111.867 -174.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 97' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -58.98 -53.44 58.39 Favored 'General case' 0 CA--C 1.554 1.13 0 CA-C-N 115.406 -0.816 . . . . 64.25 110.158 174.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -74.18 0.84 12.75 Favored 'General case' 0 CA--C 1.56 1.339 0 N-CA-C 112.611 0.597 . . . . 71.33 112.611 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' C' ' 95' ' ' GLU . 50.1 mt-10 -98.27 -50.74 4.23 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.984 0.914 . . . . 74.43 110.393 172.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 31.3 tp -71.07 -52.83 17.17 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.892 0.877 . . . . 73.23 110.463 -177.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 101' ' ' PHE . . . . . 0.462 ' O ' ' HG ' ' C' ' 105' ' ' LEU . 87.4 m-85 -86.22 -10.02 55.43 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.435 -0.802 . . . . 75.04 110.781 179.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -43.04 -55.73 4.79 Favored Glycine 0 CA--C 1.545 1.924 0 CA-C-O 118.479 -1.178 . . . . 74.41 115.026 176.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -37.6 -35.61 0.33 Allowed 'Trans proline' 0 C--N 1.392 2.837 0 C-N-CA 125.136 3.891 . . . . 64.35 116.279 175.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -130.9 24.59 4.27 Favored Glycine 0 C--N 1.349 1.276 0 CA-C-O 118.798 -1.001 . . . . 73.42 113.837 -174.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 105' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' C' ' 101' ' ' PHE . 38.1 mt -74.52 67.04 1.46 Allowed 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 118.038 0.919 . . . . 75.43 111.72 173.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 106' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 39.31 -102.85 0.03 OUTLIER 'General case' 0 CA--C 1.562 1.441 0 C-N-CA 125.643 1.577 . . . . 64.24 114.686 172.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . 67.44 26.4 73.6 Favored Glycine 0 C--N 1.362 1.995 0 N-CA-C 111.493 -0.643 . . . . 51.05 111.493 -163.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 70.47 -83.45 0.36 Allowed Glycine 0 C--N 1.347 1.174 0 N-CA-C 109.277 -1.529 . . . . 74.41 109.277 -163.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 109' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -136.45 -8.91 1.94 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.986 0.914 . . . . 74.45 110.321 169.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 110' ' ' GLY . . . . . . . . . . . . . . . -92.09 -2.73 68.44 Favored Glycine 0 C--N 1.352 1.439 0 N-CA-C 114.597 0.599 . . . . 73.14 114.597 -175.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 40.8 ttp180 54.4 16.4 1.26 Allowed 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 124.785 1.234 . . . . 75.25 113.452 176.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.51 -31.24 67.7 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.642 1.177 . . . . 75.43 110.426 166.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 113' ' ' SER . . . . . . . . . . . . . 49.2 m 72.46 49.64 0.2 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 125.78 1.632 . . . . 72.53 111.666 -176.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 42.9 ttt180 -70.6 160.11 33.13 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 115.386 -0.825 . . . . 74.05 110.374 177.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 115' ' ' LYS . . . . . 0.602 ' HE2' ' HB2' ' C' ' 170' ' ' PRO . 3.3 tpmt? -62.15 131.91 51.05 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.279 0.631 . . . . 74.15 111.521 -178.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 116' ' ' GLY . . . . . 0.443 ' HA2' ' HA3' ' C' ' 168' ' ' GLY . . . -82.28 127.81 8.15 Favored Glycine 0 C--N 1.345 1.043 0 CA-C-N 115.373 -0.83 . . . . 54.4 113.963 -174.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 117' ' ' ARG . . . . . 0.438 ' HG2' ' H ' ' C' ' 118' ' ' ASP . 56.1 ttt-85 -80.3 175.06 10.99 Favored 'General case' 0 C--O 1.252 1.214 0 C-N-CA 123.615 0.766 . . . . 74.32 109.684 174.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 118' ' ' ASP . . . . . 0.438 ' H ' ' HG2' ' C' ' 117' ' ' ARG . 3.6 p30 -65.38 155.81 34.2 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 121.687 0.756 . . . . 75.42 111.201 172.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 119' ' ' LEU . . . . . . . . . . . . . 61.9 tp -109.01 161.67 14.95 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 107.189 -1.411 . . . . 75.21 107.189 172.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 38.8 ttt-85 -131.31 119.84 22.31 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 118.77 0.714 . . . . 72.31 109.322 175.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 121' ' ' ALA . . . . . 0.412 ' HB1' HD11 ' C' ' 174' ' ' LEU . . . -138.09 118.16 13.46 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 124.129 0.972 . . . . 75.44 108.68 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 122' ' ' GLU . . . . . 0.658 ' HG2' HG22 ' B' ' 186' ' ' THR . 13.0 pt-20 -108.03 148.3 29.94 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 122.339 0.255 . . . . 74.12 110.457 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -140.71 145.89 42.08 Favored Pre-proline 0 N--CA 1.481 1.109 0 C-N-CA 122.833 0.453 . . . . 73.3 111.607 -170.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . 0.433 ' HG3' ' HG3' ' B' ' 188' ' ' ARG . 97.8 Cg_endo -75.88 130.11 12.13 Favored 'Trans proline' 0 C--N 1.377 2.038 0 C-N-CA 122.509 2.139 . . . . 72.51 110.559 166.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 125' ' ' LEU . . . . . . . . . . . . . 30.2 tp -145.14 148.58 33.76 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 108.668 -0.864 . . . . 75.32 108.668 -175.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 126' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -94.53 158.5 15.51 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 120.911 0.386 . . . . 61.53 110.488 -178.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 127' ' ' LEU . . . . . 0.523 HD11 ' HD2' ' C' ' 186' ' ' PHE . 56.9 mt -62.33 -42.56 99.48 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.656 1.182 . . . . 62.25 110.643 173.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -62.2 -38.05 87.66 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 114.495 -1.229 . . . . 75.24 110.725 173.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -79.01 -17.93 54.5 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 122.968 0.507 . . . . 75.51 111.592 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -76.63 -40.29 49.71 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-O 121.719 0.771 . . . . 73.14 109.428 172.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 131' ' ' PHE . . . . . 0.571 ' HB2' HD11 ' C' ' 215' ' ' LEU . 76.8 t80 -63.09 -34.89 78.56 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 126.065 1.746 . . . . 75.55 111.873 171.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 132' ' ' HIS . . . . . . . . . . . . . 36.6 m170 -78.35 -59.26 2.85 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 122.381 0.272 . . . . 70.15 110.345 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 53.03 -127.39 35.48 Favored Glycine 0 CA--C 1.537 1.426 0 O-C-N 124.077 0.86 . . . . 65.31 113.955 177.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.51 -146.33 38.72 Favored Glycine 0 C--N 1.349 1.303 0 C-N-CA 123.24 0.448 . . . . 73.12 113.646 177.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -92.01 112.79 24.86 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.337 1.055 . . . . 73.03 109.618 -177.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 136' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -126.64 133.36 51.01 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.389 0.675 . . . . 72.12 110.432 -175.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 137' ' ' VAL . . . . . . . . . . . . . 34.0 m -73.11 138.95 20.32 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 CA-C-O 120.976 0.417 . . . . 73.11 111.479 -176.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 138' ' ' VAL . . . . . 0.68 ' HA ' HG21 ' B' ' 182' ' ' VAL . 7.3 p -152.05 135.53 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.325 1.05 . . . . 72.14 108.986 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 139' ' ' GLU . . . . . 0.512 ' HA ' ' O ' ' C' ' 143' ' ' ARG . 0.0 OUTLIER -117.69 116.25 26.67 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.19 0.596 . . . . 74.31 109.927 170.742 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 140' ' ' VAL . . . . . . . . . . . . . 13.8 p -164.39 138.33 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.823 0.849 . . . . 73.25 110.12 174.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 62.58 13.94 6.68 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 124.869 1.268 . . . . 65.0 113.72 170.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 142' ' ' GLY . . . . . 0.582 ' HA2' ' HB2' ' C' ' 79' ' ' PRO . . . 120.18 -31.63 5.21 Favored Glycine 0 C--N 1.348 1.248 0 CA-C-O 120.103 -0.276 . . . . 52.4 112.814 -178.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 143' ' ' ARG . . . . . 0.512 ' O ' ' HA ' ' C' ' 139' ' ' GLU . 9.8 mmm180 -80.33 108.37 13.89 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.034 0.534 . . . . 75.05 111.954 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 48.6 ttt180 -113.62 91.31 3.6 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 107.635 -1.246 . . . . 71.51 107.635 166.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 145' ' ' VAL . . . . . . . . . . . . . 13.0 p -157.34 159.24 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.142 0.577 . . . . 75.03 111.174 -168.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 20.3 m -78.19 106.89 10.39 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.76 0.824 . . . . 73.22 110.146 168.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 147' ' ' VAL . . . . . 0.495 ' HB ' ' HE2' ' C' ' 164' ' ' MET . 2.6 p -80.52 119.8 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 CA-C-O 121.044 0.45 . . . . 72.53 110.137 174.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 148' ' ' ARG . . . . . 0.434 ' HD2' HG22 ' B' ' 38' ' ' ILE . 48.0 ttt180 -83.82 95.15 8.37 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.595 -0.729 . . . . 74.22 110.068 177.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 149' ' ' ILE . . . . . . . . . . . . . 38.3 pt -118.71 105.19 46.06 Favored Pre-proline 0 CA--C 1.547 0.861 0 N-CA-C 107.647 -1.242 . . . . 74.42 107.647 164.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -53.88 166.78 1.31 Allowed 'Trans proline' 0 C--N 1.384 2.428 0 C-N-CA 123.459 2.772 . . . . 61.44 113.903 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -44.12 108.85 0.13 Allowed 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 123.305 2.67 . . . . 73.2 113.425 171.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 152' ' ' GLY . . . . . . . . . . . . . . . 154.21 87.98 0.06 OUTLIER Glycine 0 C--N 1.349 1.292 0 N-CA-C 114.8 0.68 . . . . 63.11 114.8 -176.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 153' ' ' VAL . . . . . 0.528 HG22 HG12 ' C' ' 178' ' ' VAL . 12.4 p -165.53 155.54 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.617 0 C-N-CA 123.249 0.62 . . . . 74.01 110.656 172.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 154' ' ' ARG . . . . . 0.463 ' HD2' ' HG2' ' C' ' 187' ' ' ARG . 30.3 ttp180 -155.64 150.86 26.8 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 124.071 0.948 . . . . 75.32 110.419 -172.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 155' ' ' GLU . . . . . 0.532 ' HG3' ' HG ' ' B' ' 132' ' ' SER . 10.3 tp10 -42.93 130.66 4.3 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 125.589 1.556 . . . . 74.51 113.263 -177.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 84.53 -5.79 79.85 Favored Glycine 0 C--N 1.348 1.199 0 CA-C-N 115.827 -0.624 . . . . 75.21 113.252 178.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 157' ' ' SER . . . . . 0.485 ' O ' HG11 ' C' ' 178' ' ' VAL . 37.6 t -78.58 129.5 34.87 Favored 'General case' 0 C--O 1.245 0.82 0 N-CA-C 108.622 -0.881 . . . . 75.43 108.622 173.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 97.9 t -105.99 100.44 10.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 N-CA-C 108.261 -1.015 . . . . 72.31 108.261 -177.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 159' ' ' ILE . . . . . 0.658 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 26.1 mt -71.25 96.67 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.672 0 CA-C-N 115.046 -0.979 . . . . 72.31 108.85 -175.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 4.6 ttt180 -79.75 96.58 6.31 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 107.551 -1.277 . . . . 75.13 107.551 175.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 161' ' ' VAL . . . . . . . . . . . . . 2.2 p -97.99 108.44 46.46 Favored Pre-proline 0 C--O 1.247 0.938 0 CA-C-N 114.804 -1.089 . . . . 75.24 108.588 -178.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -52.05 115.97 2.49 Favored 'Trans proline' 0 C--N 1.387 2.572 0 C-N-CA 123.483 2.788 . . . . 75.23 114.55 -173.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 163' ' ' GLY . . . . . 0.574 ' H ' ' HA ' ' C' ' 173' ' ' ASP . . . 91.49 -13.82 65.53 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 117.513 1.765 . . . . 53.54 117.513 168.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 164' ' ' MET . . . . . 0.495 ' HE2' ' HB ' ' C' ' 147' ' ' VAL . 47.7 ttm -68.13 -19.07 64.79 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-N 120.45 2.125 . . . . 73.35 112.659 -170.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . -94.77 -112.54 2.51 Favored Glycine 0 C--N 1.347 1.181 0 CA-C-O 119.332 -0.704 . . . . 73.32 111.886 175.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 166' ' ' GLY . . . . . 0.413 ' HA3' ' HB3' ' C' ' 171' ' ' PRO . . . 86.65 67.23 1.36 Allowed Glycine 0 C--N 1.362 2.007 0 CA-C-N 118.057 0.929 . . . . 75.44 113.866 176.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 167' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -79.65 99.88 7.58 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 107.124 -1.436 . . . . 74.2 107.124 172.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 168' ' ' GLY . . . . . 0.443 ' HA3' ' HA2' ' C' ' 116' ' ' GLY . . . 153.31 -85.61 0.14 Allowed Glycine 0 C--O 1.213 -1.164 0 CA-C-O 118.432 -1.205 . . . . 13.44 110.397 -169.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 169' ' ' ASN . . . . . 0.53 ' HB3' ' HD3' ' C' ' 170' ' ' PRO . 2.9 t-20 179.95 -59.78 0.0 OUTLIER Pre-proline 0 N--CA 1.499 1.985 0 CA-C-O 117.387 -1.292 . . . . 62.44 112.189 163.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 170' ' ' PRO . . . . . 0.602 ' HB2' ' HE2' ' C' ' 115' ' ' LYS . 19.4 Cg_exo -67.77 100.24 0.59 Allowed 'Trans proline' 0 C--N 1.399 3.208 0 CA-C-N 122.623 1.972 . . . . 73.55 109.688 165.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 171' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' C' ' 170' ' ' PRO . 14.2 Cg_exo -71.05 132.06 20.58 Favored 'Trans proline' 0 C--N 1.362 1.267 0 C-N-CA 122.901 2.401 . . . . 74.02 114.469 -162.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -71.44 -72.87 0.86 Allowed Glycine 0 C--N 1.347 1.178 0 O-C-N 124.176 0.922 . . . . 74.42 111.331 173.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 173' ' ' ASP . . . . . 0.574 ' HA ' ' H ' ' C' ' 163' ' ' GLY . 4.9 p-10 -172.67 178.32 2.7 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.201 0.6 . . . . 74.51 111.897 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 174' ' ' LEU . . . . . 0.484 ' HB3' ' HB3' ' C' ' 164' ' ' MET . 12.6 tp -122.09 139.17 54.04 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.169 0.988 . . . . 75.22 109.002 170.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 85.9 mt -101.39 87.11 3.12 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.67 1.188 . . . . 72.15 109.594 177.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 176' ' ' LEU . . . . . 0.658 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 83.9 mt -74.22 92.93 2.28 Favored 'General case' 0 C--N 1.351 0.671 0 C-N-CA 123.09 0.556 . . . . 74.33 109.557 173.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 177' ' ' VAL . . . . . 0.431 ' HB ' ' HB3' ' C' ' 122' ' ' GLU . 22.2 t -84.51 113.52 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 108.619 -0.882 . . . . 75.23 108.619 -177.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 178' ' ' VAL . . . . . 0.528 HG12 HG22 ' C' ' 153' ' ' VAL . 7.5 p -80.76 125.17 39.26 Favored 'Isoleucine or valine' 0 C--O 1.246 0.908 0 CA-C-O 121.798 0.809 . . . . 74.01 111.036 -176.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 179' ' ' ARG . . . . . . . . . . . . . 24.3 mmt180 -110.54 122.9 48.88 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 114.028 -1.442 . . . . 74.42 107.224 169.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 180' ' ' LEU . . . . . 0.477 HD13 HD23 ' C' ' 127' ' ' LEU . 92.5 mt -85.69 149.57 25.21 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 122.774 0.43 . . . . 73.43 111.431 -177.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 181' ' ' LEU . . . . . 0.406 ' HB3' ' HD2' ' C' ' 182' ' ' PRO . 26.4 mt -65.4 165.36 18.52 Favored Pre-proline 0 CA--C 1.565 1.551 0 C-N-CA 124.624 1.17 . . . . 74.24 111.711 -178.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 182' ' ' PRO . . . . . 0.406 ' HD2' ' HB3' ' C' ' 181' ' ' LEU . 12.7 Cg_exo -36.04 -20.88 0.04 OUTLIER 'Trans proline' 0 C--N 1.403 3.423 1 C-N-CA 125.642 4.228 . . . . 73.32 118.701 -177.357 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 183' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -104.94 99.54 19.66 Favored Pre-proline 0 CA--C 1.562 1.44 0 CA-C-N 119.495 1.043 . . . . 72.0 109.123 167.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 184' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -99.26 66.39 0.06 OUTLIER 'Trans proline' 0 C--N 1.38 2.221 0 C-N-CA 123.961 3.107 . . . . 74.25 110.713 174.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 185' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 21.6 t -92.63 -45.06 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-N 115.487 -0.779 . . . . 72.23 110.144 -165.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 186' ' ' PHE . . . . . 0.523 ' HD2' HD11 ' C' ' 127' ' ' LEU . 71.1 m-85 -100.16 114.57 28.05 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.506 0.67 . . . . 61.44 111.354 -167.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 187' ' ' ARG . . . . . 0.662 ' HB3' ' HB3' ' C' ' 194' ' ' TYR . 3.2 tmt_? -95.77 107.4 19.63 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.878 1.271 . . . . 75.14 108.72 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 188' ' ' LEU . . . . . . . . . . . . . 41.1 tp -82.32 141.78 32.59 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.835 0.68 . . . . 74.14 112.835 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -145.16 108.68 4.65 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 107.103 -1.443 . . . . 73.21 107.103 161.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 71.36 -92.5 0.5 Allowed Glycine 0 C--N 1.356 1.649 0 O-C-N 123.225 0.328 . . . . 74.2 112.534 -178.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 191' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -117.92 -26.53 6.43 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.874 0.87 . . . . 75.25 110.114 174.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -86.54 153.25 21.97 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.557 -0.747 . . . . 65.13 110.731 -166.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 193' ' ' LEU . . . . . 0.426 HD12 HD13 ' C' ' 215' ' ' LEU . 84.1 mt -120.3 163.7 17.42 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.6 -0.727 . . . . 65.15 111.172 -175.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 194' ' ' TYR . . . . . 0.662 ' HB3' ' HB3' ' C' ' 187' ' ' ARG . 33.8 t80 -136.64 107.56 6.67 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 114.723 -1.126 . . . . 75.43 108.884 169.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 195' ' ' ALA . . . . . 0.488 ' HA ' ' O ' ' C' ' 185' ' ' VAL . . . -105.01 -175.33 2.76 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.725 0.81 . . . . 65.11 110.822 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 196' ' ' THR . . . . . 0.58 HG21 ' HA ' ' B' ' 159' ' ' LYS . 59.1 m -128.31 124.05 35.54 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 107.912 -1.144 . . . . 53.42 107.912 164.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 197' ' ' LEU . . . . . 0.426 HD13 ' HB2' ' C' ' 212' ' ' ALA . 35.4 tp -98.99 126.74 44.75 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 122.889 0.476 . . . . 73.5 110.743 -176.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -79.15 101.54 7.98 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.038 0.935 . . . . 64.33 108.858 177.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 199' ' ' VAL . . . . . 0.545 ' HA ' HG12 ' C' ' 210' ' ' VAL . 40.3 t -119.38 106.99 41.8 Favored Pre-proline 0 N--CA 1.478 0.936 0 C-N-CA 123.667 0.787 . . . . 73.12 109.307 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 200' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.23 147.94 67.43 Favored 'Trans proline' 0 C--N 1.373 1.836 0 C-N-CA 121.683 1.589 . . . . 73.11 111.45 175.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 201' ' ' ALA . . . . . 0.418 ' O ' HG21 ' C' ' 205' ' ' VAL . . . -55.44 -45.66 99.83 Favored Pre-proline 0 CA--C 1.551 1.016 0 N-CA-C 113.998 1.11 . . . . 74.35 113.998 -171.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 202' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -52.35 -47.32 27.57 Favored 'Trans proline' 0 C--N 1.385 2.468 0 C-N-CA 121.411 1.407 . . . . 63.15 112.569 174.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 203' ' ' ILE . . . . . 0.513 ' HA ' HG13 ' C' ' 206' ' ' VAL . 51.3 mt -69.02 -32.59 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 123.15 0.58 . . . . 74.02 111.195 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.85 -33.84 75.54 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.688 0.795 . . . . 75.02 112.145 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 205' ' ' VAL . . . . . 0.418 HG21 ' O ' ' C' ' 201' ' ' ALA . 43.1 t -85.75 -38.35 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-N 116.072 -0.513 . . . . 74.52 111.693 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 206' ' ' VAL . . . . . 0.513 HG13 ' HA ' ' C' ' 203' ' ' ILE . 14.4 p -79.09 -35.67 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 CA-C-O 120.952 0.406 . . . . 74.12 111.175 -174.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 79.8 66.8 1.63 Allowed Glycine 0 N--CA 1.435 -1.406 0 CA-C-N 115.185 -0.916 . . . . 63.21 111.948 -167.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -98.08 -137.22 9.58 Favored Glycine 0 C--O 1.244 0.766 0 N-CA-C 111.176 -0.769 . . . . 51.32 111.176 174.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 209' ' ' LYS . . . . . 0.508 ' HE2' ' HG3' ' B' ' 235' ' ' GLU . 7.2 mtmp? -134.22 133.15 40.56 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.337 0.655 . . . . 72.44 110.25 174.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 210' ' ' VAL . . . . . 0.545 HG12 ' HA ' ' C' ' 199' ' ' VAL . 35.8 m -114.84 178.49 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.012 1.325 . . . . 71.52 107.936 169.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 211' ' ' ARG . . . . . 0.6 ' HD3' ' HB2' ' C' ' 218' ' ' PRO . 24.8 ttm105 -131.56 130.24 42.01 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 118.454 0.57 . . . . 75.53 112.204 -177.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 212' ' ' ALA . . . . . 0.426 ' HB2' HD13 ' C' ' 197' ' ' LEU . . . -98.59 115.35 28.45 Favored 'General case' 0 C--N 1.348 0.519 0 C-N-CA 124.356 1.062 . . . . 74.43 108.248 169.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 213' ' ' MET . . . . . 0.564 ' HA ' ' HA ' ' C' ' 218' ' ' PRO . 2.3 tmm? -71.68 101.59 2.58 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 107.185 -1.413 . . . . 63.12 107.185 172.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 214' ' ' THR . . . . . 0.427 HG22 ' H ' ' C' ' 215' ' ' LEU . 0.6 OUTLIER -101.74 174.63 5.87 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 120.991 0.424 . . . . 72.34 110.348 -171.037 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 215' ' ' LEU . . . . . 0.571 HD11 ' HB2' ' C' ' 131' ' ' PHE . 26.5 mt -61.49 -43.42 98.9 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.793 1.637 . . . . 75.24 112.755 -173.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.86 17.5 19.36 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 115.189 -0.914 . . . . 71.0 110.927 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 217' ' ' GLY . . . . . 0.535 ' HA3' ' HD3' ' B' ' 207' ' ' LYS . . . 127.86 159.73 10.18 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-N 115.492 -0.776 . . . . 74.41 112.567 173.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 218' ' ' PRO . . . . . 0.6 ' HB2' ' HD3' ' C' ' 211' ' ' ARG . 70.3 Cg_endo -75.31 102.88 1.65 Allowed 'Trans proline' 0 CA--C 1.561 1.845 0 C-N-CA 122.764 2.309 . . . . 64.03 114.292 -178.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 219' ' ' VAL . . . . . . . . . . . . . 12.6 p -83.87 144.28 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 123.729 0.812 . . . . 52.53 110.097 -178.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 220' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -97.36 109.83 22.5 Favored 'General case' 0 C--O 1.246 0.872 0 CA-C-O 121.66 0.743 . . . . 72.32 109.636 174.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 221' ' ' VAL . . . . . 0.434 HG13 HD21 ' C' ' 233' ' ' LEU . 49.2 t -80.12 138.19 20.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 125.114 1.366 . . . . 74.03 111.136 -178.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 222' ' ' ALA . . . . . 0.56 ' H ' ' HB2' ' B' ' 239' ' ' ALA . . . -89.53 118.01 28.85 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.149 0.979 . . . . 73.3 110.309 173.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 49.0 t -92.72 130.72 35.84 Favored Pre-proline 0 CA--C 1.553 1.092 0 N-CA-C 108.18 -1.044 . . . . 73.11 108.18 174.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 224' ' ' PRO . . . . . 0.807 ' HG2' ' HG3' ' B' ' 243' ' ' GLN . 21.1 Cg_exo -72.48 157.66 52.52 Favored 'Trans proline' 0 C--N 1.37 1.697 0 C-N-CA 123.561 2.84 . . . . 73.11 111.894 164.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -58.67 142.88 98.91 Favored 'Trans proline' 0 C--N 1.382 2.337 0 C-N-CA 122.368 2.045 . . . . 74.4 111.209 174.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 226' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 67.57 95.57 0.06 Allowed 'General case' 0 N--CA 1.484 1.247 0 O-C-N 124.488 1.118 . . . . 71.5 111.331 -179.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 227' ' ' THR . . . . . 0.484 HG23 HG11 ' C' ' 253' ' ' VAL . 52.9 m -140.41 123.04 16.24 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 123.222 0.609 . . . . 73.3 112.14 175.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 228' ' ' GLN . . . . . . . . . . . . . 27.7 mp0 -97.74 158.55 15.45 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-O 122.392 1.091 . . . . 74.32 111.172 171.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -67.45 148.87 50.98 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-N 113.874 -1.512 . . . . 65.31 109.357 171.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 88.71 -5.44 84.62 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-O 119.689 -0.506 . . . . 62.04 112.93 -174.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 231' ' ' ARG . . . . . 0.422 ' NH1' HE22 ' B' ' 243' ' ' GLN . 57.1 mtt180 -76.85 168.97 19.18 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 109.053 -0.721 . . . . 75.03 109.053 163.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 232' ' ' LYS . . . . . 0.609 ' HZ1' ' HB2' ' C' ' 232' ' ' LYS . 3.9 ttmp? -143.47 139.82 30.05 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.96 0.41 . . . . 74.05 112.087 -175.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 233' ' ' LEU . . . . . 0.565 HD13 ' HB2' ' C' ' 251' ' ' LEU . 2.4 mp -105.7 155.75 18.95 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.808 1.243 . . . . 74.22 109.724 -179.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 41.1 ttp85 -128.01 89.93 3.01 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 109.095 -0.706 . . . . 72.34 109.095 172.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 235' ' ' LEU . . . . . 0.511 HD12 HD23 ' C' ' 249' ' ' LEU . 72.3 mt -73.43 114.14 11.32 Favored 'General case' 0 C--N 1.359 0.995 0 N-CA-C 109.497 -0.557 . . . . 74.34 109.497 174.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 24.7 mmmt -72.55 124.17 24.68 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.956 0.902 . . . . 73.41 111.236 -177.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 72.27 37.52 59.24 Favored Glycine 0 C--N 1.35 1.307 0 O-C-N 123.832 0.708 . . . . 71.42 113.118 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 29.8 mmtm -125.32 14.77 8.32 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.836 0.854 . . . . 75.11 111.322 177.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -96.32 -162.96 33.08 Favored Glycine 0 C--N 1.348 1.245 0 N-CA-C 111.972 -0.451 . . . . 75.2 111.972 172.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 240' ' ' PHE . . . . . 0.408 ' CD1' HD21 ' C' ' 193' ' ' LEU . 3.3 m-85 -72.51 149.59 91.08 Favored Pre-proline 0 N--CA 1.477 0.899 0 C-N-CA 123.588 0.755 . . . . 75.14 111.489 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 241' ' ' PRO . . . . . 0.435 ' HD3' ' CD2' ' C' ' 131' ' ' PHE . 31.6 Cg_exo -59.49 119.25 6.36 Favored 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 124.101 3.201 . . . . 71.53 112.572 -176.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -131.34 -172.76 13.17 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-N 115.488 -0.778 . . . . 70.14 112.822 -174.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 243' ' ' PRO . . . . . 0.544 ' HA ' ' HA ' ' B' ' 111' ' ' LEU . 37.9 Cg_endo -63.56 -40.48 30.18 Favored 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 123.781 2.988 . . . . 71.42 112.652 -178.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -84.56 10.81 10.05 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.097 0.559 . . . . 71.42 111.854 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 120.11 -75.45 0.32 Allowed Glycine 0 C--N 1.348 1.207 0 N-CA-C 110.601 -1.0 . . . . 63.24 110.601 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 246' ' ' ARG . . . . . . . . . . . . . 30.5 mtm180 -142.46 -179.97 6.6 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.845 1.258 . . . . 71.32 109.655 175.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -89.02 -161.86 37.93 Favored Glycine 0 C--N 1.346 1.137 0 N-CA-C 112.105 -0.398 . . . . 63.23 112.105 173.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -122.71 137.96 54.75 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 117.358 0.579 . . . . 73.54 109.736 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 249' ' ' LEU . . . . . 0.511 HD23 HD12 ' C' ' 235' ' ' LEU . 21.1 tp -95.04 115.11 27.01 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.198 0.999 . . . . 74.23 110.177 -175.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 250' ' ' TYR . . . . . 0.566 ' HB3' ' HD3' ' C' ' 232' ' ' LYS . 8.6 m-85 -100.91 100.13 10.72 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.253 -0.647 . . . . 71.43 109.253 -179.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 251' ' ' LEU . . . . . 0.565 ' HB2' HD13 ' C' ' 233' ' ' LEU . 1.8 mp -96.98 138.65 34.18 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.651 -0.656 . . . . 72.0 109.923 -174.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 252' ' ' GLU . . . . . 0.542 ' HG2' ' HB3' ' B' ' 157' ' ' MET . 4.9 tp10 -89.89 118.83 29.76 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.358 -0.978 . . . . 75.41 108.358 173.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 253' ' ' VAL . . . . . 0.484 HG11 HG23 ' C' ' 227' ' ' THR . 91.7 t -60.27 130.61 24.26 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 123.45 0.7 . . . . 73.5 110.842 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 254' ' ' ARG . . . . . 0.464 ' CZ ' ' HB ' ' C' ' 256' ' ' THR . 2.1 tmm_? -126.27 101.0 6.54 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 107.122 -1.436 . . . . 75.13 107.122 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 255' ' ' ILE . . . . . 0.454 ' HA ' ' O ' ' C' ' 199' ' ' VAL . 46.2 mm -73.45 125.92 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 109.577 -0.527 . . . . 75.24 109.577 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 256' ' ' THR . . . . . 0.464 ' HB ' ' CZ ' ' C' ' 254' ' ' ARG . 0.1 OUTLIER -128.09 163.47 24.55 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.102 0.961 . . . . 70.25 111.003 -175.418 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 2.8 pp -137.08 147.97 60.8 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 124.751 1.221 . . . . 75.21 107.827 173.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -79.17 15.48 1.53 Allowed 'Trans proline' 0 N--CA 1.501 1.943 0 C-N-CA 122.566 2.178 . . . . 74.41 113.089 -170.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 57.59 -84.3 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.406 1.483 . . . . 72.3 111.017 -171.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -73.09 137.83 45.48 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.215 1.006 . . . . 73.41 110.138 -177.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 261' ' ' LEU . . . . . . . . . . . . . 77.3 mt -130.16 165.03 23.17 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.756 0.822 . . . . 74.53 111.361 -178.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 14.9 p -84.09 146.4 48.41 Favored Pre-proline 0 CA--C 1.549 0.918 0 CA-C-N 114.245 -1.343 . . . . 61.23 108.854 167.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -51.38 -26.0 19.95 Favored 'Trans proline' 0 C--N 1.39 2.732 0 C-N-CA 124.256 3.304 . . . . 74.2 114.649 -172.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -66.36 -65.4 0.68 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.753 0.821 . . . . 71.04 109.754 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -56.13 -44.02 78.76 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 114.647 -1.16 . . . . 71.03 109.85 177.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 266' ' ' GLU . . . . . 0.402 ' O ' ' HG2' ' C' ' 270' ' ' LYS . 5.2 tp10 -50.44 -48.42 56.41 Favored 'General case' 0 CA--C 1.548 0.891 0 O-C-N 124.549 1.156 . . . . 73.1 110.529 179.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 267' ' ' ALA . . . . . 0.464 ' O ' ' HG2' ' C' ' 271' ' ' LYS . . . -66.57 -41.0 89.27 Favored 'General case' 0 C--N 1.355 0.835 0 CA-C-N 115.481 -0.781 . . . . 71.12 112.22 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 268' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.98 -38.42 91.0 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 120.797 0.332 . . . . 70.11 111.112 176.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -68.01 -32.56 73.03 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.39 0.676 . . . . 63.11 110.43 175.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 270' ' ' LYS . . . . . 0.596 ' HZ2' ' HB3' ' C' ' 270' ' ' LYS . 4.0 mmmp? -58.99 -49.39 78.05 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.048 0.539 . . . . 75.43 109.721 173.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 271' ' ' LYS . . . . . 0.472 ' HE2' ' HA ' ' C' ' 271' ' ' LYS . 10.8 mmpt? -59.54 -48.76 80.41 Favored 'General case' 0 C--O 1.249 1.033 0 O-C-N 124.252 0.97 . . . . 75.33 111.106 -177.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 80.4 mt -54.14 -57.84 9.6 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 124.049 0.843 . . . . 74.33 110.193 173.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -52.95 -45.92 67.93 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.938 0.895 . . . . 43.22 112.339 -173.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -63.56 -43.54 96.76 Favored 'General case' 0 C--O 1.25 1.097 0 C-N-CA 123.789 0.835 . . . . 63.21 110.8 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -56.4 -34.37 66.66 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-O 121.001 0.429 . . . . 70.04 111.444 174.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 276' ' ' TYR . . . . . 0.705 ' HA ' ' HD3' ' C' ' 279' ' ' ARG . 1.0 OUTLIER -85.26 -25.65 27.14 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 115.743 -0.662 . . . . 75.52 111.596 -179.404 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 277' ' ' TYR . . . . . 0.431 ' CE1' ' HA3' ' A' ' 208' ' ' GLY . 22.1 m-30 -68.85 -32.36 71.99 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.938 -0.393 . . . . 65.52 109.938 176.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -55.57 -18.62 7.93 Favored 'General case' 0 CA--C 1.561 1.393 0 O-C-N 123.756 0.66 . . . . 72.22 112.515 173.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 279' ' ' ARG . . . . . 0.705 ' HD3' ' HA ' ' C' ' 276' ' ' TYR . 12.6 mtp-105 -89.87 -28.88 18.94 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.061 0.944 . . . . 75.11 111.833 176.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.963 0 C-N-CA 123.292 0.637 . . . . 75.14 110.671 -174.062 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.543 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.0 OUTLIER . . . . . 0 N--CA 1.482 1.127 0 CA-C-O 119.713 -0.184 . . . . 64.12 110.807 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.38 40.56 27.38 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.41 1.084 . . . . 74.44 111.917 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -73.77 79.19 1.57 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.045 0.538 . . . . 74.04 109.769 177.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -36.0 104.35 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.63 1.572 . . . . 64.14 113.24 -178.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -72.13 112.02 7.86 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.587 -0.894 . . . . 74.32 108.587 166.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -75.98 84.3 2.88 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 107.242 -1.392 . . . . 62.43 107.242 178.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.488 ' CD1' ' HA ' ' A' ' 53' ' ' ALA . 41.7 m-85 -60.67 -29.98 69.63 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-N 114.59 -1.186 . . . . 73.34 111.996 -173.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -66.38 -42.34 88.09 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.833 -0.621 . . . . 73.33 110.432 176.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.09 -40.31 95.95 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.933 0.493 . . . . 70.01 111.19 176.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.483 HD11 ' HA ' ' A' ' 7' ' ' TYR . 62.9 mt -60.79 -39.17 80.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-N 115.807 -0.633 . . . . 74.23 110.727 178.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 92.1 mt -86.03 -7.59 58.52 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 112.287 0.477 . . . . 73.11 112.287 176.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.49 18.29 76.93 Favored Glycine 0 C--N 1.351 1.391 0 N-CA-C 114.501 0.56 . . . . 73.42 114.501 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.4 m -103.83 153.88 38.43 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 124.444 1.098 . . . . 72.52 110.041 177.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.23 165.11 20.52 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 122.785 2.323 . . . . 50.12 114.142 -176.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -81.63 61.05 4.86 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.4 1.08 . . . . 75.43 109.658 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -177.42 -26.83 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 114.073 -1.421 . . . . 71.2 108.286 -166.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -47.16 123.58 5.58 Favored 'General case' 0 C--N 1.349 0.579 0 C-N-CA 125.714 1.606 . . . . 74.14 113.137 -174.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 43.7 p -74.42 173.01 10.9 Favored 'General case' 0 C--O 1.243 0.733 0 O-C-N 124.226 0.954 . . . . 75.03 110.901 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.2 tm0? -55.81 -29.19 59.37 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.04 0.936 . . . . 71.11 110.178 179.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -57.22 -58.67 7.19 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.416 1.086 . . . . 72.43 110.845 173.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -66.03 -35.02 79.43 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.135 0.574 . . . . 71.14 111.484 -173.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.479 HG12 ' HB3' ' A' ' 57' ' ' LEU . 1.7 mp -61.76 -45.0 99.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 123.044 0.537 . . . . 73.31 110.296 173.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -61.69 -40.02 93.5 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.575 1.15 . . . . 75.22 111.035 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.628 ' HA ' ' HD3' ' A' ' 27' ' ' LYS . 18.5 mtp180 -77.15 -37.47 53.88 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.997 0.919 . . . . 73.12 111.41 -175.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.92 -37.99 89.43 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.652 -0.704 . . . . 72.43 110.161 173.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -74.97 -28.05 60.42 Favored 'General case' 0 C--O 1.215 -0.732 0 CA-C-N 115.006 -0.997 . . . . 73.1 110.964 176.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.628 ' HD3' ' HA ' ' A' ' 24' ' ' ARG . 22.6 mtpp -55.29 -53.54 54.76 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.414 -0.958 . . . . 74.22 108.414 171.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 -54.2 -67.06 0.29 Allowed 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 114.576 -1.193 . . . . 75.52 111.34 176.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 79.4 mt -70.21 -22.98 62.87 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.04 0.936 . . . . 75.12 112.952 -166.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.81 -54.79 6.66 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 109.252 -0.647 . . . . 71.54 109.252 173.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -64.11 -21.59 66.6 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 120.878 0.37 . . . . 72.33 111.509 -178.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -84.96 -44.33 13.2 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 124.721 1.209 . . . . 73.31 111.113 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -113.78 21.53 14.88 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 112.749 0.648 . . . . 72.41 112.749 -174.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -63.85 113.37 9.81 Favored Pre-proline 0 N--CA 1.484 1.263 0 CA-C-O 118.074 -0.965 . . . . 73.54 108.465 176.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.696 ' HB3' ' HG2' ' A' ' 44' ' ' GLU . 19.5 Cg_endo -57.87 -28.08 81.15 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 123.227 2.618 . . . . 75.51 113.647 -174.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -73.38 -30.55 63.36 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.881 0.873 . . . . 73.23 111.997 176.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 75.4 t -85.16 -39.23 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.017 0.527 . . . . 73.25 109.889 176.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -132.33 94.5 3.45 Favored 'General case' 0 C--O 1.244 0.793 0 C-N-CA 124.491 1.116 . . . . 64.12 109.088 -175.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.538 ' H ' ' HE3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -76.04 82.91 2.9 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 108.764 -0.828 . . . . 73.11 108.764 -179.581 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.5 m -140.08 116.22 7.99 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-O 117.998 -1.001 . . . . 71.24 108.666 177.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_exo -46.93 -42.22 25.33 Favored 'Trans proline' 0 C--N 1.387 2.579 0 C-N-CA 123.119 2.546 . . . . 73.53 112.419 175.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 34.3 tp10 -48.56 -51.29 28.47 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.05 1.34 . . . . 64.43 111.116 173.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.3 -25.6 65.22 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 115.113 -0.949 . . . . 73.42 111.031 -177.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.696 ' HG2' ' HB3' ' A' ' 35' ' ' PRO . 41.7 mt-10 -84.17 -33.94 24.11 Favored 'General case' 0 C--N 1.354 0.785 0 C-N-CA 123.324 0.65 . . . . 63.35 110.948 -174.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -76.47 -38.68 54.98 Favored 'General case' 0 C--O 1.246 0.905 0 CA-C-O 121.372 0.606 . . . . 62.44 109.459 178.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -66.35 -34.21 77.47 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.411 -0.813 . . . . 74.03 110.083 170.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -62.15 -39.74 93.63 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.361 0.665 . . . . 73.32 109.246 172.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.413 ' HG3' ' O ' ' A' ' 44' ' ' GLU . 67.1 mttm -58.14 -50.93 71.78 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 122.975 0.51 . . . . 75.14 110.688 176.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -60.29 -44.76 95.09 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.474 0.654 . . . . 71.44 111.579 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 96.6 mt -70.82 -26.91 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 124.422 1.089 . . . . 74.43 111.39 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.521 ' HA ' ' HB3' ' A' ' 54' ' ' TYR . 9.7 m-80 -94.82 -6.12 43.57 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.732 0.813 . . . . 73.43 111.474 178.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -75.94 -49.04 18.88 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 106.329 -1.73 . . . . 75.34 106.329 164.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.488 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . . . -57.27 -48.66 78.32 Favored 'General case' 0 C--N 1.349 0.573 0 CA-C-N 113.505 -1.679 . . . . 65.45 111.452 174.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.521 ' HB3' ' HA ' ' A' ' 51' ' ' ASN . 67.2 t80 -67.95 -41.31 82.66 Favored 'General case' 0 C--O 1.209 -1.07 0 CA-C-N 115.689 -0.687 . . . . 73.53 110.602 179.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.45 -51.19 60.54 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 118.42 0.554 . . . . 72.52 111.368 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.497 HG12 ' HZ ' ' A' ' 101' ' ' PHE . 47.5 t -73.65 -31.97 33.94 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 CA-C-N 115.122 -0.945 . . . . 74.52 111.204 -177.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.479 ' HB3' HG12 ' A' ' 22' ' ' ILE . 76.4 mt -103.75 3.66 34.36 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 113.961 1.097 . . . . 74.35 113.961 -175.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.3 t -63.06 -51.26 67.35 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 123.855 0.862 . . . . 74.34 111.804 -176.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -109.66 144.25 29.5 Favored Pre-proline 0 C--O 1.239 0.513 0 CA-C-N 114.439 -1.255 . . . . 74.34 108.924 -169.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.401 ' O ' ' HG2' ' A' ' 64' ' ' ARG . 48.3 Cg_exo -41.61 -51.09 4.49 Favored 'Trans proline' 0 C--N 1.383 2.379 0 C-N-CA 123.943 3.095 . . . . 72.41 114.983 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.455 ' O ' HG13 ' A' ' 65' ' ' ILE . 18.9 tp10 -79.8 -31.31 40.71 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 112.531 0.567 . . . . 72.3 112.531 -172.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.594 ' HZ3' ' HB3' ' A' ' 84' ' ' ASP . 3.0 mmmm -62.7 -42.2 99.52 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-O 122.084 0.945 . . . . 74.54 108.884 174.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.414 ' HG2' HD22 ' A' ' 57' ' ' LEU . 4.0 tmt_? -61.98 -42.65 99.37 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 113.72 -1.582 . . . . 74.11 108.443 175.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.401 ' HG2' ' O ' ' A' ' 60' ' ' PRO . 2.8 mmp_? -62.04 -34.51 76.37 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.615 0.766 . . . . 74.25 111.364 174.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 61' ' ' GLU . 62.4 mt -62.98 -44.24 99.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 109.217 -0.66 . . . . 74.41 109.217 178.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -57.79 -54.22 49.31 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.558 -0.747 . . . . 75.4 110.181 173.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -57.62 -42.52 83.47 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.703 0.801 . . . . 64.04 111.606 -175.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 40.4 p -69.68 -31.22 69.14 Favored 'General case' 0 C--N 1.348 0.535 0 CA-C-N 115.948 -0.569 . . . . 75.44 110.311 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -80.26 137.19 36.59 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 118.212 0.46 . . . . 75.32 110.335 -177.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.15 6.93 77.95 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-N 115.764 -0.653 . . . . 64.23 111.547 -174.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 95.0 m -130.37 -61.28 0.97 Allowed 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 103.671 -2.714 . . . . 71.23 103.671 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 92.0 m -87.72 150.09 23.82 Favored 'General case' 0 C--O 1.255 1.364 0 N-CA-C 105.274 -2.121 . . . . 74.23 105.274 156.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.57 -15.34 11.44 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.768 0.827 . . . . 74.04 111.136 178.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.1 123.99 87.71 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 123.695 0.798 . . . . 75.1 110.919 177.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -71.37 146.26 50.06 Favored 'Trans proline' 0 C--N 1.376 1.995 0 C-N-CA 122.413 2.075 . . . . 75.41 110.77 175.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -70.76 152.14 63.9 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 122.46 2.107 . . . . 74.25 110.982 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -58.63 148.5 81.77 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 122.809 2.34 . . . . 73.45 112.947 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -50.36 114.15 1.32 Allowed 'Trans proline' 0 C--N 1.391 2.812 0 C-N-CA 123.542 2.828 . . . . 73.2 112.782 177.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.4 ' HD2' ' HA3' ' A' ' 104' ' ' GLY . 85.8 Cg_endo -81.73 127.6 5.66 Favored 'Trans proline' 0 CA--C 1.557 1.648 0 C-N-CA 122.467 2.111 . . . . 71.05 112.192 -176.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -60.33 84.16 0.07 OUTLIER 'Trans proline' 0 C--N 1.384 2.434 0 C-N-CA 123.176 2.584 . . . . 74.31 112.854 -177.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 146.99 -44.32 0.82 Allowed Glycine 0 C--N 1.341 0.834 0 CA-C-N 114.656 -1.156 . . . . 62.41 110.549 -177.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 115.13 144.75 8.45 Favored Glycine 0 C--N 1.359 1.809 0 C-N-CA 123.282 0.468 . . . . 53.03 112.707 178.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -58.24 117.75 4.75 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.693 0.797 . . . . 74.41 109.646 174.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.594 ' HB3' ' HZ3' ' A' ' 62' ' ' LYS . 13.9 t70 -54.65 108.54 0.4 Allowed 'General case' 0 N--CA 1.476 0.852 0 O-C-N 124.339 1.024 . . . . 71.31 112.967 -171.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.569 ' HA ' ' HD2' ' A' ' 88' ' ' PHE . 14.1 m-85 -134.81 38.7 3.02 Favored 'General case' 0 C--O 1.245 0.862 0 C-N-CA 125.95 1.7 . . . . 73.24 108.068 173.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.3 m -67.18 117.75 9.64 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 113.256 -1.793 . . . . 74.44 110.732 177.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 85.24 -12.07 59.25 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-N 116.116 -0.493 . . . . 70.11 113.535 -176.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.569 ' HD2' ' HA ' ' A' ' 85' ' ' PHE . 12.2 m-85 -101.59 135.53 42.96 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 109.426 -0.583 . . . . 72.34 109.426 -172.016 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -79.45 80.41 5.82 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-O 120.909 0.385 . . . . 71.44 110.237 -174.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.4 HG22 ' HZ ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -42.14 -53.64 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 125.692 1.597 . . . . 75.21 112.996 176.841 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -73.85 -5.65 42.31 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 113.374 0.879 . . . . 75.33 113.374 -173.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -95.83 -18.71 20.17 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.209 0.604 . . . . 61.35 110.986 175.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.409 ' HE1' ' HB3' ' A' ' 48' ' ' LYS . 23.2 m-30 -83.62 179.12 7.7 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 113.068 0.766 . . . . 73.34 113.068 -171.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 68.2 p -68.14 151.95 46.23 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.892 1.277 . . . . 74.5 113.236 -170.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.6 -35.23 73.91 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 115.309 -0.86 . . . . 74.52 110.727 172.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -50.08 -51.36 43.33 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.132 1.373 . . . . 75.03 110.297 176.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.4 ' HZ ' HG22 ' A' ' 90' ' ' VAL . 0.3 OUTLIER -64.37 -46.08 84.94 Favored 'General case' 0 CA--C 1.556 1.205 0 CA-C-N 114.257 -1.338 . . . . 72.32 110.831 173.859 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.441 ' HA ' HD22 ' A' ' 105' ' ' LEU . 60.7 mt-30 -70.19 -9.9 57.18 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 112.98 0.733 . . . . 74.14 112.98 -173.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -101.96 -44.46 5.48 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.952 0.901 . . . . 70.02 110.929 173.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 17.8 tp -63.66 -56.9 12.21 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.646 0.778 . . . . 74.33 111.042 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.497 ' HZ ' HG12 ' A' ' 56' ' ' VAL . 86.5 m-85 -85.77 6.97 25.53 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 115.392 -0.822 . . . . 72.11 111.073 176.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.439 ' HA2' ' HG ' ' A' ' 105' ' ' LEU . . . -41.4 -63.16 1.67 Allowed Glycine 0 C--N 1.358 1.792 0 C-N-CA 124.867 1.223 . . . . 72.43 114.659 178.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -43.55 -23.12 0.47 Allowed 'Trans proline' 0 C--N 1.389 2.689 0 C-N-CA 124.793 3.662 . . . . 64.43 115.849 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.4 ' HA3' ' HD2' ' A' ' 79' ' ' PRO . . . -152.74 51.6 0.49 Allowed Glycine 0 C--N 1.346 1.138 0 O-C-N 121.888 -0.507 . . . . 54.4 112.035 177.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.441 HD22 ' HA ' ' A' ' 98' ' ' GLN . 25.9 mt -57.48 14.05 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.241 0 N-CA-C 116.067 1.877 . . . . 74.25 116.067 177.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER 61.76 -164.66 0.24 Allowed 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.855 0.862 . . . . 74.45 110.417 166.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 61.68 45.63 95.88 Favored Glycine 0 N--CA 1.442 -0.925 0 N-CA-C 115.678 1.031 . . . . 44.0 115.678 164.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.731 ' HA3' ' HB2' ' A' ' 114' ' ' ARG . . . 63.18 -69.47 0.03 OUTLIER Glycine 0 CA--C 1.529 0.956 0 N-CA-C 118.692 2.237 . . . . 71.34 118.692 162.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.423 ' HE2' HH11 ' A' ' 114' ' ' ARG . 61.4 m-85 -72.49 -8.94 57.72 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.308 0.643 . . . . 74.55 109.656 173.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -84.59 13.51 51.8 Favored Glycine 0 CA--C 1.542 1.776 0 CA-C-N 114.874 -1.057 . . . . 55.25 111.501 161.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? 74.96 -15.29 0.67 Allowed 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 126.942 2.097 . . . . 75.52 112.596 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -97.96 52.26 1.06 Allowed 'General case' 0 CA--C 1.562 1.419 0 N-CA-C 113.443 0.905 . . . . 75.13 113.443 -175.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.523 ' O ' ' HA2' ' A' ' 168' ' ' GLY . 25.7 m 67.53 89.12 0.1 Allowed 'General case' 0 N--CA 1.504 2.258 0 N-CA-C 114.998 1.481 . . . . 74.21 114.998 161.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.731 ' HB2' ' HA3' ' A' ' 108' ' ' GLY . 27.1 ttt180 -72.69 -148.64 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.638 0 CA-C-N 121.266 1.848 . . . . 74.52 111.901 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.4 tmtt? -10.81 111.23 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.543 0 C-N-CA 126.469 1.908 . . . . 73.31 114.093 -160.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.82 129.13 41.36 Favored Glycine 0 CA--C 1.543 1.835 0 CA-C-N 115.549 -0.751 . . . . 73.4 114.7 -175.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.522 ' N ' ' HA3' ' A' ' 166' ' ' GLY . 65.0 mtt180 -77.37 160.4 28.8 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 125.214 1.406 . . . . 74.43 111.576 172.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -85.14 84.86 7.55 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 107.321 -1.362 . . . . 74.23 107.321 163.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 9.5 tt -95.9 144.54 26.14 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.365 1.066 . . . . 75.42 109.45 -171.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.438 ' HA ' ' HB2' ' A' ' 175' ' ' LEU . 53.6 ttt-85 -102.98 143.37 32.64 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.045 0.938 . . . . 74.51 109.924 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.404 ' HB2' HD11 ' A' ' 174' ' ' LEU . . . -147.4 167.46 24.32 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.308 0.575 . . . . 54.41 112.123 -178.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.431 ' O ' HD11 ' B' ' 8' ' ' LEU . 5.7 mm-40 -103.38 107.93 18.96 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 114.49 -1.232 . . . . 72.42 107.741 -175.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 24.0 tp -99.24 100.25 9.88 Favored Pre-proline 0 N--CA 1.48 1.05 0 N-CA-C 107.888 -1.153 . . . . 74.14 107.888 177.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.566 ' HG2' ' HB ' ' B' ' 6' ' ' ILE . 43.9 Cg_endo -68.29 139.03 44.63 Favored 'Trans proline' 0 C--N 1.37 1.663 0 C-N-CA 121.323 1.348 . . . . 75.33 109.269 176.008 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.505 ' HB3' HD22 ' A' ' 180' ' ' LEU . 28.5 tp -142.56 138.7 31.02 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.151 0.887 . . . . 72.43 112.027 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 98.8 m -73.18 131.05 41.55 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 114.233 -1.349 . . . . 71.34 109.189 174.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.562 HD22 HD11 ' A' ' 180' ' ' LEU . 5.4 mt -53.48 -56.74 14.41 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 124.113 0.883 . . . . 75.21 111.085 -172.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.624 ' HG2' ' HD3' ' B' ' 2' ' ' LYS . 28.8 mp0 -41.41 -53.06 3.45 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 113.148 -1.842 . . . . 75.32 111.615 176.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -65.43 -37.42 86.84 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.454 0.702 . . . . 64.33 111.219 -178.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.538 ' HB1' ' O ' ' A' ' 153' ' ' VAL . . . -60.3 -34.66 74.08 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 124.421 1.075 . . . . 65.44 111.46 178.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -82.68 -37.69 24.46 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.563 0.745 . . . . 74.51 111.527 176.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 41.4 m170 -64.59 -40.12 94.96 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.254 0.622 . . . . 75.25 110.903 -175.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 67.34 77.84 0.3 Allowed Glycine 0 C--N 1.343 0.938 0 CA-C-N 115.452 -0.795 . . . . 71.54 112.804 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.405 ' O ' HG12 ' A' ' 149' ' ' ILE . . . -155.33 -158.99 9.05 Favored Glycine 0 C--N 1.334 0.427 0 N-CA-C 112.141 -0.384 . . . . 70.42 112.141 -179.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -68.87 123.89 22.2 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 125.001 1.32 . . . . 73.14 110.401 -175.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.589 HH11 HG22 ' B' ' 5' ' ' THR . 10.1 tpp180 -126.87 120.31 28.9 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.274 -1.01 . . . . 75.05 108.274 169.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.4 t -80.66 128.0 39.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 115.18 -0.918 . . . . 75.04 109.499 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.6 p -142.58 124.03 12.12 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 C-N-CA 124.327 1.051 . . . . 73.34 108.25 -178.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.402 ' HA ' ' HA ' ' A' ' 144' ' ' ARG . 37.4 tt0 -116.56 123.73 48.09 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.925 0.49 . . . . 71.3 111.695 -171.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.495 HG21 HD21 ' B' ' 8' ' ' LEU . 1.0 OUTLIER -153.69 149.4 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 125.406 1.483 . . . . 75.1 109.598 170.491 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 61.41 20.38 11.1 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.09 0.956 . . . . 74.24 112.33 176.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 85.89 -14.11 53.96 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-N 116.21 -0.45 . . . . 54.15 112.78 -175.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.586 ' HD3' ' SD ' ' A' ' 164' ' ' MET . 59.4 ttt180 -87.82 102.5 14.75 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 123.225 0.61 . . . . 72.43 109.579 177.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.431 ' HB3' ' HB2' ' A' ' 61' ' ' GLU . 41.9 ttt85 -92.41 89.79 6.94 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 107.926 -1.138 . . . . 74.41 107.926 171.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.3 p -96.86 142.95 13.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 115.34 -0.846 . . . . 73.53 109.508 -173.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 23.2 t -108.97 95.81 5.9 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 109.029 -0.73 . . . . 64.43 109.029 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 3.4 p -81.14 116.39 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.005 0.522 . . . . 73.42 110.041 -177.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 38.8 ttt85 -77.61 94.33 4.36 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 107.884 -1.154 . . . . 74.32 107.884 171.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.478 HD13 HD22 ' A' ' 125' ' ' LEU . 9.3 pt -70.45 150.69 95.69 Favored Pre-proline 0 CA--C 1.553 1.064 0 CA-C-N 114.494 -1.23 . . . . 74.52 110.805 -178.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.606 ' HB2' ' HZ ' ' A' ' 240' ' ' PHE . 92.9 Cg_endo -75.69 137.73 20.57 Favored 'Trans proline' 0 CA--C 1.566 2.098 0 C-N-CA 122.231 1.954 . . . . 74.22 111.997 178.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.24 101.64 0.36 Allowed 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 123.086 2.524 . . . . 74.15 114.119 -175.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 121.24 5.62 9.42 Favored Glycine 0 C--N 1.345 1.036 0 CA-C-N 115.006 -0.997 . . . . 75.51 112.914 178.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.538 ' O ' ' HB1' ' A' ' 130' ' ' ALA . 7.4 p -62.38 134.71 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 N-CA-C 109.314 -0.624 . . . . 75.43 109.314 175.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.71 ' HD3' ' HB3' ' A' ' 186' ' ' PHE . 70.0 mtt85 -139.17 174.68 10.26 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 122.761 0.424 . . . . 73.23 110.413 -173.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.544 ' HG3' ' HE ' ' A' ' 187' ' ' ARG . 4.2 tp10 -43.62 136.35 3.39 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 126.792 2.037 . . . . 72.32 113.297 -172.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.38 -15.33 46.03 Favored Glycine 0 CA--C 1.534 1.267 0 CA-C-O 118.885 -0.953 . . . . 74.33 114.627 177.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 22.8 t -63.23 151.76 39.53 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-N 118.648 1.224 . . . . 74.23 110.172 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.415 HG22 HG23 ' A' ' 177' ' ' VAL . 57.3 t -123.5 102.08 10.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 123.566 0.747 . . . . 74.02 109.431 -175.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.539 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 60.2 mt -83.43 108.57 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 108.282 -1.007 . . . . 75.24 108.282 172.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.439 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 78.1 ttt180 -82.39 110.07 17.2 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 109.381 -0.6 . . . . 75.21 109.381 177.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 3.5 p -121.66 106.52 37.22 Favored Pre-proline 0 CA--C 1.558 1.269 0 C-N-CA 123.164 0.586 . . . . 71.41 110.133 178.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.547 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 24.5 Cg_exo -64.98 129.9 24.41 Favored 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 122.938 2.425 . . . . 74.53 111.89 174.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 102.5 24.97 7.97 Favored Glycine 0 C--N 1.342 0.862 0 CA-C-O 119.713 -0.493 . . . . 70.43 114.055 177.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.586 ' SD ' ' HD3' ' A' ' 143' ' ' ARG . 18.6 tpp -138.77 -40.32 0.49 Allowed 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 117.489 0.645 . . . . 64.15 111.19 -175.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.456 ' N ' ' HB2' ' A' ' 174' ' ' LEU . . . -76.98 -85.54 0.43 Allowed Glycine 0 C--N 1.351 1.398 0 O-C-N 123.61 0.569 . . . . 73.33 112.493 -174.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.522 ' HA3' ' N ' ' A' ' 117' ' ' ARG . . . -62.33 105.04 0.86 Allowed Glycine 0 C--O 1.257 1.581 0 N-CA-C 111.697 -0.561 . . . . 74.5 111.697 171.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -60.01 124.46 20.28 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.257 -1.016 . . . . 75.42 108.257 169.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.523 ' HA2' ' O ' ' A' ' 113' ' ' SER . . . 176.47 152.92 10.09 Favored Glycine 0 CA--C 1.499 -0.967 0 O-C-N 123.758 0.661 . . . . 64.21 112.103 -176.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . 0.457 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . 3.6 t-20 -55.19 -45.45 99.85 Favored Pre-proline 0 CA--C 1.569 1.705 0 CA-C-O 118.702 -0.666 . . . . 63.54 110.903 169.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.457 ' HD3' ' HB3' ' A' ' 169' ' ' ASN . 15.1 Cg_exo -75.33 140.1 24.18 Favored 'Trans proline' 0 C--N 1.387 2.595 0 C-N-CA 121.911 1.74 . . . . 73.02 110.449 161.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.34 112.5 3.54 Favored 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 123.047 2.498 . . . . 71.25 113.159 -170.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -80.57 130.54 9.82 Favored Glycine 0 C--N 1.36 1.87 0 C-N-CA 121.004 -0.617 . . . . 72.4 113.369 177.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.547 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 22.5 m-20 -61.28 137.97 58.24 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.781 0.832 . . . . 71.14 110.392 178.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.456 ' HB2' ' N ' ' A' ' 165' ' ' GLY . 43.3 tp -113.3 138.51 49.92 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.766 -0.457 . . . . 74.2 109.766 175.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.438 ' HB2' ' HA ' ' A' ' 120' ' ' ARG . 60.3 mt -103.08 86.12 2.64 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 107.947 -1.131 . . . . 72.12 107.947 172.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.539 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 68.3 mt -66.77 89.75 0.16 Allowed 'General case' 0 C--N 1.354 0.792 0 CA-C-N 115.419 -0.81 . . . . 74.52 109.298 174.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.415 HG23 HG22 ' A' ' 158' ' ' VAL . 97.3 t -84.15 99.33 6.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 107.23 -1.396 . . . . 71.11 107.23 175.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.4 p -66.06 102.38 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 CA-C-O 122.294 1.045 . . . . 74.13 111.013 -174.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.513 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 8.1 mmm180 -85.28 96.23 9.45 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 114.137 -1.392 . . . . 73.42 107.797 174.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.562 HD11 HD22 ' A' ' 127' ' ' LEU . 19.1 mt -67.91 150.48 48.48 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 109.925 -0.398 . . . . 74.04 109.925 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 74.3 mt -52.75 144.77 24.22 Favored Pre-proline 0 N--CA 1.48 1.026 0 CA-C-O 118.067 -0.968 . . . . 73.22 110.531 178.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -56.2 81.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.388 2.615 0 C-N-CA 124.149 3.232 . . . . 74.32 112.932 -174.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.438 ' HA ' ' HD3' ' A' ' 184' ' ' PRO . 12.1 t-80 -143.84 96.91 5.46 Favored Pre-proline 0 CA--C 1.547 0.829 0 N-CA-C 105.346 -2.094 . . . . 73.35 105.346 -177.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 183' ' ' HIS . 7.3 Cg_exo -72.67 27.83 0.28 Allowed 'Trans proline' 0 N--CA 1.498 1.779 0 C-N-CA 124.738 3.625 . . . . 61.24 116.733 -162.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.537 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 61.3 t -93.91 -61.17 2.18 Favored 'Isoleucine or valine' 0 C--N 1.352 0.709 0 CA-C-N 119.648 1.113 . . . . 72.34 110.283 -172.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . 0.71 ' HB3' ' HD3' ' A' ' 154' ' ' ARG . 11.7 m-85 -114.52 148.27 38.17 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 114.792 1.404 . . . . 72.31 114.792 -166.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . 0.544 ' HE ' ' HG3' ' A' ' 155' ' ' GLU . 28.5 ttm180 -148.0 134.0 19.21 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.661 1.584 . . . . 75.51 109.192 177.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.479 ' HB2' ' HB2' ' A' ' 154' ' ' ARG . 47.0 tp -97.26 110.27 22.85 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 109.334 -0.617 . . . . 74.21 109.334 174.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.42 92.57 4.75 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 106.983 -1.488 . . . . 70.31 106.983 174.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . 0.489 ' HA3' ' HB3' ' B' ' 380' ' ' LYS . . . 68.82 -98.71 0.56 Allowed Glycine 0 C--N 1.346 1.095 0 CA-C-N 115.546 -0.752 . . . . 65.41 111.349 -174.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.48 HE22 ' HG2' ' B' ' 380' ' ' LYS . 0.7 OUTLIER -115.66 -15.42 11.38 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.118 0.567 . . . . 72.32 110.702 172.141 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -79.2 163.58 24.89 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.226 0.61 . . . . 72.32 110.061 177.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.469 HD23 ' HD2' ' A' ' 154' ' ' ARG . 80.1 mt -125.44 141.12 52.23 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.027 0.931 . . . . 74.25 110.699 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.402 ' HB2' ' HB3' ' A' ' 187' ' ' ARG . 55.3 m-85 -102.26 140.67 36.24 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.862 -1.162 . . . . 73.14 107.862 163.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.537 ' HA ' ' O ' ' A' ' 185' ' ' VAL . . . -143.92 155.97 44.26 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.557 1.143 . . . . 74.34 109.314 -173.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 25.4 m -121.27 126.31 49.24 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 108.986 -0.746 . . . . 70.21 108.986 176.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.431 ' HB2' HD23 ' A' ' 251' ' ' LEU . 49.3 tp -117.73 117.89 30.58 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.301 0.641 . . . . 74.1 110.54 -174.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -92.68 113.91 26.31 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.683 -0.858 . . . . 63.3 108.683 169.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 7.4 p -130.46 133.33 24.75 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 124.118 0.967 . . . . 74.33 108.578 -179.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -79.8 157.29 24.36 Favored 'Trans proline' 0 C--N 1.366 1.478 0 C-N-CA 121.94 1.76 . . . . 70.05 112.076 171.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -59.3 -48.55 95.89 Favored Pre-proline 0 CA--C 1.558 1.252 0 N-CA-C 114.274 1.213 . . . . 71.34 114.274 -170.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -57.42 -42.64 59.58 Favored 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 121.897 1.731 . . . . 73.32 113.652 178.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 45.3 mt -75.21 -28.24 20.37 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 CA-C-N 116.442 -0.344 . . . . 71.02 110.485 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.44 -42.4 78.92 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.46 0.704 . . . . 74.14 111.101 176.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 42.3 t -71.72 -52.12 27.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 115.184 -0.916 . . . . 64.22 111.583 -178.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 72.5 t -77.29 -31.34 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 122.867 0.467 . . . . 74.41 111.455 -176.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 77.66 71.47 1.21 Allowed Glycine 0 C--N 1.338 0.686 0 CA-C-N 116.242 -0.436 . . . . 72.35 112.015 -177.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -101.19 -123.35 5.17 Favored Glycine 0 C--N 1.346 1.102 0 N-CA-C 111.52 -0.632 . . . . 73.32 111.52 177.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -133.92 139.95 46.48 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.686 0.795 . . . . 73.34 109.395 173.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.415 HG11 HG21 ' A' ' 199' ' ' VAL . 25.1 m -120.96 162.02 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-O 121.33 0.586 . . . . 63.11 110.32 169.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 6.8 ttp180 -85.11 114.42 22.23 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.645 -1.161 . . . . 74.32 108.738 171.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -106.26 164.55 11.92 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 109.226 -0.657 . . . . 74.41 109.226 169.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 71.6 mtp -103.94 139.42 39.11 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 108.729 -0.841 . . . . 74.15 108.729 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 77.8 p -111.42 -165.41 0.99 Allowed 'General case' 0 C--O 1.243 0.755 0 N-CA-C 108.929 -0.767 . . . . 74.1 108.929 174.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.4 HD13 ' HG2' ' A' ' 154' ' ' ARG . 69.9 mt -76.23 -14.69 60.13 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.7 -0.682 . . . . 73.14 112.112 176.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -120.56 -16.61 8.27 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 118.718 0.69 . . . . 64.44 112.071 -175.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 156.82 -165.3 33.06 Favored Glycine 0 N--CA 1.475 1.293 0 CA-C-O 119.776 -0.458 . . . . 63.05 113.694 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -83.67 141.58 9.86 Favored 'Trans proline' 0 C--N 1.367 1.504 0 C-N-CA 122.926 2.417 . . . . 74.13 113.717 -174.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 34.9 m -134.29 169.57 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 124.353 1.061 . . . . 73.4 110.073 176.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -93.53 142.38 27.4 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.361 0.664 . . . . 75.04 110.416 174.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 59.3 t -130.67 119.2 45.02 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 C-N-CA 124.075 0.95 . . . . 74.51 108.452 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.401 ' HB1' ' OD1' ' B' ' 112' ' ' ASN . . . -73.02 102.31 3.47 Favored 'General case' 0 C--N 1.348 0.508 0 N-CA-C 109.181 -0.674 . . . . 70.4 109.181 177.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 48.2 t -67.36 141.2 95.64 Favored Pre-proline 0 CA--C 1.555 1.152 0 C-N-CA 124.689 1.196 . . . . 71.22 110.24 -176.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.8 150.86 39.81 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 122.168 1.912 . . . . 75.51 110.448 171.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -66.6 138.47 49.76 Favored 'Trans proline' 0 CA--C 1.55 1.291 0 C-N-CA 121.332 1.354 . . . . 72.53 112.021 170.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . 0.252 7.7 ptp180 52.43 58.77 5.05 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 127.054 2.142 . . . . 75.13 112.544 -177.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.423 ' O ' HD13 ' A' ' 255' ' ' ILE . 1.3 m -73.45 105.51 4.85 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 113.989 -1.46 . . . . 64.32 109.146 176.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . 0.411 ' HB3' ' HD2' ' A' ' 231' ' ' ARG . 5.9 tp-100 -84.41 132.34 34.59 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.275 0.63 . . . . 75.32 111.03 -174.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . 0.535 ' HB2' HG22 ' C' ' 256' ' ' THR . . . -66.81 142.04 57.49 Favored 'General case' 0 C--N 1.358 0.97 0 C-N-CA 123.815 0.846 . . . . 65.12 111.916 -177.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . 0.612 ' HA3' HD22 ' B' ' 219' ' ' ASN . . . 88.3 -10.87 69.58 Favored Glycine 0 C--N 1.342 0.906 0 CA-C-N 115.323 -0.853 . . . . 75.54 113.192 -179.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.584 HH11 ' HE1' ' B' ' 444' ' ' TYR . 86.8 mtt180 -87.15 167.07 14.48 Favored 'General case' 0 C--O 1.249 1.062 0 N-CA-C 109.417 -0.586 . . . . 74.44 109.417 172.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.92 126.24 49.5 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.106 -0.952 . . . . 72.22 109.218 -178.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.415 HD11 HD11 ' B' ' 441' ' ' ILE . 16.7 mt -83.28 99.16 9.82 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 107.363 -1.347 . . . . 71.4 107.363 177.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 69.6 ttp85 -82.38 100.8 10.21 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.442 -0.947 . . . . 73.41 108.442 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.501 HD12 HD22 ' A' ' 249' ' ' LEU . 21.6 mt -98.41 92.24 5.58 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 108.975 -0.75 . . . . 74.24 108.975 -175.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.51 ' HB3' ' HD2' ' B' ' 434' ' ' HIS . 6.2 tmtm? -60.99 128.51 36.8 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.243 0.617 . . . . 71.01 110.69 -175.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 83.16 6.11 88.39 Favored Glycine 0 C--N 1.346 1.103 0 CA-C-N 115.228 -0.896 . . . . 74.2 114.012 175.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.404 ' HE3' ' HA ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -98.14 6.73 47.21 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 117.715 0.757 . . . . 74.1 111.066 178.759 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -93.92 -162.04 35.58 Favored Glycine 0 C--N 1.34 0.79 0 CA-C-N 115.662 -0.699 . . . . 74.43 112.095 174.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . 0.606 ' HZ ' ' HB2' ' A' ' 150' ' ' PRO . 18.3 t80 -78.07 137.1 61.27 Favored Pre-proline 0 CA--C 1.551 1.016 0 CA-C-O 118.904 -0.569 . . . . 73.41 109.967 -177.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -61.16 106.65 0.4 Allowed 'Trans proline' 0 C--N 1.382 2.336 0 C-N-CA 122.152 1.902 . . . . 73.33 112.1 171.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -137.06 -153.11 6.33 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-O 119.027 -0.874 . . . . 73.52 112.776 -175.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . 0.422 ' HA ' HD12 ' B' ' 387' ' ' ILE . 59.2 Cg_exo -54.32 -42.01 71.37 Favored 'Trans proline' 0 C--N 1.384 2.416 0 C-N-CA 123.455 2.77 . . . . 72.5 113.383 176.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -82.24 23.96 0.7 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.965 0.906 . . . . 70.11 112.452 -178.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 83.14 -93.07 1.68 Allowed Glycine 0 C--N 1.35 1.308 0 N-CA-C 109.612 -1.395 . . . . 62.24 109.612 -174.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 20.1 mtm180 -128.12 141.86 51.36 Favored 'General case' 0 C--O 1.247 0.936 0 N-CA-C 107.951 -1.129 . . . . 75.41 107.951 164.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -72.99 -173.51 24.88 Favored Glycine 0 C--N 1.349 1.26 0 O-C-N 123.352 0.408 . . . . 70.31 113.884 -177.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -112.85 135.7 53.31 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.505 0.722 . . . . 75.44 110.498 -174.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.501 HD22 HD12 ' A' ' 235' ' ' LEU . 64.6 tp -97.32 104.96 17.03 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.749 -0.834 . . . . 73.32 108.749 -178.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.556 ' HE2' HG13 ' B' ' 154' ' ' ILE . 67.4 m-85 -90.12 105.98 18.18 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.515 0.726 . . . . 71.3 110.05 -177.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.431 HD23 ' HB2' ' A' ' 197' ' ' LEU . 41.5 mt -90.14 119.21 30.28 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 122.874 0.47 . . . . 74.54 109.942 177.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.11 116.44 19.4 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 107.973 -1.121 . . . . 75.41 107.973 178.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 21.8 t -78.21 102.4 4.46 Favored 'Isoleucine or valine' 0 C--O 1.245 0.841 0 CA-C-O 120.969 0.414 . . . . 71.34 111.402 -174.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -101.85 95.39 6.36 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.642 1.177 . . . . 73.14 109.066 168.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.497 ' HB ' ' O ' ' C' ' 255' ' ' ILE . 63.0 mt -77.18 141.06 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 109.879 -0.415 . . . . 74.34 109.879 175.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 21.6 p -130.03 176.68 7.87 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.777 1.231 . . . . 74.52 109.161 177.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.6 pp -137.71 158.41 71.75 Favored Pre-proline 0 CA--C 1.571 1.779 0 C-N-CA 123.625 0.77 . . . . 73.4 111.208 -175.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -55.96 -14.8 11.98 Favored 'Trans proline' 0 C--N 1.39 2.724 0 C-N-CA 123.843 3.028 . . . . 74.45 116.11 -167.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.661 ' HG2' HE21 ' C' ' 228' ' ' GLN . 39.9 mt-10 56.52 -69.98 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 125.53 1.532 . . . . 75.12 113.396 -173.008 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.36 146.19 36.83 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 108.939 -0.763 . . . . 75.12 108.939 169.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.619 HD22 ' HB2' ' A' ' 265' ' ' GLU . 66.6 mt -138.12 167.97 20.71 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.495 0.718 . . . . 72.32 109.23 172.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' THR . . . . . 0.582 ' HA ' HD21 ' B' ' 258' ' ' LEU . 71.6 p -129.75 154.13 80.95 Favored Pre-proline 0 CA--C 1.555 1.149 0 N-CA-C 107.596 -1.261 . . . . 74.31 107.596 169.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -33.65 -37.2 0.1 OUTLIER 'Trans proline' 0 C--N 1.397 3.128 0 C-N-CA 125.041 3.828 . . . . 74.33 117.221 -169.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -62.51 -68.17 0.35 Allowed 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.377 0.671 . . . . 71.44 111.798 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . 0.619 ' HB2' HD22 ' A' ' 261' ' ' LEU . 2.5 mp0 -65.25 -30.29 71.15 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 109.478 -0.564 . . . . 73.22 109.478 -176.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' GLU . . . . . 0.493 ' HA ' HD11 ' A' ' 261' ' ' LEU . 5.8 tp10 -53.21 -52.52 58.63 Favored 'General case' 0 CA--C 1.551 0.998 0 O-C-N 124.043 0.839 . . . . 73.45 109.401 174.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -61.83 -49.52 75.97 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 115.28 -0.873 . . . . 64.12 111.714 177.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 9.3 mp -56.78 -54.32 47.7 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.804 0.842 . . . . 73.14 112.145 -176.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 72.5 m95 -56.7 -49.1 76.13 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.949 0.899 . . . . 75.0 111.404 177.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . 0.665 ' HG3' HG23 ' C' ' 206' ' ' VAL . 1.1 mptm? -60.48 -34.89 74.69 Favored 'General case' 0 CA--C 1.552 1.039 0 O-C-N 123.678 0.611 . . . . 73.12 111.359 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 7.4 mmpt? -69.91 -46.87 64.45 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 117.993 0.361 . . . . 70.22 111.213 178.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' LEU . . . . . 0.428 HD23 ' HB2' ' C' ' 268' ' ' LEU . 80.9 mt -54.24 -39.83 67.16 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.827 0.851 . . . . 71.54 110.7 174.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -80.38 -41.52 24.51 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.786 1.234 . . . . 72.23 113.974 -170.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -64.93 -43.98 90.99 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 108.937 -0.764 . . . . 74.35 108.937 175.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -63.81 -38.57 91.6 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 114.909 -1.041 . . . . 72.24 110.934 173.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -59.91 -56.24 24.22 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.462 0.705 . . . . 75.02 110.109 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -63.67 -37.62 88.03 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.019 0.928 . . . . 72.14 109.967 -175.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -60.12 -26.13 66.0 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 115.463 -0.79 . . . . 75.41 111.89 173.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 49.7 mtm180 -107.38 -1.17 21.83 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.832 0.853 . . . . 75.15 111.72 178.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.248 0 N-CA-C 109.001 -0.74 . . . . 72.5 109.001 -179.231 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 111.437 0.162 . . . . 74.12 111.437 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.652 ' HB3' ' HZ1' ' B' ' 2' ' ' LYS . 0.4 OUTLIER -123.25 -1.85 8.64 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.377 0.671 . . . . 62.45 111.934 -178.734 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -93.2 0.62 57.18 Favored 'General case' 0 CA--C 1.559 1.307 0 N-CA-C 109.032 -0.729 . . . . 74.04 109.032 168.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 63.4 m -51.56 138.36 22.66 Favored 'General case' 0 C--N 1.357 0.903 0 C-N-CA 125.993 1.717 . . . . 52.14 113.165 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' THR . . . . . 0.589 HG22 HH11 ' A' ' 136' ' ' ARG . 0.3 OUTLIER -110.99 170.04 8.37 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.149 0.98 . . . . 74.34 110.108 -175.583 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.566 ' HB ' ' HG2' ' A' ' 124' ' ' PRO . 45.5 pt -132.64 173.49 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 N-CA-C 113.031 0.752 . . . . 65.34 113.031 -161.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -145.1 133.77 22.17 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.571 1.148 . . . . 72.22 108.875 171.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . 0.495 HD21 HG21 ' A' ' 140' ' ' VAL . 34.2 tp -72.83 150.77 42.42 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.868 0.867 . . . . 75.22 110.249 -176.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -79.35 -50.48 10.79 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 119.654 -0.212 . . . . 73.12 111.254 177.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 74.7 mt 62.93 109.2 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 124.338 1.055 . . . . 74.1 110.4 -167.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 85.5 mt -111.41 94.91 24.1 Favored Pre-proline 0 N--CA 1.478 0.936 0 N-CA-C 109.201 -0.666 . . . . 72.11 109.201 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -64.82 -52.71 1.17 Allowed 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 122.863 2.376 . . . . 71.41 111.897 175.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 pp -158.93 -17.6 0.07 Allowed 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 112.912 0.708 . . . . 75.11 112.912 177.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -74.72 100.91 4.12 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 109.014 -0.735 . . . . 64.54 109.014 -177.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -77.67 118.28 19.89 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 108.211 -1.033 . . . . 74.01 108.211 173.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' THR . . . . . 0.485 ' HB ' HG11 ' B' ' 18' ' ' VAL . 30.8 p -80.05 109.53 12.71 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 123.629 0.771 . . . . 71.11 110.899 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -85.42 46.05 1.69 Allowed 'Trans proline' 0 C--N 1.377 2.058 0 C-N-CA 122.904 2.402 . . . . 71.22 111.649 177.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.485 HG11 ' HB ' ' B' ' 16' ' ' THR . 8.1 m -57.34 89.2 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.12 0 C-N-CA 124.968 1.307 . . . . 63.3 112.36 -173.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 2.7 m 50.01 50.45 18.48 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.538 1.535 . . . . 71.22 110.217 -176.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -109.79 -10.53 14.77 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 114.825 -1.079 . . . . 74.33 110.21 176.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -172.38 98.7 0.15 Allowed 'General case' 0 C--O 1.24 0.591 0 C-N-CA 124.96 1.304 . . . . 75.34 107.985 173.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 73.9 mtm180 -77.54 -2.8 37.42 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 122.891 0.476 . . . . 73.31 111.071 175.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' THR . . . . . . . . . . . . . 98.5 m -109.13 100.92 42.86 Favored Pre-proline 0 CA--C 1.546 0.813 0 N-CA-C 107.926 -1.139 . . . . 72.54 107.926 158.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . 0.407 ' O ' ' HD2' ' B' ' 27' ' ' PRO . 98.1 Cg_endo -80.02 8.11 4.26 Favored 'Trans proline' 0 C--N 1.38 2.193 0 C-N-CA 122.604 2.203 . . . . 74.55 112.467 176.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -79.62 82.24 5.76 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.705 0.802 . . . . 74.53 109.157 175.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 25.4 ttt -172.57 -49.02 0.0 OUTLIER Pre-proline 0 CA--C 1.561 1.37 0 CA-C-O 118.05 -0.976 . . . . 75.13 110.831 173.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' PRO . . . . . 0.407 ' HD2' ' O ' ' B' ' 24' ' ' PRO . 65.7 Cg_exo -44.26 122.38 3.68 Favored 'Trans proline' 0 C--N 1.404 3.472 0 C-N-CA 122.942 2.428 . . . . 73.04 113.853 172.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 32.4 m -60.17 162.12 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 123.827 0.851 . . . . 75.25 112.091 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . 0.406 ' H ' HD22 ' B' ' 29' ' ' LEU . 2.0 pt? -127.38 -0.83 6.3 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.911 0.884 . . . . 73.34 110.219 179.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -130.04 -169.44 2.13 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.449 1.099 . . . . 71.25 110.523 -172.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 26.4 p30 -147.07 -167.63 2.83 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.35 1.06 . . . . 74.34 110.188 -173.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' ARG . . . . . 0.449 ' HB2' ' HB3' ' B' ' 317' ' ' SER . 6.5 ttp180 -109.1 5.79 24.35 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 124.138 0.975 . . . . 72.22 110.14 177.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.82 132.23 47.01 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.558 0.743 . . . . 73.31 111.702 -172.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . 67.32 17.41 10.2 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 125.317 1.447 . . . . 53.33 111.951 -175.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -123.32 -87.68 0.63 Allowed 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.409 0.684 . . . . 73.13 109.398 177.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 63.45 -85.45 0.05 OUTLIER Glycine 0 C--N 1.354 1.55 0 N-CA-C 111.772 -0.531 . . . . 74.33 111.772 -171.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . 0.525 ' HA ' ' HA3' ' C' ' 110' ' ' GLY . 3.0 p30 49.97 26.29 1.96 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 126.733 2.013 . . . . 61.44 115.679 170.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . 0.483 HG13 ' HD2' ' C' ' 109' ' ' PHE . 7.8 tt -163.33 132.52 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 CA-C-N 118.36 0.527 . . . . 75.44 110.243 173.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 18.1 p -134.96 -62.54 0.72 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.593 0.757 . . . . 73.32 110.436 -173.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.96 133.7 85.97 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 123.662 0.785 . . . . 73.24 111.82 -176.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -68.33 -58.37 0.12 Allowed 'Trans proline' 0 C--N 1.378 2.091 0 C-N-CA 122.728 2.285 . . . . 72.44 112.562 173.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.13 -74.14 1.46 Allowed Glycine 0 C--N 1.345 1.075 0 N-CA-C 111.865 -0.494 . . . . 61.22 111.865 -175.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . 0.637 ' HA2' ' HB2' ' B' ' 326' ' ' ASP . . . 137.41 144.94 4.84 Favored Glycine 0 C--N 1.342 0.913 0 N-CA-C 111.751 -0.539 . . . . 64.32 111.751 177.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . 0.403 ' HB1' ' H ' ' C' ' 142' ' ' GLY . . . -151.68 91.46 1.65 Allowed 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 112.609 0.596 . . . . 63.2 112.609 -171.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.438 ' NH1' ' HB2' ' B' ' 327' ' ' LYS . 0.0 OUTLIER -172.97 173.99 3.61 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 124.729 1.211 . . . . 74.21 109.431 169.07 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' ARG . . . . . 0.572 ' HB3' ' HA ' ' B' ' 179' ' ' ALA . 37.4 ttt-85 -83.53 53.27 2.46 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-O 121.735 0.779 . . . . 75.02 110.666 -178.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 3.1 tt -91.35 70.79 6.07 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 106.39 -1.708 . . . . 72.13 106.39 176.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 9.0 t -172.72 -32.34 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 113.527 -1.669 . . . . 73.12 108.49 -170.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.98 73.78 1.46 Allowed Glycine 0 C--N 1.359 1.823 0 CA-C-N 115.85 -0.614 . . . . 74.15 111.671 176.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -79.89 114.15 18.59 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.284 1.034 . . . . 64.2 110.128 -176.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' GLN . . . . . 0.442 ' HB2' HD21 ' B' ' 55' ' ' LEU . 4.0 pt20 37.45 76.61 0.05 Allowed 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 126.198 1.799 . . . . 75.3 113.747 176.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 57.0 p -106.84 104.93 14.73 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.386 0.675 . . . . 73.31 110.784 -176.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . 62.28 -78.25 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 125.193 1.397 . . . . 73.24 112.508 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.72 93.12 0.24 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.077 0.951 . . . . 75.51 110.715 -178.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . 0.442 HD21 ' HB2' ' B' ' 51' ' ' GLN . 46.7 tp -147.05 125.43 12.32 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 107.606 -1.257 . . . . 72.35 107.606 177.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 56.2 ttt180 71.41 -77.65 0.05 Allowed 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 125.199 1.4 . . . . 74.21 111.611 175.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -54.64 -50.58 67.8 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.996 1.318 . . . . 75.31 113.811 -166.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 48.1 t 68.51 -8.56 0.6 Allowed 'General case' 0 CA--C 1.56 1.35 0 C-N-CA 124.155 0.982 . . . . 62.01 113.393 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 72.7 mt 58.28 18.36 5.39 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 124.982 1.313 . . . . 72.44 112.693 -178.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' SER . . . . . 0.478 ' HB2' ' HB3' ' B' ' 346' ' ' ALA . 25.2 t -76.94 -42.4 39.38 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.37 -0.604 . . . . 71.31 109.37 179.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 32.7 t70 62.33 97.92 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.783 1.633 . . . . 71.45 110.922 -178.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' LYS . . . . . . . . . . . . . 65.2 mttm 64.86 92.48 0.06 OUTLIER Pre-proline 0 N--CA 1.479 1.024 0 C-N-CA 124.748 1.219 . . . . 72.42 111.409 176.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -62.48 148.68 92.94 Favored 'Trans proline' 0 C--N 1.369 1.634 0 C-N-CA 122.366 2.044 . . . . 72.24 112.629 172.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 58.91 37.04 24.8 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.121 0.968 . . . . 72.04 111.712 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -84.27 27.87 0.66 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.95 0.9 . . . . 73.42 112.991 -174.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -54.6 -49.99 69.12 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.992 1.317 . . . . 72.41 112.72 -173.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 37.3 pt -123.76 23.32 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 N-CA-C 112.506 0.558 . . . . 74.04 112.506 -173.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 34.9 pt -69.24 117.24 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 CA-C-N 118.351 0.523 . . . . 73.4 109.891 177.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 75.5 mt 63.44 10.11 4.6 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.349 1.06 . . . . 74.34 111.789 -174.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 84.0 mt -129.12 18.02 6.05 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.702 1.201 . . . . 65.22 109.944 -176.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 11.8 tt -66.8 118.2 9.6 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 N-CA-C 109.054 -0.721 . . . . 75.5 109.054 175.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 171.28 -165.73 38.8 Favored Glycine 0 C--O 1.243 0.694 0 N-CA-C 111.47 -0.652 . . . . 71.15 111.47 -176.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 61.71 -169.87 0.17 Allowed 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.292 1.037 . . . . 74.12 111.73 -178.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 83.81 -62.35 4.61 Favored Glycine 0 C--N 1.35 1.332 0 N-CA-C 112.323 -0.311 . . . . 72.45 112.323 -178.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 62.1 mtm -71.22 89.05 0.85 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.894 0.878 . . . . 74.01 109.582 178.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . 0.512 ' H ' HD21 ' B' ' 265' ' ' LEU . . . 86.6 53.34 2.93 Favored Glycine 0 C--N 1.344 0.973 0 CA-C-N 115.425 -0.807 . . . . 71.52 111.393 -174.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . 0.554 ' HB3' ' HB ' ' B' ' 80' ' ' ILE . 22.5 t70 -107.98 157.99 17.75 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.252 0.621 . . . . 74.35 110.683 -175.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 44.1 m -69.24 -37.43 77.97 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.847 0.859 . . . . 55.34 112.279 -177.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . 0.417 ' HB3' HH12 ' B' ' 84' ' ' ARG . 41.8 mt-10 -92.01 -47.52 7.24 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.69 0.796 . . . . 74.44 110.474 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . 0.554 ' HB ' ' HB3' ' B' ' 77' ' ' ASP . 2.7 mp -74.52 86.88 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 108.053 -1.091 . . . . 72.52 108.053 175.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 11.8 t -178.09 -37.03 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.248 1.419 . . . . 74.52 108.622 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -174.4 -88.87 0.01 OUTLIER 'General case' 0 C--N 1.361 1.081 0 C-N-CA 124.399 1.079 . . . . 75.12 109.575 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . 60.64 -77.67 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 125.579 1.552 . . . . 74.13 112.956 178.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 84' ' ' ARG . . . . . 0.471 ' NH2' ' HA ' ' B' ' 236' ' ' THR . 0.2 OUTLIER -105.51 112.67 25.85 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 108.451 -0.944 . . . . 73.0 108.451 179.896 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 69.58 117.29 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.607 1.163 . . . . 72.23 111.745 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 20.8 p90 -172.6 143.98 1.39 Allowed 'General case' 0 C--O 1.241 0.641 0 C-N-CA 124.912 1.285 . . . . 74.21 109.011 -175.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . 0.535 ' H ' ' HA ' ' B' ' 262' ' ' ALA . . . 60.34 81.34 0.18 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.448 1.099 . . . . 52.24 111.796 175.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -55.46 173.31 0.12 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.223 1.409 . . . . 74.14 113.179 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -78.23 31.08 1.84 Allowed Glycine 0 CA--C 1.536 1.348 0 CA-C-N 115.866 -0.606 . . . . 54.33 114.081 178.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . 60.47 72.58 0.52 Allowed 'General case' 0 C--N 1.352 0.714 0 C-N-CA 125.392 1.477 . . . . 75.53 111.897 176.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -74.11 -54.43 6.33 Favored Glycine 0 C--N 1.339 0.705 0 N-CA-C 110.306 -1.118 . . . . 70.11 110.306 170.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.72 -129.58 9.37 Favored Glycine 0 C--N 1.348 1.21 0 CA-C-N 115.057 -0.572 . . . . 73.42 113.862 171.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 53.54 -90.48 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.175 1.39 . . . . 74.22 111.384 -174.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 94' ' ' PHE . . . . . 0.451 ' HB2' ' O ' ' B' ' 256' ' ' TYR . 18.1 p90 160.5 -30.7 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 126.783 2.033 . . . . 72.14 108.036 -176.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . 0.5 ' HE2' HG22 ' A' ' 262' ' ' THR . 56.0 tttm -137.62 26.19 2.82 Favored 'General case' 0 CA--C 1.556 1.199 0 CA-C-N 114.448 -1.251 . . . . 74.44 109.341 -173.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . -66.79 -5.91 33.96 Favored Glycine 0 N--CA 1.482 1.765 0 N-CA-C 115.476 0.95 . . . . 75.21 115.476 -173.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 97' ' ' ILE . . . . . 0.736 HD11 HH22 ' C' ' 226' ' ' ARG . 41.6 mt -76.99 -32.52 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.163 0 C-N-CA 123.346 0.659 . . . . 73.0 110.344 173.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -129.86 124.7 33.87 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.811 0.844 . . . . 75.21 110.304 -178.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.95 -59.12 2.91 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.112 0.565 . . . . 61.12 110.555 179.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -144.05 135.13 12.47 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 124.065 0.946 . . . . 74.2 108.992 177.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -51.22 137.38 46.32 Favored 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 122.996 2.464 . . . . 74.43 112.697 175.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -79.69 77.85 6.28 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.093 0.957 . . . . 73.12 110.43 -170.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 70.0 p -90.7 124.71 35.3 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.42 0.688 . . . . 75.52 110.182 -174.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . -79.17 -11.0 85.54 Favored Glycine 0 C--N 1.348 1.216 0 O-C-N 123.198 0.311 . . . . 51.35 113.063 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 19.6 tp60 73.57 13.41 4.45 Favored 'General case' 0 CA--C 1.565 1.519 0 C-N-CA 125.419 1.487 . . . . 75.22 111.479 177.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 62.99 93.98 0.05 Allowed 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.574 1.55 . . . . 74.44 112.822 176.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 107' ' ' THR . . . . . 0.402 HG23 ' H ' ' B' ' 109' ' ' TYR . 2.8 t -107.87 162.84 13.64 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 107.764 -1.199 . . . . 75.34 107.764 165.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 45.0 p-80 -75.19 -19.68 59.69 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 122.371 0.268 . . . . 73.44 111.514 -177.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.402 ' H ' HG23 ' B' ' 107' ' ' THR . 85.1 m-85 62.68 -79.16 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.592 1.557 . . . . 74.1 110.505 -174.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -138.86 -81.39 0.31 Allowed 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 108.493 -0.928 . . . . 75.22 108.493 174.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 63.9 tp -175.69 -60.61 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.792 1.237 . . . . 70.25 107.874 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 112' ' ' ASN . . . . . 0.401 ' OD1' ' HB1' ' A' ' 222' ' ' ALA . 26.4 t-20 58.71 -82.78 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 124.698 1.199 . . . . 73.2 110.037 -170.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 113' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? 52.76 89.8 0.03 OUTLIER 'General case' 0 C--N 1.363 1.156 0 C-N-CA 125.078 1.351 . . . . 75.13 110.721 176.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 114' ' ' LYS . . . . . 0.498 ' HA ' ' HD3' ' B' ' 440' ' ' ARG . 24.8 pttm -71.61 -14.94 62.22 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 112.594 0.59 . . . . 74.21 112.594 -171.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 25.3 m 72.46 -55.0 0.68 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 125.938 1.695 . . . . 73.23 111.071 -176.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 114.02 34.98 1.57 Allowed Glycine 0 C--N 1.344 1.026 0 N-CA-C 111.325 -0.71 . . . . 55.33 111.325 177.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . 0.449 ' H ' ' HD2' ' B' ' 118' ' ' PRO . 59.9 tttp -162.38 -69.22 0.01 OUTLIER Pre-proline 0 CA--C 1.557 1.242 0 CA-C-O 117.793 -1.098 . . . . 75.35 111.089 -177.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 118' ' ' PRO . . . . . 0.449 ' HD2' ' H ' ' B' ' 117' ' ' LYS . 13.3 Cg_exo -11.49 49.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.404 3.497 1 C-N-CA 127.17 5.247 . . . . 63.21 118.437 -155.262 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 119' ' ' ASP . . . . . . . . . . . . . 20.6 t70 177.12 154.86 0.26 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.671 1.189 . . . . 75.33 109.265 -177.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 120' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -151.67 11.18 0.58 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.46 1.104 . . . . 70.1 110.219 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 56.3 t -132.83 -70.97 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 123.776 0.831 . . . . 74.32 110.666 -172.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 44.7 m -83.19 82.81 8.1 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.018 0.927 . . . . 75.25 111.089 -170.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -170.63 104.48 0.26 Allowed 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 107.627 -1.249 . . . . 70.53 107.627 171.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 44.1 t -90.54 -80.19 0.33 Allowed 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 123.327 0.651 . . . . 61.03 111.538 -173.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . 58.7 25.79 13.79 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 124.399 1.08 . . . . 74.53 111.527 -172.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -69.49 -54.32 14.84 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 123.502 0.721 . . . . 74.13 110.61 -174.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 12.4 p 42.53 35.88 0.72 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 126.019 1.728 . . . . 70.01 113.304 175.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . 0.464 ' N ' ' SD ' ' B' ' 157' ' ' MET . . . -67.45 -59.69 3.17 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.779 1.231 . . . . 74.33 111.016 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 33.1 m -75.57 88.99 2.72 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.306 -0.998 . . . . 74.41 108.306 170.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . -69.53 175.48 4.08 Favored 'General case' 0 C--O 1.248 1.002 0 CA-C-N 115.427 -0.806 . . . . 61.42 110.466 177.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 131' ' ' TRP . . . . . 0.411 ' HB2' HG23 ' B' ' 133' ' ' THR . 4.3 m-90 66.02 9.1 5.92 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 124.714 1.205 . . . . 73.51 111.551 -178.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 37.9 m 44.89 36.57 1.95 Allowed 'General case' 0 CA--C 1.559 1.326 0 C-N-CA 124.797 1.239 . . . . 74.11 112.151 -174.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 133' ' ' THR . . . . . 0.411 HG23 ' HB2' ' B' ' 131' ' ' TRP . 11.4 p -73.72 86.71 1.68 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.462 0.705 . . . . 74.52 111.074 -177.047 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . -137.9 -141.43 4.19 Favored Glycine 0 C--N 1.343 0.968 0 CA-C-N 115.374 -0.83 . . . . 55.15 111.029 177.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 135' ' ' VAL . . . . . 0.581 HG23 ' H ' ' B' ' 137' ' ' THR . 12.5 p -145.68 147.07 18.86 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 CA-C-N 117.683 0.742 . . . . 73.24 110.446 -177.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 136' ' ' LYS . . . . . 0.51 ' HE3' ' HA ' ' B' ' 215' ' ' GLU . 13.1 ptmm? -80.21 -13.91 58.86 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.304 0.641 . . . . 74.24 111.696 178.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 137' ' ' THR . . . . . 0.581 ' H ' HG23 ' B' ' 135' ' ' VAL . 87.0 m 72.52 102.29 0.07 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.492 1.517 . . . . 75.31 111.626 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 45.4 t80 69.04 151.03 0.08 Allowed 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 125.859 1.664 . . . . 75.52 112.49 177.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . 0.558 HD22 HG23 ' B' ' 329' ' ' ILE . 32.3 m-80 -50.38 -48.68 55.79 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.771 1.228 . . . . 73.24 111.885 176.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . 90.15 127.54 3.43 Favored Glycine 0 C--N 1.343 0.933 0 CA-C-N 115.483 -0.78 . . . . 75.54 111.306 -176.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -149.85 160.52 43.51 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.795 0.438 . . . . 75.34 111.368 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . 0.406 ' HA ' ' SG ' ' B' ' 190' ' ' CYS . 67.2 mt 71.63 -12.71 0.62 Allowed 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 125.607 1.563 . . . . 74.24 113.821 172.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.64 -2.06 64.69 Favored Glycine 0 C--N 1.35 1.319 0 CA-C-N 117.823 0.283 . . . . 61.25 113.366 -173.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 7.3 t -111.06 15.67 8.21 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.308 0 C-N-CA 123.936 0.894 . . . . 75.31 109.777 -176.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -90.76 134.93 34.06 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.156 0.582 . . . . 75.32 109.517 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 10.6 mt 62.52 28.73 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 C-N-CA 125.026 1.33 . . . . 72.52 110.067 -174.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -63.14 -38.68 92.12 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 125.087 1.355 . . . . 72.43 110.994 -178.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -83.05 130.4 35.13 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.601 -0.727 . . . . 75.05 110.895 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 149' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -140.11 88.56 2.23 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.857 0.863 . . . . 74.13 109.441 176.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -81.02 -40.96 23.44 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 108.5 -0.926 . . . . 74.11 108.5 164.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 151' ' ' HIS . . . . . 0.435 ' HA ' ' HD2' ' B' ' 152' ' ' PRO . 62.3 m-70 -111.69 105.73 56.66 Favored Pre-proline 0 C--O 1.242 0.667 0 CA-C-N 114.329 -1.305 . . . . 74.43 108.381 173.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 152' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' B' ' 151' ' ' HIS . 16.5 Cg_endo -55.45 -32.88 84.03 Favored 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 123.367 2.711 . . . . 64.13 111.912 174.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 43.8 p 54.32 -87.16 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 126.322 1.849 . . . . 74.2 112.68 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 154' ' ' ILE . . . . . 0.556 HG13 ' HE2' ' A' ' 250' ' ' TYR . 40.2 mm 48.52 74.52 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.359 1.008 0 C-N-CA 124.74 1.216 . . . . 74.25 109.434 -170.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 75.1 mt -74.73 71.69 1.96 Allowed 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 114.915 -1.038 . . . . 73.12 110.647 -174.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 23.5 -72.95 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 127.829 2.451 . . . . 72.23 115.783 170.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 157' ' ' MET . . . . . 0.464 ' SD ' ' N ' ' B' ' 128' ' ' ALA . 45.0 mtm -91.0 -48.1 7.18 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.518 1.127 . . . . 61.13 110.758 -173.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 158' ' ' ALA . . . . . . . . . . . . . . . -74.43 -25.71 59.61 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 114.825 -1.08 . . . . 65.11 112.875 -172.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . 0.531 ' HE3' ' HA ' ' B' ' 159' ' ' LYS . 1.0 OUTLIER -97.55 75.37 2.48 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.504 0.669 . . . . 73.24 109.297 -176.369 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.92 157.3 26.26 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 114.685 -1.143 . . . . 74.34 108.779 178.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.56 82.85 2.02 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 122.768 0.427 . . . . 71.1 110.423 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 162' ' ' GLY . . . . . 0.47 ' HA2' ' HA3' ' B' ' 166' ' ' GLY . . . -91.87 -73.02 1.24 Allowed Glycine 0 C--N 1.353 1.501 0 N-CA-C 111.141 -0.784 . . . . 73.4 111.141 177.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 60.29 -78.1 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 125.182 1.393 . . . . 75.25 112.47 173.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 164' ' ' ALA . . . . . . . . . . . . . . . -104.12 -55.32 2.39 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.571 0.748 . . . . 75.34 109.789 178.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 165' ' ' THR . . . . . 0.454 HG23 ' HB3' ' B' ' 174' ' ' GLN . 28.9 p -122.42 -75.2 0.6 Allowed 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 115.404 -0.816 . . . . 73.14 110.162 -176.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 166' ' ' GLY . . . . . 0.47 ' HA3' ' HA2' ' B' ' 162' ' ' GLY . . . 92.18 -135.37 12.69 Favored Glycine 0 C--N 1.346 1.123 0 N-CA-C 113.426 0.13 . . . . 74.53 113.426 177.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 167' ' ' ASN . . . . . 0.442 HD22 ' HB2' ' B' ' 221' ' ' ARG . 0.2 OUTLIER -92.21 42.01 1.09 Allowed 'General case' 0 CA--C 1.552 1.021 0 CA-C-O 121.811 0.815 . . . . 74.33 109.168 -173.61 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . 0.536 HG23 ' H ' ' B' ' 170' ' ' THR . 23.7 m -76.99 -5.43 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.252 1.021 . . . . 75.53 111.843 177.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 15.1 m 70.21 -0.86 2.65 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 125.428 1.491 . . . . 65.53 112.025 -177.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 170' ' ' THR . . . . . 0.536 ' H ' HG23 ' B' ' 168' ' ' VAL . 57.3 m 56.6 107.76 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 126.035 1.734 . . . . 73.13 112.786 -173.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -97.89 14.66 26.39 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.955 0.902 . . . . 73.41 110.861 174.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 172' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 64.24 14.53 8.74 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 125.847 1.659 . . . . 75.25 112.659 -177.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 173' ' ' LEU . . . . . . . . . . . . . 82.1 mt -116.95 13.63 14.94 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.282 0.633 . . . . 74.44 111.889 -173.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 174' ' ' GLN . . . . . 0.454 ' HB3' HG23 ' B' ' 165' ' ' THR . 78.5 mt-30 -138.65 -59.62 0.61 Allowed 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 111.993 0.368 . . . . 74.45 111.993 -168.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 175' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -66.02 119.49 11.46 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.334 1.053 . . . . 74.1 111.772 -170.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -156.2 -175.13 5.27 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.931 0.892 . . . . 74.11 110.668 -174.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 93.7 m -127.58 117.58 21.24 Favored Pre-proline 0 CA--C 1.555 1.167 0 C-N-CA 123.899 0.88 . . . . 74.15 109.923 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 178' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -76.5 -30.35 5.2 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 122.728 2.285 . . . . 74.53 113.846 -178.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 179' ' ' ALA . . . . . 0.572 ' HA ' ' HB3' ' B' ' 46' ' ' ARG . . . -88.04 171.58 10.18 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.3 0.64 . . . . 74.35 110.97 -177.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . -67.91 -46.38 71.74 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-O 121.347 0.594 . . . . 75.32 109.431 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 181' ' ' LEU . . . . . 0.566 ' HB2' ' HB3' ' C' ' 136' ' ' ARG . 33.3 tp -116.61 -96.57 0.46 Allowed 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 105.856 -1.905 . . . . 74.44 105.856 154.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 182' ' ' VAL . . . . . 0.567 HG12 ' HB2' ' C' ' 123' ' ' LEU . 7.4 p 156.74 138.6 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.245 0.857 0 C-N-CA 126.777 2.031 . . . . 72.43 105.688 -178.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 183' ' ' ALA . . . . . 0.725 ' HA ' ' HB3' ' C' ' 123' ' ' LEU . . . -160.76 -103.28 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 118.907 -0.568 . . . . 65.24 111.168 176.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 59.54 142.86 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 124.142 0.977 . . . . 75.32 111.372 -164.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 185' ' ' VAL . . . . . 0.541 HG11 ' HB3' ' B' ' 322' ' ' ALA . 50.8 t -69.48 157.24 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.733 0 C-N-CA 123.581 0.752 . . . . 74.01 112.707 -170.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 186' ' ' THR . . . . . 0.772 ' HA ' ' HB2' ' C' ' 122' ' ' GLU . 16.3 p -40.94 138.81 0.98 Allowed 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 126.673 1.989 . . . . 60.24 114.587 -177.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 187' ' ' SER . . . . . 0.579 ' HA ' ' HG2' ' B' ' 324' ' ' MET . 16.3 m -138.37 -67.93 0.46 Allowed 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 115.472 -0.786 . . . . 62.14 112.231 -170.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 188' ' ' ARG . . . . . 0.552 ' NH2' ' HG2' ' B' ' 330' ' ' GLU . 11.4 ptp180 -91.71 67.81 5.45 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 121.808 0.813 . . . . 72.32 111.95 -166.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -142.12 -85.89 0.17 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.063 0.945 . . . . 72.52 109.001 175.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 190' ' ' CYS . . . . . 0.457 ' SG ' ' HA2' ' B' ' 208' ' ' GLY . 84.5 m -154.68 82.43 1.1 Allowed 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 108.362 -0.977 . . . . 70.33 108.362 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 191' ' ' TYR . . . . . 0.479 ' HA ' ' HA ' ' B' ' 320' ' ' THR . 35.5 t80 -99.78 149.73 23.06 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 116.05 -0.523 . . . . 74.04 109.863 -178.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -169.75 -164.26 25.16 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 110.767 -0.933 . . . . 64.22 110.767 176.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 193' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.68 -72.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.372 1.807 0 C-N-CA 122.424 2.083 . . . . 73.22 112.753 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 194' ' ' SER . . . . . . . . . . . . . 29.8 t -156.14 37.15 0.34 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.171 0.589 . . . . 63.44 109.771 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 195' ' ' ALA . . . . . . . . . . . . . . . -63.15 -72.56 0.13 Allowed 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.549 -0.75 . . . . 74.32 112.234 -171.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 196' ' ' THR . . . . . 0.516 ' HB ' ' HB3' ' B' ' 200' ' ' CYS . 29.1 p -97.12 1.74 50.32 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.153 0.581 . . . . 73.32 112.092 -176.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 197' ' ' SER . . . . . 0.459 ' HA ' HG21 ' B' ' 318' ' ' VAL . 82.3 p -67.47 -37.92 83.63 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.202 0.601 . . . . 75.11 111.386 -177.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 198' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -84.59 -36.65 21.92 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.61 -0.723 . . . . 65.14 111.593 -178.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -152.18 123.52 7.72 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 122.882 0.473 . . . . 75.14 110.596 -176.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 200' ' ' CYS . . . . . 0.605 ' SG ' HG13 ' B' ' 318' ' ' VAL . 27.2 p -164.85 154.38 11.7 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 125.053 1.341 . . . . 73.31 108.994 179.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 201' ' ' PRO . . . . . 0.464 ' HB2' ' HB3' ' B' ' 204' ' ' ALA . 30.1 Cg_exo -64.95 149.83 88.93 Favored 'Trans proline' 0 C--N 1.37 1.664 0 C-N-CA 121.996 1.797 . . . . 74.02 110.971 164.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . -58.59 101.59 0.22 Allowed Glycine 0 C--N 1.349 1.274 0 O-C-N 123.546 0.529 . . . . 73.41 113.852 -174.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 65.61 40.83 4.31 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.828 1.251 . . . . 71.33 111.719 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 204' ' ' ALA . . . . . 0.464 ' HB3' ' HB2' ' B' ' 201' ' ' PRO . . . -73.54 114.3 11.62 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.628 -0.715 . . . . 74.01 109.882 171.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 205' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 60.61 34.35 20.18 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.549 1.14 . . . . 72.44 111.06 -177.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -55.86 -40.57 73.11 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.974 0.91 . . . . 70.3 112.601 -177.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -76.29 -24.58 54.42 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.579 0.752 . . . . 74.32 111.487 -178.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 208' ' ' GLY . . . . . 0.457 ' HA2' ' SG ' ' B' ' 190' ' ' CYS . . . 82.86 -60.72 4.85 Favored Glycine 0 C--N 1.347 1.19 0 O-C-N 123.199 0.312 . . . . 71.52 112.923 179.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . -62.46 -13.01 42.44 Favored Glycine 0 C--N 1.351 1.384 0 CA-C-O 119.802 -0.444 . . . . 63.34 113.237 172.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt 76.12 -65.77 0.3 Allowed 'General case' 0 C--N 1.364 1.234 0 C-N-CA 125.348 1.459 . . . . 74.51 111.098 168.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . -91.91 11.42 72.17 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-O 119.895 -0.392 . . . . 74.43 112.498 170.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 49.0 m 58.41 19.43 6.44 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.845 1.258 . . . . 74.04 112.308 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 2.1 pp -87.12 176.21 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 124.299 1.039 . . . . 70.12 110.502 177.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 29.5 m 77.01 -37.73 0.28 Allowed 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 125.234 1.414 . . . . 75.43 112.061 -178.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 215' ' ' GLU . . . . . 0.51 ' HA ' ' HE3' ' B' ' 136' ' ' LYS . 68.6 mm-40 -62.35 -74.41 0.09 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.12 0.968 . . . . 73.31 112.104 174.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 216' ' ' GLN . . . . . 0.427 ' NE2' HH12 ' C' ' 179' ' ' ARG . 12.6 mm-40 -100.76 94.53 6.12 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.014 0.525 . . . . 61.42 110.003 -176.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 93.7 mt -97.45 16.33 20.52 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 114.998 -1.001 . . . . 75.4 111.288 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 19.3 mt -109.25 100.41 9.54 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.559 0.743 . . . . 71.43 110.002 -170.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 219' ' ' ASN . . . . . 0.612 HD22 ' HA3' ' A' ' 230' ' ' GLY . 3.9 p-10 -97.96 53.32 1.09 Allowed 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 123.978 0.911 . . . . 71.24 109.769 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . 68.44 -88.81 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.297 1.439 . . . . 74.3 110.467 -170.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 221' ' ' ARG . . . . . 0.442 ' HB2' HD22 ' B' ' 167' ' ' ASN . 56.6 mtp180 57.67 111.5 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.773 1.229 . . . . 73.55 112.579 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -79.86 81.47 6.12 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 107.548 -1.278 . . . . 75.21 107.548 165.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -67.52 108.74 2.95 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-N 115.354 -0.839 . . . . 72.13 109.847 -170.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 21.4 t 65.07 7.86 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.577 2.01 0 C-N-CA 125.176 1.39 . . . . 75.32 110.504 -175.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 2.5 m 53.69 21.92 2.86 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 125.904 1.682 . . . . 73.55 111.21 -173.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 22.2 tp -90.92 -8.84 48.22 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.861 0.864 . . . . 74.43 110.615 -175.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . -62.73 -54.02 36.83 Favored Glycine 0 C--N 1.358 1.751 0 C-N-CA 123.033 0.349 . . . . 71.24 113.313 178.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 177.07 137.2 2.62 Favored Glycine 0 C--N 1.341 0.822 0 N-CA-C 111.56 -0.616 . . . . 72.41 111.56 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -83.09 -171.69 47.74 Favored Glycine 0 C--N 1.345 1.054 0 N-CA-C 114.015 0.366 . . . . 71.04 114.015 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -144.16 114.01 7.24 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.716 0.807 . . . . 70.23 110.296 -174.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 231' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -154.84 41.64 0.46 Allowed 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 125.04 1.336 . . . . 73.24 110.066 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 33.2 m -80.79 91.65 5.96 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-O 121.089 0.471 . . . . 74.24 110.383 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -79.62 83.36 5.61 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.654 0.781 . . . . 71.44 109.834 176.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -168.71 88.27 0.21 Allowed 'General case' 0 C--O 1.243 0.735 0 C-N-CA 125.148 1.379 . . . . 72.31 107.543 178.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -86.87 -100.64 0.07 Allowed 'General case' 0 CA--C 1.555 1.139 0 CA-C-N 115.668 -0.696 . . . . 64.41 111.416 -169.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 236' ' ' THR . . . . . 0.471 ' HA ' ' NH2' ' B' ' 84' ' ' ARG . 5.2 m 54.51 18.84 2.12 Favored 'General case' 0 CA--C 1.566 1.591 0 C-N-CA 124.815 1.246 . . . . 73.34 112.138 -175.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . 0.427 ' O ' ' HE3' ' B' ' 294' ' ' LYS . . . 52.92 78.32 0.14 Allowed 'General case' 0 C--N 1.357 0.923 0 C-N-CA 125.17 1.388 . . . . 73.03 111.33 -169.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 238' ' ' THR . . . . . 0.419 HG23 HG23 ' C' ' 219' ' ' VAL . 13.3 m -71.13 -36.28 72.04 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 121.488 0.661 . . . . 71.31 109.797 174.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -83.64 173.23 11.56 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 114.518 -1.219 . . . . 74.42 111.15 177.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . -83.17 -130.7 1.65 Allowed Glycine 0 C--N 1.346 1.126 0 CA-C-N 115.369 -0.832 . . . . 71.23 112.651 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -151.69 156.1 39.68 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.695 0.798 . . . . 71.23 108.96 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 242' ' ' TRP . . . . . 0.471 ' CD2' ' HG ' ' C' ' 233' ' ' LEU . 1.2 p-90 -168.04 115.85 0.73 Allowed 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 113.251 0.834 . . . . 70.32 113.251 -175.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 24.83 74.23 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 128.072 2.549 . . . . 74.22 115.307 166.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 126.58 -142.62 13.72 Favored Glycine 0 C--N 1.341 0.822 0 CA-C-N 115.49 -0.777 . . . . 71.54 112.396 178.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? 89.5 83.74 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 127.159 2.183 . . . . 75.34 110.145 -175.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 246' ' ' THR . . . . . 0.466 HG23 ' HG2' ' C' ' 225' ' ' PRO . 3.5 t -92.25 -168.89 2.09 Favored 'General case' 0 CA--C 1.561 1.37 0 N-CA-C 106.925 -1.509 . . . . 71.14 106.925 155.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 247' ' ' LEU . . . . . 0.503 ' HG ' ' H ' ' B' ' 248' ' ' ARG . 12.1 tp -143.84 178.19 8.0 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 119.872 1.215 . . . . 72.51 109.938 173.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 248' ' ' ARG . . . . . 0.503 ' H ' ' HG ' ' B' ' 247' ' ' LEU . 0.0 OUTLIER -132.56 148.75 52.38 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.416 0.687 . . . . 75.15 112.096 -169.136 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 249' ' ' GLU . . . . . 0.685 ' HB3' ' HB2' ' B' ' 260' ' ' SER . 7.5 tp10 -159.95 128.56 4.94 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 114.163 -1.38 . . . . 71.33 108.21 178.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -77.54 -50.02 13.47 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 122.826 0.45 . . . . 70.14 110.648 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 251' ' ' ALA . . . . . . . . . . . . . . . 39.3 -100.29 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 125.961 1.704 . . . . 64.21 113.72 -177.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -138.98 27.38 2.4 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.478 1.111 . . . . 73.12 108.64 175.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -79.18 67.16 4.83 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.446 1.098 . . . . 51.41 108.975 172.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 3.5 ptp180 -112.14 97.46 6.67 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 114.82 -1.082 . . . . 72.51 109.173 -174.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . 81.82 -24.62 4.4 Favored Glycine 0 C--N 1.342 0.894 0 CA-C-O 119.66 -0.522 . . . . 63.32 113.329 -177.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 256' ' ' TYR . . . . . 0.451 ' O ' ' HB2' ' B' ' 94' ' ' PHE . 92.8 m-85 -70.75 -95.61 0.01 OUTLIER 'General case' 0 C--N 1.355 0.837 0 C-N-CA 123.328 0.651 . . . . 71.2 109.247 176.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 16.4 pm0 -104.83 167.23 9.85 Favored 'General case' 0 C--N 1.355 0.829 0 CA-C-O 121.478 0.656 . . . . 74.31 110.492 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 258' ' ' LEU . . . . . 0.582 HD21 ' HA ' ' A' ' 262' ' ' THR . 0.3 OUTLIER -91.31 102.96 15.67 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 114.719 -1.128 . . . . 75.13 110.361 178.491 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . 0.537 ' HB ' ' H ' ' B' ' 249' ' ' GLU . 34.3 m 46.73 -163.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 C-N-CA 126.187 1.795 . . . . 63.31 113.993 -177.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 260' ' ' SER . . . . . 0.685 ' HB2' ' HB3' ' B' ' 249' ' ' GLU . 48.7 m -135.13 121.01 19.71 Favored 'General case' 0 C--N 1.36 1.037 0 O-C-N 121.869 -0.519 . . . . 73.11 111.419 178.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -64.99 -29.11 70.01 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.904 0.882 . . . . 65.51 110.923 171.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 262' ' ' ALA . . . . . 0.535 ' HA ' ' H ' ' B' ' 87' ' ' ALA . . . -57.67 -8.82 0.98 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.208 1.003 . . . . 75.22 113.116 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . 79.94 -69.91 0.1 Allowed 'General case' 0 C--N 1.356 0.851 0 C-N-CA 126.169 1.787 . . . . 70.44 109.796 173.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 45.4 t 67.13 179.27 0.22 Allowed 'General case' 0 CA--C 1.558 1.265 0 O-C-N 124.314 1.008 . . . . 51.14 111.478 173.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 265' ' ' LEU . . . . . 0.512 HD21 ' H ' ' B' ' 76' ' ' GLY . 1.0 OUTLIER -95.16 100.76 12.52 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 109.281 -0.637 . . . . 73.31 109.281 -178.143 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 266' ' ' ASN . . . . . 0.459 ' HA ' ' OG1' ' B' ' 269' ' ' THR . 17.2 t-20 -94.34 175.0 6.85 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 124.007 0.923 . . . . 71.52 111.213 -174.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 21.2 m 86.0 -47.99 0.06 Allowed 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 126.925 2.09 . . . . 73.13 112.191 172.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 7.2 p -112.42 22.11 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 123.097 0.559 . . . . 74.44 109.57 175.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 269' ' ' THR . . . . . 0.459 ' OG1' ' HA ' ' B' ' 266' ' ' ASN . 3.9 m -53.75 -48.91 69.23 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.939 0.895 . . . . 74.31 112.032 -174.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 270' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 60.95 -83.26 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.989 0 O-C-N 124.496 1.122 . . . . 72.41 111.723 -178.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 271' ' ' ALA . . . . . . . . . . . . . . . -152.8 -171.68 4.01 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 124.079 0.952 . . . . 75.3 109.956 -175.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 272' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 61.51 -86.28 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.09 1.356 . . . . 73.11 110.687 -178.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 45.9 tp60 43.53 65.37 1.01 Allowed 'General case' 0 C--N 1.353 0.734 0 C-N-CA 125.537 1.535 . . . . 73.43 111.395 -174.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -87.43 12.16 12.86 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 114.124 -1.398 . . . . 71.44 110.793 -177.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 275' ' ' LYS . . . . . 0.404 ' HZ3' ' HB2' ' B' ' 275' ' ' LYS . 3.6 ttmp? -134.98 68.31 70.54 Favored Pre-proline 0 CA--C 1.56 1.347 0 C-N-CA 123.948 0.899 . . . . 72.14 109.955 173.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -84.04 -79.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.382 2.297 0 C-N-CA 122.374 2.049 . . . . 73.04 109.081 164.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 277' ' ' LEU . . . . . 0.472 HD12 ' HB1' ' B' ' 87' ' ' ALA . 1.6 tt 178.76 -60.41 0.01 OUTLIER 'General case' 0 C--N 1.36 1.033 0 C-N-CA 125.184 1.394 . . . . 74.52 107.432 164.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 88.4 mt -112.83 -176.82 2.99 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.471 0.708 . . . . 72.2 110.015 174.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . -138.98 152.0 22.01 Favored Glycine 0 N--CA 1.474 1.204 0 N-CA-C 110.725 -0.95 . . . . 75.43 110.725 175.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 8.6 mp 61.98 101.24 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 124.41 1.084 . . . . 74.31 110.016 -171.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -110.22 148.58 31.57 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 123.65 0.78 . . . . 75.31 109.936 -175.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -174.2 -30.18 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.817 0.847 . . . . 65.41 111.787 -173.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -75.02 -67.96 0.6 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.285 0.634 . . . . 72.33 109.861 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . 70.37 152.12 0.78 Allowed Glycine 0 CA--C 1.534 1.238 0 CA-C-N 115.666 -0.697 . . . . 72.13 114.035 -177.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 76.04 -51.94 0.62 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.753 1.621 . . . . 73.03 115.241 164.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 286' ' ' MET . . . . . . . . . . . . . 23.7 mmt -48.01 -43.17 53.98 Favored Pre-proline 0 N--CA 1.493 1.678 0 N-CA-C 116.441 2.015 . . . . 74.22 116.441 -152.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 287' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -52.04 -45.28 39.9 Favored 'Trans proline' 0 C--N 1.389 2.69 0 C-N-CA 122.125 1.884 . . . . 74.24 112.738 173.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 288' ' ' VAL . . . . . . . . . . . . . 47.2 t 61.87 -78.48 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 C-N-CA 125.893 1.677 . . . . 74.32 111.08 -178.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 289' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 56.41 98.74 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.655 1.182 . . . . 74.32 110.613 -173.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 290' ' ' TRP . . . . . . . . . . . . . 15.5 m-90 -75.28 72.05 2.31 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 121.579 0.704 . . . . 75.34 109.351 177.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 291' ' ' LEU . . . . . . . . . . . . . 3.6 tt -86.84 73.84 9.89 Favored 'General case' 0 C--N 1.352 0.682 0 N-CA-C 107.568 -1.271 . . . . 73.52 107.568 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . -164.44 72.93 0.18 Allowed Glycine 0 C--O 1.244 0.762 0 CA-C-N 115.229 -0.896 . . . . 71.42 111.254 -178.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -59.04 -20.46 53.82 Favored 'Trans proline' 0 C--N 1.382 2.32 0 C-N-CA 123.255 2.637 . . . . 75.13 112.836 175.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 294' ' ' LYS . . . . . 0.427 ' HE3' ' O ' ' B' ' 237' ' ' ALA . 6.3 ptpp? 47.58 -151.24 0.11 Allowed 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 125.954 1.702 . . . . 74.44 112.345 173.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -124.17 103.48 8.28 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 109.279 -0.637 . . . . 71.35 109.279 174.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 33.0 m -92.84 -37.58 12.22 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.288 1.035 . . . . 71.52 110.862 -175.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 67.45 177.5 0.24 Allowed 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 125.525 1.53 . . . . 75.44 113.496 176.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -135.78 -79.1 0.42 Allowed 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.721 -1.127 . . . . 73.43 108.355 170.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . 60.32 -89.06 0.03 OUTLIER Glycine 0 C--N 1.354 1.561 0 CA-C-N 117.598 0.181 . . . . 72.35 113.013 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -93.95 128.38 40.24 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.312 0.645 . . . . 72.23 109.929 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 301' ' ' ILE . . . . . . . . . . . . . 6.5 tt -142.86 145.8 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.939 0.895 . . . . 75.13 109.341 177.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 25.1 t70 68.79 157.64 0.15 Allowed 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.453 1.101 . . . . 74.32 112.409 173.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 303' ' ' LYS . . . . . . . . . . . . . 62.7 tttm 63.89 66.61 1.05 Allowed Pre-proline 0 CA--C 1.565 1.529 0 C-N-CA 125.054 1.342 . . . . 74.11 111.556 175.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 304' ' ' PRO . . . . . 0.582 ' HA ' ' HG2' ' C' ' 243' ' ' PRO . 72.4 Cg_endo -82.0 140.64 11.42 Favored 'Trans proline' 0 C--N 1.38 2.231 0 C-N-CA 122.269 1.98 . . . . 75.12 113.019 178.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -127.22 85.97 2.44 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.545 0.738 . . . . 72.13 110.453 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 54.9 t -123.99 110.56 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 108.346 -0.983 . . . . 72.33 108.346 176.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 14.5 p -113.21 15.52 19.36 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.758 0.823 . . . . 74.23 110.99 177.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 308' ' ' CYS . . . . . . . . . . . . . 59.8 m -87.95 -30.49 20.01 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.587 0.755 . . . . 74.22 111.228 176.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 32.5 p -99.48 -45.52 0.22 Allowed Pre-proline 0 CA--C 1.572 1.808 0 N-CA-C 115.058 1.503 . . . . 72.2 115.058 -174.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -59.92 -63.92 0.11 Allowed 'Trans proline' 0 C--N 1.4 3.241 0 C-N-CA 122.096 1.864 . . . . 64.44 113.973 -168.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 311' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -146.14 90.98 5.61 Favored Pre-proline 0 CA--C 1.548 0.895 0 CA-C-N 117.703 0.229 . . . . 73.13 110.622 -173.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 312' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -91.54 21.86 0.74 Allowed 'Trans proline' 0 CA--C 1.559 1.772 0 C-N-CA 123.096 2.531 . . . . 70.14 113.988 171.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 313' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.74 123.01 22.45 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.583 -0.895 . . . . 75.13 108.583 174.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 314' ' ' ARG . . . . . 0.666 ' HG3' HD23 ' C' ' 175' ' ' LEU . 1.5 mmp_? -147.17 176.61 9.83 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.15 1.167 . . . . 74.53 114.15 -166.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 315' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -70.92 -57.65 4.37 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 114.702 -1.135 . . . . 75.34 109.281 173.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 316' ' ' ASP . . . . . . . . . . . . . 6.9 t70 63.66 -68.43 0.09 Allowed 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 126.067 1.747 . . . . 74.4 112.798 -177.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 317' ' ' SER . . . . . 0.449 ' HB3' ' HB2' ' B' ' 32' ' ' ARG . 50.4 m 88.72 16.66 0.06 Allowed 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 126.657 1.983 . . . . 75.41 110.61 -171.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 318' ' ' VAL . . . . . 0.605 HG13 ' SG ' ' B' ' 200' ' ' CYS 0.25 2.8 m 63.06 152.94 0.11 Allowed Pre-proline 0 N--CA 1.5 2.031 0 C-N-CA 127.815 2.446 . . . . 73.13 113.258 171.813 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 319' ' ' PRO . . . . . 0.476 ' HD2' ' HB ' ' B' ' 318' ' ' VAL . 18.1 Cg_endo -57.46 -13.72 14.29 Favored 'Trans proline' 0 C--N 1.392 2.86 0 C-N-CA 123.296 2.664 . . . . 65.1 116.484 -170.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 320' ' ' THR . . . . . 0.504 HG23 HG23 ' B' ' 318' ' ' VAL . 9.5 t -87.01 55.7 3.69 Favored 'General case' 0 N--CA 1.486 1.325 0 CA-C-O 122.149 0.976 . . . . 73.24 110.111 175.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 321' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -155.28 120.32 4.86 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.331 -0.85 . . . . 74.43 109.339 -176.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 322' ' ' ALA . . . . . 0.541 ' HB3' HG11 ' B' ' 185' ' ' VAL . . . 82.48 115.87 0.06 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.472 1.509 . . . . 64.54 114.532 163.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 323' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 65.61 -77.84 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 126.509 1.923 . . . . 74.02 114.266 164.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 324' ' ' MET . . . . . 0.579 ' HG2' ' HA ' ' B' ' 187' ' ' SER . 0.2 OUTLIER 69.2 -77.79 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 125.259 1.423 . . . . 74.22 109.958 -170.847 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 325' ' ' THR . . . . . . . . . . . . . 3.1 t -95.26 96.22 9.03 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.007 0.923 . . . . 72.33 110.197 -173.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 326' ' ' ASP . . . . . 0.637 ' HB2' ' HA2' ' B' ' 43' ' ' GLY . 3.3 p-10 -79.38 -58.0 3.42 Favored 'General case' 0 CA--C 1.556 1.196 0 CA-C-N 116.248 -0.433 . . . . 72.01 111.202 -173.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . 0.48 ' HG2' ' O ' ' B' ' 326' ' ' ASP . 0.0 OUTLIER 178.13 -37.39 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 126.985 2.114 . . . . 75.41 108.753 -176.037 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 328' ' ' ALA . . . . . . . . . . . . . . . -78.16 -51.24 10.54 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.351 0.66 . . . . 72.03 111.396 -177.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 329' ' ' ILE . . . . . 0.558 HG23 HD22 ' B' ' 139' ' ' ASN . 2.2 mp 66.63 -80.67 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.563 1.451 0 C-N-CA 124.538 1.135 . . . . 73.5 111.348 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 330' ' ' GLU . . . . . 0.552 ' HG2' ' NH2' ' B' ' 188' ' ' ARG . 44.7 mt-10 -138.53 -4.98 1.6 Allowed 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 123.556 0.743 . . . . 74.44 111.497 -176.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 331' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -139.71 174.7 10.25 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 123.418 0.687 . . . . 64.42 109.787 -173.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 332' ' ' LEU . . . . . 0.7 ' HB3' ' HB3' ' B' ' 335' ' ' ASN . 3.7 mm? -67.79 -29.91 69.21 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.61 0.764 . . . . 74.41 110.99 -178.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 333' ' ' SER . . . . . . . . . . . . . 48.9 m 58.42 -84.8 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.38 1.472 . . . . 65.04 112.897 175.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -89.63 -17.96 27.43 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.562 0.745 . . . . 65.35 112.32 -175.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 335' ' ' ASN . . . . . 0.7 ' HB3' ' HB3' ' B' ' 332' ' ' LEU . 7.0 t30 -67.41 97.75 0.59 Allowed 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 108.326 -0.99 . . . . 74.12 108.326 172.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -65.68 -51.16 61.63 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.269 1.027 . . . . 73.55 110.668 -173.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 337' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.13 108.35 4.07 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.774 0.829 . . . . 71.1 111.655 -169.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 338' ' ' GLY . . . . . . . . . . . . . . . -87.94 171.97 41.57 Favored Glycine 0 C--N 1.348 1.216 0 CA-C-N 115.495 -0.775 . . . . 73.12 111.947 170.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 339' ' ' PHE . . . . . . . . . . . . . 53.3 t80 60.19 83.35 0.14 Allowed 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.459 1.104 . . . . 74.33 109.756 -176.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 340' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -94.94 -69.25 0.76 Allowed 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 116.268 -0.424 . . . . 75.24 110.02 -174.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 341' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 61.42 78.81 0.27 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.616 1.167 . . . . 75.34 111.828 178.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 342' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -91.68 -31.4 15.84 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 115.464 -0.789 . . . . 74.32 110.743 175.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 343' ' ' VAL . . . . . . . . . . . . . 94.8 t -135.74 105.48 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.792 0.837 . . . . 65.15 109.368 -177.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -104.73 65.19 0.75 Allowed 'General case' 0 C--O 1.242 0.702 0 C-N-CA 124.01 0.924 . . . . 74.33 109.075 177.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 345' ' ' GLY . . . . . . . . . . . . . . . 73.37 13.37 79.89 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-N 115.335 -0.848 . . . . 63.14 112.762 -173.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 346' ' ' ALA . . . . . 0.478 ' HB3' ' HB2' ' B' ' 60' ' ' SER . . . -72.95 140.62 47.54 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.559 0.743 . . . . 72.51 111.433 -177.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 31.2 t -160.33 142.25 12.74 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 108.229 -1.026 . . . . 72.21 108.229 175.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 2.9 pp -75.4 142.04 15.06 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 N-CA-C 109.888 -0.412 . . . . 73.42 109.888 176.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 349' ' ' ASP . . . . . 0.439 ' HA ' ' HB3' ' B' ' 353' ' ' HIS . 24.7 t70 -89.87 -78.67 0.36 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.311 -0.996 . . . . 71.13 108.311 174.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 350' ' ' LYS . . . . . . . . . . . . . 98.1 mttt 50.81 36.11 13.76 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.461 1.104 . . . . 74.52 111.881 177.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 65.7 -70.25 0.1 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.747 1.619 . . . . 71.32 111.318 -172.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 352' ' ' ASP . . . . . 0.61 ' HB3' ' HB2' ' B' ' 355' ' ' ALA . 12.0 m-20 -79.72 75.06 6.4 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.932 0.893 . . . . 74.35 110.359 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 353' ' ' HIS . . . . . 0.439 ' HB3' ' HA ' ' B' ' 349' ' ' ASP . 2.3 p-80 -83.36 79.12 9.51 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.588 0.755 . . . . 74.33 109.085 174.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 354' ' ' ALA . . . . . . . . . . . . . . . 64.35 86.35 0.13 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 114.574 -1.193 . . . . 72.23 109.052 -164.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 355' ' ' ALA . . . . . 0.61 ' HB2' ' HB3' ' B' ' 352' ' ' ASP . . . -75.07 -97.91 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 118.826 -0.607 . . . . 75.44 110.494 -178.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 356' ' ' ASN . . . . . . . . . . . . . 12.0 m120 50.42 100.16 0.04 OUTLIER Pre-proline 0 CA--C 1.558 1.27 0 C-N-CA 125.131 1.372 . . . . 74.32 112.42 172.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 357' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.53 141.78 56.76 Favored 'Trans proline' 0 C--N 1.37 1.677 0 C-N-CA 122.541 2.16 . . . . 74.21 112.37 -168.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 358' ' ' CYS . . . . . . . . . . . . . 46.5 t -75.15 71.49 2.19 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-O 121.679 0.752 . . . . 75.21 110.044 177.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 359' ' ' GLY . . . . . . . . . . . . . . . -81.24 0.04 88.22 Favored Glycine 0 C--N 1.347 1.187 0 CA-C-N 115.042 -0.981 . . . . 72.04 113.141 -177.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 360' ' ' GLN . . . . . 0.474 ' HG2' ' HZ2' ' C' ' 236' ' ' LYS . 20.0 mt-30 61.32 74.67 0.44 Allowed 'General case' 0 C--N 1.357 0.917 0 C-N-CA 124.767 1.227 . . . . 53.34 109.734 -177.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 361' ' ' ILE . . . . . . . . . . . . . 6.6 tt -140.47 135.21 35.33 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 CA-C-N 115.254 -0.884 . . . . 64.41 109.329 -176.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 362' ' ' GLY . . . . . . . . . . . . . . . -162.25 -132.42 1.33 Allowed Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 110.193 -1.163 . . . . 72.35 110.193 176.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 363' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -170.78 139.91 1.58 Allowed 'General case' 0 C--O 1.24 0.561 0 N-CA-C 107.419 -1.326 . . . . 73.13 107.419 175.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 364' ' ' THR . . . . . . . . . . . . . 92.7 m -56.41 -59.06 5.51 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.071 0.549 . . . . 74.04 110.195 176.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 36.9 t 53.54 -82.28 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.942 0 C-N-CA 125.404 1.482 . . . . 74.51 110.781 -171.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 22.6 t70 61.96 75.43 0.41 Allowed 'General case' 0 C--O 1.241 0.613 0 C-N-CA 124.589 1.156 . . . . 52.52 109.404 -171.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 367' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.01 -27.01 26.7 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 114.026 -1.443 . . . . 75.05 107.875 166.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 368' ' ' ASP . . . . . . . . . . . . . 26.2 t70 62.47 -77.71 0.03 OUTLIER 'General case' 0 C--N 1.364 1.231 0 C-N-CA 125.808 1.643 . . . . 73.23 110.692 -177.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 369' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 44.4 27.93 0.26 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 126.31 1.844 . . . . 74.11 113.48 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 370' ' ' ALA . . . . . . . . . . . . . . . -111.98 -35.44 5.68 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.028 0.931 . . . . 74.25 110.389 -178.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 371' ' ' VAL . . . . . . . . . . . . . 66.3 t 66.51 -70.94 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 C-N-CA 125.17 1.388 . . . . 74.12 111.921 177.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 372' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -160.87 138.25 9.19 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.727 0.811 . . . . 63.2 109.365 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 373' ' ' ARG . . . . . . . . . . . . . 4.4 ppt_? -58.61 -20.52 48.1 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 124.186 0.994 . . . . 72.2 113.285 -177.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -149.09 92.5 1.97 Allowed 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 108.034 -1.098 . . . . 71.45 108.034 172.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 375' ' ' LEU . . . . . . . . . . . . . 35.4 tp -77.96 -104.55 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.146 0 CA-C-O 118.981 -0.533 . . . . 72.22 109.821 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -140.62 22.38 2.33 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 119.11 0.868 . . . . 73.13 111.385 -171.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 377' ' ' PHE . . . . . . . . . . . . . 62.7 t80 56.84 -79.79 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.922 1.289 . . . . 73.31 112.831 174.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 378' ' ' ALA . . . . . . . . . . . . . . . -145.79 -17.3 0.46 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.529 0.732 . . . . 73.45 111.465 -176.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? 69.6 125.64 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 125.486 1.514 . . . . 73.22 112.928 178.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 380' ' ' LYS . . . . . 0.489 ' HB3' ' HA3' ' A' ' 190' ' ' GLY . 52.8 tptt -105.81 162.25 13.72 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 125.271 1.429 . . . . 72.4 108.605 173.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 381' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -54.39 125.86 21.07 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.102 0.961 . . . . 74.34 110.934 176.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -91.82 28.83 8.01 Favored Glycine 0 C--N 1.346 1.139 0 O-C-N 123.684 0.615 . . . . 73.1 112.702 177.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 383' ' ' ASN . . . . . . . . . . . . . 20.8 p-10 -63.51 -50.26 70.3 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 109.182 -0.673 . . . . 73.1 109.182 175.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 384' ' ' THR . . . . . . . . . . . . . 62.2 p 40.68 -155.51 0.01 OUTLIER 'General case' 0 C--N 1.361 1.088 0 C-N-CA 126.622 1.969 . . . . 71.44 114.279 174.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 17.1 tp 61.6 39.75 14.21 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.454 1.102 . . . . 75.43 110.527 173.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 386' ' ' VAL . . . . . . . . . . . . . 25.4 t 59.02 49.16 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.542 0 C-N-CA 124.286 1.034 . . . . 75.23 109.45 -176.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 387' ' ' ILE . . . . . 0.422 HD12 ' HA ' ' A' ' 243' ' ' PRO . 2.6 mp 58.3 82.36 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 125.19 1.396 . . . . 74.12 109.989 -175.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 388' ' ' VAL . . . . . . . . . . . . . 11.8 p 38.09 68.48 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.63 0 C-N-CA 126.613 1.965 . . . . 74.43 113.609 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 389' ' ' THR . . . . . . . . . . . . . 6.0 m 69.72 -1.26 2.36 Favored 'General case' 0 CA--C 1.57 1.73 0 C-N-CA 125.66 1.584 . . . . 71.25 112.476 177.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . 57.88 28.64 16.36 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 124.71 1.204 . . . . 73.41 110.959 -167.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 391' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -139.69 -77.82 0.33 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.314 1.045 . . . . 64.12 110.467 -172.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 392' ' ' HIS . . . . . . . . . . . . . 48.4 t-80 172.75 -36.53 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.027 0.931 . . . . 72.42 109.411 -164.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . 68.27 -151.12 0.16 Allowed 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.928 1.291 . . . . 61.53 110.845 -177.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 74.43 -63.02 0.44 Allowed 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 125.356 1.463 . . . . 73.31 109.776 -167.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . -167.88 103.91 0.48 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.334 1.054 . . . . 75.42 108.412 174.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 33.5 t -98.34 -90.5 0.28 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.098 0.559 . . . . 75.55 110.593 -176.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 397' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -101.8 -77.65 0.55 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.294 0.637 . . . . 75.54 110.111 -172.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 2.6 pp -101.38 117.9 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 CA-C-O 121.402 0.62 . . . . 75.44 109.987 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 399' ' ' VAL . . . . . . . . . . . . . 3.6 m -134.97 -10.77 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 124.499 1.12 . . . . 73.32 110.284 177.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 400' ' ' ALA . . . . . . . . . . . . . . . -69.23 -44.15 26.28 Favored Pre-proline 0 CA--C 1.56 1.342 0 C-N-CA 124.304 1.042 . . . . 74.52 113.736 176.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 401' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -67.8 102.18 0.73 Allowed 'Trans proline' 0 C--N 1.39 2.744 0 CA-C-N 121.08 1.422 . . . . 71.34 111.352 174.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -80.96 -172.98 4.0 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 122.847 0.459 . . . . 74.34 110.736 -179.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 403' ' ' THR . . . . . 0.591 ' HA ' ' HD2' ' B' ' 415' ' ' LYS . 5.5 m -76.14 -52.76 9.43 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 123.192 0.597 . . . . 73.2 111.802 -171.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 404' ' ' LYS . . . . . 0.593 ' HA ' ' H ' ' B' ' 413' ' ' ASN . 36.1 ttpt -83.88 -37.78 21.97 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 115.32 -0.855 . . . . 71.14 111.874 -171.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 405' ' ' ALA . . . . . 0.467 ' O ' ' HA ' ' B' ' 410' ' ' GLN . . . 63.29 81.42 0.23 Allowed Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 124.549 1.139 . . . . 71.24 110.122 -174.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 406' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -84.14 5.85 6.09 Favored 'Trans proline' 0 C--N 1.373 1.841 0 C-N-CA 123.681 2.921 . . . . 64.23 113.98 -172.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . -61.9 -69.37 1.32 Allowed Glycine 0 C--N 1.351 1.412 0 O-C-N 123.272 0.357 . . . . 74.04 112.645 -177.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 408' ' ' LEU . . . . . . . . . . . . . 43.3 tp -150.59 142.16 23.54 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 108.738 -0.838 . . . . 72.55 108.738 177.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 21.2 m 76.21 -43.8 0.48 Allowed 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 125.46 1.504 . . . . 73.52 112.547 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 410' ' ' GLN . . . . . 0.467 ' HA ' ' O ' ' B' ' 405' ' ' ALA . 76.1 mt-30 66.37 122.03 0.02 OUTLIER 'General case' 0 C--N 1.358 0.956 0 C-N-CA 125.692 1.597 . . . . 70.42 110.974 -174.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . -60.62 -26.51 67.07 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.708 0.403 . . . . 74.33 110.23 169.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 1.7 tt 64.44 56.54 1.25 Allowed 'General case' 0 C--N 1.358 0.975 0 C-N-CA 125.198 1.399 . . . . 75.21 107.892 -177.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 413' ' ' ASN . . . . . 0.593 ' H ' ' HA ' ' B' ' 404' ' ' LYS . 3.2 m-20 74.7 -11.91 0.99 Allowed 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 113.014 -1.903 . . . . 71.14 113.485 172.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 414' ' ' THR . . . . . . . . . . . . . 70.2 p -71.75 -5.17 32.11 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 112.899 0.703 . . . . 73.24 112.899 -173.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 415' ' ' LYS . . . . . 0.591 ' HD2' ' HA ' ' B' ' 403' ' ' THR . 13.5 mmmm 77.31 -55.29 0.54 Allowed 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 126.218 1.807 . . . . 75.21 111.36 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 416' ' ' ASP . . . . . 0.509 ' HB3' HG21 ' B' ' 419' ' ' VAL . 16.2 t70 -160.46 -51.62 0.05 Allowed 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.767 1.227 . . . . 75.33 108.337 -176.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 417' ' ' GLY . . . . . . . . . . . . . . . 105.41 -50.54 0.82 Allowed Glycine 0 C--N 1.351 1.384 0 CA-C-N 115.106 -0.952 . . . . 62.31 112.293 177.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 418' ' ' ALA . . . . . . . . . . . . . . . -75.59 -21.02 58.18 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.039 0.536 . . . . 70.25 111.859 -175.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 419' ' ' VAL . . . . . 0.509 HG21 ' HB3' ' B' ' 416' ' ' ASP . 24.2 m -74.32 81.79 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.247 0 CA-C-O 122.594 1.187 . . . . 73.31 111.021 176.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 420' ' ' MET . . . . . . . . . . . . . 64.7 mtm -94.54 -8.55 37.93 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 114.979 -1.009 . . . . 73.34 111.567 -178.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 421' ' ' VAL . . . . . 0.406 HG12 ' H ' ' B' ' 423' ' ' SER . 88.7 t -74.74 -83.23 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 C-N-CA 122.71 0.404 . . . . 72.42 110.037 176.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 422' ' ' MET . . . . . . . . . . . . . 94.2 mmm 54.1 13.36 0.57 Allowed 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 124.758 1.223 . . . . 74.1 113.889 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 423' ' ' SER . . . . . 0.406 ' H ' HG12 ' B' ' 421' ' ' VAL . 23.0 t -113.03 109.66 19.2 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.214 0.606 . . . . 63.45 110.739 -170.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 424' ' ' TYR . . . . . . . . . . . . . 81.4 t80 67.58 -77.88 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.32 1.448 . . . . 74.22 111.445 176.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . 166.11 145.29 4.39 Favored Glycine 0 C--N 1.339 0.709 0 CA-C-O 119.14 -0.811 . . . . 75.12 111.116 -177.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 426' ' ' ASN . . . . . . . . . . . . . 9.2 p30 45.33 35.27 1.78 Allowed 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 125.699 1.6 . . . . 75.43 112.608 -176.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 427' ' ' SER . . . . . . . . . . . . . 20.3 m 54.73 69.68 0.7 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.629 1.171 . . . . 75.14 110.639 -172.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 46.25 106.72 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 126.274 1.83 . . . . 73.23 113.583 -174.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 429' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -61.05 96.58 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.332 0.653 . . . . 63.42 111.212 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 17.8 t70 35.61 63.78 0.52 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 126.704 2.002 . . . . 62.42 113.511 173.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 29.9 p -110.43 -35.64 5.99 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.527 -0.76 . . . . 75.05 110.698 178.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 432' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 52.82 54.93 9.72 Favored 'General case' 0 CA--C 1.557 1.222 0 CA-C-O 122.349 1.071 . . . . 71.1 110.061 -173.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 433' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -69.2 156.28 39.0 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 114.552 -1.204 . . . . 73.43 108.367 178.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 434' ' ' HIS . . . . . 0.51 ' HD2' ' HB3' ' A' ' 236' ' ' LYS . 53.8 m-70 -50.51 100.55 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.32 1.048 . . . . 73.42 110.371 -176.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 435' ' ' THR . . . . . 0.462 ' OG1' ' HD2' ' B' ' 440' ' ' ARG 0.289 9.7 t 65.58 -15.65 0.11 Allowed 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 128.021 2.528 . . . . 73.42 114.821 -173.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . 71.43 -77.04 0.62 Allowed Glycine 0 C--N 1.352 1.472 0 CA-C-N 118.378 0.536 . . . . 61.51 112.2 178.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 32.8 t -129.38 171.09 12.87 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.092 0.957 . . . . 72.35 109.041 172.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 438' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 65.76 114.79 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 124.876 1.27 . . . . 71.55 111.023 -174.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 439' ' ' LEU . . . . . 0.437 HD22 ' H ' ' B' ' 439' ' ' LEU . 1.9 pt? -73.1 87.25 1.39 Allowed 'General case' 0 CA--C 1.558 1.253 0 CA-C-O 122.78 1.276 . . . . 74.24 110.686 -178.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 440' ' ' ARG . . . . . 0.498 ' HD3' ' HA ' ' B' ' 114' ' ' LYS . 57.6 mtt180 -91.9 -10.38 39.81 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 113.915 -1.493 . . . . 74.1 111.028 178.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 441' ' ' ILE . . . . . 0.426 ' HA ' HD21 ' A' ' 235' ' ' LEU . 58.9 mt 69.69 125.46 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.001 0 C-N-CA 125.817 1.647 . . . . 74.15 113.086 174.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 442' ' ' ALA . . . . . . . . . . . . . . . -145.37 105.35 4.02 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 107.201 -1.407 . . . . 73.33 107.201 172.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . -158.01 -52.08 0.07 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.506 0.722 . . . . 74.21 109.836 -172.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 444' ' ' TYR . . . . . 0.584 ' HE1' HH11 ' A' ' 231' ' ' ARG . 0.0 OUTLIER -164.71 115.84 1.2 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.595 0.758 . . . . 71.31 110.13 176.409 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . 126.73 -65.19 0.57 Allowed Glycine 0 CA--C 1.54 1.603 0 CA-C-O 118.744 -1.031 . . . . 74.34 114.011 176.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 446' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -43.86 -29.82 2.72 Favored 'Trans proline' 0 C--N 1.397 3.081 0 C-N-CA 124.501 3.467 . . . . 72.44 115.186 178.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 447' ' ' HIS . . . . . . . . . . . . . 18.5 m80 -119.23 -75.22 0.58 Allowed 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 108.343 -0.984 . . . . 63.45 108.343 174.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . 67.24 148.09 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.911 1.284 . . . . 74.31 112.096 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 449' ' ' ALA . . . . . . . . . . . . . . . -77.13 73.68 3.71 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-O 121.565 0.698 . . . . 74.42 110.363 177.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 450' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -157.86 -62.94 0.09 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.223 1.009 . . . . 63.22 109.538 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 7.2 p -77.49 -23.04 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 C-N-CA 122.86 0.464 . . . . 74.44 110.656 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 452' ' ' VAL . . . . . . . . . . . . . 34.5 m -70.31 124.95 27.55 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 C-N-CA 122.972 0.509 . . . . 74.24 110.801 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . -99.33 7.29 59.92 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-N 115.819 -0.628 . . . . 73.44 112.272 177.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 454' ' ' LEU . . . . . . . . . . . . . 63.2 tp -72.26 -81.76 0.05 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.656 0.782 . . . . 73.13 110.131 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 455' ' ' THR . . . . . 0.514 HG23 ' HA ' ' B' ' 461' ' ' PHE . 19.1 m 45.8 70.54 0.36 Allowed 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 124.423 1.089 . . . . 72.1 112.077 -178.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -94.96 13.01 26.37 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 115.216 -0.902 . . . . 74.3 110.721 178.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 457' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -91.66 46.84 1.31 Allowed 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 124.103 0.961 . . . . 65.21 110.114 -178.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 13.7 m 59.35 72.98 0.5 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.39 1.476 . . . . 72.13 112.337 177.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 459' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 58.29 -152.28 0.4 Allowed 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.159 0.984 . . . . 73.31 111.21 171.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 75.2 mt 78.6 -56.7 0.46 Allowed 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 126.022 1.729 . . . . 65.42 112.309 172.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 461' ' ' PHE . . . . . 0.514 ' HA ' HG23 ' B' ' 455' ' ' THR . 76.3 t80 70.15 -73.47 0.09 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.086 1.355 . . . . 75.0 109.634 -172.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 462' ' ' TYR . . . . . 0.527 ' HA ' ' SD ' ' B' ' 464' ' ' MET . 14.9 t80 61.54 -171.23 0.15 Allowed 'General case' 0 CA--C 1.561 1.373 0 C-N-CA 124.149 0.979 . . . . 72.53 110.51 175.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 4.0 m 70.79 3.22 4.5 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 124.067 0.947 . . . . 71.14 112.316 177.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 464' ' ' MET . . . . . 0.527 ' SD ' ' HA ' ' B' ' 462' ' ' TYR . 0.0 OUTLIER -78.98 71.33 5.43 Favored 'General case' 0 CA--C 1.557 1.227 0 CA-C-O 122.708 1.242 . . . . 75.31 110.399 -178.557 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -102.38 4.89 39.4 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.668 1.187 . . . . 72.15 111.256 -174.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -61.44 139.56 58.19 Favored 'General case' 0 C--N 1.349 0.571 0 C-N-CA 123.395 0.678 . . . . 65.13 109.573 174.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . -60.54 -24.76 65.63 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 122.98 0.512 . . . . 75.3 111.168 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -82.3 118.96 23.54 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 108.013 -1.106 . . . . 74.32 108.013 167.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 469' ' ' GLY . . . . . . . . . . . . . . . -72.04 86.08 0.48 Allowed Glycine 0 C--N 1.348 1.199 0 N-CA-C 111.286 -0.726 . . . . 62.03 111.286 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 470' ' ' LEU . . . . . . . . . . . . . 63.9 tp -61.42 -59.06 5.83 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.147 0.979 . . . . 75.32 111.195 -177.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 471' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? . . . . . 0 C--O 1.253 1.266 0 N-CA-C 106.796 -1.557 . . . . 74.2 106.796 -175.299 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 1' ' ' MET . . . . . 0.513 ' N ' ' SD ' ' C' ' 1' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.478 0.94 0 N-CA-C 110.165 -0.309 . . . . 70.43 110.165 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 60.54 37.54 19.49 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 125.207 1.403 . . . . 70.41 112.859 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -72.8 80.62 1.15 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 122.508 0.323 . . . . 71.34 110.188 175.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -34.17 93.71 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 127.041 2.137 . . . . 70.52 112.894 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 5' ' ' LYS . . . . . 0.471 ' HE2' HD11 ' C' ' 10' ' ' ILE . 14.5 mmmm -92.84 93.29 8.33 Favored 'General case' 0 C--O 1.243 0.72 0 N-CA-C 107.812 -1.181 . . . . 72.32 107.812 169.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -73.67 97.36 2.66 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 107.193 -1.41 . . . . 65.15 107.193 175.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 7' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -61.54 -37.86 85.32 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.182 -0.917 . . . . 73.43 111.598 -171.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -60.97 -45.02 96.45 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 116.181 -0.463 . . . . 74.23 110.481 175.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.96 -40.95 99.25 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.051 0.54 . . . . 63.34 111.207 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 10' ' ' ILE . . . . . 0.471 HD11 ' HE2' ' C' ' 5' ' ' LYS . 64.6 mt -61.92 -36.07 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.213 0.605 . . . . 73.31 110.576 177.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 11' ' ' LEU . . . . . 0.598 HD11 HG23 ' C' ' 22' ' ' ILE . 68.7 mt -80.61 -13.85 58.69 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 112.46 0.541 . . . . 75.53 112.46 176.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.11 35.92 42.27 Favored Glycine 0 C--N 1.351 1.364 0 N-CA-C 113.689 0.235 . . . . 74.43 113.689 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 6.1 m -131.56 153.44 81.55 Favored Pre-proline 0 N--CA 1.482 1.151 0 C-N-CA 124.691 1.196 . . . . 71.34 109.184 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -76.51 161.08 34.7 Favored 'Trans proline' 0 C--N 1.373 1.83 0 C-N-CA 122.432 2.088 . . . . 74.43 112.293 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -67.85 80.53 0.2 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.339 0.655 . . . . 74.35 109.898 176.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -179.19 -30.03 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.673 1.189 . . . . 71.24 109.038 -174.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -47.58 119.72 2.9 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 124.744 1.277 . . . . 75.2 111.688 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 72.3 p -86.25 178.35 7.21 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.802 0.841 . . . . 74.41 110.14 177.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.45 -38.28 19.46 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 124.515 1.126 . . . . 74.45 112.195 -177.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 20' ' ' GLU . . . . . 0.405 ' O ' ' HG3' ' C' ' 24' ' ' ARG . 13.9 tp10 -66.72 -52.63 42.25 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.387 0.675 . . . . 74.53 110.953 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . 0.609 ' HA ' ' HE ' ' C' ' 24' ' ' ARG . 33.7 mt-10 -65.0 -34.37 78.27 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.636 0.775 . . . . 73.42 111.285 -176.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 22' ' ' ILE . . . . . 0.86 HD11 ' HB3' ' C' ' 57' ' ' LEU . 82.1 mt -75.56 -36.08 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.214 1.405 . . . . 75.54 111.268 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -62.87 -44.21 96.74 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.758 0.823 . . . . 74.13 109.77 175.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 24' ' ' ARG . . . . . 0.609 ' HE ' ' HA ' ' C' ' 21' ' ' GLU . 42.8 mtm180 -64.63 -46.05 84.19 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 115.332 -0.849 . . . . 73.52 110.829 178.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . 0.417 ' O ' ' HB3' ' C' ' 28' ' ' ARG . . . -61.5 -37.68 84.58 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.461 0.705 . . . . 75.32 111.682 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 26' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -62.97 -52.1 64.33 Favored 'General case' 0 C--O 1.212 -0.882 0 CA-C-N 115.121 -0.945 . . . . 72.31 109.998 176.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -58.02 -37.14 73.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 123.882 0.739 . . . . 75.33 111.369 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 28' ' ' ARG . . . . . 0.417 ' HB3' ' O ' ' C' ' 25' ' ' ALA . 20.8 ttt180 -53.15 -56.03 19.54 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.294 1.037 . . . . 75.55 110.45 172.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . 0.651 ' HB3' HD11 ' C' ' 50' ' ' ILE . 91.2 mt -80.9 -11.15 59.63 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 115.769 -0.65 . . . . 71.43 111.879 -177.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -91.31 -10.7 40.39 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.126 0.97 . . . . 75.32 110.535 177.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -93.89 -48.6 6.2 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.216 0.606 . . . . 73.5 110.342 165.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 20.6 tp60 -62.44 -48.52 79.31 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.452 0.701 . . . . 71.12 111.297 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 33' ' ' TYR . . . . . 0.41 ' HE2' HD22 ' C' ' 29' ' ' LEU . 29.4 m-85 -109.01 37.11 2.65 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.218 0.607 . . . . 72.14 109.969 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 34' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -67.89 111.48 7.81 Favored Pre-proline 0 N--CA 1.473 0.719 0 CA-C-O 118.373 -0.823 . . . . 74.34 109.378 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.74 -29.21 76.94 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 122.417 2.078 . . . . 72.22 111.318 -176.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -62.07 -33.03 73.65 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.364 1.466 . . . . 60.34 112.153 176.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 98.6 t -96.71 -62.62 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 N-CA-C 108.988 -0.745 . . . . 75.33 108.988 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -98.72 96.46 7.93 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.263 1.025 . . . . 65.41 110.604 -177.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -80.03 74.66 6.8 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 108.644 -0.873 . . . . 71.22 108.644 173.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 71.1 m -126.8 97.85 32.17 Favored Pre-proline 0 CA--C 1.538 0.506 0 N-CA-C 108.591 -0.892 . . . . 74.14 108.591 175.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -39.16 -44.19 2.64 Favored 'Trans proline' 0 C--N 1.388 2.655 0 C-N-CA 124.76 3.64 . . . . 75.0 114.545 -176.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -48.6 -55.51 10.98 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 124.811 1.244 . . . . 71.01 111.023 174.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.42 -21.21 63.77 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 115.476 -0.784 . . . . 71.45 111.272 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 44' ' ' GLU . . . . . 0.435 ' O ' ' HG3' ' C' ' 48' ' ' LYS . 43.0 mt-10 -88.76 -24.57 22.61 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.529 0.731 . . . . 74.04 110.748 -175.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -81.31 -36.54 29.65 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.615 0.766 . . . . 75.44 109.248 174.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 46' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -65.21 -36.64 84.81 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.05 -0.977 . . . . 72.32 109.167 169.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 47' ' ' PHE . . . . . 0.57 ' HA ' HD12 ' C' ' 50' ' ' ILE . 41.9 t80 -66.68 -32.62 74.06 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.449 0.7 . . . . 71.12 110.408 173.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 48' ' ' LYS . . . . . 0.44 ' HB3' ' CE1' ' C' ' 93' ' ' PHE . 95.7 mttt -64.14 -39.79 94.79 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 122.889 0.476 . . . . 72.04 110.808 172.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -69.15 -28.94 66.87 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.65 0.38 . . . . 72.33 110.774 176.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 50' ' ' ILE . . . . . 0.651 HD11 ' HB3' ' C' ' 29' ' ' LEU . 71.2 mt -73.07 -32.79 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 123.856 0.863 . . . . 75.43 110.381 173.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 51' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -77.38 -24.73 50.54 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.257 0.623 . . . . 74.04 110.62 175.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -71.09 -52.85 17.02 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 108.369 -0.974 . . . . 75.54 108.369 172.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.22 -44.41 79.53 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 113.533 -1.667 . . . . 63.1 111.467 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -74.18 -38.33 63.68 Favored 'General case' 0 C--O 1.208 -1.112 0 CA-C-N 115.425 -0.807 . . . . 75.01 110.384 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.89 -35.77 75.54 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-O 120.81 0.338 . . . . 60.54 111.469 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 47.5 t -77.84 -44.71 28.55 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 CA-C-N 115.906 -0.588 . . . . 72.43 109.875 175.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 57' ' ' LEU . . . . . 0.86 ' HB3' HD11 ' C' ' 22' ' ' ILE . 52.4 mt -98.74 0.65 44.93 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 115.428 1.64 . . . . 75.02 115.428 -166.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 30.9 t -75.56 -66.12 0.81 Allowed 'General case' 0 N--CA 1.484 1.233 0 CA-C-O 121.733 0.777 . . . . 75.33 109.686 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -86.83 132.36 42.39 Favored Pre-proline 0 C--O 1.255 1.376 0 CA-C-N 114.438 -1.255 . . . . 72.03 108.885 -169.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 60' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_exo -46.6 -30.5 8.9 Favored 'Trans proline' 0 C--N 1.388 2.626 0 C-N-CA 124.218 3.279 . . . . 73.21 114.796 -175.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -57.25 -69.74 0.15 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.572 0.749 . . . . 62.13 111.413 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.28 -25.54 63.39 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 122.773 0.429 . . . . 75.43 110.619 -173.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -61.93 -47.86 83.0 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 108.147 -1.057 . . . . 74.14 108.147 175.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -70.14 -29.34 66.23 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.156 0.582 . . . . 74.15 111.618 177.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 82.0 mt -62.08 -43.8 98.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 C-N-CA 122.72 0.408 . . . . 71.5 110.384 174.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -67.08 -46.55 73.93 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.771 -0.649 . . . . 74.31 109.797 177.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -55.1 -47.58 74.75 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.228 0.611 . . . . 73.14 110.758 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 70.4 p -70.39 -26.81 63.87 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.94 -0.573 . . . . 74.43 111.518 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -69.51 136.17 51.08 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 108.81 -0.811 . . . . 75.22 108.81 178.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.05 15.28 54.5 Favored Glycine 0 N--CA 1.473 1.107 0 N-CA-C 111.632 -0.587 . . . . 62.51 111.632 -169.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 58.2 m -148.4 -60.24 0.24 Allowed 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 103.698 -2.704 . . . . 72.34 103.698 175.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 56.8 m -75.04 140.53 43.61 Favored 'General case' 0 C--O 1.252 1.218 0 N-CA-C 105.147 -2.168 . . . . 73.35 105.147 156.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.87 -36.25 6.7 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.88 0.872 . . . . 73.23 110.873 -176.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -93.32 139.17 22.88 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 123.986 0.915 . . . . 53.23 110.096 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 75' ' ' PRO . . . . . 0.563 ' HB2' ' HH ' ' C' ' 83' ' ' TYR . 28.8 Cg_endo -61.7 144.48 97.29 Favored 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 122.691 2.261 . . . . 75.14 112.096 175.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -49.84 144.34 21.07 Favored 'Trans proline' 0 C--N 1.384 2.406 0 C-N-CA 123.826 3.017 . . . . 71.22 113.805 175.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -57.82 131.87 46.52 Favored 'Trans proline' 0 C--N 1.381 2.251 0 C-N-CA 122.697 2.265 . . . . 74.4 111.65 177.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 78' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.92 113.61 1.6 Allowed 'Trans proline' 0 C--N 1.388 2.657 0 C-N-CA 122.89 2.393 . . . . 74.44 112.221 -174.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -80.93 178.41 6.94 Favored 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 122.882 2.388 . . . . 70.12 111.902 -178.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -54.51 90.54 0.04 OUTLIER 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 122.279 1.986 . . . . 74.31 112.271 167.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 134.26 -1.64 4.14 Favored Glycine 0 N--CA 1.466 0.662 0 CA-C-N 114.937 -1.029 . . . . 75.2 112.399 175.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 67.01 -149.8 51.51 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 112.39 -0.284 . . . . 75.13 112.39 178.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 83' ' ' TYR . . . . . 0.563 ' HH ' ' HB2' ' C' ' 75' ' ' PRO . 41.1 m-85 -99.46 113.63 26.1 Favored 'General case' 0 C--O 1.244 0.803 0 N-CA-C 108.208 -1.034 . . . . 73.4 108.208 168.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 84' ' ' ASP . . . . . 0.544 ' HA ' ' HD2' ' C' ' 106' ' ' PHE . 4.8 p-10 -71.74 134.3 46.14 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-O 121.394 0.616 . . . . 75.11 110.009 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 85' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -159.25 22.24 0.19 Allowed 'General case' 0 C--O 1.248 0.999 0 CA-C-N 114.603 -1.181 . . . . 74.41 107.969 -177.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 19.0 m -62.79 128.27 35.14 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 113.141 -1.845 . . . . 52.42 111.273 -170.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 87' ' ' GLY . . . . . 0.461 ' HA2' ' HA ' ' C' ' 171' ' ' PRO . . . 99.25 -20.95 47.93 Favored Glycine 0 C--N 1.336 0.569 0 O-C-N 123.775 0.672 . . . . 74.34 112.938 178.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 88' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -93.79 150.64 20.22 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 117.457 0.628 . . . . 74.44 110.224 -178.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -82.56 73.69 9.58 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.113 0.565 . . . . 72.23 110.442 -174.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 90' ' ' VAL . . . . . . . . . . . . . 3.2 p -43.41 -41.72 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 C-N-CA 125.456 1.503 . . . . 54.42 112.486 177.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -56.76 -36.09 69.41 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.902 1.281 . . . . 75.25 111.945 -175.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -88.87 -21.02 23.88 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.02 0.528 . . . . 75.53 111.997 -175.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 93' ' ' PHE . . . . . 0.44 ' CE1' ' HB3' ' C' ' 48' ' ' LYS . 4.5 m-30 -81.75 164.74 21.51 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 122.326 0.251 . . . . 72.45 111.295 -168.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 94.5 p -60.19 152.08 25.51 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.586 1.154 . . . . 52.11 113.598 -165.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 95' ' ' GLU . . . . . 0.451 ' HG2' ' SD ' ' C' ' 1' ' ' MET . 0.0 OUTLIER -60.55 -31.79 70.88 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 114.964 -1.016 . . . . 72.35 111.062 170.96 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -59.88 -44.51 94.14 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.175 0.99 . . . . 74.24 110.426 175.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 97' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -62.1 -43.33 99.07 Favored 'General case' 0 CA--C 1.558 1.28 0 CA-C-N 114.978 -1.01 . . . . 64.25 110.362 170.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -73.68 -1.46 19.13 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.184 0.593 . . . . 71.33 111.758 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -98.95 -41.32 7.64 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.559 0.743 . . . . 74.43 112.092 168.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 23.9 tp -82.02 -35.55 28.73 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.284 0.634 . . . . 73.23 111.83 -174.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -114.14 -17.76 11.82 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.673 0.789 . . . . 75.04 110.956 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -42.72 -58.73 3.47 Favored Glycine 0 CA--C 1.541 1.67 0 CA-C-O 118.689 -1.062 . . . . 74.41 115.466 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.0 -21.19 20.53 Favored 'Trans proline' 0 C--N 1.389 2.658 0 C-N-CA 123.645 2.896 . . . . 64.35 114.224 -176.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -127.68 8.72 6.88 Favored Glycine 0 C--N 1.357 1.7 0 CA-C-O 117.051 -1.972 . . . . 73.42 114.631 -175.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 28.5 mt -46.53 83.0 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.709 0 N-CA-C 114.623 1.342 . . . . 75.43 114.623 -175.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 106' ' ' PHE . . . . . 0.544 ' HD2' ' HA ' ' C' ' 84' ' ' ASP . 0.1 OUTLIER 28.99 -107.95 0.02 OUTLIER 'General case' 0 CA--C 1.568 1.653 0 C-N-CA 127.154 2.182 . . . . 64.24 113.864 171.752 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 107' ' ' GLY . . . . . 0.563 ' HA2' ' HA2' ' C' ' 168' ' ' GLY . . . 57.92 26.49 58.12 Favored Glycine 0 C--N 1.37 2.425 0 CA-C-N 118.889 0.768 . . . . 51.05 112.826 -170.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 108' ' ' GLY . . . . . 0.442 ' HA3' ' O ' ' B' ' 37' ' ' ASP . . . 51.38 -124.35 21.95 Favored Glycine 0 C--N 1.349 1.276 0 O-C-N 124.195 0.585 . . . . 74.41 112.268 -167.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 109' ' ' PHE . . . . . 0.483 ' HD2' HG13 ' B' ' 38' ' ' ILE . 92.6 m-85 -111.19 10.61 21.83 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.124 0.97 . . . . 74.45 109.799 172.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 110' ' ' GLY . . . . . 0.525 ' HA3' ' HA ' ' B' ' 37' ' ' ASP . . . -89.41 -16.44 57.13 Favored Glycine 0 C--N 1.347 1.175 0 N-CA-C 111.029 -0.829 . . . . 73.14 111.029 172.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 58.2 13.35 2.27 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 125.028 1.331 . . . . 75.25 113.592 167.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 112' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -66.16 -20.98 66.31 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 124.864 1.265 . . . . 75.43 111.657 172.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 113' ' ' SER . . . . . . . . . . . . . 45.4 m 63.98 9.32 4.5 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 124.711 1.204 . . . . 72.53 113.173 177.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 114' ' ' ARG . . . . . 0.422 ' HD2' ' HA ' ' C' ' 114' ' ' ARG . 7.2 tpt180 -100.49 -165.82 1.25 Allowed 'General case' 0 C--O 1.21 -1.01 0 CA-C-O 117.79 -1.1 . . . . 74.05 111.228 -171.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 115' ' ' LYS . . . . . . . . . . . . . 56.7 tttp -30.55 116.91 0.15 Allowed 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 116.185 1.92 . . . . 74.15 116.185 -161.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.18 128.3 30.78 Favored Glycine 0 C--N 1.356 1.676 0 O-C-N 124.486 1.116 . . . . 54.4 111.601 169.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 117' ' ' ARG . . . . . 0.675 ' HB2' ' HB2' ' C' ' 167' ' ' GLN . 50.3 mtm180 -115.46 180.0 3.8 Favored 'General case' 0 C--O 1.254 1.313 0 CA-C-O 122.056 0.931 . . . . 74.32 110.662 -174.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 118' ' ' ASP . . . . . 0.474 ' HA ' ' O ' ' C' ' 173' ' ' ASP . 0.8 OUTLIER -57.07 107.24 0.39 Allowed 'General case' 0 C--O 1.243 0.73 0 CA-C-N 112.278 -2.237 . . . . 75.42 110.193 172.124 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 119' ' ' LEU . . . . . 0.565 HD12 ' HA3' ' C' ' 166' ' ' GLY . 0.3 OUTLIER -94.91 113.89 25.67 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 107.647 -1.242 . . . . 75.21 107.647 174.619 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' C' ' 175' ' ' LEU . 0.0 OUTLIER -104.4 124.8 49.88 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 110.125 -0.324 . . . . 72.31 110.125 -173.797 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 121' ' ' ALA . . . . . 0.506 ' HA ' ' HA ' ' B' ' 185' ' ' VAL . . . -111.43 137.15 49.59 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.388 0.675 . . . . 75.44 111.231 -177.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 122' ' ' GLU . . . . . 0.772 ' HB2' ' HA ' ' B' ' 186' ' ' THR . 5.6 tp10 -92.66 90.15 6.97 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 107.665 -1.235 . . . . 74.12 107.665 170.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 123' ' ' LEU . . . . . 0.725 ' HB3' ' HA ' ' B' ' 183' ' ' ALA . 1.1 pt? -105.36 114.28 63.49 Favored Pre-proline 0 N--CA 1.49 1.539 0 CA-C-N 118.474 0.579 . . . . 73.3 112.116 -174.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . 0.511 ' HA ' ' O ' ' C' ' 179' ' ' ARG . 36.2 Cg_exo -64.64 112.35 1.94 Allowed 'Trans proline' 0 C--N 1.386 2.528 0 C-N-CA 122.606 2.204 . . . . 72.51 110.489 164.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 125' ' ' LEU . . . . . 0.427 HD23 HG23 ' C' ' 153' ' ' VAL . 51.3 tp -131.79 147.3 52.48 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 122.552 0.341 . . . . 75.32 110.828 -169.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 126' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -92.08 151.47 20.42 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.302 0.641 . . . . 61.53 109.946 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 127' ' ' LEU . . . . . 0.408 ' CD2' HD12 ' C' ' 180' ' ' LEU . 25.2 mt -65.82 -50.99 62.66 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.425 1.09 . . . . 62.25 110.311 -177.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -53.69 -42.87 68.44 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 113.165 -1.834 . . . . 75.24 109.896 176.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 129' ' ' GLU . . . . . 0.5 ' HA ' ' HB2' ' C' ' 132' ' ' HIS . 15.1 mm-40 -82.33 -16.93 47.5 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.737 0.815 . . . . 75.51 111.821 -175.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -71.93 -31.53 66.44 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 109.014 -0.735 . . . . 73.14 109.014 172.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 131' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -73.11 -51.12 19.16 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 115.471 -0.786 . . . . 75.55 110.659 164.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 132' ' ' HIS . . . . . 0.5 ' HB2' ' HA ' ' C' ' 129' ' ' GLU . 38.3 m80 -76.32 3.82 10.16 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.005 0.522 . . . . 70.15 112.234 -171.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -58.83 88.26 0.02 OUTLIER Glycine 0 CA--C 1.539 1.544 0 N-CA-C 114.578 0.591 . . . . 65.31 114.578 171.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . -88.03 -143.9 9.12 Favored Glycine 0 C--N 1.355 1.631 0 N-CA-C 111.34 -0.704 . . . . 73.12 111.34 170.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 26.1 mp0 -70.48 93.83 0.92 Allowed 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 107.971 -1.122 . . . . 73.03 107.971 171.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 136' ' ' ARG . . . . . 0.566 ' HB3' ' HB2' ' B' ' 181' ' ' LEU . 78.7 mtt180 -115.58 138.19 51.31 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.024 0.529 . . . . 72.12 110.081 -173.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 137' ' ' VAL . . . . . 0.507 ' HA ' ' HA ' ' C' ' 146' ' ' SER . 21.5 t -76.7 103.57 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-N 116.099 -0.501 . . . . 73.11 109.877 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 138' ' ' VAL . . . . . 0.519 ' HB ' HD23 ' B' ' 181' ' ' LEU . 4.6 p -80.43 123.69 37.45 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 123.659 0.784 . . . . 72.14 109.22 174.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 139' ' ' GLU . . . . . 0.623 ' HG2' ' HG3' ' C' ' 144' ' ' ARG . 28.3 mt-10 -118.97 92.01 3.7 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.77 0.828 . . . . 74.31 109.175 -165.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 140' ' ' VAL . . . . . 0.41 HG22 ' HB3' ' C' ' 121' ' ' ALA . 7.1 p -143.53 147.39 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 C-N-CA 123.282 0.633 . . . . 73.25 111.435 -168.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 64.53 17.29 10.78 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 125.045 1.338 . . . . 65.0 111.908 -174.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 142' ' ' GLY . . . . . 0.403 ' H ' ' HB1' ' B' ' 44' ' ' ALA . . . 87.37 -8.64 76.29 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-N 115.568 -0.742 . . . . 52.4 112.947 -175.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 143' ' ' ARG . . . . . 0.429 ' HD3' ' HA ' ' C' ' 143' ' ' ARG . 6.7 mmt180 -101.47 139.94 36.45 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.446 0.641 . . . . 75.05 111.474 -177.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 144' ' ' ARG . . . . . 0.623 ' HG3' ' HG2' ' C' ' 139' ' ' GLU . 59.7 ttt180 -115.45 93.22 4.19 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-N 114.652 -1.158 . . . . 71.51 110.178 -165.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 145' ' ' VAL . . . . . . . . . . . . . 30.3 m -118.79 142.5 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 123.179 0.591 . . . . 75.03 112.001 -172.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 146' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' C' ' 137' ' ' VAL . 20.3 m -95.0 128.97 42.23 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.266 1.026 . . . . 73.22 111.054 -177.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 14.4 p -162.75 148.1 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 123.042 0.537 . . . . 72.53 110.663 175.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 29.8 ttm-85 -84.28 117.22 23.41 Favored 'General case' 0 C--N 1.349 0.571 0 N-CA-C 108.994 -0.743 . . . . 74.22 108.994 166.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 149' ' ' ILE . . . . . . . . . . . . . 42.2 pt -88.36 150.12 46.12 Favored Pre-proline 0 CA--C 1.548 0.878 0 N-CA-C 108.642 -0.873 . . . . 74.42 108.642 172.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -50.02 112.29 0.69 Allowed 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 123.183 2.589 . . . . 61.44 113.236 179.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -61.5 106.35 0.41 Allowed 'Trans proline' 0 C--N 1.383 2.376 0 C-N-CA 122.958 2.439 . . . . 73.2 112.117 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 152' ' ' GLY . . . . . . . . . . . . . . . 129.19 101.53 1.0 Allowed Glycine 0 C--N 1.343 0.922 0 CA-C-N 115.214 -0.903 . . . . 63.11 111.37 -171.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 153' ' ' VAL . . . . . 0.427 HG23 HD23 ' C' ' 125' ' ' LEU . 1.0 OUTLIER -122.77 159.84 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 CA-C-N 117.145 0.472 . . . . 74.01 110.398 -179.042 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 154' ' ' ARG . . . . . 0.618 ' HB2' ' HB2' ' C' ' 157' ' ' SER . 38.6 mtp180 -119.05 121.77 40.61 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.245 1.018 . . . . 75.32 109.105 -171.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 155' ' ' GLU . . . . . 0.683 ' HB3' ' HG2' ' C' ' 187' ' ' ARG . 9.4 tp10 -45.3 122.94 3.73 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.909 0.883 . . . . 74.51 112.45 174.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 87.52 -21.25 22.86 Favored Glycine 0 C--N 1.351 1.403 0 O-C-N 124.425 1.078 . . . . 75.21 113.276 176.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 157' ' ' SER . . . . . 0.618 ' HB2' ' HB2' ' C' ' 154' ' ' ARG . 33.8 m -88.97 -177.92 5.59 Favored 'General case' 0 C--O 1.247 0.962 0 CA-C-O 121.445 0.641 . . . . 75.43 110.733 -172.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 7.2 p -128.11 127.53 67.78 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 CA-C-N 115.48 -0.782 . . . . 72.31 111.587 -173.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 159' ' ' ILE . . . . . 0.598 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 47.9 mt -73.63 139.04 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.673 1.189 . . . . 72.31 109.194 168.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 160' ' ' ARG . . . . . 0.468 HH11 ' HD2' ' B' ' 314' ' ' ARG . 30.1 ttt85 -117.38 111.02 18.76 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 109.098 -0.705 . . . . 75.13 109.098 175.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 161' ' ' VAL . . . . . 0.61 HG13 ' HB3' ' C' ' 174' ' ' LEU . 1.6 p -106.03 98.93 20.31 Favored Pre-proline 0 CA--C 1.555 1.166 0 N-CA-C 108.295 -1.002 . . . . 75.24 108.295 168.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -76.54 140.17 21.14 Favored 'Trans proline' 0 C--N 1.384 2.433 0 C-N-CA 123.07 2.513 . . . . 75.23 112.141 178.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 110.14 -7.84 30.99 Favored Glycine 0 C--N 1.347 1.157 0 CA-C-O 119.817 -0.435 . . . . 53.54 112.455 178.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 164' ' ' MET . . . . . 0.477 ' HE2' HD23 ' C' ' 174' ' ' LEU . 3.3 ppp? -158.13 124.17 4.65 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.959 0.904 . . . . 73.35 109.383 172.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . -125.68 -116.33 2.1 Favored Glycine 0 C--N 1.346 1.123 0 C-N-CA 123.854 0.74 . . . . 73.32 112.474 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 166' ' ' GLY . . . . . 0.565 ' HA3' HD12 ' C' ' 119' ' ' LEU . . . -169.87 -61.52 0.04 OUTLIER Glycine 0 C--N 1.346 1.103 0 C-N-CA 120.21 -0.995 . . . . 75.44 114.653 175.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 167' ' ' GLN . . . . . 0.675 ' HB2' ' HB2' ' C' ' 117' ' ' ARG . 14.1 mm100 -66.69 98.58 0.53 Allowed 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 117.09 0.445 . . . . 74.2 110.692 -165.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 168' ' ' GLY . . . . . 0.563 ' HA2' ' HA2' ' C' ' 107' ' ' GLY . . . 110.34 -144.25 17.01 Favored Glycine 0 C--O 1.213 -1.173 0 CA-C-O 118.352 -1.249 . . . . 13.44 111.72 -165.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 169' ' ' ASN . . . . . 0.424 ' HB3' ' HD3' ' C' ' 170' ' ' PRO . 17.9 t-20 -150.21 -51.39 0.02 OUTLIER Pre-proline 0 CA--C 1.594 2.659 0 CA-C-N 119.723 1.762 . . . . 62.44 113.291 -177.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 170' ' ' PRO . . . . . 0.424 ' HD3' ' HB3' ' C' ' 169' ' ' ASN . 49.5 Cg_exo -48.59 177.03 0.02 OUTLIER 'Trans proline' 0 N--CA 1.522 3.188 0 C-N-CA 124.359 3.373 . . . . 73.55 116.765 168.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 171' ' ' PRO . . . . . 0.461 ' HA ' ' HA2' ' C' ' 87' ' ' GLY . 1.1 Cg_exo -31.55 119.25 0.08 OUTLIER 'Trans proline' 0 C--N 1.404 3.483 1 C-N-CA 125.417 4.078 . . . . 74.02 117.272 172.969 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -160.56 -172.24 27.56 Favored Glycine 0 C--N 1.356 1.668 0 C-N-CA 124.276 0.941 . . . . 74.42 111.333 177.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 173' ' ' ASP . . . . . 0.474 ' O ' ' HA ' ' C' ' 118' ' ' ASP . 5.8 p-10 -140.79 147.68 39.44 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.718 0.771 . . . . 74.51 111.209 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 174' ' ' LEU . . . . . 0.61 ' HB3' HG13 ' C' ' 161' ' ' VAL . 43.9 tp -97.83 112.63 24.47 Favored 'General case' 0 C--O 1.245 0.849 0 N-CA-C 109.147 -0.686 . . . . 75.22 109.147 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 175' ' ' LEU . . . . . 0.666 HD23 ' HG3' ' B' ' 314' ' ' ARG . 55.7 mt -87.18 112.25 21.78 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.245 -1.343 . . . . 72.15 109.664 174.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 176' ' ' LEU . . . . . 0.598 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 57.7 mt -100.41 97.26 8.02 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 109.355 -0.609 . . . . 74.33 109.355 174.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 177' ' ' VAL . . . . . . . . . . . . . 17.1 t -83.61 103.36 10.78 Favored 'Isoleucine or valine' 0 C--O 1.253 1.238 0 N-CA-C 107.904 -1.147 . . . . 75.23 107.904 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 178' ' ' VAL . . . . . . . . . . . . . 6.1 m -84.95 117.43 30.19 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 CA-C-N 114.397 -1.274 . . . . 74.01 112.086 -172.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 179' ' ' ARG . . . . . 0.511 ' O ' ' HA ' ' C' ' 124' ' ' PRO . 6.2 mmm180 -105.36 107.77 18.94 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 106.142 -1.799 . . . . 74.42 106.142 166.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 180' ' ' LEU . . . . . 0.603 HD13 ' HB2' ' C' ' 155' ' ' GLU . 58.4 mt -70.12 148.23 48.99 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 122.35 -0.219 . . . . 73.43 110.583 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 181' ' ' LEU . . . . . . . . . . . . . 67.5 mt -54.28 167.03 0.6 Allowed Pre-proline 0 N--CA 1.494 1.75 0 C-N-CA 125.261 1.425 . . . . 74.24 112.434 -176.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -56.64 71.43 0.04 OUTLIER 'Trans proline' 0 C--N 1.387 2.554 0 C-N-CA 123.029 2.486 . . . . 73.32 111.217 163.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 183' ' ' HIS . . . . . 0.415 ' N ' ' HD3' ' C' ' 184' ' ' PRO . 81.2 t60 -179.2 51.91 0.05 OUTLIER Pre-proline 0 CA--C 1.557 1.249 0 C-N-CA 126.768 2.027 . . . . 72.0 106.237 -164.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 184' ' ' PRO . . . . . 0.415 ' HD3' ' N ' ' C' ' 183' ' ' HIS . 61.5 Cg_endo -92.18 65.19 0.87 Allowed 'Trans proline' 0 C--N 1.386 2.537 0 C-N-CA 123.046 2.498 . . . . 74.25 110.662 -170.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 185' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 12.4 t -93.37 -33.86 5.52 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.41 0 CA-C-N 115.284 -0.871 . . . . 72.23 109.035 -171.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 186' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -127.79 106.0 8.83 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 118.809 0.732 . . . . 61.44 111.93 -175.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 187' ' ' ARG . . . . . 0.683 ' HG2' ' HB3' ' C' ' 155' ' ' GLU . 1.6 tmt_? -95.26 116.59 28.95 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 107.352 -1.351 . . . . 75.14 107.352 169.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 188' ' ' LEU . . . . . 0.48 HD12 ' HA ' ' C' ' 191' ' ' GLN . 65.3 tp -80.74 138.89 36.32 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 122.917 0.487 . . . . 74.14 111.762 -178.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -142.6 113.09 7.28 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 106.548 -1.649 . . . . 73.21 106.548 169.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 73.92 -109.44 2.8 Favored Glycine 0 N--CA 1.474 1.177 0 N-CA-C 111.413 -0.675 . . . . 74.2 111.413 -170.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 191' ' ' GLN . . . . . 0.48 ' HA ' HD12 ' C' ' 188' ' ' LEU . 28.1 mt-30 -123.85 7.0 8.7 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 123.564 0.745 . . . . 75.25 109.085 167.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 192' ' ' ASP . . . . . 0.486 ' HB3' ' HE1' ' C' ' 250' ' ' TYR . 3.8 m-20 -95.63 142.74 27.59 Favored 'General case' 0 C--N 1.344 0.351 0 C-N-CA 125.176 1.391 . . . . 65.13 109.188 -172.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 193' ' ' LEU . . . . . 0.461 HD22 ' CD2' ' C' ' 240' ' ' PHE . 86.7 mt -112.45 142.34 45.11 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.587 0.355 . . . . 65.15 110.777 -178.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 194' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -108.97 128.05 54.6 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 108.17 -1.048 . . . . 75.43 108.17 165.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 195' ' ' ALA . . . . . 0.547 ' HB2' ' HG ' ' C' ' 251' ' ' LEU . . . -127.03 -178.19 4.32 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.404 0.682 . . . . 65.11 110.768 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 33.0 m -135.54 111.03 9.14 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 107.675 -1.231 . . . . 53.42 107.675 169.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 197' ' ' LEU . . . . . 0.448 HD13 ' HB1' ' C' ' 212' ' ' ALA . 42.2 tp -88.92 136.89 32.77 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 123.436 0.694 . . . . 73.5 110.055 176.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -92.4 117.32 29.8 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 108.616 -0.883 . . . . 64.33 108.616 173.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 199' ' ' VAL . . . . . 0.562 ' HA ' HG12 ' C' ' 210' ' ' VAL . 21.4 t -125.6 106.57 26.7 Favored Pre-proline 0 CA--C 1.544 0.728 0 N-CA-C 108.09 -1.078 . . . . 73.12 108.09 176.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 200' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -67.76 141.69 55.29 Favored 'Trans proline' 0 C--N 1.369 1.613 0 C-N-CA 121.737 1.625 . . . . 73.11 111.33 176.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 201' ' ' ALA . . . . . . . . . . . . . . . -42.65 -49.16 13.3 Favored Pre-proline 0 CA--C 1.559 1.313 0 C-N-CA 125.498 1.519 . . . . 74.35 114.507 -176.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 202' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -55.34 -52.04 8.65 Favored 'Trans proline' 0 C--N 1.388 2.611 0 C-N-CA 121.558 1.505 . . . . 63.15 112.95 175.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 203' ' ' ILE . . . . . 0.445 ' HA ' HG11 ' C' ' 206' ' ' VAL . 53.0 mt -63.45 -34.57 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 122.885 0.474 . . . . 74.02 111.022 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -62.7 -43.27 99.24 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.79 0.836 . . . . 75.02 111.522 178.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 205' ' ' VAL . . . . . 0.418 HG13 ' HG3' ' C' ' 226' ' ' ARG . 88.5 t -79.29 -34.12 16.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 115.842 -0.617 . . . . 74.52 112.097 -176.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 206' ' ' VAL . . . . . 0.665 HG23 ' HG3' ' A' ' 270' ' ' LYS . 9.9 p -80.24 -32.05 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 122.183 0.193 . . . . 74.12 111.04 -177.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 79.48 56.32 3.42 Favored Glycine 0 C--N 1.336 0.582 0 N-CA-C 111.366 -0.694 . . . . 63.21 111.366 -171.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -92.84 -124.21 3.53 Favored Glycine 0 C--N 1.34 0.786 0 N-CA-C 111.104 -0.798 . . . . 51.32 111.104 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 209' ' ' LYS . . . . . 0.551 ' HB3' ' HG2' ' C' ' 220' ' ' GLU . 40.5 mtmt -148.0 149.35 31.99 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.399 0.679 . . . . 72.44 111.074 176.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 210' ' ' VAL . . . . . 0.562 HG12 ' HA ' ' C' ' 199' ' ' VAL . 15.8 m -137.76 141.68 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-N 114.546 -1.206 . . . . 71.52 108.753 174.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 211' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.73 110.54 19.4 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.264 0.626 . . . . 75.53 111.013 -176.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 212' ' ' ALA . . . . . 0.448 ' HB1' HD13 ' C' ' 197' ' ' LEU . . . -90.46 113.56 25.54 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 107.742 -1.207 . . . . 74.43 107.742 165.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 213' ' ' MET . . . . . 0.474 ' HA ' ' HA ' ' C' ' 218' ' ' PRO . 6.8 tmm? -71.62 132.45 44.64 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 107.79 -1.189 . . . . 63.12 107.79 176.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.19 175.18 8.34 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.008 0.523 . . . . 72.34 110.68 -176.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 215' ' ' LEU . . . . . . . . . . . . . 20.3 mt -68.17 -23.31 64.85 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.12 0.968 . . . . 75.24 112.074 -172.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -87.36 -26.83 23.16 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 114.684 -1.144 . . . . 71.0 109.735 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 141.47 179.44 18.64 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 109.403 -1.479 . . . . 74.41 109.403 -168.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 218' ' ' PRO . . . . . 0.474 ' HA ' ' HA ' ' C' ' 213' ' ' MET . 86.4 Cg_endo -75.15 119.11 5.47 Favored 'Trans proline' 0 CA--C 1.559 1.735 0 C-N-CA 122.561 2.174 . . . . 64.03 113.481 -175.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 219' ' ' VAL . . . . . 0.419 HG23 HG23 ' B' ' 238' ' ' THR . 8.6 p -91.66 125.32 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 N-CA-C 108.253 -1.018 . . . . 52.53 108.253 169.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 220' ' ' GLU . . . . . 0.551 ' HG2' ' HB3' ' C' ' 209' ' ' LYS . 15.6 tt0 -90.53 106.33 18.43 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.874 0.845 . . . . 72.32 108.757 177.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 221' ' ' VAL . . . . . . . . . . . . . 71.0 t -72.64 126.39 33.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 113.807 -1.542 . . . . 74.03 111.972 -174.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -72.6 117.33 14.15 Favored 'General case' 0 CA--C 1.549 0.919 0 O-C-N 124.314 1.009 . . . . 73.3 110.306 169.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 90.9 t -91.35 140.93 25.68 Favored Pre-proline 0 CA--C 1.555 1.157 0 C-N-CA 124.514 1.125 . . . . 73.11 109.794 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 224' ' ' PRO . . . . . 0.521 ' HG3' HH22 ' C' ' 231' ' ' ARG . 87.3 Cg_endo -81.03 147.54 16.66 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 123.172 2.581 . . . . 73.11 112.089 167.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 225' ' ' PRO . . . . . 0.466 ' HG2' HG23 ' B' ' 246' ' ' THR . 86.7 Cg_exo -52.45 132.45 44.95 Favored 'Trans proline' 0 C--N 1.372 1.793 0 C-N-CA 122.417 2.078 . . . . 74.4 112.793 169.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 226' ' ' ARG . . . . . 0.736 HH22 HD11 ' B' ' 97' ' ' ILE . 0.0 OUTLIER 51.31 85.6 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 126.279 1.832 . . . . 71.5 112.583 -171.703 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 227' ' ' THR . . . . . 0.503 HG21 HG12 ' C' ' 253' ' ' VAL . 90.4 m -101.11 130.79 47.21 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 114.406 -1.27 . . . . 73.3 109.854 174.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 228' ' ' GLN . . . . . 0.661 HE21 ' HG2' ' A' ' 259' ' ' GLU . 25.2 mp0 -95.4 147.39 23.57 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.499 1.12 . . . . 74.32 111.978 -176.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -72.76 124.25 24.96 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 114.989 -1.005 . . . . 65.31 109.209 173.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 108.32 -9.76 36.03 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-O 119.641 -0.533 . . . . 62.04 112.526 -172.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 231' ' ' ARG . . . . . 0.521 HH22 ' HG3' ' C' ' 224' ' ' PRO . 34.3 mtp180 -64.35 169.92 4.27 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 117.616 0.708 . . . . 75.03 110.465 169.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 232' ' ' LYS . . . . . 0.429 ' HA ' ' O ' ' C' ' 251' ' ' LEU . 33.6 ttmt -142.92 136.96 29.11 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.226 0.536 . . . . 74.05 110.552 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 233' ' ' LEU . . . . . 0.698 HD12 ' HB2' ' C' ' 251' ' ' LEU . 4.0 mp -98.01 145.92 26.02 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 114.478 -1.237 . . . . 74.22 109.759 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 11.5 ptp85 -110.02 90.9 3.45 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 124.628 1.205 . . . . 72.34 108.183 163.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 235' ' ' LEU . . . . . 0.406 HD12 HD22 ' C' ' 249' ' ' LEU . 24.8 mt -78.25 95.95 5.12 Favored 'General case' 0 C--N 1.352 0.686 0 N-CA-C 107.407 -1.331 . . . . 74.34 107.407 169.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 236' ' ' LYS . . . . . 0.474 ' HZ2' ' HG2' ' B' ' 360' ' ' GLN . 30.4 mmmt -70.75 125.71 27.57 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 114.516 -1.22 . . . . 73.41 111.594 -171.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 75.72 29.23 59.73 Favored Glycine 0 C--N 1.348 1.22 0 O-C-N 123.867 0.73 . . . . 71.42 112.423 -176.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -124.34 17.02 9.04 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.279 0.631 . . . . 75.11 110.535 176.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -77.53 -165.44 24.88 Favored Glycine 0 C--N 1.359 1.811 0 N-CA-C 110.893 -0.883 . . . . 75.2 110.893 167.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 240' ' ' PHE . . . . . 0.461 ' CD2' HD22 ' C' ' 193' ' ' LEU . 1.2 m-85 -70.67 127.29 92.05 Favored Pre-proline 0 C--O 1.257 1.472 0 CA-C-N 118.061 0.93 . . . . 75.14 108.959 176.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 241' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -61.47 94.94 0.12 Allowed 'Trans proline' 0 C--N 1.385 2.459 0 C-N-CA 123.553 2.836 . . . . 71.53 113.171 177.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 242' ' ' GLY . . . . . 0.441 ' H ' ' HA ' ' C' ' 246' ' ' ARG . . . -77.56 137.94 20.96 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-N 113.838 -1.528 . . . . 70.14 112.126 -179.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 243' ' ' PRO . . . . . 0.582 ' HG2' ' HA ' ' B' ' 304' ' ' PRO . 57.9 Cg_endo -68.47 -9.32 25.66 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 123.152 2.568 . . . . 71.42 113.804 -176.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -120.78 23.09 10.91 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.393 0.677 . . . . 71.42 110.576 176.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 115.31 143.85 8.14 Favored Glycine 0 C--N 1.341 0.83 0 N-CA-C 109.951 -1.26 . . . . 63.24 109.951 -171.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 246' ' ' ARG . . . . . 0.441 ' HA ' ' H ' ' C' ' 242' ' ' GLY . 15.3 ptp180 -99.42 170.84 8.34 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 118.01 0.905 . . . . 71.32 112.395 -171.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -92.38 -164.92 38.51 Favored Glycine 0 C--N 1.35 1.356 0 CA-C-N 114.932 -1.031 . . . . 63.23 113.581 177.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -130.35 148.11 52.14 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.08 0.952 . . . . 73.54 109.055 -172.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 249' ' ' LEU . . . . . 0.406 HD22 HD12 ' C' ' 235' ' ' LEU . 22.8 tp -101.24 137.16 39.95 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.903 0.881 . . . . 74.23 110.611 -175.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 250' ' ' TYR . . . . . 0.584 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 59.3 m-85 -127.46 101.56 6.49 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.443 1.097 . . . . 71.43 109.265 -176.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 251' ' ' LEU . . . . . 0.698 ' HB2' HD12 ' C' ' 233' ' ' LEU . 1.2 mp -101.33 139.13 37.42 Favored 'General case' 0 N--CA 1.508 2.442 0 CA-C-N 118.138 0.426 . . . . 72.0 110.923 -175.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -80.09 138.99 37.06 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 108.953 -0.758 . . . . 75.41 108.953 168.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 253' ' ' VAL . . . . . 0.503 HG12 HG21 ' C' ' 227' ' ' THR . 99.0 t -87.29 128.14 40.12 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 CA-C-O 121.079 0.466 . . . . 73.5 111.214 176.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 254' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 -110.18 111.67 23.16 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.465 1.106 . . . . 75.13 108.828 167.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 255' ' ' ILE . . . . . 0.497 ' O ' ' HB ' ' A' ' 255' ' ' ILE . 33.8 mm -80.84 120.51 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 N-CA-C 108.294 -1.002 . . . . 75.24 108.294 171.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 256' ' ' THR . . . . . 0.535 HG22 ' HB2' ' A' ' 229' ' ' ALA . 46.4 p -120.34 -172.78 2.43 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.672 0.789 . . . . 70.25 111.257 -173.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 2.7 pp -141.45 148.79 52.02 Favored Pre-proline 0 N--CA 1.489 1.477 0 C-N-CA 123.39 0.676 . . . . 75.21 110.196 178.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -61.26 -7.69 8.86 Favored 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 123.372 2.715 . . . . 74.41 114.684 -174.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 57.12 -78.35 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.908 1.283 . . . . 72.3 110.846 -166.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 22.5 ptt-85 -60.35 136.58 58.08 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 124.23 1.012 . . . . 73.41 110.26 177.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 261' ' ' LEU . . . . . 0.469 HD21 ' HB3' ' C' ' 265' ' ' GLU . 94.8 mt -143.34 148.21 35.91 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.58 0.752 . . . . 74.53 109.65 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 262' ' ' THR . . . . . 0.463 ' OG1' ' HG2' ' C' ' 265' ' ' GLU . 36.4 p -84.31 162.42 51.39 Favored Pre-proline 0 CA--C 1.548 0.898 0 N-CA-C 108.417 -0.957 . . . . 61.23 108.417 167.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -53.4 -35.84 76.94 Favored 'Trans proline' 0 C--N 1.374 1.881 0 C-N-CA 122.267 1.978 . . . . 74.2 114.202 175.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -66.43 -48.11 71.07 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 122.381 0.272 . . . . 71.04 110.514 178.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 265' ' ' GLU . . . . . 0.469 ' HB3' HD21 ' C' ' 261' ' ' LEU . 33.2 mm-40 -52.57 -51.33 60.27 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 123.612 0.57 . . . . 71.03 109.633 175.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 266' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -54.43 -41.57 69.54 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 114.354 -1.294 . . . . 73.1 110.627 -177.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 267' ' ' ALA . . . . . 0.446 ' O ' ' HG3' ' C' ' 271' ' ' LYS . . . -62.13 -46.0 90.95 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.731 -0.668 . . . . 71.12 111.573 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 268' ' ' LEU . . . . . 0.428 ' HB2' HD23 ' A' ' 272' ' ' LEU . 10.4 mp -66.33 -41.94 88.91 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 111.591 0.219 . . . . 70.11 111.591 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -63.48 -33.11 74.86 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 122.988 0.515 . . . . 63.11 111.141 176.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 270' ' ' LYS . . . . . 0.594 ' HZ2' ' HB3' ' C' ' 270' ' ' LYS . 4.2 mmmp? -61.04 -48.92 79.52 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.631 0.772 . . . . 75.43 110.076 173.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 271' ' ' LYS . . . . . 0.446 ' HG3' ' O ' ' C' ' 267' ' ' ALA . 63.2 mttm -58.55 -43.76 89.41 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.72 0.808 . . . . 75.33 111.568 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 91.2 mt -61.63 -40.36 94.59 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.368 -0.833 . . . . 74.33 110.404 176.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -64.38 -34.69 78.75 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 115.522 -0.763 . . . . 43.22 110.822 177.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 274' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' C' ' 270' ' ' LYS . 13.5 mm-40 -67.58 -40.3 84.85 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.127 0.571 . . . . 63.21 109.702 177.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -61.71 -30.84 71.02 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.457 0.703 . . . . 70.04 110.662 174.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 276' ' ' TYR . . . . . 0.545 ' HA ' ' HD3' ' C' ' 279' ' ' ARG . 9.6 m-85 -77.27 -31.6 55.0 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.069 -0.968 . . . . 75.52 112.733 172.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -76.3 -19.13 58.56 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 118.526 0.603 . . . . 65.52 110.198 175.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -69.13 -16.58 63.69 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.331 0.652 . . . . 72.22 110.538 169.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 279' ' ' ARG . . . . . 0.545 ' HD3' ' HA ' ' C' ' 276' ' ' TYR . 16.3 mtp-105 -83.52 -14.81 51.46 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.155 0.582 . . . . 75.11 110.978 173.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.085 -0.96 . . . . 75.14 110.338 -179.233 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 79.8 mtp . . . . . 0 N--CA 1.476 0.844 0 N-CA-C 111.152 0.056 . . . . 64.12 111.152 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.47 42.99 8.26 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.956 0.902 . . . . 74.44 112.285 170.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -70.54 75.83 0.57 Allowed 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.559 0.744 . . . . 74.04 110.493 177.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.487 ' HB2' ' HZ2' ' A' ' 4' ' ' LYS . 4.9 ttmp? -38.91 110.02 0.12 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 126.064 1.746 . . . . 64.14 114.472 -174.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -100.26 114.49 27.98 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 123.546 0.739 . . . . 74.32 109.071 164.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.489 ' HA ' ' OH ' ' A' ' 66' ' ' TYR . 23.9 t70 -82.46 102.94 11.65 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 107.729 -1.211 . . . . 62.43 107.729 168.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.435 ' HD1' HD13 ' A' ' 10' ' ' ILE . 32.4 m-85 -64.08 -30.44 71.51 Favored 'General case' 0 C--O 1.244 0.811 0 CA-C-N 115.576 -0.738 . . . . 73.34 112.131 -171.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.417 ' CD1' HD12 ' A' ' 22' ' ' ILE . 64.9 m-85 -62.04 -44.34 96.89 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 122.851 0.46 . . . . 73.33 110.394 174.109 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.94 -41.84 97.49 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.285 0.634 . . . . 70.01 111.229 178.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.435 HD13 ' HD1' ' A' ' 7' ' ' TYR . 65.1 mt -55.77 -43.28 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 123.469 0.707 . . . . 74.23 110.976 176.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.6 mt -79.62 -14.12 59.03 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 112.936 0.717 . . . . 73.11 112.936 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.39 36.65 59.25 Favored Glycine 0 C--N 1.351 1.378 0 O-C-N 123.026 0.204 . . . . 73.42 113.485 -176.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.3 m -119.93 157.33 52.96 Favored Pre-proline 0 N--CA 1.482 1.175 0 C-N-CA 124.764 1.226 . . . . 72.52 109.164 175.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.472 ' HG2' ' HB3' ' A' ' 17' ' ' ALA . 12.2 Cg_endo -55.93 153.1 33.05 Favored 'Trans proline' 0 C--N 1.388 2.645 0 C-N-CA 122.771 2.314 . . . . 50.12 112.508 177.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 72.3 mtp180 -81.63 59.53 4.19 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.113 0.965 . . . . 75.43 111.411 -170.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 176.37 -27.96 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.643 1.177 . . . . 71.2 109.273 -168.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.472 ' HB3' ' HG2' ' A' ' 14' ' ' PRO . . . -37.64 138.01 0.4 Allowed 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 126.864 2.065 . . . . 74.14 114.897 -171.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.9 p -61.67 162.26 8.76 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 124.6 1.16 . . . . 75.03 112.455 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -56.05 -35.93 67.47 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.118 0.967 . . . . 71.11 112.279 -175.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.46 ' HA ' ' HZ2' ' A' ' 23' ' ' LYS . 0.4 OUTLIER -74.51 -29.49 61.43 Favored 'General case' 0 C--O 1.209 -1.058 0 CA-C-O 118.939 -0.553 . . . . 72.43 110.654 -177.246 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -69.67 -39.0 77.27 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 118.516 0.598 . . . . 71.14 110.005 173.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.417 HD12 ' CD1' ' A' ' 8' ' ' TYR . 1.6 mp -61.86 -40.91 88.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 C-N-CA 124.199 1.0 . . . . 73.31 110.345 172.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.667 ' HE2' ' HA ' ' B' ' 95' ' ' LYS . 3.8 ttpm? -80.32 -25.76 39.15 Favored 'General case' 0 C--O 1.213 -0.844 0 CA-C-N 114.491 -1.231 . . . . 75.22 110.197 -174.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.428 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 73.5 mtp180 -78.07 -34.85 50.1 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.484 0.714 . . . . 73.12 109.918 173.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.78 -34.36 73.65 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 123.893 0.746 . . . . 72.43 109.982 173.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -63.96 -60.23 3.51 Favored 'General case' 0 C--O 1.209 -1.068 0 CA-C-N 115.672 -0.695 . . . . 73.1 109.533 172.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.428 ' HE3' ' HA ' ' A' ' 24' ' ' ARG . 51.6 mtmt -53.87 -38.2 64.48 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 124.31 1.044 . . . . 74.22 110.686 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.2 ttt180 -59.37 -57.91 10.93 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.521 1.128 . . . . 75.52 110.956 176.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.589 ' HB3' HD12 ' A' ' 50' ' ' ILE . 84.7 mt -76.81 -11.69 59.87 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.702 0.801 . . . . 75.12 111.18 -177.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.06 -20.44 24.36 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.909 0.884 . . . . 71.54 110.535 178.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 75.4 mtm180 -95.68 -31.9 13.02 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.052 0.541 . . . . 72.33 110.673 171.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -77.03 -55.0 5.83 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 108.981 -0.748 . . . . 73.31 108.981 -178.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.593 ' HA ' HD21 ' A' ' 38' ' ' ASN . 39.2 m-85 -93.47 33.55 1.24 Allowed 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 115.879 -0.601 . . . . 72.41 110.531 173.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 7.9 t-80 -61.28 107.75 1.23 Allowed Pre-proline 0 C--N 1.357 0.912 0 N-CA-C 108.564 -0.902 . . . . 73.54 108.564 177.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -57.87 -19.32 38.84 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 122.976 2.451 . . . . 75.51 113.086 -169.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -63.42 -42.69 98.73 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.685 1.194 . . . . 73.23 112.704 178.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.5 t -105.09 -37.46 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 123.173 0.589 . . . . 73.25 109.984 -177.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.593 HD21 ' HA ' ' A' ' 33' ' ' TYR . 63.1 t30 -98.09 68.13 1.95 Allowed 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 122.634 1.207 . . . . 64.12 108.51 178.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt -79.6 75.88 6.24 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 113.827 -1.533 . . . . 73.11 109.282 -178.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.8 m -135.55 108.29 10.12 Favored Pre-proline 0 N--CA 1.467 0.422 0 CA-C-O 118.124 -0.941 . . . . 71.24 108.622 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -39.31 -45.31 3.03 Favored 'Trans proline' 0 C--N 1.387 2.569 0 C-N-CA 124.23 3.287 . . . . 73.53 114.248 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -56.22 -46.93 79.33 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.408 0.683 . . . . 64.43 111.343 178.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.5 -16.96 61.78 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.527 0.731 . . . . 73.42 111.623 -178.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -92.07 -30.72 15.87 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.532 0.733 . . . . 63.35 110.428 -176.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -72.23 -36.62 69.16 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 109.417 -0.586 . . . . 62.44 109.417 168.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -62.84 -41.28 99.27 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 116.058 -0.519 . . . . 74.03 109.834 170.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.629 ' HA ' HD13 ' A' ' 50' ' ' ILE . 52.1 t80 -63.64 -31.56 72.77 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.583 0.753 . . . . 73.32 110.716 176.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -63.64 -45.14 91.56 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 122.567 0.347 . . . . 75.14 110.975 171.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -65.63 -25.87 67.57 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 111.821 0.304 . . . . 71.44 111.821 178.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.629 HD13 ' HA ' ' A' ' 47' ' ' PHE . 66.1 mt -74.78 -39.28 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 123.847 0.859 . . . . 74.43 110.103 172.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.444 ' HB3' ' HD1' ' A' ' 88' ' ' PHE . 94.4 m-20 -71.07 -23.56 62.16 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.684 0.793 . . . . 73.43 110.911 176.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -76.05 -53.35 8.49 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.593 1.557 . . . . 75.34 109.626 177.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.06 -47.19 78.4 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 113.928 -1.487 . . . . 65.45 110.417 176.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -68.87 -37.05 78.82 Favored 'General case' 0 C--O 1.207 -1.14 0 CA-C-N 114.64 -1.164 . . . . 73.53 110.928 176.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.407 ' HB1' ' HD2' ' A' ' 85' ' ' PHE . . . -51.93 -53.81 36.78 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 118.658 0.663 . . . . 72.52 110.462 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.474 HG11 ' HZ ' ' A' ' 101' ' ' PHE . 47.0 t -64.1 -55.93 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 113.866 -1.515 . . . . 74.52 110.273 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 78.1 mt -81.61 2.03 31.2 Favored 'General case' 0 CA--C 1.556 1.183 0 N-CA-C 113.745 1.017 . . . . 74.35 113.745 -169.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.0 t -80.19 -75.14 0.27 Allowed 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 109.215 -0.661 . . . . 74.34 109.215 174.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -68.86 116.95 46.5 Favored Pre-proline 0 C--O 1.239 0.549 0 CA-C-O 118.651 -0.69 . . . . 74.34 109.392 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -49.88 -28.0 17.27 Favored 'Trans proline' 0 C--N 1.388 2.621 0 C-N-CA 124.069 3.179 . . . . 72.41 114.294 -175.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -60.34 -62.73 1.65 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.704 0.802 . . . . 72.3 110.735 175.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.421 ' HA ' HD12 ' A' ' 65' ' ' ILE . 29.6 mtmm -64.28 -33.12 75.09 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.176 0.591 . . . . 74.54 110.737 -177.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 22.3 ttt85 -61.83 -45.76 92.45 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.065 -0.971 . . . . 74.11 110.703 176.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -70.65 -28.25 64.65 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 119.279 -0.391 . . . . 74.25 111.262 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' A' ' 62' ' ' LYS . 73.2 mt -53.24 -52.8 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 N-CA-C 108.86 -0.793 . . . . 74.41 108.86 168.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.489 ' OH ' ' HA ' ' A' ' 6' ' ' ASP . 55.9 t80 -61.97 -52.01 65.76 Favored 'General case' 0 CA--C 1.556 1.179 0 CA-C-N 114.561 -1.2 . . . . 75.4 112.004 178.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -56.37 -40.54 74.73 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.135 0.974 . . . . 64.04 111.848 -175.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 58.6 p -80.35 -22.55 41.31 Favored 'General case' 0 C--O 1.215 -0.728 0 CA-C-N 115.498 -0.774 . . . . 75.44 111.07 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -66.45 109.23 2.66 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 118.909 0.777 . . . . 75.32 108.934 176.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 113.18 13.29 10.98 Favored Glycine 0 CA--C 1.537 1.429 0 CA-C-N 115.337 -0.847 . . . . 64.23 111.565 -166.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 50.7 m -148.4 -61.08 0.25 Allowed 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 103.986 -2.598 . . . . 71.23 103.986 176.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 61.8 m -75.83 139.87 41.97 Favored 'General case' 0 C--O 1.248 1.005 0 N-CA-C 104.549 -2.389 . . . . 74.23 104.549 155.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.14 -25.8 7.94 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 122.792 0.437 . . . . 74.04 111.179 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.08 132.51 90.18 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 123.851 0.86 . . . . 75.1 110.597 176.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -55.51 141.95 81.88 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 122.74 2.294 . . . . 75.41 111.252 168.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -57.72 149.93 65.27 Favored 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 123.501 2.801 . . . . 74.25 113.009 -173.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -66.2 170.81 11.25 Favored 'Trans proline' 0 C--N 1.383 2.393 0 C-N-CA 124.095 3.197 . . . . 73.45 113.742 -173.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -33.71 127.58 0.16 Allowed 'Trans proline' 0 C--N 1.401 3.304 0 C-N-CA 124.818 3.679 . . . . 73.2 114.404 174.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.571 ' HG3' ' HA3' ' A' ' 104' ' ' GLY . 42.2 Cg_endo -77.92 119.8 4.84 Favored 'Trans proline' 0 CA--C 1.559 1.73 0 C-N-CA 123.277 2.651 . . . . 71.05 113.049 -165.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.405 ' HB2' ' HB2' ' B' ' 84' ' ' ARG . 72.0 Cg_endo -73.09 76.23 2.63 Favored 'Trans proline' 0 CA--C 1.554 1.511 0 C-N-CA 122.592 2.195 . . . . 74.31 112.746 -178.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 115.22 0.96 22.25 Favored Glycine 0 C--N 1.347 1.152 0 CA-C-N 115.075 -0.966 . . . . 62.41 112.002 -176.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.74 147.14 12.31 Favored Glycine 0 C--N 1.352 1.436 0 N-CA-C 110.713 -0.955 . . . . 53.03 110.713 -167.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -65.53 100.62 0.52 Allowed 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 118.349 1.074 . . . . 74.41 109.029 172.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -54.1 139.75 34.14 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.496 1.118 . . . . 71.31 112.519 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.491 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 65.2 m-85 -143.48 72.85 1.37 Allowed 'General case' 0 N--CA 1.47 0.55 0 O-C-N 124.136 0.897 . . . . 73.24 109.682 171.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 18.2 m -52.7 86.7 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 125.509 1.524 . . . . 74.44 112.68 -179.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.703 ' H ' ' HA3' ' A' ' 163' ' ' GLY . . . 80.7 1.39 89.2 Favored Glycine 0 C--N 1.34 0.767 0 CA-C-N 115.858 -0.61 . . . . 70.11 112.853 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.491 ' HB2' ' HB3' ' A' ' 85' ' ' PHE . 17.4 m-85 -97.24 114.29 26.01 Favored 'General case' 0 C--N 1.344 0.365 0 N-CA-C 107.727 -1.212 . . . . 72.34 107.727 -176.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -80.22 80.92 6.58 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.245 0.545 . . . . 71.44 110.191 -174.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.63 HG23 HD23 ' A' ' 105' ' ' LEU . 1.6 p -42.31 -39.42 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 125.413 1.485 . . . . 75.21 112.936 174.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -57.23 -33.36 67.47 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.008 0.923 . . . . 75.33 112.714 -176.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -105.32 11.6 32.66 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.236 0.541 . . . . 61.35 111.69 -178.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 17.2 m-30 -90.33 173.84 7.9 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 121.967 -0.458 . . . . 73.34 109.881 174.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 86.0 p -65.72 157.89 28.96 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 113.631 0.974 . . . . 74.5 113.631 -167.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.45 -42.77 96.82 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.345 1.058 . . . . 74.52 111.633 176.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -55.63 -49.93 71.52 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.092 0.957 . . . . 75.03 111.2 177.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.508 ' HE2' HG21 ' A' ' 90' ' ' VAL . 37.7 t80 -60.01 -42.84 95.17 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.443 -1.253 . . . . 72.32 110.584 176.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -78.27 -4.35 47.42 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.325 -0.852 . . . . 74.14 112.415 -178.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -102.34 -34.05 9.34 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.038 0.535 . . . . 70.02 111.286 169.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 41.6 tp -65.81 -52.13 53.25 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.223 0.609 . . . . 74.33 109.56 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.474 ' HZ ' HG11 ' A' ' 56' ' ' VAL . 88.8 m-85 -92.86 -0.49 57.23 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.529 -0.76 . . . . 72.11 110.745 174.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.403 ' N ' ' HD2' ' A' ' 103' ' ' PRO . . . -42.78 -56.65 4.27 Favored Glycine 0 C--N 1.353 1.509 0 CA-C-O 118.213 -1.326 . . . . 72.43 115.188 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.403 ' HD2' ' N ' ' A' ' 102' ' ' GLY . 4.8 Cg_exo -34.76 -32.49 0.07 OUTLIER 'Trans proline' 0 C--N 1.395 3.024 1 C-N-CA 125.697 4.264 . . . . 64.43 115.263 177.17 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.571 ' HA3' ' HG3' ' A' ' 79' ' ' PRO . . . -152.94 49.21 0.52 Allowed Glycine 0 C--N 1.351 1.4 0 C-N-CA 120.547 -0.835 . . . . 54.4 113.786 179.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.63 HD23 HG23 ' A' ' 90' ' ' VAL . 29.7 mt -58.22 79.61 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 112.444 0.535 . . . . 74.25 112.444 171.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.451 ' HD1' ' H ' ' A' ' 108' ' ' GLY . 0.1 OUTLIER 42.27 -110.29 0.14 Allowed 'General case' 0 CA--C 1.559 1.326 0 C-N-CA 126.514 1.925 . . . . 74.45 112.819 -179.751 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.429 ' H ' ' HB3' ' A' ' 106' ' ' PHE . . . 70.24 -0.66 23.01 Favored Glycine 0 C--N 1.362 2.011 0 CA-C-N 118.27 0.486 . . . . 44.0 113.663 -172.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.451 ' H ' ' HD1' ' A' ' 106' ' ' PHE . . . 62.63 -109.56 2.73 Favored Glycine 0 C--N 1.352 1.417 0 N-CA-C 112.26 -0.336 . . . . 71.34 112.26 -172.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -126.83 15.67 7.45 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.905 0.882 . . . . 74.55 109.725 176.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -89.34 -23.83 33.12 Favored Glycine 0 C--N 1.346 1.091 0 CA-C-N 115.77 -0.65 . . . . 55.25 112.853 179.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 17.1 tpp180 70.47 -22.59 0.17 Allowed 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 125.55 1.54 . . . . 75.52 113.238 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.13 -12.15 60.79 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.859 0.864 . . . . 75.13 112.156 -173.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 59.6 m 66.34 67.52 0.45 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.436 1.095 . . . . 74.21 110.209 -173.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -73.82 159.53 32.75 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 114.669 -1.151 . . . . 74.52 110.823 -178.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.528 ' HA ' ' HD2' ' A' ' 170' ' ' PRO . 8.0 tmtm? -87.36 123.63 32.52 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 107.226 -1.398 . . . . 73.31 107.226 168.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -73.71 148.71 40.51 Favored Glycine 0 CA--C 1.531 1.086 0 O-C-N 123.373 0.421 . . . . 73.4 113.335 -175.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 8.0 tmm_? -114.79 155.6 26.43 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 124.081 0.952 . . . . 74.43 110.349 -175.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -58.37 131.42 50.64 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 123.731 0.813 . . . . 74.23 111.694 -178.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.2 tt -145.63 164.77 30.69 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 108.566 -0.901 . . . . 75.42 108.566 -172.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.462 ' NH2' HH21 ' A' ' 179' ' ' ARG . 60.1 ttt180 -129.54 139.22 51.59 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.62 -0.881 . . . . 74.51 108.62 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -135.61 151.51 50.33 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.642 0.777 . . . . 54.41 108.994 177.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.415 ' H ' ' HB1' ' B' ' 9' ' ' ALA . 13.0 mm-40 -102.18 133.78 46.5 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 107.119 -1.437 . . . . 72.42 107.119 -177.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.447 ' HA ' HD13 ' B' ' 8' ' ' LEU . 39.7 tp -102.54 95.15 5.74 Favored Pre-proline 0 CA--C 1.544 0.743 0 N-CA-C 107.991 -1.114 . . . . 74.14 107.991 179.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.512 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 52.6 Cg_endo -72.39 112.73 3.52 Favored 'Trans proline' 0 C--N 1.384 2.42 0 C-N-CA 121.532 1.488 . . . . 75.33 109.085 174.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.663 ' HA ' HG23 ' B' ' 6' ' ' ILE . 42.0 tp -123.79 137.49 54.67 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.243 0.544 . . . . 72.43 110.862 -166.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 17.3 m -75.78 133.85 40.58 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 114.984 -1.007 . . . . 71.34 109.72 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 49.5 mt -49.69 -44.01 47.76 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 124.656 1.183 . . . . 75.21 112.103 -169.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -57.58 -54.07 50.97 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.009 -0.996 . . . . 75.32 110.518 -176.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -57.8 -40.29 79.55 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 115.719 -0.673 . . . . 64.33 110.788 177.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -58.76 -48.85 79.79 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 124.291 0.994 . . . . 65.44 112.246 -176.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -74.15 -41.02 62.19 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 123.274 0.359 . . . . 74.51 111.717 -177.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -68.53 -43.54 76.51 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 120.79 0.328 . . . . 75.25 110.87 -178.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.445 ' HA3' ' HA ' ' A' ' 151' ' ' PRO . . . 76.21 177.57 43.44 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-N 115.418 -0.81 . . . . 71.54 113.802 178.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 109.48 -152.41 17.14 Favored Glycine 0 C--N 1.34 0.783 0 C-N-CA 123.48 0.562 . . . . 70.42 112.178 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -77.31 111.52 13.05 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.653 0.781 . . . . 73.14 111.115 -178.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 4.4 tpm_? -101.09 124.12 46.31 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 123.919 0.888 . . . . 75.05 109.81 176.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.0 t -84.33 109.5 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 123.959 0.904 . . . . 75.04 109.308 177.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.9 p -129.56 131.07 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.335 1.054 . . . . 73.34 108.881 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.49 ' HA ' ' HA ' ' A' ' 144' ' ' ARG . 39.3 tt0 -113.93 142.45 46.11 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.035 0.445 . . . . 71.3 110.911 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.7 p -155.31 127.83 1.06 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.59 0 C-N-CA 124.4 1.08 . . . . 75.1 108.622 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 58.81 18.38 6.01 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.025 0.93 . . . . 74.24 112.536 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 103.12 -32.36 7.68 Favored Glycine 0 C--N 1.352 1.453 0 C-N-CA 122.903 0.287 . . . . 54.15 112.463 -176.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.35 105.26 4.02 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 108.898 -0.778 . . . . 72.43 108.898 178.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.49 ' HA ' ' HA ' ' A' ' 139' ' ' GLU . 16.1 ttm180 -94.9 98.81 10.98 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.755 0.822 . . . . 74.41 109.51 173.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 6.8 p -95.8 140.75 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.777 0.831 . . . . 73.53 111.303 -177.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 28.7 t -92.62 84.36 5.04 Favored 'General case' 0 C--O 1.243 0.742 0 N-CA-C 108.67 -0.863 . . . . 64.43 108.67 174.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 31.5 m -82.64 122.99 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 N-CA-C 110.257 -0.275 . . . . 73.42 110.257 -177.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -73.73 103.27 4.23 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.565 0.698 . . . . 74.32 109.525 174.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.421 HG13 ' HA2' ' A' ' 133' ' ' GLY . 18.1 pt -82.43 133.7 49.63 Favored Pre-proline 0 CA--C 1.554 1.112 0 CA-C-N 114.565 -1.198 . . . . 74.52 108.206 167.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.575 ' HB2' HG21 ' B' ' 103' ' ' THR . 26.5 Cg_endo -62.78 143.17 91.44 Favored 'Trans proline' 0 C--N 1.371 1.742 0 C-N-CA 121.939 1.759 . . . . 74.22 112.163 175.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.445 ' HA ' ' HA3' ' A' ' 133' ' ' GLY . 49.0 Cg_exo -57.47 92.14 0.05 OUTLIER 'Trans proline' 0 C--N 1.389 2.695 0 C-N-CA 123.22 2.614 . . . . 74.15 112.563 176.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.68 ' HA3' ' HD2' ' A' ' 241' ' ' PRO . . . 98.65 56.87 1.01 Allowed Glycine 0 C--N 1.335 0.474 0 CA-C-N 114.812 -1.085 . . . . 75.51 111.214 -169.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.45 HG22 HG13 ' A' ' 178' ' ' VAL . 5.4 p -78.38 131.29 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-O 121.73 0.776 . . . . 75.43 109.288 178.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.653 ' HA ' HD21 ' A' ' 188' ' ' LEU . 21.8 mtt85 -100.75 149.67 23.58 Favored 'General case' 0 C--O 1.21 -0.98 0 CA-C-N 114.587 -1.188 . . . . 73.23 110.873 -163.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -58.77 118.65 5.95 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.795 0.838 . . . . 72.32 110.916 -178.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 91.66 12.33 59.56 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-N 115.214 -0.903 . . . . 74.33 113.414 -176.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 24.0 t -70.94 113.97 8.53 Favored 'General case' 0 C--N 1.356 0.874 0 N-CA-C 108.319 -0.993 . . . . 74.23 108.319 173.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.48 HG22 HG23 ' A' ' 177' ' ' VAL . 47.2 t -85.57 90.33 2.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 C-N-CA 123.565 0.746 . . . . 74.02 109.09 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 61.6 mt -71.86 93.0 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 107.779 -1.193 . . . . 75.24 107.779 171.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -81.19 109.02 15.33 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.795 -0.639 . . . . 75.21 110.416 -174.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 3.7 p -114.63 108.17 49.73 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 123.606 0.763 . . . . 71.41 109.506 177.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.573 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 52.6 Cg_endo -68.33 155.37 69.49 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 121.95 1.766 . . . . 74.53 110.894 172.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . 0.703 ' HA3' ' H ' ' A' ' 87' ' ' GLY . . . 75.81 27.64 62.39 Favored Glycine 0 C--N 1.345 1.063 0 C-N-CA 121.44 -0.409 . . . . 70.43 114.022 176.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 36.6 tpp -134.65 -22.78 1.65 Allowed 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.031 0.532 . . . . 64.15 111.385 -178.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.58 ' HA2' HD11 ' A' ' 174' ' ' LEU . . . -68.65 -99.93 0.03 OUTLIER Glycine 0 C--N 1.354 1.54 0 N-CA-C 114.993 0.757 . . . . 73.33 114.993 -172.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -63.69 121.51 23.88 Favored Glycine 0 C--N 1.347 1.182 0 N-CA-C 111.888 -0.485 . . . . 74.5 111.888 178.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.537 HE21 ' HA ' ' A' ' 167' ' ' GLN . 0.0 OUTLIER -67.96 104.84 1.83 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.506 0.722 . . . . 75.42 110.596 -174.726 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -165.32 170.52 40.29 Favored Glycine 0 C--N 1.339 0.733 0 CA-C-O 118.785 -1.008 . . . . 64.21 111.242 -178.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . 0.503 ' ND2' ' HB3' ' A' ' 105' ' ' LEU . 24.4 t-20 -49.52 -65.88 0.74 Allowed Pre-proline 0 CA--C 1.561 1.399 0 CA-C-O 117.247 -1.359 . . . . 63.54 110.858 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.528 ' HD2' ' HA ' ' A' ' 115' ' ' LYS . 71.1 Cg_endo -93.83 94.06 0.13 Allowed 'Trans proline' 0 C--N 1.393 2.869 0 CA-C-N 122.645 1.98 . . . . 73.02 108.881 165.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -69.73 158.26 57.62 Favored 'Trans proline' 0 C--N 1.373 1.848 0 C-N-CA 122.475 2.117 . . . . 71.25 111.765 -164.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -70.1 171.74 42.04 Favored Glycine 0 C--N 1.34 0.802 0 CA-C-N 116.143 -0.48 . . . . 72.4 113.598 -174.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.573 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 31.0 t70 -67.63 142.75 56.31 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 109.329 -0.619 . . . . 71.14 109.329 172.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.58 HD11 ' HA2' ' A' ' 165' ' ' GLY . 23.4 tp -124.57 131.85 53.46 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 120.859 0.362 . . . . 74.2 110.291 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 47.1 mt -102.53 98.37 8.45 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.676 0.791 . . . . 72.12 109.271 176.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.562 HD22 HD11 ' B' ' 8' ' ' LEU . 80.2 mt -83.09 93.98 7.72 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 118.051 0.387 . . . . 74.52 110.577 178.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.48 HG23 HG22 ' A' ' 158' ' ' VAL . 24.2 t -85.47 107.43 16.18 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 N-CA-C 107.965 -1.124 . . . . 71.11 107.965 177.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.45 HG13 HG22 ' A' ' 153' ' ' VAL . 7.5 p -69.4 127.7 31.68 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 CA-C-O 121.386 0.613 . . . . 74.13 111.233 -174.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.512 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 37.0 mmt180 -116.77 101.7 8.78 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 125.193 1.397 . . . . 73.42 108.278 176.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 4.9 mt -69.92 143.14 52.81 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 118.559 0.618 . . . . 74.04 110.246 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 83.4 mt -61.32 155.47 57.21 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 123.995 0.918 . . . . 73.22 111.755 -175.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -76.95 53.59 4.23 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 122.892 2.395 . . . . 74.32 109.858 163.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 27.8 t-80 -79.19 131.3 66.49 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 125.014 1.326 . . . . 73.35 108.572 -171.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -9.06 -53.6 0.0 OUTLIER 'Trans proline' 0 C--N 1.383 2.379 1 C-N-CA 127.692 5.595 . . . . 61.24 119.748 -163.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.434 HG11 ' HB1' ' A' ' 195' ' ' ALA . 44.2 t -99.76 -59.32 3.35 Favored 'Isoleucine or valine' 0 C--N 1.356 0.855 0 CA-C-N 119.322 0.965 . . . . 72.34 109.993 -168.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . 0.624 ' HB3' HD23 ' A' ' 193' ' ' LEU . 51.8 m-85 -101.4 138.78 37.96 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 112.863 0.69 . . . . 72.31 112.863 -165.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 27.2 ttp-105 -116.58 98.51 6.58 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 106.02 -1.844 . . . . 75.51 106.02 164.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.653 HD21 ' HA ' ' A' ' 154' ' ' ARG . 56.0 tp -68.98 144.16 54.2 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.616 -0.513 . . . . 74.21 109.616 176.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -149.15 115.67 5.87 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 107.788 -1.19 . . . . 70.31 107.788 -176.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . 0.417 ' O ' ' HB3' ' A' ' 154' ' ' ARG . . . 73.29 -75.9 0.95 Allowed Glycine 0 C--N 1.349 1.29 0 CA-C-O 119.889 -0.395 . . . . 65.41 113.587 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -153.15 -2.98 0.22 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.976 0.911 . . . . 72.32 110.959 176.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -125.21 148.15 48.75 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.961 0.904 . . . . 72.32 110.446 -172.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.624 HD23 ' HB3' ' A' ' 186' ' ' PHE . 81.7 mt -90.83 149.88 21.78 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.856 0.862 . . . . 74.25 111.162 -171.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -128.58 99.59 5.43 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.312 1.045 . . . . 73.14 108.456 171.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.543 ' HB2' HD23 ' A' ' 251' ' ' LEU . . . -110.78 110.86 21.67 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.537 1.135 . . . . 74.34 111.055 -171.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 77.4 m -64.59 121.84 15.4 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 109.299 -0.63 . . . . 70.21 109.299 178.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 54.0 tp -122.62 105.73 10.36 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 123.722 0.809 . . . . 74.1 108.978 -166.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -70.35 126.2 28.96 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.144 0.497 . . . . 63.3 109.917 173.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 7.1 p -142.79 136.96 14.7 Favored Pre-proline 0 CA--C 1.548 0.894 0 N-CA-C 107.179 -1.415 . . . . 74.33 107.179 179.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.64 154.56 34.99 Favored 'Trans proline' 0 C--N 1.361 1.19 0 C-N-CA 121.55 1.5 . . . . 70.05 111.718 172.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -53.72 -47.25 97.28 Favored Pre-proline 0 CA--C 1.565 1.52 0 N-CA-C 114.718 1.377 . . . . 71.34 114.718 -174.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -59.11 -39.74 76.69 Favored 'Trans proline' 0 C--N 1.383 2.376 0 C-N-CA 122.088 1.859 . . . . 73.32 114.325 176.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 45.7 mt -75.43 -26.79 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 122.517 0.327 . . . . 71.02 110.609 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.09 -43.68 74.03 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.196 0.598 . . . . 74.14 111.158 173.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 11.1 t -69.23 -52.64 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 123.957 0.903 . . . . 64.22 112.017 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 85.3 t -85.28 -31.7 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 123.231 0.612 . . . . 74.41 111.262 -171.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 83.4 94.66 0.61 Allowed Glycine 0 CA--C 1.53 0.989 0 CA-C-N 116.308 -0.405 . . . . 72.35 113.035 -178.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -123.54 -178.15 15.34 Favored Glycine 0 N--CA 1.476 1.33 0 N-CA-C 111.487 -0.645 . . . . 73.32 111.487 174.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -81.28 134.15 35.55 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 117.963 0.882 . . . . 73.34 110.409 177.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 33.2 m -123.54 143.8 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 106.537 -1.653 . . . . 63.11 106.537 164.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -92.87 113.65 25.98 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 121.622 -0.674 . . . . 74.32 109.809 -176.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.03 128.8 46.07 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.265 1.026 . . . . 74.41 109.22 -177.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' MET . . . . . 0.454 ' HA ' ' HA ' ' A' ' 218' ' ' PRO . 1.6 mpt? -82.65 124.06 29.84 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.118 -0.697 . . . . 74.15 109.118 -177.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 77.2 p -109.3 -179.61 3.89 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 123.228 0.611 . . . . 74.1 109.784 178.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 49.3 mt -75.83 1.0 16.12 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.388 1.075 . . . . 73.14 111.987 -171.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -133.75 5.17 3.64 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 124.317 1.047 . . . . 64.44 111.592 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 137.49 170.6 11.93 Favored Glycine 0 N--CA 1.482 1.709 0 CA-C-O 119.802 -0.443 . . . . 63.05 113.545 176.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . 0.454 ' HA ' ' HA ' ' A' ' 213' ' ' MET . 85.2 Cg_endo -80.49 115.86 3.2 Favored 'Trans proline' 0 C--N 1.372 1.778 0 C-N-CA 122.955 2.437 . . . . 74.13 112.609 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 35.8 m -114.35 147.54 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.637 0.775 . . . . 73.4 109.834 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -73.85 147.18 43.54 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 109.566 -0.531 . . . . 75.04 109.566 175.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 10.1 p -137.24 116.52 15.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-O 121.544 0.688 . . . . 74.51 109.574 175.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -77.39 101.09 6.2 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 123.954 0.902 . . . . 70.4 109.522 -177.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' B' ' 441' ' ' ILE . 91.3 t -66.98 131.92 93.83 Favored Pre-proline 0 CA--C 1.556 1.205 0 CA-C-N 114.989 -1.005 . . . . 71.22 109.46 178.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.58 165.99 30.96 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.688 2.258 . . . . 75.51 110.922 175.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -69.47 158.62 56.66 Favored 'Trans proline' 0 C--N 1.37 1.695 0 C-N-CA 121.766 1.644 . . . . 72.53 111.857 175.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 15.3 mmt180 69.26 15.62 8.53 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 125.277 1.431 . . . . 75.13 112.046 175.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 4.0 m -59.89 104.65 0.31 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.188 0.995 . . . . 64.32 111.065 -179.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -92.11 139.55 30.52 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 114.418 -1.264 . . . . 75.32 111.671 -173.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . 0.622 ' HB2' HD21 ' B' ' 265' ' ' LEU . . . -54.11 153.19 5.27 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.496 1.518 . . . . 65.12 112.337 174.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 79.36 -49.15 3.53 Favored Glycine 0 C--N 1.345 1.069 0 N-CA-C 112.269 -0.332 . . . . 75.54 112.269 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -63.73 163.44 11.55 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 124.276 1.03 . . . . 74.44 111.363 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.517 ' HG3' ' HG2' ' A' ' 252' ' ' GLU . 2.9 mppt? -112.12 129.5 56.21 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 114.838 -1.074 . . . . 72.22 110.355 -175.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.578 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 79.6 mt -77.59 104.3 8.04 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 108.323 -0.992 . . . . 71.4 108.323 170.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 42.1 ttm105 -82.25 109.3 16.4 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 122.643 0.377 . . . . 73.41 110.247 177.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.502 ' HB3' ' HA ' ' B' ' 441' ' ' ILE . 0.4 OUTLIER -120.83 106.31 11.54 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 108.055 -1.091 . . . . 74.24 108.055 169.866 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -74.56 159.87 31.62 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.069 0.948 . . . . 71.01 112.666 -169.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 73.35 9.51 77.51 Favored Glycine 0 C--N 1.349 1.294 0 CA-C-N 115.496 -0.774 . . . . 74.2 113.369 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.491 ' HD2' HD12 ' B' ' 439' ' ' LEU . 0.0 OUTLIER -108.38 -11.63 15.15 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.295 0.638 . . . . 74.1 111.187 -176.49 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -79.53 -154.34 8.72 Favored Glycine 0 C--N 1.348 1.218 0 N-CA-C 112.515 -0.234 . . . . 74.43 112.515 177.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -92.41 137.69 24.47 Favored Pre-proline 0 N--CA 1.48 1.063 0 CA-C-O 118.918 -0.563 . . . . 73.41 110.132 -175.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.68 ' HD2' ' HA3' ' A' ' 152' ' ' GLY . 89.7 Cg_exo -46.78 107.99 0.14 Allowed 'Trans proline' 0 C--N 1.388 2.61 0 C-N-CA 123.973 3.115 . . . . 73.33 113.83 -178.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -134.56 -145.35 5.21 Favored Glycine 0 C--N 1.35 1.317 0 CA-C-O 119.073 -0.848 . . . . 73.52 112.585 -171.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . 0.491 ' HD3' ' HB3' ' B' ' 109' ' ' TYR . 89.3 Cg_endo -72.78 -26.93 15.37 Favored 'Trans proline' 0 C--N 1.385 2.475 0 C-N-CA 123.052 2.501 . . . . 72.5 112.655 -173.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -94.2 22.89 5.47 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.19 0.996 . . . . 70.11 111.066 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 90.13 -68.97 2.42 Favored Glycine 0 C--N 1.345 1.077 0 N-CA-C 109.579 -1.408 . . . . 62.24 109.579 -171.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.515 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 75.8 mtp180 -127.23 168.39 14.79 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.53 1.132 . . . . 75.41 109.306 166.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -84.95 -166.2 41.29 Favored Glycine 0 C--N 1.346 1.094 0 CA-C-N 116.171 -0.468 . . . . 70.31 111.973 172.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . 0.423 ' HB2' ' CE1' ' A' ' 250' ' ' TYR . 26.6 m-20 -104.39 158.99 16.09 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.371 0.669 . . . . 75.44 109.831 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.43 ' HB3' ' HG ' ' A' ' 235' ' ' LEU . 40.6 tp -106.57 122.74 46.91 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 107.619 -1.252 . . . . 73.32 107.619 167.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.423 ' CE1' ' HB2' ' A' ' 248' ' ' ASP . 42.4 m-85 -108.27 105.69 15.52 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.096 -1.076 . . . . 71.3 108.096 176.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.578 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 69.1 mt -84.41 102.83 13.06 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 108.75 -0.833 . . . . 74.54 108.75 176.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.517 ' HG2' ' HG3' ' A' ' 232' ' ' LYS . 27.7 mt-10 -74.96 96.34 3.15 Favored 'General case' 0 C--N 1.356 0.855 0 C-N-CA 123.57 0.748 . . . . 75.41 109.091 -176.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 46.3 t -55.73 133.74 19.55 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 125.571 1.548 . . . . 71.34 112.222 -172.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . 0.486 ' HA ' HD23 ' B' ' 265' ' ' LEU . 3.9 tmm_? -133.93 94.42 3.26 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 107.733 -1.21 . . . . 73.14 107.733 -179.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.443 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 77.6 mt -79.59 133.9 28.81 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-N 115.961 -0.563 . . . . 74.34 111.144 -176.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 31.1 p -129.87 176.22 8.22 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.548 1.139 . . . . 74.52 109.519 172.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.7 pp -133.23 153.03 80.51 Favored Pre-proline 0 CA--C 1.569 1.703 0 C-N-CA 123.803 0.841 . . . . 73.4 111.116 -174.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -59.18 -9.68 8.77 Favored 'Trans proline' 0 C--N 1.387 2.597 0 C-N-CA 123.999 3.133 . . . . 74.45 116.278 -166.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.484 ' HA ' ' HB3' ' C' ' 226' ' ' ARG . 36.3 mt-10 56.67 -67.52 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.075 0 C-N-CA 125.415 1.486 . . . . 75.12 113.89 -174.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.03 132.59 39.02 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.55 -0.718 . . . . 75.12 109.66 172.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.608 HD22 ' HB2' ' A' ' 265' ' ' GLU . 56.2 mt -123.73 148.92 46.15 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.414 0.686 . . . . 72.32 110.453 173.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 21.7 p -127.9 155.09 78.12 Favored Pre-proline 0 CA--C 1.558 1.259 0 C-N-CA 125.06 1.344 . . . . 74.31 108.054 172.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -17.96 -52.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.403 3.44 1 C-N-CA 126.867 5.045 . . . . 74.33 117.989 -170.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . 0.431 ' O ' HD11 ' A' ' 268' ' ' LEU . 63.3 mm-40 -55.71 -74.68 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.012 0.525 . . . . 71.44 111.285 177.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . 0.608 ' HB2' HD22 ' A' ' 261' ' ' LEU . 1.5 mp0 -64.07 -30.31 71.39 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 122.858 0.463 . . . . 73.22 109.964 -172.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' GLU . . . . . 0.55 ' HA ' HD12 ' A' ' 261' ' ' LEU . 7.6 tp10 -55.51 -62.73 1.49 Allowed 'General case' 0 C--O 1.248 1.01 0 O-C-N 123.79 0.681 . . . . 73.45 109.69 176.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -60.63 -38.86 86.16 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 115.238 -0.892 . . . . 64.12 111.354 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . 0.431 HD11 ' O ' ' A' ' 264' ' ' GLU . 2.2 mp -63.46 -48.09 79.13 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.007 0.923 . . . . 73.14 111.921 -176.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 77.9 m95 -68.79 -33.44 73.87 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.315 0.646 . . . . 75.0 111.398 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' A' ' 266' ' ' GLU . 29.8 mmtp -70.43 -39.95 74.07 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 122.405 0.282 . . . . 73.12 111.504 175.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -73.44 -30.24 63.08 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.016 0.526 . . . . 70.22 110.574 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 24.0 mt -59.67 -54.4 46.84 Favored 'General case' 0 C--O 1.205 -1.252 0 N-CA-C 108.541 -0.911 . . . . 71.54 108.541 167.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -51.28 -48.57 62.22 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 124.107 0.879 . . . . 72.23 111.948 -177.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.491 ' HG2' ' NE2' ' B' ' 252' ' ' GLN . 25.8 mt-10 -62.72 -56.96 12.87 Favored 'General case' 0 CA--C 1.551 0.989 0 O-C-N 123.371 0.419 . . . . 74.35 110.389 178.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -57.71 -65.85 0.57 Allowed 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.726 0.81 . . . . 72.24 111.761 -177.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . 0.485 ' HE2' ' HG3' ' C' ' 258' ' ' PRO . 81.9 t80 -45.61 -59.09 2.94 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.703 1.601 . . . . 75.02 112.826 178.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' TYR . . . . . 0.62 ' HA ' ' HB3' ' A' ' 280' ' ' ALA . 2.3 t80 -66.86 -35.01 79.07 Favored 'General case' 0 N--CA 1.482 1.132 0 O-C-N 123.59 0.556 . . . . 72.14 110.691 -170.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -61.38 -20.1 62.64 Favored 'General case' 0 CA--C 1.554 1.102 0 N-CA-C 112.761 0.652 . . . . 75.41 112.761 176.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.4 16.29 7.69 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-O 118.437 -0.792 . . . . 75.15 111.479 176.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . 0.62 ' HB3' ' HA ' ' A' ' 277' ' ' TYR . . . . . . . . 0 N--CA 1.495 1.802 0 N-CA-C 113.135 0.791 . . . . 72.5 113.135 -166.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.479 1.002 0 N-CA-C 109.167 -0.679 . . . . 74.12 109.167 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -63.43 108.25 1.3 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.491 0.716 . . . . 62.45 109.645 175.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 61.3 tp60 -82.7 73.92 9.7 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 109.126 -0.694 . . . . 74.04 109.126 177.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 61.4 p 45.65 -88.06 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 126.012 1.725 . . . . 52.14 114.062 172.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 59.4 m 56.95 133.5 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 126.18 1.792 . . . . 74.34 114.044 -178.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.663 HG23 ' HA ' ' A' ' 125' ' ' LEU . 37.5 pt -137.54 172.43 14.6 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 C-N-CA 122.991 0.517 . . . . 65.34 111.971 -175.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -124.97 -167.6 1.7 Allowed 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.616 1.167 . . . . 72.22 108.991 175.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . 0.562 HD11 HD22 ' A' ' 176' ' ' LEU . 11.0 tp -130.69 167.1 19.35 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 109.428 -0.582 . . . . 75.22 109.428 177.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . 0.508 ' HA ' ' SD ' ' B' ' 75' ' ' MET . . . -87.68 -67.11 0.85 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 122.804 0.441 . . . . 73.12 110.864 173.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 3.8 tt 64.05 94.27 0.05 Allowed 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.556 1.142 . . . . 74.1 108.834 -169.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 57.2 mt -79.11 114.69 46.69 Favored Pre-proline 0 CA--C 1.553 1.08 0 CA-C-O 118.751 -0.642 . . . . 72.11 109.434 -176.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -58.86 110.36 0.66 Allowed 'Trans proline' 0 C--N 1.384 2.418 0 C-N-CA 123.628 2.885 . . . . 71.41 112.94 -172.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 4.2 pp 50.86 25.47 2.18 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 126.236 1.815 . . . . 75.11 113.863 -178.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 62.5 mt 73.46 40.34 0.52 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.815 1.246 . . . . 64.54 112.193 -176.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' PHE . . . . . 0.48 ' O ' ' HD3' ' B' ' 17' ' ' PRO . 16.8 m-85 -75.8 85.91 2.79 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 106.385 -1.709 . . . . 74.01 106.385 157.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 35.6 p -85.66 104.36 5.02 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 123.741 0.816 . . . . 71.11 111.697 -174.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' PRO . . . . . 0.48 ' HD3' ' O ' ' B' ' 15' ' ' PHE . 18.2 Cg_endo -96.1 8.92 1.6 Allowed 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 123.257 2.638 . . . . 71.22 112.167 176.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.472 HG22 ' HD2' ' B' ' 17' ' ' PRO . 3.8 t -91.64 -1.38 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 C-N-CA 123.42 0.688 . . . . 63.3 110.519 -174.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 9.6 t -57.13 -39.28 74.84 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.419 0.688 . . . . 71.22 109.647 170.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' LYS . . . . . 0.463 ' NZ ' ' SG ' ' B' ' 190' ' ' CYS . 58.3 mttp -150.63 119.82 6.78 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 105.567 -2.012 . . . . 74.33 105.567 167.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -46.24 106.11 0.07 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 124.413 1.07 . . . . 75.34 111.497 -174.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . 0.567 HH21 ' HA3' ' B' ' 209' ' ' GLY . 0.2 OUTLIER -64.75 -78.03 0.05 Allowed 'General case' 0 C--N 1.357 0.898 0 O-C-N 124.289 0.993 . . . . 73.31 109.936 -175.322 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' THR . . . . . 0.449 ' HB ' ' HD2' ' B' ' 207' ' ' LYS . 21.1 m 51.19 90.79 0.08 OUTLIER Pre-proline 0 CA--C 1.556 1.19 0 C-N-CA 124.586 1.155 . . . . 72.54 111.333 -176.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . 0.408 ' HB3' HD13 ' B' ' 68' ' ' ILE . 11.9 Cg_exo -67.8 76.09 0.6 Allowed 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 122.739 2.293 . . . . 74.55 110.3 172.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . 0.447 ' HB2' HG22 ' B' ' 23' ' ' THR . 34.1 tt0 -91.42 -4.5 55.57 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 114.508 -1.223 . . . . 74.53 110.947 -172.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' MET . . . . . 0.596 ' HB3' ' HB2' ' B' ' 204' ' ' ALA . 99.4 mmm -133.04 154.7 81.44 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 124.324 1.049 . . . . 75.13 109.524 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.82 -46.78 15.13 Favored 'Trans proline' 0 C--N 1.386 2.522 0 C-N-CA 123.285 2.656 . . . . 73.04 114.722 -175.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 43.7 t 69.25 141.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 C-N-CA 124.804 1.241 . . . . 75.25 110.362 -170.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 4.4 mm? 65.72 41.93 3.76 Favored 'General case' 0 N--CA 1.5 2.053 0 C-N-CA 124.519 1.128 . . . . 73.34 110.702 -172.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -91.38 -61.25 1.69 Allowed 'General case' 0 CA--C 1.563 1.442 0 C-N-CA 124.819 1.248 . . . . 71.25 111.778 -174.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 174.02 -50.72 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.507 1.123 . . . . 74.34 111.068 -177.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' ARG . . . . . 0.521 ' HD2' ' HB2' ' B' ' 37' ' ' ASP . 3.8 tmt_? -171.99 -32.34 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 124.247 1.019 . . . . 72.22 108.466 -168.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . 81.44 -69.13 0.08 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 126.138 1.775 . . . . 73.31 112.846 172.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -57.53 131.97 51.78 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.85 0.86 . . . . 53.33 112.13 -172.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . 0.455 ' HB3' ' OH ' ' C' ' 250' ' ' TYR . 9.3 pt20 51.97 9.63 0.09 Allowed 'General case' 0 N--CA 1.502 2.171 0 C-N-CA 126.749 2.02 . . . . 73.13 113.773 -174.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . 0.497 ' HA3' ' O ' ' B' ' 56' ' ' ARG . . . 75.67 -18.83 2.81 Favored Glycine 0 CA--C 1.539 1.549 0 CA-C-O 119.592 -0.56 . . . . 74.33 113.752 -171.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . 0.521 ' HB2' ' HD2' ' B' ' 32' ' ' ARG . 38.3 t70 66.83 109.08 0.04 OUTLIER 'General case' 0 C--N 1.365 1.255 0 C-N-CA 126.359 1.864 . . . . 61.44 111.486 -178.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . 0.594 HG12 ' HB2' ' B' ' 56' ' ' ARG . 33.3 mt -75.08 89.02 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 N-CA-C 109.809 -0.441 . . . . 75.44 109.809 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 88.8 m -131.74 106.07 7.89 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.839 -1.171 . . . . 73.32 107.839 171.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . 53.61 93.65 0.05 OUTLIER Pre-proline 0 CA--C 1.555 1.135 0 C-N-CA 124.925 1.29 . . . . 73.24 112.241 -176.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . 0.455 ' HB3' ' HD3' ' B' ' 56' ' ' ARG . 15.4 Cg_exo -70.66 -14.8 33.53 Favored 'Trans proline' 0 C--N 1.377 2.038 0 C-N-CA 123.034 2.489 . . . . 72.44 112.983 -179.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.81 -71.29 2.75 Favored Glycine 0 C--N 1.347 1.188 0 N-CA-C 109.941 -1.263 . . . . 61.22 109.941 -171.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -115.54 145.63 18.71 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 114.634 -0.783 . . . . 64.32 111.247 171.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -157.75 109.17 2.28 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 108.453 -0.943 . . . . 63.2 108.453 175.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 21.0 tpp180 -59.86 -61.91 2.26 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.227 0.611 . . . . 74.21 110.993 -177.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 32.7 ttm180 73.6 -52.89 0.7 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 125.286 1.434 . . . . 75.02 111.45 -173.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 64.35 -81.75 0.03 OUTLIER 'General case' 0 C--N 1.358 0.976 0 C-N-CA 125.313 1.445 . . . . 72.13 107.615 -170.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 8.2 m -142.62 -62.93 0.43 Allowed 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 109.09 -0.707 . . . . 73.12 109.09 172.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -93.91 46.88 2.26 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 115.378 -0.828 . . . . 74.15 113.143 -175.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 10.1 t70 72.42 -54.8 0.68 Allowed 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 125.653 1.581 . . . . 64.2 112.947 176.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 62.19 33.09 17.04 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 124.415 1.086 . . . . 75.3 111.309 178.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 2.1 m 65.72 33.93 7.92 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.851 1.261 . . . . 73.31 110.586 175.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -85.43 -14.62 45.62 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 115.139 -0.937 . . . . 73.24 111.659 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.54 -84.07 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 122.779 0.432 . . . . 75.51 110.541 176.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 92.5 mt 33.67 -89.41 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 125.575 1.55 . . . . 72.35 114.109 -177.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . 0.594 ' HB2' HG12 ' B' ' 38' ' ' ILE . 0.0 OUTLIER 58.61 14.01 2.87 Favored 'General case' 0 C--N 1.366 1.295 0 C-N-CA 124.813 1.245 . . . . 74.21 111.977 -167.177 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -71.61 91.87 1.11 Allowed 'General case' 0 C--N 1.353 0.76 0 C-N-CA 124.217 1.007 . . . . 75.31 108.941 -176.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 44.1 p -161.45 169.55 21.67 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 114.936 -1.029 . . . . 62.01 109.707 -172.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . 0.41 HD22 ' H ' ' B' ' 59' ' ' LEU . 1.5 pt? -131.66 128.23 38.62 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 109.078 -0.712 . . . . 72.44 109.078 -179.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 16.1 m -65.6 122.84 18.15 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.38 0.672 . . . . 71.31 109.98 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -70.29 78.7 0.53 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.726 0.81 . . . . 71.45 110.734 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -143.94 78.89 13.69 Favored Pre-proline 0 N--CA 1.468 0.446 0 N-CA-C 106.58 -1.637 . . . . 72.42 106.58 173.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.18 84.71 1.09 Allowed 'Trans proline' 0 C--N 1.374 1.904 0 C-N-CA 121.784 1.656 . . . . 72.24 110.88 177.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 23.55 -82.3 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 127.294 2.238 . . . . 72.04 114.182 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.607 ' HZ3' ' HB2' ' B' ' 65' ' ' LYS . 9.9 mtmp? -145.82 88.49 1.83 Allowed 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 105.896 -1.89 . . . . 73.42 105.896 167.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 68.26 -169.07 0.19 Allowed 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 124.717 1.207 . . . . 72.41 108.779 -169.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 12.0 tt -76.97 67.13 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.576 1.959 0 CA-C-O 122.646 1.212 . . . . 74.04 110.661 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . 0.408 HD13 ' HB3' ' B' ' 24' ' ' PRO . 2.9 mp 45.12 -81.06 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.559 1.319 0 C-N-CA 128.159 2.583 . . . . 73.4 113.128 -178.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -87.37 4.65 42.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.934 -0.479 . . . . 74.34 111.911 -178.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 7.9 mp 64.72 21.22 12.34 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 124.505 1.122 . . . . 65.22 110.705 -173.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . 0.633 HG21 ' HA ' ' B' ' 75' ' ' MET . 38.2 mm -103.07 108.49 24.46 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 C-N-CA 123.944 0.898 . . . . 75.5 109.658 -176.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.66 -163.49 36.6 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 111.435 -0.666 . . . . 71.15 111.435 171.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -70.61 111.43 6.1 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 122.772 0.429 . . . . 74.12 109.957 178.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.68 34.42 31.45 Favored Glycine 0 C--N 1.344 0.992 0 CA-C-N 116.229 -0.442 . . . . 72.45 112.13 -174.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 75' ' ' MET . . . . . 0.633 ' HA ' HG21 ' B' ' 71' ' ' ILE . 0.0 OUTLIER 70.31 -69.46 0.17 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.741 1.616 . . . . 74.01 111.46 178.821 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . -146.97 9.01 1.3 Allowed Glycine 0 C--N 1.342 0.886 0 CA-C-O 119.698 -0.501 . . . . 71.52 112.884 176.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 32.4 t70 61.46 -81.45 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 125.265 1.426 . . . . 74.35 111.167 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 71.6 p -166.73 -15.32 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.536 1.134 . . . . 55.34 109.764 178.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -73.11 -15.82 61.48 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.384 0.674 . . . . 74.44 111.667 176.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 15.2 tt -58.57 -39.34 75.31 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.136 0 C-N-CA 123.537 0.735 . . . . 72.52 111.087 175.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 74.1 m -153.29 120.16 5.7 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 107.917 -1.142 . . . . 74.52 107.917 177.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.84 91.73 0.07 Allowed 'General case' 0 N--CA 1.473 0.723 0 O-C-N 123.705 0.628 . . . . 75.12 110.381 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -92.81 -58.41 2.35 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 114.905 -1.043 . . . . 74.13 110.489 -176.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 84' ' ' ARG . . . . . 0.448 ' HG2' ' HB1' ' B' ' 87' ' ' ALA . 6.5 tpm_? -168.4 -51.45 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.184 -0.462 . . . . 73.0 110.097 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 75.89 0.34 3.32 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 125.421 1.488 . . . . 72.23 112.189 -177.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -175.11 91.12 0.06 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.338 1.055 . . . . 74.21 109.251 176.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . 0.486 ' O ' ' HB3' ' A' ' 144' ' ' ARG . . . -118.38 107.77 14.26 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 108.69 -0.856 . . . . 52.24 108.69 174.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -83.92 48.15 1.41 Allowed 'General case' 0 CA--C 1.563 1.464 0 CA-C-O 121.839 0.828 . . . . 74.14 111.591 -172.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -90.72 59.32 3.28 Favored Glycine 0 C--N 1.351 1.373 0 N-CA-C 110.981 -0.848 . . . . 54.33 110.981 169.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -144.1 -64.11 0.37 Allowed 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.672 -0.862 . . . . 75.53 108.672 -174.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 81.03 -60.17 4.7 Favored Glycine 0 C--N 1.352 1.457 0 CA-C-N 115.776 -0.647 . . . . 70.11 112.868 178.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.29 39.19 4.31 Favored Glycine 0 C--N 1.346 1.136 0 N-CA-C 112.101 -0.4 . . . . 73.42 112.101 -177.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -94.62 131.61 40.21 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.617 0.767 . . . . 74.22 110.311 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -60.95 131.52 50.91 Favored 'General case' 0 N--CA 1.479 1.018 0 O-C-N 124.124 0.89 . . . . 72.14 111.962 -175.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . 0.667 ' HA ' ' HE2' ' A' ' 23' ' ' LYS . 82.9 tttt -76.78 -13.25 60.04 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 116.258 -0.428 . . . . 74.44 110.882 172.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.36 -165.87 31.58 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-N 115.922 -0.581 . . . . 75.21 113.115 175.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 21.6 pt -130.61 26.83 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 124.35 1.06 . . . . 73.0 109.281 -176.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -67.48 -55.89 11.74 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.132 1.373 . . . . 75.21 110.593 -171.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -128.1 21.67 6.25 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 114.972 -1.013 . . . . 61.12 109.649 176.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . 0.502 HD21 ' HD3' ' B' ' 95' ' ' LYS . 4.8 mp -111.48 111.15 55.12 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 123.909 0.884 . . . . 74.2 109.479 -174.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -66.69 146.42 78.86 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 122.966 2.444 . . . . 74.43 112.277 173.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 87.3 mt -70.98 86.79 0.72 Allowed 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.282 0.633 . . . . 73.12 109.857 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 103' ' ' THR . . . . . 0.575 HG21 ' HB2' ' A' ' 150' ' ' PRO . 2.6 m 66.82 10.43 7.56 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 124.67 1.188 . . . . 75.52 111.499 -178.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.13 73.45 2.58 Favored Glycine 0 C--N 1.348 1.22 0 CA-C-N 116.34 -0.391 . . . . 51.35 112.748 -174.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -73.52 88.12 1.63 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.305 0.642 . . . . 75.22 109.648 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 48.1 t80 70.73 -78.03 0.05 Allowed 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 125.054 1.341 . . . . 74.44 111.09 176.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 26.2 p -116.02 45.84 1.67 Allowed 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 124.211 1.004 . . . . 75.34 109.507 177.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 74.0 m80 70.42 -65.54 0.32 Allowed 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 125.399 1.48 . . . . 73.44 109.276 -165.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.491 ' HB3' ' HD3' ' A' ' 243' ' ' PRO . 36.0 t80 -150.65 134.84 16.95 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 124.224 1.009 . . . . 74.1 108.932 174.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.22 90.53 0.91 Allowed 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 107.832 -1.173 . . . . 75.22 107.832 165.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . 0.477 ' HB2' ' HA2' ' B' ' 116' ' ' GLY . 0.9 OUTLIER -54.76 145.55 19.23 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.433 1.093 . . . . 70.25 112.789 -173.988 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -71.67 -47.75 52.13 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.524 0.73 . . . . 73.2 110.39 -176.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 113' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -123.06 179.68 4.59 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.393 1.077 . . . . 75.13 109.242 177.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 114' ' ' LYS . . . . . 0.447 ' HB2' ' HZ2' ' B' ' 114' ' ' LYS . 9.5 mtmp? -56.2 -44.34 79.37 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.695 0.798 . . . . 74.21 112.474 -175.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 3.9 m -101.41 31.9 3.54 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 123.411 0.684 . . . . 73.23 109.679 178.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . 0.477 ' HA2' ' HB2' ' B' ' 111' ' ' LEU . . . 75.96 -69.84 2.12 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 111.507 -0.637 . . . . 55.33 111.507 -175.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 10.1 tptp -158.41 97.78 1.78 Allowed Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 124.601 1.16 . . . . 75.35 108.236 170.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 118' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -96.22 -154.37 0.04 OUTLIER 'Trans proline' 0 C--N 1.363 1.326 0 C-N-CA 123.404 2.736 . . . . 63.21 111.142 169.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 119' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -77.51 155.85 31.38 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 108.009 -1.108 . . . . 75.33 108.009 165.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 120' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -78.91 83.98 4.98 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-O 121.743 0.782 . . . . 70.1 109.798 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 4.2 t -117.17 29.42 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.234 0 N-CA-C 108.039 -1.097 . . . . 74.32 108.039 176.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 25.9 m -63.97 -37.95 89.3 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.258 1.023 . . . . 75.25 111.178 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -74.53 -10.78 59.88 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.699 0.8 . . . . 70.53 112.053 176.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 80.6 p 59.24 19.47 7.56 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 126.012 1.725 . . . . 61.03 112.532 -175.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -108.3 2.21 22.47 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.967 0.907 . . . . 74.53 110.162 174.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . 62.31 13.13 5.73 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 125.172 1.389 . . . . 74.13 112.54 -176.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 42.2 m 58.5 24.69 12.16 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.673 1.189 . . . . 70.01 112.163 -173.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.6 -47.65 74.97 Favored 'General case' 0 C--N 1.355 0.808 0 C-N-CA 123.918 0.887 . . . . 74.33 111.174 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 21.7 m 78.03 -50.27 0.49 Allowed 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 125.34 1.456 . . . . 74.41 112.994 172.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . 79.21 -40.25 0.24 Allowed 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 126.124 1.77 . . . . 61.42 111.433 -176.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 24.4 m-90 71.21 -61.85 0.47 Allowed 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 125.857 1.663 . . . . 73.51 111.464 178.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 21.5 p -74.83 56.37 0.73 Allowed 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 125.017 1.327 . . . . 74.11 110.865 176.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 12.1 t -140.37 -171.15 3.14 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 125.395 1.478 . . . . 74.52 108.316 -175.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 99.84 -59.64 0.76 Allowed Glycine 0 N--CA 1.474 1.229 0 N-CA-C 111.71 -0.556 . . . . 55.15 111.71 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 135' ' ' VAL . . . . . . . . . . . . . 2.3 p -67.2 93.35 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.059 0 N-CA-C 108.95 -0.759 . . . . 73.24 108.95 171.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt 85.69 -24.18 0.14 Allowed 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 126.369 1.868 . . . . 74.24 111.136 -173.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 5.9 m 61.79 27.43 16.76 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.868 1.267 . . . . 75.31 111.391 178.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -95.82 -34.93 11.69 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.355 -0.839 . . . . 75.52 110.246 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 65.09 174.96 0.21 Allowed 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 125.182 1.393 . . . . 73.24 109.703 -171.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -53.41 -56.69 18.46 Favored Glycine 0 C--N 1.353 1.518 0 N-CA-C 110.827 -0.909 . . . . 75.54 110.827 171.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . 49.36 32.06 4.27 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 125.696 1.598 . . . . 75.34 114.13 164.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 2.3 pp 48.49 19.24 0.22 Allowed 'General case' 0 N--CA 1.502 2.157 0 C-N-CA 125.759 1.624 . . . . 74.24 114.394 -177.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -90.72 27.29 8.99 Favored Glycine 0 C--N 1.342 0.873 0 N-CA-C 115.668 1.027 . . . . 61.25 115.668 -165.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.26 -56.45 12.58 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.282 0 CA-C-N 117.913 0.856 . . . . 75.31 109.374 172.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 4.3 t70 167.27 156.63 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 126.523 1.929 . . . . 75.32 107.94 176.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 21.3 mt 62.88 11.63 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 C-N-CA 124.699 1.2 . . . . 72.52 111.948 177.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 44.8 p-80 43.9 90.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 125.168 1.387 . . . . 72.43 111.708 -166.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -56.35 -53.46 57.07 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 123.398 0.679 . . . . 75.05 111.64 -175.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 149' ' ' LYS . . . . . 0.548 ' HG2' ' HB3' ' B' ' 163' ' ' LEU . 0.3 OUTLIER -65.55 144.97 56.65 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.213 1.005 . . . . 74.13 109.54 -169.533 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 150' ' ' ASP . . . . . 0.433 ' N ' ' HD2' ' B' ' 149' ' ' LYS . 16.8 t70 95.38 -27.39 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 126.891 2.077 . . . . 74.11 110.695 -178.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 13.6 p-80 -167.72 65.34 0.73 Allowed Pre-proline 0 N--CA 1.492 1.665 0 C-N-CA 123.403 0.681 . . . . 74.43 111.468 175.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -84.44 -9.87 9.03 Favored 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 122.914 2.409 . . . . 64.13 113.462 -176.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 2.4 m 64.55 28.23 13.35 Favored 'General case' 0 CA--C 1.564 1.487 0 C-N-CA 124.319 1.048 . . . . 74.2 110.219 -174.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 9.6 tt -154.54 132.82 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.939 0.896 . . . . 74.25 109.304 176.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 155' ' ' LEU . . . . . 0.58 HD23 ' HZ2' ' B' ' 231' ' ' LYS . 46.8 tp 74.65 -62.43 0.46 Allowed 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 125.615 1.566 . . . . 73.12 111.815 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 156' ' ' GLU . . . . . 0.725 ' HB3' ' HA ' ' B' ' 159' ' ' LYS . 46.9 mt-10 -73.23 99.28 2.82 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.415 0.686 . . . . 72.23 110.163 176.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 157' ' ' MET . . . . . . . . . . . . . 14.7 tmm? -58.11 -55.46 34.63 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 124.282 1.033 . . . . 61.13 111.095 -178.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 158' ' ' ALA . . . . . . . . . . . . . . . -100.02 -76.12 0.56 Allowed 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 106.934 -1.506 . . . . 65.11 106.934 166.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . 0.725 ' HA ' ' HB3' ' B' ' 156' ' ' GLU . 64.1 pttt -174.52 147.35 1.1 Allowed 'General case' 0 C--N 1.354 0.794 0 O-C-N 124.432 1.083 . . . . 73.24 109.853 163.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -102.63 -8.35 21.01 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.074 -0.966 . . . . 74.34 109.843 171.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . 60.44 24.42 14.0 Favored 'General case' 0 C--N 1.362 1.143 0 C-N-CA 124.463 1.105 . . . . 71.1 110.928 -175.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . -133.21 -59.22 0.08 OUTLIER Glycine 0 C--N 1.352 1.462 0 CA-C-N 115.697 -0.683 . . . . 73.4 112.157 -174.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . 0.548 ' HB3' ' HG2' ' B' ' 149' ' ' LYS . 50.6 tp 55.44 -86.58 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 125.063 1.345 . . . . 75.25 112.366 -179.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 164' ' ' ALA . . . . . . . . . . . . . . . -177.57 149.85 0.65 Allowed 'General case' 0 C--O 1.243 0.728 0 C-N-CA 124.942 1.297 . . . . 75.34 108.676 -171.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 8.8 t -166.71 7.74 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.805 0.842 . . . . 73.14 110.285 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . 130.03 107.29 1.22 Allowed Glycine 0 C--N 1.342 0.897 0 N-CA-C 109.727 -1.349 . . . . 74.53 109.727 -170.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 167' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -63.94 -31.52 72.73 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.582 0.753 . . . . 74.33 111.908 -176.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 8.0 p 46.64 39.18 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 C-N-CA 125.689 1.596 . . . . 75.53 112.693 178.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 32.5 t -70.52 110.9 5.66 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 113.822 -1.535 . . . . 65.53 109.922 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 170' ' ' THR . . . . . 0.589 ' HA ' ' SD ' ' C' ' 213' ' ' MET . 4.9 m 63.15 33.58 14.29 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.861 1.264 . . . . 73.13 110.19 -177.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . 76.63 -45.39 0.5 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 126.164 1.785 . . . . 73.41 111.831 -174.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 172' ' ' GLU . . . . . 0.542 ' HG3' ' H ' ' B' ' 173' ' ' LEU 0.265 10.5 pt-20 45.73 -92.74 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.454 0 C-N-CA 126.094 1.758 . . . . 75.25 114.039 -175.94 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 173' ' ' LEU . . . . . 0.542 ' H ' ' HG3' ' B' ' 172' ' ' GLU . 4.5 mm? 52.34 -91.19 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.925 0.89 . . . . 74.44 110.17 -166.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 174' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 174.74 -64.92 0.01 OUTLIER 'General case' 0 C--N 1.351 0.668 0 C-N-CA 125.374 1.47 . . . . 74.45 107.912 177.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 175' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -100.4 154.79 18.22 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.103 -0.953 . . . . 74.1 110.631 -177.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -162.58 122.87 2.41 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.476 1.11 . . . . 74.11 108.49 174.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 177' ' ' THR . . . . . 0.435 ' HA ' ' HD3' ' B' ' 178' ' ' PRO . 45.5 p -67.14 114.31 17.79 Favored Pre-proline 0 CA--C 1.555 1.166 0 C-N-CA 123.526 0.73 . . . . 74.15 110.131 179.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 178' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' B' ' 177' ' ' THR . 4.5 Cg_exo -78.84 67.12 8.6 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 123.391 2.727 . . . . 74.53 112.912 -173.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -85.26 -69.36 0.66 Allowed 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 108.276 -1.009 . . . . 74.35 108.276 173.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . 60.79 -74.69 0.03 OUTLIER 'General case' 0 C--N 1.358 0.963 0 O-C-N 125.111 1.507 . . . . 75.32 113.407 169.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 181' ' ' LEU . . . . . 0.435 ' HG ' ' HB ' ' C' ' 138' ' ' VAL . 30.3 tp -63.06 -30.14 71.36 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.146 1.378 . . . . 74.44 112.176 -177.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 182' ' ' VAL . . . . . 0.605 HG23 ' HB3' ' C' ' 139' ' ' GLU . 2.8 p -99.11 133.93 39.97 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 CA-C-N 116.189 -0.459 . . . . 72.43 110.982 174.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 183' ' ' ALA . . . . . 0.418 ' HB1' ' HA ' ' C' ' 123' ' ' LEU . . . -159.11 39.47 0.21 Allowed 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 114.806 -1.088 . . . . 65.24 108.453 163.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 42.5 p-80 54.49 171.44 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 127.216 2.207 . . . . 75.32 114.731 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 185' ' ' VAL . . . . . 0.468 HG21 HD13 ' C' ' 119' ' ' LEU . 6.9 p -78.65 134.92 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-N 115.638 -0.71 . . . . 74.01 110.469 177.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 186' ' ' THR . . . . . 0.481 HG22 ' HG3' ' C' ' 122' ' ' GLU . 8.8 t -79.6 163.89 24.26 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.395 0.678 . . . . 60.24 111.406 -177.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 187' ' ' SER . . . . . . . . . . . . . 11.6 m -81.58 -29.08 33.5 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.418 1.087 . . . . 62.14 111.005 177.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 21.7 mtm180 -88.24 115.71 25.92 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.725 0.81 . . . . 72.32 109.84 -176.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -74.33 85.7 1.96 Allowed 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.454 0.702 . . . . 72.52 109.995 -177.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 190' ' ' CYS . . . . . 0.515 ' HB2' HG21 ' C' ' 177' ' ' VAL . 36.7 m -85.81 90.14 7.96 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 114.735 -1.12 . . . . 70.33 109.64 -179.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -64.18 145.47 55.9 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 114.975 -1.011 . . . . 74.04 110.352 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -113.38 158.02 14.56 Favored Glycine 0 N--CA 1.468 0.804 0 CA-C-O 119.508 -0.606 . . . . 64.22 112.532 -178.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 193' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -95.09 -162.95 0.09 OUTLIER 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 123.273 2.649 . . . . 73.22 111.547 175.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 194' ' ' SER . . . . . . . . . . . . . 47.1 m -84.38 155.11 22.47 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 109.807 -0.442 . . . . 63.44 109.807 171.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 195' ' ' ALA . . . . . . . . . . . . . . . -138.35 145.48 41.16 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.544 0.737 . . . . 74.32 110.383 -178.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 196' ' ' THR . . . . . 0.42 ' HB ' ' O ' ' B' ' 202' ' ' GLY . 8.0 m -63.21 -66.98 0.46 Allowed 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 108.767 -0.827 . . . . 73.32 108.767 172.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 47.6 m 50.92 28.99 4.09 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.866 1.266 . . . . 75.11 113.03 174.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 198' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.07 89.32 3.01 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 108.749 -0.834 . . . . 65.14 108.749 -174.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 45.9 tttp 71.18 -8.19 1.03 Allowed 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 125.308 1.443 . . . . 75.14 112.595 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 200' ' ' CYS . . . . . . . . . . . . . 34.8 m -138.93 168.89 13.95 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 124.057 0.943 . . . . 73.31 109.897 -167.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 201' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -73.11 3.37 4.62 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 122.107 1.871 . . . . 74.02 112.458 165.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 202' ' ' GLY . . . . . 0.648 ' HA2' ' HA2' ' C' ' 190' ' ' GLY . . . -58.12 117.18 9.66 Favored Glycine 0 C--N 1.359 1.849 0 C-N-CA 123.728 0.68 . . . . 73.41 113.498 175.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 27.3 t30 -170.28 122.68 0.67 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.59 1.156 . . . . 71.33 109.027 -178.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 204' ' ' ALA . . . . . 0.596 ' HB2' ' HB3' ' B' ' 26' ' ' MET . . . -71.68 88.87 0.99 Allowed 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.207 -0.664 . . . . 74.01 109.207 174.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 205' ' ' LEU . . . . . . . . . . . . . 19.4 tp -106.57 -52.74 2.73 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.068 -0.969 . . . . 72.44 108.603 -176.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 58.01 -74.26 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.833 1.653 . . . . 70.3 110.467 -173.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 207' ' ' LYS . . . . . 0.665 ' HB2' ' HZ3' ' B' ' 207' ' ' LYS . 4.1 ttmp? -103.81 -78.11 0.56 Allowed 'General case' 0 C--O 1.243 0.72 0 N-CA-C 107.349 -1.352 . . . . 74.32 107.349 174.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 52.21 34.06 39.52 Favored Glycine 0 C--N 1.356 1.676 0 O-C-N 124.005 0.816 . . . . 71.52 114.527 173.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 209' ' ' GLY . . . . . 0.567 ' HA3' HH21 ' B' ' 22' ' ' ARG . . . 93.71 75.95 1.31 Allowed Glycine 0 C--N 1.341 0.807 0 N-CA-C 111.316 -0.714 . . . . 63.34 111.316 -174.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 210' ' ' LYS . . . . . 0.504 ' HD3' ' O ' ' C' ' 155' ' ' GLU . 4.8 ttpm? -163.97 -34.22 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.001 0.52 . . . . 74.51 111.394 -178.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . -69.38 66.95 0.55 Allowed Glycine 0 C--N 1.362 1.998 0 O-C-N 123.792 0.683 . . . . 74.43 114.067 -171.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 65.4 m -165.77 -44.04 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.641 1.576 . . . . 74.04 107.579 -172.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 49.3 mt 55.67 80.61 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.362 1.14 0 C-N-CA 125.86 1.664 . . . . 70.12 111.047 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 74.0 p -78.15 77.94 4.64 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-O 122.507 1.146 . . . . 75.43 109.443 178.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 215' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -128.06 -52.99 1.31 Allowed 'General case' 0 C--O 1.237 0.408 0 CA-C-N 113.697 -1.592 . . . . 73.31 108.16 -176.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 77.81 -20.63 0.37 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 124.824 1.328 . . . . 61.42 112.401 175.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 5.7 tt -77.21 -64.0 1.24 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.878 0.871 . . . . 75.4 110.253 -169.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . 0.527 ' HB3' ' HA ' ' B' ' 222' ' ' ALA . 51.8 mt -80.97 -36.92 30.18 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 110.139 -0.319 . . . . 71.43 110.139 173.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 70.28 103.94 0.06 Allowed 'General case' 0 C--N 1.359 1.014 0 O-C-N 124.771 1.294 . . . . 71.24 112.419 172.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . 64.81 -75.16 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 125.384 1.474 . . . . 74.3 113.42 167.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 221' ' ' ARG . . . . . . . . . . . . . 18.0 tpp180 -60.22 -40.65 90.91 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.47 1.108 . . . . 73.55 111.446 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . 0.527 ' HA ' ' HB3' ' B' ' 218' ' ' LEU . . . 60.53 49.55 6.54 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 124.216 0.948 . . . . 75.21 111.327 177.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -46.75 -64.78 0.68 Allowed 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 125.696 1.598 . . . . 72.13 112.774 -172.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 54.6 t -41.53 -62.6 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 125.558 1.543 . . . . 75.32 112.736 -167.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 225' ' ' THR . . . . . 0.582 HG23 ' HD2' ' C' ' 184' ' ' PRO . 60.2 p 50.69 -70.36 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 125.771 1.628 . . . . 73.55 113.726 -175.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 2.7 tm? 72.7 96.05 0.07 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.679 1.192 . . . . 74.43 109.282 175.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . 155.81 -22.16 0.53 Allowed Glycine 0 C--N 1.347 1.14 0 CA-C-O 119.433 -0.648 . . . . 71.24 113.313 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . -56.12 -55.38 29.64 Favored Glycine 0 CA--C 1.536 1.388 0 N-CA-C 114.299 0.48 . . . . 72.41 114.299 -173.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -118.64 50.93 0.78 Allowed Glycine 0 C--N 1.345 1.051 0 N-CA-C 111.037 -0.825 . . . . 71.04 111.037 176.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -58.33 130.99 49.3 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.054 0.942 . . . . 70.23 111.725 -174.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 231' ' ' LYS . . . . . 0.58 ' HZ2' HD23 ' B' ' 155' ' ' LEU . 86.7 tttt -68.27 130.64 43.51 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 123.814 0.696 . . . . 73.24 112.116 -169.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 14.7 t -154.95 -178.6 7.35 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.571 1.148 . . . . 74.24 108.859 177.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -132.77 94.08 3.33 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 107.795 -1.187 . . . . 71.44 107.795 172.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -148.08 173.39 12.98 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.338 0.655 . . . . 72.31 110.857 -176.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . 0.44 ' HA ' ' NZ ' ' C' ' 209' ' ' LYS . 38.1 tt0 -158.87 77.01 0.74 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.3 0.64 . . . . 64.41 110.502 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 236' ' ' THR . . . . . . . . . . . . . 85.6 m -150.77 128.18 11.39 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.761 0.824 . . . . 73.34 109.565 172.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -76.62 85.06 3.28 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.108 0.563 . . . . 73.03 109.58 172.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 4.4 m -93.67 17.29 12.06 Favored 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 123.818 0.847 . . . . 71.31 110.753 -175.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -83.29 153.29 24.72 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.678 0.791 . . . . 74.42 111.345 -176.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 240' ' ' GLY . . . . . 0.411 ' O ' ' HE3' ' B' ' 245' ' ' LYS . . . -86.86 -60.62 1.67 Allowed Glycine 0 C--N 1.349 1.288 0 CA-C-N 116.008 -0.542 . . . . 71.23 113.708 -164.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -112.18 -167.41 1.18 Allowed 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 117.49 0.645 . . . . 71.23 110.685 178.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . 0.259 0.0 OUTLIER 59.53 166.33 0.06 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 127.647 2.379 . . . . 70.32 114.567 177.496 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 243' ' ' GLN . . . . . 0.452 ' HG3' ' N ' ' B' ' 245' ' ' LYS . 1.9 pt20 51.99 -166.95 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 126.519 1.928 . . . . 74.22 114.584 170.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -78.98 -43.81 10.58 Favored Glycine 0 C--N 1.362 2.007 0 CA-C-N 115.773 -0.649 . . . . 71.54 112.246 173.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 245' ' ' LYS . . . . . 0.452 ' N ' ' HG3' ' B' ' 243' ' ' GLN . 22.9 pttm 44.74 40.77 4.46 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 126.324 1.85 . . . . 75.34 112.734 -178.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 15.3 t -145.45 174.14 11.4 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.63 0.772 . . . . 71.14 110.316 -175.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 247' ' ' LEU . . . . . . . . . . . . . 87.8 mt 64.95 -83.36 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.834 1.254 . . . . 72.51 110.834 -177.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 248' ' ' ARG . . . . . . . . . . . . . 7.4 tpp180 -164.54 11.19 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.155 0.982 . . . . 75.15 109.097 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 51.61 -145.3 0.53 Allowed 'General case' 0 C--N 1.354 0.77 0 C-N-CA 124.794 1.238 . . . . 71.33 112.239 -169.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 250' ' ' GLN . . . . . 0.487 ' HG3' ' HD3' ' C' ' 225' ' ' PRO . 46.5 mm-40 -96.59 51.88 1.19 Allowed 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 111.905 0.335 . . . . 70.14 111.905 -156.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 251' ' ' ALA . . . . . . . . . . . . . . . 75.05 -58.0 0.59 Allowed 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 125.778 1.631 . . . . 64.21 113.149 174.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . 0.491 ' NE2' ' HG2' ' A' ' 274' ' ' GLU . 88.9 mm-40 -86.51 53.26 2.75 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.475 0.71 . . . . 73.12 111.751 -177.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 253' ' ' ALA . . . . . 0.649 ' HB3' ' HE3' ' C' ' 209' ' ' LYS . . . -102.43 40.45 1.35 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.76 0.824 . . . . 51.41 109.356 175.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 42.1 ttp-105 -168.28 -64.83 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.277 0.631 . . . . 72.51 109.957 -178.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . 58.68 -100.85 0.18 Allowed Glycine 0 C--N 1.362 2.024 0 O-C-N 123.568 0.543 . . . . 63.32 111.877 -177.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 256' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -148.04 -57.9 0.24 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.291 1.037 . . . . 71.2 108.7 168.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 25.9 pt20 -143.3 174.97 10.26 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.586 0.755 . . . . 74.31 110.474 -173.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 258' ' ' LEU . . . . . 0.428 ' HB3' ' HE1' ' A' ' 277' ' ' TYR . 2.3 pt? -148.82 148.36 29.83 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.404 0.682 . . . . 75.13 109.745 178.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 15.1 m -119.24 163.56 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.745 0.818 . . . . 63.31 110.163 173.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 260' ' ' SER . . . . . . . . . . . . . 21.3 t -121.13 142.54 49.77 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.855 0.862 . . . . 73.11 108.734 177.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -101.0 -69.26 0.78 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 122.74 0.416 . . . . 65.51 110.873 178.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 262' ' ' ALA . . . . . . . . . . . . . . . -166.67 -149.92 0.11 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.528 0.731 . . . . 75.22 109.258 -169.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 263' ' ' ALA . . . . . 0.444 ' HB3' ' HB ' ' C' ' 196' ' ' THR . . . -161.64 -167.8 1.81 Allowed 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 118.024 0.375 . . . . 70.44 111.919 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 264' ' ' SER . . . . . 0.708 ' H ' HG21 ' C' ' 196' ' ' THR . 36.1 t 68.31 94.89 0.07 Allowed 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 126.284 1.834 . . . . 51.14 112.553 175.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 265' ' ' LEU . . . . . 0.622 HD21 ' HB2' ' A' ' 229' ' ' ALA . 27.8 mt -130.07 -74.63 0.54 Allowed 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 124.098 0.959 . . . . 73.31 109.923 171.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 266' ' ' ASN . . . . . 0.534 HD22 ' HB3' ' B' ' 270' ' ' GLU . 8.5 t-20 69.0 158.72 0.16 Allowed 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 125.345 1.458 . . . . 71.52 110.934 -173.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 75.9 p -72.91 -56.72 4.77 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 109.487 -0.56 . . . . 73.13 109.487 175.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 6.2 p 177.37 -40.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.661 1.584 . . . . 74.44 107.532 175.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 269' ' ' THR . . . . . . . . . . . . . 20.0 p -140.27 35.04 1.89 Allowed 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.82 1.248 . . . . 74.31 108.739 177.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 270' ' ' GLU . . . . . 0.534 ' HB3' HD22 ' B' ' 266' ' ' ASN . 8.6 pt-20 46.76 -72.52 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.052 0 C-N-CA 127.363 2.265 . . . . 72.41 114.966 -177.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 271' ' ' ALA . . . . . . . . . . . . . . . -70.2 79.37 0.52 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.934 0.893 . . . . 75.3 111.195 -178.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 272' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -125.62 -63.9 1.1 Allowed 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 107.802 -1.184 . . . . 73.11 107.802 177.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 46.6 mm-40 47.98 -86.05 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 126.542 1.937 . . . . 73.43 114.319 170.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 67.3 126.01 0.02 OUTLIER 'General case' 0 C--N 1.363 1.18 0 C-N-CA 125.265 1.426 . . . . 71.44 111.171 -176.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 275' ' ' LYS . . . . . 0.661 ' HB3' ' HZ3' ' B' ' 275' ' ' LYS . 0.0 OUTLIER 64.84 93.63 0.06 OUTLIER Pre-proline 0 CA--C 1.567 1.618 0 C-N-CA 123.896 0.879 . . . . 72.14 110.294 177.194 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -83.98 3.04 7.88 Favored 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 122.642 2.228 . . . . 73.04 113.245 175.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 277' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -72.74 116.12 12.85 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 122.997 0.519 . . . . 74.52 110.084 -179.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -54.5 -50.98 66.51 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 124.081 0.953 . . . . 72.2 112.104 176.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . 139.28 -99.67 0.27 Allowed Glycine 0 C--N 1.342 0.883 0 N-CA-C 110.92 -0.872 . . . . 75.43 110.92 -171.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.81 -37.38 0.37 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 122.9 0.48 . . . . 74.31 111.542 -178.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 76.0 t80 63.19 -87.07 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.359 1.064 . . . . 75.31 109.978 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . 60.01 27.65 17.09 Favored 'General case' 0 CA--C 1.565 1.556 0 N-CA-C 115.401 1.63 . . . . 65.41 115.401 168.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -86.02 -52.04 5.96 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.997 -0.439 . . . . 72.33 111.619 -177.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . -78.5 71.98 2.43 Favored Glycine 0 C--N 1.35 1.329 0 CA-C-N 115.571 -0.74 . . . . 72.13 112.85 -173.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 7.0 t30 57.88 91.19 0.04 OUTLIER 'General case' 0 C--N 1.358 0.978 0 C-N-CA 125.058 1.343 . . . . 73.03 111.545 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 286' ' ' MET . . . . . 0.531 ' HG3' ' HD3' ' B' ' 289' ' ' ARG . 44.8 tpp -157.05 68.36 4.3 Favored Pre-proline 0 CA--C 1.555 1.162 0 N-CA-C 109.2 -0.667 . . . . 74.22 109.2 -178.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 287' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -76.87 -68.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.385 2.451 0 C-N-CA 122.549 2.166 . . . . 74.24 112.322 -176.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 288' ' ' VAL . . . . . . . . . . . . . 27.0 m -88.75 20.93 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 123.65 0.78 . . . . 74.32 111.07 176.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 289' ' ' ARG . . . . . 0.531 ' HD3' ' HG3' ' B' ' 286' ' ' MET . 25.2 mmt85 59.6 84.34 0.12 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.155 1.382 . . . . 74.32 111.343 173.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 290' ' ' TRP . . . . . . . . . . . . . 64.6 m95 72.02 118.44 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 125.85 1.66 . . . . 75.34 110.5 -177.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 291' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -153.38 126.79 8.62 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 109.868 -0.419 . . . . 73.52 109.868 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . 63.69 -151.6 48.9 Favored Glycine 0 C--N 1.35 1.308 0 O-C-N 124.091 0.87 . . . . 71.42 113.649 174.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -92.52 15.47 1.52 Allowed 'Trans proline' 0 CA--C 1.556 1.577 0 C-N-CA 123.281 2.654 . . . . 75.13 113.272 177.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 63.0 tttp 70.31 -74.83 0.08 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.911 1.284 . . . . 74.44 112.685 177.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -61.45 -39.28 90.29 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 112.911 0.708 . . . . 71.35 112.911 -172.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 6.2 t 47.57 -178.97 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 126.446 1.898 . . . . 71.52 113.266 -176.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 20.6 t80 41.06 84.43 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 125.778 1.631 . . . . 75.44 113.447 165.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 77.38 -57.2 0.51 Allowed 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 125.731 1.612 . . . . 73.43 111.991 -178.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . -62.99 -30.36 77.18 Favored Glycine 0 C--N 1.354 1.549 0 O-C-N 123.282 0.364 . . . . 72.35 112.854 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 66.07 -74.3 0.06 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.741 1.616 . . . . 72.23 111.902 177.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 301' ' ' ILE . . . . . 0.42 HG22 ' HB2' ' B' ' 303' ' ' LYS . 17.0 tt -145.77 145.21 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 123.124 0.57 . . . . 75.13 110.857 -177.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -79.91 56.21 2.28 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.823 0.849 . . . . 74.32 109.047 171.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 303' ' ' LYS . . . . . 0.42 ' HB2' HG22 ' B' ' 301' ' ' ILE . 11.4 tmtt? -80.19 108.1 8.61 Favored Pre-proline 0 CA--C 1.549 0.916 0 N-CA-C 108.733 -0.84 . . . . 74.11 108.733 -175.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 304' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -87.66 -162.82 0.15 Allowed 'Trans proline' 0 C--N 1.375 1.929 0 C-N-CA 122.681 2.254 . . . . 75.12 111.311 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -63.94 -36.95 85.63 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 122.808 0.443 . . . . 72.13 110.518 172.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 61.8 t 62.71 -76.16 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 125.554 1.542 . . . . 72.33 110.493 -176.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 38.4 m -78.13 103.68 8.23 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.983 0.913 . . . . 74.23 109.462 177.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 308' ' ' CYS . . . . . . . . . . . . . 48.4 t -82.46 -6.63 59.42 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.286 0.634 . . . . 74.22 110.47 175.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 19.6 m -68.12 118.61 60.48 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 124.242 1.017 . . . . 72.2 109.936 173.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -60.51 -46.33 17.99 Favored 'Trans proline' 0 C--N 1.382 2.327 0 C-N-CA 122.573 2.182 . . . . 64.44 111.841 177.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 311' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -163.31 150.86 11.02 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 124.073 0.949 . . . . 73.13 109.538 177.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 312' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -77.51 148.58 26.42 Favored 'Trans proline' 0 C--N 1.377 2.054 0 C-N-CA 122.414 2.076 . . . . 70.14 111.689 175.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 313' ' ' GLN . . . . . . . . . . . . . 26.7 mp0 -79.18 120.11 23.22 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 122.982 0.513 . . . . 75.13 110.252 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 314' ' ' ARG . . . . . . . . . . . . . 2.6 ppt_? -73.98 84.72 1.76 Allowed 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 122.978 0.511 . . . . 74.53 110.823 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 315' ' ' ASN . . . . . . . . . . . . . 7.2 t30 70.33 -74.53 0.08 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.864 1.266 . . . . 75.34 110.22 -175.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 316' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -95.1 -166.77 1.51 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.922 0.889 . . . . 74.4 110.546 -178.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 4.5 m -90.42 -68.28 0.79 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.526 0.731 . . . . 75.41 111.695 -177.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 318' ' ' VAL . . . . . . . . . . . . . 62.4 t -130.52 -62.87 0.02 OUTLIER Pre-proline 0 CA--C 1.567 1.629 0 CA-C-O 118.414 -0.803 . . . . 73.13 112.664 -164.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 319' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -70.7 -12.0 30.45 Favored 'Trans proline' 0 C--N 1.386 2.528 0 C-N-CA 121.802 1.668 . . . . 65.1 114.514 -165.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 320' ' ' THR . . . . . . . . . . . . . 7.9 m 62.91 76.34 0.37 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.599 1.16 . . . . 73.24 109.73 -175.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 321' ' ' LEU . . . . . . . . . . . . . 28.0 tp -140.77 76.56 1.56 Allowed 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 116.007 -0.542 . . . . 74.43 110.925 -170.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 322' ' ' ALA . . . . . . . . . . . . . . . 63.29 -75.56 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 125.775 1.63 . . . . 64.54 114.743 166.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 323' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -96.99 178.32 5.32 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.677 0.791 . . . . 74.02 110.488 -175.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 324' ' ' MET . . . . . 0.423 ' SD ' ' N ' ' B' ' 324' ' ' MET . 1.4 mpt? -71.51 90.85 1.02 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 109.256 -0.646 . . . . 74.22 109.256 177.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 325' ' ' THR . . . . . . . . . . . . . 50.2 p -55.78 -35.87 66.73 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.155 0.982 . . . . 72.33 113.058 -172.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 326' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -161.36 -94.64 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.52 0.328 . . . . 72.01 110.336 176.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -82.91 101.3 10.93 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.774 -0.578 . . . . 75.41 110.197 -177.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 328' ' ' ALA . . . . . . . . . . . . . . . -82.72 -26.37 32.05 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 115.596 -0.729 . . . . 72.03 109.975 169.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 329' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.91 161.04 36.52 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 C-N-CA 124.834 1.254 . . . . 73.5 109.083 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 330' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -82.03 -43.35 18.06 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.903 -0.589 . . . . 74.44 110.885 174.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 331' ' ' LEU . . . . . 0.435 HD12 ' HD2' ' C' ' 234' ' ' ARG . 19.5 tp -168.54 172.03 8.47 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.32 0.648 . . . . 64.42 109.897 -167.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -65.17 114.13 4.45 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 123.989 0.916 . . . . 74.41 110.089 173.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 333' ' ' SER . . . . . . . . . . . . . 35.6 t -100.12 176.62 5.34 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.546 0.738 . . . . 65.04 110.274 175.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 334' ' ' LYS . . . . . 0.689 ' HZ2' ' HB3' ' B' ' 334' ' ' LYS . 0.0 OUTLIER -137.16 -14.66 1.53 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.54 0.736 . . . . 65.35 110.088 -173.619 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 335' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -83.82 59.51 5.25 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.657 0.783 . . . . 74.12 112.1 -168.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -174.52 -72.68 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.339 1.456 . . . . 73.55 107.201 171.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 337' ' ' LYS . . . . . . . . . . . . . 85.8 tttt 56.1 -81.69 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 125.392 1.477 . . . . 71.1 112.472 175.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 338' ' ' GLY . . . . . . . . . . . . . . . -178.54 -163.13 29.35 Favored Glycine 0 C--O 1.243 0.712 0 N-CA-C 109.817 -1.313 . . . . 73.12 109.817 -176.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 339' ' ' PHE . . . . . . . . . . . . . 40.0 t80 58.05 38.42 26.64 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.603 0.716 . . . . 74.33 109.69 176.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 340' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 63.02 -78.77 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 125.43 1.492 . . . . 75.24 110.304 -169.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 341' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -166.96 -79.15 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 105.339 -2.097 . . . . 75.34 105.339 170.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 342' ' ' GLN . . . . . 0.41 ' HA ' ' HB3' ' B' ' 347' ' ' SER . 49.6 mt-30 58.97 179.98 0.08 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 125.201 1.401 . . . . 74.32 112.829 175.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 343' ' ' VAL . . . . . 0.416 HG11 ' H ' ' B' ' 344' ' ' GLU 0.255 6.9 p 47.94 -70.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.467 0 C-N-CA 126.705 2.002 . . . . 65.15 114.215 -179.905 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 344' ' ' GLU . . . . . 0.416 ' H ' HG11 ' B' ' 343' ' ' VAL . 36.6 tt0 -64.37 -40.0 94.97 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.039 0.936 . . . . 74.33 110.25 173.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 345' ' ' GLY . . . . . . . . . . . . . . . -90.13 153.51 22.96 Favored Glycine 0 C--N 1.346 1.096 0 N-CA-C 111.1 -0.8 . . . . 63.14 111.1 174.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 346' ' ' ALA . . . . . . . . . . . . . . . -74.77 86.44 2.2 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.245 0.545 . . . . 72.51 110.622 -178.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 347' ' ' SER . . . . . 0.41 ' HB3' ' HA ' ' B' ' 342' ' ' GLN . 11.1 p -87.19 29.1 0.87 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.139 0.976 . . . . 72.21 112.079 -178.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 2.3 mp 60.91 -76.56 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.098 0 C-N-CA 125.332 1.453 . . . . 73.42 109.543 -174.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 349' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -75.46 140.47 42.89 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 120.982 0.42 . . . . 71.13 110.107 172.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 350' ' ' LYS . . . . . 0.418 ' HE3' ' HB2' ' B' ' 350' ' ' LYS . 30.2 mtmt -110.49 105.05 13.87 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 124.557 1.143 . . . . 74.52 108.571 -173.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -70.73 81.44 0.62 Allowed 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.232 0.613 . . . . 71.32 110.336 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -175.71 37.38 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.585 1.154 . . . . 74.35 108.29 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 353' ' ' HIS . . . . . . . . . . . . . 4.9 p80 63.58 -17.45 0.06 Allowed 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 127.499 2.32 . . . . 74.33 115.156 178.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 354' ' ' ALA . . . . . . . . . . . . . . . 52.41 -90.77 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.468 1.107 . . . . 72.23 111.909 -174.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 355' ' ' ALA . . . . . . . . . . . . . . . -116.42 -80.26 0.6 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.543 0.737 . . . . 75.44 109.152 177.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 356' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -164.91 61.58 0.83 Allowed Pre-proline 0 N--CA 1.485 1.315 0 C-N-CA 123.113 0.565 . . . . 74.32 111.347 178.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 357' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.4 -31.43 11.4 Favored 'Trans proline' 0 C--N 1.38 2.222 0 C-N-CA 122.476 2.117 . . . . 74.21 112.97 -177.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 358' ' ' CYS . . . . . . . . . . . . . 67.8 m -78.17 130.62 36.56 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 109.566 -0.531 . . . . 75.21 109.566 177.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 359' ' ' GLY . . . . . . . . . . . . . . . -82.44 55.04 4.96 Favored Glycine 0 C--N 1.347 1.18 0 O-C-N 123.585 0.553 . . . . 72.04 112.555 -179.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 360' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -81.13 128.04 33.31 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.727 0.811 . . . . 53.34 109.159 -179.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 361' ' ' ILE . . . . . . . . . . . . . 58.0 mt -69.66 91.3 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 N-CA-C 107.769 -1.197 . . . . 64.41 107.769 171.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 362' ' ' GLY . . . . . . . . . . . . . . . 73.34 -157.6 52.16 Favored Glycine 0 C--N 1.348 1.205 0 CA-C-N 115.6 -0.727 . . . . 72.35 111.29 -167.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 363' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 62.57 15.41 7.9 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 125.081 1.352 . . . . 73.13 111.433 174.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 364' ' ' THR . . . . . 0.407 ' HB ' ' HB2' ' B' ' 367' ' ' LEU . 1.3 m -82.51 10.5 7.15 Favored 'General case' 0 CA--C 1.562 1.424 0 C-N-CA 123.44 0.696 . . . . 74.04 111.064 -174.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 49.1 t 70.44 -75.01 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.361 1.069 0 C-N-CA 126.431 1.892 . . . . 74.51 110.845 173.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -73.65 -42.14 61.78 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.752 0.821 . . . . 52.52 111.611 -177.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 367' ' ' LEU . . . . . 0.407 ' HB2' ' HB ' ' B' ' 364' ' ' THR . 64.0 mt -74.52 -77.95 0.11 Allowed 'General case' 0 CA--C 1.546 0.8 0 O-C-N 123.307 0.379 . . . . 75.05 110.441 -176.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 368' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -142.25 158.79 43.33 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.151 0.58 . . . . 73.23 111.006 -173.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 369' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -99.1 -80.52 0.46 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.372 1.069 . . . . 74.11 110.298 175.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 370' ' ' ALA . . . . . . . . . . . . . . . -179.19 -60.71 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 108.611 -0.885 . . . . 74.25 108.611 -177.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 371' ' ' VAL . . . . . . . . . . . . . 65.6 t -102.24 -58.44 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 115.119 -0.946 . . . . 74.12 109.291 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 372' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 71.15 -16.23 0.37 Allowed 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 125.299 1.44 . . . . 63.2 114.329 176.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 373' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -74.0 86.31 1.81 Allowed 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 108.695 -0.854 . . . . 72.2 108.695 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . 61.63 18.08 9.22 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.661 0.784 . . . . 71.45 112.628 -178.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 375' ' ' LEU . . . . . . . . . . . . . 46.9 tp 69.51 150.17 0.08 Allowed 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 125.799 1.64 . . . . 72.22 111.659 -172.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -84.18 135.33 34.41 Favored 'General case' 0 CA--C 1.559 1.31 0 C-N-CA 124.232 1.013 . . . . 73.13 109.254 175.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 377' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -132.79 68.62 1.5 Allowed 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.684 0.794 . . . . 73.31 109.741 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 378' ' ' ALA . . . . . . . . . . . . . . . 56.54 -74.76 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 125.512 1.525 . . . . 73.45 113.407 177.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . 0.499 ' HA ' ' HB3' ' B' ' 400' ' ' ALA . 0.2 OUTLIER -84.57 4.57 31.51 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 124.011 0.924 . . . . 73.22 110.632 171.681 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 380' ' ' LYS . . . . . . . . . . . . . 26.2 tptp 73.88 -63.03 0.44 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.226 1.81 . . . . 72.4 111.567 -172.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 381' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -65.54 -36.76 84.73 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.969 0.908 . . . . 74.34 112.279 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 382' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' B' ' 379' ' ' LYS . . . -155.29 122.89 1.27 Allowed Glycine 0 C--N 1.346 1.115 0 N-CA-C 110.926 -0.87 . . . . 73.1 110.926 -178.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 383' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -57.65 -66.82 0.4 Allowed 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.577 0.751 . . . . 73.1 112.502 -175.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 384' ' ' THR . . . . . . . . . . . . . 1.8 p -160.53 -162.85 1.0 Allowed 'General case' 0 C--O 1.246 0.879 0 C-N-CA 125.359 1.464 . . . . 71.44 107.692 -174.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 385' ' ' LEU . . . . . 0.447 ' HB3' ' OE1' ' B' ' 432' ' ' GLN . 4.0 mm? 67.28 -173.19 0.19 Allowed 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 124.443 1.097 . . . . 75.43 111.549 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 386' ' ' VAL . . . . . 0.642 HG21 ' HB3' ' B' ' 391' ' ' ASP . 25.1 t -76.78 88.5 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 123.16 0.584 . . . . 75.23 110.159 -177.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 387' ' ' ILE . . . . . . . . . . . . . 8.6 tp -78.4 125.15 37.74 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 N-CA-C 109.557 -0.535 . . . . 74.12 109.557 178.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 388' ' ' VAL . . . . . . . . . . . . . 61.2 t 64.79 -73.84 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 125.653 1.581 . . . . 74.43 111.34 -174.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 389' ' ' THR . . . . . . . . . . . . . 14.5 t -155.74 9.7 0.27 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 122.713 0.405 . . . . 71.25 111.516 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . -144.83 126.8 15.47 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 122.816 0.446 . . . . 73.41 110.522 -176.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 391' ' ' ASP . . . . . 0.642 ' HB3' HG21 ' B' ' 386' ' ' VAL . 5.1 p-10 -85.49 -29.85 23.94 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.617 0.767 . . . . 64.12 110.746 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 392' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 65.25 -82.15 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.067 1.347 . . . . 72.42 112.005 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -158.55 -158.53 0.71 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.941 0.896 . . . . 61.53 109.008 -172.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -57.53 -59.82 4.59 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 109.663 -0.495 . . . . 73.31 109.663 172.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . -69.94 90.72 0.63 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 107.543 -1.28 . . . . 75.42 107.543 166.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 23.9 t -56.44 -29.79 62.07 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.502 1.121 . . . . 75.55 111.565 -175.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 397' ' ' GLN . . . . . 0.566 HE22 ' HB ' ' B' ' 399' ' ' VAL . 0.6 OUTLIER -131.04 144.17 51.25 Favored 'General case' 0 CA--C 1.556 1.175 0 N-CA-C 105.706 -1.961 . . . . 75.54 105.706 169.482 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 8.4 tp -65.9 -42.77 92.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 112.587 0.588 . . . . 75.44 112.587 -167.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 399' ' ' VAL . . . . . 0.566 ' HB ' HE22 ' B' ' 397' ' ' GLN . 79.4 t -64.08 145.53 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 123.449 0.7 . . . . 73.32 110.945 -178.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 400' ' ' ALA . . . . . 0.499 ' HB3' ' HA ' ' B' ' 379' ' ' LYS . . . 72.41 113.66 0.03 OUTLIER Pre-proline 0 C--N 1.357 0.905 0 O-C-N 124.967 1.417 . . . . 74.52 110.47 -178.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 401' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' B' ' 400' ' ' ALA . 11.1 Cg_exo -73.1 35.39 0.35 Allowed 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 123.494 2.796 . . . . 71.34 114.42 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 402' ' ' ASP . . . . . 0.574 ' HB3' ' HB2' ' B' ' 405' ' ' ALA . 2.3 m-20 80.36 -10.86 1.21 Allowed 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 125.898 1.679 . . . . 74.34 113.57 169.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 403' ' ' THR . . . . . 0.66 HG21 ' HG3' ' B' ' 404' ' ' LYS . 20.1 m 58.23 -81.16 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.261 0 C-N-CA 124.999 1.32 . . . . 73.2 111.992 -177.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 404' ' ' LYS . . . . . 0.66 ' HG3' HG21 ' B' ' 403' ' ' THR . 66.1 mttm -123.58 17.44 9.61 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.044 0.938 . . . . 71.14 111.285 -175.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 405' ' ' ALA . . . . . 0.574 ' HB2' ' HB3' ' B' ' 402' ' ' ASP . . . -107.92 93.84 11.48 Favored Pre-proline 0 N--CA 1.484 1.245 0 C-N-CA 122.932 0.493 . . . . 71.24 110.768 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 406' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' B' ' 404' ' ' LYS . 8.7 Cg_exo -74.54 -27.27 11.1 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 122.939 2.426 . . . . 64.23 111.302 172.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . -134.74 -119.07 1.91 Allowed Glycine 0 C--N 1.345 1.064 0 N-CA-C 111.153 -0.779 . . . . 74.04 111.153 175.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 408' ' ' LEU . . . . . . . . . . . . . 83.0 mt 70.04 5.3 5.21 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 125.053 1.341 . . . . 72.55 111.642 -175.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 11.0 t -77.71 -172.68 2.7 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 123.52 0.728 . . . . 73.52 111.716 -171.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 410' ' ' GLN . . . . . 0.485 ' NE2' ' HB2' ' B' ' 391' ' ' ASP . 0.9 OUTLIER -78.55 80.3 4.93 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 124.274 1.03 . . . . 70.42 109.467 -175.019 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . -71.77 146.63 47.96 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.187 -0.915 . . . . 74.33 109.962 177.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 73.2 mt -76.73 72.3 3.35 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.147 0.579 . . . . 75.21 109.724 -177.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 169.17 -44.8 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 126.237 1.815 . . . . 71.14 107.355 -173.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 414' ' ' THR . . . . . . . . . . . . . 55.8 m -64.01 137.06 57.82 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 114.655 -1.157 . . . . 73.24 111.265 178.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 415' ' ' LYS . . . . . 0.489 ' HE3' ' NE2' ' B' ' 432' ' ' GLN . 15.8 tptp 65.41 41.92 4.06 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.964 1.306 . . . . 75.21 110.593 176.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -74.6 84.78 2.07 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 114.994 -1.003 . . . . 75.33 110.82 -177.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 417' ' ' GLY . . . . . . . . . . . . . . . 50.4 67.8 1.72 Allowed Glycine 0 C--N 1.355 1.611 0 C-N-CA 124.232 0.92 . . . . 62.31 115.079 168.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 418' ' ' ALA . . . . . . . . . . . . . . . -66.82 -40.42 88.02 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.092 0.557 . . . . 70.25 110.626 177.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 419' ' ' VAL . . . . . . . . . . . . . 8.9 p -121.57 -27.04 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 C-N-CA 124.142 0.977 . . . . 73.31 109.657 173.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 420' ' ' MET . . . . . . . . . . . . . 16.6 tpt 79.62 -40.75 0.22 Allowed 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 125.968 1.707 . . . . 73.34 112.89 173.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 421' ' ' VAL . . . . . 0.463 ' HB ' ' HB3' ' B' ' 426' ' ' ASN . 4.1 t 59.0 67.47 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.097 0 C-N-CA 124.516 1.126 . . . . 72.42 109.761 -175.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 422' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -83.64 2.44 37.49 Favored 'General case' 0 N--CA 1.486 1.325 0 CA-C-N 115.002 -0.999 . . . . 74.1 111.619 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 423' ' ' SER . . . . . . . . . . . . . 6.7 m -55.6 -36.22 66.7 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.163 1.385 . . . . 63.45 112.512 -176.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 424' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -145.78 18.14 1.46 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.67 0.788 . . . . 74.22 110.453 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . 64.7 70.67 1.02 Allowed Glycine 0 C--N 1.351 1.393 0 CA-C-N 116.11 -0.495 . . . . 75.12 112.087 -176.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 426' ' ' ASN . . . . . 0.463 ' HB3' ' HB ' ' B' ' 421' ' ' VAL . 28.1 t-20 -101.91 -32.13 10.36 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.682 0.793 . . . . 75.43 111.137 -177.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 427' ' ' SER . . . . . . . . . . . . . 27.4 m 65.73 29.05 10.89 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.485 1.114 . . . . 75.14 111.997 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 66.47 86.7 0.13 Allowed 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 124.779 1.232 . . . . 73.23 111.128 175.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 429' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -157.41 -35.31 0.08 Allowed 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 114.187 -1.37 . . . . 63.42 110.086 -172.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -49.81 -45.81 50.36 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.697 1.199 . . . . 62.42 111.835 -177.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 18.0 p -164.74 20.98 0.06 Allowed 'General case' 0 C--O 1.237 0.427 0 CA-C-N 114.694 -1.139 . . . . 75.05 109.392 176.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 432' ' ' GLN . . . . . 0.489 ' NE2' ' HE3' ' B' ' 415' ' ' LYS . 27.8 mt-30 58.31 -79.92 0.02 OUTLIER 'General case' 0 C--N 1.362 1.15 0 C-N-CA 124.422 1.089 . . . . 71.1 110.044 -165.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 433' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -84.3 71.92 10.61 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.046 0.938 . . . . 73.43 108.696 -178.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 434' ' ' HIS . . . . . . . . . . . . . 55.0 t60 -63.84 96.84 0.14 Allowed 'General case' 0 C--N 1.35 0.616 0 N-CA-C 108.109 -1.071 . . . . 73.42 108.109 176.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 435' ' ' THR . . . . . . . . . . . . . 29.4 m -74.19 82.04 1.82 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 122.04 0.924 . . . . 73.42 109.49 -178.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . -133.85 11.04 4.85 Favored Glycine 0 C--N 1.339 0.747 0 CA-C-N 113.799 -1.546 . . . . 61.51 111.008 176.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 46.8 t -107.42 -52.68 2.73 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.922 0.889 . . . . 72.35 109.288 179.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 438' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 37.03 -77.1 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.323 0 C-N-CA 126.686 1.995 . . . . 71.55 114.406 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 439' ' ' LEU . . . . . 0.491 HD12 ' HD2' ' A' ' 238' ' ' LYS . 49.0 tp 70.4 101.84 0.06 Allowed 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.571 1.148 . . . . 74.24 111.684 173.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 440' ' ' ARG . . . . . 0.451 ' N ' ' HD2' ' B' ' 440' ' ' ARG . 5.8 mpt_? -84.6 121.59 27.84 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 109.047 -0.723 . . . . 74.1 109.047 -176.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 441' ' ' ILE . . . . . 0.553 HG21 ' HB3' ' A' ' 233' ' ' LEU . 62.3 mt -76.26 -52.64 17.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 123.346 0.658 . . . . 74.15 109.981 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 442' ' ' ALA . . . . . . . . . . . . . . . 61.5 23.58 13.83 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.649 1.18 . . . . 73.33 112.42 177.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . -70.72 -46.77 62.45 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.244 0.618 . . . . 74.21 110.667 176.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -95.43 104.69 16.6 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.284 -0.871 . . . . 71.31 110.111 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . 174.94 54.4 0.05 OUTLIER Glycine 0 CA--C 1.531 1.057 0 CA-C-N 115.286 -0.87 . . . . 74.34 111.159 170.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 446' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -69.86 -50.1 0.49 Allowed 'Trans proline' 0 C--N 1.386 2.55 0 C-N-CA 122.719 2.28 . . . . 72.44 112.406 -168.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 447' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -163.42 124.16 2.3 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 108.089 -1.078 . . . . 63.45 108.089 178.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . -108.26 73.44 0.88 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.46 0.704 . . . . 74.31 109.849 -179.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 449' ' ' ALA . . . . . . . . . . . . . . . 57.93 -166.83 0.14 Allowed 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.417 1.087 . . . . 74.42 112.275 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 450' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -128.74 149.72 50.58 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 108.814 -0.81 . . . . 63.22 108.814 175.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 11.9 p -76.28 -0.05 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.589 0 C-N-CA 124.742 1.217 . . . . 74.44 111.834 -176.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 452' ' ' VAL . . . . . . . . . . . . . 29.6 m -74.04 82.49 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.22 0 CA-C-O 122.713 1.244 . . . . 74.24 111.656 176.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . -140.65 -86.59 0.11 Allowed Glycine 0 C--N 1.339 0.718 0 CA-C-N 114.695 -1.139 . . . . 73.44 110.97 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 454' ' ' LEU . . . . . . . . . . . . . 83.5 mt 58.84 90.68 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.727 1.211 . . . . 73.13 110.186 -177.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 74.3 p -78.68 18.16 0.62 Allowed 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 124.042 0.937 . . . . 72.1 112.951 -170.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -106.85 139.07 41.85 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.04 0.936 . . . . 74.3 109.165 171.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 457' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 62.28 13.98 6.38 Favored 'General case' 0 CA--C 1.567 1.615 0 C-N-CA 124.76 1.224 . . . . 65.21 111.24 -176.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 9.9 t -71.19 -16.13 62.5 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 124.707 1.203 . . . . 72.13 111.518 -176.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 459' ' ' ASP . . . . . . . . . . . . . 26.2 t70 71.69 -64.84 0.37 Allowed 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 126.046 1.739 . . . . 73.31 111.137 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 460' ' ' LEU . . . . . 0.586 HD23 ' HA ' ' B' ' 464' ' ' MET . 33.9 tp -62.12 154.49 26.95 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.747 0.819 . . . . 65.42 110.629 175.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -57.39 95.46 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 124.502 1.121 . . . . 75.0 111.569 -175.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 35.7 t80 67.61 -79.04 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 125.412 1.485 . . . . 72.53 111.886 175.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 10.0 t -119.74 162.36 19.19 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.216 0.606 . . . . 71.14 110.843 -178.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 464' ' ' MET . . . . . 0.586 ' HA ' HD23 ' B' ' 460' ' ' LEU . 0.0 OUTLIER -86.66 173.89 9.22 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 108.871 -0.788 . . . . 75.31 108.871 175.377 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 465' ' ' LYS . . . . . 0.543 ' N ' ' SD ' ' B' ' 464' ' ' MET . 68.3 mttm -56.55 93.46 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.709 0.804 . . . . 72.15 110.719 173.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -135.53 -38.34 0.74 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.157 0.983 . . . . 65.13 108.66 175.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . -131.67 20.75 4.66 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.101 -0.954 . . . . 75.3 109.755 173.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 94.5 mt -127.11 122.85 35.4 Favored 'General case' 0 C--O 1.246 0.91 0 C-N-CA 124.055 0.942 . . . . 74.32 109.579 -177.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 469' ' ' GLY . . . . . . . . . . . . . . . -133.14 -131.54 3.18 Favored Glycine 0 C--N 1.345 1.044 0 N-CA-C 110.866 -0.894 . . . . 62.03 110.866 173.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 470' ' ' LEU . . . . . . . . . . . . . 53.1 tp -165.67 142.22 5.37 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.692 1.197 . . . . 75.32 108.34 175.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 471' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.555 1.144 0 N-CA-C 107.017 -1.475 . . . . 74.2 107.017 175.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 85.7 mtp . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 119.559 -0.257 . . . . 70.43 111.302 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.13 41.91 19.71 Favored 'General case' 0 C--N 1.355 0.823 0 C-N-CA 124.474 1.11 . . . . 70.41 110.899 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.74 -5.02 0.51 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 114.673 1.36 . . . . 71.34 114.673 -171.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 4' ' ' LYS . . . . . 0.52 ' HB2' ' HZ2' ' C' ' 4' ' ' LYS . 4.4 ttmp? 46.36 78.46 0.07 Allowed 'General case' 0 C--O 1.244 0.773 0 C-N-CA 125.93 1.692 . . . . 70.52 113.385 178.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -78.42 111.1 14.08 Favored 'General case' 0 C--O 1.246 0.882 0 N-CA-C 107.614 -1.254 . . . . 72.32 107.614 165.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 6' ' ' ASP . . . . . 0.485 ' HA ' ' OH ' ' C' ' 66' ' ' TYR . 13.9 t70 -64.73 113.35 3.72 Favored 'General case' 0 C--N 1.345 0.41 0 O-C-N 123.679 0.612 . . . . 65.15 109.837 177.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 7' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -63.83 -31.6 72.84 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 114.893 -1.049 . . . . 73.43 111.535 -176.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -64.76 -39.71 94.08 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 116.322 -0.399 . . . . 74.23 110.462 174.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.93 -41.5 86.94 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.25 0.62 . . . . 63.34 111.166 176.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 61.3 mt -58.57 -40.15 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 122.988 0.515 . . . . 73.31 110.433 178.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 94.0 mt -83.8 -12.62 55.39 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 112.606 0.595 . . . . 75.53 112.606 177.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.36 22.67 78.8 Favored Glycine 0 CA--C 1.535 1.33 0 N-CA-C 114.196 0.438 . . . . 74.43 114.196 -178.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 14.1 m -104.47 152.76 39.39 Favored Pre-proline 0 N--CA 1.482 1.136 0 C-N-CA 123.916 0.886 . . . . 71.34 110.337 177.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -64.0 157.95 50.24 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.542 2.162 . . . . 74.43 112.436 173.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 71.0 mtt180 -77.47 22.3 0.24 Allowed 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 123.508 0.723 . . . . 74.35 112.262 -179.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -120.9 8.79 10.53 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.965 1.306 . . . . 71.24 108.333 173.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.41 133.92 50.47 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 123.671 0.788 . . . . 75.2 111.328 -178.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 53.0 p -104.24 -176.11 2.99 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.564 1.146 . . . . 74.41 109.993 -178.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -48.41 -52.3 22.64 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 124.623 1.169 . . . . 74.45 112.184 -171.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.79 -48.4 63.73 Favored 'General case' 0 C--O 1.212 -0.912 0 O-C-N 123.746 0.654 . . . . 74.53 109.943 -172.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -63.93 -38.98 93.07 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.003 0.921 . . . . 73.42 111.562 -174.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 22' ' ' ILE . . . . . 0.778 HD13 ' HB3' ' C' ' 57' ' ' LEU . 78.3 mt -67.9 -50.3 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 123.977 0.911 . . . . 75.54 110.325 175.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -66.3 -22.31 66.29 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.195 -0.912 . . . . 74.13 110.017 -178.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 -74.05 -48.4 30.19 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.088 1.355 . . . . 73.52 110.035 176.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.39 -38.35 80.28 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 123.925 0.765 . . . . 75.32 110.678 175.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 26' ' ' TYR . . . . . 0.475 ' HE1' ' ND2' ' C' ' 51' ' ' ASN . 54.4 t80 -58.96 -62.52 1.82 Allowed 'General case' 0 C--O 1.208 -1.098 0 CA-C-N 115.097 -0.956 . . . . 72.31 109.857 173.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -50.33 -38.59 42.74 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 124.089 0.868 . . . . 75.33 111.582 -177.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 28' ' ' ARG . . . . . 0.411 ' HA ' ' NH2' ' C' ' 31' ' ' ARG . 59.5 ttt180 -57.95 -59.84 4.64 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.138 0.975 . . . . 75.55 110.957 176.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . 0.556 HD21 ' HE2' ' C' ' 33' ' ' TYR . 75.9 mt -76.98 -11.9 59.87 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 114.982 -1.008 . . . . 71.43 110.933 -176.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -88.83 -24.56 22.55 Favored 'General case' 0 C--O 1.213 -0.858 0 C-N-CA 124.131 0.973 . . . . 75.32 110.219 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . 0.411 ' NH2' ' HA ' ' C' ' 28' ' ' ARG . 45.3 mtm105 -85.12 -39.07 18.34 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.208 0.603 . . . . 73.5 110.204 171.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.72 -56.62 5.45 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 122.871 0.468 . . . . 71.12 110.196 -177.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 33' ' ' TYR . . . . . 0.556 ' HE2' HD21 ' C' ' 29' ' ' LEU . 50.1 m-85 -90.48 23.22 3.07 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 122.986 0.514 . . . . 72.14 111.438 -176.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 34' ' ' HIS . . . . . 0.404 ' HD2' ' HB3' ' C' ' 36' ' ' ASP . 20.6 t60 -68.99 109.1 3.72 Favored Pre-proline 0 N--CA 1.477 0.915 0 CA-C-O 118.265 -0.874 . . . . 74.34 110.114 -178.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 35' ' ' PRO . . . . . 0.511 ' HG3' ' HG2' ' C' ' 44' ' ' GLU . 76.9 Cg_exo -53.12 -25.38 29.04 Favored 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 123.663 2.909 . . . . 72.22 114.932 -173.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 36' ' ' ASP . . . . . 0.404 ' HB3' ' HD2' ' C' ' 34' ' ' HIS . 30.4 t70 -74.49 -35.74 63.25 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.508 0.723 . . . . 60.34 111.687 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 58.0 t -92.29 -56.01 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 109.336 -0.616 . . . . 75.33 109.336 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -100.62 92.17 4.99 Favored 'General case' 0 C--O 1.244 0.795 0 C-N-CA 125.098 1.359 . . . . 65.41 109.616 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.84 76.13 6.53 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.109 0.564 . . . . 71.22 109.722 -178.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 40' ' ' SER . . . . . 0.459 ' O ' ' HG3' ' C' ' 44' ' ' GLU . 69.8 m -131.23 111.42 15.45 Favored Pre-proline 0 N--CA 1.475 0.777 0 CA-C-O 118.256 -0.878 . . . . 74.14 110.221 179.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -45.1 -40.88 16.1 Favored 'Trans proline' 0 C--N 1.383 2.388 0 C-N-CA 123.718 2.946 . . . . 75.0 113.397 174.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -53.41 -48.83 68.37 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.996 0.919 . . . . 71.01 110.229 175.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 43' ' ' ALA . . . . . 0.444 ' O ' ' HB2' ' C' ' 47' ' ' PHE . . . -72.01 -18.72 61.95 Favored 'General case' 0 C--O 1.212 -0.913 0 CA-C-N 113.655 -1.611 . . . . 71.45 111.393 -177.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 44' ' ' GLU . . . . . 0.511 ' HG2' ' HG3' ' C' ' 35' ' ' PRO . 44.1 mt-10 -88.43 -40.61 13.36 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.805 0.842 . . . . 74.04 111.139 -174.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -69.93 -40.85 75.27 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 109.974 -0.38 . . . . 75.44 109.974 173.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 46' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -66.43 -35.12 79.51 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.916 -0.584 . . . . 72.32 110.774 173.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 47' ' ' PHE . . . . . 0.444 ' HB2' ' O ' ' C' ' 43' ' ' ALA . 77.3 t80 -57.73 -44.63 86.13 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.364 0.666 . . . . 71.12 109.271 173.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -58.87 -46.46 87.76 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 122.878 0.471 . . . . 72.04 111.311 176.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -64.37 -32.27 73.81 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 120.719 0.295 . . . . 72.33 111.756 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 50' ' ' ILE . . . . . 0.524 HD13 ' HB3' ' C' ' 29' ' ' LEU . 80.5 mt -74.03 -31.81 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 124.148 0.979 . . . . 75.43 110.136 175.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 51' ' ' ASN . . . . . 0.475 ' ND2' ' HE1' ' C' ' 26' ' ' TYR . 0.9 OUTLIER -82.81 -14.65 54.0 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.04 0.936 . . . . 74.04 110.811 176.805 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -81.48 -50.32 9.55 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.288 1.435 . . . . 75.54 108.429 173.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.95 -40.35 76.26 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 113.276 -1.783 . . . . 63.1 110.567 174.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -77.61 -33.97 53.57 Favored 'General case' 0 C--O 1.215 -0.72 0 CA-C-N 115.544 -0.753 . . . . 75.01 111.356 174.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 55' ' ' ALA . . . . . 0.688 ' HB1' ' HB3' ' C' ' 85' ' ' PHE . . . -51.01 -46.49 61.54 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.916 0.865 . . . . 60.54 110.266 178.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 47.2 t -76.71 -58.6 4.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-N 113.453 -1.703 . . . . 72.43 110.605 177.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 57' ' ' LEU . . . . . 0.778 ' HB3' HD13 ' C' ' 22' ' ' ILE . 69.6 mt -82.03 1.95 33.28 Favored 'General case' 0 CA--C 1.563 1.45 0 N-CA-C 114.465 1.283 . . . . 75.02 114.465 -166.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 48.4 t -50.79 -56.45 12.05 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 124.262 1.025 . . . . 75.33 113.393 -173.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -123.79 150.42 62.05 Favored Pre-proline 0 C--O 1.252 1.207 0 CA-C-N 114.359 -1.291 . . . . 72.03 108.387 -171.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 60' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -47.19 -45.7 21.22 Favored 'Trans proline' 0 C--N 1.384 2.41 0 C-N-CA 123.761 2.974 . . . . 73.21 114.389 -169.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -58.15 -53.38 58.87 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.154 0.582 . . . . 62.13 112.365 -174.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -69.96 -37.24 75.76 Favored 'General case' 0 C--O 1.247 0.948 0 CA-C-N 115.602 -0.726 . . . . 75.43 110.821 -176.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 1.1 ppt_? -64.76 -35.85 82.4 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 115.847 -0.615 . . . . 74.14 109.601 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -73.82 -29.71 62.3 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.107 0.963 . . . . 74.15 111.198 177.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 82.6 mt -62.11 -43.68 98.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 109.57 -0.53 . . . . 71.5 109.57 172.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 66' ' ' TYR . . . . . 0.485 ' OH ' ' HA ' ' C' ' 6' ' ' ASP . 22.2 t80 -57.71 -50.82 71.93 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 116.145 -0.479 . . . . 74.31 110.094 173.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -58.45 -40.89 83.86 Favored 'General case' 0 N--CA 1.48 1.074 0 O-C-N 123.813 0.696 . . . . 73.14 112.182 -178.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 40.3 p -69.13 -22.27 63.96 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 119.604 -0.236 . . . . 74.43 110.722 178.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -81.69 142.17 32.94 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 108.678 -0.86 . . . . 75.22 108.678 166.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.72 22.05 62.62 Favored Glycine 0 C--N 1.345 1.071 0 N-CA-C 110.817 -0.913 . . . . 62.51 110.817 -174.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 61.5 m -145.54 -54.72 0.29 Allowed 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 103.045 -2.946 . . . . 72.34 103.045 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 47.3 m -83.41 142.26 31.12 Favored 'General case' 0 C--O 1.26 1.646 0 N-CA-C 105.214 -2.143 . . . . 73.35 105.214 157.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.32 -33.59 28.9 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.72 0.808 . . . . 73.23 111.022 177.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.16 152.89 71.63 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 123.741 0.817 . . . . 53.23 110.521 177.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -58.95 125.77 19.17 Favored 'Trans proline' 0 C--N 1.38 2.211 0 C-N-CA 122.638 2.226 . . . . 75.14 111.162 171.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -58.03 151.02 60.91 Favored 'Trans proline' 0 C--N 1.384 2.429 0 C-N-CA 123.323 2.682 . . . . 71.22 112.215 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -49.28 111.35 0.47 Allowed 'Trans proline' 0 C--N 1.387 2.556 0 C-N-CA 123.492 2.795 . . . . 74.4 113.347 -177.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 78' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.0 133.1 45.37 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.769 2.312 . . . . 74.44 112.493 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -50.16 124.45 12.88 Favored 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 122.399 2.066 . . . . 70.12 110.244 167.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -65.68 37.81 0.13 Allowed 'Trans proline' 0 C--N 1.383 2.385 0 C-N-CA 124.741 3.627 . . . . 74.31 116.746 -172.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -163.24 -10.46 0.03 OUTLIER Glycine 0 CA--C 1.524 0.619 0 C-N-CA 123.51 0.576 . . . . 75.2 112.265 168.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 144.99 168.93 13.11 Favored Glycine 0 C--N 1.35 1.345 0 N-CA-C 114.384 0.513 . . . . 75.13 114.384 173.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -98.5 135.03 40.64 Favored 'General case' 0 C--O 1.219 -0.545 0 N-CA-C 106.744 -1.576 . . . . 73.4 106.744 171.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 84' ' ' ASP . . . . . 0.431 ' HB2' ' NE ' ' C' ' 143' ' ' ARG . 14.2 t70 -72.49 137.18 46.19 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 118.8 0.727 . . . . 75.11 112.333 -178.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 85' ' ' PHE . . . . . 0.688 ' HB3' ' HB1' ' C' ' 55' ' ' ALA . 6.8 p90 -164.49 48.46 0.11 Allowed 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.413 1.485 . . . . 74.41 109.09 170.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 86' ' ' SER . . . . . 0.66 ' HA ' ' HG2' ' C' ' 171' ' ' PRO . 68.2 m -63.38 122.89 17.32 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 115.223 -0.898 . . . . 52.42 112.056 -176.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.01 4.52 88.42 Favored Glycine 0 C--N 1.351 1.385 0 CA-C-N 115.29 -0.868 . . . . 74.34 113.401 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 88' ' ' PHE . . . . . 0.485 ' HB3' ' HZ ' ' C' ' 93' ' ' PHE . 11.7 m-85 -108.17 137.67 45.75 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 117.481 0.641 . . . . 74.44 109.579 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -79.92 78.75 6.52 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.52 0.676 . . . . 72.23 111.376 -173.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 90' ' ' VAL . . . . . . . . . . . . . 3.4 p -49.21 -34.83 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 125.478 1.511 . . . . 54.42 113.952 176.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.21 -19.99 64.8 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 123.152 0.581 . . . . 75.25 110.529 -174.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -110.91 16.05 21.46 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-O 121.01 0.433 . . . . 75.53 111.469 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 93' ' ' PHE . . . . . 0.485 ' HZ ' ' HB3' ' C' ' 88' ' ' PHE . 16.7 m-30 -89.13 166.29 13.94 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 109.797 -0.445 . . . . 72.45 109.797 172.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 80.6 p -65.53 164.62 13.71 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.683 0.793 . . . . 52.11 112.91 -170.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.14 -36.81 78.34 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 114.951 -1.022 . . . . 72.35 110.831 170.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -58.71 -45.67 89.01 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.189 0.996 . . . . 74.24 110.466 177.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 97' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -62.2 -45.63 92.5 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.936 -0.575 . . . . 64.25 109.661 176.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -81.05 -0.3 39.19 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 115.747 -0.66 . . . . 71.33 112.716 -175.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -101.55 -63.85 1.11 Allowed 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.357 0.663 . . . . 74.43 110.786 168.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 51.3 tp -55.1 -45.08 75.43 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.551 0.74 . . . . 73.23 111.265 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -98.5 -6.1 30.95 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.572 -0.74 . . . . 75.04 111.271 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -45.28 -61.42 3.6 Favored Glycine 0 C--N 1.356 1.647 0 N-CA-C 115.793 1.077 . . . . 74.41 115.793 -176.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -55.37 -27.68 59.37 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 123.097 2.531 . . . . 64.35 112.826 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -115.45 28.2 8.0 Favored Glycine 0 C--N 1.359 1.843 0 CA-C-O 118.937 -0.924 . . . . 73.42 112.815 -177.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 105' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' C' ' 169' ' ' ASN . 72.2 mt -75.14 47.84 0.38 Allowed 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 119.594 1.697 . . . . 75.43 110.528 170.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 106' ' ' PHE . . . . . 0.577 ' HB3' ' H ' ' C' ' 168' ' ' GLY . 52.6 m-85 52.03 -174.0 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 124.662 1.185 . . . . 64.24 110.396 -169.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . 3.29 -44.63 0.0 OUTLIER Glycine 0 N--CA 1.5 2.951 0 N-CA-C 118.469 2.148 . . . . 51.05 118.469 155.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 108' ' ' GLY . . . . . 0.46 ' O ' ' HG3' ' C' ' 114' ' ' ARG . . . 64.1 -145.63 49.81 Favored Glycine 0 C--N 1.356 1.673 0 CA-C-N 114.186 -1.007 . . . . 74.41 110.893 -179.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 109' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -108.34 27.31 9.47 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 107.256 -1.387 . . . . 74.45 107.256 164.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 110' ' ' GLY . . . . . . . . . . . . . . . -92.49 11.72 71.44 Favored Glycine 0 C--N 1.361 1.946 0 CA-C-N 115.246 -0.888 . . . . 73.14 114.608 -169.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? 66.11 0.56 1.67 Allowed 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 124.148 0.979 . . . . 75.25 112.357 -176.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 112' ' ' ARG . . . . . . . . . . . . . 54.4 ttp180 -80.17 45.25 0.73 Allowed 'General case' 0 CA--C 1.563 1.47 0 C-N-CA 126.608 1.963 . . . . 75.43 110.449 173.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 113' ' ' SER . . . . . . . . . . . . . 19.0 m 70.27 78.59 0.19 Allowed 'General case' 0 C--N 1.36 1.059 0 C-N-CA 123.682 0.793 . . . . 72.53 111.35 -177.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 114' ' ' ARG . . . . . 0.585 ' HG2' ' H ' ' C' ' 115' ' ' LYS . 49.4 ttp180 -66.58 -171.65 0.14 Allowed 'General case' 0 CA--C 1.579 2.076 0 C-N-CA 124.059 0.944 . . . . 74.05 109.768 176.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 115' ' ' LYS . . . . . 0.734 ' HA ' ' HD2' ' C' ' 170' ' ' PRO . 60.8 tttm -5.73 112.78 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.653 0 C-N-CA 127.563 2.345 . . . . 74.15 116.771 -159.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -67.18 140.91 38.44 Favored Glycine 0 C--N 1.355 1.585 0 CA-C-N 114.403 -1.271 . . . . 54.4 115.233 -171.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.04 -175.38 2.78 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.147 1.379 . . . . 74.32 110.18 -177.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -72.44 131.84 43.11 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 109.281 -0.637 . . . . 75.42 109.281 167.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 119' ' ' LEU . . . . . 0.468 HD13 HG21 ' B' ' 185' ' ' VAL . 36.1 tp -110.73 142.21 42.99 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.246 1.018 . . . . 75.21 108.617 -175.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -117.73 104.45 11.0 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 108.719 -0.845 . . . . 72.31 108.719 -169.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 121' ' ' ALA . . . . . 0.435 ' HB1' HD21 ' C' ' 176' ' ' LEU . . . -113.41 116.2 29.26 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.077 -0.712 . . . . 75.44 109.077 176.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 122' ' ' GLU . . . . . 0.503 ' HA ' ' O ' ' C' ' 177' ' ' VAL . 44.5 mt-10 -89.03 110.95 21.58 Favored 'General case' 0 C--N 1.347 0.462 0 N-CA-C 108.26 -1.015 . . . . 74.12 108.26 172.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 123' ' ' LEU . . . . . 0.513 HD23 ' H ' ' C' ' 123' ' ' LEU . 1.1 pt? -106.31 113.71 63.03 Favored Pre-proline 0 C--O 1.248 0.976 0 O-C-N 123.781 0.676 . . . . 73.3 109.39 -177.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -58.33 114.45 1.98 Allowed 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 122.205 1.937 . . . . 72.51 110.2 162.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 125' ' ' LEU . . . . . 0.532 ' O ' ' HA ' ' C' ' 180' ' ' LEU . 53.7 tp -142.94 154.94 44.57 Favored 'General case' 0 C--O 1.219 -0.547 0 N-CA-C 106.967 -1.494 . . . . 75.32 106.967 -171.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 126' ' ' THR . . . . . 0.438 ' HB ' HD12 ' C' ' 181' ' ' LEU . 11.1 t -119.3 171.62 8.18 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 119.735 1.152 . . . . 61.53 110.795 177.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 127' ' ' LEU . . . . . 0.441 HD22 HD12 ' C' ' 180' ' ' LEU . 10.0 mt -62.86 -47.48 83.19 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 113.724 -1.58 . . . . 62.25 110.72 -171.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -58.32 -44.58 88.69 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 114.219 -1.355 . . . . 75.24 109.896 -177.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -75.25 -24.37 57.64 Favored 'General case' 0 C--O 1.216 -0.703 0 CA-C-N 114.975 -1.011 . . . . 75.51 111.445 178.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -71.76 -31.58 66.79 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 109.611 -0.514 . . . . 73.14 109.611 175.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 131' ' ' PHE . . . . . 0.536 ' HB2' HD11 ' C' ' 215' ' ' LEU . 75.5 t80 -70.35 -41.88 72.59 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.207 1.003 . . . . 75.55 109.855 172.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 132' ' ' HIS . . . . . . . . . . . . . 24.9 m170 -76.62 -8.23 56.83 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 115.19 -0.914 . . . . 70.15 110.99 176.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -54.02 134.1 44.52 Favored Glycine 0 C--N 1.356 1.661 0 O-C-N 123.973 0.796 . . . . 65.31 113.233 176.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . 173.17 -128.37 1.51 Allowed Glycine 0 C--O 1.24 0.526 0 N-CA-C 108.969 -1.652 . . . . 73.12 108.969 -177.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -72.0 95.54 1.61 Allowed 'General case' 0 C--N 1.35 0.587 0 N-CA-C 108.357 -0.979 . . . . 73.03 108.357 175.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 136' ' ' ARG . . . . . . . . . . . . . 19.5 mmt180 -126.1 162.48 25.24 Favored 'General case' 0 C--O 1.243 0.724 0 C-N-CA 123.522 0.729 . . . . 72.12 109.837 -178.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 137' ' ' VAL . . . . . . . . . . . . . 8.6 p -78.85 123.81 36.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 CA-C-N 115.374 -0.83 . . . . 73.11 110.119 177.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 138' ' ' VAL . . . . . 0.435 ' HB ' ' HG ' ' B' ' 181' ' ' LEU . 8.8 p -115.87 131.28 68.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 108.247 -1.02 . . . . 72.14 108.247 169.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 139' ' ' GLU . . . . . 0.605 ' HB3' HG23 ' B' ' 182' ' ' VAL . 9.9 tp10 -124.32 83.31 2.13 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 107.075 -1.454 . . . . 74.31 107.075 174.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 140' ' ' VAL . . . . . . . . . . . . . 54.6 t -140.9 148.67 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 107.214 -1.402 . . . . 73.25 107.214 178.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 68.67 23.39 7.13 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 124.14 0.976 . . . . 65.0 111.524 -177.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 67.14 40.62 92.74 Favored Glycine 0 C--N 1.347 1.167 0 O-C-N 123.931 0.769 . . . . 52.4 112.94 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 143' ' ' ARG . . . . . 0.605 ' NH2' ' HA ' ' C' ' 164' ' ' MET . 25.3 ttp-105 -153.07 124.18 7.49 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-O 120.82 0.343 . . . . 75.05 110.883 179.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 62.9 ttt-85 -88.34 124.0 33.48 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.239 -0.891 . . . . 71.51 109.269 167.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 145' ' ' VAL . . . . . . . . . . . . . 8.0 p -151.52 142.38 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.083 0.553 . . . . 75.03 109.587 173.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 52.9 p -84.33 105.36 15.1 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 109.196 -0.668 . . . . 73.22 109.196 174.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 14.5 p -123.2 146.73 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 N-CA-C 109.663 -0.495 . . . . 72.53 109.663 -178.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -91.16 114.93 27.59 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 122.933 0.493 . . . . 74.22 110.465 174.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 149' ' ' ILE . . . . . . . . . . . . . 31.5 pt -93.24 153.63 41.57 Favored Pre-proline 0 CA--C 1.55 0.953 0 N-CA-C 107.955 -1.128 . . . . 74.42 107.955 164.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -47.52 122.02 6.25 Favored 'Trans proline' 0 C--N 1.384 2.404 0 C-N-CA 123.029 2.486 . . . . 61.44 112.018 177.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -61.25 109.35 0.71 Allowed 'Trans proline' 0 C--N 1.385 2.498 0 C-N-CA 123.043 2.495 . . . . 73.2 111.536 -178.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 152' ' ' GLY . . . . . . . . . . . . . . . 110.58 109.78 3.19 Favored Glycine 0 C--N 1.338 0.673 0 CA-C-N 115.456 -0.793 . . . . 63.11 111.973 -170.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 153' ' ' VAL . . . . . 0.493 ' HB ' HG21 ' C' ' 178' ' ' VAL . 2.1 m -105.27 168.75 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 123.063 0.545 . . . . 74.01 109.647 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 154' ' ' ARG . . . . . 0.423 ' O ' HG22 ' C' ' 178' ' ' VAL . 18.2 mtp180 -115.78 116.26 27.73 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 122.905 0.482 . . . . 75.32 111.258 -174.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 155' ' ' GLU . . . . . 0.518 ' HG2' ' HE ' ' C' ' 187' ' ' ARG . 2.9 tp10 -22.7 115.95 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 126.733 2.013 . . . . 74.51 114.234 168.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 57.76 10.29 6.23 Favored Glycine 0 C--N 1.351 1.406 0 O-C-N 123.827 0.704 . . . . 75.21 114.752 171.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 157' ' ' SER . . . . . 0.402 ' HB2' ' HB2' ' C' ' 154' ' ' ARG . 49.5 m -106.74 167.28 9.98 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 121.572 0.701 . . . . 75.43 110.466 -173.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 18.4 t -103.31 104.75 17.13 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 CA-C-N 114.774 -1.103 . . . . 72.31 110.439 -169.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 159' ' ' ILE . . . . . 0.436 HD13 ' HB ' ' C' ' 153' ' ' VAL . 19.1 mt -72.23 145.87 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 109.287 -0.634 . . . . 72.31 109.287 167.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -109.82 108.4 18.71 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 109.148 -0.686 . . . . 75.13 109.148 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 161' ' ' VAL . . . . . 0.511 HG22 HD12 ' C' ' 176' ' ' LEU . 49.4 t -125.87 95.23 40.27 Favored Pre-proline 0 N--CA 1.485 1.283 0 C-N-CA 123.734 0.814 . . . . 75.24 110.967 -171.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -64.53 146.57 89.48 Favored 'Trans proline' 0 C--N 1.363 1.327 0 C-N-CA 121.805 1.67 . . . . 75.23 109.736 165.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 129.78 -16.87 5.54 Favored Glycine 0 N--CA 1.475 1.296 0 C-N-CA 121.715 -0.279 . . . . 53.54 113.569 -176.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 164' ' ' MET . . . . . 0.605 ' HA ' ' NH2' ' C' ' 143' ' ' ARG . 2.9 mpp? -121.58 -79.5 0.61 Allowed 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 109.434 -0.58 . . . . 73.35 109.434 170.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 165' ' ' GLY . . . . . 0.425 ' HA2' ' O ' ' C' ' 173' ' ' ASP . . . 68.9 174.18 9.37 Favored Glycine 0 C--N 1.349 1.28 0 N-CA-C 114.436 0.535 . . . . 73.32 114.436 -178.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . -71.11 165.14 53.43 Favored Glycine 0 C--N 1.343 0.934 0 N-CA-C 111.988 -0.445 . . . . 75.44 111.988 172.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 167' ' ' GLN . . . . . 0.407 HE21 ' HA ' ' C' ' 167' ' ' GLN . 0.0 OUTLIER -67.27 144.28 56.01 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 109.828 -0.434 . . . . 74.2 109.828 -179.655 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 168' ' ' GLY . . . . . 0.577 ' H ' ' HB3' ' C' ' 106' ' ' PHE . . . 144.68 130.85 2.33 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-O 119.084 -0.842 . . . . 13.44 111.37 -174.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 169' ' ' ASN . . . . . 0.557 ' HB3' ' HD3' ' C' ' 170' ' ' PRO . 8.5 t30 -49.88 -49.82 71.74 Favored Pre-proline 0 CA--C 1.557 1.224 0 C-N-CA 124.468 1.107 . . . . 62.44 112.46 -172.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 170' ' ' PRO . . . . . 0.734 ' HD2' ' HA ' ' C' ' 115' ' ' LYS . 1.5 Cg_endo -86.87 104.71 0.64 Allowed 'Trans proline' 0 C--N 1.383 2.345 0 CA-C-N 121.522 1.579 . . . . 73.55 110.061 162.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 171' ' ' PRO . . . . . 0.66 ' HG2' ' HA ' ' C' ' 86' ' ' SER . 72.4 Cg_endo -72.83 173.09 14.05 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.906 2.404 . . . . 74.02 112.648 -175.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -117.21 -94.76 1.79 Allowed Glycine 0 C--N 1.346 1.09 0 CA-C-N 115.772 -0.649 . . . . 74.42 112.895 -177.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 173' ' ' ASP . . . . . 0.425 ' O ' ' HA2' ' C' ' 165' ' ' GLY . 6.8 t70 -166.26 151.32 8.21 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.906 0.882 . . . . 74.51 109.626 -164.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 174' ' ' LEU . . . . . 0.407 HD21 HD23 ' C' ' 176' ' ' LEU . 30.1 tp -117.84 105.15 11.64 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.554 0.741 . . . . 75.22 109.207 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 77.2 mt -74.81 96.18 3.04 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-N 114.523 -1.217 . . . . 72.15 109.744 172.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 176' ' ' LEU . . . . . 0.511 HD12 HG22 ' C' ' 161' ' ' VAL . 41.7 mt -85.77 96.87 9.88 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-N 115.313 -0.858 . . . . 74.33 109.945 178.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 177' ' ' VAL . . . . . 0.515 HG21 ' HB2' ' B' ' 190' ' ' CYS . 22.0 t -84.57 101.24 8.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 107.906 -1.146 . . . . 75.23 107.906 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 178' ' ' VAL . . . . . 0.493 HG21 ' HB ' ' C' ' 153' ' ' VAL . 0.8 OUTLIER -84.74 102.66 11.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.059 -0.973 . . . . 74.01 110.632 -171.995 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 179' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -87.95 104.08 16.28 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.291 -1.374 . . . . 74.42 107.291 175.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 180' ' ' LEU . . . . . 0.532 ' HA ' ' O ' ' C' ' 125' ' ' LEU . 96.5 mt -68.83 138.29 54.63 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 109.99 -0.374 . . . . 73.43 109.99 177.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 181' ' ' LEU . . . . . 0.438 HD12 ' HB ' ' C' ' 126' ' ' THR . 51.8 mt -56.87 167.6 1.02 Allowed Pre-proline 0 N--CA 1.493 1.679 0 C-N-CA 125.539 1.536 . . . . 74.24 112.045 -173.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 182' ' ' PRO . . . . . 0.44 ' HB3' HD22 ' B' ' 218' ' ' LEU . 87.1 Cg_exo -54.62 68.38 0.03 OUTLIER 'Trans proline' 0 C--N 1.388 2.654 0 C-N-CA 123.842 3.028 . . . . 73.32 112.58 164.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 183' ' ' HIS . . . . . 0.519 ' N ' ' HD3' ' C' ' 184' ' ' PRO . 84.3 t60 177.39 48.16 0.03 OUTLIER Pre-proline 0 CA--C 1.567 1.615 0 C-N-CA 128.466 2.707 . . . . 72.0 106.444 -169.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 184' ' ' PRO . . . . . 0.582 ' HD2' HG23 ' B' ' 225' ' ' THR . 4.3 Cg_endo -87.95 65.66 3.57 Favored 'Trans proline' 0 C--N 1.398 3.141 0 C-N-CA 123.318 2.679 . . . . 74.25 110.236 -175.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 185' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 11.1 t -94.63 -24.77 4.79 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.076 0 CA-C-N 115.0 -1.0 . . . . 72.23 109.938 -170.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 186' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -124.58 105.51 9.42 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.398 0.618 . . . . 61.44 110.759 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 187' ' ' ARG . . . . . 0.518 ' HE ' ' HG2' ' C' ' 155' ' ' GLU . 35.4 ttm105 -108.3 104.41 13.79 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.708 1.203 . . . . 75.14 108.9 -174.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 188' ' ' LEU . . . . . . . . . . . . . 58.7 tp -77.91 134.89 37.82 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.202 0.815 . . . . 74.14 113.202 -167.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -132.55 119.07 20.03 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 126.008 1.723 . . . . 73.21 107.277 164.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 190' ' ' GLY . . . . . 0.648 ' HA2' ' HA2' ' B' ' 202' ' ' GLY . . . 64.44 -99.21 0.32 Allowed Glycine 0 C--N 1.343 0.954 0 CA-C-N 116.07 -0.514 . . . . 74.2 112.614 -175.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 191' ' ' GLN . . . . . 0.462 ' HB2' ' NH2' ' B' ' 32' ' ' ARG . 50.4 mt-30 -127.3 -12.94 5.63 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.106 0.962 . . . . 75.25 109.336 173.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -86.74 148.49 25.4 Favored 'General case' 0 C--N 1.362 1.111 0 C-N-CA 123.509 0.724 . . . . 65.13 109.516 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 193' ' ' LEU . . . . . 0.448 HD21 ' CD2' ' C' ' 240' ' ' PHE . 90.1 mt -103.48 161.84 13.53 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.325 0.65 . . . . 65.15 110.681 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 194' ' ' TYR . . . . . 0.403 ' HB3' ' HB3' ' C' ' 187' ' ' ARG . 10.5 t80 -125.29 106.73 10.07 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.707 -1.22 . . . . 75.43 107.707 170.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 195' ' ' ALA . . . . . 0.448 ' HB1' HD11 ' C' ' 249' ' ' LEU . . . -105.76 -176.81 3.18 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.211 1.004 . . . . 65.11 110.268 177.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 196' ' ' THR . . . . . 0.708 HG21 ' H ' ' B' ' 264' ' ' SER . 87.0 m -139.07 120.95 15.48 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 114.953 -1.021 . . . . 53.42 108.836 166.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 197' ' ' LEU . . . . . 0.408 HD12 HD21 ' C' ' 251' ' ' LEU . 27.3 tp -90.69 115.48 27.82 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.886 0.874 . . . . 73.5 110.628 -175.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -78.15 104.06 8.49 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.826 0.85 . . . . 64.33 109.76 -178.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 199' ' ' VAL . . . . . 0.443 HG21 HG22 ' C' ' 210' ' ' VAL . 39.4 t -120.35 115.64 32.63 Favored Pre-proline 0 N--CA 1.482 1.145 0 C-N-CA 124.388 1.075 . . . . 73.12 109.481 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 200' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -69.28 149.75 70.33 Favored 'Trans proline' 0 C--N 1.367 1.529 0 C-N-CA 121.71 1.606 . . . . 73.11 111.988 175.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 201' ' ' ALA . . . . . 0.404 ' HB1' ' HH2' ' C' ' 269' ' ' TRP . . . -54.73 -47.6 97.68 Favored Pre-proline 0 CA--C 1.562 1.42 0 N-CA-C 114.263 1.209 . . . . 74.35 114.263 -170.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 202' ' ' PRO . . . . . 0.424 ' O ' HG13 ' C' ' 206' ' ' VAL . 78.2 Cg_exo -53.3 -45.74 38.85 Favored 'Trans proline' 0 C--N 1.388 2.646 0 C-N-CA 121.763 1.642 . . . . 63.15 112.728 175.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 203' ' ' ILE . . . . . . . . . . . . . 38.7 mt -67.88 -33.86 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 124.048 0.939 . . . . 74.02 111.167 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 204' ' ' ALA . . . . . 0.424 ' HA ' HG13 ' C' ' 223' ' ' VAL . . . -68.73 -34.07 74.98 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.485 0.714 . . . . 75.02 111.654 178.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 205' ' ' VAL . . . . . 0.542 HG12 ' HG3' ' C' ' 226' ' ' ARG . 95.1 t -85.26 -40.42 14.82 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 N-CA-C 112.775 0.658 . . . . 74.52 112.775 -175.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 206' ' ' VAL . . . . . 0.424 HG13 ' O ' ' C' ' 202' ' ' PRO . 6.4 p -81.36 -39.35 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-N 118.959 0.799 . . . . 74.12 110.472 176.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 207' ' ' GLY . . . . . 0.423 ' O ' ' HB2' ' B' ' 250' ' ' GLN . . . 97.27 92.49 1.89 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.387 -0.685 . . . . 63.21 111.387 -166.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -113.98 -141.36 7.76 Favored Glycine 0 C--N 1.338 0.694 0 N-CA-C 111.734 -0.546 . . . . 51.32 111.734 176.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 209' ' ' LYS . . . . . 0.649 ' HE3' ' HB3' ' B' ' 253' ' ' ALA . 8.7 mtmp? -140.21 141.28 35.94 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.126 0.571 . . . . 72.44 110.557 171.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 210' ' ' VAL . . . . . 0.443 HG22 HG21 ' C' ' 199' ' ' VAL . 15.1 m -133.59 135.34 55.84 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 C-N-CA 124.912 1.285 . . . . 71.52 107.597 169.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 211' ' ' ARG . . . . . 0.51 ' HA ' ' HA ' ' C' ' 220' ' ' GLU . 0.5 OUTLIER -89.43 122.11 32.32 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 122.279 0.232 . . . . 75.53 110.761 -174.371 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 212' ' ' ALA . . . . . 0.416 ' HB1' HG13 ' C' ' 219' ' ' VAL . . . -81.16 116.35 21.02 Favored 'General case' 0 C--O 1.248 1.023 0 N-CA-C 107.678 -1.23 . . . . 74.43 107.678 173.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 213' ' ' MET . . . . . 0.589 ' SD ' ' HA ' ' B' ' 170' ' ' THR . 4.8 tmm? -70.36 117.25 11.67 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 108.002 -1.11 . . . . 63.12 108.002 174.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 214' ' ' THR . . . . . 0.528 HG22 ' HD2' ' C' ' 238' ' ' LYS . 1.0 OUTLIER -115.57 168.12 10.3 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 122.043 0.925 . . . . 72.34 112.406 -176.954 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 215' ' ' LEU . . . . . 0.536 HD11 ' HB2' ' C' ' 131' ' ' PHE . 81.4 mt -65.98 -37.17 85.29 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 114.438 -1.256 . . . . 75.24 113.003 -169.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 216' ' ' GLU . . . . . 0.448 ' HG2' ' NH1' ' C' ' 246' ' ' ARG . 0.0 OUTLIER -105.23 9.84 33.89 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 114.492 -1.231 . . . . 71.0 110.951 -174.936 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 148.41 -144.81 12.74 Favored Glycine 0 C--N 1.353 1.484 0 CA-C-O 119.925 -0.375 . . . . 74.41 112.4 178.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -105.6 165.14 0.15 Allowed 'Trans proline' 0 CA--C 1.548 1.221 0 C-N-CA 123.61 2.873 . . . . 64.03 113.716 168.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 219' ' ' VAL . . . . . 0.473 ' HB ' ' HE3' ' C' ' 238' ' ' LYS . 4.5 p -145.7 116.54 1.83 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 107.154 -1.424 . . . . 52.53 107.154 163.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 220' ' ' GLU . . . . . 0.51 ' HA ' ' HA ' ' C' ' 211' ' ' ARG . 28.2 tt0 -82.78 110.74 18.07 Favored 'General case' 0 C--O 1.247 0.971 0 N-CA-C 108.893 -0.78 . . . . 72.32 108.893 -179.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 221' ' ' VAL . . . . . . . . . . . . . 62.1 t -88.38 126.12 41.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 CA-C-N 115.16 -0.927 . . . . 74.03 109.515 -176.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 222' ' ' ALA . . . . . 0.587 ' HA ' ' HG2' ' C' ' 209' ' ' LYS . . . -87.24 143.72 27.15 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.666 -0.697 . . . . 73.3 110.378 176.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . 0.424 HG13 ' HA ' ' C' ' 204' ' ' ALA . 56.0 t -112.22 139.41 22.46 Favored Pre-proline 0 CA--C 1.558 1.254 0 C-N-CA 125.155 1.382 . . . . 73.11 108.537 -174.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 224' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -87.76 168.34 6.98 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 123.213 2.609 . . . . 73.11 112.627 175.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 225' ' ' PRO . . . . . 0.487 ' HD3' ' HG3' ' B' ' 250' ' ' GLN . 27.6 Cg_endo -65.77 119.4 6.42 Favored 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 122.197 1.931 . . . . 74.4 112.358 174.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 226' ' ' ARG . . . . . 0.542 ' HG3' HG12 ' C' ' 205' ' ' VAL . 0.0 OUTLIER 66.48 89.81 0.1 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.211 1.804 . . . . 71.5 111.679 179.763 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 227' ' ' THR . . . . . . . . . . . . . 40.6 m -112.95 124.91 53.7 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 113.56 -1.654 . . . . 73.3 110.612 -174.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 228' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -90.52 152.02 21.1 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.946 0.898 . . . . 74.32 111.63 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 229' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' C' ' 253' ' ' VAL . . . -76.16 135.59 39.77 Favored 'General case' 0 C--O 1.243 0.745 0 CA-C-N 115.31 -0.859 . . . . 65.31 109.673 175.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 98.06 -2.38 59.75 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 115.774 -0.648 . . . . 62.04 113.339 -169.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 231' ' ' ARG . . . . . . . . . . . . . 68.8 mtt180 -66.35 172.06 4.31 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 117.75 0.775 . . . . 75.03 110.736 167.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 232' ' ' LYS . . . . . 0.556 ' HA ' ' O ' ' C' ' 251' ' ' LEU . 37.7 ttmt -154.32 143.89 21.53 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.243 0.831 . . . . 74.05 113.243 -173.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 233' ' ' LEU . . . . . 0.556 ' O ' ' HA ' ' C' ' 250' ' ' TYR . 3.4 mp -123.88 144.23 49.88 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 115.03 -0.987 . . . . 74.22 109.936 170.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 234' ' ' ARG . . . . . 0.435 ' HD2' HD12 ' B' ' 331' ' ' LEU . 16.1 ptp180 -101.66 115.85 31.45 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 108.366 -0.976 . . . . 72.34 108.366 162.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 33.7 mt -98.2 119.37 36.74 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 107.913 -1.143 . . . . 74.34 107.913 176.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -67.93 128.78 37.76 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.739 0.815 . . . . 73.41 112.087 -172.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 78.8 3.69 87.63 Favored Glycine 0 C--N 1.352 1.448 0 CA-C-N 115.731 -0.668 . . . . 71.42 113.342 176.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 238' ' ' LYS . . . . . 0.528 ' HD2' HG22 ' C' ' 214' ' ' THR . 67.0 mmtt -96.17 8.34 44.07 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.161 0.584 . . . . 75.11 111.518 -177.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -87.42 -170.09 46.17 Favored Glycine 0 C--N 1.352 1.464 0 O-C-N 123.373 0.421 . . . . 75.2 112.802 174.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 240' ' ' PHE . . . . . 0.448 ' CD2' HD21 ' C' ' 193' ' ' LEU . 2.0 m-85 -81.47 150.47 67.09 Favored Pre-proline 0 N--CA 1.48 1.073 0 N-CA-C 110.001 -0.37 . . . . 75.14 110.001 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 241' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -62.08 139.79 80.54 Favored 'Trans proline' 0 C--N 1.385 2.494 0 C-N-CA 123.26 2.64 . . . . 71.53 113.92 -174.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 242' ' ' GLY . . . . . 0.424 ' HA3' ' NE2' ' C' ' 191' ' ' GLN . . . -132.07 177.28 18.81 Favored Glycine 0 CA--C 1.522 0.485 0 CA-C-N 114.852 -1.067 . . . . 70.14 111.501 177.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.97 -11.25 27.21 Favored 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 122.792 2.328 . . . . 71.42 112.716 -175.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -110.34 -4.83 15.43 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.655 0.782 . . . . 71.42 111.858 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 147.65 -104.86 0.3 Allowed Glycine 0 C--N 1.35 1.342 0 N-CA-C 111.814 -0.514 . . . . 63.24 111.814 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 246' ' ' ARG . . . . . 0.448 ' NH1' ' HG2' ' C' ' 216' ' ' GLU . 85.0 mtm180 -146.05 167.71 22.71 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 124.78 1.232 . . . . 71.32 109.248 176.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -87.67 -156.8 30.64 Favored Glycine 0 C--N 1.346 1.136 0 N-CA-C 112.21 -0.356 . . . . 63.23 112.21 172.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -115.51 170.01 8.74 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.177 0.591 . . . . 73.54 109.585 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 249' ' ' LEU . . . . . 0.448 HD11 ' HB1' ' C' ' 195' ' ' ALA . 28.4 tp -116.02 115.06 25.46 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.406 0.682 . . . . 74.23 110.857 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 250' ' ' TYR . . . . . 0.556 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 2.1 m-30 -100.83 98.15 8.69 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.231 0.612 . . . . 71.43 109.696 -178.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 251' ' ' LEU . . . . . 0.556 ' O ' ' HA ' ' C' ' 232' ' ' LYS . 1.8 mp -94.53 126.29 39.73 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 119.448 -0.31 . . . . 72.0 110.222 -177.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -80.29 113.16 18.26 Favored 'General case' 0 C--O 1.217 -0.619 0 O-C-N 124.887 1.367 . . . . 75.41 108.579 170.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 253' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' C' ' 229' ' ' ALA . 40.5 t -72.36 133.12 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 123.15 0.58 . . . . 73.5 110.335 -174.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 254' ' ' ARG . . . . . 0.436 ' HG2' ' HG ' ' B' ' 265' ' ' LEU . 2.3 tmt_? -122.84 114.82 21.01 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.545 1.138 . . . . 75.13 108.918 -165.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 255' ' ' ILE . . . . . 0.402 HG12 ' HB2' ' C' ' 229' ' ' ALA . 20.8 mm -88.61 115.67 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 109.19 -0.67 . . . . 75.24 109.19 -179.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 256' ' ' THR . . . . . . . . . . . . . 1.4 t -124.09 151.43 43.88 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.973 0.909 . . . . 70.25 111.394 -174.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 2.4 pp -121.55 120.49 28.78 Favored Pre-proline 0 N--CA 1.482 1.173 0 N-CA-C 107.55 -1.278 . . . . 75.21 107.55 170.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 258' ' ' PRO . . . . . 0.485 ' HG3' ' HE2' ' A' ' 276' ' ' TYR . 26.6 Cg_endo -78.98 11.68 2.5 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 C-N-CA 122.845 2.364 . . . . 74.41 113.946 -161.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 69.21 -62.24 0.41 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.592 1.557 . . . . 72.3 111.025 -173.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.51 130.43 31.75 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.24 1.016 . . . . 73.41 111.098 176.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 261' ' ' LEU . . . . . . . . . . . . . 88.0 mt -156.68 143.78 18.8 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.188 1.395 . . . . 74.53 107.702 177.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 71.8 p -83.41 152.01 63.41 Favored Pre-proline 0 CA--C 1.549 0.936 0 CA-C-O 118.105 -0.95 . . . . 61.23 108.457 172.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_exo -45.6 -33.36 9.66 Favored 'Trans proline' 0 C--N 1.384 2.432 0 C-N-CA 123.486 2.79 . . . . 74.2 114.647 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -63.07 -62.01 2.0 Allowed 'General case' 0 C--O 1.251 1.148 0 C-N-CA 124.258 1.023 . . . . 71.04 110.695 175.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -50.55 -52.0 42.83 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 115.196 -0.911 . . . . 71.03 109.798 178.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 266' ' ' GLU . . . . . 0.462 ' O ' ' HG2' ' C' ' 270' ' ' LYS . 30.6 tt0 -57.75 -38.44 75.37 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.103 1.361 . . . . 73.1 111.249 -178.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -59.65 -42.92 93.89 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.386 0.674 . . . . 71.12 110.958 177.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 268' ' ' LEU . . . . . . . . . . . . . 8.2 mp -65.02 -39.13 92.95 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 115.744 -0.662 . . . . 70.11 110.791 175.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 269' ' ' TRP . . . . . 0.404 ' HH2' ' HB1' ' C' ' 201' ' ' ALA . 98.1 m95 -64.19 -29.81 70.9 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 122.582 0.353 . . . . 63.11 111.822 174.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 270' ' ' LYS . . . . . 0.462 ' HG2' ' O ' ' C' ' 266' ' ' GLU . 33.9 mmtp -68.91 -44.12 73.82 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 122.967 0.507 . . . . 75.43 109.927 176.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 11.0 mmmm -57.27 -45.98 83.52 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 123.92 0.762 . . . . 75.33 111.077 176.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 85.0 mt -62.52 -42.7 99.69 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 114.791 -1.095 . . . . 74.33 110.577 176.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -62.44 -39.16 92.44 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.491 0.716 . . . . 43.22 110.998 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -62.5 -47.82 82.28 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.542 0.737 . . . . 63.21 110.038 176.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -58.91 -30.85 68.13 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 115.319 -0.855 . . . . 70.04 111.368 176.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 276' ' ' TYR . . . . . 0.453 ' HD1' HH11 ' C' ' 279' ' ' ARG . 9.2 m-85 -80.55 -33.32 36.32 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.517 0.727 . . . . 75.52 112.662 178.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -73.36 -23.45 60.21 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 118.392 0.542 . . . . 65.52 109.822 177.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -66.79 -11.97 57.13 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 123.754 0.821 . . . . 72.22 112.289 171.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 279' ' ' ARG . . . . . 0.453 HH11 ' HD1' ' C' ' 276' ' ' TYR . 50.8 mtp180 -79.56 -12.8 59.84 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 122.845 0.458 . . . . 75.11 111.055 174.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.904 -0.57 . . . . 75.14 109.971 178.107 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.478 0.961 0 N-CA-C 109.525 -0.546 . . . . 64.12 109.525 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.61 26.01 10.63 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.224 1.409 . . . . 74.44 112.446 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -87.88 60.64 5.99 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.633 0.773 . . . . 74.04 109.99 -175.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -37.59 103.78 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.316 1.446 . . . . 64.14 113.76 -176.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.413 ' HG2' ' HB3' ' A' ' 96' ' ' PHE . 14.5 mmmm -79.7 94.58 5.75 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 107.544 -1.28 . . . . 74.32 107.544 168.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.427 ' O ' HG13 ' A' ' 10' ' ' ILE . 11.8 t70 -70.55 92.71 0.86 Allowed 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.154 -1.054 . . . . 62.43 108.154 177.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -58.84 -35.35 72.77 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.765 0.826 . . . . 73.34 112.89 -167.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -63.78 -45.22 90.73 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 116.501 -0.318 . . . . 73.33 110.515 176.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.34 -39.42 90.52 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 123.597 0.561 . . . . 70.01 110.964 178.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 6' ' ' ASP . 37.7 mt -65.46 -37.06 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 123.01 0.524 . . . . 74.23 110.55 179.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.488 ' HB2' HG21 ' A' ' 13' ' ' VAL . 81.5 mt -73.25 -16.17 61.4 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.114 0.566 . . . . 73.11 111.737 174.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.71 18.0 79.36 Favored Glycine 0 C--N 1.351 1.365 0 O-C-N 123.412 0.445 . . . . 73.42 112.782 -176.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.488 HG21 ' HB2' ' A' ' 11' ' ' LEU . 27.5 m -107.58 158.18 33.95 Favored Pre-proline 0 N--CA 1.479 0.991 0 C-N-CA 124.399 1.08 . . . . 72.52 109.57 179.001 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -64.09 158.15 49.54 Favored 'Trans proline' 0 C--N 1.378 2.117 0 C-N-CA 122.23 1.954 . . . . 50.12 111.998 178.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -72.61 11.78 0.58 Allowed 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 113.418 0.896 . . . . 75.43 113.418 -176.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -135.75 23.34 3.36 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.768 1.227 . . . . 71.2 108.017 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.55 134.22 49.7 Favored 'General case' 0 C--N 1.348 0.518 0 CA-C-N 115.233 -0.894 . . . . 74.14 110.03 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.6 p -68.84 155.93 39.32 Favored 'General case' 0 C--O 1.241 0.646 0 O-C-N 124.053 0.846 . . . . 75.03 109.362 173.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.432 ' HA ' ' HB ' ' A' ' 22' ' ' ILE . 52.1 tt0 -62.68 -19.34 63.77 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 123.026 0.53 . . . . 71.11 110.769 177.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -62.14 -53.55 53.7 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 125.019 1.328 . . . . 72.43 109.773 171.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -64.65 -32.97 74.88 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.846 0.858 . . . . 71.14 111.58 177.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.432 ' HB ' ' HA ' ' A' ' 19' ' ' GLN . 78.6 mt -69.68 -33.03 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.555 1.142 . . . . 73.31 110.846 177.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -72.99 -35.43 66.85 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.494 0.718 . . . . 75.22 110.263 175.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 52.8 mtp180 -66.55 -40.78 89.21 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.383 0.673 . . . . 73.12 110.649 173.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.81 -36.33 82.12 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.508 0.723 . . . . 72.43 110.47 178.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -59.98 -63.18 1.39 Allowed 'General case' 0 C--O 1.21 -0.985 0 CA-C-N 114.847 -1.07 . . . . 73.1 109.918 173.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -52.03 -48.37 64.56 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.066 0.547 . . . . 74.22 111.404 -177.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 50.5 ttt180 -56.38 -68.05 0.25 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.083 0.553 . . . . 75.52 111.784 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.417 ' HB3' HD13 ' A' ' 50' ' ' ILE . 93.8 mt -78.73 -43.38 25.89 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-N 115.74 -0.664 . . . . 75.12 111.753 -168.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.73 -25.35 63.8 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 118.015 -0.993 . . . . 71.54 112.814 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.582 ' HA ' ' HB2' ' A' ' 34' ' ' HIS . 81.7 mtp180 -85.02 -31.57 23.39 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 120.3 1.409 . . . . 72.33 110.969 171.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 48.0 tp60 -66.84 -32.57 73.93 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.607 0.363 . . . . 73.31 111.282 174.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -111.24 16.53 20.92 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.553 0.741 . . . . 72.41 110.493 -178.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.582 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 2.7 t-80 -67.86 116.65 40.49 Favored Pre-proline 0 C--N 1.354 0.781 0 CA-C-O 118.181 -0.914 . . . . 73.54 109.743 -175.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_exo -47.57 -31.94 14.94 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 123.317 2.678 . . . . 75.51 113.534 -178.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.408 ' HB3' ' HD1' ' A' ' 34' ' ' HIS . 18.7 t70 -59.91 -53.05 62.41 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.885 0.874 . . . . 73.23 111.493 176.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.6 t -90.44 -56.87 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 122.969 0.508 . . . . 73.25 109.737 -173.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -97.7 84.81 3.44 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 121.808 0.813 . . . . 64.12 108.816 -178.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -79.54 69.23 5.78 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 114.45 -1.25 . . . . 73.11 109.475 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.9 m -134.53 107.68 10.99 Favored Pre-proline 0 N--CA 1.473 0.703 0 CA-C-O 118.386 -0.816 . . . . 71.24 109.475 -177.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.441 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 24.5 Cg_exo -36.81 -56.11 0.78 Allowed 'Trans proline' 0 C--N 1.388 2.62 0 C-N-CA 124.713 3.609 . . . . 73.53 114.597 -177.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.475 ' HG2' ' HE3' ' A' ' 46' ' ' LYS . 28.3 tt0 -54.39 -43.48 71.47 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.088 0.955 . . . . 64.43 111.348 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.99 -31.48 69.19 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.023 -0.99 . . . . 73.42 110.375 -178.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.456 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 51.5 mt-10 -78.9 -23.13 44.98 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.224 0.61 . . . . 63.35 109.674 -178.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 41' ' ' PRO . 23.6 mm-40 -71.5 -47.9 52.43 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.366 0.666 . . . . 62.44 109.527 172.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.475 ' HE3' ' HG2' ' A' ' 42' ' ' GLU . 97.0 mttt -60.32 -37.02 79.3 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 115.0 -1.0 . . . . 74.03 110.251 175.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -57.72 -53.88 53.21 Favored 'General case' 0 C--O 1.215 -0.713 0 C-N-CA 124.115 0.966 . . . . 73.32 109.307 173.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 44' ' ' GLU . 91.2 mttt -52.41 -45.86 66.09 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.468 0.707 . . . . 75.14 111.582 -179.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -62.47 -51.76 66.17 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 123.575 0.547 . . . . 71.44 111.885 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.417 HD13 ' HB3' ' A' ' 29' ' ' LEU . 86.5 mt -64.13 -31.4 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 124.216 1.006 . . . . 74.43 110.712 -178.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -95.67 -7.78 36.54 Favored 'General case' 0 C--O 1.215 -0.735 0 C-N-CA 123.679 0.792 . . . . 73.43 111.731 -176.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -72.35 -50.25 28.12 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 106.616 -1.624 . . . . 75.34 106.616 163.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.13 -49.8 68.38 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 112.756 -2.02 . . . . 65.45 111.477 175.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -67.31 -43.93 80.44 Favored 'General case' 0 C--O 1.212 -0.883 0 CA-C-N 115.357 -0.838 . . . . 73.53 110.795 177.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.408 ' HB3' ' CD2' ' A' ' 88' ' ' PHE . . . -56.54 -33.1 65.78 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 112.446 0.536 . . . . 72.52 112.446 -176.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 95.4 t -74.06 -53.92 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 CA-C-N 115.809 -0.632 . . . . 74.52 109.894 171.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.414 ' HB3' HD12 ' A' ' 22' ' ' ILE . 82.4 mt -83.99 7.12 19.46 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 113.912 1.079 . . . . 74.35 113.912 -169.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.0 t -87.83 -41.25 13.38 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.104 0.961 . . . . 74.34 110.517 178.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -104.27 107.57 57.83 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 108.593 -0.892 . . . . 74.34 108.593 -174.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -33.75 -32.86 0.06 OUTLIER 'Trans proline' 0 C--N 1.388 2.655 1 C-N-CA 125.613 4.208 . . . . 72.41 116.953 -179.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.439 ' HB2' ' HB2' ' A' ' 144' ' ' ARG . 16.3 tp10 -63.61 -65.01 0.74 Allowed 'General case' 0 N--CA 1.485 1.316 0 CA-C-O 121.197 0.522 . . . . 72.3 110.596 179.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -65.67 -31.99 73.3 Favored 'General case' 0 C--O 1.247 0.929 0 CA-C-N 114.805 -1.089 . . . . 74.54 110.955 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.456 HH11 ' HG2' ' A' ' 63' ' ' ARG . 26.4 ttt-85 -58.27 -54.59 45.27 Favored 'General case' 0 C--N 1.344 0.345 0 CA-C-N 115.316 -0.856 . . . . 74.11 109.917 176.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -71.07 -21.26 62.26 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.527 -0.76 . . . . 74.25 111.787 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.428 HG23 ' HG2' ' A' ' 76' ' ' PRO . 50.9 mt -58.88 -50.13 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 N-CA-C 109.327 -0.62 . . . . 74.41 109.327 168.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.411 ' OH ' ' HA ' ' A' ' 6' ' ' ASP . 34.1 t80 -59.68 -49.98 75.63 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 123.68 0.613 . . . . 75.4 110.534 175.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -57.72 -34.93 69.99 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.457 0.703 . . . . 64.04 112.062 -178.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 69.7 p -89.81 -16.31 30.44 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 119.203 -0.427 . . . . 75.44 111.457 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -74.4 131.34 41.01 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 109.268 -0.642 . . . . 75.32 109.268 178.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 98.34 14.66 37.78 Favored Glycine 0 CA--C 1.53 0.982 0 N-CA-C 110.884 -0.886 . . . . 64.23 110.884 -164.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 37.6 m -146.97 -53.25 0.22 Allowed 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 103.622 -2.733 . . . . 71.23 103.622 177.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.5 m -75.45 135.58 40.71 Favored 'General case' 0 C--O 1.253 1.258 0 N-CA-C 104.408 -2.442 . . . . 74.23 104.408 155.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.23 -34.19 5.99 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.775 0.83 . . . . 74.04 110.917 -173.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -84.71 150.65 56.77 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 123.662 0.785 . . . . 75.1 109.625 176.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -60.28 133.12 47.62 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 122.393 2.062 . . . . 75.41 111.259 175.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.428 ' HG2' HG23 ' A' ' 65' ' ' ILE . 39.3 Cg_exo -60.43 153.86 57.48 Favored 'Trans proline' 0 C--N 1.375 1.934 0 C-N-CA 123.27 2.646 . . . . 74.25 113.174 -173.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.29 128.16 15.16 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.498 2.132 . . . . 73.45 111.415 175.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -62.92 116.02 3.3 Favored 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 123.043 2.495 . . . . 73.2 112.214 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -65.33 169.33 12.59 Favored 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 123.087 2.524 . . . . 71.05 111.979 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.83 86.23 0.03 OUTLIER 'Trans proline' 0 C--N 1.386 2.543 0 C-N-CA 123.394 2.729 . . . . 74.31 112.905 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.422 ' HA3' ' HA ' ' A' ' 141' ' ' ALA . . . 141.99 -37.44 1.58 Allowed Glycine 0 C--N 1.347 1.184 0 CA-C-N 115.021 -0.99 . . . . 62.41 111.411 178.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 114.14 -149.6 18.71 Favored Glycine 0 C--N 1.352 1.436 0 N-CA-C 112.274 -0.33 . . . . 53.03 112.274 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -110.98 73.62 0.83 Allowed 'General case' 0 C--O 1.242 0.66 0 C-N-CA 124.25 1.02 . . . . 74.41 108.283 175.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -57.38 125.11 21.34 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 115.511 -0.768 . . . . 71.31 110.914 177.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -121.92 24.28 9.67 Favored 'General case' 0 C--O 1.248 0.975 0 C-N-CA 123.737 0.815 . . . . 73.24 110.703 -175.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.411 ' OG ' ' HA2' ' A' ' 166' ' ' GLY . 74.0 m -50.61 124.9 11.75 Favored 'General case' 0 C--N 1.355 0.815 0 O-C-N 124.116 0.885 . . . . 74.44 111.814 176.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 129.0 -40.95 1.62 Allowed Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 109.012 -1.635 . . . . 70.11 109.012 -174.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.408 ' CD2' ' HB3' ' A' ' 55' ' ' ALA . 28.5 m-85 -137.18 143.31 42.32 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.78 0.432 . . . . 72.34 110.041 -170.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -75.37 89.37 2.62 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-O 121.515 0.674 . . . . 71.44 110.445 -177.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.551 HG21 ' ND2' ' A' ' 169' ' ' ASN . 2.8 p -38.01 -44.58 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 126.303 1.841 . . . . 75.21 114.068 172.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -70.28 -19.53 63.1 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.477 0.711 . . . . 75.33 111.789 -168.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -80.27 -24.8 39.83 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.102 0.561 . . . . 61.35 110.709 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -73.79 173.2 10.2 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 113.572 0.953 . . . . 73.34 113.572 -166.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 81.2 p -81.88 178.12 8.48 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 114.564 1.32 . . . . 74.5 114.564 -164.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -62.67 -52.52 62.99 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 113.181 -1.827 . . . . 74.52 112.307 -170.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.413 ' HB3' ' HG2' ' A' ' 5' ' ' LYS . 78.0 t80 -54.28 -41.97 69.47 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 123.501 0.72 . . . . 75.03 111.533 -178.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.475 ' CE2' HG22 ' A' ' 90' ' ' VAL . 36.9 t80 -64.9 -46.2 82.72 Favored 'General case' 0 CA--C 1.555 1.157 0 CA-C-N 114.763 -1.108 . . . . 72.32 110.513 176.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -67.05 -12.89 61.18 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.323 0.649 . . . . 74.14 112.371 178.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -89.82 -53.43 4.5 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.289 0.636 . . . . 70.02 111.36 173.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.2 tp -66.66 -52.78 41.02 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.059 0.944 . . . . 74.33 111.269 -171.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -96.21 -3.04 44.99 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.161 0.584 . . . . 72.11 111.174 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.417 ' N ' ' HD2' ' A' ' 103' ' ' PRO . . . -44.34 -55.83 5.72 Favored Glycine 0 C--N 1.354 1.551 0 CA-C-O 118.724 -1.042 . . . . 72.43 115.366 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.417 ' HD2' ' N ' ' A' ' 102' ' ' GLY . 9.5 Cg_endo -47.69 -28.11 8.93 Favored 'Trans proline' 0 C--N 1.388 2.655 0 C-N-CA 124.211 3.274 . . . . 64.43 114.941 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -134.69 35.08 2.25 Favored Glycine 0 C--N 1.346 1.134 0 CA-C-O 119.487 -0.618 . . . . 54.4 112.888 -176.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.417 ' HB3' ' OG ' ' A' ' 113' ' ' SER . 17.6 mt -67.53 26.2 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 114.683 1.364 . . . . 74.25 114.683 176.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER 58.6 -107.39 0.35 Allowed 'General case' 0 CA--C 1.562 1.437 0 C-N-CA 124.46 1.104 . . . . 74.45 110.884 163.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.594 ' H ' ' HB2' ' A' ' 169' ' ' ASN . . . 74.92 8.64 82.92 Favored Glycine 0 C--N 1.354 1.539 0 C-N-CA 123.18 0.419 . . . . 44.0 112.709 -177.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 59.34 -135.7 51.3 Favored Glycine 0 C--N 1.353 1.481 0 N-CA-C 111.854 -0.499 . . . . 71.34 111.854 -170.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -79.9 -4.66 53.28 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.125 0.57 . . . . 74.55 111.278 170.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -80.02 -35.95 26.14 Favored Glycine 0 C--N 1.348 1.242 0 N-CA-C 111.728 -0.549 . . . . 55.25 111.728 177.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 75.04 -26.02 0.2 Allowed 'General case' 0 CA--C 1.566 1.579 0 C-N-CA 125.106 1.362 . . . . 75.52 112.681 174.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 18.8 ttt180 -65.58 -8.23 18.94 Favored 'General case' 0 CA--C 1.563 1.474 0 C-N-CA 125.342 1.457 . . . . 75.13 113.148 -175.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.417 ' OG ' ' HB3' ' A' ' 105' ' ' LEU . 16.4 m 75.05 46.01 0.13 Allowed 'General case' 0 C--N 1.366 1.295 0 C-N-CA 125.018 1.327 . . . . 74.21 108.621 -171.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.21 160.09 14.97 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.127 -0.942 . . . . 74.52 111.249 -171.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -35.66 137.61 0.19 Allowed 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 127.896 2.478 . . . . 73.31 115.557 -163.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.444 ' HA2' ' HA3' ' A' ' 168' ' ' GLY . . . -84.4 167.88 43.57 Favored Glycine 0 C--N 1.343 0.935 0 N-CA-C 115.587 0.995 . . . . 73.4 115.587 -176.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.506 ' HB3' ' HB2' ' A' ' 167' ' ' GLN . 12.5 ttm180 -115.65 144.32 44.09 Favored 'General case' 0 C--O 1.26 1.628 0 C-N-CA 124.17 0.988 . . . . 74.43 111.31 -174.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.427 ' HA ' ' H ' ' A' ' 173' ' ' ASP . 9.3 p-10 -64.6 134.9 55.29 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 114.719 -1.128 . . . . 74.23 109.978 169.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.494 HD11 ' HB2' ' B' ' 11' ' ' LEU . 7.9 tp -144.12 143.67 31.23 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.08 -0.341 . . . . 75.42 110.08 -174.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.419 ' HD2' HG23 ' B' ' 19' ' ' THR . 45.8 ttm180 -97.53 111.13 23.52 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.715 -0.846 . . . . 74.51 108.715 166.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -112.56 167.13 10.71 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 107.957 -1.127 . . . . 54.41 107.957 172.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.507 ' HG2' ' HB ' ' A' ' 177' ' ' VAL . 38.2 mt-10 -127.82 118.55 23.91 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 118.786 0.721 . . . . 72.42 109.648 -172.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.423 HD21 HD12 ' A' ' 176' ' ' LEU . 57.1 tp -100.13 104.62 30.5 Favored Pre-proline 0 N--CA 1.478 0.974 0 C-N-CA 123.985 0.914 . . . . 74.14 111.372 -164.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.673 ' HA ' ' HB2' ' A' ' 179' ' ' ARG . 24.6 Cg_exo -61.68 141.04 89.47 Favored 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 122.428 2.085 . . . . 75.33 110.511 176.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 13.4 tp -148.41 149.34 31.57 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.268 0.556 . . . . 72.43 111.975 177.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 97.8 m -85.5 140.26 30.82 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.708 1.203 . . . . 71.34 109.393 175.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.568 HD11 ' HB3' ' A' ' 183' ' ' HIS . 34.0 mt -54.79 -59.88 4.12 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 124.364 1.066 . . . . 75.21 113.359 -171.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -58.82 -39.1 80.18 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 114.961 -1.018 . . . . 75.32 110.644 -178.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -72.6 -21.83 61.06 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.06 0.944 . . . . 64.33 111.591 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.553 ' HB2' ' O ' ' A' ' 153' ' ' VAL . . . -74.87 -43.5 54.07 Favored 'General case' 0 C--O 1.247 0.947 0 C-N-CA 123.795 0.838 . . . . 65.44 110.915 178.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -72.05 -32.12 66.8 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 116.128 -0.487 . . . . 74.51 110.479 173.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 52.0 m170 -59.69 -48.13 82.88 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 123.4 0.438 . . . . 75.25 110.671 175.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.415 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 81.07 -136.08 15.65 Favored Glycine 0 CA--C 1.526 0.755 0 O-C-N 123.822 0.701 . . . . 71.54 111.583 -176.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 85.34 -172.04 46.6 Favored Glycine 0 C--N 1.344 0.983 0 O-C-N 123.632 0.254 . . . . 70.42 112.75 178.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.446 ' HB3' ' HB3' ' A' ' 146' ' ' SER . 1.8 mp0 -87.96 108.42 19.19 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 108.15 -1.056 . . . . 73.14 108.15 173.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 13.8 tpp180 -93.53 122.3 35.82 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 122.85 0.46 . . . . 75.05 110.003 -173.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 95.9 t -78.68 124.36 36.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 123.582 0.753 . . . . 75.04 109.782 -178.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.3 p -151.03 133.04 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 C-N-CA 123.82 0.848 . . . . 73.34 109.873 -174.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -84.93 135.25 34.13 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.196 0.998 . . . . 71.3 110.927 -176.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.635 HG21 ' HB2' ' B' ' 10' ' ' LEU . 2.6 p -166.4 111.56 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.201 0 C-N-CA 123.544 0.738 . . . . 75.1 111.168 -178.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.422 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . 60.25 37.71 20.33 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 113.796 1.035 . . . . 74.24 113.796 168.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 77.34 11.87 85.1 Favored Glycine 0 N--CA 1.475 1.298 0 CA-C-N 116.208 -0.451 . . . . 54.15 113.125 -178.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 26.6 ttm-85 -116.78 119.86 36.75 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.775 1.23 . . . . 72.43 108.197 174.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.439 ' HB2' ' HB2' ' A' ' 61' ' ' GLU . 14.1 tpp180 -93.34 89.62 6.44 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 106.707 -1.59 . . . . 74.41 106.707 170.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 11.6 p -89.53 140.16 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-O 121.368 0.604 . . . . 73.53 110.569 -170.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.446 ' HB3' ' HB3' ' A' ' 135' ' ' GLU . 25.2 m -106.01 90.14 3.28 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 107.768 -1.197 . . . . 64.43 107.768 174.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 3.3 p -77.35 112.56 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-O 121.335 0.588 . . . . 73.42 109.44 -174.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 5.8 tpm_? -67.06 92.12 0.24 Allowed 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 108.454 -0.943 . . . . 74.32 108.454 175.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.484 HG23 HD13 ' A' ' 159' ' ' ILE . 33.3 pt -93.44 131.74 31.88 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-N 115.203 -0.908 . . . . 74.52 109.089 -179.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -63.25 139.4 71.79 Favored 'Trans proline' 0 C--N 1.37 1.667 0 C-N-CA 122.414 2.076 . . . . 74.22 111.502 175.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -59.23 114.13 1.89 Allowed 'Trans proline' 0 C--N 1.383 2.393 0 C-N-CA 123.068 2.512 . . . . 74.15 111.855 -178.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 98.87 76.43 1.26 Allowed Glycine 0 C--N 1.345 1.066 0 N-CA-C 110.068 -1.213 . . . . 75.51 110.068 -175.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.553 ' O ' ' HB2' ' A' ' 130' ' ' ALA . 4.7 p -126.23 132.02 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 124.315 1.046 . . . . 75.43 108.453 172.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.637 ' HD2' HD11 ' A' ' 215' ' ' LEU . 0.0 OUTLIER -134.71 156.86 48.06 Favored 'General case' 0 N--CA 1.483 1.176 0 O-C-N 121.715 -0.616 . . . . 73.23 110.915 -169.92 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.404 ' O ' ' HB3' ' A' ' 188' ' ' LEU . 6.1 tp10 -51.66 117.09 2.45 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 125.222 1.409 . . . . 72.32 112.223 -172.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 114.55 -9.63 21.9 Favored Glycine 0 C--N 1.339 0.748 0 CA-C-N 115.596 -0.729 . . . . 74.33 112.708 -176.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 27.5 t -76.01 144.01 41.14 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.459 -0.941 . . . . 74.23 108.459 171.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 176' ' ' LEU . 18.6 t -113.75 102.44 13.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 N-CA-C 108.357 -0.979 . . . . 74.02 108.357 174.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.611 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 50.9 mt -70.65 84.48 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.831 0 N-CA-C 107.45 -1.315 . . . . 75.24 107.45 172.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 70.9 ttt-85 -75.56 100.63 4.63 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.076 -1.083 . . . . 75.21 108.076 176.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.506 HG11 ' HB3' ' A' ' 174' ' ' LEU . 2.4 p -105.9 102.78 40.99 Favored Pre-proline 0 CA--C 1.546 0.825 0 N-CA-C 108.175 -1.046 . . . . 71.41 108.175 175.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -61.97 140.84 86.92 Favored 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 122.613 2.208 . . . . 74.53 110.582 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 83.33 26.11 44.96 Favored Glycine 0 CA--C 1.523 0.544 0 CA-C-O 118.984 -0.898 . . . . 70.43 114.557 178.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.424 ' C ' ' HB2' ' A' ' 174' ' ' LEU . 44.0 ttm -139.06 -6.06 1.44 Allowed 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 118.768 1.284 . . . . 64.15 113.423 -177.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.498 ' HA2' HD13 ' A' ' 174' ' ' LEU . . . -49.25 -59.58 6.9 Favored Glycine 0 N--CA 1.499 2.87 0 CA-C-O 122.406 1.003 . . . . 73.33 111.111 -177.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.477 ' H ' ' HA3' ' A' ' 172' ' ' GLY . . . 132.74 -86.66 0.28 Allowed Glycine 0 CA--C 1.48 -2.1 0 CA-C-N 112.227 -1.987 . . . . 74.5 109.554 158.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.506 ' HB2' ' HB3' ' A' ' 117' ' ' ARG . 19.0 mm-40 -23.36 105.32 0.02 OUTLIER 'General case' 0 C--N 1.364 1.207 0 O-C-N 129.193 3.525 . . . . 75.42 115.947 -160.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.444 ' HA3' ' HA2' ' A' ' 116' ' ' GLY . . . 137.86 -118.74 1.71 Allowed Glycine 0 N--CA 1.44 -1.071 0 N-CA-C 105.668 -2.973 . . . . 64.21 105.668 -164.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . 0.594 ' HB2' ' H ' ' A' ' 107' ' ' GLY . 57.7 t30 -165.37 -43.12 0.0 OUTLIER Pre-proline 0 N--CA 1.481 1.101 0 CA-C-N 117.769 0.784 . . . . 63.54 110.912 165.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -61.21 165.32 12.89 Favored 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 121.872 1.715 . . . . 73.02 109.647 160.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -56.28 113.75 1.59 Allowed 'Trans proline' 0 CA--C 1.548 1.186 0 C-N-CA 122.811 2.34 . . . . 71.25 116.58 -168.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.477 ' HA3' ' H ' ' A' ' 166' ' ' GLY . . . -67.46 -142.06 0.07 OUTLIER Glycine 0 C--N 1.371 2.479 0 C-N-CA 118.593 -1.765 . . . . 72.4 113.534 153.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.427 ' H ' ' HA ' ' A' ' 118' ' ' ASP . 45.1 m-20 -152.27 108.53 3.41 Favored 'General case' 0 N--CA 1.51 2.569 0 CA-C-N 118.49 1.145 . . . . 71.14 108.916 176.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.506 ' HB3' HG11 ' A' ' 161' ' ' VAL . 7.8 tp -91.55 135.13 34.08 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 118.478 0.581 . . . . 74.2 112.019 -167.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 6.2 mt -115.99 93.94 4.46 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 106.029 -1.841 . . . . 72.12 106.029 177.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.611 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 82.2 mt -88.36 101.89 14.33 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.171 0.588 . . . . 74.52 111.519 -175.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.507 ' HB ' ' HG2' ' A' ' 122' ' ' GLU . 61.4 t -82.53 97.85 4.41 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 N-CA-C 107.378 -1.341 . . . . 71.11 107.378 174.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.489 HG12 HG23 ' A' ' 153' ' ' VAL . 10.5 p -64.84 124.01 18.84 Favored 'Isoleucine or valine' 0 C--O 1.251 1.158 0 CA-C-N 115.469 -0.787 . . . . 74.13 110.585 -174.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.673 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 8.4 mmt85 -87.94 148.17 24.71 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.03 -1.441 . . . . 73.42 108.526 167.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.496 HD12 ' HA ' ' A' ' 154' ' ' ARG . 29.2 mt -118.54 152.39 36.07 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.878 -0.786 . . . . 74.04 108.878 165.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 85.9 mt -53.09 153.87 5.97 Favored Pre-proline 0 CA--C 1.558 1.264 0 O-C-N 124.389 1.056 . . . . 73.22 111.111 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.28 11.66 0.1 Allowed 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 123.456 2.771 . . . . 74.32 115.372 -174.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.568 ' HB3' HD11 ' A' ' 127' ' ' LEU . 4.0 t-80 -61.35 104.54 0.47 Allowed Pre-proline 0 CA--C 1.565 1.529 0 C-N-CA 125.166 1.386 . . . . 73.35 108.17 169.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -80.11 29.28 0.51 Allowed 'Trans proline' 0 C--N 1.368 1.571 0 C-N-CA 124.53 3.486 . . . . 61.24 117.229 -159.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.573 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 23.8 t -89.41 -51.39 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 120.379 1.445 . . . . 72.34 108.703 -172.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . 0.426 ' CZ ' ' HA ' ' A' ' 214' ' ' THR . 65.1 m-85 -114.2 129.38 56.63 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 112.267 0.469 . . . . 72.31 112.267 -169.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . 0.565 HH22 ' HB2' ' A' ' 189' ' ' GLU . 28.4 ttp85 -127.86 123.91 36.22 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.048 -1.093 . . . . 75.51 108.048 164.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.404 ' HB3' ' O ' ' A' ' 155' ' ' GLU . 9.1 tp -93.0 148.05 22.32 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 123.15 0.58 . . . . 74.21 110.475 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . 0.565 ' HB2' HH22 ' A' ' 187' ' ' ARG . 10.0 tp10 -123.5 90.58 3.31 Favored 'General case' 0 C--O 1.246 0.911 0 N-CA-C 107.583 -1.266 . . . . 70.31 107.583 163.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . 0.485 ' HA3' ' HA ' ' B' ' 415' ' ' LYS . . . 64.83 -82.2 0.06 OUTLIER Glycine 0 C--N 1.353 1.506 0 CA-C-N 114.373 -1.285 . . . . 65.41 113.494 176.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 5.3 pm0 -93.18 -45.4 7.89 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.447 0.699 . . . . 72.32 111.362 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -111.09 144.85 39.56 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.38 -0.825 . . . . 72.32 113.009 -163.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.423 ' HB2' ' HA ' ' A' ' 249' ' ' LEU . 86.7 mt -91.46 157.41 17.07 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.491 1.116 . . . . 74.25 110.971 -177.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -131.1 105.22 7.56 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 107.777 -1.194 . . . . 73.14 107.777 170.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.573 ' HA ' ' O ' ' A' ' 185' ' ' VAL . . . -104.7 -175.77 2.89 Favored 'General case' 0 C--O 1.218 -0.567 0 C-N-CA 124.393 1.077 . . . . 74.34 110.67 178.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 34.7 m -125.18 128.66 48.71 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.672 -0.862 . . . . 70.21 108.672 173.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 48.3 tp -129.55 121.17 26.62 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 109.835 -0.432 . . . . 74.1 109.835 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -85.92 122.12 29.52 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 108.886 -0.783 . . . . 63.3 108.886 169.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 7.1 p -133.19 133.24 22.77 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 107.866 -1.161 . . . . 74.33 107.866 178.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.5 152.19 59.78 Favored 'Trans proline' 0 C--N 1.364 1.372 0 C-N-CA 121.378 1.385 . . . . 70.05 111.192 175.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.662 ' HB1' ' HH2' ' A' ' 269' ' ' TRP . . . -53.92 -44.5 98.29 Favored Pre-proline 0 CA--C 1.557 1.223 0 N-CA-C 114.782 1.401 . . . . 71.34 114.782 -175.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -64.2 -37.28 42.13 Favored 'Trans proline' 0 C--N 1.381 2.266 0 CA-C-N 121.677 1.635 . . . . 73.32 112.994 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 38.0 mt -73.59 -31.52 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.021 0.529 . . . . 71.02 110.21 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.15 -44.71 79.1 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.495 0.718 . . . . 74.14 110.999 177.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 69.5 t -68.32 -63.62 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 123.208 0.603 . . . . 64.22 110.273 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 96.4 t -72.56 -40.12 62.43 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 CA-C-N 115.466 -0.788 . . . . 74.41 111.899 -168.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 96.89 108.32 2.53 Favored Glycine 0 C--N 1.339 0.726 0 N-CA-C 111.1 -0.8 . . . . 72.35 111.1 -173.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -144.33 -157.44 7.2 Favored Glycine 0 C--N 1.342 0.871 0 CA-C-O 120.137 -0.257 . . . . 73.32 112.551 -177.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.468 ' HZ1' ' HB3' ' A' ' 209' ' ' LYS . 9.7 mtpm? -117.18 130.41 56.58 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 117.17 0.485 . . . . 73.34 110.897 -176.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 29.8 m -132.94 -172.39 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 N-CA-C 107.591 -1.263 . . . . 63.11 107.591 167.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . 0.5 ' HD3' ' HB2' ' A' ' 218' ' ' PRO . 25.7 ttm180 -113.55 126.49 55.35 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 121.897 -0.502 . . . . 74.32 110.663 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -104.57 116.74 32.59 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.868 0.867 . . . . 74.41 109.009 175.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' MET . . . . . 0.421 ' SD ' ' N ' ' A' ' 213' ' ' MET . 3.3 mpp? -82.75 104.72 13.21 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.836 -0.802 . . . . 74.15 108.836 178.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' THR . . . . . 0.426 ' HA ' ' CZ ' ' A' ' 186' ' ' PHE . 82.1 p -116.49 174.09 6.26 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 123.314 0.646 . . . . 74.1 110.364 -178.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.637 HD11 ' HD2' ' A' ' 154' ' ' ARG . 14.6 mt -75.76 -17.64 59.82 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.131 0.573 . . . . 73.14 110.053 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -88.41 -5.21 58.41 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.772 1.229 . . . . 64.44 110.755 174.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 125.21 162.46 11.35 Favored Glycine 0 C--N 1.35 1.323 0 C-N-CA 123.579 0.609 . . . . 63.05 113.274 172.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . 0.5 ' HB2' ' HD3' ' A' ' 211' ' ' ARG . 60.5 Cg_endo -72.06 99.61 1.01 Allowed 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 122.463 2.109 . . . . 74.13 110.143 174.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 35.2 m -102.39 161.26 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.666 0.786 . . . . 73.4 111.466 -172.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -83.04 107.4 15.6 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 108.95 -0.759 . . . . 75.04 108.95 171.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 7.6 p -96.5 116.41 38.45 Favored 'Isoleucine or valine' 0 C--O 1.246 0.907 0 N-CA-C 109.161 -0.681 . . . . 74.51 109.161 178.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -81.97 97.32 8.04 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.646 -0.872 . . . . 70.4 108.646 175.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 97.5 t -58.22 121.82 54.44 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 124.454 1.101 . . . . 71.22 109.308 176.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.67 159.83 51.99 Favored 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 122.416 2.077 . . . . 75.51 111.453 176.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -65.04 156.35 63.19 Favored 'Trans proline' 0 C--N 1.365 1.417 0 C-N-CA 121.91 1.74 . . . . 72.53 111.711 171.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . 0.734 HH11 ' HA ' ' C' ' 260' ' ' ARG . 3.2 mmp_? 73.97 11.15 4.47 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.638 1.575 . . . . 75.13 111.89 176.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 13.2 m -59.69 120.78 10.14 Favored 'General case' 0 C--N 1.356 0.861 0 C-N-CA 124.002 0.921 . . . . 64.32 110.588 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . 0.504 ' HA ' HD13 ' A' ' 255' ' ' ILE . 48.0 tt0 -128.17 142.49 51.17 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.316 -0.402 . . . . 75.32 111.033 -166.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -60.95 133.85 56.51 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 124.1 0.875 . . . . 65.12 111.079 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 98.89 -38.67 3.01 Favored Glycine 0 C--N 1.34 0.792 0 O-C-N 123.553 0.533 . . . . 75.54 111.92 -177.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 28.5 mtm-85 -70.38 170.04 12.69 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-O 121.214 0.531 . . . . 74.44 111.053 173.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.647 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 2.9 mptp? -124.39 129.52 50.83 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.45 -0.795 . . . . 72.22 109.553 -176.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.456 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 54.7 mt -79.63 99.72 7.49 Favored 'General case' 0 C--N 1.346 0.455 0 N-CA-C 109.012 -0.736 . . . . 71.4 109.012 173.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . 0.416 ' HB3' ' HA ' ' B' ' 443' ' ' ALA . 32.8 ttp180 -72.09 100.51 2.54 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.042 0.937 . . . . 73.41 110.014 178.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.533 HD23 HG12 ' B' ' 441' ' ' ILE . 5.0 mt -87.75 102.2 14.43 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 107.64 -1.245 . . . . 74.24 107.64 176.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -51.69 126.51 17.92 Favored 'General case' 0 CA--C 1.549 0.932 0 O-C-N 124.148 0.905 . . . . 71.01 113.219 -173.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 75.3 10.22 84.37 Favored Glycine 0 C--N 1.347 1.194 0 CA-C-N 115.051 -0.977 . . . . 74.2 115.47 168.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? -84.37 -11.17 56.78 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 117.615 0.707 . . . . 74.1 110.865 175.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -98.91 -164.94 30.17 Favored Glycine 0 C--N 1.348 1.215 0 N-CA-C 111.206 -0.758 . . . . 74.43 111.206 168.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . 0.403 ' N ' ' CD1' ' A' ' 240' ' ' PHE . 2.4 m-30 -96.06 131.6 28.58 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 123.895 0.878 . . . . 73.41 110.326 -168.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.13 153.91 62.35 Favored 'Trans proline' 0 CA--C 1.547 1.139 0 C-N-CA 122.742 2.295 . . . . 73.33 112.564 177.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -148.78 -178.14 23.6 Favored Glycine 0 C--N 1.347 1.149 0 CA-C-O 119.396 -0.669 . . . . 73.52 112.876 177.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -52.75 -53.36 6.96 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 123.63 2.886 . . . . 72.5 113.315 175.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -120.46 -28.26 5.01 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 122.963 0.505 . . . . 70.11 111.575 178.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -97.67 99.64 2.27 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 111.837 -0.505 . . . . 62.24 111.837 -176.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -86.03 121.83 29.2 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 108.959 -0.756 . . . . 75.41 108.959 173.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.63 130.1 10.03 Favored Glycine 0 C--O 1.246 0.852 0 N-CA-C 114.851 0.7 . . . . 70.31 114.851 -173.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -123.12 165.38 16.94 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.933 0.893 . . . . 75.44 108.961 176.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.445 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 38.0 tp -99.33 101.68 13.04 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 109.086 -0.709 . . . . 73.32 109.086 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.647 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 14.0 m-85 -87.04 103.58 15.51 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 109.155 -0.683 . . . . 71.3 109.155 -177.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.522 HD23 ' HB1' ' A' ' 195' ' ' ALA . 87.4 mt -83.22 108.63 16.59 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 108.777 -0.823 . . . . 74.54 108.777 177.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.504 ' HG2' ' HG3' ' A' ' 232' ' ' LYS . 40.6 mt-10 -75.11 110.9 9.81 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 108.394 -0.965 . . . . 75.41 108.394 -175.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 59.5 t -67.16 125.57 24.91 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 CA-C-N 114.0 -1.454 . . . . 71.34 111.832 -170.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 3.3 mmm-85 -118.13 94.2 4.41 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 125.066 1.346 . . . . 73.14 107.626 170.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.504 HD13 ' HA ' ' A' ' 228' ' ' GLN . 57.5 mt -70.35 128.81 34.15 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 N-CA-C 109.02 -0.733 . . . . 74.34 109.02 174.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 51.9 p -122.59 146.66 47.23 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 124.434 1.094 . . . . 74.52 108.904 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . 0.484 HD13 HE21 ' C' ' 228' ' ' GLN . 2.7 pp -109.75 147.37 36.0 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 123.32 0.648 . . . . 73.4 109.458 175.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -50.49 -18.8 4.08 Favored 'Trans proline' 0 N--CA 1.505 2.16 0 C-N-CA 124.658 3.572 . . . . 74.45 115.906 -168.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 58.51 -80.33 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.761 1.225 . . . . 75.12 110.644 -168.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 12.1 ptm85 -73.93 139.43 44.91 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 109.227 -0.657 . . . . 75.12 109.227 173.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.649 ' HB3' ' HB2' ' A' ' 266' ' ' GLU . 9.3 mt -145.04 138.13 26.51 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.228 0.611 . . . . 72.32 111.403 -169.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 27.0 p -83.04 153.41 66.7 Favored Pre-proline 0 CA--C 1.555 1.15 0 C-N-CA 124.647 1.179 . . . . 74.31 109.572 175.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -39.14 -65.3 0.17 Allowed 'Trans proline' 0 C--N 1.384 2.396 0 C-N-CA 124.878 3.719 . . . . 74.33 116.798 -171.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -68.79 -40.69 79.51 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.016 0.526 . . . . 71.44 111.816 -172.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -68.13 -37.73 81.41 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.063 0.545 . . . . 73.22 110.974 -178.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' GLU . . . . . 0.649 ' HB2' ' HB3' ' A' ' 261' ' ' LEU . 41.3 tt0 -64.2 -48.07 77.29 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 121.487 0.661 . . . . 73.45 109.306 176.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . 0.404 ' HB1' ' HE3' ' A' ' 271' ' ' LYS . . . -54.66 -41.94 70.73 Favored 'General case' 0 C--O 1.208 -1.123 0 CA-C-N 113.8 -1.545 . . . . 64.12 109.81 175.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 12.4 tp -64.81 -46.47 81.87 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.234 1.014 . . . . 73.14 110.885 -175.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' TRP . . . . . 0.662 ' HH2' ' HB1' ' A' ' 201' ' ' ALA . 73.5 m95 -55.59 -44.94 77.4 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 115.232 -0.894 . . . . 75.0 111.331 173.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . 0.609 ' HE3' ' HA ' ' C' ' 206' ' ' VAL . 53.6 mtpt -90.27 -9.31 48.42 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 115.359 -0.837 . . . . 73.12 112.267 -171.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . 0.404 ' HE3' ' HB1' ' A' ' 267' ' ' ALA . 90.1 mttt -76.05 -45.09 36.0 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.55 -1.278 . . . . 70.22 107.55 166.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' LEU . . . . . 0.607 HD23 ' HB2' ' C' ' 268' ' ' LEU . 46.1 mt -55.57 -47.23 76.73 Favored 'General case' 0 C--O 1.213 -0.831 0 CA-C-N 114.4 -1.273 . . . . 71.54 110.185 169.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . 0.414 ' HA ' ' HB2' ' C' ' 202' ' ' PRO . . . -63.75 -47.27 81.7 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 124.258 0.974 . . . . 72.23 112.758 -174.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -65.8 -44.2 86.38 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 123.226 0.329 . . . . 74.35 110.909 177.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -67.27 -27.52 67.26 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 122.885 0.474 . . . . 72.24 111.598 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . 0.516 ' HE2' ' HG3' ' C' ' 258' ' ' PRO . 24.0 t80 -75.1 -74.95 0.18 Allowed 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 107.974 -1.121 . . . . 75.02 107.974 177.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -49.69 -60.5 2.83 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.307 1.843 . . . . 72.14 112.315 -175.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -70.23 -8.24 48.49 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 112.926 0.713 . . . . 75.41 112.926 -172.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . 0.454 ' HB3' ' HA ' ' B' ' 136' ' ' LYS . 1.0 OUTLIER -121.64 1.65 10.04 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-O 118.906 -0.569 . . . . 75.15 111.391 -178.971 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.416 0 O-C-N 124.392 1.058 . . . . 72.5 111.185 -172.514 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.405 ' SD ' ' N ' ' B' ' 1' ' ' MET . 3.8 mpp? . . . . . 0 N--CA 1.482 1.154 0 N-CA-C 109.302 -0.629 . . . . 74.12 109.302 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -67.33 116.88 8.59 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 108.999 -0.741 . . . . 62.45 108.999 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -86.15 68.9 10.42 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 122.344 1.068 . . . . 74.04 108.91 175.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 18.7 m -104.97 113.28 26.78 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-N 113.881 -1.509 . . . . 52.14 108.415 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.95 174.67 7.79 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 121.094 0.473 . . . . 74.34 110.524 -178.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 25.0 pt -138.93 160.13 29.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 123.357 0.663 . . . . 65.34 111.665 -163.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . 0.479 ' HB2' ' HG3' ' B' ' 75' ' ' MET . . . -136.17 143.43 44.44 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 107.09 -1.448 . . . . 72.22 107.09 166.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 35.4 tp -71.41 -89.01 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.579 0.752 . . . . 75.22 110.656 -170.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . 159.16 -61.36 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 126.188 1.795 . . . . 73.12 106.761 -175.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . 0.635 ' HB2' HG21 ' A' ' 140' ' ' VAL . 3.1 tt 53.49 115.65 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 113.561 -1.654 . . . . 74.1 110.024 -162.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.494 ' HB2' HD11 ' A' ' 119' ' ' LEU . 51.9 mt -73.03 106.28 2.15 Favored Pre-proline 0 CA--C 1.546 0.819 0 N-CA-C 108.874 -0.787 . . . . 72.11 108.874 179.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' B' ' 11' ' ' LEU . 16.9 Cg_exo -66.43 151.71 82.52 Favored 'Trans proline' 0 C--N 1.376 1.997 0 C-N-CA 123.198 2.599 . . . . 71.41 114.068 -161.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -50.43 -34.99 26.57 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.395 1.478 . . . . 75.11 111.715 168.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 38.8 tp -62.75 136.06 57.67 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.885 0.874 . . . . 64.54 109.539 175.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 43.7 t80 72.38 -82.38 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.006 1.322 . . . . 74.01 108.923 -172.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' THR . . . . . 0.413 ' HB ' ' HD2' ' B' ' 20' ' ' LYS . 33.4 m -159.37 122.74 2.01 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 123.767 0.827 . . . . 71.11 109.439 176.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.01 76.33 4.21 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 122.892 2.395 . . . . 71.22 112.168 172.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.433 HG21 ' H ' ' B' ' 19' ' ' THR . 4.0 p -159.94 176.65 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.019 0 N-CA-C 107.592 -1.262 . . . . 63.3 107.592 174.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' THR . . . . . 0.448 ' HA ' HD12 ' B' ' 11' ' ' LEU . 24.2 p -66.54 87.46 0.12 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.366 0.666 . . . . 71.22 111.938 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' LYS . . . . . 0.413 ' HD2' ' HB ' ' B' ' 16' ' ' THR . 98.8 mttt -128.71 12.06 6.26 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.573 1.149 . . . . 74.33 110.445 171.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.88 -10.1 59.4 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.314 0.645 . . . . 75.34 111.369 176.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . 0.494 ' NH1' HD13 ' B' ' 69' ' ' LEU . 25.0 tpt180 -139.33 47.68 1.88 Allowed 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 122.136 0.969 . . . . 73.31 108.782 176.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' THR . . . . . . . . . . . . . 75.5 p -119.01 86.91 32.79 Favored Pre-proline 0 CA--C 1.55 0.969 0 CA-C-N 114.752 -1.113 . . . . 72.54 109.265 176.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -80.03 148.53 19.51 Favored 'Trans proline' 0 C--N 1.374 1.878 0 C-N-CA 122.82 2.347 . . . . 74.55 112.846 -174.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -158.39 101.03 1.69 Allowed 'General case' 0 C--O 1.243 0.75 0 N-CA-C 107.751 -1.203 . . . . 74.53 107.751 177.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' MET . . . . . 0.425 ' SD ' ' HA ' ' B' ' 60' ' ' SER . 0.0 OUTLIER -164.07 150.75 9.93 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 123.848 0.859 . . . . 75.13 109.096 -174.846 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -89.56 11.64 2.83 Favored 'Trans proline' 0 C--N 1.365 1.395 0 C-N-CA 122.48 2.12 . . . . 73.04 111.79 170.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.487 HG13 ' HB1' ' B' ' 33' ' ' ALA . 13.5 m 48.17 20.31 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 C-N-CA 127.11 2.164 . . . . 75.25 113.861 -174.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 63.13 14.45 7.68 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 125.261 1.424 . . . . 73.34 113.042 178.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -165.88 151.96 9.27 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.334 1.054 . . . . 71.25 109.093 176.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -71.11 97.2 1.45 Allowed 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 108.324 -0.991 . . . . 74.34 108.324 176.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -157.02 -57.56 0.08 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.757 0.823 . . . . 72.22 109.061 -169.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . 0.49 ' HA ' ' HD3' ' B' ' 304' ' ' PRO . . . -134.87 61.23 1.68 Allowed 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.287 -0.869 . . . . 73.31 108.917 178.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -119.02 -112.22 0.34 Allowed 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 114.59 -1.186 . . . . 53.33 108.722 176.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . 0.427 ' HB2' HE22 ' B' ' 372' ' ' GLN . 51.4 mt-30 62.92 107.78 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 124.28 1.032 . . . . 73.13 110.576 -171.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . 0.516 ' HA2' ' HB3' ' B' ' 312' ' ' PRO . . . 165.58 38.48 0.02 OUTLIER Glycine 0 C--N 1.338 0.646 0 CA-C-O 119.386 -0.674 . . . . 74.33 112.715 -179.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 1.7 p30 41.73 -80.41 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 125.948 1.699 . . . . 61.44 114.303 -174.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 10.3 tt -151.27 -34.21 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.671 0 C-N-CA 124.597 1.159 . . . . 75.44 109.518 -173.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 12.7 t -149.35 -8.72 0.33 Allowed 'General case' 0 C--O 1.215 -0.737 0 CA-C-O 118.64 -0.695 . . . . 73.32 111.812 -177.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.448 ' HB1' ' HD3' ' B' ' 373' ' ' ARG . . . 51.47 92.14 0.06 OUTLIER Pre-proline 0 N--CA 1.483 1.199 0 C-N-CA 124.549 1.14 . . . . 73.24 112.005 -177.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . 0.57 ' HG2' ' HG2' ' B' ' 313' ' ' GLN . 74.3 Cg_endo -72.18 172.86 13.95 Favored 'Trans proline' 0 C--N 1.371 1.757 0 C-N-CA 122.663 2.242 . . . . 72.44 112.861 -178.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . 0.406 ' HA2' ' HB2' ' B' ' 51' ' ' GLN . . . -79.92 79.49 1.69 Allowed Glycine 0 C--N 1.337 0.595 0 CA-C-N 115.888 -0.596 . . . . 61.22 112.101 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . 0.459 ' HA2' ' NE2' ' B' ' 313' ' ' GLN . . . -65.35 -70.55 1.06 Allowed Glycine 0 C--N 1.349 1.289 0 N-CA-C 111.704 -0.558 . . . . 64.32 111.704 176.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -96.69 97.23 9.19 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 106.34 -1.726 . . . . 63.2 106.34 167.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.0 105.95 0.05 Allowed 'General case' 0 N--CA 1.484 1.239 0 O-C-N 125.037 1.461 . . . . 74.21 111.825 -174.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 18.3 tpt180 -77.31 83.85 3.75 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 114.258 -1.337 . . . . 75.02 108.137 -177.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.408 ' HB2' ' HE1' ' B' ' 377' ' ' PHE . 41.3 tp 65.39 -78.63 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.927 1.291 . . . . 72.13 110.224 -169.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 11.6 t -167.99 165.08 13.75 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.855 0.862 . . . . 73.12 110.405 -176.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.53 29.43 13.97 Favored Glycine 0 C--N 1.351 1.406 0 CA-C-N 115.866 -0.606 . . . . 74.15 112.869 175.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 29.0 t70 52.85 74.59 0.28 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.939 1.296 . . . . 64.2 110.274 -173.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' GLN . . . . . 0.406 ' HB2' ' HA2' ' B' ' 42' ' ' GLY . 10.3 tt0 67.69 -82.71 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 125.097 1.359 . . . . 75.3 111.323 -173.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' THR . . . . . 0.548 ' HB ' ' HB3' ' B' ' 55' ' ' LEU . 32.5 p -78.72 108.48 12.17 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 122.896 0.478 . . . . 73.31 110.895 -174.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.06 87.52 0.57 Allowed 'General case' 0 C--O 1.244 0.805 0 C-N-CA 123.806 0.842 . . . . 73.24 109.853 176.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . 58.08 72.58 0.51 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.738 1.215 . . . . 75.51 111.219 -178.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . 0.548 ' HB3' ' HB ' ' B' ' 52' ' ' THR . 48.5 tp -157.71 131.5 7.98 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.076 -0.713 . . . . 72.35 109.076 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 6.4 ttp180 -164.25 124.25 2.04 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 108.907 -0.775 . . . . 74.21 108.907 170.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 35.7 t70 54.25 92.66 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.41 1.484 . . . . 75.31 111.513 178.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 50.0 m -143.2 -73.86 0.28 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 122.559 0.343 . . . . 62.01 110.705 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . 0.427 HD12 HD12 ' B' ' 69' ' ' LEU . 21.9 tp -104.63 168.46 9.06 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.716 0.406 . . . . 72.44 110.756 -171.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' SER . . . . . 0.425 ' HA ' ' SD ' ' B' ' 26' ' ' MET . 23.6 p -135.18 179.36 6.37 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.589 1.155 . . . . 71.31 110.67 178.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 14.6 t70 71.5 141.79 0.05 Allowed 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 125.137 1.375 . . . . 71.45 112.789 177.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' LYS . . . . . 0.53 ' HB3' ' HZ2' ' B' ' 62' ' ' LYS . 4.9 mmmp? -119.2 -55.82 0.04 OUTLIER Pre-proline 0 CA--C 1.56 1.364 0 C-N-CA 124.396 1.078 . . . . 72.42 112.505 176.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . 0.61 ' HG2' ' HB2' ' B' ' 65' ' ' LYS . 48.3 Cg_endo -86.2 8.35 4.53 Favored 'Trans proline' 0 C--N 1.385 2.486 0 C-N-CA 121.63 1.553 . . . . 72.24 114.75 -172.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.29 39.75 15.18 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.99 0.916 . . . . 72.04 110.135 -176.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.61 ' HB2' ' HG2' ' B' ' 63' ' ' PRO . 23.6 tptp -71.97 -25.61 61.93 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-N 114.886 -1.052 . . . . 73.42 111.533 -170.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -88.2 52.68 2.52 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 123.374 0.67 . . . . 72.41 110.1 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 60.7 mt 64.69 -76.9 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 125.217 1.407 . . . . 74.04 109.627 -172.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 19.3 pt -137.02 172.36 15.11 Favored 'Isoleucine or valine' 0 C--O 1.245 0.862 0 C-N-CA 125.405 1.482 . . . . 73.4 108.46 177.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.564 ' HB3' ' HB2' ' B' ' 73' ' ' ASP . 60.2 tp -63.46 110.92 2.11 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.111 0.565 . . . . 74.34 111.514 -173.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 58.7 32.51 22.26 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.911 1.284 . . . . 65.22 110.065 177.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 28.9 pt 44.47 26.58 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 C-N-CA 126.271 1.828 . . . . 75.5 113.823 -174.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -125.79 -84.99 0.57 Allowed Glycine 0 C--N 1.353 1.495 0 N-CA-C 110.176 -1.17 . . . . 71.15 110.176 177.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . 0.564 ' HB2' ' HB3' ' B' ' 69' ' ' LEU . 20.4 t70 54.93 -87.33 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.634 1.173 . . . . 74.12 112.033 176.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -89.69 79.13 1.55 Allowed Glycine 0 C--N 1.349 1.262 0 N-CA-C 110.807 -0.917 . . . . 72.45 110.807 177.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 75' ' ' MET . . . . . 0.479 ' HG3' ' HB2' ' B' ' 7' ' ' ALA . 21.6 ptt? -68.67 172.01 6.92 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.327 0.651 . . . . 74.01 111.928 -177.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 137.46 -150.92 20.96 Favored Glycine 0 C--N 1.336 0.579 0 CA-C-N 115.554 -0.748 . . . . 71.52 111.583 -178.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -159.55 138.66 11.06 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 108.502 -0.925 . . . . 74.35 108.502 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 24.9 t -82.77 42.69 0.79 Allowed 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 123.889 0.876 . . . . 55.34 110.818 -176.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . 0.415 ' HB3' ' HA ' ' B' ' 84' ' ' ARG . 15.2 tp10 66.18 137.5 0.02 OUTLIER 'General case' 0 C--N 1.362 1.142 0 C-N-CA 125.435 1.494 . . . . 74.44 110.85 -172.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 61.4 mt -69.52 -56.29 12.14 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 123.276 0.631 . . . . 72.52 111.067 -177.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 9.3 t -151.56 -31.85 0.16 Allowed 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 113.307 0.854 . . . . 74.52 113.307 -172.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.8 -27.14 67.81 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 112.641 0.608 . . . . 75.12 112.641 -170.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . 0.4 ' HA ' ' HD1' ' B' ' 86' ' ' TYR . . . -167.94 38.24 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.448 1.099 . . . . 74.13 109.335 -176.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 84' ' ' ARG . . . . . 0.415 ' HA ' ' HB3' ' B' ' 79' ' ' GLU . 2.1 ptm180 -58.37 93.26 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.192 0.597 . . . . 73.0 112.325 -170.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 4.1 t30 59.83 16.96 6.05 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 124.922 1.289 . . . . 72.23 111.78 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 86' ' ' TYR . . . . . 0.4 ' HD1' ' HA ' ' B' ' 83' ' ' ALA . 12.8 m-85 -70.59 117.35 12.01 Favored 'General case' 0 C--N 1.352 0.692 0 CA-C-O 120.961 0.41 . . . . 74.21 110.67 -173.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -123.73 78.7 1.63 Allowed 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.631 1.173 . . . . 52.24 108.4 178.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -141.12 140.07 34.06 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.84 0.856 . . . . 74.14 108.719 -175.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -158.94 59.18 0.33 Allowed Glycine 0 C--N 1.346 1.139 0 N-CA-C 111.546 -0.622 . . . . 54.33 111.546 178.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.84 103.12 1.37 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.599 0.76 . . . . 75.53 110.321 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 75.49 24.22 71.09 Favored Glycine 0 C--N 1.345 1.039 0 CA-C-N 116.046 -0.525 . . . . 70.11 112.48 -175.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -162.72 28.27 0.25 Allowed Glycine 0 C--N 1.346 1.119 0 N-CA-C 112.207 -0.357 . . . . 73.42 112.207 -177.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -81.45 104.74 12.1 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 109.045 -0.724 . . . . 74.22 109.045 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -130.18 145.07 51.69 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.12 0.968 . . . . 72.14 109.706 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -75.23 -30.67 60.62 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.092 0.557 . . . . 74.44 109.647 169.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 112.8 7.46 21.88 Favored Glycine 0 C--N 1.353 1.476 0 CA-C-N 115.947 -0.569 . . . . 75.21 112.562 -179.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 32.5 pt -134.03 21.86 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 C-N-CA 123.96 0.904 . . . . 73.0 109.793 177.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -75.53 97.52 3.74 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.153 0.981 . . . . 75.21 110.753 -169.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -146.8 81.01 1.55 Allowed 'General case' 0 C--O 1.235 0.315 0 N-CA-C 106.548 -1.649 . . . . 61.12 106.548 174.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -79.66 111.27 19.88 Favored Pre-proline 0 N--CA 1.471 0.614 0 C-N-CA 124.069 0.948 . . . . 74.2 110.494 -169.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -90.56 157.29 4.35 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.836 2.357 . . . . 74.43 111.17 172.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -81.91 -2.96 53.07 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 116.541 -0.299 . . . . 73.12 110.464 174.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 13.5 t 52.27 24.83 3.03 Favored 'General case' 0 C--N 1.369 1.435 0 C-N-CA 126.84 2.056 . . . . 75.52 113.76 170.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 137.04 -27.16 2.93 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-O 119.688 -0.506 . . . . 51.35 112.422 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 23.6 tp60 77.7 -45.33 0.44 Allowed 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 126.104 1.762 . . . . 75.22 112.438 177.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -64.08 -17.45 63.42 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.522 1.129 . . . . 74.44 112.089 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 4.2 t -66.72 92.78 0.23 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.808 0.843 . . . . 75.34 110.058 174.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -67.62 -42.3 82.58 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 114.96 -1.018 . . . . 73.44 110.344 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -145.47 -69.62 0.28 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.832 0.853 . . . . 74.1 108.808 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -171.19 173.11 5.07 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.602 1.161 . . . . 75.22 109.721 -177.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -73.96 116.72 14.91 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-O 121.291 0.567 . . . . 70.25 109.997 176.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -81.34 145.5 30.83 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.828 -0.804 . . . . 73.2 108.828 175.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 113' ' ' LYS . . . . . 0.585 ' HZ1' ' HB2' ' B' ' 113' ' ' LYS . 0.1 OUTLIER -168.33 -37.43 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.672 0.789 . . . . 75.13 109.747 -179.703 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 96.3 mttt 63.78 -72.94 0.05 Allowed 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 125.301 1.441 . . . . 74.21 111.256 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 26.2 p -73.02 153.46 40.89 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.663 0.785 . . . . 73.23 110.124 168.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -111.22 13.88 28.41 Favored Glycine 0 C--N 1.339 0.697 0 CA-C-O 119.683 -0.51 . . . . 55.33 112.078 175.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt 64.91 134.05 0.04 OUTLIER Pre-proline 0 N--CA 1.485 1.293 0 C-N-CA 125.298 1.439 . . . . 75.35 111.633 -173.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 118' ' ' PRO . . . . . 0.547 ' HB2' ' HA ' ' B' ' 121' ' ' VAL . 71.1 Cg_endo -70.72 84.77 0.79 Allowed 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.317 2.011 . . . . 63.21 111.441 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 119' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -58.6 -56.02 27.56 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.894 1.277 . . . . 75.33 110.658 -177.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 120' ' ' TYR . . . . . 0.457 ' CD1' ' HB2' ' B' ' 123' ' ' ASP . 0.1 OUTLIER -80.9 -7.68 59.54 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 114.937 -1.029 . . . . 70.1 112.18 177.857 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 121' ' ' VAL . . . . . 0.547 ' HA ' ' HB2' ' B' ' 118' ' ' PRO . 49.3 t 58.42 -82.71 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.251 0 C-N-CA 125.894 1.678 . . . . 74.32 112.06 -179.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 68.2 p -85.29 -31.93 22.8 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.261 0.624 . . . . 75.25 111.531 -176.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . 0.461 ' HB3' ' NH1' ' C' ' 260' ' ' ARG . 38.4 t70 61.01 77.82 0.31 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.814 1.246 . . . . 70.53 110.878 -178.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 17.6 m 65.99 -78.87 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.985 1.314 . . . . 61.03 111.625 177.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -154.64 163.16 40.64 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.483 0.713 . . . . 74.53 111.061 -177.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -84.25 -20.8 31.62 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 115.124 -0.944 . . . . 74.13 111.234 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 42.1 t -142.02 159.43 42.23 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.075 0.95 . . . . 70.01 108.951 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -138.01 -73.76 0.41 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.921 0.489 . . . . 74.33 110.861 -176.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 12.1 t -74.12 -5.9 44.43 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.605 0.762 . . . . 74.41 112.771 -170.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . 62.06 -156.07 0.34 Allowed 'General case' 0 C--N 1.366 1.293 0 C-N-CA 124.056 0.942 . . . . 61.42 109.537 -173.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 80.4 t90 76.93 -49.07 0.55 Allowed 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 124.911 1.284 . . . . 73.51 111.533 178.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 47.5 p -59.87 149.85 30.29 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.837 1.255 . . . . 74.11 111.28 174.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 133' ' ' THR . . . . . 0.489 ' HA ' ' HZ3' ' B' ' 231' ' ' LYS . 5.5 m -66.02 -22.73 66.46 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 124.22 1.008 . . . . 74.52 111.466 -177.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 124.09 50.18 0.21 Allowed Glycine 0 C--N 1.342 0.913 0 CA-C-O 119.349 -0.695 . . . . 55.15 112.27 171.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 135' ' ' VAL . . . . . 0.594 HG12 ' HB2' ' B' ' 468' ' ' LEU . 70.2 t 72.63 -65.09 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 125.333 1.453 . . . . 73.24 111.35 174.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 136' ' ' LYS . . . . . 0.454 ' HA ' ' HB3' ' A' ' 279' ' ' ARG . 35.6 mmtm -126.6 34.9 4.72 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.908 1.283 . . . . 74.24 109.638 174.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 137' ' ' THR . . . . . 0.713 ' HB ' ' HB2' ' B' ' 141' ' ' ALA . 91.5 m 65.78 87.65 0.12 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.231 1.013 . . . . 75.31 110.449 -177.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 63.48 -82.12 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.467 1.507 . . . . 75.52 112.924 174.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -107.81 -15.43 14.56 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.792 0.837 . . . . 73.24 112.518 -170.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . 136.07 -0.66 3.31 Favored Glycine 0 C--N 1.347 1.16 0 CA-C-O 119.342 -0.699 . . . . 75.54 112.882 -175.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 141' ' ' ALA . . . . . 0.713 ' HB2' ' HB ' ' B' ' 137' ' ' THR . . . 59.21 42.37 18.68 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.237 1.015 . . . . 75.34 111.332 177.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 tt -79.82 94.41 5.8 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 108.866 -0.79 . . . . 74.24 108.866 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 178.17 -154.98 15.88 Favored Glycine 0 C--N 1.341 0.858 0 CA-C-N 115.021 -0.99 . . . . 61.25 111.841 178.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 19.8 m -120.68 -57.71 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 CA-C-N 117.298 0.549 . . . . 75.31 110.961 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 145' ' ' ASP . . . . . 0.535 ' O ' ' HG2' ' B' ' 148' ' ' GLU . 14.2 t70 -85.1 -52.65 5.8 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.373 0.669 . . . . 75.32 109.605 -176.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . 0.51 HD13 ' HB3' ' B' ' 141' ' ' ALA . 20.2 mt 60.87 -86.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 124.91 1.284 . . . . 72.52 110.893 174.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -134.06 -81.97 0.45 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.333 1.453 . . . . 72.43 107.126 177.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . 0.569 ' HB3' ' HE2' ' B' ' 275' ' ' LYS . 3.4 mm-40 52.84 -80.39 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 126.377 1.871 . . . . 75.05 112.07 -175.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 149' ' ' LYS . . . . . 0.624 ' HA ' ' HB2' ' B' ' 273' ' ' GLN . 2.3 ptpt -73.64 -43.06 60.51 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 124.109 0.964 . . . . 74.13 109.483 176.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 150' ' ' ASP . . . . . 0.65 ' HB3' ' HA ' ' B' ' 232' ' ' THR . 5.9 t70 53.24 34.69 18.22 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 125.301 1.441 . . . . 74.11 109.394 -174.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 24.5 m170 65.58 133.38 0.04 OUTLIER Pre-proline 0 CA--C 1.561 1.377 0 C-N-CA 125.279 1.431 . . . . 74.43 109.865 -167.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 152' ' ' PRO . . . . . 0.527 ' HB3' ' HB1' ' B' ' 271' ' ' ALA . 12.0 Cg_endo -54.42 -32.48 73.04 Favored 'Trans proline' 0 C--N 1.382 2.301 0 C-N-CA 123.196 2.597 . . . . 64.13 113.541 -173.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 10.3 m 50.99 75.89 0.17 Allowed 'General case' 0 C--O 1.246 0.916 0 C-N-CA 125.605 1.562 . . . . 74.2 111.489 177.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 18.8 pt -87.69 169.98 1.33 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.632 0 CA-C-N 115.51 -0.768 . . . . 74.25 109.437 177.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 75.1 mt 69.98 8.82 6.86 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.797 1.239 . . . . 73.12 111.871 -176.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.81 158.5 28.17 Favored 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 124.396 1.079 . . . . 72.23 109.457 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 157' ' ' MET . . . . . 0.562 ' HE3' ' HA ' ' B' ' 157' ' ' MET . 22.2 mmt -53.75 -59.42 4.64 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 124.894 1.278 . . . . 61.13 114.028 -166.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 158' ' ' ALA . . . . . . . . . . . . . . . -137.08 0.42 2.36 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 122.771 0.429 . . . . 65.11 111.705 -177.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . 0.507 ' HE3' ' HA ' ' B' ' 159' ' ' LYS . 0.4 OUTLIER 63.21 -80.78 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.486 1.515 . . . . 73.24 111.564 177.697 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -69.37 -55.48 10.26 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.245 0.618 . . . . 74.34 110.273 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -81.19 3.9 22.09 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 122.755 0.422 . . . . 71.1 111.503 175.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . -93.69 -40.78 4.6 Favored Glycine 0 C--N 1.35 1.318 0 O-C-N 123.398 0.436 . . . . 73.4 112.091 177.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . 0.504 HD22 ' HA ' ' B' ' 231' ' ' LYS . 3.1 tm? -94.29 -48.27 6.24 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.454 0.701 . . . . 75.25 110.382 -178.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 164' ' ' ALA . . . . . . . . . . . . . . . -70.44 -16.69 62.96 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 112.223 0.453 . . . . 75.34 112.223 -175.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 13.3 t -165.84 -177.95 4.53 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.194 0.997 . . . . 73.14 108.797 175.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . -118.39 54.93 0.6 Allowed Glycine 0 C--N 1.342 0.885 0 N-CA-C 109.62 -1.392 . . . . 74.53 109.62 172.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 167' ' ' ASN . . . . . . . . . . . . . 53.3 t30 65.13 -76.99 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 125.319 1.448 . . . . 74.33 109.988 -169.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 12.9 m -118.0 123.53 71.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 124.95 1.3 . . . . 75.53 107.949 174.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 43.9 m -134.68 111.21 9.8 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.368 0.667 . . . . 65.53 109.446 -175.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 26.1 m 65.57 85.38 0.14 Allowed 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.884 1.274 . . . . 73.13 111.393 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -154.53 -166.49 2.35 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-N 115.033 -0.985 . . . . 73.41 109.15 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 172' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -80.66 44.36 0.72 Allowed 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 112.649 0.611 . . . . 75.25 112.649 -177.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 173' ' ' LEU . . . . . . . . . . . . . 7.1 mp -73.26 -46.58 49.14 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 107.516 -1.29 . . . . 74.44 107.516 165.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 174' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -97.61 69.12 2.16 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 106.854 -1.536 . . . . 74.45 106.854 169.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 175' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -61.5 96.82 0.06 Allowed 'General case' 0 N--CA 1.48 1.04 0 CA-C-O 122.119 0.961 . . . . 74.1 110.844 -173.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -105.47 -20.35 13.51 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 114.806 -1.088 . . . . 74.11 110.676 -177.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 17.1 m -74.8 -43.2 4.93 Favored Pre-proline 0 CA--C 1.568 1.636 0 C-N-CA 123.893 0.877 . . . . 74.15 112.931 -177.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 178' ' ' PRO . . . . . 0.524 ' HG3' ' HG3' ' C' ' 129' ' ' GLU . 12.4 Cg_exo -69.65 127.32 14.52 Favored 'Trans proline' 0 C--N 1.39 2.745 0 C-N-CA 121.698 1.599 . . . . 74.53 111.257 175.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -61.4 -44.41 97.19 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-O 121.671 0.748 . . . . 74.35 110.822 176.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 180' ' ' ALA . . . . . 0.401 ' HB1' HG21 ' C' ' 137' ' ' VAL . . . -174.38 -43.15 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.561 1.544 . . . . 75.32 107.385 -177.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 181' ' ' LEU . . . . . 0.719 HD21 ' HB ' ' C' ' 138' ' ' VAL . 41.8 tp -177.25 -63.87 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 126.48 1.912 . . . . 74.44 106.878 169.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 182' ' ' VAL . . . . . . . . . . . . . 15.0 p -107.2 149.18 10.83 Favored 'Isoleucine or valine' 0 C--O 1.244 0.787 0 CA-C-N 114.461 -1.245 . . . . 72.43 108.556 175.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -76.33 -62.72 1.52 Allowed 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 109.088 -0.708 . . . . 65.24 109.088 172.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 26.1 t-80 -171.42 -95.06 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.72 0 O-C-N 124.335 1.022 . . . . 75.32 108.437 173.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 185' ' ' VAL . . . . . 0.566 ' HA ' ' HB3' ' C' ' 121' ' ' ALA . 58.5 t -140.0 113.66 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 CA-C-N 118.844 0.747 . . . . 74.01 110.305 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 186' ' ' THR . . . . . 0.54 ' HA ' ' HG2' ' C' ' 122' ' ' GLU . 58.6 p 62.12 4.6 1.25 Allowed 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 116.583 2.068 . . . . 60.24 116.583 162.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 187' ' ' SER . . . . . . . . . . . . . 49.0 m -147.16 107.48 4.06 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 119.378 0.99 . . . . 62.14 111.775 -174.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 18.8 tpt180 -173.02 150.44 1.99 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.468 0.707 . . . . 72.32 110.646 175.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -118.36 139.47 51.31 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.886 0.875 . . . . 72.52 108.992 166.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 190' ' ' CYS . . . . . 0.493 ' HB2' HD23 ' C' ' 181' ' ' LEU . 76.9 m -143.04 -174.39 4.17 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.895 0.878 . . . . 70.33 109.648 176.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 28.7 t80 77.13 147.01 0.09 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 125.501 1.52 . . . . 74.04 111.668 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -136.16 101.74 0.38 Allowed Glycine 0 C--N 1.34 0.752 0 N-CA-C 110.718 -0.953 . . . . 64.22 110.718 176.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 193' ' ' PRO . . . . . 0.427 ' HB3' HD23 ' B' ' 454' ' ' LEU . 94.0 Cg_endo -75.72 -10.87 20.18 Favored 'Trans proline' 0 C--N 1.372 1.789 0 C-N-CA 122.307 2.005 . . . . 73.22 113.596 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 194' ' ' SER . . . . . . . . . . . . . 23.0 t 69.05 176.59 0.27 Allowed 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 125.182 1.393 . . . . 63.44 111.142 -178.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 195' ' ' ALA . . . . . . . . . . . . . . . -123.71 29.96 6.37 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.339 1.056 . . . . 74.32 109.993 -179.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 91.3 m 67.84 -69.21 0.15 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.18 1.392 . . . . 73.32 109.898 -169.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 24.7 p -122.24 -81.43 0.64 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.242 1.017 . . . . 75.11 108.543 171.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 198' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -178.75 -40.45 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.583 1.153 . . . . 65.14 108.961 -174.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -163.61 131.58 3.61 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 106.898 -1.519 . . . . 75.14 106.898 177.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 200' ' ' CYS . . . . . . . . . . . . . 52.4 t 61.1 105.74 0.03 OUTLIER Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 124.783 1.233 . . . . 73.31 111.235 -177.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 201' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -75.51 66.82 6.43 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.857 2.371 . . . . 74.02 110.929 175.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . -76.95 119.54 5.43 Favored Glycine 0 C--N 1.346 1.112 0 CA-C-N 115.227 -0.897 . . . . 73.41 112.075 -174.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -159.76 -42.0 0.05 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.961 0.904 . . . . 71.33 108.814 176.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -157.57 119.86 3.81 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 124.046 0.938 . . . . 74.01 109.473 175.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 205' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -136.73 94.28 2.97 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 107.701 -1.222 . . . . 72.44 107.701 175.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 61.7 34.29 17.55 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 124.355 1.062 . . . . 70.3 110.915 175.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 9.1 tmtt? -70.17 112.49 6.56 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 108.978 -0.749 . . . . 74.32 108.978 -179.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 78.54 22.8 66.36 Favored Glycine 0 C--N 1.343 0.94 0 O-C-N 124.102 0.876 . . . . 71.52 112.524 -177.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . -67.83 81.55 0.17 Allowed Glycine 0 C--N 1.352 1.463 0 N-CA-C 111.787 -0.525 . . . . 63.34 111.787 177.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 18.0 tptm -83.12 136.15 34.56 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 123.543 0.737 . . . . 74.51 110.886 -171.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . -167.16 169.13 40.8 Favored Glycine 0 C--N 1.338 0.662 0 O-C-N 123.942 0.776 . . . . 74.43 111.597 174.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 22.9 t 67.84 -75.95 0.06 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.172 1.389 . . . . 74.04 111.356 176.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 46.1 mm -71.81 137.11 24.32 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 123.798 0.839 . . . . 70.12 109.558 178.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 214' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' B' ' 218' ' ' LEU . 10.4 t -88.67 -36.63 16.11 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.528 0.331 . . . . 75.43 110.218 178.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 215' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -66.41 158.91 28.16 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.25 1.02 . . . . 73.31 110.553 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 68.28 90.08 0.1 Allowed 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 124.53 1.132 . . . . 61.42 108.28 -167.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 75.6 mt 62.14 85.1 0.13 Allowed 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 108.328 -0.99 . . . . 75.4 108.328 -166.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . 0.412 ' HA ' ' O ' ' B' ' 214' ' ' THR . 36.7 tp -62.36 137.07 58.19 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 114.951 -1.022 . . . . 71.43 111.745 -168.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 66.22 13.47 9.18 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.793 1.237 . . . . 71.24 111.637 -177.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . 61.13 16.06 6.84 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.453 1.101 . . . . 74.3 111.493 -171.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 221' ' ' ARG . . . . . 0.514 ' HD2' HG13 ' B' ' 224' ' ' VAL . 0.0 OUTLIER -82.61 77.45 9.37 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 106.24 -1.763 . . . . 73.55 106.24 -179.175 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -66.93 -33.14 74.94 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 114.579 -1.191 . . . . 75.21 112.619 -167.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 223' ' ' ASP . . . . . 0.515 ' HA ' ' HB2' ' B' ' 226' ' ' LEU . 9.1 p-10 -81.47 13.92 2.77 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 113.24 0.83 . . . . 72.13 113.24 -169.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . 0.514 HG13 ' HD2' ' B' ' 221' ' ' ARG . 12.8 m -57.56 -39.53 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 CA-C-O 121.131 0.491 . . . . 75.32 110.528 169.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 25.3 p -89.45 -23.51 22.1 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.256 1.022 . . . . 73.55 111.194 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . 0.515 ' HB2' ' HA ' ' B' ' 223' ' ' ASP . 3.7 mm? -83.71 -173.65 4.84 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.351 0.66 . . . . 74.43 111.008 178.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . 158.66 48.66 0.01 OUTLIER Glycine 0 C--N 1.332 0.328 0 N-CA-C 107.572 -2.211 . . . . 71.24 107.572 -177.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 118.58 -159.38 14.39 Favored Glycine 0 C--O 1.243 0.707 0 CA-C-N 113.703 -1.248 . . . . 72.41 110.449 -162.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -177.59 -57.25 0.07 OUTLIER Glycine 0 C--N 1.341 0.823 0 N-CA-C 112.317 -0.313 . . . . 71.04 112.317 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -175.92 -41.12 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.955 0.902 . . . . 70.23 110.866 -175.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 231' ' ' LYS . . . . . 0.504 ' HA ' HD22 ' B' ' 163' ' ' LEU . 99.6 mttt -88.42 83.09 6.87 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.3 0.64 . . . . 73.24 111.178 -172.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 232' ' ' THR . . . . . 0.65 ' HA ' ' HB3' ' B' ' 150' ' ' ASP . 5.0 t -67.21 86.96 0.16 Allowed 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.873 0.844 . . . . 74.24 109.333 172.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 233' ' ' PHE . . . . . 0.426 ' HB2' ' HB2' ' B' ' 274' ' ' GLN . 81.6 m-85 -59.28 101.75 0.11 Allowed 'General case' 0 C--N 1.349 0.561 0 CA-C-N 114.341 -1.3 . . . . 71.44 112.038 -168.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -123.36 105.35 9.76 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 107.705 -1.22 . . . . 72.31 107.705 174.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -80.08 138.75 37.03 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-N 115.788 -0.642 . . . . 64.41 109.601 -176.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 236' ' ' THR . . . . . . . . . . . . . 31.7 p -73.86 96.61 2.62 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.082 0.553 . . . . 73.34 109.91 -178.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -72.13 77.0 0.96 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.708 0.803 . . . . 73.03 110.87 -177.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 30.7 m -152.32 149.69 28.93 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.827 1.251 . . . . 71.31 108.16 -177.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -168.05 -89.65 0.01 OUTLIER 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.059 0.944 . . . . 74.42 109.899 164.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . 159.11 -169.73 35.37 Favored Glycine 0 C--N 1.338 0.692 0 N-CA-C 111.404 -0.678 . . . . 71.23 111.404 -167.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 241' ' ' GLU . . . . . 0.453 ' HG3' ' HG3' ' C' ' 234' ' ' ARG . 9.7 pt-20 -93.04 -13.86 28.09 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 113.376 0.88 . . . . 71.23 113.376 -166.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 11.3 m95 55.9 -88.12 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 124.242 1.017 . . . . 70.32 111.706 -177.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 243' ' ' GLN . . . . . 0.499 ' HA ' ' NH2' ' C' ' 234' ' ' ARG . 9.9 pt20 173.67 -37.77 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 126.438 1.895 . . . . 74.22 108.059 -166.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -175.94 128.0 1.32 Allowed Glycine 0 C--N 1.348 1.247 0 N-CA-C 110.033 -1.227 . . . . 71.54 110.033 177.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 245' ' ' LYS . . . . . 0.606 ' HA ' ' HB3' ' C' ' 224' ' ' PRO . 0.0 OUTLIER -158.91 124.96 4.48 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.582 0.753 . . . . 75.34 110.128 -172.336 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 14.9 t -129.5 -166.69 1.69 Allowed 'General case' 0 CA--C 1.563 1.447 0 C-N-CA 123.54 0.736 . . . . 71.14 111.187 -170.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 247' ' ' LEU . . . . . . . . . . . . . 4.7 tt -42.0 126.64 3.26 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 126.738 2.015 . . . . 72.51 114.08 -176.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 248' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.43 116.63 32.77 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.675 0.79 . . . . 75.15 108.965 170.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -169.94 158.98 7.52 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 106.092 -1.818 . . . . 71.33 106.092 178.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 250' ' ' GLN . . . . . 0.483 ' HA ' ' HE2' ' A' ' 270' ' ' LYS . 18.7 tt0 -60.22 -28.88 68.36 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 118.909 0.777 . . . . 70.14 110.749 176.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 251' ' ' ALA . . . . . . . . . . . . . . . 71.85 -64.14 0.4 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.836 1.654 . . . . 64.21 111.491 171.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . 0.576 HE21 ' HA ' ' B' ' 252' ' ' GLN . 0.0 OUTLIER -88.85 72.26 8.54 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 108.884 -0.784 . . . . 73.12 108.884 170.613 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 253' ' ' ALA . . . . . 0.531 ' HB1' ' HB3' ' B' ' 256' ' ' TYR . . . -97.04 -48.53 5.36 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.274 -0.875 . . . . 51.41 109.822 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? 61.77 -83.12 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.628 1.571 . . . . 72.51 112.265 176.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -90.91 -38.88 5.94 Favored Glycine 0 C--N 1.345 1.047 0 N-CA-C 111.539 -0.624 . . . . 63.32 111.539 178.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 256' ' ' TYR . . . . . 0.531 ' HB3' ' HB1' ' B' ' 253' ' ' ALA . 33.1 p90 40.7 47.49 2.44 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 125.615 1.566 . . . . 71.2 112.069 -177.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -60.75 118.04 6.13 Favored 'General case' 0 C--N 1.35 0.59 0 CA-C-N 114.659 -1.155 . . . . 74.31 110.731 -173.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 258' ' ' LEU . . . . . 0.535 ' HA ' ' HB2' ' B' ' 263' ' ' ALA . 4.7 tt 74.8 -71.61 0.13 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.769 1.628 . . . . 75.13 109.862 178.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . 0.542 HG23 ' H ' ' B' ' 260' ' ' SER 0.272 19.6 m 44.25 -76.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 C-N-CA 126.805 2.042 . . . . 63.31 113.849 -176.609 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 260' ' ' SER . . . . . 0.542 ' H ' HG23 ' B' ' 259' ' ' VAL . 61.5 p -163.14 144.72 9.81 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.812 1.245 . . . . 73.11 108.49 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 73.01 -66.43 0.31 Allowed 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.899 1.279 . . . . 65.51 113.719 168.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 262' ' ' ALA . . . . . . . . . . . . . . . -44.58 -59.92 2.23 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.909 1.283 . . . . 75.22 113.121 -176.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 263' ' ' ALA . . . . . 0.535 ' HB2' ' HA ' ' B' ' 258' ' ' LEU . . . -101.02 -4.74 26.89 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 122.623 0.369 . . . . 70.44 111.61 178.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 264' ' ' SER . . . . . 0.413 ' HB2' HD13 ' B' ' 265' ' ' LEU . 12.4 m -85.82 -67.99 0.77 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 122.836 0.455 . . . . 51.14 110.302 -178.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 265' ' ' LEU . . . . . 0.413 HD13 ' HB2' ' B' ' 264' ' ' SER . 5.4 mp -95.12 -28.73 14.93 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.332 0.653 . . . . 73.31 111.401 -175.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 266' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 66.15 -72.29 0.08 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 125.12 1.368 . . . . 71.52 109.735 -166.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 24.6 p -75.82 89.18 2.87 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 108.057 -1.09 . . . . 73.13 108.057 167.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . 0.528 HG22 ' HB3' ' B' ' 270' ' ' GLU . 4.3 p -53.85 -45.12 62.35 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 124.333 1.053 . . . . 74.44 112.003 -175.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 269' ' ' THR . . . . . . . . . . . . . 30.1 p 44.11 39.44 2.85 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 125.427 1.491 . . . . 74.31 112.259 177.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 270' ' ' GLU . . . . . 0.528 ' HB3' HG22 ' B' ' 268' ' ' VAL . 0.0 OUTLIER -60.35 -19.66 56.42 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.781 1.232 . . . . 72.41 113.254 -169.531 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 271' ' ' ALA . . . . . 0.527 ' HB1' ' HB3' ' B' ' 152' ' ' PRO . . . 63.73 21.8 12.83 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 124.468 1.107 . . . . 75.3 111.753 177.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 272' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 57.85 33.7 23.51 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.924 1.289 . . . . 73.11 110.569 -175.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 273' ' ' GLN . . . . . 0.624 ' HB2' ' HA ' ' B' ' 149' ' ' LYS . 27.3 mm-40 -118.85 136.15 54.18 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.47 0.708 . . . . 73.43 109.896 178.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 274' ' ' GLN . . . . . 0.426 ' HB2' ' HB2' ' B' ' 233' ' ' PHE . 17.6 tt0 76.45 -58.85 0.52 Allowed 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 126.449 1.9 . . . . 71.44 113.298 175.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 275' ' ' LYS . . . . . 0.569 ' HE2' ' HB3' ' B' ' 148' ' ' GLU . 74.6 mmtt -54.78 109.48 1.6 Allowed Pre-proline 0 N--CA 1.478 0.938 0 C-N-CA 124.448 1.099 . . . . 72.14 112.566 -164.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -67.02 115.33 3.56 Favored 'Trans proline' 0 C--N 1.383 2.389 0 C-N-CA 122.32 2.013 . . . . 73.04 110.25 176.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 277' ' ' LEU . . . . . . . . . . . . . 96.3 mt -58.36 133.49 55.77 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.608 0.763 . . . . 74.52 111.422 -177.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 1.2 pp -86.2 13.95 7.16 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.894 0.878 . . . . 72.2 112.823 -173.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . -75.13 -110.71 0.1 OUTLIER Glycine 0 C--N 1.351 1.365 0 O-C-N 123.312 0.382 . . . . 75.43 112.432 -178.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 2.6 tt -142.56 -80.88 0.21 Allowed 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 107.117 -1.438 . . . . 74.31 107.117 176.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 68.67 -62.12 0.39 Allowed 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 125.778 1.631 . . . . 75.31 112.791 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 282' ' ' ALA . . . . . 0.497 ' HB2' ' HG3' ' B' ' 245' ' ' LYS . . . 74.68 -74.05 0.09 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.873 1.669 . . . . 65.41 109.0 -174.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -151.24 118.54 5.98 Favored 'General case' 0 C--O 1.245 0.865 0 N-CA-C 107.618 -1.253 . . . . 72.33 107.618 174.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . 61.74 -96.17 0.12 Allowed Glycine 0 C--N 1.351 1.377 0 O-C-N 123.935 0.772 . . . . 72.13 111.297 -174.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -146.88 86.12 1.64 Allowed 'General case' 0 C--O 1.244 0.766 0 N-CA-C 107.897 -1.149 . . . . 73.03 107.897 173.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 286' ' ' MET . . . . . 0.543 ' HE3' ' HA ' ' B' ' 286' ' ' MET . 6.3 mmt 68.96 163.81 0.14 Allowed Pre-proline 0 CA--C 1.558 1.256 0 C-N-CA 124.674 1.189 . . . . 74.22 113.099 173.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 287' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -71.04 -2.72 11.52 Favored 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 122.647 2.231 . . . . 74.24 112.761 167.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 288' ' ' VAL . . . . . . . . . . . . . 94.6 t 71.57 -73.35 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.366 1.291 0 C-N-CA 125.591 1.556 . . . . 74.32 110.878 176.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 289' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -135.19 -53.63 0.79 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.577 0.751 . . . . 74.32 109.839 178.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 290' ' ' TRP . . . . . . . . . . . . . 47.4 p90 -66.94 146.06 54.78 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.403 -0.817 . . . . 75.34 111.864 -174.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 291' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -111.15 -52.97 2.75 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 108.516 -0.92 . . . . 73.52 108.516 175.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . -143.71 69.79 0.41 Allowed Glycine 0 C--N 1.348 1.199 0 CA-C-N 115.573 -0.74 . . . . 71.42 112.669 -178.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -80.64 -36.21 0.47 Allowed 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 122.461 2.108 . . . . 75.13 112.956 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 294' ' ' LYS . . . . . 0.596 ' HD2' ' HH ' ' C' ' 250' ' ' TYR . 5.4 tmtp? -91.31 85.81 5.94 Favored 'General case' 0 C--N 1.356 0.881 0 N-CA-C 108.329 -0.989 . . . . 74.44 108.329 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -157.13 124.04 5.11 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 114.65 -1.159 . . . . 71.35 108.787 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 14.8 t -151.39 169.86 20.96 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 123.562 0.745 . . . . 71.52 109.906 179.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -125.61 -159.21 0.89 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.285 1.034 . . . . 75.44 109.557 -175.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 42.2 m80 73.96 -76.69 0.06 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.219 1.407 . . . . 73.43 110.477 178.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . 98.06 156.99 29.99 Favored Glycine 0 C--N 1.349 1.263 0 N-CA-C 111.606 -0.597 . . . . 72.35 111.606 -175.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -85.04 -57.48 3.08 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 109.681 -0.488 . . . . 72.23 109.681 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 301' ' ' ILE . . . . . . . . . . . . . 35.1 pt -134.63 -172.66 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 123.838 0.855 . . . . 75.13 110.025 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 26.5 t70 70.33 8.15 6.51 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 125.026 1.33 . . . . 74.32 112.967 174.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 303' ' ' LYS . . . . . 0.458 ' N ' ' HD2' ' B' ' 304' ' ' PRO . 39.7 mtmt -72.52 -29.31 1.17 Allowed Pre-proline 0 CA--C 1.562 1.404 0 C-N-CA 124.581 1.153 . . . . 74.11 112.735 173.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 304' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' B' ' 33' ' ' ALA . 43.7 Cg_endo -67.59 -8.72 23.12 Favored 'Trans proline' 0 C--N 1.397 3.119 0 CA-C-N 121.345 1.516 . . . . 75.12 112.697 164.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . 67.49 26.22 8.27 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 125.07 1.348 . . . . 72.13 111.94 176.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . 0.58 HG13 ' H ' ' B' ' 307' ' ' THR . 2.2 p -129.2 -84.77 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 CA-C-N 115.746 -0.661 . . . . 72.33 109.925 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 307' ' ' THR . . . . . 0.58 ' H ' HG13 ' B' ' 306' ' ' VAL . 3.0 m 70.61 -23.91 0.17 Allowed 'General case' 0 CA--C 1.566 1.567 0 C-N-CA 125.786 1.635 . . . . 74.23 113.549 178.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 308' ' ' CYS . . . . . 0.495 ' SG ' HG12 ' C' ' 177' ' ' VAL . 39.7 t -76.79 -115.84 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 124.19 0.996 . . . . 74.22 109.399 177.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 309' ' ' THR . . . . . 0.461 ' HB ' ' HG3' ' B' ' 372' ' ' GLN . 88.9 m 52.55 98.83 0.04 OUTLIER Pre-proline 0 CA--C 1.561 1.375 0 C-N-CA 124.442 1.097 . . . . 72.2 111.881 -177.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -77.39 56.84 5.68 Favored 'Trans proline' 0 CA--C 1.557 1.648 0 C-N-CA 122.591 2.194 . . . . 64.44 112.628 178.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 311' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -133.67 -52.6 0.03 OUTLIER Pre-proline 0 CA--C 1.567 1.615 0 CA-C-O 117.609 -1.186 . . . . 73.13 112.971 -175.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 312' ' ' PRO . . . . . 0.516 ' HB3' ' HA2' ' B' ' 36' ' ' GLY . 32.4 Cg_exo -58.13 116.03 2.95 Favored 'Trans proline' 0 C--N 1.399 3.216 0 C-N-CA 122.014 1.809 . . . . 70.14 111.954 177.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 313' ' ' GLN . . . . . 0.57 ' HG2' ' HG2' ' B' ' 41' ' ' PRO . 26.3 pt20 -165.21 17.12 0.04 OUTLIER 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 113.718 1.006 . . . . 75.13 113.718 -171.001 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 314' ' ' ARG . . . . . 0.563 ' HG2' ' HD3' ' B' ' 41' ' ' PRO . 18.0 mmt85 -61.78 -68.76 0.29 Allowed 'General case' 0 N--CA 1.501 2.108 0 CA-C-N 120.412 1.46 . . . . 74.53 109.887 176.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 315' ' ' ASN . . . . . 0.619 ' HB2' ' HZ2' ' C' ' 115' ' ' LYS . 6.0 t30 -173.04 126.3 0.45 Allowed 'General case' 0 N--CA 1.473 0.677 0 O-C-N 124.025 0.828 . . . . 75.34 109.265 170.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 316' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -79.57 -75.35 0.25 Allowed 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 109.059 -0.719 . . . . 74.4 109.059 169.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 68.6 m -156.41 177.1 11.84 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.52 0.728 . . . . 75.41 110.987 -176.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 318' ' ' VAL . . . . . . . . . . . . . 34.7 m -110.77 146.63 34.8 Favored Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 123.802 0.841 . . . . 73.13 109.356 172.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 319' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -78.7 159.14 28.26 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.593 2.195 . . . . 65.1 112.551 175.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 320' ' ' THR . . . . . . . . . . . . . 22.5 p -138.36 10.63 2.75 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.236 1.014 . . . . 73.24 110.65 178.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 321' ' ' LEU . . . . . . . . . . . . . 58.6 tp -96.81 143.32 27.83 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.393 0.677 . . . . 74.43 111.15 -175.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 322' ' ' ALA . . . . . . . . . . . . . . . -88.87 116.29 27.04 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 107.775 -1.194 . . . . 64.54 107.775 165.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 323' ' ' GLN . . . . . 0.667 ' HG3' ' SD ' ' B' ' 324' ' ' MET . 10.8 pt20 -60.98 -37.79 83.7 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 113.097 0.777 . . . . 74.02 113.097 -170.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 324' ' ' MET . . . . . 0.667 ' SD ' ' HG3' ' B' ' 323' ' ' GLN . 0.1 OUTLIER -162.62 168.8 21.18 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 112.083 0.401 . . . . 74.22 112.083 173.884 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 325' ' ' THR . . . . . 0.705 HG23 HD11 ' B' ' 348' ' ' ILE . 41.9 p -84.75 -107.51 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 124.155 0.982 . . . . 72.33 111.767 -174.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 326' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -174.4 154.27 2.09 Favored 'General case' 0 C--N 1.362 1.13 0 C-N-CA 124.275 1.03 . . . . 72.01 109.436 -175.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 81.8 tttt 176.71 41.84 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.315 0 C-N-CA 125.747 1.619 . . . . 75.41 108.733 170.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 328' ' ' ALA . . . . . . . . . . . . . . . 73.6 91.34 0.09 Allowed 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 125.303 1.441 . . . . 72.03 111.83 177.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 329' ' ' ILE . . . . . 0.473 HG21 ' HG3' ' B' ' 330' ' ' GLU . 10.7 tt -145.09 166.69 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.447 1.099 . . . . 73.5 109.127 173.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 330' ' ' GLU . . . . . 0.473 ' HG3' HG21 ' B' ' 329' ' ' ILE . 44.6 mt-10 71.42 99.22 0.07 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.06 1.344 . . . . 74.44 113.279 170.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 331' ' ' LEU . . . . . . . . . . . . . 1.2 pt? 41.28 -73.76 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 117.465 2.394 . . . . 64.42 117.465 167.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 332' ' ' LEU . . . . . 0.464 HD21 HG23 ' C' ' 18' ' ' THR . 3.2 tm? 76.63 -66.07 0.27 Allowed 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 125.827 1.651 . . . . 74.41 108.663 -163.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 333' ' ' SER . . . . . . . . . . . . . 27.8 p -111.65 -61.14 1.75 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.634 0.773 . . . . 65.04 110.053 -176.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 334' ' ' LYS . . . . . 0.565 ' HA ' ' HE2' ' B' ' 334' ' ' LYS . 9.9 mmpt? -120.93 132.12 54.75 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.169 0.987 . . . . 65.35 110.387 -176.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 335' ' ' ASN . . . . . 0.503 ' HB2' HD13 ' B' ' 341' ' ' LEU . 2.8 p-10 -92.34 -12.16 33.14 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.877 0.871 . . . . 74.12 111.109 -178.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -80.73 -5.77 57.54 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.069 0.947 . . . . 73.55 110.774 -177.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 337' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -58.9 128.77 38.9 Favored 'General case' 0 C--N 1.36 1.061 0 C-N-CA 123.86 0.864 . . . . 71.1 111.274 -177.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 338' ' ' GLY . . . . . . . . . . . . . . . 79.01 -67.07 3.31 Favored Glycine 0 C--N 1.346 1.116 0 N-CA-C 110.767 -0.933 . . . . 73.12 110.767 -170.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 339' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -166.05 -47.52 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.542 1.137 . . . . 74.33 108.894 172.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 340' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -169.78 91.65 0.21 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.405 -0.961 . . . . 75.24 108.405 -177.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 341' ' ' LEU . . . . . 0.503 HD13 ' HB2' ' B' ' 335' ' ' ASN . 5.1 mp 48.17 52.94 12.51 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.967 1.307 . . . . 75.34 112.962 174.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 342' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -73.56 -13.96 61.12 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 111.575 0.213 . . . . 74.32 111.575 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 343' ' ' VAL . . . . . . . . . . . . . 7.4 p -62.14 142.0 17.04 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 123.257 0.623 . . . . 65.15 109.448 171.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -130.69 144.19 51.26 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.437 1.095 . . . . 74.33 109.106 -178.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 345' ' ' GLY . . . . . . . . . . . . . . . -169.73 -78.74 0.04 OUTLIER Glycine 0 C--N 1.346 1.111 0 CA-C-O 119.845 -0.42 . . . . 63.14 112.927 -176.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 346' ' ' ALA . . . . . . . . . . . . . . . -57.64 115.69 2.94 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.525 0.73 . . . . 72.51 111.054 177.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 347' ' ' SER . . . . . 0.481 ' HB2' ' H ' ' B' ' 352' ' ' ASP . 61.3 p -166.75 21.85 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 113.373 0.879 . . . . 72.21 113.373 -172.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 348' ' ' ILE . . . . . 0.705 HD11 HG23 ' B' ' 325' ' ' THR . 14.9 mm 59.54 43.59 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 CA-C-O 122.346 1.069 . . . . 73.42 108.979 -173.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 349' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 60.93 15.06 5.73 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 114.812 -1.085 . . . . 71.13 112.765 173.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 350' ' ' LYS . . . . . 0.495 ' HZ2' ' HB2' ' B' ' 350' ' ' LYS . 4.6 ttmp? -141.65 112.08 7.02 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 107.59 -1.263 . . . . 74.52 107.59 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -62.51 91.76 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.836 0 O-C-N 124.063 0.852 . . . . 71.32 112.392 -163.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 352' ' ' ASP . . . . . 0.481 ' H ' ' HB2' ' B' ' 347' ' ' SER . 21.6 t70 -164.74 -79.2 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.257 1.423 . . . . 74.35 107.238 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 353' ' ' HIS . . . . . . . . . . . . . 4.9 t60 165.47 -39.7 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 125.798 1.639 . . . . 74.33 107.53 -178.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 354' ' ' ALA . . . . . . . . . . . . . . . 67.59 -95.9 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 126.106 1.762 . . . . 72.23 110.749 -175.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 355' ' ' ALA . . . . . . . . . . . . . . . 54.53 25.07 5.85 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 124.248 1.019 . . . . 75.44 112.618 -176.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 356' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -68.31 -46.15 38.5 Favored Pre-proline 0 CA--C 1.562 1.417 0 N-CA-C 113.804 1.038 . . . . 74.32 113.804 -175.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 357' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -72.72 77.82 2.18 Favored 'Trans proline' 0 C--N 1.395 3.004 0 C-N-CA 122.027 1.818 . . . . 74.21 113.175 -175.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 358' ' ' CYS . . . . . . . . . . . . . 85.3 m -103.85 160.16 15.03 Favored 'General case' 0 C--O 1.246 0.886 0 C-N-CA 123.402 0.681 . . . . 75.21 109.64 176.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 359' ' ' GLY . . . . . . . . . . . . . . . -73.12 82.88 0.63 Allowed Glycine 0 C--N 1.347 1.162 0 N-CA-C 110.899 -0.88 . . . . 72.04 110.899 173.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 360' ' ' GLN . . . . . 0.404 ' NE2' ' H ' ' B' ' 360' ' ' GLN . 0.3 OUTLIER -48.07 -51.49 24.18 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 124.707 1.203 . . . . 53.34 112.58 -176.921 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 361' ' ' ILE . . . . . . . . . . . . . 3.6 mp -109.52 78.93 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 N-CA-C 107.011 -1.477 . . . . 64.41 107.011 167.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 362' ' ' GLY . . . . . . . . . . . . . . . -174.06 -73.53 0.05 OUTLIER Glycine 0 C--N 1.344 0.974 0 CA-C-N 115.234 -0.894 . . . . 72.35 111.831 177.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 363' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -82.17 -0.73 46.32 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.954 0.901 . . . . 73.13 112.371 -171.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 364' ' ' THR . . . . . . . . . . . . . 3.0 t -160.84 77.58 0.59 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.703 0.801 . . . . 74.04 110.553 -178.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 31.4 t -125.71 -18.53 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 C-N-CA 123.195 0.598 . . . . 74.51 111.181 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 35.2 t0 68.55 28.37 5.89 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 124.712 1.205 . . . . 52.52 108.372 -167.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 367' ' ' LEU . . . . . . . . . . . . . 2.2 tt 55.74 -105.74 0.29 Allowed 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 126.228 1.811 . . . . 75.05 109.94 -178.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 368' ' ' ASP . . . . . . . . . . . . . 4.6 t70 179.24 -145.16 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.607 -0.886 . . . . 73.23 108.607 -170.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 369' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 73.34 -73.53 0.1 Allowed 'General case' 0 C--N 1.36 1.054 0 C-N-CA 126.174 1.79 . . . . 74.11 111.875 170.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 370' ' ' ALA . . . . . . . . . . . . . . . -94.03 172.38 8.26 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.337 0.655 . . . . 74.25 110.51 177.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 371' ' ' VAL . . . . . 0.418 HG13 ' H ' ' B' ' 26' ' ' MET . 6.1 p -132.12 77.43 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 C-N-CA 122.953 0.501 . . . . 74.12 109.844 177.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 372' ' ' GLN . . . . . 0.461 ' HG3' ' HB ' ' B' ' 309' ' ' THR . 2.8 mp0 69.73 -63.37 0.39 Allowed 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 125.173 1.389 . . . . 63.2 112.265 176.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 373' ' ' ARG . . . . . 0.448 ' HD3' ' HB1' ' B' ' 40' ' ' ALA . 55.9 mtp180 83.82 -4.14 1.13 Allowed 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 126.53 1.932 . . . . 72.2 112.758 169.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 374' ' ' ALA . . . . . 0.437 ' HB3' HG21 ' B' ' 309' ' ' THR . . . -74.82 -8.6 56.93 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.131 0.491 . . . . 71.45 111.023 171.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 375' ' ' LEU . . . . . 0.412 ' HG ' ' HE2' ' B' ' 62' ' ' LYS . 2.9 mm? -70.92 -6.17 36.41 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.775 1.23 . . . . 72.22 110.957 173.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.23 -24.11 67.25 Favored 'General case' 0 C--N 1.355 0.84 0 C-N-CA 123.432 0.693 . . . . 73.13 110.437 170.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 377' ' ' PHE . . . . . 0.408 ' HE1' ' HB2' ' B' ' 47' ' ' LEU . 3.4 t80 -94.12 57.64 2.41 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.717 0.807 . . . . 73.31 109.868 -179.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 378' ' ' ALA . . . . . . . . . . . . . . . -73.41 1.65 9.28 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 115.017 -0.992 . . . . 73.45 110.256 165.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . 0.451 ' O ' ' HG3' ' B' ' 380' ' ' LYS . 29.0 mttt -70.66 -9.71 57.68 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 126.424 1.89 . . . . 73.22 110.714 169.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 380' ' ' LYS . . . . . 0.697 ' HD2' ' HB2' ' B' ' 408' ' ' LEU 0.287 0.0 OUTLIER 54.88 140.42 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 127.82 2.448 . . . . 72.4 114.352 -175.783 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' B' B ' 381' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -75.6 165.22 25.41 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.711 0.804 . . . . 74.34 112.607 -175.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . 80.67 -69.82 3.13 Favored Glycine 0 C--N 1.351 1.408 0 CA-C-N 115.501 -0.772 . . . . 73.1 111.478 -176.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 383' ' ' ASN . . . . . . . . . . . . . 7.2 t30 63.4 68.9 0.58 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.895 1.278 . . . . 73.1 111.081 174.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 384' ' ' THR . . . . . 0.581 ' HA ' HG13 ' B' ' 388' ' ' VAL . 3.5 m -150.43 0.31 0.43 Allowed 'General case' 0 CA--C 1.558 1.278 0 CA-C-N 114.913 -1.04 . . . . 71.44 110.109 177.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 385' ' ' LEU . . . . . 0.461 HD12 ' HB2' ' B' ' 415' ' ' LYS . 3.3 mm? -51.6 -53.33 39.46 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 126.094 1.758 . . . . 75.43 111.846 -172.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 386' ' ' VAL . . . . . 0.66 ' HB ' ' HB2' ' B' ' 390' ' ' ALA . 18.4 t -125.43 77.76 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 N-CA-C 108.739 -0.838 . . . . 75.23 108.739 176.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 387' ' ' ILE . . . . . . . . . . . . . 20.8 mm 58.48 27.41 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 C-N-CA 124.678 1.191 . . . . 74.12 110.753 173.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 388' ' ' VAL . . . . . 0.581 HG13 ' HA ' ' B' ' 384' ' ' THR . 1.5 m 63.41 -0.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 C-N-CA 126.494 1.917 . . . . 74.43 113.404 -177.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 389' ' ' THR . . . . . . . . . . . . . 9.3 t -128.1 37.64 4.13 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.755 -0.59 . . . . 71.25 111.481 -166.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 390' ' ' ALA . . . . . 0.66 ' HB2' ' HB ' ' B' ' 386' ' ' VAL . . . -153.63 -79.25 0.1 Allowed 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 108.492 -0.929 . . . . 73.41 108.492 170.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 391' ' ' ASP . . . . . 0.61 ' HB3' ' HZ3' ' B' ' 380' ' ' LYS . 1.4 m-20 54.27 78.25 0.17 Allowed 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 116.188 1.921 . . . . 64.12 116.188 155.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 392' ' ' HIS . . . . . 0.488 ' HB3' HG23 ' A' ' 177' ' ' VAL . 11.1 t-80 179.32 142.57 0.13 Allowed 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 122.993 0.517 . . . . 72.42 111.059 160.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -118.06 145.01 45.13 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 107.582 -1.266 . . . . 61.53 107.582 166.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 394' ' ' HIS . . . . . 0.406 ' NE2' ' HB3' ' B' ' 397' ' ' GLN . 30.9 t60 -108.21 -26.74 10.43 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 118.047 0.385 . . . . 73.31 111.423 -175.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . 64.75 31.87 11.51 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.818 1.247 . . . . 75.42 113.104 171.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 23.9 t 62.37 31.19 17.39 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.634 1.174 . . . . 75.55 110.051 177.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 397' ' ' GLN . . . . . 0.406 ' HB3' ' NE2' ' B' ' 394' ' ' HIS . 16.2 pm0 44.25 29.69 0.39 Allowed 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 126.663 1.985 . . . . 75.54 113.987 -174.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 66.9 mt -70.61 93.38 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 107.395 -1.335 . . . . 75.44 107.395 173.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 399' ' ' VAL . . . . . 0.533 ' HA ' ' HA ' ' B' ' 63' ' ' PRO . 73.6 t 65.16 -82.04 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.209 0 C-N-CA 124.848 1.259 . . . . 73.32 109.556 -170.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 400' ' ' ALA . . . . . 0.428 ' HB2' ' HB ' ' B' ' 403' ' ' THR . . . 167.65 145.83 0.06 OUTLIER Pre-proline 0 N--CA 1.484 1.242 0 C-N-CA 126.278 1.831 . . . . 74.52 108.554 175.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 401' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -67.54 -43.94 5.11 Favored 'Trans proline' 0 C--N 1.373 1.84 0 C-N-CA 122.576 2.184 . . . . 71.34 110.844 170.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -86.95 22.82 1.9 Allowed 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.072 1.349 . . . . 74.34 111.55 -177.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 403' ' ' THR . . . . . 0.486 ' O ' ' HB ' ' B' ' 306' ' ' VAL . 15.1 t -64.79 -26.29 68.28 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 112.913 0.709 . . . . 73.2 112.913 -170.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 404' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -86.05 -64.11 1.21 Allowed 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 108.712 -0.847 . . . . 71.14 108.712 172.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 405' ' ' ALA . . . . . 0.516 ' HB1' ' HD3' ' B' ' 406' ' ' PRO . . . -176.03 -56.42 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.342 0 C-N-CA 124.702 1.201 . . . . 71.24 109.966 177.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 406' ' ' PRO . . . . . 0.516 ' HD3' ' HB1' ' B' ' 405' ' ' ALA . 59.1 Cg_endo -97.47 98.72 0.07 OUTLIER 'Trans proline' 0 C--N 1.394 2.94 0 C-N-CA 122.464 2.11 . . . . 64.23 111.818 176.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . -73.82 -57.89 4.7 Favored Glycine 0 C--N 1.341 0.86 0 N-CA-C 111.329 -0.708 . . . . 74.04 111.329 175.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 408' ' ' LEU . . . . . 0.697 ' HB2' ' HD2' ' B' ' 380' ' ' LYS . 4.2 mp -110.83 137.64 48.23 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 108.553 -0.906 . . . . 72.55 108.553 178.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 90.0 m -146.76 141.73 27.03 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.601 0.761 . . . . 73.52 109.578 -174.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 410' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 73.44 153.67 0.14 Allowed 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 125.054 1.342 . . . . 70.42 112.09 173.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . -113.08 161.99 16.44 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.415 0.686 . . . . 74.33 111.242 -178.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 68.35 125.64 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 125.341 1.456 . . . . 75.21 111.435 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 413' ' ' ASN . . . . . 0.445 HD21 ' N ' ' B' ' 413' ' ' ASN . 0.7 OUTLIER 69.85 9.29 7.08 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 125.221 1.408 . . . . 71.14 111.405 -173.518 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 414' ' ' THR . . . . . . . . . . . . . 41.5 p -113.66 -49.61 2.88 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.671 0.788 . . . . 73.24 111.347 -169.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 415' ' ' LYS . . . . . 0.485 ' HA ' ' HA3' ' A' ' 190' ' ' GLY . 35.2 tttp -150.58 36.83 0.65 Allowed 'General case' 0 N--CA 1.485 1.295 0 CA-C-O 121.975 0.893 . . . . 75.21 110.757 -176.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.1 -15.85 62.54 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 114.482 -1.236 . . . . 75.33 112.755 -176.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 417' ' ' GLY . . . . . . . . . . . . . . . -54.62 102.47 0.14 Allowed Glycine 0 C--N 1.352 1.472 0 O-C-N 123.982 0.801 . . . . 62.31 114.541 -173.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 418' ' ' ALA . . . . . . . . . . . . . . . -90.22 18.6 5.82 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.849 1.26 . . . . 70.25 111.354 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 419' ' ' VAL . . . . . 0.512 HG11 ' H ' ' B' ' 420' ' ' MET . 3.4 t 67.63 179.38 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.57 1.718 0 C-N-CA 125.492 1.517 . . . . 73.31 110.231 175.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 420' ' ' MET . . . . . 0.592 ' HE2' ' HA2' ' B' ' 425' ' ' GLY . 42.2 ttp 77.2 89.98 0.07 Allowed 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.644 1.178 . . . . 73.34 111.285 171.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 421' ' ' VAL . . . . . . . . . . . . . 41.2 t -80.89 -19.98 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 C-N-CA 123.744 0.818 . . . . 72.42 111.519 -174.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 422' ' ' MET . . . . . . . . . . . . . 18.2 ptm -63.0 90.78 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.421 0.688 . . . . 74.1 112.48 -173.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 423' ' ' SER . . . . . . . . . . . . . 32.6 t 56.33 -91.16 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.27 1.428 . . . . 63.45 112.202 175.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 424' ' ' TYR . . . . . 0.48 ' HD1' ' HA ' ' B' ' 428' ' ' GLU . 87.1 m-85 -92.0 117.55 29.93 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.963 -0.754 . . . . 74.22 108.963 -178.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 425' ' ' GLY . . . . . 0.592 ' HA2' ' HE2' ' B' ' 420' ' ' MET . . . -137.89 144.81 16.23 Favored Glycine 0 C--O 1.241 0.567 0 N-CA-C 110.207 -1.157 . . . . 75.12 110.207 176.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 426' ' ' ASN . . . . . . . . . . . . . 10.4 t30 66.68 -73.21 0.08 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.603 1.161 . . . . 75.43 110.175 -175.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 427' ' ' SER . . . . . . . . . . . . . 22.8 t -161.96 103.14 1.15 Allowed 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 107.805 -1.183 . . . . 75.14 107.805 173.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 428' ' ' GLU . . . . . 0.48 ' HA ' ' HD1' ' B' ' 424' ' ' TYR . 3.4 mp0 59.23 -97.98 0.08 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.59 1.156 . . . . 73.23 111.193 -177.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 429' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 56.67 23.39 7.75 Favored 'General case' 0 C--N 1.362 1.117 0 C-N-CA 124.651 1.181 . . . . 63.42 112.984 -177.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -123.46 78.37 1.58 Allowed 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.554 0.692 . . . . 62.42 109.558 -172.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 19.3 m -88.56 -57.75 2.8 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.574 1.15 . . . . 75.05 111.464 177.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 432' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.92 11.25 1.06 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 122.671 0.388 . . . . 71.1 110.824 177.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 433' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -132.7 -171.24 2.61 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.203 0.601 . . . . 73.43 111.014 -170.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 434' ' ' HIS . . . . . . . . . . . . . 41.8 m80 74.84 -102.43 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.327 1.451 . . . . 73.42 111.547 -176.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 435' ' ' THR . . . . . 0.539 ' HB ' ' HB2' ' B' ' 438' ' ' GLN . 28.1 m 48.19 -81.02 0.0 OUTLIER 'General case' 0 CA--C 1.569 1.673 0 C-N-CA 125.234 1.414 . . . . 73.42 112.886 -174.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . -166.73 -80.41 0.04 OUTLIER Glycine 0 C--N 1.348 1.22 0 N-CA-C 109.704 -1.358 . . . . 61.51 109.704 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 44.5 t -78.99 -74.58 0.28 Allowed 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 107.993 -1.114 . . . . 72.35 107.993 170.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 438' ' ' GLN . . . . . 0.539 ' HB2' ' HB ' ' B' ' 435' ' ' THR . 53.7 tp60 61.75 -72.31 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 125.686 1.594 . . . . 71.55 114.409 165.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 439' ' ' LEU . . . . . . . . . . . . 0.313 0.3 OUTLIER 46.66 -92.26 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 126.751 2.02 . . . . 74.24 113.311 -174.304 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 440' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 71.61 -36.11 0.35 Allowed 'General case' 0 N--CA 1.505 2.294 0 C-N-CA 125.453 1.501 . . . . 74.1 112.439 -171.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 441' ' ' ILE . . . . . 0.533 HG12 HD23 ' A' ' 235' ' ' LEU . 67.7 mt 78.2 -81.6 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.347 0.492 0 C-N-CA 125.411 1.484 . . . . 74.15 111.486 165.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 442' ' ' ALA . . . . . . . . . . . . . . . 62.38 -70.3 0.05 Allowed 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 124.554 1.142 . . . . 73.33 110.09 -169.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 443' ' ' ALA . . . . . 0.416 ' HA ' ' HB3' ' A' ' 234' ' ' ARG . . . 73.41 -71.5 0.13 Allowed 'General case' 0 C--N 1.357 0.894 0 C-N-CA 125.979 1.712 . . . . 74.21 112.258 170.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -87.49 170.64 11.16 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.762 0.825 . . . . 71.31 111.194 -176.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . -144.57 166.47 27.3 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 110.365 -1.094 . . . . 74.34 110.365 173.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 446' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.81 78.87 0.53 Allowed 'Trans proline' 0 C--N 1.369 1.653 0 C-N-CA 123.305 2.67 . . . . 72.44 111.934 178.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 447' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -175.4 -23.06 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.78 1.232 . . . . 63.45 110.245 -177.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . -56.52 101.45 0.06 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.612 0.765 . . . . 74.31 111.221 -178.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 449' ' ' ALA . . . . . . . . . . . . . . . -144.7 125.37 14.14 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 124.804 1.242 . . . . 74.42 108.539 177.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 450' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -134.82 -64.5 0.66 Allowed 'General case' 0 C--O 1.243 0.714 0 C-N-CA 123.745 0.818 . . . . 63.22 110.186 -174.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 99.5 t -80.16 75.85 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 122.411 1.1 . . . . 74.44 108.842 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 452' ' ' VAL . . . . . . . . . . . . . 98.8 t -141.0 -43.18 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 CA-C-N 113.674 -1.603 . . . . 74.24 107.497 177.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . -160.11 158.88 30.23 Favored Glycine 0 C--N 1.35 1.33 0 CA-C-N 114.911 -1.04 . . . . 73.44 112.1 177.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 454' ' ' LEU . . . . . 0.427 HD23 ' HB3' ' B' ' 193' ' ' PRO . 39.6 tp 59.96 -118.47 0.86 Allowed 'General case' 0 CA--C 1.565 1.554 0 C-N-CA 124.829 1.252 . . . . 73.13 110.939 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 62.0 m -167.08 134.29 2.42 Favored 'General case' 0 C--O 1.243 0.72 0 N-CA-C 106.773 -1.565 . . . . 72.1 106.773 -173.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -94.22 171.53 8.78 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 122.044 0.926 . . . . 74.3 112.499 -176.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 457' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -161.32 -155.66 0.41 Allowed 'General case' 0 CA--C 1.555 1.167 0 CA-C-N 113.432 -1.713 . . . . 65.21 108.302 -176.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 25.1 p -55.19 -63.13 1.25 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.079 0.952 . . . . 72.13 113.091 -174.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 459' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -157.51 161.79 38.84 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.62 0.768 . . . . 73.31 109.64 -175.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 7.6 mp 76.58 165.2 0.25 Allowed 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 125.506 1.522 . . . . 65.42 109.747 -167.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 69.34 8.69 6.93 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 124.902 1.281 . . . . 75.0 112.642 176.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -73.04 101.11 3.17 Favored 'General case' 0 C--N 1.359 0.991 0 N-CA-C 108.564 -0.902 . . . . 72.53 108.564 171.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 14.7 t -101.66 -155.26 0.51 Allowed 'General case' 0 CA--C 1.559 1.295 0 CA-C-N 115.265 -0.88 . . . . 71.14 110.823 -167.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 464' ' ' MET . . . . . . . . . . . . . 23.2 mmt -63.92 159.74 19.18 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.414 1.086 . . . . 75.31 111.84 179.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.08 170.09 8.12 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.518 0.727 . . . . 72.15 110.859 -177.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -150.18 148.1 28.52 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 114.95 -1.023 . . . . 65.13 109.022 173.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 467' ' ' ALA . . . . . 0.476 ' HB2' HG23 ' B' ' 135' ' ' VAL . . . -65.03 -19.2 65.88 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.854 0.861 . . . . 75.3 112.201 -178.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 468' ' ' LEU . . . . . 0.594 ' HB2' HG12 ' B' ' 135' ' ' VAL . 8.2 tt -143.41 98.66 3.29 Favored 'General case' 0 C--O 1.245 0.847 0 N-CA-C 106.648 -1.612 . . . . 74.32 106.648 168.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 469' ' ' GLY . . . . . . . . . . . . . . . -79.43 84.58 1.27 Allowed Glycine 0 C--N 1.342 0.896 0 N-CA-C 111.217 -0.753 . . . . 62.03 111.217 175.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 470' ' ' LEU . . . . . 0.417 HD23 ' H ' ' B' ' 470' ' ' LEU . 2.4 pt? -75.76 -38.3 58.49 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.33 0.652 . . . . 75.32 110.299 174.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 471' ' ' LYS . . . . . 0.554 ' HB3' ' HZ2' ' B' ' 471' ' ' LYS . 0.8 OUTLIER . . . . . 0 C--O 1.26 1.646 0 C-N-CA 124.677 1.191 . . . . 74.2 109.885 -177.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 73.3 mtm . . . . . 0 N--CA 1.476 0.856 0 CA-C-O 119.856 -0.116 . . . . 70.43 110.866 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 55.76 25.56 8.49 Favored 'General case' 0 C--N 1.358 0.941 0 C-N-CA 124.692 1.197 . . . . 70.41 112.152 -177.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.92 78.14 4.42 Favored 'General case' 0 C--N 1.35 0.62 0 N-CA-C 108.885 -0.783 . . . . 71.34 108.885 -178.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -36.55 94.54 0.01 OUTLIER 'General case' 0 C--N 1.365 1.241 0 C-N-CA 125.232 1.413 . . . . 70.52 113.371 -175.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 5' ' ' LYS . . . . . 0.422 ' HB3' HD13 ' C' ' 10' ' ' ILE . 29.7 mmtp -65.76 95.84 0.26 Allowed 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.485 -1.234 . . . . 72.32 108.625 169.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 6' ' ' ASP . . . . . 0.465 ' HA ' ' OH ' ' C' ' 66' ' ' TYR . 16.2 t70 -73.14 97.25 2.35 Favored 'General case' 0 C--N 1.343 0.321 0 N-CA-C 106.975 -1.491 . . . . 65.15 106.975 169.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 7' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -63.6 -30.23 71.37 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 114.811 -1.086 . . . . 73.43 112.389 -169.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -61.56 -44.47 96.97 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.593 0.357 . . . . 74.23 110.16 172.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.47 -42.95 98.59 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.177 0.591 . . . . 63.34 110.934 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 10' ' ' ILE . . . . . 0.422 HD13 ' HB3' ' C' ' 5' ' ' LYS . 56.2 mt -59.98 -39.09 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 C-N-CA 123.407 0.683 . . . . 73.31 110.762 178.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 93.0 mt -76.98 -20.84 55.58 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 116.081 -0.509 . . . . 75.53 112.272 175.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.55 39.48 56.18 Favored Glycine 0 C--N 1.346 1.128 0 O-C-N 123.189 0.306 . . . . 74.43 112.549 -176.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 27.2 m -120.32 157.28 53.96 Favored Pre-proline 0 N--CA 1.479 0.976 0 C-N-CA 124.915 1.286 . . . . 71.34 109.097 176.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -51.16 145.76 25.19 Favored 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 122.849 2.366 . . . . 74.43 113.105 177.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 79.2 mtt180 -74.21 18.13 0.16 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 114.105 1.15 . . . . 74.35 114.105 -175.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -148.76 21.1 1.02 Allowed 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 124.985 1.314 . . . . 71.24 108.176 177.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.47 156.41 32.53 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.314 1.046 . . . . 75.2 112.883 -170.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 18' ' ' THR . . . . . 0.464 HG23 HD21 ' B' ' 332' ' ' LEU . 70.3 p -65.18 148.39 51.77 Favored 'General case' 0 C--N 1.348 0.534 0 CA-C-N 115.365 -0.834 . . . . 74.41 108.75 170.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 19' ' ' GLN . . . . . 0.438 ' OE1' ' HD2' ' C' ' 63' ' ' ARG . 1.2 mp0 -63.29 -20.01 65.09 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 122.954 0.502 . . . . 74.45 110.477 175.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -65.4 -44.7 86.64 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.261 -0.881 . . . . 74.53 111.408 168.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . 0.429 ' HG3' ' HG1' ' C' ' 18' ' ' THR . 36.5 mt-10 -63.71 -35.3 80.12 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.114 0.565 . . . . 73.42 110.657 176.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 22' ' ' ILE . . . . . 0.63 HG12 ' HB3' ' C' ' 57' ' ' LEU . 1.7 mp -59.72 -41.33 85.01 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 CA-C-N 115.664 -0.698 . . . . 75.54 109.833 170.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 23' ' ' LYS . . . . . 0.449 ' HA ' ' HB3' ' C' ' 26' ' ' TYR . 36.0 mtmm -77.94 -14.96 59.35 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.217 0.607 . . . . 74.13 112.631 175.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -75.18 -37.39 61.24 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 108.622 -0.881 . . . . 73.52 108.622 170.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -76.94 -25.21 52.6 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.246 -0.888 . . . . 75.32 110.936 175.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 26' ' ' TYR . . . . . 0.456 ' O ' ' HB2' ' C' ' 30' ' ' ALA . 87.5 t80 -66.73 -47.43 72.32 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 109.315 -0.624 . . . . 72.31 109.315 169.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . 0.511 ' HD3' ' HA ' ' B' ' 325' ' ' THR . 45.0 mtmt -59.04 -53.69 55.52 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 109.29 -0.633 . . . . 75.33 109.29 173.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 18.5 ttm180 -50.5 -69.34 0.12 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.9 1.28 . . . . 75.55 110.589 -175.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 94.3 mt -82.17 -35.59 28.23 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 114.799 -1.092 . . . . 71.43 112.862 -169.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . 0.456 ' HB2' ' O ' ' C' ' 26' ' ' TYR . . . -87.21 -5.78 58.84 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 118.345 0.521 . . . . 75.32 112.222 -176.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . 0.535 ' HA ' ' HB2' ' C' ' 34' ' ' HIS . 99.4 mtt180 -96.68 -37.37 10.35 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 118.323 0.51 . . . . 73.5 109.902 163.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -62.02 -43.17 99.4 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.344 0.658 . . . . 71.12 111.148 177.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 33' ' ' TYR . . . . . 0.507 ' HD2' HD11 ' C' ' 50' ' ' ILE . 19.3 m-85 -109.42 26.05 11.09 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.36 1.064 . . . . 72.14 110.044 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 34' ' ' HIS . . . . . 0.535 ' HB2' ' HA ' ' C' ' 31' ' ' ARG . 37.8 t60 -63.68 112.76 7.9 Favored Pre-proline 0 N--CA 1.475 0.79 0 CA-C-O 118.505 -0.76 . . . . 74.34 109.189 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.41 -18.81 15.62 Favored 'Trans proline' 0 N--CA 1.501 1.966 0 C-N-CA 123.392 2.728 . . . . 72.22 114.834 -170.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 36' ' ' ASP . . . . . 0.424 ' HB3' ' HD2' ' C' ' 34' ' ' HIS . 13.0 t70 -80.04 -46.72 16.07 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.041 0.936 . . . . 60.34 110.804 176.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 71.0 t -84.15 -54.49 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 123.361 0.664 . . . . 75.33 109.818 -175.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -98.45 83.83 3.09 Favored 'General case' 0 C--O 1.244 0.787 0 N-CA-C 107.991 -1.115 . . . . 65.41 107.991 176.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -79.03 78.09 5.48 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.011 -0.995 . . . . 71.22 109.895 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 71.0 m -139.37 118.55 9.09 Favored Pre-proline 0 CA--C 1.542 0.673 0 C-N-CA 123.882 0.873 . . . . 74.14 108.743 174.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_exo -47.05 -38.74 24.82 Favored 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 123.606 2.871 . . . . 75.0 113.207 176.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -58.05 -44.23 87.3 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.839 0.856 . . . . 71.01 110.211 177.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.47 -21.29 61.96 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.23 -0.896 . . . . 71.45 110.603 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 44' ' ' GLU . . . . . 0.406 ' O ' ' HG2' ' C' ' 48' ' ' LYS . 0.4 OUTLIER -81.54 -33.2 31.9 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.14 0.976 . . . . 74.04 109.2 -178.776 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -68.21 -45.39 73.49 Favored 'General case' 0 C--O 1.261 1.695 0 C-N-CA 124.013 0.925 . . . . 75.44 109.475 174.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 46' ' ' LYS . . . . . 0.421 ' HA ' ' HD3' ' C' ' 46' ' ' LYS . 68.3 mmtt -61.05 -38.61 86.78 Favored 'General case' 0 C--N 1.348 0.518 0 CA-C-N 114.588 -1.187 . . . . 72.32 110.33 172.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 47' ' ' PHE . . . . . 0.675 ' HA ' HD13 ' C' ' 50' ' ' ILE . 65.3 t80 -57.77 -41.13 81.35 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.177 0.991 . . . . 71.12 110.299 176.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 48' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' C' ' 44' ' ' GLU . 72.3 mmtt -59.01 -49.94 75.97 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 122.383 0.273 . . . . 72.04 110.59 175.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -58.93 -39.43 81.55 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 124.23 0.956 . . . . 72.33 112.097 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 50' ' ' ILE . . . . . 0.675 HD13 ' HA ' ' C' ' 47' ' ' PHE . 55.2 mt -62.76 -47.89 90.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 124.254 1.022 . . . . 75.43 109.628 177.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 51' ' ' ASN . . . . . 0.555 ' HA ' ' HB3' ' C' ' 54' ' ' TYR . 64.2 m-80 -79.85 -5.91 56.36 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 115.522 -0.763 . . . . 74.04 112.176 -178.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 52' ' ' GLU . . . . . 0.445 ' HA ' ' CE2' ' C' ' 93' ' ' PHE . 32.0 tt0 -75.3 -56.23 4.92 Favored 'General case' 0 C--O 1.249 1.027 0 CA-C-O 122.166 0.984 . . . . 75.54 108.844 167.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.86 -37.31 73.7 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 113.485 -1.689 . . . . 63.1 111.442 174.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 54' ' ' TYR . . . . . 0.555 ' HB3' ' HA ' ' C' ' 51' ' ' ASN . 70.0 t80 -75.84 -34.32 60.07 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.263 -0.88 . . . . 75.01 110.5 178.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.57 -40.71 75.68 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.099 0.476 . . . . 60.54 110.508 175.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 44.4 t -79.95 -37.23 17.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 114.737 -1.12 . . . . 72.43 112.578 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 57' ' ' LEU . . . . . 0.63 ' HB3' HG12 ' C' ' 22' ' ' ILE . 94.6 mt -111.14 12.38 21.89 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 114.033 1.123 . . . . 75.02 114.033 -170.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 47.4 t -57.94 -58.97 6.05 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.239 0.616 . . . . 75.33 111.073 178.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -99.73 150.93 37.26 Favored Pre-proline 0 N--CA 1.47 0.558 0 CA-C-N 114.786 -1.097 . . . . 72.03 110.236 -178.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 60' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -54.31 -34.63 80.94 Favored 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 123.659 2.906 . . . . 73.21 112.513 171.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -66.19 -47.17 74.79 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.912 0.885 . . . . 62.13 110.645 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -66.05 -33.59 76.15 Favored 'General case' 0 C--O 1.249 1.042 0 CA-C-N 115.093 -0.958 . . . . 75.43 111.049 178.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 63' ' ' ARG . . . . . 0.438 ' HD2' ' OE1' ' C' ' 19' ' ' GLN . 13.6 ttt180 -60.94 -47.27 87.21 Favored 'General case' 0 C--O 1.218 -0.585 0 CA-C-N 115.718 -0.674 . . . . 74.14 109.901 173.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -61.83 -34.42 75.92 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 123.603 0.564 . . . . 74.15 111.285 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 72.6 mt -54.2 -57.55 5.73 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.95 0 N-CA-C 108.522 -0.918 . . . . 71.5 108.522 169.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 66' ' ' TYR . . . . . 0.465 ' OH ' ' HA ' ' C' ' 6' ' ' ASP . 10.0 t80 -52.37 -51.52 58.47 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.253 0.621 . . . . 74.31 112.025 176.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -55.22 -36.33 65.87 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.899 0.88 . . . . 73.14 111.257 -174.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 54.8 p -102.37 -14.29 16.96 Favored 'General case' 0 CA--C 1.556 1.189 0 N-CA-C 112.782 0.66 . . . . 74.43 112.782 -178.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -122.05 125.02 45.32 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.023 0.529 . . . . 75.22 109.663 -173.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 74.61 18.93 80.02 Favored Glycine 0 N--CA 1.473 1.155 0 CA-C-O 121.539 0.522 . . . . 62.51 111.937 -175.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 47.8 m -141.31 -50.33 0.42 Allowed 'General case' 0 C--O 1.239 0.505 0 N-CA-C 103.898 -2.63 . . . . 72.34 103.898 178.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 19.2 m -106.62 163.61 12.76 Favored 'General case' 0 C--O 1.253 1.244 0 N-CA-C 105.192 -2.151 . . . . 73.35 105.192 156.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.09 13.06 27.84 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.511 1.124 . . . . 73.23 111.115 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.42 -152.25 0.0 OUTLIER Pre-proline 0 CA--C 1.607 3.15 0 CA-C-O 115.936 -1.983 . . . . 53.23 113.066 -175.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 0.8 OUTLIER 0.75 118.32 0.0 OUTLIER 'Trans proline' 1 C--N 1.427 4.684 1 C-N-CA 125.92 4.413 . . . . 75.14 119.796 -158.671 . . . . . . . . 4 3 . 1 . 010 nuclear orig full ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -63.39 178.22 1.3 Allowed 'Trans proline' 0 N--CA 1.51 2.472 0 C-N-CA 123.864 3.043 . . . . 71.22 112.745 176.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 77' ' ' PRO . . . . . 0.444 ' HA ' ' HD3' ' C' ' 78' ' ' PRO . 0.7 OUTLIER -26.41 116.96 0.03 OUTLIER 'Trans proline' 0 C--N 1.401 3.318 0 C-N-CA 124.929 3.753 . . . . 74.4 115.437 173.631 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 78' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' C' ' 77' ' ' PRO . 25.3 Cg_exo -65.68 167.92 16.19 Favored 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 124.111 3.207 . . . . 74.44 114.17 -171.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -54.16 132.91 52.88 Favored 'Trans proline' 0 C--N 1.39 2.712 0 C-N-CA 123.104 2.536 . . . . 70.12 113.227 175.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -58.47 83.76 0.05 OUTLIER 'Trans proline' 0 C--N 1.39 2.726 0 C-N-CA 123.65 2.9 . . . . 74.31 111.879 176.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . 0.625 ' HA2' ' HA2' ' C' ' 108' ' ' GLY . . . -175.41 -34.08 0.04 OUTLIER Glycine 0 C--O 1.225 -0.442 0 N-CA-C 109.329 -1.508 . . . . 75.2 109.329 -176.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . 0.597 ' HA3' ' HA ' ' C' ' 106' ' ' PHE . . . 95.09 165.15 35.29 Favored Glycine 0 C--N 1.35 1.339 0 N-CA-C 116.607 1.403 . . . . 75.13 116.607 166.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -69.58 135.84 50.51 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 124.258 1.023 . . . . 73.4 108.318 168.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 84' ' ' ASP . . . . . 0.413 ' HB2' ' HB2' ' C' ' 143' ' ' ARG . 35.6 t70 -66.94 129.22 39.18 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 118.273 0.488 . . . . 75.11 109.728 175.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 85' ' ' PHE . . . . . 0.493 ' HB3' ' HG3' ' C' ' 171' ' ' PRO . 23.5 t80 -116.68 34.77 4.89 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.688 0.795 . . . . 74.41 109.857 -165.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 52.8 m -5.74 78.99 0.0 OUTLIER 'General case' 0 CA--C 1.569 1.691 0 N-CA-C 116.836 2.161 . . . . 52.42 116.836 -170.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 53.06 31.71 41.04 Favored Glycine 0 CA--C 1.545 1.959 0 N-CA-C 116.399 1.32 . . . . 74.34 116.399 175.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 88' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -101.67 155.34 18.16 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 119.134 1.467 . . . . 74.44 113.643 -173.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -85.13 79.04 9.72 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.337 0.655 . . . . 72.23 111.128 -178.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 90' ' ' VAL . . . . . . . . . . . . . 2.0 p -42.17 -37.45 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 114.4 1.259 . . . . 54.42 114.4 177.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.11 -14.64 7.21 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 114.19 1.182 . . . . 75.25 114.19 -176.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -113.32 -3.49 13.81 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 112.757 0.651 . . . . 75.53 112.757 -175.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 93' ' ' PHE . . . . . 0.445 ' CE2' ' HA ' ' C' ' 52' ' ' GLU . 2.3 m-85 -77.13 153.33 34.33 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 122.741 0.417 . . . . 72.45 110.937 -176.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 97.0 p -82.94 -178.81 7.25 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.768 0.827 . . . . 52.11 113.013 -166.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.38 -61.81 2.33 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 114.552 -1.204 . . . . 72.35 112.911 -175.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -58.07 -38.98 77.38 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 118.753 0.706 . . . . 74.24 110.743 -171.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 97' ' ' PHE . . . . . 0.431 ' CE2' ' HE2' ' C' ' 85' ' ' PHE . 83.4 t80 -60.31 -54.75 41.94 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 114.43 -1.259 . . . . 64.25 110.009 175.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -81.69 5.18 19.19 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 112.478 0.547 . . . . 71.33 112.478 -177.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -100.05 -39.11 8.28 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.836 0.855 . . . . 74.43 109.942 170.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 45.6 tp -78.5 -52.51 8.41 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.892 0.853 . . . . 73.23 109.502 -178.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 101' ' ' PHE . . . . . 0.435 ' HB3' HD11 ' C' ' 105' ' ' LEU . 96.5 m-85 -86.31 -20.72 27.96 Favored 'General case' 0 C--O 1.214 -0.77 0 CA-C-N 113.952 -1.477 . . . . 75.04 111.347 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -49.26 -50.81 27.96 Favored Glycine 0 CA--C 1.549 2.217 0 CA-C-O 118.558 -1.135 . . . . 74.41 115.754 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -49.34 -25.33 9.89 Favored 'Trans proline' 0 C--N 1.387 2.596 0 C-N-CA 124.139 3.226 . . . . 64.35 115.09 175.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 104' ' ' GLY . . . . . 0.418 ' O ' ' HA2' ' C' ' 82' ' ' GLY . . . -137.72 31.68 2.46 Favored Glycine 0 C--N 1.353 1.485 0 CA-C-O 119.401 -0.666 . . . . 73.42 112.188 174.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 105' ' ' LEU . . . . . 0.435 HD11 ' HB3' ' C' ' 101' ' ' PHE . 13.1 tp -78.14 74.51 4.69 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 118.103 0.951 . . . . 75.43 109.128 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 106' ' ' PHE . . . . . 0.597 ' HA ' ' HA3' ' C' ' 82' ' ' GLY . 1.2 m-85 58.96 -148.83 0.47 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.826 1.25 . . . . 64.24 113.586 174.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 107' ' ' GLY . . . . . 0.495 ' HA3' ' HA ' ' C' ' 113' ' ' SER . . . 70.55 42.82 62.67 Favored Glycine 0 C--N 1.359 1.811 0 N-CA-C 111.368 -0.693 . . . . 51.05 111.368 -163.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 108' ' ' GLY . . . . . 0.625 ' HA2' ' HA2' ' C' ' 81' ' ' GLY . . . -13.66 -71.7 0.01 OUTLIER Glycine 0 C--N 1.364 2.108 0 C-N-CA 125.784 1.659 . . . . 74.41 115.791 168.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 109' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -92.75 76.68 4.9 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 108.183 -1.043 . . . . 74.45 108.183 168.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 110' ' ' GLY . . . . . . . . . . . . . . . -8.56 -60.31 0.01 OUTLIER Glycine 0 C--N 1.366 2.201 0 C-N-CA 126.471 1.986 . . . . 73.14 116.564 171.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . 0.546 ' NE ' ' H ' ' C' ' 111' ' ' ARG . 0.0 OUTLIER -4.62 -43.15 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.366 0 C-N-CA 127.673 2.389 . . . . 75.25 116.394 160.942 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 112' ' ' ARG . . . . . 0.446 ' HG3' ' HB3' ' C' ' 114' ' ' ARG . 14.7 tpt180 -120.14 -38.05 2.98 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.788 0.835 . . . . 75.43 110.972 -173.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 113' ' ' SER . . . . . 0.495 ' HA ' ' HA3' ' C' ' 107' ' ' GLY . 29.1 m 47.04 22.12 0.19 Allowed 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 125.122 1.369 . . . . 72.53 113.562 -175.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 114' ' ' ARG . . . . . 0.449 ' NE ' ' HA ' ' C' ' 114' ' ' ARG . 2.6 tpm_? -115.03 -116.28 0.33 Allowed 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 117.686 -1.149 . . . . 74.05 111.476 -169.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 115' ' ' LYS . . . . . 0.619 ' HZ2' ' HB2' ' B' ' 315' ' ' ASN . 45.8 tttm -66.19 133.28 50.32 Favored 'General case' 0 C--N 1.361 1.068 0 CA-C-N 119.62 1.1 . . . . 74.15 111.808 -164.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 116' ' ' GLY . . . . . 0.459 ' HA3' ' HA ' ' C' ' 171' ' ' PRO . . . -74.88 109.52 2.81 Favored Glycine 0 CA--C 1.486 -1.734 0 N-CA-C 109.768 -1.333 . . . . 54.4 109.768 169.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 117' ' ' ARG . . . . . 0.421 ' HB2' ' O ' ' B' ' 313' ' ' GLN . 37.0 ptt180 -90.5 161.42 15.51 Favored 'General case' 0 C--O 1.264 1.835 0 N-CA-C 108.076 -1.083 . . . . 74.32 108.076 172.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -62.6 155.35 26.3 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 115.031 -0.986 . . . . 75.42 109.416 168.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 119' ' ' LEU . . . . . 0.493 HD11 ' HA ' ' C' ' 174' ' ' LEU . 0.0 OUTLIER -119.64 144.57 47.08 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 108.247 -1.02 . . . . 75.21 108.247 171.562 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.414 ' HA ' ' O ' ' C' ' 175' ' ' LEU . 19.6 ttt180 -138.9 106.77 5.66 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 109.612 -0.514 . . . . 72.31 109.612 -162.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 121' ' ' ALA . . . . . 0.566 ' HB3' ' HA ' ' B' ' 185' ' ' VAL . . . -134.83 127.67 31.24 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 115.492 -0.776 . . . . 75.44 109.835 -172.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 122' ' ' GLU . . . . . 0.54 ' HG2' ' HA ' ' B' ' 186' ' ' THR . 13.2 pt-20 -85.54 141.16 30.07 Favored 'General case' 0 C--O 1.244 0.77 0 N-CA-C 110.13 -0.322 . . . . 74.12 110.13 176.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -142.71 144.28 29.31 Favored Pre-proline 0 N--CA 1.481 1.102 0 CA-C-N 116.182 -0.463 . . . . 73.3 110.937 -170.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -75.44 121.69 6.56 Favored 'Trans proline' 0 C--N 1.368 1.603 0 C-N-CA 123.147 2.565 . . . . 72.51 111.278 173.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 125' ' ' LEU . . . . . 0.423 ' HB3' HG21 ' C' ' 178' ' ' VAL . 55.7 tp -137.37 147.11 45.25 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.279 0.631 . . . . 75.32 110.058 -177.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.73 155.21 18.44 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 123.449 0.7 . . . . 61.53 110.308 -178.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 127' ' ' LEU . . . . . 0.477 HD21 HD13 ' C' ' 180' ' ' LEU . 96.2 mt -66.3 -44.74 82.62 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.373 1.069 . . . . 62.25 111.234 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 18.4 mp0 -65.09 -33.33 75.77 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.729 1.212 . . . . 75.24 109.733 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 129' ' ' GLU . . . . . 0.524 ' HG3' ' HG3' ' B' ' 178' ' ' PRO . 53.3 mm-40 -77.83 -25.38 48.75 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.712 0.805 . . . . 75.51 112.116 177.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -74.3 -32.75 62.99 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 109.142 -0.688 . . . . 73.14 109.142 173.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 131' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -67.46 -44.89 77.51 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.407 1.083 . . . . 75.55 111.088 173.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 132' ' ' HIS . . . . . . . . . . . . . 54.2 m170 -70.72 -49.46 46.7 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 116.261 -0.427 . . . . 70.15 110.685 -176.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 68.39 -90.65 0.23 Allowed Glycine 0 C--N 1.345 1.069 0 N-CA-C 110.664 -0.974 . . . . 65.31 110.664 -170.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.28 161.83 5.7 Favored Glycine 0 C--N 1.353 1.509 0 O-C-N 123.876 0.398 . . . . 73.12 114.008 174.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -71.44 94.69 1.28 Allowed 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 109.105 -0.702 . . . . 73.03 109.105 174.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 136' ' ' ARG . . . . . 0.637 ' HB3' ' HB2' ' B' ' 181' ' ' LEU . 2.7 mpt_? -105.15 158.77 16.35 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.669 1.187 . . . . 72.12 109.051 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 137' ' ' VAL . . . . . 0.401 HG21 ' HB1' ' B' ' 180' ' ' ALA . 23.0 m -104.62 127.77 58.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 109.798 -0.445 . . . . 73.11 109.798 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 138' ' ' VAL . . . . . 0.719 ' HB ' HD21 ' B' ' 181' ' ' LEU . 6.1 p -113.12 114.61 47.44 Favored 'Isoleucine or valine' 0 C--O 1.248 0.986 0 C-N-CA 123.531 0.733 . . . . 72.14 110.052 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 139' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -120.68 93.15 3.94 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 124.829 1.252 . . . . 74.31 108.067 178.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 140' ' ' VAL . . . . . . . . . . . . . 12.7 p -147.61 149.04 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 108.877 -0.786 . . . . 73.25 108.877 -177.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 141' ' ' ALA . . . . . 0.404 ' HB2' ' NE2' ' C' ' 167' ' ' GLN . . . 65.2 19.47 11.74 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 124.75 1.22 . . . . 65.0 112.1 177.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 84.39 -4.03 84.92 Favored Glycine 0 C--N 1.344 0.991 0 CA-C-N 115.675 -0.693 . . . . 52.4 113.553 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 143' ' ' ARG . . . . . 0.528 ' NH2' ' HB3' ' C' ' 164' ' ' MET . 0.0 OUTLIER -111.41 124.37 52.12 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.41 0.684 . . . . 75.05 109.658 -176.722 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 12.9 ttt180 -114.3 121.61 44.18 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.656 1.182 . . . . 71.51 110.859 -171.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 145' ' ' VAL . . . . . 0.545 HG23 ' SD ' ' C' ' 164' ' ' MET . 21.9 m -143.25 177.1 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 C-N-CA 123.922 0.889 . . . . 75.03 110.581 172.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 23.0 t -119.36 129.79 55.01 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.761 0.825 . . . . 73.22 108.78 171.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 11.4 p -149.01 154.47 9.6 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 C-N-CA 123.489 0.716 . . . . 72.53 111.003 -178.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 22.0 ttm180 -96.06 116.19 28.58 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 108.082 -1.081 . . . . 74.22 108.082 164.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 149' ' ' ILE . . . . . 0.453 HD12 HD13 ' B' ' 181' ' ' LEU . 31.9 pt -73.22 147.41 87.86 Favored Pre-proline 0 CA--C 1.551 1.001 0 CA-C-O 118.597 -0.716 . . . . 74.42 109.302 172.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -43.07 115.07 0.51 Allowed 'Trans proline' 0 C--N 1.385 2.45 0 C-N-CA 123.698 2.932 . . . . 61.44 113.594 178.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -62.18 95.96 0.15 Allowed 'Trans proline' 0 C--N 1.386 2.533 0 C-N-CA 123.046 2.497 . . . . 73.2 111.636 178.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 152' ' ' GLY . . . . . . . . . . . . . . . 131.28 108.23 1.19 Allowed Glycine 0 C--N 1.343 0.943 0 CA-C-N 114.98 -1.009 . . . . 63.11 112.44 -174.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 153' ' ' VAL . . . . . 0.559 HG23 HG23 ' C' ' 178' ' ' VAL . 1.8 m -131.1 163.53 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 CA-C-N 117.121 0.46 . . . . 74.01 111.067 -179.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 154' ' ' ARG . . . . . . . . . . . . . 29.6 mtt85 -118.49 144.27 46.14 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.823 0.849 . . . . 75.32 109.443 -178.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 155' ' ' GLU . . . . . 0.476 ' HB2' HD11 ' C' ' 180' ' ' LEU . 4.6 tp10 -56.22 128.32 35.09 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.267 0.627 . . . . 74.51 111.974 173.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 68.29 14.66 66.79 Favored Glycine 0 C--N 1.344 1.024 0 O-C-N 123.882 0.739 . . . . 75.21 113.68 176.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 157' ' ' SER . . . . . . . . . . . . . 34.0 t -104.05 164.53 11.64 Favored 'General case' 0 C--N 1.349 0.566 0 C-N-CA 123.201 0.6 . . . . 75.43 109.534 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 158' ' ' VAL . . . . . 0.401 ' HA ' ' HA ' ' C' ' 177' ' ' VAL . 8.8 p -112.48 108.01 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.136 0 CA-C-O 121.738 0.78 . . . . 72.31 111.007 -170.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 159' ' ' ILE . . . . . . . . . . . . . 14.6 mt -71.38 117.2 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.588 1.155 . . . . 72.31 108.91 172.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 48.1 ttt-85 -95.44 119.73 34.45 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 118.532 0.605 . . . . 75.13 109.676 171.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 161' ' ' VAL . . . . . 0.609 ' HB ' ' HB3' ' C' ' 174' ' ' LEU . 92.9 t -99.0 99.02 7.1 Favored Pre-proline 0 C--O 1.246 0.892 0 N-CA-C 107.9 -1.148 . . . . 75.24 107.9 171.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -80.83 153.19 19.58 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.638 2.225 . . . . 75.23 112.002 -178.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 89.92 28.7 17.52 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-O 119.42 -0.656 . . . . 53.54 113.647 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 164' ' ' MET . . . . . 0.545 ' SD ' HG23 ' C' ' 145' ' ' VAL . 20.7 mtm -130.67 -88.14 0.49 Allowed 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 117.888 0.844 . . . . 73.35 111.717 178.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 165' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' C' ' 172' ' ' GLY . . . 131.91 147.93 6.02 Favored Glycine 0 N--CA 1.482 1.737 0 CA-C-N 118.686 0.676 . . . . 73.32 114.501 -172.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . -108.16 -105.95 3.04 Favored Glycine 0 C--N 1.371 2.494 0 N-CA-C 112.279 -0.328 . . . . 75.44 112.279 172.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 167' ' ' GLN . . . . . 0.404 ' NE2' ' HB2' ' C' ' 141' ' ' ALA . 22.7 mm-40 -105.38 107.0 17.76 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.515 0.726 . . . . 74.2 111.642 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . 129.9 159.54 9.81 Favored Glycine 0 C--N 1.357 1.702 0 CA-C-N 117.762 0.256 . . . . 13.44 113.108 171.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 169' ' ' ASN . . . . . 0.438 ' HB2' ' HD3' ' C' ' 170' ' ' PRO . 1.3 m-20 -61.72 -63.18 4.57 Favored Pre-proline 0 CA--C 1.572 1.795 0 C-N-CA 125.008 1.323 . . . . 62.44 114.01 -168.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 170' ' ' PRO . . . . . 0.438 ' HD3' ' HB2' ' C' ' 169' ' ' ASN . 73.2 Cg_endo -79.03 98.7 1.2 Allowed 'Trans proline' 0 C--N 1.406 3.569 0 CA-C-N 122.309 1.86 . . . . 73.55 110.335 173.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 171' ' ' PRO . . . . . 0.493 ' HG3' ' HB3' ' C' ' 85' ' ' PHE . 10.2 Cg_exo -69.74 142.47 48.13 Favored 'Trans proline' 0 C--N 1.369 1.658 0 C-N-CA 123.704 2.936 . . . . 74.02 116.557 -159.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 172' ' ' GLY . . . . . 0.405 ' O ' ' HA2' ' C' ' 165' ' ' GLY . . . -109.01 141.51 15.95 Favored Glycine 0 C--O 1.213 -1.208 0 N-CA-C 106.549 -2.62 . . . . 74.42 106.549 163.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 173' ' ' ASP . . . . . 0.43 ' HB3' ' O ' ' C' ' 161' ' ' VAL . 64.8 m-20 -81.12 -161.51 0.41 Allowed 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 115.349 1.611 . . . . 74.51 115.349 -159.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 174' ' ' LEU . . . . . 0.609 ' HB3' ' HB ' ' C' ' 161' ' ' VAL . 40.7 tp -94.34 141.95 27.98 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 121.504 -0.747 . . . . 75.22 110.896 -176.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 175' ' ' LEU . . . . . 0.414 ' O ' ' HA ' ' C' ' 120' ' ' ARG . 76.2 mt -130.06 84.78 2.23 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.416 1.486 . . . . 72.15 109.435 176.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 176' ' ' LEU . . . . . . . . . . . . . 69.5 mt -80.2 107.45 13.0 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.424 0.69 . . . . 74.33 109.644 175.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 177' ' ' VAL . . . . . 0.495 HG12 ' SG ' ' B' ' 308' ' ' CYS . 58.2 t -83.06 95.48 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 107.553 -1.277 . . . . 75.23 107.553 175.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 178' ' ' VAL . . . . . 0.559 HG23 HG23 ' C' ' 153' ' ' VAL . 3.0 p -71.25 122.65 23.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.875 0.845 . . . . 74.01 111.334 -174.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 179' ' ' ARG . . . . . . . . . . . . . 17.1 mmm-85 -105.62 111.74 24.55 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 107.277 -1.379 . . . . 74.42 107.277 169.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 180' ' ' LEU . . . . . 0.477 HD13 HD21 ' C' ' 127' ' ' LEU . 97.3 mt -72.12 136.85 46.67 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.35 0.595 . . . . 73.43 111.101 -177.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 181' ' ' LEU . . . . . 0.493 HD23 ' HB2' ' B' ' 190' ' ' CYS . 60.3 mt -62.98 167.14 6.51 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 126.016 1.726 . . . . 74.24 113.857 -173.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -52.04 71.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.396 3.068 0 C-N-CA 124.208 3.272 . . . . 73.32 113.165 167.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 183' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -178.15 49.0 0.05 OUTLIER Pre-proline 0 CA--C 1.549 0.933 0 N-CA-C 105.153 -2.165 . . . . 72.0 105.153 -171.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 184' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -90.2 65.29 1.88 Allowed 'Trans proline' 0 C--N 1.387 2.586 0 C-N-CA 123.229 2.619 . . . . 74.25 111.655 -163.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 185' ' ' VAL . . . . . 0.558 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 21.2 t -95.73 -59.68 3.02 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.443 0 N-CA-C 108.223 -1.029 . . . . 72.23 108.223 -174.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 186' ' ' PHE . . . . . 0.46 ' HD2' HD11 ' C' ' 127' ' ' LEU . 53.8 m-85 -100.11 125.32 46.2 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.725 0.81 . . . . 61.44 110.787 -168.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.23 109.35 12.21 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 107.256 -1.387 . . . . 75.14 107.256 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 188' ' ' LEU . . . . . 0.444 HD13 ' HD2' ' C' ' 240' ' ' PHE . 52.3 tp -77.48 154.13 32.83 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.617 0.969 . . . . 74.14 113.617 -169.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -142.25 103.47 4.29 Favored 'General case' 0 C--O 1.248 1.01 0 N-CA-C 107.06 -1.459 . . . . 73.21 107.06 158.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 75.13 -88.39 0.79 Allowed Glycine 0 C--N 1.349 1.253 0 CA-C-N 115.471 -0.786 . . . . 74.2 112.526 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 191' ' ' GLN . . . . . 0.481 ' HB3' ' HA3' ' C' ' 247' ' ' GLY . 48.3 mt-30 -123.83 -23.05 4.75 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.659 1.184 . . . . 75.25 110.303 176.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -93.23 127.26 38.74 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 123.756 0.822 . . . . 65.13 110.79 -171.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 193' ' ' LEU . . . . . . . . . . . . . 84.3 mt -86.64 165.72 15.92 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.849 0.86 . . . . 65.15 111.316 -177.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 194' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -126.96 103.69 7.61 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.56 -1.274 . . . . 75.43 107.56 165.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 195' ' ' ALA . . . . . 0.558 ' HA ' ' O ' ' C' ' 185' ' ' VAL . . . -98.41 -177.08 3.58 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 124.024 0.93 . . . . 65.11 109.843 172.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 88.6 m -132.41 106.67 8.02 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 107.9 -1.148 . . . . 53.42 107.9 168.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 197' ' ' LEU . . . . . . . . . . . . . 43.3 tp -78.12 122.22 25.34 Favored 'General case' 0 C--N 1.35 0.596 0 N-CA-C 109.327 -0.62 . . . . 73.5 109.327 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -96.18 100.44 12.08 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 108.396 -0.965 . . . . 64.33 108.396 -177.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 199' ' ' VAL . . . . . . . . . . . . . 25.6 t -108.25 124.58 34.18 Favored Pre-proline 0 N--CA 1.481 1.11 0 C-N-CA 123.285 0.634 . . . . 73.12 109.649 -176.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 200' ' ' PRO . . . . . 0.494 ' HG2' HD11 ' C' ' 203' ' ' ILE . 4.5 Cg_exo -63.31 145.92 93.26 Favored 'Trans proline' 0 C--N 1.37 1.673 0 C-N-CA 121.961 1.774 . . . . 73.11 110.834 170.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 201' ' ' ALA . . . . . 0.453 ' HB3' ' HH2' ' C' ' 269' ' ' TRP . . . -53.37 -47.4 96.33 Favored Pre-proline 0 CA--C 1.558 1.262 0 N-CA-C 113.834 1.05 . . . . 74.35 113.834 -179.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 202' ' ' PRO . . . . . 0.414 ' HB2' ' HA ' ' A' ' 273' ' ' ALA . 44.3 Cg_endo -63.77 -41.88 22.44 Favored 'Trans proline' 0 C--N 1.384 2.444 0 C-N-CA 121.509 1.473 . . . . 63.15 112.523 -179.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 203' ' ' ILE . . . . . 0.494 HD11 ' HG2' ' C' ' 200' ' ' PRO . 39.5 mt -65.73 -36.04 76.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.009 0.524 . . . . 74.02 110.324 179.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 204' ' ' ALA . . . . . 0.46 ' HA ' HG13 ' C' ' 223' ' ' VAL . . . -62.05 -43.01 99.75 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.33 0.652 . . . . 75.02 110.897 176.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 205' ' ' VAL . . . . . . . . . . . . . 70.0 t -67.97 -45.35 83.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.659 0.784 . . . . 74.52 112.529 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 206' ' ' VAL . . . . . 0.609 ' HA ' ' HE3' ' A' ' 270' ' ' LYS . 14.8 p -78.9 -31.15 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 CA-C-O 121.021 0.438 . . . . 74.12 110.98 -176.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 82.12 52.06 4.2 Favored Glycine 0 C--N 1.336 0.546 0 CA-C-N 115.345 -0.843 . . . . 63.21 111.701 -172.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -84.22 -135.83 3.08 Favored Glycine 0 C--N 1.346 1.099 0 N-CA-C 111.868 -0.493 . . . . 51.32 111.868 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 209' ' ' LYS . . . . . 0.527 ' HG2' ' HA ' ' C' ' 222' ' ' ALA . 9.7 mtmp? -137.01 139.84 41.69 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 117.509 0.654 . . . . 72.44 111.397 175.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 210' ' ' VAL . . . . . 0.465 HG13 HG21 ' C' ' 203' ' ' ILE . 22.3 m -128.33 135.59 62.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.399 1.08 . . . . 71.52 109.216 175.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 211' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -84.62 112.51 20.51 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 120.852 0.358 . . . . 75.53 110.833 -176.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -81.69 114.58 20.46 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.07 0.948 . . . . 74.43 108.607 170.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 213' ' ' MET . . . . . . . . . . . . . 4.1 tmm? -74.87 116.08 15.19 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 107.311 -1.366 . . . . 63.12 107.311 178.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.96 174.4 6.11 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.286 0.565 . . . . 72.34 110.478 -174.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 215' ' ' LEU . . . . . . . . . . . . . 27.1 mt -64.47 -29.89 70.93 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.107 1.363 . . . . 75.24 112.067 -177.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -91.65 1.4 57.18 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 114.78 -1.1 . . . . 71.0 110.826 -177.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 110.77 -170.06 13.72 Favored Glycine 0 C--N 1.341 0.843 0 N-CA-C 110.693 -0.963 . . . . 74.41 110.693 -169.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -80.5 119.12 3.67 Favored 'Trans proline' 0 CA--C 1.554 1.524 0 C-N-CA 122.566 2.178 . . . . 64.03 113.506 -173.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 219' ' ' VAL . . . . . . . . . . . . . 14.8 p -97.82 148.05 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 N-CA-C 107.728 -1.212 . . . . 52.53 107.728 165.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 220' ' ' GLU . . . . . 0.483 ' HG2' ' HB3' ' C' ' 209' ' ' LYS . 13.3 tt0 -96.93 155.94 16.56 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 108.574 -0.899 . . . . 72.32 108.574 175.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 221' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' C' ' 209' ' ' LYS . 41.9 t -122.5 116.88 50.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 124.094 0.958 . . . . 74.03 110.154 -178.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 222' ' ' ALA . . . . . 0.527 ' HA ' ' HG2' ' C' ' 209' ' ' LYS . . . -78.74 102.64 8.2 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 108.965 -0.754 . . . . 73.3 108.965 171.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . 0.46 HG13 ' HA ' ' C' ' 204' ' ' ALA . 58.2 t -76.43 142.81 71.57 Favored Pre-proline 0 CA--C 1.566 1.574 0 C-N-CA 124.643 1.177 . . . . 73.11 110.372 -177.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 224' ' ' PRO . . . . . 0.606 ' HB3' ' HA ' ' B' ' 245' ' ' LYS . 71.7 Cg_endo -78.69 154.49 26.93 Favored 'Trans proline' 0 C--N 1.38 2.186 0 C-N-CA 122.957 2.438 . . . . 73.11 113.073 168.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -58.89 119.59 6.94 Favored 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 123.496 2.797 . . . . 74.4 112.674 175.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 226' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.0 82.92 0.13 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.275 1.43 . . . . 71.5 110.795 -175.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 227' ' ' THR . . . . . . . . . . . . . 97.8 m -93.31 133.08 36.92 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 114.295 -1.32 . . . . 73.3 109.482 174.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 228' ' ' GLN . . . . . 0.484 HE21 HD13 ' A' ' 257' ' ' ILE . 1.6 mp0 -100.09 147.75 25.32 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 121.24 0.543 . . . . 74.32 110.65 176.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -67.83 140.44 56.59 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 114.967 -1.015 . . . . 65.31 109.521 173.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 105.83 -18.37 40.45 Favored Glycine 0 C--N 1.333 0.37 0 N-CA-C 111.471 -0.652 . . . . 62.04 111.471 -171.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 231' ' ' ARG . . . . . . . . . . . . . 36.1 mtt85 -62.69 168.35 3.84 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 117.105 0.452 . . . . 75.03 111.697 169.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 232' ' ' LYS . . . . . 0.66 ' HD3' ' HB3' ' C' ' 250' ' ' TYR . 3.9 ttmp? -150.18 131.76 14.86 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.33 0.586 . . . . 74.05 111.117 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 233' ' ' LEU . . . . . 0.588 ' O ' ' HA ' ' C' ' 250' ' ' TYR . 4.7 mp -88.03 158.44 18.61 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.65 1.18 . . . . 74.22 110.214 178.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 234' ' ' ARG . . . . . 0.499 ' NH2' ' HA ' ' B' ' 243' ' ' GLN . 3.1 ptt85 -128.17 87.89 2.67 Favored 'General case' 0 CA--C 1.55 0.96 0 O-C-N 125.171 1.544 . . . . 72.34 108.19 164.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 54.4 mt -77.29 120.46 22.36 Favored 'General case' 0 C--N 1.361 1.071 0 CA-C-N 115.468 -0.787 . . . . 74.34 109.008 174.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -80.94 127.28 32.39 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.686 0.795 . . . . 73.41 111.48 -172.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 72.95 36.17 57.49 Favored Glycine 0 C--N 1.347 1.154 0 O-C-N 123.853 0.721 . . . . 71.42 113.028 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 24.0 mmtm -129.01 21.52 5.8 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.561 0.745 . . . . 75.11 110.987 176.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -92.78 -164.08 37.74 Favored Glycine 0 C--N 1.353 1.505 0 O-C-N 123.559 0.537 . . . . 75.2 112.975 175.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 240' ' ' PHE . . . . . 0.444 ' HD2' HD13 ' C' ' 188' ' ' LEU . 2.5 m-85 -80.89 157.58 71.43 Favored Pre-proline 0 CA--C 1.557 1.244 0 CA-C-O 119.352 -0.356 . . . . 75.14 110.065 177.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 241' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -59.26 114.52 2.06 Favored 'Trans proline' 0 C--N 1.387 2.565 0 C-N-CA 123.415 2.744 . . . . 71.53 112.786 -177.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 242' ' ' GLY . . . . . 0.433 ' HA3' ' NE2' ' C' ' 191' ' ' GLN . . . -99.53 168.3 21.65 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-N 115.217 -0.901 . . . . 70.14 112.812 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -67.46 -23.0 44.32 Favored 'Trans proline' 0 C--N 1.374 1.89 0 C-N-CA 123.116 2.544 . . . . 71.42 112.302 176.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -95.33 -4.18 45.93 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.837 0.855 . . . . 71.42 111.3 177.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 141.55 -85.55 0.2 Allowed Glycine 0 C--N 1.349 1.274 0 N-CA-C 111.311 -0.716 . . . . 63.24 111.311 -178.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 246' ' ' ARG . . . . . . . . . . . . . 85.6 mtm180 -138.61 175.26 9.71 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.657 1.183 . . . . 71.32 110.119 178.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 247' ' ' GLY . . . . . 0.481 ' HA3' ' HB3' ' C' ' 191' ' ' GLN . . . -104.08 -158.46 24.25 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 115.201 -0.909 . . . . 63.23 111.926 165.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -118.79 174.66 6.15 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.295 0.638 . . . . 73.54 109.492 -178.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 249' ' ' LEU . . . . . 0.459 ' HG ' HD11 ' C' ' 251' ' ' LEU . 20.6 tp -126.93 118.03 23.71 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.576 0.751 . . . . 74.23 110.841 -173.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 250' ' ' TYR . . . . . 0.66 ' HB3' ' HD3' ' C' ' 232' ' ' LYS . 22.3 m-30 -100.89 106.47 17.83 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.47 0.708 . . . . 71.43 110.715 178.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 251' ' ' LEU . . . . . 0.583 ' HB2' HD11 ' C' ' 233' ' ' LEU . 2.9 mp -105.3 124.32 49.34 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-N 118.836 0.744 . . . . 72.0 111.2 -174.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -76.7 120.2 21.55 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 109.068 -0.716 . . . . 75.41 109.068 174.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 253' ' ' VAL . . . . . . . . . . . . . 72.1 t -77.16 128.16 38.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 C-N-CA 123.235 0.614 . . . . 73.5 111.289 -176.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 254' ' ' ARG . . . . . . . . . . . . . 28.2 mtm180 -107.04 137.22 45.52 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.391 -0.966 . . . . 75.13 108.391 164.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 255' ' ' ILE . . . . . 0.483 ' O ' ' HB ' ' A' ' 255' ' ' ILE . 30.2 mm -98.64 109.61 24.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 105.843 -1.91 . . . . 75.24 105.843 165.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 256' ' ' THR . . . . . . . . . . . . . 7.5 t -131.15 176.87 7.9 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 124.09 0.956 . . . . 70.25 109.793 -170.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 49.6 pt -126.81 155.65 75.01 Favored Pre-proline 0 CA--C 1.557 1.226 0 C-N-CA 123.356 0.662 . . . . 75.21 110.254 -177.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 258' ' ' PRO . . . . . 0.516 ' HG3' ' HE2' ' A' ' 276' ' ' TYR . 49.6 Cg_endo -80.86 41.4 1.14 Allowed 'Trans proline' 0 C--N 1.377 2.051 0 C-N-CA 123.625 2.883 . . . . 74.41 113.945 -175.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 60.51 -93.63 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.882 1.273 . . . . 72.3 110.015 -171.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 260' ' ' ARG . . . . . 0.734 ' HA ' HH11 ' A' ' 226' ' ' ARG . 0.0 OUTLIER -115.03 164.1 14.66 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.514 1.126 . . . . 73.41 110.197 -178.16 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 261' ' ' LEU . . . . . . . . . . . . . 45.6 mt -126.96 173.15 9.85 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.023 0.929 . . . . 74.53 111.398 -171.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 73.4 p -84.27 148.6 53.32 Favored Pre-proline 0 CA--C 1.552 1.051 0 CA-C-N 114.942 -1.026 . . . . 61.23 108.801 168.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -43.34 -36.78 6.75 Favored 'Trans proline' 0 C--N 1.382 2.324 0 C-N-CA 124.478 3.452 . . . . 74.2 115.114 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -64.23 -60.94 2.6 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.251 0.62 . . . . 71.04 110.905 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -53.32 -51.1 63.44 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.448 -0.796 . . . . 71.03 109.874 178.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 266' ' ' GLU . . . . . 0.45 ' HG3' ' HZ1' ' C' ' 270' ' ' LYS . 22.1 tp10 -55.99 -36.17 67.6 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 114.547 -1.206 . . . . 73.1 111.706 -178.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -63.76 -48.89 75.13 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.2 0.6 . . . . 71.12 111.259 176.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 268' ' ' LEU . . . . . 0.607 ' HB2' HD23 ' A' ' 272' ' ' LEU . 8.0 mp -63.94 -38.17 90.09 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 123.033 0.208 . . . . 70.11 111.379 178.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 269' ' ' TRP . . . . . 0.453 ' HH2' ' HB3' ' C' ' 201' ' ' ALA . 77.1 m95 -64.78 -33.36 75.79 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.054 0.542 . . . . 63.11 111.017 175.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 270' ' ' LYS . . . . . 0.45 ' HZ1' ' HG3' ' C' ' 266' ' ' GLU . 52.5 mttp -70.87 -31.78 68.56 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.109 0.564 . . . . 75.43 111.74 175.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -69.76 -38.79 76.88 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 120.567 0.223 . . . . 75.33 110.903 175.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 92.9 mt -60.63 -44.91 95.81 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 115.723 -0.671 . . . . 74.33 109.581 170.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -62.12 -41.69 98.48 Favored 'General case' 0 C--O 1.216 -0.709 0 CA-C-N 115.42 -0.809 . . . . 43.22 111.401 -178.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -69.54 -33.71 73.19 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.386 0.675 . . . . 63.21 111.021 178.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -60.55 -33.77 73.16 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 121.243 0.544 . . . . 70.04 110.398 171.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 276' ' ' TYR . . . . . 0.697 ' HA ' ' HD3' ' C' ' 279' ' ' ARG . 16.4 m-85 -80.91 -31.39 35.13 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.251 -0.886 . . . . 75.52 112.839 174.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 18.6 m-30 -73.17 -22.2 60.53 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 118.391 0.541 . . . . 65.52 109.886 178.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -64.94 -23.43 67.22 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.474 0.71 . . . . 72.22 111.109 171.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 279' ' ' ARG . . . . . 0.697 ' HD3' ' HA ' ' C' ' 276' ' ' TYR . 17.2 mtp-105 -78.63 -21.37 48.51 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.498 0.719 . . . . 75.11 110.515 174.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.137 0 C-N-CA 123.507 0.723 . . . . 75.14 109.231 -178.857 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.2 mtp . . . . . 0 N--CA 1.473 0.677 0 N-CA-C 109.794 -0.447 . . . . 64.12 109.794 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 60.52 21.83 11.55 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 124.664 1.186 . . . . 74.44 113.98 173.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -88.29 53.89 2.89 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 122.858 0.463 . . . . 74.04 110.744 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.8 ttpp -38.96 105.65 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 125.337 1.455 . . . . 64.14 114.103 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -77.57 131.18 37.71 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.205 1.002 . . . . 74.32 110.427 177.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -83.76 86.84 7.08 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 107.022 -1.474 . . . . 62.43 107.022 166.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.472 ' CD1' ' HA ' ' A' ' 53' ' ' ALA . 66.6 m-85 -61.2 -31.11 70.87 Favored 'General case' 0 C--O 1.249 1.063 0 CA-C-N 115.094 -0.957 . . . . 73.34 112.144 -174.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -57.37 -55.38 35.51 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.241 0.617 . . . . 73.33 109.494 172.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.73 -33.66 74.43 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.816 0.847 . . . . 70.01 111.764 -177.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 78.1 mt -62.89 -40.14 87.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.287 0.635 . . . . 74.23 110.477 175.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 93.3 mt -80.03 -2.81 45.82 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 112.49 0.552 . . . . 73.11 112.49 173.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.26 18.03 72.63 Favored Glycine 0 C--N 1.351 1.394 0 O-C-N 123.3 0.375 . . . . 73.42 113.67 177.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.591 HG22 HG12 ' A' ' 22' ' ' ILE . 22.8 m -111.55 142.06 25.79 Favored Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 123.209 0.604 . . . . 72.52 110.185 177.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -82.94 169.78 12.89 Favored 'Trans proline' 0 C--N 1.366 1.453 0 C-N-CA 122.255 1.97 . . . . 50.12 112.048 174.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.6 mmt85 -67.92 80.43 0.21 Allowed 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 114.969 -1.014 . . . . 75.43 110.422 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -174.96 -32.75 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.166 1.387 . . . . 71.2 108.399 -177.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.28 122.07 17.08 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.831 -0.622 . . . . 74.14 110.56 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 72.8 p -76.58 175.13 9.57 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.14 0.976 . . . . 75.03 110.236 178.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -50.41 -38.63 43.99 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 124.424 1.09 . . . . 71.11 112.484 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.443 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 1.8 tm-20 -74.05 -41.76 61.26 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.397 1.079 . . . . 72.43 110.265 -175.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -67.86 -37.51 81.92 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 123.871 0.869 . . . . 71.14 110.623 177.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.67 HD12 HD13 ' A' ' 57' ' ' LEU . 45.0 mt -68.06 -33.06 58.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 C-N-CA 125.342 1.457 . . . . 73.31 110.612 175.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.2 ttmm -69.76 -38.99 76.98 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.733 0.813 . . . . 75.22 109.63 177.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.443 ' HG3' ' O ' ' A' ' 20' ' ' GLU . 48.9 mtt180 -61.36 -45.67 93.41 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 123.582 0.551 . . . . 73.12 109.97 174.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.72 -46.02 84.98 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 124.262 0.976 . . . . 72.43 111.302 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -60.6 -49.81 76.02 Favored 'General case' 0 C--N 1.348 0.534 0 O-C-N 123.693 0.621 . . . . 73.1 111.02 177.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -61.43 -35.95 78.99 Favored 'General case' 0 N--CA 1.484 1.229 0 O-C-N 124.078 0.861 . . . . 74.22 111.601 -178.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.8 ttt180 -58.52 -51.11 71.27 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.642 1.177 . . . . 75.52 110.355 174.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.678 ' HB3' HD11 ' A' ' 50' ' ' ILE . 54.2 mt -73.94 -21.07 60.17 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 114.843 -1.071 . . . . 75.12 110.708 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -88.4 -9.57 52.17 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.361 1.064 . . . . 71.54 111.392 179.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 48.4 mtm105 -93.5 -46.68 7.2 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.08 0.552 . . . . 72.33 109.967 166.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -69.75 -60.12 2.51 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.451 0.7 . . . . 73.31 111.423 -174.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.423 ' HE2' HD22 ' A' ' 29' ' ' LEU . 26.4 m-85 -92.97 19.52 7.68 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.371 0.668 . . . . 72.41 111.541 -174.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 -57.52 102.91 0.33 Allowed Pre-proline 0 N--CA 1.48 1.025 0 C-N-CA 125.147 1.379 . . . . 73.54 111.323 -172.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -62.17 -25.08 76.81 Favored 'Trans proline' 0 C--N 1.375 1.935 0 C-N-CA 123.164 2.576 . . . . 75.51 113.367 -177.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -59.66 -31.11 69.25 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.446 0.698 . . . . 73.23 111.416 175.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.9 t -102.2 -63.18 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 N-CA-C 109.254 -0.647 . . . . 73.25 109.254 176.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -97.95 86.07 3.65 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.397 1.079 . . . . 64.12 109.869 -174.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -77.13 71.46 3.63 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 115.382 -0.826 . . . . 73.11 109.707 174.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 43.7 m -118.19 117.57 34.9 Favored Pre-proline 0 N--CA 1.471 0.606 0 N-CA-C 108.287 -1.005 . . . . 71.24 108.287 178.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -41.22 -50.47 4.37 Favored 'Trans proline' 0 C--N 1.388 2.637 0 C-N-CA 124.291 3.327 . . . . 73.53 113.955 -171.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -53.98 -48.51 70.29 Favored 'General case' 0 CA--C 1.549 0.922 0 O-C-N 124.583 1.177 . . . . 64.43 111.323 -179.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.3 -28.74 67.44 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.384 -0.826 . . . . 73.42 111.237 -178.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.441 ' O ' ' HD3' ' A' ' 48' ' ' LYS . 49.2 mt-10 -84.84 -36.74 21.39 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.334 0.654 . . . . 63.35 110.321 -172.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -70.29 -42.68 71.73 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.842 0.857 . . . . 62.44 109.336 177.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -57.73 -41.48 81.91 Favored 'General case' 0 C--N 1.35 0.593 0 CA-C-N 114.857 -1.065 . . . . 74.03 109.689 169.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.415 ' HA ' HD12 ' A' ' 50' ' ' ILE . 35.1 t80 -70.47 -23.2 62.65 Favored 'General case' 0 CA--C 1.547 0.845 0 O-C-N 123.468 0.48 . . . . 73.32 111.836 179.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.441 ' HD3' ' O ' ' A' ' 44' ' ' GLU . 1.9 mptm? -68.98 -41.22 78.16 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 109.702 -0.481 . . . . 75.14 109.702 171.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -65.25 -37.37 87.01 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 123.629 0.58 . . . . 71.44 110.537 176.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.678 HD11 ' HB3' ' A' ' 29' ' ' LEU . 79.9 mt -69.14 -39.43 79.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.783 1.233 . . . . 74.43 110.565 177.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -67.95 -36.14 79.61 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.606 -0.724 . . . . 73.43 110.396 175.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.427 ' O ' HG23 ' A' ' 56' ' ' VAL . 32.4 tt0 -63.78 -53.39 51.57 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.551 1.141 . . . . 75.34 110.138 179.142 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.472 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . . . -60.41 -44.15 96.02 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 113.372 -1.74 . . . . 65.45 112.063 -177.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -82.54 -18.28 42.02 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 115.994 -0.548 . . . . 73.53 111.629 177.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.427 ' HB1' ' CD2' ' A' ' 85' ' ' PHE . . . -61.55 -36.62 81.1 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.8 0.809 . . . . 72.52 109.663 172.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.469 HG21 ' HE1' ' A' ' 101' ' ' PHE . 38.0 t -69.77 -61.73 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 CA-C-N 113.439 -1.709 . . . . 74.52 110.433 170.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.67 HD13 HD12 ' A' ' 22' ' ' ILE . 52.8 mt -86.45 12.78 9.52 Favored 'General case' 0 CA--C 1.559 1.322 0 CA-C-N 114.864 -1.062 . . . . 74.35 113.166 -165.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.6 t -67.88 -56.24 9.86 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.774 0.83 . . . . 74.34 110.664 174.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -95.04 148.05 34.04 Favored Pre-proline 0 N--CA 1.47 0.547 0 CA-C-N 115.095 -0.957 . . . . 74.34 110.286 -177.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.75 -41.15 57.65 Favored 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 123.266 2.644 . . . . 72.41 111.207 169.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -60.57 -54.69 42.35 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 123.97 0.908 . . . . 72.3 111.527 -178.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.435 ' HA ' HD11 ' A' ' 65' ' ' ILE . 37.6 mtpt -73.39 -32.04 64.24 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.625 0.77 . . . . 74.54 112.386 -174.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.435 HH21 HD13 ' A' ' 22' ' ' ILE . 7.6 ptm180 -67.31 -38.94 85.78 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.636 -0.505 . . . . 74.11 109.636 175.292 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -65.05 -35.91 82.68 Favored 'General case' 0 C--N 1.362 1.134 0 O-C-N 123.593 0.558 . . . . 74.25 110.904 174.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.435 HD11 ' HA ' ' A' ' 62' ' ' LYS . 83.4 mt -55.58 -47.14 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 C-N-CA 123.366 0.666 . . . . 74.41 110.469 174.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -58.04 -55.61 32.68 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 115.578 -0.737 . . . . 75.4 111.274 170.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -58.75 -31.8 68.67 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.467 0.707 . . . . 64.04 112.135 -173.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 67.8 p -86.98 -18.3 31.02 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.301 0.64 . . . . 75.44 111.338 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -72.47 134.64 45.42 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 106.839 -1.541 . . . . 75.32 106.839 164.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.63 26.77 49.52 Favored Glycine 0 N--CA 1.471 1.0 0 N-CA-C 111.201 -0.76 . . . . 64.23 111.201 -171.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 52.8 m -144.42 -56.45 0.36 Allowed 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 102.587 -3.116 . . . . 71.23 102.587 172.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.5 m -84.2 140.95 31.37 Favored 'General case' 0 C--O 1.25 1.098 0 N-CA-C 104.782 -2.303 . . . . 74.23 104.782 157.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.23 -41.84 63.27 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.08 0.552 . . . . 74.04 110.539 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.78 151.8 53.04 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 123.731 0.812 . . . . 75.1 110.134 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -63.0 133.8 43.11 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.214 1.943 . . . . 75.41 110.58 172.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_exo -47.26 150.44 3.3 Favored 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 124.373 3.382 . . . . 74.25 115.207 -178.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -55.82 113.35 1.39 Allowed 'Trans proline' 0 C--N 1.389 2.662 0 C-N-CA 123.302 2.668 . . . . 73.45 112.46 -178.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -62.58 146.45 95.39 Favored 'Trans proline' 0 C--N 1.382 2.297 0 C-N-CA 123.397 2.731 . . . . 73.2 113.283 -178.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -66.21 150.24 84.98 Favored 'Trans proline' 0 C--N 1.373 1.844 0 C-N-CA 122.819 2.346 . . . . 71.05 111.566 174.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.476 ' HD2' ' HA3' ' A' ' 142' ' ' GLY . 74.1 Cg_endo -72.75 64.89 3.94 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 123.576 2.851 . . . . 74.31 112.124 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -178.51 -31.98 0.05 OUTLIER Glycine 0 CA--C 1.522 0.484 0 CA-C-N 114.502 -1.227 . . . . 62.41 110.047 -170.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.77 -169.03 18.8 Favored Glycine 0 C--N 1.356 1.674 0 C-N-CA 122.993 0.33 . . . . 53.03 113.115 176.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -108.0 111.76 24.0 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.326 1.05 . . . . 74.41 110.165 -178.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -67.76 155.5 39.14 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.76 1.224 . . . . 71.31 110.944 172.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.531 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 64.8 m-85 -144.39 77.64 1.55 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.894 0.878 . . . . 73.24 110.517 -177.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.463 ' HB3' ' HG2' ' A' ' 162' ' ' PRO . 6.0 m -49.42 85.06 0.0 OUTLIER 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 125.446 1.499 . . . . 74.44 113.667 -179.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.33 20.71 79.96 Favored Glycine 0 CA--C 1.535 1.299 0 CA-C-N 116.118 -0.492 . . . . 70.11 113.772 -179.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.531 ' HB2' ' HB3' ' A' ' 85' ' ' PHE . 24.2 m-85 -114.09 106.86 14.89 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 117.41 0.605 . . . . 72.34 109.502 -176.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -83.73 80.52 9.11 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 121.686 0.755 . . . . 71.44 109.907 -177.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.41 HG13 ' OD1' ' A' ' 169' ' ' ASN . 3.4 p -39.94 -32.94 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 C-N-CA 126.635 1.974 . . . . 75.21 114.688 174.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.47 ' HB2' ' NH2' ' A' ' 114' ' ' ARG . 10.5 tp10 -53.47 -38.55 63.73 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.557 1.143 . . . . 75.33 111.783 -176.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -97.18 0.68 48.74 Favored 'General case' 0 CA--C 1.554 1.126 0 CA-C-N 115.332 -0.849 . . . . 61.35 111.495 -173.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.409 ' CD2' ' HA ' ' A' ' 90' ' ' VAL . 10.3 m-30 -88.68 -178.12 5.72 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.588 0.755 . . . . 73.34 110.555 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 89.6 p -77.47 163.74 26.07 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 113.595 0.961 . . . . 74.5 113.595 -168.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.413 ' O ' ' HG3' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -61.57 -40.34 94.38 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 114.312 -1.313 . . . . 74.52 112.123 175.889 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -63.33 -39.31 94.2 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 110.085 -0.339 . . . . 75.03 110.085 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -62.14 -40.33 95.61 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.529 -0.759 . . . . 72.32 109.654 176.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -81.16 -1.61 45.24 Favored 'General case' 0 CA--C 1.558 1.272 0 CA-C-N 114.801 -1.091 . . . . 74.14 112.288 177.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 95' ' ' GLU . 51.8 mt-10 -96.6 -46.46 6.31 Favored 'General case' 0 N--CA 1.503 2.224 0 C-N-CA 123.278 0.631 . . . . 70.02 111.62 167.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 33.5 tp -65.41 -45.55 83.5 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.678 1.191 . . . . 74.33 110.215 -177.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.469 ' HE1' HG21 ' A' ' 56' ' ' VAL . 97.5 m-85 -95.71 -7.97 35.89 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.544 -0.753 . . . . 72.11 111.033 176.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -45.16 -58.58 4.98 Favored Glycine 0 CA--C 1.541 1.67 0 CA-C-O 118.656 -1.08 . . . . 72.43 115.625 -177.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -62.3 -8.21 12.01 Favored 'Trans proline' 0 C--N 1.386 2.512 0 C-N-CA 123.169 2.58 . . . . 64.43 113.86 -175.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -142.01 33.49 1.93 Allowed Glycine 0 C--N 1.357 1.731 0 CA-C-O 119.551 -0.583 . . . . 54.4 112.771 175.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.442 ' HB3' ' HG ' ' A' ' 113' ' ' SER . 7.5 mt -66.79 20.92 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.305 0 N-CA-C 114.864 1.431 . . . . 74.25 114.864 -178.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.545 ' HB3' ' ND2' ' A' ' 169' ' ' ASN . 0.2 OUTLIER 57.06 -107.26 0.37 Allowed 'General case' 0 CA--C 1.564 1.486 0 C-N-CA 124.182 0.993 . . . . 74.45 110.541 165.123 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 66.22 15.36 63.11 Favored Glycine 0 C--N 1.362 1.975 0 CA-C-N 118.044 0.384 . . . . 44.0 113.414 -176.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.497 ' H ' ' HD1' ' A' ' 106' ' ' PHE . . . 59.22 -113.77 5.48 Favored Glycine 0 C--N 1.353 1.5 0 N-CA-C 111.482 -0.647 . . . . 71.34 111.482 -170.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -109.34 -5.61 15.79 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.544 0.737 . . . . 74.55 110.197 169.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -66.96 -27.17 73.31 Favored Glycine 0 C--N 1.351 1.41 0 C-N-CA 123.099 0.381 . . . . 55.25 112.846 177.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 61.8 mtt180 77.01 -40.02 0.35 Allowed 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 126.011 1.724 . . . . 75.52 114.308 169.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 40.3 ttt180 -86.23 46.88 1.38 Allowed 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 118.599 0.636 . . . . 75.13 110.046 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.442 ' HG ' ' HB3' ' A' ' 105' ' ' LEU . 45.1 m 46.52 52.32 11.03 Favored 'General case' 0 C--N 1.36 1.052 0 C-N-CA 124.712 1.205 . . . . 74.21 112.351 167.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.47 ' NH2' ' HB2' ' A' ' 91' ' ' GLU . 0.3 OUTLIER -110.71 160.8 16.38 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 112.508 0.559 . . . . 74.52 112.508 -166.56 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 170' ' ' PRO . 39.2 ttmt -68.79 135.52 51.34 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.729 0.812 . . . . 73.31 112.365 -170.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -97.18 -168.21 33.07 Favored Glycine 0 CA--C 1.549 2.196 0 CA-C-N 115.643 -0.708 . . . . 73.4 113.29 179.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.541 HH22 ' HB3' ' B' ' 13' ' ' LEU . 7.1 tmm_? -112.95 139.06 48.92 Favored 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 124.374 1.07 . . . . 74.43 109.766 177.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -50.61 113.92 1.02 Allowed 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.962 0.887 . . . . 74.23 112.724 -176.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.448 HD11 ' HA ' ' B' ' 12' ' ' PRO . 5.4 tt -105.81 148.65 27.28 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 114.652 -1.158 . . . . 75.42 108.795 -168.041 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.418 ' HD2' ' HB2' ' A' ' 175' ' ' LEU . 14.8 tpt180 -98.21 143.13 29.04 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 108.586 -0.894 . . . . 74.51 108.586 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.559 ' HB1' HD11 ' A' ' 174' ' ' LEU . . . -138.93 166.19 25.12 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 118.768 0.713 . . . . 54.41 111.45 -178.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.507 ' HB2' ' HB2' ' B' ' 9' ' ' ALA . 18.0 mm-40 -116.61 98.4 6.52 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 106.874 -1.528 . . . . 72.42 106.874 179.024 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.481 ' HB2' HD21 ' A' ' 176' ' ' LEU . 11.7 tp -98.25 103.57 18.65 Favored Pre-proline 0 C--O 1.213 -0.86 0 N-CA-C 107.392 -1.336 . . . . 74.14 107.392 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.451 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 55.2 Cg_endo -66.81 151.22 82.83 Favored 'Trans proline' 0 C--N 1.362 1.276 0 C-N-CA 121.253 1.302 . . . . 75.33 108.847 169.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.649 ' HA ' HG23 ' B' ' 6' ' ' ILE . 17.9 tp -150.91 148.2 28.14 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 119.283 0.947 . . . . 72.43 112.016 177.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 33.8 m -76.21 127.05 32.13 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 114.436 -1.256 . . . . 71.34 109.341 175.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.591 ' HB3' HD23 ' A' ' 215' ' ' LEU . 3.5 mm? -44.61 -57.73 3.46 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 125.516 1.526 . . . . 75.21 112.452 -178.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 17.5 mp0 -59.13 -44.56 92.05 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 114.33 -1.304 . . . . 75.32 109.632 -176.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -76.63 -12.28 59.99 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 115.185 -0.916 . . . . 64.33 111.856 -178.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.556 ' HB1' ' O ' ' A' ' 153' ' ' VAL . . . -79.45 -38.5 34.48 Favored 'General case' 0 C--O 1.252 1.223 0 CA-C-O 121.772 0.796 . . . . 65.44 109.206 176.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.454 ' HB2' HH21 ' A' ' 154' ' ' ARG . 89.2 t80 -70.57 -41.87 71.85 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 114.564 -1.198 . . . . 74.51 110.762 171.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 33.6 m170 -77.22 -36.46 54.68 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.149 0.579 . . . . 75.25 112.065 -172.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.512 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 70.21 -150.35 48.58 Favored Glycine 0 CA--C 1.531 1.087 0 O-C-N 123.411 0.444 . . . . 71.54 114.009 -179.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 91.57 -174.29 37.87 Favored Glycine 0 C--N 1.352 1.461 0 C-N-CA 123.483 0.563 . . . . 70.42 112.571 178.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 21.5 mp0 -67.95 113.16 5.42 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.823 0.849 . . . . 73.14 109.231 179.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 13.1 tpp180 -108.67 122.77 47.81 Favored 'General case' 0 C--O 1.244 0.806 0 C-N-CA 123.626 0.771 . . . . 75.05 109.626 -175.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 48.7 t -73.45 114.86 13.57 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 O-C-N 124.01 0.819 . . . . 75.04 109.156 175.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.44 HG12 HG13 ' A' ' 145' ' ' VAL . 5.5 p -142.39 134.64 26.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 124.65 1.18 . . . . 73.34 107.889 177.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -123.43 144.38 49.54 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 121.973 -0.454 . . . . 71.3 110.732 -175.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.503 ' HB ' ' HB3' ' B' ' 8' ' ' LEU . 11.9 p -159.32 141.09 4.69 Favored 'Isoleucine or valine' 0 C--O 1.243 0.715 0 C-N-CA 124.646 1.178 . . . . 75.1 108.111 173.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 58.92 31.71 21.57 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.911 0.885 . . . . 74.24 110.795 -177.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.476 ' HA3' ' HD2' ' A' ' 80' ' ' PRO . . . 73.05 0.15 50.09 Favored Glycine 0 C--N 1.355 1.598 0 CA-C-N 115.399 -0.818 . . . . 54.15 114.282 -178.378 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.75 99.08 10.41 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.317 1.047 . . . . 72.43 108.311 -174.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 27.1 ttt-85 -74.82 92.38 2.51 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.464 1.106 . . . . 74.41 109.702 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.468 HG23 ' HE1' ' A' ' 164' ' ' MET . 7.5 p -95.62 136.76 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 123.217 0.607 . . . . 73.53 110.899 -177.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 40.3 t -102.02 85.2 2.64 Favored 'General case' 0 C--O 1.243 0.718 0 N-CA-C 108.523 -0.917 . . . . 64.43 108.523 177.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 89.0 t -81.16 113.17 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 108.598 -0.89 . . . . 73.42 108.598 -176.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 40.4 ttt85 -68.79 93.04 0.51 Allowed 'General case' 0 C--O 1.242 0.692 0 N-CA-C 108.552 -0.907 . . . . 74.32 108.552 173.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.512 HG13 ' HA2' ' A' ' 133' ' ' GLY . 41.2 pt -72.91 133.16 82.24 Favored Pre-proline 0 CA--C 1.553 1.084 0 CA-C-N 114.481 -1.236 . . . . 74.52 108.832 177.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -59.87 128.52 27.03 Favored 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 122.527 2.152 . . . . 74.22 111.701 177.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.09 92.78 0.09 OUTLIER 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 122.5 2.134 . . . . 74.15 110.519 172.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 126.29 60.59 0.15 Allowed Glycine 0 C--N 1.339 0.698 0 CA-C-O 121.721 0.623 . . . . 75.51 111.709 -168.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.556 ' O ' ' HB1' ' A' ' 130' ' ' ALA . 7.5 p -137.46 138.02 45.26 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.754 0 N-CA-C 107.068 -1.456 . . . . 75.43 107.068 169.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.587 HH21 HD11 ' A' ' 215' ' ' LEU . 57.6 mtt180 -151.13 175.12 12.44 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.627 0.771 . . . . 73.23 109.102 173.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.516 ' HB3' ' H ' ' A' ' 188' ' ' LEU . 17.3 tp10 -34.7 128.16 0.47 Allowed 'General case' 0 N--CA 1.502 2.162 0 C-N-CA 126.442 1.897 . . . . 72.32 114.852 -166.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.72 -9.98 66.51 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 114.823 0.689 . . . . 74.33 114.823 175.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 15.3 t -73.18 153.56 40.65 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 117.329 0.564 . . . . 74.23 109.562 174.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 85.6 t -119.94 108.16 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.749 0.82 . . . . 74.02 109.846 -175.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.551 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 59.5 mt -86.7 113.85 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 N-CA-C 108.718 -0.845 . . . . 75.24 108.718 174.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -76.27 107.08 8.27 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 108.691 -0.855 . . . . 75.21 108.691 171.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 15.0 p -117.14 114.9 38.62 Favored Pre-proline 0 CA--C 1.554 1.106 0 N-CA-C 109.281 -0.637 . . . . 71.41 109.281 174.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.463 ' HG2' ' HB3' ' A' ' 86' ' ' SER . 50.4 Cg_endo -69.22 140.83 45.72 Favored 'Trans proline' 0 C--N 1.369 1.633 0 C-N-CA 122.368 2.045 . . . . 74.53 112.62 178.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . 0.504 ' N ' ' HB3' ' A' ' 171' ' ' PRO . . . 116.2 -26.52 8.66 Favored Glycine 0 N--CA 1.477 1.409 0 C-N-CA 123.519 0.58 . . . . 70.43 113.355 166.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.487 ' SD ' ' N ' ' A' ' 164' ' ' MET . 1.0 OUTLIER -102.37 -33.25 9.63 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.213 0.605 . . . . 64.15 110.245 -174.798 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.468 ' N ' ' HB2' ' A' ' 174' ' ' LEU . . . -89.86 151.97 22.06 Favored Glycine 0 CA--C 1.493 -1.343 0 N-CA-C 108.801 -1.72 . . . . 73.33 108.801 170.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.703 ' HA3' ' HA3' ' A' ' 172' ' ' GLY . . . 53.13 79.16 0.09 OUTLIER Glycine 0 CA--C 1.48 -2.129 0 CA-C-O 118.67 -1.072 . . . . 74.5 112.335 -161.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.499 HE21 ' HA ' ' A' ' 167' ' ' GLN . 0.0 OUTLIER -55.59 104.09 0.12 Allowed 'General case' 0 C--N 1.353 0.725 0 O-C-N 128.275 2.986 . . . . 75.42 109.27 -177.4 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -174.46 -135.95 2.15 Favored Glycine 0 N--CA 1.435 -1.414 0 N-CA-C 109.32 -1.512 . . . . 64.21 109.32 -172.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . 0.545 ' ND2' ' HB3' ' A' ' 106' ' ' PHE . 0.5 OUTLIER -134.31 -57.01 0.02 OUTLIER Pre-proline 0 CA--C 1.552 1.039 0 CA-C-O 118.518 -0.753 . . . . 63.54 109.204 176.344 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.455 ' O ' ' HA ' ' A' ' 115' ' ' LYS . 17.2 Cg_exo -67.98 124.1 11.43 Favored 'Trans proline' 0 C--N 1.39 2.751 0 N-CA-C 106.461 -2.169 . . . . 73.02 106.461 160.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.504 ' HB3' ' N ' ' A' ' 163' ' ' GLY . 57.2 Cg_endo -67.46 143.08 61.85 Favored 'Trans proline' 0 C--O 1.244 0.777 0 C-N-CA 122.067 1.845 . . . . 71.25 114.612 -164.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.703 ' HA3' ' HA3' ' A' ' 166' ' ' GLY . . . -74.68 -29.54 61.24 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 119.597 -1.287 . . . . 72.4 110.872 158.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 92.58 138.79 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 127.975 2.51 . . . . 71.14 109.635 -177.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.559 HD11 ' HB1' ' A' ' 121' ' ' ALA . 26.4 tp -109.05 141.02 41.8 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 122.678 0.391 . . . . 74.2 110.343 -173.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.418 ' HB2' ' HD2' ' A' ' 120' ' ' ARG . 65.8 mt -107.98 83.2 1.75 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.332 1.053 . . . . 72.12 108.686 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.551 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 92.1 mt -66.62 101.33 0.77 Allowed 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.174 -0.921 . . . . 74.52 110.283 179.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 64.0 t -84.29 102.81 10.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 N-CA-C 107.677 -1.231 . . . . 71.11 107.677 173.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 7.3 p -66.88 128.43 30.05 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 CA-C-N 115.358 -0.837 . . . . 74.13 110.592 -177.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.451 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 33.3 mmt180 -124.09 91.82 3.54 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.255 1.422 . . . . 73.42 107.272 -174.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.581 HD13 HD13 ' A' ' 127' ' ' LEU . 27.9 mt -70.17 147.52 49.77 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.597 -0.729 . . . . 74.04 112.181 -171.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 61.9 mt -58.95 149.14 67.33 Favored Pre-proline 0 N--CA 1.479 1.024 0 C-N-CA 124.362 1.065 . . . . 73.22 110.814 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -58.86 79.42 0.05 OUTLIER 'Trans proline' 0 C--N 1.383 2.381 0 C-N-CA 123.413 2.742 . . . . 74.32 112.703 176.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 66.5 t-80 -129.39 103.5 18.01 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 105.917 -1.882 . . . . 73.35 105.917 -175.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -73.58 25.39 0.32 Allowed 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 123.638 2.892 . . . . 61.24 116.227 -163.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 71.5 t -97.57 -61.21 2.32 Favored 'Isoleucine or valine' 0 C--N 1.351 0.669 0 CA-C-N 118.425 0.557 . . . . 72.34 110.465 -177.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 15.5 m-30 -124.34 147.92 47.85 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-O 121.829 0.823 . . . . 72.31 112.714 -171.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -144.8 150.28 36.89 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.328 1.851 . . . . 75.51 106.665 172.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.639 HD11 ' HA ' ' A' ' 193' ' ' LEU . 6.3 tp -121.17 173.43 7.31 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 107.177 -1.416 . . . . 74.21 107.177 178.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -159.56 128.98 5.34 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 109.076 -0.713 . . . . 70.31 109.076 165.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 68.6 -74.55 0.31 Allowed Glycine 0 C--N 1.347 1.169 0 N-CA-C 110.979 -0.848 . . . . 65.41 110.979 -170.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.403 ' N ' HD22 ' B' ' 300' ' ' ASN . 3.4 tp-100 -164.17 -0.68 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 123.758 0.823 . . . . 72.32 111.547 172.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -95.89 146.49 24.54 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.914 -0.491 . . . . 72.32 109.685 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.639 ' HA ' HD11 ' A' ' 188' ' ' LEU . 0.8 OUTLIER -89.69 157.2 18.1 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.473 1.109 . . . . 74.25 111.486 -165.765 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -142.96 154.9 44.51 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.648 1.579 . . . . 73.14 107.631 175.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -158.84 127.16 5.21 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.902 0.881 . . . . 74.34 109.122 -176.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 31.1 m -75.66 127.23 32.62 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 118.163 0.438 . . . . 70.21 110.128 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 38.5 tp -130.7 104.32 7.12 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.522 0.729 . . . . 74.1 110.032 -175.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -89.85 124.59 34.82 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 109.261 -0.644 . . . . 63.3 109.261 171.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 8.9 p -138.06 137.62 21.53 Favored Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 123.874 0.869 . . . . 74.33 109.16 -174.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.85 155.16 53.69 Favored 'Trans proline' 0 C--N 1.378 2.086 0 C-N-CA 121.765 1.643 . . . . 70.05 111.327 174.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -52.2 -49.66 83.5 Favored Pre-proline 0 CA--C 1.552 1.043 0 N-CA-C 114.633 1.346 . . . . 71.34 114.633 -172.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.456 ' HG2' ' HE1' ' C' ' 276' ' ' TYR . 54.3 Cg_exo -58.75 -41.28 64.83 Favored 'Trans proline' 0 C--N 1.386 2.541 0 C-N-CA 121.912 1.741 . . . . 73.32 113.997 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.476 HD12 ' HB3' ' C' ' 276' ' ' TYR . 44.0 mt -68.29 -35.57 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 109.907 -0.405 . . . . 71.02 109.907 178.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.16 -45.82 79.59 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.46 0.704 . . . . 74.14 111.751 176.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 53.0 t -68.26 -48.75 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 124.194 0.998 . . . . 64.22 111.522 -176.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 54.7 t -83.13 -37.59 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.042 0.937 . . . . 74.41 111.613 -172.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 92.22 70.61 1.17 Allowed Glycine 0 C--O 1.24 0.48 0 CA-C-N 115.765 -0.652 . . . . 72.35 111.493 -174.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -92.18 -154.23 30.7 Favored Glycine 0 C--N 1.34 0.793 0 CA-C-N 115.055 -0.572 . . . . 73.32 113.312 -177.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 36.3 mtmt -130.02 132.84 46.39 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.327 -0.62 . . . . 73.34 109.327 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 29.0 m -132.52 160.37 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 N-CA-C 108.678 -0.86 . . . . 63.11 108.678 172.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -97.68 115.36 27.8 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.358 -0.979 . . . . 74.32 108.358 177.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.89 165.65 11.24 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.936 0.894 . . . . 74.41 110.326 -174.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' MET . . . . . 0.456 ' SD ' ' N ' ' A' ' 213' ' ' MET . 0.0 OUTLIER -98.98 137.04 38.08 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.241 -0.89 . . . . 74.15 109.211 -174.941 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 67.6 p -124.53 177.51 5.89 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 107.934 -1.135 . . . . 74.1 107.934 163.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.591 HD23 ' HB3' ' A' ' 127' ' ' LEU . 33.0 mt -78.26 -23.14 47.42 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.81 -0.632 . . . . 73.14 110.395 -177.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -83.62 -12.84 55.49 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.148 0.979 . . . . 64.44 111.175 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 138.28 -164.62 25.6 Favored Glycine 0 C--N 1.346 1.137 0 N-CA-C 111.564 -0.614 . . . . 63.05 111.564 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . 0.474 ' HB3' HG22 ' B' ' 384' ' ' THR . 65.0 Cg_endo -79.09 134.8 11.87 Favored 'Trans proline' 0 C--N 1.363 1.303 0 C-N-CA 122.262 1.974 . . . . 74.13 111.693 175.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 34.8 m -130.89 168.14 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 107.681 -1.229 . . . . 73.4 107.681 171.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.593 ' HB3' ' HE3' ' B' ' 422' ' ' MET . 28.4 mt-10 -106.54 152.84 23.17 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 121.856 -0.528 . . . . 75.04 111.894 -179.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 10.2 p -142.63 141.65 27.41 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 CA-C-N 114.868 -1.06 . . . . 74.51 109.319 -173.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.419 ' HB2' ' HA ' ' B' ' 440' ' ' ARG . . . -106.83 104.77 14.53 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 109.608 -0.515 . . . . 70.4 109.608 -179.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.559 ' HA ' HD13 ' B' ' 441' ' ' ILE . 66.7 t -58.53 142.78 82.27 Favored Pre-proline 0 CA--C 1.569 1.68 0 C-N-CA 125.262 1.425 . . . . 71.22 110.472 -179.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -84.31 167.36 12.13 Favored 'Trans proline' 0 C--N 1.386 2.515 0 C-N-CA 122.863 2.375 . . . . 75.51 111.195 175.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.12 145.91 28.26 Favored 'Trans proline' 0 C--N 1.367 1.546 0 C-N-CA 121.495 1.463 . . . . 72.53 112.681 174.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 71.9 mtt85 65.76 34.18 7.66 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 125.341 1.456 . . . . 75.13 111.642 175.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.492 HG23 HG11 ' A' ' 253' ' ' VAL . 89.3 m -63.15 108.67 1.31 Allowed 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 113.657 -1.611 . . . . 64.32 110.705 174.109 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -98.71 150.89 21.34 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.597 0.759 . . . . 75.32 110.824 -169.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -63.86 128.04 34.05 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.896 0.879 . . . . 65.12 110.742 177.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 97.0 -26.18 23.71 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-N 116.377 -0.374 . . . . 75.54 112.53 -178.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 55.8 mtt180 -74.36 135.3 42.47 Favored 'General case' 0 C--N 1.36 1.057 0 CA-C-O 121.623 0.725 . . . . 74.44 111.094 -178.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.604 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 33.6 mttm -102.71 112.37 25.12 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 114.219 -1.355 . . . . 72.22 109.03 -178.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.549 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 45.6 mt -75.33 99.5 4.12 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.031 0.932 . . . . 71.4 109.755 -172.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 58.9 ttt180 -73.64 123.89 24.91 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.59 1.156 . . . . 73.41 110.958 -173.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.473 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 67.3 mt -116.64 109.41 17.16 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.964 0.905 . . . . 74.24 109.889 -179.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.483 ' HB3' ' HZ1' ' A' ' 236' ' ' LYS . 3.0 mmmp? -62.5 125.31 23.5 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 123.668 0.787 . . . . 71.01 112.767 -173.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 73.08 30.65 62.79 Favored Glycine 0 C--N 1.352 1.43 0 O-C-N 124.036 0.835 . . . . 74.2 113.881 174.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -115.77 -12.38 11.49 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.333 0.653 . . . . 74.1 111.65 -178.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -87.17 -168.77 45.14 Favored Glycine 0 C--N 1.348 1.205 0 O-C-N 123.311 0.382 . . . . 74.43 112.323 171.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . 0.504 ' HE2' ' HG3' ' A' ' 154' ' ' ARG . 13.2 m-30 -95.0 154.29 39.69 Favored Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 123.039 0.536 . . . . 73.41 111.903 -169.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.474 ' HA ' ' HA ' ' A' ' 246' ' ' ARG . 59.5 Cg_endo -70.16 120.54 7.25 Favored 'Trans proline' 0 C--N 1.386 2.544 0 C-N-CA 123.339 2.692 . . . . 73.33 113.62 -176.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -157.05 -138.78 2.58 Favored Glycine 0 C--N 1.35 1.327 0 CA-C-O 119.208 -0.773 . . . . 73.52 112.645 -178.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -70.57 -16.31 34.12 Favored 'Trans proline' 0 C--N 1.385 2.493 0 C-N-CA 123.24 2.627 . . . . 72.5 113.549 -173.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -100.18 20.43 14.62 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.737 0.815 . . . . 70.11 110.643 177.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 79.09 -80.19 1.53 Allowed Glycine 0 C--N 1.351 1.398 0 N-CA-C 109.503 -1.439 . . . . 62.24 109.503 -171.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.474 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 44.8 mtm180 -125.6 159.36 32.33 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.476 1.11 . . . . 75.41 108.514 164.374 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -87.64 -176.81 48.3 Favored Glycine 0 C--N 1.339 0.696 0 CA-C-N 116.14 -0.482 . . . . 70.31 112.285 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -123.2 151.6 42.07 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.027 0.931 . . . . 75.44 109.648 178.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.473 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 53.8 tp -96.84 111.31 23.55 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 109.434 -0.58 . . . . 73.32 109.434 -178.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.604 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 18.7 m-85 -96.82 105.91 18.12 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.323 1.049 . . . . 71.3 109.539 -179.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.549 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 12.1 mt -81.63 97.4 7.86 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.949 0.5 . . . . 74.54 109.739 176.021 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -77.47 105.74 8.79 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.988 0.915 . . . . 75.41 108.726 -174.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.492 HG11 HG23 ' A' ' 227' ' ' THR . 55.0 t -88.79 144.35 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 N-CA-C 114.192 1.182 . . . . 71.34 114.192 -165.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -128.65 111.47 13.23 Favored 'General case' 0 C--N 1.351 0.666 0 C-N-CA 125.838 1.655 . . . . 73.14 108.01 168.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.405 HD12 ' HA ' ' C' ' 256' ' ' THR . 58.2 mt -76.8 138.6 20.28 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 122.955 0.502 . . . . 74.34 109.769 178.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 48.2 p -122.87 173.48 7.75 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.588 1.155 . . . . 74.52 109.307 176.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 27.3 pt -117.82 162.18 30.42 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 123.301 0.64 . . . . 73.4 109.68 175.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -66.65 5.98 0.65 Allowed 'Trans proline' 0 N--CA 1.502 1.979 0 C-N-CA 123.263 2.642 . . . . 74.45 115.609 176.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.469 ' HG3' ' NE2' ' C' ' 228' ' ' GLN . 2.4 mp0 48.52 -97.68 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.692 0.797 . . . . 75.12 109.659 -161.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' ARG . . . . . 0.635 ' HG2' ' HB3' ' B' ' 373' ' ' ARG . 0.0 OUTLIER -87.7 160.95 17.9 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.062 0.945 . . . . 75.12 111.003 -172.598 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 79.7 mt -138.51 157.38 46.29 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.673 0.789 . . . . 72.32 110.446 -175.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 78.4 p -102.67 151.19 38.24 Favored Pre-proline 0 CA--C 1.554 1.133 0 N-CA-C 108.394 -0.965 . . . . 74.31 108.394 169.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -25.79 -46.29 0.06 OUTLIER 'Trans proline' 0 C--N 1.394 2.958 1 C-N-CA 126.58 4.854 . . . . 74.33 117.932 -170.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -66.64 -62.73 1.3 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 122.935 0.494 . . . . 71.44 111.445 -176.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -66.12 -25.81 67.16 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 122.509 0.324 . . . . 73.22 110.5 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -56.75 -52.12 66.22 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 124.179 0.924 . . . . 73.45 109.455 173.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -62.39 -42.42 99.41 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.698 -1.137 . . . . 64.12 111.653 176.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 10.4 mp -58.04 -55.46 34.63 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 122.971 0.508 . . . . 73.14 111.955 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 66.4 m95 -60.12 -39.79 87.46 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.487 0.715 . . . . 75.0 111.647 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . 0.571 ' HE2' HG21 ' C' ' 206' ' ' VAL . 1.1 mptm? -64.34 -44.03 92.78 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 123.62 0.575 . . . . 73.12 111.585 177.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -63.72 -43.02 97.78 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 122.993 0.517 . . . . 70.22 110.608 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 272' ' ' LEU . . . . . 0.478 ' O ' ' HB2' ' A' ' 276' ' ' TYR . 75.6 mt -56.53 -46.01 80.83 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 124.422 1.076 . . . . 71.54 110.57 174.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . 0.454 ' HB1' HE22 ' B' ' 250' ' ' GLN . . . -74.69 -37.99 62.49 Favored 'General case' 0 C--O 1.244 0.797 0 O-C-N 124.468 1.105 . . . . 72.23 113.63 -171.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -77.3 -39.11 49.1 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.072 0.549 . . . . 74.35 109.566 -179.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . 0.408 ' HB1' ' NH2' ' A' ' 279' ' ' ARG . . . -74.19 -20.49 60.18 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.162 0.585 . . . . 72.24 111.034 174.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . 0.478 ' HB2' ' O ' ' A' ' 272' ' ' LEU . 14.7 t80 -65.16 -63.63 1.06 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.079 0.951 . . . . 75.02 108.762 172.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -64.94 -38.64 91.64 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 114.987 -1.006 . . . . 72.14 110.406 -173.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . 0.466 ' HA ' HD23 ' B' ' 278' ' ' LEU . . . -62.85 -26.15 68.62 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.236 0.614 . . . . 75.41 112.093 176.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . 0.408 ' NH2' ' HB1' ' A' ' 275' ' ' ALA . 27.5 mtm180 -117.4 31.2 6.86 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.477 0.711 . . . . 75.15 109.938 179.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.393 0 N-CA-C 109.087 -0.708 . . . . 72.5 109.087 171.984 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.481 1.081 0 N-CA-C 109.872 -0.418 . . . . 74.12 109.872 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 57.6 tttp 70.97 135.11 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.931 1.292 . . . . 62.45 113.594 176.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 63.08 30.14 16.21 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 125.62 1.568 . . . . 74.04 112.168 171.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 11.9 m -66.63 -34.96 79.04 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.769 0.428 . . . . 52.14 110.448 175.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 1.8 m 69.14 152.03 0.09 Allowed 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 125.593 1.557 . . . . 74.34 112.167 177.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.649 HG23 ' HA ' ' A' ' 125' ' ' LEU . 31.4 pt -136.83 171.2 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 N-CA-C 113.044 0.757 . . . . 65.34 113.044 -158.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -146.05 123.58 11.75 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.169 0.988 . . . . 72.22 110.187 -178.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . 0.503 ' HB3' ' HB ' ' A' ' 140' ' ' VAL . 36.3 tp -77.75 145.37 36.53 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.119 0.968 . . . . 75.22 110.908 -173.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . 0.507 ' HB2' ' HB2' ' A' ' 122' ' ' GLU . . . -88.79 -50.39 6.26 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.052 0.541 . . . . 73.12 111.828 178.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 86.9 mt 68.0 122.57 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 124.872 1.269 . . . . 74.1 111.283 -166.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.423 HD21 ' HD2' ' B' ' 15' ' ' PHE . 68.2 mt -111.11 100.84 48.42 Favored Pre-proline 0 N--CA 1.481 1.078 0 N-CA-C 108.046 -1.094 . . . . 72.11 108.046 171.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.448 ' HA ' HD11 ' A' ' 119' ' ' LEU . 13.6 Cg_endo -51.95 -65.77 0.13 Allowed 'Trans proline' 0 C--N 1.384 2.429 0 C-N-CA 123.462 2.775 . . . . 71.41 112.65 -174.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . 0.541 ' HB3' HH22 ' A' ' 117' ' ' ARG . 2.5 pt? -170.07 147.76 3.28 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.201 1.001 . . . . 75.11 108.87 175.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 94.8 mt 70.7 -23.84 0.17 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 125.146 1.378 . . . . 64.54 114.45 174.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 15' ' ' PHE . . . . . 0.423 ' HD2' HD21 ' B' ' 11' ' ' LEU . 69.6 t80 -76.43 96.78 4.12 Favored 'General case' 0 C--N 1.349 0.583 0 CA-C-O 121.447 0.641 . . . . 74.01 109.38 -178.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 41.4 m -139.57 126.69 12.74 Favored Pre-proline 0 CA--C 1.546 0.811 0 N-CA-C 107.487 -1.301 . . . . 71.11 107.487 178.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -66.92 73.85 0.45 Allowed 'Trans proline' 0 C--N 1.379 2.15 0 C-N-CA 123.086 2.524 . . . . 71.22 113.741 -177.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 57.5 t -135.47 90.19 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.092 0.957 . . . . 63.3 109.173 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 4.4 m 64.24 10.14 5.34 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 124.335 1.054 . . . . 71.22 113.199 165.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 20' ' ' LYS . . . . . 0.541 ' HB2' ' HZ2' ' B' ' 20' ' ' LYS . 0.1 OUTLIER -159.01 -72.24 0.08 Allowed 'General case' 0 N--CA 1.479 1.006 0 O-C-N 121.333 -0.854 . . . . 74.33 111.624 -175.041 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.98 77.44 5.45 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.354 0.661 . . . . 75.34 111.213 -170.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? 54.43 91.35 0.03 OUTLIER 'General case' 0 C--N 1.356 0.869 0 C-N-CA 125.377 1.471 . . . . 73.31 110.972 -177.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 23' ' ' THR . . . . . . . . . . . . . 23.4 m -101.63 107.59 52.16 Favored Pre-proline 0 CA--C 1.554 1.11 0 N-CA-C 108.906 -0.776 . . . . 72.54 108.906 178.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.02 -21.57 68.29 Favored 'Trans proline' 0 C--N 1.381 2.242 0 C-N-CA 123.441 2.761 . . . . 74.55 112.955 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -93.55 97.97 10.86 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 108.369 -0.974 . . . . 74.53 108.369 178.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' MET . . . . . 0.466 ' H ' ' HD2' ' B' ' 27' ' ' PRO . 28.0 ttt -171.26 -38.77 0.0 OUTLIER Pre-proline 0 CA--C 1.567 1.61 0 C-N-CA 124.402 1.081 . . . . 75.13 111.716 -172.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 27' ' ' PRO . . . . . 0.466 ' HD2' ' H ' ' B' ' 26' ' ' MET . 30.1 Cg_endo -62.9 168.63 10.13 Favored 'Trans proline' 0 C--N 1.394 2.949 0 C-N-CA 122.167 1.912 . . . . 73.04 112.68 167.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 64.9 t 78.2 -28.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 C-N-CA 126.08 1.752 . . . . 75.25 111.132 -172.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 80.3 mt -68.65 175.88 3.27 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.306 1.042 . . . . 73.34 112.03 173.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 63.42 34.39 12.93 Favored 'General case' 0 C--N 1.357 0.903 0 C-N-CA 124.539 1.136 . . . . 71.25 110.258 -174.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 52.0 t-20 -64.36 93.59 0.1 Allowed 'General case' 0 C--N 1.365 1.281 0 N-CA-C 108.752 -0.833 . . . . 74.34 108.752 176.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 18.5 ttp180 -108.48 11.72 26.68 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 124.99 1.316 . . . . 72.22 109.609 -172.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.56 -51.92 4.89 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.344 1.058 . . . . 73.31 108.923 172.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -119.06 107.88 14.04 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 124.275 1.03 . . . . 53.33 108.69 178.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -166.37 71.21 0.13 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.138 0.975 . . . . 73.13 108.517 -178.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 55.93 -107.78 0.92 Allowed Glycine 0 C--N 1.342 0.866 0 CA-C-N 114.635 -1.166 . . . . 74.33 114.472 178.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . 0.405 ' HA ' ' HA ' ' B' ' 41' ' ' PRO . 2.5 m-20 -65.57 -26.02 67.67 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 114.16 1.17 . . . . 61.44 114.16 -172.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 13.3 tt -74.33 -20.21 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-N 117.816 0.28 . . . . 75.44 111.544 -176.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 10.3 t -107.52 -32.38 7.73 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.021 0.528 . . . . 73.32 110.766 176.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -166.51 103.86 0.67 Allowed Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 123.954 0.902 . . . . 73.24 109.38 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' B' ' 37' ' ' ASP . 14.7 Cg_exo -68.9 72.54 1.04 Allowed 'Trans proline' 0 C--N 1.383 2.386 0 C-N-CA 123.25 2.633 . . . . 72.44 112.563 176.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 60.26 -89.72 0.04 OUTLIER Glycine 0 C--N 1.351 1.413 0 CA-C-N 115.863 -0.608 . . . . 61.22 112.4 -175.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -168.77 18.12 0.07 OUTLIER Glycine 0 CA--C 1.528 0.86 0 CA-C-O 119.599 -0.556 . . . . 64.32 112.291 174.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . 62.61 -75.68 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.654 1.182 . . . . 63.2 109.873 -170.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -65.81 138.75 58.12 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.564 0.746 . . . . 74.21 109.546 166.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -79.01 -27.61 43.27 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 108.22 -1.03 . . . . 75.02 108.22 171.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 44.0 tp 78.56 -36.63 0.2 Allowed 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 126.278 1.831 . . . . 72.13 112.894 171.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 11.8 m 75.13 -3.98 2.48 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 124.918 1.287 . . . . 73.12 111.36 -177.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.62 19.57 61.6 Favored Glycine 0 C--N 1.348 1.215 0 N-CA-C 111.359 -0.696 . . . . 74.15 111.359 -169.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -80.8 151.02 28.96 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 123.569 0.748 . . . . 64.2 110.597 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -134.95 -0.92 2.73 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.388 1.075 . . . . 75.3 110.579 -178.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 4.1 m 60.25 41.05 17.15 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 124.364 1.066 . . . . 73.31 110.621 -177.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.17 95.87 0.6 Allowed 'General case' 0 C--N 1.354 0.799 0 CA-C-N 115.223 -0.899 . . . . 73.24 109.355 177.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.642 ' HB3' HH11 ' B' ' 56' ' ' ARG . . . 65.23 10.1 6.16 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.758 1.223 . . . . 75.51 112.299 -175.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 24.0 tp 58.01 23.56 10.11 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 124.972 1.309 . . . . 72.35 110.893 -172.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . 0.642 HH11 ' HB3' ' B' ' 54' ' ' ALA . 79.1 mtt85 -120.59 -167.93 1.55 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.519 1.128 . . . . 74.21 110.043 -175.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -82.47 15.73 2.4 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 123.354 0.662 . . . . 75.31 111.601 177.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 31.1 t -64.83 -22.66 67.03 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.478 1.111 . . . . 62.01 112.395 -178.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -66.26 -27.94 68.33 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.988 0.515 . . . . 72.44 110.772 174.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 33.0 t -94.85 95.29 8.58 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.315 1.046 . . . . 71.31 109.168 178.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -66.94 145.14 55.75 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.178 0.591 . . . . 71.45 110.415 176.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 62' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm 62.77 82.01 0.22 Allowed Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 125.056 1.342 . . . . 72.42 111.721 -176.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -68.11 -13.18 37.38 Favored 'Trans proline' 0 C--N 1.382 2.295 0 C-N-CA 123.211 2.607 . . . . 72.24 112.578 170.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . 0.528 ' HB2' ' HB2' ' B' ' 262' ' ' ALA . . . 68.25 -78.53 0.04 OUTLIER 'General case' 0 C--N 1.361 1.098 0 C-N-CA 125.577 1.551 . . . . 72.04 111.085 -177.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.401 ' HE2' ' HB1' ' B' ' 263' ' ' ALA . 45.9 mtmt -107.78 -11.61 15.36 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.255 0.622 . . . . 73.42 111.126 178.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 70.5 145.93 0.06 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.697 1.199 . . . . 72.41 112.684 177.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 13.7 tt 41.0 60.34 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 C-N-CA 126.65 1.98 . . . . 74.04 112.606 176.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 31.6 pt -77.34 77.09 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 CA-C-N 114.607 -1.179 . . . . 73.4 110.783 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.31 99.24 0.9 Allowed 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 114.428 -1.26 . . . . 74.34 109.51 179.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 8.6 mp 68.16 -75.93 0.06 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.84 1.256 . . . . 65.22 110.004 -177.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 17.7 tt -135.52 123.28 37.03 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 C-N-CA 123.698 0.799 . . . . 75.5 109.256 174.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -106.79 26.36 19.76 Favored Glycine 0 N--CA 1.476 1.342 0 N-CA-C 111.296 -0.722 . . . . 71.15 111.296 177.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -111.5 -40.29 4.4 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.61 1.164 . . . . 74.12 109.805 -172.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 172.45 118.07 0.47 Allowed Glycine 0 C--N 1.337 0.604 0 N-CA-C 109.478 -1.449 . . . . 72.45 109.478 -178.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 75' ' ' MET . . . . . 0.48 ' N ' ' SD ' ' B' ' 75' ' ' MET . 0.7 OUTLIER -74.95 88.04 2.34 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 122.001 0.905 . . . . 74.01 109.29 -174.362 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 161.74 61.04 0.02 OUTLIER Glycine 0 C--N 1.333 0.371 0 N-CA-C 108.3 -1.92 . . . . 71.52 108.3 -173.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -53.07 -49.68 65.89 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 125.064 1.346 . . . . 74.35 111.052 -173.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 95.9 p 60.41 -65.45 0.05 Allowed 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 126.93 2.092 . . . . 55.34 111.745 -178.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . 0.586 ' HG3' HG12 ' B' ' 80' ' ' ILE . 10.3 tp10 74.14 -81.6 0.03 OUTLIER 'General case' 0 C--N 1.352 0.702 0 C-N-CA 125.353 1.461 . . . . 74.44 110.37 171.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . 0.586 HG12 ' HG3' ' B' ' 79' ' ' GLU . 11.2 pt -144.77 -165.62 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 125.174 1.39 . . . . 72.52 107.896 -178.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 23.1 m -69.79 155.81 39.97 Favored 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 108.343 -0.984 . . . . 74.52 108.343 168.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -49.05 95.31 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.751 1.221 . . . . 75.12 112.269 -171.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -161.08 -57.39 0.05 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.469 1.108 . . . . 74.13 108.879 -176.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -102.65 96.15 6.69 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 109.029 -0.73 . . . . 73.0 109.029 174.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -131.58 -68.81 0.64 Allowed 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 107.612 -1.255 . . . . 72.23 107.612 175.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 60.6 t80 65.74 145.49 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 125.461 1.504 . . . . 74.21 112.286 175.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . 58.28 -135.88 0.96 Allowed 'General case' 0 N--CA 1.481 1.123 0 CA-C-O 118.433 -0.794 . . . . 52.24 109.515 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 69.13 -77.11 0.05 Allowed 'General case' 0 C--N 1.364 1.21 0 C-N-CA 124.704 1.202 . . . . 74.14 110.564 168.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 170.6 -32.58 0.15 Allowed Glycine 0 C--N 1.339 0.735 0 N-CA-C 110.564 -1.015 . . . . 54.33 110.564 179.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.7 -36.31 83.42 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.262 1.025 . . . . 75.53 112.311 178.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -163.49 88.68 0.1 Allowed Glycine 0 C--N 1.343 0.969 0 N-CA-C 111.256 -0.737 . . . . 70.11 111.256 -179.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.96 -42.83 99.87 Favored Glycine 0 C--N 1.356 1.683 0 N-CA-C 111.936 -0.465 . . . . 73.42 111.936 177.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 23.8 t80 63.26 82.69 0.18 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.219 1.408 . . . . 74.22 111.071 176.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -82.64 -4.42 57.71 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 114.544 -1.207 . . . . 72.14 111.176 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . 0.569 ' HB2' HG21 ' B' ' 97' ' ' ILE . 42.1 mttp 73.74 -19.49 0.34 Allowed 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 125.592 1.557 . . . . 74.44 114.064 167.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.3 8.78 85.73 Favored Glycine 0 C--N 1.349 1.265 0 CA-C-O 120.035 -0.314 . . . . 75.21 113.609 -176.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 97' ' ' ILE . . . . . 0.569 HG21 ' HB2' ' B' ' 95' ' ' LYS . 9.3 tt -89.48 75.06 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.166 0 CA-C-O 122.599 1.19 . . . . 73.0 109.559 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -157.29 140.18 15.16 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.008 -0.996 . . . . 75.21 109.104 -178.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . 72.03 -11.31 0.79 Allowed 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 125.906 1.683 . . . . 61.12 113.408 -177.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 76.2 mt -76.57 -41.22 2.82 Favored Pre-proline 0 CA--C 1.558 1.257 0 C-N-CA 124.392 1.077 . . . . 74.2 112.089 176.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -60.23 109.78 0.68 Allowed 'Trans proline' 0 C--N 1.405 3.523 0 C-N-CA 121.945 1.764 . . . . 74.43 111.751 172.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 55.1 tp -64.2 126.78 28.85 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.68 0.792 . . . . 73.12 110.217 -178.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 27.5 m -76.03 80.99 2.88 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-O 121.769 0.795 . . . . 75.52 109.684 178.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.86 151.48 30.53 Favored Glycine 0 C--N 1.343 0.965 0 CA-C-N 114.592 -1.186 . . . . 51.35 111.743 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 26.3 mp0 -74.72 -17.74 60.61 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.052 0.941 . . . . 75.22 110.829 178.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 59.9 t80 80.83 -43.87 0.21 Allowed 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 125.245 1.418 . . . . 74.44 112.6 170.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 58.8 p -74.9 95.26 2.93 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.91 0.884 . . . . 75.34 112.183 -173.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 32.9 m80 71.49 116.31 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 125.284 1.434 . . . . 73.44 113.115 167.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -136.51 93.6 2.9 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.472 1.109 . . . . 74.1 108.139 174.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -133.56 118.02 17.78 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.435 0.694 . . . . 75.22 110.607 -172.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 3.9 pp -90.03 156.65 18.25 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.446 0.698 . . . . 70.25 109.98 173.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 112' ' ' ASN . . . . . 0.425 ' ND2' ' HB ' ' B' ' 115' ' ' THR . 27.0 t-20 68.62 -73.1 0.09 Allowed 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 124.961 1.304 . . . . 73.2 112.603 174.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 113' ' ' LYS . . . . . 0.688 ' HG2' ' HB2' ' C' ' 36' ' ' ASP . 15.7 tppt? 75.08 -69.31 0.18 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 126.232 1.813 . . . . 75.13 111.945 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.64 61.75 1.38 Allowed 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 121.765 0.793 . . . . 74.21 111.8 -173.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 115' ' ' THR . . . . . 0.425 ' HB ' ' ND2' ' B' ' 112' ' ' ASN . 69.7 m -137.47 120.84 17.0 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 108.723 -0.843 . . . . 73.23 108.723 174.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . 0.437 ' O ' ' HD3' ' B' ' 118' ' ' PRO . . . 63.12 -111.72 4.35 Favored Glycine 0 C--N 1.357 1.742 0 N-CA-C 110.019 -1.232 . . . . 55.33 110.019 -171.038 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . 0.272 4.2 tppp? 99.91 -81.18 0.0 OUTLIER Pre-proline 0 CA--C 1.574 1.877 0 C-N-CA 127.215 2.206 . . . . 75.35 115.102 164.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 118' ' ' PRO . . . . . 0.437 ' HD3' ' O ' ' B' ' 116' ' ' GLY . 10.8 Cg_endo -84.11 -74.32 0.01 OUTLIER 'Trans proline' 0 C--N 1.4 3.237 0 CA-C-N 122.4 1.893 . . . . 63.21 114.788 -160.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 119' ' ' ASP . . . . . . . . . . . . . 38.3 t70 65.24 -74.85 0.05 Allowed 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 125.071 1.348 . . . . 75.33 110.545 -167.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 120' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 57.3 75.97 0.34 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 124.458 1.103 . . . . 70.1 112.406 177.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 27.9 m -97.54 -20.43 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-N 115.301 -0.863 . . . . 74.32 110.452 170.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 35.6 m 56.29 85.71 0.07 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.657 1.183 . . . . 75.25 110.552 -172.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -73.53 177.33 5.4 Favored 'General case' 0 CA--C 1.56 1.333 0 CA-C-N 115.601 -0.727 . . . . 70.53 110.878 -174.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 39.2 p -17.35 -90.94 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 127.75 2.42 . . . . 61.03 115.58 -172.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . 177.48 -74.46 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 124.564 1.146 . . . . 74.53 110.007 176.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -171.01 -166.1 0.46 Allowed 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 114.393 -1.276 . . . . 74.13 109.379 -172.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 63.7 m -104.54 -69.08 0.82 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.64 1.176 . . . . 70.01 110.4 -179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -131.9 88.48 2.56 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 124.991 1.316 . . . . 74.33 108.63 175.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 15.3 t -67.32 131.43 45.71 Favored 'General case' 0 CA--C 1.559 1.312 0 CA-C-N 116.015 -0.539 . . . . 74.41 110.511 -174.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . 78.44 128.0 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 126.213 1.805 . . . . 61.42 110.976 -169.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 16.9 t90 71.17 -62.23 0.46 Allowed 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 126.054 1.742 . . . . 73.51 111.586 -179.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 20.8 m 79.46 -63.04 0.27 Allowed 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 125.442 1.497 . . . . 74.11 113.099 167.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 26.1 m -69.32 92.83 0.6 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.197 0.999 . . . . 74.52 110.827 -175.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 118.65 -19.99 10.29 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 116.188 -0.46 . . . . 55.15 112.717 -178.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 135' ' ' VAL . . . . . . . . . . . . . 62.1 t 66.83 -78.52 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 125.509 1.524 . . . . 73.24 112.439 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm 55.87 48.43 18.07 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.741 1.216 . . . . 74.24 111.288 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 71.3 p 62.89 -4.06 0.28 Allowed 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 126.127 1.771 . . . . 75.31 115.145 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 31.0 p90 37.15 -65.24 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.638 0 C-N-CA 127.896 2.478 . . . . 75.52 116.917 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 14.9 m120 68.08 22.16 8.48 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 125.074 1.35 . . . . 73.24 112.105 176.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . 86.44 -55.87 4.72 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-O 119.57 -0.572 . . . . 75.54 113.657 173.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . 66.81 103.51 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.714 1.206 . . . . 75.34 110.51 -173.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -151.3 -169.65 3.44 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.809 0.844 . . . . 74.24 109.511 -175.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 162.48 -20.49 0.18 Allowed Glycine 0 C--N 1.353 1.496 0 CA-C-O 119.607 -0.551 . . . . 61.25 113.919 175.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 58.3 t 71.76 -65.84 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 125.589 1.556 . . . . 75.31 111.417 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -83.14 -29.51 28.59 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.082 0.953 . . . . 75.32 110.678 176.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 2.9 pp -125.52 -177.38 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 123.841 0.856 . . . . 72.52 110.027 175.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 43.2 p-80 -143.07 144.23 32.17 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.069 0.548 . . . . 72.43 110.247 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 61.98 -79.63 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 125.221 1.408 . . . . 75.05 112.878 171.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 149' ' ' LYS . . . . . . . . . . . . . 55.6 tttm 69.42 -83.84 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 125.704 1.602 . . . . 74.13 113.259 173.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -100.01 -48.23 4.73 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 113.208 0.818 . . . . 74.11 113.208 -166.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -79.95 -62.94 0.38 Allowed Pre-proline 0 CA--C 1.566 1.561 0 N-CA-C 114.012 1.116 . . . . 74.43 114.012 -168.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.8 91.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.394 2.954 0 C-N-CA 123.352 2.701 . . . . 64.13 115.235 -161.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 153' ' ' THR . . . . . 0.455 ' HB ' ' HA ' ' B' ' 159' ' ' LYS . 4.2 m 60.27 22.96 12.38 Favored 'General case' 0 CA--C 1.56 1.36 0 C-N-CA 125.465 1.506 . . . . 74.2 113.073 168.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 154' ' ' ILE . . . . . 0.4 HD11 ' HG3' ' B' ' 159' ' ' LYS . 35.8 mm -66.44 -40.26 86.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 123.486 0.714 . . . . 74.25 109.523 175.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 3.9 tt -86.97 68.09 9.98 Favored 'General case' 0 CA--C 1.555 1.159 0 N-CA-C 108.557 -0.905 . . . . 73.12 108.557 174.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -173.89 -106.67 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.303 0 C-N-CA 124.046 0.938 . . . . 72.23 109.606 171.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 157' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -176.04 -33.96 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.915 0.886 . . . . 61.13 110.664 -174.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 158' ' ' ALA . . . . . . . . . . . . . . . -88.91 34.41 0.78 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.454 0.702 . . . . 65.11 111.125 -176.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . 0.455 ' HA ' ' HB ' ' B' ' 153' ' ' THR . 11.4 tmtt? -60.03 -72.15 0.11 Allowed 'General case' 0 C--N 1.354 0.77 0 C-N-CA 124.444 1.098 . . . . 73.24 108.953 177.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 160' ' ' ALA . . . . . 0.404 ' HB1' ' HG2' ' C' ' 182' ' ' PRO . . . 173.49 86.37 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.505 1.522 . . . . 74.34 108.193 175.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -163.34 80.28 0.45 Allowed 'General case' 0 C--O 1.24 0.564 0 C-N-CA 124.01 0.924 . . . . 71.1 108.74 178.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . -80.29 -58.28 2.79 Favored Glycine 0 C--N 1.341 0.854 0 N-CA-C 110.194 -1.162 . . . . 73.4 110.194 171.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 49.4 tp 56.59 -85.16 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 125.302 1.441 . . . . 75.25 111.377 175.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 164' ' ' ALA . . . . . . . . . . . . . . . -68.18 -34.48 76.36 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.737 0.815 . . . . 75.34 111.171 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 14.9 t -99.59 38.82 1.38 Allowed 'General case' 0 CA--C 1.558 1.263 0 CA-C-O 121.845 0.831 . . . . 73.14 109.607 173.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . -73.25 89.34 0.6 Allowed Glycine 0 C--N 1.348 1.203 0 CA-C-N 115.466 -0.788 . . . . 74.53 112.375 177.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 167' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -64.34 118.86 9.3 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.567 0.747 . . . . 74.33 109.497 177.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 71.0 t 68.36 -73.82 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.156 0 C-N-CA 125.183 1.393 . . . . 75.53 111.311 -178.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 46.9 t 63.95 -81.37 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.264 1.426 . . . . 65.53 111.313 178.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 2.7 m 59.97 24.13 13.26 Favored 'General case' 0 CA--C 1.565 1.534 0 C-N-CA 124.697 1.199 . . . . 73.13 111.174 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . 0.439 ' HB1' ' HG2' ' C' ' 128' ' ' GLU . . . -134.81 -176.03 4.1 Favored 'General case' 0 C--O 1.244 0.779 0 C-N-CA 124.581 1.153 . . . . 73.41 108.925 179.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 172' ' ' GLU . . . . . 0.59 ' HB3' ' HG2' ' C' ' 213' ' ' MET . 13.1 tp10 -78.13 80.73 4.54 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 109.749 -0.463 . . . . 75.25 109.749 177.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 173' ' ' LEU . . . . . . . . . . . . . 80.1 mt 65.5 9.48 5.84 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 124.896 1.279 . . . . 74.44 112.907 176.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 174' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -92.35 99.74 12.45 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.278 0.631 . . . . 74.45 109.732 -175.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 175' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -85.4 153.99 22.15 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.717 0.807 . . . . 74.1 111.249 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -159.18 125.57 4.52 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.023 0.929 . . . . 74.11 109.651 178.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 35.8 p -121.05 93.28 48.84 Favored Pre-proline 0 CA--C 1.554 1.126 0 C-N-CA 123.696 0.798 . . . . 74.15 110.347 176.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 178' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -83.99 -177.33 3.02 Favored 'Trans proline' 0 C--N 1.377 2.064 0 C-N-CA 122.646 2.231 . . . . 74.53 111.551 170.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -67.32 -53.0 33.61 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 108.97 -0.752 . . . . 74.35 108.97 172.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . -162.14 -28.84 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 115.127 -0.942 . . . . 75.32 110.292 175.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 181' ' ' LEU . . . . . 0.538 HD22 ' HB2' ' C' ' 136' ' ' ARG . 29.3 tp -153.45 -68.7 0.15 Allowed 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 107.636 -1.246 . . . . 74.44 107.636 168.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 182' ' ' VAL . . . . . . . . . . . . . 62.6 t -76.43 131.81 34.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 108.123 -1.066 . . . . 72.43 108.123 168.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.1 -48.79 74.77 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 123.726 0.641 . . . . 65.24 110.695 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 179.9 -170.44 0.14 Allowed 'General case' 0 N--CA 1.485 1.301 0 O-C-N 124.2 0.938 . . . . 75.32 110.738 173.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 185' ' ' VAL . . . . . 0.456 HG22 ' HA ' ' C' ' 121' ' ' ALA . 1.8 p -142.24 116.67 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 106.557 -1.645 . . . . 74.01 106.557 160.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 25.6 p 56.54 -160.71 0.21 Allowed 'General case' 0 CA--C 1.567 1.622 0 C-N-CA 123.87 0.868 . . . . 60.24 112.342 172.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 187' ' ' SER . . . . . 0.592 ' HB3' ' HA ' ' B' ' 328' ' ' ALA . 16.8 p -74.15 87.24 1.91 Allowed 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 123.414 0.686 . . . . 62.14 111.662 -178.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 188' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' B' ' 185' ' ' VAL . 7.1 mmt180 -130.73 169.16 16.05 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.648 0.779 . . . . 72.32 109.95 175.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -95.85 162.65 13.5 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.97 0.908 . . . . 72.52 110.086 176.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 190' ' ' CYS . . . . . 0.542 ' SG ' ' NZ ' ' B' ' 337' ' ' LYS . 41.9 t -127.83 150.71 49.71 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.579 0.751 . . . . 70.33 110.402 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -133.84 162.75 31.15 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.66 0.784 . . . . 74.04 110.051 -174.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -68.88 163.53 50.28 Favored Glycine 0 CA--C 1.54 1.6 0 CA-C-O 119.169 -0.795 . . . . 64.22 113.339 177.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 193' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -64.23 135.54 47.31 Favored 'Trans proline' 0 C--N 1.372 1.802 0 C-N-CA 123.25 2.633 . . . . 73.22 112.961 -171.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 194' ' ' SER . . . . . . . . . . . . . 37.9 m -145.72 103.82 3.82 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 123.522 0.729 . . . . 63.44 109.8 -178.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 195' ' ' ALA . . . . . . . . . . . . . . . -158.23 171.17 20.68 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.501 1.12 . . . . 74.32 109.338 177.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 86.6 m -103.89 -65.57 1.01 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 122.967 0.507 . . . . 73.32 110.108 176.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 73.1 m -156.95 -47.2 0.07 Allowed 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.009 -1.108 . . . . 75.11 108.009 -177.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 198' ' ' GLU . . . . . 0.427 ' HG3' ' HB2' ' C' ' 146' ' ' SER . 1.9 mm-40 62.19 -76.91 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 126.184 1.794 . . . . 65.14 109.889 178.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 73.83 -29.67 0.2 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 115.179 1.548 . . . . 75.14 115.179 163.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 200' ' ' CYS . . . . . . . . . . . . . 86.3 m -62.04 104.09 0.44 Allowed Pre-proline 0 CA--C 1.557 1.242 0 C-N-CA 124.367 1.067 . . . . 73.31 112.986 -169.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 201' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -105.84 18.74 0.13 Allowed 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 123.736 2.958 . . . . 74.02 112.863 -178.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . -74.27 -8.99 80.64 Favored Glycine 0 C--N 1.354 1.536 0 CA-C-O 118.915 -0.936 . . . . 73.41 114.629 -170.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 58.9 t30 70.5 161.81 0.23 Allowed 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 124.643 1.177 . . . . 71.33 111.862 172.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -56.74 -54.01 51.16 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 123.302 0.641 . . . . 74.01 110.065 171.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 205' ' ' LEU . . . . . . . . . . . . . 3.2 tt 48.08 82.53 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 125.365 1.466 . . . . 72.44 111.249 171.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.94 -56.39 22.26 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 123.052 0.541 . . . . 70.3 110.764 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 36.1 mmtm -156.01 -49.81 0.08 Allowed 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 125.136 1.374 . . . . 74.32 109.244 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . -90.76 -46.29 4.0 Favored Glycine 0 C--N 1.352 1.418 0 CA-C-N 116.365 -0.379 . . . . 71.52 113.311 -172.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 134.26 -47.38 1.0 Allowed Glycine 0 N--CA 1.469 0.862 0 N-CA-C 110.789 -0.924 . . . . 63.34 110.789 -176.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 66.6 tttm -140.48 109.63 6.15 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 108.109 -1.071 . . . . 74.51 108.109 175.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . -154.04 144.84 11.7 Favored Glycine 0 C--N 1.341 0.832 0 N-CA-C 110.811 -0.916 . . . . 74.43 110.811 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 47.9 t 62.2 87.9 0.1 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.577 1.151 . . . . 74.04 110.582 -177.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 10.8 tp -70.21 -33.38 54.34 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 CA-C-N 115.874 -0.603 . . . . 70.12 111.029 -176.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 26.6 m 60.83 -80.89 0.02 OUTLIER 'General case' 0 C--N 1.36 1.029 0 C-N-CA 125.705 1.602 . . . . 75.43 112.273 176.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 215' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -151.24 0.92 0.39 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.576 0.75 . . . . 73.31 111.355 -175.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -72.65 140.76 48.15 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.658 0.783 . . . . 61.42 109.876 177.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . 0.476 HD13 ' N ' ' B' ' 218' ' ' LEU 0.329 4.2 pp 54.29 -68.57 0.01 OUTLIER 'General case' 0 CA--C 1.569 1.711 0 C-N-CA 127.043 2.137 . . . . 75.4 114.24 -179.579 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . 0.476 ' N ' HD13 ' B' ' 217' ' ' LEU . 82.8 mt 57.59 -81.35 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 125.71 1.604 . . . . 71.43 112.265 -178.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 32.1 t-20 -160.21 153.56 22.11 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.342 -0.985 . . . . 71.24 108.342 178.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -144.48 174.65 10.76 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.923 0.889 . . . . 74.3 110.669 -176.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 221' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -58.09 -67.22 0.37 Allowed 'General case' 0 N--CA 1.476 0.848 0 O-C-N 124.23 0.956 . . . . 73.55 109.096 -178.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' C' ' 184' ' ' PRO . . . 36.77 61.09 0.89 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 125.101 1.501 . . . . 75.21 112.013 176.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -85.09 -160.08 0.47 Allowed 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 114.277 -1.329 . . . . 72.13 112.52 -162.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 22.2 m -58.05 -34.98 50.51 Favored 'Isoleucine or valine' 0 C--N 1.361 1.096 0 C-N-CA 123.314 0.646 . . . . 75.32 111.697 -178.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 225' ' ' THR . . . . . 0.624 HG23 HG21 ' C' ' 185' ' ' VAL . 99.3 m 72.02 -59.06 0.57 Allowed 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 126.147 1.779 . . . . 73.55 113.236 179.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 1.4 tm? 70.49 85.02 0.14 Allowed 'General case' 0 C--N 1.355 0.811 0 C-N-CA 125.441 1.496 . . . . 74.43 107.736 -170.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . -161.06 25.54 0.26 Allowed Glycine 0 C--N 1.345 1.047 0 CA-C-N 115.882 -0.599 . . . . 71.24 112.558 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . -89.14 -106.6 1.1 Allowed Glycine 0 C--N 1.352 1.458 0 N-CA-C 111.479 -0.648 . . . . 72.41 111.479 175.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . 65.51 -125.74 29.26 Favored Glycine 0 C--N 1.353 1.527 0 CA-C-O 119.549 -0.584 . . . . 71.04 113.404 175.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -157.3 152.01 25.5 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.076 0.95 . . . . 70.23 109.597 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 231' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -167.69 165.76 14.15 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.582 0.753 . . . . 73.24 109.655 -172.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 232' ' ' THR . . . . . 0.475 HG23 ' HA ' ' B' ' 280' ' ' LEU . 52.7 p -51.68 102.18 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.127 1.371 . . . . 74.24 112.783 -178.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 233' ' ' PHE . . . . . 0.753 ' HB2' HH22 ' C' ' 211' ' ' ARG . 33.3 t80 -160.17 -51.91 0.05 Allowed 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.313 0.645 . . . . 71.44 109.668 174.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . 79.33 -33.25 0.14 Allowed 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 125.433 1.493 . . . . 72.31 112.59 178.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . 0.55 ' HB3' ' HZ2' ' C' ' 209' ' ' LYS . 4.1 tm-20 69.94 139.42 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 125.374 1.47 . . . . 64.41 111.778 176.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 236' ' ' THR . . . . . 0.452 ' HB ' ' O ' ' B' ' 348' ' ' ILE . 42.3 m -141.97 84.65 1.89 Allowed 'General case' 0 C--O 1.249 1.04 0 N-CA-C 107.483 -1.303 . . . . 73.34 107.483 171.225 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . 0.45 ' HB2' ' H ' ' B' ' 355' ' ' ALA . . . 61.96 66.61 0.81 Allowed 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 114.374 -1.284 . . . . 73.03 111.099 175.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 238' ' ' THR . . . . . 0.458 HG22 HG22 ' C' ' 219' ' ' VAL . 6.2 m -150.33 98.92 2.73 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.141 0.576 . . . . 71.31 109.946 -178.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -165.63 -98.84 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 123.337 0.655 . . . . 74.42 110.44 171.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . 173.32 -148.52 10.36 Favored Glycine 0 C--N 1.35 1.334 0 N-CA-C 111.615 -0.594 . . . . 71.23 111.615 -176.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -86.38 -167.96 2.06 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.516 0.726 . . . . 71.23 111.144 -176.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 242' ' ' TRP . . . . . 0.576 ' HZ3' ' HD3' ' C' ' 231' ' ' ARG . 0.0 OUTLIER 86.59 -26.82 0.08 Allowed 'General case' 0 N--CA 1.504 2.231 0 C-N-CA 127.191 2.197 . . . . 70.32 111.66 175.872 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -102.24 120.69 40.89 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 124.054 0.942 . . . . 74.22 110.676 -168.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -60.35 -40.73 97.91 Favored Glycine 0 C--N 1.353 1.49 0 N-CA-C 110.458 -1.057 . . . . 71.54 110.458 165.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 245' ' ' LYS . . . . . 0.417 ' HE3' ' HB3' ' B' ' 357' ' ' PRO . 5.5 ttpp 63.2 13.74 7.16 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.148 1.379 . . . . 75.34 112.755 162.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 22.1 p -126.8 7.56 6.77 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.964 0.905 . . . . 71.14 110.849 -175.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 247' ' ' LEU . . . . . 0.745 HD11 ' HG2' ' C' ' 225' ' ' PRO . 5.5 tt -101.39 100.0 10.42 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 108.266 -1.012 . . . . 72.51 108.266 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 248' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 71.47 -75.41 0.08 Allowed 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 125.841 1.656 . . . . 75.15 112.642 172.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 63.33 33.35 14.05 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.183 0.993 . . . . 71.33 110.509 -173.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 250' ' ' GLN . . . . . 0.469 HE22 HG12 ' C' ' 206' ' ' VAL . 8.0 mm-40 69.95 156.02 0.14 Allowed 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 126.391 1.876 . . . . 70.14 113.082 178.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 251' ' ' ALA . . . . . . . . . . . . . . . -68.82 123.11 20.05 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.87 -0.789 . . . . 64.21 108.87 169.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -71.06 88.76 0.79 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.588 0.755 . . . . 73.12 109.616 -178.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -62.31 142.47 57.75 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.605 0.762 . . . . 51.41 110.509 179.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 30.0 ttt180 70.09 81.94 0.16 Allowed 'General case' 0 N--CA 1.48 1.051 0 O-C-N 124.805 1.315 . . . . 72.51 108.764 -172.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 255' ' ' GLY . . . . . 0.551 ' HA2' ' HA ' ' B' ' 259' ' ' VAL . . . -147.05 48.18 0.66 Allowed Glycine 0 C--N 1.349 1.258 0 CA-C-N 115.252 -0.886 . . . . 63.32 113.126 -172.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 256' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -69.82 102.28 1.91 Allowed 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 109.726 -0.472 . . . . 71.2 109.726 173.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 13.9 tm0? 64.57 -73.84 0.05 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.748 1.619 . . . . 74.31 109.957 177.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 258' ' ' LEU . . . . . . . . . . . . . 4.6 tt -131.55 80.89 1.95 Allowed 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 106.888 -1.523 . . . . 75.13 106.888 170.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . 0.551 ' HA ' ' HA2' ' B' ' 255' ' ' GLY . 58.6 t 66.81 -71.1 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 C-N-CA 125.87 1.668 . . . . 63.31 111.835 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 260' ' ' SER . . . . . . . . . . . . . 31.2 p -178.57 -38.38 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 126.404 1.882 . . . . 73.11 106.754 175.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -151.45 145.21 25.06 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-N 114.25 -1.341 . . . . 65.51 108.023 175.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 262' ' ' ALA . . . . . 0.528 ' HB2' ' HB2' ' B' ' 64' ' ' ALA . . . -76.78 -61.61 1.91 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.792 0.837 . . . . 75.22 110.17 173.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 263' ' ' ALA . . . . . 0.401 ' HB1' ' HE2' ' B' ' 65' ' ' LYS . . . -170.11 94.39 0.24 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.713 1.205 . . . . 70.44 108.726 175.259 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 13.9 m 64.68 21.46 12.4 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 124.936 1.294 . . . . 51.14 113.011 175.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 265' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -63.22 -50.86 68.57 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.456 1.102 . . . . 73.31 110.108 -175.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 266' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -75.87 -20.74 57.85 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 116.322 -0.399 . . . . 71.52 110.461 179.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 52.3 m 78.35 -38.93 0.25 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 125.931 1.693 . . . . 73.13 113.252 173.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 59.2 t -68.49 -52.47 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 122.922 0.489 . . . . 74.44 110.008 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 269' ' ' THR . . . . . . . . . . . . . 62.5 m 51.46 90.11 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.052 1.341 . . . . 74.31 111.584 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 270' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -65.86 -29.72 70.22 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.265 1.026 . . . . 72.41 111.509 -177.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 271' ' ' ALA . . . . . . . . . . . . . . . 56.4 36.02 26.85 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 124.292 0.995 . . . . 75.3 111.127 -177.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 272' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -65.58 146.51 54.74 Favored 'General case' 0 C--O 1.247 0.964 0 CA-C-N 114.692 -1.14 . . . . 73.11 110.599 -177.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -67.01 100.49 0.75 Allowed 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.588 -0.733 . . . . 73.43 109.294 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -142.5 87.35 2.0 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 107.88 -1.156 . . . . 71.44 107.88 174.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 275' ' ' LYS . . . . . . . . . . . . . 11.7 mptt 50.34 53.37 13.99 Favored Pre-proline 0 CA--C 1.56 1.33 0 CA-C-N 114.331 -1.304 . . . . 72.14 111.911 -178.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 276' ' ' PRO . . . . . 0.416 ' HD2' HD13 ' B' ' 277' ' ' LEU . 51.2 Cg_endo -83.84 14.45 2.4 Favored 'Trans proline' 0 C--N 1.391 2.776 0 C-N-CA 122.435 2.09 . . . . 73.04 112.498 -177.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 277' ' ' LEU . . . . . 0.416 HD13 ' HD2' ' B' ' 276' ' ' PRO . 5.2 mp -83.78 -99.36 0.05 Allowed 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 108.468 -0.938 . . . . 74.52 108.468 175.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 278' ' ' LEU . . . . . 0.466 HD23 ' HA ' ' A' ' 278' ' ' ALA . 80.9 mt 60.68 20.4 10.39 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-N 118.848 0.749 . . . . 72.2 112.555 177.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . 112.26 -18.72 23.13 Favored Glycine 0 N--CA 1.479 1.514 0 C-N-CA 123.168 0.413 . . . . 75.43 112.992 -175.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 280' ' ' LEU . . . . . 0.475 ' HA ' HG23 ' B' ' 232' ' ' THR . 2.9 tm? -62.92 -48.13 80.27 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.022 0.929 . . . . 74.31 109.778 178.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -73.53 -47.74 38.54 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 109.727 -0.471 . . . . 75.31 109.727 175.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . 76.95 -33.46 0.2 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 125.901 1.68 . . . . 65.41 113.123 176.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 24.2 t70 65.34 -75.32 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 125.609 1.564 . . . . 72.33 111.883 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . -81.44 68.31 3.48 Favored Glycine 0 C--N 1.342 0.914 0 N-CA-C 111.548 -0.621 . . . . 72.13 111.548 175.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -76.02 92.18 3.14 Favored 'General case' 0 C--O 1.244 0.814 0 C-N-CA 124.138 0.975 . . . . 73.03 108.548 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 286' ' ' MET . . . . . 0.432 ' HB3' ' HD2' ' B' ' 287' ' ' PRO . 64.0 mtm 71.7 168.11 0.12 Allowed Pre-proline 0 CA--C 1.564 1.504 0 C-N-CA 124.73 1.212 . . . . 74.22 110.957 -176.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 287' ' ' PRO . . . . . 0.432 ' HD2' ' HB3' ' B' ' 286' ' ' MET . 30.7 Cg_endo -62.0 -3.15 3.51 Favored 'Trans proline' 0 C--N 1.388 2.626 0 C-N-CA 122.611 2.207 . . . . 74.24 114.012 174.12 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 288' ' ' VAL . . . . . . . . . . . . . 21.5 t -78.18 74.39 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 CA-C-O 121.702 0.763 . . . . 74.32 109.438 174.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 289' ' ' ARG . . . . . . . . . . . . . 49.4 ttt180 -101.82 -15.36 16.94 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.212 1.005 . . . . 74.32 110.319 -179.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 290' ' ' TRP . . . . . . . . . . . . . 71.9 t-105 73.29 119.63 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 125.528 1.531 . . . . 75.34 109.889 -170.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 291' ' ' LEU . . . . . 0.408 HD22 HG23 ' B' ' 452' ' ' VAL . 35.4 tp 71.91 144.36 0.06 Allowed 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 125.676 1.59 . . . . 73.52 111.36 -172.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . 151.47 -64.42 0.38 Allowed Glycine 0 C--N 1.35 1.353 0 CA-C-O 119.552 -0.582 . . . . 71.42 112.261 -179.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -82.66 42.87 1.38 Allowed 'Trans proline' 0 C--N 1.383 2.382 0 C-N-CA 123.587 2.858 . . . . 75.13 113.078 -179.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -82.95 130.08 35.1 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.536 1.134 . . . . 74.44 110.936 -174.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -163.86 -51.69 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.554 1.142 . . . . 71.35 109.133 168.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 18.0 m 70.81 139.1 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 125.84 1.656 . . . . 71.52 112.384 177.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 57.5 t80 68.92 -82.21 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 125.086 1.354 . . . . 75.44 111.376 172.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 29.1 p80 39.21 82.49 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 126.176 1.79 . . . . 73.43 113.788 -175.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . -79.45 65.66 3.61 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-N 115.913 -0.585 . . . . 72.35 113.015 178.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 300' ' ' ASN . . . . . 0.403 HD22 ' N ' ' A' ' 191' ' ' GLN . 39.6 t30 -172.56 -135.65 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 106.736 -1.579 . . . . 72.23 106.736 -177.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 301' ' ' ILE . . . . . . . . . . . . . 8.0 mm 64.57 13.98 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.576 1.945 0 C-N-CA 124.134 0.973 . . . . 75.13 111.561 172.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -140.15 154.53 47.0 Favored 'General case' 0 N--CA 1.485 1.281 0 O-C-N 121.096 -1.003 . . . . 74.32 111.33 -170.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 303' ' ' LYS . . . . . 0.519 ' HB2' ' HZ3' ' B' ' 303' ' ' LYS . 0.1 OUTLIER -70.86 -47.65 15.45 Favored Pre-proline 0 CA--C 1.568 1.668 0 C-N-CA 124.377 1.071 . . . . 74.11 113.865 -168.958 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 304' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -57.57 -27.51 77.12 Favored 'Trans proline' 0 C--N 1.39 2.741 0 C-N-CA 122.233 1.955 . . . . 75.12 113.443 170.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . 68.92 -72.36 0.1 Allowed 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 125.257 1.423 . . . . 72.13 110.717 -177.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 7.4 p -104.84 144.38 14.79 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 N-CA-C 108.936 -0.764 . . . . 72.33 108.936 170.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 7.8 m -62.02 -26.76 68.43 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 124.307 1.043 . . . . 74.23 112.367 -172.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 308' ' ' CYS . . . . . . . . . . . . . 29.2 p -72.45 -11.61 60.75 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.574 0.75 . . . . 74.22 112.329 -176.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 52.9 p -119.09 85.5 29.74 Favored Pre-proline 0 CA--C 1.557 1.232 0 C-N-CA 123.403 0.681 . . . . 72.2 110.568 179.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -83.16 168.77 13.24 Favored 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 122.857 2.371 . . . . 64.44 112.582 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 311' ' ' ASN . . . . . 0.441 ' HB3' ' HD3' ' B' ' 312' ' ' PRO . 4.4 t30 -92.93 -50.24 0.28 Allowed Pre-proline 0 CA--C 1.566 1.583 0 CA-C-O 118.866 -0.587 . . . . 73.13 111.423 177.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 312' ' ' PRO . . . . . 0.441 ' HD3' ' HB3' ' B' ' 311' ' ' ASN . 41.0 Cg_endo -95.97 -152.85 0.03 OUTLIER 'Trans proline' 0 C--N 1.391 2.785 0 C-N-CA 122.545 2.163 . . . . 70.14 110.715 170.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 313' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -91.98 17.1 9.79 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.717 0.407 . . . . 75.13 111.135 174.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 314' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 69.33 -78.2 0.05 OUTLIER 'General case' 0 C--N 1.353 0.723 0 C-N-CA 125.329 1.452 . . . . 74.53 110.662 -177.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 315' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 57.35 -85.1 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.855 1.262 . . . . 75.34 111.097 -173.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 316' ' ' ASP . . . . . . . . . . . . . 35.6 t70 58.08 -80.53 0.02 OUTLIER 'General case' 0 C--N 1.355 0.837 0 C-N-CA 125.75 1.62 . . . . 74.4 112.556 177.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 317' ' ' SER . . . . . 0.486 ' HA ' HG23 ' B' ' 325' ' ' THR . 19.6 m -78.89 -25.48 43.86 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.721 0.809 . . . . 75.41 111.334 -176.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 318' ' ' VAL . . . . . 0.454 HG12 ' HA ' ' B' ' 322' ' ' ALA . 20.2 m -114.66 96.68 44.69 Favored Pre-proline 0 CA--C 1.563 1.466 0 C-N-CA 124.228 1.011 . . . . 73.13 110.166 -177.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 319' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -62.97 -49.61 4.84 Favored 'Trans proline' 0 C--N 1.382 2.326 0 C-N-CA 122.75 2.3 . . . . 65.1 112.379 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 320' ' ' THR . . . . . . . . . . . . . 24.7 m -132.55 -52.9 0.94 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.637 0.775 . . . . 73.24 109.41 -179.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 321' ' ' LEU . . . . . . . . . . . . . 96.2 mt -114.89 -179.38 3.61 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.195 0.998 . . . . 74.43 109.668 178.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 322' ' ' ALA . . . . . 0.454 ' HA ' HG12 ' B' ' 318' ' ' VAL . . . -83.29 40.48 0.71 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.799 0.84 . . . . 64.54 111.779 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 323' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -62.77 -38.35 90.25 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.481 0.713 . . . . 74.02 110.246 178.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 324' ' ' MET . . . . . 0.469 ' SD ' ' HB3' ' B' ' 317' ' ' SER . 46.6 tpp 69.18 110.58 0.05 Allowed 'General case' 0 N--CA 1.478 0.938 0 O-C-N 125.047 1.467 . . . . 74.22 113.055 169.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 325' ' ' THR . . . . . 0.486 HG23 ' HA ' ' B' ' 317' ' ' SER . 10.0 t -77.15 118.3 19.54 Favored 'General case' 0 C--O 1.246 0.88 0 N-CA-C 108.04 -1.096 . . . . 72.33 108.04 164.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 326' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -67.28 145.49 55.11 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.304 0.642 . . . . 72.01 109.593 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . 0.432 ' HD2' ' N ' ' B' ' 327' ' ' LYS . 2.3 mptp? -80.78 12.6 3.09 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.318 0.647 . . . . 75.41 112.109 -174.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 328' ' ' ALA . . . . . 0.592 ' HA ' ' HB3' ' B' ' 187' ' ' SER . . . 67.92 178.68 0.24 Allowed 'General case' 0 C--N 1.354 0.777 0 C-N-CA 125.096 1.358 . . . . 72.03 113.253 168.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 329' ' ' ILE . . . . . . . . . . . . . 20.4 tt -147.62 173.0 2.3 Favored 'Isoleucine or valine' 0 C--O 1.251 1.158 0 N-CA-C 106.378 -1.712 . . . . 73.5 106.378 173.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 330' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -55.04 -69.4 0.13 Allowed 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 109.278 -0.638 . . . . 74.44 109.278 171.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 331' ' ' LEU . . . . . . . . . . . . . 57.3 tp 45.11 -98.35 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.995 1.318 . . . . 64.42 111.174 -178.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 99.1 mt 34.18 -90.82 0.01 OUTLIER 'General case' 0 C--N 1.361 1.105 0 C-N-CA 126.25 1.82 . . . . 74.41 113.657 -178.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 333' ' ' SER . . . . . . . . . . . . . 15.6 p -167.95 -66.34 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 107.941 -1.133 . . . . 65.04 107.941 -177.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt 74.33 -41.59 0.48 Allowed 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 125.965 1.706 . . . . 65.35 113.126 172.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 335' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -67.31 93.94 0.35 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.322 1.049 . . . . 74.12 111.189 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 58.06 93.9 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.836 1.255 . . . . 73.55 113.796 168.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 337' ' ' LYS . . . . . 0.542 ' NZ ' ' SG ' ' B' ' 190' ' ' CYS . 35.3 mtpt -131.52 15.0 4.97 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.226 0.61 . . . . 71.1 110.994 171.107 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 338' ' ' GLY . . . . . . . . . . . . . . . -156.14 158.98 29.04 Favored Glycine 0 C--N 1.346 1.124 0 N-CA-C 111.495 -0.642 . . . . 73.12 111.495 -179.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 339' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -141.59 165.57 27.14 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.869 0.868 . . . . 74.33 109.773 -177.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 340' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -69.59 153.49 43.38 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.237 0.615 . . . . 75.24 110.933 -178.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 341' ' ' LEU . . . . . . . . . . . . . 5.0 tt -121.46 106.75 11.71 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 107.348 -1.353 . . . . 75.34 107.348 174.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 342' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -82.42 71.25 9.49 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-O 121.894 0.854 . . . . 74.32 111.067 -176.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 343' ' ' VAL . . . . . . . . . . . . . 7.3 p -75.51 -39.0 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-N 115.602 -0.727 . . . . 65.15 109.755 175.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 62.8 -78.79 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.848 1.659 . . . . 74.33 112.243 174.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 345' ' ' GLY . . . . . . . . . . . . . . . -95.47 166.61 25.5 Favored Glycine 0 C--N 1.347 1.163 0 C-N-CA 122.782 0.229 . . . . 63.14 112.765 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 346' ' ' ALA . . . . . . . . . . . . . . . -111.92 174.77 5.72 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.334 1.054 . . . . 72.51 109.907 177.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 41.6 t -63.61 -55.3 24.72 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 122.789 0.436 . . . . 72.21 110.08 178.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 348' ' ' ILE . . . . . 0.452 ' O ' ' HB ' ' B' ' 236' ' ' THR . 62.8 mt 64.01 -70.33 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 125.928 1.691 . . . . 73.42 111.185 -177.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 349' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -48.34 100.74 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 125.425 1.49 . . . . 71.13 112.547 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 350' ' ' LYS . . . . . 0.667 ' HZ2' ' HB3' ' B' ' 350' ' ' LYS . 5.9 ttpm? 51.61 67.84 0.89 Allowed 'General case' 0 N--CA 1.483 1.192 0 O-C-N 124.49 1.118 . . . . 74.52 111.68 163.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 351' ' ' GLN . . . . . 0.52 HE22 ' HZ ' ' B' ' 233' ' ' PHE . 25.1 mt-30 -85.52 157.05 20.52 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.267 -0.878 . . . . 71.32 112.225 -172.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 7.9 t0 65.66 -92.02 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 125.317 1.447 . . . . 74.35 111.378 172.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 353' ' ' HIS . . . . . . . . . . . . . 49.5 p-80 -143.96 12.41 1.63 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.949 0.9 . . . . 74.33 109.401 -176.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 354' ' ' ALA . . . . . . . . . . . . . . . 74.81 -178.57 0.17 Allowed 'General case' 0 N--CA 1.484 1.27 0 O-C-N 125.133 1.52 . . . . 72.23 110.115 -158.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 355' ' ' ALA . . . . . 0.45 ' H ' ' HB2' ' B' ' 237' ' ' ALA . . . -86.24 -178.08 6.4 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 122.87 0.468 . . . . 75.44 110.027 178.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 356' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -116.22 86.79 18.01 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 123.585 0.754 . . . . 74.32 109.036 173.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 357' ' ' PRO . . . . . 0.417 ' HB3' ' HE3' ' B' ' 245' ' ' LYS . 68.1 Cg_endo -81.9 -8.19 12.2 Favored 'Trans proline' 0 C--N 1.384 2.396 0 C-N-CA 122.781 2.321 . . . . 74.21 112.245 175.017 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 358' ' ' CYS . . . . . 0.407 ' HA ' ' CG2' ' B' ' 365' ' ' VAL . 30.4 p -156.21 141.57 17.56 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 124.364 1.066 . . . . 75.21 108.862 178.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 359' ' ' GLY . . . . . . . . . . . . . . . -81.36 68.39 3.46 Favored Glycine 0 C--N 1.34 0.804 0 N-CA-C 109.677 -1.369 . . . . 72.04 109.677 169.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 360' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 64.84 -68.91 0.1 Allowed 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 125.862 1.665 . . . . 53.34 109.213 -167.26 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 361' ' ' ILE . . . . . 0.43 HG23 ' H ' ' B' ' 363' ' ' GLU . 73.5 mt -79.69 141.98 14.59 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 C-N-CA 124.186 0.994 . . . . 64.41 109.211 170.45 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 362' ' ' GLY . . . . . . . . . . . . . . . -70.01 -29.49 70.67 Favored Glycine 0 C--N 1.347 1.158 0 C-N-CA 122.93 0.3 . . . . 72.35 113.78 -177.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 363' ' ' GLU . . . . . 0.43 ' H ' HG23 ' B' ' 361' ' ' ILE . 1.7 mp0 -72.55 -20.39 61.34 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.51 0.724 . . . . 73.13 111.699 -179.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 364' ' ' THR . . . . . . . . . . . . . 16.6 m -61.76 -27.46 68.75 Favored 'General case' 0 CA--C 1.557 1.22 0 C-N-CA 123.749 0.819 . . . . 74.04 111.44 179.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 365' ' ' VAL . . . . . 0.673 HG23 ' H ' ' B' ' 366' ' ' ASP . 5.6 m -110.35 -82.78 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.416 0 CA-C-O 118.758 -0.639 . . . . 74.51 111.155 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 366' ' ' ASP . . . . . 0.673 ' H ' HG23 ' B' ' 365' ' ' VAL . 24.6 t70 47.84 -96.49 0.03 OUTLIER 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 124.743 1.217 . . . . 52.52 111.654 -171.151 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 367' ' ' LEU . . . . . 0.462 HD21 ' HB2' ' C' ' 225' ' ' PRO . 7.1 mp -136.31 130.06 32.36 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 107.048 -1.464 . . . . 75.05 107.048 170.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 368' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -84.93 179.82 7.22 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 122.746 0.419 . . . . 73.23 110.462 176.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 369' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 71.23 -72.2 0.12 Allowed 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 125.231 1.412 . . . . 74.11 111.142 -170.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 370' ' ' ALA . . . . . . . . . . . . . . . 68.99 -68.87 0.17 Allowed 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 125.311 1.444 . . . . 74.25 111.527 -177.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 371' ' ' VAL . . . . . . . . . . . . . 43.4 t 65.33 -87.21 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 125.137 1.375 . . . . 74.12 109.881 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 372' ' ' GLN . . . . . . . . . . . . . 20.6 tp60 -172.29 25.83 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.557 1.543 . . . . 63.2 107.082 174.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 373' ' ' ARG . . . . . 0.635 ' HB3' ' HG2' ' A' ' 260' ' ' ARG . 99.4 mtt180 59.46 90.59 0.05 Allowed 'General case' 0 C--N 1.364 1.235 0 C-N-CA 124.787 1.235 . . . . 72.2 109.326 -165.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -61.73 116.5 4.85 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.644 -0.707 . . . . 71.45 111.267 -172.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 375' ' ' LEU . . . . . . . . . . . . . 54.7 tp -73.1 118.17 15.73 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 115.468 -0.787 . . . . 72.22 108.88 174.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.16 -29.29 69.7 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.069 0.947 . . . . 73.13 112.885 -178.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 377' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -57.77 -34.3 69.43 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.154 0.982 . . . . 73.31 111.016 178.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 378' ' ' ALA . . . . . . . . . . . . . . . -64.63 -38.8 92.26 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 115.551 -0.75 . . . . 73.45 110.427 176.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? 78.06 -24.72 0.21 Allowed 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 125.678 1.591 . . . . 73.22 112.37 170.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 380' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt 72.69 -78.95 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 125.48 1.512 . . . . 72.4 112.188 172.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 381' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -99.89 106.76 18.63 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 122.958 0.503 . . . . 74.34 110.562 -170.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . 69.56 53.92 14.75 Favored Glycine 0 C--N 1.348 1.238 0 CA-C-N 115.225 -0.898 . . . . 73.1 113.085 178.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 383' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -76.49 -59.73 2.65 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 109.575 -0.528 . . . . 73.1 109.575 176.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 384' ' ' THR . . . . . 0.474 HG22 ' HB3' ' A' ' 218' ' ' PRO . 18.5 m 61.87 -82.69 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.163 0 CA-C-N 113.883 -1.508 . . . . 71.44 111.515 -176.172 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 83.8 mt 59.87 -82.73 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.627 1.171 . . . . 75.43 109.681 -169.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 386' ' ' VAL . . . . . 0.546 ' HA ' ' HA3' ' B' ' 417' ' ' GLY . 9.2 t -121.53 41.23 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 108.037 -1.097 . . . . 75.23 108.037 174.134 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 387' ' ' ILE . . . . . . . . . . . . . 2.1 mp 70.49 -59.81 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 C-N-CA 125.773 1.629 . . . . 74.12 108.804 -168.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 388' ' ' VAL . . . . . 0.494 HG22 ' HB2' ' B' ' 391' ' ' ASP . 35.3 m -87.74 148.11 4.81 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.146 0 C-N-CA 123.93 0.892 . . . . 74.43 109.878 167.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 389' ' ' THR . . . . . . . . . . . . . 14.6 t -86.88 -29.38 22.2 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 122.924 0.49 . . . . 71.25 112.049 -175.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . -70.66 -13.08 61.94 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.429 0.691 . . . . 73.41 112.586 -174.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 391' ' ' ASP . . . . . 0.494 ' HB2' HG22 ' B' ' 388' ' ' VAL . 3.9 t70 -76.3 176.24 8.32 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.158 0.983 . . . . 64.12 110.374 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 392' ' ' HIS . . . . . . . . . . . . . 58.7 t60 67.69 21.21 9.35 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.513 1.125 . . . . 72.42 109.508 -175.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . 55.3 39.7 31.35 Favored 'General case' 0 C--N 1.36 1.037 0 C-N-CA 125.156 1.382 . . . . 61.53 111.845 -174.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 26.6 m170 -71.89 74.52 0.88 Allowed 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 122.162 0.982 . . . . 73.31 110.373 177.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . -153.16 113.8 4.06 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 105.989 -1.856 . . . . 75.42 105.989 -177.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 31.1 p -76.33 -8.05 56.27 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.988 0.915 . . . . 75.55 112.002 -174.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 397' ' ' GLN . . . . . . . . . . . . . 76.9 mm-40 -75.3 83.09 2.43 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.964 0.906 . . . . 75.54 110.273 -177.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 8.9 tt -97.71 114.54 35.22 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 C-N-CA 124.318 1.047 . . . . 75.44 109.143 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 399' ' ' VAL . . . . . . . . . . . . . 60.0 t -73.19 -75.51 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 123.159 0.584 . . . . 73.32 110.632 -173.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 400' ' ' ALA . . . . . . . . . . . . . . . -173.36 85.75 0.39 Allowed Pre-proline 0 N--CA 1.48 1.032 0 C-N-CA 123.769 0.828 . . . . 74.52 110.755 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 401' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -86.68 57.59 3.7 Favored 'Trans proline' 0 C--N 1.374 1.888 0 C-N-CA 123.512 2.808 . . . . 71.34 110.385 168.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -69.67 -56.29 7.65 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.654 1.182 . . . . 74.34 109.628 -176.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 403' ' ' THR . . . . . . . . . . . . . 3.9 t -101.75 138.79 38.26 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 115.288 -0.869 . . . . 73.2 109.026 170.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 404' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? 53.0 91.76 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.114 1.365 . . . . 71.14 110.44 -175.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 405' ' ' ALA . . . . . . . . . . . . . . . -106.86 93.42 8.86 Favored Pre-proline 0 N--CA 1.478 0.935 0 C-N-CA 122.744 0.418 . . . . 71.24 110.916 -177.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 406' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -90.98 22.47 0.72 Allowed 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 122.735 2.29 . . . . 64.23 112.647 176.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . 67.57 -99.02 0.5 Allowed Glycine 0 C--N 1.349 1.255 0 N-CA-C 111.15 -0.78 . . . . 74.04 111.15 -171.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 408' ' ' LEU . . . . . . . . . . . . . 78.6 mt 59.42 13.54 3.27 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 125.356 1.463 . . . . 72.55 113.299 -178.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 10.1 t -137.48 149.53 46.89 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 124.542 1.137 . . . . 73.52 108.821 -177.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 410' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 55.47 -66.41 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 127.381 2.273 . . . . 70.42 114.756 176.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . -123.61 -65.53 1.07 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.484 0.713 . . . . 74.33 112.435 -176.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 58.4 tp -62.42 104.56 0.52 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.353 0.661 . . . . 75.21 110.859 -173.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -170.4 -79.32 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.858 0.863 . . . . 71.14 109.138 178.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 414' ' ' THR . . . . . . . . . . . . . 77.7 p -116.62 157.71 24.91 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.742 0.817 . . . . 73.24 109.692 -178.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 415' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -119.88 -6.71 10.05 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.787 0.835 . . . . 75.21 111.901 -168.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -76.79 176.55 8.39 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.977 0.911 . . . . 75.33 111.989 -172.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 417' ' ' GLY . . . . . 0.546 ' HA3' ' HA ' ' B' ' 386' ' ' VAL . . . 99.04 14.31 36.8 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 115.213 -0.903 . . . . 62.31 113.561 177.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 418' ' ' ALA . . . . . 0.583 ' HB1' ' HB ' ' B' ' 421' ' ' VAL . . . -158.67 135.55 9.68 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 122.855 0.462 . . . . 70.25 110.885 173.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 419' ' ' VAL . . . . . . . . . . . . . 85.3 t -61.58 -43.13 96.46 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 C-N-CA 124.505 1.122 . . . . 73.31 109.965 171.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 420' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -130.01 124.37 32.78 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 107.217 -1.401 . . . . 73.34 107.217 175.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 421' ' ' VAL . . . . . 0.583 ' HB ' ' HB1' ' B' ' 418' ' ' ALA . 6.8 p -134.98 112.79 15.22 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.133 0 CA-C-O 121.426 0.631 . . . . 72.42 110.697 -174.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 422' ' ' MET . . . . . 0.593 ' HE3' ' HB3' ' A' ' 220' ' ' GLU . 0.0 OUTLIER -101.35 -3.61 28.49 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.078 0.951 . . . . 74.1 110.655 177.258 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 423' ' ' SER . . . . . . . . . . . . . 15.5 m -102.77 24.16 11.02 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.293 1.037 . . . . 63.45 109.305 171.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 424' ' ' TYR . . . . . 0.44 ' CD1' ' HG2' ' B' ' 429' ' ' GLU . 21.6 t80 -53.59 -37.41 62.94 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 125.986 1.714 . . . . 74.22 110.779 175.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . -124.95 47.6 1.01 Allowed Glycine 0 C--N 1.349 1.263 0 N-CA-C 110.785 -0.926 . . . . 75.12 110.785 172.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 426' ' ' ASN . . . . . 0.572 HD21 ' HB2' ' C' ' 280' ' ' ALA . 16.6 m120 65.69 -82.65 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 125.367 1.467 . . . . 75.43 112.042 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 427' ' ' SER . . . . . . . . . . . . . 20.4 m -102.49 101.65 11.87 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.65 0.78 . . . . 75.14 110.61 -170.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 49.7 79.43 0.08 Allowed 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 125.792 1.637 . . . . 73.23 112.418 171.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 429' ' ' GLU . . . . . 0.44 ' HG2' ' CD1' ' B' ' 424' ' ' TYR . 13.6 tp10 -88.7 162.24 16.38 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 116.467 -0.333 . . . . 63.42 110.923 -177.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -40.91 -39.31 1.12 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 126.419 1.888 . . . . 62.42 112.662 169.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 26.1 m -67.12 81.05 0.13 Allowed 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 124.023 0.929 . . . . 75.05 110.844 -179.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 432' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -119.01 31.34 6.69 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.997 1.319 . . . . 71.1 108.514 174.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 433' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -63.93 131.04 46.48 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 114.62 -1.173 . . . . 73.43 110.429 -178.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 434' ' ' HIS . . . . . . . . . . . . . 76.0 t60 67.27 33.81 5.23 Favored 'General case' 0 CA--C 1.561 1.381 0 C-N-CA 124.529 1.132 . . . . 73.42 110.894 178.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 435' ' ' THR . . . . . . . . . . . . . 15.1 t -73.74 -6.87 49.57 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 122.887 0.475 . . . . 73.42 111.56 176.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . -60.14 -30.91 71.59 Favored Glycine 0 C--N 1.359 1.835 0 C-N-CA 123.084 0.373 . . . . 61.51 112.227 170.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 30.0 m -89.39 81.33 6.62 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 107.479 -1.304 . . . . 72.35 107.479 164.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 438' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -67.55 98.01 0.64 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.241 -0.89 . . . . 71.55 111.211 -173.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 439' ' ' LEU . . . . . . . . . . . . . 80.0 mt -80.64 -4.05 52.8 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 115.017 -0.992 . . . . 74.24 110.747 171.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 440' ' ' ARG . . . . . 0.419 ' HA ' ' HB2' ' A' ' 222' ' ' ALA . 40.0 mtp85 -76.58 112.5 13.2 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 107.626 -1.25 . . . . 74.1 107.626 173.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 441' ' ' ILE . . . . . 0.559 HD13 ' HA ' ' A' ' 223' ' ' VAL . 63.9 mt -70.97 112.5 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 C-N-CA 123.202 0.601 . . . . 74.15 111.896 -167.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 442' ' ' ALA . . . . . . . . . . . . . . . -102.63 27.1 7.2 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.303 1.041 . . . . 73.33 110.39 177.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . -70.2 165.64 21.7 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.404 0.682 . . . . 74.21 111.661 178.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 17.2 m-30 77.43 -18.69 0.48 Allowed 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 125.7 1.6 . . . . 71.31 111.818 -173.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . 61.32 71.58 0.77 Allowed Glycine 0 C--N 1.353 1.494 0 CA-C-O 118.489 -1.173 . . . . 74.34 110.913 -169.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 446' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -45.29 100.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.38 2.211 0 C-N-CA 124.32 3.347 . . . . 72.44 114.662 -168.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 447' ' ' HIS . . . . . . . . . . . . . 10.3 p-80 -131.4 135.19 46.98 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.103 0.961 . . . . 63.45 109.526 175.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . -141.95 -164.38 1.78 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.961 0.904 . . . . 74.31 109.895 -178.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 449' ' ' ALA . . . . . . . . . . . . . . . 67.04 30.84 7.24 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 124.424 1.089 . . . . 74.42 110.992 -175.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 450' ' ' ASN . . . . . . . . . . . . . 9.9 t30 70.49 2.3 4.01 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 125.466 1.506 . . . . 63.22 112.474 -178.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 76.6 t -71.01 89.1 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 N-CA-C 108.82 -0.807 . . . . 74.44 108.82 176.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 452' ' ' VAL . . . . . 0.408 HG23 HD22 ' B' ' 291' ' ' LEU . 7.4 p -90.43 -33.59 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.429 1.091 . . . . 74.24 110.894 -173.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . -77.95 74.61 1.98 Allowed Glycine 0 C--N 1.35 1.309 0 CA-C-N 115.542 -0.754 . . . . 73.44 112.052 -178.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 454' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -158.93 129.84 6.13 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 106.561 -1.644 . . . . 73.13 106.561 -177.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 86.1 m -83.22 -82.65 0.15 Allowed 'General case' 0 CA--C 1.553 1.059 0 N-CA-C 109.613 -0.514 . . . . 72.1 109.613 177.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -140.03 152.67 46.42 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.653 0.781 . . . . 74.3 108.931 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 457' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 63.8 99.07 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.912 1.285 . . . . 65.21 110.642 -172.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 5.8 m -95.3 8.67 42.42 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 123.605 0.762 . . . . 72.13 110.346 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 459' ' ' ASP . . . . . . . . . . . . . 12.4 t70 68.62 110.7 0.05 OUTLIER 'General case' 0 C--N 1.362 1.131 0 C-N-CA 124.99 1.316 . . . . 73.31 109.518 -169.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 1.5 tt 69.02 109.88 0.05 Allowed 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 125.138 1.375 . . . . 65.42 109.205 178.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -78.46 67.21 4.19 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-O 121.831 0.825 . . . . 75.0 111.305 -177.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -150.54 10.68 0.66 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.955 1.302 . . . . 72.53 108.723 176.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 28.3 p -84.02 54.61 2.98 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.679 1.192 . . . . 71.14 110.398 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 464' ' ' MET . . . . . . . . . . . . . 24.4 ptt? -99.42 36.99 1.64 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.018 1.327 . . . . 75.31 109.33 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 465' ' ' LYS . . . . . 0.536 ' HE3' ' HA ' ' B' ' 465' ' ' LYS . 0.7 OUTLIER -69.46 81.61 0.39 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.07 0.948 . . . . 72.15 110.891 -173.835 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -106.26 -170.56 1.75 Allowed 'General case' 0 C--O 1.239 0.539 0 C-N-CA 124.156 0.982 . . . . 65.13 109.453 -177.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . -82.39 22.97 0.79 Allowed 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 123.726 0.81 . . . . 75.3 111.322 175.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 3.2 pp -57.03 150.53 16.82 Favored 'General case' 0 C--N 1.361 1.076 0 C-N-CA 124.193 0.997 . . . . 74.32 111.172 178.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 469' ' ' GLY . . . . . . . . . . . . . . . 70.38 -91.17 0.38 Allowed Glycine 0 C--N 1.342 0.916 0 N-CA-C 110.833 -0.907 . . . . 62.03 110.833 -171.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 470' ' ' LEU . . . . . . . . . . . . . 40.4 tp -163.48 -41.94 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.03 0.932 . . . . 75.32 109.923 177.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 471' ' ' LYS . . . . . . . . . . . . . 6.9 tmtm? . . . . . 0 CA--C 1.559 1.318 0 C-N-CA 125.137 1.375 . . . . 74.2 108.661 -172.244 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 N--CA 1.479 1.003 0 N-CA-C 109.346 -0.613 . . . . 70.43 109.346 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.94 24.38 10.92 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.772 1.229 . . . . 70.41 112.41 178.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -90.91 43.87 1.17 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.971 0.908 . . . . 71.34 111.055 -169.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -37.47 95.1 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 125.693 1.597 . . . . 70.52 114.197 -176.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -67.19 107.73 2.44 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 108.288 -1.004 . . . . 72.32 108.288 166.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -77.74 92.73 4.2 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 106.739 -1.578 . . . . 65.15 106.739 171.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 7' ' ' TYR . . . . . 0.453 ' CD1' ' HA ' ' C' ' 53' ' ' ALA . 75.8 m-85 -62.73 -25.9 68.42 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 114.51 -1.223 . . . . 73.43 112.128 -172.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -64.91 -46.49 81.46 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.382 0.673 . . . . 74.23 110.408 174.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.64 -39.44 94.36 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.266 0.626 . . . . 63.34 111.011 178.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 66.7 mt -59.75 -41.1 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 123.797 0.686 . . . . 73.31 110.475 175.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 98.0 mt -85.57 -3.55 58.9 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 112.265 0.469 . . . . 75.53 112.265 176.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 61.27 44.6 97.89 Favored Glycine 0 C--N 1.354 1.54 0 N-CA-C 114.063 0.385 . . . . 74.43 114.063 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 11.0 m -133.13 148.56 69.71 Favored Pre-proline 0 N--CA 1.487 1.423 0 C-N-CA 124.795 1.238 . . . . 71.34 109.823 177.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -75.29 161.36 38.03 Favored 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 122.721 2.281 . . . . 74.43 111.844 170.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 -77.07 20.17 0.27 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.806 0.842 . . . . 74.35 112.518 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -119.0 -15.39 9.29 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.243 1.017 . . . . 71.24 109.079 177.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.08 131.98 51.36 Favored 'General case' 0 C--N 1.355 0.828 0 C-N-CA 123.246 0.618 . . . . 75.2 109.595 175.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 59.8 p -65.59 161.8 19.57 Favored 'General case' 0 C--O 1.246 0.872 0 C-N-CA 123.047 0.539 . . . . 74.41 109.866 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 19' ' ' GLN . . . . . 0.515 ' HG2' ' HD3' ' C' ' 60' ' ' PRO . 25.1 tp60 -54.26 -38.82 66.25 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.586 0.754 . . . . 74.45 111.978 -173.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 20' ' ' GLU . . . . . 0.448 ' O ' ' HG3' ' C' ' 24' ' ' ARG . 0.4 OUTLIER -68.72 -35.6 77.35 Favored 'General case' 0 C--O 1.211 -0.933 0 CA-C-O 119.182 -0.437 . . . . 74.53 111.128 -179.058 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . 0.735 ' HG2' HH21 ' C' ' 24' ' ' ARG . 37.4 mt-10 -68.92 -38.11 79.32 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-O 121.006 0.431 . . . . 73.42 110.76 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 66.6 mt -66.15 -38.58 82.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 124.188 0.995 . . . . 75.54 109.889 174.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 23' ' ' LYS . . . . . 0.438 ' O ' ' HD3' ' C' ' 27' ' ' LYS . 6.6 ttpt -71.4 -33.85 69.85 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 114.68 -1.145 . . . . 74.13 109.972 178.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 24' ' ' ARG . . . . . 0.735 HH21 ' HG2' ' C' ' 21' ' ' GLU . 40.8 mtm180 -75.84 -24.21 55.8 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.305 0.642 . . . . 73.52 110.478 176.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.67 -43.96 87.73 Favored 'General case' 0 C--N 1.345 0.41 0 O-C-N 123.711 0.632 . . . . 75.32 109.636 170.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 26' ' ' TYR . . . . . 0.458 ' HD1' HG23 ' C' ' 50' ' ' ILE . 81.6 t80 -58.01 -52.42 65.58 Favored 'General case' 0 C--N 1.36 1.04 0 O-C-N 123.624 0.578 . . . . 72.31 110.865 171.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . 0.444 ' HE2' ' HA ' ' C' ' 24' ' ' ARG . 4.8 mppt? -61.0 -31.8 71.41 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 122.878 0.471 . . . . 75.33 111.487 -177.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 28' ' ' ARG . . . . . 0.505 HH21 HD21 ' C' ' 29' ' ' LEU . 38.9 ttp180 -62.28 -48.19 81.01 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.908 0.883 . . . . 75.55 109.602 174.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . 0.662 HD11 HD13 ' C' ' 50' ' ' ILE . 49.9 mt -74.55 -19.09 60.47 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 114.738 -1.119 . . . . 71.43 111.487 178.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.11 -22.49 33.37 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.409 0.684 . . . . 75.32 110.197 178.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . 0.402 ' HG3' ' O ' ' C' ' 27' ' ' LYS . 58.6 mtm180 -86.85 -31.78 20.61 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.252 0.621 . . . . 73.5 110.318 170.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -70.27 -60.58 2.19 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.827 0.851 . . . . 71.12 109.493 -178.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -90.61 24.52 2.63 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.028 0.931 . . . . 72.14 110.934 -177.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 34' ' ' HIS . . . . . 0.467 ' NE2' ' HB3' ' C' ' 36' ' ' ASP . 55.0 t60 -55.12 96.42 0.09 OUTLIER Pre-proline 0 N--CA 1.486 1.345 0 C-N-CA 124.963 1.305 . . . . 74.34 112.84 -164.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 35' ' ' PRO . . . . . 0.496 ' O ' ' HG2' ' C' ' 39' ' ' LYS . 57.9 Cg_endo -76.55 -2.24 12.42 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 123.429 2.753 . . . . 72.22 112.758 -167.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 36' ' ' ASP . . . . . 0.688 ' HB2' ' HG2' ' B' ' 113' ' ' LYS . 32.7 t70 -75.88 -38.03 58.28 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.949 0.899 . . . . 60.34 110.81 173.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 59.6 t -117.32 -52.69 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 122.89 0.476 . . . . 75.33 109.835 -174.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -97.51 79.29 2.73 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.701 0.762 . . . . 65.41 108.945 178.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 39' ' ' LYS . . . . . 0.582 ' HB2' ' HZ2' ' C' ' 39' ' ' LYS . 9.8 mtmp? -81.14 69.37 7.73 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 115.189 -0.914 . . . . 71.22 109.815 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 40' ' ' SER . . . . . 0.503 ' HB2' ' HB2' ' C' ' 43' ' ' ALA . 49.6 m -92.5 111.66 51.77 Favored Pre-proline 0 CA--C 1.546 0.81 0 CA-C-O 118.317 -0.849 . . . . 74.14 108.99 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -38.93 -61.09 0.42 Allowed 'Trans proline' 0 C--N 1.387 2.596 0 C-N-CA 124.571 3.514 . . . . 75.0 114.905 -174.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -61.18 -33.94 74.27 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.857 0.863 . . . . 71.01 111.397 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 43' ' ' ALA . . . . . 0.503 ' HB2' ' HB2' ' C' ' 40' ' ' SER . . . -77.35 -20.52 54.7 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.248 0.619 . . . . 71.45 110.659 -178.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -84.06 -28.44 27.6 Favored 'General case' 0 C--N 1.351 0.659 0 N-CA-C 109.127 -0.694 . . . . 74.04 109.127 176.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -70.62 -42.19 71.24 Favored 'General case' 0 C--O 1.25 1.125 0 C-N-CA 123.676 0.79 . . . . 75.44 109.602 173.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 46' ' ' LYS . . . . . 0.519 ' O ' HG12 ' C' ' 50' ' ' ILE . 63.5 mttp -58.12 -45.65 86.96 Favored 'General case' 0 C--N 1.355 0.832 0 CA-C-N 114.789 -1.096 . . . . 72.32 109.429 168.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -62.66 -30.31 71.29 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.926 0.89 . . . . 71.12 110.963 -178.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 2.7 mptm? -63.54 -50.37 69.82 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 109.07 -0.715 . . . . 72.04 109.07 171.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -67.57 -17.34 64.6 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 112.791 0.663 . . . . 72.33 112.791 176.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 50' ' ' ILE . . . . . 0.662 HD13 HD11 ' C' ' 29' ' ' LEU . 28.2 mm -78.36 -38.03 22.51 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 N-CA-C 108.832 -0.803 . . . . 75.43 108.832 173.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 51' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -78.85 -11.87 60.01 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.799 0.84 . . . . 74.04 111.399 174.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 52' ' ' GLU . . . . . 0.432 ' O ' HG22 ' C' ' 56' ' ' VAL . 30.0 tt0 -77.83 -53.07 7.92 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 108.064 -1.088 . . . . 75.54 108.064 169.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . 0.453 ' HA ' ' CD1' ' C' ' 7' ' ' TYR . . . -57.8 -34.14 69.31 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 114.432 -1.258 . . . . 63.1 111.399 175.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 54' ' ' TYR . . . . . 0.448 ' O ' ' HB2' ' C' ' 58' ' ' SER . 22.9 t80 -82.9 -32.45 27.28 Favored 'General case' 0 C--O 1.216 -0.68 0 C-N-CA 123.79 0.836 . . . . 75.01 110.378 177.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.39 -31.66 66.03 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 118.277 0.489 . . . . 60.54 110.537 173.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 56' ' ' VAL . . . . . 0.461 HG12 ' HB2' ' C' ' 66' ' ' TYR . 10.1 t -100.06 -21.3 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.245 0 CA-C-N 115.129 -0.941 . . . . 72.43 112.598 -179.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 57' ' ' LEU . . . . . 0.524 HD22 ' HG3' ' C' ' 63' ' ' ARG . 71.0 mt -127.4 29.3 5.56 Favored 'General case' 0 N--CA 1.501 2.122 0 CA-C-N 119.424 1.011 . . . . 75.02 112.655 -179.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 58' ' ' SER . . . . . 0.448 ' HB2' ' O ' ' C' ' 54' ' ' TYR . 21.4 t -68.62 -60.81 2.15 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.297 0.57 . . . . 75.33 112.221 177.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -125.9 158.98 63.8 Favored Pre-proline 0 N--CA 1.481 1.097 0 C-N-CA 124.393 1.077 . . . . 72.03 109.117 -171.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 60' ' ' PRO . . . . . 0.515 ' HD3' ' HG2' ' C' ' 19' ' ' GLN . 10.3 Cg_endo -48.89 -30.46 17.53 Favored 'Trans proline' 0 C--N 1.388 2.631 0 C-N-CA 123.162 2.574 . . . . 73.21 113.299 178.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . 0.423 ' O ' HG12 ' C' ' 65' ' ' ILE . 18.4 tt0 -50.79 -69.34 0.11 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.306 1.042 . . . . 62.13 110.625 170.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -60.22 -44.81 94.86 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-N 114.724 -1.125 . . . . 75.43 111.357 -174.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 63' ' ' ARG . . . . . 0.524 ' HG3' HD22 ' C' ' 57' ' ' LEU . 31.7 ttp-105 -62.77 -46.14 89.41 Favored 'General case' 0 C--N 1.349 0.544 0 CA-C-N 114.865 -1.062 . . . . 74.14 110.595 -174.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -72.57 -25.95 61.54 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 123.744 0.652 . . . . 74.15 111.552 -178.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 65' ' ' ILE . . . . . 0.423 HG12 ' O ' ' C' ' 61' ' ' GLU . 46.1 mm -60.13 -46.61 94.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 109.351 -0.611 . . . . 71.5 109.351 168.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 66' ' ' TYR . . . . . 0.461 ' HB2' HG12 ' C' ' 56' ' ' VAL . 18.3 t80 -63.63 -46.26 86.51 Favored 'General case' 0 C--N 1.353 0.723 0 CA-C-N 115.664 -0.698 . . . . 74.31 110.677 176.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -62.44 -33.67 75.28 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.219 0.607 . . . . 73.14 111.461 -176.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 44.5 p -78.14 -20.27 52.41 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.362 -0.381 . . . . 74.43 111.001 175.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -75.02 133.65 41.6 Favored 'General case' 0 CA--C 1.556 1.181 0 N-CA-C 108.415 -0.957 . . . . 75.22 108.415 165.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 91.28 15.6 55.25 Favored Glycine 0 N--CA 1.476 1.345 0 N-CA-C 111.225 -0.75 . . . . 62.51 111.225 -167.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 99.9 m -141.27 -60.34 0.49 Allowed 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 103.601 -2.74 . . . . 72.34 103.601 175.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 91.0 m -78.15 139.09 39.0 Favored 'General case' 0 C--O 1.251 1.155 0 N-CA-C 104.268 -2.493 . . . . 73.35 104.268 155.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.38 -45.93 4.34 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.62 0.768 . . . . 73.23 109.659 -172.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -73.87 144.32 82.5 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 123.435 0.694 . . . . 53.23 109.979 178.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.82 120.78 8.69 Favored 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 122.738 2.292 . . . . 75.14 110.989 173.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -54.27 159.59 7.79 Favored 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 123.685 2.924 . . . . 71.22 114.444 -176.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.57 127.75 14.37 Favored 'Trans proline' 0 C--N 1.381 2.242 0 C-N-CA 122.249 1.966 . . . . 74.4 110.839 172.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 78' ' ' PRO . . . . . 0.431 ' HB3' ' HA3' ' C' ' 104' ' ' GLY . 18.1 Cg_endo -59.02 129.91 34.06 Favored 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 122.609 2.206 . . . . 74.44 112.75 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.07 156.02 66.43 Favored 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 122.749 2.299 . . . . 70.12 111.45 174.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_exo -53.78 87.47 0.03 OUTLIER 'Trans proline' 0 C--N 1.385 2.494 0 C-N-CA 123.314 2.676 . . . . 74.31 112.707 176.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 159.55 -45.45 0.43 Allowed Glycine 0 C--N 1.342 0.894 0 CA-C-N 114.673 -1.149 . . . . 75.2 111.179 178.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 109.45 167.87 20.27 Favored Glycine 0 C--N 1.352 1.433 0 C-N-CA 123.669 0.652 . . . . 75.13 111.987 -175.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -78.03 112.15 14.65 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 109.293 -0.632 . . . . 73.4 109.293 176.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 84' ' ' ASP . . . . . 0.401 ' HA ' ' CE2' ' C' ' 106' ' ' PHE . 3.1 t70 -63.56 146.22 54.13 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.808 0.843 . . . . 75.11 112.801 -178.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 85' ' ' PHE . . . . . 0.467 ' O ' ' HB3' ' C' ' 171' ' ' PRO . 75.9 m-85 -138.62 71.33 1.39 Allowed 'General case' 0 C--N 1.356 0.878 0 C-N-CA 124.299 1.039 . . . . 74.41 110.207 171.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 37.0 m -51.0 86.75 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 125.05 1.34 . . . . 52.42 112.744 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 75.68 -5.54 37.66 Favored Glycine 0 CA--C 1.535 1.294 0 CA-C-N 116.067 -0.515 . . . . 74.34 113.493 -176.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 88' ' ' PHE . . . . . 0.451 ' HB2' ' HB3' ' C' ' 85' ' ' PHE . 12.8 m-85 -81.19 118.52 22.64 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.829 -0.804 . . . . 74.44 108.829 -171.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -76.86 81.4 3.44 Favored 'General case' 0 C--O 1.243 0.745 0 CA-C-O 121.204 0.526 . . . . 72.23 110.483 -173.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 90' ' ' VAL . . . . . 0.651 HG21 HD22 ' C' ' 169' ' ' ASN . 1.5 p -44.41 -40.96 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 125.46 1.504 . . . . 54.42 111.852 175.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -48.12 -40.0 22.2 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.716 1.606 . . . . 75.25 112.961 -178.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -85.1 -29.37 24.91 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.583 0.753 . . . . 75.53 112.165 -173.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 17.1 m-30 -68.98 170.39 9.9 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 113.143 0.794 . . . . 72.45 113.143 -164.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 81.0 p -71.95 172.77 9.37 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 124.77 1.228 . . . . 52.11 113.779 -164.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 95' ' ' GLU . . . . . 0.484 ' O ' ' HG3' ' C' ' 99' ' ' GLU . 4.7 mp0 -71.6 -34.0 69.5 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 115.275 -0.875 . . . . 72.35 110.953 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -61.19 -44.2 97.67 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-O 121.494 0.664 . . . . 74.24 110.33 174.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 97' ' ' PHE . . . . . 0.647 ' HE2' HG22 ' C' ' 90' ' ' VAL . 47.9 t80 -56.93 -43.77 81.8 Favored 'General case' 0 CA--C 1.554 1.103 0 CA-C-N 114.148 -1.387 . . . . 64.25 109.884 172.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -70.6 -18.97 62.88 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.055 0.542 . . . . 71.33 112.459 177.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' C' ' 95' ' ' GLU . 43.2 mt-10 -74.27 -55.35 6.13 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.127 0.489 . . . . 74.43 110.015 173.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 27.3 tp -74.91 -45.22 44.17 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.819 -1.082 . . . . 73.23 111.643 -170.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -97.24 -19.1 18.82 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.599 0.76 . . . . 75.04 112.257 -175.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -47.42 -57.96 6.93 Favored Glycine 0 CA--C 1.545 1.913 0 CA-C-O 118.947 -0.918 . . . . 74.41 115.119 -178.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -59.07 -9.41 7.97 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 123.788 2.992 . . . . 64.35 114.621 -179.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 104' ' ' GLY . . . . . 0.431 ' HA3' ' HB3' ' C' ' 78' ' ' PRO . . . -136.8 34.29 2.23 Favored Glycine 0 C--N 1.351 1.414 0 CA-C-O 119.985 -0.342 . . . . 73.42 113.116 178.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 105' ' ' LEU . . . . . 0.553 ' HB3' ' ND2' ' C' ' 169' ' ' ASN . 43.1 mt -73.18 68.97 1.03 Allowed 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.314 0.645 . . . . 75.43 111.474 172.085 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 106' ' ' PHE . . . . . 0.439 ' HB3' ' H ' ' C' ' 168' ' ' GLY . 23.2 m-85 48.56 -115.4 0.73 Allowed 'General case' 0 CA--C 1.564 1.482 0 C-N-CA 125.383 1.473 . . . . 64.24 114.36 176.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . 69.07 3.54 37.4 Favored Glycine 0 C--N 1.369 2.4 0 CA-C-O 119.89 -0.394 . . . . 51.05 113.388 -163.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 55.88 -128.13 44.51 Favored Glycine 0 C--N 1.364 2.097 0 N-CA-C 111.83 -0.508 . . . . 74.41 111.83 -171.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 109' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -109.05 9.25 26.36 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.786 0.834 . . . . 74.45 109.633 169.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 110' ' ' GLY . . . . . . . . . . . . . . . -92.0 -13.28 57.94 Favored Glycine 0 C--N 1.349 1.276 0 CA-C-N 115.976 -0.556 . . . . 73.14 112.643 -177.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? 59.16 6.88 0.77 Allowed 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 114.123 1.157 . . . . 75.25 114.123 178.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 112' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -53.54 -35.4 60.7 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.186 1.394 . . . . 75.43 111.572 169.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 113' ' ' SER . . . . . . . . . . . . . 25.0 m 52.79 30.37 8.89 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 125.002 1.321 . . . . 72.53 112.724 176.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 114' ' ' ARG . . . . . 0.482 ' HG3' ' H ' ' C' ' 115' ' ' LYS . 7.7 tpt180 -139.3 -164.66 1.71 Allowed 'General case' 0 CA--C 1.554 1.117 0 CA-C-O 117.713 -1.137 . . . . 74.05 109.646 -177.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 115' ' ' LYS . . . . . 0.482 ' H ' ' HG3' ' C' ' 114' ' ' ARG . 14.8 ttpp -14.41 121.9 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.244 0 C-N-CA 127.236 2.214 . . . . 74.15 116.48 -163.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 116' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' C' ' 170' ' ' PRO . . . -67.2 141.21 38.96 Favored Glycine 0 C--N 1.348 1.219 0 CA-C-N 115.024 -0.989 . . . . 54.4 113.102 179.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 117' ' ' ARG . . . . . 0.533 HH21 ' HB3' ' C' ' 167' ' ' GLN . 69.4 mtm180 -110.41 163.86 13.26 Favored 'General case' 0 C--O 1.265 1.891 0 CA-C-O 122.154 0.978 . . . . 74.32 110.534 -177.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.09 117.74 5.06 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 112.589 -2.096 . . . . 75.42 108.353 165.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 119' ' ' LEU . . . . . 0.504 ' HG ' ' HG2' ' C' ' 167' ' ' GLN . 3.3 tt -92.23 116.18 28.73 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 104.59 -2.374 . . . . 75.21 104.59 178.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 63.0 ttt180 -117.98 118.84 33.04 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.35 -0.982 . . . . 72.31 108.35 -164.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 121' ' ' ALA . . . . . 0.456 ' HA ' HG22 ' B' ' 185' ' ' VAL . . . -108.58 170.03 8.28 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 113.847 1.055 . . . . 75.44 113.847 -164.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -127.79 108.14 10.47 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 114.16 -1.382 . . . . 74.12 110.288 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -139.12 111.68 7.94 Favored Pre-proline 0 N--CA 1.487 1.42 0 CA-C-N 118.535 0.607 . . . . 73.3 112.431 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -65.74 121.59 9.0 Favored 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 122.037 1.824 . . . . 72.51 109.692 162.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 125' ' ' LEU . . . . . 0.47 ' O ' ' HA ' ' C' ' 180' ' ' LEU . 12.7 tp -145.56 167.93 21.85 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 107.585 -1.265 . . . . 75.32 107.585 -169.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 126' ' ' THR . . . . . . . . . . . . . 14.5 t -128.26 176.99 7.25 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 119.366 0.985 . . . . 61.53 110.911 173.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 127' ' ' LEU . . . . . . . . . . . . . 6.3 mt -60.73 -43.54 97.76 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.485 1.514 . . . . 62.25 109.696 -177.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 128' ' ' GLU . . . . . 0.439 ' HG2' ' HB1' ' B' ' 171' ' ' ALA . 1.9 mp0 -60.96 -39.67 90.43 Favored 'General case' 0 C--O 1.213 -0.836 0 CA-C-N 114.133 -1.394 . . . . 75.24 110.031 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 129' ' ' GLU . . . . . 0.532 ' HA ' ' HB2' ' C' ' 132' ' ' HIS . 50.3 mm-40 -77.2 -22.85 51.74 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.783 0.833 . . . . 75.51 111.225 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 130' ' ' ALA . . . . . 0.457 ' HB2' ' HA2' ' C' ' 152' ' ' GLY . . . -72.26 -35.26 68.73 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 109.297 -0.631 . . . . 73.14 109.297 175.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 131' ' ' PHE . . . . . 0.497 ' HB2' HD12 ' C' ' 215' ' ' LEU . 10.5 t80 -71.09 -43.56 67.47 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 114.131 -1.395 . . . . 75.55 110.855 168.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 132' ' ' HIS . . . . . 0.532 ' HB2' ' HA ' ' C' ' 129' ' ' GLU . 32.4 m170 -75.32 -6.82 51.88 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.854 0.461 . . . . 70.15 110.378 -178.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -59.57 77.81 0.01 OUTLIER Glycine 0 C--N 1.356 1.648 0 C-N-CA 123.815 0.721 . . . . 65.31 112.904 168.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . -113.94 -152.61 10.78 Favored Glycine 0 C--N 1.342 0.884 0 N-CA-C 109.417 -1.473 . . . . 73.12 109.417 174.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -71.55 92.99 1.17 Allowed 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 108.409 -0.96 . . . . 73.03 108.409 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 136' ' ' ARG . . . . . 0.538 ' HB2' HD22 ' B' ' 181' ' ' LEU . 78.3 mtp180 -139.55 159.48 42.06 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.116 0.966 . . . . 72.12 109.589 -173.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 137' ' ' VAL . . . . . . . . . . . . . 93.5 t -70.78 98.87 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.887 0 CA-C-O 121.978 0.894 . . . . 73.11 110.664 -175.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 138' ' ' VAL . . . . . . . . . . . . . 72.9 t -79.17 112.16 16.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 CA-C-N 113.853 -1.521 . . . . 72.14 107.831 169.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 139' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -115.69 82.22 1.72 Allowed 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 108.092 -1.077 . . . . 74.31 108.092 -170.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 140' ' ' VAL . . . . . 0.464 HG11 HD13 ' C' ' 174' ' ' LEU . 67.4 t -122.86 104.65 14.82 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 C-N-CA 124.292 1.037 . . . . 73.25 110.833 -169.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 69.21 15.01 8.64 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 125.145 1.378 . . . . 65.0 113.388 168.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 116.8 -30.15 6.51 Favored Glycine 0 C--N 1.339 0.746 0 N-CA-C 110.987 -0.845 . . . . 52.4 110.987 -175.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 143' ' ' ARG . . . . . 0.481 ' CZ ' ' HB ' ' C' ' 145' ' ' VAL . 13.0 tpt180 -70.73 114.32 8.7 Favored 'General case' 0 C--N 1.361 1.092 0 N-CA-C 109.055 -0.72 . . . . 75.05 109.055 177.005 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 7.5 ttt-85 -114.27 99.26 7.47 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 115.339 -0.846 . . . . 71.51 108.95 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 145' ' ' VAL . . . . . 0.564 HG21 ' HB ' ' C' ' 147' ' ' VAL . 3.1 p -124.85 124.41 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.473 1.109 . . . . 75.03 110.028 -178.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 146' ' ' SER . . . . . 0.427 ' HB2' ' HG3' ' B' ' 198' ' ' GLU . 29.2 m -87.13 86.41 7.29 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 108.906 -0.775 . . . . 73.22 108.906 177.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 147' ' ' VAL . . . . . 0.564 ' HB ' HG21 ' C' ' 145' ' ' VAL . 7.3 p -134.81 160.56 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 124.114 0.966 . . . . 72.53 110.59 -169.214 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 28.5 ttm-85 -90.18 104.89 17.41 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 108.11 -1.071 . . . . 74.22 108.11 168.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 149' ' ' ILE . . . . . 0.403 HG12 HD23 ' B' ' 181' ' ' LEU . 29.6 pt -69.34 150.73 97.09 Favored Pre-proline 0 CA--C 1.548 0.872 0 CA-C-O 117.755 -1.117 . . . . 74.42 108.438 165.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 150' ' ' PRO . . . . . 0.516 ' HD2' HG22 ' C' ' 161' ' ' VAL . 28.4 Cg_exo -38.68 107.97 0.07 OUTLIER 'Trans proline' 0 C--N 1.393 2.88 0 C-N-CA 123.415 2.743 . . . . 61.44 113.124 178.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -69.71 130.66 19.79 Favored 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 122.671 2.247 . . . . 73.2 111.541 -171.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 152' ' ' GLY . . . . . 0.539 ' HA3' HD22 ' C' ' 188' ' ' LEU . . . 91.71 112.01 1.8 Allowed Glycine 0 C--N 1.342 0.905 0 CA-C-N 115.645 -0.707 . . . . 63.11 113.091 -177.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 153' ' ' VAL . . . . . 0.599 HG21 HG22 ' C' ' 178' ' ' VAL . 3.0 m -123.64 177.66 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 C-N-CA 123.745 0.818 . . . . 74.01 109.595 -173.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 154' ' ' ARG . . . . . 0.474 ' HD2' ' HB2' ' B' ' 217' ' ' LEU . 97.0 mtt180 -135.03 155.48 50.69 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 123.429 0.692 . . . . 75.32 110.775 -178.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 155' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -67.88 102.53 1.27 Allowed 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.911 1.284 . . . . 74.51 112.036 -176.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 97.36 3.5 58.66 Favored Glycine 0 C--N 1.348 1.236 0 CA-C-N 115.354 -0.839 . . . . 75.21 113.009 179.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 157' ' ' SER . . . . . 0.432 ' HB3' ' HA ' ' B' ' 217' ' ' LEU . 52.0 m -95.75 169.82 9.74 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 117.205 0.502 . . . . 75.43 111.394 -175.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 158' ' ' VAL . . . . . 0.414 HG13 HG21 ' C' ' 177' ' ' VAL . 27.6 m -105.68 127.87 60.27 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 CA-C-O 121.604 0.716 . . . . 72.31 111.038 178.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 159' ' ' ILE . . . . . 0.583 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 15.2 mt -78.07 98.21 2.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 107.995 -1.113 . . . . 72.31 107.995 168.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 36.5 ttp180 -78.74 99.64 6.74 Favored 'General case' 0 C--O 1.239 0.51 0 O-C-N 123.794 0.684 . . . . 75.13 109.683 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 161' ' ' VAL . . . . . 0.598 ' HB ' ' HB3' ' C' ' 174' ' ' LEU . 19.3 t -95.99 113.11 61.52 Favored Pre-proline 0 C--O 1.251 1.15 0 N-CA-C 108.223 -1.028 . . . . 75.24 108.223 175.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -53.31 106.95 0.17 Allowed 'Trans proline' 0 C--N 1.381 2.277 0 C-N-CA 123.848 3.032 . . . . 75.23 114.476 -174.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 71.44 16.4 75.61 Favored Glycine 0 C--N 1.347 1.189 0 N-CA-C 115.694 1.038 . . . . 53.54 115.694 168.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 164' ' ' MET . . . . . 0.425 ' HE2' HG13 ' C' ' 161' ' ' VAL . 37.5 ttp -105.28 21.76 16.58 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 118.143 0.972 . . . . 73.35 110.939 -178.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . -78.12 -121.81 0.26 Allowed Glycine 0 C--N 1.35 1.345 0 CA-C-O 119.42 -0.656 . . . . 73.32 112.311 174.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . 150.98 -80.1 0.2 Allowed Glycine 0 C--N 1.356 1.639 0 C-N-CA 118.909 -1.615 . . . . 75.44 114.442 170.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 167' ' ' GLN . . . . . 0.533 ' HB3' HH21 ' C' ' 117' ' ' ARG . 31.6 mm-40 -14.91 101.18 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.491 0 C-N-CA 126.244 1.818 . . . . 74.2 114.043 -161.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 168' ' ' GLY . . . . . 0.439 ' H ' ' HB3' ' C' ' 106' ' ' PHE . . . 115.1 143.57 8.11 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 109.078 -1.609 . . . . 13.44 109.078 -162.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 169' ' ' ASN . . . . . 0.651 HD22 HG21 ' C' ' 90' ' ' VAL . 2.7 t-20 -54.76 -57.61 18.36 Favored Pre-proline 0 CA--C 1.572 1.812 0 N-CA-C 114.597 1.332 . . . . 62.44 114.597 -164.041 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 170' ' ' PRO . . . . . 0.447 ' HD3' ' HB3' ' C' ' 169' ' ' ASN . 33.1 Cg_exo -62.18 154.16 64.72 Favored 'Trans proline' 0 C--N 1.393 2.905 0 CA-C-N 121.93 1.725 . . . . 73.55 112.208 172.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 171' ' ' PRO . . . . . 0.467 ' HB3' ' O ' ' C' ' 85' ' ' PHE . 22.7 Cg_endo -62.08 129.88 28.75 Favored 'Trans proline' 0 C--N 1.368 1.553 0 C-N-CA 122.234 1.956 . . . . 74.02 112.828 175.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -99.39 -175.23 31.37 Favored Glycine 0 N--CA 1.474 1.174 0 N-CA-C 110.51 -1.036 . . . . 74.42 110.51 166.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 173' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -98.91 152.97 19.19 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 117.993 0.896 . . . . 74.51 109.302 178.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 174' ' ' LEU . . . . . 0.598 ' HB3' ' HB ' ' C' ' 161' ' ' VAL . 26.5 tp -99.25 121.74 41.47 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 121.946 -0.472 . . . . 75.22 110.585 -176.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 81.3 mt -117.74 87.71 2.77 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.281 0.632 . . . . 72.15 109.9 176.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 176' ' ' LEU . . . . . 0.583 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 48.6 mt -76.22 108.46 9.17 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 116.232 -0.44 . . . . 74.33 109.949 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 177' ' ' VAL . . . . . 0.414 HG21 HG13 ' C' ' 158' ' ' VAL . 61.5 t -81.82 106.46 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 N-CA-C 108.256 -1.016 . . . . 75.23 108.256 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 178' ' ' VAL . . . . . 0.599 HG22 HG21 ' C' ' 153' ' ' VAL . 4.0 p -95.64 138.83 20.24 Favored 'Isoleucine or valine' 0 C--O 1.242 0.69 0 CA-C-N 114.344 -1.298 . . . . 74.01 110.344 -177.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 179' ' ' ARG . . . . . . . . . . . . . 52.4 mmm-85 -121.68 109.9 15.31 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 107.73 -1.211 . . . . 74.42 107.73 175.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 180' ' ' LEU . . . . . 0.47 ' HA ' ' O ' ' C' ' 125' ' ' LEU . 87.6 mt -71.11 147.87 48.02 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.199 0.6 . . . . 73.43 111.843 -176.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 181' ' ' LEU . . . . . . . . . . . . . 30.5 mt -62.01 167.83 4.42 Favored Pre-proline 0 CA--C 1.559 1.316 0 C-N-CA 124.892 1.277 . . . . 74.24 112.106 -179.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 182' ' ' PRO . . . . . 0.404 ' HG2' ' HB1' ' B' ' 160' ' ' ALA . 29.3 Cg_exo -42.43 -1.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.398 3.157 1 C-N-CA 125.364 4.043 . . . . 73.32 118.557 175.458 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 183' ' ' HIS . . . . . 0.482 ' HE1' ' HE1' ' C' ' 213' ' ' MET . 0.9 OUTLIER -127.2 81.2 70.42 Favored Pre-proline 0 CA--C 1.562 1.438 0 CA-C-N 118.971 0.805 . . . . 72.0 109.792 166.017 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 184' ' ' PRO . . . . . 0.408 ' O ' ' HA ' ' B' ' 222' ' ' ALA . 88.3 Cg_endo -85.51 69.6 5.23 Favored 'Trans proline' 0 C--N 1.371 1.713 0 C-N-CA 123.628 2.886 . . . . 74.25 110.485 174.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 185' ' ' VAL . . . . . 0.624 HG21 HG23 ' B' ' 225' ' ' THR . 3.9 t -89.89 -42.37 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 109.843 -0.429 . . . . 72.23 109.843 -165.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 186' ' ' PHE . . . . . 0.592 ' HB3' HD22 ' C' ' 193' ' ' LEU . 20.9 m-85 -99.38 116.05 30.65 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.369 0.604 . . . . 61.44 112.425 -170.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 187' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -102.51 101.77 11.99 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.312 1.445 . . . . 75.14 107.339 171.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 188' ' ' LEU . . . . . 0.539 HD22 ' HA3' ' C' ' 152' ' ' GLY . 57.8 tp -92.55 141.16 28.8 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 113.301 0.852 . . . . 74.14 113.301 -169.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -125.23 101.25 6.9 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 107.857 -1.164 . . . . 73.21 107.857 160.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 72.2 -81.12 0.59 Allowed Glycine 0 C--N 1.353 1.504 0 CA-C-N 115.18 -0.918 . . . . 74.2 113.51 176.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 191' ' ' GLN . . . . . 0.582 ' HA ' ' HB2' ' C' ' 240' ' ' PHE . 19.4 mt-30 -132.64 -9.94 3.16 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.318 0.647 . . . . 75.25 111.746 178.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -105.49 115.38 30.16 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 121.23 0.538 . . . . 65.13 110.587 -176.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 193' ' ' LEU . . . . . 0.592 HD22 ' HB3' ' C' ' 186' ' ' PHE . 72.2 mt -86.0 152.27 23.06 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.932 1.293 . . . . 65.15 111.132 -178.061 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 194' ' ' TYR . . . . . 0.455 ' O ' ' HA ' ' C' ' 186' ' ' PHE . 49.7 t80 -111.98 148.96 32.68 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 107.25 -1.389 . . . . 75.43 107.25 162.211 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 195' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' C' ' 185' ' ' VAL . . . -154.42 -176.95 6.14 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.078 0.551 . . . . 65.11 111.177 -177.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 40.2 m -128.36 139.05 52.59 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.049 -0.978 . . . . 53.42 108.893 168.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 197' ' ' LEU . . . . . 0.412 HD12 HD22 ' C' ' 251' ' ' LEU . 35.9 tp -115.53 143.46 45.28 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.522 1.129 . . . . 73.5 108.473 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -113.04 102.1 10.09 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.388 -0.597 . . . . 64.33 109.388 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 199' ' ' VAL . . . . . 0.584 ' HA ' HG11 ' C' ' 210' ' ' VAL . 95.2 t -108.08 119.36 50.17 Favored Pre-proline 0 N--CA 1.473 0.698 0 C-N-CA 123.901 0.88 . . . . 73.12 109.005 176.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 200' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.94 149.54 65.91 Favored 'Trans proline' 0 C--N 1.371 1.751 0 C-N-CA 121.858 1.705 . . . . 73.11 110.934 175.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 201' ' ' ALA . . . . . . . . . . . . . . . -56.02 -43.44 99.23 Favored Pre-proline 0 CA--C 1.553 1.093 0 N-CA-C 114.093 1.145 . . . . 74.35 114.093 -174.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 202' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -54.18 -53.44 6.31 Favored 'Trans proline' 0 C--N 1.398 3.156 0 C-N-CA 121.752 1.635 . . . . 63.15 112.286 175.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 203' ' ' ILE . . . . . . . . . . . . . 41.0 mt -62.73 -32.99 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 124.554 1.142 . . . . 74.02 111.209 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.96 -43.9 81.92 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.756 0.822 . . . . 75.02 112.013 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 205' ' ' VAL . . . . . . . . . . . . . 87.9 t -71.7 -47.95 54.38 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 123.256 0.622 . . . . 74.52 111.199 -179.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 206' ' ' VAL . . . . . 0.571 HG21 ' HE2' ' A' ' 270' ' ' LYS . 14.7 p -80.1 -34.74 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 112.761 0.652 . . . . 74.12 112.761 -171.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 90.57 104.5 1.25 Allowed Glycine 0 C--N 1.343 0.92 0 N-CA-C 111.069 -0.812 . . . . 63.21 111.069 -167.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -143.44 -126.71 2.03 Favored Glycine 0 C--N 1.343 0.927 0 N-CA-C 111.679 -0.568 . . . . 51.32 111.679 -176.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 209' ' ' LYS . . . . . 0.55 ' HZ2' ' HB3' ' B' ' 235' ' ' GLU . 34.1 ttmt -157.21 137.18 12.53 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 117.633 0.717 . . . . 72.44 110.85 -176.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 210' ' ' VAL . . . . . 0.584 HG11 ' HA ' ' C' ' 199' ' ' VAL . 23.4 m -129.95 177.03 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 125.501 1.52 . . . . 71.52 109.526 174.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 211' ' ' ARG . . . . . 0.753 HH22 ' HB2' ' B' ' 233' ' ' PHE . 0.1 OUTLIER -109.46 149.99 28.76 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 118.436 0.562 . . . . 75.53 111.204 -179.845 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -129.5 118.55 22.26 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 107.45 -1.315 . . . . 74.43 107.45 166.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 213' ' ' MET . . . . . 0.59 ' HG2' ' HB3' ' B' ' 172' ' ' GLU . 1.4 tmm? -73.82 117.79 16.02 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.344 -0.984 . . . . 63.12 108.344 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 214' ' ' THR . . . . . 0.4 HG22 ' H ' ' C' ' 215' ' ' LEU . 0.2 OUTLIER -122.8 175.76 6.36 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 119.014 0.824 . . . . 72.34 112.095 -173.521 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 215' ' ' LEU . . . . . 0.497 HD12 ' HB2' ' C' ' 131' ' ' PHE . 41.7 mt -75.82 -29.8 58.78 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.459 1.503 . . . . 75.24 112.012 -171.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -87.11 3.28 46.86 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 114.803 -1.09 . . . . 71.0 110.272 176.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 118.26 -178.22 16.75 Favored Glycine 0 C--N 1.348 1.208 0 N-CA-C 110.433 -1.067 . . . . 74.41 110.433 -172.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -75.26 125.2 9.0 Favored 'Trans proline' 0 CA--C 1.554 1.477 0 C-N-CA 121.954 1.769 . . . . 64.03 111.97 178.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 219' ' ' VAL . . . . . 0.458 HG22 HG22 ' B' ' 238' ' ' THR . 14.0 p -100.56 157.51 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 N-CA-C 106.865 -1.531 . . . . 52.53 106.865 171.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 220' ' ' GLU . . . . . 0.542 ' HB3' ' HB2' ' B' ' 235' ' ' GLU . 16.5 tt0 -126.63 108.33 11.01 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.859 -0.793 . . . . 72.32 108.859 -177.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 221' ' ' VAL . . . . . 0.404 HG22 HD21 ' C' ' 235' ' ' LEU . 32.1 t -68.9 123.99 23.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 125.858 1.663 . . . . 74.03 111.2 -174.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -84.67 108.49 17.42 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 109.413 -0.588 . . . . 73.3 109.413 172.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 61.1 t -84.25 127.64 65.54 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 123.744 0.818 . . . . 73.11 110.508 -176.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 224' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -79.76 161.83 24.33 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 123.233 2.622 . . . . 73.11 111.082 168.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 225' ' ' PRO . . . . . 0.745 ' HG2' HD11 ' B' ' 247' ' ' LEU . 39.4 Cg_exo -63.12 159.05 40.7 Favored 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 122.427 2.084 . . . . 74.4 113.483 177.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 226' ' ' ARG . . . . . 0.428 ' HD2' ' O ' ' A' ' 259' ' ' GLU . 9.5 mmt180 55.3 63.0 2.24 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.514 1.526 . . . . 71.5 111.894 177.078 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 227' ' ' THR . . . . . . . . . . . . . 52.4 m -96.92 128.93 44.36 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 123.815 0.846 . . . . 73.3 110.97 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 228' ' ' GLN . . . . . 0.469 ' NE2' ' HG3' ' A' ' 259' ' ' GLU . 27.8 mp0 -105.23 147.67 27.8 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 124.545 1.138 . . . . 74.32 111.893 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -73.28 123.4 23.65 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 115.43 -0.805 . . . . 65.31 109.264 177.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 116.12 -7.41 18.99 Favored Glycine 0 C--N 1.337 0.599 0 O-C-N 123.522 0.514 . . . . 62.04 112.064 -176.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 231' ' ' ARG . . . . . 0.576 ' HD3' ' HZ3' ' B' ' 242' ' ' TRP . 36.0 mtt180 -63.02 169.57 3.27 Favored 'General case' 0 C--N 1.354 0.79 0 CA-C-N 116.846 0.323 . . . . 75.03 110.925 171.072 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 232' ' ' LYS . . . . . 0.627 ' HB2' ' HZ2' ' C' ' 232' ' ' LYS . 3.7 ttmp? -139.29 147.06 41.13 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.567 -0.531 . . . . 74.05 109.567 176.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 233' ' ' LEU . . . . . 0.467 ' O ' ' HA ' ' C' ' 250' ' ' TYR . 1.7 tt -133.01 125.01 28.77 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.693 0.797 . . . . 74.22 109.308 -166.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -93.19 104.22 16.43 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-O 121.065 0.459 . . . . 72.34 110.614 170.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 235' ' ' LEU . . . . . 0.404 HD21 HG22 ' C' ' 221' ' ' VAL . 75.8 mt -85.11 123.88 31.14 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.391 -0.966 . . . . 74.34 108.391 166.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -85.32 131.75 34.36 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 123.349 0.66 . . . . 73.41 111.541 -171.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 80.83 -1.28 84.45 Favored Glycine 0 C--N 1.351 1.402 0 O-C-N 124.033 0.833 . . . . 71.42 113.687 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 14.0 mmtm -95.11 9.05 41.03 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.19 0.996 . . . . 75.11 112.019 -172.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -86.29 -133.01 3.27 Favored Glycine 0 C--N 1.346 1.085 0 N-CA-C 111.723 -0.551 . . . . 75.2 111.723 172.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 240' ' ' PHE . . . . . 0.582 ' HB2' ' HA ' ' C' ' 191' ' ' GLN . 1.9 m-85 -103.37 128.45 27.48 Favored Pre-proline 0 N--CA 1.47 0.558 0 C-N-CA 123.105 0.562 . . . . 75.14 110.132 177.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 241' ' ' PRO . . . . . 0.509 ' HA ' ' HG2' ' C' ' 246' ' ' ARG . 31.4 Cg_exo -61.98 105.21 0.37 Allowed 'Trans proline' 0 C--N 1.37 1.688 0 C-N-CA 123.405 2.736 . . . . 71.53 112.916 173.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -75.67 173.16 53.58 Favored Glycine 0 CA--C 1.531 1.081 0 CA-C-N 115.195 -0.911 . . . . 70.14 112.798 174.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -64.86 -17.17 58.69 Favored 'Trans proline' 0 C--N 1.367 1.545 0 C-N-CA 123.184 2.589 . . . . 71.42 113.955 -170.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -130.84 1.07 4.34 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.631 0.773 . . . . 71.42 111.907 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . -173.19 -136.66 2.22 Favored Glycine 0 C--N 1.35 1.349 0 CA-C-O 119.648 -0.529 . . . . 63.24 113.09 -178.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 246' ' ' ARG . . . . . 0.509 ' HG2' ' HA ' ' C' ' 241' ' ' PRO . 77.8 mtm180 -150.04 165.06 33.89 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.826 0.851 . . . . 71.32 110.891 -176.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -102.35 -166.66 26.63 Favored Glycine 0 C--N 1.35 1.322 0 CA-C-N 114.801 -1.091 . . . . 63.23 111.951 174.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -129.44 164.12 24.36 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 121.114 0.483 . . . . 73.54 110.359 -171.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 249' ' ' LEU . . . . . . . . . . . . . 17.7 tp -120.18 127.62 52.63 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.167 0.987 . . . . 74.23 109.401 -174.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 250' ' ' TYR . . . . . 0.467 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 79.0 m-85 -117.24 100.78 7.93 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.704 0.802 . . . . 71.43 110.323 -177.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 251' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' C' ' 232' ' ' LYS . 0.6 OUTLIER -100.97 134.29 44.19 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 109.932 -0.395 . . . . 72.0 109.932 -176.133 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -76.68 107.73 9.19 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.145 -1.057 . . . . 75.41 108.145 168.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 253' ' ' VAL . . . . . . . . . . . . . 46.2 t -75.07 113.78 14.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 115.199 -0.91 . . . . 73.5 110.2 -176.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 254' ' ' ARG . . . . . . . . . . . . . 39.1 mtm180 -97.13 155.46 16.81 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.297 0.639 . . . . 75.13 110.882 177.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 255' ' ' ILE . . . . . . . . . . . . . 36.9 mm -101.56 124.88 55.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 114.764 -1.107 . . . . 75.24 108.052 166.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 256' ' ' THR . . . . . 0.405 ' HA ' HD12 ' A' ' 255' ' ' ILE . 0.2 OUTLIER -130.07 175.97 8.46 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.138 1.375 . . . . 70.25 108.536 -178.775 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 35.4 pt -131.16 147.88 67.99 Favored Pre-proline 0 N--CA 1.484 1.243 0 C-N-CA 123.491 0.716 . . . . 75.21 110.047 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -62.56 -12.89 30.3 Favored 'Trans proline' 0 C--N 1.377 2.07 0 C-N-CA 122.862 2.375 . . . . 74.41 113.858 -172.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 54.24 -67.58 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 125.481 1.512 . . . . 72.3 112.194 -164.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 8.0 ppt_? -60.07 132.7 54.76 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.264 0.626 . . . . 73.41 110.433 174.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 261' ' ' LEU . . . . . . . . . . . . . 92.4 mt -139.9 147.86 41.2 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.728 0.811 . . . . 74.53 109.978 -174.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 74.4 p -81.89 160.45 63.56 Favored Pre-proline 0 CA--C 1.553 1.084 0 N-CA-C 107.97 -1.122 . . . . 61.23 107.97 168.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -45.84 -44.08 18.67 Favored 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 122.782 2.322 . . . . 74.2 112.538 172.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -60.97 -54.18 48.14 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-N 114.18 -1.373 . . . . 71.04 111.514 176.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -50.02 -58.45 5.46 Favored 'General case' 0 C--N 1.359 0.994 0 O-C-N 124.284 0.99 . . . . 71.03 109.992 -177.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 266' ' ' GLU . . . . . 0.461 ' O ' ' HG2' ' C' ' 270' ' ' LYS . 26.8 tt0 -61.34 -38.21 86.09 Favored 'General case' 0 C--N 1.349 0.574 0 CA-C-N 114.719 -1.128 . . . . 73.1 111.336 -175.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -57.28 -46.43 83.11 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.201 0.6 . . . . 71.12 112.351 177.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 268' ' ' LEU . . . . . 0.47 ' HB2' HD21 ' A' ' 272' ' ' LEU . 10.4 mp -66.15 -39.97 90.21 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 116.407 -0.36 . . . . 70.11 110.89 177.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -60.44 -36.0 77.17 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 123.266 0.354 . . . . 63.11 111.277 174.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 270' ' ' LYS . . . . . 0.461 ' HG2' ' O ' ' C' ' 266' ' ' GLU . 34.2 mmtp -64.08 -45.94 86.49 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.397 0.679 . . . . 75.43 110.439 178.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -56.29 -47.42 78.69 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 124.036 0.835 . . . . 75.33 111.577 176.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 91.3 mt -61.42 -42.09 98.19 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 114.834 -1.075 . . . . 74.33 110.803 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -61.47 -40.4 94.39 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.373 0.669 . . . . 43.22 111.046 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -68.16 -34.06 75.62 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.715 0.806 . . . . 63.21 111.634 177.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -62.67 -31.43 72.32 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 115.838 -0.619 . . . . 70.04 110.331 172.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 276' ' ' TYR . . . . . 0.476 ' HB3' HD12 ' A' ' 203' ' ' ILE . 53.6 m-85 -79.82 -30.99 40.61 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.084 0.554 . . . . 75.52 112.437 171.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 19.0 m-30 -68.11 -24.23 65.0 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 118.517 0.599 . . . . 65.52 110.205 178.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -61.32 -8.3 3.74 Favored 'General case' 0 CA--C 1.559 1.326 0 C-N-CA 124.193 0.997 . . . . 72.22 113.425 172.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 279' ' ' ARG . . . . . . . . . . . . . 81.3 mtt180 -73.59 -24.07 60.01 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 122.739 0.416 . . . . 75.11 112.005 174.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 280' ' ' ALA . . . . . 0.572 ' HB2' HD21 ' B' ' 426' ' ' ASN . . . . . . . . 0 CA--C 1.556 1.186 0 O-C-N 124.417 1.073 . . . . 75.14 112.781 -167.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.424 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.5 OUTLIER . . . . . 0 N--CA 1.48 1.065 0 CA-C-O 121.17 0.509 . . . . 64.12 109.806 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.43 27.04 16.07 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 125.212 1.405 . . . . 74.44 113.208 176.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.24 71.26 9.29 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.508 0.723 . . . . 74.04 110.635 -176.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -40.43 100.99 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 125.716 1.606 . . . . 64.14 113.789 176.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.409 ' HB3' HD13 ' A' ' 10' ' ' ILE . 51.3 mtmt -87.96 128.18 35.38 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 108.565 -0.902 . . . . 74.32 108.565 169.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.504 ' HA ' ' OH ' ' A' ' 66' ' ' TYR . 10.7 t70 -76.48 105.81 7.75 Favored 'General case' 0 C--N 1.347 0.491 0 N-CA-C 109.187 -0.672 . . . . 62.43 109.187 -177.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -68.44 -33.31 73.98 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.692 0.797 . . . . 73.34 112.531 -170.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -64.12 -45.62 87.77 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 109.634 -0.506 . . . . 73.33 109.634 174.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.48 -42.1 95.59 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.632 -0.713 . . . . 70.01 111.375 178.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.409 HD13 ' HB3' ' A' ' 5' ' ' LYS . 81.4 mt -58.79 -42.22 84.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 123.676 0.79 . . . . 74.23 110.231 176.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.2 mt -76.14 -11.81 60.0 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 112.912 0.708 . . . . 73.11 112.912 178.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.56 35.09 56.12 Favored Glycine 0 C--N 1.351 1.385 0 O-C-N 122.972 0.17 . . . . 73.42 112.709 -178.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.5 m -127.1 154.5 76.67 Favored Pre-proline 0 CA--C 1.552 1.028 0 C-N-CA 124.916 1.286 . . . . 72.52 109.608 178.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -74.57 168.56 24.52 Favored 'Trans proline' 0 C--N 1.374 1.914 0 C-N-CA 122.282 1.988 . . . . 50.12 112.25 177.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 83.7 mtt180 -75.12 17.36 0.24 Allowed 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 113.142 0.793 . . . . 75.43 113.142 -178.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -124.78 15.42 8.67 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.101 0.96 . . . . 71.2 108.974 173.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.11 112.08 2.84 Favored 'General case' 0 C--N 1.349 0.566 0 CA-C-N 115.069 -0.969 . . . . 74.14 110.437 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 62.1 p -72.31 169.76 15.57 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.59 0.756 . . . . 75.03 109.708 176.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -54.03 -41.06 67.62 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.954 0.902 . . . . 71.11 112.07 -177.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -65.69 -41.28 92.6 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.187 0.595 . . . . 72.43 110.598 -177.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -69.29 -40.81 77.51 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.36 0.664 . . . . 71.14 111.014 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.507 HD11 ' HB3' ' A' ' 57' ' ' LEU . 60.9 mt -68.68 -32.86 56.74 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 C-N-CA 124.271 1.028 . . . . 73.31 110.721 178.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp -73.49 -37.88 65.57 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.177 0.991 . . . . 75.22 110.341 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -75.72 -29.25 58.86 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.044 0.538 . . . . 73.12 110.909 175.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.87 -33.85 71.01 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.351 0.66 . . . . 72.43 110.073 174.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -64.96 -53.05 52.36 Favored 'General case' 0 C--O 1.201 -1.466 0 CA-C-N 114.916 -1.038 . . . . 73.1 109.369 173.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -54.08 -40.14 66.96 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.643 0.777 . . . . 74.22 111.703 178.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.406 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 61.0 ttt180 -55.08 -68.19 0.21 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.174 1.39 . . . . 75.52 110.79 177.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.712 ' HB3' HD12 ' A' ' 50' ' ' ILE . 96.2 mt -74.43 -16.71 60.86 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.411 -0.813 . . . . 75.12 111.745 -174.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.21 -56.71 8.75 Favored 'General case' 0 C--O 1.204 -1.306 0 N-CA-C 108.177 -1.046 . . . . 71.54 108.177 174.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 69.2 mtp180 -55.22 -51.88 65.17 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 124.127 0.892 . . . . 72.33 110.768 177.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.406 ' HG2' ' O ' ' A' ' 28' ' ' ARG . 14.5 mm100 -54.28 -47.13 72.68 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 124.303 1.002 . . . . 73.31 111.728 -178.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.41 ' HE2' HD23 ' A' ' 29' ' ' LEU . 27.7 m-85 -117.82 29.54 7.77 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.36 0.664 . . . . 72.41 111.775 -168.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -75.84 111.79 16.56 Favored Pre-proline 0 N--CA 1.485 1.281 0 CA-C-O 117.795 -1.098 . . . . 73.54 109.705 -179.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.4 -26.86 83.71 Favored 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 122.516 2.144 . . . . 75.51 111.759 176.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -59.81 -37.39 79.04 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.126 1.37 . . . . 73.23 111.572 175.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 73.5 t -101.97 -58.66 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 CA-C-O 121.478 0.656 . . . . 73.25 109.74 -178.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -97.0 98.96 10.51 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.122 1.369 . . . . 64.12 109.739 -177.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -74.36 82.76 1.91 Allowed 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.953 -0.758 . . . . 73.11 108.953 177.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 53.7 m -139.64 113.52 7.87 Favored Pre-proline 0 N--CA 1.474 0.753 0 CA-C-O 118.492 -0.765 . . . . 71.24 109.281 177.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -48.19 -40.95 34.97 Favored 'Trans proline' 0 C--N 1.385 2.48 0 C-N-CA 123.606 2.87 . . . . 73.53 113.437 178.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -55.15 -47.03 75.68 Favored 'General case' 0 C--O 1.248 0.999 0 C-N-CA 124.578 1.151 . . . . 64.43 110.696 175.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.64 -23.04 63.43 Favored 'General case' 0 C--N 1.354 0.787 0 CA-C-N 115.077 -0.965 . . . . 73.42 110.782 -178.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.521 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 33.5 mt-10 -76.31 -49.11 17.8 Favored 'General case' 0 C--N 1.358 0.957 0 O-C-N 123.511 0.507 . . . . 63.35 109.781 -176.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -67.95 -39.68 83.38 Favored 'General case' 0 C--O 1.251 1.166 0 O-C-N 123.801 0.688 . . . . 62.44 110.927 -179.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 42.8 mttp -56.94 -48.95 77.1 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 116.168 -0.469 . . . . 74.03 110.177 170.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -59.71 -32.91 70.97 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.101 0.96 . . . . 73.32 110.84 179.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.521 ' HG2' ' O ' ' A' ' 44' ' ' GLU . 33.5 mmtp -66.66 -43.41 84.63 Favored 'General case' 0 C--N 1.349 0.548 0 CA-C-O 119.245 -0.407 . . . . 75.14 110.662 177.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -68.17 -26.56 65.81 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 123.706 0.629 . . . . 71.44 112.278 176.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.712 HD12 ' HB3' ' A' ' 29' ' ' LEU . 59.5 mt -76.76 -35.2 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 124.106 0.962 . . . . 74.43 110.242 175.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -79.3 -21.61 45.73 Favored 'General case' 0 C--O 1.212 -0.891 0 C-N-CA 123.889 0.875 . . . . 73.43 110.621 175.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -77.27 -45.64 25.71 Favored 'General case' 0 C--O 1.247 0.924 0 C-N-CA 124.977 1.311 . . . . 75.34 108.726 176.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.78 -47.45 82.51 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-N 113.672 -1.604 . . . . 65.45 110.184 174.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.487 ' HD2' ' HZ ' ' A' ' 88' ' ' PHE . 16.6 t80 -76.48 -23.27 53.8 Favored 'General case' 0 C--O 1.207 -1.166 0 CA-C-N 115.435 -0.802 . . . . 73.53 110.713 177.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.412 ' HB1' ' HD2' ' A' ' 85' ' ' PHE . . . -60.97 -36.16 78.69 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 118.833 0.742 . . . . 72.52 110.875 175.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.541 HG13 ' HB2' ' A' ' 66' ' ' TYR . 19.2 t -76.04 -57.66 5.79 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 CA-C-N 115.363 -0.835 . . . . 74.52 110.099 171.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.507 ' HB3' HD11 ' A' ' 22' ' ' ILE . 49.2 mt -87.31 12.0 12.99 Favored 'General case' 0 CA--C 1.561 1.397 0 CA-C-N 115.003 -0.999 . . . . 74.35 112.964 -164.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.438 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 26.0 t -69.06 -38.61 79.17 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 123.933 0.893 . . . . 74.34 111.228 176.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.486 ' HB2' ' HD3' ' A' ' 62' ' ' LYS . 8.8 m-20 -124.6 142.07 39.57 Favored Pre-proline 0 N--CA 1.475 0.813 0 N-CA-C 108.96 -0.755 . . . . 74.34 108.96 -177.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.412 ' O ' ' HG2' ' A' ' 64' ' ' ARG . 40.0 Cg_exo -58.04 -27.45 79.57 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 122.972 2.448 . . . . 72.41 113.115 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -59.43 -58.72 7.39 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.012 0.925 . . . . 72.3 110.817 176.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.486 ' HD3' ' HB2' ' A' ' 59' ' ' ASP . 20.8 mtpt -73.07 -29.56 63.04 Favored 'General case' 0 C--O 1.249 1.078 0 CA-C-N 114.53 -1.214 . . . . 74.54 111.029 -175.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.416 ' HG3' HD22 ' A' ' 57' ' ' LEU . 61.6 ttt-85 -60.05 -43.92 95.05 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.204 -0.907 . . . . 74.11 109.462 172.215 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.412 ' HG2' ' O ' ' A' ' 60' ' ' PRO . 22.8 mmt180 -68.93 -31.34 70.17 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 123.736 0.648 . . . . 74.25 112.029 177.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.444 HD11 ' HA ' ' A' ' 62' ' ' LYS . 87.3 mt -54.38 -46.5 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 CA-C-O 121.255 0.55 . . . . 74.41 109.653 169.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.541 ' HB2' HG13 ' A' ' 56' ' ' VAL . 7.7 t80 -63.82 -49.99 70.7 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 115.532 -0.758 . . . . 75.4 111.377 175.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -57.68 -36.07 71.43 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.997 0.919 . . . . 64.04 111.323 -176.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 60.8 p -79.31 -28.08 42.18 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 119.054 -0.498 . . . . 75.44 110.922 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -67.88 102.78 1.32 Allowed 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 109.455 -0.572 . . . . 75.32 109.455 176.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 119.68 17.63 4.64 Favored Glycine 0 N--CA 1.473 1.124 0 C-N-CA 124.053 0.835 . . . . 64.23 111.346 -170.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 67.8 m -150.61 -55.75 0.16 Allowed 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 104.208 -2.516 . . . . 71.23 104.208 177.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 34.0 m -78.98 138.45 38.06 Favored 'General case' 0 C--O 1.251 1.146 0 N-CA-C 104.466 -2.42 . . . . 74.23 104.466 156.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.75 -31.58 12.17 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.015 0.526 . . . . 74.04 110.122 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.72 152.15 87.04 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 123.923 0.889 . . . . 75.1 110.314 175.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -62.32 116.58 3.59 Favored 'Trans proline' 0 C--N 1.375 1.934 0 C-N-CA 122.262 1.975 . . . . 75.41 109.952 168.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -51.02 144.99 26.33 Favored 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 123.653 2.902 . . . . 74.25 114.07 -177.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -50.54 124.46 13.36 Favored 'Trans proline' 0 C--N 1.389 2.705 0 C-N-CA 123.828 3.019 . . . . 73.45 113.279 -174.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -63.87 135.33 47.59 Favored 'Trans proline' 0 C--N 1.379 2.152 0 C-N-CA 122.627 2.218 . . . . 73.2 112.227 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -51.16 149.91 15.07 Favored 'Trans proline' 0 C--N 1.378 2.091 0 C-N-CA 122.932 2.422 . . . . 71.05 112.281 168.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -61.3 85.23 0.09 OUTLIER 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 123.183 2.589 . . . . 74.31 113.266 -175.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 150.03 -34.29 1.02 Allowed Glycine 0 N--CA 1.466 0.674 0 N-CA-C 109.963 -1.255 . . . . 62.41 109.963 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 140.76 -152.73 23.27 Favored Glycine 0 C--N 1.35 1.32 0 C-N-CA 124.151 0.882 . . . . 53.03 110.955 175.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -99.01 113.22 25.29 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.152 0.981 . . . . 74.41 108.897 175.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -55.1 141.76 33.32 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.638 1.175 . . . . 71.31 111.47 174.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.429 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 55.8 m-85 -140.58 77.99 1.63 Allowed 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 124.429 1.092 . . . . 73.24 110.215 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.56 ' HA ' ' HA3' ' A' ' 163' ' ' GLY . 1.7 m -45.62 82.86 0.0 OUTLIER 'General case' 0 CA--C 1.561 1.392 0 C-N-CA 125.892 1.677 . . . . 74.44 113.225 -177.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 62.4 28.48 71.15 Favored Glycine 0 C--N 1.349 1.282 0 CA-C-N 116.044 -0.525 . . . . 70.11 114.306 -176.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.487 ' HZ ' ' HD2' ' A' ' 54' ' ' TYR . 30.1 m-85 -112.23 117.66 33.16 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.034 0.534 . . . . 72.34 110.031 -176.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.512 ' HA ' ' HB3' ' A' ' 170' ' ' PRO . 5.7 m-20 -82.89 74.75 9.83 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 122.405 1.097 . . . . 71.44 110.225 178.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.429 HG21 HD22 ' A' ' 105' ' ' LEU . 1.6 p -50.13 -30.0 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 126.613 1.965 . . . . 75.21 113.11 171.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -63.59 -4.99 3.33 Favored 'General case' 0 CA--C 1.566 1.595 0 C-N-CA 124.651 1.18 . . . . 75.33 111.989 177.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -119.03 -15.49 9.27 Favored 'General case' 0 CA--C 1.562 1.433 0 C-N-CA 124.652 1.181 . . . . 61.35 111.559 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.403 ' CD2' ' HA ' ' A' ' 90' ' ' VAL . 18.7 m-30 -74.94 -170.06 1.03 Allowed 'General case' 0 N--CA 1.503 2.212 0 C-N-CA 123.75 0.82 . . . . 73.34 112.625 -173.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 82.5 p -77.76 167.3 21.77 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 113.693 0.997 . . . . 74.5 113.693 -169.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.02 -49.02 77.72 Favored 'General case' 0 C--N 1.365 1.276 0 CA-C-N 115.455 -0.793 . . . . 74.52 111.665 179.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -56.35 -40.87 75.2 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.592 0.757 . . . . 75.03 110.258 -177.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -65.27 -45.88 82.74 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 114.606 -1.179 . . . . 72.32 110.228 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.502 ' HA ' HD12 ' A' ' 105' ' ' LEU . 41.1 mt-30 -80.82 1.73 29.35 Favored 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 114.994 -1.003 . . . . 74.14 111.868 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -99.64 -51.09 3.85 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 124.074 0.95 . . . . 70.02 111.748 170.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 43.0 tp -66.61 -46.92 74.31 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.548 0.739 . . . . 74.33 110.382 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -90.76 -5.05 56.19 Favored 'General case' 0 CA--C 1.55 0.981 0 CA-C-N 115.766 -0.652 . . . . 72.11 110.694 176.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -44.99 -59.39 4.47 Favored Glycine 0 CA--C 1.541 1.681 0 CA-C-O 118.651 -1.083 . . . . 72.43 114.975 178.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -59.6 -1.72 1.18 Allowed 'Trans proline' 0 C--N 1.387 2.564 0 C-N-CA 123.711 2.941 . . . . 64.43 115.126 -177.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -149.49 36.32 1.01 Allowed Glycine 0 C--N 1.354 1.574 0 CA-C-N 118.549 0.613 . . . . 54.4 112.82 173.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.502 HD12 ' HA ' ' A' ' 98' ' ' GLN . 18.3 mt -71.94 62.51 0.45 Allowed 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 117.705 0.753 . . . . 74.25 112.348 172.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 35.47 -112.07 0.07 Allowed 'General case' 0 CA--C 1.561 1.378 0 C-N-CA 126.403 1.881 . . . . 74.45 114.214 173.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 56.86 18.88 27.24 Favored Glycine 0 C--N 1.369 2.397 0 N-CA-C 111.77 -0.532 . . . . 44.0 111.77 -163.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 55.58 -114.13 4.51 Favored Glycine 0 C--N 1.361 1.972 0 O-C-N 124.604 0.826 . . . . 71.34 111.96 -166.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -125.16 16.76 8.43 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.128 0.971 . . . . 74.55 109.554 173.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -91.04 -22.23 33.42 Favored Glycine 0 C--N 1.343 0.926 0 CA-C-N 115.783 -0.644 . . . . 55.25 111.821 172.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.34 9.3 1.38 Allowed 'General case' 0 CA--C 1.565 1.539 0 C-N-CA 125.143 1.377 . . . . 75.52 113.326 174.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 42.7 tpt85 -57.24 -35.29 69.52 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.641 0.377 . . . . 75.13 110.068 164.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 59.4 m 59.99 63.87 1.37 Allowed 'General case' 0 CA--C 1.546 0.806 0 O-C-N 124.295 0.997 . . . . 74.21 110.375 -176.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -125.19 164.68 19.75 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 115.134 -0.939 . . . . 74.52 109.956 177.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.586 ' HA ' ' HD2' ' A' ' 170' ' ' PRO . 37.4 tttp -54.11 128.86 32.53 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 125.26 1.424 . . . . 73.31 112.637 -175.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -80.47 165.75 48.64 Favored Glycine 0 C--N 1.348 1.239 0 O-C-N 124.108 0.88 . . . . 73.4 115.094 -168.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.648 ' HA ' ' HA ' ' B' ' 401' ' ' PRO . 24.3 ttt180 -59.99 143.93 50.54 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.819 1.248 . . . . 74.43 111.495 176.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.613 ' HB3' ' HE3' ' B' ' 404' ' ' LYS . 3.1 p-10 -78.68 126.92 31.38 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 108.733 -0.84 . . . . 74.23 108.733 166.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 53.9 tp -119.25 132.56 55.94 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 109.386 -0.598 . . . . 75.42 109.386 -176.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 67.9 ttp85 -90.8 110.97 22.17 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 108.36 -0.978 . . . . 74.51 108.36 171.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -114.72 150.97 34.47 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.637 0.775 . . . . 54.41 109.131 178.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -106.95 118.63 37.21 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 107.134 -1.432 . . . . 72.42 107.134 -170.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 13.2 tp -99.79 100.14 10.48 Favored Pre-proline 0 N--CA 1.472 0.67 0 N-CA-C 108.892 -0.781 . . . . 74.14 108.892 -176.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.612 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 50.8 Cg_endo -71.75 111.05 3.05 Favored 'Trans proline' 0 C--N 1.374 1.891 0 N-CA-C 108.544 -1.368 . . . . 75.33 108.544 172.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.476 ' HB3' HD22 ' A' ' 180' ' ' LEU . 60.6 tp -115.78 140.22 49.43 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.438 0.637 . . . . 72.43 110.263 -171.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 93.3 m -74.87 134.4 41.66 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 114.068 -1.423 . . . . 71.34 111.078 179.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.402 HD11 ' HB2' ' A' ' 186' ' ' PHE . 91.0 mt -57.96 -38.36 75.87 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.939 0.895 . . . . 75.21 111.134 -177.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -56.2 -42.6 77.44 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 114.492 -1.231 . . . . 75.32 110.045 176.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -73.26 -34.61 65.91 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.583 0.753 . . . . 64.33 111.412 178.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -67.23 -25.94 66.35 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 121.128 0.49 . . . . 65.44 110.326 178.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -78.49 -42.75 28.78 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 114.657 -1.156 . . . . 74.51 110.538 173.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 36.6 m170 -68.32 -66.69 0.54 Allowed 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.14 0.576 . . . . 75.25 111.055 -177.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.584 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 81.97 56.48 2.89 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-N 116.068 -0.515 . . . . 71.54 112.789 177.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -126.42 -170.11 12.89 Favored Glycine 0 N--CA 1.471 1.017 0 N-CA-C 111.584 -0.606 . . . . 70.42 111.584 178.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 30.1 mp0 -71.37 104.71 3.27 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.447 0.699 . . . . 73.14 109.69 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.707 HH22 HD12 ' A' ' 159' ' ' ILE . 0.0 OUTLIER -90.93 147.08 23.37 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.298 -1.001 . . . . 75.05 108.298 174.843 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 62.3 t -102.68 132.44 48.78 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 N-CA-C 107.923 -1.139 . . . . 75.04 107.923 171.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.459 HG13 HG11 ' A' ' 145' ' ' VAL . 2.2 p -139.08 113.0 6.98 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 124.362 1.065 . . . . 73.34 108.389 -177.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -95.97 142.6 28.0 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 115.599 -0.728 . . . . 71.3 109.76 -176.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.2 p -168.97 138.59 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 123.617 0.767 . . . . 75.1 109.939 173.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 57.2 32.07 21.11 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 124.404 1.082 . . . . 74.24 112.548 175.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 78.41 0.37 78.27 Favored Glycine 0 C--N 1.35 1.349 0 CA-C-N 116.538 -0.301 . . . . 54.15 113.333 -178.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.92 104.39 14.36 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 124.266 1.026 . . . . 72.43 108.233 178.153 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 27.9 ttp-105 -92.67 104.4 16.68 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 125.135 1.374 . . . . 74.41 108.775 175.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.459 HG11 HG13 ' A' ' 138' ' ' VAL . 3.4 p -107.23 131.69 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 CA-C-O 120.935 0.398 . . . . 73.53 112.045 -175.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 37.6 t -100.4 110.55 22.76 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 108.249 -1.019 . . . . 64.43 108.249 170.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -136.37 140.53 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.8 1.24 . . . . 73.42 108.593 -178.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.497 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 52.7 ttt85 -83.41 144.55 29.54 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.354 0.662 . . . . 74.32 110.9 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.584 HG13 ' HA2' ' A' ' 133' ' ' GLY . 6.3 pt -106.56 145.62 31.41 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 124.609 1.164 . . . . 74.52 108.359 167.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -70.95 143.12 44.27 Favored 'Trans proline' 0 C--N 1.369 1.647 0 C-N-CA 122.272 1.981 . . . . 74.22 111.428 170.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.4 97.5 0.12 Allowed 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 122.606 2.204 . . . . 74.15 110.485 170.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 106.03 66.21 0.66 Allowed Glycine 0 C--N 1.339 0.74 0 CA-C-N 115.675 -0.693 . . . . 75.51 111.837 -168.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.414 HG23 HG11 ' A' ' 178' ' ' VAL . 2.1 p -111.89 110.91 33.94 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 N-CA-C 107.999 -1.112 . . . . 75.43 107.999 175.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.514 ' HG3' ' HG ' ' A' ' 188' ' ' LEU . 0.0 OUTLIER -93.87 159.5 15.16 Favored 'General case' 0 C--O 1.205 -1.278 0 C-N-CA 124.09 0.956 . . . . 73.23 110.704 -165.633 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -50.89 119.01 3.52 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.934 1.294 . . . . 72.32 110.357 175.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 93.46 1.19 66.56 Favored Glycine 0 CA--C 1.534 1.252 0 CA-C-O 119.296 -0.725 . . . . 74.33 113.875 -179.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 12.7 t -72.19 126.53 30.02 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 108.458 -0.941 . . . . 74.23 108.458 178.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.545 HG22 ' HG1' ' B' ' 389' ' ' THR . 48.4 t -102.38 105.46 18.14 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 C-N-CA 123.552 0.741 . . . . 74.02 110.416 -172.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.707 HD12 HH22 ' A' ' 136' ' ' ARG . 57.2 mt -76.3 102.23 3.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 107.777 -1.194 . . . . 75.24 107.777 166.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 58.1 ttt180 -74.42 101.06 3.99 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 107.798 -1.186 . . . . 75.21 107.798 172.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 6.2 p -124.41 95.57 42.98 Favored Pre-proline 0 CA--C 1.547 0.856 0 N-CA-C 109.448 -0.575 . . . . 71.41 109.448 177.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.556 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 28.9 Cg_endo -63.91 152.55 80.27 Favored 'Trans proline' 0 C--N 1.369 1.616 0 C-N-CA 121.963 1.776 . . . . 74.53 111.667 172.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . 0.56 ' HA3' ' HA ' ' A' ' 86' ' ' SER . . . 105.12 -25.9 23.73 Favored Glycine 0 C--N 1.335 0.514 0 CA-C-N 116.043 -0.526 . . . . 70.43 113.628 176.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -103.61 0.05 30.28 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 117.331 0.566 . . . . 64.15 110.949 178.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.58 ' HA2' HD11 ' A' ' 174' ' ' LEU . . . -82.71 -129.65 1.36 Allowed Glycine 0 C--N 1.35 1.315 0 O-C-N 123.286 0.366 . . . . 73.33 113.904 -174.077 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -73.95 158.27 52.0 Favored Glycine 0 C--N 1.338 0.683 0 CA-C-N 115.507 -0.346 . . . . 74.5 113.089 -176.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -71.7 111.53 7.06 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.955 1.302 . . . . 75.42 112.09 -169.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -174.7 159.56 28.34 Favored Glycine 0 C--O 1.221 -0.661 0 CA-C-O 118.327 -1.263 . . . . 64.21 110.723 176.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . 0.579 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . 55.3 t30 -55.35 -56.64 26.69 Favored Pre-proline 0 N--CA 1.496 1.872 0 CA-C-N 118.262 1.031 . . . . 63.54 111.36 -169.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.586 ' HD2' ' HA ' ' A' ' 115' ' ' LYS . 3.3 Cg_endo -88.55 94.4 0.38 Allowed 'Trans proline' 0 C--N 1.386 2.545 0 N-CA-C 107.403 -1.807 . . . . 73.02 107.403 157.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -65.45 154.5 73.39 Favored 'Trans proline' 0 C--N 1.378 2.086 0 C-N-CA 122.111 1.874 . . . . 71.25 111.805 -167.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.439 ' HA3' ' O ' ' A' ' 117' ' ' ARG . . . -74.28 -179.55 41.08 Favored Glycine 0 C--O 1.241 0.559 0 N-CA-C 115.372 0.909 . . . . 72.4 115.372 -164.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.556 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 7.0 m-20 -74.59 108.58 7.44 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.105 0.962 . . . . 71.14 110.425 -173.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.58 HD11 ' HA2' ' A' ' 165' ' ' GLY . 21.9 tp -82.9 99.84 10.01 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 108.759 -0.83 . . . . 74.2 108.759 176.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 77.0 mt -74.77 89.15 2.28 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.206 -0.906 . . . . 72.12 109.188 174.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.464 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 65.9 mt -75.46 90.17 2.7 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.474 -0.784 . . . . 74.52 110.025 177.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.524 HG23 HG21 ' A' ' 158' ' ' VAL . 46.3 t -84.33 103.71 11.83 Favored 'Isoleucine or valine' 0 C--O 1.244 0.809 0 N-CA-C 107.234 -1.395 . . . . 71.11 107.234 175.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.414 HG11 HG23 ' A' ' 153' ' ' VAL . 11.6 p -70.27 118.63 15.06 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 CA-C-N 115.136 -0.938 . . . . 74.13 111.396 -173.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.612 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 35.4 mmt180 -98.94 104.52 16.57 Favored 'General case' 0 C--O 1.216 -0.706 0 N-CA-C 108.263 -1.014 . . . . 73.42 108.263 170.109 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.476 HD22 ' HB3' ' A' ' 125' ' ' LEU . 77.1 mt -69.23 142.48 54.19 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 118.7 0.682 . . . . 74.04 109.534 178.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 82.9 mt -54.17 161.56 1.86 Allowed Pre-proline 0 N--CA 1.486 1.348 0 C-N-CA 124.19 0.996 . . . . 73.22 112.939 -170.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -76.34 30.72 0.4 Allowed 'Trans proline' 0 C--N 1.383 2.382 0 C-N-CA 122.791 2.327 . . . . 74.32 111.982 164.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -64.59 115.49 20.73 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 125.976 1.71 . . . . 73.35 107.283 175.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -76.5 24.73 0.45 Allowed 'Trans proline' 0 N--CA 1.497 1.709 0 C-N-CA 123.474 2.783 . . . . 61.24 115.832 -161.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.408 HG11 ' CD1' ' A' ' 186' ' ' PHE . 51.0 t -106.99 -61.01 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 122.841 0.457 . . . . 72.34 110.446 -176.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . 0.549 ' HE2' HD13 ' A' ' 193' ' ' LEU . 2.9 m-30 -131.42 165.78 22.75 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.939 0.895 . . . . 72.31 110.792 -172.051 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 22.8 ttp85 -150.4 87.73 1.46 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 114.362 -1.29 . . . . 75.51 108.338 169.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.514 ' HG ' ' HG3' ' A' ' 154' ' ' ARG . 51.5 tp -62.23 104.81 0.52 Allowed 'General case' 0 C--O 1.207 -1.157 0 CA-C-N 115.141 -0.936 . . . . 74.21 108.776 174.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -136.44 132.93 36.08 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.068 1.347 . . . . 70.31 109.02 -171.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 82.72 -84.81 1.52 Allowed Glycine 0 C--N 1.35 1.32 0 N-CA-C 110.757 -0.937 . . . . 65.41 110.757 -177.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.598 ' HG2' ' HD2' ' A' ' 243' ' ' PRO . 0.9 OUTLIER -153.89 3.73 0.27 Allowed 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 125.158 1.383 . . . . 72.32 109.962 165.917 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -118.74 175.29 5.81 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.246 1.419 . . . . 72.32 109.809 -169.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.549 HD13 ' HE2' ' A' ' 186' ' ' PHE . 41.3 mt -114.75 126.16 54.53 Favored 'General case' 0 C--O 1.215 -0.762 0 C-N-CA 123.276 0.63 . . . . 74.25 110.544 -171.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -105.21 102.23 11.73 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.469 0.707 . . . . 73.14 109.437 174.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.549 ' HB1' HD21 ' A' ' 251' ' ' LEU . . . -108.28 156.46 19.35 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.946 -0.761 . . . . 74.34 108.946 172.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 57.0 m -93.6 123.57 37.01 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 109.036 -0.727 . . . . 70.21 109.036 178.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.503 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 32.5 tp -113.09 94.62 4.98 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 108.662 -0.866 . . . . 74.1 108.662 178.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -79.5 122.09 26.02 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 107.026 -1.472 . . . . 63.3 107.026 169.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.532 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 9.2 p -133.48 137.47 29.06 Favored Pre-proline 0 CA--C 1.545 0.765 0 N-CA-C 108.156 -1.053 . . . . 74.33 108.156 -177.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.75 159.51 48.34 Favored 'Trans proline' 0 C--N 1.36 1.183 0 C-N-CA 121.796 1.664 . . . . 70.05 111.5 173.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.401 ' HB1' ' HD3' ' A' ' 202' ' ' PRO . . . -56.32 -52.94 69.08 Favored Pre-proline 0 CA--C 1.555 1.146 0 CA-C-O 117.715 -1.136 . . . . 71.34 113.242 -172.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.401 ' HD3' ' HB1' ' A' ' 201' ' ' ALA . 51.8 Cg_exo -59.3 -40.97 63.34 Favored 'Trans proline' 0 C--N 1.391 2.804 0 C-N-CA 122.03 1.82 . . . . 73.32 113.417 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.536 HD13 ' HB3' ' C' ' 276' ' ' TYR . 36.0 mt -71.93 -31.42 40.65 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.962 0 C-N-CA 122.782 0.433 . . . . 71.02 110.368 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.71 -40.73 84.26 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-O 121.155 0.502 . . . . 74.14 110.606 174.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.474 HG13 HD11 ' C' ' 261' ' ' LEU . 48.4 t -71.21 -46.92 63.45 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 C-N-CA 124.189 0.995 . . . . 64.22 112.167 -176.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.469 HG23 ' HA ' ' C' ' 270' ' ' LYS . 94.6 t -98.92 -26.38 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 123.698 0.799 . . . . 74.41 111.574 -170.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 99.03 160.29 29.46 Favored Glycine 0 C--O 1.241 0.554 0 N-CA-C 110.941 -0.864 . . . . 72.35 110.941 -170.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.462 ' O ' HG13 ' A' ' 223' ' ' VAL . . . 162.18 168.37 23.99 Favored Glycine 0 N--CA 1.467 0.73 0 N-CA-C 111.84 -0.504 . . . . 73.32 111.84 177.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -99.62 117.65 34.46 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 117.068 0.434 . . . . 73.34 110.519 -175.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 35.9 m -121.71 162.46 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 124.136 0.974 . . . . 63.11 109.055 177.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -70.39 115.29 9.41 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 120.635 0.255 . . . . 74.32 110.96 -177.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -103.12 112.54 25.44 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 108.176 -1.046 . . . . 74.41 108.176 168.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -76.48 116.57 17.29 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 107.382 -1.34 . . . . 74.15 107.382 173.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' THR . . . . . 0.404 ' HA ' ' CE1' ' A' ' 186' ' ' PHE . 72.8 p -118.79 167.92 11.24 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.804 0.442 . . . . 74.1 110.354 178.172 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 72.1 mt -66.2 -20.77 66.23 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.278 0.631 . . . . 73.14 111.595 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -91.29 -18.31 24.55 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 123.555 0.742 . . . . 64.44 111.562 177.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 147.34 170.63 15.73 Favored Glycine 0 C--N 1.36 1.909 0 CA-C-O 119.97 -0.35 . . . . 63.05 113.594 174.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.79 103.98 1.67 Allowed 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 122.482 2.122 . . . . 74.13 111.404 176.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 33.6 m -106.9 179.83 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 124.25 1.02 . . . . 73.4 110.444 -177.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -110.99 119.54 39.4 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.357 0.663 . . . . 75.04 109.248 173.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 7.2 p -96.85 121.0 46.91 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 N-CA-C 108.979 -0.749 . . . . 74.51 108.979 175.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -80.09 96.68 6.57 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.662 -0.866 . . . . 70.4 108.662 172.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.462 HG13 ' O ' ' A' ' 208' ' ' GLY . 10.7 p -68.35 132.72 91.4 Favored Pre-proline 0 CA--C 1.554 1.102 0 N-CA-C 108.916 -0.772 . . . . 71.22 108.916 178.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . 0.558 ' HG3' ' HB3' ' B' ' 443' ' ' ALA . 37.0 Cg_endo -64.39 163.55 26.3 Favored 'Trans proline' 0 C--N 1.374 1.875 0 C-N-CA 122.483 2.122 . . . . 75.51 112.455 174.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -64.77 163.9 26.21 Favored 'Trans proline' 0 C--N 1.37 1.664 0 C-N-CA 121.993 1.795 . . . . 72.53 112.95 169.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . 0.43 ' HD2' ' HB3' ' B' ' 446' ' ' PRO . 0.0 OUTLIER 41.25 67.78 0.5 Allowed 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 126.057 1.743 . . . . 75.13 112.824 -173.207 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.513 HG21 HD22 ' A' ' 233' ' ' LEU . 95.0 m -101.68 103.01 13.77 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 114.407 -1.27 . . . . 64.32 109.224 177.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . 0.787 ' HB3' ' HD3' ' A' ' 231' ' ' ARG . 5.5 tp-100 -87.18 145.96 26.2 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.166 0.986 . . . . 75.32 111.784 -172.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -73.15 143.42 47.29 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.975 0.91 . . . . 65.12 111.267 179.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 85.26 -0.59 88.73 Favored Glycine 0 C--N 1.348 1.233 0 CA-C-N 115.787 -0.642 . . . . 75.54 113.103 -178.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.787 ' HD3' ' HB3' ' A' ' 228' ' ' GLN . 78.7 mtp180 -112.03 162.49 15.33 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.536 1.134 . . . . 74.44 108.949 176.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 49.6 pttt -129.63 136.31 49.6 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 122.902 0.481 . . . . 72.22 110.389 -171.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.513 HD22 HG21 ' A' ' 227' ' ' THR . 26.3 mt -86.72 110.97 20.26 Favored 'General case' 0 C--O 1.212 -0.882 0 CA-C-N 115.281 -0.872 . . . . 71.4 110.133 -172.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -77.22 106.94 9.26 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.01 0.524 . . . . 73.41 110.25 175.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.684 HD23 ' HA ' ' B' ' 441' ' ' ILE . 8.5 mt -101.68 93.54 5.39 Favored 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 108.454 -0.943 . . . . 74.24 108.454 172.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.519 ' HG3' ' HB2' ' B' ' 457' ' ' GLN . 4.5 tmtm? -73.67 117.97 16.06 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.437 0.695 . . . . 71.01 111.939 -164.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 101.45 32.16 5.27 Favored Glycine 0 C--N 1.347 1.157 0 CA-C-N 115.813 -0.63 . . . . 74.2 112.614 175.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 2.8 mmmt -117.26 -28.19 6.23 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.941 0.896 . . . . 74.1 111.229 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -79.0 -166.87 32.04 Favored Glycine 0 C--N 1.342 0.915 0 O-C-N 123.663 0.602 . . . . 74.43 113.256 174.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -97.59 158.97 32.15 Favored Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 123.565 0.746 . . . . 73.41 110.333 -173.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.529 ' HD3' ' HA ' ' B' ' 421' ' ' VAL . 32.0 Cg_endo -58.64 151.92 59.57 Favored 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 122.656 2.237 . . . . 73.33 113.322 -173.161 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -173.88 -163.42 27.32 Favored Glycine 0 C--N 1.341 0.816 0 CA-C-N 115.65 -0.705 . . . . 73.52 113.761 177.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . 0.598 ' HD2' ' HG2' ' A' ' 191' ' ' GLN . 73.4 Cg_endo -70.8 -5.86 17.81 Favored 'Trans proline' 0 C--N 1.373 1.862 0 C-N-CA 123.708 2.939 . . . . 72.5 113.613 -179.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -103.94 23.12 13.38 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.74 0.816 . . . . 70.11 109.954 171.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 82.37 -84.44 1.51 Allowed Glycine 0 C--N 1.351 1.4 0 N-CA-C 110.78 -0.928 . . . . 62.24 110.78 -177.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 50.2 mtm180 -125.68 144.64 50.51 Favored 'General case' 0 C--O 1.246 0.871 0 N-CA-C 108.348 -0.982 . . . . 75.41 108.348 171.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -65.79 166.82 35.11 Favored Glycine 0 N--CA 1.448 -0.552 0 O-C-N 123.979 0.799 . . . . 70.31 113.457 176.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -110.91 -178.31 3.44 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 123.776 0.831 . . . . 75.44 108.89 -179.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.483 HD22 HD13 ' A' ' 235' ' ' LEU . 31.1 tp -118.63 96.53 5.32 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 107.875 -1.157 . . . . 73.32 107.875 169.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -79.69 109.52 14.17 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.285 1.034 . . . . 71.3 109.79 175.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.549 HD21 ' HB1' ' A' ' 195' ' ' ALA . 89.7 mt -97.88 97.86 9.31 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.5 -0.773 . . . . 74.54 109.483 177.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -75.61 115.97 15.84 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.374 0.67 . . . . 75.41 109.611 -176.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 91.7 t -86.43 132.89 31.11 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 C-N-CA 125.468 1.507 . . . . 71.34 113.06 -163.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -130.07 107.04 9.03 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.19 1.396 . . . . 73.14 108.565 173.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.532 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 73.4 mt -84.01 130.74 35.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 123.257 0.623 . . . . 74.34 111.016 -176.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 20.3 p -119.1 174.15 6.49 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.497 1.119 . . . . 74.52 109.844 173.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . 0.41 ' HB ' ' HD2' ' A' ' 258' ' ' PRO . 2.9 pp -136.13 154.91 77.72 Favored Pre-proline 0 CA--C 1.566 1.576 0 C-N-CA 123.696 0.798 . . . . 73.4 109.938 -179.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . 0.41 ' HD2' ' HB ' ' A' ' 257' ' ' ILE . 49.1 Cg_endo -64.67 -5.56 10.53 Favored 'Trans proline' 0 C--N 1.385 2.493 0 C-N-CA 123.457 2.771 . . . . 74.45 116.1 -163.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.501 ' HG2' ' NE2' ' C' ' 228' ' ' GLN . 31.4 mt-10 52.42 -87.37 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.422 0 C-N-CA 124.122 0.969 . . . . 75.12 112.728 -170.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.27 132.84 47.83 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 109.935 -0.394 . . . . 75.12 109.935 -177.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 97.5 mt -130.93 134.62 46.91 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.702 0.801 . . . . 72.32 110.575 -177.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 19.1 p -84.16 146.26 47.87 Favored Pre-proline 0 CA--C 1.545 0.788 0 CA-C-O 117.874 -1.06 . . . . 74.31 108.841 169.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -30.94 -42.98 0.11 Allowed 'Trans proline' 0 C--N 1.39 2.731 1 C-N-CA 126.062 4.508 . . . . 74.33 116.569 -172.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -64.59 -64.3 0.91 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.25 0.62 . . . . 71.44 110.99 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -61.48 -32.49 72.5 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.086 0.954 . . . . 73.22 110.866 -178.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -53.48 -52.95 57.89 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.779 1.231 . . . . 73.45 109.847 174.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . 0.415 ' O ' ' HG3' ' A' ' 271' ' ' LYS . . . -65.69 -41.72 92.07 Favored 'General case' 0 C--O 1.214 -0.795 0 CA-C-N 114.923 -1.035 . . . . 64.12 111.585 178.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 10.9 mp -57.24 -47.0 82.47 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 123.071 0.548 . . . . 73.14 111.544 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -64.89 -40.76 95.6 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 123.755 0.659 . . . . 75.0 111.091 178.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . 0.465 ' HE2' ' HA ' ' C' ' 206' ' ' VAL . 1.5 mptm? -71.68 -25.33 62.06 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.093 0.557 . . . . 73.12 111.98 178.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . 0.415 ' HG3' ' O ' ' A' ' 267' ' ' ALA . 97.1 mttt -73.75 -48.82 28.99 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.873 -0.788 . . . . 70.22 108.873 176.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 72.6 mt -55.28 -40.96 71.62 Favored 'General case' 0 C--O 1.198 -1.641 0 O-C-N 124.774 1.296 . . . . 71.54 109.992 172.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -65.79 -55.51 16.8 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.056 0.942 . . . . 72.23 113.105 -174.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -66.57 -43.75 84.16 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 123.787 0.679 . . . . 74.35 110.76 -176.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -62.59 -47.95 81.59 Favored 'General case' 0 C--N 1.355 0.82 0 O-C-N 123.944 0.778 . . . . 72.24 110.285 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -62.75 -45.77 91.14 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.729 0.812 . . . . 75.02 110.945 -177.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -66.82 -40.04 87.89 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 123.519 0.512 . . . . 72.14 110.103 -176.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -66.62 -17.86 65.06 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 115.824 -0.625 . . . . 75.41 111.579 174.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . 0.448 ' HG2' ' HA ' ' B' ' 278' ' ' LEU . 82.6 mtt180 -117.76 20.05 13.56 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.134 0.974 . . . . 75.15 109.733 178.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.845 0 N-CA-C 109.173 -0.677 . . . . 72.5 109.173 179.193 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 63.7 mtt . . . . . 0 N--CA 1.483 1.182 0 N-CA-C 109.104 -0.702 . . . . 74.12 109.104 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -82.06 126.65 32.25 Favored 'General case' 0 C--N 1.353 0.733 0 N-CA-C 108.649 -0.871 . . . . 62.45 108.649 172.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -106.34 37.49 2.28 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.137 0.575 . . . . 74.04 110.095 -176.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 55.2 m -53.89 -3.51 0.04 OUTLIER 'General case' 0 CA--C 1.565 1.535 0 N-CA-C 117.31 2.337 . . . . 52.14 117.31 -162.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 16.9 m -132.27 147.6 52.41 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 119.316 0.962 . . . . 74.34 110.291 171.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 15.1 pt -138.23 169.59 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 123.85 0.86 . . . . 65.34 112.384 -164.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -131.51 147.68 52.56 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 124.21 1.004 . . . . 72.22 109.672 176.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 15.2 tp -85.51 157.0 20.54 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.863 0.865 . . . . 75.22 110.918 -172.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.44 -59.52 2.67 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.322 0.649 . . . . 73.12 111.81 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 66.1 mt 61.12 18.1 8.72 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.863 1.265 . . . . 74.1 111.911 -165.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 64.5 mt 58.69 79.53 0.31 Allowed Pre-proline 0 N--CA 1.485 1.309 0 C-N-CA 124.771 1.228 . . . . 72.11 112.116 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -89.05 -84.17 0.0 OUTLIER 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 122.964 2.443 . . . . 71.41 112.422 176.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 41.8 mt -131.59 -165.26 1.55 Allowed 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 124.406 1.083 . . . . 75.11 109.946 178.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 10.4 tp -95.85 -177.67 4.11 Favored 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 123.763 0.825 . . . . 64.54 109.66 179.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -91.32 170.81 9.68 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.611 0.764 . . . . 74.01 111.585 -173.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 61.6 p -85.92 135.65 37.35 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 124.006 0.922 . . . . 71.11 110.132 176.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 17' ' ' PRO . . . . . 0.638 ' HG3' ' HA ' ' B' ' 366' ' ' ASP . 60.4 Cg_endo -66.93 97.36 0.4 Allowed 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 123.26 2.64 . . . . 71.22 113.08 -175.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 47.7 t -77.66 -35.75 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 124.17 0.988 . . . . 63.3 109.713 177.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 50.0 p -70.77 -23.37 62.39 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.865 0.866 . . . . 71.22 111.097 173.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 20' ' ' LYS . . . . . 0.566 ' HA ' ' HE3' ' B' ' 20' ' ' LYS . 0.4 OUTLIER 75.43 -64.04 0.39 Allowed 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 126.411 1.884 . . . . 74.33 111.828 179.551 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 66.34 99.56 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.919 1.288 . . . . 75.34 112.361 175.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 84.0 mmt-85 -131.29 162.48 29.96 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.254 1.022 . . . . 73.31 109.219 173.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 23' ' ' THR . . . . . 0.463 ' HA ' ' HD3' ' B' ' 24' ' ' PRO . 26.1 m -66.52 107.48 1.65 Allowed Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 123.592 0.757 . . . . 72.54 109.394 176.052 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' B' ' 23' ' ' THR . 5.9 Cg_exo -76.55 -71.47 0.01 OUTLIER 'Trans proline' 0 C--N 1.371 1.756 0 C-N-CA 122.907 2.404 . . . . 74.55 113.886 -166.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -85.79 160.09 19.58 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-O 121.27 0.557 . . . . 74.53 110.835 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 13.3 tpt -93.5 116.67 66.79 Favored Pre-proline 0 C--O 1.242 0.681 0 N-CA-C 108.203 -1.036 . . . . 75.13 108.203 169.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -61.73 84.47 0.09 OUTLIER 'Trans proline' 0 C--N 1.374 1.904 0 C-N-CA 123.48 2.787 . . . . 73.04 113.053 178.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 34.0 m -101.81 -13.63 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 124.281 1.032 . . . . 75.25 110.633 176.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 3.5 tt 64.78 -107.06 0.15 Allowed 'General case' 0 CA--C 1.562 1.437 0 C-N-CA 124.718 1.207 . . . . 73.34 108.453 -172.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 58.36 168.63 0.05 Allowed 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 125.039 1.336 . . . . 71.25 112.048 -177.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 31' ' ' ASN . . . . . 0.426 ' ND2' ' HB2' ' C' ' 236' ' ' LYS . 68.4 m-20 80.3 -49.78 0.34 Allowed 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 126.194 1.798 . . . . 74.34 111.174 177.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 71.81 -52.79 0.69 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 126.736 2.015 . . . . 72.22 110.524 -172.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . 0.637 ' HB3' ' HE2' ' C' ' 238' ' ' LYS . . . 72.74 105.93 0.07 Allowed 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 125.217 1.407 . . . . 73.31 110.323 170.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . 76.99 -52.15 0.57 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 126.502 1.921 . . . . 53.33 110.279 -164.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 68.52 -6.16 0.85 Allowed 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 125.286 1.435 . . . . 73.13 112.674 174.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -172.65 157.58 27.1 Favored Glycine 0 C--N 1.34 0.804 0 O-C-N 122.067 -0.396 . . . . 74.33 112.349 -174.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . 0.453 ' HB2' HG23 ' B' ' 165' ' ' THR . 36.7 t0 -76.24 157.9 32.14 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 124.584 1.154 . . . . 61.44 109.946 177.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 16.8 tt -64.87 -23.46 33.47 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.299 0 C-N-CA 124.432 1.093 . . . . 75.44 111.328 174.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 39' ' ' THR . . . . . 0.637 ' HB ' HD22 ' B' ' 167' ' ' ASN . 53.4 m -141.33 -51.89 0.44 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.477 0.711 . . . . 73.32 110.97 -178.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . 0.321 . . 99.57 -72.73 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.678 0 C-N-CA 127.524 2.33 . . . . 73.24 112.6 -176.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.06 114.84 4.03 Favored 'Trans proline' 0 C--N 1.398 3.156 0 CA-C-N 122.793 2.033 . . . . 72.44 112.417 178.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 179.3 -42.17 0.08 OUTLIER Glycine 0 C--N 1.349 1.271 0 CA-C-N 115.876 -0.602 . . . . 61.22 112.43 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.7 -172.02 32.33 Favored Glycine 0 C--N 1.348 1.244 0 C-N-CA 122.754 0.216 . . . . 64.32 113.319 176.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.68 -13.73 59.82 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.306 1.043 . . . . 63.2 112.254 -177.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.722 ' HG2' ' HG3' ' B' ' 46' ' ' ARG . 56.2 ttp180 75.92 -74.06 0.08 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.461 1.504 . . . . 74.21 111.764 176.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 46' ' ' ARG . . . . . 0.722 ' HG3' ' HG2' ' B' ' 45' ' ' ARG . 82.3 mtp180 -127.86 -176.55 3.81 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 123.726 0.81 . . . . 75.02 110.501 -177.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -159.74 157.77 30.05 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.473 0.709 . . . . 72.13 110.681 -178.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 48' ' ' THR . . . . . 0.455 ' OG1' ' HA ' ' B' ' 193' ' ' PRO . 1.4 t -163.25 -64.4 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.731 0.812 . . . . 73.12 110.8 178.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . 0.426 ' H ' HG22 ' B' ' 48' ' ' THR . . . 73.98 -77.33 0.98 Allowed Glycine 0 C--N 1.349 1.263 0 CA-C-N 116.607 -0.27 . . . . 74.15 113.186 -176.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -85.24 160.68 19.82 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.017 0.927 . . . . 64.2 111.173 -174.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -99.24 -26.34 14.21 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 114.711 -1.131 . . . . 75.3 109.812 167.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 12.6 t -174.85 170.17 3.35 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.02 0.928 . . . . 73.31 110.319 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . 0.571 ' HB2' ' HB2' ' B' ' 190' ' ' CYS . . . -166.56 139.03 3.71 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.5 1.12 . . . . 73.24 108.793 174.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -136.05 -88.6 0.32 Allowed 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 123.558 0.743 . . . . 75.51 111.848 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 1.1 tt -93.58 64.83 3.64 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.423 0.689 . . . . 72.35 110.104 -171.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . 0.461 ' HA ' ' HG3' ' B' ' 188' ' ' ARG . 66.0 mtt-85 73.95 -40.1 0.45 Allowed 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 125.655 1.582 . . . . 74.21 113.614 175.006 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 63.53 9.3 4.12 Favored 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 124.914 1.286 . . . . 75.31 112.537 169.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 58' ' ' SER . . . . . 0.616 ' HB2' ' HB3' ' C' ' 122' ' ' GLU . 24.0 p -104.87 85.28 2.27 Favored 'General case' 0 C--O 1.243 0.731 0 C-N-CA 125.123 1.369 . . . . 62.01 109.723 -170.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -123.8 -49.52 1.86 Allowed 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 115.261 -0.881 . . . . 72.44 109.819 -177.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 67.6 m 62.5 -175.49 0.14 Allowed 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 124.473 1.109 . . . . 71.31 111.383 -166.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.19 -10.65 27.59 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.891 0.876 . . . . 71.45 110.487 -178.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 62' ' ' LYS . . . . . 0.569 ' HB3' ' HE2' ' B' ' 303' ' ' LYS . 1.2 tmtp? -164.57 142.78 5.54 Favored Pre-proline 0 CA--C 1.555 1.147 0 N-CA-C 106.944 -1.502 . . . . 72.42 106.944 -175.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -66.99 27.32 0.11 Allowed 'Trans proline' 0 C--N 1.39 2.735 0 C-N-CA 123.463 2.775 . . . . 72.24 115.736 175.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . 0.576 ' HB3' ' HB ' ' C' ' 158' ' ' VAL . . . 68.89 -86.01 0.03 OUTLIER 'General case' 0 C--N 1.355 0.836 0 C-N-CA 125.718 1.607 . . . . 72.04 112.342 176.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? 52.15 -99.97 0.09 Allowed 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 117.844 -1.074 . . . . 73.42 110.465 -171.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 49.0 -74.08 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 126.144 1.778 . . . . 72.41 115.521 173.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . 0.571 ' HB ' ' HD2' ' C' ' 160' ' ' ARG . 7.7 pt 61.31 172.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 127.171 2.188 . . . . 74.04 112.413 -174.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . 0.552 HG12 HG13 ' B' ' 67' ' ' ILE . 49.7 mm 73.77 148.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 C-N-CA 124.73 1.212 . . . . 73.4 111.287 -178.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.492 ' HB3' ' HA2' ' C' ' 190' ' ' GLY . 87.5 mt 65.65 75.33 0.35 Allowed 'General case' 0 C--N 1.359 0.979 0 C-N-CA 124.999 1.32 . . . . 74.34 110.925 -178.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 46.3 tp -163.46 -62.76 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 114.937 -1.029 . . . . 65.22 108.623 -179.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . 0.479 HD13 ' HB3' ' C' ' 243' ' ' PRO 0.264 0.0 OUTLIER 39.86 -70.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 C-N-CA 127.737 2.415 . . . . 75.5 115.755 177.09 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 162.18 -162.53 34.32 Favored Glycine 0 C--N 1.341 0.846 0 N-CA-C 111.246 -0.742 . . . . 71.15 111.246 -175.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -124.77 158.59 32.94 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.787 0.835 . . . . 74.12 109.992 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.37 -6.22 61.23 Favored Glycine 0 C--N 1.35 1.331 0 O-C-N 123.848 0.717 . . . . 72.45 113.163 172.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 65.5 mtt 78.01 -56.53 0.49 Allowed 'General case' 0 C--N 1.366 1.291 0 C-N-CA 126.689 1.996 . . . . 74.01 111.452 176.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 86.99 0.23 85.72 Favored Glycine 0 C--N 1.346 1.12 0 CA-C-O 119.738 -0.479 . . . . 71.52 112.85 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 4.7 t70 63.35 -157.84 0.32 Allowed 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 124.759 1.224 . . . . 74.35 109.518 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 17.2 t 67.69 78.17 0.24 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.099 1.36 . . . . 55.34 110.947 176.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.77 167.01 20.83 Favored 'General case' 0 CA--C 1.553 1.096 0 CA-C-N 114.576 -1.193 . . . . 74.44 109.622 177.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . 0.597 HG21 HG22 ' B' ' 81' ' ' THR . 3.4 mp 66.27 -81.28 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.563 1.452 0 C-N-CA 124.842 1.257 . . . . 72.52 110.036 -175.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 81' ' ' THR . . . . . 0.597 HG22 HG21 ' B' ' 80' ' ' ILE . 12.6 t -166.41 175.39 8.19 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.174 0.989 . . . . 74.52 109.697 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -147.75 17.03 1.13 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.124 0.97 . . . . 75.12 110.515 175.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -95.24 178.3 5.57 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.498 0.719 . . . . 74.13 111.479 -175.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 68.2 -78.98 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.796 1.639 . . . . 73.0 111.691 178.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 59.45 -80.91 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 125.045 1.338 . . . . 72.23 111.327 -178.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -142.63 95.03 2.72 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 107.441 -1.318 . . . . 74.21 107.441 -174.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . 0.462 ' HA ' HD21 ' B' ' 155' ' ' LEU . . . -143.96 35.45 1.25 Allowed 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.08 0.466 . . . . 52.24 111.231 -171.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -155.33 139.67 16.71 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 115.662 -0.699 . . . . 74.14 109.954 -177.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -88.88 -52.24 2.83 Favored Glycine 0 C--N 1.348 1.238 0 CA-C-N 116.225 -0.443 . . . . 54.33 112.101 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . 70.54 -67.04 0.26 Allowed 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 125.233 1.413 . . . . 75.53 112.43 175.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -67.34 -4.26 29.35 Favored Glycine 0 N--CA 1.48 1.623 0 N-CA-C 114.561 0.584 . . . . 70.11 114.561 177.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -63.16 -28.0 71.47 Favored Glycine 0 C--N 1.353 1.516 0 C-N-CA 123.071 0.367 . . . . 73.42 112.72 176.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -66.29 -45.66 79.63 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.892 0.477 . . . . 74.22 110.351 177.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -67.19 -39.05 86.3 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.582 -0.735 . . . . 72.14 110.759 -178.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -79.97 6.06 12.32 Favored 'General case' 0 CA--C 1.565 1.528 0 C-N-CA 123.829 0.852 . . . . 74.44 110.87 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . -81.41 24.13 4.39 Favored Glycine 0 C--N 1.357 1.713 0 N-CA-C 114.685 0.634 . . . . 75.21 114.685 177.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 39.4 mm -116.72 -33.99 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 124.217 1.007 . . . . 73.0 109.512 175.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -132.85 138.69 47.14 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.732 0.813 . . . . 75.21 110.229 -175.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -103.71 -4.17 24.06 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.027 0.931 . . . . 61.12 111.35 177.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 59.74 69.83 1.18 Allowed Pre-proline 0 CA--C 1.557 1.24 0 C-N-CA 125.777 1.631 . . . . 74.2 110.152 -169.131 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -91.54 -172.95 0.48 Allowed 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 123.494 2.796 . . . . 74.43 111.071 170.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -66.53 135.44 54.2 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 108.732 -0.84 . . . . 73.12 108.732 173.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 19.7 p -72.11 108.62 5.4 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.741 0.817 . . . . 75.52 110.301 177.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 113.56 -3.12 24.81 Favored Glycine 0 N--CA 1.469 0.851 0 CA-C-N 115.871 -0.604 . . . . 51.35 111.703 -170.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 105' ' ' GLN . . . . . 0.455 HE21 ' HG ' ' B' ' 111' ' ' LEU . 52.8 tt0 -107.76 -82.7 0.55 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.063 0.945 . . . . 75.22 109.121 178.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 47.98 -93.1 0.02 OUTLIER 'General case' 0 C--N 1.367 1.354 0 C-N-CA 124.305 1.042 . . . . 74.44 111.534 -172.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 30.4 p -123.86 119.33 29.33 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.444 -1.317 . . . . 75.34 107.444 171.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -156.71 88.22 1.04 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 122.513 0.325 . . . . 73.44 110.803 -176.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.725 ' HA ' ' HA ' ' B' ' 114' ' ' LYS . 75.8 m-85 47.2 -79.51 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 126.777 2.031 . . . . 74.1 115.501 168.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.0 -29.61 70.75 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.145 0.978 . . . . 75.22 112.38 -174.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . 0.455 ' HG ' HE21 ' B' ' 105' ' ' GLN . 3.0 mm? -84.84 -5.69 59.34 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.469 0.707 . . . . 70.25 111.595 -178.013 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -135.99 -164.36 1.54 Allowed 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.274 1.03 . . . . 73.2 110.0 -174.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 113' ' ' LYS . . . . . 0.501 ' HE3' ' HA ' ' B' ' 113' ' ' LYS . 0.7 OUTLIER -91.94 36.79 0.97 Allowed 'General case' 0 CA--C 1.555 1.17 0 CA-C-O 121.721 0.772 . . . . 75.13 109.354 170.302 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 114' ' ' LYS . . . . . 0.725 ' HA ' ' HA ' ' B' ' 109' ' ' TYR . 96.6 mttt 58.93 15.06 3.66 Favored 'General case' 0 C--N 1.364 1.201 0 C-N-CA 125.093 1.357 . . . . 74.21 112.745 -177.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 16.3 m 65.48 -8.49 0.28 Allowed 'General case' 0 CA--C 1.566 1.592 0 C-N-CA 125.351 1.46 . . . . 73.23 113.066 -176.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -73.89 -20.79 79.73 Favored Glycine 0 C--N 1.358 1.794 0 O-C-N 122.043 -0.41 . . . . 55.33 112.985 -174.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . 0.587 ' HB2' ' HZ1' ' B' ' 117' ' ' LYS . 4.9 ttmp? -149.13 79.56 8.28 Favored Pre-proline 0 CA--C 1.548 0.901 0 N-CA-C 108.799 -0.815 . . . . 75.35 108.799 176.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 118' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -66.62 -32.46 38.51 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.319 2.013 . . . . 63.21 111.977 179.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 119' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -168.04 162.95 13.48 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.618 0.767 . . . . 75.33 110.228 177.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 120' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -130.7 117.37 19.35 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 106.989 -1.486 . . . . 70.1 106.989 169.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 7.4 p -57.34 -36.17 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 113.727 1.01 . . . . 74.32 113.727 -167.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 14.1 m -73.97 -36.57 64.57 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.871 0.468 . . . . 75.25 111.3 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -105.71 18.61 21.89 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.263 1.025 . . . . 70.53 111.61 -175.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 63.8 p -65.51 116.51 6.86 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.265 0.626 . . . . 61.03 110.045 178.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -77.59 71.38 4.07 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-O 121.942 0.877 . . . . 74.53 110.285 -178.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -160.95 -68.32 0.06 Allowed 'General case' 0 C--O 1.24 0.569 0 CA-C-N 114.596 -1.184 . . . . 74.13 108.358 -174.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 20.0 m 59.62 -76.28 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.519 1.528 . . . . 70.01 111.425 -176.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -124.1 119.01 28.24 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 124.696 1.198 . . . . 74.33 108.078 173.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 25.1 p -105.71 82.7 1.83 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.602 0.761 . . . . 74.41 111.195 -176.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . 63.03 -168.24 0.2 Allowed 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 124.08 0.952 . . . . 61.42 112.86 175.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 16.8 m-90 -125.14 138.64 54.15 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.574 1.149 . . . . 73.51 108.325 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 59.1 p 53.81 -78.0 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 125.622 1.569 . . . . 74.11 113.796 177.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 5.8 m 70.98 7.18 6.13 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.921 1.288 . . . . 74.52 112.836 171.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 70.68 35.93 67.1 Favored Glycine 0 C--N 1.355 1.607 0 N-CA-C 111.705 -0.558 . . . . 55.15 111.705 -177.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 135' ' ' VAL . . . . . . . . . . . . . 36.6 t 62.24 112.86 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.466 1.506 . . . . 73.24 110.409 -165.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -60.68 -59.1 5.93 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.244 1.018 . . . . 74.24 110.934 -173.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 4.7 m 62.39 -77.38 0.03 OUTLIER 'General case' 0 CA--C 1.56 1.332 0 C-N-CA 125.134 1.374 . . . . 75.31 111.133 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -165.52 26.41 0.05 Allowed 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 124.86 1.264 . . . . 75.52 110.134 174.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -60.59 -38.87 86.06 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.858 0.863 . . . . 73.24 112.646 -168.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -91.91 -1.32 70.51 Favored Glycine 0 C--N 1.347 1.158 0 CA-C-O 119.897 -0.391 . . . . 75.54 113.076 178.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -92.74 -47.29 7.15 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.726 0.81 . . . . 75.34 110.522 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 84.1 mt -100.61 -55.7 2.52 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.263 0.625 . . . . 74.24 110.28 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 67.56 -108.73 2.56 Favored Glycine 0 C--N 1.347 1.15 0 N-CA-C 111.374 -0.69 . . . . 61.25 111.374 -175.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 21.0 m 43.4 33.71 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 C-N-CA 126.778 2.031 . . . . 75.31 113.927 176.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 75.15 -34.93 0.27 Allowed 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 126.023 1.729 . . . . 75.32 112.442 -176.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . 0.503 HG13 ' H ' ' B' ' 147' ' ' HIS . 3.5 tp 55.09 -170.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.562 1.405 0 C-N-CA 126.607 1.963 . . . . 72.52 111.982 -177.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 147' ' ' HIS . . . . . 0.503 ' H ' HG13 ' B' ' 146' ' ' ILE . 0.2 OUTLIER 83.03 -17.27 0.52 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.084 1.354 . . . . 72.43 112.02 172.81 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 64.83 -84.77 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 125.055 1.342 . . . . 75.05 112.806 168.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 149' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -74.56 -42.77 58.2 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.585 0.754 . . . . 74.13 110.436 -174.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -67.34 -64.1 0.93 Allowed 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.007 -0.997 . . . . 74.11 108.843 174.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 51.65 89.73 0.09 OUTLIER Pre-proline 0 CA--C 1.551 1.016 0 O-C-N 124.982 1.426 . . . . 74.43 112.185 178.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -88.0 -163.44 0.16 Allowed 'Trans proline' 0 C--N 1.363 1.318 0 C-N-CA 122.295 1.997 . . . . 64.13 109.928 171.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 14.4 m -91.09 153.11 20.32 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 107.639 -1.245 . . . . 74.2 107.639 164.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 23.3 pt -46.77 118.26 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 123.818 0.847 . . . . 74.25 110.957 178.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 155' ' ' LEU . . . . . 0.462 HD21 ' HA ' ' B' ' 87' ' ' ALA . 45.6 tp -63.66 98.7 0.19 Allowed 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.465 -0.789 . . . . 73.12 111.408 -166.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -117.7 161.22 20.04 Favored 'General case' 0 C--O 1.245 0.816 0 CA-C-N 114.816 -1.084 . . . . 72.23 108.713 175.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 157' ' ' MET . . . . . 0.453 ' N ' ' SD ' ' B' ' 157' ' ' MET . 1.4 mpt? -75.92 87.88 2.9 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.884 0.874 . . . . 61.13 109.912 -173.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 158' ' ' ALA . . . . . . . . . . . . . . . -125.54 -77.61 0.59 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.476 0.71 . . . . 65.11 109.715 178.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -98.46 -2.38 39.12 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.021 0.928 . . . . 73.24 110.806 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -129.24 172.2 11.69 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.254 0.621 . . . . 74.34 111.753 -169.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . 69.2 -69.68 0.16 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.929 1.692 . . . . 71.1 111.785 -176.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 81.78 151.38 8.83 Favored Glycine 0 CA--C 1.534 1.254 0 N-CA-C 113.939 0.336 . . . . 73.4 113.939 174.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 91.1 mt -80.08 -168.63 1.71 Allowed 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.686 0.794 . . . . 75.25 110.496 174.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 164' ' ' ALA . . . . . . . . . . . . . . . 68.82 26.43 5.97 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.448 1.099 . . . . 75.34 111.065 -173.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 165' ' ' THR . . . . . 0.453 HG23 ' HB2' ' B' ' 37' ' ' ASP . 9.8 t -172.83 171.62 4.3 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.592 1.157 . . . . 73.14 109.828 -177.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . 174.66 52.26 0.05 OUTLIER Glycine 0 C--N 1.343 0.949 0 N-CA-C 110.653 -0.979 . . . . 74.53 110.653 -177.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 167' ' ' ASN . . . . . 0.637 HD22 ' HB ' ' B' ' 39' ' ' THR . 0.1 OUTLIER -54.54 132.97 45.99 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.516 1.126 . . . . 74.33 112.84 -165.238 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 39.4 t 73.94 -38.79 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 C-N-CA 126.406 1.883 . . . . 75.53 112.16 -178.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 37.1 m -78.54 -1.84 35.88 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 124.144 0.977 . . . . 65.53 111.169 173.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 8.5 p -67.37 157.63 33.62 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 123.698 0.799 . . . . 73.13 111.453 172.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -123.17 102.21 7.83 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 107.244 -1.391 . . . . 73.41 107.244 171.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 172' ' ' GLU . . . . . 0.409 ' HA ' ' OE1' ' B' ' 174' ' ' GLN . 2.5 mp0 -71.85 89.76 1.08 Allowed 'General case' 0 N--CA 1.472 0.672 0 O-C-N 123.958 0.786 . . . . 75.25 112.575 -169.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 173' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -113.17 8.63 18.29 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 114.4 -1.273 . . . . 74.44 108.459 162.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 174' ' ' GLN . . . . . 0.409 ' OE1' ' HA ' ' B' ' 172' ' ' GLU . 22.7 mp0 -94.95 156.88 16.15 Favored 'General case' 0 C--N 1.352 0.708 0 C-N-CA 125.203 1.401 . . . . 74.45 109.516 -177.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 175' ' ' ASP . . . . . 0.51 ' H ' HG21 ' C' ' 126' ' ' THR . 11.5 t70 179.06 105.6 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.418 1.087 . . . . 74.1 109.302 -175.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -97.67 25.98 5.4 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.153 0.581 . . . . 74.11 110.96 178.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 177' ' ' THR . . . . . 0.486 ' N ' ' HD2' ' B' ' 178' ' ' PRO . 9.2 m -78.94 -30.8 0.68 Allowed Pre-proline 0 CA--C 1.573 1.838 0 CA-C-O 116.534 -1.698 . . . . 74.15 115.061 -176.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 178' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' B' ' 177' ' ' THR . 10.3 Cg_endo -50.57 -42.17 50.44 Favored 'Trans proline' 1 C--N 1.417 4.147 0 CA-C-N 123.023 2.115 . . . . 74.53 112.271 -178.539 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -176.23 -172.22 0.47 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.119 1.368 . . . . 74.35 108.843 173.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . -66.11 -35.22 79.91 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 109.368 -0.604 . . . . 75.32 109.368 166.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 181' ' ' LEU . . . . . 0.529 ' HB2' ' HB3' ' C' ' 136' ' ' ARG . 58.0 tp -159.79 -69.95 0.08 Allowed 'General case' 0 C--N 1.353 0.726 0 CA-C-N 115.816 -0.629 . . . . 74.44 111.186 -176.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 182' ' ' VAL . . . . . 0.475 HG13 ' H ' ' C' ' 139' ' ' GLU . 8.2 p -79.93 150.43 4.96 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 CA-C-N 115.355 -0.839 . . . . 72.43 112.711 -163.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -119.67 38.17 3.98 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.909 0.883 . . . . 65.24 109.278 171.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 35.7 m80 56.85 -87.11 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.723 1.209 . . . . 75.32 110.589 -171.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 185' ' ' VAL . . . . . 0.55 HG23 ' HA ' ' C' ' 121' ' ' ALA . 1.5 p -161.11 121.36 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 124.382 1.073 . . . . 74.01 108.71 173.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 81.9 p 55.04 85.38 0.06 Allowed 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 125.404 1.481 . . . . 60.24 112.795 175.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 187' ' ' SER . . . . . . . . . . . . . 90.1 p -163.38 -170.63 2.31 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.156 0.582 . . . . 62.14 110.534 178.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 188' ' ' ARG . . . . . 0.52 ' HA ' ' HG2' ' C' ' 124' ' ' PRO . 0.0 OUTLIER -145.83 -173.47 4.15 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 113.07 0.767 . . . . 72.32 113.07 -173.863 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 2.4 ttpt -146.7 143.37 28.69 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.449 1.499 . . . . 72.52 107.587 168.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 190' ' ' CYS . . . . . 0.571 ' HB2' ' HB2' ' B' ' 53' ' ' ALA . 35.2 t -126.87 103.59 7.58 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.215 0.531 . . . . 70.33 110.061 175.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -95.88 -37.25 10.79 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.567 1.147 . . . . 74.04 108.776 173.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 96.63 153.26 29.53 Favored Glycine 0 C--N 1.348 1.195 0 CA-C-N 115.315 -0.857 . . . . 64.22 112.829 178.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 193' ' ' PRO . . . . . 0.455 ' HA ' ' OG1' ' B' ' 48' ' ' THR . 29.6 Cg_endo -88.71 50.11 1.51 Allowed 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 124.026 3.15 . . . . 73.22 112.548 -173.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 194' ' ' SER . . . . . . . . . . . . . 38.2 m -73.96 14.54 0.39 Allowed 'General case' 0 CA--C 1.555 1.139 0 N-CA-C 114.181 1.178 . . . . 63.44 114.181 -172.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 195' ' ' ALA . . . . . . . . . . . . . . . -56.99 -52.85 63.61 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.073 0.949 . . . . 74.32 111.185 177.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 25.2 m 51.59 109.94 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 125.74 1.616 . . . . 73.32 114.955 168.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 19.4 m -66.29 91.7 0.17 Allowed 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.19 0.596 . . . . 75.11 109.539 171.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 198' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -81.76 111.89 18.41 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.012 0.925 . . . . 65.14 111.334 -170.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt 51.02 83.73 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.844 1.258 . . . . 75.14 112.755 164.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 200' ' ' CYS . . . . . . . . . . . . . 81.2 m -139.59 -49.3 0.02 OUTLIER Pre-proline 0 CA--C 1.562 1.411 0 CA-C-O 118.135 -0.936 . . . . 73.31 112.131 -176.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 201' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -65.51 95.8 0.28 Allowed 'Trans proline' 0 C--N 1.398 3.152 0 C-N-CA 121.622 1.548 . . . . 74.02 111.847 172.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . -80.86 68.11 3.46 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-N 115.739 -0.664 . . . . 73.41 111.673 176.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 203' ' ' ASN . . . . . 0.402 ' ND2' ' HA ' ' B' ' 283' ' ' ASP . 42.2 p30 -138.66 26.13 2.56 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.991 0.916 . . . . 71.33 111.412 -176.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -71.96 83.37 0.95 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.265 0.626 . . . . 74.01 111.694 -171.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 205' ' ' LEU . . . . . . . . . . . . . 53.5 tp 56.75 -79.17 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 126.314 1.846 . . . . 72.44 112.935 174.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -56.53 -68.8 0.18 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.134 1.374 . . . . 70.3 111.079 -178.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -93.99 75.6 4.14 Favored 'General case' 0 C--N 1.344 0.344 0 N-CA-C 108.821 -0.807 . . . . 74.32 108.821 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . -147.4 34.75 1.26 Allowed Glycine 0 C--N 1.337 0.636 0 CA-C-N 114.389 -1.278 . . . . 71.52 111.476 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 82.89 -62.93 4.56 Favored Glycine 0 C--N 1.346 1.108 0 CA-C-N 115.42 -0.39 . . . . 63.34 112.306 -177.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt 67.75 -77.33 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 125.328 1.451 . . . . 74.51 110.169 -177.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . -88.54 -33.06 10.59 Favored Glycine 0 C--N 1.349 1.294 0 N-CA-C 110.863 -0.895 . . . . 74.43 110.863 171.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 36.2 m 63.7 -164.28 0.25 Allowed 'General case' 0 C--N 1.36 1.053 0 C-N-CA 124.568 1.147 . . . . 74.04 110.957 178.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 68.3 mt 75.36 -64.34 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 C-N-CA 125.291 1.437 . . . . 70.12 110.833 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 32.2 m 74.86 -27.63 0.19 Allowed 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 125.527 1.531 . . . . 75.43 112.723 176.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 215' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 75.61 -68.66 0.19 Allowed 'General case' 0 C--N 1.359 1.002 0 C-N-CA 126.378 1.871 . . . . 73.31 111.766 173.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -146.61 -81.09 0.15 Allowed 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 119.657 -0.211 . . . . 61.42 111.061 -176.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . 0.568 ' HB2' HE22 ' B' ' 274' ' ' GLN . 10.1 mp 60.18 -157.11 0.34 Allowed 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.987 0.915 . . . . 75.4 110.275 -166.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -133.21 17.41 4.08 Favored 'General case' 0 N--CA 1.483 1.204 0 O-C-N 121.701 -0.624 . . . . 71.43 112.451 -170.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 57.3 -142.23 0.74 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.255 -0.646 . . . . 71.24 109.255 -176.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . 84.72 -36.32 0.05 Allowed 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 125.149 1.38 . . . . 74.3 112.316 163.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 221' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.21 133.8 1.15 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.314 1.046 . . . . 73.55 108.342 170.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -120.5 118.78 31.15 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 108.949 -0.76 . . . . 75.21 108.949 177.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -65.39 -35.03 79.71 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.646 0.778 . . . . 72.13 109.556 178.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 2.0 p -103.53 101.68 12.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 107.281 -1.377 . . . . 75.32 107.281 166.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 5.7 t -72.12 -52.71 15.44 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 122.647 0.379 . . . . 73.55 111.085 -175.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . 0.423 HD11 ' HA ' ' B' ' 281' ' ' PHE . 8.4 tt 65.24 150.81 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 125.032 1.333 . . . . 74.43 111.628 -179.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . -163.72 137.64 4.87 Favored Glycine 0 C--N 1.341 0.814 0 N-CA-C 111.205 -0.758 . . . . 71.24 111.205 178.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . -120.92 165.73 14.03 Favored Glycine 0 N--CA 1.469 0.848 0 N-CA-C 111.273 -0.731 . . . . 72.41 111.273 177.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . 91.0 119.1 2.18 Favored Glycine 0 C--N 1.341 0.834 0 CA-C-N 116.904 0.352 . . . . 71.04 113.107 177.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -75.22 -14.57 60.54 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.512 0.725 . . . . 70.23 110.114 171.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 231' ' ' LYS . . . . . 0.592 ' HZ2' ' HB3' ' B' ' 265' ' ' LEU . 53.9 tttp 79.38 94.09 0.06 Allowed 'General case' 0 C--N 1.358 0.958 0 C-N-CA 125.81 1.644 . . . . 73.24 110.877 169.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 10.0 t -116.66 125.76 52.22 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.955 0.902 . . . . 74.24 111.397 179.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 233' ' ' PHE . . . . . 0.43 ' HE1' ' HE3' ' B' ' 231' ' ' LYS . 34.4 p90 -176.25 132.46 0.23 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.296 1.438 . . . . 71.44 108.403 170.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -136.74 -63.03 0.63 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.276 0.63 . . . . 72.31 110.155 177.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . 0.469 ' HG3' ' H ' ' B' ' 237' ' ' ALA . 13.5 tp10 -157.23 146.57 20.2 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.237 0.615 . . . . 64.41 110.031 -174.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 236' ' ' THR . . . . . . . . . . . . . 13.4 m -66.82 -24.43 66.16 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.191 1.396 . . . . 73.34 112.302 -176.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . 0.469 ' H ' ' HG3' ' B' ' 235' ' ' GLU . . . -113.28 -75.34 0.6 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.344 0.658 . . . . 73.03 110.324 175.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 238' ' ' THR . . . . . 0.434 ' OG1' ' HB3' ' B' ' 235' ' ' GLU . 0.2 OUTLIER 64.79 -9.57 0.18 Allowed 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 125.945 1.698 . . . . 71.31 113.599 -177.871 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -163.81 174.38 11.64 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.803 0.729 . . . . 74.42 111.113 -165.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . -79.51 -106.29 0.24 Allowed Glycine 0 C--N 1.345 1.051 0 CA-C-N 115.409 -0.814 . . . . 71.23 111.804 174.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.29 -179.52 5.62 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.41 0.684 . . . . 71.23 111.132 -178.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 242' ' ' TRP . . . . . 0.428 ' CZ3' HG23 ' C' ' 253' ' ' VAL . 7.8 m0 -94.18 -60.54 1.71 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.198 0.999 . . . . 70.32 109.375 -175.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -172.25 -33.16 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 113.472 -1.694 . . . . 74.22 109.097 -167.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -162.15 101.7 0.2 Allowed Glycine 0 C--N 1.347 1.185 0 N-CA-C 111.375 -0.69 . . . . 71.54 111.375 174.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 39.1 tptt -120.56 110.28 16.27 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.13 0.972 . . . . 75.34 109.976 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 1.9 p -148.16 101.99 3.32 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.859 1.264 . . . . 71.14 108.322 174.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 247' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' C' ' 206' ' ' VAL . 2.5 tm? -165.64 133.0 2.88 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 108.829 -0.804 . . . . 72.51 108.829 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 248' ' ' ARG . . . . . . . . . . . . . 31.9 mtp-105 -68.44 96.72 0.7 Allowed 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.538 0.735 . . . . 75.15 110.07 176.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -81.33 78.3 8.12 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 121.361 0.6 . . . . 71.33 110.403 -176.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -158.58 139.8 13.2 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 115.013 -0.994 . . . . 70.14 109.384 -177.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 251' ' ' ALA . . . . . . . . . . . . . . . -73.1 107.04 5.22 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 108.849 -0.797 . . . . 64.21 108.849 175.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 25.9 tp60 -67.68 -26.0 65.97 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.032 0.933 . . . . 73.12 110.844 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -73.34 77.71 1.36 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.26 0.624 . . . . 51.41 109.487 173.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -71.39 -48.18 51.55 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 115.572 -0.74 . . . . 72.51 111.155 -171.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . 62.62 -84.46 0.04 OUTLIER Glycine 0 C--N 1.352 1.444 0 O-C-N 124.571 1.169 . . . . 63.32 114.006 175.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 256' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 72.61 -61.82 0.49 Allowed 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 126.329 1.852 . . . . 71.2 111.605 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -61.46 126.79 28.61 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 124.22 1.008 . . . . 74.31 110.613 176.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 258' ' ' LEU . . . . . . . . . . . . . 26.5 tp 67.59 10.21 7.6 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 125.263 1.425 . . . . 75.13 111.852 -178.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 24.7 t 65.0 148.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 C-N-CA 125.508 1.523 . . . . 63.31 110.941 -173.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 260' ' ' SER . . . . . 0.45 ' HA ' HD22 ' B' ' 277' ' ' LEU . 66.7 p -147.5 -179.2 6.69 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 121.593 -0.692 . . . . 73.11 111.123 -175.242 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -79.63 74.34 6.3 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.969 0.907 . . . . 65.51 109.55 175.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 262' ' ' ALA . . . . . . . . . . . . . . . -173.84 -53.06 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.259 1.424 . . . . 75.22 107.915 -178.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -86.79 155.96 20.1 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 114.724 -1.125 . . . . 70.44 110.357 178.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 10.5 m 73.68 -69.29 0.19 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 126.027 1.731 . . . . 51.14 112.649 175.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 265' ' ' LEU . . . . . 0.592 ' HB3' ' HZ2' ' B' ' 231' ' ' LYS . 1.6 tt 72.34 134.26 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 125.46 1.504 . . . . 73.31 109.602 -175.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 266' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 77.82 -67.38 0.19 Allowed 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 125.736 1.614 . . . . 71.52 110.907 -176.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 49.7 m 48.13 59.68 4.1 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.42 1.088 . . . . 73.13 112.943 175.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 6.7 p -75.13 73.58 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.287 0 CA-C-O 122.69 1.233 . . . . 74.44 109.832 175.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 269' ' ' THR . . . . . . . . . . . . . 2.7 t -164.54 100.44 0.81 Allowed 'General case' 0 C--O 1.242 0.698 0 CA-C-N 114.356 -1.293 . . . . 74.31 108.574 -177.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 270' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 65.41 27.21 11.89 Favored 'General case' 0 CA--C 1.558 1.261 0 C-N-CA 124.036 0.934 . . . . 72.41 111.096 172.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 271' ' ' ALA . . . . . 0.429 ' HB2' ' HA3' ' B' ' 279' ' ' GLY . . . -82.58 4.85 23.01 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.192 0.997 . . . . 75.3 112.751 -175.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 272' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -80.72 71.46 7.62 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.387 0.675 . . . . 73.11 109.769 175.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 62.89 -6.76 0.16 Allowed 'General case' 0 CA--C 1.565 1.529 0 C-N-CA 125.797 1.639 . . . . 73.43 114.907 175.094 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 274' ' ' GLN . . . . . 0.568 HE22 ' HB2' ' B' ' 217' ' ' LEU . 26.8 mm-40 -74.44 -50.7 17.36 Favored 'General case' 0 C--N 1.357 0.931 0 N-CA-C 107.534 -1.284 . . . . 71.44 107.534 171.315 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 275' ' ' LYS . . . . . . . . . . . . . 53.6 mttp -106.89 92.27 7.33 Favored Pre-proline 0 CA--C 1.541 0.611 0 N-CA-C 106.778 -1.564 . . . . 72.14 106.778 162.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -84.23 36.67 0.59 Allowed 'Trans proline' 0 C--N 1.372 1.784 0 C-N-CA 122.974 2.449 . . . . 73.04 111.499 -178.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 277' ' ' LEU . . . . . 0.45 HD22 ' HA ' ' B' ' 260' ' ' SER . 26.1 mt -89.71 -97.7 0.1 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.661 1.184 . . . . 74.52 109.072 -173.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 278' ' ' LEU . . . . . 0.448 ' HA ' ' HG2' ' A' ' 279' ' ' ARG . 2.4 mm? -89.8 22.78 2.96 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 122.957 0.503 . . . . 72.2 111.781 -172.074 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 279' ' ' GLY . . . . . 0.429 ' HA3' ' HB2' ' B' ' 271' ' ' ALA . . . -127.76 -83.89 0.43 Allowed Glycine 0 C--N 1.348 1.231 0 CA-C-O 119.945 -0.364 . . . . 75.43 112.674 -177.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 86.1 mt 66.75 -76.36 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 125.334 1.454 . . . . 74.31 111.264 -173.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 281' ' ' PHE . . . . . 0.423 ' HA ' HD11 ' B' ' 226' ' ' LEU . 77.3 t80 -140.68 127.17 20.06 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.713 0.805 . . . . 75.31 109.485 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -92.12 123.66 35.63 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.793 0.837 . . . . 65.41 109.908 178.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 283' ' ' ASP . . . . . 0.402 ' HA ' ' ND2' ' B' ' 203' ' ' ASN . 38.1 t0 -166.05 149.48 7.58 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.467 0.707 . . . . 72.33 109.948 174.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . -136.45 -54.98 0.06 OUTLIER Glycine 0 C--N 1.342 0.876 0 CA-C-N 115.893 -0.594 . . . . 72.13 111.986 -178.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 73.54 -57.46 0.63 Allowed 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 125.535 1.534 . . . . 73.03 112.21 -175.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 286' ' ' MET . . . . . 0.408 ' HA ' ' O ' ' B' ' 290' ' ' TRP . 69.3 mtm 63.34 66.57 1.14 Allowed Pre-proline 0 CA--C 1.554 1.105 0 C-N-CA 124.866 1.266 . . . . 74.22 110.655 -173.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 287' ' ' PRO . . . . . 0.525 ' HD2' ' HA ' ' B' ' 291' ' ' LEU . 19.9 Cg_exo -68.42 112.31 2.78 Favored 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 123.248 2.632 . . . . 74.24 112.345 -177.39 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 288' ' ' VAL . . . . . 0.563 HG11 ' HG2' ' B' ' 289' ' ' ARG . 41.7 t 59.18 -80.43 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.242 0 C-N-CA 125.101 1.36 . . . . 74.32 111.965 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 289' ' ' ARG . . . . . 0.563 ' HG2' HG11 ' B' ' 288' ' ' VAL . 59.5 mmt-85 -124.68 102.66 7.7 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.647 0.779 . . . . 74.32 110.019 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 290' ' ' TRP . . . . . 0.408 ' O ' ' HA ' ' B' ' 286' ' ' MET . 8.0 m-90 65.82 -83.32 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 125.317 1.447 . . . . 75.34 112.264 176.082 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 291' ' ' LEU . . . . . 0.525 ' HA ' ' HD2' ' B' ' 287' ' ' PRO . 5.9 mp -134.11 49.3 2.27 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.406 -0.961 . . . . 73.52 108.406 177.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . 87.21 153.61 24.88 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-O 118.318 -1.268 . . . . 71.42 111.317 -170.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -38.4 92.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 124.125 3.217 . . . . 75.13 114.624 172.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 294' ' ' LYS . . . . . 0.451 ' HE2' ' HA ' ' B' ' 294' ' ' LYS . 11.4 mmpt? -70.97 -30.49 66.77 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 114.495 -1.229 . . . . 74.44 110.248 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 295' ' ' ALA . . . . . 0.533 ' HB3' ' HB2' ' C' ' 184' ' ' PRO . . . -153.56 163.76 39.41 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 124.944 1.297 . . . . 71.35 108.42 171.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 29.1 m -94.31 143.02 26.75 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.206 0.603 . . . . 71.52 109.828 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -61.83 97.13 0.07 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.768 0.827 . . . . 75.44 109.88 178.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 298' ' ' HIS . . . . . 0.473 ' HB3' HD11 ' B' ' 375' ' ' LEU . 36.8 t-80 60.82 23.15 13.15 Favored 'General case' 0 CA--C 1.563 1.475 0 C-N-CA 124.724 1.21 . . . . 73.43 111.442 177.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . -85.21 8.41 70.97 Favored Glycine 0 C--N 1.354 1.581 0 CA-C-N 115.928 -0.578 . . . . 72.35 113.151 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -86.83 53.01 2.67 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.698 1.199 . . . . 72.23 109.518 176.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 301' ' ' ILE . . . . . 0.564 HG13 ' H ' ' B' ' 302' ' ' ASP 0.275 21.2 pt 37.82 -82.79 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.564 1.484 0 C-N-CA 127.152 2.181 . . . . 75.13 114.407 -167.942 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 302' ' ' ASP . . . . . 0.564 ' H ' HG13 ' B' ' 301' ' ' ILE . 14.0 t70 65.66 100.55 0.04 OUTLIER 'General case' 0 C--O 1.242 0.701 0 C-N-CA 124.784 1.234 . . . . 74.32 113.076 -177.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 303' ' ' LYS . . . . . 0.569 ' HE2' ' HB3' ' B' ' 62' ' ' LYS . 0.1 OUTLIER 155.09 -56.84 0.0 OUTLIER Pre-proline 0 N--CA 1.486 1.354 0 C-N-CA 126.913 2.085 . . . . 74.11 109.445 158.305 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 304' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -78.38 104.9 1.9 Allowed 'Trans proline' 0 C--N 1.391 2.799 0 C-N-CA 121.849 1.699 . . . . 75.12 112.55 -177.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -166.61 -55.79 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.606 0.762 . . . . 72.13 111.384 175.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 6.3 p -77.63 -36.16 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 113.16 0.8 . . . . 72.33 113.16 -176.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 307' ' ' THR . . . . . 0.453 HG23 HD12 ' B' ' 367' ' ' LEU . 63.2 m 59.12 -87.06 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 124.163 0.985 . . . . 74.23 110.241 -158.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 308' ' ' CYS . . . . . . . . . . . . . 37.6 t 171.07 119.75 0.01 OUTLIER 'General case' 0 C--N 1.359 1.007 0 C-N-CA 125.325 1.45 . . . . 74.22 108.657 -173.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 309' ' ' THR . . . . . 0.453 ' H ' HG13 ' B' ' 68' ' ' ILE . 23.6 m -90.72 120.14 68.88 Favored Pre-proline 0 N--CA 1.475 0.777 0 C-N-CA 123.298 0.639 . . . . 72.2 109.501 176.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -65.48 -35.6 38.22 Favored 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 122.544 2.162 . . . . 64.44 112.556 -176.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 311' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -99.16 146.33 31.53 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 123.565 0.746 . . . . 73.13 110.422 -177.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 312' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -66.58 123.61 11.31 Favored 'Trans proline' 0 C--N 1.367 1.534 0 C-N-CA 122.306 2.004 . . . . 70.14 111.512 167.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 313' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -77.8 109.88 12.19 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.538 -0.912 . . . . 75.13 108.538 170.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 314' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? -65.2 131.18 45.83 Favored 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 109.466 -0.568 . . . . 74.53 109.466 -176.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 315' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -109.66 -55.44 2.43 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 108.585 -0.894 . . . . 75.34 108.585 174.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 316' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -158.69 156.53 30.09 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 115.066 -0.97 . . . . 74.4 108.518 -177.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 78.6 p -69.45 -40.37 77.2 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 122.946 0.498 . . . . 75.41 110.879 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 318' ' ' VAL . . . . . . . . . . . . . 7.6 p -141.1 77.93 19.83 Favored Pre-proline 0 CA--C 1.561 1.371 0 N-CA-C 108.406 -0.961 . . . . 73.13 108.406 176.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 319' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.98 -24.12 39.81 Favored 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 122.89 2.393 . . . . 65.1 112.423 -175.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 320' ' ' THR . . . . . . . . . . . . . 19.0 p -84.1 -9.98 58.17 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 123.956 0.902 . . . . 73.24 111.644 175.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 321' ' ' LEU . . . . . . . . . . . . . 2.8 tt 49.43 -94.17 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 126.138 1.775 . . . . 74.43 112.908 167.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 322' ' ' ALA . . . . . . . . . . . . . . . -142.8 26.74 1.7 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.046 0.938 . . . . 64.54 110.176 -177.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 323' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -84.91 99.15 10.76 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.723 0.809 . . . . 74.02 109.404 177.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 324' ' ' MET . . . . . . . . . . . . . 51.7 ttm -165.81 -22.35 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.175 0.99 . . . . 74.22 110.57 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 325' ' ' THR . . . . . . . . . . . . . 80.6 m 70.76 -83.24 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.363 1.465 . . . . 72.33 110.252 -173.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 326' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -172.31 -80.57 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.43 0.692 . . . . 72.01 109.254 -178.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . 0.554 ' HB3' ' NH2' ' C' ' 24' ' ' ARG . 0.1 OUTLIER -146.5 -32.98 0.32 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.547 0.739 . . . . 75.41 109.852 175.612 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 328' ' ' ALA . . . . . . . . . . . . . . . 50.75 -93.97 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 124.93 1.292 . . . . 72.03 112.444 173.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 329' ' ' ILE . . . . . . . . . . . . . 9.6 tp -148.73 -43.64 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.121 0 C-N-CA 122.432 0.293 . . . . 73.5 111.717 178.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 330' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -71.19 -23.2 61.99 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 112.495 0.554 . . . . 74.44 112.495 -173.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 331' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -67.65 148.66 51.07 Favored 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 108.833 -0.803 . . . . 64.42 108.833 176.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 332' ' ' LEU . . . . . 0.466 ' HG ' ' NE2' ' C' ' 19' ' ' GLN . 2.7 mm? -78.19 69.02 4.34 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 124.168 0.987 . . . . 74.41 112.95 -159.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 333' ' ' SER . . . . . . . . . . . . . 48.8 m -140.25 -76.77 0.32 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.085 0.954 . . . . 65.04 108.802 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 85.9 mttt 65.95 -66.44 0.16 Allowed 'General case' 0 C--N 1.362 1.117 0 C-N-CA 125.943 1.697 . . . . 65.35 113.319 168.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 335' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -70.63 92.45 0.86 Allowed 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 109.495 -0.558 . . . . 74.12 109.495 175.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -81.2 98.02 7.88 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.672 -0.862 . . . . 73.55 108.672 177.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 337' ' ' LYS . . . . . 0.519 ' HD2' ' ND2' ' C' ' 16' ' ' ASN . 0.3 OUTLIER -105.94 99.45 9.04 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.589 0.756 . . . . 71.1 110.848 -176.318 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 338' ' ' GLY . . . . . . . . . . . . . . . 47.63 -92.6 0.01 OUTLIER Glycine 0 C--N 1.356 1.661 0 C-N-CA 124.341 0.972 . . . . 73.12 114.087 174.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 339' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -87.03 70.93 10.3 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.938 0.895 . . . . 74.33 108.668 173.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 340' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -69.3 -23.21 63.78 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 115.48 -0.782 . . . . 75.24 110.172 171.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 341' ' ' LEU . . . . . . . . . . . . . 2.7 tm? 77.18 -64.2 0.33 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 126.352 1.861 . . . . 75.34 111.107 174.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 342' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -45.24 90.84 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 125.547 1.539 . . . . 74.32 113.332 -175.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 343' ' ' VAL . . . . . 0.408 HG23 ' H ' ' B' ' 344' ' ' GLU . 9.8 p -85.51 179.61 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 CA-C-N 114.278 -1.328 . . . . 65.15 109.265 179.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 344' ' ' GLU . . . . . 0.408 ' H ' HG23 ' B' ' 343' ' ' VAL . 9.2 tp10 -42.13 109.84 0.15 Allowed 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.521 1.128 . . . . 74.33 111.332 171.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 345' ' ' GLY . . . . . . . . . . . . . . . 151.13 99.15 0.19 Allowed Glycine 0 C--N 1.336 0.536 0 N-CA-C 109.808 -1.317 . . . . 63.14 109.808 -172.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 346' ' ' ALA . . . . . . . . . . . . . . . -62.8 -66.81 0.49 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.58 0.752 . . . . 72.51 111.255 -174.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 69.7 m -154.66 13.19 0.41 Allowed 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.921 0.888 . . . . 72.21 110.262 175.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 348' ' ' ILE . . . . . 0.428 ' HB ' ' NH2' ' C' ' 31' ' ' ARG . 21.9 mm 55.79 52.25 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.162 0 CA-C-O 123.584 1.659 . . . . 73.42 107.406 -160.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 349' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -79.4 -14.06 59.19 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 112.203 -2.271 . . . . 71.13 113.039 -165.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 350' ' ' LYS . . . . . . . . . . . . . 42.9 mttp -74.77 -19.04 60.37 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.212 0.605 . . . . 74.52 110.96 -177.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 -104.03 116.21 31.83 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 107.813 -1.18 . . . . 71.32 107.813 169.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 18.6 t70 73.89 -56.11 0.65 Allowed 'General case' 0 N--CA 1.503 2.175 0 C-N-CA 125.516 1.526 . . . . 74.35 112.863 173.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 353' ' ' HIS . . . . . . . . . . . . . 6.1 t60 91.48 -34.56 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 126.772 2.029 . . . . 74.33 112.793 167.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 354' ' ' ALA . . . . . . . . . . . . . . . -133.49 -76.64 0.48 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.608 0.363 . . . . 72.23 110.892 -171.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 355' ' ' ALA . . . . . . . . . . . . . . . 174.67 -39.02 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.034 1.334 . . . . 75.44 108.145 -172.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 356' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 54.52 58.94 11.66 Favored Pre-proline 0 CA--C 1.561 1.396 0 CA-C-N 114.249 -1.341 . . . . 74.32 111.874 177.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 357' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -77.92 -44.26 0.18 Allowed 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 122.584 2.189 . . . . 74.21 113.033 -173.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 358' ' ' CYS . . . . . . . . . . . . . 66.9 m -147.32 107.74 4.09 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.092 0.957 . . . . 75.21 108.709 -178.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 359' ' ' GLY . . . . . . . . . . . . . . . -77.79 80.16 1.36 Allowed Glycine 0 C--N 1.344 1.021 0 N-CA-C 111.0 -0.84 . . . . 72.04 111.0 175.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 360' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -72.03 80.54 0.94 Allowed 'General case' 0 CA--C 1.553 1.082 0 CA-C-O 121.763 0.792 . . . . 53.34 111.429 -178.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 361' ' ' ILE . . . . . . . . . . . . . 1.4 pt -156.07 153.69 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 125.564 1.546 . . . . 64.41 108.68 178.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 362' ' ' GLY . . . . . . . . . . . . . . . 155.67 -163.52 31.73 Favored Glycine 0 C--N 1.341 0.815 0 CA-C-N 115.952 -0.567 . . . . 72.35 112.533 -178.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 363' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -157.68 107.81 2.18 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.689 0.796 . . . . 73.13 108.901 179.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 364' ' ' THR . . . . . . . . . . . . . 77.8 m -104.41 -68.95 0.83 Allowed 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.143 -0.688 . . . . 74.04 109.143 175.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 365' ' ' VAL . . . . . 0.551 HG11 ' H ' ' B' ' 366' ' ' ASP . 3.0 t 60.16 -178.93 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.57 1.734 0 C-N-CA 124.737 1.215 . . . . 74.51 111.238 -178.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 366' ' ' ASP . . . . . 0.638 ' HA ' ' HG3' ' B' ' 17' ' ' PRO . 3.7 m-20 82.65 -12.0 0.94 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 125.488 1.515 . . . . 52.52 112.776 166.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 367' ' ' LEU . . . . . 0.453 HD12 HG23 ' B' ' 307' ' ' THR . 69.5 mt -102.38 25.76 8.6 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 108.51 -0.922 . . . . 75.05 108.51 169.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 368' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -116.16 -156.76 0.63 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.432 1.493 . . . . 73.23 109.667 -174.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 369' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 72.98 107.51 0.07 Allowed 'General case' 0 C--N 1.357 0.918 0 C-N-CA 125.452 1.501 . . . . 74.11 110.757 176.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 370' ' ' ALA . . . . . . . . . . . . . . . -151.52 166.97 29.49 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.735 0.814 . . . . 74.25 110.37 -177.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 371' ' ' VAL . . . . . . . . . . . . . 57.3 t -72.08 125.38 30.62 Favored 'Isoleucine or valine' 0 C--O 1.245 0.828 0 N-CA-C 107.505 -1.294 . . . . 74.12 107.505 166.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 372' ' ' GLN . . . . . . . . . . . . . 50.9 tp60 -61.86 133.82 55.92 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 123.842 0.714 . . . . 63.2 110.632 -175.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 373' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -68.24 -27.4 66.32 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.356 -0.838 . . . . 72.2 111.183 -175.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . 73.36 173.47 0.29 Allowed 'General case' 0 C--O 1.247 0.923 0 C-N-CA 124.909 1.284 . . . . 71.45 111.329 -177.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 375' ' ' LEU . . . . . 0.473 HD11 ' HB3' ' B' ' 298' ' ' HIS . 2.9 mm? -62.26 133.43 55.15 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 114.906 -1.043 . . . . 72.22 111.095 -171.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 64.5 20.46 12.16 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.401 1.08 . . . . 73.13 112.455 173.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 377' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 68.2 100.91 0.05 Allowed 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.979 1.311 . . . . 73.31 111.689 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 378' ' ' ALA . . . . . . . . . . . . . . . 85.38 2.76 0.65 Allowed 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 125.866 1.666 . . . . 73.45 114.228 167.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -81.9 79.23 8.49 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 121.878 0.847 . . . . 73.22 110.267 175.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 380' ' ' LYS . . . . . 0.436 ' HE2' ' HA ' ' B' ' 380' ' ' LYS . 0.6 OUTLIER -134.89 57.28 1.81 Allowed 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 106.424 -1.695 . . . . 72.4 106.424 172.203 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 381' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 57.37 -83.5 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 114.026 -1.443 . . . . 74.34 110.756 -172.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . 73.27 -79.21 0.78 Allowed Glycine 0 C--N 1.351 1.366 0 CA-C-O 121.332 0.406 . . . . 73.1 112.099 178.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 383' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -129.92 119.77 23.79 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 106.064 -1.828 . . . . 73.1 106.064 167.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 384' ' ' THR . . . . . . . . . . . . . 23.6 p -82.08 45.55 0.94 Allowed 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.409 0.684 . . . . 71.44 110.888 -178.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 37.9 tp -150.85 -55.0 0.15 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.132 0.973 . . . . 75.43 108.87 -175.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 386' ' ' VAL . . . . . . . . . . . . . 20.8 m -134.9 155.65 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 C-N-CA 124.09 0.956 . . . . 75.23 109.93 177.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 387' ' ' ILE . . . . . 0.44 HG13 HG23 ' B' ' 388' ' ' VAL . 10.9 tp -112.22 146.51 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 123.049 0.539 . . . . 74.12 109.976 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 388' ' ' VAL . . . . . 0.44 HG23 HG13 ' B' ' 387' ' ' ILE . 49.1 t 61.03 -91.34 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 C-N-CA 125.18 1.392 . . . . 74.43 111.049 -178.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 389' ' ' THR . . . . . 0.545 ' HG1' HG22 ' A' ' 158' ' ' VAL . 62.3 m -158.73 -64.93 0.08 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.89 0.876 . . . . 71.25 108.694 -177.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . -171.02 -177.19 2.14 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.357 1.063 . . . . 73.41 110.038 -174.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 391' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -63.74 -52.92 58.29 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.377 0.671 . . . . 64.12 110.664 173.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 392' ' ' HIS . . . . . . . . . . . . . 28.1 t-80 63.5 -76.94 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.618 1.167 . . . . 72.42 111.214 -175.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -153.86 74.33 0.98 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.534 0.733 . . . . 61.53 109.273 179.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 62.24 35.58 15.31 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 124.275 1.03 . . . . 73.31 110.164 -178.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . 63.19 9.57 4.03 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.978 1.311 . . . . 75.42 112.976 -177.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 43.5 t -96.46 135.97 37.6 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 123.971 0.909 . . . . 75.55 109.472 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 397' ' ' GLN . . . . . . . . . . . . . 20.4 tp60 -66.49 -48.37 70.03 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.037 0.935 . . . . 75.54 110.793 176.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 398' ' ' ILE . . . . . 0.498 HG21 ' H ' ' B' ' 399' ' ' VAL 0.264 7.6 tt 36.61 -95.86 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.571 1.787 0 C-N-CA 125.93 1.692 . . . . 75.44 111.968 -171.048 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 399' ' ' VAL . . . . . 0.514 HG22 ' H ' ' B' ' 400' ' ' ALA . 1.4 m -148.49 -61.8 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 124.921 1.288 . . . . 73.32 108.698 171.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 400' ' ' ALA . . . . . 0.546 ' HB1' ' HB ' ' B' ' 403' ' ' THR . . . 46.21 53.27 12.73 Favored Pre-proline 0 CA--C 1.567 1.61 0 C-N-CA 125.515 1.526 . . . . 74.52 113.175 -179.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 401' ' ' PRO . . . . . 0.648 ' HA ' ' HA ' ' A' ' 117' ' ' ARG . 26.1 Cg_exo -61.95 -58.61 0.36 Allowed 'Trans proline' 0 C--N 1.388 2.606 0 C-N-CA 123.021 2.481 . . . . 71.34 113.491 -169.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -95.6 26.29 4.04 Favored 'General case' 0 CA--C 1.554 1.124 0 CA-C-O 121.643 0.735 . . . . 74.34 110.499 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 403' ' ' THR . . . . . 0.546 ' HB ' ' HB1' ' B' ' 400' ' ' ALA . 9.1 m -107.56 87.4 2.49 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 108.579 -0.897 . . . . 73.2 108.579 176.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 404' ' ' LYS . . . . . 0.613 ' HE3' ' HB3' ' A' ' 118' ' ' ASP . 43.0 mmtm -129.41 143.53 50.88 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.819 0.848 . . . . 71.14 109.909 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 405' ' ' ALA . . . . . . . . . . . . . . . -170.38 -41.78 0.0 OUTLIER Pre-proline 0 CA--C 1.563 1.455 0 CA-C-O 118.108 -0.948 . . . . 71.24 112.152 -169.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 406' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -46.74 144.06 8.3 Favored 'Trans proline' 0 C--N 1.406 3.571 0 C-N-CA 122.872 2.381 . . . . 64.23 113.732 171.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . 95.56 -64.22 1.31 Allowed Glycine 0 C--N 1.342 0.916 0 N-CA-C 111.061 -0.815 . . . . 74.04 111.061 -176.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 408' ' ' LEU . . . . . . . . . . . . . 44.9 tp 57.78 -80.15 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 125.392 1.477 . . . . 72.55 112.43 175.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 21.6 m -110.56 68.13 0.66 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.654 0.781 . . . . 73.52 109.977 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 410' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 62.86 21.19 12.68 Favored 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 124.982 1.313 . . . . 70.42 113.503 170.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . -71.53 151.69 43.64 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 121.744 -0.598 . . . . 74.33 110.171 175.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 24.8 tp 71.89 10.88 6.23 Favored 'General case' 0 CA--C 1.566 1.595 0 C-N-CA 125.573 1.549 . . . . 75.21 111.817 -179.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -66.03 -37.69 86.51 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.06 0.544 . . . . 71.14 110.311 173.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 414' ' ' THR . . . . . . . . . . . . . 49.8 m 78.6 -42.61 0.33 Allowed 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 126.195 1.798 . . . . 73.24 112.191 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 415' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt 69.82 -81.79 0.03 OUTLIER 'General case' 0 C--N 1.352 0.693 0 C-N-CA 125.766 1.626 . . . . 75.21 111.17 -178.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -133.41 -175.11 3.7 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.796 0.838 . . . . 75.33 111.234 -168.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 417' ' ' GLY . . . . . 0.429 ' O ' ' HG3' ' A' ' 241' ' ' PRO . . . 155.99 -21.32 0.51 Allowed Glycine 0 C--N 1.35 1.341 0 CA-C-N 115.58 -0.737 . . . . 62.31 111.695 -177.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 418' ' ' ALA . . . . . . . . . . . . . . . -59.59 -31.48 69.5 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.076 0.95 . . . . 70.25 112.035 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 419' ' ' VAL . . . . . 0.471 HG21 ' HG2' ' B' ' 420' ' ' MET . 30.4 m -74.23 -24.1 18.87 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 C-N-CA 123.646 0.779 . . . . 73.31 112.241 178.138 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 420' ' ' MET . . . . . 0.471 ' HG2' HG21 ' B' ' 419' ' ' VAL . 26.6 mmt -99.95 23.64 9.56 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.834 0.854 . . . . 73.34 111.662 -172.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 421' ' ' VAL . . . . . 0.529 ' HA ' ' HD3' ' A' ' 241' ' ' PRO . 18.6 m -69.05 -156.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 C-N-CA 123.793 0.837 . . . . 72.42 111.789 178.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 422' ' ' MET . . . . . . . . . . . . . 20.8 ptt? -67.39 67.25 0.08 Allowed 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 122.62 1.2 . . . . 74.1 111.092 173.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 423' ' ' SER . . . . . . . . . . . . . 12.0 t -173.78 -166.66 0.32 Allowed 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 127.142 2.177 . . . . 63.45 106.405 -170.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 424' ' ' TYR . . . . . . . . . . . . . 92.9 t80 67.21 -77.02 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 124.378 1.071 . . . . 74.22 111.857 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . -73.12 165.92 54.69 Favored Glycine 0 C--N 1.35 1.323 0 CA-C-O 119.845 -0.419 . . . . 75.12 112.796 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 426' ' ' ASN . . . . . 0.513 ' HB3' ' HB ' ' B' ' 435' ' ' THR . 3.0 t30 48.6 61.17 3.2 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 125.107 1.363 . . . . 75.43 111.132 -177.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 427' ' ' SER . . . . . . . . . . . . . 16.2 t 60.7 23.55 13.41 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 124.833 1.253 . . . . 75.14 113.112 175.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 50.64 -68.56 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 127.613 2.365 . . . . 73.23 115.339 175.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 429' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -78.03 -60.05 2.53 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 107.872 -1.158 . . . . 63.42 107.872 173.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 11.9 t70 53.4 97.21 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.732 1.613 . . . . 62.42 111.794 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 14.7 m 76.53 -39.7 0.36 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.671 1.588 . . . . 75.05 111.77 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 432' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -169.47 -66.89 0.02 OUTLIER 'General case' 0 C--N 1.35 0.622 0 C-N-CA 123.774 0.829 . . . . 71.1 109.383 -172.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 433' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -166.98 166.21 15.45 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.538 0.735 . . . . 73.43 109.887 -166.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 434' ' ' HIS . . . . . . . . . . . . . 38.9 m80 66.19 18.03 10.87 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 124.652 1.181 . . . . 73.42 111.936 175.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 435' ' ' THR . . . . . 0.513 ' HB ' ' HB3' ' B' ' 426' ' ' ASN . 29.4 p 57.08 34.22 24.55 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.542 1.537 . . . . 73.42 112.381 -176.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . 166.83 27.84 0.02 OUTLIER Glycine 0 C--N 1.348 1.241 0 CA-C-O 119.322 -0.71 . . . . 61.51 113.886 175.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 39.3 t 59.28 -77.55 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.827 1.251 . . . . 72.35 110.918 -169.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 438' ' ' GLN . . . . . . . . . . . . . 3.6 pp0? -67.63 -174.94 0.47 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.079 1.352 . . . . 71.55 112.56 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 439' ' ' LEU . . . . . . . . . . . . . 94.9 mt -80.82 26.84 0.4 Allowed 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 113.805 1.039 . . . . 74.24 113.805 -169.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 440' ' ' ARG . . . . . 0.48 ' HD3' ' HG1' ' B' ' 435' ' ' THR . 30.6 mmm180 60.81 34.93 19.6 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 123.743 0.817 . . . . 74.1 112.219 174.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 441' ' ' ILE . . . . . 0.684 ' HA ' HD23 ' A' ' 235' ' ' LEU . 39.2 mt -67.34 98.4 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 CA-C-N 115.263 -0.88 . . . . 74.15 112.359 -169.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 442' ' ' ALA . . . . . . . . . . . . . . . -92.25 -88.13 0.21 Allowed 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 114.956 -1.02 . . . . 73.33 108.711 171.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 443' ' ' ALA . . . . . 0.558 ' HB3' ' HG3' ' A' ' 224' ' ' PRO . . . 66.24 -72.16 0.08 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 125.355 1.462 . . . . 74.21 114.013 168.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 444' ' ' TYR . . . . . 0.43 ' CE2' ' HA ' ' A' ' 227' ' ' THR . 88.6 m-85 -134.61 158.0 45.14 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.308 1.043 . . . . 71.31 108.512 175.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . -123.78 62.54 0.57 Allowed Glycine 0 CA--C 1.537 1.463 0 CA-C-O 119.196 -0.78 . . . . 74.34 113.086 176.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 446' ' ' PRO . . . . . 0.43 ' HB3' ' HD2' ' A' ' 226' ' ' ARG . 4.0 Cg_exo -84.44 121.19 2.58 Favored 'Trans proline' 0 C--N 1.384 2.396 0 C-N-CA 123.065 2.51 . . . . 72.44 110.316 174.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 447' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 71.87 -58.77 0.57 Allowed 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 125.959 1.704 . . . . 63.45 110.547 -171.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . 75.46 -67.21 0.25 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 125.665 1.586 . . . . 74.31 113.196 168.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 449' ' ' ALA . . . . . . . . . . . . . . . -75.55 75.59 2.58 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.851 0.86 . . . . 74.42 111.92 -173.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 450' ' ' ASN . . . . . . . . . . . . . 65.3 t30 168.73 -35.72 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 126.366 1.867 . . . . 63.22 107.976 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 42.3 t -78.81 125.85 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.268 1.027 . . . . 74.44 109.785 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 452' ' ' VAL . . . . . . . . . . . . . 30.2 m -71.97 159.24 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 123.239 0.615 . . . . 74.24 111.021 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 97.87 -58.64 1.06 Allowed Glycine 0 C--N 1.341 0.813 0 N-CA-C 111.518 -0.633 . . . . 73.44 111.518 -177.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 454' ' ' LEU . . . . . . . . . . . . . 97.1 mt 68.05 159.41 0.16 Allowed 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 125.121 1.368 . . . . 73.13 113.171 176.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 12.5 p -77.67 94.73 4.46 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 114.928 -1.033 . . . . 72.1 109.59 172.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -64.58 -52.97 54.84 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.518 -0.764 . . . . 74.3 110.938 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 457' ' ' GLN . . . . . 0.519 ' HB2' ' HG3' ' A' ' 236' ' ' LYS . 0.5 OUTLIER -81.86 96.39 7.62 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.056 -1.09 . . . . 65.21 108.056 179.424 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 43.6 p 51.18 -165.82 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 125.626 1.571 . . . . 72.13 112.802 -176.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 459' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -86.73 -48.7 8.04 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 121.986 -0.446 . . . . 73.31 111.859 -170.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 9.4 mp 49.64 49.52 19.86 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 123.787 0.835 . . . . 65.42 110.344 -171.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -63.33 119.53 9.84 Favored 'General case' 0 CA--C 1.552 1.04 0 CA-C-N 114.231 -1.35 . . . . 75.0 112.069 -171.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -125.93 29.88 5.8 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.702 1.201 . . . . 72.53 108.626 169.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 5.7 t -99.73 90.75 4.57 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 114.872 -1.058 . . . . 71.14 110.142 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 464' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -98.41 29.46 3.61 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.788 0.835 . . . . 75.31 109.065 170.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? 67.27 8.02 5.93 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 125.63 1.572 . . . . 72.15 111.006 -166.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . 54.99 -157.69 0.21 Allowed 'General case' 0 C--N 1.364 1.217 0 C-N-CA 124.735 1.214 . . . . 65.13 110.982 -172.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 467' ' ' ALA . . . . . 0.4 ' HB1' ' HA ' ' C' ' 263' ' ' PRO . . . -96.11 -27.47 15.05 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.181 0.592 . . . . 75.3 110.215 172.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 3.3 pp -162.13 -30.13 0.05 OUTLIER 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.598 1.559 . . . . 74.32 109.85 177.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 469' ' ' GLY . . . . . . . . . . . . . . . 72.21 -91.04 0.53 Allowed Glycine 0 C--N 1.35 1.336 0 C-N-CA 123.913 0.768 . . . . 62.03 112.859 177.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 470' ' ' LEU . . . . . . . . . . . . . 16.6 tp 68.08 6.98 5.54 Favored 'General case' 0 CA--C 1.562 1.418 0 C-N-CA 125.774 1.629 . . . . 75.32 112.122 -178.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 471' ' ' LYS . . . . . . . . . . . . . 64.4 tttp . . . . . 0 C--O 1.252 1.215 0 N-CA-C 107.866 -1.161 . . . . 74.2 107.866 176.632 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 77.2 mtm . . . . . 0 N--CA 1.476 0.826 0 CA-C-O 119.745 -0.169 . . . . 70.43 111.108 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.69 41.22 18.87 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.417 1.087 . . . . 70.41 111.63 177.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -72.48 77.6 1.05 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.763 0.825 . . . . 71.34 110.534 178.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -36.89 117.52 0.52 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.891 1.676 . . . . 70.52 114.288 -176.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 5' ' ' LYS . . . . . 0.466 ' HB3' HD12 ' C' ' 10' ' ' ILE . 14.1 mmmm -93.93 108.59 20.37 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 108.355 -0.98 . . . . 72.32 108.355 167.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -71.94 93.97 1.41 Allowed 'General case' 0 C--O 1.238 0.487 0 N-CA-C 107.583 -1.265 . . . . 65.15 107.583 175.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 7' ' ' TYR . . . . . 0.467 ' HA ' HD11 ' C' ' 10' ' ' ILE . 30.9 m-85 -60.41 -30.36 69.56 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 115.004 -0.998 . . . . 73.43 112.158 -171.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -66.76 -45.04 79.78 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.572 -0.74 . . . . 74.23 110.521 177.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.9 -42.58 99.25 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.088 0.555 . . . . 63.34 110.685 177.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 10' ' ' ILE . . . . . 0.467 HD11 ' HA ' ' C' ' 7' ' ' TYR . 69.5 mt -55.3 -50.95 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 123.72 0.808 . . . . 73.31 111.144 178.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 83.4 mt -74.48 -12.0 60.37 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.528 -0.76 . . . . 75.53 112.371 -179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 69.99 33.82 70.35 Favored Glycine 0 C--N 1.351 1.384 0 O-C-N 123.045 0.216 . . . . 74.43 112.754 -176.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 13' ' ' VAL . . . . . 0.455 ' HB ' ' HD2' ' C' ' 14' ' ' PRO . 11.6 m -108.46 164.39 14.86 Favored Pre-proline 0 N--CA 1.479 1.021 0 C-N-CA 124.46 1.104 . . . . 71.34 109.615 174.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 14' ' ' PRO . . . . . 0.455 ' HD2' ' HB ' ' C' ' 13' ' ' VAL . 35.5 Cg_endo -60.12 162.79 15.76 Favored 'Trans proline' 0 C--N 1.384 2.4 0 C-N-CA 122.095 1.863 . . . . 74.43 112.596 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 8.8 mmm180 -77.18 14.31 0.94 Allowed 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.042 0.937 . . . . 74.35 112.413 -170.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 16' ' ' ASN . . . . . 0.519 ' ND2' ' HD2' ' B' ' 337' ' ' LYS . 6.6 t30 -148.99 14.75 0.92 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.692 1.197 . . . . 71.24 108.716 -176.39 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.04 137.5 56.81 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 123.923 0.889 . . . . 75.2 112.914 -170.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 78.8 p -70.77 161.87 30.13 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.798 0.839 . . . . 74.41 110.649 178.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 19' ' ' GLN . . . . . 0.466 ' NE2' ' HG ' ' B' ' 332' ' ' LEU . 0.2 OUTLIER -57.52 -29.34 64.26 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.519 0.728 . . . . 74.45 111.541 -177.204 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -65.68 -47.92 73.84 Favored 'General case' 0 C--O 1.215 -0.733 0 CA-C-O 119.33 -0.367 . . . . 74.53 110.486 176.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -61.24 -35.62 77.73 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 123.711 0.632 . . . . 73.42 110.821 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.46 -44.04 97.85 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.928 0 C-N-CA 123.671 0.788 . . . . 75.54 110.756 173.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 23' ' ' LYS . . . . . 0.453 ' HZ1' HD21 ' B' ' 332' ' ' LEU . 6.5 ttpm? -73.02 -31.43 64.46 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.539 0.736 . . . . 74.13 111.304 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 24' ' ' ARG . . . . . 0.554 ' NH2' ' HB3' ' B' ' 327' ' ' LYS . 40.0 mtt180 -69.08 -45.47 70.21 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.124 0.97 . . . . 73.52 110.083 178.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -71.77 -31.81 67.01 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 124.522 1.139 . . . . 75.32 111.183 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 26' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -58.0 -60.3 3.94 Favored 'General case' 0 C--O 1.21 -0.995 0 O-C-N 124.191 0.932 . . . . 72.31 109.323 171.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . 0.43 ' O ' ' HG3' ' C' ' 31' ' ' ARG . 53.4 mtmt -63.07 -35.08 79.04 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 124.366 1.041 . . . . 75.33 111.336 -178.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 28' ' ' ARG . . . . . 0.582 ' HA ' HH21 ' C' ' 31' ' ' ARG . 63.7 ttt180 -58.11 -51.88 67.86 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.071 0.948 . . . . 75.55 110.244 177.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . 0.477 ' HA ' ' HB3' ' C' ' 32' ' ' GLN . 83.2 mt -90.62 -0.02 57.54 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 113.983 -1.462 . . . . 71.43 111.195 -177.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.15 -10.96 29.05 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.778 0.831 . . . . 75.32 110.003 169.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . 0.582 HH21 ' HA ' ' C' ' 28' ' ' ARG . 32.7 mtm105 -93.66 -35.81 12.66 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.261 0.624 . . . . 73.5 109.454 165.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 32' ' ' GLN . . . . . 0.477 ' HB3' ' HA ' ' C' ' 29' ' ' LEU . 8.3 tt0 -67.69 -60.55 2.45 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 122.489 0.316 . . . . 71.12 110.386 176.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -92.38 31.71 1.28 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.287 0.635 . . . . 72.14 109.781 178.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 34' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -58.91 106.46 0.72 Allowed Pre-proline 0 N--CA 1.481 1.078 0 C-N-CA 124.184 0.993 . . . . 74.34 109.059 -179.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -58.37 -29.45 88.25 Favored 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 123.041 2.494 . . . . 72.22 113.146 -165.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -72.28 -33.15 67.22 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.042 0.937 . . . . 60.34 112.442 178.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 61.8 t -97.73 -23.15 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 123.457 0.703 . . . . 75.33 110.689 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -128.86 83.61 2.17 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.74 0.816 . . . . 65.41 109.504 -168.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -81.85 36.05 0.44 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.134 0.973 . . . . 71.22 111.374 178.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 40' ' ' SER . . . . . 0.424 ' HB2' ' HB2' ' C' ' 43' ' ' ALA . 20.0 m -93.02 107.71 26.97 Favored Pre-proline 0 CA--C 1.544 0.742 0 N-CA-C 108.63 -0.878 . . . . 74.14 108.63 -178.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -43.39 -54.67 3.4 Favored 'Trans proline' 0 C--N 1.386 2.507 0 C-N-CA 124.437 3.425 . . . . 75.0 114.439 -171.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -67.29 -31.14 71.25 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.974 0.91 . . . . 71.01 110.777 -176.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 43' ' ' ALA . . . . . 0.424 ' HB2' ' HB2' ' C' ' 40' ' ' SER . . . -77.31 -19.13 56.84 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.021 0.528 . . . . 71.45 110.68 177.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -82.9 -28.06 30.23 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.11 0.564 . . . . 74.04 109.504 176.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -75.63 -32.74 60.36 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.542 0.737 . . . . 75.44 109.832 173.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 46' ' ' LYS . . . . . . . . . . . . . 41.1 mmtm -65.17 -44.02 89.87 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.73 -0.668 . . . . 72.32 109.992 168.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -56.71 -37.01 70.32 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.529 0.732 . . . . 71.12 110.171 174.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -62.41 -44.33 96.71 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 123.745 0.653 . . . . 72.04 111.72 174.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -66.35 -33.87 76.69 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 122.334 0.253 . . . . 72.33 111.628 176.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 50' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.56 -39.44 85.05 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 C-N-CA 123.77 0.828 . . . . 75.43 109.751 173.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 51' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -72.08 -29.29 63.97 Favored 'General case' 0 C--O 1.212 -0.88 0 C-N-CA 124.034 0.934 . . . . 74.04 110.785 177.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -67.51 -57.53 6.33 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.566 1.146 . . . . 75.54 109.966 177.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.57 -47.12 85.32 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-N 113.158 -1.837 . . . . 63.1 111.629 -176.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -60.22 -57.76 11.4 Favored 'General case' 0 C--O 1.203 -1.362 0 CA-C-N 115.051 -0.977 . . . . 75.01 110.567 174.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.97 -30.77 64.38 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 113.174 0.805 . . . . 60.54 113.174 -170.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 94.3 t -73.78 -60.06 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 N-CA-C 109.843 -0.429 . . . . 72.43 109.843 170.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 57' ' ' LEU . . . . . 0.415 HD11 ' HB2' ' C' ' 7' ' ' TYR . 79.7 mt -81.64 4.6 21.06 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 113.454 0.909 . . . . 75.02 113.454 -169.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 41.8 t -74.62 -36.53 62.92 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.447 1.099 . . . . 75.33 109.717 177.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -82.96 127.78 68.16 Favored Pre-proline 0 C--N 1.331 -0.206 0 N-CA-C 108.399 -0.963 . . . . 72.03 108.399 174.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 60' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -54.71 -32.91 78.05 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.571 2.181 . . . . 73.21 111.073 165.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -55.4 -64.64 0.78 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.957 1.303 . . . . 62.13 110.864 174.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 62' ' ' LYS . . . . . 0.404 ' HA ' HD12 ' C' ' 65' ' ' ILE . 36.8 mtpt -76.45 -16.0 59.78 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.13 0.972 . . . . 75.43 112.197 -173.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -71.37 -45.15 63.57 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 107.816 -1.179 . . . . 74.14 107.816 171.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -72.13 -24.06 61.41 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.199 0.599 . . . . 74.15 111.861 175.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 65' ' ' ILE . . . . . 0.404 HD12 ' HA ' ' C' ' 62' ' ' LYS . 90.3 mt -66.06 -42.93 92.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 N-CA-C 109.204 -0.665 . . . . 71.5 109.204 171.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -60.58 -48.89 79.77 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 115.486 -0.779 . . . . 74.31 109.5 174.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -57.39 -42.73 82.76 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.801 0.84 . . . . 73.14 112.112 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 35.8 p -74.13 -23.18 59.25 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.659 0.384 . . . . 74.43 111.431 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -74.11 142.93 45.56 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 109.133 -0.692 . . . . 75.22 109.133 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.64 11.99 65.18 Favored Glycine 0 N--CA 1.476 1.351 0 N-CA-C 112.072 -0.411 . . . . 62.51 112.072 -171.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 36.2 m -144.75 -54.26 0.32 Allowed 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 104.259 -2.497 . . . . 72.34 104.259 175.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 55.0 m -88.73 151.98 22.08 Favored 'General case' 0 C--O 1.246 0.88 0 N-CA-C 104.949 -2.241 . . . . 73.35 104.949 156.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.56 -17.33 2.27 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.872 0.869 . . . . 73.23 110.29 -176.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.88 132.55 77.28 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 123.572 0.749 . . . . 53.23 110.466 174.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -61.46 156.87 44.17 Favored 'Trans proline' 0 C--N 1.377 2.071 0 C-N-CA 123.413 2.742 . . . . 75.14 112.48 175.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -63.21 169.08 9.87 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 123.421 2.748 . . . . 71.22 112.81 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.85 122.58 5.92 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 121.86 1.707 . . . . 74.4 111.305 171.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 78' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.81 122.8 7.53 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 122.51 2.14 . . . . 74.44 112.043 175.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -82.72 159.55 16.4 Favored 'Trans proline' 0 CA--C 1.557 1.672 0 C-N-CA 122.72 2.28 . . . . 70.12 112.109 173.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.27 84.77 0.04 OUTLIER 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 123.123 2.549 . . . . 74.31 112.18 169.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . 0.515 ' HA3' ' HB1' ' C' ' 141' ' ' ALA . . . 160.21 -30.18 0.37 Allowed Glycine 0 C--O 1.239 0.43 0 CA-C-N 114.559 -1.2 . . . . 75.2 110.316 -178.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 92.14 178.86 41.58 Favored Glycine 0 C--N 1.35 1.311 0 CA-C-N 115.196 -0.502 . . . . 75.13 112.314 173.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -80.68 102.16 9.71 Favored 'General case' 0 C--O 1.243 0.761 0 N-CA-C 106.927 -1.508 . . . . 73.4 106.927 168.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -53.73 132.69 41.56 Favored 'General case' 0 C--O 1.248 0.978 0 O-C-N 124.769 1.293 . . . . 75.11 111.42 -174.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 85' ' ' PHE . . . . . 0.483 ' CD1' ' HB ' ' C' ' 90' ' ' VAL . 2.1 t80 -156.18 24.02 0.36 Allowed 'General case' 0 C--O 1.243 0.761 0 CA-C-N 114.624 -1.171 . . . . 74.41 110.697 -173.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 52.3 m -58.45 128.38 36.85 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.274 -0.876 . . . . 52.42 111.01 -176.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 91.47 -30.31 6.55 Favored Glycine 0 C--N 1.342 0.906 0 CA-C-O 119.591 -0.561 . . . . 74.34 113.175 -179.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 88' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -94.44 137.74 33.22 Favored 'General case' 0 C--N 1.355 0.823 0 N-CA-C 108.443 -0.947 . . . . 74.44 108.443 -177.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -86.64 70.45 10.41 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.244 0.618 . . . . 72.23 111.142 -169.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 90' ' ' VAL . . . . . 0.483 ' HB ' ' CD1' ' C' ' 85' ' ' PHE . 1.3 p -39.59 -47.13 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 C-N-CA 125.138 1.375 . . . . 54.42 113.446 178.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -69.93 -23.38 63.2 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 114.695 -1.139 . . . . 75.25 111.753 -167.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -100.77 -7.18 23.96 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.293 0.637 . . . . 75.53 111.1 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 8.1 m-30 -78.73 -172.12 2.85 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 109.869 -0.419 . . . . 72.45 109.869 176.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 88.0 p -68.27 148.81 50.26 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 112.332 0.493 . . . . 52.11 112.332 -170.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.63 -38.26 89.55 Favored 'General case' 0 CA--C 1.551 1.009 0 CA-C-N 114.871 -1.059 . . . . 72.35 110.869 175.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -49.05 -52.45 25.38 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.658 1.183 . . . . 74.24 111.375 171.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 97' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -62.37 -43.68 98.25 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 114.409 -1.268 . . . . 64.25 110.626 178.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -73.3 -5.06 37.15 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.428 0.691 . . . . 71.33 112.341 -178.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -100.08 -41.96 6.93 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.267 0.627 . . . . 74.43 111.712 167.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 26.6 tp -67.24 -42.86 83.28 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.329 0.652 . . . . 73.23 111.573 -173.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -109.91 5.13 22.18 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-O 121.062 0.458 . . . . 75.04 109.875 173.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -44.96 -52.56 7.87 Favored Glycine 0 CA--C 1.538 1.514 0 CA-C-O 118.416 -1.213 . . . . 74.41 115.153 -177.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -35.03 -29.05 0.05 OUTLIER 'Trans proline' 0 C--N 1.389 2.658 0 C-N-CA 125.045 3.83 . . . . 64.35 117.142 175.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -145.73 21.79 1.82 Allowed Glycine 0 C--N 1.36 1.91 0 CA-C-N 118.552 0.615 . . . . 73.42 113.891 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 6.9 mt -75.05 76.54 2.24 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 113.284 0.846 . . . . 75.43 113.284 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 106' ' ' PHE . . . . . 0.495 ' HB3' ' O ' ' C' ' 168' ' ' GLY . 3.7 m-30 45.29 -105.73 0.1 Allowed 'General case' 0 CA--C 1.563 1.451 0 O-C-N 124.622 1.202 . . . . 64.24 112.913 162.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . 111.04 28.33 3.92 Favored Glycine 0 C--N 1.36 1.879 0 N-CA-C 116.182 1.233 . . . . 51.05 116.182 164.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 108' ' ' GLY . . . . . 0.699 ' HA2' ' HA ' ' C' ' 114' ' ' ARG . . . -11.14 -89.79 0.01 OUTLIER Glycine 0 N--CA 1.477 1.38 0 N-CA-C 118.165 2.026 . . . . 74.41 118.165 169.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 109' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -75.72 -8.06 55.89 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 117.034 0.417 . . . . 74.45 111.352 -170.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 110' ' ' GLY . . . . . . . . . . . . . . . -90.56 3.57 81.67 Favored Glycine 0 C--N 1.348 1.248 0 N-CA-C 111.206 -0.758 . . . . 73.14 111.206 173.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 64.5 mtm180 57.97 8.92 0.81 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 125.55 1.54 . . . . 75.25 113.21 175.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 112' ' ' ARG . . . . . . . . . . . . . 53.1 ttt180 -81.94 47.48 1.11 Allowed 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 125.694 1.597 . . . . 75.43 109.657 176.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 113' ' ' SER . . . . . 0.423 ' HB3' ' HB3' ' C' ' 167' ' ' GLN . 28.5 m 90.3 75.97 0.01 OUTLIER 'General case' 0 C--N 1.365 1.252 0 C-N-CA 126.17 1.788 . . . . 72.53 110.963 -166.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 114' ' ' ARG . . . . . 0.699 ' HA ' ' HA2' ' C' ' 108' ' ' GLY . 18.1 ttm180 -74.48 -163.35 0.2 Allowed 'General case' 0 CA--C 1.581 2.172 0 C-N-CA 123.948 0.899 . . . . 74.05 110.107 170.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 115' ' ' LYS . . . . . 0.687 ' H ' ' HG2' ' C' ' 114' ' ' ARG . 24.3 ttpp -8.0 111.25 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.303 0 C-N-CA 128.058 2.543 . . . . 74.15 116.121 -164.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -63.09 112.83 5.31 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-N 114.626 -1.17 . . . . 54.4 113.573 -171.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 16.2 mtm180 -58.21 124.53 19.73 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.43 0.692 . . . . 74.32 109.25 174.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -57.92 135.22 56.87 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 123.836 0.71 . . . . 75.42 109.249 176.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 119' ' ' LEU . . . . . . . . . . . . . 4.9 tt -95.28 121.34 36.83 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 107.57 -1.27 . . . . 75.21 107.57 -172.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.76 94.78 5.26 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 107.668 -1.234 . . . . 72.31 107.668 -168.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 121' ' ' ALA . . . . . 0.55 ' HA ' HG23 ' B' ' 185' ' ' VAL . . . -108.58 113.0 25.65 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 108.308 -0.997 . . . . 75.44 108.308 -176.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 122' ' ' GLU . . . . . 0.616 ' HB3' ' HB2' ' B' ' 58' ' ' SER . 0.0 OUTLIER -94.15 110.52 22.23 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 106.959 -1.497 . . . . 74.12 106.959 -178.649 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -129.82 133.32 24.89 Favored Pre-proline 0 N--CA 1.48 1.031 0 C-N-CA 122.481 0.313 . . . . 73.3 111.801 -165.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . 0.52 ' HG2' ' HA ' ' B' ' 188' ' ' ARG . 10.7 Cg_exo -73.53 119.57 6.01 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 123.077 2.518 . . . . 72.51 111.172 170.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 125' ' ' LEU . . . . . . . . . . . . . 47.1 tp -128.97 165.32 21.34 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.187 0.995 . . . . 75.32 108.631 -177.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 126' ' ' THR . . . . . 0.51 HG21 ' H ' ' B' ' 175' ' ' ASP . 0.2 OUTLIER -105.61 170.9 7.62 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 121.541 0.686 . . . . 61.53 111.686 179.405 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 127' ' ' LEU . . . . . 0.424 HD23 ' CD2' ' C' ' 183' ' ' HIS . 2.4 mt -81.46 -56.69 3.87 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 114.583 -1.189 . . . . 62.25 109.698 -162.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -49.07 -47.13 45.27 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 112.756 -2.02 . . . . 75.24 110.33 170.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -67.88 -33.0 73.88 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 115.707 -0.679 . . . . 75.51 111.456 -177.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 130' ' ' ALA . . . . . 0.441 ' HB3' HG22 ' C' ' 153' ' ' VAL . . . -68.17 -31.95 71.87 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 123.698 0.623 . . . . 73.14 110.721 173.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 131' ' ' PHE . . . . . 0.403 ' HB2' HD12 ' C' ' 215' ' ' LEU . 74.0 t80 -75.28 -31.85 60.85 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 124.029 0.932 . . . . 75.55 111.37 174.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 132' ' ' HIS . . . . . . . . . . . . . 34.6 m170 -79.62 -55.64 4.88 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 112.335 0.495 . . . . 70.15 112.335 -173.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.07 -111.41 3.34 Favored Glycine 0 C--N 1.345 1.068 0 N-CA-C 110.253 -1.139 . . . . 65.31 110.253 -167.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.41 168.2 35.53 Favored Glycine 0 C--N 1.356 1.645 0 CA-C-N 117.426 0.613 . . . . 73.12 113.511 177.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -71.05 93.65 1.04 Allowed 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 108.932 -0.766 . . . . 73.03 108.932 175.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 136' ' ' ARG . . . . . 0.529 ' HB3' ' HB2' ' B' ' 181' ' ' LEU . 9.6 mpt_? -117.47 133.5 55.9 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.452 1.101 . . . . 72.12 109.493 -174.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 137' ' ' VAL . . . . . . . . . . . . . 27.8 m -71.91 131.12 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-O 121.346 0.593 . . . . 73.11 111.616 -176.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 138' ' ' VAL . . . . . 0.485 HG11 ' SD ' ' C' ' 164' ' ' MET . 13.2 p -115.3 130.12 70.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 C-N-CA 124.684 1.194 . . . . 72.14 107.808 170.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 139' ' ' GLU . . . . . 0.475 ' H ' HG13 ' B' ' 182' ' ' VAL . 42.4 mt-10 -126.61 86.52 2.52 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 108.117 -1.068 . . . . 74.31 108.117 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 140' ' ' VAL . . . . . . . . . . . . . 11.0 m -125.39 107.59 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 123.25 0.62 . . . . 73.25 111.319 -175.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 141' ' ' ALA . . . . . 0.515 ' HB1' ' HA3' ' C' ' 81' ' ' GLY . . . 56.31 28.74 13.84 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.812 1.245 . . . . 65.0 113.27 173.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 119.49 -24.3 8.13 Favored Glycine 0 C--N 1.353 1.475 0 CA-C-N 116.5 -0.318 . . . . 52.4 113.663 177.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 143' ' ' ARG . . . . . 0.547 ' HG2' ' HG3' ' C' ' 164' ' ' MET . 0.3 OUTLIER -76.44 97.63 4.35 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.511 0.724 . . . . 75.05 109.059 178.838 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 40.9 ttp180 -113.42 95.45 5.37 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 109.17 -0.678 . . . . 71.51 109.17 176.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 145' ' ' VAL . . . . . . . . . . . . . 7.6 p -142.31 141.62 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 123.438 0.695 . . . . 75.03 111.254 -176.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 28.0 t -80.4 101.4 8.99 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 108.754 -0.832 . . . . 73.22 108.754 170.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 12.4 p -122.79 152.58 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.102 0.961 . . . . 72.53 110.014 -176.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -99.98 98.86 9.57 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 107.488 -1.301 . . . . 74.22 107.488 171.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 149' ' ' ILE . . . . . 0.642 HD13 HG21 ' C' ' 159' ' ' ILE . 45.9 pt -68.72 151.39 97.27 Favored Pre-proline 0 CA--C 1.55 0.961 0 N-CA-C 108.873 -0.788 . . . . 74.42 108.873 173.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -43.09 110.53 0.17 Allowed 'Trans proline' 0 C--N 1.387 2.604 0 C-N-CA 123.451 2.767 . . . . 61.44 113.543 -178.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -62.3 131.3 33.61 Favored 'Trans proline' 0 C--N 1.386 2.53 0 C-N-CA 122.786 2.324 . . . . 73.2 110.992 178.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 152' ' ' GLY . . . . . . . . . . . . . . . 102.13 61.57 0.74 Allowed Glycine 0 C--N 1.334 0.422 0 N-CA-C 110.396 -1.082 . . . . 63.11 110.396 -171.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 153' ' ' VAL . . . . . 0.523 ' HB ' HG12 ' C' ' 159' ' ' ILE . 0.9 OUTLIER -77.98 158.64 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 108.679 -0.86 . . . . 74.01 108.679 -179.691 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 154' ' ' ARG . . . . . 0.71 ' HG2' HD22 ' C' ' 188' ' ' LEU . 33.8 mtp180 -110.52 111.69 23.1 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 118.757 -0.639 . . . . 75.32 110.179 -170.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 155' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -43.29 120.29 1.84 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.735 1.214 . . . . 74.51 112.853 173.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 156' ' ' GLY . . . . . 0.426 ' HA3' ' HE2' ' B' ' 298' ' ' HIS . . . 75.12 -7.8 20.47 Favored Glycine 0 C--N 1.354 1.551 0 C-N-CA 124.395 0.997 . . . . 75.21 114.182 177.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 157' ' ' SER . . . . . 0.479 ' HB2' ' HB2' ' C' ' 154' ' ' ARG . 69.4 m -109.91 -172.78 2.11 Favored 'General case' 0 C--O 1.246 0.905 0 C-N-CA 124.461 1.105 . . . . 75.43 110.735 -175.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 158' ' ' VAL . . . . . 0.576 ' HB ' ' HB3' ' B' ' 64' ' ' ALA . 12.1 p -88.25 138.99 18.07 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 CA-C-N 114.346 -1.297 . . . . 72.31 112.894 -170.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 159' ' ' ILE . . . . . 0.665 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 8.7 mt -108.31 93.25 2.41 Favored 'Isoleucine or valine' 0 C--O 1.245 0.819 0 N-CA-C 105.428 -2.064 . . . . 72.31 105.428 161.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 160' ' ' ARG . . . . . 0.571 ' HD2' ' HB ' ' B' ' 67' ' ' ILE . 6.1 ptm180 -82.27 123.65 29.24 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 108.951 -0.759 . . . . 75.13 108.951 178.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 161' ' ' VAL . . . . . 0.613 HG12 ' HB3' ' C' ' 174' ' ' LEU . 2.0 p -126.47 95.9 37.22 Favored Pre-proline 0 C--O 1.247 0.966 0 N-CA-C 107.694 -1.225 . . . . 75.24 107.694 170.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.26 147.75 88.12 Favored 'Trans proline' 0 C--N 1.381 2.268 0 C-N-CA 122.499 2.133 . . . . 75.23 110.836 175.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 87.64 25.73 31.88 Favored Glycine 0 C--N 1.338 0.686 0 CA-C-O 119.372 -0.682 . . . . 53.54 112.039 -171.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 164' ' ' MET . . . . . 0.547 ' HG3' ' HG2' ' C' ' 143' ' ' ARG . 34.4 ttm -156.44 23.26 0.35 Allowed 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 117.373 0.586 . . . . 73.35 112.144 -177.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . -86.77 -160.94 35.46 Favored Glycine 0 N--CA 1.48 1.604 0 N-CA-C 114.36 0.504 . . . . 73.32 114.36 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . -96.63 -175.46 35.45 Favored Glycine 0 C--N 1.357 1.733 0 C-N-CA 123.02 0.343 . . . . 75.44 113.514 -177.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 167' ' ' GLN . . . . . 0.442 HE21 ' HA ' ' C' ' 167' ' ' GLN . 0.0 OUTLIER -43.42 122.01 2.46 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 126.036 1.734 . . . . 74.2 113.334 -176.941 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 168' ' ' GLY . . . . . 0.495 ' O ' ' HB3' ' C' ' 106' ' ' PHE . . . 177.07 -126.46 1.11 Allowed Glycine 0 C--N 1.349 1.288 0 CA-C-O 118.889 -0.951 . . . . 13.44 112.003 -175.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 169' ' ' ASN . . . . . 0.554 ' HB3' ' HD3' ' C' ' 170' ' ' PRO . 2.2 t-20 -174.53 -66.57 0.0 OUTLIER Pre-proline 0 CA--C 1.565 1.532 0 CA-C-O 117.759 -1.115 . . . . 62.44 110.731 163.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 170' ' ' PRO . . . . . 0.554 ' HD3' ' HB3' ' C' ' 169' ' ' ASN . 6.9 Cg_exo -69.31 -70.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.403 3.439 0 CA-C-N 122.015 1.755 . . . . 73.55 113.685 -177.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 171' ' ' PRO . . . . . 0.528 ' HD3' ' HB2' ' C' ' 170' ' ' PRO . 85.0 Cg_endo -93.85 126.08 0.53 Allowed 'Trans proline' 0 C--N 1.405 3.542 0 CA-C-N 123.901 2.429 . . . . 74.02 111.521 178.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -154.43 107.79 0.34 Allowed Glycine 0 C--N 1.331 0.25 0 N-CA-C 109.293 -1.523 . . . . 74.42 109.293 176.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 173' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -126.06 121.99 34.53 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 123.447 0.699 . . . . 74.51 109.473 -166.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 174' ' ' LEU . . . . . 0.613 ' HB3' HG12 ' C' ' 161' ' ' VAL . 61.8 tp -81.96 107.3 14.57 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 109.467 -0.568 . . . . 75.22 109.467 177.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 175' ' ' LEU . . . . . 0.446 HD22 HG22 ' C' ' 158' ' ' VAL . 11.4 mt -89.76 87.91 7.16 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 115.632 -0.713 . . . . 72.15 109.641 174.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 176' ' ' LEU . . . . . 0.665 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 98.5 mt -73.8 98.12 2.89 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 108.431 -0.951 . . . . 74.33 108.431 171.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 177' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' C' ' 122' ' ' GLU . 23.7 t -81.24 97.96 3.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 106.585 -1.635 . . . . 75.23 106.585 178.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 178' ' ' VAL . . . . . . . . . . . . . 3.5 p -87.86 129.95 38.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.012 -0.994 . . . . 74.01 110.756 -169.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 179' ' ' ARG . . . . . 0.405 ' O ' ' HA ' ' C' ' 124' ' ' PRO . 7.4 mmm180 -115.26 107.05 14.76 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 106.216 -1.772 . . . . 74.42 106.216 169.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 180' ' ' LEU . . . . . . . . . . . . . 80.8 mt -68.38 138.51 55.42 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 109.147 -0.686 . . . . 73.43 109.147 175.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 181' ' ' LEU . . . . . . . . . . . . . 86.7 mt -50.55 129.76 26.36 Favored Pre-proline 0 N--CA 1.495 1.817 0 CA-C-O 117.848 -1.072 . . . . 74.24 108.672 -173.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER 11.42 -67.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.39 2.723 1 C-N-CA 126.135 4.557 . . . . 73.32 116.329 -153.024 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 183' ' ' HIS . . . . . 0.424 ' CD2' HD23 ' C' ' 127' ' ' LEU . 37.7 t-80 57.29 73.33 0.79 Allowed Pre-proline 0 N--CA 1.479 0.992 0 C-N-CA 124.18 0.992 . . . . 72.0 111.964 168.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 184' ' ' PRO . . . . . 0.533 ' HB2' ' HB3' ' B' ' 295' ' ' ALA . 63.8 Cg_endo -93.22 59.22 0.44 Allowed 'Trans proline' 0 C--N 1.358 1.042 0 N-CA-C 107.678 -1.701 . . . . 74.25 107.678 163.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 185' ' ' VAL . . . . . 0.601 HG12 ' SD ' ' C' ' 213' ' ' MET . 2.2 t -119.5 -59.01 2.95 Favored 'Isoleucine or valine' 0 C--N 1.362 1.133 0 N-CA-C 108.652 -0.87 . . . . 72.23 108.652 178.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 186' ' ' PHE . . . . . 0.483 ' HZ ' ' HA ' ' C' ' 214' ' ' THR . 40.8 m-85 -128.82 173.02 10.73 Favored 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 113.564 0.95 . . . . 61.44 113.564 -172.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 187' ' ' ARG . . . . . 0.443 ' NH1' ' HB2' ' C' ' 189' ' ' GLU . 2.1 tmt_? -152.61 120.92 6.3 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.983 1.313 . . . . 75.14 108.138 167.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 188' ' ' LEU . . . . . 0.71 HD22 ' HG2' ' C' ' 154' ' ' ARG . 48.7 tp -85.59 129.9 34.7 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 118.765 0.711 . . . . 74.14 112.797 -175.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 189' ' ' GLU . . . . . 0.443 ' HB2' ' NH1' ' C' ' 187' ' ' ARG . 14.6 tp10 -133.8 122.41 23.24 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 107.618 -1.253 . . . . 73.21 107.618 165.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 190' ' ' GLY . . . . . 0.492 ' HA2' ' HB3' ' B' ' 69' ' ' LEU . . . 67.27 -107.98 2.25 Favored Glycine 0 C--N 1.344 1.025 0 N-CA-C 111.473 -0.651 . . . . 74.2 111.473 -172.237 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 191' ' ' GLN . . . . . 0.416 ' NE2' ' HA3' ' C' ' 242' ' ' GLY . 24.7 mt-30 -122.93 -16.93 6.92 Favored 'General case' 0 C--O 1.258 1.513 0 C-N-CA 124.506 1.123 . . . . 75.25 109.446 174.247 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -81.37 135.8 35.69 Favored 'General case' 0 C--N 1.355 0.816 0 C-N-CA 124.76 1.224 . . . . 65.13 110.295 -178.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 193' ' ' LEU . . . . . 0.505 HD23 ' CD2' ' C' ' 240' ' ' PHE . 95.4 mt -92.9 154.04 18.44 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.771 0.428 . . . . 65.15 110.67 177.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 194' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -116.64 105.75 12.77 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.076 -1.453 . . . . 75.43 107.076 167.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 195' ' ' ALA . . . . . 0.51 ' HB1' ' HG ' ' C' ' 251' ' ' LEU . . . -103.07 -177.5 3.39 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 124.017 0.927 . . . . 65.11 110.536 177.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 46.7 m -134.64 110.83 9.55 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 108.702 -0.851 . . . . 53.42 108.702 168.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 197' ' ' LEU . . . . . . . . . . . . . 47.9 tp -85.22 146.13 27.23 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 109.139 -0.689 . . . . 73.5 109.139 174.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 198' ' ' ASP . . . . . 0.498 ' HA ' ' HB2' ' C' ' 254' ' ' ARG . 28.4 t70 -117.89 105.88 12.39 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 108.661 -0.866 . . . . 64.33 108.661 -179.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 199' ' ' VAL . . . . . . . . . . . . . 44.7 t -115.05 122.12 33.99 Favored Pre-proline 0 N--CA 1.48 1.046 0 C-N-CA 124.095 0.958 . . . . 73.12 109.435 -176.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 200' ' ' PRO . . . . . 0.412 ' HA ' ' O ' ' C' ' 256' ' ' THR . 55.3 Cg_endo -70.36 148.91 62.24 Favored 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 122.021 1.814 . . . . 73.11 111.341 175.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 201' ' ' ALA . . . . . . . . . . . . . . . -53.9 -45.41 98.92 Favored Pre-proline 0 CA--C 1.559 1.318 0 C-N-CA 124.844 1.258 . . . . 74.35 113.763 -172.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 202' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -55.49 -49.27 16.63 Favored 'Trans proline' 0 C--N 1.396 3.064 0 C-N-CA 121.879 1.719 . . . . 63.15 112.847 175.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 203' ' ' ILE . . . . . . . . . . . . . 58.0 mt -68.12 -33.14 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.721 0.808 . . . . 74.02 110.869 -178.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 204' ' ' ALA . . . . . 0.413 ' HA ' HG12 ' C' ' 223' ' ' VAL . . . -64.25 -44.07 92.93 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.653 0.781 . . . . 75.02 110.856 178.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 205' ' ' VAL . . . . . 0.515 ' HA ' ' HA ' ' C' ' 226' ' ' ARG . 87.0 t -75.4 -39.16 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 115.508 -0.769 . . . . 74.52 112.131 -176.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 206' ' ' VAL . . . . . 0.465 ' HA ' ' HE2' ' A' ' 270' ' ' LYS . 14.6 p -77.34 -37.04 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 CA-C-N 118.078 0.399 . . . . 74.12 110.635 -178.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 86.57 57.68 2.05 Favored Glycine 0 C--N 1.337 0.631 0 N-CA-C 111.384 -0.687 . . . . 63.21 111.384 -168.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -89.49 -131.61 4.36 Favored Glycine 0 C--N 1.345 1.075 0 N-CA-C 110.915 -0.874 . . . . 51.32 110.915 177.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 209' ' ' LYS . . . . . 0.534 ' HZ2' ' HB2' ' C' ' 209' ' ' LYS . 4.6 ttmp? -150.44 143.35 24.72 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.345 0.658 . . . . 72.44 110.123 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 210' ' ' VAL . . . . . . . . . . . . . 30.4 m -134.34 167.98 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 C-N-CA 124.824 1.25 . . . . 71.52 109.486 177.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 211' ' ' ARG . . . . . 0.463 ' HA ' ' HA ' ' C' ' 220' ' ' GLU . 36.2 ttm180 -92.24 127.77 37.85 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 122.608 0.363 . . . . 75.53 111.027 179.247 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -102.47 122.99 45.41 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 107.817 -1.179 . . . . 74.43 107.817 164.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 213' ' ' MET . . . . . 0.601 ' SD ' HG12 ' C' ' 185' ' ' VAL . 1.3 tmt? -77.63 136.63 38.26 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.757 -0.831 . . . . 63.12 108.757 175.195 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 214' ' ' THR . . . . . 0.483 ' HA ' ' HZ ' ' C' ' 186' ' ' PHE . 0.1 OUTLIER -134.32 166.8 21.98 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.014 0.526 . . . . 72.34 110.932 178.15 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 215' ' ' LEU . . . . . 0.403 HD12 ' HB2' ' C' ' 131' ' ' PHE . 52.1 mt -60.12 -38.77 84.03 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.752 1.221 . . . . 75.24 112.851 -171.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.41 14.64 22.55 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.044 0.938 . . . . 71.0 111.844 -174.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 148.77 169.2 15.28 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-O 119.645 -0.531 . . . . 74.41 112.735 176.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -91.73 118.3 0.49 Allowed 'Trans proline' 0 CA--C 1.56 1.815 0 C-N-CA 122.829 2.353 . . . . 64.03 113.004 176.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 219' ' ' VAL . . . . . 0.438 HG11 ' OG1' ' C' ' 214' ' ' THR . 2.9 p -100.01 115.26 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.13 0.572 . . . . 52.53 110.174 178.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 220' ' ' GLU . . . . . 0.498 ' HG2' ' HG2' ' C' ' 209' ' ' LYS . 24.8 tt0 -82.93 103.79 12.66 Favored 'General case' 0 CA--C 1.556 1.173 0 N-CA-C 108.015 -1.106 . . . . 72.32 108.015 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 221' ' ' VAL . . . . . . . . . . . . . 7.6 p -101.79 138.87 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.648 0.779 . . . . 74.03 112.513 -168.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -81.45 117.58 21.99 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.839 1.256 . . . . 73.3 112.424 -173.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . 0.413 HG12 ' HA ' ' C' ' 204' ' ' ALA . 59.7 t -77.7 142.09 65.39 Favored Pre-proline 0 CA--C 1.564 1.491 0 C-N-CA 125.801 1.64 . . . . 73.11 110.423 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 224' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -84.47 155.26 12.26 Favored 'Trans proline' 0 C--N 1.384 2.444 0 C-N-CA 123.408 2.739 . . . . 73.11 113.188 174.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.88 117.67 4.33 Favored 'Trans proline' 0 C--N 1.382 2.306 0 C-N-CA 123.49 2.793 . . . . 74.4 113.3 176.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 226' ' ' ARG . . . . . 0.515 ' HA ' ' HA ' ' C' ' 205' ' ' VAL . 0.0 OUTLIER 65.35 88.69 0.1 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.652 1.581 . . . . 71.5 112.224 -177.917 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 227' ' ' THR . . . . . . . . . . . . . 58.4 m -106.5 131.57 53.53 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 114.337 -1.301 . . . . 73.3 110.345 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 228' ' ' GLN . . . . . 0.501 ' NE2' ' HG2' ' A' ' 259' ' ' GLU . 22.8 mp0 -103.81 152.68 21.61 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.833 0.853 . . . . 74.32 110.816 177.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -69.27 140.71 54.46 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.032 -0.985 . . . . 65.31 109.523 177.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 93.28 -3.88 73.14 Favored Glycine 0 C--N 1.338 0.654 0 CA-C-O 119.639 -0.534 . . . . 62.04 112.942 -174.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 231' ' ' ARG . . . . . 0.407 ' HD2' ' H ' ' C' ' 228' ' ' GLN . 54.3 mtt180 -64.81 174.51 1.82 Allowed 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 117.564 0.682 . . . . 75.03 111.376 168.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 232' ' ' LYS . . . . . 0.638 ' HZ1' ' HB2' ' C' ' 232' ' ' LYS . 2.6 ttmp? -143.29 151.43 40.51 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.641 0.734 . . . . 74.05 111.064 179.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 233' ' ' LEU . . . . . 0.524 HD12 HD12 ' C' ' 251' ' ' LEU . 1.9 tt -127.97 142.35 51.27 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.049 1.74 . . . . 74.22 107.873 -169.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 234' ' ' ARG . . . . . 0.425 ' HA ' ' O ' ' C' ' 249' ' ' LEU . 36.3 ptt180 -115.22 116.78 28.91 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 121.577 0.703 . . . . 72.34 111.379 173.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 235' ' ' LEU . . . . . 0.456 ' HB2' ' HB3' ' C' ' 249' ' ' LEU . 67.9 mt -109.63 99.42 8.61 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 108.839 -0.8 . . . . 74.34 108.839 171.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 236' ' ' LYS . . . . . 0.426 ' HB2' ' ND2' ' B' ' 31' ' ' ASN . 30.6 mmmt -69.4 126.19 28.99 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 114.335 -1.302 . . . . 73.41 110.949 -172.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 87.56 7.06 76.2 Favored Glycine 0 C--N 1.349 1.269 0 O-C-N 123.749 0.656 . . . . 71.42 113.956 -177.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 238' ' ' LYS . . . . . 0.637 ' HE2' ' HB3' ' B' ' 33' ' ' ALA . 74.5 mmtt -109.91 17.16 21.43 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.469 0.708 . . . . 75.11 111.412 -178.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 239' ' ' GLY . . . . . 0.416 ' HA2' ' HG ' ' C' ' 193' ' ' LEU . . . -86.78 -166.11 42.06 Favored Glycine 0 C--N 1.348 1.239 0 N-CA-C 112.081 -0.408 . . . . 75.2 112.081 174.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 240' ' ' PHE . . . . . 0.505 ' CD2' HD23 ' C' ' 193' ' ' LEU . 2.2 m-85 -86.79 152.61 54.23 Favored Pre-proline 0 CA--C 1.558 1.261 0 N-CA-C 108.845 -0.798 . . . . 75.14 108.845 175.092 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 241' ' ' PRO . . . . . 0.43 ' HA ' ' HG2' ' C' ' 246' ' ' ARG . 31.5 Cg_exo -43.34 141.07 3.49 Favored 'Trans proline' 0 C--N 1.382 2.309 0 C-N-CA 124.622 3.548 . . . . 71.53 115.674 178.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 242' ' ' GLY . . . . . 0.416 ' HA3' ' NE2' ' C' ' 191' ' ' GLN . . . -133.88 148.95 19.61 Favored Glycine 0 C--N 1.348 1.217 0 CA-C-O 119.097 -0.835 . . . . 70.14 112.422 -176.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 243' ' ' PRO . . . . . 0.479 ' HB3' HD13 ' B' ' 71' ' ' ILE . 36.3 Cg_endo -60.09 -40.36 61.48 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 123.729 2.953 . . . . 71.42 113.462 -169.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -118.45 19.46 13.34 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.865 0.866 . . . . 71.42 110.787 -175.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 142.16 136.3 3.21 Favored Glycine 0 C--N 1.344 1.022 0 N-CA-C 110.063 -1.215 . . . . 63.24 110.063 -175.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 246' ' ' ARG . . . . . 0.43 ' HG2' ' HA ' ' C' ' 241' ' ' PRO . 90.5 mtt180 -78.25 150.72 33.37 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 117.349 0.575 . . . . 71.32 110.918 -172.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -72.76 -170.47 17.03 Favored Glycine 0 C--N 1.35 1.311 0 O-C-N 124.29 0.993 . . . . 63.23 114.831 -171.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -129.9 155.1 46.59 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.761 0.824 . . . . 73.54 109.017 -170.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 249' ' ' LEU . . . . . 0.489 HD11 ' HB2' ' C' ' 195' ' ' ALA . 24.0 tp -100.27 133.37 44.77 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.934 0.894 . . . . 74.23 110.89 -171.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 250' ' ' TYR . . . . . 0.477 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 1.0 OUTLIER -122.7 100.56 6.98 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.236 1.014 . . . . 71.43 111.084 178.662 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 251' ' ' LEU . . . . . 0.524 HD12 HD12 ' C' ' 233' ' ' LEU . 1.6 mp -97.0 125.69 41.6 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 118.9 -0.572 . . . . 72.0 110.586 -176.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -82.6 136.22 34.86 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 108.852 -0.795 . . . . 75.41 108.852 167.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 253' ' ' VAL . . . . . 0.428 HG23 ' CZ3' ' B' ' 242' ' ' TRP . 47.0 t -92.71 138.03 20.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 123.887 0.875 . . . . 73.5 112.82 -168.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 254' ' ' ARG . . . . . 0.498 ' HB2' ' HA ' ' C' ' 198' ' ' ASP . 20.6 mmt85 -102.65 136.07 43.15 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.2 1.4 . . . . 75.13 108.49 168.106 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 255' ' ' ILE . . . . . . . . . . . . . 32.7 mm -102.14 104.45 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 107.188 -1.412 . . . . 75.24 107.188 163.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 256' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' C' ' 200' ' ' PRO . 1.7 t -107.82 148.25 29.79 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.365 1.066 . . . . 70.25 109.902 -175.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 2.9 pp -111.9 145.73 33.31 Favored Pre-proline 0 N--CA 1.476 0.853 0 N-CA-C 109.393 -0.595 . . . . 75.21 109.393 176.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -60.4 -8.41 8.66 Favored 'Trans proline' 0 N--CA 1.507 2.268 0 C-N-CA 123.036 2.49 . . . . 74.41 115.36 -169.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 58.61 -68.5 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.572 1.549 . . . . 72.3 112.38 -168.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.17 149.68 44.75 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.771 0.829 . . . . 73.41 109.377 170.33 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 261' ' ' LEU . . . . . 0.474 HD11 HG13 ' A' ' 205' ' ' VAL . 77.6 mt -141.41 148.39 39.52 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.077 0.465 . . . . 74.53 111.089 -178.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 69.2 p -94.28 154.66 40.38 Favored Pre-proline 0 CA--C 1.554 1.129 0 N-CA-C 108.544 -0.91 . . . . 61.23 108.544 168.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 263' ' ' PRO . . . . . 0.4 ' HA ' ' HB1' ' B' ' 467' ' ' ALA . 86.0 Cg_exo -45.27 -45.06 15.52 Favored 'Trans proline' 0 C--N 1.391 2.798 0 C-N-CA 123.553 2.836 . . . . 74.2 114.188 -176.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -61.37 -52.59 64.01 Favored 'General case' 0 C--O 1.249 1.045 0 CA-C-N 115.1 -0.955 . . . . 71.04 110.856 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -52.06 -60.32 3.33 Favored 'General case' 0 C--N 1.362 1.129 0 O-C-N 124.537 1.148 . . . . 71.03 110.373 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 266' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -61.43 -33.82 74.35 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 124.179 0.924 . . . . 73.1 111.732 -172.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -59.63 -51.52 69.44 Favored 'General case' 0 CA--C 1.552 1.042 0 O-C-N 123.273 0.358 . . . . 71.12 111.359 173.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 268' ' ' LEU . . . . . . . . . . . . . 11.1 mp -66.61 -41.74 87.92 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 119.327 -0.368 . . . . 70.11 111.766 179.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -58.76 -38.57 78.74 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.654 0.782 . . . . 63.11 110.716 177.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 270' ' ' LYS . . . . . 0.611 ' HB3' ' HZ3' ' C' ' 270' ' ' LYS . 9.6 mtpm? -66.51 -46.38 76.4 Favored 'General case' 0 C--N 1.361 1.091 0 C-N-CA 122.997 0.519 . . . . 75.43 111.139 176.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.83 -37.59 74.11 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 123.66 0.6 . . . . 75.33 111.405 178.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 82.5 mt -68.35 -42.48 79.16 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.537 -0.756 . . . . 74.33 110.356 174.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -67.58 -25.6 65.86 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.408 0.683 . . . . 43.22 111.369 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -81.31 -36.34 29.91 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.252 1.021 . . . . 63.21 109.879 176.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -61.02 -28.36 68.99 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.522 -0.763 . . . . 70.04 110.327 168.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 276' ' ' TYR . . . . . 0.536 ' HB3' HD13 ' A' ' 203' ' ' ILE . 7.9 m-85 -82.08 -32.4 30.32 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.419 1.088 . . . . 75.52 111.863 175.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 23.0 m-30 -64.68 -30.16 71.17 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 109.483 -0.562 . . . . 65.52 109.483 172.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -66.38 -15.48 63.32 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 123.784 0.834 . . . . 72.22 112.41 175.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 279' ' ' ARG . . . . . . . . . . . . . 26.3 mtp-105 -82.47 -15.67 51.66 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.1 0.56 . . . . 75.11 111.091 175.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.065 0 C-N-CA 122.938 0.495 . . . . 75.14 109.718 178.317 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 80.5 mtp . . . . . 0 N--CA 1.48 1.035 0 N-CA-C 110.586 -0.153 . . . . 64.12 110.586 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.29 40.77 11.04 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.574 1.149 . . . . 74.44 112.059 177.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -74.66 77.56 2.03 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.523 0.729 . . . . 74.04 110.229 177.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -35.82 110.79 0.11 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 125.489 1.515 . . . . 64.14 114.312 -177.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -87.9 102.77 15.04 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 107.479 -1.304 . . . . 74.32 107.479 163.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.484 ' HA ' ' OH ' ' A' ' 66' ' ' TYR . 7.3 t0 -71.37 92.7 1.08 Allowed 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 108.455 -0.943 . . . . 62.43 108.455 178.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -62.93 -36.28 82.89 Favored 'General case' 0 C--O 1.244 0.796 0 C-N-CA 123.613 0.765 . . . . 73.34 111.979 -171.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.405 ' HE1' HD13 ' A' ' 22' ' ' ILE . 77.7 m-85 -62.98 -44.49 95.9 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.595 -0.73 . . . . 73.33 110.674 175.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.91 -36.91 83.33 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.965 0.506 . . . . 70.01 111.431 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.404 HG13 ' O ' ' A' ' 6' ' ' ASP . 76.3 mt -61.61 -41.69 91.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.134 0.574 . . . . 74.23 110.086 176.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.1 mt -75.28 -14.12 60.48 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-N 116.145 -0.48 . . . . 73.11 111.955 175.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.49 24.13 76.77 Favored Glycine 0 C--N 1.353 1.476 0 CA-C-N 116.745 -0.207 . . . . 73.42 113.256 -177.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.5 m -108.48 152.38 42.04 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 124.128 0.971 . . . . 72.52 110.008 178.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -58.87 152.51 57.08 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.904 2.402 . . . . 50.12 112.602 174.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -69.49 7.34 0.84 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 112.664 0.616 . . . . 75.43 112.664 178.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -128.44 28.5 5.44 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.025 1.33 . . . . 71.2 107.786 177.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.6 168.7 2.75 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.96 0.904 . . . . 74.14 111.436 176.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 67.2 p -114.08 172.91 6.71 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.275 0.63 . . . . 75.03 109.642 175.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -58.02 -36.53 72.82 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.327 0.651 . . . . 71.11 110.393 176.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -66.59 -43.96 83.48 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.474 0.709 . . . . 72.43 111.433 177.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -67.42 -40.2 85.54 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.204 0.602 . . . . 71.14 111.743 -178.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.548 HD11 ' HB3' ' A' ' 57' ' ' LEU . 69.0 mt -71.59 -38.78 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.135 0.974 . . . . 73.31 110.748 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -65.25 -50.94 63.85 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.198 -0.91 . . . . 75.22 110.295 177.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 31.9 mtm180 -67.52 -33.12 74.42 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.352 0.661 . . . . 73.12 111.565 -178.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.32 -49.91 73.74 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 123.902 0.751 . . . . 72.43 109.588 174.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -60.58 -44.02 96.68 Favored 'General case' 0 C--O 1.206 -1.19 0 O-C-N 124.088 0.868 . . . . 73.1 110.589 178.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -58.69 -46.74 86.58 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.846 0.859 . . . . 74.22 110.833 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 47.4 ttt180 -57.14 -53.85 53.42 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.134 0.974 . . . . 75.52 110.671 177.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.623 ' HB3' HD11 ' A' ' 50' ' ' ILE . 73.6 mt -77.35 -21.66 53.01 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 115.274 -0.875 . . . . 75.12 111.368 -172.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -80.29 -32.09 38.17 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.443 0.697 . . . . 71.54 110.785 178.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 78.3 mtp180 -81.08 -39.99 24.83 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 122.938 0.495 . . . . 72.33 110.245 174.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.521 HE21 ' HA ' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -70.12 -50.13 43.75 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.297 0.639 . . . . 73.31 111.34 -175.288 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.496 ' HE2' HD23 ' A' ' 29' ' ' LEU . 15.6 m-85 -100.21 30.19 3.94 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.153 0.581 . . . . 72.41 109.628 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -65.71 111.44 6.32 Favored Pre-proline 0 C--N 1.354 0.763 0 N-CA-C 108.59 -0.893 . . . . 73.54 108.59 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -53.87 -38.37 85.79 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 123.186 2.591 . . . . 75.51 113.778 -168.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -70.24 -28.94 65.65 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.055 0.942 . . . . 73.23 112.3 -179.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 46.9 t -88.51 -61.58 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 N-CA-C 109.122 -0.696 . . . . 73.25 109.122 177.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -100.13 90.26 4.31 Favored 'General case' 0 C--O 1.243 0.759 0 C-N-CA 124.384 1.074 . . . . 64.12 108.881 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -81.04 69.93 7.75 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 108.67 -0.863 . . . . 73.11 108.67 178.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.2 m -125.03 106.04 28.8 Favored Pre-proline 0 C--O 1.237 0.4 0 N-CA-C 107.883 -1.154 . . . . 71.24 107.883 178.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_exo -43.89 -44.7 11.78 Favored 'Trans proline' 0 C--N 1.388 2.626 0 C-N-CA 123.749 2.966 . . . . 73.53 112.979 -177.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -50.81 -52.43 41.24 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.395 1.078 . . . . 64.43 111.31 176.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.7 -28.45 69.08 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 114.434 -1.257 . . . . 73.42 110.426 -177.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -82.19 -33.6 29.37 Favored 'General case' 0 C--O 1.219 -0.55 0 O-C-N 123.936 0.772 . . . . 63.35 110.293 -175.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.648 ' HA ' ' HD3' ' A' ' 48' ' ' LYS . 44.0 mt-10 -66.89 -46.35 75.19 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.961 0.905 . . . . 62.44 109.983 176.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -62.22 -42.64 99.49 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 114.224 -1.353 . . . . 74.03 109.875 174.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -56.99 -40.53 76.73 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.302 1.041 . . . . 73.32 110.725 176.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.648 ' HD3' ' HA ' ' A' ' 45' ' ' GLU . 24.0 mtpp -60.68 -48.75 80.38 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.703 0.801 . . . . 75.14 109.982 177.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -65.57 -26.5 67.89 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 123.38 0.425 . . . . 71.44 111.848 177.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.623 HD11 ' HB3' ' A' ' 29' ' ' LEU . 72.7 mt -74.5 -29.49 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 124.241 1.016 . . . . 74.43 110.058 175.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -73.27 -35.08 66.12 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.126 0.57 . . . . 73.43 110.444 172.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -67.86 -45.31 74.93 Favored 'General case' 0 C--O 1.256 1.443 0 C-N-CA 124.76 1.224 . . . . 75.34 110.302 175.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.13 -51.31 70.15 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 113.762 -1.563 . . . . 65.45 110.186 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 92.5 t80 -63.26 -35.26 79.75 Favored 'General case' 0 C--O 1.205 -1.267 0 CA-C-N 114.7 -1.136 . . . . 73.53 110.691 174.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.04 -51.34 66.61 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.298 0.639 . . . . 72.52 111.838 -177.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 94.4 t -75.39 -38.78 40.7 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 CA-C-N 115.121 -0.945 . . . . 74.52 110.893 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.548 ' HB3' HD11 ' A' ' 22' ' ' ILE . 73.1 mt -89.02 3.97 49.88 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 113.43 0.9 . . . . 74.35 113.43 -174.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.2 t -68.18 -73.12 0.15 Allowed 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.751 0.821 . . . . 74.34 110.497 -179.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -83.41 120.54 75.75 Favored Pre-proline 0 C--O 1.25 1.095 0 N-CA-C 108.346 -0.983 . . . . 74.34 108.346 178.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.547 ' O ' ' HG3' ' A' ' 64' ' ' ARG . 9.5 Cg_endo -53.82 -19.76 15.76 Favored 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 123.582 2.855 . . . . 72.41 115.187 -172.179 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -72.63 -53.14 12.63 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 119.397 0.999 . . . . 72.3 111.183 178.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -56.25 -41.16 75.32 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 122.417 1.103 . . . . 74.54 110.112 173.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.439 ' HG3' HD22 ' A' ' 57' ' ' LEU . 32.6 ttt180 -60.12 -43.09 95.91 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 113.273 -1.785 . . . . 74.11 111.142 175.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.547 ' HG3' ' O ' ' A' ' 60' ' ' PRO . 42.1 mtm180 -62.04 -37.23 84.16 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-O 118.974 -0.536 . . . . 74.25 110.314 177.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 84.9 mt -57.65 -44.55 85.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 O-C-N 123.982 0.801 . . . . 74.41 109.655 176.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.484 ' OH ' ' HA ' ' A' ' 6' ' ' ASP . 35.1 t80 -61.13 -50.51 72.89 Favored 'General case' 0 CA--C 1.558 1.25 0 CA-C-N 115.912 -0.585 . . . . 75.4 111.163 175.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -65.26 -23.85 67.16 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.857 0.863 . . . . 64.04 112.425 -179.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 81.5 p -97.0 -7.3 33.32 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 122.855 0.462 . . . . 75.44 110.601 176.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -73.28 103.76 4.09 Favored 'General case' 0 C--N 1.353 0.737 0 N-CA-C 106.997 -1.483 . . . . 75.32 106.997 168.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 110.15 23.95 5.9 Favored Glycine 0 CA--C 1.531 1.055 0 N-CA-C 110.947 -0.861 . . . . 64.23 110.947 -164.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 94.3 m -145.69 -56.33 0.3 Allowed 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 104.633 -2.358 . . . . 71.23 104.633 172.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 85.8 m -89.85 148.22 23.31 Favored 'General case' 0 C--O 1.252 1.235 0 N-CA-C 105.23 -2.137 . . . . 74.23 105.23 157.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.78 -42.32 4.53 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 123.405 0.682 . . . . 74.04 110.895 -178.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.25 134.98 51.13 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 123.346 0.658 . . . . 75.1 109.315 177.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -52.28 126.16 19.7 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.718 2.279 . . . . 75.41 111.749 175.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_exo -57.51 160.99 12.76 Favored 'Trans proline' 0 C--N 1.375 1.974 0 C-N-CA 123.305 2.67 . . . . 74.25 113.562 -177.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -64.48 121.25 8.78 Favored 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 122.195 1.93 . . . . 73.45 111.523 173.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.475 ' HG3' ' HA3' ' A' ' 104' ' ' GLY . 35.9 Cg_endo -63.25 136.43 55.63 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 122.871 2.38 . . . . 73.2 111.702 177.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.541 ' HB3' HD11 ' B' ' 29' ' ' LEU . 51.8 Cg_exo -57.89 157.07 25.61 Favored 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 123.183 2.589 . . . . 71.05 112.626 175.052 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -60.37 84.46 0.07 OUTLIER 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 122.801 2.334 . . . . 74.31 111.411 172.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.21 -32.3 0.32 Allowed Glycine 0 CA--C 1.525 0.672 0 CA-C-N 114.312 -1.313 . . . . 62.41 109.824 -176.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.92 156.32 31.37 Favored Glycine 0 C--N 1.351 1.366 0 C-N-CA 123.413 0.53 . . . . 53.03 113.072 171.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -63.06 94.47 0.07 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.809 0.843 . . . . 74.41 110.169 170.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -76.78 157.89 31.28 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 109.002 -0.74 . . . . 71.31 109.002 169.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.521 ' HE2' ' HD2' ' A' ' 93' ' ' PHE . 16.1 t80 -127.49 50.46 2.01 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.567 0.699 . . . . 73.24 109.563 -178.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.421 ' HB3' HH22 ' B' ' 22' ' ' ARG . 57.8 m -0.41 83.69 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.484 0 C-N-CA 127.288 2.235 . . . . 74.44 116.475 -174.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.86 -13.94 2.94 Favored Glycine 0 N--CA 1.482 1.748 0 N-CA-C 116.655 1.422 . . . . 70.11 116.655 168.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.492 ' HB3' ' HE2' ' A' ' 93' ' ' PHE . 63.5 m-85 -90.34 136.98 32.72 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 118.158 0.979 . . . . 72.34 110.179 -174.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -66.17 92.51 0.18 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.091 0.556 . . . . 71.44 110.695 -170.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.561 HG11 ' HG3' ' A' ' 91' ' ' GLU . 2.3 p -40.9 -51.49 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 125.12 1.368 . . . . 75.21 113.0 171.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.561 ' HG3' HG11 ' A' ' 90' ' ' VAL . 40.3 mt-10 -71.87 -12.1 61.11 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.614 0.766 . . . . 75.33 111.528 -173.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -87.09 -34.35 19.17 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.518 0.727 . . . . 61.35 110.632 174.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.521 ' HD2' ' HE2' ' A' ' 85' ' ' PHE . 26.5 m-85 -91.49 174.14 7.53 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.158 0.799 . . . . 73.34 113.158 -168.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 88.5 p -58.76 151.39 21.32 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 115.395 1.628 . . . . 74.5 115.395 -162.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.91 -42.87 80.72 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.028 -1.442 . . . . 74.52 110.877 170.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -50.61 -50.99 52.76 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.185 0.994 . . . . 75.03 111.042 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.502 ' HE2' HG21 ' A' ' 90' ' ' VAL . 1.4 t80 -59.69 -50.56 73.35 Favored 'General case' 0 CA--C 1.555 1.172 0 O-C-N 124.226 0.954 . . . . 72.32 109.829 174.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -66.56 -6.6 15.71 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.207 0.603 . . . . 74.14 112.249 -176.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -103.0 -30.95 10.47 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.168 0.987 . . . . 70.02 111.831 170.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 26.3 tp -73.59 -56.19 5.33 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.341 0.657 . . . . 74.33 110.842 -177.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -93.51 -6.55 46.54 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.115 0.566 . . . . 72.11 110.662 174.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -47.48 -55.75 8.93 Favored Glycine 0 C--N 1.351 1.394 0 CA-C-O 118.767 -1.018 . . . . 72.43 115.579 -177.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -46.4 -13.83 0.11 Allowed 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 124.792 3.661 . . . . 64.43 116.746 176.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.475 ' HA3' ' HG3' ' A' ' 78' ' ' PRO . . . -149.93 29.03 1.14 Allowed Glycine 0 C--N 1.355 1.585 0 CA-C-O 118.599 -1.112 . . . . 54.4 114.215 174.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.504 ' HB3' ' ND2' ' A' ' 169' ' ' ASN . 15.1 mt -60.99 79.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 113.005 0.743 . . . . 74.25 113.005 177.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.763 ' HB3' ' HA ' ' A' ' 169' ' ' ASN . 0.5 OUTLIER 24.72 -100.9 0.01 OUTLIER 'General case' 0 CA--C 1.569 1.7 0 C-N-CA 127.249 2.219 . . . . 74.45 113.956 170.175 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 80.06 6.28 89.23 Favored Glycine 0 C--N 1.363 2.046 0 CA-C-N 117.896 0.317 . . . . 44.0 113.431 -176.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 59.61 -129.51 48.74 Favored Glycine 0 C--N 1.348 1.231 0 N-CA-C 111.317 -0.713 . . . . 71.34 111.317 -172.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -97.82 -2.13 41.64 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.35 0.66 . . . . 74.55 110.294 169.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -81.09 -26.96 51.43 Favored Glycine 0 C--N 1.355 1.597 0 N-CA-C 111.896 -0.482 . . . . 55.25 111.896 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? 60.15 3.65 0.55 Allowed 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 115.248 1.573 . . . . 75.52 115.248 170.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.86 -15.67 60.18 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 122.795 0.438 . . . . 75.13 109.994 174.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 40.4 m 70.23 46.4 0.61 Allowed 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.622 1.169 . . . . 74.21 110.518 -177.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -86.17 159.22 19.57 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 114.948 -1.024 . . . . 74.52 112.369 -174.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -59.11 146.1 39.9 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 124.826 1.251 . . . . 73.31 111.756 174.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -88.65 169.98 37.87 Favored Glycine 0 C--N 1.353 1.478 0 CA-C-N 116.337 -0.392 . . . . 73.4 112.961 178.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.95 -178.25 3.33 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.523 0.729 . . . . 74.43 110.353 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -77.07 142.54 39.77 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 109.04 -0.726 . . . . 74.23 109.04 170.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.454 HD11 ' HB3' ' B' ' 10' ' ' LEU . 7.7 tt -144.18 125.75 14.98 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 107.658 -1.238 . . . . 75.42 107.658 -175.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.495 ' NH2' ' HB ' ' A' ' 177' ' ' VAL . 0.0 OUTLIER -97.58 126.44 42.88 Favored 'General case' 0 C--O 1.217 -0.625 0 N-CA-C 107.293 -1.373 . . . . 74.51 107.293 175.903 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.472 ' HB3' HD21 ' A' ' 176' ' ' LEU . . . -120.42 155.7 32.93 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-N 118.39 0.541 . . . . 54.41 111.534 -177.07 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.536 ' HB2' ' HB2' ' B' ' 9' ' ' ALA . 1.2 mm-40 -92.8 111.7 23.41 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 106.244 -1.761 . . . . 72.42 106.244 175.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.525 ' HB3' ' HA ' ' A' ' 178' ' ' VAL . 61.1 tp -101.35 96.17 5.79 Favored Pre-proline 0 N--CA 1.476 0.854 0 N-CA-C 108.29 -1.004 . . . . 74.14 108.29 177.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.609 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 58.5 Cg_endo -73.23 112.37 3.51 Favored 'Trans proline' 0 C--N 1.376 2.016 0 C-N-CA 121.406 1.404 . . . . 75.33 110.001 178.198 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.506 ' HB3' HD22 ' A' ' 180' ' ' LEU . 52.8 tp -116.73 138.9 51.13 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.413 0.625 . . . . 72.43 111.536 -168.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.597 ' HB ' ' HG2' ' A' ' 129' ' ' GLU . 93.3 m -72.3 125.73 28.06 Favored 'General case' 0 CA--C 1.553 1.072 0 CA-C-N 113.856 -1.52 . . . . 71.34 109.369 174.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.415 ' HB3' HD22 ' A' ' 215' ' ' LEU . 48.9 mt -53.4 -39.7 64.48 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 124.032 0.933 . . . . 75.21 112.249 -171.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.469 ' HB2' ' H2 ' ' B' ' 1' ' ' MET . 3.8 mp0 -69.03 -33.85 74.28 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 115.465 -0.789 . . . . 75.32 110.628 -177.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.597 ' HG2' ' HB ' ' A' ' 126' ' ' THR . 12.2 mm-40 -72.99 -26.42 61.33 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 109.949 -0.389 . . . . 64.33 109.949 175.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.429 ' HB1' ' O ' ' A' ' 153' ' ' VAL . . . -66.7 -37.62 85.08 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 123.393 0.433 . . . . 65.44 110.54 174.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -65.38 -50.52 65.22 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 115.025 -0.989 . . . . 74.51 111.287 173.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 30.9 m170 -70.74 -45.19 65.29 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.183 0.593 . . . . 75.25 111.624 -171.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.07 -163.27 54.11 Favored Glycine 0 C--N 1.339 0.742 0 O-C-N 123.465 0.478 . . . . 71.54 112.834 -175.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 96.93 -173.84 29.64 Favored Glycine 0 C--N 1.345 1.051 0 N-CA-C 112.554 -0.219 . . . . 70.42 112.554 179.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 2.0 mp0 -78.88 109.53 13.24 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 122.655 -0.321 . . . . 73.14 110.357 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -90.97 126.46 36.08 Favored 'General case' 0 C--O 1.248 1.022 0 N-CA-C 109.317 -0.623 . . . . 75.05 109.317 173.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 76.3 t -80.31 116.31 24.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 114.742 -1.117 . . . . 75.04 108.483 168.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.637 ' HB ' HG12 ' A' ' 145' ' ' VAL . 62.2 t -124.75 129.21 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.08 0.952 . . . . 73.34 109.042 -175.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.439 ' HG2' ' HB3' ' B' ' 30' ' ' GLU . 14.7 tp10 -98.03 142.92 29.15 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 122.996 0.518 . . . . 71.3 110.941 -177.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.528 ' HB ' ' HB3' ' B' ' 8' ' ' LEU . 8.1 p -160.67 121.86 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 C-N-CA 123.515 0.726 . . . . 75.1 111.023 174.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 65.51 14.3 9.4 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.471 1.108 . . . . 74.24 113.911 169.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 84.6 28.04 33.69 Favored Glycine 0 N--CA 1.479 1.518 0 N-CA-C 111.9 -0.48 . . . . 54.15 111.9 -174.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 17.9 tpt85 -152.62 97.31 2.23 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 107.737 -1.208 . . . . 72.43 107.737 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.606 ' HB3' ' HA ' ' B' ' 28' ' ' VAL . 0.0 OUTLIER -64.54 129.96 41.86 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 114.908 -1.042 . . . . 74.41 111.424 179.375 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.637 HG12 ' HB ' ' A' ' 138' ' ' VAL . 1.4 p -91.79 130.09 41.46 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 C-N-CA 124.346 1.058 . . . . 73.53 109.223 165.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.534 ' HB2' ' NH1' ' A' ' 144' ' ' ARG . 47.5 t -92.96 132.03 37.43 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 108.317 -0.994 . . . . 64.43 108.317 167.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 2.1 p -139.81 118.01 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 O-C-N 123.65 0.594 . . . . 73.42 109.919 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.464 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 47.8 ttt85 -74.37 93.41 2.41 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 107.864 -1.162 . . . . 74.32 107.864 167.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.544 ' HB ' HG13 ' A' ' 153' ' ' VAL . 34.2 pt -71.75 125.23 91.7 Favored Pre-proline 0 CA--C 1.55 0.956 0 N-CA-C 108.408 -0.96 . . . . 74.52 108.408 175.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -59.39 138.28 83.3 Favored 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 122.371 2.048 . . . . 74.22 111.951 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -62.84 93.02 0.14 Allowed 'Trans proline' 0 C--N 1.374 1.877 0 C-N-CA 121.996 1.797 . . . . 74.15 110.116 171.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.471 ' HA2' ' CD2' ' A' ' 240' ' ' PHE . . . 125.02 24.21 1.69 Allowed Glycine 0 C--N 1.345 1.046 0 CA-C-N 115.1 -0.954 . . . . 75.51 113.084 -173.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.565 HG21 HD13 ' A' ' 159' ' ' ILE . 2.6 p -75.38 149.67 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 123.626 0.77 . . . . 75.43 110.366 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.474 ' O ' HG11 ' A' ' 178' ' ' VAL . 0.1 OUTLIER -119.24 -165.35 1.14 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.507 0.723 . . . . 73.23 112.099 -161.043 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.535 ' HB3' ' O ' ' A' ' 188' ' ' LEU . 3.0 tp10 -86.6 141.36 29.06 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 105.481 -2.044 . . . . 72.32 105.481 160.252 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 65.71 9.03 43.46 Favored Glycine 0 CA--C 1.535 1.311 0 N-CA-C 115.322 0.889 . . . . 74.33 115.322 177.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.484 ' O ' HG12 ' A' ' 178' ' ' VAL . 23.2 t -74.64 117.89 16.98 Favored 'General case' 0 C--N 1.355 0.833 0 N-CA-C 107.949 -1.13 . . . . 74.23 107.949 175.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.487 HG23 HG22 ' A' ' 177' ' ' VAL . 41.7 t -84.84 88.63 2.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.577 -0.898 . . . . 74.02 108.577 -178.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.565 HD13 HG21 ' A' ' 153' ' ' VAL . 30.0 mt -72.3 98.82 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 107.704 -1.221 . . . . 75.24 107.704 174.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -79.61 98.19 6.81 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 114.581 -1.19 . . . . 75.21 108.687 -176.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.402 ' HA ' ' HD2' ' A' ' 162' ' ' PRO . 3.4 p -123.51 94.92 45.81 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 123.649 0.78 . . . . 71.41 109.473 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.613 ' HG2' ' HG2' ' B' ' 20' ' ' LYS . 10.8 Cg_endo -56.65 143.67 88.47 Favored 'Trans proline' 0 C--N 1.363 1.336 0 C-N-CA 123.025 2.483 . . . . 74.53 112.874 167.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 95.51 20.37 27.27 Favored Glycine 0 N--CA 1.445 -0.764 0 CA-C-N 114.658 -1.155 . . . . 70.43 115.056 172.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.463 ' HG3' HG23 ' A' ' 145' ' ' VAL . 24.9 mmt -143.99 7.96 1.43 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.16 0.584 . . . . 64.15 110.433 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.574 ' HA2' HD11 ' A' ' 174' ' ' LEU . . . -90.55 -121.13 2.31 Favored Glycine 0 C--N 1.346 1.115 0 CA-C-N 115.672 -0.694 . . . . 73.33 114.436 -168.129 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 171' ' ' PRO . . . -60.94 115.71 8.25 Favored Glycine 0 C--N 1.362 2.007 0 CA-C-O 119.493 -0.615 . . . . 74.5 113.494 -169.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -59.59 146.25 41.5 Favored 'General case' 0 C--N 1.35 0.615 0 O-C-N 125.087 1.11 . . . . 75.42 111.034 -175.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 169.18 -125.25 1.24 Allowed Glycine 0 CA--C 1.495 -1.197 0 N-CA-C 106.816 -2.514 . . . . 64.21 106.816 -174.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . 0.763 ' HA ' ' HB3' ' A' ' 106' ' ' PHE . 43.4 t-20 -98.31 -57.09 0.17 Allowed Pre-proline 0 CA--C 1.55 0.981 0 N-CA-C 107.415 -1.328 . . . . 63.54 107.415 170.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.653 ' HD3' ' HB3' ' A' ' 169' ' ' ASN . 59.5 Cg_endo -95.03 109.18 0.13 Allowed 'Trans proline' 0 C--N 1.382 2.341 0 C-N-CA 122.033 1.822 . . . . 73.02 110.937 165.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.468 ' HA ' ' O ' ' A' ' 166' ' ' GLY . 29.6 Cg_endo -61.59 113.58 1.87 Allowed 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 121.74 1.627 . . . . 71.25 108.936 174.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -63.94 -142.06 0.02 OUTLIER Glycine 0 N--CA 1.484 1.841 0 N-CA-C 116.096 1.198 . . . . 72.4 116.096 -166.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.592 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 38.9 t70 -80.85 124.71 29.32 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 122.177 -0.602 . . . . 71.14 109.427 -177.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.574 HD11 ' HA2' ' A' ' 165' ' ' GLY . 26.9 tp -106.88 118.36 36.48 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.148 0.499 . . . . 74.2 110.5 -174.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.617 HD11 ' HB2' ' B' ' 15' ' ' PHE . 47.5 mt -94.58 85.53 4.54 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 124.061 0.944 . . . . 72.12 108.764 176.175 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.527 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 43.1 mt -72.73 84.37 1.19 Allowed 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.025 -0.534 . . . . 74.52 109.852 178.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.495 ' HB ' ' NH2' ' A' ' 120' ' ' ARG . 46.6 t -82.9 98.71 5.13 Favored 'Isoleucine or valine' 0 C--O 1.248 1.026 0 N-CA-C 104.917 -2.253 . . . . 71.11 104.917 176.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.525 ' HA ' ' HB3' ' A' ' 123' ' ' LEU . 10.0 p -76.27 113.29 15.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 112.108 -2.315 . . . . 74.13 111.001 -166.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.609 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 30.8 mmm-85 -90.16 106.45 18.49 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-N 115.499 -0.773 . . . . 73.42 108.989 178.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.506 HD22 ' HB3' ' A' ' 125' ' ' LEU . 23.3 mt -68.66 147.36 51.98 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 118.76 0.709 . . . . 74.04 110.29 177.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 83.9 mt -55.37 159.1 4.8 Favored Pre-proline 0 N--CA 1.484 1.261 0 C-N-CA 124.17 0.988 . . . . 73.22 112.289 -176.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -74.87 24.01 0.39 Allowed 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 122.991 2.46 . . . . 74.32 112.689 170.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.403 ' ND1' HD11 ' A' ' 127' ' ' LEU . 65.5 t-80 -61.62 116.09 18.67 Favored Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 125.231 1.412 . . . . 73.35 108.327 174.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -75.51 24.89 0.4 Allowed 'Trans proline' 0 C--N 1.371 1.727 0 C-N-CA 124.146 3.23 . . . . 61.24 116.902 -160.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 97.0 t -97.24 -57.82 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 119.168 0.895 . . . . 72.34 109.695 -179.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . 0.475 ' CE1' ' HB1' ' A' ' 195' ' ' ALA . 19.1 m-85 -132.87 143.61 49.63 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 112.551 0.574 . . . . 72.31 112.551 -171.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . 0.712 HH22 ' HB3' ' B' ' 411' ' ' ALA . 0.0 OUTLIER -114.12 83.33 1.85 Allowed 'General case' 0 C--O 1.239 0.508 0 N-CA-C 106.735 -1.58 . . . . 75.51 106.735 163.389 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.535 ' O ' ' HB3' ' A' ' 155' ' ' GLU . 48.1 tp -75.07 131.1 40.32 Favored 'General case' 0 C--O 1.202 -1.395 0 CA-C-N 114.465 -1.243 . . . . 74.21 109.367 177.076 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . 0.4 ' HG3' ' HA ' ' B' ' 410' ' ' GLN . 0.4 OUTLIER -147.2 129.89 16.05 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.089 -1.078 . . . . 70.31 108.089 171.94 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 66.26 -81.86 0.1 Allowed Glycine 0 C--N 1.344 0.98 0 O-C-N 124.352 1.032 . . . . 65.41 112.564 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.503 ' HB2' ' HA2' ' A' ' 247' ' ' GLY . 0.7 OUTLIER -129.97 -32.63 1.83 Allowed 'General case' 0 C--O 1.249 1.071 0 C-N-CA 123.834 0.853 . . . . 72.32 109.867 179.268 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -88.26 149.38 23.85 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.625 -0.716 . . . . 72.32 111.776 -166.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.462 HD21 ' HB2' ' A' ' 188' ' ' LEU . 88.6 mt -103.25 158.99 15.94 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.532 1.133 . . . . 74.25 108.97 173.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.668 ' HB2' ' HB3' ' A' ' 187' ' ' ARG . 28.5 m-85 -131.35 101.33 5.5 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 108.707 -0.849 . . . . 73.14 108.707 168.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.476 ' HB3' HD21 ' A' ' 251' ' ' LEU . . . -105.4 131.48 52.78 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 109.145 -0.687 . . . . 74.34 109.145 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' THR . . . . . 0.581 ' HA ' ' HB2' ' A' ' 252' ' ' GLU . 30.4 m -71.72 110.75 6.47 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 109.308 -0.627 . . . . 70.21 109.308 177.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.516 HD22 HD12 ' A' ' 251' ' ' LEU . 50.1 tp -103.15 101.14 11.09 Favored 'General case' 0 C--N 1.347 0.487 0 N-CA-C 110.111 -0.329 . . . . 74.1 110.111 -178.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -73.6 127.7 33.47 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.562 -1.273 . . . . 63.3 107.562 164.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.577 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 7.1 p -142.18 135.35 14.14 Favored Pre-proline 0 CA--C 1.539 0.545 0 N-CA-C 107.889 -1.152 . . . . 74.33 107.889 178.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.3 158.72 37.0 Favored 'Trans proline' 0 C--N 1.361 1.222 0 C-N-CA 121.475 1.45 . . . . 70.05 112.196 172.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.406 ' HB2' ' HD3' ' A' ' 202' ' ' PRO . . . -56.83 -49.66 92.57 Favored Pre-proline 0 N--CA 1.481 1.109 0 N-CA-C 113.233 0.827 . . . . 71.34 113.233 -178.08 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.406 ' HD3' ' HB2' ' A' ' 201' ' ' ALA . 57.1 Cg_exo -57.28 -45.42 35.14 Favored 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 121.953 1.768 . . . . 73.32 113.802 178.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 55.4 mt -71.39 -29.69 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 122.953 0.501 . . . . 71.02 110.86 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.89 -42.2 85.92 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.715 0.406 . . . . 74.14 110.391 175.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 46.0 t -68.85 -55.66 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.593 0.757 . . . . 64.22 111.292 -178.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.641 HG22 ' HA ' ' C' ' 270' ' ' LYS . 61.4 t -83.06 -41.69 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-O 120.872 0.367 . . . . 74.41 111.173 -172.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 88.96 168.89 44.27 Favored Glycine 0 C--N 1.338 0.692 0 CA-C-N 115.968 -0.56 . . . . 72.35 111.973 -174.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 161.32 -125.34 1.43 Allowed Glycine 0 C--O 1.224 -0.495 0 N-CA-C 110.149 -1.18 . . . . 73.32 110.149 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -137.97 135.74 36.29 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 118.099 0.95 . . . . 73.34 110.882 175.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 28.4 m -129.34 -176.71 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 124.181 0.993 . . . . 63.11 109.276 170.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -80.86 133.24 35.55 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.32 0.648 . . . . 74.32 110.765 176.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -119.92 111.94 18.57 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.542 -1.281 . . . . 74.41 107.542 165.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -71.81 129.16 37.96 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.055 -0.72 . . . . 74.15 109.055 177.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 43.4 p -109.27 179.82 4.05 Favored 'General case' 0 C--O 1.243 0.763 0 N-CA-C 107.744 -1.206 . . . . 74.1 107.744 171.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.415 HD22 ' HB3' ' A' ' 127' ' ' LEU . 72.2 mt -61.21 -22.11 64.46 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 114.021 1.119 . . . . 73.14 114.021 -170.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -142.64 28.7 1.6 Allowed 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 112.705 0.632 . . . . 64.44 112.705 -177.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 155.89 159.67 9.51 Favored Glycine 0 N--CA 1.477 1.419 0 N-CA-C 114.28 0.472 . . . . 63.05 114.28 173.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -87.69 130.39 2.7 Favored 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 123.199 2.599 . . . . 74.13 113.305 178.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 30.9 m -110.99 175.59 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 123.749 0.82 . . . . 73.4 110.262 175.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -101.82 111.22 23.4 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.803 0.841 . . . . 75.04 109.355 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 14.7 p -100.15 133.81 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 123.156 0.582 . . . . 74.51 109.584 177.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -86.64 104.47 16.08 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 122.955 0.502 . . . . 70.4 110.49 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 60.2 t -71.24 128.74 89.95 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 123.914 0.886 . . . . 71.22 109.857 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . 0.51 ' HD3' HD13 ' B' ' 441' ' ' ILE . 79.0 Cg_endo -74.62 167.02 28.07 Favored 'Trans proline' 0 C--N 1.373 1.835 0 C-N-CA 122.743 2.295 . . . . 75.51 111.636 172.11 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . 0.448 ' HB2' ' HE ' ' A' ' 226' ' ' ARG . 58.8 Cg_endo -70.35 159.99 51.07 Favored 'Trans proline' 0 C--N 1.365 1.418 0 C-N-CA 122.712 2.274 . . . . 72.53 113.441 171.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . 0.448 ' HE ' ' HB2' ' A' ' 225' ' ' PRO 0.266 0.0 OUTLIER 38.03 55.96 1.64 Allowed 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 126.428 1.891 . . . . 75.13 113.378 -175.913 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.495 HG22 HD21 ' A' ' 233' ' ' LEU . 64.2 m -84.2 90.44 7.51 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 113.06 -1.882 . . . . 64.32 108.953 173.198 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -86.15 146.45 26.58 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.766 0.826 . . . . 75.32 111.545 -171.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -64.8 148.45 51.23 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.846 0.858 . . . . 65.12 112.333 -176.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . 0.402 ' HA3' ' NH2' ' C' ' 254' ' ' ARG . . . 90.78 -21.16 34.71 Favored Glycine 0 C--N 1.345 1.041 0 CA-C-N 115.434 -0.803 . . . . 75.54 113.311 -178.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.524 ' HD3' ' OH ' ' B' ' 444' ' ' TYR . 99.8 mtt180 -81.2 170.81 15.64 Favored 'General case' 0 C--O 1.245 0.821 0 C-N-CA 123.757 0.823 . . . . 74.44 110.993 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.419 ' HG3' ' HB3' ' A' ' 250' ' ' TYR . 0.3 OUTLIER -129.02 117.28 20.65 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 114.601 -1.181 . . . . 72.22 109.03 -178.892 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.495 HD21 HG22 ' A' ' 227' ' ' THR . 58.2 mt -78.33 110.86 13.73 Favored 'General case' 0 C--O 1.218 -0.558 0 N-CA-C 108.034 -1.098 . . . . 71.4 108.034 175.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -80.99 106.51 13.05 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.974 0.909 . . . . 73.41 109.974 175.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.649 ' HB3' ' HA ' ' B' ' 441' ' ' ILE . 0.2 OUTLIER -118.68 107.22 13.43 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.229 0.537 . . . . 74.24 109.757 171.912 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 248' ' ' ASP . 25.6 mtpp -76.52 159.75 30.08 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.36 1.064 . . . . 71.01 111.079 -177.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 66.37 18.56 67.63 Favored Glycine 0 C--N 1.348 1.207 0 CA-C-N 115.688 -0.687 . . . . 74.2 113.279 -176.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.595 ' HG3' HD13 ' A' ' 235' ' ' LEU . 45.5 mmtm -114.32 -29.93 6.76 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.229 1.011 . . . . 74.1 109.805 -179.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -79.04 -154.98 8.56 Favored Glycine 0 C--N 1.343 0.95 0 CA-C-N 115.001 -1.0 . . . . 74.43 111.107 169.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . 0.471 ' CD2' ' HA2' ' A' ' 152' ' ' GLY . 35.3 m-85 -95.35 123.44 56.72 Favored Pre-proline 0 C--O 1.239 0.504 0 N-CA-C 109.519 -0.548 . . . . 73.41 109.519 -173.383 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.681 ' HA ' ' HA ' ' A' ' 246' ' ' ARG . 73.8 Cg_endo -73.24 132.16 17.52 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 122.721 2.281 . . . . 73.33 113.116 -170.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -101.65 -167.48 27.44 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 110.757 -0.937 . . . . 73.52 110.757 167.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -60.07 -62.54 0.15 Allowed 'Trans proline' 0 C--N 1.377 2.037 0 C-N-CA 122.915 2.41 . . . . 72.5 111.649 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -106.34 -25.31 11.98 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.449 0.7 . . . . 70.11 110.104 170.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -89.84 67.42 2.7 Favored Glycine 0 C--N 1.352 1.447 0 CA-C-N 115.759 -0.655 . . . . 62.24 112.457 -175.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.681 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 52.3 mtm-85 -69.92 118.24 12.51 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 123.529 0.732 . . . . 75.41 109.853 175.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.503 ' HA2' ' HB2' ' A' ' 191' ' ' GLN . . . -52.85 149.86 10.4 Favored Glycine 0 C--N 1.351 1.376 0 N-CA-C 117.346 1.698 . . . . 70.31 117.346 -167.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . 0.473 ' HA ' ' HA ' ' A' ' 236' ' ' LYS . 0.8 OUTLIER -98.46 172.87 7.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 113.858 -1.171 . . . . 75.44 109.173 -179.228 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.506 ' HB3' ' HG ' ' A' ' 235' ' ' LEU . 17.5 tp -137.06 101.78 4.65 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 106.21 -1.774 . . . . 73.32 106.21 170.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.419 ' HB3' ' HG3' ' A' ' 232' ' ' LYS . 84.6 m-85 -85.98 112.14 20.93 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 123.553 0.741 . . . . 71.3 109.219 174.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.516 HD12 HD22 ' A' ' 197' ' ' LEU . 94.0 mt -88.92 121.12 30.96 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.152 -0.931 . . . . 74.54 110.065 178.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.581 ' HB2' ' HA ' ' A' ' 196' ' ' THR . 45.9 mm-40 -75.15 91.49 2.6 Favored 'General case' 0 C--N 1.352 0.711 0 N-CA-C 108.132 -1.062 . . . . 75.41 108.132 177.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 42.0 t -65.41 115.59 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 O-C-N 123.705 0.628 . . . . 71.34 110.239 -178.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . 0.448 ' HD3' ' HA ' ' A' ' 254' ' ' ARG . 7.2 mmt180 -129.23 102.22 6.36 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.703 0.801 . . . . 73.14 108.921 172.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.577 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 60.9 mt -77.38 134.04 29.4 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-N 114.174 -1.375 . . . . 74.34 110.706 -179.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 28.4 p -127.7 174.5 9.05 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.638 1.175 . . . . 74.52 109.503 173.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.9 pp -134.98 152.89 78.08 Favored Pre-proline 0 CA--C 1.567 1.625 0 C-N-CA 123.583 0.753 . . . . 73.4 110.768 -177.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -65.95 -6.77 15.06 Favored 'Trans proline' 0 N--CA 1.51 2.448 0 C-N-CA 123.854 3.036 . . . . 74.45 115.58 -166.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.436 ' O ' ' HG2' ' C' ' 226' ' ' ARG . 39.1 mt-10 48.16 -83.62 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.751 1.221 . . . . 75.12 112.368 -164.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 7.1 ppt_? -61.02 137.86 58.21 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.388 0.675 . . . . 75.12 110.115 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.443 HD13 ' HA ' ' A' ' 266' ' ' GLU . 74.1 mt -137.86 140.92 40.68 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.321 0.581 . . . . 72.32 111.1 -172.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 37.0 p -83.4 138.74 41.57 Favored Pre-proline 0 CA--C 1.554 1.097 0 CA-C-O 117.683 -1.151 . . . . 74.31 108.745 175.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -24.79 -56.02 0.07 OUTLIER 'Trans proline' 0 C--N 1.386 2.55 1 C-N-CA 126.309 4.673 . . . . 74.33 117.382 -169.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -80.94 -33.22 34.14 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 112.481 0.548 . . . . 71.44 112.481 -173.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -69.95 -35.61 74.64 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 122.833 0.453 . . . . 73.22 110.066 174.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' GLU . . . . . 0.443 ' HA ' HD13 ' A' ' 261' ' ' LEU . 8.1 tp10 -54.36 -52.98 59.9 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 124.119 0.968 . . . . 73.45 109.091 169.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . 0.535 ' O ' ' HG3' ' A' ' 271' ' ' LYS . . . -57.42 -43.96 84.24 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 114.291 -1.322 . . . . 64.12 111.486 177.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 4.7 mp -59.55 -53.23 60.53 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 123.983 0.913 . . . . 73.14 111.286 -176.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -53.88 -48.15 70.35 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 124.198 0.937 . . . . 75.0 110.608 175.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . 0.501 ' HG3' HG22 ' C' ' 206' ' ' VAL . 1.0 OUTLIER -62.76 -34.82 78.03 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 123.875 0.735 . . . . 73.12 112.715 -179.327 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . 0.535 ' HG3' ' O ' ' A' ' 267' ' ' ALA . 64.2 mttm -62.33 -59.03 5.58 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.814 -0.81 . . . . 70.22 108.814 177.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 272' ' ' LEU . . . . . 0.517 ' O ' ' HB2' ' A' ' 276' ' ' TYR . 82.2 mt -49.2 -46.19 45.35 Favored 'General case' 0 C--N 1.358 0.963 0 O-C-N 125.564 1.79 . . . . 71.54 110.366 178.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . 0.546 ' HA ' ' HB2' ' C' ' 202' ' ' PRO . . . -79.12 -47.73 15.57 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 114.556 1.317 . . . . 72.23 114.556 -165.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -74.48 -31.4 62.2 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 110.123 -0.325 . . . . 74.35 110.123 -178.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . 0.452 ' O ' ' HG3' ' A' ' 279' ' ' ARG . . . -68.19 -42.04 80.51 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 109.756 -0.461 . . . . 72.24 109.756 169.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . 0.517 ' HB2' ' O ' ' A' ' 272' ' ' LEU . 32.7 t80 -56.26 -49.99 72.64 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 124.906 1.283 . . . . 75.02 110.683 178.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -64.18 -41.57 97.05 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 114.556 -1.202 . . . . 72.14 109.54 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -68.99 -10.42 57.39 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 123.432 0.693 . . . . 75.41 112.599 176.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . 0.568 ' HA ' HD23 ' B' ' 278' ' ' LEU . 74.4 mtt180 -89.51 -11.28 43.34 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.377 0.671 . . . . 75.15 111.23 175.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.302 0 N-CA-C 109.206 -0.664 . . . . 72.5 109.206 177.851 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.469 ' H2 ' ' HB2' ' A' ' 128' ' ' GLU . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.407 0 N-CA-C 108.683 -0.858 . . . . 74.12 108.683 . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -81.16 -46.96 14.11 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 108.352 -0.981 . . . . 62.45 108.352 170.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 20.6 mm-40 -138.43 91.38 2.54 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.395 1.478 . . . . 74.04 108.531 173.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' SER . . . . . 0.405 ' HB2' ' HB2' ' B' ' 1' ' ' MET . 47.6 t -108.35 151.69 25.66 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 123.991 0.916 . . . . 52.14 108.774 174.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 4.5 m -123.87 156.19 36.68 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 123.121 0.568 . . . . 74.34 110.813 -172.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.437 HG21 ' HA ' ' A' ' 125' ' ' LEU . 25.8 pt -139.32 174.21 9.81 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 C-N-CA 124.325 1.05 . . . . 65.34 111.449 -165.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -115.15 -163.31 0.87 Allowed 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.113 0.965 . . . . 72.22 110.295 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . 0.545 HD21 HG11 ' A' ' 145' ' ' VAL . 14.9 tp -148.09 178.89 8.16 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.129 0.571 . . . . 75.22 110.66 -178.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . 0.536 ' HB2' ' HB2' ' A' ' 122' ' ' GLU . . . -156.91 105.51 2.18 Favored 'General case' 0 C--N 1.358 0.937 0 C-N-CA 124.576 1.15 . . . . 73.12 108.389 178.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . 0.454 ' HB3' HD11 ' A' ' 119' ' ' LEU . 93.6 mt -79.59 121.27 25.05 Favored 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 123.997 0.919 . . . . 74.1 111.522 -173.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.53 HD21 ' HA ' ' B' ' 370' ' ' ALA . 2.9 mt -126.82 168.03 15.77 Favored Pre-proline 0 N--CA 1.506 2.357 0 C-N-CA 124.679 1.191 . . . . 72.11 109.195 -178.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.404 ' HB2' ' H ' ' B' ' 13' ' ' LEU . 69.3 Cg_endo -74.84 -137.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.394 2.968 0 C-N-CA 123.222 2.615 . . . . 71.41 113.513 -174.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . 0.404 ' H ' ' HB2' ' B' ' 12' ' ' PRO . 90.4 mt 89.88 179.22 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.49 0 C-N-CA 126.138 1.775 . . . . 75.11 113.249 172.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 63.1 tp -134.15 148.52 50.95 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 124.338 1.055 . . . . 64.54 111.623 -165.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 15' ' ' PHE . . . . . 0.617 ' HB2' HD11 ' A' ' 175' ' ' LEU . 0.5 OUTLIER -170.59 -151.85 0.08 Allowed 'General case' 0 CA--C 1.569 1.697 0 C-N-CA 124.133 0.973 . . . . 74.01 110.153 174.733 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 97.9 m -146.48 135.2 11.05 Favored Pre-proline 0 CA--C 1.567 1.605 0 C-N-CA 124.317 1.047 . . . . 71.11 110.119 -175.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 17' ' ' PRO . . . . . 0.541 ' HB3' ' HB3' ' A' ' 162' ' ' PRO . 17.9 Cg_exo -70.09 129.4 17.19 Favored 'Trans proline' 0 C--N 1.384 2.42 0 C-N-CA 123.473 2.782 . . . . 71.22 114.076 -179.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 88.0 t -136.53 -81.68 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 C-N-CA 123.362 0.665 . . . . 63.3 112.171 174.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 19' ' ' THR . . . . . 0.458 ' O ' ' HD2' ' A' ' 162' ' ' PRO . 56.4 m -84.96 120.99 27.13 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.468 0.707 . . . . 71.22 112.884 -163.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 20' ' ' LYS . . . . . 0.613 ' HG2' ' HG2' ' A' ' 162' ' ' PRO . 52.5 mttp -124.88 119.83 29.92 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.499 0.72 . . . . 74.33 110.524 -173.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -160.91 119.61 2.53 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.775 0.83 . . . . 75.34 109.914 176.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . 0.421 HH22 ' HB3' ' A' ' 86' ' ' SER . 2.5 mpt_? -123.68 -178.28 3.98 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.836 0.826 . . . . 73.31 112.054 -176.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 23' ' ' THR . . . . . . . . . . . . . 2.2 t -135.47 160.49 67.68 Favored Pre-proline 0 CA--C 1.563 1.458 0 C-N-CA 125.472 1.509 . . . . 72.54 107.973 175.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . 0.526 ' HA ' ' HG2' ' A' ' 60' ' ' PRO . 11.5 Cg_exo -36.4 119.27 0.21 Allowed 'Trans proline' 0 C--N 1.387 2.557 0 C-N-CA 124.156 3.237 . . . . 74.55 115.66 171.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -90.97 45.88 1.28 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.842 0.857 . . . . 74.53 111.17 174.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 14.2 tmm? -69.36 -44.39 26.03 Favored Pre-proline 0 CA--C 1.568 1.639 0 CA-C-N 115.723 -0.671 . . . . 75.13 110.069 167.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -87.38 49.97 1.95 Allowed 'Trans proline' 0 C--N 1.397 3.118 0 C-N-CA 122.314 2.009 . . . . 73.04 111.945 171.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.606 ' HA ' ' HB3' ' A' ' 144' ' ' ARG . 11.5 p -80.32 -17.41 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 C-N-CA 123.27 0.628 . . . . 75.25 112.241 -175.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . 0.587 ' HG ' HG11 ' B' ' 28' ' ' VAL . 60.2 mt -121.92 111.26 16.86 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.531 0.732 . . . . 73.34 110.352 -175.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.439 ' HB3' ' HG2' ' A' ' 139' ' ' GLU . 13.0 tp10 -147.13 146.62 29.97 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.492 0.717 . . . . 71.25 109.252 171.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -106.35 -24.83 12.15 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.612 0.765 . . . . 74.34 110.416 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 11.8 tpp180 -73.52 99.82 3.12 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 121.538 0.685 . . . . 72.22 110.459 178.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -103.71 132.01 50.35 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 114.291 -1.322 . . . . 73.31 107.796 168.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -160.68 -174.13 4.29 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.39 0.676 . . . . 53.33 110.581 -176.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 73.18 -74.3 0.09 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.968 1.707 . . . . 73.13 111.371 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -99.35 161.78 19.83 Favored Glycine 0 C--N 1.341 0.837 0 CA-C-N 116.163 -0.471 . . . . 74.33 113.221 -174.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -155.75 178.51 10.17 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 123.683 0.793 . . . . 61.44 108.996 -178.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . 0.558 HD11 ' HA ' ' B' ' 367' ' ' LEU . 2.3 mp -60.75 -22.99 27.71 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.404 0 C-N-CA 125.594 1.558 . . . . 75.44 111.263 170.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 8.3 m 76.72 32.2 0.53 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 125.342 1.457 . . . . 73.32 108.189 -162.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.689 ' HB2' HG21 ' B' ' 309' ' ' THR . . . -64.99 -36.34 15.77 Favored Pre-proline 0 CA--C 1.561 1.404 0 CA-C-N 113.645 -1.616 . . . . 73.24 111.834 171.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . 0.65 ' HB3' ' HB ' ' B' ' 361' ' ' ILE . 44.0 Cg_exo -47.4 -32.87 15.81 Favored 'Trans proline' 0 C--N 1.397 3.099 0 C-N-CA 122.872 2.381 . . . . 72.44 114.62 164.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -77.28 -7.38 86.9 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-O 119.616 -0.546 . . . . 61.22 113.99 -176.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -133.14 177.3 19.04 Favored Glycine 0 C--N 1.353 1.484 0 CA-C-N 117.552 0.676 . . . . 64.32 113.544 -175.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -162.57 120.87 2.13 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.647 1.179 . . . . 63.2 109.045 174.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? 45.46 -88.59 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 126.272 1.829 . . . . 74.21 111.232 -170.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.33 67.05 0.71 Allowed 'General case' 0 C--O 1.24 0.554 0 N-CA-C 105.173 -2.158 . . . . 75.02 105.173 177.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 35.2 tp 78.12 152.9 0.13 Allowed 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 126.053 1.741 . . . . 72.13 109.866 -169.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 33.1 p -80.59 50.99 1.4 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.042 0.937 . . . . 73.12 112.401 -176.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -82.31 63.96 4.34 Favored Glycine 0 C--N 1.343 0.967 0 N-CA-C 109.285 -1.526 . . . . 74.15 109.285 165.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . 0.455 ' O ' HD23 ' B' ' 111' ' ' LEU . 15.3 t70 -89.16 -64.44 1.14 Allowed 'General case' 0 C--N 1.351 0.643 0 C-N-CA 124.245 1.018 . . . . 64.2 109.027 -177.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 59.27 -83.46 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 125.105 1.362 . . . . 75.3 110.578 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 9.5 m 50.85 77.4 0.13 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 125.352 1.461 . . . . 73.31 112.404 176.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -157.8 -53.2 0.07 Allowed 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 121.117 0.484 . . . . 73.24 109.951 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -158.37 -179.23 7.91 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.426 -0.806 . . . . 75.51 110.809 -175.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 2.8 pp -121.81 25.6 9.12 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.177 0.991 . . . . 72.35 109.619 175.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 78.29 -47.15 0.44 Allowed 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 125.936 1.694 . . . . 74.21 112.425 -179.021 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 22.8 t70 78.74 -49.88 0.45 Allowed 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 125.766 1.627 . . . . 75.31 111.967 177.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 42.3 m -72.11 74.93 0.95 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 123.842 0.857 . . . . 62.01 111.047 -178.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . 0.583 HD12 HG22 ' B' ' 196' ' ' THR . 60.4 mt -91.45 71.24 6.0 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 124.028 0.931 . . . . 72.44 108.736 -177.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 31.0 m -139.56 -31.63 0.67 Allowed 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 114.814 -1.084 . . . . 71.31 110.169 -177.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 63.46 77.28 0.33 Allowed 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 125.065 1.346 . . . . 71.45 109.631 175.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 62' ' ' LYS . . . . . . . . . . . . . 41.6 mtpt -90.66 124.62 61.9 Favored Pre-proline 0 N--CA 1.472 0.673 0 CA-C-N 115.538 -0.755 . . . . 72.42 111.172 -169.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -76.55 -11.41 18.74 Favored 'Trans proline' 0 C--N 1.38 2.214 0 C-N-CA 122.85 2.366 . . . . 72.24 113.031 176.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 69.85 -70.24 0.15 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 125.388 1.475 . . . . 72.04 110.482 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.499 ' HG2' ' H ' ' B' ' 66' ' ' ASN . 75.2 tttt -76.41 177.35 7.42 Favored 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 124.449 1.1 . . . . 73.42 108.835 170.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 66' ' ' ASN . . . . . 0.499 ' H ' ' HG2' ' B' ' 65' ' ' LYS . 4.1 m-20 72.97 13.72 4.89 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.79 1.236 . . . . 72.41 112.967 173.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . 0.404 ' H ' HD12 ' B' ' 67' ' ' ILE . 0.2 OUTLIER -80.74 -23.96 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 122.999 0.52 . . . . 74.04 110.997 176.778 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 22.8 pt -95.97 -39.66 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 123.663 0.785 . . . . 73.4 110.775 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 95.7 mt -127.99 126.98 42.41 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 107.3 -1.37 . . . . 74.34 107.3 177.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 82.2 mt -49.76 -43.78 48.3 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.384 1.074 . . . . 65.22 113.005 -171.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . 0.478 HG13 ' HB3' ' B' ' 73' ' ' ASP . 38.3 pt -111.82 2.84 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 123.109 0.564 . . . . 75.5 111.957 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 64.0 33.12 86.39 Favored Glycine 0 C--N 1.357 1.723 0 CA-C-O 121.047 0.248 . . . . 71.15 112.614 178.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . 0.478 ' HB3' HG13 ' B' ' 71' ' ' ILE . 17.1 p-10 -74.03 -61.1 1.97 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.655 1.182 . . . . 74.12 112.925 -170.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.23 45.62 85.21 Favored Glycine 0 CA--C 1.535 1.291 0 N-CA-C 111.825 -0.51 . . . . 72.45 111.825 -168.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -62.64 123.83 19.42 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.845 0.858 . . . . 74.01 110.337 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . -150.31 56.76 0.46 Allowed Glycine 0 C--N 1.338 0.664 0 N-CA-C 110.024 -1.23 . . . . 71.52 110.024 175.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . 0.549 ' HA ' ' HB2' ' B' ' 88' ' ' GLU . 11.5 t70 -75.55 136.71 40.55 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 122.655 0.382 . . . . 74.35 110.882 -174.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 78' ' ' SER . . . . . 0.65 ' HA ' ' HB3' ' B' ' 84' ' ' ARG . 48.9 m 70.69 37.17 1.44 Allowed 'General case' 0 N--CA 1.477 0.907 0 O-C-N 124.723 1.264 . . . . 55.34 111.207 -176.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -116.41 121.68 42.61 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.215 -0.902 . . . . 74.44 110.069 177.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 31.2 mm 53.63 -91.69 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.56 1.331 0 C-N-CA 125.778 1.631 . . . . 72.52 112.417 173.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 81' ' ' THR . . . . . 0.422 ' OG1' ' HA ' ' B' ' 84' ' ' ARG . 20.5 p 21.32 -86.53 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 127.201 2.2 . . . . 74.52 115.124 -178.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -152.78 56.99 0.8 Allowed 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 106.293 -1.743 . . . . 75.12 106.293 174.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . 73.63 -61.15 0.51 Allowed 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 125.329 1.452 . . . . 74.13 107.475 -157.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 84' ' ' ARG . . . . . 0.65 ' HB3' ' HA ' ' B' ' 78' ' ' SER . 7.8 ptm180 -153.34 -174.6 5.0 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.602 1.161 . . . . 73.0 108.951 163.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -133.14 -83.51 0.47 Allowed 'General case' 0 N--CA 1.479 1.025 0 CA-C-O 119.108 -0.472 . . . . 72.23 109.87 -178.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -149.4 -55.57 0.18 Allowed 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 112.884 0.698 . . . . 74.21 112.884 -176.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -122.53 29.1 7.06 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 113.07 0.767 . . . . 52.24 113.07 -162.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 88' ' ' GLU . . . . . 0.549 ' HB2' ' HA ' ' B' ' 77' ' ' ASP . 5.3 mp0 -74.36 -21.51 59.64 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.156 0.583 . . . . 74.14 109.995 -178.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -62.05 -15.56 50.34 Favored Glycine 0 C--N 1.356 1.66 0 CA-C-O 119.205 -0.775 . . . . 54.33 113.493 173.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . 74.84 -66.07 0.31 Allowed 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.545 1.538 . . . . 75.53 112.993 167.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -71.29 -105.12 0.05 OUTLIER Glycine 0 C--N 1.351 1.381 0 O-C-N 123.639 0.587 . . . . 70.11 112.431 179.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 107.05 -175.48 20.61 Favored Glycine 0 C--N 1.344 1.016 0 CA-C-N 116.978 0.389 . . . . 73.42 112.631 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -60.12 99.71 0.08 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.659 1.184 . . . . 74.22 111.11 -176.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 66.17 -71.53 0.09 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 125.536 1.534 . . . . 72.14 112.376 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? 61.15 103.52 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.738 1.215 . . . . 74.44 111.55 173.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . -81.94 46.74 3.55 Favored Glycine 0 N--CA 1.475 1.28 0 CA-C-O 120.947 0.193 . . . . 75.21 112.876 178.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 49.9 mm -121.04 -35.86 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 124.85 1.26 . . . . 73.0 108.832 177.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -145.02 159.93 42.17 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.899 0.88 . . . . 75.21 109.649 -176.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . 77.08 -50.52 0.55 Allowed 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 125.912 1.685 . . . . 61.12 112.844 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . 0.498 ' HB2' ' HD3' ' B' ' 101' ' ' PRO . 5.5 mp -84.25 -57.45 0.4 Allowed Pre-proline 0 CA--C 1.566 1.595 0 C-N-CA 123.802 0.841 . . . . 74.2 110.76 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 101' ' ' PRO . . . . . 0.498 ' HD3' ' HB2' ' B' ' 100' ' ' LEU . 76.2 Cg_endo -91.4 96.35 0.22 Allowed 'Trans proline' 0 C--N 1.393 2.879 0 C-N-CA 121.793 1.662 . . . . 74.43 113.42 -177.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 8.5 mp -90.33 160.98 15.84 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 108.549 -0.908 . . . . 73.12 108.549 168.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 34.9 p -50.56 -68.4 0.17 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.28 1.032 . . . . 75.52 112.165 -174.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . -159.67 150.72 21.23 Favored Glycine 0 C--N 1.343 0.971 0 N-CA-C 111.845 -0.502 . . . . 51.35 111.845 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -151.65 139.57 19.99 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 123.68 0.792 . . . . 75.22 109.455 -178.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 106' ' ' TYR . . . . . 0.487 ' O ' ' HD3' ' C' ' 148' ' ' ARG . 6.5 p90 -159.77 -54.17 0.06 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.886 0.874 . . . . 74.44 110.15 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 1.4 m 64.41 -1.99 0.68 Allowed 'General case' 0 N--CA 1.509 2.514 0 C-N-CA 125.304 1.442 . . . . 75.34 112.911 -176.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 71.9 t60 -164.99 97.03 0.73 Allowed 'General case' 0 C--O 1.243 0.742 0 N-CA-C 107.249 -1.389 . . . . 73.44 107.249 -171.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -76.88 103.01 6.59 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 107.718 -1.215 . . . . 74.1 107.718 173.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -81.7 15.8 2.02 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.82 0.848 . . . . 75.22 111.996 -176.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . 0.455 HD23 ' O ' ' B' ' 50' ' ' ASP . 4.8 tt 73.67 -64.24 0.4 Allowed 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.897 1.679 . . . . 70.25 111.077 174.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -74.65 83.73 2.08 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.695 0.76 . . . . 73.2 110.016 176.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 113' ' ' LYS . . . . . . . . . . . . . 52.9 tptt -144.75 30.42 1.2 Allowed 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 107.452 -1.314 . . . . 75.13 107.452 177.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 114' ' ' LYS . . . . . 0.415 ' HB2' ' HZ1' ' B' ' 114' ' ' LYS . 0.0 OUTLIER -145.63 142.98 29.57 Favored 'General case' 0 C--N 1.349 0.545 0 CA-C-N 114.895 -1.048 . . . . 74.21 110.578 -176.853 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 4.1 m 64.58 154.82 0.07 Allowed 'General case' 0 CA--C 1.563 1.452 0 C-N-CA 125.449 1.499 . . . . 73.23 113.605 170.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . 0.458 ' O ' ' HD3' ' B' ' 118' ' ' PRO . . . 116.04 67.11 0.4 Allowed Glycine 0 C--N 1.347 1.162 0 CA-C-N 115.783 -0.644 . . . . 55.33 112.174 174.255 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -90.06 105.8 12.48 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 123.431 0.692 . . . . 75.35 110.439 172.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 118' ' ' PRO . . . . . 0.458 ' HD3' ' O ' ' B' ' 116' ' ' GLY . 1.8 Cg_endo -85.02 94.71 0.66 Allowed 'Trans proline' 0 C--N 1.366 1.453 0 C-N-CA 122.403 2.068 . . . . 63.21 108.281 165.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 119' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -77.52 -97.35 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 115.662 -0.699 . . . . 75.33 110.54 -174.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 120' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -130.61 97.53 4.4 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 109.129 -0.693 . . . . 70.1 109.129 -178.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 3.3 t -118.11 39.47 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.037 0 N-CA-C 107.947 -1.131 . . . . 74.32 107.947 176.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 47.6 p 55.58 58.48 4.51 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 125.369 1.467 . . . . 75.25 111.264 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . 0.465 ' HB3' ' H ' ' B' ' 405' ' ' ALA . 6.9 m-20 -88.06 48.74 1.68 Allowed 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 114.85 -1.068 . . . . 70.53 111.126 -173.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 20.4 t -104.06 112.73 25.85 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 107.496 -1.298 . . . . 61.03 107.496 175.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . 0.575 ' HB2' ' H ' ' B' ' 299' ' ' GLY . . . -155.77 31.02 0.36 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.22 0.608 . . . . 74.53 110.595 -177.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . 0.433 ' HB2' ' HA ' ' B' ' 297' ' ' TYR . . . 50.94 72.32 0.36 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.647 1.179 . . . . 74.13 112.249 -177.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 38.5 t -77.32 -26.96 52.67 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 115.543 -0.753 . . . . 70.01 110.627 177.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . 0.584 ' HB3' ' HB2' ' B' ' 131' ' ' TRP . . . -145.26 110.7 5.31 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.879 0.871 . . . . 74.33 109.353 -179.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 23.1 p -98.91 -62.06 1.29 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.738 0.815 . . . . 74.41 110.98 -178.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . -78.25 -22.95 47.58 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.27 0.628 . . . . 61.42 111.416 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 131' ' ' TRP . . . . . 0.584 ' HB2' ' HB3' ' B' ' 128' ' ' ALA . 22.8 m-90 -76.43 92.45 3.39 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.032 0.933 . . . . 73.51 109.296 -177.021 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 28.7 p -139.04 -66.39 0.47 Allowed 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 115.446 -0.797 . . . . 74.11 110.826 -175.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 43.1 p -88.44 48.05 1.58 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.963 0.905 . . . . 74.52 111.38 -173.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 64.24 -116.16 8.76 Favored Glycine 0 C--N 1.348 1.238 0 N-CA-C 111.739 -0.544 . . . . 55.15 111.739 -179.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 135' ' ' VAL . . . . . . . . . . . . . 21.6 t -95.43 58.97 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.055 0 N-CA-C 108.707 -0.849 . . . . 73.24 108.707 177.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 85.0 tttt 53.7 57.6 5.93 Favored 'General case' 0 CA--C 1.561 1.379 0 C-N-CA 124.749 1.219 . . . . 74.24 111.724 177.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 36.8 m -81.66 89.08 6.22 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.249 0.547 . . . . 75.31 110.2 -177.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -143.82 143.21 31.23 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 115.108 -0.951 . . . . 75.52 108.787 173.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 69.72 -74.88 0.08 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.181 1.392 . . . . 73.24 111.364 -176.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . 67.38 -100.67 0.61 Allowed Glycine 0 C--N 1.346 1.129 0 O-C-N 123.211 0.319 . . . . 75.54 112.649 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 141' ' ' ALA . . . . . 0.493 ' HB1' ' HB3' ' B' ' 145' ' ' ASP . . . -111.7 -10.42 14.07 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.808 0.843 . . . . 75.34 111.128 177.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 64.31 -76.62 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 125.493 1.517 . . . . 74.24 110.229 -175.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 177.54 32.03 0.05 OUTLIER Glycine 0 C--N 1.338 0.66 0 N-CA-C 110.027 -1.229 . . . . 61.25 110.027 175.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 16.0 m -133.99 22.99 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.089 1.356 . . . . 75.31 109.965 -176.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 145' ' ' ASP . . . . . 0.493 ' HB3' ' HB1' ' B' ' 141' ' ' ALA . 10.0 p-10 -51.9 -42.48 62.77 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.448 1.099 . . . . 75.32 110.79 178.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . 0.529 HG22 ' HG3' ' B' ' 148' ' ' GLU . 15.6 tt 157.97 -10.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 C-N-CA 127.644 2.377 . . . . 72.52 107.792 -175.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 51.3 m170 82.23 25.12 0.19 Allowed 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 126.328 1.851 . . . . 72.43 112.334 177.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . 0.529 ' HG3' HG22 ' B' ' 146' ' ' ILE . 55.9 mt-10 -76.64 -41.83 44.32 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 109.009 -0.737 . . . . 75.05 109.009 165.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 149' ' ' LYS . . . . . . . . . . . . . 18.0 mmtp -100.52 -53.75 3.02 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.675 -0.861 . . . . 74.13 108.675 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 29.8 t70 62.22 -86.14 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.344 1.458 . . . . 74.11 111.16 177.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 151' ' ' HIS . . . . . 0.555 ' H ' ' HD2' ' B' ' 152' ' ' PRO . 42.4 m80 -149.88 -48.15 0.02 OUTLIER Pre-proline 0 CA--C 1.565 1.552 0 C-N-CA 124.817 1.247 . . . . 74.43 112.261 -172.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 152' ' ' PRO . . . . . 0.555 ' HD2' ' H ' ' B' ' 151' ' ' HIS . 55.2 Cg_endo -66.09 85.5 0.25 Allowed 'Trans proline' 0 C--N 1.402 3.368 0 CA-C-N 121.972 1.74 . . . . 64.13 112.638 178.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 60.7 m -86.85 92.97 9.17 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 107.863 -1.162 . . . . 74.2 107.863 174.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 154' ' ' ILE . . . . . 0.422 HG22 ' O ' ' B' ' 262' ' ' ALA . 2.3 pp -102.81 128.73 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 115.286 -0.87 . . . . 74.25 110.401 -170.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 155' ' ' LEU . . . . . 0.473 ' HG ' ' H ' ' B' ' 156' ' ' GLU . 20.7 tp 59.67 -170.93 0.13 Allowed 'General case' 0 CA--C 1.571 1.765 0 C-N-CA 124.621 1.168 . . . . 73.12 111.593 170.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 156' ' ' GLU . . . . . 0.473 ' H ' ' HG ' ' B' ' 155' ' ' LEU . 56.6 mm-40 -57.99 -36.96 73.37 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.503 0.721 . . . . 72.23 110.34 166.183 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 157' ' ' MET . . . . . . . . . . . . . 1.5 tmt? 75.21 -14.64 0.74 Allowed 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 125.728 1.611 . . . . 61.13 111.813 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 158' ' ' ALA . . . . . . . . . . . . . . . 76.45 -60.16 0.48 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 126.371 1.868 . . . . 65.11 111.816 179.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -76.12 -37.12 58.44 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.833 0.853 . . . . 73.24 110.746 -175.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -61.76 -49.96 74.27 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.767 -0.651 . . . . 74.34 109.502 175.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -64.49 -29.46 70.5 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.144 0.978 . . . . 71.1 111.952 177.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . -66.99 -36.9 91.66 Favored Glycine 0 C--N 1.352 1.448 0 O-C-N 123.49 0.494 . . . . 73.4 112.919 179.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 67.2 tp -77.91 -51.41 10.46 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.338 0.655 . . . . 75.25 109.578 175.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 164' ' ' ALA . . . . . . . . . . . . . . . -158.29 117.4 3.14 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 114.902 -1.045 . . . . 75.34 108.428 -173.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 9.7 t -57.43 -35.35 69.96 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 123.282 0.633 . . . . 73.14 111.794 -177.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . 61.71 29.41 72.04 Favored Glycine 0 C--N 1.355 1.62 0 O-C-N 123.652 0.595 . . . . 74.53 112.524 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 167' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -76.94 142.41 40.06 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.014 0.926 . . . . 74.33 110.351 -173.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 9.3 p -67.04 135.19 29.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 122.512 0.325 . . . . 75.53 110.217 -178.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 94.3 p 55.86 33.15 21.03 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.259 1.424 . . . . 65.53 112.4 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 15.3 t -68.35 -19.87 64.68 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.759 0.424 . . . . 73.13 111.115 174.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . 70.51 -73.82 0.09 Allowed 'General case' 0 C--N 1.361 1.069 0 C-N-CA 126.034 1.734 . . . . 73.41 111.483 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 172' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 65.31 102.07 0.04 OUTLIER 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 125.196 1.398 . . . . 75.25 109.216 -176.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 173' ' ' LEU . . . . . 0.515 HD23 ' HG2' ' C' ' 128' ' ' GLU . 3.4 mm? -73.65 -39.94 64.09 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.686 0.795 . . . . 74.44 111.18 -172.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 174' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 69.96 -67.83 0.22 Allowed 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 125.343 1.457 . . . . 74.45 110.69 -176.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 175' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -106.25 139.83 40.14 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.038 0.935 . . . . 74.1 108.779 171.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -115.31 70.06 0.74 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.509 0.723 . . . . 74.11 109.721 -178.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 39.3 m -158.65 111.78 1.64 Allowed Pre-proline 0 CA--C 1.553 1.082 0 C-N-CA 124.197 0.999 . . . . 74.15 108.423 175.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 178' ' ' PRO . . . . . 0.563 ' HD3' ' HG3' ' C' ' 129' ' ' GLU . 90.6 Cg_endo -83.7 -42.51 0.08 OUTLIER 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 122.752 2.301 . . . . 74.53 113.25 179.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -167.79 27.37 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.405 1.082 . . . . 74.35 109.618 -174.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 180' ' ' ALA . . . . . 0.531 ' HB1' ' HB ' ' C' ' 137' ' ' VAL . . . 61.5 -79.19 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 124.461 1.104 . . . . 75.32 109.881 -165.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 181' ' ' LEU . . . . . 0.562 HD22 ' HB ' ' C' ' 138' ' ' VAL . 15.4 tp -168.29 21.48 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.315 0 C-N-CA 123.587 0.755 . . . . 74.44 110.364 172.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 182' ' ' VAL . . . . . . . . . . . . . 26.2 t -136.16 148.98 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.403 -0.81 . . . . 72.43 110.701 -173.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -149.07 -72.38 0.19 Allowed 'General case' 0 C--N 1.359 0.999 0 C-N-CA 123.376 0.67 . . . . 65.24 110.933 169.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 56.0 p-80 -150.52 161.37 42.67 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 122.402 0.281 . . . . 75.32 111.548 -174.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 185' ' ' VAL . . . . . . . . . . . . . 21.3 t -98.73 161.38 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.379 0 C-N-CA 124.389 1.076 . . . . 74.01 109.065 175.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 11.1 t -153.12 -171.25 3.86 Favored 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 123.871 0.868 . . . . 60.24 110.098 -176.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 187' ' ' SER . . . . . . . . . . . . . 45.8 m -92.89 130.94 38.32 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.28 1.032 . . . . 62.14 110.24 178.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 188' ' ' ARG . . . . . 0.498 ' HG2' ' H ' ' B' ' 189' ' ' LYS . 21.5 ttm180 178.55 -163.96 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 124.69 1.196 . . . . 72.32 108.335 -176.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 189' ' ' LYS . . . . . 0.498 ' H ' ' HG2' ' B' ' 188' ' ' ARG . 15.0 ptpt -147.63 152.22 37.51 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.673 1.189 . . . . 72.52 108.52 170.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 190' ' ' CYS . . . . . . . . . . . . . 51.2 m -140.27 137.82 34.52 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.308 0.643 . . . . 70.33 111.211 -173.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -166.88 143.71 4.66 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.265 1.026 . . . . 74.04 109.896 173.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 148.2 66.92 0.01 OUTLIER Glycine 0 C--N 1.352 1.462 0 CA-C-O 119.298 -0.723 . . . . 64.22 112.34 173.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 193' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -70.75 134.69 26.43 Favored 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 123.455 2.77 . . . . 73.22 113.889 -174.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 194' ' ' SER . . . . . 0.517 ' H ' ' HB2' ' C' ' 162' ' ' PRO . 52.2 p -162.35 171.83 16.58 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.861 1.264 . . . . 63.44 109.121 172.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 195' ' ' ALA . . . . . . . . . . . . . . . -136.39 -165.42 1.72 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.188 0.595 . . . . 74.32 111.227 -174.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 196' ' ' THR . . . . . 0.583 HG22 HD12 ' B' ' 59' ' ' LEU . 81.2 m 76.84 129.54 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 125.836 1.654 . . . . 73.32 111.645 -179.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 70.5 p -163.08 -175.85 4.55 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 124.172 0.989 . . . . 75.11 109.367 178.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 198' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 74.56 135.23 0.05 Allowed 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 125.299 1.439 . . . . 65.14 112.016 168.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 199' ' ' LYS . . . . . 0.418 ' HB3' HH22 ' C' ' 148' ' ' ARG . 52.8 tttp -161.23 90.86 0.83 Allowed 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 115.301 -0.863 . . . . 75.14 108.997 -176.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 200' ' ' CYS . . . . . . . . . . . . . 66.1 m -60.38 -46.71 97.57 Favored Pre-proline 0 CA--C 1.563 1.454 0 N-CA-C 113.289 0.848 . . . . 73.31 113.289 -178.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 201' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -75.06 3.16 5.9 Favored 'Trans proline' 0 C--N 1.39 2.747 0 C-N-CA 121.974 1.783 . . . . 74.02 113.23 178.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . -86.47 46.95 3.66 Favored Glycine 0 C--N 1.351 1.362 0 C-N-CA 122.804 0.24 . . . . 73.41 112.694 178.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -141.12 136.97 32.44 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.769 1.227 . . . . 71.33 108.64 -178.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -74.51 127.79 33.94 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.556 0.743 . . . . 74.01 109.813 177.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 205' ' ' LEU . . . . . . . . . . . . . 56.0 tp -62.81 -67.89 0.38 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.062 0.945 . . . . 72.44 110.932 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -156.42 -89.07 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 106.541 -1.651 . . . . 70.3 106.541 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 4.2 tmtm? 179.69 -75.84 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 107.785 -1.191 . . . . 74.32 107.785 178.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 121.59 51.29 0.24 Allowed Glycine 0 C--N 1.343 0.957 0 N-CA-C 109.143 -1.583 . . . . 71.52 109.143 -163.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . -66.98 -33.93 85.4 Favored Glycine 0 C--N 1.35 1.337 0 CA-C-N 114.769 -0.716 . . . . 63.34 114.109 -171.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -90.68 143.11 27.07 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.436 0.694 . . . . 74.51 110.096 177.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . 179.19 -65.19 0.08 OUTLIER Glycine 0 C--N 1.339 0.746 0 N-CA-C 109.898 -1.281 . . . . 74.43 109.898 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 46.5 m -82.77 95.64 7.94 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 123.93 0.892 . . . . 74.04 109.771 174.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . 0.57 ' HB ' HD23 ' B' ' 218' ' ' LEU . 61.0 mt -72.61 131.48 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 N-CA-C 108.746 -0.835 . . . . 70.12 108.746 175.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 214' ' ' THR . . . . . 0.662 ' HA ' ' HB2' ' B' ' 219' ' ' ASN . 11.1 t -127.22 151.64 48.43 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 123.685 0.794 . . . . 75.43 109.937 -179.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 215' ' ' GLU . . . . . 0.455 ' O ' ' HA ' ' B' ' 220' ' ' ALA . 36.8 tt0 72.8 -68.31 0.23 Allowed 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.794 1.638 . . . . 73.31 112.676 177.189 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -76.54 109.05 9.96 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.375 0.67 . . . . 61.42 110.175 -173.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 86.6 mt 67.68 -73.65 0.08 Allowed 'General case' 0 N--CA 1.478 0.974 0 O-C-N 124.896 1.372 . . . . 75.4 111.182 -179.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . 0.57 HD23 ' HB ' ' B' ' 213' ' ' ILE . 26.8 tp -78.8 133.57 37.05 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.692 0.797 . . . . 71.43 109.361 177.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 219' ' ' ASN . . . . . 0.662 ' HB2' ' HA ' ' B' ' 214' ' ' THR . 93.6 m-20 58.51 49.08 11.07 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.924 0.89 . . . . 71.24 109.94 -172.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . 0.455 ' HA ' ' O ' ' B' ' 215' ' ' GLU . . . -52.36 103.22 0.06 Allowed 'General case' 0 C--N 1.353 0.749 0 C-N-CA 124.567 1.147 . . . . 74.3 112.569 -168.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 221' ' ' ARG . . . . . . . . . . . . . 65.1 mtm180 64.9 -78.31 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 125.412 1.485 . . . . 73.55 110.287 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -166.98 134.01 2.41 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 125.115 1.366 . . . . 75.21 107.706 172.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -67.91 -34.16 76.09 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.456 0.702 . . . . 72.13 111.301 -179.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 12.9 t -83.76 -8.63 11.33 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.175 0 CA-C-N 115.797 -0.638 . . . . 75.32 110.14 176.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 16.5 m 71.9 108.01 0.07 Allowed 'General case' 0 C--N 1.361 1.083 0 C-N-CA 125.564 1.546 . . . . 73.55 110.006 -178.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 63.2 mt 69.77 166.87 0.28 Allowed 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.953 1.301 . . . . 74.43 111.117 -172.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . -84.34 62.25 4.6 Favored Glycine 0 CA--C 1.532 1.127 0 CA-C-N 116.242 -0.435 . . . . 71.24 112.573 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . -126.26 7.21 7.61 Favored Glycine 0 N--CA 1.476 1.348 0 C-N-CA 123.124 0.392 . . . . 72.41 112.534 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -87.63 -173.02 47.98 Favored Glycine 0 C--N 1.344 1.015 0 C-N-CA 122.836 0.255 . . . . 71.04 112.881 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . 74.54 -53.84 0.67 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.704 1.602 . . . . 70.23 111.179 -173.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 231' ' ' LYS . . . . . 0.517 ' HZ2' ' HB3' ' B' ' 231' ' ' LYS . 8.0 mtpm? 65.14 19.19 11.72 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 124.943 1.297 . . . . 73.24 111.188 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 9.8 t -143.3 137.83 29.11 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.709 1.203 . . . . 74.24 109.122 -179.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -130.01 72.64 1.49 Allowed 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 108.645 -0.872 . . . . 71.44 108.645 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -149.62 122.2 8.57 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.045 -0.979 . . . . 72.31 108.963 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -120.47 -168.86 1.71 Allowed 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.822 0.849 . . . . 64.41 110.436 -176.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 236' ' ' THR . . . . . . . . . . . . . 8.0 m -64.43 -26.55 68.5 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.963 0.905 . . . . 73.34 111.549 177.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . 70.21 121.33 0.03 OUTLIER 'General case' 0 C--N 1.361 1.085 0 C-N-CA 125.423 1.489 . . . . 73.03 110.748 -174.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 20.8 m -69.27 -24.66 64.0 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 123.529 0.732 . . . . 71.31 111.206 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -75.86 145.57 40.46 Favored 'General case' 0 C--N 1.348 0.532 0 C-N-CA 123.833 0.853 . . . . 74.42 112.262 -177.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 240' ' ' GLY . . . . . 0.428 ' H ' HD23 ' C' ' 235' ' ' LEU . . . -74.93 -138.78 0.59 Allowed Glycine 0 CA--C 1.533 1.158 0 CA-C-N 114.656 -1.157 . . . . 71.23 111.984 168.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 241' ' ' GLU . . . . . 0.539 ' HB3' ' HZ2' ' B' ' 245' ' ' LYS . 10.5 pt-20 -158.93 172.65 17.82 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.068 0.547 . . . . 71.23 111.221 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 242' ' ' TRP . . . . . 0.493 ' HH2' HG21 ' C' ' 227' ' ' THR . 0.0 OUTLIER -157.2 -46.65 0.07 Allowed 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.247 1.419 . . . . 70.32 108.514 -172.147 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 243' ' ' GLN . . . . . 0.589 ' HB2' ' HG2' ' C' ' 224' ' ' PRO . 35.8 mt-30 -117.76 -170.06 1.8 Allowed 'General case' 0 C--O 1.247 0.928 0 N-CA-C 107.71 -1.218 . . . . 74.22 107.71 166.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -78.37 89.4 1.11 Allowed Glycine 0 C--N 1.345 1.036 0 N-CA-C 111.147 -0.781 . . . . 71.54 111.147 171.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 245' ' ' LYS . . . . . 0.539 ' HZ2' ' HB3' ' B' ' 241' ' ' GLU . 1.7 pptp? -77.11 141.74 40.07 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.05 0.54 . . . . 75.34 111.513 -177.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 72.8 m -151.02 140.2 21.21 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.059 0.944 . . . . 71.14 109.446 -178.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 247' ' ' LEU . . . . . . . . . . . . . 74.9 mt -84.46 130.05 34.8 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.449 0.7 . . . . 72.51 109.53 176.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 248' ' ' ARG . . . . . 0.651 ' HG3' HG23 ' C' ' 206' ' ' VAL . 25.0 mmm180 -85.14 -173.47 4.72 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.69 0.796 . . . . 75.15 111.187 177.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -109.99 153.98 23.8 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.728 0.811 . . . . 71.33 109.757 -176.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -76.49 89.75 3.27 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 107.09 -1.448 . . . . 70.14 107.09 166.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 251' ' ' ALA . . . . . . . . . . . . . . . -72.38 74.25 1.01 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.506 0.723 . . . . 64.21 109.605 -177.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 59.71 110.16 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 125.546 1.538 . . . . 73.12 110.5 -164.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -70.69 -20.15 62.7 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.553 0.741 . . . . 51.41 111.231 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 66.1 mtp180 72.06 81.01 0.15 Allowed 'General case' 0 C--N 1.359 1.01 0 C-N-CA 125.263 1.425 . . . . 72.51 111.742 170.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -174.14 -102.9 0.16 Allowed Glycine 0 C--N 1.346 1.112 0 CA-C-N 114.937 -1.029 . . . . 63.32 111.908 178.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 256' ' ' TYR . . . . . . . . . . . . . 41.2 t80 55.12 41.22 31.84 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.845 1.307 . . . . 71.2 109.759 -172.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -156.67 -53.48 0.08 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 114.527 -1.215 . . . . 74.31 108.999 -174.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 258' ' ' LEU . . . . . . . . . . . . . 29.8 tp -166.83 -37.78 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 115.499 -0.773 . . . . 75.13 110.795 -175.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 39.1 t -65.67 -65.89 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.711 0.804 . . . . 63.31 112.208 -164.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 260' ' ' SER . . . . . 0.465 ' HA ' HD21 ' B' ' 278' ' ' LEU . 32.6 p -102.27 33.97 2.91 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 121.948 0.88 . . . . 73.11 110.884 -178.045 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -103.08 59.65 0.77 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-N 114.613 -1.176 . . . . 65.51 108.35 -177.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 262' ' ' ALA . . . . . 0.422 ' O ' HG22 ' B' ' 154' ' ' ILE . . . 58.74 72.78 0.51 Allowed 'General case' 0 C--N 1.356 0.863 0 CA-C-N 114.274 -1.33 . . . . 75.22 110.001 -174.295 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . 59.69 -92.29 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.632 1.173 . . . . 70.44 111.271 -175.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 45.6 m 51.47 33.07 9.63 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.419 1.088 . . . . 51.14 113.882 177.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 265' ' ' LEU . . . . . . . . . . . . . 10.6 mp -61.24 160.0 11.23 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.271 0.628 . . . . 73.31 111.333 175.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 266' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -68.56 89.04 0.36 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.297 0.639 . . . . 71.52 110.152 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 26.2 m 59.68 -84.41 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 125.251 1.421 . . . . 73.13 111.918 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 49.0 t 67.16 131.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 C-N-CA 125.245 1.418 . . . . 74.44 111.221 -177.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 269' ' ' THR . . . . . . . . . . . . . 1.3 m -92.37 -144.8 0.21 Allowed 'General case' 0 CA--C 1.563 1.448 0 N-CA-C 108.124 -1.065 . . . . 74.31 108.124 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 270' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 68.14 33.88 4.23 Favored 'General case' 0 CA--C 1.563 1.452 0 C-N-CA 123.806 0.842 . . . . 72.41 111.087 168.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 271' ' ' ALA . . . . . 0.427 ' O ' ' HE3' ' B' ' 275' ' ' LYS . . . 66.46 -79.17 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.861 1.265 . . . . 75.3 112.0 178.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 272' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -167.58 32.22 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.801 0.84 . . . . 73.11 109.573 -177.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.82 -62.95 1.49 Allowed 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 109.308 -0.627 . . . . 73.43 109.308 -177.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -94.5 -4.08 48.75 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 116.321 -0.4 . . . . 71.44 111.965 -177.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 275' ' ' LYS . . . . . 0.427 ' HE3' ' O ' ' B' ' 271' ' ' ALA . 6.8 mtmp? -61.34 -44.83 94.24 Favored Pre-proline 0 CA--C 1.562 1.411 0 CA-C-O 118.535 -0.745 . . . . 72.14 112.468 178.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -88.0 6.32 5.01 Favored 'Trans proline' 0 C--N 1.389 2.689 0 C-N-CA 122.342 2.028 . . . . 73.04 113.472 176.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 277' ' ' LEU . . . . . . . . . . . . . 67.0 tp -113.0 108.36 17.23 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 108.829 -0.804 . . . . 74.52 108.829 178.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 278' ' ' LEU . . . . . 0.568 HD23 ' HA ' ' A' ' 279' ' ' ARG . 5.1 mp -59.24 -65.67 0.63 Allowed 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.741 0.816 . . . . 72.2 110.263 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . 58.85 18.91 41.58 Favored Glycine 0 C--N 1.356 1.664 0 CA-C-N 115.045 -0.98 . . . . 75.43 113.122 -174.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 280' ' ' LEU . . . . . 0.603 ' HB3' HG21 ' C' ' 262' ' ' THR . 6.5 tt 75.19 -40.7 0.44 Allowed 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 126.337 1.855 . . . . 74.31 110.126 -169.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 80.0 t80 74.04 105.68 0.07 Allowed 'General case' 0 C--N 1.36 1.044 0 C-N-CA 125.672 1.589 . . . . 75.31 110.744 176.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -163.73 -83.42 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.713 0.805 . . . . 65.41 109.061 177.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -101.93 31.98 3.65 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-O 121.663 0.745 . . . . 72.33 109.638 176.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 284' ' ' GLY . . . . . 0.705 ' HA2' ' HG3' ' C' ' 260' ' ' ARG . . . -84.9 69.11 3.37 Favored Glycine 0 C--N 1.351 1.363 0 CA-C-N 114.944 -1.025 . . . . 72.13 110.838 173.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -155.97 176.61 12.42 Favored 'General case' 0 C--O 1.244 0.786 0 C-N-CA 123.604 0.762 . . . . 73.03 110.348 -177.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 286' ' ' MET . . . . . . . . . . . . . 12.7 tmm? 64.21 84.63 0.18 Allowed Pre-proline 0 CA--C 1.553 1.089 0 C-N-CA 124.961 1.304 . . . . 74.22 110.825 178.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 287' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -91.65 118.55 0.51 Allowed 'Trans proline' 0 C--N 1.368 1.602 0 C-N-CA 123.07 2.513 . . . . 74.24 111.215 166.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 288' ' ' VAL . . . . . . . . . . . . . 44.3 t -70.14 91.51 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 108.429 -0.952 . . . . 74.32 108.429 177.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 289' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -115.68 146.06 42.19 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.153 0.981 . . . . 74.32 109.408 -172.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 290' ' ' TRP . . . . . . . . . . . . . 6.3 m0 75.18 -49.41 0.64 Allowed 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 125.618 1.567 . . . . 75.34 112.27 178.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 291' ' ' LEU . . . . . . . . . . . . . 58.4 tp -52.89 -51.09 62.43 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.456 1.103 . . . . 73.52 111.355 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . -94.54 -69.41 1.07 Allowed Glycine 0 CA--C 1.535 1.288 0 CA-C-N 115.441 -0.799 . . . . 71.42 111.35 174.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.05 88.21 0.83 Allowed 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 123.26 2.64 . . . . 75.13 112.645 -178.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 294' ' ' LYS . . . . . 0.568 ' HZ3' ' HB3' ' B' ' 294' ' ' LYS . 4.9 ttpm? 179.06 -26.34 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 125.175 1.39 . . . . 74.44 109.391 179.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -79.84 36.02 0.32 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.137 0.975 . . . . 71.35 112.766 -175.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 9.8 t -167.74 150.36 5.82 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.053 0.941 . . . . 71.52 110.795 178.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 297' ' ' TYR . . . . . 0.433 ' HA ' ' HB2' ' B' ' 126' ' ' ALA . 90.9 t80 -179.11 118.5 0.07 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 126.046 1.738 . . . . 75.44 106.81 174.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 56.5 t60 67.6 107.65 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.083 0.953 . . . . 73.43 111.094 -178.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 299' ' ' GLY . . . . . 0.575 ' H ' ' HB2' ' B' ' 125' ' ' ALA . . . -87.91 176.59 45.91 Favored Glycine 0 N--CA 1.469 0.869 0 N-CA-C 110.99 -0.844 . . . . 72.35 110.99 166.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 54.7 t30 70.17 156.44 0.15 Allowed 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 124.354 1.062 . . . . 72.23 111.784 178.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 301' ' ' ILE . . . . . . . . . . . . . 18.3 pt -60.92 -33.91 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.252 0.621 . . . . 75.13 111.285 175.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -161.23 -106.17 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.924 0 CA-C-O 119.094 -0.479 . . . . 74.32 110.505 174.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 303' ' ' LYS . . . . . . . . . . . . . 7.6 mtmp? -157.22 -42.96 0.0 OUTLIER Pre-proline 0 CA--C 1.578 2.023 0 CA-C-O 117.382 -1.294 . . . . 74.11 114.174 -164.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 304' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -49.19 141.42 23.62 Favored 'Trans proline' 0 C--N 1.402 3.346 0 C-N-CA 122.838 2.359 . . . . 75.12 114.766 177.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -133.33 160.24 37.92 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.117 0.967 . . . . 72.13 110.133 -178.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . 0.472 ' HB ' ' HD3' ' B' ' 373' ' ' ARG . 2.8 p -61.63 111.07 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.916 0.887 . . . . 72.33 112.307 -175.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -161.36 99.66 1.18 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.42 1.088 . . . . 74.23 109.105 176.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 308' ' ' CYS . . . . . 0.529 ' HB3' ' HG2' ' B' ' 369' ' ' GLU . 51.6 t -164.83 -30.98 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.44 0.696 . . . . 74.22 110.728 175.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 309' ' ' THR . . . . . 0.689 HG21 ' HB2' ' B' ' 40' ' ' ALA . 97.9 m -56.71 130.04 77.39 Favored Pre-proline 0 N--CA 1.481 1.093 0 CA-C-O 117.928 -1.034 . . . . 72.2 111.55 176.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -53.32 -67.12 0.09 OUTLIER 'Trans proline' 0 C--N 1.393 2.898 0 C-N-CA 123.708 2.939 . . . . 64.44 112.799 -176.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 311' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -175.06 147.96 1.07 Allowed Pre-proline 0 N--CA 1.479 0.986 0 C-N-CA 123.31 0.644 . . . . 73.13 110.328 175.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 312' ' ' PRO . . . . . 0.516 ' HG3' ' HA ' ' B' ' 41' ' ' PRO . 21.4 Cg_endo -92.4 -147.22 0.03 OUTLIER 'Trans proline' 0 C--N 1.365 1.433 0 C-N-CA 123.351 2.701 . . . . 70.14 110.636 170.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 313' ' ' GLN . . . . . 0.58 HE22 ' HB2' ' B' ' 316' ' ' ASP . 0.5 OUTLIER -64.92 105.17 0.97 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.332 0.653 . . . . 75.13 109.439 175.544 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 314' ' ' ARG . . . . . . . . . . . . . 35.1 mmt180 -124.69 79.3 1.76 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.588 1.155 . . . . 74.53 108.564 177.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 315' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -156.26 -57.76 0.09 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.524 0.73 . . . . 75.34 109.316 -177.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 316' ' ' ASP . . . . . 0.58 ' HB2' HE22 ' B' ' 313' ' ' GLN . 2.8 m-20 -81.93 69.81 8.71 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.893 0.877 . . . . 74.4 108.664 176.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 25.6 t -117.85 87.64 2.76 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.149 -0.932 . . . . 75.41 109.096 -176.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 318' ' ' VAL . . . . . . . . . . . . . 34.1 m 39.59 62.08 5.49 Favored Pre-proline 0 CA--C 1.57 1.743 0 C-N-CA 126.597 1.959 . . . . 73.13 114.112 -178.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 319' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -86.34 -179.13 3.0 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 122.587 2.191 . . . . 65.1 112.627 -178.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 320' ' ' THR . . . . . . . . . . . . . 57.8 m 74.02 -56.7 0.64 Allowed 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 126.404 1.882 . . . . 73.24 111.936 -173.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 321' ' ' LEU . . . . . . . . . . . . . 34.9 tp -83.32 64.67 7.91 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 124.122 0.969 . . . . 74.43 110.125 -177.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 322' ' ' ALA . . . . . . . . . . . . . . . -89.6 -59.42 2.21 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.497 -0.774 . . . . 64.54 110.431 -178.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 323' ' ' GLN . . . . . 0.472 ' NE2' ' HG3' ' B' ' 342' ' ' GLN . 9.6 tt0 58.38 76.55 0.33 Allowed 'General case' 0 CA--C 1.553 1.096 0 CA-C-O 121.816 0.817 . . . . 74.02 109.658 -178.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 324' ' ' MET . . . . . . . . . . . . . 41.9 ttp 59.61 -105.9 0.26 Allowed 'General case' 0 CA--C 1.561 1.403 0 CA-C-N 113.783 -1.553 . . . . 74.22 109.426 -168.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 325' ' ' THR . . . . . . . . . . . . . 31.5 m 63.5 -63.41 0.13 Allowed 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 125.81 1.644 . . . . 72.33 113.838 178.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 326' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -48.96 132.51 18.61 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 125.097 1.359 . . . . 72.01 112.812 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 1.7 tmmt? 64.6 -77.25 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.881 0 O-C-N 125.451 1.72 . . . . 75.41 110.59 176.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 328' ' ' ALA . . . . . . . . . . . . . . . 64.55 -72.18 0.07 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 125.69 1.596 . . . . 72.03 111.244 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 329' ' ' ILE . . . . . . . . . . . . . 17.4 pt 53.0 125.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 C-N-CA 127.652 2.381 . . . . 73.5 113.624 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 330' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 50.72 16.49 0.32 Allowed 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 125.975 1.71 . . . . 74.44 113.669 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 331' ' ' LEU . . . . . . . . . . . . . 6.9 mp -107.93 179.29 4.27 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.072 1.349 . . . . 64.42 108.681 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 67.62 -72.9 0.09 Allowed 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 125.127 1.371 . . . . 74.41 110.729 -176.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 333' ' ' SER . . . . . 0.445 ' HB3' ' HB2' ' B' ' 336' ' ' GLU . 18.8 m 74.63 -10.27 1.2 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 125.948 1.699 . . . . 65.04 112.147 -177.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 61.3 mttm 63.84 -77.12 0.03 OUTLIER 'General case' 0 C--N 1.365 1.267 0 C-N-CA 125.263 1.425 . . . . 65.35 112.025 178.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 335' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -76.75 -48.92 17.24 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 122.871 0.468 . . . . 74.12 111.517 -178.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 336' ' ' GLU . . . . . 0.445 ' HB2' ' HB3' ' B' ' 333' ' ' SER . 4.0 mp0 -66.19 86.82 0.1 Allowed 'General case' 0 C--N 1.353 0.718 0 O-C-N 124.236 0.96 . . . . 73.55 109.374 -177.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 337' ' ' LYS . . . . . . . . . . . . . 44.8 tttp 64.72 -77.01 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 126.549 1.939 . . . . 71.1 111.434 -171.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 338' ' ' GLY . . . . . . . . . . . . . . . 135.17 -36.81 2.01 Favored Glycine 0 C--N 1.343 0.936 0 N-CA-C 110.813 -0.915 . . . . 73.12 110.813 -174.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 339' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 60.45 -80.76 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.567 1.547 . . . . 74.33 112.175 176.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 340' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -88.76 102.64 15.2 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 108.563 -0.903 . . . . 75.24 108.563 174.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 341' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -101.74 130.24 48.09 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 108.655 -0.868 . . . . 75.34 108.655 172.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 342' ' ' GLN . . . . . 0.472 ' HG3' ' NE2' ' B' ' 323' ' ' GLN . 10.2 tt0 -63.34 94.23 0.08 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.612 0.765 . . . . 74.32 109.447 178.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 343' ' ' VAL . . . . . . . . . . . . . 14.5 p -63.16 -33.85 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.242 1.017 . . . . 65.15 112.233 -170.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -97.26 119.53 35.96 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.258 0.623 . . . . 74.33 110.305 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 345' ' ' GLY . . . . . . . . . . . . . . . 78.28 -75.35 1.94 Allowed Glycine 0 C--N 1.344 1.016 0 O-C-N 124.189 0.931 . . . . 63.14 113.567 173.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 346' ' ' ALA . . . . . . . . . . . . . . . 64.22 16.93 10.4 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.813 1.245 . . . . 72.51 111.82 -177.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 28.2 t -92.39 27.66 2.18 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.279 1.031 . . . . 72.21 110.731 -175.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 348' ' ' ILE . . . . . 0.458 HG22 ' HB2' ' B' ' 351' ' ' GLN . 10.9 mt 55.03 47.02 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 107.633 -1.247 . . . . 73.42 107.633 -171.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 349' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -59.75 -36.8 77.35 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 113.163 -1.835 . . . . 71.13 113.066 -160.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 350' ' ' LYS . . . . . 0.571 ' HD2' ' H ' ' B' ' 350' ' ' LYS . 0.0 OUTLIER -74.38 -25.45 59.5 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.312 -0.858 . . . . 74.52 111.866 -175.349 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 351' ' ' GLN . . . . . 0.458 ' HB2' HG22 ' B' ' 348' ' ' ILE . 21.0 tp60 -63.58 167.21 5.89 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.551 0.74 . . . . 71.32 110.271 -179.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -47.5 105.96 0.08 Allowed 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 125.332 1.453 . . . . 74.35 111.737 -171.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 353' ' ' HIS . . . . . . . . . . . . . 44.6 p-80 -141.18 173.37 11.55 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.56 0.744 . . . . 74.33 110.768 -171.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 354' ' ' ALA . . . . . . . . . . . . . . . 57.92 43.13 21.87 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.959 1.304 . . . . 72.23 111.911 176.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 355' ' ' ALA . . . . . . . . . . . . . . . 65.09 19.12 11.73 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.499 1.12 . . . . 75.44 112.744 173.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 356' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -133.73 140.64 37.26 Favored Pre-proline 0 N--CA 1.479 1.024 0 C-N-CA 123.009 0.524 . . . . 74.32 110.509 177.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 357' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -89.27 42.66 0.6 Allowed 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 123.564 2.843 . . . . 74.21 111.304 173.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 358' ' ' CYS . . . . . . . . . . . . . 47.9 t 69.82 -0.96 2.49 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 124.679 1.192 . . . . 75.21 111.984 -177.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 359' ' ' GLY . . . . . . . . . . . . . . . 66.98 -95.53 0.28 Allowed Glycine 0 C--N 1.353 1.507 0 N-CA-C 109.892 -1.283 . . . . 72.04 109.892 -166.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 360' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 55.64 -80.16 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 126.322 1.849 . . . . 53.34 113.239 167.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 361' ' ' ILE . . . . . 0.65 ' HB ' ' HB3' ' B' ' 41' ' ' PRO . 2.8 pp -72.22 -20.56 20.04 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 125.107 1.363 . . . . 64.41 111.905 -175.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 362' ' ' GLY . . . . . . . . . . . . . . . -70.72 -17.21 74.82 Favored Glycine 0 C--N 1.354 1.562 0 O-C-N 123.76 0.663 . . . . 72.35 113.224 178.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 363' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -81.98 -16.25 51.02 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.551 0.74 . . . . 73.13 111.439 -178.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 364' ' ' THR . . . . . . . . . . . . . 17.3 p -126.17 118.31 24.94 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.847 0.859 . . . . 74.04 111.181 -177.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 3.0 m -123.54 84.22 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 N-CA-C 107.598 -1.26 . . . . 74.51 107.598 168.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -76.46 -37.11 57.42 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 115.285 -0.871 . . . . 52.52 112.499 -162.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 367' ' ' LEU . . . . . 0.558 ' HA ' HD11 ' B' ' 38' ' ' ILE . 3.1 tt 61.85 73.51 0.47 Allowed 'General case' 0 CA--C 1.553 1.08 0 N-CA-C 108.343 -0.984 . . . . 75.05 108.343 -171.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 368' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -107.69 -72.18 0.73 Allowed 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 116.085 -0.507 . . . . 73.23 111.975 -171.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 369' ' ' GLU . . . . . 0.529 ' HG2' ' HB3' ' B' ' 308' ' ' CYS . 0.3 OUTLIER -55.97 134.87 52.55 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.684 1.194 . . . . 74.11 111.241 -164.497 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 370' ' ' ALA . . . . . 0.53 ' HA ' HD21 ' B' ' 11' ' ' LEU . . . -153.3 40.61 0.53 Allowed 'General case' 0 CA--C 1.557 1.231 0 N-CA-C 113.11 0.782 . . . . 74.25 113.11 -170.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 371' ' ' VAL . . . . . . . . . . . . . 9.9 p -144.79 -25.83 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.575 -0.703 . . . . 74.12 112.889 175.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 372' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -112.21 175.55 5.39 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.174 0.99 . . . . 63.2 110.176 -173.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 373' ' ' ARG . . . . . 0.472 ' HD3' ' HB ' ' B' ' 306' ' ' VAL . 33.2 mtm180 89.15 122.09 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 126.525 1.93 . . . . 72.2 112.278 170.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 374' ' ' ALA . . . . . 0.455 ' HB1' HG12 ' A' ' 177' ' ' VAL . . . 61.2 121.43 0.01 OUTLIER 'General case' 0 C--N 1.359 1.007 0 C-N-CA 126.088 1.755 . . . . 71.45 113.71 163.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 375' ' ' LEU . . . . . 0.478 ' HA ' ' HA ' ' B' ' 378' ' ' ALA . 85.5 mt 70.43 15.07 7.34 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.891 1.276 . . . . 72.22 112.338 -178.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.84 -29.77 66.0 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.246 0.618 . . . . 73.13 109.605 171.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 377' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -103.92 -25.91 12.86 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.22 1.008 . . . . 73.31 110.579 167.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 378' ' ' ALA . . . . . 0.478 ' HA ' ' HA ' ' B' ' 375' ' ' LEU . . . 74.95 -166.01 0.08 Allowed 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 124.972 1.309 . . . . 73.45 112.688 172.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? 71.39 109.28 0.06 Allowed 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 125.469 1.508 . . . . 73.22 111.191 -173.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 380' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -157.04 -56.34 0.08 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.013 0.925 . . . . 72.4 108.815 176.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 381' ' ' GLU . . . . . 0.409 ' HG3' ' HG2' ' B' ' 415' ' ' LYS . 14.8 tt0 -74.64 113.85 12.38 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.624 -0.716 . . . . 74.34 109.639 176.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -74.27 -46.21 21.8 Favored Glycine 0 C--N 1.342 0.906 0 N-CA-C 110.637 -0.985 . . . . 73.1 110.637 168.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 383' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -168.18 -179.07 3.9 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.817 1.247 . . . . 73.1 108.696 176.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 384' ' ' THR . . . . . . . . . . . . . 14.4 t -119.61 11.66 12.08 Favored 'General case' 0 CA--C 1.558 1.269 0 C-N-CA 123.313 0.645 . . . . 71.44 111.296 -175.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 5.0 mp -101.25 -73.4 0.65 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.588 0.755 . . . . 75.43 109.096 -178.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 386' ' ' VAL . . . . . . . . . . . . . 2.5 m -139.41 116.77 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.023 1.329 . . . . 75.23 108.037 175.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 387' ' ' ILE . . . . . 0.603 HG13 ' H ' ' B' ' 388' ' ' VAL . 8.6 tp -83.21 -155.55 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.572 1.805 0 C-N-CA 123.783 0.833 . . . . 74.12 110.622 -174.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 388' ' ' VAL . . . . . 0.603 ' H ' HG13 ' B' ' 387' ' ' ILE . 19.2 t 72.26 2.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 C-N-CA 125.507 1.523 . . . . 74.43 110.502 -174.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 389' ' ' THR . . . . . . . . . . . . . 8.1 m -66.6 -36.41 82.55 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.648 1.179 . . . . 71.25 110.421 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . -84.55 114.86 22.27 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 124.117 0.967 . . . . 73.41 110.018 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 391' ' ' ASP . . . . . . . . . . . . . 32.0 t70 65.29 -102.6 0.09 Allowed 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 124.71 1.204 . . . . 64.12 111.943 173.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 392' ' ' HIS . . . . . . . . . . . . . 48.3 p-80 171.56 10.36 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 125.852 1.661 . . . . 72.42 109.624 -173.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . 65.15 78.73 0.27 Allowed 'General case' 0 C--N 1.363 1.155 0 C-N-CA 124.98 1.312 . . . . 61.53 111.33 -174.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -135.89 170.14 16.47 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.218 -1.031 . . . . 73.31 108.218 168.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . 65.57 15.31 9.98 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.812 0.845 . . . . 75.42 111.827 -178.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 29.8 t -78.51 85.0 4.61 Favored 'General case' 0 C--N 1.348 0.529 0 N-CA-C 107.2 -1.407 . . . . 75.55 107.2 171.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 397' ' ' GLN . . . . . 0.431 ' HB2' ' OH ' ' A' ' 194' ' ' TYR . 2.7 mp0 57.62 -148.88 0.47 Allowed 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 124.297 1.039 . . . . 75.54 110.778 178.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 2.9 pt 68.72 155.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 C-N-CA 126.767 2.027 . . . . 75.44 114.0 168.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 399' ' ' VAL . . . . . . . . . . . . . 53.6 t 68.43 155.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 C-N-CA 125.177 1.391 . . . . 73.32 111.778 177.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 400' ' ' ALA . . . . . . . . . . . . . . . 74.62 172.29 0.1 OUTLIER Pre-proline 0 N--CA 1.48 1.027 0 C-N-CA 125.326 1.451 . . . . 74.52 110.348 -177.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 401' ' ' PRO . . . . . 0.495 ' HG2' ' HG2' ' C' ' 184' ' ' PRO . 41.2 Cg_exo -44.19 119.98 2.33 Favored 'Trans proline' 0 C--N 1.384 2.405 0 C-N-CA 122.472 2.114 . . . . 71.34 112.673 167.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 22.5 p-10 -82.16 11.35 5.38 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.824 1.25 . . . . 74.34 111.561 -178.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 403' ' ' THR . . . . . . . . . . . . . 34.0 p -115.98 2.58 13.51 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.734 1.614 . . . . 73.2 111.099 -172.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 404' ' ' LYS . . . . . . . . . . . . . 52.6 tttm -168.86 103.71 0.4 Allowed 'General case' 0 C--N 1.355 0.821 0 C-N-CA 122.904 0.481 . . . . 71.14 110.387 176.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 405' ' ' ALA . . . . . 0.465 ' H ' ' HB3' ' B' ' 123' ' ' ASP . . . -177.17 124.18 0.28 Allowed Pre-proline 0 N--CA 1.476 0.829 0 C-N-CA 124.954 1.302 . . . . 71.24 108.529 171.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 406' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -65.74 86.49 0.22 Allowed 'Trans proline' 0 C--N 1.383 2.376 0 C-N-CA 122.719 2.279 . . . . 64.23 112.241 177.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . -124.75 -93.95 1.01 Allowed Glycine 0 C--N 1.348 1.208 0 N-CA-C 109.41 -1.476 . . . . 74.04 109.41 174.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 408' ' ' LEU . . . . . . . . . . . . . 5.8 mp 61.47 -90.12 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.6 1.16 . . . . 72.55 111.067 174.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 77.9 m -83.65 151.93 25.04 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.761 0.824 . . . . 73.52 109.173 178.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 410' ' ' GLN . . . . . 0.4 ' HA ' ' HG3' ' A' ' 189' ' ' GLU . 10.1 mm100 70.72 153.69 0.12 Allowed 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 125.049 1.34 . . . . 70.42 112.361 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 411' ' ' ALA . . . . . 0.712 ' HB3' HH22 ' A' ' 187' ' ' ARG . . . -141.3 -87.58 0.17 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.189 -0.914 . . . . 74.33 108.774 178.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 43.0 tp 174.68 139.75 0.05 OUTLIER 'General case' 0 C--N 1.359 1.0 0 C-N-CA 124.57 1.148 . . . . 75.21 109.736 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 17.2 t30 72.88 164.17 0.28 Allowed 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.735 1.214 . . . . 71.14 113.944 163.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 414' ' ' THR . . . . . 0.6 ' HA ' HG21 ' B' ' 387' ' ' ILE . 11.8 m 82.91 124.32 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 126.956 2.102 . . . . 73.24 112.865 172.066 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 415' ' ' LYS . . . . . 0.441 ' HE3' ' O ' ' A' ' 158' ' ' VAL . 22.1 tptm -130.68 -54.12 1.07 Allowed 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.208 1.403 . . . . 75.21 108.762 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -88.16 -178.13 5.87 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.754 0.822 . . . . 75.33 109.971 174.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 417' ' ' GLY . . . . . . . . . . . . . . . -151.84 174.11 30.96 Favored Glycine 0 C--N 1.346 1.084 0 C-N-CA 121.899 -0.191 . . . . 62.31 113.063 -176.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 418' ' ' ALA . . . . . . . . . . . . . . . -97.6 175.46 6.19 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.448 1.099 . . . . 70.25 110.462 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 419' ' ' VAL . . . . . . . . . . . . . 68.9 t -77.5 108.86 11.36 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 C-N-CA 123.322 0.649 . . . . 73.31 109.846 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 420' ' ' MET . . . . . 0.511 ' HG3' ' H ' ' B' ' 421' ' ' VAL . 23.2 ptm 46.31 -79.11 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 127.267 2.227 . . . . 73.34 114.678 177.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 421' ' ' VAL . . . . . 0.511 ' H ' ' HG3' ' B' ' 420' ' ' MET . 27.2 m -119.36 -38.02 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 123.702 0.801 . . . . 72.42 110.9 -176.269 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 422' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER 61.89 -72.64 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 125.682 1.593 . . . . 74.1 111.708 -174.383 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 423' ' ' SER . . . . . . . . . . . . . 38.0 m -82.48 111.35 18.42 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.871 0.868 . . . . 63.45 110.876 -178.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 424' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 62.07 -161.48 0.29 Allowed 'General case' 0 N--CA 1.477 0.878 0 O-C-N 124.36 1.038 . . . . 74.22 112.525 170.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . 157.1 -84.94 0.13 Allowed Glycine 0 C--N 1.338 0.684 0 N-CA-C 109.593 -1.403 . . . . 75.12 109.593 173.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 426' ' ' ASN . . . . . 0.819 ' HB2' ' HB2' ' B' ' 432' ' ' GLN . 0.0 OUTLIER -173.28 102.57 0.12 Allowed 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 107.819 -1.178 . . . . 75.43 107.819 -179.89 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 427' ' ' SER . . . . . . . . . . . . . 44.0 m 62.54 20.05 11.68 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 124.237 1.015 . . . . 75.14 110.552 -167.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 50.93 25.99 2.46 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 125.024 1.33 . . . . 73.23 112.061 -168.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 429' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -149.57 -90.39 0.07 Allowed 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 109.082 -0.71 . . . . 63.42 109.082 -176.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -168.82 -171.22 1.32 Allowed 'General case' 0 CA--C 1.555 1.155 0 N-CA-C 109.141 -0.689 . . . . 62.42 109.141 -171.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 28.4 t 80.95 -1.83 1.79 Allowed 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 125.37 1.468 . . . . 75.05 113.249 168.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 432' ' ' GLN . . . . . 0.819 ' HB2' ' HB2' ' B' ' 426' ' ' ASN . 14.7 mm100 -101.89 -47.84 4.46 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 118.418 0.554 . . . . 71.1 110.033 173.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 433' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 64.79 -80.25 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.681 1.192 . . . . 73.43 110.116 -176.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 434' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -78.26 81.43 4.62 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 107.733 -1.21 . . . . 73.42 107.733 167.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 435' ' ' THR . . . . . . . . . . . . . 3.1 t -68.41 -48.82 63.67 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.02 -0.991 . . . . 73.42 109.652 175.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . 56.9 16.61 18.55 Favored Glycine 0 C--N 1.356 1.671 0 N-CA-C 114.503 0.561 . . . . 61.51 114.503 175.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 37.5 p -71.65 -44.01 65.08 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 123.987 0.915 . . . . 72.35 110.396 -176.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 438' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -152.71 -81.46 0.09 Allowed 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.916 -1.038 . . . . 71.55 109.554 -174.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 439' ' ' LEU . . . . . . . . . . . . . 5.9 mp 53.62 -85.27 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.955 0.902 . . . . 74.24 109.121 -164.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 440' ' ' ARG . . . . . . . . . . . . . 18.4 mmt180 65.73 171.66 0.22 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 124.967 1.307 . . . . 74.1 113.148 172.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 441' ' ' ILE . . . . . 0.649 ' HA ' ' HB3' ' A' ' 235' ' ' LEU . 27.5 mt -114.72 121.96 67.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 114.842 -1.072 . . . . 74.15 109.802 179.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 442' ' ' ALA . . . . . 0.447 ' HA ' ' HA ' ' B' ' 458' ' ' THR . . . -60.9 -39.6 89.94 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.746 0.818 . . . . 73.33 110.7 178.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . -73.54 142.16 46.69 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.378 0.671 . . . . 74.21 110.7 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 444' ' ' TYR . . . . . 0.556 ' HB3' ' ND2' ' B' ' 450' ' ' ASN . 84.0 m-85 64.43 -86.11 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.311 1.044 . . . . 71.31 110.97 175.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . 64.23 -136.26 39.99 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-O 119.462 -0.632 . . . . 74.34 112.671 -176.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 446' ' ' PRO . . . . . 0.53 ' HD3' ' HA ' ' B' ' 459' ' ' ASP . 71.9 Cg_endo -99.71 47.94 0.06 OUTLIER 'Trans proline' 0 CA--C 1.555 1.554 0 C-N-CA 123.309 2.673 . . . . 72.44 112.089 168.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 447' ' ' HIS . . . . . . . . . . . . . 70.5 t60 -77.49 76.76 4.02 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.522 0.729 . . . . 63.45 111.13 -175.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . 65.33 -77.59 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.085 1.354 . . . . 74.31 112.009 177.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 449' ' ' ALA . . . . . . . . . . . . . . . -142.83 7.43 1.65 Allowed 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.729 0.812 . . . . 74.42 111.422 178.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 450' ' ' ASN . . . . . 0.556 ' ND2' ' HB3' ' B' ' 444' ' ' TYR . 5.4 m-20 55.5 17.07 2.08 Favored 'General case' 0 N--CA 1.502 2.125 0 C-N-CA 125.331 1.453 . . . . 63.22 114.5 173.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 65.0 t -69.37 96.05 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 122.934 0.494 . . . . 74.44 109.943 -174.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 452' ' ' VAL . . . . . . . . . . . . . 7.1 t 62.32 25.71 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.564 1.482 0 C-N-CA 125.2 1.4 . . . . 74.24 109.942 -177.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . -91.13 68.54 2.21 Favored Glycine 0 C--N 1.35 1.327 0 CA-C-N 115.456 -0.793 . . . . 73.44 113.348 -170.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 454' ' ' LEU . . . . . . . . . . . . . 2.2 tt -78.15 70.82 4.57 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.068 -1.086 . . . . 73.13 108.068 175.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 55.8 p -127.47 144.26 51.09 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 124.508 1.123 . . . . 72.1 109.917 -171.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -77.49 82.94 3.91 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.632 0.773 . . . . 74.3 110.07 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 457' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -101.78 -29.57 11.8 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.07 1.348 . . . . 65.21 110.957 -179.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 458' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' B' ' 442' ' ' ALA . 62.2 m 71.64 120.98 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.675 1.59 . . . . 72.13 110.837 -174.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 459' ' ' ASP . . . . . 0.53 ' HA ' ' HD3' ' B' ' 446' ' ' PRO . 34.7 t70 -68.97 138.66 54.75 Favored 'General case' 0 C--N 1.352 0.704 0 C-N-CA 123.189 0.595 . . . . 73.31 111.321 -175.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 30.6 tp -123.71 -12.01 7.67 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.387 1.075 . . . . 65.42 108.73 176.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 72.5 t80 55.04 88.57 0.04 OUTLIER 'General case' 0 C--N 1.36 1.063 0 C-N-CA 125.227 1.411 . . . . 75.0 111.102 -172.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -110.68 -14.48 14.03 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 115.313 -0.858 . . . . 72.53 110.397 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 26.0 m -78.26 92.81 4.54 Favored 'General case' 0 C--N 1.35 0.621 0 CA-C-O 121.676 0.75 . . . . 71.14 110.5 -175.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 464' ' ' MET . . . . . . . . . . . . . 19.2 ptp -147.02 20.71 1.25 Allowed 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 114.33 -1.304 . . . . 75.31 109.308 177.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 465' ' ' LYS . . . . . 0.474 ' HZ2' ' HB3' ' B' ' 465' ' ' LYS . 0.5 OUTLIER -149.4 146.59 27.55 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 124.597 1.159 . . . . 72.15 109.589 -174.423 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -90.31 1.61 56.36 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.77 0.828 . . . . 65.13 110.663 173.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . 67.74 -76.61 0.05 Allowed 'General case' 0 C--N 1.368 1.374 0 C-N-CA 125.709 1.604 . . . . 75.3 111.399 176.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 5.0 tt -78.08 -26.74 48.33 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 124.119 0.967 . . . . 74.32 109.494 178.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 469' ' ' GLY . . . . . . . . . . . . . . . -85.55 66.65 3.74 Favored Glycine 0 C--N 1.349 1.274 0 CA-C-N 116.086 -0.506 . . . . 62.03 113.449 -176.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 470' ' ' LEU . . . . . . . . . . . . . 3.2 pp -131.29 -6.58 3.8 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.433 0.693 . . . . 75.32 111.249 175.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 471' ' ' LYS . . . . . . . . . . . . . 61.5 tttp . . . . . 0 C--O 1.252 1.186 0 N-CA-C 108.907 -0.775 . . . . 74.2 108.907 -175.643 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 67.2 mtt . . . . . 0 N--CA 1.479 1.001 0 N-CA-C 109.315 -0.624 . . . . 70.43 109.315 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.03 24.08 12.3 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.368 1.467 . . . . 70.41 112.885 178.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.0 76.56 3.55 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.262 0.625 . . . . 71.34 110.257 -178.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 4' ' ' LYS . . . . . 0.418 ' HZ3' ' HB2' ' C' ' 4' ' ' LYS . 5.0 ttmp? -38.33 99.43 0.02 OUTLIER 'General case' 0 C--N 1.364 1.2 0 C-N-CA 124.691 1.196 . . . . 70.52 113.536 -176.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 5' ' ' LYS . . . . . 0.445 ' HG3' ' OG ' ' C' ' 94' ' ' SER . 1.3 mmmp? -67.64 96.87 0.57 Allowed 'General case' 0 C--O 1.241 0.651 0 N-CA-C 107.319 -1.363 . . . . 72.32 107.319 165.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 6' ' ' ASP . . . . . 0.484 ' HA ' ' OH ' ' C' ' 66' ' ' TYR . 38.4 t70 -70.42 96.56 1.16 Allowed 'General case' 0 C--N 1.348 0.539 0 N-CA-C 108.453 -0.943 . . . . 65.15 108.453 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 7' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -58.36 -34.32 70.54 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 113.835 -1.53 . . . . 73.43 111.737 -173.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -62.0 -47.22 85.76 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 115.777 -0.647 . . . . 74.23 110.42 175.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.99 -40.32 93.0 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.252 0.621 . . . . 63.34 111.288 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 58.6 mt -60.93 -39.59 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.079 0.552 . . . . 73.31 110.227 176.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 87.0 mt -80.26 -6.97 58.77 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 112.785 0.661 . . . . 75.53 112.785 177.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 69.2 31.39 71.85 Favored Glycine 0 C--N 1.353 1.5 0 O-C-N 123.055 0.222 . . . . 74.43 113.189 -178.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 26.9 m -126.34 154.67 74.78 Favored Pre-proline 0 N--CA 1.481 1.107 0 C-N-CA 124.932 1.293 . . . . 71.34 109.268 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -80.36 167.56 19.23 Favored 'Trans proline' 0 C--N 1.371 1.743 0 C-N-CA 122.401 2.067 . . . . 74.43 112.754 178.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -72.85 74.29 1.14 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.12 0.968 . . . . 74.35 109.652 173.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -178.3 -19.3 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.164 1.386 . . . . 71.24 108.538 -176.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -49.42 112.04 0.58 Allowed 'General case' 0 C--N 1.354 0.782 0 C-N-CA 125.176 1.391 . . . . 75.2 112.345 175.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 77.9 p -73.62 -177.94 2.91 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.011 0.925 . . . . 74.41 111.429 -178.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -51.74 -52.25 50.06 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.307 0.643 . . . . 74.45 111.846 -176.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -67.18 -32.01 72.81 Favored 'General case' 0 C--O 1.206 -1.227 0 CA-C-O 118.679 -0.677 . . . . 74.53 112.107 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -68.92 -40.77 78.87 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 119.014 0.824 . . . . 73.42 110.767 -179.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 22' ' ' ILE . . . . . 0.833 HD13 ' HB3' ' C' ' 57' ' ' LEU . 96.6 mt -69.62 -37.77 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.553 1.141 . . . . 75.54 110.199 174.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 23' ' ' LYS . . . . . 0.477 ' O ' ' HG3' ' C' ' 27' ' ' LYS . 10.4 tppt? -65.41 -42.86 92.08 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 114.942 -1.026 . . . . 74.13 109.636 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 24' ' ' ARG . . . . . 0.438 ' HA ' ' HD2' ' C' ' 27' ' ' LYS . 97.3 mtt180 -77.71 -28.23 50.84 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 124.607 1.163 . . . . 73.52 110.669 -177.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.72 -43.65 95.9 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 123.895 0.747 . . . . 75.32 109.065 172.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 26' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -65.08 -45.36 85.55 Favored 'General case' 0 C--O 1.213 -0.818 0 CA-C-N 114.939 -1.028 . . . . 72.31 110.886 176.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' C' ' 23' ' ' LYS . 83.9 mttt -55.57 -46.19 77.22 Favored 'General case' 0 N--CA 1.502 2.14 0 C-N-CA 123.824 0.85 . . . . 75.33 110.143 178.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 25.0 ttm180 -56.07 -56.58 19.1 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 114.338 -1.301 . . . . 75.55 110.203 178.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . 0.51 HD11 HD11 ' C' ' 50' ' ' ILE . 66.1 mt -80.46 -9.61 59.76 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 114.543 -1.208 . . . . 71.43 111.636 -172.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.77 -27.52 26.83 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.702 0.801 . . . . 75.32 110.248 173.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 81.9 mtm180 -90.9 -21.71 21.26 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 123.56 0.537 . . . . 73.5 111.107 171.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -82.55 -55.67 4.33 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.363 0.665 . . . . 71.12 110.187 -178.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -89.63 17.08 6.8 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.221 0.609 . . . . 72.14 110.984 178.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 34' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -47.14 94.8 0.08 OUTLIER Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 125.151 1.38 . . . . 74.34 112.365 -169.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -75.35 -8.87 20.02 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 123.313 2.675 . . . . 72.22 112.817 -164.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -65.05 -41.32 95.26 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.62 1.168 . . . . 60.34 110.107 171.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 88.5 t -97.06 -48.11 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 115.683 -0.69 . . . . 75.33 109.868 -178.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -97.0 75.02 2.62 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 108.152 -1.055 . . . . 65.41 108.152 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 39' ' ' LYS . . . . . 0.533 ' HB2' ' HZ2' ' C' ' 39' ' ' LYS . 10.5 mtmp? -75.8 75.83 2.75 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 114.377 -1.283 . . . . 71.22 109.247 177.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 49.7 m -139.42 132.72 15.59 Favored Pre-proline 0 C--O 1.245 0.831 0 CA-C-N 115.027 -0.988 . . . . 74.14 109.847 -176.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . 0.469 ' HA ' ' HB2' ' C' ' 44' ' ' GLU . 81.7 Cg_exo -47.37 -33.16 16.22 Favored 'Trans proline' 0 C--N 1.389 2.709 0 C-N-CA 124.049 3.166 . . . . 75.0 113.059 174.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -45.17 -59.62 2.54 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.418 1.087 . . . . 71.01 110.494 171.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.6 -7.93 59.65 Favored 'General case' 0 C--O 1.211 -0.923 0 CA-C-N 114.339 -1.301 . . . . 71.45 110.646 -177.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 44' ' ' GLU . . . . . 0.469 ' HB2' ' HA ' ' C' ' 41' ' ' PRO . 22.0 mm-40 -78.26 -60.57 2.32 Favored 'General case' 0 C--O 1.213 -0.825 0 N-CA-C 108.422 -0.955 . . . . 74.04 108.422 175.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -53.28 -47.89 68.79 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.147 0.979 . . . . 75.44 110.925 176.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 46' ' ' LYS . . . . . 0.504 ' O ' HG12 ' C' ' 50' ' ' ILE . 49.4 mttp -65.48 -52.28 53.99 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.301 -0.863 . . . . 72.32 112.32 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -68.98 -23.1 64.08 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 118.511 0.596 . . . . 71.12 111.624 -178.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 48' ' ' LYS . . . . . 0.429 ' HD3' ' O ' ' C' ' 44' ' ' GLU . 13.1 mptt -75.85 -35.89 59.78 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 122.59 0.356 . . . . 72.04 110.27 177.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -67.28 -33.23 74.87 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 117.763 0.256 . . . . 72.33 110.351 170.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 50' ' ' ILE . . . . . 0.51 HD11 HD11 ' C' ' 29' ' ' LEU . 22.8 mm -66.34 -38.88 82.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 N-CA-C 109.538 -0.542 . . . . 75.43 109.538 173.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 51' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -65.3 -42.29 93.2 Favored 'General case' 0 C--O 1.204 -1.335 0 C-N-CA 123.637 0.775 . . . . 74.04 110.08 178.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -61.82 -52.73 62.97 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.329 1.052 . . . . 75.54 110.097 177.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.13 -56.56 19.41 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-N 113.582 -1.644 . . . . 63.1 111.571 -176.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -64.51 -35.82 82.2 Favored 'General case' 0 C--O 1.204 -1.318 0 CA-C-N 114.19 -1.368 . . . . 75.01 111.226 177.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.78 -39.72 92.66 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 118.779 0.718 . . . . 60.54 111.747 -176.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 78.8 t -72.94 -50.34 33.27 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 O-C-N 123.597 0.56 . . . . 72.43 109.715 174.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 57' ' ' LEU . . . . . 0.833 ' HB3' HD13 ' C' ' 22' ' ' ILE . 60.9 mt -88.12 1.43 54.36 Favored 'General case' 0 CA--C 1.56 1.362 0 N-CA-C 114.582 1.327 . . . . 75.02 114.582 -168.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 41.5 t -55.8 -38.08 69.47 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 124.599 1.16 . . . . 75.33 112.719 -173.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -121.41 137.91 27.54 Favored Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 107.409 -1.33 . . . . 72.03 107.409 -168.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 60' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -48.9 -36.64 34.75 Favored 'Trans proline' 0 C--N 1.381 2.261 0 C-N-CA 123.839 3.026 . . . . 73.21 113.441 -177.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -58.12 -66.76 0.43 Allowed 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 114.261 -1.336 . . . . 62.13 111.398 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 1.8 mtpm? -72.4 -23.31 61.08 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.54 0.736 . . . . 75.43 111.7 -174.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 -57.24 -50.13 73.85 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.276 -0.874 . . . . 74.14 109.153 169.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 64' ' ' ARG . . . . . 0.51 ' HA ' ' HB2' ' C' ' 67' ' ' ASP . 27.4 mmt180 -72.7 -21.81 60.99 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.636 -0.711 . . . . 74.15 112.117 178.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 1.6 mp -58.86 -46.92 90.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-N 118.556 0.616 . . . . 71.5 109.417 167.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 66' ' ' TYR . . . . . 0.484 ' OH ' ' HA ' ' C' ' 6' ' ' ASP . 37.0 t80 -62.41 -51.41 67.65 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 115.78 -0.646 . . . . 74.31 110.52 174.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 67' ' ' ASP . . . . . 0.51 ' HB2' ' HA ' ' C' ' 64' ' ' ARG . 27.4 m-20 -59.83 -31.14 69.46 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.704 0.802 . . . . 73.14 112.021 -176.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 39.9 p -81.31 -26.93 35.26 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 119.269 -0.396 . . . . 74.43 110.986 176.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 69' ' ' TYR . . . . . 0.403 ' HE2' ' HE1' ' C' ' 96' ' ' PHE . 71.2 t80 -72.6 133.52 44.73 Favored 'General case' 0 C--N 1.359 1.019 0 N-CA-C 108.518 -0.919 . . . . 75.22 108.518 173.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.46 16.94 41.11 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.286 -0.726 . . . . 62.51 111.286 -164.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 63.1 m -146.76 -61.42 0.3 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 103.497 -2.779 . . . . 72.34 103.497 172.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 28.3 m -76.5 142.08 41.04 Favored 'General case' 0 C--O 1.25 1.099 0 N-CA-C 104.997 -2.223 . . . . 73.35 104.997 157.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.46 -10.74 8.39 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.342 0.657 . . . . 73.23 110.82 177.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -77.5 138.61 63.26 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 123.242 0.617 . . . . 53.23 109.529 171.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -63.16 136.66 57.2 Favored 'Trans proline' 0 C--N 1.373 1.836 0 C-N-CA 122.602 2.201 . . . . 75.14 111.808 174.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.04 159.37 53.31 Favored 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 123.323 2.682 . . . . 71.22 112.229 -178.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -59.51 116.38 3.25 Favored 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 122.693 2.262 . . . . 74.4 112.637 174.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 78' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -68.48 136.5 36.8 Favored 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 122.675 2.25 . . . . 74.44 111.82 175.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 79' ' ' PRO . . . . . 0.618 ' HB3' ' HA3' ' C' ' 142' ' ' GLY . 38.5 Cg_exo -45.77 159.46 0.21 Allowed 'Trans proline' 0 CA--C 1.567 2.134 0 C-N-CA 123.955 3.103 . . . . 70.12 114.303 166.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -66.02 84.21 0.25 Allowed 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 123.075 2.516 . . . . 74.31 111.892 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 146.67 -28.19 1.62 Allowed Glycine 0 C--N 1.336 0.567 0 CA-C-N 114.668 -1.151 . . . . 75.2 110.799 -178.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 146.93 173.77 18.43 Favored Glycine 0 C--N 1.344 1.026 0 C-N-CA 123.857 0.741 . . . . 75.13 112.004 172.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 83' ' ' TYR . . . . . 0.461 ' HA ' ' HD2' ' C' ' 79' ' ' PRO . 76.5 m-85 -52.05 120.34 5.29 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.009 0.924 . . . . 73.4 110.591 176.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 84' ' ' ASP . . . . . 0.578 ' HB2' ' HG2' ' C' ' 79' ' ' PRO . 44.3 t0 -60.65 124.83 21.55 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 124.502 1.126 . . . . 75.11 110.385 -176.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 85' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -169.34 17.94 0.02 OUTLIER 'General case' 0 C--O 1.257 1.492 0 CA-C-N 114.185 -1.37 . . . . 74.41 107.493 -167.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 19.6 m -59.08 116.44 3.84 Favored 'General case' 0 C--N 1.361 1.09 0 CA-C-N 113.755 -1.566 . . . . 52.42 110.781 -166.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 87' ' ' GLY . . . . . 0.572 ' HA2' ' HA ' ' C' ' 171' ' ' PRO . . . 124.1 -20.57 7.1 Favored Glycine 0 C--N 1.342 0.867 0 O-C-N 123.732 0.645 . . . . 74.34 112.936 179.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 88' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -123.32 131.96 53.84 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 117.599 0.7 . . . . 74.44 111.804 -169.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -75.42 86.16 2.56 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.553 0.741 . . . . 72.23 111.154 -171.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 90' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -39.8 -43.72 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 C-N-CA 125.901 1.68 . . . . 54.42 114.74 174.228 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -65.07 -18.52 65.37 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.327 0.651 . . . . 75.25 112.149 -174.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -79.3 -30.44 42.89 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 122.848 0.459 . . . . 75.53 110.693 177.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -85.47 174.64 9.36 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.484 0.714 . . . . 72.45 112.908 -164.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 94' ' ' SER . . . . . 0.445 ' OG ' ' HG3' ' C' ' 5' ' ' LYS . 93.7 p -78.88 178.24 8.11 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 114.363 1.246 . . . . 52.11 114.363 -163.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -62.61 -54.02 45.91 Favored 'General case' 0 C--N 1.355 0.818 0 CA-C-N 113.888 -1.505 . . . . 72.35 111.2 -176.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 96' ' ' PHE . . . . . 0.403 ' HE1' ' HE2' ' C' ' 69' ' ' TYR . 48.6 t80 -48.44 -50.19 32.28 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 123.629 0.772 . . . . 74.24 111.626 -176.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 97' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -60.14 -52.01 67.14 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 114.592 -1.186 . . . . 64.25 110.116 175.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 98' ' ' GLN . . . . . 0.618 ' HA ' HD11 ' C' ' 105' ' ' LEU . 22.2 mt-30 -73.13 3.78 5.18 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 112.753 0.649 . . . . 71.33 112.753 -178.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -100.47 -54.5 2.83 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.879 0.872 . . . . 74.43 111.796 168.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 28.9 tp -63.84 -44.76 92.19 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.215 0.606 . . . . 73.23 110.809 -176.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 101' ' ' PHE . . . . . 0.447 ' O ' ' HG ' ' C' ' 105' ' ' LEU . 42.3 m-85 -94.78 -5.76 44.53 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.387 -0.824 . . . . 75.04 110.152 177.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -42.61 -60.97 2.67 Favored Glycine 0 CA--C 1.541 1.669 0 CA-C-O 118.553 -1.137 . . . . 74.41 115.076 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -41.42 -24.49 0.23 Allowed 'Trans proline' 0 C--N 1.391 2.785 0 C-N-CA 125.05 3.833 . . . . 64.35 116.584 -179.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -149.29 38.92 0.94 Allowed Glycine 0 C--N 1.35 1.352 0 CA-C-O 119.226 -0.763 . . . . 73.42 112.706 -176.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 105' ' ' LEU . . . . . 0.618 HD11 ' HA ' ' C' ' 98' ' ' GLN . 38.5 mt -64.2 80.66 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 114.647 1.351 . . . . 75.43 114.647 176.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 106' ' ' PHE . . . . . 0.487 ' HB3' ' H ' ' C' ' 107' ' ' GLY . 0.6 OUTLIER 48.23 -150.79 0.14 Allowed 'General case' 0 CA--C 1.556 1.202 0 N-CA-C 117.158 2.281 . . . . 64.24 117.158 162.893 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 107' ' ' GLY . . . . . 0.487 ' H ' ' HB3' ' C' ' 106' ' ' PHE . . . 93.15 -1.19 69.83 Favored Glycine 0 C--N 1.353 1.494 0 N-CA-C 111.766 -0.534 . . . . 51.05 111.766 -165.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 61.76 -136.65 46.61 Favored Glycine 0 C--N 1.35 1.353 0 N-CA-C 111.776 -0.53 . . . . 74.41 111.776 -175.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 109' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -86.62 -0.9 57.11 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.162 0.585 . . . . 74.45 110.61 176.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 110' ' ' GLY . . . . . . . . . . . . . . . -93.98 -28.41 11.02 Favored Glycine 0 C--N 1.356 1.663 0 CA-C-N 116.417 -0.356 . . . . 73.14 112.768 178.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 13.7 mmm180 67.76 -11.49 0.33 Allowed 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 114.477 1.288 . . . . 75.25 114.477 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 112' ' ' ARG . . . . . . . . . . . . . 39.1 ttp180 -78.6 12.96 1.79 Allowed 'General case' 0 CA--C 1.565 1.547 0 C-N-CA 123.988 0.915 . . . . 75.43 112.423 -178.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 113' ' ' SER . . . . . . . . . . . . . 66.4 m 66.6 36.97 4.61 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.743 1.217 . . . . 72.53 112.113 175.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 114' ' ' ARG . . . . . 0.51 ' HG2' ' H ' ' C' ' 115' ' ' LYS . 2.1 ttp180 -70.3 174.35 5.72 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 115.55 -0.75 . . . . 74.05 111.608 -174.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 115' ' ' LYS . . . . . 0.629 ' HA ' ' HD2' ' C' ' 170' ' ' PRO . 61.8 tttp -47.1 143.25 3.21 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.336 1.054 . . . . 74.15 110.441 168.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 116' ' ' GLY . . . . . 0.423 ' HA2' ' HA3' ' C' ' 168' ' ' GLY . . . -44.01 124.51 5.23 Favored Glycine 0 C--N 1.359 1.809 0 CA-C-O 118.822 -0.988 . . . . 54.4 110.653 169.113 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 37.8 ttp180 -57.24 101.99 0.08 Allowed 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.401 -0.963 . . . . 74.32 108.401 -177.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -47.05 100.55 0.02 OUTLIER 'General case' 0 C--N 1.351 0.653 0 O-C-N 124.739 1.274 . . . . 75.42 107.734 172.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 119' ' ' LEU . . . . . . . . . . . . . 23.3 tp -91.15 119.21 31.07 Favored 'General case' 0 C--N 1.338 0.095 0 CA-C-N 114.466 -1.243 . . . . 75.21 109.441 -161.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.436 ' HD3' ' N ' ' B' ' 188' ' ' ARG . 10.6 mtt180 -112.22 88.56 2.84 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 114.312 -1.313 . . . . 72.31 107.734 -169.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 121' ' ' ALA . . . . . 0.474 ' HB2' HD21 ' C' ' 176' ' ' LEU . . . -109.46 142.38 40.55 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 109.363 -0.606 . . . . 75.44 109.363 -174.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -126.97 127.81 45.4 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 107.152 -1.425 . . . . 74.12 107.152 178.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -138.51 147.32 54.6 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 123.249 0.62 . . . . 73.3 110.992 -167.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . 0.439 ' HA ' ' O ' ' C' ' 179' ' ' ARG . 6.1 Cg_exo -80.78 122.73 4.47 Favored 'Trans proline' 0 C--N 1.368 1.576 0 C-N-CA 123.184 2.59 . . . . 72.51 110.445 166.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 125' ' ' LEU . . . . . 0.44 ' O ' ' HA ' ' C' ' 180' ' ' LEU . 18.1 tp -132.23 151.97 51.56 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 108.995 -0.743 . . . . 75.32 108.995 -177.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 126' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -95.04 152.61 18.18 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-O 120.734 0.302 . . . . 61.53 110.47 -178.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 127' ' ' LEU . . . . . 0.518 HD11 ' HD2' ' C' ' 186' ' ' PHE . 89.4 mt -60.51 -49.16 78.67 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.272 1.029 . . . . 62.25 111.029 177.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 128' ' ' GLU . . . . . 0.515 ' HG2' HD23 ' B' ' 173' ' ' LEU . 22.1 mp0 -66.32 -33.45 75.76 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 115.564 -0.743 . . . . 75.24 110.564 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 129' ' ' GLU . . . . . 0.563 ' HG3' ' HD3' ' B' ' 178' ' ' PRO . 13.5 mm-40 -68.83 -29.09 67.35 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.423 0.689 . . . . 75.51 111.363 176.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -75.18 -40.95 59.01 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 109.256 -0.646 . . . . 73.14 109.256 176.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 131' ' ' PHE . . . . . 0.555 ' HB2' HD12 ' C' ' 215' ' ' LEU . 84.6 t80 -55.06 -40.12 69.95 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.044 0.937 . . . . 75.55 110.744 174.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 132' ' ' HIS . . . . . . . . . . . . . 35.4 m170 -64.75 -59.52 4.14 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 115.545 -0.752 . . . . 70.15 109.676 174.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 62.77 -132.59 43.82 Favored Glycine 0 C--N 1.352 1.434 0 CA-C-N 115.719 -0.673 . . . . 65.31 111.925 -176.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 134' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' C' ' 148' ' ' ARG . . . 63.52 -151.65 48.52 Favored Glycine 0 C--N 1.351 1.41 0 O-C-N 123.956 0.445 . . . . 73.12 112.905 175.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -70.82 107.96 4.25 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.268 0.627 . . . . 73.03 109.784 178.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 136' ' ' ARG . . . . . 0.559 ' HB2' HD23 ' B' ' 181' ' ' LEU . 5.6 mmp_? -106.48 145.51 31.72 Favored 'General case' 0 C--O 1.249 1.029 0 C-N-CA 123.942 0.897 . . . . 72.12 109.185 171.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 137' ' ' VAL . . . . . 0.531 ' HB ' ' HB1' ' B' ' 180' ' ' ALA . 82.9 t -72.07 106.57 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.175 0.99 . . . . 73.11 110.412 -178.168 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 138' ' ' VAL . . . . . 0.562 ' HB ' HD22 ' B' ' 181' ' ' LEU . 12.1 p -119.54 111.73 34.26 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 CA-C-O 121.534 0.683 . . . . 72.14 110.173 176.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 139' ' ' GLU . . . . . 0.473 ' HA ' ' O ' ' C' ' 143' ' ' ARG . 1.4 tm-20 -119.32 99.85 6.95 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 106.882 -1.525 . . . . 74.31 106.882 169.289 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 140' ' ' VAL . . . . . . . . . . . . . 7.3 p -139.03 134.83 42.15 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 109.128 -0.693 . . . . 73.25 109.128 -179.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 141' ' ' ALA . . . . . 0.518 ' HB1' ' HG2' ' C' ' 167' ' ' GLN . . . 68.7 6.81 5.72 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.759 1.223 . . . . 65.0 112.713 -179.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 142' ' ' GLY . . . . . 0.618 ' HA3' ' HB3' ' C' ' 79' ' ' PRO . . . 105.49 -8.1 43.64 Favored Glycine 0 C--N 1.349 1.304 0 N-CA-C 112.611 -0.196 . . . . 52.4 112.611 -176.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 143' ' ' ARG . . . . . 0.473 ' O ' ' HA ' ' C' ' 139' ' ' GLU . 23.9 ttt85 -86.42 104.21 15.7 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.403 0.681 . . . . 75.05 110.615 179.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 39.8 ttt180 -98.18 107.76 20.31 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.684 0.794 . . . . 71.51 109.9 177.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 145' ' ' VAL . . . . . . . . . . . . . 7.2 p -150.94 157.14 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 123.914 0.886 . . . . 75.03 109.787 177.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 41.3 m -100.83 105.1 16.37 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.106 -1.072 . . . . 73.22 108.106 168.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 147' ' ' VAL . . . . . 0.427 HG22 HG13 ' C' ' 161' ' ' VAL . 7.6 p -104.67 146.26 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 N-CA-C 110.311 -0.255 . . . . 72.53 110.311 -173.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 148' ' ' ARG . . . . . 0.487 ' HD3' ' O ' ' B' ' 106' ' ' TYR . 12.6 ttm180 -85.78 109.73 18.86 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 116.224 -0.444 . . . . 74.22 110.318 177.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 149' ' ' ILE . . . . . . . . . . . . . 31.3 pt -91.99 150.08 39.94 Favored Pre-proline 0 C--O 1.245 0.846 0 CA-C-N 114.971 -1.013 . . . . 74.42 108.334 169.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 150' ' ' PRO . . . . . 0.503 ' HD2' HG22 ' C' ' 159' ' ' ILE . 19.3 Cg_endo -56.04 125.76 20.13 Favored 'Trans proline' 0 C--N 1.383 2.359 0 C-N-CA 122.744 2.296 . . . . 61.44 110.974 178.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -57.07 93.77 0.05 OUTLIER 'Trans proline' 0 C--N 1.383 2.346 0 C-N-CA 123.187 2.592 . . . . 73.2 111.971 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 152' ' ' GLY . . . . . . . . . . . . . . . 114.25 131.44 5.21 Favored Glycine 0 C--N 1.342 0.9 0 CA-C-N 115.259 -0.882 . . . . 63.11 112.633 -174.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 p -145.66 158.95 12.5 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.11 0 C-N-CA 123.694 0.797 . . . . 74.01 110.664 -177.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 154' ' ' ARG . . . . . . . . . . . . . 16.7 mtt85 -101.98 153.19 20.11 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 124.399 1.08 . . . . 75.32 110.335 -173.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 155' ' ' GLU . . . . . 0.414 ' HB2' HD12 ' C' ' 180' ' ' LEU . 12.7 tp10 -65.59 127.25 31.14 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.891 0.877 . . . . 74.51 110.372 169.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 76.18 6.08 82.4 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-N 115.576 -0.738 . . . . 75.21 114.566 178.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 157' ' ' SER . . . . . . . . . . . . . 26.7 t -107.38 156.41 18.96 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 117.337 0.569 . . . . 75.43 111.229 -175.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 158' ' ' VAL . . . . . 0.425 ' HB ' ' HB3' ' C' ' 175' ' ' LEU . 18.4 m -93.31 134.25 31.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-N 114.83 -1.077 . . . . 72.31 111.772 -176.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 159' ' ' ILE . . . . . 0.557 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 80.9 mt -86.88 132.04 33.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 C-N-CA 124.187 0.995 . . . . 72.31 108.53 166.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 160' ' ' ARG . . . . . 0.422 ' NH1' HD12 ' B' ' 111' ' ' LEU . 21.3 ttm180 -82.49 99.97 9.8 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 109.084 -0.71 . . . . 75.13 109.084 171.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 161' ' ' VAL . . . . . 0.427 HG13 HG22 ' C' ' 147' ' ' VAL . 63.5 t -96.24 95.37 1.96 Allowed Pre-proline 0 CA--C 1.548 0.866 0 N-CA-C 106.432 -1.692 . . . . 75.24 106.432 169.016 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 162' ' ' PRO . . . . . 0.517 ' HB2' ' H ' ' B' ' 194' ' ' SER . 26.9 Cg_endo -94.86 165.68 1.7 Allowed 'Trans proline' 0 C--N 1.361 1.232 0 C-N-CA 123.05 2.5 . . . . 75.23 115.226 -162.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 65.83 13.41 59.18 Favored Glycine 0 C--N 1.345 1.044 0 CA-C-N 114.114 -1.403 . . . . 53.54 114.829 172.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 164' ' ' MET . . . . . 0.432 ' SD ' ' NH2' ' C' ' 143' ' ' ARG . 35.1 mtm -136.81 -88.68 0.29 Allowed 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 117.468 0.634 . . . . 73.35 110.067 -175.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . 79.85 -152.56 35.24 Favored Glycine 0 C--N 1.351 1.412 0 CA-C-N 116.762 -0.199 . . . . 73.32 113.369 -172.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . -98.77 -159.64 29.68 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-N 115.307 -0.447 . . . . 75.44 112.819 -178.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 167' ' ' GLN . . . . . 0.518 ' HG2' ' HB1' ' C' ' 141' ' ' ALA . 27.4 mm-40 -70.66 118.91 14.05 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.899 0.88 . . . . 74.2 111.533 -174.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 168' ' ' GLY . . . . . 0.423 ' HA3' ' HA2' ' C' ' 116' ' ' GLY . . . 161.77 162.48 13.13 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 109.929 -1.269 . . . . 13.44 109.929 178.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 169' ' ' ASN . . . . . 0.683 ' HB2' ' HD3' ' C' ' 170' ' ' PRO . 1.7 m-20 -73.57 -68.41 0.36 Allowed Pre-proline 0 CA--C 1.578 2.051 0 CA-C-O 117.846 -1.073 . . . . 62.44 112.97 -166.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 170' ' ' PRO . . . . . 0.683 ' HD3' ' HB2' ' C' ' 169' ' ' ASN . 34.1 Cg_exo -63.73 176.17 2.48 Favored 'Trans proline' 0 C--N 1.401 3.298 0 C-N-CA 122.475 2.117 . . . . 73.55 113.281 172.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 171' ' ' PRO . . . . . 0.572 ' HA ' ' HA2' ' C' ' 87' ' ' GLY . 29.7 Cg_endo -62.28 139.23 76.35 Favored 'Trans proline' 0 C--N 1.389 2.666 0 C-N-CA 122.551 2.167 . . . . 74.02 111.76 172.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -116.18 -34.03 1.41 Allowed Glycine 0 C--N 1.336 0.574 0 CA-C-N 116.089 -0.505 . . . . 74.42 112.56 177.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 173' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 71.04 147.97 0.08 Allowed 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 125.089 1.355 . . . . 74.51 111.273 -179.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 174' ' ' LEU . . . . . . . . . . . . . 11.0 tp -121.97 128.55 51.61 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.904 0.882 . . . . 75.22 108.853 -174.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 175' ' ' LEU . . . . . 0.464 ' HB2' HH11 ' B' ' 188' ' ' ARG . 71.8 mt -110.49 130.58 55.53 Favored 'General case' 0 C--O 1.243 0.721 0 C-N-CA 123.597 0.759 . . . . 72.15 109.23 172.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 176' ' ' LEU . . . . . 0.557 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 95.7 mt -108.33 107.97 18.77 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.373 0.669 . . . . 74.33 110.884 178.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 177' ' ' VAL . . . . . . . . . . . . . 56.0 t -81.53 101.12 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 107.147 -1.427 . . . . 75.23 107.147 173.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 178' ' ' VAL . . . . . 0.416 HG12 ' HB3' ' C' ' 125' ' ' LEU . 39.7 t -76.65 128.87 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 114.599 -1.182 . . . . 74.01 110.755 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 179' ' ' ARG . . . . . 0.439 ' O ' ' HA ' ' C' ' 124' ' ' PRO . 36.6 mmt180 -111.94 101.03 9.36 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 105.325 -2.102 . . . . 74.42 105.325 171.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 180' ' ' LEU . . . . . 0.44 ' HA ' ' O ' ' C' ' 125' ' ' LEU . 28.9 mt -68.93 133.03 47.65 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 108.922 -0.77 . . . . 73.43 108.922 -176.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 181' ' ' LEU . . . . . . . . . . . . . 85.0 mt -54.05 163.01 1.29 Allowed Pre-proline 0 N--CA 1.493 1.717 0 C-N-CA 125.31 1.444 . . . . 74.24 113.317 -167.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -51.52 77.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.391 2.813 0 C-N-CA 123.744 2.963 . . . . 73.32 111.982 164.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 183' ' ' HIS . . . . . . . . . . . . . 75.3 t60 -174.08 53.92 0.15 Allowed Pre-proline 0 CA--C 1.553 1.059 0 N-CA-C 104.112 -2.551 . . . . 72.0 104.112 -170.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 184' ' ' PRO . . . . . 0.495 ' HG2' ' HG2' ' B' ' 401' ' ' PRO . 92.1 Cg_endo -86.67 65.79 4.68 Favored 'Trans proline' 0 C--N 1.388 2.65 0 C-N-CA 123.535 2.823 . . . . 74.25 112.079 -164.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 185' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 11.7 t -95.89 -50.24 11.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 108.047 -1.094 . . . . 72.23 108.047 -178.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 186' ' ' PHE . . . . . 0.518 ' HD2' HD11 ' C' ' 127' ' ' LEU . 34.0 m-85 -117.67 156.39 28.28 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.488 0.715 . . . . 61.44 111.956 -174.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 187' ' ' ARG . . . . . 0.478 ' O ' ' HB3' ' C' ' 194' ' ' TYR . 33.8 ttp180 -153.64 112.11 3.64 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.476 1.51 . . . . 75.14 107.742 177.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 188' ' ' LEU . . . . . 0.419 HD22 ' O ' ' C' ' 190' ' ' GLY . 47.9 tp -80.73 153.1 28.02 Favored 'General case' 0 CA--C 1.558 1.263 0 N-CA-C 115.392 1.627 . . . . 74.14 115.392 -163.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -126.92 99.59 5.8 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.889 1.675 . . . . 73.21 107.182 159.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 190' ' ' GLY . . . . . 0.419 ' O ' HD22 ' C' ' 188' ' ' LEU . . . 63.61 -80.09 0.04 OUTLIER Glycine 0 CA--C 1.539 1.575 0 N-CA-C 114.194 0.438 . . . . 74.2 114.194 175.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 191' ' ' GLN . . . . . 0.414 HE21 ' HA3' ' C' ' 242' ' ' GLY . 42.8 mt-30 -122.42 -34.86 3.2 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.877 1.271 . . . . 75.25 109.635 177.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -83.63 125.12 31.5 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.189 0.995 . . . . 65.13 110.983 -174.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 193' ' ' LEU . . . . . 0.426 ' HG ' ' HA2' ' C' ' 239' ' ' GLY . 91.7 mt -80.65 159.09 25.44 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.253 0.621 . . . . 65.15 112.017 -179.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 194' ' ' TYR . . . . . 0.478 ' HB3' ' O ' ' C' ' 187' ' ' ARG . 43.7 t80 -119.12 106.94 12.88 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 108.112 -1.07 . . . . 75.43 108.112 165.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 195' ' ' ALA . . . . . 0.474 ' HB1' HD13 ' C' ' 249' ' ' LEU . . . -108.2 -174.9 2.63 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.553 0.741 . . . . 65.11 110.099 175.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 29.3 m -138.47 119.06 13.93 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.586 -0.733 . . . . 53.42 109.604 174.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 197' ' ' LEU . . . . . 0.489 HD11 ' HB3' ' C' ' 212' ' ' ALA . 53.5 tp -98.78 118.21 35.01 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.292 0.637 . . . . 73.5 109.375 -179.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 198' ' ' ASP . . . . . 0.575 ' HA ' ' HB2' ' C' ' 254' ' ' ARG . 26.4 t70 -85.69 99.97 11.67 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.501 0.721 . . . . 64.33 109.087 -178.102 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 199' ' ' VAL . . . . . 0.446 HG21 HG21 ' C' ' 210' ' ' VAL . 21.4 t -110.59 123.6 35.26 Favored Pre-proline 0 N--CA 1.479 0.989 0 N-CA-C 108.661 -0.866 . . . . 73.12 108.661 -178.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 200' ' ' PRO . . . . . 0.412 ' HD2' HG13 ' C' ' 210' ' ' VAL . 46.2 Cg_endo -69.09 147.22 66.72 Favored 'Trans proline' 0 C--N 1.367 1.546 0 C-N-CA 121.565 1.51 . . . . 73.11 110.553 173.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 201' ' ' ALA . . . . . 0.523 ' HB3' ' HH2' ' C' ' 269' ' ' TRP . . . -52.59 -45.46 96.06 Favored Pre-proline 0 CA--C 1.555 1.158 0 C-N-CA 124.638 1.175 . . . . 74.35 113.467 -176.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 202' ' ' PRO . . . . . 0.546 ' HB2' ' HA ' ' A' ' 273' ' ' ALA . 23.7 Cg_endo -57.99 -49.71 12.09 Favored 'Trans proline' 0 C--N 1.391 2.774 0 C-N-CA 121.384 1.389 . . . . 63.15 112.304 177.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 203' ' ' ILE . . . . . . . . . . . . . 29.2 mt -64.42 -32.34 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 123.218 0.607 . . . . 74.02 111.145 178.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.8 -37.6 84.87 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.134 0.574 . . . . 75.02 111.512 179.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 205' ' ' VAL . . . . . 0.45 ' HA ' ' HA ' ' C' ' 226' ' ' ARG . 91.2 t -82.09 -37.24 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 123.233 0.613 . . . . 74.52 111.972 -178.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 206' ' ' VAL . . . . . 0.651 HG23 ' HG3' ' B' ' 248' ' ' ARG . 8.3 p -87.61 -33.58 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 N-CA-C 111.975 0.361 . . . . 74.12 111.975 -175.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 90.33 126.44 3.22 Favored Glycine 0 C--N 1.344 0.98 0 N-CA-C 111.076 -0.81 . . . . 63.21 111.076 -167.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -159.93 -137.3 2.2 Favored Glycine 0 C--N 1.336 0.57 0 CA-C-N 117.81 0.805 . . . . 51.32 111.466 179.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 209' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' C' ' 221' ' ' VAL . 7.6 mtmp? -139.26 134.75 33.06 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 123.43 0.692 . . . . 72.44 110.603 171.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 210' ' ' VAL . . . . . 0.446 HG21 HG21 ' C' ' 199' ' ' VAL . 27.7 m -134.3 140.57 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 107.754 -1.202 . . . . 71.52 107.754 169.021 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 211' ' ' ARG . . . . . 0.538 ' HA ' ' HA ' ' C' ' 220' ' ' GLU . 32.4 ttm105 -80.5 133.12 35.78 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 122.975 0.51 . . . . 75.53 111.66 -175.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 212' ' ' ALA . . . . . 0.489 ' HB3' HD11 ' C' ' 197' ' ' LEU . . . -104.18 130.36 51.94 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.785 1.234 . . . . 74.43 107.704 164.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 213' ' ' MET . . . . . . . . . . . . . 6.6 ttt -70.39 149.49 47.24 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 109.264 -0.643 . . . . 63.12 109.264 168.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 214' ' ' THR . . . . . 0.508 HG23 ' HD2' ' C' ' 238' ' ' LYS . 0.1 OUTLIER -139.92 169.14 18.26 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.173 0.511 . . . . 72.34 110.415 168.101 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 215' ' ' LEU . . . . . 0.555 HD12 ' HB2' ' C' ' 131' ' ' PHE . 54.4 mt -61.82 -36.05 80.02 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.144 1.378 . . . . 75.24 112.667 -172.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.78 -2.67 27.63 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.396 0.679 . . . . 71.0 112.11 -177.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 155.69 171.41 22.14 Favored Glycine 0 C--O 1.212 -1.274 0 CA-C-O 119.556 -0.58 . . . . 74.41 112.492 -178.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -88.26 126.01 1.91 Allowed 'Trans proline' 0 CA--C 1.556 1.618 0 C-N-CA 122.998 2.465 . . . . 64.03 112.748 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 219' ' ' VAL . . . . . 0.413 HG13 ' HB2' ' C' ' 212' ' ' ALA . 3.3 p -103.2 115.12 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 123.925 0.89 . . . . 52.53 109.696 177.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 220' ' ' GLU . . . . . 0.538 ' HA ' ' HA ' ' C' ' 211' ' ' ARG . 23.6 tt0 -84.43 109.38 17.83 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 109.491 -0.559 . . . . 72.32 109.491 -179.012 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 221' ' ' VAL . . . . . 0.439 HG11 HD23 ' C' ' 233' ' ' LEU . 47.7 t -74.13 127.88 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 124.491 1.116 . . . . 74.03 111.957 -174.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 222' ' ' ALA . . . . . 0.424 ' HA ' ' HG2' ' C' ' 209' ' ' LYS . . . -80.97 103.52 10.85 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 124.199 0.937 . . . . 73.3 109.05 167.162 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 62.1 t -79.04 129.47 72.91 Favored Pre-proline 0 CA--C 1.553 1.079 0 C-N-CA 123.744 0.818 . . . . 73.11 109.721 176.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 224' ' ' PRO . . . . . 0.589 ' HG2' ' HB2' ' B' ' 243' ' ' GLN . 3.1 Cg_exo -78.68 160.64 28.01 Favored 'Trans proline' 0 C--N 1.371 1.722 0 C-N-CA 123.925 3.084 . . . . 73.11 112.103 169.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.51 143.49 98.02 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 122.944 2.429 . . . . 74.4 112.93 176.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 226' ' ' ARG . . . . . 0.45 ' HA ' ' HA ' ' C' ' 205' ' ' VAL . 0.6 OUTLIER 55.18 86.02 0.06 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.468 1.907 . . . . 71.5 113.79 173.748 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 227' ' ' THR . . . . . 0.493 HG21 ' HH2' ' B' ' 242' ' ' TRP . 82.1 m -123.93 133.36 53.74 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 114.828 -1.078 . . . . 73.3 111.143 -178.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 228' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -104.77 155.71 18.65 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.712 0.768 . . . . 74.32 110.702 176.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -72.23 145.59 47.86 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.328 -0.851 . . . . 65.31 109.936 176.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 95.42 -9.34 69.36 Favored Glycine 0 N--CA 1.464 0.561 0 CA-C-N 115.746 -0.661 . . . . 62.04 112.118 -171.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 231' ' ' ARG . . . . . 0.415 ' NH1' ' HA ' ' C' ' 227' ' ' THR . 81.8 mtt180 -69.55 178.34 2.54 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 117.339 0.569 . . . . 75.03 110.761 167.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 232' ' ' LYS . . . . . 0.578 ' HD3' ' HB3' ' C' ' 250' ' ' TYR . 1.9 ttmp? -153.93 126.86 8.29 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 112.258 0.466 . . . . 74.05 112.258 -174.295 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 233' ' ' LEU . . . . . 0.608 ' O ' ' HA ' ' C' ' 250' ' ' TYR . 5.1 mp -86.39 158.66 19.57 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.488 1.115 . . . . 74.22 110.437 175.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 19.1 ptt-85 -128.92 88.46 2.72 Favored 'General case' 0 CA--C 1.556 1.204 0 O-C-N 124.712 1.257 . . . . 72.34 109.513 170.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 235' ' ' LEU . . . . . 0.468 ' HB2' ' HB3' ' C' ' 249' ' ' LEU . 56.9 mt -86.55 105.99 17.22 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 108.213 -1.032 . . . . 74.34 108.213 174.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -67.71 132.75 48.05 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.36 0.664 . . . . 73.41 111.639 -168.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 80.95 1.38 89.79 Favored Glycine 0 C--N 1.349 1.254 0 N-CA-C 115.018 0.767 . . . . 71.42 115.018 174.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 238' ' ' LYS . . . . . 0.508 ' HD2' HG23 ' C' ' 214' ' ' THR . 73.8 mmtt -92.8 13.18 21.09 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 123.588 0.755 . . . . 75.11 111.116 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 239' ' ' GLY . . . . . 0.426 ' HA2' ' HG ' ' C' ' 193' ' ' LEU . . . -95.17 -169.6 36.3 Favored Glycine 0 C--N 1.358 1.772 0 C-N-CA 122.977 0.322 . . . . 75.2 113.205 177.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 240' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -78.73 148.28 72.49 Favored Pre-proline 0 N--CA 1.481 1.102 0 C-N-CA 123.027 0.531 . . . . 75.14 110.397 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 241' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -63.64 137.31 58.5 Favored 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 123.43 2.753 . . . . 71.53 112.103 -178.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 242' ' ' GLY . . . . . 0.414 ' HA3' HE21 ' C' ' 191' ' ' GLN . . . -131.71 168.6 22.26 Favored Glycine 0 C--N 1.342 0.911 0 CA-C-O 120.169 -0.24 . . . . 70.14 113.678 -175.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -73.91 -2.38 12.17 Favored 'Trans proline' 0 C--N 1.38 2.206 0 C-N-CA 123.642 2.894 . . . . 71.42 114.553 -173.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -137.62 11.8 2.95 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.655 0.782 . . . . 71.42 111.118 178.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 137.43 167.79 11.17 Favored Glycine 0 C--N 1.348 1.214 0 N-CA-C 111.111 -0.795 . . . . 63.24 111.111 -176.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 246' ' ' ARG . . . . . . . . . . . . . 26.8 mtm-85 -81.85 151.32 27.38 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-N 117.275 0.537 . . . . 71.32 109.914 176.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -78.13 -169.93 35.31 Favored Glycine 0 C--N 1.34 0.798 0 O-C-N 123.872 0.733 . . . . 63.23 113.48 -178.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -123.79 142.66 50.89 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.122 -1.066 . . . . 73.54 108.122 -173.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 249' ' ' LEU . . . . . 0.474 HD13 ' HB1' ' C' ' 195' ' ' ALA . 25.6 tp -83.89 109.52 17.65 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.95 -0.568 . . . . 74.23 109.797 -179.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 250' ' ' TYR . . . . . 0.608 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 22.0 m-30 -101.02 100.53 11.15 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 109.498 -0.556 . . . . 71.43 109.498 179.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 251' ' ' LEU . . . . . 0.546 ' HB2' HD12 ' C' ' 233' ' ' LEU . 2.2 mp -100.39 121.91 42.29 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 119.166 -0.445 . . . . 72.0 110.338 -172.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 252' ' ' GLU . . . . . 0.435 ' HB2' ' HE1' ' C' ' 194' ' ' TYR . 25.3 tt0 -75.07 129.7 38.04 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-O 121.129 0.49 . . . . 75.41 109.681 170.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 253' ' ' VAL . . . . . 0.483 HG11 HG23 ' C' ' 227' ' ' THR . 60.4 t -76.23 135.19 27.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 115.166 -0.925 . . . . 73.5 111.012 -175.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 254' ' ' ARG . . . . . 0.575 ' HB2' ' HA ' ' C' ' 198' ' ' ASP . 11.4 mmt85 -103.8 135.19 45.8 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.321 1.448 . . . . 75.13 108.32 165.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 255' ' ' ILE . . . . . . . . . . . . . 33.0 mm -106.94 105.34 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 107.028 -1.471 . . . . 75.24 107.028 165.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 256' ' ' THR . . . . . . . . . . . . . 3.5 t -115.76 171.72 7.58 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.037 0.935 . . . . 70.25 110.067 -173.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 10.7 pt -134.95 152.93 78.18 Favored Pre-proline 0 CA--C 1.552 1.037 0 C-N-CA 123.987 0.915 . . . . 75.21 109.876 -173.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -80.79 20.98 0.91 Allowed 'Trans proline' 0 C--N 1.381 2.274 0 C-N-CA 123.372 2.715 . . . . 74.41 113.737 -168.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 57.3 -89.81 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.778 1.231 . . . . 72.3 111.18 -174.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 260' ' ' ARG . . . . . 0.705 ' HG3' ' HA2' ' B' ' 284' ' ' GLY . 0.0 OUTLIER -80.39 145.86 31.78 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 123.214 0.606 . . . . 73.41 109.473 -179.317 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 261' ' ' LEU . . . . . . . . . . . . . 96.4 mt -128.73 154.69 46.1 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.89 0.876 . . . . 74.53 109.566 176.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 262' ' ' THR . . . . . 0.603 HG21 ' HB3' ' B' ' 280' ' ' LEU . 45.1 p -84.92 155.72 61.11 Favored Pre-proline 0 CA--C 1.555 1.142 0 N-CA-C 109.252 -0.647 . . . . 61.23 109.252 170.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -34.35 -51.81 0.62 Allowed 'Trans proline' 0 C--N 1.382 2.302 1 C-N-CA 125.684 4.256 . . . . 74.2 115.836 -178.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -62.94 -55.05 29.33 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.954 0.501 . . . . 71.04 110.259 -177.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -49.31 -55.14 13.77 Favored 'General case' 0 C--N 1.356 0.866 0 O-C-N 124.451 1.094 . . . . 71.03 109.675 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 266' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' C' ' 270' ' ' LYS . 15.4 tp10 -54.62 -43.27 72.09 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 124.655 1.222 . . . . 73.1 110.997 -177.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -60.6 -45.42 94.07 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.508 0.723 . . . . 71.12 112.217 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 268' ' ' LEU . . . . . 0.5 ' HB2' HD21 ' A' ' 272' ' ' LEU . 10.3 mp -66.35 -50.99 61.69 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 116.729 -0.214 . . . . 70.11 110.93 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 269' ' ' TRP . . . . . 0.523 ' HH2' ' HB3' ' C' ' 201' ' ' ALA . 92.5 m95 -56.95 -32.41 65.99 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.292 0.637 . . . . 63.11 111.039 177.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 270' ' ' LYS . . . . . 0.641 ' HA ' HG22 ' A' ' 206' ' ' VAL . 10.2 tmtt? -67.76 -46.46 72.02 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.987 0.915 . . . . 75.43 110.336 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -63.2 -37.21 86.32 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 122.73 0.412 . . . . 75.33 111.486 177.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 272' ' ' LEU . . . . . 0.401 HD12 ' HA ' ' C' ' 269' ' ' TRP . 75.1 mt -64.9 -37.11 86.54 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.295 0.638 . . . . 74.33 110.125 176.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -63.43 -45.39 91.16 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.438 0.695 . . . . 43.22 111.055 177.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -65.72 -36.71 84.38 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.289 0.636 . . . . 63.21 111.036 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -62.7 -33.07 74.33 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 115.596 -0.729 . . . . 70.04 110.584 174.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 276' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -73.46 -42.34 62.06 Favored 'General case' 0 CA--C 1.554 1.114 0 CA-C-N 115.36 -0.836 . . . . 75.52 111.939 174.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -68.05 -22.61 64.94 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.949 -0.469 . . . . 65.52 111.403 178.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -59.77 -22.53 62.26 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.504 0.722 . . . . 72.22 112.131 174.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 279' ' ' ARG . . . . . . . . . . . . . 39.0 mtm180 -72.66 -29.84 63.77 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 122.743 0.417 . . . . 75.11 110.738 178.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.044 0 C-N-CA 123.7 0.8 . . . . 75.14 109.378 -173.402 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.47 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.1 mpt? . . . . . 0 N--CA 1.475 0.786 0 N-CA-C 109.87 -0.418 . . . . 64.12 109.87 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.76 16.06 7.54 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 125.333 1.453 . . . . 74.44 113.649 175.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -80.72 76.76 7.6 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.256 0.622 . . . . 74.04 110.224 -174.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -37.28 105.22 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 126.722 2.009 . . . . 64.14 113.039 -178.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -77.68 109.34 11.57 Favored 'General case' 0 C--O 1.245 0.863 0 C-N-CA 124.031 0.932 . . . . 74.32 109.413 171.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.53 ' HA ' ' HH ' ' A' ' 66' ' ' TYR . 7.3 t70 -82.34 94.53 7.39 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 108.459 -0.941 . . . . 62.43 108.459 177.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -60.54 -37.46 81.3 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.191 0.997 . . . . 73.34 111.672 -174.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.49 ' HB3' ' O ' ' A' ' 13' ' ' VAL . 95.1 m-85 -67.28 -35.74 80.12 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 114.609 -1.178 . . . . 73.33 111.324 178.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.86 -40.13 72.51 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 122.897 0.479 . . . . 70.01 111.014 177.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 77.0 mt -56.0 -42.75 72.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 123.613 0.765 . . . . 74.23 109.455 174.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 87.7 mt -81.06 -17.47 50.0 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 115.212 -0.903 . . . . 73.11 112.392 176.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.09 18.74 78.06 Favored Glycine 0 CA--C 1.536 1.398 0 N-CA-C 114.71 0.644 . . . . 73.42 114.71 -178.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.49 ' O ' ' HB3' ' A' ' 8' ' ' TYR . 19.6 m -103.89 144.07 27.94 Favored Pre-proline 0 N--CA 1.484 1.228 0 C-N-CA 123.666 0.787 . . . . 72.52 109.252 173.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -54.58 151.01 32.81 Favored 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 122.889 2.393 . . . . 50.12 113.282 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.33 69.48 1.61 Allowed 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.692 0.797 . . . . 75.43 110.561 179.253 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 170.92 -24.36 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.805 1.242 . . . . 71.2 109.422 -173.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.09 138.85 19.12 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.283 1.033 . . . . 74.14 111.761 -177.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 67.2 p -63.49 166.08 7.1 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.17 0.988 . . . . 75.03 111.033 -175.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -56.64 -33.37 66.25 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.985 0.914 . . . . 71.11 111.384 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -69.72 -36.1 75.6 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 122.89 0.476 . . . . 72.43 111.062 -178.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -72.02 -42.06 66.83 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.629 0.772 . . . . 71.14 110.664 177.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 73.7 mt -58.59 -39.53 76.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 124.558 1.143 . . . . 73.31 110.241 173.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.73 ' HG2' ' HE3' ' A' ' 27' ' ' LYS . 33.9 ttmt -71.67 -37.94 70.71 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 114.555 -1.202 . . . . 75.22 110.259 -177.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 49.1 mtp180 -57.36 -52.46 65.25 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.503 0.721 . . . . 73.12 110.319 173.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.33 -38.47 91.14 Favored 'General case' 0 C--O 1.246 0.899 0 CA-C-N 114.435 -1.257 . . . . 72.43 111.653 -177.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -61.87 -60.75 3.18 Favored 'General case' 0 C--O 1.209 -1.067 0 CA-C-N 115.433 -0.803 . . . . 73.1 109.487 177.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.73 ' HE3' ' HG2' ' A' ' 23' ' ' LYS . 10.1 mtmp? -58.71 -33.58 70.36 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 124.266 0.979 . . . . 74.22 111.913 -177.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 14.6 ttt180 -52.74 -58.72 5.94 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.299 1.04 . . . . 75.52 109.856 171.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.615 ' HB3' HD11 ' A' ' 50' ' ' ILE . 88.1 mt -81.21 -10.28 59.64 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 115.172 -0.922 . . . . 75.12 111.991 -178.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.492 ' HA ' ' HE1' ' A' ' 47' ' ' PHE . . . -94.53 -14.59 24.92 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.772 0.829 . . . . 71.54 111.34 -178.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.4 mtm105 -97.96 -38.09 9.53 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.957 -0.757 . . . . 72.33 108.957 168.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -65.43 -47.36 76.48 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.26 0.624 . . . . 73.31 111.092 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -107.4 29.21 7.37 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.515 0.726 . . . . 72.41 110.734 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -68.23 101.51 0.31 Allowed Pre-proline 0 N--CA 1.483 1.204 0 C-N-CA 123.979 0.911 . . . . 73.54 110.547 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.517 ' O ' ' HG3' ' A' ' 39' ' ' LYS . 46.6 Cg_exo -55.07 -39.82 89.0 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 123.073 2.516 . . . . 75.51 113.306 -169.176 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -46.89 -36.94 8.11 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.799 1.239 . . . . 73.23 112.786 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 48.7 t -101.79 -49.25 10.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 C-N-CA 123.657 0.783 . . . . 73.25 109.28 178.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -107.27 75.26 1.01 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 125.121 1.368 . . . . 64.12 110.665 -176.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.585 ' HZ3' ' HB2' ' A' ' 39' ' ' LYS . 9.0 mtmp? -78.02 72.47 4.56 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 109.636 -0.505 . . . . 73.11 109.636 172.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 70.4 m -116.9 113.31 39.85 Favored Pre-proline 0 N--CA 1.471 0.621 0 N-CA-C 107.906 -1.146 . . . . 71.24 107.906 176.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -42.8 -53.29 4.01 Favored 'Trans proline' 0 C--N 1.387 2.591 0 C-N-CA 124.58 3.52 . . . . 73.53 114.191 -170.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -52.12 -46.82 65.49 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.221 1.009 . . . . 64.43 111.817 176.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.82 -29.16 69.01 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.597 0.759 . . . . 73.42 110.982 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.501 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 46.1 mt-10 -84.47 -29.7 25.83 Favored 'General case' 0 C--N 1.352 0.707 0 C-N-CA 123.423 0.689 . . . . 63.35 110.461 -175.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -72.31 -43.45 64.16 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.929 0.892 . . . . 62.44 109.791 176.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 40.2 mmtm -62.65 -39.7 94.72 Favored 'General case' 0 C--N 1.345 0.405 0 CA-C-N 115.038 -0.983 . . . . 74.03 109.631 171.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.492 ' HE1' ' HA ' ' A' ' 30' ' ' ALA . 60.0 t80 -63.08 -30.14 71.36 Favored 'General case' 0 C--N 1.356 0.866 0 O-C-N 123.867 0.729 . . . . 73.32 110.656 176.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' A' ' 44' ' ' GLU . 34.3 mmtp -62.98 -47.36 83.49 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 109.893 -0.41 . . . . 75.14 109.893 171.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -67.95 -25.88 65.67 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 112.384 0.513 . . . . 71.44 112.384 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.615 HD11 ' HB3' ' A' ' 29' ' ' LEU . 63.0 mt -79.47 -33.46 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 C-N-CA 124.515 1.126 . . . . 74.43 110.102 176.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -70.22 -39.14 75.29 Favored 'General case' 0 C--O 1.208 -1.08 0 CA-C-N 115.265 -0.879 . . . . 73.43 109.81 173.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -61.01 -48.75 80.37 Favored 'General case' 0 C--O 1.247 0.952 0 C-N-CA 124.986 1.314 . . . . 75.34 109.541 176.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.32 -60.42 3.36 Favored 'General case' 0 C--N 1.352 0.69 0 CA-C-N 113.52 -1.673 . . . . 65.45 111.188 177.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -63.92 -35.73 81.62 Favored 'General case' 0 C--O 1.214 -0.771 0 CA-C-N 115.686 -0.688 . . . . 73.53 111.412 -179.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.14 -53.34 58.29 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.579 0.752 . . . . 72.52 110.831 -177.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 66.4 t -62.84 -50.86 78.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 114.533 -1.212 . . . . 74.52 110.352 177.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 67.2 mt -76.07 -8.3 56.67 Favored 'General case' 0 CA--C 1.557 1.242 0 N-CA-C 113.152 0.797 . . . . 74.35 113.152 -172.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.2 t -65.42 -58.46 5.8 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.405 1.082 . . . . 74.34 111.853 -176.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.488 ' HB2' ' HD3' ' A' ' 62' ' ' LYS . 13.4 m-20 -99.31 142.33 24.41 Favored Pre-proline 0 C--O 1.244 0.778 0 C-N-CA 123.419 0.688 . . . . 74.34 109.432 -174.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.503 ' O ' ' HG2' ' A' ' 64' ' ' ARG . 48.7 Cg_exo -54.55 -47.23 27.92 Favored 'Trans proline' 0 C--N 1.385 2.447 0 C-N-CA 123.167 2.578 . . . . 72.41 112.941 -172.114 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.467 ' O ' HG12 ' A' ' 65' ' ' ILE . 3.1 mp0 -58.78 -58.2 9.64 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.505 0.722 . . . . 72.3 111.213 -174.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.488 ' HD3' ' HB2' ' A' ' 59' ' ' ASP . 37.9 mtpt -58.28 -43.52 88.05 Favored 'General case' 0 C--O 1.257 1.492 0 C-N-CA 124.29 1.036 . . . . 74.54 111.135 -178.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -59.04 -46.81 87.3 Favored 'General case' 0 C--N 1.349 0.581 0 CA-C-N 114.667 -1.152 . . . . 74.11 110.793 178.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.503 ' HG2' ' O ' ' A' ' 60' ' ' PRO . 30.2 mmm180 -77.6 -18.66 56.61 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 123.677 0.61 . . . . 74.25 111.305 -175.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 61' ' ' GLU . 28.3 mm -62.29 -50.93 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 N-CA-C 108.081 -1.081 . . . . 74.41 108.081 168.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.53 ' HH ' ' HA ' ' A' ' 6' ' ' ASP . 54.0 t80 -60.35 -52.25 66.07 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 114.908 -1.042 . . . . 75.4 111.001 175.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -63.31 -31.22 72.31 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.457 0.703 . . . . 64.04 112.059 -172.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.3 p -76.65 -31.55 57.41 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 119.166 -0.445 . . . . 75.44 110.773 173.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -64.06 115.12 4.63 Favored 'General case' 0 CA--C 1.556 1.2 0 N-CA-C 109.492 -0.559 . . . . 75.32 109.492 178.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 115.38 5.66 18.82 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 123.562 0.601 . . . . 64.23 111.969 -169.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 86.2 m -147.59 -56.62 0.24 Allowed 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 104.823 -2.288 . . . . 71.23 104.823 178.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.4 m -82.79 141.92 31.95 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 104.446 -2.427 . . . . 74.23 104.446 156.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.79 -35.08 10.25 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 118.617 0.644 . . . . 74.04 111.145 -179.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -93.24 134.18 27.41 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 123.393 0.677 . . . . 75.1 109.412 179.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.92 116.93 3.61 Favored 'Trans proline' 0 C--N 1.373 1.833 0 C-N-CA 122.299 1.999 . . . . 75.41 110.532 171.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -52.14 142.32 45.58 Favored 'Trans proline' 0 C--N 1.38 2.19 0 C-N-CA 123.035 2.49 . . . . 74.25 112.611 177.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -43.4 129.86 6.58 Favored 'Trans proline' 0 C--N 1.388 2.642 0 C-N-CA 123.969 3.113 . . . . 73.45 113.424 -174.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.41 ' HG3' ' HA3' ' A' ' 104' ' ' GLY . 28.2 Cg_endo -58.41 144.02 96.98 Favored 'Trans proline' 0 C--N 1.387 2.579 0 C-N-CA 122.84 2.36 . . . . 73.2 112.705 -171.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -65.89 167.49 17.59 Favored 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 122.876 2.384 . . . . 71.05 112.59 -177.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.84 88.45 0.07 OUTLIER 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 122.665 2.244 . . . . 74.31 111.694 176.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 149.91 -40.88 0.84 Allowed Glycine 0 CA--C 1.524 0.611 0 CA-C-N 113.728 -1.578 . . . . 62.41 109.525 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 110.63 -169.51 13.46 Favored Glycine 0 C--N 1.351 1.383 0 C-N-CA 123.594 0.616 . . . . 53.03 111.686 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -84.72 88.36 7.37 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 123.431 0.692 . . . . 74.41 109.867 176.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -58.11 157.96 7.49 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 114.407 -1.269 . . . . 71.31 111.828 175.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -154.56 72.44 0.86 Allowed 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 108.597 -0.89 . . . . 73.24 108.597 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.441 ' HG ' ' HE2' ' A' ' 164' ' ' MET . 2.4 m -43.58 84.99 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 126.134 1.774 . . . . 74.44 115.218 -165.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.461 ' N ' ' HA3' ' A' ' 163' ' ' GLY . . . 67.78 10.81 59.23 Favored Glycine 0 C--N 1.352 1.449 0 CA-C-N 115.815 -0.629 . . . . 70.11 114.008 175.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -93.23 122.95 36.15 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.231 -1.396 . . . . 72.34 107.231 178.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -69.74 90.39 0.59 Allowed 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 110.177 -0.305 . . . . 71.44 110.177 -173.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.465 HG23 ' HE2' ' A' ' 97' ' ' PHE . 2.4 p -34.81 -50.31 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 125.578 1.551 . . . . 75.21 114.084 175.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -59.84 -34.22 72.81 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.255 1.022 . . . . 75.33 111.297 -173.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -78.08 -30.84 49.87 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.218 1.007 . . . . 61.35 111.753 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -82.14 172.19 13.48 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 122.746 0.419 . . . . 73.34 110.161 -173.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 83.8 p -57.56 150.06 19.94 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 114.093 1.145 . . . . 74.5 114.093 -164.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.96 -41.8 71.58 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 114.568 -1.196 . . . . 74.52 110.881 170.135 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -59.76 -43.06 94.5 Favored 'General case' 0 C--N 1.354 0.769 0 C-N-CA 123.226 0.61 . . . . 75.03 110.755 -177.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.465 ' HE2' HG23 ' A' ' 90' ' ' VAL . 26.5 t80 -58.58 -49.99 75.42 Favored 'General case' 0 CA--C 1.548 0.895 0 O-C-N 123.761 0.663 . . . . 72.32 109.242 173.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.51 ' HA ' HD13 ' A' ' 105' ' ' LEU . 46.4 mt-30 -71.97 -5.6 36.04 Favored 'General case' 0 CA--C 1.557 1.237 0 CA-C-N 115.347 -0.842 . . . . 74.14 112.291 -178.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -97.65 -47.61 5.55 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 124.239 1.015 . . . . 70.02 111.903 173.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 37.2 tp -70.86 -52.75 18.34 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.655 0.782 . . . . 74.33 109.739 -176.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -86.16 -11.64 52.01 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 115.718 -0.674 . . . . 72.11 110.745 178.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -39.27 -58.82 1.94 Allowed Glycine 0 CA--C 1.543 1.792 0 CA-C-O 118.623 -1.098 . . . . 72.43 114.742 177.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -35.02 -36.92 0.13 Allowed 'Trans proline' 0 C--N 1.394 2.937 0 C-N-CA 125.289 3.993 . . . . 64.43 116.362 176.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.41 ' HA3' ' HG3' ' A' ' 78' ' ' PRO . . . -145.77 42.38 0.97 Allowed Glycine 0 C--N 1.354 1.53 0 CA-C-O 119.224 -0.764 . . . . 54.4 112.117 -178.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.51 HD13 ' HA ' ' A' ' 98' ' ' GLN . 8.1 mt -63.2 71.73 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.071 0.948 . . . . 74.25 112.867 177.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.739 ' HB3' ' HA ' ' A' ' 169' ' ' ASN . 1.5 t80 32.4 -105.13 0.02 OUTLIER 'General case' 0 CA--C 1.562 1.413 0 C-N-CA 126.3 1.84 . . . . 74.45 111.738 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 80.48 -40.03 2.38 Favored Glycine 0 C--N 1.359 1.844 0 CA-C-O 119.213 -0.77 . . . . 44.0 113.204 179.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.669 ' HA3' ' HB3' ' A' ' 167' ' ' GLN . . . 51.06 -121.21 10.73 Favored Glycine 0 C--N 1.359 1.839 0 C-N-CA 123.514 0.578 . . . . 71.34 113.519 179.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -84.37 -8.53 58.96 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.468 0.707 . . . . 74.55 111.313 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -77.54 -35.74 35.81 Favored Glycine 0 C--N 1.35 1.308 0 N-CA-C 110.639 -0.984 . . . . 55.25 110.639 168.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 20.1 tpp180 73.51 -40.79 0.47 Allowed 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 126.707 2.003 . . . . 75.52 114.203 171.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.01 21.54 1.94 Allowed 'General case' 0 CA--C 1.565 1.548 0 C-N-CA 125.182 1.393 . . . . 75.13 110.859 -168.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 48.1 m 60.28 41.94 15.76 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-O 122.175 0.988 . . . . 74.21 109.013 -167.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 17.2 ttp180 -80.48 162.42 24.39 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 114.006 -1.452 . . . . 74.52 110.836 -173.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.594 ' HA ' ' HD2' ' A' ' 170' ' ' PRO . 21.9 ttmm -70.52 149.69 46.9 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.223 0.609 . . . . 73.31 109.842 174.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -89.36 161.18 29.86 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-N 116.65 -0.25 . . . . 73.4 113.7 -177.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -100.97 145.59 28.47 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.797 1.239 . . . . 74.43 108.174 175.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -58.6 144.95 41.25 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 118.717 0.69 . . . . 74.23 112.014 -175.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.8 tt -144.5 137.13 26.68 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 109.049 -0.723 . . . . 75.42 109.049 -173.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -93.19 130.56 38.83 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.306 0.642 . . . . 74.51 109.364 174.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.51 ' HB2' HD12 ' B' ' 8' ' ' LEU . . . -141.31 140.86 33.9 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.415 -0.957 . . . . 54.41 108.415 176.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.461 ' HG3' HD13 ' B' ' 11' ' ' LEU . 42.6 mt-10 -123.11 109.27 13.83 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 108.704 -0.85 . . . . 72.42 108.704 -166.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.768 HD23 HD23 ' A' ' 176' ' ' LEU . 3.8 pp -101.27 114.84 65.71 Favored Pre-proline 0 N--CA 1.484 1.252 0 N-CA-C 110.293 -0.262 . . . . 74.14 110.293 -169.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.613 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 40.4 Cg_endo -67.24 109.56 1.79 Allowed 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 120.7 0.933 . . . . 75.33 110.309 173.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.713 ' HA ' HG23 ' B' ' 6' ' ' ILE . 57.7 tp -110.25 144.25 39.21 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 123.555 0.742 . . . . 72.43 110.829 -171.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 40.5 m -71.43 136.71 47.8 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 114.908 -1.042 . . . . 71.34 110.892 178.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.863 ' HB3' HD23 ' A' ' 215' ' ' LEU . 59.4 mt -54.37 -49.5 69.68 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.109 0.963 . . . . 75.21 111.688 -177.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -54.99 -46.51 75.14 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 114.646 -1.161 . . . . 75.32 111.452 175.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -65.66 -29.43 69.99 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 122.743 0.417 . . . . 64.33 111.451 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -66.75 -47.54 71.91 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.878 0.471 . . . . 65.44 110.503 178.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -63.96 -44.51 92.55 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 114.762 -1.108 . . . . 74.51 111.518 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 30.8 m170 -76.64 -45.58 29.39 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 115.709 -0.678 . . . . 75.25 111.404 -174.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.476 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 74.49 -153.25 45.85 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 123.54 0.525 . . . . 71.54 112.689 -177.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 81.72 -153.12 32.66 Favored Glycine 0 C--N 1.348 1.245 0 C-N-CA 123.223 0.439 . . . . 70.42 112.935 178.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -72.22 97.4 1.97 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.286 0.635 . . . . 73.14 110.09 -177.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.66 HH11 HD11 ' A' ' 125' ' ' LEU . 5.2 tmm_? -96.05 120.4 36.28 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 107.365 -1.346 . . . . 75.05 107.365 173.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 59.6 t -85.75 134.61 26.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 108.945 -0.761 . . . . 75.04 108.945 178.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.491 ' HB ' HG13 ' A' ' 145' ' ' VAL . 85.9 t -116.41 133.44 62.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 C-N-CA 124.007 0.923 . . . . 73.34 108.627 176.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -106.81 114.16 28.09 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 107.719 -1.215 . . . . 71.3 107.719 171.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.554 ' HB ' ' HB3' ' B' ' 8' ' ' LEU . 3.1 p -147.09 108.44 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 122.81 0.444 . . . . 75.1 111.845 -170.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 62.5 20.67 12.1 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.31 1.044 . . . . 74.24 112.198 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 92.64 4.87 65.31 Favored Glycine 0 C--N 1.352 1.428 0 CA-C-N 116.257 -0.429 . . . . 54.15 112.782 -175.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.455 ' HA ' ' NE ' ' A' ' 143' ' ' ARG . 3.7 tpm_? -98.59 106.67 18.97 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.567 0.747 . . . . 72.43 109.998 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 49.5 ttp180 -85.32 98.75 10.71 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.716 0.806 . . . . 74.41 109.252 174.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.491 HG13 ' HB ' ' A' ' 138' ' ' VAL . 2.5 p -110.8 131.93 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 123.458 0.703 . . . . 73.53 110.906 -177.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 48.3 t -89.35 93.28 9.48 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.705 0.802 . . . . 64.43 109.501 177.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 43.4 t -93.95 111.17 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 109.353 -0.61 . . . . 73.42 109.353 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 58.9 ttt85 -77.84 105.18 8.86 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 109.432 -0.581 . . . . 74.32 109.432 175.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.476 HG13 ' HA2' ' A' ' 133' ' ' GLY . 33.2 pt -90.71 149.17 40.04 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 123.766 0.826 . . . . 74.52 110.409 177.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -63.73 132.14 33.97 Favored 'Trans proline' 0 C--N 1.379 2.158 0 C-N-CA 122.843 2.362 . . . . 74.22 111.794 175.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.409 ' HA ' ' HA3' ' A' ' 133' ' ' GLY . 50.5 Cg_exo -56.24 95.54 0.06 OUTLIER 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 123.155 2.57 . . . . 74.15 112.184 171.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 107.81 47.32 0.97 Allowed Glycine 0 C--N 1.341 0.828 0 N-CA-C 111.255 -0.738 . . . . 75.51 111.255 -172.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 5.2 p -86.25 141.39 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 108.219 -1.03 . . . . 75.43 108.219 175.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.515 ' HG2' ' HA ' ' A' ' 191' ' ' GLN . 0.0 OUTLIER -118.97 135.76 54.44 Favored 'General case' 0 C--O 1.198 -1.62 0 CA-C-O 117.116 -1.421 . . . . 73.23 110.146 -160.839 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.448 ' HB3' ' HB3' ' A' ' 188' ' ' LEU . 5.0 tp10 -43.62 129.94 5.35 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 119.386 0.994 . . . . 72.32 111.381 174.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 88.3 -7.47 81.49 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-O 119.062 -0.855 . . . . 74.33 113.594 -175.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 8.2 t -66.26 113.53 4.65 Favored 'General case' 0 C--N 1.362 1.129 0 N-CA-C 107.247 -1.39 . . . . 74.23 107.247 176.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 58.9 t -85.12 91.27 3.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 107.696 -1.224 . . . . 74.02 107.696 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.579 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 32.8 mt -70.71 82.82 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 107.3 -1.37 . . . . 75.24 107.3 174.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 63.2 ttt-85 -74.57 97.93 3.26 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 107.804 -1.184 . . . . 75.21 107.804 179.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.402 ' HA ' ' HD2' ' A' ' 162' ' ' PRO . 2.5 p -106.82 104.71 52.67 Favored Pre-proline 0 C--O 1.242 0.707 0 N-CA-C 108.834 -0.802 . . . . 71.41 108.834 -178.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 161' ' ' VAL . 29.0 Cg_endo -62.03 104.16 0.32 Allowed 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 122.055 1.836 . . . . 74.53 109.956 173.132 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . 0.461 ' HA3' ' N ' ' A' ' 87' ' ' GLY . . . 124.56 26.82 1.38 Allowed Glycine 0 C--N 1.341 0.843 0 N-CA-C 115.759 1.063 . . . . 70.43 115.759 174.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.441 ' HE2' ' HG ' ' A' ' 86' ' ' SER . 22.5 mmt -138.63 1.75 2.15 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 117.999 0.899 . . . . 64.15 111.33 172.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.639 ' HA2' HD12 ' A' ' 174' ' ' LEU . . . -84.01 -123.09 0.98 Allowed Glycine 0 C--N 1.351 1.38 0 N-CA-C 114.252 0.461 . . . . 73.33 114.252 -171.004 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -58.54 143.95 43.96 Favored Glycine 0 C--N 1.351 1.37 0 O-C-N 124.122 0.542 . . . . 74.5 111.864 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.669 ' HB3' ' HA3' ' A' ' 108' ' ' GLY . 27.1 mm-40 -68.47 103.98 1.8 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.956 0.902 . . . . 75.42 111.937 -164.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -156.05 168.62 33.52 Favored Glycine 0 C--N 1.338 0.69 0 N-CA-C 109.759 -1.337 . . . . 64.21 109.759 177.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . 0.739 ' HA ' ' HB3' ' A' ' 106' ' ' PHE . 0.3 OUTLIER -62.14 -53.62 57.32 Favored Pre-proline 0 N--CA 1.485 1.289 0 CA-C-N 118.401 1.1 . . . . 63.54 110.032 -179.198 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.631 ' HD3' ' HB3' ' A' ' 169' ' ' ASN . 24.4 Cg_endo -95.99 90.79 0.09 OUTLIER 'Trans proline' 0 C--N 1.387 2.558 0 C-N-CA 122.089 1.86 . . . . 73.02 108.079 159.303 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 169' ' ' ASN . 25.3 Cg_exo -60.58 174.82 1.42 Allowed 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 122.786 2.324 . . . . 71.25 113.857 -171.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -66.35 175.15 21.01 Favored Glycine 0 N--CA 1.472 1.052 0 N-CA-C 115.397 0.919 . . . . 72.4 115.397 -175.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -69.79 97.43 1.09 Allowed 'General case' 0 C--O 1.242 0.693 0 N-CA-C 108.225 -1.028 . . . . 71.14 108.225 172.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.639 HD12 ' HA2' ' A' ' 165' ' ' GLY . 21.4 tp -78.47 104.0 8.78 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 109.518 -0.549 . . . . 74.2 109.518 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 68.4 mt -71.67 81.58 0.85 Allowed 'General case' 0 C--O 1.242 0.67 0 C-N-CA 124.1 0.96 . . . . 72.12 109.07 173.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.768 HD23 HD23 ' A' ' 123' ' ' LEU . 34.8 mt -76.02 90.06 3.01 Favored 'General case' 0 C--N 1.35 0.627 0 CA-C-N 115.978 -0.556 . . . . 74.52 110.133 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.437 ' HB ' ' HG2' ' A' ' 122' ' ' GLU . 17.4 t -82.22 105.04 11.65 Favored 'Isoleucine or valine' 0 C--O 1.246 0.886 0 N-CA-C 106.954 -1.498 . . . . 71.11 106.954 179.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.21 106.42 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.037 0 CA-C-N 114.924 -1.034 . . . . 74.13 110.963 -174.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.613 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 33.7 mmt180 -91.89 94.46 9.32 Favored 'General case' 0 C--O 1.208 -1.089 0 C-N-CA 123.233 0.613 . . . . 73.42 110.215 179.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.537 HD21 ' HB3' ' A' ' 125' ' ' LEU . 17.6 mt -67.12 143.73 56.48 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 121.379 -0.826 . . . . 74.04 110.564 -177.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 82.5 mt -54.37 144.62 41.01 Favored Pre-proline 0 N--CA 1.476 0.835 0 O-C-N 124.367 1.042 . . . . 73.22 111.329 -172.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -75.17 36.52 0.45 Allowed 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 123.041 2.494 . . . . 74.32 113.073 176.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.52 ' HB3' HD11 ' A' ' 127' ' ' LEU . 24.1 t-80 -61.45 126.26 86.16 Favored Pre-proline 0 CA--C 1.549 0.929 0 N-CA-C 107.636 -1.246 . . . . 73.35 107.636 171.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 183' ' ' HIS . 21.2 Cg_exo -66.16 24.06 0.1 OUTLIER 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 124.078 3.185 . . . . 61.24 118.689 -160.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 16.2 t -102.93 -59.99 3.1 Favored 'Isoleucine or valine' 0 C--N 1.367 1.366 0 CA-C-N 121.23 1.832 . . . . 72.34 109.362 175.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . 0.532 ' CD1' ' HB1' ' A' ' 195' ' ' ALA . 49.0 m-85 -120.09 140.6 50.8 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.006 0.743 . . . . 72.31 113.006 -168.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -117.49 92.18 3.78 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 104.604 -2.369 . . . . 75.51 104.604 162.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.605 ' HA ' ' HA ' ' A' ' 193' ' ' LEU . 13.9 tp -73.33 162.14 29.68 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.468 1.107 . . . . 74.21 109.897 -177.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . 0.422 ' H ' HD13 ' A' ' 188' ' ' LEU . 11.4 tp10 -163.99 129.53 2.95 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.766 0.827 . . . . 70.31 109.464 171.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 75.25 -77.99 1.15 Allowed Glycine 0 C--N 1.348 1.237 0 O-C-N 123.388 0.43 . . . . 65.41 112.986 175.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.515 ' HA ' ' HG2' ' A' ' 154' ' ' ARG . 0.5 OUTLIER -153.26 -0.8 0.24 Allowed 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 124.708 1.203 . . . . 72.32 110.364 170.28 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 6.4 p-10 -117.95 133.19 56.16 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.998 1.319 . . . . 72.32 111.566 -172.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.605 ' HA ' ' HA ' ' A' ' 188' ' ' LEU . 18.2 mt -88.43 155.11 19.86 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.611 1.165 . . . . 74.25 110.126 -171.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -126.2 99.13 5.75 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 108.489 -0.93 . . . . 73.14 108.489 167.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.532 ' HB1' ' CD1' ' A' ' 186' ' ' PHE . . . -103.02 173.19 6.42 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.021 0.929 . . . . 74.34 109.325 175.005 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' THR . . . . . 0.538 HG21 ' HD3' ' B' ' 293' ' ' PRO . 30.7 m -110.88 149.06 31.15 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 108.457 -0.942 . . . . 70.21 108.457 171.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.407 HD21 HD13 ' A' ' 251' ' ' LEU . 49.5 tp -142.44 109.53 5.55 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 109.248 -0.649 . . . . 74.1 109.248 -176.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -86.35 121.93 29.61 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 108.296 -1.002 . . . . 63.3 108.296 173.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 7.5 p -140.36 133.25 14.8 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 123.987 0.915 . . . . 74.33 108.588 -176.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.69 156.55 48.93 Favored 'Trans proline' 0 C--N 1.369 1.645 0 C-N-CA 121.858 1.705 . . . . 70.05 111.911 175.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -57.51 -46.64 99.77 Favored Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 124.725 1.21 . . . . 71.34 114.038 -170.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -57.86 -45.04 35.28 Favored 'Trans proline' 0 C--N 1.39 2.75 0 C-N-CA 121.643 1.562 . . . . 73.32 113.082 175.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.485 HD13 ' HB3' ' C' ' 276' ' ' TYR . 33.8 mt -71.33 -27.19 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.087 0.555 . . . . 71.02 110.273 -179.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -71.52 -47.33 55.93 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.359 0.663 . . . . 74.14 111.08 177.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 53.0 t -65.71 -49.94 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 123.629 0.772 . . . . 64.22 111.309 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 59.0 t -88.74 -43.47 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.588 0.755 . . . . 74.41 111.509 -170.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 96.19 121.75 3.98 Favored Glycine 0 C--N 1.338 0.666 0 CA-C-N 115.947 -0.569 . . . . 72.35 112.683 -174.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.4 ' H ' ' HB ' ' A' ' 223' ' ' VAL . . . -141.98 -137.2 3.34 Favored Glycine 0 C--N 1.341 0.827 0 N-CA-C 111.095 -0.802 . . . . 73.32 111.095 178.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -136.24 137.71 41.07 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 118.006 0.903 . . . . 73.34 109.739 174.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 26.9 m -133.74 149.47 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 N-CA-C 108.59 -0.893 . . . . 63.11 108.59 172.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . 0.412 ' HD2' ' O ' ' B' ' 408' ' ' LEU . 21.3 ttm105 -75.36 107.58 7.57 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 121.101 0.477 . . . . 74.32 110.12 177.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -105.78 144.81 31.99 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.348 1.059 . . . . 74.41 109.181 175.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' MET . . . . . 0.514 ' SD ' ' N ' ' A' ' 213' ' ' MET . 0.5 OUTLIER -87.02 151.82 22.92 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 123.07 0.548 . . . . 74.15 109.898 -177.998 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 81.3 p -122.05 -162.67 1.01 Allowed 'General case' 0 C--O 1.243 0.732 0 N-CA-C 108.36 -0.978 . . . . 74.1 108.36 170.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.863 HD23 ' HB3' ' A' ' 127' ' ' LEU . 34.1 mt -65.36 -42.63 92.57 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.159 0.584 . . . . 73.14 110.781 177.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -129.3 30.35 5.0 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 115.331 -0.85 . . . . 64.44 112.351 -165.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 155.45 158.2 8.65 Favored Glycine 0 C--N 1.352 1.457 0 CA-C-O 119.75 -0.472 . . . . 63.05 113.888 173.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . 0.437 ' HA ' ' HA ' ' A' ' 213' ' ' MET . 42.4 Cg_endo -94.25 101.67 0.13 Allowed 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 123.277 2.651 . . . . 74.13 112.716 178.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 29.7 m -90.63 173.67 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 123.822 0.849 . . . . 73.4 109.771 -176.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.535 ' HG3' ' HA ' ' B' ' 438' ' ' GLN . 25.9 pt-20 -100.74 124.01 45.76 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 108.47 -0.937 . . . . 75.04 108.47 169.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 14.4 p -100.22 129.21 51.29 Favored 'Isoleucine or valine' 0 C--O 1.245 0.867 0 N-CA-C 108.493 -0.928 . . . . 74.51 108.493 173.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.54 ' HB3' ' HA ' ' B' ' 440' ' ' ARG . . . -84.43 101.24 11.87 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 109.379 -0.6 . . . . 70.4 109.379 178.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.4 ' HB ' ' H ' ' A' ' 208' ' ' GLY . 62.4 t -58.33 136.49 85.16 Favored Pre-proline 0 CA--C 1.553 1.067 0 CA-C-N 113.677 -1.601 . . . . 71.22 110.064 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . 0.554 ' HG3' HD13 ' B' ' 441' ' ' ILE . 32.0 Cg_endo -81.8 176.32 8.5 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 122.987 2.458 . . . . 75.51 110.716 177.021 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -71.53 159.09 52.27 Favored 'Trans proline' 0 C--N 1.359 1.131 0 C-N-CA 120.607 0.871 . . . . 72.53 110.844 165.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . 0.552 ' HD2' ' O ' ' C' ' 259' ' ' GLU . 11.1 mmt180 65.81 26.95 11.16 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 124.56 1.144 . . . . 75.13 113.195 168.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.501 HG21 HD23 ' A' ' 233' ' ' LEU . 31.4 m -65.1 84.43 0.05 OUTLIER 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 124.969 1.308 . . . . 64.32 109.568 175.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -86.39 138.89 31.44 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.291 1.036 . . . . 75.32 110.713 -171.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -50.11 127.26 16.42 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.39 1.476 . . . . 65.12 112.112 -176.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . 0.474 ' HA3' ' HB3' ' B' ' 290' ' ' TRP . . . 88.29 -25.06 9.6 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-N 115.543 -0.753 . . . . 75.54 114.462 172.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.408 ' O ' HG23 ' A' ' 253' ' ' VAL . 70.8 mtt180 -67.5 156.01 37.69 Favored 'General case' 0 C--N 1.345 0.408 0 N-CA-C 109.323 -0.621 . . . . 74.44 109.323 172.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.4 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 2.5 mppt? -110.46 123.29 49.63 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.558 -0.904 . . . . 72.22 108.558 -176.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.526 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 80.7 mt -72.42 111.53 7.69 Favored 'General case' 0 C--O 1.217 -0.645 0 N-CA-C 107.525 -1.287 . . . . 71.4 107.525 179.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -95.21 100.28 12.11 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 123.462 0.476 . . . . 73.41 110.185 -178.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.7 ' HB3' ' HB ' ' B' ' 441' ' ' ILE . 0.2 OUTLIER -107.31 107.02 17.74 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.547 0.739 . . . . 74.24 109.455 -179.659 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.594 ' HA ' ' HB3' ' A' ' 248' ' ' ASP . 14.2 mmmm -67.54 148.91 50.84 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.702 0.801 . . . . 71.01 111.73 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.445 ' HA2' ' HB2' ' A' ' 246' ' ' ARG . . . 73.55 23.79 76.2 Favored Glycine 0 C--N 1.352 1.45 0 CA-C-N 116.164 -0.471 . . . . 74.2 113.566 177.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.562 ' HG3' HD13 ' A' ' 235' ' ' LEU . 46.6 mmtm -123.05 -26.23 4.4 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.873 0.869 . . . . 74.1 110.985 -174.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -80.19 -155.19 10.58 Favored Glycine 0 C--N 1.345 1.079 0 CA-C-N 115.948 -0.569 . . . . 74.43 113.009 171.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . 0.472 ' HZ ' HD11 ' A' ' 215' ' ' LEU . 3.9 m-85 -94.92 139.03 21.98 Favored Pre-proline 0 N--CA 1.478 0.95 0 CA-C-O 118.893 -0.575 . . . . 73.41 111.175 -168.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.56 ' HA ' ' HA ' ' A' ' 246' ' ' ARG . 59.6 Cg_exo -42.4 129.04 4.75 Favored 'Trans proline' 0 C--N 1.391 2.79 0 C-N-CA 124.437 3.425 . . . . 73.33 114.585 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -165.23 -147.15 5.04 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-O 119.334 -0.703 . . . . 73.52 112.586 -176.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . 0.437 ' HD2' ' HG2' ' A' ' 191' ' ' GLN . 28.1 Cg_exo -62.71 -28.42 76.51 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 123.761 2.974 . . . . 72.5 113.138 -177.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -90.82 21.28 4.2 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.964 0.906 . . . . 70.11 111.524 -179.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 78.28 -70.11 2.65 Favored Glycine 0 C--N 1.35 1.346 0 N-CA-C 109.762 -1.335 . . . . 62.24 109.762 -170.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.56 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 64.0 mtm180 -122.65 144.82 48.88 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 107.154 -1.425 . . . . 75.41 107.154 164.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -69.55 -165.81 4.81 Favored Glycine 0 C--N 1.335 0.514 0 CA-C-O 121.435 0.464 . . . . 70.31 113.919 172.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . 0.594 ' HB3' ' HA ' ' A' ' 236' ' ' LYS . 0.9 OUTLIER -121.0 173.53 7.2 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.589 0.755 . . . . 75.44 111.492 -174.049 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.457 ' HB3' ' HG ' ' A' ' 235' ' ' LEU . 16.2 tp -126.56 136.25 52.32 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.297 -1.001 . . . . 73.32 108.297 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.453 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 56.5 m-85 -111.78 113.94 26.61 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.352 1.061 . . . . 71.3 109.112 176.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.526 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 78.2 mt -102.39 106.85 17.67 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 109.262 -0.644 . . . . 74.54 109.262 178.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -76.79 117.94 18.9 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 109.435 -0.58 . . . . 75.41 109.435 -178.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 231' ' ' ARG . 49.2 t -71.61 134.19 30.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-N 114.477 -1.238 . . . . 71.34 111.31 -171.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -130.94 91.23 3.02 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 106.82 -1.548 . . . . 73.14 106.82 177.113 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.494 HD13 HG23 ' C' ' 257' ' ' ILE . 62.0 mt -77.52 127.88 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 122.767 0.427 . . . . 74.34 111.243 -173.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 25.6 p -116.11 165.16 13.46 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.738 1.215 . . . . 74.52 110.263 175.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . 0.479 ' HB ' ' HD2' ' A' ' 258' ' ' PRO . 2.9 pp -134.17 154.54 80.13 Favored Pre-proline 0 N--CA 1.486 1.363 0 C-N-CA 123.519 0.728 . . . . 73.4 109.079 174.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . 0.479 ' HD2' ' HB ' ' A' ' 257' ' ' ILE . 18.4 Cg_endo -54.28 -17.84 12.89 Favored 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 123.705 2.937 . . . . 74.45 116.336 -164.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 59.18 -64.49 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 125.234 1.414 . . . . 75.12 113.119 -167.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -79.24 129.68 34.7 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.792 -0.568 . . . . 75.12 111.013 178.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.405 HD13 ' HD2' ' C' ' 226' ' ' ARG . 67.4 mt -143.29 154.59 43.94 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.412 1.085 . . . . 72.32 109.852 177.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' THR . . . . . 0.416 ' HB ' ' HD2' ' A' ' 263' ' ' PRO . 18.0 p -132.33 159.3 72.84 Favored Pre-proline 0 CA--C 1.564 1.515 0 C-N-CA 124.791 1.236 . . . . 74.31 108.787 174.066 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' PRO . . . . . 0.416 ' HD2' ' HB ' ' A' ' 262' ' ' THR . 39.2 Cg_exo -17.21 -58.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.398 3.155 1 C-N-CA 127.317 5.344 . . . . 74.33 119.167 -170.921 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -70.9 -47.51 58.76 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 118.056 0.389 . . . . 71.44 111.861 -173.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -66.05 -36.97 84.67 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 109.506 -0.553 . . . . 73.22 109.506 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' GLU . . . . . 0.461 ' O ' ' HG3' ' A' ' 270' ' ' LYS . 4.2 tp10 -52.55 -48.97 65.81 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 124.509 1.131 . . . . 73.45 109.238 172.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -58.65 -51.16 71.11 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.697 1.199 . . . . 64.12 112.835 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 11.0 mp -59.94 -46.62 88.81 Favored 'General case' 0 N--CA 1.483 1.223 0 O-C-N 123.717 0.636 . . . . 73.14 110.689 -178.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -65.61 -34.93 79.37 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 123.58 0.752 . . . . 75.0 112.385 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . 0.643 ' HB3' ' HZ1' ' A' ' 270' ' ' LYS . 9.1 mtpm? -63.06 -55.31 26.6 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 122.961 0.504 . . . . 73.12 110.793 176.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 30.7 mmtm -62.98 -27.99 69.78 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 124.085 0.865 . . . . 70.22 111.634 -178.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 272' ' ' LEU . . . . . 0.414 ' O ' ' HB2' ' A' ' 276' ' ' TYR . 40.9 mt -60.12 -55.42 34.05 Favored 'General case' 0 C--O 1.207 -1.158 0 O-C-N 123.836 0.71 . . . . 71.54 109.887 167.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -63.34 -33.42 75.48 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.874 0.87 . . . . 72.23 113.184 -176.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.437 ' HA ' ' HB3' ' B' ' 250' ' ' GLN . 43.9 mt-10 -69.57 -55.34 10.39 Favored 'General case' 0 C--O 1.252 1.203 0 C-N-CA 123.957 0.903 . . . . 74.35 109.736 179.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -77.26 -2.86 36.86 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-N 115.032 -0.985 . . . . 72.24 111.668 178.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . 0.434 ' CE2' ' HB3' ' C' ' 258' ' ' PRO . 33.4 t80 -79.53 -61.79 1.89 Allowed 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.236 -1.024 . . . . 75.02 108.236 171.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 277' ' ' TYR . . . . . 0.518 ' HA ' ' HB3' ' A' ' 280' ' ' ALA . 2.6 t80 -58.03 -38.76 76.84 Favored 'General case' 0 C--N 1.356 0.877 0 O-C-N 124.988 1.43 . . . . 72.14 109.53 -175.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -48.03 -38.05 16.31 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.67 1.188 . . . . 75.41 113.7 175.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . 0.533 ' HA ' HD22 ' B' ' 277' ' ' LEU . 0.1 OUTLIER -132.55 37.85 3.47 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 109.319 -0.623 . . . . 75.15 109.319 179.139 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . 0.518 ' HB3' ' HA ' ' A' ' 277' ' ' TYR . . . . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 118.89 -0.576 . . . . 72.5 112.102 -175.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 61.1 mtm . . . . . 0 N--CA 1.483 1.18 0 N-CA-C 109.488 -0.56 . . . . 74.12 109.488 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt 67.09 -77.42 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 125.335 1.454 . . . . 62.45 111.552 177.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 36.6 tp60 -154.51 128.01 8.57 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 107.258 -1.386 . . . . 74.04 107.258 -177.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 39.4 m -141.75 100.65 3.8 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 108.763 -0.828 . . . . 52.14 108.763 -178.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 8.6 m -64.09 153.34 37.86 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.353 0.661 . . . . 74.34 112.428 -168.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.713 HG23 ' HA ' ' A' ' 125' ' ' LEU . 19.1 pt -117.55 -177.64 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 N-CA-C 113.12 0.785 . . . . 65.34 113.12 -167.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -135.76 143.66 45.39 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 114.572 -1.194 . . . . 72.22 110.322 177.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . 0.554 ' HB3' ' HB ' ' A' ' 140' ' ' VAL . 36.9 tp -115.76 157.72 23.91 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.842 1.257 . . . . 75.22 108.494 173.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -103.73 -35.66 8.14 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.016 0.526 . . . . 73.12 111.926 178.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . 0.405 ' HG ' HG23 ' A' ' 140' ' ' VAL . 88.4 mt 76.68 2.58 3.4 Favored 'General case' 0 N--CA 1.502 2.145 0 C-N-CA 125.556 1.543 . . . . 74.1 110.726 -162.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.461 HD13 ' HG3' ' A' ' 122' ' ' GLU . 65.0 mt 64.43 36.32 0.2 Allowed Pre-proline 0 CA--C 1.578 2.043 0 N-CA-C 116.383 1.994 . . . . 72.11 116.383 177.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.77 -23.87 13.9 Favored 'Trans proline' 0 C--N 1.402 3.344 0 CA-C-N 122.511 1.933 . . . . 71.41 109.661 160.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 2.2 pp -136.31 153.43 51.16 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 126.027 1.731 . . . . 75.11 107.218 169.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -148.02 145.72 28.61 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 122.436 0.294 . . . . 64.54 110.509 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -119.37 103.56 9.58 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.013 0.925 . . . . 74.01 108.712 176.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 40.2 p -82.46 157.48 67.54 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 123.573 0.749 . . . . 71.11 109.181 172.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -59.37 95.85 0.09 OUTLIER 'Trans proline' 0 C--N 1.384 2.404 0 C-N-CA 122.379 2.053 . . . . 71.22 111.464 176.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 6.3 p -69.35 91.14 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.139 0 CA-C-O 122.203 1.001 . . . . 63.3 110.721 -178.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 10.1 t -160.84 159.51 29.93 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 114.789 -1.096 . . . . 71.22 109.325 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 45.7 tptt -153.69 -45.33 0.09 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.167 0.587 . . . . 74.33 109.827 -178.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -147.19 -29.98 0.35 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.215 0.606 . . . . 75.34 111.153 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 68.33 -73.5 0.08 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 125.02 1.328 . . . . 73.31 110.135 -172.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 23' ' ' THR . . . . . . . . . . . . . 29.0 m -123.33 96.2 44.42 Favored Pre-proline 0 CA--C 1.546 0.789 0 N-CA-C 107.634 -1.247 . . . . 72.54 107.634 173.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.87 84.0 0.86 Allowed 'Trans proline' 0 C--N 1.38 2.227 0 C-N-CA 122.618 2.212 . . . . 74.55 110.825 176.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -73.98 90.86 1.98 Allowed 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 114.803 -1.089 . . . . 74.53 109.598 178.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 52.5 mtp -155.47 -49.04 0.01 OUTLIER Pre-proline 0 N--CA 1.499 2.02 0 C-N-CA 124.641 1.177 . . . . 75.13 111.67 175.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -80.17 42.4 1.31 Allowed 'Trans proline' 0 C--N 1.402 3.391 0 C-N-CA 122.772 2.314 . . . . 73.04 112.527 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 34.9 m -107.6 -2.7 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 123.948 0.899 . . . . 75.25 111.607 -176.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 30.6 tp -53.25 -53.86 44.7 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 125.221 1.408 . . . . 73.34 112.464 -173.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.504 ' HA ' ' O ' ' B' ' 371' ' ' VAL . 0.0 OUTLIER -105.52 2.98 28.91 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 114.143 -1.39 . . . . 71.25 111.376 -169.631 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -74.64 -20.42 59.9 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 123.068 0.547 . . . . 74.34 110.501 -178.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 32' ' ' ARG . . . . . 0.552 ' HB3' ' HA ' ' B' ' 375' ' ' LEU . 4.9 tpm_? -146.93 -60.05 0.29 Allowed 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 122.83 0.452 . . . . 72.22 111.337 175.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . 0.546 ' HA ' ' HB3' ' B' ' 373' ' ' ARG . . . 56.03 80.02 0.15 Allowed 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.675 1.19 . . . . 73.31 111.59 -167.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.48 12.21 2.11 Favored 'General case' 0 CA--C 1.555 1.173 0 N-CA-C 113.168 0.803 . . . . 53.33 113.168 -175.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . 0.457 ' HA ' HE21 ' B' ' 35' ' ' GLN . 0.1 OUTLIER -157.99 -63.8 0.09 Allowed 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 118.499 0.591 . . . . 73.13 111.363 174.705 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 122.87 -71.9 0.41 Allowed Glycine 0 C--N 1.339 0.732 0 N-CA-C 110.563 -1.015 . . . . 74.33 110.563 -175.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . 0.417 ' HB2' HH22 ' C' ' 234' ' ' ARG . 11.9 m-20 58.55 94.29 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 125.288 1.435 . . . . 61.44 111.124 -179.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 45.7 pt -127.67 13.96 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.981 0 C-N-CA 123.955 0.902 . . . . 75.44 112.262 -172.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 7.6 m -52.46 107.12 0.19 Allowed 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 123.607 0.763 . . . . 73.32 111.171 -170.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -48.31 107.04 0.68 Allowed Pre-proline 0 N--CA 1.482 1.128 0 O-C-N 125.267 1.605 . . . . 73.24 113.779 -166.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -78.19 -46.4 0.12 Allowed 'Trans proline' 0 C--N 1.37 1.671 0 C-N-CA 122.346 2.031 . . . . 72.44 109.654 167.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.6 113.87 0.25 Allowed Glycine 0 C--N 1.351 1.396 0 CA-C-N 114.901 -1.045 . . . . 61.22 112.466 176.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.67 103.15 0.92 Allowed Glycine 0 CA--C 1.532 1.108 0 CA-C-O 119.692 -0.504 . . . . 64.32 111.854 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . 62.89 96.4 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 125.223 1.409 . . . . 63.2 111.269 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.529 ' HG2' HG23 ' B' ' 236' ' ' THR . 4.9 mmp_? -82.37 98.92 9.09 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 122.677 0.391 . . . . 74.21 110.851 -174.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.24 23.57 1.23 Allowed 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 126.609 1.964 . . . . 75.02 113.797 178.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 68.6 tp -58.15 -42.75 86.58 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.515 1.126 . . . . 72.13 111.556 -174.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 29.1 m 70.36 -64.1 0.38 Allowed 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 125.933 1.693 . . . . 73.12 111.29 -178.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -166.32 -90.54 0.08 OUTLIER Glycine 0 C--N 1.339 0.711 0 N-CA-C 110.517 -1.033 . . . . 74.15 110.517 173.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -105.79 91.54 3.79 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 107.548 -1.279 . . . . 64.2 107.548 172.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 9.7 pm0 -64.38 -28.58 69.79 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.036 0.935 . . . . 75.3 111.485 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 3.3 m -104.49 150.03 24.93 Favored 'General case' 0 CA--C 1.554 1.127 0 N-CA-C 108.303 -0.999 . . . . 73.31 108.303 177.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.22 145.32 55.33 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 112.888 0.699 . . . . 73.24 112.888 -165.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.51 ' HA ' ' HA3' ' B' ' 162' ' ' GLY . . . -80.92 170.94 15.63 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.493 1.117 . . . . 75.51 110.844 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . 0.403 HD23 ' N ' ' B' ' 56' ' ' ARG . 0.0 OUTLIER -51.15 -37.6 47.24 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.722 1.209 . . . . 72.35 112.983 -175.451 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . 0.555 ' HD3' ' SD ' ' B' ' 157' ' ' MET . 44.3 ttt180 52.15 -82.73 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 125.231 1.412 . . . . 74.21 113.374 175.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -78.9 -84.75 0.08 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.472 0.709 . . . . 75.31 110.371 -174.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 22.3 t 63.75 26.29 14.41 Favored 'General case' 0 CA--C 1.565 1.547 0 C-N-CA 124.404 1.082 . . . . 62.01 112.498 176.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -81.78 137.69 35.28 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.481 0.712 . . . . 72.44 110.209 172.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 79.9 p -85.9 2.65 45.19 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.792 0.837 . . . . 71.31 111.649 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -77.14 -11.17 59.78 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 124.092 0.957 . . . . 71.45 111.922 178.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 62' ' ' LYS . . . . . 0.405 ' HA ' ' HD3' ' B' ' 62' ' ' LYS . 27.8 mmtp -78.03 154.52 80.17 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 123.934 0.894 . . . . 72.42 110.84 -174.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -47.87 -33.09 18.88 Favored 'Trans proline' 0 C--N 1.391 2.768 0 C-N-CA 124.511 3.474 . . . . 72.24 113.953 -174.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 57.25 -89.56 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.096 1.359 . . . . 72.04 111.503 174.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -91.04 -49.23 6.52 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.704 0.801 . . . . 73.42 110.509 -176.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -79.6 96.7 6.24 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.181 -0.674 . . . . 72.41 109.181 -178.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . 0.523 HG13 ' H ' ' B' ' 69' ' ' LEU . 7.0 tp -161.55 143.3 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.103 0.961 . . . . 74.04 108.476 -174.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 43.6 pt -61.4 -20.57 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 123.322 0.649 . . . . 73.4 112.55 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.523 ' H ' HG13 ' B' ' 67' ' ' ILE . 1.4 tt 55.47 -103.11 0.17 Allowed 'General case' 0 CA--C 1.559 1.293 0 C-N-CA 124.775 1.23 . . . . 74.34 109.788 176.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 95.2 mt -147.88 26.56 1.0 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.428 1.491 . . . . 65.22 107.6 176.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 50.9 mm -64.99 121.74 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 124.865 1.266 . . . . 75.5 111.121 -171.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 142.73 61.41 0.03 OUTLIER Glycine 0 C--N 1.341 0.819 0 N-CA-C 110.114 -1.194 . . . . 71.15 110.114 -176.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 65.7 -76.86 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 125.437 1.495 . . . . 74.12 110.221 -172.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -156.35 53.04 0.42 Allowed Glycine 0 C--N 1.342 0.878 0 N-CA-C 110.445 -1.062 . . . . 72.45 110.445 177.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 7.8 tpt -74.15 93.82 2.35 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 109.15 -0.685 . . . . 74.01 109.15 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 123.4 -41.18 1.82 Allowed Glycine 0 N--CA 1.47 0.952 0 N-CA-C 111.351 -0.699 . . . . 71.52 111.351 -175.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -76.15 -62.49 1.59 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.833 0.853 . . . . 74.35 109.9 178.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 19.7 t 61.39 24.15 14.3 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 125.034 1.333 . . . . 55.34 111.405 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . 0.624 ' HG3' HG22 ' B' ' 80' ' ' ILE . 11.2 tp10 -97.52 153.82 17.91 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 124.452 1.101 . . . . 74.44 110.12 -177.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . 0.624 HG22 ' HG3' ' B' ' 79' ' ' GLU . 22.6 pt 50.5 21.53 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 C-N-CA 126.813 2.045 . . . . 72.52 114.5 176.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 81' ' ' THR . . . . . 0.461 HG22 ' H ' ' B' ' 82' ' ' ALA . 0.6 OUTLIER -108.11 -68.5 0.9 Allowed 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.438 0.695 . . . . 74.52 109.685 173.87 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . 0.461 ' H ' HG22 ' B' ' 81' ' ' THR . . . 62.5 6.43 1.98 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.632 1.173 . . . . 75.12 113.39 -178.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . 65.07 -69.27 0.1 Allowed 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.881 1.273 . . . . 74.13 111.607 -171.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? 69.28 -84.97 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 125.26 1.424 . . . . 73.0 109.596 176.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 50.98 -87.45 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 125.633 1.573 . . . . 72.23 111.642 -177.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -111.91 88.23 2.75 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.137 -1.06 . . . . 74.21 108.137 177.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.83 -174.98 4.68 Favored 'General case' 0 C--O 1.247 0.925 0 C-N-CA 124.904 1.282 . . . . 52.24 108.967 -178.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 63.37 28.26 15.52 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 124.039 0.936 . . . . 74.14 110.897 175.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -87.18 -125.93 2.1 Favored Glycine 0 C--N 1.344 1.016 0 CA-C-O 119.33 -0.706 . . . . 54.33 111.338 179.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . 65.63 -71.47 0.08 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 125.196 1.398 . . . . 75.53 111.737 178.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.68 -8.63 78.78 Favored Glycine 0 C--N 1.347 1.192 0 CA-C-O 119.66 -0.522 . . . . 70.11 113.193 175.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -84.84 45.61 3.54 Favored Glycine 0 C--N 1.356 1.643 0 CA-C-N 116.977 0.388 . . . . 73.42 112.385 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -161.59 119.18 2.26 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.632 1.173 . . . . 74.22 108.67 178.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -89.48 63.14 6.23 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 121.561 0.696 . . . . 72.14 109.301 177.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -110.55 153.24 25.41 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.537 -0.756 . . . . 74.44 110.315 -178.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 69.67 -92.85 0.36 Allowed Glycine 0 C--N 1.345 1.072 0 O-C-N 123.979 0.8 . . . . 75.21 111.682 -176.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 97' ' ' ILE . . . . . 0.427 HG12 ' HB3' ' B' ' 100' ' ' LEU . 0.7 OUTLIER 74.78 -29.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 C-N-CA 126.319 1.848 . . . . 73.0 112.79 178.386 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 69.33 -78.7 0.04 OUTLIER 'General case' 0 C--N 1.361 1.079 0 C-N-CA 125.84 1.656 . . . . 75.21 111.79 171.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -157.64 30.85 0.27 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.66 0.784 . . . . 61.12 110.142 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . 0.512 ' HB3' ' HD3' ' B' ' 101' ' ' PRO . 2.8 tm? -59.83 -56.53 34.75 Favored Pre-proline 0 CA--C 1.566 1.561 0 C-N-CA 124.189 0.996 . . . . 74.2 111.038 -178.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 101' ' ' PRO . . . . . 0.512 ' HD3' ' HB3' ' B' ' 100' ' ' LEU . 40.7 Cg_endo -96.18 22.23 0.4 Allowed 'Trans proline' 0 C--N 1.392 2.839 0 C-N-CA 122.144 1.896 . . . . 74.43 112.73 -179.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 63.6 tp -80.14 -51.39 9.04 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 109.707 -0.479 . . . . 73.12 109.707 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 103' ' ' THR . . . . . 0.584 HG23 ' H ' ' B' ' 105' ' ' GLN . 18.1 m 68.68 151.99 0.09 Allowed 'General case' 0 N--CA 1.483 1.215 0 O-C-N 124.92 1.387 . . . . 75.52 111.222 -173.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . -63.75 -34.06 88.91 Favored Glycine 0 C--N 1.352 1.422 0 N-CA-C 111.846 -0.502 . . . . 51.35 111.846 173.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 105' ' ' GLN . . . . . 0.584 ' H ' HG23 ' B' ' 103' ' ' THR . 87.8 mt-30 68.7 99.08 0.06 Allowed 'General case' 0 C--N 1.36 1.058 0 C-N-CA 125.523 1.529 . . . . 75.22 110.473 176.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 69.93 166.95 0.29 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.126 1.37 . . . . 74.44 111.624 -179.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 66.8 p -79.17 102.24 8.39 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 109.053 -0.721 . . . . 75.34 109.053 178.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 25.8 m170 -68.8 106.5 2.7 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 109.436 -0.579 . . . . 73.44 109.436 177.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -60.96 -25.51 66.88 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.206 -0.906 . . . . 74.1 111.114 176.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . 66.79 -163.8 0.23 Allowed 'General case' 0 C--O 1.247 0.928 0 C-N-CA 124.594 1.158 . . . . 75.22 110.356 -177.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 2.9 mm? 61.67 34.88 17.32 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 124.119 0.967 . . . . 70.25 109.914 -177.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -73.02 101.21 3.18 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.621 0.769 . . . . 73.2 110.004 -175.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 113' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt 58.78 37.71 24.91 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.427 1.091 . . . . 75.13 109.747 -179.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 40.7 tptt -66.83 95.04 0.34 Allowed 'General case' 0 C--O 1.246 0.905 0 CA-C-N 114.249 -1.341 . . . . 74.21 111.509 -168.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 47.9 p 45.72 64.78 1.32 Allowed 'General case' 0 C--O 1.242 0.665 0 O-C-N 124.623 1.202 . . . . 73.23 111.617 -175.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -56.87 -41.71 91.62 Favored Glycine 0 C--N 1.353 1.505 0 N-CA-C 109.785 -1.326 . . . . 55.33 109.785 168.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . 0.507 ' HG3' ' HG2' ' B' ' 464' ' ' MET . 24.6 mmtp -136.04 156.36 77.08 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-N 113.269 -1.466 . . . . 75.35 107.826 161.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 118' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.5 -15.19 48.56 Favored 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 122.695 2.263 . . . . 63.21 111.839 170.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 119' ' ' ASP . . . . . . . . . . . . . 23.6 t0 77.0 155.14 0.16 Allowed 'General case' 0 C--N 1.359 0.982 0 C-N-CA 126.369 1.867 . . . . 75.33 111.024 174.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 120' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -78.54 134.87 37.21 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.006 0.922 . . . . 70.1 109.636 177.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 14.0 p -82.5 1.89 3.41 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.493 0 C-N-CA 123.874 0.869 . . . . 74.32 110.237 174.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 82.8 p -71.41 85.19 0.82 Allowed 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 124.864 1.266 . . . . 75.25 112.268 -171.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.03 -52.98 3.66 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.052 1.341 . . . . 70.53 108.955 178.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 9.4 t 61.18 21.18 11.66 Favored 'General case' 0 CA--C 1.56 1.328 0 C-N-CA 125.529 1.532 . . . . 61.03 113.463 170.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -70.46 103.06 2.35 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.169 0.588 . . . . 74.53 109.486 175.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -156.27 -63.82 0.11 Allowed 'General case' 0 C--O 1.24 0.605 0 C-N-CA 123.768 0.827 . . . . 74.13 109.432 -176.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 41.2 m 56.86 -157.06 0.28 Allowed 'General case' 0 CA--C 1.563 1.472 0 C-N-CA 124.205 1.002 . . . . 70.01 110.998 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -81.06 -11.17 59.57 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 118.668 0.667 . . . . 74.33 110.884 174.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 16.3 m -63.85 -23.97 67.56 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.561 0.744 . . . . 74.41 110.505 171.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 130' ' ' ALA . . . . . 0.565 ' HB2' HG12 ' B' ' 135' ' ' VAL . . . -56.33 -29.49 61.37 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.453 1.101 . . . . 61.42 113.031 177.117 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 18.6 m95 -88.68 -4.92 58.43 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.192 0.597 . . . . 73.51 111.841 -175.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 132' ' ' SER . . . . . 0.529 ' HA ' ' HB2' ' B' ' 167' ' ' ASN . 48.1 t -76.38 99.35 4.81 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 108.423 -0.954 . . . . 74.11 108.423 172.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 8.7 m 78.84 -40.05 0.25 Allowed 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 125.768 1.627 . . . . 74.52 112.11 -176.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 136.69 168.94 11.57 Favored Glycine 0 C--N 1.351 1.376 0 N-CA-C 112.123 -0.391 . . . . 55.15 112.123 176.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 135' ' ' VAL . . . . . 0.589 HG22 ' SG ' ' B' ' 200' ' ' CYS . 27.0 m -86.57 21.01 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 C-N-CA 123.642 0.777 . . . . 73.24 111.837 -176.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 136' ' ' LYS . . . . . 0.544 ' HB2' HD11 ' B' ' 205' ' ' LEU . 2.5 pptp? -132.96 175.13 9.64 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.497 0.719 . . . . 74.24 111.656 -168.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 13.2 t -137.9 -170.25 2.73 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.145 0.978 . . . . 75.31 108.431 175.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -145.4 111.93 5.81 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.046 0.538 . . . . 75.52 110.47 175.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 4.4 m120 63.06 -87.13 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.934 1.694 . . . . 73.24 112.474 167.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -151.13 50.76 0.53 Allowed Glycine 0 C--N 1.346 1.115 0 N-CA-C 111.013 -0.835 . . . . 75.54 111.013 -175.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.03 76.49 1.71 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.847 0.859 . . . . 75.34 109.7 177.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 87.2 mt -122.79 1.27 9.36 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.064 0.945 . . . . 74.24 111.745 -171.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 143' ' ' GLY . . . . . 0.439 ' HA2' ' HA ' ' B' ' 147' ' ' HIS . . . -79.09 81.33 1.43 Allowed Glycine 0 C--N 1.347 1.176 0 O-C-N 123.145 0.278 . . . . 61.25 113.34 -176.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 20.3 t -89.81 -58.42 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 N-CA-C 108.868 -0.79 . . . . 75.31 108.868 175.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 145' ' ' ASP . . . . . 0.53 ' HB3' ' HA ' ' B' ' 350' ' ' LYS . 8.7 p-10 -132.59 -41.9 0.95 Allowed 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 108.28 -1.007 . . . . 75.32 108.28 169.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 11.2 tt -85.27 105.24 13.99 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 N-CA-C 107.295 -1.372 . . . . 72.52 107.295 171.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 147' ' ' HIS . . . . . 0.439 ' HA ' ' HA2' ' B' ' 143' ' ' GLY . 5.8 p80 -80.34 142.72 34.2 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.841 -0.618 . . . . 72.43 110.436 -171.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -82.46 138.62 34.32 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 107.226 -1.398 . . . . 75.05 107.226 163.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 149' ' ' LYS . . . . . . . . . . . . . 42.1 pttt -89.28 -27.46 20.55 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.177 0.591 . . . . 74.13 110.243 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 27.8 t70 61.56 -81.62 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 125.557 1.543 . . . . 74.11 112.006 169.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 68.5 m80 -149.67 -62.64 0.02 OUTLIER Pre-proline 0 CA--C 1.562 1.425 0 C-N-CA 124.492 1.117 . . . . 74.43 111.347 -177.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 152' ' ' PRO . . . . . 0.6 ' HB2' ' HB2' ' B' ' 155' ' ' LEU . 65.5 Cg_endo -75.66 2.56 6.81 Favored 'Trans proline' 0 C--N 1.395 3.007 0 C-N-CA 121.698 1.599 . . . . 64.13 114.923 -162.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 24.4 m 67.11 -77.8 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 125.384 1.474 . . . . 74.2 111.537 177.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 45.1 pt -123.45 -35.41 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.942 0.897 . . . . 74.25 110.681 178.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 155' ' ' LEU . . . . . 0.6 ' HB2' ' HB2' ' B' ' 152' ' ' PRO . 13.0 tp 49.71 -148.99 0.26 Allowed 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 124.514 1.125 . . . . 73.12 109.957 -175.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 156' ' ' GLU . . . . . 0.496 ' H ' ' HG ' ' B' ' 155' ' ' LEU . 16.9 mp0 -67.39 -58.13 5.33 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 107.108 -1.442 . . . . 72.23 107.108 158.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 157' ' ' MET . . . . . 0.555 ' SD ' ' HD3' ' B' ' 56' ' ' ARG . 1.9 mpp? -130.51 129.3 42.71 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 106.153 -1.795 . . . . 61.13 106.153 165.238 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 158' ' ' ALA . . . . . 0.635 ' HB2' ' HB ' ' B' ' 214' ' ' THR . . . -70.06 77.19 0.5 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 108.784 -0.821 . . . . 65.11 108.784 172.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' B' ' 210' ' ' LYS . 8.9 tmtt? 56.72 110.29 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 126.354 1.862 . . . . 73.24 111.443 -168.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -80.37 138.93 36.74 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 123.362 0.665 . . . . 74.34 110.512 177.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -69.23 -21.46 63.93 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.608 0.763 . . . . 71.1 111.783 -178.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 162' ' ' GLY . . . . . 0.51 ' HA3' ' HA ' ' B' ' 54' ' ' ALA . . . -82.38 56.56 5.0 Favored Glycine 0 C--N 1.351 1.397 0 O-C-N 123.369 0.418 . . . . 73.4 112.067 173.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 4.4 tt -158.26 77.89 0.8 Allowed 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 106.219 -1.771 . . . . 75.25 106.219 -176.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 164' ' ' ALA . . . . . . . . . . . . . . . -161.46 161.08 29.99 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.072 0.949 . . . . 75.34 109.477 -177.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 49.6 p -88.35 -50.33 6.4 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 123.57 0.748 . . . . 73.14 110.373 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . 74.32 -152.51 45.1 Favored Glycine 0 C--N 1.349 1.28 0 CA-C-N 116.031 -0.531 . . . . 74.53 112.158 -177.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 167' ' ' ASN . . . . . 0.529 ' HB2' ' HA ' ' B' ' 132' ' ' SER . 28.3 t-20 -126.38 -69.9 0.75 Allowed 'General case' 0 C--O 1.243 0.718 0 N-CA-C 108.697 -0.853 . . . . 74.33 108.697 176.035 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 88.4 t 68.13 -65.58 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 C-N-CA 125.491 1.516 . . . . 75.53 111.624 -177.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 169' ' ' SER . . . . . 0.595 ' HB3' ' HA ' ' B' ' 173' ' ' LEU . 43.4 m -71.28 79.18 0.72 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.981 0.912 . . . . 65.53 110.966 176.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 9.6 m -90.9 -45.15 8.94 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.156 0.982 . . . . 73.13 110.212 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -110.95 -55.63 2.47 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.929 0.892 . . . . 73.41 109.278 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 172' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -81.95 95.81 7.5 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.212 1.005 . . . . 75.25 109.473 175.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 173' ' ' LEU . . . . . 0.595 ' HA ' ' HB3' ' B' ' 169' ' ' SER . 11.1 mp -83.14 -67.95 0.75 Allowed 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 122.675 0.39 . . . . 74.44 111.109 -178.14 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 174' ' ' GLN . . . . . 0.445 ' HB3' ' HG3' ' B' ' 193' ' ' PRO . 7.4 tp-100 -168.73 141.82 2.91 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 107.934 -1.136 . . . . 74.45 107.934 -175.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 175' ' ' ASP . . . . . . . . . . . . . 13.0 t70 73.37 107.73 0.07 Allowed 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 125.264 1.425 . . . . 74.1 109.476 -173.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -113.79 21.93 14.49 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.07 0.948 . . . . 74.11 108.964 173.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 19.0 p -123.08 92.66 48.95 Favored Pre-proline 0 C--O 1.244 0.764 0 C-N-CA 124.063 0.945 . . . . 74.15 110.456 -169.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 178' ' ' PRO . . . . . 0.73 ' HA ' ' HD2' ' B' ' 189' ' ' LYS . 19.2 Cg_exo -68.78 -48.33 1.02 Allowed 'Trans proline' 0 C--N 1.371 1.759 0 C-N-CA 122.089 1.859 . . . . 74.53 111.414 170.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -163.34 -42.88 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.905 0.882 . . . . 74.35 109.042 172.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 180' ' ' ALA . . . . . 0.608 ' HB3' HG21 ' C' ' 137' ' ' VAL . . . -161.77 -69.81 0.06 Allowed 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 108.505 -0.924 . . . . 75.32 108.505 172.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 20.1 tp -88.35 -68.72 0.75 Allowed 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 107.171 -1.418 . . . . 74.44 107.171 160.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 182' ' ' VAL . . . . . 0.517 ' HA ' ' HB2' ' B' ' 178' ' ' PRO . 78.4 t -135.64 -70.95 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.705 0.802 . . . . 72.43 109.644 175.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -171.64 -89.44 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.257 0.623 . . . . 65.24 110.537 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 26.7 p-80 -168.01 -167.58 0.85 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.481 0.712 . . . . 75.32 110.869 -173.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 185' ' ' VAL . . . . . . . . . . . . . 89.6 t -56.6 113.81 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 124.1 0.96 . . . . 74.01 111.011 -179.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 75.3 p 47.04 69.52 0.49 Allowed 'General case' 0 C--N 1.358 0.951 0 C-N-CA 125.688 1.595 . . . . 60.24 112.114 -178.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 187' ' ' SER . . . . . . . . . . . . . 47.3 t -145.46 145.27 31.03 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.201 1.0 . . . . 62.14 109.508 -177.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 188' ' ' ARG . . . . . 0.448 ' HB2' ' HG2' ' C' ' 124' ' ' PRO . 0.0 OUTLIER -128.64 146.91 50.73 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.8 0.44 . . . . 72.32 111.731 -173.271 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 189' ' ' LYS . . . . . 0.73 ' HD2' ' HA ' ' B' ' 178' ' ' PRO . 10.2 tmtt? -163.98 96.85 0.82 Allowed 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 107.432 -1.322 . . . . 72.52 107.432 171.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 190' ' ' CYS . . . . . . . . . . . . . 27.7 p -94.93 -179.75 4.95 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 123.687 0.795 . . . . 70.33 109.159 173.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 48.3 p90 -125.53 153.67 43.27 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 120.77 0.319 . . . . 74.04 110.596 175.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -167.11 77.53 0.12 Allowed Glycine 0 C--N 1.338 0.683 0 N-CA-C 110.615 -0.994 . . . . 64.22 110.615 178.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 193' ' ' PRO . . . . . 0.445 ' HG3' ' HB3' ' B' ' 174' ' ' GLN . 92.0 Cg_endo -75.44 -7.61 18.9 Favored 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 123.13 2.553 . . . . 73.22 114.131 -170.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 194' ' ' SER . . . . . . . . . . . . . 41.3 t 75.79 -61.33 0.47 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.481 1.513 . . . . 63.44 111.698 -175.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 195' ' ' ALA . . . . . . . . . . . . . . . 67.98 11.49 8.39 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.813 1.245 . . . . 74.32 112.3 -177.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 2.2 t 53.1 8.12 0.1 Allowed 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 127.017 2.127 . . . . 73.32 115.246 177.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 36.9 m 53.77 24.69 4.56 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.576 1.151 . . . . 75.11 112.702 -177.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 198' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 68.35 145.26 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 125.361 1.464 . . . . 65.14 112.063 -173.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -90.89 88.5 7.06 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 107.624 -1.251 . . . . 75.14 107.624 166.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 200' ' ' CYS . . . . . 0.589 ' SG ' HG22 ' B' ' 135' ' ' VAL . 67.1 m -59.73 -43.62 95.6 Favored Pre-proline 0 CA--C 1.565 1.54 0 N-CA-C 115.032 1.493 . . . . 73.31 115.032 -168.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 201' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -76.64 64.49 7.45 Favored 'Trans proline' 0 C--N 1.397 3.089 0 CA-C-N 121.589 1.603 . . . . 74.02 111.758 173.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . -126.7 143.42 14.32 Favored Glycine 0 C--N 1.346 1.136 0 CA-C-N 115.507 -0.77 . . . . 73.41 112.012 -177.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 66.06 -78.72 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 125.651 1.58 . . . . 71.33 111.882 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -139.86 158.21 44.46 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.88 0.872 . . . . 74.01 110.212 -177.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 205' ' ' LEU . . . . . 0.544 HD11 ' HB2' ' B' ' 136' ' ' LYS . 21.1 tp -161.11 -63.84 0.06 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.224 0.61 . . . . 72.44 109.789 -177.262 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -111.34 -56.35 2.39 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.503 -0.925 . . . . 70.3 108.503 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 207' ' ' LYS . . . . . 0.44 ' HD3' ' N ' ' B' ' 208' ' ' GLY . 1.1 tmtp? -78.4 139.81 38.74 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 108.432 -0.951 . . . . 74.32 108.432 175.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 208' ' ' GLY . . . . . 0.44 ' N ' ' HD3' ' B' ' 207' ' ' LYS . . . 174.68 -99.19 0.13 Allowed Glycine 0 C--N 1.343 0.932 0 N-CA-C 111.748 -0.541 . . . . 71.52 111.748 173.135 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 124.05 33.72 0.77 Allowed Glycine 0 C--N 1.343 0.959 0 N-CA-C 111.17 -0.772 . . . . 63.34 111.17 -173.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 210' ' ' LYS . . . . . 0.452 ' O ' ' HG3' ' B' ' 159' ' ' LYS . 0.0 OUTLIER -149.9 45.17 0.92 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.889 0.876 . . . . 74.51 109.763 -179.574 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . -78.58 -89.96 0.39 Allowed Glycine 0 C--N 1.343 0.972 0 N-CA-C 110.793 -0.923 . . . . 74.43 110.793 175.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 13.3 p 41.31 -86.26 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.22 0 C-N-CA 126.536 1.934 . . . . 74.04 115.589 172.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 50.9 mt 59.19 87.85 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 125.148 1.379 . . . . 70.12 108.947 -163.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 214' ' ' THR . . . . . 0.635 ' HB ' ' HB2' ' B' ' 158' ' ' ALA . 88.0 m -141.49 -56.86 0.48 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.833 0.853 . . . . 75.43 109.022 -174.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 215' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 71.32 -65.58 0.34 Allowed 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 125.744 1.617 . . . . 73.31 110.922 -173.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.4 136.69 43.5 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.463 1.105 . . . . 61.42 109.126 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 3.3 pp -117.94 152.29 35.74 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.813 0.445 . . . . 75.4 110.635 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . 0.489 ' H ' HD21 ' B' ' 218' ' ' LEU . 2.2 pt? -124.14 22.59 8.65 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.986 0.914 . . . . 71.43 109.684 -177.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -72.78 -10.48 59.84 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 124.551 1.141 . . . . 71.24 112.378 -175.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -65.29 -35.06 79.87 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.258 0.623 . . . . 74.3 110.112 171.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 221' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 71.49 -60.84 0.5 Allowed 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 126.573 1.949 . . . . 73.55 111.462 176.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -53.7 -32.55 52.27 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.37 0.668 . . . . 75.21 110.732 168.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -114.44 138.74 50.2 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 108.507 -0.923 . . . . 72.13 108.507 165.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 3.2 p -134.69 134.19 54.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 124.097 0.959 . . . . 75.32 108.757 -176.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 35.7 p -92.19 -166.41 1.54 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.062 0.545 . . . . 73.55 110.396 175.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 76.87 -48.6 0.54 Allowed 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 126.028 1.731 . . . . 74.43 111.502 -176.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . 83.12 5.09 89.46 Favored Glycine 0 C--N 1.346 1.099 0 CA-C-N 116.423 -0.353 . . . . 71.24 113.115 179.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 87.89 -24.23 11.48 Favored Glycine 0 C--N 1.355 1.59 0 CA-C-O 119.552 -0.582 . . . . 72.41 113.866 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -71.25 -61.25 4.02 Favored Glycine 0 C--N 1.356 1.654 0 CA-C-N 117.367 0.584 . . . . 71.04 111.835 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -73.01 103.11 3.68 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.157 0.583 . . . . 70.23 110.24 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 231' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -123.59 132.89 54.0 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.142 0.977 . . . . 73.24 109.285 177.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 30.2 p -74.04 104.13 4.76 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.487 0.715 . . . . 74.24 109.616 176.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -71.97 160.02 33.24 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 109.84 -0.43 . . . . 71.44 109.84 174.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -69.44 165.76 20.19 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.151 0.58 . . . . 72.31 110.845 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -58.78 118.48 5.76 Favored 'General case' 0 N--CA 1.48 1.066 0 O-C-N 123.499 0.5 . . . . 64.41 109.908 178.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 236' ' ' THR . . . . . 0.529 HG23 ' HG2' ' B' ' 45' ' ' ARG . 98.5 m -61.83 116.14 4.59 Favored 'General case' 0 C--O 1.242 0.694 0 O-C-N 124.433 1.083 . . . . 73.34 109.989 177.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -63.8 94.17 0.09 Allowed 'General case' 0 C--N 1.348 0.527 0 O-C-N 124.076 0.86 . . . . 73.03 108.946 173.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 33.0 m -71.02 -25.02 62.49 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.047 -0.979 . . . . 71.31 110.016 175.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 239' ' ' ALA . . . . . 0.416 ' HA ' HD21 ' C' ' 235' ' ' LEU . . . -68.96 137.96 54.18 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 114.671 -1.15 . . . . 74.42 111.16 172.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . -70.34 -101.57 0.04 OUTLIER Glycine 0 C--N 1.355 1.586 0 N-CA-C 110.923 -0.871 . . . . 71.23 110.923 172.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 241' ' ' GLU . . . . . 0.467 ' HB3' ' HG3' ' B' ' 245' ' ' LYS . 24.0 pt-20 -175.31 171.58 2.87 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.847 0.859 . . . . 71.23 111.462 169.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -98.27 -66.11 0.92 Allowed 'General case' 0 C--O 1.237 0.408 0 N-CA-C 107.094 -1.447 . . . . 70.32 107.094 -175.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 243' ' ' GLN . . . . . 0.674 ' HG2' HH22 ' B' ' 373' ' ' ARG . 44.9 mt-30 -141.72 19.49 2.17 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 112.586 -2.097 . . . . 74.22 106.974 -175.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 114.41 164.88 15.09 Favored Glycine 0 CA--C 1.535 1.341 0 N-CA-C 109.75 -1.34 . . . . 71.54 109.75 -156.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 245' ' ' LYS . . . . . 0.467 ' HG3' ' HB3' ' B' ' 241' ' ' GLU . 0.2 OUTLIER -150.05 164.64 35.03 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.727 0.811 . . . . 75.34 111.019 177.223 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 34.0 m -138.8 134.99 34.15 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.488 0.715 . . . . 71.14 110.397 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 247' ' ' LEU . . . . . . . . . . . . . 95.9 mt -118.29 109.61 16.53 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.313 1.045 . . . . 72.51 108.885 175.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 248' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -129.57 140.73 51.13 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.813 0.845 . . . . 75.15 109.328 177.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -67.3 135.02 52.67 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.993 0.917 . . . . 71.33 110.544 178.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 250' ' ' GLN . . . . . 0.437 ' HB3' ' HA ' ' A' ' 274' ' ' GLU . 8.8 mp0 -102.17 -77.8 0.55 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.606 0.762 . . . . 70.14 110.207 -172.029 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 251' ' ' ALA . . . . . . . . . . . . . . . -84.54 4.86 30.06 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.425 0.69 . . . . 64.21 112.421 -172.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . 0.591 HE21 ' HB2' ' B' ' 349' ' ' ASP . 1.7 mp0 -72.21 145.28 48.1 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.485 1.114 . . . . 73.12 111.805 -171.173 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . 67.85 -75.76 0.06 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.843 1.657 . . . . 51.41 111.833 -177.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -137.08 6.14 2.83 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.263 0.625 . . . . 72.51 111.098 -176.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -67.84 -23.43 74.18 Favored Glycine 0 C--N 1.355 1.621 0 O-C-N 122.389 -0.194 . . . . 63.32 112.644 178.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 256' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -64.16 -40.59 96.46 Favored 'General case' 0 C--N 1.357 0.917 0 C-N-CA 123.264 0.626 . . . . 71.2 110.442 172.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 257' ' ' GLN . . . . . 0.586 ' HB2' HG21 ' B' ' 325' ' ' THR . 12.5 pt20 41.95 103.57 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 126.549 1.94 . . . . 74.31 113.289 -177.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 258' ' ' LEU . . . . . . . . . . . . . 86.6 mt -33.38 112.92 0.14 Allowed 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 126.192 1.797 . . . . 75.13 113.922 -169.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 9.0 p -133.87 158.91 42.6 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 124.041 0.937 . . . . 63.31 109.925 -174.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 260' ' ' SER . . . . . . . . . . . . . 22.5 p -95.68 16.7 16.63 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.552 0.741 . . . . 73.11 110.351 174.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 261' ' ' ASP . . . . . 0.454 ' HB3' ' HG ' ' B' ' 264' ' ' SER . 27.5 t70 62.5 178.3 0.14 Allowed 'General case' 0 C--N 1.37 1.492 0 C-N-CA 124.846 1.258 . . . . 65.51 110.391 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 262' ' ' ALA . . . . . . . . . . . . . . . -60.47 -39.15 86.59 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.959 0.504 . . . . 75.22 110.795 171.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -143.13 -51.93 0.36 Allowed 'General case' 0 C--N 1.349 0.545 0 C-N-CA 123.125 0.57 . . . . 70.44 111.878 -176.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 264' ' ' SER . . . . . 0.454 ' HG ' ' HB3' ' B' ' 261' ' ' ASP . 66.1 m 72.21 -57.36 0.62 Allowed 'General case' 0 N--CA 1.504 2.259 0 C-N-CA 125.595 1.558 . . . . 51.14 111.669 -172.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 265' ' ' LEU . . . . . . . . . . . . . 19.7 tp -58.97 -17.25 23.05 Favored 'General case' 0 CA--C 1.56 1.331 0 C-N-CA 125.762 1.625 . . . . 73.31 112.258 178.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 266' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -79.5 79.61 5.95 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.734 0.814 . . . . 71.52 109.554 175.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 33.5 p -167.03 178.66 5.61 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.053 0.941 . . . . 73.13 110.369 -178.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 57.7 t -66.15 -70.07 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 124.009 0.923 . . . . 74.44 111.553 -173.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 269' ' ' THR . . . . . . . . . . . . . 6.9 m -73.28 -24.28 60.41 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.167 0.587 . . . . 74.31 110.011 178.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 270' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 57.53 16.39 3.29 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 126.547 1.939 . . . . 72.41 114.352 173.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 271' ' ' ALA . . . . . . . . . . . . . . . -65.5 -50.22 66.08 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.788 0.835 . . . . 75.3 111.121 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 272' ' ' ASN . . . . . 0.596 HD22 ' HB ' ' B' ' 343' ' ' VAL . 22.3 p-10 -156.38 -52.37 0.08 Allowed 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 111.969 0.359 . . . . 73.11 111.969 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -157.42 76.97 0.84 Allowed 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 121.657 0.741 . . . . 73.43 110.032 -170.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -114.5 18.45 16.78 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.946 0.898 . . . . 71.44 109.266 173.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 275' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -68.18 150.5 97.71 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 123.73 0.812 . . . . 72.14 111.805 -175.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -81.15 58.27 6.89 Favored 'Trans proline' 0 C--N 1.372 1.783 0 C-N-CA 123.054 2.502 . . . . 73.04 109.737 163.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 277' ' ' LEU . . . . . 0.533 HD22 ' HA ' ' A' ' 279' ' ' ARG . 22.9 tp -83.0 159.15 22.26 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.421 1.089 . . . . 74.52 109.668 -174.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 70.28 86.97 0.12 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.495 1.518 . . . . 72.2 109.105 -173.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . -159.13 -172.57 26.41 Favored Glycine 0 C--N 1.347 1.171 0 CA-C-N 115.86 -0.609 . . . . 75.43 113.348 -178.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 280' ' ' LEU . . . . . 0.473 HD11 ' HB3' ' C' ' 198' ' ' ASP . 17.1 tp -97.17 136.52 37.57 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 108.999 -0.741 . . . . 74.31 108.999 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -80.19 -60.39 2.35 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.491 0.716 . . . . 75.31 112.166 -165.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -73.25 -35.58 66.25 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 109.55 -0.537 . . . . 65.41 109.55 174.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 283' ' ' ASP . . . . . 0.408 ' HA ' HD21 ' B' ' 280' ' ' LEU . 6.1 t0 70.2 -71.62 0.12 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 126.064 1.746 . . . . 72.33 112.209 169.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . -81.51 39.98 2.56 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 123.489 0.566 . . . . 72.13 112.971 177.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -79.28 85.93 5.08 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 107.484 -1.302 . . . . 73.03 107.484 173.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 286' ' ' MET . . . . . 0.503 ' H ' ' HD2' ' B' ' 287' ' ' PRO . 47.6 mtm -131.6 -53.97 0.03 OUTLIER Pre-proline 0 CA--C 1.561 1.394 0 CA-C-N 115.395 -0.821 . . . . 74.22 112.261 -168.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 287' ' ' PRO . . . . . 0.524 ' HB3' ' HG2' ' C' ' 184' ' ' PRO . 62.8 Cg_endo -70.04 161.22 46.8 Favored 'Trans proline' 0 C--N 1.403 3.425 0 C-N-CA 121.778 1.652 . . . . 74.24 112.75 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 288' ' ' VAL . . . . . . . . . . . . . 4.9 p -76.33 81.66 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.301 0 CA-C-O 123.01 1.386 . . . . 74.32 109.89 177.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 289' ' ' ARG . . . . . 0.447 ' NE ' ' H ' ' B' ' 290' ' ' TRP . 1.2 tpm_? -151.47 174.32 13.53 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 113.959 -1.473 . . . . 74.32 107.207 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 290' ' ' TRP . . . . . 0.474 ' HB3' ' HA3' ' A' ' 230' ' ' GLY . 5.2 m-90 79.94 -5.01 1.89 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.764 1.225 . . . . 75.34 112.39 171.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 291' ' ' LEU . . . . . . . . . . . . . 5.2 mp -123.4 95.76 4.72 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 107.993 -1.114 . . . . 73.52 107.993 172.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . -53.63 -60.48 8.23 Favored Glycine 0 CA--C 1.539 1.54 0 O-C-N 123.879 0.737 . . . . 71.42 114.755 179.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 293' ' ' PRO . . . . . 0.538 ' HD3' HG21 ' A' ' 196' ' ' THR . 43.6 Cg_endo -86.76 32.91 0.44 Allowed 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 123.13 2.553 . . . . 75.13 113.087 -177.068 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 30.0 tttm 64.42 -85.88 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.69 1.196 . . . . 74.44 111.122 -177.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . 176.03 42.79 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.299 1.04 . . . . 71.35 108.666 -169.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 2.9 t 51.49 -169.82 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 125.718 1.607 . . . . 71.52 111.828 -172.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -128.43 91.34 3.22 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 108.087 -1.079 . . . . 75.44 108.087 170.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -87.24 -24.29 24.44 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.086 -0.961 . . . . 73.43 110.997 -176.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . 100.26 -11.9 60.16 Favored Glycine 0 C--N 1.345 1.057 0 O-C-N 123.466 0.479 . . . . 72.35 112.548 -173.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 300' ' ' ASN . . . . . 0.521 ' HB2' ' HB2' ' B' ' 374' ' ' ALA . 3.7 p-10 -165.1 26.79 0.06 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.843 0.857 . . . . 72.23 110.315 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 301' ' ' ILE . . . . . 0.694 HG12 ' HZ2' ' C' ' 232' ' ' LYS . 0.3 OUTLIER 49.44 -78.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 C-N-CA 127.099 2.16 . . . . 75.13 113.277 -174.73 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -62.04 158.12 17.27 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 125.51 1.524 . . . . 74.32 111.99 -171.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 303' ' ' LYS . . . . . 0.507 ' N ' ' HD3' ' B' ' 304' ' ' PRO . 8.2 tmtt? 66.39 57.67 1.01 Allowed Pre-proline 0 CA--C 1.567 1.623 0 C-N-CA 125.967 1.707 . . . . 74.11 111.386 -169.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 304' ' ' PRO . . . . . 0.507 ' HD3' ' N ' ' B' ' 303' ' ' LYS . 1.7 Cg_endo -87.38 95.58 0.46 Allowed 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 123.119 2.546 . . . . 75.12 110.518 169.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . 73.7 -68.92 0.2 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.803 1.641 . . . . 72.13 110.265 -177.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . 0.445 HG21 ' HA ' ' B' ' 303' ' ' LYS . 62.5 t 64.38 90.77 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 125.281 1.432 . . . . 72.33 111.789 176.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 307' ' ' THR . . . . . 0.69 HG22 ' HB2' ' C' ' 226' ' ' ARG . 39.3 p 68.3 -24.3 0.13 Allowed 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 126.535 1.934 . . . . 74.23 114.105 177.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 308' ' ' CYS . . . . . . . . . . . . . 59.3 m 56.93 -74.8 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 124.903 1.281 . . . . 74.22 110.256 -170.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 54.6 p -84.64 118.38 70.91 Favored Pre-proline 0 CA--C 1.55 0.978 0 N-CA-C 107.799 -1.186 . . . . 72.2 107.799 163.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -59.49 152.94 58.03 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 122.625 2.216 . . . . 64.44 112.137 -177.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 311' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -58.65 109.59 1.97 Allowed Pre-proline 0 N--CA 1.479 1.004 0 C-N-CA 123.855 0.862 . . . . 73.13 110.75 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 312' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -85.46 -17.01 4.53 Favored 'Trans proline' 0 C--N 1.373 1.818 0 C-N-CA 121.867 1.712 . . . . 70.14 112.706 176.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 313' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 53.34 167.34 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 C-N-CA 127.127 2.171 . . . . 75.13 114.278 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 314' ' ' ARG . . . . . 0.576 ' NH1' ' HA ' ' B' ' 316' ' ' ASP . 0.0 OUTLIER -167.19 150.4 6.4 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.285 0.634 . . . . 74.53 110.609 178.805 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 315' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -86.26 144.06 27.61 Favored 'General case' 0 C--O 1.245 0.845 0 N-CA-C 107.953 -1.129 . . . . 75.34 107.953 170.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 316' ' ' ASP . . . . . 0.576 ' HA ' ' NH1' ' B' ' 314' ' ' ARG . 10.7 m-20 -86.99 68.28 10.02 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 122.975 0.51 . . . . 74.4 110.955 -172.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 24.8 m 54.19 -82.89 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 125.778 1.631 . . . . 75.41 112.414 -178.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 318' ' ' VAL . . . . . . . . . . . . . 7.4 m -101.6 106.62 47.37 Favored Pre-proline 0 CA--C 1.558 1.258 0 C-N-CA 124.411 1.084 . . . . 73.13 110.402 -176.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 319' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.58 94.77 0.85 Allowed 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 122.736 2.291 . . . . 65.1 111.501 176.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 320' ' ' THR . . . . . . . . . . . . . 26.1 m 65.44 86.8 0.12 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.672 1.189 . . . . 73.24 110.683 -179.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 321' ' ' LEU . . . . . . . . . . . . . 45.0 tp -101.85 -23.82 14.12 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.919 0.887 . . . . 74.43 110.166 176.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 322' ' ' ALA . . . . . . . . . . . . . . . 67.19 -169.74 0.2 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.783 1.233 . . . . 64.54 110.986 -173.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 323' ' ' GLN . . . . . 0.516 ' HG2' ' H ' ' B' ' 324' ' ' MET . 26.1 tt0 66.07 -170.46 0.19 Allowed 'General case' 0 CA--C 1.57 1.745 0 C-N-CA 124.461 1.104 . . . . 74.02 110.253 178.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 324' ' ' MET . . . . . 0.516 ' H ' ' HG2' ' B' ' 323' ' ' GLN . 50.3 ttm 79.59 -56.35 0.4 Allowed 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 125.44 1.496 . . . . 74.22 112.113 174.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 325' ' ' THR . . . . . 0.586 HG21 ' HB2' ' B' ' 257' ' ' GLN . 47.3 p -80.7 70.55 7.48 Favored 'General case' 0 CA--C 1.553 1.078 0 CA-C-O 121.718 0.771 . . . . 72.33 110.463 178.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 326' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -75.73 -63.64 1.25 Allowed 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.246 1.018 . . . . 72.01 110.187 -178.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 39.51 40.33 0.59 Allowed 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 126.31 1.844 . . . . 75.41 113.796 -178.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 328' ' ' ALA . . . . . . . . . . . . . . . -64.16 -51.31 64.43 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.166 0.587 . . . . 72.03 111.097 -178.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 329' ' ' ILE . . . . . . . . . . . . . 33.4 pt -137.24 -175.54 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 123.797 0.839 . . . . 73.5 111.03 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 330' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' B' ' 331' ' ' LEU . 8.0 tp10 64.8 99.56 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 125.736 1.615 . . . . 74.44 113.331 176.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 331' ' ' LEU . . . . . 0.458 ' HG ' ' H ' ' B' ' 332' ' ' LEU . 13.3 tp 175.2 -145.22 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 125.52 1.528 . . . . 64.42 107.344 168.21 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 332' ' ' LEU . . . . . 0.458 ' H ' ' HG ' ' B' ' 331' ' ' LEU . 7.1 mp -80.81 -176.1 5.67 Favored 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 124.117 0.967 . . . . 74.41 109.87 170.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 333' ' ' SER . . . . . . . . . . . . . 41.7 t -61.58 -30.17 70.5 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.312 1.045 . . . . 65.04 112.225 -177.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -79.78 4.84 15.17 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.479 0.712 . . . . 65.35 112.667 -176.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 335' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -116.94 -170.47 1.84 Allowed 'General case' 0 CA--C 1.553 1.07 0 N-CA-C 107.371 -1.344 . . . . 74.12 107.371 167.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 77.47 -3.33 2.45 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 125.01 1.324 . . . . 73.55 112.62 168.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 337' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -75.52 -8.26 56.3 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.573 0.749 . . . . 71.1 109.966 162.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 338' ' ' GLY . . . . . . . . . . . . . . . 107.83 -146.66 16.33 Favored Glycine 0 C--N 1.353 1.507 0 N-CA-C 111.282 -0.727 . . . . 73.12 111.282 -179.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 339' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -114.89 158.1 22.43 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.049 1.34 . . . . 74.33 108.804 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 340' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -79.42 85.66 5.2 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 121.22 0.533 . . . . 75.24 110.858 -172.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 341' ' ' LEU . . . . . . . . . . . . . 51.3 mt -128.92 5.48 5.43 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.17 0.988 . . . . 75.34 110.03 169.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 342' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -92.33 106.6 18.57 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 107.774 -1.195 . . . . 74.32 107.774 176.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 343' ' ' VAL . . . . . 0.596 ' HB ' HD22 ' B' ' 272' ' ' ASN . 39.2 t 53.65 84.37 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 C-N-CA 124.686 1.195 . . . . 65.15 109.363 -167.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 344' ' ' GLU . . . . . 0.627 ' HG2' ' H ' ' B' ' 345' ' ' GLY . 0.1 OUTLIER -94.86 -103.8 0.15 Allowed 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 123.926 0.89 . . . . 74.33 110.912 -166.703 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 345' ' ' GLY . . . . . 0.627 ' H ' ' HG2' ' B' ' 344' ' ' GLU . . . 79.52 -61.75 4.19 Favored Glycine 0 C--N 1.357 1.695 0 CA-C-N 119.601 1.091 . . . . 63.14 112.905 -177.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 346' ' ' ALA . . . . . . . . . . . . . . . -67.65 92.74 0.34 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.244 1.018 . . . . 72.51 110.643 178.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 32.3 t -170.94 -49.45 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.936 1.294 . . . . 72.21 108.996 178.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 30.7 mm -94.85 -58.39 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 123.158 0.583 . . . . 73.42 109.683 -175.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 349' ' ' ASP . . . . . 0.591 ' HB2' HE21 ' B' ' 252' ' ' GLN . 11.1 m-20 48.0 74.92 0.15 Allowed 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 125.5 1.52 . . . . 71.13 113.367 171.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 350' ' ' LYS . . . . . 0.53 ' HA ' ' HB3' ' B' ' 145' ' ' ASP . 28.3 ttpt 75.59 -61.91 0.46 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 125.563 1.545 . . . . 74.52 111.132 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 351' ' ' GLN . . . . . 0.487 HE21 ' HA ' ' B' ' 351' ' ' GLN . 0.0 OUTLIER 67.26 -171.48 0.19 Allowed 'General case' 0 CA--C 1.561 1.376 0 C-N-CA 123.689 0.795 . . . . 71.32 109.305 -178.733 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 352' ' ' ASP . . . . . 0.46 ' N ' ' HG3' ' B' ' 351' ' ' GLN . 4.5 m-20 -73.37 43.79 0.14 Allowed 'General case' 0 CA--C 1.562 1.408 0 C-N-CA 124.344 1.058 . . . . 74.35 110.926 166.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 353' ' ' HIS . . . . . . . . . . . . . 19.8 t-80 -141.26 92.79 2.51 Favored 'General case' 0 C--N 1.355 0.834 0 C-N-CA 125.294 1.438 . . . . 74.33 108.567 -171.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 354' ' ' ALA . . . . . . . . . . . . . . . -170.36 -67.82 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.925 0.89 . . . . 72.23 109.404 -178.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 355' ' ' ALA . . . . . 0.417 ' HB2' ' HD2' ' B' ' 357' ' ' PRO . . . -170.76 169.6 6.92 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.293 1.037 . . . . 75.44 109.641 -178.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 356' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -83.24 -49.37 0.73 Allowed Pre-proline 0 CA--C 1.56 1.346 0 CA-C-O 118.162 -0.923 . . . . 74.32 112.336 177.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 357' ' ' PRO . . . . . 0.417 ' HD2' ' HB2' ' B' ' 355' ' ' ALA . 74.0 Cg_endo -72.05 93.49 0.72 Allowed 'Trans proline' 0 C--N 1.404 3.477 0 C-N-CA 121.709 1.606 . . . . 74.21 112.993 -172.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 358' ' ' CYS . . . . . . . . . . . . . 57.7 m -74.54 -50.64 17.29 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 107.82 -1.178 . . . . 75.21 107.82 168.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 359' ' ' GLY . . . . . . . . . . . . . . . -107.59 87.38 0.49 Allowed Glycine 0 C--N 1.345 1.054 0 N-CA-C 109.817 -1.313 . . . . 72.04 109.817 171.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 360' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 -50.85 132.91 26.93 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.318 1.047 . . . . 53.34 110.599 175.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 361' ' ' ILE . . . . . 0.441 HG22 ' H ' ' B' ' 363' ' ' GLU . 71.2 mt 74.39 -59.79 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 C-N-CA 125.657 1.583 . . . . 64.41 110.35 -172.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 362' ' ' GLY . . . . . . . . . . . . . . . 82.81 -12.15 49.75 Favored Glycine 0 C--N 1.348 1.238 0 C-N-CA 122.788 0.232 . . . . 72.35 113.668 175.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 363' ' ' GLU . . . . . 0.441 ' H ' HG22 ' B' ' 361' ' ' ILE . 36.9 mt-10 -101.43 8.43 42.15 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.26 1.024 . . . . 73.13 110.207 176.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 364' ' ' THR . . . . . . . . . . . . . 24.1 p -83.68 60.32 5.66 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.207 1.003 . . . . 74.04 109.978 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 35.8 m -89.24 156.41 3.07 Favored 'Isoleucine or valine' 0 C--O 1.245 0.838 0 CA-C-N 114.625 -1.17 . . . . 74.51 110.073 -178.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -80.75 85.09 6.15 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 109.172 -0.677 . . . . 52.52 109.172 177.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 367' ' ' LEU . . . . . . . . . . . . . 56.9 mt 62.51 -166.34 0.22 Allowed 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 124.511 1.125 . . . . 75.05 111.236 177.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 368' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -70.93 -47.23 60.18 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.782 -0.822 . . . . 73.23 108.782 172.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 369' ' ' GLU . . . . . 0.589 ' HG2' ' H ' ' B' ' 371' ' ' VAL . 0.0 OUTLIER -170.79 -33.54 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 114.34 -1.3 . . . . 74.11 109.282 170.218 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 370' ' ' ALA . . . . . 0.463 ' HB1' HE21 ' B' ' 372' ' ' GLN . . . 56.77 31.36 19.32 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 125.022 1.329 . . . . 74.25 111.56 -175.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 371' ' ' VAL . . . . . 0.589 ' H ' ' HG2' ' B' ' 369' ' ' GLU . 4.6 t 53.39 38.16 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.786 0 C-N-CA 124.839 1.255 . . . . 74.12 110.907 -175.173 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 372' ' ' GLN . . . . . 0.463 HE21 ' HB1' ' B' ' 370' ' ' ALA . 43.4 mt-30 -102.74 100.23 10.24 Favored 'General case' 0 N--CA 1.483 1.217 0 O-C-N 121.181 -0.95 . . . . 63.2 110.402 178.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 373' ' ' ARG . . . . . 0.674 HH22 ' HG2' ' B' ' 243' ' ' GLN . 0.2 OUTLIER -157.75 -82.17 0.06 Allowed 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 109.133 -0.691 . . . . 72.2 109.133 171.758 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 374' ' ' ALA . . . . . 0.521 ' HB2' ' HB2' ' B' ' 300' ' ' ASN . . . 170.39 179.4 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 125.606 1.562 . . . . 71.45 108.693 -171.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 375' ' ' LEU . . . . . 0.552 ' HA ' ' HB3' ' B' ' 32' ' ' ARG . 79.9 mt -68.78 -175.38 0.69 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 122.565 0.346 . . . . 72.22 111.236 170.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -60.88 97.02 0.05 Allowed 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 121.446 0.641 . . . . 73.13 110.74 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 377' ' ' PHE . . . . . 0.401 ' HB2' ' HB3' ' B' ' 303' ' ' LYS . 42.0 p90 -79.69 7.09 9.12 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.462 1.105 . . . . 73.31 112.515 -177.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 378' ' ' ALA . . . . . . . . . . . . . . . -77.57 23.28 0.23 Allowed 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 124.243 1.017 . . . . 73.45 112.056 178.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -99.57 164.12 12.21 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 124.775 1.23 . . . . 73.22 109.401 177.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 380' ' ' LYS . . . . . 0.4 ' NZ ' HD11 ' B' ' 385' ' ' LEU . 25.2 tttt -70.31 -88.47 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.097 0 O-C-N 123.76 0.662 . . . . 72.4 110.416 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 381' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 179.37 -75.88 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 106.593 -1.632 . . . . 74.34 106.593 -166.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 382' ' ' GLY . . . . . 0.42 ' HA3' ' HG ' ' B' ' 385' ' ' LEU . . . -99.74 75.22 0.47 Allowed Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 108.679 -1.768 . . . . 73.1 108.679 172.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 383' ' ' ASN . . . . . . . . . . . . . 49.7 m-20 -64.2 -27.33 68.99 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 113.868 -1.166 . . . . 73.1 111.036 -175.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 384' ' ' THR . . . . . . . . . . . . . 14.7 t -121.9 28.72 7.44 Favored 'General case' 0 CA--C 1.56 1.349 0 C-N-CA 123.574 0.749 . . . . 71.44 111.585 -174.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 385' ' ' LEU . . . . . 0.482 HD13 ' H ' ' B' ' 418' ' ' ALA . 70.3 mt -63.17 135.71 57.31 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 122.4 0.28 . . . . 75.43 111.107 177.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 386' ' ' VAL . . . . . . . . . . . . . 42.3 t 66.04 -75.59 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 125.343 1.457 . . . . 75.23 110.457 -172.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 387' ' ' ILE . . . . . . . . . . . . . 35.9 pt -119.7 162.85 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.365 1.066 . . . . 74.12 109.574 178.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 388' ' ' VAL . . . . . . . . . . . . . 11.8 p -70.9 109.66 3.34 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 CA-C-O 121.602 0.715 . . . . 74.43 109.681 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 389' ' ' THR . . . . . . . . . . . . . 9.1 m -136.18 28.85 3.1 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.121 0.969 . . . . 71.25 109.002 -173.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . -83.82 -91.68 0.08 Allowed 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 115.59 -0.732 . . . . 73.41 111.771 -171.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 391' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 53.94 -88.36 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 125.077 1.351 . . . . 64.12 112.266 -175.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 392' ' ' HIS . . . . . . . . . . . . . 32.0 m-70 -114.51 95.28 5.18 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 107.272 -1.381 . . . . 72.42 107.272 178.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . 65.39 -86.37 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.023 1.329 . . . . 61.53 110.782 -174.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -163.05 127.52 3.0 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 107.058 -1.46 . . . . 73.31 107.058 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . -62.14 98.97 0.12 Allowed 'General case' 0 CA--C 1.542 0.657 0 O-C-N 123.792 0.682 . . . . 75.42 110.196 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 45.7 t -123.84 -49.88 1.85 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.499 1.12 . . . . 75.55 108.833 178.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 397' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 66.31 65.07 0.5 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.999 1.32 . . . . 75.54 110.3 177.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 1.7 mp 77.45 -33.63 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 124.889 1.276 . . . . 75.44 112.874 171.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 399' ' ' VAL . . . . . . . . . . . . . 15.5 m -59.24 -42.29 86.59 Favored 'Isoleucine or valine' 0 C--N 1.36 1.043 0 C-N-CA 122.962 0.505 . . . . 73.32 111.64 -170.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 400' ' ' ALA . . . . . . . . . . . . . . . 55.79 103.53 0.03 OUTLIER Pre-proline 0 N--CA 1.483 1.179 0 C-N-CA 125.09 1.356 . . . . 74.52 112.131 175.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 401' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -49.8 98.44 0.04 OUTLIER 'Trans proline' 0 C--N 1.386 2.516 0 C-N-CA 123.261 2.641 . . . . 71.34 112.969 -178.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -76.06 -62.47 1.59 Allowed 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 114.5 -1.227 . . . . 74.34 109.702 -173.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 403' ' ' THR . . . . . . . . . . . . . 15.1 t -160.45 -155.03 0.41 Allowed 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 124.301 1.04 . . . . 73.2 108.3 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 404' ' ' LYS . . . . . . . . . . . . . 64.7 mttp 76.32 -62.74 0.41 Allowed 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 125.288 1.435 . . . . 71.14 111.74 176.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 405' ' ' ALA . . . . . . . . . . . . . . . -114.41 89.28 17.49 Favored Pre-proline 0 N--CA 1.477 0.902 0 C-N-CA 123.552 0.741 . . . . 71.24 111.003 178.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 406' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -83.33 10.27 3.74 Favored 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 122.566 2.177 . . . . 64.23 112.495 164.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 407' ' ' GLY . . . . . 0.632 ' HA3' ' HA3' ' B' ' 417' ' ' GLY . . . 91.03 -42.77 2.85 Favored Glycine 0 C--N 1.358 1.794 0 C-N-CA 122.954 0.311 . . . . 74.04 113.639 172.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 408' ' ' LEU . . . . . 0.412 ' O ' ' HD2' ' A' ' 211' ' ' ARG . 3.3 pp -68.74 -18.0 64.15 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.486 0.714 . . . . 72.55 111.691 177.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 53.3 m -65.14 140.27 58.77 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.655 1.182 . . . . 73.52 111.771 178.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 410' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -63.96 128.75 37.18 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.923 0.889 . . . . 70.42 109.305 173.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . 74.74 -60.04 0.53 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 125.493 1.517 . . . . 74.33 112.208 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -74.68 88.96 2.23 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 122.084 0.945 . . . . 75.21 109.82 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 27.3 p30 -151.57 -161.53 1.34 Allowed 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 114.108 -1.406 . . . . 71.14 109.663 -174.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 414' ' ' THR . . . . . . . . . . . . . 4.0 m 69.49 165.66 0.27 Allowed 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 124.968 1.307 . . . . 73.24 110.583 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 415' ' ' LYS . . . . . 0.485 ' HZ1' ' HB2' ' B' ' 415' ' ' LYS . 0.1 OUTLIER 77.77 -46.59 0.46 Allowed 'General case' 0 N--CA 1.505 2.307 0 C-N-CA 125.748 1.619 . . . . 75.21 111.561 -178.823 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -160.12 -170.69 2.93 Favored 'General case' 0 CA--C 1.557 1.239 0 N-CA-C 107.707 -1.22 . . . . 75.33 107.707 -179.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 417' ' ' GLY . . . . . 0.632 ' HA3' ' HA3' ' B' ' 407' ' ' GLY . . . 104.18 52.31 0.89 Allowed Glycine 0 N--CA 1.468 0.823 0 C-N-CA 122.715 0.198 . . . . 62.31 112.877 174.327 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 418' ' ' ALA . . . . . 0.482 ' H ' HD13 ' B' ' 385' ' ' LEU . . . 60.6 -88.7 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.171 1.388 . . . . 70.25 111.997 178.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 419' ' ' VAL . . . . . 0.402 HG12 ' HB2' ' B' ' 423' ' ' SER . 31.5 m -136.72 -17.26 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 C-N-CA 123.868 0.867 . . . . 73.31 110.806 -176.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 420' ' ' MET . . . . . 0.521 ' HE1' ' ND2' ' B' ' 426' ' ' ASN . 23.4 mtp 69.02 -67.64 0.21 Allowed 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 125.525 1.53 . . . . 73.34 111.178 -173.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 421' ' ' VAL . . . . . 0.532 HG22 ' HG2' ' B' ' 422' ' ' MET . 1.4 p -147.83 -53.89 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 125.731 1.612 . . . . 72.42 107.527 175.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 422' ' ' MET . . . . . 0.532 ' HG2' HG22 ' B' ' 421' ' ' VAL . 25.6 mmt -132.34 129.65 39.74 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 106.997 -1.482 . . . . 74.1 106.997 176.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 423' ' ' SER . . . . . 0.402 ' HB2' HG12 ' B' ' 419' ' ' VAL . 13.6 t -85.88 46.95 1.37 Allowed 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 123.583 0.753 . . . . 63.45 110.923 -178.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 424' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -157.42 101.26 1.86 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.205 1.002 . . . . 74.22 108.828 -178.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . 55.03 39.42 69.15 Favored Glycine 0 C--N 1.354 1.537 0 O-C-N 124.113 0.883 . . . . 75.12 113.982 175.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 426' ' ' ASN . . . . . 0.521 ' ND2' ' HE1' ' B' ' 420' ' ' MET . 10.3 m120 69.46 -73.44 0.09 Allowed 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 125.137 1.375 . . . . 75.43 111.015 -178.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 427' ' ' SER . . . . . 0.497 ' HB2' ' HB2' ' B' ' 422' ' ' MET . 40.3 m 57.6 30.79 19.36 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 125.12 1.368 . . . . 75.14 111.669 -177.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 428' ' ' GLU . . . . . 0.416 ' HA ' HG12 ' B' ' 421' ' ' VAL . 8.6 pt-20 -78.48 79.99 4.89 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.283 1.033 . . . . 73.23 109.848 179.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 429' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -58.44 136.54 57.5 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 114.324 -1.307 . . . . 63.42 111.789 -176.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 18.9 t70 63.32 -82.37 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.87 1.268 . . . . 62.42 112.005 175.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 18.8 t -161.37 19.91 0.12 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.174 0.59 . . . . 75.05 110.535 -175.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 432' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 42.42 47.16 4.25 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 125.757 1.623 . . . . 71.1 112.739 -178.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 433' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -53.08 141.87 21.6 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.555 1.142 . . . . 73.43 113.498 -170.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 434' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -82.38 52.17 1.99 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.48 1.112 . . . . 73.42 109.88 177.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 435' ' ' THR . . . . . . . . . . . . . 15.3 t -88.59 -166.23 1.54 Allowed 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 123.701 0.8 . . . . 73.42 110.259 -170.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . 92.27 11.27 59.97 Favored Glycine 0 C--N 1.347 1.169 0 CA-C-O 119.75 -0.472 . . . . 61.51 112.977 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 49.5 m 58.57 30.75 20.24 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.255 1.022 . . . . 72.35 111.029 -178.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 438' ' ' GLN . . . . . 0.535 ' HA ' ' HG3' ' A' ' 220' ' ' GLU . 2.0 pt20 58.41 9.29 1.02 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 126.887 2.075 . . . . 71.55 113.741 -175.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 439' ' ' LEU . . . . . 0.424 HD12 ' HD2' ' A' ' 238' ' ' LYS . 4.0 mm? 60.12 -78.52 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 125.021 1.328 . . . . 74.24 111.714 -175.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 440' ' ' ARG . . . . . 0.54 ' HA ' ' HB3' ' A' ' 222' ' ' ALA . 27.2 tpt180 59.25 95.86 0.03 OUTLIER 'General case' 0 C--N 1.355 0.836 0 C-N-CA 125.457 1.503 . . . . 74.1 108.839 -168.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 441' ' ' ILE . . . . . 0.7 ' HB ' ' HB3' ' A' ' 235' ' ' LEU . 6.1 pt -75.24 -41.29 43.96 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 N-CA-C 114.422 1.268 . . . . 74.15 114.422 -151.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 442' ' ' ALA . . . . . . . . . . . . . . . 56.1 82.29 0.11 Allowed 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 124.441 1.096 . . . . 73.33 112.075 -168.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . -130.66 -57.68 1.05 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.317 1.047 . . . . 74.21 108.375 173.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -81.55 78.37 8.31 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 114.829 -1.078 . . . . 71.31 108.639 169.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 445' ' ' GLY . . . . . 0.402 ' O ' ' HE3' ' B' ' 465' ' ' LYS . . . -61.18 -55.84 27.12 Favored Glycine 0 C--N 1.349 1.268 0 CA-C-N 114.559 -1.2 . . . . 74.34 112.271 172.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 446' ' ' PRO . . . . . 0.607 ' HG2' ' HB2' ' B' ' 471' ' ' LYS . 39.4 Cg_exo -60.25 145.34 98.77 Favored 'Trans proline' 0 C--N 1.381 2.251 0 C-N-CA 122.373 2.049 . . . . 72.44 112.276 175.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 447' ' ' HIS . . . . . . . . . . . . . 31.3 t-80 -65.98 -42.81 89.36 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.581 0.752 . . . . 63.45 111.828 -175.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 448' ' ' ALA . . . . . 0.475 ' HB2' ' HB3' ' C' ' 260' ' ' ARG . . . -93.23 -25.74 17.67 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 122.993 0.517 . . . . 74.31 111.179 178.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 449' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' B' ' 470' ' ' LEU . . . 61.48 -77.41 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.158 1.383 . . . . 74.42 112.482 177.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 450' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 65.6 -60.4 0.27 Allowed 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 125.261 1.425 . . . . 63.22 111.898 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 451' ' ' VAL . . . . . 0.557 HG21 ' HE3' ' B' ' 471' ' ' LYS . 62.0 t 83.02 139.52 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 125.789 1.636 . . . . 74.44 111.493 166.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 452' ' ' VAL . . . . . 0.444 ' O ' HG11 ' B' ' 451' ' ' VAL . 8.5 p -62.72 165.3 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.545 0 C-N-CA 124.559 1.144 . . . . 74.24 110.126 172.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . -62.88 87.48 0.05 OUTLIER Glycine 0 CA--C 1.538 1.469 0 O-C-N 122.282 -0.261 . . . . 73.44 112.917 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 454' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.85 107.76 5.16 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.08 0.952 . . . . 73.13 108.861 -177.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 8.5 t -75.89 -40.92 53.46 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.628 0.771 . . . . 72.1 112.192 -173.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -85.67 -11.43 53.8 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 112.398 0.518 . . . . 74.3 112.398 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 457' ' ' GLN . . . . . 0.403 ' OE1' HG12 ' B' ' 451' ' ' VAL . 16.9 tp60 54.62 43.54 30.04 Favored 'General case' 0 CA--C 1.558 1.271 0 CA-C-O 122.266 1.032 . . . . 65.21 111.374 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 5.2 t -84.46 59.09 5.23 Favored 'General case' 0 CA--C 1.553 1.092 0 CA-C-O 122.47 1.129 . . . . 72.13 110.138 175.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 459' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -169.3 150.42 4.31 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 114.446 -1.252 . . . . 73.31 109.242 -173.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 460' ' ' LEU . . . . . 0.706 ' HA ' ' HD2' ' B' ' 471' ' ' LYS . 2.5 pt? -156.74 139.72 15.35 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.831 0.852 . . . . 65.42 109.949 173.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -129.32 146.93 51.12 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.877 0.871 . . . . 75.0 109.488 176.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -110.02 78.1 1.1 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.621 1.168 . . . . 72.53 109.32 -178.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 81.2 p -92.55 -177.23 4.53 Favored 'General case' 0 C--O 1.247 0.929 0 CA-C-N 116.045 -0.525 . . . . 71.14 109.775 174.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 464' ' ' MET . . . . . 0.507 ' HG2' ' HG3' ' B' ' 117' ' ' LYS . 1.3 tpt -71.08 138.12 49.5 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 123.215 0.606 . . . . 75.31 110.467 177.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 465' ' ' LYS . . . . . 0.402 ' HE3' ' O ' ' B' ' 445' ' ' GLY . 11.5 mptt -87.41 65.56 8.72 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.058 0.943 . . . . 72.15 108.62 177.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -82.94 -146.97 0.08 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.143 0.977 . . . . 65.13 109.973 -178.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . -80.35 -32.13 37.81 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 118.91 0.777 . . . . 75.3 110.067 175.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 11.1 mp -117.17 -124.35 0.29 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 124.407 1.083 . . . . 74.32 109.767 176.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 469' ' ' GLY . . . . . . . . . . . . . . . 100.86 121.13 4.72 Favored Glycine 0 C--N 1.354 1.557 0 N-CA-C 111.393 -0.683 . . . . 62.03 111.393 -171.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 470' ' ' LEU . . . . . 0.492 ' HA ' ' O ' ' B' ' 449' ' ' ALA . 6.8 tt -114.65 147.74 39.15 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.058 0.943 . . . . 75.32 109.376 175.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 471' ' ' LYS . . . . . 0.706 ' HD2' ' HA ' ' B' ' 460' ' ' LEU . 9.3 ttpp . . . . . 0 CA--C 1.561 1.4 0 C-N-CA 123.179 0.592 . . . . 74.2 110.538 -177.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 61.9 mtm . . . . . 0 N--CA 1.485 1.282 0 CA-C-O 119.651 -0.214 . . . . 70.43 111.094 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.56 40.89 32.03 Favored 'General case' 0 C--N 1.359 0.985 0 C-N-CA 124.286 1.034 . . . . 70.41 111.437 -176.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -73.99 77.79 1.68 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.163 0.585 . . . . 71.34 110.308 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 4' ' ' LYS . . . . . 0.641 ' HZ2' ' HB3' ' C' ' 4' ' ' LYS . 5.5 ttpm? -37.64 96.2 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 125.616 1.566 . . . . 70.52 113.179 178.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 5' ' ' LYS . . . . . 0.51 ' HB3' HD12 ' C' ' 10' ' ' ILE . 97.4 mttt -96.86 106.93 19.34 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.72 0.808 . . . . 72.32 109.561 174.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -73.83 97.62 2.79 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 107.076 -1.453 . . . . 65.15 107.076 166.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 7' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -61.16 -26.04 67.42 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 114.451 -1.249 . . . . 73.43 112.257 -172.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -68.67 -46.77 68.22 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.851 0.461 . . . . 74.23 109.792 176.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.3 -42.88 92.35 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.366 0.666 . . . . 63.34 110.678 178.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 10' ' ' ILE . . . . . 0.51 HD12 ' HB3' ' C' ' 5' ' ' LYS . 83.3 mt -54.17 -47.39 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 C-N-CA 124.023 0.929 . . . . 73.31 110.615 174.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 85.8 mt -75.79 -13.6 60.29 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 115.397 -0.82 . . . . 75.53 112.787 179.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.66 21.29 75.06 Favored Glycine 0 C--N 1.351 1.393 0 CA-C-N 117.903 0.32 . . . . 74.43 113.655 -177.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 12.5 m -106.19 160.58 25.7 Favored Pre-proline 0 N--CA 1.483 1.187 0 C-N-CA 124.291 1.036 . . . . 71.34 110.271 176.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -56.82 153.37 37.47 Favored 'Trans proline' 0 C--N 1.388 2.65 0 C-N-CA 122.714 2.276 . . . . 74.43 112.152 177.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 63.6 mtp180 -70.67 7.21 1.16 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 113.661 0.985 . . . . 74.35 113.661 -174.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -135.93 21.94 3.29 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.276 1.031 . . . . 71.24 108.594 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.04 128.07 34.99 Favored 'General case' 0 C--N 1.35 0.608 0 CA-C-N 114.684 -1.144 . . . . 75.2 111.089 -176.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 70.8 p -71.44 169.22 15.84 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 123.662 0.785 . . . . 74.41 110.252 177.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -50.98 -38.59 51.89 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.052 0.941 . . . . 74.45 111.615 -178.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 20' ' ' GLU . . . . . 0.432 ' O ' ' HG3' ' C' ' 24' ' ' ARG . 0.3 OUTLIER -69.68 -45.56 68.04 Favored 'General case' 0 CA--C 1.553 1.061 0 O-C-N 123.952 0.783 . . . . 74.53 110.539 -176.14 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -63.47 -43.41 97.42 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.724 0.773 . . . . 73.42 110.741 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 22' ' ' ILE . . . . . 0.69 HD12 ' HB3' ' C' ' 57' ' ' LEU . 89.8 mt -63.13 -34.3 65.88 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 CA-C-N 114.044 -1.435 . . . . 75.54 110.75 175.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -72.67 -29.95 63.86 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.928 0.891 . . . . 74.13 111.223 176.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 24' ' ' ARG . . . . . 0.432 ' HG3' ' O ' ' C' ' 20' ' ' GLU . 94.6 mtt180 -64.81 -53.05 52.94 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.142 0.577 . . . . 73.52 109.541 175.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.93 -40.96 97.32 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 114.704 -1.135 . . . . 75.32 111.24 178.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 26' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -52.48 -64.43 0.82 Allowed 'General case' 0 C--O 1.212 -0.877 0 O-C-N 124.789 1.306 . . . . 72.31 110.309 176.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -59.01 -38.73 79.9 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 124.339 1.025 . . . . 75.33 111.45 -174.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 -55.03 -53.68 52.67 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 123.715 0.634 . . . . 75.55 110.588 177.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . 0.508 ' HB3' HD11 ' C' ' 50' ' ' ILE . 72.4 mt -82.65 -17.14 45.66 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 115.009 -0.996 . . . . 71.43 111.941 -176.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -85.84 -16.6 38.17 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.738 0.815 . . . . 75.32 110.472 179.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -95.19 -37.7 10.92 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.525 0.73 . . . . 73.5 109.954 170.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 25.8 tp60 -65.07 -47.76 76.17 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.393 0.677 . . . . 71.12 111.187 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -108.69 22.7 15.57 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.333 0.653 . . . . 72.14 111.069 -175.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 34' ' ' HIS . . . . . 0.519 ' CD2' ' HB3' ' C' ' 36' ' ' ASP . 54.3 t60 -60.51 99.39 0.18 Allowed Pre-proline 0 N--CA 1.487 1.412 0 C-N-CA 124.913 1.285 . . . . 74.34 111.547 -174.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -61.97 -22.37 74.15 Favored 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 123.51 2.806 . . . . 72.22 113.916 -167.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 36' ' ' ASP . . . . . 0.519 ' HB3' ' CD2' ' C' ' 34' ' ' HIS . 9.4 t70 -56.44 -43.88 79.91 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.38 1.072 . . . . 60.34 111.603 174.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . 0.406 HG22 ' HD2' ' C' ' 34' ' ' HIS . 51.7 t -99.94 -46.24 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-O 121.762 0.791 . . . . 75.33 109.754 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -100.93 84.5 2.7 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.391 1.476 . . . . 65.41 109.921 -175.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -83.37 54.88 2.96 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.402 0.681 . . . . 71.22 110.663 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 44.3 m -104.37 108.33 60.14 Favored Pre-proline 0 N--CA 1.475 0.791 0 CA-C-O 118.572 -0.728 . . . . 74.14 109.136 -178.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -40.75 -52.12 3.34 Favored 'Trans proline' 0 C--N 1.387 2.6 0 C-N-CA 124.655 3.57 . . . . 75.0 114.707 -174.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 42' ' ' GLU . . . . . 0.466 ' HG3' ' HZ3' ' C' ' 46' ' ' LYS . 41.8 tt0 -56.81 -47.39 80.35 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 124.043 0.839 . . . . 71.01 110.813 178.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.05 -20.87 66.32 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 115.966 -0.561 . . . . 71.45 110.901 -178.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -86.29 -28.87 23.47 Favored 'General case' 0 C--N 1.355 0.814 0 C-N-CA 123.21 0.604 . . . . 74.04 109.995 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -60.85 -50.26 74.17 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.753 -0.832 . . . . 75.44 108.753 171.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 46' ' ' LYS . . . . . 0.466 ' HZ3' ' HG3' ' C' ' 42' ' ' GLU . 12.3 mptt -62.5 -48.79 78.04 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 113.811 -1.541 . . . . 72.32 110.07 179.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -56.25 -39.19 72.18 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.809 0.844 . . . . 71.12 110.79 178.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -62.02 -49.19 77.01 Favored 'General case' 0 C--O 1.214 -0.794 0 O-C-N 123.841 0.713 . . . . 72.04 109.97 179.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -70.68 -22.02 62.53 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 112.557 0.577 . . . . 72.33 112.557 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 50' ' ' ILE . . . . . 0.508 HD11 ' HB3' ' C' ' 29' ' ' LEU . 73.2 mt -80.11 -36.78 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 124.423 1.089 . . . . 75.43 110.69 176.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 51' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -89.63 -8.64 52.07 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.031 0.932 . . . . 74.04 110.521 177.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 52' ' ' GLU . . . . . 0.407 ' O ' HG23 ' C' ' 56' ' ' VAL . 29.4 tt0 -79.0 -47.19 16.71 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.93 1.292 . . . . 75.54 107.928 166.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.42 -44.34 80.29 Favored 'General case' 0 C--N 1.346 0.431 0 CA-C-N 114.243 -1.344 . . . . 63.1 110.684 173.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -80.93 -22.84 39.31 Favored 'General case' 0 CA--C 1.553 1.06 0 CA-C-N 115.501 -0.772 . . . . 75.01 111.125 178.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.85 -38.24 78.28 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 118.839 0.745 . . . . 60.54 110.22 171.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 56' ' ' VAL . . . . . 0.407 HG23 ' O ' ' C' ' 52' ' ' GLU . 26.1 t -77.34 -47.69 26.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-N 114.891 -1.049 . . . . 72.43 110.501 174.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 57' ' ' LEU . . . . . 0.69 ' HB3' HD12 ' C' ' 22' ' ' ILE . 85.1 mt -103.72 20.8 17.36 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 113.569 0.952 . . . . 75.02 113.569 -166.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 33.6 t -55.89 -43.1 76.92 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 124.161 0.984 . . . . 75.33 113.275 177.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -140.71 156.91 68.82 Favored Pre-proline 0 N--CA 1.472 0.664 0 C-N-CA 124.379 1.072 . . . . 72.03 109.559 -170.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 60' ' ' PRO . . . . . 0.465 ' O ' ' HG2' ' C' ' 64' ' ' ARG . 19.6 Cg_endo -54.62 -29.21 59.8 Favored 'Trans proline' 0 C--N 1.394 2.959 0 C-N-CA 123.408 2.739 . . . . 73.21 112.454 179.176 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -54.04 -63.16 1.24 Allowed 'General case' 0 C--O 1.252 1.199 0 C-N-CA 124.823 1.249 . . . . 62.13 111.801 177.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 44.0 mtpt -81.55 -24.64 36.45 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 113.94 -1.482 . . . . 75.43 110.152 -171.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -54.3 -50.13 68.05 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.763 1.225 . . . . 74.14 109.595 166.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 64' ' ' ARG . . . . . 0.465 ' HG2' ' O ' ' C' ' 60' ' ' PRO . 20.9 mmt180 -71.11 -29.02 64.74 Favored 'General case' 0 C--N 1.358 0.967 0 CA-C-O 119.13 -0.462 . . . . 74.15 111.801 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 69.4 mt -56.86 -44.92 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-O 121.296 0.57 . . . . 71.5 110.317 168.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -63.19 -48.15 79.6 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.994 -0.548 . . . . 74.31 110.969 176.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -58.84 -41.4 86.86 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 123.581 0.551 . . . . 73.14 111.725 -177.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 64.9 p -67.8 -28.99 68.06 Favored 'General case' 0 C--N 1.349 0.574 0 O-C-N 123.341 0.4 . . . . 74.43 110.671 176.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -77.26 142.71 39.36 Favored 'General case' 0 C--N 1.359 0.989 0 N-CA-C 109.052 -0.721 . . . . 75.22 109.052 171.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.69 13.3 82.6 Favored Glycine 0 C--N 1.346 1.102 0 N-CA-C 112.009 -0.436 . . . . 62.51 112.009 -177.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 28.8 m -136.93 -54.5 0.71 Allowed 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 103.749 -2.686 . . . . 72.34 103.749 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 82.2 m -97.51 150.17 21.37 Favored 'General case' 0 C--O 1.255 1.354 0 N-CA-C 104.532 -2.395 . . . . 73.35 104.532 156.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.12 -34.16 11.8 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.844 0.858 . . . . 73.23 110.258 -178.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -70.64 128.1 91.31 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 123.742 0.817 . . . . 53.23 110.732 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -67.13 150.38 82.12 Favored 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 122.647 2.231 . . . . 75.14 111.176 172.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -58.75 147.39 88.44 Favored 'Trans proline' 0 C--N 1.373 1.856 0 C-N-CA 122.645 2.23 . . . . 71.22 112.123 173.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.43 147.42 68.55 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 122.388 2.059 . . . . 74.4 112.113 171.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 78' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -59.05 123.05 12.63 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.975 2.45 . . . . 74.44 112.618 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -71.91 170.68 18.25 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 122.872 2.382 . . . . 70.12 112.178 178.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 80' ' ' PRO . . . . . 0.522 ' HB2' ' HB3' ' C' ' 141' ' ' ALA . 82.4 Cg_exo -48.8 89.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.393 2.911 0 C-N-CA 123.468 2.779 . . . . 74.31 113.607 178.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 118.29 -40.1 2.4 Favored Glycine 0 C--O 1.225 -0.464 0 CA-C-N 114.651 -1.158 . . . . 75.2 110.255 177.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . 0.513 ' HA3' ' HA ' ' C' ' 106' ' ' PHE . . . 126.5 -176.04 17.68 Favored Glycine 0 C--N 1.347 1.18 0 N-CA-C 111.249 -0.741 . . . . 75.13 111.249 -172.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -73.98 124.13 25.63 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.839 0.856 . . . . 73.4 111.152 -176.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 84' ' ' ASP . . . . . 0.64 ' HB3' HH21 ' C' ' 143' ' ' ARG . 6.9 p-10 -70.77 149.15 47.18 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.616 0.766 . . . . 75.11 110.506 177.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 85' ' ' PHE . . . . . 0.529 ' HB3' ' HB2' ' C' ' 88' ' ' PHE . 53.6 m-85 -148.37 74.86 1.3 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.641 0.777 . . . . 74.41 110.056 -179.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 16.5 m -54.98 86.57 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 125.131 1.373 . . . . 52.42 113.645 -175.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 85.49 13.45 70.45 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-N 115.686 -0.688 . . . . 74.34 112.829 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 88' ' ' PHE . . . . . 0.529 ' HB2' ' HB3' ' C' ' 85' ' ' PHE . 18.5 m-85 -115.34 108.15 16.16 Favored 'General case' 0 C--N 1.355 0.815 0 C-N-CA 123.135 0.574 . . . . 74.44 109.641 -174.071 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -74.46 88.13 2.1 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 108.042 -1.095 . . . . 72.23 108.042 177.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 90' ' ' VAL . . . . . 0.616 HG23 HD22 ' C' ' 105' ' ' LEU . 2.1 p -47.35 -40.65 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 CA-C-N 114.317 -1.311 . . . . 54.42 113.151 176.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 91' ' ' GLU . . . . . 0.446 ' HB2' ' ND2' ' C' ' 169' ' ' ASN . 33.7 tt0 -65.99 -21.3 66.4 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.863 0.865 . . . . 75.25 111.43 -175.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -86.42 -21.59 27.03 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 123.728 0.811 . . . . 75.53 111.239 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -77.24 -177.72 4.72 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.339 0.656 . . . . 72.45 112.338 -175.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 92.4 p -78.14 173.31 12.38 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 113.307 0.854 . . . . 52.11 113.307 -168.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.21 -51.07 71.59 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 114.333 -1.303 . . . . 72.35 111.557 178.038 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -56.17 -40.51 74.0 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.984 0.914 . . . . 74.24 111.087 -175.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 97' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -64.72 -50.36 67.22 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 114.519 -1.219 . . . . 64.25 110.04 177.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -80.06 2.69 22.89 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 115.213 -0.903 . . . . 71.33 112.56 -177.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -100.07 -45.12 5.77 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.568 0.747 . . . . 74.43 110.507 170.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 13.2 tp -62.74 -58.29 7.96 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.242 0.617 . . . . 73.23 110.127 176.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -81.87 -11.36 58.97 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 115.71 -0.677 . . . . 75.04 111.408 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -37.38 -63.18 0.84 Allowed Glycine 0 C--N 1.358 1.767 0 C-N-CA 124.807 1.194 . . . . 74.41 115.679 -177.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_exo -46.21 -34.13 13.08 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 123.841 3.028 . . . . 64.35 115.282 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -119.05 27.88 6.87 Favored Glycine 0 C--N 1.356 1.647 0 CA-C-O 119.318 -0.712 . . . . 73.42 113.823 -175.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 105' ' ' LEU . . . . . 0.616 HD22 HG23 ' C' ' 90' ' ' VAL . 29.0 mt -68.67 81.79 0.28 Allowed 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 117.761 0.78 . . . . 75.43 112.706 176.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 106' ' ' PHE . . . . . 0.513 ' HA ' ' HA3' ' C' ' 82' ' ' GLY . 0.2 OUTLIER 36.61 -113.84 0.1 Allowed 'General case' 0 CA--C 1.558 1.269 0 C-N-CA 126.864 2.066 . . . . 64.24 115.464 174.928 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . 68.48 2.2 26.31 Favored Glycine 0 C--N 1.359 1.861 0 N-CA-C 112.219 -0.353 . . . . 51.05 112.219 -162.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 108' ' ' GLY . . . . . 0.62 ' HA3' ' HA ' ' C' ' 167' ' ' GLN . . . 55.56 -142.59 36.82 Favored Glycine 0 C--N 1.36 1.898 0 N-CA-C 111.389 -0.684 . . . . 74.41 111.389 -168.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 109' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -85.05 -0.58 54.95 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 122.797 0.439 . . . . 74.45 109.988 170.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 110' ' ' GLY . . . . . . . . . . . . . . . -90.1 -15.41 57.61 Favored Glycine 0 C--N 1.361 1.95 0 CA-C-O 119.832 -0.427 . . . . 73.14 112.36 -178.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 52.8 15.22 0.51 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 114.694 1.368 . . . . 75.25 114.694 174.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 112' ' ' ARG . . . . . . . . . . . . . 38.2 ttp-105 -56.93 -32.59 66.12 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.147 0.979 . . . . 75.43 111.366 169.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 113' ' ' SER . . . . . . . . . . . . . 31.7 m 58.12 32.28 21.81 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.714 1.206 . . . . 72.53 111.246 -176.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 18.2 mtp85 -135.38 -178.69 5.22 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.791 0.836 . . . . 74.05 110.782 177.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 115' ' ' LYS . . . . . 0.492 ' HA ' ' HD2' ' C' ' 170' ' ' PRO . 56.6 tttp -28.73 129.02 0.08 Allowed 'General case' 0 N--CA 1.503 2.18 0 C-N-CA 126.207 1.803 . . . . 74.15 115.378 -163.059 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 116' ' ' GLY . . . . . 0.5 ' HA2' ' HA3' ' C' ' 168' ' ' GLY . . . -89.72 144.91 18.02 Favored Glycine 0 C--N 1.344 1.004 0 O-C-N 123.986 0.804 . . . . 54.4 113.902 -174.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.09 -176.82 2.99 Favored 'General case' 0 C--O 1.26 1.621 0 C-N-CA 124.301 1.041 . . . . 74.32 108.907 168.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 118' ' ' ASP . . . . . 0.469 ' HA ' ' O ' ' C' ' 173' ' ' ASP . 4.8 p-10 -60.62 152.99 24.9 Favored 'General case' 0 C--O 1.244 0.764 0 CA-C-N 115.127 -0.942 . . . . 75.42 112.828 -171.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 119' ' ' LEU . . . . . 0.457 ' O ' HD12 ' C' ' 174' ' ' LEU . 20.0 tp -110.85 118.28 35.71 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 106.57 -1.641 . . . . 75.21 106.57 173.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 21.8 ttm180 -112.37 106.03 14.45 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 121.207 0.527 . . . . 72.31 110.761 -167.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 121' ' ' ALA . . . . . . . . . . . . . . . -124.13 117.28 24.3 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.445 -0.798 . . . . 75.44 109.314 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -82.14 125.44 30.89 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 108.478 -0.934 . . . . 74.12 108.478 170.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 123' ' ' LEU . . . . . 0.414 HD12 HD22 ' C' ' 176' ' ' LEU . 2.2 pt? -130.33 115.3 17.34 Favored Pre-proline 0 CA--C 1.554 1.134 0 C-N-CA 123.03 0.532 . . . . 73.3 110.461 -171.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . 0.448 ' HG2' ' HB2' ' B' ' 188' ' ' ARG . 53.6 Cg_exo -62.78 115.69 3.08 Favored 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 123.301 2.667 . . . . 72.51 113.707 170.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 125' ' ' LEU . . . . . 0.565 HD22 HG13 ' C' ' 153' ' ' VAL . 19.0 tp -131.32 166.52 21.05 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 106.308 -1.738 . . . . 75.32 106.308 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 126' ' ' THR . . . . . . . . . . . . . 11.7 t -129.54 176.03 8.31 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 120.833 1.651 . . . . 61.53 112.1 175.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 127' ' ' LEU . . . . . 0.445 HD22 HD11 ' C' ' 180' ' ' LEU . 7.4 mt -60.79 -41.67 96.07 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.003 1.721 . . . . 62.25 110.069 -177.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -65.02 -43.63 91.83 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 113.867 -1.515 . . . . 75.24 110.716 176.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -72.59 -21.17 61.17 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-N 115.47 -0.786 . . . . 75.51 111.224 -179.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 130' ' ' ALA . . . . . 0.459 ' HB1' HG12 ' C' ' 153' ' ' VAL . . . -78.57 -46.25 19.84 Favored 'General case' 0 C--O 1.22 -0.456 0 O-C-N 124.139 0.899 . . . . 73.14 109.194 174.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 131' ' ' PHE . . . . . 0.529 ' HB2' HD11 ' C' ' 215' ' ' LEU . 88.1 t80 -50.68 -42.99 57.42 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.709 1.204 . . . . 75.55 110.796 173.074 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 132' ' ' HIS . . . . . . . . . . . . . 28.0 m170 -67.44 -67.43 0.46 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.187 -0.915 . . . . 70.15 108.754 175.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 50.51 -139.28 22.04 Favored Glycine 0 C--N 1.358 1.791 0 O-C-N 124.198 0.936 . . . . 65.31 113.662 175.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.86 -152.97 37.58 Favored Glycine 0 C--N 1.342 0.913 0 O-C-N 123.958 0.446 . . . . 73.12 113.27 177.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -79.15 94.4 5.37 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 108.554 -0.906 . . . . 73.03 108.554 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 136' ' ' ARG . . . . . . . . . . . . . 28.1 mmm-85 -103.39 125.35 49.95 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.778 0.831 . . . . 72.12 109.382 -177.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 137' ' ' VAL . . . . . 0.608 HG21 ' HB3' ' B' ' 180' ' ' ALA . 31.6 m -77.43 135.96 25.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 N-CA-C 109.361 -0.607 . . . . 73.11 109.361 174.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 138' ' ' VAL . . . . . . . . . . . . . 7.3 p -136.28 126.42 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.607 0.763 . . . . 72.14 109.35 -176.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 139' ' ' GLU . . . . . 0.487 ' HG3' ' HB2' ' C' ' 144' ' ' ARG . 1.6 mp0 -86.72 75.81 9.6 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.543 -0.539 . . . . 74.31 109.543 -176.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 140' ' ' VAL . . . . . . . . . . . . . 87.0 t -86.04 113.02 23.41 Favored 'Isoleucine or valine' 0 C--O 1.246 0.891 0 N-CA-C 108.396 -0.964 . . . . 73.25 108.396 -178.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 141' ' ' ALA . . . . . 0.522 ' HB3' ' HB2' ' C' ' 80' ' ' PRO . . . 62.78 37.01 12.75 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 124.565 1.165 . . . . 65.0 110.914 176.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 101.55 -34.81 5.36 Favored Glycine 0 C--N 1.351 1.363 0 CA-C-N 114.856 -1.065 . . . . 52.4 112.803 177.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 143' ' ' ARG . . . . . 0.64 HH21 ' HB3' ' C' ' 84' ' ' ASP . 0.2 OUTLIER -92.4 118.96 31.47 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 117.179 0.489 . . . . 75.05 111.324 -171.508 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 144' ' ' ARG . . . . . 0.507 ' HG3' ' HB ' ' C' ' 137' ' ' VAL . 35.4 ttm180 -73.92 115.95 13.97 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.194 -0.912 . . . . 71.51 109.638 171.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 145' ' ' VAL . . . . . . . . . . . . . 4.2 p -131.51 128.87 61.46 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 C-N-CA 124.049 0.94 . . . . 75.03 109.775 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 36.1 t -75.45 93.02 2.9 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 123.977 0.911 . . . . 73.22 110.582 -177.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 8.8 p -88.15 119.12 35.04 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 N-CA-C 109.241 -0.652 . . . . 72.53 109.241 175.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -75.53 104.33 6.04 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 109.513 -0.551 . . . . 74.22 109.513 174.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 149' ' ' ILE . . . . . 0.445 HG21 HG21 ' C' ' 159' ' ' ILE . 36.0 pt -120.29 95.46 49.07 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 107.133 -1.432 . . . . 74.42 107.133 165.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -49.78 161.14 0.96 Allowed 'Trans proline' 0 C--N 1.395 2.994 0 C-N-CA 124.271 3.314 . . . . 61.44 114.205 -174.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -43.56 94.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.389 2.7 0 C-N-CA 123.345 2.697 . . . . 73.2 112.247 174.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 152' ' ' GLY . . . . . 0.427 ' HA2' ' CD2' ' C' ' 240' ' ' PHE . . . 151.44 132.76 1.93 Allowed Glycine 0 C--N 1.348 1.222 0 CA-C-N 115.073 -0.967 . . . . 63.11 113.637 -174.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 153' ' ' VAL . . . . . 0.589 HG22 HG12 ' C' ' 178' ' ' VAL . 0.6 OUTLIER -153.59 160.23 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.028 0 CA-C-N 116.745 0.273 . . . . 74.01 110.948 169.696 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 154' ' ' ARG . . . . . 0.439 ' HG2' ' HB3' ' C' ' 188' ' ' LEU . 22.1 mtp180 -121.36 123.49 42.26 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.206 1.002 . . . . 75.32 110.447 -170.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 155' ' ' GLU . . . . . 0.456 ' HB2' HD12 ' C' ' 180' ' ' LEU . 13.3 tp10 -51.18 124.74 12.26 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.439 0.696 . . . . 74.51 112.241 171.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 76.28 12.39 84.23 Favored Glycine 0 C--N 1.348 1.241 0 O-C-N 124.394 1.059 . . . . 75.21 114.008 170.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 157' ' ' SER . . . . . . . . . . . . . 55.4 m -101.94 156.1 17.74 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.202 0.525 . . . . 75.43 110.829 -178.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 158' ' ' VAL . . . . . 0.599 HG13 HG22 ' C' ' 177' ' ' VAL . 27.1 m -96.56 111.71 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 CA-C-N 115.103 -0.953 . . . . 72.31 109.161 175.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 159' ' ' ILE . . . . . 0.702 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 57.1 mt -71.39 94.95 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 107.903 -1.147 . . . . 72.31 107.903 170.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 12.1 ttp180 -86.87 100.75 12.78 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 109.336 -0.616 . . . . 75.13 109.336 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 161' ' ' VAL . . . . . 0.585 HG11 ' HB3' ' C' ' 174' ' ' LEU . 2.1 p -101.03 102.46 20.19 Favored Pre-proline 0 CA--C 1.553 1.076 0 N-CA-C 108.866 -0.79 . . . . 75.24 108.866 172.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -63.76 136.34 53.07 Favored 'Trans proline' 0 C--N 1.386 2.52 0 C-N-CA 122.921 2.414 . . . . 75.23 112.855 -175.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 163' ' ' GLY . . . . . 0.407 ' O ' ' HB2' ' C' ' 171' ' ' PRO . . . 98.29 -6.82 61.69 Favored Glycine 0 C--N 1.341 0.847 0 CA-C-N 115.317 -0.856 . . . . 53.54 113.512 177.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 164' ' ' MET . . . . . . . . . . . . . 82.7 mtp -103.26 30.68 4.74 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 118.016 0.908 . . . . 73.35 110.883 178.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 165' ' ' GLY . . . . . 0.485 ' HA2' ' O ' ' C' ' 173' ' ' ASP . . . -57.34 162.8 7.73 Favored Glycine 0 C--N 1.351 1.393 0 CA-C-N 114.932 -1.031 . . . . 73.32 114.82 177.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . -117.85 -59.55 0.29 Allowed Glycine 0 C--N 1.346 1.101 0 C-N-CA 121.532 -0.366 . . . . 75.44 112.764 -170.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 167' ' ' GLN . . . . . 0.62 ' HA ' ' HA3' ' C' ' 108' ' ' GLY . 29.9 mm-40 -88.46 99.07 12.0 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 110.164 -0.31 . . . . 74.2 110.164 -173.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 168' ' ' GLY . . . . . 0.5 ' HA3' ' HA2' ' C' ' 116' ' ' GLY . . . 123.04 147.96 7.5 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-O 119.564 -0.575 . . . . 13.44 112.9 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 169' ' ' ASN . . . . . 0.507 ' HA ' ' HB2' ' C' ' 106' ' ' PHE . 7.3 t30 -61.04 -59.41 13.91 Favored Pre-proline 0 N--CA 1.491 1.607 0 CA-C-O 117.621 -1.18 . . . . 62.44 113.781 -169.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 170' ' ' PRO . . . . . 0.492 ' HD2' ' HA ' ' C' ' 115' ' ' LYS . 6.6 Cg_exo -75.12 106.08 2.21 Favored 'Trans proline' 0 C--N 1.39 2.76 0 C-N-CA 122.01 1.807 . . . . 73.55 109.792 170.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 171' ' ' PRO . . . . . 0.407 ' HB2' ' O ' ' C' ' 163' ' ' GLY . 17.0 Cg_exo -66.58 126.02 14.79 Favored 'Trans proline' 0 C--N 1.372 1.798 0 C-N-CA 122.75 2.3 . . . . 74.02 113.229 -167.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -71.37 -74.94 0.68 Allowed Glycine 0 C--N 1.355 1.619 0 O-C-N 123.797 0.686 . . . . 74.42 113.464 -177.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 173' ' ' ASP . . . . . 0.485 ' O ' ' HA2' ' C' ' 165' ' ' GLY . 4.6 p-10 -164.05 166.64 21.21 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.04 0.936 . . . . 74.51 109.746 175.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 174' ' ' LEU . . . . . 0.585 ' HB3' HG11 ' C' ' 161' ' ' VAL . 31.6 tp -113.48 113.76 25.6 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.901 -0.778 . . . . 75.22 108.901 176.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 175' ' ' LEU . . . . . 0.436 HD22 ' HB ' ' C' ' 158' ' ' VAL . 70.4 mt -87.72 93.54 9.47 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 123.882 0.873 . . . . 72.15 109.879 170.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 176' ' ' LEU . . . . . 0.702 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 82.3 mt -82.92 100.44 10.4 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 108.989 -0.745 . . . . 74.33 108.989 170.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 177' ' ' VAL . . . . . 0.599 HG22 HG13 ' C' ' 158' ' ' VAL . 41.4 t -81.49 93.35 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 108.49 -0.93 . . . . 75.23 108.49 -178.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 178' ' ' VAL . . . . . 0.589 HG12 HG22 ' C' ' 153' ' ' VAL . 2.1 p -76.77 125.29 36.43 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 CA-C-N 115.329 -0.85 . . . . 74.01 110.996 -172.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 179' ' ' ARG . . . . . 0.417 ' O ' ' HA ' ' C' ' 124' ' ' PRO . 34.8 mmt180 -120.29 112.9 19.62 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 114.355 -1.293 . . . . 74.42 108.308 178.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 180' ' ' LEU . . . . . 0.524 ' HA ' ' O ' ' C' ' 125' ' ' LEU . 80.5 mt -69.48 143.32 53.54 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 116.561 -0.291 . . . . 73.43 111.579 -178.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 181' ' ' LEU . . . . . . . . . . . . . 36.6 mt -60.94 156.49 47.07 Favored Pre-proline 0 N--CA 1.482 1.17 0 CA-C-O 117.731 -1.128 . . . . 74.24 109.92 -179.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -49.02 79.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.395 2.987 0 C-N-CA 124.205 3.27 . . . . 73.32 115.516 -174.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 183' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 171.87 76.78 0.04 OUTLIER Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 128.456 2.702 . . . . 72.0 106.82 172.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 184' ' ' PRO . . . . . 0.524 ' HG2' ' HB3' ' B' ' 287' ' ' PRO . 71.9 Cg_endo -74.22 68.86 4.99 Favored 'Trans proline' 0 C--N 1.38 2.19 0 C-N-CA 123.686 2.924 . . . . 74.25 111.533 178.015 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 185' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 13.1 t -90.48 -41.16 13.32 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.702 0 N-CA-C 109.326 -0.62 . . . . 72.23 109.326 -168.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 186' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -122.25 111.03 16.44 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 120.9 0.381 . . . . 61.44 111.718 -172.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 187' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -95.98 112.9 24.51 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 106.562 -1.644 . . . . 75.14 106.562 170.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 188' ' ' LEU . . . . . 0.439 ' HB3' ' HG2' ' C' ' 154' ' ' ARG . 62.0 tp -80.75 144.8 31.88 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-O 121.272 0.558 . . . . 74.14 112.465 -175.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -136.9 101.52 4.6 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.634 1.574 . . . . 73.21 107.124 169.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 72.41 -97.27 0.77 Allowed Glycine 0 C--N 1.349 1.263 0 N-CA-C 112.084 -0.406 . . . . 74.2 112.084 -175.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 191' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -119.86 -18.57 8.21 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 124.323 1.049 . . . . 75.25 110.321 175.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -94.53 140.94 29.18 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.168 0.987 . . . . 65.13 110.467 -172.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 193' ' ' LEU . . . . . 0.534 HD22 ' CE2' ' C' ' 240' ' ' PHE . 88.5 mt -100.25 170.18 8.62 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 113.119 0.785 . . . . 65.15 113.119 -169.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 194' ' ' TYR . . . . . 0.423 ' HA ' ' O ' ' C' ' 250' ' ' TYR . 52.1 t80 -127.97 108.42 10.66 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.787 0.835 . . . . 75.43 110.197 167.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 195' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' C' ' 185' ' ' VAL . . . -110.68 -175.85 2.82 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.823 0.849 . . . . 65.11 109.125 168.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 17.9 m -121.8 132.15 54.44 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 108.432 -0.951 . . . . 53.42 108.432 167.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 197' ' ' LEU . . . . . 0.471 HD23 HD13 ' C' ' 233' ' ' LEU . 53.7 tp -102.1 145.68 29.01 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.459 0.704 . . . . 73.5 110.444 -177.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 198' ' ' ASP . . . . . 0.473 ' HB3' HD11 ' B' ' 280' ' ' LEU . 6.0 t70 -116.61 101.61 8.75 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.274 -1.01 . . . . 64.33 108.274 -179.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 199' ' ' VAL . . . . . . . . . . . . . 39.5 t -115.13 126.29 27.98 Favored Pre-proline 0 N--CA 1.476 0.872 0 N-CA-C 108.826 -0.805 . . . . 73.12 108.826 177.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 200' ' ' PRO . . . . . 0.572 ' HG2' HD11 ' C' ' 203' ' ' ILE . 24.0 Cg_exo -60.73 150.01 84.81 Favored 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 122.588 2.192 . . . . 73.11 112.204 168.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 201' ' ' ALA . . . . . 0.432 ' HA ' HG21 ' C' ' 255' ' ' ILE . . . -51.84 -57.92 13.02 Favored Pre-proline 0 CA--C 1.56 1.358 0 C-N-CA 124.756 1.222 . . . . 74.35 113.409 177.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 202' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -71.46 -30.68 14.9 Favored 'Trans proline' 0 C--N 1.389 2.71 0 CA-C-N 121.585 1.602 . . . . 63.15 112.544 -174.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 203' ' ' ILE . . . . . 0.572 HD11 ' HG2' ' C' ' 200' ' ' PRO . 20.4 mt -64.43 -40.48 89.21 Favored 'Isoleucine or valine' 0 C--N 1.361 1.085 0 N-CA-C 109.307 -0.627 . . . . 74.02 109.307 172.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 204' ' ' ALA . . . . . 0.524 ' HB1' ' HB ' ' C' ' 227' ' ' THR . . . -62.06 -39.06 91.1 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.24 -0.891 . . . . 75.02 110.816 176.447 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 205' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' C' ' 226' ' ' ARG . 53.4 t -74.06 -48.86 36.27 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 N-CA-C 114.027 1.121 . . . . 74.52 114.027 -173.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 206' ' ' VAL . . . . . . . . . . . . . 9.0 p -92.73 -33.55 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 CA-C-N 119.551 1.069 . . . . 74.12 111.453 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 105.58 121.69 4.9 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.399 -0.68 . . . . 63.21 111.399 -173.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -145.41 -136.22 2.95 Favored Glycine 0 C--N 1.339 0.709 0 N-CA-C 110.833 -0.907 . . . . 51.32 110.833 178.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 209' ' ' LYS . . . . . . . . . . . . . 20.2 ttpp -151.7 118.48 5.78 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 117.523 0.661 . . . . 72.44 109.903 175.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 210' ' ' VAL . . . . . . . . . . . . . 19.1 m -111.35 170.0 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 124.829 1.252 . . . . 71.52 109.671 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 211' ' ' ARG . . . . . . . . . . . . . 8.1 tmm_? -103.25 125.35 49.87 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 120.922 0.391 . . . . 75.53 110.909 -179.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 212' ' ' ALA . . . . . 0.425 ' HB3' HG12 ' C' ' 219' ' ' VAL . . . -105.72 152.36 23.27 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.849 1.26 . . . . 74.43 109.728 168.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 213' ' ' MET . . . . . . . . . . . . . 17.8 mmm -85.15 142.06 29.74 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.439 0.695 . . . . 63.12 110.017 174.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 214' ' ' THR . . . . . 0.51 HG21 ' HD3' ' C' ' 238' ' ' LYS . 0.2 OUTLIER -141.23 175.05 9.96 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.114 0.566 . . . . 72.34 111.204 172.619 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 215' ' ' LEU . . . . . 0.529 HD11 ' HB2' ' C' ' 131' ' ' PHE . 23.9 mt -61.92 -48.46 80.33 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.246 1.018 . . . . 75.24 111.394 -173.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -91.21 13.62 16.61 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 114.399 -1.273 . . . . 71.0 111.416 -176.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 124.39 -171.21 16.56 Favored Glycine 0 C--N 1.351 1.392 0 N-CA-C 111.824 -0.51 . . . . 74.41 111.824 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -81.7 129.55 6.44 Favored 'Trans proline' 0 CA--C 1.558 1.719 0 C-N-CA 122.675 2.25 . . . . 64.03 113.848 -178.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 219' ' ' VAL . . . . . 0.425 HG12 ' HB3' ' C' ' 212' ' ' ALA . 5.1 p -97.5 140.32 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 N-CA-C 108.361 -0.978 . . . . 52.53 108.361 172.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 220' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -98.44 107.98 20.56 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 118.583 0.629 . . . . 72.32 109.651 179.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 221' ' ' VAL . . . . . . . . . . . . . 37.9 t -69.8 116.04 10.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 126.058 1.743 . . . . 74.03 112.708 -179.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -76.01 113.67 13.78 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.493 0.717 . . . . 73.3 109.146 168.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 47.0 t -92.17 138.08 24.61 Favored Pre-proline 0 CA--C 1.561 1.371 0 C-N-CA 124.136 0.975 . . . . 73.11 110.646 -174.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 224' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -86.22 164.19 9.86 Favored 'Trans proline' 0 C--N 1.387 2.6 0 C-N-CA 123.377 2.718 . . . . 73.11 112.103 173.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.07 128.48 21.87 Favored 'Trans proline' 0 C--N 1.377 2.079 0 C-N-CA 122.751 2.3 . . . . 74.4 113.705 177.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 226' ' ' ARG . . . . . 0.69 ' HB2' HG22 ' B' ' 307' ' ' THR . 0.0 OUTLIER 59.43 89.09 0.07 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.814 2.045 . . . . 71.5 110.988 179.886 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 227' ' ' THR . . . . . 0.524 ' HB ' ' HB1' ' C' ' 204' ' ' ALA . 24.7 m -106.63 135.68 47.73 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 113.789 -1.551 . . . . 73.3 110.221 178.058 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 228' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -110.35 142.83 41.47 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 124.291 1.036 . . . . 74.32 110.479 -175.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -71.23 137.46 48.67 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.677 -0.86 . . . . 65.31 108.677 174.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 100.99 0.68 54.97 Favored Glycine 0 CA--C 1.521 0.411 0 CA-C-N 116.08 -0.509 . . . . 62.04 112.286 -170.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 231' ' ' ARG . . . . . 0.459 ' HD2' HG21 ' C' ' 227' ' ' THR . 86.2 mtt180 -76.08 172.4 12.85 Favored 'General case' 0 C--N 1.359 1.018 0 CA-C-N 117.115 0.458 . . . . 75.03 110.142 164.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 232' ' ' LYS . . . . . 0.694 ' HZ2' HG12 ' B' ' 301' ' ' ILE . 4.0 ttmp? -148.07 109.4 4.35 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.394 0.616 . . . . 74.05 110.164 175.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 233' ' ' LEU . . . . . 0.603 ' O ' ' HA ' ' C' ' 250' ' ' TYR . 0.5 OUTLIER -72.14 144.75 48.5 Favored 'General case' 0 C--O 1.209 -1.075 0 C-N-CA 125.781 1.632 . . . . 74.22 109.429 -178.02 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 234' ' ' ARG . . . . . 0.417 HH22 ' HB2' ' B' ' 37' ' ' ASP . 10.1 ptt180 -118.37 90.48 3.34 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 124.912 1.285 . . . . 72.34 110.108 173.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 235' ' ' LEU . . . . . 0.545 ' HB2' ' HB3' ' C' ' 249' ' ' LEU . 66.4 mt -77.79 116.41 18.29 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.509 0.723 . . . . 74.34 111.057 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -63.02 117.03 5.88 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.089 0.956 . . . . 73.41 112.65 -176.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 77.78 11.79 85.08 Favored Glycine 0 C--N 1.351 1.399 0 CA-C-N 115.223 -0.899 . . . . 71.42 114.688 175.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 238' ' ' LYS . . . . . 0.749 ' HZ3' ' HA ' ' C' ' 238' ' ' LYS . 0.1 OUTLIER -99.96 8.53 43.99 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.008 0.523 . . . . 75.11 111.053 178.447 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -86.44 -151.25 18.26 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 110.852 -0.899 . . . . 75.2 110.852 164.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 240' ' ' PHE . . . . . 0.534 ' CE2' HD22 ' C' ' 193' ' ' LEU . 48.3 m-85 -90.57 137.02 27.46 Favored Pre-proline 0 N--CA 1.476 0.856 0 CA-C-N 117.036 0.418 . . . . 75.14 110.65 175.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 241' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -57.39 120.98 9.25 Favored 'Trans proline' 0 C--N 1.383 2.382 0 C-N-CA 123.254 2.636 . . . . 71.53 111.353 175.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -100.28 157.77 19.48 Favored Glycine 0 C--N 1.348 1.246 0 CA-C-O 119.612 -0.549 . . . . 70.14 113.096 -173.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -65.62 -21.98 58.61 Favored 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 123.036 2.491 . . . . 71.42 113.61 -176.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -132.06 25.56 4.58 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.778 0.831 . . . . 71.42 110.57 178.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 164.25 -137.78 4.92 Favored Glycine 0 C--N 1.346 1.124 0 N-CA-C 111.549 -0.62 . . . . 63.24 111.549 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 246' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.12 163.07 39.33 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.037 0.935 . . . . 71.32 109.664 173.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -86.87 170.53 41.84 Favored Glycine 0 C--O 1.242 0.613 0 CA-C-N 116.088 -0.506 . . . . 63.23 111.986 178.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -124.32 136.42 54.09 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 107.763 -1.199 . . . . 73.54 107.763 -178.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 249' ' ' LEU . . . . . 0.545 ' HB3' ' HB2' ' C' ' 235' ' ' LEU . 19.4 tp -81.57 117.86 22.3 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.18 0.592 . . . . 74.23 109.877 -176.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 250' ' ' TYR . . . . . 0.657 ' HB3' ' HD3' ' C' ' 232' ' ' LYS . 19.4 m-30 -99.68 101.76 13.05 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 122.799 0.439 . . . . 71.43 109.915 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 251' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' C' ' 232' ' ' LYS . 2.0 mp -101.44 124.4 47.05 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 119.375 -0.345 . . . . 72.0 110.303 -175.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -70.97 109.31 5.0 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.544 -0.91 . . . . 75.41 108.544 173.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 253' ' ' VAL . . . . . . . . . . . . . 57.0 t -77.52 128.96 37.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 123.427 0.691 . . . . 73.5 111.655 -169.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 254' ' ' ARG . . . . . 0.432 HH11 ' HB3' ' B' ' 290' ' ' TRP . 20.9 mtm180 -108.64 147.26 32.13 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.125 0.97 . . . . 75.13 109.568 170.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 255' ' ' ILE . . . . . 0.432 HG21 ' HA ' ' C' ' 201' ' ' ALA . 36.5 mm -107.05 125.56 63.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 C-N-CA 124.452 1.101 . . . . 75.24 108.065 171.002 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 256' ' ' THR . . . . . . . . . . . . . 60.2 p -122.94 -175.59 3.21 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.855 0.862 . . . . 70.25 111.69 -171.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 257' ' ' ILE . . . . . 0.533 ' HB ' ' HD2' ' C' ' 258' ' ' PRO . 44.9 pt -135.48 161.58 62.32 Favored Pre-proline 0 CA--C 1.571 1.756 0 C-N-CA 123.53 0.732 . . . . 75.21 111.233 -179.081 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 258' ' ' PRO . . . . . 0.533 ' HD2' ' HB ' ' C' ' 257' ' ' ILE . 61.3 Cg_endo -69.43 11.26 0.37 Allowed 'Trans proline' 0 C--N 1.395 3.021 0 C-N-CA 123.733 2.956 . . . . 74.41 116.696 -170.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 259' ' ' GLU . . . . . 0.552 ' O ' ' HD2' ' A' ' 226' ' ' ARG . 5.5 mm-40 60.85 -84.29 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.607 0.763 . . . . 72.3 109.775 -170.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 260' ' ' ARG . . . . . 0.475 ' HB3' ' HB2' ' B' ' 448' ' ' ALA . 0.1 OUTLIER -92.47 172.02 8.66 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.45 0.7 . . . . 73.41 110.771 175.333 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 261' ' ' LEU . . . . . 0.464 ' HB2' HH12 ' A' ' 226' ' ' ARG . 11.3 mt -149.47 163.33 38.08 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 121.604 0.716 . . . . 74.53 111.919 176.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 1.2 p -104.36 147.62 34.66 Favored Pre-proline 0 CA--C 1.562 1.404 0 CA-C-N 113.494 -1.685 . . . . 61.23 108.997 171.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -45.51 -48.8 11.37 Favored 'Trans proline' 0 C--N 1.39 2.758 0 C-N-CA 125.038 3.825 . . . . 74.2 115.868 -166.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -64.62 -51.2 63.91 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-O 121.303 0.573 . . . . 71.04 111.242 -173.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 11.4 mp0 -60.98 -45.53 94.4 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 114.502 -1.226 . . . . 71.03 109.44 -177.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 266' ' ' GLU . . . . . 0.423 ' HG2' ' HE3' ' C' ' 270' ' ' LYS . 42.4 tt0 -61.42 -37.44 83.5 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 114.934 -1.03 . . . . 73.1 111.076 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -63.71 -38.55 91.54 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.591 0.756 . . . . 71.12 111.52 177.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 268' ' ' LEU . . . . . . . . . . . . . 11.1 mp -62.23 -43.38 98.96 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 123.242 0.339 . . . . 70.11 110.72 172.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 92.9 m95 -58.34 -36.11 72.94 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 122.904 0.482 . . . . 63.11 111.104 174.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 270' ' ' LYS . . . . . 0.423 ' HE3' ' HG2' ' C' ' 266' ' ' GLU . 99.5 mttt -70.75 -39.35 73.32 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.543 0.737 . . . . 75.43 111.442 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.64 -38.35 89.11 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.954 0.502 . . . . 75.33 110.611 178.009 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 88.8 mt -73.49 -31.31 63.68 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.618 0.767 . . . . 74.33 110.891 176.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -66.24 -40.93 90.57 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.295 0.638 . . . . 43.22 110.021 175.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -69.3 -37.84 77.99 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.13 0.972 . . . . 63.21 110.97 178.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -62.85 -30.76 71.75 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.298 0.639 . . . . 70.04 110.43 172.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 276' ' ' TYR . . . . . 0.485 ' HB3' HD13 ' A' ' 203' ' ' ILE . 1.6 m-85 -75.25 -38.04 60.73 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.705 0.802 . . . . 75.52 111.492 173.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -69.56 -24.26 63.68 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 122.456 0.302 . . . . 65.52 110.254 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -63.45 -20.1 65.28 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.922 0.889 . . . . 72.22 112.176 173.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 279' ' ' ARG . . . . . 0.437 ' HD3' ' HA ' ' C' ' 276' ' ' TYR . 14.9 mtp-105 -75.22 -9.64 58.74 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.251 0.62 . . . . 75.11 111.8 176.098 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.151 0 CA-C-O 118.252 -0.88 . . . . 75.14 108.673 174.149 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.3 mtm . . . . . 0 C--O 1.234 0.282 0 N-CA-C 108.934 -0.765 . . . . 64.12 108.934 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.15 22.28 13.02 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 114.417 -1.265 . . . . 74.44 113.892 169.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -86.96 44.83 1.2 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.926 0.491 . . . . 74.04 110.485 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -37.81 97.12 0.01 OUTLIER 'General case' 0 C--N 1.364 1.229 0 C-N-CA 125.786 1.634 . . . . 64.14 113.357 -176.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.512 ' HB3' HD13 ' A' ' 10' ' ' ILE . 14.3 mmmm -63.4 110.86 2.07 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.29 -1.004 . . . . 74.32 108.29 170.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -73.39 93.64 1.97 Allowed 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 107.638 -1.245 . . . . 62.43 107.638 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.432 ' CD1' ' HA ' ' A' ' 53' ' ' ALA . 62.4 m-85 -63.82 -30.13 71.26 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 114.88 -1.055 . . . . 73.34 112.291 -168.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -66.4 -44.47 82.92 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 116.215 -0.448 . . . . 73.33 109.961 173.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.47 -37.58 87.85 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.943 0.497 . . . . 70.01 111.421 178.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.512 HD13 ' HB3' ' A' ' 5' ' ' LYS . 72.9 mt -64.13 -36.22 76.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 123.452 0.701 . . . . 74.23 110.462 176.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.0 mt -81.05 -10.36 59.7 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 112.331 0.493 . . . . 73.11 112.331 173.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.02 32.4 60.71 Favored Glycine 0 C--N 1.35 1.352 0 N-CA-C 113.888 0.315 . . . . 73.42 113.888 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.4 m -126.07 155.21 73.77 Favored Pre-proline 0 N--CA 1.482 1.148 0 C-N-CA 124.346 1.058 . . . . 72.52 110.377 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.2 158.98 55.16 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 122.491 2.128 . . . . 50.12 112.335 173.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 35.3 mtm180 -82.02 64.37 6.67 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.068 0.947 . . . . 75.43 110.347 -177.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -179.7 -14.81 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.257 1.423 . . . . 71.2 109.032 -175.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.52 131.15 29.1 Favored 'General case' 0 C--N 1.36 1.061 0 C-N-CA 123.604 0.762 . . . . 74.14 111.325 176.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 58.1 p -63.37 164.6 8.85 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 123.867 0.729 . . . . 75.03 111.148 -175.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 47.6 tp60 -61.32 -27.39 68.45 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.376 0.671 . . . . 71.11 111.538 -176.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -67.97 -46.29 71.78 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.47 -0.786 . . . . 72.43 109.771 175.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -67.24 -35.96 80.65 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.209 0.604 . . . . 71.14 111.012 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.423 HG23 ' HB3' ' A' ' 57' ' ' LEU . 70.9 mt -66.06 -47.13 86.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.361 1.064 . . . . 73.31 110.586 178.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 51.4 tttt -55.65 -48.43 75.02 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.597 1.159 . . . . 75.22 110.533 173.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 63.9 mtt180 -75.94 -15.97 60.08 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 115.805 -0.634 . . . . 73.12 111.763 -177.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -77.26 -40.13 45.8 Favored 'General case' 0 C--O 1.251 1.17 0 C-N-CA 123.356 0.663 . . . . 72.43 110.262 173.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.515 ' HD1' HG23 ' A' ' 50' ' ' ILE . 64.6 t80 -55.45 -56.79 16.09 Favored 'General case' 0 C--N 1.352 0.702 0 CA-C-N 114.83 -1.077 . . . . 73.1 108.984 169.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.426 ' O ' ' HG3' ' A' ' 31' ' ' ARG . 55.5 mtpt -60.7 -38.98 86.84 Favored 'General case' 0 N--CA 1.483 1.208 0 O-C-N 124.248 0.967 . . . . 74.22 111.701 -177.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 45.6 ttt180 -52.04 -60.23 3.44 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 125.122 1.369 . . . . 75.52 110.913 175.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 95.9 mt -79.22 -13.5 59.65 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 114.876 -1.056 . . . . 75.12 111.314 -178.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.89 -14.72 46.93 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.309 0.643 . . . . 71.54 110.934 175.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.426 ' HG3' ' O ' ' A' ' 27' ' ' LYS . 82.7 mtm180 -89.63 -39.55 13.16 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.248 0.619 . . . . 72.33 109.734 168.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -67.28 -59.73 3.18 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.272 0.558 . . . . 73.31 111.447 178.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.678 ' HD2' HD11 ' A' ' 50' ' ' ILE . 21.3 m-85 -91.0 25.83 2.31 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.958 0.903 . . . . 72.41 110.718 -178.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 40.1 t60 -62.61 108.57 1.73 Allowed Pre-proline 0 C--N 1.358 0.955 0 CA-C-O 118.439 -0.791 . . . . 73.54 110.215 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.462 ' HB3' ' HG2' ' A' ' 44' ' ' GLU . 16.5 Cg_endo -53.64 -40.17 80.41 Favored 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 123.281 2.654 . . . . 75.51 113.447 -167.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -60.65 -40.7 93.01 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.553 0.741 . . . . 73.23 112.551 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 64.8 t -89.8 -30.08 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 CA-C-O 121.184 0.516 . . . . 73.25 110.28 -175.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 53.6 t-20 -108.44 97.29 6.98 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 124.397 1.079 . . . . 64.12 108.845 -172.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -81.1 71.11 8.07 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.618 0.767 . . . . 73.11 109.795 -177.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 62.2 m -152.07 112.55 2.88 Favored Pre-proline 0 N--CA 1.476 0.86 0 C-N-CA 123.88 0.872 . . . . 71.24 109.156 178.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -51.31 -36.02 55.76 Favored 'Trans proline' 0 C--N 1.388 2.633 0 C-N-CA 123.347 2.698 . . . . 73.53 111.662 176.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -47.34 -51.15 20.3 Favored 'General case' 0 C--N 1.35 0.596 0 C-N-CA 124.993 1.317 . . . . 64.43 111.339 174.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.79 -20.05 61.23 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.004 -0.998 . . . . 73.42 111.307 -175.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.462 ' HG2' ' HB3' ' A' ' 35' ' ' PRO . 40.4 mt-10 -86.03 -33.34 21.05 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.594 0.758 . . . . 63.35 110.777 -177.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -70.62 -42.7 70.57 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.831 -0.803 . . . . 62.44 108.831 174.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.523 ' O ' HG13 ' A' ' 50' ' ' ILE . 13.2 mptt -65.55 -32.87 74.7 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 114.76 -1.109 . . . . 74.03 110.685 171.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.667 ' HA ' HD13 ' A' ' 50' ' ' ILE . 86.9 t80 -62.86 -40.3 97.06 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.402 0.681 . . . . 73.32 110.453 175.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.475 ' HB3' ' HE1' ' A' ' 93' ' ' PHE . 48.2 mtmt -69.11 -33.43 73.48 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.929 -0.578 . . . . 75.14 110.799 176.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -65.37 -30.79 71.66 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-N 117.734 0.243 . . . . 71.44 111.577 172.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.678 HD11 ' HD2' ' A' ' 33' ' ' TYR . 31.1 mt -65.18 -43.48 95.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 109.012 -0.736 . . . . 74.43 109.012 172.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.443 ' HB3' ' HD1' ' A' ' 88' ' ' PHE . 43.7 m-80 -69.11 -21.53 64.03 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 115.282 -0.872 . . . . 73.43 111.716 175.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -73.37 -51.79 16.11 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-O 122.244 1.021 . . . . 75.34 108.974 175.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.432 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . . . -57.24 -41.75 80.15 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 113.35 -1.75 . . . . 65.45 111.032 175.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.426 ' O ' ' HB2' ' A' ' 58' ' ' SER . 13.0 t80 -79.15 -22.93 44.38 Favored 'General case' 0 C--O 1.212 -0.887 0 CA-C-N 114.887 -1.051 . . . . 73.53 110.279 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.93 -26.54 65.13 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.815 -0.553 . . . . 72.52 110.789 173.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.566 HG22 ' HE1' ' A' ' 101' ' ' PHE . 20.6 t -95.68 -23.12 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 115.8 -0.636 . . . . 74.52 111.778 173.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.474 HD22 ' HG2' ' A' ' 63' ' ' ARG . 62.3 mt -123.72 26.07 7.86 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.575 -0.703 . . . . 74.35 112.292 -174.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.426 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 16.5 t -66.24 -48.24 71.17 Favored 'General case' 0 N--CA 1.502 2.16 0 CA-C-O 121.45 0.643 . . . . 74.34 111.801 176.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -110.28 154.32 42.94 Favored Pre-proline 0 N--CA 1.475 0.798 0 CA-C-N 114.697 -1.138 . . . . 74.34 109.109 -176.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.12 -28.26 83.07 Favored 'Trans proline' 0 C--N 1.382 2.333 0 C-N-CA 122.637 2.225 . . . . 72.41 111.818 173.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -70.68 -53.73 14.59 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.269 1.028 . . . . 72.3 111.534 -179.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.461 ' HZ3' HG23 ' B' ' 19' ' ' THR . 62.9 mttp -58.48 -40.15 81.93 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 121.692 0.758 . . . . 74.54 110.475 175.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.474 ' HG2' HD22 ' A' ' 57' ' ' LEU . 4.5 tmt_? -58.39 -42.19 86.55 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 113.92 -1.491 . . . . 74.11 109.762 178.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -72.19 -27.28 62.46 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 118.601 -0.714 . . . . 74.25 112.721 175.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 78.9 mt -62.66 -45.97 97.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 CA-C-N 118.754 0.706 . . . . 74.41 109.456 174.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -64.87 -45.39 86.22 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 115.688 -0.687 . . . . 75.4 110.503 176.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -54.61 -42.8 71.58 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 122.892 0.477 . . . . 64.04 111.194 176.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 80.8 p -82.28 -12.68 57.88 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 118.889 -0.577 . . . . 75.44 111.58 -178.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -65.72 120.46 13.03 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 108.305 -0.998 . . . . 75.32 108.305 172.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 109.14 8.3 27.58 Favored Glycine 0 C--N 1.344 1.021 0 CA-C-N 115.948 -0.569 . . . . 64.23 111.929 -164.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 85.9 m -147.27 -57.94 0.26 Allowed 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 103.862 -2.644 . . . . 71.23 103.862 176.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 27.1 m -71.37 123.83 23.2 Favored 'General case' 0 C--O 1.246 0.874 0 N-CA-C 103.402 -2.814 . . . . 74.23 103.402 154.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.32 -35.0 6.19 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 117.934 0.334 . . . . 74.04 110.628 -178.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.35 138.91 74.88 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 123.232 0.613 . . . . 75.1 109.832 173.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -57.0 149.9 59.27 Favored 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 122.769 2.312 . . . . 75.41 110.994 171.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -57.3 136.18 74.7 Favored 'Trans proline' 0 CA--C 1.564 1.984 0 C-N-CA 122.695 2.263 . . . . 74.25 112.249 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.43 123.24 13.32 Favored 'Trans proline' 0 C--N 1.386 2.538 0 C-N-CA 123.668 2.912 . . . . 73.45 113.916 -173.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -67.39 120.15 7.19 Favored 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 122.766 2.311 . . . . 73.2 112.842 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.514 ' HG3' HG22 ' B' ' 18' ' ' VAL . 84.7 Cg_endo -78.97 167.12 22.46 Favored 'Trans proline' 0 C--N 1.378 2.108 0 C-N-CA 122.826 2.351 . . . . 71.05 111.621 173.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.24 82.89 0.05 OUTLIER 'Trans proline' 0 C--N 1.388 2.605 0 C-N-CA 123.415 2.743 . . . . 74.31 112.131 175.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 147.37 -44.8 0.79 Allowed Glycine 0 C--N 1.337 0.637 0 CA-C-N 114.74 -1.118 . . . . 62.41 110.331 -176.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.414 ' HA3' ' HA ' ' A' ' 106' ' ' PHE . . . 104.39 -160.52 15.73 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 116.478 0.139 . . . . 53.03 113.134 -176.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -106.77 128.68 54.44 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.993 0.917 . . . . 74.41 111.486 -175.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.434 ' HA ' ' HD2' ' A' ' 106' ' ' PHE . 13.2 t70 -70.14 144.58 51.98 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.017 1.327 . . . . 71.31 112.811 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.589 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 54.0 m-85 -136.54 72.18 1.43 Allowed 'General case' 0 C--N 1.358 0.977 0 CA-C-O 121.998 0.904 . . . . 73.24 111.453 -178.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 51.3 m -52.93 105.59 0.13 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 113.398 -1.728 . . . . 74.44 113.314 177.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.639 ' H ' ' HA3' ' A' ' 163' ' ' GLY . . . 67.9 2.3 23.02 Favored Glycine 0 C--N 1.343 0.938 0 C-N-CA 123.187 0.423 . . . . 70.11 113.976 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.589 ' HB2' ' HB3' ' A' ' 85' ' ' PHE . 19.0 m-85 -95.78 121.77 37.86 Favored 'General case' 0 C--N 1.349 0.569 0 N-CA-C 108.948 -0.76 . . . . 72.34 108.948 -174.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -82.85 60.06 5.16 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 122.119 0.962 . . . . 71.44 109.899 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.499 ' HA ' ' CD2' ' A' ' 93' ' ' PHE . 1.3 p -47.97 -38.69 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 126.532 1.933 . . . . 75.21 113.531 -179.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -55.61 -31.66 62.45 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 124.048 0.939 . . . . 75.33 112.236 -178.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -108.7 0.64 20.66 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.39 0.676 . . . . 61.35 112.111 -176.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.499 ' CD2' ' HA ' ' A' ' 90' ' ' VAL . 20.9 m-30 -72.05 178.97 3.48 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.907 -0.495 . . . . 73.34 110.697 177.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 77.5 p -58.94 155.72 12.84 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.637 0.775 . . . . 74.5 113.007 -173.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.46 ' O ' ' HG3' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -58.85 -41.67 87.52 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.165 -0.925 . . . . 74.52 110.631 173.381 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -57.92 -44.18 86.68 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.79 0.436 . . . . 75.03 111.286 175.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -59.92 -44.39 94.34 Favored 'General case' 0 C--O 1.244 0.805 0 CA-C-O 121.424 0.631 . . . . 72.32 109.814 177.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -75.44 -2.6 29.45 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 114.314 -1.312 . . . . 74.14 111.753 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.46 ' HG3' ' O ' ' A' ' 95' ' ' GLU . 48.8 mt-10 -93.88 -47.61 6.66 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 123.011 0.525 . . . . 70.02 110.949 163.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 48.8 tp -63.45 -32.16 73.52 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.54 1.136 . . . . 74.33 111.679 -171.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.566 ' HE1' HG22 ' A' ' 56' ' ' VAL . 93.7 m-85 -120.13 9.24 11.08 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.979 0.512 . . . . 72.11 110.477 173.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.42 ' HA2' ' HG ' ' A' ' 105' ' ' LEU . . . -48.47 -62.2 4.56 Favored Glycine 0 C--N 1.352 1.458 0 C-N-CA 124.702 1.144 . . . . 72.43 115.894 -172.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -56.63 -17.34 22.14 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 123.366 2.711 . . . . 64.43 113.474 178.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -129.57 43.22 1.33 Allowed Glycine 0 C--N 1.35 1.329 0 CA-C-O 119.679 -0.512 . . . . 54.4 112.287 178.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.469 HD22 HG23 ' A' ' 90' ' ' VAL . 33.7 mt -78.95 56.98 2.06 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 117.855 0.827 . . . . 74.25 111.065 170.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.658 ' HB3' ' HA ' ' A' ' 169' ' ' ASN . 0.2 OUTLIER 35.05 -108.55 0.04 OUTLIER 'General case' 0 CA--C 1.568 1.651 0 C-N-CA 126.29 1.836 . . . . 74.45 112.565 178.215 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 72.06 12.2 75.34 Favored Glycine 0 C--N 1.357 1.701 0 CA-C-N 118.485 0.584 . . . . 44.0 112.722 -173.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.599 ' H ' ' HD1' ' A' ' 106' ' ' PHE . . . 64.38 -112.65 5.18 Favored Glycine 0 C--N 1.342 0.865 0 C-N-CA 124.058 0.837 . . . . 71.34 113.446 -178.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -114.33 -5.32 12.94 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.912 0.885 . . . . 74.55 109.636 173.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -80.84 -29.32 42.98 Favored Glycine 0 C--N 1.357 1.71 0 N-CA-C 111.547 -0.621 . . . . 55.25 111.547 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.8 tpp180 63.39 2.18 1.12 Allowed 'General case' 0 CA--C 1.566 1.566 0 C-N-CA 125.39 1.476 . . . . 75.52 113.503 171.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 75.2 ttt180 -65.78 -23.89 66.81 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.16 0.984 . . . . 75.13 111.463 171.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 69.5 m 74.02 46.97 0.16 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.777 1.231 . . . . 74.21 111.227 -178.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.401 ' HD3' ' N ' ' A' ' 115' ' ' LYS . 1.7 tmt_? -111.09 160.53 16.8 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 115.089 -0.96 . . . . 74.52 109.265 174.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.446 ' HG3' ' O ' ' A' ' 170' ' ' PRO . 87.1 tttt -57.57 148.69 23.32 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 125.047 1.339 . . . . 73.31 112.789 -175.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -81.31 171.94 53.55 Favored Glycine 0 C--N 1.345 1.05 0 CA-C-N 115.438 -0.801 . . . . 73.4 113.371 174.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.8 tmm_? -87.19 140.43 29.55 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 108.568 -0.901 . . . . 74.43 108.568 176.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -53.68 116.9 2.74 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.949 0.9 . . . . 74.23 111.383 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.0 tt -109.86 140.99 43.18 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 121.833 -0.542 . . . . 75.42 109.953 -167.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 29.6 ttt-85 -99.01 107.52 19.97 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.992 0.917 . . . . 74.51 108.755 -178.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.413 ' HB1' HD12 ' A' ' 174' ' ' LEU . . . -111.14 165.14 12.15 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.275 0.63 . . . . 54.41 109.425 178.065 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.438 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 19.4 mm-40 -123.78 111.41 16.1 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 107.49 -1.3 . . . . 72.42 107.49 -174.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.416 ' O ' ' HA ' ' A' ' 178' ' ' VAL . 60.0 tp -99.71 96.66 4.85 Favored Pre-proline 0 N--CA 1.487 1.398 0 CA-C-N 118.869 0.759 . . . . 74.14 109.55 -172.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.438 ' HD3' ' O ' ' A' ' 122' ' ' GLU . 39.3 Cg_endo -74.92 112.19 3.5 Favored 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 121.189 1.259 . . . . 75.33 110.067 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.627 ' HA ' HG23 ' B' ' 6' ' ' ILE . 38.2 tp -117.26 141.71 47.96 Favored 'General case' 0 C--N 1.338 0.08 0 C-N-CA 123.856 0.863 . . . . 72.43 110.113 -169.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.408 ' HB ' ' HG2' ' A' ' 129' ' ' GLU . 27.0 m -74.78 130.17 38.98 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.177 0.991 . . . . 71.34 110.199 178.298 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 64.9 mt -53.84 -52.87 58.99 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.225 1.01 . . . . 75.21 111.852 -177.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.439 ' HA ' ' HB3' ' A' ' 215' ' ' LEU . 5.7 mp0 -58.83 -38.17 78.06 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.938 0.895 . . . . 75.32 110.377 -176.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.415 ' HB3' ' CZ ' ' A' ' 136' ' ' ARG . 16.0 mm-40 -74.95 -28.4 60.56 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 114.925 -1.034 . . . . 64.33 110.837 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -68.79 -35.64 77.29 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.969 0.508 . . . . 65.44 111.182 176.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.414 ' HB2' HD12 ' A' ' 215' ' ' LEU . 77.6 t80 -67.19 -49.56 64.18 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 123.481 0.488 . . . . 74.51 110.815 173.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 34.6 m170 -70.35 -36.49 74.23 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 123.526 0.516 . . . . 75.25 111.789 -175.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.452 ' HA3' ' HG3' ' A' ' 151' ' ' PRO . . . 72.7 -171.37 50.13 Favored Glycine 0 CA--C 1.528 0.889 0 O-C-N 123.451 0.469 . . . . 71.54 113.574 -176.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.15 172.95 25.25 Favored Glycine 0 N--CA 1.476 1.347 0 C-N-CA 122.704 0.193 . . . . 70.42 112.788 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.751 ' HG2' HH21 ' B' ' 22' ' ' ARG . 1.8 mp0 -71.68 108.82 5.21 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.362 0.665 . . . . 73.14 111.112 -174.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.415 ' CZ ' ' HB3' ' A' ' 129' ' ' GLU . 6.5 tpp180 -92.84 122.11 34.89 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 108.628 -0.878 . . . . 75.05 108.628 -177.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 94.6 t -78.39 96.71 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 109.237 -0.653 . . . . 75.04 109.237 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.579 ' HB ' HG13 ' B' ' 6' ' ' ILE . 0.2 OUTLIER -112.27 118.37 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 108.294 -1.002 . . . . 73.34 108.294 176.388 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 144' ' ' ARG . 30.5 mt-10 -101.29 133.99 45.04 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.092 0.557 . . . . 71.3 111.152 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.472 HG12 HD21 ' B' ' 8' ' ' LEU . 15.0 p -170.64 139.08 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.039 0 O-C-N 123.628 0.58 . . . . 75.1 111.613 -178.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.597 ' HA ' ' HA ' ' B' ' 15' ' ' PHE . . . 55.43 26.28 8.67 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 115.696 1.739 . . . . 74.24 115.696 163.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 98.22 10.15 52.08 Favored Glycine 0 N--CA 1.476 1.301 0 C-N-CA 121.694 -0.289 . . . . 54.15 113.02 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.479 ' HA ' ' HA ' ' B' ' 20' ' ' LYS . 34.0 ttm105 -144.07 106.58 4.42 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 123.343 0.657 . . . . 72.43 110.958 -171.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.485 ' H ' ' HA ' ' B' ' 20' ' ' LYS . 32.4 ttm180 -78.48 93.57 4.79 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 107.173 -1.418 . . . . 74.41 107.173 162.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 1.5 p -84.83 107.82 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 108.306 -0.998 . . . . 73.53 108.306 175.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.414 ' HB3' ' HG2' ' B' ' 22' ' ' ARG . 26.9 t -84.53 83.03 8.15 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 107.586 -1.265 . . . . 64.43 107.586 172.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.6 p -87.86 109.65 19.87 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 CA-C-O 121.422 0.629 . . . . 73.42 110.343 -173.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.42 ' HB2' ' HG3' ' A' ' 135' ' ' GLU . 20.3 ttm180 -57.47 93.42 0.01 OUTLIER 'General case' 0 C--O 1.24 0.565 0 CA-C-N 115.232 -0.895 . . . . 74.32 108.924 166.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.635 ' HB ' HG13 ' A' ' 153' ' ' VAL . 28.8 pt -72.88 118.64 70.01 Favored Pre-proline 0 CA--C 1.547 0.85 0 CA-C-N 114.068 -1.424 . . . . 74.52 108.192 173.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.563 ' HB3' ' HG3' ' B' ' 314' ' ' ARG . 31.8 Cg_exo -63.52 128.69 23.02 Favored 'Trans proline' 0 C--N 1.368 1.578 0 C-N-CA 122.248 1.965 . . . . 74.22 110.723 177.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.726 ' HB2' ' HB2' ' B' ' 315' ' ' ASN . 52.1 Cg_exo -53.36 100.37 0.06 OUTLIER 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 122.579 2.186 . . . . 74.15 111.272 177.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.422 ' HA2' ' CD2' ' A' ' 240' ' ' PHE . . . 116.75 36.44 1.06 Allowed Glycine 0 C--N 1.342 0.914 0 CA-C-N 115.532 -0.758 . . . . 75.51 112.647 -173.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.635 HG13 ' HB ' ' A' ' 149' ' ' ILE . 2.1 p -91.66 132.8 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 123.843 0.857 . . . . 75.43 108.737 176.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.402 ' HB3' ' HA ' ' A' ' 189' ' ' GLU . 0.1 OUTLIER -101.97 168.1 9.62 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.983 0.913 . . . . 73.23 113.047 -161.09 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.57 ' HB3' ' O ' ' A' ' 188' ' ' LEU . 9.0 tp10 -68.37 127.1 31.75 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 108.747 -0.835 . . . . 72.32 108.747 167.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 73.07 14.59 78.81 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-N 115.378 -0.828 . . . . 74.33 113.362 -174.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 46.5 t -66.34 109.76 2.82 Favored 'General case' 0 C--N 1.359 0.999 0 N-CA-C 107.721 -1.214 . . . . 74.23 107.721 171.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.452 HG21 ' H ' ' B' ' 34' ' ' ALA . 58.6 t -84.86 87.13 2.37 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 N-CA-C 108.59 -0.893 . . . . 74.02 108.59 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.634 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 54.6 mt -74.01 91.89 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.642 0 N-CA-C 107.763 -1.199 . . . . 75.24 107.763 174.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.427 ' HB2' ' HB2' ' B' ' 31' ' ' ASN . 70.1 ttt180 -74.87 105.25 5.82 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 115.566 -0.743 . . . . 75.21 109.528 179.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 4.3 p -115.05 110.36 45.97 Favored Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 123.68 0.792 . . . . 71.41 108.94 173.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.467 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 46.5 Cg_endo -66.61 153.8 76.69 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 122.698 2.265 . . . . 74.53 111.684 177.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . 0.639 ' HA3' ' H ' ' A' ' 87' ' ' GLY . . . 76.93 15.9 81.25 Favored Glycine 0 C--N 1.34 0.756 0 CA-C-N 115.827 -0.624 . . . . 70.43 113.892 178.241 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 49.2 mtt -125.46 -3.13 7.37 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 117.954 0.877 . . . . 64.15 111.465 177.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.501 ' HA2' HD13 ' A' ' 174' ' ' LEU . . . -85.15 -124.12 1.29 Allowed Glycine 0 C--N 1.343 0.956 0 N-CA-C 113.739 0.256 . . . . 73.33 113.739 -168.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -65.13 164.54 36.36 Favored Glycine 0 C--N 1.348 1.225 0 O-C-N 123.97 0.453 . . . . 74.5 113.422 -176.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.404 ' HB3' ' CA ' ' A' ' 108' ' ' GLY . 29.3 mm-40 -65.47 105.65 1.23 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.47 1.108 . . . . 75.42 111.581 -171.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -169.96 167.21 40.34 Favored Glycine 0 C--N 1.354 1.563 0 CA-C-O 118.96 -0.911 . . . . 64.21 112.124 -178.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . 0.658 ' HA ' ' HB3' ' A' ' 106' ' ' PHE . 48.3 t30 -63.74 -59.04 12.57 Favored Pre-proline 0 N--CA 1.493 1.694 0 CA-C-N 118.077 0.938 . . . . 63.54 110.752 -173.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.512 ' HD3' ' HB3' ' A' ' 169' ' ' ASN . 27.1 Cg_endo -94.64 95.13 0.11 Allowed 'Trans proline' 0 C--N 1.381 2.247 0 N-CA-C 106.181 -2.276 . . . . 73.02 106.181 156.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_exo -51.9 175.73 0.06 OUTLIER 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 123.391 2.727 . . . . 71.25 115.205 -170.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -62.72 -178.6 4.01 Favored Glycine 0 N--CA 1.474 1.229 0 CA-C-O 121.844 0.691 . . . . 72.4 114.499 -176.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.467 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 3.5 m-20 -79.9 104.76 10.7 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.441 -0.948 . . . . 71.14 108.441 171.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.501 HD13 ' HA2' ' A' ' 165' ' ' GLY . 18.2 tp -78.95 124.64 28.44 Favored 'General case' 0 C--N 1.346 0.421 0 N-CA-C 109.29 -0.633 . . . . 74.2 109.29 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.451 ' HB3' HG11 ' A' ' 158' ' ' VAL . 42.8 mt -101.28 88.88 3.59 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 106.661 -1.607 . . . . 72.12 106.661 -177.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.634 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 91.2 mt -72.66 83.18 1.15 Allowed 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 109.357 -0.608 . . . . 74.52 109.357 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.431 HG21 HG23 ' A' ' 158' ' ' VAL . 23.3 t -84.36 98.89 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 107.97 -1.122 . . . . 71.11 107.97 -176.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 98.6 t -56.58 140.46 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 N-CA-C 113.046 0.758 . . . . 74.13 113.046 -172.318 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.409 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 62.5 mmt-85 -114.52 89.92 3.21 Favored 'General case' 0 C--N 1.343 0.296 0 N-CA-C 107.463 -1.31 . . . . 73.42 107.463 163.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.402 HD21 ' HA ' ' A' ' 180' ' ' LEU . 10.7 mt -66.63 125.01 24.43 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 107.675 -1.232 . . . . 74.04 107.675 178.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 44.4 mt -51.85 152.9 4.82 Favored Pre-proline 0 N--CA 1.485 1.279 0 O-C-N 124.639 1.212 . . . . 73.22 113.628 -162.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -72.36 23.41 0.27 Allowed 'Trans proline' 0 C--N 1.382 2.321 0 C-N-CA 123.311 2.674 . . . . 74.32 113.366 178.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.449 ' HA ' ' HD3' ' A' ' 184' ' ' PRO . 59.7 t-80 -59.84 105.49 0.57 Allowed Pre-proline 0 CA--C 1.556 1.179 0 N-CA-C 106.399 -1.704 . . . . 73.35 106.399 164.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 183' ' ' HIS . 13.7 Cg_exo -69.2 25.31 0.16 Allowed 'Trans proline' 0 C--N 1.375 1.921 0 C-N-CA 124.049 3.166 . . . . 61.24 117.534 -161.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 87.5 t -97.02 -58.92 3.49 Favored 'Isoleucine or valine' 0 C--N 1.35 0.623 0 CA-C-N 119.524 1.056 . . . . 72.34 110.422 -175.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . 0.416 ' HB3' HD23 ' A' ' 193' ' ' LEU . 46.7 m-85 -121.51 121.4 37.41 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 118.373 0.533 . . . . 72.31 112.22 -174.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.57 92.15 4.99 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 107.215 -1.402 . . . . 75.51 107.215 165.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.57 ' O ' ' HB3' ' A' ' 155' ' ' GLU . 53.7 tp -87.91 139.97 29.97 Favored 'General case' 0 C--O 1.207 -1.157 0 C-N-CA 123.769 0.828 . . . . 74.21 109.855 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . 0.402 ' HA ' ' HB3' ' A' ' 154' ' ' ARG . 40.0 tt0 -162.22 125.47 3.0 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 118.482 0.583 . . . . 70.31 110.003 177.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 73.59 -65.37 1.74 Allowed Glycine 0 C--N 1.356 1.691 0 O-C-N 123.586 0.554 . . . . 65.41 112.223 -173.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.56 ' NE2' ' HB2' ' B' ' 304' ' ' PRO . 4.3 pm0 -164.45 -19.42 0.03 OUTLIER 'General case' 0 C--O 1.249 1.037 0 C-N-CA 125.694 1.598 . . . . 72.32 109.104 177.073 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -94.65 134.81 36.83 Favored 'General case' 0 C--N 1.358 0.968 0 C-N-CA 123.908 0.883 . . . . 72.32 112.005 -169.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.552 ' HB2' ' HA ' ' A' ' 249' ' ' LEU . 66.8 mt -95.91 150.12 20.79 Favored 'General case' 0 C--O 1.22 -0.463 0 C-N-CA 125.788 1.635 . . . . 74.25 110.368 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -133.74 105.27 6.72 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 106.944 -1.502 . . . . 73.14 106.944 169.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.481 ' HB2' HD22 ' A' ' 251' ' ' LEU . . . -118.6 119.33 34.16 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.658 1.183 . . . . 74.34 109.906 -172.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 31.8 m -69.83 129.41 39.47 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 123.358 0.411 . . . . 70.21 109.912 -175.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 54.6 tp -128.79 99.99 5.53 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 109.001 -0.74 . . . . 74.1 109.001 -170.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -80.21 121.43 25.6 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.955 -0.757 . . . . 63.3 108.955 176.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 6.3 p -138.68 135.58 18.02 Favored Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 124.714 1.206 . . . . 74.33 108.374 -175.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -74.12 152.73 45.86 Favored 'Trans proline' 0 C--N 1.368 1.553 0 C-N-CA 121.923 1.748 . . . . 70.05 111.081 173.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -53.35 -50.57 82.0 Favored Pre-proline 0 CA--C 1.553 1.07 0 N-CA-C 113.93 1.085 . . . . 71.34 113.93 -173.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -55.52 -46.25 33.58 Favored 'Trans proline' 0 C--N 1.38 2.19 0 C-N-CA 121.902 1.735 . . . . 73.32 113.581 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 19.6 mt -70.32 -32.32 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 CA-C-N 116.141 -0.481 . . . . 71.02 110.927 -176.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.89 -42.4 85.58 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.004 0.522 . . . . 74.14 111.301 175.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.404 ' CG1' HD13 ' C' ' 261' ' ' LEU . 53.9 t -73.17 -40.85 58.43 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.037 0 C-N-CA 124.082 0.953 . . . . 64.22 112.577 -174.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 65.0 t -95.58 -34.77 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 122.614 0.366 . . . . 74.41 111.694 -175.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 93.42 108.84 1.94 Allowed Glycine 0 C--N 1.335 0.508 0 CA-C-N 116.354 -0.384 . . . . 72.35 112.166 -178.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -141.45 -161.94 8.93 Favored Glycine 0 N--CA 1.469 0.841 0 N-CA-C 110.741 -0.943 . . . . 73.32 110.741 177.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 44.5 mtmt -100.43 124.11 45.52 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 118.426 1.113 . . . . 73.34 110.814 176.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 31.4 m -108.89 166.07 4.75 Favored 'Isoleucine or valine' 0 C--O 1.247 0.924 0 C-N-CA 125.014 1.326 . . . . 63.11 108.973 170.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . 0.638 ' HG2' HG21 ' B' ' 421' ' ' VAL . 0.0 OUTLIER -95.16 117.41 30.18 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.022 -0.733 . . . . 74.32 109.022 174.501 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -119.71 130.97 55.27 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 107.481 -1.303 . . . . 74.41 107.481 172.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' MET . . . . . 0.593 ' HA ' ' HA ' ' A' ' 218' ' ' PRO . 0.8 OUTLIER -80.27 148.62 30.69 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 122.46 0.304 . . . . 74.15 110.505 -176.497 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 71.5 p -117.67 -177.81 3.33 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 108.808 -0.812 . . . . 74.1 108.808 168.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.439 ' HB3' ' HA ' ' A' ' 128' ' ' GLU . 86.0 mt -76.89 -1.98 31.23 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.642 -0.708 . . . . 73.14 112.098 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -126.89 -2.17 6.56 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.145 0.578 . . . . 64.44 111.805 177.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 149.17 167.31 13.82 Favored Glycine 0 N--CA 1.481 1.635 0 N-CA-C 114.626 0.61 . . . . 63.05 114.626 173.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . 0.593 ' HA ' ' HA ' ' A' ' 213' ' ' MET . 2.7 Cg_exo -76.19 116.59 4.4 Favored 'Trans proline' 0 C--N 1.374 1.888 0 C-N-CA 123.662 2.908 . . . . 74.13 111.968 -177.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.634 HG11 HG22 ' B' ' 435' ' ' THR . 34.7 m -106.42 162.29 5.32 Favored 'Isoleucine or valine' 0 C--O 1.254 1.317 0 C-N-CA 123.98 0.912 . . . . 73.4 112.03 -172.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.634 ' HA ' HH21 ' A' ' 211' ' ' ARG . 29.4 mt-10 -86.49 103.12 14.72 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 114.213 -1.358 . . . . 75.04 109.889 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.472 HG11 HD12 ' B' ' 441' ' ' ILE . 39.7 t -106.93 116.9 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.172 0.589 . . . . 74.51 109.48 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.451 ' O ' HG13 ' B' ' 441' ' ' ILE . . . -77.88 99.36 5.95 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 109.255 -0.646 . . . . 70.4 109.255 174.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 14.3 p -64.9 134.0 95.93 Favored Pre-proline 0 CA--C 1.559 1.326 0 N-CA-C 109.491 -0.559 . . . . 71.22 109.491 177.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -61.44 168.71 7.64 Favored 'Trans proline' 0 C--N 1.38 2.227 0 C-N-CA 122.735 2.29 . . . . 75.51 112.654 176.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.77 150.96 31.34 Favored 'Trans proline' 0 C--N 1.374 1.904 0 C-N-CA 121.624 1.549 . . . . 72.53 112.474 172.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 45.3 mtt-85 66.29 27.34 10.17 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 125.692 1.597 . . . . 75.13 110.963 169.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.547 HG21 HD22 ' A' ' 233' ' ' LEU . 80.6 m -63.59 104.87 0.7 Allowed 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 113.06 -1.882 . . . . 64.32 110.843 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -85.14 139.83 31.4 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 123.945 0.898 . . . . 75.32 110.647 -176.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -62.24 157.4 19.59 Favored 'General case' 0 C--N 1.356 0.863 0 C-N-CA 124.152 0.981 . . . . 65.12 111.082 177.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 81.1 -38.74 2.41 Favored Glycine 0 C--N 1.346 1.088 0 CA-C-N 116.637 -0.256 . . . . 75.54 112.606 177.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -69.07 166.94 17.06 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 123.686 0.794 . . . . 74.44 110.26 173.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.7 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 2.7 mptp? -124.85 131.87 53.39 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 115.13 -0.941 . . . . 72.22 108.772 -178.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.547 HD22 HG21 ' A' ' 227' ' ' THR . 59.4 mt -76.62 97.54 4.44 Favored 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 107.903 -1.147 . . . . 71.4 107.903 176.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . 0.408 ' HG3' ' HB3' ' A' ' 248' ' ' ASP . 40.7 ttp180 -78.73 103.52 8.73 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 123.599 0.562 . . . . 73.41 109.737 -176.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.466 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 10.7 mt -100.04 89.33 4.0 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.217 -1.031 . . . . 74.24 108.217 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -71.0 139.08 50.42 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.751 0.42 . . . . 71.01 110.977 -173.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 79.32 2.6 87.76 Favored Glycine 0 CA--C 1.536 1.346 0 O-C-N 123.533 0.521 . . . . 74.2 113.271 -174.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.496 ' HE3' ' HA ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -105.83 -16.45 14.66 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 117.47 0.635 . . . . 74.1 111.73 -179.395 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -72.32 -163.29 6.63 Favored Glycine 0 CA--C 1.534 1.238 0 O-C-N 123.412 0.445 . . . . 74.43 112.87 173.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . 0.422 ' CD2' ' HA2' ' A' ' 152' ' ' GLY . 58.6 m-85 -95.01 166.26 15.29 Favored Pre-proline 0 N--CA 1.485 1.284 0 CA-C-O 118.282 -0.866 . . . . 73.41 109.869 -177.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' ' 240' ' ' PHE . 10.2 Cg_endo -49.69 146.26 15.86 Favored 'Trans proline' 0 C--N 1.392 2.868 0 C-N-CA 123.399 2.733 . . . . 73.33 113.943 -177.062 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.41 ' HA3' ' HB3' ' A' ' 191' ' ' GLN . . . -168.65 -158.68 12.91 Favored Glycine 0 C--N 1.338 0.657 0 CA-C-N 114.928 -1.033 . . . . 73.52 112.002 -178.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -78.46 -5.52 14.95 Favored 'Trans proline' 0 C--N 1.369 1.626 0 C-N-CA 123.284 2.656 . . . . 72.5 112.749 -173.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -113.51 22.0 14.57 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.003 0.921 . . . . 70.11 110.309 177.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 90.84 -75.28 1.63 Allowed Glycine 0 C--N 1.345 1.031 0 N-CA-C 109.996 -1.241 . . . . 62.24 109.996 -174.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 73.9 mtp180 -119.94 175.29 5.98 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.994 0.918 . . . . 75.41 109.279 168.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -105.58 -161.03 23.14 Favored Glycine 0 C--N 1.341 0.85 0 CA-C-N 115.988 -0.551 . . . . 70.31 114.306 -177.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . 0.408 ' HB3' ' HG3' ' A' ' 234' ' ' ARG . 19.3 m-20 -110.7 134.75 52.18 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 124.032 0.933 . . . . 75.44 108.813 -174.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.552 ' HA ' ' HB2' ' A' ' 193' ' ' LEU . 12.3 tp -98.95 95.51 7.21 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.0 -1.111 . . . . 73.32 108.0 176.21 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.7 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 84.4 m-85 -82.27 108.28 15.6 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 109.523 -0.547 . . . . 71.3 109.523 178.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.517 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 86.7 mt -86.8 105.7 17.19 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 109.298 -0.63 . . . . 74.54 109.298 172.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -76.54 106.99 8.5 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.358 0.663 . . . . 75.41 109.504 -174.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 23.9 t -69.27 127.93 31.91 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 124.252 1.021 . . . . 71.34 112.089 -170.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -127.5 93.93 3.85 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 107.365 -1.346 . . . . 73.14 107.365 178.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.408 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 69.6 mt -83.25 136.11 23.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 C-N-CA 122.641 0.377 . . . . 74.34 110.762 -177.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 22.5 p -124.93 169.57 11.95 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.594 1.157 . . . . 74.52 109.497 172.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . 0.468 HD12 ' H ' ' A' ' 259' ' ' GLU . 2.3 pp -109.58 141.18 23.07 Favored Pre-proline 0 N--CA 1.484 1.25 0 C-N-CA 122.928 0.491 . . . . 73.4 109.92 178.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . 0.531 ' HB3' ' HE1' ' C' ' 276' ' ' TYR . 12.7 Cg_endo -52.53 -20.95 13.03 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 124.598 3.532 . . . . 74.45 115.615 -170.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.468 ' H ' HD12 ' A' ' 257' ' ' ILE . 23.2 mt-10 50.85 -78.93 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.561 1.144 . . . . 75.12 110.576 -160.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' ARG . . . . . 0.406 ' HD3' ' HB3' ' B' ' 402' ' ' ASP . 0.0 OUTLIER -48.59 129.34 16.26 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.271 1.029 . . . . 75.12 111.713 176.973 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.416 HD22 ' HB3' ' A' ' 265' ' ' GLU . 89.1 mt -154.99 144.85 21.6 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.555 1.142 . . . . 72.32 109.096 -179.073 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 64.2 p -93.86 156.72 39.06 Favored Pre-proline 0 CA--C 1.555 1.151 0 CA-C-O 118.06 -0.971 . . . . 74.31 109.101 171.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' PRO . . . . . 0.446 ' HG2' HD11 ' B' ' 375' ' ' LEU . 11.3 Cg_exo -34.98 -48.07 0.69 Allowed 'Trans proline' 0 C--N 1.388 2.639 0 C-N-CA 124.843 3.695 . . . . 74.33 116.532 -177.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -68.46 -49.47 59.6 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.05 0.54 . . . . 71.44 111.406 -178.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . 0.416 ' HB3' HD22 ' A' ' 261' ' ' LEU . 49.9 mt-10 -56.95 -43.77 81.91 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.077 0.551 . . . . 73.22 110.344 178.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -57.12 -45.81 83.18 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 114.483 -1.235 . . . . 73.45 110.513 177.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -60.93 -41.67 96.65 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.162 -0.926 . . . . 64.12 111.685 178.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . 0.402 ' HG ' ' HG ' ' C' ' 268' ' ' LEU . 9.7 mp -64.78 -48.53 74.17 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.296 0.638 . . . . 73.14 111.193 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 68.5 m95 -57.86 -45.58 86.08 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.142 0.577 . . . . 75.0 111.583 178.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . 0.636 ' HE3' HG21 ' C' ' 206' ' ' VAL . 44.9 mttp -65.16 -42.95 93.22 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-N 115.536 -0.756 . . . . 73.12 111.547 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 34.4 mmtm -63.31 -42.94 99.05 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 122.88 0.472 . . . . 70.22 111.789 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 272' ' ' LEU . . . . . 0.428 ' O ' ' HB2' ' A' ' 276' ' ' TYR . 67.5 mt -54.93 -49.28 71.69 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 124.251 0.97 . . . . 71.54 109.435 172.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -70.06 -33.22 71.66 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.076 1.139 . . . . 72.23 114.076 -175.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 270' ' ' LYS . 40.6 mt-10 -65.08 -53.94 37.81 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.373 -0.973 . . . . 74.35 108.373 176.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -69.87 -20.83 63.38 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 113.567 -1.651 . . . . 72.24 112.161 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . 0.571 ' HE2' ' HB3' ' C' ' 258' ' ' PRO . 23.8 t80 -75.49 -64.07 1.15 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.188 0.995 . . . . 75.02 109.4 178.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -72.09 -23.06 61.28 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 114.799 -1.091 . . . . 72.14 111.848 -170.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -59.24 -26.99 65.37 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 112.762 0.653 . . . . 75.41 112.762 172.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -77.58 -15.14 59.42 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 116.429 -0.351 . . . . 75.15 110.497 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.131 0 C-N-CA 123.857 0.863 . . . . 72.5 109.042 175.507 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 14.6 tpt . . . . . 0 N--CA 1.479 0.979 0 N-CA-C 109.391 -0.596 . . . . 74.12 109.391 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt 59.86 33.94 21.69 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 124.568 1.147 . . . . 62.45 112.126 175.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 59.22 72.94 0.5 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.736 1.214 . . . . 74.04 109.814 -173.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 11.1 p -82.87 -17.51 43.57 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 115.029 -0.987 . . . . 52.14 111.864 -176.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 4.5 m 68.94 158.72 0.16 Allowed 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 125.234 1.413 . . . . 74.34 113.252 174.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.627 HG23 ' HA ' ' A' ' 125' ' ' LEU . 14.5 pt -138.57 175.08 8.93 Favored 'Isoleucine or valine' 0 C--N 1.364 1.199 0 C-N-CA 123.316 0.646 . . . . 65.34 111.117 -172.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -150.38 141.81 23.39 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.074 0.95 . . . . 72.22 109.017 172.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . 0.472 HD21 HG12 ' A' ' 140' ' ' VAL . 52.7 tp -75.76 143.03 42.22 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.263 1.025 . . . . 75.22 109.91 -174.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.93 -68.1 0.35 Allowed 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 109.513 -0.551 . . . . 73.12 109.513 172.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 6.6 tt 53.39 101.23 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 125.365 1.466 . . . . 74.1 110.527 -176.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 31.0 mt -49.68 120.9 11.52 Favored Pre-proline 0 CA--C 1.556 1.209 0 C-N-CA 124.732 1.213 . . . . 72.11 110.769 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -54.21 136.4 68.07 Favored 'Trans proline' 0 C--N 1.383 2.348 0 C-N-CA 124.139 3.226 . . . . 71.41 114.634 -155.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 41.4 mt -150.0 -47.62 0.13 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.415 1.486 . . . . 75.11 108.801 177.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -155.84 162.9 40.38 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.717 0.807 . . . . 64.54 109.766 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 15' ' ' PHE . . . . . 0.597 ' HA ' ' HA ' ' A' ' 141' ' ' ALA . 62.6 t80 -154.26 117.31 4.48 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.307 0.643 . . . . 74.01 109.83 173.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 1.3 p -146.88 169.84 8.77 Favored Pre-proline 0 CA--C 1.558 1.26 0 C-N-CA 125.649 1.58 . . . . 71.11 108.283 174.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -105.06 23.57 0.1 Allowed 'Trans proline' 0 CA--C 1.557 1.663 0 C-N-CA 122.934 2.423 . . . . 71.22 112.656 164.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.514 HG22 ' HG3' ' A' ' 79' ' ' PRO . 4.8 p -66.57 -66.67 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 N-CA-C 114.941 1.46 . . . . 63.3 114.941 -163.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 19' ' ' THR . . . . . 0.461 HG23 ' HZ3' ' A' ' 62' ' ' LYS . 25.4 m -87.8 -53.6 4.68 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 122.523 0.329 . . . . 71.22 111.55 -163.081 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 20' ' ' LYS . . . . . 0.485 ' HA ' ' H ' ' A' ' 144' ' ' ARG . 92.4 mttt 70.56 178.89 0.25 Allowed 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 124.771 1.228 . . . . 74.33 110.367 -171.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -179.79 151.63 0.45 Allowed 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.539 0.685 . . . . 75.34 112.494 178.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . 0.751 HH21 ' HG2' ' A' ' 135' ' ' GLU . 26.0 mtp-105 -141.86 104.51 4.52 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.491 1.116 . . . . 73.31 108.766 172.035 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 23' ' ' THR . . . . . 0.434 ' N ' ' HD3' ' B' ' 24' ' ' PRO . 17.8 p -139.43 52.86 4.3 Favored Pre-proline 0 N--CA 1.497 1.915 0 CA-C-N 118.806 0.73 . . . . 72.54 112.583 168.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . 0.444 ' HD2' ' HG2' ' B' ' 25' ' ' GLU . 8.7 Cg_endo -101.15 0.19 0.57 Allowed 'Trans proline' 0 C--N 1.371 1.745 0 C-N-CA 122.444 2.096 . . . . 74.55 113.859 176.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . 0.444 ' HG2' ' HD2' ' B' ' 24' ' ' PRO . 69.8 mm-40 -75.22 -20.32 59.31 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.573 0.749 . . . . 74.53 112.634 -167.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 26' ' ' MET . . . . . 0.406 ' H ' ' HD2' ' B' ' 27' ' ' PRO . 51.2 ttm -170.89 -50.35 0.0 OUTLIER Pre-proline 0 CA--C 1.567 1.611 0 CA-C-O 118.264 -0.874 . . . . 75.13 112.542 -171.284 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 27' ' ' PRO . . . . . 0.406 ' HD2' ' H ' ' B' ' 26' ' ' MET . 72.7 Cg_endo -71.07 10.51 0.66 Allowed 'Trans proline' 0 C--N 1.399 3.214 0 C-N-CA 122.212 1.941 . . . . 73.04 115.355 -172.148 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 29.0 m -70.51 142.77 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 N-CA-C 109.146 -0.687 . . . . 75.25 109.146 166.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 32.0 tp -141.93 166.94 23.34 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.119 0.568 . . . . 73.34 110.64 -171.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -76.29 155.27 34.43 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.093 0.957 . . . . 71.25 110.104 173.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 31' ' ' ASN . . . . . 0.427 ' HB2' ' HB2' ' A' ' 160' ' ' ARG . 28.7 t-20 -129.41 168.5 16.21 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.992 0.917 . . . . 74.34 109.738 -175.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 21.5 ptt-85 -65.68 -0.63 2.2 Favored 'General case' 0 CA--C 1.561 1.392 0 C-N-CA 125.02 1.328 . . . . 72.22 113.372 173.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . 75.41 118.15 0.05 Allowed 'General case' 0 C--N 1.365 1.242 0 C-N-CA 126.535 1.934 . . . . 73.31 108.482 -166.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . 0.452 ' H ' HG21 ' A' ' 158' ' ' VAL . . . -64.53 99.01 0.28 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.211 0.529 . . . . 53.33 110.082 178.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -87.28 170.75 11.17 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.081 0.952 . . . . 73.13 110.673 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -132.33 178.42 18.03 Favored Glycine 0 C--N 1.34 0.792 0 CA-C-N 116.004 -0.544 . . . . 74.33 112.148 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -76.01 -53.7 7.98 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.601 0.76 . . . . 61.44 110.235 179.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 48.7 mm 76.03 -59.8 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 C-N-CA 125.483 1.513 . . . . 75.44 113.277 168.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 54.6 m -59.11 -67.18 0.4 Allowed 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.054 0.942 . . . . 73.32 112.642 -173.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.493 ' HB3' ' HD3' ' B' ' 41' ' ' PRO . . . -112.2 -54.37 0.05 OUTLIER Pre-proline 0 N--CA 1.489 1.511 0 CA-C-O 118.286 -0.864 . . . . 73.24 112.13 -174.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . 0.493 ' HD3' ' HB3' ' B' ' 40' ' ' ALA . 15.1 Cg_exo -71.81 107.98 2.33 Favored 'Trans proline' 0 C--N 1.388 2.642 0 CA-C-N 121.795 1.677 . . . . 72.44 111.662 172.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -167.84 -125.18 0.76 Allowed Glycine 0 C--N 1.344 1.016 0 N-CA-C 110.974 -0.85 . . . . 61.22 110.974 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -159.99 -152.82 6.66 Favored Glycine 0 C--N 1.344 1.025 0 N-CA-C 111.852 -0.499 . . . . 64.32 111.852 179.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . 59.31 87.07 0.08 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.817 1.247 . . . . 63.2 109.837 -172.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 20.2 mtp180 64.86 -142.68 0.24 Allowed 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 124.128 0.971 . . . . 74.21 109.172 -171.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 82.9 mtt180 70.82 103.34 0.06 Allowed 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.485 1.114 . . . . 75.02 111.026 176.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 79.4 mt 62.06 23.42 13.81 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.989 0.915 . . . . 72.13 112.004 172.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 28.1 m -80.27 -41.48 24.93 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 114.762 -1.108 . . . . 73.12 109.58 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -161.95 31.25 0.31 Allowed Glycine 0 C--N 1.338 0.649 0 CA-C-N 114.58 -1.191 . . . . 74.15 110.375 175.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -85.71 -2.27 58.03 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.513 1.125 . . . . 64.2 112.447 -167.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -116.41 -63.29 1.47 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 122.94 0.496 . . . . 75.3 111.86 -175.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 41.2 p -109.51 -45.89 3.62 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.108 0.563 . . . . 73.31 111.761 -173.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.7 -55.36 35.83 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.693 0.797 . . . . 73.24 112.138 -170.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -99.53 4.46 45.95 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.232 0.613 . . . . 75.51 110.642 175.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 94.0 mt 65.52 -167.38 0.22 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 125.194 1.398 . . . . 72.35 110.644 -170.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 92.4 mtt-85 -113.14 107.71 16.3 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.283 0.633 . . . . 74.21 109.575 176.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 9.3 t70 66.38 -176.4 0.19 Allowed 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 124.39 1.076 . . . . 75.31 110.467 175.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 51.1 m -143.1 39.6 1.46 Allowed 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.743 -0.598 . . . . 62.01 110.228 177.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 45.9 tp -60.35 102.6 0.18 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.423 0.689 . . . . 72.44 110.641 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 29.4 m -91.61 84.07 5.43 Favored 'General case' 0 C--O 1.244 0.779 0 C-N-CA 123.853 0.861 . . . . 71.31 109.882 -177.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 14.3 t70 62.57 -94.75 0.04 OUTLIER 'General case' 0 CA--C 1.563 1.462 0 O-C-N 124.309 1.006 . . . . 71.45 111.267 169.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 62' ' ' LYS . . . . . 0.477 ' HB3' ' HZ2' ' C' ' 27' ' ' LYS . 87.9 tttt 162.21 91.09 0.01 OUTLIER Pre-proline 0 C--N 1.359 0.981 0 C-N-CA 126.854 2.061 . . . . 72.42 106.64 -176.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -68.75 -36.4 14.06 Favored 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 122.557 2.172 . . . . 72.24 113.055 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -97.97 105.31 17.44 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.703 0.801 . . . . 72.04 111.029 -173.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 7.6 tmtt? -92.32 69.88 5.14 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 106.996 -1.483 . . . . 73.42 106.996 170.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -127.57 155.14 44.3 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.247 0.619 . . . . 72.41 110.135 -177.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 16.1 tt -124.88 140.79 46.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 124.051 0.941 . . . . 74.04 108.742 176.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 8.3 tt -64.13 102.04 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.118 0 CA-C-O 121.398 0.618 . . . . 73.4 109.812 177.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 57.1 tp -67.85 -59.7 3.09 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.767 -0.651 . . . . 74.34 110.099 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 57.8 tp -162.54 147.43 12.17 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.176 0.59 . . . . 65.22 109.935 -177.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 29.4 pt -72.04 134.15 30.43 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 C-N-CA 123.462 0.705 . . . . 75.5 110.613 173.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -82.13 135.0 13.61 Favored Glycine 0 C--N 1.344 1.024 0 CA-C-O 119.327 -0.707 . . . . 71.15 112.318 -178.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 4.1 t70 69.98 175.73 0.28 Allowed 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 125.224 1.409 . . . . 74.12 110.825 177.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -125.51 -103.03 1.38 Allowed Glycine 0 C--N 1.352 1.432 0 O-C-N 121.864 -0.522 . . . . 72.45 112.625 178.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 75' ' ' MET . . . . . 0.496 ' HA ' ' HB2' ' B' ' 79' ' ' GLU . 1.0 OUTLIER 62.41 -84.31 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 125.276 1.43 . . . . 74.01 110.169 -172.272 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 59.01 -85.47 0.01 OUTLIER Glycine 0 C--N 1.355 1.6 0 N-CA-C 114.55 0.58 . . . . 71.52 114.55 175.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -88.53 21.64 2.86 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.784 1.234 . . . . 74.35 111.767 -176.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 17.0 m 76.71 -0.72 2.97 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 125.796 1.638 . . . . 55.34 111.411 -168.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . 0.496 ' HB2' ' HA ' ' B' ' 75' ' ' MET . 32.3 tt0 54.01 44.95 28.59 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 125.149 1.38 . . . . 74.44 111.49 176.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 2.2 pp 48.29 16.03 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 C-N-CA 126.41 1.884 . . . . 72.52 114.638 -177.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 20.4 m -75.79 -26.85 57.69 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.716 0.806 . . . . 74.52 110.414 -178.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.13 -29.93 65.85 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 115.423 -0.808 . . . . 75.12 110.494 172.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -77.42 119.35 20.91 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.156 0.583 . . . . 74.13 110.311 177.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 61.1 mtp85 -92.57 35.42 1.02 Allowed 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.871 0.868 . . . . 73.0 111.427 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 9.1 t30 61.05 -79.72 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.936 1.294 . . . . 72.23 111.232 -174.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -61.24 -72.19 0.12 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.673 0.789 . . . . 74.21 110.963 -177.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . 175.26 -72.47 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.897 1.279 . . . . 52.24 107.976 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -102.45 -78.44 0.54 Allowed 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 114.743 -1.117 . . . . 74.14 108.487 -177.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 145.89 -92.32 0.16 Allowed Glycine 0 C--N 1.349 1.261 0 N-CA-C 112.303 -0.319 . . . . 54.33 112.303 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -162.12 30.11 0.12 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.578 0.751 . . . . 75.53 110.305 -174.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.18 -78.93 0.78 Allowed Glycine 0 C--N 1.344 1.022 0 CA-C-N 115.769 -0.651 . . . . 70.11 112.199 -175.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . 0.493 ' HA2' ' HA ' ' B' ' 210' ' ' LYS . . . -175.66 -152.54 9.53 Favored Glycine 0 C--N 1.339 0.709 0 N-CA-C 111.615 -0.594 . . . . 73.42 111.615 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -93.34 -18.62 22.2 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.286 0.635 . . . . 74.22 111.346 178.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -56.33 -62.67 1.56 Allowed 'General case' 0 N--CA 1.479 1.02 0 CA-C-O 119.115 -0.469 . . . . 72.14 110.817 -178.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 6.8 tmtm? 60.53 -77.85 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 O-C-N 124.33 1.019 . . . . 74.44 108.906 -174.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . -171.04 42.82 0.19 Allowed Glycine 0 C--N 1.346 1.121 0 N-CA-C 110.199 -1.16 . . . . 75.21 110.199 172.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 13.7 pt -70.13 -31.56 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 123.58 0.752 . . . . 73.0 112.051 -173.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -147.7 -153.68 0.51 Allowed 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 109.327 -0.62 . . . . 75.21 109.327 -172.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . 69.59 24.89 5.43 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.156 1.383 . . . . 61.12 112.346 -175.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 5.9 mp -58.91 -46.36 99.54 Favored Pre-proline 0 N--CA 1.484 1.255 0 CA-C-O 118.511 -0.757 . . . . 74.2 110.809 167.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -67.19 -5.83 14.7 Favored 'Trans proline' 0 C--N 1.4 3.262 0 C-N-CA 121.896 1.731 . . . . 74.43 113.268 177.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . 0.469 ' HB3' ' H ' ' B' ' 114' ' ' LYS . 69.3 mt 71.05 -69.54 0.18 Allowed 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 125.902 1.681 . . . . 73.12 111.156 173.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 3.6 t -88.04 -46.32 9.44 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.472 1.109 . . . . 75.52 110.445 171.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 71.96 12.05 74.82 Favored Glycine 0 C--N 1.35 1.345 0 CA-C-O 119.512 -0.605 . . . . 51.35 114.539 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -162.38 -63.81 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 117.553 0.677 . . . . 75.22 111.253 -175.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -93.59 107.09 19.0 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.076 0.551 . . . . 74.44 110.931 -171.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 83.8 m -137.14 -63.46 0.6 Allowed 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.217 -1.031 . . . . 75.34 108.217 176.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 57.72 -77.15 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 126.024 1.73 . . . . 73.44 113.107 173.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -129.61 -63.98 0.9 Allowed 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 108.893 -0.781 . . . . 74.1 108.893 173.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -136.6 121.58 18.87 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.159 0.984 . . . . 75.22 109.666 179.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . 0.415 HD11 ' N ' ' B' ' 112' ' ' ASN . 1.5 tm? -150.92 151.54 32.32 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.637 -0.875 . . . . 70.25 108.637 -178.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 112' ' ' ASN . . . . . 0.415 ' N ' HD11 ' B' ' 111' ' ' LEU . 19.7 m120 -74.79 113.14 11.74 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.041 0.537 . . . . 73.2 109.978 178.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 113' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.72 -165.08 0.33 Allowed 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 123.657 0.783 . . . . 75.13 110.357 176.133 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 114' ' ' LYS . . . . . 0.469 ' H ' ' HB3' ' B' ' 102' ' ' LEU . 1.4 tpmt? -58.22 -35.55 71.83 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.358 0.663 . . . . 74.21 111.378 -177.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 11.9 m 65.6 -76.06 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.86 1.664 . . . . 73.23 110.269 -176.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -161.42 174.7 38.0 Favored Glycine 0 C--O 1.242 0.65 0 N-CA-C 109.961 -1.256 . . . . 55.33 109.961 172.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . 0.436 ' N ' ' HE3' ' B' ' 117' ' ' LYS . 0.8 OUTLIER 68.4 136.96 0.05 OUTLIER Pre-proline 0 CA--C 1.57 1.744 0 C-N-CA 124.538 1.135 . . . . 75.35 111.01 -175.928 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 118' ' ' PRO . . . . . 0.648 ' HD2' ' HB ' ' B' ' 121' ' ' VAL . 19.4 Cg_exo -67.62 72.67 0.65 Allowed 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 123.196 2.597 . . . . 63.21 111.21 169.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 119' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 56.19 -92.01 0.03 OUTLIER 'General case' 0 C--N 1.352 0.711 0 C-N-CA 125.609 1.564 . . . . 75.33 110.955 -170.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 120' ' ' TYR . . . . . 0.678 ' HB2' ' HG ' ' B' ' 280' ' ' LEU . 41.4 t80 -104.61 -19.85 13.85 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.402 0.681 . . . . 70.1 110.874 -175.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 121' ' ' VAL . . . . . 0.648 ' HB ' ' HD2' ' B' ' 118' ' ' PRO 0.288 8.3 p 52.05 -68.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 C-N-CA 127.385 2.274 . . . . 74.32 114.336 -174.433 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 32.5 m -55.55 95.67 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 124.44 1.096 . . . . 75.25 112.538 -174.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -98.21 4.84 48.88 Favored 'General case' 0 CA--C 1.553 1.07 0 CA-C-N 115.345 -0.843 . . . . 70.53 109.904 172.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 44.5 t 60.98 -100.74 0.1 Allowed 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 125.646 1.579 . . . . 61.03 112.265 171.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . 0.515 ' HA ' ' HE2' ' B' ' 210' ' ' LYS . . . -163.96 -58.4 0.04 OUTLIER 'General case' 0 C--N 1.36 1.023 0 CA-C-N 118.852 0.751 . . . . 74.53 112.872 -172.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -71.65 163.41 27.82 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 122.745 0.418 . . . . 74.13 111.893 -172.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 35.5 m 65.1 -175.37 0.18 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.68 1.192 . . . . 70.01 112.541 177.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . 66.38 -68.68 0.13 Allowed 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 125.127 1.371 . . . . 74.33 111.669 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 129' ' ' THR . . . . . 0.622 HG23 ' HA2' ' B' ' 209' ' ' GLY . 34.1 p -67.81 -40.09 83.88 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.178 0.591 . . . . 74.41 109.533 166.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . -79.93 -164.34 0.66 Allowed 'General case' 0 CA--C 1.553 1.065 0 CA-C-N 115.334 -0.848 . . . . 61.42 109.526 169.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 131' ' ' TRP . . . . . 0.549 ' HH2' HD22 ' B' ' 205' ' ' LEU . 25.1 m0 69.7 27.0 4.8 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 124.249 1.02 . . . . 73.51 110.375 -166.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 132' ' ' SER . . . . . 0.556 ' HB2' ' HD2' ' B' ' 231' ' ' LYS . 12.8 p -155.37 -83.97 0.06 Allowed 'General case' 0 CA--C 1.541 0.635 0 N-CA-C 106.558 -1.645 . . . . 74.11 106.558 172.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 31.9 m -154.0 -84.46 0.07 Allowed 'General case' 0 CA--C 1.551 0.983 0 N-CA-C 108.249 -1.019 . . . . 74.52 108.249 170.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . -151.02 37.74 0.86 Allowed Glycine 0 C--N 1.35 1.347 0 N-CA-C 110.266 -1.133 . . . . 55.15 110.266 178.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 135' ' ' VAL . . . . . . . . . . . . . 8.3 p -158.78 160.21 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.32 1.048 . . . . 73.24 108.51 -173.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 136' ' ' LYS . . . . . 0.453 ' HG3' ' H ' ' B' ' 137' ' ' THR . 0.5 OUTLIER -131.41 176.73 8.05 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 122.736 0.414 . . . . 74.24 110.325 -179.846 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 137' ' ' THR . . . . . 0.453 ' H ' ' HG3' ' B' ' 136' ' ' LYS . 5.5 t -55.34 92.88 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 125.171 1.388 . . . . 75.31 112.889 -176.143 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 58.9 t80 73.68 -74.41 0.09 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.797 1.639 . . . . 75.52 112.295 172.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . 0.431 ' OD1' ' HA ' ' B' ' 212' ' ' SER . 12.7 t30 70.05 154.29 0.12 Allowed 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 125.242 1.417 . . . . 73.24 112.609 -177.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . 91.15 -3.88 80.56 Favored Glycine 0 C--N 1.348 1.229 0 CA-C-N 115.559 -0.746 . . . . 75.54 112.272 -176.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -91.51 -0.3 57.59 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.007 0.923 . . . . 75.34 111.447 -178.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -79.6 109.33 13.89 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.115 -1.069 . . . . 74.24 108.115 176.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -108.68 -34.46 2.63 Favored Glycine 0 C--N 1.342 0.91 0 O-C-N 123.61 0.569 . . . . 61.25 111.907 174.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 5.0 p -104.53 131.34 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.886 0.874 . . . . 75.31 110.175 -179.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -95.52 -36.97 11.09 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.702 0.801 . . . . 75.32 110.47 176.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 44.0 mm -62.74 127.57 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 123.753 0.821 . . . . 72.52 111.334 -178.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 61.57 4.27 0.98 Allowed 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 125.832 1.653 . . . . 72.43 113.561 175.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -92.88 163.82 13.56 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.444 0.698 . . . . 75.05 110.9 -171.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 149' ' ' LYS . . . . . 0.414 ' HE2' ' HA ' ' B' ' 260' ' ' SER . 20.5 tptp -75.47 97.48 3.69 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 123.327 0.651 . . . . 74.13 112.19 -172.04 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -85.15 142.95 29.12 Favored 'General case' 0 CA--C 1.553 1.072 0 CA-C-N 115.362 -0.836 . . . . 74.11 109.553 165.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 58.2 m80 66.26 116.1 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.593 0 C-N-CA 125.569 1.548 . . . . 74.43 112.619 -175.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 152' ' ' PRO . . . . . 0.438 ' HD2' ' HA3' ' B' ' 209' ' ' GLY . 57.9 Cg_endo -72.08 166.78 28.62 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.094 1.863 . . . . 64.13 110.723 163.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 12.7 t -160.43 -31.74 0.06 Allowed 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 112.429 0.529 . . . . 74.2 112.429 -174.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 9.8 tt -94.41 76.25 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 CA-C-O 121.859 0.838 . . . . 74.25 110.615 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 7.3 mp 51.28 -86.13 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 125.82 1.648 . . . . 73.12 113.397 174.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -159.73 -79.25 0.06 Allowed 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 107.505 -1.294 . . . . 72.23 107.505 -177.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 157' ' ' MET . . . . . 0.533 ' HB3' HD22 ' B' ' 218' ' ' LEU . 26.8 ptm 167.34 164.61 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 126.292 1.837 . . . . 61.13 108.511 179.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 158' ' ' ALA . . . . . . . . . . . . . . . -163.32 -171.34 2.56 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.278 1.031 . . . . 65.11 108.473 174.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 54.6 tptt -102.67 -15.0 16.47 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 123.148 0.579 . . . . 73.24 109.558 169.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -151.98 -75.09 0.14 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.734 0.814 . . . . 74.34 110.398 177.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -156.71 -82.87 0.06 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.433 0.693 . . . . 71.1 109.976 178.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 162' ' ' GLY . . . . . 0.676 ' HA2' ' HB2' ' B' ' 235' ' ' GLU . . . 76.81 -71.38 2.16 Favored Glycine 0 C--N 1.352 1.432 0 C-N-CA 122.71 0.195 . . . . 73.4 113.077 -178.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 71.5 mt 67.33 23.9 9.13 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.93 1.292 . . . . 75.25 112.48 173.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 164' ' ' ALA . . . . . . . . . . . . . . . -90.63 -100.77 0.1 Allowed 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 122.868 0.467 . . . . 75.34 111.06 178.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 87.0 m 63.22 -69.96 0.07 Allowed 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 124.721 1.209 . . . . 73.14 111.441 -167.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . -87.82 -167.79 43.82 Favored Glycine 0 C--N 1.346 1.132 0 N-CA-C 112.129 -0.388 . . . . 74.53 112.129 174.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 167' ' ' ASN . . . . . 0.418 HD22 ' HB3' ' B' ' 75' ' ' MET . 38.0 p30 -70.3 -26.56 63.85 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 117.375 0.588 . . . . 74.33 110.694 175.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 26.9 m 39.86 42.27 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 126.616 1.966 . . . . 75.53 113.574 176.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 169' ' ' SER . . . . . 0.702 ' HB2' ' HB3' ' B' ' 172' ' ' GLU . 55.7 p -63.51 -32.67 74.2 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-N 115.177 -0.919 . . . . 65.53 111.62 -177.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 32.4 m 58.31 88.92 0.06 Allowed 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.817 1.247 . . . . 73.13 111.834 170.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . 77.4 -19.62 0.42 Allowed 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 125.342 1.457 . . . . 73.41 112.299 -178.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 172' ' ' GLU . . . . . 0.702 ' HB3' ' HB2' ' B' ' 169' ' ' SER . 3.0 tm-20 -74.75 103.36 4.99 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 108.823 -0.806 . . . . 75.25 108.823 173.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 173' ' ' LEU . . . . . 0.573 ' HG ' ' HG2' ' B' ' 174' ' ' GLN . 2.4 pt? -168.34 -41.08 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 107.594 -1.262 . . . . 74.44 107.594 166.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 174' ' ' GLN . . . . . 0.573 ' HG2' ' HG ' ' B' ' 173' ' ' LEU . 27.0 pt20 -172.95 -175.23 1.2 Allowed 'General case' 0 C--O 1.244 0.77 0 C-N-CA 125.251 1.421 . . . . 74.45 108.377 177.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 175' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -70.86 -82.21 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 116.021 -0.536 . . . . 74.1 110.21 169.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . 171.91 -42.26 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.123 1.369 . . . . 74.11 108.006 -171.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 16.1 p -139.58 73.46 35.3 Favored Pre-proline 0 CA--C 1.557 1.233 0 C-N-CA 125.141 1.376 . . . . 74.15 108.576 172.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 178' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.85 169.27 22.49 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 122.665 2.244 . . . . 74.53 112.778 -175.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -119.08 21.32 12.4 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.836 0.854 . . . . 74.35 109.57 176.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . 58.37 -79.24 0.02 OUTLIER 'General case' 0 C--N 1.359 1.0 0 C-N-CA 124.953 1.301 . . . . 75.32 110.472 -164.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 181' ' ' LEU . . . . . 0.451 HD21 ' HB3' ' C' ' 136' ' ' ARG . 12.8 tp -162.94 26.61 0.09 Allowed 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.699 0.762 . . . . 74.44 109.505 174.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 182' ' ' VAL . . . . . 0.482 HG13 ' HB3' ' C' ' 139' ' ' GLU . 76.7 t -83.44 147.45 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.505 1.122 . . . . 72.43 110.761 -174.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 183' ' ' ALA . . . . . 0.421 ' HB1' HD13 ' C' ' 123' ' ' LEU . . . -134.05 -13.69 2.43 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.54 0.736 . . . . 65.24 112.222 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 55.53 -138.77 1.02 Allowed 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.995 0.918 . . . . 75.32 108.836 -174.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 185' ' ' VAL . . . . . . . . . . . . . 61.0 t -114.76 102.17 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 106.997 -1.483 . . . . 74.01 106.997 158.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 66.6 p 55.79 84.97 0.07 Allowed 'General case' 0 CA--C 1.56 1.364 0 C-N-CA 125.456 1.503 . . . . 60.24 112.798 177.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 187' ' ' SER . . . . . . . . . . . . . 64.5 p -116.95 172.48 7.23 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.7 1.2 . . . . 62.14 111.036 -178.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -136.34 152.15 50.35 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.52 0.728 . . . . 72.32 111.358 -179.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 189' ' ' LYS . . . . . 0.545 ' H ' ' HG2' ' C' ' 124' ' ' PRO . 55.1 tttp -115.81 116.63 28.36 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.796 1.238 . . . . 72.52 109.633 -174.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 190' ' ' CYS . . . . . . . . . . . . . 8.1 p -99.91 151.39 21.37 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.634 0.774 . . . . 70.33 109.994 174.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -153.85 136.8 15.44 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.225 0.61 . . . . 74.04 110.195 -176.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -93.85 105.62 3.31 Favored Glycine 0 C--N 1.348 1.239 0 CA-C-O 118.79 -1.006 . . . . 64.22 111.201 173.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 193' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -69.17 157.43 61.56 Favored 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 122.593 2.195 . . . . 73.22 112.611 178.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 194' ' ' SER . . . . . . . . . . . . . 32.7 t -73.87 151.48 40.46 Favored 'General case' 0 C--O 1.244 0.802 0 C-N-CA 123.457 0.703 . . . . 63.44 111.132 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 195' ' ' ALA . . . . . . . . . . . . . . . -64.18 105.04 0.82 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.634 0.773 . . . . 74.32 110.889 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 88.4 m -102.11 116.03 31.8 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.91 0.884 . . . . 73.32 109.907 -179.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 30.4 t -108.63 128.59 54.98 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.999 -0.741 . . . . 75.11 108.999 176.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 198' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 55.68 -94.11 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.725 1.21 . . . . 65.14 111.358 176.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 199' ' ' LYS . . . . . 0.57 ' HB3' ' HZ2' ' B' ' 199' ' ' LYS . 4.3 mmmp? -140.47 -63.25 0.48 Allowed 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 106.79 -1.559 . . . . 75.14 106.79 171.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 200' ' ' CYS . . . . . . . . . . . . . 97.5 m -161.1 73.55 2.63 Favored Pre-proline 0 CA--C 1.562 1.442 0 C-N-CA 125.388 1.475 . . . . 73.31 108.984 173.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 201' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -78.41 -23.49 8.6 Favored 'Trans proline' 0 C--N 1.374 1.891 0 C-N-CA 122.452 2.101 . . . . 74.02 113.039 -175.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . -85.39 93.52 1.84 Allowed Glycine 0 C--N 1.346 1.093 0 CA-C-N 115.88 -0.6 . . . . 73.41 111.701 -178.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 203' ' ' ASN . . . . . 0.559 HD22 ' H ' ' B' ' 207' ' ' LYS . 65.8 t30 70.36 7.77 6.35 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 124.922 1.289 . . . . 71.33 112.414 174.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . 59.25 -84.98 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 125.744 1.618 . . . . 74.01 113.389 174.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 205' ' ' LEU . . . . . 0.549 HD22 ' HH2' ' B' ' 131' ' ' TRP . 0.0 OUTLIER -110.39 8.83 23.42 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.532 0.733 . . . . 72.44 111.88 -174.488 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 206' ' ' GLU . . . . . 0.478 ' HA ' ' ND2' ' B' ' 203' ' ' ASN . 36.4 mm-40 67.14 118.52 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.396 1.078 . . . . 70.3 111.192 -173.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 207' ' ' LYS . . . . . 0.559 ' H ' HD22 ' B' ' 203' ' ' ASN . 9.6 mtpm? -123.79 34.25 5.12 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.796 1.239 . . . . 74.32 110.493 -174.011 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . -67.94 80.67 0.19 Allowed Glycine 0 C--N 1.357 1.707 0 O-C-N 123.385 0.428 . . . . 71.52 114.167 -174.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 209' ' ' GLY . . . . . 0.622 ' HA2' HG23 ' B' ' 129' ' ' THR . . . -120.7 68.98 0.4 Allowed Glycine 0 C--N 1.342 0.886 0 N-CA-C 112.006 -0.437 . . . . 63.34 112.006 -175.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 210' ' ' LYS . . . . . 0.515 ' HE2' ' HA ' ' B' ' 125' ' ' ALA . 3.4 mptp? -72.83 -28.3 62.46 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.768 0.827 . . . . 74.51 110.937 -174.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . -153.43 -168.48 17.27 Favored Glycine 0 C--O 1.248 0.982 0 N-CA-C 110.136 -1.186 . . . . 74.43 110.136 175.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 212' ' ' SER . . . . . 0.431 ' HA ' ' OD1' ' B' ' 139' ' ' ASN . 67.5 m 58.18 31.74 21.14 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.47 0.708 . . . . 74.04 111.902 -179.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 24.8 pt -68.57 -36.26 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 CA-C-N 115.984 -0.553 . . . . 70.12 110.475 -179.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 214' ' ' THR . . . . . 0.495 HG23 ' HG3' ' B' ' 215' ' ' GLU . 6.8 m 57.56 -77.46 0.02 OUTLIER 'General case' 0 C--N 1.36 1.056 0 C-N-CA 126.194 1.798 . . . . 75.43 111.702 -176.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 215' ' ' GLU . . . . . 0.495 ' HG3' HG23 ' B' ' 214' ' ' THR . 0.0 OUTLIER -174.22 -25.26 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 126.029 1.732 . . . . 73.31 109.044 178.393 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 216' ' ' GLN . . . . . 0.407 ' NE2' ' HE3' ' B' ' 149' ' ' LYS . 8.9 tt0 62.68 79.65 0.25 Allowed 'General case' 0 C--N 1.359 1.018 0 C-N-CA 125.685 1.594 . . . . 61.42 110.824 177.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . 0.522 ' HA ' ' HB2' ' B' ' 221' ' ' ARG . 0.0 OUTLIER -59.54 -29.3 67.81 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 115.007 -0.997 . . . . 75.4 113.664 -176.557 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . 0.533 HD22 ' HB3' ' B' ' 157' ' ' MET . 2.6 mm? -62.73 -38.97 92.59 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.525 0.33 . . . . 71.43 110.821 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -103.78 86.77 2.66 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.181 0.592 . . . . 71.24 110.456 -173.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . 72.05 7.99 5.87 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.94 1.296 . . . . 74.3 114.382 168.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 221' ' ' ARG . . . . . 0.522 ' HB2' ' HA ' ' B' ' 217' ' ' LEU . 7.8 mpt_? -110.46 6.03 21.8 Favored 'General case' 0 N--CA 1.499 2.002 0 CA-C-N 118.472 0.578 . . . . 73.55 111.241 173.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -162.81 -47.54 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.431 1.092 . . . . 75.21 109.111 175.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 70.4 -53.09 0.65 Allowed 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 126.968 2.107 . . . . 72.13 114.2 170.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 11.4 p -64.95 -16.02 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 124.681 1.192 . . . . 75.32 112.336 177.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 225' ' ' THR . . . . . 0.401 HG23 HD22 ' B' ' 217' ' ' LEU . 23.8 p -66.53 87.55 0.12 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.725 0.81 . . . . 73.55 111.443 177.074 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 8.5 tt -81.71 105.75 13.1 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-N 115.119 -0.946 . . . . 74.43 108.501 176.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . -173.54 64.6 0.12 Allowed Glycine 0 C--N 1.342 0.869 0 CA-C-N 115.775 -0.648 . . . . 71.24 111.545 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . -76.88 90.57 0.98 Allowed Glycine 0 C--N 1.342 0.897 0 N-CA-C 111.491 -0.643 . . . . 72.41 111.491 177.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -155.5 169.2 33.33 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-O 121.044 0.247 . . . . 71.04 113.624 -176.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -99.63 69.12 1.6 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.039 0.936 . . . . 70.23 110.288 -176.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 231' ' ' LYS . . . . . 0.556 ' HD2' ' HB2' ' B' ' 132' ' ' SER . 31.5 tttp 67.72 9.58 7.18 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 125.387 1.475 . . . . 73.24 113.015 173.078 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 232' ' ' THR . . . . . 0.421 HG23 ' H ' ' B' ' 233' ' ' PHE . 0.9 OUTLIER -93.31 169.91 10.02 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.009 0.524 . . . . 74.24 110.274 -172.956 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 233' ' ' PHE . . . . . 0.421 ' H ' HG23 ' B' ' 232' ' ' THR . 32.3 t80 -69.26 -91.45 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.496 0.718 . . . . 71.44 112.52 -168.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -150.19 21.27 0.86 Allowed 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 118.723 0.692 . . . . 72.31 112.557 -168.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . 0.676 ' HB2' ' HA2' ' B' ' 162' ' ' GLY . 12.8 mp0 -74.21 127.85 34.03 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.23 0.612 . . . . 64.41 109.869 -173.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 236' ' ' THR . . . . . . . . . . . . . 26.2 m -114.61 -79.69 0.59 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.311 0.644 . . . . 73.34 109.529 -178.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -83.72 89.56 7.17 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.08 0.552 . . . . 73.03 111.125 -172.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 238' ' ' THR . . . . . 0.451 HG21 HG23 ' C' ' 219' ' ' VAL . 6.9 m -75.62 -16.56 60.2 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-N 115.594 -0.73 . . . . 71.31 110.197 172.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 239' ' ' ALA . . . . . 0.625 ' HB2' ' HA ' ' C' ' 221' ' ' VAL . . . -60.79 -177.09 0.07 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.032 1.333 . . . . 74.42 114.117 -178.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . -103.21 -95.48 2.33 Favored Glycine 0 C--N 1.341 0.837 0 N-CA-C 110.32 -1.112 . . . . 71.23 110.32 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -166.07 157.12 13.29 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.506 0.723 . . . . 71.23 110.789 -179.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -170.58 -69.37 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.17 0.988 . . . . 70.32 109.971 174.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -136.74 -6.97 1.91 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.389 1.076 . . . . 74.22 110.505 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 142.74 -163.79 27.21 Favored Glycine 0 C--N 1.352 1.468 0 N-CA-C 113.472 0.149 . . . . 71.54 113.472 174.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -167.48 131.33 1.79 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.322 1.049 . . . . 75.34 109.526 -174.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 246' ' ' THR . . . . . 0.509 ' HB ' ' HG ' ' B' ' 247' ' ' LEU . 0.6 OUTLIER -163.15 151.39 13.82 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 112.848 0.684 . . . . 71.14 112.848 -179.626 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 247' ' ' LEU . . . . . 0.509 ' HG ' ' HB ' ' B' ' 246' ' ' THR . 85.2 mt 75.44 154.02 0.15 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 126.585 1.954 . . . . 72.51 115.374 159.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 248' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.98 60.84 0.13 Allowed 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 106.082 -1.821 . . . . 75.15 106.082 -177.019 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -77.22 163.93 26.08 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 113.638 0.977 . . . . 71.33 113.638 -163.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -115.45 175.71 5.4 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 114.58 -1.191 . . . . 70.14 112.491 -167.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 251' ' ' ALA . . . . . 0.529 ' HB1' ' HB3' ' B' ' 254' ' ' ARG . . . -138.11 94.04 2.83 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.59 1.156 . . . . 64.21 108.217 175.067 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.01 -32.19 67.69 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 114.068 1.136 . . . . 73.12 114.068 -170.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -154.08 7.26 0.33 Allowed 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.261 0.624 . . . . 51.41 110.772 175.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . 0.529 ' HB3' ' HB1' ' B' ' 251' ' ' ALA . 0.0 OUTLIER -80.14 102.37 9.34 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 109.013 -0.736 . . . . 72.51 109.013 -173.114 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . 90.51 71.54 1.23 Allowed Glycine 0 C--N 1.35 1.345 0 O-C-N 123.823 0.702 . . . . 63.32 111.408 -177.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 256' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -155.25 -48.48 0.08 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.28 0.632 . . . . 71.2 110.114 -175.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 257' ' ' GLN . . . . . 0.558 ' HG3' ' HG ' ' B' ' 258' ' ' LEU . 8.7 tp-100 63.86 -83.29 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.923 1.289 . . . . 74.31 109.702 -171.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 258' ' ' LEU . . . . . 0.558 ' HG ' ' HG3' ' B' ' 257' ' ' GLN . 3.3 pp -159.67 -8.15 0.06 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.531 1.132 . . . . 75.13 110.636 175.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . 0.546 HG21 ' H ' ' B' ' 260' ' ' SER . 5.6 m -87.62 -70.41 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 C-N-CA 123.452 0.701 . . . . 63.31 111.772 -174.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 260' ' ' SER . . . . . 0.546 ' H ' HG21 ' B' ' 259' ' ' VAL . 74.9 m -167.38 -56.0 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.355 1.062 . . . . 73.11 109.748 -174.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -144.78 -71.54 0.27 Allowed 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 114.58 -1.191 . . . . 65.51 108.839 -167.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 262' ' ' ALA . . . . . 0.443 ' HB1' ' H ' ' B' ' 280' ' ' LEU . . . 64.87 7.36 3.88 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.754 1.222 . . . . 75.22 113.392 178.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -109.76 -30.6 7.79 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.788 0.835 . . . . 70.44 112.036 -171.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 78.7 p -58.64 -50.34 74.22 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.124 0.97 . . . . 51.14 113.384 -167.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 265' ' ' LEU . . . . . 0.424 HD13 ' HB3' ' B' ' 280' ' ' LEU . 95.9 mt -59.94 -38.21 81.78 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.196 0.598 . . . . 73.31 112.006 -176.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 266' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -66.19 -29.52 69.81 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 115.749 -0.66 . . . . 71.52 110.581 176.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 267' ' ' SER . . . . . 0.464 ' HA ' ' HG3' ' C' ' 260' ' ' ARG . 49.5 m -89.44 -26.88 20.73 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.111 0.964 . . . . 73.13 112.642 -177.007 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . 0.479 HG11 HG23 ' B' ' 269' ' ' THR . 41.0 t -77.48 -48.75 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 123.576 0.75 . . . . 74.44 110.257 -178.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 269' ' ' THR . . . . . 0.479 HG23 HG11 ' B' ' 268' ' ' VAL . 36.7 p -119.69 -172.9 2.42 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.667 0.787 . . . . 74.31 110.703 -176.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 270' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 79.28 -53.97 0.43 Allowed 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 126.216 1.806 . . . . 72.41 112.949 172.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 271' ' ' ALA . . . . . . . . . . . . . . . 75.55 -13.41 0.87 Allowed 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 125.173 1.389 . . . . 75.3 114.158 175.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 272' ' ' ASN . . . . . 0.604 HD22 ' HG3' ' B' ' 293' ' ' PRO . 8.9 p30 -172.53 -168.68 0.54 Allowed 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 118.446 0.566 . . . . 73.11 111.415 -179.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 72.31 43.53 0.49 Allowed 'General case' 0 C--N 1.364 1.206 0 C-N-CA 125.662 1.585 . . . . 73.43 109.502 -177.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 62.84 -79.4 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 125.216 1.407 . . . . 71.44 111.064 -177.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 275' ' ' LYS . . . . . . . . . . . . . 25.3 mmtp 58.39 73.54 0.72 Allowed Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 124.312 1.045 . . . . 72.14 109.634 -176.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.53 157.31 51.76 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 123.103 2.536 . . . . 73.04 113.36 -178.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 277' ' ' LEU . . . . . . . . . . . . . 1.5 pp -86.38 35.98 0.68 Allowed 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 115.126 -0.943 . . . . 74.52 110.965 177.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 61.7 tp -65.35 -52.43 53.79 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.137 1.375 . . . . 72.2 110.875 -173.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . -171.46 72.43 0.11 Allowed Glycine 0 C--N 1.339 0.721 0 CA-C-N 114.77 -1.105 . . . . 75.43 110.465 -177.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 280' ' ' LEU . . . . . 0.678 ' HG ' ' HB2' ' B' ' 120' ' ' TYR . 3.7 mm? 72.45 -66.99 0.28 Allowed 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 125.697 1.599 . . . . 74.31 110.97 178.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 14.3 t80 58.91 -164.67 0.2 Allowed 'General case' 0 CA--C 1.566 1.59 0 C-N-CA 124.712 1.205 . . . . 75.31 111.804 170.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . 76.48 -74.07 0.08 Allowed 'General case' 0 C--N 1.361 1.074 0 C-N-CA 125.304 1.441 . . . . 65.41 111.522 167.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -146.01 -15.42 0.46 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.626 0.77 . . . . 72.33 110.666 -175.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . -73.83 -91.66 0.14 Allowed Glycine 0 C--N 1.356 1.647 0 C-N-CA 123.108 0.385 . . . . 72.13 113.937 -172.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -86.17 -35.51 20.07 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 117.095 0.448 . . . . 73.03 110.8 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 286' ' ' MET . . . . . . . . . . . . . 89.7 mtp -110.83 97.6 34.34 Favored Pre-proline 0 N--CA 1.475 0.807 0 C-N-CA 123.92 0.888 . . . . 74.22 108.769 177.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 287' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -76.44 82.88 2.15 Favored 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 122.475 2.117 . . . . 74.24 111.265 174.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 288' ' ' VAL . . . . . . . . . . . . . 11.5 p -76.19 157.49 5.64 Favored 'Isoleucine or valine' 0 C--O 1.243 0.719 0 CA-C-N 115.441 -0.799 . . . . 74.32 109.001 173.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 289' ' ' ARG . . . . . . . . . . . . . 63.1 mtp180 -63.71 132.98 52.72 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 109.974 -0.38 . . . . 74.32 109.974 176.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 290' ' ' TRP . . . . . . . . . . . . . 2.6 m-90 -86.69 4.1 42.04 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 115.356 -0.838 . . . . 75.34 112.441 -166.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 291' ' ' LEU . . . . . . . . . . . . . 28.9 tp 71.21 -71.56 0.13 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.975 1.71 . . . . 73.52 111.044 -176.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . -167.55 -62.26 0.03 OUTLIER Glycine 0 CA--C 1.534 1.244 0 CA-C-O 119.06 -0.856 . . . . 71.42 113.075 -174.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 293' ' ' PRO . . . . . 0.604 ' HG3' HD22 ' B' ' 272' ' ' ASN . 18.1 Cg_endo -55.95 -47.88 22.67 Favored 'Trans proline' 0 C--N 1.383 2.392 0 C-N-CA 123.624 2.883 . . . . 75.13 113.697 -175.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 6.0 tmtm? 57.44 -80.92 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 125.656 1.583 . . . . 74.44 111.16 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -81.25 12.95 3.14 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.735 0.814 . . . . 71.35 112.272 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 11.3 m 78.75 34.39 0.24 Allowed 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 125.697 1.599 . . . . 71.52 111.314 175.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 82.8 t80 60.37 99.33 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 124.356 1.062 . . . . 75.44 112.693 169.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 67.8 m-70 -125.88 114.81 19.03 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.774 0.83 . . . . 73.43 108.855 176.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . -163.4 21.56 0.17 Allowed Glycine 0 C--N 1.341 0.847 0 CA-C-O 119.768 -0.462 . . . . 72.35 113.379 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -64.87 -24.46 67.54 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.341 0.656 . . . . 72.23 111.188 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 301' ' ' ILE . . . . . . . . . . . . . 48.6 mm 68.93 -75.42 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.207 0 C-N-CA 125.608 1.563 . . . . 75.13 109.601 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -173.87 -47.77 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.648 1.179 . . . . 74.32 107.952 170.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 303' ' ' LYS . . . . . . . . . . . . . 24.3 tptp -177.32 115.49 0.25 Allowed Pre-proline 0 CA--C 1.547 0.828 0 N-CA-C 107.442 -1.318 . . . . 74.11 107.442 -176.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 304' ' ' PRO . . . . . 0.56 ' HB2' ' NE2' ' A' ' 191' ' ' GLN . 42.4 Cg_exo -56.33 -34.33 93.75 Favored 'Trans proline' 0 C--N 1.386 2.514 0 C-N-CA 122.881 2.388 . . . . 75.12 112.579 -177.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 305' ' ' ALA . . . . . 0.609 ' HB2' ' HB ' ' B' ' 309' ' ' THR . . . -153.87 136.13 14.88 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.065 -1.087 . . . . 72.13 108.065 168.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 58.1 t -54.43 -70.57 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 124.314 1.046 . . . . 72.33 111.731 -170.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 39.1 m -148.73 -60.98 0.24 Allowed 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 120.987 0.422 . . . . 74.23 110.447 -175.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 308' ' ' CYS . . . . . . . . . . . . . 42.1 t -127.06 36.73 4.39 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.682 0.793 . . . . 74.22 109.146 176.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 309' ' ' THR . . . . . 0.609 ' HB ' ' HB2' ' B' ' 305' ' ' ALA . 9.0 m -65.86 -44.85 64.0 Favored Pre-proline 0 CA--C 1.571 1.767 0 CA-C-N 115.003 -0.999 . . . . 72.2 111.723 177.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 310' ' ' PRO . . . . . 0.464 ' HD3' ' HB2' ' B' ' 305' ' ' ALA . 48.6 Cg_endo -92.72 160.38 2.83 Favored 'Trans proline' 0 C--N 1.391 2.814 0 C-N-CA 121.87 1.713 . . . . 64.44 112.282 171.124 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 311' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -81.81 157.91 68.64 Favored Pre-proline 0 CA--C 1.549 0.911 0 N-CA-C 107.891 -1.152 . . . . 73.13 107.891 167.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 312' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -71.6 125.91 11.62 Favored 'Trans proline' 0 C--N 1.363 1.327 0 C-N-CA 121.759 1.639 . . . . 70.14 111.476 173.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 313' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -85.75 4.23 37.75 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.468 0.707 . . . . 75.13 111.031 179.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 314' ' ' ARG . . . . . 0.563 ' HG3' ' HB3' ' A' ' 150' ' ' PRO . 9.4 mpt_? 61.8 -164.48 0.24 Allowed 'General case' 0 C--N 1.373 1.606 0 C-N-CA 124.763 1.225 . . . . 74.53 109.91 -176.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 315' ' ' ASN . . . . . 0.726 ' HB2' ' HB2' ' A' ' 151' ' ' PRO . 3.8 m-80 -146.07 151.81 38.32 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.411 0.684 . . . . 75.34 109.309 165.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 316' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -127.85 172.6 10.71 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 107.223 -1.399 . . . . 74.4 107.223 175.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 100.0 p 54.98 52.34 12.03 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.532 1.133 . . . . 75.41 110.947 -174.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 318' ' ' VAL . . . . . 0.469 ' N ' ' HD2' ' B' ' 319' ' ' PRO . 25.4 m -69.78 -22.55 0.65 Allowed Pre-proline 0 CA--C 1.568 1.64 0 N-CA-C 115.207 1.558 . . . . 73.13 115.207 -173.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 319' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' B' ' 318' ' ' VAL . 10.7 Cg_endo -55.53 -33.11 85.39 Favored 'Trans proline' 0 C--N 1.403 3.412 0 CA-C-N 122.784 2.03 . . . . 65.1 112.375 166.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 320' ' ' THR . . . . . . . . . . . . . 41.3 m 62.21 -79.34 0.03 OUTLIER 'General case' 0 C--N 1.359 0.985 0 C-N-CA 124.892 1.277 . . . . 73.24 111.25 179.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 321' ' ' LEU . . . . . . . . . . . . . 49.7 tp -103.58 83.86 2.21 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 108.324 -0.991 . . . . 74.43 108.324 175.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 322' ' ' ALA . . . . . . . . . . . . . . . -82.33 -30.24 30.55 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 115.778 -0.646 . . . . 64.54 110.484 177.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 323' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -119.23 101.01 7.68 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.251 1.02 . . . . 74.02 110.529 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 324' ' ' MET . . . . . . . . . . . . . 23.7 ptp -105.96 15.98 25.75 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.944 0.898 . . . . 74.22 109.884 171.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 325' ' ' THR . . . . . . . . . . . . . 3.5 m 62.07 28.81 17.4 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.711 1.204 . . . . 72.33 110.251 -174.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 326' ' ' ASP . . . . . . . . . . . . . 36.7 t70 64.1 -73.01 0.05 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.308 1.443 . . . . 72.01 109.788 -171.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -87.62 133.4 33.82 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 107.899 -1.149 . . . . 75.41 107.899 168.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 328' ' ' ALA . . . . . . . . . . . . . . . -64.42 -57.6 8.83 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.854 0.462 . . . . 72.03 110.746 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 329' ' ' ILE . . . . . 0.607 ' HB ' ' HB3' ' B' ' 431' ' ' SER . 4.0 mp -123.93 -68.35 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 107.985 -1.117 . . . . 73.5 107.985 172.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 330' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 72.45 -38.02 0.41 Allowed 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 125.807 1.643 . . . . 74.44 113.047 -175.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 331' ' ' LEU . . . . . . . . . . . . . 33.6 tp -55.84 -38.94 70.73 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.443 1.097 . . . . 64.42 112.305 -178.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 332' ' ' LEU . . . . . 0.475 ' HG ' HG23 ' B' ' 329' ' ' ILE . 96.9 mt -72.71 -10.87 60.3 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 113.196 0.813 . . . . 74.41 113.196 -178.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 333' ' ' SER . . . . . . . . . . . . . 10.4 t -67.28 112.48 4.55 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 122.992 0.517 . . . . 65.04 109.84 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -166.46 -155.29 0.2 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.725 1.21 . . . . 65.35 108.203 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 335' ' ' ASN . . . . . 0.491 HD21 ' HB2' ' B' ' 339' ' ' PHE . 5.0 t-20 86.38 -47.21 0.05 Allowed 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 125.366 1.466 . . . . 74.12 111.439 176.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.29 -23.3 62.3 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 124.153 0.981 . . . . 73.55 112.702 -175.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 337' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -59.56 -39.18 83.19 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.58 1.152 . . . . 71.1 110.836 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 338' ' ' GLY . . . . . . . . . . . . . . . 150.17 33.77 0.04 OUTLIER Glycine 0 C--N 1.348 1.237 0 C-N-CA 121.645 -0.312 . . . . 73.12 113.548 176.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 339' ' ' PHE . . . . . 0.491 ' HB2' HD21 ' B' ' 335' ' ' ASN . 86.0 m-85 -91.77 89.29 7.02 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 122.935 0.494 . . . . 74.33 109.852 -178.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 340' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -88.76 174.63 7.89 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.524 0.73 . . . . 75.24 111.304 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 341' ' ' LEU . . . . . . . . . . . . . 54.9 tp -71.84 105.73 3.91 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 124.308 1.043 . . . . 75.34 110.792 -175.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 342' ' ' GLN . . . . . . . . . . . . . 48.1 tp60 -95.98 -40.08 9.45 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.121 0.968 . . . . 74.32 111.534 -178.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 343' ' ' VAL . . . . . . . . . . . . . 59.6 t -64.09 -24.23 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 123.443 0.697 . . . . 65.15 111.469 -175.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -134.98 143.47 46.85 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 108.682 -0.858 . . . . 74.33 108.682 178.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 345' ' ' GLY . . . . . . . . . . . . . . . -166.25 106.15 0.26 Allowed Glycine 0 C--N 1.353 1.515 0 CA-C-O 119.395 -0.67 . . . . 63.14 111.686 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 346' ' ' ALA . . . . . . . . . . . . . . . 65.98 11.29 7.62 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 124.785 1.234 . . . . 72.51 113.164 175.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 14.0 m -99.06 0.81 44.47 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.274 1.029 . . . . 72.21 110.844 -178.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 70.2 mt 67.91 -77.35 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 125.964 1.706 . . . . 73.42 110.801 -177.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 349' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -72.01 -83.31 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.21 0.604 . . . . 71.13 110.41 -176.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 350' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -139.36 146.53 40.34 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.97 0.908 . . . . 74.52 108.803 177.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -97.5 136.5 37.84 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 108.0 -1.111 . . . . 71.32 108.0 170.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 26.6 t70 76.2 -59.43 0.51 Allowed 'General case' 0 CA--C 1.55 0.967 0 O-C-N 124.713 1.258 . . . . 74.35 111.106 179.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 353' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -86.03 164.69 17.2 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.473 0.709 . . . . 74.33 111.64 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 354' ' ' ALA . . . . . . . . . . . . . . . 64.95 8.5 4.71 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 124.546 1.139 . . . . 72.23 112.871 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 355' ' ' ALA . . . . . . . . . . . . . . . -92.76 5.95 49.31 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.039 0.935 . . . . 75.44 110.759 174.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 356' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -63.94 -45.04 80.48 Favored Pre-proline 0 CA--C 1.554 1.099 0 C-N-CA 125.049 1.34 . . . . 74.32 112.667 -178.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 357' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -68.08 -17.09 45.74 Favored 'Trans proline' 0 C--N 1.388 2.609 0 C-N-CA 121.899 1.733 . . . . 74.21 112.714 171.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 358' ' ' CYS . . . . . . . . . . . . . 56.9 m 65.5 18.39 11.26 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.721 1.209 . . . . 75.21 111.698 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 359' ' ' GLY . . . . . . . . . . . . . . . 65.02 -86.78 0.08 OUTLIER Glycine 0 C--N 1.353 1.474 0 N-CA-C 111.302 -0.719 . . . . 72.04 111.302 -172.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 360' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -79.49 93.97 5.51 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 108.966 -0.753 . . . . 53.34 108.966 174.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 361' ' ' ILE . . . . . . . . . . . . . 7.9 tp -86.54 -20.56 7.74 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.227 0 C-N-CA 124.1 0.96 . . . . 64.41 110.264 177.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 362' ' ' GLY . . . . . . . . . . . . . . . 118.29 -10.78 13.04 Favored Glycine 0 C--N 1.347 1.192 0 CA-C-N 116.089 -0.505 . . . . 72.35 112.52 -178.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 363' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -81.25 97.48 7.66 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.333 0.653 . . . . 73.13 109.466 179.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 364' ' ' THR . . . . . . . . . . . . . 26.7 p -103.81 93.73 5.05 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.25 1.02 . . . . 74.04 110.758 -176.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 97.9 t -101.26 -56.67 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 N-CA-C 108.457 -0.942 . . . . 74.51 108.457 175.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -128.64 158.3 38.91 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 107.931 -1.137 . . . . 52.52 107.931 177.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 367' ' ' LEU . . . . . . . . . . . . . 81.4 mt -112.93 22.05 14.82 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.114 0.966 . . . . 75.05 110.607 178.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 368' ' ' ASP . . . . . 0.5 ' HA ' HG11 ' B' ' 371' ' ' VAL . 11.0 p-10 -69.0 -10.11 55.86 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 113.932 1.086 . . . . 73.23 113.932 -175.01 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 369' ' ' GLU . . . . . 0.456 ' HA ' ' NH1' ' B' ' 373' ' ' ARG . 16.9 tp10 -97.66 12.23 34.33 Favored 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 123.587 0.755 . . . . 74.11 110.542 177.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 370' ' ' ALA . . . . . . . . . . . . . . . -147.84 -23.84 0.36 Allowed 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 112.751 0.649 . . . . 74.25 112.751 178.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 371' ' ' VAL . . . . . 0.5 HG11 ' HA ' ' B' ' 368' ' ' ASP . 7.3 p -60.78 -66.55 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.333 0 N-CA-C 112.967 0.729 . . . . 74.12 112.967 -167.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 372' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -175.6 107.32 0.09 Allowed 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 108.67 -0.863 . . . . 63.2 108.67 -174.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 373' ' ' ARG . . . . . 0.456 ' NH1' ' HA ' ' B' ' 369' ' ' GLU . 1.9 mpp_? -119.99 -11.37 9.3 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 123.219 0.608 . . . . 72.2 111.32 174.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . 73.85 -55.59 0.66 Allowed 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 125.883 1.673 . . . . 71.45 112.223 -175.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 375' ' ' LEU . . . . . 0.446 HD11 ' HG2' ' A' ' 263' ' ' PRO . 8.4 tt 75.77 -7.18 1.85 Allowed 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 125.228 1.411 . . . . 72.22 111.395 178.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -69.89 81.18 0.47 Allowed 'General case' 0 C--N 1.357 0.897 0 CA-C-O 121.969 0.89 . . . . 73.13 109.579 173.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 377' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -163.37 -44.35 0.03 OUTLIER 'General case' 0 C--O 1.224 -0.272 0 CA-C-N 113.92 -1.491 . . . . 73.31 107.933 -175.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 378' ' ' ALA . . . . . 0.433 ' HA ' ' HB3' ' B' ' 381' ' ' GLU . . . -55.51 -24.48 31.89 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 124.741 1.216 . . . . 73.45 113.249 -178.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -65.37 -51.57 59.58 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.882 0.873 . . . . 73.22 110.36 175.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 380' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -84.84 -15.28 45.3 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.66 0.784 . . . . 72.4 110.86 -178.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 381' ' ' GLU . . . . . 0.433 ' HB3' ' HA ' ' B' ' 378' ' ' ALA . 23.9 tt0 -72.06 -34.47 68.76 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.399 1.08 . . . . 74.34 109.999 175.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 382' ' ' GLY . . . . . 0.438 ' HA2' HG23 ' B' ' 403' ' ' THR . . . -73.82 66.39 1.75 Allowed Glycine 0 C--N 1.345 1.079 0 N-CA-C 111.666 -0.574 . . . . 73.1 111.666 176.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 383' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -73.87 -46.14 46.61 Favored 'General case' 0 C--N 1.351 0.633 0 C-N-CA 123.988 0.915 . . . . 73.1 109.368 -176.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 384' ' ' THR . . . . . . . . . . . . . 5.2 m 69.63 1.13 3.24 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 124.442 1.097 . . . . 71.44 112.473 173.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 1.3 pp -100.99 165.04 11.53 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.692 0.797 . . . . 75.43 111.728 -177.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 386' ' ' VAL . . . . . . . . . . . . . 10.0 p -94.74 27.41 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 C-N-CA 124.352 1.061 . . . . 75.23 109.884 -179.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 387' ' ' ILE . . . . . . . . . . . . . 48.8 mm 72.49 -66.34 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 126.418 1.887 . . . . 74.12 110.767 -171.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 388' ' ' VAL . . . . . . . . . . . . . 90.4 t 75.31 -49.56 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 C-N-CA 125.564 1.546 . . . . 74.43 111.464 -178.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 389' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 78.58 -12.09 1.13 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 126.914 2.086 . . . . 71.25 113.193 173.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . 53.11 73.74 0.34 Allowed 'General case' 0 C--N 1.363 1.164 0 C-N-CA 124.406 1.082 . . . . 73.41 111.352 176.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 391' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 68.48 -76.3 0.06 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.153 1.381 . . . . 64.12 110.628 -172.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 392' ' ' HIS . . . . . . . . . . . . . 30.1 p-80 -157.1 16.77 0.28 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.013 0.925 . . . . 72.42 110.859 -177.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -68.17 -55.98 10.41 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.552 0.741 . . . . 61.53 110.837 -175.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 44.0 t-80 68.41 -71.47 0.11 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 126.126 1.77 . . . . 73.31 111.579 179.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . 54.42 -100.57 0.11 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.315 1.046 . . . . 75.42 109.308 -169.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 16.5 m 63.71 -17.79 0.07 Allowed 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 124.947 1.299 . . . . 75.55 114.344 177.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 397' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 62.2 -68.83 0.06 Allowed 'General case' 0 C--N 1.356 0.852 0 C-N-CA 126.591 1.956 . . . . 75.54 111.226 -171.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 398' ' ' ILE . . . . . 0.402 HD11 ' HA ' ' B' ' 401' ' ' PRO . 20.9 pt -85.59 155.17 3.46 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.209 0 C-N-CA 124.213 1.005 . . . . 75.44 110.639 172.201 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 399' ' ' VAL . . . . . . . . . . . . . 11.5 p -78.65 -25.62 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 122.553 0.341 . . . . 73.32 110.86 -175.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 400' ' ' ALA . . . . . . . . . . . . . . . -123.31 83.3 52.19 Favored Pre-proline 0 CA--C 1.557 1.219 0 C-N-CA 124.017 0.927 . . . . 74.52 110.247 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 401' ' ' PRO . . . . . 0.402 ' HA ' HD11 ' B' ' 398' ' ' ILE . 50.2 Cg_endo -69.78 -52.82 0.3 Allowed 'Trans proline' 0 C--N 1.386 2.552 0 C-N-CA 122.818 2.345 . . . . 71.34 111.868 176.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 402' ' ' ASP . . . . . 0.406 ' HB3' ' HD3' ' A' ' 260' ' ' ARG . 6.6 t70 59.15 -179.64 0.08 Allowed 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 125.128 1.371 . . . . 74.34 112.478 174.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 403' ' ' THR . . . . . 0.438 HG23 ' HA2' ' B' ' 382' ' ' GLY . 85.8 m -147.61 106.22 3.8 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.992 0.917 . . . . 73.2 108.968 172.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 404' ' ' LYS . . . . . . . . . . . . . 24.6 tptp -84.89 -29.81 24.93 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 122.699 0.4 . . . . 71.14 109.997 177.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 405' ' ' ALA . . . . . . . . . . . . . . . -50.3 105.6 0.54 Allowed Pre-proline 0 CA--C 1.558 1.262 0 C-N-CA 124.727 1.211 . . . . 71.24 112.286 -177.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 406' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -72.1 1.33 6.07 Favored 'Trans proline' 0 C--N 1.384 2.413 0 C-N-CA 123.281 2.654 . . . . 64.23 114.224 -174.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . -74.36 -24.9 71.94 Favored Glycine 0 C--N 1.344 1.016 0 N-CA-C 111.957 -0.457 . . . . 74.04 111.957 169.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 408' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -105.94 26.78 9.25 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.283 1.033 . . . . 72.55 109.993 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 9.5 t -64.41 -25.32 67.96 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 124.195 0.998 . . . . 73.52 112.827 -178.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 410' ' ' GLN . . . . . . . . . . . . . 71.0 mm-40 67.33 -77.27 0.05 OUTLIER 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.609 1.564 . . . . 70.42 110.362 -174.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . 60.45 -76.84 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 125.3 1.44 . . . . 74.33 112.435 174.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 5.8 mp -64.5 -37.58 88.04 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.195 0.998 . . . . 75.21 110.09 178.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -76.99 85.2 3.51 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.103 -0.953 . . . . 71.14 109.012 175.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 414' ' ' THR . . . . . . . . . . . . . 12.9 p -98.52 82.15 2.82 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.067 0.947 . . . . 73.24 108.879 174.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 415' ' ' LYS . . . . . 0.592 ' HZ1' ' HB2' ' B' ' 415' ' ' LYS . 5.0 ttmp? -133.25 -44.01 0.85 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.521 0.728 . . . . 75.21 109.867 -175.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 70.43 138.28 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.968 1.707 . . . . 75.33 111.5 -177.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 417' ' ' GLY . . . . . . . . . . . . . . . -65.82 -36.53 92.32 Favored Glycine 0 C--N 1.346 1.126 0 N-CA-C 110.663 -0.975 . . . . 62.31 110.663 169.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 418' ' ' ALA . . . . . . . . . . . . . . . -139.27 114.5 9.64 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.091 0.957 . . . . 70.25 108.481 171.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 419' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.5 140.89 18.96 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 C-N-CA 123.668 0.787 . . . . 73.31 109.487 175.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 420' ' ' MET . . . . . 0.476 ' SD ' ' N ' ' B' ' 421' ' ' VAL . 9.5 tmm? 72.66 153.97 0.14 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 124.813 1.245 . . . . 73.34 109.111 -169.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 421' ' ' VAL . . . . . 0.638 HG21 ' HG2' ' A' ' 211' ' ' ARG . 15.9 m -67.96 91.2 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.331 0 CA-C-O 122.115 0.96 . . . . 72.42 112.63 -174.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 422' ' ' MET . . . . . . . . . . . . . 13.6 tpt -63.6 -48.99 75.11 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 115.175 -0.921 . . . . 74.1 108.67 166.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 423' ' ' SER . . . . . . . . . . . . . 46.2 m -148.8 -57.02 0.21 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 107.282 -1.377 . . . . 63.45 107.282 170.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 424' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -140.51 107.63 5.47 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.49 1.116 . . . . 74.22 108.407 172.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . -171.12 152.36 18.08 Favored Glycine 0 C--N 1.344 0.987 0 N-CA-C 110.787 -0.925 . . . . 75.12 110.787 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 426' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 64.53 87.77 0.11 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.717 1.207 . . . . 75.43 111.012 -177.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 427' ' ' SER . . . . . . . . . . . . . 34.6 p -74.09 86.88 1.87 Allowed 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 115.213 -0.903 . . . . 75.14 110.925 -176.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 58.56 28.0 16.45 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 125.197 1.399 . . . . 73.23 112.385 175.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 429' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 62.39 -89.76 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 124.718 1.207 . . . . 63.42 110.738 -172.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 18.5 t70 177.12 -86.93 0.0 OUTLIER 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.176 1.39 . . . . 62.42 108.102 -174.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 431' ' ' SER . . . . . 0.607 ' HB3' ' HB ' ' B' ' 329' ' ' ILE . 51.4 m -167.68 10.88 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 124.452 1.101 . . . . 75.05 111.564 -174.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 432' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -71.9 -49.34 38.72 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.387 0.675 . . . . 71.1 110.882 -173.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 433' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -135.51 -40.92 0.71 Allowed 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.245 -0.889 . . . . 73.43 109.758 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 434' ' ' HIS . . . . . . . . . . . . . 59.6 t-80 66.89 102.54 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.284 1.034 . . . . 73.42 110.68 177.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 435' ' ' THR . . . . . 0.634 HG22 HG11 ' A' ' 219' ' ' VAL . 1.7 m -69.1 -25.47 64.43 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.65 0.78 . . . . 73.42 112.649 -167.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . -66.01 94.72 0.22 Allowed Glycine 0 C--N 1.349 1.283 0 N-CA-C 111.49 -0.644 . . . . 61.51 111.49 174.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 24.9 p -79.93 -85.98 0.08 Allowed 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 123.319 0.648 . . . . 72.35 111.74 -172.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 438' ' ' GLN . . . . . . . . . . . . . 13.9 tm0? -107.74 -76.39 0.61 Allowed 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 108.05 -1.092 . . . . 71.55 108.05 -177.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 439' ' ' LEU . . . . . . . . . . . . . 1.7 pp 34.79 45.58 0.16 Allowed 'General case' 0 N--CA 1.502 2.138 0 C-N-CA 126.347 1.859 . . . . 74.24 114.96 169.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 440' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -75.1 -4.1 36.63 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 115.964 -0.562 . . . . 74.1 112.327 -169.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 441' ' ' ILE . . . . . 0.574 HG22 ' H ' ' B' ' 443' ' ' ALA . 46.2 mm 76.42 -83.87 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 125.355 1.462 . . . . 74.15 111.673 170.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 442' ' ' ALA . . . . . . . . . . . . . . . 67.63 2.34 2.95 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 124.654 1.182 . . . . 73.33 114.176 -177.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 443' ' ' ALA . . . . . 0.574 ' H ' HG22 ' B' ' 441' ' ' ILE . . . -89.23 154.6 19.99 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.641 0.776 . . . . 74.21 110.709 178.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 65.08 -80.26 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.865 1.266 . . . . 71.31 110.787 -174.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . 168.28 78.72 0.04 OUTLIER Glycine 0 C--N 1.341 0.816 0 N-CA-C 110.717 -0.953 . . . . 74.34 110.717 -177.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 446' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -79.58 0.11 10.28 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 122.544 2.163 . . . . 72.44 111.536 175.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 447' ' ' HIS . . . . . 0.457 ' HB3' HD22 ' B' ' 450' ' ' ASN . 26.9 m80 -123.32 87.8 2.81 Favored 'General case' 0 C--N 1.35 0.623 0 C-N-CA 124.407 1.083 . . . . 63.45 108.453 178.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . -124.72 117.05 23.35 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.963 1.305 . . . . 74.31 109.238 -177.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 449' ' ' ALA . . . . . . . . . . . . . . . 57.82 67.22 0.99 Allowed 'General case' 0 CA--C 1.549 0.906 0 O-C-N 124.207 0.942 . . . . 74.42 110.467 -174.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 450' ' ' ASN . . . . . 0.457 HD22 ' HB3' ' B' ' 447' ' ' HIS . 14.9 m120 -64.11 -68.68 0.33 Allowed 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 114.774 -1.103 . . . . 63.22 111.354 -174.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 46.8 t 62.16 -74.07 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 C-N-CA 125.038 1.335 . . . . 74.44 111.365 -178.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 452' ' ' VAL . . . . . . . . . . . . . 29.8 m -85.49 172.59 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 123.585 0.754 . . . . 74.24 109.786 171.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . -148.18 44.05 0.79 Allowed Glycine 0 N--CA 1.466 0.687 0 N-CA-C 110.924 -0.87 . . . . 73.44 110.924 175.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 454' ' ' LEU . . . . . . . . . . . . . 42.4 tp -146.7 120.39 9.2 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.32 0.648 . . . . 73.13 109.664 -176.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 11.1 t -154.54 13.49 0.42 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.115 0.966 . . . . 72.1 109.753 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -82.22 -19.59 39.41 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.327 1.051 . . . . 74.3 112.65 -165.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 457' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -65.6 154.72 37.95 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.348 0.659 . . . . 65.21 111.114 -179.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 46.8 p -57.76 -26.56 62.04 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.443 1.097 . . . . 72.13 112.855 -178.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 459' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -62.15 -37.76 86.43 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.772 0.829 . . . . 73.31 110.602 174.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 94.1 mt 66.87 99.12 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.497 1.519 . . . . 65.42 110.672 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -76.13 -176.32 3.48 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.675 0.79 . . . . 75.0 110.578 178.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 462' ' ' TYR . . . . . 0.488 ' HB3' ' HA3' ' B' ' 469' ' ' GLY . 39.7 m-85 -74.96 107.48 7.06 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 109.247 -0.649 . . . . 72.53 109.247 174.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 463' ' ' THR . . . . . 0.575 HG21 ' HA ' ' B' ' 470' ' ' LEU . 12.5 t -68.96 -179.35 1.46 Allowed 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 122.95 0.5 . . . . 71.14 111.104 -179.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 464' ' ' MET . . . . . . . . . . . . . 21.7 mmt -76.98 20.37 0.26 Allowed 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 123.933 0.893 . . . . 75.31 113.203 -168.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt -80.28 140.26 36.28 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 109.37 -0.604 . . . . 72.15 109.37 169.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -73.79 147.27 43.57 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 122.791 0.436 . . . . 65.13 109.911 170.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . 72.38 111.96 0.06 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.299 1.439 . . . . 75.3 111.825 -178.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 39.3 tp 66.04 -73.37 0.07 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 125.4 1.48 . . . . 74.32 110.724 -177.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 469' ' ' GLY . . . . . 0.488 ' HA3' ' HB3' ' B' ' 462' ' ' TYR . . . 142.73 -96.13 0.19 Allowed Glycine 0 C--N 1.345 1.058 0 N-CA-C 112.202 -0.359 . . . . 62.03 112.202 172.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 470' ' ' LEU . . . . . 0.575 ' HA ' HG21 ' B' ' 463' ' ' THR . 46.5 tp -62.58 -55.09 30.44 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.421 0.688 . . . . 75.32 111.157 -175.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 471' ' ' LYS . . . . . . . . . . . . . 5.3 mtpm? . . . . . 0 CA--C 1.55 0.966 0 CA-C-N 115.04 -0.982 . . . . 74.2 108.772 179.697 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 68.3 mtm . . . . . 0 N--CA 1.481 1.082 0 N-CA-C 110.426 -0.213 . . . . 70.43 110.426 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.39 29.4 18.96 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.932 1.293 . . . . 70.41 112.69 175.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -74.68 76.9 2.04 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.382 0.673 . . . . 71.34 109.693 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -37.72 101.63 0.02 OUTLIER 'General case' 0 C--N 1.354 0.773 0 C-N-CA 125.765 1.626 . . . . 70.52 113.756 -176.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 5' ' ' LYS . . . . . 0.468 ' HE2' HD11 ' C' ' 10' ' ' ILE . 14.6 mmmm -73.32 98.94 2.78 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.46 -1.311 . . . . 72.32 107.46 164.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -71.15 92.78 1.01 Allowed 'General case' 0 C--O 1.234 0.258 0 N-CA-C 107.759 -1.2 . . . . 65.15 107.759 177.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 7' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -58.64 -29.96 66.94 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 114.668 -1.151 . . . . 73.43 112.17 -170.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -67.33 -48.75 66.63 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.112 -0.949 . . . . 74.23 110.002 176.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.12 -38.52 86.66 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.978 0.511 . . . . 63.34 110.941 178.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 10' ' ' ILE . . . . . 0.468 HD11 ' HE2' ' C' ' 5' ' ' LYS . 59.5 mt -61.79 -39.36 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.335 0.654 . . . . 73.31 110.185 176.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 96.0 mt -80.44 -7.47 59.16 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 112.586 0.587 . . . . 75.53 112.586 176.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.37 35.84 51.41 Favored Glycine 0 C--N 1.352 1.454 0 CA-C-N 117.917 0.326 . . . . 74.43 113.636 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 6.3 m -133.55 155.89 80.15 Favored Pre-proline 0 N--CA 1.483 1.206 0 C-N-CA 125.109 1.364 . . . . 71.34 109.576 177.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -81.98 155.42 17.49 Favored 'Trans proline' 0 C--N 1.371 1.714 0 C-N-CA 122.195 1.93 . . . . 74.43 112.306 174.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 90.1 mtm-85 -67.35 75.98 0.16 Allowed 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.747 0.819 . . . . 74.35 110.311 174.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -177.48 -31.63 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.572 1.149 . . . . 71.24 108.779 -175.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.68 134.22 56.52 Favored 'General case' 0 C--N 1.353 0.748 0 CA-C-N 115.578 -0.737 . . . . 75.2 110.401 177.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 75.0 p -71.36 173.46 7.8 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.319 0.648 . . . . 74.41 111.671 -175.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 19' ' ' GLN . . . . . 0.454 HE22 ' HE2' ' C' ' 23' ' ' LYS . 0.1 OUTLIER -60.24 -39.55 87.09 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.347 1.059 . . . . 74.45 110.376 -176.005 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 20' ' ' GLU . . . . . 0.41 ' O ' ' HG3' ' C' ' 24' ' ' ARG . 7.8 tm-20 -66.64 -34.94 78.98 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 123.148 0.579 . . . . 74.53 110.015 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -70.97 -36.95 72.73 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 122.734 0.414 . . . . 73.42 110.773 176.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 1.4 mp -63.87 -34.52 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.333 1.053 . . . . 75.54 110.078 173.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 23' ' ' LYS . . . . . 0.524 ' O ' ' HG3' ' C' ' 27' ' ' LYS . 13.7 tppt? -66.55 -45.18 80.22 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.295 0.638 . . . . 74.13 109.305 178.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 24' ' ' ARG . . . . . 0.41 ' HG3' ' O ' ' C' ' 20' ' ' GLU . 63.1 mtm-85 -63.49 -41.99 98.55 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 123.459 0.475 . . . . 73.52 110.839 178.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.95 -38.45 86.14 Favored 'General case' 0 C--O 1.253 1.251 0 CA-C-N 115.257 -0.883 . . . . 75.32 110.987 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 26' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -57.14 -55.78 30.25 Favored 'General case' 0 C--O 1.216 -0.685 0 CA-C-N 114.541 -1.208 . . . . 72.31 109.13 173.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . 0.524 ' HG3' ' O ' ' C' ' 23' ' ' LYS . 33.2 mtmt -57.39 -41.56 80.47 Favored 'General case' 0 N--CA 1.483 1.186 0 O-C-N 124.424 1.078 . . . . 75.33 110.824 -177.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -55.32 -51.45 66.69 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.004 0.921 . . . . 75.55 110.961 178.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 82.3 mt -86.07 -6.02 59.1 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.724 -0.671 . . . . 71.43 111.498 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.41 -0.09 49.75 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.934 0.893 . . . . 75.32 110.011 171.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . 0.406 ' HG3' ' O ' ' C' ' 27' ' ' LYS . 95.7 mtt180 -100.94 -41.89 6.64 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.26 1.024 . . . . 73.5 109.208 165.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.33 -50.16 49.07 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 115.637 -0.71 . . . . 71.12 109.629 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 33' ' ' TYR . . . . . 0.425 ' HB3' ' O ' ' C' ' 43' ' ' ALA . 37.2 m-85 -95.4 14.94 20.9 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.924 0.49 . . . . 72.14 111.52 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 34' ' ' HIS . . . . . . . . . . . . . 12.4 t60 -61.4 107.82 1.27 Allowed Pre-proline 0 N--CA 1.489 1.48 0 C-N-CA 124.36 1.064 . . . . 74.34 110.792 -177.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -61.74 -21.31 71.87 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 123.018 2.479 . . . . 72.22 114.16 -172.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.05 -26.31 36.44 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.951 0.9 . . . . 60.34 111.668 178.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 90.2 t -97.39 -58.33 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 109.046 -0.724 . . . . 75.33 109.046 176.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -98.12 84.21 3.24 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 114.801 -1.09 . . . . 65.41 108.907 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.26 79.21 0.99 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 114.866 -1.061 . . . . 71.22 108.635 175.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 67.1 m -140.38 114.9 7.53 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-O 118.301 -0.857 . . . . 74.14 109.387 -178.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -52.12 -41.85 62.61 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 123.326 2.684 . . . . 75.0 112.774 -176.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -48.62 -50.62 31.94 Favored 'General case' 0 N--CA 1.483 1.18 0 O-C-N 124.078 0.861 . . . . 71.01 110.85 173.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 43' ' ' ALA . . . . . 0.425 ' O ' ' HB3' ' C' ' 33' ' ' TYR . . . -71.55 -23.55 61.78 Favored 'General case' 0 C--O 1.216 -0.679 0 CA-C-N 114.768 -1.105 . . . . 71.45 110.931 -176.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 44' ' ' GLU . . . . . 0.469 ' O ' ' HG3' ' C' ' 48' ' ' LYS . 47.9 mt-10 -80.72 -33.48 35.22 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 122.992 0.517 . . . . 74.04 110.672 -176.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 45' ' ' GLU . . . . . 0.411 ' HA ' ' HD2' ' C' ' 48' ' ' LYS . 40.3 mt-10 -76.36 -39.4 53.95 Favored 'General case' 0 C--O 1.244 0.763 0 C-N-CA 123.316 0.647 . . . . 75.44 109.643 178.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 46' ' ' LYS . . . . . 0.527 ' O ' HG12 ' C' ' 50' ' ' ILE . 99.6 mttt -64.26 -34.7 78.71 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.008 -0.997 . . . . 72.32 110.131 170.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -66.34 -35.87 81.45 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.919 0.888 . . . . 71.12 110.297 175.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 48' ' ' LYS . . . . . 0.469 ' HG3' ' O ' ' C' ' 44' ' ' GLU . 95.1 mttt -60.67 -42.32 96.83 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 109.773 -0.454 . . . . 72.04 109.773 173.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -66.67 -33.8 76.45 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 123.653 0.596 . . . . 72.33 111.578 174.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 50' ' ' ILE . . . . . 0.527 HG12 ' O ' ' C' ' 46' ' ' LYS . 32.8 mm -65.72 -33.93 66.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 109.005 -0.739 . . . . 75.43 109.005 175.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 51' ' ' ASN . . . . . 0.55 ' HA ' ' HB3' ' C' ' 54' ' ' TYR . 36.3 m-80 -93.0 -3.98 53.46 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.123 0.969 . . . . 74.04 112.333 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -81.53 -51.45 8.25 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 107.243 -1.391 . . . . 75.54 107.243 165.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.14 -37.29 71.82 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 112.503 -2.135 . . . . 63.1 111.304 173.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 54' ' ' TYR . . . . . 0.55 ' HB3' ' HA ' ' C' ' 51' ' ' ASN . 58.1 t80 -78.18 -39.21 41.51 Favored 'General case' 0 C--O 1.215 -0.724 0 CA-C-N 115.5 -0.773 . . . . 75.01 110.411 174.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.52 -28.32 44.46 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 118.751 0.705 . . . . 60.54 111.56 177.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 56' ' ' VAL . . . . . 0.455 ' O ' ' HB2' ' C' ' 62' ' ' LYS . 47.3 t -83.28 -67.09 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 CA-C-O 121.288 0.566 . . . . 72.43 110.443 169.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 57' ' ' LEU . . . . . . . . . . . . . 52.1 mt -84.47 15.5 3.67 Favored 'General case' 0 CA--C 1.565 1.538 0 N-CA-C 113.066 0.765 . . . . 75.02 113.066 -164.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 45.5 t -61.2 -45.8 93.09 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 124.188 0.995 . . . . 75.33 112.291 -178.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -123.31 149.83 58.82 Favored Pre-proline 0 C--O 1.242 0.69 0 CA-C-N 114.897 -1.047 . . . . 72.03 108.639 -173.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 60' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -51.43 -26.97 22.9 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 123.299 2.666 . . . . 73.21 113.088 174.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -62.56 -70.28 0.21 Allowed 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.439 -0.8 . . . . 62.13 111.272 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 62' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' C' ' 56' ' ' VAL . 0.0 OUTLIER -70.64 -20.66 62.71 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 122.117 0.167 . . . . 75.43 110.857 -175.568 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -53.59 -62.11 1.87 Allowed 'General case' 0 C--N 1.354 0.776 0 O-C-N 124.002 0.814 . . . . 74.14 109.864 168.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -70.1 -27.56 64.69 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 112.249 0.463 . . . . 74.15 112.249 -176.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 88.5 mt -57.71 -50.27 78.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 109.68 -0.489 . . . . 71.5 109.68 172.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -61.74 -47.61 84.45 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.112 0.565 . . . . 74.31 111.691 174.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -53.94 -32.16 52.75 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.119 0.568 . . . . 73.14 111.979 -178.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 68' ' ' THR . . . . . 0.427 ' O ' ' HB ' ' C' ' 72' ' ' THR . 40.1 p -97.02 -24.09 15.96 Favored 'General case' 0 CA--C 1.553 1.069 0 N-CA-C 112.512 0.56 . . . . 74.43 112.512 176.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 69' ' ' TYR . . . . . 0.439 ' HE2' ' HD3' ' C' ' 78' ' ' PRO . 3.4 t80 -118.25 120.29 37.22 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.31 -0.869 . . . . 75.22 110.763 -172.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.94 23.58 66.25 Favored Glycine 0 C--N 1.346 1.136 0 N-CA-C 111.616 -0.594 . . . . 62.51 111.616 -173.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 54.8 m -142.18 -53.58 0.42 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 103.745 -2.687 . . . . 72.34 103.745 175.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 72' ' ' THR . . . . . 0.427 ' HB ' ' O ' ' C' ' 68' ' ' THR . 21.1 m -105.25 173.3 6.36 Favored 'General case' 0 CA--C 1.564 1.498 0 N-CA-C 104.969 -2.234 . . . . 73.35 104.969 158.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -90.85 11.41 22.67 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 118.999 0.818 . . . . 73.23 111.081 173.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.12 -163.35 0.0 OUTLIER Pre-proline 0 CA--C 1.594 2.646 0 C-N-CA 125.728 1.611 . . . . 53.23 112.305 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER 8.2 109.24 0.0 OUTLIER 'Trans proline' 1 C--N 1.419 4.25 0 C-N-CA 125.153 3.902 . . . . 75.14 118.512 -156.134 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -62.12 165.96 13.59 Favored 'Trans proline' 0 C--N 1.387 2.556 0 C-N-CA 123.52 2.813 . . . . 71.22 113.321 -179.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -21.39 106.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.405 3.517 1 C-N-CA 126.157 4.572 . . . . 74.4 116.029 178.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 78' ' ' PRO . . . . . 0.585 ' HG2' ' HA ' ' C' ' 101' ' ' PHE . 1.3 Cg_exo -37.59 146.45 0.11 Allowed 'Trans proline' 0 C--N 1.379 2.133 1 C-N-CA 126.277 4.651 . . . . 74.44 117.639 -171.781 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -58.87 119.43 6.68 Favored 'Trans proline' 0 C--N 1.391 2.813 0 C-N-CA 123.555 2.837 . . . . 70.12 113.411 -178.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -62.12 75.49 0.1 OUTLIER 'Trans proline' 0 C--N 1.391 2.811 0 C-N-CA 123.56 2.84 . . . . 74.31 110.321 169.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -167.48 -24.89 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 113.704 -1.589 . . . . 75.2 110.281 -166.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . 0.413 ' HA2' ' O ' ' C' ' 104' ' ' GLY . . . 118.21 141.73 6.81 Favored Glycine 0 C--N 1.361 1.969 0 N-CA-C 116.377 1.311 . . . . 75.13 116.377 163.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 83' ' ' TYR . . . . . 0.494 ' CE1' ' HB3' ' C' ' 78' ' ' PRO . 22.7 m-85 -110.03 92.93 4.24 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 107.311 -1.366 . . . . 73.4 107.311 165.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -27.67 135.29 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 127.471 2.308 . . . . 75.11 116.157 -175.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 85' ' ' PHE . . . . . 0.522 ' CZ ' HD22 ' C' ' 105' ' ' LEU . 16.0 m-85 -135.49 74.21 1.5 Allowed 'General case' 0 C--N 1.346 0.451 0 CA-C-N 115.167 -0.924 . . . . 74.41 110.999 -177.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 86' ' ' SER . . . . . 0.518 ' OG ' ' HA2' ' C' ' 163' ' ' GLY . 1.4 m -55.82 83.21 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 123.715 0.806 . . . . 52.42 110.523 177.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 62.65 16.0 54.92 Favored Glycine 0 CA--C 1.54 1.637 0 CA-C-O 119.007 -0.885 . . . . 74.34 114.624 -170.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 88' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -86.46 120.81 28.19 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 118.536 1.168 . . . . 74.44 109.772 -174.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -76.56 88.67 3.28 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 120.856 0.36 . . . . 72.23 110.604 -174.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 90' ' ' VAL . . . . . . . . . . . . . 6.0 p -45.43 -43.96 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 124.333 1.053 . . . . 54.42 113.06 175.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -61.48 -31.2 71.17 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.745 0.818 . . . . 75.25 111.381 -176.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -79.08 -24.89 43.18 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.275 -0.875 . . . . 75.53 111.083 -176.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 19.1 m-30 -73.83 165.51 24.98 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 122.637 0.375 . . . . 72.45 110.787 -175.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 86.3 p -67.62 163.45 21.33 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 113.509 0.929 . . . . 52.11 113.509 -167.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.11 -42.91 95.72 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.027 -0.988 . . . . 72.35 110.645 172.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -58.44 -43.53 88.82 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.161 0.584 . . . . 74.24 110.653 178.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 97' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -61.51 -43.67 98.45 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.203 -0.908 . . . . 64.25 109.691 177.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 98' ' ' GLN . . . . . 0.526 ' HA ' HD13 ' C' ' 105' ' ' LEU . 48.6 mt-30 -82.58 -5.21 58.65 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 115.091 -0.958 . . . . 71.33 113.306 -177.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -101.4 -35.95 9.03 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.412 0.685 . . . . 74.43 110.947 172.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 46.3 tp -74.2 -61.4 1.87 Allowed 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 109.067 -0.716 . . . . 73.23 109.067 -178.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 101' ' ' PHE . . . . . 0.585 ' HA ' ' HG2' ' C' ' 78' ' ' PRO . 65.6 m-85 -92.08 8.72 36.54 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 115.389 -0.823 . . . . 75.04 111.55 -177.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -46.52 -58.28 6.05 Favored Glycine 0 CA--C 1.544 1.895 0 N-CA-C 117.629 1.811 . . . . 74.41 117.629 -169.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . 0.449 ' HD2' ' HD2' ' C' ' 78' ' ' PRO . 52.9 Cg_exo -58.49 -18.55 39.84 Favored 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 123.359 2.706 . . . . 64.35 114.41 179.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 104' ' ' GLY . . . . . 0.413 ' O ' ' HA2' ' C' ' 82' ' ' GLY . . . -105.35 -1.71 41.05 Favored Glycine 0 C--N 1.348 1.197 0 CA-C-O 119.501 -0.61 . . . . 73.42 113.814 179.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 105' ' ' LEU . . . . . 0.526 HD13 ' HA ' ' C' ' 98' ' ' GLN . 15.3 mt -83.56 32.97 0.46 Allowed 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 119.284 1.542 . . . . 75.43 113.595 -175.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 106' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 53.03 -117.64 1.22 Allowed 'General case' 0 CA--C 1.557 1.216 0 N-CA-C 107.846 -1.168 . . . . 64.24 107.846 -177.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.48 54.68 1.22 Allowed Glycine 0 C--N 1.368 2.344 0 N-CA-C 120.815 3.086 . . . . 51.05 120.815 155.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 61.82 -77.1 0.02 OUTLIER Glycine 0 CA--C 1.554 2.483 0 N-CA-C 115.95 1.14 . . . . 74.41 115.95 162.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 109' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -77.0 -7.54 55.81 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 124.757 1.223 . . . . 74.45 111.049 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 110' ' ' GLY . . . . . . . . . . . . . . . -65.91 13.45 0.33 Allowed Glycine 0 CA--C 1.556 2.656 0 N-CA-C 116.574 1.389 . . . . 73.14 116.574 176.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 47.8 ttp180 87.79 -42.03 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 125.745 1.618 . . . . 75.25 113.399 167.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 112' ' ' ARG . . . . . . . . . . . . . 7.5 tpm_? -114.7 -44.55 3.06 Favored 'General case' 0 N--CA 1.503 2.192 0 CA-C-N 119.104 0.866 . . . . 75.43 108.895 168.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 113' ' ' SER . . . . . . . . . . . . . 22.9 m -4.28 80.23 0.0 OUTLIER 'General case' 0 C--O 1.205 -1.278 0 C-N-CA 127.271 2.228 . . . . 72.53 115.821 154.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 114' ' ' ARG . . . . . 0.439 ' HB3' ' H ' ' C' ' 115' ' ' LYS . 18.4 mmt180 -133.12 -131.4 0.18 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.75 -1.219 . . . . 74.05 111.524 176.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 115' ' ' LYS . . . . . 0.439 ' H ' ' HB3' ' C' ' 114' ' ' ARG . 7.6 tmtt? -82.25 106.05 13.83 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 103.441 -2.8 . . . . 74.15 103.441 161.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -63.28 132.06 42.06 Favored Glycine 0 C--N 1.344 1.022 0 O-C-N 123.858 0.724 . . . . 54.4 111.965 -171.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 60.4 mtt180 -80.26 174.91 11.13 Favored 'General case' 0 C--O 1.247 0.947 0 N-CA-C 108.963 -0.755 . . . . 74.32 108.963 175.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 118' ' ' ASP . . . . . 0.402 ' HA ' ' O ' ' C' ' 172' ' ' GLY . 1.0 OUTLIER -70.39 130.91 43.19 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-O 120.865 0.364 . . . . 75.42 110.293 174.667 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 119' ' ' LEU . . . . . . . . . . . . . 5.1 tt -90.47 137.35 32.43 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 105.15 -2.167 . . . . 75.21 105.15 -179.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.48 148.88 50.31 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 110.14 -0.318 . . . . 72.31 110.14 -172.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.27 118.56 6.84 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.525 -0.761 . . . . 75.44 109.45 177.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -83.93 132.54 34.76 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 109.772 -0.455 . . . . 74.12 109.772 178.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 123' ' ' LEU . . . . . 0.421 HD13 ' HB1' ' B' ' 183' ' ' ALA . 2.6 pt? -144.69 129.88 9.38 Favored Pre-proline 0 N--CA 1.481 1.1 0 C-N-CA 122.646 0.378 . . . . 73.3 110.185 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . 0.545 ' HG2' ' H ' ' B' ' 189' ' ' LYS . 17.3 Cg_exo -72.14 124.83 10.33 Favored 'Trans proline' 0 C--N 1.366 1.452 0 C-N-CA 122.218 1.945 . . . . 72.51 111.281 165.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 125' ' ' LEU . . . . . . . . . . . . . 38.0 tp -142.64 155.05 44.89 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.199 1.0 . . . . 75.32 109.015 -170.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 126' ' ' THR . . . . . 0.615 ' HB ' ' HG2' ' C' ' 129' ' ' GLU . 1.8 m -101.45 158.04 16.36 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 122.965 0.506 . . . . 61.53 110.289 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 127' ' ' LEU . . . . . 0.489 HD22 HD11 ' C' ' 180' ' ' LEU . 56.1 mt -64.45 -44.69 90.33 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.581 1.153 . . . . 62.25 110.92 178.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -59.93 -36.98 78.19 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 114.954 -1.021 . . . . 75.24 110.505 175.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 129' ' ' GLU . . . . . 0.615 ' HG2' ' HB ' ' C' ' 126' ' ' THR . 6.8 mm-40 -78.54 -22.08 47.81 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.105 0.562 . . . . 75.51 111.401 -179.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -73.79 -31.68 63.39 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 121.118 0.485 . . . . 73.14 109.935 174.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 131' ' ' PHE . . . . . 0.417 ' CZ ' ' HB3' ' C' ' 216' ' ' GLU . 49.4 t80 -69.19 -46.84 66.5 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 114.575 -1.193 . . . . 75.55 110.186 167.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 132' ' ' HIS . . . . . . . . . . . . . 28.1 m170 -78.03 -6.32 54.17 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.152 0.581 . . . . 70.15 111.608 -176.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -55.45 -94.29 0.01 OUTLIER Glycine 0 C--N 1.355 1.631 0 O-C-N 123.977 0.798 . . . . 65.31 113.259 175.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . 55.06 -137.0 45.1 Favored Glycine 0 C--N 1.355 1.636 0 CA-C-N 117.306 0.553 . . . . 73.12 112.799 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 135' ' ' GLU . . . . . 0.496 ' HG3' ' HB2' ' C' ' 148' ' ' ARG . 2.5 mp0 -76.29 96.4 3.96 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 108.839 -0.8 . . . . 73.03 108.839 172.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 136' ' ' ARG . . . . . 0.483 ' HA ' ' HE ' ' C' ' 136' ' ' ARG . 2.4 tpm_? -140.43 160.2 40.52 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-O 120.842 0.353 . . . . 72.12 110.296 -175.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 137' ' ' VAL . . . . . . . . . . . . . 19.9 m -74.73 96.19 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.191 0 CA-C-O 122.249 1.023 . . . . 73.11 111.741 -177.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 138' ' ' VAL . . . . . . . . . . . . . 42.8 t -90.36 136.54 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 114.621 -1.172 . . . . 72.14 108.758 172.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 139' ' ' GLU . . . . . 0.496 ' HA ' ' O ' ' C' ' 143' ' ' ARG . 1.4 tm-20 -124.09 115.89 21.89 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 108.165 -1.05 . . . . 74.31 108.165 174.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 140' ' ' VAL . . . . . . . . . . . . . 66.8 t -137.64 109.13 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 124.187 0.995 . . . . 73.25 109.148 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 63.59 25.75 14.45 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.265 1.026 . . . . 65.0 113.186 173.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 108.68 -8.24 34.29 Favored Glycine 0 N--CA 1.473 1.153 0 CA-C-N 116.666 -0.243 . . . . 52.4 113.006 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 143' ' ' ARG . . . . . 0.681 HH12 ' HA ' ' C' ' 164' ' ' MET . 27.4 mmm-85 -87.85 95.98 10.3 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.135 0.574 . . . . 75.05 110.718 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 47.1 ttp180 -96.9 98.84 10.44 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 108.631 -0.878 . . . . 71.51 108.631 175.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 145' ' ' VAL . . . . . 0.522 HG22 ' NH2' ' C' ' 143' ' ' ARG . 69.8 t -132.38 133.09 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.061 0.944 . . . . 75.03 110.525 -169.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 15.7 m -85.59 85.03 7.44 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 108.455 -0.943 . . . . 73.22 108.455 170.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 10.4 p -118.54 145.35 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 123.232 0.613 . . . . 72.53 110.428 -171.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 148' ' ' ARG . . . . . 0.496 ' HB2' ' HG3' ' C' ' 135' ' ' GLU . 42.3 ttm180 -78.25 105.76 9.7 Favored 'General case' 0 C--N 1.348 0.518 0 N-CA-C 108.468 -0.938 . . . . 74.22 108.468 169.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 149' ' ' ILE . . . . . 0.612 HD11 HG21 ' C' ' 159' ' ' ILE . 6.9 pt -80.82 152.71 72.33 Favored Pre-proline 0 C--O 1.246 0.869 0 N-CA-C 107.299 -1.371 . . . . 74.42 107.299 165.048 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -39.79 108.91 0.08 OUTLIER 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 122.828 2.352 . . . . 61.44 112.12 168.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -63.98 107.91 0.85 Allowed 'Trans proline' 0 C--N 1.382 2.32 0 C-N-CA 122.928 2.419 . . . . 73.2 110.662 -176.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 152' ' ' GLY . . . . . . . . . . . . . . . 105.11 137.61 9.11 Favored Glycine 0 C--N 1.34 0.803 0 CA-C-N 115.837 -0.62 . . . . 63.11 113.955 -170.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 153' ' ' VAL . . . . . 0.576 HG21 HG22 ' C' ' 178' ' ' VAL . 1.9 m -134.57 171.84 17.13 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.192 0 C-N-CA 123.029 0.532 . . . . 74.01 110.922 -175.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 154' ' ' ARG . . . . . . . . . . . . . 8.7 mtp180 -135.34 145.06 47.03 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.176 0.99 . . . . 75.32 108.906 -174.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 155' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -56.17 126.07 24.51 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 118.601 0.637 . . . . 74.51 111.766 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 60.84 24.04 62.01 Favored Glycine 0 C--N 1.351 1.364 0 CA-C-N 115.305 -0.861 . . . . 75.21 114.01 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 157' ' ' SER . . . . . . . . . . . . . 37.7 m -107.91 163.59 13.0 Favored 'General case' 0 C--O 1.246 0.87 0 CA-C-O 121.209 0.528 . . . . 75.43 110.275 178.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 20.7 m -102.67 110.42 29.3 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 CA-C-N 114.997 -1.001 . . . . 72.31 110.528 -174.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 159' ' ' ILE . . . . . 0.612 HG21 HD11 ' C' ' 149' ' ' ILE . 7.4 mt -71.51 97.9 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.791 0 N-CA-C 108.251 -1.018 . . . . 72.31 108.251 172.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 160' ' ' ARG . . . . . 0.442 ' HA ' ' O ' ' C' ' 174' ' ' LEU . 15.3 ttp180 -79.62 102.63 9.02 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.591 -0.732 . . . . 75.13 110.572 -177.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 161' ' ' VAL . . . . . 0.644 HG23 ' HB3' ' C' ' 174' ' ' LEU . 0.7 OUTLIER -109.2 130.34 22.86 Favored Pre-proline 0 CA--C 1.548 0.892 0 N-CA-C 108.221 -1.029 . . . . 75.24 108.221 178.05 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -76.67 147.35 27.81 Favored 'Trans proline' 0 C--N 1.369 1.617 0 C-N-CA 122.528 2.152 . . . . 75.23 111.014 169.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 163' ' ' GLY . . . . . 0.518 ' HA2' ' OG ' ' C' ' 86' ' ' SER . . . 112.53 24.88 4.84 Favored Glycine 0 N--CA 1.47 0.917 0 CA-C-O 119.38 -0.678 . . . . 53.54 114.015 174.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 164' ' ' MET . . . . . 0.681 ' HA ' HH12 ' C' ' 143' ' ' ARG . 26.4 mmt -130.2 -79.75 0.54 Allowed 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 118.002 0.901 . . . . 73.35 110.769 -179.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 165' ' ' GLY . . . . . 0.526 ' H ' ' HA ' ' C' ' 173' ' ' ASP . . . 84.13 139.36 4.12 Favored Glycine 0 C--N 1.349 1.3 0 N-CA-C 114.033 0.373 . . . . 73.32 114.033 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . -76.37 -170.93 31.9 Favored Glycine 0 C--N 1.363 2.045 0 CA-C-N 117.213 0.507 . . . . 75.44 112.5 167.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 167' ' ' GLN . . . . . 0.556 HE21 ' HA ' ' C' ' 167' ' ' GLN . 0.0 OUTLIER -77.08 105.78 8.38 Favored 'General case' 0 N--CA 1.479 0.982 0 O-C-N 122.18 -0.6 . . . . 74.2 111.841 -174.192 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . 149.85 171.38 18.25 Favored Glycine 0 C--N 1.346 1.138 0 CA-C-O 121.492 0.496 . . . . 13.44 113.713 177.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 169' ' ' ASN . . . . . 0.489 ' HB3' ' HD2' ' C' ' 170' ' ' PRO . 1.0 OUTLIER -60.2 158.98 24.33 Favored Pre-proline 0 CA--C 1.559 1.317 0 C-N-CA 126.642 1.977 . . . . 62.44 109.498 175.537 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 170' ' ' PRO . . . . . 0.489 ' HD2' ' HB3' ' C' ' 169' ' ' ASN . 6.5 Cg_exo -0.05 75.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.403 3.415 1 C-N-CA 126.326 4.684 . . . . 73.55 115.511 -162.054 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 171' ' ' PRO . . . . . 0.504 ' HD2' ' O ' ' C' ' 85' ' ' PHE . 93.9 Cg_endo -81.97 176.54 8.18 Favored 'Trans proline' 0 C--N 1.37 1.708 0 C-N-CA 123.065 2.51 . . . . 74.02 114.965 -165.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 172' ' ' GLY . . . . . 0.433 ' O ' ' HA2' ' C' ' 165' ' ' GLY . . . -95.49 127.82 9.29 Favored Glycine 0 C--N 1.342 0.882 0 CA-C-N 114.247 -1.342 . . . . 74.42 110.118 -178.038 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 173' ' ' ASP . . . . . 0.526 ' HA ' ' H ' ' C' ' 165' ' ' GLY . 50.0 m-20 -72.85 -162.05 0.1 Allowed 'General case' 0 CA--C 1.555 1.15 0 N-CA-C 114.038 1.125 . . . . 74.51 114.038 -169.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 174' ' ' LEU . . . . . 0.644 ' HB3' HG23 ' C' ' 161' ' ' VAL . 38.2 tp -87.99 142.29 27.91 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 112.621 0.6 . . . . 75.22 112.621 -164.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 49.8 mt -129.21 95.23 3.99 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.681 1.592 . . . . 72.15 107.95 177.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 176' ' ' LEU . . . . . 0.574 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 95.4 mt -82.24 109.04 16.16 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 110.037 -0.357 . . . . 74.33 110.037 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 177' ' ' VAL . . . . . . . . . . . . . 57.8 t -83.52 95.63 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 107.657 -1.238 . . . . 75.23 107.657 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 178' ' ' VAL . . . . . 0.576 HG22 HG21 ' C' ' 153' ' ' VAL . 3.3 p -87.26 140.19 16.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 121.342 0.591 . . . . 74.01 112.117 -172.129 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 179' ' ' ARG . . . . . 0.457 ' O ' ' HA ' ' C' ' 124' ' ' PRO . 36.7 mmt180 -117.65 105.5 12.1 Favored 'General case' 0 C--N 1.342 0.276 0 C-N-CA 124.939 1.296 . . . . 74.42 107.872 177.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 180' ' ' LEU . . . . . 0.489 HD11 HD22 ' C' ' 127' ' ' LEU . 96.2 mt -73.45 143.02 46.84 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 122.547 0.339 . . . . 73.43 111.47 -175.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 181' ' ' LEU . . . . . . . . . . . . . 16.8 mt -61.19 166.86 4.47 Favored Pre-proline 0 CA--C 1.56 1.359 0 C-N-CA 124.66 1.184 . . . . 74.24 112.27 -178.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 99.4 Cg_exo -52.71 12.59 0.02 OUTLIER 'Trans proline' 0 C--N 1.39 2.755 0 C-N-CA 124.305 3.337 . . . . 73.32 118.361 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 183' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -129.38 74.24 81.08 Favored Pre-proline 0 CA--C 1.564 1.51 0 CA-C-N 119.069 0.85 . . . . 72.0 108.779 163.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 184' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -86.43 66.08 4.9 Favored 'Trans proline' 0 C--N 1.378 2.091 0 C-N-CA 123.099 2.532 . . . . 74.25 110.484 178.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 185' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 26.2 t -91.47 -45.25 14.53 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.552 0 CA-C-N 115.623 -0.717 . . . . 72.23 109.331 -166.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 186' ' ' PHE . . . . . 0.486 ' HB3' HD12 ' C' ' 193' ' ' LEU . 42.8 m-85 -103.95 101.45 11.23 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.534 0.734 . . . . 61.44 110.058 -173.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 187' ' ' ARG . . . . . . . . . . . . . 18.1 ttt180 -103.61 129.51 50.89 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.403 0.681 . . . . 75.14 109.298 -177.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 188' ' ' LEU . . . . . 0.527 HD12 ' HD2' ' C' ' 240' ' ' PHE . 53.7 tp -79.93 144.73 33.1 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 112.421 0.526 . . . . 74.14 112.421 -173.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -143.75 116.75 8.86 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 107.176 -1.416 . . . . 73.21 107.176 163.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 63.1 -97.08 0.18 Allowed Glycine 0 C--N 1.345 1.075 0 N-CA-C 111.436 -0.666 . . . . 74.2 111.436 -172.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 191' ' ' GLN . . . . . 0.432 ' HA ' HD11 ' C' ' 188' ' ' LEU . 45.8 mt-30 -129.01 -10.34 4.82 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.992 0.917 . . . . 75.25 110.675 171.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 192' ' ' ASP . . . . . 0.404 ' O ' HD13 ' C' ' 188' ' ' LEU . 22.2 m-20 -82.86 161.91 21.77 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.706 0.802 . . . . 65.13 110.448 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 193' ' ' LEU . . . . . 0.601 HD21 ' CD2' ' C' ' 240' ' ' PHE . 79.6 mt -123.03 161.33 24.5 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 122.885 0.474 . . . . 65.15 111.901 -176.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 194' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -124.27 128.99 49.98 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 107.824 -1.176 . . . . 75.43 107.824 168.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 195' ' ' ALA . . . . . 0.485 ' HA ' ' O ' ' C' ' 185' ' ' VAL . . . -136.33 -176.65 4.4 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.576 1.15 . . . . 65.11 109.305 -177.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 87.9 m -137.98 119.93 15.42 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 108.594 -0.891 . . . . 53.42 108.594 171.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 197' ' ' LEU . . . . . . . . . . . . . 55.8 tp -96.66 124.1 40.55 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.066 0.546 . . . . 73.5 110.606 -175.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -77.75 104.59 8.39 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.42 1.088 . . . . 64.33 109.64 179.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 199' ' ' VAL . . . . . 0.519 HG22 HG22 ' C' ' 210' ' ' VAL . 41.1 t -121.53 120.4 28.84 Favored Pre-proline 0 N--CA 1.481 1.105 0 C-N-CA 124.413 1.085 . . . . 73.12 109.196 -178.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 200' ' ' PRO . . . . . 0.45 ' HG2' HD12 ' C' ' 203' ' ' ILE . 12.9 Cg_exo -66.3 150.53 84.6 Favored 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 122.534 2.156 . . . . 73.11 112.12 173.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 201' ' ' ALA . . . . . . . . . . . . . . . -57.09 -48.42 97.44 Favored Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 123.746 0.819 . . . . 74.35 113.068 178.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 202' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -57.13 -49.34 14.42 Favored 'Trans proline' 0 C--N 1.383 2.369 0 C-N-CA 121.631 1.554 . . . . 63.15 112.856 175.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 203' ' ' ILE . . . . . 0.45 HD12 ' HG2' ' C' ' 200' ' ' PRO . 27.2 mt -63.11 -29.53 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 123.276 0.631 . . . . 74.02 111.055 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -74.45 -36.59 63.36 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.612 0.765 . . . . 75.02 112.217 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 205' ' ' VAL . . . . . . . . . . . . . 69.1 t -76.73 -41.15 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 122.909 0.483 . . . . 74.52 111.984 -179.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 206' ' ' VAL . . . . . 0.636 HG21 ' HE3' ' A' ' 270' ' ' LYS . 12.4 p -90.88 -34.61 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 112.218 0.451 . . . . 74.12 112.218 -176.202 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 94.03 127.65 4.86 Favored Glycine 0 C--N 1.344 0.999 0 N-CA-C 111.644 -0.582 . . . . 63.21 111.644 -167.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -156.81 -131.18 1.32 Allowed Glycine 0 C--N 1.346 1.108 0 N-CA-C 111.042 -0.823 . . . . 51.32 111.042 177.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 209' ' ' LYS . . . . . 0.511 ' HG2' ' HA ' ' C' ' 222' ' ' ALA . 8.2 mtmp? -147.07 140.77 25.71 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.486 0.714 . . . . 72.44 111.072 173.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 210' ' ' VAL . . . . . 0.519 HG22 HG22 ' C' ' 199' ' ' VAL . 17.8 m -136.6 138.92 45.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 125.216 1.406 . . . . 71.52 108.32 172.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 211' ' ' ARG . . . . . 0.423 ' HA ' ' HA ' ' C' ' 220' ' ' GLU . 36.0 ttm180 -86.82 126.82 34.88 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.376 0.51 . . . . 75.53 112.376 -173.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 212' ' ' ALA . . . . . 0.463 ' HB3' HG11 ' C' ' 219' ' ' VAL . . . -92.56 114.84 27.5 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 123.97 0.908 . . . . 74.43 108.568 164.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 213' ' ' MET . . . . . . . . . . . . . 5.4 tmm? -77.31 105.8 8.65 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 107.895 -1.15 . . . . 63.12 107.895 175.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 214' ' ' THR . . . . . 0.465 ' OG1' HG12 ' C' ' 219' ' ' VAL . 0.2 OUTLIER -100.75 173.09 6.68 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.49 0.662 . . . . 72.34 110.594 -176.269 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 215' ' ' LEU . . . . . 0.412 HD11 ' CE1' ' C' ' 240' ' ' PHE . 25.9 mt -69.91 -26.72 64.29 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 114.488 -1.233 . . . . 75.24 112.836 -169.358 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 216' ' ' GLU . . . . . 0.417 ' HB3' ' CZ ' ' C' ' 131' ' ' PHE . 0.0 OUTLIER -111.52 8.69 21.13 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.206 1.002 . . . . 71.0 111.614 -178.985 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 137.92 172.67 12.63 Favored Glycine 0 C--N 1.341 0.833 0 CA-C-O 119.803 -0.443 . . . . 74.41 112.607 179.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -87.62 119.48 1.36 Allowed 'Trans proline' 0 CA--C 1.555 1.562 0 C-N-CA 123.178 2.586 . . . . 64.03 113.099 -174.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 219' ' ' VAL . . . . . 0.465 HG12 ' OG1' ' C' ' 214' ' ' THR . 3.8 p -98.71 115.4 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 108.961 -0.755 . . . . 52.53 108.961 173.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 220' ' ' GLU . . . . . 0.423 ' HA ' ' HA ' ' C' ' 211' ' ' ARG . 46.1 tt0 -80.99 106.6 13.12 Favored 'General case' 0 C--O 1.244 0.77 0 N-CA-C 108.716 -0.846 . . . . 72.32 108.716 178.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 221' ' ' VAL . . . . . 0.625 ' HA ' ' HB2' ' B' ' 239' ' ' ALA . 88.3 t -77.85 127.34 38.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 114.786 -1.097 . . . . 74.03 110.589 -176.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 222' ' ' ALA . . . . . 0.511 ' HA ' ' HG2' ' C' ' 209' ' ' LYS . . . -95.58 130.51 42.41 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.585 0.754 . . . . 73.3 111.099 177.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 94.8 t -108.35 140.31 21.62 Favored Pre-proline 0 CA--C 1.558 1.28 0 C-N-CA 125.328 1.451 . . . . 73.11 110.065 -173.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 224' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -89.47 168.59 5.0 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 123.556 2.838 . . . . 73.11 111.958 169.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -58.35 142.66 97.82 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.386 2.057 . . . . 74.4 112.428 170.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 226' ' ' ARG . . . . . 0.406 ' HD2' ' HA ' ' A' ' 259' ' ' GLU . 30.8 mmt-85 66.44 95.12 0.06 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.531 1.533 . . . . 71.5 111.073 -176.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 227' ' ' THR . . . . . 0.415 ' O ' HG12 ' A' ' 257' ' ' ILE . 25.7 m -137.29 116.78 12.84 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.637 0.775 . . . . 73.3 111.32 173.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 228' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -101.8 155.88 17.86 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.842 0.857 . . . . 74.32 111.17 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -70.37 144.0 51.75 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 115.197 -0.91 . . . . 65.31 109.986 175.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 97.02 -11.85 65.75 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-O 119.2 -0.778 . . . . 62.04 113.024 -172.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 231' ' ' ARG . . . . . . . . . . . . . 54.9 mtt180 -69.37 174.34 4.93 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 118.348 1.074 . . . . 75.03 111.04 170.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 232' ' ' LYS . . . . . 0.419 ' HD3' ' HB3' ' C' ' 250' ' ' TYR . 28.0 ttmt -147.75 141.95 26.15 Favored 'General case' 0 C--N 1.355 0.819 0 CA-C-O 121.371 0.605 . . . . 74.05 112.222 -176.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 233' ' ' LEU . . . . . 0.555 ' O ' ' HA ' ' C' ' 250' ' ' TYR . 3.3 mp -114.63 154.53 28.21 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.945 1.298 . . . . 74.22 109.519 -179.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -122.95 120.72 34.23 Favored 'General case' 0 C--O 1.243 0.744 0 N-CA-C 109.19 -0.67 . . . . 72.34 109.19 167.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 44.5 mt -107.54 125.35 51.19 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.418 -0.956 . . . . 74.34 108.418 177.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -74.3 130.11 39.08 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.848 0.859 . . . . 73.41 112.192 -171.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 77.87 -0.69 71.03 Favored Glycine 0 C--N 1.35 1.336 0 CA-C-N 115.16 -0.927 . . . . 71.42 114.013 178.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 238' ' ' LYS . . . . . 0.419 ' HE3' ' HB ' ' C' ' 219' ' ' VAL . 75.1 mmtt -92.11 8.6 37.11 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.361 0.664 . . . . 75.11 112.06 -173.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -81.63 -168.29 40.5 Favored Glycine 0 C--N 1.349 1.303 0 N-CA-C 111.367 -0.693 . . . . 75.2 111.367 167.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 240' ' ' PHE . . . . . 0.601 ' CD2' HD21 ' C' ' 193' ' ' LEU . 18.4 m-85 -78.86 149.59 74.16 Favored Pre-proline 0 CA--C 1.558 1.287 0 CA-C-N 117.105 0.452 . . . . 75.14 110.249 178.019 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 241' ' ' PRO . . . . . 0.433 ' HA ' ' HG2' ' C' ' 246' ' ' ARG . 83.5 Cg_endo -82.65 142.18 11.38 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 123.492 2.794 . . . . 71.53 112.501 -173.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -132.63 165.06 23.91 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-O 119.422 -0.654 . . . . 70.14 112.69 -178.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -67.79 -1.81 7.48 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 123.527 2.818 . . . . 71.42 113.768 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -121.82 -15.45 7.88 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.657 0.783 . . . . 71.42 111.299 174.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 154.7 174.7 24.99 Favored Glycine 0 C--N 1.357 1.703 0 CA-C-O 120.16 -0.244 . . . . 63.24 113.474 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 246' ' ' ARG . . . . . 0.433 ' HG2' ' HA ' ' C' ' 241' ' ' PRO . 59.3 mtm180 -91.94 157.32 16.89 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 123.983 0.913 . . . . 71.32 111.049 179.049 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -85.38 -161.19 34.14 Favored Glycine 0 C--N 1.353 1.493 0 CA-C-O 120.137 -0.257 . . . . 63.23 113.705 176.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -127.41 136.47 51.89 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 117.458 0.629 . . . . 73.54 109.906 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 249' ' ' LEU . . . . . 0.422 HD13 ' HB3' ' C' ' 195' ' ' ALA . 31.0 tp -86.22 119.87 26.97 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.6 0.76 . . . . 74.23 110.59 -177.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 250' ' ' TYR . . . . . 0.555 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 14.3 m-85 -100.84 102.79 13.93 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 109.372 -0.603 . . . . 71.43 109.372 176.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 251' ' ' LEU . . . . . 0.43 ' HB2' HD13 ' C' ' 233' ' ' LEU . 1.3 mp -97.52 135.93 38.66 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.58 -0.896 . . . . 72.0 108.58 -178.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -98.17 121.07 39.64 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 108.906 -0.776 . . . . 75.41 108.906 175.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 253' ' ' VAL . . . . . 0.401 HG11 HG21 ' C' ' 227' ' ' THR . 92.0 t -58.48 138.32 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 124.403 1.081 . . . . 73.5 111.897 -176.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 254' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -131.72 109.06 9.9 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.22 1.008 . . . . 75.13 108.295 -178.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 255' ' ' ILE . . . . . . . . . . . . . 41.4 mm -81.34 123.05 37.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 122.759 0.423 . . . . 75.24 110.186 179.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 256' ' ' THR . . . . . 0.407 ' O ' ' HA ' ' C' ' 200' ' ' PRO . 0.0 OUTLIER -125.79 151.78 46.29 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.157 1.383 . . . . 70.25 109.177 -179.565 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 2.8 pp -114.77 153.14 46.9 Favored Pre-proline 0 N--CA 1.49 1.532 0 C-N-CA 122.883 0.473 . . . . 75.21 111.137 -176.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 258' ' ' PRO . . . . . 0.571 ' HB3' ' HE2' ' A' ' 276' ' ' TYR . 37.7 Cg_endo -62.01 -2.9 3.28 Favored 'Trans proline' 0 C--N 1.385 2.46 0 C-N-CA 123.451 2.767 . . . . 74.41 115.119 -173.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 58.38 -83.33 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.111 1.364 . . . . 72.3 111.567 -173.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 260' ' ' ARG . . . . . 0.464 ' HG3' ' HA ' ' B' ' 267' ' ' SER . 0.0 OUTLIER -66.41 158.09 30.24 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 122.878 0.471 . . . . 73.41 110.631 -177.178 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 261' ' ' LEU . . . . . 0.668 HD11 ' HA ' ' C' ' 266' ' ' GLU . 95.7 mt -145.96 130.86 18.15 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.542 -0.54 . . . . 74.53 109.542 175.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 58.3 p -82.84 154.69 67.97 Favored Pre-proline 0 N--CA 1.479 0.988 0 CA-C-O 117.264 -1.351 . . . . 61.23 107.729 170.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -34.66 -40.59 0.23 Allowed 'Trans proline' 0 N--CA 1.508 2.353 0 C-N-CA 124.314 3.343 . . . . 74.2 116.52 -175.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -76.58 -54.95 5.99 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.83 0.452 . . . . 71.04 110.963 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 265' ' ' GLU . . . . . 0.451 ' HB3' HD21 ' C' ' 261' ' ' LEU . 16.0 mm-40 -44.56 -51.88 8.55 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 124.1 0.875 . . . . 71.03 109.84 173.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 266' ' ' GLU . . . . . 0.668 ' HA ' HD11 ' C' ' 261' ' ' LEU . 7.9 tp10 -48.82 -60.29 2.86 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 112.856 -1.974 . . . . 73.1 111.007 176.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -53.23 -43.43 67.29 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 124.131 0.894 . . . . 71.12 112.92 -175.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 268' ' ' LEU . . . . . 0.409 ' O ' ' HG ' ' C' ' 272' ' ' LEU . 10.5 mp -65.13 -54.12 34.63 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 116.564 -0.289 . . . . 70.11 111.123 179.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 93.3 m95 -60.36 -31.51 70.41 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 111.76 0.281 . . . . 63.11 111.76 178.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 270' ' ' LYS . . . . . 0.521 ' HZ1' ' HB3' ' C' ' 270' ' ' LYS . 4.5 mmmp? -61.4 -52.63 63.81 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.483 0.713 . . . . 75.43 109.801 176.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 42.3 mtpt -59.8 -38.9 83.25 Favored 'General case' 0 N--CA 1.481 1.102 0 O-C-N 123.858 0.724 . . . . 75.33 111.848 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 272' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' C' ' 268' ' ' LEU . 78.1 mt -63.0 -41.88 99.7 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 123.823 0.702 . . . . 74.33 111.174 178.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -71.81 -41.13 68.61 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 115.599 -0.728 . . . . 43.22 112.257 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -67.84 -34.07 76.0 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.263 0.625 . . . . 63.21 110.084 179.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -62.87 -37.53 87.24 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 114.974 -1.012 . . . . 70.04 110.451 172.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 276' ' ' TYR . . . . . 0.531 ' HE1' ' HB3' ' A' ' 258' ' ' PRO . 0.2 OUTLIER -66.72 -44.84 80.54 Favored 'General case' 0 CA--C 1.554 1.107 0 CA-C-N 115.184 -0.916 . . . . 75.52 111.612 173.903 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -69.04 -22.61 64.04 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 122.707 0.403 . . . . 65.52 110.15 -178.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -69.49 0.34 5.4 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.982 0.913 . . . . 72.22 113.012 175.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 279' ' ' ARG . . . . . . . . . . . . . 73.3 mtm180 -82.24 -31.25 30.31 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 117.945 0.339 . . . . 75.11 110.335 168.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.98 0 C-N-CA 123.763 0.825 . . . . 75.14 109.246 -177.252 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.3 mtm . . . . . 0 N--CA 1.479 1.015 0 CA-C-O 119.532 -0.27 . . . . 64.12 111.433 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.43 36.84 24.15 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.362 1.065 . . . . 74.44 111.331 -178.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.61 79.14 4.11 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 114.646 -1.161 . . . . 74.04 111.066 -171.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.404 ' HE2' ' HD2' ' A' ' 69' ' ' TYR . 40.9 ttmt -36.89 103.0 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.351 1.06 . . . . 64.14 113.255 176.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 49.5 mtpt -80.93 120.17 24.4 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 108.061 -1.088 . . . . 74.32 108.061 168.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -71.22 94.92 1.21 Allowed 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 108.23 -1.026 . . . . 62.43 108.23 178.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -63.39 -28.7 70.17 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 114.513 -1.221 . . . . 73.34 112.016 -172.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -67.01 -43.48 82.79 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 122.888 0.475 . . . . 73.33 110.14 176.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.05 -43.66 98.0 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 123.65 0.594 . . . . 70.01 110.467 177.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 65.8 mt -57.4 -40.62 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 123.917 0.761 . . . . 74.23 110.662 176.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 87.2 mt -79.4 -21.09 46.11 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 112.448 0.536 . . . . 73.11 112.448 177.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.62 49.59 8.91 Favored Glycine 0 CA--C 1.539 1.56 0 CA-C-N 117.688 0.222 . . . . 73.42 113.35 -175.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.53 HG13 ' HB3' ' A' ' 25' ' ' ALA . 3.4 m -134.25 161.45 63.64 Favored Pre-proline 0 N--CA 1.491 1.602 0 C-N-CA 125.226 1.41 . . . . 72.52 109.581 175.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -46.73 147.76 4.31 Favored 'Trans proline' 0 C--N 1.392 2.862 0 C-N-CA 123.104 2.536 . . . . 50.12 113.032 173.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 61.7 mtp180 -80.88 27.32 0.39 Allowed 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 113.359 0.874 . . . . 75.43 113.359 -166.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -161.08 20.74 0.13 Allowed 'General case' 0 CA--C 1.559 1.319 0 C-N-CA 124.894 1.278 . . . . 71.2 108.646 172.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.58 147.25 51.95 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.762 1.225 . . . . 74.14 112.731 -171.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.2 p -79.89 176.95 9.27 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.806 0.843 . . . . 75.03 112.658 -175.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -52.2 -47.09 65.79 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.492 1.517 . . . . 71.11 113.09 -172.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.455 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 17.2 tp10 -75.42 -28.16 59.27 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 111.656 0.243 . . . . 72.43 111.656 -174.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -65.81 -46.78 77.36 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 121.031 0.443 . . . . 71.14 109.973 174.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.597 HG12 ' HB3' ' A' ' 57' ' ' LEU . 1.7 mp -61.33 -36.39 72.57 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 CA-C-N 114.632 -1.167 . . . . 73.31 110.912 174.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.495 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 1.6 tppp? -63.12 -47.98 80.48 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.937 0.895 . . . . 75.22 109.639 179.376 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.455 ' HA ' ' HD2' ' A' ' 27' ' ' LYS . 52.8 mtm180 -67.76 -38.22 83.16 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.166 0.987 . . . . 73.12 111.424 -177.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.53 ' HB3' HG13 ' A' ' 13' ' ' VAL . . . -61.72 -43.88 98.01 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.725 0.81 . . . . 72.43 110.49 176.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -59.07 -49.24 78.65 Favored 'General case' 0 C--O 1.202 -1.404 0 CA-C-N 114.335 -1.302 . . . . 73.1 110.238 174.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.495 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 88.2 mttt -52.63 -50.33 63.35 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.732 0.813 . . . . 74.22 110.854 -178.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 54.1 ttp180 -55.8 -55.88 27.11 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 114.501 -1.227 . . . . 75.52 111.571 178.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.604 ' HB3' HD12 ' A' ' 50' ' ' ILE . 96.8 mt -76.64 -18.97 58.28 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.476 0.711 . . . . 75.12 112.527 -174.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -86.33 -29.16 23.21 Favored 'General case' 0 C--O 1.211 -0.93 0 C-N-CA 123.134 0.574 . . . . 71.54 110.153 -178.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 45.7 mtp180 -83.94 -35.01 24.33 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 122.446 0.298 . . . . 72.33 110.397 173.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -71.79 -45.49 61.42 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.332 0.653 . . . . 73.31 110.72 -179.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.429 ' HA ' HD21 ' A' ' 38' ' ' ASN . 22.4 m-85 -107.56 35.98 2.89 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.516 0.726 . . . . 72.41 109.829 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -66.11 114.72 17.88 Favored Pre-proline 0 N--CA 1.476 0.866 0 N-CA-C 108.63 -0.878 . . . . 73.54 108.63 178.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.04 -15.2 21.64 Favored 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 123.249 2.633 . . . . 75.51 114.564 -168.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -94.66 -32.1 13.54 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.814 0.846 . . . . 73.23 111.882 177.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 99.3 t -85.46 -59.97 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 CA-C-O 121.679 0.752 . . . . 73.25 109.084 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.429 HD21 ' HA ' ' A' ' 33' ' ' TYR . 37.4 t30 -98.7 75.64 2.15 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 114.507 -1.224 . . . . 64.12 108.745 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -78.04 79.6 4.49 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 114.538 -1.21 . . . . 73.11 108.891 177.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.2 m -131.59 125.62 20.66 Favored Pre-proline 0 N--CA 1.471 0.623 0 N-CA-C 108.812 -0.811 . . . . 71.24 108.812 176.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -43.09 -45.73 9.33 Favored 'Trans proline' 0 C--N 1.383 2.392 0 C-N-CA 123.498 2.798 . . . . 73.53 113.281 171.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -51.27 -47.53 62.47 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.893 1.277 . . . . 64.43 111.194 174.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.23 -23.67 62.05 Favored 'General case' 0 C--N 1.35 0.623 0 CA-C-N 114.498 -1.228 . . . . 73.42 111.13 -177.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.45 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 46.9 mt-10 -78.82 -41.27 30.64 Favored 'General case' 0 C--N 1.359 0.989 0 O-C-N 123.623 0.577 . . . . 63.35 109.651 -178.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -64.58 -46.89 80.79 Favored 'General case' 0 C--O 1.251 1.174 0 C-N-CA 124.25 1.02 . . . . 62.44 110.622 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -61.9 -44.0 97.69 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 114.951 -1.022 . . . . 74.03 110.087 173.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -61.56 -31.36 71.39 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.717 0.807 . . . . 73.32 110.867 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.45 ' HG2' ' O ' ' A' ' 44' ' ' GLU . 33.0 mmtp -65.16 -50.64 65.18 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.072 0.549 . . . . 75.14 109.993 175.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -64.51 -29.88 70.91 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 123.247 0.342 . . . . 71.44 111.56 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.604 HD12 ' HB3' ' A' ' 29' ' ' LEU . 84.6 mt -74.1 -31.89 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.577 1.151 . . . . 74.43 110.208 175.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -72.59 -36.64 68.19 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.579 0.752 . . . . 73.43 110.522 175.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -66.88 -49.46 65.58 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.286 1.034 . . . . 75.34 109.976 176.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.1 -52.06 66.98 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 114.558 -1.201 . . . . 65.45 111.138 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.441 ' HH ' ' HD3' ' A' ' 23' ' ' LYS . 59.1 t80 -63.52 -33.65 76.04 Favored 'General case' 0 C--O 1.209 -1.026 0 CA-C-N 115.166 -0.924 . . . . 73.53 110.615 178.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.54 -56.46 20.99 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.798 0.439 . . . . 72.52 110.861 177.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.404 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 48.5 t -66.28 -33.42 63.43 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 CA-C-N 114.595 -1.184 . . . . 74.52 111.303 -176.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.597 ' HB3' HG12 ' A' ' 22' ' ' ILE . 75.4 mt -102.38 -5.02 24.63 Favored 'General case' 0 CA--C 1.555 1.163 0 N-CA-C 114.416 1.265 . . . . 74.35 114.416 -172.295 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 34.8 t -75.03 -56.82 4.36 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 118.497 0.59 . . . . 74.34 109.916 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.502 ' HB2' ' HE3' ' A' ' 62' ' ' LYS . 12.9 m-20 -80.62 127.38 75.67 Favored Pre-proline 0 C--O 1.255 1.35 0 CA-C-N 115.372 -0.831 . . . . 74.34 110.041 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.45 ' O ' ' HG2' ' A' ' 64' ' ' ARG . 64.6 Cg_exo -53.11 -26.43 32.93 Favored 'Trans proline' 0 C--N 1.387 2.575 0 C-N-CA 123.57 2.847 . . . . 72.41 113.02 177.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -54.13 -65.72 0.52 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.006 1.322 . . . . 72.3 111.688 174.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.572 ' HE2' ' HB3' ' A' ' 84' ' ' ASP . 21.9 mttt -72.08 -26.14 62.04 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 115.667 -0.697 . . . . 74.54 110.117 -173.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.6 tpt180 -55.34 -51.34 67.1 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 124.015 0.822 . . . . 74.11 109.802 168.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.45 ' HG2' ' O ' ' A' ' 60' ' ' PRO . 1.7 mmp_? -63.67 -36.56 84.24 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.889 0.476 . . . . 74.25 111.392 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.623 HD11 ' HG3' ' A' ' 79' ' ' PRO . 79.5 mt -60.73 -40.19 84.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 123.753 0.658 . . . . 74.41 110.535 175.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -69.18 -41.83 76.66 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.827 -0.624 . . . . 75.4 109.462 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -61.36 -43.09 99.46 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.222 0.609 . . . . 64.04 110.899 177.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 50.9 p -72.07 -20.44 61.66 Favored 'General case' 0 C--N 1.348 0.537 0 CA-C-N 115.701 -0.682 . . . . 75.44 110.653 177.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.404 ' HD2' ' HE2' ' A' ' 4' ' ' LYS . 46.2 t80 -86.01 101.18 12.69 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 108.243 -1.021 . . . . 75.32 108.243 173.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 115.2 17.63 6.63 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.894 -0.882 . . . . 64.23 110.894 -166.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 90.6 m -142.17 -61.39 0.45 Allowed 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 103.822 -2.659 . . . . 71.23 103.822 173.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 50.9 m -79.92 146.35 32.17 Favored 'General case' 0 C--O 1.251 1.178 0 N-CA-C 105.032 -2.211 . . . . 74.23 105.032 157.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.36 -39.85 10.26 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.025 0.53 . . . . 74.04 111.375 -177.163 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.47 155.9 56.65 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 123.633 0.773 . . . . 75.1 110.528 -176.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -57.08 119.71 7.14 Favored 'Trans proline' 0 C--N 1.384 2.4 0 C-N-CA 122.673 2.249 . . . . 75.41 111.266 175.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.45 155.99 23.53 Favored 'Trans proline' 0 C--N 1.384 2.431 0 C-N-CA 122.909 2.406 . . . . 74.25 112.841 178.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -56.12 135.45 69.93 Favored 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 122.512 2.141 . . . . 73.45 111.123 174.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -42.61 118.69 1.2 Allowed 'Trans proline' 0 C--N 1.383 2.36 0 C-N-CA 123.687 2.925 . . . . 73.2 113.821 177.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.623 ' HG3' HD11 ' A' ' 65' ' ' ILE . 52.2 Cg_endo -62.31 166.58 12.7 Favored 'Trans proline' 0 C--N 1.383 2.391 0 C-N-CA 123.723 2.949 . . . . 71.05 112.342 -176.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -49.45 83.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.398 3.155 0 C-N-CA 124.095 3.197 . . . . 74.31 114.007 -175.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.55 ' HA2' ' HG2' ' A' ' 111' ' ' ARG . . . 136.26 -61.81 0.61 Allowed Glycine 0 N--CA 1.445 -0.701 0 CA-C-N 113.905 -1.498 . . . . 62.41 109.551 -176.175 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.4 ' O ' ' HG2' ' A' ' 79' ' ' PRO . . . 144.86 -157.75 27.39 Favored Glycine 0 N--CA 1.468 0.812 0 N-CA-C 110.579 -1.008 . . . . 53.03 110.579 -169.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.409 ' HB3' ' HD1' ' A' ' 101' ' ' PHE . 96.3 m-85 -105.1 106.54 17.08 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.489 0.716 . . . . 74.41 109.884 -177.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.572 ' HB3' ' HE2' ' A' ' 62' ' ' LYS . 5.0 t70 -78.98 138.59 38.12 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.298 1.039 . . . . 71.31 112.313 -177.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -136.59 68.98 1.42 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.802 0.841 . . . . 73.24 109.812 170.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 59.0 m -53.32 94.71 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 125.104 1.362 . . . . 74.44 113.766 -176.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.593 ' H ' ' NH2' ' A' ' 114' ' ' ARG . . . 70.34 9.14 63.76 Favored Glycine 0 C--N 1.352 1.436 0 CA-C-N 115.901 -0.591 . . . . 70.11 114.144 178.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -96.23 130.59 43.27 Favored 'General case' 0 C--O 1.241 0.63 0 N-CA-C 107.71 -1.218 . . . . 72.34 107.71 -179.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -75.32 81.56 2.42 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 121.668 0.747 . . . . 71.44 111.134 -171.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.502 HG21 ' CZ ' ' A' ' 97' ' ' PHE . 0.9 OUTLIER -40.02 -41.19 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 126.633 1.973 . . . . 75.21 112.4 171.66 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -69.51 -5.85 26.84 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.328 1.051 . . . . 75.33 113.167 -172.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -115.45 -12.08 11.74 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.997 0.519 . . . . 61.35 111.753 -177.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 20.8 m-30 -85.53 168.57 14.39 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 112.919 0.711 . . . . 73.34 112.919 -167.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 98.7 p -65.69 168.51 7.59 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 124.919 1.288 . . . . 74.5 114.233 -164.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.24 -35.9 82.34 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 115.308 -0.86 . . . . 74.52 111.148 174.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -58.29 -47.08 84.79 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.96 0.904 . . . . 75.03 109.901 177.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.502 ' CZ ' HG21 ' A' ' 90' ' ' VAL . 5.3 t80 -56.94 -52.28 65.83 Favored 'General case' 0 CA--C 1.554 1.126 0 O-C-N 124.348 1.03 . . . . 72.32 110.114 172.226 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -65.59 -17.23 64.43 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 112.81 0.67 . . . . 74.14 112.81 -173.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -99.9 -36.5 9.38 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 112.93 0.715 . . . . 70.02 112.93 178.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 50.6 tp -78.23 -41.91 32.82 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-O 121.392 0.615 . . . . 74.33 110.355 -179.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.409 ' HD1' ' HB3' ' A' ' 83' ' ' TYR . 43.3 m-85 -97.18 -24.88 15.51 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.213 1.005 . . . . 72.11 111.278 -175.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -44.17 -56.13 5.47 Favored Glycine 0 CA--C 1.545 1.958 0 CA-C-O 118.807 -0.996 . . . . 72.43 115.193 -178.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_exo -47.32 -25.8 5.13 Favored 'Trans proline' 0 C--N 1.391 2.769 0 C-N-CA 124.039 3.16 . . . . 64.43 115.53 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -133.11 28.96 3.27 Favored Glycine 0 C--N 1.354 1.581 0 CA-C-O 119.53 -0.594 . . . . 54.4 113.427 -177.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 44.6 mt -72.19 72.25 0.9 Allowed 'General case' 0 CA--C 1.563 1.477 0 CA-C-N 117.316 0.558 . . . . 74.25 112.151 170.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.714 ' HB3' ' HB3' ' A' ' 112' ' ' ARG . 11.8 p90 32.4 -130.76 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 127.27 2.228 . . . . 74.45 116.199 163.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.436 ' HA2' ' H ' ' A' ' 169' ' ' ASN . . . 92.2 36.36 6.32 Favored Glycine 0 C--N 1.354 1.541 0 N-CA-C 111.49 -0.644 . . . . 44.0 111.49 -165.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 71.39 -74.29 0.71 Allowed Glycine 0 C--N 1.359 1.838 0 CA-C-O 121.434 0.463 . . . . 71.34 112.847 167.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -73.47 -8.01 54.15 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.4 1.08 . . . . 74.55 109.601 169.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -77.32 8.39 32.97 Favored Glycine 0 CA--C 1.544 1.884 0 CA-C-N 115.774 -0.648 . . . . 55.25 113.788 164.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.55 ' HG2' ' HA2' ' A' ' 81' ' ' GLY . 31.3 ttp180 83.86 -38.14 0.07 Allowed 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 125.539 1.536 . . . . 75.52 114.224 163.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.714 ' HB3' ' HB3' ' A' ' 106' ' ' PHE . 16.3 tpp85 -78.29 -35.77 47.46 Favored 'General case' 0 N--CA 1.506 2.325 0 CA-C-N 119.286 0.948 . . . . 75.13 111.994 178.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.548 ' HB3' ' HA ' ' A' ' 167' ' ' GLN . 69.0 m 58.14 67.54 0.94 Allowed 'General case' 0 CA--C 1.557 1.213 0 O-C-N 124.116 0.885 . . . . 74.21 112.277 177.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.593 ' NH2' ' H ' ' A' ' 87' ' ' GLY . 0.6 OUTLIER -110.49 -118.32 0.29 Allowed 'General case' 0 C--O 1.19 -2.064 0 N-CA-C 116.443 2.016 . . . . 74.52 116.443 -167.618 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.423 ' H ' ' HB3' ' A' ' 114' ' ' ARG . 48.6 tptt -70.33 81.57 0.54 Allowed 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 115.85 1.796 . . . . 73.31 115.85 -159.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.614 ' H ' ' HA3' ' A' ' 172' ' ' GLY . . . -121.29 -155.56 9.53 Favored Glycine 0 CA--C 1.548 2.152 0 C-N-CA 127.317 2.389 . . . . 73.4 112.76 162.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.06 143.46 56.7 Favored 'General case' 0 C--O 1.285 2.97 0 N-CA-C 116.361 1.985 . . . . 74.43 116.361 178.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.577 ' HA ' ' O ' ' A' ' 173' ' ' ASP . 14.8 p-10 -76.16 104.57 6.75 Favored 'General case' 0 CA--C 1.552 1.052 0 CA-C-N 112.175 -2.284 . . . . 74.23 113.151 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.466 ' O ' HD13 ' A' ' 174' ' ' LEU . 6.4 tt -93.37 165.36 12.82 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.1 1.36 . . . . 75.42 107.556 174.122 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 30.4 ttp85 -112.66 130.82 55.91 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 118.503 0.592 . . . . 74.51 110.127 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.442 ' HB1' HD11 ' A' ' 174' ' ' LEU . . . -146.33 176.54 9.69 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.998 0.919 . . . . 54.41 110.886 -175.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -107.89 139.88 41.83 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-N 114.533 -1.212 . . . . 72.42 109.197 -171.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.561 ' HB2' HD13 ' A' ' 176' ' ' LEU . 45.7 tp -100.18 96.97 5.55 Favored Pre-proline 0 N--CA 1.473 0.71 0 N-CA-C 107.368 -1.345 . . . . 74.14 107.368 170.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.505 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 53.0 Cg_endo -75.54 107.31 2.44 Favored 'Trans proline' 0 C--N 1.37 1.704 0 N-CA-C 106.923 -1.991 . . . . 75.33 106.923 171.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.506 ' HB3' HD22 ' A' ' 180' ' ' LEU . 59.5 tp -116.54 127.47 54.55 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 109.241 -0.651 . . . . 72.43 109.241 -167.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.616 HG22 ' HB2' ' B' ' 4' ' ' SER . 50.6 m -57.03 130.55 46.58 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 124.66 1.225 . . . . 71.34 110.965 -178.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.42 HD11 ' HD1' ' A' ' 183' ' ' HIS . 35.4 mt -47.62 -47.22 29.01 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.358 1.063 . . . . 75.21 111.232 -178.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -56.23 -49.53 73.87 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 114.391 -1.277 . . . . 75.32 110.695 178.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -64.26 -33.71 76.45 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.298 0.639 . . . . 64.33 111.7 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.412 ' HB2' HD23 ' A' ' 180' ' ' LEU . . . -62.46 -38.68 90.76 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.459 0.704 . . . . 65.44 110.825 177.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -66.33 -46.02 78.26 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 114.874 -1.057 . . . . 74.51 111.071 173.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.508 ' HE1' ' HA ' ' B' ' 2' ' ' LYS . 24.0 m170 -66.55 -65.52 0.67 Allowed 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.282 0.633 . . . . 75.25 111.378 -173.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.511 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 90.82 179.76 43.15 Favored Glycine 0 C--N 1.346 1.117 0 CA-C-N 116.14 -0.482 . . . . 71.54 112.421 -177.029 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.59 -157.45 27.67 Favored Glycine 0 C--N 1.345 1.038 0 C-N-CA 123.298 0.475 . . . . 70.42 112.313 179.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 13.7 mp0 -70.98 98.77 1.67 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.929 0.892 . . . . 73.14 111.091 -176.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 7.1 tpp180 -94.01 119.95 33.59 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.872 0.869 . . . . 75.05 109.295 172.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.481 ' O ' HG21 ' B' ' 5' ' ' THR . 76.2 t -79.44 106.01 9.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 114.749 -1.114 . . . . 75.04 109.218 172.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.6 p -111.32 125.1 68.63 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 N-CA-C 108.86 -0.793 . . . . 73.34 108.86 172.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.538 ' HB3' ' HG3' ' A' ' 144' ' ' ARG . 6.4 pt-20 -124.97 116.46 22.19 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.547 0.739 . . . . 71.3 111.426 -166.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.498 HG12 ' HB2' ' B' ' 8' ' ' LEU . 9.2 p -159.92 155.19 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.166 0.986 . . . . 75.1 108.963 177.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 61.63 22.68 13.13 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 124.274 1.03 . . . . 74.24 112.757 174.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 87.42 -13.05 61.15 Favored Glycine 0 C--N 1.353 1.486 0 CA-C-N 116.369 -0.378 . . . . 54.15 113.285 -177.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 22.7 tpt180 -95.81 115.09 26.92 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.395 0.678 . . . . 72.43 110.251 178.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.538 ' HG3' ' HB3' ' A' ' 139' ' ' GLU . 13.1 ttt180 -100.55 88.22 3.57 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.081 0.952 . . . . 74.41 108.726 173.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 11.2 p -94.88 144.99 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 123.083 0.553 . . . . 73.53 110.909 -173.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 22.9 t -107.64 86.97 2.39 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 109.226 -0.657 . . . . 64.43 109.226 176.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.7 p -85.02 124.17 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 123.305 0.642 . . . . 73.42 110.003 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 61.6 ttt85 -75.88 95.74 3.58 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.311 0.577 . . . . 74.32 109.652 177.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.511 HG13 ' HA2' ' A' ' 133' ' ' GLY . 33.6 pt -77.37 140.2 64.76 Favored Pre-proline 0 CA--C 1.557 1.225 0 CA-C-N 115.255 -0.884 . . . . 74.52 109.977 175.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -61.86 130.83 32.54 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.547 2.164 . . . . 74.22 112.301 174.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -61.96 112.11 1.42 Allowed 'Trans proline' 0 C--N 1.377 2.065 0 C-N-CA 122.389 2.059 . . . . 74.15 111.45 170.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 84.37 46.3 5.87 Favored Glycine 0 C--N 1.343 0.951 0 N-CA-C 111.128 -0.789 . . . . 75.51 111.128 -171.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -80.36 153.1 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 N-CA-C 109.525 -0.546 . . . . 75.43 109.525 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.543 ' HG2' ' HA ' ' A' ' 191' ' ' GLN . 0.0 OUTLIER -124.91 159.46 31.09 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 123.448 0.699 . . . . 73.23 110.926 -174.629 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.425 ' HB2' ' HB3' ' A' ' 188' ' ' LEU . 10.4 tp10 -57.73 126.29 26.71 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.222 1.409 . . . . 72.32 110.998 -179.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 103.52 -10.32 53.46 Favored Glycine 0 C--N 1.347 1.148 0 CA-C-O 119.175 -0.792 . . . . 74.33 113.993 178.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 33.6 t -63.63 112.18 2.71 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 117.693 0.746 . . . . 74.23 109.962 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.455 HG23 HG21 ' A' ' 177' ' ' VAL . 41.8 t -89.51 115.96 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.156 0.582 . . . . 74.02 110.672 -176.32 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 55.2 mt -108.22 108.14 24.54 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 123.967 0.907 . . . . 75.24 108.684 175.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -75.39 101.17 4.67 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 108.68 -0.859 . . . . 75.21 108.68 174.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.524 HG21 ' HE3' ' A' ' 164' ' ' MET . 7.6 p -124.15 113.58 27.99 Favored Pre-proline 0 CA--C 1.541 0.62 0 N-CA-C 108.26 -1.015 . . . . 71.41 108.26 -173.095 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.412 ' HA ' ' H ' ' A' ' 174' ' ' LEU . 10.1 Cg_exo -71.66 146.43 48.94 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 121.106 1.204 . . . . 74.53 111.839 178.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . 0.497 ' H ' ' HA ' ' A' ' 173' ' ' ASP . . . 131.36 -23.91 4.24 Favored Glycine 0 C--N 1.344 0.977 0 N-CA-C 116.646 1.418 . . . . 70.43 116.646 170.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.524 ' HE3' HG21 ' A' ' 161' ' ' VAL . 3.1 mpp? -124.47 -3.8 7.84 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 113.498 0.925 . . . . 64.15 113.498 -165.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.595 ' HA2' HD12 ' A' ' 174' ' ' LEU . . . -74.7 -100.23 0.1 OUTLIER Glycine 0 N--CA 1.474 1.202 0 CA-C-O 118.653 -1.082 . . . . 73.33 113.836 -174.299 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.631 ' HA3' ' HB2' ' A' ' 171' ' ' PRO . . . -70.04 167.17 49.19 Favored Glycine 0 C--N 1.377 2.808 0 C-N-CA 118.079 -2.01 . . . . 74.5 111.333 172.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.548 ' HA ' ' HB3' ' A' ' 113' ' ' SER . 0.0 OUTLIER -104.32 102.85 12.52 Favored 'General case' 0 CA--C 1.56 1.359 0 CA-C-N 118.675 1.238 . . . . 75.42 114.095 -177.434 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 122.1 -161.64 16.17 Favored Glycine 0 C--N 1.369 2.392 0 N-CA-C 115.653 1.021 . . . . 64.21 115.653 164.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . 0.436 ' H ' ' HA2' ' A' ' 107' ' ' GLY . 20.4 m120 -63.88 -45.91 81.27 Favored Pre-proline 0 CA--C 1.576 1.953 0 CA-C-O 118.494 -0.765 . . . . 63.54 111.023 174.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.492 ' HB2' ' HD3' ' A' ' 171' ' ' PRO . 12.6 Cg_exo -72.67 -56.7 0.09 OUTLIER 'Trans proline' 0 CA--C 1.593 3.451 0 CA-C-N 121.973 1.74 . . . . 73.02 116.001 175.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.631 ' HB2' ' HA3' ' A' ' 166' ' ' GLY . 18.8 Cg_endo -98.75 155.27 0.7 Allowed 'Trans proline' 0 C--N 1.399 3.189 0 C-N-CA 122.647 2.231 . . . . 71.25 111.24 167.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.614 ' HA3' ' H ' ' A' ' 116' ' ' GLY . . . -170.13 -80.04 0.05 OUTLIER Glycine 0 C--N 1.379 2.951 0 N-CA-C 120.489 2.956 . . . . 72.4 120.489 -164.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.577 ' O ' ' HA ' ' A' ' 118' ' ' ASP . 59.0 m-20 -63.08 162.96 10.71 Favored 'General case' 0 N--CA 1.509 2.476 0 CA-C-N 118.054 0.927 . . . . 71.14 112.179 -168.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.595 HD12 ' HA2' ' A' ' 165' ' ' GLY . 20.1 tp -128.42 147.85 50.68 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 120.132 1.333 . . . . 74.2 113.608 -177.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 8.4 mt -111.09 92.75 4.17 Favored 'General case' 0 CA--C 1.555 1.145 0 N-CA-C 106.774 -1.565 . . . . 72.12 106.774 168.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.561 HD13 ' HB2' ' A' ' 123' ' ' LEU . 15.0 mt -76.19 138.51 40.71 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 118.132 0.424 . . . . 74.52 111.607 178.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.455 HG21 HG23 ' A' ' 158' ' ' VAL . 47.4 t -119.71 116.0 49.25 Favored 'Isoleucine or valine' 0 C--O 1.242 0.677 0 N-CA-C 106.017 -1.846 . . . . 71.11 106.017 164.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.457 ' HA ' ' HB3' ' A' ' 123' ' ' LEU . 10.1 p -72.12 120.32 20.3 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 CA-C-O 121.848 0.832 . . . . 74.13 111.314 -171.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.505 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 32.3 mmt180 -106.82 99.53 9.09 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 107.849 -1.167 . . . . 73.42 107.849 172.109 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.746 HD11 ' HG ' ' A' ' 188' ' ' LEU . 80.4 mt -70.12 131.22 43.96 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 109.162 -0.681 . . . . 74.04 109.162 179.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.469 HD11 ' HA ' ' A' ' 126' ' ' THR . 54.7 mt -53.38 150.5 11.92 Favored Pre-proline 0 N--CA 1.481 1.084 0 O-C-N 124.606 1.191 . . . . 73.22 113.666 -163.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -83.21 49.1 2.9 Favored 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 122.796 2.331 . . . . 74.32 108.488 160.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.42 ' HD1' HD11 ' A' ' 127' ' ' LEU . 26.6 t-80 -69.97 131.5 89.08 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 107.254 -1.387 . . . . 73.35 107.254 178.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_exo -16.84 -34.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.386 2.522 1 C-N-CA 127.977 5.784 . . . . 61.24 120.623 -164.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 4.8 t -95.06 -59.57 3.05 Favored 'Isoleucine or valine' 0 C--N 1.353 0.744 0 CA-C-N 120.011 1.278 . . . . 72.34 108.728 -172.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . 0.453 ' CD1' ' HB1' ' A' ' 195' ' ' ALA . 49.2 m-85 -115.76 154.62 29.28 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 121.177 0.513 . . . . 72.31 111.333 -169.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 26.6 ttp180 -138.6 129.57 26.77 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 107.032 -1.47 . . . . 75.51 107.032 165.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.746 ' HG ' HD11 ' A' ' 180' ' ' LEU . 4.5 mm? -79.51 166.16 22.24 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.96 0.886 . . . . 74.21 112.3 -176.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -163.83 96.86 0.83 Allowed 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 105.663 -1.976 . . . . 70.31 105.663 174.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 62.02 -122.6 29.11 Favored Glycine 0 CA--C 1.531 1.075 0 N-CA-C 111.413 -0.675 . . . . 65.41 111.413 -168.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.543 ' HA ' ' HG2' ' A' ' 154' ' ' ARG . 2.2 mp0 -86.39 -13.89 45.0 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.793 0.837 . . . . 72.32 111.512 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -107.98 156.57 19.08 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 121.718 0.771 . . . . 72.32 112.684 -168.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.526 HD21 ' HE1' ' A' ' 240' ' ' PHE . 59.5 mt -103.61 155.7 18.35 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.781 1.633 . . . . 74.25 111.06 -170.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -132.04 100.13 4.95 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 107.845 -1.168 . . . . 73.14 107.845 169.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.568 ' HB3' HD21 ' A' ' 251' ' ' LEU . . . -105.32 116.0 31.2 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.429 1.091 . . . . 74.34 110.656 -176.463 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 38.3 m -71.4 102.62 2.68 Favored 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 109.409 -0.589 . . . . 70.21 109.409 176.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.546 HD21 HD13 ' A' ' 251' ' ' LEU . 33.2 tp -101.26 104.42 15.45 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 108.727 -0.842 . . . . 74.1 108.727 -174.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -84.4 108.68 17.35 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.891 -0.781 . . . . 63.3 108.891 175.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 6.2 p -120.76 137.27 26.2 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 124.71 1.204 . . . . 74.33 108.316 -177.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.29 156.84 33.28 Favored 'Trans proline' 0 C--N 1.363 1.327 0 C-N-CA 121.485 1.457 . . . . 70.05 111.605 173.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.455 ' HB2' ' HH2' ' A' ' 269' ' ' TRP . . . -56.46 -48.82 96.35 Favored Pre-proline 0 CA--C 1.557 1.227 0 N-CA-C 114.701 1.371 . . . . 71.34 114.701 -168.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -57.5 -42.71 58.25 Favored 'Trans proline' 0 C--N 1.395 2.995 0 CA-C-N 121.526 1.581 . . . . 73.32 112.079 178.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.433 HG12 ' HE1' ' C' ' 277' ' ' TYR . 20.2 mt -73.21 -28.74 26.51 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 CA-C-N 115.262 -0.881 . . . . 71.02 110.634 -176.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -72.05 -48.64 42.89 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.348 0.659 . . . . 74.14 111.371 178.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.472 HG13 HD13 ' C' ' 261' ' ' LEU . 95.6 t -72.03 -41.54 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.469 0.708 . . . . 64.22 111.747 -175.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 70.3 t -87.32 -41.9 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 116.07 -0.513 . . . . 74.41 111.384 -176.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 91.73 83.81 1.46 Allowed Glycine 0 CA--C 1.525 0.711 0 CA-C-N 116.097 -0.501 . . . . 72.35 112.83 -177.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -126.22 -172.42 13.35 Favored Glycine 0 N--CA 1.473 1.149 0 N-CA-C 111.363 -0.695 . . . . 73.32 111.363 173.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.54 ' HZ3' ' HB2' ' B' ' 413' ' ' ASN . 50.2 mtmt -85.06 133.16 34.24 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 117.75 0.775 . . . . 73.34 112.522 -174.281 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 34.8 m -121.55 170.55 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 124.253 1.021 . . . . 63.11 108.726 166.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 22.2 ttm180 -82.43 109.36 16.6 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 109.473 -0.566 . . . . 74.32 109.473 172.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -103.18 132.32 49.52 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 108.426 -0.953 . . . . 74.41 108.426 173.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' MET . . . . . 0.444 ' SD ' ' N ' ' A' ' 213' ' ' MET . 1.5 mpt? -92.38 135.75 33.77 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.494 -0.558 . . . . 74.15 109.494 -175.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 55.8 p -111.79 -176.45 2.94 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.379 0.672 . . . . 74.1 109.517 174.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 58.5 mt -80.41 -4.17 52.59 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.658 0.783 . . . . 73.14 111.949 -177.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.417 ' HA ' ' HE2' ' B' ' 2' ' ' LYS . 56.3 mm-40 -115.65 -17.93 10.99 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.356 0.662 . . . . 64.44 111.507 176.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 156.16 175.35 27.04 Favored Glycine 0 C--N 1.354 1.536 0 C-N-CA 121.465 -0.398 . . . . 63.05 114.012 176.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -77.93 124.41 6.76 Favored 'Trans proline' 0 C--N 1.372 1.795 0 C-N-CA 122.934 2.423 . . . . 74.13 112.349 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 30.9 m -121.11 179.92 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 124.451 1.1 . . . . 73.4 109.429 177.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -102.58 150.27 23.58 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.356 0.662 . . . . 75.04 109.584 172.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 209' ' ' LYS . 2.8 p -145.98 141.36 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 N-CA-C 108.972 -0.751 . . . . 74.51 108.972 176.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -86.45 100.81 12.62 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.045 0.538 . . . . 70.4 110.47 -178.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 91.8 t -53.9 143.29 41.88 Favored Pre-proline 0 N--CA 1.494 1.734 0 C-N-CA 125.204 1.402 . . . . 71.22 111.136 -179.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . 0.41 ' HG3' ' O ' ' B' ' 441' ' ' ILE . 32.7 Cg_exo -62.11 162.83 21.59 Favored 'Trans proline' 0 C--N 1.386 2.534 0 C-N-CA 122.627 2.218 . . . . 75.51 112.406 172.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.54 155.47 35.92 Favored 'Trans proline' 0 C--N 1.367 1.521 0 C-N-CA 121.408 1.405 . . . . 72.53 111.134 166.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 65.33 20.59 11.87 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 125.305 1.442 . . . . 75.13 112.244 173.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.428 HG23 HD21 ' A' ' 233' ' ' LEU . 96.5 m -59.19 104.52 0.25 Allowed 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 124.715 1.206 . . . . 64.32 111.202 -176.028 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 5.3 tp60 -98.11 133.97 41.83 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.689 1.196 . . . . 75.32 111.994 -168.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -62.48 140.32 58.6 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.833 1.253 . . . . 65.12 112.892 -173.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 92.37 -35.69 3.94 Favored Glycine 0 C--N 1.349 1.291 0 O-C-N 123.877 0.736 . . . . 75.54 112.005 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -74.04 161.76 29.71 Favored 'General case' 0 C--N 1.349 0.555 0 C-N-CA 123.867 0.867 . . . . 74.44 111.352 -177.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.718 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 3.4 mptp? -113.34 118.46 34.65 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.909 0.884 . . . . 72.22 109.065 -175.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.489 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 39.0 mt -76.79 100.25 5.41 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.764 -0.828 . . . . 71.4 108.764 178.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 54.3 ttm-85 -71.86 105.86 3.97 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 110.245 -0.279 . . . . 73.41 110.245 179.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.571 HD22 ' HA ' ' B' ' 441' ' ' ILE . 9.1 mt -95.31 104.06 15.94 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 107.508 -1.293 . . . . 74.24 107.508 173.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 18.0 tptp -71.47 118.82 14.76 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.353 0.661 . . . . 71.01 111.181 -172.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 85.47 32.21 19.92 Favored Glycine 0 C--N 1.35 1.347 0 O-C-N 123.418 0.449 . . . . 74.2 113.251 177.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -125.62 5.69 7.52 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.68 0.792 . . . . 74.1 112.443 -175.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -93.86 -157.5 33.15 Favored Glycine 0 N--CA 1.469 0.868 0 C-N-CA 123.378 0.513 . . . . 74.43 112.451 171.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . 0.526 ' HE1' HD21 ' A' ' 193' ' ' LEU . 27.2 m-85 -83.38 140.44 41.9 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 122.954 0.502 . . . . 73.41 111.136 -175.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 240' ' ' PHE . 3.6 Cg_exo -77.41 138.09 17.26 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 123.558 2.839 . . . . 73.33 112.587 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 178.19 -138.52 3.75 Favored Glycine 0 CA--C 1.534 1.275 0 CA-C-O 119.056 -0.858 . . . . 73.52 112.449 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -67.69 -12.52 35.8 Favored 'Trans proline' 0 C--N 1.382 2.337 0 C-N-CA 123.844 3.03 . . . . 72.5 114.086 -177.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -103.96 21.77 15.78 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.744 0.418 . . . . 70.11 110.37 175.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 71.88 -93.74 0.58 Allowed Glycine 0 C--N 1.353 1.483 0 N-CA-C 110.329 -1.108 . . . . 62.24 110.329 -173.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 -126.18 131.46 52.0 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 107.626 -1.25 . . . . 75.41 107.626 167.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -70.35 -168.0 7.0 Favored Glycine 0 C--N 1.352 1.419 0 O-C-N 123.266 0.354 . . . . 70.31 112.871 178.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -111.55 173.34 6.4 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 117.513 0.656 . . . . 75.44 111.112 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.501 HD23 HD13 ' A' ' 235' ' ' LEU . 23.5 tp -128.9 104.07 7.39 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.556 -0.905 . . . . 73.32 108.556 176.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.718 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 0.4 OUTLIER -89.81 105.65 17.94 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.701 -0.852 . . . . 71.3 108.701 -178.881 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.568 HD21 ' HB3' ' A' ' 195' ' ' ALA . 66.3 mt -84.93 101.95 12.75 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.906 -0.775 . . . . 74.54 108.906 177.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.576 ' HG2' ' HG3' ' A' ' 232' ' ' LYS . 26.0 mt-10 -76.36 104.47 6.89 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.025 0.93 . . . . 75.41 108.743 -177.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 40.6 t -67.11 127.68 29.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 114.316 -1.311 . . . . 71.34 112.145 -167.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.49 91.93 3.4 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 107.516 -1.291 . . . . 73.14 107.516 175.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.531 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 66.7 mt -79.4 133.55 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 109.777 -0.453 . . . . 74.34 109.777 -178.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 19.6 p -130.52 175.26 9.13 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.144 0.978 . . . . 74.52 110.481 174.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . 0.417 HD12 ' H ' ' A' ' 259' ' ' GLU . 2.7 pp -132.38 152.45 80.09 Favored Pre-proline 0 CA--C 1.558 1.26 0 C-N-CA 123.843 0.857 . . . . 73.4 109.557 -178.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -76.55 8.63 2.91 Favored 'Trans proline' 0 N--CA 1.507 2.301 0 C-N-CA 123.157 2.571 . . . . 74.45 115.03 -165.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.571 ' HG2' ' NE2' ' C' ' 228' ' ' GLN . 33.3 mt-10 53.11 -85.53 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.616 1.166 . . . . 75.12 111.219 -163.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.83 158.93 5.86 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.163 0.985 . . . . 75.12 111.878 179.135 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.598 HD21 ' HB3' ' A' ' 265' ' ' GLU . 74.7 mt -143.39 151.22 40.15 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.416 0.686 . . . . 72.32 110.558 178.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 58.3 p -83.67 161.57 55.74 Favored Pre-proline 0 CA--C 1.559 1.303 0 N-CA-C 108.689 -0.856 . . . . 74.31 108.689 166.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -42.06 -47.03 6.95 Favored 'Trans proline' 0 C--N 1.385 2.45 0 C-N-CA 123.779 2.986 . . . . 74.33 115.217 177.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -67.14 -47.42 71.15 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.017 0.527 . . . . 71.44 109.856 -179.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . 0.598 ' HB3' HD21 ' A' ' 261' ' ' LEU . 43.6 mt-10 -56.83 -42.46 79.67 Favored 'General case' 0 C--N 1.352 0.693 0 O-C-N 123.873 0.733 . . . . 73.22 110.866 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -62.58 -50.13 72.53 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 123.195 0.31 . . . . 73.45 110.292 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -54.97 -51.61 65.65 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 124.158 0.912 . . . . 64.12 111.569 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . 0.46 ' HB2' HD22 ' C' ' 272' ' ' LEU . 10.1 mp -73.67 -43.62 58.89 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.291 0.637 . . . . 73.14 111.935 -173.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 269' ' ' TRP . . . . . 0.455 ' HH2' ' HB2' ' A' ' 201' ' ' ALA . 62.5 m95 -58.68 -45.79 88.66 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 123.358 0.663 . . . . 75.0 111.086 177.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . 0.714 ' HB3' ' HZ1' ' A' ' 270' ' ' LYS . 8.7 mtpm? -63.34 -50.06 71.48 Favored 'General case' 0 C--N 1.352 0.693 0 CA-C-N 115.842 -0.617 . . . . 73.12 111.012 178.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -64.38 -29.66 70.72 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.045 0.538 . . . . 70.22 111.979 -179.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 272' ' ' LEU . . . . . 0.4 ' O ' ' HB2' ' A' ' 276' ' ' TYR . 31.5 mt -61.62 -52.41 64.48 Favored 'General case' 0 C--O 1.211 -0.943 0 N-CA-C 109.377 -0.601 . . . . 71.54 109.377 172.238 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -64.68 -37.04 86.23 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 123.904 0.752 . . . . 72.23 112.824 -178.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -67.18 -47.65 70.3 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.823 0.849 . . . . 74.35 110.485 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . 0.508 ' O ' ' HG2' ' A' ' 279' ' ' ARG . . . -59.68 -60.13 4.34 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.546 0.738 . . . . 72.24 109.767 175.32 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . 0.4 ' HB2' ' O ' ' A' ' 272' ' ' LEU . 24.5 t80 -39.24 -58.96 1.1 Allowed 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 127.45 2.3 . . . . 75.02 111.939 178.072 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -62.45 -46.02 90.44 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 114.572 -1.195 . . . . 72.14 109.963 -176.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -69.81 -8.9 52.24 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.005 0.742 . . . . 75.41 113.005 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . 0.508 ' HG2' ' O ' ' A' ' 275' ' ' ALA . 8.7 mmm180 -93.26 -7.45 45.02 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 117.902 0.319 . . . . 75.15 111.63 177.164 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . 0.524 ' HA ' HD23 ' B' ' 59' ' ' LEU . . . . . . . . 0 CA--C 1.555 1.163 0 CA-C-O 118.309 -0.853 . . . . 72.5 109.811 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.2 mmt . . . . . 0 N--CA 1.475 0.796 0 N-CA-C 110.135 -0.321 . . . . 74.12 110.135 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.508 ' HA ' ' HE1' ' A' ' 132' ' ' HIS . 0.2 OUTLIER -78.68 1.45 22.86 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.934 0.894 . . . . 62.45 113.286 -165.996 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.62 10.04 4.71 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.811 0.845 . . . . 74.04 111.118 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' SER . . . . . 0.616 ' HB2' HG22 ' A' ' 126' ' ' THR . 60.8 m -70.81 101.11 2.04 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-O 121.599 0.714 . . . . 52.14 110.703 -176.172 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' THR . . . . . 0.481 HG21 ' O ' ' A' ' 137' ' ' VAL . 92.9 m -85.85 154.78 21.3 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 114.337 -1.301 . . . . 74.34 110.986 -179.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.443 HD13 ' HA ' ' A' ' 125' ' ' LEU . 21.9 pt -126.61 178.44 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 C-N-CA 124.509 1.124 . . . . 65.34 111.487 -167.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -147.19 134.5 20.66 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.805 1.242 . . . . 72.22 108.448 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . 0.498 ' HB2' HG12 ' A' ' 140' ' ' VAL . 1.5 mm? -63.59 150.9 43.04 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 118.575 0.625 . . . . 75.22 111.569 -178.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.04 -43.17 79.33 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 114.787 -1.097 . . . . 73.12 110.054 173.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 29.9 mt 74.34 -40.76 0.46 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 126.477 1.911 . . . . 74.1 113.525 -179.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.424 ' N ' ' HD3' ' B' ' 12' ' ' PRO . 53.1 mt 55.53 53.26 8.5 Favored Pre-proline 0 CA--C 1.565 1.533 0 C-N-CA 124.566 1.146 . . . . 72.11 110.714 -173.121 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.741 ' HD2' ' HB3' ' B' ' 15' ' ' PHE . 11.2 Cg_exo -68.59 122.55 9.52 Favored 'Trans proline' 0 C--N 1.392 2.818 0 C-N-CA 122.571 2.181 . . . . 71.41 111.068 -175.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 45.43 -76.16 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 126.47 1.908 . . . . 75.11 113.775 -173.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 18.6 tp -145.76 29.59 1.11 Allowed 'General case' 0 N--CA 1.484 1.255 0 CA-C-O 121.569 0.699 . . . . 64.54 110.201 -175.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 15' ' ' PHE . . . . . 0.741 ' HB3' ' HD2' ' B' ' 12' ' ' PRO . 87.3 t80 -92.04 101.94 14.49 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.147 0.579 . . . . 74.01 109.454 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 3.1 t -167.21 150.29 5.95 Favored Pre-proline 0 N--CA 1.478 0.971 0 C-N-CA 125.171 1.388 . . . . 71.11 108.521 -178.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -58.87 -18.34 41.55 Favored 'Trans proline' 0 C--N 1.375 1.964 0 C-N-CA 122.478 2.119 . . . . 71.22 113.722 171.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 5.2 t -96.63 14.34 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.494 0 C-N-CA 123.826 0.85 . . . . 63.3 110.327 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 19' ' ' THR . . . . . 0.509 HG22 ' HD2' ' B' ' 20' ' ' LYS . 9.8 t -59.67 -39.09 83.33 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.49 0.716 . . . . 71.22 111.654 -178.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 20' ' ' LYS . . . . . 0.509 ' HD2' HG22 ' B' ' 19' ' ' THR . 2.6 mptp? -140.11 161.95 36.4 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.483 1.113 . . . . 74.33 108.711 172.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.85 80.18 5.22 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 109.119 -0.697 . . . . 75.34 109.119 174.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 34.7 mtm180 -80.43 -50.96 9.39 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.183 -0.917 . . . . 73.31 110.184 -176.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 23' ' ' THR . . . . . . . . . . . . . 10.6 m 57.34 87.82 0.13 Allowed Pre-proline 0 CA--C 1.556 1.201 0 O-C-N 124.746 1.279 . . . . 72.54 110.225 -170.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -81.67 42.46 1.33 Allowed 'Trans proline' 0 C--N 1.372 1.787 0 C-N-CA 123.163 2.575 . . . . 74.55 112.617 -179.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -62.5 -54.62 37.27 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.254 1.021 . . . . 74.53 110.59 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 26' ' ' MET . . . . . 0.523 ' HE2' ' HB2' ' C' ' 192' ' ' ASP . 65.9 mtt -119.04 164.8 19.25 Favored Pre-proline 0 CA--C 1.544 0.722 0 CA-C-N 114.847 -1.07 . . . . 75.13 110.091 -174.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 27' ' ' PRO . . . . . 0.415 ' HD2' HG23 ' B' ' 296' ' ' THR . 61.7 Cg_exo -47.54 -31.49 13.93 Favored 'Trans proline' 0 C--N 1.382 2.305 0 C-N-CA 123.385 2.723 . . . . 73.04 114.198 165.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 84.0 t 71.73 -70.49 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 C-N-CA 125.317 1.447 . . . . 75.25 111.212 176.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -109.97 104.3 13.18 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 108.616 -0.883 . . . . 73.34 108.616 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -96.64 -19.96 18.64 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.549 0.74 . . . . 71.25 109.577 170.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 70.15 -80.07 0.04 OUTLIER 'General case' 0 C--N 1.357 0.902 0 C-N-CA 126.234 1.813 . . . . 74.34 111.229 175.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -80.59 85.31 6.01 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.262 0.553 . . . . 72.22 110.406 -173.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -129.68 84.81 2.24 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.436 -0.949 . . . . 73.31 108.436 174.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -127.52 92.94 3.59 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.18 0.992 . . . . 53.33 109.333 -178.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 67.19 91.48 0.09 Allowed 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.654 1.182 . . . . 73.13 110.609 -179.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.72 89.96 0.1 Allowed Glycine 0 C--N 1.343 0.97 0 N-CA-C 110.846 -0.902 . . . . 74.33 110.846 -178.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 61.99 95.46 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.297 1.439 . . . . 61.44 111.262 -173.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 2.8 mp -67.26 106.98 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 N-CA-C 107.343 -1.354 . . . . 75.44 107.343 172.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 14.7 t -68.3 -22.26 64.73 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 123.571 0.749 . . . . 73.32 112.473 -173.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . 58.3 78.13 0.37 Allowed Pre-proline 0 N--CA 1.48 1.042 0 C-N-CA 124.521 1.128 . . . . 73.24 110.577 -174.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.94 -158.27 0.09 OUTLIER 'Trans proline' 0 C--N 1.372 1.811 0 C-N-CA 122.895 2.397 . . . . 72.44 112.039 -177.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . 0.577 ' HA3' ' HB2' ' C' ' 246' ' ' ARG . . . -82.7 76.01 2.29 Favored Glycine 0 C--N 1.344 1.026 0 N-CA-C 114.074 0.39 . . . . 61.22 114.074 -174.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -93.52 -114.77 2.41 Favored Glycine 0 C--N 1.342 0.891 0 N-CA-C 111.141 -0.784 . . . . 64.32 111.141 171.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.81 124.36 24.66 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.587 0.755 . . . . 63.2 110.461 178.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.435 ' NE ' ' HB ' ' B' ' 232' ' ' THR . 14.1 mtp180 -86.22 -176.34 5.88 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.805 0.842 . . . . 74.21 110.645 -178.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 16.3 tpt180 -113.7 141.11 47.64 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.674 0.789 . . . . 75.02 109.168 176.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -137.68 67.4 1.43 Allowed 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.872 0.844 . . . . 72.13 109.335 175.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 9.8 m -56.75 -33.39 66.53 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 114.769 -1.105 . . . . 73.12 111.842 -178.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 159.53 61.2 0.01 OUTLIER Glycine 0 C--N 1.341 0.851 0 N-CA-C 109.762 -1.335 . . . . 74.15 109.762 177.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 28.9 t70 68.49 -97.41 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.785 1.234 . . . . 64.2 109.203 -165.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 51' ' ' GLN . . . . . 0.458 ' HG3' ' HB3' ' B' ' 53' ' ' ALA . 36.4 tp60 175.38 -30.66 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.929 1.292 . . . . 75.3 110.222 177.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 6.9 m 59.32 40.27 21.39 Favored 'General case' 0 CA--C 1.557 1.213 0 CA-C-O 122.187 0.994 . . . . 73.31 109.326 -174.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . 0.458 ' HB3' ' HG3' ' B' ' 51' ' ' GLN . . . -80.06 66.3 5.51 Favored 'General case' 0 C--N 1.354 0.786 0 CA-C-N 114.715 -1.13 . . . . 73.24 109.766 179.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.432 ' HB1' ' O ' ' B' ' 161' ' ' ALA . . . -97.56 166.86 11.31 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-N 114.533 -1.212 . . . . 75.51 109.952 -176.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . 0.484 ' HB3' ' HB3' ' B' ' 58' ' ' SER . 8.1 mp 75.49 -36.57 0.3 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 125.555 1.542 . . . . 72.35 112.063 -173.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 54.3 ttp85 73.4 -74.9 0.08 Allowed 'General case' 0 C--N 1.365 1.243 0 C-N-CA 125.411 1.484 . . . . 74.21 110.07 179.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -131.26 -14.89 3.32 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.947 0.899 . . . . 75.31 110.951 172.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 58' ' ' SER . . . . . 0.484 ' HB3' ' HB3' ' B' ' 55' ' ' LEU . 89.8 p 59.6 12.91 3.06 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 125.944 1.698 . . . . 62.01 113.659 -177.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . 0.524 HD23 ' HA ' ' A' ' 280' ' ' ALA . 97.8 mt -90.06 125.34 35.38 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 123.898 0.879 . . . . 72.44 109.147 176.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 73.9 p -75.49 168.13 20.59 Favored 'General case' 0 C--O 1.24 0.588 0 O-C-N 123.722 0.638 . . . . 71.31 110.866 174.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -69.88 155.04 41.16 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 114.853 -1.067 . . . . 71.45 110.603 174.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 62' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -140.48 93.54 8.75 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 124.462 1.105 . . . . 72.42 108.115 171.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -72.46 -16.03 27.59 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 122.593 2.195 . . . . 72.24 112.435 176.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 70.41 -70.7 0.14 Allowed 'General case' 0 C--N 1.365 1.259 0 C-N-CA 125.955 1.702 . . . . 72.04 111.734 179.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 56.1 pttt -124.5 -1.08 8.08 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.984 0.914 . . . . 73.42 111.27 178.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 60.1 t30 73.98 -63.11 0.44 Allowed 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 125.761 1.624 . . . . 72.41 111.227 -176.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 1.8 pp -78.42 68.86 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.278 0 C-N-CA 124.221 1.008 . . . . 74.04 111.913 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 10.3 tt -48.28 -40.75 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 C-N-CA 125.205 1.402 . . . . 73.4 113.834 -173.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 44.5 tp -125.17 -10.96 7.04 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.16 0.584 . . . . 74.34 111.263 -176.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 2.9 tt 61.59 87.26 0.1 Allowed 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 108.003 -1.11 . . . . 65.22 108.003 -166.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 15.1 tt -92.62 142.31 13.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 C-N-CA 123.798 0.839 . . . . 75.5 109.749 -178.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -83.5 179.93 52.39 Favored Glycine 0 C--N 1.347 1.161 0 N-CA-C 112.266 -0.334 . . . . 71.15 112.266 176.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -72.27 118.91 15.74 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.122 0.569 . . . . 74.12 109.531 177.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.55 24.83 73.94 Favored Glycine 0 C--N 1.353 1.519 0 O-C-N 123.682 0.614 . . . . 72.45 112.111 -172.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 75' ' ' MET . . . . . 0.589 ' HG3' ' HB2' ' B' ' 193' ' ' PRO . 0.6 OUTLIER 69.33 -67.48 0.22 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 126.01 1.724 . . . . 74.01 110.936 -171.796 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 107.08 67.06 0.64 Allowed Glycine 0 C--N 1.343 0.928 0 N-CA-C 110.616 -0.994 . . . . 71.52 110.616 -176.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -140.96 156.67 46.02 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.532 0.733 . . . . 74.35 109.826 -174.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 92.7 p 58.39 -78.86 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 127.036 2.135 . . . . 55.34 112.706 179.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 68.16 -73.08 0.09 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.375 1.47 . . . . 74.44 110.661 -174.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 14.8 pt -136.33 30.33 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 124.885 1.274 . . . . 72.52 108.494 174.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 56.4 m 74.49 -48.48 0.65 Allowed 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 126.411 1.884 . . . . 74.52 110.369 -170.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.56 127.79 32.91 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 109.047 -0.723 . . . . 75.12 109.047 164.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -177.04 -47.99 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.305 1.442 . . . . 74.13 107.424 -176.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -81.21 -168.47 1.84 Allowed 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 114.144 -1.389 . . . . 73.0 109.504 176.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -75.08 81.33 2.25 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 108.538 -0.912 . . . . 72.23 108.538 176.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 66.55 170.63 0.24 Allowed 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 125.631 1.572 . . . . 74.21 112.25 -179.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.38 137.57 9.3 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.263 0.625 . . . . 52.24 110.013 -177.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -79.97 104.5 10.59 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.812 0.845 . . . . 74.14 109.443 178.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.49 91.66 0.28 Allowed Glycine 0 C--N 1.345 1.053 0 O-C-N 123.454 0.471 . . . . 54.33 111.939 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.8 -30.57 70.03 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.539 0.736 . . . . 75.53 111.748 -178.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.63 -78.97 0.59 Allowed Glycine 0 C--N 1.348 1.208 0 CA-C-N 116.06 -0.518 . . . . 70.11 111.906 -177.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 68.86 -88.4 0.22 Allowed Glycine 0 C--N 1.351 1.41 0 N-CA-C 111.298 -0.721 . . . . 73.42 111.298 -178.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -161.19 48.88 0.22 Allowed 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 107.508 -1.293 . . . . 74.22 107.508 174.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -58.37 -42.11 86.25 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 115.666 -0.697 . . . . 72.14 110.237 178.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . 0.454 ' HB3' ' HB2' ' B' ' 98' ' ' ASP . 14.5 mmmm -132.75 -44.4 0.89 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.85 0.86 . . . . 74.44 110.235 176.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.16 -98.87 2.26 Favored Glycine 0 C--N 1.348 1.234 0 N-CA-C 111.552 -0.619 . . . . 75.21 111.552 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 3.2 mp -92.24 -66.94 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 108.391 -0.966 . . . . 73.0 108.391 175.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . 0.454 ' HB2' ' HB3' ' B' ' 95' ' ' LYS . 26.7 t70 61.06 -82.26 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 125.127 1.371 . . . . 75.21 112.409 174.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -159.97 92.76 1.03 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 106.652 -1.61 . . . . 61.12 106.652 179.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 6.5 tt -64.54 114.64 15.15 Favored Pre-proline 0 CA--C 1.55 0.957 0 C-N-CA 123.966 0.906 . . . . 74.2 110.218 -175.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -56.29 121.3 9.77 Favored 'Trans proline' 0 C--N 1.386 2.504 0 C-N-CA 122.715 2.276 . . . . 74.43 110.871 172.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . 0.605 HD11 ' HB2' ' C' ' 118' ' ' ASP . 62.3 mt -76.75 10.4 2.24 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.191 0.996 . . . . 73.12 113.083 -166.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 26.7 m -72.49 -43.3 63.83 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.905 0.882 . . . . 75.52 110.458 170.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . -151.85 -167.67 15.33 Favored Glycine 0 C--N 1.346 1.089 0 CA-C-N 115.508 -0.769 . . . . 51.35 112.339 -175.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 105' ' ' GLN . . . . . 0.548 ' HB3' ' HA ' ' B' ' 110' ' ' ALA . 21.8 tt0 -77.74 80.17 4.2 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 108.888 -0.782 . . . . 75.22 108.888 175.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 32.7 t80 77.11 -55.62 0.54 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 126.081 1.752 . . . . 74.44 112.312 177.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 15.0 p -129.54 103.31 6.8 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.188 0.595 . . . . 75.34 110.574 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 61.9 m80 66.1 -77.46 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 125.283 1.433 . . . . 73.44 113.289 171.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -128.34 167.59 16.74 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.954 1.301 . . . . 74.1 108.329 -175.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . 0.548 ' HA ' ' HB3' ' B' ' 105' ' ' GLN . . . -64.04 149.46 47.43 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.369 0.604 . . . . 75.22 111.394 175.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . 0.46 HD13 HE21 ' B' ' 105' ' ' GLN . 8.3 mp -74.73 -8.3 55.98 Favored 'General case' 0 CA--C 1.554 1.099 0 CA-C-N 115.537 -0.756 . . . . 70.25 110.139 172.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -70.37 84.47 0.58 Allowed 'General case' 0 C--N 1.362 1.128 0 C-N-CA 124.15 0.98 . . . . 73.2 109.641 170.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 113' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -166.12 -168.66 1.29 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.176 1.39 . . . . 75.13 108.049 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -81.07 13.32 2.82 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 113.072 0.767 . . . . 74.21 113.072 -174.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 10.9 t -165.49 153.29 10.98 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.896 0.879 . . . . 73.23 109.741 168.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 107.19 -41.74 2.11 Favored Glycine 0 N--CA 1.472 1.051 0 CA-C-O 119.95 -0.361 . . . . 55.33 112.713 176.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -141.45 94.48 7.53 Favored Pre-proline 0 N--CA 1.48 1.052 0 C-N-CA 123.267 0.627 . . . . 75.35 109.965 176.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 118' ' ' PRO . . . . . 0.58 ' HA ' ' HD2' ' B' ' 193' ' ' PRO . 91.5 Cg_endo -82.99 162.34 15.76 Favored 'Trans proline' 0 C--N 1.367 1.549 0 C-N-CA 122.564 2.176 . . . . 63.21 111.206 165.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 119' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -150.03 -179.27 7.03 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 108.704 -0.851 . . . . 75.33 108.704 178.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 120' ' ' TYR . . . . . . . . . . . . . 29.7 p90 -143.47 177.48 8.43 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.034 0.934 . . . . 70.1 109.674 -171.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 121' ' ' VAL . . . . . 0.525 HG13 ' H ' ' B' ' 122' ' ' THR . 2.1 p -164.02 -68.74 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 N-CA-C 107.902 -1.147 . . . . 74.32 107.902 166.146 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 122' ' ' THR . . . . . 0.525 ' H ' HG13 ' B' ' 121' ' ' VAL . 39.8 p 47.72 14.7 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 115.69 1.737 . . . . 75.25 115.69 171.027 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -177.99 143.51 0.31 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.271 1.029 . . . . 70.53 108.813 -175.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 46.8 m 58.99 24.95 13.22 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.244 1.018 . . . . 61.03 111.94 178.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -68.28 -15.08 63.43 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.672 1.189 . . . . 74.53 112.35 -176.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . 63.63 -167.69 0.21 Allowed 'General case' 0 C--N 1.365 1.26 0 C-N-CA 124.535 1.134 . . . . 74.13 109.638 -171.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 127' ' ' SER . . . . . 0.575 ' H ' HD21 ' B' ' 218' ' ' LEU . 16.0 m 59.99 -156.02 0.35 Allowed 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 123.299 0.64 . . . . 70.01 110.771 177.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -170.13 93.37 0.23 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.297 1.039 . . . . 74.33 108.475 165.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 73.8 p 49.86 -93.48 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.249 0 C-N-CA 125.644 1.578 . . . . 74.41 112.747 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . 173.77 81.98 0.0 OUTLIER 'General case' 0 C--O 1.238 0.481 0 N-CA-C 105.451 -2.055 . . . . 61.42 105.451 -178.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 131' ' ' TRP . . . . . 0.491 ' HE1' ' HB3' ' B' ' 164' ' ' ALA . 87.1 t90 80.09 -37.48 0.16 Allowed 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 125.424 1.49 . . . . 73.51 112.527 -174.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 32.0 t -70.0 78.85 0.49 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.626 1.17 . . . . 74.11 113.229 -166.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 12.0 t 177.91 172.96 0.61 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 125.179 1.391 . . . . 74.52 109.216 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 134' ' ' GLY . . . . . 0.466 ' HA3' HG22 ' B' ' 165' ' ' THR . . . 80.39 -73.82 2.44 Favored Glycine 0 C--N 1.349 1.273 0 N-CA-C 110.999 -0.841 . . . . 55.15 110.999 -178.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 135' ' ' VAL . . . . . 0.597 HG11 HD21 ' B' ' 155' ' ' LEU . 11.8 m -73.74 123.83 29.71 Favored 'Isoleucine or valine' 0 C--O 1.242 0.662 0 N-CA-C 108.342 -0.984 . . . . 73.24 108.342 169.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? 76.18 -10.59 1.27 Allowed 'General case' 0 CA--C 1.559 1.318 0 C-N-CA 125.737 1.615 . . . . 74.24 111.731 -174.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 26.8 m 69.7 -67.54 0.22 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 125.891 1.677 . . . . 75.31 112.157 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -68.26 -55.31 12.62 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.739 1.216 . . . . 75.52 112.17 -172.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -152.86 125.38 8.22 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 108.788 -0.819 . . . . 73.24 108.788 -172.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -68.73 -81.17 0.21 Allowed Glycine 0 C--N 1.35 1.311 0 O-C-N 123.544 0.528 . . . . 75.54 112.726 -179.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . 64.14 -1.49 0.69 Allowed 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 125.326 1.451 . . . . 75.34 114.628 175.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . 0.511 ' HB3' HG12 ' B' ' 144' ' ' VAL . 32.4 mt 52.96 94.66 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.854 1.262 . . . . 74.24 111.855 -170.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -79.32 58.86 4.38 Favored Glycine 0 C--N 1.351 1.415 0 N-CA-C 112.052 -0.419 . . . . 61.25 112.052 174.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 144' ' ' VAL . . . . . 0.511 HG12 ' HB3' ' B' ' 142' ' ' LEU . 11.4 p -143.7 158.28 16.49 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 C-N-CA 124.274 1.03 . . . . 75.31 108.874 -174.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -69.75 84.69 0.47 Allowed 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 124.311 1.045 . . . . 75.32 111.955 -175.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . 0.411 HG21 HH21 ' A' ' 279' ' ' ARG . 3.7 mp 60.32 9.92 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.586 2.36 0 C-N-CA 125.427 1.491 . . . . 72.52 112.157 174.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 49.5 p-80 46.8 88.11 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 126.148 1.779 . . . . 72.43 113.061 -174.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -95.55 -44.78 7.35 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.46 -0.775 . . . . 75.05 112.821 -172.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 149' ' ' LYS . . . . . 0.477 ' HB2' HG23 ' B' ' 153' ' ' THR . 0.8 OUTLIER -80.94 123.61 28.45 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 122.793 0.437 . . . . 74.13 110.352 -174.439 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 24.6 t70 57.34 -92.67 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.696 1.198 . . . . 74.11 110.222 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 151' ' ' HIS . . . . . 0.446 ' HB2' ' HD3' ' B' ' 152' ' ' PRO . 91.2 m-70 -144.97 -61.7 0.02 OUTLIER Pre-proline 0 CA--C 1.561 1.383 0 CA-C-O 118.044 -0.979 . . . . 74.43 110.309 176.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 152' ' ' PRO . . . . . 0.446 ' HD3' ' HB2' ' B' ' 151' ' ' HIS . 43.5 Cg_endo -85.97 -0.89 8.64 Favored 'Trans proline' 0 C--N 1.399 3.205 0 CA-C-N 122.3 1.857 . . . . 64.13 113.139 178.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 153' ' ' THR . . . . . 0.477 HG23 ' HB2' ' B' ' 149' ' ' LYS . 72.9 m 62.28 79.63 0.25 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 125.291 1.436 . . . . 74.2 111.876 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 9.5 tt 48.97 24.42 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 C-N-CA 126.698 1.999 . . . . 74.25 113.087 175.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 155' ' ' LEU . . . . . 0.597 HD21 HG11 ' B' ' 135' ' ' VAL . 4.8 tt -66.21 -49.97 65.44 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 107.704 -1.221 . . . . 73.12 107.704 178.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -98.69 111.01 23.52 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 108.2 -1.037 . . . . 72.23 108.2 165.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 157' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -68.54 -45.82 71.14 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 108.31 -0.996 . . . . 61.13 108.31 173.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 158' ' ' ALA . . . . . . . . . . . . . . . -74.15 96.38 2.73 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 108.52 -0.918 . . . . 65.11 108.52 167.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -72.87 87.93 1.32 Allowed 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 108.752 -0.833 . . . . 73.24 108.752 177.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -97.97 2.12 48.65 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 114.882 -1.054 . . . . 74.34 110.15 176.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . 0.432 ' O ' ' HB1' ' B' ' 54' ' ' ALA . . . 67.68 16.55 9.82 Favored 'General case' 0 C--N 1.359 1.009 0 C-N-CA 124.896 1.279 . . . . 71.1 112.449 176.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . -70.82 -29.35 69.42 Favored Glycine 0 C--N 1.347 1.163 0 CA-C-O 120.053 -0.304 . . . . 73.4 112.555 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 35.4 tp 73.63 84.27 0.11 Allowed 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.652 1.581 . . . . 75.25 109.379 -172.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 164' ' ' ALA . . . . . 0.491 ' HB3' ' HE1' ' B' ' 131' ' ' TRP . . . 63.07 -78.95 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 126.142 1.777 . . . . 75.34 112.972 176.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 165' ' ' THR . . . . . 0.512 HG23 HG12 ' B' ' 135' ' ' VAL . 10.9 p -112.03 14.96 20.81 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.214 1.005 . . . . 73.14 112.042 -175.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . 78.31 67.76 1.58 Allowed Glycine 0 C--N 1.344 0.997 0 N-CA-C 111.559 -0.617 . . . . 74.53 111.559 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 167' ' ' ASN . . . . . 0.428 ' HB2' ' HD1' ' B' ' 131' ' ' TRP . 2.9 t-20 -54.77 -50.17 69.12 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.613 0.765 . . . . 74.33 110.294 176.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 20.1 m 43.74 22.7 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 C-N-CA 126.398 1.879 . . . . 75.53 114.76 174.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 169' ' ' SER . . . . . 0.463 ' HB3' HD12 ' B' ' 226' ' ' LEU . 50.6 m -70.27 113.82 7.81 Favored 'General case' 0 C--N 1.352 0.676 0 N-CA-C 108.303 -0.999 . . . . 65.53 108.303 176.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 170' ' ' THR . . . . . 0.504 ' O ' ' HD2' ' B' ' 231' ' ' LYS . 24.5 m 82.17 -50.05 0.21 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 126.472 1.909 . . . . 73.13 110.479 -171.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -50.4 -36.9 34.88 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.844 1.258 . . . . 73.41 113.702 -177.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 172' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -65.52 -45.05 84.99 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.89 0.876 . . . . 75.25 111.444 -178.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 173' ' ' LEU . . . . . 0.536 HD11 ' HB3' ' B' ' 231' ' ' LYS . 33.3 tp 77.4 -17.17 0.58 Allowed 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 125.224 1.41 . . . . 74.44 112.715 176.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 174' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -98.52 101.17 12.53 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 121.811 -0.556 . . . . 74.45 111.963 -170.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 175' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 70.8 172.79 0.31 Allowed 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 114.236 1.199 . . . . 74.1 114.236 163.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -164.65 -175.31 3.77 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-N 113.501 -1.681 . . . . 74.11 107.85 176.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 60.5 m -108.14 95.25 14.86 Favored Pre-proline 0 N--CA 1.479 0.979 0 N-CA-C 108.533 -0.914 . . . . 74.15 108.533 166.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 178' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -87.64 -176.75 1.82 Allowed 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 123.05 2.5 . . . . 74.53 112.362 175.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -84.02 -177.76 6.77 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.68 0.792 . . . . 74.35 110.726 175.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 180' ' ' ALA . . . . . 0.482 ' HB3' HG22 ' C' ' 137' ' ' VAL . . . -63.71 -63.68 1.1 Allowed 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 109.16 -0.681 . . . . 75.32 109.16 170.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 181' ' ' LEU . . . . . 0.541 HD11 ' HB2' ' C' ' 136' ' ' ARG . 45.1 tp -143.85 -67.28 0.34 Allowed 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 106.727 -1.582 . . . . 74.44 106.727 167.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 182' ' ' VAL . . . . . 0.551 HG22 ' HB2' ' C' ' 125' ' ' LEU . 14.7 p -151.4 153.78 9.34 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 N-CA-C 107.185 -1.413 . . . . 72.43 107.185 -177.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -83.08 63.97 7.41 Favored 'General case' 0 CA--C 1.562 1.438 0 N-CA-C 115.266 1.58 . . . . 65.24 115.266 -158.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 12.3 m170 60.79 -176.16 0.11 Allowed 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 114.379 1.252 . . . . 75.32 114.379 161.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 185' ' ' VAL . . . . . . . . . . . . . 2.6 p -99.72 112.6 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 122.816 0.446 . . . . 74.01 110.509 173.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 72.6 p 62.56 -67.8 0.07 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 126.76 2.024 . . . . 60.24 114.467 168.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 187' ' ' SER . . . . . . . . . . . . . 16.2 m -53.69 96.23 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.584 1.154 . . . . 62.14 111.353 177.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 19.1 mmm180 -138.66 139.76 38.6 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.538 0.735 . . . . 72.32 111.077 -177.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -115.35 80.61 1.45 Allowed 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.068 -1.086 . . . . 72.52 108.068 170.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 190' ' ' CYS . . . . . . . . . . . . . 25.6 p -169.45 149.54 4.02 Favored 'General case' 0 C--O 1.245 0.832 0 CA-C-N 115.012 -0.995 . . . . 70.33 109.194 178.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 43.9 t80 69.68 160.78 0.2 Allowed 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 124.876 1.27 . . . . 74.04 112.154 174.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 157.07 -161.18 30.97 Favored Glycine 0 C--N 1.347 1.152 0 CA-C-O 119.258 -0.745 . . . . 64.22 113.227 174.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 193' ' ' PRO . . . . . 0.589 ' HB2' ' HG3' ' B' ' 75' ' ' MET . 58.0 Cg_exo -48.36 100.95 0.04 OUTLIER 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 124.155 3.237 . . . . 73.22 112.878 171.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 194' ' ' SER . . . . . . . . . . . . . 33.0 m -107.63 149.58 27.91 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.374 -0.83 . . . . 63.44 109.579 178.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 195' ' ' ALA . . . . . . . . . . . . . . . -83.69 1.78 40.86 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.654 0.782 . . . . 74.32 111.72 179.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 196' ' ' THR . . . . . 0.622 HG23 ' HA2' ' B' ' 202' ' ' GLY . 35.7 m 80.88 -52.24 0.31 Allowed 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 126.451 1.9 . . . . 73.32 112.165 179.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 24.4 m 72.15 10.07 5.99 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 125.005 1.322 . . . . 75.11 112.906 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 198' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -96.01 81.61 3.41 Favored 'General case' 0 CA--C 1.551 0.983 0 N-CA-C 107.744 -1.206 . . . . 65.14 107.744 176.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 25.9 pttm 47.45 -69.4 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.152 0 C-N-CA 127.409 2.284 . . . . 75.14 115.724 179.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 200' ' ' CYS . . . . . . . . . . . . . 83.2 m -140.66 -54.84 0.02 OUTLIER Pre-proline 0 CA--C 1.569 1.711 0 C-N-CA 124.511 1.124 . . . . 73.31 111.686 -178.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 201' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -82.7 -179.16 4.34 Favored 'Trans proline' 0 C--N 1.403 3.412 0 CA-C-N 121.747 1.66 . . . . 74.02 113.751 -177.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 202' ' ' GLY . . . . . 0.622 ' HA2' HG23 ' B' ' 196' ' ' THR . . . -97.34 46.56 1.66 Allowed Glycine 0 C--N 1.351 1.375 0 CA-C-N 115.068 -0.969 . . . . 73.41 111.976 178.273 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -87.13 73.75 9.74 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.82 0.848 . . . . 71.33 109.393 -176.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . 65.6 158.55 0.11 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.819 1.248 . . . . 74.01 111.483 -175.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 205' ' ' LEU . . . . . 0.497 ' HB3' HG21 ' B' ' 196' ' ' THR . 2.2 pt? -155.14 165.04 37.93 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.081 0.467 . . . . 72.44 111.241 -173.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -95.01 -13.4 25.27 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 124.329 1.052 . . . . 70.3 110.226 173.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 207' ' ' LYS . . . . . 0.594 ' HB2' ' HG3' ' C' ' 182' ' ' PRO . 4.5 tmtm? 85.4 -36.96 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 126.612 1.965 . . . . 74.32 110.172 -166.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 98.56 69.38 0.94 Allowed Glycine 0 C--N 1.344 1.02 0 N-CA-C 111.517 -0.633 . . . . 71.52 111.517 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . -102.47 -57.84 0.79 Allowed Glycine 0 C--N 1.344 1.025 0 N-CA-C 110.963 -0.855 . . . . 63.34 110.963 174.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -105.01 -22.56 13.1 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.014 0.925 . . . . 74.51 111.275 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . -72.62 148.24 41.56 Favored Glycine 0 C--N 1.347 1.193 0 O-C-N 123.586 0.554 . . . . 74.43 112.265 -177.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 34.5 t 75.05 -56.8 0.62 Allowed 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 125.992 1.717 . . . . 74.04 111.078 -174.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 6.5 tt -67.19 112.37 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 C-N-CA 123.454 0.701 . . . . 70.12 111.366 177.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 85.0 m -79.39 84.43 5.29 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 108.233 -1.025 . . . . 75.43 108.233 167.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 215' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -63.08 -30.06 71.3 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 114.649 -1.16 . . . . 73.31 110.913 -178.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 64.08 83.36 0.17 Allowed 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.72 1.208 . . . . 61.42 109.5 176.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 23.7 tp -160.44 -77.76 0.06 Allowed 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 109.242 -0.651 . . . . 75.4 109.242 176.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . 0.575 HD21 ' H ' ' B' ' 127' ' ' SER . 2.7 mm? -86.56 67.18 9.8 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 107.44 -1.318 . . . . 71.43 107.44 172.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -62.41 122.53 15.94 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 114.697 -1.138 . . . . 71.24 111.331 -171.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . 78.09 -42.49 0.35 Allowed 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 125.641 1.576 . . . . 74.3 112.968 177.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 221' ' ' ARG . . . . . . . . . . . . . 45.3 ttt180 -48.05 -43.69 30.61 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.272 1.429 . . . . 73.55 111.911 176.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . 70.53 7.74 6.33 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 125.133 1.373 . . . . 75.21 112.017 -175.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 19.6 t70 67.29 -68.25 0.16 Allowed 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 126.188 1.795 . . . . 72.13 113.817 174.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 11.3 p -50.2 -34.63 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 125.14 1.376 . . . . 75.32 112.828 -178.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 69.5 p 50.37 27.41 2.73 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 125.335 1.454 . . . . 73.55 113.631 177.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . 0.463 HD12 ' HB3' ' B' ' 169' ' ' SER . 6.8 mp 51.19 79.24 0.1 Allowed 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.762 1.225 . . . . 74.43 111.799 173.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . 96.32 -45.75 1.88 Allowed Glycine 0 C--N 1.346 1.133 0 CA-C-N 116.033 -0.531 . . . . 71.24 111.973 -177.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 64.95 -99.3 0.35 Allowed Glycine 0 C--N 1.354 1.54 0 C-N-CA 123.402 0.525 . . . . 72.41 112.638 178.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -83.78 71.0 3.07 Favored Glycine 0 C--N 1.346 1.096 0 N-CA-C 111.405 -0.678 . . . . 71.04 111.405 178.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -163.33 -30.69 0.04 OUTLIER 'General case' 0 C--O 1.244 0.769 0 C-N-CA 124.054 0.942 . . . . 70.23 110.115 -176.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 231' ' ' LYS . . . . . 0.536 ' HB3' HD11 ' B' ' 173' ' ' LEU . 34.1 tttt -54.54 107.32 0.27 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.121 0.969 . . . . 73.24 111.25 177.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 232' ' ' THR . . . . . 0.435 ' HB ' ' NE ' ' B' ' 45' ' ' ARG . 5.4 m -143.67 148.1 35.27 Favored 'General case' 0 C--O 1.244 0.789 0 N-CA-C 107.374 -1.343 . . . . 74.24 107.374 170.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -68.93 141.74 54.91 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 108.876 -0.787 . . . . 71.44 108.876 -179.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -73.77 166.55 23.1 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 112.919 0.711 . . . . 72.31 112.919 -165.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -65.5 -48.41 72.66 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 113.964 -1.471 . . . . 64.41 109.685 -171.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 236' ' ' THR . . . . . . . . . . . . . 25.4 p -72.07 -69.83 0.37 Allowed 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.198 -0.91 . . . . 73.34 109.631 172.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -160.14 -76.86 0.06 Allowed 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 107.824 -1.176 . . . . 73.03 107.824 175.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 238' ' ' THR . . . . . 0.544 HG23 HG23 ' C' ' 219' ' ' VAL . 3.0 m -132.36 -66.75 0.68 Allowed 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 107.527 -1.286 . . . . 71.31 107.527 171.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -84.09 169.13 15.21 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.746 -0.661 . . . . 74.42 110.204 175.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 240' ' ' GLY . . . . . 0.426 ' H ' HD23 ' C' ' 235' ' ' LEU . . . -109.91 -93.08 2.22 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 110.778 -0.929 . . . . 71.23 110.778 -173.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -165.34 161.2 18.89 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.7 0.8 . . . . 71.23 110.097 -179.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 13.8 m95 -108.19 -82.08 0.56 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.655 0.782 . . . . 70.32 108.944 177.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -153.12 -162.21 1.44 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.765 1.626 . . . . 74.22 107.772 -171.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -73.7 79.53 0.83 Allowed Glycine 0 C--N 1.349 1.274 0 N-CA-C 111.199 -0.76 . . . . 71.54 111.199 170.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 2.1 pptp? -74.72 155.0 38.16 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.946 0.898 . . . . 75.34 111.55 -174.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 9.7 t -165.03 158.69 17.15 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.413 0.685 . . . . 71.14 110.434 -175.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 247' ' ' LEU . . . . . . . . . . . . . 34.2 tp -101.56 127.5 48.24 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.077 0.951 . . . . 72.51 109.43 -179.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 248' ' ' ARG . . . . . 0.485 ' HG3' ' HG2' ' C' ' 226' ' ' ARG . 9.9 ptp180 -133.15 71.52 1.47 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 122.319 1.057 . . . . 75.15 109.17 -178.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -86.65 -43.74 12.39 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 113.62 -1.627 . . . . 71.33 112.52 -170.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -66.35 -57.5 7.32 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 123.555 0.534 . . . . 70.14 112.307 -164.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 251' ' ' ALA . . . . . 0.438 ' H ' ' HG ' ' B' ' 280' ' ' LEU . . . 54.7 -78.88 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 125.058 1.343 . . . . 64.21 112.163 -175.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -84.49 64.21 8.29 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 124.493 1.117 . . . . 73.12 108.09 172.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -69.95 -31.77 69.68 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.378 -0.828 . . . . 51.41 110.336 178.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . 0.438 ' HG2' ' HA ' ' B' ' 257' ' ' GLN . 71.8 ttt180 -142.44 -72.18 0.32 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 107.657 -1.238 . . . . 72.51 107.657 177.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . 70.08 -76.6 0.45 Allowed Glycine 0 C--N 1.357 1.747 0 O-C-N 123.766 0.666 . . . . 63.32 113.676 172.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 256' ' ' TYR . . . . . 0.687 ' HA ' ' HA ' ' B' ' 266' ' ' ASN . 92.3 m-85 -75.74 -0.6 21.47 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.448 1.099 . . . . 71.2 112.73 -178.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 257' ' ' GLN . . . . . 0.438 ' HA ' ' HG2' ' B' ' 254' ' ' ARG . 12.4 mm100 64.44 -88.65 0.03 OUTLIER 'General case' 0 C--N 1.356 0.866 0 C-N-CA 125.38 1.472 . . . . 74.31 109.586 -176.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 258' ' ' LEU . . . . . . . . . . . . . 53.9 tp -176.21 -69.71 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.32 1.048 . . . . 75.13 108.724 169.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 13.0 m -139.14 135.04 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.196 0.998 . . . . 63.31 108.963 178.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 260' ' ' SER . . . . . . . . . . . . . 58.1 m -151.82 80.64 1.27 Allowed 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 106.79 -1.559 . . . . 73.11 106.79 173.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 66.4 -69.43 0.12 Allowed 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 125.009 1.324 . . . . 65.51 109.99 -166.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 262' ' ' ALA . . . . . . . . . . . . . . . -82.17 145.53 30.04 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.478 0.711 . . . . 75.22 110.55 171.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -74.11 131.79 41.65 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.127 0.571 . . . . 70.44 109.726 175.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 80.1 p 49.92 46.07 24.57 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.631 1.572 . . . . 51.14 111.35 -175.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 265' ' ' LEU . . . . . . . . . . . . . 61.1 tp -59.39 -31.19 69.01 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.929 0.892 . . . . 73.31 111.425 -179.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 266' ' ' ASN . . . . . 0.687 ' HA ' ' HA ' ' B' ' 256' ' ' TYR . 64.6 t30 81.6 -70.49 0.07 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.154 1.382 . . . . 71.52 111.458 170.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 21.8 m 65.13 -76.16 0.04 OUTLIER 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 125.019 1.328 . . . . 73.13 112.959 173.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 10.2 p -59.32 -32.72 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.668 0.787 . . . . 74.44 112.485 -173.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 269' ' ' THR . . . . . 0.458 ' HA ' ' HD3' ' B' ' 276' ' ' PRO . 16.4 m -84.47 -11.83 55.44 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 123.259 0.624 . . . . 74.31 112.345 -176.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 270' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -139.51 -60.01 0.56 Allowed 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.486 -0.759 . . . . 72.41 112.585 -177.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 271' ' ' ALA . . . . . . . . . . . . . . . -70.54 112.14 6.58 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.75 0.82 . . . . 75.3 110.911 -174.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 272' ' ' ASN . . . . . . . . . . . . . 8.9 t30 70.91 -74.82 0.08 Allowed 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 126.103 1.761 . . . . 73.11 112.021 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 17.3 mp0 -60.41 -48.13 83.08 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.406 0.682 . . . . 73.43 111.072 -175.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 57.29 22.94 8.24 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.823 1.249 . . . . 71.44 112.272 178.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 275' ' ' LYS . . . . . 0.497 ' HD2' HD13 ' B' ' 278' ' ' LEU . 37.1 ttpt -157.78 99.2 1.85 Allowed Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 123.699 0.8 . . . . 72.14 109.797 -169.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 276' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' B' ' 269' ' ' THR . 85.5 Cg_endo -85.22 -59.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 122.541 2.161 . . . . 73.04 112.742 173.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 277' ' ' LEU . . . . . . . . . . . . . 97.9 mt -137.74 94.77 2.95 Favored 'General case' 0 C--N 1.356 0.87 0 C-N-CA 124.573 1.149 . . . . 74.52 109.536 -170.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 278' ' ' LEU . . . . . 0.497 HD13 ' HD2' ' B' ' 275' ' ' LYS . 0.7 OUTLIER -86.05 -13.19 48.12 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 124.287 1.035 . . . . 72.2 109.871 178.648 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . -64.06 -20.91 65.3 Favored Glycine 0 N--CA 1.478 1.466 0 N-CA-C 114.165 0.426 . . . . 75.43 114.165 -178.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 280' ' ' LEU . . . . . 0.438 ' HG ' ' H ' ' B' ' 251' ' ' ALA . 2.4 mm? -90.7 11.79 21.11 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.773 0.829 . . . . 74.31 111.318 178.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -147.87 111.19 4.92 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.935 0.894 . . . . 75.31 108.613 -176.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -83.99 33.21 0.48 Allowed 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 124.178 0.991 . . . . 65.41 112.422 -176.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 16.3 t70 64.57 26.86 13.33 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.56 1.144 . . . . 72.33 110.366 -179.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . 82.71 53.95 3.4 Favored Glycine 0 C--N 1.35 1.346 0 N-CA-C 111.245 -0.742 . . . . 72.13 111.245 -174.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 9.1 t30 68.36 110.32 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 125.034 1.333 . . . . 73.03 110.885 -172.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 286' ' ' MET . . . . . . . . . . . . . 47.8 tpp -74.22 119.68 77.58 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 123.651 0.78 . . . . 74.22 110.212 -179.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 287' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -67.67 112.5 2.66 Favored 'Trans proline' 0 C--N 1.377 2.071 0 C-N-CA 122.77 2.313 . . . . 74.24 111.18 178.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 288' ' ' VAL . . . . . . . . . . . . . 33.8 m -111.99 158.19 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.385 0.674 . . . . 74.32 109.785 177.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 289' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -107.47 171.44 7.38 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.103 0.961 . . . . 74.32 109.531 179.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 290' ' ' TRP . . . . . . . . . . . . . 60.6 m95 56.73 27.49 12.8 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 124.715 1.206 . . . . 75.34 111.275 -178.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 291' ' ' LEU . . . . . 0.438 HD23 ' H ' ' B' ' 291' ' ' LEU . 2.7 pt? -90.23 1.08 56.85 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.1 0.96 . . . . 73.52 112.703 -169.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . -168.46 -102.41 0.16 Allowed Glycine 0 C--N 1.344 1.008 0 CA-C-O 119.008 -0.885 . . . . 71.42 111.609 178.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 293' ' ' PRO . . . . . 0.567 ' HB2' HG22 ' B' ' 296' ' ' THR . 96.5 Cg_endo -77.39 80.79 2.81 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.789 2.326 . . . . 75.13 112.403 -176.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -83.24 -27.19 30.08 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 115.681 -0.691 . . . . 74.44 110.703 177.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -128.21 89.85 2.98 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 107.763 -1.199 . . . . 71.35 107.763 173.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 296' ' ' THR . . . . . 0.567 HG22 ' HB2' ' B' ' 293' ' ' PRO . 29.0 p -74.37 90.55 2.16 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 124.017 0.927 . . . . 71.52 110.195 -173.198 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 297' ' ' TYR . . . . . 0.554 ' HD2' ' HA ' ' B' ' 300' ' ' ASN . 77.7 t80 66.73 1.79 2.35 Favored 'General case' 0 CA--C 1.562 1.426 0 C-N-CA 124.824 1.25 . . . . 75.44 111.264 -173.299 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 3.6 t60 53.01 84.8 0.05 Allowed 'General case' 0 C--N 1.361 1.086 0 C-N-CA 125.029 1.332 . . . . 73.43 110.64 -167.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . 71.01 63.16 3.24 Favored Glycine 0 C--N 1.344 0.98 0 CA-C-N 114.912 -1.04 . . . . 72.35 111.751 -178.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 300' ' ' ASN . . . . . 0.554 ' HA ' ' HD2' ' B' ' 297' ' ' TYR . 53.8 t30 -58.02 89.83 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.572 1.149 . . . . 72.23 110.902 -177.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 301' ' ' ILE . . . . . . . . . . . . . 50.2 mm 74.89 -34.15 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.559 1.32 0 C-N-CA 125.77 1.628 . . . . 75.13 112.751 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 31.6 t70 57.54 87.28 0.07 Allowed 'General case' 0 C--N 1.361 1.069 0 C-N-CA 124.353 1.061 . . . . 74.32 109.162 -172.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 303' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -154.38 130.88 5.7 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 109.287 -0.634 . . . . 74.11 109.287 -169.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 304' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -69.82 -163.56 0.11 Allowed 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 122.842 2.361 . . . . 75.12 110.899 166.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -81.58 60.96 4.79 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 122.827 0.451 . . . . 72.13 110.276 174.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 78.4 t 66.89 -54.34 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 C-N-CA 126.399 1.88 . . . . 72.33 113.145 -178.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 51.3 m 83.77 -53.58 0.14 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 126.518 1.927 . . . . 74.23 111.143 173.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 308' ' ' CYS . . . . . . . . . . . . . 24.6 p -81.13 20.01 0.86 Allowed 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.697 0.799 . . . . 74.22 113.082 -172.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 18.4 p -120.79 82.5 35.01 Favored Pre-proline 0 CA--C 1.556 1.209 0 C-N-CA 123.201 0.601 . . . . 72.2 110.258 171.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -84.59 -168.43 0.53 Allowed 'Trans proline' 0 C--N 1.375 1.925 0 C-N-CA 122.536 2.157 . . . . 64.44 112.199 170.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 311' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -136.03 101.14 10.49 Favored Pre-proline 0 N--CA 1.48 1.028 0 C-N-CA 123.957 0.903 . . . . 73.13 108.877 173.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 312' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -76.73 102.28 1.6 Allowed 'Trans proline' 0 C--N 1.374 1.88 0 C-N-CA 121.975 1.783 . . . . 70.14 111.481 170.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 313' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -95.83 156.33 16.37 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.899 0.48 . . . . 75.13 109.796 175.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 314' ' ' ARG . . . . . . . . . . . . . 13.3 ptp180 -123.42 72.72 1.14 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.128 0.971 . . . . 74.53 109.023 -178.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 315' ' ' ASN . . . . . . . . . . . . . 7.9 t30 71.22 -61.4 0.48 Allowed 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 125.507 1.523 . . . . 75.34 109.759 -167.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 316' ' ' ASP . . . . . 0.405 ' HB3' ' HD2' ' B' ' 319' ' ' PRO . 6.7 m-20 -87.51 148.43 24.92 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.491 1.116 . . . . 74.4 109.685 172.07 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 31.3 p -83.07 -70.97 0.52 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.101 0.56 . . . . 75.41 109.925 175.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 318' ' ' VAL . . . . . . . . . . . . . 41.7 t -81.31 -47.66 1.08 Allowed Pre-proline 0 CA--C 1.568 1.647 0 CA-C-O 118.453 -0.784 . . . . 73.13 111.38 -179.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 319' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' B' ' 316' ' ' ASP . 24.2 Cg_exo -65.38 157.71 56.5 Favored 'Trans proline' 0 C--N 1.398 3.147 0 C-N-CA 121.936 1.757 . . . . 65.1 112.404 173.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 320' ' ' THR . . . . . 0.584 ' HA ' ' HA ' ' B' ' 325' ' ' THR . 6.7 m 69.67 -11.53 0.51 Allowed 'General case' 0 CA--C 1.566 1.572 0 C-N-CA 125.595 1.558 . . . . 73.24 113.16 178.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 321' ' ' LEU . . . . . . . . . . . . . 56.1 tp -70.42 98.14 1.38 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.813 0.845 . . . . 74.43 111.054 -172.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 322' ' ' ALA . . . . . . . . . . . . . . . 76.63 -34.77 0.23 Allowed 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 126.267 1.827 . . . . 64.54 112.961 178.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 323' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -161.82 -171.66 2.99 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 125.861 1.664 . . . . 74.02 107.68 178.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 324' ' ' MET . . . . . . . . . . . . . 18.6 ptp 44.44 79.99 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 125.642 1.577 . . . . 74.22 112.642 177.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 325' ' ' THR . . . . . 0.584 ' HA ' ' HA ' ' B' ' 320' ' ' THR . 35.3 p -60.45 -58.04 10.17 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 115.243 -0.889 . . . . 72.33 112.995 -171.017 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 326' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -109.37 -63.77 1.32 Allowed 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 122.91 0.484 . . . . 72.01 109.996 178.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -160.04 98.14 1.3 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.938 0.895 . . . . 75.41 108.908 -171.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 328' ' ' ALA . . . . . . . . . . . . . . . -114.98 89.92 3.21 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 108.658 -0.867 . . . . 72.03 108.658 177.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 329' ' ' ILE . . . . . . . . . . . . . 48.2 pt -121.74 175.46 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.077 0.951 . . . . 73.5 111.373 -171.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 330' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -94.04 144.4 25.51 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.898 0.879 . . . . 74.44 108.739 169.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 331' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -66.89 -49.9 64.14 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.793 0.837 . . . . 64.42 110.212 176.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 5.4 tt -165.92 109.83 0.81 Allowed 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 109.231 -0.655 . . . . 74.41 109.231 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 333' ' ' SER . . . . . . . . . . . . . 17.2 m -86.79 125.45 33.95 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 108.335 -0.987 . . . . 65.04 108.335 169.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 23.4 mtpp -81.93 71.69 8.97 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-O 121.671 0.748 . . . . 65.35 111.246 177.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 335' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -74.34 -34.8 63.53 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 114.542 -1.208 . . . . 74.12 110.935 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.19 -20.43 60.2 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.769 0.828 . . . . 73.55 111.182 176.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 337' ' ' LYS . . . . . . . . . . . . . 23.3 tptm 76.91 -23.84 0.24 Allowed 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 125.862 1.665 . . . . 71.1 112.592 174.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 338' ' ' GLY . . . . . . . . . . . . . . . 68.26 47.86 55.9 Favored Glycine 0 C--N 1.345 1.058 0 N-CA-C 110.931 -0.868 . . . . 73.12 110.931 -170.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 339' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -72.93 82.13 1.2 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.618 0.767 . . . . 74.33 110.29 -177.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 340' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 56.85 16.39 2.72 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 125.585 1.554 . . . . 75.24 112.959 178.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 341' ' ' LEU . . . . . . . . . . . . . 72.2 mt 57.29 46.79 17.93 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.63 1.172 . . . . 75.34 110.968 -173.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 342' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -111.74 153.7 26.1 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.595 0.758 . . . . 74.32 111.273 -178.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 343' ' ' VAL . . . . . . . . . . . . . 6.7 t 63.72 3.46 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.576 1.947 0 C-N-CA 126.18 1.792 . . . . 65.15 112.717 175.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.53 -15.66 30.29 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.447 0.699 . . . . 74.33 112.269 -175.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 345' ' ' GLY . . . . . . . . . . . . . . . 140.5 -44.01 1.08 Allowed Glycine 0 C--N 1.348 1.247 0 CA-C-N 117.624 0.193 . . . . 63.14 112.628 174.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 346' ' ' ALA . . . . . . . . . . . . . . . -103.28 29.29 5.68 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.709 0.804 . . . . 72.51 111.2 -175.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 9.6 m -62.66 93.05 0.05 Allowed 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.392 1.077 . . . . 72.21 112.404 -172.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 2.7 mp 69.97 -61.53 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 C-N-CA 125.848 1.659 . . . . 73.42 111.373 -179.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 349' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -70.5 166.92 19.47 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.972 0.909 . . . . 71.13 112.495 177.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 350' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -158.44 156.19 29.92 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 114.466 -1.243 . . . . 74.52 108.106 -178.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -63.43 150.69 43.02 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.634 0.373 . . . . 71.32 110.649 177.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -118.24 108.43 15.13 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 122.8 0.44 . . . . 74.35 110.812 -177.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 353' ' ' HIS . . . . . . . . . . . . . 51.9 m80 54.08 39.24 30.43 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.735 1.214 . . . . 74.33 111.988 174.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 354' ' ' ALA . . . . . . . . . . . . . . . 69.04 -72.21 0.11 Allowed 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 125.109 1.364 . . . . 72.23 110.068 -168.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 355' ' ' ALA . . . . . . . . . . . . . . . -148.8 -64.98 0.24 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.4 0.68 . . . . 75.44 109.685 179.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 356' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -163.1 127.27 1.91 Allowed Pre-proline 0 N--CA 1.477 0.888 0 N-CA-C 108.079 -1.082 . . . . 74.32 108.079 178.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 357' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -54.85 -51.62 9.92 Favored 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 123.09 2.527 . . . . 74.21 113.381 -176.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 358' ' ' CYS . . . . . . . . . . . . . 67.3 m -70.41 -24.33 62.91 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.04 0.536 . . . . 75.21 111.457 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 359' ' ' GLY . . . . . . . . . . . . . . . -74.1 -31.96 59.05 Favored Glycine 0 C--N 1.347 1.174 0 CA-C-N 116.256 -0.429 . . . . 72.04 112.7 178.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 360' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -96.14 38.9 1.16 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.181 0.592 . . . . 53.34 111.217 -176.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 361' ' ' ILE . . . . . . . . . . . . . 2.7 pp -70.64 -7.83 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 C-N-CA 123.4 0.68 . . . . 64.41 112.177 174.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 362' ' ' GLY . . . . . . . . . . . . . . . -145.48 -168.72 13.23 Favored Glycine 0 C--N 1.342 0.89 0 N-CA-C 111.196 -0.762 . . . . 72.35 111.196 172.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 363' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 63.22 -80.84 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 125.413 1.485 . . . . 73.13 112.189 176.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 364' ' ' THR . . . . . . . . . . . . . 66.6 p -96.38 27.37 3.8 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.76 0.824 . . . . 74.04 111.849 -173.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 8.1 m -65.76 -29.76 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 123.492 0.717 . . . . 74.51 111.784 173.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -84.0 -10.47 57.87 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.276 0.63 . . . . 52.52 111.191 174.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 367' ' ' LEU . . . . . . . . . . . . . 9.2 mp 64.98 169.47 0.19 Allowed 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 124.787 1.235 . . . . 75.05 112.449 178.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 368' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -84.89 86.25 7.38 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 122.203 1.002 . . . . 73.23 108.549 170.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 369' ' ' GLU . . . . . 0.452 ' HB3' ' HB3' ' B' ' 372' ' ' GLN . 50.7 mt-10 -75.03 -64.35 1.07 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 114.412 -1.267 . . . . 74.11 111.084 -176.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 370' ' ' ALA . . . . . . . . . . . . . . . 66.13 -73.36 0.07 Allowed 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.307 1.443 . . . . 74.25 111.452 -175.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 371' ' ' VAL . . . . . . . . . . . . . 9.2 p -74.81 -30.0 23.64 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.085 0 C-N-CA 124.472 1.109 . . . . 74.12 112.582 -177.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 372' ' ' GLN . . . . . 0.452 ' HB3' ' HB3' ' B' ' 369' ' ' GLU . 0.2 OUTLIER -66.28 -61.73 1.86 Allowed 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.19 0.596 . . . . 63.2 110.881 -170.381 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 373' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -111.75 148.31 33.77 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 122.961 0.504 . . . . 72.2 111.014 178.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . 65.76 -82.84 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 125.47 1.508 . . . . 71.45 112.177 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 375' ' ' LEU . . . . . . . . . . . . . 44.4 tp 50.16 -102.18 0.1 Allowed 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.882 1.273 . . . . 72.22 111.356 -175.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -127.43 -7.67 5.78 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.004 0.921 . . . . 73.13 110.345 176.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 377' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -59.47 -65.41 0.68 Allowed 'General case' 0 C--N 1.355 0.832 0 O-C-N 124.098 0.874 . . . . 73.31 109.217 -177.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 378' ' ' ALA . . . . . . . . . . . . . . . 60.54 -1.38 0.22 Allowed 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 114.741 1.385 . . . . 73.45 114.741 171.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -77.14 86.56 3.61 Favored 'General case' 0 C--N 1.351 0.639 0 N-CA-C 108.751 -0.833 . . . . 73.22 108.751 -176.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 380' ' ' LYS . . . . . . . . . . . . . 88.8 tttt 48.8 91.42 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.402 1.481 . . . . 72.4 112.752 177.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 381' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -61.66 -45.52 93.68 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 108.52 -0.918 . . . . 74.34 108.52 171.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -166.29 -162.42 17.7 Favored Glycine 0 C--N 1.34 0.798 0 CA-C-N 114.118 -1.401 . . . . 73.1 109.624 171.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 383' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -74.82 169.41 17.95 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 109.289 -0.634 . . . . 73.1 109.289 170.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 384' ' ' THR . . . . . . . . . . . . . 48.3 p -80.94 76.04 7.9 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-O 121.898 0.856 . . . . 71.44 111.627 -173.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -159.67 109.04 1.83 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.901 1.28 . . . . 75.43 107.943 171.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 386' ' ' VAL . . . . . . . . . . . . . 4.4 m -86.79 67.19 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.694 0.798 . . . . 75.23 110.572 -175.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 387' ' ' ILE . . . . . 0.485 HG12 HG23 ' B' ' 388' ' ' VAL . 9.8 tt -65.49 129.09 29.39 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.094 0 CA-C-N 115.317 -0.856 . . . . 74.12 109.824 177.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 388' ' ' VAL . . . . . 0.485 HG23 HG12 ' B' ' 387' ' ' ILE . 65.9 t 77.02 -51.91 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 C-N-CA 125.882 1.673 . . . . 74.43 111.997 -178.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 389' ' ' THR . . . . . . . . . . . . . 35.2 p -85.02 16.92 3.14 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 123.652 0.781 . . . . 71.25 112.713 -176.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . -66.36 -66.42 0.55 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.635 0.774 . . . . 73.41 111.317 177.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 391' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -145.25 -87.78 0.11 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.468 0.707 . . . . 64.12 109.876 -173.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 392' ' ' HIS . . . . . . . . . . . . . 40.0 m80 52.46 83.16 0.06 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.331 1.052 . . . . 72.42 111.218 -168.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -76.17 69.17 2.69 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.203 0.601 . . . . 61.53 109.762 173.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 33.1 m80 56.2 -84.88 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 126.176 1.79 . . . . 73.31 112.361 -178.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . -153.51 -0.9 0.22 Allowed 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 112.884 0.698 . . . . 75.42 112.884 -174.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 66.3 m -96.75 19.62 12.21 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 112.118 0.414 . . . . 75.55 112.118 -177.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 397' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 67.8 -73.99 0.08 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.84 1.256 . . . . 75.54 109.679 -174.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 12.6 tt -157.87 135.26 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 C-N-CA 124.261 1.024 . . . . 75.44 108.567 176.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 399' ' ' VAL . . . . . 0.554 HG23 ' H ' ' B' ' 400' ' ' ALA 0.26 29.8 m 44.6 -79.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 C-N-CA 126.699 2.0 . . . . 73.32 114.599 -178.919 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 400' ' ' ALA . . . . . 0.554 ' H ' HG23 ' B' ' 399' ' ' VAL . . . -113.3 129.38 24.64 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 123.802 0.841 . . . . 74.52 108.843 -177.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 401' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -70.63 81.58 1.02 Allowed 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 122.745 2.297 . . . . 71.34 112.126 -179.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 25.8 t70 65.35 107.71 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.859 1.264 . . . . 74.34 111.162 -178.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 403' ' ' THR . . . . . 0.457 ' H ' ' HG3' ' B' ' 406' ' ' PRO . 89.0 m -140.94 101.16 3.99 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 122.909 0.484 . . . . 73.2 110.575 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 404' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp 63.3 -75.57 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.551 1.54 . . . . 71.14 113.195 169.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 405' ' ' ALA . . . . . . . . . . . . . . . -125.56 76.5 69.57 Favored Pre-proline 0 CA--C 1.555 1.135 0 C-N-CA 123.656 0.782 . . . . 71.24 110.832 179.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 406' ' ' PRO . . . . . 0.457 ' HG3' ' H ' ' B' ' 403' ' ' THR . 9.8 Cg_endo -94.1 115.58 0.24 Allowed 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 123.25 2.633 . . . . 64.23 110.586 169.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . -64.99 137.94 38.98 Favored Glycine 0 CA--C 1.535 1.324 0 CA-C-N 116.741 -0.208 . . . . 74.04 113.114 -177.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 408' ' ' LEU . . . . . . . . . . . . . 3.9 tt -139.62 99.73 3.79 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 107.573 -1.269 . . . . 72.55 107.573 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 93.4 m 73.86 -66.25 0.31 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 125.236 1.414 . . . . 73.52 112.187 176.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 410' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -111.94 104.7 12.99 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.942 0.897 . . . . 70.42 109.692 -179.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . -148.87 -83.65 0.1 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.677 0.791 . . . . 74.33 109.023 174.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 96.2 mt -142.33 -60.78 0.45 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.879 0.871 . . . . 75.21 109.881 -177.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 413' ' ' ASN . . . . . 0.54 ' HB2' ' HZ3' ' A' ' 209' ' ' LYS . 0.2 OUTLIER -118.6 5.16 11.64 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.953 0.901 . . . . 71.14 110.62 -174.092 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 414' ' ' THR . . . . . . . . . . . . . 11.8 p -75.52 118.38 18.31 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.661 0.784 . . . . 73.24 110.538 -177.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 415' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt 67.09 -72.47 0.09 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.856 1.262 . . . . 75.21 111.46 -176.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -68.94 129.03 38.79 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.639 0.776 . . . . 75.33 109.422 173.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 417' ' ' GLY . . . . . . . . . . . . . . . 97.24 -28.66 13.05 Favored Glycine 0 C--N 1.346 1.086 0 N-CA-C 111.899 -0.48 . . . . 62.31 111.899 -174.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 418' ' ' ALA . . . . . . . . . . . . . . . -80.78 70.76 7.62 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 108.858 -0.793 . . . . 70.25 108.858 173.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 419' ' ' VAL . . . . . . . . . . . . . 29.3 m -77.18 160.74 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 114.693 -1.139 . . . . 73.31 110.441 -177.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 420' ' ' MET . . . . . . . . . . . . . 14.9 tpt 75.82 -20.62 0.34 Allowed 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 125.707 1.603 . . . . 73.34 111.924 -175.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 421' ' ' VAL . . . . . . . . . . . . . 26.3 t -78.27 73.57 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.073 0 C-N-CA 123.966 0.906 . . . . 72.42 109.274 176.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 422' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -175.7 -72.63 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 107.1 -1.445 . . . . 74.1 107.1 -178.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 423' ' ' SER . . . . . . . . . . . . . 28.3 t 61.77 -79.43 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.348 0 C-N-CA 125.629 1.572 . . . . 63.45 112.214 -179.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 424' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -138.49 21.82 2.73 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 123.588 0.755 . . . . 74.22 110.766 176.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . -168.88 -145.08 4.45 Favored Glycine 0 C--N 1.336 0.549 0 N-CA-C 110.87 -0.892 . . . . 75.12 110.87 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 426' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -166.26 -1.57 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.548 0.739 . . . . 75.43 109.875 175.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 427' ' ' SER . . . . . . . . . . . . . 16.3 m 70.1 11.58 7.63 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 125.198 1.399 . . . . 75.14 111.015 -171.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 163.85 96.47 0.0 OUTLIER 'General case' 0 C--N 1.359 1.018 0 C-N-CA 127.553 2.341 . . . . 73.23 105.814 -179.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 429' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -87.42 31.28 0.75 Allowed 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.273 0.629 . . . . 63.42 111.68 -169.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -76.95 90.34 3.54 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 108.365 -0.976 . . . . 62.42 108.365 176.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 52.9 m 63.19 17.49 10.24 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.868 1.267 . . . . 75.05 112.121 -172.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 432' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 51.57 40.31 26.79 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 124.628 1.171 . . . . 71.1 111.255 -172.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 433' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -77.87 87.56 4.08 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 115.36 -0.836 . . . . 73.43 110.302 -175.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 434' ' ' HIS . . . . . . . . . . . . . 39.3 p-80 -98.81 73.61 2.01 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.579 -0.897 . . . . 73.42 108.579 172.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 435' ' ' THR . . . . . . . . . . . . . 55.0 m -44.64 -46.61 10.26 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 125.473 1.509 . . . . 73.42 113.133 -173.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . -108.3 154.55 16.49 Favored Glycine 0 C--N 1.344 0.997 0 N-CA-C 111.423 -0.671 . . . . 61.51 111.423 174.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 58.6 p -74.25 -29.73 61.82 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.392 0.677 . . . . 72.35 110.261 173.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 438' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 62.36 22.9 13.53 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 125.37 1.468 . . . . 71.55 112.066 178.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 439' ' ' LEU . . . . . . . . . . . . . 88.5 mt -75.29 93.49 2.88 Favored 'General case' 0 C--N 1.352 0.678 0 N-CA-C 109.197 -0.668 . . . . 74.24 109.197 175.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 440' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -56.44 110.72 0.82 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.492 0.717 . . . . 74.1 110.73 177.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 441' ' ' ILE . . . . . 0.571 ' HA ' HD22 ' A' ' 235' ' ' LEU . 18.0 tt -134.11 19.58 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 CA-C-O 122.514 1.15 . . . . 74.15 109.904 175.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 442' ' ' ALA . . . . . . . . . . . . . . . -80.78 79.07 7.49 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.509 -0.768 . . . . 73.33 109.754 175.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . -93.31 -56.8 2.81 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.837 0.855 . . . . 74.21 109.463 176.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 3.1 m-30 -89.95 86.65 6.67 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.41 -0.814 . . . . 71.31 109.257 176.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . -79.24 115.01 4.01 Favored Glycine 0 C--N 1.342 0.883 0 N-CA-C 109.976 -1.25 . . . . 74.34 109.976 169.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 446' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -66.9 83.31 0.32 Allowed 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 122.66 2.24 . . . . 72.44 112.124 -178.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 447' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -82.21 85.34 6.83 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.089 -0.96 . . . . 63.45 109.988 -178.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . -106.86 -153.66 0.5 Allowed 'General case' 0 C--O 1.245 0.82 0 CA-C-N 114.634 -1.166 . . . . 74.31 108.39 172.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 449' ' ' ALA . . . . . 0.508 ' O ' ' HA ' ' B' ' 461' ' ' PHE . . . 67.6 -81.23 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.31 1.044 . . . . 74.42 111.372 175.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 450' ' ' ASN . . . . . 0.416 ' HB3' HG11 ' B' ' 452' ' ' VAL . 7.5 m120 -155.33 166.15 34.42 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.018 0.927 . . . . 63.22 110.871 -178.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 7.4 p -100.21 20.76 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 123.926 0.89 . . . . 74.44 110.689 175.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 452' ' ' VAL . . . . . 0.416 HG11 ' HB3' ' B' ' 450' ' ' ASN . 15.8 m -57.58 116.86 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 C-N-CA 124.296 1.038 . . . . 74.24 111.682 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 100.09 -31.79 8.04 Favored Glycine 0 C--N 1.343 0.968 0 CA-C-N 115.691 -0.686 . . . . 73.44 113.282 179.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 454' ' ' LEU . . . . . 0.458 HD21 ' HB2' ' B' ' 456' ' ' ASP . 0.5 OUTLIER -78.81 -40.95 31.55 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.237 0.615 . . . . 73.13 110.588 -175.035 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 9.4 m 69.5 0.9 3.11 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 124.529 1.131 . . . . 72.1 112.658 179.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 456' ' ' ASP . . . . . 0.458 ' HB2' HD21 ' B' ' 454' ' ' LEU . 30.6 t70 -73.81 -16.66 61.14 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.869 0.868 . . . . 74.3 111.86 -175.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 457' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 69.18 15.52 8.62 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 125.185 1.394 . . . . 65.21 112.742 -176.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 7.4 t -77.99 63.25 2.94 Favored 'General case' 0 CA--C 1.556 1.207 0 CA-C-O 122.703 1.24 . . . . 72.13 109.495 171.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 459' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -102.02 128.37 48.49 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.216 -0.902 . . . . 73.31 110.192 -171.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 95.9 mt -128.02 82.34 2.08 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 106.996 -1.483 . . . . 65.42 106.996 166.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 461' ' ' PHE . . . . . 0.508 ' HA ' ' O ' ' B' ' 449' ' ' ALA . 44.8 p90 -61.93 -36.77 82.36 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 115.205 -0.907 . . . . 75.0 111.788 -178.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 462' ' ' TYR . . . . . 0.446 ' HD2' ' H ' ' B' ' 465' ' ' LYS . 39.2 p90 -81.24 -14.33 57.59 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.193 0.997 . . . . 72.53 111.566 176.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 94.3 m 65.08 -77.8 0.04 OUTLIER 'General case' 0 C--N 1.36 1.047 0 C-N-CA 125.215 1.406 . . . . 71.14 110.432 -172.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 464' ' ' MET . . . . . 0.541 ' HB3' HD22 ' B' ' 468' ' ' LEU . 6.3 tpt -151.48 92.07 1.73 Allowed 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 107.519 -1.289 . . . . 75.31 107.519 171.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 465' ' ' LYS . . . . . 0.446 ' H ' ' HD2' ' B' ' 462' ' ' TYR . 83.4 tttt 63.65 -80.01 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 125.119 1.367 . . . . 72.15 110.665 -170.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -177.1 149.33 0.68 Allowed 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.105 0.962 . . . . 65.13 110.197 178.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . 56.23 88.61 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.283 1.433 . . . . 75.3 113.338 170.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 468' ' ' LEU . . . . . 0.541 HD22 ' HB3' ' B' ' 464' ' ' MET . 6.0 mp -115.7 17.57 16.12 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.303 0.641 . . . . 74.32 110.538 175.053 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 469' ' ' GLY . . . . . . . . . . . . . . . 80.32 -1.12 82.56 Favored Glycine 0 C--N 1.347 1.19 0 CA-C-N 116.827 -0.17 . . . . 62.03 113.44 -176.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 470' ' ' LEU . . . . . . . . . . . . . 1.3 pp -124.18 -164.99 1.3 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.947 1.299 . . . . 75.32 108.976 178.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 471' ' ' LYS . . . . . 0.415 ' HE2' ' HA ' ' B' ' 471' ' ' LYS . 0.6 OUTLIER . . . . . 0 CA--C 1.56 1.359 0 C-N-CA 123.202 0.601 . . . . 74.2 109.604 178.012 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 1' ' ' MET . . . . . 0.476 ' HE2' ' HG2' ' C' ' 95' ' ' GLU . 62.9 mtm . . . . . 0 N--CA 1.481 1.107 0 N-CA-C 109.309 -0.626 . . . . 70.43 109.309 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 74.72 -33.56 0.25 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 126.081 1.752 . . . . 70.41 113.575 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -74.64 79.41 2.01 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.206 1.002 . . . . 71.34 111.304 -177.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -36.86 117.51 0.51 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.974 1.71 . . . . 70.52 114.133 173.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -76.07 102.58 5.75 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.849 -0.796 . . . . 72.32 108.849 165.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 6' ' ' ASP . . . . . 0.438 ' HA ' ' OH ' ' C' ' 66' ' ' TYR . 8.6 t70 -75.01 94.24 2.83 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.184 -1.043 . . . . 65.15 108.184 176.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 7' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -61.44 -35.51 77.78 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-N 115.264 -0.88 . . . . 73.43 112.361 -171.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -60.12 -50.24 74.49 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 116.121 -0.49 . . . . 74.23 110.179 175.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.7 -39.16 93.62 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.899 -0.591 . . . . 63.34 111.506 -178.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 81.5 mt -58.14 -42.13 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 C-N-CA 123.665 0.786 . . . . 73.31 110.163 176.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 95.9 mt -74.35 -24.01 59.11 Favored 'General case' 0 N--CA 1.48 1.075 0 CA-C-N 116.19 -0.459 . . . . 75.53 112.025 175.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.99 38.31 10.44 Favored Glycine 0 C--N 1.345 1.079 0 CA-C-N 116.93 -0.123 . . . . 74.43 113.187 -176.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 6.0 m -125.78 157.14 69.87 Favored Pre-proline 0 N--CA 1.481 1.116 0 C-N-CA 124.786 1.235 . . . . 71.34 110.226 176.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -67.77 165.38 27.95 Favored 'Trans proline' 0 C--N 1.383 2.386 0 C-N-CA 122.782 2.321 . . . . 74.43 112.423 177.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -77.54 16.38 0.66 Allowed 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 123.18 0.592 . . . . 74.35 111.982 -179.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -119.18 -0.15 11.1 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.786 1.635 . . . . 71.24 108.406 178.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.46 133.01 47.99 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.406 0.682 . . . . 75.2 111.94 -171.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 68.4 p -87.69 175.47 7.86 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.452 1.101 . . . . 74.41 110.862 -178.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -51.5 -39.14 57.01 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.183 0.993 . . . . 74.45 111.527 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -62.59 -47.46 83.72 Favored 'General case' 0 C--N 1.349 0.584 0 O-C-N 123.811 0.694 . . . . 74.53 111.258 178.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -66.77 -37.99 85.69 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.659 0.784 . . . . 73.42 111.322 -177.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 22' ' ' ILE . . . . . 0.603 HG12 ' HB3' ' C' ' 57' ' ' LEU . 1.7 mp -62.28 -42.56 95.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.323 1.049 . . . . 75.54 110.439 175.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -69.24 -39.65 78.37 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 114.853 -1.067 . . . . 74.13 110.891 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -70.27 -33.63 71.81 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.737 0.815 . . . . 73.52 110.572 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -74.65 -36.26 62.85 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.777 0.831 . . . . 75.32 110.624 177.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 26' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -60.03 -48.28 82.35 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 115.447 -0.797 . . . . 72.31 108.988 172.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -60.1 -44.76 94.6 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.317 1.047 . . . . 75.33 111.203 178.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 22.6 ttt180 -51.25 -52.16 47.38 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.744 1.217 . . . . 75.55 110.963 177.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . 0.439 HD22 ' HE2' ' C' ' 33' ' ' TYR . 83.3 mt -83.6 -12.47 56.02 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 114.585 -1.189 . . . . 71.43 111.506 -178.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.19 -2.65 55.01 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.684 0.793 . . . . 75.32 110.41 173.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 76.6 mtp180 -95.89 -45.35 6.99 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.6 0.76 . . . . 73.5 109.045 166.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -68.31 -52.84 29.08 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 115.343 -0.844 . . . . 71.12 111.188 -178.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 33' ' ' TYR . . . . . 0.439 ' HE2' HD22 ' C' ' 29' ' ' LEU . 37.3 m-85 -100.97 26.26 7.16 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.577 0.751 . . . . 72.14 110.464 -178.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 34' ' ' HIS . . . . . . . . . . . . . 13.0 t60 -55.12 99.16 0.19 Allowed Pre-proline 0 N--CA 1.488 1.46 0 C-N-CA 124.765 1.226 . . . . 74.34 110.738 -177.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -59.58 -27.88 86.05 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 123.088 2.525 . . . . 72.22 113.97 -167.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -72.1 -25.86 61.92 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.357 0.663 . . . . 60.34 111.929 -177.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 67.2 t -113.22 -25.59 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 CA-C-O 121.352 0.596 . . . . 75.33 110.783 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -105.43 83.98 2.03 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 106.807 -1.553 . . . . 65.41 106.807 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.96 76.5 7.9 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.89 -0.782 . . . . 71.22 108.89 -178.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 67.4 m -143.08 108.43 5.37 Favored Pre-proline 0 C--O 1.235 0.329 0 N-CA-C 107.004 -1.48 . . . . 74.14 107.004 172.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . 0.44 ' O ' ' HG2' ' C' ' 45' ' ' GLU . 76.9 Cg_exo -46.79 -30.59 9.53 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 123.548 2.832 . . . . 75.0 114.161 175.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -57.14 -45.53 83.48 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.752 0.821 . . . . 71.01 111.216 175.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.54 -19.19 62.91 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.508 -0.769 . . . . 71.45 110.84 178.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 44' ' ' GLU . . . . . 0.411 ' O ' ' HG3' ' C' ' 48' ' ' LYS . 36.5 mt-10 -87.6 -30.36 20.54 Favored 'General case' 0 C--N 1.358 0.95 0 C-N-CA 123.184 0.594 . . . . 74.04 110.409 -178.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 45' ' ' GLU . . . . . 0.44 ' HG2' ' O ' ' C' ' 41' ' ' PRO . 11.8 mm-40 -72.39 -40.09 67.51 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 108.895 -0.78 . . . . 75.44 108.895 174.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 46' ' ' LYS . . . . . 0.426 ' O ' HG13 ' C' ' 50' ' ' ILE . 48.4 mttp -63.25 -38.11 89.88 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-N 114.587 -1.188 . . . . 72.32 110.413 170.217 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 47' ' ' PHE . . . . . 0.801 ' HA ' HD12 ' C' ' 50' ' ' ILE . 26.8 t80 -62.45 -35.28 78.81 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 123.526 0.516 . . . . 71.12 110.387 175.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 48' ' ' LYS . . . . . 0.432 ' HB3' ' CE1' ' C' ' 93' ' ' PHE . 98.3 mttt -63.16 -44.74 94.64 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.099 0.56 . . . . 72.04 111.009 174.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -61.13 -36.38 79.6 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 120.997 0.427 . . . . 72.33 111.407 177.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 50' ' ' ILE . . . . . 0.801 HD12 ' HA ' ' C' ' 47' ' ' PHE . 52.5 mt -65.89 -40.28 87.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 124.051 0.94 . . . . 75.43 109.887 174.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 51' ' ' ASN . . . . . 0.418 ' HB3' ' CD1' ' C' ' 88' ' ' PHE . 28.5 m-80 -75.93 -16.68 59.98 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.067 0.947 . . . . 74.04 111.757 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -73.18 -53.39 11.08 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 108.939 -0.763 . . . . 75.54 108.939 170.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.29 -42.88 82.57 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 113.852 -1.522 . . . . 63.1 111.051 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -68.44 -40.67 81.06 Favored 'General case' 0 C--O 1.204 -1.307 0 CA-C-N 114.655 -1.157 . . . . 75.01 110.129 175.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.55 -35.04 73.46 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 112.373 0.508 . . . . 60.54 112.373 -179.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 56' ' ' VAL . . . . . 0.402 HG11 ' HZ ' ' C' ' 101' ' ' PHE . 15.6 t -96.39 -16.48 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 O-C-N 123.47 0.482 . . . . 72.43 111.882 -177.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 57' ' ' LEU . . . . . 0.603 ' HB3' HG12 ' C' ' 22' ' ' ILE . 92.9 mt -118.81 11.01 12.52 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.086 -1.009 . . . . 75.02 113.153 177.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 58' ' ' SER . . . . . 0.463 ' HB3' ' HD2' ' C' ' 62' ' ' LYS . 43.1 t -52.7 -34.21 51.2 Favored 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 124.749 1.219 . . . . 75.33 113.315 -176.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -134.28 155.93 79.45 Favored Pre-proline 0 N--CA 1.474 0.763 0 C-N-CA 124.803 1.241 . . . . 72.03 108.891 -174.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 60' ' ' PRO . . . . . 0.4 ' O ' ' HG2' ' C' ' 64' ' ' ARG . 50.3 Cg_exo -55.5 -29.73 70.61 Favored 'Trans proline' 0 C--N 1.383 2.347 0 C-N-CA 122.79 2.327 . . . . 73.21 112.354 169.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -56.8 -61.84 2.15 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.738 0.815 . . . . 62.13 110.278 174.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 62' ' ' LYS . . . . . 0.463 ' HD2' ' HB3' ' C' ' 58' ' ' SER . 56.1 mttp -64.31 -37.79 88.75 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 114.527 -1.215 . . . . 75.43 110.785 -176.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -56.28 -49.61 73.75 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 114.072 -1.422 . . . . 74.14 110.389 178.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 64' ' ' ARG . . . . . 0.4 ' HG2' ' O ' ' C' ' 60' ' ' PRO . 29.9 mmt180 -73.1 -27.54 61.77 Favored 'General case' 0 C--N 1.35 0.595 0 CA-C-O 118.591 -0.718 . . . . 74.15 111.755 -177.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 81.3 mt -58.73 -47.29 89.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-O 121.215 0.531 . . . . 71.5 109.585 170.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 66' ' ' TYR . . . . . 0.438 ' OH ' ' HA ' ' C' ' 6' ' ' ASP . 25.2 t80 -60.17 -52.75 63.98 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.028 -0.987 . . . . 74.31 110.323 175.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -62.05 -34.38 76.15 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.356 0.662 . . . . 73.14 111.831 -175.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 72.0 p -77.24 -24.97 51.12 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 119.223 -0.418 . . . . 74.43 110.634 176.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -66.7 128.95 38.23 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 108.816 -0.809 . . . . 75.22 108.816 173.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 93.79 15.55 48.91 Favored Glycine 0 C--N 1.344 1.021 0 N-CA-C 111.498 -0.641 . . . . 62.51 111.498 -168.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 86.3 m -143.95 -62.46 0.39 Allowed 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 102.959 -2.978 . . . . 72.34 102.959 174.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 27.1 m -70.41 132.93 46.35 Favored 'General case' 0 C--O 1.25 1.115 0 N-CA-C 104.615 -2.365 . . . . 73.35 104.615 155.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.16 -43.83 6.18 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 122.853 0.461 . . . . 73.23 111.316 -173.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -90.89 136.95 27.05 Favored Pre-proline 0 N--CA 1.477 0.886 0 C-N-CA 123.653 0.781 . . . . 53.23 109.834 -179.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.33 138.43 86.19 Favored 'Trans proline' 0 C--N 1.376 2.02 0 C-N-CA 122.761 2.308 . . . . 75.14 111.856 171.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -59.73 152.63 61.78 Favored 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 122.604 2.202 . . . . 71.22 112.417 176.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -51.67 136.77 50.3 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 122.98 2.454 . . . . 74.4 111.848 178.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 78' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.87 124.03 15.28 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 123.052 2.501 . . . . 74.44 112.565 -176.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.87 173.91 2.02 Favored 'Trans proline' 0 N--CA 1.51 2.46 0 C-N-CA 123.727 2.951 . . . . 70.12 114.447 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -57.11 88.62 0.04 OUTLIER 'Trans proline' 0 C--N 1.392 2.856 0 C-N-CA 122.857 2.372 . . . . 74.31 112.628 171.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 130.34 -23.93 4.51 Favored Glycine 0 N--CA 1.467 0.738 0 CA-C-N 114.442 -1.254 . . . . 75.2 110.729 178.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . 0.63 ' HA3' ' HA ' ' C' ' 106' ' ' PHE . . . 107.75 -171.1 15.92 Favored Glycine 0 C--N 1.349 1.289 0 C-N-CA 124.852 1.215 . . . . 75.13 111.006 176.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -65.0 90.18 0.08 Allowed 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.59 -0.893 . . . . 73.4 108.59 165.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 84' ' ' ASP . . . . . 0.61 ' HB3' ' HG3' ' C' ' 143' ' ' ARG . 18.4 t0 -62.36 139.79 58.54 Favored 'General case' 0 C--O 1.241 0.652 0 O-C-N 124.1 0.875 . . . . 75.11 109.624 178.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 85' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -153.74 6.49 0.33 Allowed 'General case' 0 C--O 1.243 0.73 0 CA-C-N 115.447 -0.797 . . . . 74.41 110.273 -175.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 86' ' ' SER . . . . . 0.472 ' HB3' ' O ' ' C' ' 163' ' ' GLY . 74.8 m -64.41 146.75 53.99 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.315 -0.857 . . . . 52.42 110.859 -177.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 97.9 -28.03 16.35 Favored Glycine 0 C--N 1.339 0.719 0 N-CA-C 110.765 -0.934 . . . . 74.34 110.765 -165.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 88' ' ' PHE . . . . . 0.418 ' CD1' ' HB3' ' C' ' 51' ' ' ASN . 23.2 m-85 -116.07 138.03 51.59 Favored 'General case' 0 C--N 1.356 0.882 0 N-CA-C 108.684 -0.858 . . . . 74.44 108.684 -178.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -74.73 81.85 2.08 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.638 0.775 . . . . 72.23 110.589 -174.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 90' ' ' VAL . . . . . 0.456 HG13 ' HA ' ' C' ' 170' ' ' PRO . 6.5 p -41.54 -43.69 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 C-N-CA 125.119 1.368 . . . . 54.42 112.845 177.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 91' ' ' GLU . . . . . 0.424 ' HG2' HG11 ' C' ' 90' ' ' VAL . 51.5 mm-40 -74.97 8.09 2.76 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.653 1.181 . . . . 75.25 113.288 -172.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -120.38 -27.35 5.23 Favored 'General case' 0 C--O 1.243 0.753 0 C-N-CA 123.811 0.844 . . . . 75.53 110.929 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 93' ' ' PHE . . . . . 0.432 ' CE1' ' HB3' ' C' ' 48' ' ' LYS . 2.3 m-30 -77.73 170.95 15.7 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 120.864 0.364 . . . . 72.45 111.726 -165.022 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 87.1 p -63.02 164.21 8.65 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 114.964 1.468 . . . . 52.11 114.964 -162.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 95' ' ' GLU . . . . . 0.476 ' HG2' ' HE2' ' C' ' 1' ' ' MET . 0.0 OUTLIER -66.59 -33.02 74.74 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 113.749 -1.568 . . . . 72.35 111.401 173.767 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -66.61 -40.08 88.67 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 120.938 0.399 . . . . 74.24 110.469 176.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 97' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -58.85 -44.13 90.92 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 115.415 -0.811 . . . . 64.25 109.73 170.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 98' ' ' GLN . . . . . 0.423 ' O ' ' HA3' ' C' ' 102' ' ' GLY . 69.4 mt-30 -66.78 -18.62 65.46 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 123.463 0.705 . . . . 71.33 112.05 177.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . 0.454 ' HG3' ' O ' ' C' ' 95' ' ' GLU . 47.5 mt-10 -81.14 -48.15 12.52 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.156 0.583 . . . . 74.43 112.123 171.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 19.3 tp -82.14 -49.42 10.17 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 116.149 -0.478 . . . . 73.23 111.517 -168.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 101' ' ' PHE . . . . . 0.402 ' HZ ' HG11 ' C' ' 56' ' ' VAL . 93.2 m-85 -100.12 -25.11 14.4 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.117 0.567 . . . . 75.04 111.474 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 102' ' ' GLY . . . . . 0.423 ' HA3' ' O ' ' C' ' 98' ' ' GLN . . . -43.08 -58.27 3.83 Favored Glycine 0 CA--C 1.546 2.02 0 CA-C-O 118.961 -0.911 . . . . 74.41 115.325 -178.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -54.68 -22.35 28.5 Favored 'Trans proline' 0 C--N 1.387 2.583 0 C-N-CA 123.843 3.029 . . . . 64.35 113.957 -177.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -126.29 16.17 6.74 Favored Glycine 0 C--N 1.356 1.658 0 CA-C-O 118.756 -1.024 . . . . 73.42 113.95 -177.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 34.4 mt -57.76 89.15 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 117.829 0.814 . . . . 75.43 111.607 176.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 106' ' ' PHE . . . . . 0.63 ' HA ' ' HA3' ' C' ' 82' ' ' GLY . 50.7 m-85 60.05 -108.2 0.36 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.138 1.375 . . . . 64.24 113.142 175.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 107' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' C' ' 113' ' ' SER . . . 73.61 5.79 69.44 Favored Glycine 0 CA--C 1.549 2.209 0 N-CA-C 110.846 -0.902 . . . . 51.05 110.846 -160.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . -13.11 -74.77 0.01 OUTLIER Glycine 0 C--N 1.387 3.371 0 C-N-CA 127.302 2.382 . . . . 74.41 115.953 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 109' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -100.76 75.65 1.73 Allowed 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 108.349 -0.982 . . . . 74.45 108.349 172.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 110' ' ' GLY . . . . . . . . . . . . . . . -10.04 -69.99 0.01 OUTLIER Glycine 0 N--CA 1.493 2.469 0 C-N-CA 126.126 1.822 . . . . 73.14 115.407 171.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -5.76 -41.4 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.885 0 C-N-CA 126.927 2.091 . . . . 75.25 116.607 161.251 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 112' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -122.65 -38.26 2.67 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.009 1.324 . . . . 75.43 109.638 179.062 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 113' ' ' SER . . . . . 0.451 ' HA ' ' HA2' ' C' ' 107' ' ' GLY . 67.6 m 55.19 14.56 1.05 Allowed 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 125.198 1.399 . . . . 72.53 112.728 -173.482 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 26.9 tpt180 -144.96 -112.61 0.1 Allowed 'General case' 0 C--O 1.194 -1.816 0 CA-C-O 117.297 -1.335 . . . . 74.05 110.412 -163.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 115' ' ' LYS . . . . . . . . . . . . . 25.3 tptp -38.15 111.88 0.19 Allowed 'General case' 0 N--CA 1.507 2.395 0 CA-C-N 121.248 1.84 . . . . 74.15 114.193 -167.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -67.59 121.86 15.97 Favored Glycine 0 C--N 1.362 1.99 0 O-C-N 124.257 0.973 . . . . 54.4 112.473 -174.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 74.9 mtt85 -89.86 173.17 8.39 Favored 'General case' 0 C--O 1.253 1.261 0 C-N-CA 123.422 0.689 . . . . 74.32 111.51 -178.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 118' ' ' ASP . . . . . 0.605 ' HB2' HD11 ' B' ' 102' ' ' LEU . 4.0 m-20 -66.93 133.93 50.99 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 107.69 -1.226 . . . . 75.42 107.69 169.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 119' ' ' LEU . . . . . 0.429 HD11 ' HB2' ' C' ' 141' ' ' ALA . 3.9 tt -93.61 137.49 32.82 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 106.607 -1.627 . . . . 75.21 106.607 -177.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 6.0 mmm-85 -128.0 104.02 7.56 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.194 0.521 . . . . 72.31 109.682 -172.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 121' ' ' ALA . . . . . 0.462 ' HB2' HD22 ' C' ' 176' ' ' LEU . . . -109.29 115.52 30.15 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.206 -1.405 . . . . 75.44 107.206 172.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -104.42 88.93 3.08 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 105.174 -2.158 . . . . 74.12 105.174 174.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 123' ' ' LEU . . . . . 0.455 ' HG ' HG23 ' B' ' 182' ' ' VAL . 1.7 pt? -125.52 136.21 27.98 Favored Pre-proline 0 N--CA 1.485 1.294 0 N-CA-C 114.252 1.204 . . . . 73.3 114.252 -158.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . 0.473 ' HA ' ' O ' ' C' ' 179' ' ' ARG . 53.2 Cg_exo -57.42 140.41 93.06 Favored 'Trans proline' 0 C--N 1.39 2.753 0 C-N-CA 123.816 3.01 . . . . 72.51 114.519 175.127 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 125' ' ' LEU . . . . . 0.551 ' HB2' HG22 ' B' ' 182' ' ' VAL . 54.3 tp -158.38 155.56 28.9 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.071 0.948 . . . . 75.32 109.791 176.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 126' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -102.49 153.7 19.8 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.122 0.569 . . . . 61.53 110.427 178.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 127' ' ' LEU . . . . . 0.647 HD12 ' HD2' ' C' ' 186' ' ' PHE . 98.0 mt -63.15 -44.46 95.46 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.237 1.015 . . . . 62.25 111.353 176.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 12.2 mp0 -62.04 -37.27 84.29 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 114.729 -1.123 . . . . 75.24 110.553 177.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -67.95 -37.82 82.06 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.68 0.792 . . . . 75.51 111.283 177.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -68.27 -33.58 74.62 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 123.748 0.655 . . . . 73.14 109.972 178.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 131' ' ' PHE . . . . . 0.415 ' HB2' HD13 ' C' ' 215' ' ' LEU . 83.0 t80 -67.21 -42.46 84.05 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.412 1.085 . . . . 75.55 111.007 174.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 132' ' ' HIS . . . . . . . . . . . . . 35.3 m170 -61.89 -40.96 97.23 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 123.585 0.553 . . . . 70.15 110.076 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 64.09 -108.37 2.22 Favored Glycine 0 C--N 1.355 1.588 0 N-CA-C 111.04 -0.824 . . . . 65.31 111.04 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . 70.49 147.09 0.37 Allowed Glycine 0 C--N 1.354 1.568 0 O-C-N 124.23 0.606 . . . . 73.12 114.535 173.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -80.19 92.94 5.76 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 107.359 -1.349 . . . . 73.03 107.359 176.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 136' ' ' ARG . . . . . 0.541 ' HB2' HD11 ' B' ' 181' ' ' LEU . 72.7 mtp180 -123.82 155.89 37.16 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 124.08 0.952 . . . . 72.12 109.501 -168.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 137' ' ' VAL . . . . . 0.482 HG22 ' HB3' ' B' ' 180' ' ' ALA . 31.3 m -78.97 122.52 34.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 CA-C-O 121.242 0.544 . . . . 73.11 111.893 -172.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 138' ' ' VAL . . . . . 0.524 ' HB ' HD22 ' B' ' 181' ' ' LEU . 12.9 p -111.56 140.8 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 107.681 -1.229 . . . . 72.14 107.681 169.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 139' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -109.83 100.77 9.7 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 108.131 -1.063 . . . . 74.31 108.131 179.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 140' ' ' VAL . . . . . . . . . . . . . 11.7 p -143.62 134.88 22.65 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.111 0 C-N-CA 123.484 0.714 . . . . 73.25 109.579 -173.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 141' ' ' ALA . . . . . 0.429 ' HB2' HD11 ' C' ' 119' ' ' LEU . . . 67.26 -1.67 1.43 Allowed 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 125.301 1.44 . . . . 65.0 114.173 178.263 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 119.55 -2.13 13.86 Favored Glycine 0 C--N 1.348 1.238 0 CA-C-O 119.23 -0.761 . . . . 52.4 114.231 179.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 143' ' ' ARG . . . . . 0.61 ' HG3' ' HB3' ' C' ' 84' ' ' ASP . 64.2 mtm180 -119.41 130.7 55.42 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 118.367 1.083 . . . . 75.05 111.744 175.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -83.76 103.61 13.19 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 107.709 -1.219 . . . . 71.51 107.709 164.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 145' ' ' VAL . . . . . . . . . . . . . 7.3 p -125.18 130.41 73.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.162 0.585 . . . . 75.03 111.733 -174.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 46.2 m -74.5 95.94 2.84 Favored 'General case' 0 C--N 1.353 0.736 0 C-N-CA 123.602 0.761 . . . . 73.22 110.369 176.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 35.1 m -123.42 152.29 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.538 0.735 . . . . 72.53 109.564 177.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 45.5 ttp180 -107.1 105.7 15.84 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 107.594 -1.262 . . . . 74.22 107.594 170.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 149' ' ' ILE . . . . . . . . . . . . . 31.6 pt -69.52 147.43 96.76 Favored Pre-proline 0 CA--C 1.55 0.946 0 CA-C-O 118.235 -0.888 . . . . 74.42 108.647 170.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -35.9 115.75 0.12 Allowed 'Trans proline' 0 C--N 1.394 2.925 0 C-N-CA 124.185 3.256 . . . . 61.44 113.578 -178.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -57.21 95.58 0.06 OUTLIER 'Trans proline' 0 C--N 1.39 2.715 0 C-N-CA 123.052 2.501 . . . . 73.2 111.886 -176.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 152' ' ' GLY . . . . . . . . . . . . . . . 109.64 136.11 7.4 Favored Glycine 0 C--N 1.345 1.08 0 CA-C-N 114.785 -1.098 . . . . 63.11 114.873 -174.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 153' ' ' VAL . . . . . 0.422 HG13 HD11 ' C' ' 159' ' ' ILE . 7.0 m -146.61 174.47 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 124.613 1.165 . . . . 74.01 111.077 172.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 154' ' ' ARG . . . . . 0.499 ' HB3' ' H ' ' C' ' 188' ' ' LEU . 11.7 ptt180 -124.72 168.74 12.77 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.495 1.118 . . . . 75.32 109.11 174.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 155' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -60.03 119.88 8.62 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.319 0.648 . . . . 74.51 111.104 176.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 82.27 15.05 75.26 Favored Glycine 0 C--N 1.351 1.368 0 CA-C-N 115.649 -0.705 . . . . 75.21 113.476 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 157' ' ' SER . . . . . . . . . . . . . 34.1 t -75.63 125.59 29.34 Favored 'General case' 0 C--N 1.353 0.736 0 N-CA-C 109.162 -0.681 . . . . 75.43 109.162 176.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 6.0 p -98.5 97.06 5.62 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 CA-C-O 121.844 0.83 . . . . 72.31 109.714 -177.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 159' ' ' ILE . . . . . 0.662 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 58.0 mt -70.71 113.17 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-N 115.179 -0.919 . . . . 72.31 109.678 175.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 160' ' ' ARG . . . . . 0.421 ' HA ' ' O ' ' C' ' 174' ' ' LEU . 61.8 ttt180 -99.22 101.25 12.51 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 109.696 -0.483 . . . . 75.13 109.696 179.006 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 161' ' ' VAL . . . . . 0.676 ' HB ' ' HB3' ' C' ' 174' ' ' LEU . 97.7 t -82.95 119.7 74.79 Favored Pre-proline 0 C--O 1.25 1.116 0 N-CA-C 108.455 -0.943 . . . . 75.24 108.455 174.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -60.64 106.04 0.34 Allowed 'Trans proline' 0 C--N 1.384 2.42 0 C-N-CA 123.335 2.69 . . . . 75.23 113.163 -173.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 163' ' ' GLY . . . . . 0.472 ' O ' ' HB3' ' C' ' 86' ' ' SER . . . 91.06 -25.34 14.5 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 118.581 -1.122 . . . . 53.54 114.927 169.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 164' ' ' MET . . . . . 0.475 ' HE2' HG13 ' C' ' 161' ' ' VAL . 39.6 ttp -87.39 50.66 2.05 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 118.536 1.168 . . . . 73.35 112.783 -165.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . -125.69 -96.11 1.03 Allowed Glycine 0 N--CA 1.472 1.041 0 N-CA-C 110.665 -0.974 . . . . 73.32 110.665 171.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . 61.98 40.29 98.69 Favored Glycine 0 C--N 1.353 1.475 0 N-CA-C 115.61 1.004 . . . . 75.44 115.61 162.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 167' ' ' GLN . . . . . 0.613 HE21 ' HA ' ' C' ' 167' ' ' GLN . 0.0 OUTLIER -64.96 105.26 0.99 Allowed 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 117.155 0.477 . . . . 74.2 110.126 177.689 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . 159.0 -67.91 0.27 Allowed Glycine 0 C--O 1.219 -0.827 0 N-CA-C 110.867 -0.893 . . . . 13.44 110.867 -178.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 169' ' ' ASN . . . . . 0.598 ' HB3' ' HD3' ' C' ' 170' ' ' PRO . 26.6 t-20 -173.7 -62.21 0.0 OUTLIER Pre-proline 0 CA--C 1.575 1.916 0 C-N-CA 124.172 0.989 . . . . 62.44 111.569 172.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 170' ' ' PRO . . . . . 0.598 ' HD3' ' HB3' ' C' ' 169' ' ' ASN . 13.4 Cg_exo -72.63 160.34 46.7 Favored 'Trans proline' 0 C--N 1.4 3.259 0 C-N-CA 121.802 1.668 . . . . 73.55 111.618 172.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 171' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.79 152.47 78.4 Favored 'Trans proline' 0 C--N 1.374 1.875 0 C-N-CA 122.163 1.909 . . . . 74.02 113.073 177.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -130.96 -103.48 0.97 Allowed Glycine 0 C--N 1.341 0.855 0 N-CA-C 109.29 -1.524 . . . . 74.42 109.29 174.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 173' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -170.68 162.91 7.98 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 124.72 1.208 . . . . 74.51 109.474 165.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 174' ' ' LEU . . . . . 0.676 ' HB3' ' HB ' ' C' ' 161' ' ' VAL . 28.3 tp -104.86 137.47 42.58 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.425 0.69 . . . . 75.22 110.523 -175.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 96.8 mt -124.08 92.02 3.58 Favored 'General case' 0 C--O 1.246 0.88 0 C-N-CA 124.62 1.168 . . . . 72.15 109.538 177.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 176' ' ' LEU . . . . . 0.662 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 74.3 mt -83.21 92.38 7.45 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 108.817 -0.808 . . . . 74.33 108.817 173.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 177' ' ' VAL . . . . . . . . . . . . . 96.0 t -83.45 102.24 9.16 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 N-CA-C 107.642 -1.244 . . . . 75.23 107.642 174.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 178' ' ' VAL . . . . . . . . . . . . . 5.9 p -74.83 132.14 33.84 Favored 'Isoleucine or valine' 0 C--O 1.249 1.039 0 CA-C-N 114.433 -1.258 . . . . 74.01 111.693 -173.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 179' ' ' ARG . . . . . 0.473 ' O ' ' HA ' ' C' ' 124' ' ' PRO . 23.0 mmt180 -110.74 103.27 11.79 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 106.844 -1.539 . . . . 74.42 106.844 170.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 180' ' ' LEU . . . . . 0.501 HD12 HD22 ' C' ' 127' ' ' LEU . 83.9 mt -69.92 148.33 49.11 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 116.006 -0.543 . . . . 73.43 111.059 -179.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 181' ' ' LEU . . . . . . . . . . . . . 63.5 mt -66.83 166.91 15.77 Favored Pre-proline 0 CA--C 1.552 1.045 0 CA-C-N 115.083 -0.962 . . . . 74.24 111.299 -175.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 182' ' ' PRO . . . . . 0.594 ' HG3' ' HB2' ' B' ' 207' ' ' LYS . 18.1 Cg_endo -57.33 78.1 0.04 OUTLIER 'Trans proline' 0 C--N 1.394 2.936 0 C-N-CA 122.99 2.46 . . . . 73.32 111.815 170.186 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 183' ' ' HIS . . . . . 0.424 ' N ' ' HD3' ' C' ' 184' ' ' PRO . 62.6 t60 176.68 51.65 0.03 OUTLIER Pre-proline 0 CA--C 1.556 1.202 0 C-N-CA 127.772 2.429 . . . . 72.0 105.591 -173.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 184' ' ' PRO . . . . . 0.424 ' HD3' ' N ' ' C' ' 183' ' ' HIS . 79.8 Cg_endo -94.47 65.12 0.31 Allowed 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 122.919 2.413 . . . . 74.25 110.903 -169.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 185' ' ' VAL . . . . . 0.529 HG12 ' HB3' ' C' ' 195' ' ' ALA . 6.7 t -94.09 -52.64 9.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 108.951 -0.759 . . . . 72.23 108.951 -167.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 186' ' ' PHE . . . . . 0.647 ' HD2' HD12 ' C' ' 127' ' ' LEU . 67.1 m-85 -99.79 121.35 41.15 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.437 0.695 . . . . 61.44 110.288 -169.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 187' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -114.99 107.59 15.58 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.066 0.946 . . . . 75.14 108.699 179.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 188' ' ' LEU . . . . . 0.499 ' H ' ' HB3' ' C' ' 154' ' ' ARG . 58.8 tp -77.12 140.69 40.31 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.479 1.112 . . . . 74.14 112.964 -171.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -142.0 123.58 15.02 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 106.925 -1.509 . . . . 73.21 106.925 163.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 68.02 -111.54 4.1 Favored Glycine 0 CA--C 1.536 1.377 0 N-CA-C 111.526 -0.629 . . . . 74.2 111.526 -172.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 191' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -113.89 -10.95 12.89 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 124.086 0.954 . . . . 75.25 110.057 172.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 192' ' ' ASP . . . . . 0.523 ' HB2' ' HE2' ' B' ' 26' ' ' MET . 10.0 m-20 -95.96 147.45 23.68 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.029 0.932 . . . . 65.13 109.98 -168.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 193' ' ' LEU . . . . . 0.489 HD23 ' CD2' ' C' ' 240' ' ' PHE . 84.6 mt -104.21 158.25 16.57 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.018 0.527 . . . . 65.15 111.115 -176.15 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 194' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -131.46 106.67 8.38 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 108.119 -1.067 . . . . 75.43 108.119 165.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 195' ' ' ALA . . . . . 0.529 ' HB3' HG12 ' C' ' 185' ' ' VAL . . . -116.15 -177.75 3.24 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.159 0.984 . . . . 65.11 109.549 176.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 25.2 m -128.73 111.42 13.13 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 109.32 -0.622 . . . . 53.42 109.32 178.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 197' ' ' LEU . . . . . 0.498 HD13 ' HB1' ' C' ' 212' ' ' ALA . 55.2 tp -85.18 130.88 34.52 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.289 1.036 . . . . 73.5 110.497 -179.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -89.8 112.14 23.37 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.359 0.663 . . . . 64.33 109.386 174.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 199' ' ' VAL . . . . . 0.542 ' HA ' HG11 ' C' ' 210' ' ' VAL . 59.3 t -117.77 113.55 38.04 Favored Pre-proline 0 N--CA 1.471 0.612 0 C-N-CA 124.347 1.059 . . . . 73.12 108.621 177.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 200' ' ' PRO . . . . . 0.451 ' HA ' ' O ' ' C' ' 256' ' ' THR . 39.7 Cg_endo -68.3 146.25 68.57 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 121.788 1.659 . . . . 73.11 110.907 176.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 201' ' ' ALA . . . . . 0.405 ' HB2' ' HH2' ' C' ' 269' ' ' TRP . . . -53.23 -46.18 97.98 Favored Pre-proline 0 CA--C 1.56 1.357 0 C-N-CA 124.917 1.287 . . . . 74.35 114.271 -172.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 202' ' ' PRO . . . . . 0.4 ' HA ' ' HE3' ' A' ' 269' ' ' TRP . 28.5 Cg_endo -59.3 -45.51 26.63 Favored 'Trans proline' 0 C--N 1.397 3.09 0 CA-C-N 121.212 1.469 . . . . 63.15 111.977 178.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 203' ' ' ILE . . . . . . . . . . . . . 42.4 mt -66.1 -30.54 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 123.84 0.856 . . . . 74.02 110.675 178.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.32 -42.69 79.01 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.332 0.653 . . . . 75.02 111.799 178.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 205' ' ' VAL . . . . . 0.502 HG13 HD12 ' A' ' 261' ' ' LEU . 57.5 t -75.71 -46.84 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 116.016 -0.538 . . . . 74.52 111.942 -176.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 206' ' ' VAL . . . . . . . . . . . . . 14.1 p -81.14 -28.9 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 CA-C-O 120.743 0.306 . . . . 74.12 111.118 -179.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 80.12 83.13 0.71 Allowed Glycine 0 C--N 1.337 0.624 0 N-CA-C 111.431 -0.668 . . . . 63.21 111.431 -174.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -105.92 -127.83 5.98 Favored Glycine 0 C--N 1.34 0.78 0 N-CA-C 110.365 -1.094 . . . . 51.32 110.365 176.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 209' ' ' LYS . . . . . 0.494 ' HG2' ' HA ' ' C' ' 222' ' ' ALA . 8.2 mtmp? -139.19 145.32 39.17 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.494 0.664 . . . . 72.44 110.545 172.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 210' ' ' VAL . . . . . 0.542 HG11 ' HA ' ' C' ' 199' ' ' VAL . 34.1 m -126.87 178.6 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.299 1.44 . . . . 71.52 107.671 173.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 211' ' ' ARG . . . . . 0.49 ' HD3' ' HB2' ' C' ' 218' ' ' PRO . 33.6 ttm-85 -128.65 124.01 34.65 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 118.522 0.601 . . . . 75.53 112.167 -178.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 212' ' ' ALA . . . . . 0.498 ' HB1' HD13 ' C' ' 197' ' ' LEU . . . -97.81 114.24 26.23 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 107.756 -1.202 . . . . 74.43 107.756 166.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 213' ' ' MET . . . . . 0.445 ' HA ' ' HA ' ' C' ' 218' ' ' PRO . 2.3 tmm? -77.06 98.53 5.03 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 107.112 -1.44 . . . . 63.12 107.112 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 214' ' ' THR . . . . . 0.461 ' OG1' HG11 ' C' ' 219' ' ' VAL . 1.0 OUTLIER -100.98 170.67 8.13 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.359 0.599 . . . . 72.34 109.746 -172.991 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 215' ' ' LEU . . . . . 0.415 HD13 ' HB2' ' C' ' 131' ' ' PHE . 8.4 mt -61.94 -43.55 98.61 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.24 1.416 . . . . 75.24 110.956 -173.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -93.35 17.83 10.65 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 113.824 -1.535 . . . . 71.0 111.627 -177.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 125.44 152.86 8.32 Favored Glycine 0 C--N 1.344 0.982 0 CA-C-N 116.006 -0.543 . . . . 74.41 111.744 178.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 218' ' ' PRO . . . . . 0.49 ' HB2' ' HD3' ' C' ' 211' ' ' ARG . 68.8 Cg_endo -74.98 103.29 1.7 Allowed 'Trans proline' 0 CA--C 1.554 1.507 0 C-N-CA 122.377 2.051 . . . . 64.03 112.517 175.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 219' ' ' VAL . . . . . 0.544 HG23 HG23 ' B' ' 238' ' ' THR . 1.5 p -75.43 127.4 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 122.938 0.495 . . . . 52.53 109.667 178.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 220' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -87.0 104.62 16.48 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 107.383 -1.339 . . . . 72.32 107.383 171.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 221' ' ' VAL . . . . . . . . . . . . . 47.6 t -71.22 125.96 30.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 125.733 1.613 . . . . 74.03 111.631 -177.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 222' ' ' ALA . . . . . 0.494 ' HA ' ' HG2' ' C' ' 209' ' ' LYS . . . -78.55 106.94 10.85 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.174 0.59 . . . . 73.3 109.821 171.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 60.4 t -83.05 132.69 49.95 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 123.906 0.882 . . . . 73.11 109.179 178.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 224' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -83.13 156.76 15.0 Favored 'Trans proline' 0 C--N 1.379 2.179 0 C-N-CA 123.271 2.647 . . . . 73.11 110.979 172.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -57.64 134.52 63.63 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 122.309 2.006 . . . . 74.4 112.012 174.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 226' ' ' ARG . . . . . 0.485 ' HG2' ' HG3' ' B' ' 248' ' ' ARG . 9.8 mpt_? 70.97 82.16 0.15 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.617 1.167 . . . . 71.5 110.374 177.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 227' ' ' THR . . . . . . . . . . . . . 53.2 m -115.91 123.23 47.58 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.775 0.83 . . . . 73.3 110.612 179.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 228' ' ' GLN . . . . . 0.571 ' NE2' ' HG2' ' A' ' 259' ' ' GLU . 24.7 mp0 -102.33 150.8 22.96 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.307 1.043 . . . . 74.32 111.197 -179.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -72.47 134.11 45.16 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 114.559 -1.2 . . . . 65.31 109.563 176.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 102.88 -6.45 51.75 Favored Glycine 0 C--N 1.339 0.712 0 O-C-N 123.681 0.613 . . . . 62.04 112.375 -173.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 231' ' ' ARG . . . . . . . . . . . . . 59.6 mtt180 -65.38 171.97 3.54 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 117.266 0.533 . . . . 75.03 110.85 167.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 232' ' ' LYS . . . . . 0.438 ' HA ' ' O ' ' C' ' 251' ' ' LEU . 37.1 ttmt -148.51 124.74 10.83 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.2 -0.455 . . . . 74.05 110.849 -177.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 233' ' ' LEU . . . . . 0.568 ' O ' ' HA ' ' C' ' 250' ' ' TYR . 6.3 mp -84.66 156.9 21.3 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.444 1.098 . . . . 74.22 110.254 174.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 18.2 ptt-85 -128.0 85.2 2.32 Favored 'General case' 0 CA--C 1.553 1.08 0 O-C-N 124.966 1.416 . . . . 72.34 108.527 166.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 235' ' ' LEU . . . . . 0.471 HD11 HD23 ' C' ' 249' ' ' LEU . 49.8 mt -79.0 116.02 19.04 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.434 -0.803 . . . . 74.34 108.849 176.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -77.28 129.62 36.12 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 123.219 0.607 . . . . 73.41 111.835 -169.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 76.18 14.74 82.0 Favored Glycine 0 C--N 1.346 1.088 0 O-C-N 124.451 1.095 . . . . 71.42 114.731 177.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 14.2 mmtm -98.87 9.65 43.0 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.386 0.674 . . . . 75.11 111.493 -179.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 239' ' ' GLY . . . . . 0.413 ' HA2' ' HG ' ' C' ' 193' ' ' LEU . . . -86.88 -169.55 46.0 Favored Glycine 0 C--N 1.346 1.113 0 O-C-N 123.447 0.467 . . . . 75.2 112.763 177.298 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 240' ' ' PHE . . . . . 0.489 ' CD2' HD23 ' C' ' 193' ' ' LEU . 12.8 m-85 -81.35 150.7 67.99 Favored Pre-proline 0 C--O 1.247 0.968 0 CA-C-O 119.167 -0.444 . . . . 75.14 110.005 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 241' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_exo -71.44 96.14 0.72 Allowed 'Trans proline' 0 C--N 1.388 2.647 0 C-N-CA 123.418 2.745 . . . . 71.53 112.341 -175.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -83.03 177.52 53.2 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 115.255 -0.884 . . . . 70.14 113.278 178.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -69.82 -18.93 36.46 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 123.134 2.556 . . . . 71.42 112.602 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -111.21 15.51 21.46 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.052 0.941 . . . . 71.42 110.563 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 109.42 177.26 21.33 Favored Glycine 0 C--N 1.354 1.534 0 N-CA-C 111.712 -0.555 . . . . 63.24 111.712 -175.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 246' ' ' ARG . . . . . 0.577 ' HB2' ' HA3' ' B' ' 42' ' ' GLY . 34.2 mtm180 -71.72 147.81 47.02 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.124 0.569 . . . . 71.32 111.393 -179.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -78.64 -159.0 12.97 Favored Glycine 0 N--CA 1.48 1.59 0 O-C-N 123.43 0.456 . . . . 63.23 113.329 176.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -124.47 135.96 53.64 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 108.944 -0.761 . . . . 73.54 108.944 -175.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 249' ' ' LEU . . . . . 0.471 HD23 HD11 ' C' ' 235' ' ' LEU . 18.7 tp -83.89 121.9 27.98 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.0 0.92 . . . . 74.23 110.397 -179.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 250' ' ' TYR . . . . . 0.568 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 23.1 m-85 -101.64 109.94 21.83 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.221 -0.659 . . . . 71.43 109.221 175.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 251' ' ' LEU . . . . . 0.487 ' HB2' ' HB2' ' C' ' 233' ' ' LEU . 68.5 mt -102.64 112.85 25.8 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 116.402 -0.363 . . . . 72.0 110.917 -175.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -70.4 128.46 36.27 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 108.537 -0.912 . . . . 75.41 108.537 168.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 253' ' ' VAL . . . . . . . . . . . . . 84.6 t -82.01 122.53 36.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.014 -0.539 . . . . 73.5 110.944 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 254' ' ' ARG . . . . . . . . . . . . . 13.8 mmt180 -102.1 114.42 28.54 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 107.853 -1.166 . . . . 75.13 107.853 164.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 255' ' ' ILE . . . . . 0.507 ' O ' ' HB ' ' A' ' 255' ' ' ILE . 34.2 mm -76.7 119.16 24.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 106.455 -1.683 . . . . 75.24 106.455 164.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 256' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' C' ' 200' ' ' PRO . 2.3 t -134.4 172.32 13.06 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.594 1.158 . . . . 70.25 109.416 -171.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 2.9 pp -135.2 156.11 78.38 Favored Pre-proline 0 N--CA 1.482 1.137 0 C-N-CA 123.273 0.629 . . . . 75.21 109.793 -176.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -77.43 22.31 0.59 Allowed 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 122.835 2.357 . . . . 74.41 114.952 -170.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 61.55 -78.49 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.98 1.312 . . . . 72.3 111.098 -174.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.11 178.23 8.2 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.389 0.675 . . . . 73.41 110.026 179.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 261' ' ' LEU . . . . . 0.539 HD23 ' HB3' ' C' ' 265' ' ' GLU . 85.6 mt -142.57 151.36 41.48 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.888 0.875 . . . . 74.53 109.504 169.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 66.2 p -82.76 155.36 68.21 Favored Pre-proline 0 N--CA 1.479 0.981 0 N-CA-C 107.689 -1.226 . . . . 61.23 107.689 166.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -39.21 -44.27 2.71 Favored 'Trans proline' 0 C--N 1.381 2.285 0 C-N-CA 123.814 3.009 . . . . 74.2 115.592 178.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -67.43 -50.4 59.55 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.298 0.639 . . . . 71.04 110.826 -178.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 265' ' ' GLU . . . . . 0.539 ' HB3' HD23 ' C' ' 261' ' ' LEU . 47.8 mt-10 -55.31 -52.08 64.64 Favored 'General case' 0 C--N 1.358 0.968 0 O-C-N 123.927 0.767 . . . . 71.03 109.943 176.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 266' ' ' GLU . . . . . 0.433 ' O ' ' HG2' ' C' ' 270' ' ' LYS . 3.7 tp10 -43.98 -56.08 4.2 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.596 1.558 . . . . 73.1 111.209 176.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -59.97 -48.85 80.01 Favored 'General case' 0 CA--C 1.549 0.93 0 O-C-N 124.217 0.948 . . . . 71.12 112.503 -176.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 268' ' ' LEU . . . . . . . . . . . . . 11.1 mp -65.37 -44.19 88.41 Favored 'General case' 0 N--CA 1.481 1.12 0 O-C-N 123.392 0.433 . . . . 70.11 111.319 -178.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 269' ' ' TRP . . . . . 0.405 ' HH2' ' HB2' ' C' ' 201' ' ' ALA . 78.3 m95 -61.26 -37.68 83.99 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.558 0.743 . . . . 63.11 111.221 177.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 270' ' ' LYS . . . . . 0.433 ' HG2' ' O ' ' C' ' 266' ' ' GLU . 31.1 mmtp -64.73 -47.23 79.03 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.142 0.577 . . . . 75.43 110.695 178.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 271' ' ' LYS . . . . . 0.645 ' HB3' ' HZ2' ' C' ' 271' ' ' LYS . 9.1 mtpm? -64.15 -41.46 97.16 Favored 'General case' 0 N--CA 1.484 1.234 0 O-C-N 123.534 0.521 . . . . 75.33 111.486 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 272' ' ' LEU . . . . . 0.46 HD22 ' HB2' ' A' ' 268' ' ' LEU . 69.2 mt -57.92 -45.85 85.88 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 123.92 0.763 . . . . 74.33 110.146 174.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -60.67 -44.2 96.74 Favored 'General case' 0 C--O 1.209 -1.063 0 O-C-N 124.4 1.062 . . . . 43.22 111.718 -176.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -63.13 -49.92 72.48 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-O 121.437 0.637 . . . . 63.21 110.428 178.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -61.17 -23.25 65.43 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 114.493 -1.231 . . . . 70.04 111.342 176.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 276' ' ' TYR . . . . . 0.434 ' HB2' ' O ' ' C' ' 272' ' ' LEU . 6.7 t80 -89.46 -31.69 17.57 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.416 1.086 . . . . 75.52 110.665 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 277' ' ' TYR . . . . . 0.433 ' HE1' HG12 ' A' ' 203' ' ' ILE . 22.7 m-85 -68.24 -25.61 65.27 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 109.176 -0.676 . . . . 65.52 109.176 176.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -53.48 -26.61 21.25 Favored 'General case' 0 CA--C 1.554 1.13 0 O-C-N 124.331 1.019 . . . . 72.22 112.954 171.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 279' ' ' ARG . . . . . . . . . . . . . 26.4 mtm180 -73.5 -16.45 61.28 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 117.898 0.317 . . . . 75.11 111.726 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.087 0 C-N-CA 123.289 0.636 . . . . 75.14 109.764 -177.231 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.6 mtm . . . . . 0 N--CA 1.474 0.742 0 N-CA-C 109.59 -0.522 . . . . 64.12 109.59 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.49 ' HA ' ' HD1' ' A' ' 96' ' ' PHE . . . 63.11 34.37 13.74 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.692 1.197 . . . . 74.44 113.68 173.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -86.78 49.68 1.86 Allowed 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.109 0.564 . . . . 74.04 111.079 -179.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -37.0 113.27 0.24 Allowed 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 125.398 1.479 . . . . 64.14 114.869 -174.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.522 ' HB3' HD11 ' A' ' 10' ' ' ILE . 99.5 mttt -81.21 123.23 28.29 Favored 'General case' 0 C--O 1.245 0.85 0 N-CA-C 108.924 -0.769 . . . . 74.32 108.924 167.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.463 ' HA ' ' OH ' ' A' ' 66' ' ' TYR . 37.2 t70 -75.53 103.97 5.89 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 107.58 -1.267 . . . . 62.43 107.58 167.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -61.83 -27.57 68.86 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 114.876 -1.056 . . . . 73.34 111.873 -173.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.485 ' HE1' HD13 ' A' ' 22' ' ' ILE . 30.7 m-85 -68.12 -42.26 80.5 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 116.355 -0.384 . . . . 73.33 110.038 175.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.21 -45.58 92.69 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.13 0.572 . . . . 70.01 110.403 177.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.522 HD11 ' HB3' ' A' ' 5' ' ' LYS . 64.0 mt -52.91 -47.78 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 123.236 0.614 . . . . 74.23 110.41 175.144 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.433 ' HB3' ' HB1' ' A' ' 25' ' ' ALA . 88.6 mt -81.16 -9.47 59.79 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 115.159 -0.928 . . . . 73.11 113.16 -178.164 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.71 27.7 68.66 Favored Glycine 0 CA--C 1.543 1.824 0 N-CA-C 114.412 0.525 . . . . 73.42 114.412 179.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.9 m -114.49 162.08 25.28 Favored Pre-proline 0 N--CA 1.486 1.345 0 C-N-CA 124.507 1.123 . . . . 72.52 110.087 176.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -64.3 163.72 25.43 Favored 'Trans proline' 0 C--N 1.389 2.688 0 C-N-CA 122.38 2.053 . . . . 50.12 112.769 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 41.1 mtp180 -83.23 41.43 0.76 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.065 0.946 . . . . 75.43 112.135 -170.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -172.86 -5.24 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.053 1.341 . . . . 71.2 109.355 -171.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -40.8 131.43 2.42 Favored 'General case' 0 C--N 1.364 1.229 0 C-N-CA 125.879 1.672 . . . . 74.14 112.674 178.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 63.2 p -78.29 -178.94 5.96 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.2 0.6 . . . . 75.03 112.249 -174.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -46.44 -58.72 3.49 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 124.915 1.286 . . . . 71.11 112.778 -177.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -71.1 -33.36 70.1 Favored 'General case' 0 C--O 1.211 -0.966 0 CA-C-O 119.111 -0.471 . . . . 72.43 111.114 -174.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -62.12 -49.29 76.48 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.137 0.494 . . . . 71.14 110.959 179.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.497 HD11 HD11 ' A' ' 57' ' ' LEU . 71.9 mt -61.76 -42.41 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.123 0.969 . . . . 73.31 110.518 177.205 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -70.85 -28.17 64.38 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.121 -0.945 . . . . 75.22 111.624 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -73.06 -36.94 66.97 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.331 0.653 . . . . 73.12 110.12 175.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.433 ' HB1' ' HB3' ' A' ' 11' ' ' LEU . . . -66.95 -39.95 87.42 Favored 'General case' 0 C--O 1.246 0.909 0 O-C-N 124.028 0.83 . . . . 72.43 110.874 175.006 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.473 ' HD1' HG23 ' A' ' 50' ' ' ILE . 48.8 t80 -57.03 -66.87 0.38 Allowed 'General case' 0 C--O 1.203 -1.391 0 CA-C-N 114.398 -1.273 . . . . 73.1 109.08 172.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -50.74 -40.93 55.88 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.567 1.147 . . . . 74.22 111.888 -178.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.8 ttt180 -57.5 -67.54 0.32 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.247 0.619 . . . . 75.52 110.59 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 83.9 mt -71.72 -22.79 61.58 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.499 -0.773 . . . . 75.12 111.577 -173.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.9 -26.14 29.62 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.466 0.707 . . . . 71.54 110.782 -178.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 85.0 mtt180 -83.82 -26.48 29.5 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 122.951 0.501 . . . . 72.33 110.551 172.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -70.58 -52.18 23.32 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 121.004 0.431 . . . . 73.31 110.393 173.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.448 ' HD2' HD12 ' A' ' 50' ' ' ILE . 14.4 m-85 -97.97 35.51 1.71 Allowed 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.988 0.915 . . . . 72.41 109.843 -177.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.48 ' CD2' ' HB3' ' A' ' 36' ' ' ASP . 18.3 t60 -76.63 109.91 10.07 Favored Pre-proline 0 N--CA 1.473 0.695 0 C-N-CA 124.763 1.225 . . . . 73.54 110.156 -172.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -52.21 -37.22 69.73 Favored 'Trans proline' 0 C--N 1.379 2.148 0 C-N-CA 123.584 2.856 . . . . 75.51 113.274 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.48 ' HB3' ' CD2' ' A' ' 34' ' ' HIS . 15.9 t70 -64.28 -31.49 72.71 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.93 0.892 . . . . 73.23 111.778 178.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 85.3 t -84.79 -54.25 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 122.868 0.467 . . . . 73.25 109.876 176.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -133.9 110.05 9.46 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.319 1.048 . . . . 64.12 109.762 -174.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -85.97 63.7 8.18 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.376 0.671 . . . . 73.11 109.983 -178.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 66.9 m -99.8 112.56 64.0 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-O 117.654 -1.165 . . . . 71.24 108.459 174.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -38.61 -53.54 1.79 Allowed 'Trans proline' 0 C--N 1.39 2.732 0 C-N-CA 124.411 3.408 . . . . 73.53 114.044 -177.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -63.12 -35.04 78.96 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.671 0.788 . . . . 64.43 111.816 -178.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.438 ' O ' ' HB3' ' A' ' 33' ' ' TYR . . . -71.2 -29.78 65.58 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 122.829 0.452 . . . . 73.42 110.157 176.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -82.54 -26.74 32.16 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 109.422 -0.585 . . . . 63.35 109.422 -178.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -69.01 -41.83 77.25 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.913 0.885 . . . . 62.44 109.653 172.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 9.7 mptt -64.66 -41.02 96.39 Favored 'General case' 0 C--O 1.212 -0.903 0 CA-C-N 115.315 -0.857 . . . . 74.03 110.271 174.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.494 ' HA ' HD11 ' A' ' 50' ' ' ILE . 90.7 t80 -55.78 -45.42 78.18 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.794 0.838 . . . . 73.32 109.684 174.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.456 ' HB3' ' HE1' ' A' ' 93' ' ' PHE . 52.4 mtpt -60.25 -41.26 92.84 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.866 0.866 . . . . 75.14 111.435 176.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -67.61 -34.47 77.07 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.479 0.712 . . . . 71.44 111.717 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.494 HD11 ' HA ' ' A' ' 47' ' ' PHE . 53.8 mt -69.33 -35.93 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.496 1.118 . . . . 74.43 109.499 174.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.415 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 26.9 m-80 -83.43 -13.55 54.54 Favored 'General case' 0 C--O 1.206 -1.222 0 C-N-CA 124.224 1.01 . . . . 73.43 111.401 178.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -74.27 -56.8 4.47 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 107.646 -1.242 . . . . 75.34 107.646 169.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -52.94 -50.64 63.6 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-N 113.152 -1.84 . . . . 65.45 110.515 177.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -66.35 -41.91 88.86 Favored 'General case' 0 C--O 1.205 -1.247 0 CA-C-N 115.296 -0.865 . . . . 73.53 110.857 178.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 51' ' ' ASN . . . -53.62 -39.65 65.11 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 118.76 0.709 . . . . 72.52 111.986 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 61.1 t -70.8 -51.06 39.31 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 CA-C-N 115.794 -0.639 . . . . 74.52 110.748 174.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.497 HD11 HD11 ' A' ' 22' ' ' ILE . 48.6 mt -89.81 -0.1 57.34 Favored 'General case' 0 CA--C 1.568 1.657 0 N-CA-C 113.806 1.039 . . . . 74.35 113.806 -167.069 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 48.0 t -71.07 -51.15 26.89 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 124.091 0.956 . . . . 74.34 111.411 -173.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -86.59 125.19 68.07 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 114.613 -1.176 . . . . 74.34 107.87 177.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -53.21 -26.01 32.21 Favored 'Trans proline' 0 C--N 1.374 1.921 0 C-N-CA 123.322 2.681 . . . . 72.41 113.335 178.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -70.93 -56.26 6.61 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.957 0.903 . . . . 72.3 110.911 177.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.451 ' HA ' HD13 ' A' ' 65' ' ' ILE . 46.4 mtpt -66.96 -27.7 67.67 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 123.829 0.852 . . . . 74.54 111.477 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -60.92 -55.5 32.17 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 114.48 -1.236 . . . . 74.11 109.713 171.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -54.21 -40.61 67.78 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 124.165 0.916 . . . . 74.25 111.159 177.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.65 HD12 ' HE1' ' A' ' 83' ' ' TYR . 77.3 mt -51.92 -63.78 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.025 0 O-C-N 124.404 1.065 . . . . 74.41 109.265 174.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.463 ' OH ' ' HA ' ' A' ' 6' ' ' ASP . 32.6 t80 -50.19 -54.66 19.41 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 119.024 -0.512 . . . . 75.4 112.071 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -43.27 -55.22 4.13 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 124.433 1.083 . . . . 64.04 110.585 -178.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.44 ' HB ' ' HB2' ' A' ' 74' ' ' ALA . 69.1 p -98.47 -2.53 38.73 Favored 'General case' 0 CA--C 1.551 1.019 0 CA-C-N 115.071 -0.968 . . . . 75.44 113.258 -171.271 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -117.78 118.72 32.82 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 118.754 0.706 . . . . 75.32 109.428 -178.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.08 21.81 72.81 Favored Glycine 0 C--N 1.344 0.991 0 CA-C-O 121.6 0.556 . . . . 64.23 112.781 177.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 90.6 m -146.67 -51.81 0.22 Allowed 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 103.969 -2.604 . . . . 71.23 103.969 178.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 60.6 m -102.2 161.43 13.7 Favored 'General case' 0 C--O 1.258 1.533 0 CA-C-N 112.198 -2.273 . . . . 74.23 105.165 158.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.89 12.3 17.77 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.409 0.683 . . . . 74.04 112.203 179.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.44 ' HB2' ' HB ' ' A' ' 68' ' ' THR . . . -70.3 -152.05 0.0 OUTLIER Pre-proline 0 CA--C 1.589 2.456 0 CA-C-O 116.775 -1.583 . . . . 75.1 111.333 176.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.479 ' HA ' ' HD2' ' A' ' 76' ' ' PRO . 6.2 Cg_exo 7.76 107.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.412 3.909 0 C-N-CA 124.384 3.39 . . . . 75.41 117.835 -153.026 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.479 ' HD2' ' HA ' ' A' ' 75' ' ' PRO . 28.9 Cg_endo -57.98 -177.44 0.09 OUTLIER 'Trans proline' 0 N--CA 1.518 2.961 0 C-N-CA 124.519 3.48 . . . . 74.25 113.217 174.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -39.11 131.49 1.36 Allowed 'Trans proline' 0 C--N 1.402 3.351 0 C-N-CA 123.111 2.54 . . . . 73.45 114.056 173.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.466 ' HG2' ' HB2' ' A' ' 103' ' ' PRO . 0.5 OUTLIER -29.03 123.31 0.05 OUTLIER 'Trans proline' 0 C--N 1.382 2.324 1 C-N-CA 126.105 4.537 . . . . 73.2 117.314 -172.433 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -78.39 156.45 28.96 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 123.137 2.558 . . . . 71.05 114.07 -176.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -56.35 80.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.393 2.915 0 C-N-CA 124.384 3.389 . . . . 74.31 113.191 175.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -178.15 -34.85 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 N-CA-C 109.903 -1.279 . . . . 62.41 109.903 -177.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 75.63 168.82 25.41 Favored Glycine 0 C--N 1.353 1.52 0 N-CA-C 115.194 0.838 . . . . 53.03 115.194 171.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.65 ' HE1' HD12 ' A' ' 65' ' ' ILE . 27.0 m-85 -111.06 102.25 10.72 Favored 'General case' 0 C--O 1.243 0.731 0 C-N-CA 124.789 1.236 . . . . 74.41 109.406 178.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -89.49 152.79 21.26 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.148 0.579 . . . . 71.31 110.819 175.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -127.65 77.89 1.78 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.386 1.074 . . . . 73.24 108.367 175.153 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 9.0 m -38.37 86.67 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 126.982 2.113 . . . . 74.44 115.505 -172.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 76.03 -7.27 29.8 Favored Glycine 0 C--N 1.35 1.32 0 CA-C-N 116.041 -0.527 . . . . 70.11 113.789 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -89.71 125.29 35.22 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.609 1.164 . . . . 72.34 108.208 -178.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -71.71 88.68 0.99 Allowed 'General case' 0 N--CA 1.482 1.139 0 CA-C-O 121.52 0.676 . . . . 71.44 110.082 -175.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -47.13 -43.05 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 126.112 1.765 . . . . 75.21 111.949 177.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -73.88 -6.5 47.55 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 115.214 -0.903 . . . . 75.33 111.889 -173.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -91.64 -27.93 17.81 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.976 0.911 . . . . 61.35 110.787 172.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.456 ' HE1' ' HB3' ' A' ' 48' ' ' LYS . 23.8 m-85 -76.78 -176.2 3.76 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 112.802 0.667 . . . . 73.34 112.802 -170.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 67.8 p -56.86 145.28 30.22 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.194 0.998 . . . . 74.5 112.944 -167.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.63 -41.26 85.55 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.0 -1.0 . . . . 74.52 111.428 177.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.49 ' HD1' ' HA ' ' A' ' 2' ' ' ALA . 74.2 t80 -58.91 -44.3 91.25 Favored 'General case' 0 C--N 1.355 0.812 0 C-N-CA 123.038 0.535 . . . . 75.03 110.145 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -58.08 -49.64 76.21 Favored 'General case' 0 CA--C 1.555 1.16 0 CA-C-N 116.077 -0.51 . . . . 72.32 109.963 174.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -73.98 -3.92 32.08 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 112.428 0.529 . . . . 74.14 112.428 -178.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -95.73 -60.15 1.71 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.427 0.691 . . . . 70.02 110.398 171.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 24.2 tp -58.5 -56.77 17.9 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.916 1.286 . . . . 74.33 110.785 -177.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -84.25 -8.13 59.13 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 114.251 -1.341 . . . . 72.11 111.043 178.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -40.65 -66.28 0.88 Allowed Glycine 0 C--N 1.351 1.376 0 N-CA-C 116.114 1.206 . . . . 72.43 116.114 -174.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.466 ' HB2' ' HG2' ' A' ' 78' ' ' PRO . 23.7 Cg_exo -62.6 -14.86 42.43 Favored 'Trans proline' 0 C--N 1.373 1.864 0 C-N-CA 122.749 2.299 . . . . 64.43 114.06 -175.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -103.36 -2.23 47.58 Favored Glycine 0 C--N 1.358 1.773 0 CA-C-O 118.91 -0.939 . . . . 54.4 113.825 -177.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.427 ' HB3' ' OD1' ' A' ' 169' ' ' ASN . 86.6 mt -63.32 77.11 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 124.065 0.946 . . . . 74.25 113.007 -177.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 19.65 -105.14 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.256 0 C-N-CA 127.9 2.48 . . . . 74.45 116.36 174.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 71.85 2.88 53.59 Favored Glycine 0 C--N 1.35 1.353 0 CA-C-O 119.576 -0.569 . . . . 44.0 112.664 -164.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 53.9 -125.73 33.7 Favored Glycine 0 C--N 1.355 1.584 0 O-C-N 123.923 0.425 . . . . 71.34 112.763 -172.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -88.21 -6.96 57.53 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.125 0.97 . . . . 74.55 111.194 177.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -80.51 -38.85 16.08 Favored Glycine 0 C--N 1.345 1.058 0 CA-C-N 116.387 -0.37 . . . . 55.25 112.651 179.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? 65.68 -7.46 0.35 Allowed 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 114.572 1.323 . . . . 75.52 114.572 176.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.57 -20.24 66.13 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.321 1.049 . . . . 75.13 110.632 171.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 46.2 m 71.83 70.61 0.16 Allowed 'General case' 0 C--N 1.351 0.671 0 C-N-CA 124.529 1.132 . . . . 74.21 110.673 177.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.424 ' HG3' ' H ' ' A' ' 115' ' ' LYS . 2.2 tpm_? -135.28 172.75 12.56 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.515 0.726 . . . . 74.52 110.453 178.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.424 ' H ' ' HG3' ' A' ' 114' ' ' ARG . 51.7 tttm -60.87 142.87 55.87 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.396 1.078 . . . . 73.31 112.906 -177.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -85.99 -178.3 50.0 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 115.7 -0.682 . . . . 73.4 113.646 177.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.44 ' O ' ' HA3' ' A' ' 172' ' ' GLY . 13.4 ptt180 -96.05 173.43 7.43 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.796 0.838 . . . . 74.43 111.061 179.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -78.82 138.76 38.33 Favored 'General case' 0 CA--C 1.549 0.941 0 N-CA-C 109.267 -0.642 . . . . 74.23 109.267 166.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 9.3 tt -144.95 139.33 27.48 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 107.966 -1.124 . . . . 75.42 107.966 -173.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.53 ' HA ' ' HB2' ' A' ' 175' ' ' LEU . 2.8 tmm_? -100.26 119.04 37.78 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 108.891 -0.781 . . . . 74.51 108.891 175.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.465 ' HB2' HD12 ' A' ' 174' ' ' LEU . . . -111.73 169.87 8.53 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-O 121.7 0.762 . . . . 54.41 110.41 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -120.26 113.42 20.39 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 106.497 -1.668 . . . . 72.42 106.497 -176.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 51.1 tp -98.64 98.02 5.53 Favored Pre-proline 0 N--CA 1.473 0.682 0 N-CA-C 108.194 -1.039 . . . . 74.14 108.194 -178.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.619 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 73.4 Cg_endo -77.05 114.24 3.77 Favored 'Trans proline' 0 C--N 1.372 1.789 0 C-N-CA 121.32 1.347 . . . . 75.33 108.958 177.194 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.523 ' HA ' HG23 ' B' ' 6' ' ' ILE . 61.6 tp -123.06 139.56 53.95 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.075 0.55 . . . . 72.43 110.687 -169.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 27.2 m -68.56 128.86 38.14 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.861 0.864 . . . . 71.34 109.99 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.537 HD21 ' HB3' ' A' ' 180' ' ' LEU . 75.7 mt -50.93 -49.88 58.8 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 124.187 0.995 . . . . 75.21 111.21 -174.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -55.93 -49.4 73.59 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.239 -1.346 . . . . 75.32 109.911 -178.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -75.06 -19.84 59.82 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 114.631 -1.168 . . . . 64.33 111.677 -176.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -68.86 -43.69 74.88 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.334 0.653 . . . . 65.44 109.723 174.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -70.8 -35.51 72.57 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 115.126 -0.943 . . . . 74.51 111.364 176.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -73.65 -39.95 64.09 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 116.202 -0.453 . . . . 75.25 111.885 -178.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.581 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 77.29 -166.44 53.67 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-N 116.513 -0.312 . . . . 71.54 113.42 -176.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 100.08 179.04 30.32 Favored Glycine 0 C--N 1.35 1.311 0 C-N-CA 122.828 0.251 . . . . 70.42 113.161 176.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.623 ' HB3' ' HG ' ' A' ' 146' ' ' SER . 2.1 mp0 -74.75 100.63 4.07 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 122.96 0.504 . . . . 73.14 110.2 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -90.57 123.99 34.67 Favored 'General case' 0 C--O 1.244 0.8 0 N-CA-C 109.307 -0.627 . . . . 75.05 109.307 -177.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 98.3 t -72.39 108.41 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 N-CA-C 109.043 -0.725 . . . . 75.04 109.043 173.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.521 HG12 HG12 ' A' ' 145' ' ' VAL . 3.1 p -121.57 133.16 68.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 124.752 1.221 . . . . 73.34 108.312 175.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -122.42 146.59 47.22 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.037 0.535 . . . . 71.3 110.243 -170.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 10.7 p -163.89 135.03 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 123.26 0.624 . . . . 75.1 110.06 175.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 61.9 19.89 11.05 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.727 1.211 . . . . 74.24 112.871 176.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 96.87 -19.91 52.84 Favored Glycine 0 C--N 1.348 1.226 0 CA-C-N 116.386 -0.37 . . . . 54.15 112.844 -176.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.515 ' NH2' ' HE3' ' A' ' 164' ' ' MET . 1.0 OUTLIER -80.31 115.8 20.04 Favored 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 108.58 -0.896 . . . . 72.43 108.58 -179.213 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 42.2 ttt180 -98.38 99.53 10.73 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.187 0.995 . . . . 74.41 109.781 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.521 HG12 HG12 ' A' ' 138' ' ' VAL . 6.7 p -104.37 153.01 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 C-N-CA 123.231 0.612 . . . . 73.53 110.446 -177.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.623 ' HG ' ' HB3' ' A' ' 135' ' ' GLU . 32.0 t -124.61 103.99 8.44 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.599 0.759 . . . . 64.43 109.6 -179.057 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 4.8 p -101.38 121.99 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 123.169 0.588 . . . . 73.42 110.646 -175.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -73.84 99.36 3.19 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.422 0.629 . . . . 74.32 109.969 173.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.581 HG13 ' HA2' ' A' ' 133' ' ' GLY . 24.1 pt -80.96 142.89 52.48 Favored Pre-proline 0 CA--C 1.558 1.25 0 CA-C-N 114.608 -1.178 . . . . 74.52 109.622 173.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -66.43 136.28 42.63 Favored 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 122.538 2.159 . . . . 74.22 113.24 174.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -56.36 96.9 0.06 OUTLIER 'Trans proline' 0 C--N 1.385 2.45 0 C-N-CA 123.084 2.523 . . . . 74.15 112.409 168.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 104.57 39.63 2.35 Favored Glycine 0 C--N 1.339 0.713 0 CA-C-N 115.298 -0.865 . . . . 75.51 111.675 -174.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 11.6 p -78.56 140.94 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 N-CA-C 109.158 -0.682 . . . . 75.43 109.158 177.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 9.5 mtm105 -115.23 147.15 40.7 Favored 'General case' 0 C--O 1.205 -1.264 0 CA-C-N 115.937 -0.574 . . . . 73.23 111.77 -164.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -53.77 120.01 5.7 Favored 'General case' 0 CA--C 1.551 0.984 0 O-C-N 124.266 0.979 . . . . 72.32 110.355 175.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 105.09 -8.34 45.23 Favored Glycine 0 C--N 1.347 1.14 0 CA-C-N 115.536 -0.757 . . . . 74.33 113.425 -176.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 44.1 m -68.32 105.09 2.03 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 117.447 0.623 . . . . 74.23 110.253 177.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.409 HG21 HG21 ' A' ' 177' ' ' VAL . 41.5 t -85.17 90.81 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-N 115.117 -0.947 . . . . 74.02 109.31 -178.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.583 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 56.9 mt -70.44 91.64 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 108.404 -0.961 . . . . 75.24 108.404 175.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 67.9 ttt-85 -78.38 100.05 6.62 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.778 -0.647 . . . . 75.21 109.273 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.6 p -106.6 105.39 54.56 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 123.662 0.785 . . . . 71.41 109.266 177.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.459 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 23.8 Cg_exo -65.25 104.18 0.59 Allowed 'Trans proline' 0 C--N 1.377 2.058 0 C-N-CA 122.551 2.168 . . . . 74.53 111.283 175.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . 0.43 ' HA2' ' O ' ' A' ' 171' ' ' PRO . . . 126.99 25.77 1.18 Allowed Glycine 0 C--N 1.342 0.873 0 N-CA-C 115.801 1.081 . . . . 70.43 115.801 175.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.515 ' HE3' ' NH2' ' A' ' 143' ' ' ARG . 24.7 mmt -137.57 0.44 2.26 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 119.013 1.406 . . . . 64.15 112.057 177.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.7 ' HA2' HD13 ' A' ' 174' ' ' LEU . . . -75.85 -108.22 0.12 Allowed Glycine 0 N--CA 1.477 1.404 0 C-N-CA 123.685 0.66 . . . . 73.33 114.274 -170.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -58.22 119.05 15.25 Favored Glycine 0 C--N 1.344 0.992 0 N-CA-C 110.051 -1.22 . . . . 74.5 110.051 168.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -64.45 109.09 1.83 Allowed 'General case' 0 CA--C 1.538 0.503 0 O-C-N 124.67 0.865 . . . . 75.42 110.056 -175.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -146.77 174.14 26.71 Favored Glycine 0 C--N 1.339 0.739 0 N-CA-C 110.1 -1.2 . . . . 64.21 110.1 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . 0.427 ' OD1' ' HB3' ' A' ' 105' ' ' LEU . 50.4 t30 -59.61 -61.05 8.66 Favored Pre-proline 0 CA--C 1.565 1.525 0 CA-C-O 118.629 -0.7 . . . . 63.54 109.742 -176.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.427 ' HD3' ' HB3' ' A' ' 169' ' ' ASN . 19.6 Cg_endo -94.81 96.16 0.11 Allowed 'Trans proline' 0 C--N 1.382 2.314 0 CA-C-N 121.44 1.55 . . . . 73.02 108.16 154.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.43 ' O ' ' HA2' ' A' ' 163' ' ' GLY . 18.1 Cg_exo -61.59 167.41 9.95 Favored 'Trans proline' 0 C--N 1.385 2.473 0 C-N-CA 122.361 2.041 . . . . 71.25 112.638 -169.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.44 ' HA3' ' O ' ' A' ' 117' ' ' ARG . . . -85.81 -168.83 45.25 Favored Glycine 0 C--O 1.216 -0.989 0 C-N-CA 121.172 -0.537 . . . . 72.4 113.247 -177.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.459 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 13.6 m-20 -72.59 138.69 46.99 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 122.94 0.496 . . . . 71.14 110.467 -176.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.7 HD13 ' HA2' ' A' ' 165' ' ' GLY . 25.6 tp -119.21 132.05 55.9 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 110.0 -0.37 . . . . 74.2 110.0 177.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.53 ' HB2' ' HA ' ' A' ' 120' ' ' ARG . 44.6 mt -102.09 85.74 2.73 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 107.999 -1.112 . . . . 72.12 107.999 176.083 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.583 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 79.8 mt -71.72 85.83 0.92 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 109.543 -0.539 . . . . 74.52 109.543 176.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.409 HG21 HG21 ' A' ' 158' ' ' VAL . 18.9 t -82.64 102.22 8.33 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 N-CA-C 106.787 -1.56 . . . . 71.11 106.787 178.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 8.2 p -67.92 107.7 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.961 0 CA-C-O 122.516 1.151 . . . . 74.13 110.705 -171.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.619 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 36.0 mmt180 -95.18 100.08 11.95 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.116 -1.402 . . . . 73.42 108.953 175.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.537 ' HB3' HD21 ' A' ' 127' ' ' LEU . 26.3 mt -68.98 142.91 54.53 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 109.753 -0.462 . . . . 74.04 109.753 -179.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 55.2 mt -53.97 159.06 3.02 Favored Pre-proline 0 N--CA 1.486 1.336 0 C-N-CA 124.281 1.032 . . . . 73.22 113.142 -168.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -74.8 28.72 0.35 Allowed 'Trans proline' 0 C--N 1.38 2.215 0 C-N-CA 123.488 2.792 . . . . 74.32 112.485 167.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 64.8 t-80 -60.1 104.83 0.48 Allowed Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 125.722 1.609 . . . . 73.35 106.881 169.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -70.03 24.53 0.18 Allowed 'Trans proline' 0 C--N 1.382 2.34 0 C-N-CA 124.513 3.475 . . . . 61.24 116.801 -160.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 49.1 t -98.92 -50.94 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 118.721 0.691 . . . . 72.34 109.349 178.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . 0.474 ' HB3' HD22 ' A' ' 193' ' ' LEU . 82.9 m-85 -127.74 124.8 38.65 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.045 0.538 . . . . 72.31 110.864 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 52.1 ttp85 -103.5 87.96 2.98 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 107.007 -1.479 . . . . 75.51 107.007 164.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 193' ' ' LEU . 16.3 tp -66.9 155.84 37.37 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.29 0.636 . . . . 74.21 109.601 177.089 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -163.92 121.07 1.73 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.236 0.614 . . . . 70.31 109.384 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 74.62 -79.23 0.97 Allowed Glycine 0 C--N 1.348 1.238 0 N-CA-C 112.239 -0.344 . . . . 65.41 112.239 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.519 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 3.8 pm0 -146.25 -13.3 0.46 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.567 1.147 . . . . 72.32 110.251 173.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -112.03 140.31 46.81 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.285 1.034 . . . . 72.32 111.503 -169.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.474 HD22 ' HB3' ' A' ' 186' ' ' PHE . 35.5 mt -90.2 153.88 20.17 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.312 1.445 . . . . 74.25 111.027 -172.354 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -128.2 98.89 5.24 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 107.738 -1.208 . . . . 73.14 107.738 170.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.435 ' HB2' HD22 ' A' ' 251' ' ' LEU . . . -113.08 130.1 56.28 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.755 0.822 . . . . 74.34 109.932 -176.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 41.2 m -77.25 131.43 38.18 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 109.579 -0.526 . . . . 70.21 109.579 -176.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.427 HD22 HD13 ' A' ' 251' ' ' LEU . 57.1 tp -124.91 108.03 11.47 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 123.216 0.606 . . . . 74.1 109.704 -170.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -80.72 107.74 13.79 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 108.513 -0.921 . . . . 63.3 108.513 173.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 6.7 p -126.51 130.59 23.85 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 124.055 0.942 . . . . 74.33 108.58 -179.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.45 157.44 40.88 Favored 'Trans proline' 0 C--N 1.365 1.409 0 C-N-CA 121.627 1.551 . . . . 70.05 111.96 173.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.43 ' HB1' ' HD3' ' A' ' 202' ' ' PRO . . . -54.09 -53.29 60.21 Favored Pre-proline 0 CA--C 1.559 1.295 0 N-CA-C 114.177 1.177 . . . . 71.34 114.177 -169.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.43 ' HD3' ' HB1' ' A' ' 201' ' ' ALA . 50.4 Cg_exo -58.5 -35.63 98.43 Favored 'Trans proline' 0 C--N 1.382 2.292 0 C-N-CA 122.02 1.813 . . . . 73.32 113.682 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 46.2 mt -74.51 -33.89 34.03 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 N-CA-C 109.966 -0.383 . . . . 71.02 109.966 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . 0.51 ' HA ' HG12 ' A' ' 223' ' ' VAL . . . -67.92 -41.32 82.78 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.303 0.641 . . . . 74.14 111.275 175.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.496 HG12 HD13 ' C' ' 261' ' ' LEU . 55.1 t -78.94 -42.16 24.02 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 C-N-CA 123.865 0.866 . . . . 64.22 112.466 -172.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 84.6 t -84.17 -33.0 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 122.793 0.437 . . . . 74.41 110.288 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 88.04 48.5 4.08 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-N 115.551 -0.749 . . . . 72.35 111.796 -177.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -76.93 173.86 54.62 Favored Glycine 0 C--N 1.341 0.853 0 N-CA-C 111.334 -0.706 . . . . 73.32 111.334 173.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.531 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 46.8 mtmt -84.76 129.92 34.76 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 117.694 0.747 . . . . 73.34 111.915 -178.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 30.2 m -111.56 -172.12 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.961 0 N-CA-C 106.237 -1.764 . . . . 63.11 106.237 161.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . 0.502 ' HD3' ' HB2' ' A' ' 218' ' ' PRO . 15.5 ttm180 -127.39 132.16 50.2 Favored 'General case' 0 C--O 1.237 0.432 0 O-C-N 121.954 -0.466 . . . . 74.32 110.353 177.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -99.51 111.75 24.05 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 108.29 -1.004 . . . . 74.41 108.29 174.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' MET . . . . . 0.577 ' HA ' ' HA ' ' A' ' 218' ' ' PRO . 3.5 mpp? -71.93 123.78 23.46 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 108.602 -0.888 . . . . 74.15 108.602 173.584 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' THR . . . . . 0.464 ' HA ' ' HE1' ' A' ' 186' ' ' PHE . 24.5 p -108.81 -177.74 3.4 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 109.405 -0.591 . . . . 74.1 109.405 179.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.434 HD13 ' HZ ' ' A' ' 240' ' ' PHE . 61.5 mt -58.82 -27.21 64.88 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.661 1.184 . . . . 73.14 113.141 -171.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -142.34 28.84 1.64 Allowed 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 116.323 -0.399 . . . . 64.44 111.222 -175.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 155.72 146.59 4.48 Favored Glycine 0 C--N 1.35 1.346 0 O-C-N 121.513 -0.742 . . . . 63.05 114.612 171.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . 0.577 ' HA ' ' HA ' ' A' ' 213' ' ' MET . 72.9 Cg_endo -85.94 108.82 0.98 Allowed 'Trans proline' 0 C--N 1.369 1.613 0 C-N-CA 122.962 2.441 . . . . 74.13 112.567 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 30.1 m -103.05 150.28 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 123.592 0.757 . . . . 73.4 109.648 -178.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -79.36 142.32 36.14 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 117.802 0.273 . . . . 75.04 110.613 -177.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 3.9 m -134.1 110.87 14.34 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 C-N-CA 124.163 0.985 . . . . 74.51 108.578 174.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.531 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -72.61 114.53 10.85 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 109.145 -0.687 . . . . 70.4 109.145 174.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.604 ' HA ' HD13 ' B' ' 441' ' ' ILE . 50.5 t -59.53 146.63 79.46 Favored Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 124.357 1.063 . . . . 71.22 109.425 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . 0.59 ' HD3' ' HB ' ' B' ' 441' ' ' ILE . 60.4 Cg_endo -70.75 158.9 54.36 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 121.592 1.528 . . . . 75.51 109.316 169.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -72.34 151.46 54.14 Favored 'Trans proline' 0 CA--C 1.549 1.25 0 CA-C-N 119.925 1.009 . . . . 72.53 111.969 171.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 46.1 mtt180 64.82 39.26 6.22 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 125.331 1.452 . . . . 75.13 110.894 169.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.564 HG21 HD21 ' A' ' 233' ' ' LEU . 53.2 m -74.42 109.58 8.01 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 112.989 -1.914 . . . . 64.32 111.716 -177.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . 0.407 ' HB3' ' HD2' ' A' ' 231' ' ' ARG . 5.8 tp60 -84.86 140.96 30.78 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.618 1.167 . . . . 75.32 111.521 -177.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -63.31 145.56 55.29 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.061 0.944 . . . . 65.12 112.184 -179.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 86.29 -24.89 7.58 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-N 116.334 -0.394 . . . . 75.54 113.355 178.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.407 ' HD2' ' HB3' ' A' ' 228' ' ' GLN . 93.7 mtt180 -69.15 160.83 30.37 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-O 121.46 0.648 . . . . 74.44 110.905 176.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.628 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 2.8 mppt? -115.16 114.87 25.85 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.112 -1.07 . . . . 72.22 108.112 178.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.564 HD21 HG21 ' A' ' 227' ' ' THR . 87.9 mt -76.16 103.44 6.2 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 115.46 -0.791 . . . . 71.4 109.905 -175.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -76.14 105.09 6.99 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 123.712 0.632 . . . . 73.41 109.982 177.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.567 ' HB3' ' HA ' ' B' ' 441' ' ' ILE . 0.4 OUTLIER -108.45 115.45 30.13 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.006 -1.109 . . . . 74.24 108.006 167.772 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -69.73 141.44 53.46 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 114.651 -1.159 . . . . 71.01 111.978 -167.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 69.98 17.42 73.58 Favored Glycine 0 C--N 1.348 1.221 0 O-C-N 123.936 0.773 . . . . 74.2 113.922 174.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.444 ' HG3' HD11 ' A' ' 235' ' ' LEU . 33.7 mmtp -107.62 5.15 26.65 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.225 0.61 . . . . 74.1 111.086 -176.075 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -101.74 -156.3 26.42 Favored Glycine 0 C--N 1.347 1.19 0 C-N-CA 123.194 0.426 . . . . 74.43 112.659 173.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . 0.434 ' HZ ' HD13 ' A' ' 215' ' ' LEU . 3.4 m-85 -94.23 145.18 29.28 Favored Pre-proline 0 N--CA 1.481 1.079 0 C-N-CA 123.136 0.575 . . . . 73.41 111.065 -172.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -60.56 119.09 6.07 Favored 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 123.52 2.813 . . . . 73.33 112.85 178.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -156.42 -148.19 4.99 Favored Glycine 0 C--N 1.35 1.323 0 CA-C-O 118.548 -1.14 . . . . 73.52 113.746 -173.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . 0.519 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 74.2 Cg_exo -51.92 -38.52 68.82 Favored 'Trans proline' 0 C--N 1.39 2.747 0 C-N-CA 124.138 3.225 . . . . 72.5 113.84 -176.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -82.98 15.33 2.8 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.821 0.848 . . . . 70.11 112.207 -178.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 81.16 -71.57 2.89 Favored Glycine 0 C--N 1.345 1.048 0 N-CA-C 109.814 -1.314 . . . . 62.24 109.814 -169.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 23.1 mtp180 -122.12 147.49 46.08 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.491 1.117 . . . . 75.41 108.723 168.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -86.14 -177.44 49.89 Favored Glycine 0 C--N 1.339 0.706 0 CA-C-N 116.303 -0.408 . . . . 70.31 112.346 175.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -111.45 170.93 7.79 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.29 0.636 . . . . 75.44 110.072 -179.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.515 ' HB3' ' HG ' ' A' ' 235' ' ' LEU . 34.0 tp -114.91 134.39 55.19 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.361 -1.348 . . . . 73.32 107.361 170.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.628 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 62.0 m-85 -116.38 106.28 13.45 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 107.945 -1.131 . . . . 71.3 107.945 175.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.435 HD22 ' HB2' ' A' ' 195' ' ' ALA . 49.5 mt -90.23 108.2 19.61 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 109.51 -0.552 . . . . 74.54 109.51 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.504 ' HG2' ' HG3' ' A' ' 232' ' ' LYS . 30.6 mt-10 -76.33 111.5 11.84 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.663 1.185 . . . . 75.41 109.068 -172.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 27.5 t -69.81 119.24 15.49 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 C-N-CA 123.827 0.851 . . . . 71.34 111.902 -168.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.28 91.67 3.59 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 107.433 -1.321 . . . . 73.14 107.433 174.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.478 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 62.4 mt -78.61 129.68 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 O-C-N 123.204 0.315 . . . . 74.34 110.305 -177.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 51.9 p -113.94 166.46 11.57 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.939 0.895 . . . . 74.52 109.703 173.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . 0.596 HG23 HG23 ' C' ' 255' ' ' ILE . 2.6 pp -118.17 157.52 48.67 Favored Pre-proline 0 CA--C 1.56 1.329 0 C-N-CA 123.735 0.814 . . . . 73.4 110.378 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . 0.512 ' HD2' ' HB ' ' A' ' 257' ' ' ILE . 25.7 Cg_endo -56.23 -17.2 19.65 Favored 'Trans proline' 0 N--CA 1.513 2.631 0 C-N-CA 124.42 3.413 . . . . 74.45 115.165 -168.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.646 ' HG2' HE21 ' C' ' 228' ' ' GLN . 40.5 mt-10 50.01 -81.61 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 124.859 1.264 . . . . 75.12 111.659 -166.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.6 161.49 29.52 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 120.114 1.325 . . . . 75.12 109.806 173.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.678 HD22 ' HB3' ' A' ' 265' ' ' GLU . 54.6 mt -147.47 146.5 29.55 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.37 0.668 . . . . 72.32 109.936 173.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 72.5 p -83.97 161.35 55.67 Favored Pre-proline 0 CA--C 1.551 1.011 0 N-CA-C 107.958 -1.127 . . . . 74.31 107.958 165.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' PRO . . . . . 0.407 ' HG3' ' HA ' ' B' ' 376' ' ' GLU . 10.4 Cg_endo -50.24 -40.25 52.08 Favored 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 123.279 2.653 . . . . 74.33 113.562 -179.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -63.1 -56.99 12.16 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.745 -0.661 . . . . 71.44 110.53 177.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . 0.678 ' HB3' HD22 ' A' ' 261' ' ' LEU . 53.0 mt-10 -57.38 -35.97 70.66 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 123.626 0.579 . . . . 73.22 111.102 -179.032 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' GLU . . . . . 0.556 ' HA ' HD12 ' A' ' 261' ' ' LEU . 7.3 tp10 -59.69 -50.41 73.96 Favored 'General case' 0 C--O 1.248 0.984 0 C-N-CA 123.985 0.914 . . . . 73.45 109.519 178.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -60.71 -41.54 95.45 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 114.627 -1.169 . . . . 64.12 111.814 177.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 10.1 mp -69.85 -45.28 68.11 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.42 0.688 . . . . 73.14 111.786 -176.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 63.1 m95 -66.68 -35.38 80.02 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.563 0.745 . . . . 75.0 111.62 -179.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . 0.462 ' HE2' HG21 ' C' ' 206' ' ' VAL . 96.2 mttt -85.22 -16.79 39.09 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 116.216 -0.447 . . . . 73.12 112.142 177.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . 0.401 ' HB3' ' HZ2' ' A' ' 271' ' ' LYS . 4.0 mmmp? -74.47 -32.79 62.69 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 110.029 -0.36 . . . . 70.22 110.029 166.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 91.6 mt -61.87 -58.24 8.7 Favored 'General case' 0 C--O 1.212 -0.892 0 N-CA-C 108.338 -0.986 . . . . 71.54 108.338 170.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -57.5 -32.59 67.16 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.52 1.128 . . . . 72.23 112.793 -177.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -65.17 -62.68 1.4 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.443 0.697 . . . . 74.35 109.35 172.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -70.6 -6.35 36.02 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.276 0.631 . . . . 72.24 112.564 -175.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -93.64 -80.51 0.39 Allowed 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 107.612 -1.255 . . . . 75.02 107.612 174.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -73.27 -38.1 66.06 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.33 -0.85 . . . . 72.14 112.005 -166.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -73.37 -4.54 34.05 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 122.345 -0.222 . . . . 75.41 111.1 178.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -120.96 10.74 10.88 Favored 'General case' 0 C--N 1.358 0.961 0 C-N-CA 123.451 0.7 . . . . 75.15 110.059 176.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.142 0 C-N-CA 123.603 0.761 . . . . 72.5 111.314 -178.502 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.436 ' HB3' ' HB3' ' B' ' 4' ' ' SER . 1.5 mpt? . . . . . 0 N--CA 1.477 0.898 0 N-CA-C 110.238 -0.282 . . . . 74.12 110.238 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -79.77 -49.43 12.04 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.189 0.596 . . . . 62.45 110.608 176.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -93.88 19.89 8.37 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.312 0.645 . . . . 74.04 112.3 -171.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' SER . . . . . 0.436 ' HB3' ' HB3' ' B' ' 1' ' ' MET . 13.9 p -65.97 -56.31 12.33 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-O 120.945 0.403 . . . . 52.14 110.156 178.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 4.1 m 67.78 151.8 0.08 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.501 1.52 . . . . 74.34 112.328 174.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.523 HG23 ' HA ' ' A' ' 125' ' ' LEU . 46.2 pt -130.93 159.99 42.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 123.019 0.527 . . . . 65.34 111.645 -162.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -131.93 134.74 45.99 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.828 0.851 . . . . 72.22 110.104 178.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 32.7 tp -73.15 144.69 46.81 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.429 0.691 . . . . 75.22 110.378 -176.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.39 -50.03 10.67 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 122.477 0.311 . . . . 73.12 111.345 178.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 31.4 mt 71.22 -25.09 0.17 Allowed 'General case' 0 N--CA 1.504 2.251 0 C-N-CA 125.295 1.438 . . . . 74.1 113.282 -172.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 61.0 mt 56.56 69.47 1.76 Allowed Pre-proline 0 CA--C 1.558 1.278 0 C-N-CA 124.468 1.107 . . . . 72.11 109.649 -168.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -91.03 -151.01 0.04 OUTLIER 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 123.17 2.58 . . . . 71.41 112.368 -176.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -59.21 -30.53 68.29 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.071 0.948 . . . . 75.11 112.676 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 3.2 pp -135.37 153.98 51.65 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.405 0.682 . . . . 64.54 110.183 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -156.82 132.0 9.11 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 108.767 -0.827 . . . . 74.01 108.767 177.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 36.6 p -110.94 98.62 39.35 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 123.659 0.784 . . . . 71.11 110.065 178.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -91.61 -163.01 0.11 Allowed 'Trans proline' 0 C--N 1.373 1.86 0 C-N-CA 123.015 2.476 . . . . 71.22 112.119 174.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 34.6 m -71.48 -6.85 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 C-N-CA 123.81 0.844 . . . . 63.3 112.7 179.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 11.8 m -58.1 -44.05 87.44 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.618 0.767 . . . . 71.22 110.678 175.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -76.82 -73.94 0.26 Allowed 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 115.751 -0.659 . . . . 74.33 110.317 178.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.87 88.78 7.13 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.358 -0.608 . . . . 75.34 109.358 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 37.5 mtp85 -65.64 -60.5 2.85 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 114.573 -1.194 . . . . 73.31 109.093 -178.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 23' ' ' THR . . . . . 0.421 ' HB ' ' HD3' ' B' ' 24' ' ' PRO 0.276 18.0 m 98.05 -84.22 0.0 OUTLIER Pre-proline 0 CA--C 1.57 1.748 0 C-N-CA 127.219 2.208 . . . . 72.54 114.85 164.626 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . 0.421 ' HD3' ' HB ' ' B' ' 23' ' ' THR . 27.5 Cg_endo -85.41 26.13 0.66 Allowed 'Trans proline' 0 C--N 1.392 2.844 0 CA-C-N 122.47 1.918 . . . . 74.55 114.935 -154.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -79.95 83.22 5.9 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 122.889 0.476 . . . . 74.53 110.215 179.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 59.0 mtm -75.61 -44.01 4.15 Favored Pre-proline 0 CA--C 1.561 1.393 0 CA-C-N 115.083 -0.962 . . . . 75.13 111.662 174.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -59.22 108.11 0.41 Allowed 'Trans proline' 0 C--N 1.397 3.095 0 C-N-CA 121.982 1.788 . . . . 73.04 112.689 176.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 5.8 m -73.67 99.73 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 CA-C-N 115.38 -0.827 . . . . 75.25 109.781 176.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 66.4 mt 71.19 -72.41 0.11 Allowed 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 125.949 1.7 . . . . 73.34 111.096 -178.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.96 -4.16 3.57 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.27 1.028 . . . . 71.25 110.522 178.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 7.2 t30 64.28 65.62 0.66 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.492 1.517 . . . . 74.34 109.654 -172.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 32' ' ' ARG . . . . . 0.535 ' HG3' ' H ' ' B' ' 33' ' ' ALA . 14.9 ptp180 -63.99 -73.82 0.11 Allowed 'General case' 0 CA--C 1.558 1.286 0 CA-C-N 113.944 -1.48 . . . . 72.22 113.175 -175.201 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . 0.535 ' H ' ' HG3' ' B' ' 32' ' ' ARG . . . 165.78 -61.05 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 126.11 1.764 . . . . 73.31 108.548 -174.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -157.28 -73.76 0.09 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.81 0.844 . . . . 53.33 111.215 -177.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -77.83 -69.26 0.56 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.257 0.623 . . . . 73.13 110.423 -172.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . 0.407 ' HA2' ' HD3' ' B' ' 32' ' ' ARG . . . -170.65 140.98 6.25 Favored Glycine 0 C--N 1.342 0.889 0 CA-C-O 118.718 -1.045 . . . . 74.33 111.292 -175.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 20.4 t70 69.28 156.46 0.14 Allowed 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 124.342 1.057 . . . . 61.44 111.478 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 50.5 mm -60.92 -59.47 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 123.528 0.731 . . . . 75.44 112.043 -172.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 9.7 t -163.14 179.41 7.49 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.123 0.569 . . . . 73.32 109.959 -177.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.8 114.17 8.98 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 123.576 0.75 . . . . 73.24 110.571 177.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -68.6 102.59 0.87 Allowed 'Trans proline' 0 C--N 1.382 2.32 0 C-N-CA 122.741 2.294 . . . . 72.44 111.605 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -73.2 -64.44 2.52 Favored Glycine 0 C--N 1.34 0.79 0 CA-C-N 115.62 -0.718 . . . . 61.22 112.812 -177.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 62.13 41.72 99.71 Favored Glycine 0 C--N 1.349 1.293 0 N-CA-C 111.134 -0.787 . . . . 64.32 111.134 -172.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -84.84 -173.87 4.96 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.218 1.007 . . . . 63.2 111.356 -175.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.59 32.59 7.08 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.591 1.156 . . . . 74.21 110.353 -179.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 46' ' ' ARG . . . . . 0.513 ' HG3' ' HA ' ' B' ' 236' ' ' THR . 19.6 ttm180 -91.59 45.37 1.23 Allowed 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.857 0.863 . . . . 75.02 110.706 -174.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -86.04 96.71 9.95 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 107.986 -1.116 . . . . 72.13 107.986 177.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 22.6 m 79.65 -45.89 0.33 Allowed 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 125.981 1.713 . . . . 73.12 111.578 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.5 -60.81 4.67 Favored Glycine 0 C--N 1.343 0.943 0 N-CA-C 111.11 -0.796 . . . . 74.15 111.11 -175.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 18.9 t70 61.08 -87.72 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.243 1.417 . . . . 64.2 110.576 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 62.41 16.61 8.76 Favored 'General case' 0 CA--C 1.559 1.324 0 C-N-CA 124.684 1.194 . . . . 75.3 111.782 173.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 52' ' ' THR . . . . . 0.517 ' HB ' ' HB1' ' B' ' 158' ' ' ALA . 22.2 p -134.95 -13.35 2.16 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 112.784 0.661 . . . . 73.31 112.784 -171.31 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.98 81.92 4.36 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 122.907 0.483 . . . . 73.24 111.337 -178.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . 52.42 53.59 12.08 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.962 1.305 . . . . 75.51 112.768 174.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 44.7 tp -75.18 109.41 8.65 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 109.037 -0.727 . . . . 72.35 109.037 175.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . 0.425 HH21 ' HB3' ' B' ' 64' ' ' ALA . 0.3 OUTLIER -64.47 121.03 13.42 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.637 0.775 . . . . 74.21 110.833 -179.839 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -168.25 -79.34 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.467 1.107 . . . . 75.31 108.411 170.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 21.3 m -81.9 89.52 6.37 Favored 'General case' 0 C--N 1.347 0.47 0 N-CA-C 108.599 -0.889 . . . . 62.01 108.599 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . 0.61 ' HA ' ' HB3' ' B' ' 63' ' ' PRO . 57.7 mt 64.5 -78.38 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.053 0 O-C-N 124.646 1.216 . . . . 72.44 111.451 175.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 14.4 m 72.41 -67.65 0.25 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.93 1.692 . . . . 71.31 111.89 172.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . 0.58 ' HB3' ' HB2' ' B' ' 272' ' ' ASN . 10.0 t0 -151.4 -68.61 0.18 Allowed 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 107.974 -1.121 . . . . 71.45 107.974 176.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 62' ' ' LYS . . . . . 0.4 ' HB2' ' HB3' ' B' ' 273' ' ' GLN . 11.3 mptt -118.53 118.24 33.82 Favored Pre-proline 0 N--CA 1.481 1.082 0 N-CA-C 107.645 -1.243 . . . . 72.42 107.645 162.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . 0.61 ' HB3' ' HA ' ' B' ' 59' ' ' LEU . 65.9 Cg_endo -82.24 28.19 0.57 Allowed 'Trans proline' 0 C--N 1.38 2.205 0 C-N-CA 123.277 2.651 . . . . 72.24 113.165 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . 0.614 ' HA ' ' HG2' ' B' ' 273' ' ' GLN . . . 70.92 -15.94 0.37 Allowed 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 125.435 1.494 . . . . 72.04 113.894 -177.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 85.0 tttt 56.31 63.74 1.9 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.964 1.306 . . . . 73.42 110.394 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -85.46 12.41 8.5 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 114.567 -1.197 . . . . 72.41 111.573 -177.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 9.4 tt -69.78 86.53 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.342 0 CA-C-O 121.695 0.759 . . . . 74.04 110.311 178.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 2.2 mp 61.63 -83.77 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.181 0 C-N-CA 125.567 1.547 . . . . 73.4 110.784 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 56.2 tp -178.93 148.35 0.39 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.937 1.295 . . . . 74.34 108.894 -177.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 7.4 mp -69.1 95.1 0.71 Allowed 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 108.614 -0.884 . . . . 65.22 108.614 170.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 2.8 pp -73.05 -23.7 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.747 0.819 . . . . 75.5 111.883 -177.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 131.89 99.05 0.76 Allowed Glycine 0 C--N 1.348 1.243 0 N-CA-C 111.912 -0.475 . . . . 71.15 111.912 178.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -101.21 158.68 15.85 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.149 0.58 . . . . 74.12 109.734 175.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -158.39 61.73 0.32 Allowed Glycine 0 C--N 1.333 0.412 0 N-CA-C 109.774 -1.33 . . . . 72.45 109.774 174.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 24.8 ttt 63.31 36.18 11.89 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-O 122.496 1.141 . . . . 74.01 109.08 -174.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . -91.11 62.86 2.85 Favored Glycine 0 C--N 1.348 1.222 0 CA-C-N 114.699 -1.137 . . . . 71.52 111.973 -175.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -70.62 -33.81 71.42 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.074 0.55 . . . . 74.35 109.74 177.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 92.6 p 50.84 38.35 19.61 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 125.933 1.693 . . . . 55.34 113.172 174.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . 0.484 ' HG3' ' HA ' ' B' ' 111' ' ' LEU . 9.0 tp10 -130.3 90.19 2.9 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 108.732 -0.84 . . . . 74.44 108.732 177.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 33.4 mm 56.01 67.28 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 125.326 1.45 . . . . 72.52 110.581 -177.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 81' ' ' THR . . . . . 0.513 ' HA ' ' CE1' ' B' ' 108' ' ' HIS . 41.2 p -71.74 -29.43 64.52 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 115.744 -0.662 . . . . 74.52 112.161 -176.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 60.9 15.61 6.18 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.559 1.143 . . . . 75.12 112.151 -177.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -104.83 115.17 29.85 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 123.591 0.757 . . . . 74.13 110.225 -172.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 41.4 mmt180 -94.63 132.05 39.76 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.558 0.743 . . . . 73.0 110.482 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . 0.478 HD21 ' HA ' ' B' ' 99' ' ' ALA . 49.4 t-20 -74.25 -83.61 0.05 Allowed 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 107.754 -1.202 . . . . 72.23 107.754 169.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 4.7 t80 60.5 -174.86 0.12 Allowed 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.824 0.849 . . . . 74.21 112.07 169.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.03 -15.91 52.0 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 122.827 0.451 . . . . 52.24 110.496 168.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -74.07 -63.79 1.15 Allowed 'General case' 0 C--N 1.351 0.636 0 C-N-CA 123.78 0.832 . . . . 74.14 110.38 177.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -70.61 -42.48 62.89 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 115.773 -0.649 . . . . 54.33 112.441 -177.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . 56.21 19.26 3.75 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.77 1.228 . . . . 75.53 113.075 176.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -89.78 61.25 3.46 Favored Glycine 0 C--N 1.35 1.325 0 N-CA-C 112.134 -0.386 . . . . 70.11 112.134 -176.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -160.86 -169.82 24.63 Favored Glycine 0 C--N 1.34 0.759 0 N-CA-C 111.953 -0.459 . . . . 73.42 111.953 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -105.64 9.12 33.33 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.406 1.082 . . . . 74.22 111.984 -174.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 54.9 t80 66.91 6.11 4.45 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 124.827 1.251 . . . . 72.14 112.756 174.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -69.87 -12.69 61.81 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 124.376 1.071 . . . . 74.44 113.714 -172.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 94.08 -34.12 4.86 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 112.563 -0.215 . . . . 75.21 112.563 -176.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 14.3 tt -105.76 -0.54 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 123.643 0.777 . . . . 73.0 110.17 178.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -78.18 1.58 20.93 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 125.181 1.392 . . . . 75.21 112.617 -176.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . 0.478 ' HA ' HD21 ' B' ' 85' ' ' ASN . . . -81.03 31.49 0.32 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.015 0.926 . . . . 61.12 111.894 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 91.9 mt -73.15 154.73 90.47 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 124.838 1.255 . . . . 74.2 110.798 -177.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -67.05 83.37 0.34 Allowed 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 122.837 2.358 . . . . 74.43 111.718 173.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 38.4 tp -95.29 -11.22 28.24 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.101 -0.954 . . . . 73.12 109.867 176.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 13.6 t -156.07 170.66 21.66 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.315 0.646 . . . . 75.52 110.399 -176.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . -152.52 146.55 15.25 Favored Glycine 0 C--N 1.344 0.973 0 N-CA-C 111.192 -0.763 . . . . 51.35 111.192 177.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -75.87 89.9 2.92 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.326 0.65 . . . . 75.22 110.084 -178.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 44.1 t80 61.76 -177.24 0.12 Allowed 'General case' 0 CA--C 1.568 1.662 0 C-N-CA 124.348 1.059 . . . . 74.44 111.654 177.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 40.1 m -49.82 121.02 4.77 Favored 'General case' 0 C--N 1.355 0.831 0 C-N-CA 123.847 0.859 . . . . 75.34 110.428 170.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 108' ' ' HIS . . . . . 0.513 ' CE1' ' HA ' ' B' ' 81' ' ' THR . 2.8 m-70 -79.44 98.37 6.76 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 107.069 -1.456 . . . . 73.44 107.069 -176.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -77.61 -30.13 52.2 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 122.455 0.302 . . . . 74.1 110.972 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.35 -69.07 0.24 Allowed 'General case' 0 N--CA 1.477 0.911 0 O-C-N 123.776 0.673 . . . . 75.22 111.11 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . 0.484 ' HA ' ' HG3' ' B' ' 79' ' ' GLU . 94.5 mt 48.67 -87.59 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.955 1.302 . . . . 70.25 111.818 -179.147 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -169.18 114.72 0.57 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.159 1.384 . . . . 73.2 107.721 177.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 113' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp 70.65 7.34 6.18 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 124.749 1.22 . . . . 75.13 112.207 -175.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt 62.42 -76.96 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.501 1.521 . . . . 74.21 112.514 -178.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 14.2 t -129.6 12.26 5.85 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.402 0.681 . . . . 73.23 110.498 -177.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -91.17 13.44 66.31 Favored Glycine 0 C--N 1.35 1.312 0 CA-C-N 116.616 -0.266 . . . . 55.33 113.087 177.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . 0.53 ' HB3' ' HD3' ' B' ' 118' ' ' PRO . 6.6 tmtm? -164.03 -52.12 0.01 OUTLIER Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 124.55 1.14 . . . . 75.35 108.118 -178.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 118' ' ' PRO . . . . . 0.53 ' HD3' ' HB3' ' B' ' 117' ' ' LYS . 12.1 Cg_endo -94.08 66.83 0.38 Allowed 'Trans proline' 0 C--N 1.385 2.464 0 C-N-CA 122.265 1.977 . . . . 63.21 109.368 169.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 119' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -56.62 99.41 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 113.957 -1.474 . . . . 75.33 112.265 -167.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 120' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -90.33 -43.3 10.44 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.561 0.745 . . . . 70.1 110.498 -176.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 7.9 p -63.16 -42.37 96.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 123.003 0.521 . . . . 74.32 111.297 -176.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 81.7 p -88.63 94.33 9.86 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 108.976 -0.749 . . . . 75.25 108.976 173.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 54.56 -85.81 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 125.542 1.537 . . . . 70.53 112.815 178.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 57.1 p -172.85 28.64 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.1 0.96 . . . . 61.03 109.993 -172.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . 63.54 30.52 15.12 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.741 1.217 . . . . 74.53 110.955 -173.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -82.11 143.37 31.53 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.956 0.902 . . . . 74.13 111.52 -177.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 50.2 m -139.03 143.16 38.31 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.816 0.846 . . . . 70.01 109.956 176.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -139.39 179.15 6.71 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.791 0.836 . . . . 74.33 111.102 -172.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 20.2 m 76.63 -51.75 0.58 Allowed 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 126.027 1.731 . . . . 74.41 112.106 -178.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . -55.94 142.29 36.23 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.3 1.04 . . . . 61.42 112.078 177.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 66.4 p-90 -63.57 -22.86 67.13 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.48 0.712 . . . . 73.51 112.286 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 50.1 p -77.76 -54.18 6.65 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.034 0.934 . . . . 74.11 112.326 -175.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 73.7 p -104.67 -24.84 12.9 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.434 0.694 . . . . 74.52 112.0 -173.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . -72.96 -0.77 53.43 Favored Glycine 0 N--CA 1.476 1.309 0 CA-C-N 115.921 -0.581 . . . . 55.15 114.281 -177.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 135' ' ' VAL . . . . . . . . . . . . . 16.8 m -97.14 21.02 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.118 0 C-N-CA 124.214 1.006 . . . . 73.24 110.286 170.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 136' ' ' LYS . . . . . 0.461 ' O ' ' HB3' ' B' ' 59' ' ' LEU . 87.1 tttt 67.98 108.99 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 125.448 1.499 . . . . 74.24 111.683 177.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 137' ' ' THR . . . . . 0.52 ' HA ' HD13 ' B' ' 59' ' ' LEU . 11.0 p -80.04 50.84 1.27 Allowed 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.119 0.968 . . . . 75.31 112.245 -179.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 62.2 t80 62.98 -76.3 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.442 1.497 . . . . 75.52 110.306 -175.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 59.18 -82.82 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 125.111 1.364 . . . . 73.24 113.321 171.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . 98.07 -149.18 19.12 Favored Glycine 0 C--N 1.351 1.406 0 N-CA-C 111.049 -0.82 . . . . 75.54 111.049 -170.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -80.43 85.92 5.83 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 122.961 0.504 . . . . 75.34 109.887 178.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . 0.417 HD13 HD11 ' B' ' 146' ' ' ILE . 0.7 OUTLIER -86.64 20.57 2.47 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.868 0.867 . . . . 74.24 112.468 -174.153 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 101.71 -46.79 1.23 Allowed Glycine 0 C--N 1.346 1.098 0 N-CA-C 111.576 -0.61 . . . . 61.25 111.576 -178.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 3.6 t -92.8 34.57 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 CA-C-O 121.817 0.818 . . . . 75.31 109.479 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 60.61 -98.4 0.08 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.271 1.428 . . . . 75.32 111.427 -178.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . 0.417 HD11 HD13 ' B' ' 142' ' ' LEU . 34.1 mt 50.91 52.39 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 CA-C-O 122.51 1.148 . . . . 72.52 109.702 -175.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -67.94 -80.5 0.04 OUTLIER 'General case' 0 C--N 1.358 0.965 0 CA-C-N 114.116 -1.402 . . . . 72.43 110.769 -176.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -176.74 121.39 0.14 Allowed 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 107.491 -1.3 . . . . 75.05 107.491 -174.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 149' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm 54.99 31.21 15.59 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 123.692 0.797 . . . . 74.13 110.307 -163.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -130.6 129.55 42.87 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.633 1.173 . . . . 74.11 108.635 -173.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 39.1 m80 69.38 165.22 0.13 Allowed Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 124.452 1.095 . . . . 74.43 111.267 -170.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -58.88 -171.82 0.05 OUTLIER 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 122.55 2.167 . . . . 64.13 112.767 166.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 1.4 t 56.45 -159.55 0.23 Allowed 'General case' 0 CA--C 1.568 1.637 0 C-N-CA 124.698 1.199 . . . . 74.2 110.916 -176.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 154' ' ' ILE . . . . . 0.416 ' HA ' ' HB2' ' B' ' 136' ' ' LYS . 64.5 mt 74.76 -75.55 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 C-N-CA 124.747 1.219 . . . . 74.25 110.157 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 155' ' ' LEU . . . . . 0.613 HD21 ' H ' ' B' ' 155' ' ' LEU . 2.1 pt? -90.54 -27.52 19.11 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 108.765 -0.828 . . . . 73.12 108.765 172.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 64.84 28.79 12.76 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 125.084 1.353 . . . . 72.23 111.63 168.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 157' ' ' MET . . . . . . . . . . . . . 84.9 mtp 58.62 24.05 11.62 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 124.19 0.996 . . . . 61.13 111.21 -176.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 158' ' ' ALA . . . . . 0.517 ' HB1' ' HB ' ' B' ' 52' ' ' THR . . . 68.43 -69.92 0.14 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.003 1.721 . . . . 65.11 113.268 179.136 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 12.0 mptt 66.1 -166.51 0.22 Allowed 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 124.681 1.192 . . . . 73.24 110.047 -166.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 160' ' ' ALA . . . . . 0.673 ' HA ' ' HA ' ' B' ' 230' ' ' ALA . . . 65.84 -156.98 0.27 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.912 0.885 . . . . 74.34 111.588 176.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . 78.35 -60.99 0.39 Allowed 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 125.333 1.453 . . . . 71.1 112.503 176.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . -74.78 -5.81 75.74 Favored Glycine 0 CA--C 1.535 1.309 0 N-CA-C 114.902 0.721 . . . . 73.4 114.902 -175.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . 0.532 ' HG ' HD13 ' B' ' 226' ' ' LEU . 2.7 tm? -167.13 155.67 9.88 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 108.981 -0.748 . . . . 75.25 108.981 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 164' ' ' ALA . . . . . . . . . . . . . . . -131.68 133.54 44.98 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.112 0.965 . . . . 75.34 109.82 -178.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 20.1 p -119.79 -66.31 1.08 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.015 0.526 . . . . 73.14 111.084 176.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.35 -178.59 53.83 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-O 119.775 -0.458 . . . . 74.53 112.826 -174.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 167' ' ' ASN . . . . . . . . . . . . . 7.5 t30 57.05 95.47 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 125.361 1.464 . . . . 74.33 112.062 -178.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . 0.501 HG23 ' H ' ' B' ' 174' ' ' GLN . 7.5 t 59.62 50.17 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 C-N-CA 124.991 1.316 . . . . 75.53 109.507 -177.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 31.3 t -142.95 -45.38 0.3 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.456 -0.793 . . . . 65.53 111.9 -172.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 170' ' ' THR . . . . . 0.647 ' HB ' ' HB3' ' B' ' 231' ' ' LYS . 9.4 t -110.13 -43.43 3.95 Favored 'General case' 0 N--CA 1.478 0.969 0 O-C-N 122.163 -0.336 . . . . 73.13 111.848 -175.229 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -164.29 -42.57 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 122.425 0.29 . . . . 73.41 111.382 -173.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 172' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.34 120.95 12.0 Favored 'General case' 0 CA--C 1.555 1.142 0 O-C-N 123.69 0.619 . . . . 75.25 110.614 -178.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 173' ' ' LEU . . . . . . . . . . . . . 4.6 tt -107.67 102.51 11.74 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 108.492 -0.929 . . . . 74.44 108.492 -173.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 174' ' ' GLN . . . . . 0.501 ' H ' HG23 ' B' ' 168' ' ' VAL . 0.9 OUTLIER -102.29 99.03 9.08 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 107.584 -1.265 . . . . 74.45 107.584 177.415 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 175' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -122.67 18.12 10.34 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.688 0.795 . . . . 74.1 109.723 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . 57.94 87.05 0.07 Allowed 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.665 1.186 . . . . 74.11 110.715 -172.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 177' ' ' THR . . . . . 0.403 HG22 ' HG3' ' C' ' 129' ' ' GLU . 15.2 t -71.8 -31.9 1.94 Allowed Pre-proline 0 CA--C 1.574 1.889 0 CA-C-O 117.287 -1.339 . . . . 74.15 113.923 -178.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 178' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -86.29 -163.81 0.19 Allowed 'Trans proline' 0 C--N 1.402 3.373 0 CA-C-N 122.875 2.062 . . . . 74.53 111.957 174.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -52.24 -51.61 57.33 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.465 0.706 . . . . 74.35 109.979 171.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . -176.92 -57.57 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 105.869 -1.9 . . . . 75.32 105.869 170.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 46.1 tp -142.75 123.18 13.95 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 106.35 -1.722 . . . . 74.44 106.35 163.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 182' ' ' VAL . . . . . 0.685 ' HB ' ' HB2' ' C' ' 123' ' ' LEU . 69.5 t -68.67 131.94 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.064 0.546 . . . . 72.43 110.817 -172.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -119.54 16.78 12.91 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.767 0.827 . . . . 65.24 112.264 -172.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 28.5 m-70 -62.18 100.39 0.17 Allowed 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 122.789 0.436 . . . . 75.32 111.138 -178.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 185' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' C' ' 121' ' ' ALA . 60.6 t -68.04 151.63 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.826 0.851 . . . . 74.01 110.102 177.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 186' ' ' THR . . . . . 0.471 ' HB ' ' HG2' ' C' ' 122' ' ' GLU . 15.0 t -125.87 172.25 10.04 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.889 0.875 . . . . 60.24 110.576 -177.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 187' ' ' SER . . . . . . . . . . . . . 20.7 m -83.93 134.35 34.67 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.824 0.85 . . . . 62.14 112.437 -170.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 188' ' ' ARG . . . . . 0.438 ' HD3' ' HD2' ' C' ' 120' ' ' ARG . 59.8 ttt85 -173.61 160.95 3.87 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.828 1.251 . . . . 72.32 108.739 177.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -141.31 112.9 7.61 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 108.726 -0.842 . . . . 72.52 108.726 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 190' ' ' CYS . . . . . . . . . . . . . 6.8 p -177.35 -176.89 0.66 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.806 1.242 . . . . 70.33 109.878 173.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -163.79 168.97 18.96 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.654 1.182 . . . . 74.04 109.511 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . 0.622 ' HA3' HD22 ' B' ' 203' ' ' ASN . . . -80.79 147.67 28.11 Favored Glycine 0 CA--C 1.54 1.624 0 CA-C-O 118.835 -0.981 . . . . 64.22 113.025 -179.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 193' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -52.63 -44.55 46.69 Favored 'Trans proline' 0 C--N 1.382 2.34 0 C-N-CA 124.609 3.539 . . . . 73.22 115.491 -173.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 194' ' ' SER . . . . . . . . . . . . . 9.0 m 78.33 88.16 0.07 Allowed 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 125.382 1.473 . . . . 63.44 112.509 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 195' ' ' ALA . . . . . . . . . . . . . . . -162.05 106.19 1.2 Allowed 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 123.606 0.762 . . . . 74.32 110.613 178.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 196' ' ' THR . . . . . 0.586 HG23 ' H ' ' B' ' 197' ' ' SER . 2.2 m 60.86 -150.06 0.41 Allowed 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 124.821 1.248 . . . . 73.32 110.793 174.309 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 197' ' ' SER . . . . . 0.586 ' H ' HG23 ' B' ' 196' ' ' THR . 37.3 m -58.0 104.6 0.21 Allowed 'General case' 0 C--N 1.363 1.186 0 CA-C-N 119.245 0.93 . . . . 75.11 109.676 172.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 198' ' ' GLU . . . . . 0.538 ' HG3' ' HD3' ' B' ' 201' ' ' PRO . 35.8 tp10 -69.8 -24.45 63.49 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 113.714 1.005 . . . . 65.14 113.714 -163.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt 69.43 2.64 3.81 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 124.265 1.026 . . . . 75.14 112.925 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 200' ' ' CYS . . . . . 0.463 ' HB3' ' HA2' ' C' ' 172' ' ' GLY . 69.8 m 60.71 79.36 0.29 Allowed Pre-proline 0 CA--C 1.566 1.59 0 C-N-CA 124.261 1.024 . . . . 73.31 112.453 177.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 201' ' ' PRO . . . . . 0.538 ' HD3' ' HG3' ' B' ' 198' ' ' GLU . 29.1 Cg_endo -97.88 16.96 0.56 Allowed 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 123.788 2.992 . . . . 74.02 112.963 177.228 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 116.95 79.59 0.74 Allowed Glycine 0 C--N 1.338 0.672 0 N-CA-C 110.745 -0.942 . . . . 73.41 110.745 -173.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 203' ' ' ASN . . . . . 0.622 HD22 ' HA3' ' B' ' 192' ' ' GLY . 18.8 m120 -144.41 -138.52 0.1 Allowed 'General case' 0 CA--C 1.572 1.822 0 C-N-CA 123.942 0.897 . . . . 71.33 109.441 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 204' ' ' ALA . . . . . 0.919 ' HA ' ' HA3' ' C' ' 166' ' ' GLY . . . -74.34 -172.13 1.36 Allowed 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 115.585 1.698 . . . . 74.01 115.585 -169.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 205' ' ' LEU . . . . . 0.535 ' HG ' ' NH1' ' C' ' 143' ' ' ARG . 0.5 OUTLIER -83.76 -92.73 0.07 Allowed 'General case' 0 CA--C 1.578 2.021 0 C-N-CA 124.962 1.305 . . . . 72.44 112.047 -165.182 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 206' ' ' GLU . . . . . 0.41 ' HG2' ' HZ ' ' C' ' 88' ' ' PHE . 6.0 tp10 2.47 93.32 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 128.346 2.658 . . . . 70.3 117.193 -157.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm 52.3 -176.87 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 125.574 1.55 . . . . 74.32 114.613 165.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . -115.99 -59.53 0.33 Allowed Glycine 0 C--N 1.339 0.697 0 N-CA-C 110.258 -1.137 . . . . 71.52 110.258 169.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 124.73 -168.41 16.85 Favored Glycine 0 C--N 1.341 0.842 0 CA-C-O 119.372 -0.682 . . . . 63.34 111.582 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp 69.07 -64.28 0.34 Allowed 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 125.492 1.517 . . . . 74.51 113.113 176.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . -53.92 103.64 0.18 Allowed Glycine 0 C--N 1.356 1.662 0 O-C-N 123.409 0.443 . . . . 74.43 112.62 177.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 48.9 m -110.76 -2.87 16.02 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.788 1.235 . . . . 74.04 111.635 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 21.8 pt -82.05 116.98 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-O 121.219 0.533 . . . . 70.12 110.661 179.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 37.0 p -143.05 -38.79 0.34 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.624 1.17 . . . . 75.43 109.085 174.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 215' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -58.98 -48.69 80.64 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.709 0.804 . . . . 73.31 110.45 179.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 46.32 29.84 0.92 Allowed 'General case' 0 N--CA 1.5 2.044 0 C-N-CA 126.238 1.815 . . . . 61.42 113.588 172.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 64.3 tp -71.57 88.89 0.95 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.541 0.736 . . . . 75.4 111.029 -173.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . 0.471 HD22 ' N ' ' B' ' 221' ' ' ARG . 1.8 tt 75.58 -48.76 0.61 Allowed 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 126.336 1.854 . . . . 71.43 111.086 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 39.4 t30 76.92 -66.3 0.25 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 126.2 1.8 . . . . 71.24 110.164 178.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -60.06 -23.93 64.15 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.884 0.874 . . . . 74.3 112.473 177.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 221' ' ' ARG . . . . . 0.471 ' N ' HD22 ' B' ' 218' ' ' LEU . 26.1 mmt180 67.62 6.34 4.94 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 124.69 1.196 . . . . 73.55 112.819 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -172.71 165.85 5.39 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.72 1.208 . . . . 75.21 109.999 -178.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 71.15 -69.02 0.19 Allowed 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 125.737 1.615 . . . . 72.13 112.485 173.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 41.0 t 70.07 -73.45 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 125.777 1.631 . . . . 75.32 110.217 -175.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 8.8 t -144.81 13.85 1.51 Allowed 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.936 0.895 . . . . 73.55 110.043 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . 0.532 HD13 ' HG ' ' B' ' 163' ' ' LEU . 8.4 mp 67.83 -74.97 0.07 Allowed 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 125.647 1.579 . . . . 74.43 110.56 -177.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . -133.35 -5.14 3.03 Favored Glycine 0 N--CA 1.476 1.303 0 C-N-CA 122.946 0.308 . . . . 71.24 113.249 177.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 90.64 165.93 40.66 Favored Glycine 0 C--N 1.345 1.063 0 CA-C-N 116.562 0.181 . . . . 72.41 112.998 -179.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . 61.9 60.63 7.75 Favored Glycine 0 C--N 1.347 1.175 0 O-C-N 123.881 0.401 . . . . 71.04 112.489 -178.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . 0.673 ' HA ' ' HA ' ' B' ' 160' ' ' ALA . . . -147.05 104.62 3.7 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.261 0.625 . . . . 70.23 109.555 -172.24 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 231' ' ' LYS . . . . . 0.647 ' HB3' ' HB ' ' B' ' 170' ' ' THR . 0.0 OUTLIER -120.37 -51.38 2.19 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.247 0.619 . . . . 73.24 112.466 -165.039 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 72.9 p -66.62 129.14 38.86 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.312 0.645 . . . . 74.24 112.2 -168.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -77.28 129.72 36.24 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.87 0.868 . . . . 71.44 109.431 178.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -110.29 81.86 1.5 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.131 0.572 . . . . 72.31 112.517 -171.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -134.79 76.96 1.66 Allowed 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 106.779 -1.563 . . . . 64.41 106.779 165.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 236' ' ' THR . . . . . 0.513 ' HA ' ' HG3' ' B' ' 46' ' ' ARG . 63.5 m 71.04 -67.14 0.26 Allowed 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 124.837 1.255 . . . . 73.34 109.014 -164.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -133.07 -163.73 1.39 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.849 1.26 . . . . 73.03 107.628 170.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 90.8 m -75.14 -16.24 60.54 Favored 'General case' 0 CA--C 1.56 1.348 0 C-N-CA 123.185 0.594 . . . . 71.31 110.148 170.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -88.95 168.1 12.66 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 113.88 1.067 . . . . 74.42 113.88 -176.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 240' ' ' GLY . . . . . 0.487 ' H ' HD21 ' C' ' 235' ' ' LEU . . . -102.44 -118.79 4.48 Favored Glycine 0 C--N 1.34 0.766 0 CA-C-N 112.94 -1.936 . . . . 71.23 110.543 176.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -161.11 -179.49 7.53 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-O 121.705 0.764 . . . . 71.23 110.334 174.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 242' ' ' TRP . . . . . 0.401 ' CZ3' HG23 ' C' ' 253' ' ' VAL . 2.6 m0 -106.17 -52.57 2.78 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 106.468 -1.678 . . . . 70.32 106.468 174.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 179.76 -152.13 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.139 0 CA-C-N 112.987 -1.915 . . . . 74.22 107.802 -167.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -62.02 116.31 9.18 Favored Glycine 0 CA--C 1.542 1.751 0 CA-C-N 117.785 0.266 . . . . 71.54 113.629 175.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? -105.8 105.59 15.69 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.052 0.941 . . . . 75.34 108.886 179.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 21.8 m -76.71 143.71 39.81 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 109.116 -0.698 . . . . 71.14 109.116 171.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 247' ' ' LEU . . . . . . . . . . . . . 3.9 pp -116.41 137.24 52.32 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 119.464 1.029 . . . . 72.51 111.861 178.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 248' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 177.12 94.73 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 126.433 1.893 . . . . 75.15 107.236 172.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.77 -39.22 90.89 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.563 1.145 . . . . 71.33 112.66 -179.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 172.29 -76.95 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.519 1.128 . . . . 70.14 109.913 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 251' ' ' ALA . . . . . . . . . . . . . . . -168.46 49.71 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.437 1.095 . . . . 64.21 108.766 -170.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . 0.555 HE21 ' HB3' ' B' ' 367' ' ' LEU . 22.9 tt0 -68.45 -10.92 58.57 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 114.636 -1.165 . . . . 73.12 111.582 -178.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 253' ' ' ALA . . . . . 0.528 ' HA ' HD11 ' B' ' 367' ' ' LEU . . . -56.56 -33.51 66.21 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.405 0.682 . . . . 51.41 110.709 172.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 28.6 tpt180 -84.97 141.93 29.99 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 123.031 0.532 . . . . 72.51 110.489 173.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . 141.05 -86.94 0.19 Allowed Glycine 0 C--N 1.351 1.374 0 N-CA-C 111.465 -0.654 . . . . 63.32 111.465 177.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 256' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 63.12 -78.02 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 125.569 1.548 . . . . 71.2 112.36 177.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -68.2 -27.22 66.2 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.644 0.778 . . . . 74.31 110.545 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 258' ' ' LEU . . . . . . . . . . . . . 6.0 tt 68.55 -77.92 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 125.67 1.588 . . . . 75.13 108.37 -175.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . 0.515 ' HA ' ' HG3' ' B' ' 357' ' ' PRO . 8.3 p -88.85 155.3 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 C-N-CA 123.55 0.74 . . . . 63.31 110.016 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 260' ' ' SER . . . . . . . . . . . . . 48.0 m -73.91 85.65 1.75 Allowed 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 122.665 0.386 . . . . 73.11 110.633 176.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 26.7 t70 59.46 -86.52 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 125.306 1.442 . . . . 65.51 112.502 176.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 262' ' ' ALA . . . . . . . . . . . . . . . -118.82 131.1 56.08 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.903 0.881 . . . . 75.22 110.659 -174.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -162.24 -32.19 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.79 0.836 . . . . 70.44 110.486 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 20.6 t 74.88 -69.62 0.17 Allowed 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 125.41 1.484 . . . . 51.14 111.327 174.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 265' ' ' LEU . . . . . . . . . . . . . 2.9 pp -122.19 5.34 9.75 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.977 0.911 . . . . 73.31 110.444 173.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 266' ' ' ASN . . . . . 0.426 ' ND2' ' H ' ' B' ' 267' ' ' SER 0.255 2.1 p-10 47.35 -76.87 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 126.634 1.974 . . . . 71.52 113.374 -166.092 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 267' ' ' SER . . . . . 0.426 ' H ' ' ND2' ' B' ' 266' ' ' ASN . 36.8 p -164.41 22.39 0.06 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.651 0.78 . . . . 73.13 109.71 -173.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 28.7 m -140.36 162.94 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.684 0.794 . . . . 74.44 110.106 -174.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 269' ' ' THR . . . . . . . . . . . . . 12.1 p -140.84 22.61 2.28 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.838 0.855 . . . . 74.31 109.744 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 270' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -102.76 101.38 11.46 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.404 0.681 . . . . 72.41 111.306 -175.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 271' ' ' ALA . . . . . . . . . . . . . . . -78.29 -35.14 48.34 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.312 0.645 . . . . 75.3 110.432 169.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 272' ' ' ASN . . . . . 0.58 ' HB2' ' HB3' ' B' ' 61' ' ' ASP . 41.3 m-80 -127.47 137.64 52.73 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.775 0.83 . . . . 73.11 109.722 178.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 273' ' ' GLN . . . . . 0.614 ' HG2' ' HA ' ' B' ' 64' ' ' ALA . 7.3 tp-100 63.82 138.13 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 125.533 1.533 . . . . 73.43 112.413 -173.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 72.7 -61.83 0.49 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.439 1.496 . . . . 71.44 109.997 -176.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 275' ' ' LYS . . . . . 0.419 ' HE3' ' HA ' ' B' ' 272' ' ' ASN . 92.4 mttt 45.79 47.66 4.32 Favored Pre-proline 0 N--CA 1.486 1.326 0 C-N-CA 125.264 1.426 . . . . 72.14 111.471 175.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -74.09 90.53 0.97 Allowed 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 122.357 2.038 . . . . 73.04 111.106 -166.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 277' ' ' LEU . . . . . . . . . . . . . 75.3 mt -106.29 7.9 31.58 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 114.719 -1.128 . . . . 74.52 109.311 175.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 90.8 mt -98.87 131.7 44.77 Favored 'General case' 0 C--N 1.351 0.634 0 C-N-CA 123.962 0.905 . . . . 72.2 109.655 177.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . -129.44 38.12 2.06 Favored Glycine 0 C--N 1.332 0.343 0 N-CA-C 109.276 -1.53 . . . . 75.43 109.276 176.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 88.5 mt -55.8 -40.72 73.08 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.622 1.169 . . . . 74.31 110.523 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -136.38 144.27 44.46 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 108.365 -0.976 . . . . 75.31 108.365 172.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -126.24 167.48 15.39 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.505 0.722 . . . . 65.41 111.258 -176.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 70.01 -72.99 0.1 Allowed 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 125.6 1.56 . . . . 72.33 111.726 175.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . -78.38 74.27 2.1 Favored Glycine 0 C--N 1.351 1.38 0 C-N-CA 122.546 0.117 . . . . 72.13 113.35 -177.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -135.16 -71.02 0.48 Allowed 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.765 -0.828 . . . . 73.03 108.765 178.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 286' ' ' MET . . . . . . . . . . . . . 96.5 mmm -92.61 -45.48 0.33 Allowed Pre-proline 0 N--CA 1.486 1.342 0 CA-C-O 118.788 -0.625 . . . . 74.22 110.647 175.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 287' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -87.06 -170.05 0.57 Allowed 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 121.673 1.582 . . . . 74.24 112.012 165.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 288' ' ' VAL . . . . . . . . . . . . . 38.6 t 62.05 -84.53 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 125.198 1.399 . . . . 74.32 110.096 -174.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 289' ' ' ARG . . . . . . . . . . . . . 52.5 ttp180 53.81 87.14 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.085 1.354 . . . . 74.32 111.735 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 290' ' ' TRP . . . . . . . . . . . . . 42.9 p90 -76.81 159.0 30.45 Favored 'General case' 0 C--O 1.246 0.878 0 C-N-CA 122.779 0.432 . . . . 75.34 110.006 175.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 291' ' ' LEU . . . . . . . . . . . . . 9.2 mp -77.86 -47.72 18.13 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.967 0.507 . . . . 73.52 109.852 -178.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . 121.46 -73.33 0.36 Allowed Glycine 0 CA--C 1.533 1.17 0 CA-C-O 119.42 -0.656 . . . . 71.42 111.994 -176.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 293' ' ' PRO . . . . . 0.475 ' HG3' ' SD ' ' B' ' 464' ' ' MET . 6.2 Cg_exo -75.78 108.45 2.69 Favored 'Trans proline' 0 C--N 1.383 2.381 0 C-N-CA 122.405 2.07 . . . . 75.13 111.247 179.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -61.64 -41.13 97.07 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 109.109 -0.701 . . . . 74.44 109.109 173.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -129.26 113.41 14.98 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.24 -0.891 . . . . 71.35 108.605 168.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 75.2 m -73.51 83.78 1.51 Allowed 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 109.11 -0.7 . . . . 71.52 109.11 175.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -158.13 140.7 14.55 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 114.825 -1.08 . . . . 75.44 108.734 -179.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 22.3 m170 -135.93 -172.24 3.06 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.741 1.216 . . . . 73.43 109.456 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . 72.37 34.36 60.76 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.074 -0.81 . . . . 72.35 111.074 -168.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -149.72 -42.48 0.14 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.076 0.55 . . . . 72.23 111.954 -175.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 301' ' ' ILE . . . . . . . . . . . . . 14.9 tt -128.61 16.55 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-O 121.974 0.892 . . . . 75.13 110.833 -170.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -81.27 -24.88 37.0 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.805 0.842 . . . . 74.32 111.737 -172.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 303' ' ' LYS . . . . . 0.596 ' HZ1' ' HB2' ' B' ' 303' ' ' LYS . 4.7 ttmp? 62.13 83.34 0.21 Allowed Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 124.791 1.237 . . . . 74.11 110.49 -175.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 304' ' ' PRO . . . . . 0.699 ' HA ' ' HB ' ' B' ' 307' ' ' THR . 33.5 Cg_exo -61.37 -10.44 15.96 Favored 'Trans proline' 0 C--N 1.383 2.367 0 C-N-CA 123.533 2.822 . . . . 75.12 113.939 178.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -62.05 -40.07 94.5 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.586 0.755 . . . . 72.13 111.24 172.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 34.7 m -121.67 33.02 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 123.619 0.768 . . . . 72.33 110.054 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 307' ' ' THR . . . . . 0.699 ' HB ' ' HA ' ' B' ' 304' ' ' PRO . 8.9 t -58.01 -31.68 67.2 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.512 1.125 . . . . 74.23 113.424 -176.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 308' ' ' CYS . . . . . . . . . . . . . 49.7 t -86.84 -28.7 22.74 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.185 0.594 . . . . 74.22 110.562 177.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 309' ' ' THR . . . . . 0.435 ' HB ' ' HD3' ' B' ' 310' ' ' PRO 0.261 36.5 m 105.1 -62.93 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.867 0 C-N-CA 128.19 2.596 . . . . 72.2 111.825 -174.405 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 310' ' ' PRO . . . . . 0.435 ' HD3' ' HB ' ' B' ' 309' ' ' THR . 37.5 Cg_exo -60.98 114.97 2.4 Favored 'Trans proline' 0 C--N 1.393 2.908 0 CA-C-N 122.232 1.833 . . . . 64.44 113.612 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 311' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -78.7 -34.02 0.95 Allowed Pre-proline 0 CA--C 1.57 1.742 0 CA-C-O 116.949 -1.5 . . . . 73.13 114.644 176.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 312' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -75.78 75.57 3.99 Favored 'Trans proline' 0 C--N 1.404 3.474 0 CA-C-N 123.186 2.173 . . . . 70.14 112.465 -175.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 313' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -50.15 -46.87 54.35 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.892 1.677 . . . . 75.13 112.049 -171.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 314' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 -70.56 82.54 0.59 Allowed 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.159 0.984 . . . . 74.53 112.18 -176.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 315' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -161.86 43.96 0.15 Allowed 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 122.593 1.187 . . . . 75.34 107.858 178.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 316' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -148.53 -42.79 0.15 Allowed 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 114.439 -1.255 . . . . 74.4 112.087 -164.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 51.1 m 56.99 33.88 24.04 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 124.144 0.978 . . . . 75.41 111.446 -176.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 318' ' ' VAL . . . . . . . . . . . . 0.253 7.4 p 36.83 87.21 0.12 Allowed Pre-proline 0 CA--C 1.564 1.493 0 C-N-CA 126.706 2.002 . . . . 73.13 112.281 -167.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 319' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -64.77 -26.1 60.5 Favored 'Trans proline' 0 C--N 1.388 2.655 0 C-N-CA 123.274 2.649 . . . . 65.1 113.293 -173.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 320' ' ' THR . . . . . . . . . . . . . 19.3 m 59.74 80.76 0.19 Allowed 'General case' 0 C--N 1.354 0.768 0 O-C-N 124.612 1.195 . . . . 73.24 109.363 -173.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 321' ' ' LEU . . . . . . . . . . . . . 60.4 mt -64.25 -55.8 19.0 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 114.858 -1.065 . . . . 74.43 110.213 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 322' ' ' ALA . . . . . . . . . . . . . . . 56.75 22.66 7.13 Favored 'General case' 0 CA--C 1.553 1.091 0 CA-C-N 114.677 -1.147 . . . . 64.54 110.933 -172.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 323' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -77.45 76.46 3.99 Favored 'General case' 0 C--N 1.359 0.991 0 C-N-CA 123.834 0.854 . . . . 74.02 109.554 -178.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 324' ' ' MET . . . . . . . . . . . . . 21.9 ptp -103.54 -21.94 13.69 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.147 0.979 . . . . 74.22 110.366 -178.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 325' ' ' THR . . . . . . . . . . . . . 31.9 m -75.98 97.06 3.9 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.137 0.575 . . . . 72.33 110.224 178.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 326' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -67.34 136.09 54.28 Favored 'General case' 0 C--N 1.351 0.649 0 C-N-CA 123.272 0.629 . . . . 72.01 110.091 175.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -134.43 17.48 3.67 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.062 0.945 . . . . 75.41 109.541 178.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 328' ' ' ALA . . . . . . . . . . . . . . . -99.95 -44.43 6.04 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.405 -0.816 . . . . 72.03 111.173 -175.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 329' ' ' ILE . . . . . . . . . . . . . 35.5 mm 61.73 81.8 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 C-N-CA 124.776 1.23 . . . . 73.5 109.348 -175.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 330' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 71.41 137.81 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 126.189 1.796 . . . . 74.44 111.211 -176.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 331' ' ' LEU . . . . . 0.491 HD12 ' HA ' ' B' ' 438' ' ' GLN . 50.3 tp -70.0 -58.68 3.55 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.564 -0.744 . . . . 64.42 110.227 -179.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 332' ' ' LEU . . . . . 0.438 HD22 ' HG ' ' B' ' 331' ' ' LEU . 4.1 mm? -106.86 -147.47 0.41 Allowed 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 108.348 -0.982 . . . . 74.41 108.348 171.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 333' ' ' SER . . . . . 0.433 ' HB2' ' OE1' ' B' ' 457' ' ' GLN . 8.7 t 82.92 24.84 0.14 Allowed 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 125.361 1.464 . . . . 65.04 110.867 174.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -97.43 24.96 6.04 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.045 0.938 . . . . 65.35 110.419 178.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 335' ' ' ASN . . . . . . . . . . . . . 60.7 t30 57.19 69.58 0.73 Allowed 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.853 0.861 . . . . 74.12 109.726 179.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 17.0 mp0 -57.56 -68.1 0.27 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.595 1.158 . . . . 73.55 110.884 -170.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 337' ' ' LYS . . . . . 0.409 ' HD2' ' HB2' ' B' ' 447' ' ' HIS . 22.3 ttmm 174.0 141.13 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 125.352 1.461 . . . . 71.1 108.798 167.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 338' ' ' GLY . . . . . . . . . . . . . . . -79.38 5.98 58.65 Favored Glycine 0 CA--C 1.536 1.355 0 CA-C-O 119.234 -0.759 . . . . 73.12 114.96 -177.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 339' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -156.28 147.22 22.07 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 118.289 1.044 . . . . 74.33 111.019 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 340' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -131.56 -71.22 0.56 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.156 0.582 . . . . 75.24 111.091 -175.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 341' ' ' LEU . . . . . . . . . . . . . 1.7 pp -64.58 -25.8 68.13 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 112.473 0.545 . . . . 75.34 112.473 -171.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 342' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 74.2 -15.48 0.6 Allowed 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 125.565 1.546 . . . . 74.32 112.171 172.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 343' ' ' VAL . . . . . . . . . . . . . 13.3 t 60.46 32.92 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.42 0 C-N-CA 124.444 1.098 . . . . 65.15 108.394 -167.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -62.66 130.68 46.08 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.312 1.045 . . . . 74.33 110.786 -176.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 345' ' ' GLY . . . . . . . . . . . . . . . -147.55 -21.03 0.09 OUTLIER Glycine 0 C--N 1.345 1.043 0 O-C-N 123.406 0.441 . . . . 63.14 113.161 -175.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 346' ' ' ALA . . . . . . . . . . . . . . . -73.77 151.94 40.48 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 117.362 0.581 . . . . 72.51 111.784 -177.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 19.9 t 77.29 -43.88 0.43 Allowed 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 126.068 1.747 . . . . 72.21 112.239 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 61.1 mt -85.2 -42.73 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.829 0.852 . . . . 73.42 110.312 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 349' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 64.67 -82.51 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.676 1.59 . . . . 71.13 110.881 -173.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 350' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -129.23 -87.41 0.53 Allowed 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.001 -0.74 . . . . 74.52 109.001 178.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 48.26 85.16 0.03 OUTLIER 'General case' 0 C--N 1.362 1.151 0 C-N-CA 124.452 1.101 . . . . 71.32 110.526 -171.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -53.74 -25.68 19.85 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.186 0.995 . . . . 74.35 113.352 -171.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 353' ' ' HIS . . . . . . . . . . . . . 49.8 m80 76.41 -35.35 0.24 Allowed 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 125.416 1.486 . . . . 74.33 111.568 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 354' ' ' ALA . . . . . . . . . . . . . . . -62.87 97.05 0.1 Allowed 'General case' 0 C--O 1.242 0.686 0 C-N-CA 124.149 0.98 . . . . 72.23 110.26 168.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 355' ' ' ALA . . . . . . . . . . . . . . . -72.42 -77.85 0.09 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.523 -0.762 . . . . 75.44 110.825 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 356' ' ' ASN . . . . . 0.509 ' HB3' ' HD3' ' B' ' 357' ' ' PRO . 27.4 t-20 173.78 -58.76 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.336 0 C-N-CA 125.045 1.338 . . . . 74.32 109.31 -176.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 357' ' ' PRO . . . . . 0.515 ' HG3' ' HA ' ' B' ' 259' ' ' VAL . 4.5 Cg_endo -102.07 -174.22 0.1 Allowed 'Trans proline' 0 C--N 1.393 2.92 0 C-N-CA 122.678 2.252 . . . . 74.21 113.5 -175.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 358' ' ' CYS . . . . . . . . . . . . . 60.3 m -99.82 60.81 1.11 Allowed 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 108.978 -0.749 . . . . 75.21 108.978 170.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 359' ' ' GLY . . . . . . . . . . . . . . . -76.71 77.71 1.42 Allowed Glycine 0 C--N 1.349 1.254 0 CA-C-N 114.813 -1.085 . . . . 72.04 112.968 -176.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 360' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -117.93 149.68 40.49 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.43 0.692 . . . . 53.34 110.58 -178.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 361' ' ' ILE . . . . . . . . . . . . . 16.4 tt -159.16 155.26 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.931 0.892 . . . . 64.41 108.629 -178.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 362' ' ' GLY . . . . . . . . . . . . . . . -127.26 -106.12 1.38 Allowed Glycine 0 C--N 1.348 1.23 0 C-N-CA 121.6 -0.333 . . . . 72.35 113.296 -178.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 363' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -75.07 -19.78 59.82 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.831 0.852 . . . . 73.13 112.327 -171.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 364' ' ' THR . . . . . 0.496 HG22 HG21 ' B' ' 365' ' ' VAL . 3.8 t 55.34 168.28 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 126.484 1.914 . . . . 74.04 113.862 -173.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 365' ' ' VAL . . . . . 0.496 HG21 HG22 ' B' ' 364' ' ' THR . 58.6 t 70.05 140.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 125.475 1.51 . . . . 74.51 111.896 -178.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 2.3 p30 32.78 53.34 0.35 Allowed 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 126.47 1.908 . . . . 52.52 114.428 178.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 367' ' ' LEU . . . . . 0.555 ' HB3' HE21 ' B' ' 252' ' ' GLN . 3.1 pp -57.08 -16.7 8.02 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 124.0 0.92 . . . . 75.05 113.367 179.049 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 368' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -58.2 -60.92 3.0 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.982 1.713 . . . . 73.23 111.397 178.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 369' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 52.62 -100.7 0.1 Allowed 'General case' 0 CA--C 1.564 1.49 0 C-N-CA 124.988 1.315 . . . . 74.11 109.34 -168.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 370' ' ' ALA . . . . . . . . . . . . . . . 176.43 -70.65 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 124.668 1.187 . . . . 74.25 110.551 176.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 371' ' ' VAL . . . . . . . . . . . . . 29.5 t -110.71 -18.25 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 C-N-CA 123.519 0.728 . . . . 74.12 112.266 -167.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 372' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -71.96 86.31 1.0 Allowed 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 120.959 0.409 . . . . 63.2 111.751 -176.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 373' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -162.37 157.71 23.0 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.499 1.12 . . . . 72.2 108.715 170.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 374' ' ' ALA . . . . . 0.401 ' HB2' ' HA ' ' A' ' 263' ' ' PRO . . . -78.16 156.74 29.7 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.312 0.645 . . . . 71.45 112.554 -170.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 375' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -144.81 160.01 41.95 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.65 1.18 . . . . 72.22 108.932 -177.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 376' ' ' GLU . . . . . 0.407 ' HA ' ' HG3' ' A' ' 263' ' ' PRO . 2.9 mp0 -64.07 -32.39 73.93 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.371 0.669 . . . . 73.13 111.218 -174.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 377' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -65.26 100.65 0.48 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.829 0.852 . . . . 73.31 110.067 177.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 378' ' ' ALA . . . . . . . . . . . . . . . -87.53 0.75 55.13 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 115.353 -0.839 . . . . 73.45 111.602 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt 75.34 -57.65 0.59 Allowed 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 125.831 1.652 . . . . 73.22 111.095 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 380' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.21 157.37 29.36 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 108.974 -0.75 . . . . 72.4 108.974 170.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 381' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -84.18 22.24 1.25 Allowed 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 123.702 0.801 . . . . 74.34 110.908 -176.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . 71.81 3.58 55.69 Favored Glycine 0 C--N 1.352 1.467 0 C-N-CA 122.84 0.257 . . . . 73.1 112.741 -171.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 383' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -93.69 99.1 11.58 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.015 0.926 . . . . 73.1 110.487 -173.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 384' ' ' THR . . . . . . . . . . . . . 35.8 p -108.12 -56.48 2.24 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.522 -0.918 . . . . 71.44 108.522 174.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 62.59 150.35 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 126.029 1.731 . . . . 75.43 113.589 178.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 386' ' ' VAL . . . . . 0.643 HG23 ' HD2' ' B' ' 415' ' ' LYS . 7.7 p 47.05 23.78 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.606 0 C-N-CA 126.774 2.03 . . . . 75.23 113.609 178.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 387' ' ' ILE . . . . . . . . . . . . . 34.8 mm 57.37 -74.35 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 125.21 1.404 . . . . 74.12 110.867 -172.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 388' ' ' VAL . . . . . 0.525 HG12 HG13 ' B' ' 386' ' ' VAL 0.285 4.3 m 46.47 -102.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 125.856 1.662 . . . . 74.43 111.979 -171.371 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 389' ' ' THR . . . . . 0.445 ' H ' HG21 ' B' ' 388' ' ' VAL . 45.2 p -94.89 -34.87 12.26 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 109.348 -0.612 . . . . 71.25 109.348 173.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . 57.51 69.69 0.72 Allowed 'General case' 0 C--O 1.245 0.825 0 C-N-CA 125.418 1.487 . . . . 73.41 109.794 -174.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 391' ' ' ASP . . . . . . . . . . . . . 14.4 t70 74.08 -66.01 0.32 Allowed 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 113.35 -1.75 . . . . 64.12 109.319 -170.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 392' ' ' HIS . . . . . 0.534 ' HD2' ' HB3' ' B' ' 404' ' ' LYS . 16.2 t-80 -157.21 -21.72 0.09 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.19 0.596 . . . . 72.42 110.478 174.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -69.44 76.12 0.39 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.302 1.041 . . . . 61.53 113.502 -167.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 81.5 t60 173.08 126.14 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 126.287 1.835 . . . . 73.31 107.5 177.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . 54.97 60.88 3.21 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 124.085 0.866 . . . . 75.42 110.096 -174.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 78.5 p -70.21 83.47 0.54 Allowed 'General case' 0 CA--C 1.555 1.152 0 CA-C-N 114.089 -1.414 . . . . 75.55 112.128 -169.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 397' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -174.62 -28.93 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 125.024 1.33 . . . . 75.54 108.425 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 9.1 tt -42.57 -46.41 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 C-N-CA 125.085 1.354 . . . . 75.44 113.089 -174.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 399' ' ' VAL . . . . . . . . . . . . . 13.9 t -132.29 72.56 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 N-CA-C 107.888 -1.152 . . . . 73.32 107.888 170.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 400' ' ' ALA . . . . . . . . . . . . . . . -71.0 -43.41 13.4 Favored Pre-proline 0 CA--C 1.563 1.455 0 N-CA-C 114.103 1.149 . . . . 74.52 114.103 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 401' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -52.31 114.01 1.46 Allowed 'Trans proline' 0 C--N 1.397 3.083 0 C-N-CA 122.335 2.023 . . . . 71.34 113.254 179.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 12.9 t70 66.89 -85.15 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 125.058 1.343 . . . . 74.34 110.775 -179.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 403' ' ' THR . . . . . . . . . . . . . 34.4 p -150.25 -156.98 0.77 Allowed 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 125.601 1.56 . . . . 73.2 107.73 178.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 404' ' ' LYS . . . . . 0.534 ' HB3' ' HD2' ' B' ' 392' ' ' HIS . 0.0 OUTLIER -84.09 -9.37 58.66 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.53 0.332 . . . . 71.14 111.733 168.697 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 405' ' ' ALA . . . . . . . . . . . . . . . -60.81 -32.31 10.86 Favored Pre-proline 0 CA--C 1.563 1.472 0 N-CA-C 114.237 1.199 . . . . 71.24 114.237 -177.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 406' ' ' PRO . . . . . . . . . . . . . 0.7 OUTLIER -33.85 -39.41 0.14 Allowed 'Trans proline' 0 C--N 1.393 2.883 0 C-N-CA 123.734 2.956 . . . . 64.23 115.472 163.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . 130.67 142.22 5.06 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-N 116.495 -0.32 . . . . 74.04 112.912 172.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 408' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -156.08 136.82 13.38 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 124.299 1.039 . . . . 72.55 108.539 177.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 9.7 t -134.8 -29.35 1.16 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.469 0.708 . . . . 73.52 110.881 -178.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 410' ' ' GLN . . . . . . . . . . . . . 65.2 tp60 -121.74 81.76 1.86 Allowed 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.217 0.607 . . . . 70.42 110.371 -175.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . -95.4 -82.93 0.37 Allowed 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 106.985 -1.487 . . . . 74.33 106.985 164.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 54.9 tp 54.73 -78.41 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.357 1.463 . . . . 75.21 112.642 176.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 17.8 m120 60.91 -161.26 0.29 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 125.176 1.39 . . . . 71.14 110.591 -177.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 414' ' ' THR . . . . . . . . . . . . . 52.6 p -84.22 38.21 0.65 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.645 0.778 . . . . 73.24 109.93 171.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 415' ' ' LYS . . . . . 0.643 ' HD2' HG23 ' B' ' 386' ' ' VAL . 55.3 mtmt 52.47 46.2 27.13 Favored 'General case' 0 C--N 1.356 0.856 0 C-N-CA 124.846 1.259 . . . . 75.21 110.792 -164.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 31.5 t70 58.22 -97.98 0.08 Allowed 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 112.781 -2.009 . . . . 75.33 110.686 -178.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 417' ' ' GLY . . . . . 0.412 ' O ' ' HD2' ' A' ' 211' ' ' ARG . . . -105.85 34.46 5.74 Favored Glycine 0 C--N 1.345 1.03 0 N-CA-C 111.894 -0.482 . . . . 62.31 111.894 179.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 418' ' ' ALA . . . . . . . . . . . . . . . 72.68 -66.74 0.29 Allowed 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 125.535 1.534 . . . . 70.25 110.926 -175.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 419' ' ' VAL . . . . . . . . . . . . . 57.4 t 64.45 -71.86 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 C-N-CA 125.652 1.581 . . . . 73.31 112.32 176.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 420' ' ' MET . . . . . 0.452 ' HB2' HG21 ' B' ' 386' ' ' VAL . 27.2 ttt -46.21 -26.62 0.82 Allowed 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 125.823 1.649 . . . . 73.34 113.175 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 421' ' ' VAL . . . . . . . . . . . . . 21.2 t -77.26 63.13 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.347 0 CA-C-O 121.906 0.86 . . . . 72.42 109.777 175.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 422' ' ' MET . . . . . 0.451 ' HB3' ' NH2' ' A' ' 211' ' ' ARG . 19.6 ptp -141.97 -4.22 1.06 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.087 1.355 . . . . 74.1 109.795 176.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 423' ' ' SER . . . . . 0.437 ' HB3' ' HB3' ' B' ' 426' ' ' ASN . 16.3 m 76.46 -24.99 0.21 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 125.919 1.688 . . . . 63.45 112.559 -176.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 424' ' ' TYR . . . . . . . . . . . . . 31.0 t80 73.16 -71.65 0.13 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.948 1.299 . . . . 74.22 109.948 173.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . -150.91 16.67 0.93 Allowed Glycine 0 CA--C 1.532 1.115 0 CA-C-N 116.265 -0.425 . . . . 75.12 112.358 172.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 426' ' ' ASN . . . . . 0.437 ' HB3' ' HB3' ' B' ' 423' ' ' SER . 29.2 t-20 -66.15 -45.13 82.06 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.275 1.03 . . . . 75.43 112.263 -172.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 427' ' ' SER . . . . . 0.668 ' HB3' ' HA ' ' B' ' 431' ' ' SER . 26.8 t -71.7 121.68 19.29 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 109.003 -0.74 . . . . 75.14 109.003 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -55.26 -61.13 2.53 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.228 1.411 . . . . 73.23 113.889 -161.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 429' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -84.0 79.45 9.49 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.056 0.542 . . . . 63.42 110.658 -174.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 38.7 t70 54.94 37.93 29.6 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 124.068 0.947 . . . . 62.42 111.457 171.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 431' ' ' SER . . . . . 0.668 ' HA ' ' HB3' ' B' ' 427' ' ' SER . 29.7 t 66.63 -79.18 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.379 1.072 . . . . 75.05 110.27 -166.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 432' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 64.67 7.68 3.96 Favored 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 124.018 0.927 . . . . 71.1 111.995 179.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 433' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -69.67 -22.73 63.42 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.687 0.795 . . . . 73.43 111.47 -177.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 434' ' ' HIS . . . . . . . . . . . . . 61.3 t-80 72.13 168.71 0.31 Allowed 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 124.953 1.301 . . . . 73.42 112.113 171.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 435' ' ' THR . . . . . 0.495 ' O ' ' HG ' ' B' ' 439' ' ' LEU . 53.2 m 82.38 -54.54 0.21 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.344 1.858 . . . . 73.42 111.861 174.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . -53.54 -67.41 2.15 Favored Glycine 0 N--CA 1.481 1.695 0 CA-C-N 118.519 0.599 . . . . 61.51 113.994 -174.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 23.9 m -64.84 -23.33 67.2 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.279 0.632 . . . . 72.35 111.82 177.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 438' ' ' GLN . . . . . 0.491 ' HA ' HD12 ' B' ' 331' ' ' LEU . 22.8 mp0 -79.7 -23.3 42.48 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.2 1.0 . . . . 71.55 111.248 -172.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 439' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' B' ' 435' ' ' THR . 93.8 mt -79.85 35.83 0.32 Allowed 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.651 0.781 . . . . 74.24 111.205 177.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 440' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -67.7 169.7 9.07 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 123.643 0.777 . . . . 74.1 112.108 -174.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 441' ' ' ILE . . . . . 0.604 HD13 ' HA ' ' A' ' 223' ' ' VAL . 47.2 mt -95.02 140.33 17.0 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 CA-C-N 114.748 -1.115 . . . . 74.15 109.731 177.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 442' ' ' ALA . . . . . . . . . . . . . . . -83.76 -80.99 0.18 Allowed 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 108.751 -0.833 . . . . 73.33 108.751 172.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 443' ' ' ALA . . . . . 0.491 ' HB3' ' HG3' ' A' ' 224' ' ' PRO . . . 56.73 -85.08 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 125.464 1.506 . . . . 74.21 113.173 173.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 31.4 p90 -167.49 -160.78 0.37 Allowed 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.959 0.904 . . . . 71.31 110.32 -177.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . 137.72 -89.05 0.21 Allowed Glycine 0 C--N 1.347 1.163 0 CA-C-O 119.75 -0.472 . . . . 74.34 111.972 174.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 446' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -97.77 -163.34 0.07 OUTLIER 'Trans proline' 0 C--N 1.368 1.578 0 C-N-CA 123.151 2.567 . . . . 72.44 110.616 168.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 447' ' ' HIS . . . . . 0.409 ' HB2' ' HD2' ' B' ' 337' ' ' LYS . 7.7 p80 -144.92 51.17 1.24 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 122.274 1.035 . . . . 63.45 108.997 170.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . 176.24 142.61 0.07 Allowed 'General case' 0 C--O 1.24 0.569 0 CA-C-N 112.416 -2.174 . . . . 74.31 106.822 172.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 449' ' ' ALA . . . . . . . . . . . . . . . -169.63 -58.16 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 122.078 0.942 . . . . 74.42 108.721 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 450' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -120.32 172.11 8.04 Favored 'General case' 0 CA--C 1.552 1.042 0 CA-C-N 113.681 -1.599 . . . . 63.22 108.228 178.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 67.4 t 78.45 -57.58 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 C-N-CA 125.598 1.559 . . . . 74.44 110.771 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 452' ' ' VAL . . . . . . . . . . . . . 28.3 m -62.88 -26.89 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 123.853 0.861 . . . . 74.24 112.168 175.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . -69.74 -27.48 73.21 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-O 119.905 -0.386 . . . . 73.44 113.074 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 454' ' ' LEU . . . . . . . . . . . . . 87.2 mt 61.85 21.39 12.22 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 124.499 1.119 . . . . 73.13 110.691 -175.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 38.5 p -100.14 151.8 20.99 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 124.288 1.035 . . . . 72.1 110.566 -176.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -70.32 146.59 50.43 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.372 0.669 . . . . 74.3 109.982 -177.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 457' ' ' GLN . . . . . 0.433 ' OE1' ' HB2' ' B' ' 333' ' ' SER . 47.8 mt-30 -100.44 4.14 43.56 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.274 0.842 . . . . 65.21 113.274 -166.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 36.2 p -66.3 -56.02 13.21 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 118.445 0.566 . . . . 72.13 109.563 177.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 459' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -161.28 82.05 0.62 Allowed 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.21 -0.905 . . . . 73.31 109.921 178.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 23.9 tp -163.98 -86.71 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.49 -0.777 . . . . 65.42 109.535 175.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 65.94 -63.9 0.22 Allowed 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 125.08 1.352 . . . . 75.0 111.899 -175.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 20.8 t80 66.09 54.51 0.98 Allowed 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 125.465 1.506 . . . . 72.53 110.728 174.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 62.1 m -74.42 86.15 2.01 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 115.147 -0.933 . . . . 71.14 110.199 174.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 464' ' ' MET . . . . . 0.475 ' SD ' ' HG3' ' B' ' 293' ' ' PRO . 24.9 ttt -120.76 144.05 48.48 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 107.974 -1.121 . . . . 75.31 107.974 178.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 465' ' ' LYS . . . . . 0.404 ' HB2' ' HZ3' ' B' ' 465' ' ' LYS . 3.4 ttmp? 77.12 -38.87 0.31 Allowed 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 125.342 1.457 . . . . 72.15 112.525 -177.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -67.82 -20.31 65.16 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.726 0.81 . . . . 65.13 112.248 178.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . -84.62 0.87 48.6 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 123.883 0.873 . . . . 75.3 111.613 175.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 468' ' ' LEU . . . . . 0.594 ' HA ' ' HG2' ' C' ' 266' ' ' GLU . 67.5 tp -113.19 112.07 23.14 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.619 1.168 . . . . 74.32 108.761 179.183 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 469' ' ' GLY . . . . . . . . . . . . . . . 74.3 144.38 0.89 Allowed Glycine 0 C--N 1.351 1.394 0 O-C-N 123.311 0.382 . . . . 62.03 112.887 -176.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 470' ' ' LEU . . . . . . . . . . . . . 6.6 tt -85.98 -48.25 8.85 Favored 'General case' 0 N--CA 1.485 1.275 0 O-C-N 121.868 -0.783 . . . . 75.32 109.081 176.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 471' ' ' LYS . . . . . . . . . . . . . 11.1 tmtt? . . . . . 0 CA--C 1.557 1.218 0 N-CA-C 107.119 -1.437 . . . . 74.2 107.119 -165.295 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 70.8 mtm . . . . . 0 N--CA 1.477 0.882 0 N-CA-C 110.738 -0.097 . . . . 70.43 110.738 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . 0.436 ' HA ' ' HD1' ' C' ' 96' ' ' PHE . . . 65.33 41.32 4.38 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.714 1.206 . . . . 70.41 112.039 174.293 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -75.79 72.83 2.72 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.554 0.741 . . . . 71.34 109.798 175.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -37.91 123.8 1.1 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.237 1.815 . . . . 70.52 114.951 -174.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 22.3 mmtp -93.53 122.68 36.22 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.6 -0.727 . . . . 72.32 109.591 166.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -82.65 86.18 6.89 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 107.48 -1.304 . . . . 65.15 107.48 170.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 7' ' ' TYR . . . . . 0.421 ' HB3' ' HA ' ' C' ' 53' ' ' ALA . 73.9 m-85 -61.61 -35.12 76.95 Favored 'General case' 0 C--O 1.244 0.764 0 CA-C-N 114.341 -1.299 . . . . 73.43 111.198 -176.164 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -60.26 -46.86 88.34 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.584 -0.735 . . . . 74.23 110.113 175.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.55 -39.19 92.83 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.888 0.475 . . . . 63.34 111.27 179.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 69.0 mt -57.86 -39.79 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 122.984 0.513 . . . . 73.31 110.704 174.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 11' ' ' LEU . . . . . 0.496 HD13 HG21 ' C' ' 22' ' ' ILE . 67.9 mt -79.92 -17.13 53.85 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 122.898 0.479 . . . . 75.53 112.068 176.059 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.66 26.7 45.22 Favored Glycine 0 CA--C 1.537 1.445 0 N-CA-C 113.887 0.315 . . . . 74.43 113.887 -178.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 12.3 m -120.0 156.83 54.11 Favored Pre-proline 0 CA--C 1.555 1.167 0 C-N-CA 124.76 1.224 . . . . 71.34 110.069 178.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.62 164.03 36.79 Favored 'Trans proline' 0 C--N 1.383 2.357 0 C-N-CA 122.85 2.366 . . . . 74.43 112.283 177.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -70.03 8.06 0.82 Allowed 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 114.068 1.136 . . . . 74.35 114.068 -174.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -128.01 16.13 6.79 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.508 0.723 . . . . 71.24 109.432 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.5 123.44 19.23 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.354 1.062 . . . . 75.2 110.788 178.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 76.0 p -74.0 177.18 5.83 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.303 0.641 . . . . 74.41 111.003 -177.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.46 -55.44 21.92 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 124.269 1.028 . . . . 74.45 111.191 -171.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -67.9 -29.11 68.12 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.393 0.677 . . . . 74.53 112.008 -174.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -71.16 -47.37 58.14 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-O 121.12 0.486 . . . . 73.42 110.682 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 22' ' ' ILE . . . . . 0.771 HD12 ' HB3' ' C' ' 57' ' ' LEU . 82.3 mt -57.89 -44.01 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 124.447 1.099 . . . . 75.54 110.27 172.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 23' ' ' LYS . . . . . 0.456 ' HG2' ' HE2' ' C' ' 27' ' ' LYS . 79.1 tttt -66.35 -35.86 81.43 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 113.723 -1.58 . . . . 74.13 111.257 -176.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 27.2 mtm180 -78.95 -33.84 44.96 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 123.323 0.649 . . . . 73.52 111.463 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.98 -44.61 95.56 Favored 'General case' 0 C--O 1.257 1.482 0 CA-C-O 121.812 0.815 . . . . 75.32 110.032 173.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 26' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -60.95 -57.89 10.72 Favored 'General case' 0 C--O 1.201 -1.48 0 CA-C-N 113.797 -1.547 . . . . 72.31 110.125 175.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . 0.456 ' HE2' ' HG2' ' C' ' 23' ' ' LYS . 49.9 mtmt -54.8 -35.55 64.0 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 123.698 0.799 . . . . 75.33 111.142 -176.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 39.7 ttp180 -57.13 -57.77 11.14 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.026 0.531 . . . . 75.55 109.75 172.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . 0.611 ' HB3' HD12 ' C' ' 50' ' ' ILE . 95.5 mt -74.71 -14.84 60.78 Favored 'General case' 0 CA--C 1.557 1.229 0 CA-C-N 115.686 -0.688 . . . . 71.43 112.586 -177.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.32 -23.46 19.26 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.376 1.07 . . . . 75.32 111.129 -176.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -88.86 -35.98 16.25 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 109.041 -0.726 . . . . 73.5 109.041 171.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.45 -50.1 55.01 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 122.996 0.518 . . . . 71.12 109.759 -178.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -97.43 25.8 5.39 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.886 0.474 . . . . 72.14 111.178 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 34' ' ' HIS . . . . . . . . . . . . . 13.2 t-160 -59.92 106.87 0.83 Allowed Pre-proline 0 N--CA 1.487 1.406 0 CA-C-O 118.708 -0.663 . . . . 74.34 111.324 -173.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.06 -22.49 69.7 Favored 'Trans proline' 0 C--N 1.383 2.355 0 C-N-CA 123.351 2.701 . . . . 72.22 113.233 -172.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -70.08 -36.48 74.95 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.782 0.833 . . . . 60.34 111.094 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 62.1 t -98.81 -57.54 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 CA-C-O 121.676 0.75 . . . . 75.33 109.266 -179.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -94.0 79.49 4.1 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 124.836 1.254 . . . . 65.41 107.979 -178.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -75.59 78.85 2.59 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-N 113.738 -1.574 . . . . 71.22 109.196 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 26.7 m -132.54 107.09 13.1 Favored Pre-proline 0 C--O 1.236 0.352 0 N-CA-C 108.35 -0.981 . . . . 74.14 108.35 178.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . 0.43 ' O ' ' HG2' ' C' ' 45' ' ' GLU . 48.0 Cg_exo -42.02 -45.7 7.13 Favored 'Trans proline' 0 C--N 1.386 2.512 0 C-N-CA 123.814 3.009 . . . . 75.0 113.308 178.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -59.92 -41.16 91.14 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.672 0.789 . . . . 71.01 111.481 -179.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.89 -27.34 65.7 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 115.678 -0.692 . . . . 71.45 109.956 178.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 44' ' ' GLU . . . . . 0.475 ' O ' ' HG3' ' C' ' 48' ' ' LYS . 38.5 mt-10 -79.2 -27.72 42.58 Favored 'General case' 0 C--O 1.215 -0.759 0 O-C-N 123.827 0.704 . . . . 74.04 109.508 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 45' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' C' ' 41' ' ' PRO . 29.6 mm-40 -70.78 -48.08 56.16 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.636 0.774 . . . . 75.44 110.344 177.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 46' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -57.89 -42.77 85.32 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 114.8 -1.091 . . . . 72.32 109.484 172.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -65.62 -30.15 70.82 Favored 'General case' 0 C--O 1.213 -0.834 0 CA-C-N 115.04 -0.982 . . . . 71.12 111.202 178.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 48' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' C' ' 44' ' ' GLU . 92.8 mttt -64.89 -43.42 92.94 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.057 0.543 . . . . 72.04 110.384 174.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -61.9 -39.69 92.86 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.595 0.712 . . . . 72.33 111.221 177.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 50' ' ' ILE . . . . . 0.611 HD12 ' HB3' ' C' ' 29' ' ' LEU . 79.0 mt -67.35 -34.1 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 CA-C-N 115.018 -0.992 . . . . 75.43 110.468 173.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 51' ' ' ASN . . . . . 0.509 ' HB3' ' CD1' ' C' ' 88' ' ' PHE . 70.8 m-20 -76.92 -17.06 59.17 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.586 1.154 . . . . 74.04 111.408 177.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -75.48 -51.27 13.39 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 108.103 -1.073 . . . . 75.54 108.103 171.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . 0.421 ' HA ' ' HB3' ' C' ' 7' ' ' TYR . . . -55.3 -38.15 68.29 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 113.752 -1.567 . . . . 63.1 111.518 174.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -80.9 -29.87 35.55 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.132 0.973 . . . . 75.01 110.454 178.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.56 -28.21 66.93 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 123.17 0.588 . . . . 60.54 110.559 174.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 21.1 t -92.02 -45.31 14.34 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.166 0 CA-C-N 115.285 -0.871 . . . . 72.43 112.023 175.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 57' ' ' LEU . . . . . 0.771 ' HB3' HD12 ' C' ' 22' ' ' ILE . 87.3 mt -104.52 4.58 33.19 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 115.584 1.698 . . . . 75.02 115.584 -163.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 38.6 t -66.71 -74.55 0.11 Allowed 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 118.56 0.618 . . . . 75.33 112.414 -177.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -66.6 140.97 96.72 Favored Pre-proline 0 C--N 1.349 0.571 0 N-CA-C 108.7 -0.852 . . . . 72.03 108.7 176.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 60' ' ' PRO . . . . . 0.451 ' O ' ' HG2' ' C' ' 64' ' ' ARG . 18.1 Cg_endo -58.29 -27.75 82.05 Favored 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 122.067 1.845 . . . . 73.21 111.013 174.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -65.01 -52.23 57.24 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.541 0.736 . . . . 62.13 111.418 175.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 62' ' ' LYS . . . . . 0.537 ' HD3' ' HB3' ' C' ' 84' ' ' ASP . 46.4 mtmt -66.06 -36.49 83.35 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 121.163 0.506 . . . . 75.43 110.72 -178.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 45.0 ttt-85 -57.44 -46.06 84.0 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.14 -0.936 . . . . 74.14 108.74 175.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 64' ' ' ARG . . . . . 0.451 ' HG2' ' O ' ' C' ' 60' ' ' PRO . 24.0 mmt180 -68.75 -24.65 64.47 Favored 'General case' 0 C--O 1.213 -0.823 0 CA-C-N 115.442 -0.799 . . . . 74.15 111.999 177.046 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 65' ' ' ILE . . . . . 0.518 HG12 ' HG2' ' C' ' 76' ' ' PRO . 78.4 mt -60.89 -45.28 98.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 108.906 -0.776 . . . . 71.5 108.906 171.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -60.86 -51.38 69.57 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 115.146 -0.933 . . . . 74.31 109.95 174.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -58.01 -40.0 79.69 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.605 0.762 . . . . 73.14 111.862 -177.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 63.5 p -74.64 -24.83 58.89 Favored 'General case' 0 C--O 1.217 -0.615 0 CA-C-O 119.288 -0.387 . . . . 74.43 110.339 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -75.28 120.12 20.32 Favored 'General case' 0 C--N 1.356 0.868 0 N-CA-C 108.653 -0.869 . . . . 75.22 108.653 174.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.55 24.87 22.59 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.293 -0.723 . . . . 62.51 111.293 -169.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 56.8 m -145.62 -62.49 0.33 Allowed 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 103.269 -2.863 . . . . 72.34 103.269 171.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 23.6 m -85.1 148.67 26.02 Favored 'General case' 0 C--O 1.254 1.29 0 N-CA-C 105.458 -2.052 . . . . 73.35 105.458 157.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.94 -28.56 15.11 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.273 0.629 . . . . 73.23 110.703 176.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -87.56 136.97 32.43 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 123.594 0.757 . . . . 53.23 110.253 178.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -68.51 127.59 15.85 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.435 2.09 . . . . 75.14 110.495 175.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 76' ' ' PRO . . . . . 0.518 ' HG2' HG12 ' C' ' 65' ' ' ILE . 9.8 Cg_endo -51.87 132.87 43.8 Favored 'Trans proline' 0 C--N 1.387 2.602 0 C-N-CA 123.058 2.505 . . . . 71.22 111.741 177.469 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -48.08 128.54 16.94 Favored 'Trans proline' 0 C--N 1.387 2.585 0 C-N-CA 123.877 3.051 . . . . 74.4 114.101 -169.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 78' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -67.95 154.72 72.08 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 122.383 2.055 . . . . 74.44 111.574 178.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.97 156.39 39.14 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.398 2.065 . . . . 70.12 111.439 170.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -54.75 85.56 0.03 OUTLIER 'Trans proline' 0 C--N 1.388 2.645 0 C-N-CA 123.367 2.712 . . . . 74.31 113.13 177.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 153.17 -42.11 0.66 Allowed Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 114.032 -1.44 . . . . 75.2 110.492 -179.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 137.54 169.44 11.63 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-N 115.151 -0.525 . . . . 75.13 112.1 178.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -57.93 148.81 24.52 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.008 0.923 . . . . 73.4 110.36 172.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 84' ' ' ASP . . . . . 0.537 ' HB3' ' HD3' ' C' ' 62' ' ' LYS . 18.0 t0 -57.32 130.82 47.95 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 123.739 0.649 . . . . 75.11 111.88 -179.114 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 85' ' ' PHE . . . . . 0.483 ' CD1' ' HB2' ' C' ' 88' ' ' PHE . 0.3 OUTLIER -148.91 32.97 0.76 Allowed 'General case' 0 C--O 1.241 0.624 0 O-C-N 123.625 0.578 . . . . 74.41 111.543 -170.808 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 86' ' ' SER . . . . . 0.565 ' HA ' ' O ' ' C' ' 169' ' ' ASN . 18.3 m -70.89 93.75 1.0 Allowed 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.286 -0.87 . . . . 52.42 112.721 -169.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 86.62 10.02 74.01 Favored Glycine 0 C--N 1.346 1.112 0 CA-C-N 114.796 -1.093 . . . . 74.34 113.306 177.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 88' ' ' PHE . . . . . 0.509 ' CD1' ' HB3' ' C' ' 51' ' ' ASN . 10.2 m-85 -92.62 138.18 31.72 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 108.384 -0.969 . . . . 74.44 108.384 -176.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -84.32 76.63 10.1 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 122.029 -0.42 . . . . 72.23 110.799 -168.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 90' ' ' VAL . . . . . . . . . . . . . 4.2 p -43.46 -55.53 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 C-N-CA 125.177 1.391 . . . . 54.42 114.594 -176.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -70.76 -19.71 62.69 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.52 0.328 . . . . 75.25 111.813 -173.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -87.64 -23.0 24.38 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 110.221 -0.289 . . . . 75.53 110.221 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 93' ' ' PHE . . . . . 0.509 ' HE2' ' HB3' ' C' ' 88' ' ' PHE . 11.9 m-30 -72.35 171.86 11.42 Favored 'General case' 0 C--N 1.352 0.683 0 N-CA-C 113.314 0.857 . . . . 72.45 113.314 -168.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 49.7 m -60.24 150.51 29.93 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 114.288 -1.324 . . . . 52.11 112.463 -172.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 95' ' ' GLU . . . . . 0.428 ' O ' ' HG3' ' C' ' 99' ' ' GLU . 0.0 OUTLIER -66.38 -45.05 81.37 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.448 0.699 . . . . 72.35 110.854 -178.542 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 96' ' ' PHE . . . . . 0.436 ' HD1' ' HA ' ' C' ' 2' ' ' ALA . 33.2 t80 -52.09 -44.41 64.38 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.556 1.142 . . . . 74.24 110.946 172.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 97' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -66.56 -39.7 88.65 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 114.118 -1.401 . . . . 64.25 110.605 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -76.66 -9.7 58.85 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.644 0.778 . . . . 71.33 112.037 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . 0.428 ' HG3' ' O ' ' C' ' 95' ' ' GLU . 51.1 mt-10 -90.28 -47.02 8.03 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.916 0.486 . . . . 74.43 111.102 169.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 25.6 tp -66.6 -50.0 64.48 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.844 0.858 . . . . 73.23 110.808 -176.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -92.54 -1.23 57.09 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.664 -0.698 . . . . 75.04 111.257 177.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -45.47 -61.42 3.69 Favored Glycine 0 C--N 1.356 1.68 0 CA-C-O 118.769 -1.017 . . . . 74.41 114.704 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -46.66 -18.8 0.57 Allowed 'Trans proline' 0 C--N 1.391 2.808 0 C-N-CA 124.511 3.474 . . . . 64.35 114.735 179.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -150.62 53.32 0.5 Allowed Glycine 0 C--N 1.347 1.163 0 CA-C-O 119.894 -0.392 . . . . 73.42 112.728 177.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 32.6 mt -67.4 20.74 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.268 0 N-CA-C 113.94 1.089 . . . . 75.43 113.94 172.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 69.99 -167.03 0.17 Allowed 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 126.687 1.995 . . . . 64.24 113.132 169.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . 106.54 -6.18 38.39 Favored Glycine 0 C--N 1.346 1.098 0 CA-C-N 115.958 -0.565 . . . . 51.05 111.775 -163.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 67.58 -125.86 23.81 Favored Glycine 0 C--N 1.347 1.17 0 N-CA-C 112.035 -0.426 . . . . 74.41 112.035 177.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 109' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -82.12 -8.2 59.65 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 122.88 0.472 . . . . 74.45 110.981 175.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 110' ' ' GLY . . . . . . . . . . . . . . . -89.95 -32.02 10.39 Favored Glycine 0 C--N 1.345 1.061 0 N-CA-C 111.929 -0.468 . . . . 73.14 111.929 177.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . 0.414 ' HD3' ' O ' ' C' ' 111' ' ' ARG . 0.5 OUTLIER 69.7 -18.03 0.22 Allowed 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 125.404 1.482 . . . . 75.25 112.908 176.749 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 112' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -78.98 18.19 0.66 Allowed 'General case' 0 CA--C 1.563 1.46 0 C-N-CA 123.985 0.914 . . . . 75.43 111.65 -174.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 113' ' ' SER . . . . . . . . . . . . . 53.5 m 50.32 38.04 16.73 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.514 0.725 . . . . 72.53 111.685 -177.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.03 -168.39 2.21 Favored 'General case' 0 C--O 1.21 -1.004 0 CA-C-N 115.491 -0.777 . . . . 74.05 110.816 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 115' ' ' LYS . . . . . 0.462 ' HA ' ' HD2' ' C' ' 170' ' ' PRO . 15.4 tptm -53.81 141.86 25.73 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.231 1.012 . . . . 74.15 112.892 -170.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 116' ' ' GLY . . . . . 0.413 ' HA3' ' N ' ' B' ' 204' ' ' ALA . . . -55.45 128.89 45.54 Favored Glycine 0 C--N 1.367 2.258 0 N-CA-C 110.197 -1.161 . . . . 54.4 110.197 167.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 117' ' ' ARG . . . . . 0.436 ' O ' ' HA2' ' C' ' 166' ' ' GLY . 49.8 ttp180 -88.19 116.62 26.52 Favored 'General case' 0 C--O 1.253 1.246 0 N-CA-C 108.96 -0.755 . . . . 74.32 108.96 177.02 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -40.8 120.58 1.32 Allowed 'General case' 0 N--CA 1.483 1.189 0 O-C-N 124.465 1.103 . . . . 75.42 109.908 175.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 119' ' ' LEU . . . . . . . . . . . . . 13.5 tp -94.81 154.36 17.3 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 118.687 -1.205 . . . . 75.21 108.289 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.438 ' HD2' ' HD3' ' B' ' 188' ' ' ARG . 0.0 OUTLIER -143.49 112.71 6.77 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 105.823 -1.917 . . . . 72.31 105.823 -175.403 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 121' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' B' ' 185' ' ' VAL . . . -132.38 116.52 16.95 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 109.002 -0.74 . . . . 75.44 109.002 -177.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 122' ' ' GLU . . . . . 0.476 ' HA ' ' O ' ' C' ' 177' ' ' VAL . 13.8 pt-20 -88.91 131.44 35.13 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 109.357 -0.609 . . . . 74.12 109.357 178.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 123' ' ' LEU . . . . . 0.685 ' HB2' ' HB ' ' B' ' 182' ' ' VAL . 2.6 pt? -134.86 124.37 16.63 Favored Pre-proline 0 N--CA 1.478 0.964 0 N-CA-C 111.89 0.33 . . . . 73.3 111.89 -170.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . 0.416 ' HD2' HG12 ' B' ' 182' ' ' VAL . 16.2 Cg_exo -68.95 117.84 5.29 Favored 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 122.924 2.416 . . . . 72.51 110.314 170.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 125' ' ' LEU . . . . . 0.513 HD22 HG13 ' C' ' 153' ' ' VAL . 42.9 tp -143.68 146.77 33.46 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 122.896 0.479 . . . . 75.32 109.785 -169.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 126' ' ' THR . . . . . 0.457 HG21 HD13 ' C' ' 181' ' ' LEU . 34.0 p -93.93 166.75 12.02 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.753 0.787 . . . . 61.53 110.379 171.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 127' ' ' LEU . . . . . 0.488 HD21 HD11 ' C' ' 180' ' ' LEU . 15.2 mt -71.25 -37.7 71.94 Favored 'General case' 0 C--O 1.249 1.065 0 CA-C-N 114.04 -1.436 . . . . 62.25 109.358 178.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 11.2 mp0 -61.36 -49.87 75.19 Favored 'General case' 0 C--O 1.216 -0.696 0 CA-C-N 113.085 -1.871 . . . . 75.24 109.134 178.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 129' ' ' GLU . . . . . 0.683 ' HA ' ' HB2' ' C' ' 132' ' ' HIS . 28.7 mm-40 -81.52 -7.48 59.59 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 123.848 0.717 . . . . 75.51 111.562 178.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -68.6 -46.34 69.58 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 109.478 -0.564 . . . . 73.14 109.478 166.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 131' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -67.11 -51.27 56.31 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 115.719 -0.673 . . . . 75.55 110.426 169.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 132' ' ' HIS . . . . . 0.683 ' HB2' ' HA ' ' C' ' 129' ' ' GLU . 30.6 m170 -74.06 -1.17 18.95 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.694 0.798 . . . . 70.15 111.604 -174.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -63.3 -101.37 0.01 OUTLIER Glycine 0 C--N 1.352 1.453 0 N-CA-C 111.365 -0.694 . . . . 65.31 111.365 165.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 134' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' C' ' 148' ' ' ARG . . . 53.74 -108.49 0.83 Allowed Glycine 0 C--N 1.349 1.253 0 N-CA-C 111.61 -0.596 . . . . 73.12 111.61 -177.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -77.13 95.99 4.38 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.173 -1.047 . . . . 73.03 108.173 174.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 136' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.29 138.53 47.88 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 123.755 0.822 . . . . 72.12 109.291 -174.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 137' ' ' VAL . . . . . 0.513 HG13 ' HG ' ' C' ' 146' ' ' SER . 34.0 m -86.61 131.54 34.51 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 N-CA-C 109.181 -0.674 . . . . 73.11 109.181 174.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 138' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' C' ' 144' ' ' ARG . 7.6 p -133.96 143.74 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.22 1.008 . . . . 72.14 108.464 -176.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 139' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -123.47 82.99 2.07 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.237 0.541 . . . . 74.31 109.813 176.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 140' ' ' VAL . . . . . 0.55 HG11 ' HG2' ' C' ' 164' ' ' MET . 6.9 p -96.34 137.21 24.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 115.299 -0.864 . . . . 73.25 109.226 176.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 55.93 28.27 12.37 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 123.978 0.911 . . . . 65.0 111.701 -177.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 72.2 31.19 64.12 Favored Glycine 0 C--N 1.35 1.338 0 CA-C-N 116.343 -0.39 . . . . 52.4 113.394 -179.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 143' ' ' ARG . . . . . 0.535 ' NH1' ' HG ' ' B' ' 205' ' ' LEU . 55.5 ttt180 -128.03 104.3 7.71 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.561 0.744 . . . . 75.05 109.632 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 144' ' ' ARG . . . . . 0.406 ' HA ' ' O ' ' C' ' 138' ' ' VAL . 49.1 ttt180 -85.35 107.42 17.34 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.618 0.767 . . . . 71.51 110.845 -178.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 145' ' ' VAL . . . . . . . . . . . . . 22.7 t -123.05 140.98 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.534 0.734 . . . . 75.03 110.187 178.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 146' ' ' SER . . . . . 0.513 ' HG ' HG13 ' C' ' 137' ' ' VAL . 20.0 m -83.13 96.0 8.26 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 108.88 -0.785 . . . . 73.22 108.88 168.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 147' ' ' VAL . . . . . 0.472 HG23 ' HE3' ' C' ' 164' ' ' MET . 29.4 m -98.73 157.93 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 123.528 0.731 . . . . 72.53 109.839 -178.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 148' ' ' ARG . . . . . 0.451 HH22 ' HB3' ' C' ' 243' ' ' PRO . 62.8 ttt180 -116.73 94.5 4.63 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 108.638 -0.875 . . . . 74.22 108.638 167.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 149' ' ' ILE . . . . . . . . . . . . . 19.4 pt -79.03 150.94 75.54 Favored Pre-proline 0 N--CA 1.476 0.863 0 N-CA-C 107.818 -1.179 . . . . 74.42 107.818 170.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -53.82 120.85 8.56 Favored 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 122.092 1.861 . . . . 61.44 110.875 176.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -60.04 98.39 0.12 Allowed 'Trans proline' 0 C--N 1.386 2.515 0 C-N-CA 122.509 2.139 . . . . 73.2 110.204 177.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 152' ' ' GLY . . . . . 0.412 ' HA2' ' CZ ' ' C' ' 240' ' ' PHE . . . 147.63 145.34 4.16 Favored Glycine 0 C--N 1.347 1.18 0 CA-C-N 115.943 -0.572 . . . . 63.11 113.35 -172.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 153' ' ' VAL . . . . . 0.513 HG13 HD22 ' C' ' 125' ' ' LEU . 2.9 p -159.99 155.07 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.314 0 N-CA-C 112.708 0.633 . . . . 74.01 112.708 172.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 154' ' ' ARG . . . . . . . . . . . . . 16.7 ttm180 -120.72 132.07 54.87 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.626 1.57 . . . . 75.32 109.089 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 155' ' ' GLU . . . . . 0.571 ' HB2' HD12 ' C' ' 180' ' ' LEU . 8.3 tp10 -41.61 127.65 3.14 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 124.779 1.232 . . . . 74.51 112.887 175.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 74.04 0.76 57.6 Favored Glycine 0 C--N 1.352 1.429 0 N-CA-C 114.44 0.536 . . . . 75.21 114.44 173.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 157' ' ' SER . . . . . . . . . . . . . 36.1 t -92.71 155.52 17.65 Favored 'General case' 0 C--O 1.255 1.365 0 CA-C-O 121.519 0.676 . . . . 75.43 109.877 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 158' ' ' VAL . . . . . 0.534 HG11 HG21 ' C' ' 177' ' ' VAL . 29.7 m -99.54 122.0 50.84 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 CA-C-N 114.209 -1.36 . . . . 72.31 110.086 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 159' ' ' ILE . . . . . 0.651 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 31.7 mt -80.22 105.14 9.46 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 N-CA-C 107.198 -1.408 . . . . 72.31 107.198 170.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 62.0 ttm-85 -74.33 99.25 3.43 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 107.658 -1.238 . . . . 75.13 107.658 173.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 161' ' ' VAL . . . . . . . . . . . . . 2.4 p -117.48 101.97 52.28 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 124.301 1.041 . . . . 75.24 109.736 -178.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.69 145.46 81.41 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.106 1.87 . . . . 75.23 110.144 168.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 99.36 4.05 56.34 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-O 119.468 -0.629 . . . . 53.54 113.857 -176.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 164' ' ' MET . . . . . 0.58 ' SD ' HD22 ' C' ' 174' ' ' LEU . 19.1 ttm -144.42 5.75 1.25 Allowed 'General case' 0 CA--C 1.559 1.293 0 CA-C-N 117.668 0.734 . . . . 73.35 112.698 -174.236 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . -129.43 177.56 17.93 Favored Glycine 0 N--CA 1.488 2.143 0 CA-C-O 118.421 -1.211 . . . . 73.32 113.203 177.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 166' ' ' GLY . . . . . 0.919 ' HA3' ' HA ' ' B' ' 204' ' ' ALA . . . 98.28 106.11 2.54 Favored Glycine 0 C--N 1.364 2.087 0 CA-C-N 119.636 1.718 . . . . 75.44 116.366 176.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 167' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -99.98 100.18 11.04 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 105.87 -1.9 . . . . 74.2 105.87 160.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . 163.12 -139.11 5.7 Favored Glycine 0 C--O 1.208 -1.521 0 CA-C-O 119.188 -0.784 . . . . 13.44 112.521 -169.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 169' ' ' ASN . . . . . 0.594 ' HB3' ' HD3' ' C' ' 170' ' ' PRO . 2.1 t30 -145.3 -66.05 0.02 OUTLIER Pre-proline 0 CA--C 1.574 1.87 0 CA-C-O 116.846 -1.55 . . . . 62.44 111.254 -176.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 170' ' ' PRO . . . . . 0.594 ' HD3' ' HB3' ' C' ' 169' ' ' ASN . 73.9 Cg_exo -54.12 142.45 66.43 Favored 'Trans proline' 0 C--N 1.405 3.528 0 CA-C-N 124.046 2.481 . . . . 73.55 112.897 174.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 171' ' ' PRO . . . . . 0.542 ' HA ' ' HB2' ' B' ' 204' ' ' ALA . 60.9 Cg_endo -85.18 150.55 10.7 Favored 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 123.424 2.749 . . . . 74.02 115.22 -161.013 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 172' ' ' GLY . . . . . 0.465 ' HA3' ' H ' ' B' ' 203' ' ' ASN . . . -160.96 -109.3 0.24 Allowed Glycine 0 C--N 1.357 1.71 0 CA-C-O 118.629 -1.095 . . . . 74.42 113.495 177.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 173' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -173.56 171.94 3.76 Favored 'General case' 0 C--O 1.263 1.785 0 CA-C-O 123.782 1.753 . . . . 74.51 115.19 -168.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 174' ' ' LEU . . . . . 0.58 HD22 ' SD ' ' C' ' 164' ' ' MET . 9.9 tp -110.89 143.25 41.81 Favored 'General case' 0 C--N 1.353 0.723 0 CA-C-N 112.008 -2.36 . . . . 75.22 108.934 170.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 175' ' ' LEU . . . . . 0.472 ' HB3' ' HB ' ' C' ' 158' ' ' VAL . 72.1 mt -106.97 95.68 5.89 Favored 'General case' 0 C--O 1.249 1.036 0 N-CA-C 108.054 -1.091 . . . . 72.15 108.054 171.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 176' ' ' LEU . . . . . 0.651 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 67.5 mt -72.61 101.14 2.95 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.767 -0.651 . . . . 74.33 109.913 175.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 177' ' ' VAL . . . . . 0.534 HG21 HG11 ' C' ' 158' ' ' VAL . 25.3 t -82.67 96.94 3.95 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 N-CA-C 107.701 -1.222 . . . . 75.23 107.701 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 178' ' ' VAL . . . . . 0.419 HG22 HG13 ' C' ' 153' ' ' VAL . 8.5 p -72.99 135.45 27.68 Favored 'Isoleucine or valine' 0 C--O 1.248 1.003 0 CA-C-O 121.938 0.875 . . . . 74.01 111.62 -172.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 179' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -110.57 94.55 5.06 Favored 'General case' 0 C--O 1.243 0.717 0 N-CA-C 106.596 -1.631 . . . . 74.42 106.596 171.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 180' ' ' LEU . . . . . 0.571 HD12 ' HB2' ' C' ' 155' ' ' GLU . 80.0 mt -69.17 136.5 52.2 Favored 'General case' 0 C--N 1.351 0.631 0 CA-C-O 120.981 0.419 . . . . 73.43 110.462 178.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 181' ' ' LEU . . . . . 0.457 HD13 HG21 ' C' ' 126' ' ' THR . 98.7 mt -72.88 165.21 54.51 Favored Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 123.806 0.842 . . . . 74.24 111.234 -173.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -53.84 80.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.391 2.78 0 C-N-CA 123.154 2.569 . . . . 73.32 112.478 169.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 183' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -172.93 60.72 0.26 Allowed Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 126.165 1.786 . . . . 72.0 106.373 -175.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 184' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -82.51 65.38 8.21 Favored 'Trans proline' 0 C--N 1.384 2.397 0 C-N-CA 123.066 2.511 . . . . 74.25 111.293 -176.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 185' ' ' VAL . . . . . . . . . . . . . 17.8 t -95.45 -36.75 6.94 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.593 0 CA-C-N 115.705 -0.68 . . . . 72.23 109.248 -177.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 186' ' ' PHE . . . . . 0.401 ' HD1' ' HB3' ' C' ' 195' ' ' ALA . 38.0 m-85 -133.38 157.39 45.66 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.287 1.035 . . . . 61.44 110.825 -178.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 187' ' ' ARG . . . . . 0.424 ' HE ' ' HB3' ' C' ' 155' ' ' GLU . 35.8 ttt180 -150.73 131.82 14.37 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 108.967 -0.753 . . . . 75.14 108.967 168.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 188' ' ' LEU . . . . . 0.459 HD13 ' HD2' ' C' ' 240' ' ' PHE . 39.5 tp -79.93 146.83 31.9 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 114.266 1.21 . . . . 74.14 114.266 -168.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -139.79 100.6 3.99 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 126.157 1.783 . . . . 73.21 106.907 165.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 70.88 -95.9 0.57 Allowed Glycine 0 N--CA 1.477 1.375 0 CA-C-N 116.495 -0.32 . . . . 74.2 112.597 -176.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 191' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -124.4 -14.08 6.99 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.423 1.089 . . . . 75.25 109.805 169.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -84.38 153.53 23.39 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.397 0.679 . . . . 65.13 109.456 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 193' ' ' LEU . . . . . 0.512 HD21 ' CE2' ' C' ' 240' ' ' PHE . 89.1 mt -117.32 156.27 28.11 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.26 0.553 . . . . 65.15 111.636 -173.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 194' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -121.44 109.45 14.87 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 107.199 -1.408 . . . . 75.43 107.199 168.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 195' ' ' ALA . . . . . 0.601 ' HB2' ' HG ' ' C' ' 251' ' ' LEU . . . -111.42 -177.56 3.23 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 123.576 0.75 . . . . 65.11 111.578 -175.142 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 38.8 m -136.05 118.48 15.77 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.293 -0.867 . . . . 53.42 109.572 170.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 197' ' ' LEU . . . . . 0.437 HD11 ' HB1' ' C' ' 212' ' ' ALA . 51.4 tp -98.25 136.38 38.53 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.428 0.691 . . . . 73.5 109.758 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 198' ' ' ASP . . . . . 0.463 ' HB3' HG22 ' C' ' 256' ' ' THR . 66.9 m-20 -101.83 102.0 12.54 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 109.122 -0.696 . . . . 64.33 109.122 179.229 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 199' ' ' VAL . . . . . . . . . . . . . 21.4 t -107.05 117.15 57.17 Favored Pre-proline 0 N--CA 1.473 0.72 0 N-CA-C 108.41 -0.959 . . . . 73.12 108.41 178.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 200' ' ' PRO . . . . . 0.472 ' HD2' HG13 ' C' ' 210' ' ' VAL . 45.4 Cg_endo -69.49 151.76 70.66 Favored 'Trans proline' 0 C--N 1.371 1.718 0 C-N-CA 122.001 1.801 . . . . 73.11 111.81 175.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 201' ' ' ALA . . . . . . . . . . . . . . . -54.65 -47.16 98.74 Favored Pre-proline 0 CA--C 1.564 1.489 0 N-CA-C 114.425 1.268 . . . . 74.35 114.425 -171.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 202' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -54.49 -51.37 10.65 Favored 'Trans proline' 0 C--N 1.384 2.41 0 C-N-CA 121.813 1.675 . . . . 63.15 112.916 175.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 203' ' ' ILE . . . . . 0.452 HG21 HG11 ' C' ' 210' ' ' VAL . 53.9 mt -64.92 -32.86 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.303 0.641 . . . . 74.02 111.032 -178.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -63.72 -48.07 78.55 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.737 0.815 . . . . 75.02 111.187 178.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 205' ' ' VAL . . . . . . . . . . . . . 79.5 t -69.35 -43.26 81.19 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 CA-C-N 115.125 -0.943 . . . . 74.52 112.315 -176.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 206' ' ' VAL . . . . . 0.462 HG21 ' HE2' ' A' ' 270' ' ' LYS . 9.1 p -79.26 -36.19 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 123.248 0.343 . . . . 74.12 111.715 -176.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 82.21 71.77 1.29 Allowed Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.773 -0.649 . . . . 63.21 111.912 -168.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -100.81 -128.32 6.33 Favored Glycine 0 C--N 1.342 0.907 0 N-CA-C 111.249 -0.74 . . . . 51.32 111.249 176.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 209' ' ' LYS . . . . . 0.482 ' HG2' ' HA ' ' C' ' 222' ' ' ALA . 8.5 mtmp? -140.7 143.62 35.15 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.207 0.603 . . . . 72.44 110.424 174.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 210' ' ' VAL . . . . . 0.472 HG13 ' HD2' ' C' ' 200' ' ' PRO . 30.4 m -135.18 149.93 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 124.453 1.101 . . . . 71.52 108.207 172.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 211' ' ' ARG . . . . . . . . . . . . . 8.1 tmm_? -94.94 126.63 40.41 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 122.74 0.416 . . . . 75.53 111.033 -175.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 212' ' ' ALA . . . . . 0.437 ' HB1' HD11 ' C' ' 197' ' ' LEU . . . -96.92 118.73 33.98 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 107.201 -1.407 . . . . 74.43 107.201 167.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 213' ' ' MET . . . . . . . . . . . . . 4.3 tmm? -76.68 104.96 7.46 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 108.445 -0.946 . . . . 63.12 108.445 -178.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.49 168.74 10.0 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.857 0.837 . . . . 72.34 110.561 -176.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 215' ' ' LEU . . . . . . . . . . . . . 14.6 mt -71.53 -32.34 68.05 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 113.636 -1.62 . . . . 75.24 111.66 -168.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.28 17.75 19.93 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 114.813 -1.085 . . . . 71.0 111.366 -177.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 144.92 164.51 10.65 Favored Glycine 0 C--N 1.355 1.587 0 CA-C-O 119.685 -0.509 . . . . 74.41 112.521 176.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -84.12 113.37 1.8 Allowed 'Trans proline' 0 CA--C 1.552 1.397 0 C-N-CA 122.633 2.222 . . . . 64.03 112.027 177.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 219' ' ' VAL . . . . . . . . . . . . . 12.1 p -93.62 130.65 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 109.941 -0.392 . . . . 52.53 109.941 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 220' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -98.33 105.74 17.93 Favored 'General case' 0 C--N 1.349 0.559 0 N-CA-C 109.184 -0.673 . . . . 72.32 109.184 176.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 221' ' ' VAL . . . . . 0.491 HG11 HD23 ' C' ' 233' ' ' LEU . 70.7 t -73.14 131.74 34.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 125.236 1.414 . . . . 74.03 112.35 -177.033 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 222' ' ' ALA . . . . . 0.482 ' HA ' ' HG2' ' C' ' 209' ' ' LYS . . . -81.19 108.1 14.55 Favored 'General case' 0 CA--C 1.548 0.887 0 O-C-N 123.91 0.756 . . . . 73.3 110.247 169.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 83.7 t -81.85 136.19 48.0 Favored Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 124.87 1.268 . . . . 73.11 109.697 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 224' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -83.81 160.2 14.09 Favored 'Trans proline' 0 C--N 1.383 2.366 0 C-N-CA 123.019 2.479 . . . . 73.11 111.8 172.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -62.09 140.3 83.29 Favored 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 122.292 1.995 . . . . 74.4 111.4 174.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 226' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? 63.31 68.14 0.62 Allowed 'General case' 0 N--CA 1.477 0.883 0 O-C-N 124.243 0.964 . . . . 71.5 110.635 -178.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 227' ' ' THR . . . . . 0.438 ' O ' HG12 ' A' ' 257' ' ' ILE . 16.8 m -93.44 115.17 27.7 Favored 'General case' 0 C--O 1.219 -0.521 0 C-N-CA 123.051 0.54 . . . . 73.3 109.729 176.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 228' ' ' GLN . . . . . 0.646 HE21 ' HG2' ' A' ' 259' ' ' GLU . 27.4 mp0 -89.57 151.36 21.97 Favored 'General case' 0 C--O 1.246 0.895 0 C-N-CA 124.521 1.128 . . . . 74.32 111.94 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -72.17 108.42 5.34 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 113.914 -1.494 . . . . 65.31 109.016 174.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 121.0 1.22 11.53 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 119.215 -0.77 . . . . 62.04 113.569 -176.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 231' ' ' ARG . . . . . 0.454 ' HD2' ' H ' ' C' ' 228' ' ' GLN . 19.3 mtp180 -71.53 -179.78 2.68 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 118.107 0.953 . . . . 75.03 110.872 172.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 232' ' ' LYS . . . . . 0.432 ' HA ' ' O ' ' C' ' 251' ' ' LEU . 31.7 ttmt -143.27 144.88 32.31 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.38 0.609 . . . . 74.05 111.76 -176.115 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 233' ' ' LEU . . . . . 0.664 HD13 ' HB2' ' C' ' 251' ' ' LEU . 5.3 mp -114.05 156.98 23.14 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.198 1.399 . . . . 74.22 109.986 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 20.9 ptt180 -129.92 86.11 2.37 Favored 'General case' 0 CA--C 1.553 1.081 0 O-C-N 124.948 1.405 . . . . 72.34 109.19 170.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 235' ' ' LEU . . . . . 0.543 ' HB2' ' HB3' ' C' ' 249' ' ' LEU . 59.6 mt -83.36 98.62 9.56 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 108.464 -0.939 . . . . 74.34 108.464 173.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -65.71 133.38 50.94 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.805 0.842 . . . . 73.41 111.273 -175.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 237' ' ' GLY . . . . . 0.402 ' O ' ' HD3' ' C' ' 246' ' ' ARG . . . 77.24 7.29 86.85 Favored Glycine 0 C--N 1.348 1.207 0 O-C-N 123.444 0.465 . . . . 71.42 114.058 179.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -105.95 16.3 25.31 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.279 0.632 . . . . 75.11 111.603 -177.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -78.6 -135.06 0.95 Allowed Glycine 0 C--N 1.348 1.214 0 N-CA-C 111.285 -0.726 . . . . 75.2 111.285 170.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 240' ' ' PHE . . . . . 0.512 ' CE2' HD21 ' C' ' 193' ' ' LEU . 48.2 m-85 -97.59 116.53 65.82 Favored Pre-proline 0 C--O 1.247 0.964 0 N-CA-C 109.201 -0.666 . . . . 75.14 109.201 168.237 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 241' ' ' PRO . . . . . 0.49 ' HA ' ' HG2' ' C' ' 246' ' ' ARG . 48.9 Cg_exo -59.13 99.99 0.12 Allowed 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 123.446 2.764 . . . . 71.53 113.071 169.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -82.82 159.32 37.87 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-N 114.428 -1.26 . . . . 70.14 111.927 175.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 243' ' ' PRO . . . . . 0.451 ' HB3' HH22 ' C' ' 148' ' ' ARG . 59.4 Cg_endo -70.16 -1.71 9.25 Favored 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 122.89 2.394 . . . . 71.42 113.688 -179.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -119.47 -10.98 9.56 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.549 0.74 . . . . 71.42 111.425 176.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 158.22 157.86 8.69 Favored Glycine 0 C--N 1.346 1.116 0 N-CA-C 112.147 -0.381 . . . . 63.24 112.147 -178.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 246' ' ' ARG . . . . . 0.49 ' HG2' ' HA ' ' C' ' 241' ' ' PRO . 41.8 mtt180 -85.89 146.47 26.7 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.733 0.813 . . . . 71.32 111.576 -179.074 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -82.78 -172.23 48.1 Favored Glycine 0 C--N 1.35 1.349 0 N-CA-C 111.573 -0.611 . . . . 63.23 111.573 165.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -115.7 164.54 14.21 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 117.567 0.683 . . . . 73.54 109.886 -176.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 249' ' ' LEU . . . . . 0.543 ' HB3' ' HB2' ' C' ' 235' ' ' LEU . 34.2 tp -113.12 109.19 18.39 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 123.734 0.814 . . . . 74.23 109.08 177.145 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 250' ' ' TYR . . . . . 0.534 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 39.1 m-85 -102.0 103.14 13.74 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 108.97 -0.752 . . . . 71.43 108.97 177.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 251' ' ' LEU . . . . . 0.664 ' HB2' HD13 ' C' ' 233' ' ' LEU . 2.8 mp -96.78 147.56 23.8 Favored 'General case' 0 N--CA 1.505 2.275 0 N-CA-C 109.903 -0.406 . . . . 72.0 109.903 -173.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -107.53 137.67 45.14 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 108.883 -0.784 . . . . 75.41 108.883 169.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 253' ' ' VAL . . . . . 0.401 HG23 ' CZ3' ' B' ' 242' ' ' TRP . 45.8 t -89.68 142.59 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 113.377 0.88 . . . . 73.5 113.377 -169.132 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 254' ' ' ARG . . . . . . . . . . . . . 42.8 mtm180 -119.78 145.27 46.75 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.405 1.082 . . . . 75.13 108.255 163.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 255' ' ' ILE . . . . . 0.596 HG23 HG23 ' A' ' 257' ' ' ILE . 29.6 mm -98.32 123.46 50.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 107.958 -1.127 . . . . 75.24 107.958 169.199 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 256' ' ' THR . . . . . 0.463 HG22 ' HB3' ' C' ' 198' ' ' ASP . 0.5 OUTLIER -127.3 172.71 10.37 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.524 1.13 . . . . 70.25 109.215 -173.569 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 2.8 pp -136.91 157.53 74.6 Favored Pre-proline 0 CA--C 1.567 1.621 0 C-N-CA 124.124 0.969 . . . . 75.21 109.529 177.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -80.98 17.01 1.51 Allowed 'Trans proline' 0 C--N 1.384 2.404 0 C-N-CA 122.775 2.317 . . . . 74.41 114.209 -167.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 55.32 -83.45 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.507 1.123 . . . . 72.3 110.547 -164.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 2.4 ptp85 -78.68 134.75 37.09 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 124.312 1.045 . . . . 73.41 110.812 -174.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 261' ' ' LEU . . . . . 0.496 HD13 HG12 ' A' ' 205' ' ' VAL . 65.3 mt -113.54 154.17 27.56 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 115.065 -0.971 . . . . 74.53 111.347 -170.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 52.7 p -83.74 164.05 46.38 Favored Pre-proline 0 CA--C 1.555 1.14 0 N-CA-C 108.31 -0.996 . . . . 61.23 108.31 169.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -51.05 -42.31 53.36 Favored 'Trans proline' 0 C--N 1.382 2.298 0 C-N-CA 122.417 2.078 . . . . 74.2 112.933 173.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -57.82 -58.14 9.68 Favored 'General case' 0 C--O 1.252 1.213 0 C-N-CA 124.058 0.943 . . . . 71.04 110.316 178.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -48.01 -67.22 0.29 Allowed 'General case' 0 C--N 1.357 0.91 0 O-C-N 125.056 1.473 . . . . 71.03 109.999 177.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 266' ' ' GLU . . . . . 0.594 ' HG2' ' HA ' ' B' ' 468' ' ' LEU . 8.3 tp10 -49.18 -51.33 33.29 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.2 1.4 . . . . 73.1 111.838 -171.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -60.7 -49.11 78.84 Favored 'General case' 0 C--O 1.257 1.479 0 CA-C-N 115.582 -0.736 . . . . 71.12 112.012 -177.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 268' ' ' LEU . . . . . 0.411 ' O ' ' HG ' ' C' ' 272' ' ' LEU . 7.6 mp -65.39 -38.3 89.58 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.428 -0.806 . . . . 70.11 110.906 -178.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 73.1 m95 -58.41 -41.72 85.58 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.103 0.561 . . . . 63.11 110.693 175.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 270' ' ' LYS . . . . . 0.507 ' HE2' ' HG3' ' C' ' 266' ' ' GLU . 68.3 mmtt -56.08 -51.53 67.53 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 123.327 0.392 . . . . 75.43 110.134 176.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -56.45 -43.63 79.69 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 114.872 -1.058 . . . . 75.33 111.541 -178.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 272' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' C' ' 268' ' ' LEU . 82.8 mt -65.83 -41.1 92.2 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.14 -0.937 . . . . 74.33 110.656 -179.065 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -59.17 -42.68 91.37 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.758 0.423 . . . . 43.22 110.431 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -63.26 -38.99 93.32 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.23 0.612 . . . . 63.21 111.28 176.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -61.69 -30.04 70.49 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.037 0.535 . . . . 70.04 111.366 174.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 276' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -78.68 -33.86 46.63 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.04 0.536 . . . . 75.52 112.042 176.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -63.14 -32.53 73.94 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 120.993 0.425 . . . . 65.52 109.955 170.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -68.48 -14.21 62.85 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 123.587 0.755 . . . . 72.22 112.066 175.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 279' ' ' ARG . . . . . . . . . . . . . 42.4 mtm180 -83.86 -16.26 45.11 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 122.749 0.419 . . . . 75.11 110.394 174.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.628 0 N-CA-C 108.268 -1.012 . . . . 75.14 108.268 173.582 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.0 mmt . . . . . 0 N--CA 1.478 0.971 0 N-CA-C 108.594 -0.891 . . . . 64.12 108.594 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.66 33.04 21.84 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.707 1.203 . . . . 74.44 111.603 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -86.14 57.23 4.37 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.272 0.629 . . . . 74.04 111.0 -176.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -36.48 100.74 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 125.6 1.56 . . . . 64.14 114.135 -175.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.456 ' HG2' ' HB3' ' A' ' 96' ' ' PHE . 70.5 mmtt -93.44 94.32 8.63 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 107.907 -1.145 . . . . 74.32 107.907 171.158 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.409 ' O ' HG13 ' A' ' 10' ' ' ILE . 49.3 t0 -69.37 95.71 0.82 Allowed 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 107.305 -1.368 . . . . 62.43 107.305 173.09 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -61.82 -35.32 77.89 Favored 'General case' 0 C--O 1.244 0.803 0 O-C-N 124.121 0.888 . . . . 73.34 112.252 -171.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -65.04 -45.91 83.47 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.079 -0.51 . . . . 73.33 110.045 177.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.01 -37.86 84.02 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 123.435 0.459 . . . . 70.01 111.119 179.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 6' ' ' ASP . 68.3 mt -61.7 -39.58 83.73 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 C-N-CA 123.367 0.667 . . . . 74.23 110.318 175.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 92.9 mt -80.3 -5.52 56.42 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 112.543 0.572 . . . . 73.11 112.543 176.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.23 34.24 58.23 Favored Glycine 0 C--N 1.354 1.577 0 O-C-N 123.146 0.279 . . . . 73.42 113.396 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 23.8 m -133.23 158.77 74.91 Favored Pre-proline 0 CA--C 1.559 1.295 0 C-N-CA 124.853 1.261 . . . . 72.52 109.622 -177.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -75.3 166.55 28.63 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 122.417 2.078 . . . . 50.12 112.145 176.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -70.49 9.84 0.57 Allowed 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 113.706 1.002 . . . . 75.43 113.706 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -116.86 -1.19 12.07 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.493 1.117 . . . . 71.2 108.897 -177.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.63 121.73 14.62 Favored 'General case' 0 C--N 1.347 0.492 0 C-N-CA 124.477 1.111 . . . . 74.14 110.133 176.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.7 p -75.07 173.0 11.35 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.543 0.737 . . . . 75.03 110.931 -176.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -58.02 -33.11 68.61 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.796 0.839 . . . . 71.11 110.801 178.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.447 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 16.9 tp10 -58.0 -49.57 76.37 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.149 0.98 . . . . 72.43 110.567 171.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -70.68 -30.01 66.47 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.477 0.711 . . . . 71.14 111.85 -176.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.4 mp -69.25 -39.93 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 123.718 0.807 . . . . 73.31 109.213 174.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -64.0 -42.52 97.13 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 124.122 0.889 . . . . 75.22 110.357 178.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.514 ' HA ' ' HD3' ' A' ' 27' ' ' LYS . 66.2 mtm180 -68.69 -44.72 73.38 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.087 0.555 . . . . 73.12 110.849 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.2 -40.31 89.6 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.434 -0.803 . . . . 72.43 110.243 177.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -64.92 -47.73 76.67 Favored 'General case' 0 C--O 1.201 -1.486 0 CA-C-N 115.164 -0.926 . . . . 73.1 110.6 177.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.514 ' HD3' ' HA ' ' A' ' 24' ' ' ARG . 25.4 mtpp -50.07 -47.74 53.47 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 123.674 0.789 . . . . 74.22 110.428 178.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.451 ' HA ' ' NH2' ' A' ' 31' ' ' ARG . 8.1 tpt180 -56.52 -56.19 24.39 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 114.326 -1.306 . . . . 75.52 111.285 176.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.602 HD21 ' HE2' ' A' ' 33' ' ' TYR . 64.5 mt -82.62 -12.06 57.94 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.594 0.758 . . . . 75.12 112.297 -171.132 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 34' ' ' HIS . . . -93.37 -18.79 21.99 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.733 0.813 . . . . 71.54 110.015 179.106 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.451 ' NH2' ' HA ' ' A' ' 28' ' ' ARG . 48.8 mtm180 -84.96 -44.98 12.62 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 123.311 0.382 . . . . 72.33 110.204 165.088 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -67.5 -48.29 67.51 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.43 0.692 . . . . 73.31 111.03 -174.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.602 ' HE2' HD21 ' A' ' 29' ' ' LEU . 60.6 m-85 -102.9 24.82 10.11 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.169 0.588 . . . . 72.41 111.308 -176.01 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.482 ' CD2' ' HB3' ' A' ' 36' ' ' ASP . 48.8 t60 -71.09 102.05 0.44 Allowed Pre-proline 0 N--CA 1.482 1.141 0 C-N-CA 124.362 1.065 . . . . 73.54 110.726 -177.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.521 ' HB3' ' HG2' ' A' ' 44' ' ' GLU . 23.6 Cg_exo -62.06 -25.8 77.78 Favored 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 123.066 2.511 . . . . 75.51 113.29 -168.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.482 ' HB3' ' CD2' ' A' ' 34' ' ' HIS . 8.0 t70 -62.92 -40.18 96.83 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.117 1.367 . . . . 73.23 112.208 179.109 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 98.5 t -103.83 -44.7 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-O 121.431 0.634 . . . . 73.25 109.684 -177.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -98.44 83.1 2.97 Favored 'General case' 0 C--O 1.243 0.721 0 C-N-CA 124.344 1.057 . . . . 64.12 108.333 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -78.26 79.22 4.71 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.146 -0.934 . . . . 73.11 108.616 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 74.3 m -138.71 115.62 8.9 Favored Pre-proline 0 CA--C 1.542 0.671 0 CA-C-N 115.297 -0.865 . . . . 71.24 108.985 178.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_exo -46.15 -42.83 21.34 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 124.213 3.275 . . . . 73.53 114.353 -178.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -51.33 -49.82 60.64 Favored 'General case' 0 N--CA 1.482 1.161 0 O-C-N 124.245 0.966 . . . . 64.43 110.49 175.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.26 -26.85 67.54 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-N 114.676 -1.147 . . . . 73.42 111.602 -177.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.521 ' HG2' ' HB3' ' A' ' 35' ' ' PRO . 39.8 mt-10 -81.68 -34.48 30.67 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 122.86 0.464 . . . . 63.35 110.964 -173.041 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -82.3 -32.44 29.48 Favored 'General case' 0 C--O 1.246 0.897 0 N-CA-C 110.305 -0.257 . . . . 62.44 110.305 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 36.5 mmtm -62.54 -40.63 97.4 Favored 'General case' 0 C--N 1.348 0.502 0 CA-C-N 115.715 -0.675 . . . . 74.03 109.369 167.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -60.16 -38.63 83.74 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.555 0.742 . . . . 73.32 110.489 175.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -56.74 -57.49 12.2 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 120.793 0.33 . . . . 75.14 110.341 174.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -58.61 -41.43 85.85 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 115.151 -0.931 . . . . 71.44 111.786 -176.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.444 HD11 ' HB3' ' A' ' 29' ' ' LEU . 77.3 mt -74.33 -33.1 32.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.777 1.231 . . . . 74.43 111.217 -176.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -88.31 -10.58 49.04 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 119.237 -0.411 . . . . 73.43 111.28 179.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -75.89 -49.19 18.59 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 108.06 -1.089 . . . . 75.34 108.06 166.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -53.5 -46.9 70.21 Favored 'General case' 0 C--N 1.35 0.623 0 CA-C-N 113.625 -1.625 . . . . 65.45 111.307 174.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -69.05 -44.66 72.21 Favored 'General case' 0 C--O 1.216 -0.662 0 CA-C-N 115.026 -0.988 . . . . 73.53 110.618 177.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -50.1 -37.74 35.32 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.41 0.684 . . . . 72.52 112.224 -179.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 88.3 t -76.86 -57.74 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.971 0 CA-C-N 115.267 -0.878 . . . . 74.52 110.943 175.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 65.9 mt -87.22 6.04 35.12 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 113.619 0.97 . . . . 74.35 113.619 -166.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 37.2 t -73.03 -42.15 63.46 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 124.154 0.981 . . . . 74.34 111.349 -178.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -116.25 138.22 24.09 Favored Pre-proline 0 N--CA 1.471 0.579 0 CA-C-N 115.112 -0.949 . . . . 74.34 108.483 -171.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -58.61 -20.95 52.81 Favored 'Trans proline' 0 C--N 1.383 2.375 0 C-N-CA 123.844 3.029 . . . . 72.41 113.416 -172.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -66.6 -70.01 0.27 Allowed 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.622 0.769 . . . . 72.3 110.867 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt -67.22 -25.28 66.03 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.698 0.799 . . . . 74.54 110.894 -178.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -54.97 -56.92 14.34 Favored 'General case' 0 C--N 1.35 0.614 0 CA-C-N 114.791 -1.095 . . . . 74.11 109.702 169.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -58.13 -37.91 75.5 Favored 'General case' 0 C--N 1.364 1.236 0 O-C-N 123.784 0.677 . . . . 74.25 111.362 178.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.53 HG23 ' HG2' ' A' ' 76' ' ' PRO . 1.7 mp -54.31 -48.64 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 123.521 0.513 . . . . 74.41 110.997 175.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -69.72 -43.13 73.0 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 119.43 -0.319 . . . . 75.4 110.88 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -57.68 -39.95 78.3 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.156 0.582 . . . . 64.04 111.344 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 63.1 p -74.17 -25.5 59.76 Favored 'General case' 0 C--N 1.347 0.495 0 CA-C-N 115.617 -0.72 . . . . 75.44 110.6 177.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -72.86 136.41 45.32 Favored 'General case' 0 CA--C 1.551 0.983 0 N-CA-C 108.752 -0.833 . . . . 75.32 108.752 169.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.95 18.0 56.88 Favored Glycine 0 N--CA 1.471 1.007 0 N-CA-C 111.513 -0.635 . . . . 64.23 111.513 -171.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 34.9 m -144.33 -58.81 0.38 Allowed 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 103.415 -2.809 . . . . 71.23 103.415 176.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 51.3 m -80.93 142.82 33.14 Favored 'General case' 0 C--O 1.25 1.127 0 N-CA-C 105.411 -2.07 . . . . 74.23 105.411 156.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.67 -25.22 13.23 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.66 0.784 . . . . 74.04 110.637 178.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.98 143.19 77.29 Favored Pre-proline 0 C--O 1.245 0.843 0 C-N-CA 123.71 0.804 . . . . 75.1 110.094 175.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -62.55 143.56 93.06 Favored 'Trans proline' 0 C--N 1.371 1.761 0 C-N-CA 122.224 1.95 . . . . 75.41 109.921 170.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.53 ' HG2' HG23 ' A' ' 65' ' ' ILE . 31.6 Cg_exo -59.98 144.37 99.47 Favored 'Trans proline' 0 C--N 1.371 1.741 0 C-N-CA 122.831 2.354 . . . . 74.25 112.293 -179.132 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.53 119.21 6.27 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 122.647 2.231 . . . . 73.45 111.421 176.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -65.74 134.35 37.45 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 122.76 2.307 . . . . 73.2 112.78 -173.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -72.92 145.49 40.34 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.387 2.058 . . . . 71.05 111.201 174.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -59.88 87.01 0.07 OUTLIER 'Trans proline' 0 C--N 1.384 2.402 0 C-N-CA 122.924 2.416 . . . . 74.31 111.605 178.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 155.26 -46.67 0.52 Allowed Glycine 0 C--N 1.332 0.308 0 N-CA-C 109.141 -1.584 . . . . 62.41 109.141 -176.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.515 ' HA3' ' HA ' ' A' ' 106' ' ' PHE . . . 117.01 -174.01 14.99 Favored Glycine 0 C--N 1.346 1.102 0 CA-C-N 115.575 -0.313 . . . . 53.03 113.55 174.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -92.78 130.45 38.39 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.825 0.85 . . . . 74.41 110.655 -178.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.65 158.19 30.63 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 124.464 1.103 . . . . 71.31 110.432 174.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -153.35 75.33 1.06 Allowed 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 107.93 -1.137 . . . . 73.24 107.93 177.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.401 ' HA ' ' HE2' ' A' ' 164' ' ' MET . 12.9 m -38.4 84.87 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 127.229 2.212 . . . . 74.44 116.536 -164.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 71.69 20.17 78.42 Favored Glycine 0 C--N 1.342 0.88 0 N-CA-C 114.791 0.676 . . . . 70.11 114.791 174.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -122.04 135.87 54.87 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 123.62 0.768 . . . . 72.34 109.454 -174.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -74.9 88.47 2.32 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 115.842 -0.617 . . . . 71.44 111.22 -171.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.6 p -33.11 -47.9 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.562 1.426 0 C-N-CA 126.34 1.856 . . . . 75.21 113.529 169.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -64.76 -22.85 67.07 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.048 0.939 . . . . 75.33 111.984 -170.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -89.38 -27.74 20.24 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.216 0.606 . . . . 61.35 112.437 -178.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -75.7 173.93 10.45 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 113.288 0.847 . . . . 73.34 113.288 -166.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 53.2 p -71.56 175.43 5.58 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 114.655 1.354 . . . . 74.5 114.655 -161.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -67.23 -50.64 59.95 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 113.562 -1.654 . . . . 74.52 110.374 -174.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.456 ' HB3' ' HG2' ' A' ' 5' ' ' LYS . 72.5 t80 -54.01 -41.06 67.55 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 124.48 1.113 . . . . 75.03 111.729 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -60.46 -51.97 67.2 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 115.384 -0.825 . . . . 72.32 110.121 172.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.524 ' HA ' HD12 ' A' ' 105' ' ' LEU . 46.8 mt-30 -70.04 -3.14 14.99 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.609 0.763 . . . . 74.14 112.281 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -98.29 -47.98 5.24 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.191 0.996 . . . . 70.02 111.684 170.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 52.8 tp -73.4 -50.77 20.05 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.394 0.678 . . . . 74.33 110.531 -172.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -90.11 -7.44 53.75 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.363 -0.835 . . . . 72.11 110.067 175.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.42 ' HA2' ' HG ' ' A' ' 105' ' ' LEU . . . -44.64 -59.1 4.42 Favored Glycine 0 C--N 1.364 2.096 0 CA-C-O 118.058 -1.412 . . . . 72.43 115.078 -178.078 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -40.56 -25.8 0.2 Allowed 'Trans proline' 0 C--N 1.391 2.809 0 C-N-CA 124.687 3.591 . . . . 64.43 115.739 178.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -149.11 54.79 0.5 Allowed Glycine 0 C--N 1.348 1.216 0 N-CA-C 111.461 -0.656 . . . . 54.4 111.461 177.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.524 HD12 ' HA ' ' A' ' 98' ' ' GLN . 13.4 mt -69.0 73.3 0.27 Allowed 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 117.468 0.634 . . . . 74.25 110.998 171.142 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.594 ' CG ' ' HA3' ' A' ' 168' ' ' GLY . 0.1 OUTLIER 43.97 -115.02 0.39 Allowed 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 125.639 1.576 . . . . 74.45 113.152 177.769 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.48 ' H ' ' HB3' ' A' ' 106' ' ' PHE . . . 60.8 20.86 57.65 Favored Glycine 0 C--N 1.36 1.863 0 CA-C-O 119.712 -0.493 . . . . 44.0 112.965 -168.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 57.19 -133.66 52.6 Favored Glycine 0 C--N 1.36 1.903 0 N-CA-C 111.577 -0.609 . . . . 71.34 111.577 -171.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -83.25 -7.51 59.59 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.715 0.406 . . . . 74.55 110.469 174.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -92.24 -10.99 60.34 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-O 119.018 -0.879 . . . . 55.25 114.17 -177.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 45.1 tpt85 58.76 5.55 0.5 Allowed 'General case' 0 N--CA 1.506 2.361 0 CA-C-N 118.137 0.968 . . . . 75.52 113.439 174.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -61.21 -21.42 63.83 Favored 'General case' 0 CA--C 1.562 1.429 0 C-N-CA 124.498 1.119 . . . . 75.13 113.721 -176.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 35.3 m 58.46 46.46 15.05 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.324 1.05 . . . . 74.21 110.546 -174.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -92.63 156.37 17.14 Favored 'General case' 0 CA--C 1.553 1.072 0 CA-C-N 115.517 -0.765 . . . . 74.52 109.338 -173.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -96.11 148.6 22.51 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.547 0.739 . . . . 73.31 110.953 -174.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.575 ' HA2' ' HA ' ' A' ' 170' ' ' PRO . . . -106.37 177.42 22.19 Favored Glycine 0 CA--C 1.5 -0.886 0 N-CA-C 122.751 3.86 . . . . 73.4 122.751 -162.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -120.97 150.18 41.51 Favored 'General case' 0 C--O 1.266 1.926 0 CA-C-N 111.197 -2.501 . . . . 74.43 110.034 175.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -66.21 149.95 49.54 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.837 1.255 . . . . 74.23 112.466 -174.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 10.0 tt -149.32 147.05 27.87 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.881 -0.785 . . . . 75.42 108.881 178.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.477 HH21 HG22 ' A' ' 177' ' ' VAL . 33.8 mtp-105 -94.26 122.76 37.13 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.011 0.524 . . . . 74.51 109.961 176.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.438 ' HB1' HD11 ' A' ' 174' ' ' LEU . . . -113.57 166.63 11.33 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.549 -0.908 . . . . 54.41 108.549 171.115 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -127.59 118.9 24.79 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.666 -1.235 . . . . 72.42 107.666 -174.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 25.4 tp -99.92 99.76 9.84 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 108.611 -0.885 . . . . 74.14 108.611 -169.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 56.3 Cg_endo -73.61 113.55 3.81 Favored 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 121.69 1.594 . . . . 75.33 108.637 176.04 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.552 ' HA ' HG22 ' B' ' 6' ' ' ILE . 28.0 tp -120.82 138.43 54.05 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 123.44 0.696 . . . . 72.43 109.848 -169.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 96.6 m -67.79 128.85 38.01 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 114.408 -1.269 . . . . 71.34 110.062 176.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.817 ' HB3' HD21 ' A' ' 215' ' ' LEU . 8.2 mt -54.8 -47.63 73.78 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 122.264 1.031 . . . . 75.21 111.914 -173.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.423 ' HG2' ' HA2' ' B' ' 96' ' ' GLY . 16.7 mp0 -62.28 -44.04 97.45 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 113.292 -1.776 . . . . 75.32 109.997 -177.019 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -76.57 -20.09 57.2 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 115.577 -0.738 . . . . 64.33 111.798 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 153' ' ' VAL . . . -69.26 -39.98 78.1 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.523 0.729 . . . . 65.44 109.636 175.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.435 ' HB2' HD11 ' A' ' 215' ' ' LEU . 47.8 t80 -75.78 -38.91 57.86 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 115.06 -0.973 . . . . 74.51 111.564 176.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 54.4 m170 -71.25 -35.51 71.45 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 122.565 0.346 . . . . 75.25 111.188 -178.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.401 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 75.94 -141.15 26.83 Favored Glycine 0 C--N 1.344 1.012 0 CA-C-N 116.069 -0.514 . . . . 71.54 113.039 -179.317 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 84.09 -175.48 51.5 Favored Glycine 0 C--N 1.348 1.249 0 C-N-CA 123.254 0.454 . . . . 70.42 113.036 178.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.447 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 1.2 mp0 -72.29 111.87 7.87 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.249 0.62 . . . . 73.14 109.588 174.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 8.3 tpp180 -93.65 119.32 32.52 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.246 0.618 . . . . 75.05 109.611 -178.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 74.9 t -81.65 105.37 11.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 108.326 -0.99 . . . . 75.04 108.326 175.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.0 p -124.99 123.33 65.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 C-N-CA 124.396 1.078 . . . . 73.34 108.44 176.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -121.2 146.63 46.58 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.119 0.568 . . . . 71.3 109.971 -177.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 11.0 p -160.4 131.66 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-N 115.5 -0.773 . . . . 75.1 109.509 -177.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 59.93 24.64 13.75 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 124.319 1.048 . . . . 74.24 112.007 -177.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 92.85 -24.65 23.17 Favored Glycine 0 C--N 1.355 1.627 0 CA-C-N 116.13 -0.486 . . . . 54.15 112.387 -176.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 66.1 ttp85 -74.52 99.81 3.7 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.772 0.829 . . . . 72.43 110.489 -177.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -89.97 116.13 27.79 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 123.674 0.79 . . . . 74.41 109.977 178.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.476 HG21 ' HE1' ' A' ' 164' ' ' MET . 7.3 p -121.5 148.39 24.93 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 C-N-CA 123.993 0.917 . . . . 73.53 109.506 177.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.446 ' OG ' ' HB3' ' A' ' 135' ' ' GLU . 34.6 t -113.48 87.56 2.64 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.109 0.963 . . . . 64.43 109.035 179.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 29.6 m -83.83 112.51 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-N 116.093 -0.503 . . . . 73.42 109.729 -176.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.447 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 57.4 ttt85 -68.46 95.01 0.59 Allowed 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.329 0.585 . . . . 74.32 109.461 177.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.613 ' HB ' HG13 ' A' ' 153' ' ' VAL . 44.6 pt -81.45 138.13 48.16 Favored Pre-proline 0 CA--C 1.554 1.108 0 CA-C-N 114.896 -1.047 . . . . 74.52 109.506 178.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.48 140.38 43.59 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 122.282 1.988 . . . . 74.22 111.525 177.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.07 93.53 0.11 Allowed 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 123.076 2.518 . . . . 74.15 111.913 174.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 138.59 -5.74 3.19 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-O 118.946 -0.919 . . . . 75.51 113.22 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.613 HG13 ' HB ' ' A' ' 149' ' ' ILE . 7.5 p -58.8 123.22 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 C-N-CA 123.767 0.827 . . . . 75.43 110.969 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.748 ' HD3' HD23 ' A' ' 193' ' ' LEU . 95.4 mtt180 -140.67 167.97 20.91 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 121.704 -0.622 . . . . 73.23 111.271 -173.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.461 ' HB3' ' H ' ' A' ' 188' ' ' LEU . 10.3 tp10 -35.62 118.46 0.48 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 126.977 2.111 . . . . 72.32 114.119 -172.115 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 107.95 -27.25 15.0 Favored Glycine 0 C--N 1.342 0.867 0 CA-C-O 119.398 -0.668 . . . . 74.33 112.92 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 30.7 t -59.6 112.51 1.82 Allowed 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.533 0.733 . . . . 74.23 110.133 -178.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 48.4 t -86.67 96.88 5.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 115.633 -0.712 . . . . 74.02 109.266 -179.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.578 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 65.8 mt -72.91 102.5 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 N-CA-C 108.409 -0.96 . . . . 75.24 108.409 171.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 51.9 ttt-85 -85.53 103.36 14.32 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.929 -0.578 . . . . 75.21 109.991 -175.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.448 HG11 ' HB3' ' A' ' 174' ' ' LEU . 4.4 p -120.64 116.81 31.64 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 122.895 0.478 . . . . 71.41 109.999 178.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.559 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 48.3 Cg_endo -68.86 175.77 6.92 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.573 2.182 . . . . 74.53 112.809 178.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 65.05 6.37 25.03 Favored Glycine 0 C--N 1.351 1.404 0 N-CA-C 115.787 1.075 . . . . 70.43 115.787 173.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.476 ' HE1' HG21 ' A' ' 145' ' ' VAL . 64.1 mtt -131.44 -1.7 3.91 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 117.776 0.788 . . . . 64.15 112.796 -173.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -54.63 -89.11 0.01 OUTLIER Glycine 0 N--CA 1.487 2.091 0 N-CA-C 110.54 -1.024 . . . . 73.33 110.54 -176.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.562 ' O ' ' HA ' ' A' ' 171' ' ' PRO . . . -74.89 161.49 53.43 Favored Glycine 0 CA--C 1.541 1.689 0 N-CA-C 106.185 -2.766 . . . . 74.5 106.185 155.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.52 HE21 ' HA ' ' A' ' 167' ' ' GLN . 0.0 OUTLIER -102.7 99.67 9.67 Favored 'General case' 0 CA--C 1.56 1.339 0 CA-C-N 120.153 1.977 . . . . 75.42 113.61 -174.162 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.594 ' HA3' ' CG ' ' A' ' 106' ' ' PHE . . . 75.06 -19.68 2.13 Favored Glycine 0 C--N 1.363 2.076 0 N-CA-C 119.471 2.548 . . . . 64.21 119.471 158.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . 0.541 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . 10.8 t30 -107.8 -43.88 0.12 Allowed Pre-proline 0 C--N 1.319 -0.757 0 N-CA-C 105.111 -2.181 . . . . 63.54 105.111 164.122 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.575 ' HA ' ' HA2' ' A' ' 116' ' ' GLY . 97.2 Cg_endo -106.64 52.28 0.02 OUTLIER 'Trans proline' 0 CA--C 1.587 3.126 0 C-N-CA 122.361 2.041 . . . . 73.02 114.687 158.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.562 ' HA ' ' O ' ' A' ' 166' ' ' GLY . 59.0 Cg_endo -63.89 102.61 0.37 Allowed 'Trans proline' 1 C--N 1.43 4.855 0 C-N-CA 122.746 2.297 . . . . 71.25 110.997 -177.771 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -116.75 -169.63 15.24 Favored Glycine 0 N--CA 1.482 1.761 0 C-N-CA 120.665 -0.779 . . . . 72.4 114.677 -169.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.559 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 33.5 m-20 -79.33 105.84 10.93 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 108.725 -0.842 . . . . 71.14 108.725 169.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.448 ' HB3' HG11 ' A' ' 161' ' ' VAL . 20.8 tp -82.73 108.67 16.26 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.416 -0.811 . . . . 74.2 110.004 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 82.4 mt -85.93 93.68 9.0 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.764 -0.828 . . . . 72.12 108.764 175.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.578 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 92.2 mt -78.02 93.88 4.55 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-N 115.794 -0.639 . . . . 74.52 109.958 178.3 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.477 HG22 HH21 ' A' ' 120' ' ' ARG . 41.9 t -81.99 98.21 4.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 106.137 -1.801 . . . . 71.11 106.137 174.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 12.8 p -65.39 110.77 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-O 121.797 0.808 . . . . 74.13 110.101 -174.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.477 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 11.9 mmm-85 -91.32 127.45 36.75 Favored 'General case' 0 C--O 1.219 -0.509 0 N-CA-C 107.636 -1.246 . . . . 73.42 107.636 173.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.426 HD12 HD21 ' A' ' 127' ' ' LEU . 15.5 mt -91.16 147.33 23.13 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.806 -0.442 . . . . 74.04 109.806 176.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 89.3 mt -55.88 162.77 2.49 Favored Pre-proline 0 N--CA 1.487 1.395 0 C-N-CA 124.979 1.312 . . . . 73.22 113.841 -169.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.23 14.55 0.29 Allowed 'Trans proline' 0 C--N 1.395 2.987 0 C-N-CA 123.052 2.501 . . . . 74.32 113.696 173.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 184' ' ' PRO . 66.2 t-80 -60.85 105.36 0.57 Allowed Pre-proline 0 CA--C 1.563 1.47 0 N-CA-C 106.317 -1.734 . . . . 73.35 106.317 165.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 183' ' ' HIS . 6.6 Cg_exo -72.13 28.24 0.26 Allowed 'Trans proline' 0 N--CA 1.506 2.222 0 C-N-CA 124.764 3.643 . . . . 61.24 118.161 -158.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 21.6 t -93.97 -57.95 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-N 119.583 1.083 . . . . 72.34 110.303 -172.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . 0.553 ' HB3' HD22 ' A' ' 193' ' ' LEU . 26.8 m-85 -124.81 155.82 38.79 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 112.815 0.672 . . . . 72.31 112.815 -169.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -147.39 99.18 3.1 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 106.076 -1.824 . . . . 75.51 106.076 171.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.461 ' H ' ' HB3' ' A' ' 155' ' ' GLU . 0.7 OUTLIER -78.83 158.03 28.25 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 122.736 0.415 . . . . 74.21 111.429 -175.356 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . 0.448 ' HG2' ' HA ' ' B' ' 120' ' ' TYR . 26.6 tt0 -148.61 128.64 13.58 Favored 'General case' 0 C--O 1.247 0.937 0 N-CA-C 107.439 -1.319 . . . . 70.31 107.439 166.035 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . 0.446 ' HA3' ' HB3' ' B' ' 120' ' ' TYR . . . 70.85 -82.38 0.41 Allowed Glycine 0 C--N 1.349 1.267 0 O-C-N 123.653 0.596 . . . . 65.41 112.716 -178.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.409 ' OE1' ' HD2' ' A' ' 243' ' ' PRO . 0.1 OUTLIER -147.63 -5.8 0.47 Allowed 'General case' 0 C--O 1.252 1.222 0 C-N-CA 123.19 0.596 . . . . 72.32 111.776 179.856 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -111.23 147.84 34.13 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 122.886 0.474 . . . . 72.32 111.262 -175.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.748 HD23 ' HD3' ' A' ' 154' ' ' ARG . 83.8 mt -93.54 137.25 33.01 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.191 0.996 . . . . 74.25 111.035 -177.149 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -105.74 103.37 12.86 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 108.063 -1.088 . . . . 73.14 108.063 165.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.492 ' HB1' HD23 ' A' ' 251' ' ' LEU . . . -103.15 172.55 6.75 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.285 1.034 . . . . 74.34 110.759 179.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 91.1 m -119.81 131.84 55.43 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.625 0.77 . . . . 70.21 108.956 171.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.42 HD13 HG22 ' A' ' 210' ' ' VAL . 38.2 tp -113.86 129.05 56.63 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.358 0.663 . . . . 74.1 110.793 -176.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -88.15 120.64 29.69 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 107.411 -1.329 . . . . 63.3 107.411 167.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.2 p -142.88 120.65 7.11 Favored Pre-proline 0 CA--C 1.544 0.747 0 N-CA-C 109.404 -0.591 . . . . 74.33 109.404 179.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.72 151.22 74.69 Favored 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 121.763 1.642 . . . . 70.05 111.038 174.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -51.05 -45.54 88.34 Favored Pre-proline 0 CA--C 1.552 1.021 0 N-CA-C 114.756 1.391 . . . . 71.34 114.756 -173.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -55.96 -45.79 35.99 Favored 'Trans proline' 0 C--N 1.388 2.616 0 C-N-CA 122.013 1.809 . . . . 73.32 113.584 175.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.568 HD13 ' HB3' ' C' ' 276' ' ' TYR . 27.8 mt -71.4 -28.27 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 123.082 0.553 . . . . 71.02 110.645 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.95 -41.86 77.47 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.043 0.537 . . . . 74.14 110.761 177.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 34.1 t -71.18 -48.19 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.602 0.761 . . . . 64.22 111.828 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 86.8 t -94.26 -35.5 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.059 0.544 . . . . 74.41 112.1 -169.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 88.68 111.7 1.17 Allowed Glycine 0 CA--C 1.53 0.977 0 CA-C-N 116.366 -0.379 . . . . 72.35 113.569 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -173.62 -158.7 18.54 Favored Glycine 0 C--N 1.351 1.402 0 CA-C-O 120.174 -0.237 . . . . 73.32 112.763 177.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -80.31 119.2 22.73 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.343 0.868 . . . . 73.34 113.343 -167.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.42 HG22 HD13 ' A' ' 197' ' ' LEU . 29.2 m -110.84 -172.74 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 114.158 -1.383 . . . . 63.11 107.665 162.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . 0.461 ' HD2' ' HB2' ' A' ' 218' ' ' PRO . 60.2 ttp180 -126.4 115.93 20.38 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 109.823 -0.436 . . . . 74.32 109.823 172.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -105.68 160.06 15.5 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.94 -0.763 . . . . 74.41 108.94 172.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 54.1 ttm -97.09 147.86 23.62 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 109.164 -0.68 . . . . 74.15 109.164 176.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 81.4 p -124.86 -173.3 2.77 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 108.455 -0.943 . . . . 74.1 108.455 169.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.817 HD21 ' HB3' ' A' ' 127' ' ' LEU . 22.5 mt -72.64 -19.78 61.38 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.044 0.538 . . . . 73.14 110.699 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -110.6 25.95 11.22 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.978 0.911 . . . . 64.44 110.506 178.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 98.94 -175.26 28.53 Favored Glycine 0 C--N 1.351 1.373 0 N-CA-C 114.839 0.696 . . . . 63.05 114.839 173.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . 0.461 ' HB2' ' HD2' ' A' ' 211' ' ' ARG . 83.8 Cg_endo -76.58 132.07 13.05 Favored 'Trans proline' 0 CA--C 1.557 1.671 0 C-N-CA 123.399 2.733 . . . . 74.13 113.719 -174.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.4 ' HA ' HG23 ' B' ' 384' ' ' THR . 27.2 m -125.7 153.93 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 124.891 1.276 . . . . 73.4 110.257 177.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -79.79 130.08 35.02 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.947 -0.39 . . . . 75.04 109.947 173.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 88.9 t -119.96 121.73 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 123.6 0.76 . . . . 74.51 110.269 -176.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -81.33 103.5 11.14 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.184 0.593 . . . . 70.4 109.812 177.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.59 ' HA ' HD12 ' B' ' 441' ' ' ILE . 92.9 t -67.64 146.58 98.58 Favored Pre-proline 0 CA--C 1.56 1.328 0 C-N-CA 125.497 1.519 . . . . 71.22 110.609 177.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -83.04 161.82 15.66 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 122.434 2.09 . . . . 75.51 111.268 172.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . 0.547 ' HD2' ' HD3' ' B' ' 446' ' ' PRO . 11.3 Cg_exo -70.47 148.4 60.37 Favored 'Trans proline' 0 C--N 1.365 1.44 0 C-N-CA 122.23 1.953 . . . . 72.53 112.647 176.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 57.6 mtt-85 69.32 28.41 4.82 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.578 1.551 . . . . 75.13 111.575 171.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.439 HG21 HD23 ' A' ' 233' ' ' LEU . 19.6 m -69.27 104.45 2.23 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.665 1.586 . . . . 64.32 110.512 174.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . 0.401 HE21 ' HG3' ' C' ' 259' ' ' GLU . 6.0 tt0 -101.21 151.61 21.65 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.712 0.805 . . . . 75.32 110.475 -177.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . 0.426 ' HA ' ' HB ' ' A' ' 253' ' ' VAL . . . -75.01 152.01 38.74 Favored 'General case' 0 C--N 1.355 0.847 0 N-CA-C 113.19 0.811 . . . . 65.12 113.19 -169.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 85.73 -3.34 87.28 Favored Glycine 0 C--N 1.348 1.209 0 CA-C-N 114.719 -1.128 . . . . 75.54 112.988 -176.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -98.02 156.74 16.5 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.671 0.788 . . . . 74.44 110.563 -178.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -104.82 112.39 25.48 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.936 0.895 . . . . 72.22 108.683 176.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.439 HD23 HG21 ' A' ' 227' ' ' THR . 65.9 mt -75.8 99.83 4.56 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 107.906 -1.146 . . . . 71.4 107.906 174.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -83.58 100.46 10.82 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 109.578 -0.527 . . . . 73.41 109.578 176.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.516 ' HG ' ' HB3' ' A' ' 249' ' ' LEU . 0.3 OUTLIER -95.94 115.48 27.49 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 107.838 -1.171 . . . . 74.24 107.838 172.118 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.537 ' HB3' ' HZ1' ' A' ' 236' ' ' LYS . 1.5 mmmp? -68.09 136.66 54.1 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 114.577 -1.192 . . . . 71.01 112.203 -171.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 84.99 35.82 12.08 Favored Glycine 0 C--N 1.349 1.282 0 O-C-N 123.807 0.692 . . . . 74.2 114.375 169.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -116.04 -23.2 8.62 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.787 0.435 . . . . 74.1 111.68 -177.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -89.06 -173.64 46.47 Favored Glycine 0 C--N 1.348 1.211 0 N-CA-C 111.063 -0.815 . . . . 74.43 111.063 171.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -96.27 164.24 18.89 Favored Pre-proline 0 N--CA 1.49 1.563 0 CA-C-N 117.794 0.797 . . . . 73.41 111.398 -173.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 246' ' ' ARG . 96.4 Cg_exo -48.75 135.57 28.03 Favored 'Trans proline' 0 C--N 1.388 2.655 0 C-N-CA 123.356 2.704 . . . . 73.33 114.949 175.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -161.42 -162.42 12.87 Favored Glycine 0 C--N 1.347 1.144 0 CA-C-O 119.253 -0.749 . . . . 73.52 112.601 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . 0.517 ' HB2' ' HE1' ' B' ' 120' ' ' TYR . 32.0 Cg_exo -58.15 -23.65 62.6 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 123.399 2.733 . . . . 72.5 113.164 177.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -88.09 19.06 3.84 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.777 0.831 . . . . 70.11 111.716 176.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 81.44 -82.41 1.57 Allowed Glycine 0 C--N 1.349 1.26 0 N-CA-C 110.269 -1.132 . . . . 62.24 110.269 -174.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.493 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 70.2 mtm180 -126.51 151.86 47.27 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.709 1.203 . . . . 75.41 108.032 169.149 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -83.74 175.96 52.13 Favored Glycine 0 C--N 1.347 1.185 0 N-CA-C 114.192 0.437 . . . . 70.31 114.192 -174.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -122.83 -175.68 3.22 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.113 0.965 . . . . 75.44 110.906 -174.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.516 ' HB3' ' HG ' ' A' ' 235' ' ' LEU . 50.9 tp -127.58 130.44 49.07 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.048 -1.093 . . . . 73.32 108.048 169.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -113.24 105.33 13.29 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 107.429 -1.323 . . . . 71.3 107.429 178.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.492 HD23 ' HB1' ' A' ' 195' ' ' ALA . 36.8 mt -93.6 110.92 22.5 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.129 0.571 . . . . 74.54 110.016 -176.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -77.69 109.72 11.92 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.256 0.623 . . . . 75.41 109.491 -177.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.426 ' HB ' ' HA ' ' A' ' 229' ' ' ALA . 31.9 t -68.99 111.25 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 CA-C-N 114.669 -1.151 . . . . 71.34 111.691 -170.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -110.8 99.93 8.76 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 107.803 -1.184 . . . . 73.14 107.803 167.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.55 HD13 ' HA ' ' C' ' 256' ' ' THR . 72.4 mt -76.9 122.18 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 114.853 -1.067 . . . . 74.34 109.985 179.261 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 61.8 p -107.46 165.36 11.46 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 124.164 0.986 . . . . 74.52 109.667 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . 0.717 HD13 HE21 ' C' ' 228' ' ' GLN . 2.8 pp -130.86 152.24 80.26 Favored Pre-proline 0 CA--C 1.557 1.231 0 C-N-CA 123.517 0.727 . . . . 73.4 110.285 -176.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_exo -53.44 -16.4 7.43 Favored 'Trans proline' 0 C--N 1.383 2.344 0 C-N-CA 123.891 3.061 . . . . 74.45 116.744 -169.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.424 ' HA ' ' HB3' ' C' ' 226' ' ' ARG . 64.8 mt-10 50.54 -74.22 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 124.581 1.152 . . . . 75.12 112.947 -167.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.51 139.71 42.35 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 109.814 -0.439 . . . . 75.12 109.814 174.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.63 HD21 ' HB2' ' A' ' 265' ' ' GLU . 83.4 mt -134.99 152.25 51.56 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.436 0.694 . . . . 72.32 109.949 174.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.0 155.6 39.74 Favored Pre-proline 0 CA--C 1.552 1.039 0 N-CA-C 106.513 -1.662 . . . . 74.31 106.513 164.137 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -42.95 -27.92 1.06 Allowed 'Trans proline' 0 C--N 1.39 2.74 0 C-N-CA 124.325 3.35 . . . . 74.33 115.515 -174.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -60.51 -71.49 0.13 Allowed 'General case' 0 C--O 1.252 1.194 0 C-N-CA 124.28 1.032 . . . . 71.44 111.842 178.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . 0.63 ' HB2' HD21 ' A' ' 261' ' ' LEU . 2.1 mp0 -65.83 -30.92 71.62 Favored 'General case' 0 C--N 1.356 0.871 0 N-CA-C 109.265 -0.643 . . . . 73.22 109.265 -177.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' GLU . . . . . 0.575 ' HA ' HD12 ' A' ' 261' ' ' LEU . 4.7 tp10 -51.58 -54.77 24.08 Favored 'General case' 0 C--N 1.355 0.815 0 O-C-N 124.294 0.996 . . . . 73.45 109.678 174.122 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -65.71 -37.41 86.36 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.214 0.606 . . . . 64.12 112.108 -177.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . 0.481 HD22 ' HE3' ' C' ' 271' ' ' LYS . 9.3 mp -59.47 -60.33 4.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 123.452 0.47 . . . . 73.14 110.982 175.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -55.65 -38.43 69.54 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.359 1.064 . . . . 75.0 112.465 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . 0.627 ' HE2' ' HA ' ' C' ' 206' ' ' VAL . 0.0 OUTLIER -65.47 -50.17 66.33 Favored 'General case' 0 N--CA 1.478 0.969 0 O-C-N 123.52 0.512 . . . . 73.12 110.181 -179.784 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . 0.453 ' HZ3' HD23 ' C' ' 268' ' ' LEU . 3.2 tmpt? -57.64 -48.9 78.18 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 123.68 0.612 . . . . 70.22 109.89 179.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 272' ' ' LEU . . . . . 0.482 ' O ' ' HB2' ' A' ' 276' ' ' TYR . 83.9 mt -52.43 -50.5 62.43 Favored 'General case' 0 C--N 1.357 0.916 0 O-C-N 124.413 1.07 . . . . 71.54 110.586 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -72.33 -43.49 64.05 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.019 1.118 . . . . 72.23 114.019 -171.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -75.39 -36.16 60.92 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.038 0.535 . . . . 74.35 110.13 -175.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -72.33 -32.91 66.92 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 116.293 -0.412 . . . . 72.24 110.414 171.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . 0.521 ' HE2' ' HG3' ' C' ' 258' ' ' PRO . 51.4 t80 -55.93 -53.01 62.08 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.344 1.058 . . . . 75.02 109.37 176.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.37 -34.75 75.02 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 115.401 -0.818 . . . . 72.14 110.391 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -63.0 -10.54 14.23 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 112.757 0.651 . . . . 75.41 112.757 173.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . 0.443 HH22 ' CD ' ' C' ' 265' ' ' GLU . 49.7 mtm180 -122.95 3.65 9.39 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.777 0.831 . . . . 75.15 111.033 174.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.465 0 C-N-CA 123.576 0.75 . . . . 72.5 109.775 176.501 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.297 0 N-CA-C 111.394 0.146 . . . . 74.12 111.394 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.505 ' HB3' ' HB2' ' B' ' 94' ' ' PHE . 74.8 tttt -89.62 120.22 30.72 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.727 0.811 . . . . 62.45 110.056 -179.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -82.05 -10.94 59.05 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.743 -0.598 . . . . 74.04 112.154 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 19.5 m 58.97 -84.11 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 125.384 1.474 . . . . 52.14 112.838 177.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 11.8 m -95.49 150.8 19.92 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.277 0.631 . . . . 74.34 110.139 -175.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.552 HG22 ' HA ' ' A' ' 125' ' ' LEU . 38.2 pt -134.13 169.92 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 123.388 0.675 . . . . 65.34 112.329 -163.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -139.44 134.38 32.27 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.314 1.046 . . . . 72.22 109.582 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 52.9 tp -74.32 147.87 41.88 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.213 1.005 . . . . 75.22 111.705 -171.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.35 -57.73 3.96 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.075 0.55 . . . . 73.12 111.559 178.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 21.8 mt 67.43 -13.31 0.23 Allowed 'General case' 0 N--CA 1.506 2.367 0 C-N-CA 124.961 1.304 . . . . 74.1 113.449 -169.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 83.9 mt 58.68 71.83 0.93 Allowed Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 125.155 1.382 . . . . 72.11 112.305 -176.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -71.38 -55.7 0.13 Allowed 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 122.84 2.36 . . . . 71.41 110.059 173.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -148.82 129.69 14.28 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 108.051 -1.092 . . . . 75.11 108.051 169.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -151.0 107.92 3.55 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 107.388 -1.338 . . . . 64.54 107.388 -176.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -133.6 88.67 2.5 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 108.032 -1.099 . . . . 74.01 108.032 176.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 23.8 p -71.36 141.43 85.77 Favored Pre-proline 0 CA--C 1.547 0.861 0 CA-C-N 115.822 -0.626 . . . . 71.11 109.472 172.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.18 86.33 0.79 Allowed 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 122.273 1.982 . . . . 71.22 111.105 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 35.5 m -85.53 -27.81 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 CA-C-N 115.043 -0.981 . . . . 63.3 110.011 176.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 32.5 p -69.84 -33.46 72.32 Favored 'General case' 0 C--N 1.348 0.538 0 CA-C-N 115.089 -0.96 . . . . 71.22 109.682 169.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 23.6 mtpp 62.04 -79.43 0.03 OUTLIER 'General case' 0 C--N 1.357 0.905 0 C-N-CA 126.0 1.72 . . . . 74.33 111.332 -179.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -153.44 -95.17 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 108.031 -1.1 . . . . 75.34 108.031 177.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . 0.611 ' HB3' HH11 ' C' ' 154' ' ' ARG . 5.0 ppt_? 42.31 27.4 0.08 Allowed 'General case' 0 N--CA 1.508 2.425 0 C-N-CA 126.032 1.733 . . . . 73.31 114.966 176.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 23' ' ' THR . . . . . . . . . . . . . 70.6 p -81.14 154.8 72.47 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 123.59 0.756 . . . . 72.54 109.529 177.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -59.34 106.28 0.3 Allowed 'Trans proline' 0 C--N 1.37 1.69 0 C-N-CA 122.322 2.015 . . . . 74.55 110.606 171.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -61.46 -48.17 82.33 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.333 0.587 . . . . 74.53 110.033 178.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 26' ' ' MET . . . . . 0.444 ' SD ' ' HB3' ' B' ' 29' ' ' LEU . 43.0 ttm -132.85 128.95 20.98 Favored Pre-proline 0 CA--C 1.544 0.714 0 N-CA-C 107.512 -1.292 . . . . 75.13 107.512 172.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 27' ' ' PRO . . . . . 0.564 ' HG2' ' HB3' ' B' ' 315' ' ' ASN . 83.7 Cg_exo -48.08 -42.19 32.73 Favored 'Trans proline' 0 C--N 1.384 2.437 0 C-N-CA 123.966 3.111 . . . . 73.04 113.5 -179.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.509 HG13 ' HD2' ' B' ' 319' ' ' PRO . 4.9 p -171.31 138.29 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 C-N-CA 124.569 1.147 . . . . 75.25 109.048 174.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . 0.444 ' HB3' ' SD ' ' B' ' 26' ' ' MET . 0.4 OUTLIER -127.27 134.23 50.08 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.602 1.161 . . . . 73.34 108.789 174.969 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 70.6 151.76 0.1 Allowed 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 125.153 1.381 . . . . 71.25 110.495 -174.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -106.64 -38.72 6.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.939 -0.476 . . . . 74.34 111.623 179.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -159.36 104.27 1.64 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 122.606 0.363 . . . . 72.22 110.6 178.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -94.08 103.1 15.18 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 106.474 -1.676 . . . . 73.31 106.474 164.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.85 -63.1 1.29 Allowed 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.097 0.959 . . . . 53.33 112.298 -166.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 57.72 -162.5 0.21 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.816 0.847 . . . . 73.13 111.063 179.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 59.96 63.08 5.39 Favored Glycine 0 C--N 1.355 1.625 0 CA-C-O 119.653 -0.526 . . . . 74.33 112.806 172.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 24.8 t70 65.33 -88.54 0.03 OUTLIER 'General case' 0 C--N 1.355 0.828 0 C-N-CA 124.355 1.062 . . . . 61.44 109.738 -173.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 13.3 tt 171.54 -29.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 124.679 1.192 . . . . 75.44 109.261 -177.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 8.9 t -57.14 -54.49 46.19 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.44 1.096 . . . . 73.32 112.891 -168.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.52 ' HB2' ' HB2' ' B' ' 328' ' ' ALA . . . -178.4 82.22 0.22 Allowed Pre-proline 0 C--N 1.36 1.052 0 C-N-CA 123.324 0.649 . . . . 73.24 111.863 -177.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -88.83 -174.71 1.07 Allowed 'Trans proline' 0 C--N 1.365 1.416 0 C-N-CA 122.635 2.223 . . . . 72.44 111.211 162.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 151.98 -72.81 0.27 Allowed Glycine 0 C--N 1.345 1.071 0 C-N-CA 121.844 -0.217 . . . . 61.22 113.146 170.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -152.82 137.22 5.74 Favored Glycine 0 C--N 1.335 0.493 0 N-CA-C 111.356 -0.698 . . . . 64.32 111.356 -176.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . 0.424 ' HA ' ' HB2' ' B' ' 336' ' ' GLU . . . -75.62 2.6 11.44 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.409 0.684 . . . . 63.2 112.675 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.555 ' HB2' ' HD2' ' B' ' 337' ' ' LYS . 22.0 mmt180 66.81 -68.86 0.14 Allowed 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 126.114 1.766 . . . . 74.21 112.274 176.143 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 46' ' ' ARG . . . . . 0.44 HH12 ' HB3' ' C' ' 139' ' ' GLU . 10.0 ttm180 73.22 -86.93 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 125.325 1.45 . . . . 75.02 110.728 177.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.414 ' HG ' ' H ' ' B' ' 48' ' ' THR . 18.4 tp 164.52 -176.17 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 126.187 1.795 . . . . 72.13 106.445 -169.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 48' ' ' THR . . . . . 0.54 ' HA ' ' HD3' ' C' ' 144' ' ' ARG . 88.5 m -56.52 -55.72 30.26 Favored 'General case' 0 C--N 1.352 0.704 0 CA-C-N 118.431 0.559 . . . . 73.12 109.73 168.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.37 -1.02 78.44 Favored Glycine 0 C--N 1.347 1.148 0 CA-C-O 119.812 -0.438 . . . . 74.15 113.122 177.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . 0.514 ' HA ' ' ND1' ' B' ' 184' ' ' HIS . 13.3 t70 -79.11 -75.97 0.22 Allowed 'General case' 0 C--N 1.356 0.86 0 N-CA-C 107.053 -1.462 . . . . 64.2 107.053 172.061 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 59.93 11.37 2.56 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 125.103 1.361 . . . . 75.3 112.816 174.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 44.7 p -134.46 -162.84 1.29 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.231 1.012 . . . . 73.31 109.719 -169.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -127.44 82.12 2.07 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.846 -0.798 . . . . 73.24 108.846 171.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.423 ' HB3' ' HD2' ' B' ' 184' ' ' HIS . . . -77.8 113.6 15.83 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 108.989 -0.745 . . . . 75.51 108.989 174.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 88.5 mt -103.53 -14.26 16.26 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.413 0.685 . . . . 72.35 110.842 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . 0.558 ' HG3' HD12 ' B' ' 59' ' ' LEU . 0.0 OUTLIER 68.87 106.74 0.05 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.476 1.51 . . . . 74.21 110.585 -176.117 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -63.15 -71.57 0.16 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.62 1.168 . . . . 75.31 110.799 -177.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 27.2 t -90.1 74.48 7.17 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 121.846 0.832 . . . . 62.01 110.298 178.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . 0.558 HD12 ' HG3' ' B' ' 56' ' ' ARG . 0.5 OUTLIER -146.95 3.97 0.83 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 113.907 -1.497 . . . . 72.44 108.216 164.079 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 18.7 t -169.88 176.14 4.9 Favored 'General case' 0 C--O 1.248 1.016 0 C-N-CA 125.75 1.62 . . . . 71.31 107.32 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 15.6 t70 66.74 -74.72 0.06 Allowed 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 124.158 0.983 . . . . 71.45 110.893 -177.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 62' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -123.03 85.97 50.99 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 124.366 1.066 . . . . 72.42 109.228 175.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -87.08 123.45 1.97 Allowed 'Trans proline' 0 C--N 1.371 1.713 0 C-N-CA 122.555 2.17 . . . . 72.24 109.699 167.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -79.18 -24.97 42.86 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.303 0.641 . . . . 72.04 111.608 -176.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 64.66 -78.42 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.786 1.234 . . . . 73.42 110.102 -173.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 68.75 -66.32 0.25 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 125.403 1.481 . . . . 72.41 111.432 -177.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . 0.432 HD11 HD13 ' B' ' 69' ' ' LEU . 16.7 tt 51.34 112.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 C-N-CA 126.948 2.099 . . . . 74.04 113.298 172.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 34.1 mt -70.17 -5.32 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.598 0 C-N-CA 124.007 0.923 . . . . 73.4 112.051 -171.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.604 HD11 ' HG3' ' B' ' 312' ' ' PRO . 63.7 mt -79.92 60.19 3.42 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 124.25 1.02 . . . . 74.34 111.345 177.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -143.84 21.88 1.78 Allowed 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 108.088 -1.078 . . . . 65.22 108.088 169.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 61.8 mt 61.38 64.19 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 C-N-CA 124.847 1.259 . . . . 75.5 108.443 -168.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -113.0 4.58 25.61 Favored Glycine 0 C--N 1.349 1.272 0 CA-C-N 113.898 -1.501 . . . . 71.15 112.863 -177.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -106.49 151.52 24.86 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.229 1.012 . . . . 74.12 109.807 -178.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 56.4 -97.56 0.06 OUTLIER Glycine 0 C--N 1.356 1.666 0 O-C-N 123.561 0.538 . . . . 72.45 111.859 -175.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.7 93.95 9.74 Favored 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 108.063 -1.088 . . . . 74.01 108.063 168.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . -98.23 95.17 1.59 Allowed Glycine 0 C--N 1.343 0.961 0 CA-C-O 119.023 -0.876 . . . . 71.52 112.238 -176.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 29.5 t70 51.75 -88.91 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 125.423 1.489 . . . . 74.35 111.979 179.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 45.4 m -85.91 66.36 9.57 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.08 0.952 . . . . 55.34 109.525 177.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . 0.559 ' HG3' HG22 ' B' ' 80' ' ' ILE . 11.1 pt-20 -64.51 -34.11 77.46 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 114.712 -1.131 . . . . 74.44 111.912 178.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . 0.559 HG22 ' HG3' ' B' ' 79' ' ' GLU . 15.9 tt -169.3 -32.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.802 1.241 . . . . 72.52 108.653 -178.098 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 14.3 m 62.41 73.9 0.45 Allowed 'General case' 0 C--N 1.36 1.046 0 C-N-CA 124.858 1.263 . . . . 74.52 110.433 174.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 61.52 -78.53 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 125.112 1.365 . . . . 75.12 112.073 -175.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . 69.23 109.21 0.05 Allowed 'General case' 0 C--N 1.36 1.024 0 C-N-CA 125.462 1.505 . . . . 74.13 110.47 -174.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -69.4 87.13 0.44 Allowed 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 108.381 -0.97 . . . . 73.0 108.381 -179.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 75.03 -19.5 0.38 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 125.458 1.503 . . . . 72.23 113.304 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 75.3 t80 66.98 -75.82 0.06 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.978 1.311 . . . . 74.21 111.885 178.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.01 -166.67 2.61 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.884 0.873 . . . . 52.24 110.305 -177.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 60.18 -91.5 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.996 1.318 . . . . 74.14 112.002 175.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -94.8 64.46 1.48 Allowed Glycine 0 C--N 1.348 1.21 0 N-CA-C 111.16 -0.776 . . . . 54.33 111.16 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.26 -45.74 86.8 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.067 0.547 . . . . 75.53 109.966 176.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.3 173.36 36.1 Favored Glycine 0 C--N 1.347 1.173 0 CA-C-N 115.402 -0.817 . . . . 70.11 114.019 171.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.26 -27.49 5.08 Favored Glycine 0 C--N 1.343 0.966 0 CA-C-O 119.064 -0.853 . . . . 73.42 114.576 173.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 34.7 t80 67.6 -71.98 0.1 Allowed 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 125.25 1.42 . . . . 74.22 110.635 -175.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 94' ' ' PHE . . . . . 0.505 ' HB2' ' HB3' ' B' ' 2' ' ' LYS . 81.7 m-85 67.75 40.24 2.49 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 125.403 1.481 . . . . 72.14 111.55 175.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 51.7 mttp 66.73 -82.08 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.965 1.306 . . . . 74.44 111.605 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 96' ' ' GLY . . . . . 0.423 ' HA2' ' HG2' ' A' ' 128' ' ' GLU . . . 90.93 -52.82 3.27 Favored Glycine 0 C--N 1.35 1.331 0 N-CA-C 111.04 -0.824 . . . . 75.21 111.04 -171.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 1.2 pp -94.24 75.36 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 124.395 1.078 . . . . 73.0 110.19 176.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -84.25 73.81 10.4 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 109.011 -0.737 . . . . 75.21 109.011 178.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -81.38 99.48 8.72 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 114.75 -1.114 . . . . 61.12 109.769 -175.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . 0.526 ' HG ' ' HD3' ' B' ' 101' ' ' PRO . 4.1 pp -164.79 -36.39 0.0 OUTLIER Pre-proline 0 CA--C 1.572 1.813 0 C-N-CA 124.616 1.166 . . . . 74.2 112.911 176.165 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 101' ' ' PRO . . . . . 0.526 ' HD3' ' HG ' ' B' ' 100' ' ' LEU . 42.4 Cg_endo -91.98 6.8 3.35 Favored 'Trans proline' 0 C--N 1.406 3.592 0 CA-C-N 122.735 2.012 . . . . 74.43 113.569 177.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -78.42 83.58 4.63 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 122.191 0.996 . . . . 73.12 109.982 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 9.9 t -166.61 151.49 7.75 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-N 114.81 -1.086 . . . . 75.52 109.563 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 149.12 130.64 1.9 Allowed Glycine 0 C--N 1.337 0.635 0 N-CA-C 110.32 -1.112 . . . . 51.35 110.32 -178.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 -73.35 81.99 1.4 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.637 0.775 . . . . 75.22 110.083 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 106' ' ' TYR . . . . . 0.561 ' HB3' HD11 ' B' ' 412' ' ' LEU . 18.4 m-85 62.02 10.47 3.66 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.456 1.502 . . . . 74.44 113.943 171.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 22.7 m -88.71 92.42 9.19 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.635 0.731 . . . . 75.34 110.635 -175.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 23.4 p-80 -114.57 55.41 0.75 Allowed 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 108.078 -1.082 . . . . 73.44 108.078 172.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -73.22 94.85 2.03 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 114.486 -1.234 . . . . 74.1 109.848 -176.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -81.88 -6.39 59.06 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.896 0.879 . . . . 75.22 111.708 178.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 53.6 tp 71.17 -73.85 0.09 Allowed 'General case' 0 C--N 1.362 1.124 0 C-N-CA 125.274 1.429 . . . . 70.25 110.647 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 9.9 t30 61.48 40.04 14.25 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 124.371 1.068 . . . . 73.2 110.365 178.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 113' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -69.59 123.58 21.7 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.12 -0.945 . . . . 75.13 108.745 178.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 52.7 tttm 62.75 23.31 13.89 Favored 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 124.355 1.062 . . . . 74.21 110.032 -177.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 20.2 m 65.18 -77.42 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 125.288 1.435 . . . . 73.23 110.57 -171.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 64.23 30.75 78.67 Favored Glycine 0 C--N 1.359 1.848 0 O-C-N 123.221 0.325 . . . . 55.33 113.676 175.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . 0.622 ' HZ2' ' HB3' ' B' ' 117' ' ' LYS . 6.1 ttpm? -129.1 135.2 27.24 Favored Pre-proline 0 CA--C 1.553 1.075 0 C-N-CA 124.151 0.98 . . . . 75.35 109.317 -172.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 118' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -73.88 176.35 9.57 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 123.136 2.558 . . . . 63.21 114.775 -170.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 119' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -90.64 169.62 10.84 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 114.288 -1.324 . . . . 75.33 110.487 177.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 120' ' ' TYR . . . . . 0.517 ' HE1' ' HB2' ' A' ' 243' ' ' PRO . 29.6 p90 -133.65 150.2 51.57 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.43 1.092 . . . . 70.1 109.551 -177.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 10.3 t 50.38 46.87 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-O 122.833 1.301 . . . . 74.32 109.507 -178.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 3.1 m -97.82 30.68 2.9 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 114.549 -1.205 . . . . 75.25 110.347 -171.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 4.2 p30 46.12 30.74 1.01 Allowed 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 125.368 1.467 . . . . 70.53 112.335 -173.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 46.2 t -71.33 106.19 3.78 Favored 'General case' 0 C--N 1.354 0.765 0 N-CA-C 108.157 -1.053 . . . . 61.03 108.157 178.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . 61.63 31.39 18.72 Favored 'General case' 0 CA--C 1.55 0.96 0 O-C-N 124.446 1.091 . . . . 74.53 110.477 -171.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . 62.91 69.23 0.6 Allowed 'General case' 0 C--N 1.358 0.978 0 C-N-CA 125.192 1.397 . . . . 74.13 111.277 -178.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 27.2 p -90.17 106.24 18.35 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.281 0.632 . . . . 70.01 110.561 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . 64.0 37.6 9.18 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 124.642 1.177 . . . . 74.33 112.53 174.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 41.2 p -108.2 0.72 21.64 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.995 0.918 . . . . 74.41 112.257 -178.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . -82.27 155.98 24.56 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 121.074 0.464 . . . . 61.42 111.781 -177.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 24.1 m-90 -104.52 164.61 11.63 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.613 1.165 . . . . 73.51 109.416 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 36.7 p -154.65 138.7 16.43 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.111 0.564 . . . . 74.11 110.707 -176.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 49.8 m 71.55 -71.14 0.14 Allowed 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 125.409 1.484 . . . . 74.52 111.037 -178.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . -141.45 -53.89 0.04 OUTLIER Glycine 0 C--N 1.349 1.283 0 N-CA-C 112.118 -0.393 . . . . 55.15 112.118 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 135' ' ' VAL . . . . . . . . . . . . . 18.5 m -113.18 -167.56 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 N-CA-C 108.7 -0.852 . . . . 73.24 108.7 179.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 3.2 tmtp? -71.2 -55.63 7.73 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 108.302 -0.999 . . . . 74.24 108.302 177.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 19.6 m -87.08 69.79 10.2 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-N 115.537 -0.756 . . . . 75.31 110.012 -178.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 61.08 -89.86 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.27 0 C-N-CA 125.123 1.369 . . . . 75.52 112.065 177.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -135.6 -2.33 2.44 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.188 0.995 . . . . 73.24 110.255 -175.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -64.18 84.44 0.06 OUTLIER Glycine 0 C--N 1.353 1.473 0 C-N-CA 123.142 0.401 . . . . 75.54 112.875 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.43 -49.47 48.5 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.024 0.93 . . . . 75.34 110.086 -177.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 35.9 tp -92.73 -16.64 25.21 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 115.319 -0.855 . . . . 74.24 109.885 172.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 83.84 -58.39 5.02 Favored Glycine 0 C--N 1.353 1.479 0 N-CA-C 111.819 -0.512 . . . . 61.25 111.819 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 144' ' ' VAL . . . . . 0.655 HG21 ' HB2' ' B' ' 151' ' ' HIS . 58.5 t -76.86 -40.77 31.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 124.665 1.186 . . . . 75.31 109.745 174.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 68.47 -79.55 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.131 1.373 . . . . 75.32 113.084 173.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 17.1 tt -132.86 -8.17 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 C-N-CA 123.135 0.574 . . . . 72.52 111.236 -175.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 -59.79 -45.13 93.26 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.847 0.859 . . . . 72.43 111.619 -177.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -140.24 163.91 31.5 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.121 1.368 . . . . 75.05 108.154 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 149' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -92.14 -9.58 41.93 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.049 0.54 . . . . 74.13 109.985 170.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -96.61 169.51 9.84 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.375 1.07 . . . . 74.11 109.979 -178.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 151' ' ' HIS . . . . . 0.655 ' HB2' HG21 ' B' ' 144' ' ' VAL . 34.1 m-70 65.73 85.62 0.15 Allowed Pre-proline 0 N--CA 1.485 1.305 0 C-N-CA 125.155 1.382 . . . . 74.43 109.446 -178.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.45 -16.14 24.55 Favored 'Trans proline' 0 C--N 1.374 1.891 0 C-N-CA 122.566 2.178 . . . . 64.13 113.02 -176.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 28.3 m 69.18 -68.55 0.18 Allowed 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 125.455 1.502 . . . . 74.2 110.482 -177.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 8.1 tp -88.3 134.51 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 N-CA-C 108.504 -0.924 . . . . 74.25 108.504 168.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 155' ' ' LEU . . . . . 0.575 HD23 ' H ' ' B' ' 155' ' ' LEU . 2.2 pt? -111.86 -4.41 14.6 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.441 0.696 . . . . 73.12 111.504 -173.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -88.72 -68.61 0.76 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.258 0.623 . . . . 72.23 110.026 -176.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 157' ' ' MET . . . . . . . . . . . . . 19.8 mmt -145.24 174.48 11.05 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.777 1.231 . . . . 61.13 108.691 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 158' ' ' ALA . . . . . . . . . . . . . . . -164.89 94.57 0.67 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.244 0.617 . . . . 65.11 109.543 175.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' B' ' 203' ' ' ASN . 36.6 ttpt -152.14 80.51 1.25 Allowed 'General case' 0 C--O 1.242 0.679 0 C-N-CA 122.841 0.456 . . . . 73.24 109.973 175.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 160' ' ' ALA . . . . . 0.458 ' HB2' ' HA ' ' B' ' 201' ' ' PRO . . . -172.85 133.46 0.56 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.262 1.025 . . . . 74.34 109.407 173.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.56 -34.27 62.88 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.422 0.689 . . . . 71.1 110.671 177.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 71.57 -155.68 52.35 Favored Glycine 0 C--N 1.352 1.463 0 CA-C-O 119.443 -0.643 . . . . 73.4 112.18 -178.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 9.4 tt 67.32 123.54 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 125.025 1.33 . . . . 75.25 111.889 177.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 164' ' ' ALA . . . . . . . . . . . . . . . -139.8 170.56 15.65 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.607 0.763 . . . . 75.34 109.614 175.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 3.2 t -73.59 75.36 1.49 Allowed 'General case' 0 CA--C 1.553 1.079 0 CA-C-O 121.925 0.869 . . . . 73.14 110.045 176.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . 84.16 -56.14 5.03 Favored Glycine 0 C--N 1.349 1.273 0 CA-C-N 114.988 -1.005 . . . . 74.53 111.98 -176.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 167' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -145.54 153.9 41.6 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 124.101 0.96 . . . . 74.33 109.582 -178.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . 0.588 HG22 ' HG3' ' B' ' 193' ' ' PRO . 88.4 t -61.14 104.97 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.952 1.301 . . . . 75.53 111.135 -176.007 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 25.2 m -88.64 -178.62 5.85 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.17 0.988 . . . . 65.53 110.567 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 72.6 p -63.5 -58.06 8.22 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.475 0.71 . . . . 73.13 110.288 178.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . 59.44 -81.21 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 125.389 1.476 . . . . 73.41 113.517 170.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 172' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -83.3 73.33 10.14 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.55 0.74 . . . . 75.25 110.786 -171.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 173' ' ' LEU . . . . . . . . . . . . . 21.7 tp 61.41 22.78 13.13 Favored 'General case' 0 CA--C 1.562 1.419 0 C-N-CA 124.876 1.271 . . . . 74.44 112.128 173.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 174' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 73.51 -8.64 1.32 Allowed 'General case' 0 N--CA 1.505 2.324 0 C-N-CA 124.629 1.172 . . . . 74.45 111.456 -173.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 175' ' ' ASP . . . . . . . . . . . . . 28.2 t70 71.56 135.05 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 127.159 2.184 . . . . 74.1 112.44 -177.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -96.34 -8.03 33.68 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.964 0.905 . . . . 74.11 112.154 -175.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 16.7 m -64.23 -40.77 55.59 Favored Pre-proline 0 CA--C 1.568 1.647 0 CA-C-O 118.377 -0.821 . . . . 74.15 112.843 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 178' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -58.56 156.31 32.33 Favored 'Trans proline' 0 C--N 1.399 3.231 0 C-N-CA 121.858 1.705 . . . . 74.53 112.568 172.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 179' ' ' ALA . . . . . 0.411 ' HB3' ' NE ' ' B' ' 46' ' ' ARG . . . -88.9 24.93 1.92 Allowed 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.997 0.919 . . . . 74.35 112.669 -170.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . 68.3 -67.26 0.2 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.329 1.452 . . . . 75.32 110.541 -169.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 35.1 tp -154.63 114.86 3.86 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 109.109 -0.7 . . . . 74.44 109.109 -178.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 182' ' ' VAL . . . . . . . . . . . . . 14.4 p 44.53 111.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 C-N-CA 127.033 2.133 . . . . 72.43 116.196 178.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -103.61 84.61 2.31 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 107.579 -1.267 . . . . 65.24 107.579 167.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 184' ' ' HIS . . . . . 0.515 ' NE2' ' HB3' ' B' ' 187' ' ' SER . 23.7 p-80 64.85 165.3 0.16 Allowed 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 126.871 2.068 . . . . 75.32 113.841 174.041 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 185' ' ' VAL . . . . . 0.636 HG23 ' HA ' ' C' ' 121' ' ' ALA . 7.7 p -84.94 116.18 28.05 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.969 0 CA-C-N 115.02 -0.991 . . . . 74.01 111.875 -170.094 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 80.4 p 48.45 79.72 0.07 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 125.868 1.667 . . . . 60.24 114.09 166.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 187' ' ' SER . . . . . 0.515 ' HB3' ' NE2' ' B' ' 184' ' ' HIS . 29.9 t -179.16 -33.19 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.359 0.663 . . . . 62.14 110.556 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.01 -78.17 0.12 Allowed 'General case' 0 CA--C 1.542 0.671 0 O-C-N 123.564 0.54 . . . . 72.32 109.687 -174.243 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 189' ' ' LYS . . . . . 0.693 ' HZ1' ' HA2' ' B' ' 299' ' ' GLY . 4.5 ttmp? 54.08 91.5 0.03 OUTLIER 'General case' 0 CA--C 1.56 1.364 0 C-N-CA 124.204 1.002 . . . . 72.52 111.906 -175.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 190' ' ' CYS . . . . . 0.854 ' HA ' ' HA ' ' B' ' 294' ' ' LYS . 54.0 t -142.58 92.71 2.44 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.054 0.541 . . . . 70.33 110.338 178.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 191' ' ' TYR . . . . . 0.618 ' HB2' HD23 ' C' ' 181' ' ' LEU . 49.7 p90 -157.79 149.71 22.05 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 111.991 0.367 . . . . 74.04 111.991 -174.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 63.04 174.12 2.41 Favored Glycine 0 C--N 1.35 1.34 0 O-C-N 124.387 1.054 . . . . 64.22 114.73 172.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 193' ' ' PRO . . . . . 0.588 ' HG3' HG22 ' B' ' 168' ' ' VAL . 73.0 Cg_endo -71.07 162.6 42.09 Favored 'Trans proline' 0 C--N 1.366 1.465 0 C-N-CA 122.531 2.154 . . . . 73.22 111.833 178.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 194' ' ' SER . . . . . . . . . . . . . 46.6 m -87.07 41.91 1.0 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.371 0.668 . . . . 63.44 111.174 178.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.05 -23.08 64.0 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.754 0.822 . . . . 74.32 110.805 175.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 196' ' ' THR . . . . . 0.461 HG23 ' HB ' ' B' ' 296' ' ' THR . 5.2 t -89.63 23.28 2.7 Favored 'General case' 0 CA--C 1.561 1.39 0 C-N-CA 124.698 1.199 . . . . 73.32 110.946 174.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 22.7 m 71.55 103.07 0.07 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.327 1.451 . . . . 75.11 112.599 169.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 198' ' ' GLU . . . . . 0.7 ' HB2' ' HA ' ' B' ' 296' ' ' THR . 6.5 tm-20 -160.31 -79.34 0.05 Allowed 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 107.267 -1.383 . . . . 65.14 107.267 172.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.59 -34.79 40.47 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.892 -0.781 . . . . 75.14 108.892 171.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 200' ' ' CYS . . . . . . . . . . . . . 55.3 m 68.93 154.19 0.14 Allowed Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 125.74 1.616 . . . . 73.31 113.2 168.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 201' ' ' PRO . . . . . 0.458 ' HA ' ' HB2' ' B' ' 160' ' ' ALA . 66.2 Cg_endo -83.5 164.28 14.47 Favored 'Trans proline' 0 C--N 1.369 1.617 0 C-N-CA 122.393 2.062 . . . . 74.02 111.789 170.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 150.86 -121.33 1.21 Allowed Glycine 0 C--N 1.335 0.48 0 N-CA-C 110.29 -1.124 . . . . 73.41 110.29 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 203' ' ' ASN . . . . . 0.4 ' O ' ' HA ' ' B' ' 159' ' ' LYS . 29.2 p-10 -91.88 -162.23 0.9 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.3 0.64 . . . . 71.33 109.372 174.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 204' ' ' ALA . . . . . 0.444 ' H ' HD23 ' B' ' 217' ' ' LEU . . . -96.14 28.24 3.29 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.204 0.602 . . . . 74.01 110.846 177.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 205' ' ' LEU . . . . . . . . . . . . . 41.2 tp 64.36 -75.15 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.352 1.461 . . . . 72.44 110.126 -171.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 206' ' ' GLU . . . . . 0.509 ' HG2' ' HA2' ' B' ' 211' ' ' GLY . 0.5 OUTLIER -131.73 125.91 33.19 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 106.871 -1.529 . . . . 70.3 106.871 176.692 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 207' ' ' LYS . . . . . 0.453 ' HA ' ' HE2' ' B' ' 207' ' ' LYS . 0.6 OUTLIER -64.49 -37.86 89.01 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.881 0.873 . . . . 74.32 112.139 -173.197 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 137.09 10.85 1.1 Allowed Glycine 0 N--CA 1.469 0.897 0 CA-C-N 116.016 -0.538 . . . . 71.52 111.944 -174.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . -170.94 132.01 2.36 Favored Glycine 0 C--N 1.342 0.915 0 N-CA-C 110.723 -0.951 . . . . 63.34 110.723 -177.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 77.5 tttt 70.59 -78.01 0.05 Allowed 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 125.049 1.34 . . . . 74.51 111.393 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 211' ' ' GLY . . . . . 0.509 ' HA2' ' HG2' ' B' ' 206' ' ' GLU . . . 166.63 53.89 0.03 OUTLIER Glycine 0 C--N 1.335 0.492 0 N-CA-C 107.55 -2.22 . . . . 74.43 107.55 -169.036 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 50.3 m 65.58 88.38 0.11 Allowed 'General case' 0 C--N 1.354 0.78 0 C-N-CA 125.257 1.423 . . . . 74.04 108.738 -162.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 8.7 tp -68.54 -21.43 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 124.065 0.946 . . . . 70.12 111.413 -179.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 51.1 p -81.64 -1.49 46.84 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.332 0.653 . . . . 75.43 110.817 173.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 215' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 68.66 -69.45 0.15 Allowed 'General case' 0 C--N 1.366 1.285 0 C-N-CA 126.179 1.791 . . . . 73.31 109.916 -178.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -112.8 168.55 9.59 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.139 0.976 . . . . 61.42 109.133 169.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . 0.444 HD23 ' H ' ' B' ' 204' ' ' ALA . 3.5 pp -145.15 21.66 1.56 Allowed 'General case' 0 N--CA 1.484 1.229 0 CA-C-O 121.674 0.75 . . . . 75.4 109.639 173.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -79.91 179.26 7.67 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 114.628 -1.169 . . . . 71.43 110.136 -177.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 12.2 t30 61.71 32.5 18.33 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 122.587 1.184 . . . . 71.24 108.809 -171.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -64.04 -24.49 67.72 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 114.332 -1.303 . . . . 74.3 112.484 -174.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 221' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -90.29 44.33 1.2 Allowed 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.861 0.864 . . . . 73.55 110.053 178.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -87.55 147.83 25.15 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 123.34 0.656 . . . . 75.21 109.419 175.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 223' ' ' ASP . . . . . 0.566 ' HA ' HG23 ' B' ' 269' ' ' THR . 28.7 t70 66.74 -82.82 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.692 1.197 . . . . 72.13 110.88 -177.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 45.2 t -84.41 84.11 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 108.194 -1.039 . . . . 75.32 108.194 173.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 15.0 m -74.84 -11.28 60.1 Favored 'General case' 0 CA--C 1.553 1.095 0 CA-C-N 114.902 -1.044 . . . . 73.55 111.255 -179.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 31.5 mt 73.2 108.65 0.07 Allowed 'General case' 0 C--N 1.366 1.302 0 C-N-CA 125.451 1.5 . . . . 74.43 109.765 178.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . -67.59 -18.37 69.92 Favored Glycine 0 C--N 1.351 1.397 0 O-C-N 123.461 0.476 . . . . 71.24 112.822 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 80.32 29.94 43.15 Favored Glycine 0 C--N 1.35 1.349 0 O-C-N 124.045 0.497 . . . . 72.41 112.002 177.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -166.01 -146.56 4.87 Favored Glycine 0 C--N 1.342 0.915 0 O-C-N 123.564 0.214 . . . . 71.04 112.753 -176.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -159.22 16.13 0.17 Allowed 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.761 0.824 . . . . 70.23 111.393 -171.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 231' ' ' LYS . . . . . . . . . . . . . 5.3 mptt 65.9 95.61 0.06 Allowed 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.484 1.114 . . . . 73.24 111.82 171.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 70.8 p 77.52 -41.4 0.36 Allowed 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 127.693 2.397 . . . . 74.24 112.709 177.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 65.19 -174.93 0.18 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.215 1.006 . . . . 71.44 110.323 -170.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -140.71 48.17 1.73 Allowed 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.084 0.469 . . . . 72.31 110.12 -173.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -101.92 126.2 48.77 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 108.335 -0.987 . . . . 64.41 108.335 178.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 236' ' ' THR . . . . . . . . . . . . . 45.1 m -80.65 -63.42 1.41 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.838 0.855 . . . . 73.34 111.3 -176.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -166.95 90.31 0.38 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.452 0.701 . . . . 73.03 110.4 -175.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 238' ' ' THR . . . . . 0.528 HG23 HG23 ' C' ' 219' ' ' VAL . 59.3 m -132.58 109.18 9.57 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 107.072 -1.455 . . . . 71.31 107.072 169.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -162.78 -88.56 0.02 OUTLIER 'General case' 0 C--O 1.236 0.387 0 N-CA-C 109.42 -0.585 . . . . 74.42 109.42 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 240' ' ' GLY . . . . . 0.572 ' HA3' ' HA ' ' C' ' 235' ' ' LEU . . . 162.55 -128.9 1.95 Allowed Glycine 0 C--N 1.339 0.705 0 N-CA-C 110.628 -0.989 . . . . 71.23 110.628 -169.04 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 241' ' ' GLU . . . . . 0.659 ' HG3' ' HG3' ' C' ' 234' ' ' ARG . 6.4 pt-20 -150.24 138.08 20.05 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.412 0.685 . . . . 71.23 109.784 -175.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 242' ' ' TRP . . . . . 0.409 ' CD2' ' HG ' ' C' ' 233' ' ' LEU . 1.0 OUTLIER -173.16 117.24 0.29 Allowed 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 107.155 -1.424 . . . . 70.32 107.155 170.628 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 243' ' ' GLN . . . . . 0.485 ' HA ' ' HB2' ' B' ' 367' ' ' LEU . 30.6 mt-30 59.69 -82.56 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 124.104 0.962 . . . . 74.22 109.081 -168.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' B' ' 365' ' ' VAL . . . 179.83 88.22 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 107.362 -2.295 . . . . 71.54 107.362 177.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 245' ' ' LYS . . . . . 0.437 ' HD3' ' HB3' ' C' ' 222' ' ' ALA . 0.0 OUTLIER -64.29 155.64 31.45 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 112.337 0.495 . . . . 75.34 112.337 -172.721 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 246' ' ' THR . . . . . 0.402 ' HA ' ' HB3' ' B' ' 363' ' ' GLU . 12.3 t -147.53 157.49 43.59 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.137 0.575 . . . . 71.14 111.075 -179.12 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 247' ' ' LEU . . . . . 0.47 HD11 ' HE3' ' C' ' 209' ' ' LYS . 40.7 tp -113.72 95.64 5.44 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 107.537 -1.282 . . . . 72.51 107.537 171.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 248' ' ' ARG . . . . . 0.536 ' HB3' HG23 ' C' ' 206' ' ' VAL . 0.9 OUTLIER -87.99 120.15 29.04 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 107.856 -1.164 . . . . 75.15 107.856 179.436 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -160.25 114.21 2.18 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 107.832 -1.173 . . . . 71.33 107.832 -170.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -123.7 85.94 2.5 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.41 0.684 . . . . 70.14 109.827 -174.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 251' ' ' ALA . . . . . . . . . . . . . . . 62.13 -86.94 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.13 1.372 . . . . 64.21 112.065 178.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . 0.555 ' NE2' ' HB2' ' B' ' 278' ' ' LEU . 59.6 tt0 172.24 -179.41 0.07 Allowed 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.98 0.912 . . . . 73.12 109.183 -168.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -58.17 159.5 5.85 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.993 0.917 . . . . 51.41 110.387 162.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 4.1 ppt_? -62.46 -22.04 65.92 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 112.956 0.725 . . . . 72.51 112.956 -170.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 255' ' ' GLY . . . . . 0.541 ' HA3' HD22 ' B' ' 277' ' ' LEU . . . -62.87 -25.0 67.26 Favored Glycine 0 C--N 1.357 1.746 0 O-C-N 123.43 0.456 . . . . 63.32 113.042 178.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 256' ' ' TYR . . . . . 0.437 ' HD2' HD23 ' B' ' 258' ' ' LEU . 36.1 t80 62.54 16.25 8.59 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.797 1.239 . . . . 71.2 112.895 166.261 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 257' ' ' GLN . . . . . 0.483 ' HG3' HD23 ' B' ' 278' ' ' LEU . 24.5 tm0? 67.01 3.27 3.05 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 124.747 1.219 . . . . 74.31 111.994 178.128 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 258' ' ' LEU . . . . . 0.437 HD23 ' HD2' ' B' ' 256' ' ' TYR . 2.5 pp -83.43 24.91 0.79 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.258 -0.901 . . . . 75.13 112.039 -177.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 30.1 m -63.56 -15.91 17.27 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 C-N-CA 124.765 1.226 . . . . 63.31 112.372 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 260' ' ' SER . . . . . . . . . . . . . 49.2 m 65.37 33.2 9.16 Favored 'General case' 0 C--N 1.366 1.299 0 C-N-CA 124.615 1.166 . . . . 73.11 111.816 172.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 30.6 t70 71.47 147.78 0.08 Allowed 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 125.431 1.492 . . . . 65.51 111.385 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 262' ' ' ALA . . . . . . . . . . . . . . . 75.95 -49.23 0.6 Allowed 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 125.651 1.581 . . . . 75.22 111.487 -175.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . 73.64 -69.83 0.18 Allowed 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 125.326 1.45 . . . . 70.44 110.967 177.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 47.3 t -137.33 -22.89 1.13 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.047 0.939 . . . . 51.14 110.027 176.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 265' ' ' LEU . . . . . . . . . . . . . 56.9 tp 57.29 94.99 0.02 OUTLIER 'General case' 0 C--N 1.357 0.911 0 C-N-CA 125.294 1.438 . . . . 73.31 111.569 178.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 266' ' ' ASN . . . . . 0.677 ' HB3' ' HD2' ' B' ' 275' ' ' LYS . 45.9 t30 -130.7 119.5 22.48 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 107.621 -1.251 . . . . 71.52 107.621 176.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 30.9 m -63.68 -33.65 76.1 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.877 0.871 . . . . 73.13 112.571 -168.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 8.5 p -72.66 128.7 35.72 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 N-CA-C 109.545 -0.539 . . . . 74.44 109.545 176.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 269' ' ' THR . . . . . 0.566 HG23 ' HA ' ' B' ' 223' ' ' ASP . 8.3 t -62.73 -42.6 99.74 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.27 0.628 . . . . 74.31 110.532 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 270' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' B' ' 269' ' ' THR . 4.7 pt-20 64.55 -11.32 0.13 Allowed 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 127.62 2.368 . . . . 72.41 115.716 168.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 271' ' ' ALA . . . . . . . . . . . . . . . 66.39 -9.32 0.32 Allowed 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 125.392 1.477 . . . . 75.3 114.785 174.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 272' ' ' ASN . . . . . 0.403 ' HA ' HG22 ' C' ' 262' ' ' THR . 96.8 m-20 -99.67 31.86 3.06 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.479 0.711 . . . . 73.11 111.116 -174.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 15.4 tm0? 62.4 -84.0 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.404 1.082 . . . . 73.43 109.901 -178.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 274' ' ' GLN . . . . . 0.438 ' HB3' ' HD3' ' B' ' 275' ' ' LYS . 7.2 tp60 65.63 -72.28 0.08 Allowed 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 126.144 1.778 . . . . 71.44 113.497 178.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 275' ' ' LYS . . . . . 0.677 ' HD2' ' HB3' ' B' ' 266' ' ' ASN . 2.2 mppt? -81.16 -60.96 0.41 Allowed Pre-proline 0 CA--C 1.562 1.436 0 CA-C-O 118.705 -0.664 . . . . 72.14 111.727 -172.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 276' ' ' PRO . . . . . 0.474 ' HD3' ' HB2' ' B' ' 275' ' ' LYS . 89.4 Cg_endo -88.66 103.93 0.43 Allowed 'Trans proline' 0 C--N 1.393 2.887 0 C-N-CA 121.949 1.766 . . . . 73.04 112.621 -172.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 277' ' ' LEU . . . . . 0.541 HD22 ' HA3' ' B' ' 255' ' ' GLY . 6.5 mp -74.95 -7.65 54.21 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 122.819 0.448 . . . . 74.52 111.388 175.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 278' ' ' LEU . . . . . 0.555 ' HB2' ' NE2' ' B' ' 252' ' ' GLN . 37.3 tp -162.32 -57.33 0.04 OUTLIER 'General case' 0 C--O 1.234 0.27 0 N-CA-C 107.525 -1.287 . . . . 72.2 107.525 172.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . 75.47 -77.67 1.21 Allowed Glycine 0 C--N 1.347 1.178 0 CA-C-N 115.082 -0.963 . . . . 75.43 111.651 -176.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 63.79 72.05 0.48 Allowed 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.132 1.373 . . . . 74.31 109.728 178.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -160.91 -47.32 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.78 -0.646 . . . . 75.31 110.06 178.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -156.93 148.13 22.05 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.726 0.81 . . . . 65.41 110.042 -178.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -170.9 -59.8 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.799 1.24 . . . . 72.33 108.324 -179.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . 96.28 137.35 9.3 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-N 114.503 -1.226 . . . . 72.13 112.958 176.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -93.54 -159.01 0.66 Allowed 'General case' 0 CA--C 1.551 0.995 0 N-CA-C 107.948 -1.13 . . . . 73.03 107.948 172.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 286' ' ' MET . . . . . . . . . . . . . 57.8 mtt -124.94 74.93 66.43 Favored Pre-proline 0 N--CA 1.488 1.463 0 CA-C-N 118.731 0.696 . . . . 74.22 111.715 -175.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 287' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -86.95 -33.13 0.17 Allowed 'Trans proline' 0 C--N 1.384 2.441 0 C-N-CA 122.732 2.288 . . . . 74.24 113.485 170.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 288' ' ' VAL . . . . . . . . . . . . . 29.3 t 53.22 -89.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 125.614 1.566 . . . . 74.32 111.717 -176.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 289' ' ' ARG . . . . . 0.533 ' NH1' ' HB3' ' B' ' 291' ' ' LEU . 0.4 OUTLIER 169.74 89.14 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 104.755 -2.313 . . . . 74.32 104.755 179.504 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 290' ' ' TRP . . . . . . . . . . . . . 70.0 m95 -93.81 143.71 26.09 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.247 0.546 . . . . 75.34 111.117 -177.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 291' ' ' LEU . . . . . 0.533 ' HB3' ' NH1' ' B' ' 289' ' ' ARG . 2.3 pt? -153.45 174.06 14.87 Favored 'General case' 0 C--O 1.243 0.714 0 CA-C-N 114.633 -1.167 . . . . 73.52 109.893 -179.279 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . -113.9 83.65 0.34 Allowed Glycine 0 C--N 1.344 0.977 0 CA-C-O 118.965 -0.908 . . . . 71.42 112.703 177.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -83.13 65.06 7.9 Favored 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 123.099 2.533 . . . . 75.13 111.31 174.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 294' ' ' LYS . . . . . 0.854 ' HA ' ' HA ' ' B' ' 190' ' ' CYS . 15.0 ptpt 55.4 8.36 0.28 Allowed 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 127.042 2.137 . . . . 74.44 115.709 174.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 295' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' B' ' 191' ' ' TYR . . . 61.63 -75.0 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.986 1.314 . . . . 71.35 111.593 -175.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 296' ' ' THR . . . . . 0.7 ' HA ' ' HB2' ' B' ' 198' ' ' GLU . 9.5 t -150.14 -15.25 0.25 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.084 0.953 . . . . 71.52 111.014 -179.007 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 20.5 t80 64.73 20.44 12.13 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 125.23 1.412 . . . . 75.44 111.915 -178.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 298' ' ' HIS . . . . . 0.467 ' H ' HG21 ' B' ' 296' ' ' THR . 65.0 m170 -72.49 85.58 1.14 Allowed 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 108.804 -0.813 . . . . 73.43 108.804 171.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 299' ' ' GLY . . . . . 0.693 ' HA2' ' HZ1' ' B' ' 189' ' ' LYS . . . -60.91 -37.84 94.42 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-N 115.441 -0.799 . . . . 72.35 113.559 -171.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -67.68 -34.58 77.21 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.037 0.935 . . . . 72.23 111.232 176.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 301' ' ' ILE . . . . . . . . . . . . . 16.1 tt 37.32 90.28 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.366 1.315 0 C-N-CA 126.467 1.907 . . . . 75.13 112.09 -172.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 302' ' ' ASP . . . . . 0.449 ' O ' ' HG2' ' B' ' 303' ' ' LYS . 18.3 t70 -75.25 81.66 2.37 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.41 -0.814 . . . . 74.32 111.389 -170.404 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 303' ' ' LYS . . . . . 0.64 ' HE3' ' HA ' ' B' ' 303' ' ' LYS . 0.0 OUTLIER -172.0 -61.22 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.36 0 C-N-CA 126.891 2.076 . . . . 74.11 107.758 162.717 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 304' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -92.66 -28.37 0.14 Allowed 'Trans proline' 0 C--N 1.395 3.007 0 C-N-CA 121.863 1.709 . . . . 75.12 114.561 176.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . 50.55 -95.11 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.969 1.308 . . . . 72.13 111.826 -172.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . 0.487 HG23 HH12 ' B' ' 56' ' ' ARG . 26.4 m -142.06 156.58 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 125.176 1.391 . . . . 72.33 108.144 170.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 8.7 t -91.66 111.35 22.83 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 108.172 -1.048 . . . . 74.23 108.172 171.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 308' ' ' CYS . . . . . . . . . . . . . 44.3 t -88.76 21.21 3.12 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.025 0.93 . . . . 74.22 111.374 -173.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 42.2 p -77.28 112.63 24.76 Favored Pre-proline 0 CA--C 1.553 1.082 0 C-N-CA 124.166 0.986 . . . . 72.2 110.733 -177.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -74.86 107.66 2.53 Favored 'Trans proline' 0 C--N 1.377 2.037 0 C-N-CA 122.226 1.951 . . . . 64.44 110.673 174.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 311' ' ' ASN . . . . . 0.552 HD21 ' HD2' ' C' ' 160' ' ' ARG . 3.7 t30 -72.63 136.83 80.47 Favored Pre-proline 0 CA--C 1.552 1.052 0 N-CA-C 109.245 -0.65 . . . . 73.13 109.245 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 312' ' ' PRO . . . . . 0.604 ' HG3' HD11 ' B' ' 69' ' ' LEU . 52.8 Cg_exo -57.1 166.65 3.96 Favored 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 123.076 2.518 . . . . 70.14 113.823 178.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 313' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -85.58 45.7 1.22 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.866 0.867 . . . . 75.13 110.48 -178.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 314' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -70.18 106.01 3.14 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.009 0.923 . . . . 74.53 108.817 -177.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 315' ' ' ASN . . . . . 0.564 ' HB3' ' HG2' ' B' ' 27' ' ' PRO . 51.8 t30 72.22 125.19 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.471 1.509 . . . . 75.34 112.037 178.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 316' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -102.53 -16.97 15.95 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.876 0.87 . . . . 74.4 110.964 176.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 15.2 m -91.63 106.36 18.42 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.706 0.802 . . . . 75.41 111.009 -170.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 318' ' ' VAL . . . . . . . . . . . . . 2.9 p -75.54 117.42 63.23 Favored Pre-proline 0 CA--C 1.556 1.188 0 C-N-CA 123.366 0.666 . . . . 73.13 109.576 171.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 319' ' ' PRO . . . . . 0.509 ' HD2' HG13 ' B' ' 28' ' ' VAL . 73.4 Cg_exo -54.55 107.5 0.23 Allowed 'Trans proline' 0 C--N 1.382 2.324 0 C-N-CA 123.07 2.513 . . . . 65.1 112.176 175.026 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 320' ' ' THR . . . . . . . . . . . . . 14.4 t -162.44 170.28 19.01 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.427 0.691 . . . . 73.24 110.328 -178.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 321' ' ' LEU . . . . . . . . . . . . . 50.4 tp -108.36 -90.93 0.44 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 122.887 0.475 . . . . 74.43 110.04 -178.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 322' ' ' ALA . . . . . 0.543 ' HA ' ' HB2' ' C' ' 27' ' ' LYS . . . -156.07 -62.35 0.11 Allowed 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 107.203 -1.406 . . . . 64.54 107.203 -179.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 323' ' ' GLN . . . . . 0.402 ' HA ' ' HG2' ' C' ' 24' ' ' ARG . 26.4 mt-30 -82.2 101.37 10.43 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 114.97 -1.014 . . . . 74.02 108.43 169.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 324' ' ' MET . . . . . 0.5 ' HB2' ' HE2' ' C' ' 27' ' ' LYS . 17.1 tmm? -73.7 -49.14 27.17 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 106.59 -1.633 . . . . 74.22 106.59 169.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 325' ' ' THR . . . . . 0.42 ' HA ' ' NH2' ' C' ' 24' ' ' ARG . 91.7 m 75.16 -55.95 0.63 Allowed 'General case' 0 C--N 1.356 0.869 0 C-N-CA 126.46 1.904 . . . . 72.33 113.358 168.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 326' ' ' ASP . . . . . 0.619 ' HB3' HD12 ' B' ' 329' ' ' ILE . 1.4 t70 58.99 -92.1 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.814 0 O-C-N 124.203 0.94 . . . . 72.01 109.216 -170.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 20.2 tptp 174.64 -38.86 0.01 OUTLIER 'General case' 0 C--N 1.36 1.053 0 C-N-CA 124.127 0.971 . . . . 75.41 110.376 -178.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 328' ' ' ALA . . . . . 0.52 ' HB2' ' HB2' ' B' ' 40' ' ' ALA . . . -138.64 -12.56 1.32 Allowed 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 115.874 1.805 . . . . 72.03 115.874 -165.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 329' ' ' ILE . . . . . 0.619 HD12 ' HB3' ' B' ' 326' ' ' ASP . 0.2 OUTLIER -58.2 -27.06 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.757 0 CA-C-N 120.922 1.692 . . . . 73.5 113.039 -177.197 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 330' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -106.78 -11.73 15.7 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.867 0.867 . . . . 74.44 112.426 -172.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 331' ' ' LEU . . . . . . . . . . . . . 3.4 pp -149.58 -157.33 0.81 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.611 0.764 . . . . 64.42 110.034 -177.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 332' ' ' LEU . . . . . 0.412 HD12 ' HB3' ' B' ' 335' ' ' ASN . 2.0 tm? 81.13 -41.35 0.16 Allowed 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 125.566 1.546 . . . . 74.41 111.973 174.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 333' ' ' SER . . . . . . . . . . . . . 19.9 m 78.76 120.91 0.05 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.917 1.687 . . . . 65.04 110.819 -173.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm 65.39 -83.06 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.488 1.515 . . . . 65.35 111.638 -175.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 335' ' ' ASN . . . . . 0.412 ' HB3' HD12 ' B' ' 332' ' ' LEU . 2.0 p-10 50.53 120.81 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 126.013 1.725 . . . . 74.12 112.421 -168.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 336' ' ' GLU . . . . . 0.424 ' HB2' ' HA ' ' B' ' 44' ' ' ALA . 46.8 mt-10 74.84 -51.35 0.67 Allowed 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 125.654 1.582 . . . . 73.55 113.024 -179.096 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 337' ' ' LYS . . . . . 0.555 ' HD2' ' HB2' ' B' ' 45' ' ' ARG . 61.9 tttm -52.07 -41.44 62.36 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.709 1.204 . . . . 71.1 113.049 -174.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 338' ' ' GLY . . . . . . . . . . . . . . . -147.03 13.06 1.46 Allowed Glycine 0 C--N 1.34 0.761 0 CA-C-N 116.133 -0.485 . . . . 73.12 112.891 177.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 339' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -146.4 125.58 12.96 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.405 0.682 . . . . 74.33 110.174 -177.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 340' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -78.2 -23.24 47.63 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 108.951 -0.759 . . . . 75.24 108.951 165.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 341' ' ' LEU . . . . . . . . . . . . . 31.4 tp 67.63 -78.01 0.04 OUTLIER 'General case' 0 C--N 1.357 0.909 0 C-N-CA 125.734 1.614 . . . . 75.34 110.62 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 342' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -161.32 27.5 0.13 Allowed 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 123.037 0.535 . . . . 74.32 109.81 -176.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 343' ' ' VAL . . . . . . . . . . . . . 7.6 p -71.51 82.45 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.236 0 CA-C-O 122.211 1.005 . . . . 65.15 110.531 -177.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 61.75 10.0 3.18 Favored 'General case' 0 C--N 1.36 1.064 0 CA-C-N 114.221 -1.354 . . . . 74.33 112.679 -177.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 345' ' ' GLY . . . . . . . . . . . . . . . 77.54 -63.18 3.41 Favored Glycine 0 C--N 1.351 1.393 0 N-CA-C 111.305 -0.718 . . . . 63.14 111.305 -170.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 346' ' ' ALA . . . . . . . . . . . . . . . -122.19 119.7 32.02 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.246 1.018 . . . . 72.51 109.59 172.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 18.5 m -80.03 89.5 5.36 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.624 0.769 . . . . 72.21 108.949 174.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 14.9 tt -155.56 30.95 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.108 0 C-N-CA 123.994 0.917 . . . . 73.42 109.006 -173.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 349' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 61.0 69.05 0.7 Allowed 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.64 1.176 . . . . 71.13 108.924 -172.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 350' ' ' LYS . . . . . 0.649 ' HB3' ' HZ1' ' B' ' 350' ' ' LYS . 0.0 OUTLIER -81.37 84.58 6.62 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.041 -0.981 . . . . 74.52 108.697 -172.155 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 55.85 19.89 3.8 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 125.131 1.372 . . . . 71.32 113.647 171.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -80.55 157.06 26.19 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 122.634 0.374 . . . . 74.35 110.458 -173.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 353' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -55.33 -40.92 71.75 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.026 0.931 . . . . 74.33 111.29 175.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 354' ' ' ALA . . . . . . . . . . . . . . . 76.46 -61.9 0.43 Allowed 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 125.543 1.537 . . . . 72.23 113.738 168.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 355' ' ' ALA . . . . . . . . . . . . . . . 74.2 4.83 4.61 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 125.259 1.424 . . . . 75.44 111.312 -167.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 356' ' ' ASN . . . . . 0.402 ' N ' ' HD2' ' B' ' 357' ' ' PRO . 1.8 m-20 -76.08 -43.77 3.67 Favored Pre-proline 0 CA--C 1.557 1.223 0 C-N-CA 124.574 1.15 . . . . 74.32 111.269 175.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 357' ' ' PRO . . . . . 0.402 ' HD2' ' N ' ' B' ' 356' ' ' ASN . 58.1 Cg_endo -67.8 172.18 11.04 Favored 'Trans proline' 0 C--N 1.403 3.412 0 C-N-CA 121.877 1.718 . . . . 74.21 113.472 177.156 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 358' ' ' CYS . . . . . . . . . . . . . 48.3 t 79.34 158.11 0.17 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 126.012 1.725 . . . . 75.21 111.741 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 359' ' ' GLY . . . . . . . . . . . . . . . -167.8 78.3 0.11 Allowed Glycine 0 C--N 1.342 0.869 0 CA-C-N 115.301 -0.863 . . . . 72.04 111.635 178.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 360' ' ' GLN . . . . . 0.516 HE21 ' HG3' ' C' ' 236' ' ' LYS . 12.3 mm-40 59.99 -153.63 0.38 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.792 1.237 . . . . 53.34 112.398 175.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 361' ' ' ILE . . . . . . . . . . . . . 34.2 mm -53.71 152.22 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 124.609 1.164 . . . . 64.41 111.365 178.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 362' ' ' GLY . . . . . . . . . . . . . . . -65.72 -156.39 0.32 Allowed Glycine 0 C--N 1.352 1.449 0 C-N-CA 123.287 0.47 . . . . 72.35 114.245 178.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 363' ' ' GLU . . . . . 0.402 ' HB3' ' HA ' ' B' ' 246' ' ' THR . 3.7 mm-40 -81.0 82.11 7.06 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 108.753 -0.832 . . . . 73.13 108.753 -175.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 364' ' ' THR . . . . . . . . . . . . . 5.5 t -92.52 -42.7 9.56 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 114.974 -1.012 . . . . 74.04 112.978 -165.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 365' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' B' ' 244' ' ' GLY . 50.2 t 58.89 105.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 124.37 1.068 . . . . 74.51 110.816 -167.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -153.28 167.61 28.77 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.675 0.79 . . . . 52.52 109.238 -174.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 367' ' ' LEU . . . . . 0.485 ' HB2' ' HA ' ' B' ' 243' ' ' GLN . 96.3 mt 58.97 100.06 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.697 1.199 . . . . 75.05 112.527 175.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 368' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -62.48 126.6 27.89 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.466 0.706 . . . . 73.23 110.738 178.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 369' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -137.29 128.63 28.11 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.385 0.674 . . . . 74.11 109.313 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 370' ' ' ALA . . . . . . . . . . . . . . . -162.24 105.29 1.14 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.958 0.903 . . . . 74.25 108.896 -173.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 371' ' ' VAL . . . . . . . . . . . . . 11.7 m -127.29 -48.12 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 112.905 0.706 . . . . 74.12 112.905 -168.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 372' ' ' GLN . . . . . 0.429 ' HB3' ' HG2' ' C' ' 228' ' ' GLN . 49.9 tp60 -95.43 -79.62 0.43 Allowed 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 119.237 -0.411 . . . . 63.2 110.716 -163.028 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 373' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 44.73 16.87 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.417 0 C-N-CA 127.083 2.153 . . . . 72.2 116.067 -179.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 374' ' ' ALA . . . . . 0.453 ' HB2' HH22 ' C' ' 279' ' ' ARG . . . 61.58 12.1 4.28 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.253 1.021 . . . . 71.45 112.165 -170.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 375' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 64.58 -77.28 0.04 OUTLIER 'General case' 0 C--N 1.356 0.875 0 C-N-CA 126.615 1.966 . . . . 72.22 110.487 -174.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -91.37 124.6 35.68 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.868 0.867 . . . . 73.13 110.803 -175.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 377' ' ' PHE . . . . . 0.428 ' O ' ' HG2' ' C' ' 279' ' ' ARG . 83.3 m-85 -86.95 -16.05 37.0 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.561 0.744 . . . . 73.31 110.469 169.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 378' ' ' ALA . . . . . . . . . . . . . . . -87.39 -63.78 1.25 Allowed 'General case' 0 C--N 1.344 0.352 0 C-N-CA 123.267 0.627 . . . . 73.45 110.936 -178.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . 0.501 ' HE2' ' HG2' ' B' ' 381' ' ' GLU 0.263 8.2 ptmm? 48.48 -77.53 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 125.915 1.686 . . . . 73.22 112.504 -164.562 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 380' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? 57.27 79.8 0.18 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.903 0.881 . . . . 72.4 111.563 -176.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 381' ' ' GLU . . . . . 0.501 ' HG2' ' HE2' ' B' ' 379' ' ' LYS . 40.9 mm-40 -90.08 -30.2 17.85 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.236 -0.438 . . . . 74.34 110.006 178.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . 64.58 58.14 10.96 Favored Glycine 0 C--N 1.351 1.39 0 N-CA-C 111.284 -0.727 . . . . 73.1 111.284 -174.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 383' ' ' ASN . . . . . . . . . . . . 0.271 10.7 p30 72.5 -16.25 0.45 Allowed 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 126.994 2.118 . . . . 73.1 114.676 176.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 384' ' ' THR . . . . . 0.4 HG23 ' HA ' ' A' ' 219' ' ' VAL . 3.1 m 58.6 44.52 17.48 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 124.747 1.219 . . . . 71.44 110.796 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 96.4 mt 61.77 22.97 13.4 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 124.273 1.029 . . . . 75.43 111.268 -175.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 386' ' ' VAL . . . . . 0.45 ' O ' HG21 ' B' ' 387' ' ' ILE . 3.1 t 53.05 23.19 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 C-N-CA 125.722 1.609 . . . . 75.23 111.121 -173.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 387' ' ' ILE . . . . . 0.45 HG21 ' O ' ' B' ' 386' ' ' VAL 0.262 6.3 tt 67.33 -41.74 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 C-N-CA 128.031 2.532 . . . . 74.12 114.789 -177.253 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 388' ' ' VAL . . . . . . . . . . . . . 4.8 p 55.61 20.09 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 C-N-CA 126.185 1.794 . . . . 74.43 113.34 175.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 389' ' ' THR . . . . . . . . . . . . . 56.0 m -156.02 157.5 36.24 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.162 0.985 . . . . 71.25 109.169 -176.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . 68.94 36.19 2.62 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 124.464 1.106 . . . . 73.41 110.695 177.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 391' ' ' ASP . . . . . 0.524 ' HB3' ' HA2' ' B' ' 436' ' ' GLY . 5.0 p-10 -75.48 -163.99 0.3 Allowed 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 114.588 -1.187 . . . . 64.12 111.123 176.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 392' ' ' HIS . . . . . . . . . . . . . 57.4 t60 -63.36 -48.23 78.78 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.144 0.978 . . . . 72.42 111.287 -176.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -99.71 5.37 45.71 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.522 0.729 . . . . 61.53 111.514 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 11.6 m170 66.46 16.91 10.56 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 124.903 1.281 . . . . 73.31 112.002 172.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . -163.11 -56.44 0.04 OUTLIER 'General case' 0 C--O 1.238 0.454 0 C-N-CA 123.633 0.773 . . . . 75.42 109.586 -172.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 77.4 p 51.73 -173.32 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 125.853 1.661 . . . . 75.55 113.572 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 397' ' ' GLN . . . . . 0.554 ' HB2' ' HB3' ' B' ' 401' ' ' PRO . 2.3 mp0 -72.24 116.67 12.95 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.549 -0.908 . . . . 75.54 108.549 170.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 398' ' ' ILE . . . . . 0.607 HG21 ' HD2' ' B' ' 415' ' ' LYS . 14.1 tt -57.71 144.69 9.85 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 O-C-N 123.826 0.704 . . . . 75.44 110.706 176.021 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 399' ' ' VAL . . . . . . . . . . . . . 58.3 t 74.68 -83.93 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 C-N-CA 125.43 1.492 . . . . 73.32 110.661 -176.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 400' ' ' ALA . . . . . . . . . . . . . . . -128.05 91.41 44.77 Favored Pre-proline 0 N--CA 1.492 1.631 0 N-CA-C 113.309 0.855 . . . . 74.52 113.309 -168.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 401' ' ' PRO . . . . . 0.554 ' HB3' ' HB2' ' B' ' 397' ' ' GLN . 68.5 Cg_endo -96.36 -171.67 0.19 Allowed 'Trans proline' 0 C--N 1.371 1.715 0 C-N-CA 123.559 2.839 . . . . 71.34 111.186 160.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -166.02 94.21 0.56 Allowed 'General case' 0 N--CA 1.482 1.172 0 CA-C-O 120.922 0.391 . . . . 74.34 110.799 -178.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 403' ' ' THR . . . . . 0.522 ' H ' ' HB2' ' B' ' 433' ' ' GLU . 7.5 m 61.14 12.24 3.95 Favored 'General case' 0 CA--C 1.569 1.695 0 C-N-CA 124.817 1.247 . . . . 73.2 111.897 174.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 404' ' ' LYS . . . . . 0.408 ' HZ1' ' HB2' ' B' ' 404' ' ' LYS . 9.3 mtmp? -148.46 86.89 1.55 Allowed 'General case' 0 C--O 1.243 0.724 0 C-N-CA 125.363 1.465 . . . . 71.14 107.259 -171.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 405' ' ' ALA . . . . . . . . . . . . . . . -66.04 -43.66 57.71 Favored Pre-proline 0 CA--C 1.56 1.339 0 CA-C-N 115.261 -0.881 . . . . 71.24 111.944 179.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 406' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -94.02 50.41 0.31 Allowed 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 122.291 1.994 . . . . 64.23 111.386 165.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . -70.22 -71.61 0.99 Allowed Glycine 0 C--N 1.344 1.017 0 CA-C-N 115.867 -0.606 . . . . 74.04 113.741 -176.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 408' ' ' LEU . . . . . 0.433 HD13 ' N ' ' B' ' 409' ' ' THR . 0.8 OUTLIER -148.99 151.7 35.01 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 109.0 -0.741 . . . . 72.55 109.0 -170.75 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 409' ' ' THR . . . . . 0.433 ' N ' HD13 ' B' ' 408' ' ' LEU . 52.8 p 56.06 24.32 7.73 Favored 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 125.591 1.556 . . . . 73.52 111.811 -174.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 410' ' ' GLN . . . . . 0.499 ' HA ' ' OG1' ' B' ' 414' ' ' THR . 0.1 OUTLIER -81.06 81.34 7.32 Favored 'General case' 0 C--N 1.35 0.624 0 N-CA-C 108.073 -1.084 . . . . 70.42 108.073 178.616 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . -77.26 -62.14 1.75 Allowed 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 114.753 -1.112 . . . . 74.33 109.523 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 412' ' ' LEU . . . . . 0.561 HD11 ' HB3' ' B' ' 106' ' ' TYR . 1.7 tm? -158.95 93.72 1.18 Allowed 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 106.258 -1.756 . . . . 75.21 106.258 -178.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 78.33 -43.04 0.35 Allowed 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 125.605 1.562 . . . . 71.14 112.791 -179.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 414' ' ' THR . . . . . 0.499 ' OG1' ' HA ' ' B' ' 410' ' ' GLN . 1.7 m 66.03 37.16 5.41 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.86 1.264 . . . . 73.24 109.833 -176.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 415' ' ' LYS . . . . . 0.607 ' HD2' HG21 ' B' ' 398' ' ' ILE . 92.6 mttt 72.42 118.0 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 125.355 1.462 . . . . 75.21 110.313 -178.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -70.96 84.06 0.68 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.293 1.037 . . . . 75.33 111.067 -175.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 417' ' ' GLY . . . . . . . . . . . . . . . 78.26 154.02 7.01 Favored Glycine 0 C--N 1.345 1.053 0 CA-C-N 115.418 -0.81 . . . . 62.31 113.395 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 418' ' ' ALA . . . . . . . . . . . . . . . -85.87 73.26 10.38 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.101 -1.074 . . . . 70.25 108.101 170.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 419' ' ' VAL . . . . . . . . . . . . . 31.5 m -60.54 131.15 25.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 CA-C-N 114.117 -1.401 . . . . 73.31 112.635 -168.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 420' ' ' MET . . . . . . . . . . . . . 70.6 mtm 72.11 -59.95 0.54 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 126.082 1.753 . . . . 73.34 112.572 177.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 421' ' ' VAL . . . . . . . . . . . . . 19.9 m -58.53 -52.25 61.87 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 C-N-CA 124.235 1.014 . . . . 72.42 112.679 -177.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 422' ' ' MET . . . . . 0.624 ' HE1' ' HB3' ' B' ' 434' ' ' HIS . 8.4 tpt 60.99 139.99 0.01 OUTLIER 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 124.65 1.18 . . . . 74.1 112.567 -176.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 423' ' ' SER . . . . . . . . . . . . . 34.5 t -81.0 -14.17 58.19 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.445 0.698 . . . . 63.45 111.821 -178.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 424' ' ' TYR . . . . . 0.428 ' H ' ' HG3' ' B' ' 422' ' ' MET . 8.5 m-85 64.87 -153.92 0.29 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.836 1.254 . . . . 74.22 110.83 -178.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . 107.14 74.16 0.87 Allowed Glycine 0 C--N 1.345 1.073 0 N-CA-C 109.956 -1.258 . . . . 75.12 109.956 -174.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 426' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -62.11 -35.56 79.07 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.545 0.738 . . . . 75.43 112.236 -174.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 427' ' ' SER . . . . . . . . . . . . . 27.8 t -108.14 36.9 2.62 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.376 0.67 . . . . 75.14 109.354 177.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 69.73 -74.75 0.08 Allowed 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 125.974 1.71 . . . . 73.23 111.046 -177.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 429' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 34.03 -74.45 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 127.846 2.458 . . . . 63.42 117.008 167.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -71.84 -68.05 0.49 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.396 0.678 . . . . 62.42 111.257 -170.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 11.8 p -98.34 -12.03 21.91 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-O 119.124 -0.465 . . . . 75.05 112.052 -175.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 432' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 59.48 -74.24 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 125.288 1.435 . . . . 71.1 113.988 170.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 433' ' ' GLU . . . . . 0.522 ' HB2' ' H ' ' B' ' 403' ' ' THR . 55.2 tt0 -80.76 -16.3 54.19 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.488 0.715 . . . . 73.43 110.585 175.227 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 434' ' ' HIS . . . . . 0.624 ' HB3' ' HE1' ' B' ' 422' ' ' MET . 87.6 m-70 67.91 13.42 9.16 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.677 1.191 . . . . 73.42 113.895 166.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 435' ' ' THR . . . . . . . . . . . . . 4.8 m 61.67 26.35 16.04 Favored 'General case' 0 CA--C 1.563 1.463 0 CA-C-O 122.495 1.141 . . . . 73.42 109.371 -174.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 436' ' ' GLY . . . . . 0.524 ' HA2' ' HB3' ' B' ' 391' ' ' ASP . . . 141.54 90.31 0.16 Allowed Glycine 0 C--N 1.348 1.195 0 N-CA-C 109.075 -1.61 . . . . 61.51 109.075 -168.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 37.1 p -85.43 70.22 10.77 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.663 0.785 . . . . 72.35 110.22 -177.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 438' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 58.65 169.66 0.06 Allowed 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 126.43 1.892 . . . . 71.55 112.935 -176.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 439' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -85.96 83.12 7.88 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 107.628 -1.249 . . . . 74.24 107.628 177.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 440' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -95.98 146.82 24.3 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.14 0.576 . . . . 74.1 110.789 -179.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 441' ' ' ILE . . . . . 0.59 HD12 ' HA ' ' A' ' 223' ' ' VAL . 58.7 mt -97.99 138.08 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.861 0.864 . . . . 74.15 110.58 -179.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 442' ' ' ALA . . . . . . . . . . . . . . . -132.87 98.91 4.43 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 107.758 -1.201 . . . . 73.33 107.758 170.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . -133.92 -67.86 0.58 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.551 0.741 . . . . 74.21 110.054 -174.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -151.6 153.12 33.86 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.838 0.855 . . . . 71.31 109.639 174.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . 125.3 -82.99 0.35 Allowed Glycine 0 CA--C 1.53 0.974 0 CA-C-O 119.229 -0.762 . . . . 74.34 111.229 -177.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 446' ' ' PRO . . . . . 0.547 ' HD3' ' HD2' ' A' ' 225' ' ' PRO . 94.5 Cg_endo -80.54 135.5 10.49 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 122.726 2.284 . . . . 72.44 112.379 -176.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 447' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -139.06 152.28 47.43 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.966 0.907 . . . . 63.45 108.998 178.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . -68.11 134.65 50.91 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.103 0.561 . . . . 74.31 109.969 175.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 449' ' ' ALA . . . . . . . . . . . . . . . -109.43 113.16 25.73 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.766 0.826 . . . . 74.42 108.916 177.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 450' ' ' ASN . . . . . 0.507 HD21 ' HG ' ' B' ' 454' ' ' LEU . 28.2 p-10 -72.51 -27.47 62.28 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.341 0.657 . . . . 63.22 111.065 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 451' ' ' VAL . . . . . 0.532 HG11 ' HA ' ' B' ' 464' ' ' MET 0.283 35.1 m 49.52 -76.77 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 C-N-CA 127.26 2.224 . . . . 74.44 114.131 177.72 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 452' ' ' VAL . . . . . 0.509 ' H ' HG23 ' B' ' 451' ' ' VAL . 62.0 t -68.64 -40.72 82.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 123.278 0.631 . . . . 74.24 109.814 -179.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 155.4 -163.86 31.76 Favored Glycine 0 C--N 1.338 0.68 0 CA-C-N 115.22 -0.9 . . . . 73.44 111.157 -178.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 454' ' ' LEU . . . . . 0.507 ' HG ' HD21 ' B' ' 450' ' ' ASN . 0.4 OUTLIER -156.92 152.01 26.19 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.085 0.554 . . . . 73.13 111.094 -179.421 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 56.8 p -92.6 3.39 55.65 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.318 1.047 . . . . 72.1 111.07 177.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -70.53 -65.8 0.68 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.965 0.906 . . . . 74.3 110.577 -178.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 457' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -170.97 134.0 0.94 Allowed 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 106.912 -1.514 . . . . 65.21 106.912 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 30.6 p -50.7 95.99 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.166 0.986 . . . . 72.13 111.653 -177.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 459' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -166.79 166.03 15.94 Favored 'General case' 0 C--O 1.243 0.741 0 C-N-CA 124.515 1.126 . . . . 73.31 108.313 -178.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 78.6 mt 62.89 33.12 15.34 Favored 'General case' 0 C--N 1.359 0.984 0 CA-C-O 122.09 0.947 . . . . 65.42 109.9 -175.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -64.67 125.55 25.11 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 114.346 -1.297 . . . . 75.0 109.832 178.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 68.9 t80 68.5 14.0 9.04 Favored 'General case' 0 CA--C 1.567 1.598 0 C-N-CA 124.498 1.119 . . . . 72.53 111.786 -179.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 84.0 m -73.9 83.56 1.7 Allowed 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 122.223 1.011 . . . . 71.14 109.086 172.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 464' ' ' MET . . . . . 0.532 ' HA ' HG11 ' B' ' 451' ' ' VAL . 54.3 mtt -128.05 137.03 52.01 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 113.986 -1.461 . . . . 75.31 108.209 -175.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -75.87 93.49 3.2 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 108.315 -0.995 . . . . 72.15 108.315 172.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -71.61 -172.24 0.76 Allowed 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.14 -0.936 . . . . 65.13 110.685 176.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . -60.91 -45.53 94.28 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 109.414 -0.588 . . . . 75.3 109.414 170.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 5.0 mp -109.67 -161.46 0.76 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.056 0.943 . . . . 74.32 108.786 173.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 469' ' ' GLY . . . . . . . . . . . . . . . -84.54 177.62 51.45 Favored Glycine 0 C--N 1.35 1.308 0 N-CA-C 112.334 -0.307 . . . . 62.03 112.334 171.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 470' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.47 121.96 14.13 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 122.929 0.492 . . . . 75.32 110.667 -178.315 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 471' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.258 1.537 0 C-N-CA 124.978 1.311 . . . . 74.2 110.394 175.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 64.6 mtm . . . . . 0 N--CA 1.471 0.621 0 N-CA-C 109.481 -0.563 . . . . 70.43 109.481 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.7 21.15 7.03 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.662 1.185 . . . . 70.41 113.026 177.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -86.91 45.28 1.25 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.418 0.687 . . . . 71.34 110.588 -178.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 4' ' ' LYS . . . . . 0.612 ' HB3' ' HZ1' ' C' ' 4' ' ' LYS . 6.7 ttpm? -39.42 100.76 0.02 OUTLIER 'General case' 0 C--N 1.351 0.674 0 C-N-CA 125.301 1.44 . . . . 70.52 112.996 171.245 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -76.42 123.18 25.6 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 106.445 -1.687 . . . . 72.32 106.445 166.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -72.4 96.0 1.83 Allowed 'General case' 0 C--O 1.245 0.818 0 N-CA-C 108.705 -0.85 . . . . 65.15 108.705 -176.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 7' ' ' TYR . . . . . 0.441 ' CD1' ' HA ' ' C' ' 53' ' ' ALA . 50.2 m-85 -66.89 -24.2 66.08 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 113.893 -1.503 . . . . 73.43 112.083 -169.099 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -66.36 -49.11 68.0 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.803 -0.443 . . . . 74.23 109.803 174.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.09 -41.87 97.47 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 123.635 0.584 . . . . 63.34 110.986 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 58.3 mt -59.05 -41.83 84.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 123.645 0.591 . . . . 73.31 110.715 176.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 11' ' ' LEU . . . . . 0.408 ' HB2' HG23 ' C' ' 13' ' ' VAL . 78.4 mt -69.97 -26.24 64.0 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 115.994 -0.548 . . . . 75.53 111.869 174.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.95 22.31 55.52 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-N 116.694 -0.23 . . . . 74.43 112.953 -173.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 13' ' ' VAL . . . . . 0.408 HG23 ' HB2' ' C' ' 11' ' ' LEU . 19.0 m -107.23 150.5 40.02 Favored Pre-proline 0 N--CA 1.481 1.077 0 C-N-CA 124.184 0.994 . . . . 71.34 109.588 174.156 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -66.38 163.15 33.33 Favored 'Trans proline' 0 C--N 1.371 1.738 0 C-N-CA 122.455 2.103 . . . . 74.43 111.809 178.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -77.27 21.59 0.24 Allowed 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 123.175 0.59 . . . . 74.35 112.326 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -131.49 18.3 4.81 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.1 1.36 . . . . 71.24 107.691 173.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.23 123.72 18.07 Favored 'General case' 0 C--N 1.353 0.74 0 C-N-CA 124.166 0.986 . . . . 75.2 111.322 -178.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 44.0 p -66.72 170.29 6.65 Favored 'General case' 0 C--O 1.251 1.168 0 N-CA-C 109.059 -0.719 . . . . 74.41 109.059 170.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 59.4 tp60 -61.43 -36.42 80.31 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.538 -0.301 . . . . 74.45 111.081 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 20' ' ' GLU . . . . . 0.442 ' HB3' ' NH1' ' C' ' 24' ' ' ARG . 0.1 OUTLIER -73.27 -36.59 66.38 Favored 'General case' 0 C--O 1.212 -0.91 0 CA-C-O 118.869 -0.586 . . . . 74.53 110.171 179.773 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -55.93 -48.79 75.07 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.383 0.611 . . . . 73.42 111.188 174.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 22' ' ' ILE . . . . . 0.501 HD13 ' HB3' ' C' ' 57' ' ' LEU . 71.7 mt -61.6 -43.05 96.36 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-N 114.743 -1.117 . . . . 75.54 110.964 176.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 23' ' ' LYS . . . . . 0.536 ' O ' ' HG3' ' C' ' 27' ' ' LYS . 13.1 tppt? -68.76 -25.45 64.73 Favored 'General case' 0 CA--C 1.558 1.287 0 CA-C-N 115.34 -0.845 . . . . 74.13 110.158 179.214 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 24' ' ' ARG . . . . . 0.442 ' NH1' ' HB3' ' C' ' 20' ' ' GLU . 68.5 mtt85 -71.94 -50.95 24.66 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.775 0.83 . . . . 73.52 110.283 178.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.87 -37.73 74.45 Favored 'General case' 0 C--O 1.246 0.917 0 O-C-N 124.296 0.997 . . . . 75.32 110.293 177.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 26' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -56.31 -71.37 0.09 Allowed 'General case' 0 C--N 1.358 0.968 0 CA-C-O 117.642 -1.171 . . . . 72.31 110.487 172.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . 0.543 ' HB2' ' HA ' ' B' ' 322' ' ' ALA . 39.0 mttp -50.24 -39.59 45.17 Favored 'General case' 0 N--CA 1.504 2.237 0 C-N-CA 123.633 0.773 . . . . 75.33 112.259 -173.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -54.75 -62.7 1.49 Allowed 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.691 1.197 . . . . 75.55 110.852 176.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . 0.486 HD12 HD12 ' C' ' 50' ' ' ILE . 42.3 mt -81.66 -8.81 59.75 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 115.25 -0.886 . . . . 71.43 111.256 -175.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . 0.475 ' HA ' ' HE1' ' C' ' 47' ' ' PHE . . . -93.36 -14.51 26.79 Favored 'General case' 0 C--O 1.215 -0.763 0 C-N-CA 124.23 1.012 . . . . 75.32 110.579 179.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 54.1 mtm180 -92.4 -41.67 10.19 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 109.245 -0.65 . . . . 73.5 109.245 164.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 23.9 tp60 -63.78 -50.61 68.35 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.764 0.826 . . . . 71.12 111.564 -175.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 33' ' ' TYR . . . . . 0.415 ' HE2' HD22 ' C' ' 29' ' ' LEU . 32.6 m-85 -104.26 20.16 18.87 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.235 0.614 . . . . 72.14 110.846 -177.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 34' ' ' HIS . . . . . 0.422 ' CD2' ' HB3' ' C' ' 36' ' ' ASP . 5.8 t60 -62.57 114.48 12.17 Favored Pre-proline 0 N--CA 1.475 0.819 0 CA-C-O 118.405 -0.807 . . . . 74.34 109.461 -179.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -51.15 -33.47 44.09 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 123.345 2.696 . . . . 72.22 114.414 -173.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 36' ' ' ASP . . . . . 0.422 ' HB3' ' CD2' ' C' ' 34' ' ' HIS . 15.7 t70 -68.51 -44.13 75.32 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.745 0.818 . . . . 60.34 111.639 177.404 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 61.5 t -80.51 -51.14 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 CA-C-O 121.495 0.664 . . . . 75.33 110.05 -173.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -112.67 96.79 6.17 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 114.809 -1.087 . . . . 65.41 108.939 177.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -84.08 67.03 9.53 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.899 0.479 . . . . 71.22 109.961 178.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 49.4 m -124.41 109.77 28.73 Favored Pre-proline 0 N--CA 1.477 0.878 0 C-N-CA 123.645 0.778 . . . . 74.14 108.933 177.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -43.82 -47.21 10.09 Favored 'Trans proline' 0 C--N 1.386 2.547 0 C-N-CA 124.197 3.265 . . . . 75.0 113.775 -177.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -55.25 -42.36 73.4 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.913 0.885 . . . . 71.01 111.299 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.68 -27.37 61.19 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 114.972 -1.013 . . . . 71.45 110.754 -178.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -81.51 -24.69 36.51 Favored 'General case' 0 C--N 1.352 0.689 0 O-C-N 123.774 0.671 . . . . 74.04 109.955 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -73.32 -45.07 57.5 Favored 'General case' 0 C--O 1.244 0.774 0 C-N-CA 123.709 0.804 . . . . 75.44 109.688 173.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 46' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -60.83 -41.03 94.99 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 115.605 -0.725 . . . . 72.32 110.36 171.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 47' ' ' PHE . . . . . 0.475 ' HE1' ' HA ' ' C' ' 30' ' ' ALA . 84.6 t80 -57.09 -45.99 82.92 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 124.149 0.906 . . . . 71.12 109.933 176.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 48' ' ' LYS . . . . . 0.476 ' HE3' ' HB3' ' C' ' 89' ' ' ASP . 48.5 mtpt -58.98 -46.26 88.54 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 123.965 0.791 . . . . 72.04 111.555 178.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -60.56 -43.15 97.56 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.303 0.573 . . . . 72.33 112.099 178.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 50' ' ' ILE . . . . . 0.486 HD12 HD12 ' C' ' 29' ' ' LEU . 82.8 mt -70.56 -29.35 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 124.187 0.995 . . . . 75.43 110.526 178.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 51' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -90.21 -5.58 56.23 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.802 0.841 . . . . 74.04 111.212 178.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -78.0 -48.49 16.06 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 107.319 -1.363 . . . . 75.54 107.319 164.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . 0.441 ' HA ' ' CD1' ' C' ' 7' ' ' TYR . . . -53.87 -43.6 69.7 Favored 'General case' 0 C--N 1.344 0.331 0 CA-C-N 113.236 -1.802 . . . . 63.1 111.29 174.235 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -79.32 -30.37 42.75 Favored 'General case' 0 C--O 1.214 -0.8 0 CA-C-N 114.934 -1.03 . . . . 75.01 111.111 176.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.82 -36.92 68.01 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 119.01 0.823 . . . . 60.54 111.172 176.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 56' ' ' VAL . . . . . 0.426 HG13 ' HZ ' ' C' ' 101' ' ' PHE . 35.3 t -78.78 -55.02 10.82 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 CA-C-N 114.894 -1.048 . . . . 72.43 110.445 174.024 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 57' ' ' LEU . . . . . 0.501 ' HB3' HD13 ' C' ' 22' ' ' ILE . 79.4 mt -92.56 19.18 7.59 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 113.021 0.749 . . . . 75.02 113.021 -168.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 29.9 t -51.31 -61.48 2.21 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.852 1.261 . . . . 75.33 113.657 -177.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -133.03 151.59 78.2 Favored Pre-proline 0 N--CA 1.476 0.846 0 N-CA-C 108.422 -0.955 . . . . 72.03 108.422 -172.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 60' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -41.01 -31.53 0.77 Allowed 'Trans proline' 0 C--N 1.386 2.528 0 C-N-CA 124.997 3.798 . . . . 73.21 116.417 -175.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -70.13 -58.97 3.2 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 118.078 0.399 . . . . 62.13 111.242 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -65.23 -28.63 69.5 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.028 0.442 . . . . 75.43 111.544 179.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 45.0 tpt85 -54.71 -53.46 54.68 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.371 1.069 . . . . 74.14 110.001 168.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -73.11 -19.16 61.2 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 115.806 -0.634 . . . . 74.15 112.386 -179.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 68.0 mt -65.34 -44.46 94.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 N-CA-C 108.869 -0.789 . . . . 71.5 108.869 170.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -60.54 -47.76 84.77 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.725 -0.67 . . . . 74.31 110.334 173.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -56.62 -45.79 81.3 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.312 0.645 . . . . 73.14 111.814 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 67.2 p -71.62 -25.48 62.18 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.197 -0.456 . . . . 74.43 110.829 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 69' ' ' TYR . . . . . 0.404 ' CD1' HD11 ' C' ' 100' ' ' LEU . 5.6 t80 -79.68 137.07 36.95 Favored 'General case' 0 C--N 1.358 0.953 0 N-CA-C 109.728 -0.471 . . . . 75.22 109.728 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.48 17.89 53.82 Favored Glycine 0 N--CA 1.473 1.144 0 N-CA-C 111.339 -0.704 . . . . 62.51 111.339 -170.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 87.7 m -147.32 -58.98 0.27 Allowed 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 103.615 -2.735 . . . . 72.34 103.615 176.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 34.7 m -84.48 148.96 26.26 Favored 'General case' 0 C--O 1.249 1.048 0 N-CA-C 105.403 -2.073 . . . . 73.35 105.403 156.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.96 -16.13 7.65 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.929 0.892 . . . . 73.23 110.202 -176.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.92 125.88 87.64 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 123.086 0.554 . . . . 53.23 109.781 174.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -61.57 148.49 92.89 Favored 'Trans proline' 0 C--N 1.372 1.804 0 C-N-CA 122.684 2.256 . . . . 75.14 111.373 169.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -65.83 165.24 24.13 Favored 'Trans proline' 0 CA--C 1.56 1.806 0 C-N-CA 122.735 2.29 . . . . 71.22 112.725 -179.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -67.37 158.54 56.56 Favored 'Trans proline' 0 C--N 1.374 1.918 0 C-N-CA 122.868 2.379 . . . . 74.4 111.427 167.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 78' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.27 116.83 3.5 Favored 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 122.498 2.132 . . . . 74.44 111.758 175.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -66.7 155.67 69.37 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 122.469 2.112 . . . . 70.12 110.087 177.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 80' ' ' PRO . . . . . 0.416 ' HB2' ' HA ' ' C' ' 141' ' ' ALA . 97.9 Cg_exo -46.52 76.27 0.01 OUTLIER 'Trans proline' 0 N--CA 1.509 2.428 0 C-N-CA 124.819 3.68 . . . . 74.31 116.309 -172.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 137.51 -47.06 0.97 Allowed Glycine 0 CA--C 1.53 1.01 0 CA-C-N 115.879 -0.6 . . . . 75.2 112.266 -178.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . 0.407 ' HA3' ' CE1' ' C' ' 106' ' ' PHE . . . 141.25 164.61 10.03 Favored Glycine 0 N--CA 1.473 1.151 0 N-CA-C 109.799 -1.32 . . . . 75.13 109.799 -174.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 83' ' ' TYR . . . . . 0.444 ' HH ' ' HG2' ' C' ' 103' ' ' PRO . 89.9 m-85 -70.18 115.15 9.05 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 122.945 0.498 . . . . 73.4 110.028 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -52.09 121.99 7.74 Favored 'General case' 0 C--O 1.242 0.662 0 O-C-N 124.698 1.249 . . . . 75.11 111.661 176.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 85' ' ' PHE . . . . . 0.507 ' HA ' ' HD2' ' C' ' 88' ' ' PHE . 56.3 m-85 -135.39 59.23 1.73 Allowed 'General case' 0 N--CA 1.475 0.789 0 O-C-N 124.074 0.859 . . . . 74.41 110.444 169.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 25.0 m -61.0 89.59 0.02 OUTLIER 'General case' 0 C--N 1.354 0.783 0 CA-C-N 114.311 -1.313 . . . . 52.42 113.326 179.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 79.74 13.45 82.35 Favored Glycine 0 C--N 1.35 1.36 0 CA-C-N 115.271 -0.877 . . . . 74.34 112.967 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 88' ' ' PHE . . . . . 0.507 ' HD2' ' HA ' ' C' ' 85' ' ' PHE . 5.7 m-85 -100.8 119.77 39.13 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 107.657 -1.238 . . . . 74.44 107.657 -178.05 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 89' ' ' ASP . . . . . 0.476 ' HB3' ' HE3' ' C' ' 48' ' ' LYS . 62.7 t0 -80.19 72.21 6.99 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-O 121.647 0.737 . . . . 72.23 110.622 -176.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 90' ' ' VAL . . . . . 0.557 HG23 ' HE2' ' C' ' 97' ' ' PHE . 5.3 p -49.91 -42.53 18.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 125.416 1.486 . . . . 54.42 113.261 -176.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -66.39 -23.07 66.26 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.512 0.725 . . . . 75.25 111.575 -173.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -90.38 -19.54 23.86 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.429 0.691 . . . . 75.53 111.112 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 20.1 m-30 -77.81 178.02 7.72 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.138 0.575 . . . . 72.45 111.778 -174.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 94' ' ' SER . . . . . 0.411 ' O ' ' HB3' ' C' ' 97' ' ' PHE . 78.4 p -62.16 153.87 28.94 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.607 0.763 . . . . 52.11 112.323 -171.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 95' ' ' GLU . . . . . 0.461 ' O ' ' HG3' ' C' ' 99' ' ' GLU . 0.0 OUTLIER -68.49 -32.14 71.9 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.723 -0.671 . . . . 72.35 111.199 178.582 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -51.38 -53.1 39.84 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.131 0.972 . . . . 74.24 110.556 169.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 97' ' ' PHE . . . . . 0.557 ' HE2' HG23 ' C' ' 90' ' ' VAL . 48.6 t80 -56.6 -47.51 79.46 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-N 113.775 -1.557 . . . . 64.25 110.327 178.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -76.58 -9.21 58.49 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 114.753 -1.112 . . . . 71.33 112.988 -176.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . 0.461 ' HG3' ' O ' ' C' ' 95' ' ' GLU . 61.7 mt-10 -82.61 -51.31 7.87 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.211 0.604 . . . . 74.43 109.563 166.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 100' ' ' LEU . . . . . 0.404 HD11 ' CD1' ' C' ' 69' ' ' TYR . 18.7 tp -59.35 -44.84 92.62 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 114.438 -1.256 . . . . 73.23 111.911 -171.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 101' ' ' PHE . . . . . 0.426 ' HZ ' HG13 ' C' ' 56' ' ' VAL . 48.2 m-85 -105.38 11.47 32.69 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.375 0.27 . . . . 75.04 111.03 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -42.23 -64.63 1.48 Allowed Glycine 0 C--N 1.357 1.745 0 C-N-CA 124.823 1.201 . . . . 74.41 114.538 -171.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . 0.444 ' HG2' ' HH ' ' C' ' 83' ' ' TYR . 15.0 Cg_exo -29.93 -31.44 0.02 OUTLIER 'Trans proline' 0 C--N 1.389 2.69 1 C-N-CA 126.299 4.666 . . . . 64.35 117.266 176.599 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -156.83 52.67 0.41 Allowed Glycine 0 C--N 1.354 1.538 0 C-N-CA 120.934 -0.651 . . . . 73.42 113.024 179.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 105' ' ' LEU . . . . . 0.483 ' HB3' HG22 ' C' ' 90' ' ' VAL . 92.7 mt -55.88 13.86 0.0 OUTLIER 'General case' 0 CA--C 1.579 2.065 0 N-CA-C 117.218 2.303 . . . . 75.43 117.218 177.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 106' ' ' PHE . . . . . 0.799 ' HA ' ' HB3' ' C' ' 114' ' ' ARG 0.302 2.2 m-30 46.51 -98.98 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 121.008 1.731 . . . . 64.24 113.444 178.484 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . 112.71 47.83 0.66 Allowed Glycine 0 C--O 1.229 -0.212 0 N-CA-C 115.55 0.98 . . . . 51.05 115.55 170.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . -15.75 -70.76 0.01 OUTLIER Glycine 0 N--CA 1.49 2.296 0 C-N-CA 125.026 1.298 . . . . 74.41 115.115 161.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 109' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -97.38 -4.27 38.69 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.075 0.95 . . . . 74.45 111.704 178.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 110' ' ' GLY . . . . . . . . . . . . . . . -73.65 -16.8 79.04 Favored Glycine 0 C--N 1.357 1.706 0 N-CA-C 111.521 -0.632 . . . . 73.14 111.521 175.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 88.0 mtt-85 79.68 -40.52 0.22 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.896 2.078 . . . . 75.25 113.856 166.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 112' ' ' ARG . . . . . . . . . . . . . 3.3 tpp180 -126.75 -39.54 1.97 Allowed 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 119.47 1.032 . . . . 75.43 112.626 174.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 113' ' ' SER . . . . . . . . . . . . . 15.3 m -7.31 -36.23 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.696 0 N-CA-C 120.066 3.358 . . . . 72.53 120.066 -176.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 114' ' ' ARG . . . . . 0.799 ' HB3' ' HA ' ' C' ' 106' ' ' PHE . 1.6 tpm_? -164.17 170.93 15.71 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 125.548 1.539 . . . . 74.05 107.983 169.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 115' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -78.14 114.12 16.72 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 118.59 -0.719 . . . . 74.15 110.469 175.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -61.85 109.35 2.49 Favored Glycine 0 C--N 1.359 1.831 0 N-CA-C 109.813 -1.315 . . . . 54.4 109.813 166.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 117' ' ' ARG . . . . . 0.503 ' HD3' HD11 ' B' ' 59' ' ' LEU . 67.0 mtt180 -97.49 113.13 24.76 Favored 'General case' 0 C--O 1.257 1.463 0 CA-C-O 122.304 1.049 . . . . 74.32 110.903 -172.052 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -74.36 109.28 7.72 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 111.612 -2.54 . . . . 75.42 105.647 162.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 119' ' ' LEU . . . . . 0.566 HD12 ' HA2' ' C' ' 165' ' ' GLY . 70.0 mt -91.01 106.84 18.8 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.341 -0.391 . . . . 75.21 110.445 -162.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -90.01 94.45 9.8 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 106.604 -1.628 . . . . 72.31 106.604 -178.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 121' ' ' ALA . . . . . 0.636 ' HA ' HG23 ' B' ' 185' ' ' VAL . . . -105.44 113.8 27.6 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 109.104 -0.702 . . . . 75.44 109.104 -171.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -73.31 107.74 5.79 Favored 'General case' 0 C--O 1.244 0.775 0 N-CA-C 106.981 -1.489 . . . . 74.12 106.981 171.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -116.13 137.27 23.31 Favored Pre-proline 0 N--CA 1.474 0.756 0 CA-C-O 120.48 0.181 . . . . 73.3 111.465 -179.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.13 116.84 4.54 Favored 'Trans proline' 0 C--N 1.371 1.734 0 C-N-CA 122.984 2.456 . . . . 72.51 110.802 168.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 125' ' ' LEU . . . . . 0.497 HD21 HG11 ' C' ' 153' ' ' VAL . 13.6 tp -152.63 161.28 42.78 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 109.479 -0.563 . . . . 75.32 109.479 -178.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 126' ' ' THR . . . . . 0.511 ' HB ' ' HG ' ' C' ' 181' ' ' LEU . 6.2 t -125.98 175.25 7.84 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.56 0.695 . . . . 61.53 109.96 171.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 127' ' ' LEU . . . . . 0.478 HD21 HD12 ' C' ' 180' ' ' LEU . 13.6 mt -60.4 -48.52 81.41 Favored 'General case' 0 C--O 1.245 0.821 0 C-N-CA 125.55 1.54 . . . . 62.25 110.303 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 128' ' ' GLU . . . . . 0.512 ' HG3' ' HA ' ' C' ' 215' ' ' LEU . 8.5 mp0 -63.55 -33.06 74.75 Favored 'General case' 0 C--O 1.215 -0.723 0 CA-C-N 114.009 -1.45 . . . . 75.24 110.748 178.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 129' ' ' GLU . . . . . 0.416 ' HA ' ' HB2' ' C' ' 132' ' ' HIS . 19.4 mm-40 -84.65 -13.65 50.89 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.779 0.832 . . . . 75.51 111.771 178.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 130' ' ' ALA . . . . . 0.459 ' HB1' HG13 ' C' ' 153' ' ' VAL . . . -76.33 -34.61 59.0 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.876 -0.787 . . . . 73.14 108.876 170.115 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 131' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -70.54 -46.28 63.89 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 113.993 -1.458 . . . . 75.55 111.512 168.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 132' ' ' HIS . . . . . 0.416 ' HB2' ' HA ' ' C' ' 129' ' ' GLU . 35.8 m170 -80.65 -9.71 59.77 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 123.365 0.666 . . . . 70.15 111.02 -178.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -66.44 -120.16 0.01 OUTLIER Glycine 0 C--N 1.354 1.528 0 O-C-N 123.921 0.763 . . . . 65.31 113.371 177.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . 64.85 -103.69 0.81 Allowed Glycine 0 C--N 1.342 0.91 0 N-CA-C 110.852 -0.899 . . . . 73.12 110.852 -173.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 135' ' ' GLU . . . . . 0.704 ' HG3' ' HB2' ' C' ' 148' ' ' ARG . 2.7 mp0 -87.94 94.06 9.66 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.03 0.932 . . . . 73.03 109.277 -177.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 136' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -142.41 166.95 23.28 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.502 0.721 . . . . 72.12 110.263 -177.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 137' ' ' VAL . . . . . . . . . . . . . 17.7 m -73.89 88.66 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.1 0 CA-C-N 115.251 -0.886 . . . . 73.11 111.202 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 138' ' ' VAL . . . . . 0.527 ' O ' ' HA ' ' C' ' 144' ' ' ARG . 37.4 t -80.21 129.76 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.912 0.885 . . . . 72.14 109.819 175.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 139' ' ' GLU . . . . . 0.44 ' HB3' HH12 ' B' ' 46' ' ' ARG . 8.3 tp10 -124.95 113.73 18.21 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 108.3 -1.0 . . . . 74.31 108.3 169.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 140' ' ' VAL . . . . . 0.608 HG12 ' HB ' ' B' ' 185' ' ' VAL . 30.7 t -150.02 126.88 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.215 1.006 . . . . 73.25 108.341 167.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 141' ' ' ALA . . . . . 0.416 ' HA ' ' HB2' ' C' ' 80' ' ' PRO . . . 65.04 32.4 10.43 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.172 0.989 . . . . 65.0 112.895 172.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 73.03 26.94 69.64 Favored Glycine 0 C--N 1.344 0.991 0 N-CA-C 111.722 -0.551 . . . . 52.4 111.722 -178.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 143' ' ' ARG . . . . . . . . . . . . . 45.2 mtp180 -115.74 96.27 5.53 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 107.539 -1.282 . . . . 75.05 107.539 171.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 144' ' ' ARG . . . . . 0.54 ' HD3' ' HA ' ' B' ' 48' ' ' THR . 29.2 ttp-105 -114.25 104.22 11.87 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 123.491 0.716 . . . . 71.51 109.539 -178.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 145' ' ' VAL . . . . . . . . . . . . . 7.7 p -150.47 146.21 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.34 0.656 . . . . 75.03 110.639 -175.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 24.7 m -77.62 88.29 3.92 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 108.601 -0.889 . . . . 73.22 108.601 171.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 11.2 p -117.18 154.44 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.656 0.782 . . . . 72.53 109.91 -173.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 148' ' ' ARG . . . . . 0.704 ' HB2' ' HG3' ' C' ' 135' ' ' GLU . 31.5 ttt85 -92.54 114.27 26.77 Favored 'General case' 0 C--O 1.242 0.669 0 O-C-N 123.801 0.688 . . . . 74.22 111.02 177.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 149' ' ' ILE . . . . . 0.438 HD13 HD12 ' C' ' 159' ' ' ILE . 26.2 pt -94.47 154.26 40.24 Favored Pre-proline 0 CA--C 1.552 1.028 0 N-CA-C 107.493 -1.299 . . . . 74.42 107.493 163.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -51.15 115.6 2.15 Favored 'Trans proline' 0 CA--C 1.565 2.038 0 C-N-CA 122.311 2.007 . . . . 61.44 111.378 174.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -61.36 113.45 1.78 Allowed 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 123.359 2.706 . . . . 73.2 111.169 -178.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 152' ' ' GLY . . . . . . . . . . . . . . . 129.28 142.15 5.24 Favored Glycine 0 C--N 1.34 0.779 0 O-C-N 123.449 0.468 . . . . 63.11 114.13 -172.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 153' ' ' VAL . . . . . 0.497 HG11 HD21 ' C' ' 125' ' ' LEU . 3.0 p -164.69 168.36 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.39 0 N-CA-C 112.524 0.564 . . . . 74.01 112.524 174.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 154' ' ' ARG . . . . . 0.611 HH11 ' HB3' ' B' ' 22' ' ' ARG . 0.8 OUTLIER -125.81 169.48 12.57 Favored 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 125.806 1.642 . . . . 75.32 108.563 176.96 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 155' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -65.06 128.45 35.83 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.158 0.583 . . . . 74.51 110.289 169.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 71.82 12.0 74.19 Favored Glycine 0 C--N 1.348 1.215 0 O-C-N 123.891 0.744 . . . . 75.21 113.478 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 157' ' ' SER . . . . . 0.46 ' HB2' ' HB3' ' C' ' 154' ' ' ARG . 43.6 t -78.82 140.98 38.1 Favored 'General case' 0 C--O 1.252 1.206 0 C-N-CA 123.117 0.567 . . . . 75.43 109.903 -179.073 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 158' ' ' VAL . . . . . 0.475 HG21 ' HB3' ' C' ' 175' ' ' LEU . 5.4 p -108.78 96.94 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 O-C-N 125.077 1.485 . . . . 72.31 108.956 -174.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 159' ' ' ILE . . . . . 0.614 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 56.4 mt -78.41 111.45 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 108.687 -0.857 . . . . 72.31 108.687 178.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 160' ' ' ARG . . . . . 0.552 ' HD2' HD21 ' B' ' 311' ' ' ASN . 26.4 ttt180 -85.58 107.94 17.73 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 108.826 -0.805 . . . . 75.13 108.826 173.134 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 161' ' ' VAL . . . . . . . . . . . . . 2.2 t -98.17 105.66 30.0 Favored Pre-proline 0 CA--C 1.557 1.228 0 N-CA-C 106.219 -1.771 . . . . 75.24 106.219 171.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -64.68 132.02 31.43 Favored 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 123.512 2.808 . . . . 75.23 113.042 -171.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 64.83 19.57 65.52 Favored Glycine 0 C--N 1.347 1.194 0 O-C-N 124.01 0.819 . . . . 53.54 113.348 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 164' ' ' MET . . . . . . . . . . . . . 31.8 mmm -110.08 -2.48 16.96 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.583 0.753 . . . . 73.35 111.753 -178.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 165' ' ' GLY . . . . . 0.566 ' HA2' HD12 ' C' ' 119' ' ' LEU . . . -89.5 -111.87 1.33 Allowed Glycine 0 C--N 1.347 1.162 0 N-CA-C 108.293 -1.923 . . . . 73.32 108.293 164.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . -156.78 118.11 0.82 Allowed Glycine 0 C--N 1.335 0.498 0 C-N-CA 120.692 -0.766 . . . . 75.44 111.831 161.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 167' ' ' GLN . . . . . 0.535 ' HA ' ' H ' ' C' ' 172' ' ' GLY . 15.0 mm-40 -71.23 101.9 2.42 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 107.792 -1.188 . . . . 74.2 107.792 175.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . -115.77 -125.5 3.88 Favored Glycine 0 N--CA 1.467 0.758 0 N-CA-C 110.275 -1.13 . . . . 13.44 110.275 178.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 169' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -61.41 -67.19 1.15 Allowed Pre-proline 0 CA--C 1.574 1.865 0 CA-C-N 117.956 0.878 . . . . 62.44 110.562 175.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 170' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -93.94 113.82 0.22 Allowed 'Trans proline' 0 C--N 1.393 2.878 0 CA-C-N 122.107 1.788 . . . . 73.55 109.143 163.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 171' ' ' PRO . . . . . 0.485 ' HA ' ' HA ' ' C' ' 167' ' ' GLN . 6.5 Cg_exo -33.87 131.78 0.15 Allowed 'Trans proline' 0 C--N 1.372 1.763 0 C-N-CA 124.609 3.54 . . . . 74.02 115.514 -178.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 172' ' ' GLY . . . . . 0.535 ' H ' ' HA ' ' C' ' 167' ' ' GLN . . . -120.85 115.93 3.04 Favored Glycine 0 C--N 1.341 0.828 0 N-CA-C 110.968 -0.853 . . . . 74.42 110.968 -171.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 173' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -107.75 158.9 16.91 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 108.512 -0.921 . . . . 74.51 108.512 175.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 174' ' ' LEU . . . . . . . . . . . . . 9.8 tp -81.41 107.56 14.29 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 109.739 -0.467 . . . . 75.22 109.739 -177.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 175' ' ' LEU . . . . . 0.475 ' HB3' HG21 ' C' ' 158' ' ' VAL . 78.6 mt -95.12 82.22 3.75 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.43 1.092 . . . . 72.15 110.084 179.505 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 176' ' ' LEU . . . . . 0.614 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 75.7 mt -68.4 100.76 1.12 Allowed 'General case' 0 CA--C 1.546 0.804 0 CA-C-O 121.022 0.439 . . . . 74.33 110.86 178.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 177' ' ' VAL . . . . . . . . . . . . . 61.0 t -85.53 101.57 10.11 Favored 'Isoleucine or valine' 0 C--O 1.244 0.784 0 C-N-CA 124.147 0.979 . . . . 75.23 108.398 176.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 178' ' ' VAL . . . . . 0.45 HG22 HG21 ' C' ' 153' ' ' VAL . 52.1 t -84.93 135.82 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 N-CA-C 112.538 0.57 . . . . 74.01 112.538 -174.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 179' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -110.76 113.27 25.73 Favored 'General case' 0 C--O 1.254 1.33 0 C-N-CA 124.981 1.312 . . . . 74.42 108.436 169.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 180' ' ' LEU . . . . . 0.478 HD12 HD21 ' C' ' 127' ' ' LEU . 91.8 mt -76.53 153.76 35.15 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 124.572 1.149 . . . . 73.43 111.445 178.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 181' ' ' LEU . . . . . 0.618 HD23 ' HB2' ' B' ' 191' ' ' TYR . 8.2 mt -65.73 168.4 8.75 Favored Pre-proline 0 N--CA 1.49 1.553 0 C-N-CA 123.105 0.562 . . . . 74.24 110.892 -179.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -60.45 70.07 0.07 OUTLIER 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 122.482 2.121 . . . . 73.32 110.793 160.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 183' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -160.44 62.39 1.73 Allowed Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 106.753 -1.573 . . . . 72.0 106.753 -167.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 184' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -85.34 64.53 5.97 Favored 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 123.03 2.486 . . . . 74.25 111.217 -170.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 185' ' ' VAL . . . . . 0.612 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 18.1 t -95.55 -56.42 5.22 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.905 0 N-CA-C 107.826 -1.176 . . . . 72.23 107.826 -173.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 186' ' ' PHE . . . . . 0.44 ' HD1' ' HB3' ' C' ' 195' ' ' ALA . 33.9 m-85 -114.8 153.66 29.99 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.56 0.744 . . . . 61.44 110.832 -174.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 187' ' ' ARG . . . . . . . . . . . . . 7.5 mtm180 -143.42 115.74 8.5 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.569 1.148 . . . . 75.14 108.772 175.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 188' ' ' LEU . . . . . 0.429 HD13 ' HD2' ' C' ' 240' ' ' PHE . 55.6 tp -77.48 143.27 38.63 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.973 0.731 . . . . 74.14 112.973 -171.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -141.76 105.22 4.67 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 107.14 -1.429 . . . . 73.21 107.14 166.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 74.32 -101.06 1.21 Allowed Glycine 0 CA--C 1.536 1.37 0 N-CA-C 111.885 -0.486 . . . . 74.2 111.885 -175.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 191' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -123.14 -5.13 8.41 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 124.246 1.018 . . . . 75.25 110.744 172.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -101.92 140.14 36.61 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.299 0.64 . . . . 65.13 110.088 -174.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 193' ' ' LEU . . . . . 0.424 HD22 ' CE2' ' C' ' 240' ' ' PHE . 82.0 mt -99.39 153.24 19.14 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.558 0.743 . . . . 65.15 111.273 -174.134 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 194' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -113.73 107.27 15.52 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 107.418 -1.327 . . . . 75.43 107.418 168.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 195' ' ' ALA . . . . . 0.612 ' HA ' ' O ' ' C' ' 185' ' ' VAL . . . -105.09 -178.59 3.7 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.164 0.586 . . . . 65.11 110.119 175.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 26.0 m -142.35 99.33 3.48 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 107.457 -1.312 . . . . 53.42 107.457 171.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 197' ' ' LEU . . . . . 0.438 HD11 ' HB1' ' C' ' 212' ' ' ALA . 25.7 tp -80.44 121.31 25.58 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.773 -0.649 . . . . 73.5 111.013 -171.115 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -74.51 100.1 3.78 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 108.166 -1.05 . . . . 64.33 108.166 175.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 199' ' ' VAL . . . . . . . . . . . . . 58.5 t -111.32 117.69 48.97 Favored Pre-proline 0 N--CA 1.474 0.731 0 N-CA-C 108.23 -1.026 . . . . 73.12 108.23 178.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 200' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -72.17 143.96 40.95 Favored 'Trans proline' 0 C--N 1.369 1.625 0 C-N-CA 121.727 1.618 . . . . 73.11 109.81 174.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 201' ' ' ALA . . . . . 0.425 ' N ' ' HD2' ' C' ' 202' ' ' PRO . . . -55.0 -44.28 99.52 Favored Pre-proline 0 CA--C 1.552 1.058 0 N-CA-C 114.119 1.155 . . . . 74.35 114.119 -173.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 202' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' C' ' 201' ' ' ALA . 17.3 Cg_endo -55.29 -46.99 28.51 Favored 'Trans proline' 0 C--N 1.393 2.906 0 C-N-CA 121.883 1.722 . . . . 63.15 112.67 176.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 203' ' ' ILE . . . . . 0.453 ' HA ' HG13 ' C' ' 206' ' ' VAL . 48.0 mt -68.18 -37.52 78.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.14 0.576 . . . . 74.02 110.871 -178.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 204' ' ' ALA . . . . . 0.423 ' HA ' HG12 ' C' ' 223' ' ' VAL . . . -58.53 -44.13 89.44 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.477 0.711 . . . . 75.02 111.338 176.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 205' ' ' VAL . . . . . 0.509 ' HA ' ' HA ' ' C' ' 226' ' ' ARG . 81.7 t -72.74 -42.65 61.87 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 115.156 -0.929 . . . . 74.52 111.786 -177.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 206' ' ' VAL . . . . . 0.627 ' HA ' ' HE2' ' A' ' 270' ' ' LYS . 11.3 p -77.05 -29.38 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 CA-C-O 120.676 0.274 . . . . 74.12 110.74 -174.185 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 77.18 51.91 5.93 Favored Glycine 0 C--N 1.341 0.826 0 N-CA-C 110.634 -0.987 . . . . 63.21 110.634 -171.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -91.78 -120.37 2.55 Favored Glycine 0 C--N 1.344 1.026 0 N-CA-C 111.246 -0.741 . . . . 51.32 111.246 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 209' ' ' LYS . . . . . 0.575 ' HG2' ' HG2' ' C' ' 220' ' ' GLU . 34.6 ttmt -151.72 133.17 14.64 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.619 0.723 . . . . 72.44 111.208 -178.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 210' ' ' VAL . . . . . . . . . . . . . 26.8 m -115.16 -175.28 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 126.596 1.958 . . . . 71.52 108.091 174.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 211' ' ' ARG . . . . . 0.467 ' HD3' ' HB2' ' C' ' 218' ' ' PRO . 36.9 ttm105 -142.85 127.99 18.61 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 118.236 0.471 . . . . 75.53 111.908 -178.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 212' ' ' ALA . . . . . 0.438 ' HB1' HD11 ' C' ' 197' ' ' LEU . . . -101.68 113.49 26.7 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 108.039 -1.097 . . . . 74.43 108.039 168.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 213' ' ' MET . . . . . 0.55 ' HA ' ' HA ' ' C' ' 218' ' ' PRO . 2.9 ttp -69.73 105.87 2.89 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 107.86 -1.163 . . . . 63.12 107.86 174.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 214' ' ' THR . . . . . 0.47 ' OG1' HG12 ' C' ' 219' ' ' VAL . 0.2 OUTLIER -101.02 175.63 5.53 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.506 0.669 . . . . 72.34 110.243 -173.144 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 215' ' ' LEU . . . . . 0.512 ' HA ' ' HG3' ' C' ' 128' ' ' GLU . 9.2 mt -63.0 -41.14 99.5 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.711 1.604 . . . . 75.24 111.326 -175.179 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -92.77 0.33 57.4 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 114.32 -1.309 . . . . 71.0 111.15 -177.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 134.36 162.65 9.98 Favored Glycine 0 C--N 1.343 0.931 0 N-CA-C 111.669 -0.572 . . . . 74.41 111.669 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 218' ' ' PRO . . . . . 0.55 ' HA ' ' HA ' ' C' ' 213' ' ' MET . 59.9 Cg_endo -70.04 107.88 2.01 Favored 'Trans proline' 0 CA--C 1.555 1.575 0 C-N-CA 122.708 2.272 . . . . 64.03 112.952 -178.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 219' ' ' VAL . . . . . 0.528 HG23 HG23 ' B' ' 238' ' ' THR . 7.3 p -80.71 120.85 33.12 Favored 'Isoleucine or valine' 0 C--N 1.355 0.832 0 N-CA-C 107.664 -1.236 . . . . 52.53 107.664 174.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 220' ' ' GLU . . . . . 0.575 ' HG2' ' HG2' ' C' ' 209' ' ' LYS . 16.3 tt0 -92.75 103.79 16.12 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 107.583 -1.266 . . . . 72.32 107.583 -179.059 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 221' ' ' VAL . . . . . . . . . . . . . 60.8 t -85.88 123.29 39.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 113.534 -1.666 . . . . 74.03 112.319 -165.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 222' ' ' ALA . . . . . 0.437 ' HB3' ' HD3' ' B' ' 245' ' ' LYS . . . -74.84 143.56 43.85 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.311 0.644 . . . . 73.3 110.508 173.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . 0.423 HG12 ' HA ' ' C' ' 204' ' ' ALA . 98.0 t -116.62 138.11 24.22 Favored Pre-proline 0 N--CA 1.485 1.299 0 C-N-CA 124.316 1.047 . . . . 73.11 109.512 -174.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 224' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -78.74 156.02 27.43 Favored 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 123.279 2.653 . . . . 73.11 111.488 170.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.48 124.46 16.31 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 123.346 2.697 . . . . 74.4 113.137 -175.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 226' ' ' ARG . . . . . 0.509 ' HA ' ' HA ' ' C' ' 205' ' ' VAL . 0.0 OUTLIER 58.53 90.87 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.62 1.568 . . . . 71.5 112.378 -179.495 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 227' ' ' THR . . . . . 0.554 ' HA ' ' NH1' ' C' ' 231' ' ' ARG . 21.6 m -110.03 127.96 55.13 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 114.817 -1.083 . . . . 73.3 111.378 179.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 228' ' ' GLN . . . . . 0.717 HE21 HD13 ' A' ' 257' ' ' ILE . 0.8 OUTLIER -96.54 153.52 17.8 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.11 0.964 . . . . 74.32 111.859 -179.596 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -70.45 134.01 47.38 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 114.681 -1.145 . . . . 65.31 109.69 173.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 110.45 -19.28 26.77 Favored Glycine 0 C--N 1.339 0.702 0 O-C-N 123.613 0.571 . . . . 62.04 112.088 -173.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 231' ' ' ARG . . . . . 0.554 ' NH1' ' HA ' ' C' ' 227' ' ' THR . 71.3 mtt180 -65.78 174.9 2.13 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 117.138 0.469 . . . . 75.03 111.46 173.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 232' ' ' LYS . . . . . 0.452 ' HD3' ' HB3' ' C' ' 250' ' ' TYR . 30.2 ttmt -142.85 145.71 33.42 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 121.206 0.527 . . . . 74.05 111.525 -178.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 233' ' ' LEU . . . . . 0.702 HD12 ' HB2' ' C' ' 251' ' ' LEU . 1.7 mp -113.26 145.33 41.2 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.815 1.246 . . . . 74.22 108.412 178.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 234' ' ' ARG . . . . . 0.659 ' HG3' ' HG3' ' B' ' 241' ' ' GLU . 9.2 ptp85 -120.29 95.06 4.59 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 121.957 0.884 . . . . 72.34 109.432 169.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 235' ' ' LEU . . . . . 0.572 ' HA ' ' HA3' ' B' ' 240' ' ' GLY . 26.0 mt -84.67 107.66 16.99 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.611 -0.722 . . . . 74.34 109.324 178.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 236' ' ' LYS . . . . . 0.516 ' HG3' HE21 ' B' ' 360' ' ' GLN . 71.1 mmtt -69.07 122.99 19.85 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 123.627 0.771 . . . . 73.41 111.483 -174.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 76.54 32.56 50.6 Favored Glycine 0 C--N 1.344 0.994 0 O-C-N 124.199 0.937 . . . . 71.42 113.192 178.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 33.5 mmtm -123.83 14.99 9.34 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.821 0.848 . . . . 75.11 111.209 175.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -91.62 -147.39 20.02 Favored Glycine 0 C--N 1.353 1.477 0 N-CA-C 111.178 -0.769 . . . . 75.2 111.178 170.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 240' ' ' PHE . . . . . 0.437 ' CE1' HD13 ' C' ' 215' ' ' LEU . 39.9 m-85 -94.56 142.12 24.36 Favored Pre-proline 0 N--CA 1.482 1.141 0 CA-C-N 117.572 0.686 . . . . 75.14 111.302 178.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 241' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' C' ' 240' ' ' PHE . 3.3 Cg_exo -76.65 113.99 3.76 Favored 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 123.837 3.025 . . . . 71.53 113.69 -172.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -96.78 159.96 21.65 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-O 119.015 -0.88 . . . . 70.14 111.396 170.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.58 -13.43 37.27 Favored 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 122.781 2.32 . . . . 71.42 112.857 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -103.25 -16.71 15.6 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.515 0.726 . . . . 71.42 110.935 174.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 157.88 158.41 8.96 Favored Glycine 0 C--N 1.356 1.641 0 O-C-N 123.119 0.262 . . . . 63.24 113.702 177.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 246' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -73.65 152.62 40.44 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.804 0.842 . . . . 71.32 110.22 174.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.44 -164.69 22.9 Favored Glycine 0 C--N 1.346 1.112 0 O-C-N 123.702 0.626 . . . . 63.23 112.004 173.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -119.72 154.48 34.06 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 108.877 -0.786 . . . . 73.54 108.877 -178.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 249' ' ' LEU . . . . . 0.534 ' HB3' ' HB2' ' C' ' 235' ' ' LEU . 19.0 tp -99.61 109.24 21.76 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.637 -0.71 . . . . 74.23 109.284 175.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 250' ' ' TYR . . . . . 0.591 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 20.2 m-85 -99.44 100.36 11.39 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 109.236 -0.653 . . . . 71.43 109.236 178.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 251' ' ' LEU . . . . . 0.702 ' HB2' HD12 ' C' ' 233' ' ' LEU . 0.8 OUTLIER -100.4 140.37 34.74 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.232 -0.655 . . . . 72.0 109.232 -176.716 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -89.54 128.43 36.01 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 108.225 -1.028 . . . . 75.41 108.225 168.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 253' ' ' VAL . . . . . 0.514 HG13 HG21 ' C' ' 227' ' ' THR . 80.0 t -67.97 131.97 32.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 123.641 0.776 . . . . 73.5 110.25 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 254' ' ' ARG . . . . . 0.402 ' HB3' HH11 ' C' ' 254' ' ' ARG . 0.0 OUTLIER -126.72 93.06 3.67 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.354 -1.351 . . . . 75.13 107.354 179.226 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 255' ' ' ILE . . . . . . . . . . . . . 49.8 mm -73.11 127.49 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 O-C-N 123.853 0.721 . . . . 75.24 109.788 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 256' ' ' THR . . . . . 0.55 ' HA ' HD13 ' A' ' 255' ' ' ILE . 1.7 t -144.73 171.04 14.97 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 124.412 1.07 . . . . 70.25 110.396 -171.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 2.7 pp -132.59 148.31 69.06 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 123.735 0.814 . . . . 75.21 109.398 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 258' ' ' PRO . . . . . 0.521 ' HG3' ' HE2' ' A' ' 276' ' ' TYR . 98.5 Cg_endo -74.53 11.14 1.37 Allowed 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 123.323 2.682 . . . . 74.41 114.277 -172.179 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 259' ' ' GLU . . . . . 0.401 ' HG3' HE21 ' A' ' 228' ' ' GLN . 18.0 mt-10 62.1 -80.64 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 125.194 1.398 . . . . 72.3 111.101 -171.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 2.8 ptp85 -77.87 143.89 37.41 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.518 1.527 . . . . 73.41 110.928 -173.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 261' ' ' LEU . . . . . . . . . . . . . 75.3 mt -141.7 169.98 16.58 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.046 0.938 . . . . 74.53 110.107 -177.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 262' ' ' THR . . . . . 0.403 HG22 ' HA ' ' B' ' 272' ' ' ASN . 23.9 p -84.04 152.02 61.37 Favored Pre-proline 0 CA--C 1.552 1.024 0 N-CA-C 107.765 -1.198 . . . . 61.23 107.765 169.019 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -48.12 -34.64 24.24 Favored 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 123.173 2.582 . . . . 74.2 113.9 176.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.52 -56.14 9.36 Favored 'General case' 0 C--O 1.268 2.037 0 C-N-CA 124.249 1.019 . . . . 71.04 110.624 -178.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 265' ' ' GLU . . . . . 0.443 ' CD ' HH22 ' A' ' 279' ' ' ARG . 40.7 mm-40 -51.16 -55.09 19.66 Favored 'General case' 0 C--N 1.359 1.002 0 CA-C-N 114.953 -1.021 . . . . 71.03 110.359 175.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 266' ' ' GLU . . . . . 0.479 ' O ' ' HG2' ' C' ' 270' ' ' LYS . 30.8 tt0 -61.15 -31.46 71.18 Favored 'General case' 0 C--O 1.217 -0.652 0 CA-C-N 114.186 -1.37 . . . . 73.1 111.39 -175.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -60.76 -45.15 95.46 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 123.461 0.475 . . . . 71.12 110.866 174.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 268' ' ' LEU . . . . . 0.514 ' HA ' ' HE2' ' C' ' 271' ' ' LYS . 11.2 mp -64.18 -42.32 96.74 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 116.202 -0.454 . . . . 70.11 111.465 174.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -65.12 -25.36 67.73 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 122.797 0.439 . . . . 63.11 111.296 175.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 270' ' ' LYS . . . . . 0.479 ' HG2' ' O ' ' C' ' 266' ' ' GLU . 13.2 mmmm -67.93 -49.66 60.53 Favored 'General case' 0 C--N 1.363 1.175 0 C-N-CA 122.837 0.455 . . . . 75.43 109.867 175.235 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 271' ' ' LYS . . . . . 0.514 ' HE2' ' HA ' ' C' ' 268' ' ' LEU . 52.7 mtmt -57.62 -44.72 85.72 Favored 'General case' 0 N--CA 1.484 1.243 0 O-C-N 123.688 0.618 . . . . 75.33 111.294 178.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 88.3 mt -62.08 -41.41 98.16 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.237 0.615 . . . . 74.33 111.189 175.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -64.83 -45.35 86.56 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 115.573 -0.74 . . . . 43.22 111.545 -177.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -70.26 -32.42 70.24 Favored 'General case' 0 C--O 1.242 0.667 0 O-C-N 124.142 0.901 . . . . 63.21 110.62 -178.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -61.82 -34.13 75.39 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.684 -0.689 . . . . 70.04 110.678 170.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 276' ' ' TYR . . . . . 0.568 ' HB3' HD13 ' A' ' 203' ' ' ILE . 10.0 m-85 -83.49 -25.48 31.07 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 113.047 0.758 . . . . 75.52 113.047 174.212 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 20.3 m-30 -72.81 -21.23 61.01 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 118.524 0.602 . . . . 65.52 109.933 176.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -61.81 -3.6 1.2 Allowed 'General case' 0 CA--C 1.558 1.266 0 CA-C-N 115.02 -0.991 . . . . 72.22 112.821 169.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 279' ' ' ARG . . . . . 0.453 HH22 ' HB2' ' B' ' 374' ' ' ALA . 81.7 mtt180 -72.7 -14.12 61.5 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.255 0.622 . . . . 75.11 112.441 171.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.257 0 C-N-CA 124.452 1.101 . . . . 75.14 112.683 -175.924 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.5 mtm . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 119.508 -0.282 . . . . 64.12 111.511 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 49.91 34.22 7.61 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.929 1.292 . . . . 74.44 112.333 -175.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.5 71.57 9.58 Favored 'General case' 0 C--N 1.349 0.559 0 C-N-CA 123.308 0.643 . . . . 74.04 109.957 -176.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -38.91 106.53 0.05 Allowed 'General case' 0 C--N 1.353 0.723 0 C-N-CA 124.533 1.133 . . . . 64.14 113.072 176.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.469 ' HE3' ' HB3' ' A' ' 94' ' ' SER . 94.6 mttt -70.84 133.08 46.19 Favored 'General case' 0 C--O 1.244 0.766 0 N-CA-C 108.917 -0.772 . . . . 74.32 108.917 166.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -75.44 86.74 2.58 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 106.388 -1.708 . . . . 62.43 106.388 168.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -60.62 -34.67 74.59 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-N 115.002 -0.999 . . . . 73.34 111.231 -173.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -62.56 -45.02 94.87 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.517 -0.765 . . . . 73.33 110.713 175.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.81 -42.84 99.52 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.871 0.468 . . . . 70.01 111.254 178.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.421 HD13 ' HB3' ' A' ' 5' ' ' LYS . 71.3 mt -55.88 -45.13 79.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 C-N-CA 123.508 0.723 . . . . 74.23 110.311 177.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.663 HD11 HG23 ' A' ' 22' ' ' ILE . 83.1 mt -69.43 -29.87 67.68 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 115.898 -0.592 . . . . 73.11 111.674 175.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.3 46.54 5.24 Favored Glycine 0 C--N 1.344 0.995 0 CA-C-O 120.946 0.192 . . . . 73.42 112.737 -173.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.512 HG12 ' HB3' ' A' ' 25' ' ' ALA . 3.1 m -141.5 154.76 67.06 Favored Pre-proline 0 N--CA 1.483 1.204 0 C-N-CA 125.166 1.387 . . . . 72.52 109.615 178.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -69.07 165.7 29.26 Favored 'Trans proline' 0 N--CA 1.502 1.994 0 C-N-CA 123.239 2.626 . . . . 50.12 113.328 178.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -73.68 14.23 0.39 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 113.855 1.057 . . . . 75.43 113.855 -172.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -135.74 19.97 3.3 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 108.954 -0.758 . . . . 71.2 108.954 175.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.36 121.96 15.56 Favored 'General case' 0 C--N 1.343 0.291 0 CA-C-N 115.095 -0.957 . . . . 74.14 110.137 178.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 39.9 p -76.88 171.13 15.25 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.554 -0.748 . . . . 75.03 110.166 175.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 15.9 mp0 -53.54 -28.98 34.57 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 124.399 1.08 . . . . 71.11 112.359 -177.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -71.95 -48.0 48.37 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.017 0.927 . . . . 72.43 110.869 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -63.88 -41.97 97.6 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 121.742 0.782 . . . . 71.14 110.493 178.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.663 HG23 HD11 ' A' ' 11' ' ' LEU . 74.9 mt -68.07 -32.07 54.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 114.093 -1.412 . . . . 73.31 111.174 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -70.53 -35.97 73.46 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.463 0.705 . . . . 75.22 110.907 175.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 45.9 mtm105 -61.94 -50.85 70.48 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 109.68 -0.489 . . . . 73.12 109.68 173.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.512 ' HB3' HG12 ' A' ' 13' ' ' VAL . . . -62.08 -37.66 85.88 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 114.891 -1.05 . . . . 72.43 111.764 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -60.26 -64.21 1.03 Allowed 'General case' 0 C--O 1.207 -1.142 0 CA-C-N 114.831 -1.077 . . . . 73.1 109.362 176.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -55.15 -30.5 59.97 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 124.167 0.917 . . . . 74.22 112.021 -177.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.461 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 50.2 ttp180 -59.46 -67.98 0.32 Allowed 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.567 -0.531 . . . . 75.52 109.567 172.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.612 ' HB3' HD12 ' A' ' 50' ' ' ILE . 91.8 mt -70.9 -14.34 62.35 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.171 0.588 . . . . 75.12 112.171 -175.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.631 ' HA ' ' HE1' ' A' ' 47' ' ' PHE . . . -82.96 -38.66 22.43 Favored 'General case' 0 C--O 1.206 -1.229 0 C-N-CA 123.695 0.798 . . . . 71.54 109.864 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.0 mtm180 -78.98 -33.41 45.11 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 122.497 0.319 . . . . 72.33 110.692 176.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' A' ' 28' ' ' ARG . 15.1 mm100 -67.46 -62.44 1.42 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 122.962 0.505 . . . . 73.31 110.44 177.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.448 ' HE2' HD21 ' A' ' 29' ' ' LEU . 21.7 m-85 -94.83 31.39 1.84 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.288 0.635 . . . . 72.41 110.941 -176.027 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -61.5 105.65 0.65 Allowed Pre-proline 0 N--CA 1.482 1.16 0 C-N-CA 123.877 0.871 . . . . 73.54 109.983 -178.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.65 -14.53 36.56 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.423 2.082 . . . . 75.51 111.444 -172.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -62.65 -37.48 86.53 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.399 1.08 . . . . 73.23 111.065 173.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 46.7 t -104.58 -51.64 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 CA-C-O 121.356 0.598 . . . . 73.25 109.862 -178.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -99.12 86.13 3.38 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.552 1.141 . . . . 64.12 110.72 -177.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.589 ' HZ3' ' HB2' ' A' ' 39' ' ' LYS . 10.4 mtmp? -85.78 61.06 6.61 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.352 0.596 . . . . 73.11 110.402 176.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 66.4 m -107.13 110.58 63.46 Favored Pre-proline 0 N--CA 1.476 0.845 0 CA-C-O 118.176 -0.916 . . . . 71.24 109.202 176.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.417 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 2.8 Cg_endo -38.07 -53.62 1.57 Allowed 'Trans proline' 0 C--N 1.393 2.911 0 C-N-CA 124.941 3.761 . . . . 73.53 114.151 -172.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -47.43 -52.9 15.54 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 124.657 1.183 . . . . 64.43 112.005 177.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.58 -24.89 63.75 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 114.599 -1.182 . . . . 73.42 111.244 -176.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -85.03 -36.46 21.24 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.753 0.821 . . . . 63.35 110.84 -175.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.417 ' HG2' ' O ' ' A' ' 41' ' ' PRO . 28.0 mm-40 -68.74 -47.73 65.53 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 108.854 -0.795 . . . . 62.44 108.854 177.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 49.4 mttp -65.87 -33.15 75.18 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 114.856 -1.065 . . . . 74.03 111.38 175.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.631 ' HE1' ' HA ' ' A' ' 30' ' ' ALA . 88.2 t80 -58.6 -44.64 89.94 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.051 0.54 . . . . 73.32 110.292 173.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.521 ' HB3' ' HE1' ' A' ' 93' ' ' PHE . 48.5 mtmt -62.45 -39.54 93.7 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.258 -0.428 . . . . 75.14 111.055 177.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -65.4 -28.7 69.44 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.044 0.45 . . . . 71.44 111.926 176.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.612 HD12 ' HB3' ' A' ' 29' ' ' LEU . 68.2 mt -73.86 -32.9 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.516 0.726 . . . . 74.43 109.834 173.088 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.416 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 25.9 m-80 -81.19 -14.7 57.3 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.541 0.736 . . . . 73.43 111.3 174.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -73.68 -55.56 6.11 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.82 1.248 . . . . 75.34 108.484 170.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.76 -51.47 65.6 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 113.448 -1.705 . . . . 65.45 110.707 175.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -60.82 -45.91 92.59 Favored 'General case' 0 C--O 1.21 -0.984 0 CA-C-N 114.936 -1.029 . . . . 73.53 110.649 177.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 51' ' ' ASN . . . -52.64 -52.58 54.93 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.355 0.662 . . . . 72.52 112.246 -177.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 97.3 t -61.11 -49.44 84.64 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 O-C-N 124.201 0.938 . . . . 74.52 109.782 178.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.54 ' HB3' HD13 ' A' ' 22' ' ' ILE . 69.5 mt -87.75 -6.82 58.0 Favored 'General case' 0 CA--C 1.56 1.335 0 N-CA-C 114.6 1.333 . . . . 74.35 114.6 -168.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.2 t -79.83 -32.63 40.65 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 123.268 0.627 . . . . 74.34 110.694 -177.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -100.55 129.43 27.78 Favored Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 108.296 -1.002 . . . . 74.34 108.296 -176.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.82 -40.18 86.33 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 123.297 2.665 . . . . 72.41 113.499 -172.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.415 ' O ' HG13 ' A' ' 65' ' ' ILE . 13.0 mp0 -64.77 -56.09 15.71 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.055 0.942 . . . . 72.3 110.067 -178.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.449 ' HA ' HD11 ' A' ' 65' ' ' ILE . 44.3 mtpt -65.11 -36.49 84.44 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.838 0.855 . . . . 74.54 111.65 -176.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 54.2 ttt180 -56.91 -49.98 73.93 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 124.051 0.844 . . . . 74.11 108.967 174.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -69.73 -25.27 63.76 Favored 'General case' 0 C--O 1.214 -0.814 0 CA-C-N 115.091 -0.959 . . . . 74.25 112.354 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.556 HG12 ' HG2' ' A' ' 76' ' ' PRO . 85.1 mt -61.14 -48.08 90.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 108.763 -0.828 . . . . 74.41 108.763 172.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -58.03 -58.26 9.22 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 115.414 -0.812 . . . . 75.4 110.774 173.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -58.13 -38.47 76.6 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.415 1.086 . . . . 64.04 112.381 -172.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 73.1 p -76.14 -33.1 59.4 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 118.935 -0.555 . . . . 75.44 110.459 178.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -63.46 120.71 12.2 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-N 118.535 0.607 . . . . 75.32 109.915 -176.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 107.61 5.61 33.79 Favored Glycine 0 CA--C 1.54 1.597 0 C-N-CA 123.443 0.544 . . . . 64.23 112.034 -166.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 91.4 m -146.53 -57.7 0.28 Allowed 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 104.583 -2.377 . . . . 71.23 104.583 175.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 96.4 m -79.14 149.14 32.11 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 105.277 -2.12 . . . . 74.23 105.277 155.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.58 -17.77 3.23 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 122.863 0.465 . . . . 74.04 111.942 -171.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -101.98 140.96 21.63 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 123.42 0.688 . . . . 75.1 109.666 177.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.13 126.85 13.53 Favored 'Trans proline' 0 C--N 1.374 1.884 0 C-N-CA 122.803 2.335 . . . . 75.41 112.322 177.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.556 ' HG2' HG12 ' A' ' 65' ' ' ILE . 71.4 Cg_exo -53.7 149.28 32.92 Favored 'Trans proline' 0 C--N 1.385 2.495 0 C-N-CA 123.751 2.967 . . . . 74.25 113.419 177.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -55.36 136.83 75.42 Favored 'Trans proline' 0 C--N 1.383 2.39 0 C-N-CA 122.941 2.427 . . . . 73.45 112.181 -176.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -61.27 126.02 18.34 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.907 2.404 . . . . 73.2 112.796 -178.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -58.09 157.95 23.41 Favored 'Trans proline' 0 C--N 1.382 2.328 0 C-N-CA 123.415 2.743 . . . . 71.05 113.038 173.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.534 ' HD2' ' HA3' ' A' ' 142' ' ' GLY . 79.8 Cg_exo -48.78 82.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.388 2.64 0 C-N-CA 124.648 3.565 . . . . 74.31 115.42 178.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 136.84 -39.55 1.62 Allowed Glycine 0 N--CA 1.467 0.766 0 N-CA-C 109.881 -1.287 . . . . 62.41 109.881 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 144.61 -176.89 23.5 Favored Glycine 0 C--N 1.344 0.982 0 C-N-CA 124.237 0.922 . . . . 53.03 110.969 176.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -58.79 98.47 0.04 OUTLIER 'General case' 0 C--O 1.243 0.738 0 N-CA-C 107.604 -1.258 . . . . 74.41 107.604 164.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -64.8 110.68 2.49 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.51 0.671 . . . . 71.31 109.307 -173.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -133.05 23.9 4.2 Favored 'General case' 0 C--O 1.259 1.567 0 C-N-CA 124.862 1.265 . . . . 73.24 108.664 -168.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.432 ' O ' ' HA2' ' A' ' 163' ' ' GLY . 73.4 m -58.5 146.28 36.0 Favored 'General case' 0 C--N 1.349 0.559 0 CA-C-N 113.986 -1.461 . . . . 74.44 112.279 -171.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.414 ' H ' ' HG2' ' A' ' 171' ' ' PRO . . . 79.73 -9.08 45.97 Favored Glycine 0 CA--C 1.536 1.382 0 CA-C-O 118.803 -0.998 . . . . 70.11 114.629 -176.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.419 ' HB3' ' HE2' ' A' ' 93' ' ' PHE . 51.8 m-85 -112.74 142.63 45.13 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 119.383 1.591 . . . . 72.34 112.575 -176.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -82.42 75.89 9.31 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 124.149 0.98 . . . . 71.44 111.126 -172.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.593 HG21 ' HE2' ' A' ' 97' ' ' PHE . 2.5 p -39.4 -48.55 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.62 0 C-N-CA 125.787 1.635 . . . . 75.21 113.904 176.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.17 -36.52 70.88 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 124.157 0.983 . . . . 75.33 112.195 -176.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -72.69 -31.7 65.23 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.949 -0.568 . . . . 61.35 110.902 -175.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.521 ' HE1' ' HB3' ' A' ' 48' ' ' LYS . 15.4 m-30 -80.05 174.71 11.32 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.905 -0.589 . . . . 73.34 111.939 -164.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.469 ' HB3' ' HE3' ' A' ' 5' ' ' LYS . 78.7 p -57.1 149.41 19.47 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.808 0.843 . . . . 74.5 113.129 -168.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.16 -39.61 72.59 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 114.839 -1.073 . . . . 74.52 110.084 168.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -54.49 -47.25 73.26 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.384 1.074 . . . . 75.03 110.896 176.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.593 ' HE2' HG21 ' A' ' 90' ' ' VAL . 44.3 t80 -59.42 -50.07 75.35 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 115.338 -0.847 . . . . 72.32 110.092 175.315 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -76.31 -2.18 30.36 Favored 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 112.403 0.52 . . . . 74.14 112.403 -175.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -93.94 -59.3 2.01 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.652 0.781 . . . . 70.02 110.191 169.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 33.4 tp -62.46 -46.18 89.68 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.979 0.912 . . . . 74.33 111.24 -176.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -92.75 -3.65 54.44 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.104 0.562 . . . . 72.11 111.477 177.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -46.35 -57.73 6.28 Favored Glycine 0 CA--C 1.544 1.87 0 CA-C-O 118.988 -0.895 . . . . 72.43 115.195 177.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -68.21 11.51 0.26 Allowed 'Trans proline' 0 C--N 1.382 2.317 0 C-N-CA 123.637 2.891 . . . . 64.43 114.635 -178.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -147.05 16.5 1.54 Allowed Glycine 0 C--N 1.348 1.228 0 CA-C-O 119.078 -0.845 . . . . 54.4 113.077 171.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 35.5 mt -66.65 79.81 0.11 Allowed 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 118.01 0.905 . . . . 74.25 111.61 174.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 38.55 -113.27 0.12 Allowed 'General case' 0 CA--C 1.56 1.34 0 C-N-CA 126.632 1.973 . . . . 74.45 115.813 172.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 70.31 0.49 29.96 Favored Glycine 0 C--N 1.368 2.311 0 N-CA-C 112.29 -0.324 . . . . 44.0 112.29 -162.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 55.46 -122.84 28.1 Favored Glycine 0 C--N 1.355 1.604 0 C-N-CA 123.198 0.428 . . . . 71.34 113.284 -171.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -105.78 -0.05 25.71 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.875 0.87 . . . . 74.55 110.077 175.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -93.56 -25.47 18.22 Favored Glycine 0 C--N 1.353 1.478 0 CA-C-O 119.599 -0.556 . . . . 55.25 113.553 -178.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.6 tpm_? 67.45 -11.01 0.32 Allowed 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 124.972 1.309 . . . . 75.52 112.986 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.42 12.25 0.49 Allowed 'General case' 0 CA--C 1.562 1.424 0 O-C-N 121.184 -0.947 . . . . 75.13 111.636 178.34 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 51.8 m 53.39 37.92 26.65 Favored 'General case' 0 C--N 1.367 1.338 0 C-N-CA 124.308 1.043 . . . . 74.21 111.141 176.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 21.2 tpt180 -76.68 158.05 31.32 Favored 'General case' 0 C--N 1.344 0.359 0 CA-C-N 114.221 -1.354 . . . . 74.52 111.935 -169.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -60.7 129.49 41.8 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.061 0.944 . . . . 73.31 109.181 175.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.402 ' HA2' HH11 ' A' ' 117' ' ' ARG . . . -64.53 160.52 40.4 Favored Glycine 0 C--N 1.343 0.954 0 CA-C-O 121.664 0.591 . . . . 73.4 113.471 178.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.461 ' H ' ' HA3' ' A' ' 166' ' ' GLY . 2.7 mpt_? -102.87 165.43 11.05 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.424 1.09 . . . . 74.43 110.923 -168.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -76.44 115.75 16.48 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 106.698 -1.593 . . . . 74.23 106.698 163.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.53 HD13 ' HA2' ' A' ' 166' ' ' GLY . 3.6 tt -114.99 136.85 52.67 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 107.756 -1.201 . . . . 75.42 107.756 -174.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 29.8 ttt-85 -117.02 135.94 53.33 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 108.554 -0.906 . . . . 74.51 108.554 174.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.97 168.7 23.06 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 121.192 0.52 . . . . 54.41 111.407 -177.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -111.66 112.77 24.7 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.324 1.05 . . . . 72.42 109.439 -169.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 37.5 tp -100.92 96.2 5.39 Favored Pre-proline 0 CA--C 1.549 0.909 0 N-CA-C 108.796 -0.816 . . . . 74.14 108.796 -178.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -83.53 114.27 2.07 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 122.695 2.263 . . . . 75.33 110.61 -173.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.52 ' HB3' HD21 ' A' ' 180' ' ' LEU . 46.3 tp -117.41 141.55 48.19 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.152 0.501 . . . . 72.43 111.134 -169.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 24.0 m -69.41 142.05 53.96 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 114.908 -1.042 . . . . 71.34 110.277 173.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.577 HD13 ' HB2' ' A' ' 186' ' ' PHE . 84.5 mt -57.65 -46.53 84.1 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.245 0.618 . . . . 75.21 110.389 179.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -62.67 -37.51 86.7 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 115.071 -0.968 . . . . 75.32 110.519 -177.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -76.6 -21.4 55.63 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.256 0.622 . . . . 64.33 111.574 178.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -71.71 -40.9 69.18 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.023 0.529 . . . . 65.44 110.166 171.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -65.02 -42.43 94.38 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.477 1.111 . . . . 74.51 110.547 177.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 41.7 m170 -69.16 -48.3 62.66 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.384 -0.826 . . . . 75.25 111.273 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.465 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 71.3 -141.96 33.36 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 115.941 -0.572 . . . . 71.54 112.496 -175.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 71.97 -161.2 54.25 Favored Glycine 0 C--N 1.349 1.297 0 C-N-CA 122.987 0.327 . . . . 70.42 113.141 178.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.662 ' HB3' ' HB2' ' A' ' 146' ' ' SER . 26.2 mp0 -69.54 118.46 12.44 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 122.949 0.5 . . . . 73.14 110.146 178.354 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 11.1 tpp180 -101.21 118.91 37.92 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.794 -0.817 . . . . 75.05 108.794 176.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.513 ' HB ' HG23 ' B' ' 5' ' ' THR . 97.2 t -81.74 96.0 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 121.413 0.625 . . . . 75.04 109.465 -178.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.1 p -115.47 124.11 71.65 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-N 114.985 -1.007 . . . . 73.34 108.435 173.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 144' ' ' ARG . 32.1 mt-10 -85.13 115.11 22.73 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 114.792 -1.095 . . . . 71.3 110.246 178.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 33.9 m -122.58 127.65 75.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 124.226 1.011 . . . . 75.1 110.684 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 63.17 21.26 12.76 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.105 0.962 . . . . 74.24 112.575 177.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.534 ' HA3' ' HD2' ' A' ' 80' ' ' PRO . . . 90.2 -17.95 51.04 Favored Glycine 0 C--N 1.35 1.33 0 C-N-CA 122.689 0.185 . . . . 54.15 113.075 -175.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -87.83 118.64 27.49 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.201 1.001 . . . . 72.43 108.831 176.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.407 ' HA ' ' HA ' ' A' ' 139' ' ' GLU . 45.4 ttm105 -82.4 115.46 21.44 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.592 0.757 . . . . 74.41 109.05 178.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 14.7 p -125.47 149.54 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-O 121.4 0.619 . . . . 73.53 110.607 -177.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.662 ' HB2' ' HB3' ' A' ' 135' ' ' GLU . 35.9 p -107.55 93.27 4.45 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 124.382 1.073 . . . . 64.43 110.45 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 3.4 p -80.57 112.68 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 123.108 0.563 . . . . 73.42 109.564 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -67.02 95.28 0.38 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.658 0.742 . . . . 74.32 110.378 176.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.465 HG13 ' HA2' ' A' ' 133' ' ' GLY . 44.5 pt -78.15 140.58 61.63 Favored Pre-proline 0 CA--C 1.556 1.186 0 CA-C-N 114.42 -1.264 . . . . 74.52 108.713 170.047 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -66.31 138.48 51.19 Favored 'Trans proline' 0 C--N 1.373 1.833 0 C-N-CA 121.995 1.797 . . . . 74.22 112.187 176.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -63.82 92.63 0.17 Allowed 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 122.424 2.083 . . . . 74.15 110.749 171.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 123.4 27.35 1.49 Allowed Glycine 0 CA--C 1.526 0.736 0 CA-C-N 114.756 -1.111 . . . . 75.51 110.993 -171.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 5.7 p -73.67 137.45 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 123.294 0.637 . . . . 75.43 109.552 179.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.548 HH21 ' HG2' ' A' ' 241' ' ' PRO . 0.0 OUTLIER -112.36 154.61 25.47 Favored 'General case' 0 C--O 1.211 -0.941 0 CA-C-N 116.372 -0.376 . . . . 73.23 111.816 -163.704 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -54.0 124.26 15.02 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 124.049 0.843 . . . . 72.32 110.248 171.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.46 4.88 70.13 Favored Glycine 0 C--N 1.342 0.9 0 CA-C-O 119.159 -0.8 . . . . 74.33 113.747 -178.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 58.3 m -67.78 102.09 1.17 Allowed 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 118.157 0.979 . . . . 74.23 108.857 170.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 53.9 t -83.94 91.4 2.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 107.34 -1.356 . . . . 74.02 107.34 177.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.624 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 53.0 mt -71.99 85.12 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.801 0 N-CA-C 107.618 -1.253 . . . . 75.24 107.618 174.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -74.17 99.52 3.42 Favored 'General case' 0 C--N 1.353 0.76 0 N-CA-C 107.378 -1.342 . . . . 75.21 107.378 175.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.0 p -110.13 118.75 48.87 Favored Pre-proline 0 CA--C 1.548 0.903 0 CA-C-N 115.076 -0.966 . . . . 71.41 110.872 -169.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -79.06 125.3 6.45 Favored 'Trans proline' 0 C--N 1.369 1.626 0 C-N-CA 122.386 2.057 . . . . 74.53 106.841 160.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . 0.432 ' HA2' ' O ' ' A' ' 86' ' ' SER . . . 130.0 -23.75 4.63 Favored Glycine 0 N--CA 1.469 0.9 0 N-CA-C 111.303 -0.719 . . . . 70.43 111.303 -165.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -134.22 144.55 48.5 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 106.152 -1.795 . . . . 64.15 106.152 163.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -175.85 -160.95 24.27 Favored Glycine 0 CA--C 1.498 -0.993 0 N-CA-C 114.596 0.598 . . . . 73.33 114.596 171.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.53 ' HA2' HD13 ' A' ' 119' ' ' LEU . . . -57.79 135.64 51.56 Favored Glycine 0 C--N 1.356 1.691 0 O-C-N 124.476 0.75 . . . . 74.5 112.322 175.059 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -70.38 105.11 2.91 Favored 'General case' 0 CA--C 1.548 0.899 0 O-C-N 125.686 1.462 . . . . 75.42 110.105 -172.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -170.39 155.7 25.51 Favored Glycine 0 C--N 1.339 0.727 0 CA-C-O 118.887 -0.952 . . . . 64.21 111.253 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . 0.485 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . 7.3 t30 -64.74 -56.26 22.99 Favored Pre-proline 0 N--CA 1.488 1.438 0 CA-C-O 117.826 -1.083 . . . . 63.54 111.41 -170.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.485 ' HD3' ' HB3' ' A' ' 169' ' ' ASN . 1.7 Cg_endo -82.68 91.74 0.96 Allowed 'Trans proline' 0 C--N 1.388 2.649 0 N-CA-C 106.965 -1.975 . . . . 73.02 106.965 162.137 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.424 ' CG ' ' HA ' ' A' ' 86' ' ' SER . 56.0 Cg_endo -76.6 174.58 12.61 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 123.479 2.786 . . . . 71.25 117.232 -156.017 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -95.48 -158.86 32.73 Favored Glycine 0 C--N 1.363 2.05 0 CA-C-N 114.724 -1.125 . . . . 72.4 114.736 -177.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -133.52 146.08 50.73 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 125.386 1.474 . . . . 71.14 108.147 -177.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 41.8 tp -118.26 141.63 48.31 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 120.966 0.412 . . . . 74.2 112.015 -172.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 68.9 mt -97.2 91.67 5.65 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 124.268 1.027 . . . . 72.12 108.284 171.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.624 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 85.4 mt -74.28 85.61 1.93 Allowed 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.392 -0.966 . . . . 74.52 108.392 170.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 46.5 t -83.34 97.82 4.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 107.037 -1.468 . . . . 71.11 107.037 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 8.9 p -68.41 125.88 27.1 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 CA-C-N 115.558 -0.746 . . . . 74.13 110.144 -173.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 40.4 mmm-85 -116.94 97.61 6.04 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.497 1.119 . . . . 73.42 108.215 -176.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.52 HD21 ' HB3' ' A' ' 125' ' ' LEU . 45.3 mt -69.34 141.11 54.31 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 110.067 -0.346 . . . . 74.04 110.067 -179.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 79.6 mt -57.52 148.2 56.51 Favored Pre-proline 0 CA--C 1.549 0.929 0 O-C-N 124.066 0.854 . . . . 73.22 111.202 -177.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -77.43 48.19 2.49 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 123.084 2.523 . . . . 74.32 110.441 167.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -70.28 136.94 86.54 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 125.27 1.428 . . . . 73.35 109.051 -172.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -58.32 12.09 0.04 OUTLIER 'Trans proline' 0 C--N 1.381 2.253 0 C-N-CA 124.202 3.268 . . . . 61.24 118.127 -168.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 40.2 t -106.63 -55.2 5.61 Favored 'Isoleucine or valine' 0 C--N 1.352 0.702 0 CA-C-N 119.43 1.014 . . . . 72.34 109.181 172.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . 0.577 ' HB2' HD13 ' A' ' 127' ' ' LEU . 23.1 m-85 -134.49 147.11 50.3 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 115.061 -0.972 . . . . 72.31 111.681 -168.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -133.79 90.96 2.77 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 106.177 -1.786 . . . . 75.51 106.177 165.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.473 HD12 ' HG ' ' A' ' 193' ' ' LEU . 60.0 tp -71.47 161.33 31.21 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 124.48 1.112 . . . . 74.21 111.652 -177.129 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -154.28 107.54 2.89 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 122.905 0.482 . . . . 70.31 110.59 174.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 82.22 -53.37 4.76 Favored Glycine 0 C--N 1.36 1.861 0 C-N-CA 123.375 0.512 . . . . 65.41 114.216 174.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -178.97 -21.43 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 126.917 2.087 . . . . 72.32 107.789 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -85.31 120.37 26.72 Favored 'General case' 0 C--N 1.357 0.923 0 CA-C-N 114.405 -1.271 . . . . 72.32 109.509 -178.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.523 HD12 HD13 ' A' ' 249' ' ' LEU . 0.6 OUTLIER -89.97 142.7 27.46 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.06 0.944 . . . . 74.25 110.112 -170.23 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -119.3 145.18 46.35 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 107.878 -1.156 . . . . 73.14 107.878 166.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.434 ' HB2' HD21 ' A' ' 251' ' ' LEU . . . -144.63 175.84 9.85 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.609 1.164 . . . . 74.34 109.485 -171.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' THR . . . . . 0.441 ' OG1' ' HA ' ' B' ' 120' ' ' TYR . 2.9 m -118.41 139.84 50.77 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.643 -0.873 . . . . 70.21 108.643 172.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.566 HD22 HD11 ' A' ' 251' ' ' LEU . 34.5 tp -145.61 105.87 4.05 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 110.127 -0.323 . . . . 74.1 110.127 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -73.62 133.38 43.46 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 109.285 -0.635 . . . . 63.3 109.285 167.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 7.3 p -143.59 133.03 11.63 Favored Pre-proline 0 CA--C 1.548 0.879 0 N-CA-C 107.781 -1.192 . . . . 74.33 107.781 178.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.28 146.15 35.46 Favored 'Trans proline' 0 C--N 1.368 1.586 0 C-N-CA 121.313 1.342 . . . . 70.05 110.404 169.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.484 ' HB3' ' HH2' ' A' ' 269' ' ' TRP . . . -44.13 -52.0 17.16 Favored Pre-proline 0 CA--C 1.568 1.669 0 N-CA-C 115.644 1.72 . . . . 71.34 115.644 -173.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.423 ' HD3' ' HB3' ' A' ' 201' ' ' ALA . 50.5 Cg_exo -60.07 -38.55 76.86 Favored 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 121.809 1.673 . . . . 73.32 113.845 -179.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 46.3 mt -70.17 -29.4 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 110.016 -0.364 . . . . 71.02 110.016 179.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.18 -48.83 61.1 Favored 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 123.069 0.548 . . . . 74.14 111.941 172.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 201' ' ' ALA . 93.4 t -65.54 -43.04 94.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 C-N-CA 123.837 0.855 . . . . 64.22 111.859 -175.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.496 HG21 ' HB3' ' C' ' 273' ' ' ALA . 70.4 t -92.55 -34.68 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.594 0.757 . . . . 74.41 111.458 -173.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 88.09 89.21 1.12 Allowed Glycine 0 C--N 1.341 0.845 0 N-CA-C 111.319 -0.712 . . . . 72.35 111.319 -175.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -107.4 -139.28 9.1 Favored Glycine 0 C--N 1.34 0.798 0 CA-C-O 120.277 -0.18 . . . . 73.32 112.67 -177.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -130.85 128.21 40.16 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.175 0.99 . . . . 73.34 108.917 177.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 29.3 m -129.83 159.24 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 109.038 -0.727 . . . . 63.11 109.038 175.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 55.2 ttm-85 -93.93 107.24 19.16 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 109.494 -0.558 . . . . 74.32 109.494 178.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -102.25 124.35 47.69 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 124.111 0.964 . . . . 74.41 109.436 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' MET . . . . . 0.421 ' HA ' ' HA ' ' A' ' 218' ' ' PRO . 1.0 OUTLIER -75.08 126.08 30.27 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.202 0.601 . . . . 74.15 109.747 175.922 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 72.7 p -116.1 -178.01 3.3 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 123.876 0.87 . . . . 74.1 108.726 173.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.418 ' HG ' ' HE2' ' A' ' 186' ' ' PHE . 63.8 mt -77.01 -7.6 55.93 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 122.778 0.431 . . . . 73.14 110.727 174.521 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -99.98 -19.66 16.46 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.225 1.01 . . . . 64.44 110.553 176.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 139.53 172.84 12.86 Favored Glycine 0 C--N 1.353 1.504 0 CA-C-O 119.858 -0.412 . . . . 63.05 113.451 175.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . 0.421 ' HA ' ' HA ' ' A' ' 213' ' ' MET . 4.0 Cg_exo -75.9 99.32 1.27 Allowed 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 122.93 2.42 . . . . 74.13 111.285 178.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 32.5 m -103.2 159.34 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.208 1.003 . . . . 73.4 110.619 -174.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.63 ' HB2' ' HB2' ' B' ' 428' ' ' GLU . 36.8 mt-10 -93.8 105.07 17.12 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.152 -0.684 . . . . 75.04 109.152 179.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 8.7 p -101.64 137.52 29.09 Favored 'Isoleucine or valine' 0 C--O 1.253 1.273 0 C-N-CA 123.832 0.853 . . . . 74.51 110.021 -174.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -86.42 102.75 14.34 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.784 0.834 . . . . 70.4 110.744 -178.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.446 ' HA ' HD13 ' B' ' 441' ' ' ILE . 48.8 t -63.48 137.76 97.17 Favored Pre-proline 0 CA--C 1.56 1.353 0 C-N-CA 124.458 1.103 . . . . 71.22 110.304 179.3 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . 0.605 ' HB2' ' HB2' ' B' ' 444' ' ' TYR . 65.0 Cg_endo -79.98 164.01 22.76 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 122.673 2.249 . . . . 75.51 110.612 174.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.99 152.4 46.11 Favored 'Trans proline' 0 C--N 1.369 1.63 0 C-N-CA 121.786 1.657 . . . . 72.53 112.814 178.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . 0.56 HH12 ' HG ' ' C' ' 261' ' ' LEU . 63.5 mtt-85 67.54 26.06 8.22 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 125.533 1.533 . . . . 75.13 111.873 172.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.472 HG23 HD21 ' A' ' 233' ' ' LEU . 10.5 m -61.17 104.01 0.34 Allowed 'General case' 0 CA--C 1.559 1.323 0 C-N-CA 125.699 1.6 . . . . 64.32 111.026 175.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . 0.565 ' HB3' ' HD2' ' A' ' 231' ' ' ARG . 4.8 tp-100 -97.38 143.89 27.67 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.085 0.954 . . . . 75.32 111.263 -173.252 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -63.57 150.91 42.94 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.588 0.755 . . . . 65.12 112.462 -177.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 83.71 -28.27 4.03 Favored Glycine 0 C--N 1.349 1.271 0 O-C-N 123.684 0.615 . . . . 75.54 112.523 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.565 ' HD2' ' HB3' ' A' ' 228' ' ' GLN . 76.6 mtt180 -77.63 167.11 22.12 Favored 'General case' 0 C--N 1.347 0.492 0 C-N-CA 123.971 0.908 . . . . 74.44 110.469 178.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.449 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 12.5 mptt -121.82 120.55 34.89 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 115.067 -0.97 . . . . 72.22 108.571 -178.078 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.472 HD21 HG23 ' A' ' 227' ' ' THR . 81.8 mt -74.59 110.3 8.77 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 108.595 -0.891 . . . . 71.4 108.595 177.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . 0.545 ' HG3' ' HB3' ' A' ' 248' ' ' ASP . 39.9 ttp180 -87.63 100.77 13.05 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 122.622 0.369 . . . . 73.41 110.121 178.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.492 HD12 ' HG3' ' A' ' 238' ' ' LYS . 0.2 OUTLIER -100.84 106.84 18.25 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 106.466 -1.679 . . . . 74.24 106.466 170.662 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -76.18 143.95 40.81 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 115.045 -0.979 . . . . 71.01 111.708 -169.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 71.35 32.62 64.97 Favored Glycine 0 C--N 1.348 1.2 0 O-C-N 123.704 0.627 . . . . 74.2 112.536 -178.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.492 ' HG3' HD12 ' A' ' 235' ' ' LEU . 43.9 mmtm -125.32 -17.18 5.71 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.985 0.914 . . . . 74.1 110.453 178.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . 0.511 ' HA2' HD13 ' A' ' 193' ' ' LEU . . . -79.6 -151.86 6.85 Favored Glycine 0 C--N 1.353 1.474 0 CA-C-N 116.298 -0.41 . . . . 74.43 112.655 176.354 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -96.72 146.06 30.65 Favored Pre-proline 0 N--CA 1.482 1.169 0 C-N-CA 122.882 0.473 . . . . 73.41 109.857 -179.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.719 ' HA ' ' HA ' ' A' ' 246' ' ' ARG . 33.1 Cg_endo -61.27 167.26 9.66 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 123.203 2.602 . . . . 73.33 114.195 -175.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -175.2 -176.35 43.4 Favored Glycine 0 CA--C 1.535 1.335 0 CA-C-N 115.213 -0.903 . . . . 73.52 112.18 177.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -62.44 -19.31 67.05 Favored 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 123.68 2.92 . . . . 72.5 113.961 -175.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -102.53 22.52 13.4 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 124.027 0.931 . . . . 70.11 110.855 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 90.18 -164.38 30.9 Favored Glycine 0 C--N 1.35 1.338 0 N-CA-C 111.471 -0.651 . . . . 62.24 111.471 -174.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.719 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 25.1 ttm180 -73.08 139.37 46.45 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 117.664 0.732 . . . . 75.41 110.383 177.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -70.06 179.11 28.58 Favored Glycine 0 C--N 1.34 0.775 0 CA-C-N 115.709 -0.678 . . . . 70.31 113.379 -176.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . 0.545 ' HB3' ' HG3' ' A' ' 234' ' ' ARG . 55.7 m-20 -106.12 140.57 38.89 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.52 0.728 . . . . 75.44 109.493 -173.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.523 HD13 HD12 ' A' ' 193' ' ' LEU . 34.4 tp -97.61 120.0 37.19 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.349 -0.982 . . . . 73.32 108.349 178.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.449 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 2.9 m-85 -100.93 106.18 17.49 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.363 1.065 . . . . 71.3 108.66 177.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.566 HD11 HD22 ' A' ' 197' ' ' LEU . 47.1 mt -87.03 121.45 29.51 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.392 0.677 . . . . 74.54 109.659 177.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.446 ' HG2' ' HE3' ' A' ' 232' ' ' LYS . 2.8 tm-20 -74.38 107.3 6.45 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 107.45 -1.315 . . . . 75.41 107.45 -178.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.489 HG13 HG13 ' A' ' 255' ' ' ILE . 42.6 t -67.36 99.67 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.687 0 O-C-N 124.117 0.886 . . . . 71.34 110.223 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.25 92.16 4.39 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 107.181 -1.414 . . . . 73.14 107.181 177.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.489 HG13 HG13 ' A' ' 253' ' ' VAL . 70.2 mt -83.8 130.95 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-O 120.779 0.323 . . . . 74.34 110.583 -177.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 51.8 p -128.99 169.38 14.75 Favored 'General case' 0 C--O 1.253 1.265 0 C-N-CA 123.942 0.897 . . . . 74.52 109.585 172.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . 0.545 HD12 HG22 ' C' ' 205' ' ' VAL . 2.1 pp -119.14 155.95 52.91 Favored Pre-proline 0 CA--C 1.564 1.513 0 N-CA-C 108.121 -1.066 . . . . 73.4 108.121 173.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . 0.624 ' HG3' ' HH ' ' C' ' 276' ' ' TYR . 42.8 Cg_endo -76.27 9.21 2.56 Favored 'Trans proline' 0 N--CA 1.512 2.564 0 C-N-CA 123.027 2.485 . . . . 74.45 115.328 -162.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 56.72 -90.72 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 123.858 0.863 . . . . 75.12 109.925 -164.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' ARG . . . . . 0.448 HH22 HG21 ' A' ' 262' ' ' THR . 0.0 OUTLIER -74.33 144.32 44.53 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.589 0.756 . . . . 75.12 111.521 -175.029 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.435 HD11 HG11 ' C' ' 205' ' ' VAL . 49.5 mt -123.41 178.67 5.05 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.046 0.938 . . . . 72.32 111.165 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' THR . . . . . 0.448 HG21 HH22 ' A' ' 260' ' ' ARG . 1.2 p -128.16 143.88 49.61 Favored Pre-proline 0 CA--C 1.556 1.181 0 CA-C-N 114.007 -1.451 . . . . 74.31 108.43 176.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -28.26 -53.91 0.14 Allowed 'Trans proline' 0 C--N 1.39 2.757 1 C-N-CA 126.166 4.577 . . . . 74.33 117.734 -167.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -70.25 -47.52 60.98 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 122.589 0.356 . . . . 71.44 110.68 -174.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -64.51 -29.22 70.26 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.284 1.034 . . . . 73.22 110.319 178.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 266' ' ' GLU . . . . . 0.425 ' HA ' HD12 ' A' ' 261' ' ' LEU . 8.1 tp10 -62.76 -50.53 70.69 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.736 0.814 . . . . 73.45 109.047 175.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -62.76 -37.13 85.4 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 114.991 -1.004 . . . . 64.12 112.097 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . 0.491 HD21 ' HB3' ' C' ' 271' ' ' LYS . 6.7 mp -64.73 -56.05 16.08 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.704 0.802 . . . . 73.14 111.396 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 269' ' ' TRP . . . . . 0.484 ' HH2' ' HB3' ' A' ' 201' ' ' ALA . 68.1 m95 -58.62 -41.73 86.57 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.431 0.693 . . . . 75.0 111.279 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -60.25 -58.54 8.07 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 123.828 0.705 . . . . 73.12 111.516 178.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 30.8 mmtm -66.34 -33.64 76.18 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 112.418 0.525 . . . . 70.22 112.418 -175.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 13.7 mt -54.25 -53.54 52.3 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 109.224 -0.658 . . . . 71.54 109.224 169.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . 0.487 ' HA ' ' HB2' ' C' ' 202' ' ' PRO . . . -67.41 -37.84 83.68 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.671 1.188 . . . . 72.23 113.664 -172.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.484 ' HB3' ' HA ' ' B' ' 250' ' ' GLN . 37.6 mt-10 -67.81 -53.81 24.08 Favored 'General case' 0 C--O 1.243 0.733 0 C-N-CA 123.956 0.902 . . . . 74.35 109.398 -179.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -66.29 -30.41 70.82 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 115.538 -0.755 . . . . 72.24 111.145 178.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -68.57 -44.65 74.0 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.474 0.71 . . . . 75.02 109.945 178.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 277' ' ' TYR . . . . . 0.437 ' HA ' ' HB2' ' A' ' 280' ' ' ALA . 70.3 t80 -65.12 -37.53 87.75 Favored 'General case' 0 C--O 1.242 0.674 0 O-C-N 124.06 0.85 . . . . 72.14 110.245 -178.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -57.79 -23.83 54.3 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 115.571 -0.74 . . . . 75.41 111.683 173.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 67.7 mtm-85 -102.89 -15.76 16.08 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 124.026 0.93 . . . . 75.15 111.398 176.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . 0.437 ' HB2' ' HA ' ' A' ' 277' ' ' TYR . . . . . . . . 0 C--O 1.259 1.561 0 C-N-CA 123.851 0.86 . . . . 72.5 110.275 -176.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 62.9 mtm . . . . . 0 N--CA 1.482 1.148 0 N-CA-C 109.25 -0.648 . . . . 74.12 109.25 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 61.93 -158.23 0.33 Allowed 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.766 0.826 . . . . 62.45 109.777 -177.221 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -90.47 67.5 6.58 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 108.108 -1.071 . . . . 74.04 108.108 169.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 21.8 p -69.94 97.57 1.15 Allowed 'General case' 0 C--O 1.244 0.776 0 CA-C-N 115.53 -0.759 . . . . 52.14 110.543 -177.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' THR . . . . . 0.513 HG23 ' HB ' ' A' ' 137' ' ' VAL . 0.0 OUTLIER -97.07 166.17 11.72 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.475 -0.784 . . . . 74.34 111.71 -174.59 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 19.7 pt -133.78 166.57 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 115.248 -0.887 . . . . 65.34 112.385 -157.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -128.59 155.31 45.15 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.878 1.271 . . . . 72.22 108.625 173.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 45.7 tp -89.36 -98.55 0.1 Allowed 'General case' 0 CA--C 1.55 0.961 0 CA-C-O 119.131 -0.461 . . . . 75.22 110.574 -173.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . 166.31 -55.0 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 125.126 1.371 . . . . 73.12 109.065 -173.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 93.0 mt 57.95 91.29 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.983 1.313 . . . . 74.1 110.459 -168.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 78.7 mt -100.82 100.85 13.68 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 123.526 0.73 . . . . 72.11 109.434 -177.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -75.86 72.15 5.27 Favored 'Trans proline' 0 C--N 1.381 2.281 0 C-N-CA 122.974 2.449 . . . . 71.41 111.349 -177.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 7.4 mp 59.75 31.31 20.76 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.637 1.175 . . . . 75.11 110.635 -175.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 29.0 tp -79.48 14.91 1.42 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 124.726 1.211 . . . . 64.54 111.994 -172.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -82.57 69.22 9.29 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.105 0.962 . . . . 74.01 109.742 179.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 2.5 t -142.84 68.55 18.83 Favored Pre-proline 0 CA--C 1.56 1.344 0 CA-C-N 115.225 -0.898 . . . . 71.11 110.351 -179.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 17' ' ' PRO . . . . . 0.481 ' HB3' ' HB2' ' B' ' 21' ' ' ALA . 39.6 Cg_exo -64.7 96.39 0.25 Allowed 'Trans proline' 0 C--N 1.385 2.483 0 C-N-CA 122.895 2.397 . . . . 71.22 112.319 172.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 12.8 m -76.19 86.3 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.344 0 C-N-CA 123.395 0.678 . . . . 63.3 111.144 -179.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 20.6 m 76.04 -48.16 0.58 Allowed 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 126.202 1.801 . . . . 71.22 112.525 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -69.56 112.15 5.87 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 107.841 -1.17 . . . . 74.33 107.841 170.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . 0.481 ' HB2' ' HB3' ' B' ' 17' ' ' PRO . . . 74.28 169.31 0.3 Allowed 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 125.267 1.427 . . . . 75.34 110.68 -164.4 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 72.67 -65.57 0.35 Allowed 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 124.966 1.306 . . . . 73.31 109.823 -165.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 23' ' ' THR . . . . . . . . . . . . . 31.0 m -128.3 88.46 52.55 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 124.036 0.934 . . . . 72.54 108.562 176.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -57.06 112.35 1.08 Allowed 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 123.28 2.654 . . . . 74.55 112.796 -179.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -95.6 111.99 23.8 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.049 0.54 . . . . 74.53 109.721 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 26' ' ' MET . . . . . 0.411 ' SD ' ' N ' ' B' ' 26' ' ' MET . 1.5 mpt? -79.06 158.83 74.29 Favored Pre-proline 0 CA--C 1.557 1.214 0 C-N-CA 123.798 0.839 . . . . 75.13 109.995 176.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -66.87 84.85 0.31 Allowed 'Trans proline' 0 C--N 1.384 2.441 0 C-N-CA 122.373 2.049 . . . . 73.04 110.625 172.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.498 HG11 ' H ' ' B' ' 29' ' ' LEU 0.276 5.1 p 39.53 -80.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 C-N-CA 126.42 1.888 . . . . 75.25 113.747 -168.233 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . 0.498 ' H ' HG11 ' B' ' 28' ' ' VAL . 81.8 mt 72.92 -38.59 0.42 Allowed 'General case' 0 N--CA 1.499 2.0 0 C-N-CA 126.387 1.875 . . . . 73.34 113.663 -179.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -72.47 84.1 1.11 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.789 0.836 . . . . 71.25 110.817 -174.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -99.13 -20.09 16.84 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.258 0.623 . . . . 74.34 110.994 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -84.24 76.02 10.14 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.543 0.737 . . . . 72.22 110.469 -174.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -91.44 -24.65 19.64 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 115.067 -0.97 . . . . 73.31 111.062 177.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . 76.03 -43.51 0.48 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 126.173 1.789 . . . . 53.33 112.535 178.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 69.74 -73.67 0.09 Allowed 'General case' 0 C--N 1.361 1.074 0 C-N-CA 125.714 1.606 . . . . 73.13 110.955 176.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 161.85 45.14 0.02 OUTLIER Glycine 0 C--N 1.341 0.842 0 N-CA-C 110.253 -1.139 . . . . 74.33 110.253 177.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -68.95 119.89 13.98 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.651 0.78 . . . . 61.44 110.963 -175.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 38.5 mm 57.4 -88.24 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.166 0 C-N-CA 125.407 1.483 . . . . 75.44 110.25 -170.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 15.5 p -155.69 12.34 0.32 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 124.759 1.223 . . . . 73.32 109.948 178.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . 51.82 64.87 7.11 Favored Pre-proline 0 CA--C 1.562 1.406 0 C-N-CA 124.078 0.951 . . . . 73.24 111.117 -166.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -75.35 6.6 3.44 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 123.545 2.83 . . . . 72.44 114.185 -176.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -79.75 61.77 4.24 Favored Glycine 0 C--N 1.35 1.324 0 C-N-CA 122.92 0.295 . . . . 61.22 112.735 176.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -172.0 14.49 0.05 OUTLIER Glycine 0 C--N 1.345 1.079 0 C-N-CA 123.502 0.573 . . . . 64.32 112.198 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . 66.64 -73.5 0.07 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.668 1.587 . . . . 63.2 111.345 -177.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 20.1 tpp180 -156.54 -60.35 0.1 Allowed 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 106.563 -1.643 . . . . 74.21 106.563 175.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 71.6 mtt180 -131.39 -173.05 3.01 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 114.98 -1.009 . . . . 75.02 109.518 171.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 1.8 pp -83.1 -171.57 3.65 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.278 0.631 . . . . 72.13 111.247 178.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 31.1 m 69.13 80.08 0.19 Allowed 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.101 1.36 . . . . 73.12 109.993 -175.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.28 111.04 3.28 Favored Glycine 0 C--N 1.35 1.336 0 CA-C-N 114.904 -1.043 . . . . 74.15 112.804 -176.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -64.36 -45.46 87.66 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.055 0.942 . . . . 64.2 110.26 175.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 51' ' ' GLN . . . . . 0.65 ' HB2' HD22 ' B' ' 55' ' ' LEU . 73.6 mt-30 65.22 -75.86 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 125.399 1.479 . . . . 75.3 111.512 -179.399 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 32.2 m -117.2 -60.44 1.83 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.489 0.715 . . . . 73.31 109.392 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -176.56 -58.68 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.446 1.099 . . . . 73.24 109.385 177.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -147.49 103.52 3.55 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.654 0.782 . . . . 75.51 109.419 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . 0.65 HD22 ' HB2' ' B' ' 51' ' ' GLN . 2.8 mm? -87.23 109.2 19.32 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.751 0.82 . . . . 72.35 108.861 -178.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 79.17 -16.45 0.67 Allowed 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 125.235 1.414 . . . . 74.21 113.021 176.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 48.9 t0 74.3 142.52 0.07 Allowed 'General case' 0 C--N 1.372 1.555 0 C-N-CA 124.887 1.275 . . . . 75.31 109.902 -175.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 23.6 m -107.7 170.52 7.93 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.489 0.716 . . . . 62.01 112.153 -169.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 4.5 mm? 77.53 79.45 0.08 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 125.957 1.703 . . . . 72.44 112.47 -178.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 68.1 m -143.98 23.19 1.72 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.862 1.265 . . . . 71.31 109.134 171.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . 0.558 ' HB2' ' HD2' ' B' ' 63' ' ' PRO . 2.2 m-20 -85.68 -59.63 2.25 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.162 0.985 . . . . 71.45 110.082 -168.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 62' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -175.4 -48.32 0.0 OUTLIER Pre-proline 0 CA--C 1.555 1.142 0 C-N-CA 125.424 1.49 . . . . 72.42 108.362 -175.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . 0.558 ' HD2' ' HB2' ' B' ' 61' ' ' ASP . 73.2 Cg_endo -71.37 -165.18 0.18 Allowed 'Trans proline' 0 C--N 1.406 3.597 0 C-N-CA 122.08 1.853 . . . . 72.24 113.671 174.208 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 78.66 100.28 0.06 Allowed 'General case' 0 C--N 1.361 1.087 0 C-N-CA 126.0 1.72 . . . . 72.04 109.758 -170.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.76 ' HZ3' HG22 ' B' ' 68' ' ' ILE . 57.0 tttm 84.16 -64.42 0.08 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 126.063 1.745 . . . . 73.42 110.904 175.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 66' ' ' ASN . . . . . 0.436 HD22 ' HA ' ' B' ' 63' ' ' PRO . 20.5 m120 57.69 -88.7 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 124.449 1.099 . . . . 72.41 113.055 175.119 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 60.9 mt -76.76 98.07 1.79 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.69 0 C-N-CA 123.313 0.645 . . . . 74.04 109.31 -175.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . 0.76 HG22 ' HZ3' ' B' ' 65' ' ' LYS . 2.9 pp -66.08 142.78 16.34 Favored 'Isoleucine or valine' 0 C--O 1.246 0.906 0 CA-C-N 114.995 -1.002 . . . . 73.4 108.462 168.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.61 132.05 44.86 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 107.013 -1.477 . . . . 74.34 107.013 176.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 7.6 mp -55.54 -34.11 64.41 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.151 0.98 . . . . 65.22 111.73 -173.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 31.6 pt -136.56 157.25 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 124.906 1.283 . . . . 75.5 108.973 173.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.75 -29.32 3.75 Favored Glycine 0 N--CA 1.478 1.481 0 CA-C-O 119.56 -0.578 . . . . 71.15 114.104 174.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . 0.471 ' HB3' ' HG3' ' B' ' 221' ' ' ARG . 15.7 t70 -53.35 -43.61 67.85 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 124.966 1.306 . . . . 74.12 110.499 178.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -132.71 124.77 3.92 Favored Glycine 0 C--N 1.334 0.47 0 N-CA-C 108.396 -1.882 . . . . 72.45 108.396 163.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 14.2 tpt -79.69 86.36 5.3 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 117.583 0.691 . . . . 74.01 109.778 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 70.7 -176.24 36.25 Favored Glycine 0 CA--C 1.534 1.252 0 CA-C-N 115.292 -0.867 . . . . 71.52 113.379 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . 0.687 ' HA ' HG13 ' B' ' 224' ' ' VAL . 5.8 p-10 -95.91 148.38 22.69 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.826 0.85 . . . . 74.35 109.768 173.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 17.9 m -73.18 85.71 1.38 Allowed 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 121.638 0.732 . . . . 55.34 111.239 -174.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -75.55 -16.4 60.27 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 114.629 -1.169 . . . . 74.44 111.391 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 6.6 tp -50.08 -39.99 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 124.611 1.165 . . . . 72.52 111.131 175.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 26.7 m -116.4 -81.24 0.61 Allowed 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 108.448 -0.945 . . . . 74.52 108.448 170.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 58.9 169.47 0.06 Allowed 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 124.585 1.154 . . . . 75.12 112.976 -173.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . 70.08 -67.3 0.24 Allowed 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 125.058 1.343 . . . . 74.13 113.101 176.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 30.5 tpt180 65.58 103.74 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.682 1.193 . . . . 73.0 109.124 -175.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . 0.441 ' HB2' ' HA2' ' B' ' 89' ' ' GLY . 6.2 m-20 69.18 87.32 0.12 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.045 0.938 . . . . 72.23 108.797 -164.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -76.71 -18.32 58.58 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.553 0.741 . . . . 74.21 111.453 -174.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -81.19 -80.74 0.14 Allowed 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 109.201 -0.666 . . . . 52.24 109.201 172.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -112.79 98.24 7.07 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.683 0.793 . . . . 74.14 109.481 177.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . 0.441 ' HA2' ' HB2' ' B' ' 85' ' ' ASN . . . -81.78 14.57 30.49 Favored Glycine 0 C--N 1.351 1.397 0 CA-C-N 115.726 -0.67 . . . . 54.33 113.544 178.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -87.89 158.98 18.55 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.644 0.778 . . . . 75.53 110.284 176.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -93.83 -32.51 7.54 Favored Glycine 0 C--N 1.341 0.824 0 CA-C-N 115.894 -0.594 . . . . 70.11 111.822 171.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -90.36 126.51 8.37 Favored Glycine 0 C--N 1.343 0.957 0 N-CA-C 111.881 -0.488 . . . . 73.42 111.881 177.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . 0.445 ' CE2' ' HA ' ' B' ' 304' ' ' PRO . 93.7 m-85 -122.86 138.68 54.58 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.834 0.853 . . . . 74.22 109.646 -178.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 63.66 118.08 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 125.244 1.418 . . . . 72.14 110.891 -175.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -83.63 56.94 3.82 Favored 'General case' 0 CA--C 1.561 1.402 0 CA-C-O 123.122 1.439 . . . . 74.44 109.834 -178.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . -166.21 141.6 7.08 Favored Glycine 0 C--N 1.332 0.309 0 CA-C-N 114.431 -1.259 . . . . 75.21 110.37 -176.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 2.1 pp -120.12 164.44 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-O 121.432 0.634 . . . . 73.0 111.551 -174.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -111.66 24.96 12.14 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.694 1.198 . . . . 75.21 109.549 173.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.76 105.48 0.66 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.768 0.827 . . . . 61.12 111.269 -174.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 3.5 pp -58.54 149.98 58.61 Favored Pre-proline 0 CA--C 1.558 1.258 0 C-N-CA 124.956 1.303 . . . . 74.2 112.503 -178.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -61.77 93.09 0.12 Allowed 'Trans proline' 0 C--N 1.384 2.414 0 C-N-CA 123.27 2.647 . . . . 74.43 112.739 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -113.1 -173.73 2.31 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.02 0.928 . . . . 73.12 110.249 179.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 6.2 t 57.62 14.87 2.55 Favored 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 126.718 2.007 . . . . 75.52 114.824 172.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.53 -82.18 1.09 Allowed Glycine 0 C--N 1.347 1.185 0 N-CA-C 111.179 -0.769 . . . . 51.35 111.179 172.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -141.16 153.41 45.34 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 124.478 1.111 . . . . 75.22 108.748 173.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 106' ' ' TYR . . . . . 0.464 ' HA ' ' HA2' ' B' ' 382' ' ' GLY . 60.1 t80 73.21 -13.35 0.71 Allowed 'General case' 0 N--CA 1.501 2.097 0 C-N-CA 124.639 1.176 . . . . 74.44 112.899 174.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 49.8 p -107.39 2.13 24.15 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.642 1.177 . . . . 75.34 111.291 -177.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -163.96 151.33 12.23 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.559 0.743 . . . . 73.44 109.69 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -92.82 147.34 22.94 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.903 -0.777 . . . . 74.1 108.903 171.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . 68.08 118.26 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.991 1.316 . . . . 75.22 113.027 173.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 48.3 tp -129.19 85.26 2.3 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.951 0.9 . . . . 70.25 108.742 177.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 57.41 -162.62 0.2 Allowed 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 125.017 1.327 . . . . 73.2 111.69 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 113' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? 69.36 -78.25 0.05 OUTLIER 'General case' 0 C--N 1.357 0.932 0 C-N-CA 125.988 1.715 . . . . 75.13 111.014 173.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -66.82 86.46 0.13 Allowed 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 121.645 0.736 . . . . 74.21 111.442 -173.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 29.5 p -100.02 -91.51 0.3 Allowed 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 108.067 -1.086 . . . . 73.23 108.067 171.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 52.85 -101.23 0.07 OUTLIER Glycine 0 C--N 1.359 1.86 0 N-CA-C 114.681 0.633 . . . . 55.33 114.681 175.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . 0.404 ' HE3' ' HD2' ' B' ' 118' ' ' PRO . 32.5 mmmt 70.21 164.79 0.14 Allowed Pre-proline 0 N--CA 1.49 1.555 0 C-N-CA 125.578 1.551 . . . . 75.35 112.079 -177.195 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 118' ' ' PRO . . . . . 0.404 ' HD2' ' HE3' ' B' ' 117' ' ' LYS . 80.2 Cg_endo -73.77 -150.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.389 2.684 0 C-N-CA 122.287 1.992 . . . . 63.21 111.458 171.04 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 119' ' ' ASP . . . . . 0.438 ' HB3' ' HB2' ' B' ' 126' ' ' ALA . 1.8 m-20 80.92 -59.81 0.26 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.245 1.418 . . . . 75.33 111.159 175.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 120' ' ' TYR . . . . . 0.441 ' HA ' ' OG1' ' A' ' 196' ' ' THR . 52.9 m-85 64.78 -74.69 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.802 1.241 . . . . 70.1 113.311 168.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 7.3 p -155.98 -30.83 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.559 1.313 0 C-N-CA 123.167 0.587 . . . . 74.32 111.536 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 20.8 m -144.79 7.07 1.23 Allowed 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 123.722 0.809 . . . . 75.25 111.313 -173.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -103.88 157.11 17.31 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 124.0 0.92 . . . . 70.53 110.582 -176.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 16.2 m 57.6 -82.93 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 125.397 1.479 . . . . 61.03 112.872 176.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -155.01 29.92 0.41 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.822 0.849 . . . . 74.53 110.492 -178.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . 0.438 ' HB2' ' HB3' ' B' ' 119' ' ' ASP . . . -69.13 138.49 54.27 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 122.962 0.505 . . . . 74.13 110.436 177.141 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 10.9 m 73.1 1.43 4.01 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.729 1.212 . . . . 70.01 112.296 -177.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -95.05 114.66 26.5 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.434 0.694 . . . . 74.33 110.533 -177.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 129' ' ' THR . . . . . 0.595 ' HB ' ' HA ' ' B' ' 133' ' ' THR . 6.7 m -147.02 172.44 13.73 Favored 'General case' 0 CA--C 1.557 1.235 0 N-CA-C 107.94 -1.133 . . . . 74.41 107.94 179.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . -61.74 130.76 47.34 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.187 0.595 . . . . 61.42 110.842 175.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 131' ' ' TRP . . . . . 0.478 ' HA ' ' OD1' ' B' ' 167' ' ' ASN . 5.7 m-90 57.9 44.68 19.5 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.566 1.146 . . . . 73.51 110.698 -177.099 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 38.0 t 71.62 -59.94 0.53 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 126.291 1.836 . . . . 74.11 110.696 -173.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 133' ' ' THR . . . . . 0.595 ' HA ' ' HB ' ' B' ' 129' ' ' THR . 10.7 t -159.66 22.16 0.18 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.566 0.746 . . . . 74.52 110.048 178.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.08 23.47 61.34 Favored Glycine 0 C--N 1.348 1.242 0 CA-C-N 115.708 -0.678 . . . . 55.15 111.821 -170.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 135' ' ' VAL . . . . . . . . . . . . . 60.2 t 61.11 -80.39 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.559 1.309 0 C-N-CA 125.912 1.685 . . . . 73.24 112.331 -177.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 8.2 mtpm? -69.47 84.29 0.41 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.02 0.528 . . . . 74.24 112.042 -172.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 55.1 m -162.16 -33.96 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.489 1.516 . . . . 75.31 108.97 179.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -52.96 91.94 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.423 0 C-N-CA 124.629 1.171 . . . . 75.52 111.719 -177.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 56.9 t30 67.47 -67.13 0.18 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 125.464 1.506 . . . . 73.24 110.846 -170.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . 159.65 131.43 1.24 Allowed Glycine 0 C--N 1.341 0.83 0 N-CA-C 111.192 -0.763 . . . . 75.54 111.192 174.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -90.44 -4.9 56.68 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.461 0.705 . . . . 75.34 111.704 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 6.3 tt 79.05 -60.17 0.38 Allowed 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 126.352 1.861 . . . . 74.24 110.088 179.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -72.7 86.4 0.54 Allowed Glycine 0 CA--C 1.533 1.202 0 CA-C-O 119.981 -0.344 . . . . 61.25 113.526 -177.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 144' ' ' VAL . . . . . 0.46 HG22 ' HB2' ' B' ' 148' ' ' GLU . 54.9 t 64.47 80.25 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 125.228 1.411 . . . . 75.31 112.215 171.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -106.79 -47.27 3.77 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.496 0.718 . . . . 75.32 110.403 174.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 26.2 pt -101.25 -42.42 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 122.746 0.418 . . . . 72.52 110.809 177.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -163.65 -75.32 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 122.753 0.421 . . . . 72.43 110.276 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . 0.46 ' HB2' HG22 ' B' ' 144' ' ' VAL . 10.0 mm-40 54.41 -170.91 0.06 Allowed 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.842 1.257 . . . . 75.05 111.864 -170.521 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 149' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -160.4 96.85 1.2 Allowed 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.046 0.45 . . . . 74.13 110.734 173.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -96.04 -83.92 0.36 Allowed 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 107.172 -1.418 . . . . 74.11 107.172 167.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 151' ' ' HIS . . . . . 0.709 ' HB2' ' HG3' ' B' ' 206' ' ' GLU . 43.2 t60 -176.18 -57.68 0.0 OUTLIER Pre-proline 0 N--CA 1.486 1.336 0 CA-C-O 118.539 -0.743 . . . . 74.43 111.922 175.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -83.0 161.82 15.75 Favored 'Trans proline' 0 C--N 1.388 2.65 0 C-N-CA 121.533 1.488 . . . . 64.13 112.406 -171.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 67.4 p -72.29 -28.09 62.88 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.191 -0.913 . . . . 74.2 111.055 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 154' ' ' ILE . . . . . 0.529 HG23 ' HG ' ' B' ' 155' ' ' LEU . 41.1 mm 67.25 -71.18 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 125.358 1.463 . . . . 74.25 110.004 -176.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 155' ' ' LEU . . . . . 0.529 ' HG ' HG23 ' B' ' 154' ' ' ILE . 74.8 mt -122.04 -43.57 2.33 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.813 0.845 . . . . 73.12 110.011 176.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 156' ' ' GLU . . . . . 0.435 ' HG3' ' H ' ' B' ' 158' ' ' ALA . 8.4 tp10 -148.5 147.55 29.22 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.041 0.937 . . . . 72.23 109.657 178.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 157' ' ' MET . . . . . . . . . . . . . 53.6 ttm -57.25 -30.73 64.88 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 124.849 1.26 . . . . 61.13 112.274 -177.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 158' ' ' ALA . . . . . 0.435 ' H ' ' HG3' ' B' ' 156' ' ' GLU . . . -109.65 107.65 17.78 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.426 0.69 . . . . 65.11 110.751 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 82.8 tttt 67.66 11.38 8.35 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 124.666 1.186 . . . . 73.24 112.993 168.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . 71.63 -54.16 0.68 Allowed 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 125.446 1.498 . . . . 74.34 111.833 -175.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . 75.01 -40.86 0.45 Allowed 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 115.629 1.714 . . . . 71.1 115.629 164.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . -76.58 13.64 8.02 Favored Glycine 0 CA--C 1.538 1.487 0 N-CA-C 114.35 0.5 . . . . 73.4 114.35 -171.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -76.12 -11.73 59.99 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.2 1.0 . . . . 75.25 109.968 175.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 164' ' ' ALA . . . . . . . . . . . . . . . -50.58 -32.05 17.59 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 125.051 1.34 . . . . 75.34 112.162 173.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 26.4 m -54.86 107.3 0.28 Allowed 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.591 1.156 . . . . 73.14 111.199 175.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . 152.91 -47.81 0.55 Allowed Glycine 0 C--N 1.346 1.132 0 N-CA-C 111.259 -0.736 . . . . 74.53 111.259 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 167' ' ' ASN . . . . . 0.478 ' OD1' ' HA ' ' B' ' 131' ' ' TRP . 9.3 p30 -110.1 22.3 15.74 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.473 0.709 . . . . 74.33 110.624 -179.112 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 30.3 m -78.24 -173.4 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.179 0 C-N-CA 123.556 0.742 . . . . 75.53 111.726 -178.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 18.9 m -57.53 103.82 0.15 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.419 1.088 . . . . 65.53 111.058 179.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 25.6 m 64.77 -77.99 0.03 OUTLIER 'General case' 0 C--N 1.36 1.026 0 C-N-CA 124.884 1.274 . . . . 73.13 110.591 -172.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . 177.64 175.04 0.48 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.907 1.283 . . . . 73.41 108.992 178.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 172' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.76 147.61 28.31 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 106.429 -1.693 . . . . 75.25 106.429 163.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 173' ' ' LEU . . . . . 0.648 ' HB2' ' HB3' ' B' ' 335' ' ' ASN . 6.7 mp -71.21 -0.05 8.97 Favored 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 123.191 0.596 . . . . 74.44 112.168 -173.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 174' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -61.96 78.97 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.946 0.898 . . . . 74.45 110.64 172.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 175' ' ' ASP . . . . . . . . . . . . . 39.2 t70 63.04 148.04 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 125.655 1.582 . . . . 74.1 112.268 -168.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -138.98 34.01 2.15 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.579 0.752 . . . . 74.11 110.139 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 10.7 m -116.98 93.38 41.82 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 123.609 0.763 . . . . 74.15 109.598 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 178' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -81.28 -23.17 5.34 Favored 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 122.524 2.149 . . . . 74.53 112.602 175.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -175.3 -71.78 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.919 1.287 . . . . 74.35 108.46 175.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 180' ' ' ALA . . . . . 0.542 ' HB1' HG21 ' C' ' 137' ' ' VAL . . . -170.03 -76.97 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.197 1.399 . . . . 75.32 107.553 177.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 181' ' ' LEU . . . . . 0.653 HD22 ' HB2' ' C' ' 136' ' ' ARG . 33.9 tp -132.46 -58.01 0.94 Allowed 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 107.518 -1.289 . . . . 74.44 107.518 163.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 182' ' ' VAL . . . . . 0.43 HG11 HG11 ' C' ' 138' ' ' VAL . 11.5 p -74.04 160.51 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-N 114.883 -1.053 . . . . 72.43 110.812 178.163 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -90.33 22.75 3.21 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.888 0.875 . . . . 65.24 111.305 173.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 77.1 t60 64.98 -83.65 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.138 1.375 . . . . 75.32 107.885 -166.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 185' ' ' VAL . . . . . 0.446 HG22 ' HA ' ' C' ' 121' ' ' ALA . 1.7 p -165.56 122.33 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 123.921 0.888 . . . . 74.01 109.002 168.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 66.7 p 51.95 -74.74 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.283 0 O-C-N 125.52 1.762 . . . . 60.24 113.005 174.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 187' ' ' SER . . . . . . . . . . . . . 21.7 m -59.48 119.13 6.93 Favored 'General case' 0 C--N 1.352 0.717 0 C-N-CA 123.877 0.871 . . . . 62.14 110.396 171.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 188' ' ' ARG . . . . . 0.686 ' HD3' ' SG ' ' B' ' 190' ' ' CYS . 34.6 ttt180 -134.18 149.6 51.04 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.774 -0.824 . . . . 72.32 108.774 178.332 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -83.91 7.74 17.23 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 123.176 0.59 . . . . 72.52 112.312 -176.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 190' ' ' CYS . . . . . 0.686 ' SG ' ' HD3' ' B' ' 188' ' ' ARG . 28.1 p -80.82 75.32 7.76 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 123.077 0.551 . . . . 70.33 110.51 179.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -157.98 -178.9 7.65 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.433 0.693 . . . . 74.04 109.917 177.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 114.96 85.4 1.28 Allowed Glycine 0 C--N 1.348 1.217 0 N-CA-C 110.988 -0.845 . . . . 64.22 110.988 -176.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 193' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -56.67 -23.5 49.54 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 123.524 2.816 . . . . 73.22 113.643 175.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 194' ' ' SER . . . . . . . . . . . . . 95.5 p 55.5 26.98 9.61 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 125.611 1.565 . . . . 63.44 112.684 176.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 195' ' ' ALA . . . . . . . . . . . . . . . -147.97 109.99 4.53 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.73 0.812 . . . . 74.32 109.567 -177.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 30.5 p -73.02 -61.0 1.97 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.955 0.902 . . . . 73.32 109.872 177.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 71.8 m -149.79 -177.74 6.06 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.136 1.374 . . . . 75.11 108.003 168.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 198' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -65.01 85.47 0.05 OUTLIER 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 123.446 0.698 . . . . 65.14 110.482 177.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 12.6 mptt 67.11 -73.85 0.07 Allowed 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 126.072 1.749 . . . . 75.14 111.44 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 200' ' ' CYS . . . . . 0.546 ' H ' ' HD2' ' B' ' 201' ' ' PRO . 86.3 m -147.55 -54.57 0.02 OUTLIER Pre-proline 0 CA--C 1.561 1.384 0 C-N-CA 124.385 1.074 . . . . 73.31 111.713 175.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 201' ' ' PRO . . . . . 0.546 ' HD2' ' H ' ' B' ' 200' ' ' CYS . 61.7 Cg_endo -67.94 -29.01 35.05 Favored 'Trans proline' 0 C--N 1.395 3.021 0 C-N-CA 122.04 1.827 . . . . 74.02 113.218 -173.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 81.57 -59.3 4.84 Favored Glycine 0 C--N 1.35 1.359 0 N-CA-C 111.985 -0.446 . . . . 73.41 111.985 -177.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -70.38 161.93 29.56 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.452 1.101 . . . . 71.33 110.29 173.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -57.14 112.76 1.46 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.928 0.891 . . . . 74.01 112.094 -178.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 205' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -98.47 -33.07 11.16 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.322 1.049 . . . . 72.44 110.513 -178.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 206' ' ' GLU . . . . . 0.709 ' HG3' ' HB2' ' B' ' 151' ' ' HIS . 34.9 tt0 77.52 96.33 0.06 Allowed 'General case' 0 N--CA 1.479 0.989 0 O-C-N 125.1 1.5 . . . . 70.3 110.093 -172.19 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 21.6 pttm -125.1 163.96 21.25 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.848 1.259 . . . . 74.32 109.693 -179.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 82.53 21.0 60.86 Favored Glycine 0 N--CA 1.471 0.995 0 N-CA-C 111.908 -0.477 . . . . 71.52 111.908 -175.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . -74.87 -177.32 39.08 Favored Glycine 0 C--N 1.345 1.047 0 CA-C-N 115.194 -0.503 . . . . 63.34 113.193 175.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 210' ' ' LYS . . . . . 0.484 ' HE3' ' HA ' ' B' ' 210' ' ' LYS . 0.3 OUTLIER 73.03 -62.49 0.47 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.403 1.481 . . . . 74.51 110.171 -173.164 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . -64.78 87.23 0.08 OUTLIER Glycine 0 C--N 1.352 1.453 0 O-C-N 123.164 0.29 . . . . 74.43 112.662 177.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 35.3 t -72.41 92.99 1.49 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.795 0.838 . . . . 74.04 111.113 -173.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . 0.475 HG13 ' H ' ' B' ' 214' ' ' THR 0.259 18.7 pt 40.42 -74.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 C-N-CA 127.407 2.283 . . . . 70.12 115.026 -176.406 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 214' ' ' THR . . . . . 0.475 ' H ' HG13 ' B' ' 213' ' ' ILE . 8.6 t -171.22 -26.25 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.143 0.977 . . . . 75.43 110.093 178.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 215' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 71.24 170.21 0.32 Allowed 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 125.275 1.43 . . . . 73.31 112.121 -176.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 66.24 28.53 9.97 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.054 1.342 . . . . 61.42 112.157 -177.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -82.79 73.93 9.79 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 107.989 -1.115 . . . . 75.4 107.989 168.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 22.1 tp -127.24 30.17 5.45 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 108.253 -1.017 . . . . 71.43 108.253 -178.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 56.95 -153.38 0.37 Allowed 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 114.027 -1.442 . . . . 71.24 111.479 -174.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . 73.68 10.47 4.79 Favored 'General case' 0 C--N 1.36 1.043 0 C-N-CA 124.165 0.986 . . . . 74.3 112.25 174.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 221' ' ' ARG . . . . . 0.54 ' HG2' HD12 ' B' ' 68' ' ' ILE . 0.0 OUTLIER -105.59 -71.36 0.75 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.48 0.712 . . . . 73.55 111.328 -177.415 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -141.54 27.2 1.89 Allowed 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.874 0.87 . . . . 75.21 110.883 -170.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -98.0 -52.3 3.75 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 125.617 1.567 . . . . 72.13 109.465 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . 0.687 HG13 ' HA ' ' B' ' 77' ' ' ASP . 14.5 p -85.96 -31.79 6.68 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 CA-C-N 114.611 -1.177 . . . . 75.32 110.21 175.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 3.8 m -83.8 -43.18 15.68 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.707 0.803 . . . . 73.55 110.602 -172.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 7.4 mp -118.33 166.37 12.72 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.816 0.846 . . . . 74.43 109.69 176.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . -177.24 -44.7 0.06 OUTLIER Glycine 0 C--N 1.342 0.9 0 N-CA-C 110.729 -0.949 . . . . 71.24 110.729 178.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . -94.05 -126.6 4.54 Favored Glycine 0 C--N 1.346 1.116 0 CA-C-N 114.863 -0.669 . . . . 72.41 112.052 172.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . 72.6 20.37 79.52 Favored Glycine 0 C--N 1.345 1.07 0 N-CA-C 111.732 -0.547 . . . . 71.04 111.732 -171.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -80.68 136.22 36.15 Favored 'General case' 0 C--N 1.351 0.656 0 C-N-CA 124.385 1.074 . . . . 70.23 110.101 -174.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 231' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -75.45 120.36 20.78 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.259 1.024 . . . . 73.24 109.709 -175.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 3.1 t -170.47 100.1 0.26 Allowed 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 124.166 0.986 . . . . 74.24 110.297 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -163.27 73.75 0.33 Allowed 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.865 0.866 . . . . 71.44 109.921 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . 0.458 ' H ' ' HA ' ' B' ' 363' ' ' GLU . . . -161.82 134.55 6.0 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 116.513 -0.312 . . . . 72.31 111.091 175.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.38 94.72 5.84 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 106.589 -1.634 . . . . 64.41 106.589 171.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 236' ' ' THR . . . . . 0.564 ' H ' HD23 ' B' ' 247' ' ' LEU . 33.4 m 76.86 -30.52 0.18 Allowed 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 125.06 1.344 . . . . 73.34 111.961 178.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . 72.19 -72.53 0.11 Allowed 'General case' 0 C--N 1.361 1.085 0 C-N-CA 126.305 1.842 . . . . 73.03 112.066 170.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 238' ' ' THR . . . . . 0.467 ' HB ' ' HA ' ' C' ' 219' ' ' VAL . 6.3 m -140.83 -8.46 1.06 Allowed 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 123.357 0.663 . . . . 71.31 110.826 -175.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 239' ' ' ALA . . . . . 0.447 ' HB2' ' HA ' ' C' ' 221' ' ' VAL . . . -77.14 172.95 12.42 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.867 1.062 . . . . 74.42 113.867 -167.125 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 240' ' ' GLY . . . . . 0.405 ' H ' HD21 ' C' ' 235' ' ' LEU . . . -113.05 -101.3 2.5 Favored Glycine 0 C--N 1.339 0.723 0 CA-C-N 114.015 -1.448 . . . . 71.23 109.634 177.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -157.51 162.16 38.84 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.588 0.709 . . . . 71.23 111.562 -175.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 242' ' ' TRP . . . . . 0.548 ' HH2' HG21 ' C' ' 199' ' ' VAL . 5.4 m95 -107.04 -47.36 3.71 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 114.106 -1.406 . . . . 70.32 107.478 172.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 177.69 -35.78 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 111.532 -2.576 . . . . 74.22 105.504 -166.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -156.5 -176.0 28.1 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 113.487 -1.688 . . . . 71.54 109.459 166.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -170.16 153.59 4.63 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.661 0.784 . . . . 75.34 110.303 175.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 246' ' ' THR . . . . . 0.532 HG23 ' HD3' ' C' ' 225' ' ' PRO . 11.2 t -167.31 174.43 8.08 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.426 0.691 . . . . 71.14 109.898 168.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 247' ' ' LEU . . . . . 0.636 HD11 ' HB3' ' B' ' 363' ' ' GLU . 2.2 pp -159.87 160.17 33.33 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 124.472 1.109 . . . . 72.51 108.868 178.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 248' ' ' ARG . . . . . 0.403 ' HD3' ' O ' ' B' ' 249' ' ' GLU . 0.0 OUTLIER -157.63 174.88 14.68 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.353 0.596 . . . . 75.15 111.221 -179.594 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 249' ' ' GLU . . . . . 0.675 ' HG2' ' HA3' ' B' ' 362' ' ' GLY . 2.5 tm-20 -86.9 163.11 17.34 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 114.751 -1.113 . . . . 71.33 109.943 -171.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 250' ' ' GLN . . . . . 0.484 ' HA ' ' HB3' ' A' ' 274' ' ' GLU . 1.9 mp0 -76.91 11.26 1.82 Allowed 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 124.494 1.118 . . . . 70.14 112.641 -176.298 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 251' ' ' ALA . . . . . . . . . . . . . . . 61.33 28.02 17.58 Favored 'General case' 0 C--N 1.361 1.072 0 C-N-CA 124.953 1.301 . . . . 64.21 110.688 -171.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 69.41 -87.17 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.681 1.992 . . . . 73.12 112.474 173.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . 57.69 -84.91 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 124.096 0.958 . . . . 51.41 111.072 -170.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 12.0 ttp180 174.76 -60.28 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.998 1.719 . . . . 72.51 106.652 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . 177.69 -170.86 43.39 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-N 114.371 -1.286 . . . . 63.32 110.934 -178.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 256' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -94.78 39.55 1.1 Allowed 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 117.492 0.646 . . . . 71.2 110.757 -175.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 69.22 -152.08 0.14 Allowed 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.306 1.043 . . . . 74.31 110.828 -177.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 258' ' ' LEU . . . . . 0.525 HD23 ' HA ' ' B' ' 266' ' ' ASN . 41.9 tp -49.83 134.13 21.17 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.263 1.025 . . . . 75.13 112.684 -178.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 2.4 p -124.8 85.83 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 N-CA-C 107.902 -1.147 . . . . 63.31 107.902 172.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 260' ' ' SER . . . . . 0.574 ' HB3' ' HB2' ' B' ' 265' ' ' LEU . 44.6 t -87.8 93.6 9.5 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.192 -0.913 . . . . 73.11 109.971 178.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 22.4 t70 65.74 -79.41 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.985 1.314 . . . . 65.51 112.392 174.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 262' ' ' ALA . . . . . . . . . . . . . . . -76.79 -76.13 0.18 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.909 0.884 . . . . 75.22 111.341 -176.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -165.82 130.82 2.38 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 123.526 0.73 . . . . 70.44 109.408 -177.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 264' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' B' ' 258' ' ' LEU . 88.0 p 52.33 -93.71 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 125.504 1.522 . . . . 51.14 112.81 -178.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 265' ' ' LEU . . . . . 0.574 ' HB2' ' HB3' ' B' ' 260' ' ' SER . 84.3 mt 52.81 43.6 31.29 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.665 1.186 . . . . 73.31 111.623 -173.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 266' ' ' ASN . . . . . 0.525 ' HA ' HD23 ' B' ' 258' ' ' LEU . 13.5 m120 -65.35 150.45 48.26 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 115.243 -0.89 . . . . 71.52 110.535 178.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 33.0 t -72.82 86.56 1.26 Allowed 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 123.107 0.563 . . . . 73.13 110.699 -175.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 60.2 t 64.36 -79.84 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 C-N-CA 125.904 1.682 . . . . 74.44 110.211 -175.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 269' ' ' THR . . . . . . . . . . . . . 40.8 p -91.42 -54.87 3.73 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.238 -1.023 . . . . 74.31 108.238 169.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 270' ' ' GLU . . . . . 0.558 ' HB2' HD22 ' B' ' 277' ' ' LEU . 9.0 tp10 -178.02 -35.08 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.325 1.45 . . . . 72.41 109.277 178.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 271' ' ' ALA . . . . . . . . . . . . . . . 79.56 -51.37 0.4 Allowed 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 126.066 1.747 . . . . 75.3 110.248 -169.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 272' ' ' ASN . . . . . 0.435 ' HB2' ' HG3' ' B' ' 270' ' ' GLU . 3.6 m-20 -62.07 144.26 55.49 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 109.415 -0.587 . . . . 73.11 109.415 169.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 65.36 27.26 11.96 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.075 0.95 . . . . 73.43 110.734 -172.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 60.96 -91.37 0.03 OUTLIER 'General case' 0 C--N 1.355 0.827 0 C-N-CA 125.83 1.652 . . . . 71.44 111.735 179.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 275' ' ' LYS . . . . . 0.58 ' HZ2' ' HB3' ' B' ' 275' ' ' LYS . 7.8 mtpm? -128.88 -57.87 0.03 OUTLIER Pre-proline 0 CA--C 1.557 1.25 0 CA-C-O 118.243 -0.884 . . . . 72.14 112.013 -169.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 276' ' ' PRO . . . . . 0.433 ' HD3' ' HB2' ' B' ' 275' ' ' LYS . 91.1 Cg_endo -78.73 81.5 2.76 Favored 'Trans proline' 0 C--N 1.395 2.991 0 C-N-CA 121.488 1.459 . . . . 73.04 112.898 -172.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 277' ' ' LEU . . . . . 0.558 HD22 ' HB2' ' B' ' 270' ' ' GLU . 47.2 tp -74.95 94.08 2.78 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.439 -0.8 . . . . 74.52 109.082 175.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 1.6 tm? 77.23 -57.68 0.51 Allowed 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 125.667 1.587 . . . . 72.2 110.845 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . -158.71 -164.06 13.79 Favored Glycine 0 C--N 1.344 1.022 0 O-C-N 122.396 -0.19 . . . . 75.43 112.892 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 280' ' ' LEU . . . . . 0.552 HD13 ' HB2' ' B' ' 456' ' ' ASP . 3.0 tm? -98.17 148.08 23.94 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.286 1.035 . . . . 74.31 109.522 -176.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -150.66 -52.72 0.14 Allowed 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 108.645 -0.872 . . . . 75.31 108.645 171.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 282' ' ' ALA . . . . . 0.559 ' HB3' HD23 ' B' ' 454' ' ' LEU . . . -155.22 30.03 0.4 Allowed 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 115.18 -0.918 . . . . 65.41 110.02 -176.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -99.36 -18.6 17.44 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.703 0.801 . . . . 72.33 111.49 -172.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 284' ' ' GLY . . . . . 0.521 ' HA3' ' HA ' ' B' ' 456' ' ' ASP . . . -65.83 -48.77 63.68 Favored Glycine 0 CA--C 1.534 1.228 0 CA-C-O 119.707 -0.496 . . . . 72.13 114.077 -176.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 60.25 61.41 1.81 Allowed 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 122.002 0.906 . . . . 73.03 111.74 173.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 286' ' ' MET . . . . . . . . . . . . . 44.5 mtt -152.57 173.55 4.44 Favored Pre-proline 0 N--CA 1.489 1.487 0 C-N-CA 124.396 1.078 . . . . 74.22 109.43 -177.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 287' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -45.1 115.18 0.82 Allowed 'Trans proline' 0 C--N 1.388 2.65 0 C-N-CA 122.858 2.372 . . . . 74.24 112.045 166.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 288' ' ' VAL . . . . . 0.446 HG12 ' HB ' ' B' ' 455' ' ' THR . 43.0 t -63.28 86.24 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.17 0 C-N-CA 124.432 1.093 . . . . 74.32 113.315 -160.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 289' ' ' ARG . . . . . . . . . . . . . 19.9 ptt180 36.56 -154.43 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 127.979 2.511 . . . . 74.32 116.481 163.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 290' ' ' TRP . . . . . 0.426 ' HA ' ' HG ' ' B' ' 460' ' ' LEU . 6.0 m0 66.06 22.85 11.13 Favored 'General case' 0 C--N 1.363 1.179 0 C-N-CA 124.684 1.194 . . . . 75.34 111.332 176.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 291' ' ' LEU . . . . . . . . . . . . . 2.3 pp -146.09 -16.67 0.45 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.392 1.077 . . . . 73.52 110.598 176.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . -79.2 155.53 40.36 Favored Glycine 0 C--N 1.355 1.599 0 CA-C-O 119.448 -0.64 . . . . 71.42 113.284 -174.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -82.7 174.18 9.82 Favored 'Trans proline' 0 C--N 1.373 1.837 0 C-N-CA 123.32 2.68 . . . . 75.13 112.796 -177.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -78.4 -15.46 58.65 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.924 -0.58 . . . . 74.44 111.822 -179.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . 53.64 41.51 32.06 Favored 'General case' 0 C--N 1.36 1.053 0 C-N-CA 124.387 1.075 . . . . 71.35 111.416 172.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 31.4 p -79.64 72.41 6.32 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 114.936 -1.029 . . . . 71.52 110.837 -175.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -101.0 6.84 43.66 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.154 -0.93 . . . . 75.44 110.625 178.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 69.79 -60.86 0.46 Allowed 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 126.423 1.889 . . . . 73.43 111.852 -176.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . 84.47 -158.5 34.12 Favored Glycine 0 C--N 1.347 1.167 0 N-CA-C 110.865 -0.894 . . . . 72.35 110.865 -177.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -87.31 -33.39 19.23 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.913 -0.773 . . . . 72.23 108.913 172.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 301' ' ' ILE . . . . . . . . . . . . . 76.1 mt 66.19 -64.88 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.059 0 C-N-CA 125.989 1.716 . . . . 75.13 109.271 -165.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 37.3 t70 66.2 76.85 0.3 Allowed 'General case' 0 C--N 1.352 0.702 0 C-N-CA 124.327 1.051 . . . . 74.32 110.39 168.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 303' ' ' LYS . . . . . 0.662 ' HB3' ' HA ' ' B' ' 306' ' ' VAL . 0.1 OUTLIER 57.48 95.73 0.05 OUTLIER Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 125.543 1.537 . . . . 74.11 110.641 -175.698 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 304' ' ' PRO . . . . . 0.445 ' HA ' ' CE2' ' B' ' 93' ' ' PHE . 41.4 Cg_exo -55.65 94.52 0.05 OUTLIER 'Trans proline' 0 C--N 1.383 2.391 0 C-N-CA 123.428 2.752 . . . . 75.12 113.076 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . 59.15 25.91 14.53 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 124.304 1.042 . . . . 72.13 111.21 -174.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . 0.662 ' HA ' ' HB3' ' B' ' 303' ' ' LYS . 40.2 t 65.17 -68.37 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.135 0 C-N-CA 126.443 1.897 . . . . 72.33 111.179 -171.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 85.6 m 69.36 -70.54 0.14 Allowed 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 125.428 1.491 . . . . 74.23 111.585 178.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 308' ' ' CYS . . . . . . . . . . . . . 52.3 t -65.68 94.64 0.21 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.51 0.724 . . . . 74.22 110.273 177.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 17.2 p -126.44 137.67 30.82 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 124.3 1.04 . . . . 72.2 109.746 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -78.41 -144.66 0.03 OUTLIER 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.66 2.24 . . . . 64.44 110.106 169.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 311' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -111.58 86.58 7.06 Favored Pre-proline 0 N--CA 1.478 0.953 0 N-CA-C 108.534 -0.913 . . . . 73.13 108.534 169.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 312' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -94.68 19.56 0.68 Allowed 'Trans proline' 0 C--N 1.377 2.043 0 C-N-CA 122.868 2.379 . . . . 70.14 113.408 -176.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 313' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -54.01 -67.44 0.26 Allowed 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.95 0.9 . . . . 75.13 111.11 -177.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 314' ' ' ARG . . . . . . . . . . . . . 46.9 mtp180 63.21 -84.81 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.86 1.264 . . . . 74.53 110.385 -176.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 315' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -97.46 -28.81 13.82 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.702 0.801 . . . . 75.34 109.894 175.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 316' ' ' ASP . . . . . . . . . . . . . 26.6 t70 68.35 -77.58 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.215 1.806 . . . . 74.4 110.604 -174.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 70.4 m -145.19 -58.89 0.34 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.183 0.593 . . . . 75.41 110.506 -174.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 318' ' ' VAL . . . . . 0.523 HG12 HD21 ' B' ' 356' ' ' ASN . 30.8 m -85.71 142.09 36.71 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 123.189 0.596 . . . . 73.13 110.418 -177.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 319' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -49.84 -48.1 20.7 Favored 'Trans proline' 0 C--N 1.384 2.423 0 C-N-CA 123.541 2.827 . . . . 65.1 114.572 -176.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 320' ' ' THR . . . . . 0.471 HG21 ' HA ' ' B' ' 357' ' ' PRO . 28.6 m 59.51 81.78 0.16 Allowed 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.81 0.844 . . . . 73.24 111.131 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 321' ' ' LEU . . . . . 0.486 ' HB3' ' HA ' ' B' ' 354' ' ' ALA . 58.8 tp -83.72 -43.59 15.34 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.45 -0.796 . . . . 74.43 110.255 -179.017 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 322' ' ' ALA . . . . . . . . . . . . . . . -159.76 -162.92 1.07 Allowed 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 116.129 -0.487 . . . . 64.54 111.7 -170.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 323' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -134.47 170.89 15.08 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 124.779 1.232 . . . . 74.02 107.867 169.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 324' ' ' MET . . . . . . . . . . . . . 43.8 mtm 78.05 113.82 0.07 Allowed 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 125.687 1.595 . . . . 74.22 109.451 -174.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 325' ' ' THR . . . . . . . . . . . . . 69.4 p 50.93 60.13 4.1 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 125.245 1.418 . . . . 72.33 109.9 -170.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 326' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -135.12 -3.29 2.48 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 112.841 -1.981 . . . . 72.01 111.899 -158.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 33.1 mtmm -110.38 -2.99 16.37 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.757 0.823 . . . . 75.41 111.021 -178.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 328' ' ' ALA . . . . . . . . . . . . . . . 72.17 159.4 0.21 Allowed 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 125.69 1.596 . . . . 72.03 112.727 -175.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 329' ' ' ILE . . . . . . . . . . . . . 19.7 pt 47.63 30.3 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 C-N-CA 126.5 1.92 . . . . 73.5 114.788 178.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 330' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -83.58 56.14 3.49 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 123.683 0.793 . . . . 74.44 111.107 179.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 331' ' ' LEU . . . . . . . . . . . . . 2.4 tt -176.31 135.78 0.26 Allowed 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 105.777 -1.934 . . . . 64.42 105.777 -178.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 2.7 pp -66.72 145.35 55.64 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 118.555 0.616 . . . . 74.41 111.086 178.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 333' ' ' SER . . . . . . . . . . . . . 16.2 t -103.02 66.66 0.92 Allowed 'General case' 0 C--O 1.242 0.709 0 C-N-CA 123.498 0.719 . . . . 65.04 109.56 -176.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 334' ' ' LYS . . . . . 0.466 ' HE2' ' HB3' ' B' ' 337' ' ' LYS . 19.1 tptm 70.15 -71.49 0.13 Allowed 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 125.397 1.479 . . . . 65.35 110.185 -178.384 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 335' ' ' ASN . . . . . 0.648 ' HB3' ' HB2' ' B' ' 173' ' ' LEU . 20.7 m120 58.95 -86.23 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 125.89 1.676 . . . . 74.12 113.269 172.121 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -83.51 -9.96 58.63 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 123.188 0.595 . . . . 73.55 112.127 -175.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 337' ' ' LYS . . . . . 0.466 ' HB3' ' HE2' ' B' ' 334' ' ' LYS . 45.1 mmtm -95.5 18.52 12.55 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.255 0.622 . . . . 71.1 110.385 169.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 338' ' ' GLY . . . . . . . . . . . . . . . -165.37 -157.28 9.73 Favored Glycine 0 C--N 1.344 1.02 0 N-CA-C 111.561 -0.615 . . . . 73.12 111.561 178.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 339' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -108.49 -5.0 16.78 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.699 0.8 . . . . 74.33 110.691 178.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 340' ' ' PHE . . . . . . . . . . . . . 46.3 t80 55.87 62.36 2.43 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 124.966 1.307 . . . . 75.24 110.149 -174.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 341' ' ' LEU . . . . . . . . . . . . . 6.6 tt -72.38 -49.08 36.6 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 114.286 -1.325 . . . . 75.34 109.623 -175.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 342' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -92.9 95.75 9.69 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.871 -0.604 . . . . 74.32 111.002 -176.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 343' ' ' VAL . . . . . . . . . . . . . 42.1 t -76.35 -32.43 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.923 0.889 . . . . 65.15 109.535 175.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -61.27 -34.82 75.81 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.488 0.715 . . . . 74.33 111.075 175.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 345' ' ' GLY . . . . . . . . . . . . . . . -101.37 43.2 1.76 Allowed Glycine 0 C--N 1.349 1.279 0 CA-C-N 115.909 -0.587 . . . . 63.14 111.731 177.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 346' ' ' ALA . . . . . . . . . . . . . . . -78.78 85.07 4.81 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.107 0.563 . . . . 72.51 109.699 176.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 21.2 t 65.7 -162.04 0.26 Allowed 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 124.781 1.232 . . . . 72.21 111.084 177.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 42.9 mm -81.27 79.12 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 C-N-CA 123.633 0.773 . . . . 73.42 110.187 -178.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 349' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -88.55 141.11 28.79 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.07 -0.968 . . . . 71.13 109.679 175.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 350' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? 74.84 -42.86 0.5 Allowed 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 125.586 1.554 . . . . 74.52 113.168 175.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -59.82 -77.35 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.469 0.708 . . . . 71.32 110.187 177.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 30.2 t70 58.33 -179.26 0.07 Allowed 'General case' 0 CA--C 1.567 1.609 0 C-N-CA 124.156 0.982 . . . . 74.35 111.924 178.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 353' ' ' HIS . . . . . . . . . . . . . 49.0 m80 -108.73 -28.61 9.13 Favored 'General case' 0 N--CA 1.479 1.018 0 O-C-N 121.148 -0.97 . . . . 74.33 112.11 178.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 354' ' ' ALA . . . . . 0.486 ' HA ' ' HB3' ' B' ' 321' ' ' LEU . . . -111.95 -21.89 11.34 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 112.883 0.697 . . . . 72.23 112.883 -175.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 355' ' ' ALA . . . . . . . . . . . . . . . 62.56 52.86 2.78 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.242 1.017 . . . . 75.44 109.966 -171.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 356' ' ' ASN . . . . . 0.523 HD21 HG12 ' B' ' 318' ' ' VAL . 33.0 t30 71.07 126.93 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.631 0 C-N-CA 125.114 1.366 . . . . 74.32 111.358 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 357' ' ' PRO . . . . . 0.471 ' HA ' HG21 ' B' ' 320' ' ' THR . 45.0 Cg_endo -79.61 51.99 4.11 Favored 'Trans proline' 0 C--N 1.381 2.242 0 C-N-CA 123.369 2.713 . . . . 74.21 112.664 178.048 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 358' ' ' CYS . . . . . . . . . . . . . 90.3 m 65.08 -73.05 0.06 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 125.165 1.386 . . . . 75.21 111.687 -171.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 359' ' ' GLY . . . . . . . . . . . . . . . 86.56 -12.23 61.71 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 123.168 0.413 . . . . 72.04 112.168 -172.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 360' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -88.39 45.79 1.32 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.393 1.477 . . . . 53.34 111.764 -170.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 361' ' ' ILE . . . . . . . . . . . . . 19.3 mm -85.4 -29.38 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 108.523 -0.918 . . . . 64.41 108.523 174.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 362' ' ' GLY . . . . . 0.675 ' HA3' ' HG2' ' B' ' 249' ' ' GLU . . . 72.25 58.37 5.14 Favored Glycine 0 C--N 1.344 0.979 0 CA-C-N 115.151 -0.931 . . . . 72.35 112.82 176.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 363' ' ' GLU . . . . . 0.636 ' HB3' HD11 ' B' ' 247' ' ' LEU . 6.9 mm-40 66.81 -80.92 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.05 1.34 . . . . 73.13 110.615 178.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 364' ' ' THR . . . . . . . . . . . . . 58.0 m -155.33 -23.98 0.11 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.218 1.407 . . . . 74.04 109.287 -177.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 365' ' ' VAL . . . . . 0.556 HG23 ' HG3' ' B' ' 249' ' ' GLU . 7.2 t 66.62 168.38 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.568 1.661 0 C-N-CA 124.922 1.289 . . . . 74.51 109.523 -172.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 29.5 t70 75.47 -7.77 1.72 Allowed 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 114.045 1.128 . . . . 52.52 114.045 161.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 367' ' ' LEU . . . . . . . . . . . . . 96.5 mt -90.51 -1.87 57.9 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 113.305 0.854 . . . . 75.05 113.305 -174.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 368' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -75.38 -159.27 0.1 Allowed 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 122.784 0.434 . . . . 73.23 110.55 174.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 369' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 54.12 52.26 13.05 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.783 0.833 . . . . 74.11 109.403 -167.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 370' ' ' ALA . . . . . . . . . . . . . . . -63.19 -177.01 0.16 Allowed 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 114.407 -1.27 . . . . 74.25 112.65 -176.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 371' ' ' VAL . . . . . . . . . . . . . 8.1 t -69.41 1.09 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.573 1.848 0 C-N-CA 123.176 0.591 . . . . 74.12 110.997 178.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 372' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 83.62 -18.48 0.43 Allowed 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 126.444 1.898 . . . . 63.2 111.966 169.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 373' ' ' ARG . . . . . . . . . . . . . 13.2 tpt180 74.77 -53.61 0.67 Allowed 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 125.811 1.644 . . . . 72.2 110.456 -175.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -67.98 -21.47 65.06 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.129 0.972 . . . . 71.45 112.61 178.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 375' ' ' LEU . . . . . . . . . . . . . 91.4 mt 69.89 -70.36 0.15 Allowed 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 125.423 1.489 . . . . 72.22 110.471 -175.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -119.45 -179.59 3.91 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.399 1.08 . . . . 73.13 108.937 174.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 377' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -118.87 67.44 0.78 Allowed 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.666 -0.864 . . . . 73.31 108.666 175.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 378' ' ' ALA . . . . . . . . . . . . . . . -79.29 -3.45 46.09 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 115.481 -0.781 . . . . 73.45 111.96 -178.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.21 74.13 0.43 Allowed 'General case' 0 C--N 1.357 0.894 0 C-N-CA 125.09 1.356 . . . . 73.22 109.931 -174.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 380' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -84.29 -9.82 58.16 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 114.693 -1.14 . . . . 72.4 110.253 179.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 381' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -85.21 179.82 7.15 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.493 1.517 . . . . 74.34 111.251 178.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 382' ' ' GLY . . . . . 0.464 ' HA2' ' HA ' ' B' ' 106' ' ' TYR . . . -175.78 -96.99 0.1 Allowed Glycine 0 C--N 1.346 1.089 0 CA-C-N 115.62 -0.718 . . . . 73.1 111.378 179.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 383' ' ' ASN . . . . . . . . . . . . . 58.6 t-20 -163.24 138.81 6.71 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 107.647 -1.242 . . . . 73.1 107.647 178.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 384' ' ' THR . . . . . . . . . . . . . 41.6 p -99.29 76.44 2.06 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.115 0.566 . . . . 71.44 109.945 -177.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 5.8 mp -67.63 87.22 0.21 Allowed 'General case' 0 C--N 1.358 0.966 0 N-CA-C 108.356 -0.979 . . . . 75.43 108.356 174.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 386' ' ' VAL . . . . . 0.402 ' N ' ' SD ' ' B' ' 422' ' ' MET . 58.4 t 76.75 -54.94 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 126.574 1.949 . . . . 75.23 110.305 -175.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 387' ' ' ILE . . . . . 0.45 HG21 ' HB2' ' B' ' 395' ' ' ALA . 5.0 tp -149.75 -62.86 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.169 0 C-N-CA 123.558 0.743 . . . . 74.12 110.407 179.032 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 388' ' ' VAL . . . . . . . . . . . . . 91.0 t 61.39 123.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 125.62 1.568 . . . . 74.43 112.13 -174.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 389' ' ' THR . . . . . . . . . . . . . 42.8 m -150.09 112.52 4.7 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.968 0.907 . . . . 71.25 108.662 176.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . 68.9 112.28 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.08 1.352 . . . . 73.41 112.194 177.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 391' ' ' ASP . . . . . . . . . . . . . 18.2 t70 67.15 -92.1 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.373 1.069 . . . . 64.12 110.632 176.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 392' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -144.94 1.89 1.01 Allowed 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 124.554 1.142 . . . . 72.42 109.746 178.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -64.83 122.92 18.07 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 123.94 0.896 . . . . 61.53 110.311 -174.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -67.05 88.89 0.16 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.478 0.711 . . . . 73.31 109.386 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 395' ' ' ALA . . . . . 0.45 ' HB2' HG21 ' B' ' 387' ' ' ILE . . . 64.72 5.67 2.89 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 125.122 1.369 . . . . 75.42 113.09 -176.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 37.6 m 54.6 87.66 0.04 OUTLIER 'General case' 0 C--N 1.361 1.095 0 C-N-CA 124.436 1.094 . . . . 75.55 110.995 -172.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 397' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -90.12 24.09 2.61 Favored 'General case' 0 CA--C 1.569 1.686 0 C-N-CA 123.932 0.893 . . . . 75.54 111.041 -170.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . 0.26 12.0 tt 46.88 107.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 C-N-CA 126.565 1.946 . . . . 75.44 113.675 -173.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 399' ' ' VAL . . . . . . . . . . . . . 55.9 t 64.75 -97.72 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 C-N-CA 125.244 1.418 . . . . 73.32 110.697 -178.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 400' ' ' ALA . . . . . . . . . . . . . . . -174.55 63.91 0.26 Allowed Pre-proline 0 CA--C 1.561 1.381 0 C-N-CA 123.003 0.521 . . . . 74.52 111.524 -174.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 401' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -89.66 111.1 0.48 Allowed 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 122.822 2.348 . . . . 71.34 112.822 -178.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 17.8 t70 66.93 11.6 8.44 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 125.613 1.565 . . . . 74.34 112.172 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 403' ' ' THR . . . . . . . . . . . . . 81.0 p -82.21 9.74 8.17 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.391 0.676 . . . . 73.2 110.967 176.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 404' ' ' LYS . . . . . . . . . . . . . 53.4 mmtt 64.16 -93.38 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.285 1.834 . . . . 71.14 109.652 178.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 405' ' ' ALA . . . . . 0.454 ' HB3' ' HD3' ' B' ' 406' ' ' PRO . . . 175.19 -59.81 0.0 OUTLIER Pre-proline 0 CA--C 1.557 1.238 0 C-N-CA 125.376 1.471 . . . . 71.24 109.739 175.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 406' ' ' PRO . . . . . 0.454 ' HD3' ' HB3' ' B' ' 405' ' ' ALA . 71.4 Cg_endo -77.0 97.01 1.12 Allowed 'Trans proline' 0 C--N 1.396 3.042 0 C-N-CA 121.874 1.716 . . . . 64.23 112.7 -176.11 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . 63.53 33.79 88.19 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 115.014 -0.994 . . . . 74.04 114.495 170.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 408' ' ' LEU . . . . . . . . . . . . . 73.1 mt 61.19 -79.26 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 125.117 1.367 . . . . 72.55 110.983 -176.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 24.6 m 66.56 -63.69 0.25 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.989 1.716 . . . . 73.52 112.559 175.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 410' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 83.27 -25.1 0.15 Allowed 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 126.398 1.879 . . . . 70.42 113.047 172.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . 74.68 -56.62 0.63 Allowed 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 125.877 1.671 . . . . 74.33 112.719 177.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -59.56 172.34 0.7 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 125.191 1.396 . . . . 75.21 112.612 -176.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -68.02 82.14 0.22 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.208 1.003 . . . . 71.14 110.458 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 414' ' ' THR . . . . . . . . . . . . . 6.5 t -170.43 -51.01 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.722 1.209 . . . . 73.24 108.635 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 415' ' ' LYS . . . . . 0.609 ' HD3' ' SD ' ' B' ' 420' ' ' MET . 3.8 mptp? 65.83 -65.55 0.18 Allowed 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 125.502 1.521 . . . . 75.21 111.032 -177.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 37.6 t70 80.06 -56.52 0.36 Allowed 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 125.867 1.667 . . . . 75.33 112.702 166.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 417' ' ' GLY . . . . . . . . . . . . . . . -71.72 72.04 0.86 Allowed Glycine 0 C--N 1.347 1.17 0 N-CA-C 111.487 -0.645 . . . . 62.31 111.487 174.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 418' ' ' ALA . . . . . . . . . . . . . . . 65.69 -166.27 0.22 Allowed 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 125.244 1.418 . . . . 70.25 111.583 -172.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 419' ' ' VAL . . . . . . . . . . . . . 76.6 t 70.02 -80.93 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 125.637 1.575 . . . . 73.31 109.597 -175.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 420' ' ' MET . . . . . 0.609 ' SD ' ' HD3' ' B' ' 415' ' ' LYS . 87.1 mtp -97.82 176.43 5.8 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.404 0.681 . . . . 73.34 109.945 175.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 421' ' ' VAL . . . . . . . . . . . . . 60.9 t 74.41 -62.31 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 C-N-CA 125.465 1.506 . . . . 72.42 110.615 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 422' ' ' MET . . . . . 0.402 ' SD ' ' N ' ' B' ' 386' ' ' VAL . 91.8 mmm -66.0 -39.33 90.2 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.831 0.852 . . . . 74.1 111.425 172.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 423' ' ' SER . . . . . . . . . . . . . 68.5 m -151.79 -155.13 0.59 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.859 1.263 . . . . 63.45 108.176 -178.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 424' ' ' TYR . . . . . 0.51 ' HH ' ' HA ' ' B' ' 428' ' ' GLU . 34.3 p90 -157.3 -38.9 0.07 Allowed 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 107.884 -1.154 . . . . 74.22 107.884 162.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . -121.19 -164.03 12.2 Favored Glycine 0 C--N 1.346 1.136 0 N-CA-C 110.664 -0.974 . . . . 75.12 110.664 166.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 426' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -65.29 -44.07 89.13 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.45 0.643 . . . . 75.43 109.411 175.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 427' ' ' SER . . . . . 0.686 ' HB3' ' HB2' ' B' ' 430' ' ' ASP . 36.1 t -156.74 176.46 12.71 Favored 'General case' 0 C--O 1.245 0.834 0 N-CA-C 107.896 -1.15 . . . . 75.14 107.896 170.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 428' ' ' GLU . . . . . 0.63 ' HB2' ' HB2' ' A' ' 220' ' ' GLU . 0.4 OUTLIER -71.83 -76.4 0.11 Allowed 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 108.51 -0.922 . . . . 73.23 108.51 179.435 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 429' ' ' GLU . . . . . 0.503 ' HA ' ' HA ' ' B' ' 433' ' ' GLU . 0.0 OUTLIER -85.74 49.88 1.86 Allowed 'General case' 0 N--CA 1.481 1.078 0 CA-C-O 121.897 0.856 . . . . 63.42 109.857 -179.24 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 430' ' ' ASP . . . . . 0.686 ' HB2' ' HB3' ' B' ' 427' ' ' SER . 32.6 t70 -84.6 78.73 9.79 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 125.21 1.404 . . . . 62.42 108.429 178.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 19.9 t 78.37 -51.14 0.48 Allowed 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 126.431 1.892 . . . . 75.05 113.373 174.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 432' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -110.54 -2.23 16.56 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 118.837 0.744 . . . . 71.1 112.825 -174.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 433' ' ' GLU . . . . . 0.503 ' HA ' ' HA ' ' B' ' 429' ' ' GLU . 2.1 mp0 58.4 95.06 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 124.05 0.94 . . . . 73.43 109.917 -170.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 434' ' ' HIS . . . . . 0.448 ' NE2' ' HB3' ' B' ' 430' ' ' ASP . 22.1 m-70 -65.99 -39.96 90.77 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.952 0.901 . . . . 73.42 112.056 -168.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 435' ' ' THR . . . . . . . . . . . . . 96.7 m -144.65 -69.65 0.3 Allowed 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 111.992 0.367 . . . . 73.42 111.992 177.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . -55.82 -49.05 68.28 Favored Glycine 0 C--N 1.351 1.373 0 O-C-N 123.761 0.663 . . . . 61.51 114.398 -166.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 15.8 m 73.2 -55.64 0.67 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.988 1.715 . . . . 72.35 112.589 176.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 438' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.84 -104.89 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 124.576 1.15 . . . . 71.55 109.545 176.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 439' ' ' LEU . . . . . 0.537 HD13 ' HG3' ' B' ' 428' ' ' GLU . 65.7 mt 54.42 16.17 1.2 Allowed 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 125.168 1.387 . . . . 74.24 113.878 176.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 440' ' ' ARG . . . . . . . . . . . . . 76.2 mtp180 -92.75 112.5 24.48 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 108.618 -0.882 . . . . 74.1 108.618 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 441' ' ' ILE . . . . . 0.487 HG12 HD11 ' A' ' 235' ' ' LEU . 53.9 mt -76.24 101.79 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 CA-C-O 120.84 0.352 . . . . 74.15 110.456 -178.294 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 442' ' ' ALA . . . . . . . . . . . . . . . -87.88 84.32 7.02 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 108.743 -0.836 . . . . 73.33 108.743 172.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . -131.07 -54.37 1.04 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.747 0.819 . . . . 74.21 109.822 -175.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 444' ' ' TYR . . . . . 0.605 ' HB2' ' HB2' ' A' ' 224' ' ' PRO . 6.4 m-85 -106.6 28.16 8.13 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.913 0.885 . . . . 71.31 109.619 177.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . 100.87 -167.3 19.63 Favored Glycine 0 C--N 1.344 0.98 0 CA-C-N 115.539 -0.755 . . . . 74.34 111.629 -175.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 446' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -79.43 164.65 23.76 Favored 'Trans proline' 0 C--N 1.368 1.579 0 C-N-CA 122.617 2.212 . . . . 72.44 112.45 177.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 447' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -83.22 0.32 45.98 Favored 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 123.587 0.755 . . . . 63.45 110.164 176.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . -63.86 91.47 0.06 Allowed 'General case' 0 C--N 1.359 1.003 0 C-N-CA 124.391 1.076 . . . . 74.31 110.37 174.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 449' ' ' ALA . . . . . . . . . . . . . . . -82.49 -5.08 58.49 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.743 0.817 . . . . 74.42 111.7 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 450' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 67.11 94.24 0.07 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.42 1.488 . . . . 63.22 110.479 177.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 451' ' ' VAL . . . . . 0.669 HG11 ' H ' ' B' ' 464' ' ' MET . 84.2 t -73.15 -45.63 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.684 0.794 . . . . 74.44 111.21 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 452' ' ' VAL . . . . . 0.513 HG11 ' H ' ' B' ' 453' ' ' GLY . 2.5 p -64.23 -75.13 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 O-C-N 123.877 0.736 . . . . 74.24 112.334 -175.106 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 453' ' ' GLY . . . . . 0.513 ' H ' HG11 ' B' ' 452' ' ' VAL . . . 55.91 -102.7 0.19 Allowed Glycine 0 C--N 1.346 1.1 0 CA-C-O 121.025 0.236 . . . . 73.44 112.555 -171.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 454' ' ' LEU . . . . . 0.559 HD23 ' HB3' ' B' ' 282' ' ' ALA . 1.9 pt? -161.14 -41.84 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 107.694 -1.224 . . . . 73.13 107.694 -176.138 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 455' ' ' THR . . . . . 0.446 ' HB ' HG12 ' B' ' 288' ' ' VAL . 4.9 m 49.88 -85.63 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 126.57 1.948 . . . . 72.1 114.166 171.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 456' ' ' ASP . . . . . 0.552 ' HB2' HD13 ' B' ' 280' ' ' LEU . 7.1 t70 -171.19 -162.52 0.25 Allowed 'General case' 0 CA--C 1.554 1.132 0 N-CA-C 107.747 -1.205 . . . . 74.3 107.747 -172.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 457' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -146.51 -32.03 0.34 Allowed 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 118.704 0.684 . . . . 65.21 111.205 174.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 33.3 p -87.1 -12.21 47.83 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.966 1.098 . . . . 72.13 113.966 -168.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 459' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -95.95 173.93 7.19 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 119.534 1.061 . . . . 73.31 111.466 174.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 460' ' ' LEU . . . . . 0.426 ' HG ' ' HA ' ' B' ' 290' ' ' TRP . 5.8 tt -160.15 104.08 1.48 Allowed 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 107.564 -1.273 . . . . 65.42 107.564 -176.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -132.94 -87.62 0.43 Allowed 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.576 0.75 . . . . 75.0 110.379 177.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -149.58 162.76 39.54 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.001 -1.111 . . . . 72.53 108.001 -173.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 41.8 p -63.7 168.66 4.67 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 122.98 0.512 . . . . 71.14 111.587 176.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 464' ' ' MET . . . . . 0.669 ' H ' HG11 ' B' ' 451' ' ' VAL . 1.8 tpt 75.2 131.69 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.865 1.266 . . . . 75.31 110.791 -178.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 36.1 mtmm -69.88 85.98 0.51 Allowed 'General case' 0 C--N 1.355 0.826 0 N-CA-C 108.884 -0.784 . . . . 72.15 108.884 173.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -164.48 -52.5 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.353 -1.294 . . . . 65.13 108.608 -174.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 467' ' ' ALA . . . . . 0.413 ' HA ' ' NZ ' ' C' ' 271' ' ' LYS . . . -90.41 69.55 6.94 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.131 -0.94 . . . . 75.3 110.844 179.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -91.64 -172.47 3.23 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 123.019 0.527 . . . . 74.32 111.185 -178.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 469' ' ' GLY . . . . . . . . . . . . . . . -115.51 -82.6 1.02 Allowed Glycine 0 C--N 1.356 1.645 0 N-CA-C 112.19 -0.364 . . . . 62.03 112.19 174.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 470' ' ' LEU . . . . . 0.404 HD13 ' N ' ' B' ' 471' ' ' LYS . 3.8 pp -170.67 -38.98 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.636 1.175 . . . . 75.32 108.486 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 471' ' ' LYS . . . . . 0.404 ' N ' HD13 ' B' ' 470' ' ' LEU . 5.2 tmtm? . . . . . 0 C--O 1.252 1.19 0 N-CA-C 104.167 -2.531 . . . . 74.2 104.167 172.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 59.0 mtm . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 119.613 -0.232 . . . . 70.43 110.48 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 52.68 39.82 29.12 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.152 0.981 . . . . 70.41 111.957 -177.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -84.46 64.18 8.26 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 109.56 -0.533 . . . . 71.34 109.56 178.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -40.5 95.67 0.01 OUTLIER 'General case' 0 C--N 1.359 0.99 0 C-N-CA 125.564 1.546 . . . . 70.52 114.045 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -87.72 124.52 33.67 Favored 'General case' 0 C--O 1.247 0.942 0 N-CA-C 108.899 -0.778 . . . . 72.32 108.899 170.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -75.84 112.88 12.7 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.629 -0.878 . . . . 65.15 108.629 175.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 7' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -64.47 -26.16 68.32 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.713 0.805 . . . . 73.43 112.711 -171.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -70.89 -45.07 65.0 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 109.319 -0.623 . . . . 74.23 109.319 178.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.57 -36.91 84.16 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.973 -1.012 . . . . 63.34 110.762 176.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 56.6 mt -59.46 -46.57 92.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 122.908 0.483 . . . . 73.31 110.06 174.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 11' ' ' LEU . . . . . 0.595 ' HB3' ' HB1' ' C' ' 25' ' ' ALA . 56.6 mt -71.39 -6.73 42.36 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 112.639 0.607 . . . . 75.53 112.639 176.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.84 21.09 79.66 Favored Glycine 0 C--N 1.355 1.629 0 C-N-CA 122.812 0.244 . . . . 74.43 113.62 178.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 31.3 m -113.98 161.51 27.57 Favored Pre-proline 0 N--CA 1.477 0.885 0 C-N-CA 124.111 0.964 . . . . 71.34 110.259 -177.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -54.89 148.52 46.32 Favored 'Trans proline' 0 C--N 1.382 2.294 0 C-N-CA 122.617 2.211 . . . . 74.43 113.05 174.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 68.4 mtm180 -76.94 19.9 0.28 Allowed 'General case' 0 CA--C 1.559 1.296 0 C-N-CA 123.757 0.823 . . . . 74.35 112.969 -172.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -136.97 8.17 2.97 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 125.076 1.35 . . . . 71.24 109.344 179.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.07 141.13 58.84 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.851 0.86 . . . . 75.2 112.242 -174.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 47.7 p -93.24 176.44 6.4 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.276 1.03 . . . . 74.41 112.335 -174.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -53.41 -36.34 61.39 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 125.288 1.435 . . . . 74.45 112.585 -175.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -57.95 -47.98 81.31 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.55 1.14 . . . . 74.53 111.405 175.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -76.89 -29.98 56.0 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.042 -1.436 . . . . 73.42 111.194 -174.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 22' ' ' ILE . . . . . 0.425 HG12 ' HB3' ' C' ' 57' ' ' LEU . 1.7 mp -72.28 -34.11 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 C-N-CA 124.119 0.968 . . . . 75.54 110.058 175.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 23' ' ' LYS . . . . . 0.524 ' HD3' ' NH2' ' C' ' 148' ' ' ARG . 34.1 ttpt -61.5 -50.64 71.9 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.694 0.798 . . . . 74.13 109.973 173.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 50.1 mtm180 -75.5 -20.23 58.89 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 115.582 -0.736 . . . . 73.52 112.423 -178.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . 0.595 ' HB1' ' HB3' ' C' ' 11' ' ' LEU . . . -74.23 -38.75 63.45 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.098 0.559 . . . . 75.32 110.238 172.364 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 26' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -63.8 -43.69 95.57 Favored 'General case' 0 C--O 1.216 -0.7 0 CA-C-N 114.846 -1.07 . . . . 72.31 109.524 174.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -55.48 -55.14 35.21 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.886 0.474 . . . . 75.33 109.994 175.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -46.5 -62.39 1.39 Allowed 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.047 1.339 . . . . 75.55 111.956 -179.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 62.7 mt -74.46 -38.83 62.85 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.385 -0.825 . . . . 71.43 112.168 -173.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.01 2.96 32.25 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 122.573 0.349 . . . . 75.32 111.742 -178.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -95.94 -44.99 7.12 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 108.944 -0.761 . . . . 73.5 108.944 163.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 21.3 tp60 -67.65 -55.86 11.63 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 123.501 0.5 . . . . 71.12 112.216 -176.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 33' ' ' TYR . . . . . 0.471 ' HD2' HD11 ' C' ' 50' ' ' ILE . 11.1 m-85 -95.66 25.5 4.54 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.699 0.8 . . . . 72.14 110.942 -178.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 34' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 -64.9 114.86 16.44 Favored Pre-proline 0 CA--C 1.546 0.813 0 CA-C-O 118.251 -0.881 . . . . 74.34 109.691 -177.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -55.62 -16.14 14.02 Favored 'Trans proline' 0 C--N 1.38 2.211 0 C-N-CA 123.216 2.611 . . . . 72.22 114.314 -177.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -67.75 -53.26 28.79 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.486 0.714 . . . . 60.34 110.391 169.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 77.1 t -77.07 -50.67 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.801 0.84 . . . . 75.33 110.508 -173.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -114.26 86.58 2.45 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.775 1.23 . . . . 65.41 109.011 -178.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -75.96 77.21 2.84 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 116.056 -0.52 . . . . 71.22 109.786 178.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 22.5 m -135.37 121.06 14.01 Favored Pre-proline 0 N--CA 1.471 0.608 0 CA-C-O 118.284 -0.865 . . . . 74.14 109.278 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -47.99 -37.16 29.22 Favored 'Trans proline' 0 C--N 1.384 2.443 0 C-N-CA 123.346 2.697 . . . . 75.0 112.694 174.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -59.94 -41.84 92.69 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.16 0.984 . . . . 71.01 110.246 177.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.7 -17.98 61.06 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 116.2 -0.455 . . . . 71.45 110.521 177.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 44' ' ' GLU . . . . . 0.539 ' HA ' ' HB3' ' C' ' 47' ' ' PHE . 50.1 mt-10 -86.22 -14.88 42.6 Favored 'General case' 0 C--N 1.358 0.953 0 C-N-CA 123.045 0.538 . . . . 74.04 110.371 177.137 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 45' ' ' GLU . . . . . 0.425 ' O ' ' HB2' ' C' ' 48' ' ' LYS . 32.6 mt-10 -82.72 -38.29 23.52 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.924 -0.769 . . . . 75.44 108.924 169.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 46' ' ' LYS . . . . . 0.5 ' O ' HG13 ' C' ' 50' ' ' ILE . 59.0 mttp -64.13 -32.04 73.46 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.597 -0.729 . . . . 72.32 110.115 166.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 47' ' ' PHE . . . . . 0.539 ' HB3' ' HA ' ' C' ' 44' ' ' GLU . 46.3 t80 -78.29 -21.98 48.91 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.582 0.753 . . . . 71.12 110.533 177.141 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 48' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' C' ' 45' ' ' GLU . 50.6 mttp -60.35 -53.13 61.29 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 107.961 -1.125 . . . . 72.04 107.961 164.033 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -56.81 -40.19 75.53 Favored 'General case' 0 CA--C 1.55 0.954 0 O-C-N 124.447 1.092 . . . . 72.33 112.132 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 50' ' ' ILE . . . . . 0.5 HG13 ' O ' ' C' ' 46' ' ' LYS . 69.9 mt -62.75 -55.13 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 C-N-CA 123.312 0.645 . . . . 75.43 110.082 176.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 51' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -71.67 -20.91 61.87 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 114.823 -1.08 . . . . 74.04 112.174 -173.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -79.52 -54.29 6.05 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.279 1.032 . . . . 75.54 108.548 178.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.71 -33.74 72.0 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 114.125 -1.398 . . . . 63.1 111.732 176.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -81.66 -33.74 31.13 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 119.138 -0.458 . . . . 75.01 110.452 177.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 55' ' ' ALA . . . . . 0.434 ' HB1' ' HD2' ' C' ' 85' ' ' PHE . . . -56.6 -35.33 68.12 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 118.023 0.374 . . . . 60.54 110.535 174.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 56' ' ' VAL . . . . . 0.447 ' O ' ' HB2' ' C' ' 62' ' ' LYS . 46.2 t -81.02 -62.2 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 CA-C-N 115.559 -0.746 . . . . 72.43 110.986 176.087 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 57' ' ' LEU . . . . . 0.425 ' HB3' HG12 ' C' ' 22' ' ' ILE . 39.4 mt -79.84 -7.88 58.96 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 114.169 1.174 . . . . 75.02 114.169 -164.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 32.6 t -59.92 -51.9 67.69 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.335 0.588 . . . . 75.33 110.433 178.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.86 126.39 80.14 Favored Pre-proline 0 C--O 1.246 0.891 0 CA-C-N 114.787 -1.097 . . . . 72.03 108.805 172.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 60' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -59.12 -23.77 70.61 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.095 1.863 . . . . 73.21 111.231 168.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -64.8 -54.74 26.49 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 124.568 1.147 . . . . 62.13 110.905 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 62' ' ' LYS . . . . . 0.447 ' HB2' ' O ' ' C' ' 56' ' ' VAL . 70.3 mttt -69.77 -30.85 68.51 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 115.873 -0.603 . . . . 75.43 110.804 178.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 1.3 ttp180 -57.91 -43.6 86.3 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.62 -0.882 . . . . 74.14 108.62 175.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -72.13 -28.4 63.24 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 115.053 -0.976 . . . . 74.15 112.32 177.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 65' ' ' ILE . . . . . 0.466 HD12 ' HE1' ' C' ' 83' ' ' TYR . 78.6 mt -59.82 -44.54 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 109.878 -0.416 . . . . 71.5 109.878 170.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -67.58 -42.65 82.2 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 116.169 -0.469 . . . . 74.31 110.207 176.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -58.91 -39.96 83.06 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.329 0.652 . . . . 73.14 111.423 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 71.6 p -77.1 -19.33 57.13 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 122.948 0.499 . . . . 74.43 110.983 177.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -74.08 114.29 12.23 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 108.517 -0.92 . . . . 75.22 108.517 170.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 112.26 11.92 14.69 Favored Glycine 0 N--CA 1.472 1.084 0 N-CA-C 111.699 -0.561 . . . . 62.51 111.699 -166.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 95.2 m -144.38 -50.39 0.29 Allowed 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 105.05 -2.204 . . . . 72.34 105.05 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 33.1 m -93.8 137.3 33.19 Favored 'General case' 0 C--O 1.249 1.078 0 N-CA-C 103.527 -2.768 . . . . 73.35 103.527 156.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.06 -31.75 13.44 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 118.384 0.538 . . . . 73.23 110.687 177.191 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.94 140.91 74.39 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 123.582 0.753 . . . . 53.23 109.968 176.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -53.03 115.87 2.56 Favored 'Trans proline' 0 C--N 1.376 2.016 0 C-N-CA 123.173 2.582 . . . . 75.14 112.306 176.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -53.44 148.9 32.18 Favored 'Trans proline' 0 C--N 1.391 2.772 0 C-N-CA 123.911 3.074 . . . . 71.22 113.276 -178.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -50.87 118.62 4.37 Favored 'Trans proline' 0 C--N 1.389 2.663 0 C-N-CA 123.24 2.627 . . . . 74.4 113.521 -178.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 78' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.11 139.48 80.31 Favored 'Trans proline' 0 C--N 1.386 2.511 0 C-N-CA 123.343 2.695 . . . . 74.44 112.943 -178.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.58 158.02 17.31 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 123.078 2.519 . . . . 70.12 112.591 177.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -74.91 42.48 0.84 Allowed 'Trans proline' 0 C--N 1.382 2.312 0 C-N-CA 123.678 2.918 . . . . 74.31 112.735 174.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -159.46 16.86 0.23 Allowed Glycine 0 CA--C 1.529 0.951 0 N-CA-C 108.585 -1.806 . . . . 75.2 108.585 177.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 67.6 -171.93 32.86 Favored Glycine 0 C--N 1.365 2.179 0 C-N-CA 124.439 1.019 . . . . 75.13 111.959 -175.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 83' ' ' TYR . . . . . 0.466 ' HE1' HD12 ' C' ' 65' ' ' ILE . 58.8 m-85 -83.58 98.15 9.44 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 105.991 -1.855 . . . . 73.4 105.991 162.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 84' ' ' ASP . . . . . 0.478 ' OD1' ' HA3' ' C' ' 163' ' ' GLY . 0.3 OUTLIER -56.32 137.18 52.88 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 112.015 0.376 . . . . 75.11 112.015 -175.114 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 85' ' ' PHE . . . . . 0.458 ' HB3' ' HB2' ' C' ' 88' ' ' PHE . 30.7 m-85 -133.06 73.1 1.5 Allowed 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.523 1.129 . . . . 74.41 108.325 177.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 50.4 m -51.64 85.72 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 124.308 1.043 . . . . 52.42 112.345 178.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 65.61 19.11 66.7 Favored Glycine 0 CA--C 1.534 1.273 0 CA-C-N 115.566 -0.743 . . . . 74.34 113.672 -175.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 88' ' ' PHE . . . . . 0.458 ' HB2' ' HB3' ' C' ' 85' ' ' PHE . 23.0 m-85 -101.81 118.55 37.16 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 109.411 -0.588 . . . . 74.44 109.411 -176.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -75.74 90.23 2.86 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.216 0.531 . . . . 72.23 109.686 -178.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 90' ' ' VAL . . . . . . . . . . . . . 1.6 p -41.12 -47.99 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 CA-C-N 113.96 -1.473 . . . . 54.42 113.326 171.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 91' ' ' GLU . . . . . 0.485 ' HB2' ' HG3' ' C' ' 112' ' ' ARG . 45.5 tt0 -68.78 -19.32 64.31 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.275 0.63 . . . . 75.25 111.635 -175.221 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -93.06 -2.89 55.16 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.354 0.662 . . . . 75.53 111.583 -178.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -95.21 174.77 6.89 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 122.714 0.405 . . . . 72.45 111.803 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 90.0 p -66.23 167.15 10.71 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 114.643 1.349 . . . . 52.11 114.643 -168.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 95' ' ' GLU . . . . . 0.409 ' O ' ' HG3' ' C' ' 99' ' ' GLU . 0.0 OUTLIER -59.49 -50.89 72.19 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 114.962 -1.017 . . . . 72.35 112.026 178.744 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -57.13 -46.44 82.66 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.608 0.763 . . . . 74.24 110.502 -176.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 97' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -54.64 -52.29 62.77 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 114.756 -1.111 . . . . 64.25 110.634 175.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 98' ' ' GLN . . . . . 0.517 ' HA ' HD22 ' C' ' 105' ' ' LEU . 98.0 mt-30 -69.0 -18.29 64.03 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.617 -0.719 . . . . 71.33 112.558 -175.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . 0.409 ' HG3' ' O ' ' C' ' 95' ' ' GLU . 44.3 mt-10 -86.65 -52.42 5.55 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.729 0.411 . . . . 74.43 111.087 176.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 54.5 tp -62.09 -39.58 92.94 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.528 0.731 . . . . 73.23 111.012 -178.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -96.57 7.49 46.41 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.987 -0.551 . . . . 75.04 110.839 178.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 102' ' ' GLY . . . . . 0.494 ' HA2' ' HG ' ' C' ' 105' ' ' LEU . . . -43.38 -62.34 2.49 Favored Glycine 0 C--N 1.356 1.672 0 C-N-CA 124.906 1.241 . . . . 74.41 114.916 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -49.6 -21.22 5.07 Favored 'Trans proline' 0 C--N 1.384 2.431 0 C-N-CA 123.985 3.123 . . . . 64.35 115.105 -177.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -146.97 41.26 0.97 Allowed Glycine 0 C--N 1.36 1.909 0 CA-C-O 119.576 -0.569 . . . . 73.42 112.823 178.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 105' ' ' LEU . . . . . 0.517 HD22 ' HA ' ' C' ' 98' ' ' GLN . 13.2 mt -56.77 13.36 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.59 0 N-CA-C 115.717 1.747 . . . . 75.43 115.717 177.223 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 106' ' ' PHE . . . . . 0.54 ' HA ' ' HB2' ' C' ' 169' ' ' ASN . 0.2 OUTLIER 72.35 -104.44 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.044 0.937 . . . . 64.24 111.821 166.077 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 107' ' ' GLY . . . . . 0.449 ' HA2' ' HB2' ' C' ' 112' ' ' ARG . . . 109.56 24.84 5.71 Favored Glycine 0 N--CA 1.466 0.668 0 N-CA-C 111.376 -0.69 . . . . 51.05 111.376 -161.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . -15.48 -67.7 0.01 OUTLIER Glycine 0 C--N 1.364 2.111 0 C-N-CA 124.882 1.229 . . . . 74.41 113.343 160.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 109' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -91.01 78.51 5.94 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 107.631 -1.248 . . . . 74.45 107.631 167.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 110' ' ' GLY . . . . . . . . . . . . . . . 0.51 -69.16 0.0 OUTLIER Glycine 0 N--CA 1.498 2.779 0 C-N-CA 127.308 2.385 . . . . 73.14 116.86 -179.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 17.9 mtp180 -7.04 -40.31 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.914 0 C-N-CA 126.432 1.893 . . . . 75.25 116.031 158.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 112' ' ' ARG . . . . . 0.485 ' HG3' ' HB2' ' C' ' 91' ' ' GLU . 5.5 mpt_? -85.96 47.09 1.4 Allowed 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 126.347 1.859 . . . . 75.43 110.213 -174.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 113' ' ' SER . . . . . . . . . . . . . 44.4 m 84.76 -0.2 0.87 Allowed 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 117.179 2.289 . . . . 72.53 117.179 162.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 114' ' ' ARG . . . . . 0.711 ' HB3' ' HA ' ' C' ' 169' ' ' ASN . 0.1 OUTLIER -154.75 158.85 40.14 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 120.725 1.602 . . . . 74.05 112.376 174.23 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 115' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -103.47 131.43 50.58 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.762 1.023 . . . . 74.15 113.762 -177.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -109.56 165.88 12.49 Favored Glycine 0 CA--C 1.542 1.732 0 O-C-N 123.456 0.473 . . . . 54.4 112.901 163.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 4.6 ppt_? -116.51 137.25 52.32 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.714 -0.847 . . . . 74.32 108.714 167.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 118' ' ' ASP . . . . . 0.871 ' HA ' ' HA2' ' C' ' 166' ' ' GLY . 8.7 p-10 -61.3 134.85 57.41 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 123.851 0.861 . . . . 75.42 111.517 -172.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 119' ' ' LEU . . . . . 0.527 ' HB2' ' O ' ' C' ' 165' ' ' GLY . 0.2 OUTLIER -92.81 143.62 26.1 Favored 'General case' 0 N--CA 1.504 2.252 0 C-N-CA 119.293 -0.963 . . . . 75.21 109.697 -176.979 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -128.87 95.44 4.09 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 107.947 -1.131 . . . . 72.31 107.947 175.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 121' ' ' ALA . . . . . 0.446 ' HA ' HG22 ' B' ' 185' ' ' VAL . . . -108.33 114.1 27.7 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 108.542 -0.911 . . . . 75.44 108.542 -177.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 122' ' ' GLU . . . . . 0.486 ' HA ' ' O ' ' C' ' 177' ' ' VAL . 37.4 mt-10 -95.27 101.44 13.17 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 107.114 -1.439 . . . . 74.12 107.114 172.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 123' ' ' LEU . . . . . 0.536 HD22 ' H ' ' C' ' 123' ' ' LEU . 1.7 pt? -105.57 115.52 61.63 Favored Pre-proline 0 N--CA 1.478 0.942 0 CA-C-N 115.702 -0.681 . . . . 73.3 110.896 -168.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . 0.507 ' HA ' ' O ' ' C' ' 179' ' ' ARG . 85.8 Cg_exo -52.76 113.46 1.26 Allowed 'Trans proline' 0 C--N 1.384 2.426 0 C-N-CA 122.506 2.138 . . . . 72.51 111.121 164.276 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 125' ' ' LEU . . . . . 0.545 HD21 HG12 ' C' ' 153' ' ' VAL . 37.8 tp -129.99 143.84 51.01 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.648 0.379 . . . . 75.32 110.106 -175.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 126' ' ' THR . . . . . 0.409 ' HB ' ' HG2' ' C' ' 129' ' ' GLU . 2.5 m -85.37 149.49 25.4 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 116.033 -0.531 . . . . 61.53 110.917 -177.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 127' ' ' LEU . . . . . . . . . . . . . 9.8 mt -70.61 -52.14 23.47 Favored 'General case' 0 C--O 1.247 0.962 0 C-N-CA 124.198 0.999 . . . . 62.25 109.038 -178.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 128' ' ' GLU . . . . . 0.528 ' HG3' ' HA ' ' C' ' 215' ' ' LEU . 1.7 mp0 -59.49 -34.72 72.93 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 113.88 -1.509 . . . . 75.24 111.227 178.026 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 129' ' ' GLU . . . . . 0.531 ' HA ' ' HB2' ' C' ' 132' ' ' HIS . 17.7 mm-40 -84.47 -19.55 33.18 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.616 0.366 . . . . 75.51 111.544 -179.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -70.5 -33.68 71.49 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 108.882 -0.785 . . . . 73.14 108.882 171.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 131' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -65.46 -49.06 70.53 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 115.482 -0.781 . . . . 75.55 109.91 167.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 132' ' ' HIS . . . . . 0.531 ' HB2' ' HA ' ' C' ' 129' ' ' GLU . 32.8 m170 -72.18 -3.82 25.62 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 112.704 0.631 . . . . 70.15 112.704 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -54.41 165.13 2.83 Favored Glycine 0 CA--C 1.547 2.047 0 N-CA-C 115.715 1.046 . . . . 65.31 115.715 174.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . 158.52 -130.44 2.53 Favored Glycine 0 C--N 1.348 1.218 0 N-CA-C 110.269 -1.133 . . . . 73.12 110.269 -174.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 17.0 mp0 -81.2 95.53 6.95 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 108.263 -1.014 . . . . 73.03 108.263 169.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 136' ' ' ARG . . . . . 0.653 ' HB2' HD22 ' B' ' 181' ' ' LEU . 26.9 mmt180 -121.83 147.04 46.48 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 122.897 0.479 . . . . 72.12 110.662 -172.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 137' ' ' VAL . . . . . 0.542 HG21 ' HB1' ' B' ' 180' ' ' ALA . 8.0 m -74.42 132.55 33.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 121.69 0.757 . . . . 73.11 110.72 -175.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 138' ' ' VAL . . . . . 0.469 HG13 ' HE2' ' C' ' 164' ' ' MET . 2.3 t -139.02 133.31 40.64 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 C-N-CA 124.656 1.183 . . . . 72.14 109.269 -175.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 139' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' C' ' 143' ' ' ARG . 1.6 tm-20 -125.28 109.17 12.49 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 107.898 -1.149 . . . . 74.31 107.898 171.075 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 140' ' ' VAL . . . . . . . . . . . . . 3.2 p -143.32 134.03 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.022 0.929 . . . . 73.25 109.174 178.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 64.42 8.17 4.1 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.613 1.165 . . . . 65.0 113.329 177.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 105.29 1.46 41.17 Favored Glycine 0 C--N 1.351 1.37 0 CA-C-O 119.63 -0.539 . . . . 52.4 113.817 -178.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 143' ' ' ARG . . . . . 0.404 ' O ' ' HA ' ' C' ' 139' ' ' GLU . 77.2 ttt180 -100.14 124.98 46.17 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 118.037 0.918 . . . . 75.05 110.708 -179.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 49.2 ttt-85 -96.22 116.57 29.22 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.163 0.985 . . . . 71.51 108.944 170.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 145' ' ' VAL . . . . . 0.447 HG12 ' SD ' ' C' ' 164' ' ' MET . 7.7 p -151.74 147.4 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 122.714 0.405 . . . . 75.03 111.104 -177.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 50.8 m -85.39 93.47 8.74 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 108.044 -1.095 . . . . 73.22 108.044 166.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 6.2 p -81.33 154.41 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-O 120.853 0.359 . . . . 72.53 110.414 -175.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 148' ' ' ARG . . . . . 0.524 ' NH2' ' HD3' ' C' ' 23' ' ' LYS . 53.5 ttm-85 -113.77 95.79 5.51 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 108.275 -1.009 . . . . 74.22 108.275 172.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 149' ' ' ILE . . . . . . . . . . . . . 34.8 pt -106.91 150.99 40.45 Favored Pre-proline 0 CA--C 1.548 0.898 0 N-CA-C 108.49 -0.93 . . . . 74.42 108.49 171.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -40.24 111.73 0.15 Allowed 'Trans proline' 0 C--N 1.384 2.409 0 C-N-CA 124.311 3.341 . . . . 61.44 115.042 -179.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -64.09 93.78 0.19 Allowed 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.996 2.464 . . . . 73.2 109.856 166.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 152' ' ' GLY . . . . . . . . . . . . . . . 113.17 90.6 1.87 Allowed Glycine 0 C--N 1.341 0.816 0 N-CA-C 110.004 -1.238 . . . . 63.11 110.004 -165.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 153' ' ' VAL . . . . . 0.545 HG12 HD21 ' C' ' 125' ' ' LEU . 2.0 p -115.51 156.74 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 C-N-CA 123.051 0.54 . . . . 74.01 110.152 -174.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 154' ' ' ARG . . . . . 0.513 ' HB2' ' HB3' ' C' ' 157' ' ' SER . 56.7 mtp180 -107.54 135.26 49.3 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.68 0.792 . . . . 75.32 110.675 -174.192 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 155' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -47.04 120.91 3.33 Favored 'General case' 0 CA--C 1.553 1.059 0 CA-C-N 118.663 0.665 . . . . 74.51 111.588 166.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.59 -0.49 88.23 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-O 119.263 -0.743 . . . . 75.21 114.496 176.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 157' ' ' SER . . . . . 0.513 ' HB3' ' HB2' ' C' ' 154' ' ' ARG . 91.5 p -77.83 147.96 34.93 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 118.183 0.991 . . . . 75.43 109.93 177.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 6.1 p -119.63 109.58 26.69 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 CA-C-O 121.668 0.746 . . . . 72.31 109.902 -173.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 159' ' ' ILE . . . . . 0.577 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 17.3 mt -88.24 116.01 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.613 1.165 . . . . 72.31 109.078 -178.127 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -91.01 111.84 23.48 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.521 -0.548 . . . . 75.13 109.521 177.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 161' ' ' VAL . . . . . . . . . . . . . 1.9 p -122.21 96.4 46.39 Favored Pre-proline 0 CA--C 1.558 1.286 0 C-N-CA 124.254 1.022 . . . . 75.24 108.964 177.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 162' ' ' PRO . . . . . 0.741 ' HA ' ' HA ' ' C' ' 173' ' ' ASP . 10.6 Cg_endo -57.05 128.03 28.18 Favored 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 122.847 2.364 . . . . 75.23 113.329 176.023 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 163' ' ' GLY . . . . . 0.478 ' HA3' ' OD1' ' C' ' 84' ' ' ASP . . . 107.31 13.03 22.12 Favored Glycine 0 C--N 1.348 1.209 0 N-CA-C 115.179 0.832 . . . . 53.54 115.179 172.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 164' ' ' MET . . . . . 0.469 ' HE2' HG13 ' C' ' 138' ' ' VAL . 5.7 mtm -126.67 32.0 5.23 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 117.991 0.896 . . . . 73.35 112.216 -176.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 165' ' ' GLY . . . . . 0.598 ' H ' ' HA2' ' C' ' 172' ' ' GLY . . . 112.35 122.49 4.07 Favored Glycine 0 C--O 1.192 -2.483 0 CA-C-O 115.526 -2.819 . . . . 73.32 107.48 -176.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 166' ' ' GLY . . . . . 0.871 ' HA2' ' HA ' ' C' ' 118' ' ' ASP . . . 144.5 -143.57 12.23 Favored Glycine 0 C--O 1.199 -2.035 0 CA-C-N 122.379 3.089 . . . . 75.44 113.239 -161.18 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 167' ' ' GLN . . . . . 0.528 ' H ' ' HB3' ' C' ' 173' ' ' ASP . 22.2 mm-40 -90.07 114.33 26.21 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 118.968 1.384 . . . . 74.2 110.539 177.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . -167.59 -150.97 6.74 Favored Glycine 0 N--CA 1.479 1.502 0 CA-C-O 119.654 -0.526 . . . . 13.44 113.118 -175.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 169' ' ' ASN . . . . . 0.711 ' HA ' ' HB3' ' C' ' 114' ' ' ARG . 25.1 t-20 -72.33 -56.23 4.31 Favored Pre-proline 0 C--N 1.358 0.973 0 N-CA-C 108.354 -0.98 . . . . 62.44 108.354 168.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 170' ' ' PRO . . . . . 0.581 ' HD3' ' HB3' ' C' ' 169' ' ' ASN . 57.7 Cg_endo -98.83 -160.11 0.05 OUTLIER 'Trans proline' 0 C--N 1.365 1.409 0 N-CA-C 105.292 -2.619 . . . . 73.55 105.292 159.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 171' ' ' PRO . . . . . 0.46 ' HA ' ' O ' ' C' ' 166' ' ' GLY . 22.3 Cg_exo -47.17 119.47 3.52 Favored 'Trans proline' 0 CA--C 1.587 3.13 0 CA-C-N 121.543 1.587 . . . . 74.02 114.733 160.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 172' ' ' GLY . . . . . 0.598 ' HA2' ' H ' ' C' ' 165' ' ' GLY . . . -150.96 84.45 0.16 Allowed Glycine 1 CA--C 1.587 4.575 0 N-CA-C 117.169 1.628 . . . . 74.42 117.169 168.999 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 173' ' ' ASP . . . . . 0.741 ' HA ' ' HA ' ' C' ' 162' ' ' PRO . 29.0 t70 163.05 93.21 0.0 OUTLIER 'General case' 0 N--CA 1.535 3.817 0 C-N-CA 127.58 2.352 . . . . 74.51 108.231 -178.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 174' ' ' LEU . . . . . 0.455 HD23 ' HE3' ' C' ' 164' ' ' MET . 15.1 tp -104.45 139.79 38.87 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 114.724 -1.125 . . . . 75.22 113.035 -162.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 66.9 mt -110.26 92.26 3.98 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.462 1.105 . . . . 72.15 109.398 172.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 176' ' ' LEU . . . . . 0.577 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 68.1 mt -75.29 93.6 2.89 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-N 114.796 -1.093 . . . . 74.33 110.953 175.222 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 177' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' C' ' 122' ' ' GLU . 59.4 t -84.53 101.33 8.91 Favored 'Isoleucine or valine' 0 C--O 1.244 0.777 0 N-CA-C 107.28 -1.378 . . . . 75.23 107.28 172.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 178' ' ' VAL . . . . . . . . . . . . . 28.9 m -76.92 122.05 30.58 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 CA-C-O 121.927 0.87 . . . . 74.01 110.18 -176.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 179' ' ' ARG . . . . . 0.507 ' O ' ' HA ' ' C' ' 124' ' ' PRO . 9.9 mmm180 -113.71 111.87 22.52 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 106.376 -1.713 . . . . 74.42 106.376 174.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 180' ' ' LEU . . . . . . . . . . . . . 53.2 mt -67.8 148.19 51.56 Favored 'General case' 0 CA--C 1.558 1.253 0 CA-C-N 117.619 0.191 . . . . 73.43 111.026 -176.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 181' ' ' LEU . . . . . . . . . . . . . 41.1 mt -53.23 167.75 0.41 Allowed Pre-proline 0 N--CA 1.5 2.068 0 C-N-CA 125.671 1.588 . . . . 74.24 113.827 -171.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -61.66 68.7 0.1 Allowed 'Trans proline' 0 C--N 1.393 2.9 0 C-N-CA 122.861 2.374 . . . . 73.32 110.252 161.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 183' ' ' HIS . . . . . 0.418 ' N ' ' HD3' ' C' ' 184' ' ' PRO . 81.6 t60 172.85 47.52 0.01 OUTLIER Pre-proline 0 CA--C 1.562 1.404 0 C-N-CA 129.031 2.932 . . . . 72.0 104.503 -167.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 184' ' ' PRO . . . . . 0.418 ' HD3' ' N ' ' C' ' 183' ' ' HIS . 85.8 Cg_endo -95.05 63.89 0.23 Allowed 'Trans proline' 0 C--N 1.387 2.573 0 C-N-CA 122.395 2.064 . . . . 74.25 109.713 -167.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 185' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 9.8 t -92.85 -23.02 5.66 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.476 0 CA-C-N 114.748 -1.114 . . . . 72.23 109.271 -168.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 186' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -130.68 101.03 5.51 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 118.746 0.703 . . . . 61.44 110.945 -175.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 187' ' ' ARG . . . . . . . . . . . . . 40.7 ttt85 -94.57 117.27 29.86 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 114.494 -1.23 . . . . 75.14 108.066 171.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 188' ' ' LEU . . . . . 0.494 HD13 ' HA ' ' C' ' 191' ' ' GLN . 61.5 tp -82.03 145.95 29.95 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 121.489 0.661 . . . . 74.14 111.824 -179.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 189' ' ' GLU . . . . . 0.431 ' HA ' ' NE ' ' C' ' 154' ' ' ARG . 31.2 tt0 -143.71 111.98 6.32 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 107.064 -1.458 . . . . 73.21 107.064 164.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 67.49 -100.51 0.61 Allowed Glycine 0 C--N 1.35 1.316 0 N-CA-C 111.271 -0.732 . . . . 74.2 111.271 -171.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 191' ' ' GLN . . . . . 0.494 ' HA ' HD13 ' C' ' 188' ' ' LEU . 48.9 mt-30 -125.61 -6.27 6.93 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.531 0.732 . . . . 75.25 111.136 171.185 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -84.8 138.99 32.26 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 122.892 0.477 . . . . 65.13 110.475 179.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 193' ' ' LEU . . . . . 0.476 HD21 ' CD2' ' C' ' 240' ' ' PHE . 90.4 mt -101.49 163.61 12.18 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.408 0.623 . . . . 65.15 111.142 178.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 194' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -129.82 115.4 17.19 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 114.59 -1.186 . . . . 75.43 108.915 172.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 195' ' ' ALA . . . . . 0.529 ' HA ' ' O ' ' C' ' 185' ' ' VAL . . . -114.59 -178.32 3.34 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.73 0.812 . . . . 65.11 111.242 176.208 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 196' ' ' THR . . . . . 0.434 ' HA ' ' O ' ' C' ' 252' ' ' GLU . 78.1 m -136.32 114.53 11.57 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 108.27 -1.011 . . . . 53.42 108.27 164.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 197' ' ' LEU . . . . . . . . . . . . . 45.7 tp -88.85 132.57 34.6 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 123.814 0.846 . . . . 73.5 110.542 -176.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -88.22 105.32 17.46 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 108.551 -0.907 . . . . 64.33 108.551 175.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 199' ' ' VAL . . . . . 0.548 HG21 ' HH2' ' B' ' 242' ' ' TRP . 51.2 t -115.22 118.5 39.92 Favored Pre-proline 0 N--CA 1.469 0.504 0 N-CA-C 108.019 -1.104 . . . . 73.12 108.019 177.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 200' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.69 138.36 31.8 Favored 'Trans proline' 0 C--N 1.372 1.785 0 C-N-CA 121.76 1.64 . . . . 73.11 110.612 175.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 201' ' ' ALA . . . . . . . . . . . . . . . -41.47 -48.14 9.19 Favored Pre-proline 0 CA--C 1.562 1.411 0 N-CA-C 115.363 1.616 . . . . 74.35 115.363 178.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 202' ' ' PRO . . . . . 0.487 ' HB2' ' HA ' ' A' ' 273' ' ' ALA . 11.9 Cg_endo -53.36 -54.46 4.92 Favored 'Trans proline' 0 C--N 1.386 2.548 0 CA-C-N 121.281 1.493 . . . . 63.15 112.638 176.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 203' ' ' ILE . . . . . . . . . . . . . 63.9 mt -63.74 -29.88 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 123.197 0.599 . . . . 74.02 110.703 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.96 -35.79 78.98 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.995 0.918 . . . . 75.02 112.377 179.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 205' ' ' VAL . . . . . 0.545 HG22 HD12 ' A' ' 257' ' ' ILE . 46.3 t -80.04 -42.8 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 CA-C-O 119.355 -0.355 . . . . 74.52 111.675 179.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 206' ' ' VAL . . . . . . . . . . . . . 10.9 p -80.18 -36.84 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 112.558 0.577 . . . . 74.12 112.558 -172.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 83.31 89.45 0.73 Allowed Glycine 0 C--N 1.344 1.024 0 N-CA-C 111.755 -0.538 . . . . 63.21 111.755 -166.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -127.8 -129.55 3.23 Favored Glycine 0 C--N 1.344 1.006 0 N-CA-C 111.03 -0.828 . . . . 51.32 111.03 177.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 209' ' ' LYS . . . . . 0.576 ' HG2' ' HA ' ' C' ' 222' ' ' ALA . 5.9 mtmp? -136.3 146.95 47.19 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 117.711 0.756 . . . . 72.44 111.71 170.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 210' ' ' VAL . . . . . 0.407 HG21 HG23 ' C' ' 199' ' ' VAL . 33.4 m -128.67 168.22 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 125.225 1.41 . . . . 71.52 107.678 169.075 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 211' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -106.19 136.43 45.91 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 118.117 0.417 . . . . 75.53 111.391 -177.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 212' ' ' ALA . . . . . 0.498 ' HB1' HG12 ' C' ' 219' ' ' VAL . . . -120.56 120.72 36.64 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 107.6 -1.259 . . . . 74.43 107.6 171.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 213' ' ' MET . . . . . 0.426 ' SD ' ' N ' ' C' ' 214' ' ' THR . 8.7 tmm? -71.98 146.38 47.77 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.431 -0.951 . . . . 63.12 108.431 173.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 214' ' ' THR . . . . . 0.538 HG23 ' HD2' ' C' ' 238' ' ' LYS . 0.1 OUTLIER -141.79 168.85 18.78 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 119.035 0.834 . . . . 72.34 112.333 178.165 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 215' ' ' LEU . . . . . 0.528 ' HA ' ' HG3' ' C' ' 128' ' ' GLU . 30.8 mt -62.8 -35.78 80.99 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 124.566 1.146 . . . . 75.24 113.444 -166.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.48 -2.21 15.61 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 114.546 -1.207 . . . . 71.0 111.495 -171.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 164.37 -168.16 38.61 Favored Glycine 0 C--O 1.21 -1.363 0 CA-C-O 119.6 -0.556 . . . . 74.41 111.786 -174.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -94.41 165.42 1.91 Allowed 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 122.302 2.001 . . . . 64.03 112.554 171.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 219' ' ' VAL . . . . . 0.637 ' HB ' ' HE3' ' C' ' 238' ' ' LYS . 2.2 p -142.96 112.9 2.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 108.073 -1.084 . . . . 52.53 108.073 168.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 220' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -90.78 108.12 19.62 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 108.277 -1.009 . . . . 72.32 108.277 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 221' ' ' VAL . . . . . 0.447 ' HA ' ' HB2' ' B' ' 239' ' ' ALA . 39.4 t -71.33 127.15 32.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 114.012 -1.449 . . . . 74.03 112.767 -171.163 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 222' ' ' ALA . . . . . 0.576 ' HA ' ' HG2' ' C' ' 209' ' ' LYS . . . -81.41 109.09 15.57 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 123.713 0.633 . . . . 73.3 109.346 169.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 58.1 t -82.02 139.6 46.13 Favored Pre-proline 0 CA--C 1.558 1.263 0 C-N-CA 124.282 1.033 . . . . 73.11 110.116 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 224' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -84.93 160.81 11.86 Favored 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 122.929 2.419 . . . . 73.11 111.938 170.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 225' ' ' PRO . . . . . 0.532 ' HD3' HG23 ' B' ' 246' ' ' THR . 25.7 Cg_exo -63.36 140.57 77.33 Favored 'Trans proline' 0 C--N 1.372 1.779 0 C-N-CA 122.247 1.965 . . . . 74.4 110.828 169.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 226' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? 70.0 83.62 0.15 Allowed 'General case' 0 N--CA 1.483 1.189 0 O-C-N 124.403 1.065 . . . . 71.5 111.174 177.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 227' ' ' THR . . . . . 0.584 HG21 HD12 ' C' ' 255' ' ' ILE . 52.7 m -128.1 122.05 31.11 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.874 -0.603 . . . . 73.3 112.404 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 228' ' ' GLN . . . . . 0.469 HE21 HG13 ' A' ' 257' ' ' ILE . 26.1 mp0 -108.89 162.28 14.35 Favored 'General case' 0 C--O 1.253 1.259 0 CA-C-O 122.615 1.197 . . . . 74.32 111.152 168.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -65.64 138.29 57.91 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 112.934 -1.939 . . . . 65.31 109.32 175.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 101.56 -4.79 54.21 Favored Glycine 0 CA--C 1.523 0.574 0 CA-C-O 119.616 -0.547 . . . . 62.04 113.012 -174.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 231' ' ' ARG . . . . . . . . . . . . . 43.1 mtt85 -70.19 171.3 9.97 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 108.567 -0.901 . . . . 75.03 108.567 162.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 232' ' ' LYS . . . . . 0.481 ' HA ' ' O ' ' C' ' 251' ' ' LEU . 32.6 ttmt -155.48 126.18 6.92 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.274 0.559 . . . . 74.05 111.744 -178.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 233' ' ' LEU . . . . . 0.612 HD11 ' HB2' ' C' ' 251' ' ' LEU . 4.5 mp -84.92 155.03 21.84 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 114.762 -1.108 . . . . 74.22 110.712 -178.077 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -122.78 100.62 7.0 Favored 'General case' 0 CA--C 1.55 0.953 0 O-C-N 125.099 1.5 . . . . 72.34 108.941 165.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 235' ' ' LEU . . . . . 0.405 HD21 ' H ' ' B' ' 240' ' ' GLY . 61.3 mt -95.22 114.88 26.72 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.495 0.718 . . . . 74.34 109.165 176.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -71.83 130.82 42.0 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.795 0.838 . . . . 73.41 111.899 -174.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 85.01 -12.81 57.0 Favored Glycine 0 C--N 1.352 1.426 0 CA-C-N 116.029 -0.532 . . . . 71.42 113.123 178.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 238' ' ' LYS . . . . . 0.637 ' HE3' ' HB ' ' C' ' 219' ' ' VAL . 68.5 mmtt -92.25 13.13 20.1 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.743 0.817 . . . . 75.11 112.279 -172.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -80.16 -163.25 27.77 Favored Glycine 0 C--N 1.352 1.462 0 N-CA-C 110.992 -0.843 . . . . 75.2 110.992 164.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 240' ' ' PHE . . . . . 0.487 ' HD2' HD11 ' C' ' 188' ' ' LEU . 1.9 m-85 -73.21 124.23 90.36 Favored Pre-proline 0 C--O 1.249 1.036 0 CA-C-N 118.167 0.983 . . . . 75.14 109.141 175.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 241' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' C' ' 240' ' ' PHE . 39.4 Cg_exo -63.51 107.28 0.69 Allowed 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 123.353 2.702 . . . . 71.53 114.381 178.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -79.41 158.3 43.44 Favored Glycine 0 C--N 1.341 0.834 0 CA-C-O 118.904 -0.942 . . . . 70.14 111.371 168.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -57.31 -30.1 86.43 Favored 'Trans proline' 0 C--N 1.374 1.89 0 C-N-CA 123.53 2.82 . . . . 71.42 113.826 -170.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -134.27 17.55 3.72 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.023 0.529 . . . . 71.42 111.439 -177.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 175.77 115.29 0.41 Allowed Glycine 0 C--N 1.346 1.116 0 N-CA-C 111.761 -0.535 . . . . 63.24 111.761 -178.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 246' ' ' ARG . . . . . . . . . . . . . 52.4 mtm180 -82.21 156.33 24.46 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.508 0.723 . . . . 71.32 110.264 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -82.24 -160.93 28.17 Favored Glycine 0 N--CA 1.479 1.509 0 N-CA-C 113.825 0.29 . . . . 63.23 113.825 178.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -133.41 133.31 42.2 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 121.539 0.685 . . . . 73.54 110.647 -175.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 249' ' ' LEU . . . . . . . . . . . . . 19.2 tp -88.96 129.5 35.62 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.108 0.963 . . . . 74.23 110.85 -175.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 250' ' ' TYR . . . . . 0.579 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 26.8 m-85 -112.38 101.62 9.81 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.856 0.863 . . . . 71.43 110.092 177.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 251' ' ' LEU . . . . . 0.612 ' HB2' HD11 ' C' ' 233' ' ' LEU . 3.3 mp -96.94 117.1 30.4 Favored 'General case' 0 N--CA 1.504 2.249 0 C-N-CA 120.845 -0.342 . . . . 72.0 110.59 -175.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 252' ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' C' ' 196' ' ' THR . 6.3 tp10 -70.55 128.94 37.86 Favored 'General case' 0 C--O 1.218 -0.578 0 N-CA-C 108.522 -0.918 . . . . 75.41 108.522 170.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 253' ' ' VAL . . . . . . . . . . . . . 78.1 t -85.41 140.27 16.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 O-C-N 121.815 -0.553 . . . . 73.5 111.306 -174.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 254' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 -128.81 121.57 28.59 Favored 'General case' 0 C--N 1.346 0.456 0 C-N-CA 124.337 1.055 . . . . 75.13 108.899 169.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 255' ' ' ILE . . . . . 0.584 HD12 HG21 ' C' ' 227' ' ' THR . 38.7 mm -87.7 125.97 41.28 Favored 'Isoleucine or valine' 0 C--N 1.344 0.328 0 CA-C-N 115.854 -0.612 . . . . 75.24 109.775 178.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 256' ' ' THR . . . . . . . . . . . . . 43.9 p -121.61 -174.8 2.94 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.024 0.93 . . . . 70.25 111.027 -173.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 257' ' ' ILE . . . . . 0.412 ' HB ' HG21 ' A' ' 205' ' ' VAL . 2.8 pp -140.0 156.45 70.43 Favored Pre-proline 0 CA--C 1.561 1.381 0 C-N-CA 123.408 0.683 . . . . 75.21 110.815 -176.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -56.5 -10.86 5.56 Favored 'Trans proline' 0 C--N 1.387 2.576 0 C-N-CA 124.046 3.164 . . . . 74.41 115.795 -174.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 53.87 -84.62 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 124.772 1.229 . . . . 72.3 110.006 -163.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.28 155.68 39.24 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.012 0.925 . . . . 73.41 110.827 176.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 261' ' ' LEU . . . . . 0.56 ' HG ' HH12 ' A' ' 226' ' ' ARG . 85.2 mt -130.97 141.36 50.25 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.297 0.639 . . . . 74.53 110.161 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 80.6 p -84.65 164.66 41.57 Favored Pre-proline 0 CA--C 1.558 1.279 0 N-CA-C 107.812 -1.181 . . . . 61.23 107.812 166.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -45.61 -41.87 18.82 Favored 'Trans proline' 0 C--N 1.387 2.574 0 C-N-CA 122.783 2.322 . . . . 74.2 113.776 176.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -55.25 -63.37 1.18 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.037 1.335 . . . . 71.04 111.056 175.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -58.4 -41.46 84.95 Favored 'General case' 0 C--N 1.348 0.525 0 CA-C-N 114.442 -1.253 . . . . 71.03 110.719 -176.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 266' ' ' GLU . . . . . 0.54 ' HA ' HD11 ' C' ' 261' ' ' LEU . 11.0 tp10 -56.31 -51.64 67.47 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.908 0.883 . . . . 73.1 110.43 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -59.44 -49.99 75.68 Favored 'General case' 0 CA--C 1.553 1.085 0 CA-C-N 115.747 -0.66 . . . . 71.12 112.114 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 268' ' ' LEU . . . . . . . . . . . . . 10.3 mp -71.4 -38.31 71.47 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 112.536 0.569 . . . . 70.11 112.536 -174.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -70.98 -30.21 66.41 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 122.629 0.371 . . . . 63.11 111.09 177.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 26.8 mmtp -68.14 -40.45 82.44 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 122.913 0.485 . . . . 75.43 111.172 173.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 271' ' ' LYS . . . . . 0.491 ' HB3' HD21 ' A' ' 268' ' ' LEU . 3.4 mmtm -64.14 -41.3 97.25 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 121.048 0.451 . . . . 75.33 111.256 175.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 72.7 mt -61.41 -42.31 98.54 Favored 'General case' 0 C--O 1.217 -0.649 0 CA-C-N 115.728 -0.669 . . . . 74.33 110.177 172.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 273' ' ' ALA . . . . . 0.496 ' HB3' HG21 ' A' ' 206' ' ' VAL . . . -56.51 -43.09 79.41 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.07 0.548 . . . . 43.22 110.899 -179.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -58.66 -52.15 66.9 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.177 0.991 . . . . 63.21 110.845 174.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -57.88 -28.92 64.62 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 115.05 -0.977 . . . . 70.04 112.09 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 276' ' ' TYR . . . . . 0.624 ' HH ' ' HG3' ' A' ' 258' ' ' PRO . 2.6 m-85 -95.87 -17.23 21.27 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.532 0.733 . . . . 75.52 111.943 -179.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 19.5 m-30 -67.41 -33.88 76.1 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.544 -0.91 . . . . 65.52 108.544 168.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -71.66 -1.05 12.37 Favored 'General case' 0 CA--C 1.557 1.228 0 CA-C-N 114.671 -1.15 . . . . 72.22 112.737 173.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 279' ' ' ARG . . . . . . . . . . . . . 30.2 mtp-105 -99.63 -1.71 37.37 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.403 0.681 . . . . 75.11 110.973 171.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.051 0 CA-C-O 118.551 -0.738 . . . . 75.14 109.722 175.671 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.6 mtp . . . . . 0 N--CA 1.476 0.837 0 N-CA-C 109.197 -0.668 . . . . 64.12 109.197 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.8 23.92 14.26 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.465 1.106 . . . . 74.44 111.957 178.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -83.57 65.44 8.45 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.433 0.693 . . . . 74.04 110.672 -174.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -38.46 98.36 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.599 1.56 . . . . 64.14 114.288 -175.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.407 ' NZ ' ' HB3' ' A' ' 94' ' ' SER . 29.3 mmtp -73.18 97.66 2.46 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 107.766 -1.198 . . . . 74.32 107.766 164.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.495 ' HA ' ' OH ' ' A' ' 66' ' ' TYR . 14.3 t70 -74.06 90.55 2.01 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.562 -1.273 . . . . 62.43 107.562 174.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -58.16 -31.69 67.49 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 113.919 -1.491 . . . . 73.34 112.264 -170.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -66.22 -44.56 83.48 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 122.822 0.449 . . . . 73.33 110.736 177.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.73 -41.83 99.36 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 122.992 0.517 . . . . 70.01 110.828 178.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 65.6 mt -58.73 -41.19 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 O-C-N 124.071 0.857 . . . . 74.23 110.683 177.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 87.6 mt -80.11 -12.21 59.69 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 112.681 0.622 . . . . 73.11 112.681 177.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.86 17.85 78.61 Favored Glycine 0 C--N 1.349 1.267 0 O-C-N 122.958 0.161 . . . . 73.42 113.403 -176.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.9 m -101.34 154.4 37.24 Favored Pre-proline 0 N--CA 1.482 1.144 0 C-N-CA 124.075 0.95 . . . . 72.52 109.623 174.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -58.5 154.56 41.21 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 122.695 2.263 . . . . 50.12 113.534 176.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 79.0 mtt180 -77.02 66.7 2.89 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.184 0.994 . . . . 75.43 109.797 177.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -178.86 -25.24 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 114.629 -1.169 . . . . 71.2 109.088 -168.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.21 133.32 39.48 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 125.098 1.359 . . . . 74.14 113.338 -174.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 51.1 p -78.44 172.98 12.85 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.768 0.827 . . . . 75.03 111.16 179.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 22.7 tm0? -50.4 -37.26 36.69 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.814 1.246 . . . . 71.11 111.016 176.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.44 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 0.3 OUTLIER -61.47 -47.56 85.09 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 124.502 1.121 . . . . 72.43 110.217 -179.522 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -70.32 -34.52 72.78 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.308 1.043 . . . . 71.14 111.211 -178.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.5 mp -64.6 -36.96 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.375 1.07 . . . . 73.31 110.04 174.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -73.42 -30.47 63.26 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.766 0.826 . . . . 75.22 110.42 179.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.44 ' HG3' ' O ' ' A' ' 20' ' ' GLU . 95.3 mtt180 -62.02 -54.67 38.24 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.296 0.57 . . . . 73.12 110.031 172.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.8 -34.29 72.84 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 114.541 -1.208 . . . . 72.43 111.61 178.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -62.82 -49.95 72.92 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.957 0.903 . . . . 73.1 111.12 176.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.418 ' HE2' ' HA ' ' A' ' 24' ' ' ARG . 49.5 mtmt -57.57 -55.15 38.55 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 109.799 -0.445 . . . . 74.22 109.799 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.7 ttp-105 -52.57 -65.89 0.48 Allowed 'General case' 0 N--CA 1.479 1.022 0 O-C-N 123.825 0.703 . . . . 75.52 111.523 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.71 ' HB3' HD12 ' A' ' 50' ' ' ILE . 95.4 mt -72.23 -48.7 40.85 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.186 -0.915 . . . . 75.12 112.434 -170.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.75 -15.54 59.73 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 112.872 0.693 . . . . 71.54 112.872 -173.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -81.3 -40.24 23.96 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 119.187 0.903 . . . . 72.33 109.57 165.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -63.43 -33.94 76.65 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 115.46 -0.791 . . . . 73.31 111.84 -179.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.438 ' HB3' ' O ' ' A' ' 43' ' ' ALA . 21.7 m-85 -111.6 15.97 20.85 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.89 0.876 . . . . 72.41 110.474 -175.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -69.8 119.35 70.72 Favored Pre-proline 0 C--N 1.352 0.685 0 C-N-CA 123.492 0.717 . . . . 73.54 109.332 -176.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.468 ' HG3' ' HG2' ' A' ' 44' ' ' GLU . 32.6 Cg_exo -60.51 -8.66 9.34 Favored 'Trans proline' 0 C--N 1.373 1.829 0 C-N-CA 123.12 2.547 . . . . 75.51 114.369 -178.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -73.56 -43.74 59.1 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.965 0.506 . . . . 73.23 110.601 170.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 52.3 t -95.75 -63.66 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 123.286 0.634 . . . . 73.25 110.168 -177.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -98.28 80.58 2.67 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 122.303 1.049 . . . . 64.12 109.223 -173.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -76.43 81.45 3.15 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 114.205 -1.361 . . . . 73.11 109.638 178.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 69.8 m -140.43 113.94 7.38 Favored Pre-proline 0 N--CA 1.475 0.78 0 C-N-CA 124.152 0.981 . . . . 71.24 108.439 174.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -40.82 -46.17 4.86 Favored 'Trans proline' 0 C--N 1.387 2.568 0 C-N-CA 124.31 3.34 . . . . 73.53 114.05 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -54.37 -50.43 67.52 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.679 1.192 . . . . 64.43 109.924 177.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.438 ' O ' ' HB3' ' A' ' 33' ' ' TYR . . . -62.55 -31.86 72.73 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 115.121 -0.945 . . . . 73.42 110.691 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.627 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 47.9 mt-10 -77.4 -34.4 54.82 Favored 'General case' 0 C--O 1.217 -0.626 0 O-C-N 123.75 0.656 . . . . 63.35 109.945 -173.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -65.59 -44.22 87.32 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.533 0.733 . . . . 62.44 109.932 174.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -58.13 -44.94 88.07 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 123.772 0.67 . . . . 74.03 109.869 174.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -58.96 -38.97 80.29 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.085 1.354 . . . . 73.32 110.968 178.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.627 ' HG2' ' O ' ' A' ' 44' ' ' GLU . 32.9 mmtp -66.55 -43.45 85.04 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 122.688 0.395 . . . . 75.14 110.925 179.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -58.59 -42.54 88.3 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 123.855 0.722 . . . . 71.44 111.184 175.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.71 HD12 ' HB3' ' A' ' 29' ' ' LEU . 62.3 mt -76.1 -28.68 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 124.935 1.294 . . . . 74.43 111.321 -176.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.416 ' HA ' ' HB3' ' A' ' 54' ' ' TYR . 13.7 m-80 -93.61 -5.65 48.31 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.587 0.755 . . . . 73.43 111.421 175.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -77.01 -53.47 7.77 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 107.49 -1.3 . . . . 75.34 107.49 164.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.18 -37.09 76.53 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 112.962 -1.927 . . . . 65.45 111.133 176.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.416 ' HB3' ' HA ' ' A' ' 51' ' ' ASN . 61.4 t80 -73.43 -47.27 43.04 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-O 118.811 -0.614 . . . . 73.53 110.537 173.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -50.27 -36.18 30.31 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 123.231 0.613 . . . . 72.52 112.368 -178.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.517 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 61.3 t -78.74 -67.48 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 CA-C-N 114.697 -1.138 . . . . 74.52 110.025 175.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.443 HD22 ' HG2' ' A' ' 63' ' ' ARG . 46.3 mt -80.09 4.59 16.74 Favored 'General case' 0 CA--C 1.564 1.483 0 N-CA-C 113.484 0.92 . . . . 74.35 113.484 -165.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.5 t -76.24 -25.0 54.57 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 123.875 0.87 . . . . 74.34 110.275 174.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -109.99 117.47 51.87 Favored Pre-proline 0 N--CA 1.449 -0.524 0 N-CA-C 107.142 -1.429 . . . . 74.34 107.142 176.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.434 ' O ' ' HG2' ' A' ' 64' ' ' ARG . 84.0 Cg_exo -46.96 -26.47 4.89 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 123.147 2.565 . . . . 72.41 113.318 171.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -63.62 -61.21 2.47 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 122.962 0.505 . . . . 72.3 111.274 175.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.517 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 34.8 mttp -66.79 -26.72 67.09 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 122.375 0.27 . . . . 74.54 111.029 -178.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.443 ' HG2' HD22 ' A' ' 57' ' ' LEU . 4.2 tmt_? -61.58 -48.17 82.2 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.845 1.258 . . . . 74.11 108.826 176.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.434 ' HG2' ' O ' ' A' ' 60' ' ' PRO . 19.7 mmm180 -67.1 -33.84 76.33 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.516 -0.765 . . . . 74.25 111.717 176.325 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.412 HD11 ' HA ' ' A' ' 62' ' ' LYS . 84.5 mt -60.49 -42.87 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 C-N-CA 123.077 0.551 . . . . 74.41 110.169 176.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.495 ' OH ' ' HA ' ' A' ' 6' ' ' ASP . 32.5 t80 -62.76 -51.92 65.23 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.623 -0.717 . . . . 75.4 110.068 175.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -54.17 -41.48 68.57 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 123.826 0.704 . . . . 64.04 111.271 -178.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 68.7 p -79.07 -22.39 45.37 Favored 'General case' 0 C--N 1.348 0.506 0 CA-C-N 115.637 -0.711 . . . . 75.44 111.931 -178.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -70.9 112.46 7.1 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 109.186 -0.672 . . . . 75.32 109.186 177.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 111.34 9.34 21.95 Favored Glycine 0 N--CA 1.473 1.109 0 CA-C-N 115.832 -0.622 . . . . 64.23 111.638 -170.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.8 m -141.44 -59.4 0.48 Allowed 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 104.177 -2.527 . . . . 71.23 104.177 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.5 m -76.64 141.81 40.87 Favored 'General case' 0 C--O 1.252 1.232 0 N-CA-C 104.472 -2.418 . . . . 74.23 104.472 155.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.66 -49.38 6.32 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.243 0.617 . . . . 74.04 111.219 -178.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -97.08 142.49 24.61 Favored Pre-proline 0 N--CA 1.477 0.893 0 C-N-CA 123.037 0.535 . . . . 75.1 110.441 -174.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.403 ' HB2' ' HG3' ' A' ' 103' ' ' PRO . 37.2 Cg_exo -59.34 151.85 65.03 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 123.114 2.543 . . . . 75.41 112.697 174.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.05 158.86 45.52 Favored 'Trans proline' 0 C--N 1.377 2.053 0 C-N-CA 123.216 2.611 . . . . 74.25 114.36 -175.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.96 120.26 7.96 Favored 'Trans proline' 0 C--N 1.386 2.54 0 C-N-CA 123.221 2.614 . . . . 73.45 112.198 171.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.18 118.31 5.6 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 122.859 2.372 . . . . 73.2 112.087 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.58 ' HB2' ' HA3' ' A' ' 142' ' ' GLY . 6.5 Cg_exo -74.16 165.62 31.52 Favored 'Trans proline' 0 CA--C 1.566 2.115 0 C-N-CA 122.868 2.378 . . . . 71.05 111.726 178.151 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_exo -51.91 85.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.393 2.913 0 C-N-CA 123.921 3.081 . . . . 74.31 114.428 -176.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 141.29 -44.89 0.99 Allowed Glycine 0 C--N 1.338 0.69 0 N-CA-C 109.767 -1.333 . . . . 62.41 109.767 178.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.42 -168.19 33.27 Favored Glycine 0 C--N 1.351 1.399 0 C-N-CA 123.38 0.514 . . . . 53.03 113.535 176.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -70.14 100.48 1.66 Allowed 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.476 1.11 . . . . 74.41 110.215 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.475 ' HA ' ' HD2' ' A' ' 106' ' ' PHE . 32.6 t0 -60.84 115.82 3.97 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.84 0.856 . . . . 71.31 109.783 173.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -112.9 70.24 0.71 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.458 1.103 . . . . 73.24 108.374 -174.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 16.1 m -44.57 86.56 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 126.232 1.813 . . . . 74.44 115.479 -164.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 65.44 23.39 70.21 Favored Glycine 0 C--N 1.353 1.489 0 CA-C-N 115.496 -0.774 . . . . 70.11 114.741 173.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -102.4 136.25 42.56 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 109.617 -0.512 . . . . 72.34 109.617 -178.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -77.37 91.16 3.83 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 122.111 -0.368 . . . . 71.44 110.033 -175.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.4 p -34.69 -56.65 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 115.019 1.488 . . . . 75.21 115.019 175.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -64.4 -26.32 68.41 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 118.363 0.529 . . . . 75.33 112.369 -178.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -79.85 -21.04 44.6 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.614 0.765 . . . . 61.35 111.006 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -94.82 170.33 9.51 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 107.974 -1.121 . . . . 73.34 107.974 177.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.407 ' HB3' ' NZ ' ' A' ' 5' ' ' LYS . 80.4 p -60.3 149.65 32.84 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 113.826 1.047 . . . . 74.5 113.826 -165.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.424 ' O ' ' HG3' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -61.06 -30.16 70.16 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 114.893 -1.049 . . . . 74.52 110.486 168.127 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -57.83 -45.07 86.7 Favored 'General case' 0 C--N 1.355 0.812 0 C-N-CA 124.002 0.921 . . . . 75.03 110.838 172.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -63.5 -44.54 94.02 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 115.311 -0.859 . . . . 72.32 109.729 175.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -68.47 -9.8 51.26 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 115.963 -0.562 . . . . 74.14 111.917 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.424 ' HG3' ' O ' ' A' ' 95' ' ' GLU . 38.7 mt-10 -88.78 -59.29 2.27 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 124.119 0.968 . . . . 70.02 111.208 165.099 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 33.8 tp -60.83 -35.67 77.13 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.943 1.297 . . . . 74.33 112.474 -167.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -116.14 6.43 13.95 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.117 0.567 . . . . 72.11 110.67 176.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -42.84 -57.99 3.81 Favored Glycine 0 C--N 1.357 1.721 0 C-N-CA 124.629 1.109 . . . . 72.43 115.131 177.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.403 ' HG3' ' HB2' ' A' ' 75' ' ' PRO . 28.3 Cg_endo -56.88 -19.08 30.17 Favored 'Trans proline' 0 C--N 1.39 2.752 0 C-N-CA 123.264 2.643 . . . . 64.43 113.377 -173.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -142.1 39.89 1.34 Allowed Glycine 0 C--N 1.354 1.563 0 CA-C-O 119.718 -0.49 . . . . 54.4 112.426 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.461 ' HB3' ' ND2' ' A' ' 169' ' ' ASN . 48.6 mt -61.72 72.61 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 123.026 0.53 . . . . 74.25 111.487 169.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.635 ' HB3' ' HA ' ' A' ' 169' ' ' ASN . 2.2 t80 21.09 -106.12 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.432 0 C-N-CA 127.109 2.163 . . . . 74.45 112.774 -170.12 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 58.99 41.41 96.37 Favored Glycine 0 C--N 1.364 2.11 0 CA-C-O 119.744 -0.475 . . . . 44.0 112.644 178.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.82 ' HA3' ' HB3' ' A' ' 167' ' ' GLN . . . -14.11 -70.57 0.01 OUTLIER Glycine 0 C--N 1.367 2.269 0 C-N-CA 124.896 1.236 . . . . 71.34 114.887 165.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -86.42 72.46 10.3 Favored 'General case' 0 C--O 1.251 1.153 0 N-CA-C 108.783 -0.821 . . . . 74.55 108.783 169.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -13.39 -67.84 0.01 OUTLIER Glycine 0 C--N 1.368 2.319 0 C-N-CA 126.03 1.776 . . . . 55.25 115.324 170.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -4.88 -44.08 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.527 0 C-N-CA 127.447 2.299 . . . . 75.52 116.496 162.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.493 ' HG2' ' HB2' ' A' ' 114' ' ' ARG . 59.5 ttt180 -113.77 -35.28 5.21 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.427 0.691 . . . . 75.13 110.755 -172.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 33.0 m 54.51 31.46 14.88 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 124.17 0.988 . . . . 74.21 111.443 -176.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.493 ' HB2' ' HG2' ' A' ' 112' ' ' ARG . 7.6 mmt180 -148.11 -175.28 4.83 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.465 0.706 . . . . 74.52 110.922 -173.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -44.4 143.94 1.16 Allowed 'General case' 0 N--CA 1.479 1.008 0 O-C-N 125.45 1.719 . . . . 73.31 114.907 -163.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -90.22 -173.47 44.89 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-N 115.129 -0.941 . . . . 73.4 113.601 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -93.86 164.07 13.26 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 124.926 1.29 . . . . 74.43 109.572 -177.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -74.25 99.67 3.51 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 121.216 -0.927 . . . . 74.23 109.887 174.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 38.3 tp -95.5 141.19 29.32 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 121.039 0.447 . . . . 75.42 111.484 -167.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -93.0 122.18 35.09 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 107.184 -1.413 . . . . 74.51 107.184 169.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -129.9 168.99 15.77 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.399 -0.593 . . . . 54.41 109.399 176.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -128.91 115.4 17.8 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.482 -0.933 . . . . 72.42 108.482 -175.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 65.3 tp -99.59 100.39 10.71 Favored Pre-proline 0 N--CA 1.472 0.659 0 N-CA-C 108.432 -0.951 . . . . 74.14 108.432 -173.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.52 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 46.4 Cg_endo -67.41 135.86 37.96 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 121.587 1.525 . . . . 75.33 109.535 178.047 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.636 ' HA ' HG23 ' B' ' 6' ' ' ILE . 57.1 tp -146.66 154.93 42.03 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 118.467 0.576 . . . . 72.43 110.311 -176.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 48.5 m -84.67 145.24 28.07 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 124.536 1.134 . . . . 71.34 110.337 178.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.704 ' HB3' HD23 ' A' ' 215' ' ' LEU . 18.7 mt -55.83 -60.55 3.3 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.927 0.891 . . . . 75.21 112.233 -175.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -51.33 -46.37 62.6 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 114.447 -1.252 . . . . 75.32 110.836 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -70.48 -23.94 62.77 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.138 0.975 . . . . 64.33 111.997 -177.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -67.91 -48.01 67.17 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 123.198 0.599 . . . . 65.44 109.596 176.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.424 ' HA ' ' HA2' ' A' ' 152' ' ' GLY . 61.0 t80 -71.85 -28.92 63.88 Favored 'General case' 0 CA--C 1.556 1.199 0 O-C-N 124.015 0.822 . . . . 74.51 111.702 178.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 49.6 m170 -69.61 -53.43 18.85 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 122.663 0.385 . . . . 75.25 111.039 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.556 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 81.19 -167.7 49.65 Favored Glycine 0 CA--C 1.538 1.474 0 CA-C-N 116.266 -0.425 . . . . 71.54 113.199 -178.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.82 -175.75 23.46 Favored Glycine 0 N--CA 1.477 1.41 0 C-N-CA 123.563 0.601 . . . . 70.42 112.205 -179.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.445 ' HB3' ' HB3' ' A' ' 146' ' ' SER . 2.5 mp0 -72.16 108.8 5.53 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.696 -0.853 . . . . 73.14 108.696 176.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 17.8 tpt180 -91.47 127.05 36.76 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.625 -0.88 . . . . 75.05 108.625 -177.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.412 ' HB ' HG22 ' B' ' 5' ' ' THR . 61.6 t -72.7 118.04 17.2 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 N-CA-C 108.779 -0.822 . . . . 75.04 108.779 176.139 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.494 ' HB ' HG12 ' A' ' 145' ' ' VAL . 59.2 t -132.23 115.8 27.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 124.056 0.942 . . . . 73.34 109.236 -175.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -79.62 124.73 28.8 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 109.04 -0.726 . . . . 71.3 109.04 170.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.475 HG22 HD22 ' B' ' 8' ' ' LEU . 12.2 p -167.68 138.13 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 122.899 0.48 . . . . 75.1 110.57 172.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 64.66 12.3 7.45 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.933 1.293 . . . . 74.24 112.205 -178.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.58 ' HA3' ' HB2' ' A' ' 79' ' ' PRO . . . 76.05 20.41 77.6 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-N 116.562 -0.29 . . . . 54.15 113.132 -172.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.469 ' NE ' ' HB3' ' A' ' 84' ' ' ASP . 1.0 OUTLIER -123.85 114.32 19.71 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 107.926 -1.138 . . . . 72.43 107.926 175.866 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 55.0 ttt-85 -73.16 87.57 1.43 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.3 1.04 . . . . 74.41 109.357 176.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.494 HG12 ' HB ' ' A' ' 138' ' ' VAL . 5.7 p -86.06 134.48 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 123.572 0.749 . . . . 73.53 111.136 -176.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.445 ' HB3' ' HB3' ' A' ' 135' ' ' GLU . 15.2 m -94.41 84.86 4.43 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 114.879 -1.055 . . . . 64.43 108.515 174.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 90.0 t -79.92 108.84 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 N-CA-C 108.207 -1.034 . . . . 73.42 108.207 -177.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.415 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 50.5 ttt180 -76.23 92.87 3.32 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 109.116 -0.698 . . . . 74.32 109.116 -177.045 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.63 ' HB ' HG13 ' A' ' 153' ' ' VAL . 42.2 pt -80.1 137.96 53.04 Favored Pre-proline 0 CA--C 1.555 1.163 0 CA-C-N 114.481 -1.236 . . . . 74.52 109.266 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -62.56 141.58 86.74 Favored 'Trans proline' 0 C--N 1.374 1.888 0 C-N-CA 122.519 2.146 . . . . 74.22 112.245 176.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -58.88 93.79 0.08 OUTLIER 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 122.659 2.24 . . . . 74.15 111.045 170.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.424 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . 104.85 77.19 1.13 Allowed Glycine 0 C--N 1.335 0.524 0 CA-C-N 115.032 -0.986 . . . . 75.51 110.85 -172.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.63 HG13 ' HB ' ' A' ' 149' ' ' ILE . 5.8 p -135.01 103.37 4.3 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.239 0 C-N-CA 123.899 0.88 . . . . 75.43 109.248 174.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.608 ' HD2' HD12 ' A' ' 193' ' ' LEU . 60.5 mtt180 -113.32 173.74 6.25 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 113.3 0.852 . . . . 73.23 113.3 -166.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.523 ' HB2' ' HB2' ' A' ' 180' ' ' LEU . 8.6 tp10 -47.65 94.06 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 127.222 2.209 . . . . 72.32 113.965 -167.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 121.49 8.57 7.59 Favored Glycine 0 N--CA 1.478 1.471 0 CA-C-O 119.82 -0.433 . . . . 74.33 114.065 178.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 21.8 t -80.9 147.76 30.18 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 109.048 -0.723 . . . . 74.23 109.048 171.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 61.2 t -114.49 94.15 2.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 C-N-CA 123.584 0.754 . . . . 74.02 109.072 -178.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.579 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 51.7 mt -74.95 95.13 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 N-CA-C 108.212 -1.033 . . . . 75.24 108.212 173.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -79.94 118.01 21.3 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.395 -0.366 . . . . 75.21 110.127 179.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.5 p -118.08 108.89 41.6 Favored Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 123.653 0.781 . . . . 71.41 109.594 175.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -76.37 115.3 4.07 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 123.103 2.536 . . . . 74.53 111.141 175.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 125.56 -28.07 5.08 Favored Glycine 0 CA--C 1.507 -0.458 0 N-CA-C 111.205 -0.758 . . . . 70.43 111.205 176.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 87.9 mtp -94.77 144.21 25.82 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 105.229 -2.137 . . . . 64.15 105.229 162.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 171.4 -124.79 1.14 Allowed Glycine 0 CA--C 1.498 -0.995 0 C-N-CA 121.724 -0.274 . . . . 73.33 112.434 175.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -68.93 160.98 52.11 Favored Glycine 0 C--O 1.245 0.787 0 O-C-N 124.508 0.769 . . . . 74.5 111.967 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.82 ' HB3' ' HA3' ' A' ' 108' ' ' GLY . 31.9 mm-40 -68.87 104.58 2.09 Favored 'General case' 0 CA--C 1.55 0.972 0 O-C-N 125.142 1.143 . . . . 75.42 111.706 -169.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -171.33 162.57 35.24 Favored Glycine 0 C--N 1.344 1.016 0 CA-C-O 118.762 -1.021 . . . . 64.21 112.182 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . 0.635 ' HA ' ' HB3' ' A' ' 106' ' ' PHE . 49.5 t-20 -56.54 -58.69 15.43 Favored Pre-proline 0 N--CA 1.503 2.214 0 CA-C-O 118.288 -0.863 . . . . 63.54 110.571 -171.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.594 ' HD3' ' HB3' ' A' ' 169' ' ' ASN . 12.8 Cg_endo -91.6 97.21 0.21 Allowed 'Trans proline' 0 C--N 1.383 2.376 0 N-CA-C 107.779 -1.662 . . . . 73.02 107.779 157.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.43 165.3 3.32 Favored 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 122.502 2.134 . . . . 71.25 113.861 -170.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -69.0 -118.34 0.03 OUTLIER Glycine 0 N--CA 1.484 1.881 0 N-CA-C 115.401 0.92 . . . . 72.4 115.401 -170.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -135.7 118.89 16.56 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 107.667 -1.234 . . . . 71.14 107.667 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 11.2 tp -105.58 132.46 51.71 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.082 0.467 . . . . 74.2 111.303 -166.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 58.9 mt -108.37 94.69 5.2 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 114.915 -1.039 . . . . 72.12 108.445 176.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.579 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 72.2 mt -78.5 93.84 4.85 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.564 -0.744 . . . . 74.52 109.732 -179.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.0 t -83.4 96.76 4.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 107.498 -1.297 . . . . 71.11 107.498 176.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 12.8 p -65.76 110.37 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.083 0 CA-C-N 115.009 -0.996 . . . . 74.13 111.032 -172.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.52 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 38.8 mmm-85 -96.88 96.14 8.33 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 114.817 -1.083 . . . . 73.42 109.677 179.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.523 ' HB2' ' HB2' ' A' ' 155' ' ' GLU . 29.3 mt -69.59 151.21 46.23 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 122.423 -0.173 . . . . 74.04 110.895 178.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 99.3 mt -51.63 143.08 21.64 Favored Pre-proline 0 N--CA 1.481 1.076 0 C-N-CA 124.173 0.989 . . . . 73.22 111.489 -175.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.2 86.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.387 2.582 0 C-N-CA 123.475 2.784 . . . . 74.32 112.407 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.508 ' HA ' ' HD3' ' A' ' 184' ' ' PRO . 16.3 t-80 -136.96 112.69 9.64 Favored Pre-proline 0 CA--C 1.546 0.823 0 N-CA-C 107.0 -1.482 . . . . 73.35 107.0 -178.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . 0.508 ' HD3' ' HA ' ' A' ' 183' ' ' HIS . 14.2 Cg_exo -70.35 27.05 0.19 Allowed 'Trans proline' 0 CA--C 1.556 1.611 0 C-N-CA 124.42 3.413 . . . . 61.24 117.916 -162.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 14.5 t -94.66 -60.08 2.76 Favored 'Isoleucine or valine' 0 C--N 1.364 1.225 0 CA-C-N 121.102 1.774 . . . . 72.34 109.13 177.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . 0.428 ' HB3' HD22 ' A' ' 193' ' ' LEU . 48.7 m-85 -109.29 140.92 42.33 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 114.765 1.394 . . . . 72.31 114.765 -164.041 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 7.9 tpp180 -145.13 94.38 2.52 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 126.592 1.957 . . . . 75.51 106.839 172.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.513 ' HA ' ' HA ' ' A' ' 193' ' ' LEU . 22.5 tp -75.0 150.24 39.03 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.056 0.942 . . . . 74.21 110.556 173.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -131.25 100.15 5.09 Favored 'General case' 0 C--O 1.244 0.805 0 N-CA-C 107.879 -1.156 . . . . 70.31 107.879 167.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 65.92 -87.51 0.11 Allowed Glycine 0 C--N 1.352 1.448 0 CA-C-N 115.522 -0.763 . . . . 65.41 113.412 176.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.533 HE21 ' HA3' ' A' ' 242' ' ' GLY . 33.3 tt0 -107.04 -35.13 6.96 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.078 0.951 . . . . 72.32 110.931 -175.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.446 ' HB2' ' HE1' ' A' ' 250' ' ' TYR . 10.6 p-10 -108.02 125.13 51.19 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-O 121.699 0.762 . . . . 72.32 110.598 -168.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.608 HD12 ' HD2' ' A' ' 154' ' ' ARG . 0.4 OUTLIER -91.9 125.7 36.7 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.12 -0.946 . . . . 74.25 108.628 -169.985 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.43 ' HA ' ' HB2' ' A' ' 250' ' ' TYR . 39.3 m-85 -95.97 158.25 15.53 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.837 -0.801 . . . . 73.14 108.837 170.113 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 185' ' ' VAL . . . -156.05 176.17 13.01 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 123.155 0.582 . . . . 74.34 109.581 -173.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 35.6 m -130.51 142.08 50.48 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.824 0.849 . . . . 70.21 108.792 172.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 47.6 tp -135.47 125.21 25.41 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 123.796 0.838 . . . . 74.1 109.526 -174.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -82.99 126.2 32.26 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 109.186 -0.672 . . . . 63.3 109.186 170.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 7.5 p -141.19 134.08 14.34 Favored Pre-proline 0 CA--C 1.542 0.662 0 N-CA-C 107.508 -1.293 . . . . 74.33 107.508 175.031 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -78.65 161.22 27.91 Favored 'Trans proline' 0 CA--C 1.545 1.047 0 C-N-CA 121.537 1.491 . . . . 70.05 111.377 169.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.498 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -55.55 -53.89 57.35 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 124.621 1.169 . . . . 71.34 113.899 -171.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -67.53 -28.98 37.78 Favored 'Trans proline' 0 C--N 1.384 2.421 0 CA-C-N 120.769 1.31 . . . . 73.32 112.032 -173.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 17.8 mt -73.74 -34.06 39.75 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 C-N-CA 123.632 0.773 . . . . 71.02 110.318 176.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.79 -38.61 80.12 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 122.858 0.463 . . . . 74.14 111.389 176.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 201' ' ' ALA . 39.9 t -78.43 -42.93 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 123.096 0.558 . . . . 64.22 111.941 -175.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.416 HG11 ' HD2' ' C' ' 270' ' ' LYS . 56.0 t -89.38 -37.81 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 122.507 0.323 . . . . 74.41 111.45 -177.006 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 101.0 105.45 2.8 Favored Glycine 0 C--N 1.337 0.604 0 CA-C-N 116.413 -0.358 . . . . 72.35 112.421 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.422 ' HA3' ' CE1' ' C' ' 277' ' ' TYR . . . -158.69 178.46 34.88 Favored Glycine 0 C--N 1.347 1.152 0 CA-C-N 116.631 0.215 . . . . 73.32 113.163 -178.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.42 ' HE3' ' HB2' ' A' ' 209' ' ' LYS . 38.1 mtmt -79.98 137.38 36.83 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.945 0.498 . . . . 73.34 111.63 -172.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.425 HG12 ' HA ' ' A' ' 199' ' ' VAL . 27.5 m -130.45 151.74 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.83 1.252 . . . . 63.11 108.0 167.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 43.3 ttp180 -84.18 115.13 22.26 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 110.054 -0.35 . . . . 74.32 110.054 -179.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.29 132.09 47.0 Favored 'General case' 0 C--O 1.245 0.832 0 C-N-CA 123.502 0.721 . . . . 74.41 109.415 174.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' MET . . . . . 0.509 ' SD ' ' N ' ' A' ' 213' ' ' MET . 1.0 OUTLIER -86.37 101.79 13.43 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 107.64 -1.244 . . . . 74.15 107.64 178.931 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 60.2 p -111.23 168.99 9.09 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 108.896 -0.779 . . . . 74.1 108.896 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.704 HD23 ' HB3' ' A' ' 127' ' ' LEU . 7.2 mt -79.14 -6.76 57.28 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 120.865 0.364 . . . . 73.14 111.183 -172.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -100.31 -4.36 29.39 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.697 1.199 . . . . 64.44 110.92 173.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 132.67 -175.36 20.02 Favored Glycine 0 C--N 1.351 1.37 0 CA-C-O 120.038 -0.312 . . . . 63.05 113.312 174.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -83.68 101.36 0.92 Allowed 'Trans proline' 0 C--N 1.369 1.628 0 C-N-CA 122.754 2.302 . . . . 74.13 111.155 175.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 34.9 m -101.37 162.2 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 123.151 0.58 . . . . 73.4 109.836 -177.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -100.82 112.63 25.09 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 109.397 -0.594 . . . . 75.04 109.397 176.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.459 HG13 HD13 ' B' ' 441' ' ' ILE . 76.6 t -93.84 106.3 17.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 107.985 -1.117 . . . . 74.51 107.985 177.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -71.91 99.65 2.27 Favored 'General case' 0 C--N 1.347 0.495 0 N-CA-C 107.923 -1.14 . . . . 70.4 107.923 172.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 90.6 t -62.77 133.33 95.04 Favored Pre-proline 0 CA--C 1.543 0.705 0 CA-C-N 114.015 -1.448 . . . . 71.22 109.569 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -58.03 155.63 32.89 Favored 'Trans proline' 0 C--N 1.376 1.986 0 C-N-CA 122.493 2.129 . . . . 75.51 112.614 171.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.33 156.77 64.81 Favored 'Trans proline' 0 C--N 1.372 1.771 0 C-N-CA 121.798 1.665 . . . . 72.53 112.33 172.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . 0.416 HH21 ' HG ' ' C' ' 261' ' ' LEU . 1.5 ptp85 43.53 48.45 6.3 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 126.484 1.914 . . . . 75.13 113.047 -178.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 20.1 m -86.63 115.68 24.25 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 113.053 -1.885 . . . . 64.32 109.815 175.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -87.13 147.3 25.7 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.652 0.781 . . . . 75.32 111.291 -175.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -63.65 132.92 52.61 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.884 0.874 . . . . 65.12 110.9 175.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 99.29 -19.82 52.39 Favored Glycine 0 C--N 1.343 0.924 0 CA-C-O 119.612 -0.549 . . . . 75.54 112.902 177.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 30.1 mtm-85 -77.35 158.93 29.87 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 117.289 0.544 . . . . 74.44 110.424 175.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -108.97 123.46 49.15 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.122 0.969 . . . . 72.22 109.883 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.446 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 57.5 mt -77.9 108.3 11.05 Favored 'General case' 0 C--N 1.348 0.542 0 N-CA-C 108.489 -0.93 . . . . 71.4 108.489 173.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -88.07 109.37 19.8 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 122.96 0.504 . . . . 73.41 110.927 -178.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.539 ' HG ' ' HB3' ' A' ' 249' ' ' LEU . 0.6 OUTLIER -121.85 111.79 17.55 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.15 0.58 . . . . 74.24 111.577 -179.194 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.442 ' HE3' ' HB3' ' A' ' 248' ' ' ASP . 4.2 mmpt? -52.87 147.92 8.36 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.862 1.265 . . . . 71.01 113.096 174.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 101.56 -17.32 55.36 Favored Glycine 0 C--N 1.351 1.377 0 CA-C-N 115.562 -0.745 . . . . 74.2 114.315 173.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -104.91 5.75 33.12 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 112.567 0.58 . . . . 74.1 112.567 -175.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -100.23 174.81 26.59 Favored Glycine 0 C--N 1.349 1.27 0 N-CA-C 112.383 -0.287 . . . . 74.43 112.383 166.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -100.53 163.92 17.24 Favored Pre-proline 0 N--CA 1.48 1.074 0 C-N-CA 125.155 1.382 . . . . 73.41 112.584 -163.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -46.94 140.63 13.07 Favored 'Trans proline' 0 C--N 1.394 2.952 0 C-N-CA 124.23 3.286 . . . . 73.33 114.563 174.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.533 ' HA3' HE21 ' A' ' 191' ' ' GLN . . . 175.75 -167.48 39.33 Favored Glycine 0 CA--C 1.534 1.271 0 CA-C-N 115.422 -0.808 . . . . 73.52 112.122 179.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -56.32 -28.81 73.96 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 123.733 2.956 . . . . 72.5 114.439 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -92.83 22.43 4.85 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.562 0.745 . . . . 70.11 111.843 -178.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 78.18 -93.1 1.19 Allowed Glycine 0 C--N 1.348 1.233 0 N-CA-C 109.762 -1.335 . . . . 62.24 109.762 -172.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 30.3 mtp180 -127.19 148.09 50.19 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.88 0.872 . . . . 75.41 108.904 166.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -78.32 -157.03 9.64 Favored Glycine 0 CA--C 1.535 1.33 0 CA-C-O 121.637 0.576 . . . . 70.31 113.902 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . 0.442 ' HB3' ' HE3' ' A' ' 236' ' ' LYS . 0.4 OUTLIER -134.49 165.0 26.2 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.404 1.081 . . . . 75.44 111.223 -174.96 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.539 ' HB3' ' HG ' ' A' ' 235' ' ' LEU . 61.6 tp -100.39 153.31 19.44 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.493 1.117 . . . . 73.32 109.756 178.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.446 ' HE1' ' HB2' ' A' ' 192' ' ' ASP . 62.9 m-85 -128.65 103.6 7.18 Favored 'General case' 0 C--O 1.219 -0.536 0 N-CA-C 108.873 -0.788 . . . . 71.3 108.873 177.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.446 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 32.8 mt -90.09 104.16 16.76 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.122 -0.696 . . . . 74.54 109.122 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -77.36 125.27 29.07 Favored 'General case' 0 C--N 1.362 1.141 0 CA-C-O 121.64 0.734 . . . . 75.41 109.933 -176.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 61.1 t -78.76 117.61 24.6 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-N 114.271 -1.331 . . . . 71.34 111.701 -169.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 15.8 mmm-85 -114.49 96.17 5.63 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.126 -1.064 . . . . 73.14 108.126 170.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.496 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 69.8 mt -75.44 133.95 30.27 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 CA-C-N 114.86 -1.064 . . . . 74.34 110.12 178.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 22.6 p -126.09 -177.95 4.13 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.865 1.266 . . . . 74.52 110.144 178.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . 0.539 HG23 HG21 ' C' ' 255' ' ' ILE . 2.4 pp -139.01 159.66 65.93 Favored Pre-proline 0 N--CA 1.491 1.589 0 C-N-CA 123.803 0.841 . . . . 73.4 110.655 -177.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -60.96 -9.44 12.06 Favored 'Trans proline' 0 C--N 1.393 2.903 0 C-N-CA 123.112 2.541 . . . . 74.45 115.519 -167.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.724 ' HG2' HE21 ' C' ' 228' ' ' GLN . 42.4 mt-10 57.0 -64.92 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 125.824 1.649 . . . . 75.12 114.288 -174.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' ARG . . . . . 0.529 ' HB2' ' HG3' ' B' ' 376' ' ' GLU . 0.0 OUTLIER -92.15 157.16 16.87 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 109.326 -0.62 . . . . 75.12 109.326 168.157 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.594 HD11 ' HA ' ' A' ' 266' ' ' GLU . 64.2 mt -141.9 131.47 23.95 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 118.287 0.494 . . . . 72.32 111.237 -178.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.46 148.35 52.1 Favored Pre-proline 0 CA--C 1.555 1.143 0 N-CA-C 107.702 -1.222 . . . . 74.31 107.702 167.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' PRO . . . . . 0.51 ' HG3' HD22 ' B' ' 375' ' ' LEU . 56.0 Cg_exo -40.8 -31.82 0.76 Allowed 'Trans proline' 0 C--N 1.392 2.838 0 C-N-CA 124.939 3.76 . . . . 74.33 116.58 -167.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -61.38 -68.08 0.35 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.448 0.699 . . . . 71.44 110.758 176.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . 0.533 ' HB2' HD22 ' A' ' 261' ' ' LEU . 1.7 mp0 -67.17 -28.28 67.98 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 123.487 0.492 . . . . 73.22 110.28 -175.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 266' ' ' GLU . . . . . 0.594 ' HA ' HD11 ' A' ' 261' ' ' LEU . 8.3 tp10 -50.38 -58.46 5.65 Favored 'General case' 0 C--O 1.253 1.249 0 C-N-CA 124.258 1.023 . . . . 73.45 109.459 171.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . 0.447 ' O ' ' HG2' ' A' ' 271' ' ' LYS . . . -59.13 -58.43 8.67 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 114.702 -1.135 . . . . 64.12 111.15 177.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 10.2 mp -57.6 -45.92 84.69 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 123.852 0.861 . . . . 73.14 112.854 -170.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 63.3 m95 -60.23 -46.92 88.1 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 123.749 0.655 . . . . 75.0 110.805 175.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . 0.614 ' HE2' ' HA ' ' C' ' 206' ' ' VAL . 2.2 mptm? -63.05 -34.33 77.35 Favored 'General case' 0 CA--C 1.548 0.874 0 O-C-N 123.727 0.642 . . . . 73.12 112.03 178.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' A' ' 267' ' ' ALA . 26.4 mmmt -73.96 -40.31 63.12 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 118.084 0.402 . . . . 70.22 110.366 -177.558 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 39.5 mt -57.72 -39.38 77.11 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 123.467 0.707 . . . . 71.54 110.204 170.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -65.97 -45.1 82.92 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 124.129 0.893 . . . . 72.23 112.644 -177.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -67.35 -42.85 82.83 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.811 0.844 . . . . 74.35 110.763 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -62.53 -44.13 97.1 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.38 -0.827 . . . . 72.24 110.231 177.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -63.69 -44.25 94.25 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.415 1.086 . . . . 75.02 109.909 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -62.71 -43.6 98.4 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.82 1.248 . . . . 72.14 109.492 -177.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -75.02 -5.03 41.83 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 115.236 -0.893 . . . . 75.41 112.563 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 43.7 mtm180 -115.38 -0.88 13.01 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.808 0.843 . . . . 75.15 110.08 173.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.1 0 N-CA-C 108.546 -0.909 . . . . 72.5 108.546 178.975 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.425 ' N ' ' SD ' ' B' ' 1' ' ' MET . 1.6 mpt? . . . . . 0 N--CA 1.476 0.874 0 N-CA-C 109.627 -0.509 . . . . 74.12 109.627 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 85.1 tttt 65.43 143.89 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 125.483 1.513 . . . . 62.45 111.906 -176.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 64.64 1.66 1.43 Allowed 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 125.164 1.386 . . . . 74.04 113.479 -178.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 43.3 m -72.57 95.28 1.8 Allowed 'General case' 0 C--N 1.354 0.797 0 C-N-CA 123.468 0.707 . . . . 52.14 109.111 -179.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' THR . . . . . 0.412 HG22 ' HB ' ' A' ' 137' ' ' VAL . 0.1 OUTLIER -83.39 160.85 21.53 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.418 -0.81 . . . . 74.34 111.102 -171.879 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.636 HG23 ' HA ' ' A' ' 125' ' ' LEU . 38.5 pt -130.34 168.89 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 112.943 0.72 . . . . 65.34 112.943 -154.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -145.25 124.78 13.17 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.82 0.848 . . . . 72.22 108.975 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . 0.475 HD22 HG22 ' A' ' 140' ' ' VAL . 60.7 tp -63.53 138.3 58.46 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.066 0.946 . . . . 75.22 110.894 -174.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.52 -48.63 80.9 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 124.183 0.927 . . . . 73.12 111.074 177.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 6.1 tt 53.67 89.79 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.155 0 O-C-N 124.53 1.144 . . . . 74.1 108.957 -172.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 91.7 mt -66.44 112.06 8.36 Favored Pre-proline 0 CA--C 1.547 0.833 0 N-CA-C 110.045 -0.354 . . . . 72.11 110.045 -176.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -83.85 -152.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.373 1.826 0 C-N-CA 122.839 2.36 . . . . 71.41 111.969 -173.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . 0.549 ' H ' HD21 ' B' ' 13' ' ' LEU . 2.6 pt? -87.78 19.86 3.29 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 123.044 0.538 . . . . 75.11 111.079 175.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 6.0 tt -153.15 100.09 2.44 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 107.62 -1.252 . . . . 64.54 107.62 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -159.88 17.16 0.15 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.353 0.661 . . . . 74.01 111.122 175.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 16' ' ' THR . . . . . 0.541 HG23 HG23 ' B' ' 18' ' ' VAL . 9.5 t -70.93 140.48 86.13 Favored Pre-proline 0 CA--C 1.561 1.397 0 C-N-CA 123.28 0.632 . . . . 71.11 111.437 -175.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -80.12 24.54 0.64 Allowed 'Trans proline' 0 C--N 1.386 2.531 0 C-N-CA 123.428 2.752 . . . . 71.22 114.234 -175.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.541 HG23 HG23 ' B' ' 16' ' ' THR . 32.7 m -68.01 -14.4 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 123.494 0.718 . . . . 63.3 111.998 176.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 9.9 t -63.63 -21.02 66.14 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.841 0.856 . . . . 71.22 111.814 174.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -111.44 46.21 1.13 Allowed 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 124.155 0.982 . . . . 74.33 108.555 175.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.1 -34.46 77.68 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 115.738 -0.665 . . . . 75.34 111.304 177.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.52 75.98 5.86 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 121.616 0.722 . . . . 73.31 109.292 177.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 23' ' ' THR . . . . . 0.435 ' HB ' ' HD3' ' B' ' 24' ' ' PRO . 73.7 m -88.86 -47.25 0.43 Allowed Pre-proline 0 CA--C 1.556 1.199 0 N-CA-C 108.605 -0.887 . . . . 72.54 108.605 162.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . 0.532 ' HA ' ' NH1' ' C' ' 154' ' ' ARG . 84.4 Cg_endo -92.84 101.43 0.16 Allowed 'Trans proline' 0 C--N 1.391 2.814 0 C-N-CA 121.803 1.669 . . . . 74.55 111.578 167.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -76.13 -72.76 0.31 Allowed 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.072 -0.714 . . . . 74.53 109.072 175.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 26' ' ' MET . . . . . 0.412 ' HB2' ' NH2' ' C' ' 154' ' ' ARG . 15.4 tmm? 58.92 88.87 0.12 Allowed Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 125.036 1.334 . . . . 75.13 110.844 -178.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_exo -47.55 115.61 1.48 Allowed 'Trans proline' 0 C--N 1.372 1.809 0 C-N-CA 122.568 2.179 . . . . 73.04 111.107 164.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 7.7 p -70.95 76.19 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.392 0 CA-C-O 123.221 1.486 . . . . 75.25 111.588 -172.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -121.69 90.32 3.29 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 113.968 -1.469 . . . . 73.34 107.489 177.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -134.71 -74.76 0.47 Allowed 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 107.455 -1.313 . . . . 71.25 107.455 177.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 43.7 t30 56.19 -84.33 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 124.576 1.15 . . . . 74.34 111.447 -178.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -137.9 85.94 2.14 Favored 'General case' 0 C--N 1.351 0.636 0 C-N-CA 124.989 1.316 . . . . 72.22 108.157 177.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.42 79.57 8.83 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 109.08 -0.711 . . . . 73.31 109.08 175.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -93.16 -3.3 54.2 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.861 0.865 . . . . 53.33 112.043 -175.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -79.35 83.0 5.43 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-O 122.162 0.982 . . . . 73.13 111.121 179.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -148.98 -128.78 1.72 Allowed Glycine 0 C--N 1.338 0.666 0 N-CA-C 108.407 -1.877 . . . . 74.33 108.407 172.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 29.8 t70 64.16 -70.81 0.07 Allowed 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 125.068 1.347 . . . . 61.44 113.026 168.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 36.1 mm -67.56 -26.66 36.07 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.968 0 C-N-CA 124.066 0.946 . . . . 75.44 110.902 176.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 42.9 p -62.25 89.76 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 123.588 0.755 . . . . 73.32 112.328 -176.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -164.02 98.46 0.94 Allowed Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 124.537 1.135 . . . . 73.24 108.041 -178.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -72.44 85.09 1.11 Allowed 'Trans proline' 0 C--N 1.372 1.783 0 C-N-CA 123.058 2.505 . . . . 72.44 112.566 -178.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -78.29 140.12 23.34 Favored Glycine 0 C--N 1.347 1.161 0 CA-C-N 115.641 -0.709 . . . . 61.22 111.904 177.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.27 -24.63 29.42 Favored Glycine 0 C--N 1.346 1.105 0 CA-C-O 119.765 -0.464 . . . . 64.32 112.363 -175.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . 65.45 4.2 2.65 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 124.931 1.293 . . . . 63.2 113.507 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 31.0 tpt180 61.4 -74.22 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 125.392 1.477 . . . . 74.21 111.598 -170.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 46' ' ' ARG . . . . . 0.45 ' HG2' ' HB3' ' B' ' 234' ' ' ALA . 17.3 tpp180 -142.9 -81.81 0.19 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.61 0.764 . . . . 75.02 109.628 -171.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 8.9 mp 54.8 -88.0 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 123.716 0.806 . . . . 72.13 110.991 -167.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 92.9 m 71.42 -47.0 0.65 Allowed 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 125.632 1.573 . . . . 73.12 112.812 -176.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.94 64.15 3.73 Favored Glycine 0 C--N 1.347 1.175 0 C-N-CA 123.243 0.449 . . . . 74.15 113.542 178.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -136.69 -11.18 1.81 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.618 1.167 . . . . 64.2 109.797 176.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 57.0 tp60 67.13 80.38 0.22 Allowed 'General case' 0 C--N 1.362 1.11 0 C-N-CA 124.97 1.308 . . . . 75.3 109.93 -175.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 18.3 m -83.23 78.15 9.66 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.399 0.68 . . . . 73.31 110.083 -178.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . 58.41 -82.52 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 125.204 1.402 . . . . 73.24 111.7 -178.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . 55.64 -88.0 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.233 1.413 . . . . 75.51 112.605 174.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . 0.531 ' HB3' ' HG3' ' B' ' 350' ' ' LYS . 0.6 OUTLIER 72.14 -49.58 0.69 Allowed 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 126.071 1.748 . . . . 72.35 111.412 -177.404 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 36.1 ttm180 77.2 144.56 0.08 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 125.18 1.392 . . . . 74.21 110.889 172.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 26.2 t70 66.43 -99.53 0.06 Allowed 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 124.6 1.16 . . . . 75.31 110.745 -174.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 26.2 p -179.39 -79.41 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.226 1.011 . . . . 62.01 109.768 -174.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . 0.512 ' HB3' ' HH ' ' B' ' 297' ' ' TYR . 92.6 mt -142.68 -77.51 0.25 Allowed 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 107.911 -1.144 . . . . 72.44 107.911 -174.148 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 49.2 m 51.32 -79.18 0.01 OUTLIER 'General case' 0 C--N 1.366 1.283 0 C-N-CA 125.665 1.586 . . . . 71.31 113.466 -177.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . 0.43 ' HB3' ' HB3' ' B' ' 222' ' ' ALA . 38.6 t70 -84.4 170.81 13.19 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.875 0.87 . . . . 71.45 112.243 -171.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 62' ' ' LYS . . . . . 0.518 ' HZ1' ' HB2' ' B' ' 62' ' ' LYS . 0.0 OUTLIER 79.5 65.36 0.18 Allowed Pre-proline 0 C--N 1.351 0.668 0 C-N-CA 126.844 2.058 . . . . 72.42 108.578 -178.405 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . 0.518 ' HB2' ' HB1' ' B' ' 295' ' ' ALA . 35.6 Cg_endo -86.01 41.2 0.82 Allowed 'Trans proline' 0 C--N 1.378 2.079 0 C-N-CA 123.739 2.959 . . . . 72.24 111.543 -173.311 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -138.94 -24.96 0.89 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.537 1.135 . . . . 72.04 110.769 -172.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.481 ' HG3' ' H ' ' B' ' 66' ' ' ASN 0.257 21.3 ptmt 46.79 -77.48 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.316 0 C-N-CA 125.829 1.652 . . . . 73.42 113.109 -169.211 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 66' ' ' ASN . . . . . 0.481 ' H ' ' HG3' ' B' ' 65' ' ' LYS . 45.6 t30 -80.11 -65.4 1.01 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.638 0.775 . . . . 72.41 109.263 175.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 4.0 tt -175.11 34.87 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.563 1.47 0 N-CA-C 107.621 -1.251 . . . . 74.04 107.621 -173.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 78.4 mt 72.56 -58.36 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 C-N-CA 126.01 1.724 . . . . 73.4 109.994 -168.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 67.7 mt -74.02 148.79 41.67 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.287 1.035 . . . . 74.34 110.509 175.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 3.2 tt -166.83 90.8 0.4 Allowed 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 109.434 -0.58 . . . . 65.22 109.434 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . 0.556 HG21 ' H ' ' B' ' 73' ' ' ASP . 9.0 tp 175.17 -25.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 C-N-CA 125.535 1.534 . . . . 75.5 108.884 169.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.89 -36.32 3.26 Favored Glycine 0 C--N 1.341 0.819 0 N-CA-C 108.981 -1.648 . . . . 71.15 108.981 -172.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . 0.556 ' H ' HG21 ' B' ' 71' ' ' ILE . 5.0 m-20 72.6 23.96 2.93 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.587 1.555 . . . . 74.12 113.608 161.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -80.36 55.3 4.62 Favored Glycine 0 C--N 1.349 1.27 0 N-CA-C 110.758 -0.937 . . . . 72.45 110.758 164.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 14.4 tpt -162.42 18.24 0.09 Allowed 'General case' 0 CA--C 1.559 1.318 0 C-N-CA 124.796 1.239 . . . . 74.01 108.657 -170.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . -62.68 -40.56 99.33 Favored Glycine 0 C--N 1.361 1.964 0 CA-C-N 116.055 -0.52 . . . . 71.52 112.493 -177.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 32.0 t70 69.65 -73.05 0.1 Allowed 'General case' 0 C--N 1.357 0.894 0 C-N-CA 125.448 1.499 . . . . 74.35 113.085 167.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 34.1 m -90.53 -78.85 0.37 Allowed 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.353 0.661 . . . . 55.34 111.745 -174.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . 0.417 ' HA ' ' HB2' ' B' ' 82' ' ' ALA . 0.0 OUTLIER -148.22 -159.02 0.97 Allowed 'General case' 0 N--CA 1.485 1.324 0 CA-C-O 118.704 -0.665 . . . . 74.44 109.712 -174.664 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . 0.516 HG13 ' H ' ' B' ' 81' ' ' THR 0.296 49.7 pt 54.14 -69.47 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 C-N-CA 127.372 2.269 . . . . 72.52 114.028 179.987 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 81' ' ' THR . . . . . 0.516 ' H ' HG13 ' B' ' 80' ' ' ILE . 32.7 m -66.43 -36.3 82.46 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.251 0.62 . . . . 74.52 109.63 171.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . 0.417 ' HB2' ' HA ' ' B' ' 79' ' ' GLU . . . -67.08 -36.46 82.03 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.094 0.957 . . . . 75.12 111.337 174.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.64 -25.66 64.04 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.543 0.737 . . . . 74.13 111.066 176.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 56.7 ttt180 68.48 -79.22 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.214 1.406 . . . . 73.0 111.766 173.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -158.42 19.7 0.23 Allowed 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.227 0.611 . . . . 72.23 110.573 -179.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 61.2 t80 69.96 -70.96 0.13 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.829 1.252 . . . . 74.21 110.443 -169.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . 66.65 -77.9 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.78 1.232 . . . . 52.24 110.987 -179.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -125.5 149.36 48.34 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.901 0.881 . . . . 74.14 109.416 178.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 167.72 -0.42 0.04 OUTLIER Glycine 0 C--N 1.342 0.897 0 CA-C-O 119.242 -0.754 . . . . 54.33 113.423 177.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . 74.94 -60.13 0.53 Allowed 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 125.386 1.474 . . . . 75.53 112.355 177.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . 0.467 ' HA2' ' HE1' ' B' ' 94' ' ' PHE . . . -82.23 66.53 3.86 Favored Glycine 0 C--N 1.351 1.368 0 C-N-CA 123.206 0.431 . . . . 70.11 113.516 -178.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -98.96 51.36 1.16 Allowed Glycine 0 C--N 1.342 0.916 0 CA-C-O 119.885 -0.397 . . . . 73.42 112.198 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 66.8 125.59 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 125.277 1.431 . . . . 74.22 112.231 -177.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 94' ' ' PHE . . . . . 0.467 ' HE1' ' HA2' ' B' ' 91' ' ' GLY . 71.3 m-85 -125.98 -170.34 2.17 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.052 0.941 . . . . 72.14 110.278 -178.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt 67.92 -82.45 0.03 OUTLIER 'General case' 0 C--N 1.363 1.158 0 C-N-CA 125.395 1.478 . . . . 74.44 110.561 -178.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 173.58 65.18 0.05 OUTLIER Glycine 0 C--N 1.332 0.36 0 N-CA-C 109.299 -1.521 . . . . 75.21 109.299 -175.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 10.8 tp -62.72 146.18 12.87 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 C-N-CA 123.706 0.802 . . . . 73.0 110.802 -177.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -77.37 3.52 12.99 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.334 1.053 . . . . 75.21 112.361 -179.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -114.39 95.12 5.11 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.022 0.929 . . . . 61.12 109.484 177.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 93.9 mt -77.19 126.24 85.47 Favored Pre-proline 0 N--CA 1.48 1.027 0 C-N-CA 123.261 0.625 . . . . 74.2 109.759 176.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -63.77 133.18 37.99 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 122.749 2.299 . . . . 74.43 111.639 175.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . 0.515 HD12 ' HE2' ' B' ' 106' ' ' TYR 0.267 0.1 OUTLIER 38.55 -92.08 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.353 0 C-N-CA 126.568 1.947 . . . . 73.12 113.803 -175.22 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 7.2 m 58.71 -80.97 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 125.046 1.339 . . . . 75.52 112.446 -178.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . -75.28 -18.61 79.97 Favored Glycine 0 C--N 1.356 1.647 0 CA-C-O 120.117 -0.268 . . . . 51.35 112.86 -179.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -69.31 -5.33 22.48 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.4 0.68 . . . . 75.22 112.149 177.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 106' ' ' TYR . . . . . 0.515 ' HE2' HD12 ' B' ' 102' ' ' LEU . 76.6 m-85 -81.86 -53.01 6.52 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 123.586 0.754 . . . . 74.44 110.154 169.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 50.6 m 69.9 -34.69 0.29 Allowed 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 125.369 1.468 . . . . 75.34 114.002 176.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -61.85 93.44 0.04 OUTLIER 'General case' 0 C--N 1.361 1.081 0 C-N-CA 124.958 1.303 . . . . 73.44 109.804 178.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 65.8 t80 176.8 -15.95 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.093 1.757 . . . . 74.1 108.547 -170.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . 0.492 ' HB2' ' HB3' ' B' ' 282' ' ' ALA . . . -58.21 -49.92 75.37 Favored 'General case' 0 C--N 1.353 0.718 0 C-N-CA 124.44 1.096 . . . . 75.22 111.187 179.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -99.38 78.41 2.2 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 107.258 -1.386 . . . . 70.25 107.258 169.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -153.72 71.45 0.87 Allowed 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 108.221 -1.029 . . . . 73.2 108.221 173.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 113' ' ' LYS . . . . . 0.427 ' HG2' ' O ' ' B' ' 256' ' ' TYR . 16.5 tppt? -164.62 -82.96 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 114.576 -1.193 . . . . 75.13 109.221 174.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -168.19 110.53 0.58 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.128 0.571 . . . . 74.21 109.508 -170.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 8.9 m 63.55 155.69 0.06 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 124.648 1.179 . . . . 73.23 112.424 177.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 125.93 -168.97 17.92 Favored Glycine 0 C--N 1.346 1.088 0 N-CA-C 111.522 -0.631 . . . . 55.33 111.522 179.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . 0.566 ' HE2' ' HE2' ' B' ' 120' ' ' TYR . 13.8 mmmm -135.82 -56.57 0.02 OUTLIER Pre-proline 0 CA--C 1.566 1.594 0 N-CA-C 114.079 1.14 . . . . 75.35 114.079 -178.152 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 118' ' ' PRO . . . . . 0.683 ' HB2' ' HA ' ' B' ' 281' ' ' PHE . 71.1 Cg_endo -65.26 128.59 20.77 Favored 'Trans proline' 0 C--N 1.389 2.664 0 C-N-CA 122.195 1.93 . . . . 63.21 112.654 -161.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 119' ' ' ASP . . . . . . . . . . . . . 20.7 t70 169.47 -41.04 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 125.258 1.423 . . . . 75.33 109.16 -176.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 120' ' ' TYR . . . . . 0.566 ' HE2' ' HE2' ' B' ' 117' ' ' LYS . 0.2 OUTLIER -76.33 -153.72 0.05 OUTLIER 'General case' 0 CA--C 1.558 1.251 0 CA-C-N 113.654 -1.612 . . . . 70.1 112.455 -175.729 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 121' ' ' VAL . . . . . 0.489 ' HB ' ' H ' ' B' ' 221' ' ' ARG . 7.6 p -135.89 114.3 15.4 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.162 0 C-N-CA 124.075 0.95 . . . . 74.32 109.463 165.142 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 1.4 m 64.96 24.57 12.67 Favored 'General case' 0 CA--C 1.566 1.567 0 C-N-CA 124.915 1.286 . . . . 75.25 113.454 168.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 67.63 -79.36 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 C-N-CA 124.647 1.179 . . . . 70.53 111.828 174.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 41.4 t -70.04 -55.34 9.79 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 125.087 1.355 . . . . 61.03 110.642 -175.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . 68.85 -64.26 0.33 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 125.381 1.473 . . . . 74.53 112.366 178.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -129.94 13.92 5.78 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.772 0.829 . . . . 74.13 111.177 177.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 30.8 t 62.94 86.78 0.11 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.408 1.083 . . . . 70.01 111.357 -179.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . 68.69 -73.36 0.09 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 125.247 1.419 . . . . 74.33 111.387 -175.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 12.6 t -156.67 5.33 0.16 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.219 1.008 . . . . 74.41 110.29 176.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . 55.88 -87.29 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.177 1.391 . . . . 61.42 111.327 -168.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 3.6 p90 -164.43 164.38 22.03 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.944 1.297 . . . . 73.51 109.245 -175.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 15.0 m -86.4 92.46 8.84 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.082 0.553 . . . . 74.11 110.083 -179.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 12.9 m 70.79 97.02 0.07 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.915 1.286 . . . . 74.52 111.561 175.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . -167.49 159.54 32.89 Favored Glycine 0 C--N 1.346 1.114 0 CA-C-O 119.763 -0.465 . . . . 55.15 112.788 176.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 135' ' ' VAL . . . . . . . . . . . . . 61.9 t 61.65 -81.46 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 125.113 1.365 . . . . 73.24 111.413 -178.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 136' ' ' LYS . . . . . 0.437 ' HB3' ' HD2' ' B' ' 138' ' ' TYR . 60.8 tttp -79.96 -21.26 43.96 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.064 0.546 . . . . 74.24 110.648 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 19.3 m 77.5 -44.5 0.43 Allowed 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 125.021 1.329 . . . . 75.31 111.09 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 138' ' ' TYR . . . . . 0.437 ' HD2' ' HB3' ' B' ' 136' ' ' LYS 0.25 3.6 p90 47.78 -80.24 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 127.043 2.137 . . . . 75.52 114.756 170.577 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -69.46 -24.44 63.79 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 122.97 0.508 . . . . 73.24 111.272 -176.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . 98.51 -77.32 0.56 Allowed Glycine 0 C--N 1.351 1.362 0 O-C-N 123.974 0.796 . . . . 75.54 112.334 176.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . 64.9 -76.62 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 125.082 1.353 . . . . 75.34 112.009 -178.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 2.0 pp -108.26 -10.07 15.42 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.712 0.805 . . . . 74.24 111.529 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -124.51 167.23 16.87 Favored Glycine 0 C--N 1.353 1.487 0 C-N-CA 123.658 0.647 . . . . 61.25 112.09 178.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 7.8 p 39.6 43.26 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 C-N-CA 126.126 1.77 . . . . 75.31 112.417 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -66.91 104.39 1.35 Allowed 'General case' 0 C--O 1.244 0.782 0 CA-C-N 114.899 -1.046 . . . . 75.32 108.364 -178.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 73.3 mt 72.63 -63.16 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 125.337 1.455 . . . . 72.52 110.794 -174.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 25.7 t-80 -159.39 -61.57 0.07 Allowed 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 121.051 0.453 . . . . 72.43 110.134 -178.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -110.59 -117.18 0.3 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.758 0.823 . . . . 75.05 109.424 -175.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 149' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt 69.01 -69.31 0.16 Allowed 'General case' 0 C--N 1.369 1.435 0 C-N-CA 125.517 1.527 . . . . 74.13 111.879 175.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -86.08 -37.35 18.93 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.455 0.702 . . . . 74.11 110.94 174.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 30.9 t-80 -64.78 105.72 0.8 Allowed Pre-proline 0 CA--C 1.557 1.224 0 C-N-CA 124.636 1.174 . . . . 74.43 111.52 -174.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -93.7 -31.2 0.07 OUTLIER 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 122.992 2.461 . . . . 64.13 114.452 -175.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 153' ' ' THR . . . . . 0.412 ' HG1' ' HA ' ' B' ' 205' ' ' LEU . 21.7 p -103.82 99.18 8.95 Favored 'General case' 0 C--N 1.349 0.546 0 C-N-CA 123.77 0.828 . . . . 74.2 110.493 -170.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 3.1 mp -90.62 -29.86 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-N 115.294 -0.866 . . . . 74.25 109.51 174.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 93.8 mt -65.32 85.09 0.06 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.5 0.72 . . . . 73.12 111.617 -176.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 60.35 103.18 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.774 1.63 . . . . 72.23 112.423 176.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 157' ' ' MET . . . . . 0.451 ' HB3' ' HG2' ' B' ' 207' ' ' LYS . 1.9 mpt? -71.36 -21.69 62.0 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.626 0.77 . . . . 61.13 110.766 176.023 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 158' ' ' ALA . . . . . . . . . . . . . . . -69.52 -20.59 63.7 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.067 0.947 . . . . 65.11 111.967 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 33.7 mmtm -53.89 -35.83 62.02 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.941 0.896 . . . . 73.24 111.595 174.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -79.03 74.41 5.56 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.447 0.699 . . . . 74.34 110.285 176.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -87.61 81.92 7.58 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.628 -0.714 . . . . 71.1 109.947 179.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 83.96 -72.11 2.87 Favored Glycine 0 C--N 1.347 1.144 0 CA-C-N 115.772 -0.649 . . . . 73.4 112.716 178.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . 0.274 2.4 pp 59.96 -64.53 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 127.813 2.445 . . . . 75.25 114.082 177.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 164' ' ' ALA . . . . . . . . . . . . . . . -90.76 -6.36 54.48 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.25 0.62 . . . . 75.34 111.825 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 50.3 p -72.23 86.55 1.09 Allowed 'General case' 0 CA--C 1.548 0.88 0 CA-C-O 121.706 0.765 . . . . 73.14 111.193 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . -153.53 101.62 0.21 Allowed Glycine 0 C--N 1.337 0.609 0 N-CA-C 110.548 -1.021 . . . . 74.53 110.548 179.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 167' ' ' ASN . . . . . 0.646 HD21 ' HG2' ' C' ' 129' ' ' GLU . 52.9 t30 58.36 27.28 15.14 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.856 1.263 . . . . 74.33 111.864 -178.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 9.9 m -72.15 93.69 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-N 115.454 -0.794 . . . . 75.53 109.299 176.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 48.7 m 70.85 11.09 7.1 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.114 1.366 . . . . 65.53 111.907 -174.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 22.6 m 62.22 144.41 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 125.497 1.519 . . . . 73.13 112.591 -176.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -63.72 -56.84 12.55 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.877 0.471 . . . . 73.41 110.133 175.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 172' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.61 -36.18 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.706 0.802 . . . . 75.25 109.601 173.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 173' ' ' LEU . . . . . . . . . . . . . 28.9 tp -159.3 144.94 16.1 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.808 0.843 . . . . 74.44 109.571 179.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 174' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 65.62 -82.41 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.487 1.515 . . . . 74.45 112.907 176.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 175' ' ' ASP . . . . . . . . . . . . . 10.4 t70 57.23 -83.1 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 124.387 1.075 . . . . 74.1 108.853 -164.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . 57.95 19.61 6.01 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 124.952 1.301 . . . . 74.11 113.548 171.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 8.7 m -78.95 -54.79 1.01 Allowed Pre-proline 0 CA--C 1.564 1.509 0 C-N-CA 123.428 0.691 . . . . 74.15 112.648 -172.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 178' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -82.23 174.18 10.19 Favored 'Trans proline' 0 C--N 1.387 2.574 0 C-N-CA 122.097 1.864 . . . . 74.53 114.023 -166.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . 76.66 -39.65 0.35 Allowed 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 126.197 1.799 . . . . 74.35 114.308 169.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . 54.54 48.45 20.41 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.838 0.828 . . . . 75.32 109.088 -168.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 31.2 tp 62.25 -77.56 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.28 0 CA-C-N 113.277 -1.783 . . . . 74.44 111.584 -166.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 182' ' ' VAL . . . . . 0.658 ' HA ' ' HB3' ' C' ' 123' ' ' LEU . 91.3 t -96.5 141.3 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 123.839 0.856 . . . . 72.43 111.364 -175.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -134.8 8.05 3.52 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.5 0.72 . . . . 65.24 112.708 -176.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 184' ' ' HIS . . . . . 0.428 ' CD2' ' HB3' ' C' ' 122' ' ' GLU . 80.0 t60 -145.44 152.33 39.64 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 118.104 0.411 . . . . 75.32 110.371 179.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 185' ' ' VAL . . . . . . . . . . . . . 71.4 t 76.44 -50.48 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 C-N-CA 126.124 1.77 . . . . 74.01 110.439 -170.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 1.9 t -156.21 123.68 5.47 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.191 0.996 . . . . 60.24 110.529 -174.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 187' ' ' SER . . . . . . . . . . . . . 22.5 t 174.05 166.26 0.21 Allowed 'General case' 0 C--O 1.244 0.77 0 C-N-CA 125.197 1.399 . . . . 62.14 108.539 174.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 52.3 ttt180 -83.33 77.86 9.73 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 107.691 -1.226 . . . . 72.32 107.691 171.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -155.2 137.31 14.7 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 106.743 -1.577 . . . . 72.52 106.743 -170.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 190' ' ' CYS . . . . . . . . . . . . . 66.6 m -72.39 94.0 1.59 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 122.982 0.513 . . . . 70.33 110.651 -177.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 191' ' ' TYR . . . . . 0.566 ' HA ' ' HA ' ' B' ' 197' ' ' SER . 7.8 p90 -129.47 164.89 22.72 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.078 0.951 . . . . 74.04 109.958 -175.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 58.06 -103.16 0.3 Allowed Glycine 0 C--N 1.351 1.368 0 O-C-N 124.481 1.113 . . . . 64.22 114.391 165.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 193' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -55.97 -23.37 42.91 Favored 'Trans proline' 0 C--N 1.388 2.636 0 C-N-CA 123.572 2.848 . . . . 73.22 113.082 176.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 194' ' ' SER . . . . . . . . . . . . . 50.5 m -86.55 72.29 10.28 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 109.228 -0.656 . . . . 63.44 109.228 171.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 195' ' ' ALA . . . . . . . . . . . . . . . 61.45 -80.63 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 125.22 1.408 . . . . 74.32 113.157 175.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 97.3 m -127.51 146.54 50.47 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.884 1.274 . . . . 73.32 109.527 -176.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 197' ' ' SER . . . . . 0.566 ' HA ' ' HA ' ' B' ' 191' ' ' TYR . 11.1 t -84.72 -83.12 0.16 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 122.907 0.483 . . . . 75.11 110.99 -178.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 198' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -101.3 175.09 5.7 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 122.882 0.473 . . . . 65.14 109.966 -178.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp 72.04 -65.74 0.34 Allowed 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 125.354 1.462 . . . . 75.14 112.902 174.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 200' ' ' CYS . . . . . 0.426 ' SG ' ' HB3' ' B' ' 203' ' ' ASN . 42.4 t 58.91 62.07 4.45 Favored Pre-proline 0 CA--C 1.556 1.205 0 C-N-CA 124.469 1.108 . . . . 73.31 109.911 -174.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 201' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.45 -26.18 24.6 Favored 'Trans proline' 0 C--N 1.383 2.342 0 C-N-CA 123.082 2.522 . . . . 74.02 113.29 -166.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . -71.65 -31.0 65.61 Favored Glycine 0 C--N 1.352 1.428 0 O-C-N 123.386 0.429 . . . . 73.41 112.296 178.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 203' ' ' ASN . . . . . 0.426 ' HB3' ' SG ' ' B' ' 200' ' ' CYS . 44.6 t-20 -94.39 64.37 3.13 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 108.417 -0.957 . . . . 71.33 108.417 175.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -92.43 86.23 5.6 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 108.431 -0.951 . . . . 74.01 108.431 175.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 205' ' ' LEU . . . . . 0.412 ' HA ' ' HG1' ' B' ' 153' ' ' THR . 0.6 OUTLIER -86.97 65.8 9.14 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.949 0.881 . . . . 72.44 109.982 -174.378 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -83.49 136.35 34.32 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 114.24 -1.345 . . . . 70.3 109.611 175.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 207' ' ' LYS . . . . . 0.529 ' HB2' ' HA ' ' B' ' 210' ' ' LYS . 82.8 mttt -91.74 7.26 42.59 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.795 0.838 . . . . 74.32 110.753 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 72.75 -100.03 0.97 Allowed Glycine 0 C--N 1.352 1.441 0 O-C-N 123.385 0.428 . . . . 71.52 112.041 -177.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . -81.08 5.1 67.7 Favored Glycine 0 C--N 1.351 1.39 0 CA-C-O 119.545 -0.586 . . . . 63.34 113.034 177.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 210' ' ' LYS . . . . . 0.529 ' HA ' ' HB2' ' B' ' 207' ' ' LYS . 29.2 mmtp 51.98 75.1 0.23 Allowed 'General case' 0 C--N 1.364 1.203 0 C-N-CA 125.741 1.616 . . . . 74.51 110.904 174.271 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . 68.0 63.19 3.77 Favored Glycine 0 C--N 1.354 1.546 0 N-CA-C 110.787 -0.925 . . . . 74.43 110.787 -172.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 39.5 p -56.38 -72.15 0.08 Allowed 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 124.106 0.962 . . . . 74.04 112.636 -167.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . 0.468 ' HA ' HD22 ' B' ' 217' ' ' LEU . 0.2 OUTLIER -137.87 157.04 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 C-N-CA 123.528 0.731 . . . . 70.12 110.531 178.487 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 40.7 p -123.88 -61.35 1.38 Allowed 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 107.573 -1.269 . . . . 75.43 107.573 172.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 215' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -105.13 -61.85 1.42 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.064 0.946 . . . . 73.31 108.565 166.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -155.31 -45.56 0.08 Allowed 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.055 -0.975 . . . . 61.42 110.945 -173.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . 0.468 HD22 ' HA ' ' B' ' 213' ' ' ILE . 3.8 mm? 60.67 -179.5 0.1 Allowed 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.254 1.022 . . . . 75.4 110.756 -166.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 63.7 tp 77.1 -40.79 0.37 Allowed 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 125.132 1.373 . . . . 71.43 112.208 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 69.18 -74.49 0.08 Allowed 'General case' 0 C--N 1.359 0.996 0 C-N-CA 125.329 1.452 . . . . 71.24 110.359 -173.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . 65.36 113.86 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.319 1.447 . . . . 74.3 111.508 176.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 221' ' ' ARG . . . . . 0.489 ' H ' ' HB ' ' B' ' 121' ' ' VAL . 44.7 mtm180 65.7 -167.41 0.21 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 124.797 1.239 . . . . 73.55 110.052 -174.125 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . 0.43 ' HB3' ' HB3' ' B' ' 61' ' ' ASP . . . 72.69 -17.6 0.39 Allowed 'General case' 0 N--CA 1.505 2.291 0 C-N-CA 124.801 1.24 . . . . 75.21 113.75 175.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -60.23 -39.12 85.55 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.424 0.689 . . . . 72.13 109.58 177.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 18.7 m 48.67 -154.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 C-N-CA 125.765 1.626 . . . . 75.32 112.257 174.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 19.3 m 83.37 -66.15 0.08 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.166 1.386 . . . . 73.55 111.669 166.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 28.8 mt -73.52 156.86 37.72 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 122.643 0.377 . . . . 74.43 111.823 -170.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 227' ' ' GLY . . . . . 0.438 ' HA2' ' HD3' ' B' ' 118' ' ' PRO . . . -144.02 -71.69 0.02 OUTLIER Glycine 0 C--N 1.341 0.823 0 CA-C-N 115.493 -0.776 . . . . 71.24 111.21 -179.098 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . -103.67 23.27 33.18 Favored Glycine 0 C--N 1.347 1.158 0 CA-C-O 119.846 -0.419 . . . . 72.41 112.48 176.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -79.05 64.88 3.65 Favored Glycine 0 C--N 1.356 1.691 0 C-N-CA 123.108 0.385 . . . . 71.04 112.256 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . 0.46 ' HB3' ' HD3' ' B' ' 117' ' ' LYS . . . -122.1 -152.9 0.53 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.893 1.277 . . . . 70.23 108.071 -175.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 231' ' ' LYS . . . . . 0.459 ' HD2' ' HB2' ' B' ' 230' ' ' ALA . 0.1 OUTLIER 57.31 46.53 18.32 Favored 'General case' 0 C--N 1.361 1.102 0 C-N-CA 124.143 0.977 . . . . 73.24 110.06 175.025 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 232' ' ' THR . . . . . 0.583 ' HA ' ' SG ' ' B' ' 358' ' ' CYS . 26.4 p -66.23 85.44 0.1 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.144 0.978 . . . . 74.24 112.158 -170.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -91.93 126.1 36.88 Favored 'General case' 0 C--N 1.351 0.631 0 N-CA-C 108.313 -0.995 . . . . 71.44 108.313 175.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . 0.45 ' HB3' ' HG2' ' B' ' 46' ' ' ARG . . . -177.05 119.84 0.12 Allowed 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 108.547 -0.908 . . . . 72.31 108.547 -176.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . 0.681 ' HA ' ' HE2' ' C' ' 209' ' ' LYS . 43.4 mt-10 -132.77 169.18 17.08 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 121.475 0.655 . . . . 64.41 112.66 -177.102 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 236' ' ' THR . . . . . . . . . . . . . 5.0 t -167.18 115.89 0.82 Allowed 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 113.831 -1.531 . . . . 73.34 108.116 175.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -89.14 52.68 2.45 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 121.732 0.777 . . . . 73.03 111.02 -177.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 8.9 m -78.69 -17.7 55.51 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-N 115.047 -0.979 . . . . 71.31 109.562 172.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 239' ' ' ALA . . . . . 0.493 ' HB3' ' HA ' ' C' ' 221' ' ' VAL . . . -67.91 -179.36 1.17 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.345 1.058 . . . . 74.42 111.964 176.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 240' ' ' GLY . . . . . 0.455 ' HA3' ' O ' ' C' ' 234' ' ' ARG . . . -103.38 -114.09 3.89 Favored Glycine 0 C--N 1.343 0.956 0 CA-C-O 119.718 -0.49 . . . . 71.23 111.903 -176.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -149.99 142.55 24.47 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.217 0.607 . . . . 71.23 111.087 -178.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -179.63 117.25 0.06 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 125.279 1.432 . . . . 70.32 108.971 173.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 243' ' ' GLN . . . . . 0.568 HE21 ' HG2' ' C' ' 224' ' ' PRO . 26.2 mt-30 65.36 -79.48 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 125.068 1.347 . . . . 74.22 113.004 176.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 152.63 100.13 0.19 Allowed Glycine 0 C--N 1.347 1.177 0 N-CA-C 111.699 -0.561 . . . . 71.54 111.699 -177.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 245' ' ' LYS . . . . . 0.461 ' HA ' ' HA ' ' C' ' 224' ' ' PRO . 0.0 OUTLIER -64.53 110.79 2.43 Favored 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 123.835 0.854 . . . . 75.34 111.48 -178.341 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 6.9 p -145.04 79.83 1.6 Allowed 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 122.885 0.474 . . . . 71.14 111.083 -176.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 247' ' ' LEU . . . . . 0.503 HD23 ' HA2' ' C' ' 208' ' ' GLY . 2.8 pp -68.87 146.12 53.11 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 116.299 -0.41 . . . . 72.51 110.141 169.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 248' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -154.91 109.32 2.97 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.784 -0.45 . . . . 75.15 109.784 177.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 177.59 173.07 0.55 Allowed 'General case' 0 N--CA 1.484 1.23 0 O-C-N 125.411 1.695 . . . . 71.33 109.136 161.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -160.93 114.69 2.04 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.027 0.531 . . . . 70.14 109.973 -174.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 251' ' ' ALA . . . . . . . . . . . . . . . -100.05 94.4 6.24 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.936 0.895 . . . . 64.21 110.11 175.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 6.0 pm0 -138.28 0.96 2.16 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.219 1.008 . . . . 73.12 109.575 174.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -75.8 89.21 2.86 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.617 0.767 . . . . 51.41 110.827 -170.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 28.6 tpt180 70.72 124.98 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 125.624 1.57 . . . . 72.51 111.928 175.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -117.38 108.92 1.78 Allowed Glycine 0 C--N 1.355 1.626 0 CA-C-O 119.635 -0.536 . . . . 63.32 113.127 -173.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 256' ' ' TYR . . . . . 0.427 ' O ' ' HG2' ' B' ' 113' ' ' LYS . 56.3 t80 73.91 -26.69 0.19 Allowed 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 125.828 1.651 . . . . 71.2 113.848 173.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 9.5 mp0 60.76 79.02 0.26 Allowed 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 108.798 -0.816 . . . . 74.31 108.798 -169.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 258' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -50.31 131.59 24.18 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.492 1.117 . . . . 75.13 112.445 -175.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 10.9 m 54.26 9.04 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.408 0 C-N-CA 126.775 2.03 . . . . 63.31 114.702 179.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 260' ' ' SER . . . . . . . . . . . . . 33.5 t -93.86 -4.29 50.32 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.693 0.797 . . . . 73.11 110.734 -178.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -64.2 -49.84 70.42 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 123.441 0.697 . . . . 65.51 110.684 178.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 262' ' ' ALA . . . . . . . . . . . . . . . 50.6 27.36 2.88 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 124.995 1.318 . . . . 75.22 112.032 -175.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -114.18 -24.95 8.7 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.073 0.949 . . . . 70.44 111.743 -168.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 34.1 t -153.46 126.75 8.55 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 108.947 -0.76 . . . . 51.14 108.947 -179.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 265' ' ' LEU . . . . . 0.456 ' HA ' ' HG3' ' B' ' 270' ' ' GLU . 3.4 tm? 67.14 127.44 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 124.681 1.192 . . . . 73.31 109.811 -174.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 266' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 63.75 45.15 4.62 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 124.473 1.109 . . . . 71.52 108.975 -171.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 44.4 t -158.29 173.62 16.41 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 114.682 -1.145 . . . . 73.13 109.756 -171.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 53.8 t -62.55 -29.12 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 124.54 1.136 . . . . 74.44 110.68 178.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 269' ' ' THR . . . . . . . . . . . . . 21.5 p -109.31 55.31 0.64 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.309 1.044 . . . . 74.31 110.287 176.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 270' ' ' GLU . . . . . 0.456 ' HG3' ' HA ' ' B' ' 265' ' ' LEU . 34.4 tt0 -79.31 -23.78 43.27 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 114.969 -1.014 . . . . 72.41 110.731 174.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 271' ' ' ALA . . . . . . . . . . . . . . . -70.68 1.92 4.74 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.871 0.868 . . . . 75.3 111.818 176.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 272' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -57.96 -28.61 64.5 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.254 1.422 . . . . 73.11 110.917 167.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 76.79 -20.14 0.39 Allowed 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 125.814 1.645 . . . . 73.43 112.188 175.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 274' ' ' GLN . . . . . 0.48 ' HB3' ' O ' ' B' ' 282' ' ' ALA . 47.3 mt-30 -116.91 168.65 10.05 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 125.582 1.553 . . . . 71.44 109.205 -174.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 275' ' ' LYS . . . . . . . . . . . . . 55.4 tttp -154.28 130.61 5.6 Favored Pre-proline 0 N--CA 1.475 0.785 0 N-CA-C 109.477 -0.564 . . . . 72.14 109.477 175.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -68.63 154.92 70.52 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 122.43 2.087 . . . . 73.04 110.944 169.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 277' ' ' LEU . . . . . 0.609 HD23 ' HB3' ' B' ' 280' ' ' LEU . 2.2 pt? -165.62 171.49 13.03 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.911 0.484 . . . . 74.52 111.27 175.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 2.2 pp -72.32 -6.38 42.87 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.937 0.895 . . . . 72.2 112.695 -177.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . -132.87 -160.01 9.39 Favored Glycine 0 C--N 1.348 1.215 0 N-CA-C 110.774 -0.931 . . . . 75.43 110.774 173.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 280' ' ' LEU . . . . . 0.609 ' HB3' HD23 ' B' ' 277' ' ' LEU . 27.1 tp 54.39 -90.11 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.778 1.231 . . . . 74.31 111.166 176.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 281' ' ' PHE . . . . . 0.683 ' HA ' ' HB2' ' B' ' 118' ' ' PRO . 58.5 t80 177.42 -89.87 0.0 OUTLIER 'General case' 0 C--N 1.36 1.052 0 C-N-CA 125.203 1.401 . . . . 75.31 107.784 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 282' ' ' ALA . . . . . 0.492 ' HB3' ' HB2' ' B' ' 110' ' ' ALA . . . 179.75 14.53 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.145 1.378 . . . . 65.41 109.644 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -89.64 161.94 15.87 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.949 0.9 . . . . 72.33 110.357 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . -106.91 123.45 7.32 Favored Glycine 0 C--N 1.349 1.275 0 N-CA-C 111.674 -0.57 . . . . 72.13 111.674 -178.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 33.0 p-10 -73.02 -21.33 60.83 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.367 0.667 . . . . 73.03 111.776 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 286' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -91.62 114.05 60.64 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 123.526 0.73 . . . . 74.22 109.497 177.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 287' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -79.72 152.48 22.54 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.684 2.256 . . . . 74.24 111.444 170.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 288' ' ' VAL . . . . . . . . . . . . . 35.1 m -66.65 -19.57 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 122.696 0.398 . . . . 74.32 112.008 179.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 289' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 72.69 150.07 0.1 Allowed 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 124.912 1.285 . . . . 74.32 110.673 -177.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 290' ' ' TRP . . . . . . . . . . . . . 49.7 t90 79.47 -24.54 0.21 Allowed 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 125.389 1.476 . . . . 75.34 112.272 -179.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 291' ' ' LEU . . . . . . . . . . . . . 8.1 mp 70.96 -72.82 0.11 Allowed 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 125.035 1.334 . . . . 73.52 111.078 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . 85.93 -100.15 2.46 Favored Glycine 0 C--N 1.351 1.414 0 CA-C-O 119.013 -0.881 . . . . 71.42 111.333 -177.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -57.71 130.91 41.02 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.314 2.01 . . . . 75.13 110.433 164.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -70.64 -61.43 1.77 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 122.57 0.348 . . . . 74.44 110.379 -175.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 295' ' ' ALA . . . . . 0.518 ' HB1' ' HB2' ' B' ' 63' ' ' PRO . . . 63.51 6.9 2.73 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.928 1.291 . . . . 71.35 113.294 -179.347 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 22.6 p -75.82 98.01 4.05 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.315 0.646 . . . . 71.52 109.621 -179.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 297' ' ' TYR . . . . . 0.512 ' HH ' ' HB3' ' B' ' 59' ' ' LEU . 27.6 p90 -73.83 147.29 43.47 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 115.884 -0.598 . . . . 75.44 110.351 -178.06 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 24.5 p-80 -163.48 155.3 17.35 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.189 0.596 . . . . 73.43 110.848 -169.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . -93.29 -35.29 6.33 Favored Glycine 0 C--N 1.339 0.7 0 CA-C-N 116.248 -0.433 . . . . 72.35 112.374 172.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 58.3 t30 -106.4 149.98 26.48 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.923 0.889 . . . . 72.23 110.896 -175.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 301' ' ' ILE . . . . . . . . . . . . 0.262 2.6 pp 48.39 -178.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 C-N-CA 127.267 2.227 . . . . 75.13 114.983 178.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 33.0 t70 54.73 48.61 19.83 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 125.009 1.324 . . . . 74.32 111.925 173.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 303' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -110.65 135.09 20.74 Favored Pre-proline 0 N--CA 1.481 1.114 0 C-N-CA 123.894 0.878 . . . . 74.11 110.513 -177.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 304' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -70.72 -21.13 29.43 Favored 'Trans proline' 0 C--N 1.379 2.157 0 C-N-CA 122.902 2.401 . . . . 75.12 112.401 171.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -107.96 164.22 12.46 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.536 0.734 . . . . 72.13 111.219 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 20.6 m -126.3 31.5 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 C-N-CA 124.156 0.982 . . . . 72.33 110.69 -176.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 89.0 m 66.61 -74.56 0.06 Allowed 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 125.165 1.386 . . . . 74.23 111.194 -178.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 308' ' ' CYS . . . . . . . . . . . . . 16.5 p -115.49 137.57 51.93 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 124.386 1.075 . . . . 74.22 108.884 176.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 6.6 m -61.34 -47.18 94.64 Favored Pre-proline 0 CA--C 1.563 1.468 0 CA-C-O 118.88 -0.581 . . . . 72.2 111.65 -178.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.35 107.01 2.23 Favored 'Trans proline' 0 C--N 1.386 2.529 0 C-N-CA 121.435 1.424 . . . . 64.44 110.279 163.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 311' ' ' ASN . . . . . 0.424 ' N ' ' HD2' ' B' ' 312' ' ' PRO . 17.8 m120 -85.0 -48.24 0.62 Allowed Pre-proline 0 CA--C 1.561 1.394 0 CA-C-O 118.148 -0.93 . . . . 73.13 111.646 176.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 312' ' ' PRO . . . . . 0.424 ' HD2' ' N ' ' B' ' 311' ' ' ASN . 19.8 Cg_endo -57.66 -62.96 0.17 Allowed 'Trans proline' 0 C--N 1.402 3.35 0 C-N-CA 122.545 2.163 . . . . 70.14 112.482 178.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 313' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 73.52 -45.76 0.62 Allowed 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 125.914 1.686 . . . . 75.13 114.238 172.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 314' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 177.52 -31.28 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.313 1.045 . . . . 74.53 108.983 -165.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 315' ' ' ASN . . . . . 0.406 ' O ' ' HG3' ' B' ' 324' ' ' MET . 29.0 m-80 -73.68 -2.73 24.42 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.354 1.062 . . . . 75.34 111.947 -176.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 316' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -90.73 -38.34 13.11 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.806 0.842 . . . . 74.4 111.46 -179.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 18.1 t -159.51 -159.07 0.71 Allowed 'General case' 0 CA--C 1.553 1.06 0 N-CA-C 109.624 -0.51 . . . . 75.41 109.624 -168.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 318' ' ' VAL . . . . . . . . . . . . . 5.5 m 63.67 143.93 0.07 OUTLIER Pre-proline 0 N--CA 1.497 1.894 0 C-N-CA 127.603 2.361 . . . . 73.13 113.748 176.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 319' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -61.48 140.42 87.28 Favored 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 122.498 2.132 . . . . 65.1 110.905 174.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 320' ' ' THR . . . . . . . . . . . . . 2.7 m 67.17 83.67 0.16 Allowed 'General case' 0 CA--C 1.557 1.25 0 C-N-CA 124.526 1.13 . . . . 73.24 109.151 -173.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 321' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -91.66 8.27 37.65 Favored 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 124.294 1.037 . . . . 74.43 113.012 -169.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 322' ' ' ALA . . . . . . . . . . . . . . . 70.49 -101.67 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.225 1.41 . . . . 64.54 112.298 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 323' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -134.75 28.42 3.57 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.694 0.798 . . . . 74.02 110.901 -171.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 324' ' ' MET . . . . . 0.406 ' HG3' ' O ' ' B' ' 315' ' ' ASN . 1.3 tmt? -63.96 -58.18 7.5 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 109.017 -0.734 . . . . 74.22 109.017 171.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 325' ' ' THR . . . . . . . . . . . . . 13.9 p -70.22 103.94 2.5 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 109.059 -0.719 . . . . 72.33 109.059 169.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 326' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -172.01 -48.65 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.867 0.867 . . . . 72.01 109.255 -175.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt 64.63 45.18 3.6 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.633 1.173 . . . . 75.41 111.617 176.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 328' ' ' ALA . . . . . . . . . . . . . . . 64.25 25.35 13.54 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.411 1.084 . . . . 72.03 113.12 167.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 329' ' ' ILE . . . . . . . . . . . . . 3.0 mp 51.85 39.79 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.734 0 CA-C-O 122.6 1.191 . . . . 73.5 110.752 -175.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 330' ' ' GLU . . . . . 0.578 ' HB3' ' HA ' ' B' ' 333' ' ' SER . 46.7 mt-10 -93.29 -67.09 0.88 Allowed 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.522 -0.763 . . . . 74.44 110.054 176.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 331' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 54.52 93.59 0.02 OUTLIER 'General case' 0 C--N 1.365 1.252 0 C-N-CA 125.215 1.406 . . . . 64.42 111.202 178.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 68.0 mt 73.65 0.91 3.78 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 124.977 1.311 . . . . 74.41 111.366 -168.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 333' ' ' SER . . . . . 0.578 ' HA ' ' HB3' ' B' ' 330' ' ' GLU . 19.7 t 54.26 78.8 0.15 Allowed 'General case' 0 C--N 1.356 0.856 0 C-N-CA 125.231 1.412 . . . . 65.04 112.183 -177.03 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.97 16.0 3.05 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 116.289 -0.414 . . . . 65.35 110.519 172.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 335' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -57.69 -61.62 2.38 Favored 'General case' 0 C--N 1.361 1.08 0 C-N-CA 123.861 0.865 . . . . 74.12 110.063 173.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 336' ' ' GLU . . . . . 0.512 ' HG2' ' H ' ' B' ' 338' ' ' GLY . 38.9 tt0 -166.78 146.85 5.72 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 124.352 1.061 . . . . 73.55 108.471 174.249 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 337' ' ' LYS . . . . . 0.576 ' HE3' ' HA ' ' B' ' 337' ' ' LYS . 0.6 OUTLIER -81.47 -36.17 29.63 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.312 0.645 . . . . 71.1 110.365 177.084 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 338' ' ' GLY . . . . . 0.512 ' H ' ' HG2' ' B' ' 336' ' ' GLU . . . 72.57 44.92 38.68 Favored Glycine 0 C--N 1.35 1.334 0 N-CA-C 111.161 -0.776 . . . . 73.12 111.161 -174.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 339' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -80.87 85.32 6.2 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.265 1.026 . . . . 74.33 109.2 -171.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 340' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -78.46 -40.93 34.15 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 115.689 -0.687 . . . . 75.24 112.063 -173.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 341' ' ' LEU . . . . . . . . . . . . . 98.3 mt 55.21 34.51 22.87 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 124.199 1.0 . . . . 75.34 111.616 -177.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 342' ' ' GLN . . . . . 0.512 HE22 ' HB2' ' B' ' 349' ' ' ASP . 6.7 tp-100 -70.47 87.57 0.65 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.186 0.994 . . . . 74.32 110.534 -176.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 343' ' ' VAL . . . . . . . . . . . . . 27.2 m -73.64 162.05 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 122.957 0.503 . . . . 65.15 110.578 176.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -111.61 177.96 4.48 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.985 0.914 . . . . 74.33 110.919 -174.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 345' ' ' GLY . . . . . . . . . . . . . . . 79.3 -85.97 1.22 Allowed Glycine 0 C--N 1.355 1.604 0 O-C-N 123.389 0.43 . . . . 63.14 112.061 179.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 346' ' ' ALA . . . . . . . . . . . . . . . -76.87 -39.38 51.27 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.212 -0.662 . . . . 72.51 109.212 171.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 347' ' ' SER . . . . . 0.404 ' HB2' ' HB2' ' B' ' 350' ' ' LYS . 19.6 m 66.9 124.36 0.02 OUTLIER 'General case' 0 C--N 1.361 1.104 0 C-N-CA 125.807 1.643 . . . . 72.21 112.48 174.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 11.7 tt -59.53 -33.85 52.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 C-N-CA 123.422 0.689 . . . . 73.42 111.18 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 349' ' ' ASP . . . . . 0.512 ' HB2' HE22 ' B' ' 342' ' ' GLN . 25.9 t70 -68.09 -36.78 80.36 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.87 0.868 . . . . 71.13 110.971 177.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 350' ' ' LYS . . . . . 0.531 ' HG3' ' HB3' ' B' ' 55' ' ' LEU . 11.0 mptt -92.48 -77.65 0.43 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.276 0.631 . . . . 74.52 110.704 -175.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 54.68 25.73 6.74 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.713 1.205 . . . . 71.32 112.438 -175.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -65.62 145.57 55.9 Favored 'General case' 0 C--N 1.351 0.666 0 CA-C-O 121.348 0.594 . . . . 74.35 110.755 -178.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 353' ' ' HIS . . . . . . . . . . . . . 11.2 p80 -143.44 -3.74 0.91 Allowed 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 114.856 -1.065 . . . . 74.33 110.356 -175.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 354' ' ' ALA . . . . . . . . . . . . . . . 69.22 -60.13 0.47 Allowed 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 125.47 1.508 . . . . 72.23 112.764 -177.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 355' ' ' ALA . . . . . . . . . . . . . . . 83.25 130.81 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 126.459 1.904 . . . . 75.44 110.673 178.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 356' ' ' ASN . . . . . . . . . . . . . 11.5 m120 68.48 129.05 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.482 0 C-N-CA 125.328 1.451 . . . . 74.32 110.736 -173.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 357' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -61.36 -28.21 83.91 Favored 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 122.228 1.952 . . . . 74.21 111.514 171.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 358' ' ' CYS . . . . . 0.583 ' SG ' ' HA ' ' B' ' 232' ' ' THR . 24.2 t 60.78 38.8 17.89 Favored 'General case' 0 C--N 1.361 1.07 0 C-N-CA 124.924 1.289 . . . . 75.21 111.303 173.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 359' ' ' GLY . . . . . . . . . . . . . . . -84.84 55.01 4.97 Favored Glycine 0 C--N 1.348 1.225 0 CA-C-N 115.206 -0.906 . . . . 72.04 113.257 -177.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 360' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 54.27 7.13 0.12 Allowed 'General case' 0 N--CA 1.502 2.154 0 C-N-CA 127.255 2.222 . . . . 53.34 116.351 170.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 361' ' ' ILE . . . . . . . . . . . . 0.292 16.3 tt 45.55 -70.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 C-N-CA 126.521 1.928 . . . . 64.41 113.373 -166.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 362' ' ' GLY . . . . . . . . . . . . . . . -122.26 179.48 16.19 Favored Glycine 0 C--N 1.35 1.325 0 N-CA-C 111.956 -0.458 . . . . 72.35 111.956 175.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 363' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -89.27 54.26 2.9 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.986 0.914 . . . . 73.13 109.5 -178.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 364' ' ' THR . . . . . . . . . . . . . 32.3 m 52.71 -101.45 0.11 Allowed 'General case' 0 CA--C 1.561 1.392 0 C-N-CA 125.042 1.337 . . . . 74.04 110.624 -169.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 74.2 t -143.27 -69.56 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 N-CA-C 107.484 -1.302 . . . . 74.51 107.484 174.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 36.6 t70 54.3 85.7 0.05 Allowed 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.148 1.379 . . . . 52.52 112.276 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 367' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -167.91 84.51 0.2 Allowed 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 105.797 -1.927 . . . . 75.05 105.797 176.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 368' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 57.41 40.27 27.53 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 124.111 0.964 . . . . 73.23 109.866 -169.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 369' ' ' GLU . . . . . . . . . . . . . 8.8 tm-20 -137.79 -21.93 1.1 Allowed 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 114.384 -1.28 . . . . 74.11 110.409 -164.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 370' ' ' ALA . . . . . . . . . . . . . . . -54.46 95.57 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.28 1.032 . . . . 74.25 111.935 -176.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 371' ' ' VAL . . . . . 0.482 HG13 HD23 ' B' ' 375' ' ' LEU . 2.4 p 56.31 6.57 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 C-N-CA 126.706 2.002 . . . . 74.12 113.255 -177.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 372' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -86.06 75.73 9.89 Favored 'General case' 0 C--N 1.352 0.693 0 N-CA-C 107.863 -1.162 . . . . 63.2 107.863 -175.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 373' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 -127.85 -48.37 1.37 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 114.228 -1.351 . . . . 72.2 109.055 -175.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -126.77 -84.54 0.61 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.365 0.666 . . . . 71.45 109.491 177.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 375' ' ' LEU . . . . . 0.51 HD22 ' HG3' ' A' ' 263' ' ' PRO . 79.1 mt 72.27 -43.31 0.56 Allowed 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 125.381 1.472 . . . . 72.22 113.225 178.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 376' ' ' GLU . . . . . 0.529 ' HG3' ' HB2' ' A' ' 260' ' ' ARG . 12.4 mm-40 73.45 -60.59 0.53 Allowed 'General case' 0 N--CA 1.5 2.028 0 C-N-CA 125.92 1.688 . . . . 73.13 113.444 171.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 377' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 71.2 -80.22 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.396 1.478 . . . . 73.31 111.302 177.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 378' ' ' ALA . . . . . . . . . . . . . . . -92.34 25.0 3.13 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.663 0.785 . . . . 73.45 111.637 -173.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . 0.504 ' HE3' ' HG2' ' A' ' 260' ' ' ARG . 63.2 tttp -139.55 102.24 4.41 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.846 0.858 . . . . 73.22 109.104 -177.051 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 380' ' ' LYS . . . . . 0.406 ' HZ1' ' HB1' ' C' ' 278' ' ' ALA . 85.7 tttt -99.99 -50.43 4.0 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.584 0.754 . . . . 72.4 109.392 174.068 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 381' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 60.52 38.26 19.11 Favored 'General case' 0 CA--C 1.555 1.163 0 CA-C-O 122.221 1.01 . . . . 74.34 111.07 172.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -147.58 67.38 0.39 Allowed Glycine 0 C--N 1.343 0.919 0 CA-C-N 114.903 -1.044 . . . . 73.1 110.493 -178.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 383' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -137.46 105.69 5.74 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.677 1.191 . . . . 73.1 107.924 -178.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 384' ' ' THR . . . . . 0.408 ' HB ' ' HA ' ' C' ' 280' ' ' ALA . 35.8 m -113.44 -63.05 1.5 Allowed 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 111.977 0.362 . . . . 71.44 111.977 -171.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 86.3 mt -108.56 -86.91 0.51 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.502 0.721 . . . . 75.43 111.615 -171.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 386' ' ' VAL . . . . . 0.492 HG11 HD12 ' B' ' 387' ' ' ILE . 14.3 p -97.22 -26.15 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 122.619 0.368 . . . . 75.23 111.548 -169.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 387' ' ' ILE . . . . . 0.502 HG22 ' HB3' ' B' ' 391' ' ' ASP . 2.3 mp -72.51 86.99 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.074 0 CA-C-O 122.414 1.102 . . . . 74.12 109.233 173.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 388' ' ' VAL . . . . . . . . . . . . . 2.7 m -157.67 -42.26 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 127.579 2.352 . . . . 74.43 105.994 174.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 389' ' ' THR . . . . . . . . . . . . . 41.5 m -100.69 -35.43 9.48 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 114.361 -1.29 . . . . 71.25 108.584 168.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . -77.72 142.21 38.88 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 108.864 -0.791 . . . . 73.41 108.864 167.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 391' ' ' ASP . . . . . 0.502 ' HB3' HG22 ' B' ' 387' ' ' ILE . 30.1 t70 57.03 27.98 14.14 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 122.163 0.983 . . . . 64.12 110.678 -179.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 392' ' ' HIS . . . . . . . . . . . . . 29.1 t60 -68.62 94.04 0.55 Allowed 'General case' 0 C--N 1.351 0.641 0 CA-C-N 114.701 -1.136 . . . . 72.42 109.817 -177.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -154.63 117.23 4.34 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 123.828 0.851 . . . . 61.53 109.029 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -71.95 -23.02 61.38 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.096 0.558 . . . . 73.31 111.137 175.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . 64.54 -74.44 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.651 1.58 . . . . 75.42 111.645 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 36.9 t -66.84 120.84 14.23 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.082 0.953 . . . . 75.55 110.614 177.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 397' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -70.38 -10.37 58.87 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 112.416 0.524 . . . . 75.54 112.416 -177.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 86.6 mt -49.19 -50.45 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 124.244 1.017 . . . . 75.44 110.655 174.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 399' ' ' VAL . . . . . . . . . . . . . 15.3 m -88.74 112.41 23.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-N 115.536 -0.756 . . . . 73.32 110.069 176.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 400' ' ' ALA . . . . . . . . . . . . . . . -77.6 -41.44 2.27 Favored Pre-proline 0 CA--C 1.563 1.443 0 CA-C-O 118.03 -0.986 . . . . 74.52 112.18 176.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 401' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -61.47 88.3 0.1 OUTLIER 'Trans proline' 0 C--N 1.397 3.082 0 C-N-CA 122.075 1.85 . . . . 71.34 113.377 174.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -108.4 -70.88 0.78 Allowed 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 107.866 -1.161 . . . . 74.34 107.866 174.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 403' ' ' THR . . . . . . . . . . . . . 20.1 m -72.95 -30.45 63.86 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.529 0.732 . . . . 73.2 109.94 176.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 404' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -93.15 72.18 4.6 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.984 0.914 . . . . 71.14 109.692 -179.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 405' ' ' ALA . . . . . 0.465 ' HB2' ' HD3' ' B' ' 406' ' ' PRO . . . -170.19 -52.2 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.341 0 C-N-CA 124.018 0.927 . . . . 71.24 111.058 177.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 406' ' ' PRO . . . . . 0.465 ' HD3' ' HB2' ' B' ' 405' ' ' ALA . 42.0 Cg_endo -107.85 20.07 0.09 OUTLIER 'Trans proline' 0 C--N 1.387 2.567 0 C-N-CA 123.057 2.505 . . . . 64.23 113.835 176.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . -75.3 79.5 1.05 Allowed Glycine 0 C--N 1.354 1.548 0 N-CA-C 114.096 0.398 . . . . 74.04 114.096 -171.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 408' ' ' LEU . . . . . 0.547 HD11 HD22 ' B' ' 412' ' ' LEU . 14.7 tp 64.1 41.68 6.16 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 125.074 1.349 . . . . 72.55 110.939 178.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 30.5 p -67.72 -36.17 80.11 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.336 -0.847 . . . . 73.52 111.965 178.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 410' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -73.92 155.78 38.33 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.745 0.818 . . . . 70.42 111.225 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . -85.29 -3.88 58.97 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.558 0.743 . . . . 74.33 112.233 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 412' ' ' LEU . . . . . 0.547 HD22 HD11 ' B' ' 408' ' ' LEU . 3.3 mm? 69.29 -68.93 0.17 Allowed 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 125.62 1.568 . . . . 75.21 110.877 -175.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 18.4 m120 67.22 173.72 0.26 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.126 1.37 . . . . 71.14 111.219 -178.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 414' ' ' THR . . . . . . . . . . . . . 30.2 p -67.01 -54.56 20.51 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.028 -1.101 . . . . 73.24 108.028 167.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 415' ' ' LYS . . . . . 0.464 ' HG2' ' HB2' ' B' ' 418' ' ' ALA . 35.6 ttmt 59.72 18.61 7.38 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 124.536 1.134 . . . . 75.21 111.483 171.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -58.85 -49.18 78.72 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.948 1.299 . . . . 75.33 111.308 -171.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 417' ' ' GLY . . . . . . . . . . . . . . . -61.98 -28.78 70.97 Favored Glycine 0 C--N 1.347 1.179 0 O-C-N 123.857 0.723 . . . . 62.31 113.251 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 418' ' ' ALA . . . . . 0.464 ' HB2' ' HG2' ' B' ' 415' ' ' LYS . . . -80.95 -40.34 24.63 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.423 0.689 . . . . 70.25 110.971 178.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 419' ' ' VAL . . . . . . . . . . . . . 32.8 m -92.51 32.6 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 123.245 0.618 . . . . 73.31 110.812 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 420' ' ' MET . . . . . . . . . . . . . 26.4 ptm -68.54 -7.6 33.94 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.737 0.815 . . . . 73.34 112.065 176.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 421' ' ' VAL . . . . . . . . . . . . . 34.1 m -76.58 -27.96 17.42 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 C-N-CA 122.752 0.421 . . . . 72.42 110.604 172.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 422' ' ' MET . . . . . 0.493 ' HA ' ' HB ' ' B' ' 435' ' ' THR . 1.7 tmt? -95.04 134.07 38.13 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.374 1.07 . . . . 74.1 109.556 179.336 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 423' ' ' SER . . . . . . . . . . . . . 22.8 t 64.08 -73.88 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 125.503 1.521 . . . . 63.45 112.358 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 424' ' ' TYR . . . . . . . . . . . . 0.259 50.1 p90 50.91 -74.16 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 126.815 2.046 . . . . 74.22 113.993 -178.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . -163.39 28.97 0.24 Allowed Glycine 0 N--CA 1.468 0.774 0 N-CA-C 111.17 -0.772 . . . . 75.12 111.17 -177.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 426' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -69.34 -43.23 74.08 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.683 1.193 . . . . 75.43 111.835 -173.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 427' ' ' SER . . . . . . . . . . . . . 22.4 t 78.43 -42.43 0.33 Allowed 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 125.328 1.451 . . . . 75.14 112.054 -178.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -57.4 -39.31 75.83 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.167 0.587 . . . . 73.23 109.952 172.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 429' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 71.12 111.41 0.06 Allowed 'General case' 0 CA--C 1.546 0.794 0 O-C-N 124.862 1.351 . . . . 63.42 110.873 165.369 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 430' ' ' ASP . . . . . 0.559 ' HB2' ' HB3' ' B' ' 433' ' ' GLU . 6.7 p-10 -69.24 -26.67 64.91 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.353 1.061 . . . . 62.42 112.959 -171.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 15.3 m 63.11 44.3 5.88 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.349 1.06 . . . . 75.05 110.792 179.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 432' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 70.67 54.46 0.27 Allowed 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 124.668 1.187 . . . . 71.1 109.859 -179.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 433' ' ' GLU . . . . . 0.559 ' HB3' ' HB2' ' B' ' 430' ' ' ASP . 33.1 tt0 -109.85 22.29 15.83 Favored 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 124.273 1.029 . . . . 73.43 109.153 173.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 434' ' ' HIS . . . . . . . . . . . . . 16.4 t60 76.24 -64.35 0.35 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 125.589 1.556 . . . . 73.42 111.569 176.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 435' ' ' THR . . . . . 0.493 ' HB ' ' HA ' ' B' ' 422' ' ' MET . 2.4 m 70.01 146.65 0.06 Allowed 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 125.423 1.489 . . . . 73.42 111.971 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . 95.54 -0.05 63.06 Favored Glycine 0 C--N 1.341 0.811 0 N-CA-C 110.712 -0.955 . . . . 61.51 110.712 -163.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 16.4 m -90.68 121.02 32.22 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.023 1.329 . . . . 72.35 109.16 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 438' ' ' GLN . . . . . . . . . . . . . 47.1 tp60 60.54 90.57 0.06 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.361 1.064 . . . . 71.55 110.024 -172.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 439' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -89.49 33.08 0.83 Allowed 'General case' 0 CA--C 1.555 1.16 0 CA-C-N 115.035 -0.984 . . . . 74.24 111.518 -173.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 440' ' ' ARG . . . . . . . . . . . . . 52.1 ttp180 70.07 100.81 0.06 Allowed 'General case' 0 C--N 1.367 1.337 0 C-N-CA 124.731 1.212 . . . . 74.1 110.89 178.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 441' ' ' ILE . . . . . 0.459 HD13 HG13 ' A' ' 221' ' ' VAL . 55.1 mt -127.58 116.48 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 124.037 0.935 . . . . 74.15 109.945 -176.156 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 442' ' ' ALA . . . . . . . . . . . . . . . -105.77 37.62 2.2 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.84 0.856 . . . . 73.33 110.235 177.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . -77.78 -65.09 1.01 Allowed 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.538 -0.755 . . . . 74.21 111.193 -177.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -98.33 154.3 17.92 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.414 0.686 . . . . 71.31 109.78 -176.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . -153.01 -161.59 10.41 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-O 119.244 -0.753 . . . . 74.34 111.407 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 446' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -78.08 144.18 20.93 Favored 'Trans proline' 0 C--N 1.37 1.678 0 C-N-CA 122.669 2.246 . . . . 72.44 111.983 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 447' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -73.78 131.15 41.26 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 108.664 -0.865 . . . . 63.45 108.664 179.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . -67.93 84.62 0.22 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 123.552 0.741 . . . . 74.31 109.547 175.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 449' ' ' ALA . . . . . . . . . . . . . . . -139.23 129.28 25.14 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 124.859 1.264 . . . . 74.42 108.214 -176.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 450' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 46.02 -163.6 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 125.269 1.428 . . . . 63.22 112.681 -176.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 59.2 t 63.28 -79.31 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 124.568 1.147 . . . . 74.44 110.583 -174.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 452' ' ' VAL . . . . . 0.467 HG13 ' H ' ' B' ' 453' ' ' GLY 0.279 2.7 p 40.29 -82.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.371 1.54 0 C-N-CA 126.792 2.037 . . . . 74.24 113.575 179.998 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 453' ' ' GLY . . . . . 0.467 ' H ' HG13 ' B' ' 452' ' ' VAL . . . 176.14 -75.11 0.08 OUTLIER Glycine 0 C--N 1.339 0.709 0 CA-C-N 118.42 0.554 . . . . 73.44 112.534 176.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 454' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 60.55 -78.41 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.949 1.3 . . . . 73.13 110.423 -171.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 30.8 m 66.37 -79.82 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.342 1.457 . . . . 72.1 111.435 179.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -116.24 -25.01 7.73 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.437 1.095 . . . . 74.3 109.91 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 457' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -71.53 127.56 32.98 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.851 0.86 . . . . 65.21 108.818 175.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 18.8 p -108.69 87.78 2.57 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.557 0.743 . . . . 72.13 111.274 -176.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 459' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -115.96 155.41 28.07 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.072 -1.085 . . . . 73.31 108.072 172.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 2.0 pp -73.12 -0.37 13.9 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 113.691 0.997 . . . . 65.42 113.691 -176.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -68.76 0.2 4.59 Favored 'General case' 0 CA--C 1.563 1.476 0 N-CA-C 113.516 0.932 . . . . 75.0 113.516 -175.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 20.4 p90 -78.65 23.35 0.32 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.217 -0.927 . . . . 72.53 111.94 172.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 4.6 m -71.16 77.16 0.7 Allowed 'General case' 0 CA--C 1.56 1.332 0 C-N-CA 125.158 1.383 . . . . 71.14 110.59 173.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 464' ' ' MET . . . . . . . . . . . . . 18.9 ptm -96.93 92.67 6.22 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-O 121.733 0.778 . . . . 75.31 110.212 177.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -123.98 85.39 2.41 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 108.27 -1.011 . . . . 72.15 108.27 170.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -91.43 -173.41 3.58 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 114.974 -1.012 . . . . 65.13 110.189 177.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . 71.93 -69.25 0.19 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 125.438 1.495 . . . . 75.3 111.539 178.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 2.2 pp -82.97 -12.04 57.63 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.558 0.743 . . . . 74.32 111.281 173.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 469' ' ' GLY . . . . . . . . . . . . . . . -143.05 -173.65 14.81 Favored Glycine 0 C--N 1.353 1.504 0 C-N-CA 123.436 0.541 . . . . 62.03 111.889 177.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 470' ' ' LEU . . . . . . . . . . . . . 58.5 tp -163.71 139.91 6.7 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.084 0.954 . . . . 75.32 109.666 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 471' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.546 0.805 0 N-CA-C 107.007 -1.479 . . . . 74.2 107.007 173.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 1' ' ' MET . . . . . 0.508 ' N ' ' SD ' ' C' ' 1' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.474 0.775 0 N-CA-C 109.197 -0.668 . . . . 70.43 109.197 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.59 25.91 12.19 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 125.908 1.683 . . . . 70.41 113.543 176.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -85.38 66.67 9.81 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.006 0.522 . . . . 71.34 110.008 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -38.72 104.96 0.04 OUTLIER 'General case' 0 C--N 1.358 0.939 0 C-N-CA 125.504 1.522 . . . . 70.52 112.779 178.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 5' ' ' LYS . . . . . 0.425 ' HE2' HD11 ' C' ' 10' ' ' ILE . 47.6 mtpt -97.34 112.37 24.22 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.625 -0.88 . . . . 72.32 108.625 173.083 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -71.07 105.01 3.19 Favored 'General case' 0 C--O 1.244 0.788 0 N-CA-C 108.806 -0.813 . . . . 65.15 108.806 174.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 7' ' ' TYR . . . . . 0.411 ' HA ' HD13 ' C' ' 10' ' ' ILE . 75.5 m-85 -63.42 -26.54 68.78 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 114.544 -1.207 . . . . 73.43 112.074 -173.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -63.58 -48.23 78.25 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 109.578 -0.527 . . . . 74.23 109.578 173.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.95 -37.84 83.77 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.102 0.561 . . . . 63.34 111.544 179.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 10' ' ' ILE . . . . . 0.425 HD11 ' HE2' ' C' ' 5' ' ' LYS . 63.8 mt -58.78 -43.9 89.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 C-N-CA 123.225 0.61 . . . . 73.31 110.465 174.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 73.4 mt -76.32 -11.83 59.97 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 115.77 -0.65 . . . . 75.53 112.698 177.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.32 40.22 55.7 Favored Glycine 0 C--N 1.35 1.353 0 N-CA-C 112.821 -0.112 . . . . 74.43 112.821 -176.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 14.6 m -131.78 156.66 79.83 Favored Pre-proline 0 N--CA 1.485 1.295 0 C-N-CA 124.927 1.291 . . . . 71.34 109.826 178.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -80.97 177.16 8.23 Favored 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 122.452 2.101 . . . . 74.43 112.421 176.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 90.5 mtt180 -83.78 36.99 0.57 Allowed 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 122.485 1.136 . . . . 74.35 111.297 176.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -117.34 -15.59 10.35 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.702 2.001 . . . . 71.24 107.417 172.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.79 104.69 0.56 Allowed 'General case' 0 C--N 1.35 0.621 0 CA-C-N 114.383 -1.28 . . . . 75.2 112.834 -169.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 76.7 p -71.28 -170.13 0.46 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.894 1.278 . . . . 74.41 110.841 174.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.83 -42.89 90.34 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 124.276 1.03 . . . . 74.45 110.152 177.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 20' ' ' GLU . . . . . 0.485 ' O ' ' HG3' ' C' ' 24' ' ' ARG . 0.9 OUTLIER -75.58 -35.74 60.52 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 116.235 -0.438 . . . . 74.53 110.326 -175.582 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -68.52 -38.85 81.26 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-O 121.223 0.535 . . . . 73.42 110.55 178.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 1.1 mp -60.14 -39.53 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.397 1.079 . . . . 75.54 109.796 169.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -70.01 -31.39 69.04 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.297 -0.865 . . . . 74.13 110.812 178.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 24' ' ' ARG . . . . . 0.485 ' HG3' ' O ' ' C' ' 20' ' ' GLU . 89.0 mtt180 -65.81 -44.87 84.35 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 109.398 -0.593 . . . . 73.52 109.398 177.435 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.09 -34.9 79.11 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 114.57 -1.196 . . . . 75.32 111.562 176.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 26' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -67.9 -48.15 66.8 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 123.816 0.698 . . . . 72.31 110.631 177.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -59.37 -56.11 26.18 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.381 -0.6 . . . . 75.33 109.381 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 32.3 ttt180 -50.49 -70.76 0.08 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.947 0.899 . . . . 75.55 111.489 177.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 86.7 mt -75.0 -50.31 16.98 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.42 -0.809 . . . . 71.43 112.04 -168.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' C' ' 34' ' ' HIS . . . -67.57 -28.52 67.85 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-O 117.714 -1.136 . . . . 75.32 112.239 -176.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . 0.47 ' HA ' ' HB2' ' C' ' 34' ' ' HIS . 74.5 mtm180 -80.9 -28.24 35.95 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 120.051 1.296 . . . . 73.5 110.842 173.117 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -65.34 -31.33 72.4 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.212 0.605 . . . . 71.12 110.367 171.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 33' ' ' TYR . . . . . 0.449 ' HB3' ' O ' ' C' ' 43' ' ' ALA . 21.7 m-85 -111.02 8.13 21.8 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.884 0.873 . . . . 72.14 112.056 -174.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 34' ' ' HIS . . . . . 0.47 ' HB2' ' HA ' ' C' ' 31' ' ' ARG . 9.4 t-160 -75.43 114.33 34.79 Favored Pre-proline 0 N--CA 1.479 1.003 0 CA-C-O 118.26 -0.876 . . . . 74.34 110.152 -174.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.52 -20.53 49.9 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 122.423 2.082 . . . . 72.22 112.882 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -53.5 -43.69 68.45 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.773 1.229 . . . . 60.34 112.181 173.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 86.5 t -107.53 -52.49 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 123.109 0.564 . . . . 75.33 109.955 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -98.37 90.68 4.88 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.128 0.971 . . . . 65.41 109.898 -176.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -74.84 81.4 2.12 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 109.113 -0.699 . . . . 71.22 109.113 176.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 70.8 m -137.37 117.02 10.31 Favored Pre-proline 0 N--CA 1.48 1.037 0 C-N-CA 123.459 0.704 . . . . 74.14 109.756 176.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -50.52 -43.33 45.52 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 123.882 3.055 . . . . 75.0 114.005 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -58.06 -40.3 80.66 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.406 0.682 . . . . 71.01 110.549 175.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 43' ' ' ALA . . . . . 0.449 ' O ' ' HB3' ' C' ' 33' ' ' TYR . . . -73.41 -17.93 61.21 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 115.661 -0.7 . . . . 71.45 110.259 -178.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 44' ' ' GLU . . . . . 0.434 ' O ' ' HD3' ' C' ' 48' ' ' LYS . 44.1 mt-10 -74.87 -43.9 51.9 Favored 'General case' 0 C--N 1.358 0.947 0 N-CA-C 109.217 -0.66 . . . . 74.04 109.217 175.01 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -57.69 -46.03 84.87 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 121.672 0.748 . . . . 75.44 110.048 175.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 46' ' ' LYS . . . . . 0.551 ' O ' HG12 ' C' ' 50' ' ' ILE . 99.9 mttt -63.6 -39.56 94.67 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 114.237 -1.347 . . . . 72.32 110.802 176.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -62.94 -32.53 73.86 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.869 0.868 . . . . 71.12 110.476 177.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 48' ' ' LYS . . . . . 0.434 ' HD3' ' O ' ' C' ' 44' ' ' GLU . 2.5 mptm? -65.81 -47.32 75.48 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 122.959 0.504 . . . . 72.04 109.702 173.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -58.57 -44.59 89.81 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.13 0.572 . . . . 72.33 111.304 178.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 50' ' ' ILE . . . . . 0.551 HG12 ' O ' ' C' ' 46' ' ' LYS . 20.3 mm -63.21 -49.31 83.7 Favored 'Isoleucine or valine' 0 C--N 1.361 1.078 0 CA-C-N 115.686 -0.688 . . . . 75.43 109.733 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 51' ' ' ASN . . . . . 0.501 ' HA ' ' HB3' ' C' ' 54' ' ' TYR . 22.0 m-80 -79.9 -9.18 59.65 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.703 0.801 . . . . 74.04 112.169 -176.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -71.26 -61.37 1.79 Allowed 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 107.842 -1.17 . . . . 75.54 107.842 167.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.65 -41.72 86.71 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 113.626 -1.624 . . . . 63.1 112.216 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 54' ' ' TYR . . . . . 0.501 ' HB3' ' HA ' ' C' ' 51' ' ' ASN . 67.2 t80 -65.1 -52.68 54.04 Favored 'General case' 0 C--O 1.213 -0.837 0 CA-C-N 115.148 -0.933 . . . . 75.01 109.884 177.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.68 -38.2 63.95 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 112.199 0.444 . . . . 60.54 112.199 -177.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 98.2 t -64.61 -55.61 20.39 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 O-C-N 123.99 0.807 . . . . 72.43 110.887 173.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 57' ' ' LEU . . . . . . . . . . . . . 68.0 mt -94.27 7.58 44.86 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 113.616 0.969 . . . . 75.02 113.616 -168.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 43.8 t -69.65 -81.03 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.719 0.807 . . . . 75.33 110.919 -175.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -83.8 145.4 47.0 Favored Pre-proline 0 C--O 1.248 1.021 0 N-CA-C 109.37 -0.604 . . . . 72.03 109.37 -174.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 60' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -47.13 -33.92 16.4 Favored 'Trans proline' 0 C--N 1.387 2.588 0 C-N-CA 124.546 3.497 . . . . 73.21 113.634 -176.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -56.11 -71.03 0.1 Allowed 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 124.492 1.117 . . . . 62.13 111.62 178.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 33.8 mtmt -66.01 -29.08 69.39 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.74 0.816 . . . . 75.43 111.185 -174.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 23.8 tpt85 -54.19 -52.47 61.1 Favored 'General case' 0 C--N 1.356 0.876 0 O-C-N 124.277 0.986 . . . . 74.14 109.583 170.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -63.33 -35.99 82.21 Favored 'General case' 0 C--N 1.357 0.896 0 CA-C-O 118.613 -0.708 . . . . 74.15 111.915 178.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 1.5 mp -55.98 -45.31 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-N 118.281 0.492 . . . . 71.5 110.363 175.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -61.59 -55.17 33.7 Favored 'General case' 0 C--N 1.358 0.957 0 N-CA-C 109.937 -0.394 . . . . 74.31 109.937 176.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -56.48 -36.48 69.15 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.646 0.778 . . . . 73.14 112.586 -176.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 45.5 p -77.35 -30.65 54.0 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 119.085 -0.484 . . . . 74.43 110.92 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -66.82 128.39 36.13 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 118.425 0.557 . . . . 75.22 110.471 -179.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.19 14.85 55.4 Favored Glycine 0 C--N 1.345 1.059 0 N-CA-C 111.582 -0.607 . . . . 62.51 111.582 -176.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 29.8 m -142.48 -57.44 0.44 Allowed 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 103.942 -2.614 . . . . 72.34 103.942 177.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 49.5 m -79.73 141.15 36.61 Favored 'General case' 0 C--O 1.257 1.494 0 N-CA-C 104.871 -2.27 . . . . 73.35 104.871 154.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.4 -40.07 10.12 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.486 0.714 . . . . 73.23 109.833 178.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -77.88 128.28 79.56 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 123.886 0.874 . . . . 53.23 110.619 -175.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -62.48 121.28 9.18 Favored 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 122.642 2.228 . . . . 75.14 110.746 174.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -52.23 131.19 38.67 Favored 'Trans proline' 0 C--N 1.38 2.193 0 C-N-CA 123.328 2.685 . . . . 71.22 113.001 -179.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -53.03 126.79 22.62 Favored 'Trans proline' 0 C--N 1.39 2.743 0 C-N-CA 123.392 2.728 . . . . 74.4 112.232 -175.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 78' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -64.09 148.53 91.39 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 122.738 2.292 . . . . 74.44 112.317 -172.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -57.34 158.1 19.81 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 122.512 2.141 . . . . 70.12 111.251 171.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -53.42 80.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.386 2.52 0 C-N-CA 124.069 3.179 . . . . 74.31 115.259 -171.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 149.75 -41.91 0.81 Allowed Glycine 0 C--N 1.341 0.826 0 N-CA-C 110.773 -0.931 . . . . 75.2 110.773 -178.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 145.86 174.86 18.42 Favored Glycine 0 C--N 1.343 0.921 0 C-N-CA 123.472 0.558 . . . . 75.13 111.881 177.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -53.56 124.32 14.64 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.209 1.004 . . . . 73.4 109.799 169.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -58.1 110.85 1.01 Allowed 'General case' 0 N--CA 1.479 0.984 0 O-C-N 123.88 0.737 . . . . 75.11 111.179 175.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 85' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -142.86 31.62 1.42 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.371 1.469 . . . . 74.41 108.736 170.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 86' ' ' SER . . . . . 0.459 ' OG ' ' HD2' ' C' ' 143' ' ' ARG . 7.4 m -71.04 106.88 3.86 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 114.216 -1.356 . . . . 52.42 110.191 -173.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 100.84 -21.8 42.21 Favored Glycine 0 C--N 1.337 0.626 0 CA-C-N 116.107 -0.497 . . . . 74.34 112.811 -176.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 88' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -88.0 130.65 34.9 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 108.203 -1.036 . . . . 74.44 108.203 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -75.68 69.55 2.39 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.964 0.905 . . . . 72.23 110.664 -170.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 90' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -48.34 -43.27 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 125.679 1.592 . . . . 54.42 112.114 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -62.76 -30.78 71.7 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.267 0.627 . . . . 75.25 111.91 -176.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -81.53 -26.02 35.43 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.511 0.324 . . . . 75.53 110.607 177.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 15.1 m-30 -68.95 166.75 17.24 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.499 0.319 . . . . 72.45 110.855 -174.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 65.1 p -63.68 162.2 13.6 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 114.3 1.222 . . . . 52.11 114.3 -165.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 95' ' ' GLU . . . . . 0.429 ' O ' ' HG3' ' C' ' 99' ' ' GLU . 0.0 OUTLIER -63.39 -44.17 95.47 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 114.988 -1.006 . . . . 72.35 111.931 178.245 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -55.79 -46.95 77.85 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.313 0.645 . . . . 74.24 110.545 177.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 97' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -56.58 -46.85 80.59 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 113.77 -1.559 . . . . 64.25 110.271 175.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 98' ' ' GLN . . . . . 0.479 ' HA ' ' CD1' ' C' ' 105' ' ' LEU . 93.1 mt-30 -73.89 -12.71 60.75 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.183 0.808 . . . . 71.33 113.183 -176.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' C' ' 95' ' ' GLU . 46.8 mt-10 -87.1 -48.43 8.08 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.19 0.596 . . . . 74.43 111.211 172.195 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 13.3 tp -66.6 -60.1 3.01 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.588 0.755 . . . . 73.23 111.313 -175.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -85.23 -8.98 58.29 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 116.205 -0.452 . . . . 75.04 110.994 -177.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -39.0 -55.24 2.34 Favored Glycine 0 C--N 1.365 2.157 0 CA-C-O 118.407 -1.218 . . . . 74.41 114.943 -176.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -29.24 -37.47 0.04 OUTLIER 'Trans proline' 0 C--N 1.391 2.782 1 C-N-CA 125.731 4.287 . . . . 64.35 116.888 173.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -147.52 36.45 1.17 Allowed Glycine 0 C--N 1.352 1.454 0 C-N-CA 121.559 -0.353 . . . . 73.42 112.982 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 105' ' ' LEU . . . . . 0.479 ' CD1' ' HA ' ' C' ' 98' ' ' GLN . 4.1 mt -68.61 14.2 0.08 Allowed 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 115.629 1.714 . . . . 75.43 115.629 -174.078 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 106' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 54.92 -160.13 0.17 Allowed 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 119.21 0.914 . . . . 64.24 110.088 -170.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . 85.73 64.25 1.5 Allowed Glycine 0 C--N 1.36 1.877 0 C-N-CA 118.566 -1.778 . . . . 51.05 117.459 162.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 64.7 -81.57 0.06 OUTLIER Glycine 0 N--CA 1.48 1.606 0 N-CA-C 114.896 0.719 . . . . 74.41 114.896 162.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 109' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -73.07 -5.34 38.31 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.217 1.007 . . . . 74.45 112.093 -177.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 110' ' ' GLY . . . . . 0.451 ' HA3' ' HG ' ' C' ' 113' ' ' SER . . . -71.03 9.99 3.53 Favored Glycine 0 CA--C 1.56 2.872 0 N-CA-C 115.879 1.112 . . . . 73.14 115.879 172.104 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 82.06 -40.9 0.12 Allowed 'General case' 0 N--CA 1.503 2.222 0 C-N-CA 125.753 1.621 . . . . 75.25 114.705 170.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 112' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -105.75 -46.2 4.2 Favored 'General case' 0 N--CA 1.503 2.189 0 CA-C-N 119.776 1.171 . . . . 75.43 107.991 169.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 113' ' ' SER . . . . . 0.451 ' HG ' ' HA3' ' C' ' 110' ' ' GLY . 31.3 m -1.09 79.64 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 128.142 2.577 . . . . 72.53 115.662 153.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 114' ' ' ARG . . . . . 0.562 ' HG3' ' H ' ' C' ' 115' ' ' LYS . 0.3 OUTLIER -99.13 -161.87 0.91 Allowed 'General case' 0 CA--C 1.557 1.213 0 O-C-N 121.453 -0.78 . . . . 74.05 111.263 177.696 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 115' ' ' LYS . . . . . 0.774 ' HG3' ' HB2' ' C' ' 170' ' ' PRO . 84.8 tttt -83.68 140.15 32.33 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 106.467 -1.679 . . . . 74.15 106.467 160.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -57.56 109.13 1.61 Allowed Glycine 0 C--N 1.347 1.174 0 N-CA-C 111.252 -0.739 . . . . 54.4 111.252 176.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 67.7 mtp180 -93.91 163.55 13.45 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.545 0.738 . . . . 74.32 109.977 177.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 118' ' ' ASP . . . . . 0.42 ' HA ' ' O ' ' C' ' 173' ' ' ASP . 9.6 p-10 -73.33 93.52 1.92 Allowed 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 108.57 -0.9 . . . . 75.42 108.57 174.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 119' ' ' LEU . . . . . 0.467 HD11 ' HA ' ' C' ' 174' ' ' LEU . 0.0 OUTLIER -95.33 157.08 16.05 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 108.233 -1.025 . . . . 75.21 108.233 -178.544 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.64 126.41 48.97 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.94 -0.392 . . . . 72.31 109.94 -174.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 121' ' ' ALA . . . . . . . . . . . . . . . -125.19 118.71 26.65 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 108.747 -0.834 . . . . 75.44 108.747 -178.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 122' ' ' GLU . . . . . 0.428 ' HB3' ' CD2' ' B' ' 184' ' ' HIS . 37.2 tt0 -94.88 148.16 22.6 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 122.676 0.39 . . . . 74.12 110.839 -171.116 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 123' ' ' LEU . . . . . 0.658 ' HB3' ' HA ' ' B' ' 182' ' ' VAL . 1.0 OUTLIER -144.61 114.82 5.19 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 122.862 0.465 . . . . 73.3 111.137 -177.318 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -66.18 114.45 3.03 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 121.862 1.708 . . . . 72.51 108.964 162.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 125' ' ' LEU . . . . . 0.548 HD21 HG13 ' C' ' 153' ' ' VAL . 18.4 tp -138.15 155.52 48.64 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.579 0.351 . . . . 75.32 110.846 -164.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 126' ' ' THR . . . . . . . . . . . . . 15.0 p -100.09 160.6 14.19 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-O 121.871 0.843 . . . . 61.53 111.218 173.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 127' ' ' LEU . . . . . 0.451 HD22 HD13 ' C' ' 180' ' ' LEU . 8.4 mt -67.13 -35.46 79.77 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 113.46 -1.7 . . . . 62.25 108.479 174.127 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -62.88 -47.23 84.2 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 113.145 -1.843 . . . . 75.24 109.605 176.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 129' ' ' GLU . . . . . 0.646 ' HG2' HD21 ' B' ' 167' ' ' ASN . 12.1 mm-40 -66.46 -28.82 68.89 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 122.854 0.462 . . . . 75.51 111.732 176.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.85 -41.23 97.85 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 123.463 0.477 . . . . 73.14 110.51 175.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 131' ' ' PHE . . . . . 0.405 ' HB2' HD13 ' C' ' 215' ' ' LEU . 52.3 t80 -65.31 -43.0 92.46 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.965 0.906 . . . . 75.55 110.292 172.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 132' ' ' HIS . . . . . 0.467 ' O ' ' HD3' ' C' ' 136' ' ' ARG . 23.5 m170 -80.01 -1.8 41.35 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.206 -0.906 . . . . 70.15 110.781 -176.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -69.15 65.47 0.52 Allowed Glycine 0 C--N 1.358 1.8 0 C-N-CA 123.977 0.799 . . . . 65.31 114.447 174.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . -93.47 -126.23 4.25 Favored Glycine 0 C--N 1.343 0.936 0 N-CA-C 109.442 -1.463 . . . . 73.12 109.442 165.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 13.8 mp0 -71.97 94.79 1.5 Allowed 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 117.667 0.734 . . . . 73.03 109.119 175.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 136' ' ' ARG . . . . . 0.467 ' HD3' ' O ' ' C' ' 132' ' ' HIS . 17.9 mmm180 -110.82 147.64 34.07 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.45 0.7 . . . . 72.12 110.313 -175.081 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 137' ' ' VAL . . . . . . . . . . . . . 35.8 m -91.73 144.19 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 108.823 -0.806 . . . . 73.11 108.823 178.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 138' ' ' VAL . . . . . 0.438 HG21 HG21 ' C' ' 140' ' ' VAL . 14.7 p -160.64 151.0 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 O-C-N 123.211 0.32 . . . . 72.14 110.936 -177.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 139' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -120.1 113.27 20.22 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 107.561 -1.274 . . . . 74.31 107.561 171.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 140' ' ' VAL . . . . . 0.438 HG21 HG21 ' C' ' 138' ' ' VAL . 90.0 t -130.14 101.61 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 123.759 0.824 . . . . 73.25 110.794 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 141' ' ' ALA . . . . . 0.661 ' HB2' HH21 ' C' ' 143' ' ' ARG . . . 55.45 44.65 26.69 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.576 1.551 . . . . 65.0 112.562 168.04 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 103.08 6.26 45.72 Favored Glycine 0 C--N 1.347 1.175 0 CA-C-N 115.46 -0.791 . . . . 52.4 113.183 178.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 143' ' ' ARG . . . . . 0.661 HH21 ' HB2' ' C' ' 141' ' ' ALA . 0.0 OUTLIER -120.82 95.39 4.69 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 117.452 0.626 . . . . 75.05 110.19 -176.95 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 52.9 ttt180 -90.49 87.25 6.69 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 107.767 -1.197 . . . . 71.51 107.767 168.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 145' ' ' VAL . . . . . . . . . . . . . 27.4 m -119.66 148.77 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 115.4 -0.818 . . . . 75.03 111.574 -176.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 16.0 p -99.11 96.9 8.1 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 124.492 1.117 . . . . 73.22 108.433 168.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 14.8 p -124.83 151.52 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.753 0.821 . . . . 72.53 110.471 -173.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 24.2 ttm180 -98.24 110.15 22.78 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 109.952 -0.388 . . . . 74.22 109.952 169.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 149' ' ' ILE . . . . . 0.428 HD11 HD13 ' C' ' 159' ' ' ILE . 39.8 pt -78.82 153.88 78.04 Favored Pre-proline 0 CA--C 1.552 1.038 0 N-CA-C 108.085 -1.08 . . . . 74.42 108.085 164.297 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -43.03 111.73 0.24 Allowed 'Trans proline' 0 C--N 1.385 2.45 0 C-N-CA 122.989 2.459 . . . . 61.44 112.879 175.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.95 102.6 0.13 Allowed 'Trans proline' 0 C--N 1.389 2.708 0 C-N-CA 123.507 2.805 . . . . 73.2 111.257 -178.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 152' ' ' GLY . . . . . 0.496 ' HA3' HD21 ' C' ' 188' ' ' LEU . . . 132.06 140.33 4.49 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 116.025 -0.534 . . . . 63.11 112.635 -171.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 153' ' ' VAL . . . . . 0.622 HG21 HG11 ' C' ' 178' ' ' VAL . 0.3 OUTLIER -152.59 167.26 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 N-CA-C 112.267 0.469 . . . . 74.01 112.267 -174.899 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 154' ' ' ARG . . . . . 0.532 ' NH1' ' HA ' ' B' ' 24' ' ' PRO . 19.2 mtt180 -138.61 162.89 33.47 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.529 1.131 . . . . 75.32 109.28 -173.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 155' ' ' GLU . . . . . 0.443 ' HB2' HD11 ' C' ' 180' ' ' LEU . 10.2 tp10 -72.76 132.65 43.89 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 123.98 0.912 . . . . 74.51 111.953 178.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 65.17 19.73 66.41 Favored Glycine 0 C--N 1.359 1.839 0 O-C-N 123.745 0.653 . . . . 75.21 113.601 173.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 157' ' ' SER . . . . . 0.448 ' OG ' ' HB2' ' C' ' 154' ' ' ARG . 53.4 m -98.18 172.19 7.75 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.241 0.616 . . . . 75.43 111.018 -172.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 7.7 p -127.13 118.55 50.46 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.987 0 CA-C-N 115.173 -0.921 . . . . 72.31 110.062 -173.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 159' ' ' ILE . . . . . 0.682 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 25.4 mt -94.58 103.56 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 108.281 -1.007 . . . . 72.31 108.281 178.019 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 160' ' ' ARG . . . . . 0.471 HH12 ' HB3' ' C' ' 162' ' ' PRO . 64.4 ttp85 -83.55 100.92 11.09 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 109.819 -0.437 . . . . 75.13 109.819 -179.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 161' ' ' VAL . . . . . 0.604 ' HB ' ' HB3' ' C' ' 174' ' ' LEU . 58.2 t -94.59 103.37 11.02 Favored Pre-proline 0 CA--C 1.554 1.13 0 N-CA-C 108.404 -0.961 . . . . 75.24 108.404 175.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 162' ' ' PRO . . . . . 0.471 ' HB3' HH12 ' C' ' 160' ' ' ARG . 90.9 Cg_endo -73.87 164.19 35.2 Favored 'Trans proline' 0 C--N 1.373 1.843 0 C-N-CA 122.924 2.416 . . . . 75.23 113.879 -172.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.46 -25.14 6.58 Favored Glycine 0 C--N 1.345 1.055 0 CA-C-N 114.886 -1.052 . . . . 53.54 114.294 172.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 164' ' ' MET . . . . . 0.407 ' SD ' ' HG2' ' C' ' 143' ' ' ARG . 23.9 ttp -83.5 -77.7 0.24 Allowed 'General case' 0 C--N 1.356 0.853 0 CA-C-N 117.779 0.789 . . . . 73.35 110.071 -172.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . 87.21 -173.27 44.32 Favored Glycine 0 C--N 1.342 0.887 0 CA-C-O 120.116 -0.269 . . . . 73.32 113.664 179.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . -83.2 -125.53 1.03 Allowed Glycine 0 C--N 1.345 1.048 0 CA-C-O 119.98 -0.344 . . . . 75.44 112.826 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 167' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -79.64 146.64 32.39 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 117.037 0.419 . . . . 74.2 110.851 -177.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 168' ' ' GLY . . . . . 0.54 ' HA3' ' O ' ' C' ' 114' ' ' ARG . . . 78.11 -166.48 52.8 Favored Glycine 0 C--N 1.348 1.216 0 O-C-N 123.876 0.735 . . . . 13.44 112.934 -175.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 169' ' ' ASN . . . . . . . . . . . . . 23.0 t30 -104.6 -64.35 0.04 OUTLIER Pre-proline 0 CA--C 1.558 1.275 0 CA-C-O 117.214 -1.374 . . . . 62.44 114.421 -164.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 170' ' ' PRO . . . . . 0.774 ' HB2' ' HG3' ' C' ' 115' ' ' LYS . 95.6 Cg_exo -42.67 117.4 0.86 Allowed 'Trans proline' 0 C--N 1.408 3.679 0 C-N-CA 123.3 2.667 . . . . 73.55 114.216 -162.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 171' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -36.27 115.72 0.13 Allowed 'Trans proline' 0 C--N 1.397 3.099 1 C-N-CA 125.614 4.21 . . . . 74.02 115.876 -163.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -118.87 -150.51 8.8 Favored Glycine 0 C--N 1.345 1.03 0 CA-C-N 115.863 -0.608 . . . . 74.42 112.358 178.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 173' ' ' ASP . . . . . 0.42 ' O ' ' HA ' ' C' ' 118' ' ' ASP . 11.6 m-20 -136.43 147.12 47.09 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-O 121.794 0.807 . . . . 74.51 111.189 -178.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 174' ' ' LEU . . . . . 0.604 ' HB3' ' HB ' ' C' ' 161' ' ' VAL . 19.0 tp -103.06 136.72 42.34 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 114.194 -1.366 . . . . 75.22 107.71 168.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 66.5 mt -123.44 85.87 2.49 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.321 1.049 . . . . 72.15 108.97 -178.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 176' ' ' LEU . . . . . 0.682 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 82.0 mt -71.43 108.15 4.71 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.156 -0.475 . . . . 74.33 110.352 179.384 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 177' ' ' VAL . . . . . . . . . . . . . 25.1 t -84.96 93.46 3.57 Favored 'Isoleucine or valine' 0 C--N 1.347 0.472 0 N-CA-C 108.253 -1.017 . . . . 75.23 108.253 178.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 178' ' ' VAL . . . . . 0.622 HG11 HG21 ' C' ' 153' ' ' VAL . 2.4 p -84.11 117.15 29.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.292 -0.867 . . . . 74.01 110.525 -175.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 179' ' ' ARG . . . . . . . . . . . . . 6.1 mmm180 -108.2 116.0 31.16 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 107.8 -1.185 . . . . 74.42 107.8 172.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 180' ' ' LEU . . . . . 0.451 HD13 HD22 ' C' ' 127' ' ' LEU . 92.9 mt -74.59 148.33 40.89 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 120.854 0.359 . . . . 73.43 110.499 178.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 181' ' ' LEU . . . . . . . . . . . . . 80.9 mt -70.14 166.09 37.12 Favored Pre-proline 0 CA--C 1.552 1.049 0 CA-C-O 118.236 -0.888 . . . . 74.24 109.348 177.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -54.2 76.15 0.03 OUTLIER 'Trans proline' 0 C--N 1.393 2.869 0 C-N-CA 123.224 2.616 . . . . 73.32 112.58 170.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 183' ' ' HIS . . . . . 0.441 ' N ' ' HD3' ' C' ' 184' ' ' PRO . 74.5 t60 174.88 54.48 0.03 OUTLIER Pre-proline 0 CA--C 1.561 1.384 0 C-N-CA 126.895 2.078 . . . . 72.0 106.384 -167.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 184' ' ' PRO . . . . . 0.441 ' HD3' ' N ' ' C' ' 183' ' ' HIS . 66.3 Cg_endo -93.83 65.1 0.41 Allowed 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.409 2.739 . . . . 74.25 110.628 -174.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 185' ' ' VAL . . . . . 0.515 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 16.4 t -93.28 -58.04 3.93 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.559 0 N-CA-C 108.946 -0.761 . . . . 72.23 108.946 -167.249 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 186' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -101.23 104.31 15.35 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 121.201 0.524 . . . . 61.44 111.052 -169.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 187' ' ' ARG . . . . . 0.435 ' NH1' ' HB2' ' C' ' 189' ' ' GLU . 4.0 tmt_? -95.63 122.37 38.32 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 107.79 -1.189 . . . . 75.14 107.79 174.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 188' ' ' LEU . . . . . 0.538 HD13 ' HD2' ' C' ' 240' ' ' PHE . 59.2 tp -80.34 147.94 30.87 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.689 0.396 . . . . 74.14 111.861 -177.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 189' ' ' GLU . . . . . 0.435 ' HB2' ' NH1' ' C' ' 187' ' ' ARG . 8.8 tp10 -144.93 110.54 5.33 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 107.756 -1.202 . . . . 73.21 107.756 161.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 67.88 -93.12 0.26 Allowed Glycine 0 C--N 1.35 1.345 0 N-CA-C 111.58 -0.608 . . . . 74.2 111.58 -172.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 191' ' ' GLN . . . . . 0.508 ' NE2' ' HA3' ' C' ' 242' ' ' GLY . 51.0 mt-30 -128.37 -16.39 4.42 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.383 1.073 . . . . 75.25 110.553 173.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -91.63 134.86 34.33 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.09 0.956 . . . . 65.13 110.249 -173.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 193' ' ' LEU . . . . . 0.631 ' HG ' ' HA2' ' C' ' 239' ' ' GLY . 17.4 mt -98.27 173.13 7.15 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 122.878 0.471 . . . . 65.15 112.043 -171.062 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 194' ' ' TYR . . . . . 0.509 ' HA ' ' O ' ' C' ' 250' ' ' TYR . 35.4 t80 -139.05 107.04 5.69 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 114.824 -1.08 . . . . 75.43 108.843 171.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 195' ' ' ALA . . . . . 0.515 ' HA ' ' O ' ' C' ' 185' ' ' VAL . . . -106.72 -176.16 3.0 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.322 1.049 . . . . 65.11 109.871 175.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 41.0 m -132.31 110.66 10.75 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 108.909 -0.774 . . . . 53.42 108.909 167.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 197' ' ' LEU . . . . . 0.437 ' HB2' HD21 ' C' ' 251' ' ' LEU . 35.6 tp -97.7 109.38 22.14 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.835 0.854 . . . . 73.5 109.169 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -88.94 104.5 17.01 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-O 121.917 0.865 . . . . 64.33 110.071 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 199' ' ' VAL . . . . . 0.403 ' HA ' HG11 ' C' ' 210' ' ' VAL . 42.3 t -92.35 123.22 62.92 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 124.958 1.303 . . . . 73.12 109.148 179.215 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 200' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.48 149.44 68.66 Favored 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 121.95 1.767 . . . . 73.11 110.826 176.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 201' ' ' ALA . . . . . 0.423 ' HB3' ' HH2' ' C' ' 269' ' ' TRP . . . -54.89 -46.84 99.47 Favored Pre-proline 0 CA--C 1.553 1.061 0 CA-C-O 117.579 -1.2 . . . . 74.35 113.909 -169.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 202' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -54.08 -47.16 28.57 Favored 'Trans proline' 0 C--N 1.395 3.006 0 C-N-CA 121.926 1.751 . . . . 63.15 112.625 176.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 203' ' ' ILE . . . . . . . . . . . . . 48.6 mt -69.77 -37.75 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.152 0.981 . . . . 74.02 111.156 -177.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -61.71 -43.95 97.87 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.507 0.723 . . . . 75.02 110.87 178.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 205' ' ' VAL . . . . . 0.409 ' HA ' ' HA ' ' C' ' 226' ' ' ARG . 78.7 t -74.16 -40.99 51.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 115.024 -0.989 . . . . 74.52 112.378 -176.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 206' ' ' VAL . . . . . 0.614 ' HA ' ' HE2' ' A' ' 270' ' ' LYS . 11.1 p -78.15 -33.99 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 CA-C-N 118.047 0.385 . . . . 74.12 110.839 -177.189 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 85.13 52.64 3.37 Favored Glycine 0 C--N 1.338 0.652 0 CA-C-N 115.779 -0.646 . . . . 63.21 111.518 -170.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 208' ' ' GLY . . . . . 0.503 ' HA2' HD23 ' B' ' 247' ' ' LEU . . . -90.13 -123.49 2.56 Favored Glycine 0 C--N 1.345 1.055 0 CA-C-N 115.104 -0.548 . . . . 51.32 111.778 -177.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 209' ' ' LYS . . . . . 0.681 ' HE2' ' HA ' ' B' ' 235' ' ' GLU . 6.5 mtmp? -147.2 144.13 28.7 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.53 0.681 . . . . 72.44 111.103 175.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 210' ' ' VAL . . . . . 0.403 HG11 ' HA ' ' C' ' 199' ' ' VAL . 16.2 m -122.67 178.66 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 113.6 -1.637 . . . . 71.52 107.468 167.073 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 211' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -132.3 130.29 40.64 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.922 0.392 . . . . 75.53 110.542 -178.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 212' ' ' ALA . . . . . 0.529 ' HB2' HG11 ' C' ' 219' ' ' VAL . . . -104.85 113.98 27.91 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 107.171 -1.418 . . . . 74.43 107.171 173.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 213' ' ' MET . . . . . . . . . . . . . 5.4 tmm? -67.38 135.51 53.31 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 107.84 -1.17 . . . . 63.12 107.84 171.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 214' ' ' THR . . . . . 0.516 HG22 ' HD2' ' C' ' 238' ' ' LYS . 0.1 OUTLIER -134.46 171.42 14.33 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-O 122.088 0.947 . . . . 72.34 111.962 -174.896 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 215' ' ' LEU . . . . . 0.405 HD13 ' HB2' ' C' ' 131' ' ' PHE . 27.4 mt -73.24 -31.16 63.96 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 114.151 -1.386 . . . . 75.24 113.08 -163.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.92 8.04 21.97 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.956 -1.02 . . . . 71.0 111.362 -178.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 149.37 -163.11 29.18 Favored Glycine 0 C--N 1.351 1.381 0 CA-C-O 119.479 -0.623 . . . . 74.41 111.938 -177.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -96.44 163.89 1.19 Allowed 'Trans proline' 0 C--N 1.362 1.269 0 C-N-CA 122.984 2.456 . . . . 64.03 113.415 173.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 219' ' ' VAL . . . . . 0.755 ' HB ' ' HE3' ' C' ' 238' ' ' LYS . 1.7 p -142.44 114.64 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.099 0 N-CA-C 108.154 -1.054 . . . . 52.53 108.154 166.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 220' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -90.84 107.74 19.38 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.081 -1.081 . . . . 72.32 108.081 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 221' ' ' VAL . . . . . 0.493 ' HA ' ' HB3' ' B' ' 239' ' ' ALA . 56.0 t -76.07 129.77 36.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 125.124 1.37 . . . . 74.03 111.798 -172.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 222' ' ' ALA . . . . . 0.517 ' HA ' ' HG2' ' C' ' 209' ' ' LYS . . . -90.99 123.77 34.72 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.59 0.756 . . . . 73.3 109.848 173.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 58.4 t -99.17 142.0 23.84 Favored Pre-proline 0 CA--C 1.561 1.389 0 C-N-CA 125.149 1.38 . . . . 73.11 110.168 -172.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 224' ' ' PRO . . . . . 0.568 ' HG2' HE21 ' B' ' 243' ' ' GLN . 5.1 Cg_exo -85.6 158.9 10.73 Favored 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 123.958 3.105 . . . . 73.11 112.923 168.388 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -55.95 128.52 30.59 Favored 'Trans proline' 0 C--N 1.385 2.497 0 C-N-CA 123.462 2.775 . . . . 74.4 113.448 178.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 226' ' ' ARG . . . . . 0.53 HH11 HD12 ' A' ' 261' ' ' LEU . 0.0 OUTLIER 52.45 81.14 0.09 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.756 1.622 . . . . 71.5 112.141 -178.82 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 227' ' ' THR . . . . . 0.529 HG21 HG13 ' C' ' 253' ' ' VAL . 54.7 m -93.64 142.27 27.54 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 114.869 -1.06 . . . . 73.3 110.204 176.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 228' ' ' GLN . . . . . 0.724 HE21 ' HG2' ' A' ' 259' ' ' GLU . 27.3 mp0 -101.94 146.56 27.69 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.733 0.813 . . . . 74.32 112.271 -173.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -69.56 118.14 12.05 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 114.647 -1.16 . . . . 65.31 108.519 169.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 113.12 -2.3 25.47 Favored Glycine 0 C--N 1.339 0.717 0 CA-C-O 119.6 -0.556 . . . . 62.04 112.205 -175.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 231' ' ' ARG . . . . . . . . . . . . . 60.0 mtp85 -73.79 -179.49 3.68 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 117.126 0.463 . . . . 75.03 111.273 171.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 232' ' ' LYS . . . . . 0.578 ' HD3' ' HB3' ' C' ' 250' ' ' TYR . 34.4 ttmt -148.61 146.43 28.22 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.891 -0.595 . . . . 74.05 111.225 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 233' ' ' LEU . . . . . 0.635 HD12 ' HB2' ' C' ' 251' ' ' LEU . 0.9 OUTLIER -117.26 155.61 29.17 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.998 1.319 . . . . 74.22 108.495 177.349 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 234' ' ' ARG . . . . . 0.455 ' O ' ' HA3' ' B' ' 240' ' ' GLY . 16.8 ptt180 -127.07 109.6 12.05 Favored 'General case' 0 N--CA 1.475 0.775 0 O-C-N 123.702 0.626 . . . . 72.34 109.583 166.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 235' ' ' LEU . . . . . 0.433 HD13 HD23 ' C' ' 249' ' ' LEU . 26.8 mt -95.82 128.08 42.39 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.614 0.765 . . . . 74.34 109.185 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -79.87 125.76 30.13 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.25 0.62 . . . . 73.41 112.284 -168.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 77.77 13.71 83.16 Favored Glycine 0 C--N 1.353 1.481 0 O-C-N 124.124 0.89 . . . . 71.42 113.458 178.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 238' ' ' LYS . . . . . 0.755 ' HE3' ' HB ' ' C' ' 219' ' ' VAL . 69.6 mmtt -105.05 19.85 19.88 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.592 0.757 . . . . 75.11 111.446 -178.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 239' ' ' GLY . . . . . 0.631 ' HA2' ' HG ' ' C' ' 193' ' ' LEU . . . -92.53 -171.08 40.86 Favored Glycine 0 C--N 1.345 1.071 0 CA-C-N 116.217 -0.447 . . . . 75.2 112.749 171.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 240' ' ' PHE . . . . . 0.538 ' HD2' HD13 ' C' ' 188' ' ' LEU . 11.9 m-85 -79.04 154.68 77.61 Favored Pre-proline 0 CA--C 1.563 1.447 0 C-N-CA 122.965 0.506 . . . . 75.14 110.221 177.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 241' ' ' PRO . . . . . 0.626 ' HA ' ' HG2' ' C' ' 246' ' ' ARG . 18.6 Cg_exo -67.55 136.73 40.4 Favored 'Trans proline' 0 C--N 1.396 3.05 0 C-N-CA 124.183 3.255 . . . . 71.53 114.355 -172.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 242' ' ' GLY . . . . . 0.508 ' HA3' ' NE2' ' C' ' 191' ' ' GLN . . . -134.2 171.96 21.97 Favored Glycine 0 C--N 1.35 1.344 0 CA-C-N 115.514 -0.767 . . . . 70.14 113.041 178.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.01 -25.06 38.53 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 123.764 2.976 . . . . 71.42 113.321 -177.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -112.7 14.52 20.02 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.894 0.878 . . . . 71.42 111.008 178.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 119.45 177.09 16.3 Favored Glycine 0 C--N 1.349 1.299 0 N-CA-C 112.078 -0.409 . . . . 63.24 112.078 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 246' ' ' ARG . . . . . 0.626 ' HG2' ' HA ' ' C' ' 241' ' ' PRO . 72.4 mtm-85 -85.09 158.77 20.33 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.856 0.862 . . . . 71.32 111.005 -177.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.82 -155.03 6.18 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 114.045 0.378 . . . . 63.23 114.045 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -124.96 139.11 54.12 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.363 0.665 . . . . 73.54 109.578 -179.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 249' ' ' LEU . . . . . 0.464 HD13 ' HB1' ' C' ' 195' ' ' ALA . 28.8 tp -85.2 115.27 22.88 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.927 0.891 . . . . 74.23 110.836 -177.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 250' ' ' TYR . . . . . 0.585 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 16.0 m-30 -99.91 101.7 12.89 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 110.022 -0.362 . . . . 71.43 110.022 179.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 251' ' ' LEU . . . . . 0.635 ' HB2' HD12 ' C' ' 233' ' ' LEU . 0.8 OUTLIER -100.62 138.41 37.72 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.632 -0.668 . . . . 72.0 109.802 -175.716 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -87.57 125.44 34.35 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.895 -0.78 . . . . 75.41 108.895 171.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 253' ' ' VAL . . . . . 0.529 HG13 HG21 ' C' ' 227' ' ' THR . 59.3 t -74.5 136.84 24.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 123.213 0.605 . . . . 73.5 110.899 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 254' ' ' ARG . . . . . . . . . . . . . 40.8 mtm180 -116.12 147.11 41.67 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 107.63 -1.248 . . . . 75.13 107.63 163.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 255' ' ' ILE . . . . . 0.539 HG21 HG23 ' A' ' 257' ' ' ILE . 33.4 mm -97.89 119.07 45.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 106.757 -1.571 . . . . 75.24 106.757 164.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 256' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.4 173.59 7.89 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.031 1.333 . . . . 70.25 108.461 -178.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 2.3 pp -144.12 153.27 56.36 Favored Pre-proline 0 N--CA 1.477 0.888 0 C-N-CA 123.181 0.592 . . . . 75.21 110.569 -174.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.51 6.1 1.35 Allowed 'Trans proline' 0 C--N 1.385 2.495 0 C-N-CA 122.812 2.341 . . . . 74.41 114.278 -175.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 52.43 -84.29 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.858 1.663 . . . . 72.3 112.825 -174.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.14 140.1 58.83 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.908 0.883 . . . . 73.41 110.718 -177.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 261' ' ' LEU . . . . . 0.495 HD21 ' HB3' ' C' ' 265' ' ' GLU . 65.1 mt -124.7 152.97 43.04 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.363 0.665 . . . . 74.53 111.101 -176.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 67.6 p -85.05 168.35 21.15 Favored Pre-proline 0 CA--C 1.556 1.202 0 N-CA-C 107.572 -1.27 . . . . 61.23 107.572 164.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -51.16 -37.44 58.61 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 122.799 2.333 . . . . 74.2 112.863 171.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -58.71 -64.08 1.06 Allowed 'General case' 0 C--O 1.251 1.138 0 C-N-CA 124.762 1.225 . . . . 71.04 110.845 175.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 265' ' ' GLU . . . . . 0.495 ' HB3' HD21 ' C' ' 261' ' ' LEU . 32.1 mm-40 -53.21 -44.06 67.72 Favored 'General case' 0 C--N 1.352 0.704 0 O-C-N 124.375 1.047 . . . . 71.03 110.493 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 266' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -58.72 -43.02 90.01 Favored 'General case' 0 C--O 1.214 -0.791 0 C-N-CA 123.462 0.705 . . . . 73.1 110.374 -178.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -62.22 -51.84 66.17 Favored 'General case' 0 CA--C 1.555 1.157 0 O-C-N 123.726 0.641 . . . . 71.12 111.764 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 268' ' ' LEU . . . . . . . . . . . . . 8.7 mp -66.75 -48.69 68.33 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 116.498 -0.319 . . . . 70.11 111.238 -176.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 269' ' ' TRP . . . . . 0.423 ' HH2' ' HB3' ' C' ' 201' ' ' ALA . 94.6 m95 -61.22 -32.53 72.31 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.511 0.724 . . . . 63.11 111.281 176.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 270' ' ' LYS . . . . . 0.416 ' HD2' HG11 ' A' ' 206' ' ' VAL . 1.2 mmmm -61.35 -52.34 65.07 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 123.433 0.693 . . . . 75.43 110.872 176.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -63.48 -37.57 87.82 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 123.686 0.616 . . . . 75.33 111.233 -178.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 95.5 mt -67.14 -35.1 79.0 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 122.744 0.418 . . . . 74.33 111.586 173.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -64.3 -45.53 87.55 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.35 0.66 . . . . 43.22 110.479 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -69.27 -38.72 78.53 Favored 'General case' 0 C--O 1.245 0.845 0 O-C-N 124.38 1.05 . . . . 63.21 110.931 -179.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -60.91 -30.7 70.34 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.768 -0.651 . . . . 70.04 110.554 172.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 276' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -94.05 -13.73 26.58 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 122.984 0.514 . . . . 75.52 112.304 177.374 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 277' ' ' TYR . . . . . 0.422 ' CE1' ' HA3' ' A' ' 208' ' ' GLY . 22.6 m-30 -70.3 -30.65 67.7 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.001 -1.111 . . . . 65.52 108.001 169.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 278' ' ' ALA . . . . . 0.455 ' HA ' HG12 ' B' ' 387' ' ' ILE . . . -63.79 2.61 0.46 Allowed 'General case' 0 CA--C 1.557 1.249 0 CA-C-N 114.177 -1.374 . . . . 72.22 113.07 169.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 279' ' ' ARG . . . . . . . . . . . . . 51.9 ttt180 -73.91 -33.54 64.01 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.043 0.537 . . . . 75.11 110.882 171.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 280' ' ' ALA . . . . . 0.408 ' HA ' ' HB ' ' B' ' 384' ' ' THR . . . . . . . . 0 CA--C 1.555 1.168 0 O-C-N 123.333 0.396 . . . . 75.14 110.725 -169.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 113.409 0.892 . . . . 62.43 113.409 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.8 mmtp -68.07 107.27 2.66 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-N 115.239 -0.891 . . . . 74.32 108.725 168.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -72.83 88.77 1.34 Allowed 'General case' 0 C--O 1.241 0.637 0 N-CA-C 107.415 -1.328 . . . . 61.41 107.415 174.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -60.26 -30.64 69.57 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 114.827 -1.079 . . . . 73.34 111.678 -175.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -64.9 -53.53 45.13 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.958 -0.565 . . . . 73.33 110.357 176.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.16 -34.63 76.78 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 122.72 0.408 . . . . 60.32 111.3 -178.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 76.5 mt -59.96 -43.35 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 N-CA-C 109.865 -0.42 . . . . 74.23 109.865 172.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.445 HD23 HG23 ' A' ' 50' ' ' ILE . 97.0 mt -75.71 -12.24 60.15 Favored 'General case' 0 CA--C 1.555 1.172 0 CA-C-N 116.042 -0.527 . . . . 51.33 112.3 175.118 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.52 36.56 33.41 Favored Glycine 0 C--N 1.349 1.302 0 CA-C-N 117.75 0.25 . . . . 53.33 113.686 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.8 m -131.34 159.8 70.07 Favored Pre-proline 0 N--CA 1.484 1.25 0 C-N-CA 124.935 1.294 . . . . 71.43 109.14 177.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -75.96 166.35 28.19 Favored 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 122.524 2.149 . . . . 50.12 112.846 177.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 43.3 mtm-85 -74.73 21.02 0.11 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 113.309 0.855 . . . . 75.43 113.309 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -122.15 6.67 9.72 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.184 0.993 . . . . 64.11 108.982 174.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.47 136.26 47.54 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.508 0.723 . . . . 64.31 111.936 -175.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.5 p -85.6 176.44 8.19 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.284 1.034 . . . . 71.11 110.691 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.3 tm0? -57.15 -37.65 72.38 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.384 0.674 . . . . 64.21 109.978 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.44 ' HB3' ' NH1' ' A' ' 24' ' ' ARG . 43.3 mm-40 -56.69 -54.33 47.34 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 123.772 0.67 . . . . 72.43 111.054 174.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -63.25 -38.82 92.66 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.994 0.518 . . . . 64.03 111.016 -177.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.6 mp -59.55 -39.52 79.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 124.52 1.128 . . . . 73.31 110.6 173.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -68.25 -56.07 9.96 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.414 -0.812 . . . . 71.24 111.056 -175.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.44 ' NH1' ' HB3' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -66.85 -28.84 68.67 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 122.976 0.172 . . . . 54.12 111.203 -179.204 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.434 ' HB1' ' O ' ' A' ' 11' ' ' LEU . . . -62.66 -51.09 68.63 Favored 'General case' 0 C--O 1.245 0.866 0 O-C-N 123.609 0.568 . . . . 64.0 110.754 173.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -58.75 -45.77 88.93 Favored 'General case' 0 C--O 1.215 -0.711 0 CA-C-N 114.73 -1.123 . . . . 73.1 110.469 178.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.427 ' O ' ' HG3' ' A' ' 31' ' ' ARG . 57.3 mtpt -63.14 -44.01 96.75 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 123.888 0.743 . . . . 74.22 111.128 -177.188 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.1 ttp85 -54.86 -48.25 73.17 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.609 0.763 . . . . 71.15 110.6 175.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.679 ' HB3' HD13 ' A' ' 50' ' ' ILE . 81.6 mt -77.39 -20.65 54.39 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 115.619 -0.719 . . . . 74.11 111.671 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.535 ' HA ' ' HE1' ' A' ' 47' ' ' PHE . . . -81.21 -22.32 38.92 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.615 0.766 . . . . 63.3 111.118 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.427 ' HG3' ' O ' ' A' ' 27' ' ' LYS . 58.1 mtm180 -91.75 -41.85 10.46 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 122.981 0.512 . . . . 72.33 110.047 174.255 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -69.45 -55.36 10.5 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.319 0.648 . . . . 63.33 111.191 -176.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -96.85 31.25 2.41 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 122.849 0.46 . . . . 63.25 110.27 179.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.492 ' HD2' HG23 ' A' ' 37' ' ' VAL . 44.2 t60 -60.26 101.6 0.26 Allowed Pre-proline 0 N--CA 1.477 0.904 0 C-N-CA 123.99 0.916 . . . . 63.41 110.234 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -70.11 -13.9 34.35 Favored 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 123.061 2.507 . . . . 74.13 113.216 -164.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.409 ' HB3' ' CD2' ' A' ' 34' ' ' HIS . 28.5 t70 -71.53 -35.12 70.58 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.477 0.711 . . . . 72.45 110.526 175.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.492 HG23 ' HD2' ' A' ' 34' ' ' HIS . 99.0 t -94.52 -48.97 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-O 121.309 0.576 . . . . 65.53 109.46 178.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -100.54 71.91 1.54 Allowed 'General case' 0 C--O 1.249 1.035 0 C-N-CA 124.104 0.961 . . . . 61.35 109.486 -177.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -74.36 81.34 1.88 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.049 -0.978 . . . . 73.11 108.873 176.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 67.4 m -138.83 108.67 7.71 Favored Pre-proline 0 C--O 1.24 0.571 0 CA-C-O 118.168 -0.92 . . . . 54.41 108.724 177.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -30.93 -52.43 0.25 Allowed 'Trans proline' 0 C--N 1.392 2.846 0 C-N-CA 125.284 3.989 . . . . 72.23 115.784 -175.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -51.3 -51.39 54.71 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.492 0.717 . . . . 64.43 111.743 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.24 -22.26 62.91 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 115.381 -0.827 . . . . 72.14 111.752 -177.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -88.91 -37.56 15.19 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.372 0.669 . . . . 62.01 110.514 -173.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.515 ' HA ' ' HE2' ' A' ' 48' ' ' LYS . 35.8 mm-40 -70.22 -41.48 73.56 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 108.807 -0.812 . . . . 62.44 108.807 175.247 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 15.4 tppt? -59.35 -45.54 91.1 Favored 'General case' 0 C--N 1.348 0.541 0 CA-C-N 114.641 -1.163 . . . . 74.03 110.011 173.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.59 ' HA ' HD12 ' A' ' 50' ' ' ILE . 71.3 t80 -58.09 -40.69 81.76 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 123.954 0.784 . . . . 73.24 110.984 176.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.524 ' HB3' ' CE1' ' A' ' 93' ' ' PHE . 43.4 mtmt -66.78 -32.83 74.38 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 119.414 -0.327 . . . . 75.14 111.858 178.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.85 -34.58 76.98 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 120.831 0.348 . . . . 71.44 110.439 172.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.679 HD13 ' HB3' ' A' ' 29' ' ' LEU . 73.3 mt -66.97 -30.27 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.049 0.939 . . . . 70.53 109.721 174.087 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.414 ' O ' ' HB2' ' A' ' 55' ' ' ALA . 11.7 m-80 -83.29 -19.89 35.46 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.815 0.846 . . . . 73.43 112.125 174.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -70.98 -52.11 21.69 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 122.509 1.147 . . . . 63.42 108.389 171.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.66 -54.3 45.95 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 112.801 -1.999 . . . . 65.45 111.088 176.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -63.18 -37.84 88.81 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-N 115.262 -0.881 . . . . 72.32 111.176 177.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.414 ' HB2' ' O ' ' A' ' 51' ' ' ASN . . . -51.2 -53.53 34.17 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 122.98 0.512 . . . . 53.01 111.407 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 68.0 t -68.02 -44.11 85.0 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 CA-C-N 114.377 -1.283 . . . . 74.52 110.449 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.492 HD22 ' HD2' ' A' ' 63' ' ' ARG . 41.9 mt -91.48 5.8 48.02 Favored 'General case' 0 CA--C 1.563 1.457 0 N-CA-C 113.875 1.065 . . . . 62.04 113.875 -170.195 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.8 t -80.68 -47.89 13.37 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 123.218 0.607 . . . . 74.34 110.926 177.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -93.35 134.36 26.98 Favored Pre-proline 0 N--CA 1.474 0.768 0 CA-C-O 117.72 -1.133 . . . . 74.34 109.906 -173.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.521 ' O ' ' HG2' ' A' ' 64' ' ' ARG . 9.1 Cg_endo -49.7 -43.98 37.81 Favored 'Trans proline' 0 C--N 1.385 2.492 0 C-N-CA 124.014 3.142 . . . . 72.41 114.027 -177.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.404 ' O ' HG13 ' A' ' 65' ' ' ILE . 3.8 mp0 -67.88 -54.14 21.15 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 122.939 0.496 . . . . 72.3 111.635 -177.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.529 ' HA ' HD12 ' A' ' 65' ' ' ILE . 47.4 mtpt -61.52 -35.17 76.96 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.536 0.734 . . . . 74.54 110.787 -178.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.492 ' HD2' HD22 ' A' ' 57' ' ' LEU . 46.4 tpt85 -54.52 -58.27 8.13 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 114.311 -1.313 . . . . 74.11 108.891 171.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.521 ' HG2' ' O ' ' A' ' 60' ' ' PRO . 1.2 mmp_? -61.58 -28.7 69.53 Favored 'General case' 0 C--O 1.214 -0.801 0 CA-C-N 115.354 -0.839 . . . . 74.25 111.783 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.583 HG23 ' HD2' ' A' ' 76' ' ' PRO . 89.6 mt -61.69 -47.7 92.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 122.931 0.492 . . . . 64.42 109.677 176.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -60.79 -53.77 53.33 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 115.961 -0.563 . . . . 75.4 110.28 175.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -54.13 -44.73 71.61 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.533 0.733 . . . . 64.04 111.801 -176.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 53.7 p -73.77 -27.33 61.1 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.73 0.412 . . . . 75.13 111.332 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -73.37 119.49 17.67 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 109.105 -0.702 . . . . 63.45 109.105 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 101.19 16.22 25.88 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-N 115.964 -0.562 . . . . 52.54 111.964 -168.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 62.9 m -143.29 -59.27 0.42 Allowed 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 104.021 -2.585 . . . . 71.23 104.021 174.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.4 m -83.56 148.85 26.95 Favored 'General case' 0 C--O 1.249 1.061 0 N-CA-C 105.225 -2.139 . . . . 74.23 105.225 157.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.56 -30.15 9.21 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.273 1.029 . . . . 74.04 110.734 -176.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.17 139.9 61.03 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 123.321 0.648 . . . . 75.1 110.005 175.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -62.34 119.02 5.94 Favored 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 122.33 2.02 . . . . 75.41 111.111 175.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.583 ' HD2' HG23 ' A' ' 65' ' ' ILE . 78.6 Cg_exo -51.55 122.14 9.75 Favored 'Trans proline' 0 C--N 1.384 2.42 0 C-N-CA 123.357 2.705 . . . . 74.25 113.183 178.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -44.11 134.51 8.52 Favored 'Trans proline' 0 C--N 1.389 2.703 0 C-N-CA 124.504 3.469 . . . . 62.44 115.176 -168.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -63.15 135.03 48.64 Favored 'Trans proline' 0 C--N 1.386 2.545 0 C-N-CA 122.965 2.444 . . . . 43.51 112.456 -177.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.15 157.66 16.85 Favored 'Trans proline' 0 C--N 1.381 2.268 0 C-N-CA 122.953 2.436 . . . . 71.05 112.1 175.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -60.39 84.45 0.07 OUTLIER 'Trans proline' 0 C--N 1.38 2.222 0 C-N-CA 122.718 2.279 . . . . 51.35 112.185 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 155.01 -42.32 0.59 Allowed Glycine 0 CA--C 1.527 0.785 0 N-CA-C 109.873 -1.291 . . . . 62.41 109.873 -176.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 128.44 -160.5 22.13 Favored Glycine 0 C--N 1.351 1.414 0 CA-C-N 115.103 -0.548 . . . . 53.03 111.79 176.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -97.65 107.55 20.07 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 123.402 0.681 . . . . 74.41 109.166 176.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -54.91 155.09 4.65 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 115.632 -0.713 . . . . 71.31 111.849 170.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -155.98 60.16 0.59 Allowed 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 108.448 -0.945 . . . . 70.22 108.448 174.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 20.4 m -31.93 86.05 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 126.692 1.997 . . . . 74.44 116.39 -169.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 57.13 24.87 52.68 Favored Glycine 0 CA--C 1.536 1.347 0 N-CA-C 114.953 0.741 . . . . 70.11 114.953 176.009 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -96.58 154.38 17.31 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.412 0.685 . . . . 72.34 110.063 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -82.03 72.05 9.07 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 123.864 0.866 . . . . 71.44 111.476 -168.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.449 HG23 ' HE2' ' A' ' 97' ' ' PHE . 2.1 p -46.31 -50.37 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 C-N-CA 125.171 1.388 . . . . 75.21 113.537 -175.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.41 ' HG2' HG13 ' A' ' 90' ' ' VAL . 11.7 mm-40 -71.64 -4.04 24.99 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 113.55 0.944 . . . . 75.33 113.55 -171.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -107.42 -17.97 13.98 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.157 0.583 . . . . 45.35 111.27 178.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.524 ' CE1' ' HB3' ' A' ' 48' ' ' LYS . 7.6 m-30 -85.64 176.13 8.36 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 122.497 0.319 . . . . 71.01 111.134 -171.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 89.5 p -59.46 151.09 24.86 Favored 'General case' 0 C--O 1.247 0.926 0 N-CA-C 114.163 1.172 . . . . 74.5 114.163 -166.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.403 ' HG3' ' H ' ' A' ' 96' ' ' PHE . 3.4 pt-20 -53.34 -44.65 68.65 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 114.54 -1.209 . . . . 74.31 110.007 167.136 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.403 ' H ' ' HG3' ' A' ' 95' ' ' GLU . 73.8 t80 -49.79 -51.04 42.44 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.614 1.166 . . . . 75.03 111.331 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.449 ' HE2' HG23 ' A' ' 90' ' ' VAL . 3.5 t80 -58.78 -54.89 42.02 Favored 'General case' 0 CA--C 1.55 0.97 0 O-C-N 123.981 0.801 . . . . 63.23 110.28 174.48 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -70.8 -6.66 39.45 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 113.371 0.878 . . . . 73.05 113.371 -172.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -101.83 -38.8 7.68 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.275 0.63 . . . . 70.02 111.834 174.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 30.3 tp -69.01 -49.32 58.78 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 121.305 0.574 . . . . 55.03 109.798 177.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -92.04 -8.72 45.16 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 115.231 -0.895 . . . . 72.11 111.42 178.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -45.5 -59.07 4.94 Favored Glycine 0 N--CA 1.482 1.765 0 N-CA-C 115.579 0.991 . . . . 72.43 115.579 178.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -45.37 -23.1 1.12 Allowed 'Trans proline' 0 C--N 1.388 2.635 0 C-N-CA 124.45 3.433 . . . . 23.1 115.441 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -144.28 39.69 1.22 Allowed Glycine 0 C--N 1.354 1.53 0 CA-C-O 118.989 -0.895 . . . . 44.4 113.399 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 13.1 mt -66.02 38.03 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 114.79 1.404 . . . . 74.25 114.79 178.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.647 ' HB3' ' HA ' ' A' ' 169' ' ' ASN . 0.3 OUTLIER 55.78 -102.81 0.16 Allowed 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 123.888 0.875 . . . . 72.25 110.639 162.433 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 70.2 13.3 70.07 Favored Glycine 0 C--N 1.362 2.003 0 C-N-CA 122.776 0.227 . . . . 44.0 112.811 176.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.569 ' H ' ' HD1' ' A' ' 106' ' ' PHE . . . . . . . . 0 C--N 1.346 1.104 0 C-N-CA 123.522 0.582 . . . . 71.34 112.568 -173.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.476 ' HA ' ' HD2' ' A' ' 170' ' ' PRO . 27.1 tptp . . . . . 0 N--CA 1.475 0.808 0 CA-C-O 120.926 0.393 . . . . 72.15 111.331 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -87.46 144.39 19.06 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-N 115.603 -0.726 . . . . 55.22 112.364 172.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -86.92 160.59 18.64 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.156 0.583 . . . . 71.34 111.821 -177.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -60.26 139.22 57.72 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.147 0.579 . . . . 74.23 111.305 176.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.445 HD23 ' N ' ' A' ' 120' ' ' ARG . 4.8 tt -145.89 160.78 41.33 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 107.994 -1.113 . . . . 70.23 107.994 -179.051 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.445 ' N ' HD23 ' A' ' 119' ' ' LEU . 0.3 OUTLIER -124.77 123.89 40.96 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 109.501 -0.555 . . . . 74.51 109.501 176.794 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.406 ' HB3' HD21 ' A' ' 174' ' ' LEU . . . -129.89 164.95 23.05 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.479 0.712 . . . . 41.51 110.477 -177.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.439 ' O ' HD12 ' B' ' 8' ' ' LEU . 4.2 mm-40 -106.73 120.34 41.73 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 106.976 -1.49 . . . . 61.0 106.976 -172.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.413 HD22 HD13 ' A' ' 176' ' ' LEU . 47.4 tp -97.92 99.84 7.55 Favored Pre-proline 0 CA--C 1.54 0.594 0 N-CA-C 108.191 -1.04 . . . . 54.05 108.191 -176.453 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.599 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 93.3 Cg_endo -77.74 110.99 3.04 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 121.374 1.383 . . . . 75.33 109.407 177.437 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.63 ' HA ' HG21 ' B' ' 6' ' ' ILE . 44.2 tp -119.57 136.22 54.46 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.87 0.468 . . . . 64.01 110.862 -168.125 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 67.9 m -67.92 129.41 39.84 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.927 0.891 . . . . 71.34 110.221 -179.142 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.475 HD23 ' HB3' ' A' ' 180' ' ' LEU . 51.5 mt -55.11 -43.37 74.0 Favored 'General case' 0 N--CA 1.481 1.123 0 O-C-N 124.376 1.048 . . . . 70.54 111.163 -174.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -57.34 -46.44 83.28 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 114.76 -1.109 . . . . 75.32 110.442 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -72.39 -29.0 63.35 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 115.339 -0.846 . . . . 64.33 110.719 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -67.12 -33.25 75.04 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.199 0.6 . . . . 41.43 110.564 175.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -66.62 -56.22 11.7 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 123.754 0.659 . . . . 74.51 109.744 172.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -61.27 -50.25 73.77 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 114.895 -1.048 . . . . 75.25 112.162 -169.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.04 131.9 0.28 Allowed Glycine 0 C--N 1.344 0.988 0 O-C-N 123.595 0.559 . . . . 71.54 112.937 -178.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 153.93 -161.34 29.9 Favored Glycine 0 C--N 1.338 0.643 0 N-CA-C 111.693 -0.563 . . . . 70.42 111.693 -177.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -71.23 134.7 47.06 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 109.813 -0.44 . . . . 73.14 109.813 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.556 ' NE ' ' HA ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -120.45 124.68 46.05 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 120.759 0.314 . . . . 74.4 110.634 179.701 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.44 ' HB ' HG23 ' B' ' 5' ' ' THR . 92.6 t -77.9 103.63 5.15 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-N 115.118 -0.947 . . . . 71.24 109.452 175.414 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 57.4 t -115.98 112.51 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.679 1.191 . . . . 73.14 107.792 177.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -111.97 129.54 56.15 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 120.98 0.419 . . . . 71.3 110.675 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.415 HG11 HD23 ' B' ' 8' ' ' LEU . 7.9 p -169.65 149.94 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.99 0 C-N-CA 124.906 1.282 . . . . 75.1 108.388 -177.514 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 60.68 19.56 9.58 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 113.237 0.828 . . . . 74.24 113.237 174.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 98.68 -31.03 8.59 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 116.402 -0.363 . . . . 31.1 112.607 -178.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.566 ' NH1' ' SD ' ' A' ' 164' ' ' MET . 66.3 ttt180 -86.7 137.62 32.3 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 122.804 0.441 . . . . 72.12 110.811 -178.187 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 43.1 ttm105 -112.34 97.15 6.43 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 108.189 -1.041 . . . . 74.41 108.189 169.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.6 p -87.21 145.73 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 CA-C-N 115.457 -0.792 . . . . 73.53 111.405 -177.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 39.8 t -103.59 89.05 3.23 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 108.475 -0.935 . . . . 31.45 108.475 170.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 4.9 p -94.45 118.44 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 109.702 -0.481 . . . . 73.42 109.702 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 58.1 ttt85 -72.95 104.16 3.99 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.022 0.439 . . . . 74.14 110.142 177.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 23.6 pt -74.18 143.14 79.81 Favored Pre-proline 0 CA--C 1.554 1.123 0 CA-C-N 115.184 -0.916 . . . . 74.13 110.164 175.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -63.32 138.46 66.27 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.782 2.321 . . . . 60.34 112.315 175.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -62.78 106.38 0.51 Allowed 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.801 2.334 . . . . 74.15 111.837 174.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 90.71 46.68 3.9 Favored Glycine 0 C--N 1.342 0.904 0 CA-C-N 115.508 -0.769 . . . . 75.51 112.184 -176.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.488 HG22 HG11 ' A' ' 178' ' ' VAL . 4.6 p -81.04 126.85 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.314 0.646 . . . . 75.43 110.784 -174.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.707 ' HD2' ' HA ' ' A' ' 191' ' ' GLN . 12.9 mtm180 -108.71 156.98 18.97 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.422 1.089 . . . . 73.23 110.225 -166.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.547 ' HB3' ' HA ' ' A' ' 189' ' ' GLU . 12.9 tp10 -49.62 130.36 20.57 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.011 0.925 . . . . 72.32 112.376 -177.156 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 89.78 0.18 78.85 Favored Glycine 0 C--N 1.347 1.152 0 CA-C-N 115.483 -0.78 . . . . 14.21 114.008 177.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 58.2 m -67.39 115.31 6.89 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 117.717 0.758 . . . . 74.23 109.784 174.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.505 HG22 HG22 ' A' ' 177' ' ' VAL . 90.3 t -95.98 106.02 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 124.164 0.986 . . . . 72.34 110.209 -174.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.515 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 54.1 mt -87.73 100.67 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 108.243 -1.021 . . . . 75.24 108.243 172.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 65.2 ttt-85 -75.15 100.45 4.27 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 109.247 -0.649 . . . . 61.32 109.247 176.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 4.5 p -125.28 117.36 25.28 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 123.927 0.891 . . . . 61.33 109.348 -178.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.19 147.54 79.09 Favored 'Trans proline' 0 C--N 1.371 1.759 0 C-N-CA 121.451 1.434 . . . . 74.53 110.435 169.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.578 ' HA2' ' HD2' ' A' ' 171' ' ' PRO . . . 124.28 -19.72 7.16 Favored Glycine 0 C--N 1.341 0.838 0 N-CA-C 115.213 0.845 . . . . 70.43 115.213 174.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.566 ' SD ' ' NH1' ' A' ' 143' ' ' ARG . 3.6 mpp? -124.12 8.93 8.61 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 117.687 0.744 . . . . 64.15 111.675 -178.356 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -87.92 -126.14 2.37 Favored Glycine 0 N--CA 1.477 1.382 0 CA-C-N 117.926 0.33 . . . . 73.33 113.32 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -62.71 153.65 43.93 Favored Glycine 0 C--N 1.357 1.72 0 O-C-N 123.481 0.165 . . . . 74.5 112.698 175.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -70.29 123.02 20.67 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.14 0.576 . . . . 75.42 110.903 -173.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -174.48 167.27 39.53 Favored Glycine 0 C--N 1.345 1.066 0 CA-C-O 119.365 -0.686 . . . . 64.21 111.571 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ASN . . . . . 0.647 ' HA ' ' HB3' ' A' ' 106' ' ' PHE . 2.9 t-20 -69.98 -50.78 15.96 Favored Pre-proline 0 N--CA 1.479 0.982 0 CA-C-N 118.281 1.04 . . . . 63.11 110.279 174.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.559 ' HD3' ' HB3' ' A' ' 169' ' ' ASN . 8.3 Cg_endo -90.45 84.69 0.4 Allowed 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 121.703 1.602 . . . . 71.13 108.237 160.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.578 ' HD2' ' HA2' ' A' ' 163' ' ' GLY . 2.7 Cg_exo -71.26 178.99 4.87 Favored 'Trans proline' 0 C--N 1.369 1.657 0 C-N-CA 122.525 2.15 . . . . 71.25 113.007 -163.466 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -62.85 146.46 50.22 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 117.494 1.758 . . . . 72.4 117.494 -162.033 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -69.5 89.04 0.5 Allowed 'General case' 0 C--O 1.241 0.658 0 C-N-CA 124.872 1.269 . . . . 71.14 108.547 175.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.406 HD21 ' HB3' ' A' ' 121' ' ' ALA . 22.6 tp -83.14 149.18 27.03 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 114.994 -1.003 . . . . 64.32 111.332 -173.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 80.3 mt -110.56 95.93 5.87 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.037 0.935 . . . . 72.12 108.618 174.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.515 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 93.0 mt -71.21 92.25 1.0 Allowed 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 109.835 -0.431 . . . . 70.05 109.835 175.036 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.505 HG22 HG22 ' A' ' 158' ' ' VAL . 57.5 t -82.7 100.4 6.38 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 N-CA-C 106.923 -1.51 . . . . 61.43 106.923 173.271 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.488 HG11 HG22 ' A' ' 153' ' ' VAL . 9.9 p -65.87 113.45 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 CA-C-O 122.036 0.922 . . . . 70.33 110.922 -171.521 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.599 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 37.6 mmt180 -102.51 106.46 17.18 Favored 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 106.705 -1.591 . . . . 53.32 106.705 171.354 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.719 HD12 ' HB3' ' A' ' 188' ' ' LEU . 33.0 mt -70.09 143.29 52.46 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 118.921 0.782 . . . . 72.4 109.884 178.263 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 44.0 mt -54.08 158.07 3.91 Favored Pre-proline 0 N--CA 1.49 1.551 0 C-N-CA 124.314 1.046 . . . . 73.14 112.82 -167.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -75.92 44.01 1.22 Allowed 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 123.298 2.665 . . . . 71.42 111.022 163.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 62.0 t-80 -70.73 131.94 87.43 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 125.371 1.469 . . . . 73.35 107.178 177.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -64.34 12.3 0.1 OUTLIER 'Trans proline' 0 C--N 1.37 1.68 0 C-N-CA 123.557 2.838 . . . . 61.24 117.427 -162.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 4.1 t -112.03 -64.54 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.89 0 CA-C-N 120.455 1.479 . . . . 64.21 110.1 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' PHE . . . . . 0.552 ' CD1' ' HB2' ' A' ' 195' ' ' ALA . 39.2 m-85 -126.41 163.57 23.01 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 121.614 0.721 . . . . 72.31 111.869 -168.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 31.5 ttp-105 -141.35 96.07 2.93 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 107.102 -1.444 . . . . 75.51 107.102 161.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.719 ' HB3' HD12 ' A' ' 180' ' ' LEU . 54.5 tp -66.24 117.25 8.25 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.784 0.834 . . . . 74.21 110.465 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' GLU . . . . . 0.551 ' HB3' ' HE1' ' A' ' 194' ' ' TYR . 35.8 tt0 -138.36 132.76 32.02 Favored 'General case' 0 C--O 1.247 0.925 0 C-N-CA 124.164 0.986 . . . . 70.31 109.084 -177.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 78.0 -82.78 1.2 Allowed Glycine 0 C--N 1.343 0.924 0 CA-C-N 115.687 -0.688 . . . . 65.41 111.56 -177.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.707 ' HA ' ' HD2' ' A' ' 154' ' ' ARG . 4.7 pm0 -147.68 -4.79 0.49 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.978 0.911 . . . . 72.32 110.647 174.491 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -130.73 156.18 45.37 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 122.997 0.519 . . . . 72.32 112.087 -165.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.495 HD21 ' HE1' ' A' ' 240' ' ' PHE . 68.9 mt -90.4 144.49 25.76 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.999 0.92 . . . . 63.44 110.334 -174.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.551 ' HE1' ' HB3' ' A' ' 189' ' ' GLU . 63.7 m-85 -117.24 110.45 18.13 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 109.049 -0.723 . . . . 73.14 109.049 171.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.604 ' HB3' HD23 ' A' ' 251' ' ' LEU . . . -121.52 -175.02 2.99 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.827 0.851 . . . . 74.34 110.999 178.201 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 22.8 m -125.08 145.63 49.83 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.715 0.806 . . . . 70.21 109.184 175.108 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.577 HD22 HD13 ' A' ' 251' ' ' LEU . 21.9 tp -133.77 101.16 4.99 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.931 -0.396 . . . . 72.21 109.931 176.168 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -80.67 113.49 18.9 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.321 -0.992 . . . . 61.43 108.321 166.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 6.4 p -133.26 133.21 22.65 Favored Pre-proline 0 N--CA 1.481 1.089 0 C-N-CA 123.652 0.781 . . . . 64.4 109.097 -171.244 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.37 151.89 60.25 Favored 'Trans proline' 0 C--N 1.375 1.941 0 C-N-CA 121.386 1.391 . . . . 64.51 112.146 177.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -55.52 -45.81 99.81 Favored Pre-proline 0 CA--C 1.553 1.083 0 N-CA-C 114.507 1.299 . . . . 71.34 114.507 -171.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -57.73 -45.4 33.46 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 121.442 1.428 . . . . 63.54 112.734 175.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 41.9 mt -71.11 -27.67 30.44 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 CA-C-N 116.117 -0.492 . . . . 64.32 111.12 -178.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -72.38 -45.0 61.74 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.268 0.627 . . . . 71.51 111.428 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 73.7 t -71.5 -49.86 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 123.356 0.662 . . . . 63.23 111.52 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.504 HG21 ' HA ' ' C' ' 270' ' ' LYS . 47.8 t -83.67 -35.18 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.196 0.598 . . . . 74.41 110.907 -172.095 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 91.87 73.96 1.26 Allowed Glycine 0 C--N 1.348 1.202 0 CA-C-N 116.084 -0.507 . . . . 72.35 113.35 176.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -110.42 170.33 13.99 Favored Glycine 0 N--CA 1.473 1.134 0 C-N-CA 122.853 0.263 . . . . 55.24 112.646 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -81.22 128.23 33.56 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.016 0.527 . . . . 45.21 111.921 -175.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.561 HG21 HD11 ' A' ' 197' ' ' LEU . 34.4 m -116.02 168.38 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.124 0.97 . . . . 63.11 108.705 169.186 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 37.9 ttp-105 -88.51 105.69 17.79 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.643 -0.873 . . . . 71.41 108.643 174.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -103.31 123.48 46.86 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.791 -0.818 . . . . 62.04 108.791 176.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 57.6 mtm -68.06 143.8 55.36 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 122.904 0.482 . . . . 71.23 110.72 -177.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 8.5 m -136.71 166.01 24.56 Favored 'General case' 0 CA--C 1.554 1.106 0 N-CA-C 108.762 -0.829 . . . . 74.1 108.762 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.457 HD21 ' HD2' ' A' ' 186' ' ' PHE . 52.6 mt -65.72 -12.85 57.21 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 114.495 1.294 . . . . 63.31 114.495 -170.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -128.2 31.3 5.08 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 109.355 -0.609 . . . . 64.44 109.355 178.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 112.9 160.71 14.61 Favored Glycine 0 C--N 1.351 1.408 0 CA-C-N 114.883 -1.053 . . . . 33.0 112.887 176.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -74.44 142.56 29.93 Favored 'Trans proline' 0 C--N 1.372 1.783 0 C-N-CA 123.141 2.56 . . . . 70.23 111.917 -178.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 34.7 m -128.88 152.0 36.44 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 C-N-CA 124.026 0.93 . . . . 73.4 109.898 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -78.62 117.97 20.28 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-O 121.248 0.547 . . . . 75.04 110.476 176.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 66.2 t -118.11 114.52 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 123.774 0.83 . . . . 74.13 109.063 -177.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -67.78 101.97 1.15 Allowed 'General case' 0 C--N 1.349 0.556 0 N-CA-C 109.525 -0.546 . . . . 60.25 109.525 172.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 96.3 t -53.9 137.58 55.29 Favored Pre-proline 0 CA--C 1.554 1.105 0 C-N-CA 124.354 1.062 . . . . 63.14 109.823 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -56.22 156.31 21.34 Favored 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 122.522 2.148 . . . . 75.51 111.864 174.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -77.97 151.82 27.76 Favored 'Trans proline' 0 C--N 1.366 1.449 0 C-N-CA 121.616 1.544 . . . . 72.53 111.553 177.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 67.4 mtt-85 67.1 26.68 8.82 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 125.056 1.342 . . . . 74.04 111.498 174.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.444 HG23 HD21 ' A' ' 233' ' ' LEU . 28.8 m -64.16 109.01 1.71 Allowed 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 124.581 1.153 . . . . 64.32 111.468 177.373 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -101.53 146.56 27.5 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.324 1.05 . . . . 75.32 110.572 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -71.01 145.45 49.98 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.225 0.61 . . . . 62.31 112.367 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 95.19 -1.32 64.68 Favored Glycine 0 C--N 1.342 0.901 0 CA-C-N 115.241 -0.89 . . . . 73.32 112.368 -176.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -109.56 167.97 9.75 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.69 0.796 . . . . 74.0 111.449 -176.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -118.59 115.71 25.12 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.079 0.952 . . . . 72.22 109.919 -177.354 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.516 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 73.9 mt -80.51 110.19 15.74 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 122.76 0.424 . . . . 71.4 110.279 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 234' ' ' ARG . . . . . 0.486 ' HA ' ' O ' ' A' ' 249' ' ' LEU . 42.4 ttm180 -74.18 106.65 5.93 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 124.309 1.006 . . . . 64.14 110.392 175.373 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.445 HD12 HD23 ' A' ' 249' ' ' LEU . 5.0 mt -112.14 101.57 9.82 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 108.331 -0.988 . . . . 61.12 108.331 173.182 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -67.43 156.18 37.21 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.399 0.68 . . . . 64.43 111.89 -177.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 81.18 -6.81 62.1 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 116.512 -0.313 . . . . 74.2 113.627 177.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.19 -39.83 20.47 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.651 0.781 . . . . 73.01 109.968 176.233 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -78.98 173.84 55.34 Favored Glycine 0 C--N 1.347 1.153 0 O-C-N 123.676 0.61 . . . . 74.43 111.944 178.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' PHE . . . . . 0.495 ' HE1' HD21 ' A' ' 193' ' ' LEU . 63.2 m-85 -96.45 160.4 29.7 Favored Pre-proline 0 N--CA 1.473 0.703 0 C-N-CA 123.875 0.87 . . . . 73.13 111.472 -167.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' A' ' 245' ' ' GLY . 11.7 Cg_endo -52.7 140.35 56.46 Favored 'Trans proline' 0 C--N 1.387 2.568 0 C-N-CA 122.79 2.327 . . . . 73.33 112.348 175.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 179.94 -153.04 11.45 Favored Glycine 0 C--N 1.341 0.821 0 CA-C-O 118.738 -1.035 . . . . 73.52 111.597 -176.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' PRO . . . . . 0.493 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 85.0 Cg_exo -50.0 -43.52 41.48 Favored 'Trans proline' 0 C--N 1.382 2.342 0 C-N-CA 123.955 3.103 . . . . 70.45 114.482 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -85.29 21.45 1.71 Allowed 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.544 0.738 . . . . 70.11 112.372 -175.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 245' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 241' ' ' PRO . . . 81.1 -77.1 2.07 Favored Glycine 0 C--N 1.347 1.192 0 N-CA-C 109.253 -1.539 . . . . 62.24 109.253 -170.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 73.1 mtp180 -126.19 160.64 29.69 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.243 1.017 . . . . 75.41 108.537 163.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -92.18 172.03 34.57 Favored Glycine 0 C--O 1.25 1.124 0 CA-C-O 122.134 0.852 . . . . 42.24 113.589 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -101.2 -170.95 1.91 Allowed 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 114.105 -1.048 . . . . 75.44 110.238 -177.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.486 ' O ' ' HA ' ' A' ' 234' ' ' ARG . 22.3 tp -121.54 144.61 48.62 Favored 'General case' 0 C--O 1.216 -0.704 0 N-CA-C 107.041 -1.466 . . . . 70.31 107.041 164.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -124.84 106.24 9.87 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 108.471 -0.937 . . . . 52.51 108.471 173.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.604 HD23 ' HB3' ' A' ' 195' ' ' ALA . 83.1 mt -90.35 119.3 30.53 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 115.386 -0.825 . . . . 72.24 110.712 -179.117 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -77.21 104.0 7.47 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.011 -0.737 . . . . 75.41 109.011 177.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 38.8 t -73.15 123.53 28.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 115.254 -0.885 . . . . 24.43 111.582 -173.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -125.02 100.96 6.82 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 107.379 -1.341 . . . . 73.14 107.379 166.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.535 ' HB ' ' O ' ' C' ' 255' ' ' ILE . 64.0 mt -75.23 137.15 23.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 115.909 -0.587 . . . . 74.34 109.946 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 39.9 p -119.44 169.49 9.98 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.081 0.952 . . . . 73.43 108.667 173.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 257' ' ' ILE . . . . . 0.517 ' HB ' ' HD2' ' A' ' 258' ' ' PRO . 2.9 pp -134.38 157.0 78.43 Favored Pre-proline 0 CA--C 1.561 1.392 0 N-CA-C 108.547 -0.909 . . . . 73.4 108.547 175.089 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 258' ' ' PRO . . . . . 0.517 ' HD2' ' HB ' ' A' ' 257' ' ' ILE . 37.3 Cg_endo -58.81 -12.34 14.53 Favored 'Trans proline' 0 C--N 1.385 2.481 0 C-N-CA 123.617 2.878 . . . . 74.45 116.147 -162.199 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 259' ' ' GLU . . . . . 0.58 ' HA ' ' HB3' ' C' ' 226' ' ' ARG . 29.9 tt0 58.25 -70.26 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 125.352 1.461 . . . . 63.24 112.646 -172.338 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -74.01 131.01 40.96 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 109.285 -0.635 . . . . 75.12 109.285 172.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 19.6 mt -138.58 144.24 39.73 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.78 0.8 . . . . 55.32 111.587 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 24.5 p -96.92 148.9 35.07 Favored Pre-proline 0 CA--C 1.559 1.32 0 CA-C-N 114.167 -1.378 . . . . 44.34 108.954 173.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -39.87 -47.55 3.76 Favored 'Trans proline' 0 C--N 1.387 2.566 0 C-N-CA 125.114 3.876 . . . . 74.33 116.937 -168.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -67.92 -49.16 63.48 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 122.747 0.419 . . . . 71.44 111.417 -175.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -58.48 -44.57 89.39 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 109.91 -0.404 . . . . 64.2 109.91 177.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 266' ' ' GLU . . . . . 0.407 ' OE1' ' HD2' ' C' ' 226' ' ' ARG . 11.8 tp10 -62.65 -33.65 75.47 Favored 'General case' 0 CA--C 1.549 0.92 0 O-C-N 123.754 0.659 . . . . 73.45 111.278 178.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -66.63 -41.71 87.9 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 122.843 0.457 . . . . 64.12 110.782 176.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 10.9 mp -65.54 -47.73 74.87 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.13 0.572 . . . . 73.14 110.7 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 65.9 m95 -58.63 -43.97 89.87 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.925 0.89 . . . . 75.0 111.752 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 270' ' ' LYS . . . . . 0.485 ' O ' ' HG3' ' A' ' 274' ' ' GLU . 42.9 mttp -67.53 -42.78 82.17 Favored 'General case' 0 C--O 1.215 -0.736 0 CA-C-O 119.215 -0.422 . . . . 62.43 111.44 178.202 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 271' ' ' LYS . . . . . 0.417 ' HA ' ' HD3' ' A' ' 271' ' ' LYS . 32.2 mmtm -62.87 -35.62 80.59 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 117.884 0.311 . . . . 70.22 111.706 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 272' ' ' LEU . . . . . 0.652 HD21 ' HB2' ' C' ' 268' ' ' LEU . 86.7 mt -60.31 -50.81 72.14 Favored 'General case' 0 C--O 1.214 -0.768 0 O-C-N 123.909 0.755 . . . . 63.4 109.5 169.44 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 273' ' ' ALA . . . . . 0.445 ' HA ' ' HB2' ' C' ' 202' ' ' PRO . . . -65.41 -29.93 70.68 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.492 1.117 . . . . 64.51 113.721 -174.641 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.485 ' HG3' ' O ' ' A' ' 270' ' ' LYS . 41.1 mt-10 -81.3 -49.09 11.15 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 123.27 0.628 . . . . 74.35 109.311 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -67.7 -18.81 65.05 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 115.605 -0.725 . . . . 71.44 111.156 177.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 276' ' ' TYR . . . . . 0.404 ' HE2' ' HG3' ' C' ' 258' ' ' PRO . 21.0 t80 -77.9 -76.66 0.18 Allowed 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 108.349 -0.982 . . . . 75.02 108.349 171.623 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -50.05 -60.63 2.76 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.673 1.189 . . . . 70.12 111.543 -171.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -61.63 -28.65 69.52 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 123.7 0.625 . . . . 75.41 111.795 -174.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 279' ' ' ARG . . . . . 0.487 ' HA ' ' HE ' ' A' ' 279' ' ' ARG . 4.6 mmp_? -117.84 32.48 6.13 Favored 'General case' 0 C--N 1.349 0.548 0 N-CA-C 109.507 -0.553 . . . . 74.13 109.507 -174.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.198 0 N-CA-C 108.709 -0.848 . . . . 72.21 108.709 171.524 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 68.4 mtm . . . . . 0 N--CA 1.483 1.185 0 N-CA-C 109.936 -0.394 . . . . 71.44 109.936 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -104.06 84.96 2.31 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.473 0.709 . . . . 54.1 109.354 -173.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -67.78 -72.34 0.18 Allowed 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 109.44 -0.578 . . . . 74.04 109.44 178.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 22.4 m 64.88 -65.87 0.14 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 125.132 1.373 . . . . 52.14 112.716 176.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 5' ' ' THR . . . . . 0.44 HG23 ' HB ' ' A' ' 137' ' ' VAL . 4.3 m -74.44 153.44 39.18 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 123.635 0.774 . . . . 70.11 111.254 177.126 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.63 HG21 ' HA ' ' A' ' 125' ' ' LEU . 41.6 pt -135.6 -179.84 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 123.173 0.589 . . . . 64.44 112.282 -169.484 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -130.35 -158.24 0.88 Allowed 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 124.258 1.023 . . . . 72.01 109.612 178.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 8' ' ' LEU . . . . . 0.439 HD12 ' O ' ' A' ' 122' ' ' GLU . 45.3 tp -141.4 149.75 41.47 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.735 0.814 . . . . 75.22 109.802 179.08 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.84 -51.25 8.81 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 122.747 0.419 . . . . 62.4 111.764 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 27.0 mt 74.71 -22.46 0.26 Allowed 'General case' 0 N--CA 1.499 2.013 0 C-N-CA 125.381 1.472 . . . . 74.1 113.788 -174.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 79.9 mt . . . . . 0 CA--C 1.565 1.549 0 C-N-CA 124.385 1.074 . . . . 45.35 111.877 -172.442 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.061 0 N-CA-C 109.506 -0.553 . . . . 61.34 109.506 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . -172.73 -56.06 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 114.527 -1.215 . . . . 74.4 108.482 170.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 181' ' ' LEU . . . . . 0.628 ' HB2' ' HB3' ' C' ' 136' ' ' ARG . 59.3 tp -105.9 -89.38 0.43 Allowed 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 107.602 -1.259 . . . . 62.04 107.602 169.234 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 182' ' ' VAL . . . . . 0.505 HG11 ' HB2' ' C' ' 123' ' ' LEU . 30.5 m -129.04 -173.04 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.932 0 C-N-CA 124.716 1.206 . . . . 71.31 108.477 170.552 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -171.94 95.99 0.16 Allowed 'General case' 0 CA--C 1.547 0.865 0 CA-C-O 118.414 -0.803 . . . . 65.24 112.394 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 11.1 p-80 164.56 159.19 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.724 0 C-N-CA 125.551 1.54 . . . . 74.15 112.396 160.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 185' ' ' VAL . . . . . . . . . . . . . 34.8 t . . . . . 0 N--CA 1.494 1.737 0 C-N-CA 124.901 1.28 . . . . 71.33 109.33 169.932 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 23.0 m . . . . . 0 CA--C 1.557 1.213 0 CA-C-O 120.796 0.331 . . . . 71.31 110.639 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 239' ' ' ALA . . . . . 0.555 ' HB2' ' HA ' ' C' ' 221' ' ' VAL . . . -55.27 -78.63 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.184 0.994 . . . . 74.42 112.951 -175.418 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . 152.82 -114.32 0.62 Allowed Glycine 0 C--N 1.339 0.699 0 N-CA-C 110.623 -0.991 . . . . 71.23 110.623 -172.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -151.61 136.07 16.91 Favored 'General case' 0 C--O 1.245 0.855 0 C-N-CA 123.455 0.702 . . . . 71.21 110.012 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 242' ' ' TRP . . . . . 0.528 ' CD2' ' HG ' ' C' ' 233' ' ' LEU . 4.7 p-90 -172.21 138.24 0.96 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.809 0.843 . . . . 70.32 112.106 173.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 71.8 mm-40 62.99 -75.0 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.819 1.648 . . . . 74.22 111.765 175.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 178.96 58.9 0.07 OUTLIER Glycine 0 C--N 1.342 0.9 0 N-CA-C 112.226 -0.35 . . . . 63.11 112.226 177.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 245' ' ' LYS . . . . . 0.771 ' HE2' ' HB1' ' C' ' 222' ' ' ALA . 52.8 tptt . . . . . 0 CA--C 1.541 0.607 0 CA-C-O 120.883 0.373 . . . . 75.34 110.767 177.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.287 0 CA-C-O 120.889 0.376 . . . . 52.01 110.881 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -39.11 102.75 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.607 1.563 . . . . 70.52 113.548 177.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 5' ' ' LYS . . . . . 0.484 ' HE2' HD11 ' C' ' 10' ' ' ILE . 48.0 mtpt -84.47 125.44 32.37 Favored 'General case' 0 C--O 1.245 0.832 0 N-CA-C 109.402 -0.592 . . . . 63.2 109.402 173.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -77.16 100.98 5.96 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.627 -0.879 . . . . 63.22 108.627 177.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 7' ' ' TYR . . . . . 0.54 ' HD1' HD12 ' C' ' 10' ' ' ILE . 23.4 m-85 -63.27 -31.17 72.25 Favored 'General case' 0 C--O 1.252 1.185 0 C-N-CA 123.741 0.817 . . . . 73.43 112.158 -172.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 8' ' ' TYR . . . . . 0.422 ' HE1' HD11 ' C' ' 22' ' ' ILE . 89.7 m-85 -60.51 -47.77 84.71 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.828 -0.624 . . . . 72.53 109.846 174.05 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.7 -38.02 88.05 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.546 0.738 . . . . 52.31 111.102 -177.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 10' ' ' ILE . . . . . 0.54 HD12 ' HD1' ' C' ' 7' ' ' TYR . 72.0 mt -58.28 -39.93 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 123.225 0.61 . . . . 63.34 110.41 175.408 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 11' ' ' LEU . . . . . 0.528 ' O ' ' HB1' ' C' ' 25' ' ' ALA . 86.0 mt -86.3 -11.67 51.57 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 112.654 0.613 . . . . 45.45 112.654 175.005 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.69 24.15 65.58 Favored Glycine 0 CA--C 1.535 1.328 0 N-CA-C 114.347 0.499 . . . . 64.33 114.347 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 5.8 m -105.84 156.19 37.02 Favored Pre-proline 0 N--CA 1.486 1.374 0 C-N-CA 124.056 0.942 . . . . 64.04 109.955 171.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -78.4 168.29 21.71 Favored 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 122.825 2.35 . . . . 74.43 114.427 -178.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 80.2 mtt180 -75.01 72.2 2.13 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.766 0.827 . . . . 71.52 109.87 173.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 175.11 -19.94 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.99 1.316 . . . . 71.24 108.896 -175.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -46.49 133.47 9.98 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 125.484 1.513 . . . . 71.14 113.447 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 18.2 p -74.19 148.2 41.85 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 123.946 0.779 . . . . 74.41 109.074 175.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 19' ' ' GLN . . . . . 0.402 ' HA ' HD12 ' C' ' 22' ' ' ILE . 25.9 tt0 -51.51 -34.11 34.58 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 124.069 0.948 . . . . 74.45 112.131 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.11 -44.98 67.86 Favored 'General case' 0 CA--C 1.556 1.201 0 CA-C-N 114.838 -1.074 . . . . 64.05 110.331 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -73.38 -27.27 61.39 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 123.023 0.529 . . . . 73.42 111.659 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 22' ' ' ILE . . . . . 0.514 HD13 HD13 ' C' ' 57' ' ' LEU . 76.5 mt -61.97 -44.29 98.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 123.94 0.896 . . . . 61.32 109.073 169.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 23' ' ' LYS . . . . . 0.439 ' O ' ' HG3' ' C' ' 27' ' ' LYS . 5.1 ttpm? -65.02 -32.64 74.46 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 114.922 -1.036 . . . . 74.13 111.388 175.428 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 24' ' ' ARG . . . . . 0.636 ' HA ' ' HE3' ' C' ' 27' ' ' LYS . 56.1 mtt180 -62.67 -46.91 85.98 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 120.961 0.41 . . . . 73.52 111.118 175.329 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 25' ' ' ALA . . . . . 0.528 ' HB1' ' O ' ' C' ' 11' ' ' LEU . . . -62.13 -39.17 91.69 Favored 'General case' 0 C--O 1.251 1.14 0 CA-C-N 114.814 -1.084 . . . . 75.32 111.389 177.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 26' ' ' TYR . . . . . 0.477 ' HD1' HG22 ' C' ' 50' ' ' ILE . 38.9 t80 -54.3 -54.7 36.66 Favored 'General case' 0 C--O 1.207 -1.147 0 CA-C-N 115.115 -0.948 . . . . 72.31 109.975 170.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 27' ' ' LYS . . . . . 0.636 ' HE3' ' HA ' ' C' ' 24' ' ' ARG . 10.3 mtmp? -56.85 -40.13 75.54 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 123.319 0.647 . . . . 74.1 111.452 -176.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 28' ' ' ARG . . . . . 0.466 ' HA ' ' NH2' ' C' ' 31' ' ' ARG . 34.8 ttp180 -57.9 -52.25 66.26 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 123.936 0.773 . . . . 71.15 110.606 177.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 29' ' ' LEU . . . . . 0.425 ' HA ' ' HB3' ' C' ' 32' ' ' GLN . 80.6 mt -84.28 -9.72 58.25 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-N 114.905 -1.043 . . . . 60.22 111.756 -176.135 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -86.85 -23.5 25.26 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.991 0.917 . . . . 75.32 110.214 175.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 31' ' ' ARG . . . . . 0.466 ' NH2' ' HA ' ' C' ' 28' ' ' ARG . 54.7 mtm180 -80.4 -45.88 16.94 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.518 0.727 . . . . 73.5 109.108 167.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 32' ' ' GLN . . . . . 0.425 ' HB3' ' HA ' ' C' ' 29' ' ' LEU . 59.4 tp60 -60.94 -50.97 71.26 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.245 1.018 . . . . 71.12 112.263 -175.635 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 33' ' ' TYR . . . . . 0.514 ' HB3' ' O ' ' C' ' 43' ' ' ALA . 31.2 m-85 -103.94 20.03 18.92 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.066 0.547 . . . . 70.15 111.843 -172.241 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 34' ' ' HIS . . . . . 0.478 ' HB3' ' HB ' ' C' ' 37' ' ' VAL . 5.7 t60 -63.87 114.34 13.22 Favored Pre-proline 0 N--CA 1.482 1.16 0 CA-C-O 118.526 -0.75 . . . . 72.34 111.023 -172.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 35' ' ' PRO . . . . . 0.431 ' HA ' ' HG2' ' C' ' 44' ' ' GLU . 34.7 Cg_exo -40.25 -50.43 3.58 Favored 'Trans proline' 0 C--N 1.385 2.488 0 C-N-CA 124.868 3.712 . . . . 71.32 116.111 -166.084 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -91.39 -23.7 19.97 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 111.797 0.295 . . . . 60.34 111.797 -173.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 37' ' ' VAL . . . . . 0.478 ' HB ' ' HB3' ' C' ' 34' ' ' HIS . 69.0 t -74.67 -41.94 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 108.658 -0.867 . . . . 75.33 108.658 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -112.8 96.12 5.79 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.399 -1.334 . . . . 54.22 107.399 175.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -70.61 76.44 0.59 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.801 0.841 . . . . 62.24 110.138 -175.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 62.5 m -152.04 104.62 2.81 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 123.659 0.784 . . . . 74.14 109.306 -176.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -44.64 -38.4 12.33 Favored 'Trans proline' 0 C--N 1.382 2.305 0 C-N-CA 123.882 3.054 . . . . 63.44 113.554 173.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -52.02 -49.94 62.38 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.647 0.779 . . . . 65.44 110.588 174.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 43' ' ' ALA . . . . . 0.514 ' O ' ' HB3' ' C' ' 33' ' ' TYR . . . -71.11 -21.72 62.18 Favored 'General case' 0 C--O 1.213 -0.831 0 CA-C-N 115.143 -0.935 . . . . 62.05 110.805 -178.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 44' ' ' GLU . . . . . 0.471 ' O ' ' HG3' ' C' ' 48' ' ' LYS . 38.0 mt-10 -76.37 -36.06 58.34 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.481 -0.563 . . . . 74.04 109.481 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -73.27 -38.73 65.84 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.756 0.822 . . . . 42.53 110.382 176.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 46' ' ' LYS . . . . . 0.5 ' O ' HG12 ' C' ' 50' ' ' ILE . 0.4 OUTLIER -63.91 -39.16 93.53 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.751 -0.659 . . . . 72.32 109.355 172.711 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -63.52 -34.53 78.0 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.08 0.952 . . . . 62.23 110.317 176.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 48' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' C' ' 44' ' ' GLU . 94.6 mttt -63.28 -43.47 97.83 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.487 -0.324 . . . . 72.04 110.28 174.076 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -64.11 -33.88 76.77 Favored 'General case' 0 CA--C 1.555 1.148 0 O-C-N 122.928 0.142 . . . . 72.33 110.741 176.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 50' ' ' ILE . . . . . 0.5 HG12 ' O ' ' C' ' 46' ' ' LYS . 13.2 mm -65.11 -42.48 94.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 CA-C-O 121.571 0.701 . . . . 75.43 109.441 175.018 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 51' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -76.31 -18.18 59.07 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 114.454 -1.248 . . . . 74.04 111.972 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 52' ' ' GLU . . . . . 0.454 ' O ' HG23 ' C' ' 56' ' ' VAL . 33.6 tt0 -74.86 -56.52 4.68 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.323 1.049 . . . . 63.42 108.611 176.346 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.95 -44.37 78.37 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 113.823 -1.535 . . . . 63.1 110.781 177.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -67.45 -38.6 84.73 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.33 -0.85 . . . . 75.01 111.152 176.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.32 -36.57 68.87 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 117.891 0.314 . . . . 60.54 111.197 177.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 56' ' ' VAL . . . . . 0.464 HG13 ' HZ ' ' C' ' 101' ' ' PHE . 3.0 t -94.98 -11.82 8.73 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 CA-C-N 115.902 -0.59 . . . . 72.43 111.871 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 57' ' ' LEU . . . . . 0.514 HD13 HD13 ' C' ' 22' ' ' ILE . 86.5 mt -126.37 19.86 7.44 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.98 -1.075 . . . . 75.02 113.654 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 45.9 t -80.74 -56.52 4.09 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 123.22 0.608 . . . . 62.42 112.456 178.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 59' ' ' ASP . . . . . 0.624 ' HB2' ' HD3' ' C' ' 62' ' ' LYS . 3.6 m-20 -108.68 153.6 42.16 Favored Pre-proline 0 N--CA 1.487 1.414 0 CA-C-O 118.086 -0.959 . . . . 72.03 109.904 -168.354 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 60' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -44.09 -43.47 12.75 Favored 'Trans proline' 0 C--N 1.397 3.106 0 C-N-CA 124.453 3.436 . . . . 33.23 114.192 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -61.89 -60.4 3.7 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.637 -0.71 . . . . 62.13 111.491 -178.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 62' ' ' LYS . . . . . 0.624 ' HD3' ' HB2' ' C' ' 59' ' ' ASP . 0.1 OUTLIER -62.67 -40.12 96.08 Favored 'General case' 0 C--O 1.248 1.01 0 O-C-N 124.244 0.965 . . . . 75.23 109.419 -173.164 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 47.2 tpt85 -51.84 -55.79 17.84 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 114.06 -1.427 . . . . 64.42 109.993 176.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -74.93 -18.07 60.46 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.333 -0.849 . . . . 74.15 112.499 -177.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 69.2 mt -62.94 -48.85 86.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 108.645 -0.872 . . . . 62.34 108.645 170.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -65.7 -43.86 87.88 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.799 -0.637 . . . . 74.22 110.681 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -61.59 -36.13 79.8 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 122.765 0.426 . . . . 73.14 111.578 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 74.4 p -83.9 -15.49 47.84 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 119.144 -0.455 . . . . 63.2 111.165 175.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -71.33 136.25 47.75 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.42 -0.956 . . . . 75.22 108.42 175.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.64 19.21 55.0 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 111.296 -0.721 . . . . 62.51 111.296 -167.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 58.6 m -145.84 -59.07 0.32 Allowed 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 103.274 -2.862 . . . . 72.34 103.274 174.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 13.3 m -79.88 137.47 36.92 Favored 'General case' 0 C--O 1.251 1.168 0 N-CA-C 104.63 -2.359 . . . . 73.35 104.63 156.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.09 -30.9 5.53 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.957 0.903 . . . . 73.23 110.15 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.45 124.86 91.4 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 115.614 -0.721 . . . . 53.23 109.219 174.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -53.31 146.1 41.97 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 122.871 2.381 . . . . 75.14 112.293 173.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -51.89 139.59 50.1 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 123.01 2.473 . . . . 63.14 112.849 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.66 138.9 86.81 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 122.743 2.295 . . . . 51.51 111.705 172.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 78' ' ' PRO . . . . . 0.512 ' HB3' ' HB2' ' C' ' 103' ' ' PRO . 18.0 Cg_endo -59.22 116.45 3.28 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 122.85 2.366 . . . . 74.44 112.581 -176.313 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -64.21 124.05 12.82 Favored 'Trans proline' 0 C--N 1.376 2.023 0 C-N-CA 122.324 2.016 . . . . 61.04 109.729 171.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -55.32 83.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.392 2.824 0 C-N-CA 123.751 2.967 . . . . 51.5 112.697 -175.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 161.91 -59.99 0.29 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 109.245 -1.542 . . . . 75.2 109.245 -174.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.437 ' HA3' ' HG3' ' C' ' 167' ' ' GLN . . . 143.61 172.69 14.61 Favored Glycine 0 C--N 1.358 1.795 0 C-N-CA 123.069 0.366 . . . . 74.45 112.761 -177.174 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -90.37 119.02 30.31 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.684 -0.858 . . . . 70.14 108.684 171.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 84' ' ' ASP . . . . . 0.612 ' HB2' ' HA ' ' C' ' 164' ' ' MET . 6.6 p-10 -70.29 133.21 46.76 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.509 0.724 . . . . 63.13 111.156 -178.336 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 85' ' ' PHE . . . . . 0.597 ' HB3' ' HB2' ' C' ' 88' ' ' PHE . 54.8 m-85 -139.43 69.81 1.37 Allowed 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.813 0.816 . . . . 74.41 110.796 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 16.7 m -61.5 96.07 0.06 Allowed 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 114.276 -1.329 . . . . 45.43 111.442 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.11 5.11 90.34 Favored Glycine 0 C--N 1.347 1.14 0 CA-C-N 115.807 -0.633 . . . . 74.33 113.317 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 88' ' ' PHE . . . . . 0.597 ' HB2' ' HB3' ' C' ' 85' ' ' PHE . 6.3 m-85 -103.78 118.07 35.83 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 108.154 -1.054 . . . . 74.44 108.154 -179.06 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -83.7 73.32 10.28 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 122.2 1.0 . . . . 72.23 110.766 -176.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 90' ' ' VAL . . . . . 0.535 HG23 ' HE2' ' C' ' 97' ' ' PHE . 2.4 p -41.32 -43.28 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 C-N-CA 126.551 1.94 . . . . 54.41 113.961 175.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -61.78 -32.01 72.26 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.831 0.852 . . . . 74.21 112.049 -175.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -101.26 4.18 41.55 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.482 0.313 . . . . 75.53 111.471 -176.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 93' ' ' PHE . . . . . 0.454 ' CD2' ' HA ' ' C' ' 90' ' ' VAL . 19.4 m-30 -78.04 177.5 8.26 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 110.23 -0.285 . . . . 72.45 110.23 174.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 77.4 p -62.18 158.63 16.49 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.829 0.852 . . . . 45.51 113.269 -173.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 95' ' ' GLU . . . . . 0.465 ' O ' ' HG3' ' C' ' 99' ' ' GLU . 0.0 OUTLIER -64.25 -25.69 68.17 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 123.51 0.507 . . . . 55.43 111.008 170.98 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -62.44 -45.41 93.19 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.694 0.798 . . . . 65.02 110.413 172.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 97' ' ' PHE . . . . . 0.535 ' HE2' HG23 ' C' ' 90' ' ' VAL . 32.5 t80 -64.93 -37.17 86.74 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 115.02 -0.991 . . . . 64.25 109.432 175.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 98' ' ' GLN . . . . . 0.409 ' HB2' ' HA ' ' C' ' 95' ' ' GLU . 70.3 mt-30 -71.12 -17.27 62.57 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.021 -0.99 . . . . 51.52 112.003 178.478 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 99' ' ' GLU . . . . . 0.465 ' HG3' ' O ' ' C' ' 95' ' ' GLU . 40.2 mt-10 -78.22 -57.9 3.54 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 109.602 -0.518 . . . . 74.43 109.602 167.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 26.6 tp -65.94 -31.26 72.08 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 114.369 -1.287 . . . . 73.23 112.336 -166.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 101' ' ' PHE . . . . . 0.464 ' HZ ' HG13 ' C' ' 56' ' ' VAL . 76.6 m-85 -120.34 13.37 11.88 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.377 0.671 . . . . 73.25 110.885 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -43.55 -63.8 2.05 Favored Glycine 0 C--N 1.352 1.437 0 N-CA-C 116.241 1.256 . . . . 54.11 116.241 -173.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 103' ' ' PRO . . . . . 0.512 ' HB2' ' HB3' ' C' ' 78' ' ' PRO . 38.8 Cg_exo -58.81 -6.3 3.31 Favored 'Trans proline' 0 C--N 1.373 1.837 0 C-N-CA 123.545 2.83 . . . . 62.02 115.225 -174.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -147.28 41.02 0.97 Allowed Glycine 0 C--N 1.351 1.407 0 CA-C-O 119.634 -0.537 . . . . 43.23 112.712 176.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 105' ' ' LEU . . . . . 0.408 HD11 ' HA ' ' C' ' 98' ' ' GLN . 38.0 mt . . . . . 0 N--CA 1.495 1.813 0 N-CA-C 116.445 2.017 . . . . 73.03 116.445 -177.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 116' ' ' GLY . . . . . 0.592 ' HA2' ' HA3' ' C' ' 168' ' ' GLY . . . . . . . . 0 CA--C 1.51 -0.241 0 CA-C-O 120.064 -0.298 . . . . 45.25 113.302 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 117' ' ' ARG . . . . . 0.452 ' HB2' ' HA3' ' C' ' 166' ' ' GLY . 52.1 mmm-85 -70.03 97.9 1.23 Allowed 'General case' 0 C--O 1.249 1.027 0 N-CA-C 107.314 -1.365 . . . . 64.44 107.314 174.544 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.09 98.12 0.56 Allowed 'General case' 0 C--O 1.242 0.659 0 CA-C-N 114.767 -1.106 . . . . 75.42 108.166 -178.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 119' ' ' LEU . . . . . 0.41 ' O ' HD12 ' C' ' 174' ' ' LEU . 56.0 tp -93.05 98.67 11.49 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 108.134 -1.061 . . . . 75.21 108.134 -168.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.444 HH12 HG21 ' C' ' 158' ' ' VAL . 40.8 ttm-85 -100.48 114.83 28.76 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.58 -0.896 . . . . 72.31 108.58 -177.073 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 121' ' ' ALA . . . . . 0.505 ' HB3' HD23 ' C' ' 176' ' ' LEU . . . -115.46 130.25 56.82 Favored 'General case' 0 C--O 1.219 -0.534 0 C-N-CA 123.644 0.777 . . . . 63.21 110.366 -174.015 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 122' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' C' ' 177' ' ' VAL . 11.5 pt-20 -90.06 147.63 23.53 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 109.413 -0.588 . . . . 73.22 109.413 174.419 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 123' ' ' LEU . . . . . 0.505 ' HB2' HG11 ' B' ' 182' ' ' VAL . 2.6 pt? -143.81 123.12 7.34 Favored Pre-proline 0 N--CA 1.482 1.173 0 N-CA-C 112.68 0.622 . . . . 73.3 112.68 -176.378 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 124' ' ' PRO . . . . . 0.445 ' HA ' ' O ' ' C' ' 179' ' ' ARG . 24.3 Cg_exo -65.7 117.67 4.83 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 122.739 2.293 . . . . 72.51 110.905 170.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 125' ' ' LEU . . . . . 0.458 HD23 HG11 ' C' ' 153' ' ' VAL . 44.7 tp -145.32 153.72 41.56 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.92 0.488 . . . . 74.03 110.311 -172.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 126' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.31 166.01 10.68 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.766 0.827 . . . . 61.53 109.873 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 127' ' ' LEU . . . . . 0.5 HD21 HD13 ' C' ' 180' ' ' LEU . 94.4 mt -78.13 -36.79 47.42 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.854 0.862 . . . . 62.25 111.333 -178.187 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 128' ' ' GLU . . . . . 0.425 ' HG3' ' HA ' ' C' ' 215' ' ' LEU . 18.0 mp0 -70.52 -32.18 69.54 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.987 -1.006 . . . . 75.24 109.542 173.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -87.4 -8.71 56.25 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.095 0.558 . . . . 73.53 111.416 176.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -76.56 -43.19 40.04 Favored 'General case' 0 C--O 1.22 -0.461 0 N-CA-C 108.191 -1.04 . . . . 64.34 108.191 164.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 131' ' ' PHE . . . . . 0.461 ' HB2' HD13 ' C' ' 215' ' ' LEU . 77.5 t80 -60.2 -37.99 81.94 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.781 1.233 . . . . 75.55 111.234 174.145 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 132' ' ' HIS . . . . . . . . . . . . . 65.7 m170 -78.68 -69.96 0.53 Allowed 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.831 -0.622 . . . . 60.22 110.669 177.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 49.46 -103.81 0.09 OUTLIER Glycine 0 C--N 1.353 1.52 0 O-C-N 124.047 0.842 . . . . 65.31 112.986 -178.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.98 -153.8 34.67 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 114.525 0.57 . . . . 53.24 114.525 170.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -93.42 93.86 8.39 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.152 -1.055 . . . . 71.2 108.152 -167.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 136' ' ' ARG . . . . . 0.628 ' HB3' ' HB2' ' B' ' 181' ' ' LEU . 0.9 OUTLIER -142.19 147.45 36.61 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 122.229 -0.295 . . . . 72.12 110.979 -167.977 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 137' ' ' VAL . . . . . 0.583 ' HA ' ' HA ' ' C' ' 146' ' ' SER . 7.7 p -95.07 129.99 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-O 121.493 0.664 . . . . 71.12 111.364 -177.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 138' ' ' VAL . . . . . . . . . . . . . 3.0 p -114.84 140.72 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.612 1.165 . . . . 72.14 108.953 178.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 139' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -108.0 111.59 23.74 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 107.8 -1.185 . . . . 74.31 107.8 172.641 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 140' ' ' VAL . . . . . 0.415 HG21 ' HB2' ' C' ' 121' ' ' ALA . 2.7 p -130.63 128.15 62.94 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 C-N-CA 123.896 0.878 . . . . 63.22 109.215 -179.174 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 65.37 33.36 9.03 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.803 0.841 . . . . 15.23 112.388 174.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 78.7 12.5 84.15 Favored Glycine 0 C--N 1.345 1.044 0 CA-C-N 116.399 -0.364 . . . . 45.25 112.302 -176.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 143' ' ' ARG . . . . . . . . . . . . . 29.1 tpt180 -126.32 100.83 6.45 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.445 0.698 . . . . 73.04 109.991 -168.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -83.99 129.33 34.92 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.181 -0.918 . . . . 71.51 109.225 176.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 145' ' ' VAL . . . . . . . . . . . . . 3.7 p -166.34 140.26 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 123.822 0.849 . . . . 75.03 109.854 -174.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 146' ' ' SER . . . . . 0.583 ' HA ' ' HA ' ' C' ' 137' ' ' VAL . 56.8 p -100.7 146.05 27.69 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.075 0.55 . . . . 54.21 111.998 -174.079 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 8.9 p -151.67 150.33 13.22 Favored 'Isoleucine or valine' 0 C--O 1.242 0.711 0 CA-C-N 115.716 -0.674 . . . . 72.53 109.838 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 20.3 ttt180 -105.36 94.67 5.34 Favored 'General case' 0 C--N 1.347 0.482 0 N-CA-C 107.971 -1.122 . . . . 74.22 107.971 168.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 149' ' ' ILE . . . . . 0.418 HD12 HD13 ' C' ' 159' ' ' ILE . 37.8 pt -75.97 146.68 79.44 Favored Pre-proline 0 CA--C 1.55 0.956 0 CA-C-O 118.603 -0.713 . . . . 71.41 109.513 176.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.37 115.75 2.8 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 122.408 2.072 . . . . 61.44 111.619 177.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -51.72 111.69 0.65 Allowed 'Trans proline' 0 C--N 1.384 2.424 0 C-N-CA 123.633 2.889 . . . . 73.2 114.081 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 152' ' ' GLY . . . . . . . . . . . . . . . 139.77 136.28 3.35 Favored Glycine 0 C--N 1.35 1.324 0 CA-C-N 115.373 -0.83 . . . . 54.32 113.175 -174.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 153' ' ' VAL . . . . . 0.458 HG11 HD23 ' C' ' 125' ' ' LEU . 1.7 p -160.38 160.72 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.777 0 CA-C-N 117.192 0.496 . . . . 71.13 112.2 177.119 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 154' ' ' ARG . . . . . 0.475 ' HD3' ' O ' ' C' ' 188' ' ' LEU . 43.9 ttp180 -128.2 139.68 52.33 Favored 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 125.052 1.341 . . . . 75.32 109.225 177.147 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 155' ' ' GLU . . . . . 0.609 ' HB2' HD12 ' C' ' 180' ' ' LEU . 21.8 tp10 -40.51 123.53 1.83 Allowed 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 125.464 1.506 . . . . 74.51 113.9 176.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 81.09 -13.46 32.02 Favored Glycine 0 C--N 1.353 1.486 0 CA-C-N 115.054 -0.976 . . . . 64.51 113.951 176.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 157' ' ' SER . . . . . . . . . . . . . 17.1 m -83.56 166.28 18.36 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.226 0.61 . . . . 75.43 111.203 -174.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 158' ' ' VAL . . . . . 0.547 HG22 HG22 ' C' ' 177' ' ' VAL . 21.5 t -111.66 136.44 47.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 CA-C-N 115.245 -0.889 . . . . 64.44 110.884 -163.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 159' ' ' ILE . . . . . 0.687 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 27.2 mt -105.99 122.13 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 107.136 -1.431 . . . . 52.25 107.136 172.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 16.8 ttm180 -83.8 141.22 31.54 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 117.947 0.339 . . . . 72.21 110.151 178.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 161' ' ' VAL . . . . . 0.505 ' HB ' ' HB3' ' C' ' 174' ' ' LEU . 39.8 t -128.74 97.65 26.74 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 107.24 -1.393 . . . . 75.24 107.24 164.288 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -62.92 127.67 21.05 Favored 'Trans proline' 0 C--N 1.377 2.038 0 C-N-CA 122.92 2.413 . . . . 63.42 113.489 -172.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 163' ' ' GLY . . . . . 0.676 ' H ' ' HB3' ' C' ' 173' ' ' ASP . . . 84.67 -18.39 25.61 Favored Glycine 0 CA--C 1.541 1.665 0 N-CA-C 115.135 0.814 . . . . 53.31 115.135 177.15 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 164' ' ' MET . . . . . 0.612 ' HA ' ' HB2' ' C' ' 84' ' ' ASP . 31.3 ttp -94.77 38.71 1.11 Allowed 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 117.94 0.87 . . . . 73.35 112.317 -167.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . -109.02 -147.01 11.96 Favored Glycine 0 N--CA 1.473 1.132 0 CA-C-N 115.718 -0.674 . . . . 64.24 112.649 174.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 166' ' ' GLY . . . . . 0.452 ' HA3' ' HB2' ' C' ' 117' ' ' ARG . . . -88.88 -177.22 46.53 Favored Glycine 0 C--N 1.351 1.405 0 CA-C-O 119.868 -0.407 . . . . 75.44 112.992 -179.102 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 167' ' ' GLN . . . . . 0.437 ' HG3' ' HA3' ' C' ' 82' ' ' GLY . 28.4 mt-30 -49.97 129.21 20.16 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.168 1.387 . . . . 64.31 112.894 -173.314 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 168' ' ' GLY . . . . . 0.592 ' HA3' ' HA2' ' C' ' 116' ' ' GLY . . . 165.71 158.07 10.47 Favored Glycine 0 C--N 1.351 1.412 0 N-CA-C 114.984 0.754 . . . . 13.44 114.984 173.286 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 169' ' ' ASN . . . . . 0.548 ' HB3' ' HD3' ' C' ' 170' ' ' PRO . 5.0 t30 -90.37 -55.43 0.28 Allowed Pre-proline 0 CA--C 1.557 1.213 0 CA-C-N 114.166 -1.017 . . . . 62.44 110.298 165.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 170' ' ' PRO . . . . . 0.548 ' HD3' ' HB3' ' C' ' 169' ' ' ASN . 20.9 Cg_exo -64.44 118.52 5.48 Favored 'Trans proline' 0 C--N 1.399 3.221 0 CA-C-N 120.883 1.351 . . . . 51.41 109.029 175.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 171' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -46.17 107.0 0.1 Allowed 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 123.335 2.69 . . . . 74.02 114.073 -167.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -82.62 -48.15 5.67 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-N 115.154 -0.93 . . . . 74.42 111.154 175.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 173' ' ' ASP . . . . . 0.676 ' HB3' ' H ' ' C' ' 163' ' ' GLY . 2.4 p30 50.84 173.11 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 115.709 1.744 . . . . 74.51 115.709 172.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 174' ' ' LEU . . . . . 0.505 ' HB3' ' HB ' ' C' ' 161' ' ' VAL . 49.5 tp -100.73 132.87 45.91 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 115.488 -0.778 . . . . 75.22 109.759 -177.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 90.0 mt -127.54 89.31 2.93 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.924 0.869 . . . . 71.32 110.316 -173.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 176' ' ' LEU . . . . . 0.687 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 96.0 mt -76.36 97.26 4.2 Favored 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 114.262 -1.336 . . . . 43.02 111.945 -175.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 177' ' ' VAL . . . . . 0.547 HG22 HG22 ' C' ' 158' ' ' VAL . 71.5 t -83.56 109.94 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 108.334 -0.987 . . . . 74.43 108.334 174.58 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 178' ' ' VAL . . . . . 0.433 ' HA ' HD23 ' C' ' 123' ' ' LEU . 8.2 p -75.14 136.03 25.96 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 CA-C-O 121.919 0.866 . . . . 74.01 111.707 -173.214 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 179' ' ' ARG . . . . . 0.445 ' O ' ' HA ' ' C' ' 124' ' ' PRO . 8.5 mmm180 -109.76 96.1 6.03 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 105.563 -2.014 . . . . 72.33 105.563 171.338 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 180' ' ' LEU . . . . . 0.609 HD12 ' HB2' ' C' ' 155' ' ' GLU . 77.0 mt -68.97 148.52 50.02 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-O 121.26 0.552 . . . . 70.51 111.046 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 181' ' ' LEU . . . . . . . . . . . . . 56.8 mt -68.97 171.49 6.37 Favored Pre-proline 0 N--CA 1.484 1.235 0 CA-C-N 114.217 -1.356 . . . . 74.2 110.494 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -60.98 67.37 0.09 OUTLIER 'Trans proline' 0 C--N 1.384 2.423 0 C-N-CA 122.543 2.162 . . . . 64.12 111.855 166.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 183' ' ' HIS . . . . . 0.595 ' H ' ' HD3' ' C' ' 184' ' ' PRO . 71.1 t60 -170.25 27.39 0.01 OUTLIER Pre-proline 0 CA--C 1.582 2.195 0 C-N-CA 126.726 2.01 . . . . 62.13 109.894 -177.1 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 184' ' ' PRO . . . . . 0.595 ' HD3' ' H ' ' C' ' 183' ' ' HIS . 12.2 Cg_endo -84.74 68.22 6.2 Favored 'Trans proline' 0 C--N 1.405 3.522 0 C-N-CA 122.542 2.161 . . . . 71.54 110.513 -173.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 185' ' ' VAL . . . . . 0.596 HG12 ' HB1' ' C' ' 195' ' ' ALA . 5.9 t -90.4 -40.95 13.21 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.573 0 N-CA-C 107.658 -1.238 . . . . 72.23 107.658 -172.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 186' ' ' PHE . . . . . 0.415 ' HB2' HD13 ' C' ' 127' ' ' LEU . 74.5 m-85 -99.24 104.56 16.5 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.687 0.795 . . . . 61.44 109.825 -172.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 187' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -94.41 113.3 25.15 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.292 1.437 . . . . 75.14 108.465 -177.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 188' ' ' LEU . . . . . 0.588 HD13 ' HD2' ' C' ' 240' ' ' PHE . 64.7 tp -81.93 146.99 29.5 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 113.233 0.827 . . . . 74.14 113.233 -171.289 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -145.59 101.88 3.62 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.033 1.333 . . . . 71.33 107.55 164.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 74.73 -102.25 1.39 Allowed Glycine 0 C--N 1.346 1.115 0 N-CA-C 112.159 -0.376 . . . . 74.2 112.159 -175.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 191' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -112.24 -13.68 13.45 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.493 0.717 . . . . 60.21 110.363 170.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -87.72 141.06 28.89 Favored 'General case' 0 C--O 1.213 -0.835 0 C-N-CA 123.689 0.796 . . . . 65.13 110.685 -170.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 193' ' ' LEU . . . . . . . . . . . . . 85.6 mt -106.58 167.56 9.77 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 122.899 0.48 . . . . 52.2 110.871 -176.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 194' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -143.2 105.3 4.4 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.567 -0.531 . . . . 75.43 109.567 171.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 195' ' ' ALA . . . . . 0.596 ' HB1' HG12 ' C' ' 185' ' ' VAL . . . -119.52 -176.35 3.14 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.607 1.163 . . . . 65.11 109.324 177.337 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 30.1 m -123.78 133.58 53.8 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 109.306 -0.628 . . . . 51.32 109.306 176.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 197' ' ' LEU . . . . . 0.458 HD13 ' HB2' ' C' ' 212' ' ' ALA . 32.0 tp -107.2 122.73 47.11 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.403 0.681 . . . . 73.5 109.567 -178.14 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -82.56 98.16 8.83 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 108.566 -0.901 . . . . 44.52 108.566 176.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 199' ' ' VAL . . . . . . . . . . . . . 60.3 t -107.77 121.42 44.11 Favored Pre-proline 0 N--CA 1.478 0.964 0 C-N-CA 123.296 0.639 . . . . 61.21 109.335 -175.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 200' ' ' PRO . . . . . 0.612 ' HG2' HD12 ' C' ' 203' ' ' ILE . 15.9 Cg_exo -63.23 140.69 78.92 Favored 'Trans proline' 0 C--N 1.367 1.541 0 C-N-CA 121.839 1.693 . . . . 71.34 111.181 172.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 201' ' ' ALA . . . . . 0.404 ' N ' ' HD2' ' C' ' 202' ' ' PRO . . . -53.5 -46.43 98.13 Favored Pre-proline 0 CA--C 1.554 1.107 0 N-CA-C 113.49 0.922 . . . . 74.35 113.49 178.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 202' ' ' PRO . . . . . 0.445 ' HB2' ' HA ' ' A' ' 273' ' ' ALA . 39.2 Cg_endo -62.06 -42.64 28.76 Favored 'Trans proline' 0 C--N 1.384 2.407 0 CA-C-N 120.722 1.294 . . . . 63.15 111.946 178.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 203' ' ' ILE . . . . . 0.612 HD12 ' HG2' ' C' ' 200' ' ' PRO . 24.8 mt -64.48 -34.68 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 122.839 0.456 . . . . 63.4 110.958 177.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 204' ' ' ALA . . . . . 0.496 ' HA ' HG11 ' C' ' 223' ' ' VAL . . . -68.13 -35.29 77.87 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.687 0.795 . . . . 75.02 111.913 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 205' ' ' VAL . . . . . 0.535 ' HA ' ' HA ' ' C' ' 226' ' ' ARG . 95.6 t -77.96 -42.09 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-N 115.836 -0.62 . . . . 63.41 112.498 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 206' ' ' VAL . . . . . 0.466 HG23 ' HG2' ' A' ' 270' ' ' LYS . 11.7 p -76.6 -32.73 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 CA-C-O 121.028 0.442 . . . . 52.12 110.009 -177.056 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 84.3 49.95 4.48 Favored Glycine 0 N--CA 1.44 -1.062 0 CA-C-N 115.095 -0.957 . . . . 63.21 111.846 -172.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -84.37 -136.92 3.44 Favored Glycine 0 C--N 1.347 1.187 0 CA-C-O 119.62 -0.545 . . . . 51.32 112.03 177.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 209' ' ' LYS . . . . . 0.493 ' HB3' ' HG2' ' C' ' 220' ' ' GLU . 9.2 mtmp? -139.02 140.89 38.27 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 117.649 0.724 . . . . 72.12 112.83 -178.08 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 210' ' ' VAL . . . . . . . . . . . . . 57.5 t -132.78 129.48 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 124.953 1.301 . . . . 62.05 108.614 178.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 211' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -80.28 125.57 30.04 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 118.16 0.436 . . . . 72.44 111.505 -177.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 212' ' ' ALA . . . . . 0.458 ' HB2' HD13 ' C' ' 197' ' ' LEU . . . -103.12 120.08 40.04 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 108.038 -1.097 . . . . 74.43 108.038 165.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 213' ' ' MET . . . . . . . . . . . . . 5.4 tmm? -79.12 108.53 12.68 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 108.331 -0.989 . . . . 63.12 108.331 -177.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.93 171.85 7.1 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 118.128 0.422 . . . . 54.24 110.772 -173.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 215' ' ' LEU . . . . . 0.461 HD13 ' HB2' ' C' ' 131' ' ' PHE . 25.2 mt -58.41 -37.84 76.15 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 125.302 1.441 . . . . 44.41 113.49 -165.026 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 216' ' ' GLU . . . . . 0.47 ' HG2' HH11 ' C' ' 246' ' ' ARG . 0.0 OUTLIER -110.1 -6.32 15.14 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.057 0.943 . . . . 71.0 111.483 -174.579 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 169.42 156.23 10.62 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-O 119.761 -0.466 . . . . 64.11 113.303 -177.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.74 111.17 3.08 Favored 'Trans proline' 0 CA--C 1.557 1.656 0 C-N-CA 122.933 2.422 . . . . 52.13 112.403 178.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 219' ' ' VAL . . . . . 0.503 ' HB ' ' HE3' ' C' ' 238' ' ' LYS . 9.0 p -84.21 140.16 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 O-C-N 122.07 -0.394 . . . . 52.53 110.019 176.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 220' ' ' GLU . . . . . 0.493 ' HG2' ' HB3' ' C' ' 209' ' ' LYS . 25.5 tt0 -101.23 108.02 19.56 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 107.657 -1.238 . . . . 72.32 107.657 176.046 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 221' ' ' VAL . . . . . 0.555 ' HA ' ' HB2' ' B' ' 239' ' ' ALA . 42.5 t -77.07 119.48 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 124.055 0.942 . . . . 74.03 111.897 -174.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 222' ' ' ALA . . . . . 0.771 ' HB1' ' HE2' ' B' ' 245' ' ' LYS . . . -80.69 112.71 18.31 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.537 0.735 . . . . 73.3 110.277 169.073 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 223' ' ' VAL . . . . . 0.496 HG11 ' HA ' ' C' ' 204' ' ' ALA . 63.8 t -89.19 138.89 28.65 Favored Pre-proline 0 CA--C 1.559 1.306 0 C-N-CA 124.719 1.208 . . . . 73.11 110.028 -178.077 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 224' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.62 154.38 64.36 Favored 'Trans proline' 0 C--N 1.389 2.705 0 C-N-CA 122.501 2.134 . . . . 54.33 112.147 172.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.31 114.21 1.83 Allowed 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 122.768 2.312 . . . . 74.0 111.906 174.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 226' ' ' ARG . . . . . 0.58 ' HB3' ' HA ' ' A' ' 259' ' ' GLU . 0.0 OUTLIER 70.69 97.91 0.07 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.879 1.672 . . . . 70.15 112.406 -178.186 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 227' ' ' THR . . . . . 0.48 HG22 HG11 ' C' ' 253' ' ' VAL . 50.5 m -120.29 129.28 53.95 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 124.726 1.21 . . . . 70.3 111.562 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 228' ' ' GLN . . . . . 0.424 ' H ' ' HD2' ' C' ' 231' ' ' ARG . 27.0 mp0 -95.14 156.43 16.32 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 124.247 1.019 . . . . 74.32 111.635 175.164 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 229' ' ' ALA . . . . . 0.457 ' HB2' ' H ' ' C' ' 255' ' ' ILE . . . -75.72 131.32 39.77 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 114.84 -1.073 . . . . 62.12 109.742 177.145 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 110.95 -18.96 25.9 Favored Glycine 0 C--N 1.339 0.697 0 CA-C-N 115.711 -0.677 . . . . 62.04 112.085 -170.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 231' ' ' ARG . . . . . 0.424 ' HD2' ' H ' ' C' ' 228' ' ' GLN . 56.4 mtt180 -62.35 161.86 10.9 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 116.754 0.277 . . . . 74.12 110.318 169.16 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 232' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -137.65 138.91 39.93 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.042 0.449 . . . . 71.45 110.76 -174.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 233' ' ' LEU . . . . . 0.64 ' O ' ' HA ' ' C' ' 250' ' ' TYR . 6.1 mp -97.11 153.01 18.22 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 114.366 -1.288 . . . . 74.21 109.431 176.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 17.3 ptt180 -130.78 91.33 3.05 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 107.855 -1.165 . . . . 72.34 107.855 162.109 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 235' ' ' LEU . . . . . 0.575 HD12 HD23 ' C' ' 249' ' ' LEU . 17.1 mt -71.4 106.41 3.9 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 114.29 -1.323 . . . . 73.43 109.061 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 26.2 mmmt -69.82 115.25 8.83 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 113.997 -1.456 . . . . 71.55 110.872 -171.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 81.39 33.15 29.18 Favored Glycine 0 C--N 1.346 1.1 0 CA-C-N 115.799 -0.637 . . . . 71.42 112.955 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 238' ' ' LYS . . . . . 0.503 ' HE3' ' HB ' ' C' ' 219' ' ' VAL . 64.6 mmtt -125.77 24.41 7.11 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.723 0.809 . . . . 72.03 111.364 177.437 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -102.32 -156.1 25.77 Favored Glycine 0 C--N 1.344 1.007 0 N-CA-C 111.652 -0.579 . . . . 31.21 111.652 171.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 240' ' ' PHE . . . . . 0.588 ' HD2' HD13 ' C' ' 188' ' ' LEU . 56.8 m-85 -81.67 153.38 70.49 Favored Pre-proline 0 CA--C 1.553 1.086 0 C-N-CA 122.868 0.467 . . . . 75.14 109.915 175.039 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 241' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -66.95 136.05 39.93 Favored 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 123.746 2.964 . . . . 70.21 114.806 -168.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -134.9 173.11 21.71 Favored Glycine 0 C--N 1.351 1.416 0 CA-C-N 115.487 -0.779 . . . . 70.14 112.869 175.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -60.91 -42.8 34.76 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 123.899 3.066 . . . . 71.42 112.796 -174.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -83.53 -17.36 42.1 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.725 0.81 . . . . 71.42 110.698 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 143.92 -179.19 21.46 Favored Glycine 0 C--N 1.346 1.108 0 CA-C-N 115.621 -0.718 . . . . 51.32 111.423 -176.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 246' ' ' ARG . . . . . 0.47 HH11 ' HG2' ' C' ' 216' ' ' GLU . 80.8 mtm180 -71.34 159.52 34.42 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.298 0.639 . . . . 61.31 111.192 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -70.42 -164.29 4.99 Favored Glycine 0 C--N 1.353 1.504 0 CA-C-N 116.074 -0.512 . . . . 63.23 113.463 178.109 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -117.17 124.46 49.18 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 108.803 -0.814 . . . . 73.54 108.803 -173.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 249' ' ' LEU . . . . . 0.575 HD23 HD12 ' C' ' 235' ' ' LEU . 11.0 tp -79.58 119.99 23.31 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.902 -0.777 . . . . 74.23 108.902 177.183 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 250' ' ' TYR . . . . . 0.64 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 20.0 m-85 -96.24 111.93 23.83 Favored 'General case' 0 C--O 1.221 -0.419 0 N-CA-C 108.205 -1.035 . . . . 71.43 108.205 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 251' ' ' LEU . . . . . 0.588 HD12 HD22 ' C' ' 233' ' ' LEU . 77.1 mt -105.32 123.02 47.16 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 109.218 -0.66 . . . . 64.53 109.218 -177.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -81.32 120.27 24.72 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.273 -1.01 . . . . 73.41 108.273 173.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 253' ' ' VAL . . . . . 0.48 HG11 HG22 ' C' ' 227' ' ' THR . 60.3 t -72.29 128.93 35.66 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 C-N-CA 123.018 0.527 . . . . 73.5 110.954 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 254' ' ' ARG . . . . . . . . . . . . . 39.4 mtm105 -112.38 129.77 56.2 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 107.462 -1.31 . . . . 74.13 107.462 162.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 255' ' ' ILE . . . . . 0.535 ' O ' ' HB ' ' A' ' 255' ' ' ILE . 37.9 mm -94.65 114.21 30.75 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.775 0 N-CA-C 106.14 -1.8 . . . . 75.24 106.14 173.458 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 256' ' ' THR . . . . . 0.486 ' O ' ' HA ' ' C' ' 200' ' ' PRO . 0.1 OUTLIER -132.56 155.28 48.94 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 123.991 0.916 . . . . 53.32 108.93 -170.642 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 2.7 pp -124.0 151.07 64.58 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 109.086 -0.709 . . . . 64.54 109.086 -175.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 258' ' ' PRO . . . . . 0.404 ' HG3' ' HE2' ' A' ' 276' ' ' TYR . 68.9 Cg_endo -75.04 8.88 2.23 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.45 2.1 . . . . 73.21 113.025 -171.064 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 61.37 -79.25 0.02 OUTLIER 'General case' 0 C--N 1.359 0.987 0 C-N-CA 125.718 1.607 . . . . 72.3 110.268 -170.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 2.6 ptp85 -72.95 142.63 47.82 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.396 1.478 . . . . 73.41 110.671 -178.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 261' ' ' LEU . . . . . 0.473 HD22 ' HB3' ' C' ' 265' ' ' GLU . 85.6 mt -139.04 168.25 20.25 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.771 0.829 . . . . 71.21 110.579 -174.403 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 49.4 p -86.53 162.94 43.78 Favored Pre-proline 0 CA--C 1.553 1.063 0 N-CA-C 108.401 -0.963 . . . . 61.23 108.401 168.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -50.49 -40.99 53.85 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 122.738 2.292 . . . . 74.2 113.107 173.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -60.44 -59.21 5.77 Favored 'General case' 0 C--O 1.262 1.73 0 C-N-CA 124.011 0.924 . . . . 71.04 110.846 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 265' ' ' GLU . . . . . 0.473 ' HB3' HD22 ' C' ' 261' ' ' LEU . 49.3 mm-40 -51.04 -63.5 1.11 Allowed 'General case' 0 C--N 1.353 0.724 0 CA-C-N 114.416 -1.265 . . . . 65.11 110.538 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 266' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -55.58 -38.68 69.7 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.365 1.066 . . . . 64.21 111.58 -173.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -58.01 -51.31 70.18 Favored 'General case' 0 C--O 1.248 1.008 0 O-C-N 123.606 0.566 . . . . 70.32 111.427 177.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 268' ' ' LEU . . . . . 0.652 ' HB2' HD21 ' A' ' 272' ' ' LEU . 10.6 mp -64.68 -39.8 94.29 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 119.288 -0.387 . . . . 52.44 111.332 178.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -58.88 -36.64 74.98 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 122.854 0.462 . . . . 61.11 111.683 176.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 270' ' ' LYS . . . . . 0.504 ' HA ' HG21 ' A' ' 206' ' ' VAL . 9.5 mtpm? -72.71 -34.96 67.47 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.244 0.618 . . . . 75.43 111.352 178.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 271' ' ' LYS . . . . . 0.403 ' HA ' ' HD3' ' C' ' 271' ' ' LYS . 69.3 mmtt -68.17 -32.83 73.36 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 123.108 0.255 . . . . 75.33 111.627 175.213 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 272' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' C' ' 268' ' ' LEU . 68.6 mt -67.89 -41.56 82.57 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.202 0.601 . . . . 74.33 109.622 173.261 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -62.68 -38.61 91.03 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 115.732 -0.667 . . . . 34.13 111.227 176.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -66.22 -37.51 85.71 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.781 0.832 . . . . 63.21 110.756 176.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -62.9 -35.25 79.43 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.891 0.476 . . . . 70.04 111.046 173.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 276' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -69.97 -45.76 66.7 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.559 -0.746 . . . . 75.52 112.179 175.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -63.84 -33.98 76.89 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-O 121.066 0.46 . . . . 44.24 109.801 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -63.29 -17.21 62.28 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 114.882 -1.054 . . . . 55.2 112.659 178.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 279' ' ' ARG . . . . . . . . . . . . . 70.3 mtm180 -73.21 -24.46 60.52 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 122.486 0.314 . . . . 71.52 111.298 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.558 1.255 0 CA-C-O 118.459 -0.781 . . . . 75.14 109.771 -176.481 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.5 tmmm? . . . . . 0 N--CA 1.48 1.057 0 N-CA-C 112.63 0.604 . . . . 62.43 112.63 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.638 ' HB3' HD11 ' A' ' 10' ' ' ILE . 48.8 mtpt -97.92 109.32 22.1 Favored 'General case' 0 C--O 1.244 0.782 0 N-CA-C 107.882 -1.155 . . . . 74.32 107.882 172.296 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.516 ' HA ' ' OH ' ' A' ' 66' ' ' TYR . 24.9 t70 -70.98 109.33 5.03 Favored 'General case' 0 C--N 1.351 0.657 0 N-CA-C 108.101 -1.074 . . . . 61.41 108.101 173.133 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -65.65 -32.23 73.68 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-N 115.114 -0.948 . . . . 73.34 111.998 -170.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -63.25 -43.49 97.87 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 109.846 -0.427 . . . . 73.33 109.846 173.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.4 -45.86 90.31 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.52 0.728 . . . . 60.32 111.337 178.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.638 HD11 ' HB3' ' A' ' 5' ' ' LYS . 66.1 mt -56.09 -45.02 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 O-C-N 123.903 0.752 . . . . 74.23 110.613 177.255 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.514 HD13 HG23 ' A' ' 22' ' ' ILE . 69.1 mt -69.74 -23.19 63.35 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 115.644 -0.707 . . . . 51.33 112.207 176.327 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.78 44.4 7.24 Favored Glycine 0 C--N 1.349 1.253 0 O-C-N 123.182 0.301 . . . . 53.33 112.976 -176.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.0 m -138.17 152.62 72.07 Favored Pre-proline 0 N--CA 1.486 1.326 0 C-N-CA 124.658 1.183 . . . . 71.43 109.839 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -59.26 157.3 30.99 Favored 'Trans proline' 0 C--N 1.384 2.397 0 C-N-CA 122.799 2.333 . . . . 50.12 112.366 177.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 10.9 mtm105 -72.68 8.71 1.35 Allowed 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 113.676 0.991 . . . . 75.43 113.676 -167.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -129.45 14.66 6.06 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.073 0.949 . . . . 64.11 109.474 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.76 131.78 51.79 Favored 'General case' 0 C--N 1.35 0.61 0 C-N-CA 124.273 1.029 . . . . 64.31 111.361 -176.044 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.1 p -71.98 162.63 29.17 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.568 0.747 . . . . 71.11 110.594 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 8.6 tm0? -55.23 -31.57 61.6 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.096 0.958 . . . . 64.21 110.301 178.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -62.93 -51.11 68.21 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 125.033 1.333 . . . . 72.43 110.481 177.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -71.97 -32.36 67.18 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.613 0.765 . . . . 64.03 111.361 -178.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.599 HD13 ' HB3' ' A' ' 57' ' ' LEU . 61.4 mt -70.66 -30.71 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.269 1.427 . . . . 73.31 110.116 176.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.428 ' HG2' ' HE2' ' A' ' 27' ' ' LYS . 13.7 ttmm -69.74 -44.82 69.46 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.745 0.818 . . . . 71.24 109.114 174.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 71.4 mtp180 -59.62 -42.06 91.81 Favored 'General case' 0 N--CA 1.485 1.275 0 O-C-N 123.981 0.801 . . . . 54.12 111.008 176.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.25 -39.22 75.13 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.783 0.833 . . . . 64.0 111.297 -178.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -60.44 -54.78 41.46 Favored 'General case' 0 C--O 1.216 -0.662 0 CA-C-N 114.917 -1.038 . . . . 73.1 109.361 176.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.428 ' HE2' ' HG2' ' A' ' 23' ' ' LYS . 68.4 mttm -56.75 -42.17 78.86 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.892 0.877 . . . . 74.22 110.964 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -55.7 -55.96 26.03 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.672 0.789 . . . . 71.15 110.855 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.593 ' HB3' HD13 ' A' ' 50' ' ' ILE . 95.3 mt -79.25 -15.17 58.41 Favored 'General case' 0 CA--C 1.555 1.137 0 CA-C-N 115.471 -0.786 . . . . 74.11 111.579 -176.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.66 -20.5 33.46 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.983 0.913 . . . . 63.3 110.985 175.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 28.3 mtm180 -96.55 -25.36 15.65 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.591 0.757 . . . . 72.33 110.164 172.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -69.07 -65.75 0.67 Allowed 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 107.964 -1.124 . . . . 63.33 107.964 176.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -92.89 29.91 1.71 Allowed 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.061 0.544 . . . . 63.25 110.896 -177.271 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.406 ' CE1' ' HB3' ' A' ' 36' ' ' ASP . 9.4 t-160 -52.71 99.91 0.22 Allowed Pre-proline 0 N--CA 1.486 1.366 0 C-N-CA 125.52 1.528 . . . . 63.41 112.365 -170.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -60.95 -17.88 54.05 Favored 'Trans proline' 0 C--N 1.384 2.415 0 C-N-CA 123.336 2.691 . . . . 74.13 113.914 -171.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.406 ' HB3' ' CE1' ' A' ' 34' ' ' HIS . 32.1 t70 -66.98 -39.17 87.12 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.447 0.699 . . . . 72.45 111.862 176.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 82.2 t -102.28 -52.09 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 123.174 0.589 . . . . 65.53 109.624 -178.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -96.71 87.51 4.36 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 124.166 0.986 . . . . 61.35 109.568 -178.212 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -84.39 49.19 1.63 Allowed 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 115.439 -0.8 . . . . 73.11 110.653 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 74.0 m -91.94 115.62 64.96 Favored Pre-proline 0 N--CA 1.471 0.59 0 CA-C-O 118.054 -0.974 . . . . 54.41 108.548 176.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.403 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 85.2 Cg_exo -44.77 -49.6 9.34 Favored 'Trans proline' 0 C--N 1.384 2.439 0 C-N-CA 123.756 2.971 . . . . 72.23 113.295 -176.297 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -54.8 -43.32 72.78 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.963 0.905 . . . . 64.43 111.312 178.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.94 -27.68 64.95 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.513 -0.767 . . . . 72.14 110.926 -177.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.441 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 50.1 mt-10 -84.0 -29.98 26.54 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.173 0.589 . . . . 62.01 110.47 -175.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 41' ' ' PRO . 44.6 mt-10 -77.54 -38.45 48.67 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.186 0.595 . . . . 62.44 109.991 177.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -66.14 -34.24 77.59 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.855 -0.611 . . . . 74.03 109.766 170.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.805 ' HA ' HD12 ' A' ' 50' ' ' ILE . 88.0 t80 -62.04 -37.22 84.11 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 122.879 0.472 . . . . 73.24 110.475 172.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 44' ' ' GLU . 97.7 mttt -64.89 -35.12 80.13 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.723 0.409 . . . . 75.14 111.327 174.347 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -69.88 -29.9 67.22 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 122.421 0.288 . . . . 71.44 111.753 175.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.805 HD12 ' HA ' ' A' ' 47' ' ' PHE . 47.3 mt -70.43 -40.91 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 123.405 0.682 . . . . 70.53 109.794 173.235 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.413 ' HB3' ' HD1' ' A' ' 88' ' ' PHE . 3.2 m-20 -74.25 -20.15 60.26 Favored 'General case' 0 C--O 1.21 -0.99 0 C-N-CA 123.747 0.819 . . . . 73.43 110.934 176.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -74.92 -48.59 23.82 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.682 1.193 . . . . 63.42 109.564 174.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.25 -47.18 87.22 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 113.674 -1.603 . . . . 65.45 110.691 177.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 45.4 t80 -73.92 -23.6 59.56 Favored 'General case' 0 C--O 1.216 -0.661 0 CA-C-N 114.9 -1.045 . . . . 72.32 110.249 176.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.437 ' HA ' ' CD2' ' A' ' 88' ' ' PHE . . . -56.35 -50.82 70.4 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 118.357 0.526 . . . . 53.01 110.272 172.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.405 HG13 ' HZ ' ' A' ' 101' ' ' PHE . 38.3 t -64.46 -51.77 63.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 O-C-N 124.588 1.18 . . . . 74.52 110.409 177.488 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.599 ' HB3' HD13 ' A' ' 22' ' ' ILE . 45.1 mt -94.05 13.07 24.15 Favored 'General case' 0 CA--C 1.565 1.555 0 N-CA-C 113.095 0.776 . . . . 62.04 113.095 -166.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.1 t -66.77 -63.05 1.15 Allowed 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 123.668 0.787 . . . . 74.34 112.135 175.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.607 ' HB2' ' HD3' ' A' ' 62' ' ' LYS . 9.0 m-20 -100.64 145.53 30.49 Favored Pre-proline 0 N--CA 1.475 0.816 0 CA-C-O 118.478 -0.773 . . . . 74.34 110.046 -173.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.421 ' O ' ' HG2' ' A' ' 64' ' ' ARG . 19.8 Cg_endo -56.65 -32.25 89.96 Favored 'Trans proline' 0 C--N 1.384 2.404 0 C-N-CA 123.427 2.751 . . . . 72.41 113.294 -175.016 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -66.12 -47.67 73.37 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.707 0.803 . . . . 72.3 111.855 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.607 ' HD3' ' HB2' ' A' ' 59' ' ' ASP . 32.1 mtpt -74.59 -33.49 62.65 Favored 'General case' 0 C--O 1.252 1.209 0 C-N-CA 123.958 0.903 . . . . 74.54 110.641 -176.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 22.2 tpt85 -52.9 -51.39 61.35 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 113.922 -1.49 . . . . 74.11 108.827 167.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.421 ' HG2' ' O ' ' A' ' 60' ' ' PRO . 4.7 mmp_? -59.7 -38.97 83.07 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 123.802 0.689 . . . . 74.25 111.644 176.349 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.577 HG23 ' HD2' ' A' ' 76' ' ' PRO . 87.2 mt -54.96 -45.34 76.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 C-N-CA 122.681 0.392 . . . . 64.42 110.512 178.081 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.516 ' OH ' ' HA ' ' A' ' 6' ' ' ASP . 5.2 t80 -65.44 -49.22 69.96 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 120.77 -0.372 . . . . 75.4 110.813 175.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -57.8 -35.52 70.94 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.347 0.659 . . . . 64.04 112.062 -176.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 61.0 p -75.82 -32.27 59.76 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.044 0.538 . . . . 75.13 110.213 177.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -69.31 110.15 4.5 Favored 'General case' 0 C--N 1.359 0.992 0 N-CA-C 108.865 -0.791 . . . . 63.45 108.865 176.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 108.39 15.4 14.0 Favored Glycine 0 C--N 1.342 0.908 0 CA-C-N 115.905 -0.589 . . . . 52.54 112.151 -171.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 43.7 m -142.83 -57.17 0.43 Allowed 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 104.95 -2.241 . . . . 71.23 104.95 176.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.9 m -89.79 146.72 24.27 Favored 'General case' 0 C--O 1.25 1.121 0 N-CA-C 104.438 -2.43 . . . . 74.23 104.438 156.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.54 -35.56 19.45 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 109.981 -0.377 . . . . 74.04 109.981 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -84.02 131.05 52.47 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 123.85 0.86 . . . . 75.1 110.373 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -64.99 133.48 36.0 Favored 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 122.465 2.11 . . . . 75.41 110.717 173.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.577 ' HD2' HG23 ' A' ' 65' ' ' ILE . 58.7 Cg_exo -44.97 143.89 4.15 Favored 'Trans proline' 0 C--N 1.382 2.298 0 C-N-CA 124.211 3.274 . . . . 74.25 114.404 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -42.97 130.35 5.76 Favored 'Trans proline' 0 C--N 1.387 2.554 0 C-N-CA 124.115 3.21 . . . . 62.44 113.383 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -49.06 119.75 4.76 Favored 'Trans proline' 0 C--N 1.386 2.512 0 C-N-CA 123.378 2.719 . . . . 43.51 112.559 -177.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -51.91 164.15 1.17 Allowed 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 123.648 2.899 . . . . 71.05 113.785 177.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -53.18 88.29 0.03 OUTLIER 'Trans proline' 0 C--N 1.384 2.397 0 C-N-CA 123.379 2.719 . . . . 51.35 113.498 178.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 133.92 -33.53 2.52 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-N 114.541 -1.209 . . . . 62.41 110.33 177.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 139.67 -171.41 23.8 Favored Glycine 0 C--N 1.34 0.752 0 N-CA-C 109.835 -1.306 . . . . 53.03 109.835 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -67.48 105.4 1.82 Allowed 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.274 -1.01 . . . . 74.41 108.274 167.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.465 ' HB3' ' HD2' ' A' ' 62' ' ' LYS . 9.4 t70 -63.87 144.69 56.87 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 122.951 0.5 . . . . 71.31 112.186 -176.603 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.444 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 67.7 m-85 -139.37 71.11 1.37 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.917 0.887 . . . . 70.22 109.886 174.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.526 ' HA ' ' O ' ' A' ' 162' ' ' PRO . 51.0 m -59.99 85.36 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.244 0 CA-C-N 114.787 -1.097 . . . . 74.44 112.863 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 95.73 11.63 54.84 Favored Glycine 0 C--N 1.35 1.349 0 CA-C-N 115.646 -0.706 . . . . 70.11 113.972 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.444 ' HB2' ' HB3' ' A' ' 85' ' ' PHE . 26.7 m-85 -123.65 114.05 19.47 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 117.951 0.876 . . . . 72.34 110.575 -170.401 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -80.37 83.25 6.24 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-O 121.401 0.619 . . . . 71.44 110.504 -174.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.825 HG21 HD22 ' A' ' 105' ' ' LEU . 1.6 p -49.21 -42.21 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 N-CA-C 114.543 1.312 . . . . 75.21 114.543 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -66.07 -18.63 65.47 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 120.897 0.379 . . . . 75.33 111.01 -176.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -95.38 -7.24 39.05 Favored 'General case' 0 CA--C 1.559 1.298 0 C-N-CA 123.659 0.783 . . . . 45.35 111.167 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 21.6 m-30 -87.77 -172.46 3.87 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 123.491 0.716 . . . . 71.01 111.87 -177.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 86.1 p -74.78 166.68 23.22 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 113.349 0.87 . . . . 74.5 113.349 -169.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.03 -49.42 77.46 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 114.96 -1.018 . . . . 74.31 111.789 178.097 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -58.94 -40.0 83.3 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.597 0.759 . . . . 75.03 110.718 -175.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -62.63 -49.5 74.94 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.423 -1.262 . . . . 63.23 110.195 176.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.538 ' HA ' HD11 ' A' ' 105' ' ' LEU . 46.3 mt-30 -77.86 -4.37 46.34 Favored 'General case' 0 CA--C 1.552 1.038 0 CA-C-N 115.482 -0.781 . . . . 73.05 112.735 -178.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -92.54 -50.24 5.71 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.628 0.771 . . . . 70.02 109.918 172.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 26.0 tp -58.94 -54.85 42.47 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.1 0.96 . . . . 55.03 110.581 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.405 ' HZ ' HG13 ' A' ' 56' ' ' VAL . 88.5 m-85 -87.48 -1.54 58.0 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 115.801 -0.636 . . . . 72.11 111.098 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -41.28 -58.37 2.87 Favored Glycine 0 N--CA 1.482 1.74 0 N-CA-C 115.879 1.112 . . . . 72.43 115.879 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -50.35 -20.15 5.49 Favored 'Trans proline' 0 C--N 1.385 2.467 0 C-N-CA 124.318 3.346 . . . . 23.1 115.216 -177.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -141.59 31.89 2.09 Favored Glycine 0 C--N 1.355 1.632 0 CA-C-O 119.239 -0.756 . . . . 44.4 113.901 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.825 HD22 HG21 ' A' ' 90' ' ' VAL . 39.8 mt -66.68 78.19 0.11 Allowed 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 117.746 0.773 . . . . 74.25 112.028 171.445 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.438 ' HB2' ' HA ' ' A' ' 169' ' ' ASN . 24.5 m-85 36.5 -108.68 0.05 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.202 1.401 . . . . 72.25 114.78 177.182 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 59.77 16.12 37.06 Favored Glycine 0 C--N 1.36 1.916 0 N-CA-C 111.256 -0.738 . . . . 44.0 111.256 -160.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.36 1.887 0 O-C-N 124.321 0.66 . . . . 71.34 112.612 -164.876 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 43.4 tttp . . . . . 0 N--CA 1.494 1.746 0 N-CA-C 113.01 0.745 . . . . 72.15 113.01 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -85.34 -177.76 50.65 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-N 115.566 -0.743 . . . . 55.22 113.725 178.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.56 ' H ' ' HA3' ' A' ' 166' ' ' GLY . 22.1 ttm180 -94.19 164.52 13.02 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.186 1.394 . . . . 71.34 110.362 176.287 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.421 ' N ' ' HG2' ' A' ' 117' ' ' ARG . 7.9 p-10 -82.95 124.8 30.72 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 108.221 -1.029 . . . . 74.23 108.221 164.448 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 10.5 tt -122.75 121.31 36.02 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.42 -1.326 . . . . 70.23 107.42 -172.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.543 ' HA ' ' HB2' ' A' ' 175' ' ' LEU . 3.7 tmt_? -92.21 110.62 22.01 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 109.001 -0.74 . . . . 74.51 109.001 -177.26 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -111.21 171.93 7.18 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.265 1.026 . . . . 41.51 109.564 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.463 ' HA ' ' O ' ' A' ' 177' ' ' VAL . 68.0 mt-10 -121.75 125.84 47.51 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 109.0 -0.741 . . . . 61.0 109.0 -177.332 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 46.2 tp -98.79 100.91 10.58 Favored Pre-proline 0 N--CA 1.471 0.614 0 N-CA-C 107.307 -1.368 . . . . 54.05 107.307 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.598 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 55.4 Cg_endo -71.37 113.45 3.62 Favored 'Trans proline' 0 C--N 1.373 1.839 0 N-CA-C 108.587 -1.351 . . . . 75.33 108.587 176.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.494 ' HB3' HD23 ' A' ' 180' ' ' LEU . 47.1 tp -122.85 134.57 54.39 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 119.021 0.828 . . . . 64.01 111.067 -171.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.542 ' HA ' HD12 ' A' ' 181' ' ' LEU . 22.8 m -64.81 134.67 54.59 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 114.275 -1.329 . . . . 71.34 110.333 176.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 47.3 mt -59.55 -38.46 81.13 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 122.927 0.491 . . . . 70.54 111.524 -174.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -59.17 -42.56 91.05 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.385 0.674 . . . . 75.32 109.558 177.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.576 ' HG2' ' HB3' ' B' ' 4' ' ' SER . 50.0 mm-40 -65.78 -37.36 86.1 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.926 0.89 . . . . 64.33 111.768 173.358 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -66.07 -30.22 70.7 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 121.088 0.47 . . . . 41.43 110.838 -177.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -78.58 -59.78 2.64 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 115.016 -0.993 . . . . 74.51 110.551 177.124 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 44.7 m80 -75.87 -44.55 40.12 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.33 0.652 . . . . 75.25 112.323 -167.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.423 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 85.7 -170.05 43.55 Favored Glycine 0 N--CA 1.477 1.377 0 N-CA-C 114.117 0.407 . . . . 71.54 114.117 176.175 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 108.16 -166.68 13.06 Favored Glycine 0 C--N 1.353 1.51 0 C-N-CA 123.077 0.37 . . . . 70.42 113.019 177.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -70.7 105.83 3.32 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 122.957 0.503 . . . . 73.14 110.598 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 3.1 tpp180 -94.26 120.12 34.04 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 109.124 -0.695 . . . . 74.4 109.124 171.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 58.1 t -84.07 115.02 25.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 N-CA-C 107.889 -1.152 . . . . 71.24 107.889 173.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.443 HG13 HG13 ' A' ' 145' ' ' VAL . 2.7 p -129.44 129.92 67.19 Favored 'Isoleucine or valine' 0 C--O 1.246 0.916 0 C-N-CA 123.593 0.757 . . . . 73.14 109.754 -177.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -92.86 144.5 25.22 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.223 1.009 . . . . 71.3 110.189 -177.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.611 ' HB ' ' HB3' ' B' ' 8' ' ' LEU . 6.6 p -162.68 105.79 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 120.933 0.397 . . . . 75.1 111.07 174.114 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 57.84 34.23 24.13 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.092 0.957 . . . . 74.24 111.473 178.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 95.41 -19.68 53.1 Favored Glycine 0 C--N 1.35 1.311 0 CA-C-N 115.796 -0.638 . . . . 31.1 113.29 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 18.3 tpt85 -76.26 103.26 6.2 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.878 0.871 . . . . 72.12 110.503 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -87.87 97.22 10.81 Favored 'General case' 0 C--O 1.243 0.732 0 C-N-CA 123.873 0.869 . . . . 74.41 109.386 173.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.443 HG13 HG13 ' A' ' 138' ' ' VAL . 3.6 p -102.47 125.3 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-O 121.209 0.528 . . . . 73.53 110.14 177.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 34.6 t -91.48 83.97 5.48 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 108.189 -1.041 . . . . 31.45 108.189 174.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.7 p -92.5 123.56 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 115.703 -0.681 . . . . 73.42 109.705 -176.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 24.2 ttm180 -71.52 107.31 4.35 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.158 0.504 . . . . 74.14 110.037 174.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.423 HG13 ' HA2' ' A' ' 133' ' ' GLY . 20.2 pt -76.96 126.03 86.13 Favored Pre-proline 0 CA--C 1.555 1.172 0 CA-C-N 114.9 -1.045 . . . . 74.13 109.073 170.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -64.12 132.11 32.99 Favored 'Trans proline' 0 C--N 1.37 1.706 0 C-N-CA 122.493 2.128 . . . . 60.34 112.169 176.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -56.91 109.78 0.5 Allowed 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 122.888 2.392 . . . . 74.15 111.499 172.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.42 ' HA3' ' HD2' ' A' ' 241' ' ' PRO . . . 97.2 48.78 1.98 Allowed Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.844 -0.503 . . . . 75.51 111.844 -174.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 4.5 p -96.61 137.85 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.564 0.745 . . . . 75.43 109.507 177.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.414 ' HG2' ' HA ' ' A' ' 191' ' ' GLN . 0.0 OUTLIER -116.48 168.18 10.39 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.613 0.765 . . . . 73.23 111.519 -169.528 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.52 ' HB3' ' HA ' ' A' ' 189' ' ' GLU . 15.9 tp10 -56.61 129.91 42.98 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.594 0.758 . . . . 72.32 111.165 177.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 78.08 10.96 85.83 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-N 115.548 -0.751 . . . . 14.21 114.235 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 10.7 t -75.18 129.85 38.2 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 118.015 0.908 . . . . 74.23 108.665 175.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 21.7 t -108.61 114.78 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 123.199 0.6 . . . . 72.34 110.7 -167.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.553 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 48.4 mt -93.93 92.35 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 107.212 -1.403 . . . . 75.24 107.212 169.485 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 31.5 ttt180 -74.2 100.39 3.67 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 109.422 -0.584 . . . . 61.32 109.422 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.2 p -126.35 99.35 30.82 Favored Pre-proline 0 CA--C 1.557 1.239 0 C-N-CA 124.129 0.972 . . . . 61.33 110.427 -176.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.526 ' O ' ' HA ' ' A' ' 86' ' ' SER . 65.1 Cg_exo -50.56 158.02 3.04 Favored 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 123.062 2.508 . . . . 74.53 114.186 172.437 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 108.96 -26.82 14.26 Favored Glycine 0 N--CA 1.48 1.571 0 N-CA-C 113.872 0.309 . . . . 70.43 113.872 169.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.425 ' HB2' HD22 ' A' ' 174' ' ' LEU . 63.7 mtm -118.67 -0.04 11.39 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 122.608 0.363 . . . . 64.15 110.891 -177.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -88.17 -106.9 0.99 Allowed Glycine 0 C--N 1.351 1.379 0 N-CA-C 111.025 -0.83 . . . . 73.33 111.025 175.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.56 ' HA3' ' H ' ' A' ' 117' ' ' ARG . . . -69.1 117.73 8.18 Favored Glycine 0 C--O 1.251 1.196 0 N-CA-C 111.589 -0.604 . . . . 74.5 111.589 171.185 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -75.17 104.78 5.88 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 109.218 -0.66 . . . . 75.42 109.218 -175.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -169.92 158.21 30.18 Favored Glycine 0 C--N 1.339 0.725 0 N-CA-C 110.826 -0.91 . . . . 64.21 110.826 -176.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ASN . . . . . 0.527 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . 54.0 t30 -61.59 -62.82 5.15 Favored Pre-proline 0 N--CA 1.488 1.43 0 CA-C-O 117.438 -1.268 . . . . 63.11 110.619 -169.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.527 ' HD3' ' HB3' ' A' ' 169' ' ' ASN . 21.2 Cg_exo -63.1 109.32 0.92 Allowed 'Trans proline' 0 C--N 1.391 2.779 0 CA-C-N 122.487 1.924 . . . . 71.13 107.789 162.353 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -60.3 128.46 26.31 Favored 'Trans proline' 0 CA--C 1.55 1.301 0 C-N-CA 123.379 2.719 . . . . 71.25 113.622 -163.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -77.34 136.85 19.43 Favored Glycine 0 C--N 1.358 1.752 0 N-CA-C 111.377 -0.689 . . . . 72.4 111.377 175.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.497 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 15.1 m-20 -61.98 128.81 37.94 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.935 0.894 . . . . 71.14 112.034 -172.186 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.425 HD22 ' HB2' ' A' ' 164' ' ' MET . 49.6 tp -102.69 107.84 18.88 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.887 -0.783 . . . . 64.32 108.887 169.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.543 ' HB2' ' HA ' ' A' ' 120' ' ' ARG . 42.7 mt -79.3 94.21 5.43 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 108.663 -0.866 . . . . 72.12 108.663 176.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.553 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 91.8 mt -74.22 82.13 1.83 Allowed 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 109.468 -0.567 . . . . 70.05 109.468 175.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 122' ' ' GLU . 11.8 t -87.87 103.7 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 N-CA-C 107.261 -1.385 . . . . 61.43 107.261 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 8.1 p -73.91 119.15 20.57 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.219 0 N-CA-C 113.39 0.885 . . . . 70.33 113.39 -165.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.598 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 20.8 mmt180 -92.71 102.23 14.64 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.195 0.998 . . . . 53.32 109.437 170.336 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.494 HD23 ' HB3' ' A' ' 125' ' ' LEU . 96.0 mt -72.91 136.12 45.18 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 122.052 -0.405 . . . . 72.4 110.757 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.542 HD12 ' HA ' ' A' ' 126' ' ' THR . 85.5 mt -55.71 156.25 9.57 Favored Pre-proline 0 N--CA 1.484 1.247 0 C-N-CA 124.649 1.18 . . . . 73.14 112.507 -174.324 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -82.47 40.72 1.0 Allowed 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 122.943 2.429 . . . . 71.42 111.515 171.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' HIS . . . . . 0.427 ' HA ' ' HD3' ' A' ' 184' ' ' PRO . 51.9 t-80 -62.24 125.44 85.57 Favored Pre-proline 0 CA--C 1.551 0.997 0 N-CA-C 107.615 -1.254 . . . . 73.35 107.615 172.196 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 183' ' ' HIS . 23.5 Cg_exo -66.17 23.85 0.09 OUTLIER 'Trans proline' 0 N--CA 1.502 2.014 0 C-N-CA 124.239 3.292 . . . . 61.24 118.289 -162.177 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 58.9 t -106.3 -59.32 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 120.294 1.406 . . . . 64.21 109.809 177.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' PHE . . . . . 0.506 ' CE1' ' HB2' ' A' ' 195' ' ' ALA . 21.6 m-85 -127.14 125.6 41.47 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.92 -0.582 . . . . 72.31 111.061 -172.021 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.427 HH22 ' HG2' ' A' ' 155' ' ' GLU . 0.0 OUTLIER -102.31 71.56 1.24 Allowed 'General case' 0 C--O 1.237 0.399 0 N-CA-C 106.452 -1.684 . . . . 75.51 106.452 171.316 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.438 ' HB2' HD23 ' A' ' 193' ' ' LEU . 7.4 tp -64.27 132.95 51.75 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 113.348 -1.751 . . . . 74.21 110.516 -176.288 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' GLU . . . . . 0.52 ' HA ' ' HB3' ' A' ' 155' ' ' GLU . 11.9 tp10 -138.75 123.6 18.78 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.691 1.196 . . . . 70.31 109.643 -178.07 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 70.73 -75.04 0.58 Allowed Glycine 0 C--N 1.354 1.545 0 O-C-N 123.491 0.495 . . . . 65.41 113.694 175.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.414 ' HA ' ' HG2' ' A' ' 154' ' ' ARG . 2.9 pm0 -145.02 -14.29 0.53 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.669 1.188 . . . . 72.32 110.792 175.006 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.431 ' HB3' ' H ' ' A' ' 248' ' ' ASP . 2.6 p-10 -112.57 137.23 51.1 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.274 1.43 . . . . 72.32 112.708 -165.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.504 HD22 ' HB3' ' A' ' 186' ' ' PHE . 77.3 mt -88.84 159.85 17.51 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.836 1.254 . . . . 63.44 111.003 -173.475 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -130.78 101.59 5.72 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 108.256 -1.016 . . . . 73.14 108.256 169.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.506 ' HB2' ' CE1' ' A' ' 186' ' ' PHE . . . -104.75 148.14 26.93 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 108.806 -0.812 . . . . 74.34 108.806 175.163 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 26.1 m -86.87 141.45 28.77 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 109.601 -0.518 . . . . 70.21 109.601 175.035 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 56.4 tp -138.88 102.33 4.53 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.15 0.58 . . . . 72.21 109.548 -173.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -79.95 125.75 30.15 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 108.968 -0.753 . . . . 61.43 108.968 173.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.491 HG23 HG11 ' A' ' 210' ' ' VAL . 5.5 p -139.81 136.78 17.68 Favored Pre-proline 0 CA--C 1.55 0.956 0 C-N-CA 124.462 1.105 . . . . 64.4 108.626 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -77.58 155.32 31.57 Favored 'Trans proline' 0 C--N 1.368 1.595 0 C-N-CA 121.714 1.609 . . . . 64.51 112.483 173.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.417 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -58.1 -50.24 89.18 Favored Pre-proline 0 CA--C 1.552 1.038 0 N-CA-C 113.785 1.032 . . . . 71.34 113.785 -169.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.432 ' HG2' ' CE2' ' C' ' 276' ' ' TYR . 86.1 Cg_exo -55.02 -46.64 31.72 Favored 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 121.548 1.499 . . . . 63.54 113.426 176.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.438 HD11 ' HB3' ' C' ' 276' ' ' TYR . 40.5 mt -71.75 -24.03 22.83 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.28 0 C-N-CA 122.375 0.27 . . . . 64.32 110.492 -177.424 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -74.7 -47.03 33.81 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.121 0.569 . . . . 71.51 111.706 175.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 201' ' ' ALA . 90.3 t -70.91 -38.43 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 C-N-CA 123.736 0.814 . . . . 63.23 111.075 -176.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 55.3 t -89.76 -41.21 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 124.173 0.989 . . . . 74.41 111.782 -175.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 95.45 148.6 24.46 Favored Glycine 0 C--N 1.339 0.739 0 CA-C-N 115.581 -0.736 . . . . 72.35 111.339 -168.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 177.44 -142.67 5.82 Favored Glycine 0 C--N 1.333 0.399 0 N-CA-C 111.235 -0.746 . . . . 55.24 111.235 -177.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -125.76 123.41 38.76 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 117.277 0.538 . . . . 45.21 110.666 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.491 HG11 HG23 ' A' ' 199' ' ' VAL . 22.5 m -124.02 -171.47 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 125.425 1.49 . . . . 63.11 109.207 174.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -126.6 131.9 51.4 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.336 0.654 . . . . 71.41 111.525 178.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -114.02 166.31 11.74 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.395 1.078 . . . . 62.04 109.043 167.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 27.9 ttt -111.49 145.01 39.79 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 122.757 0.423 . . . . 71.23 110.486 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 17.4 p -114.05 -171.07 1.84 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.139 0.976 . . . . 74.1 108.868 171.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 83.5 mt -80.3 -5.24 55.97 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.93 0.715 . . . . 63.31 112.93 -175.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -139.91 9.74 2.38 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 112.848 0.685 . . . . 64.44 112.848 -177.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 154.07 175.83 25.75 Favored Glycine 0 N--CA 1.472 1.046 0 CA-C-O 119.382 -0.677 . . . . 33.0 112.413 177.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -81.65 175.79 9.12 Favored 'Trans proline' 0 C--N 1.362 1.288 0 C-N-CA 122.29 1.993 . . . . 70.23 112.559 178.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 3.2 m -148.77 132.78 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.096 1.358 . . . . 73.4 108.425 178.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -86.72 104.45 16.13 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.418 -0.956 . . . . 75.04 108.418 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 41.1 t -99.78 134.47 39.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 123.968 0.907 . . . . 74.13 110.721 -169.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -83.08 105.24 13.9 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 122.847 0.459 . . . . 60.25 109.815 174.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.433 HG11 HG22 ' A' ' 203' ' ' ILE . 11.5 p -79.23 139.97 56.56 Favored Pre-proline 0 CA--C 1.563 1.469 0 C-N-CA 124.35 1.06 . . . . 63.14 109.811 -178.202 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -82.04 178.68 6.18 Favored 'Trans proline' 0 C--N 1.384 2.426 0 C-N-CA 123.094 2.529 . . . . 75.51 111.806 -175.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -80.8 150.99 18.8 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 121.6 1.533 . . . . 72.53 112.387 171.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' ARG . . . . . 0.52 HH21 ' HB2' ' C' ' 261' ' ' LEU . 79.1 mtt85 67.01 25.15 9.34 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 125.159 1.383 . . . . 74.04 112.45 175.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.458 HG23 HD21 ' A' ' 233' ' ' LEU . 37.7 m -61.52 117.11 5.3 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 124.7 1.2 . . . . 64.32 110.466 175.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -110.33 139.7 45.27 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.978 0.911 . . . . 75.32 112.161 -167.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -64.57 133.79 53.05 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.459 1.104 . . . . 62.31 111.772 -177.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 230' ' ' GLY . . . . . 0.521 ' HA3' HH12 ' C' ' 254' ' ' ARG . . . 93.19 -24.63 24.13 Favored Glycine 0 C--N 1.341 0.836 0 CA-C-N 115.85 -0.614 . . . . 73.32 112.803 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 67.6 mtt180 -72.32 147.28 46.49 Favored 'General case' 0 C--N 1.347 0.478 0 CA-C-O 121.41 0.624 . . . . 74.0 109.744 171.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.766 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 2.9 mptp? -106.29 119.34 39.0 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.254 -1.387 . . . . 72.22 107.254 174.424 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.5 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 70.6 mt -74.38 100.21 3.73 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.32 -0.993 . . . . 71.4 108.32 -177.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 66.1 ttt180 -76.6 104.61 7.19 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 124.07 0.856 . . . . 64.14 110.564 -172.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.623 ' HB3' ' HG3' ' A' ' 238' ' ' LYS . 49.2 mt -103.11 96.56 6.87 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.542 0.737 . . . . 61.12 110.694 -178.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 23.8 mtpp -74.52 138.26 43.01 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 122.707 0.403 . . . . 64.43 111.231 -177.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 82.81 16.73 69.55 Favored Glycine 0 C--N 1.346 1.086 0 CA-C-N 115.603 -0.726 . . . . 74.2 112.876 -174.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.623 ' HG3' ' HB3' ' A' ' 235' ' ' LEU . 0.0 OUTLIER -121.05 -17.73 7.7 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.276 0.63 . . . . 73.01 112.572 -174.256 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -78.69 -167.42 32.2 Favored Glycine 0 C--N 1.339 0.722 0 N-CA-C 111.904 -0.478 . . . . 74.43 111.904 171.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -86.01 151.4 54.54 Favored Pre-proline 0 CA--C 1.557 1.239 0 CA-C-O 118.895 -0.574 . . . . 73.13 109.509 -172.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.42 ' HD2' ' HA3' ' A' ' 152' ' ' GLY . 29.7 Cg_exo -38.91 107.92 0.07 OUTLIER 'Trans proline' 0 C--N 1.389 2.673 0 C-N-CA 124.675 3.583 . . . . 73.33 115.52 -179.259 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -133.92 -158.15 8.5 Favored Glycine 0 C--N 1.35 1.354 0 CA-C-O 119.255 -0.747 . . . . 73.52 112.33 -176.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -59.8 -39.65 70.69 Favored 'Trans proline' 0 C--N 1.383 2.357 0 C-N-CA 123.695 2.93 . . . . 70.45 113.595 -174.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -89.25 21.62 3.19 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.417 0.687 . . . . 70.11 111.567 -176.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 97.29 -74.44 0.67 Allowed Glycine 0 C--N 1.346 1.121 0 N-CA-C 109.794 -1.322 . . . . 62.24 109.794 -173.035 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 17.1 mtp180 -122.55 157.91 31.04 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.124 0.97 . . . . 75.41 108.675 168.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -79.43 -158.54 14.52 Favored Glycine 0 C--N 1.344 0.995 0 O-C-N 123.315 0.384 . . . . 42.24 113.486 176.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 248' ' ' ASP . . . . . 0.431 ' H ' ' HB3' ' A' ' 192' ' ' ASP . 7.4 m-20 -104.44 172.32 6.86 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.142 0.577 . . . . 75.44 110.019 -177.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.577 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 32.5 tp -136.65 97.5 3.56 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 107.831 -1.174 . . . . 70.31 107.831 175.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.766 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 62.2 m-85 -79.45 108.57 13.07 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.266 1.026 . . . . 52.51 110.091 178.247 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.5 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 88.6 mt -93.42 108.31 20.0 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 122.91 0.484 . . . . 72.24 110.061 176.019 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 252' ' ' GLU . . . . . 0.538 ' HG2' ' HG3' ' A' ' 232' ' ' LYS . 35.5 mt-10 -77.67 102.64 7.17 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.531 1.132 . . . . 75.41 109.708 -172.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.417 HG12 HG13 ' A' ' 255' ' ' ILE . 42.9 t -67.93 126.07 26.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 115.008 -0.997 . . . . 24.43 111.619 -172.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -124.2 92.25 3.63 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 107.275 -1.38 . . . . 73.14 107.275 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.479 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 63.5 mt -82.79 127.69 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 122.815 0.446 . . . . 74.34 111.41 -173.336 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 69.1 p -111.07 154.68 23.89 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.291 1.036 . . . . 73.43 109.675 175.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 257' ' ' ILE . . . . . 0.488 HD12 ' H ' ' A' ' 259' ' ' GLU . 2.5 pp -103.06 150.08 37.5 Favored Pre-proline 0 CA--C 1.558 1.263 0 C-N-CA 123.069 0.548 . . . . 73.4 109.653 175.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -51.7 -21.98 12.33 Favored 'Trans proline' 0 N--CA 1.509 2.394 0 C-N-CA 124.519 3.48 . . . . 74.45 115.133 -170.124 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 259' ' ' GLU . . . . . 0.488 ' H ' HD12 ' A' ' 257' ' ' ILE . 29.3 mt-10 52.17 -78.46 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.991 1.317 . . . . 63.24 111.548 -167.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.9 132.19 46.88 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.566 0.746 . . . . 75.12 111.332 176.342 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.588 HD22 ' HB2' ' A' ' 265' ' ' GLU . 96.2 mt -143.44 150.54 39.17 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.312 1.045 . . . . 55.32 109.723 176.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 20.9 p -118.64 156.69 51.23 Favored Pre-proline 0 CA--C 1.555 1.167 0 CA-C-O 117.774 -1.108 . . . . 44.34 109.204 170.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -21.12 -50.2 0.03 OUTLIER 'Trans proline' 0 C--N 1.401 3.322 1 C-N-CA 126.871 5.047 . . . . 74.33 117.433 -172.137 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -56.56 -69.44 0.15 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.314 0.646 . . . . 71.44 111.289 178.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 265' ' ' GLU . . . . . 0.588 ' HB2' HD22 ' A' ' 261' ' ' LEU . 2.1 mp0 -71.32 -28.75 64.32 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.601 0.36 . . . . 64.2 110.062 -172.484 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 266' ' ' GLU . . . . . 0.403 ' HA ' HD13 ' A' ' 261' ' ' LEU . 18.8 tp10 -55.86 -60.97 2.7 Favored 'General case' 0 C--O 1.255 1.345 0 C-N-CA 124.22 1.008 . . . . 73.45 110.467 175.424 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -60.58 -38.01 83.22 Favored 'General case' 0 C--O 1.22 -0.472 0 CA-C-N 114.38 -1.282 . . . . 64.12 110.675 178.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 268' ' ' LEU . . . . . 0.483 HD21 ' HB2' ' C' ' 271' ' ' LYS . 11.8 tp -65.26 -40.1 93.52 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.106 0.962 . . . . 73.14 111.026 -174.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 44.4 m95 -69.41 -37.84 77.65 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.582 -0.736 . . . . 75.0 110.609 176.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 270' ' ' LYS . . . . . 0.666 ' HE2' ' HA ' ' C' ' 206' ' ' VAL . 1.1 mptm? -67.02 -39.47 87.05 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 123.473 0.483 . . . . 62.43 111.632 176.206 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -62.33 -48.83 78.07 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.089 0.556 . . . . 70.22 109.884 177.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 18.5 mt -54.36 -51.46 64.72 Favored 'General case' 0 C--O 1.203 -1.371 0 O-C-N 124.55 1.156 . . . . 63.4 110.446 173.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 273' ' ' ALA . . . . . 0.618 ' HA ' ' HB2' ' C' ' 202' ' ' PRO . . . -67.33 -39.95 85.89 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.697 0.999 . . . . 64.51 113.697 -168.285 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -86.86 -33.15 19.9 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.589 0.756 . . . . 74.35 110.996 -173.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -71.22 -33.21 69.69 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 109.916 -0.401 . . . . 71.44 109.916 169.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -67.35 -41.54 85.0 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.946 0.898 . . . . 75.02 109.453 174.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 277' ' ' TYR . . . . . 0.459 ' HE1' ' H ' ' C' ' 209' ' ' LYS . 25.2 t80 -62.62 -43.39 98.94 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 124.105 0.878 . . . . 70.12 108.783 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -66.55 -7.88 23.04 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-N 115.199 -0.909 . . . . 75.41 112.647 175.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 73.7 mmt-85 -127.79 13.95 6.91 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 123.885 0.874 . . . . 74.13 111.127 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.658 0 C-N-CA 122.847 0.459 . . . . 72.21 111.309 -173.864 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.0 ttt . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 109.577 -0.527 . . . . 71.44 109.577 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -101.06 -178.05 3.63 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.533 0.733 . . . . 54.1 111.038 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -59.85 103.17 0.19 Allowed 'General case' 0 C--N 1.354 0.777 0 C-N-CA 123.379 0.672 . . . . 74.04 109.375 176.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 4' ' ' SER . . . . . 0.576 ' HB3' ' HG2' ' A' ' 129' ' ' GLU . 50.5 m -83.5 27.25 0.61 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.443 1.097 . . . . 52.14 112.163 -173.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 6.4 m -123.06 145.95 48.1 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 109.011 -0.737 . . . . 70.11 109.011 177.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 29.4 pt -140.18 177.76 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 C-N-CA 123.356 0.662 . . . . 64.44 111.75 -158.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -147.03 127.28 13.86 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.847 0.859 . . . . 72.01 110.053 178.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 8' ' ' LEU . . . . . 0.611 ' HB3' ' HB ' ' A' ' 140' ' ' VAL . 19.3 tp -65.48 148.85 51.02 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.797 1.239 . . . . 75.22 112.196 -171.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.35 -49.56 33.27 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.522 0.729 . . . . 62.4 111.886 177.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 4.2 tt 60.48 102.6 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 124.594 1.158 . . . . 74.1 110.151 -173.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.413 ' HB2' ' O ' ' A' ' 120' ' ' ARG . 74.8 mt . . . . . 0 N--CA 1.481 1.086 0 CA-C-O 118.24 -0.886 . . . . 45.35 109.738 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.237 0 N-CA-C 109.263 -0.643 . . . . 61.34 109.263 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . 63.48 -74.98 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.909 1.284 . . . . 74.4 110.67 -164.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 16.8 tp -161.43 13.69 0.09 Allowed 'General case' 0 CA--C 1.56 1.365 0 N-CA-C 111.919 0.341 . . . . 62.04 111.919 -168.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 182' ' ' VAL . . . . . 0.664 ' HA ' ' HB2' ' C' ' 139' ' ' GLU . 12.4 p -117.7 150.09 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 CA-C-O 118.533 -0.746 . . . . 71.31 110.008 178.001 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -169.05 6.57 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 115.21 1.559 . . . . 65.24 115.21 -177.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 79.7 m80 76.4 161.49 0.23 Allowed 'General case' 0 N--CA 1.507 2.399 0 C-N-CA 124.548 1.139 . . . . 74.15 111.437 177.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 185' ' ' VAL . . . . . 0.584 HG23 ' HA ' ' C' ' 141' ' ' ALA . 92.7 t . . . . . 0 N--CA 1.479 0.995 0 C-N-CA 122.901 0.48 . . . . 71.33 111.407 -173.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 238' ' ' THR . . . . . 0.514 HG22 HG23 ' C' ' 219' ' ' VAL . 21.9 m . . . . . 0 N--CA 1.471 0.616 0 N-CA-C 110.132 -0.322 . . . . 71.31 110.132 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 239' ' ' ALA . . . . . 0.425 ' HA ' HG22 ' C' ' 219' ' ' VAL . . . -159.71 -82.8 0.04 OUTLIER 'General case' 0 C--O 1.24 0.593 0 O-C-N 123.837 0.711 . . . . 74.42 109.561 -178.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 240' ' ' GLY . . . . . 0.417 ' HA3' ' HA ' ' C' ' 235' ' ' LEU . . . 161.91 -108.67 0.36 Allowed Glycine 0 C--N 1.333 0.367 0 N-CA-C 109.678 -1.369 . . . . 71.23 109.678 -170.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -159.92 160.45 33.53 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.35 0.66 . . . . 71.21 111.125 178.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 26.7 m95 -123.77 -83.08 0.65 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.165 0.986 . . . . 70.32 108.715 168.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -154.49 -54.87 0.1 Allowed 'General case' 0 C--N 1.362 1.152 0 C-N-CA 125.985 1.714 . . . . 74.22 106.654 -168.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -147.34 -163.28 10.49 Favored Glycine 0 C--N 1.355 1.614 0 CA-C-N 113.843 -1.526 . . . . 63.11 110.628 173.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? . . . . . 0 N--CA 1.488 1.439 0 N-CA-C 108.89 -0.781 . . . . 75.34 108.89 175.878 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.976 0 N-CA-C 109.825 -0.435 . . . . 52.01 109.825 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 4' ' ' LYS . . . . . 0.468 ' HE2' ' HE2' ' C' ' 69' ' ' TYR . 38.7 ttmt -39.42 101.15 0.02 OUTLIER 'General case' 0 C--N 1.353 0.739 0 C-N-CA 125.421 1.488 . . . . 70.52 113.766 -177.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -66.32 95.62 0.31 Allowed 'General case' 0 C--O 1.244 0.807 0 N-CA-C 108.558 -0.905 . . . . 63.2 108.558 164.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -74.7 94.71 2.74 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 106.758 -1.571 . . . . 63.22 106.758 173.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 7' ' ' TYR . . . . . 0.426 ' HB3' ' HA ' ' C' ' 53' ' ' ALA . 50.1 m-85 -56.53 -35.74 68.42 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 114.766 -1.107 . . . . 73.43 111.551 -170.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 8' ' ' TYR . . . . . 0.422 ' HD1' HG23 ' C' ' 13' ' ' VAL . 65.4 m-85 -65.9 -42.65 89.95 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.411 -1.268 . . . . 72.53 111.801 175.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.42 -39.52 94.0 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 122.643 0.377 . . . . 52.31 110.848 177.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 59.2 mt -56.88 -43.14 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.446 0.698 . . . . 63.34 109.939 175.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 11' ' ' LEU . . . . . 0.543 ' HB3' ' HB1' ' C' ' 25' ' ' ALA . 96.2 mt -76.94 -15.15 59.75 Favored 'General case' 0 CA--C 1.556 1.195 0 CA-C-N 115.268 -0.878 . . . . 45.45 113.205 177.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.67 18.86 80.04 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 113.797 0.279 . . . . 64.33 113.797 -176.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 13' ' ' VAL . . . . . 0.422 HG22 ' HB2' ' C' ' 11' ' ' LEU . 30.1 m -111.73 155.03 43.75 Favored Pre-proline 0 N--CA 1.483 1.206 0 C-N-CA 124.442 1.097 . . . . 64.04 110.015 179.412 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -60.59 156.53 41.67 Favored 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 123.155 2.57 . . . . 74.43 113.729 177.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 33.4 mtp-105 -69.95 7.12 1.0 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 113.804 1.038 . . . . 71.52 113.804 -174.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -127.6 9.07 6.47 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.305 1.042 . . . . 71.24 109.302 -177.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.09 130.28 45.45 Favored 'General case' 0 C--N 1.356 0.883 0 C-N-CA 123.97 0.908 . . . . 71.14 110.951 -175.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 71.5 p -68.47 166.86 15.99 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.56 0.744 . . . . 74.41 110.713 -177.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 62.4 tp60 -57.75 -33.62 68.67 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.784 0.833 . . . . 74.45 111.908 -172.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -70.1 -40.53 74.9 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.038 0.535 . . . . 64.05 111.288 177.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -65.64 -39.9 91.92 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 122.757 0.423 . . . . 73.42 110.748 179.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 22' ' ' ILE . . . . . 0.572 HD13 ' HB3' ' C' ' 57' ' ' LEU . 86.1 mt -64.75 -42.57 95.34 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 C-N-CA 124.054 0.942 . . . . 61.32 110.372 176.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -61.99 -47.13 86.17 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.367 1.067 . . . . 74.13 111.326 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 78.7 mtm180 -71.24 -35.53 71.47 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 115.987 -0.551 . . . . 73.52 110.758 -178.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 25' ' ' ALA . . . . . 0.543 ' HB1' ' HB3' ' C' ' 11' ' ' LEU . . . -64.11 -40.39 96.09 Favored 'General case' 0 C--O 1.249 1.031 0 C-N-CA 123.11 0.564 . . . . 75.32 110.457 176.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 26' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -57.91 -60.25 4.0 Favored 'General case' 0 C--O 1.214 -0.778 0 CA-C-N 114.77 -1.105 . . . . 72.31 109.873 175.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -60.49 -41.32 94.01 Favored 'General case' 0 N--CA 1.483 1.183 0 O-C-N 124.068 0.855 . . . . 74.1 111.653 -174.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -53.07 -58.67 6.22 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.456 1.103 . . . . 71.15 110.922 176.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 97.1 mt -80.79 -11.09 59.66 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.521 -0.763 . . . . 60.22 111.06 -176.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -80.43 -26.23 38.54 Favored 'General case' 0 C--O 1.216 -0.684 0 C-N-CA 122.906 0.482 . . . . 75.32 109.731 171.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -81.2 -39.81 24.85 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.929 0.892 . . . . 73.5 110.404 175.082 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -70.16 -51.15 33.53 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.171 0.588 . . . . 71.12 109.789 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 33' ' ' TYR . . . . . 0.434 ' HB3' ' O ' ' C' ' 43' ' ' ALA . 35.6 m-85 -89.73 14.65 11.27 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 115.739 -0.664 . . . . 70.15 111.798 -176.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 34' ' ' HIS . . . . . 0.493 ' HD2' ' HB3' ' C' ' 36' ' ' ASP . 6.7 t60 -62.15 103.55 0.4 Allowed Pre-proline 0 N--CA 1.487 1.397 0 C-N-CA 123.947 0.899 . . . . 72.34 110.76 -174.392 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 35' ' ' PRO . . . . . 0.571 ' HB3' ' HG2' ' C' ' 44' ' ' GLU . 31.7 Cg_exo -59.55 -26.88 83.48 Favored 'Trans proline' 0 C--N 1.381 2.274 0 C-N-CA 123.285 2.656 . . . . 71.32 113.12 -171.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 36' ' ' ASP . . . . . 0.493 ' HB3' ' HD2' ' C' ' 34' ' ' HIS . 25.2 t70 -64.87 -39.0 92.86 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.25 1.02 . . . . 60.34 111.833 177.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 43.5 t -94.1 -54.34 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-O 121.277 0.56 . . . . 75.33 109.677 -177.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -100.04 92.21 5.14 Favored 'General case' 0 C--O 1.243 0.732 0 C-N-CA 124.558 1.143 . . . . 54.22 109.219 178.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -79.39 76.51 5.96 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 109.346 -0.613 . . . . 62.24 109.346 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 49.5 m -129.27 118.07 19.11 Favored Pre-proline 0 CA--C 1.538 0.491 0 CA-C-O 118.091 -0.957 . . . . 74.14 108.787 177.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -45.04 -45.26 14.47 Favored 'Trans proline' 0 C--N 1.382 2.335 0 C-N-CA 123.917 3.078 . . . . 63.44 113.679 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -60.08 -39.85 87.51 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.482 -0.781 . . . . 65.44 110.94 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 43' ' ' ALA . . . . . 0.434 ' O ' ' HB3' ' C' ' 33' ' ' TYR . . . -74.42 -19.79 60.28 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.885 -0.598 . . . . 62.05 111.447 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 44' ' ' GLU . . . . . 0.571 ' HG2' ' HB3' ' C' ' 35' ' ' PRO . 39.4 mt-10 -78.35 -45.57 22.21 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 109.547 -0.538 . . . . 74.04 109.547 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -68.7 -39.68 80.37 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.258 -0.883 . . . . 42.53 109.915 177.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 46' ' ' LYS . . . . . 0.56 ' O ' HG12 ' C' ' 50' ' ' ILE . 23.1 mmtm -61.7 -42.77 99.39 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.069 -0.514 . . . . 72.32 110.836 174.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -55.93 -43.13 77.09 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.551 0.74 . . . . 62.23 110.027 175.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 48' ' ' LYS . . . . . 0.404 ' HA ' ' HB2' ' C' ' 51' ' ' ASN . 97.1 mttt -72.59 -23.32 60.94 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-N 115.641 -0.709 . . . . 72.04 112.091 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -78.05 -25.61 47.85 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 118.139 0.427 . . . . 72.33 110.342 172.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 50' ' ' ILE . . . . . 0.56 HG12 ' O ' ' C' ' 46' ' ' LYS . 18.2 mm -75.35 -36.13 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 N-CA-C 108.287 -1.005 . . . . 75.43 108.287 172.116 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 51' ' ' ASN . . . . . 0.404 ' HB2' ' HA ' ' C' ' 48' ' ' LYS . 4.0 m-20 -68.27 -36.61 79.66 Favored 'General case' 0 C--O 1.2 -1.548 0 CA-C-N 114.883 -1.053 . . . . 74.04 110.018 173.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -65.52 -47.05 77.26 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.902 1.281 . . . . 63.42 109.986 178.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 53' ' ' ALA . . . . . 0.426 ' HA ' ' HB3' ' C' ' 7' ' ' TYR . . . -57.85 -61.41 2.55 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 113.998 -1.455 . . . . 63.1 111.01 178.331 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 54' ' ' TYR . . . . . 0.545 ' HD1' HG22 ' C' ' 22' ' ' ILE . 76.6 t80 -71.17 -12.87 61.72 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.745 -0.661 . . . . 75.01 111.533 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.64 -57.69 7.51 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 108.95 -0.759 . . . . 60.54 108.95 171.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 48.4 t -69.04 -22.69 26.41 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 CA-C-N 114.543 -1.208 . . . . 72.43 110.814 -178.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 57' ' ' LEU . . . . . 0.572 ' HB3' HD13 ' C' ' 22' ' ' ILE . 64.7 mt -109.13 9.2 26.2 Favored 'General case' 0 CA--C 1.564 1.484 0 N-CA-C 112.772 0.656 . . . . 75.02 112.772 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 46.6 t -51.69 -45.55 63.54 Favored 'General case' 0 N--CA 1.503 2.215 0 C-N-CA 124.66 1.184 . . . . 62.42 113.292 176.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 59' ' ' ASP . . . . . 0.429 ' HB2' ' HG3' ' C' ' 62' ' ' LYS . 2.0 m-20 -114.85 148.78 41.19 Favored Pre-proline 0 C--O 1.241 0.608 0 CA-C-N 115.492 -0.776 . . . . 72.03 109.145 177.343 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 60' ' ' PRO . . . . . 0.503 ' O ' ' HG2' ' C' ' 64' ' ' ARG . 69.0 Cg_exo -55.75 -30.6 76.76 Favored 'Trans proline' 0 C--N 1.374 1.921 0 C-N-CA 122.636 2.224 . . . . 33.23 111.984 167.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -64.41 -49.48 71.38 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.925 0.89 . . . . 62.13 111.054 175.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 62' ' ' LYS . . . . . 0.429 ' HG3' ' HB2' ' C' ' 59' ' ' ASP . 28.1 mtpp -66.7 -30.92 71.28 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-O 121.259 0.552 . . . . 75.23 110.07 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 23.0 tpt180 -60.65 -41.68 95.44 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 115.272 -0.876 . . . . 64.42 110.145 168.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 64' ' ' ARG . . . . . 0.503 ' HG2' ' O ' ' C' ' 60' ' ' PRO . 30.5 mmm180 -65.68 -27.09 68.1 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-O 119.305 -0.379 . . . . 74.15 111.525 176.136 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 1.7 mp -63.46 -45.08 98.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 109.581 -0.526 . . . . 62.34 109.581 168.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -58.46 -46.39 86.69 Favored 'General case' 0 CA--C 1.562 1.429 0 N-CA-C 109.312 -0.625 . . . . 74.22 109.312 174.029 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -61.85 -35.68 78.99 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 124.122 0.969 . . . . 73.14 112.009 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 40.7 p -73.99 -22.55 59.56 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 119.421 -0.323 . . . . 63.2 110.775 177.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 69' ' ' TYR . . . . . 0.468 ' HE2' ' HE2' ' C' ' 4' ' ' LYS . 79.9 t80 -76.11 108.05 8.76 Favored 'General case' 0 C--N 1.355 0.84 0 N-CA-C 107.648 -1.241 . . . . 75.22 107.648 168.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 102.64 27.71 6.63 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.202 -0.759 . . . . 62.51 111.202 -167.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 25.1 m -145.95 -57.64 0.31 Allowed 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 103.494 -2.78 . . . . 72.34 103.494 173.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 5.4 m -81.2 140.18 35.09 Favored 'General case' 0 C--O 1.254 1.32 0 N-CA-C 104.618 -2.364 . . . . 73.35 104.618 157.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.23 -32.63 15.69 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.647 0.779 . . . . 73.23 110.505 -178.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -92.98 159.06 36.47 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 124.056 0.942 . . . . 53.23 109.888 177.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -59.5 150.85 73.08 Favored 'Trans proline' 0 CA--C 1.56 1.786 0 C-N-CA 122.318 2.012 . . . . 75.14 112.141 168.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -68.0 164.16 32.96 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 122.729 2.286 . . . . 63.14 112.788 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -60.64 129.73 30.53 Favored 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 122.973 2.449 . . . . 51.51 111.97 173.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 78' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -59.61 115.17 2.42 Favored 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 123.158 2.572 . . . . 74.44 113.182 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 79' ' ' PRO . . . . . 0.404 ' HA ' ' HD3' ' C' ' 80' ' ' PRO . 38.9 Cg_endo -66.16 130.6 24.55 Favored 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 122.532 2.155 . . . . 61.04 111.332 175.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 80' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' C' ' 79' ' ' PRO . 24.8 Cg_exo -62.0 88.66 0.1 Allowed 'Trans proline' 0 C--N 1.379 2.179 0 C-N-CA 122.733 2.289 . . . . 51.5 111.754 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 155.77 -33.51 0.62 Allowed Glycine 0 N--CA 1.465 0.63 0 N-CA-C 110.238 -1.145 . . . . 75.2 110.238 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 126.96 157.7 9.58 Favored Glycine 0 C--N 1.352 1.47 0 CA-C-N 114.837 -0.682 . . . . 74.45 113.462 173.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -67.69 107.89 2.72 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 107.636 -1.246 . . . . 70.14 107.636 164.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -67.21 130.19 42.31 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.396 0.617 . . . . 63.13 111.719 -169.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 85' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -132.57 52.53 2.07 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.565 1.146 . . . . 74.41 108.122 174.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 50.9 m -64.01 96.38 0.14 Allowed 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 113.295 -1.775 . . . . 45.43 111.862 -174.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 114.95 -13.95 19.56 Favored Glycine 0 C--N 1.348 1.243 0 CA-C-N 115.658 -0.701 . . . . 74.33 113.105 176.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 88' ' ' PHE . . . . . 0.409 ' HB3' ' HZ ' ' C' ' 93' ' ' PHE . 38.8 m-85 -112.3 144.01 42.44 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 117.392 0.596 . . . . 74.44 110.376 -169.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 89' ' ' ASP . . . . . 0.548 ' HA ' ' HG2' ' C' ' 171' ' ' PRO . 46.0 t0 -77.11 74.46 3.69 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.861 0.839 . . . . 72.23 110.746 -175.537 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 90' ' ' VAL . . . . . 0.471 HG12 ' HG3' ' C' ' 171' ' ' PRO . 5.2 p -48.85 -47.46 16.23 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.003 0 C-N-CA 126.128 1.771 . . . . 54.41 113.063 -171.24 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -61.78 -27.2 68.58 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 112.836 0.68 . . . . 74.21 112.836 -173.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -83.74 -11.09 57.61 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 111.796 0.295 . . . . 75.53 111.796 -173.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 93' ' ' PHE . . . . . 0.409 ' HZ ' ' HB3' ' C' ' 88' ' ' PHE . 13.5 m-30 -74.6 171.29 14.12 Favored 'General case' 0 CA--C 1.557 1.233 0 CA-C-O 120.846 0.355 . . . . 72.45 111.581 -174.128 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 93.6 p -76.52 174.34 10.43 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 115.105 1.52 . . . . 45.51 115.105 -164.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -51.87 -47.93 64.29 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.34 1.456 . . . . 55.43 112.644 174.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -56.94 -45.67 82.6 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.547 0.739 . . . . 65.02 110.59 -177.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 97' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.33 -47.76 80.73 Favored 'General case' 0 CA--C 1.56 1.34 0 CA-C-N 114.359 -1.291 . . . . 64.25 110.208 172.492 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -66.79 -14.09 62.23 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.739 0.815 . . . . 51.52 112.29 -179.138 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -95.73 -39.2 9.99 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.085 0.554 . . . . 74.43 112.196 177.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 43.8 tp -83.13 -51.28 7.65 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-O 121.403 0.621 . . . . 73.23 110.929 -176.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -87.75 -18.79 28.63 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.001 0.921 . . . . 73.25 110.607 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -40.33 -56.24 2.89 Favored Glycine 0 C--N 1.358 1.781 0 CA-C-O 118.137 -1.369 . . . . 54.11 115.335 177.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 0.8 OUTLIER -28.9 -37.15 0.04 OUTLIER 'Trans proline' 0 C--N 1.389 2.695 1 C-N-CA 125.831 4.354 . . . . 62.02 116.663 174.281 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -149.44 47.3 0.63 Allowed Glycine 0 C--N 1.345 1.056 0 C-N-CA 121.266 -0.492 . . . . 43.23 112.621 -179.093 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 105' ' ' LEU . . . . . 0.543 ' HB3' HD22 ' C' ' 169' ' ' ASN . 37.1 mt . . . . . 0 N--CA 1.48 1.042 0 CA-C-O 121.266 0.555 . . . . 73.03 111.606 170.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 CA-C-O 121.297 0.387 . . . . 45.25 113.829 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -88.5 163.54 15.87 Favored 'General case' 0 C--O 1.244 0.769 0 C-N-CA 124.733 1.213 . . . . 64.44 110.694 178.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -68.87 144.63 54.18 Favored 'General case' 0 C--O 1.245 0.849 0 N-CA-C 108.47 -0.937 . . . . 75.42 108.47 168.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 119' ' ' LEU . . . . . 0.468 HD21 HG23 ' C' ' 140' ' ' VAL . 0.0 OUTLIER -133.53 152.72 51.95 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 121.266 0.555 . . . . 75.21 110.625 175.97 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -105.49 113.52 27.15 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.046 -0.979 . . . . 72.31 108.714 -173.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 121' ' ' ALA . . . . . 0.685 ' HB1' ' HG3' ' C' ' 139' ' ' GLU . . . -111.79 116.84 31.36 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.485 -1.672 . . . . 63.21 106.485 172.255 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 122' ' ' GLU . . . . . 0.588 ' HB2' ' HB ' ' C' ' 177' ' ' VAL . 20.7 tt0 -114.5 138.09 51.03 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 122.638 0.375 . . . . 73.22 110.429 -171.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -142.14 133.38 13.07 Favored Pre-proline 0 CA--C 1.544 0.72 0 CA-C-N 115.403 -0.817 . . . . 73.3 111.164 -168.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.93 128.55 18.97 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.383 2.056 . . . . 72.51 110.624 164.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 125' ' ' LEU . . . . . 0.481 ' O ' ' HA ' ' C' ' 180' ' ' LEU . 14.0 tp -153.56 165.48 35.76 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 106.763 -1.569 . . . . 74.03 106.763 -174.353 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 126' ' ' THR . . . . . 0.422 ' H ' ' HB2' ' C' ' 129' ' ' GLU . 15.1 t -127.69 175.96 7.9 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 119.69 1.132 . . . . 61.53 110.278 173.428 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 127' ' ' LEU . . . . . 0.438 HD13 ' CD2' ' C' ' 186' ' ' PHE . 33.5 mt -58.89 -47.82 83.61 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.494 1.518 . . . . 62.25 110.876 -178.358 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 128' ' ' GLU . . . . . 0.497 ' HG3' ' HA ' ' C' ' 215' ' ' LEU . 11.4 mp0 -60.92 -36.73 80.07 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 114.904 -1.044 . . . . 75.24 110.281 177.232 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 129' ' ' GLU . . . . . 0.422 ' HB2' ' H ' ' C' ' 126' ' ' THR . 34.7 mm-40 -78.77 -22.67 46.04 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.548 0.739 . . . . 73.53 112.519 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 130' ' ' ALA . . . . . 0.424 ' HB2' HG22 ' C' ' 153' ' ' VAL . . . -74.39 -33.16 62.97 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 108.92 -0.77 . . . . 64.34 108.92 174.217 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 131' ' ' PHE . . . . . 0.42 ' HB3' ' O ' ' C' ' 128' ' ' GLU . 54.8 t80 -65.64 -48.62 71.54 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 113.922 -1.49 . . . . 75.55 110.07 169.057 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 132' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -73.69 -12.88 60.87 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.331 0.652 . . . . 60.22 112.013 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -37.42 -84.87 0.01 OUTLIER Glycine 0 C--N 1.365 2.176 0 O-C-N 124.649 1.218 . . . . 65.31 114.606 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 134' ' ' GLY . . . . . 0.45 ' O ' ' HA ' ' C' ' 148' ' ' ARG . . . 49.36 -135.31 23.44 Favored Glycine 0 C--N 1.356 1.666 0 O-C-N 124.278 0.634 . . . . 53.24 114.237 174.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 135' ' ' GLU . . . . . 0.522 ' HG3' ' HB2' ' C' ' 148' ' ' ARG . 1.4 mp0 -89.92 91.96 8.81 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 108.044 -1.095 . . . . 71.2 108.044 177.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 136' ' ' ARG . . . . . . . . . . . . . 66.5 mtm180 -140.82 169.29 17.9 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 121.976 0.893 . . . . 72.12 110.751 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 137' ' ' VAL . . . . . 0.623 ' HB ' ' HG2' ' C' ' 144' ' ' ARG . 15.8 m -75.14 95.41 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 CA-C-N 113.769 -1.56 . . . . 71.12 111.122 -176.299 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 138' ' ' VAL . . . . . 0.471 HG12 ' HB ' ' C' ' 145' ' ' VAL . 2.9 p -79.7 161.24 4.12 Favored 'Isoleucine or valine' 0 C--O 1.251 1.132 0 CA-C-N 114.176 -1.375 . . . . 72.14 112.48 -172.309 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 139' ' ' GLU . . . . . 0.685 ' HG3' ' HB1' ' C' ' 121' ' ' ALA . 7.7 tp10 -82.5 136.57 34.85 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 113.636 -1.62 . . . . 74.31 111.686 175.1 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 140' ' ' VAL . . . . . 0.468 HG23 HD21 ' C' ' 119' ' ' LEU . 5.5 p -169.76 99.52 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 124.534 1.133 . . . . 63.22 108.821 163.43 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 141' ' ' ALA . . . . . 0.584 ' HA ' HG23 ' B' ' 185' ' ' VAL . . . 66.32 22.64 10.83 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.247 1.019 . . . . 15.23 111.921 -178.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 86.93 -14.17 57.52 Favored Glycine 0 C--N 1.346 1.09 0 CA-C-N 116.208 -0.451 . . . . 45.25 112.726 -174.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 143' ' ' ARG . . . . . 0.62 HH11 HG22 ' C' ' 145' ' ' VAL . 0.0 OUTLIER -74.82 120.94 21.04 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 108.588 -0.893 . . . . 73.04 108.588 -178.688 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 144' ' ' ARG . . . . . 0.623 ' HG2' ' HB ' ' C' ' 137' ' ' VAL . 51.2 ttp180 -87.7 92.36 9.08 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 125.451 1.501 . . . . 71.51 109.918 -169.303 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 145' ' ' VAL . . . . . 0.62 HG22 HH11 ' C' ' 143' ' ' ARG . 65.5 t -98.27 121.03 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 C-N-CA 122.679 0.391 . . . . 75.03 111.067 -174.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 19.8 m -75.02 101.73 4.59 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.165 0.586 . . . . 54.21 109.819 177.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 7.5 p -152.36 158.99 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 122.337 0.255 . . . . 72.53 110.739 -174.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 148' ' ' ARG . . . . . 0.522 ' HB2' ' HG3' ' C' ' 135' ' ' GLU . 42.7 ttm180 -91.44 123.68 35.04 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 109.412 -0.588 . . . . 74.22 109.412 170.361 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 149' ' ' ILE . . . . . . . . . . . . . 34.2 pt -105.03 151.42 39.47 Favored Pre-proline 0 CA--C 1.548 0.904 0 N-CA-C 107.297 -1.371 . . . . 71.41 107.297 163.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -47.95 115.5 1.51 Allowed 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.852 2.368 . . . . 61.44 112.484 175.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 151' ' ' PRO . . . . . 0.537 ' HG2' ' HA2' ' C' ' 242' ' ' GLY . 28.9 Cg_endo -61.87 109.06 0.72 Allowed 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 122.613 2.209 . . . . 73.2 111.155 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 152' ' ' GLY . . . . . . . . . . . . . . . 124.5 122.96 2.7 Favored Glycine 0 C--N 1.343 0.925 0 CA-C-N 115.376 -0.829 . . . . 54.32 113.739 -173.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 153' ' ' VAL . . . . . 0.694 HG21 HG21 ' C' ' 178' ' ' VAL . 5.7 m -141.78 176.04 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 C-N-CA 123.586 0.754 . . . . 71.13 110.658 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 154' ' ' ARG . . . . . 0.718 ' HB2' ' HB2' ' C' ' 157' ' ' SER . 15.6 mtp180 -125.85 169.13 12.95 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 124.378 1.071 . . . . 75.32 109.877 -178.488 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 155' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -69.81 126.54 30.01 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.744 0.418 . . . . 74.51 110.814 175.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 67.9 11.7 61.14 Favored Glycine 0 C--N 1.349 1.288 0 CA-C-N 115.719 -0.673 . . . . 64.51 113.559 -178.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 157' ' ' SER . . . . . 0.718 ' HB2' ' HB2' ' C' ' 154' ' ' ARG . 33.0 t -74.07 132.8 42.67 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.131 0.572 . . . . 75.43 110.523 -174.021 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 158' ' ' VAL . . . . . 0.54 ' HB ' HD22 ' C' ' 175' ' ' LEU . 16.1 m -86.08 95.94 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 CA-C-N 115.527 -0.761 . . . . 64.44 109.192 171.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 159' ' ' ILE . . . . . 0.775 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 8.3 mt -68.55 90.53 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 107.468 -1.308 . . . . 52.25 107.468 171.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -83.59 100.19 10.65 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.404 -0.591 . . . . 72.21 109.404 -176.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 161' ' ' VAL . . . . . 0.519 HG13 ' HB3' ' C' ' 174' ' ' LEU . 2.6 p -102.84 103.98 36.51 Favored Pre-proline 0 CA--C 1.561 1.391 0 N-CA-C 108.477 -0.935 . . . . 75.24 108.477 175.288 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -62.54 142.55 90.51 Favored 'Trans proline' 0 C--N 1.386 2.534 0 C-N-CA 123.633 2.889 . . . . 63.42 113.805 -175.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 86.15 -24.98 7.32 Favored Glycine 0 C--N 1.347 1.188 0 CA-C-N 115.638 -0.71 . . . . 53.31 113.719 177.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 164' ' ' MET . . . . . . . . . . . . . 41.6 mtp -78.64 -6.47 55.77 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 113.403 0.89 . . . . 73.35 113.403 -174.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . -106.03 -151.5 19.43 Favored Glycine 0 C--N 1.334 0.465 0 N-CA-C 111.856 -0.497 . . . . 64.24 111.856 173.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . 109.27 73.36 0.77 Allowed Glycine 0 C--N 1.342 0.906 0 C-N-CA 121.562 -0.351 . . . . 75.44 112.392 -173.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 167' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -77.32 102.37 6.71 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 105.999 -1.852 . . . . 64.31 105.999 163.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . 115.51 153.1 10.21 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 108.109 -1.997 . . . . 13.44 108.109 -161.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 169' ' ' ASN . . . . . 0.543 HD22 ' HB3' ' C' ' 105' ' ' LEU . 25.0 t-20 -66.07 -66.66 1.22 Allowed Pre-proline 0 CA--C 1.583 2.245 0 CA-C-O 116.74 -1.6 . . . . 62.44 112.833 -168.391 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 170' ' ' PRO . . . . . 0.46 ' HD3' ' HB3' ' C' ' 169' ' ' ASN . 51.8 Cg_exo -51.08 111.94 0.67 Allowed 'Trans proline' 0 C--N 1.401 3.309 0 CA-C-N 123.076 2.134 . . . . 51.41 113.381 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 171' ' ' PRO . . . . . 0.548 ' HG2' ' HA ' ' C' ' 89' ' ' ASP . 71.6 Cg_exo -47.58 139.9 17.32 Favored 'Trans proline' 0 C--N 1.383 2.377 0 C-N-CA 124.465 3.443 . . . . 74.02 115.698 -164.112 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -108.69 -127.17 5.5 Favored Glycine 0 C--N 1.344 1.004 0 N-CA-C 111.329 -0.708 . . . . 74.42 111.329 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 173' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -151.88 156.47 40.19 Favored 'General case' 0 C--O 1.249 1.077 0 CA-C-O 121.606 0.717 . . . . 74.51 110.423 173.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 174' ' ' LEU . . . . . 0.519 ' HB3' HG13 ' C' ' 161' ' ' VAL . 39.4 tp -104.32 123.48 47.47 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.488 -0.778 . . . . 75.22 110.367 -177.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 175' ' ' LEU . . . . . 0.54 HD22 ' HB ' ' C' ' 158' ' ' VAL . 92.8 mt -101.95 94.87 6.01 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.619 1.167 . . . . 71.32 108.159 173.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 176' ' ' LEU . . . . . 0.775 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 44.2 mt -78.78 101.47 7.62 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.472 -0.566 . . . . 43.02 109.472 174.3 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 177' ' ' VAL . . . . . 0.588 ' HB ' ' HB2' ' C' ' 122' ' ' GLU . 39.5 t -84.32 94.13 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 107.172 -1.418 . . . . 74.43 107.172 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 178' ' ' VAL . . . . . 0.694 HG21 HG21 ' C' ' 153' ' ' VAL . 2.7 p -82.02 125.3 39.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.623 0.725 . . . . 74.01 110.68 -178.566 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 179' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -104.81 106.73 17.35 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 114.772 -1.104 . . . . 72.33 108.101 175.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 180' ' ' LEU . . . . . 0.481 ' HA ' ' O ' ' C' ' 125' ' ' LEU . 97.3 mt -70.37 148.93 47.85 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 123.677 0.611 . . . . 70.51 110.505 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 181' ' ' LEU . . . . . 0.416 HD12 ' HB ' ' C' ' 126' ' ' THR . 80.2 mt -72.62 166.58 41.12 Favored Pre-proline 0 N--CA 1.483 1.216 0 C-N-CA 123.443 0.697 . . . . 74.2 110.418 -174.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -55.57 78.74 0.03 OUTLIER 'Trans proline' 0 C--N 1.384 2.426 0 C-N-CA 122.837 2.358 . . . . 64.12 111.867 166.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 183' ' ' HIS . . . . . . . . . . . . . 76.3 t60 -173.11 57.21 0.21 Allowed Pre-proline 0 CA--C 1.559 1.297 0 CA-C-N 113.459 -1.7 . . . . 62.13 107.039 -171.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 184' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -86.16 66.73 5.12 Favored 'Trans proline' 0 C--N 1.385 2.454 0 C-N-CA 123.176 2.584 . . . . 71.54 111.323 -174.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 185' ' ' VAL . . . . . 0.514 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 21.2 t -92.66 -43.17 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 108.595 -0.891 . . . . 72.23 108.595 -173.049 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 186' ' ' PHE . . . . . 0.608 ' HB3' HD22 ' C' ' 193' ' ' LEU . 56.0 m-85 -119.75 119.85 34.83 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.307 0.643 . . . . 61.44 111.738 -171.258 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 187' ' ' ARG . . . . . 0.406 ' HB3' ' HB3' ' C' ' 194' ' ' TYR . 2.2 tmt_? -96.58 109.7 22.25 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 107.03 -1.47 . . . . 75.14 107.03 171.166 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 188' ' ' LEU . . . . . 0.614 HD13 ' HD2' ' C' ' 240' ' ' PHE . 67.2 tp -82.21 151.25 26.96 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.654 0.74 . . . . 74.14 112.502 -177.06 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -142.02 101.92 4.03 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.252 1.421 . . . . 71.33 107.298 164.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 68.28 -89.53 0.21 Allowed Glycine 0 C--N 1.35 1.354 0 O-C-N 123.205 0.316 . . . . 74.2 113.188 -177.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 191' ' ' GLN . . . . . 0.45 HE21 ' H ' ' C' ' 242' ' ' GLY . 28.4 mt-30 -119.88 -22.91 6.59 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.61 1.164 . . . . 60.21 110.789 175.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -86.45 129.0 35.01 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.574 0.749 . . . . 65.13 110.934 -173.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 193' ' ' LEU . . . . . 0.608 HD22 ' HB3' ' C' ' 186' ' ' PHE . 62.6 mt -93.72 166.71 12.08 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.913 0.485 . . . . 52.2 111.106 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 194' ' ' TYR . . . . . 0.515 ' HA ' ' O ' ' C' ' 250' ' ' TYR . 4.1 t80 -137.82 103.65 5.06 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 109.049 -0.723 . . . . 75.43 109.049 169.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 195' ' ' ALA . . . . . 0.524 ' HB3' ' HG ' ' C' ' 251' ' ' LEU . . . -101.77 -177.38 3.41 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 124.032 0.933 . . . . 65.11 110.093 176.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 56.3 m -132.56 130.17 39.96 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 108.113 -1.069 . . . . 51.32 108.113 168.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 197' ' ' LEU . . . . . . . . . . . . . 51.7 tp -106.54 135.24 48.39 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 123.769 0.828 . . . . 73.5 110.699 -171.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -78.98 101.7 7.92 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.395 0.678 . . . . 44.52 109.619 173.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 199' ' ' VAL . . . . . . . . . . . . . 40.8 t -119.11 109.94 38.54 Favored Pre-proline 0 N--CA 1.473 0.68 0 N-CA-C 108.052 -1.092 . . . . 61.21 108.052 175.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 200' ' ' PRO . . . . . 0.519 ' HG2' HD12 ' C' ' 203' ' ' ILE . 25.6 Cg_exo -60.7 147.2 95.65 Favored 'Trans proline' 0 C--N 1.363 1.325 0 C-N-CA 122.188 1.925 . . . . 71.34 111.546 175.206 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 201' ' ' ALA . . . . . . . . . . . . . . . -50.46 -48.39 81.6 Favored Pre-proline 0 CA--C 1.561 1.384 0 O-C-N 123.885 0.74 . . . . 74.35 112.6 176.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 202' ' ' PRO . . . . . 0.618 ' HB2' ' HA ' ' A' ' 273' ' ' ALA . 20.3 Cg_endo -58.34 -49.81 11.33 Favored 'Trans proline' 0 C--N 1.387 2.584 0 C-N-CA 121.572 1.515 . . . . 63.15 113.161 174.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 203' ' ' ILE . . . . . 0.519 HD12 ' HG2' ' C' ' 200' ' ' PRO . 37.6 mt -63.84 -29.32 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 C-N-CA 122.933 0.493 . . . . 63.4 111.22 -178.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.43 -46.02 67.76 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.166 0.986 . . . . 75.02 111.531 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 205' ' ' VAL . . . . . . . . . . . . . 72.6 t -68.52 -40.42 81.99 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 CA-C-N 115.466 -0.788 . . . . 63.41 111.617 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 206' ' ' VAL . . . . . 0.666 ' HA ' ' HE2' ' A' ' 270' ' ' LYS . 14.3 p -80.13 -38.25 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 112.787 0.662 . . . . 52.12 112.787 -173.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 85.05 71.56 1.31 Allowed Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 116.054 -0.521 . . . . 63.21 112.091 -167.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -98.62 -138.68 10.4 Favored Glycine 0 C--N 1.341 0.813 0 N-CA-C 111.294 -0.722 . . . . 51.32 111.294 176.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 209' ' ' LYS . . . . . 0.591 ' HG2' ' HA ' ' C' ' 222' ' ' ALA . 43.7 mtmt -139.7 146.3 39.45 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.451 0.7 . . . . 72.12 110.221 170.096 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 210' ' ' VAL . . . . . . . . . . . . . 19.9 m -138.15 137.17 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 107.923 -1.14 . . . . 62.05 107.923 173.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 211' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -75.7 127.79 33.8 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 120.685 0.278 . . . . 72.44 110.983 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -95.79 119.19 33.85 Favored 'General case' 0 C--O 1.245 0.854 0 N-CA-C 108.637 -0.875 . . . . 74.43 108.637 165.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 213' ' ' MET . . . . . . . . . . . . . 2.6 tmm? -72.08 121.69 19.66 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 107.583 -1.265 . . . . 63.12 107.583 176.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 214' ' ' THR . . . . . 0.504 ' OG1' HG12 ' C' ' 219' ' ' VAL . 0.2 OUTLIER -126.21 168.13 14.49 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 122.909 0.484 . . . . 54.24 110.568 -174.51 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 215' ' ' LEU . . . . . 0.497 ' HA ' ' HG3' ' C' ' 128' ' ' GLU . 17.0 mt -55.7 -45.27 77.9 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 125.398 1.479 . . . . 44.41 112.043 -176.291 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -78.64 -28.5 45.52 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 113.547 -1.66 . . . . 71.0 111.416 -176.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 154.98 -164.38 31.78 Favored Glycine 0 C--N 1.343 0.935 0 CA-C-O 119.575 -0.569 . . . . 64.11 112.018 -169.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -84.87 116.49 1.86 Allowed 'Trans proline' 0 CA--C 1.552 1.424 0 C-N-CA 122.691 2.261 . . . . 52.13 113.223 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 219' ' ' VAL . . . . . 0.514 HG23 HG22 ' B' ' 238' ' ' THR . 10.8 p -101.09 117.26 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 108.311 -0.996 . . . . 52.53 108.311 171.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 220' ' ' GLU . . . . . 0.446 ' HG2' ' HD2' ' C' ' 209' ' ' LYS . 27.4 tt0 -91.28 105.36 17.73 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 121.467 0.651 . . . . 72.32 109.986 -171.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 221' ' ' VAL . . . . . 0.413 HG11 HD21 ' C' ' 233' ' ' LEU . 64.4 t -70.23 119.92 17.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 114.846 -1.07 . . . . 74.03 112.019 -174.161 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 222' ' ' ALA . . . . . 0.591 ' HA ' ' HG2' ' C' ' 209' ' ' LYS . . . -76.76 99.13 5.01 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 124.149 0.906 . . . . 73.3 109.806 169.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 98.6 t -73.79 138.54 76.77 Favored Pre-proline 0 CA--C 1.555 1.161 0 C-N-CA 123.651 0.781 . . . . 73.11 109.126 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 224' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -92.35 172.86 2.32 Favored 'Trans proline' 0 C--N 1.368 1.605 0 C-N-CA 123.778 2.985 . . . . 54.33 111.787 174.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -72.85 154.24 53.52 Favored 'Trans proline' 0 C--N 1.371 1.714 0 C-N-CA 121.57 1.513 . . . . 74.0 110.837 174.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 226' ' ' ARG . . . . . 0.517 HH22 ' HB2' ' A' ' 261' ' ' LEU . 10.4 mpt_? 57.95 58.67 3.49 Favored 'General case' 0 N--CA 1.483 1.204 0 O-C-N 124.023 0.827 . . . . 70.15 111.651 177.413 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 227' ' ' THR . . . . . 0.615 HG22 HG11 ' C' ' 253' ' ' VAL . 90.0 m -97.28 112.23 24.13 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 122.29 -0.256 . . . . 70.3 110.625 178.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 228' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -89.03 163.41 15.53 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.941 0.897 . . . . 74.32 112.206 -178.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -70.36 115.02 9.06 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 113.516 -1.674 . . . . 62.12 109.58 175.082 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 102.26 8.65 43.67 Favored Glycine 0 C--N 1.336 0.546 0 O-C-N 123.562 0.539 . . . . 62.04 113.449 -178.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 231' ' ' ARG . . . . . 0.402 ' HD3' ' HA ' ' C' ' 227' ' ' THR . 41.4 mtp180 -67.89 169.87 9.11 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 117.502 0.651 . . . . 74.12 109.435 164.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 232' ' ' LYS . . . . . 0.451 ' HA ' ' O ' ' C' ' 251' ' ' LEU . 35.4 ttmt -142.06 142.96 32.88 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.794 0.807 . . . . 71.45 112.288 -173.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 233' ' ' LEU . . . . . 0.678 HD13 ' HB2' ' C' ' 251' ' ' LEU . 3.2 mp -106.72 154.45 20.95 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.766 1.626 . . . . 74.21 108.542 178.006 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 10.5 ptp85 -130.89 88.08 2.57 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 122.268 1.032 . . . . 72.34 108.77 165.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 235' ' ' LEU . . . . . 0.417 ' HA ' ' HA3' ' B' ' 240' ' ' GLY . 30.5 mt -77.59 118.07 19.64 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 114.874 -1.057 . . . . 73.43 109.624 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -81.03 124.71 29.4 Favored 'General case' 0 C--O 1.241 0.605 0 CA-C-N 115.081 -0.963 . . . . 71.55 111.547 -168.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 66.78 29.64 75.0 Favored Glycine 0 C--N 1.345 1.038 0 CA-C-N 115.219 -0.901 . . . . 71.42 112.442 -177.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 34.4 mmtm -118.24 4.42 11.93 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.722 0.809 . . . . 72.03 110.722 178.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 239' ' ' GLY . . . . . 0.466 ' HA2' HD12 ' C' ' 193' ' ' LEU . . . -88.67 -135.4 5.25 Favored Glycine 0 C--N 1.347 1.164 0 N-CA-C 110.625 -0.99 . . . . 31.21 110.625 170.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 240' ' ' PHE . . . . . 0.614 ' HD2' HD13 ' C' ' 188' ' ' LEU . 44.8 m-85 -101.57 108.01 53.8 Favored Pre-proline 0 C--O 1.25 1.093 0 CA-C-N 116.968 0.384 . . . . 75.14 110.092 171.068 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 241' ' ' PRO . . . . . 0.705 ' HA ' ' H ' ' C' ' 246' ' ' ARG . 40.5 Cg_endo -67.51 113.28 2.87 Favored 'Trans proline' 0 C--N 1.366 1.462 0 C-N-CA 122.027 1.818 . . . . 70.21 110.281 170.164 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 242' ' ' GLY . . . . . 0.537 ' HA2' ' HG2' ' C' ' 151' ' ' PRO . . . -90.45 -162.45 38.27 Favored Glycine 0 N--CA 1.483 1.773 0 CA-C-N 115.347 -0.842 . . . . 70.14 113.217 -169.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -58.95 -33.38 98.69 Favored 'Trans proline' 0 C--N 1.374 1.888 0 C-N-CA 122.677 2.251 . . . . 71.42 112.11 170.233 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -79.01 -24.43 43.7 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.127 0.571 . . . . 71.42 110.59 169.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 74.89 98.8 0.1 Allowed Glycine 0 C--N 1.343 0.959 0 CA-C-O 119.38 -0.678 . . . . 51.32 114.149 176.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 246' ' ' ARG . . . . . 0.705 ' H ' ' HA ' ' C' ' 241' ' ' PRO . 10.5 ptt180 -162.48 -72.81 0.05 OUTLIER 'General case' 0 CA--C 1.558 1.257 0 N-CA-C 114.187 1.18 . . . . 61.31 114.187 168.478 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 247' ' ' GLY . . . . . 0.591 ' H ' ' HG3' ' C' ' 246' ' ' ARG . . . 45.62 128.27 0.0 OUTLIER Glycine 0 C--N 1.358 1.758 0 N-CA-C 117.449 1.74 . . . . 63.23 117.449 -159.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -125.95 119.29 27.35 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 108.308 -0.997 . . . . 73.54 108.308 175.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 249' ' ' LEU . . . . . 0.439 ' HG ' HD11 ' C' ' 251' ' ' LEU . 15.4 tp -86.78 118.49 26.22 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.039 -0.982 . . . . 74.23 109.726 -173.218 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 250' ' ' TYR . . . . . 0.592 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 20.4 m-85 -98.46 119.88 37.93 Favored 'General case' 0 C--O 1.211 -0.948 0 N-CA-C 108.138 -1.06 . . . . 71.43 108.138 175.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 251' ' ' LEU . . . . . 0.678 ' HB2' HD13 ' C' ' 233' ' ' LEU . 2.6 mp -111.24 139.46 46.62 Favored 'General case' 0 N--CA 1.506 2.355 0 CA-C-N 118.706 0.684 . . . . 64.53 110.029 178.363 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -94.2 131.14 40.08 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.984 -0.747 . . . . 73.41 108.984 171.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 253' ' ' VAL . . . . . 0.615 HG11 HG22 ' C' ' 227' ' ' THR . 83.9 t -78.65 123.93 36.28 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 C-N-CA 123.619 0.768 . . . . 73.5 111.557 -175.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 254' ' ' ARG . . . . . 0.521 HH12 ' HA3' ' A' ' 230' ' ' GLY . 9.8 mmt85 -101.36 120.92 41.0 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 109.167 -0.679 . . . . 74.13 109.167 166.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 255' ' ' ILE . . . . . . . . . . . . . 36.0 mm -83.78 94.6 3.49 Favored 'Isoleucine or valine' 0 C--O 1.241 0.636 0 O-C-N 124.265 0.978 . . . . 75.24 108.801 170.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 256' ' ' THR . . . . . 0.519 ' O ' ' HA ' ' C' ' 200' ' ' PRO . 0.0 OUTLIER -97.45 144.11 27.5 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 114.883 -1.053 . . . . 53.32 109.731 -179.799 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 2.8 pp -98.79 153.16 38.0 Favored Pre-proline 0 CA--C 1.558 1.267 0 C-N-CA 122.742 0.417 . . . . 64.54 111.227 -177.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -41.7 -24.34 0.26 Allowed 'Trans proline' 0 C--N 1.389 2.672 1 C-N-CA 125.369 4.046 . . . . 73.21 118.333 -170.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 59.88 -73.33 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 124.477 1.111 . . . . 72.3 111.08 -165.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.06 159.14 31.43 Favored 'General case' 0 C--N 1.352 0.674 0 N-CA-C 109.026 -0.731 . . . . 73.41 109.026 171.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 261' ' ' LEU . . . . . 0.52 ' HB2' HH21 ' A' ' 226' ' ' ARG . 75.7 mt -145.12 170.9 15.33 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.045 -1.095 . . . . 71.21 108.045 165.354 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 262' ' ' THR . . . . . 0.44 ' H ' ' HB2' ' C' ' 265' ' ' GLU . 45.1 p -122.09 159.96 49.52 Favored Pre-proline 0 CA--C 1.547 0.844 0 N-CA-C 107.587 -1.264 . . . . 61.23 107.587 164.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -38.82 -47.65 2.74 Favored 'Trans proline' 0 C--N 1.387 2.554 0 C-N-CA 123.535 2.823 . . . . 74.2 113.982 175.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -68.82 -53.26 22.54 Favored 'General case' 0 C--N 1.351 0.639 0 CA-C-N 115.886 -0.597 . . . . 71.04 111.344 -178.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 265' ' ' GLU . . . . . 0.44 ' HB2' ' H ' ' C' ' 262' ' ' THR . 47.0 mt-10 -48.24 -56.86 6.91 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 123.806 0.691 . . . . 65.11 109.474 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 266' ' ' GLU . . . . . 0.521 ' O ' ' HG2' ' C' ' 270' ' ' LYS . 33.9 tt0 -57.23 -41.53 79.71 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 114.908 -1.042 . . . . 64.21 111.364 -177.333 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -61.69 -41.81 98.09 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 123.424 0.69 . . . . 70.32 112.784 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 268' ' ' LEU . . . . . 0.418 ' HG ' HD11 ' A' ' 268' ' ' LEU . 10.8 mp -67.14 -40.31 86.71 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.783 0.433 . . . . 52.44 110.177 177.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -59.03 -36.51 75.11 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 116.353 -0.385 . . . . 61.11 110.761 172.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 270' ' ' LYS . . . . . 0.521 ' HG2' ' O ' ' C' ' 266' ' ' GLU . 25.3 mmtp -60.74 -50.65 72.62 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 122.859 0.464 . . . . 75.43 110.276 177.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 271' ' ' LYS . . . . . 0.483 ' HB2' HD21 ' A' ' 268' ' ' LEU . 47.2 mtpt -53.68 -41.37 66.83 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 124.112 0.883 . . . . 75.33 111.326 177.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 95.5 mt -60.96 -45.54 94.32 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 123.799 0.687 . . . . 74.33 111.135 176.005 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -64.13 -31.01 72.04 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.153 0.581 . . . . 34.13 111.98 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 274' ' ' GLU . . . . . 0.487 ' HG3' ' O ' ' C' ' 270' ' ' LYS . 30.7 mt-10 -77.66 -34.51 53.04 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.143 0.577 . . . . 63.21 110.402 177.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -67.06 -24.23 65.95 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 115.824 -0.625 . . . . 70.04 110.48 171.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 276' ' ' TYR . . . . . 0.444 ' HD1' HH11 ' C' ' 279' ' ' ARG . 4.1 m-85 -80.51 -35.87 34.0 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.281 -0.872 . . . . 75.52 112.077 175.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -66.98 -28.35 68.19 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 109.491 -0.559 . . . . 44.24 109.491 169.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -72.19 3.3 4.7 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 123.8 0.84 . . . . 55.2 112.878 173.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 279' ' ' ARG . . . . . 0.444 HH11 ' HD1' ' C' ' 276' ' ' TYR . 71.9 mtp180 -74.51 -18.85 60.55 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 118.15 0.432 . . . . 71.52 110.4 168.259 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.558 1.269 0 N-CA-C 109.602 -0.518 . . . . 75.14 109.602 175.826 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.416 ' HA ' ' CG ' ' A' ' 96' ' ' PHE . 37.1 ttpt . . . . . 0 N--CA 1.476 0.827 0 N-CA-C 115.37 1.618 . . . . 62.43 115.37 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.448 ' HD2' HD11 ' A' ' 10' ' ' ILE . 27.7 mmtp -72.26 105.2 3.95 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 108.84 -0.8 . . . . 74.32 108.84 164.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -72.99 96.06 2.09 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 105.905 -1.887 . . . . 61.41 105.905 165.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.433 ' HB2' HD11 ' A' ' 57' ' ' LEU . 67.6 m-85 -61.87 -31.18 71.43 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-N 114.96 -1.018 . . . . 73.34 111.503 -170.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -67.41 -40.23 85.57 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.408 -0.815 . . . . 73.33 109.884 176.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.85 -37.93 89.2 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 122.908 0.483 . . . . 60.32 110.921 177.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.448 HD11 ' HD2' ' A' ' 5' ' ' LYS . 65.3 mt -59.33 -41.46 84.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 123.1 0.56 . . . . 74.23 110.267 173.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.6 mt -80.49 -8.54 59.6 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 115.756 -0.656 . . . . 51.33 112.606 176.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 70.01 18.23 74.37 Favored Glycine 0 C--N 1.353 1.484 0 N-CA-C 114.239 0.455 . . . . 53.33 114.239 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.3 m -103.14 163.3 17.78 Favored Pre-proline 0 N--CA 1.486 1.347 0 C-N-CA 124.374 1.07 . . . . 71.43 110.709 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -47.54 146.75 7.24 Favored 'Trans proline' 0 C--N 1.387 2.577 0 C-N-CA 123.6 2.867 . . . . 50.12 114.043 174.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -71.36 15.78 0.12 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 114.284 1.216 . . . . 75.43 114.284 -170.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -159.8 33.56 0.18 Allowed 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 108.625 -0.88 . . . . 64.11 108.625 173.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.34 149.58 50.16 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.436 1.094 . . . . 64.31 111.834 -177.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 76.1 p -77.8 170.76 16.03 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.516 0.726 . . . . 71.11 111.88 -174.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -55.95 -41.28 74.46 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.673 1.189 . . . . 64.21 112.559 -172.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.36 -32.2 66.25 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 122.629 0.372 . . . . 72.43 110.581 -177.448 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.455 ' HG2' ' NH2' ' A' ' 24' ' ' ARG . 40.1 mt-10 -65.96 -40.97 91.75 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 121.101 0.476 . . . . 64.03 109.771 175.214 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.419 HG12 ' HB3' ' A' ' 57' ' ' LEU . 1.6 mp -65.04 -38.57 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-N 114.763 -1.108 . . . . 73.31 110.416 176.055 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -75.55 -33.36 60.66 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.567 0.747 . . . . 71.24 111.307 -175.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.461 ' HA ' ' NZ ' ' A' ' 27' ' ' LYS . 85.3 mtm-85 -72.78 -43.64 62.55 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 122.693 0.397 . . . . 54.12 110.566 175.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.04 -31.07 70.48 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.797 -0.638 . . . . 64.0 111.146 177.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -62.55 -58.65 6.79 Favored 'General case' 0 C--O 1.213 -0.856 0 CA-C-O 118.61 -0.709 . . . . 73.1 109.381 173.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.461 ' NZ ' ' HA ' ' A' ' 24' ' ' ARG . 35.5 mtmm -53.97 -39.43 65.98 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 123.949 0.781 . . . . 74.22 111.241 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -54.38 -58.3 7.98 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.182 0.993 . . . . 71.15 110.966 177.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.44 ' HA ' ' HB3' ' A' ' 32' ' ' GLN . 75.4 mt -86.38 -8.99 57.23 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 115.074 -0.967 . . . . 74.11 111.635 -173.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.12 -21.62 25.88 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.686 0.794 . . . . 63.3 109.95 174.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -90.87 -31.76 16.3 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.483 0.713 . . . . 72.33 110.509 170.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.44 ' HB3' ' HA ' ' A' ' 29' ' ' LEU . 29.9 tt0 -73.36 -49.06 29.3 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.999 0.52 . . . . 63.33 111.326 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -98.15 23.78 7.86 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.077 0.551 . . . . 63.25 110.796 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 51.1 t60 -63.2 101.38 0.26 Allowed Pre-proline 0 CA--C 1.554 1.101 0 C-N-CA 124.968 1.307 . . . . 63.41 112.195 -170.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -73.79 -5.44 17.05 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 123.561 2.841 . . . . 74.13 112.552 -172.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -73.73 -27.29 61.11 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 124.571 1.148 . . . . 72.45 111.479 174.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 60.5 t -123.47 -46.71 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 CA-C-O 121.561 0.696 . . . . 65.53 109.716 178.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -98.62 80.96 2.62 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.703 1.201 . . . . 61.35 109.883 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.48 69.4 10.05 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 115.806 -0.633 . . . . 73.11 109.649 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 24.2 m -108.86 134.46 20.34 Favored Pre-proline 0 N--CA 1.479 0.988 0 CA-C-O 118.518 -0.753 . . . . 54.41 109.822 -179.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -48.07 -52.24 8.6 Favored 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 123.88 3.054 . . . . 72.23 113.419 -178.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.411 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 8.2 tp10 -62.42 -32.61 73.48 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 122.85 0.46 . . . . 64.43 110.873 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -82.15 -14.75 55.21 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.928 0.491 . . . . 72.14 110.435 -179.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.425 ' O ' ' HD3' ' A' ' 48' ' ' LYS . 49.0 mm-40 -68.67 -58.9 3.57 Favored 'General case' 0 C--N 1.358 0.94 0 N-CA-C 107.21 -1.404 . . . . 62.01 107.21 170.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -53.23 -47.01 69.35 Favored 'General case' 0 C--N 1.352 0.705 0 CA-C-N 113.842 -1.527 . . . . 62.44 110.396 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.517 ' O ' HG12 ' A' ' 50' ' ' ILE . 0.1 OUTLIER -71.02 -48.9 50.39 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 114.747 -1.115 . . . . 74.03 111.193 -172.385 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -53.45 -46.54 69.91 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 123.849 0.718 . . . . 73.24 110.508 177.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.425 ' HD3' ' O ' ' A' ' 44' ' ' GLU . 2.1 mtpm? -63.3 -36.37 83.46 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 115.37 -0.832 . . . . 75.14 111.525 178.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -69.99 -30.26 67.55 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 122.62 0.368 . . . . 71.44 111.274 173.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.517 HG12 ' O ' ' A' ' 46' ' ' LYS . 18.3 mm -68.95 -36.87 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 108.843 -0.799 . . . . 70.53 108.843 175.322 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.416 ' O ' ' HB2' ' A' ' 55' ' ' ALA . 11.5 m-80 -80.5 -20.09 44.41 Favored 'General case' 0 C--O 1.211 -0.955 0 CA-C-N 114.435 -1.257 . . . . 73.43 111.385 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -71.98 -50.38 29.28 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.328 1.051 . . . . 63.42 109.01 171.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.16 -50.78 71.77 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 113.494 -1.684 . . . . 65.45 111.076 176.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -64.51 -37.96 89.34 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-N 115.068 -0.969 . . . . 72.32 110.525 177.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.416 ' HB2' ' O ' ' A' ' 51' ' ' ASN . . . -54.23 -46.91 72.66 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.289 0.636 . . . . 53.01 112.169 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 67.9 t -72.94 -45.86 53.9 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.116 0 CA-C-N 115.955 -0.566 . . . . 74.52 110.996 177.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.433 HD11 ' HB2' ' A' ' 7' ' ' TYR . 64.2 mt -93.57 0.84 56.77 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 114.206 1.188 . . . . 62.04 114.206 -166.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.1 t -73.58 -52.79 12.25 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.464 0.649 . . . . 74.34 109.85 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -88.89 137.21 29.95 Favored Pre-proline 0 C--O 1.241 0.657 0 CA-C-N 114.737 -1.119 . . . . 74.34 109.745 -176.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.417 ' O ' ' HG2' ' A' ' 64' ' ' ARG . 48.0 Cg_exo -56.19 -26.9 63.14 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 123.346 2.697 . . . . 72.41 112.576 178.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -64.4 -59.88 3.83 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.814 0.846 . . . . 72.3 111.451 -176.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.402 ' HA ' HD12 ' A' ' 65' ' ' ILE . 42.0 mtmt -77.36 -23.62 50.82 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 115.842 -0.617 . . . . 74.54 111.275 -176.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 44.9 tpt85 -54.77 -54.64 39.49 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 108.919 -0.771 . . . . 74.11 108.919 166.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.473 ' HA ' ' HE ' ' A' ' 64' ' ' ARG . 2.2 mmp_? -63.27 -33.37 75.36 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.582 0.753 . . . . 74.25 112.168 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.702 HG23 ' HG3' ' A' ' 76' ' ' PRO . 89.2 mt -59.46 -45.59 93.54 Favored 'Isoleucine or valine' 0 C--O 1.253 1.24 0 C-N-CA 123.105 0.562 . . . . 64.42 110.783 174.094 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -66.74 -42.03 86.9 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 116.237 -0.438 . . . . 75.4 109.823 178.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -53.93 -45.82 71.32 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 123.161 0.585 . . . . 64.04 110.852 175.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 50.5 p -75.36 -19.3 59.66 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.224 -0.444 . . . . 75.13 112.013 -178.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -70.5 112.33 6.7 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 109.04 -0.726 . . . . 63.45 109.04 174.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 103.36 19.99 11.68 Favored Glycine 0 N--CA 1.474 1.171 0 N-CA-C 111.711 -0.556 . . . . 52.54 111.711 -172.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 97.6 m -142.05 -58.09 0.46 Allowed 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 103.623 -2.732 . . . . 71.23 103.623 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 29.4 m -77.8 134.37 38.03 Favored 'General case' 0 C--O 1.256 1.427 0 N-CA-C 104.399 -2.445 . . . . 74.23 104.399 155.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.18 -29.27 16.55 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.328 0.651 . . . . 74.04 111.15 -177.275 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -94.22 168.35 11.73 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 124.085 0.954 . . . . 75.1 109.929 177.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -53.32 140.36 62.7 Favored 'Trans proline' 0 C--N 1.378 2.108 0 C-N-CA 122.164 1.909 . . . . 75.41 112.621 165.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.702 ' HG3' HG23 ' A' ' 65' ' ' ILE . 91.4 Cg_endo -72.52 175.53 10.01 Favored 'Trans proline' 0 C--N 1.375 1.925 0 C-N-CA 123.644 2.896 . . . . 74.25 112.562 -177.05 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.46 121.15 9.31 Favored 'Trans proline' 0 C--N 1.38 2.2 0 C-N-CA 122.002 1.801 . . . . 62.44 111.186 171.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -63.32 130.2 27.84 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.594 2.196 . . . . 43.51 112.063 176.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -59.5 141.57 97.58 Favored 'Trans proline' 0 C--N 1.381 2.269 0 C-N-CA 122.64 2.227 . . . . 71.05 111.32 172.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.29 78.28 0.45 Allowed 'Trans proline' 0 C--N 1.382 2.298 0 C-N-CA 123.156 2.571 . . . . 51.35 112.694 -177.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 159.29 -35.38 0.48 Allowed Glycine 0 N--CA 1.467 0.713 0 N-CA-C 109.669 -1.372 . . . . 62.41 109.669 -174.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.446 ' HA3' ' HA ' ' A' ' 106' ' ' PHE . . . 130.04 167.22 12.01 Favored Glycine 0 C--N 1.351 1.375 0 CA-C-N 114.899 -0.651 . . . . 53.03 112.926 170.178 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -69.25 100.9 1.38 Allowed 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 108.175 -1.046 . . . . 74.41 108.175 166.288 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.464 ' O ' ' HD1' ' A' ' 85' ' ' PHE . 12.6 t70 -63.61 152.16 39.65 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.88 0.872 . . . . 71.31 112.969 -174.379 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.464 ' HD1' ' O ' ' A' ' 84' ' ' ASP . 0.3 OUTLIER -148.54 72.43 1.19 Allowed 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 124.699 1.199 . . . . 70.22 107.783 169.882 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.572 ' HA ' ' HA3' ' A' ' 163' ' ' GLY . 44.8 m -55.3 87.75 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 114.562 1.319 . . . . 74.44 114.562 -174.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.608 ' HA2' ' HB3' ' A' ' 171' ' ' PRO . . . 94.56 14.48 50.21 Favored Glycine 0 N--CA 1.47 0.942 0 CA-C-N 116.237 -0.438 . . . . 70.11 113.425 176.309 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -123.19 111.72 16.82 Favored 'General case' 0 C--O 1.245 0.835 0 C-N-CA 122.922 0.489 . . . . 72.34 110.133 -169.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -68.69 92.97 0.49 Allowed 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.077 0.551 . . . . 71.44 110.917 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.489 HG13 ' HG2' ' A' ' 91' ' ' GLU . 2.2 p -31.82 -49.21 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 125.521 1.529 . . . . 75.21 114.311 169.129 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.489 ' HG2' HG13 ' A' ' 90' ' ' VAL . 7.7 mm-40 -68.27 -14.88 63.31 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.992 0.738 . . . . 75.33 112.992 -169.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -78.54 -42.3 29.75 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.504 0.722 . . . . 45.35 111.228 171.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -77.59 178.85 6.94 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 113.46 0.911 . . . . 71.01 113.46 -165.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 67.4 p -58.18 144.4 40.76 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.777 1.231 . . . . 74.5 113.711 -166.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.449 ' O ' ' HG3' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -53.65 -43.02 68.45 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 114.401 -1.272 . . . . 74.31 110.973 172.516 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.416 ' CG ' ' HA ' ' A' ' 4' ' ' LYS . 37.0 t80 -51.18 -52.88 40.01 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.368 1.067 . . . . 75.03 111.479 176.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -57.62 -46.68 83.81 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 114.786 -1.097 . . . . 63.23 110.179 178.074 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.452 ' HA ' HD11 ' A' ' 105' ' ' LEU . 96.3 mt-30 -70.04 -13.01 62.02 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 115.757 -0.656 . . . . 73.05 112.527 -178.244 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.449 ' HG3' ' O ' ' A' ' 95' ' ' GLU . 52.5 mt-10 -88.87 -52.63 5.01 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 122.982 0.513 . . . . 70.02 111.515 172.378 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 36.2 tp -65.14 -50.95 64.04 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.368 0.667 . . . . 55.03 111.014 -175.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -87.88 -6.0 58.3 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 115.606 -0.725 . . . . 72.11 110.74 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -42.68 -59.17 3.29 Favored Glycine 0 C--N 1.355 1.585 0 CA-C-O 118.625 -1.097 . . . . 72.43 114.859 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -39.83 -26.89 0.18 Allowed 'Trans proline' 0 C--N 1.393 2.877 0 C-N-CA 124.883 3.722 . . . . 23.1 116.365 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -152.03 37.63 0.81 Allowed Glycine 0 C--N 1.354 1.568 0 CA-C-O 118.975 -0.903 . . . . 44.4 113.427 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.452 HD11 ' HA ' ' A' ' 98' ' ' GLN . 33.9 mt -53.52 85.19 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 117.487 0.644 . . . . 74.25 112.232 174.031 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.446 ' HA ' ' HA3' ' A' ' 82' ' ' GLY . 0.6 OUTLIER 20.99 -110.88 0.01 OUTLIER 'General case' 0 CA--C 1.565 1.533 0 C-N-CA 127.348 2.259 . . . . 72.25 113.526 177.638 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.473 ' HA2' ' HA2' ' A' ' 168' ' ' GLY . . . 58.46 13.74 17.74 Favored Glycine 0 C--N 1.366 2.236 0 N-CA-C 114.388 0.515 . . . . 44.0 114.388 178.599 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.35 1.342 0 N-CA-C 110.753 -0.939 . . . . 71.34 110.753 -165.241 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.332 0 N-CA-C 113.374 0.879 . . . . 72.15 113.374 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -100.97 -164.13 27.81 Favored Glycine 0 CA--C 1.546 1.984 0 CA-C-N 115.573 -0.74 . . . . 55.22 113.304 -178.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.433 ' H ' ' HA3' ' A' ' 166' ' ' GLY . 2.6 tmt_? -108.8 137.61 46.46 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 124.121 0.968 . . . . 71.34 112.257 176.622 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -57.87 99.04 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 122.194 0.997 . . . . 74.23 111.685 173.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 53.5 tp -103.92 157.54 17.02 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 114.45 -1.25 . . . . 70.23 110.698 -173.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 40.5 ttp180 -109.38 142.25 40.6 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 108.817 -0.809 . . . . 74.51 108.817 170.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.547 ' HB2' HD11 ' A' ' 174' ' ' LEU . . . -128.36 159.33 35.66 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.598 0.713 . . . . 41.51 111.113 177.511 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.4 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 0.7 OUTLIER -116.47 109.73 17.68 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 105.944 -1.873 . . . . 61.0 105.944 -177.311 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.513 ' HB3' ' HA ' ' A' ' 178' ' ' VAL . 37.5 tp -98.86 96.58 4.11 Favored Pre-proline 0 N--CA 1.475 0.805 0 N-CA-C 108.228 -1.027 . . . . 54.05 108.228 -174.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.552 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 97.5 Cg_endo -78.75 107.72 2.31 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 121.065 1.176 . . . . 75.33 109.307 -176.471 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.438 ' HB3' HD23 ' A' ' 180' ' ' LEU . 43.1 tp -106.76 131.47 53.84 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 122.755 0.422 . . . . 64.01 110.238 -167.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 72.9 m -59.41 124.19 19.25 Favored 'General case' 0 CA--C 1.555 1.171 0 O-C-N 124.609 1.193 . . . . 71.34 109.037 173.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.601 ' HB3' HD22 ' A' ' 215' ' ' LEU . 61.1 mt -53.78 -40.02 65.91 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 124.16 0.984 . . . . 70.54 111.743 -171.088 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 16.0 mp0 -65.02 -35.42 81.14 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 114.228 -1.351 . . . . 75.32 109.683 -178.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -78.67 -22.45 46.77 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.657 0.783 . . . . 64.33 111.165 177.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -68.05 -33.73 75.13 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 109.952 -0.388 . . . . 41.43 109.952 171.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.41 ' HB2' HD12 ' A' ' 215' ' ' LEU . 82.3 t80 -74.75 -47.55 30.54 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 115.236 -0.893 . . . . 74.51 111.488 173.259 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 51.2 m170 -69.87 -53.82 16.28 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.416 0.686 . . . . 75.25 110.921 -173.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.91 -168.42 41.23 Favored Glycine 0 C--N 1.344 1.003 0 CA-C-N 115.78 -0.645 . . . . 71.54 112.84 -178.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 98.44 -164.62 21.17 Favored Glycine 0 C--N 1.349 1.28 0 C-N-CA 123.011 0.339 . . . . 70.42 113.512 175.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -72.06 110.59 6.64 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.535 0.734 . . . . 73.14 110.409 177.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -93.85 122.48 36.38 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 122.861 0.464 . . . . 74.4 110.604 177.481 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 57.4 t -78.18 113.93 18.08 Favored 'Isoleucine or valine' 0 C--O 1.243 0.728 0 N-CA-C 108.428 -0.953 . . . . 71.24 108.428 169.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.586 HG13 HG13 ' A' ' 145' ' ' VAL . 3.8 p -134.25 136.57 53.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 124.49 1.116 . . . . 73.14 108.683 178.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -123.78 133.32 53.85 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.312 0.645 . . . . 71.3 110.677 -167.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.572 HG11 HD23 ' B' ' 8' ' ' LEU . 12.4 p -166.04 135.34 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.128 0.971 . . . . 75.1 109.318 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 53.23 38.49 27.76 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.196 0.999 . . . . 74.24 112.774 173.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 86.52 -21.82 16.23 Favored Glycine 0 C--N 1.353 1.504 0 CA-C-N 116.551 -0.295 . . . . 31.1 113.323 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.584 HH12 ' HG2' ' A' ' 164' ' ' MET . 12.1 tpt180 -81.82 99.27 8.91 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.138 0.975 . . . . 72.12 111.019 -179.187 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 38.0 ttp180 -84.65 89.38 7.47 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 107.867 -1.16 . . . . 74.41 107.867 165.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.586 HG13 HG13 ' A' ' 138' ' ' VAL . 3.0 p -97.09 145.58 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 114.783 -1.099 . . . . 73.53 110.877 -175.459 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 34.2 t -106.04 85.38 2.2 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.425 -0.807 . . . . 31.45 109.1 177.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 35.7 m -84.58 121.88 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 N-CA-C 109.929 -0.397 . . . . 73.42 109.929 -177.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -74.44 97.16 3.02 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.101 0.477 . . . . 74.14 109.817 -178.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 26.9 pt -78.35 123.41 85.8 Favored Pre-proline 0 CA--C 1.557 1.219 0 CA-C-N 115.267 -0.878 . . . . 74.13 109.305 174.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -63.16 135.02 48.58 Favored 'Trans proline' 0 C--N 1.372 1.78 0 C-N-CA 122.642 2.228 . . . . 60.34 112.204 176.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -61.84 96.15 0.14 Allowed 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 122.373 2.048 . . . . 74.15 111.143 171.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.565 ' HA2' ' HD2' ' A' ' 240' ' ' PHE . . . 116.5 35.14 1.21 Allowed Glycine 0 C--N 1.342 0.896 0 CA-C-N 115.481 -0.782 . . . . 75.51 111.536 -172.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.525 HG22 HG11 ' A' ' 178' ' ' VAL . 4.7 p -89.26 135.47 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 123.39 0.676 . . . . 75.43 109.496 -178.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.797 ' HD2' ' HA ' ' A' ' 191' ' ' GLN . 7.9 mtm-85 -123.77 148.72 46.4 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 115.322 -0.854 . . . . 73.23 110.502 -162.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.445 ' HB3' ' O ' ' A' ' 188' ' ' LEU . 6.8 tp10 -52.58 118.82 3.89 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 124.357 1.063 . . . . 72.32 110.464 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 105.78 -2.54 38.86 Favored Glycine 0 C--N 1.344 1.006 0 CA-C-N 115.71 -0.677 . . . . 14.21 113.276 -176.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 26.6 t -72.34 104.31 3.69 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 108.915 -0.772 . . . . 74.23 108.915 177.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.492 HG22 HG22 ' A' ' 177' ' ' VAL . 55.6 t -86.03 95.88 4.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 123.689 0.795 . . . . 72.34 109.558 -178.198 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.531 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 47.7 mt -77.84 92.82 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 N-CA-C 107.809 -1.182 . . . . 75.24 107.809 169.474 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 65.5 ttt-85 -72.68 114.96 11.39 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 107.928 -1.138 . . . . 61.32 107.928 177.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.497 HG11 ' SD ' ' A' ' 164' ' ' MET . 7.1 p -125.46 129.51 24.4 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 123.523 0.729 . . . . 61.33 109.154 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.488 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 97.8 Cg_endo -73.93 149.3 41.89 Favored 'Trans proline' 0 CA--C 1.552 1.413 0 C-N-CA 122.069 1.846 . . . . 74.53 111.949 177.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.572 ' HA3' ' HA ' ' A' ' 86' ' ' SER . . . 83.43 -25.51 4.98 Favored Glycine 0 N--CA 1.48 1.602 0 N-CA-C 116.244 1.258 . . . . 70.43 116.244 169.156 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.584 ' HG2' HH12 ' A' ' 143' ' ' ARG . 66.5 mtp -75.0 -23.67 58.28 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 117.679 0.74 . . . . 64.15 111.763 -178.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.472 ' HA2' HD13 ' A' ' 174' ' ' LEU . . . -82.37 -103.21 0.44 Allowed Glycine 0 C--N 1.35 1.35 0 CA-C-O 119.747 -0.474 . . . . 73.33 113.255 -175.192 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.433 ' HA3' ' H ' ' A' ' 117' ' ' ARG . . . -54.99 115.61 5.8 Favored Glycine 0 C--O 1.278 2.861 0 O-C-N 124.005 0.473 . . . . 74.5 113.422 173.034 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -56.85 103.45 0.11 Allowed 'General case' 0 C--N 1.355 0.812 0 O-C-N 127.59 2.582 . . . . 75.42 109.088 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.473 ' HA2' ' HA2' ' A' ' 107' ' ' GLY . . . -176.85 139.12 4.29 Favored Glycine 0 N--CA 1.436 -1.32 0 CA-C-N 113.347 -1.751 . . . . 64.21 108.943 -170.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ASN . . . . . 0.512 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . 11.5 t-20 -73.55 -49.46 6.49 Favored Pre-proline 0 CA--C 1.559 1.294 0 N-CA-C 109.04 -0.726 . . . . 63.11 109.04 -173.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.512 ' HD3' ' HB3' ' A' ' 169' ' ' ASN . 28.2 Cg_exo -68.58 146.3 67.08 Favored 'Trans proline' 0 C--N 1.379 2.132 0 N-CA-C 107.991 -1.58 . . . . 71.13 107.991 156.355 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.608 ' HB3' ' HA2' ' A' ' 87' ' ' GLY . 56.4 Cg_endo -64.17 120.99 8.49 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.878 2.385 . . . . 71.25 116.312 -161.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -62.93 -43.0 99.56 Favored Glycine 0 C--N 1.374 2.681 0 C-N-CA 119.169 -1.491 . . . . 72.4 111.927 161.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.488 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 14.1 m-20 95.31 147.74 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 127.396 2.279 . . . . 71.14 108.563 175.35 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.547 HD11 ' HB2' ' A' ' 121' ' ' ALA . 27.9 tp -140.17 143.94 36.38 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.09 0.471 . . . . 64.32 111.162 -171.428 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 54.0 mt -108.95 90.57 3.33 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 114.746 -1.115 . . . . 72.12 108.254 170.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.531 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 78.7 mt -69.37 87.43 0.44 Allowed 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 109.335 -0.617 . . . . 70.05 109.335 174.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.492 HG22 HG22 ' A' ' 158' ' ' VAL . 11.9 t -84.31 104.67 12.86 Favored 'Isoleucine or valine' 0 C--O 1.245 0.827 0 N-CA-C 106.182 -1.784 . . . . 61.43 106.182 174.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.525 HG11 HG22 ' A' ' 153' ' ' VAL . 9.9 p -67.51 125.67 25.55 Favored 'Isoleucine or valine' 0 C--N 1.349 0.566 0 CA-C-O 121.961 0.886 . . . . 70.33 109.381 -175.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.552 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 28.6 mmt180 -111.94 119.18 37.63 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 107.54 -1.281 . . . . 53.32 107.54 179.285 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.438 HD23 ' HB3' ' A' ' 125' ' ' LEU . 56.7 mt -83.38 144.02 29.92 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-N 118.348 0.522 . . . . 72.4 110.014 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 41.6 mt -54.22 153.54 9.41 Favored Pre-proline 0 N--CA 1.488 1.447 0 C-N-CA 123.898 0.879 . . . . 73.14 112.808 -169.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.93 16.79 0.41 Allowed 'Trans proline' 0 C--N 1.387 2.557 0 C-N-CA 122.97 2.447 . . . . 71.42 113.329 175.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -60.91 101.9 0.28 Allowed Pre-proline 0 CA--C 1.557 1.247 0 N-CA-C 107.213 -1.403 . . . . 73.35 107.213 164.277 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -78.55 25.87 0.53 Allowed 'Trans proline' 0 C--N 1.375 1.932 0 C-N-CA 124.066 3.177 . . . . 61.24 115.478 -161.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 82.3 t -96.88 -32.27 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 109.946 -0.39 . . . . 64.21 109.946 -176.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' PHE . . . . . 0.771 ' HE1' ' HA ' ' A' ' 214' ' ' THR . 35.3 m-85 -145.9 98.87 3.18 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 121.279 0.561 . . . . 72.31 111.935 178.599 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.625 ' HB3' ' HB2' ' A' ' 194' ' ' TYR . 52.3 ttt180 -85.93 81.63 8.45 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 107.863 -1.162 . . . . 75.51 107.863 164.333 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.453 ' HB2' HD23 ' A' ' 193' ' ' LEU . 35.5 tp -78.1 94.52 4.7 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-N 115.228 -0.896 . . . . 74.21 108.671 175.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -114.26 129.98 56.64 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.185 0.594 . . . . 70.31 109.753 -176.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 77.11 -73.89 1.92 Allowed Glycine 0 C--N 1.351 1.389 0 O-C-N 123.85 0.719 . . . . 65.41 111.98 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.797 ' HA ' ' HD2' ' A' ' 154' ' ' ARG . 13.6 pt20 -154.78 -7.23 0.14 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.655 0.782 . . . . 72.32 111.173 172.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -123.05 152.87 40.57 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.472 -0.785 . . . . 72.32 110.671 -167.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.453 HD23 ' HB2' ' A' ' 188' ' ' LEU . 38.8 mt -95.33 152.52 18.31 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 114.642 -1.163 . . . . 63.44 111.032 -168.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.625 ' HB2' ' HB3' ' A' ' 187' ' ' ARG . 91.8 m-85 -132.61 103.93 6.39 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 107.633 -1.247 . . . . 73.14 107.633 171.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.464 ' HB3' HD23 ' A' ' 251' ' ' LEU . . . -129.9 112.6 13.7 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.472 1.109 . . . . 74.34 110.008 -172.126 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 86.0 m -68.72 122.56 18.81 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-O 120.944 0.402 . . . . 70.21 111.187 -179.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.496 HD22 HD13 ' A' ' 251' ' ' LEU . 44.7 tp -108.97 119.54 39.86 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.861 0.865 . . . . 72.21 110.337 -173.027 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -80.02 116.96 20.44 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 108.296 -1.001 . . . . 61.43 108.296 174.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 2.8 p -144.23 127.66 8.82 Favored Pre-proline 0 N--CA 1.478 0.951 0 C-N-CA 123.335 0.654 . . . . 64.4 110.282 -175.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' PRO . . . . . 0.408 ' HA ' ' O ' ' A' ' 256' ' ' THR . 55.5 Cg_endo -72.8 150.87 50.59 Favored 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 121.868 1.712 . . . . 64.51 111.88 176.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -42.24 -60.23 2.23 Favored Pre-proline 0 N--CA 1.487 1.406 0 N-CA-C 116.485 2.032 . . . . 71.34 116.485 -173.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -75.07 -18.96 18.15 Favored 'Trans proline' 0 C--N 1.382 2.339 0 CA-C-N 121.524 1.58 . . . . 63.54 113.081 -173.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 16.4 mt -73.37 -34.73 44.21 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 N-CA-C 109.257 -0.646 . . . . 64.32 109.257 172.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.54 -42.87 81.99 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 123.094 0.558 . . . . 71.51 111.482 173.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 71.6 t -72.96 -44.45 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 123.59 0.756 . . . . 63.23 112.513 -174.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 78.7 t -88.76 -37.08 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 122.759 0.424 . . . . 74.41 110.933 -176.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 98.53 77.55 1.33 Allowed Glycine 0 C--N 1.339 0.713 0 N-CA-C 111.651 -0.58 . . . . 72.35 111.651 -176.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -103.44 -144.35 13.73 Favored Glycine 0 C--N 1.34 0.763 0 CA-C-N 115.255 -0.472 . . . . 55.24 112.042 178.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.537 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 43.1 mtmt -127.55 147.03 50.33 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 122.863 0.465 . . . . 45.21 110.614 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 24.8 m -137.14 -177.07 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.634 1.174 . . . . 63.11 108.861 170.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 26.2 ttm180 -116.62 129.24 56.04 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.609 0.763 . . . . 71.41 108.998 171.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -109.03 149.37 29.36 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.444 -0.947 . . . . 62.04 108.444 173.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -88.78 145.95 25.3 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.059 -0.719 . . . . 71.23 109.059 174.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' THR . . . . . 0.771 ' HA ' ' HE1' ' A' ' 186' ' ' PHE . 41.0 p -127.94 174.27 9.32 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 123.914 0.886 . . . . 74.1 109.635 172.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.601 HD22 ' HB3' ' A' ' 127' ' ' LEU . 24.6 mt -59.19 -36.56 75.56 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.001 0.92 . . . . 63.31 110.889 -176.469 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.423 ' HA ' ' NZ ' ' B' ' 2' ' ' LYS . 15.1 mm-40 -98.87 2.07 46.32 Favored 'General case' 0 CA--C 1.554 1.127 0 CA-C-N 114.714 -1.13 . . . . 64.44 112.539 -172.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 140.8 -173.53 23.12 Favored Glycine 0 N--CA 1.483 1.77 0 CA-C-O 119.253 -0.748 . . . . 33.0 112.785 176.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -79.28 155.67 25.41 Favored 'Trans proline' 0 C--N 1.369 1.643 0 C-N-CA 122.644 2.229 . . . . 70.23 111.8 176.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 18.4 m -148.26 157.08 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 C-N-CA 123.888 0.875 . . . . 73.4 111.066 -177.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -91.24 124.93 35.82 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.951 0.9 . . . . 75.04 109.809 178.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 97.1 t -136.13 123.3 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.22 1.008 . . . . 74.13 109.163 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.537 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -89.98 133.68 34.66 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 118.163 0.438 . . . . 60.25 111.207 178.135 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 44.5 t -78.61 145.42 67.17 Favored Pre-proline 0 CA--C 1.561 1.384 0 C-N-CA 125.571 1.548 . . . . 63.14 110.051 -178.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -78.93 172.12 15.45 Favored 'Trans proline' 0 C--N 1.386 2.509 0 C-N-CA 122.767 2.312 . . . . 75.51 111.51 172.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.42 150.74 28.73 Favored 'Trans proline' 0 C--N 1.373 1.829 0 C-N-CA 121.87 1.713 . . . . 72.53 113.274 175.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' ARG . . . . . 0.49 HH12 ' HB2' ' C' ' 261' ' ' LEU . 85.9 mtt-85 64.16 30.04 13.81 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 125.851 1.661 . . . . 74.04 111.477 172.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.578 HG23 HD21 ' A' ' 233' ' ' LEU . 43.7 m -66.15 106.27 1.6 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.516 1.526 . . . . 64.32 111.291 178.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 228' ' ' GLN . . . . . 0.442 ' HB3' ' HD2' ' A' ' 231' ' ' ARG . 6.4 tp-100 -93.16 140.39 29.57 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.021 0.928 . . . . 75.32 110.657 -176.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 229' ' ' ALA . . . . . 0.454 ' HA ' ' HB ' ' A' ' 253' ' ' VAL . . . -66.07 157.59 30.68 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.849 0.86 . . . . 62.31 111.782 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 82.96 -40.19 2.79 Favored Glycine 0 C--N 1.347 1.179 0 CA-C-N 116.189 -0.459 . . . . 73.32 112.043 -177.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.442 ' HD2' ' HB3' ' A' ' 228' ' ' GLN . 92.6 mtt180 -66.4 157.67 31.3 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 124.147 0.979 . . . . 74.0 111.437 175.408 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.752 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 3.3 mptp? -109.94 125.59 53.01 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 114.856 -1.065 . . . . 72.22 108.418 177.13 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.578 HD21 HG23 ' A' ' 227' ' ' THR . 87.4 mt -76.14 104.82 6.85 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.883 -0.784 . . . . 71.4 108.883 177.065 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 18.4 ttp180 -84.95 109.6 18.27 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.27 0.628 . . . . 64.14 110.324 178.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.485 HD12 ' HG3' ' A' ' 238' ' ' LYS . 0.4 OUTLIER -120.57 117.1 26.73 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.972 0.909 . . . . 61.12 109.75 175.127 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 30.8 mmtm -60.69 151.08 30.18 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.916 1.286 . . . . 64.43 113.277 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 71.23 32.21 65.63 Favored Glycine 0 C--N 1.356 1.656 0 CA-C-N 114.682 -1.145 . . . . 74.2 113.604 172.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.485 ' HG3' HD12 ' A' ' 235' ' ' LEU . 41.8 mmtm -130.32 -30.31 1.94 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.524 0.73 . . . . 73.01 110.565 -174.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -73.04 173.87 47.64 Favored Glycine 0 C--N 1.351 1.396 0 O-C-N 123.301 0.376 . . . . 74.43 112.451 171.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 240' ' ' PHE . . . . . 0.565 ' HD2' ' HA2' ' A' ' 152' ' ' GLY . 5.7 m-85 -91.78 158.15 40.51 Favored Pre-proline 0 N--CA 1.48 1.044 0 C-N-CA 123.204 0.602 . . . . 73.13 110.85 -169.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -61.09 111.05 0.97 Allowed 'Trans proline' 0 C--N 1.387 2.558 0 C-N-CA 123.054 2.503 . . . . 73.33 112.158 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -125.31 -150.34 7.73 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-O 119.337 -0.702 . . . . 73.52 112.212 179.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 243' ' ' PRO . . . . . 0.435 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 32.6 Cg_endo -63.33 -30.77 73.48 Favored 'Trans proline' 0 C--N 1.373 1.848 0 C-N-CA 122.895 2.397 . . . . 70.45 113.07 -177.43 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 0.432 ' HB3' HE22 ' A' ' 191' ' ' GLN . . . -107.28 12.7 27.93 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.867 0.867 . . . . 70.11 111.4 178.445 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 87.66 -161.61 32.37 Favored Glycine 0 C--N 1.345 1.053 0 CA-C-N 116.327 -0.397 . . . . 62.24 112.158 -174.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 66.4 mtt85 -59.46 108.83 0.77 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.337 0.655 . . . . 75.41 110.676 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -70.5 -157.39 2.11 Favored Glycine 0 C--N 1.347 1.142 0 CA-C-N 115.605 -0.725 . . . . 42.24 113.758 -178.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -100.48 166.28 11.01 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.924 0.869 . . . . 75.44 110.641 178.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.441 ' HB3' ' HG ' ' A' ' 235' ' ' LEU . 14.5 tp -102.64 128.36 49.36 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 106.284 -1.746 . . . . 70.31 106.284 164.357 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.752 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 18.6 m-85 -108.77 105.1 14.54 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 107.609 -1.256 . . . . 52.51 107.609 173.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.534 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 40.1 mt -90.7 103.93 16.57 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 109.245 -0.65 . . . . 72.24 109.245 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 252' ' ' GLU . . . . . 0.498 ' HG2' ' HG3' ' A' ' 232' ' ' LYS . 22.3 mt-10 -76.7 101.69 5.89 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.146 0.978 . . . . 75.41 108.758 -170.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.454 ' HB ' ' HA ' ' A' ' 229' ' ' ALA . 27.0 t -64.31 122.96 16.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-N 114.849 -1.068 . . . . 24.43 112.504 -167.417 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 5.7 mmt180 -122.42 96.29 4.98 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.423 1.089 . . . . 73.14 108.604 169.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.447 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 73.1 mt -72.94 117.09 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 114.171 -1.377 . . . . 74.34 109.57 178.456 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 256' ' ' THR . . . . . 0.408 ' O ' ' HA ' ' A' ' 200' ' ' PRO . 41.1 p -110.3 174.17 5.99 Favored 'General case' 0 C--O 1.255 1.348 0 C-N-CA 124.445 1.098 . . . . 73.43 110.092 178.374 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 26.1 pt -132.87 151.8 78.68 Favored Pre-proline 0 CA--C 1.554 1.135 0 CA-C-N 114.93 -1.032 . . . . 73.4 108.778 177.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -87.22 22.09 0.97 Allowed 'Trans proline' 0 C--N 1.365 1.429 0 C-N-CA 122.725 2.283 . . . . 74.45 112.962 -171.007 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 33.83 -87.89 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 125.303 1.441 . . . . 63.24 113.49 -165.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.47 132.52 47.14 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.775 0.83 . . . . 75.12 110.945 -170.21 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.535 HD11 HG11 ' C' ' 205' ' ' VAL . 86.0 mt -127.64 170.42 12.7 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.521 0.728 . . . . 55.32 111.094 -174.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 75.1 p -104.8 159.78 28.21 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-N 114.598 -1.183 . . . . 44.34 110.174 171.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_exo -32.7 -46.92 0.3 Allowed 'Trans proline' 0 C--N 1.383 2.346 0 C-N-CA 124.831 3.687 . . . . 74.33 116.044 172.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -57.62 -64.41 0.91 Allowed 'General case' 0 C--O 1.25 1.114 0 C-N-CA 123.987 0.915 . . . . 71.44 111.197 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -59.5 -48.3 82.17 Favored 'General case' 0 C--N 1.349 0.562 0 CA-C-N 114.54 -1.209 . . . . 64.2 110.2 -176.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 266' ' ' GLU . . . . . 0.536 ' O ' ' HG2' ' A' ' 270' ' ' LYS . 7.1 tp10 -53.03 -52.93 56.88 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 124.617 1.198 . . . . 73.45 111.099 -176.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -63.5 -45.19 91.84 Favored 'General case' 0 C--O 1.254 1.294 0 O-C-N 124.199 0.937 . . . . 64.12 111.94 -178.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 9.4 mp -63.38 -34.09 76.97 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-N 115.826 -0.624 . . . . 73.14 111.358 178.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 269' ' ' TRP . . . . . 0.44 ' O ' HG11 ' C' ' 206' ' ' VAL . 61.7 m95 -75.97 -30.51 58.63 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 118.677 -0.677 . . . . 75.0 111.349 177.149 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 270' ' ' LYS . . . . . 0.536 ' HG2' ' O ' ' A' ' 266' ' ' GLU . 0.0 OUTLIER -57.37 -60.73 3.2 Favored 'General case' 0 C--O 1.267 2.005 0 N-CA-C 108.214 -1.032 . . . . 62.43 108.214 175.103 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? -55.67 -50.24 70.78 Favored 'General case' 0 C--N 1.357 0.928 0 CA-C-N 112.002 -2.363 . . . . 70.22 110.66 -178.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 272' ' ' LEU . . . . . 0.407 HD12 HD12 ' C' ' 272' ' ' LEU . 2.1 tt -58.1 -58.93 6.28 Favored 'General case' 0 C--O 1.191 -2.026 0 O-C-N 124.298 0.999 . . . . 63.4 108.992 -177.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 273' ' ' ALA . . . . . 0.472 ' O ' ' HB3' ' A' ' 276' ' ' TYR . . . -56.21 -48.77 75.77 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 114.236 1.199 . . . . 64.51 114.236 -170.007 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -89.21 -21.85 23.06 Favored 'General case' 0 C--O 1.252 1.189 0 N-CA-C 112.68 0.622 . . . . 74.35 112.68 -172.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -80.47 -26.24 38.4 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.988 -0.445 . . . . 71.44 110.697 168.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 276' ' ' TYR . . . . . 0.472 ' HB3' ' O ' ' A' ' 273' ' ' ALA . 2.2 t80 -58.92 -55.81 30.28 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 125.79 1.636 . . . . 75.02 107.797 170.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -44.91 -66.1 0.44 Allowed 'General case' 0 C--O 1.249 1.077 0 O-C-N 125.538 1.774 . . . . 70.12 109.431 173.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -62.82 -14.24 43.11 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 114.76 -1.109 . . . . 75.41 113.841 -175.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 86.7 mtm180 -132.17 34.16 3.82 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 122.927 0.491 . . . . 74.13 110.228 -175.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.568 1.673 0 O-C-N 124.261 0.976 . . . . 72.21 113.134 175.712 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.443 ' SD ' ' N ' ' B' ' 1' ' ' MET . 1.6 mpt? . . . . . 0 N--CA 1.48 1.073 0 N-CA-C 110.338 -0.245 . . . . 71.44 110.338 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 2' ' ' LYS . . . . . 0.423 ' NZ ' ' HA ' ' A' ' 216' ' ' GLU . 13.3 mptt -75.16 116.93 16.43 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.668 0.787 . . . . 54.1 110.788 178.085 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -168.58 -38.15 0.02 OUTLIER 'General case' 0 C--O 1.242 0.701 0 C-N-CA 124.361 1.064 . . . . 74.04 109.358 174.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 23.3 t 65.39 -177.59 0.18 Allowed 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.567 1.147 . . . . 52.14 111.027 -179.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 94.6 m 68.69 131.76 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.561 1.144 . . . . 70.11 112.182 177.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 138' ' ' VAL . 42.8 pt -140.5 173.44 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.584 0.754 . . . . 64.44 110.565 -175.111 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -132.82 129.83 39.03 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.544 0.738 . . . . 72.01 110.269 177.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 8' ' ' LEU . . . . . 0.572 HD23 HG11 ' A' ' 140' ' ' VAL . 50.1 tp -78.51 155.56 29.72 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.036 0.934 . . . . 75.22 110.97 -174.269 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.31 -68.31 0.69 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 122.932 0.493 . . . . 62.4 111.437 176.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 10' ' ' LEU . . . . . 0.499 HD23 ' HB2' ' A' ' 121' ' ' ALA . 51.7 mt 68.32 2.98 3.51 Favored 'General case' 0 N--CA 1.501 2.094 0 C-N-CA 124.871 1.269 . . . . 74.1 111.844 -164.025 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 56.7 mt . . . . . 0 CA--C 1.555 1.169 0 C-N-CA 124.564 1.146 . . . . 45.35 112.137 -175.367 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.449 0 N-CA-C 107.346 -1.353 . . . . 61.34 107.346 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 180' ' ' ALA . . . . . 0.532 ' HB1' HG13 ' C' ' 137' ' ' VAL . . . -145.77 -63.0 0.33 Allowed 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 105.292 -2.114 . . . . 74.4 105.292 169.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 181' ' ' LEU . . . . . 0.583 ' HB3' HG12 ' C' ' 138' ' ' VAL . 37.0 tp -148.37 -32.44 0.25 Allowed 'General case' 0 CA--C 1.553 1.087 0 CA-C-N 114.22 -1.355 . . . . 62.04 108.837 160.234 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 182' ' ' VAL . . . . . 0.662 HG12 HD13 ' C' ' 123' ' ' LEU . 32.6 m -118.6 -176.88 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 C-N-CA 124.53 1.132 . . . . 71.31 111.499 177.11 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 183' ' ' ALA . . . . . 0.517 ' HB2' ' HD2' ' C' ' 124' ' ' PRO . . . -112.21 -95.44 0.44 Allowed 'General case' 0 C--N 1.357 0.92 0 C-N-CA 123.976 0.91 . . . . 65.24 110.163 167.161 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 35.9 m80 -157.58 -171.19 3.47 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 123.689 0.796 . . . . 74.15 110.881 -170.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 185' ' ' VAL . . . . . 0.574 HG22 HD21 ' C' ' 119' ' ' LEU . 25.1 t . . . . . 0 N--CA 1.499 1.98 0 C-N-CA 124.761 1.224 . . . . 71.33 112.853 -171.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 56.8 m . . . . . 0 N--CA 1.496 1.871 0 CA-C-O 118.359 -0.829 . . . . 71.31 110.495 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -173.92 -174.48 0.94 Allowed 'General case' 0 C--N 1.377 1.782 0 N-CA-C 114.028 1.121 . . . . 74.42 114.028 174.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . -116.62 -138.21 6.19 Favored Glycine 0 C--N 1.362 2.004 0 C-N-CA 125.348 1.451 . . . . 71.23 110.902 175.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 241' ' ' GLU . . . . . 0.427 ' HB3' ' HE3' ' B' ' 245' ' ' LYS . 11.6 pt-20 -156.65 177.05 11.92 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 117.452 0.626 . . . . 71.21 111.066 174.417 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 242' ' ' TRP . . . . . 0.474 ' CD2' ' HG ' ' C' ' 233' ' ' LEU . 0.0 OUTLIER -158.87 -39.46 0.06 Allowed 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.991 1.316 . . . . 70.32 108.944 179.483 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -126.36 -168.32 1.84 Allowed 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 107.484 -1.302 . . . . 74.22 107.484 162.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -71.87 91.42 0.51 Allowed Glycine 0 C--N 1.344 1.007 0 CA-C-N 116.611 -0.268 . . . . 63.11 112.529 171.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 245' ' ' LYS . . . . . 0.427 ' HE3' ' HB3' ' B' ' 241' ' ' GLU . 0.7 OUTLIER . . . . . 0 N--CA 1.482 1.158 0 C-N-CA 124.525 1.13 . . . . 75.34 110.592 176.122 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.95 0 CA-C-O 120.89 0.376 . . . . 52.01 110.576 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -38.52 110.12 0.12 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.129 1.772 . . . . 70.52 113.253 177.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 5' ' ' LYS . . . . . 0.53 ' HB3' HD11 ' C' ' 10' ' ' ILE . 37.7 mtpt -95.71 104.73 16.66 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 108.506 -0.924 . . . . 63.2 108.506 167.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -66.98 104.32 1.35 Allowed 'General case' 0 C--N 1.351 0.658 0 N-CA-C 109.08 -0.711 . . . . 63.22 109.08 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 7' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -63.92 -29.59 70.75 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 124.088 0.868 . . . . 73.43 112.443 -169.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -71.34 -40.43 70.71 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 122.516 0.326 . . . . 72.53 110.38 178.232 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.11 -37.82 88.69 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 122.825 0.45 . . . . 52.31 110.271 177.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 10' ' ' ILE . . . . . 0.53 HD11 ' HB3' ' C' ' 5' ' ' LYS . 69.4 mt -59.74 -40.25 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 123.186 0.594 . . . . 63.34 110.128 173.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 92.7 mt -82.08 -8.2 59.65 Favored 'General case' 0 CA--C 1.556 1.186 0 N-CA-C 112.935 0.717 . . . . 45.45 112.935 176.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 67.67 35.7 86.36 Favored Glycine 0 C--N 1.352 1.464 0 N-CA-C 113.845 0.298 . . . . 64.33 113.845 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 11.7 m -124.15 160.31 52.89 Favored Pre-proline 0 N--CA 1.486 1.372 0 C-N-CA 125.08 1.352 . . . . 64.04 110.175 178.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -56.91 152.24 44.41 Favored 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 122.933 2.422 . . . . 74.43 113.485 175.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -79.67 28.56 0.26 Allowed 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 113.746 1.017 . . . . 71.52 113.746 -171.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -154.83 27.73 0.43 Allowed 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 108.008 -1.108 . . . . 71.24 108.008 171.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.07 154.24 40.11 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.183 -0.917 . . . . 71.14 111.896 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 69.4 p -95.53 179.42 5.15 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.002 0.921 . . . . 74.41 111.912 -172.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -52.94 -45.0 67.47 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.46 1.104 . . . . 74.45 111.957 -177.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -70.41 -32.85 70.64 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 123.56 0.537 . . . . 64.05 111.746 -177.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -71.57 -43.04 67.05 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 122.907 0.483 . . . . 73.42 110.489 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 1.7 mp -64.86 -38.24 82.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 123.758 0.823 . . . . 61.32 110.221 175.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -64.43 -52.25 59.07 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.124 0.969 . . . . 74.13 111.031 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -69.8 -34.14 73.32 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.467 -0.788 . . . . 73.52 111.087 -177.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -72.38 -35.58 68.5 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.292 0.637 . . . . 75.32 110.979 178.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 26' ' ' TYR . . . . . 0.454 ' HD1' HG22 ' C' ' 50' ' ' ILE . 32.8 t80 -56.75 -61.35 2.49 Favored 'General case' 0 C--O 1.209 -1.065 0 O-C-N 124.261 0.976 . . . . 72.31 108.98 171.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -58.22 -41.67 84.57 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 124.15 0.906 . . . . 74.1 111.929 -177.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 45.7 ttt180 -50.75 -53.89 27.9 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.981 1.312 . . . . 71.15 110.699 176.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 87.1 mt -92.11 -6.2 51.32 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.228 -0.896 . . . . 60.22 111.743 -176.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.65 -4.7 47.18 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.694 0.798 . . . . 75.32 110.145 173.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 58.6 mtp180 -103.96 -35.2 8.21 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.92 0.888 . . . . 73.5 109.53 166.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.98 -55.15 15.73 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 109.506 -0.553 . . . . 71.12 109.506 178.168 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -89.9 7.22 38.39 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 112.046 0.387 . . . . 70.15 112.046 -177.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 34' ' ' HIS . . . . . . . . . . . . . 31.8 t60 -61.28 105.3 0.57 Allowed Pre-proline 0 N--CA 1.478 0.964 0 C-N-CA 124.241 1.016 . . . . 72.34 110.406 -176.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -53.87 -28.36 48.27 Favored 'Trans proline' 0 N--CA 1.507 2.29 0 C-N-CA 123.467 2.778 . . . . 71.32 115.393 -171.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -68.79 -31.81 71.08 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.534 0.734 . . . . 60.34 111.711 178.1 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 97.9 t -90.96 -50.7 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.402 0.681 . . . . 75.33 109.93 176.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -105.38 92.22 4.11 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.426 1.491 . . . . 54.22 108.605 -173.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -76.36 81.53 3.1 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 108.733 -0.839 . . . . 62.24 108.733 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 45.9 m -147.84 128.63 6.97 Favored Pre-proline 0 N--CA 1.48 1.06 0 C-N-CA 123.244 0.618 . . . . 74.14 110.342 177.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.8 -40.2 86.12 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 122.903 2.402 . . . . 63.44 111.002 174.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -53.0 -46.19 68.22 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 114.871 -1.059 . . . . 65.44 111.004 174.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.71 -16.9 56.69 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 122.616 0.367 . . . . 62.05 110.649 -175.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -73.97 -47.99 33.53 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 107.68 -1.23 . . . . 74.04 107.68 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -70.58 -38.06 74.0 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 114.055 -1.429 . . . . 42.53 111.465 178.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 46' ' ' LYS . . . . . 0.533 ' O ' HG12 ' C' ' 50' ' ' ILE . 34.0 mmtm -64.54 -37.34 87.22 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 116.224 -0.444 . . . . 72.32 110.577 175.095 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -62.2 -40.98 97.9 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.486 0.715 . . . . 62.23 109.665 175.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -60.3 -38.37 83.42 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 123.391 0.432 . . . . 72.04 111.554 173.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -68.48 -33.91 74.99 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 122.744 0.418 . . . . 72.33 111.473 177.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 50' ' ' ILE . . . . . 0.533 HG12 ' O ' ' C' ' 46' ' ' LYS . 26.6 mm -68.77 -32.82 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 N-CA-C 109.246 -0.65 . . . . 75.43 109.246 174.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 51' ' ' ASN . . . . . 0.401 ' HB3' ' HD1' ' C' ' 88' ' ' PHE . 4.3 m-20 -74.12 -32.1 63.04 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 114.998 -1.001 . . . . 74.04 111.05 177.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -66.35 -57.28 7.81 Favored 'General case' 0 C--O 1.248 0.992 0 C-N-CA 123.966 0.906 . . . . 63.42 109.903 175.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -52.15 -54.98 24.03 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 113.632 -1.622 . . . . 63.1 111.194 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -61.19 -46.11 91.84 Favored 'General case' 0 C--O 1.21 -1.024 0 CA-C-N 115.278 -0.874 . . . . 75.01 111.405 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.42 -47.55 72.66 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 122.841 0.456 . . . . 60.54 112.007 -176.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 90.5 t -63.93 -44.08 97.87 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 O-C-N 123.93 0.769 . . . . 72.43 110.331 177.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 57' ' ' LEU . . . . . . . . . . . . . 52.4 mt -88.17 0.17 56.37 Favored 'General case' 0 CA--C 1.564 1.482 0 N-CA-C 113.283 0.846 . . . . 75.02 113.283 -174.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 33.5 t -87.1 -51.31 6.07 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.142 0.977 . . . . 62.42 109.801 -178.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.44 123.06 84.56 Favored Pre-proline 0 C--O 1.217 -0.631 0 N-CA-C 107.845 -1.169 . . . . 72.03 107.845 172.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 60' ' ' PRO . . . . . 0.555 ' HD2' ' HA ' ' C' ' 145' ' ' VAL . 15.0 Cg_endo -55.95 -29.21 72.38 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 122.696 2.264 . . . . 33.23 111.216 170.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -65.39 -64.38 0.88 Allowed 'General case' 0 C--N 1.35 0.595 0 CA-C-N 115.626 -0.715 . . . . 62.13 110.825 176.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 62' ' ' LYS . . . . . 0.501 ' HD3' ' HB3' ' C' ' 83' ' ' TYR . 27.0 mtmm -64.69 -26.62 68.45 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.826 0.45 . . . . 75.23 111.414 -177.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 47.3 tpt85 -57.83 -58.49 8.13 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.642 1.177 . . . . 64.42 109.0 173.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -74.74 -16.79 60.72 Favored 'General case' 0 C--N 1.348 0.518 0 CA-C-N 115.182 -0.917 . . . . 74.15 112.215 -176.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 65' ' ' ILE . . . . . 0.635 HG23 ' HD2' ' C' ' 76' ' ' PRO . 65.2 mt -65.97 -48.26 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 N-CA-C 108.791 -0.818 . . . . 62.34 108.791 169.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -58.61 -51.77 68.49 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.311 -0.859 . . . . 74.22 110.181 176.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -54.44 -51.26 65.53 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.47 0.708 . . . . 73.14 111.643 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 68.0 p -76.0 -13.65 60.23 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 118.958 -0.544 . . . . 63.2 112.376 -177.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -67.52 107.09 2.36 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 109.004 -0.739 . . . . 75.22 109.004 176.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 114.29 17.78 7.01 Favored Glycine 0 C--N 1.343 0.945 0 CA-C-N 115.514 -0.766 . . . . 62.51 111.743 -167.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 98.8 m -148.89 -59.78 0.23 Allowed 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 104.064 -2.569 . . . . 72.34 104.064 176.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 12.4 m -77.9 138.95 39.18 Favored 'General case' 0 C--O 1.256 1.431 0 N-CA-C 104.571 -2.381 . . . . 73.35 104.571 158.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -100.05 -54.82 2.79 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 108.75 -0.833 . . . . 73.23 108.75 -173.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -72.12 151.63 92.54 Favored Pre-proline 0 CA--C 1.546 0.824 0 CA-C-N 114.688 -1.142 . . . . 53.23 109.765 173.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -56.29 123.51 14.01 Favored 'Trans proline' 0 C--N 1.369 1.63 0 C-N-CA 122.338 2.025 . . . . 75.14 110.921 169.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 76' ' ' PRO . . . . . 0.635 ' HD2' HG23 ' C' ' 65' ' ' ILE . 84.3 Cg_exo -50.98 145.79 23.71 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 123.004 2.469 . . . . 63.14 112.817 172.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 77' ' ' PRO . . . . . 0.441 ' HA ' ' HD3' ' C' ' 78' ' ' PRO . 10.8 Cg_endo -51.57 125.79 17.77 Favored 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 123.642 2.894 . . . . 51.51 112.587 -177.126 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 78' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' C' ' 77' ' ' PRO . 14.0 Cg_exo -69.21 141.3 47.05 Favored 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 122.89 2.393 . . . . 74.44 111.95 -177.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 79' ' ' PRO . . . . . 0.417 ' HB2' ' O ' ' C' ' 142' ' ' GLY . 30.9 Cg_endo -61.83 152.68 73.08 Favored 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 122.522 2.148 . . . . 61.04 111.218 174.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -50.73 82.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.392 2.859 0 C-N-CA 124.242 3.295 . . . . 51.5 114.494 -169.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 153.36 -53.05 0.46 Allowed Glycine 0 C--N 1.335 0.481 0 N-CA-C 109.811 -1.315 . . . . 75.2 109.811 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 141.13 -150.76 22.05 Favored Glycine 0 C--N 1.353 1.528 0 CA-C-N 115.615 -0.292 . . . . 74.45 113.662 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 83' ' ' TYR . . . . . 0.501 ' HB3' ' HD3' ' C' ' 62' ' ' LYS . 29.4 m-85 -104.01 122.24 44.83 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.274 1.43 . . . . 70.14 108.855 -177.011 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 84' ' ' ASP . . . . . 0.491 ' HB2' ' NE ' ' C' ' 143' ' ' ARG . 5.5 t70 -80.82 128.38 33.59 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 112.367 0.506 . . . . 63.13 112.367 -169.447 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 85' ' ' PHE . . . . . 0.535 ' HA ' ' HD2' ' C' ' 88' ' ' PHE . 77.0 m-85 -139.46 29.99 2.15 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.263 1.025 . . . . 74.41 109.776 176.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 13.7 m -78.6 84.94 4.68 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 114.89 -1.05 . . . . 45.43 111.39 -173.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 87' ' ' GLY . . . . . 0.591 ' N ' ' HA ' ' C' ' 171' ' ' PRO . . . 130.59 -19.73 5.0 Favored Glycine 0 N--CA 1.47 0.959 0 N-CA-C 110.24 -1.144 . . . . 74.33 110.24 -174.356 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 88' ' ' PHE . . . . . 0.535 ' HD2' ' HA ' ' C' ' 85' ' ' PHE . 32.5 m-85 -100.0 129.89 46.1 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 107.921 -1.14 . . . . 74.44 107.921 178.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -75.75 78.88 2.69 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.548 0.689 . . . . 72.23 110.804 -175.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 90' ' ' VAL . . . . . 0.451 HG21 ' ND2' ' C' ' 169' ' ' ASN . 5.6 p -50.06 -35.93 11.79 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 C-N-CA 125.981 1.713 . . . . 54.41 113.482 -174.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -65.94 -26.05 67.41 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 123.499 0.72 . . . . 74.21 112.124 -175.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -78.17 -26.56 47.72 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 122.674 0.389 . . . . 75.53 111.88 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 9.3 m-30 -70.13 164.33 24.38 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 123.345 0.403 . . . . 72.45 111.343 -167.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 52.1 p -59.43 149.85 28.25 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 113.969 1.1 . . . . 45.51 113.969 -166.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.71 -35.71 75.07 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 114.738 -1.119 . . . . 55.43 110.525 171.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -53.73 -50.91 64.92 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.542 1.137 . . . . 65.02 110.858 172.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 97' ' ' PHE . . . . . 0.414 ' HZ ' HG23 ' C' ' 90' ' ' VAL . 1.1 t80 -58.96 -43.04 91.23 Favored 'General case' 0 CA--C 1.552 1.043 0 CA-C-N 114.511 -1.222 . . . . 64.25 110.767 175.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -69.31 -21.4 63.85 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.077 0.551 . . . . 51.52 112.026 -177.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -82.69 -50.0 9.19 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.293 0.637 . . . . 74.43 110.621 173.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 38.6 tp -67.45 -63.73 1.0 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.775 0.83 . . . . 73.23 110.553 -175.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -80.26 -0.71 37.63 Favored 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 123.091 0.556 . . . . 73.25 112.413 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -45.57 -58.84 5.1 Favored Glycine 0 CA--C 1.544 1.85 0 CA-C-O 118.933 -0.926 . . . . 54.11 115.411 178.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -62.65 -3.38 4.36 Favored 'Trans proline' 0 C--N 1.385 2.466 0 C-N-CA 123.535 2.824 . . . . 62.02 114.528 -176.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -141.71 38.28 1.52 Allowed Glycine 0 C--N 1.354 1.535 0 CA-C-O 119.118 -0.823 . . . . 43.23 112.62 174.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 43.0 mt . . . . . 0 N--CA 1.505 2.285 0 CA-C-N 118.58 1.19 . . . . 73.03 113.922 175.71 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 116' ' ' GLY . . . . . 0.432 ' HA2' ' HA3' ' C' ' 168' ' ' GLY . . . . . . . . 0 N--CA 1.47 0.948 0 N-CA-C 113.981 0.352 . . . . 45.25 113.981 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 117' ' ' ARG . . . . . 0.546 ' HB2' ' HB2' ' C' ' 167' ' ' GLN . 2.4 mmp_? -116.29 147.51 41.46 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 124.492 1.117 . . . . 64.44 111.498 177.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -68.9 113.66 6.52 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 108.322 -0.992 . . . . 75.42 108.322 174.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 119' ' ' LEU . . . . . 0.574 HD21 HG22 ' B' ' 185' ' ' VAL . 5.7 tt -92.12 119.34 31.69 Favored 'General case' 0 C--O 1.219 -0.512 0 N-CA-C 105.953 -1.869 . . . . 75.21 105.953 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.418 ' HG2' HD12 ' C' ' 175' ' ' LEU . 98.3 mtt180 -97.48 132.95 42.69 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 107.399 -1.334 . . . . 72.31 107.399 176.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 121' ' ' ALA . . . . . . . . . . . . . . . -143.02 117.37 9.63 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.294 -0.632 . . . . 63.21 109.294 -178.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 122' ' ' GLU . . . . . 0.473 ' HA ' ' O ' ' C' ' 177' ' ' VAL . 12.7 pt-20 -99.17 130.0 45.46 Favored 'General case' 0 C--N 1.348 0.529 0 CA-C-O 120.959 0.409 . . . . 73.22 109.913 177.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 123' ' ' LEU . . . . . 0.662 HD13 HG12 ' B' ' 182' ' ' VAL . 0.4 OUTLIER -122.96 120.9 27.41 Favored Pre-proline 0 N--CA 1.473 0.7 0 C-N-CA 123.447 0.699 . . . . 73.3 111.92 -166.132 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 124' ' ' PRO . . . . . 0.517 ' HD2' ' HB2' ' B' ' 183' ' ' ALA . 80.4 Cg_exo -51.19 116.96 3.0 Favored 'Trans proline' 0 C--N 1.37 1.68 0 C-N-CA 122.82 2.347 . . . . 72.51 111.298 162.082 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 125' ' ' LEU . . . . . . . . . . . . . 26.3 tp -138.64 140.26 38.83 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.373 1.069 . . . . 74.03 108.6 -175.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.4 156.24 21.91 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.069 0.461 . . . . 61.53 111.192 -177.036 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 127' ' ' LEU . . . . . 0.619 ' HB3' HD22 ' C' ' 215' ' ' LEU . 95.9 mt -63.72 -44.99 91.94 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.124 0.97 . . . . 62.25 110.776 177.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -52.84 -46.39 67.77 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 114.885 -1.052 . . . . 75.24 110.513 172.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -67.01 -33.84 76.42 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.092 0.957 . . . . 73.53 111.553 -176.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -72.44 -33.1 66.84 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 123.866 0.729 . . . . 64.34 110.344 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 131' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -68.09 -41.38 81.94 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.2 0.6 . . . . 75.55 110.361 172.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 132' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -66.72 -68.91 0.34 Allowed 'General case' 0 N--CA 1.481 1.118 0 O-C-N 123.653 0.595 . . . . 60.22 111.284 -175.059 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 62.93 93.25 0.02 OUTLIER Glycine 0 CA--C 1.541 1.678 0 O-C-N 123.735 0.647 . . . . 65.31 113.239 -176.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . -135.89 161.38 24.82 Favored Glycine 0 N--CA 1.479 1.516 0 CA-C-O 119.473 -0.626 . . . . 53.24 111.802 177.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -71.88 95.53 1.56 Allowed 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 108.727 -0.842 . . . . 71.2 108.727 176.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 136' ' ' ARG . . . . . 0.47 ' HB2' HD22 ' B' ' 181' ' ' LEU . 90.0 mtt180 -123.93 163.52 21.16 Favored 'General case' 0 C--O 1.248 1.006 0 C-N-CA 123.563 0.745 . . . . 72.12 109.733 -173.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 137' ' ' VAL . . . . . 0.532 HG13 ' HB1' ' B' ' 180' ' ' ALA . 7.8 p -79.84 125.34 38.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 121.553 0.692 . . . . 71.12 110.621 -169.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 138' ' ' VAL . . . . . 0.583 HG12 ' HB3' ' B' ' 181' ' ' LEU . 8.1 m -112.46 141.84 26.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 124.068 0.947 . . . . 72.14 108.554 173.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 139' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -124.76 100.61 6.7 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 107.742 -1.207 . . . . 74.31 107.742 170.091 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 140' ' ' VAL . . . . . 0.487 HG21 HD21 ' C' ' 174' ' ' LEU . 61.3 t -116.59 100.33 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 109.376 -0.601 . . . . 63.22 109.376 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 63.41 30.69 15.4 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.444 0.698 . . . . 15.23 111.151 177.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 142' ' ' GLY . . . . . 0.417 ' O ' ' HB2' ' C' ' 79' ' ' PRO . . . 101.86 -11.6 57.59 Favored Glycine 0 C--N 1.343 0.917 0 CA-C-N 115.713 -0.676 . . . . 45.25 112.409 -179.237 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 143' ' ' ARG . . . . . 0.491 ' NE ' ' HB2' ' C' ' 84' ' ' ASP . 6.0 tpp180 -76.63 92.87 3.54 Favored 'General case' 0 C--N 1.352 0.699 0 N-CA-C 109.573 -0.529 . . . . 73.04 109.573 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 144' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' C' ' 138' ' ' VAL . 39.3 ttp85 -96.66 94.62 7.42 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 115.083 -0.962 . . . . 71.51 108.778 178.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 145' ' ' VAL . . . . . 0.555 ' HA ' ' HD2' ' C' ' 60' ' ' PRO . 28.6 m -131.5 176.16 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-N 114.978 -1.01 . . . . 75.03 109.879 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 49.0 m -125.12 118.83 26.97 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 109.05 -0.722 . . . . 54.21 109.05 178.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 14.1 p -142.0 150.99 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.103 0.561 . . . . 72.53 110.101 -173.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 45.2 ttp180 -103.34 110.58 22.62 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 108.346 -0.983 . . . . 74.22 108.346 169.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 149' ' ' ILE . . . . . 0.547 ' HB ' HD13 ' C' ' 159' ' ' ILE . 38.0 pt -76.46 148.29 80.04 Favored Pre-proline 0 CA--C 1.557 1.245 0 N-CA-C 109.267 -0.642 . . . . 71.41 109.267 170.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -47.88 119.64 4.03 Favored 'Trans proline' 0 C--N 1.381 2.268 0 C-N-CA 124.033 3.156 . . . . 61.44 113.723 -174.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -63.26 132.72 37.36 Favored 'Trans proline' 0 C--N 1.383 2.364 0 C-N-CA 122.903 2.402 . . . . 73.2 110.969 174.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 152' ' ' GLY . . . . . 0.578 ' HA2' ' HB3' ' C' ' 240' ' ' PHE . . . 86.92 53.92 2.74 Favored Glycine 0 C--N 1.334 0.435 0 N-CA-C 111.338 -0.705 . . . . 54.32 111.338 -173.221 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 153' ' ' VAL . . . . . 0.588 HG21 HD11 ' C' ' 159' ' ' ILE . 12.5 p -101.99 143.84 14.17 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.245 0 C-N-CA 123.539 0.736 . . . . 71.13 110.531 -172.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 154' ' ' ARG . . . . . 0.626 ' HA ' ' HB3' ' C' ' 188' ' ' LEU . 49.9 mtp180 -96.82 155.2 16.88 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.698 0.799 . . . . 75.32 112.329 -167.231 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 155' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -53.42 108.82 0.37 Allowed 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 123.267 0.627 . . . . 74.51 110.064 162.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 89.25 18.13 53.92 Favored Glycine 0 C--N 1.343 0.959 0 CA-C-O 119.803 -0.443 . . . . 64.51 113.454 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 157' ' ' SER . . . . . . . . . . . . . 3.5 m -73.35 107.1 5.47 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 117.148 0.474 . . . . 75.43 110.314 172.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 158' ' ' VAL . . . . . 0.488 HG12 HD22 ' C' ' 175' ' ' LEU . 42.1 t -85.02 90.25 2.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-N 114.438 -1.255 . . . . 64.44 108.378 176.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 159' ' ' ILE . . . . . 0.588 HD11 HG21 ' C' ' 153' ' ' VAL . 53.0 mt -75.88 118.96 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 114.972 -1.013 . . . . 52.25 110.179 -178.056 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 53.1 ttt180 -78.06 119.71 21.87 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 109.918 -0.401 . . . . 72.21 109.918 173.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 161' ' ' VAL . . . . . 0.607 HG11 ' SD ' ' C' ' 164' ' ' MET . 21.2 t -125.97 95.47 39.48 Favored Pre-proline 0 CA--C 1.551 1.017 0 N-CA-C 109.062 -0.718 . . . . 75.24 109.062 176.423 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.43 119.63 5.85 Favored 'Trans proline' 0 C--N 1.368 1.59 0 C-N-CA 122.388 2.058 . . . . 63.42 111.253 172.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 113.24 23.32 5.23 Favored Glycine 0 C--N 1.341 0.815 0 CA-C-N 115.899 -0.591 . . . . 53.31 112.843 178.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 164' ' ' MET . . . . . 0.607 ' SD ' HG11 ' C' ' 161' ' ' VAL . 28.6 mtp -148.95 3.96 0.63 Allowed 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 112.884 0.698 . . . . 73.35 112.884 -178.211 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 165' ' ' GLY . . . . . 0.414 ' HA3' ' O ' ' C' ' 173' ' ' ASP . . . -126.37 -123.04 2.63 Favored Glycine 0 N--CA 1.48 1.603 0 CA-C-O 118.346 -1.252 . . . . 64.24 111.067 -177.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . 68.57 73.62 0.68 Allowed Glycine 0 C--N 1.363 2.041 0 CA-C-N 118.516 1.158 . . . . 75.44 113.501 165.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 167' ' ' GLN . . . . . 0.546 ' HB2' ' HB2' ' C' ' 117' ' ' ARG . 14.2 mm100 -67.14 98.06 0.57 Allowed 'General case' 0 C--N 1.348 0.502 0 N-CA-C 107.033 -1.469 . . . . 64.31 107.033 170.292 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 168' ' ' GLY . . . . . 0.432 ' HA3' ' HA2' ' C' ' 116' ' ' GLY . . . 136.57 -140.55 11.58 Favored Glycine 0 C--O 1.217 -0.939 0 CA-C-N 112.745 -2.025 . . . . 13.44 108.881 -161.329 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 169' ' ' ASN . . . . . 0.451 ' ND2' HG21 ' C' ' 90' ' ' VAL . 62.6 t30 -153.3 -51.6 0.02 OUTLIER Pre-proline 0 N--CA 1.497 1.894 0 CA-C-N 119.918 1.859 . . . . 62.44 111.952 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 170' ' ' PRO . . . . . 0.431 ' HD3' ' HB3' ' C' ' 169' ' ' ASN . 86.3 Cg_exo -53.81 161.99 4.13 Favored 'Trans proline' 0 C--N 1.393 2.912 0 C-N-CA 122.559 2.173 . . . . 51.41 113.504 164.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 171' ' ' PRO . . . . . 0.591 ' HA ' ' N ' ' C' ' 87' ' ' GLY . 1.5 Cg_exo -28.63 104.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.39 2.759 1 C-N-CA 125.494 4.13 . . . . 74.02 117.854 -174.438 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -121.66 -146.61 7.42 Favored Glycine 0 C--N 1.341 0.819 0 N-CA-C 109.387 -1.485 . . . . 74.42 109.387 170.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 173' ' ' ASP . . . . . 0.414 ' O ' ' HA3' ' C' ' 165' ' ' GLY . 27.2 t70 -171.16 159.5 5.94 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 117.607 0.703 . . . . 74.51 111.053 -176.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 174' ' ' LEU . . . . . 0.487 HD21 HG21 ' C' ' 140' ' ' VAL . 17.5 tp -124.89 115.4 20.56 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.727 0.811 . . . . 75.22 110.166 170.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 175' ' ' LEU . . . . . 0.488 HD22 HG12 ' C' ' 158' ' ' VAL . 76.7 mt -92.05 89.99 7.19 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.172 0.989 . . . . 71.32 110.291 174.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 176' ' ' LEU . . . . . . . . . . . . . 58.1 mt -76.66 93.78 3.69 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.48 0.712 . . . . 43.02 111.002 176.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 177' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' C' ' 122' ' ' GLU . 8.2 t -86.64 100.71 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 123.371 0.668 . . . . 74.43 109.69 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 178' ' ' VAL . . . . . 0.465 HG12 HD11 ' C' ' 123' ' ' LEU . 14.8 m -73.64 112.43 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.199 0 CA-C-O 122.336 1.065 . . . . 74.01 111.154 -174.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 179' ' ' ARG . . . . . 0.403 ' O ' ' HA ' ' C' ' 124' ' ' PRO . 7.0 mmm180 -91.4 115.39 27.99 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 114.291 -1.322 . . . . 72.33 107.687 170.139 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 180' ' ' LEU . . . . . . . . . . . . . 77.4 mt -69.07 135.39 50.71 Favored 'General case' 0 CA--C 1.561 1.398 0 CA-C-N 118.3 0.5 . . . . 70.51 111.436 178.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 181' ' ' LEU . . . . . 0.435 HD23 ' HB3' ' C' ' 124' ' ' PRO . 16.4 mt -53.43 169.65 0.31 Allowed Pre-proline 0 N--CA 1.501 2.102 0 C-N-CA 126.896 2.078 . . . . 74.2 113.965 -175.595 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -60.86 62.22 0.09 OUTLIER 'Trans proline' 0 C--N 1.397 3.112 0 C-N-CA 123.936 3.09 . . . . 64.12 112.442 161.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 183' ' ' HIS . . . . . 0.513 ' N ' ' HD3' ' C' ' 184' ' ' PRO . 85.7 t60 -162.06 28.17 0.03 OUTLIER Pre-proline 0 CA--C 1.572 1.803 0 C-N-CA 127.82 2.448 . . . . 62.13 107.203 -179.143 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 184' ' ' PRO . . . . . 0.513 ' HD3' ' N ' ' C' ' 183' ' ' HIS . 44.2 Cg_endo -91.81 67.57 1.0 Allowed 'Trans proline' 0 C--N 1.396 3.061 0 C-N-CA 123.719 2.946 . . . . 71.54 111.731 -162.44 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 185' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 2.9 t -87.81 -23.28 6.56 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.788 0 N-CA-C 107.751 -1.203 . . . . 72.23 107.751 -176.302 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 186' ' ' PHE . . . . . 0.532 ' HD2' HD13 ' C' ' 127' ' ' LEU . 56.7 m-85 -125.57 100.55 6.5 Favored 'General case' 0 C--N 1.346 0.439 0 N-CA-C 108.931 -0.766 . . . . 61.44 108.931 -178.031 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 187' ' ' ARG . . . . . 0.427 ' NH2' ' HB2' ' C' ' 184' ' ' PRO . 32.1 ttm105 -99.89 107.82 19.91 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 107.477 -1.305 . . . . 75.14 107.477 -177.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 188' ' ' LEU . . . . . 0.626 ' HB3' ' HA ' ' C' ' 154' ' ' ARG . 53.3 tp -76.52 127.89 33.71 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.199 0.814 . . . . 74.14 113.199 -163.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -112.97 104.46 12.43 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.9 1.28 . . . . 71.33 108.082 169.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 190' ' ' GLY . . . . . 0.405 ' H ' ' NE ' ' C' ' 154' ' ' ARG . . . 68.2 -103.29 0.98 Allowed Glycine 0 CA--C 1.534 1.247 0 CA-C-N 116.437 -0.347 . . . . 74.2 112.533 -176.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 191' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -113.85 -16.4 12.24 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 124.226 1.01 . . . . 60.21 110.469 175.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -99.52 130.7 45.79 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.409 1.084 . . . . 65.13 110.126 -173.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 193' ' ' LEU . . . . . 0.461 HD22 ' HB3' ' C' ' 186' ' ' PHE . 71.1 mt -74.41 152.55 39.49 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.743 0.817 . . . . 52.2 111.501 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 194' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -120.09 106.66 12.19 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 107.531 -1.285 . . . . 75.43 107.531 167.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 195' ' ' ALA . . . . . 0.48 ' HA ' ' O ' ' C' ' 185' ' ' VAL . . . -109.38 -177.73 3.37 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.264 1.026 . . . . 65.11 110.315 -177.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 95.8 m -137.83 118.42 13.95 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.598 -0.89 . . . . 51.32 108.598 165.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 197' ' ' LEU . . . . . . . . . . . . . 62.3 tp -97.09 139.48 33.03 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.182 -0.917 . . . . 73.5 110.482 -175.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -93.53 100.87 13.07 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 109.015 -0.735 . . . . 44.52 109.015 -178.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 199' ' ' VAL . . . . . 0.552 HG22 HG21 ' C' ' 210' ' ' VAL . 94.7 t -114.41 119.35 40.22 Favored Pre-proline 0 N--CA 1.484 1.232 0 C-N-CA 124.068 0.947 . . . . 61.21 109.226 -178.298 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 200' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -72.68 145.78 42.1 Favored 'Trans proline' 0 C--N 1.366 1.469 0 C-N-CA 121.664 1.576 . . . . 71.34 110.75 174.079 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 201' ' ' ALA . . . . . 0.435 ' N ' ' HD2' ' C' ' 202' ' ' PRO . . . -58.26 -38.82 70.27 Favored Pre-proline 0 CA--C 1.552 1.037 0 N-CA-C 115.348 1.61 . . . . 74.35 115.348 -173.428 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 202' ' ' PRO . . . . . 0.552 ' O ' HG13 ' C' ' 206' ' ' VAL . 19.4 Cg_endo -58.45 -52.43 5.54 Favored 'Trans proline' 0 C--N 1.382 2.337 0 CA-C-N 121.547 1.588 . . . . 63.15 111.417 174.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 203' ' ' ILE . . . . . . . . . . . . . 41.7 mt -63.34 -27.6 43.37 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 123.887 0.875 . . . . 63.4 110.793 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.21 -41.59 76.87 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.567 -0.742 . . . . 75.02 112.229 175.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 205' ' ' VAL . . . . . 0.535 HG11 HD11 ' A' ' 261' ' ' LEU . 90.7 t -72.14 -43.65 66.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 122.578 0.351 . . . . 63.41 111.175 -178.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 206' ' ' VAL . . . . . 0.552 HG13 ' O ' ' C' ' 202' ' ' PRO . 0.6 OUTLIER -98.25 -38.08 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 N-CA-C 111.656 0.243 . . . . 52.12 111.656 -168.265 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 106.01 123.62 5.18 Favored Glycine 0 CA--C 1.529 0.914 0 O-C-N 123.122 0.264 . . . . 63.21 112.787 -173.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -158.38 -130.92 1.22 Allowed Glycine 0 C--N 1.34 0.797 0 N-CA-C 110.197 -1.161 . . . . 51.32 110.197 176.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 209' ' ' LYS . . . . . 0.555 ' HG2' ' HA ' ' C' ' 222' ' ' ALA . 8.6 mtmp? -147.65 146.86 29.48 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 117.673 0.737 . . . . 72.12 111.558 176.296 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 210' ' ' VAL . . . . . 0.552 HG21 HG22 ' C' ' 199' ' ' VAL . 31.1 m -141.84 142.59 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 124.417 1.087 . . . . 62.05 109.354 173.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 211' ' ' ARG . . . . . 0.402 HH11 ' HB2' ' C' ' 218' ' ' PRO . 45.2 ttm-85 -81.45 127.81 33.2 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.656 0.782 . . . . 72.44 111.801 -172.359 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -105.98 112.19 25.14 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 107.574 -1.269 . . . . 74.43 107.574 169.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 213' ' ' MET . . . . . 0.578 ' HA ' ' HA ' ' C' ' 218' ' ' PRO . 4.0 ttp -77.97 100.62 6.52 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.812 -0.81 . . . . 63.12 108.812 -176.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.68 177.63 8.8 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 118.02 0.373 . . . . 54.24 110.154 -174.385 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 215' ' ' LEU . . . . . 0.619 HD22 ' HB3' ' C' ' 127' ' ' LEU . 12.3 mt -51.26 -61.25 2.35 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.295 1.038 . . . . 44.41 111.109 -173.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -92.86 13.36 20.65 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.239 -0.891 . . . . 71.0 111.933 -173.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 144.35 154.86 6.25 Favored Glycine 0 C--N 1.346 1.112 0 CA-C-O 119.831 -0.427 . . . . 64.11 113.128 177.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 218' ' ' PRO . . . . . 0.578 ' HA ' ' HA ' ' C' ' 213' ' ' MET . 52.8 Cg_endo -69.1 125.76 12.89 Favored 'Trans proline' 0 C--N 1.365 1.403 0 C-N-CA 122.896 2.398 . . . . 52.13 114.878 179.199 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 219' ' ' VAL . . . . . . . . . . . . . 9.6 p -100.71 173.21 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.809 0 N-CA-C 106.103 -1.814 . . . . 52.53 106.103 168.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 220' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -118.36 158.18 25.74 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.703 -0.48 . . . . 72.32 109.703 174.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 221' ' ' VAL . . . . . . . . . . . . . 38.0 t -115.31 127.95 72.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 124.801 1.24 . . . . 74.03 109.592 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 222' ' ' ALA . . . . . 0.555 ' HA ' ' HG2' ' C' ' 209' ' ' LYS . . . -80.14 102.32 9.31 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 108.69 -0.856 . . . . 73.3 108.69 170.065 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 48.5 t -76.67 126.58 85.8 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-N 115.294 -0.866 . . . . 73.11 109.344 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 224' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' B' ' 245' ' ' LYS . 6.1 Cg_exo -79.87 163.9 23.12 Favored 'Trans proline' 0 C--N 1.366 1.479 0 C-N-CA 123.715 2.943 . . . . 54.33 112.848 171.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -56.73 146.7 75.89 Favored 'Trans proline' 0 C--N 1.37 1.668 0 C-N-CA 122.128 1.885 . . . . 74.0 112.003 164.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 226' ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? 65.51 71.25 0.44 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.533 1.133 . . . . 70.15 110.929 171.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 227' ' ' THR . . . . . 0.528 HG22 HD11 ' C' ' 255' ' ' ILE . 8.0 m -116.95 125.85 52.05 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 124.287 1.035 . . . . 70.3 111.419 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 228' ' ' GLN . . . . . . . . . . . . . 24.9 mp0 -108.23 157.21 18.53 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.404 1.081 . . . . 74.32 111.017 -177.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -77.03 110.59 11.8 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 114.842 -1.072 . . . . 62.12 110.416 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 108.69 8.95 27.59 Favored Glycine 0 N--CA 1.475 1.25 0 CA-C-O 119.871 -0.405 . . . . 62.04 113.0 -169.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 231' ' ' ARG . . . . . . . . . . . . . 49.9 mtp85 -76.07 168.34 20.22 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 109.223 -0.658 . . . . 74.12 109.223 164.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 232' ' ' LYS . . . . . 0.521 ' HD3' ' HB3' ' C' ' 250' ' ' TYR . 2.4 ttmp? -134.29 146.96 50.51 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-O 121.493 0.663 . . . . 71.45 112.452 178.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 233' ' ' LEU . . . . . 0.728 HD13 ' HB2' ' C' ' 251' ' ' LEU . 5.1 mp -111.27 155.61 22.75 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.323 1.449 . . . . 74.21 111.22 -173.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 29.5 ptt-85 -125.93 91.72 3.44 Favored 'General case' 0 CA--C 1.571 1.769 0 O-C-N 125.477 1.736 . . . . 72.34 110.87 175.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 235' ' ' LEU . . . . . 0.477 ' HB2' ' HB3' ' C' ' 249' ' ' LEU . 79.5 mt -90.96 103.72 16.4 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.876 -0.787 . . . . 73.43 108.876 170.072 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -69.71 129.63 40.13 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.525 0.73 . . . . 71.55 111.863 -175.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 75.13 25.9 67.7 Favored Glycine 0 C--N 1.353 1.507 0 O-C-N 123.882 0.739 . . . . 71.42 114.196 175.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 31.1 mmtm -115.14 13.34 16.79 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.172 0.589 . . . . 72.03 110.621 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 239' ' ' GLY . . . . . 0.433 ' HA2' ' HG ' ' C' ' 193' ' ' LEU . . . -91.3 -163.16 38.47 Favored Glycine 0 C--N 1.353 1.51 0 O-C-N 123.511 0.507 . . . . 31.21 113.323 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 240' ' ' PHE . . . . . 0.578 ' HB3' ' HA2' ' C' ' 152' ' ' GLY . 4.6 m-85 -87.05 154.09 54.78 Favored Pre-proline 0 CA--C 1.552 1.05 0 N-CA-C 110.005 -0.368 . . . . 75.14 110.005 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 241' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.33 113.59 1.67 Allowed 'Trans proline' 0 C--N 1.386 2.513 0 C-N-CA 122.915 2.41 . . . . 70.21 111.382 175.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -111.11 164.54 12.14 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-O 118.945 -0.92 . . . . 70.14 111.714 177.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -68.65 -20.7 40.22 Favored 'Trans proline' 0 C--N 1.37 1.692 0 C-N-CA 122.902 2.401 . . . . 71.42 112.536 -178.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -98.18 20.87 11.69 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.1 0.96 . . . . 71.42 110.489 176.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 97.01 177.94 34.79 Favored Glycine 0 C--N 1.348 1.197 0 N-CA-C 111.263 -0.735 . . . . 51.32 111.263 -171.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 246' ' ' ARG . . . . . . . . . . . . . 69.4 mtm180 -71.89 142.6 49.52 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 117.465 0.632 . . . . 61.31 110.593 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -79.42 -158.18 13.79 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 123.846 0.716 . . . . 63.23 112.723 177.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -116.89 -179.86 3.81 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.725 0.81 . . . . 73.54 108.896 -174.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 249' ' ' LEU . . . . . 0.477 ' HB3' ' HB2' ' C' ' 235' ' ' LEU . 10.3 tp -122.41 109.43 14.38 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.48 -0.933 . . . . 74.23 108.48 176.039 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 250' ' ' TYR . . . . . 0.638 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 23.5 m-85 -101.14 105.71 16.89 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.601 -0.727 . . . . 71.43 109.736 178.109 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 251' ' ' LEU . . . . . 0.728 ' HB2' HD13 ' C' ' 233' ' ' LEU . 2.0 mp -98.79 149.89 22.41 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 109.536 -0.542 . . . . 64.53 109.536 -173.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -104.61 128.93 52.76 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 108.16 -1.052 . . . . 73.41 108.16 175.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 253' ' ' VAL . . . . . . . . . . . . . 67.7 t -74.99 134.66 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 112.247 0.462 . . . . 73.5 112.247 -172.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 254' ' ' ARG . . . . . 0.402 ' CZ ' ' HB ' ' C' ' 256' ' ' THR . 1.5 tmm_? -121.69 93.94 4.16 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 107.293 -1.373 . . . . 74.13 107.293 177.122 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 255' ' ' ILE . . . . . 0.528 HD11 HG22 ' C' ' 227' ' ' THR . 46.1 mm -68.49 124.52 24.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 O-C-N 123.264 0.353 . . . . 75.24 110.077 176.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 256' ' ' THR . . . . . 0.402 ' HB ' ' CZ ' ' C' ' 254' ' ' ARG . 0.0 OUTLIER -133.27 170.33 15.6 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.855 1.262 . . . . 53.32 110.772 -174.596 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 257' ' ' ILE . . . . . 0.45 ' HB ' ' HD2' ' C' ' 258' ' ' PRO . 2.9 pp -130.19 157.6 76.67 Favored Pre-proline 0 CA--C 1.556 1.204 0 C-N-CA 124.025 0.93 . . . . 64.54 109.44 178.288 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 258' ' ' PRO . . . . . 0.45 ' HD2' ' HB ' ' C' ' 257' ' ' ILE . 74.3 Cg_endo -67.14 -8.56 22.24 Favored 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 122.817 2.345 . . . . 73.21 114.031 -166.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 56.94 -71.88 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 125.024 1.329 . . . . 72.3 111.246 -164.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -73.88 152.33 40.21 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.831 0.852 . . . . 73.41 111.483 177.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 261' ' ' LEU . . . . . 0.588 HD13 ' HA ' ' C' ' 266' ' ' GLU . 31.2 mt -146.41 141.04 26.77 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.07 0.548 . . . . 71.21 112.043 179.28 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 53.7 p -87.72 145.33 36.73 Favored Pre-proline 0 CA--C 1.551 0.983 0 CA-C-O 117.914 -1.041 . . . . 61.23 108.369 167.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -45.02 -31.3 5.4 Favored 'Trans proline' 0 C--N 1.382 2.34 0 C-N-CA 124.471 3.448 . . . . 74.2 114.906 -176.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -56.83 -72.45 0.08 Allowed 'General case' 0 C--O 1.257 1.465 0 C-N-CA 124.599 1.159 . . . . 71.04 111.482 174.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -68.36 -24.87 64.85 Favored 'General case' 0 C--O 1.212 -0.888 0 CA-C-N 115.068 -0.969 . . . . 65.11 110.339 -176.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 266' ' ' GLU . . . . . 0.588 ' HA ' HD13 ' C' ' 261' ' ' LEU . 11.3 tp10 -59.09 -48.31 82.08 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.689 0.795 . . . . 64.21 109.95 173.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -63.74 -35.58 81.05 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.18 0.592 . . . . 70.32 111.386 177.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 268' ' ' LEU . . . . . . . . . . . . . 11.2 mp -64.52 -50.88 65.64 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 112.279 0.474 . . . . 52.44 112.279 174.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 269' ' ' TRP . . . . . 0.501 ' HH2' ' HD3' ' C' ' 202' ' ' PRO . 89.6 m95 -60.95 -32.74 72.25 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.46 0.704 . . . . 61.11 110.774 178.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 270' ' ' LYS . . . . . 0.433 ' NZ ' ' HB3' ' C' ' 270' ' ' LYS . 3.7 mmmp? -62.42 -57.75 10.13 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.092 0.957 . . . . 75.43 111.241 175.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 31.1 mmtm -66.39 -24.8 66.54 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.476 0.711 . . . . 75.33 112.475 -177.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 272' ' ' LEU . . . . . 0.407 HD12 HD12 ' A' ' 272' ' ' LEU . 55.4 mt -81.67 -32.46 31.77 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 122.981 0.512 . . . . 74.33 110.744 174.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -63.61 -40.19 96.29 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 109.613 -0.514 . . . . 34.13 109.613 172.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -64.23 -42.48 96.53 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.431 1.092 . . . . 63.21 110.355 175.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -62.17 -28.27 69.55 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.1 0.56 . . . . 70.04 111.316 173.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 276' ' ' TYR . . . . . 0.471 ' HA ' ' HD3' ' C' ' 279' ' ' ARG . 3.0 m-85 -85.05 -25.21 27.76 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.254 0.464 . . . . 75.52 112.254 178.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -68.73 -33.74 74.44 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 108.361 -0.977 . . . . 44.24 108.361 171.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -64.87 -15.63 62.17 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 115.127 -0.942 . . . . 55.2 112.491 172.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 279' ' ' ARG . . . . . 0.471 ' HD3' ' HA ' ' C' ' 276' ' ' TYR . 27.0 mtp-105 -82.15 -33.79 29.42 Favored 'General case' 0 C--N 1.357 0.906 0 N-CA-C 109.27 -0.641 . . . . 71.52 109.27 172.268 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.869 0 CA-C-O 118.329 -0.843 . . . . 75.14 109.502 -170.238 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt . . . . . 0 CA--C 1.54 0.588 0 N-CA-C 112.991 0.737 . . . . 62.43 112.991 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.618 ' HD2' HD11 ' A' ' 10' ' ' ILE . 29.0 mmtp -79.28 93.02 5.2 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 108.273 -1.01 . . . . 74.32 108.273 164.125 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -73.93 96.62 2.66 Favored 'General case' 0 C--N 1.352 0.686 0 N-CA-C 107.573 -1.269 . . . . 61.41 107.573 172.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.464 ' CD1' ' HA ' ' A' ' 53' ' ' ALA . 56.2 m-85 -64.39 -22.25 66.9 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 114.954 -1.021 . . . . 73.34 111.726 -171.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -63.48 -50.6 69.03 Favored 'General case' 0 C--N 1.353 0.72 0 O-C-N 123.484 0.49 . . . . 73.33 109.891 171.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.31 -40.25 96.82 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.392 0.677 . . . . 60.32 111.072 -178.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.618 HD11 ' HD2' ' A' ' 5' ' ' LYS . 68.5 mt -58.37 -43.66 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 123.284 0.633 . . . . 74.23 110.261 174.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 92.4 mt -83.26 -2.18 55.0 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 115.845 -0.616 . . . . 51.33 112.586 177.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 67.86 19.41 71.51 Favored Glycine 0 C--N 1.349 1.28 0 N-CA-C 114.639 0.616 . . . . 53.33 114.639 177.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.9 m -102.85 158.49 31.66 Favored Pre-proline 0 N--CA 1.481 1.1 0 C-N-CA 124.06 0.944 . . . . 71.43 110.874 178.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -60.81 158.26 34.1 Favored 'Trans proline' 0 C--N 1.387 2.553 0 C-N-CA 122.77 2.313 . . . . 50.12 112.156 177.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 27.8 mtp180 -74.88 10.85 1.25 Allowed 'General case' 0 CA--C 1.558 1.272 0 O-C-N 121.95 -0.469 . . . . 75.43 112.031 -178.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -119.19 5.63 11.25 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.777 1.631 . . . . 64.11 109.012 -178.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.33 138.53 55.5 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.717 0.807 . . . . 64.31 111.332 -176.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 33.9 p -90.26 -179.71 5.7 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.389 0.676 . . . . 71.11 110.1 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -52.43 -31.95 36.99 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.901 0.88 . . . . 64.21 112.683 179.063 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 19.3 tp10 -87.34 -28.51 22.19 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 112.055 0.391 . . . . 72.43 112.055 -173.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -66.12 -42.94 88.48 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 109.118 -0.697 . . . . 64.03 109.118 168.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.34 -39.85 84.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 O-C-N 124.332 1.02 . . . . 73.31 111.051 174.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -59.89 -56.0 27.2 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.935 0.894 . . . . 71.24 110.521 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 -69.56 -26.77 64.65 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 114.688 -1.142 . . . . 54.12 110.998 -176.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -75.3 -37.26 60.92 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.359 0.663 . . . . 64.0 111.079 178.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -60.06 -54.27 47.91 Favored 'General case' 0 C--O 1.216 -0.66 0 N-CA-C 108.947 -0.76 . . . . 73.1 108.947 173.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.9 mtpt -62.87 -38.02 89.2 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 124.287 0.992 . . . . 74.22 111.526 -178.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.9 ttt180 -53.14 -55.9 20.48 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.615 1.166 . . . . 71.15 110.119 174.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.7 ' HB3' HD13 ' A' ' 50' ' ' ILE . 96.5 mt -79.63 -16.22 56.2 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 115.035 -0.984 . . . . 74.11 111.613 -177.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -81.9 -19.92 39.85 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.717 0.807 . . . . 63.3 110.554 175.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 -89.7 -37.17 14.77 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.186 0.594 . . . . 72.33 110.323 171.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -69.47 -60.45 2.32 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.103 0.478 . . . . 63.33 110.391 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -93.42 34.24 1.18 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.552 0.741 . . . . 63.25 110.286 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.9 t-160 -61.58 102.5 0.31 Allowed Pre-proline 0 C--N 1.356 0.849 0 C-N-CA 124.051 0.94 . . . . 63.41 109.581 178.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -67.89 -19.66 46.16 Favored 'Trans proline' 0 C--N 1.371 1.751 0 C-N-CA 122.879 2.386 . . . . 74.13 112.279 -168.043 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -59.34 -39.08 82.03 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.453 1.101 . . . . 72.45 111.129 173.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.3 t -101.63 -46.63 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 123.494 0.717 . . . . 65.53 110.466 -176.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -100.51 85.63 2.99 Favored 'General case' 0 C--O 1.245 0.826 0 C-N-CA 124.482 1.113 . . . . 61.35 109.933 -177.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.72 69.94 9.6 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.316 0.646 . . . . 73.11 109.525 178.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.0 m -121.21 110.03 34.74 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-O 118.191 -0.909 . . . . 54.41 108.794 177.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -35.88 -61.9 0.26 Allowed 'Trans proline' 0 C--N 1.389 2.658 0 C-N-CA 125.157 3.904 . . . . 72.23 115.051 -171.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -67.49 -27.01 66.65 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 122.891 0.476 . . . . 64.43 111.957 -175.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.44 -30.46 67.3 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-O 121.001 0.429 . . . . 72.14 109.919 175.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.424 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 35.3 mt-10 -83.29 -28.6 28.98 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.166 -0.925 . . . . 62.01 109.337 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.478 ' HA ' ' HZ2' ' A' ' 48' ' ' LYS . 50.7 mt-10 -66.81 -43.46 83.76 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.325 0.65 . . . . 62.44 109.977 173.121 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 35.0 mmtm -61.61 -42.25 98.61 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 115.057 -0.974 . . . . 74.03 109.939 173.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.597 ' HA ' HD12 ' A' ' 50' ' ' ILE . 91.1 t80 -57.41 -37.16 72.28 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 123.737 0.648 . . . . 73.24 111.112 176.052 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.478 ' HZ2' ' HA ' ' A' ' 45' ' ' GLU . 10.4 mtmp? -70.85 -33.59 70.79 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.947 0.499 . . . . 75.14 111.472 176.081 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -71.14 -23.64 62.11 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 122.741 0.416 . . . . 71.44 111.082 173.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.7 HD13 ' HB3' ' A' ' 29' ' ' LEU . 59.9 mt -79.53 -35.68 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.718 1.207 . . . . 70.53 109.331 174.141 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -65.38 -35.86 82.25 Favored 'General case' 0 C--O 1.209 -1.05 0 CA-C-N 115.628 -0.715 . . . . 73.43 109.827 171.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -65.61 -48.9 70.71 Favored 'General case' 0 C--O 1.247 0.946 0 C-N-CA 125.344 1.458 . . . . 63.42 110.542 177.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.464 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . . . -57.87 -48.28 80.27 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 114.265 -1.334 . . . . 65.45 111.243 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -79.19 -19.87 49.78 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 115.044 -0.98 . . . . 72.32 110.891 177.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.31 -45.72 87.49 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 118.404 0.547 . . . . 53.01 109.865 174.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.594 HG13 ' HZ ' ' A' ' 101' ' ' PHE . 22.7 t -71.43 -56.37 10.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 114.138 -1.392 . . . . 74.52 110.042 175.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.676 HD22 ' HD2' ' A' ' 63' ' ' ARG . 43.5 mt -91.93 15.73 12.53 Favored 'General case' 0 CA--C 1.56 1.346 0 N-CA-C 113.644 0.979 . . . . 62.04 113.644 -164.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.2 t -71.63 -71.54 0.26 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 122.813 0.445 . . . . 74.34 110.798 171.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -79.97 143.18 57.02 Favored Pre-proline 0 N--CA 1.471 0.619 0 CA-C-N 115.439 -0.801 . . . . 74.34 110.113 -176.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -58.47 -27.06 80.73 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 123.155 2.57 . . . . 72.41 112.932 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -67.31 -59.12 3.67 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.711 0.805 . . . . 72.3 111.002 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.504 ' HA ' HD12 ' A' ' 65' ' ' ILE . 27.9 mtpt -70.07 -28.92 65.83 Favored 'General case' 0 C--O 1.248 0.987 0 CA-C-N 114.893 -1.048 . . . . 74.54 110.829 -177.358 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.676 ' HD2' HD22 ' A' ' 57' ' ' LEU . 31.6 tpt85 -54.21 -55.61 26.28 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 114.635 -1.166 . . . . 74.11 109.401 168.221 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.43 ' HA ' ' HE ' ' A' ' 64' ' ' ARG . 2.8 mmp_? -65.2 -25.68 67.81 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 115.761 -0.654 . . . . 74.25 112.113 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.504 HD12 ' HA ' ' A' ' 62' ' ' LYS . 78.6 mt -59.38 -47.15 91.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 CA-C-N 118.231 0.469 . . . . 64.42 110.138 171.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -58.35 -52.97 63.35 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 116.033 -0.53 . . . . 75.4 110.255 173.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -56.67 -41.85 77.99 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.477 0.711 . . . . 64.04 112.599 -176.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.8 p -74.13 -23.02 59.23 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 122.844 0.458 . . . . 75.13 110.95 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -71.0 126.58 29.96 Favored 'General case' 0 C--N 1.357 0.909 0 N-CA-C 107.42 -1.326 . . . . 63.45 107.42 170.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.82 13.93 41.88 Favored Glycine 0 N--CA 1.471 1.027 0 N-CA-C 112.108 -0.397 . . . . 52.54 112.108 -169.161 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 42.6 m -140.79 -57.56 0.51 Allowed 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 103.786 -2.672 . . . . 71.23 103.786 173.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 46.7 m -83.82 140.55 31.96 Favored 'General case' 0 C--O 1.247 0.951 0 N-CA-C 104.832 -2.284 . . . . 74.23 104.832 155.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.41 -26.29 17.3 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.027 0.531 . . . . 74.04 110.889 178.226 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -88.82 163.16 36.19 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 123.911 0.884 . . . . 75.1 110.516 176.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -58.23 143.88 96.43 Favored 'Trans proline' 0 C--N 1.371 1.716 0 C-N-CA 122.268 1.979 . . . . 75.41 111.657 163.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.92 159.61 47.73 Favored 'Trans proline' 0 CA--C 1.557 1.665 0 C-N-CA 122.397 2.065 . . . . 74.25 111.341 174.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -51.41 114.57 1.62 Allowed 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 122.927 2.418 . . . . 62.44 112.911 173.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -61.04 140.31 89.13 Favored 'Trans proline' 0 C--N 1.384 2.4 0 C-N-CA 123.311 2.674 . . . . 43.51 112.556 177.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.52 163.86 37.37 Favored 'Trans proline' 0 C--N 1.374 1.896 0 C-N-CA 122.766 2.311 . . . . 71.05 112.445 177.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -58.18 87.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.38 2.186 0 C-N-CA 123.122 2.548 . . . . 51.35 112.648 174.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 150.96 -34.1 0.94 Allowed Glycine 0 C--N 1.338 0.645 0 CA-C-N 114.281 -1.327 . . . . 62.41 110.006 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 106.5 -160.39 14.49 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-N 114.754 -0.723 . . . . 53.03 111.722 178.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -90.89 103.5 16.2 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 123.478 0.711 . . . . 74.41 109.3 178.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -61.63 152.51 30.53 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.728 0.811 . . . . 71.31 111.658 171.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.564 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 70.8 m-85 -142.09 75.04 1.47 Allowed 'General case' 0 C--N 1.353 0.745 0 C-N-CA 124.582 1.153 . . . . 70.22 109.411 172.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.518 ' HA ' ' O ' ' A' ' 162' ' ' PRO . 74.0 m -53.84 84.38 0.0 OUTLIER 'General case' 0 CA--C 1.562 1.405 0 C-N-CA 124.392 1.077 . . . . 74.44 113.316 -178.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 88.32 19.31 53.12 Favored Glycine 0 C--N 1.351 1.369 0 CA-C-N 115.691 -0.686 . . . . 70.11 113.992 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.564 ' HB2' ' HB3' ' A' ' 85' ' ' PHE . 37.4 m-85 -125.95 113.53 17.29 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 118.102 0.951 . . . . 72.34 110.402 -174.042 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -78.0 86.71 4.18 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.655 0.74 . . . . 71.44 111.008 -176.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.691 HG21 HD22 ' A' ' 105' ' ' LEU . 2.3 p -46.49 -36.31 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 124.926 1.291 . . . . 75.21 113.402 172.325 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.477 ' HB2' ' HG3' ' A' ' 170' ' ' PRO . 16.9 tp10 -54.32 -28.25 41.28 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.197 0.999 . . . . 75.33 111.563 -178.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -84.59 -39.53 18.61 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.654 0.781 . . . . 45.35 112.061 178.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 15.3 m-30 -66.15 162.58 19.46 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 113.404 0.89 . . . . 71.01 113.404 -162.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 92.2 p -65.03 164.55 12.63 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 114.025 1.12 . . . . 74.5 114.025 -165.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.88 -39.33 71.37 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 114.392 -1.276 . . . . 74.31 112.948 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -58.81 -45.59 89.59 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 121.654 0.74 . . . . 75.03 110.302 178.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -64.65 -41.0 96.42 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 113.995 -1.457 . . . . 63.23 110.109 178.009 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -73.35 -10.67 59.99 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 115.313 -0.858 . . . . 73.05 111.922 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -90.41 -54.48 3.99 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 118.267 0.485 . . . . 70.02 110.507 169.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 29.0 tp -60.47 -28.02 68.0 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.597 1.159 . . . . 55.03 111.786 -174.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.594 ' HZ ' HG13 ' A' ' 56' ' ' VAL . 95.4 m-85 -117.28 -3.97 11.42 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 123.072 0.549 . . . . 72.11 111.72 177.209 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -47.61 -60.63 5.21 Favored Glycine 0 CA--C 1.537 1.438 0 N-CA-C 116.035 1.174 . . . . 72.43 116.035 -175.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -66.1 5.53 0.65 Allowed 'Trans proline' 0 C--N 1.375 1.935 0 C-N-CA 123.303 2.669 . . . . 23.1 114.789 -175.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -150.58 30.92 1.03 Allowed Glycine 0 C--N 1.356 1.639 0 CA-C-O 118.79 -1.006 . . . . 44.4 112.755 170.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.691 HD22 HG21 ' A' ' 90' ' ' VAL . 17.2 mt -60.8 78.64 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 117.421 0.61 . . . . 74.25 112.502 176.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.413 ' HD1' ' H ' ' A' ' 108' ' ' GLY . 0.4 OUTLIER 38.48 -109.05 0.07 Allowed 'General case' 0 CA--C 1.563 1.464 0 C-N-CA 126.628 1.971 . . . . 72.25 113.069 -176.009 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 70.78 15.45 73.68 Favored Glycine 0 C--N 1.366 2.237 0 CA-C-O 119.165 -0.797 . . . . 44.0 114.323 -177.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.738 ' HA3' ' HB3' ' A' ' 167' ' ' GLN . . . . . . . . 0 C--N 1.366 2.202 0 C-N-CA 125.895 1.712 . . . . 71.34 115.63 166.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.603 ' HD2' ' HB2' ' A' ' 170' ' ' PRO . 24.3 tptp . . . . . 0 N--CA 1.493 1.696 0 N-CA-C 114.533 1.308 . . . . 72.15 114.533 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -83.64 175.79 52.22 Favored Glycine 0 CA--C 1.54 1.637 0 CA-C-N 115.844 -0.616 . . . . 55.22 112.592 175.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.768 ' H ' ' HA3' ' A' ' 166' ' ' GLY . 0.0 OUTLIER -116.72 174.0 6.32 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 124.118 0.967 . . . . 71.34 111.697 -178.359 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -78.46 101.66 7.43 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-O 122.02 0.914 . . . . 74.23 110.089 175.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 10.4 tt -112.2 139.84 47.4 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.938 0.895 . . . . 70.23 108.825 -174.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.4 ' HA ' ' HB2' ' A' ' 175' ' ' LEU . 58.3 ttt180 -94.42 139.02 31.66 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.33 0.652 . . . . 74.51 111.207 -178.129 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.4 ' HB2' HD23 ' B' ' 10' ' ' LEU . . . -134.77 169.43 17.37 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 123.981 0.912 . . . . 41.51 109.368 170.441 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.408 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 0.3 OUTLIER -117.64 115.74 25.68 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 107.0 -1.482 . . . . 61.0 107.0 -174.082 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 50.5 tp -100.52 100.23 11.74 Favored Pre-proline 0 N--CA 1.476 0.846 0 N-CA-C 108.912 -0.773 . . . . 54.05 108.912 -175.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.559 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 77.4 Cg_endo -84.16 111.73 1.64 Allowed 'Trans proline' 0 C--N 1.374 1.909 0 C-N-CA 121.323 1.348 . . . . 75.33 110.049 176.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.597 ' HA ' HG21 ' B' ' 6' ' ' ILE . 52.3 tp -104.99 137.09 43.28 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.706 0.402 . . . . 64.01 110.338 -176.292 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 90.0 m -68.06 126.69 30.3 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.035 0.934 . . . . 71.34 109.638 177.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 53.9 mt -53.6 -51.88 61.61 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.625 1.17 . . . . 70.54 112.47 -171.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -58.77 -37.39 76.16 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 115.115 -0.948 . . . . 75.32 110.007 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.464 ' HB3' ' NH2' ' A' ' 136' ' ' ARG . 44.6 mm-40 -80.48 -14.81 57.95 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.048 -0.978 . . . . 64.33 112.34 -178.43 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -70.51 -52.18 23.62 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 107.823 -1.177 . . . . 41.43 107.823 167.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -53.98 -40.1 66.59 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 116.028 -0.533 . . . . 74.51 110.913 175.128 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 35.9 m170 -78.41 -29.57 47.23 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 122.838 0.455 . . . . 75.25 112.099 -178.113 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 64.04 -138.05 41.42 Favored Glycine 0 N--CA 1.479 1.531 0 O-C-N 123.271 0.357 . . . . 71.54 113.844 176.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.36 -161.09 46.5 Favored Glycine 0 C--N 1.357 1.696 0 O-C-N 123.781 0.342 . . . . 70.42 113.002 175.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -76.23 119.09 19.65 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 109.255 -0.646 . . . . 73.14 109.255 170.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.464 ' NH2' ' HB3' ' A' ' 129' ' ' GLU . 10.0 tpp180 -93.52 123.35 36.77 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 109.336 -0.616 . . . . 74.4 109.336 175.285 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.411 HG11 ' HE ' ' A' ' 144' ' ' ARG . 98.2 t -88.37 104.07 14.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 109.018 -0.734 . . . . 71.24 109.018 175.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.401 HG22 HD11 ' B' ' 6' ' ' ILE . 15.3 t -102.64 125.36 56.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 CA-C-N 115.041 -0.981 . . . . 73.14 108.598 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -102.98 134.03 47.1 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.554 0.741 . . . . 71.3 109.968 -178.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.416 ' HB ' ' HB3' ' B' ' 8' ' ' LEU . 7.2 p -168.3 113.91 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 122.782 0.433 . . . . 75.1 111.547 178.377 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 61.26 24.78 14.84 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.396 1.078 . . . . 74.24 113.047 170.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 99.38 -11.25 61.59 Favored Glycine 0 C--N 1.349 1.286 0 CA-C-N 116.766 -0.197 . . . . 31.1 112.871 -178.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.417 ' NH2' HG23 ' A' ' 145' ' ' VAL . 16.4 tpt180 -87.9 108.42 19.17 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.872 0.869 . . . . 72.12 109.959 175.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.411 ' HE ' HG11 ' A' ' 137' ' ' VAL . 75.4 ttt180 -105.4 94.87 5.45 Favored 'General case' 0 C--O 1.244 0.794 0 C-N-CA 123.916 0.887 . . . . 74.41 108.864 175.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.418 HG22 HG13 ' A' ' 147' ' ' VAL . 11.5 p -95.58 143.67 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 123.205 0.602 . . . . 73.53 110.959 -176.242 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 33.3 t -118.16 85.6 2.38 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.82 0.848 . . . . 31.45 109.277 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.418 HG13 HG22 ' A' ' 145' ' ' VAL . 11.1 m -92.88 114.04 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 C-N-CA 123.364 0.666 . . . . 73.42 111.745 -173.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -71.32 105.56 3.54 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.449 -0.574 . . . . 74.14 109.449 173.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 21.2 pt -102.14 153.9 37.73 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 124.644 1.178 . . . . 74.13 109.772 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -57.6 -166.34 0.02 OUTLIER 'Trans proline' 0 N--CA 1.519 3.007 0 C-N-CA 124.305 3.337 . . . . 60.34 112.591 170.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -46.13 90.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.399 3.217 0 C-N-CA 121.621 1.547 . . . . 74.15 110.864 162.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 36.52 -94.58 0.01 OUTLIER Glycine 0 C--N 1.346 1.131 0 CA-C-N 113.011 -1.904 . . . . 75.51 114.521 -162.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.73 HG11 HG21 ' A' ' 178' ' ' VAL . 5.5 p 172.71 166.34 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 113.364 -1.418 . . . . 75.43 107.986 -162.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.93 146.64 50.57 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 108.59 -0.892 . . . . 73.23 108.59 177.306 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.56 ' HG2' ' NH1' ' A' ' 187' ' ' ARG . 14.9 tp10 -48.95 129.81 17.67 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.447 1.099 . . . . 72.32 112.263 -177.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 91.08 -4.9 81.58 Favored Glycine 0 C--N 1.346 1.114 0 CA-C-N 115.438 -0.801 . . . . 14.21 113.774 179.251 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 57.8 m -66.23 113.82 4.85 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 117.499 0.649 . . . . 74.23 110.409 179.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.415 HG22 HG22 ' A' ' 177' ' ' VAL . 61.1 t -90.13 94.93 5.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 C-N-CA 123.892 0.877 . . . . 72.34 108.949 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.595 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 60.1 mt -77.76 108.8 11.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 108.604 -0.887 . . . . 75.24 108.604 175.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 30.1 ttt180 -76.64 107.09 8.68 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.474 -0.565 . . . . 61.32 109.474 178.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.439 HG13 ' HB3' ' A' ' 174' ' ' LEU . 3.8 p -125.93 95.86 38.74 Favored Pre-proline 0 CA--C 1.55 0.958 0 N-CA-C 109.304 -0.628 . . . . 61.33 109.304 174.237 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.518 ' O ' ' HA ' ' A' ' 86' ' ' SER . 30.0 Cg_exo -62.25 142.04 90.04 Favored 'Trans proline' 0 C--N 1.369 1.636 0 C-N-CA 122.524 2.149 . . . . 74.53 111.597 174.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.424 ' N ' ' HB3' ' A' ' 171' ' ' PRO . . . 121.04 -26.36 6.79 Favored Glycine 0 N--CA 1.475 1.299 0 CA-C-N 117.855 0.298 . . . . 70.43 112.759 175.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 68.4 mtm -116.36 2.74 13.24 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 122.761 0.424 . . . . 64.15 110.858 -178.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.406 ' HA2' HD13 ' A' ' 174' ' ' LEU . . . -83.39 -108.99 0.52 Allowed Glycine 0 C--N 1.353 1.505 0 N-CA-C 110.875 -0.89 . . . . 73.33 110.875 175.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.768 ' HA3' ' H ' ' A' ' 117' ' ' ARG . . . -57.69 108.62 1.44 Allowed Glycine 0 C--O 1.263 1.932 0 N-CA-C 110.902 -0.879 . . . . 74.5 110.902 164.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.738 ' HB3' ' HA3' ' A' ' 108' ' ' GLY . 27.1 mm-40 -67.47 105.2 1.75 Allowed 'General case' 0 N--CA 1.446 -0.63 0 O-C-N 125.453 1.325 . . . . 75.42 109.204 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -178.26 169.08 40.67 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 110.871 -0.891 . . . . 64.21 110.871 -176.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ASN . . . . . 0.519 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . 34.3 t30 -63.03 -67.98 0.94 Allowed Pre-proline 0 CA--C 1.57 1.722 0 CA-C-O 117.026 -1.464 . . . . 63.11 111.639 -170.269 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.603 ' HB2' ' HD2' ' A' ' 115' ' ' LYS . 17.0 Cg_exo -66.23 116.01 3.8 Favored 'Trans proline' 0 C--N 1.396 3.066 0 CA-C-N 122.878 2.063 . . . . 71.13 109.922 167.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.424 ' HB3' ' N ' ' A' ' 163' ' ' GLY . 18.8 Cg_exo -40.5 127.27 2.32 Favored 'Trans proline' 0 C--N 1.368 1.592 0 C-N-CA 125.214 3.943 . . . . 71.25 117.131 -171.274 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -83.11 132.14 10.87 Favored Glycine 0 C--N 1.367 2.289 0 CA-C-O 119.159 -0.801 . . . . 72.4 111.987 164.043 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.445 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 22.8 m-20 -64.48 108.35 1.63 Allowed 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.166 0.586 . . . . 71.14 110.82 -175.047 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.452 HD21 HD21 ' B' ' 8' ' ' LEU . 38.3 tp -83.64 129.31 34.96 Favored 'General case' 0 C--N 1.349 0.545 0 N-CA-C 109.623 -0.51 . . . . 64.32 109.623 175.108 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.4 ' HB2' ' HA ' ' A' ' 120' ' ' ARG . 55.6 mt -99.1 88.45 3.95 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 107.999 -1.112 . . . . 72.12 107.999 178.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.595 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 75.1 mt -70.62 87.32 0.67 Allowed 'General case' 0 C--N 1.35 0.609 0 N-CA-C 109.06 -0.719 . . . . 70.05 109.06 174.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.415 HG22 HG22 ' A' ' 158' ' ' VAL . 19.7 t -82.62 102.15 8.22 Favored 'Isoleucine or valine' 0 C--O 1.248 1.017 0 N-CA-C 105.749 -1.945 . . . . 61.43 105.749 175.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.73 HG21 HG11 ' A' ' 153' ' ' VAL . 5.4 p -73.42 131.89 34.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 115.034 -0.985 . . . . 70.33 110.865 -169.206 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.559 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 28.9 mmt180 -112.72 127.27 56.09 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 106.261 -1.755 . . . . 53.32 106.261 167.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.426 HD23 ' HB3' ' A' ' 125' ' ' LEU . 27.7 mt -80.12 147.7 31.28 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.477 -0.935 . . . . 72.4 108.477 169.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 20.2 mt -53.28 152.49 8.17 Favored Pre-proline 0 N--CA 1.482 1.145 0 O-C-N 124.174 0.921 . . . . 73.14 113.021 -167.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -65.16 5.23 0.53 Allowed 'Trans proline' 0 C--N 1.383 2.354 0 C-N-CA 123.566 2.844 . . . . 71.42 113.425 175.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 61.2 t-80 -59.56 104.0 0.41 Allowed Pre-proline 0 CA--C 1.56 1.341 0 C-N-CA 124.894 1.278 . . . . 73.35 107.985 168.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -80.81 26.36 0.6 Allowed 'Trans proline' 0 C--N 1.372 1.773 0 C-N-CA 123.792 2.995 . . . . 61.24 115.537 -162.161 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.424 HG12 ' HD1' ' A' ' 186' ' ' PHE . 75.5 t -95.22 -61.03 2.28 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.901 0 CA-C-O 118.715 -0.659 . . . . 64.21 110.848 -175.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' PHE . . . . . 0.424 ' HD1' HG12 ' A' ' 185' ' ' VAL . 3.9 m-85 -138.11 92.57 2.67 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 119.064 0.847 . . . . 72.31 110.34 -176.105 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.56 ' NH1' ' HG2' ' A' ' 155' ' ' GLU . 62.1 ttp85 -98.09 98.24 9.58 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.867 0.867 . . . . 75.51 109.391 176.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 193' ' ' LEU . 61.9 tp -68.78 142.15 55.0 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.163 0.985 . . . . 74.21 110.864 178.02 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -152.7 129.03 10.56 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.792 1.237 . . . . 70.31 109.973 -174.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 68.51 -80.5 0.22 Allowed Glycine 0 C--N 1.351 1.412 0 N-CA-C 111.916 -0.474 . . . . 65.41 111.916 -177.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.573 ' HG3' ' HB3' ' A' ' 244' ' ' ALA . 14.6 mm100 -147.47 -11.18 0.41 Allowed 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 125.069 1.347 . . . . 72.32 110.533 166.06 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -103.7 148.81 25.61 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.492 1.117 . . . . 72.32 110.944 -174.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 188' ' ' LEU . 11.6 mt -90.36 162.67 15.03 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.245 1.018 . . . . 63.44 111.02 -175.192 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -131.16 114.51 15.19 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.303 1.041 . . . . 73.14 109.142 173.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.524 ' HB3' HD23 ' A' ' 251' ' ' LEU . . . -135.68 174.92 10.08 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.64 1.176 . . . . 74.34 110.458 -176.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 27.9 m -120.72 144.87 48.02 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.818 0.847 . . . . 70.21 108.878 173.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.503 HD21 HG21 ' A' ' 210' ' ' VAL . 44.7 tp -129.4 115.92 18.26 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.621 0.768 . . . . 72.21 109.457 -175.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -90.24 121.05 31.92 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 108.092 -1.077 . . . . 61.43 108.092 173.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.5 p -139.5 131.02 14.85 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 124.054 0.942 . . . . 64.4 109.136 -173.09 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -72.35 148.58 49.23 Favored 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 121.602 1.535 . . . . 64.51 110.77 174.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -49.54 -47.4 78.17 Favored Pre-proline 0 CA--C 1.561 1.374 0 N-CA-C 114.131 1.16 . . . . 71.34 114.131 -174.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -51.66 -48.09 23.11 Favored 'Trans proline' 0 C--N 1.384 2.442 0 C-N-CA 122.022 1.815 . . . . 63.54 113.725 176.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 22.9 mt -73.12 -29.36 28.31 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 CA-C-N 115.74 -0.664 . . . . 64.32 110.514 -176.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.4 -41.71 76.06 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.979 0.512 . . . . 71.51 111.493 176.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 54.6 t -74.26 -46.88 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 123.867 0.867 . . . . 63.23 111.875 -175.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 91.5 t -90.56 -31.35 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 122.884 0.473 . . . . 74.41 111.569 -175.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 82.49 111.22 0.45 Allowed Glycine 0 C--N 1.343 0.928 0 N-CA-C 112.37 -0.292 . . . . 72.35 112.37 178.272 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.465 ' HA3' ' CE1' ' C' ' 277' ' ' TYR . . . -145.47 -132.61 2.47 Favored Glycine 0 C--O 1.217 -0.957 0 CA-C-O 119.178 -0.79 . . . . 55.24 111.719 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -112.05 134.83 53.36 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 118.008 0.904 . . . . 45.21 110.377 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.503 HG21 HD21 ' A' ' 197' ' ' LEU . 12.2 m -132.88 162.34 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 124.796 1.238 . . . . 63.11 108.633 171.29 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 5.8 tpp180 -86.1 126.96 34.58 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 109.314 -0.624 . . . . 71.41 109.314 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.44 109.93 21.84 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.409 -0.96 . . . . 62.04 108.409 170.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 16.9 tpt -83.0 111.82 19.2 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 108.45 -0.944 . . . . 71.23 108.45 177.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 26.5 p -107.55 -174.47 2.54 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 109.502 -0.555 . . . . 74.1 109.502 -174.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 80.7 mt -63.94 -33.9 76.77 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.019 0.927 . . . . 63.31 111.942 -176.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -97.24 -6.63 34.14 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.421 0.688 . . . . 64.44 112.118 -177.313 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 135.06 -179.03 18.08 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-O 120.054 -0.303 . . . . 33.0 112.61 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -79.6 147.35 19.72 Favored 'Trans proline' 0 CA--C 1.549 1.238 0 C-N-CA 122.94 2.426 . . . . 70.23 113.455 -176.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 31.7 m -136.04 -177.91 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.624 1.569 . . . . 73.4 107.556 172.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -109.77 127.77 54.85 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 118.499 0.59 . . . . 75.04 109.745 169.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 7.0 m -107.52 132.25 55.54 Favored 'Isoleucine or valine' 0 C--O 1.242 0.683 0 C-N-CA 124.178 0.991 . . . . 74.13 108.512 168.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -80.24 97.3 6.89 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.572 -0.899 . . . . 60.25 108.572 178.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 14.9 p -65.62 137.39 96.36 Favored Pre-proline 0 N--CA 1.479 1.007 0 C-N-CA 124.186 0.994 . . . . 63.14 109.732 -175.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -72.04 165.93 31.12 Favored 'Trans proline' 0 C--N 1.374 1.9 0 C-N-CA 122.158 1.906 . . . . 75.51 111.931 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -73.58 164.11 35.75 Favored 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 122.214 1.942 . . . . 72.53 112.916 172.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 64.2 mtt-85 61.44 26.94 16.61 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 125.377 1.471 . . . . 74.04 111.812 169.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.525 HG23 HD21 ' A' ' 233' ' ' LEU . 94.6 m -72.06 103.87 3.4 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.19 1.396 . . . . 64.32 110.873 -176.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -87.08 138.11 31.77 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.636 1.174 . . . . 75.32 110.313 -175.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' ALA . . . . . 0.482 ' HA ' ' HB ' ' A' ' 253' ' ' VAL . . . -67.2 156.64 35.76 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.561 0.744 . . . . 62.31 111.973 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 83.51 -14.87 38.48 Favored Glycine 0 N--CA 1.471 0.99 0 CA-C-N 116.024 -0.535 . . . . 73.32 112.892 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -92.42 160.78 14.93 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 123.691 0.796 . . . . 74.0 110.4 177.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -113.49 113.5 25.22 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.783 0.833 . . . . 72.22 108.79 178.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.525 HD21 HG23 ' A' ' 227' ' ' THR . 64.7 mt -76.24 117.21 17.69 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.793 0.837 . . . . 71.4 109.683 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 27.8 ttm-85 -85.97 102.69 14.0 Favored 'General case' 0 CA--C 1.551 1.001 0 N-CA-C 108.679 -0.859 . . . . 64.14 108.679 172.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.532 HD12 HD23 ' A' ' 249' ' ' LEU . 3.1 mt -87.76 110.9 20.81 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 108.581 -0.896 . . . . 61.12 108.581 -178.108 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -59.38 127.84 34.1 Favored 'General case' 0 CA--C 1.555 1.135 0 O-C-N 124.098 0.874 . . . . 64.43 113.254 -177.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 82.59 6.37 88.63 Favored Glycine 0 C--N 1.353 1.5 0 N-CA-C 114.847 0.699 . . . . 74.2 114.847 170.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -95.31 -20.51 19.1 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 117.515 0.657 . . . . 73.01 112.714 -172.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -82.21 -173.01 48.42 Favored Glycine 0 N--CA 1.478 1.451 0 N-CA-C 113.717 0.247 . . . . 74.43 113.717 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -84.87 146.95 47.21 Favored Pre-proline 0 N--CA 1.483 1.213 0 C-N-CA 122.898 0.479 . . . . 73.13 111.811 -167.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -68.98 157.16 62.96 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 123.323 2.682 . . . . 73.33 113.326 173.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 169.84 -156.51 27.38 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 119.305 -0.719 . . . . 73.52 112.07 -178.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -61.99 -28.27 80.43 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 123.786 2.991 . . . . 70.45 113.286 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 0.573 ' HB3' ' HG3' ' A' ' 191' ' ' GLN . . . -87.38 22.32 2.2 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.252 0.621 . . . . 70.11 111.416 176.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 75.01 -97.32 1.01 Allowed Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.47 -1.052 . . . . 62.24 110.47 -175.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 39.2 mtp180 -128.05 152.4 48.01 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.718 0.807 . . . . 75.41 110.167 166.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -91.57 -175.65 43.07 Favored Glycine 0 C--N 1.342 0.876 0 CA-C-N 116.082 -0.508 . . . . 42.24 112.031 171.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -112.62 -173.25 2.21 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.601 0.76 . . . . 75.44 110.588 178.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.532 HD23 HD12 ' A' ' 235' ' ' LEU . 19.1 tp -125.55 115.6 20.44 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 122.102 -0.374 . . . . 70.31 110.17 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -80.44 123.08 27.74 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.545 -0.539 . . . . 52.51 109.545 172.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.524 HD23 ' HB3' ' A' ' 195' ' ' ALA . 57.8 mt -114.67 119.21 35.93 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.414 0.685 . . . . 72.24 109.415 171.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -77.46 116.94 18.45 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 106.579 -1.637 . . . . 75.41 106.579 176.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.482 ' HB ' ' HA ' ' A' ' 229' ' ' ALA . 24.3 t -75.71 109.68 9.6 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 CA-C-O 121.234 0.54 . . . . 24.43 110.569 -173.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.78 93.36 4.42 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.054 1.341 . . . . 73.14 107.625 177.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.4 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 58.6 mt -83.57 132.41 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-O 120.758 0.313 . . . . 74.34 110.308 -177.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 28.0 p -121.48 172.11 8.3 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.619 1.167 . . . . 73.43 109.889 174.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 257' ' ' ILE . . . . . 0.511 HD12 ' H ' ' A' ' 259' ' ' GLU . 2.1 pp -126.48 154.86 75.15 Favored Pre-proline 0 CA--C 1.562 1.429 0 N-CA-C 107.966 -1.124 . . . . 73.4 107.966 175.125 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 258' ' ' PRO . . . . . 0.461 ' HG3' ' OH ' ' C' ' 276' ' ' TYR . 61.2 Cg_endo -75.96 14.42 1.08 Allowed 'Trans proline' 0 N--CA 1.511 2.549 0 C-N-CA 123.36 2.707 . . . . 74.45 115.713 -164.235 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 259' ' ' GLU . . . . . 0.511 ' H ' HD12 ' A' ' 257' ' ' ILE . 5.6 mm-40 54.1 -125.12 2.28 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 124.142 0.977 . . . . 63.24 111.682 -170.677 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 260' ' ' ARG . . . . . 0.48 ' H ' ' HD3' ' A' ' 260' ' ' ARG . 0.0 OUTLIER -63.61 140.61 58.89 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 118.449 0.568 . . . . 75.12 110.904 -170.443 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.417 HD11 ' CG1' ' C' ' 205' ' ' VAL . 84.9 mt -110.34 160.6 16.42 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.248 0.619 . . . . 55.32 111.584 -171.265 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 21.3 p -103.92 146.85 33.32 Favored Pre-proline 0 CA--C 1.554 1.118 0 C-N-CA 124.652 1.181 . . . . 44.34 108.94 174.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 263' ' ' PRO . . . . . 0.469 ' O ' ' HB3' ' A' ' 266' ' ' GLU . 21.7 Cg_exo -29.46 -58.74 0.14 Allowed 'Trans proline' 0 C--N 1.389 2.692 1 C-N-CA 126.089 4.526 . . . . 74.33 117.948 -163.209 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -72.28 -45.41 60.22 Favored 'General case' 0 C--O 1.211 -0.949 0 CA-C-O 119.217 -0.42 . . . . 71.44 110.711 -176.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -60.17 -31.49 70.16 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 123.955 0.784 . . . . 64.2 109.819 178.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 266' ' ' GLU . . . . . 0.471 ' O ' ' HD3' ' A' ' 270' ' ' LYS . 8.3 tp10 -59.47 -60.58 3.62 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.925 0.89 . . . . 73.45 109.045 171.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -63.99 -21.58 66.56 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 115.235 -0.893 . . . . 64.12 112.198 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 268' ' ' LEU . . . . . 0.418 ' HA ' ' HE2' ' A' ' 271' ' ' LYS . 26.3 tp -79.7 -48.7 13.24 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.548 1.139 . . . . 73.14 110.24 -173.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 70.6 m95 -61.03 -39.07 88.37 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.336 -0.847 . . . . 75.0 110.401 172.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 270' ' ' LYS . . . . . 0.609 ' HG3' HG23 ' C' ' 206' ' ' VAL . 1.0 OUTLIER -63.08 -45.7 90.92 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 123.689 0.618 . . . . 62.43 111.676 176.09 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 271' ' ' LYS . . . . . 0.418 ' HE2' ' HA ' ' A' ' 268' ' ' LEU . 30.3 mtmm -56.63 -50.01 73.28 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 123.082 0.553 . . . . 70.22 110.813 176.345 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 272' ' ' LEU . . . . . 0.418 ' O ' ' HB2' ' A' ' 276' ' ' TYR . 57.8 mt -51.32 -50.97 58.36 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 124.444 1.09 . . . . 63.4 110.4 175.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -72.73 -34.1 66.84 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 114.158 1.17 . . . . 64.51 114.158 -168.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -78.06 -41.68 34.66 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 122.75 0.42 . . . . 74.35 110.105 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -67.39 -30.8 70.67 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 115.98 -0.555 . . . . 71.44 110.52 174.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 276' ' ' TYR . . . . . 0.418 ' HB2' ' O ' ' A' ' 272' ' ' LEU . 35.1 t80 -66.15 -62.76 1.31 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.326 1.051 . . . . 75.02 109.596 176.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -60.43 -44.04 96.19 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.525 1.13 . . . . 70.12 111.168 -172.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -63.13 -17.82 62.75 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 112.467 0.543 . . . . 75.41 112.467 -179.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 -128.27 19.62 6.37 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.668 0.787 . . . . 74.13 111.016 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.08 0 CA-C-O 118.786 -0.626 . . . . 72.21 110.552 -174.956 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.482 1.167 0 N-CA-C 108.866 -0.79 . . . . 71.44 108.866 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 2' ' ' LYS . . . . . 0.6 ' HA ' ' HE3' ' B' ' 2' ' ' LYS . 0.5 OUTLIER -69.31 129.34 39.52 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 123.656 0.597 . . . . 54.1 110.046 -177.22 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 22.7 tm0? -144.71 145.01 31.5 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 108.462 -0.94 . . . . 74.04 108.462 -173.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 72.5 p 54.86 -85.21 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 125.859 1.663 . . . . 52.14 113.041 -178.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 11.3 m -75.01 157.63 34.58 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.018 0.527 . . . . 70.11 110.218 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.597 HG21 ' HA ' ' A' ' 125' ' ' LEU . 36.3 pt -131.43 170.26 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 123.158 0.583 . . . . 64.44 111.071 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -142.04 132.98 25.88 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.583 0.753 . . . . 72.01 109.955 -177.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 8' ' ' LEU . . . . . 0.452 HD21 HD21 ' A' ' 174' ' ' LEU . 48.5 tp -79.05 154.42 29.46 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.775 0.83 . . . . 75.22 111.338 -173.326 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -79.17 -63.56 1.39 Allowed 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.349 0.66 . . . . 62.4 112.153 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 10' ' ' LEU . . . . . 0.4 HD23 ' HB2' ' A' ' 121' ' ' ALA . 86.5 mt 62.91 117.43 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 124.865 1.266 . . . . 74.1 110.566 -163.36 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 28.2 mt . . . . . 0 CA--C 1.584 2.278 0 N-CA-C 116.298 1.962 . . . . 45.35 116.298 -176.756 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.594 0 N-CA-C 109.441 -0.577 . . . . 61.34 109.441 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . -70.81 -36.91 73.19 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.182 0.593 . . . . 74.4 110.547 175.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 13.1 tp -159.72 18.77 0.16 Allowed 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 114.629 -1.169 . . . . 62.04 109.179 176.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 182' ' ' VAL . . . . . 0.602 HG22 ' HA ' ' C' ' 138' ' ' VAL . 55.9 t -76.86 107.0 7.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 116.089 -0.505 . . . . 71.31 111.119 -169.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 183' ' ' ALA . . . . . 0.426 ' HB2' ' HB3' ' C' ' 123' ' ' LEU . . . -86.62 -36.4 18.84 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.13 -0.941 . . . . 65.24 110.214 170.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 184' ' ' HIS . . . . . 0.525 ' HB2' HG12 ' B' ' 182' ' ' VAL . 6.3 t-80 58.42 28.88 17.46 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 125.259 1.424 . . . . 74.15 112.382 171.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 185' ' ' VAL . . . . . . . . . . . . . 53.5 t . . . . . 0 N--CA 1.481 1.123 0 C-N-CA 124.226 1.01 . . . . 71.33 109.443 -168.408 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 41.0 m . . . . . 0 N--CA 1.485 1.298 0 CA-C-O 122.986 1.374 . . . . 71.31 107.752 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 239' ' ' ALA . . . . . 0.733 ' HB2' ' H ' ' C' ' 222' ' ' ALA . . . -97.32 -173.67 2.73 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 114.329 -1.305 . . . . 74.42 111.945 -173.275 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . -117.1 -151.9 9.49 Favored Glycine 0 C--N 1.341 0.848 0 CA-C-N 114.799 -1.091 . . . . 71.23 111.06 178.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -110.39 141.68 43.12 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.941 0.896 . . . . 71.21 112.026 -165.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 242' ' ' TRP . . . . . 0.428 ' HB3' ' HA ' ' C' ' 233' ' ' LEU . 0.4 OUTLIER -171.09 -39.55 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.584 1.154 . . . . 70.32 109.577 174.231 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 243' ' ' GLN . . . . . 0.725 ' HG3' ' HG2' ' C' ' 224' ' ' PRO . 16.1 pt20 -157.36 162.93 39.08 Favored 'General case' 0 C--O 1.244 0.791 0 C-N-CA 124.47 1.108 . . . . 74.22 108.881 169.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -69.07 116.78 7.46 Favored Glycine 0 C--N 1.351 1.384 0 N-CA-C 111.896 -0.482 . . . . 63.11 111.896 -175.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 245' ' ' LYS . . . . . 0.565 ' HE2' ' HB1' ' C' ' 222' ' ' ALA . 9.2 tmtm? . . . . . 0 N--CA 1.476 0.839 0 CA-C-N 117.245 0.522 . . . . 75.34 110.474 -175.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.812 0 CA-C-O 120.668 0.27 . . . . 52.01 110.34 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -37.92 100.97 0.02 OUTLIER 'General case' 0 C--N 1.356 0.872 0 C-N-CA 125.778 1.631 . . . . 70.52 113.442 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 5' ' ' LYS . . . . . 0.635 ' HD2' HD11 ' C' ' 10' ' ' ILE . 25.0 mmtp -74.47 101.14 4.04 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 108.943 -0.762 . . . . 63.2 108.943 167.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 6' ' ' ASP . . . . . 0.408 ' HA ' ' OH ' ' C' ' 66' ' ' TYR . 13.5 t70 -73.73 93.12 2.06 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 106.261 -1.755 . . . . 63.22 106.261 168.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 7' ' ' TYR . . . . . 0.453 ' CD1' ' HA ' ' C' ' 53' ' ' ALA . 63.5 m-85 -61.13 -29.37 69.73 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.074 -0.966 . . . . 73.43 111.744 -171.345 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 8' ' ' TYR . . . . . 0.496 ' HD1' HG23 ' C' ' 13' ' ' VAL . 32.1 m-85 -64.05 -46.08 85.97 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.316 -0.856 . . . . 72.53 111.171 173.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.9 -39.39 94.08 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.103 0.561 . . . . 52.31 111.231 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 10' ' ' ILE . . . . . 0.635 HD11 ' HD2' ' C' ' 5' ' ' LYS . 62.2 mt -57.67 -43.81 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 C-N-CA 123.173 0.589 . . . . 63.34 110.042 174.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 11' ' ' LEU . . . . . 0.49 ' HB3' ' HB1' ' C' ' 25' ' ' ALA . 92.0 mt -82.72 -3.05 55.91 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 115.44 -0.8 . . . . 45.45 112.834 178.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 63.03 34.53 90.22 Favored Glycine 0 C--N 1.355 1.592 0 N-CA-C 114.088 0.395 . . . . 64.33 114.088 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 13' ' ' VAL . . . . . 0.496 HG23 ' HD1' ' C' ' 8' ' ' TYR . 8.3 m -129.38 154.33 80.68 Favored Pre-proline 0 N--CA 1.486 1.362 0 C-N-CA 124.776 1.23 . . . . 64.04 109.456 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -77.24 171.18 18.23 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 122.356 2.037 . . . . 74.43 112.778 -179.09 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 62.6 mtt180 -80.4 29.05 0.3 Allowed 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.518 0.727 . . . . 71.52 111.682 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -117.17 -15.94 10.43 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 125.659 1.583 . . . . 71.24 108.341 175.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.07 110.21 1.52 Allowed 'General case' 0 C--N 1.354 0.77 0 CA-C-N 114.918 -1.037 . . . . 71.14 110.655 -178.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 41.3 p -74.15 174.9 8.06 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 122.936 0.494 . . . . 74.41 109.857 172.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.93 -44.31 29.82 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 124.772 1.229 . . . . 74.45 111.745 -173.557 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 20' ' ' GLU . . . . . 0.668 ' HA ' ' HE3' ' C' ' 23' ' ' LYS . 2.3 tm-20 -65.08 -40.43 94.62 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.241 1.016 . . . . 64.05 110.851 -175.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 21' ' ' GLU . . . . . 0.49 ' HG2' ' NH2' ' C' ' 24' ' ' ARG . 33.6 mt-10 -70.57 -39.39 73.93 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.733 0.813 . . . . 73.42 110.837 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 22' ' ' ILE . . . . . 0.869 HD13 ' HB3' ' C' ' 57' ' ' LEU . 97.0 mt -64.07 -38.18 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.175 1.39 . . . . 61.32 110.368 175.412 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 23' ' ' LYS . . . . . 0.668 ' HE3' ' HA ' ' C' ' 20' ' ' GLU . 22.1 ttpp -67.76 -35.41 78.67 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.144 1.377 . . . . 74.13 110.438 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 24' ' ' ARG . . . . . 0.49 ' NH2' ' HG2' ' C' ' 21' ' ' GLU . 39.7 mtm180 -73.88 -33.04 63.89 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 115.848 -0.615 . . . . 73.52 112.361 172.337 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 25' ' ' ALA . . . . . 0.49 ' HB1' ' HB3' ' C' ' 11' ' ' LEU . . . -63.18 -38.4 91.04 Favored 'General case' 0 C--O 1.251 1.162 0 CA-C-O 121.465 0.65 . . . . 75.32 110.045 174.395 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 26' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -60.74 -58.46 8.38 Favored 'General case' 0 C--O 1.208 -1.1 0 CA-C-N 113.92 -1.491 . . . . 72.31 109.342 173.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 27' ' ' LYS . . . . . 0.412 ' HD3' ' HA ' ' C' ' 24' ' ' ARG . 27.5 mtpp -42.92 -52.3 5.2 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 124.042 0.839 . . . . 74.1 111.574 178.529 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -53.95 -62.65 1.52 Allowed 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.375 -1.284 . . . . 71.15 111.423 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 93.4 mt -84.65 -6.48 59.36 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 112.499 0.555 . . . . 60.22 112.499 -171.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.58 -17.07 20.68 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.134 0.574 . . . . 75.32 110.859 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 65.3 mtm180 -94.61 -33.08 13.14 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 123.324 0.39 . . . . 73.5 110.219 167.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -69.91 -52.77 21.83 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.042 0.537 . . . . 71.12 109.766 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 33' ' ' TYR . . . . . 0.417 ' HD1' ' HB1' ' C' ' 43' ' ' ALA . 51.2 m-85 -88.37 10.38 20.11 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 119.504 -0.284 . . . . 70.15 111.013 178.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 34' ' ' HIS . . . . . . . . . . . . . 14.5 t60 -61.11 116.76 20.68 Favored Pre-proline 0 C--N 1.363 1.173 0 CA-C-O 118.325 -0.845 . . . . 72.34 109.788 -178.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -45.46 -53.43 5.5 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 123.901 3.067 . . . . 71.32 114.272 -172.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -56.14 -40.86 74.47 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.332 0.653 . . . . 60.34 112.63 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 62.1 t -80.13 -31.37 13.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 CA-C-N 115.542 -0.754 . . . . 75.33 110.442 -173.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -143.57 74.85 1.45 Allowed 'General case' 0 C--O 1.243 0.752 0 N-CA-C 108.245 -1.02 . . . . 54.22 108.245 -174.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -69.83 79.54 0.46 Allowed 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 114.919 -1.037 . . . . 62.24 109.975 178.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 16.1 m -136.17 102.17 10.03 Favored Pre-proline 0 CA--C 1.537 0.467 0 N-CA-C 107.486 -1.301 . . . . 74.14 107.486 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -32.83 -55.25 0.36 Allowed 'Trans proline' 0 C--N 1.389 2.703 0 C-N-CA 124.796 3.664 . . . . 63.44 115.256 -175.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.4 -40.57 91.43 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.299 0.64 . . . . 65.44 111.079 -178.129 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 43' ' ' ALA . . . . . 0.417 ' HB1' ' HD1' ' C' ' 33' ' ' TYR . . . -71.54 -24.0 61.86 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.368 0.667 . . . . 62.05 111.205 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -85.81 -28.71 24.31 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.4 -0.592 . . . . 74.04 109.4 -178.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -71.56 -40.87 69.68 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.728 0.811 . . . . 42.53 109.627 170.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 46' ' ' LYS . . . . . 0.529 ' O ' HG12 ' C' ' 50' ' ' ILE . 38.0 mmtm -67.05 -33.18 74.97 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 115.155 -0.93 . . . . 72.32 110.342 173.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -58.58 -46.96 85.84 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.608 0.763 . . . . 62.23 109.376 172.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 48' ' ' LYS . . . . . 0.639 ' HB3' ' HE1' ' C' ' 93' ' ' PHE . 55.4 mtpt -56.58 -42.61 78.95 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 123.894 0.746 . . . . 72.04 110.947 175.335 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -69.68 -24.58 63.62 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 122.936 0.494 . . . . 72.33 112.187 177.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 50' ' ' ILE . . . . . 0.529 HG12 ' O ' ' C' ' 46' ' ' LYS . 27.6 mm -69.71 -41.58 80.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.793 -0.818 . . . . 75.43 108.793 172.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 51' ' ' ASN . . . . . 0.492 ' HB3' ' CD1' ' C' ' 88' ' ' PHE . 58.7 m-80 -68.37 -32.75 73.05 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-N 114.79 -1.096 . . . . 74.04 111.18 177.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -65.84 -54.07 31.57 Favored 'General case' 0 C--O 1.248 0.988 0 C-N-CA 124.677 1.191 . . . . 63.42 110.317 176.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 53' ' ' ALA . . . . . 0.453 ' HA ' ' CD1' ' C' ' 7' ' ' TYR . . . -56.6 -51.04 70.17 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-N 113.627 -1.624 . . . . 63.1 111.297 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -64.35 -35.73 81.83 Favored 'General case' 0 C--O 1.197 -1.664 0 CA-C-N 114.874 -1.057 . . . . 75.01 110.528 177.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 55' ' ' ALA . . . . . 0.441 ' HB2' ' CD2' ' C' ' 88' ' ' PHE . . . -58.97 -44.64 91.55 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 118.378 0.535 . . . . 60.54 111.706 -178.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 86.2 t -68.06 -42.5 85.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 CA-C-O 121.367 0.603 . . . . 72.43 110.432 174.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 57' ' ' LEU . . . . . 0.869 ' HB3' HD13 ' C' ' 22' ' ' ILE . 80.7 mt -93.35 5.13 52.6 Favored 'General case' 0 CA--C 1.563 1.467 0 N-CA-C 113.483 0.92 . . . . 75.02 113.483 -171.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 30.4 t -81.42 -44.24 17.78 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.419 0.688 . . . . 62.42 110.262 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -80.06 128.78 72.47 Favored Pre-proline 0 CA--C 1.515 -0.401 0 CA-C-O 118.246 -0.883 . . . . 72.03 109.08 175.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 60' ' ' PRO . . . . . 0.568 ' O ' ' HG2' ' C' ' 64' ' ' ARG . 87.7 Cg_exo -51.41 -33.11 45.26 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.026 1.817 . . . . 33.23 110.978 162.444 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 61' ' ' GLU . . . . . 0.47 ' HB2' ' HB3' ' C' ' 144' ' ' ARG . 8.6 tp10 -61.36 -63.97 1.1 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.424 0.689 . . . . 62.13 111.365 176.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -64.81 -23.92 67.39 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 122.886 0.474 . . . . 75.23 111.336 -177.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 63' ' ' ARG . . . . . 0.497 HH21 ' HB3' ' C' ' 66' ' ' TYR . 2.6 tpm_? -63.98 -50.57 68.04 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.827 0.851 . . . . 64.42 110.115 172.394 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 64' ' ' ARG . . . . . 0.568 ' HG2' ' O ' ' C' ' 60' ' ' PRO . 28.5 mmm180 -69.62 -25.02 63.74 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 122.369 0.268 . . . . 74.15 110.894 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 66.6 mt -62.97 -46.52 96.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 N-CA-C 109.46 -0.57 . . . . 62.34 109.46 169.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 66' ' ' TYR . . . . . 0.497 ' HB3' HH21 ' C' ' 63' ' ' ARG . 6.5 t80 -58.78 -46.94 86.36 Favored 'General case' 0 CA--C 1.555 1.142 0 CA-C-N 115.33 -0.85 . . . . 74.22 109.809 176.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -56.23 -46.99 79.34 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.869 0.868 . . . . 73.14 111.265 177.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 27.5 p -78.03 -11.85 59.94 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.144 -0.48 . . . . 63.2 111.809 -177.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -73.82 101.63 3.79 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 107.922 -1.14 . . . . 75.22 107.922 173.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 107.77 22.23 7.42 Favored Glycine 0 C--N 1.347 1.172 0 CA-C-N 116.054 -0.521 . . . . 62.51 111.989 -172.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 92.4 m -144.33 -56.72 0.36 Allowed 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 104.233 -2.506 . . . . 72.34 104.233 175.203 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 21.9 m -78.74 140.35 38.3 Favored 'General case' 0 C--O 1.256 1.437 0 N-CA-C 104.619 -2.363 . . . . 73.35 104.619 156.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.5 -22.95 15.75 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.63 0.772 . . . . 73.23 111.273 -176.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.64 154.69 38.38 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 123.423 0.689 . . . . 53.23 109.594 174.13 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -58.82 119.98 7.57 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.194 1.93 . . . . 75.14 110.774 168.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.43 121.25 9.7 Favored 'Trans proline' 0 C--N 1.383 2.376 0 C-N-CA 122.732 2.288 . . . . 63.14 110.918 177.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -41.28 127.54 3.02 Favored 'Trans proline' 0 C--N 1.393 2.887 0 C-N-CA 124.119 3.213 . . . . 51.51 114.091 -169.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 78' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -52.22 142.36 46.21 Favored 'Trans proline' 0 C--N 1.391 2.764 0 C-N-CA 123.8 3.0 . . . . 74.44 113.633 -175.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 79' ' ' PRO . . . . . 0.411 ' HB2' ' HA2' ' C' ' 142' ' ' GLY . 70.8 Cg_exo -54.67 162.87 4.36 Favored 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 123.551 2.834 . . . . 61.04 113.67 176.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -53.97 87.38 0.03 OUTLIER 'Trans proline' 0 C--N 1.387 2.567 0 C-N-CA 123.641 2.894 . . . . 51.5 113.007 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 144.58 -49.51 0.68 Allowed Glycine 0 CA--C 1.524 0.627 0 CA-C-N 113.54 -1.664 . . . . 75.2 109.332 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 142.69 -164.1 27.13 Favored Glycine 0 C--N 1.348 1.237 0 CA-C-N 114.807 -0.697 . . . . 74.45 111.669 -177.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -92.52 111.51 23.13 Favored 'General case' 0 C--O 1.245 0.866 0 C-N-CA 123.907 0.883 . . . . 70.14 108.896 171.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -89.38 -174.4 4.36 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 109.409 -0.589 . . . . 63.13 109.409 170.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 85' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -162.56 71.27 0.3 Allowed 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 107.644 -1.243 . . . . 74.41 107.644 176.482 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 86' ' ' SER . . . . . 0.412 ' OG ' ' HD3' ' C' ' 143' ' ' ARG . 50.5 m -33.73 96.71 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 118.042 2.608 . . . . 45.43 118.042 -166.006 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 68.16 12.71 63.5 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-N 116.093 -0.503 . . . . 74.33 113.695 173.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 88' ' ' PHE . . . . . 0.492 ' CD1' ' HB3' ' C' ' 51' ' ' ASN . 16.8 m-85 -103.74 150.85 23.67 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 124.271 1.028 . . . . 74.44 108.385 -178.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -83.54 69.31 10.06 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.061 0.458 . . . . 72.23 110.995 -173.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 90' ' ' VAL . . . . . 0.435 HG23 ' CE2' ' C' ' 97' ' ' PHE . 0.8 OUTLIER -43.55 -43.35 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 125.719 1.608 . . . . 54.41 111.945 173.007 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -60.8 -30.77 70.26 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 114.787 -1.097 . . . . 74.21 111.641 -172.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -110.85 4.86 20.16 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.107 0.563 . . . . 75.53 111.289 -176.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 93' ' ' PHE . . . . . 0.639 ' HE1' ' HB3' ' C' ' 48' ' ' LYS . 10.5 m-30 -79.84 -177.14 5.79 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.841 -0.537 . . . . 72.45 112.302 -178.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 96.6 p -67.15 161.18 25.23 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.631 0.975 . . . . 45.51 113.631 -165.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -57.81 -56.08 26.53 Favored 'General case' 0 C--O 1.217 -0.641 0 CA-C-N 113.902 -1.499 . . . . 55.43 110.356 176.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -50.88 -45.27 60.03 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.868 0.867 . . . . 65.02 112.226 -176.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 97' ' ' PHE . . . . . 0.435 ' CE2' HG23 ' C' ' 90' ' ' VAL . 7.5 t80 -58.17 -53.18 61.21 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 115.23 -0.895 . . . . 64.25 110.214 174.111 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -77.49 4.38 11.23 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 122.707 0.403 . . . . 51.52 112.047 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -98.47 -45.54 6.08 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.534 0.733 . . . . 74.43 110.663 170.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 22.9 tp -78.65 -56.34 4.5 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.169 0.588 . . . . 73.23 110.281 -178.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 101' ' ' PHE . . . . . 0.484 ' O ' ' HG ' ' C' ' 105' ' ' LEU . 90.4 m-85 -85.26 -15.52 43.19 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.346 -0.843 . . . . 73.25 111.257 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -46.49 -54.78 8.47 Favored Glycine 0 CA--C 1.545 1.932 0 CA-C-O 118.941 -0.922 . . . . 54.11 114.951 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_exo -45.01 -24.5 1.32 Allowed 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 124.681 3.587 . . . . 62.02 116.434 175.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -128.58 14.56 6.09 Favored Glycine 0 C--N 1.355 1.633 0 CA-C-O 118.605 -1.108 . . . . 43.23 114.237 -178.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 105' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' C' ' 101' ' ' PHE . 49.3 mt . . . . . 0 N--CA 1.492 1.671 0 CA-C-N 118.247 1.024 . . . . 73.03 112.246 177.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.478 0 CA-C-O 120.153 -0.248 . . . . 45.25 113.269 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 117' ' ' ARG . . . . . 0.456 ' HG2' ' H ' ' C' ' 118' ' ' ASP . 46.3 ttt-85 -82.98 174.67 10.69 Favored 'General case' 0 C--O 1.25 1.08 0 C-N-CA 123.459 0.704 . . . . 64.44 109.523 175.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 118' ' ' ASP . . . . . 0.456 ' H ' ' HG2' ' C' ' 117' ' ' ARG . 5.0 p-10 -64.52 151.76 43.62 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 121.59 0.709 . . . . 75.42 110.985 173.114 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 119' ' ' LEU . . . . . . . . . . . . . 61.1 tp -108.17 164.04 12.65 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 106.828 -1.545 . . . . 75.21 106.828 172.251 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 74.0 ttt-85 -138.69 120.94 15.85 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 118.665 0.666 . . . . 72.31 109.654 177.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 121' ' ' ALA . . . . . 0.467 ' HB3' HD11 ' C' ' 174' ' ' LEU . . . -140.84 118.81 11.85 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.28 1.032 . . . . 63.21 108.827 -178.106 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -102.05 147.6 26.39 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 110.317 -0.253 . . . . 73.22 110.317 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 123' ' ' LEU . . . . . 0.426 ' HB3' ' HB2' ' B' ' 183' ' ' ALA . 1.9 pt? -134.98 144.94 52.46 Favored Pre-proline 0 N--CA 1.478 0.954 0 C-N-CA 122.998 0.519 . . . . 73.3 111.237 -173.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.4 116.39 4.1 Favored 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 123.011 2.474 . . . . 72.51 110.076 165.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 125' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' C' ' 180' ' ' LEU . 38.4 tp -133.1 149.55 52.12 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.928 0.891 . . . . 74.03 108.687 -176.074 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 126' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.26 157.12 16.03 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 122.635 0.374 . . . . 61.53 110.775 -176.413 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 127' ' ' LEU . . . . . 0.557 HD13 ' HD2' ' C' ' 186' ' ' PHE . 17.9 mt -58.31 -47.02 85.03 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.809 1.244 . . . . 62.25 110.201 173.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 128' ' ' GLU . . . . . 0.463 ' HG3' ' HA ' ' C' ' 215' ' ' LEU . 1.8 mp0 -63.0 -38.08 89.77 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 114.267 -1.333 . . . . 75.24 110.903 178.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -79.54 -17.47 53.94 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 122.749 0.42 . . . . 73.53 111.707 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -75.37 -40.76 57.72 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 109.193 -0.669 . . . . 64.34 109.193 171.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 131' ' ' PHE . . . . . 0.603 ' HB2' HD13 ' C' ' 215' ' ' LEU . 69.2 t80 -62.38 -35.77 80.2 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.61 1.564 . . . . 75.55 111.91 172.007 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 132' ' ' HIS . . . . . . . . . . . . . 43.7 m170 -77.07 -51.31 11.27 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 110.318 -0.253 . . . . 60.22 110.318 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 50.55 -129.29 29.37 Favored Glycine 0 C--N 1.351 1.411 0 O-C-N 124.306 1.004 . . . . 65.31 113.894 177.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.29 -147.51 33.08 Favored Glycine 0 C--N 1.348 1.233 0 C-N-CA 123.128 0.394 . . . . 53.24 113.483 174.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -92.79 110.26 21.7 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.866 0.867 . . . . 71.2 109.898 -177.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 136' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -117.52 135.51 53.89 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.184 0.994 . . . . 72.12 110.152 -174.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 137' ' ' VAL . . . . . . . . . . . . . 35.8 m -76.86 143.98 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 122.644 0.378 . . . . 71.12 111.574 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 138' ' ' VAL . . . . . 0.602 ' HA ' HG22 ' B' ' 182' ' ' VAL . 7.4 p -158.93 139.7 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.28 1.032 . . . . 72.14 108.981 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 139' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' C' ' 143' ' ' ARG . 0.0 OUTLIER -123.8 94.84 4.35 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.559 0.743 . . . . 74.31 110.621 176.112 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 140' ' ' VAL . . . . . . . . . . . . . 11.5 p -147.77 139.85 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 122.977 0.511 . . . . 63.22 111.154 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 61.36 15.58 6.68 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 125.001 1.32 . . . . 15.23 113.72 173.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 142' ' ' GLY . . . . . 0.411 ' HA2' ' HB2' ' C' ' 79' ' ' PRO . . . 114.4 -26.64 9.5 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-N 116.489 -0.323 . . . . 45.25 112.602 -178.439 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 143' ' ' ARG . . . . . 0.457 ' O ' ' HA ' ' C' ' 139' ' ' GLU . 7.7 mmm180 -80.34 101.16 8.79 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.182 0.593 . . . . 73.04 111.593 178.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 144' ' ' ARG . . . . . 0.47 ' HB3' ' HB2' ' C' ' 61' ' ' GLU . 75.2 ttt180 -109.87 89.79 3.12 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 107.402 -1.333 . . . . 71.51 107.402 169.194 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 145' ' ' VAL . . . . . 0.433 HG11 HH21 ' C' ' 143' ' ' ARG . 12.6 p -161.05 163.8 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.904 0 C-N-CA 123.369 0.668 . . . . 75.03 111.26 -166.3 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 20.3 m -85.99 113.26 21.94 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 123.898 0.879 . . . . 54.21 109.972 168.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 3.9 p -89.18 129.45 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.477 0.711 . . . . 72.53 110.192 175.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 42.9 ttt180 -86.59 95.07 9.63 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.152 0.581 . . . . 74.22 109.846 178.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 149' ' ' ILE . . . . . . . . . . . . . 40.7 pt -116.53 107.02 47.53 Favored Pre-proline 0 CA--C 1.546 0.827 0 N-CA-C 108.209 -1.034 . . . . 71.41 108.209 165.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -54.2 167.4 1.25 Allowed 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 123.075 2.516 . . . . 61.44 114.005 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -47.69 115.06 1.27 Allowed 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 123.062 2.508 . . . . 73.2 113.063 171.001 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 152' ' ' GLY . . . . . . . . . . . . . . . 150.43 88.45 0.07 OUTLIER Glycine 0 C--N 1.344 1.021 0 C-N-CA 120.441 -0.885 . . . . 54.32 114.527 -178.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 153' ' ' VAL . . . . . 0.594 HG22 HG11 ' C' ' 178' ' ' VAL . 14.0 p -165.26 151.83 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.201 0 C-N-CA 122.885 0.474 . . . . 71.13 110.001 173.22 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 154' ' ' ARG . . . . . 0.575 ' HD2' ' HG2' ' C' ' 187' ' ' ARG . 37.4 ttp180 -150.55 149.18 29.59 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.182 0.993 . . . . 75.32 109.819 -170.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 155' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -42.3 129.8 3.81 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 125.288 1.435 . . . . 74.51 112.849 -177.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.87 -13.72 58.42 Favored Glycine 0 C--N 1.348 1.219 0 CA-C-N 115.753 -0.658 . . . . 64.51 113.238 177.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 157' ' ' SER . . . . . 0.521 ' O ' HG12 ' C' ' 178' ' ' VAL . 43.8 t -74.8 140.43 43.97 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 108.832 -0.803 . . . . 75.43 108.832 174.162 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 58.6 t -119.73 105.84 18.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.629 -0.714 . . . . 64.44 109.266 -173.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 159' ' ' ILE . . . . . 0.689 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 15.3 mt -72.06 97.16 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.66 0 CA-C-N 114.805 -1.089 . . . . 52.25 108.954 -177.091 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 7.2 ttt180 -78.96 97.61 6.11 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 107.673 -1.232 . . . . 72.21 107.673 175.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 161' ' ' VAL . . . . . . . . . . . . . 2.2 p -101.53 103.99 31.22 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 124.457 1.103 . . . . 75.24 108.734 -178.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -55.36 123.98 15.16 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 123.407 2.738 . . . . 63.42 114.207 -173.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 163' ' ' GLY . . . . . 0.725 ' H ' ' HA ' ' C' ' 173' ' ' ASP . . . 89.79 -10.13 74.8 Favored Glycine 0 N--CA 1.441 -1.003 0 N-CA-C 117.236 1.654 . . . . 53.31 117.236 169.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 164' ' ' MET . . . . . 0.495 ' SD ' HD23 ' C' ' 174' ' ' LEU . 46.9 ttm -75.12 -13.23 60.46 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 119.954 1.877 . . . . 73.35 111.028 -177.303 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . -102.75 -117.12 4.27 Favored Glycine 0 C--N 1.347 1.156 0 CA-C-O 119.368 -0.685 . . . . 64.24 111.691 173.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 166' ' ' GLY . . . . . 0.475 ' HA3' ' HA ' ' C' ' 171' ' ' PRO . . . 87.44 68.86 1.31 Allowed Glycine 0 C--N 1.358 1.766 0 CA-C-N 117.781 0.791 . . . . 75.44 113.7 176.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 167' ' ' GLN . . . . . . . . . . . . . 19.9 mm-40 -80.14 100.21 8.13 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 106.97 -1.493 . . . . 64.31 106.97 173.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . 150.51 -89.23 0.14 Allowed Glycine 0 C--O 1.213 -1.167 0 CA-C-O 118.295 -1.281 . . . . 13.44 110.014 -168.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 169' ' ' ASN . . . . . 0.55 ' HB3' ' HD3' ' C' ' 170' ' ' PRO . 2.9 t-20 -176.36 -59.95 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.706 0 CA-C-O 117.165 -1.398 . . . . 62.44 112.216 164.365 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 170' ' ' PRO . . . . . 0.55 ' HD3' ' HB3' ' C' ' 169' ' ' ASN . 32.4 Cg_exo -61.52 98.91 0.16 Allowed 'Trans proline' 0 C--N 1.402 3.345 0 CA-C-N 122.446 1.909 . . . . 51.41 110.418 165.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 171' ' ' PRO . . . . . 0.543 ' HB2' ' HA2' ' C' ' 163' ' ' GLY . 7.5 Cg_exo -72.33 120.55 6.83 Favored 'Trans proline' 0 C--N 1.362 1.289 0 C-N-CA 122.34 2.027 . . . . 74.02 113.118 -163.24 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -63.78 -73.3 0.56 Allowed Glycine 0 C--N 1.347 1.164 0 O-C-N 124.029 0.831 . . . . 74.42 111.701 175.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 173' ' ' ASP . . . . . 0.725 ' HA ' ' H ' ' C' ' 163' ' ' GLY . 5.4 p-10 -170.46 175.99 4.56 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.245 0.545 . . . . 74.51 111.828 -179.085 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 174' ' ' LEU . . . . . 0.495 HD23 ' SD ' ' C' ' 164' ' ' MET . 11.2 tp -120.87 136.16 55.0 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 114.633 -1.167 . . . . 75.22 108.254 168.23 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 175' ' ' LEU . . . . . 0.404 ' N ' HD12 ' C' ' 174' ' ' LEU . 81.7 mt -98.88 88.92 4.14 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.659 1.184 . . . . 71.32 109.449 176.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 176' ' ' LEU . . . . . 0.689 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 78.8 mt -75.3 94.73 3.06 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.303 0.641 . . . . 43.02 110.012 174.596 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 177' ' ' VAL . . . . . . . . . . . . . 23.5 t -84.62 114.72 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 108.597 -0.89 . . . . 74.43 108.597 -178.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 178' ' ' VAL . . . . . 0.594 HG11 HG22 ' C' ' 153' ' ' VAL . 8.4 p -82.12 126.04 39.88 Favored 'Isoleucine or valine' 0 C--O 1.251 1.15 0 CA-C-O 121.941 0.877 . . . . 74.01 110.822 -176.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 179' ' ' ARG . . . . . . . . . . . . . 24.3 mmt180 -113.82 111.09 21.18 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.188 -1.412 . . . . 72.33 107.188 170.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 180' ' ' LEU . . . . . 0.413 ' HA ' ' O ' ' C' ' 125' ' ' LEU . 93.1 mt -73.29 148.52 43.5 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.86 0.362 . . . . 70.51 110.906 -177.533 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 181' ' ' LEU . . . . . 0.41 ' HB3' ' HD2' ' C' ' 182' ' ' PRO . 24.9 mt -62.12 166.29 6.84 Favored Pre-proline 0 CA--C 1.564 1.483 0 C-N-CA 124.405 1.082 . . . . 74.2 111.899 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 182' ' ' PRO . . . . . 0.41 ' HD2' ' HB3' ' C' ' 181' ' ' LEU . 12.1 Cg_exo -33.95 -20.84 0.02 OUTLIER 'Trans proline' 0 C--N 1.396 3.068 1 C-N-CA 125.413 4.075 . . . . 64.12 118.26 179.329 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 183' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -104.85 96.8 11.34 Favored Pre-proline 0 CA--C 1.568 1.644 0 CA-C-N 119.14 0.882 . . . . 62.13 110.147 165.296 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 184' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -98.14 65.91 0.09 OUTLIER 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 123.658 2.905 . . . . 71.54 110.575 171.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 185' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 36.9 t -94.02 -43.44 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 CA-C-N 115.952 -0.567 . . . . 72.23 110.611 -164.57 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 186' ' ' PHE . . . . . 0.557 ' HD2' HD13 ' C' ' 127' ' ' LEU . 68.1 m-85 -99.9 116.55 32.23 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-O 121.205 0.526 . . . . 61.44 111.345 -167.267 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 187' ' ' ARG . . . . . 0.688 ' HB3' ' HB3' ' C' ' 194' ' ' TYR . 3.2 tmt_? -96.12 107.91 20.28 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.997 1.319 . . . . 75.14 108.919 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 188' ' ' LEU . . . . . . . . . . . . . 45.8 tp -84.16 140.92 31.42 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.445 0.535 . . . . 74.14 112.445 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -144.97 106.28 4.21 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 107.069 -1.456 . . . . 71.33 107.069 162.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 74.96 -96.43 0.96 Allowed Glycine 0 C--N 1.355 1.633 0 N-CA-C 112.022 -0.431 . . . . 74.2 112.022 -177.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 191' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -115.19 -31.28 6.06 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.108 0.963 . . . . 60.21 110.154 173.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -76.97 152.66 35.15 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 116.072 -0.513 . . . . 65.13 111.551 -170.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 193' ' ' LEU . . . . . 0.47 HD21 ' CD1' ' C' ' 240' ' ' PHE . 88.1 mt -119.82 165.59 14.38 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.735 0.814 . . . . 52.2 111.257 -176.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 194' ' ' TYR . . . . . 0.688 ' HB3' ' HB3' ' C' ' 187' ' ' ARG . 27.5 t80 -139.47 107.3 5.66 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.097 -0.956 . . . . 75.43 109.585 170.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 195' ' ' ALA . . . . . 0.479 ' HA ' ' O ' ' C' ' 185' ' ' VAL . . . -104.67 -174.99 2.67 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.22 1.008 . . . . 65.11 110.907 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 65.9 m -132.11 121.09 23.24 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 108.088 -1.079 . . . . 51.32 108.088 164.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 197' ' ' LEU . . . . . . . . . . . . . 41.0 tp -97.53 125.86 42.48 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.292 0.637 . . . . 73.5 111.183 -172.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -73.84 101.85 3.88 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.005 0.922 . . . . 44.52 108.87 176.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 199' ' ' VAL . . . . . 0.572 ' HA ' HG11 ' C' ' 210' ' ' VAL . 26.9 t -121.72 109.28 34.37 Favored Pre-proline 0 N--CA 1.475 0.812 0 N-CA-C 108.62 -0.881 . . . . 61.21 108.62 178.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 200' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -68.45 147.13 70.49 Favored 'Trans proline' 0 C--N 1.37 1.702 0 C-N-CA 121.588 1.526 . . . . 71.34 111.317 175.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 201' ' ' ALA . . . . . 0.505 ' O ' HG23 ' C' ' 205' ' ' VAL . . . -52.44 -49.24 86.65 Favored Pre-proline 0 CA--C 1.553 1.07 0 CA-C-O 118.02 -0.99 . . . . 74.35 112.958 -173.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 202' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -51.12 -47.27 26.58 Favored 'Trans proline' 0 C--N 1.387 2.6 0 C-N-CA 121.649 1.566 . . . . 63.15 112.891 176.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 203' ' ' ILE . . . . . 0.518 ' HA ' HG12 ' C' ' 206' ' ' VAL . 47.0 mt -68.56 -34.18 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 123.044 0.538 . . . . 63.4 111.139 -178.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -70.24 -28.45 65.26 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.659 0.783 . . . . 75.02 112.208 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 205' ' ' VAL . . . . . 0.505 HG23 ' O ' ' C' ' 201' ' ' ALA . 55.0 t -86.39 -40.1 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 116.084 -0.507 . . . . 63.41 111.374 178.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 206' ' ' VAL . . . . . 0.609 HG23 ' HG3' ' A' ' 270' ' ' LYS . 14.0 p -80.16 -37.83 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 O-C-N 123.375 0.422 . . . . 52.12 111.355 -171.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 88.08 61.6 1.48 Allowed Glycine 0 N--CA 1.438 -1.177 0 CA-C-N 115.741 -0.663 . . . . 63.21 112.257 -168.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -101.38 -136.65 9.39 Favored Glycine 0 C--O 1.246 0.882 0 N-CA-C 111.431 -0.668 . . . . 51.32 111.431 176.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 209' ' ' LYS . . . . . 0.564 ' HG2' ' HA ' ' C' ' 222' ' ' ALA . 8.3 mtmp? -140.28 136.3 33.15 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.395 0.617 . . . . 72.12 110.92 178.413 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 210' ' ' VAL . . . . . 0.572 HG11 ' HA ' ' C' ' 199' ' ' VAL . 34.3 m -119.24 -179.86 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.539 1.535 . . . . 62.05 107.272 169.22 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 211' ' ' ARG . . . . . 0.62 ' HD3' ' HB2' ' C' ' 218' ' ' PRO . 23.1 ttm105 -132.76 130.6 40.15 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 118.976 0.807 . . . . 72.44 112.095 -178.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -97.0 115.05 26.74 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.32 1.048 . . . . 74.43 108.492 168.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 213' ' ' MET . . . . . . . . . . . . . 4.2 tmm? -71.56 101.91 2.6 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 107.418 -1.327 . . . . 63.12 107.418 171.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 214' ' ' THR . . . . . 0.408 ' OG1' HG12 ' C' ' 219' ' ' VAL . 0.2 OUTLIER -98.88 174.25 6.46 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.348 0.594 . . . . 54.24 110.234 -173.78 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 215' ' ' LEU . . . . . 0.603 HD13 ' HB2' ' C' ' 131' ' ' PHE . 30.7 mt -65.48 -33.89 77.0 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.309 1.444 . . . . 44.41 112.712 -169.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.23 10.71 23.7 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 114.94 -1.027 . . . . 71.0 111.472 -178.149 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 143.65 149.37 5.08 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-O 119.86 -0.411 . . . . 64.11 112.453 176.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 218' ' ' PRO . . . . . 0.62 ' HB2' ' HD3' ' C' ' 211' ' ' ARG . 73.3 Cg_endo -77.24 106.42 2.23 Favored 'Trans proline' 0 CA--C 1.557 1.634 0 C-N-CA 122.606 2.204 . . . . 52.13 113.081 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 219' ' ' VAL . . . . . 0.408 HG12 ' OG1' ' C' ' 214' ' ' THR . 7.2 p -88.32 138.26 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 123.558 0.743 . . . . 52.53 109.903 -178.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 220' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -89.01 111.21 21.88 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 108.734 -0.839 . . . . 72.32 108.734 174.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 221' ' ' VAL . . . . . . . . . . . . . 58.7 t -78.97 128.09 38.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 114.539 -1.209 . . . . 74.03 110.627 -178.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 222' ' ' ALA . . . . . 0.733 ' H ' ' HB2' ' B' ' 239' ' ' ALA . . . -85.42 105.48 16.08 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 124.424 1.09 . . . . 73.3 109.678 176.026 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 59.1 t -85.71 126.73 65.33 Favored Pre-proline 0 C--O 1.213 -0.858 0 N-CA-C 108.105 -1.072 . . . . 73.11 108.105 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 224' ' ' PRO . . . . . 0.725 ' HG2' ' HG3' ' B' ' 243' ' ' GLN . 10.4 Cg_exo -79.09 156.77 26.48 Favored 'Trans proline' 0 CA--C 1.555 1.546 0 C-N-CA 123.847 3.031 . . . . 54.33 112.221 166.325 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.43 148.17 64.02 Favored 'Trans proline' 0 C--N 1.387 2.587 0 C-N-CA 123.208 2.605 . . . . 74.0 113.635 -178.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 226' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.5 91.64 0.08 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.229 1.011 . . . . 70.15 112.215 178.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 227' ' ' THR . . . . . 0.511 HG22 HG11 ' C' ' 253' ' ' VAL . 34.0 m -140.9 124.46 16.85 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 115.37 -0.832 . . . . 70.3 111.869 176.27 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 228' ' ' GLN . . . . . . . . . . . . . 27.1 mp0 -98.11 161.39 13.74 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-O 122.483 1.135 . . . . 74.32 111.024 170.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 229' ' ' ALA . . . . . 0.437 ' HB2' ' H ' ' C' ' 255' ' ' ILE . . . -67.85 150.04 49.08 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-N 113.729 -1.578 . . . . 62.12 109.375 173.257 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 86.46 -4.17 86.38 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.304 -0.474 . . . . 62.04 113.03 -174.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 231' ' ' ARG . . . . . . . . . . . . . 45.5 mtt180 -76.65 170.34 16.61 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 117.789 0.794 . . . . 74.12 109.334 163.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 232' ' ' LYS . . . . . 0.568 ' HD3' ' HB3' ' C' ' 250' ' ' TYR . 3.9 ttmp? -146.55 139.68 25.58 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.205 0.457 . . . . 71.45 111.921 -173.157 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 233' ' ' LEU . . . . . 0.584 ' O ' ' HA ' ' C' ' 250' ' ' TYR . 2.4 mp -107.77 151.79 25.23 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.625 1.17 . . . . 74.21 109.89 -177.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -118.83 90.18 3.28 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.638 0.775 . . . . 72.34 109.255 171.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 235' ' ' LEU . . . . . 0.558 HD12 HD23 ' C' ' 249' ' ' LEU . 49.1 mt -74.25 108.39 7.01 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 109.13 -0.693 . . . . 73.43 109.13 172.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -71.08 125.57 27.25 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.879 0.872 . . . . 71.55 111.125 -175.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 71.44 37.14 62.66 Favored Glycine 0 C--N 1.349 1.251 0 O-C-N 123.532 0.52 . . . . 71.42 112.968 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 20.4 mmtm -126.07 14.95 7.9 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.913 0.885 . . . . 72.03 111.065 176.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -93.0 -167.48 38.91 Favored Glycine 0 C--N 1.352 1.449 0 N-CA-C 112.002 -0.439 . . . . 31.21 112.002 171.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 240' ' ' PHE . . . . . 0.47 ' CD1' HD21 ' C' ' 193' ' ' LEU . 3.6 m-85 -69.06 153.45 96.06 Favored Pre-proline 0 N--CA 1.478 0.96 0 C-N-CA 123.74 0.816 . . . . 75.14 111.529 176.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 241' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -65.91 118.86 5.85 Favored 'Trans proline' 0 C--N 1.377 2.054 0 C-N-CA 123.75 2.967 . . . . 70.21 112.411 -175.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -126.84 -169.52 12.74 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-N 115.719 -0.673 . . . . 70.14 112.548 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -72.14 -31.61 11.84 Favored 'Trans proline' 0 C--N 1.383 2.344 0 C-N-CA 123.049 2.5 . . . . 71.42 111.006 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -80.35 6.35 12.34 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.82 0.848 . . . . 71.42 111.807 176.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 111.04 -76.56 0.22 Allowed Glycine 0 C--N 1.349 1.285 0 N-CA-C 109.907 -1.277 . . . . 51.32 109.907 -178.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 246' ' ' ARG . . . . . . . . . . . . . 29.4 mtm180 -146.09 166.44 26.12 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.847 1.259 . . . . 61.31 109.468 174.562 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -80.57 -158.89 19.53 Favored Glycine 0 C--N 1.347 1.172 0 CA-C-N 116.345 -0.388 . . . . 63.23 112.241 172.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -123.82 135.24 53.65 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 117.085 0.443 . . . . 73.54 109.836 -177.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 249' ' ' LEU . . . . . 0.558 HD23 HD12 ' C' ' 235' ' ' LEU . 21.0 tp -88.33 116.15 26.35 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 114.97 -1.014 . . . . 74.23 110.133 -178.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 250' ' ' TYR . . . . . 0.584 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 16.0 m-85 -102.05 99.87 10.07 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 109.838 -0.431 . . . . 71.43 109.838 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 251' ' ' LEU . . . . . 0.564 ' HB2' HD13 ' C' ' 233' ' ' LEU . 1.6 mp -97.15 136.2 38.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.8 -0.563 . . . . 64.53 110.152 -174.383 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -88.14 118.71 27.91 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 108.047 -1.094 . . . . 73.41 108.047 174.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 253' ' ' VAL . . . . . 0.511 HG11 HG22 ' C' ' 227' ' ' THR . 94.0 t -60.14 131.14 24.66 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 123.348 0.659 . . . . 73.5 111.066 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 254' ' ' ARG . . . . . 0.47 ' CZ ' ' HB ' ' C' ' 256' ' ' THR . 2.1 tmm_? -124.02 98.32 5.74 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 107.507 -1.294 . . . . 74.13 107.507 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 255' ' ' ILE . . . . . 0.437 ' H ' ' HB2' ' C' ' 229' ' ' ALA . 52.0 mm -72.45 120.4 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 123.356 0.41 . . . . 75.24 109.903 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 256' ' ' THR . . . . . 0.47 ' HB ' ' CZ ' ' C' ' 254' ' ' ARG . 0.0 OUTLIER -125.39 164.46 20.38 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.012 0.925 . . . . 53.32 111.1 -176.131 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 2.8 pp -137.61 149.07 63.76 Favored Pre-proline 0 CA--C 1.554 1.099 0 C-N-CA 124.224 1.01 . . . . 64.54 108.328 175.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -80.11 16.52 1.49 Allowed 'Trans proline' 0 C--N 1.375 1.936 0 C-N-CA 122.599 2.2 . . . . 73.21 113.243 -171.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 57.83 -79.87 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.237 1.415 . . . . 72.3 111.635 -173.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -78.53 148.13 33.52 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.97 0.908 . . . . 73.41 109.901 -178.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 261' ' ' LEU . . . . . . . . . . . . . 82.1 mt -132.88 165.59 24.27 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 121.524 0.678 . . . . 71.21 111.329 -178.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 1.6 p -83.61 147.4 52.27 Favored Pre-proline 0 CA--C 1.552 1.035 0 CA-C-N 114.635 -1.166 . . . . 61.23 108.894 164.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -47.73 -31.63 15.1 Favored 'Trans proline' 0 C--N 1.387 2.558 0 C-N-CA 124.476 3.451 . . . . 74.2 114.988 -173.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -60.43 -65.76 0.63 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.88 0.872 . . . . 71.04 109.73 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -57.67 -42.56 83.82 Favored 'General case' 0 C--O 1.216 -0.697 0 CA-C-N 114.466 -1.243 . . . . 65.11 109.767 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 266' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -51.82 -46.12 64.19 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 123.992 0.917 . . . . 64.21 110.718 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -67.81 -43.67 79.08 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.5 0.72 . . . . 70.32 112.05 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 268' ' ' LEU . . . . . . . . . . . . . 10.6 mp -64.72 -37.35 87.29 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 120.765 0.317 . . . . 52.44 111.295 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 84.5 m95 -70.03 -32.26 70.31 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.536 0.735 . . . . 61.11 110.377 175.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 3.9 mmmp? -57.91 -50.65 72.61 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 122.852 0.461 . . . . 75.43 109.823 171.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 9.7 mmpt? -56.33 -52.53 64.2 Favored 'General case' 0 C--O 1.252 1.223 0 O-C-N 124.183 0.927 . . . . 75.33 111.191 -178.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 57.6 mt -51.99 -60.65 2.94 Favored 'General case' 0 C--N 1.355 0.845 0 CA-C-N 115.323 -0.853 . . . . 74.33 110.216 174.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -51.9 -44.77 63.94 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.927 0.891 . . . . 34.13 112.338 -173.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -62.21 -45.49 93.14 Favored 'General case' 0 C--O 1.252 1.235 0 C-N-CA 123.579 0.752 . . . . 63.21 110.818 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -58.54 -32.03 68.49 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 116.096 -0.502 . . . . 70.04 111.399 175.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 276' ' ' TYR . . . . . 0.703 ' HA ' ' HD3' ' C' ' 279' ' ' ARG . 1.4 m-85 -85.56 -23.09 27.8 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.09 0.556 . . . . 75.52 111.801 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 277' ' ' TYR . . . . . 0.465 ' CE1' ' HA3' ' A' ' 208' ' ' GLY . 20.4 m-30 -70.43 -30.74 67.67 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 109.424 -0.584 . . . . 44.24 109.424 174.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -59.72 -18.74 45.09 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-N 115.361 -0.836 . . . . 55.2 112.384 171.203 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 279' ' ' ARG . . . . . 0.703 ' HD3' ' HA ' ' C' ' 276' ' ' TYR . 17.5 mtp-105 -87.76 -26.91 22.65 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.784 0.834 . . . . 71.52 110.844 175.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.025 0 C-N-CA 123.243 0.617 . . . . 75.14 110.277 -172.654 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt . . . . . 0 N--CA 1.479 0.988 0 N-CA-C 114.165 1.172 . . . . 62.43 114.165 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -65.85 109.1 2.36 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 109.278 -0.638 . . . . 74.32 109.278 169.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -73.83 89.35 1.84 Allowed 'General case' 0 C--O 1.246 0.917 0 N-CA-C 107.165 -1.42 . . . . 61.41 107.165 170.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.445 ' HB2' HD11 ' A' ' 57' ' ' LEU . 67.1 m-85 -61.29 -27.94 68.83 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 113.9 -1.5 . . . . 73.34 111.565 -172.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -68.13 -41.7 81.27 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 122.962 0.505 . . . . 73.33 110.255 177.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.13 -41.77 97.07 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.045 0.538 . . . . 60.32 110.497 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 65.2 mt -58.93 -36.73 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 O-C-N 123.804 0.69 . . . . 74.23 110.29 174.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 91.2 mt -84.71 -10.49 57.21 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 113.303 0.853 . . . . 51.33 113.303 177.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 68.74 32.52 74.33 Favored Glycine 0 CA--C 1.537 1.427 0 N-CA-C 114.03 0.372 . . . . 53.33 114.03 -178.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.3 m -118.35 162.67 29.04 Favored Pre-proline 0 N--CA 1.484 1.226 0 C-N-CA 124.609 1.164 . . . . 71.43 109.554 174.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.401 ' HG2' ' HB2' ' A' ' 17' ' ' ALA . 11.9 Cg_endo -54.79 152.35 28.83 Favored 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 122.772 2.315 . . . . 50.12 112.586 175.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 76.1 mtt-85 -74.84 19.43 0.14 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 113.648 0.981 . . . . 75.43 113.648 -172.016 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -148.79 12.68 0.89 Allowed 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 124.605 1.162 . . . . 64.11 109.128 -177.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.401 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . . . -66.06 145.49 55.79 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.789 1.235 . . . . 64.31 113.457 -171.032 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.1 p -70.45 162.71 28.22 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.363 1.065 . . . . 71.11 111.658 -178.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -57.82 -30.18 65.53 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.145 0.978 . . . . 64.21 111.262 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.499 ' HA ' ' HE2' ' A' ' 23' ' ' LYS . 0.8 OUTLIER -69.07 -40.92 78.17 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.746 0.818 . . . . 72.43 109.899 178.949 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.507 ' HG2' ' NH2' ' A' ' 24' ' ' ARG . 42.7 mt-10 -67.98 -35.96 79.23 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.415 0.686 . . . . 64.03 110.833 176.385 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.81 -33.76 65.54 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 C-N-CA 124.592 1.157 . . . . 73.31 110.326 175.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.499 ' HE2' ' HA ' ' A' ' 20' ' ' GLU . 37.6 ttpt -76.19 -33.26 59.29 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.74 1.216 . . . . 71.24 110.483 179.418 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.507 ' NH2' ' HG2' ' A' ' 21' ' ' GLU . 50.2 mtm-85 -70.82 -40.97 72.14 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.156 0.583 . . . . 54.12 110.235 173.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.97 -33.88 75.5 Favored 'General case' 0 C--O 1.237 0.402 0 O-C-N 124.163 0.914 . . . . 64.0 110.719 176.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -60.33 -56.97 15.0 Favored 'General case' 0 C--O 1.215 -0.724 0 O-C-N 123.913 0.758 . . . . 73.1 109.9 176.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.496 ' NZ ' ' HA ' ' A' ' 24' ' ' ARG . 35.1 mtmm -60.32 -44.81 95.12 Favored 'General case' 0 N--CA 1.482 1.164 0 O-C-N 123.869 0.73 . . . . 74.22 111.132 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 46.1 ttt180 -47.25 -52.61 15.55 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 125.087 1.355 . . . . 71.15 111.945 176.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.539 HD13 HD12 ' A' ' 50' ' ' ILE . 62.7 mt -91.74 -13.94 30.78 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.559 -0.746 . . . . 74.11 111.656 -173.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -80.51 -18.51 48.3 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.259 0.624 . . . . 63.3 109.991 172.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 51.1 mtp180 -94.55 -39.11 10.56 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.04 0.936 . . . . 72.33 110.331 172.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -71.22 -40.24 71.24 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 122.537 0.335 . . . . 63.33 111.671 -177.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -106.97 24.62 12.5 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.879 0.472 . . . . 63.25 110.319 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 75.8 t60 -57.18 94.79 0.05 OUTLIER Pre-proline 0 N--CA 1.484 1.259 0 C-N-CA 124.73 1.212 . . . . 63.41 112.105 -171.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -72.02 -22.2 23.22 Favored 'Trans proline' 0 C--N 1.368 1.575 0 C-N-CA 122.652 2.235 . . . . 74.13 111.883 -164.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -53.57 -35.82 61.21 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.473 1.509 . . . . 72.45 111.615 176.132 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 89.4 t -115.42 -40.32 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 CA-C-O 120.905 0.383 . . . . 65.53 110.113 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -100.5 82.46 2.47 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.23 1.012 . . . . 61.35 110.045 -177.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.99 60.87 6.51 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.043 0.537 . . . . 73.11 110.189 -178.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 63.2 m -105.14 123.85 38.42 Favored Pre-proline 0 N--CA 1.481 1.096 0 CA-C-O 117.81 -1.09 . . . . 54.41 109.706 -177.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -40.88 -51.91 3.51 Favored 'Trans proline' 0 C--N 1.391 2.778 0 C-N-CA 124.767 3.645 . . . . 72.23 114.322 -175.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -51.94 -51.17 58.9 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.067 0.947 . . . . 64.43 110.849 175.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.04 -15.46 60.64 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.403 0.681 . . . . 72.14 111.81 -178.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.6 mm-40 -74.93 -60.77 2.14 Favored 'General case' 0 C--N 1.36 1.024 0 N-CA-C 108.236 -1.024 . . . . 62.01 108.236 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -56.59 -44.45 81.07 Favored 'General case' 0 C--N 1.354 0.793 0 CA-C-N 114.214 -1.357 . . . . 62.44 109.826 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.492 ' O ' HG12 ' A' ' 50' ' ' ILE . 9.6 tppt? -66.89 -43.77 82.61 Favored 'General case' 0 C--N 1.357 0.897 0 O-C-N 124.249 0.968 . . . . 74.03 111.078 -175.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -55.66 -44.39 77.21 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 123.765 0.665 . . . . 73.24 110.523 175.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.7 mtpm? -65.37 -35.64 81.58 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 115.54 -0.754 . . . . 75.14 111.578 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -67.96 -31.24 70.83 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 122.921 0.488 . . . . 71.44 110.747 173.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.539 HD12 HD13 ' A' ' 29' ' ' LEU . 12.0 mm -67.01 -37.54 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 N-CA-C 109.099 -0.704 . . . . 70.53 109.099 173.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.43 ' O ' ' HB2' ' A' ' 55' ' ' ALA . 53.2 m-80 -69.43 -31.54 69.94 Favored 'General case' 0 C--O 1.207 -1.137 0 CA-C-N 115.283 -0.871 . . . . 73.43 111.388 177.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -64.22 -53.77 43.92 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.788 0.804 . . . . 63.42 109.874 174.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.418 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . . . -56.8 -53.27 59.8 Favored 'General case' 0 C--O 1.25 1.096 0 CA-C-N 113.569 -1.651 . . . . 65.45 111.915 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -61.51 -40.35 94.3 Favored 'General case' 0 C--O 1.209 -1.054 0 CA-C-N 115.023 -0.989 . . . . 72.32 110.517 176.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.43 ' HB2' ' O ' ' A' ' 51' ' ' ASN . . . -54.8 -47.51 73.93 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.297 0.639 . . . . 53.01 112.123 -176.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 78.7 t -69.71 -45.36 77.79 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 O-C-N 123.738 0.649 . . . . 74.52 110.671 177.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.445 HD11 ' HB2' ' A' ' 7' ' ' TYR . 58.4 mt -90.84 6.47 44.24 Favored 'General case' 0 CA--C 1.563 1.455 0 N-CA-C 113.603 0.964 . . . . 62.04 113.603 -172.094 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 44.4 t -71.95 -51.87 19.95 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 124.409 1.084 . . . . 74.34 111.339 -178.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -102.29 140.05 20.8 Favored Pre-proline 0 C--O 1.243 0.763 0 CA-C-N 115.209 -0.905 . . . . 74.34 109.172 -176.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.402 ' O ' ' HG2' ' A' ' 64' ' ' ARG . 75.5 Cg_exo -53.25 -26.21 33.25 Favored 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 123.705 2.937 . . . . 72.41 113.142 177.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -61.69 -62.07 2.07 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 124.485 1.114 . . . . 72.3 111.054 -179.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.458 ' HA ' HD12 ' A' ' 65' ' ' ILE . 41.2 mtmt -76.04 -24.0 55.16 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 115.688 -0.687 . . . . 74.54 111.303 -176.269 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 42.1 tpt85 -55.76 -53.33 57.92 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 124.099 0.875 . . . . 74.11 109.005 168.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' A' ' 60' ' ' PRO . 1.8 mmp_? -64.19 -34.91 79.17 Favored 'General case' 0 C--N 1.36 1.05 0 C-N-CA 123.459 0.704 . . . . 74.25 112.172 178.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.458 HD12 ' HA ' ' A' ' 62' ' ' LYS . 94.7 mt -57.09 -44.93 83.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 CA-C-O 121.15 0.5 . . . . 64.42 110.811 174.175 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -63.97 -44.88 91.41 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 115.77 -0.65 . . . . 75.4 110.09 177.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -60.61 -32.58 71.71 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 123.075 0.55 . . . . 64.04 112.019 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 48.6 p -84.4 -15.33 46.67 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.576 0.35 . . . . 75.13 111.571 178.276 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -72.71 106.4 4.69 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 108.636 -0.876 . . . . 63.45 108.636 170.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 105.54 18.08 12.42 Favored Glycine 0 N--CA 1.472 1.091 0 N-CA-C 111.535 -0.626 . . . . 52.54 111.535 -171.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 85.0 m -137.55 -56.64 0.69 Allowed 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 103.733 -2.691 . . . . 71.23 103.733 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.7 m -82.54 141.32 32.71 Favored 'General case' 0 C--O 1.251 1.156 0 N-CA-C 104.385 -2.45 . . . . 74.23 104.385 155.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.54 -23.13 20.99 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.364 0.665 . . . . 74.04 111.736 -176.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -111.46 169.17 6.6 Favored Pre-proline 0 N--CA 1.478 0.936 0 C-N-CA 124.181 0.993 . . . . 75.1 110.029 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -52.11 135.79 52.66 Favored 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 122.253 1.969 . . . . 75.41 112.386 167.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.455 ' HG3' HG23 ' A' ' 65' ' ' ILE . 73.0 Cg_endo -70.17 173.0 11.98 Favored 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 123.127 2.551 . . . . 74.25 112.259 -178.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -62.58 119.82 7.07 Favored 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 121.759 1.639 . . . . 62.44 111.185 170.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -64.16 145.78 89.63 Favored 'Trans proline' 0 C--N 1.382 2.331 0 C-N-CA 122.848 2.366 . . . . 43.51 112.829 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -63.66 149.62 90.43 Favored 'Trans proline' 0 C--N 1.38 2.205 0 C-N-CA 122.946 2.43 . . . . 71.05 111.954 171.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -67.87 76.35 0.61 Allowed 'Trans proline' 0 C--N 1.382 2.322 0 C-N-CA 123.601 2.867 . . . . 51.35 112.711 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 159.33 -35.47 0.48 Allowed Glycine 0 N--CA 1.462 0.384 0 N-CA-C 109.288 -1.525 . . . . 62.41 109.288 -174.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 128.13 171.36 12.99 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-N 114.804 -0.698 . . . . 53.03 112.331 171.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -67.31 107.36 2.36 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 107.977 -1.119 . . . . 74.41 107.977 166.033 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.451 ' O ' ' HD1' ' A' ' 85' ' ' PHE . 23.6 t70 -61.86 153.22 29.54 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.802 0.841 . . . . 71.31 112.615 -175.451 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.451 ' HD1' ' O ' ' A' ' 84' ' ' ASP . 0.1 OUTLIER -153.52 70.77 0.86 Allowed 'General case' 0 CA--C 1.553 1.059 0 N-CA-C 107.761 -1.2 . . . . 70.22 107.761 170.428 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.593 ' HA ' ' HA3' ' A' ' 163' ' ' GLY . 41.5 m -57.9 86.76 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 125.006 1.322 . . . . 74.44 114.367 -174.037 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.572 ' HA2' ' HB3' ' A' ' 171' ' ' PRO . . . 98.16 12.22 46.48 Favored Glycine 0 N--CA 1.47 0.936 0 CA-C-N 116.368 -0.378 . . . . 70.11 113.721 176.035 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.409 ' CD1' ' HB3' ' A' ' 51' ' ' ASN . 30.2 m-85 -123.58 110.32 14.88 Favored 'General case' 0 C--O 1.245 0.846 0 C-N-CA 122.831 0.453 . . . . 72.34 110.16 -170.096 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -70.23 94.8 0.94 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 122.803 0.441 . . . . 71.44 110.066 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.561 HG13 ' HG2' ' A' ' 91' ' ' GLU . 2.3 p -27.41 -50.39 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 126.203 1.801 . . . . 75.21 114.961 166.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.561 ' HG2' HG13 ' A' ' 90' ' ' VAL . 9.7 mm-40 -67.86 -12.89 61.56 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.994 0.918 . . . . 75.33 112.854 -168.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -80.97 -39.17 26.45 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.127 0.971 . . . . 45.35 111.438 175.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.421 ' CD2' ' HE2' ' A' ' 85' ' ' PHE . 22.3 m-85 -83.28 179.73 7.62 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 115.429 -0.805 . . . . 71.01 112.357 -166.031 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 80.1 p -59.14 142.42 51.6 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.446 1.098 . . . . 74.5 112.598 -170.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.4 -28.53 69.85 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.024 -0.989 . . . . 74.31 111.343 174.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -52.32 -55.27 22.58 Favored 'General case' 0 C--N 1.367 1.333 0 C-N-CA 123.026 0.53 . . . . 75.03 110.607 169.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -56.77 -43.53 80.92 Favored 'General case' 0 CA--C 1.548 0.887 0 O-C-N 124.065 0.853 . . . . 63.23 109.586 178.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.578 ' HA ' HD11 ' A' ' 105' ' ' LEU . 92.7 mt-30 -70.87 -12.33 61.48 Favored 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 115.458 -0.792 . . . . 73.05 112.307 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -88.07 -57.71 2.83 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.83 0.852 . . . . 70.02 111.766 171.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 51.0 tp -64.39 -42.51 96.08 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.69 0.796 . . . . 55.03 111.506 -174.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -94.62 -4.75 47.19 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-N 115.811 -0.632 . . . . 72.11 110.331 178.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -43.48 -59.24 3.69 Favored Glycine 0 C--N 1.356 1.663 0 CA-C-O 118.49 -1.172 . . . . 72.43 114.882 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -43.42 -24.15 0.58 Allowed 'Trans proline' 0 C--N 1.392 2.834 0 C-N-CA 124.717 3.612 . . . . 23.1 116.143 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -150.79 36.8 0.9 Allowed Glycine 0 C--N 1.352 1.457 0 CA-C-O 119.241 -0.755 . . . . 44.4 113.016 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.578 HD11 ' HA ' ' A' ' 98' ' ' GLN . 18.1 mt -54.33 84.62 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.147 0.579 . . . . 74.25 111.997 173.206 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.414 ' CD2' ' HA ' ' A' ' 84' ' ' ASP . 0.4 OUTLIER 19.19 -110.18 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 127.938 2.495 . . . . 72.25 113.831 176.192 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 58.46 16.86 30.43 Favored Glycine 0 C--N 1.361 1.931 0 CA-C-O 119.771 -0.461 . . . . 44.0 113.869 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.356 1.664 0 N-CA-C 111.396 -0.682 . . . . 71.34 111.396 -167.702 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.543 0.697 0 N-CA-C 112.188 0.44 . . . . 72.15 112.188 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -77.86 -163.57 21.41 Favored Glycine 0 CA--C 1.543 1.803 0 CA-C-N 115.476 -0.784 . . . . 55.22 114.6 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.455 ' H ' ' HA3' ' A' ' 166' ' ' GLY . 0.9 OUTLIER -112.74 130.33 56.1 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 124.587 1.155 . . . . 71.34 111.751 178.69 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -52.23 120.56 5.61 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.622 0.725 . . . . 74.23 111.487 176.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 67.2 tp -129.1 157.33 42.06 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 115.138 -0.937 . . . . 70.23 110.287 -171.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 34.3 ttp180 -111.18 146.67 36.47 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 108.793 -0.817 . . . . 74.51 108.793 171.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.556 ' HB2' HD11 ' A' ' 174' ' ' LEU . . . -128.35 158.19 38.91 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.604 0.716 . . . . 41.51 110.762 177.228 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.407 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 0.4 OUTLIER -112.76 108.1 16.99 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 105.262 -2.125 . . . . 61.0 105.262 -179.443 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.557 ' HB3' ' HA ' ' A' ' 178' ' ' VAL . 41.9 tp -98.44 97.44 4.68 Favored Pre-proline 0 N--CA 1.476 0.841 0 N-CA-C 108.042 -1.096 . . . . 54.05 108.042 -175.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.584 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 98.5 Cg_endo -79.22 107.62 2.23 Favored 'Trans proline' 0 C--N 1.381 2.237 0 C-N-CA 121.005 1.137 . . . . 75.33 109.309 -177.285 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.517 ' HB3' HD23 ' A' ' 180' ' ' LEU . 54.2 tp -109.63 132.05 54.5 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 122.362 0.265 . . . . 64.01 110.637 -166.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 97.4 m -62.59 124.87 22.11 Favored 'General case' 0 CA--C 1.551 0.986 0 O-C-N 124.496 1.122 . . . . 71.34 109.165 176.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.412 ' HB3' HD22 ' A' ' 215' ' ' LEU . 73.7 mt -52.77 -43.39 65.8 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 124.266 1.027 . . . . 70.54 112.195 -170.154 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -60.12 -35.84 76.14 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 114.36 -1.291 . . . . 75.32 110.241 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -83.01 -20.54 34.86 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.998 0.919 . . . . 64.33 111.314 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -66.64 -35.58 80.52 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 109.86 -0.422 . . . . 41.43 109.86 168.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -74.51 -48.05 29.46 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 115.298 -0.864 . . . . 74.51 111.831 173.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 33.3 m170 -74.03 -40.17 63.05 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 123.221 0.608 . . . . 75.25 111.886 -171.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 74.11 -151.33 43.73 Favored Glycine 0 CA--C 1.531 1.084 0 O-C-N 123.618 0.574 . . . . 71.54 113.092 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 86.34 -167.63 39.51 Favored Glycine 0 N--CA 1.473 1.166 0 C-N-CA 123.117 0.389 . . . . 70.42 112.435 -178.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.424 ' HB3' ' OG ' ' A' ' 146' ' ' SER . 2.6 mp0 -76.65 118.84 19.7 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.908 0.483 . . . . 73.14 110.289 175.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -94.47 119.88 33.85 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.658 0.783 . . . . 74.4 110.083 177.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 77.2 t -75.83 111.56 12.42 Favored 'Isoleucine or valine' 0 C--O 1.244 0.788 0 N-CA-C 108.704 -0.85 . . . . 71.24 108.704 168.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.557 HG13 HG13 ' A' ' 145' ' ' VAL . 3.5 p -135.69 138.09 48.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 124.452 1.101 . . . . 73.14 108.444 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -124.27 141.98 51.63 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.185 0.594 . . . . 71.3 110.974 -170.324 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.55 HG11 HD23 ' B' ' 8' ' ' LEU . 12.3 p -169.11 137.07 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 124.571 1.149 . . . . 75.1 109.07 176.342 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 55.49 33.21 20.55 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.129 0.972 . . . . 74.24 112.394 174.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 87.25 -23.6 11.32 Favored Glycine 0 C--N 1.352 1.443 0 CA-C-N 116.092 -0.504 . . . . 31.1 113.255 -178.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.548 ' NH1' ' HG2' ' A' ' 164' ' ' MET . 11.5 tpt180 -74.41 100.09 3.71 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.211 1.005 . . . . 72.12 110.543 179.069 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 19.7 ttp180 -84.47 92.53 8.1 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 107.912 -1.144 . . . . 74.41 107.912 165.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.557 HG13 HG13 ' A' ' 138' ' ' VAL . 3.7 p -98.53 143.02 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 115.041 -0.981 . . . . 73.53 110.796 -175.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.424 ' OG ' ' HB3' ' A' ' 135' ' ' GLU . 17.3 t -105.53 84.96 2.16 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 108.46 -0.941 . . . . 31.45 108.46 177.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 34.8 m -83.17 115.4 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 CA-C-O 121.244 0.545 . . . . 73.42 110.192 -177.058 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 48.5 ttt180 -74.18 103.36 4.58 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 109.426 -0.583 . . . . 74.14 109.426 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.447 ' HB ' HG11 ' A' ' 153' ' ' VAL . 36.3 pt -94.05 139.22 22.51 Favored Pre-proline 0 CA--C 1.557 1.243 0 C-N-CA 123.818 0.847 . . . . 74.13 109.508 176.426 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -73.26 140.7 31.09 Favored 'Trans proline' 0 C--N 1.372 1.784 0 C-N-CA 122.345 2.03 . . . . 60.34 111.846 176.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -57.85 93.18 0.06 OUTLIER 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 122.653 2.235 . . . . 74.15 111.494 167.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.605 ' HA2' ' HD2' ' A' ' 240' ' ' PHE . . . 124.62 31.48 0.89 Allowed Glycine 0 C--N 1.341 0.847 0 CA-C-N 115.558 -0.746 . . . . 75.51 112.474 -176.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.447 HG11 ' HB ' ' A' ' 149' ' ' ILE . 3.4 p -86.36 137.23 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 123.391 0.676 . . . . 75.43 110.323 -178.269 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.849 ' HD2' ' HA ' ' A' ' 191' ' ' GLN . 2.7 mtm-85 -127.46 151.29 49.03 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.815 0.846 . . . . 73.23 110.908 -163.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -53.24 116.9 2.65 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 124.694 1.246 . . . . 72.32 110.477 178.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 107.16 2.26 35.89 Favored Glycine 0 C--N 1.345 1.081 0 CA-C-N 115.76 -0.654 . . . . 14.21 113.54 -175.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 28.1 t -78.03 104.32 8.53 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 108.091 -1.078 . . . . 74.23 108.091 172.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.442 HG22 HG22 ' A' ' 177' ' ' VAL . 41.8 t -87.06 91.89 3.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 C-N-CA 124.74 1.216 . . . . 72.34 109.585 -178.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.551 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 58.9 mt -76.02 97.04 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 N-CA-C 108.576 -0.898 . . . . 75.24 108.576 173.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 74.0 ttt-85 -75.28 103.91 5.63 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.563 -0.532 . . . . 61.32 109.563 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.483 HG11 ' SD ' ' A' ' 164' ' ' MET . 7.5 p -116.46 123.15 30.95 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 123.505 0.722 . . . . 61.33 109.431 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -65.28 148.68 88.74 Favored 'Trans proline' 0 C--N 1.364 1.359 0 C-N-CA 122.707 2.271 . . . . 74.53 113.113 174.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.593 ' HA3' ' HA ' ' A' ' 86' ' ' SER . . . 83.5 -25.74 4.92 Favored Glycine 0 N--CA 1.479 1.516 0 N-CA-C 116.482 1.353 . . . . 70.43 116.482 166.35 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.548 ' HG2' ' NH1' ' A' ' 143' ' ' ARG . 66.7 mtp -75.11 -21.68 58.73 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 117.502 0.651 . . . . 64.15 111.691 -179.074 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.531 ' HA2' HD13 ' A' ' 174' ' ' LEU . . . -80.2 -106.62 0.28 Allowed Glycine 0 C--N 1.348 1.236 0 CA-C-O 119.346 -0.697 . . . . 73.33 113.107 -175.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.455 ' HA3' ' H ' ' A' ' 117' ' ' ARG . . . -53.13 109.02 0.86 Allowed Glycine 0 C--O 1.275 2.658 0 O-C-N 123.85 0.382 . . . . 74.5 112.849 168.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -54.29 104.07 0.1 Allowed 'General case' 0 C--N 1.351 0.673 0 O-C-N 127.854 2.737 . . . . 75.42 108.676 177.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -173.26 143.98 7.51 Favored Glycine 0 N--CA 1.44 -1.066 0 N-CA-C 108.556 -1.818 . . . . 64.21 108.556 -171.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ASN . . . . . 0.54 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . 0.2 OUTLIER -73.16 -49.58 7.04 Favored Pre-proline 0 CA--C 1.558 1.27 0 N-CA-C 109.396 -0.594 . . . . 63.11 109.396 -171.688 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.54 ' HD3' ' HB3' ' A' ' 169' ' ' ASN . 18.8 Cg_exo -71.76 149.76 54.92 Favored 'Trans proline' 0 C--N 1.375 1.965 0 N-CA-C 108.19 -1.504 . . . . 71.13 108.19 156.006 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.572 ' HB3' ' HA2' ' A' ' 87' ' ' GLY . 74.1 Cg_endo -69.61 124.12 10.82 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 122.716 2.278 . . . . 71.25 116.247 -162.107 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -62.26 -46.73 93.33 Favored Glycine 0 C--N 1.374 2.641 0 C-N-CA 119.41 -1.376 . . . . 72.4 111.117 161.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 101.8 147.71 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 128.49 2.716 . . . . 71.14 108.438 177.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.556 HD11 ' HB2' ' A' ' 121' ' ' ALA . 28.3 tp -137.14 138.51 40.35 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.115 0.483 . . . . 64.32 110.768 -175.315 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 48.0 mt -105.34 89.8 3.23 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 114.731 -1.122 . . . . 72.12 108.166 171.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.551 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 64.6 mt -68.39 88.27 0.32 Allowed 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 109.684 -0.487 . . . . 70.05 109.684 175.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.442 HG22 HG22 ' A' ' 158' ' ' VAL . 18.2 t -85.36 104.01 12.89 Favored 'Isoleucine or valine' 0 C--O 1.25 1.1 0 N-CA-C 106.384 -1.71 . . . . 61.43 106.384 174.381 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.557 ' HA ' ' HB3' ' A' ' 123' ' ' LEU . 8.2 p -67.49 119.55 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 CA-C-N 115.216 -0.902 . . . . 70.33 109.688 -175.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.584 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 36.7 mmt180 -103.07 109.08 20.51 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-N 114.18 -1.373 . . . . 53.32 107.868 176.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.517 HD23 ' HB3' ' A' ' 125' ' ' LEU . 59.6 mt -74.79 143.05 44.17 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.683 -0.636 . . . . 72.4 109.496 177.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 86.2 mt -52.86 154.72 4.72 Favored Pre-proline 0 N--CA 1.486 1.325 0 C-N-CA 123.94 0.896 . . . . 73.14 112.82 -168.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.25 21.43 0.39 Allowed 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 122.695 2.263 . . . . 71.42 112.783 171.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' HIS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 184' ' ' PRO . 36.7 t-80 -61.64 106.7 0.87 Allowed Pre-proline 0 CA--C 1.557 1.215 0 C-N-CA 125.817 1.647 . . . . 73.35 108.114 168.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 183' ' ' HIS . 8.0 Cg_exo -73.95 25.04 0.34 Allowed 'Trans proline' 0 C--N 1.373 1.86 0 C-N-CA 124.137 3.225 . . . . 61.24 116.428 -162.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 69.1 t -97.25 -39.08 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 118.569 0.622 . . . . 64.21 109.672 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' PHE . . . . . 0.683 ' HE1' ' HA ' ' A' ' 214' ' ' THR . 35.4 m-85 -146.29 111.59 5.44 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.114 0.483 . . . . 72.31 112.069 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.677 ' HB3' ' HB2' ' A' ' 194' ' ' TYR . 59.4 ttt180 -91.93 82.39 5.14 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 106.889 -1.523 . . . . 75.51 106.889 162.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.499 ' HB2' HD23 ' A' ' 193' ' ' LEU . 40.8 tp -79.5 95.39 5.8 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.438 -0.801 . . . . 74.21 108.872 177.412 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -118.74 131.12 56.12 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.609 0.764 . . . . 70.31 109.951 -174.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 77.62 -77.51 1.59 Allowed Glycine 0 C--N 1.353 1.48 0 N-CA-C 111.497 -0.641 . . . . 65.41 111.497 -178.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.849 ' HA ' ' HD2' ' A' ' 154' ' ' ARG . 13.2 pt20 -153.34 -6.03 0.18 Allowed 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.041 0.936 . . . . 72.32 111.061 173.007 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -122.18 150.43 42.25 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.459 0.704 . . . . 72.32 110.975 -167.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.499 HD23 ' HB2' ' A' ' 188' ' ' LEU . 38.5 mt -92.17 152.31 19.95 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.935 1.294 . . . . 63.44 111.089 -170.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.677 ' HB2' ' HB3' ' A' ' 187' ' ' ARG . 89.0 m-85 -131.34 103.09 6.25 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 107.964 -1.124 . . . . 73.14 107.964 169.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.483 ' HB3' HD23 ' A' ' 251' ' ' LEU . . . -122.93 115.95 22.78 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.464 1.106 . . . . 74.34 110.648 -173.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' THR . . . . . 0.458 ' HA ' ' HB2' ' A' ' 252' ' ' GLU . 93.6 m -71.43 111.63 6.9 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 121.082 0.468 . . . . 70.21 110.686 -177.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.493 HD22 HD13 ' A' ' 251' ' ' LEU . 37.5 tp -99.04 119.85 38.49 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.772 0.829 . . . . 72.21 110.809 -173.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -82.38 115.86 21.6 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 108.363 -0.977 . . . . 61.43 108.363 172.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.1 p -143.62 126.35 8.75 Favored Pre-proline 0 N--CA 1.479 1.022 0 C-N-CA 123.375 0.67 . . . . 64.4 110.138 -175.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 256' ' ' THR . 54.1 Cg_endo -72.11 152.1 56.18 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 121.942 1.762 . . . . 64.51 112.095 176.552 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -44.22 -59.31 3.89 Favored Pre-proline 0 N--CA 1.484 1.268 0 N-CA-C 116.267 1.951 . . . . 71.34 116.267 -172.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -74.07 -19.82 19.88 Favored 'Trans proline' 0 C--N 1.384 2.411 0 CA-C-N 121.84 1.693 . . . . 63.54 112.76 -174.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 17.7 mt -75.11 -30.27 22.97 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 N-CA-C 109.521 -0.548 . . . . 64.32 109.521 172.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -72.22 -43.03 65.04 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-O 121.129 0.49 . . . . 71.51 111.23 173.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 54.5 t -71.94 -41.77 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 123.803 0.841 . . . . 63.23 112.375 -174.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 97.2 t -93.06 -32.61 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 122.546 0.338 . . . . 74.41 110.747 -178.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 89.83 77.19 1.32 Allowed Glycine 0 C--N 1.343 0.923 0 CA-C-N 116.312 -0.404 . . . . 72.35 112.137 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -96.03 -136.55 8.84 Favored Glycine 0 C--N 1.342 0.867 0 N-CA-C 112.056 -0.418 . . . . 55.24 112.056 178.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 46.0 mtmt -130.47 144.27 51.29 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.12 0.568 . . . . 45.21 110.013 178.385 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 16.8 m -136.32 176.71 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.533 1.133 . . . . 63.11 109.526 174.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 20.5 ttm180 -109.75 112.2 24.12 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.578 0.751 . . . . 71.41 109.529 175.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -104.6 126.62 51.86 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.721 -0.844 . . . . 62.04 108.721 176.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' MET . . . . . 0.638 ' HA ' ' HA ' ' A' ' 218' ' ' PRO . 3.5 mpp? -74.52 138.92 43.45 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.916 0.486 . . . . 71.23 110.245 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 214' ' ' THR . . . . . 0.683 ' HA ' ' HE1' ' A' ' 186' ' ' PHE . 69.0 p -117.95 179.29 4.13 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 122.999 0.52 . . . . 74.1 110.34 171.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.412 HD22 ' HB3' ' A' ' 127' ' ' LEU . 55.5 mt -67.33 -20.13 65.55 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 115.231 -0.895 . . . . 63.31 111.592 -178.475 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -109.24 19.71 19.12 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.619 0.767 . . . . 64.44 111.404 179.068 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 110.47 174.29 20.41 Favored Glycine 0 N--CA 1.474 1.224 0 CA-C-O 119.426 -0.652 . . . . 33.0 113.23 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' PRO . . . . . 0.638 ' HA ' ' HA ' ' A' ' 213' ' ' MET . 83.9 Cg_endo -76.43 145.98 27.26 Favored 'Trans proline' 0 C--N 1.368 1.581 0 C-N-CA 122.744 2.296 . . . . 70.23 112.622 -175.131 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 24.3 m -139.89 163.9 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 C-N-CA 123.777 0.831 . . . . 73.4 111.371 -176.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -91.28 117.54 29.73 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.154 0.982 . . . . 75.04 110.157 -178.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 57.9 t -128.81 126.59 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 124.269 1.027 . . . . 74.13 109.037 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -88.04 131.5 34.63 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.495 0.318 . . . . 60.25 111.372 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 38.4 t -73.5 146.81 86.65 Favored Pre-proline 0 CA--C 1.57 1.744 0 C-N-CA 125.749 1.62 . . . . 63.14 110.602 -178.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -78.91 171.69 16.12 Favored 'Trans proline' 0 C--N 1.388 2.613 0 C-N-CA 122.924 2.416 . . . . 75.51 111.308 169.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -81.06 150.48 17.94 Favored 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 121.92 1.746 . . . . 72.53 113.133 176.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 84.8 mtt-85 63.22 31.16 15.72 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 126.007 1.723 . . . . 74.04 111.527 174.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.595 HG23 HD21 ' A' ' 233' ' ' LEU . 50.2 m -63.26 105.75 0.78 Allowed 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 113.796 -1.547 . . . . 64.32 111.081 177.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -90.18 140.03 30.06 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.291 1.036 . . . . 75.32 110.197 -176.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -66.04 160.19 24.31 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.838 0.855 . . . . 62.31 111.461 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 81.02 -41.38 2.6 Favored Glycine 0 C--N 1.347 1.162 0 CA-C-N 116.382 -0.372 . . . . 73.32 112.405 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -67.19 156.19 36.88 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 124.339 1.056 . . . . 74.0 110.907 177.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.766 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 3.5 mptp? -106.93 124.59 49.84 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-N 114.686 -1.143 . . . . 72.22 108.492 176.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.595 HD21 HG23 ' A' ' 227' ' ' THR . 86.0 mt -74.72 106.43 6.27 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.417 -0.957 . . . . 71.4 108.417 176.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 20.6 ttp180 -87.93 110.92 20.93 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.043 0.537 . . . . 64.14 110.687 178.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.483 ' HG ' ' HB3' ' A' ' 249' ' ' LEU . 0.3 OUTLIER -120.26 117.94 29.15 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.101 0.96 . . . . 61.12 109.982 176.154 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 36.0 mmtm -59.68 151.16 25.62 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 125.155 1.382 . . . . 64.43 112.752 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 71.39 34.88 63.54 Favored Glycine 0 C--N 1.354 1.583 0 CA-C-N 114.985 -1.007 . . . . 74.2 113.757 171.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.443 ' HG3' HD12 ' A' ' 235' ' ' LEU . 41.2 mmtm -130.08 -38.87 1.4 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.16 0.584 . . . . 73.01 110.895 -176.496 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -71.38 168.9 50.43 Favored Glycine 0 C--N 1.35 1.318 0 CA-C-N 116.219 -0.446 . . . . 74.43 112.17 175.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 240' ' ' PHE . . . . . 0.605 ' HD2' ' HA2' ' A' ' 152' ' ' GLY . 4.4 m-85 -87.44 158.15 52.07 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 123.533 0.733 . . . . 73.13 111.067 -165.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -62.6 109.3 0.85 Allowed 'Trans proline' 0 C--N 1.385 2.452 0 C-N-CA 123.051 2.5 . . . . 73.33 111.994 177.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.435 ' HA3' ' HB3' ' A' ' 191' ' ' GLN . . . -122.38 -149.63 7.99 Favored Glycine 0 C--N 1.338 0.644 0 CA-C-O 119.174 -0.792 . . . . 73.52 112.696 -179.159 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 243' ' ' PRO . . . . . 0.455 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 26.1 Cg_endo -60.14 -45.71 22.17 Favored 'Trans proline' 0 C--N 1.375 1.932 0 C-N-CA 123.179 2.586 . . . . 70.45 112.845 -176.097 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -88.43 -19.51 26.45 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.256 0.622 . . . . 70.11 111.073 177.204 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 126.72 -158.46 20.76 Favored Glycine 0 C--N 1.347 1.166 0 N-CA-C 111.192 -0.763 . . . . 62.24 111.192 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 61.5 mtt180 -57.68 108.41 0.56 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.336 0.654 . . . . 75.41 110.612 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -72.21 -161.82 5.62 Favored Glycine 0 C--O 1.248 1.03 0 CA-C-O 121.977 0.765 . . . . 42.24 113.708 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -102.3 168.31 9.42 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.411 0.684 . . . . 75.44 110.549 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.483 ' HB3' ' HG ' ' A' ' 235' ' ' LEU . 16.0 tp -101.54 128.61 47.71 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 106.794 -1.558 . . . . 70.31 106.794 164.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.766 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 7.0 m-85 -108.93 104.83 14.14 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 107.763 -1.199 . . . . 52.51 107.763 174.265 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.551 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 46.3 mt -90.08 103.94 16.56 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 109.098 -0.705 . . . . 72.24 109.098 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 252' ' ' GLU . . . . . 0.504 ' HG2' ' HG3' ' A' ' 232' ' ' LYS . 23.2 mt-10 -75.91 100.09 4.72 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.229 1.012 . . . . 75.41 108.866 -171.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 38.4 t -64.97 120.43 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 CA-C-N 114.564 -1.198 . . . . 24.43 112.241 -168.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.8 mmt180 -118.33 94.72 4.59 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.489 1.115 . . . . 73.14 108.065 169.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.439 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 73.5 mt -70.76 115.67 10.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 114.706 -1.133 . . . . 74.34 109.234 176.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 256' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 200' ' ' PRO . 40.0 p -111.41 173.12 6.5 Favored 'General case' 0 C--O 1.255 1.346 0 C-N-CA 124.248 1.019 . . . . 73.43 109.994 178.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 23.0 pt -134.25 151.72 76.89 Favored Pre-proline 0 CA--C 1.556 1.195 0 CA-C-N 114.918 -1.037 . . . . 73.4 108.523 176.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 258' ' ' PRO . . . . . 0.427 ' O ' ' HD2' ' A' ' 260' ' ' ARG . 11.1 Cg_endo -87.56 20.12 1.25 Allowed 'Trans proline' 0 C--N 1.37 1.667 0 C-N-CA 122.699 2.266 . . . . 74.45 113.426 -166.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 259' ' ' GLU . . . . . 0.419 ' HA ' ' HG3' ' C' ' 226' ' ' ARG . 3.4 mp0 40.52 -89.27 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.806 1.242 . . . . 63.24 112.18 -162.432 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 260' ' ' ARG . . . . . 0.427 ' HD2' ' O ' ' A' ' 258' ' ' PRO . 0.4 OUTLIER -69.62 138.77 53.37 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.072 0.949 . . . . 75.12 111.425 -168.012 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.538 HD11 HG11 ' C' ' 205' ' ' VAL . 98.2 mt -129.28 173.14 10.78 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.016 0.926 . . . . 55.32 110.108 -178.004 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 40.7 p -114.16 156.7 43.83 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 124.252 1.021 . . . . 44.34 109.644 171.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -33.07 -45.22 0.27 Allowed 'Trans proline' 0 C--N 1.396 3.034 1 C-N-CA 125.351 4.034 . . . . 74.33 116.505 -176.394 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -59.31 -61.27 2.75 Favored 'General case' 0 C--O 1.249 1.045 0 C-N-CA 123.926 0.89 . . . . 71.44 110.778 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -57.71 -47.57 82.02 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-N 114.901 -1.045 . . . . 64.2 110.581 -178.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 266' ' ' GLU . . . . . 0.534 ' O ' ' HG2' ' A' ' 270' ' ' LYS . 7.2 tp10 -55.05 -50.68 68.52 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 124.543 1.152 . . . . 73.45 110.866 -176.099 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -62.45 -46.68 87.4 Favored 'General case' 0 C--O 1.254 1.34 0 O-C-N 124.229 0.956 . . . . 64.12 112.151 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 10.0 mp -63.22 -34.81 78.46 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 116.053 -0.522 . . . . 73.14 111.472 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 269' ' ' TRP . . . . . 0.451 ' O ' HG11 ' C' ' 206' ' ' VAL . 68.6 m95 -74.59 -29.74 61.44 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 118.709 -0.662 . . . . 75.0 111.345 177.205 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 270' ' ' LYS . . . . . 0.534 ' HG2' ' O ' ' A' ' 266' ' ' GLU . 0.0 OUTLIER -58.53 -61.05 2.88 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.442 -0.947 . . . . 62.43 108.442 174.478 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? -54.61 -48.97 71.56 Favored 'General case' 0 C--N 1.364 1.203 0 CA-C-N 112.636 -2.075 . . . . 70.22 110.562 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 272' ' ' LEU . . . . . 0.436 HD12 HD12 ' C' ' 272' ' ' LEU . 1.8 tt -58.01 -66.03 0.54 Allowed 'General case' 0 C--O 1.186 -2.268 0 O-C-N 124.244 0.965 . . . . 63.4 108.846 -179.397 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 273' ' ' ALA . . . . . 0.468 ' HA ' ' HB2' ' C' ' 202' ' ' PRO . . . -50.24 -50.67 49.17 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 114.849 1.426 . . . . 64.51 114.849 -170.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -88.66 -24.52 22.75 Favored 'General case' 0 C--O 1.255 1.379 0 N-CA-C 112.727 0.64 . . . . 74.35 112.727 -170.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -77.7 -36.21 51.34 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 121.846 -0.534 . . . . 71.44 110.631 170.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 276' ' ' TYR . . . . . 0.406 ' HB3' ' O ' ' A' ' 273' ' ' ALA . 2.7 t80 -47.2 -57.47 5.12 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 126.567 1.947 . . . . 75.02 109.66 167.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -44.81 -66.1 0.44 Allowed 'General case' 0 C--O 1.248 1.019 0 O-C-N 125.515 1.759 . . . . 70.12 109.426 174.044 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -65.14 -9.54 23.78 Favored 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 114.598 -1.183 . . . . 75.41 114.087 -176.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 279' ' ' ARG . . . . . 0.479 ' NH2' ' HG2' ' C' ' 264' ' ' GLU . 77.7 mtm180 -132.92 31.95 3.84 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.308 0.643 . . . . 74.13 110.08 -176.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.566 1.587 0 C-N-CA 124.07 0.948 . . . . 72.21 113.177 177.332 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.48 1.04 0 N-CA-C 109.814 -0.439 . . . . 71.44 109.814 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -72.5 101.04 2.86 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.548 0.739 . . . . 54.1 109.791 174.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -164.39 -40.98 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.312 1.045 . . . . 74.04 109.434 175.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 16.6 t 68.64 -173.45 0.19 Allowed 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.331 1.052 . . . . 52.14 111.225 176.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 17.9 m 70.46 135.62 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.992 1.317 . . . . 70.11 112.346 -178.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 38.7 pt -143.27 176.79 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.392 1.077 . . . . 64.44 109.629 -176.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -137.38 132.64 33.8 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.329 0.652 . . . . 72.01 110.307 177.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 8' ' ' LEU . . . . . 0.55 HD23 HG11 ' A' ' 140' ' ' VAL . 39.0 tp -81.07 157.02 25.54 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.319 1.048 . . . . 75.22 111.086 -171.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.62 -72.34 0.42 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 122.856 0.462 . . . . 62.4 111.287 176.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 10' ' ' LEU . . . . . 0.455 HD23 ' HB2' ' A' ' 121' ' ' ALA . 33.6 mt 72.35 -7.54 1.35 Allowed 'General case' 0 N--CA 1.503 2.193 0 C-N-CA 125.588 1.555 . . . . 74.1 112.46 -165.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 28.6 mt . . . . . 0 CA--C 1.563 1.473 0 C-N-CA 124.727 1.211 . . . . 45.35 112.257 -176.333 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.622 0 N-CA-C 107.436 -1.32 . . . . 61.34 107.436 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 180' ' ' ALA . . . . . 0.498 ' HB1' HG13 ' C' ' 137' ' ' VAL . . . -135.1 -63.14 0.7 Allowed 'General case' 0 C--O 1.238 0.473 0 N-CA-C 104.791 -2.299 . . . . 74.4 104.791 166.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 181' ' ' LEU . . . . . 0.532 HD22 ' HB2' ' C' ' 136' ' ' ARG . 21.8 tp -152.85 -6.72 0.19 Allowed 'General case' 0 CA--C 1.567 1.611 0 CA-C-N 114.613 -1.176 . . . . 62.04 110.689 158.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 182' ' ' VAL . . . . . 0.643 ' HA ' ' HB2' ' C' ' 123' ' ' LEU . 14.7 m -136.75 178.3 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 C-N-CA 124.583 1.153 . . . . 71.31 112.555 -175.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 183' ' ' ALA . . . . . 0.717 ' HB3' ' HD2' ' C' ' 124' ' ' PRO . . . -143.69 55.37 1.33 Allowed 'General case' 0 CA--C 1.552 1.049 0 CA-C-N 115.118 -0.946 . . . . 65.24 110.401 164.124 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 32.6 m170 70.3 -168.77 0.16 Allowed 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 114.959 1.466 . . . . 74.15 114.959 162.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 185' ' ' VAL . . . . . 0.558 HG22 HD21 ' C' ' 119' ' ' LEU . 45.9 t . . . . . 0 N--CA 1.496 1.866 0 C-N-CA 125.615 1.566 . . . . 71.33 113.263 -164.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 95.2 m . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 118.674 -0.679 . . . . 71.31 110.79 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -170.24 -179.35 3.06 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 113.44 0.904 . . . . 74.42 113.44 176.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . -114.89 -142.85 7.95 Favored Glycine 0 C--N 1.36 1.887 0 CA-C-N 114.678 -1.146 . . . . 71.23 111.757 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -167.31 156.92 10.56 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.753 0.821 . . . . 71.21 110.18 177.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 242' ' ' TRP . . . . . 0.472 ' CE2' ' HG ' ' C' ' 233' ' ' LEU . 0.0 OUTLIER -137.53 -35.19 0.67 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.176 1.391 . . . . 70.32 108.75 -172.947 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -123.72 -173.49 2.76 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 106.212 -1.773 . . . . 74.22 106.212 157.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -74.36 103.92 1.58 Allowed Glycine 0 C--N 1.335 0.483 0 C-N-CA 121.417 -0.421 . . . . 63.11 112.556 174.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 1.6 pptp? . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 122.039 0.923 . . . . 75.34 110.532 174.723 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.694 0 CA-C-O 121.33 0.586 . . . . 52.01 109.647 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 4' ' ' LYS . . . . . 0.4 ' HE2' ' HB3' ' C' ' 4' ' ' LYS . 31.0 ttpt -38.53 105.73 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.11 1.764 . . . . 70.52 113.589 177.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 5' ' ' LYS . . . . . 0.499 ' HB3' HD11 ' C' ' 10' ' ' ILE . 49.7 mtpt -88.47 104.15 16.53 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 107.425 -1.324 . . . . 63.2 107.425 164.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -67.8 108.35 2.94 Favored 'General case' 0 C--N 1.35 0.595 0 N-CA-C 108.401 -0.962 . . . . 63.22 108.401 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 7' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -64.96 -33.61 76.45 Favored 'General case' 0 C--O 1.244 0.81 0 O-C-N 124.162 0.914 . . . . 73.43 111.814 -169.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -68.11 -41.36 81.87 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.76 -0.654 . . . . 72.53 110.219 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.53 -39.73 94.31 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.274 0.629 . . . . 52.31 110.883 179.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 10' ' ' ILE . . . . . 0.499 HD11 ' HB3' ' C' ' 5' ' ' LYS . 81.7 mt -56.98 -43.17 80.39 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 123.686 0.795 . . . . 63.34 110.027 173.172 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 96.2 mt -76.59 -15.81 59.75 Favored 'General case' 0 CA--C 1.556 1.174 0 N-CA-C 112.952 0.723 . . . . 45.45 112.952 176.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.88 21.29 71.69 Favored Glycine 0 C--N 1.351 1.413 0 N-CA-C 114.021 0.368 . . . . 64.33 114.021 -177.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 23.8 m -112.52 160.26 31.07 Favored Pre-proline 0 N--CA 1.486 1.353 0 C-N-CA 124.463 1.105 . . . . 64.04 110.479 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -55.04 157.58 13.15 Favored 'Trans proline' 0 C--N 1.385 2.46 0 C-N-CA 123.582 2.855 . . . . 74.43 114.509 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 65.1 mtt85 -78.98 28.62 0.22 Allowed 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 124.113 0.965 . . . . 71.52 113.58 -176.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -158.59 15.35 0.19 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.508 1.123 . . . . 71.24 108.631 174.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.28 148.15 33.15 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.371 1.068 . . . . 71.14 112.605 -171.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 74.6 p -87.66 -175.79 5.31 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.831 0.853 . . . . 74.41 112.245 -171.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -53.11 -55.2 25.83 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.155 0.982 . . . . 74.45 111.741 -174.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -63.99 -31.37 72.53 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 123.833 0.708 . . . . 64.05 111.673 -176.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -67.59 -49.77 61.54 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 122.237 0.215 . . . . 73.42 110.516 179.112 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 1.7 mp -64.0 -42.51 95.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 C-N-CA 123.548 0.739 . . . . 61.32 110.932 177.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -64.41 -52.54 57.64 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.233 1.013 . . . . 74.13 111.008 -176.042 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -75.29 -26.84 59.04 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.662 -0.699 . . . . 73.52 111.433 -174.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -73.34 -36.49 66.17 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 122.583 0.353 . . . . 75.32 110.893 173.222 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 26' ' ' TYR . . . . . 0.557 ' HD1' HG22 ' C' ' 50' ' ' ILE . 51.3 t80 -58.63 -56.21 25.13 Favored 'General case' 0 C--O 1.211 -0.973 0 N-CA-C 109.031 -0.729 . . . . 72.31 109.031 173.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -56.23 -45.69 79.84 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 124.614 1.196 . . . . 74.1 111.593 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 44.7 ttt180 -50.47 -55.1 17.4 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.479 1.112 . . . . 71.15 111.245 177.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 84.4 mt -85.26 -12.01 53.47 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 114.929 -1.032 . . . . 60.22 111.558 -175.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -91.75 -4.89 54.47 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.637 0.775 . . . . 75.32 110.155 173.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 36.7 mtp-105 -95.95 -43.47 7.8 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.887 0.875 . . . . 73.5 109.741 166.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.52 -54.29 25.4 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 109.212 -0.662 . . . . 71.12 109.212 -178.268 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -90.5 13.5 15.59 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 116.222 -0.445 . . . . 70.15 111.722 -178.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 34' ' ' HIS . . . . . 0.408 ' HD2' HG23 ' C' ' 37' ' ' VAL . 40.3 t60 -60.61 106.69 0.82 Allowed Pre-proline 0 N--CA 1.479 1.023 0 CA-C-O 118.386 -0.816 . . . . 72.34 109.248 -179.12 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.28 -36.58 47.48 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 123.687 2.925 . . . . 71.32 114.855 -171.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -66.07 -34.63 78.5 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.45 1.1 . . . . 60.34 111.894 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 37' ' ' VAL . . . . . 0.408 HG23 ' HD2' ' C' ' 34' ' ' HIS . 80.0 t -89.15 -50.69 13.06 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 122.916 0.486 . . . . 75.33 110.429 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -102.63 104.0 14.33 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.746 1.219 . . . . 54.22 109.507 -173.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -83.86 35.16 0.51 Allowed 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 123.498 0.719 . . . . 62.24 111.973 -174.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 59.6 m -97.38 132.57 25.13 Favored Pre-proline 0 N--CA 1.488 1.434 0 CA-C-O 119.047 -0.501 . . . . 74.14 110.548 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -49.22 -42.49 39.82 Favored 'Trans proline' 0 C--N 1.384 2.413 0 C-N-CA 123.199 2.599 . . . . 63.44 112.15 168.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -58.32 -37.23 74.68 Favored 'General case' 0 C--N 1.353 0.75 0 CA-C-N 115.542 -0.754 . . . . 65.44 111.025 177.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.56 -21.79 59.33 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 119.431 -0.319 . . . . 62.05 110.768 -178.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -69.59 -51.01 39.13 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 108.987 -0.746 . . . . 74.04 108.987 174.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 45' ' ' GLU . . . . . 0.437 ' O ' ' HG3' ' C' ' 49' ' ' GLU . 42.1 mt-10 -67.88 -47.35 69.09 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 114.103 -1.408 . . . . 42.53 110.793 -175.159 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 46' ' ' LYS . . . . . 0.554 ' O ' HG12 ' C' ' 50' ' ' ILE . 35.8 mmtm -60.35 -43.11 96.81 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-N 115.329 -0.851 . . . . 72.32 111.097 175.468 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -58.22 -40.96 83.03 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 123.656 0.597 . . . . 62.23 110.546 178.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -64.68 -34.26 77.88 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 123.747 0.654 . . . . 72.04 111.601 175.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 49' ' ' GLU . . . . . 0.437 ' HG3' ' O ' ' C' ' 45' ' ' GLU . 41.6 mt-10 -69.42 -33.0 72.33 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 122.653 0.381 . . . . 72.33 111.139 174.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 50' ' ' ILE . . . . . 0.557 HG22 ' HD1' ' C' ' 26' ' ' TYR . 14.7 mm -71.66 -34.41 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 N-CA-C 108.903 -0.777 . . . . 75.43 108.903 176.153 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 51' ' ' ASN . . . . . 0.449 ' HB3' ' HD1' ' C' ' 88' ' ' PHE . 94.6 m-20 -69.18 -36.71 77.62 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-N 114.642 -1.163 . . . . 74.04 110.662 176.196 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 62.2 tt0 -62.68 -54.34 40.89 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.9 0.88 . . . . 63.42 110.128 177.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -52.64 -60.88 2.71 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-N 113.467 -1.697 . . . . 63.1 111.224 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -61.19 -38.66 87.32 Favored 'General case' 0 C--O 1.21 -1.019 0 CA-C-N 115.072 -0.967 . . . . 75.01 111.895 -178.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.61 -51.26 70.58 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 122.827 0.451 . . . . 60.54 111.463 -177.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 56' ' ' VAL . . . . . 0.511 ' HA ' ' HE3' ' C' ' 62' ' ' LYS . 75.0 t -60.49 -40.63 84.92 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 O-C-N 124.307 1.004 . . . . 72.43 110.394 176.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 57' ' ' LEU . . . . . . . . . . . . . 46.9 mt -89.15 -0.8 57.74 Favored 'General case' 0 CA--C 1.565 1.544 0 N-CA-C 113.025 0.75 . . . . 75.02 113.025 -176.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 32.8 t -77.25 -57.39 3.86 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 124.339 1.056 . . . . 62.42 111.066 -178.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 59' ' ' ASP . . . . . 0.419 ' HA ' HG12 ' C' ' 145' ' ' VAL . 0.9 OUTLIER -65.83 122.83 82.81 Favored Pre-proline 0 C--N 1.354 0.796 0 N-CA-C 107.955 -1.128 . . . . 72.03 107.955 173.231 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 60' ' ' PRO . . . . . 0.54 ' HD2' ' HA ' ' C' ' 145' ' ' VAL . 19.1 Cg_endo -56.17 -27.78 67.34 Favored 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 123.066 2.51 . . . . 33.23 111.177 173.274 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 61' ' ' GLU . . . . . 0.67 ' HG2' ' HD3' ' C' ' 79' ' ' PRO . 3.2 tp10 -58.08 -66.06 0.54 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.249 1.02 . . . . 62.13 110.416 172.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 62' ' ' LYS . . . . . 0.511 ' HE3' ' HA ' ' C' ' 56' ' ' VAL . 17.7 mtmt -70.1 -22.99 62.97 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.426 0.69 . . . . 75.23 111.565 -173.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 48.8 tpt85 -61.18 -55.84 27.61 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.759 1.224 . . . . 64.42 109.233 172.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 -75.24 -19.15 59.9 Favored 'General case' 0 C--N 1.351 0.668 0 CA-C-N 115.26 -0.882 . . . . 74.15 111.523 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 65' ' ' ILE . . . . . 0.493 HG12 ' HB2' ' C' ' 76' ' ' PRO . 36.0 mt -66.03 -46.87 86.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.28 0.632 . . . . 62.34 109.55 171.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -61.46 -46.95 87.93 Favored 'General case' 0 C--N 1.353 0.727 0 O-C-N 123.803 0.689 . . . . 74.22 109.667 177.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -55.05 -48.6 73.22 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 123.675 0.609 . . . . 73.14 111.649 177.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 76.7 p -79.73 -9.15 59.61 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 112.568 0.581 . . . . 63.2 112.568 -178.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -72.38 100.37 2.65 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 108.229 -1.026 . . . . 75.22 108.229 174.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 125.05 10.83 4.54 Favored Glycine 0 N--CA 1.47 0.918 0 CA-C-N 115.348 -0.842 . . . . 62.51 111.704 -165.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 29.5 m -142.61 -55.53 0.43 Allowed 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 104.526 -2.398 . . . . 72.34 104.526 175.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 70.6 m -84.12 135.48 34.38 Favored 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 103.613 -2.736 . . . . 73.35 103.613 154.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.42 -31.09 8.31 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 118.987 0.812 . . . . 73.23 111.147 178.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -72.69 153.18 91.5 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 123.425 0.69 . . . . 53.23 109.254 171.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -54.3 113.55 1.41 Allowed 'Trans proline' 0 C--N 1.373 1.822 0 C-N-CA 122.56 2.173 . . . . 75.14 112.06 171.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 76' ' ' PRO . . . . . 0.493 ' HB2' HG12 ' C' ' 65' ' ' ILE . 45.8 Cg_exo -59.01 148.3 85.91 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 122.979 2.453 . . . . 63.14 111.525 175.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -57.82 124.43 16.0 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.985 2.457 . . . . 51.51 112.963 -169.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 78' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -63.33 153.25 75.61 Favored 'Trans proline' 0 C--N 1.38 2.221 0 C-N-CA 122.541 2.16 . . . . 74.44 111.904 175.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 79' ' ' PRO . . . . . 0.67 ' HD3' ' HG2' ' C' ' 61' ' ' GLU . 37.7 Cg_endo -66.36 147.44 82.94 Favored 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 122.128 1.885 . . . . 61.04 109.531 170.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 80' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' C' ' 79' ' ' PRO . 53.6 Cg_exo -55.22 78.77 0.03 OUTLIER 'Trans proline' 0 C--N 1.384 2.436 0 C-N-CA 124.139 3.226 . . . . 51.5 114.646 -176.028 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 163.7 -51.89 0.3 Allowed Glycine 0 CA--C 1.519 0.283 0 N-CA-C 108.326 -1.909 . . . . 75.2 108.326 -174.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 134.14 -157.63 22.96 Favored Glycine 0 C--N 1.351 1.383 0 C-N-CA 123.09 0.376 . . . . 74.45 113.102 173.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -97.25 121.1 38.76 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.181 0.992 . . . . 70.14 109.007 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 84' ' ' ASP . . . . . 0.499 ' HB2' ' NE ' ' C' ' 143' ' ' ARG . 7.8 t70 -79.5 126.12 30.45 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 112.516 0.562 . . . . 63.13 112.516 -171.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 85' ' ' PHE . . . . . 0.402 ' HA ' ' HD2' ' C' ' 88' ' ' PHE . 87.0 m-85 -137.61 31.7 2.54 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.184 0.994 . . . . 74.41 109.288 173.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 15.5 m -81.07 85.24 6.33 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 114.657 -1.156 . . . . 45.43 110.869 -172.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 87' ' ' GLY . . . . . 0.454 ' N ' ' HA ' ' C' ' 171' ' ' PRO . . . 129.31 -15.85 5.76 Favored Glycine 0 N--CA 1.471 0.971 0 N-CA-C 110.626 -0.99 . . . . 74.33 110.626 -172.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 88' ' ' PHE . . . . . 0.449 ' HD1' ' HB3' ' C' ' 51' ' ' ASN . 33.2 m-85 -108.57 135.87 49.11 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 108.023 -1.102 . . . . 74.44 108.023 178.067 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -77.18 79.26 3.7 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.014 0.525 . . . . 72.23 110.271 -175.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 90' ' ' VAL . . . . . 0.544 HG23 ' HZ ' ' C' ' 97' ' ' PHE . 3.4 p -48.48 -40.85 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 C-N-CA 124.96 1.304 . . . . 54.41 112.574 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -62.92 -29.89 71.13 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.715 0.806 . . . . 74.21 111.42 -177.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -72.32 -33.42 67.34 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.057 0.543 . . . . 75.53 112.023 178.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 93' ' ' PHE . . . . . 0.403 ' HZ ' ' HB3' ' C' ' 88' ' ' PHE . 10.6 m-30 -70.38 166.22 20.76 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 122.72 0.408 . . . . 72.45 111.208 -166.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 75.5 p -57.32 149.65 19.84 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 113.306 0.854 . . . . 45.51 113.306 -168.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.4 -32.94 70.63 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 115.299 -0.864 . . . . 55.43 111.118 170.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -52.97 -52.06 59.43 Favored 'General case' 0 C--N 1.357 0.915 0 C-N-CA 125.016 1.327 . . . . 65.02 109.934 174.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 97' ' ' PHE . . . . . 0.544 ' HZ ' HG23 ' C' ' 90' ' ' VAL . 1.8 t80 -60.35 -44.12 95.86 Favored 'General case' 0 CA--C 1.557 1.22 0 CA-C-N 113.256 -1.793 . . . . 64.25 110.677 174.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -70.79 -12.82 61.78 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 112.568 0.581 . . . . 51.52 112.568 -177.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -93.25 -40.61 10.34 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.298 0.639 . . . . 74.43 110.818 173.018 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 23.7 tp -75.03 -63.57 1.24 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.021 0.528 . . . . 73.23 110.795 -178.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -80.65 -11.43 59.64 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 122.851 0.46 . . . . 73.25 111.841 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -41.03 -60.91 2.11 Favored Glycine 0 CA--C 1.541 1.715 0 CA-C-O 118.726 -1.041 . . . . 54.11 115.137 178.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -50.14 -28.13 18.91 Favored 'Trans proline' 0 C--N 1.386 2.551 0 C-N-CA 124.113 3.209 . . . . 62.02 114.693 -177.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -126.77 30.55 4.16 Favored Glycine 0 C--N 1.358 1.757 0 CA-C-O 118.516 -1.158 . . . . 43.23 113.145 -175.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 34.5 mt . . . . . 0 N--CA 1.496 1.839 0 CA-C-N 118.373 1.086 . . . . 73.03 112.688 177.628 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.667 0 N-CA-C 113.618 0.207 . . . . 45.25 113.618 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 117' ' ' ARG . . . . . 0.446 ' NE ' ' HA ' ' C' ' 117' ' ' ARG . 2.2 mmp_? -116.71 155.51 28.75 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.21 1.004 . . . . 64.44 112.156 178.509 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -66.89 108.61 2.62 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-O 121.756 0.789 . . . . 75.42 109.428 175.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 119' ' ' LEU . . . . . 0.558 HD21 HG22 ' B' ' 185' ' ' VAL . 3.9 tt -89.22 112.74 23.84 Favored 'General case' 0 C--O 1.224 -0.28 0 N-CA-C 105.814 -1.921 . . . . 75.21 105.814 -174.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -93.66 132.68 37.77 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.516 -1.29 . . . . 72.31 107.516 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 121' ' ' ALA . . . . . . . . . . . . . . . -143.52 117.0 9.12 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.161 -0.681 . . . . 63.21 109.161 -177.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 122' ' ' GLU . . . . . 0.539 ' HA ' ' O ' ' C' ' 177' ' ' VAL . 13.1 pt-20 -92.91 125.47 37.52 Favored 'General case' 0 C--N 1.353 0.754 0 N-CA-C 109.036 -0.727 . . . . 73.22 109.036 176.237 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 123' ' ' LEU . . . . . 0.643 ' HB2' ' HA ' ' B' ' 182' ' ' VAL . 0.8 OUTLIER -121.51 105.72 38.49 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 115.873 -0.603 . . . . 73.3 111.63 -170.048 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 124' ' ' PRO . . . . . 0.717 ' HD2' ' HB3' ' B' ' 183' ' ' ALA . 28.2 Cg_exo -42.33 113.77 0.34 Allowed 'Trans proline' 0 C--N 1.374 1.9 0 C-N-CA 123.314 2.676 . . . . 72.51 112.02 161.091 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 125' ' ' LEU . . . . . . . . . . . . . 42.9 tp -140.09 140.78 36.16 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.829 1.252 . . . . 74.03 108.401 -170.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.43 154.11 22.98 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 121.006 0.431 . . . . 61.53 111.156 -176.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 127' ' ' LEU . . . . . 0.665 ' HB3' HD22 ' C' ' 215' ' ' LEU . 96.2 mt -63.22 -44.28 95.72 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.519 1.128 . . . . 62.25 111.067 177.288 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -53.55 -49.03 68.55 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 114.964 -1.016 . . . . 75.24 110.302 172.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -66.19 -32.31 73.67 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.889 0.876 . . . . 73.53 111.484 -176.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -73.05 -31.54 64.48 Favored 'General case' 0 CA--C 1.541 0.596 0 O-C-N 124.087 0.867 . . . . 64.34 110.475 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 131' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -69.45 -43.16 73.85 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.448 0.699 . . . . 75.55 110.395 171.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 132' ' ' HIS . . . . . . . . . . . . . 38.2 m170 -67.11 -67.65 0.44 Allowed 'General case' 0 N--CA 1.485 1.28 0 O-C-N 124.007 0.817 . . . . 60.22 111.924 -172.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 67.52 99.28 0.03 OUTLIER Glycine 0 CA--C 1.542 1.734 0 O-C-N 123.423 0.452 . . . . 65.31 113.607 -178.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . -142.52 162.12 27.33 Favored Glycine 0 N--CA 1.476 1.311 0 CA-C-O 119.244 -0.753 . . . . 53.24 111.272 178.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 53.6 mp0 -71.45 92.81 1.12 Allowed 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 108.565 -0.902 . . . . 71.2 108.565 177.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 136' ' ' ARG . . . . . 0.532 ' HB2' HD22 ' B' ' 181' ' ' LEU . 99.0 mtt180 -124.75 154.71 40.47 Favored 'General case' 0 C--O 1.247 0.941 0 C-N-CA 124.084 0.954 . . . . 72.12 109.302 -173.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 137' ' ' VAL . . . . . 0.498 HG13 ' HB1' ' B' ' 180' ' ' ALA . 7.6 p -81.12 108.8 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-O 121.919 0.866 . . . . 71.12 111.828 -165.117 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 138' ' ' VAL . . . . . 0.415 HG12 HG13 ' B' ' 182' ' ' VAL . 20.8 m -87.78 133.98 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 108.012 -1.107 . . . . 72.14 108.012 165.355 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 139' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' C' ' 143' ' ' ARG . 1.2 tm-20 -124.7 105.34 9.23 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 108.03 -1.1 . . . . 74.31 108.03 169.215 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 140' ' ' VAL . . . . . . . . . . . . . 67.1 t -127.81 110.41 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 123.796 0.838 . . . . 63.22 109.181 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 63.86 29.32 14.64 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.149 0.979 . . . . 15.23 110.976 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 97.76 -12.96 64.26 Favored Glycine 0 C--N 1.349 1.257 0 CA-C-N 115.003 -0.999 . . . . 45.25 112.738 -178.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 143' ' ' ARG . . . . . 0.499 ' NE ' ' HB2' ' C' ' 84' ' ' ASP . 5.9 tpp180 -75.26 93.92 2.93 Favored 'General case' 0 C--N 1.353 0.717 0 CA-C-N 117.253 0.527 . . . . 73.04 109.84 -177.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 28.8 ttp85 -104.73 96.68 6.74 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 124.373 1.069 . . . . 71.51 109.511 -176.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 145' ' ' VAL . . . . . 0.54 ' HA ' ' HD2' ' C' ' 60' ' ' PRO . 25.7 m -133.02 146.38 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.64 0.776 . . . . 75.03 110.615 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 46.4 m -89.79 92.48 9.06 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.949 -0.76 . . . . 54.21 108.949 174.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 147' ' ' VAL . . . . . 0.599 HG11 ' HE1' ' C' ' 164' ' ' MET . 10.8 p -113.16 145.37 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 122.942 0.497 . . . . 72.53 109.977 -174.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -101.16 101.81 12.61 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 108.499 -0.926 . . . . 74.22 108.499 170.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 149' ' ' ILE . . . . . . . . . . . . . 36.0 pt -73.57 137.1 77.49 Favored Pre-proline 0 CA--C 1.551 1.006 0 N-CA-C 107.734 -1.21 . . . . 71.41 107.734 165.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 150' ' ' PRO . . . . . 0.444 ' HA ' ' HD3' ' C' ' 151' ' ' PRO . 51.5 Cg_endo -63.76 142.66 83.9 Favored 'Trans proline' 0 C--N 1.37 1.702 0 C-N-CA 122.417 2.078 . . . . 61.44 113.136 -167.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 151' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' C' ' 150' ' ' PRO . 26.1 Cg_exo -62.92 149.95 89.94 Favored 'Trans proline' 0 C--N 1.379 2.148 0 C-N-CA 122.843 2.362 . . . . 73.2 111.719 176.075 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 152' ' ' GLY . . . . . 0.71 ' HA2' ' HB3' ' C' ' 240' ' ' PHE . . . 80.59 52.79 4.29 Favored Glycine 0 C--N 1.336 0.557 0 CA-C-N 116.216 -0.447 . . . . 54.32 112.435 -176.472 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 153' ' ' VAL . . . . . 0.527 HG21 HD11 ' C' ' 159' ' ' ILE . 8.3 p -104.14 142.83 16.87 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.312 0 C-N-CA 123.009 0.524 . . . . 71.13 110.26 -177.275 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 154' ' ' ARG . . . . . 0.593 ' HA ' ' HB3' ' C' ' 188' ' ' LEU . 57.5 mtp180 -97.51 161.35 13.82 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.762 0.825 . . . . 75.32 112.094 -168.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 155' ' ' GLU . . . . . 0.473 ' HG2' ' HE ' ' C' ' 187' ' ' ARG . 8.3 tp10 -54.22 115.7 2.21 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.682 0.793 . . . . 74.51 110.102 162.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 78.1 19.67 74.34 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-O 119.536 -0.591 . . . . 64.51 113.862 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 157' ' ' SER . . . . . . . . . . . . . 3.4 m -70.62 108.53 4.41 Favored 'General case' 0 C--N 1.355 0.842 0 CA-C-N 117.365 0.583 . . . . 75.43 110.105 172.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 158' ' ' VAL . . . . . 0.507 HG13 HG22 ' C' ' 177' ' ' VAL . 22.0 t -84.43 88.46 2.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 114.698 -1.137 . . . . 64.44 108.437 176.395 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 159' ' ' ILE . . . . . 0.527 HD11 HG21 ' C' ' 153' ' ' VAL . 37.5 mt -72.14 118.02 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 115.184 -0.916 . . . . 52.25 109.587 -178.308 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -75.95 118.61 18.91 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 109.091 -0.707 . . . . 72.21 109.091 173.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 161' ' ' VAL . . . . . 0.462 HG11 ' SD ' ' C' ' 164' ' ' MET . 20.6 t -125.85 95.55 39.61 Favored Pre-proline 0 CA--C 1.55 0.96 0 N-CA-C 109.556 -0.535 . . . . 75.24 109.556 174.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.38 128.11 12.5 Favored 'Trans proline' 0 C--N 1.369 1.609 0 C-N-CA 122.264 1.976 . . . . 63.42 111.342 173.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 101.92 23.92 8.93 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-N 115.793 -0.64 . . . . 53.31 113.466 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 164' ' ' MET . . . . . 0.599 ' HE1' HG11 ' C' ' 147' ' ' VAL . 28.2 mtp -151.81 6.9 0.47 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 112.619 0.6 . . . . 73.35 112.619 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 165' ' ' GLY . . . . . 0.415 ' HA3' ' O ' ' C' ' 173' ' ' ASP . . . -121.92 -122.89 2.88 Favored Glycine 0 N--CA 1.478 1.458 0 CA-C-O 118.348 -1.251 . . . . 64.24 111.515 -177.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . 69.4 81.93 0.21 Allowed Glycine 0 C--N 1.359 1.816 0 CA-C-N 118.149 0.974 . . . . 75.44 113.823 165.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 167' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -69.23 99.41 1.16 Allowed 'General case' 0 C--N 1.348 0.512 0 N-CA-C 107.035 -1.469 . . . . 64.31 107.035 166.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . 131.51 -142.51 13.91 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 108.395 -1.882 . . . . 13.44 108.395 -161.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 169' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -145.74 -62.2 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.774 0 CA-C-N 120.226 2.013 . . . . 62.44 111.784 175.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 170' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -61.88 162.79 20.97 Favored 'Trans proline' 0 C--N 1.399 3.191 0 C-N-CA 122.174 1.916 . . . . 51.41 112.345 173.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 171' ' ' PRO . . . . . 0.454 ' HA ' ' N ' ' C' ' 87' ' ' GLY . 5.8 Cg_exo -10.38 108.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.396 3.078 1 C-N-CA 127.079 5.186 . . . . 74.02 118.497 -165.189 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -140.32 -156.41 6.87 Favored Glycine 0 C--N 1.342 0.912 0 N-CA-C 109.311 -1.516 . . . . 74.42 109.311 170.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 173' ' ' ASP . . . . . 0.415 ' O ' ' HA3' ' C' ' 165' ' ' GLY . 14.5 t70 -166.3 158.29 13.85 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 117.843 0.822 . . . . 74.51 110.087 -177.018 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 174' ' ' LEU . . . . . 0.434 HD12 ' O ' ' C' ' 119' ' ' LEU . 45.2 tp -118.82 107.53 13.73 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.674 0.79 . . . . 75.22 109.758 175.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 175' ' ' LEU . . . . . 0.451 HD22 HG12 ' C' ' 158' ' ' VAL . 73.8 mt -86.44 85.85 7.33 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.962 0.905 . . . . 71.32 110.273 175.135 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 176' ' ' LEU . . . . . 0.43 ' HG ' ' HG ' ' C' ' 174' ' ' LEU . 47.9 mt -75.3 92.7 2.79 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.594 0.758 . . . . 43.02 110.543 177.372 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 177' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' C' ' 122' ' ' GLU . 6.5 t -84.92 94.13 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 C-N-CA 123.423 0.689 . . . . 74.43 109.921 179.287 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 178' ' ' VAL . . . . . . . . . . . . . 23.0 m -68.78 119.53 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 O-C-N 121.344 -0.848 . . . . 74.01 110.781 -176.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 179' ' ' ARG . . . . . 0.474 ' O ' ' HA ' ' C' ' 124' ' ' PRO . 7.0 mmm180 -100.93 119.7 39.09 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 107.023 -1.473 . . . . 72.33 107.023 171.447 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 180' ' ' LEU . . . . . 0.454 HD13 HD21 ' C' ' 127' ' ' LEU . 75.5 mt -68.6 134.99 50.78 Favored 'General case' 0 CA--C 1.559 1.29 0 CA-C-N 118.171 0.441 . . . . 70.51 111.397 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 181' ' ' LEU . . . . . 0.436 HD23 ' HB3' ' C' ' 124' ' ' PRO . 18.5 mt -53.12 169.64 0.29 Allowed Pre-proline 0 N--CA 1.502 2.148 0 C-N-CA 126.521 1.928 . . . . 74.2 113.538 -176.123 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -59.99 64.5 0.07 OUTLIER 'Trans proline' 0 C--N 1.405 3.543 0 C-N-CA 123.486 2.791 . . . . 64.12 112.268 161.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 183' ' ' HIS . . . . . 0.527 ' N ' ' HD3' ' C' ' 184' ' ' PRO . 76.4 t60 -162.37 26.15 0.02 OUTLIER Pre-proline 0 CA--C 1.576 1.957 0 C-N-CA 127.77 2.428 . . . . 62.13 107.705 -176.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 184' ' ' PRO . . . . . 0.527 ' HD3' ' N ' ' C' ' 183' ' ' HIS . 11.0 Cg_endo -88.49 67.67 3.0 Favored 'Trans proline' 0 C--N 1.401 3.341 0 C-N-CA 123.588 2.859 . . . . 71.54 111.377 -163.382 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 185' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 9.0 t -89.48 -23.93 6.05 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.492 0 N-CA-C 108.146 -1.057 . . . . 72.23 108.146 -177.532 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 186' ' ' PHE . . . . . 0.484 ' HD2' HD13 ' C' ' 127' ' ' LEU . 48.4 m-85 -127.85 101.82 6.51 Favored 'General case' 0 C--N 1.352 0.704 0 C-N-CA 123.737 0.815 . . . . 61.44 109.266 -178.039 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 187' ' ' ARG . . . . . 0.473 ' HE ' ' HG2' ' C' ' 155' ' ' GLU . 27.9 ttm105 -97.72 110.65 23.17 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 124.557 1.143 . . . . 75.14 108.182 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 188' ' ' LEU . . . . . 0.593 ' HB3' ' HA ' ' C' ' 154' ' ' ARG . 59.5 tp -76.77 131.94 38.99 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.387 0.613 . . . . 74.14 112.6 -166.266 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -116.08 106.3 13.59 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.147 1.379 . . . . 71.33 108.377 167.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 66.85 -99.8 0.51 Allowed Glycine 0 C--N 1.348 1.239 0 CA-C-N 116.053 -0.521 . . . . 74.2 112.454 -178.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 191' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -117.53 -14.21 10.28 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 124.262 1.025 . . . . 60.21 110.183 175.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -101.32 128.71 47.36 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.678 1.191 . . . . 65.13 110.401 -173.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 193' ' ' LEU . . . . . 0.432 ' HG ' ' HA2' ' C' ' 239' ' ' GLY . 77.8 mt -73.74 153.75 39.89 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.828 0.851 . . . . 52.2 111.883 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 194' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -123.83 106.72 10.7 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 107.266 -1.383 . . . . 75.43 107.266 169.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 195' ' ' ALA . . . . . 0.461 ' HA ' ' O ' ' C' ' 185' ' ' VAL . . . -110.76 -177.91 3.34 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.286 1.034 . . . . 65.11 110.38 -174.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 90.2 m -137.75 121.12 17.05 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 108.638 -0.875 . . . . 51.32 108.638 164.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 197' ' ' LEU . . . . . . . . . . . . . 63.2 tp -100.48 143.5 30.59 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.586 1.155 . . . . 73.5 110.232 -175.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -100.61 101.59 12.53 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 123.656 0.782 . . . . 44.52 109.004 -178.056 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 199' ' ' VAL . . . . . 0.406 HG22 HG21 ' C' ' 210' ' ' VAL . 94.9 t -114.51 125.58 29.0 Favored Pre-proline 0 N--CA 1.486 1.354 0 C-N-CA 124.404 1.081 . . . . 61.21 109.864 -176.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 200' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -74.06 145.05 34.83 Favored 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 121.675 1.583 . . . . 71.34 111.125 174.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 201' ' ' ALA . . . . . 0.461 ' O ' HG23 ' C' ' 205' ' ' VAL . . . -58.66 -38.89 70.25 Favored Pre-proline 0 CA--C 1.552 1.024 0 N-CA-C 115.263 1.579 . . . . 74.35 115.263 -173.507 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 202' ' ' PRO . . . . . 0.542 ' O ' HG13 ' C' ' 206' ' ' VAL . 21.2 Cg_endo -59.13 -52.33 5.16 Favored 'Trans proline' 0 C--N 1.388 2.613 0 CA-C-N 121.711 1.647 . . . . 63.15 111.205 175.364 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 203' ' ' ILE . . . . . . . . . . . . . 43.4 mt -62.49 -28.25 44.36 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 C-N-CA 124.228 1.011 . . . . 63.4 110.737 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.62 -43.4 76.44 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.5 -0.773 . . . . 75.02 112.305 175.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 205' ' ' VAL . . . . . 0.538 HG11 HD11 ' A' ' 261' ' ' LEU . 65.2 t -69.39 -45.42 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 122.373 0.269 . . . . 63.41 110.964 -178.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 206' ' ' VAL . . . . . 0.542 HG13 ' O ' ' C' ' 202' ' ' PRO . 0.7 OUTLIER -96.58 -38.09 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 111.514 0.19 . . . . 52.12 111.514 -167.717 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 106.07 119.49 4.55 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 112.455 -0.258 . . . . 63.21 112.455 -173.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -156.44 -137.64 2.37 Favored Glycine 0 C--N 1.336 0.56 0 N-CA-C 109.79 -1.324 . . . . 51.32 109.79 176.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 209' ' ' LYS . . . . . 0.682 ' HG2' ' HA ' ' C' ' 222' ' ' ALA . 10.2 mtmp? -142.37 151.94 42.38 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 118.08 0.94 . . . . 72.12 111.712 177.547 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 210' ' ' VAL . . . . . 0.406 HG21 HG22 ' C' ' 199' ' ' VAL . 30.2 m -139.42 174.0 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 125.644 1.577 . . . . 62.05 108.516 174.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 211' ' ' ARG . . . . . 0.682 HH11 ' HB2' ' C' ' 218' ' ' PRO . 40.5 ttm-85 -109.66 127.64 54.7 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 118.431 0.56 . . . . 72.44 110.778 -176.249 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -107.97 113.14 26.11 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 107.335 -1.358 . . . . 74.43 107.335 169.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 213' ' ' MET . . . . . 0.677 ' HA ' ' HA ' ' C' ' 218' ' ' PRO . 4.2 ttp -80.28 98.95 7.63 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 108.954 -0.758 . . . . 63.12 108.954 -176.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.11 177.74 8.58 Favored 'General case' 0 C--O 1.244 0.798 0 O-C-N 123.342 0.401 . . . . 54.24 109.936 -174.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 215' ' ' LEU . . . . . 0.665 HD22 ' HB3' ' C' ' 127' ' ' LEU . 11.9 mt -52.68 -60.81 2.8 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.055 0.942 . . . . 44.41 110.506 -175.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -86.76 8.61 21.94 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.211 -0.904 . . . . 71.0 112.185 -174.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 142.07 157.03 7.0 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-O 119.925 -0.375 . . . . 64.11 113.307 177.116 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 218' ' ' PRO . . . . . 0.682 ' HB2' HH11 ' C' ' 211' ' ' ARG . 31.8 Cg_endo -63.22 121.99 10.03 Favored 'Trans proline' 0 C--N 1.364 1.389 0 C-N-CA 122.95 2.433 . . . . 52.13 115.322 177.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 219' ' ' VAL . . . . . . . . . . . . . 8.0 p -98.77 167.84 1.8 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.928 0 N-CA-C 107.05 -1.463 . . . . 52.53 107.05 170.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 220' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -101.04 158.45 16.0 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 109.338 -0.616 . . . . 72.32 109.338 173.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 221' ' ' VAL . . . . . . . . . . . . . 33.3 t -121.97 123.22 68.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 125.2 1.4 . . . . 74.03 108.309 173.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 222' ' ' ALA . . . . . 0.682 ' HA ' ' HG2' ' C' ' 209' ' ' LYS . . . -84.15 101.92 12.19 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 123.118 0.567 . . . . 73.3 109.565 169.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 61.0 t -75.53 123.39 88.49 Favored Pre-proline 0 CA--C 1.549 0.91 0 CA-C-N 114.409 -1.269 . . . . 73.11 109.222 178.302 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 224' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -76.37 164.44 30.85 Favored 'Trans proline' 0 C--N 1.369 1.651 0 C-N-CA 123.552 2.835 . . . . 54.33 112.917 172.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -55.96 146.52 68.2 Favored 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 122.361 2.041 . . . . 74.0 112.684 165.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 226' ' ' ARG . . . . . 0.419 ' HG3' ' HA ' ' A' ' 259' ' ' GLU . 8.0 mpt_? 66.65 66.5 0.45 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.764 1.225 . . . . 70.15 110.814 171.619 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 227' ' ' THR . . . . . 0.533 ' HA ' ' HD3' ' C' ' 231' ' ' ARG . 16.7 m -114.89 121.79 44.29 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 114.697 -1.138 . . . . 70.3 110.779 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 228' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -111.27 163.01 14.4 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.922 0.889 . . . . 74.32 110.809 -178.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -77.18 111.43 12.79 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 114.403 -1.271 . . . . 62.12 109.965 -178.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 110.61 6.2 27.12 Favored Glycine 0 N--CA 1.476 1.311 0 CA-C-O 119.896 -0.391 . . . . 62.04 113.115 -169.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 231' ' ' ARG . . . . . 0.533 ' HD3' ' HA ' ' C' ' 227' ' ' THR . 39.4 mtp85 -77.84 169.78 17.71 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 109.623 -0.51 . . . . 74.12 109.623 164.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 232' ' ' LYS . . . . . 0.446 ' HB2' ' NZ ' ' C' ' 232' ' ' LYS . 2.1 ttmp? -135.08 151.02 50.36 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.424 0.63 . . . . 71.45 112.461 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 233' ' ' LEU . . . . . 0.715 HD13 ' HB2' ' C' ' 251' ' ' LEU . 5.6 mp -113.96 157.21 22.75 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.672 1.589 . . . . 74.21 110.874 -176.084 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 28.5 ptt-85 -134.57 97.12 3.71 Favored 'General case' 0 CA--C 1.559 1.324 0 O-C-N 125.327 1.642 . . . . 72.34 110.65 173.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 235' ' ' LEU . . . . . 0.478 ' HB2' ' HB3' ' C' ' 249' ' ' LEU . 87.5 mt -93.29 104.44 16.61 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.9 0.88 . . . . 73.43 108.819 171.201 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -68.89 132.28 46.48 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.756 0.822 . . . . 71.55 112.184 -174.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 74.37 22.58 77.32 Favored Glycine 0 C--N 1.357 1.711 0 O-C-N 123.925 0.766 . . . . 71.42 113.965 177.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 27.9 mmtm -115.79 17.96 15.88 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.462 0.705 . . . . 72.03 111.382 -178.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 239' ' ' GLY . . . . . 0.432 ' HA2' ' HG ' ' C' ' 193' ' ' LEU . . . -91.61 -159.04 35.13 Favored Glycine 0 C--N 1.349 1.252 0 O-C-N 123.421 0.45 . . . . 31.21 112.851 177.209 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 240' ' ' PHE . . . . . 0.71 ' HB3' ' HA2' ' C' ' 152' ' ' GLY . 4.4 m-85 -88.65 154.84 50.82 Favored Pre-proline 0 CA--C 1.551 0.997 0 CA-C-O 119.102 -0.475 . . . . 75.14 109.776 179.038 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 241' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -67.93 101.62 0.7 Allowed 'Trans proline' 0 C--N 1.387 2.596 0 C-N-CA 122.83 2.353 . . . . 70.21 110.66 177.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -94.12 167.86 28.14 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-N 115.623 -0.717 . . . . 70.14 112.152 177.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.02 -23.52 29.53 Favored 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 123.023 2.482 . . . . 71.42 111.412 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -99.0 27.34 5.09 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.318 1.047 . . . . 71.42 110.064 175.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 92.07 177.98 41.94 Favored Glycine 0 C--N 1.351 1.377 0 CA-C-N 115.918 -0.583 . . . . 51.32 112.186 -177.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 246' ' ' ARG . . . . . . . . . . . . . 80.1 mtm180 -72.48 138.21 46.87 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 122.699 0.399 . . . . 61.31 110.267 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -79.01 -155.54 9.07 Favored Glycine 0 C--N 1.344 1.025 0 O-C-N 123.857 0.723 . . . . 63.23 112.374 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -120.25 177.6 4.96 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 108.562 -0.903 . . . . 73.54 108.562 -175.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 249' ' ' LEU . . . . . 0.478 ' HB3' ' HB2' ' C' ' 235' ' ' LEU . 12.8 tp -119.7 109.28 15.45 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.877 -0.786 . . . . 74.23 108.877 177.138 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 250' ' ' TYR . . . . . 0.609 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 19.9 m-85 -101.5 105.57 16.58 Favored 'General case' 0 C--N 1.343 0.325 0 CA-C-N 115.901 -0.59 . . . . 71.43 109.605 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 251' ' ' LEU . . . . . 0.715 ' HB2' HD13 ' C' ' 233' ' ' LEU . 2.1 mp -99.71 149.47 23.29 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 109.595 -0.52 . . . . 64.53 109.595 -173.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -103.44 128.17 50.65 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.388 -0.967 . . . . 73.41 108.388 175.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 253' ' ' VAL . . . . . . . . . . . . . 95.1 t -74.15 133.28 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.172 0.589 . . . . 73.5 111.896 -172.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 254' ' ' ARG . . . . . 0.511 ' NH2' ' HB ' ' C' ' 256' ' ' THR . 1.3 tmm_? -122.27 94.98 4.47 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 107.321 -1.363 . . . . 74.13 107.321 176.511 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 255' ' ' ILE . . . . . 0.482 HD11 HG22 ' C' ' 227' ' ' THR . 46.6 mm -69.17 131.35 34.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 122.634 0.374 . . . . 75.24 110.459 177.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 256' ' ' THR . . . . . 0.511 ' HB ' ' NH2' ' C' ' 254' ' ' ARG . 0.0 OUTLIER -140.8 172.0 13.3 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.538 1.135 . . . . 53.32 111.153 -174.514 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 2.9 pp -130.96 154.18 81.94 Favored Pre-proline 0 CA--C 1.556 1.181 0 C-N-CA 124.351 1.06 . . . . 64.54 109.29 177.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -72.38 -2.62 11.99 Favored 'Trans proline' 0 C--N 1.377 2.065 0 C-N-CA 122.451 2.101 . . . . 73.21 113.631 -166.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 57.14 -72.12 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 125.229 1.412 . . . . 72.3 111.74 -166.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 -69.75 148.03 49.72 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.597 0.759 . . . . 73.41 111.103 177.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 261' ' ' LEU . . . . . 0.472 HD13 ' HA ' ' C' ' 266' ' ' GLU . 72.7 mt -138.35 141.47 39.69 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.243 0.617 . . . . 71.21 111.416 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 46.7 p -82.09 150.8 65.58 Favored Pre-proline 0 CA--C 1.545 0.771 0 N-CA-C 107.995 -1.113 . . . . 61.23 107.995 170.01 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -47.04 -39.46 25.43 Favored 'Trans proline' 0 N--CA 1.509 2.394 0 C-N-CA 123.77 2.98 . . . . 74.2 113.759 -177.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 264' ' ' GLU . . . . . 0.479 ' HG2' ' NH2' ' A' ' 279' ' ' ARG . 2.8 tp10 -55.89 -67.62 0.27 Allowed 'General case' 0 C--O 1.246 0.877 0 C-N-CA 124.578 1.151 . . . . 71.04 111.093 175.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -66.04 -28.63 69.0 Favored 'General case' 0 C--O 1.212 -0.885 0 CA-C-N 115.176 -0.92 . . . . 65.11 110.847 -173.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 266' ' ' GLU . . . . . 0.472 ' HA ' HD13 ' C' ' 261' ' ' LEU . 11.6 tp10 -57.88 -50.15 74.3 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.025 0.93 . . . . 64.21 109.575 174.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -60.4 -38.53 84.27 Favored 'General case' 0 CA--C 1.548 0.887 0 O-C-N 123.853 0.72 . . . . 70.32 111.592 176.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 268' ' ' LEU . . . . . . . . . . . . . 11.0 mp -65.06 -47.68 76.45 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 112.445 0.535 . . . . 52.44 112.445 177.243 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 269' ' ' TRP . . . . . 0.444 ' HH2' ' HD3' ' C' ' 202' ' ' PRO . 90.5 m95 -64.74 -33.42 75.92 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.302 0.641 . . . . 61.11 110.603 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 270' ' ' LYS . . . . . 0.4 ' NZ ' ' HB3' ' C' ' 270' ' ' LYS . 4.6 mmmp? -64.9 -48.64 73.47 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.739 0.816 . . . . 75.43 111.547 177.031 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 13.0 mmtm -65.74 -37.96 87.83 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.059 0.543 . . . . 75.33 111.917 179.132 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 272' ' ' LEU . . . . . 0.436 HD12 HD12 ' A' ' 272' ' ' LEU . 64.3 mt -76.53 -22.46 54.35 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.761 -0.654 . . . . 74.33 111.226 177.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -67.28 -47.04 71.82 Favored 'General case' 0 C--O 1.218 -0.572 0 N-CA-C 109.226 -0.657 . . . . 34.13 109.226 171.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -60.69 -37.36 81.38 Favored 'General case' 0 N--CA 1.483 1.215 0 O-C-N 124.291 0.994 . . . . 63.21 111.099 176.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -63.58 -37.2 86.43 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.625 0.77 . . . . 70.04 111.287 175.182 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 276' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -83.25 -22.33 33.09 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 116.311 -0.404 . . . . 75.52 112.077 178.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 20.8 m-30 -68.16 -35.93 78.84 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 108.408 -0.96 . . . . 44.24 108.408 172.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -59.39 -27.26 65.83 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 114.898 -1.047 . . . . 55.2 111.439 171.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 279' ' ' ARG . . . . . . . . . . . . . 25.3 mtp-105 -74.95 -31.54 61.52 Favored 'General case' 0 C--N 1.364 1.236 0 N-CA-C 109.648 -0.501 . . . . 71.52 109.648 175.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 N-CA-C 109.185 -0.672 . . . . 75.14 109.185 -175.233 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp . . . . . 0 CA--C 1.548 0.88 0 N-CA-C 112.955 0.724 . . . . 62.43 112.955 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -89.42 129.12 35.98 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.663 0.785 . . . . 74.32 110.269 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -84.07 86.55 7.19 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 107.007 -1.479 . . . . 61.41 107.007 170.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.435 ' CD1' ' HA ' ' A' ' 53' ' ' ALA . 69.9 m-85 -61.0 -25.96 67.26 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 114.988 -1.005 . . . . 73.34 112.024 -174.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.506 ' HE1' ' HE2' ' A' ' 66' ' ' TYR . 49.3 m-85 -66.69 -52.54 43.58 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.602 -0.726 . . . . 73.33 109.581 175.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.61 -36.54 76.51 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.592 0.757 . . . . 60.32 110.885 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 69.8 mt -59.43 -44.16 92.07 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.097 0 C-N-CA 123.91 0.884 . . . . 74.23 110.943 174.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.5 mt -77.18 -6.95 54.91 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 112.515 0.561 . . . . 51.33 112.515 175.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.92 17.83 76.29 Favored Glycine 0 C--N 1.352 1.434 0 C-N-CA 122.961 0.315 . . . . 53.33 113.561 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.6 m -108.83 152.24 42.22 Favored Pre-proline 0 CA--C 1.554 1.125 0 C-N-CA 124.055 0.942 . . . . 71.43 110.008 176.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -86.41 172.72 6.88 Favored 'Trans proline' 0 C--N 1.368 1.599 0 C-N-CA 122.366 2.044 . . . . 50.12 112.928 178.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 11.9 mmt85 -68.85 78.48 0.31 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.127 -0.942 . . . . 75.43 109.345 172.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -174.37 -31.82 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 114.335 -1.302 . . . . 64.11 108.431 -172.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.43 120.92 15.29 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.624 -0.716 . . . . 64.31 111.304 -178.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 76.2 p -82.62 175.25 10.31 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.989 0.916 . . . . 71.11 110.027 174.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -47.96 -39.81 20.43 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 124.728 1.211 . . . . 64.21 113.033 -176.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.449 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 0.5 OUTLIER -69.35 -44.82 70.83 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.521 0.729 . . . . 72.43 109.796 -175.689 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -67.39 -34.69 77.78 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 124.036 0.935 . . . . 64.03 111.455 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.555 HD13 HD13 ' A' ' 57' ' ' LEU . 77.9 mt -67.23 -36.6 77.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.98 1.312 . . . . 73.31 110.461 175.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -69.84 -38.64 76.56 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.233 -0.894 . . . . 71.24 109.672 178.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 20' ' ' GLU . 94.9 mtt180 -60.25 -48.56 81.22 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.509 0.723 . . . . 54.12 109.896 175.453 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.81 -43.71 98.31 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 124.541 1.151 . . . . 64.0 111.668 -177.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -61.55 -54.81 38.17 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.55 -0.75 . . . . 73.1 110.638 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.434 ' HA ' ' HB3' ' A' ' 30' ' ' ALA . 57.3 mtpt -62.66 -32.73 73.84 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 124.119 0.887 . . . . 74.22 111.7 -177.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.405 ' HA ' ' NH2' ' A' ' 31' ' ' ARG . 14.9 ttt180 -57.99 -55.38 35.63 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.341 1.056 . . . . 71.15 110.058 174.02 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.635 ' HB3' HD13 ' A' ' 50' ' ' ILE . 78.8 mt -74.94 -15.13 60.7 Favored 'General case' 0 CA--C 1.552 1.026 0 CA-C-N 114.865 -1.061 . . . . 74.11 110.925 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.477 ' HA ' ' HE1' ' A' ' 47' ' ' PHE . . . -89.75 -12.0 40.6 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.032 0.933 . . . . 63.3 111.723 176.469 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.405 ' NH2' ' HA ' ' A' ' 28' ' ' ARG . 47.1 mtm105 -90.68 -42.93 10.45 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 109.714 -0.476 . . . . 72.33 109.714 167.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -68.68 -61.4 1.83 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.491 0.717 . . . . 63.33 111.345 -177.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -92.11 17.5 9.41 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.227 0.611 . . . . 63.25 112.211 -172.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 7.2 t-160 -57.38 101.85 0.28 Allowed Pre-proline 0 CA--C 1.555 1.156 0 C-N-CA 124.645 1.178 . . . . 63.41 111.654 -172.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.87 -32.03 75.78 Favored 'Trans proline' 0 C--N 1.388 2.65 0 C-N-CA 123.883 3.055 . . . . 74.13 113.71 -171.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -47.0 -43.68 19.61 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.609 1.164 . . . . 72.45 112.331 176.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 60.3 t -104.65 -24.77 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.665 0.786 . . . . 65.53 110.069 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -127.48 73.96 1.48 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.259 0.624 . . . . 61.35 110.474 -170.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -79.16 69.19 5.3 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 109.066 -0.716 . . . . 73.11 109.066 171.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.4 m -112.06 105.05 56.43 Favored Pre-proline 0 CA--C 1.535 0.38 0 N-CA-C 107.28 -1.378 . . . . 54.41 107.28 177.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -37.3 -49.38 1.72 Allowed 'Trans proline' 0 C--N 1.389 2.698 0 C-N-CA 124.689 3.593 . . . . 72.23 114.647 -173.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -51.95 -54.32 30.99 Favored 'General case' 0 N--CA 1.48 1.042 0 O-C-N 124.314 1.009 . . . . 64.43 111.086 177.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.09 -21.54 63.12 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 114.798 -1.092 . . . . 72.14 111.385 -177.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.475 ' O ' ' HD3' ' A' ' 48' ' ' LYS . 51.8 mt-10 -83.25 -38.69 21.88 Favored 'General case' 0 C--N 1.355 0.818 0 C-N-CA 122.824 0.45 . . . . 62.01 109.891 -176.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -65.73 -43.98 87.4 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.485 0.714 . . . . 62.44 109.445 175.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -58.62 -41.01 84.94 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 114.696 -1.138 . . . . 74.03 110.265 171.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.477 ' HE1' ' HA ' ' A' ' 30' ' ' ALA . 40.9 t80 -69.51 -25.32 63.99 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 123.407 0.442 . . . . 73.24 111.886 179.076 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.475 ' HD3' ' O ' ' A' ' 44' ' ' GLU . 2.0 mptm? -70.32 -39.13 74.95 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 109.944 -0.391 . . . . 75.14 109.944 174.103 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -63.43 -41.36 98.69 Favored 'General case' 0 CA--C 1.55 0.962 0 O-C-N 123.907 0.754 . . . . 71.44 110.568 174.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.635 HD13 ' HB3' ' A' ' 29' ' ' LEU . 69.4 mt -67.91 -40.53 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 124.621 1.168 . . . . 70.53 110.994 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -63.76 -41.03 98.05 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.261 -0.881 . . . . 73.43 110.379 174.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.426 ' O ' HG23 ' A' ' 56' ' ' VAL . 33.4 tt0 -61.27 -48.85 79.52 Favored 'General case' 0 C--O 1.246 0.906 0 C-N-CA 124.62 1.168 . . . . 63.42 110.591 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.435 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . . . -58.01 -48.07 81.15 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 114.163 -1.38 . . . . 65.45 111.564 -178.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -82.8 -14.52 54.26 Favored 'General case' 0 C--O 1.212 -0.915 0 CA-C-N 115.774 -0.648 . . . . 72.32 111.649 178.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.11 -35.62 81.7 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.777 0.799 . . . . 53.01 109.661 173.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.426 HG22 ' CE1' ' A' ' 101' ' ' PHE . 34.4 t -73.05 -58.7 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 CA-C-N 113.748 -1.569 . . . . 74.52 110.264 170.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.555 HD13 HD13 ' A' ' 22' ' ' ILE . 51.8 mt -90.11 15.09 10.83 Favored 'General case' 0 CA--C 1.558 1.256 0 CA-C-N 115.215 -0.902 . . . . 62.04 113.109 -166.031 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 44.2 t -67.01 -68.07 0.4 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.283 0.633 . . . . 74.34 109.806 173.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -80.95 135.82 51.29 Favored Pre-proline 0 C--O 1.238 0.456 0 CA-C-N 114.799 -1.091 . . . . 74.34 108.792 176.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.465 ' O ' ' HG2' ' A' ' 64' ' ' ARG . 51.3 Cg_exo -56.43 -28.32 72.54 Favored 'Trans proline' 0 C--N 1.369 1.627 0 C-N-CA 123.016 2.477 . . . . 72.41 112.082 170.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -71.29 -48.31 51.52 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.438 0.695 . . . . 72.3 111.285 -178.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.52 ' HA ' HD12 ' A' ' 65' ' ' ILE . 37.6 mtpt -70.87 -27.25 63.68 Favored 'General case' 0 C--O 1.257 1.493 0 CA-C-O 121.36 0.6 . . . . 74.54 110.934 178.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.425 HH21 ' CD1' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -65.58 -41.76 92.5 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 115.382 -0.827 . . . . 74.11 109.436 171.159 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.465 ' HG2' ' O ' ' A' ' 60' ' ' PRO . 4.5 mmp_? -59.22 -41.68 89.22 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.572 0.749 . . . . 74.25 110.734 176.272 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.612 ' HA ' ' HG2' ' A' ' 76' ' ' PRO . 91.0 mt -53.34 -51.12 43.78 Favored 'Isoleucine or valine' 0 C--O 1.251 1.15 0 C-N-CA 124.037 0.935 . . . . 64.42 110.57 175.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.506 ' HE2' ' HE1' ' A' ' 8' ' ' TYR . 37.9 t80 -58.2 -52.16 66.73 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 115.826 -0.624 . . . . 75.4 111.653 173.221 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -56.91 -33.74 67.23 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.144 0.978 . . . . 64.04 112.041 -173.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 40.5 p -91.42 -14.91 29.76 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.133 0.573 . . . . 75.13 112.214 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -72.1 125.41 27.19 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 107.513 -1.291 . . . . 63.45 107.513 166.16 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.84 23.91 29.11 Favored Glycine 0 N--CA 1.47 0.918 0 N-CA-C 111.281 -0.728 . . . . 52.54 111.281 -171.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 60.0 m -144.88 -57.67 0.35 Allowed 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 103.321 -2.844 . . . . 71.23 103.321 175.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 34.2 m -78.91 134.48 36.88 Favored 'General case' 0 C--O 1.25 1.099 0 N-CA-C 104.348 -2.464 . . . . 74.23 104.348 155.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.27 -31.78 67.9 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.396 0.678 . . . . 74.04 110.733 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -92.17 161.33 33.35 Favored Pre-proline 0 C--O 1.244 0.769 0 C-N-CA 124.177 0.991 . . . . 75.1 110.561 177.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -63.85 138.65 64.35 Favored 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 121.822 1.681 . . . . 75.41 110.172 164.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.612 ' HG2' ' HA ' ' A' ' 65' ' ' ILE . 82.6 Cg_exo -52.99 156.98 8.81 Favored 'Trans proline' 0 N--CA 1.501 1.917 0 C-N-CA 124.062 3.175 . . . . 74.25 114.77 178.288 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -58.27 124.87 16.86 Favored 'Trans proline' 0 C--N 1.385 2.483 0 C-N-CA 123.065 2.51 . . . . 62.44 112.382 -178.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -70.1 130.67 19.3 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 123.086 2.524 . . . . 43.51 112.245 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -60.91 142.64 98.2 Favored 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 122.827 2.351 . . . . 71.05 111.436 171.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.78 84.47 0.31 Allowed 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 122.83 2.353 . . . . 51.35 111.937 -177.172 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 165.85 -38.19 0.27 Allowed Glycine 0 C--N 1.333 0.383 0 CA-C-N 114.18 -1.373 . . . . 62.41 109.722 -177.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 113.29 -165.21 12.02 Favored Glycine 0 C--N 1.35 1.346 0 CA-C-N 115.212 -0.494 . . . . 53.03 112.921 176.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -109.58 108.43 18.87 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.125 0.97 . . . . 74.41 109.882 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -66.54 156.09 35.89 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.965 0.906 . . . . 71.31 111.369 173.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.555 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 59.9 m-85 -144.8 77.66 1.54 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.015 0.926 . . . . 70.22 110.491 -175.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.493 ' HB3' ' HG2' ' A' ' 162' ' ' PRO . 7.0 m -48.43 85.61 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.356 0 C-N-CA 125.596 1.558 . . . . 74.44 113.597 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.03 10.95 81.47 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-N 116.013 -0.539 . . . . 70.11 113.628 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.555 ' HB2' ' HB3' ' A' ' 85' ' ' PHE . 25.2 m-85 -104.25 103.57 13.35 Favored 'General case' 0 C--N 1.351 0.652 0 C-N-CA 123.211 0.604 . . . . 72.34 109.492 -175.48 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -82.55 83.29 7.63 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 121.469 0.652 . . . . 71.44 110.034 -174.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.3 p -44.56 -33.27 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 C-N-CA 126.058 1.743 . . . . 75.21 114.36 176.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -55.99 -30.91 62.51 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.369 1.068 . . . . 75.33 111.647 -177.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -100.04 -6.65 26.09 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 123.787 0.835 . . . . 45.35 111.334 -175.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 12.8 m-30 -86.41 176.83 7.67 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 123.632 0.773 . . . . 71.01 110.929 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 91.9 p -67.56 161.39 25.7 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 113.161 0.8 . . . . 74.5 113.161 -169.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.85 -39.09 90.64 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 114.788 -1.096 . . . . 74.31 111.437 174.149 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -61.64 -40.39 94.71 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 122.655 0.382 . . . . 75.03 110.343 177.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.418 ' CD1' ' HG3' ' A' ' 52' ' ' GLU . 61.0 t80 -62.0 -41.46 98.08 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-O 121.493 0.663 . . . . 63.23 109.624 176.291 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -80.54 -1.22 41.01 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 114.693 -1.139 . . . . 73.05 112.531 177.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -100.15 -44.35 6.01 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 123.682 0.793 . . . . 70.02 111.872 170.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 24.7 tp -64.58 -47.68 77.81 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.454 1.101 . . . . 55.03 109.803 178.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.426 ' CE1' HG22 ' A' ' 56' ' ' VAL . 98.5 m-85 -92.65 -7.04 48.03 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.375 -0.83 . . . . 72.11 111.272 177.187 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -45.7 -58.89 5.16 Favored Glycine 0 CA--C 1.538 1.492 0 C-N-CA 124.458 1.028 . . . . 72.43 115.668 -177.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -61.9 -8.7 12.22 Favored 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 123.042 2.495 . . . . 23.1 114.046 -176.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -139.85 32.77 2.18 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-O 119.658 -0.523 . . . . 44.4 112.74 175.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.1 mt -68.34 22.47 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 115.007 1.484 . . . . 74.25 115.007 -177.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.511 ' HB3' ' ND2' ' A' ' 169' ' ' ASN . 0.2 OUTLIER 55.83 -107.34 0.38 Allowed 'General case' 0 CA--C 1.566 1.56 0 C-N-CA 124.06 0.944 . . . . 72.25 110.779 164.583 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 67.26 16.68 67.29 Favored Glycine 0 C--N 1.361 1.925 0 CA-C-O 120.043 -0.309 . . . . 44.0 113.479 -179.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.469 ' H ' ' HD1' ' A' ' 106' ' ' PHE . . . . . . . . 0 C--N 1.352 1.438 0 N-CA-C 111.414 -0.674 . . . . 71.34 111.414 -171.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.432 ' HA ' ' O ' ' A' ' 170' ' ' PRO . 34.8 ttmt . . . . . 0 N--CA 1.477 0.905 0 N-CA-C 113.142 0.793 . . . . 72.15 113.142 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -97.77 -170.98 32.82 Favored Glycine 0 CA--C 1.544 1.867 0 CA-C-N 115.316 -0.856 . . . . 55.22 113.716 176.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -110.21 140.28 44.5 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.327 1.051 . . . . 71.34 111.049 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -44.09 104.11 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 125.393 1.477 . . . . 74.23 112.953 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.44 ' O ' HD12 ' A' ' 174' ' ' LEU . 5.3 tt -100.39 144.53 29.28 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.209 -0.905 . . . . 70.23 108.788 -171.226 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.57 ' HD2' ' HB2' ' A' ' 175' ' ' LEU . 16.4 tpt180 -96.67 142.64 28.47 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 108.58 -0.896 . . . . 74.51 108.58 -178.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.559 ' HB2' HD11 ' A' ' 174' ' ' LEU . . . -139.62 166.98 23.15 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 118.737 0.698 . . . . 41.51 111.279 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.448 ' HB2' ' HB3' ' B' ' 9' ' ' ALA . 8.1 mm-40 -120.45 101.31 7.69 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 106.193 -1.78 . . . . 61.0 106.193 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.534 HD22 HD13 ' A' ' 176' ' ' LEU . 15.3 tp -99.1 101.87 13.85 Favored Pre-proline 0 C--O 1.215 -0.732 0 N-CA-C 107.918 -1.142 . . . . 54.05 107.918 -177.518 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.494 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 41.8 Cg_endo -64.63 150.3 88.42 Favored 'Trans proline' 0 C--N 1.368 1.592 0 N-CA-C 108.972 -1.203 . . . . 75.33 108.972 171.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.619 ' HA ' HG21 ' B' ' 6' ' ' ILE . 16.7 tp -152.12 145.99 25.16 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 119.294 0.952 . . . . 64.01 112.152 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 49.2 m -77.47 126.76 31.42 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 114.669 -1.151 . . . . 71.34 109.307 175.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.666 ' HB3' HD22 ' A' ' 215' ' ' LEU . 3.1 mm? -43.86 -55.88 4.24 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 125.955 1.702 . . . . 70.54 112.973 -176.055 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 -59.52 -45.47 91.64 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 114.42 -1.264 . . . . 75.32 109.917 -176.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -77.19 -11.81 59.87 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.376 -0.829 . . . . 64.33 111.976 -177.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.602 ' HB1' ' O ' ' A' ' 153' ' ' VAL . . . -79.24 -41.81 27.39 Favored 'General case' 0 C--O 1.251 1.181 0 CA-C-O 122.0 0.905 . . . . 41.43 109.433 175.293 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -67.99 -40.04 83.14 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 114.204 -1.362 . . . . 74.51 110.813 172.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 38.9 m170 -77.86 -43.74 29.34 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.386 0.674 . . . . 75.25 111.92 -173.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.474 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 74.7 -163.61 54.38 Favored Glycine 0 CA--C 1.533 1.209 0 N-CA-C 114.386 0.514 . . . . 71.54 114.386 178.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 102.42 -168.01 18.31 Favored Glycine 0 N--CA 1.477 1.42 0 C-N-CA 123.612 0.625 . . . . 70.42 112.743 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 11.1 mp0 -68.56 102.82 1.54 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.368 0.667 . . . . 73.14 109.442 176.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 4.2 tpp180 -94.05 122.71 36.84 Favored 'General case' 0 C--O 1.245 0.819 0 C-N-CA 123.413 0.685 . . . . 74.4 109.616 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 59.4 t -78.35 109.45 13.0 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 N-CA-C 108.99 -0.744 . . . . 71.24 108.99 176.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.484 HG13 HG13 ' A' ' 145' ' ' VAL . 3.0 p -133.19 122.43 45.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 124.3 1.04 . . . . 73.14 108.673 178.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -107.56 136.93 46.5 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.262 0.625 . . . . 71.3 109.403 -175.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.589 ' HB ' ' HB3' ' B' ' 8' ' ' LEU . 7.6 p -152.29 132.34 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.445 0.698 . . . . 75.1 109.995 178.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 62.31 22.95 13.55 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.389 1.076 . . . . 74.24 112.091 176.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 87.42 10.78 70.16 Favored Glycine 0 C--N 1.346 1.115 0 CA-C-O 119.872 -0.404 . . . . 31.1 113.181 -178.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.13 99.17 6.44 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 108.359 -0.978 . . . . 72.12 108.359 -176.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 19.2 ttt180 -71.55 92.58 1.14 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.51 1.124 . . . . 74.41 109.969 176.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.484 HG13 HG13 ' A' ' 138' ' ' VAL . 7.7 p -92.94 133.74 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-O 121.065 0.459 . . . . 73.53 110.406 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 32.8 t -98.52 85.45 3.37 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 108.57 -0.9 . . . . 31.45 108.57 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 96.3 t -81.62 113.08 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 109.166 -0.679 . . . . 73.42 109.166 -176.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 60.5 ttt85 -68.41 93.7 0.5 Allowed 'General case' 0 C--O 1.241 0.655 0 N-CA-C 108.894 -0.78 . . . . 74.14 108.894 172.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.474 HG13 ' HA2' ' A' ' 133' ' ' GLY . 47.5 pt -78.68 135.72 59.81 Favored Pre-proline 0 CA--C 1.551 0.99 0 CA-C-N 115.035 -0.984 . . . . 74.13 108.933 178.068 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -58.92 128.7 28.88 Favored 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 122.445 2.097 . . . . 60.34 111.539 174.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.84 92.48 0.05 OUTLIER 'Trans proline' 0 C--N 1.382 2.294 0 C-N-CA 122.655 2.236 . . . . 74.15 110.979 170.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 125.92 66.84 0.17 Allowed Glycine 0 C--N 1.336 0.529 0 C-N-CA 121.127 -0.559 . . . . 75.51 111.851 -167.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.602 ' O ' ' HB1' ' A' ' 130' ' ' ALA . 7.5 p -140.78 139.88 33.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 N-CA-C 107.351 -1.352 . . . . 75.43 107.351 171.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.594 ' HG3' ' HE2' ' A' ' 240' ' ' PHE . 52.0 mtt85 -153.02 173.59 15.23 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.072 0.949 . . . . 73.23 109.194 174.425 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.57 ' HB3' ' H ' ' A' ' 188' ' ' LEU . 16.7 tp10 -35.38 122.31 0.61 Allowed 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 126.505 1.922 . . . . 72.32 114.975 -168.088 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 93.15 -13.38 67.78 Favored Glycine 0 C--N 1.342 0.871 0 CA-C-O 119.655 -0.525 . . . . 14.21 114.174 176.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.464 ' O ' HG12 ' A' ' 178' ' ' VAL . 17.9 t -71.39 139.29 49.72 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 109.274 -0.639 . . . . 74.23 109.274 175.238 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 71.2 t -105.55 119.53 54.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 123.565 0.746 . . . . 72.34 109.131 -178.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.545 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 60.4 mt -98.49 115.19 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 N-CA-C 108.394 -0.965 . . . . 75.24 108.394 174.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -78.3 106.0 9.93 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 109.068 -0.716 . . . . 61.32 109.068 173.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 13.3 p -113.6 113.01 48.09 Favored Pre-proline 0 CA--C 1.556 1.205 0 N-CA-C 109.417 -0.586 . . . . 61.33 109.417 173.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.493 ' HG2' ' HB3' ' A' ' 86' ' ' SER . 43.2 Cg_endo -68.88 139.73 44.15 Favored 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 122.672 2.248 . . . . 74.53 113.042 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.457 ' N ' ' HB3' ' A' ' 171' ' ' PRO . . . 109.67 -26.68 13.75 Favored Glycine 0 N--CA 1.476 1.335 0 C-N-CA 123.442 0.544 . . . . 70.43 113.689 167.583 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.472 ' N ' ' SD ' ' A' ' 164' ' ' MET . 1.3 mpt? -95.67 -31.06 13.43 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.232 0.613 . . . . 64.15 109.9 -177.304 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.494 ' N ' ' HB2' ' A' ' 174' ' ' LEU . . . -94.32 153.39 21.03 Favored Glycine 0 CA--C 1.492 -1.4 0 N-CA-C 108.742 -1.743 . . . . 73.33 108.742 168.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.826 ' HA3' ' HA3' ' A' ' 172' ' ' GLY . . . 53.44 80.54 0.07 OUTLIER Glycine 0 CA--C 1.475 -2.407 0 CA-C-O 118.872 -0.96 . . . . 74.5 112.968 -162.129 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 10.5 mm-40 -56.52 105.11 0.18 Allowed 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 128.149 2.911 . . . . 75.42 109.059 -178.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -176.89 -140.61 3.66 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.096 -1.602 . . . . 64.21 109.096 -172.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ASN . . . . . 0.511 ' ND2' ' HB3' ' A' ' 106' ' ' PHE . 0.7 OUTLIER -133.04 -54.28 0.02 OUTLIER Pre-proline 0 N--CA 1.484 1.232 0 CA-C-N 117.613 0.707 . . . . 63.11 109.608 176.421 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.432 ' O ' ' HA ' ' A' ' 115' ' ' LYS . 19.1 Cg_exo -67.74 123.44 10.73 Favored 'Trans proline' 0 C--N 1.388 2.625 0 N-CA-C 106.44 -2.177 . . . . 71.13 106.44 159.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.457 ' HB3' ' N ' ' A' ' 163' ' ' GLY . 41.1 Cg_endo -63.43 141.24 80.19 Favored 'Trans proline' 0 N--CA 1.483 0.874 0 C-N-CA 122.508 2.139 . . . . 71.25 114.858 -164.342 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.826 ' HA3' ' HA3' ' A' ' 166' ' ' GLY . . . -79.52 -26.41 56.92 Favored Glycine 0 C--N 1.348 1.217 0 C-N-CA 119.553 -1.308 . . . . 72.4 111.924 159.416 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 89.24 137.37 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 127.385 2.274 . . . . 71.14 110.116 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.559 HD11 ' HB2' ' A' ' 121' ' ' ALA . 24.5 tp -111.21 136.89 49.62 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.26 0.624 . . . . 64.32 110.16 -174.247 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.57 ' HB2' ' HD2' ' A' ' 120' ' ' ARG . 59.2 mt -105.75 84.79 2.12 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.239 1.015 . . . . 72.12 109.102 -178.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.545 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 95.4 mt -69.03 100.38 1.22 Allowed 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 115.204 -0.907 . . . . 70.05 110.812 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 57.7 t -84.52 102.5 10.56 Favored 'Isoleucine or valine' 0 C--O 1.242 0.69 0 N-CA-C 107.726 -1.213 . . . . 61.43 107.726 173.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 9.1 p -69.37 122.53 21.03 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.211 0 CA-C-N 115.48 -0.782 . . . . 70.33 111.254 -173.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.494 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 23.6 mmt180 -112.44 93.58 4.51 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.449 1.5 . . . . 53.32 108.217 -178.515 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.561 HD13 HD13 ' A' ' 127' ' ' LEU . 22.4 mt -70.19 149.39 47.56 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.428 0.529 . . . . 72.4 112.428 -175.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 77.9 mt -59.44 159.68 15.95 Favored Pre-proline 0 CA--C 1.554 1.127 0 C-N-CA 124.49 1.116 . . . . 73.14 111.71 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -70.8 32.98 0.23 Allowed 'Trans proline' 0 C--N 1.384 2.439 0 C-N-CA 123.365 2.71 . . . . 71.42 114.7 175.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' HIS . . . . . 0.493 ' HB3' ' HG ' ' A' ' 127' ' ' LEU . 56.2 t-80 -67.39 106.53 1.26 Allowed Pre-proline 0 CA--C 1.553 1.091 0 C-N-CA 125.165 1.386 . . . . 73.35 107.533 165.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -75.39 24.51 0.4 Allowed 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 123.877 3.051 . . . . 61.24 115.683 -163.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 97.5 t -97.94 -61.76 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 122.595 0.358 . . . . 64.21 111.165 -173.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 14.6 m-30 -124.31 140.52 52.88 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 121.604 0.716 . . . . 72.31 111.937 -171.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -139.02 141.8 38.29 Favored 'General case' 0 C--O 1.215 -0.734 0 C-N-CA 125.883 1.673 . . . . 75.51 106.557 171.012 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.624 HD12 ' HA ' ' A' ' 193' ' ' LEU . 5.4 tp -106.36 176.3 5.21 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 107.211 -1.404 . . . . 74.21 107.211 178.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -163.16 128.08 3.05 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 109.019 -0.734 . . . . 70.31 109.019 168.219 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 69.0 -74.19 0.36 Allowed Glycine 0 C--N 1.349 1.256 0 N-CA-C 111.005 -0.838 . . . . 65.41 111.005 -169.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -163.81 -2.42 0.03 OUTLIER 'General case' 0 CA--C 1.564 1.495 0 C-N-CA 124.115 0.966 . . . . 72.32 110.996 173.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -98.62 150.88 21.29 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 122.818 0.447 . . . . 72.32 110.599 -178.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.624 ' HA ' HD12 ' A' ' 188' ' ' LEU . 0.4 OUTLIER -88.81 155.93 19.26 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.347 1.059 . . . . 63.44 110.796 -167.112 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -142.57 151.31 41.43 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.642 1.577 . . . . 73.14 108.134 173.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.437 ' HB3' HD23 ' A' ' 251' ' ' LEU . . . -152.72 136.68 16.33 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.168 0.987 . . . . 74.34 108.662 177.014 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 32.2 m -77.79 133.69 38.18 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 118.008 0.367 . . . . 70.21 110.026 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 32.3 tp -134.01 97.59 3.92 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.047 0.539 . . . . 72.21 110.262 -176.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -85.71 121.42 28.35 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 108.723 -0.843 . . . . 61.43 108.723 170.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 7.7 p -138.25 137.37 20.66 Favored Pre-proline 0 N--CA 1.482 1.164 0 C-N-CA 123.754 0.822 . . . . 64.4 109.179 -171.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -72.32 153.97 56.19 Favored 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 121.607 1.538 . . . . 64.51 111.386 177.061 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.4 ' HB3' ' HH2' ' A' ' 269' ' ' TRP . . . -50.98 -50.91 72.08 Favored Pre-proline 0 CA--C 1.553 1.076 0 N-CA-C 114.696 1.369 . . . . 71.34 114.696 -171.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.563 ' HG2' ' HE1' ' C' ' 276' ' ' TYR . 47.6 Cg_exo -61.2 -37.78 71.53 Favored 'Trans proline' 0 C--N 1.386 2.552 0 C-N-CA 121.851 1.7 . . . . 63.54 113.969 -179.179 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.531 HD11 ' HB3' ' C' ' 276' ' ' TYR . 34.9 mt -67.2 -37.64 79.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 N-CA-C 109.754 -0.462 . . . . 64.32 109.754 176.27 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.06 -42.83 88.94 Favored 'General case' 0 CA--C 1.554 1.127 0 CA-C-N 115.571 -0.741 . . . . 71.51 111.688 177.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 54.3 t -70.21 -48.49 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 124.081 0.952 . . . . 63.23 111.435 -176.219 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 57.7 t -85.14 -39.24 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-N 115.137 -0.938 . . . . 74.41 111.781 -170.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 97.67 90.08 1.9 Allowed Glycine 0 C--O 1.242 0.638 0 N-CA-C 110.873 -0.891 . . . . 72.35 110.873 -171.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.524 ' HA3' HG23 ' A' ' 203' ' ' ILE . . . -115.49 -151.48 9.91 Favored Glycine 0 C--N 1.339 0.735 0 CA-C-N 115.468 -0.366 . . . . 55.24 113.54 -175.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 27.1 mtmt -137.55 132.41 33.12 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.311 -0.625 . . . . 45.21 109.311 -176.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 30.9 m -134.39 149.84 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 108.512 -0.922 . . . . 63.11 108.512 173.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -87.12 113.3 22.75 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 109.019 -0.734 . . . . 71.41 109.019 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.55 165.57 11.17 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.02 0.928 . . . . 62.04 110.052 -176.008 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' MET . . . . . 0.464 ' N ' ' SD ' ' A' ' 213' ' ' MET . 0.0 OUTLIER -98.21 151.9 19.95 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 115.658 -0.701 . . . . 71.23 109.455 -175.712 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 63.8 p -133.13 -173.82 3.31 Favored 'General case' 0 C--O 1.242 0.697 0 C-N-CA 124.814 1.246 . . . . 74.1 107.721 167.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.666 HD22 ' HB3' ' A' ' 127' ' ' LEU . 28.4 mt -81.12 -26.6 36.04 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.133 0.573 . . . . 63.31 109.901 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -87.64 -17.44 31.86 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 114.977 -1.01 . . . . 64.44 111.723 -176.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 149.34 -156.83 26.98 Favored Glycine 0 C--N 1.344 1.016 0 CA-C-O 119.35 -0.694 . . . . 33.0 111.687 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -87.61 139.92 5.03 Favored 'Trans proline' 0 C--N 1.365 1.395 0 C-N-CA 122.641 2.227 . . . . 70.23 112.055 173.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 35.1 m -132.14 169.66 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.791 1.236 . . . . 73.4 107.796 171.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -111.92 134.46 53.46 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 121.726 -0.609 . . . . 75.04 111.372 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 7.5 p -119.51 140.22 44.23 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 124.745 1.218 . . . . 74.13 109.352 -176.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -103.62 103.2 13.11 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.971 0.508 . . . . 60.25 110.05 -178.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 70.5 t -58.8 140.78 85.83 Favored Pre-proline 0 CA--C 1.567 1.614 0 C-N-CA 125.432 1.493 . . . . 63.14 110.7 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -84.72 170.47 10.12 Favored 'Trans proline' 0 C--N 1.387 2.604 0 C-N-CA 123.25 2.634 . . . . 75.51 111.549 177.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.16 148.08 30.51 Favored 'Trans proline' 0 C--N 1.368 1.558 0 C-N-CA 121.748 1.632 . . . . 72.53 113.155 174.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 63.3 mtt85 63.62 32.34 14.0 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 125.329 1.451 . . . . 74.04 111.978 175.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.48 HG23 HD21 ' A' ' 233' ' ' LEU . 90.8 m -62.31 106.68 0.78 Allowed 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 113.689 -1.596 . . . . 64.32 110.498 172.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -95.53 151.37 19.37 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.389 0.675 . . . . 75.32 110.888 -170.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -62.27 117.84 6.63 Favored 'General case' 0 C--N 1.351 0.669 0 C-N-CA 123.981 0.912 . . . . 62.31 110.774 177.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 105.51 -23.64 29.46 Favored Glycine 0 C--N 1.34 0.805 0 CA-C-N 115.903 -0.589 . . . . 73.32 112.885 178.088 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 231' ' ' ARG . 46.5 mtt180 -72.79 136.25 45.4 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-O 121.552 0.691 . . . . 74.0 110.944 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.727 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 39.3 mttm -101.14 112.0 24.36 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 114.09 -1.413 . . . . 72.22 109.299 -179.061 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.536 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 45.9 mt -75.86 100.94 4.95 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.068 0.947 . . . . 71.4 110.175 -172.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 57.1 ttt180 -73.26 125.22 27.28 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.529 1.132 . . . . 64.14 110.895 -172.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.505 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 76.7 mt -118.74 107.25 13.43 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.19 0.996 . . . . 61.12 109.614 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 3.5 mmmp? -60.93 126.06 25.99 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 113.127 0.788 . . . . 64.43 113.127 -172.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 73.6 33.64 57.96 Favored Glycine 0 C--N 1.354 1.543 0 O-C-N 123.852 0.72 . . . . 74.2 114.05 173.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -114.58 -18.31 11.47 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.242 0.617 . . . . 73.01 111.387 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -81.9 -170.14 44.03 Favored Glycine 0 C--N 1.346 1.128 0 N-CA-C 112.004 -0.438 . . . . 74.43 112.004 170.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 240' ' ' PHE . . . . . 0.594 ' HE2' ' HG3' ' A' ' 154' ' ' ARG . 9.9 m-85 -94.69 154.92 39.9 Favored Pre-proline 0 N--CA 1.478 0.965 0 C-N-CA 122.844 0.457 . . . . 73.13 112.149 -170.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -66.65 123.06 10.58 Favored 'Trans proline' 0 C--N 1.387 2.595 0 C-N-CA 123.216 2.611 . . . . 73.33 112.831 -178.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -151.42 -150.03 5.22 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-O 119.368 -0.685 . . . . 73.52 112.426 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -65.06 -29.84 56.56 Favored 'Trans proline' 0 C--N 1.378 2.108 0 C-N-CA 123.249 2.633 . . . . 70.45 113.179 -175.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -87.59 20.77 2.79 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.8 0.84 . . . . 70.11 111.57 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 85.55 -89.76 1.63 Allowed Glycine 0 C--N 1.35 1.332 0 N-CA-C 109.736 -1.346 . . . . 62.24 109.736 -173.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 59.1 mtm180 -127.12 157.56 39.36 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.045 0.938 . . . . 75.41 109.109 165.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -81.38 179.78 53.35 Favored Glycine 0 C--O 1.241 0.561 0 CA-C-N 115.736 -0.665 . . . . 42.24 112.179 178.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -125.27 154.26 41.96 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.725 0.81 . . . . 75.44 109.085 -179.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.562 HD13 HD13 ' A' ' 193' ' ' LEU . 40.1 tp -96.64 112.22 24.05 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 109.466 -0.568 . . . . 70.31 109.466 -179.143 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.727 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 22.0 m-85 -97.79 105.84 18.05 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.577 1.151 . . . . 52.51 109.307 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.536 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 16.4 mt -79.6 98.8 7.04 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 109.67 -0.493 . . . . 72.24 109.67 175.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -77.34 103.52 7.32 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 108.465 -0.939 . . . . 75.41 108.465 -175.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.456 HG11 HG22 ' A' ' 227' ' ' THR . 56.6 t -87.73 144.07 9.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 N-CA-C 114.259 1.207 . . . . 24.43 114.259 -166.04 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 6.7 mmm180 -128.32 113.61 15.83 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.475 1.51 . . . . 73.14 107.619 165.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 62.1 mt -75.96 138.88 19.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 122.986 0.515 . . . . 74.34 109.747 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 46.7 p -124.11 175.82 6.76 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 124.709 1.204 . . . . 73.43 109.304 177.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 257' ' ' ILE . . . . . 0.48 ' HB ' ' HD2' ' A' ' 258' ' ' PRO . 28.6 pt -121.82 164.72 23.41 Favored Pre-proline 0 CA--C 1.556 1.189 0 C-N-CA 123.762 0.825 . . . . 73.4 109.286 175.365 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 258' ' ' PRO . . . . . 0.48 ' HD2' ' HB ' ' A' ' 257' ' ' ILE . 60.8 Cg_endo -69.65 6.53 1.24 Allowed 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 122.687 2.258 . . . . 74.45 114.851 177.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 259' ' ' GLU . . . . . 0.478 ' HG3' ' NE2' ' C' ' 228' ' ' GLN . 0.8 OUTLIER 49.35 -96.79 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.615 0.766 . . . . 63.24 109.494 -161.012 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.93 158.56 19.88 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.086 0.954 . . . . 75.12 110.778 -173.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.456 HD13 ' HA ' ' A' ' 266' ' ' GLU . 67.9 mt -135.64 -178.04 4.94 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.732 0.813 . . . . 55.32 110.719 -175.018 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 5.2 p -133.52 146.44 60.6 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 124.697 1.199 . . . . 44.34 109.033 176.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -17.69 -60.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.393 2.918 1 C-N-CA 127.402 5.401 . . . . 74.33 118.037 -168.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -65.03 -59.36 4.23 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.036 0.534 . . . . 71.44 111.197 -175.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -62.91 -29.69 70.97 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.712 0.805 . . . . 64.2 110.659 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 266' ' ' GLU . . . . . 0.456 ' HA ' HD13 ' A' ' 261' ' ' LEU . 8.6 tp10 -57.71 -54.74 43.48 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 124.236 1.015 . . . . 73.45 109.433 175.371 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -64.34 -33.41 75.77 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 114.681 -1.145 . . . . 64.12 111.691 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 8.8 mp -61.42 -52.22 65.46 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.0 0.52 . . . . 73.14 111.429 177.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 269' ' ' TRP . . . . . 0.4 ' HH2' ' HB3' ' A' ' 201' ' ' ALA . 61.2 m95 -61.7 -38.82 89.27 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.344 0.658 . . . . 75.0 111.805 178.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 270' ' ' LYS . . . . . 0.465 ' HE2' HG23 ' C' ' 206' ' ' VAL . 1.0 OUTLIER -67.55 -40.22 84.99 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.758 -0.655 . . . . 62.43 111.368 179.278 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -64.3 -41.93 96.61 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.071 0.548 . . . . 70.22 110.521 175.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 272' ' ' LEU . . . . . 0.499 ' O ' ' HB2' ' A' ' 276' ' ' TYR . 51.8 mt -55.5 -45.96 77.02 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 124.012 0.82 . . . . 63.4 110.574 175.178 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -77.13 -32.92 56.76 Favored 'General case' 0 C--O 1.246 0.874 0 O-C-N 124.389 1.055 . . . . 64.51 113.005 -173.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -72.47 -48.09 43.61 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.318 0.647 . . . . 74.35 110.061 177.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 275' ' ' ALA . . . . . 0.448 ' HB1' ' NH2' ' A' ' 279' ' ' ARG . . . -71.97 -20.77 61.68 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.51 0.724 . . . . 71.44 111.225 177.041 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 276' ' ' TYR . . . . . 0.499 ' HB2' ' O ' ' A' ' 272' ' ' LEU . 21.7 t80 -63.14 -64.96 0.76 Allowed 'General case' 0 C--N 1.356 0.884 0 C-N-CA 123.803 0.841 . . . . 75.02 108.847 171.346 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -63.32 -40.6 97.76 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.316 -0.856 . . . . 70.12 110.432 -172.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -59.35 -30.72 68.59 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.659 0.784 . . . . 75.41 111.834 176.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 279' ' ' ARG . . . . . 0.448 ' NH2' ' HB1' ' A' ' 275' ' ' ALA . 23.6 mtm180 -118.22 34.74 5.04 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.347 0.659 . . . . 74.13 109.855 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.386 0 N-CA-C 109.235 -0.654 . . . . 72.21 109.235 174.439 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.478 0.974 0 N-CA-C 109.283 -0.636 . . . . 71.44 109.283 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 59.5 tttp 71.34 115.57 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.772 1.229 . . . . 54.1 112.052 -176.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 66.4 48.34 1.58 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.575 1.55 . . . . 74.04 111.533 170.019 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 25.5 m -67.5 -22.74 65.44 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 114.816 -1.084 . . . . 52.14 110.574 172.086 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 2.5 m 71.29 150.37 0.09 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.793 1.637 . . . . 70.11 111.469 176.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.619 HG21 ' HA ' ' A' ' 125' ' ' LEU . 36.5 pt -136.97 167.67 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 113.146 0.795 . . . . 64.44 113.146 -162.511 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -145.57 124.33 12.61 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.274 1.03 . . . . 72.01 109.647 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 8' ' ' LEU . . . . . 0.589 ' HB3' ' HB ' ' A' ' 140' ' ' VAL . 44.2 tp -74.26 150.47 40.23 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.168 0.987 . . . . 75.22 111.264 -172.418 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 9' ' ' ALA . . . . . 0.448 ' HB3' ' HB2' ' A' ' 122' ' ' GLU . . . -90.74 -50.32 5.97 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.192 0.597 . . . . 62.4 112.117 -178.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 84.8 mt 66.65 115.61 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 124.677 1.191 . . . . 74.1 111.678 -170.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 56.2 mt . . . . . 0 CA--C 1.553 1.062 0 N-CA-C 108.007 -1.108 . . . . 45.35 108.007 171.888 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.972 0 CA-C-O 121.242 0.544 . . . . 61.34 110.111 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . 70.94 -34.77 0.31 Allowed 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 126.438 1.895 . . . . 74.4 113.304 -173.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 181' ' ' LEU . . . . . 0.519 HD22 ' HB2' ' C' ' 136' ' ' ARG . 60.5 tp -161.29 -71.75 0.06 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.139 0.976 . . . . 62.04 108.928 170.206 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 182' ' ' VAL . . . . . . . . . . . . . 49.2 t -86.71 131.08 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 109.263 -0.643 . . . . 71.31 109.263 177.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -66.19 -56.83 9.39 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 123.908 0.755 . . . . 65.24 111.263 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -169.52 178.73 4.08 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-O 121.64 0.733 . . . . 74.15 111.173 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 185' ' ' VAL . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.469 0.487 0 N-CA-C 107.564 -1.273 . . . . 71.33 107.564 160.364 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 31.4 m . . . . . 0 N--CA 1.488 1.456 0 N-CA-C 110.07 -0.345 . . . . 71.31 110.07 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -172.47 -179.19 2.16 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.054 0.942 . . . . 74.42 109.815 173.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . -106.0 -125.38 5.49 Favored Glycine 0 C--N 1.346 1.123 0 N-CA-C 112.178 -0.369 . . . . 71.23 112.178 -178.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -104.69 -168.68 1.51 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.895 0.878 . . . . 71.21 110.844 -176.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 242' ' ' TRP . . . . . 0.564 ' HZ3' ' HD3' ' C' ' 231' ' ' ARG . 0.0 OUTLIER 92.43 -13.66 0.18 Allowed 'General case' 0 N--CA 1.508 2.452 0 C-N-CA 128.035 2.534 . . . . 70.32 111.867 176.968 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -124.89 119.34 28.52 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.434 0.635 . . . . 74.22 111.989 -164.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -69.54 -33.83 72.66 Favored Glycine 0 C--N 1.345 1.056 0 N-CA-C 110.16 -1.176 . . . . 63.11 110.16 162.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 8.2 ttpp . . . . . 0 CA--C 1.558 1.285 0 C-N-CA 124.597 1.159 . . . . 75.34 113.443 161.482 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.127 0 CA-C-O 119.464 -0.303 . . . . 52.01 111.814 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -37.38 94.95 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.489 1.516 . . . . 70.52 113.862 -175.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -66.49 104.36 1.24 Allowed 'General case' 0 C--O 1.239 0.514 0 N-CA-C 107.915 -1.142 . . . . 63.2 107.915 166.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -74.63 90.98 2.3 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 107.531 -1.285 . . . . 63.22 107.531 172.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 7' ' ' TYR . . . . . 0.423 ' CD1' ' HA ' ' C' ' 53' ' ' ALA . 72.4 m-85 -62.21 -26.01 68.12 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 114.387 -1.279 . . . . 73.43 111.99 -171.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -63.13 -47.86 80.96 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.54 0.736 . . . . 72.53 110.543 173.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.75 -39.58 93.87 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.06 0.544 . . . . 52.31 110.972 178.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 65.9 mt -59.26 -39.93 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 C-N-CA 123.374 0.669 . . . . 63.34 110.737 176.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 11' ' ' LEU . . . . . 0.415 ' O ' ' HB1' ' C' ' 25' ' ' ALA . 95.5 mt -90.14 -0.17 57.47 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 112.497 0.555 . . . . 45.45 112.497 177.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 59.59 37.92 92.93 Favored Glycine 0 C--N 1.352 1.459 0 N-CA-C 114.107 0.403 . . . . 64.33 114.107 178.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 7.2 m -126.03 139.41 34.28 Favored Pre-proline 0 N--CA 1.482 1.141 0 C-N-CA 124.775 1.23 . . . . 64.04 109.209 177.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -76.87 159.83 34.31 Favored 'Trans proline' 0 C--N 1.368 1.605 0 C-N-CA 122.192 1.928 . . . . 74.43 111.976 176.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 53.6 mtt180 -74.08 76.34 1.74 Allowed 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.329 -0.989 . . . . 71.52 108.329 171.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 62.2 t30 176.39 -27.59 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.17 1.388 . . . . 71.24 108.487 -172.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.45 135.93 57.85 Favored 'General case' 0 C--N 1.351 0.664 0 CA-C-N 115.653 -0.703 . . . . 71.14 110.172 172.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 72.0 p -65.99 160.87 22.69 Favored 'General case' 0 C--O 1.246 0.899 0 O-C-N 123.668 0.605 . . . . 74.41 109.671 177.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 19' ' ' GLN . . . . . 0.558 ' HG2' ' HD3' ' C' ' 60' ' ' PRO . 24.8 tp60 -56.57 -33.67 66.38 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.233 0.613 . . . . 74.45 111.808 -176.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -75.0 -28.78 60.67 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 119.121 -0.466 . . . . 64.05 111.698 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 21' ' ' GLU . . . . . 0.527 ' HG2' HH21 ' C' ' 24' ' ' ARG . 46.3 mt-10 -69.36 -41.13 76.97 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 121.109 0.481 . . . . 73.42 110.161 174.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 22' ' ' ILE . . . . . 0.432 HG21 ' HB3' ' C' ' 57' ' ' LEU . 57.2 mt -66.44 -38.3 81.45 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 CA-C-N 114.735 -1.12 . . . . 61.32 110.12 176.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 23' ' ' LYS . . . . . 0.441 ' O ' ' HD3' ' C' ' 27' ' ' LYS . 4.5 ttpt -70.11 -40.49 74.86 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 114.69 -1.141 . . . . 74.13 109.617 179.201 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 24' ' ' ARG . . . . . 0.527 HH21 ' HG2' ' C' ' 21' ' ' GLU . 46.6 mtm105 -72.57 -22.39 61.0 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.276 0.63 . . . . 73.52 111.283 176.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 25' ' ' ALA . . . . . 0.415 ' HB1' ' O ' ' C' ' 11' ' ' LEU . . . -66.96 -45.2 78.46 Favored 'General case' 0 C--O 1.242 0.661 0 O-C-N 123.537 0.523 . . . . 75.32 109.603 171.583 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 26' ' ' TYR . . . . . 0.553 ' HD1' HG22 ' C' ' 50' ' ' ILE . 83.4 t80 -57.76 -52.95 63.35 Favored 'General case' 0 C--N 1.355 0.82 0 CA-C-N 115.5 -0.773 . . . . 72.31 110.698 171.441 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 27' ' ' LYS . . . . . 0.459 ' HE2' ' HA ' ' C' ' 24' ' ' ARG . 6.0 mppt? -60.69 -32.63 71.84 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.433 0.693 . . . . 74.1 111.62 -176.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -61.98 -48.81 78.7 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.974 0.91 . . . . 71.15 109.494 174.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 29' ' ' LEU . . . . . 0.59 HD13 HD12 ' C' ' 50' ' ' ILE . 76.6 mt -77.39 -13.4 59.94 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 114.781 -1.1 . . . . 60.22 111.664 178.333 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -86.93 -19.68 28.45 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.488 0.715 . . . . 75.32 110.02 176.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 60.4 mtm180 -91.92 -27.23 18.03 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.309 0.644 . . . . 73.5 110.364 169.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -72.84 -59.93 2.48 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.415 0.686 . . . . 71.12 109.218 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -90.25 22.31 3.39 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.92 0.888 . . . . 70.15 110.901 -178.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 34' ' ' HIS . . . . . 0.407 ' NE2' ' HB3' ' C' ' 36' ' ' ASP . 75.8 t60 -53.18 93.97 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.586 0 C-N-CA 125.565 1.546 . . . . 72.34 113.043 -166.007 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 35' ' ' PRO . . . . . 0.423 ' O ' ' HG2' ' C' ' 39' ' ' LYS . 53.3 Cg_endo -76.55 -6.05 16.64 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.901 2.401 . . . . 71.32 111.806 -168.208 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 36' ' ' ASP . . . . . 0.407 ' HB3' ' NE2' ' C' ' 34' ' ' HIS . 24.0 t70 -63.73 -35.91 82.15 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.442 1.097 . . . . 60.34 111.46 172.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 41.1 t -122.92 -46.9 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 CA-C-O 121.191 0.519 . . . . 75.33 109.753 -177.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -98.33 81.85 2.82 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.005 0.922 . . . . 54.22 109.678 -178.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 39' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' C' ' 35' ' ' PRO . 9.7 mtmp? -84.74 70.03 10.76 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 115.641 -0.709 . . . . 62.24 109.919 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 40' ' ' SER . . . . . 0.4 ' HB2' ' HB3' ' C' ' 43' ' ' ALA . 49.4 m -95.22 108.59 39.8 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-O 118.254 -0.879 . . . . 74.14 108.74 175.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -41.35 -53.01 3.33 Favored 'Trans proline' 0 C--N 1.386 2.542 0 C-N-CA 124.457 3.438 . . . . 63.44 115.157 -174.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -65.72 -31.6 72.69 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.302 0.641 . . . . 65.44 111.335 -178.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 43' ' ' ALA . . . . . 0.4 ' HB3' ' HB2' ' C' ' 40' ' ' SER . . . -77.46 -18.93 56.71 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.036 0.534 . . . . 62.05 110.546 176.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 44' ' ' GLU . . . . . 0.452 ' HA ' ' HB3' ' C' ' 47' ' ' PHE . 51.0 mt-10 -89.91 -19.39 24.61 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.797 0.839 . . . . 74.04 109.634 177.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -77.07 -39.82 48.42 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.069 0.947 . . . . 42.53 109.53 168.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 46' ' ' LYS . . . . . 0.531 ' O ' HG12 ' C' ' 50' ' ' ILE . 63.3 mttp -61.35 -48.04 83.11 Favored 'General case' 0 C--N 1.35 0.606 0 CA-C-N 115.094 -0.957 . . . . 72.32 108.847 169.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 47' ' ' PHE . . . . . 0.452 ' HB3' ' HA ' ' C' ' 44' ' ' GLU . 59.5 t80 -64.22 -27.97 69.42 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.179 0.991 . . . . 62.23 110.856 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 48' ' ' LYS . . . . . 0.518 ' HE2' ' HB3' ' C' ' 89' ' ' ASP . 2.9 tptm -62.82 -48.78 77.62 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 108.698 -0.853 . . . . 72.04 108.698 172.203 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -70.79 -19.68 62.67 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 112.557 0.577 . . . . 72.33 112.557 176.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 50' ' ' ILE . . . . . 0.59 HD12 HD13 ' C' ' 29' ' ' LEU . 23.6 mm -78.75 -34.43 17.39 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 N-CA-C 108.787 -0.82 . . . . 75.43 108.787 174.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 51' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -79.1 -18.23 53.66 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 124.069 0.947 . . . . 74.04 111.276 175.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 52' ' ' GLU . . . . . 0.429 ' O ' HG23 ' C' ' 56' ' ' VAL . 32.6 tt0 -76.18 -50.23 15.09 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.569 -0.9 . . . . 63.42 108.569 170.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 53' ' ' ALA . . . . . 0.423 ' HA ' ' CD1' ' C' ' 7' ' ' TYR . . . -60.57 -33.38 72.62 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 114.593 -1.185 . . . . 63.1 111.247 176.243 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 54' ' ' TYR . . . . . 0.458 ' O ' ' HB2' ' C' ' 58' ' ' SER . 20.8 t80 -81.92 -32.9 30.66 Favored 'General case' 0 C--O 1.214 -0.783 0 C-N-CA 123.788 0.835 . . . . 75.01 110.207 176.324 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.81 -34.37 67.63 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 120.915 0.388 . . . . 60.54 110.247 174.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 56' ' ' VAL . . . . . 0.429 HG23 ' O ' ' C' ' 52' ' ' GLU . 14.8 t -97.61 -24.62 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.26 0 CA-C-N 115.065 -0.97 . . . . 72.43 112.308 -178.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 57' ' ' LEU . . . . . 0.432 ' HB3' HG21 ' C' ' 22' ' ' ILE . 61.9 mt -125.46 29.77 5.94 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 119.242 0.928 . . . . 75.02 112.746 -177.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 58' ' ' SER . . . . . 0.458 ' HB2' ' O ' ' C' ' 54' ' ' TYR . 23.1 t -69.8 -56.44 7.13 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.238 0.542 . . . . 62.42 111.8 175.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -130.05 157.19 77.74 Favored Pre-proline 0 N--CA 1.479 0.981 0 C-N-CA 124.313 1.045 . . . . 72.03 109.303 -171.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 60' ' ' PRO . . . . . 0.558 ' HD3' ' HG2' ' C' ' 19' ' ' GLN . 18.2 Cg_endo -54.26 -21.05 21.42 Favored 'Trans proline' 0 C--N 1.391 2.797 0 C-N-CA 122.921 2.414 . . . . 33.23 112.992 -179.358 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -51.35 -75.62 0.03 OUTLIER 'General case' 0 CA--C 1.565 1.537 0 C-N-CA 124.554 1.142 . . . . 62.13 110.832 170.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.39 -28.68 67.32 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.592 0.757 . . . . 75.23 111.338 -176.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 10.1 ttp180 -66.14 -44.74 83.31 Favored 'General case' 0 C--N 1.351 0.644 0 N-CA-C 109.496 -0.557 . . . . 64.42 109.496 -177.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -71.0 -29.98 66.1 Favored 'General case' 0 C--N 1.359 1.003 0 O-C-N 123.876 0.735 . . . . 74.15 111.015 178.185 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 47.5 mm -57.19 -48.55 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 CA-C-O 121.196 0.522 . . . . 62.34 110.049 170.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -67.23 -40.72 86.39 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.773 -0.649 . . . . 74.22 111.012 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -59.42 -45.8 90.52 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 122.95 0.5 . . . . 73.14 110.565 178.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 74.2 p -73.14 -15.72 61.47 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.522 -0.763 . . . . 63.2 111.271 178.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -73.05 116.91 14.14 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 106.948 -1.501 . . . . 75.22 106.948 167.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 111.2 9.5 21.95 Favored Glycine 0 N--CA 1.472 1.073 0 N-CA-C 111.475 -0.65 . . . . 62.51 111.475 -165.088 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 88.3 m -141.57 -59.01 0.48 Allowed 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 103.755 -2.683 . . . . 72.34 103.755 176.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 34.4 m -73.96 134.16 43.09 Favored 'General case' 0 C--O 1.251 1.164 0 N-CA-C 103.88 -2.637 . . . . 73.35 103.88 155.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.03 -37.45 5.36 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.329 0.652 . . . . 73.23 110.8 -170.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -88.86 150.7 46.17 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 123.992 0.917 . . . . 53.23 109.098 174.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -52.37 117.66 3.85 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 122.838 2.359 . . . . 75.14 111.629 172.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.89 156.75 18.41 Favored 'Trans proline' 0 C--N 1.382 2.325 0 C-N-CA 123.494 2.796 . . . . 63.14 113.745 -176.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -66.53 121.38 8.62 Favored 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 122.209 1.939 . . . . 51.51 111.044 172.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 78' ' ' PRO . . . . . 0.449 ' HB3' ' HA3' ' C' ' 104' ' ' GLY . 32.0 Cg_endo -61.82 135.38 55.58 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 122.886 2.391 . . . . 74.44 113.414 -174.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.22 159.06 54.84 Favored 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 123.001 2.467 . . . . 61.04 112.455 176.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.49 85.9 0.04 OUTLIER 'Trans proline' 0 C--N 1.391 2.815 0 C-N-CA 123.553 2.835 . . . . 51.5 112.873 177.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 159.01 -45.33 0.45 Allowed Glycine 0 C--N 1.341 0.856 0 CA-C-N 114.967 -1.015 . . . . 75.2 111.358 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 111.55 175.23 20.02 Favored Glycine 0 C--N 1.351 1.37 0 C-N-CA 123.514 0.578 . . . . 74.45 112.053 -174.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -83.94 113.24 20.84 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.996 -0.742 . . . . 70.14 108.996 177.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -63.08 144.87 56.52 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 123.928 0.767 . . . . 63.13 112.639 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 85' ' ' PHE . . . . . 0.529 ' O ' ' HG3' ' C' ' 171' ' ' PRO . 78.3 m-85 -137.31 72.24 1.42 Allowed 'General case' 0 C--O 1.212 -0.88 0 C-N-CA 124.567 1.147 . . . . 74.41 109.348 171.087 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 50.7 m -47.49 86.61 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 124.31 1.044 . . . . 45.43 112.924 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 67.64 13.13 62.89 Favored Glycine 0 C--N 1.349 1.275 0 CA-C-N 115.513 -0.767 . . . . 74.33 114.611 -178.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 88' ' ' PHE . . . . . 0.493 ' HB2' ' HB3' ' C' ' 85' ' ' PHE . 18.6 m-85 -92.22 128.97 38.26 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 109.081 -0.711 . . . . 74.44 109.081 -177.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 89' ' ' ASP . . . . . 0.518 ' HB3' ' HE2' ' C' ' 48' ' ' LYS . 27.9 t70 -83.69 78.59 9.67 Favored 'General case' 0 C--O 1.246 0.898 0 CA-C-O 121.665 0.745 . . . . 72.23 110.509 -172.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 90' ' ' VAL . . . . . 0.72 HG23 ' HE2' ' C' ' 97' ' ' PHE . 1.3 p -43.44 -36.43 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.22 0 C-N-CA 125.934 1.694 . . . . 54.41 112.415 172.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -50.21 -36.53 31.16 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.648 1.579 . . . . 74.21 112.891 -178.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -119.26 21.41 12.26 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.524 0.729 . . . . 75.53 111.234 -170.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 21.5 m-30 -94.17 175.49 6.68 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.805 -0.559 . . . . 72.45 111.123 175.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 94' ' ' SER . . . . . 0.408 ' O ' ' HB3' ' C' ' 97' ' ' PHE . 84.5 p -74.4 173.45 10.27 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 113.754 1.02 . . . . 45.51 113.754 -164.099 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 95' ' ' GLU . . . . . 0.455 ' O ' ' HG3' ' C' ' 99' ' ' GLU . 4.0 mp0 -73.21 -36.52 66.52 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 114.71 -1.132 . . . . 55.43 110.617 178.419 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -60.57 -42.56 96.88 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-O 121.535 0.683 . . . . 65.02 110.289 173.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 97' ' ' PHE . . . . . 0.72 ' HE2' HG23 ' C' ' 90' ' ' VAL . 48.9 t80 -58.46 -43.4 88.85 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 114.282 -1.326 . . . . 64.25 109.933 174.406 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -66.56 -29.21 69.24 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 122.664 0.386 . . . . 51.52 111.814 176.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 99' ' ' GLU . . . . . 0.455 ' HG3' ' O ' ' C' ' 95' ' ' GLU . 45.0 mt-10 -67.21 -56.15 11.09 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 122.752 0.421 . . . . 74.43 110.24 178.424 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 26.7 tp -75.33 -50.18 16.81 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.392 -0.822 . . . . 73.23 111.802 -172.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -91.66 -20.3 21.75 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.299 0.64 . . . . 73.25 112.555 -173.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -46.46 -58.18 6.07 Favored Glycine 0 CA--C 1.541 1.68 0 CA-C-O 118.933 -0.926 . . . . 54.11 115.107 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -63.43 -3.29 5.04 Favored 'Trans proline' 0 C--N 1.385 2.462 0 C-N-CA 123.186 2.591 . . . . 62.02 114.464 -177.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 104' ' ' GLY . . . . . 0.449 ' HA3' ' HB3' ' C' ' 78' ' ' PRO . . . -137.91 32.53 2.35 Favored Glycine 0 C--N 1.349 1.284 0 CA-C-O 119.953 -0.359 . . . . 43.23 113.14 176.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 48.3 mt . . . . . 0 N--CA 1.486 1.337 0 C-N-CA 123.019 0.528 . . . . 73.03 111.733 173.881 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 116' ' ' GLY . . . . . 0.41 ' HA2' ' HA3' ' C' ' 168' ' ' GLY . . . . . . . . 0 CA--C 1.499 -0.921 0 CA-C-O 120.926 0.181 . . . . 45.25 113.182 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 17.1 mtm180 -116.4 171.88 7.56 Favored 'General case' 0 C--O 1.263 1.81 0 CA-C-O 122.369 1.081 . . . . 64.44 111.397 -173.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 118' ' ' ASP . . . . . 0.459 ' HA ' ' O ' ' C' ' 173' ' ' ASP . 3.4 m-20 -61.3 117.95 6.28 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 112.37 -2.195 . . . . 75.42 109.138 170.286 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 119' ' ' LEU . . . . . 0.637 ' HG ' ' HG2' ' C' ' 167' ' ' GLN . 3.0 tt -92.89 120.72 33.52 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 105.818 -1.919 . . . . 75.21 105.818 -178.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.581 ' HE ' HG21 ' C' ' 177' ' ' VAL . 57.0 ttt180 -117.56 114.19 23.07 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.625 -0.509 . . . . 72.31 109.625 -164.072 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 121' ' ' ALA . . . . . . . . . . . . . . . -108.66 169.95 8.33 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 122.812 0.445 . . . . 63.21 111.805 -171.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -131.86 114.49 14.74 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 123.88 0.872 . . . . 73.22 109.636 -176.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -140.03 115.43 7.88 Favored Pre-proline 0 N--CA 1.483 1.221 0 CA-C-N 117.992 0.36 . . . . 73.3 111.858 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 124' ' ' PRO . . . . . 0.412 ' HA ' ' O ' ' C' ' 179' ' ' ARG . 24.6 Cg_exo -66.88 116.03 3.91 Favored 'Trans proline' 0 C--N 1.378 2.098 0 C-N-CA 122.229 1.952 . . . . 72.51 109.486 162.568 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 125' ' ' LEU . . . . . 0.462 ' O ' ' HA ' ' C' ' 180' ' ' LEU . 14.8 tp -139.58 166.87 23.43 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 107.392 -1.336 . . . . 74.03 107.392 -170.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 126' ' ' THR . . . . . 0.418 ' HB ' HD12 ' C' ' 181' ' ' LEU . 14.2 t -127.01 175.32 8.18 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 119.1 0.864 . . . . 61.53 110.976 175.038 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 127' ' ' LEU . . . . . 0.458 HD11 ' H ' ' C' ' 185' ' ' VAL . 6.5 mt -59.86 -44.55 94.09 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 126.092 1.757 . . . . 62.25 110.011 -177.12 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -58.16 -45.25 87.77 Favored 'General case' 0 C--O 1.213 -0.848 0 CA-C-N 113.694 -1.593 . . . . 75.24 109.586 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 129' ' ' GLU . . . . . 0.536 ' HA ' ' HB2' ' C' ' 132' ' ' HIS . 20.0 mm-40 -77.74 -18.0 56.98 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 124.446 1.091 . . . . 73.53 111.659 -178.307 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 130' ' ' ALA . . . . . 0.486 ' HB1' ' HA2' ' C' ' 152' ' ' GLY . . . -71.86 -36.67 70.18 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.066 -0.716 . . . . 64.34 109.066 174.359 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 131' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -73.07 -46.71 49.98 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 114.753 -1.112 . . . . 75.55 111.176 167.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 132' ' ' HIS . . . . . 0.536 ' HB2' ' HA ' ' C' ' 129' ' ' GLU . 32.7 m170 -74.79 -7.57 53.81 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 118.998 -0.525 . . . . 60.22 111.24 -172.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -70.28 66.96 0.72 Allowed Glycine 0 C--N 1.354 1.537 0 O-C-N 123.712 0.632 . . . . 65.31 113.482 172.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . -88.45 -139.8 6.88 Favored Glycine 0 C--N 1.348 1.206 0 N-CA-C 109.657 -1.377 . . . . 53.24 109.657 169.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -72.73 93.62 1.67 Allowed 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 108.727 -0.842 . . . . 71.2 108.727 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 136' ' ' ARG . . . . . 0.519 ' HB2' HD22 ' B' ' 181' ' ' LEU . 57.2 mtp180 -141.91 163.11 33.77 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.722 0.809 . . . . 72.12 110.756 -171.17 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 137' ' ' VAL . . . . . . . . . . . . . 54.2 t -71.33 95.48 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 CA-C-N 115.019 -0.991 . . . . 71.12 110.9 -171.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 138' ' ' VAL . . . . . 0.404 ' HB ' HG13 ' C' ' 145' ' ' VAL . 97.9 t -79.01 112.22 16.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 107.055 -1.461 . . . . 72.14 107.055 165.244 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 139' ' ' GLU . . . . . . . . . . . . . 53.7 tt0 -121.48 78.44 1.43 Allowed 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 107.567 -1.272 . . . . 74.31 107.567 -167.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 140' ' ' VAL . . . . . 0.481 HG11 HD11 ' C' ' 174' ' ' LEU . 89.3 t -128.1 104.56 12.04 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 CA-C-N 114.31 -1.313 . . . . 63.22 110.755 -166.515 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 68.14 24.31 7.7 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.979 1.312 . . . . 15.23 113.045 168.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 107.5 -29.48 10.43 Favored Glycine 0 C--N 1.338 0.689 0 N-CA-C 111.273 -0.731 . . . . 45.25 111.273 -176.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 143' ' ' ARG . . . . . 0.443 ' CZ ' ' HB ' ' C' ' 145' ' ' VAL . 14.0 tpt180 -70.37 106.94 3.57 Favored 'General case' 0 C--N 1.363 1.192 0 N-CA-C 108.8 -0.815 . . . . 73.04 108.8 177.53 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 11.4 ttt-85 -113.83 96.74 6.0 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-N 114.864 -1.062 . . . . 71.51 108.773 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 145' ' ' VAL . . . . . 0.537 HG22 ' HB ' ' C' ' 147' ' ' VAL . 3.1 p -127.71 130.28 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 124.273 1.029 . . . . 75.03 110.085 -175.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 55.5 m -90.76 86.53 6.36 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 108.803 -0.814 . . . . 54.21 108.803 174.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 147' ' ' VAL . . . . . 0.537 ' HB ' HG22 ' C' ' 145' ' ' VAL . 9.7 p -131.51 159.34 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-N 114.981 -1.008 . . . . 72.53 110.473 -170.418 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 23.1 ttm180 -88.56 104.52 16.91 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 108.392 -0.966 . . . . 74.22 108.392 170.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 149' ' ' ILE . . . . . 0.415 HD12 HD13 ' C' ' 159' ' ' ILE . 30.5 pt -69.74 151.52 96.4 Favored Pre-proline 0 CA--C 1.548 0.88 0 CA-C-O 118.045 -0.979 . . . . 71.41 108.861 166.435 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 150' ' ' PRO . . . . . 0.498 ' HD2' HG22 ' C' ' 161' ' ' VAL . 34.8 Cg_exo -39.27 108.66 0.08 OUTLIER 'Trans proline' 0 C--N 1.39 2.74 0 C-N-CA 123.547 2.831 . . . . 61.44 112.864 176.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -66.6 122.09 9.45 Favored 'Trans proline' 0 C--N 1.382 2.302 0 C-N-CA 122.537 2.158 . . . . 73.2 111.447 -171.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 152' ' ' GLY . . . . . 0.599 ' HA3' HD23 ' C' ' 188' ' ' LEU . . . 99.47 122.72 4.84 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-N 115.52 -0.764 . . . . 54.32 113.386 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 153' ' ' VAL . . . . . 0.684 HG21 HG21 ' C' ' 178' ' ' VAL . 3.5 m -129.99 176.13 9.23 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 C-N-CA 123.745 0.818 . . . . 71.13 109.487 -174.014 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 154' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -133.66 160.05 38.68 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.375 0.67 . . . . 75.32 110.322 177.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 155' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -67.25 103.75 1.32 Allowed 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 124.786 1.234 . . . . 74.51 112.125 -176.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 97.89 -0.79 59.29 Favored Glycine 0 C--N 1.354 1.542 0 CA-C-N 115.583 -0.735 . . . . 64.51 113.163 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 157' ' ' SER . . . . . . . . . . . . . 55.6 m -90.39 170.34 10.32 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.082 0.553 . . . . 75.43 111.966 -172.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 158' ' ' VAL . . . . . 0.528 HG12 HG22 ' C' ' 177' ' ' VAL . 28.2 m -104.99 125.77 59.97 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 CA-C-N 115.488 -0.778 . . . . 64.44 111.086 178.481 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 159' ' ' ILE . . . . . 0.586 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 17.3 mt -76.04 98.66 1.7 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.6 0 N-CA-C 108.082 -1.081 . . . . 52.25 108.082 166.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 21.6 ttp180 -81.97 101.25 10.18 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.993 0.917 . . . . 72.21 110.012 -178.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 161' ' ' VAL . . . . . 0.549 ' HB ' ' HB3' ' C' ' 174' ' ' LEU . 16.1 t -100.19 112.87 64.92 Favored Pre-proline 0 CA--C 1.551 1.004 0 N-CA-C 107.83 -1.174 . . . . 75.24 107.83 175.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -50.48 99.11 0.04 OUTLIER 'Trans proline' 0 C--N 1.384 2.418 0 C-N-CA 124.034 3.156 . . . . 63.42 114.745 -172.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 67.29 23.6 73.32 Favored Glycine 0 C--N 1.347 1.143 0 N-CA-C 115.73 1.052 . . . . 53.31 115.73 169.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 164' ' ' MET . . . . . . . . . . . . . 43.6 ttp -98.0 18.67 15.47 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 117.582 0.691 . . . . 73.35 109.795 174.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . -74.94 -120.95 0.1 Allowed Glycine 0 C--N 1.357 1.727 0 CA-C-N 115.81 -0.632 . . . . 64.24 112.248 174.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . 153.03 -82.87 0.17 Allowed Glycine 0 C--N 1.35 1.354 0 C-N-CA 119.057 -1.544 . . . . 75.44 114.669 172.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 167' ' ' GLN . . . . . 0.637 ' HG2' ' HG ' ' C' ' 119' ' ' LEU . 26.2 mm-40 -14.99 102.49 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.479 0 C-N-CA 126.294 1.837 . . . . 64.31 113.933 -160.337 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 168' ' ' GLY . . . . . 0.41 ' HA3' ' HA2' ' C' ' 116' ' ' GLY . . . 108.88 145.3 11.22 Favored Glycine 0 CA--C 1.535 1.301 0 N-CA-C 108.996 -1.642 . . . . 13.44 108.996 -161.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 169' ' ' ASN . . . . . 0.539 ' HB3' ' HD3' ' C' ' 170' ' ' PRO . 48.6 t30 -61.42 -59.61 13.02 Favored Pre-proline 0 CA--C 1.576 1.954 0 N-CA-C 114.687 1.365 . . . . 62.44 114.687 -164.204 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 170' ' ' PRO . . . . . 0.539 ' HD3' ' HB3' ' C' ' 169' ' ' ASN . 7.9 Cg_exo -71.41 104.55 1.59 Allowed 'Trans proline' 0 C--N 1.398 3.142 0 C-N-CA 122.303 2.002 . . . . 51.41 110.693 175.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 171' ' ' PRO . . . . . 0.529 ' HG3' ' O ' ' C' ' 85' ' ' PHE . 58.1 Cg_endo -61.35 126.83 20.25 Favored 'Trans proline' 0 N--CA 1.502 1.972 0 C-N-CA 123.736 2.957 . . . . 74.02 114.688 -161.563 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -80.49 -167.18 36.09 Favored Glycine 0 C--N 1.354 1.538 0 O-C-N 123.48 0.488 . . . . 74.42 112.269 172.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 173' ' ' ASP . . . . . 0.459 ' O ' ' HA ' ' C' ' 118' ' ' ASP . 13.0 t70 -86.62 155.62 20.35 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 123.54 0.736 . . . . 74.51 110.556 -174.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 174' ' ' LEU . . . . . 0.549 ' HB3' ' HB ' ' C' ' 161' ' ' VAL . 27.7 tp -98.24 114.86 27.26 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 121.496 -0.752 . . . . 75.22 110.198 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 175' ' ' LEU . . . . . 0.445 ' O ' ' HA ' ' C' ' 120' ' ' ARG . 79.6 mt -110.97 91.03 3.5 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.316 0.646 . . . . 71.32 109.867 176.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 176' ' ' LEU . . . . . 0.586 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 62.0 mt -81.02 105.88 12.58 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 109.178 -0.675 . . . . 43.02 109.178 178.201 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 177' ' ' VAL . . . . . 0.581 HG21 ' HE ' ' C' ' 120' ' ' ARG . 60.3 t -81.51 107.68 13.93 Favored 'Isoleucine or valine' 0 C--O 1.249 1.045 0 CA-C-O 121.901 0.857 . . . . 74.43 108.832 -178.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 178' ' ' VAL . . . . . 0.684 HG21 HG21 ' C' ' 153' ' ' VAL . 4.0 p -93.86 140.41 16.58 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 CA-C-N 114.113 -1.403 . . . . 74.01 110.464 -178.331 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 179' ' ' ARG . . . . . 0.412 ' O ' ' HA ' ' C' ' 124' ' ' PRO . 50.9 mmm-85 -121.92 111.56 17.22 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 107.402 -1.333 . . . . 72.33 107.402 172.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 180' ' ' LEU . . . . . 0.462 ' HA ' ' O ' ' C' ' 125' ' ' LEU . 84.5 mt -70.52 145.88 50.57 Favored 'General case' 0 C--O 1.237 0.432 0 O-C-N 123.543 0.527 . . . . 70.51 111.299 -175.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 181' ' ' LEU . . . . . 0.418 HD12 ' HB ' ' C' ' 126' ' ' THR . 31.1 mt -60.01 168.53 2.06 Favored Pre-proline 0 CA--C 1.555 1.171 0 C-N-CA 124.914 1.286 . . . . 74.2 111.886 -178.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -42.0 -3.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.395 3.023 0 C-N-CA 124.834 3.69 . . . . 64.12 118.14 174.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 183' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -125.3 83.39 61.16 Favored Pre-proline 0 CA--C 1.569 1.69 0 CA-C-N 118.865 0.757 . . . . 62.13 110.499 166.134 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 184' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -85.57 69.57 5.18 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 123.671 2.914 . . . . 71.54 110.311 173.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 185' ' ' VAL . . . . . 0.458 ' H ' HD11 ' C' ' 127' ' ' LEU . 4.3 t -90.83 -43.77 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 N-CA-C 109.993 -0.373 . . . . 72.23 109.993 -166.218 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 186' ' ' PHE . . . . . 0.662 ' HB3' HD22 ' C' ' 193' ' ' LEU . 21.7 m-85 -99.75 113.0 25.21 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.708 0.766 . . . . 61.44 112.151 -170.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 187' ' ' ARG . . . . . 0.493 ' HB3' ' HB3' ' C' ' 194' ' ' TYR . 36.0 ttm180 -96.98 101.23 12.76 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 107.257 -1.386 . . . . 75.14 107.257 171.232 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 188' ' ' LEU . . . . . 0.599 HD23 ' HA3' ' C' ' 152' ' ' GLY . 41.1 tp -93.88 144.73 25.18 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 112.856 0.687 . . . . 74.14 112.856 -171.382 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -131.42 111.02 11.45 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 107.242 -1.392 . . . . 71.33 107.242 159.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 70.32 -86.37 0.33 Allowed Glycine 0 C--N 1.351 1.362 0 O-C-N 123.704 0.627 . . . . 74.2 113.141 177.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 191' ' ' GLN . . . . . 0.578 ' HA ' ' HB2' ' C' ' 240' ' ' PHE . 71.8 mt-30 -132.51 -10.76 3.18 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.289 0.636 . . . . 60.21 112.028 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -104.66 121.58 43.85 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 121.303 0.573 . . . . 65.13 110.839 -177.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 193' ' ' LEU . . . . . 0.662 HD22 ' HB3' ' C' ' 186' ' ' PHE . 56.7 mt -90.87 153.15 20.42 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.353 1.461 . . . . 52.2 111.034 -177.368 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 194' ' ' TYR . . . . . 0.493 ' HB3' ' HB3' ' C' ' 187' ' ' ARG . 46.7 t80 -112.05 148.79 33.13 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 106.983 -1.488 . . . . 75.43 106.983 162.099 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 195' ' ' ALA . . . . . 0.4 ' HA ' ' O ' ' C' ' 185' ' ' VAL . . . -154.66 -175.24 5.32 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.253 0.621 . . . . 65.11 110.946 -177.128 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 58.3 m -130.74 145.9 52.07 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.072 0.949 . . . . 51.32 108.813 168.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 197' ' ' LEU . . . . . . . . . . . . . 36.3 tp -127.4 113.64 16.48 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.359 1.064 . . . . 73.5 108.861 -176.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 198' ' ' ASP . . . . . 0.47 ' HB3' HG21 ' C' ' 256' ' ' THR . 19.9 m-20 -86.11 101.76 13.26 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 109.778 -0.453 . . . . 44.52 109.778 -178.245 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 199' ' ' VAL . . . . . 0.553 ' HA ' HG11 ' C' ' 210' ' ' VAL . 88.8 t -105.58 123.22 40.13 Favored Pre-proline 0 N--CA 1.474 0.747 0 C-N-CA 123.775 0.83 . . . . 61.21 109.13 177.549 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 200' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.88 148.03 56.91 Favored 'Trans proline' 0 C--N 1.369 1.655 0 C-N-CA 121.896 1.731 . . . . 71.34 110.929 176.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 201' ' ' ALA . . . . . . . . . . . . . . . -55.0 -43.59 99.14 Favored Pre-proline 0 CA--C 1.553 1.069 0 N-CA-C 114.174 1.176 . . . . 74.35 114.174 -175.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 202' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -54.38 -52.78 7.44 Favored 'Trans proline' 0 C--N 1.394 2.971 0 C-N-CA 121.733 1.622 . . . . 63.15 112.666 175.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 203' ' ' ILE . . . . . . . . . . . . . 44.6 mt -65.18 -31.04 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 124.089 0.956 . . . . 63.4 111.269 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.34 -43.26 81.99 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.736 0.814 . . . . 75.02 111.817 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 205' ' ' VAL . . . . . . . . . . . . . 87.4 t -72.62 -47.81 49.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 115.866 -0.606 . . . . 63.41 111.22 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 206' ' ' VAL . . . . . 0.465 HG23 ' HE2' ' A' ' 270' ' ' LYS . 11.5 p -80.96 -34.12 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 112.842 0.682 . . . . 52.12 112.842 -171.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 89.86 111.77 1.4 Allowed Glycine 0 CA--C 1.531 1.04 0 N-CA-C 111.623 -0.591 . . . . 63.21 111.623 -169.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -153.24 -121.46 0.85 Allowed Glycine 0 C--N 1.348 1.217 0 CA-C-O 119.606 -0.552 . . . . 51.32 111.76 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 209' ' ' LYS . . . . . . . . . . . . . 31.7 mtmt -151.81 153.09 33.57 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.672 0.789 . . . . 72.12 111.6 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 210' ' ' VAL . . . . . 0.553 HG11 ' HA ' ' C' ' 199' ' ' VAL . 29.3 m -139.97 178.06 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 126.764 2.026 . . . . 62.05 108.393 174.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 211' ' ' ARG . . . . . 0.429 ' NE ' ' HB2' ' C' ' 218' ' ' PRO . 0.0 OUTLIER -111.84 147.93 34.7 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.018 0.527 . . . . 72.44 111.296 177.213 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -127.18 121.29 30.91 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 107.369 -1.345 . . . . 74.43 107.369 164.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 213' ' ' MET . . . . . . . . . . . . . 1.4 tmm? -76.02 112.99 13.03 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 108.281 -1.007 . . . . 63.12 108.281 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 214' ' ' THR . . . . . 0.423 HG22 ' H ' ' C' ' 215' ' ' LEU . 0.2 OUTLIER -117.99 175.39 5.69 Favored 'General case' 0 N--CA 1.485 1.325 0 CA-C-N 118.86 0.755 . . . . 54.24 111.962 -173.373 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 215' ' ' LEU . . . . . 0.423 ' H ' HG22 ' C' ' 214' ' ' THR . 35.7 mt -73.82 -33.49 64.18 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.247 1.419 . . . . 44.41 112.384 -171.314 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -83.41 -4.65 58.69 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 115.262 -0.881 . . . . 71.0 110.647 175.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 132.09 173.22 13.26 Favored Glycine 0 C--N 1.342 0.878 0 N-CA-C 110.898 -0.881 . . . . 64.11 110.898 -175.299 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 218' ' ' PRO . . . . . 0.429 ' HB2' ' NE ' ' C' ' 211' ' ' ARG . 93.5 Cg_endo -75.56 113.22 3.7 Favored 'Trans proline' 0 CA--C 1.55 1.316 0 C-N-CA 122.253 1.969 . . . . 52.13 112.0 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 219' ' ' VAL . . . . . . . . . . . . . 14.6 p -89.03 152.3 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 108.034 -1.099 . . . . 52.53 108.034 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 220' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -111.57 107.69 16.93 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.194 -1.039 . . . . 72.32 108.194 176.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 221' ' ' VAL . . . . . 0.429 HG22 HD11 ' C' ' 235' ' ' LEU . 53.9 t -75.86 129.08 37.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 114.281 -1.327 . . . . 74.03 111.415 -174.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -77.95 138.07 38.66 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.016 0.436 . . . . 73.3 110.507 169.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 57.5 t -118.25 124.17 28.82 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 124.066 0.946 . . . . 73.11 108.916 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 224' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -76.47 162.41 33.37 Favored 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 123.065 2.51 . . . . 54.33 111.067 169.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -60.71 156.14 44.52 Favored 'Trans proline' 0 C--N 1.369 1.632 0 C-N-CA 122.526 2.151 . . . . 74.0 113.333 176.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 226' ' ' ARG . . . . . 0.468 ' HD2' ' O ' ' A' ' 259' ' ' GLU . 11.8 mmt180 59.59 63.52 1.5 Allowed 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 125.269 1.428 . . . . 70.15 111.764 176.123 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 227' ' ' THR . . . . . . . . . . . . . 57.8 m -100.33 132.28 45.79 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.644 0.777 . . . . 70.3 111.51 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 228' ' ' GLN . . . . . 0.478 ' NE2' ' HG3' ' A' ' 259' ' ' GLU . 26.7 mp0 -111.17 150.6 29.27 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 124.562 1.145 . . . . 74.32 112.376 -179.16 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 229' ' ' ALA . . . . . 0.457 ' HB2' ' H ' ' C' ' 255' ' ' ILE . . . -75.1 118.85 18.49 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 114.551 -1.204 . . . . 62.12 109.606 177.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 116.58 -1.35 20.24 Favored Glycine 0 C--N 1.339 0.747 0 O-C-N 123.688 0.617 . . . . 62.04 112.287 -176.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 231' ' ' ARG . . . . . 0.564 ' HD3' ' HZ3' ' B' ' 242' ' ' TRP . 32.4 mtt180 -66.42 172.99 3.55 Favored 'General case' 0 C--N 1.355 0.819 0 CA-C-O 120.843 0.354 . . . . 74.12 110.691 167.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 232' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' C' ' 251' ' ' LEU . 3.6 ttmp? -142.88 146.29 33.94 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 109.582 -0.525 . . . . 71.45 109.582 175.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 233' ' ' LEU . . . . . 0.425 ' O ' ' HA ' ' C' ' 250' ' ' TYR . 3.5 tt -132.91 125.36 29.72 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.726 0.811 . . . . 74.21 108.838 -168.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 35.5 ttp180 -92.31 104.25 16.62 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.776 0.322 . . . . 72.34 110.397 170.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 235' ' ' LEU . . . . . 0.483 HD12 HD23 ' C' ' 249' ' ' LEU . 72.2 mt -81.56 116.41 21.31 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 107.903 -1.147 . . . . 73.43 107.903 164.184 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -80.27 134.08 36.05 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 123.328 0.651 . . . . 71.55 110.963 -176.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 70.9 26.97 73.02 Favored Glycine 0 C--N 1.349 1.269 0 O-C-N 123.933 0.77 . . . . 71.42 113.235 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 21.7 mmtm -120.62 12.15 11.42 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.958 0.903 . . . . 72.03 111.515 -177.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -90.44 -133.1 5.29 Favored Glycine 0 C--N 1.343 0.966 0 N-CA-C 111.316 -0.714 . . . . 31.21 111.316 172.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 240' ' ' PHE . . . . . 0.578 ' HB2' ' HA ' ' C' ' 191' ' ' GLN . 3.5 m-85 -97.35 118.49 64.42 Favored Pre-proline 0 C--O 1.237 0.436 0 C-N-CA 123.068 0.547 . . . . 75.14 109.907 174.028 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 241' ' ' PRO . . . . . 0.515 ' HA ' ' HA ' ' C' ' 246' ' ' ARG . 87.4 Cg_exo -50.94 103.88 0.07 OUTLIER 'Trans proline' 0 C--N 1.365 1.432 0 C-N-CA 123.557 2.838 . . . . 70.21 113.069 166.238 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -77.42 174.0 54.79 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-N 114.707 -1.133 . . . . 70.14 112.974 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -66.82 -11.08 30.61 Favored 'Trans proline' 0 C--N 1.368 1.559 0 C-N-CA 123.123 2.549 . . . . 71.42 114.038 -171.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -137.29 1.72 2.44 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.687 0.795 . . . . 71.42 111.735 179.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . -171.75 -138.38 2.54 Favored Glycine 0 C--N 1.348 1.238 0 CA-C-O 119.706 -0.497 . . . . 51.32 112.949 -177.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 246' ' ' ARG . . . . . 0.515 ' HA ' ' HA ' ' C' ' 241' ' ' PRO . 85.5 mtm180 -148.44 160.87 42.62 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.845 0.858 . . . . 61.31 111.004 -178.197 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -96.46 -169.3 34.32 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 114.879 -1.055 . . . . 63.23 112.173 173.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -126.33 169.94 12.41 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.104 0.562 . . . . 73.54 110.495 -173.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 249' ' ' LEU . . . . . 0.483 HD23 HD12 ' C' ' 235' ' ' LEU . 17.6 tp -129.25 127.14 40.63 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.945 0.898 . . . . 74.23 109.38 -176.022 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 250' ' ' TYR . . . . . 0.425 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 89.5 m-85 -117.06 101.17 8.26 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.695 0.798 . . . . 71.43 110.141 -178.091 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 251' ' ' LEU . . . . . 0.447 ' O ' ' HA ' ' C' ' 232' ' ' LYS . 0.9 OUTLIER -99.23 129.76 45.48 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 119.286 -0.388 . . . . 64.53 110.113 -176.039 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -73.11 108.45 6.0 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.076 -1.083 . . . . 73.41 108.076 166.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 253' ' ' VAL . . . . . 0.43 HG11 ' HH2' ' B' ' 242' ' ' TRP . 46.7 t -78.79 110.69 14.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.732 -0.667 . . . . 73.5 109.977 -176.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 254' ' ' ARG . . . . . . . . . . . . . 41.0 mtm180 -94.06 159.01 15.35 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.498 0.719 . . . . 74.13 111.321 175.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 255' ' ' ILE . . . . . 0.457 ' H ' ' HB2' ' C' ' 229' ' ' ALA . 35.4 mm -105.82 127.23 60.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 114.235 -1.348 . . . . 75.24 107.983 169.184 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 256' ' ' THR . . . . . 0.47 HG21 ' HB3' ' C' ' 198' ' ' ASP . 0.3 OUTLIER -133.49 172.82 12.21 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.917 1.287 . . . . 53.32 108.775 -177.685 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 35.1 pt -127.02 145.55 54.4 Favored Pre-proline 0 N--CA 1.481 1.099 0 C-N-CA 123.434 0.694 . . . . 64.54 110.109 -178.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -63.33 -11.83 27.52 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.698 2.266 . . . . 73.21 113.72 -173.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 53.32 -67.25 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.961 1.704 . . . . 72.3 112.64 -165.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 8.1 ppt_? -59.77 133.65 56.29 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.33 0.652 . . . . 73.41 110.351 174.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 261' ' ' LEU . . . . . 0.556 HD22 ' HB3' ' C' ' 265' ' ' GLU . 91.2 mt -143.34 161.75 37.52 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.73 0.812 . . . . 71.21 110.488 -173.021 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 63.4 p -91.18 165.56 21.17 Favored Pre-proline 0 CA--C 1.55 0.954 0 N-CA-C 108.62 -0.882 . . . . 61.23 108.62 167.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -48.92 -42.13 38.37 Favored 'Trans proline' 0 C--N 1.381 2.281 0 C-N-CA 122.293 1.996 . . . . 74.2 111.988 169.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -64.18 -58.13 7.5 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 114.202 -1.363 . . . . 71.04 111.244 -178.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 265' ' ' GLU . . . . . 0.556 ' HB3' HD22 ' C' ' 261' ' ' LEU . 0.5 OUTLIER -48.85 -58.37 4.93 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.877 0.871 . . . . 65.11 110.924 177.793 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 266' ' ' GLU . . . . . 0.544 ' O ' ' HG2' ' C' ' 270' ' ' LYS . 33.6 tt0 -58.36 -39.49 79.67 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 124.17 0.919 . . . . 64.21 110.939 -175.419 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -60.2 -44.13 95.36 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.712 0.805 . . . . 70.32 112.408 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 268' ' ' LEU . . . . . . . . . . . . . 11.1 mp -65.65 -40.71 92.78 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 116.709 -0.223 . . . . 52.44 110.745 176.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -59.81 -36.37 76.62 Favored 'General case' 0 N--CA 1.483 1.177 0 O-C-N 123.558 0.536 . . . . 61.11 110.946 174.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 270' ' ' LYS . . . . . 0.544 ' HG2' ' O ' ' C' ' 266' ' ' GLU . 30.5 mmtp -63.9 -46.92 82.68 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.684 0.794 . . . . 75.43 110.368 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -61.68 -45.06 95.6 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.55 0.74 . . . . 75.33 111.708 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 92.7 mt -62.0 -43.75 98.18 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.236 -0.893 . . . . 74.33 110.315 177.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -59.39 -41.21 88.87 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.558 -0.746 . . . . 34.13 110.695 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -69.31 -31.91 70.69 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.185 0.594 . . . . 63.21 111.595 177.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -62.44 -31.95 72.74 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 122.531 0.332 . . . . 70.04 110.473 171.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 276' ' ' TYR . . . . . 0.563 ' HE1' ' HG2' ' A' ' 202' ' ' PRO . 79.2 m-85 -77.35 -34.56 55.15 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 122.887 0.475 . . . . 75.52 112.207 171.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 15.2 m-30 -66.27 -27.48 67.97 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.797 -0.446 . . . . 44.24 109.797 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -65.53 -1.96 3.01 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 124.413 1.085 . . . . 55.2 113.244 175.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 279' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -72.84 -22.89 60.72 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 122.697 0.399 . . . . 71.52 110.917 171.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.077 0 C-N-CA 123.581 0.752 . . . . 75.14 110.154 178.829 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt . . . . . 0 N--CA 1.472 0.668 0 N-CA-C 113.474 0.916 . . . . 62.43 113.474 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -70.74 88.92 0.73 Allowed 'General case' 0 C--O 1.241 0.62 0 N-CA-C 107.584 -1.265 . . . . 74.32 107.584 162.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.466 ' HA ' ' OH ' ' A' ' 66' ' ' TYR . 34.7 t70 -75.45 93.81 3.02 Favored 'General case' 0 C--N 1.354 0.782 0 N-CA-C 107.511 -1.292 . . . . 61.41 107.511 173.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.615 ' HB2' HD11 ' A' ' 57' ' ' LEU . 50.7 m-85 -60.17 -28.61 68.07 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 113.783 -1.553 . . . . 73.34 111.836 -169.558 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.429 ' CD1' HD11 ' A' ' 22' ' ' ILE . 50.3 m-85 -65.47 -47.63 75.45 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.035 0.534 . . . . 73.33 110.454 177.218 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.5 -38.69 91.9 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.871 -0.604 . . . . 60.32 111.427 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 69.6 mt -60.45 -38.98 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 123.733 0.646 . . . . 74.23 110.107 174.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.467 ' HB3' ' HB1' ' A' ' 25' ' ' ALA . 93.7 mt -86.31 2.81 45.98 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 115.36 -0.836 . . . . 51.33 112.505 178.421 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 63.83 18.23 61.65 Favored Glycine 0 C--N 1.356 1.64 0 N-CA-C 114.771 0.668 . . . . 53.33 114.771 177.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.6 m -107.48 155.35 39.75 Favored Pre-proline 0 N--CA 1.482 1.167 0 C-N-CA 124.389 1.075 . . . . 71.43 110.076 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.88 154.88 30.1 Favored 'Trans proline' 0 C--N 1.383 2.356 0 C-N-CA 123.0 2.466 . . . . 50.12 113.106 177.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 55.7 mtp180 -76.39 13.75 0.89 Allowed 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 112.763 0.653 . . . . 75.43 112.763 -173.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -119.96 -5.41 10.07 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 125.141 1.376 . . . . 64.11 109.402 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.465 ' HB1' ' HB2' ' A' ' 21' ' ' GLU . . . -58.34 127.28 31.35 Favored 'General case' 0 C--N 1.347 0.477 0 C-N-CA 124.75 1.22 . . . . 64.31 111.51 -175.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.563 ' HA ' HH21 ' A' ' 63' ' ' ARG . 79.8 p -84.17 177.05 8.37 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 122.881 0.473 . . . . 71.11 110.658 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -46.71 -32.65 3.72 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 124.982 1.313 . . . . 64.21 113.292 -175.459 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -81.59 -30.06 33.11 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 112.264 0.468 . . . . 72.43 112.264 -173.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.465 ' HB2' ' HB1' ' A' ' 17' ' ' ALA . 2.5 mp0 -72.92 -33.67 66.12 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 109.601 -0.518 . . . . 64.03 109.601 170.085 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.499 HG21 ' HB2' ' A' ' 57' ' ' LEU . 1.7 mp -67.29 -33.72 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.738 0.815 . . . . 73.31 110.265 173.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.416 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 4.6 tppp? -64.28 -53.5 47.96 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.824 0.85 . . . . 71.24 109.717 176.024 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -59.12 -44.43 92.01 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 124.166 0.916 . . . . 54.12 110.935 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.467 ' HB1' ' HB3' ' A' ' 11' ' ' LEU . . . -66.7 -35.54 80.37 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.792 0.837 . . . . 64.0 111.849 -177.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -64.12 -50.49 68.04 Favored 'General case' 0 C--O 1.215 -0.711 0 CA-C-N 115.403 -0.817 . . . . 73.1 109.784 175.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.416 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 54.8 mtpt -59.07 -42.82 91.27 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 123.947 0.779 . . . . 74.22 110.737 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.0 ttt180 -53.25 -55.55 23.6 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.283 1.433 . . . . 71.15 110.728 176.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.752 ' HB3' HD13 ' A' ' 50' ' ' ILE . 95.5 mt -79.28 -15.63 57.68 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.603 -0.726 . . . . 74.11 111.793 -176.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.21 -18.78 38.06 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.55 0.74 . . . . 63.3 110.595 175.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -86.07 -45.86 11.02 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 122.977 0.511 . . . . 72.33 110.37 169.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -63.86 -57.65 9.2 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.006 0.522 . . . . 63.33 110.434 -177.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -97.35 38.56 1.25 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.556 0.742 . . . . 63.25 110.025 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 7.7 t-160 -63.94 103.58 0.43 Allowed Pre-proline 0 C--N 1.354 0.782 0 C-N-CA 123.769 0.828 . . . . 63.41 109.478 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -68.38 -14.46 40.15 Favored 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 122.534 2.156 . . . . 74.13 112.86 -167.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -67.85 -39.93 83.75 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.502 1.121 . . . . 72.45 111.305 173.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 96.5 t -96.58 -51.18 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 123.291 0.636 . . . . 65.53 110.08 -177.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -102.16 89.86 3.74 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.174 0.989 . . . . 61.35 110.898 -176.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.22 44.83 1.17 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.426 0.69 . . . . 73.11 110.58 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 74.0 m -89.72 130.48 42.93 Favored Pre-proline 0 N--CA 1.474 0.766 0 CA-C-O 117.918 -1.039 . . . . 54.41 108.447 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -38.61 -70.35 0.07 OUTLIER 'Trans proline' 0 C--N 1.392 2.836 0 C-N-CA 124.76 3.64 . . . . 72.23 114.334 -172.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.483 ' HA ' ' HB2' ' A' ' 45' ' ' GLU . 30.9 tt0 -75.81 -7.21 53.89 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 116.61 -0.268 . . . . 64.43 111.642 -174.337 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.37 -35.62 68.53 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 108.929 -0.767 . . . . 72.14 108.929 172.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -86.56 -30.51 21.83 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-N 115.874 -0.603 . . . . 62.01 109.95 -178.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.514 ' HA ' ' HZ2' ' A' ' 48' ' ' LYS . 41.2 mt-10 -67.17 -46.49 73.83 Favored 'General case' 0 C--O 1.244 0.792 0 C-N-CA 123.339 0.656 . . . . 62.44 110.285 174.153 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 32.3 mmtm -61.19 -39.38 89.97 Favored 'General case' 0 C--O 1.214 -0.785 0 CA-C-N 115.633 -0.712 . . . . 74.03 110.383 171.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.457 ' HA ' HD12 ' A' ' 50' ' ' ILE . 85.2 t80 -58.46 -36.69 74.09 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 123.376 0.423 . . . . 73.24 111.179 176.357 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.514 ' HZ2' ' HA ' ' A' ' 45' ' ' GLU . 10.5 mtmp? -69.68 -32.81 71.65 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.009 0.523 . . . . 75.14 111.607 175.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -77.59 -22.65 50.55 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 122.603 0.361 . . . . 71.44 111.873 175.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.752 HD13 ' HB3' ' A' ' 29' ' ' LEU . 60.3 mt -77.82 -34.02 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 124.321 1.048 . . . . 70.53 108.737 172.486 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -64.89 -39.65 93.87 Favored 'General case' 0 C--O 1.218 -0.582 0 CA-C-N 114.817 -1.083 . . . . 73.43 109.641 171.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -61.04 -51.27 69.9 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.349 1.06 . . . . 63.42 110.603 176.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.18 -55.81 27.03 Favored 'General case' 0 C--O 1.255 1.395 0 CA-C-N 114.465 -1.243 . . . . 65.45 112.105 -178.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -65.01 -38.48 91.05 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.069 -0.968 . . . . 72.32 110.978 178.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.549 ' HB1' ' HD2' ' A' ' 85' ' ' PHE . . . -54.0 -50.07 67.44 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.334 0.654 . . . . 53.01 111.399 -178.574 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 70.9 t -62.71 -53.15 50.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 CA-C-N 114.706 -1.134 . . . . 74.52 110.74 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.615 HD11 ' HB2' ' A' ' 7' ' ' TYR . 55.1 mt -90.76 6.77 42.8 Favored 'General case' 0 CA--C 1.559 1.318 0 N-CA-C 113.796 1.036 . . . . 62.04 113.796 -168.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.6 t -78.4 -54.15 6.5 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.202 0.601 . . . . 74.34 110.539 176.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -75.89 131.23 76.66 Favored Pre-proline 0 C--O 1.236 0.373 0 CA-C-N 115.322 -0.853 . . . . 74.34 109.393 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.427 ' O ' ' HG2' ' A' ' 64' ' ' ARG . 22.9 Cg_endo -58.35 -32.62 96.51 Favored 'Trans proline' 0 C--N 1.385 2.491 0 C-N-CA 123.201 2.601 . . . . 72.41 112.344 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -66.45 -51.56 55.56 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.557 0.743 . . . . 72.3 110.878 -178.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 36.5 mtpt -73.74 -26.67 60.79 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.042 0.937 . . . . 74.54 111.669 -177.035 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.563 HH21 ' HA ' ' A' ' 18' ' ' THR . 42.6 tpt85 -59.28 -53.64 55.99 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.959 0.904 . . . . 74.11 108.925 168.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.482 ' HA ' ' HE ' ' A' ' 64' ' ' ARG . 2.4 mmp_? -61.92 -31.89 72.25 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 124.163 0.914 . . . . 74.25 111.611 178.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 64.2 mt -60.16 -47.77 90.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.16 0.584 . . . . 64.42 110.373 174.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.466 ' OH ' ' HA ' ' A' ' 6' ' ' ASP . 21.3 t80 -60.26 -48.14 83.02 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 116.037 -0.529 . . . . 75.4 110.14 177.541 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -54.06 -47.89 71.18 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.044 0.537 . . . . 64.04 111.546 178.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 72.2 p -72.54 -17.78 61.69 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.799 -0.637 . . . . 75.13 111.824 -177.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -74.84 107.34 6.86 Favored 'General case' 0 C--N 1.361 1.079 0 N-CA-C 107.808 -1.182 . . . . 63.45 107.808 170.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 119.71 10.76 7.53 Favored Glycine 0 N--CA 1.469 0.874 0 N-CA-C 111.744 -0.543 . . . . 52.54 111.744 -167.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 90.6 m -145.13 -56.62 0.33 Allowed 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 105.11 -2.181 . . . . 71.23 105.11 177.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 22.0 m -88.0 143.73 26.93 Favored 'General case' 0 C--O 1.251 1.157 0 N-CA-C 104.421 -2.437 . . . . 74.23 104.421 156.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.22 -31.06 9.29 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.288 0.635 . . . . 74.04 110.728 -178.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -83.85 150.63 59.37 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 123.371 0.669 . . . . 75.1 109.483 173.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.442 ' HG2' ' HG2' ' A' ' 103' ' ' PRO . 55.7 Cg_exo -56.87 135.94 73.63 Favored 'Trans proline' 0 C--N 1.371 1.733 0 C-N-CA 122.864 2.376 . . . . 75.41 112.946 175.229 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.01 162.98 39.46 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 123.612 2.875 . . . . 74.25 112.801 178.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -50.42 115.62 2.03 Favored 'Trans proline' 0 C--N 1.385 2.449 0 C-N-CA 123.444 2.762 . . . . 62.44 113.678 176.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -68.97 134.17 28.95 Favored 'Trans proline' 0 C--N 1.381 2.251 0 C-N-CA 122.568 2.179 . . . . 43.51 111.895 177.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -61.41 154.46 58.73 Favored 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 122.883 2.388 . . . . 71.05 112.656 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.57 87.8 0.05 OUTLIER 'Trans proline' 0 C--N 1.382 2.326 0 C-N-CA 123.375 2.716 . . . . 51.35 112.943 178.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 148.28 -39.89 0.96 Allowed Glycine 0 N--CA 1.463 0.443 0 N-CA-C 109.492 -1.443 . . . . 62.41 109.492 179.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 117.28 -165.62 12.48 Favored Glycine 0 C--N 1.345 1.068 0 CA-C-N 114.607 -0.796 . . . . 53.03 111.991 178.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -90.99 106.09 18.28 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.629 0.772 . . . . 74.41 108.942 178.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -78.14 149.05 33.86 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.454 0.702 . . . . 71.31 111.725 177.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.549 ' HD2' ' HB1' ' A' ' 55' ' ' ALA . 75.9 m-85 -134.61 75.04 1.56 Allowed 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.311 1.044 . . . . 70.22 110.006 -176.029 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.9 m -49.72 85.59 0.0 OUTLIER 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 125.688 1.595 . . . . 74.44 113.479 -179.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 86.18 12.04 71.46 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-O 119.573 -0.57 . . . . 70.11 114.172 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.616 ' HB3' ' HZ ' ' A' ' 93' ' ' PHE . 45.9 m-85 -119.75 117.45 28.27 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 117.883 0.841 . . . . 72.34 110.334 -174.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -73.77 87.48 1.73 Allowed 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 121.528 0.68 . . . . 71.44 110.391 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.63 HG12 ' HD3' ' A' ' 171' ' ' PRO . 6.0 p -49.45 -32.16 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 125.51 1.524 . . . . 75.21 113.378 173.576 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -56.2 -24.22 40.5 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.45 1.1 . . . . 75.33 111.847 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -86.1 -30.63 22.41 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.932 0.893 . . . . 45.35 112.483 -178.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.616 ' HZ ' ' HB3' ' A' ' 88' ' ' PHE . 10.3 m-30 -65.75 153.27 42.25 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 112.903 0.705 . . . . 71.01 112.903 -165.322 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 84.8 p -64.74 171.1 3.59 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 115.667 1.729 . . . . 74.5 115.667 -165.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.56 -42.4 82.97 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 114.46 -1.246 . . . . 74.31 112.725 177.208 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -57.14 -46.02 83.06 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.984 0.914 . . . . 75.03 109.592 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.429 ' CE2' HG23 ' A' ' 90' ' ' VAL . 48.9 t80 -62.46 -43.52 98.61 Favored 'General case' 0 CA--C 1.553 1.084 0 CA-C-N 113.631 -1.622 . . . . 63.23 110.468 177.199 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -69.26 -13.21 62.27 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.064 0.546 . . . . 73.05 111.64 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -92.59 -30.8 15.44 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.238 0.615 . . . . 70.02 111.408 170.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 25.1 tp -82.25 -63.38 1.39 Allowed 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.491 0.716 . . . . 55.03 111.412 -177.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -93.77 -6.89 45.0 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.7 0.8 . . . . 72.11 112.727 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -43.74 -56.04 5.19 Favored Glycine 0 CA--C 1.545 1.964 0 N-CA-C 116.315 1.286 . . . . 72.43 116.315 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.442 ' HG2' ' HG2' ' A' ' 75' ' ' PRO . 33.4 Cg_exo -63.14 -3.67 5.25 Favored 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 123.625 2.884 . . . . 23.1 115.367 -176.074 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -139.42 26.96 2.65 Favored Glycine 0 C--N 1.352 1.468 0 CA-C-O 119.159 -0.801 . . . . 44.4 112.968 175.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.524 HD22 HG21 ' A' ' 90' ' ' VAL . 23.2 mt -65.38 81.07 0.05 Allowed 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 117.583 0.692 . . . . 74.25 111.708 176.396 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 43.62 -108.73 0.13 Allowed 'General case' 0 CA--C 1.56 1.327 0 C-N-CA 126.274 1.83 . . . . 72.25 113.072 -178.249 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.1 5.63 71.57 Favored Glycine 0 C--N 1.368 2.314 0 CA-C-O 118.979 -0.9 . . . . 44.0 114.271 -174.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.689 ' HA3' ' HB3' ' A' ' 167' ' ' GLN . . . . . . . . 0 C--N 1.37 2.422 0 C-N-CA 125.781 1.658 . . . . 71.34 115.905 168.259 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 25.1 tptp . . . . . 0 N--CA 1.486 1.327 0 N-CA-C 113.32 0.859 . . . . 72.15 113.32 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -89.63 176.48 43.0 Favored Glycine 0 CA--C 1.541 1.712 0 O-C-N 123.691 0.619 . . . . 55.22 113.013 175.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.739 ' H ' ' HA3' ' A' ' 166' ' ' GLY . 0.0 OUTLIER -116.24 175.79 5.39 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.451 1.1 . . . . 71.34 111.211 179.537 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -86.84 95.93 10.03 Favored 'General case' 0 CA--C 1.565 1.521 0 CA-C-O 122.035 0.921 . . . . 74.23 111.025 178.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 9.2 tt -100.89 150.62 22.65 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.671 1.189 . . . . 70.23 109.3 -178.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -98.37 138.75 35.15 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.54 0.736 . . . . 74.51 111.376 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.552 ' HB2' HD11 ' A' ' 174' ' ' LEU . . . -128.74 170.5 13.23 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.939 0.895 . . . . 41.51 109.85 170.413 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -122.21 114.72 21.23 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 106.402 -1.703 . . . . 61.0 106.402 -178.392 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 53.4 tp -99.25 101.46 12.89 Favored Pre-proline 0 N--CA 1.475 0.796 0 N-CA-C 108.208 -1.034 . . . . 54.05 108.208 -175.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.57 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 7.1 Cg_endo -86.07 111.05 1.09 Allowed 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 121.403 1.402 . . . . 75.33 109.488 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.564 ' HA ' HG21 ' B' ' 6' ' ' ILE . 47.7 tp -106.48 136.95 45.35 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 110.058 -0.349 . . . . 64.01 110.058 -176.329 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.463 HG21 ' H ' ' B' ' 4' ' ' SER . 99.9 m -65.54 131.09 45.52 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.985 0.914 . . . . 71.34 110.049 175.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 69.3 mt -57.26 -50.81 71.71 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.908 0.883 . . . . 70.54 111.385 -175.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -59.94 -37.55 79.86 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 114.824 -1.08 . . . . 75.32 110.606 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.421 ' HB2' ' HB ' ' A' ' 126' ' ' THR . 45.1 mm-40 -82.06 -12.71 58.11 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 115.425 -0.807 . . . . 64.33 112.056 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -71.29 -54.04 12.21 Favored 'General case' 0 C--N 1.347 0.471 0 N-CA-C 107.719 -1.215 . . . . 41.43 107.719 167.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -51.98 -44.41 64.02 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 116.138 -0.483 . . . . 74.51 110.984 174.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 50.8 m170 -73.51 -30.13 62.91 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 116.468 -0.333 . . . . 75.25 111.786 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 67.9 -129.05 26.72 Favored Glycine 0 C--N 1.349 1.26 0 O-C-N 123.216 0.323 . . . . 71.54 113.257 177.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.445 ' O ' HG12 ' A' ' 149' ' ' ILE . . . 83.24 -175.59 52.74 Favored Glycine 0 C--N 1.35 1.31 0 C-N-CA 123.007 0.337 . . . . 70.42 113.856 175.596 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.9 111.36 13.66 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 107.783 -1.191 . . . . 73.14 107.783 169.178 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.407 ' NH2' ' HB3' ' A' ' 129' ' ' GLU . 13.8 tpp180 -90.16 121.35 32.12 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 109.186 -0.672 . . . . 74.4 109.186 -175.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.494 HG11 ' HE ' ' A' ' 144' ' ' ARG . 97.6 t -86.68 108.33 17.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 CA-C-N 115.204 -0.907 . . . . 71.24 108.904 177.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.453 HG22 HD11 ' B' ' 6' ' ' ILE . 14.6 t -107.37 113.03 42.52 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 115.005 -0.998 . . . . 73.14 108.417 -178.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -99.05 133.21 43.65 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.586 0.754 . . . . 71.3 109.535 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.447 HG11 HD23 ' B' ' 8' ' ' LEU . 7.3 p -166.14 119.24 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.904 0 C-N-CA 123.595 0.758 . . . . 75.1 110.776 -179.039 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 61.51 19.29 10.2 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.052 1.341 . . . . 74.24 113.741 172.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 102.01 -2.73 51.66 Favored Glycine 0 C--N 1.351 1.376 0 CA-C-N 117.555 0.161 . . . . 31.1 112.993 -177.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 20.7 tpt180 -99.94 112.83 25.09 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.07 0.948 . . . . 72.12 109.589 175.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.494 ' HE ' HG11 ' A' ' 137' ' ' VAL . 74.9 ttt180 -108.02 93.89 4.78 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.122 0.969 . . . . 74.41 108.642 175.58 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 15.0 p -94.59 149.99 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 123.318 0.647 . . . . 73.53 110.031 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 32.4 t -120.85 98.55 6.06 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.734 0.814 . . . . 31.45 108.872 176.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 19.0 m -103.48 116.63 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.375 0.67 . . . . 73.42 110.951 -176.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -67.41 112.37 4.58 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 109.608 -0.516 . . . . 74.14 109.608 172.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.445 HG12 ' O ' ' A' ' 134' ' ' GLY . 23.7 pt -101.62 152.29 38.04 Favored Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 123.727 0.811 . . . . 74.13 110.283 178.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -58.85 -165.57 0.03 OUTLIER 'Trans proline' 0 N--CA 1.517 2.872 0 C-N-CA 124.568 3.512 . . . . 60.34 112.451 168.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_exo -48.9 89.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.398 3.148 0 CA-C-N 121.025 1.402 . . . . 74.15 109.867 159.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 40.17 -98.01 0.01 OUTLIER Glycine 0 CA--C 1.494 -1.267 0 CA-C-N 112.727 -2.033 . . . . 75.51 114.647 -162.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.708 HG11 HG21 ' A' ' 178' ' ' VAL . 5.5 p 173.43 161.67 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 113.116 -1.542 . . . . 75.43 107.938 -162.203 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.04 152.86 43.72 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.452 -0.944 . . . . 73.23 108.452 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.453 ' HG2' ' NH1' ' A' ' 187' ' ' ARG . 11.3 tp10 -50.76 130.81 25.42 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 124.008 0.923 . . . . 72.32 112.662 -174.312 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.83 9.35 85.07 Favored Glycine 0 C--N 1.346 1.1 0 CA-C-N 115.412 -0.813 . . . . 14.21 114.072 178.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 42.0 m -66.18 109.84 2.78 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-N 118.016 0.908 . . . . 74.23 109.087 173.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 46.7 t -88.65 90.47 3.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 123.801 0.84 . . . . 72.34 109.024 -178.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.545 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 59.6 mt -74.24 104.96 3.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 108.656 -0.868 . . . . 75.24 108.656 175.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 46.7 ttt180 -74.86 108.85 7.87 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 109.32 -0.622 . . . . 61.32 109.32 177.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.482 HG13 ' HB3' ' A' ' 174' ' ' LEU . 3.8 p -119.48 95.58 49.33 Favored Pre-proline 0 CA--C 1.554 1.114 0 C-N-CA 123.898 0.879 . . . . 61.33 108.825 174.075 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.702 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 51.4 Cg_exo -59.74 126.41 20.44 Favored 'Trans proline' 0 C--N 1.372 1.77 0 C-N-CA 122.495 2.13 . . . . 74.53 114.014 175.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 128.05 -30.4 3.92 Favored Glycine 0 N--CA 1.47 0.93 0 CA-C-N 114.852 -1.067 . . . . 70.43 113.774 169.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 69.8 mtm -95.27 3.52 54.44 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 117.191 0.495 . . . . 64.15 111.699 -178.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.518 ' HA2' HD13 ' A' ' 174' ' ' LEU . . . -90.11 -98.32 1.13 Allowed Glycine 0 C--N 1.348 1.227 0 N-CA-C 110.856 -0.898 . . . . 73.33 110.856 175.346 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.739 ' HA3' ' H ' ' A' ' 117' ' ' ARG . . . -61.01 101.4 0.31 Allowed Glycine 0 C--O 1.265 2.089 0 N-CA-C 111.277 -0.729 . . . . 74.5 111.277 164.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.689 ' HB3' ' HA3' ' A' ' 108' ' ' GLY . 12.4 mm100 -64.93 105.87 1.12 Allowed 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 113.151 -1.525 . . . . 75.42 109.066 177.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 174.21 164.9 29.96 Favored Glycine 0 C--O 1.238 0.344 0 N-CA-C 110.393 -1.083 . . . . 64.21 110.393 -175.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ASN . . . . . 0.529 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . 40.1 t30 -60.8 -72.01 0.3 Allowed Pre-proline 0 CA--C 1.563 1.457 0 CA-C-O 116.657 -1.639 . . . . 63.11 112.116 -164.423 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.529 ' HD3' ' HB3' ' A' ' 169' ' ' ASN . 22.4 Cg_exo -65.65 115.75 3.56 Favored 'Trans proline' 0 C--N 1.389 2.71 0 CA-C-N 123.569 2.31 . . . . 71.13 109.854 171.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.63 ' HD3' HG12 ' A' ' 90' ' ' VAL . 8.7 Cg_exo -38.45 123.0 0.66 Allowed 'Trans proline' 0 C--N 1.375 1.965 1 C-N-CA 125.671 4.247 . . . . 71.25 117.42 -166.48 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -88.0 127.25 8.45 Favored Glycine 0 C--N 1.366 2.225 0 N-CA-C 111.112 -0.795 . . . . 72.4 111.112 164.042 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.702 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 4.9 m-20 -61.3 136.85 58.19 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.994 0.917 . . . . 71.14 111.792 -169.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.552 HD11 ' HB2' ' A' ' 121' ' ' ALA . 32.3 tp -113.7 126.93 55.79 Favored 'General case' 0 C--N 1.343 0.292 0 N-CA-C 109.786 -0.449 . . . . 64.32 109.786 173.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 83.7 mt -95.36 90.06 5.67 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.296 -0.865 . . . . 72.12 108.879 178.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.545 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 81.9 mt -70.07 88.51 0.6 Allowed 'General case' 0 C--N 1.354 0.799 0 N-CA-C 109.282 -0.636 . . . . 70.05 109.282 174.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 17.1 t -82.22 101.32 6.86 Favored 'Isoleucine or valine' 0 C--O 1.246 0.895 0 N-CA-C 105.54 -2.022 . . . . 61.43 105.54 175.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.708 HG21 HG11 ' A' ' 153' ' ' VAL . 6.0 p -71.2 136.38 25.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 115.217 -0.901 . . . . 70.33 111.01 -171.069 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.57 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 30.7 mmt180 -119.7 120.78 37.6 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.745 -1.576 . . . . 53.32 106.745 169.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 32.7 mt -74.82 147.2 41.39 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 109.062 -0.718 . . . . 72.4 109.062 171.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.421 ' HA ' ' HD3' ' A' ' 182' ' ' PRO . 18.5 mt -53.73 150.46 13.65 Favored Pre-proline 0 N--CA 1.484 1.241 0 C-N-CA 123.662 0.785 . . . . 73.14 112.936 -167.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 181' ' ' LEU . 24.2 Cg_exo -66.95 8.8 0.31 Allowed 'Trans proline' 0 C--N 1.387 2.558 0 C-N-CA 124.312 3.342 . . . . 71.42 113.921 176.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -60.65 103.11 0.34 Allowed Pre-proline 0 CA--C 1.562 1.423 0 C-N-CA 125.377 1.471 . . . . 73.35 107.938 165.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -80.86 26.17 0.61 Allowed 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 123.636 2.89 . . . . 61.24 115.471 -162.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.413 HG12 ' HD1' ' A' ' 186' ' ' PHE . 77.3 t -96.08 -58.94 3.44 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.908 0 CA-C-O 118.644 -0.693 . . . . 64.21 111.15 -173.183 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' PHE . . . . . 0.413 ' HD1' HG12 ' A' ' 185' ' ' VAL . 4.0 m-85 -139.41 91.77 2.52 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 119.191 0.905 . . . . 72.31 110.575 -177.026 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.453 ' NH1' ' HG2' ' A' ' 155' ' ' GLU . 44.8 ttp85 -101.26 103.8 14.82 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.073 0.949 . . . . 75.51 109.526 178.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.433 HD23 ' O ' ' A' ' 153' ' ' VAL . 51.2 tp -71.02 141.47 50.95 Favored 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 124.103 0.961 . . . . 74.21 111.218 179.225 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' GLU . . . . . 0.417 ' HG3' ' HB3' ' A' ' 155' ' ' GLU . 34.2 tt0 -151.8 126.1 9.33 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.822 1.249 . . . . 70.31 109.825 -175.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 70.15 -81.93 0.35 Allowed Glycine 0 C--N 1.352 1.424 0 N-CA-C 111.625 -0.59 . . . . 65.41 111.625 -176.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -147.88 -10.08 0.4 Allowed 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 125.349 1.46 . . . . 72.32 109.882 166.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -101.06 148.31 25.2 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.325 1.05 . . . . 72.32 111.205 -176.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 14.4 mt -90.92 159.89 15.96 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.26 1.024 . . . . 63.44 110.782 -176.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.505 ' HA ' ' HB2' ' A' ' 250' ' ' TYR . 41.8 m-85 -126.95 110.46 13.02 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.375 1.07 . . . . 73.14 108.919 173.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.527 ' HB3' HD23 ' A' ' 251' ' ' LEU . . . -125.88 166.95 15.95 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.217 1.007 . . . . 74.34 110.796 -178.197 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 24.5 m -112.9 147.42 37.08 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 108.493 -0.928 . . . . 70.21 108.493 171.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.559 HD22 HD13 ' A' ' 251' ' ' LEU . 50.8 tp -139.55 113.37 8.64 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.423 0.689 . . . . 72.21 109.51 -173.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -89.03 124.76 34.59 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 108.402 -0.962 . . . . 61.43 108.402 174.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.9 p -140.47 131.3 13.85 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 124.276 1.031 . . . . 64.4 108.966 -174.155 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -72.74 150.24 49.85 Favored 'Trans proline' 0 C--N 1.379 2.139 0 C-N-CA 121.554 1.503 . . . . 64.51 110.973 173.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -50.94 -46.93 87.73 Favored Pre-proline 0 CA--C 1.558 1.278 0 N-CA-C 114.654 1.353 . . . . 71.34 114.654 -173.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -52.85 -46.58 32.7 Favored 'Trans proline' 0 C--N 1.383 2.394 0 C-N-CA 121.895 1.73 . . . . 63.54 113.754 176.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.41 HG23 ' HE1' ' C' ' 277' ' ' TYR . 20.3 mt -72.54 -30.28 33.65 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 CA-C-N 115.68 -0.691 . . . . 64.32 110.403 -176.452 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.3 -42.66 75.13 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.205 0.602 . . . . 71.51 111.909 175.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 50.1 t -71.47 -48.62 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 123.903 0.881 . . . . 63.23 111.847 -176.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 53.2 t -87.49 -34.38 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-N 115.731 -0.668 . . . . 74.41 111.472 -173.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 85.21 113.88 0.74 Allowed Glycine 0 C--N 1.337 0.637 0 N-CA-C 111.989 -0.445 . . . . 72.35 111.989 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.44 ' HA3' ' CE1' ' C' ' 277' ' ' TYR . . . -149.7 -136.52 2.62 Favored Glycine 0 C--O 1.219 -0.805 0 CA-C-O 119.386 -0.675 . . . . 55.24 111.747 -178.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? -114.92 129.98 56.82 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 117.684 0.742 . . . . 45.21 110.444 -177.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.461 HG21 HD21 ' A' ' 197' ' ' LEU . 7.1 m -128.31 157.72 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.711 1.205 . . . . 63.11 108.489 171.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 211' ' ' ARG . . . . . 0.506 HH11 ' HG2' ' A' ' 220' ' ' GLU . 7.6 tpp180 -87.98 122.09 31.17 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 109.307 -0.627 . . . . 71.41 109.307 -175.3 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -99.69 110.98 23.36 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.943 -0.762 . . . . 62.04 108.943 176.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 17.0 tpt -82.37 116.48 21.88 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.701 -0.852 . . . . 71.23 108.701 177.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 19.7 p -108.23 -172.29 2.03 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.024 0.53 . . . . 74.1 109.583 -176.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 81.3 mt -67.15 -26.14 66.51 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.861 0.864 . . . . 63.31 112.372 -176.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -105.26 -19.19 13.88 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.15 0.58 . . . . 64.44 111.989 -175.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 152.68 -178.83 29.61 Favored Glycine 0 C--N 1.343 0.933 0 CA-C-O 119.92 -0.378 . . . . 33.0 112.426 -177.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -82.85 149.86 14.12 Favored 'Trans proline' 0 CA--C 1.552 1.423 0 C-N-CA 122.749 2.3 . . . . 70.23 113.545 -176.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 27.9 m -136.22 -178.81 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 125.657 1.583 . . . . 73.4 108.008 172.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.506 ' HG2' HH11 ' A' ' 211' ' ' ARG . 50.2 mt-10 -107.2 131.2 54.43 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 109.483 -0.562 . . . . 75.04 109.483 168.089 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 7.0 m -111.65 128.82 67.95 Favored 'Isoleucine or valine' 0 C--O 1.243 0.738 0 N-CA-C 108.242 -1.022 . . . . 74.13 108.242 167.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -78.23 99.2 6.16 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 109.001 -0.74 . . . . 60.25 109.001 177.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 14.8 p -67.64 137.53 93.09 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 124.066 0.947 . . . . 63.14 109.276 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -76.3 170.86 19.18 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 122.242 1.961 . . . . 75.51 110.958 -177.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.75 161.17 45.96 Favored 'Trans proline' 0 C--N 1.371 1.728 0 C-N-CA 121.378 1.385 . . . . 72.53 112.226 172.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 57.7 mtt-85 64.4 24.19 13.15 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 125.188 1.395 . . . . 74.04 112.02 168.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.537 HG23 HD21 ' A' ' 233' ' ' LEU . 98.6 m -68.27 102.38 1.37 Allowed 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 125.238 1.415 . . . . 64.32 111.162 -178.395 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -87.72 139.16 30.81 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.981 1.312 . . . . 75.32 110.88 -176.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' ALA . . . . . 0.458 ' HA ' ' HB ' ' A' ' 253' ' ' VAL . . . -68.13 156.98 36.33 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.405 0.682 . . . . 62.31 112.197 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 84.42 -19.08 20.66 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-N 115.886 -0.597 . . . . 73.32 112.929 -179.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -90.92 160.96 15.4 Favored 'General case' 0 C--N 1.351 0.672 0 C-N-CA 123.762 0.825 . . . . 74.0 110.654 178.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -115.95 114.44 24.63 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.193 0.997 . . . . 72.22 108.615 -177.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.537 HD21 HG23 ' A' ' 227' ' ' THR . 84.9 mt -75.71 118.67 18.78 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.817 0.847 . . . . 71.4 110.64 -177.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 27.2 ttm-85 -90.48 103.13 15.85 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 109.492 -0.559 . . . . 64.14 109.492 172.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.602 HD12 ' HG3' ' A' ' 238' ' ' LYS . 0.1 OUTLIER -97.17 123.54 40.97 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.477 0.711 . . . . 61.12 109.174 173.968 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -69.98 132.09 45.4 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 114.592 -1.185 . . . . 64.43 113.48 -169.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 79.44 3.3 88.67 Favored Glycine 0 C--N 1.354 1.575 0 CA-C-N 115.774 -0.648 . . . . 74.2 114.433 171.108 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.602 ' HG3' HD12 ' A' ' 235' ' ' LEU . 0.0 OUTLIER -90.38 -7.26 53.66 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 112.536 0.569 . . . . 73.01 112.536 -172.406 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -85.91 -166.07 41.6 Favored Glycine 0 C--N 1.351 1.399 0 C-N-CA 123.101 0.382 . . . . 74.43 113.791 175.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -89.64 147.95 38.96 Favored Pre-proline 0 N--CA 1.485 1.308 0 C-N-CA 123.375 0.67 . . . . 73.13 111.429 -171.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -66.3 146.75 81.87 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 123.576 2.851 . . . . 73.33 113.28 174.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -177.87 -155.3 13.79 Favored Glycine 0 CA--C 1.534 1.278 0 CA-C-O 118.969 -0.906 . . . . 73.52 112.138 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -64.49 -33.52 56.8 Favored 'Trans proline' 0 C--N 1.385 2.472 0 C-N-CA 123.746 2.964 . . . . 70.45 113.522 -176.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -89.96 21.03 3.84 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.136 0.574 . . . . 70.11 111.165 176.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 72.38 -152.14 47.69 Favored Glycine 0 C--N 1.35 1.346 0 N-CA-C 110.803 -0.919 . . . . 62.24 110.803 -169.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 27.4 mtp180 -76.29 137.43 39.89 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 109.608 -0.516 . . . . 75.41 109.608 170.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -80.39 -161.5 24.8 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 112.155 -0.378 . . . . 42.24 112.155 173.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -110.92 -174.38 2.46 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 123.734 0.814 . . . . 75.44 110.138 -178.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.526 ' HB3' ' HG ' ' A' ' 235' ' ' LEU . 18.6 tp -127.68 133.22 49.6 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.381 -0.97 . . . . 70.31 108.381 175.066 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.505 ' HB2' ' HA ' ' A' ' 194' ' ' TYR . 3.1 m-85 -96.55 126.34 41.67 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 108.611 -0.885 . . . . 52.51 108.611 173.055 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.559 HD13 HD22 ' A' ' 197' ' ' LEU . 88.7 mt -115.52 108.66 16.74 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.691 -0.855 . . . . 72.24 108.691 172.051 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -76.65 115.87 16.8 Favored 'General case' 0 C--N 1.348 0.529 0 N-CA-C 106.817 -1.549 . . . . 75.41 106.817 -176.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.458 ' HB ' ' HA ' ' A' ' 229' ' ' ALA . 22.7 t -76.25 116.06 18.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 CA-C-N 115.548 -0.751 . . . . 24.43 110.68 -169.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -119.15 91.68 3.61 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 107.091 -1.448 . . . . 73.14 107.091 178.403 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.406 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 62.5 mt -81.23 129.89 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 116.469 -0.332 . . . . 74.34 110.292 -176.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 32.3 p -120.28 173.22 7.26 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.645 1.178 . . . . 73.43 109.618 173.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 257' ' ' ILE . . . . . 0.449 HD12 ' H ' ' A' ' 259' ' ' GLU . 2.1 pp -125.14 155.03 71.64 Favored Pre-proline 0 CA--C 1.562 1.433 0 N-CA-C 107.888 -1.152 . . . . 73.4 107.888 173.593 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 258' ' ' PRO . . . . . 0.499 ' HG3' ' OH ' ' C' ' 276' ' ' TYR . 37.9 Cg_endo -78.51 18.6 0.94 Allowed 'Trans proline' 0 N--CA 1.512 2.568 0 C-N-CA 123.382 2.721 . . . . 74.45 115.64 -164.145 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 259' ' ' GLU . . . . . 0.449 ' H ' HD12 ' A' ' 257' ' ' ILE . 5.9 mm-40 51.67 -122.91 2.06 Favored 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 124.015 0.926 . . . . 63.24 111.959 -169.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 260' ' ' ARG . . . . . 0.515 ' H ' ' HD3' ' A' ' 260' ' ' ARG . 0.0 OUTLIER -67.34 149.54 50.19 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 118.679 0.672 . . . . 75.12 111.743 -169.162 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 69.8 mt -120.77 160.67 22.89 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.596 0.758 . . . . 55.32 111.657 -171.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 27.5 p -90.56 148.34 38.47 Favored Pre-proline 0 CA--C 1.556 1.183 0 CA-C-O 117.782 -1.104 . . . . 44.34 108.92 170.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 263' ' ' PRO . . . . . 0.514 ' O ' ' HB3' ' A' ' 266' ' ' GLU . 31.5 Cg_exo -35.23 -54.0 0.7 Allowed 'Trans proline' 0 C--N 1.394 2.932 1 C-N-CA 125.418 4.079 . . . . 74.33 117.298 -167.453 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -77.87 -38.29 46.31 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 121.962 -0.461 . . . . 71.44 111.439 -176.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -64.91 -26.54 68.36 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 122.912 0.485 . . . . 64.2 110.623 173.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 266' ' ' GLU . . . . . 0.514 ' HB3' ' O ' ' A' ' 263' ' ' PRO . 7.9 tp10 -63.14 -58.35 7.51 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 108.353 -0.98 . . . . 73.45 108.353 172.216 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -66.31 -18.31 65.28 Favored 'General case' 0 CA--C 1.553 1.086 0 CA-C-N 115.321 -0.854 . . . . 64.12 112.871 177.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 41.5 tp -78.27 -47.0 18.83 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.691 0.797 . . . . 73.14 110.412 -177.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 68.6 m95 -63.08 -38.13 89.95 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.478 -0.783 . . . . 75.0 110.495 173.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 270' ' ' LYS . . . . . 0.5 ' HG3' HG23 ' C' ' 206' ' ' VAL . 0.9 OUTLIER -63.45 -44.07 95.57 Favored 'General case' 0 CA--C 1.557 1.216 0 O-C-N 123.672 0.607 . . . . 62.43 111.778 175.311 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 29.8 mtmm -57.18 -49.89 74.56 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 123.124 0.57 . . . . 70.22 110.664 175.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 24.7 mt -51.73 -51.0 59.49 Favored 'General case' 0 C--O 1.216 -0.7 0 O-C-N 124.596 1.185 . . . . 63.4 110.862 175.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -68.19 -38.42 81.96 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 113.935 1.087 . . . . 64.51 113.935 -169.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -76.96 -42.79 37.68 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 123.467 0.48 . . . . 74.35 110.154 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 275' ' ' ALA . . . . . 0.414 ' HB1' ' NH2' ' A' ' 279' ' ' ARG . . . -66.02 -30.1 70.58 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.82 -0.627 . . . . 71.44 110.899 175.018 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -67.71 -60.17 2.74 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.377 1.071 . . . . 75.02 109.636 177.063 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -60.35 -41.72 94.23 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.345 1.058 . . . . 70.12 111.017 -172.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -60.89 -20.59 62.21 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.337 0.655 . . . . 75.41 112.705 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 279' ' ' ARG . . . . . 0.414 ' NH2' ' HB1' ' A' ' 275' ' ' ALA . 87.6 mtm180 -128.99 18.37 6.09 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.8 0.84 . . . . 74.13 111.005 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.022 0 CA-C-O 118.412 -0.804 . . . . 72.21 110.754 -175.734 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.404 ' SD ' ' N ' ' B' ' 1' ' ' MET . 1.0 OUTLIER . . . . . 0 N--CA 1.482 1.171 0 N-CA-C 108.775 -0.824 . . . . 71.44 108.775 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 2' ' ' LYS . . . . . 0.577 ' HA ' ' HE3' ' B' ' 2' ' ' LYS . 0.4 OUTLIER -70.77 90.03 0.77 Allowed 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 109.425 -0.583 . . . . 54.1 109.425 179.238 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 23.9 tm0? -113.11 160.36 18.27 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.253 1.021 . . . . 74.04 108.95 -173.118 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 4' ' ' SER . . . . . 0.463 ' H ' HG21 ' A' ' 126' ' ' THR . 80.7 p 59.25 -80.45 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 126.785 2.034 . . . . 52.14 111.655 -177.309 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 6.4 m -76.65 153.88 34.81 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 109.01 -0.737 . . . . 70.11 109.01 172.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.564 HG21 ' HA ' ' A' ' 125' ' ' LEU . 31.7 pt -128.74 173.76 13.14 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 CA-C-O 121.033 0.444 . . . . 64.44 111.207 -174.215 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -146.54 127.66 14.69 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.395 -0.821 . . . . 72.01 109.458 -177.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 8' ' ' LEU . . . . . 0.549 HD21 HD21 ' A' ' 174' ' ' LEU . 38.3 tp -73.1 150.73 42.02 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.419 0.688 . . . . 75.22 111.049 -176.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.68 -60.37 2.38 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 122.873 0.469 . . . . 62.4 111.027 176.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 67.3 mt 62.17 127.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 124.584 1.153 . . . . 74.1 110.114 -163.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 24.6 mt . . . . . 0 CA--C 1.561 1.383 0 O-C-N 121.706 -0.621 . . . . 45.35 110.318 178.389 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.638 0 N-CA-C 110.41 -0.218 . . . . 61.34 110.41 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.89 -39.57 93.74 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.449 0.699 . . . . 74.4 110.676 176.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 181' ' ' LEU . . . . . 0.459 HD21 HD11 ' C' ' 149' ' ' ILE . 14.8 tp -163.08 27.85 0.09 Allowed 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 114.769 -1.105 . . . . 62.04 108.341 176.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 182' ' ' VAL . . . . . 0.7 HG22 ' HA ' ' C' ' 138' ' ' VAL . 53.9 t -80.58 113.78 20.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 115.768 -0.651 . . . . 71.31 110.892 -171.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -90.21 -40.58 12.1 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.507 -0.769 . . . . 65.24 110.231 170.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 52.65 35.86 19.36 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 124.813 1.245 . . . . 74.15 111.599 175.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 185' ' ' VAL . . . . . . . . . . . . . 48.9 t . . . . . 0 N--CA 1.483 1.178 0 C-N-CA 124.755 1.222 . . . . 71.33 110.326 -170.436 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 94.0 m . . . . . 0 N--CA 1.485 1.31 0 CA-C-O 123.722 1.725 . . . . 71.31 106.642 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 239' ' ' ALA . . . . . 0.611 ' HB2' ' H ' ' C' ' 222' ' ' ALA . . . -100.31 -178.73 3.91 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.171 -1.377 . . . . 74.42 112.592 -167.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 240' ' ' GLY . . . . . 0.414 ' HA3' ' HA ' ' C' ' 235' ' ' LEU . . . -107.34 -140.08 9.43 Favored Glycine 0 C--N 1.343 0.938 0 CA-C-N 114.589 -1.187 . . . . 71.23 110.629 176.663 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -133.95 147.93 51.11 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.403 0.681 . . . . 71.21 111.571 -170.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -167.95 -44.21 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.018 1.327 . . . . 70.32 109.193 176.015 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 243' ' ' GLN . . . . . 0.812 ' HG3' ' HG2' ' C' ' 224' ' ' PRO . 6.7 pt20 -159.45 164.1 34.82 Favored 'General case' 0 C--O 1.245 0.82 0 C-N-CA 123.969 0.908 . . . . 74.22 111.17 177.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -67.1 98.15 0.42 Allowed Glycine 0 C--N 1.355 1.633 0 O-C-N 124.179 0.924 . . . . 63.11 113.567 -169.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 245' ' ' LYS . . . . . 0.519 ' HE2' ' HB1' ' C' ' 222' ' ' ALA . 9.2 tmtm? . . . . . 0 N--CA 1.47 0.545 0 C-N-CA 123.589 0.756 . . . . 75.34 110.009 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.97 0 N-CA-C 110.542 -0.17 . . . . 52.01 110.542 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -38.3 110.38 0.13 Allowed 'General case' 0 C--N 1.363 1.183 0 C-N-CA 125.362 1.465 . . . . 70.52 114.698 -172.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 5' ' ' LYS . . . . . 0.722 ' HD2' HD11 ' C' ' 10' ' ' ILE . 23.2 mmtp -82.57 99.81 9.75 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 115.479 -0.782 . . . . 63.2 109.822 170.055 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -75.04 89.58 2.44 Favored 'General case' 0 C--O 1.246 0.875 0 N-CA-C 107.092 -1.447 . . . . 63.22 107.092 169.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 7' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -61.1 -28.36 69.03 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 114.917 -1.038 . . . . 73.43 112.145 -170.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 8' ' ' TYR . . . . . 0.421 ' HD1' HG23 ' C' ' 13' ' ' VAL . 64.1 m-85 -72.62 -41.44 65.54 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.356 0.662 . . . . 72.53 111.548 177.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.84 -43.05 99.62 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 123.386 0.429 . . . . 52.31 110.497 175.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 10' ' ' ILE . . . . . 0.722 HD11 ' HD2' ' C' ' 5' ' ' LYS . 73.1 mt -59.06 -44.55 91.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 O-C-N 123.956 0.785 . . . . 63.34 110.619 176.107 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 85.1 mt -78.69 -3.33 43.58 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 112.896 0.702 . . . . 45.45 112.896 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 61.29 39.79 97.71 Favored Glycine 0 C--N 1.356 1.655 0 O-C-N 123.302 0.376 . . . . 64.33 113.438 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 13' ' ' VAL . . . . . 0.421 HG23 ' HD1' ' C' ' 8' ' ' TYR . 11.8 m -135.69 158.49 74.09 Favored Pre-proline 0 N--CA 1.48 1.057 0 C-N-CA 125.084 1.354 . . . . 64.04 109.075 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.29 163.66 38.38 Favored 'Trans proline' 0 C--N 1.377 2.071 0 C-N-CA 122.125 1.884 . . . . 74.43 112.49 178.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 58.1 mtt180 -77.81 21.96 0.29 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.004 0.921 . . . . 71.52 111.876 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -117.33 -14.16 10.41 Favored 'General case' 0 C--O 1.243 0.749 0 C-N-CA 125.951 1.7 . . . . 71.24 108.37 178.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.15 114.97 1.34 Allowed 'General case' 0 C--N 1.356 0.879 0 C-N-CA 124.214 1.006 . . . . 71.14 110.538 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 54.4 p -74.21 167.02 22.43 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.596 0.758 . . . . 74.41 109.092 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -50.91 -40.68 57.44 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 124.014 0.926 . . . . 74.45 111.187 -173.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 20' ' ' GLU . . . . . 0.677 ' HA ' ' HE3' ' C' ' 23' ' ' LYS . 3.7 tm-20 -66.04 -40.79 91.27 Favored 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 124.467 1.107 . . . . 64.05 110.685 -178.124 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 21' ' ' GLU . . . . . 0.515 ' HG2' ' NH2' ' C' ' 24' ' ' ARG . 32.7 mt-10 -72.26 -34.44 68.24 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 115.651 -0.704 . . . . 73.42 111.258 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 22' ' ' ILE . . . . . 0.903 HD13 ' HB3' ' C' ' 57' ' ' LEU . 96.1 mt -68.61 -38.98 79.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 124.785 1.234 . . . . 61.32 110.16 176.283 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 23' ' ' LYS . . . . . 0.677 ' HE3' ' HA ' ' C' ' 20' ' ' GLU . 22.2 ttpp -62.98 -35.88 81.64 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 113.896 -1.502 . . . . 74.13 110.063 177.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 24' ' ' ARG . . . . . 0.515 ' NH2' ' HG2' ' C' ' 21' ' ' GLU . 45.6 mtm180 -77.35 -30.07 53.68 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 113.235 0.828 . . . . 73.52 113.235 173.052 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.03 -37.38 86.97 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 121.617 0.723 . . . . 75.32 109.918 171.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 26' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -68.52 -41.93 79.24 Favored 'General case' 0 C--O 1.209 -1.051 0 CA-C-N 113.869 -1.514 . . . . 72.31 110.474 175.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 27' ' ' LYS . . . . . 0.451 ' HD3' ' HG2' ' C' ' 24' ' ' ARG . 27.5 mtpp -50.89 -56.23 13.29 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 118.369 0.531 . . . . 74.1 110.385 173.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -55.61 -58.88 5.95 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 114.944 -1.026 . . . . 71.15 112.138 -177.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 87.1 mt -83.21 -21.28 33.48 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 112.894 0.702 . . . . 60.22 112.894 -169.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 30' ' ' ALA . . . . . 0.478 ' O ' ' HB2' ' C' ' 34' ' ' HIS . . . -78.97 -30.54 44.5 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 118.809 0.732 . . . . 75.32 110.406 176.374 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 65.1 mtm180 -73.59 -45.54 52.6 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 109.997 -0.371 . . . . 73.5 109.997 170.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.63 -46.61 84.89 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.617 0.767 . . . . 71.12 111.023 -174.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 33' ' ' TYR . . . . . 0.5 ' HD1' ' HB1' ' C' ' 43' ' ' ALA . 52.7 m-85 -90.76 4.72 50.84 Favored 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 123.466 0.706 . . . . 70.15 112.071 -178.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 34' ' ' HIS . . . . . 0.478 ' HB2' ' O ' ' C' ' 30' ' ' ALA . 54.4 t-80 -60.64 113.35 7.4 Favored Pre-proline 0 N--CA 1.49 1.551 0 CA-C-O 118.206 -0.902 . . . . 72.34 110.959 -177.089 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -48.47 -36.65 31.61 Favored 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 124.283 3.322 . . . . 71.32 115.287 -171.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -69.99 -41.35 74.52 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 122.688 0.395 . . . . 60.34 111.324 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 45.3 t -85.03 -28.71 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-O 121.036 0.446 . . . . 75.33 110.123 -175.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -139.0 80.22 1.77 Allowed 'General case' 0 C--O 1.248 0.981 0 C-N-CA 124.204 1.002 . . . . 54.22 108.83 -174.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -70.31 84.8 0.57 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 114.778 -1.101 . . . . 62.24 109.402 176.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 40' ' ' SER . . . . . 0.576 ' HB2' ' HB3' ' C' ' 43' ' ' ALA . 16.4 m -138.68 103.75 7.65 Favored Pre-proline 0 CA--C 1.542 0.655 0 CA-C-O 117.836 -1.078 . . . . 74.14 108.117 175.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 41' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' C' ' 40' ' ' SER . 5.3 Cg_exo -37.33 -54.23 1.19 Allowed 'Trans proline' 0 C--N 1.393 2.874 0 C-N-CA 124.702 3.601 . . . . 63.44 114.183 -176.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.56 -36.49 83.96 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.973 0.509 . . . . 65.44 110.698 -177.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 43' ' ' ALA . . . . . 0.576 ' HB3' ' HB2' ' C' ' 40' ' ' SER . . . -75.17 -17.51 60.37 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.168 0.587 . . . . 62.05 111.313 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -86.2 -31.93 21.48 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.333 0.653 . . . . 74.04 109.491 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -70.1 -41.74 73.63 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.57 -0.741 . . . . 42.53 109.502 170.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 46' ' ' LYS . . . . . 0.538 ' O ' HG12 ' C' ' 50' ' ' ILE . 33.6 mmtm -63.32 -36.3 83.24 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-N 115.201 -0.908 . . . . 72.32 110.468 173.032 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -57.2 -49.0 77.38 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.604 0.762 . . . . 62.23 109.337 174.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 48' ' ' LYS . . . . . 0.551 ' HB3' ' HE1' ' C' ' 93' ' ' PHE . 52.0 mtpt -57.87 -38.23 75.36 Favored 'General case' 0 CA--C 1.551 1.009 0 O-C-N 123.762 0.663 . . . . 72.04 111.631 175.478 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -76.31 -19.39 58.29 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.203 0.601 . . . . 72.33 112.267 178.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 50' ' ' ILE . . . . . 0.538 HG12 ' O ' ' C' ' 46' ' ' LYS . 28.4 mm -76.0 -38.96 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 108.474 -0.936 . . . . 75.43 108.474 171.383 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 51' ' ' ASN . . . . . 0.467 ' HB3' ' CD1' ' C' ' 88' ' ' PHE . 55.7 m-80 -68.42 -30.76 69.73 Favored 'General case' 0 C--O 1.217 -0.645 0 CA-C-N 114.474 -1.239 . . . . 74.04 110.736 176.009 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -68.51 -55.15 12.69 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.845 1.258 . . . . 63.42 110.528 175.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.26 -50.41 69.55 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 114.035 -1.438 . . . . 63.1 111.162 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -63.56 -39.41 94.33 Favored 'General case' 0 C--O 1.198 -1.638 0 CA-C-N 115.023 -0.99 . . . . 75.01 110.775 176.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 55' ' ' ALA . . . . . 0.484 ' HB2' ' CD2' ' C' ' 88' ' ' PHE . . . -56.31 -45.04 80.43 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 118.531 0.605 . . . . 60.54 112.255 -178.082 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 56' ' ' VAL . . . . . 0.443 ' O ' ' HB2' ' C' ' 62' ' ' LYS . 96.1 t -65.7 -46.42 89.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 CA-C-O 121.752 0.786 . . . . 72.43 109.826 173.479 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 57' ' ' LEU . . . . . 0.903 ' HB3' HD13 ' C' ' 22' ' ' ILE . 81.6 mt -92.37 9.54 33.7 Favored 'General case' 0 CA--C 1.56 1.344 0 N-CA-C 113.365 0.876 . . . . 75.02 113.365 -169.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 21.9 t -86.16 -24.15 26.27 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.54 0.736 . . . . 62.42 110.491 179.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -101.61 131.54 22.82 Favored Pre-proline 0 C--O 1.241 0.633 0 N-CA-C 108.336 -0.987 . . . . 72.03 108.336 174.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 60' ' ' PRO . . . . . 0.494 ' O ' ' HG2' ' C' ' 64' ' ' ARG . 73.7 Cg_exo -53.48 -32.51 63.39 Favored 'Trans proline' 0 C--N 1.375 1.934 0 C-N-CA 122.833 2.356 . . . . 33.23 111.444 164.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -68.09 -49.44 61.26 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.078 0.951 . . . . 62.13 111.561 -177.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 62' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' C' ' 56' ' ' VAL . 62.1 mttp -73.27 -23.98 60.38 Favored 'General case' 0 CA--C 1.559 1.302 0 C-N-CA 122.386 0.274 . . . . 75.23 110.751 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 -61.38 -43.3 99.1 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 109.39 -0.596 . . . . 64.42 109.39 167.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 64' ' ' ARG . . . . . 0.494 ' HG2' ' O ' ' C' ' 60' ' ' PRO . 28.5 mmm180 -68.72 -32.07 71.6 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 119.272 -0.394 . . . . 74.15 111.56 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 65' ' ' ILE . . . . . 0.442 HG23 ' HD2' ' C' ' 76' ' ' PRO . 80.1 mt -62.29 -42.19 94.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 N-CA-C 109.716 -0.475 . . . . 62.34 109.716 171.169 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -63.25 -44.86 93.99 Favored 'General case' 0 CA--C 1.553 1.079 0 CA-C-N 115.573 -0.739 . . . . 74.22 109.756 176.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -58.11 -42.13 85.06 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.184 0.994 . . . . 73.14 111.064 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 68' ' ' THR . . . . . 0.425 ' OG1' ' HG2' ' C' ' 76' ' ' PRO . 39.9 p -83.93 -10.31 58.05 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.602 -0.726 . . . . 63.2 112.013 -178.126 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -71.81 96.7 1.68 Allowed 'General case' 0 C--N 1.36 1.037 0 N-CA-C 108.197 -1.038 . . . . 75.22 108.197 171.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 104.34 30.98 4.81 Favored Glycine 0 C--N 1.346 1.104 0 CA-C-N 116.075 -0.511 . . . . 62.51 111.94 -173.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 84.9 m -146.78 -54.16 0.24 Allowed 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 103.877 -2.638 . . . . 72.34 103.877 174.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 24.7 m -86.24 141.71 29.09 Favored 'General case' 0 C--O 1.256 1.406 0 N-CA-C 104.811 -2.292 . . . . 73.35 104.811 157.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.15 -27.62 20.58 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 123.752 0.821 . . . . 73.23 111.612 -177.389 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -97.24 155.77 37.03 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 123.911 0.884 . . . . 53.23 109.806 176.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_exo -60.12 114.74 2.23 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 122.65 2.234 . . . . 75.14 111.079 168.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 76' ' ' PRO . . . . . 0.442 ' HD2' HG23 ' C' ' 65' ' ' ILE . 50.0 Cg_exo -55.97 122.74 12.3 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 123.091 2.527 . . . . 63.14 111.596 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -43.63 139.85 4.74 Favored 'Trans proline' 0 C--N 1.39 2.725 0 C-N-CA 124.31 3.34 . . . . 51.51 114.849 -166.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 78' ' ' PRO . . . . . 0.494 ' HB2' ' HA2' ' C' ' 82' ' ' GLY . 25.9 Cg_endo -58.86 145.25 97.42 Favored 'Trans proline' 0 C--N 1.387 2.564 0 C-N-CA 123.483 2.788 . . . . 74.44 113.743 -172.245 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 79' ' ' PRO . . . . . 0.595 ' HB2' ' HA2' ' C' ' 142' ' ' GLY . 51.0 Cg_exo -55.93 163.24 6.03 Favored 'Trans proline' 0 C--N 1.385 2.458 0 C-N-CA 123.559 2.84 . . . . 61.04 112.923 176.311 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -55.12 87.07 0.04 OUTLIER 'Trans proline' 0 C--N 1.392 2.832 0 C-N-CA 123.569 2.846 . . . . 51.5 112.855 -177.044 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 145.65 -52.19 0.58 Allowed Glycine 0 C--N 1.339 0.742 0 CA-C-N 113.829 -1.532 . . . . 75.2 109.443 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.494 ' HA2' ' HB2' ' C' ' 78' ' ' PRO . . . 144.34 -170.84 25.95 Favored Glycine 0 C--N 1.344 0.998 0 C-N-CA 123.526 0.584 . . . . 74.45 111.653 -177.614 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -86.93 104.18 16.01 Favored 'General case' 0 C--O 1.244 0.806 0 C-N-CA 123.653 0.781 . . . . 70.14 109.273 171.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -86.55 -176.21 5.75 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.384 -0.598 . . . . 63.13 109.384 170.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 85' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -161.1 70.98 0.39 Allowed 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 107.507 -1.294 . . . . 74.41 107.507 177.196 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 55.0 m -36.78 95.18 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 117.875 2.546 . . . . 45.43 117.875 -164.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 75.55 6.68 81.65 Favored Glycine 0 C--N 1.355 1.608 0 C-N-CA 123.044 0.354 . . . . 74.33 113.292 174.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 88' ' ' PHE . . . . . 0.484 ' CD2' ' HB2' ' C' ' 55' ' ' ALA . 11.9 m-85 -105.59 131.13 53.35 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 107.489 -1.3 . . . . 74.44 107.489 -177.202 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -80.99 81.97 7.09 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 120.966 0.412 . . . . 72.23 111.337 -170.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 90' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -43.58 -36.14 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 C-N-CA 125.405 1.482 . . . . 54.41 112.74 171.26 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -62.66 -20.09 64.47 Favored 'General case' 0 CA--C 1.561 1.394 0 C-N-CA 124.352 1.061 . . . . 74.21 112.884 -175.052 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -119.82 7.37 10.97 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 122.865 0.466 . . . . 75.53 111.008 178.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 93' ' ' PHE . . . . . 0.551 ' HE1' ' HB3' ' C' ' 48' ' ' LYS . 13.9 m-30 -83.9 -174.28 5.19 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.129 -0.982 . . . . 72.45 112.114 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 97.6 p -71.3 161.8 30.48 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.839 1.052 . . . . 45.51 113.839 -167.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -59.44 -56.34 23.25 Favored 'General case' 0 C--O 1.215 -0.745 0 CA-C-N 114.249 -1.342 . . . . 55.43 110.837 174.291 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -51.03 -46.56 61.63 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 124.169 0.918 . . . . 65.02 111.867 -174.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 97' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -58.98 -53.44 58.39 Favored 'General case' 0 CA--C 1.554 1.13 0 CA-C-N 115.406 -0.816 . . . . 64.25 110.158 174.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -74.18 0.84 12.75 Favored 'General case' 0 CA--C 1.56 1.339 0 N-CA-C 112.611 0.597 . . . . 51.52 112.611 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -98.27 -50.74 4.23 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.984 0.914 . . . . 74.43 110.393 172.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 31.3 tp -71.07 -52.83 17.17 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.892 0.877 . . . . 73.23 110.463 -177.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 101' ' ' PHE . . . . . 0.477 ' O ' ' HG ' ' C' ' 105' ' ' LEU . 87.4 m-85 -86.22 -10.02 55.43 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.435 -0.802 . . . . 73.25 110.781 179.148 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -43.04 -55.73 4.79 Favored Glycine 0 CA--C 1.545 1.924 0 CA-C-O 118.479 -1.178 . . . . 54.11 115.026 176.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -37.6 -35.61 0.33 Allowed 'Trans proline' 0 C--N 1.392 2.837 0 C-N-CA 125.136 3.891 . . . . 62.02 116.279 175.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -130.9 24.59 4.27 Favored Glycine 0 C--N 1.349 1.276 0 CA-C-O 118.798 -1.001 . . . . 43.23 113.837 -174.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 105' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' C' ' 101' ' ' PHE . 38.1 mt . . . . . 0 N--CA 1.489 1.521 0 CA-C-N 118.038 0.919 . . . . 73.03 111.72 173.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 116' ' ' GLY . . . . . 0.436 ' HA2' ' HA3' ' C' ' 168' ' ' GLY . . . . . . . . 0 CA--C 1.524 0.611 0 N-CA-C 113.963 0.345 . . . . 45.25 113.963 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 117' ' ' ARG . . . . . 0.44 ' HG2' ' H ' ' C' ' 118' ' ' ASP . 56.1 ttt-85 -80.3 175.06 10.99 Favored 'General case' 0 C--O 1.252 1.214 0 C-N-CA 123.615 0.766 . . . . 64.44 109.684 174.45 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 118' ' ' ASP . . . . . 0.44 ' H ' ' HG2' ' C' ' 117' ' ' ARG . 3.6 p30 -65.38 155.81 34.2 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 121.687 0.756 . . . . 75.42 111.201 172.631 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 119' ' ' LEU . . . . . . . . . . . . . 61.9 tp -109.01 161.67 14.95 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 107.189 -1.411 . . . . 75.21 107.189 172.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 38.8 ttt-85 -131.31 119.84 22.31 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 118.77 0.714 . . . . 72.31 109.322 175.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 121' ' ' ALA . . . . . 0.469 ' HB3' HD11 ' C' ' 174' ' ' LEU . . . -138.09 118.16 13.46 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 124.129 0.972 . . . . 63.21 108.68 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 122' ' ' GLU . . . . . 0.445 ' HB3' ' HB ' ' C' ' 177' ' ' VAL . 13.0 pt-20 -108.03 148.3 29.94 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 122.339 0.255 . . . . 73.22 110.457 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -140.71 145.89 42.08 Favored Pre-proline 0 N--CA 1.481 1.109 0 C-N-CA 122.833 0.453 . . . . 73.3 111.607 -170.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -75.88 130.11 12.13 Favored 'Trans proline' 0 C--N 1.377 2.038 0 C-N-CA 122.509 2.139 . . . . 72.51 110.559 166.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 125' ' ' LEU . . . . . . . . . . . . . 30.2 tp -145.14 148.58 33.76 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 108.668 -0.864 . . . . 74.03 108.668 -175.048 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 126' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -94.53 158.5 15.51 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 120.911 0.386 . . . . 61.53 110.488 -178.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 127' ' ' LEU . . . . . 0.61 HD13 ' HD2' ' C' ' 186' ' ' PHE . 56.9 mt -62.33 -42.56 99.48 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.656 1.182 . . . . 62.25 110.643 173.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 128' ' ' GLU . . . . . 0.405 ' HG3' ' HA ' ' C' ' 215' ' ' LEU . 2.7 mp0 -62.2 -38.05 87.66 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 114.495 -1.229 . . . . 75.24 110.725 173.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -79.01 -17.93 54.5 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 122.968 0.507 . . . . 73.53 111.592 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -76.63 -40.29 49.71 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-O 121.719 0.771 . . . . 64.34 109.428 172.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 131' ' ' PHE . . . . . 0.622 ' HB2' HD13 ' C' ' 215' ' ' LEU . 76.8 t80 -63.09 -34.89 78.56 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 126.065 1.746 . . . . 75.55 111.873 171.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 132' ' ' HIS . . . . . . . . . . . . . 36.6 m170 -78.35 -59.26 2.85 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 122.381 0.272 . . . . 60.22 110.345 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 53.03 -127.39 35.48 Favored Glycine 0 CA--C 1.537 1.426 0 O-C-N 124.077 0.86 . . . . 65.31 113.955 177.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.51 -146.33 38.72 Favored Glycine 0 C--N 1.349 1.303 0 C-N-CA 123.24 0.448 . . . . 53.24 113.646 177.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -92.01 112.79 24.86 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.337 1.055 . . . . 71.2 109.618 -177.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 136' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -126.64 133.36 51.01 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.389 0.675 . . . . 72.12 110.432 -175.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 137' ' ' VAL . . . . . . . . . . . . . 34.0 m -73.11 138.95 20.32 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 CA-C-O 120.976 0.417 . . . . 71.12 111.479 -176.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 138' ' ' VAL . . . . . 0.7 ' HA ' HG22 ' B' ' 182' ' ' VAL . 7.3 p -152.05 135.53 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.325 1.05 . . . . 72.14 108.986 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 139' ' ' GLU . . . . . 0.5 ' HA ' ' O ' ' C' ' 143' ' ' ARG . 0.0 OUTLIER -117.69 116.25 26.67 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.19 0.596 . . . . 74.31 109.927 170.742 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 140' ' ' VAL . . . . . . . . . . . . . 13.8 p -164.39 138.33 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.823 0.849 . . . . 63.22 110.12 174.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 62.58 13.94 6.68 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 124.869 1.268 . . . . 15.23 113.72 170.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 142' ' ' GLY . . . . . 0.595 ' HA2' ' HB2' ' C' ' 79' ' ' PRO . . . 120.18 -31.63 5.21 Favored Glycine 0 C--N 1.348 1.248 0 CA-C-O 120.103 -0.276 . . . . 45.25 112.814 -178.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 143' ' ' ARG . . . . . 0.5 ' O ' ' HA ' ' C' ' 139' ' ' GLU . 9.8 mmm180 -80.33 108.37 13.89 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.034 0.534 . . . . 73.04 111.954 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 48.6 ttt180 -113.62 91.31 3.6 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 107.635 -1.246 . . . . 71.51 107.635 166.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 145' ' ' VAL . . . . . . . . . . . . . 13.0 p -157.34 159.24 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.142 0.577 . . . . 75.03 111.174 -168.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 20.3 m -78.19 106.89 10.39 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.76 0.824 . . . . 54.21 110.146 168.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 2.6 p -80.52 119.8 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 CA-C-O 121.044 0.45 . . . . 72.53 110.137 174.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 48.0 ttt180 -83.82 95.15 8.37 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.595 -0.729 . . . . 74.22 110.068 177.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 149' ' ' ILE . . . . . 0.459 HD11 HD21 ' B' ' 181' ' ' LEU . 38.3 pt -118.71 105.19 46.06 Favored Pre-proline 0 CA--C 1.547 0.861 0 N-CA-C 107.647 -1.242 . . . . 71.41 107.647 164.057 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -53.88 166.78 1.31 Allowed 'Trans proline' 0 C--N 1.384 2.428 0 C-N-CA 123.459 2.772 . . . . 61.44 113.903 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -44.12 108.85 0.13 Allowed 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 123.305 2.67 . . . . 73.2 113.425 171.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 152' ' ' GLY . . . . . . . . . . . . . . . 154.21 87.98 0.06 OUTLIER Glycine 0 C--N 1.349 1.292 0 N-CA-C 114.8 0.68 . . . . 54.32 114.8 -176.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 153' ' ' VAL . . . . . 0.549 HG21 HD11 ' C' ' 159' ' ' ILE . 12.4 p -165.53 155.54 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.617 0 C-N-CA 123.249 0.62 . . . . 71.13 110.656 172.182 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 154' ' ' ARG . . . . . 0.503 ' HD2' ' HG2' ' C' ' 187' ' ' ARG . 30.3 ttp180 -155.64 150.86 26.8 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 124.071 0.948 . . . . 75.32 110.419 -172.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 155' ' ' GLU . . . . . 0.411 ' N ' ' HG2' ' C' ' 154' ' ' ARG . 10.3 tp10 -42.93 130.66 4.3 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 125.589 1.556 . . . . 74.51 113.263 -177.223 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 84.53 -5.79 79.85 Favored Glycine 0 C--N 1.348 1.199 0 CA-C-N 115.827 -0.624 . . . . 64.51 113.252 178.105 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 157' ' ' SER . . . . . 0.499 ' O ' HG12 ' C' ' 178' ' ' VAL . 37.6 t -78.58 129.5 34.87 Favored 'General case' 0 C--O 1.245 0.82 0 N-CA-C 108.622 -0.881 . . . . 75.43 108.622 173.28 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 97.9 t -105.99 100.44 10.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 N-CA-C 108.261 -1.015 . . . . 64.44 108.261 -177.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 159' ' ' ILE . . . . . 0.665 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 26.1 mt -71.25 96.67 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.672 0 CA-C-N 115.046 -0.979 . . . . 52.25 108.85 -175.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 4.6 ttt180 -79.75 96.58 6.31 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 107.551 -1.277 . . . . 72.21 107.551 175.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 161' ' ' VAL . . . . . . . . . . . . . 2.2 p -97.99 108.44 46.46 Favored Pre-proline 0 C--O 1.247 0.938 0 CA-C-N 114.804 -1.089 . . . . 75.24 108.588 -178.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -52.05 115.97 2.49 Favored 'Trans proline' 0 C--N 1.387 2.572 0 C-N-CA 123.483 2.788 . . . . 63.42 114.55 -173.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 163' ' ' GLY . . . . . 0.671 ' H ' ' HA ' ' C' ' 173' ' ' ASP . . . 91.49 -13.82 65.53 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 117.513 1.765 . . . . 53.31 117.513 168.215 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 164' ' ' MET . . . . . 0.498 ' HB3' ' HB3' ' C' ' 174' ' ' LEU . 47.7 ttm -68.13 -19.07 64.79 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-N 120.45 2.125 . . . . 73.35 112.659 -170.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . -94.77 -112.54 2.51 Favored Glycine 0 C--N 1.347 1.181 0 CA-C-O 119.332 -0.704 . . . . 64.24 111.886 175.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 166' ' ' GLY . . . . . 0.405 ' HA3' ' HB3' ' C' ' 171' ' ' PRO . . . 86.65 67.23 1.36 Allowed Glycine 0 C--N 1.362 2.007 0 CA-C-N 118.057 0.929 . . . . 75.44 113.866 176.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 167' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -79.65 99.88 7.58 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 107.124 -1.436 . . . . 64.31 107.124 172.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 168' ' ' GLY . . . . . 0.436 ' HA3' ' HA2' ' C' ' 116' ' ' GLY . . . 153.31 -85.61 0.14 Allowed Glycine 0 C--O 1.213 -1.164 0 CA-C-O 118.432 -1.205 . . . . 13.44 110.397 -169.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 169' ' ' ASN . . . . . 0.544 ' HB3' ' HD3' ' C' ' 170' ' ' PRO . 2.9 t-20 179.95 -59.78 0.0 OUTLIER Pre-proline 0 N--CA 1.499 1.985 0 CA-C-O 117.387 -1.292 . . . . 62.44 112.189 163.388 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 170' ' ' PRO . . . . . 0.544 ' HD3' ' HB3' ' C' ' 169' ' ' ASN . 19.4 Cg_exo -67.77 100.24 0.59 Allowed 'Trans proline' 0 C--N 1.399 3.208 0 CA-C-N 122.623 1.972 . . . . 51.41 109.688 165.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 171' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' C' ' 170' ' ' PRO . 14.2 Cg_exo -71.05 132.06 20.58 Favored 'Trans proline' 0 C--N 1.362 1.267 0 C-N-CA 122.901 2.401 . . . . 74.02 114.469 -162.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -71.44 -72.87 0.86 Allowed Glycine 0 C--N 1.347 1.178 0 O-C-N 124.176 0.922 . . . . 74.42 111.331 173.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 173' ' ' ASP . . . . . 0.671 ' HA ' ' H ' ' C' ' 163' ' ' GLY . 4.9 p-10 -172.67 178.32 2.7 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.201 0.6 . . . . 74.51 111.897 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 174' ' ' LEU . . . . . 0.498 ' HB3' ' HB3' ' C' ' 164' ' ' MET . 12.6 tp -122.09 139.17 54.04 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.169 0.988 . . . . 75.22 109.002 170.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 175' ' ' LEU . . . . . 0.4 ' N ' HD12 ' C' ' 174' ' ' LEU . 85.9 mt -101.39 87.11 3.12 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.67 1.188 . . . . 71.32 109.594 177.058 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 176' ' ' LEU . . . . . 0.665 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 83.9 mt -74.22 92.93 2.28 Favored 'General case' 0 C--N 1.351 0.671 0 C-N-CA 123.09 0.556 . . . . 43.02 109.557 173.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 177' ' ' VAL . . . . . 0.445 ' HB ' ' HB3' ' C' ' 122' ' ' GLU . 22.2 t -84.51 113.52 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 108.619 -0.882 . . . . 74.43 108.619 -177.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 178' ' ' VAL . . . . . 0.549 HG11 HG22 ' C' ' 153' ' ' VAL . 7.5 p -80.76 125.17 39.26 Favored 'Isoleucine or valine' 0 C--O 1.246 0.908 0 CA-C-O 121.798 0.809 . . . . 74.01 111.036 -176.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 179' ' ' ARG . . . . . . . . . . . . . 24.3 mmt180 -110.54 122.9 48.88 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 114.028 -1.442 . . . . 72.33 107.224 169.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 180' ' ' LEU . . . . . 0.556 HD13 HD21 ' C' ' 127' ' ' LEU . 92.5 mt -85.69 149.57 25.21 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 122.774 0.43 . . . . 70.51 111.431 -177.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 181' ' ' LEU . . . . . 0.401 ' HB3' ' HD2' ' C' ' 182' ' ' PRO . 26.4 mt -65.4 165.36 18.52 Favored Pre-proline 0 CA--C 1.565 1.551 0 C-N-CA 124.624 1.17 . . . . 74.2 111.711 -178.369 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 182' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' C' ' 181' ' ' LEU . 12.7 Cg_exo -36.04 -20.88 0.04 OUTLIER 'Trans proline' 0 C--N 1.403 3.423 1 C-N-CA 125.642 4.228 . . . . 64.12 118.701 -177.357 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 183' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -104.94 99.54 19.66 Favored Pre-proline 0 CA--C 1.562 1.44 0 CA-C-N 119.495 1.043 . . . . 62.13 109.123 167.601 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 184' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -99.26 66.39 0.06 OUTLIER 'Trans proline' 0 C--N 1.38 2.221 0 C-N-CA 123.961 3.107 . . . . 71.54 110.713 174.183 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 185' ' ' VAL . . . . . 0.549 ' H ' HD11 ' C' ' 127' ' ' LEU . 21.6 t -92.63 -45.06 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-N 115.487 -0.779 . . . . 72.23 110.144 -165.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 186' ' ' PHE . . . . . 0.61 ' HD2' HD13 ' C' ' 127' ' ' LEU . 71.1 m-85 -100.16 114.57 28.05 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.506 0.67 . . . . 61.44 111.354 -167.047 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 187' ' ' ARG . . . . . 0.675 ' HB3' ' HB3' ' C' ' 194' ' ' TYR . 3.2 tmt_? -95.77 107.4 19.63 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.878 1.271 . . . . 75.14 108.72 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 188' ' ' LEU . . . . . . . . . . . . . 41.1 tp -82.32 141.78 32.59 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.835 0.68 . . . . 74.14 112.835 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -145.16 108.68 4.65 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 107.103 -1.443 . . . . 71.33 107.103 161.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 71.36 -92.5 0.5 Allowed Glycine 0 C--N 1.356 1.649 0 O-C-N 123.225 0.328 . . . . 74.2 112.534 -178.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 191' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -117.92 -26.53 6.43 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.874 0.87 . . . . 60.21 110.114 174.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -86.54 153.25 21.97 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.557 -0.747 . . . . 65.13 110.731 -166.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 193' ' ' LEU . . . . . 0.42 HD21 ' CD1' ' C' ' 240' ' ' PHE . 84.1 mt -120.3 163.7 17.42 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.6 -0.727 . . . . 52.2 111.172 -175.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 194' ' ' TYR . . . . . 0.675 ' HB3' ' HB3' ' C' ' 187' ' ' ARG . 33.8 t80 -136.64 107.56 6.67 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 114.723 -1.126 . . . . 75.43 108.884 169.394 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 195' ' ' ALA . . . . . 0.501 ' HB2' HD11 ' C' ' 249' ' ' LEU . . . -105.01 -175.33 2.76 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.725 0.81 . . . . 65.11 110.822 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 59.1 m -128.31 124.05 35.54 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 107.912 -1.144 . . . . 51.32 107.912 164.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 197' ' ' LEU . . . . . 0.425 HD13 ' HB2' ' C' ' 212' ' ' ALA . 35.4 tp -98.99 126.74 44.75 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 122.889 0.476 . . . . 73.5 110.743 -176.55 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -79.15 101.54 7.98 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.038 0.935 . . . . 44.52 108.858 177.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 199' ' ' VAL . . . . . 0.557 ' HA ' HG11 ' C' ' 210' ' ' VAL . 40.3 t -119.38 106.99 41.8 Favored Pre-proline 0 N--CA 1.478 0.936 0 C-N-CA 123.667 0.787 . . . . 61.21 109.307 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 200' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.23 147.94 67.43 Favored 'Trans proline' 0 C--N 1.373 1.836 0 C-N-CA 121.683 1.589 . . . . 71.34 111.45 175.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 201' ' ' ALA . . . . . 0.446 ' O ' HG23 ' C' ' 205' ' ' VAL . . . -55.44 -45.66 99.83 Favored Pre-proline 0 CA--C 1.551 1.016 0 N-CA-C 113.998 1.11 . . . . 74.35 113.998 -171.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 202' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -52.35 -47.32 27.57 Favored 'Trans proline' 0 C--N 1.385 2.468 0 C-N-CA 121.411 1.407 . . . . 63.15 112.569 174.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 203' ' ' ILE . . . . . 0.531 ' HA ' HG12 ' C' ' 206' ' ' VAL . 51.3 mt -69.02 -32.59 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 123.15 0.58 . . . . 63.4 111.195 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.85 -33.84 75.54 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.688 0.795 . . . . 75.02 112.145 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 205' ' ' VAL . . . . . 0.446 HG23 ' O ' ' C' ' 201' ' ' ALA . 43.1 t -85.75 -38.35 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-N 116.072 -0.513 . . . . 63.41 111.693 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 206' ' ' VAL . . . . . 0.531 HG12 ' HA ' ' C' ' 203' ' ' ILE . 14.4 p -79.09 -35.67 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 CA-C-O 120.952 0.406 . . . . 52.12 111.175 -174.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 79.8 66.8 1.63 Allowed Glycine 0 N--CA 1.435 -1.406 0 CA-C-N 115.185 -0.916 . . . . 63.21 111.948 -167.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -98.08 -137.22 9.58 Favored Glycine 0 C--O 1.244 0.766 0 N-CA-C 111.176 -0.769 . . . . 51.32 111.176 174.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 209' ' ' LYS . . . . . 0.419 ' HG2' ' HA ' ' C' ' 222' ' ' ALA . 7.2 mtmp? -134.22 133.15 40.56 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.337 0.655 . . . . 72.12 110.25 174.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 210' ' ' VAL . . . . . 0.557 HG11 ' HA ' ' C' ' 199' ' ' VAL . 35.8 m -114.84 178.49 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.012 1.325 . . . . 62.05 107.936 169.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 211' ' ' ARG . . . . . 0.604 ' HD3' ' HB2' ' C' ' 218' ' ' PRO . 24.8 ttm105 -131.56 130.24 42.01 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 118.454 0.57 . . . . 72.44 112.204 -177.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 212' ' ' ALA . . . . . 0.425 ' HB2' HD13 ' C' ' 197' ' ' LEU . . . -98.59 115.35 28.45 Favored 'General case' 0 C--N 1.348 0.519 0 C-N-CA 124.356 1.062 . . . . 74.43 108.248 169.037 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 213' ' ' MET . . . . . 0.423 ' HA ' ' HA ' ' C' ' 218' ' ' PRO . 2.3 tmm? -71.68 101.59 2.58 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 107.185 -1.413 . . . . 63.12 107.185 172.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 214' ' ' THR . . . . . 0.48 HG22 ' H ' ' C' ' 215' ' ' LEU . 0.6 OUTLIER -101.74 174.63 5.87 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 120.991 0.424 . . . . 54.24 110.348 -171.037 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 215' ' ' LEU . . . . . 0.622 HD13 ' HB2' ' C' ' 131' ' ' PHE . 26.5 mt -61.49 -43.42 98.9 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.793 1.637 . . . . 44.41 112.755 -173.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.86 17.5 19.36 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 115.189 -0.914 . . . . 71.0 110.927 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 127.86 159.73 10.18 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-N 115.492 -0.776 . . . . 64.11 112.567 173.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 218' ' ' PRO . . . . . 0.604 ' HB2' ' HD3' ' C' ' 211' ' ' ARG . 70.3 Cg_endo -75.31 102.88 1.65 Allowed 'Trans proline' 0 CA--C 1.561 1.845 0 C-N-CA 122.764 2.309 . . . . 52.13 114.292 -178.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 219' ' ' VAL . . . . . 0.405 HG12 ' OG1' ' C' ' 214' ' ' THR . 12.6 p -83.87 144.28 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 123.729 0.812 . . . . 52.53 110.097 -178.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 220' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -97.36 109.83 22.5 Favored 'General case' 0 C--O 1.246 0.872 0 CA-C-O 121.66 0.743 . . . . 72.32 109.636 174.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 221' ' ' VAL . . . . . 0.435 HG11 HD22 ' C' ' 233' ' ' LEU . 49.2 t -80.12 138.19 20.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 125.114 1.366 . . . . 74.03 111.136 -178.271 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 222' ' ' ALA . . . . . 0.611 ' H ' ' HB2' ' B' ' 239' ' ' ALA . . . -89.53 118.01 28.85 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.149 0.979 . . . . 73.3 110.309 173.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 49.0 t -92.72 130.72 35.84 Favored Pre-proline 0 CA--C 1.553 1.092 0 N-CA-C 108.18 -1.044 . . . . 73.11 108.18 174.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 224' ' ' PRO . . . . . 0.812 ' HG2' ' HG3' ' B' ' 243' ' ' GLN . 21.1 Cg_exo -72.48 157.66 52.52 Favored 'Trans proline' 0 C--N 1.37 1.697 0 C-N-CA 123.561 2.84 . . . . 54.33 111.894 164.541 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -58.67 142.88 98.91 Favored 'Trans proline' 0 C--N 1.382 2.337 0 C-N-CA 122.368 2.045 . . . . 74.0 111.209 174.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 226' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 67.57 95.57 0.06 Allowed 'General case' 0 N--CA 1.484 1.247 0 O-C-N 124.488 1.118 . . . . 70.15 111.331 -179.182 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 227' ' ' THR . . . . . 0.501 HG22 HG11 ' C' ' 253' ' ' VAL . 52.9 m -140.41 123.04 16.24 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 123.222 0.609 . . . . 70.3 112.14 175.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 228' ' ' GLN . . . . . . . . . . . . . 27.7 mp0 -97.74 158.55 15.45 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-O 122.392 1.091 . . . . 74.32 111.172 171.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 229' ' ' ALA . . . . . 0.459 ' HB2' ' H ' ' C' ' 255' ' ' ILE . . . -67.45 148.87 50.98 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-N 113.874 -1.512 . . . . 62.12 109.357 171.133 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 88.71 -5.44 84.62 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-O 119.689 -0.506 . . . . 62.04 112.93 -174.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 231' ' ' ARG . . . . . 0.424 ' NH1' HE22 ' B' ' 243' ' ' GLN . 57.1 mtt180 -76.85 168.97 19.18 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 109.053 -0.721 . . . . 74.12 109.053 163.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 232' ' ' LYS . . . . . 0.562 ' HD3' ' HB3' ' C' ' 250' ' ' TYR . 3.9 ttmp? -143.47 139.82 30.05 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.96 0.41 . . . . 71.45 112.087 -175.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 233' ' ' LEU . . . . . 0.576 HD13 ' HB2' ' C' ' 251' ' ' LEU . 2.4 mp -105.7 155.75 18.95 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.808 1.243 . . . . 74.21 109.724 -179.538 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 41.1 ttp85 -128.01 89.93 3.01 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 109.095 -0.706 . . . . 72.34 109.095 172.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 235' ' ' LEU . . . . . 0.578 HD12 HD23 ' C' ' 249' ' ' LEU . 72.3 mt -73.43 114.14 11.32 Favored 'General case' 0 C--N 1.359 0.995 0 N-CA-C 109.497 -0.557 . . . . 73.43 109.497 174.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 24.7 mmmt -72.55 124.17 24.68 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.956 0.902 . . . . 71.55 111.236 -177.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 72.27 37.52 59.24 Favored Glycine 0 C--N 1.35 1.307 0 O-C-N 123.832 0.708 . . . . 71.42 113.118 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 29.8 mmtm -125.32 14.77 8.32 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.836 0.854 . . . . 72.03 111.322 177.155 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -96.32 -162.96 33.08 Favored Glycine 0 C--N 1.348 1.245 0 N-CA-C 111.972 -0.451 . . . . 31.21 111.972 172.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 240' ' ' PHE . . . . . 0.42 ' CD1' HD21 ' C' ' 193' ' ' LEU . 3.3 m-85 -72.51 149.59 91.08 Favored Pre-proline 0 N--CA 1.477 0.899 0 C-N-CA 123.588 0.755 . . . . 75.14 111.489 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 241' ' ' PRO . . . . . 0.435 ' HD3' ' CD2' ' C' ' 131' ' ' PHE . 31.6 Cg_exo -59.49 119.25 6.36 Favored 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 124.101 3.201 . . . . 70.21 112.572 -176.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -131.34 -172.76 13.17 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-N 115.488 -0.778 . . . . 70.14 112.822 -174.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.56 -40.48 30.18 Favored 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 123.781 2.988 . . . . 71.42 112.652 -178.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -84.56 10.81 10.05 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.097 0.559 . . . . 71.42 111.854 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 120.11 -75.45 0.32 Allowed Glycine 0 C--N 1.348 1.207 0 N-CA-C 110.601 -1.0 . . . . 51.32 110.601 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 246' ' ' ARG . . . . . . . . . . . . . 30.5 mtm180 -142.46 -179.97 6.6 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.845 1.258 . . . . 61.31 109.655 175.069 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -89.02 -161.86 37.93 Favored Glycine 0 C--N 1.346 1.137 0 N-CA-C 112.105 -0.398 . . . . 63.23 112.105 173.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -122.71 137.96 54.75 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 117.358 0.579 . . . . 73.54 109.736 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 249' ' ' LEU . . . . . 0.578 HD23 HD12 ' C' ' 235' ' ' LEU . 21.1 tp -95.04 115.11 27.01 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.198 0.999 . . . . 74.23 110.177 -175.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 250' ' ' TYR . . . . . 0.562 ' HB3' ' HD3' ' C' ' 232' ' ' LYS . 8.6 m-85 -100.91 100.13 10.72 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.253 -0.647 . . . . 71.43 109.253 -179.296 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 251' ' ' LEU . . . . . 0.576 ' HB2' HD13 ' C' ' 233' ' ' LEU . 1.8 mp -96.98 138.65 34.18 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.651 -0.656 . . . . 64.53 109.923 -174.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -89.89 118.83 29.76 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.358 -0.978 . . . . 73.41 108.358 173.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 253' ' ' VAL . . . . . 0.501 HG11 HG22 ' C' ' 227' ' ' THR . 91.7 t -60.27 130.61 24.26 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 123.45 0.7 . . . . 73.5 110.842 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 254' ' ' ARG . . . . . 0.468 ' CZ ' ' HB ' ' C' ' 256' ' ' THR . 2.1 tmm_? -126.27 101.0 6.54 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 107.122 -1.436 . . . . 74.13 107.122 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 255' ' ' ILE . . . . . 0.459 ' H ' ' HB2' ' C' ' 229' ' ' ALA . 46.2 mm -73.45 125.92 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 109.577 -0.527 . . . . 75.24 109.577 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 256' ' ' THR . . . . . 0.468 ' HB ' ' CZ ' ' C' ' 254' ' ' ARG . 0.1 OUTLIER -128.09 163.47 24.55 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.102 0.961 . . . . 53.32 111.003 -175.418 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 2.8 pp -137.08 147.97 60.8 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 124.751 1.221 . . . . 64.54 107.827 173.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -79.17 15.48 1.53 Allowed 'Trans proline' 0 N--CA 1.501 1.943 0 C-N-CA 122.566 2.178 . . . . 73.21 113.089 -170.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 57.59 -84.3 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.406 1.483 . . . . 72.3 111.017 -171.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -73.09 137.83 45.48 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.215 1.006 . . . . 73.41 110.138 -177.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 261' ' ' LEU . . . . . . . . . . . . . 77.3 mt -130.16 165.03 23.17 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.756 0.822 . . . . 71.21 111.361 -178.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 14.9 p -84.09 146.4 48.41 Favored Pre-proline 0 CA--C 1.549 0.918 0 CA-C-N 114.245 -1.343 . . . . 61.23 108.854 167.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -51.38 -26.0 19.95 Favored 'Trans proline' 0 C--N 1.39 2.732 0 C-N-CA 124.256 3.304 . . . . 74.2 114.649 -172.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -66.36 -65.4 0.68 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.753 0.821 . . . . 71.04 109.754 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -56.13 -44.02 78.76 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 114.647 -1.16 . . . . 65.11 109.85 177.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 266' ' ' GLU . . . . . 0.409 ' O ' ' HG2' ' C' ' 270' ' ' LYS . 5.2 tp10 -50.44 -48.42 56.41 Favored 'General case' 0 CA--C 1.548 0.891 0 O-C-N 124.549 1.156 . . . . 64.21 110.529 179.157 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 267' ' ' ALA . . . . . 0.475 ' O ' ' HG2' ' C' ' 271' ' ' LYS . . . -66.57 -41.0 89.27 Favored 'General case' 0 C--N 1.355 0.835 0 CA-C-N 115.481 -0.781 . . . . 70.32 112.22 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 268' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.98 -38.42 91.0 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 120.797 0.332 . . . . 52.44 111.112 176.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -68.01 -32.56 73.03 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.39 0.676 . . . . 61.11 110.43 175.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 270' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' C' ' 266' ' ' GLU . 4.0 mmmp? -58.99 -49.39 78.05 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.048 0.539 . . . . 75.43 109.721 173.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 271' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' C' ' 267' ' ' ALA . 10.8 mmpt? -59.54 -48.76 80.41 Favored 'General case' 0 C--O 1.249 1.033 0 O-C-N 124.252 0.97 . . . . 75.33 111.106 -177.291 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 80.4 mt -54.14 -57.84 9.6 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 124.049 0.843 . . . . 74.33 110.193 173.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -52.95 -45.92 67.93 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.938 0.895 . . . . 34.13 112.339 -173.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -63.56 -43.54 96.76 Favored 'General case' 0 C--O 1.25 1.097 0 C-N-CA 123.789 0.835 . . . . 63.21 110.8 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -56.4 -34.37 66.66 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-O 121.001 0.429 . . . . 70.04 111.444 174.063 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 276' ' ' TYR . . . . . 0.716 ' HA ' ' HD3' ' C' ' 279' ' ' ARG . 1.0 OUTLIER -85.26 -25.65 27.14 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 115.743 -0.662 . . . . 75.52 111.596 -179.404 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 277' ' ' TYR . . . . . 0.44 ' CE1' ' HA3' ' A' ' 208' ' ' GLY . 22.1 m-30 -68.85 -32.36 71.99 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.938 -0.393 . . . . 44.24 109.938 176.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -55.57 -18.62 7.93 Favored 'General case' 0 CA--C 1.561 1.393 0 O-C-N 123.756 0.66 . . . . 55.2 112.515 173.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 279' ' ' ARG . . . . . 0.716 ' HD3' ' HA ' ' C' ' 276' ' ' TYR . 12.6 mtp-105 -89.87 -28.88 18.94 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.061 0.944 . . . . 71.52 111.833 176.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.963 0 C-N-CA 123.292 0.637 . . . . 75.14 110.671 -174.062 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt . . . . . 0 N--CA 1.476 0.864 0 N-CA-C 113.24 0.83 . . . . 62.43 113.24 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -72.13 112.02 7.86 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.587 -0.894 . . . . 74.32 108.587 166.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -75.98 84.3 2.88 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 107.242 -1.392 . . . . 61.41 107.242 178.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.485 ' HA ' HD12 ' A' ' 10' ' ' ILE . 41.7 m-85 -60.67 -29.98 69.63 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-N 114.59 -1.186 . . . . 73.34 111.996 -173.12 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -66.38 -42.34 88.09 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.833 -0.621 . . . . 73.33 110.432 176.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.09 -40.31 95.95 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.933 0.493 . . . . 60.32 111.19 176.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.485 HD12 ' HA ' ' A' ' 7' ' ' TYR . 62.9 mt -60.79 -39.17 80.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-N 115.807 -0.633 . . . . 74.23 110.727 178.192 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 92.1 mt -86.03 -7.59 58.52 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 112.287 0.477 . . . . 51.33 112.287 176.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.49 18.29 76.93 Favored Glycine 0 C--N 1.351 1.391 0 N-CA-C 114.501 0.56 . . . . 53.33 114.501 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.4 m -103.83 153.88 38.43 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 124.444 1.098 . . . . 71.43 110.041 177.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.23 165.11 20.52 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 122.785 2.323 . . . . 50.12 114.142 -176.081 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -81.63 61.05 4.86 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.4 1.08 . . . . 75.43 109.658 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -177.42 -26.83 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 114.073 -1.421 . . . . 64.11 108.286 -166.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -47.16 123.58 5.58 Favored 'General case' 0 C--N 1.349 0.579 0 C-N-CA 125.714 1.606 . . . . 64.31 113.137 -174.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 43.7 p -74.42 173.01 10.9 Favored 'General case' 0 C--O 1.243 0.733 0 O-C-N 124.226 0.954 . . . . 71.11 110.901 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.2 tm0? -55.81 -29.19 59.37 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.04 0.936 . . . . 64.21 110.178 179.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -57.22 -58.67 7.19 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.416 1.086 . . . . 72.43 110.845 173.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -66.03 -35.02 79.43 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.135 0.574 . . . . 64.03 111.484 -173.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.51 HG12 ' HB3' ' A' ' 57' ' ' LEU . 1.7 mp -61.76 -45.0 99.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 123.044 0.537 . . . . 73.31 110.296 173.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -61.69 -40.02 93.5 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.575 1.15 . . . . 71.24 111.035 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.613 ' HA ' ' HD3' ' A' ' 27' ' ' LYS . 18.5 mtp180 -77.15 -37.47 53.88 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.997 0.919 . . . . 54.12 111.41 -175.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.92 -37.99 89.43 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.652 -0.704 . . . . 64.0 110.161 173.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -74.97 -28.05 60.42 Favored 'General case' 0 C--O 1.215 -0.732 0 CA-C-N 115.006 -0.997 . . . . 73.1 110.964 176.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.613 ' HD3' ' HA ' ' A' ' 24' ' ' ARG . 22.6 mtpp -55.29 -53.54 54.76 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.414 -0.958 . . . . 74.22 108.414 171.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 -54.2 -67.06 0.29 Allowed 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 114.576 -1.193 . . . . 71.15 111.34 176.213 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 79.4 mt -70.21 -22.98 62.87 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.04 0.936 . . . . 74.11 112.952 -166.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.81 -54.79 6.66 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 109.252 -0.647 . . . . 63.3 109.252 173.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -64.11 -21.59 66.6 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 120.878 0.37 . . . . 72.33 111.509 -178.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -84.96 -44.33 13.2 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 124.721 1.209 . . . . 63.33 111.113 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -113.78 21.53 14.88 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 112.749 0.648 . . . . 63.25 112.749 -174.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -63.85 113.37 9.81 Favored Pre-proline 0 N--CA 1.484 1.263 0 CA-C-O 118.074 -0.965 . . . . 63.41 108.465 176.321 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.709 ' HB3' ' HG2' ' A' ' 44' ' ' GLU . 19.5 Cg_endo -57.87 -28.08 81.15 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 123.227 2.618 . . . . 74.13 113.647 -174.311 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -73.38 -30.55 63.36 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.881 0.873 . . . . 72.45 111.997 176.183 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 75.4 t -85.16 -39.23 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.017 0.527 . . . . 65.53 109.889 176.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -132.33 94.5 3.45 Favored 'General case' 0 C--O 1.244 0.793 0 C-N-CA 124.491 1.116 . . . . 61.35 109.088 -175.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.606 ' HE3' ' H ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -76.04 82.91 2.9 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 108.764 -0.828 . . . . 73.11 108.764 -179.581 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.5 m -140.08 116.22 7.99 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-O 117.998 -1.001 . . . . 54.41 108.666 177.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_exo -46.93 -42.22 25.33 Favored 'Trans proline' 0 C--N 1.387 2.579 0 C-N-CA 123.119 2.546 . . . . 72.23 112.419 175.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 34.3 tp10 -48.56 -51.29 28.47 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.05 1.34 . . . . 64.43 111.116 173.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.3 -25.6 65.22 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 115.113 -0.949 . . . . 72.14 111.031 -177.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.709 ' HG2' ' HB3' ' A' ' 35' ' ' PRO . 41.7 mt-10 -84.17 -33.94 24.11 Favored 'General case' 0 C--N 1.354 0.785 0 C-N-CA 123.324 0.65 . . . . 62.01 110.948 -174.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -76.47 -38.68 54.98 Favored 'General case' 0 C--O 1.246 0.905 0 CA-C-O 121.372 0.606 . . . . 62.44 109.459 178.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -66.35 -34.21 77.47 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.411 -0.813 . . . . 74.03 110.083 170.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -62.15 -39.74 93.63 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.361 0.665 . . . . 73.24 109.246 172.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.412 ' HG3' ' O ' ' A' ' 44' ' ' GLU . 67.1 mttm -58.14 -50.93 71.78 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 122.975 0.51 . . . . 75.14 110.688 176.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -60.29 -44.76 95.09 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.474 0.654 . . . . 71.44 111.579 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 96.6 mt -70.82 -26.91 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 124.422 1.089 . . . . 70.53 111.39 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.531 ' HA ' ' HB3' ' A' ' 54' ' ' TYR . 9.7 m-80 -94.82 -6.12 43.57 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.732 0.813 . . . . 73.43 111.474 178.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -75.94 -49.04 18.88 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 106.329 -1.73 . . . . 63.42 106.329 164.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.476 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . . . -57.27 -48.66 78.32 Favored 'General case' 0 C--N 1.349 0.573 0 CA-C-N 113.505 -1.679 . . . . 65.45 111.452 174.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.531 ' HB3' ' HA ' ' A' ' 51' ' ' ASN . 67.2 t80 -67.95 -41.31 82.66 Favored 'General case' 0 C--O 1.209 -1.07 0 CA-C-N 115.689 -0.687 . . . . 72.32 110.602 179.141 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.45 -51.19 60.54 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 118.42 0.554 . . . . 53.01 111.368 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.505 HG13 ' HZ ' ' A' ' 101' ' ' PHE . 47.5 t -73.65 -31.97 33.94 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 CA-C-N 115.122 -0.945 . . . . 74.52 111.204 -177.349 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.51 ' HB3' HG12 ' A' ' 22' ' ' ILE . 76.4 mt -103.75 3.66 34.36 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 113.961 1.097 . . . . 62.04 113.961 -175.267 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.3 t -63.06 -51.26 67.35 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 123.855 0.862 . . . . 74.34 111.804 -176.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -109.66 144.25 29.5 Favored Pre-proline 0 C--O 1.239 0.513 0 CA-C-N 114.439 -1.255 . . . . 74.34 108.924 -169.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.414 ' O ' ' HG2' ' A' ' 64' ' ' ARG . 48.3 Cg_exo -41.61 -51.09 4.49 Favored 'Trans proline' 0 C--N 1.383 2.379 0 C-N-CA 123.943 3.095 . . . . 72.41 114.983 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.467 ' HB2' ' HB3' ' A' ' 144' ' ' ARG . 18.9 tp10 -79.8 -31.31 40.71 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 112.531 0.567 . . . . 72.3 112.531 -172.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -62.7 -42.2 99.52 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-O 122.084 0.945 . . . . 74.54 108.884 174.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.441 ' HG2' HD22 ' A' ' 57' ' ' LEU . 4.0 tmt_? -61.98 -42.65 99.37 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 113.72 -1.582 . . . . 74.11 108.443 175.064 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.414 ' HG2' ' O ' ' A' ' 60' ' ' PRO . 2.8 mmp_? -62.04 -34.51 76.37 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.615 0.766 . . . . 74.25 111.364 174.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 61' ' ' GLU . 62.4 mt -62.98 -44.24 99.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 109.217 -0.66 . . . . 64.42 109.217 178.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -57.79 -54.22 49.31 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.558 -0.747 . . . . 75.4 110.181 173.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -57.62 -42.52 83.47 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.703 0.801 . . . . 64.04 111.606 -175.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 40.4 p -69.68 -31.22 69.14 Favored 'General case' 0 C--N 1.348 0.535 0 CA-C-N 115.948 -0.569 . . . . 75.13 110.311 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -80.26 137.19 36.59 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 118.212 0.46 . . . . 63.45 110.335 -177.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.15 6.93 77.95 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-N 115.764 -0.653 . . . . 52.54 111.547 -174.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 95.0 m -130.37 -61.28 0.97 Allowed 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 103.671 -2.714 . . . . 71.23 103.671 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 92.0 m -87.72 150.09 23.82 Favored 'General case' 0 C--O 1.255 1.364 0 N-CA-C 105.274 -2.121 . . . . 74.23 105.274 156.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.57 -15.34 11.44 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.768 0.827 . . . . 74.04 111.136 178.452 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.1 123.99 87.71 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 123.695 0.798 . . . . 75.1 110.919 177.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.455 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 61.2 Cg_endo -71.37 146.26 50.06 Favored 'Trans proline' 0 C--N 1.376 1.995 0 C-N-CA 122.413 2.075 . . . . 75.41 110.77 175.338 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 75' ' ' PRO . 7.1 Cg_exo -70.76 152.14 63.9 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 122.46 2.107 . . . . 74.25 110.982 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -58.63 148.5 81.77 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 122.809 2.34 . . . . 62.44 112.947 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -50.36 114.15 1.32 Allowed 'Trans proline' 0 C--N 1.391 2.812 0 C-N-CA 123.542 2.828 . . . . 43.51 112.782 177.2 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.467 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 85.8 Cg_endo -81.73 127.6 5.66 Favored 'Trans proline' 0 CA--C 1.557 1.648 0 C-N-CA 122.467 2.111 . . . . 71.05 112.192 -176.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 79' ' ' PRO . 34.0 Cg_exo -60.33 84.16 0.07 OUTLIER 'Trans proline' 0 C--N 1.384 2.434 0 C-N-CA 123.176 2.584 . . . . 51.35 112.854 -177.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 146.99 -44.32 0.82 Allowed Glycine 0 C--N 1.341 0.834 0 CA-C-N 114.656 -1.156 . . . . 62.41 110.549 -177.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 115.13 144.75 8.45 Favored Glycine 0 C--N 1.359 1.809 0 C-N-CA 123.282 0.468 . . . . 53.03 112.707 178.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -58.24 117.75 4.75 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.693 0.797 . . . . 74.41 109.646 174.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -54.65 108.54 0.4 Allowed 'General case' 0 N--CA 1.476 0.852 0 O-C-N 124.339 1.024 . . . . 71.31 112.967 -171.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.58 ' HA ' ' HD2' ' A' ' 88' ' ' PHE . 14.1 m-85 -134.81 38.7 3.02 Favored 'General case' 0 C--O 1.245 0.862 0 C-N-CA 125.95 1.7 . . . . 70.22 108.068 173.171 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.3 m -67.18 117.75 9.64 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 113.256 -1.793 . . . . 74.44 110.732 177.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 85.24 -12.07 59.25 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-N 116.116 -0.493 . . . . 70.11 113.535 -176.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.58 ' HD2' ' HA ' ' A' ' 85' ' ' PHE . 12.2 m-85 -101.59 135.53 42.96 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 109.426 -0.583 . . . . 72.34 109.426 -172.016 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -79.45 80.41 5.82 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-O 120.909 0.385 . . . . 71.44 110.237 -174.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.422 HG23 ' HZ ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -42.14 -53.64 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 125.692 1.597 . . . . 75.21 112.996 176.841 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -73.85 -5.65 42.31 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 113.374 0.879 . . . . 75.33 113.374 -173.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -95.83 -18.71 20.17 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.209 0.604 . . . . 45.35 110.986 175.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.407 ' HE1' ' HB3' ' A' ' 48' ' ' LYS . 23.2 m-30 -83.62 179.12 7.7 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 113.068 0.766 . . . . 71.01 113.068 -171.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 68.2 p -68.14 151.95 46.23 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.892 1.277 . . . . 74.5 113.236 -170.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.6 -35.23 73.91 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 115.309 -0.86 . . . . 74.31 110.727 172.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -50.08 -51.36 43.33 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.132 1.373 . . . . 75.03 110.297 176.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.422 ' HZ ' HG23 ' A' ' 90' ' ' VAL . 0.3 OUTLIER -64.37 -46.08 84.94 Favored 'General case' 0 CA--C 1.556 1.205 0 CA-C-N 114.257 -1.338 . . . . 63.23 110.831 173.859 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.452 ' HA ' HD21 ' A' ' 105' ' ' LEU . 60.7 mt-30 -70.19 -9.9 57.18 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 112.98 0.733 . . . . 73.05 112.98 -173.015 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -101.96 -44.46 5.48 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.952 0.901 . . . . 70.02 110.929 173.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 17.8 tp -63.66 -56.9 12.21 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.646 0.778 . . . . 55.03 111.042 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.505 ' HZ ' HG13 ' A' ' 56' ' ' VAL . 86.5 m-85 -85.77 6.97 25.53 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 115.392 -0.822 . . . . 72.11 111.073 176.209 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.437 ' HA2' ' HG ' ' A' ' 105' ' ' LEU . . . -41.4 -63.16 1.67 Allowed Glycine 0 C--N 1.358 1.792 0 C-N-CA 124.867 1.223 . . . . 72.43 114.659 178.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -43.55 -23.12 0.47 Allowed 'Trans proline' 0 C--N 1.389 2.689 0 C-N-CA 124.793 3.662 . . . . 23.1 115.849 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.417 ' HA3' ' HD2' ' A' ' 79' ' ' PRO . . . -152.74 51.6 0.49 Allowed Glycine 0 C--N 1.346 1.138 0 O-C-N 121.888 -0.507 . . . . 44.4 112.035 177.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.452 HD21 ' HA ' ' A' ' 98' ' ' GLN . 25.9 mt -57.48 14.05 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.241 0 N-CA-C 116.067 1.877 . . . . 74.25 116.067 177.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER 61.76 -164.66 0.24 Allowed 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.855 0.862 . . . . 72.25 110.417 166.156 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 61.68 45.63 95.88 Favored Glycine 0 N--CA 1.442 -0.925 0 N-CA-C 115.678 1.031 . . . . 44.0 115.678 164.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.956 0 N-CA-C 118.692 2.237 . . . . 71.34 118.692 162.069 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.404 ' HA ' ' HD2' ' A' ' 170' ' ' PRO . 7.4 tmtt? . . . . . 0 N--CA 1.51 2.543 0 N-CA-C 114.093 1.146 . . . . 72.15 114.093 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.82 129.13 41.36 Favored Glycine 0 CA--C 1.543 1.835 0 CA-C-N 115.549 -0.751 . . . . 55.22 114.7 -175.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.542 ' N ' ' HA3' ' A' ' 166' ' ' GLY . 65.0 mtt180 -77.37 160.4 28.8 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 125.214 1.406 . . . . 71.34 111.576 172.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -85.14 84.86 7.55 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 107.321 -1.362 . . . . 74.23 107.321 163.096 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 9.5 tt -95.9 144.54 26.14 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.365 1.066 . . . . 70.23 109.45 -171.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.432 ' HA ' ' HB2' ' A' ' 175' ' ' LEU . 53.6 ttt-85 -102.98 143.37 32.64 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.045 0.938 . . . . 74.51 109.924 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.468 ' HB3' HD11 ' A' ' 174' ' ' LEU . . . -147.4 167.46 24.32 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.308 0.575 . . . . 41.51 112.123 -178.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.438 ' O ' HD12 ' B' ' 8' ' ' LEU . 5.7 mm-40 -103.38 107.93 18.96 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 114.49 -1.232 . . . . 61.0 107.741 -175.393 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 24.0 tp -99.24 100.25 9.88 Favored Pre-proline 0 N--CA 1.48 1.05 0 N-CA-C 107.888 -1.153 . . . . 54.05 107.888 177.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.579 ' HG2' ' HB ' ' B' ' 6' ' ' ILE . 43.9 Cg_endo -68.29 139.03 44.63 Favored 'Trans proline' 0 C--N 1.37 1.663 0 C-N-CA 121.323 1.348 . . . . 75.33 109.269 176.008 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.507 HD21 HD12 ' A' ' 149' ' ' ILE . 28.5 tp -142.56 138.7 31.02 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.151 0.887 . . . . 64.01 112.027 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 98.8 m -73.18 131.05 41.55 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 114.233 -1.349 . . . . 71.34 109.189 174.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.57 HD22 HD13 ' A' ' 180' ' ' LEU . 5.4 mt -53.48 -56.74 14.41 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 124.113 0.883 . . . . 70.54 111.085 -172.306 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.628 ' HG2' ' HD3' ' B' ' 2' ' ' LYS . 28.8 mp0 -41.41 -53.06 3.45 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 113.148 -1.842 . . . . 75.32 111.615 176.184 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -65.43 -37.42 86.84 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.454 0.702 . . . . 64.33 111.219 -178.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.585 ' HB1' ' O ' ' A' ' 153' ' ' VAL . . . -60.3 -34.66 74.08 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 124.421 1.075 . . . . 41.43 111.46 178.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -82.68 -37.69 24.46 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.563 0.745 . . . . 74.51 111.527 176.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 41.4 m170 -64.59 -40.12 94.96 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.254 0.622 . . . . 75.25 110.903 -175.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 67.34 77.84 0.3 Allowed Glycine 0 C--N 1.343 0.938 0 CA-C-N 115.452 -0.795 . . . . 71.54 112.804 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.412 ' O ' HG12 ' A' ' 149' ' ' ILE . . . -155.33 -158.99 9.05 Favored Glycine 0 C--N 1.334 0.427 0 N-CA-C 112.141 -0.384 . . . . 70.42 112.141 -179.195 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -68.87 123.89 22.2 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 125.001 1.32 . . . . 73.14 110.401 -175.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.58 HH11 HG23 ' B' ' 5' ' ' THR . 10.1 tpp180 -126.87 120.31 28.9 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.274 -1.01 . . . . 74.4 108.274 169.504 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.4 t -80.66 128.0 39.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 115.18 -0.918 . . . . 71.24 109.499 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.6 p -142.58 124.03 12.12 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 C-N-CA 124.327 1.051 . . . . 73.14 108.25 -178.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -116.56 123.73 48.09 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.925 0.49 . . . . 71.3 111.695 -171.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.515 HG21 HD23 ' B' ' 8' ' ' LEU . 1.0 OUTLIER -153.69 149.4 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 125.406 1.483 . . . . 75.1 109.598 170.491 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 61.41 20.38 11.1 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.09 0.956 . . . . 74.24 112.33 176.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 85.89 -14.11 53.96 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-N 116.21 -0.45 . . . . 31.1 112.78 -175.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.586 ' HD3' ' SD ' ' A' ' 164' ' ' MET . 59.4 ttt180 -87.82 102.5 14.75 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 123.225 0.61 . . . . 72.12 109.579 177.21 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.467 ' HB3' ' HB2' ' A' ' 61' ' ' GLU . 41.9 ttt85 -92.41 89.79 6.94 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 107.926 -1.138 . . . . 74.41 107.926 171.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.3 p -96.86 142.95 13.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 115.34 -0.846 . . . . 73.53 109.508 -173.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 23.2 t -108.97 95.81 5.9 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 109.029 -0.73 . . . . 31.45 109.029 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 3.4 p -81.14 116.39 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.005 0.522 . . . . 73.42 110.041 -177.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 38.8 ttt85 -77.61 94.33 4.36 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 107.884 -1.154 . . . . 74.14 107.884 171.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.507 HD12 HD21 ' A' ' 125' ' ' LEU . 9.3 pt -70.45 150.69 95.69 Favored Pre-proline 0 CA--C 1.553 1.064 0 CA-C-N 114.494 -1.23 . . . . 74.13 110.805 -178.412 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.613 ' HB2' ' HZ ' ' A' ' 240' ' ' PHE . 92.9 Cg_endo -75.69 137.73 20.57 Favored 'Trans proline' 0 CA--C 1.566 2.098 0 C-N-CA 122.231 1.954 . . . . 60.34 111.997 178.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.24 101.64 0.36 Allowed 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 123.086 2.524 . . . . 74.15 114.119 -175.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 121.24 5.62 9.42 Favored Glycine 0 C--N 1.345 1.036 0 CA-C-N 115.006 -0.997 . . . . 75.51 112.914 178.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.585 ' O ' ' HB1' ' A' ' 130' ' ' ALA . 7.4 p -62.38 134.71 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 N-CA-C 109.314 -0.624 . . . . 75.43 109.314 175.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.712 ' HD3' ' HB3' ' A' ' 186' ' ' PHE . 70.0 mtt85 -139.17 174.68 10.26 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 122.761 0.424 . . . . 73.23 110.413 -173.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.599 ' HG3' ' HE ' ' A' ' 187' ' ' ARG . 4.2 tp10 -43.62 136.35 3.39 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 126.792 2.037 . . . . 72.32 113.297 -172.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.38 -15.33 46.03 Favored Glycine 0 CA--C 1.534 1.267 0 CA-C-O 118.885 -0.953 . . . . 14.21 114.627 177.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 22.8 t -63.23 151.76 39.53 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-N 118.648 1.224 . . . . 74.23 110.172 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.426 HG22 HG22 ' A' ' 177' ' ' VAL . 57.3 t -123.5 102.08 10.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 123.566 0.747 . . . . 72.34 109.431 -175.194 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.554 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 60.2 mt -83.43 108.57 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 108.282 -1.007 . . . . 75.24 108.282 172.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.433 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 78.1 ttt180 -82.39 110.07 17.2 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 109.381 -0.6 . . . . 61.32 109.381 177.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.402 HG13 ' HB3' ' A' ' 174' ' ' LEU . 3.5 p -121.66 106.52 37.22 Favored Pre-proline 0 CA--C 1.558 1.269 0 C-N-CA 123.164 0.586 . . . . 61.33 110.133 178.303 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.528 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 24.5 Cg_exo -64.98 129.9 24.41 Favored 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 122.938 2.425 . . . . 74.53 111.89 174.562 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 102.5 24.97 7.97 Favored Glycine 0 C--N 1.342 0.862 0 CA-C-O 119.713 -0.493 . . . . 70.43 114.055 177.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.586 ' SD ' ' HD3' ' A' ' 143' ' ' ARG . 18.6 tpp -138.77 -40.32 0.49 Allowed 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 117.489 0.645 . . . . 64.15 111.19 -175.333 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.46 ' N ' ' HB2' ' A' ' 174' ' ' LEU . . . -76.98 -85.54 0.43 Allowed Glycine 0 C--N 1.351 1.398 0 O-C-N 123.61 0.569 . . . . 73.33 112.493 -174.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.542 ' HA3' ' N ' ' A' ' 117' ' ' ARG . . . -62.33 105.04 0.86 Allowed Glycine 0 C--O 1.257 1.581 0 N-CA-C 111.697 -0.561 . . . . 74.5 111.697 171.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -60.01 124.46 20.28 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.257 -1.016 . . . . 75.42 108.257 169.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 176.47 152.92 10.09 Favored Glycine 0 CA--C 1.499 -0.967 0 O-C-N 123.758 0.661 . . . . 64.21 112.103 -176.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ASN . . . . . 0.469 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . 29.6 t30 -55.19 -45.45 99.85 Favored Pre-proline 0 CA--C 1.569 1.705 0 CA-C-O 118.702 -0.666 . . . . 63.11 110.903 169.553 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.469 ' HD3' ' HB3' ' A' ' 169' ' ' ASN . 15.1 Cg_exo -75.33 140.1 24.18 Favored 'Trans proline' 0 C--N 1.387 2.595 0 C-N-CA 121.911 1.74 . . . . 71.13 110.449 161.523 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.34 112.5 3.54 Favored 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 123.047 2.498 . . . . 71.25 113.159 -170.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -80.57 130.54 9.82 Favored Glycine 0 C--N 1.36 1.87 0 C-N-CA 121.004 -0.617 . . . . 72.4 113.369 177.189 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.528 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 22.5 m-20 -61.28 137.97 58.24 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.781 0.832 . . . . 71.14 110.392 178.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.468 HD11 ' HB3' ' A' ' 121' ' ' ALA . 43.3 tp -113.3 138.51 49.92 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.766 -0.457 . . . . 64.32 109.766 175.381 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.432 ' HB2' ' HA ' ' A' ' 120' ' ' ARG . 60.3 mt -103.08 86.12 2.64 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 107.947 -1.131 . . . . 72.12 107.947 172.417 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.554 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 68.3 mt -66.77 89.75 0.16 Allowed 'General case' 0 C--N 1.354 0.792 0 CA-C-N 115.419 -0.81 . . . . 70.05 109.298 174.421 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.426 HG22 HG22 ' A' ' 158' ' ' VAL . 97.3 t -84.15 99.33 6.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 107.23 -1.396 . . . . 61.43 107.23 175.386 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.4 p -66.06 102.38 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 CA-C-O 122.294 1.045 . . . . 70.33 111.013 -174.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.548 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 8.1 mmm180 -85.28 96.23 9.45 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 114.137 -1.392 . . . . 53.32 107.797 174.049 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.57 HD13 HD22 ' A' ' 127' ' ' LEU . 19.1 mt -67.91 150.48 48.48 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 109.925 -0.398 . . . . 72.4 109.925 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 74.3 mt -52.75 144.77 24.22 Favored Pre-proline 0 N--CA 1.48 1.026 0 CA-C-O 118.067 -0.968 . . . . 73.14 110.531 178.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -56.2 81.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.388 2.615 0 C-N-CA 124.149 3.232 . . . . 71.42 112.932 -174.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' HIS . . . . . 0.412 ' CG ' HD11 ' A' ' 127' ' ' LEU . 12.1 t-80 -143.84 96.91 5.46 Favored Pre-proline 0 CA--C 1.547 0.829 0 N-CA-C 105.346 -2.094 . . . . 73.35 105.346 -177.225 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -72.67 27.83 0.28 Allowed 'Trans proline' 0 N--CA 1.498 1.779 0 C-N-CA 124.738 3.625 . . . . 61.24 116.733 -162.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.547 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 61.3 t -93.91 -61.17 2.18 Favored 'Isoleucine or valine' 0 C--N 1.352 0.709 0 CA-C-N 119.648 1.113 . . . . 64.21 110.283 -172.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' PHE . . . . . 0.712 ' HB3' ' HD3' ' A' ' 154' ' ' ARG . 11.7 m-85 -114.52 148.27 38.17 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 114.792 1.404 . . . . 72.31 114.792 -166.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.599 ' HE ' ' HG3' ' A' ' 155' ' ' GLU . 28.5 ttm180 -148.0 134.0 19.21 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.661 1.584 . . . . 75.51 109.192 177.41 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.48 ' HB2' ' HB2' ' A' ' 154' ' ' ARG . 47.0 tp -97.26 110.27 22.85 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 109.334 -0.617 . . . . 74.21 109.334 174.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.42 92.57 4.75 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 106.983 -1.488 . . . . 70.31 106.983 174.31 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 68.82 -98.71 0.56 Allowed Glycine 0 C--N 1.346 1.095 0 CA-C-N 115.546 -0.752 . . . . 65.41 111.349 -174.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.432 ' NE2' ' H ' ' A' ' 191' ' ' GLN . 0.7 OUTLIER -115.66 -15.42 11.38 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.118 0.567 . . . . 72.32 110.702 172.141 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.403 ' O ' HD12 ' A' ' 188' ' ' LEU . 15.3 m-20 -79.2 163.58 24.89 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.226 0.61 . . . . 72.32 110.061 177.166 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.507 HD22 ' HD2' ' A' ' 154' ' ' ARG . 80.1 mt -125.44 141.12 52.23 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.027 0.931 . . . . 63.44 110.699 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.408 ' HB2' ' HB3' ' A' ' 187' ' ' ARG . 55.3 m-85 -102.26 140.67 36.24 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.862 -1.162 . . . . 73.14 107.862 163.075 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.547 ' HA ' ' O ' ' A' ' 185' ' ' VAL . . . -143.92 155.97 44.26 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.557 1.143 . . . . 74.34 109.314 -173.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 25.4 m -121.27 126.31 49.24 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 108.986 -0.746 . . . . 70.21 108.986 176.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.478 ' HB2' HD22 ' A' ' 251' ' ' LEU . 49.3 tp -117.73 117.89 30.58 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.301 0.641 . . . . 72.21 110.54 -174.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -92.68 113.91 26.31 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.683 -0.858 . . . . 61.43 108.683 169.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 7.4 p -130.46 133.33 24.75 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 124.118 0.967 . . . . 64.4 108.578 -179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -79.8 157.29 24.36 Favored 'Trans proline' 0 C--N 1.366 1.478 0 C-N-CA 121.94 1.76 . . . . 64.51 112.076 171.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -59.3 -48.55 95.89 Favored Pre-proline 0 CA--C 1.558 1.252 0 N-CA-C 114.274 1.213 . . . . 71.34 114.274 -170.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -57.42 -42.64 59.58 Favored 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 121.897 1.731 . . . . 63.54 113.652 178.121 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 45.3 mt -75.21 -28.24 20.37 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 CA-C-N 116.442 -0.344 . . . . 64.32 110.485 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.44 -42.4 78.92 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.46 0.704 . . . . 71.51 111.101 176.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 42.3 t -71.72 -52.12 27.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 115.184 -0.916 . . . . 63.23 111.583 -178.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 72.5 t -77.29 -31.34 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 122.867 0.467 . . . . 74.41 111.455 -176.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 77.66 71.47 1.21 Allowed Glycine 0 C--N 1.338 0.686 0 CA-C-N 116.242 -0.436 . . . . 72.35 112.015 -177.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -101.19 -123.35 5.17 Favored Glycine 0 C--N 1.346 1.102 0 N-CA-C 111.52 -0.632 . . . . 55.24 111.52 177.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -133.92 139.95 46.48 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.686 0.795 . . . . 45.21 109.395 173.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.427 HG11 HG23 ' A' ' 199' ' ' VAL . 25.1 m -120.96 162.02 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-O 121.33 0.586 . . . . 63.11 110.32 169.361 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 6.8 ttp180 -85.11 114.42 22.23 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.645 -1.161 . . . . 71.41 108.738 171.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -106.26 164.55 11.92 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 109.226 -0.657 . . . . 62.04 109.226 169.068 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' MET . . . . . 0.414 ' HB2' HG21 ' A' ' 185' ' ' VAL . 71.6 mtp -103.94 139.42 39.11 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 108.729 -0.841 . . . . 71.23 108.729 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 77.8 p -111.42 -165.41 0.99 Allowed 'General case' 0 C--O 1.243 0.755 0 N-CA-C 108.929 -0.767 . . . . 74.1 108.929 174.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.438 HD11 ' HG2' ' A' ' 154' ' ' ARG . 69.9 mt -76.23 -14.69 60.13 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.7 -0.682 . . . . 63.31 112.112 176.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -120.56 -16.61 8.27 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 118.718 0.69 . . . . 64.44 112.071 -175.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 156.82 -165.3 33.06 Favored Glycine 0 N--CA 1.475 1.293 0 CA-C-O 119.776 -0.458 . . . . 33.0 113.694 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -83.67 141.58 9.86 Favored 'Trans proline' 0 C--N 1.367 1.504 0 C-N-CA 122.926 2.417 . . . . 70.23 113.717 -174.211 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 34.9 m -134.29 169.57 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 124.353 1.061 . . . . 73.4 110.073 176.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -93.53 142.38 27.4 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.361 0.664 . . . . 75.04 110.416 174.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 59.3 t -130.67 119.2 45.02 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 C-N-CA 124.075 0.95 . . . . 74.13 108.452 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -73.02 102.31 3.47 Favored 'General case' 0 C--N 1.348 0.508 0 N-CA-C 109.181 -0.674 . . . . 60.25 109.181 177.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 48.2 t -67.36 141.2 95.64 Favored Pre-proline 0 CA--C 1.555 1.152 0 C-N-CA 124.689 1.196 . . . . 63.14 110.24 -176.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.8 150.86 39.81 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 122.168 1.912 . . . . 75.51 110.448 171.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 225' ' ' PRO . . . . . 0.403 ' O ' ' HG2' ' A' ' 226' ' ' ARG . 21.1 Cg_exo -66.6 138.47 49.76 Favored 'Trans proline' 0 CA--C 1.55 1.291 0 C-N-CA 121.332 1.354 . . . . 72.53 112.021 170.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 226' ' ' ARG . . . . . 0.403 ' HG2' ' O ' ' A' ' 225' ' ' PRO 0.252 7.7 ptp180 52.43 58.77 5.05 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 127.054 2.142 . . . . 74.04 112.544 -177.391 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.498 ' O ' HD11 ' A' ' 255' ' ' ILE . 1.3 m -73.45 105.51 4.85 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 113.989 -1.46 . . . . 64.32 109.146 176.351 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 228' ' ' GLN . . . . . 0.412 ' HB3' ' HD2' ' A' ' 231' ' ' ARG . 5.9 tp-100 -84.41 132.34 34.59 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.275 0.63 . . . . 75.32 111.03 -174.27 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 229' ' ' ALA . . . . . 0.537 ' HB3' HG22 ' C' ' 256' ' ' THR . . . -66.81 142.04 57.49 Favored 'General case' 0 C--N 1.358 0.97 0 C-N-CA 123.815 0.846 . . . . 62.31 111.916 -177.283 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 88.3 -10.87 69.58 Favored Glycine 0 C--N 1.342 0.906 0 CA-C-N 115.323 -0.853 . . . . 73.32 113.192 -179.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.412 ' HD2' ' HB3' ' A' ' 228' ' ' GLN . 86.8 mtt180 -87.15 167.07 14.48 Favored 'General case' 0 C--O 1.249 1.062 0 N-CA-C 109.417 -0.586 . . . . 74.0 109.417 172.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.407 ' HD3' ' HA ' ' A' ' 252' ' ' GLU . 0.2 OUTLIER -120.92 126.24 49.5 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.106 -0.952 . . . . 72.22 109.218 -178.168 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 16.7 mt -83.28 99.16 9.82 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 107.363 -1.347 . . . . 71.4 107.363 177.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 69.6 ttp85 -82.38 100.8 10.21 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.442 -0.947 . . . . 64.14 108.442 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.52 HD12 HD23 ' A' ' 249' ' ' LEU . 21.6 mt -98.41 92.24 5.58 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 108.975 -0.75 . . . . 61.12 108.975 -175.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? -60.99 128.51 36.8 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.243 0.617 . . . . 64.43 110.69 -175.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 83.16 6.11 88.39 Favored Glycine 0 C--N 1.346 1.103 0 CA-C-N 115.228 -0.896 . . . . 74.2 114.012 175.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.14 6.73 47.21 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 117.715 0.757 . . . . 73.01 111.066 178.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -93.92 -162.04 35.58 Favored Glycine 0 C--N 1.34 0.79 0 CA-C-N 115.662 -0.699 . . . . 74.43 112.095 174.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 240' ' ' PHE . . . . . 0.613 ' HZ ' ' HB2' ' A' ' 150' ' ' PRO . 18.3 t80 -78.07 137.1 61.27 Favored Pre-proline 0 CA--C 1.551 1.016 0 CA-C-O 118.904 -0.569 . . . . 73.13 109.967 -177.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -61.16 106.65 0.4 Allowed 'Trans proline' 0 C--N 1.382 2.336 0 C-N-CA 122.152 1.902 . . . . 73.33 112.1 171.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -137.06 -153.11 6.33 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-O 119.027 -0.874 . . . . 73.52 112.776 -175.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -54.32 -42.01 71.37 Favored 'Trans proline' 0 C--N 1.384 2.416 0 C-N-CA 123.455 2.77 . . . . 70.45 113.383 176.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -82.24 23.96 0.7 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.965 0.906 . . . . 70.11 112.452 -178.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 83.14 -93.07 1.68 Allowed Glycine 0 C--N 1.35 1.308 0 N-CA-C 109.612 -1.395 . . . . 62.24 109.612 -174.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 20.1 mtm180 -128.12 141.86 51.36 Favored 'General case' 0 C--O 1.247 0.936 0 N-CA-C 107.951 -1.129 . . . . 75.41 107.951 164.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -72.99 -173.51 24.88 Favored Glycine 0 C--N 1.349 1.26 0 O-C-N 123.352 0.408 . . . . 42.24 113.884 -177.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -112.85 135.7 53.31 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.505 0.722 . . . . 75.44 110.498 -174.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.52 HD23 HD12 ' A' ' 235' ' ' LEU . 64.6 tp -97.32 104.96 17.03 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.749 -0.834 . . . . 70.31 108.749 -178.019 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -90.12 105.98 18.18 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.515 0.726 . . . . 52.51 110.05 -177.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.478 HD22 ' HB2' ' A' ' 197' ' ' LEU . 41.5 mt -90.14 119.21 30.28 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 122.874 0.47 . . . . 72.24 109.942 177.068 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 252' ' ' GLU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 232' ' ' LYS . 0.4 OUTLIER -79.11 116.44 19.4 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 107.973 -1.121 . . . . 75.41 107.973 178.639 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 21.8 t -78.21 102.4 4.46 Favored 'Isoleucine or valine' 0 C--O 1.245 0.841 0 CA-C-O 120.969 0.414 . . . . 24.43 111.402 -174.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -101.85 95.39 6.36 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.642 1.177 . . . . 73.14 109.066 168.2 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.502 ' HB ' ' O ' ' C' ' 255' ' ' ILE . 63.0 mt -77.18 141.06 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 109.879 -0.415 . . . . 74.34 109.879 175.232 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 21.6 p -130.03 176.68 7.87 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.777 1.231 . . . . 73.43 109.161 177.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.6 pp -137.71 158.41 71.75 Favored Pre-proline 0 CA--C 1.571 1.779 0 C-N-CA 123.625 0.77 . . . . 73.4 111.208 -175.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -55.96 -14.8 11.98 Favored 'Trans proline' 0 C--N 1.39 2.724 0 C-N-CA 123.843 3.028 . . . . 74.45 116.11 -167.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 259' ' ' GLU . . . . . 0.453 ' HA ' ' HB3' ' C' ' 226' ' ' ARG . 39.9 mt-10 56.52 -69.98 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 125.53 1.532 . . . . 63.24 113.396 -173.008 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.36 146.19 36.83 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 108.939 -0.763 . . . . 75.12 108.939 169.443 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.627 HD22 ' HB2' ' A' ' 265' ' ' GLU . 66.6 mt -138.12 167.97 20.71 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.495 0.718 . . . . 55.32 109.23 172.169 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 71.6 p -129.75 154.13 80.95 Favored Pre-proline 0 CA--C 1.555 1.149 0 N-CA-C 107.596 -1.261 . . . . 44.34 107.596 169.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -33.65 -37.2 0.1 OUTLIER 'Trans proline' 0 C--N 1.397 3.128 0 C-N-CA 125.041 3.828 . . . . 74.33 117.221 -169.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -62.51 -68.17 0.35 Allowed 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.377 0.671 . . . . 71.44 111.798 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 265' ' ' GLU . . . . . 0.627 ' HB2' HD22 ' A' ' 261' ' ' LEU . 2.5 mp0 -65.25 -30.29 71.15 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 109.478 -0.564 . . . . 64.2 109.478 -176.254 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 266' ' ' GLU . . . . . 0.474 ' HA ' HD13 ' A' ' 261' ' ' LEU . 5.8 tp10 -53.21 -52.52 58.63 Favored 'General case' 0 CA--C 1.551 0.998 0 O-C-N 124.043 0.839 . . . . 73.45 109.401 174.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -61.83 -49.52 75.97 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 115.28 -0.873 . . . . 64.12 111.714 177.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 9.3 mp -56.78 -54.32 47.7 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.804 0.842 . . . . 73.14 112.145 -176.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 72.5 m95 -56.7 -49.1 76.13 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.949 0.899 . . . . 75.0 111.404 177.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 270' ' ' LYS . . . . . 0.659 ' HG3' HG23 ' C' ' 206' ' ' VAL . 1.1 mptm? -60.48 -34.89 74.69 Favored 'General case' 0 CA--C 1.552 1.039 0 O-C-N 123.678 0.611 . . . . 62.43 111.359 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 7.4 mmpt? -69.91 -46.87 64.45 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 117.993 0.361 . . . . 70.22 111.213 178.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 272' ' ' LEU . . . . . 0.443 HD21 ' HB2' ' C' ' 268' ' ' LEU . 80.9 mt -54.24 -39.83 67.16 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.827 0.851 . . . . 63.4 110.7 174.553 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -80.38 -41.52 24.51 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.786 1.234 . . . . 64.51 113.974 -170.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -64.93 -43.98 90.99 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 108.937 -0.764 . . . . 74.35 108.937 175.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -63.81 -38.57 91.6 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 114.909 -1.041 . . . . 71.44 110.934 173.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -59.91 -56.24 24.22 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.462 0.705 . . . . 75.02 110.109 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -63.67 -37.62 88.03 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.019 0.928 . . . . 70.12 109.967 -175.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -60.12 -26.13 66.0 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 115.463 -0.79 . . . . 75.41 111.89 173.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 49.7 mtm180 -107.38 -1.17 21.83 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.832 0.853 . . . . 74.13 111.72 178.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.248 0 N-CA-C 109.001 -0.74 . . . . 72.21 109.001 -179.231 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 111.437 0.162 . . . . 71.44 111.437 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 2' ' ' LYS . . . . . 0.628 ' HD3' ' HG2' ' A' ' 128' ' ' GLU . 0.4 OUTLIER -123.25 -1.85 8.64 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.377 0.671 . . . . 54.1 111.934 -178.734 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -93.2 0.62 57.18 Favored 'General case' 0 CA--C 1.559 1.307 0 N-CA-C 109.032 -0.729 . . . . 74.04 109.032 168.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 63.4 m -51.56 138.36 22.66 Favored 'General case' 0 C--N 1.357 0.903 0 C-N-CA 125.993 1.717 . . . . 52.14 113.165 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 5' ' ' THR . . . . . 0.58 HG23 HH11 ' A' ' 136' ' ' ARG . 0.3 OUTLIER -110.99 170.04 8.37 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.149 0.98 . . . . 70.11 110.108 -175.583 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.579 ' HB ' ' HG2' ' A' ' 124' ' ' PRO . 45.5 pt -132.64 173.49 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 N-CA-C 113.031 0.752 . . . . 64.44 113.031 -161.006 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -145.1 133.77 22.17 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.571 1.148 . . . . 72.01 108.875 171.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 8' ' ' LEU . . . . . 0.515 HD23 HG21 ' A' ' 140' ' ' VAL . 34.2 tp -72.83 150.77 42.42 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.868 0.867 . . . . 75.22 110.249 -176.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -79.35 -50.48 10.79 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 119.654 -0.212 . . . . 62.4 111.254 177.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 74.7 mt 62.93 109.2 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 124.338 1.055 . . . . 74.1 110.4 -167.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 85.5 mt . . . . . 0 N--CA 1.478 0.936 0 N-CA-C 109.201 -0.666 . . . . 45.35 109.201 177.986 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.993 0 CA-C-O 120.184 0.04 . . . . 61.34 110.97 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . -67.91 -46.38 71.74 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-O 121.347 0.594 . . . . 74.4 109.431 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 181' ' ' LEU . . . . . 0.582 ' HB2' ' HB3' ' C' ' 136' ' ' ARG . 33.3 tp -116.61 -96.57 0.46 Allowed 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 105.856 -1.905 . . . . 62.04 105.856 154.025 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 182' ' ' VAL . . . . . 0.585 HG13 ' HB2' ' C' ' 123' ' ' LEU . 7.4 p 156.74 138.6 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.245 0.857 0 C-N-CA 126.777 2.031 . . . . 71.31 105.688 -178.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 183' ' ' ALA . . . . . 0.712 ' HA ' ' HB3' ' C' ' 123' ' ' LEU . . . -160.76 -103.28 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 118.907 -0.568 . . . . 65.24 111.168 176.343 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 59.54 142.86 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 124.142 0.977 . . . . 74.15 111.372 -164.193 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 185' ' ' VAL . . . . . 0.527 ' HA ' ' HA ' ' C' ' 121' ' ' ALA . 50.8 t . . . . . 0 CA--C 1.57 1.733 0 C-N-CA 123.581 0.752 . . . . 71.33 112.707 -170.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 238' ' ' THR . . . . . 0.456 HG22 HG23 ' C' ' 219' ' ' VAL . 13.3 m . . . . . 0 N--CA 1.479 1.003 0 CA-C-O 121.488 0.661 . . . . 71.31 109.797 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -83.64 173.23 11.56 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 114.518 -1.219 . . . . 74.42 111.15 177.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 240' ' ' GLY . . . . . 0.412 ' H ' HD22 ' C' ' 235' ' ' LEU . . . -83.17 -130.7 1.65 Allowed Glycine 0 C--N 1.346 1.126 0 CA-C-N 115.369 -0.832 . . . . 71.23 112.651 178.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -151.69 156.1 39.68 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.695 0.798 . . . . 71.21 108.96 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 242' ' ' TRP . . . . . 0.471 ' CD2' ' HG ' ' C' ' 233' ' ' LEU . 1.2 p-90 -168.04 115.85 0.73 Allowed 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 113.251 0.834 . . . . 70.32 113.251 -175.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 24.83 74.23 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 128.072 2.549 . . . . 74.22 115.307 166.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 126.58 -142.62 13.72 Favored Glycine 0 C--N 1.341 0.822 0 CA-C-N 115.49 -0.777 . . . . 63.11 112.396 178.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? . . . . . 0 N--CA 1.482 1.16 0 C-N-CA 127.159 2.183 . . . . 75.34 110.145 -175.066 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.772 0 N-CA-C 110.188 -0.301 . . . . 52.01 110.188 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -34.17 93.71 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 127.041 2.137 . . . . 70.52 112.894 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 5' ' ' LYS . . . . . 0.495 ' HE2' HD11 ' C' ' 10' ' ' ILE . 14.5 mmmm -92.84 93.29 8.33 Favored 'General case' 0 C--O 1.243 0.72 0 N-CA-C 107.812 -1.181 . . . . 63.2 107.812 169.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -73.67 97.36 2.66 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 107.193 -1.41 . . . . 63.22 107.193 175.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 7' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -61.54 -37.86 85.32 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.182 -0.917 . . . . 73.43 111.598 -171.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -60.97 -45.02 96.45 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 116.181 -0.463 . . . . 72.53 110.481 175.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.96 -40.95 99.25 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.051 0.54 . . . . 52.31 111.207 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 10' ' ' ILE . . . . . 0.495 HD11 ' HE2' ' C' ' 5' ' ' LYS . 64.6 mt -61.92 -36.07 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.213 0.605 . . . . 63.34 110.576 177.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 11' ' ' LEU . . . . . 0.583 HD13 HG23 ' C' ' 22' ' ' ILE . 68.7 mt -80.61 -13.85 58.69 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 112.46 0.541 . . . . 45.45 112.46 176.128 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.11 35.92 42.27 Favored Glycine 0 C--N 1.351 1.364 0 N-CA-C 113.689 0.235 . . . . 64.33 113.689 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 6.1 m -131.56 153.44 81.55 Favored Pre-proline 0 N--CA 1.482 1.151 0 C-N-CA 124.691 1.196 . . . . 64.04 109.184 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -76.51 161.08 34.7 Favored 'Trans proline' 0 C--N 1.373 1.83 0 C-N-CA 122.432 2.088 . . . . 74.43 112.293 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -67.85 80.53 0.2 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.339 0.655 . . . . 71.52 109.898 176.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -179.19 -30.03 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.673 1.189 . . . . 71.24 109.038 -174.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -47.58 119.72 2.9 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 124.744 1.277 . . . . 71.14 111.688 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 72.3 p -86.25 178.35 7.21 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.802 0.841 . . . . 74.41 110.14 177.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -48.45 -38.28 19.46 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 124.515 1.126 . . . . 74.45 112.195 -177.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 20' ' ' GLU . . . . . 0.402 ' O ' ' HG3' ' C' ' 24' ' ' ARG . 13.9 tp10 -66.72 -52.63 42.25 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.387 0.675 . . . . 64.05 110.953 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 21' ' ' GLU . . . . . 0.662 ' HA ' ' HE ' ' C' ' 24' ' ' ARG . 33.7 mt-10 -65.0 -34.37 78.27 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.636 0.775 . . . . 73.42 111.285 -176.317 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 22' ' ' ILE . . . . . 0.896 HD13 ' HB3' ' C' ' 57' ' ' LEU . 82.1 mt -75.56 -36.08 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.214 1.405 . . . . 61.32 111.268 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -62.87 -44.21 96.74 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.758 0.823 . . . . 74.13 109.77 175.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 24' ' ' ARG . . . . . 0.662 ' HE ' ' HA ' ' C' ' 21' ' ' GLU . 42.8 mtm180 -64.63 -46.05 84.19 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 115.332 -0.849 . . . . 73.52 110.829 178.246 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 25' ' ' ALA . . . . . 0.42 ' O ' ' HB3' ' C' ' 28' ' ' ARG . . . -61.5 -37.68 84.58 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.461 0.705 . . . . 75.32 111.682 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 26' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -62.97 -52.1 64.33 Favored 'General case' 0 C--O 1.212 -0.882 0 CA-C-N 115.121 -0.945 . . . . 72.31 109.998 176.274 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -58.02 -37.14 73.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 123.882 0.739 . . . . 74.1 111.369 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 28' ' ' ARG . . . . . 0.42 ' HB3' ' O ' ' C' ' 25' ' ' ALA . 20.8 ttt180 -53.15 -56.03 19.54 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.294 1.037 . . . . 71.15 110.45 172.303 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 29' ' ' LEU . . . . . 0.671 ' HB3' HD13 ' C' ' 50' ' ' ILE . 91.2 mt -80.9 -11.15 59.63 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 115.769 -0.65 . . . . 60.22 111.879 -177.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -91.31 -10.7 40.39 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.126 0.97 . . . . 75.32 110.535 177.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -93.89 -48.6 6.2 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.216 0.606 . . . . 73.5 110.342 165.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 20.6 tp60 -62.44 -48.52 79.31 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.452 0.701 . . . . 71.12 111.297 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 33' ' ' TYR . . . . . 0.417 ' HE2' HD22 ' C' ' 29' ' ' LEU . 29.4 m-85 -109.01 37.11 2.65 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.218 0.607 . . . . 70.15 109.969 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 34' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -67.89 111.48 7.81 Favored Pre-proline 0 N--CA 1.473 0.719 0 CA-C-O 118.373 -0.823 . . . . 72.34 109.378 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.74 -29.21 76.94 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 122.417 2.078 . . . . 71.32 111.318 -176.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -62.07 -33.03 73.65 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.364 1.466 . . . . 60.34 112.153 176.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 98.6 t -96.71 -62.62 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 N-CA-C 108.988 -0.745 . . . . 75.33 108.988 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -98.72 96.46 7.93 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.263 1.025 . . . . 54.22 110.604 -177.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -80.03 74.66 6.8 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 108.644 -0.873 . . . . 62.24 108.644 173.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 71.1 m -126.8 97.85 32.17 Favored Pre-proline 0 CA--C 1.538 0.506 0 N-CA-C 108.591 -0.892 . . . . 74.14 108.591 175.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -39.16 -44.19 2.64 Favored 'Trans proline' 0 C--N 1.388 2.655 0 C-N-CA 124.76 3.64 . . . . 63.44 114.545 -176.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -48.6 -55.51 10.98 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 124.811 1.244 . . . . 65.44 111.023 174.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.42 -21.21 63.77 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 115.476 -0.784 . . . . 62.05 111.272 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 44' ' ' GLU . . . . . 0.437 ' O ' ' HG3' ' C' ' 48' ' ' LYS . 43.0 mt-10 -88.76 -24.57 22.61 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.529 0.731 . . . . 74.04 110.748 -175.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -81.31 -36.54 29.65 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.615 0.766 . . . . 42.53 109.248 174.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 46' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -65.21 -36.64 84.81 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.05 -0.977 . . . . 72.32 109.167 169.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 47' ' ' PHE . . . . . 0.572 ' HA ' HD12 ' C' ' 50' ' ' ILE . 41.9 t80 -66.68 -32.62 74.06 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.449 0.7 . . . . 62.23 110.408 173.521 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 48' ' ' LYS . . . . . 0.442 ' HB3' ' CE1' ' C' ' 93' ' ' PHE . 95.7 mttt -64.14 -39.79 94.79 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 122.889 0.476 . . . . 72.04 110.808 172.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -69.15 -28.94 66.87 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.65 0.38 . . . . 72.33 110.774 176.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 50' ' ' ILE . . . . . 0.671 HD13 ' HB3' ' C' ' 29' ' ' LEU . 71.2 mt -73.07 -32.79 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 123.856 0.863 . . . . 75.43 110.381 173.014 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 51' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -77.38 -24.73 50.54 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.257 0.623 . . . . 74.04 110.62 175.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -71.09 -52.85 17.02 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 108.369 -0.974 . . . . 63.42 108.369 172.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.22 -44.41 79.53 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 113.533 -1.667 . . . . 63.1 111.467 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -74.18 -38.33 63.68 Favored 'General case' 0 C--O 1.208 -1.112 0 CA-C-N 115.425 -0.807 . . . . 75.01 110.384 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.89 -35.77 75.54 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-O 120.81 0.338 . . . . 60.54 111.469 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 47.5 t -77.84 -44.71 28.55 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 CA-C-N 115.906 -0.588 . . . . 72.43 109.875 175.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 57' ' ' LEU . . . . . 0.896 ' HB3' HD13 ' C' ' 22' ' ' ILE . 52.4 mt -98.74 0.65 44.93 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 115.428 1.64 . . . . 75.02 115.428 -166.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 30.9 t -75.56 -66.12 0.81 Allowed 'General case' 0 N--CA 1.484 1.233 0 CA-C-O 121.733 0.777 . . . . 62.42 109.686 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -86.83 132.36 42.39 Favored Pre-proline 0 C--O 1.255 1.376 0 CA-C-N 114.438 -1.255 . . . . 72.03 108.885 -169.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 60' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_exo -46.6 -30.5 8.9 Favored 'Trans proline' 0 C--N 1.388 2.626 0 C-N-CA 124.218 3.279 . . . . 33.23 114.796 -175.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -57.25 -69.74 0.15 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.572 0.749 . . . . 62.13 111.413 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.28 -25.54 63.39 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 122.773 0.429 . . . . 75.23 110.619 -173.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -61.93 -47.86 83.0 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 108.147 -1.057 . . . . 64.42 108.147 175.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -70.14 -29.34 66.23 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.156 0.582 . . . . 74.15 111.618 177.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 82.0 mt -62.08 -43.8 98.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 C-N-CA 122.72 0.408 . . . . 62.34 110.384 174.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -67.08 -46.55 73.93 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.771 -0.649 . . . . 74.22 109.797 177.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -55.1 -47.58 74.75 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.228 0.611 . . . . 73.14 110.758 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 70.4 p -70.39 -26.81 63.87 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.94 -0.573 . . . . 63.2 111.518 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -69.51 136.17 51.08 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 108.81 -0.811 . . . . 75.22 108.81 178.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.05 15.28 54.5 Favored Glycine 0 N--CA 1.473 1.107 0 N-CA-C 111.632 -0.587 . . . . 62.51 111.632 -169.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 58.2 m -148.4 -60.24 0.24 Allowed 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 103.698 -2.704 . . . . 72.34 103.698 175.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 56.8 m -75.04 140.53 43.61 Favored 'General case' 0 C--O 1.252 1.218 0 N-CA-C 105.147 -2.168 . . . . 73.35 105.147 156.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.87 -36.25 6.7 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.88 0.872 . . . . 73.23 110.873 -176.485 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -93.32 139.17 22.88 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 123.986 0.915 . . . . 53.23 110.096 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -61.7 144.48 97.29 Favored 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 122.691 2.261 . . . . 75.14 112.096 175.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -49.84 144.34 21.07 Favored 'Trans proline' 0 C--N 1.384 2.406 0 C-N-CA 123.826 3.017 . . . . 63.14 113.805 175.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 77' ' ' PRO . . . . . 0.42 ' HA ' ' HD3' ' C' ' 78' ' ' PRO . 18.2 Cg_endo -57.82 131.87 46.52 Favored 'Trans proline' 0 C--N 1.381 2.251 0 C-N-CA 122.697 2.265 . . . . 51.51 111.65 177.346 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 78' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' C' ' 77' ' ' PRO . 32.2 Cg_exo -57.92 113.61 1.6 Allowed 'Trans proline' 0 C--N 1.388 2.657 0 C-N-CA 122.89 2.393 . . . . 74.44 112.221 -174.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -80.93 178.41 6.94 Favored 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 122.882 2.388 . . . . 61.04 111.902 -178.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -54.51 90.54 0.04 OUTLIER 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 122.279 1.986 . . . . 51.5 112.271 167.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 134.26 -1.64 4.14 Favored Glycine 0 N--CA 1.466 0.662 0 CA-C-N 114.937 -1.029 . . . . 75.2 112.399 175.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 67.01 -149.8 51.51 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 112.39 -0.284 . . . . 74.45 112.39 178.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -99.46 113.63 26.1 Favored 'General case' 0 C--O 1.244 0.803 0 N-CA-C 108.208 -1.034 . . . . 70.14 108.208 168.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 84' ' ' ASP . . . . . 0.404 ' HB3' ' HG3' ' C' ' 143' ' ' ARG . 4.8 p-10 -71.74 134.3 46.14 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-O 121.394 0.616 . . . . 63.13 110.009 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 85' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -159.25 22.24 0.19 Allowed 'General case' 0 C--O 1.248 0.999 0 CA-C-N 114.603 -1.181 . . . . 74.41 107.969 -177.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 86' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' C' ' 169' ' ' ASN . 19.0 m -62.79 128.27 35.14 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 113.141 -1.845 . . . . 45.43 111.273 -170.081 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 87' ' ' GLY . . . . . 0.572 ' HA2' ' HA ' ' C' ' 171' ' ' PRO . . . 99.25 -20.95 47.93 Favored Glycine 0 C--N 1.336 0.569 0 O-C-N 123.775 0.672 . . . . 74.33 112.938 178.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 88' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -93.79 150.64 20.22 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 117.457 0.628 . . . . 74.44 110.224 -178.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -82.56 73.69 9.58 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.113 0.565 . . . . 72.23 110.442 -174.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 90' ' ' VAL . . . . . . . . . . . . . 3.2 p -43.41 -41.72 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 C-N-CA 125.456 1.503 . . . . 54.41 112.486 177.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -56.76 -36.09 69.41 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.902 1.281 . . . . 74.21 111.945 -175.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -88.87 -21.02 23.88 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.02 0.528 . . . . 75.53 111.997 -175.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 93' ' ' PHE . . . . . 0.442 ' CE1' ' HB3' ' C' ' 48' ' ' LYS . 4.5 m-30 -81.75 164.74 21.51 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 122.326 0.251 . . . . 72.45 111.295 -168.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 94.5 p -60.19 152.08 25.51 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.586 1.154 . . . . 45.51 113.598 -165.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.55 -31.79 70.88 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 114.964 -1.016 . . . . 55.43 111.062 170.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -59.88 -44.51 94.14 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.175 0.99 . . . . 65.02 110.426 175.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 97' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -62.1 -43.33 99.07 Favored 'General case' 0 CA--C 1.558 1.28 0 CA-C-N 114.978 -1.01 . . . . 64.25 110.362 170.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -73.68 -1.46 19.13 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.184 0.593 . . . . 51.52 111.758 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -98.95 -41.32 7.64 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.559 0.743 . . . . 74.43 112.092 168.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 23.9 tp -82.02 -35.55 28.73 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.284 0.634 . . . . 73.23 111.83 -174.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -114.14 -17.76 11.82 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.673 0.789 . . . . 73.25 110.956 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -42.72 -58.73 3.47 Favored Glycine 0 CA--C 1.541 1.67 0 CA-C-O 118.689 -1.062 . . . . 54.11 115.466 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.0 -21.19 20.53 Favored 'Trans proline' 0 C--N 1.389 2.658 0 C-N-CA 123.645 2.896 . . . . 62.02 114.224 -176.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -127.68 8.72 6.88 Favored Glycine 0 C--N 1.357 1.7 0 CA-C-O 117.051 -1.972 . . . . 43.23 114.631 -175.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 28.5 mt . . . . . 0 N--CA 1.513 2.709 0 N-CA-C 114.623 1.342 . . . . 73.03 114.623 -175.677 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.413 0 N-CA-C 111.601 -0.6 . . . . 45.25 111.601 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 117' ' ' ARG . . . . . 0.693 ' HB2' ' HB2' ' C' ' 167' ' ' GLN . 50.3 mtm180 -115.46 180.0 3.8 Favored 'General case' 0 C--O 1.254 1.313 0 CA-C-O 122.056 0.931 . . . . 64.44 110.662 -174.03 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 118' ' ' ASP . . . . . 0.484 ' HA ' ' O ' ' C' ' 173' ' ' ASP . 0.8 OUTLIER -57.07 107.24 0.39 Allowed 'General case' 0 C--O 1.243 0.73 0 CA-C-N 112.278 -2.237 . . . . 75.42 110.193 172.124 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 119' ' ' LEU . . . . . 0.576 HD12 ' HA3' ' C' ' 166' ' ' GLY . 0.3 OUTLIER -94.91 113.89 25.67 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 107.647 -1.242 . . . . 75.21 107.647 174.619 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.463 ' HA ' ' O ' ' C' ' 175' ' ' LEU . 0.0 OUTLIER -104.4 124.8 49.88 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 110.125 -0.324 . . . . 72.31 110.125 -173.797 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 121' ' ' ALA . . . . . 0.527 ' HA ' ' HA ' ' B' ' 185' ' ' VAL . . . -111.43 137.15 49.59 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.388 0.675 . . . . 63.21 111.231 -177.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -92.66 90.15 6.97 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 107.665 -1.235 . . . . 73.22 107.665 170.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 123' ' ' LEU . . . . . 0.712 ' HB3' ' HA ' ' B' ' 183' ' ' ALA . 1.1 pt? -105.36 114.28 63.49 Favored Pre-proline 0 N--CA 1.49 1.539 0 CA-C-N 118.474 0.579 . . . . 73.3 112.116 -174.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 124' ' ' PRO . . . . . 0.544 ' HA ' ' O ' ' C' ' 179' ' ' ARG . 36.2 Cg_exo -64.64 112.35 1.94 Allowed 'Trans proline' 0 C--N 1.386 2.528 0 C-N-CA 122.606 2.204 . . . . 72.51 110.489 164.406 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 125' ' ' LEU . . . . . 0.408 HD23 HG21 ' C' ' 153' ' ' VAL . 51.3 tp -131.79 147.3 52.48 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 122.552 0.341 . . . . 74.03 110.828 -169.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 126' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -92.08 151.47 20.42 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.302 0.641 . . . . 61.53 109.946 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 127' ' ' LEU . . . . . 0.42 ' CD2' HD13 ' C' ' 180' ' ' LEU . 25.2 mt -65.82 -50.99 62.66 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.425 1.09 . . . . 62.25 110.311 -177.355 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -53.69 -42.87 68.44 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 113.165 -1.834 . . . . 75.24 109.896 176.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 129' ' ' GLU . . . . . 0.508 ' HA ' ' HB2' ' C' ' 132' ' ' HIS . 15.1 mm-40 -82.33 -16.93 47.5 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.737 0.815 . . . . 73.53 111.821 -175.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -71.93 -31.53 66.44 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 109.014 -0.735 . . . . 64.34 109.014 172.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 131' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -73.11 -51.12 19.16 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 115.471 -0.786 . . . . 75.55 110.659 164.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 132' ' ' HIS . . . . . 0.508 ' HB2' ' HA ' ' C' ' 129' ' ' GLU . 38.3 m80 -76.32 3.82 10.16 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.005 0.522 . . . . 60.22 112.234 -171.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -58.83 88.26 0.02 OUTLIER Glycine 0 CA--C 1.539 1.544 0 N-CA-C 114.578 0.591 . . . . 65.31 114.578 171.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . -88.03 -143.9 9.12 Favored Glycine 0 C--N 1.355 1.631 0 N-CA-C 111.34 -0.704 . . . . 53.24 111.34 170.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 26.1 mp0 -70.48 93.83 0.92 Allowed 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 107.971 -1.122 . . . . 71.2 107.971 171.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 136' ' ' ARG . . . . . 0.582 ' HB3' ' HB2' ' B' ' 181' ' ' LEU . 78.7 mtt180 -115.58 138.19 51.31 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.024 0.529 . . . . 72.12 110.081 -173.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 137' ' ' VAL . . . . . 0.507 ' HA ' ' HA ' ' C' ' 146' ' ' SER . 21.5 t -76.7 103.57 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-N 116.099 -0.501 . . . . 71.12 109.877 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 138' ' ' VAL . . . . . 0.508 ' HB ' HD23 ' B' ' 181' ' ' LEU . 4.6 p -80.43 123.69 37.45 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 123.659 0.784 . . . . 72.14 109.22 174.15 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 139' ' ' GLU . . . . . 0.642 ' HG2' ' HG3' ' C' ' 144' ' ' ARG . 28.3 mt-10 -118.97 92.01 3.7 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.77 0.828 . . . . 74.31 109.175 -165.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 140' ' ' VAL . . . . . 0.438 ' HB ' ' HB1' ' B' ' 183' ' ' ALA . 7.1 p -143.53 147.39 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 C-N-CA 123.282 0.633 . . . . 63.22 111.435 -168.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 64.53 17.29 10.78 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 125.045 1.338 . . . . 15.23 111.908 -174.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 87.37 -8.64 76.29 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-N 115.568 -0.742 . . . . 45.25 112.947 -175.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 143' ' ' ARG . . . . . 0.432 ' HD3' ' HA ' ' C' ' 143' ' ' ARG . 6.7 mmt180 -101.47 139.94 36.45 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.446 0.641 . . . . 73.04 111.474 -177.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 144' ' ' ARG . . . . . 0.642 ' HG3' ' HG2' ' C' ' 139' ' ' GLU . 59.7 ttt180 -115.45 93.22 4.19 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-N 114.652 -1.158 . . . . 71.51 110.178 -165.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 145' ' ' VAL . . . . . . . . . . . . . 30.3 m -118.79 142.5 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 123.179 0.591 . . . . 75.03 112.001 -172.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 146' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' C' ' 137' ' ' VAL . 20.3 m -95.0 128.97 42.23 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.266 1.026 . . . . 54.21 111.054 -177.256 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 14.4 p -162.75 148.1 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 123.042 0.537 . . . . 72.53 110.663 175.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 29.8 ttm-85 -84.28 117.22 23.41 Favored 'General case' 0 C--N 1.349 0.571 0 N-CA-C 108.994 -0.743 . . . . 74.22 108.994 166.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 149' ' ' ILE . . . . . 0.452 HD13 HD21 ' B' ' 181' ' ' LEU . 42.2 pt -88.36 150.12 46.12 Favored Pre-proline 0 CA--C 1.548 0.878 0 N-CA-C 108.642 -0.873 . . . . 71.41 108.642 172.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -50.02 112.29 0.69 Allowed 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 123.183 2.589 . . . . 61.44 113.236 179.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -61.5 106.35 0.41 Allowed 'Trans proline' 0 C--N 1.383 2.376 0 C-N-CA 122.958 2.439 . . . . 73.2 112.117 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 152' ' ' GLY . . . . . . . . . . . . . . . 129.19 101.53 1.0 Allowed Glycine 0 C--N 1.343 0.922 0 CA-C-N 115.214 -0.903 . . . . 54.32 111.37 -171.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 153' ' ' VAL . . . . . 0.408 HG21 HD23 ' C' ' 125' ' ' LEU . 1.0 OUTLIER -122.77 159.84 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 CA-C-N 117.145 0.472 . . . . 71.13 110.398 -179.042 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 154' ' ' ARG . . . . . 0.624 ' HB2' ' HB2' ' C' ' 157' ' ' SER . 38.6 mtp180 -119.05 121.77 40.61 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.245 1.018 . . . . 75.32 109.105 -171.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 155' ' ' GLU . . . . . 0.712 ' HB3' ' HG2' ' C' ' 187' ' ' ARG . 9.4 tp10 -45.3 122.94 3.73 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.909 0.883 . . . . 74.51 112.45 174.589 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 87.52 -21.25 22.86 Favored Glycine 0 C--N 1.351 1.403 0 O-C-N 124.425 1.078 . . . . 64.51 113.276 176.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 157' ' ' SER . . . . . 0.624 ' HB2' ' HB2' ' C' ' 154' ' ' ARG . 33.8 m -88.97 -177.92 5.59 Favored 'General case' 0 C--O 1.247 0.962 0 CA-C-O 121.445 0.641 . . . . 75.43 110.733 -172.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 7.2 p -128.11 127.53 67.78 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 CA-C-N 115.48 -0.782 . . . . 64.44 111.587 -173.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 159' ' ' ILE . . . . . 0.597 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 47.9 mt -73.63 139.04 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.673 1.189 . . . . 52.25 109.194 168.109 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 30.1 ttt85 -117.38 111.02 18.76 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 109.098 -0.705 . . . . 72.21 109.098 175.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 161' ' ' VAL . . . . . 0.619 HG13 ' HB3' ' C' ' 174' ' ' LEU . 1.6 p -106.03 98.93 20.31 Favored Pre-proline 0 CA--C 1.555 1.166 0 N-CA-C 108.295 -1.002 . . . . 75.24 108.295 168.086 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -76.54 140.17 21.14 Favored 'Trans proline' 0 C--N 1.384 2.433 0 C-N-CA 123.07 2.513 . . . . 63.42 112.141 178.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 110.14 -7.84 30.99 Favored Glycine 0 C--N 1.347 1.157 0 CA-C-O 119.817 -0.435 . . . . 53.31 112.455 178.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 164' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -158.13 124.17 4.65 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.959 0.904 . . . . 73.35 109.383 172.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . -125.68 -116.33 2.1 Favored Glycine 0 C--N 1.346 1.123 0 C-N-CA 123.854 0.74 . . . . 64.24 112.474 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 166' ' ' GLY . . . . . 0.576 ' HA3' HD12 ' C' ' 119' ' ' LEU . . . -169.87 -61.52 0.04 OUTLIER Glycine 0 C--N 1.346 1.103 0 C-N-CA 120.21 -0.995 . . . . 75.44 114.653 175.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 167' ' ' GLN . . . . . 0.693 ' HB2' ' HB2' ' C' ' 117' ' ' ARG . 14.1 mm100 -66.69 98.58 0.53 Allowed 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 117.09 0.445 . . . . 64.31 110.692 -165.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . 110.34 -144.25 17.01 Favored Glycine 0 C--O 1.213 -1.173 0 CA-C-O 118.352 -1.249 . . . . 13.44 111.72 -165.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 169' ' ' ASN . . . . . 0.444 ' HB3' ' HD3' ' C' ' 170' ' ' PRO . 17.9 t-20 -150.21 -51.39 0.02 OUTLIER Pre-proline 0 CA--C 1.594 2.659 0 CA-C-N 119.723 1.762 . . . . 62.44 113.291 -177.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 170' ' ' PRO . . . . . 0.444 ' HD3' ' HB3' ' C' ' 169' ' ' ASN . 49.5 Cg_exo -48.59 177.03 0.02 OUTLIER 'Trans proline' 0 N--CA 1.522 3.188 0 C-N-CA 124.359 3.373 . . . . 51.41 116.765 168.617 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 171' ' ' PRO . . . . . 0.572 ' HA ' ' HA2' ' C' ' 87' ' ' GLY . 1.1 Cg_exo -31.55 119.25 0.08 OUTLIER 'Trans proline' 0 C--N 1.404 3.483 1 C-N-CA 125.417 4.078 . . . . 74.02 117.272 172.969 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -160.56 -172.24 27.56 Favored Glycine 0 C--N 1.356 1.668 0 C-N-CA 124.276 0.941 . . . . 74.42 111.333 177.15 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 173' ' ' ASP . . . . . 0.484 ' O ' ' HA ' ' C' ' 118' ' ' ASP . 5.8 p-10 -140.79 147.68 39.44 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.718 0.771 . . . . 74.51 111.209 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 174' ' ' LEU . . . . . 0.619 ' HB3' HG13 ' C' ' 161' ' ' VAL . 43.9 tp -97.83 112.63 24.47 Favored 'General case' 0 C--O 1.245 0.849 0 N-CA-C 109.147 -0.686 . . . . 75.22 109.147 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 175' ' ' LEU . . . . . 0.463 ' O ' ' HA ' ' C' ' 120' ' ' ARG . 55.7 mt -87.18 112.25 21.78 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.245 -1.343 . . . . 71.32 109.664 174.162 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 176' ' ' LEU . . . . . 0.597 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 57.7 mt -100.41 97.26 8.02 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 109.355 -0.609 . . . . 43.02 109.355 174.044 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 177' ' ' VAL . . . . . . . . . . . . . 17.1 t -83.61 103.36 10.78 Favored 'Isoleucine or valine' 0 C--O 1.253 1.238 0 N-CA-C 107.904 -1.147 . . . . 74.43 107.904 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 178' ' ' VAL . . . . . . . . . . . . . 6.1 m -84.95 117.43 30.19 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 CA-C-N 114.397 -1.274 . . . . 74.01 112.086 -172.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 179' ' ' ARG . . . . . 0.544 ' O ' ' HA ' ' C' ' 124' ' ' PRO . 6.2 mmm180 -105.36 107.77 18.94 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 106.142 -1.799 . . . . 72.33 106.142 166.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 180' ' ' LEU . . . . . 0.618 HD12 ' HB2' ' C' ' 155' ' ' GLU . 58.4 mt -70.12 148.23 48.99 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 122.35 -0.219 . . . . 70.51 110.583 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 181' ' ' LEU . . . . . . . . . . . . . 67.5 mt -54.28 167.03 0.6 Allowed Pre-proline 0 N--CA 1.494 1.75 0 C-N-CA 125.261 1.425 . . . . 74.2 112.434 -176.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -56.64 71.43 0.04 OUTLIER 'Trans proline' 0 C--N 1.387 2.554 0 C-N-CA 123.029 2.486 . . . . 64.12 111.217 163.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 183' ' ' HIS . . . . . 0.41 ' N ' ' HD3' ' C' ' 184' ' ' PRO . 81.2 t60 -179.2 51.91 0.05 OUTLIER Pre-proline 0 CA--C 1.557 1.249 0 C-N-CA 126.768 2.027 . . . . 62.13 106.237 -164.093 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 184' ' ' PRO . . . . . 0.41 ' HD3' ' N ' ' C' ' 183' ' ' HIS . 61.5 Cg_endo -92.18 65.19 0.87 Allowed 'Trans proline' 0 C--N 1.386 2.537 0 C-N-CA 123.046 2.498 . . . . 71.54 110.662 -170.022 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 185' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 12.4 t -93.37 -33.86 5.52 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.41 0 CA-C-N 115.284 -0.871 . . . . 72.23 109.035 -171.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 186' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -127.79 106.0 8.83 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 118.809 0.732 . . . . 61.44 111.93 -175.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 187' ' ' ARG . . . . . 0.712 ' HG2' ' HB3' ' C' ' 155' ' ' GLU . 1.6 tmt_? -95.26 116.59 28.95 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 107.352 -1.351 . . . . 75.14 107.352 169.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 188' ' ' LEU . . . . . 0.482 HD13 ' HD2' ' C' ' 240' ' ' PHE . 65.3 tp -80.74 138.89 36.32 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 122.917 0.487 . . . . 74.14 111.762 -178.045 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -142.6 113.09 7.28 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 106.548 -1.649 . . . . 71.33 106.548 169.102 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 73.92 -109.44 2.8 Favored Glycine 0 N--CA 1.474 1.177 0 N-CA-C 111.413 -0.675 . . . . 74.2 111.413 -170.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 191' ' ' GLN . . . . . 0.455 ' HA ' HD11 ' C' ' 188' ' ' LEU . 28.1 mt-30 -123.85 7.0 8.7 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 123.564 0.745 . . . . 60.21 109.085 167.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 192' ' ' ASP . . . . . 0.481 ' HB3' ' HE1' ' C' ' 250' ' ' TYR . 3.8 m-20 -95.63 142.74 27.59 Favored 'General case' 0 C--N 1.344 0.351 0 C-N-CA 125.176 1.391 . . . . 65.13 109.188 -172.378 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 193' ' ' LEU . . . . . 0.472 HD21 ' CD2' ' C' ' 240' ' ' PHE . 86.7 mt -112.45 142.34 45.11 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.587 0.355 . . . . 52.2 110.777 -178.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 194' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -108.97 128.05 54.6 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 108.17 -1.048 . . . . 75.43 108.17 165.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 195' ' ' ALA . . . . . 0.584 ' HB3' ' HG ' ' C' ' 251' ' ' LEU . . . -127.03 -178.19 4.32 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.404 0.682 . . . . 65.11 110.768 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 33.0 m -135.54 111.03 9.14 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 107.675 -1.231 . . . . 51.32 107.675 169.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 197' ' ' LEU . . . . . 0.462 HD13 ' HB2' ' C' ' 212' ' ' ALA . 42.2 tp -88.92 136.89 32.77 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 123.436 0.694 . . . . 73.5 110.055 176.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -92.4 117.32 29.8 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 108.616 -0.883 . . . . 44.52 108.616 173.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 199' ' ' VAL . . . . . 0.581 ' HA ' HG11 ' C' ' 210' ' ' VAL . 21.4 t -125.6 106.57 26.7 Favored Pre-proline 0 CA--C 1.544 0.728 0 N-CA-C 108.09 -1.078 . . . . 61.21 108.09 176.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 200' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -67.76 141.69 55.29 Favored 'Trans proline' 0 C--N 1.369 1.613 0 C-N-CA 121.737 1.625 . . . . 71.34 111.33 176.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 201' ' ' ALA . . . . . . . . . . . . . . . -42.65 -49.16 13.3 Favored Pre-proline 0 CA--C 1.559 1.313 0 C-N-CA 125.498 1.519 . . . . 74.35 114.507 -176.191 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 202' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -55.34 -52.04 8.65 Favored 'Trans proline' 0 C--N 1.388 2.611 0 C-N-CA 121.558 1.505 . . . . 63.15 112.95 175.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 203' ' ' ILE . . . . . 0.483 ' HA ' HG12 ' C' ' 206' ' ' VAL . 53.0 mt -63.45 -34.57 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 122.885 0.474 . . . . 63.4 111.022 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -62.7 -43.27 99.24 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.79 0.836 . . . . 75.02 111.522 178.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 205' ' ' VAL . . . . . 0.48 ' HA ' ' H ' ' C' ' 226' ' ' ARG . 88.5 t -79.29 -34.12 16.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 115.842 -0.617 . . . . 63.41 112.097 -176.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 206' ' ' VAL . . . . . 0.659 HG23 ' HG3' ' A' ' 270' ' ' LYS . 9.9 p -80.24 -32.05 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 122.183 0.193 . . . . 52.12 111.04 -177.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 79.48 56.32 3.42 Favored Glycine 0 C--N 1.336 0.582 0 N-CA-C 111.366 -0.694 . . . . 63.21 111.366 -171.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -92.84 -124.21 3.53 Favored Glycine 0 C--N 1.34 0.786 0 N-CA-C 111.104 -0.798 . . . . 51.32 111.104 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 209' ' ' LYS . . . . . 0.554 ' HB3' ' HG2' ' C' ' 220' ' ' GLU . 40.5 mtmt -148.0 149.35 31.99 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.399 0.679 . . . . 72.12 111.074 176.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 210' ' ' VAL . . . . . 0.581 HG11 ' HA ' ' C' ' 199' ' ' VAL . 15.8 m -137.76 141.68 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-N 114.546 -1.206 . . . . 62.05 108.753 174.408 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 211' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.73 110.54 19.4 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.264 0.626 . . . . 72.44 111.013 -176.062 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 212' ' ' ALA . . . . . 0.462 ' HB2' HD13 ' C' ' 197' ' ' LEU . . . -90.46 113.56 25.54 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 107.742 -1.207 . . . . 74.43 107.742 165.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 213' ' ' MET . . . . . . . . . . . . . 6.8 tmm? -71.62 132.45 44.64 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 107.79 -1.189 . . . . 63.12 107.79 176.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 214' ' ' THR . . . . . 0.444 ' OG1' HG12 ' C' ' 219' ' ' VAL . 0.2 OUTLIER -127.19 175.18 8.34 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.008 0.523 . . . . 54.24 110.68 -176.93 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 215' ' ' LEU . . . . . . . . . . . . . 20.3 mt -68.17 -23.31 64.85 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.12 0.968 . . . . 44.41 112.074 -172.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -87.36 -26.83 23.16 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 114.684 -1.144 . . . . 71.0 109.735 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 141.47 179.44 18.64 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 109.403 -1.479 . . . . 64.11 109.403 -168.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -75.15 119.11 5.47 Favored 'Trans proline' 0 CA--C 1.559 1.735 0 C-N-CA 122.561 2.174 . . . . 52.13 113.481 -175.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 219' ' ' VAL . . . . . 0.456 HG23 HG22 ' B' ' 238' ' ' THR . 8.6 p -91.66 125.32 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 N-CA-C 108.253 -1.018 . . . . 52.53 108.253 169.165 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 220' ' ' GLU . . . . . 0.554 ' HG2' ' HB3' ' C' ' 209' ' ' LYS . 15.6 tt0 -90.53 106.33 18.43 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.874 0.845 . . . . 72.32 108.757 177.248 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 221' ' ' VAL . . . . . . . . . . . . . 71.0 t -72.64 126.39 33.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 113.807 -1.542 . . . . 74.03 111.972 -174.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -72.6 117.33 14.15 Favored 'General case' 0 CA--C 1.549 0.919 0 O-C-N 124.314 1.009 . . . . 73.3 110.306 169.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 90.9 t -91.35 140.93 25.68 Favored Pre-proline 0 CA--C 1.555 1.157 0 C-N-CA 124.514 1.125 . . . . 73.11 109.794 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 224' ' ' PRO . . . . . 0.543 ' HG3' HH22 ' C' ' 231' ' ' ARG . 87.3 Cg_endo -81.03 147.54 16.66 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 123.172 2.581 . . . . 54.33 112.089 167.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -52.45 132.45 44.95 Favored 'Trans proline' 0 C--N 1.372 1.793 0 C-N-CA 122.417 2.078 . . . . 74.0 112.793 169.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 226' ' ' ARG . . . . . 0.48 ' H ' ' HA ' ' C' ' 205' ' ' VAL . 0.0 OUTLIER 51.31 85.6 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 126.279 1.832 . . . . 70.15 112.583 -171.703 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 227' ' ' THR . . . . . 0.531 HG22 HG11 ' C' ' 253' ' ' VAL . 90.4 m -101.11 130.79 47.21 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 114.406 -1.27 . . . . 70.3 109.854 174.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 228' ' ' GLN . . . . . 0.535 ' NE2' ' HD2' ' C' ' 231' ' ' ARG . 3.6 mp0 -95.4 147.39 23.57 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.499 1.12 . . . . 74.32 111.978 -176.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -72.76 124.25 24.96 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 114.989 -1.005 . . . . 62.12 109.209 173.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 108.32 -9.76 36.03 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-O 119.641 -0.533 . . . . 62.04 112.526 -172.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 231' ' ' ARG . . . . . 0.543 HH22 ' HG3' ' C' ' 224' ' ' PRO . 34.3 mtp180 -64.35 169.92 4.27 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 117.616 0.708 . . . . 74.12 110.465 169.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 232' ' ' LYS . . . . . 0.45 ' HA ' ' O ' ' C' ' 251' ' ' LEU . 33.6 ttmt -142.92 136.96 29.11 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.226 0.536 . . . . 71.45 110.552 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 233' ' ' LEU . . . . . 0.739 HD13 ' HB2' ' C' ' 251' ' ' LEU . 4.0 mp -98.01 145.92 26.02 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 114.478 -1.237 . . . . 74.21 109.759 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 11.5 ptp85 -110.02 90.9 3.45 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 124.628 1.205 . . . . 72.34 108.183 163.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 235' ' ' LEU . . . . . 0.438 HD12 HD23 ' C' ' 249' ' ' LEU . 24.8 mt -78.25 95.95 5.12 Favored 'General case' 0 C--N 1.352 0.686 0 N-CA-C 107.407 -1.331 . . . . 73.43 107.407 169.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -70.75 125.71 27.57 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 114.516 -1.22 . . . . 71.55 111.594 -171.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 75.72 29.23 59.73 Favored Glycine 0 C--N 1.348 1.22 0 O-C-N 123.867 0.73 . . . . 71.42 112.423 -176.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -124.34 17.02 9.04 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.279 0.631 . . . . 72.03 110.535 176.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -77.53 -165.44 24.88 Favored Glycine 0 C--N 1.359 1.811 0 N-CA-C 110.893 -0.883 . . . . 31.21 110.893 167.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 240' ' ' PHE . . . . . 0.482 ' HD2' HD13 ' C' ' 188' ' ' LEU . 1.2 m-85 -70.67 127.29 92.05 Favored Pre-proline 0 C--O 1.257 1.472 0 CA-C-N 118.061 0.93 . . . . 75.14 108.959 176.355 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 241' ' ' PRO . . . . . 0.444 ' HA ' ' HB3' ' C' ' 246' ' ' ARG . 32.0 Cg_exo -61.47 94.94 0.12 Allowed 'Trans proline' 0 C--N 1.385 2.459 0 C-N-CA 123.553 2.836 . . . . 70.21 113.171 177.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 242' ' ' GLY . . . . . 0.517 ' H ' ' HA ' ' C' ' 246' ' ' ARG . . . -77.56 137.94 20.96 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-N 113.838 -1.528 . . . . 70.14 112.126 -179.159 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.47 -9.32 25.66 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 123.152 2.568 . . . . 71.42 113.804 -176.175 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -120.78 23.09 10.91 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.393 0.677 . . . . 71.42 110.576 176.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 115.31 143.85 8.14 Favored Glycine 0 C--N 1.341 0.83 0 N-CA-C 109.951 -1.26 . . . . 51.32 109.951 -171.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 246' ' ' ARG . . . . . 0.517 ' HA ' ' H ' ' C' ' 242' ' ' GLY . 15.3 ptp180 -99.42 170.84 8.34 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 118.01 0.905 . . . . 61.31 112.395 -171.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -92.38 -164.92 38.51 Favored Glycine 0 C--N 1.35 1.356 0 CA-C-N 114.932 -1.031 . . . . 63.23 113.581 177.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -130.35 148.11 52.14 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.08 0.952 . . . . 73.54 109.055 -172.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 249' ' ' LEU . . . . . 0.438 HD23 HD12 ' C' ' 235' ' ' LEU . 22.8 tp -101.24 137.16 39.95 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.903 0.881 . . . . 74.23 110.611 -175.101 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 250' ' ' TYR . . . . . 0.589 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 59.3 m-85 -127.46 101.56 6.49 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.443 1.097 . . . . 71.43 109.265 -176.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 251' ' ' LEU . . . . . 0.739 ' HB2' HD13 ' C' ' 233' ' ' LEU . 1.2 mp -101.33 139.13 37.42 Favored 'General case' 0 N--CA 1.508 2.442 0 CA-C-N 118.138 0.426 . . . . 64.53 110.923 -175.197 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -80.09 138.99 37.06 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 108.953 -0.758 . . . . 73.41 108.953 168.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 253' ' ' VAL . . . . . 0.531 HG11 HG22 ' C' ' 227' ' ' THR . 99.0 t -87.29 128.14 40.12 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 CA-C-O 121.079 0.466 . . . . 73.5 111.214 176.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 254' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 -110.18 111.67 23.16 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.465 1.106 . . . . 74.13 108.828 167.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 255' ' ' ILE . . . . . 0.502 ' O ' ' HB ' ' A' ' 255' ' ' ILE . 33.8 mm -80.84 120.51 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 N-CA-C 108.294 -1.002 . . . . 75.24 108.294 171.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 256' ' ' THR . . . . . 0.537 HG22 ' HB3' ' A' ' 229' ' ' ALA . 46.4 p -120.34 -172.78 2.43 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.672 0.789 . . . . 53.32 111.257 -173.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 2.7 pp -141.45 148.79 52.02 Favored Pre-proline 0 N--CA 1.489 1.477 0 C-N-CA 123.39 0.676 . . . . 64.54 110.196 178.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -61.26 -7.69 8.86 Favored 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 123.372 2.715 . . . . 73.21 114.684 -174.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 57.12 -78.35 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.908 1.283 . . . . 72.3 110.846 -166.189 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 22.5 ptt-85 -60.35 136.58 58.08 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 124.23 1.012 . . . . 73.41 110.26 177.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 261' ' ' LEU . . . . . 0.494 HD22 ' HB3' ' C' ' 265' ' ' GLU . 94.8 mt -143.34 148.21 35.91 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.58 0.752 . . . . 71.21 109.65 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 262' ' ' THR . . . . . 0.467 ' OG1' ' HG2' ' C' ' 265' ' ' GLU . 36.4 p -84.31 162.42 51.39 Favored Pre-proline 0 CA--C 1.548 0.898 0 N-CA-C 108.417 -0.957 . . . . 61.23 108.417 167.506 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -53.4 -35.84 76.94 Favored 'Trans proline' 0 C--N 1.374 1.881 0 C-N-CA 122.267 1.978 . . . . 74.2 114.202 175.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -66.43 -48.11 71.07 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 122.381 0.272 . . . . 71.04 110.514 178.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 265' ' ' GLU . . . . . 0.494 ' HB3' HD22 ' C' ' 261' ' ' LEU . 33.2 mm-40 -52.57 -51.33 60.27 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 123.612 0.57 . . . . 65.11 109.633 175.237 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 266' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -54.43 -41.57 69.54 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 114.354 -1.294 . . . . 64.21 110.627 -177.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 267' ' ' ALA . . . . . 0.447 ' O ' ' HG3' ' C' ' 271' ' ' LYS . . . -62.13 -46.0 90.95 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.731 -0.668 . . . . 70.32 111.573 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 268' ' ' LEU . . . . . 0.443 ' HB2' HD21 ' A' ' 272' ' ' LEU . 10.4 mp -66.33 -41.94 88.91 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 111.591 0.219 . . . . 52.44 111.591 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -63.48 -33.11 74.86 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 122.988 0.515 . . . . 61.11 111.141 176.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 270' ' ' LYS . . . . . 0.456 ' O ' ' HG2' ' C' ' 274' ' ' GLU . 4.2 mmmp? -61.04 -48.92 79.52 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.631 0.772 . . . . 75.43 110.076 173.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 271' ' ' LYS . . . . . 0.447 ' HG3' ' O ' ' C' ' 267' ' ' ALA . 63.2 mttm -58.55 -43.76 89.41 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.72 0.808 . . . . 75.33 111.568 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 91.2 mt -61.63 -40.36 94.59 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.368 -0.833 . . . . 74.33 110.404 176.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -64.38 -34.69 78.75 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 115.522 -0.763 . . . . 34.13 110.822 177.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 274' ' ' GLU . . . . . 0.456 ' HG2' ' O ' ' C' ' 270' ' ' LYS . 13.5 mm-40 -67.58 -40.3 84.85 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.127 0.571 . . . . 63.21 109.702 177.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -61.71 -30.84 71.02 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.457 0.703 . . . . 70.04 110.662 174.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 276' ' ' TYR . . . . . 0.551 ' HA ' ' HD3' ' C' ' 279' ' ' ARG . 9.6 m-85 -77.27 -31.6 55.0 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.069 -0.968 . . . . 75.52 112.733 172.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -76.3 -19.13 58.56 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 118.526 0.603 . . . . 44.24 110.198 175.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -69.13 -16.58 63.69 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.331 0.652 . . . . 55.2 110.538 169.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 279' ' ' ARG . . . . . 0.551 ' HD3' ' HA ' ' C' ' 276' ' ' TYR . 16.3 mtp-105 -83.52 -14.81 51.46 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.155 0.582 . . . . 71.52 110.978 173.061 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.085 -0.96 . . . . 75.14 110.338 -179.233 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.9 ttmp? . . . . . 0 N--CA 1.483 1.219 0 N-CA-C 114.472 1.286 . . . . 62.43 114.472 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -100.26 114.49 27.98 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 123.546 0.739 . . . . 74.32 109.071 164.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.502 ' HA ' ' OH ' ' A' ' 66' ' ' TYR . 23.9 t70 -82.46 102.94 11.65 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 107.729 -1.211 . . . . 61.41 107.729 168.122 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.434 ' HD1' HD12 ' A' ' 10' ' ' ILE . 32.4 m-85 -64.08 -30.44 71.51 Favored 'General case' 0 C--O 1.244 0.811 0 CA-C-N 115.576 -0.738 . . . . 73.34 112.131 -171.621 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.428 ' CD1' HD11 ' A' ' 22' ' ' ILE . 64.9 m-85 -62.04 -44.34 96.89 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 122.851 0.46 . . . . 73.33 110.394 174.109 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.94 -41.84 97.49 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.285 0.634 . . . . 60.32 111.229 178.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.434 HD12 ' HD1' ' A' ' 7' ' ' TYR . 65.1 mt -55.77 -43.28 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 123.469 0.707 . . . . 74.23 110.976 176.336 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.6 mt -79.62 -14.12 59.03 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 112.936 0.717 . . . . 51.33 112.936 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.39 36.65 59.25 Favored Glycine 0 C--N 1.351 1.378 0 O-C-N 123.026 0.204 . . . . 53.33 113.485 -176.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.3 m -119.93 157.33 52.96 Favored Pre-proline 0 N--CA 1.482 1.175 0 C-N-CA 124.764 1.226 . . . . 71.43 109.164 175.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.502 ' HG2' ' HB2' ' A' ' 17' ' ' ALA . 12.2 Cg_endo -55.93 153.1 33.05 Favored 'Trans proline' 0 C--N 1.388 2.645 0 C-N-CA 122.771 2.314 . . . . 50.12 112.508 177.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 72.3 mtp180 -81.63 59.53 4.19 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.113 0.965 . . . . 75.43 111.411 -170.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 176.37 -27.96 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.643 1.177 . . . . 64.11 109.273 -168.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.502 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . . . -37.64 138.01 0.4 Allowed 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 126.864 2.065 . . . . 64.31 114.897 -171.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.9 p -61.67 162.26 8.76 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 124.6 1.16 . . . . 71.11 112.455 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -56.05 -35.93 67.47 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.118 0.967 . . . . 64.21 112.279 -175.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.51 -29.49 61.43 Favored 'General case' 0 C--O 1.209 -1.058 0 CA-C-O 118.939 -0.553 . . . . 72.43 110.654 -177.246 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -69.67 -39.0 77.27 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 118.516 0.598 . . . . 64.03 110.005 173.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.428 HD11 ' CD1' ' A' ' 8' ' ' TYR . 1.6 mp -61.86 -40.91 88.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 C-N-CA 124.199 1.0 . . . . 73.31 110.345 172.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.8 ttpm? -80.32 -25.76 39.15 Favored 'General case' 0 C--O 1.213 -0.844 0 CA-C-N 114.491 -1.231 . . . . 71.24 110.197 -174.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.454 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 73.5 mtp180 -78.07 -34.85 50.1 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.484 0.714 . . . . 54.12 109.918 173.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.78 -34.36 73.65 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 123.893 0.746 . . . . 64.0 109.982 173.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -63.96 -60.23 3.51 Favored 'General case' 0 C--O 1.209 -1.068 0 CA-C-N 115.672 -0.695 . . . . 73.1 109.533 172.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.454 ' HE3' ' HA ' ' A' ' 24' ' ' ARG . 51.6 mtmt -53.87 -38.2 64.48 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 124.31 1.044 . . . . 74.22 110.686 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.2 ttt180 -59.37 -57.91 10.93 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.521 1.128 . . . . 71.15 110.956 176.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.602 ' HB3' HD13 ' A' ' 50' ' ' ILE . 84.7 mt -76.81 -11.69 59.87 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.702 0.801 . . . . 74.11 111.18 -177.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.06 -20.44 24.36 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.909 0.884 . . . . 63.3 110.535 178.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 75.4 mtm180 -95.68 -31.9 13.02 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.052 0.541 . . . . 72.33 110.673 171.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -77.03 -55.0 5.83 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 108.981 -0.748 . . . . 63.33 108.981 -178.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -93.47 33.55 1.24 Allowed 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 115.879 -0.601 . . . . 63.25 110.531 173.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 7.9 t-80 -61.28 107.75 1.23 Allowed Pre-proline 0 C--N 1.357 0.912 0 N-CA-C 108.564 -0.902 . . . . 63.41 108.564 177.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -57.87 -19.32 38.84 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 122.976 2.451 . . . . 74.13 113.086 -169.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -63.42 -42.69 98.73 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.685 1.194 . . . . 72.45 112.704 178.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.5 t -105.09 -37.46 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 123.173 0.589 . . . . 65.53 109.984 -177.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -98.09 68.13 1.95 Allowed 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 122.634 1.207 . . . . 61.35 108.51 178.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt -79.6 75.88 6.24 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 113.827 -1.533 . . . . 73.11 109.282 -178.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.8 m -135.55 108.29 10.12 Favored Pre-proline 0 N--CA 1.467 0.422 0 CA-C-O 118.124 -0.941 . . . . 54.41 108.622 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -39.31 -45.31 3.03 Favored 'Trans proline' 0 C--N 1.387 2.569 0 C-N-CA 124.23 3.287 . . . . 72.23 114.248 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -56.22 -46.93 79.33 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.408 0.683 . . . . 64.43 111.343 178.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.5 -16.96 61.78 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.527 0.731 . . . . 72.14 111.623 -178.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -92.07 -30.72 15.87 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.532 0.733 . . . . 62.01 110.428 -176.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -72.23 -36.62 69.16 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 109.417 -0.586 . . . . 62.44 109.417 168.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -62.84 -41.28 99.27 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 116.058 -0.519 . . . . 74.03 109.834 170.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.625 ' HA ' HD12 ' A' ' 50' ' ' ILE . 52.1 t80 -63.64 -31.56 72.77 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.583 0.753 . . . . 73.24 110.716 176.294 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -63.64 -45.14 91.56 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 122.567 0.347 . . . . 75.14 110.975 171.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -65.63 -25.87 67.57 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 111.821 0.304 . . . . 71.44 111.821 178.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.625 HD12 ' HA ' ' A' ' 47' ' ' PHE . 66.1 mt -74.78 -39.28 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 123.847 0.859 . . . . 70.53 110.103 172.315 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.438 ' HB3' ' HD1' ' A' ' 88' ' ' PHE . 94.4 m-20 -71.07 -23.56 62.16 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.684 0.793 . . . . 73.43 110.911 176.312 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -76.05 -53.35 8.49 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.593 1.557 . . . . 63.42 109.626 177.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.06 -47.19 78.4 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 113.928 -1.487 . . . . 65.45 110.417 176.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -68.87 -37.05 78.82 Favored 'General case' 0 C--O 1.207 -1.14 0 CA-C-N 114.64 -1.164 . . . . 72.32 110.928 176.17 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -51.93 -53.81 36.78 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 118.658 0.663 . . . . 53.01 110.462 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.477 HG13 ' HZ ' ' A' ' 101' ' ' PHE . 47.0 t -64.1 -55.93 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 113.866 -1.515 . . . . 74.52 110.273 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 78.1 mt -81.61 2.03 31.2 Favored 'General case' 0 CA--C 1.556 1.183 0 N-CA-C 113.745 1.017 . . . . 62.04 113.745 -169.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.0 t -80.19 -75.14 0.27 Allowed 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 109.215 -0.661 . . . . 74.34 109.215 174.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -68.86 116.95 46.5 Favored Pre-proline 0 C--O 1.239 0.549 0 CA-C-O 118.651 -0.69 . . . . 74.34 109.392 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -49.88 -28.0 17.27 Favored 'Trans proline' 0 C--N 1.388 2.621 0 C-N-CA 124.069 3.179 . . . . 72.41 114.294 -175.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -60.34 -62.73 1.65 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.704 0.802 . . . . 72.3 110.735 175.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.448 ' HA ' HD12 ' A' ' 65' ' ' ILE . 29.6 mtmm -64.28 -33.12 75.09 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.176 0.591 . . . . 74.54 110.737 -177.221 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 22.3 ttt85 -61.83 -45.76 92.45 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.065 -0.971 . . . . 74.11 110.703 176.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -70.65 -28.25 64.65 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 119.279 -0.391 . . . . 74.25 111.262 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.448 HD12 ' HA ' ' A' ' 62' ' ' LYS . 73.2 mt -53.24 -52.8 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 N-CA-C 108.86 -0.793 . . . . 64.42 108.86 168.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.502 ' OH ' ' HA ' ' A' ' 6' ' ' ASP . 55.9 t80 -61.97 -52.01 65.76 Favored 'General case' 0 CA--C 1.556 1.179 0 CA-C-N 114.561 -1.2 . . . . 75.4 112.004 178.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -56.37 -40.54 74.73 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.135 0.974 . . . . 64.04 111.848 -175.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 58.6 p -80.35 -22.55 41.31 Favored 'General case' 0 C--O 1.215 -0.728 0 CA-C-N 115.498 -0.774 . . . . 75.13 111.07 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -66.45 109.23 2.66 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 118.909 0.777 . . . . 63.45 108.934 176.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 113.18 13.29 10.98 Favored Glycine 0 CA--C 1.537 1.429 0 CA-C-N 115.337 -0.847 . . . . 52.54 111.565 -166.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 50.7 m -148.4 -61.08 0.25 Allowed 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 103.986 -2.598 . . . . 71.23 103.986 176.078 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 61.8 m -75.83 139.87 41.97 Favored 'General case' 0 C--O 1.248 1.005 0 N-CA-C 104.549 -2.389 . . . . 74.23 104.549 155.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.14 -25.8 7.94 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 122.792 0.437 . . . . 74.04 111.179 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.08 132.51 90.18 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 123.851 0.86 . . . . 75.1 110.597 176.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -55.51 141.95 81.88 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 122.74 2.294 . . . . 75.41 111.252 168.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -57.72 149.93 65.27 Favored 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 123.501 2.801 . . . . 74.25 113.009 -173.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -66.2 170.81 11.25 Favored 'Trans proline' 0 C--N 1.383 2.393 0 C-N-CA 124.095 3.197 . . . . 62.44 113.742 -173.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -33.71 127.58 0.16 Allowed 'Trans proline' 0 C--N 1.401 3.304 0 C-N-CA 124.818 3.679 . . . . 43.51 114.404 174.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.569 ' HG3' ' HA3' ' A' ' 104' ' ' GLY . 42.2 Cg_endo -77.92 119.8 4.84 Favored 'Trans proline' 0 CA--C 1.559 1.73 0 C-N-CA 123.277 2.651 . . . . 71.05 113.049 -165.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.09 76.23 2.63 Favored 'Trans proline' 0 CA--C 1.554 1.511 0 C-N-CA 122.592 2.195 . . . . 51.35 112.746 -178.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 115.22 0.96 22.25 Favored Glycine 0 C--N 1.347 1.152 0 CA-C-N 115.075 -0.966 . . . . 62.41 112.002 -176.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.74 147.14 12.31 Favored Glycine 0 C--N 1.352 1.436 0 N-CA-C 110.713 -0.955 . . . . 53.03 110.713 -167.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -65.53 100.62 0.52 Allowed 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 118.349 1.074 . . . . 74.41 109.029 172.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -54.1 139.75 34.14 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.496 1.118 . . . . 71.31 112.519 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.486 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 65.2 m-85 -143.48 72.85 1.37 Allowed 'General case' 0 N--CA 1.47 0.55 0 O-C-N 124.136 0.897 . . . . 70.22 109.682 171.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 18.2 m -52.7 86.7 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 125.509 1.524 . . . . 74.44 112.68 -179.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.781 ' H ' ' HA3' ' A' ' 163' ' ' GLY . . . 80.7 1.39 89.2 Favored Glycine 0 C--N 1.34 0.767 0 CA-C-N 115.858 -0.61 . . . . 70.11 112.853 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.486 ' HB2' ' HB3' ' A' ' 85' ' ' PHE . 17.4 m-85 -97.24 114.29 26.01 Favored 'General case' 0 C--N 1.344 0.365 0 N-CA-C 107.727 -1.212 . . . . 72.34 107.727 -176.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -80.22 80.92 6.58 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.245 0.545 . . . . 71.44 110.191 -174.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.63 HG21 HD22 ' A' ' 105' ' ' LEU . 1.6 p -42.31 -39.42 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 125.413 1.485 . . . . 75.21 112.936 174.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -57.23 -33.36 67.47 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.008 0.923 . . . . 75.33 112.714 -176.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -105.32 11.6 32.66 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.236 0.541 . . . . 45.35 111.69 -178.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 17.2 m-30 -90.33 173.84 7.9 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 121.967 -0.458 . . . . 71.01 109.881 174.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 86.0 p -65.72 157.89 28.96 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 113.631 0.974 . . . . 74.5 113.631 -167.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.45 -42.77 96.82 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.345 1.058 . . . . 74.31 111.633 176.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -55.63 -49.93 71.52 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.092 0.957 . . . . 75.03 111.2 177.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.526 ' HE2' HG23 ' A' ' 90' ' ' VAL . 37.7 t80 -60.01 -42.84 95.17 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.443 -1.253 . . . . 63.23 110.584 176.09 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -78.27 -4.35 47.42 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.325 -0.852 . . . . 73.05 112.415 -178.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -102.34 -34.05 9.34 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.038 0.535 . . . . 70.02 111.286 169.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 41.6 tp -65.81 -52.13 53.25 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.223 0.609 . . . . 55.03 109.56 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.477 ' HZ ' HG13 ' A' ' 56' ' ' VAL . 88.8 m-85 -92.86 -0.49 57.23 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.529 -0.76 . . . . 72.11 110.745 174.151 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.402 ' N ' ' HD2' ' A' ' 103' ' ' PRO . . . -42.78 -56.65 4.27 Favored Glycine 0 C--N 1.353 1.509 0 CA-C-O 118.213 -1.326 . . . . 72.43 115.188 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.402 ' HD2' ' N ' ' A' ' 102' ' ' GLY . 4.8 Cg_exo -34.76 -32.49 0.07 OUTLIER 'Trans proline' 0 C--N 1.395 3.024 1 C-N-CA 125.697 4.264 . . . . 23.1 115.263 177.17 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.569 ' HA3' ' HG3' ' A' ' 79' ' ' PRO . . . -152.94 49.21 0.52 Allowed Glycine 0 C--N 1.351 1.4 0 C-N-CA 120.547 -0.835 . . . . 44.4 113.786 179.007 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.63 HD22 HG21 ' A' ' 90' ' ' VAL . 29.7 mt -58.22 79.61 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 112.444 0.535 . . . . 74.25 112.444 171.497 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.51 ' HD1' ' H ' ' A' ' 108' ' ' GLY . 0.1 OUTLIER 42.27 -110.29 0.14 Allowed 'General case' 0 CA--C 1.559 1.326 0 C-N-CA 126.514 1.925 . . . . 72.25 112.819 -179.751 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 70.24 -0.66 23.01 Favored Glycine 0 C--N 1.362 2.011 0 CA-C-N 118.27 0.486 . . . . 44.0 113.663 -172.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.51 ' H ' ' HD1' ' A' ' 106' ' ' PHE . . . . . . . . 0 C--N 1.352 1.417 0 N-CA-C 112.26 -0.336 . . . . 71.34 112.26 -172.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.524 ' HA ' ' HD2' ' A' ' 170' ' ' PRO . 8.0 tmtm? . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 107.226 -1.398 . . . . 72.15 107.226 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -73.71 148.71 40.51 Favored Glycine 0 CA--C 1.531 1.086 0 O-C-N 123.373 0.421 . . . . 55.22 113.335 -175.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.417 ' H ' ' HA3' ' A' ' 166' ' ' GLY . 8.0 tmm_? -114.79 155.6 26.43 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 124.081 0.952 . . . . 71.34 110.349 -175.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -58.37 131.42 50.64 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 123.731 0.813 . . . . 74.23 111.694 -178.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.2 tt -145.63 164.77 30.69 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 108.566 -0.901 . . . . 70.23 108.566 -172.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.483 ' NH2' HH21 ' A' ' 179' ' ' ARG . 60.1 ttt180 -129.54 139.22 51.59 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.62 -0.881 . . . . 74.51 108.62 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -135.61 151.51 50.33 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.642 0.777 . . . . 41.51 108.994 177.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.525 ' H ' ' HB3' ' B' ' 9' ' ' ALA . 13.0 mm-40 -102.18 133.78 46.5 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 107.119 -1.437 . . . . 61.0 107.119 -177.389 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.456 ' HA ' HD12 ' B' ' 8' ' ' LEU . 39.7 tp -102.54 95.15 5.74 Favored Pre-proline 0 CA--C 1.544 0.743 0 N-CA-C 107.991 -1.114 . . . . 54.05 107.991 179.034 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.536 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 52.6 Cg_endo -72.39 112.73 3.52 Favored 'Trans proline' 0 C--N 1.384 2.42 0 C-N-CA 121.532 1.488 . . . . 75.33 109.085 174.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.669 ' HA ' HG21 ' B' ' 6' ' ' ILE . 42.0 tp -123.79 137.49 54.67 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.243 0.544 . . . . 64.01 110.862 -166.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 17.3 m -75.78 133.85 40.58 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 114.984 -1.007 . . . . 71.34 109.72 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 49.5 mt -49.69 -44.01 47.76 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 124.656 1.183 . . . . 70.54 112.103 -169.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -57.58 -54.07 50.97 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.009 -0.996 . . . . 75.32 110.518 -176.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -57.8 -40.29 79.55 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 115.719 -0.673 . . . . 64.33 110.788 177.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -58.76 -48.85 79.79 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 124.291 0.994 . . . . 41.43 112.246 -176.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -74.15 -41.02 62.19 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 123.274 0.359 . . . . 74.51 111.717 -177.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -68.53 -43.54 76.51 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 120.79 0.328 . . . . 75.25 110.87 -178.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.423 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 76.21 177.57 43.44 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-N 115.418 -0.81 . . . . 71.54 113.802 178.485 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 109.48 -152.41 17.14 Favored Glycine 0 C--N 1.34 0.783 0 C-N-CA 123.48 0.562 . . . . 70.42 112.178 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -77.31 111.52 13.05 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.653 0.781 . . . . 73.14 111.115 -178.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 4.4 tpm_? -101.09 124.12 46.31 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 123.919 0.888 . . . . 74.4 109.81 176.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.0 t -84.33 109.5 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 123.959 0.904 . . . . 71.24 109.308 177.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.9 p -129.56 131.07 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.335 1.054 . . . . 73.14 108.881 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 144' ' ' ARG . 39.3 tt0 -113.93 142.45 46.11 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.035 0.445 . . . . 71.3 110.911 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.7 p -155.31 127.83 1.06 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.59 0 C-N-CA 124.4 1.08 . . . . 75.1 108.622 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 58.81 18.38 6.01 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.025 0.93 . . . . 74.24 112.536 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 103.12 -32.36 7.68 Favored Glycine 0 C--N 1.352 1.453 0 C-N-CA 122.903 0.287 . . . . 31.1 112.463 -176.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.35 105.26 4.02 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 108.898 -0.778 . . . . 72.12 108.898 178.615 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.469 ' HA ' ' HA ' ' A' ' 139' ' ' GLU . 16.1 ttm180 -94.9 98.81 10.98 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.755 0.822 . . . . 74.41 109.51 173.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 6.8 p -95.8 140.75 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.777 0.831 . . . . 73.53 111.303 -177.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 28.7 t -92.62 84.36 5.04 Favored 'General case' 0 C--O 1.243 0.742 0 N-CA-C 108.67 -0.863 . . . . 31.45 108.67 174.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 31.5 m -82.64 122.99 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 N-CA-C 110.257 -0.275 . . . . 73.42 110.257 -177.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -73.73 103.27 4.23 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.565 0.698 . . . . 74.14 109.525 174.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.423 HG13 ' HA2' ' A' ' 133' ' ' GLY . 18.1 pt -82.43 133.7 49.63 Favored Pre-proline 0 CA--C 1.554 1.112 0 CA-C-N 114.565 -1.198 . . . . 74.13 108.206 167.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -62.78 143.17 91.44 Favored 'Trans proline' 0 C--N 1.371 1.742 0 C-N-CA 121.939 1.759 . . . . 60.34 112.163 175.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -57.47 92.14 0.05 OUTLIER 'Trans proline' 0 C--N 1.389 2.695 0 C-N-CA 123.22 2.614 . . . . 74.15 112.563 176.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.687 ' HA3' ' HD2' ' A' ' 241' ' ' PRO . . . 98.65 56.87 1.01 Allowed Glycine 0 C--N 1.335 0.474 0 CA-C-N 114.812 -1.085 . . . . 75.51 111.214 -169.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.449 HG22 HG11 ' A' ' 178' ' ' VAL . 5.4 p -78.38 131.29 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-O 121.73 0.776 . . . . 75.43 109.288 178.214 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.676 ' HA ' HD21 ' A' ' 188' ' ' LEU . 21.8 mtt85 -100.75 149.67 23.58 Favored 'General case' 0 C--O 1.21 -0.98 0 CA-C-N 114.587 -1.188 . . . . 73.23 110.873 -163.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -58.77 118.65 5.95 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.795 0.838 . . . . 72.32 110.916 -178.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 91.66 12.33 59.56 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-N 115.214 -0.903 . . . . 14.21 113.414 -176.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 24.0 t -70.94 113.97 8.53 Favored 'General case' 0 C--N 1.356 0.874 0 N-CA-C 108.319 -0.993 . . . . 74.23 108.319 173.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.488 HG22 HG22 ' A' ' 177' ' ' VAL . 47.2 t -85.57 90.33 2.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 C-N-CA 123.565 0.746 . . . . 72.34 109.09 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 61.6 mt -71.86 93.0 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 107.779 -1.193 . . . . 75.24 107.779 171.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -81.19 109.02 15.33 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.795 -0.639 . . . . 61.32 110.416 -174.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 3.7 p -114.63 108.17 49.73 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 123.606 0.763 . . . . 61.33 109.506 177.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.612 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 52.6 Cg_endo -68.33 155.37 69.49 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 121.95 1.766 . . . . 74.53 110.894 172.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.781 ' HA3' ' H ' ' A' ' 87' ' ' GLY . . . 75.81 27.64 62.39 Favored Glycine 0 C--N 1.345 1.063 0 C-N-CA 121.44 -0.409 . . . . 70.43 114.022 176.289 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 36.6 tpp -134.65 -22.78 1.65 Allowed 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.031 0.532 . . . . 64.15 111.385 -178.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.6 ' HA2' HD13 ' A' ' 174' ' ' LEU . . . -68.65 -99.93 0.03 OUTLIER Glycine 0 C--N 1.354 1.54 0 N-CA-C 114.993 0.757 . . . . 73.33 114.993 -172.063 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.417 ' HA3' ' H ' ' A' ' 117' ' ' ARG . . . -63.69 121.51 23.88 Favored Glycine 0 C--N 1.347 1.182 0 N-CA-C 111.888 -0.485 . . . . 74.5 111.888 178.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -67.96 104.84 1.83 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.506 0.722 . . . . 75.42 110.596 -174.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -165.32 170.52 40.29 Favored Glycine 0 C--N 1.339 0.733 0 CA-C-O 118.785 -1.008 . . . . 64.21 111.242 -178.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ASN . . . . . 0.51 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . 24.4 t-20 -49.52 -65.88 0.74 Allowed Pre-proline 0 CA--C 1.561 1.399 0 CA-C-O 117.247 -1.359 . . . . 63.11 110.858 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.524 ' HD2' ' HA ' ' A' ' 115' ' ' LYS . 71.1 Cg_endo -93.83 94.06 0.13 Allowed 'Trans proline' 0 C--N 1.393 2.869 0 CA-C-N 122.645 1.98 . . . . 71.13 108.881 165.609 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -69.73 158.26 57.62 Favored 'Trans proline' 0 C--N 1.373 1.848 0 C-N-CA 122.475 2.117 . . . . 71.25 111.765 -164.38 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -70.1 171.74 42.04 Favored Glycine 0 C--N 1.34 0.802 0 CA-C-N 116.143 -0.48 . . . . 72.4 113.598 -174.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.612 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 31.0 t70 -67.63 142.75 56.31 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 109.329 -0.619 . . . . 71.14 109.329 172.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.6 HD13 ' HA2' ' A' ' 165' ' ' GLY . 23.4 tp -124.57 131.85 53.46 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 120.859 0.362 . . . . 64.32 110.291 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 47.1 mt -102.53 98.37 8.45 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.676 0.791 . . . . 72.12 109.271 176.17 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.642 HD22 HD11 ' B' ' 8' ' ' LEU . 80.2 mt -83.09 93.98 7.72 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 118.051 0.387 . . . . 70.05 110.577 178.472 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.488 HG22 HG22 ' A' ' 158' ' ' VAL . 24.2 t -85.47 107.43 16.18 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 N-CA-C 107.965 -1.124 . . . . 61.43 107.965 177.535 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.449 HG11 HG22 ' A' ' 153' ' ' VAL . 7.5 p -69.4 127.7 31.68 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 CA-C-O 121.386 0.613 . . . . 70.33 111.233 -174.117 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.536 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 37.0 mmt180 -116.77 101.7 8.78 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 125.193 1.397 . . . . 53.32 108.278 176.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 4.9 mt -69.92 143.14 52.81 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 118.559 0.618 . . . . 72.4 110.246 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 83.4 mt -61.32 155.47 57.21 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 123.995 0.918 . . . . 73.14 111.755 -175.154 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -76.95 53.59 4.23 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 122.892 2.395 . . . . 71.42 109.858 163.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 27.8 t-80 -79.19 131.3 66.49 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 125.014 1.326 . . . . 73.35 108.572 -171.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -9.06 -53.6 0.0 OUTLIER 'Trans proline' 0 C--N 1.383 2.379 1 C-N-CA 127.692 5.595 . . . . 61.24 119.748 -163.312 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 44.2 t -99.76 -59.32 3.35 Favored 'Isoleucine or valine' 0 C--N 1.356 0.855 0 CA-C-N 119.322 0.965 . . . . 64.21 109.993 -168.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' PHE . . . . . 0.631 ' HB3' HD22 ' A' ' 193' ' ' LEU . 51.8 m-85 -101.4 138.78 37.96 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 112.863 0.69 . . . . 72.31 112.863 -165.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 27.2 ttp-105 -116.58 98.51 6.58 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 106.02 -1.844 . . . . 75.51 106.02 164.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.676 HD21 ' HA ' ' A' ' 154' ' ' ARG . 56.0 tp -68.98 144.16 54.2 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.616 -0.513 . . . . 74.21 109.616 176.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -149.15 115.67 5.87 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 107.788 -1.19 . . . . 70.31 107.788 -176.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' GLY . . . . . 0.432 ' O ' ' HB3' ' A' ' 154' ' ' ARG . . . 73.29 -75.9 0.95 Allowed Glycine 0 C--N 1.349 1.29 0 CA-C-O 119.889 -0.395 . . . . 65.41 113.587 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -153.15 -2.98 0.22 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.976 0.911 . . . . 72.32 110.959 176.191 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -125.21 148.15 48.75 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.961 0.904 . . . . 72.32 110.446 -172.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.631 HD22 ' HB3' ' A' ' 186' ' ' PHE . 81.7 mt -90.83 149.88 21.78 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.856 0.862 . . . . 63.44 111.162 -171.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -128.58 99.59 5.43 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.312 1.045 . . . . 73.14 108.456 171.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.564 ' HB3' HD23 ' A' ' 251' ' ' LEU . . . -110.78 110.86 21.67 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.537 1.135 . . . . 74.34 111.055 -171.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 77.4 m -64.59 121.84 15.4 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 109.299 -0.63 . . . . 70.21 109.299 178.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 54.0 tp -122.62 105.73 10.36 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 123.722 0.809 . . . . 72.21 108.978 -166.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -70.35 126.2 28.96 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.144 0.497 . . . . 61.43 109.917 173.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 7.1 p -142.79 136.96 14.7 Favored Pre-proline 0 CA--C 1.548 0.894 0 N-CA-C 107.179 -1.415 . . . . 64.4 107.179 179.081 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.64 154.56 34.99 Favored 'Trans proline' 0 C--N 1.361 1.19 0 C-N-CA 121.55 1.5 . . . . 64.51 111.718 172.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -53.72 -47.25 97.28 Favored Pre-proline 0 CA--C 1.565 1.52 0 N-CA-C 114.718 1.377 . . . . 71.34 114.718 -174.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -59.11 -39.74 76.69 Favored 'Trans proline' 0 C--N 1.383 2.376 0 C-N-CA 122.088 1.859 . . . . 63.54 114.325 176.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 45.7 mt -75.43 -26.79 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 122.517 0.327 . . . . 64.32 110.609 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.09 -43.68 74.03 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.196 0.598 . . . . 71.51 111.158 173.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 11.1 t -69.23 -52.64 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 123.957 0.903 . . . . 63.23 112.017 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 85.3 t -85.28 -31.7 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 123.231 0.612 . . . . 74.41 111.262 -171.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 83.4 94.66 0.61 Allowed Glycine 0 CA--C 1.53 0.989 0 CA-C-N 116.308 -0.405 . . . . 72.35 113.035 -178.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -123.54 -178.15 15.34 Favored Glycine 0 N--CA 1.476 1.33 0 N-CA-C 111.487 -0.645 . . . . 55.24 111.487 174.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -81.28 134.15 35.55 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 117.963 0.882 . . . . 45.21 110.409 177.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 33.2 m -123.54 143.8 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 106.537 -1.653 . . . . 63.11 106.537 164.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' ARG . . . . . 0.428 ' HE ' ' HG2' ' A' ' 220' ' ' GLU . 29.8 ttm180 -92.87 113.65 25.98 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 121.622 -0.674 . . . . 71.41 109.809 -176.333 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.03 128.8 46.07 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.265 1.026 . . . . 62.04 109.22 -177.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' MET . . . . . 0.409 ' HA ' ' HA ' ' A' ' 218' ' ' PRO . 1.6 mpt? -82.65 124.06 29.84 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.118 -0.697 . . . . 71.23 109.118 -177.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 77.2 p -109.3 -179.61 3.89 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 123.228 0.611 . . . . 74.1 109.784 178.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 49.3 mt -75.83 1.0 16.12 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.388 1.075 . . . . 63.31 111.987 -171.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -133.75 5.17 3.64 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 124.317 1.047 . . . . 64.44 111.592 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 137.49 170.6 11.93 Favored Glycine 0 N--CA 1.482 1.709 0 CA-C-O 119.802 -0.443 . . . . 33.0 113.545 176.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' PRO . . . . . 0.409 ' HA ' ' HA ' ' A' ' 213' ' ' MET . 85.2 Cg_endo -80.49 115.86 3.2 Favored 'Trans proline' 0 C--N 1.372 1.778 0 C-N-CA 122.955 2.437 . . . . 70.23 112.609 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 35.8 m -114.35 147.54 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.637 0.775 . . . . 73.4 109.834 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.428 ' HG2' ' HE ' ' A' ' 211' ' ' ARG . 42.0 mt-10 -73.85 147.18 43.54 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 109.566 -0.531 . . . . 75.04 109.566 175.756 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 10.1 p -137.24 116.52 15.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-O 121.544 0.688 . . . . 74.13 109.574 175.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -77.39 101.09 6.2 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 123.954 0.902 . . . . 60.25 109.522 -177.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 91.3 t -66.98 131.92 93.83 Favored Pre-proline 0 CA--C 1.556 1.205 0 CA-C-N 114.989 -1.005 . . . . 63.14 109.46 178.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.58 165.99 30.96 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.688 2.258 . . . . 75.51 110.922 175.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -69.47 158.62 56.66 Favored 'Trans proline' 0 C--N 1.37 1.695 0 C-N-CA 121.766 1.644 . . . . 72.53 111.857 175.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 15.3 mmt180 69.26 15.62 8.53 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 125.277 1.431 . . . . 74.04 112.046 175.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.429 HG23 HD21 ' A' ' 233' ' ' LEU . 4.0 m -59.89 104.65 0.31 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.188 0.995 . . . . 64.32 111.065 -179.139 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -92.11 139.55 30.52 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 114.418 -1.264 . . . . 75.32 111.671 -173.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -54.11 153.19 5.27 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.496 1.518 . . . . 62.31 112.337 174.141 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 79.36 -49.15 3.53 Favored Glycine 0 C--N 1.345 1.069 0 N-CA-C 112.269 -0.332 . . . . 73.32 112.269 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -63.73 163.44 11.55 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 124.276 1.03 . . . . 74.0 111.363 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.534 ' HG3' ' HG2' ' A' ' 252' ' ' GLU . 2.9 mppt? -112.12 129.5 56.21 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 114.838 -1.074 . . . . 72.22 110.355 -175.377 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.58 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 79.6 mt -77.59 104.3 8.04 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 108.323 -0.992 . . . . 71.4 108.323 170.398 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 42.1 ttm105 -82.25 109.3 16.4 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 122.643 0.377 . . . . 64.14 110.247 177.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.426 ' HG ' ' HB3' ' A' ' 249' ' ' LEU . 0.4 OUTLIER -120.83 106.31 11.54 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 108.055 -1.091 . . . . 61.12 108.055 169.866 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -74.56 159.87 31.62 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.069 0.948 . . . . 64.43 112.666 -169.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 73.35 9.51 77.51 Favored Glycine 0 C--N 1.349 1.294 0 CA-C-N 115.496 -0.774 . . . . 74.2 113.369 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.38 -11.63 15.15 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.295 0.638 . . . . 73.01 111.187 -176.49 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -79.53 -154.34 8.72 Favored Glycine 0 C--N 1.348 1.218 0 N-CA-C 112.515 -0.234 . . . . 74.43 112.515 177.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -92.41 137.69 24.47 Favored Pre-proline 0 N--CA 1.48 1.063 0 CA-C-O 118.918 -0.563 . . . . 73.13 110.132 -175.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.687 ' HD2' ' HA3' ' A' ' 152' ' ' GLY . 89.7 Cg_exo -46.78 107.99 0.14 Allowed 'Trans proline' 0 C--N 1.388 2.61 0 C-N-CA 123.973 3.115 . . . . 73.33 113.83 -178.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -134.56 -145.35 5.21 Favored Glycine 0 C--N 1.35 1.317 0 CA-C-O 119.073 -0.848 . . . . 73.52 112.585 -171.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -72.78 -26.93 15.37 Favored 'Trans proline' 0 C--N 1.385 2.475 0 C-N-CA 123.052 2.501 . . . . 70.45 112.655 -173.005 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -94.2 22.89 5.47 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.19 0.996 . . . . 70.11 111.066 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 90.13 -68.97 2.42 Favored Glycine 0 C--N 1.345 1.077 0 N-CA-C 109.579 -1.408 . . . . 62.24 109.579 -171.04 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.604 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 75.8 mtp180 -127.23 168.39 14.79 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.53 1.132 . . . . 75.41 109.306 166.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -84.95 -166.2 41.29 Favored Glycine 0 C--N 1.346 1.094 0 CA-C-N 116.171 -0.468 . . . . 42.24 111.973 172.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 248' ' ' ASP . . . . . 0.438 ' HB2' ' CE1' ' A' ' 250' ' ' TYR . 26.6 m-20 -104.39 158.99 16.09 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.371 0.669 . . . . 75.44 109.831 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.426 ' HB3' ' HG ' ' A' ' 235' ' ' LEU . 40.6 tp -106.57 122.74 46.91 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 107.619 -1.252 . . . . 70.31 107.619 167.65 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.438 ' CE1' ' HB2' ' A' ' 248' ' ' ASP . 42.4 m-85 -108.27 105.69 15.52 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.096 -1.076 . . . . 52.51 108.096 176.003 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.58 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 69.1 mt -84.41 102.83 13.06 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 108.75 -0.833 . . . . 72.24 108.75 176.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 252' ' ' GLU . . . . . 0.534 ' HG2' ' HG3' ' A' ' 232' ' ' LYS . 27.7 mt-10 -74.96 96.34 3.15 Favored 'General case' 0 C--N 1.356 0.855 0 C-N-CA 123.57 0.748 . . . . 75.41 109.091 -176.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 46.3 t -55.73 133.74 19.55 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 125.571 1.548 . . . . 24.43 112.222 -172.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -133.93 94.42 3.26 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 107.733 -1.21 . . . . 73.14 107.733 -179.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.451 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 77.6 mt -79.59 133.9 28.81 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-N 115.961 -0.563 . . . . 74.34 111.144 -176.236 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 31.1 p -129.87 176.22 8.22 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.548 1.139 . . . . 73.43 109.519 172.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.7 pp -133.23 153.03 80.51 Favored Pre-proline 0 CA--C 1.569 1.703 0 C-N-CA 123.803 0.841 . . . . 73.4 111.116 -174.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 258' ' ' PRO . . . . . 0.422 ' HG2' HD21 ' A' ' 261' ' ' LEU . 23.5 Cg_endo -59.18 -9.68 8.77 Favored 'Trans proline' 0 C--N 1.387 2.597 0 C-N-CA 123.999 3.133 . . . . 74.45 116.278 -166.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 259' ' ' GLU . . . . . 0.499 ' HA ' ' HB3' ' C' ' 226' ' ' ARG . 36.3 mt-10 56.67 -67.52 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.075 0 C-N-CA 125.415 1.486 . . . . 63.24 113.89 -174.246 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.03 132.59 39.02 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.55 -0.718 . . . . 75.12 109.66 172.039 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.613 HD22 ' HB2' ' A' ' 265' ' ' GLU . 56.2 mt -123.73 148.92 46.15 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.414 0.686 . . . . 55.32 110.453 173.355 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 21.7 p -127.9 155.09 78.12 Favored Pre-proline 0 CA--C 1.558 1.259 0 C-N-CA 125.06 1.344 . . . . 44.34 108.054 172.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -17.96 -52.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.403 3.44 1 C-N-CA 126.867 5.045 . . . . 74.33 117.989 -170.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 264' ' ' GLU . . . . . 0.442 ' O ' HD13 ' A' ' 268' ' ' LEU . 63.3 mm-40 -55.71 -74.68 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.012 0.525 . . . . 71.44 111.285 177.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 265' ' ' GLU . . . . . 0.613 ' HB2' HD22 ' A' ' 261' ' ' LEU . 1.5 mp0 -64.07 -30.31 71.39 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 122.858 0.463 . . . . 64.2 109.964 -172.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 266' ' ' GLU . . . . . 0.529 ' HA ' HD13 ' A' ' 261' ' ' LEU . 7.6 tp10 -55.51 -62.73 1.49 Allowed 'General case' 0 C--O 1.248 1.01 0 O-C-N 123.79 0.681 . . . . 73.45 109.69 176.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -60.63 -38.86 86.16 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 115.238 -0.892 . . . . 64.12 111.354 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 268' ' ' LEU . . . . . 0.442 HD13 ' O ' ' A' ' 264' ' ' GLU . 2.2 mp -63.46 -48.09 79.13 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.007 0.923 . . . . 73.14 111.921 -176.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 77.9 m95 -68.79 -33.44 73.87 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.315 0.646 . . . . 75.0 111.398 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 270' ' ' LYS . . . . . 0.433 ' HG2' ' O ' ' A' ' 266' ' ' GLU . 29.8 mmtp -70.43 -39.95 74.07 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 122.405 0.282 . . . . 62.43 111.504 175.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -73.44 -30.24 63.08 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.016 0.526 . . . . 70.22 110.574 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 24.0 mt -59.67 -54.4 46.84 Favored 'General case' 0 C--O 1.205 -1.252 0 N-CA-C 108.541 -0.911 . . . . 63.4 108.541 167.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -51.28 -48.57 62.22 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 124.107 0.879 . . . . 64.51 111.948 -177.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.41 ' HG3' ' O ' ' A' ' 270' ' ' LYS . 25.8 mt-10 -62.72 -56.96 12.87 Favored 'General case' 0 CA--C 1.551 0.989 0 O-C-N 123.371 0.419 . . . . 74.35 110.389 178.533 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -57.71 -65.85 0.57 Allowed 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.726 0.81 . . . . 71.44 111.761 -177.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 276' ' ' TYR . . . . . 0.516 ' HE2' ' HG3' ' C' ' 258' ' ' PRO . 81.9 t80 -45.61 -59.09 2.94 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.703 1.601 . . . . 75.02 112.826 178.165 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 277' ' ' TYR . . . . . 0.572 ' HA ' ' HB2' ' A' ' 280' ' ' ALA . 2.3 t80 -66.86 -35.01 79.07 Favored 'General case' 0 N--CA 1.482 1.132 0 O-C-N 123.59 0.556 . . . . 70.12 110.691 -170.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -61.38 -20.1 62.64 Favored 'General case' 0 CA--C 1.554 1.102 0 N-CA-C 112.761 0.652 . . . . 75.41 112.761 176.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.4 16.29 7.69 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-O 118.437 -0.792 . . . . 74.13 111.479 176.365 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 280' ' ' ALA . . . . . 0.572 ' HB2' ' HA ' ' A' ' 277' ' ' TYR . . . . . . . . 0 N--CA 1.495 1.802 0 N-CA-C 113.135 0.791 . . . . 72.21 113.135 -166.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.479 1.002 0 N-CA-C 109.167 -0.679 . . . . 71.44 109.167 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 2' ' ' LYS . . . . . 0.4 ' HE3' ' O ' ' B' ' 4' ' ' SER . 58.0 tptt -63.43 108.25 1.3 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.491 0.716 . . . . 54.1 109.645 175.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 61.3 tp60 -82.7 73.92 9.7 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 109.126 -0.694 . . . . 74.04 109.126 177.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 4' ' ' SER . . . . . 0.4 ' O ' ' HE3' ' B' ' 2' ' ' LYS . 61.4 p 45.65 -88.06 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 126.012 1.725 . . . . 52.14 114.062 172.513 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 59.4 m 56.95 133.5 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 126.18 1.792 . . . . 70.11 114.044 -178.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.669 HG21 ' HA ' ' A' ' 125' ' ' LEU . 37.5 pt -137.54 172.43 14.6 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 C-N-CA 122.991 0.517 . . . . 64.44 111.971 -175.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -124.97 -167.6 1.7 Allowed 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.616 1.167 . . . . 72.01 108.991 175.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 8' ' ' LEU . . . . . 0.642 HD11 HD22 ' A' ' 176' ' ' LEU . 11.0 tp -130.69 167.1 19.35 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 109.428 -0.582 . . . . 75.22 109.428 177.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 9' ' ' ALA . . . . . 0.525 ' HB3' ' H ' ' A' ' 122' ' ' GLU . . . -87.68 -67.11 0.85 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 122.804 0.441 . . . . 62.4 110.864 173.379 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 3.8 tt 64.05 94.27 0.05 Allowed 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.556 1.142 . . . . 74.1 108.834 -169.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 57.2 mt . . . . . 0 CA--C 1.553 1.08 0 CA-C-O 118.751 -0.642 . . . . 45.35 109.434 -176.515 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.475 0 N-CA-C 108.276 -1.009 . . . . 61.34 108.276 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . 60.79 -74.69 0.03 OUTLIER 'General case' 0 C--N 1.358 0.963 0 O-C-N 125.111 1.507 . . . . 74.4 113.407 169.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 181' ' ' LEU . . . . . 0.439 ' HG ' ' HB ' ' C' ' 138' ' ' VAL . 30.3 tp -63.06 -30.14 71.36 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.146 1.378 . . . . 62.04 112.176 -177.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 182' ' ' VAL . . . . . 0.58 HG21 ' HB3' ' C' ' 139' ' ' GLU . 2.8 p -99.11 133.93 39.97 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 CA-C-N 116.189 -0.459 . . . . 71.31 110.982 174.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 183' ' ' ALA . . . . . 0.433 ' HB3' ' HA ' ' C' ' 123' ' ' LEU . . . -159.11 39.47 0.21 Allowed 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 114.806 -1.088 . . . . 65.24 108.453 163.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 42.5 p-80 54.49 171.44 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 127.216 2.207 . . . . 74.15 114.731 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 185' ' ' VAL . . . . . 0.478 HG21 HD11 ' C' ' 119' ' ' LEU . 6.9 p . . . . . 0 N--CA 1.479 1.007 0 CA-C-N 115.638 -0.71 . . . . 71.33 110.469 177.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 4.4 m . . . . . 0 CA--C 1.557 1.214 0 CA-C-O 121.792 0.806 . . . . 71.31 110.753 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 239' ' ' ALA . . . . . 0.426 ' HA ' HD22 ' C' ' 235' ' ' LEU . . . -83.29 153.29 24.72 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.678 0.791 . . . . 74.42 111.345 -176.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 240' ' ' GLY . . . . . 0.424 ' O ' ' HE3' ' B' ' 245' ' ' LYS . . . -86.86 -60.62 1.67 Allowed Glycine 0 C--N 1.349 1.288 0 CA-C-N 116.008 -0.542 . . . . 71.23 113.708 -164.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 241' ' ' GLU . . . . . 0.422 ' HG2' ' H ' ' C' ' 234' ' ' ARG . 15.4 pt-20 -112.18 -167.41 1.18 Allowed 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 117.49 0.645 . . . . 71.21 110.685 178.627 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 242' ' ' TRP . . . . . 0.416 ' CH2' HG21 ' C' ' 253' ' ' VAL 0.259 0.0 OUTLIER 59.53 166.33 0.06 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 127.647 2.379 . . . . 70.32 114.567 177.496 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' B' B ' 243' ' ' GLN . . . . . 0.466 ' HG3' ' H ' ' B' ' 245' ' ' LYS . 1.9 pt20 51.99 -166.95 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 126.519 1.928 . . . . 74.22 114.584 170.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -78.98 -43.81 10.58 Favored Glycine 0 C--N 1.362 2.007 0 CA-C-N 115.773 -0.649 . . . . 63.11 112.246 173.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 245' ' ' LYS . . . . . 0.466 ' H ' ' HG3' ' B' ' 243' ' ' GLN . 22.9 pttm . . . . . 0 N--CA 1.497 1.888 0 C-N-CA 126.324 1.85 . . . . 75.34 112.734 -178.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 114.673 1.36 . . . . 52.01 114.673 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 4.4 ttmp? 46.36 78.46 0.07 Allowed 'General case' 0 C--O 1.244 0.773 0 C-N-CA 125.93 1.692 . . . . 70.52 113.385 178.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -78.42 111.1 14.08 Favored 'General case' 0 C--O 1.246 0.882 0 N-CA-C 107.614 -1.254 . . . . 63.2 107.614 165.247 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 6' ' ' ASP . . . . . 0.49 ' HA ' ' OH ' ' C' ' 66' ' ' TYR . 13.9 t70 -64.73 113.35 3.72 Favored 'General case' 0 C--N 1.345 0.41 0 O-C-N 123.679 0.612 . . . . 63.22 109.837 177.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 7' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -63.83 -31.6 72.84 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 114.893 -1.049 . . . . 73.43 111.535 -176.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -64.76 -39.71 94.08 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 116.322 -0.399 . . . . 72.53 110.462 174.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.93 -41.5 86.94 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.25 0.62 . . . . 52.31 111.166 176.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 61.3 mt -58.57 -40.15 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 122.988 0.515 . . . . 63.34 110.433 178.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 94.0 mt -83.8 -12.62 55.39 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 112.606 0.595 . . . . 45.45 112.606 177.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.36 22.67 78.8 Favored Glycine 0 CA--C 1.535 1.33 0 N-CA-C 114.196 0.438 . . . . 64.33 114.196 -178.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 14.1 m -104.47 152.76 39.39 Favored Pre-proline 0 N--CA 1.482 1.136 0 C-N-CA 123.916 0.886 . . . . 64.04 110.337 177.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -64.0 157.95 50.24 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.542 2.162 . . . . 74.43 112.436 173.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 71.0 mtt180 -77.47 22.3 0.24 Allowed 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 123.508 0.723 . . . . 71.52 112.262 -179.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -120.9 8.79 10.53 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.965 1.306 . . . . 71.24 108.333 173.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.41 133.92 50.47 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 123.671 0.788 . . . . 71.14 111.328 -178.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 53.0 p -104.24 -176.11 2.99 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.564 1.146 . . . . 74.41 109.993 -178.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -48.41 -52.3 22.64 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 124.623 1.169 . . . . 74.45 112.184 -171.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.79 -48.4 63.73 Favored 'General case' 0 C--O 1.212 -0.912 0 O-C-N 123.746 0.654 . . . . 64.05 109.943 -172.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -63.93 -38.98 93.07 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.003 0.921 . . . . 73.42 111.562 -174.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 22' ' ' ILE . . . . . 0.816 HD13 ' HB3' ' C' ' 57' ' ' LEU . 78.3 mt -67.9 -50.3 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 123.977 0.911 . . . . 61.32 110.325 175.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -66.3 -22.31 66.29 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.195 -0.912 . . . . 74.13 110.017 -178.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 -74.05 -48.4 30.19 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.088 1.355 . . . . 73.52 110.035 176.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.39 -38.35 80.28 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 123.925 0.765 . . . . 75.32 110.678 175.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 26' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -58.96 -62.52 1.82 Allowed 'General case' 0 C--O 1.208 -1.098 0 CA-C-N 115.097 -0.956 . . . . 72.31 109.857 173.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -50.33 -38.59 42.74 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 124.089 0.868 . . . . 74.1 111.582 -177.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 28' ' ' ARG . . . . . 0.405 ' HA ' ' NH2' ' C' ' 31' ' ' ARG . 59.5 ttt180 -57.95 -59.84 4.64 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.138 0.975 . . . . 71.15 110.957 176.434 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 29' ' ' LEU . . . . . 0.57 HD22 ' HE2' ' C' ' 33' ' ' TYR . 75.9 mt -76.98 -11.9 59.87 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 114.982 -1.008 . . . . 60.22 110.933 -176.52 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -88.83 -24.56 22.55 Favored 'General case' 0 C--O 1.213 -0.858 0 C-N-CA 124.131 0.973 . . . . 75.32 110.219 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 31' ' ' ARG . . . . . 0.405 ' NH2' ' HA ' ' C' ' 28' ' ' ARG . 45.3 mtm105 -85.12 -39.07 18.34 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.208 0.603 . . . . 73.5 110.204 171.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.72 -56.62 5.45 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 122.871 0.468 . . . . 71.12 110.196 -177.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 33' ' ' TYR . . . . . 0.57 ' HE2' HD22 ' C' ' 29' ' ' LEU . 50.1 m-85 -90.48 23.22 3.07 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 122.986 0.514 . . . . 70.15 111.438 -176.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 34' ' ' HIS . . . . . 0.404 ' HD2' ' HB3' ' C' ' 36' ' ' ASP . 20.6 t60 -68.99 109.1 3.72 Favored Pre-proline 0 N--CA 1.477 0.915 0 CA-C-O 118.265 -0.874 . . . . 72.34 110.114 -178.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 35' ' ' PRO . . . . . 0.505 ' HG3' ' HG2' ' C' ' 44' ' ' GLU . 76.9 Cg_exo -53.12 -25.38 29.04 Favored 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 123.663 2.909 . . . . 71.32 114.932 -173.45 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 36' ' ' ASP . . . . . 0.404 ' HB3' ' HD2' ' C' ' 34' ' ' HIS . 30.4 t70 -74.49 -35.74 63.25 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.508 0.723 . . . . 60.34 111.687 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 58.0 t -92.29 -56.01 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 109.336 -0.616 . . . . 75.33 109.336 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -100.62 92.17 4.99 Favored 'General case' 0 C--O 1.244 0.795 0 C-N-CA 125.098 1.359 . . . . 54.22 109.616 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.84 76.13 6.53 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.109 0.564 . . . . 62.24 109.722 -178.151 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 40' ' ' SER . . . . . 0.463 ' O ' ' HG3' ' C' ' 44' ' ' GLU . 69.8 m -131.23 111.42 15.45 Favored Pre-proline 0 N--CA 1.475 0.777 0 CA-C-O 118.256 -0.878 . . . . 74.14 110.221 179.102 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -45.1 -40.88 16.1 Favored 'Trans proline' 0 C--N 1.383 2.388 0 C-N-CA 123.718 2.946 . . . . 63.44 113.397 174.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -53.41 -48.83 68.37 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.996 0.919 . . . . 65.44 110.229 175.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 43' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' C' ' 47' ' ' PHE . . . -72.01 -18.72 61.95 Favored 'General case' 0 C--O 1.212 -0.913 0 CA-C-N 113.655 -1.611 . . . . 62.05 111.393 -177.226 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 44' ' ' GLU . . . . . 0.505 ' HG2' ' HG3' ' C' ' 35' ' ' PRO . 44.1 mt-10 -88.43 -40.61 13.36 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.805 0.842 . . . . 74.04 111.139 -174.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -69.93 -40.85 75.27 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 109.974 -0.38 . . . . 42.53 109.974 173.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 46' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -66.43 -35.12 79.51 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.916 -0.584 . . . . 72.32 110.774 173.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 47' ' ' PHE . . . . . 0.468 ' HB2' ' O ' ' C' ' 43' ' ' ALA . 77.3 t80 -57.73 -44.63 86.13 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.364 0.666 . . . . 62.23 109.271 173.186 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -58.87 -46.46 87.76 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 122.878 0.471 . . . . 72.04 111.311 176.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -64.37 -32.27 73.81 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 120.719 0.295 . . . . 72.33 111.756 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 50' ' ' ILE . . . . . 0.536 HD13 ' HB3' ' C' ' 29' ' ' LEU . 80.5 mt -74.03 -31.81 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 124.148 0.979 . . . . 75.43 110.136 175.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 51' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -82.81 -14.65 54.0 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.04 0.936 . . . . 74.04 110.811 176.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -81.48 -50.32 9.55 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.288 1.435 . . . . 63.42 108.429 173.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.95 -40.35 76.26 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 113.276 -1.783 . . . . 63.1 110.567 174.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 54' ' ' TYR . . . . . 0.408 ' O ' ' HB2' ' C' ' 58' ' ' SER . 78.7 t80 -77.61 -33.97 53.57 Favored 'General case' 0 C--O 1.215 -0.72 0 CA-C-N 115.544 -0.753 . . . . 75.01 111.356 174.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 55' ' ' ALA . . . . . 0.713 ' HB1' ' HB3' ' C' ' 85' ' ' PHE . . . -51.01 -46.49 61.54 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.916 0.865 . . . . 60.54 110.266 178.246 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 47.2 t -76.71 -58.6 4.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-N 113.453 -1.703 . . . . 72.43 110.605 177.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 57' ' ' LEU . . . . . 0.816 ' HB3' HD13 ' C' ' 22' ' ' ILE . 69.6 mt -82.03 1.95 33.28 Favored 'General case' 0 CA--C 1.563 1.45 0 N-CA-C 114.465 1.283 . . . . 75.02 114.465 -166.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 58' ' ' SER . . . . . 0.408 ' HB2' ' O ' ' C' ' 54' ' ' TYR . 48.4 t -50.79 -56.45 12.05 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 124.262 1.025 . . . . 62.42 113.393 -173.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -123.79 150.42 62.05 Favored Pre-proline 0 C--O 1.252 1.207 0 CA-C-N 114.359 -1.291 . . . . 72.03 108.387 -171.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 60' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -47.19 -45.7 21.22 Favored 'Trans proline' 0 C--N 1.384 2.41 0 C-N-CA 123.761 2.974 . . . . 33.23 114.389 -169.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -58.15 -53.38 58.87 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.154 0.582 . . . . 62.13 112.365 -174.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -69.96 -37.24 75.76 Favored 'General case' 0 C--O 1.247 0.948 0 CA-C-N 115.602 -0.726 . . . . 75.23 110.821 -176.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 1.1 ppt_? -64.76 -35.85 82.4 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 115.847 -0.615 . . . . 64.42 109.601 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -73.82 -29.71 62.3 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.107 0.963 . . . . 74.15 111.198 177.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 82.6 mt -62.11 -43.68 98.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 109.57 -0.53 . . . . 62.34 109.57 172.115 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 66' ' ' TYR . . . . . 0.49 ' OH ' ' HA ' ' C' ' 6' ' ' ASP . 22.2 t80 -57.71 -50.82 71.93 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 116.145 -0.479 . . . . 74.22 110.094 173.229 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -58.45 -40.89 83.86 Favored 'General case' 0 N--CA 1.48 1.074 0 O-C-N 123.813 0.696 . . . . 73.14 112.182 -178.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 40.3 p -69.13 -22.27 63.96 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 119.604 -0.236 . . . . 63.2 110.722 178.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -81.69 142.17 32.94 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 108.678 -0.86 . . . . 75.22 108.678 166.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.72 22.05 62.62 Favored Glycine 0 C--N 1.345 1.071 0 N-CA-C 110.817 -0.913 . . . . 62.51 110.817 -174.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 61.5 m -145.54 -54.72 0.29 Allowed 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 103.045 -2.946 . . . . 72.34 103.045 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 47.3 m -83.41 142.26 31.12 Favored 'General case' 0 C--O 1.26 1.646 0 N-CA-C 105.214 -2.143 . . . . 73.35 105.214 157.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.32 -33.59 28.9 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.72 0.808 . . . . 73.23 111.022 177.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.16 152.89 71.63 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 123.741 0.817 . . . . 53.23 110.521 177.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -58.95 125.77 19.17 Favored 'Trans proline' 0 C--N 1.38 2.211 0 C-N-CA 122.638 2.226 . . . . 75.14 111.162 171.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -58.03 151.02 60.91 Favored 'Trans proline' 0 C--N 1.384 2.429 0 C-N-CA 123.323 2.682 . . . . 63.14 112.215 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -49.28 111.35 0.47 Allowed 'Trans proline' 0 C--N 1.387 2.556 0 C-N-CA 123.492 2.795 . . . . 51.51 113.347 -177.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 78' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.0 133.1 45.37 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.769 2.312 . . . . 74.44 112.493 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 79' ' ' PRO . . . . . 0.413 ' HA ' ' HD3' ' C' ' 80' ' ' PRO . 81.2 Cg_exo -50.16 124.45 12.88 Favored 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 122.399 2.066 . . . . 61.04 110.244 167.23 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 80' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' C' ' 79' ' ' PRO . 32.0 Cg_exo -65.68 37.81 0.13 Allowed 'Trans proline' 0 C--N 1.383 2.385 0 C-N-CA 124.741 3.627 . . . . 51.5 116.746 -172.501 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -163.24 -10.46 0.03 OUTLIER Glycine 0 CA--C 1.524 0.619 0 C-N-CA 123.51 0.576 . . . . 75.2 112.265 168.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 144.99 168.93 13.11 Favored Glycine 0 C--N 1.35 1.345 0 N-CA-C 114.384 0.513 . . . . 74.45 114.384 173.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -98.5 135.03 40.64 Favored 'General case' 0 C--O 1.219 -0.545 0 N-CA-C 106.744 -1.576 . . . . 70.14 106.744 171.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 84' ' ' ASP . . . . . 0.442 ' HB2' ' NE ' ' C' ' 143' ' ' ARG . 14.2 t70 -72.49 137.18 46.19 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 118.8 0.727 . . . . 63.13 112.333 -178.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 85' ' ' PHE . . . . . 0.713 ' HB3' ' HB1' ' C' ' 55' ' ' ALA . 6.8 p90 -164.49 48.46 0.11 Allowed 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.413 1.485 . . . . 74.41 109.09 170.043 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 86' ' ' SER . . . . . 0.67 ' HA ' ' HG2' ' C' ' 171' ' ' PRO . 68.2 m -63.38 122.89 17.32 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 115.223 -0.898 . . . . 45.43 112.056 -176.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.01 4.52 88.42 Favored Glycine 0 C--N 1.351 1.385 0 CA-C-N 115.29 -0.868 . . . . 74.33 113.401 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 88' ' ' PHE . . . . . 0.496 ' HB3' ' HZ ' ' C' ' 93' ' ' PHE . 11.7 m-85 -108.17 137.67 45.75 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 117.481 0.641 . . . . 74.44 109.579 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -79.92 78.75 6.52 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.52 0.676 . . . . 72.23 111.376 -173.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 90' ' ' VAL . . . . . . . . . . . . . 3.4 p -49.21 -34.83 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 125.478 1.511 . . . . 54.41 113.952 176.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.21 -19.99 64.8 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 123.152 0.581 . . . . 74.21 110.529 -174.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -110.91 16.05 21.46 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-O 121.01 0.433 . . . . 75.53 111.469 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 93' ' ' PHE . . . . . 0.496 ' HZ ' ' HB3' ' C' ' 88' ' ' PHE . 16.7 m-30 -89.13 166.29 13.94 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 109.797 -0.445 . . . . 72.45 109.797 172.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 80.6 p -65.53 164.62 13.71 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.683 0.793 . . . . 45.51 112.91 -170.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.14 -36.81 78.34 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 114.951 -1.022 . . . . 55.43 110.831 170.582 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -58.71 -45.67 89.01 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.189 0.996 . . . . 65.02 110.466 177.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 97' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -62.2 -45.63 92.5 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.936 -0.575 . . . . 64.25 109.661 176.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -81.05 -0.3 39.19 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 115.747 -0.66 . . . . 51.52 112.716 -175.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -101.55 -63.85 1.11 Allowed 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.357 0.663 . . . . 74.43 110.786 168.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 51.3 tp -55.1 -45.08 75.43 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.551 0.74 . . . . 73.23 111.265 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -98.5 -6.1 30.95 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.572 -0.74 . . . . 73.25 111.271 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -45.28 -61.42 3.6 Favored Glycine 0 C--N 1.356 1.647 0 N-CA-C 115.793 1.077 . . . . 54.11 115.793 -176.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -55.37 -27.68 59.37 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 123.097 2.531 . . . . 62.02 112.826 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -115.45 28.2 8.0 Favored Glycine 0 C--N 1.359 1.843 0 CA-C-O 118.937 -0.924 . . . . 43.23 112.815 -177.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 72.2 mt . . . . . 0 N--CA 1.495 1.776 0 CA-C-N 119.594 1.697 . . . . 73.03 110.528 170.981 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.878 0 N-CA-C 115.233 0.853 . . . . 45.25 115.233 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.04 -175.38 2.78 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.147 1.379 . . . . 64.44 110.18 -177.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -72.44 131.84 43.11 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 109.281 -0.637 . . . . 75.42 109.281 167.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 119' ' ' LEU . . . . . 0.478 HD11 HG21 ' B' ' 185' ' ' VAL . 36.1 tp -110.73 142.21 42.99 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.246 1.018 . . . . 75.21 108.617 -175.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -117.73 104.45 11.0 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 108.719 -0.845 . . . . 72.31 108.719 -169.095 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 121' ' ' ALA . . . . . 0.446 ' HB3' HD23 ' C' ' 176' ' ' LEU . . . -113.41 116.2 29.26 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.077 -0.712 . . . . 63.21 109.077 176.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 122' ' ' GLU . . . . . 0.493 ' HA ' ' O ' ' C' ' 177' ' ' VAL . 44.5 mt-10 -89.03 110.95 21.58 Favored 'General case' 0 C--N 1.347 0.462 0 N-CA-C 108.26 -1.015 . . . . 73.22 108.26 172.237 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 123' ' ' LEU . . . . . 0.6 ' H ' HD23 ' C' ' 123' ' ' LEU . 1.1 pt? -106.31 113.71 63.03 Favored Pre-proline 0 C--O 1.248 0.976 0 O-C-N 123.781 0.676 . . . . 73.3 109.39 -177.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -58.33 114.45 1.98 Allowed 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 122.205 1.937 . . . . 72.51 110.2 162.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 125' ' ' LEU . . . . . 0.547 ' O ' ' HA ' ' C' ' 180' ' ' LEU . 53.7 tp -142.94 154.94 44.57 Favored 'General case' 0 C--O 1.219 -0.547 0 N-CA-C 106.967 -1.494 . . . . 74.03 106.967 -171.309 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 126' ' ' THR . . . . . 0.452 ' HB ' HD12 ' C' ' 181' ' ' LEU . 11.1 t -119.3 171.62 8.18 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 119.735 1.152 . . . . 61.53 110.795 177.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 127' ' ' LEU . . . . . 0.505 HD11 ' H ' ' C' ' 185' ' ' VAL . 10.0 mt -62.86 -47.48 83.19 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 113.724 -1.58 . . . . 62.25 110.72 -171.224 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -58.32 -44.58 88.69 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 114.219 -1.355 . . . . 75.24 109.896 -177.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -75.25 -24.37 57.64 Favored 'General case' 0 C--O 1.216 -0.703 0 CA-C-N 114.975 -1.011 . . . . 73.53 111.445 178.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 130' ' ' ALA . . . . . 0.422 ' HB1' ' H ' ' C' ' 153' ' ' VAL . . . -71.76 -31.58 66.79 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 109.611 -0.514 . . . . 64.34 109.611 175.297 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 131' ' ' PHE . . . . . 0.551 ' HB2' HD13 ' C' ' 215' ' ' LEU . 75.5 t80 -70.35 -41.88 72.59 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.207 1.003 . . . . 75.55 109.855 172.111 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 132' ' ' HIS . . . . . . . . . . . . . 24.9 m170 -76.62 -8.23 56.83 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 115.19 -0.914 . . . . 60.22 110.99 176.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -54.02 134.1 44.52 Favored Glycine 0 C--N 1.356 1.661 0 O-C-N 123.973 0.796 . . . . 65.31 113.233 176.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . 173.17 -128.37 1.51 Allowed Glycine 0 C--O 1.24 0.526 0 N-CA-C 108.969 -1.652 . . . . 53.24 108.969 -177.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -72.0 95.54 1.61 Allowed 'General case' 0 C--N 1.35 0.587 0 N-CA-C 108.357 -0.979 . . . . 71.2 108.357 175.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 136' ' ' ARG . . . . . . . . . . . . . 19.5 mmt180 -126.1 162.48 25.24 Favored 'General case' 0 C--O 1.243 0.724 0 C-N-CA 123.522 0.729 . . . . 72.12 109.837 -178.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 137' ' ' VAL . . . . . . . . . . . . . 8.6 p -78.85 123.81 36.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 CA-C-N 115.374 -0.83 . . . . 71.12 110.119 177.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 138' ' ' VAL . . . . . 0.439 ' HB ' ' HG ' ' B' ' 181' ' ' LEU . 8.8 p -115.87 131.28 68.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 108.247 -1.02 . . . . 72.14 108.247 169.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 139' ' ' GLU . . . . . 0.58 ' HB3' HG21 ' B' ' 182' ' ' VAL . 9.9 tp10 -124.32 83.31 2.13 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 107.075 -1.454 . . . . 74.31 107.075 174.278 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 140' ' ' VAL . . . . . . . . . . . . . 54.6 t -140.9 148.67 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 107.214 -1.402 . . . . 63.22 107.214 178.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 68.67 23.39 7.13 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 124.14 0.976 . . . . 15.23 111.524 -177.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 67.14 40.62 92.74 Favored Glycine 0 C--N 1.347 1.167 0 O-C-N 123.931 0.769 . . . . 45.25 112.94 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 143' ' ' ARG . . . . . 0.587 ' NH2' ' HA ' ' C' ' 164' ' ' MET . 25.3 ttp-105 -153.07 124.18 7.49 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-O 120.82 0.343 . . . . 73.04 110.883 179.343 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 62.9 ttt-85 -88.34 124.0 33.48 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.239 -0.891 . . . . 71.51 109.269 167.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 145' ' ' VAL . . . . . . . . . . . . . 8.0 p -151.52 142.38 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.083 0.553 . . . . 75.03 109.587 173.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 52.9 p -84.33 105.36 15.1 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 109.196 -0.668 . . . . 54.21 109.196 174.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 14.5 p -123.2 146.73 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 N-CA-C 109.663 -0.495 . . . . 72.53 109.663 -178.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -91.16 114.93 27.59 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 122.933 0.493 . . . . 74.22 110.465 174.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 149' ' ' ILE . . . . . . . . . . . . . 31.5 pt -93.24 153.63 41.57 Favored Pre-proline 0 CA--C 1.55 0.953 0 N-CA-C 107.955 -1.128 . . . . 71.41 107.955 164.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -47.52 122.02 6.25 Favored 'Trans proline' 0 C--N 1.384 2.404 0 C-N-CA 123.029 2.486 . . . . 61.44 112.018 177.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -61.25 109.35 0.71 Allowed 'Trans proline' 0 C--N 1.385 2.498 0 C-N-CA 123.043 2.495 . . . . 73.2 111.536 -178.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 152' ' ' GLY . . . . . . . . . . . . . . . 110.58 109.78 3.19 Favored Glycine 0 C--N 1.338 0.673 0 CA-C-N 115.456 -0.793 . . . . 54.32 111.973 -170.117 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 153' ' ' VAL . . . . . 0.522 ' HB ' HG21 ' C' ' 178' ' ' VAL . 2.1 m -105.27 168.75 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 123.063 0.545 . . . . 71.13 109.647 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 154' ' ' ARG . . . . . 0.44 ' O ' HG23 ' C' ' 178' ' ' VAL . 18.2 mtp180 -115.78 116.26 27.73 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 122.905 0.482 . . . . 75.32 111.258 -174.223 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 155' ' ' GLU . . . . . 0.547 ' HG2' ' HE ' ' C' ' 187' ' ' ARG . 2.9 tp10 -22.7 115.95 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 126.733 2.013 . . . . 74.51 114.234 168.205 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 57.76 10.29 6.23 Favored Glycine 0 C--N 1.351 1.406 0 O-C-N 123.827 0.704 . . . . 64.51 114.752 171.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 157' ' ' SER . . . . . 0.425 ' HB2' ' HB2' ' C' ' 154' ' ' ARG . 49.5 m -106.74 167.28 9.98 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 121.572 0.701 . . . . 75.43 110.466 -173.303 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 18.4 t -103.31 104.75 17.13 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 CA-C-N 114.774 -1.103 . . . . 64.44 110.439 -169.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 159' ' ' ILE . . . . . 0.44 HD11 ' HB ' ' C' ' 153' ' ' VAL . 19.1 mt -72.23 145.87 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 109.287 -0.634 . . . . 52.25 109.287 167.298 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -109.82 108.4 18.71 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 109.148 -0.686 . . . . 72.21 109.148 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 161' ' ' VAL . . . . . 0.576 HG21 HD12 ' C' ' 176' ' ' LEU . 49.4 t -125.87 95.23 40.27 Favored Pre-proline 0 N--CA 1.485 1.283 0 C-N-CA 123.734 0.814 . . . . 75.24 110.967 -171.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -64.53 146.57 89.48 Favored 'Trans proline' 0 C--N 1.363 1.327 0 C-N-CA 121.805 1.67 . . . . 63.42 109.736 165.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 129.78 -16.87 5.54 Favored Glycine 0 N--CA 1.475 1.296 0 C-N-CA 121.715 -0.279 . . . . 53.31 113.569 -176.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 164' ' ' MET . . . . . 0.587 ' HA ' ' NH2' ' C' ' 143' ' ' ARG . 2.9 mpp? -121.58 -79.5 0.61 Allowed 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 109.434 -0.58 . . . . 73.35 109.434 170.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 165' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' C' ' 173' ' ' ASP . . . 68.9 174.18 9.37 Favored Glycine 0 C--N 1.349 1.28 0 N-CA-C 114.436 0.535 . . . . 64.24 114.436 -178.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . -71.11 165.14 53.43 Favored Glycine 0 C--N 1.343 0.934 0 N-CA-C 111.988 -0.445 . . . . 75.44 111.988 172.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 167' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -67.27 144.28 56.01 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 109.828 -0.434 . . . . 64.31 109.828 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . 144.68 130.85 2.33 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-O 119.084 -0.842 . . . . 13.44 111.37 -174.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 169' ' ' ASN . . . . . 0.569 ' HB3' ' HD3' ' C' ' 170' ' ' PRO . 8.5 t30 -49.88 -49.82 71.74 Favored Pre-proline 0 CA--C 1.557 1.224 0 C-N-CA 124.468 1.107 . . . . 62.44 112.46 -172.358 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 170' ' ' PRO . . . . . 0.569 ' HD3' ' HB3' ' C' ' 169' ' ' ASN . 1.5 Cg_endo -86.87 104.71 0.64 Allowed 'Trans proline' 0 C--N 1.383 2.345 0 CA-C-N 121.522 1.579 . . . . 51.41 110.061 162.41 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 171' ' ' PRO . . . . . 0.67 ' HG2' ' HA ' ' C' ' 86' ' ' SER . 72.4 Cg_endo -72.83 173.09 14.05 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.906 2.404 . . . . 74.02 112.648 -175.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -117.21 -94.76 1.79 Allowed Glycine 0 C--N 1.346 1.09 0 CA-C-N 115.772 -0.649 . . . . 74.42 112.895 -177.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 173' ' ' ASP . . . . . 0.44 ' O ' ' HA2' ' C' ' 165' ' ' GLY . 6.8 t70 -166.26 151.32 8.21 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.906 0.882 . . . . 74.51 109.626 -164.535 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 174' ' ' LEU . . . . . . . . . . . . . 30.1 tp -117.84 105.15 11.64 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.554 0.741 . . . . 75.22 109.207 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 77.2 mt -74.81 96.18 3.04 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-N 114.523 -1.217 . . . . 71.32 109.744 172.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 176' ' ' LEU . . . . . 0.576 HD12 HG21 ' C' ' 161' ' ' VAL . 41.7 mt -85.77 96.87 9.88 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-N 115.313 -0.858 . . . . 43.02 109.945 178.175 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 177' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' C' ' 122' ' ' GLU . 22.0 t -84.57 101.24 8.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 107.906 -1.146 . . . . 74.43 107.906 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 178' ' ' VAL . . . . . 0.522 HG21 ' HB ' ' C' ' 153' ' ' VAL . 0.8 OUTLIER -84.74 102.66 11.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.059 -0.973 . . . . 74.01 110.632 -171.995 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 179' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -87.95 104.08 16.28 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.291 -1.374 . . . . 72.33 107.291 175.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 180' ' ' LEU . . . . . 0.547 ' HA ' ' O ' ' C' ' 125' ' ' LEU . 96.5 mt -68.83 138.29 54.63 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 109.99 -0.374 . . . . 70.51 109.99 177.53 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 181' ' ' LEU . . . . . 0.452 HD12 ' HB ' ' C' ' 126' ' ' THR . 51.8 mt -56.87 167.6 1.02 Allowed Pre-proline 0 N--CA 1.493 1.679 0 C-N-CA 125.539 1.536 . . . . 74.2 112.045 -173.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -54.62 68.38 0.03 OUTLIER 'Trans proline' 0 C--N 1.388 2.654 0 C-N-CA 123.842 3.028 . . . . 64.12 112.58 164.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 183' ' ' HIS . . . . . 0.508 ' N ' ' HD3' ' C' ' 184' ' ' PRO . 84.3 t60 177.39 48.16 0.03 OUTLIER Pre-proline 0 CA--C 1.567 1.615 0 C-N-CA 128.466 2.707 . . . . 62.13 106.444 -169.472 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 184' ' ' PRO . . . . . 0.508 ' HD3' ' N ' ' C' ' 183' ' ' HIS . 4.3 Cg_endo -87.95 65.66 3.57 Favored 'Trans proline' 0 C--N 1.398 3.141 0 C-N-CA 123.318 2.679 . . . . 71.54 110.236 -175.299 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 185' ' ' VAL . . . . . 0.505 ' H ' HD11 ' C' ' 127' ' ' LEU . 11.1 t -94.63 -24.77 4.79 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.076 0 CA-C-N 115.0 -1.0 . . . . 72.23 109.938 -170.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 186' ' ' PHE . . . . . 0.426 ' CD1' HD13 ' C' ' 127' ' ' LEU . 32.4 m-85 -124.58 105.51 9.42 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.398 0.618 . . . . 61.44 110.759 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 187' ' ' ARG . . . . . 0.547 ' HE ' ' HG2' ' C' ' 155' ' ' GLU . 35.4 ttm105 -108.3 104.41 13.79 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.708 1.203 . . . . 75.14 108.9 -174.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 188' ' ' LEU . . . . . . . . . . . . . 58.7 tp -77.91 134.89 37.82 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.202 0.815 . . . . 74.14 113.202 -167.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -132.55 119.07 20.03 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 126.008 1.723 . . . . 71.33 107.277 164.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 64.44 -99.21 0.32 Allowed Glycine 0 C--N 1.343 0.954 0 CA-C-N 116.07 -0.514 . . . . 74.2 112.614 -175.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 191' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -127.3 -12.94 5.63 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.106 0.962 . . . . 60.21 109.336 173.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -86.74 148.49 25.4 Favored 'General case' 0 C--N 1.362 1.111 0 C-N-CA 123.509 0.724 . . . . 65.13 109.516 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 193' ' ' LEU . . . . . 0.458 HD21 ' CD2' ' C' ' 240' ' ' PHE . 90.1 mt -103.48 161.84 13.53 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.325 0.65 . . . . 52.2 110.681 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 194' ' ' TYR . . . . . 0.413 ' HB3' ' HB3' ' C' ' 187' ' ' ARG . 10.5 t80 -125.29 106.73 10.07 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.707 -1.22 . . . . 75.43 107.707 170.298 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 195' ' ' ALA . . . . . 0.496 ' HB2' HD11 ' C' ' 249' ' ' LEU . . . -105.76 -176.81 3.18 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.211 1.004 . . . . 65.11 110.268 177.224 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 87.0 m -139.07 120.95 15.48 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 114.953 -1.021 . . . . 51.32 108.836 166.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 197' ' ' LEU . . . . . 0.424 HD13 HD22 ' C' ' 251' ' ' LEU . 27.3 tp -90.69 115.48 27.82 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.886 0.874 . . . . 73.5 110.628 -175.317 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -78.15 104.06 8.49 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.826 0.85 . . . . 44.52 109.76 -178.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 199' ' ' VAL . . . . . 0.535 HG22 HG21 ' C' ' 210' ' ' VAL . 39.4 t -120.35 115.64 32.63 Favored Pre-proline 0 N--CA 1.482 1.145 0 C-N-CA 124.388 1.075 . . . . 61.21 109.481 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 200' ' ' PRO . . . . . 0.4 ' HG2' HD12 ' C' ' 203' ' ' ILE . 38.1 Cg_endo -69.28 149.75 70.33 Favored 'Trans proline' 0 C--N 1.367 1.529 0 C-N-CA 121.71 1.606 . . . . 71.34 111.988 175.1 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 201' ' ' ALA . . . . . 0.427 ' O ' HG23 ' C' ' 205' ' ' VAL . . . -54.73 -47.6 97.68 Favored Pre-proline 0 CA--C 1.562 1.42 0 N-CA-C 114.263 1.209 . . . . 74.35 114.263 -170.296 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 202' ' ' PRO . . . . . 0.436 ' O ' HG12 ' C' ' 206' ' ' VAL . 78.2 Cg_exo -53.3 -45.74 38.85 Favored 'Trans proline' 0 C--N 1.388 2.646 0 C-N-CA 121.763 1.642 . . . . 63.15 112.728 175.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 203' ' ' ILE . . . . . 0.4 HD12 ' HG2' ' C' ' 200' ' ' PRO . 38.7 mt -67.88 -33.86 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 124.048 0.939 . . . . 63.4 111.167 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 204' ' ' ALA . . . . . 0.411 ' HA ' HG11 ' C' ' 223' ' ' VAL . . . -68.73 -34.07 74.98 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.485 0.714 . . . . 75.02 111.654 178.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 205' ' ' VAL . . . . . 0.55 HG13 ' HG3' ' C' ' 226' ' ' ARG . 95.1 t -85.26 -40.42 14.82 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 N-CA-C 112.775 0.658 . . . . 63.41 112.775 -175.263 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 206' ' ' VAL . . . . . 0.436 HG12 ' O ' ' C' ' 202' ' ' PRO . 6.4 p -81.36 -39.35 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-N 118.959 0.799 . . . . 52.12 110.472 176.3 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 97.27 92.49 1.89 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.387 -0.685 . . . . 63.21 111.387 -166.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -113.98 -141.36 7.76 Favored Glycine 0 C--N 1.338 0.694 0 N-CA-C 111.734 -0.546 . . . . 51.32 111.734 176.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 209' ' ' LYS . . . . . 0.595 ' HG2' ' HA ' ' C' ' 222' ' ' ALA . 8.7 mtmp? -140.21 141.28 35.94 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.126 0.571 . . . . 72.12 110.557 171.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 210' ' ' VAL . . . . . 0.535 HG21 HG22 ' C' ' 199' ' ' VAL . 15.1 m -133.59 135.34 55.84 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 C-N-CA 124.912 1.285 . . . . 62.05 107.597 169.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 211' ' ' ARG . . . . . 0.498 ' HA ' ' HA ' ' C' ' 220' ' ' GLU . 0.5 OUTLIER -89.43 122.11 32.32 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 122.279 0.232 . . . . 72.44 110.761 -174.371 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 212' ' ' ALA . . . . . 0.477 ' HB3' HG13 ' C' ' 219' ' ' VAL . . . -81.16 116.35 21.02 Favored 'General case' 0 C--O 1.248 1.023 0 N-CA-C 107.678 -1.23 . . . . 74.43 107.678 173.312 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 213' ' ' MET . . . . . . . . . . . . . 4.8 tmm? -70.36 117.25 11.67 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 108.002 -1.11 . . . . 63.12 108.002 174.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 214' ' ' THR . . . . . 0.526 HG21 ' HD2' ' C' ' 238' ' ' LYS . 1.0 OUTLIER -115.57 168.12 10.3 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 122.043 0.925 . . . . 54.24 112.406 -176.954 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 215' ' ' LEU . . . . . 0.551 HD13 ' HB2' ' C' ' 131' ' ' PHE . 81.4 mt -65.98 -37.17 85.29 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 114.438 -1.256 . . . . 44.41 113.003 -169.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 216' ' ' GLU . . . . . 0.46 ' HG2' HH11 ' C' ' 246' ' ' ARG . 0.0 OUTLIER -105.23 9.84 33.89 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 114.492 -1.231 . . . . 71.0 110.951 -174.936 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 148.41 -144.81 12.74 Favored Glycine 0 C--N 1.353 1.484 0 CA-C-O 119.925 -0.375 . . . . 64.11 112.4 178.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -105.6 165.14 0.15 Allowed 'Trans proline' 0 CA--C 1.548 1.221 0 C-N-CA 123.61 2.873 . . . . 52.13 113.716 168.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 219' ' ' VAL . . . . . 0.477 HG13 ' HB3' ' C' ' 212' ' ' ALA . 4.5 p -145.7 116.54 1.83 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 107.154 -1.424 . . . . 52.53 107.154 163.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 220' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' C' ' 211' ' ' ARG . 28.2 tt0 -82.78 110.74 18.07 Favored 'General case' 0 C--O 1.247 0.971 0 N-CA-C 108.893 -0.78 . . . . 72.32 108.893 -179.112 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 221' ' ' VAL . . . . . . . . . . . . . 62.1 t -88.38 126.12 41.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 CA-C-N 115.16 -0.927 . . . . 74.03 109.515 -176.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 222' ' ' ALA . . . . . 0.595 ' HA ' ' HG2' ' C' ' 209' ' ' LYS . . . -87.24 143.72 27.15 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.666 -0.697 . . . . 73.3 110.378 176.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 223' ' ' VAL . . . . . 0.411 HG11 ' HA ' ' C' ' 204' ' ' ALA . 56.0 t -112.22 139.41 22.46 Favored Pre-proline 0 CA--C 1.558 1.254 0 C-N-CA 125.155 1.382 . . . . 73.11 108.537 -174.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 224' ' ' PRO . . . . . 0.415 ' HD3' ' CZ2' ' B' ' 242' ' ' TRP . 55.1 Cg_endo -87.76 168.34 6.98 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 123.213 2.609 . . . . 54.33 112.627 175.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -65.77 119.4 6.42 Favored 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 122.197 1.931 . . . . 74.0 112.358 174.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 226' ' ' ARG . . . . . 0.55 ' HG3' HG13 ' C' ' 205' ' ' VAL . 0.0 OUTLIER 66.48 89.81 0.1 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.211 1.804 . . . . 70.15 111.679 179.763 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 227' ' ' THR . . . . . . . . . . . . . 40.6 m -112.95 124.91 53.7 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 113.56 -1.654 . . . . 70.3 110.612 -174.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 228' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -90.52 152.02 21.1 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.946 0.898 . . . . 74.32 111.63 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 229' ' ' ALA . . . . . 0.442 ' HA ' ' O ' ' C' ' 253' ' ' VAL . . . -76.16 135.59 39.77 Favored 'General case' 0 C--O 1.243 0.745 0 CA-C-N 115.31 -0.859 . . . . 62.12 109.673 175.169 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 98.06 -2.38 59.75 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 115.774 -0.648 . . . . 62.04 113.339 -169.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 231' ' ' ARG . . . . . . . . . . . . . 68.8 mtt180 -66.35 172.06 4.31 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 117.75 0.775 . . . . 74.12 110.736 167.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 232' ' ' LYS . . . . . 0.559 ' HA ' ' O ' ' C' ' 251' ' ' LEU . 37.7 ttmt -154.32 143.89 21.53 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.243 0.831 . . . . 71.45 113.243 -173.236 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 233' ' ' LEU . . . . . 0.558 ' O ' ' HA ' ' C' ' 250' ' ' TYR . 3.4 mp -123.88 144.23 49.88 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 115.03 -0.987 . . . . 74.21 109.936 170.108 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 234' ' ' ARG . . . . . 0.422 ' H ' ' HG2' ' B' ' 241' ' ' GLU . 16.1 ptp180 -101.66 115.85 31.45 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 108.366 -0.976 . . . . 72.34 108.366 162.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 235' ' ' LEU . . . . . 0.426 HD22 ' HA ' ' B' ' 239' ' ' ALA . 33.7 mt -98.2 119.37 36.74 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 107.913 -1.143 . . . . 73.43 107.913 176.49 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -67.93 128.78 37.76 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.739 0.815 . . . . 71.55 112.087 -172.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 78.8 3.69 87.63 Favored Glycine 0 C--N 1.352 1.448 0 CA-C-N 115.731 -0.668 . . . . 71.42 113.342 176.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 238' ' ' LYS . . . . . 0.526 ' HD2' HG21 ' C' ' 214' ' ' THR . 67.0 mmtt -96.17 8.34 44.07 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.161 0.584 . . . . 72.03 111.518 -177.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -87.42 -170.09 46.17 Favored Glycine 0 C--N 1.352 1.464 0 O-C-N 123.373 0.421 . . . . 31.21 112.802 174.035 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 240' ' ' PHE . . . . . 0.458 ' CD2' HD21 ' C' ' 193' ' ' LEU . 2.0 m-85 -81.47 150.47 67.09 Favored Pre-proline 0 N--CA 1.48 1.073 0 N-CA-C 110.001 -0.37 . . . . 75.14 110.001 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 241' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -62.08 139.79 80.54 Favored 'Trans proline' 0 C--N 1.385 2.494 0 C-N-CA 123.26 2.64 . . . . 70.21 113.92 -174.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -132.07 177.28 18.81 Favored Glycine 0 CA--C 1.522 0.485 0 CA-C-N 114.852 -1.067 . . . . 70.14 111.501 177.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.97 -11.25 27.21 Favored 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 122.792 2.328 . . . . 71.42 112.716 -175.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -110.34 -4.83 15.43 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.655 0.782 . . . . 71.42 111.858 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 147.65 -104.86 0.3 Allowed Glycine 0 C--N 1.35 1.342 0 N-CA-C 111.814 -0.514 . . . . 51.32 111.814 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 246' ' ' ARG . . . . . 0.46 HH11 ' HG2' ' C' ' 216' ' ' GLU . 85.0 mtm180 -146.05 167.71 22.71 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 124.78 1.232 . . . . 61.31 109.248 176.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -87.67 -156.8 30.64 Favored Glycine 0 C--N 1.346 1.136 0 N-CA-C 112.21 -0.356 . . . . 63.23 112.21 172.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -115.51 170.01 8.74 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.177 0.591 . . . . 73.54 109.585 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 249' ' ' LEU . . . . . 0.496 HD11 ' HB2' ' C' ' 195' ' ' ALA . 28.4 tp -116.02 115.06 25.46 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.406 0.682 . . . . 74.23 110.857 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 250' ' ' TYR . . . . . 0.558 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 2.1 m-30 -100.83 98.15 8.69 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.231 0.612 . . . . 71.43 109.696 -178.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 251' ' ' LEU . . . . . 0.559 ' O ' ' HA ' ' C' ' 232' ' ' LYS . 1.8 mp -94.53 126.29 39.73 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 119.448 -0.31 . . . . 64.53 110.222 -177.275 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -80.29 113.16 18.26 Favored 'General case' 0 C--O 1.217 -0.619 0 O-C-N 124.887 1.367 . . . . 73.41 108.579 170.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 253' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' C' ' 229' ' ' ALA . 40.5 t -72.36 133.12 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 123.15 0.58 . . . . 73.5 110.335 -174.462 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 254' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -122.84 114.82 21.01 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.545 1.138 . . . . 74.13 108.918 -165.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 255' ' ' ILE . . . . . 0.429 HG12 ' HB2' ' C' ' 229' ' ' ALA . 20.8 mm -88.61 115.67 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 109.19 -0.67 . . . . 75.24 109.19 -179.047 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 256' ' ' THR . . . . . . . . . . . . . 1.4 t -124.09 151.43 43.88 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.973 0.909 . . . . 53.32 111.394 -174.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 2.4 pp -121.55 120.49 28.78 Favored Pre-proline 0 N--CA 1.482 1.173 0 N-CA-C 107.55 -1.278 . . . . 64.54 107.55 170.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 258' ' ' PRO . . . . . 0.516 ' HG3' ' HE2' ' A' ' 276' ' ' TYR . 26.6 Cg_endo -78.98 11.68 2.5 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 C-N-CA 122.845 2.364 . . . . 73.21 113.946 -161.532 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 69.21 -62.24 0.41 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.592 1.557 . . . . 72.3 111.025 -173.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.51 130.43 31.75 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.24 1.016 . . . . 73.41 111.098 176.075 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 261' ' ' LEU . . . . . . . . . . . . . 88.0 mt -156.68 143.78 18.8 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.188 1.395 . . . . 71.21 107.702 177.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 71.8 p -83.41 152.01 63.41 Favored Pre-proline 0 CA--C 1.549 0.936 0 CA-C-O 118.105 -0.95 . . . . 61.23 108.457 172.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_exo -45.6 -33.36 9.66 Favored 'Trans proline' 0 C--N 1.384 2.432 0 C-N-CA 123.486 2.79 . . . . 74.2 114.647 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -63.07 -62.01 2.0 Allowed 'General case' 0 C--O 1.251 1.148 0 C-N-CA 124.258 1.023 . . . . 71.04 110.695 175.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -50.55 -52.0 42.83 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 115.196 -0.911 . . . . 65.11 109.798 178.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 266' ' ' GLU . . . . . 0.467 ' O ' ' HG2' ' C' ' 270' ' ' LYS . 30.6 tt0 -57.75 -38.44 75.37 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.103 1.361 . . . . 64.21 111.249 -178.253 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -59.65 -42.92 93.89 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.386 0.674 . . . . 70.32 110.958 177.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 268' ' ' LEU . . . . . . . . . . . . . 8.2 mp -65.02 -39.13 92.95 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 115.744 -0.662 . . . . 52.44 110.791 175.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -64.19 -29.81 70.9 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 122.582 0.353 . . . . 61.11 111.822 174.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 270' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' C' ' 266' ' ' GLU . 33.9 mmtp -68.91 -44.12 73.82 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 122.967 0.507 . . . . 75.43 109.927 176.256 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 11.0 mmmm -57.27 -45.98 83.52 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 123.92 0.762 . . . . 75.33 111.077 176.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 85.0 mt -62.52 -42.7 99.69 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 114.791 -1.095 . . . . 74.33 110.577 176.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -62.44 -39.16 92.44 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.491 0.716 . . . . 34.13 110.998 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -62.5 -47.82 82.28 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.542 0.737 . . . . 63.21 110.038 176.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -58.91 -30.85 68.13 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 115.319 -0.855 . . . . 70.04 111.368 176.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 276' ' ' TYR . . . . . 0.459 ' HD1' HH11 ' C' ' 279' ' ' ARG . 9.2 m-85 -80.55 -33.32 36.32 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.517 0.727 . . . . 75.52 112.662 178.042 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -73.36 -23.45 60.21 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 118.392 0.542 . . . . 44.24 109.822 177.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -66.79 -11.97 57.13 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 123.754 0.821 . . . . 55.2 112.289 171.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 279' ' ' ARG . . . . . 0.459 HH11 ' HD1' ' C' ' 276' ' ' TYR . 50.8 mtp180 -79.56 -12.8 59.84 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 122.845 0.458 . . . . 71.52 111.055 174.658 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.904 -0.57 . . . . 75.14 109.971 178.107 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 88.0 tttt . . . . . 0 N--CA 1.477 0.891 0 N-CA-C 113.76 1.022 . . . . 62.43 113.76 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.427 ' HG2' ' HB3' ' A' ' 96' ' ' PHE . 14.5 mmmm -79.7 94.58 5.75 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 107.544 -1.28 . . . . 74.32 107.544 168.179 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.428 ' O ' HG13 ' A' ' 10' ' ' ILE . 11.8 t70 -70.55 92.71 0.86 Allowed 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.154 -1.054 . . . . 61.41 108.154 177.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -58.84 -35.35 72.77 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.765 0.826 . . . . 73.34 112.89 -167.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.407 ' CE1' HD11 ' A' ' 22' ' ' ILE . 88.7 m-85 -63.78 -45.22 90.73 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 116.501 -0.318 . . . . 73.33 110.515 176.366 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.34 -39.42 90.52 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 123.597 0.561 . . . . 60.32 110.964 178.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 6' ' ' ASP . 37.7 mt -65.46 -37.06 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 123.01 0.524 . . . . 74.23 110.55 179.159 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.509 ' HB2' HG22 ' A' ' 13' ' ' VAL . 81.5 mt -73.25 -16.17 61.4 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.114 0.566 . . . . 51.33 111.737 174.52 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.71 18.0 79.36 Favored Glycine 0 C--N 1.351 1.365 0 O-C-N 123.412 0.445 . . . . 53.33 112.782 -176.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.509 HG22 ' HB2' ' A' ' 11' ' ' LEU . 27.5 m -107.58 158.18 33.95 Favored Pre-proline 0 N--CA 1.479 0.991 0 C-N-CA 124.399 1.08 . . . . 71.43 109.57 179.001 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -64.09 158.15 49.54 Favored 'Trans proline' 0 C--N 1.378 2.117 0 C-N-CA 122.23 1.954 . . . . 50.12 111.998 178.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -72.61 11.78 0.58 Allowed 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 113.418 0.896 . . . . 75.43 113.418 -176.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -135.75 23.34 3.36 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.768 1.227 . . . . 64.11 108.017 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.55 134.22 49.7 Favored 'General case' 0 C--N 1.348 0.518 0 CA-C-N 115.233 -0.894 . . . . 64.31 110.03 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.6 p -68.84 155.93 39.32 Favored 'General case' 0 C--O 1.241 0.646 0 O-C-N 124.053 0.846 . . . . 71.11 109.362 173.006 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.439 ' HA ' ' HB ' ' A' ' 22' ' ' ILE . 52.1 tt0 -62.68 -19.34 63.77 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 123.026 0.53 . . . . 64.21 110.769 177.478 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -62.14 -53.55 53.7 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 125.019 1.328 . . . . 72.43 109.773 171.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -64.65 -32.97 74.88 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.846 0.858 . . . . 64.03 111.58 177.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.449 HD13 ' HB3' ' A' ' 57' ' ' LEU . 78.6 mt -69.68 -33.03 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.555 1.142 . . . . 73.31 110.846 177.412 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -72.99 -35.43 66.85 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.494 0.718 . . . . 71.24 110.263 175.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 52.8 mtp180 -66.55 -40.78 89.21 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.383 0.673 . . . . 54.12 110.649 173.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.81 -36.33 82.12 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.508 0.723 . . . . 64.0 110.47 178.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -59.98 -63.18 1.39 Allowed 'General case' 0 C--O 1.21 -0.985 0 CA-C-N 114.847 -1.07 . . . . 73.1 109.918 173.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -52.03 -48.37 64.56 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.066 0.547 . . . . 74.22 111.404 -177.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 50.5 ttt180 -56.38 -68.05 0.25 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.083 0.553 . . . . 71.15 111.784 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.44 ' HB3' HD13 ' A' ' 50' ' ' ILE . 93.8 mt -78.73 -43.38 25.89 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-N 115.74 -0.664 . . . . 74.11 111.753 -168.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.73 -25.35 63.8 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 118.015 -0.993 . . . . 63.3 112.814 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.56 ' HA ' ' HB2' ' A' ' 34' ' ' HIS . 81.7 mtp180 -85.02 -31.57 23.39 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 120.3 1.409 . . . . 72.33 110.969 171.024 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 48.0 tp60 -66.84 -32.57 73.93 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.607 0.363 . . . . 63.33 111.282 174.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.428 ' HB3' ' HB2' ' A' ' 47' ' ' PHE . 23.8 m-85 -111.24 16.53 20.92 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.553 0.741 . . . . 63.25 110.493 -178.009 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.56 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 2.7 t-80 -67.86 116.65 40.49 Favored Pre-proline 0 C--N 1.354 0.781 0 CA-C-O 118.181 -0.914 . . . . 63.41 109.743 -175.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_exo -47.57 -31.94 14.94 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 123.317 2.678 . . . . 74.13 113.534 -178.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -59.91 -53.05 62.41 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.885 0.874 . . . . 72.45 111.493 176.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.6 t -90.44 -56.87 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 122.969 0.508 . . . . 65.53 109.737 -173.199 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -97.7 84.81 3.44 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 121.808 0.813 . . . . 61.35 108.816 -178.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -79.54 69.23 5.78 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 114.45 -1.25 . . . . 73.11 109.475 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.9 m -134.53 107.68 10.99 Favored Pre-proline 0 N--CA 1.473 0.703 0 CA-C-O 118.386 -0.816 . . . . 54.41 109.475 -177.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.443 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 24.5 Cg_exo -36.81 -56.11 0.78 Allowed 'Trans proline' 0 C--N 1.388 2.62 0 C-N-CA 124.713 3.609 . . . . 72.23 114.597 -177.207 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.476 ' HG2' ' HE3' ' A' ' 46' ' ' LYS . 28.3 tt0 -54.39 -43.48 71.47 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.088 0.955 . . . . 64.43 111.348 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.99 -31.48 69.19 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.023 -0.99 . . . . 72.14 110.375 -178.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.444 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 51.5 mt-10 -78.9 -23.13 44.98 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.224 0.61 . . . . 62.01 109.674 -178.153 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 41' ' ' PRO . 23.6 mm-40 -71.5 -47.9 52.43 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.366 0.666 . . . . 62.44 109.527 172.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.476 ' HE3' ' HG2' ' A' ' 42' ' ' GLU . 97.0 mttt -60.32 -37.02 79.3 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 115.0 -1.0 . . . . 74.03 110.251 175.325 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.428 ' HB2' ' HB3' ' A' ' 33' ' ' TYR . 85.1 t80 -57.72 -53.88 53.21 Favored 'General case' 0 C--O 1.215 -0.713 0 C-N-CA 124.115 0.966 . . . . 73.24 109.307 173.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 44' ' ' GLU . 91.2 mttt -52.41 -45.86 66.09 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.468 0.707 . . . . 75.14 111.582 -179.113 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -62.47 -51.76 66.17 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 123.575 0.547 . . . . 71.44 111.885 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.44 HD13 ' HB3' ' A' ' 29' ' ' LEU . 86.5 mt -64.13 -31.4 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 124.216 1.006 . . . . 70.53 110.712 -178.488 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -95.67 -7.78 36.54 Favored 'General case' 0 C--O 1.215 -0.735 0 C-N-CA 123.679 0.792 . . . . 73.43 111.731 -176.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -72.35 -50.25 28.12 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 106.616 -1.624 . . . . 63.42 106.616 163.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.13 -49.8 68.38 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 112.756 -2.02 . . . . 65.45 111.477 175.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -67.31 -43.93 80.44 Favored 'General case' 0 C--O 1.212 -0.883 0 CA-C-N 115.357 -0.838 . . . . 72.32 110.795 177.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.451 ' HB2' ' CD2' ' A' ' 88' ' ' PHE . . . -56.54 -33.1 65.78 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 112.446 0.536 . . . . 53.01 112.446 -176.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 95.4 t -74.06 -53.92 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 CA-C-N 115.809 -0.632 . . . . 74.52 109.894 171.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.449 ' HB3' HD13 ' A' ' 22' ' ' ILE . 82.4 mt -83.99 7.12 19.46 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 113.912 1.079 . . . . 62.04 113.912 -169.381 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.0 t -87.83 -41.25 13.38 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.104 0.961 . . . . 74.34 110.517 178.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -104.27 107.57 57.83 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 108.593 -0.892 . . . . 74.34 108.593 -174.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -33.75 -32.86 0.06 OUTLIER 'Trans proline' 0 C--N 1.388 2.655 1 C-N-CA 125.613 4.208 . . . . 72.41 116.953 -179.332 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.458 ' HB2' ' HB2' ' A' ' 144' ' ' ARG . 16.3 tp10 -63.61 -65.01 0.74 Allowed 'General case' 0 N--CA 1.485 1.316 0 CA-C-O 121.197 0.522 . . . . 72.3 110.596 179.069 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -65.67 -31.99 73.3 Favored 'General case' 0 C--O 1.247 0.929 0 CA-C-N 114.805 -1.089 . . . . 74.54 110.955 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.496 HH11 ' HG2' ' A' ' 63' ' ' ARG . 26.4 ttt-85 -58.27 -54.59 45.27 Favored 'General case' 0 C--N 1.344 0.345 0 CA-C-N 115.316 -0.856 . . . . 74.11 109.917 176.213 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -71.07 -21.26 62.26 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.527 -0.76 . . . . 74.25 111.787 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.461 HG23 ' HG2' ' A' ' 76' ' ' PRO . 50.9 mt -58.88 -50.13 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 N-CA-C 109.327 -0.62 . . . . 64.42 109.327 168.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.422 ' OH ' ' HA ' ' A' ' 6' ' ' ASP . 34.1 t80 -59.68 -49.98 75.63 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 123.68 0.613 . . . . 75.4 110.534 175.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -57.72 -34.93 69.99 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.457 0.703 . . . . 64.04 112.062 -178.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 69.7 p -89.81 -16.31 30.44 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 119.203 -0.427 . . . . 75.13 111.457 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -74.4 131.34 41.01 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 109.268 -0.642 . . . . 63.45 109.268 178.205 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 98.34 14.66 37.78 Favored Glycine 0 CA--C 1.53 0.982 0 N-CA-C 110.884 -0.886 . . . . 52.54 110.884 -164.026 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 37.6 m -146.97 -53.25 0.22 Allowed 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 103.622 -2.733 . . . . 71.23 103.622 177.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.5 m -75.45 135.58 40.71 Favored 'General case' 0 C--O 1.253 1.258 0 N-CA-C 104.408 -2.442 . . . . 74.23 104.408 155.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.23 -34.19 5.99 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.775 0.83 . . . . 74.04 110.917 -173.436 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -84.71 150.65 56.77 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 123.662 0.785 . . . . 75.1 109.625 176.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.419 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 34.6 Cg_exo -60.28 133.12 47.62 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 122.393 2.062 . . . . 75.41 111.259 175.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.461 ' HG2' HG23 ' A' ' 65' ' ' ILE . 39.3 Cg_exo -60.43 153.86 57.48 Favored 'Trans proline' 0 C--N 1.375 1.934 0 C-N-CA 123.27 2.646 . . . . 74.25 113.174 -173.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.29 128.16 15.16 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.498 2.132 . . . . 62.44 111.415 175.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -62.92 116.02 3.3 Favored 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 123.043 2.495 . . . . 43.51 112.214 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -65.33 169.33 12.59 Favored 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 123.087 2.524 . . . . 71.05 111.979 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.83 86.23 0.03 OUTLIER 'Trans proline' 0 C--N 1.386 2.543 0 C-N-CA 123.394 2.729 . . . . 51.35 112.905 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.429 ' HA3' ' HA ' ' A' ' 141' ' ' ALA . . . 141.99 -37.44 1.58 Allowed Glycine 0 C--N 1.347 1.184 0 CA-C-N 115.021 -0.99 . . . . 62.41 111.411 178.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 114.14 -149.6 18.71 Favored Glycine 0 C--N 1.352 1.436 0 N-CA-C 112.274 -0.33 . . . . 53.03 112.274 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -110.98 73.62 0.83 Allowed 'General case' 0 C--O 1.242 0.66 0 C-N-CA 124.25 1.02 . . . . 74.41 108.283 175.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -57.38 125.11 21.34 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 115.511 -0.768 . . . . 71.31 110.914 177.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -121.92 24.28 9.67 Favored 'General case' 0 C--O 1.248 0.975 0 C-N-CA 123.737 0.815 . . . . 70.22 110.703 -175.234 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.412 ' OG ' ' HA2' ' A' ' 166' ' ' GLY . 74.0 m -50.61 124.9 11.75 Favored 'General case' 0 C--N 1.355 0.815 0 O-C-N 124.116 0.885 . . . . 74.44 111.814 176.3 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 129.0 -40.95 1.62 Allowed Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 109.012 -1.635 . . . . 70.11 109.012 -174.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.451 ' CD2' ' HB2' ' A' ' 55' ' ' ALA . 28.5 m-85 -137.18 143.31 42.32 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.78 0.432 . . . . 72.34 110.041 -170.261 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -75.37 89.37 2.62 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-O 121.515 0.674 . . . . 71.44 110.445 -177.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.557 HG21 ' ND2' ' A' ' 169' ' ' ASN . 2.8 p -38.01 -44.58 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 126.303 1.841 . . . . 75.21 114.068 172.136 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -70.28 -19.53 63.1 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.477 0.711 . . . . 75.33 111.789 -168.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -80.27 -24.8 39.83 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.102 0.561 . . . . 45.35 110.709 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -73.79 173.2 10.2 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 113.572 0.953 . . . . 71.01 113.572 -166.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.401 ' OG ' ' HG3' ' A' ' 5' ' ' LYS . 81.2 p -81.88 178.12 8.48 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 114.564 1.32 . . . . 74.5 114.564 -164.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -62.67 -52.52 62.99 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 113.181 -1.827 . . . . 74.31 112.307 -170.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.427 ' HB3' ' HG2' ' A' ' 5' ' ' LYS . 78.0 t80 -54.28 -41.97 69.47 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 123.501 0.72 . . . . 75.03 111.533 -178.365 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.511 ' CE2' HG23 ' A' ' 90' ' ' VAL . 36.9 t80 -64.9 -46.2 82.72 Favored 'General case' 0 CA--C 1.555 1.157 0 CA-C-N 114.763 -1.108 . . . . 63.23 110.513 176.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -67.05 -12.89 61.18 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.323 0.649 . . . . 73.05 112.371 178.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -89.82 -53.43 4.5 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.289 0.636 . . . . 70.02 111.36 173.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.2 tp -66.66 -52.78 41.02 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.059 0.944 . . . . 55.03 111.269 -171.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -96.21 -3.04 44.99 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.161 0.584 . . . . 72.11 111.174 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.419 ' N ' ' HD2' ' A' ' 103' ' ' PRO . . . -44.34 -55.83 5.72 Favored Glycine 0 C--N 1.354 1.551 0 CA-C-O 118.724 -1.042 . . . . 72.43 115.366 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.419 ' HD2' ' N ' ' A' ' 102' ' ' GLY . 9.5 Cg_endo -47.69 -28.11 8.93 Favored 'Trans proline' 0 C--N 1.388 2.655 0 C-N-CA 124.211 3.274 . . . . 23.1 114.941 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -134.69 35.08 2.25 Favored Glycine 0 C--N 1.346 1.134 0 CA-C-O 119.487 -0.618 . . . . 44.4 112.888 -176.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 17.6 mt -67.53 26.2 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 114.683 1.364 . . . . 74.25 114.683 176.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER 58.6 -107.39 0.35 Allowed 'General case' 0 CA--C 1.562 1.437 0 C-N-CA 124.46 1.104 . . . . 72.25 110.884 163.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.661 ' H ' ' HB2' ' A' ' 169' ' ' ASN . . . 74.92 8.64 82.92 Favored Glycine 0 C--N 1.354 1.539 0 C-N-CA 123.18 0.419 . . . . 44.0 112.709 -177.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.353 1.481 0 N-CA-C 111.854 -0.499 . . . . 71.34 111.854 -170.486 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 27.9 tptp . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 115.557 1.688 . . . . 72.15 115.557 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.453 ' HA2' ' HA3' ' A' ' 168' ' ' GLY . . . -84.4 167.88 43.57 Favored Glycine 0 C--N 1.343 0.935 0 N-CA-C 115.587 0.995 . . . . 55.22 115.587 -176.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.519 ' HB3' ' HB2' ' A' ' 167' ' ' GLN . 12.5 ttm180 -115.65 144.32 44.09 Favored 'General case' 0 C--O 1.26 1.628 0 C-N-CA 124.17 0.988 . . . . 71.34 111.31 -174.274 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.467 ' HA ' ' H ' ' A' ' 173' ' ' ASP . 9.3 p-10 -64.6 134.9 55.29 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 114.719 -1.128 . . . . 74.23 109.978 169.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.505 HD11 ' HB2' ' B' ' 11' ' ' LEU . 7.9 tp -144.12 143.67 31.23 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.08 -0.341 . . . . 70.23 110.08 -174.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 45.8 ttm180 -97.53 111.13 23.52 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.715 -0.846 . . . . 74.51 108.715 166.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -112.56 167.13 10.71 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 107.957 -1.127 . . . . 41.51 107.957 172.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.497 ' HG2' ' HB ' ' A' ' 177' ' ' VAL . 38.2 mt-10 -127.82 118.55 23.91 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 118.786 0.721 . . . . 61.0 109.648 -172.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.442 HD22 HD13 ' A' ' 176' ' ' LEU . 57.1 tp -100.13 104.62 30.5 Favored Pre-proline 0 N--CA 1.478 0.974 0 C-N-CA 123.985 0.914 . . . . 54.05 111.372 -164.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.653 ' HA ' ' HB2' ' A' ' 179' ' ' ARG . 24.6 Cg_exo -61.68 141.04 89.47 Favored 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 122.428 2.085 . . . . 75.33 110.511 176.077 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 13.4 tp -148.41 149.34 31.57 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.268 0.556 . . . . 64.01 111.975 177.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 97.8 m -85.5 140.26 30.82 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.708 1.203 . . . . 71.34 109.393 175.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.576 ' HB3' HD22 ' A' ' 215' ' ' LEU . 34.0 mt -54.79 -59.88 4.12 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 124.364 1.066 . . . . 70.54 113.359 -171.387 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -58.82 -39.1 80.18 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 114.961 -1.018 . . . . 75.32 110.644 -178.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -72.6 -21.83 61.06 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.06 0.944 . . . . 64.33 111.591 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.593 ' HB1' ' O ' ' A' ' 153' ' ' VAL . . . -74.87 -43.5 54.07 Favored 'General case' 0 C--O 1.247 0.947 0 C-N-CA 123.795 0.838 . . . . 41.43 110.915 178.542 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -72.05 -32.12 66.8 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 116.128 -0.487 . . . . 74.51 110.479 173.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -59.69 -48.13 82.88 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 123.4 0.438 . . . . 75.25 110.671 175.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.42 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 81.07 -136.08 15.65 Favored Glycine 0 CA--C 1.526 0.755 0 O-C-N 123.822 0.701 . . . . 71.54 111.583 -176.534 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 85.34 -172.04 46.6 Favored Glycine 0 C--N 1.344 0.983 0 O-C-N 123.632 0.254 . . . . 70.42 112.75 178.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.487 ' HB3' ' HB3' ' A' ' 146' ' ' SER . 1.8 mp0 -87.96 108.42 19.19 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 108.15 -1.056 . . . . 73.14 108.15 173.15 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 13.8 tpp180 -93.53 122.3 35.82 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 122.85 0.46 . . . . 74.4 110.003 -173.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 95.9 t -78.68 124.36 36.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 123.582 0.753 . . . . 71.24 109.782 -178.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.3 p -151.03 133.04 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 C-N-CA 123.82 0.848 . . . . 73.14 109.873 -174.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -84.93 135.25 34.13 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.196 0.998 . . . . 71.3 110.927 -176.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.66 HG23 ' HB2' ' B' ' 10' ' ' LEU . 2.6 p -166.4 111.56 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.201 0 C-N-CA 123.544 0.738 . . . . 75.1 111.168 -178.356 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.429 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . 60.25 37.71 20.33 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 113.796 1.035 . . . . 74.24 113.796 168.303 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 77.34 11.87 85.1 Favored Glycine 0 N--CA 1.475 1.298 0 CA-C-N 116.208 -0.451 . . . . 31.1 113.125 -178.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 26.6 ttm-85 -116.78 119.86 36.75 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.775 1.23 . . . . 72.12 108.197 174.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.458 ' HB2' ' HB2' ' A' ' 61' ' ' GLU . 14.1 tpp180 -93.34 89.62 6.44 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 106.707 -1.59 . . . . 74.41 106.707 170.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 11.6 p -89.53 140.16 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-O 121.368 0.604 . . . . 73.53 110.569 -170.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.487 ' HB3' ' HB3' ' A' ' 135' ' ' GLU . 25.2 m -106.01 90.14 3.28 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 107.768 -1.197 . . . . 31.45 107.768 174.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 3.3 p -77.35 112.56 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-O 121.335 0.588 . . . . 73.42 109.44 -174.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 5.8 tpm_? -67.06 92.12 0.24 Allowed 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 108.454 -0.943 . . . . 74.14 108.454 175.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.56 HG22 HD13 ' A' ' 159' ' ' ILE . 33.3 pt -93.44 131.74 31.88 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-N 115.203 -0.908 . . . . 74.13 109.089 -179.06 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -63.25 139.4 71.79 Favored 'Trans proline' 0 C--N 1.37 1.667 0 C-N-CA 122.414 2.076 . . . . 60.34 111.502 175.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -59.23 114.13 1.89 Allowed 'Trans proline' 0 C--N 1.383 2.393 0 C-N-CA 123.068 2.512 . . . . 74.15 111.855 -178.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 98.87 76.43 1.26 Allowed Glycine 0 C--N 1.345 1.066 0 N-CA-C 110.068 -1.213 . . . . 75.51 110.068 -175.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.593 ' O ' ' HB1' ' A' ' 130' ' ' ALA . 4.7 p -126.23 132.02 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 124.315 1.046 . . . . 75.43 108.453 172.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.65 ' HD2' HD12 ' A' ' 215' ' ' LEU . 0.0 OUTLIER -134.71 156.86 48.06 Favored 'General case' 0 N--CA 1.483 1.176 0 O-C-N 121.715 -0.616 . . . . 73.23 110.915 -169.92 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -51.66 117.09 2.45 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 125.222 1.409 . . . . 72.32 112.223 -172.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 114.55 -9.63 21.9 Favored Glycine 0 C--N 1.339 0.748 0 CA-C-N 115.596 -0.729 . . . . 14.21 112.708 -176.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 27.5 t -76.01 144.01 41.14 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.459 -0.941 . . . . 74.23 108.459 171.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 18.6 t -113.75 102.44 13.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 N-CA-C 108.357 -0.979 . . . . 72.34 108.357 174.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.632 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 50.9 mt -70.65 84.48 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.831 0 N-CA-C 107.45 -1.315 . . . . 75.24 107.45 172.055 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 70.9 ttt-85 -75.56 100.63 4.63 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.076 -1.083 . . . . 61.32 108.076 176.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.516 HG13 ' HB3' ' A' ' 174' ' ' LEU . 2.4 p -105.9 102.78 40.99 Favored Pre-proline 0 CA--C 1.546 0.825 0 N-CA-C 108.175 -1.046 . . . . 61.33 108.175 175.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -61.97 140.84 86.92 Favored 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 122.613 2.208 . . . . 74.53 110.582 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.409 ' HA2' ' HB2' ' A' ' 171' ' ' PRO . . . 83.33 26.11 44.96 Favored Glycine 0 CA--C 1.523 0.544 0 CA-C-O 118.984 -0.898 . . . . 70.43 114.557 178.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.435 ' C ' ' HB2' ' A' ' 174' ' ' LEU . 44.0 ttm -139.06 -6.06 1.44 Allowed 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 118.768 1.284 . . . . 64.15 113.423 -177.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.477 ' HA2' HD13 ' A' ' 174' ' ' LEU . . . -49.25 -59.58 6.9 Favored Glycine 0 N--CA 1.499 2.87 0 CA-C-O 122.406 1.003 . . . . 73.33 111.111 -177.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.509 ' H ' ' HA3' ' A' ' 172' ' ' GLY . . . 132.74 -86.66 0.28 Allowed Glycine 0 CA--C 1.48 -2.1 0 CA-C-N 112.227 -1.987 . . . . 74.5 109.554 158.403 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.519 ' HB2' ' HB3' ' A' ' 117' ' ' ARG . 10.0 mm100 -23.36 105.32 0.02 OUTLIER 'General case' 0 C--N 1.364 1.207 0 O-C-N 129.193 3.525 . . . . 75.42 115.947 -160.699 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.453 ' HA3' ' HA2' ' A' ' 116' ' ' GLY . . . 137.86 -118.74 1.71 Allowed Glycine 0 N--CA 1.44 -1.071 0 N-CA-C 105.668 -2.973 . . . . 64.21 105.668 -164.625 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ASN . . . . . 0.661 ' HB2' ' H ' ' A' ' 107' ' ' GLY . 57.7 t30 -165.37 -43.12 0.0 OUTLIER Pre-proline 0 N--CA 1.481 1.101 0 CA-C-N 117.769 0.784 . . . . 63.11 110.912 165.179 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -61.21 165.32 12.89 Favored 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 121.872 1.715 . . . . 71.13 109.647 160.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.409 ' HB2' ' HA2' ' A' ' 163' ' ' GLY . 18.6 Cg_endo -56.28 113.75 1.59 Allowed 'Trans proline' 0 CA--C 1.548 1.186 0 C-N-CA 122.811 2.34 . . . . 71.25 116.58 -168.055 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.509 ' HA3' ' H ' ' A' ' 166' ' ' GLY . . . -67.46 -142.06 0.07 OUTLIER Glycine 0 C--N 1.371 2.479 0 C-N-CA 118.593 -1.765 . . . . 72.4 113.534 153.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.467 ' H ' ' HA ' ' A' ' 118' ' ' ASP . 45.1 m-20 -152.27 108.53 3.41 Favored 'General case' 0 N--CA 1.51 2.569 0 CA-C-N 118.49 1.145 . . . . 71.14 108.916 176.133 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.516 ' HB3' HG13 ' A' ' 161' ' ' VAL . 7.8 tp -91.55 135.13 34.08 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 118.478 0.581 . . . . 64.32 112.019 -167.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 6.2 mt -115.99 93.94 4.46 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 106.029 -1.841 . . . . 72.12 106.029 177.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.632 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 82.2 mt -88.36 101.89 14.33 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.171 0.588 . . . . 70.05 111.519 -175.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.497 ' HB ' ' HG2' ' A' ' 122' ' ' GLU . 61.4 t -82.53 97.85 4.41 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 N-CA-C 107.378 -1.341 . . . . 61.43 107.378 174.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.507 HG11 HG22 ' A' ' 153' ' ' VAL . 10.5 p -64.84 124.01 18.84 Favored 'Isoleucine or valine' 0 C--O 1.251 1.158 0 CA-C-N 115.469 -0.787 . . . . 70.33 110.585 -174.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.653 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 8.4 mmt85 -87.94 148.17 24.71 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.03 -1.441 . . . . 53.32 108.526 167.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.488 HD11 ' HA ' ' A' ' 154' ' ' ARG . 29.2 mt -118.54 152.39 36.07 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.878 -0.786 . . . . 72.4 108.878 165.229 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 85.9 mt -53.09 153.87 5.97 Favored Pre-proline 0 CA--C 1.558 1.264 0 O-C-N 124.389 1.056 . . . . 73.14 111.111 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.28 11.66 0.1 Allowed 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 123.456 2.771 . . . . 71.42 115.372 -174.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' HIS . . . . . 0.57 ' HB3' HD11 ' A' ' 127' ' ' LEU . 4.0 t-80 -61.35 104.54 0.47 Allowed Pre-proline 0 CA--C 1.565 1.529 0 C-N-CA 125.166 1.386 . . . . 73.35 108.17 169.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -80.11 29.28 0.51 Allowed 'Trans proline' 0 C--N 1.368 1.571 0 C-N-CA 124.53 3.486 . . . . 61.24 117.229 -159.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.582 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 23.8 t -89.41 -51.39 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 120.379 1.445 . . . . 64.21 108.703 -172.347 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' PHE . . . . . 0.428 ' CZ ' ' HA ' ' A' ' 214' ' ' THR . 65.1 m-85 -114.2 129.38 56.63 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 112.267 0.469 . . . . 72.31 112.267 -169.377 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.571 HH22 ' HB2' ' A' ' 189' ' ' GLU . 28.4 ttp85 -127.86 123.91 36.22 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.048 -1.093 . . . . 75.51 108.048 164.581 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 9.1 tp -93.0 148.05 22.32 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 123.15 0.58 . . . . 74.21 110.475 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' GLU . . . . . 0.571 ' HB2' HH22 ' A' ' 187' ' ' ARG . 10.0 tp10 -123.5 90.58 3.31 Favored 'General case' 0 C--O 1.246 0.911 0 N-CA-C 107.583 -1.266 . . . . 70.31 107.583 163.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 64.83 -82.2 0.06 OUTLIER Glycine 0 C--N 1.353 1.506 0 CA-C-N 114.373 -1.285 . . . . 65.41 113.494 176.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 5.3 pm0 -93.18 -45.4 7.89 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.447 0.699 . . . . 72.32 111.362 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -111.09 144.85 39.56 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.38 -0.825 . . . . 72.32 113.009 -163.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.428 ' HB2' ' HA ' ' A' ' 249' ' ' LEU . 86.7 mt -91.46 157.41 17.07 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.491 1.116 . . . . 63.44 110.971 -177.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -131.1 105.22 7.56 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 107.777 -1.194 . . . . 73.14 107.777 170.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.582 ' HA ' ' O ' ' A' ' 185' ' ' VAL . . . -104.7 -175.77 2.89 Favored 'General case' 0 C--O 1.218 -0.567 0 C-N-CA 124.393 1.077 . . . . 74.34 110.67 178.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 34.7 m -125.18 128.66 48.71 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.672 -0.862 . . . . 70.21 108.672 173.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.423 HD22 HD13 ' A' ' 251' ' ' LEU . 48.3 tp -129.55 121.17 26.62 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 109.835 -0.432 . . . . 72.21 109.835 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -85.92 122.12 29.52 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 108.886 -0.783 . . . . 61.43 108.886 169.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 7.1 p -133.19 133.24 22.77 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 107.866 -1.161 . . . . 64.4 107.866 178.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.5 152.19 59.78 Favored 'Trans proline' 0 C--N 1.364 1.372 0 C-N-CA 121.378 1.385 . . . . 64.51 111.192 175.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.64 ' HB3' ' HH2' ' A' ' 269' ' ' TRP . . . -53.92 -44.5 98.29 Favored Pre-proline 0 CA--C 1.557 1.223 0 N-CA-C 114.782 1.401 . . . . 71.34 114.782 -175.22 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -64.2 -37.28 42.13 Favored 'Trans proline' 0 C--N 1.381 2.266 0 CA-C-N 121.677 1.635 . . . . 63.54 112.994 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 38.0 mt -73.59 -31.52 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.021 0.529 . . . . 64.32 110.21 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.15 -44.71 79.1 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.495 0.718 . . . . 71.51 110.999 177.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 69.5 t -68.32 -63.62 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 123.208 0.603 . . . . 63.23 110.273 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 96.4 t -72.56 -40.12 62.43 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 CA-C-N 115.466 -0.788 . . . . 74.41 111.899 -168.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 96.89 108.32 2.53 Favored Glycine 0 C--N 1.339 0.726 0 N-CA-C 111.1 -0.8 . . . . 72.35 111.1 -173.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -144.33 -157.44 7.2 Favored Glycine 0 C--N 1.342 0.871 0 CA-C-O 120.137 -0.257 . . . . 55.24 112.551 -177.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -117.18 130.41 56.58 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 117.17 0.485 . . . . 45.21 110.897 -176.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 29.8 m -132.94 -172.39 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 N-CA-C 107.591 -1.263 . . . . 63.11 107.591 167.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' ARG . . . . . 0.497 ' HD3' ' HB2' ' A' ' 218' ' ' PRO . 25.7 ttm180 -113.55 126.49 55.35 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 121.897 -0.502 . . . . 71.41 110.663 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -104.57 116.74 32.59 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.868 0.867 . . . . 62.04 109.009 175.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' MET . . . . . 0.421 ' N ' ' SD ' ' A' ' 213' ' ' MET . 3.3 mpp? -82.75 104.72 13.21 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.836 -0.802 . . . . 71.23 108.836 178.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 214' ' ' THR . . . . . 0.428 ' HA ' ' CZ ' ' A' ' 186' ' ' PHE . 82.1 p -116.49 174.09 6.26 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 123.314 0.646 . . . . 74.1 110.364 -178.351 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.65 HD12 ' HD2' ' A' ' 154' ' ' ARG . 14.6 mt -75.76 -17.64 59.82 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.131 0.573 . . . . 63.31 110.053 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.406 ' HG2' ' OG1' ' A' ' 214' ' ' THR . 1.5 pm0 -88.41 -5.21 58.41 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.772 1.229 . . . . 64.44 110.755 174.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 125.21 162.46 11.35 Favored Glycine 0 C--N 1.35 1.323 0 C-N-CA 123.579 0.609 . . . . 33.0 113.274 172.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' PRO . . . . . 0.497 ' HB2' ' HD3' ' A' ' 211' ' ' ARG . 60.5 Cg_endo -72.06 99.61 1.01 Allowed 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 122.463 2.109 . . . . 70.23 110.143 174.539 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 35.2 m -102.39 161.26 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.666 0.786 . . . . 73.4 111.466 -172.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -83.04 107.4 15.6 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 108.95 -0.759 . . . . 75.04 108.95 171.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 7.6 p -96.5 116.41 38.45 Favored 'Isoleucine or valine' 0 C--O 1.246 0.907 0 N-CA-C 109.161 -0.681 . . . . 74.13 109.161 178.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -81.97 97.32 8.04 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.646 -0.872 . . . . 60.25 108.646 175.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 97.5 t -58.22 121.82 54.44 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 124.454 1.101 . . . . 63.14 109.308 176.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.67 159.83 51.99 Favored 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 122.416 2.077 . . . . 75.51 111.453 176.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -65.04 156.35 63.19 Favored 'Trans proline' 0 C--N 1.365 1.417 0 C-N-CA 121.91 1.74 . . . . 72.53 111.711 171.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' ARG . . . . . 0.775 HH11 ' HA ' ' C' ' 260' ' ' ARG . 3.2 mmp_? 73.97 11.15 4.47 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.638 1.575 . . . . 74.04 111.89 176.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 13.2 m -59.69 120.78 10.14 Favored 'General case' 0 C--N 1.356 0.861 0 C-N-CA 124.002 0.921 . . . . 64.32 110.588 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 228' ' ' GLN . . . . . 0.523 ' HA ' HD11 ' A' ' 255' ' ' ILE . 48.0 tt0 -128.17 142.49 51.17 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.316 -0.402 . . . . 75.32 111.033 -166.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -60.95 133.85 56.51 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 124.1 0.875 . . . . 62.31 111.079 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 98.89 -38.67 3.01 Favored Glycine 0 C--N 1.34 0.792 0 O-C-N 123.553 0.533 . . . . 73.32 111.92 -177.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 28.5 mtm-85 -70.38 170.04 12.69 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-O 121.214 0.531 . . . . 74.0 111.053 173.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.667 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 2.9 mptp? -124.39 129.52 50.83 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.45 -0.795 . . . . 72.22 109.553 -176.39 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.452 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 54.7 mt -79.63 99.72 7.49 Favored 'General case' 0 C--N 1.346 0.455 0 N-CA-C 109.012 -0.736 . . . . 71.4 109.012 173.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 32.8 ttp180 -72.09 100.51 2.54 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.042 0.937 . . . . 64.14 110.014 178.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.495 HD11 HD11 ' A' ' 251' ' ' LEU . 5.0 mt -87.75 102.2 14.43 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 107.64 -1.245 . . . . 61.12 107.64 176.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -51.69 126.51 17.92 Favored 'General case' 0 CA--C 1.549 0.932 0 O-C-N 124.148 0.905 . . . . 64.43 113.219 -173.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 75.3 10.22 84.37 Favored Glycine 0 C--N 1.347 1.194 0 CA-C-N 115.051 -0.977 . . . . 74.2 115.47 168.29 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? -84.37 -11.17 56.78 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 117.615 0.707 . . . . 73.01 110.865 175.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -98.91 -164.94 30.17 Favored Glycine 0 C--N 1.348 1.215 0 N-CA-C 111.206 -0.758 . . . . 74.43 111.206 168.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 240' ' ' PHE . . . . . 0.403 ' N ' ' CD1' ' A' ' 240' ' ' PHE . 2.4 m-30 -96.06 131.6 28.58 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 123.895 0.878 . . . . 73.13 110.326 -168.275 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.13 153.91 62.35 Favored 'Trans proline' 0 CA--C 1.547 1.139 0 C-N-CA 122.742 2.295 . . . . 73.33 112.564 177.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -148.78 -178.14 23.6 Favored Glycine 0 C--N 1.347 1.149 0 CA-C-O 119.396 -0.669 . . . . 73.52 112.876 177.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -52.75 -53.36 6.96 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 123.63 2.886 . . . . 70.45 113.315 175.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -120.46 -28.26 5.01 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 122.963 0.505 . . . . 70.11 111.575 178.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -97.67 99.64 2.27 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 111.837 -0.505 . . . . 62.24 111.837 -176.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -86.03 121.83 29.2 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 108.959 -0.756 . . . . 75.41 108.959 173.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.63 130.1 10.03 Favored Glycine 0 C--O 1.246 0.852 0 N-CA-C 114.851 0.7 . . . . 42.24 114.851 -173.219 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -123.12 165.38 16.94 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.933 0.893 . . . . 75.44 108.961 176.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.464 HD23 HD12 ' A' ' 235' ' ' LEU . 38.0 tp -99.33 101.68 13.04 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 109.086 -0.709 . . . . 70.31 109.086 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.667 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 14.0 m-85 -87.04 103.58 15.51 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 109.155 -0.683 . . . . 52.51 109.155 -177.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.576 HD23 ' HB3' ' A' ' 195' ' ' ALA . 87.4 mt -83.22 108.63 16.59 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 108.777 -0.823 . . . . 72.24 108.777 177.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 252' ' ' GLU . . . . . 0.516 ' HG2' ' HG3' ' A' ' 232' ' ' LYS . 40.6 mt-10 -75.11 110.9 9.81 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 108.394 -0.965 . . . . 75.41 108.394 -175.407 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 59.5 t -67.16 125.57 24.91 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 CA-C-N 114.0 -1.454 . . . . 24.43 111.832 -170.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 3.3 mmm-85 -118.13 94.2 4.41 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 125.066 1.346 . . . . 73.14 107.626 170.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.523 HD11 ' HA ' ' A' ' 228' ' ' GLN . 57.5 mt -70.35 128.81 34.15 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 N-CA-C 109.02 -0.733 . . . . 74.34 109.02 174.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 51.9 p -122.59 146.66 47.23 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 124.434 1.094 . . . . 73.43 108.904 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 257' ' ' ILE . . . . . 0.421 HG23 HG21 ' C' ' 255' ' ' ILE . 2.7 pp -109.75 147.37 36.0 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 123.32 0.648 . . . . 73.4 109.458 175.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -50.49 -18.8 4.08 Favored 'Trans proline' 0 N--CA 1.505 2.16 0 C-N-CA 124.658 3.572 . . . . 74.45 115.906 -168.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 58.51 -80.33 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.761 1.225 . . . . 63.24 110.644 -168.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 12.1 ptm85 -73.93 139.43 44.91 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 109.227 -0.657 . . . . 75.12 109.227 173.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.641 ' HB3' ' HB2' ' A' ' 266' ' ' GLU . 9.3 mt -145.04 138.13 26.51 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.228 0.611 . . . . 55.32 111.403 -169.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 27.0 p -83.04 153.41 66.7 Favored Pre-proline 0 CA--C 1.555 1.15 0 C-N-CA 124.647 1.179 . . . . 44.34 109.572 175.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -39.14 -65.3 0.17 Allowed 'Trans proline' 0 C--N 1.384 2.396 0 C-N-CA 124.878 3.719 . . . . 74.33 116.798 -171.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -68.79 -40.69 79.51 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.016 0.526 . . . . 71.44 111.816 -172.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -68.13 -37.73 81.41 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.063 0.545 . . . . 64.2 110.974 -178.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 266' ' ' GLU . . . . . 0.641 ' HB2' ' HB3' ' A' ' 261' ' ' LEU . 41.3 tt0 -64.2 -48.07 77.29 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 121.487 0.661 . . . . 73.45 109.306 176.347 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 267' ' ' ALA . . . . . 0.427 ' HB1' ' HE3' ' A' ' 271' ' ' LYS . . . -54.66 -41.94 70.73 Favored 'General case' 0 C--O 1.208 -1.123 0 CA-C-N 113.8 -1.545 . . . . 64.12 109.81 175.535 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 12.4 tp -64.81 -46.47 81.87 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.234 1.014 . . . . 73.14 110.885 -175.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 269' ' ' TRP . . . . . 0.64 ' HH2' ' HB3' ' A' ' 201' ' ' ALA . 73.5 m95 -55.59 -44.94 77.4 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 115.232 -0.894 . . . . 75.0 111.331 173.51 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 270' ' ' LYS . . . . . 0.615 ' HE3' ' HA ' ' C' ' 206' ' ' VAL . 53.6 mtpt -90.27 -9.31 48.42 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 115.359 -0.837 . . . . 62.43 112.267 -171.264 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 271' ' ' LYS . . . . . 0.427 ' HE3' ' HB1' ' A' ' 267' ' ' ALA . 90.1 mttt -76.05 -45.09 36.0 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.55 -1.278 . . . . 70.22 107.55 166.546 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 272' ' ' LEU . . . . . 0.622 HD21 ' HB2' ' C' ' 268' ' ' LEU . 46.1 mt -55.57 -47.23 76.73 Favored 'General case' 0 C--O 1.213 -0.831 0 CA-C-N 114.4 -1.273 . . . . 63.4 110.185 169.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 273' ' ' ALA . . . . . 0.532 ' HB3' ' HA ' ' A' ' 270' ' ' LYS . . . -63.75 -47.27 81.7 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 124.258 0.974 . . . . 64.51 112.758 -174.399 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -65.8 -44.2 86.38 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 123.226 0.329 . . . . 74.35 110.909 177.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -67.27 -27.52 67.26 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 122.885 0.474 . . . . 71.44 111.598 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 276' ' ' TYR . . . . . 0.514 ' HE2' ' HG3' ' C' ' 258' ' ' PRO . 24.0 t80 -75.1 -74.95 0.18 Allowed 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 107.974 -1.121 . . . . 75.02 107.974 177.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -49.69 -60.5 2.83 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.307 1.843 . . . . 70.12 112.315 -175.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -70.23 -8.24 48.49 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 112.926 0.713 . . . . 75.41 112.926 -172.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 279' ' ' ARG . . . . . 0.467 ' HA ' ' HE ' ' A' ' 279' ' ' ARG . 1.0 OUTLIER -121.64 1.65 10.04 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-O 118.906 -0.569 . . . . 74.13 111.391 -178.971 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.416 0 O-C-N 124.392 1.058 . . . . 72.21 111.185 -172.514 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mpp? . . . . . 0 N--CA 1.482 1.154 0 N-CA-C 109.302 -0.629 . . . . 71.44 109.302 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -67.33 116.88 8.59 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 108.999 -0.741 . . . . 54.1 108.999 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -86.15 68.9 10.42 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 122.344 1.068 . . . . 74.04 108.91 175.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 18.7 m -104.97 113.28 26.78 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-N 113.881 -1.509 . . . . 52.14 108.415 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.95 174.67 7.79 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 121.094 0.473 . . . . 70.11 110.524 -178.086 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 25.0 pt -138.93 160.13 29.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 123.357 0.663 . . . . 64.44 111.665 -163.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -136.17 143.43 44.44 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 107.09 -1.448 . . . . 72.01 107.09 166.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 35.4 tp -71.41 -89.01 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.579 0.752 . . . . 75.22 110.656 -170.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . 159.16 -61.36 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 126.188 1.795 . . . . 62.4 106.761 -175.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 10' ' ' LEU . . . . . 0.66 ' HB2' HG23 ' A' ' 140' ' ' VAL . 3.1 tt 53.49 115.65 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 113.561 -1.654 . . . . 74.1 110.024 -162.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.505 ' HB2' HD11 ' A' ' 119' ' ' LEU . 51.9 mt . . . . . 0 CA--C 1.546 0.819 0 N-CA-C 108.874 -0.787 . . . . 45.35 108.874 179.023 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.186 0 CA-C-O 121.671 0.748 . . . . 61.34 110.822 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 180' ' ' ALA . . . . . 0.401 ' HB1' HG23 ' C' ' 137' ' ' VAL . . . -174.38 -43.15 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.561 1.544 . . . . 74.4 107.385 -177.011 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 181' ' ' LEU . . . . . 0.738 HD23 ' HB ' ' C' ' 138' ' ' VAL . 41.8 tp -177.25 -63.87 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 126.48 1.912 . . . . 62.04 106.878 169.088 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 182' ' ' VAL . . . . . . . . . . . . . 15.0 p -107.2 149.18 10.83 Favored 'Isoleucine or valine' 0 C--O 1.244 0.787 0 CA-C-N 114.461 -1.245 . . . . 71.31 108.556 175.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -76.33 -62.72 1.52 Allowed 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 109.088 -0.708 . . . . 65.24 109.088 172.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 26.1 t-80 -171.42 -95.06 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.72 0 O-C-N 124.335 1.022 . . . . 74.15 108.437 173.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 185' ' ' VAL . . . . . 0.575 ' HA ' ' HB1' ' C' ' 121' ' ' ALA . 58.5 t . . . . . 0 N--CA 1.489 1.489 0 CA-C-N 118.844 0.747 . . . . 71.33 110.305 -179.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 30.7 m . . . . . 0 C--O 1.237 0.412 0 N-CA-C 108.16 -1.052 . . . . 71.31 108.16 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -168.05 -89.65 0.01 OUTLIER 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.059 0.944 . . . . 74.42 109.899 164.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . 159.11 -169.73 35.37 Favored Glycine 0 C--N 1.338 0.692 0 N-CA-C 111.404 -0.678 . . . . 71.23 111.404 -167.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 241' ' ' GLU . . . . . 0.473 ' HG3' ' HG3' ' C' ' 234' ' ' ARG . 9.7 pt-20 -93.04 -13.86 28.09 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 113.376 0.88 . . . . 71.21 113.376 -166.486 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 11.3 m95 55.9 -88.12 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 124.242 1.017 . . . . 70.32 111.706 -177.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 243' ' ' GLN . . . . . 0.509 ' HA ' ' NH2' ' C' ' 234' ' ' ARG . 9.9 pt20 173.67 -37.77 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 126.438 1.895 . . . . 74.22 108.059 -166.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -175.94 128.0 1.32 Allowed Glycine 0 C--N 1.348 1.247 0 N-CA-C 110.033 -1.227 . . . . 63.11 110.033 177.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 245' ' ' LYS . . . . . 0.649 ' HA ' ' HB3' ' C' ' 224' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.817 0 C-N-CA 123.582 0.753 . . . . 75.34 110.128 -172.336 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.542 0 N-CA-C 108.885 -0.783 . . . . 52.01 108.885 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -36.55 94.54 0.01 OUTLIER 'General case' 0 C--N 1.365 1.241 0 C-N-CA 125.232 1.413 . . . . 70.52 113.371 -175.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 5' ' ' LYS . . . . . 0.433 ' HB3' HD11 ' C' ' 10' ' ' ILE . 29.7 mmtp -65.76 95.84 0.26 Allowed 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.485 -1.234 . . . . 63.2 108.625 169.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 6' ' ' ASP . . . . . 0.478 ' HA ' ' OH ' ' C' ' 66' ' ' TYR . 16.2 t70 -73.14 97.25 2.35 Favored 'General case' 0 C--N 1.343 0.321 0 N-CA-C 106.975 -1.491 . . . . 63.22 106.975 169.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 7' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -63.6 -30.23 71.37 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 114.811 -1.086 . . . . 73.43 112.389 -169.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -61.56 -44.47 96.97 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.593 0.357 . . . . 72.53 110.16 172.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.47 -42.95 98.59 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.177 0.591 . . . . 52.31 110.934 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 10' ' ' ILE . . . . . 0.433 HD11 ' HB3' ' C' ' 5' ' ' LYS . 56.2 mt -59.98 -39.09 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 C-N-CA 123.407 0.683 . . . . 63.34 110.762 178.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 93.0 mt -76.98 -20.84 55.58 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 116.081 -0.509 . . . . 45.45 112.272 175.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.55 39.48 56.18 Favored Glycine 0 C--N 1.346 1.128 0 O-C-N 123.189 0.306 . . . . 64.33 112.549 -176.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 27.2 m -120.32 157.28 53.96 Favored Pre-proline 0 N--CA 1.479 0.976 0 C-N-CA 124.915 1.286 . . . . 64.04 109.097 176.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -51.16 145.76 25.19 Favored 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 122.849 2.366 . . . . 74.43 113.105 177.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 79.2 mtt180 -74.21 18.13 0.16 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 114.105 1.15 . . . . 71.52 114.105 -175.044 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -148.76 21.1 1.02 Allowed 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 124.985 1.314 . . . . 71.24 108.176 177.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.47 156.41 32.53 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.314 1.046 . . . . 71.14 112.883 -170.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 70.3 p -65.18 148.39 51.77 Favored 'General case' 0 C--N 1.348 0.534 0 CA-C-N 115.365 -0.834 . . . . 74.41 108.75 170.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 19' ' ' GLN . . . . . 0.447 ' OE1' ' HD2' ' C' ' 63' ' ' ARG . 1.2 mp0 -63.29 -20.01 65.09 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 122.954 0.502 . . . . 74.45 110.477 175.538 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -65.4 -44.7 86.64 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.261 -0.881 . . . . 64.05 111.408 168.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -63.71 -35.3 80.12 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.114 0.565 . . . . 73.42 110.657 176.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 22' ' ' ILE . . . . . 0.652 HG12 ' HB3' ' C' ' 57' ' ' LEU . 1.7 mp -59.72 -41.33 85.01 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 CA-C-N 115.664 -0.698 . . . . 61.32 109.833 170.307 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 23' ' ' LYS . . . . . 0.468 ' HA ' ' HB3' ' C' ' 26' ' ' TYR . 36.0 mtmm -77.94 -14.96 59.35 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.217 0.607 . . . . 74.13 112.631 175.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -75.18 -37.39 61.24 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 108.622 -0.881 . . . . 73.52 108.622 170.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -76.94 -25.21 52.6 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.246 -0.888 . . . . 75.32 110.936 175.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 26' ' ' TYR . . . . . 0.528 ' O ' ' HB3' ' C' ' 30' ' ' ALA . 87.5 t80 -66.73 -47.43 72.32 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 109.315 -0.624 . . . . 72.31 109.315 169.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 27' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' C' ' 23' ' ' LYS . 45.0 mtmt -59.04 -53.69 55.52 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 109.29 -0.633 . . . . 74.1 109.29 173.343 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 18.5 ttm180 -50.5 -69.34 0.12 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.9 1.28 . . . . 71.15 110.589 -175.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 29' ' ' LEU . . . . . 0.406 ' HB3' ' CD1' ' C' ' 50' ' ' ILE . 94.3 mt -82.17 -35.59 28.23 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 114.799 -1.092 . . . . 60.22 112.862 -169.362 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 30' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' C' ' 26' ' ' TYR . . . -87.21 -5.78 58.84 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 118.345 0.521 . . . . 75.32 112.222 -176.408 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 31' ' ' ARG . . . . . 0.506 ' HA ' ' HB2' ' C' ' 34' ' ' HIS . 99.4 mtt180 -96.68 -37.37 10.35 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 118.323 0.51 . . . . 73.5 109.902 163.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -62.02 -43.17 99.4 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.344 0.658 . . . . 71.12 111.148 177.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 33' ' ' TYR . . . . . 0.523 ' HD2' HD11 ' C' ' 50' ' ' ILE . 19.3 m-85 -109.42 26.05 11.09 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.36 1.064 . . . . 70.15 110.044 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 34' ' ' HIS . . . . . 0.506 ' HB2' ' HA ' ' C' ' 31' ' ' ARG . 37.8 t60 -63.68 112.76 7.9 Favored Pre-proline 0 N--CA 1.475 0.79 0 CA-C-O 118.505 -0.76 . . . . 72.34 109.189 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.41 -18.81 15.62 Favored 'Trans proline' 0 N--CA 1.501 1.966 0 C-N-CA 123.392 2.728 . . . . 71.32 114.834 -170.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 36' ' ' ASP . . . . . 0.417 ' HB3' ' HD2' ' C' ' 34' ' ' HIS . 13.0 t70 -80.04 -46.72 16.07 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.041 0.936 . . . . 60.34 110.804 176.025 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 71.0 t -84.15 -54.49 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 123.361 0.664 . . . . 75.33 109.818 -175.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -98.45 83.83 3.09 Favored 'General case' 0 C--O 1.244 0.787 0 N-CA-C 107.991 -1.115 . . . . 54.22 107.991 176.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -79.03 78.09 5.48 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.011 -0.995 . . . . 62.24 109.895 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 71.0 m -139.37 118.55 9.09 Favored Pre-proline 0 CA--C 1.542 0.673 0 C-N-CA 123.882 0.873 . . . . 74.14 108.743 174.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_exo -47.05 -38.74 24.82 Favored 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 123.606 2.871 . . . . 63.44 113.207 176.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -58.05 -44.23 87.3 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.839 0.856 . . . . 65.44 110.211 177.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.47 -21.29 61.96 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.23 -0.896 . . . . 62.05 110.603 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 44' ' ' GLU . . . . . 0.407 ' O ' ' HG2' ' C' ' 48' ' ' LYS . 0.4 OUTLIER -81.54 -33.2 31.9 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.14 0.976 . . . . 74.04 109.2 -178.776 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -68.21 -45.39 73.49 Favored 'General case' 0 C--O 1.261 1.695 0 C-N-CA 124.013 0.925 . . . . 42.53 109.475 174.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 46' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -61.05 -38.61 86.78 Favored 'General case' 0 C--N 1.348 0.518 0 CA-C-N 114.588 -1.187 . . . . 72.32 110.33 172.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 47' ' ' PHE . . . . . 0.676 ' HA ' HD12 ' C' ' 50' ' ' ILE . 65.3 t80 -57.77 -41.13 81.35 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.177 0.991 . . . . 62.23 110.299 176.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 48' ' ' LYS . . . . . 0.407 ' HG2' ' O ' ' C' ' 44' ' ' GLU . 72.3 mmtt -59.01 -49.94 75.97 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 122.383 0.273 . . . . 72.04 110.59 175.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -58.93 -39.43 81.55 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 124.23 0.956 . . . . 72.33 112.097 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 50' ' ' ILE . . . . . 0.676 HD12 ' HA ' ' C' ' 47' ' ' PHE . 55.2 mt -62.76 -47.89 90.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 124.254 1.022 . . . . 75.43 109.628 177.173 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 51' ' ' ASN . . . . . 0.561 ' HA ' ' HB3' ' C' ' 54' ' ' TYR . 64.2 m-80 -79.85 -5.91 56.36 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 115.522 -0.763 . . . . 74.04 112.176 -178.479 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 52' ' ' GLU . . . . . 0.444 ' HA ' ' CE2' ' C' ' 93' ' ' PHE . 32.0 tt0 -75.3 -56.23 4.92 Favored 'General case' 0 C--O 1.249 1.027 0 CA-C-O 122.166 0.984 . . . . 63.42 108.844 167.562 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.86 -37.31 73.7 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 113.485 -1.689 . . . . 63.1 111.442 174.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 54' ' ' TYR . . . . . 0.561 ' HB3' ' HA ' ' C' ' 51' ' ' ASN . 70.0 t80 -75.84 -34.32 60.07 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.263 -0.88 . . . . 75.01 110.5 178.258 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.57 -40.71 75.68 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.099 0.476 . . . . 60.54 110.508 175.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 44.4 t -79.95 -37.23 17.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 114.737 -1.12 . . . . 72.43 112.578 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 57' ' ' LEU . . . . . 0.652 ' HB3' HG12 ' C' ' 22' ' ' ILE . 94.6 mt -111.14 12.38 21.89 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 114.033 1.123 . . . . 75.02 114.033 -170.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 47.4 t -57.94 -58.97 6.05 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.239 0.616 . . . . 62.42 111.073 178.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -99.73 150.93 37.26 Favored Pre-proline 0 N--CA 1.47 0.558 0 CA-C-N 114.786 -1.097 . . . . 72.03 110.236 -178.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 60' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -54.31 -34.63 80.94 Favored 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 123.659 2.906 . . . . 33.23 112.513 171.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -66.19 -47.17 74.79 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.912 0.885 . . . . 62.13 110.645 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -66.05 -33.59 76.15 Favored 'General case' 0 C--O 1.249 1.042 0 CA-C-N 115.093 -0.958 . . . . 75.23 111.049 178.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 63' ' ' ARG . . . . . 0.447 ' HD2' ' OE1' ' C' ' 19' ' ' GLN . 13.6 ttt180 -60.94 -47.27 87.21 Favored 'General case' 0 C--O 1.218 -0.585 0 CA-C-N 115.718 -0.674 . . . . 64.42 109.901 173.391 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -61.83 -34.42 75.92 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 123.603 0.564 . . . . 74.15 111.285 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 72.6 mt -54.2 -57.55 5.73 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.95 0 N-CA-C 108.522 -0.918 . . . . 62.34 108.522 169.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 66' ' ' TYR . . . . . 0.478 ' OH ' ' HA ' ' C' ' 6' ' ' ASP . 10.0 t80 -52.37 -51.52 58.47 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.253 0.621 . . . . 74.22 112.025 176.454 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -55.22 -36.33 65.87 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.899 0.88 . . . . 73.14 111.257 -174.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 68' ' ' THR . . . . . 0.402 ' O ' ' HB ' ' C' ' 72' ' ' THR . 54.8 p -102.37 -14.29 16.96 Favored 'General case' 0 CA--C 1.556 1.189 0 N-CA-C 112.782 0.66 . . . . 63.2 112.782 -178.386 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -122.05 125.02 45.32 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.023 0.529 . . . . 75.22 109.663 -173.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 74.61 18.93 80.02 Favored Glycine 0 N--CA 1.473 1.155 0 CA-C-O 121.539 0.522 . . . . 62.51 111.937 -175.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 47.8 m -141.31 -50.33 0.42 Allowed 'General case' 0 C--O 1.239 0.505 0 N-CA-C 103.898 -2.63 . . . . 72.34 103.898 178.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 72' ' ' THR . . . . . 0.402 ' HB ' ' O ' ' C' ' 68' ' ' THR . 19.2 m -106.62 163.61 12.76 Favored 'General case' 0 C--O 1.253 1.244 0 N-CA-C 105.192 -2.151 . . . . 73.35 105.192 156.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.09 13.06 27.84 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.511 1.124 . . . . 73.23 111.115 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.42 -152.25 0.0 OUTLIER Pre-proline 0 CA--C 1.607 3.15 0 CA-C-O 115.936 -1.983 . . . . 53.23 113.066 -175.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 75' ' ' PRO . . . . . 0.481 ' HA ' ' HD2' ' C' ' 76' ' ' PRO . 0.8 OUTLIER 0.75 118.32 0.0 OUTLIER 'Trans proline' 1 C--N 1.427 4.684 1 C-N-CA 125.92 4.413 . . . . 75.14 119.796 -158.671 . . . . . . . . 5 4 . 1 . 010 nuclear build core ' C' C ' 76' ' ' PRO . . . . . 0.481 ' HD2' ' HA ' ' C' ' 75' ' ' PRO . 55.7 Cg_endo -63.39 178.22 1.3 Allowed 'Trans proline' 0 N--CA 1.51 2.472 0 C-N-CA 123.864 3.043 . . . . 63.14 112.745 176.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 77' ' ' PRO . . . . . 0.523 ' HA ' ' HD3' ' C' ' 78' ' ' PRO . 0.7 OUTLIER -26.41 116.96 0.03 OUTLIER 'Trans proline' 0 C--N 1.401 3.318 0 C-N-CA 124.929 3.753 . . . . 51.51 115.437 173.631 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 78' ' ' PRO . . . . . 0.523 ' HD3' ' HA ' ' C' ' 77' ' ' PRO . 25.3 Cg_exo -65.68 167.92 16.19 Favored 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 124.111 3.207 . . . . 74.44 114.17 -171.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -54.16 132.91 52.88 Favored 'Trans proline' 0 C--N 1.39 2.712 0 C-N-CA 123.104 2.536 . . . . 61.04 113.227 175.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -58.47 83.76 0.05 OUTLIER 'Trans proline' 0 C--N 1.39 2.726 0 C-N-CA 123.65 2.9 . . . . 51.5 111.879 176.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.41 -34.08 0.04 OUTLIER Glycine 0 C--O 1.225 -0.442 0 N-CA-C 109.329 -1.508 . . . . 75.2 109.329 -176.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.438 ' HA2' ' O ' ' C' ' 104' ' ' GLY . . . 95.09 165.15 35.29 Favored Glycine 0 C--N 1.35 1.339 0 N-CA-C 116.607 1.403 . . . . 74.45 116.607 166.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -69.58 135.84 50.51 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 124.258 1.023 . . . . 70.14 108.318 168.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 84' ' ' ASP . . . . . 0.402 ' HB2' ' HB2' ' C' ' 143' ' ' ARG . 35.6 t70 -66.94 129.22 39.18 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 118.273 0.488 . . . . 63.13 109.728 175.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 85' ' ' PHE . . . . . 0.524 ' HB3' ' HG3' ' C' ' 171' ' ' PRO . 23.5 t80 -116.68 34.77 4.89 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.688 0.795 . . . . 74.41 109.857 -165.287 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 52.8 m -5.74 78.99 0.0 OUTLIER 'General case' 0 CA--C 1.569 1.691 0 N-CA-C 116.836 2.161 . . . . 45.43 116.836 -170.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 53.06 31.71 41.04 Favored Glycine 0 CA--C 1.545 1.959 0 N-CA-C 116.399 1.32 . . . . 74.33 116.399 175.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 88' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -101.67 155.34 18.16 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 119.134 1.467 . . . . 74.44 113.643 -173.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -85.13 79.04 9.72 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.337 0.655 . . . . 72.23 111.128 -178.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 90' ' ' VAL . . . . . . . . . . . . . 2.0 p -42.17 -37.45 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 114.4 1.259 . . . . 54.41 114.4 177.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.11 -14.64 7.21 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 114.19 1.182 . . . . 74.21 114.19 -176.045 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -113.32 -3.49 13.81 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 112.757 0.651 . . . . 75.53 112.757 -175.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 93' ' ' PHE . . . . . 0.444 ' CE2' ' HA ' ' C' ' 52' ' ' GLU . 2.3 m-85 -77.13 153.33 34.33 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 122.741 0.417 . . . . 72.45 110.937 -176.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 97.0 p -82.94 -178.81 7.25 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.768 0.827 . . . . 45.51 113.013 -166.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.38 -61.81 2.33 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 114.552 -1.204 . . . . 55.43 112.911 -175.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 96' ' ' PHE . . . . . 0.413 ' HB3' ' HG2' ' C' ' 5' ' ' LYS . 84.4 t80 -58.07 -38.98 77.38 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 118.753 0.706 . . . . 65.02 110.743 -171.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 97' ' ' PHE . . . . . 0.446 ' CE2' ' HE2' ' C' ' 85' ' ' PHE . 83.4 t80 -60.31 -54.75 41.94 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 114.43 -1.259 . . . . 64.25 110.009 175.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -81.69 5.18 19.19 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 112.478 0.547 . . . . 51.52 112.478 -177.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -100.05 -39.11 8.28 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.836 0.855 . . . . 74.43 109.942 170.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 45.6 tp -78.5 -52.51 8.41 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.892 0.853 . . . . 73.23 109.502 -178.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 101' ' ' PHE . . . . . 0.446 ' HB3' HD13 ' C' ' 105' ' ' LEU . 96.5 m-85 -86.31 -20.72 27.96 Favored 'General case' 0 C--O 1.214 -0.77 0 CA-C-N 113.952 -1.477 . . . . 73.25 111.347 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -49.26 -50.81 27.96 Favored Glycine 0 CA--C 1.549 2.217 0 CA-C-O 118.558 -1.135 . . . . 54.11 115.754 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -49.34 -25.33 9.89 Favored 'Trans proline' 0 C--N 1.387 2.596 0 C-N-CA 124.139 3.226 . . . . 62.02 115.09 175.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 104' ' ' GLY . . . . . 0.438 ' O ' ' HA2' ' C' ' 82' ' ' GLY . . . -137.72 31.68 2.46 Favored Glycine 0 C--N 1.353 1.485 0 CA-C-O 119.401 -0.666 . . . . 43.23 112.188 174.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 105' ' ' LEU . . . . . 0.446 HD13 ' HB3' ' C' ' 101' ' ' PHE . 13.1 tp . . . . . 0 N--CA 1.476 0.843 0 CA-C-N 118.103 0.951 . . . . 73.03 109.128 179.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 116' ' ' GLY . . . . . 0.551 ' HA3' ' HA ' ' C' ' 171' ' ' PRO . . . . . . . . 0 CA--C 1.486 -1.734 0 N-CA-C 109.768 -1.333 . . . . 45.25 109.768 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -90.5 161.42 15.51 Favored 'General case' 0 C--O 1.264 1.835 0 N-CA-C 108.076 -1.083 . . . . 64.44 108.076 172.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -62.6 155.35 26.3 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 115.031 -0.986 . . . . 75.42 109.416 168.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 119' ' ' LEU . . . . . 0.478 HD13 ' HA ' ' C' ' 174' ' ' LEU . 0.0 OUTLIER -119.64 144.57 47.08 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 108.247 -1.02 . . . . 75.21 108.247 171.562 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.439 ' HA ' ' O ' ' C' ' 175' ' ' LEU . 19.6 ttt180 -138.9 106.77 5.66 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 109.612 -0.514 . . . . 72.31 109.612 -162.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 121' ' ' ALA . . . . . 0.575 ' HB1' ' HA ' ' B' ' 185' ' ' VAL . . . -134.83 127.67 31.24 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 115.492 -0.776 . . . . 63.21 109.835 -172.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 122' ' ' GLU . . . . . 0.474 ' HA ' ' O ' ' C' ' 177' ' ' VAL . 13.2 pt-20 -85.54 141.16 30.07 Favored 'General case' 0 C--O 1.244 0.77 0 N-CA-C 110.13 -0.322 . . . . 73.22 110.13 176.448 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -142.71 144.28 29.31 Favored Pre-proline 0 N--CA 1.481 1.102 0 CA-C-N 116.182 -0.463 . . . . 73.3 110.937 -170.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -75.44 121.69 6.56 Favored 'Trans proline' 0 C--N 1.368 1.603 0 C-N-CA 123.147 2.565 . . . . 72.51 111.278 173.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 125' ' ' LEU . . . . . 0.521 ' HB3' HG23 ' C' ' 178' ' ' VAL . 55.7 tp -137.37 147.11 45.25 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.279 0.631 . . . . 74.03 110.058 -177.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.73 155.21 18.44 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 123.449 0.7 . . . . 61.53 110.308 -178.169 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 127' ' ' LEU . . . . . 0.508 HD13 ' HD2' ' C' ' 186' ' ' PHE . 96.2 mt -66.3 -44.74 82.62 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.373 1.069 . . . . 62.25 111.234 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 18.4 mp0 -65.09 -33.33 75.77 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.729 1.212 . . . . 75.24 109.733 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 53.3 mm-40 -77.83 -25.38 48.75 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.712 0.805 . . . . 73.53 112.116 177.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -74.3 -32.75 62.99 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 109.142 -0.688 . . . . 64.34 109.142 173.085 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 131' ' ' PHE . . . . . 0.423 ' HB2' HD13 ' C' ' 215' ' ' LEU . 70.7 t80 -67.46 -44.89 77.51 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.407 1.083 . . . . 75.55 111.088 173.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 132' ' ' HIS . . . . . . . . . . . . . 54.2 m170 -70.72 -49.46 46.7 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 116.261 -0.427 . . . . 60.22 110.685 -176.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 68.39 -90.65 0.23 Allowed Glycine 0 C--N 1.345 1.069 0 N-CA-C 110.664 -0.974 . . . . 65.31 110.664 -170.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.28 161.83 5.7 Favored Glycine 0 C--N 1.353 1.509 0 O-C-N 123.876 0.398 . . . . 53.24 114.008 174.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -71.44 94.69 1.28 Allowed 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 109.105 -0.702 . . . . 71.2 109.105 174.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 136' ' ' ARG . . . . . 0.641 ' HB3' ' HB2' ' B' ' 181' ' ' LEU . 2.7 mpt_? -105.15 158.77 16.35 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.669 1.187 . . . . 72.12 109.051 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 137' ' ' VAL . . . . . 0.401 HG23 ' HB1' ' B' ' 180' ' ' ALA . 23.0 m -104.62 127.77 58.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 109.798 -0.445 . . . . 71.12 109.798 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 138' ' ' VAL . . . . . 0.738 ' HB ' HD23 ' B' ' 181' ' ' LEU . 6.1 p -113.12 114.61 47.44 Favored 'Isoleucine or valine' 0 C--O 1.248 0.986 0 C-N-CA 123.531 0.733 . . . . 72.14 110.052 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 139' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -120.68 93.15 3.94 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 124.829 1.252 . . . . 74.31 108.067 178.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 140' ' ' VAL . . . . . . . . . . . . . 12.7 p -147.61 149.04 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 108.877 -0.786 . . . . 63.22 108.877 -177.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 65.2 19.47 11.74 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 124.75 1.22 . . . . 15.23 112.1 177.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 84.39 -4.03 84.92 Favored Glycine 0 C--N 1.344 0.991 0 CA-C-N 115.675 -0.693 . . . . 45.25 113.553 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 143' ' ' ARG . . . . . 0.526 ' NH2' ' HB3' ' C' ' 164' ' ' MET . 0.0 OUTLIER -111.41 124.37 52.12 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.41 0.684 . . . . 73.04 109.658 -176.722 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 12.9 ttt180 -114.3 121.61 44.18 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.656 1.182 . . . . 71.51 110.859 -171.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 145' ' ' VAL . . . . . 0.549 HG21 ' SD ' ' C' ' 164' ' ' MET . 21.9 m -143.25 177.1 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 C-N-CA 123.922 0.889 . . . . 75.03 110.581 172.193 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 23.0 t -119.36 129.79 55.01 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.761 0.825 . . . . 54.21 108.78 171.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 11.4 p -149.01 154.47 9.6 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 C-N-CA 123.489 0.716 . . . . 72.53 111.003 -178.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 22.0 ttm180 -96.06 116.19 28.58 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 108.082 -1.081 . . . . 74.22 108.082 164.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 149' ' ' ILE . . . . . 0.457 HD13 HD11 ' B' ' 181' ' ' LEU . 31.9 pt -73.22 147.41 87.86 Favored Pre-proline 0 CA--C 1.551 1.001 0 CA-C-O 118.597 -0.716 . . . . 71.41 109.302 172.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -43.07 115.07 0.51 Allowed 'Trans proline' 0 C--N 1.385 2.45 0 C-N-CA 123.698 2.932 . . . . 61.44 113.594 178.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -62.18 95.96 0.15 Allowed 'Trans proline' 0 C--N 1.386 2.533 0 C-N-CA 123.046 2.497 . . . . 73.2 111.636 178.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 152' ' ' GLY . . . . . . . . . . . . . . . 131.28 108.23 1.19 Allowed Glycine 0 C--N 1.343 0.943 0 CA-C-N 114.98 -1.009 . . . . 54.32 112.44 -174.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 153' ' ' VAL . . . . . 0.705 HG21 HG21 ' C' ' 178' ' ' VAL . 1.8 m -131.1 163.53 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 CA-C-N 117.121 0.46 . . . . 71.13 111.067 -179.021 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 154' ' ' ARG . . . . . 0.416 ' HE ' ' HA ' ' C' ' 189' ' ' GLU . 29.6 mtt85 -118.49 144.27 46.14 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.823 0.849 . . . . 75.32 109.443 -178.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 155' ' ' GLU . . . . . 0.497 ' HB2' HD12 ' C' ' 180' ' ' LEU . 4.6 tp10 -56.22 128.32 35.09 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.267 0.627 . . . . 74.51 111.974 173.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 68.29 14.66 66.79 Favored Glycine 0 C--N 1.344 1.024 0 O-C-N 123.882 0.739 . . . . 64.51 113.68 176.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 157' ' ' SER . . . . . . . . . . . . . 34.0 t -104.05 164.53 11.64 Favored 'General case' 0 C--N 1.349 0.566 0 C-N-CA 123.201 0.6 . . . . 75.43 109.534 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 8.8 p -112.48 108.01 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.136 0 CA-C-O 121.738 0.78 . . . . 64.44 111.007 -170.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 159' ' ' ILE . . . . . . . . . . . . . 14.6 mt -71.38 117.2 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.588 1.155 . . . . 52.25 108.91 172.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 48.1 ttt-85 -95.44 119.73 34.45 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 118.532 0.605 . . . . 72.21 109.676 171.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 161' ' ' VAL . . . . . 0.611 ' HB ' ' HB3' ' C' ' 174' ' ' LEU . 92.9 t -99.0 99.02 7.1 Favored Pre-proline 0 C--O 1.246 0.892 0 N-CA-C 107.9 -1.148 . . . . 75.24 107.9 171.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -80.83 153.19 19.58 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.638 2.225 . . . . 63.42 112.002 -178.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 89.92 28.7 17.52 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-O 119.42 -0.656 . . . . 53.31 113.647 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 164' ' ' MET . . . . . 0.549 ' SD ' HG21 ' C' ' 145' ' ' VAL . 20.7 mtm -130.67 -88.14 0.49 Allowed 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 117.888 0.844 . . . . 73.35 111.717 178.478 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 165' ' ' GLY . . . . . 0.421 ' HA3' ' HB3' ' C' ' 171' ' ' PRO . . . 131.91 147.93 6.02 Favored Glycine 0 N--CA 1.482 1.737 0 CA-C-N 118.686 0.676 . . . . 64.24 114.501 -172.146 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . -108.16 -105.95 3.04 Favored Glycine 0 C--N 1.371 2.494 0 N-CA-C 112.279 -0.328 . . . . 75.44 112.279 172.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 167' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -105.38 107.0 17.76 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.515 0.726 . . . . 64.31 111.642 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . 129.9 159.54 9.81 Favored Glycine 0 C--N 1.357 1.702 0 CA-C-N 117.762 0.256 . . . . 13.44 113.108 171.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 169' ' ' ASN . . . . . 0.471 ' HB2' ' HD3' ' C' ' 170' ' ' PRO . 1.3 m-20 -61.72 -63.18 4.57 Favored Pre-proline 0 CA--C 1.572 1.795 0 C-N-CA 125.008 1.323 . . . . 62.44 114.01 -168.542 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 170' ' ' PRO . . . . . 0.471 ' HD3' ' HB2' ' C' ' 169' ' ' ASN . 73.2 Cg_endo -79.03 98.7 1.2 Allowed 'Trans proline' 0 C--N 1.406 3.569 0 CA-C-N 122.309 1.86 . . . . 51.41 110.335 173.504 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 171' ' ' PRO . . . . . 0.551 ' HA ' ' HA3' ' C' ' 116' ' ' GLY . 10.2 Cg_exo -69.74 142.47 48.13 Favored 'Trans proline' 0 C--N 1.369 1.658 0 C-N-CA 123.704 2.936 . . . . 74.02 116.557 -159.289 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 172' ' ' GLY . . . . . 0.4 ' O ' ' HA2' ' C' ' 165' ' ' GLY . . . -109.01 141.51 15.95 Favored Glycine 0 C--O 1.213 -1.208 0 N-CA-C 106.549 -2.62 . . . . 74.42 106.549 163.345 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 173' ' ' ASP . . . . . 0.444 ' HB3' ' O ' ' C' ' 161' ' ' VAL . 64.8 m-20 -81.12 -161.51 0.41 Allowed 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 115.349 1.611 . . . . 74.51 115.349 -159.124 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 174' ' ' LEU . . . . . 0.611 ' HB3' ' HB ' ' C' ' 161' ' ' VAL . 40.7 tp -94.34 141.95 27.98 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 121.504 -0.747 . . . . 75.22 110.896 -176.069 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 175' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' C' ' 120' ' ' ARG . 76.2 mt -130.06 84.78 2.23 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.416 1.486 . . . . 71.32 109.435 176.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 176' ' ' LEU . . . . . . . . . . . . . 69.5 mt -80.2 107.45 13.0 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.424 0.69 . . . . 43.02 109.644 175.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 177' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' C' ' 122' ' ' GLU . 58.2 t -83.06 95.48 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 107.553 -1.277 . . . . 74.43 107.553 175.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 178' ' ' VAL . . . . . 0.705 HG21 HG21 ' C' ' 153' ' ' VAL . 3.0 p -71.25 122.65 23.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.875 0.845 . . . . 74.01 111.334 -174.5 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 179' ' ' ARG . . . . . . . . . . . . . 17.1 mmm-85 -105.62 111.74 24.55 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 107.277 -1.379 . . . . 72.33 107.277 169.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 180' ' ' LEU . . . . . 0.502 HD13 HD21 ' C' ' 127' ' ' LEU . 97.3 mt -72.12 136.85 46.67 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.35 0.595 . . . . 70.51 111.101 -177.374 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 181' ' ' LEU . . . . . . . . . . . . . 60.3 mt -62.98 167.14 6.51 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 126.016 1.726 . . . . 74.2 113.857 -173.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -52.04 71.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.396 3.068 0 C-N-CA 124.208 3.272 . . . . 64.12 113.165 167.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 183' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -178.15 49.0 0.05 OUTLIER Pre-proline 0 CA--C 1.549 0.933 0 N-CA-C 105.153 -2.165 . . . . 62.13 105.153 -171.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 184' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -90.2 65.29 1.88 Allowed 'Trans proline' 0 C--N 1.387 2.586 0 C-N-CA 123.229 2.619 . . . . 71.54 111.655 -163.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 185' ' ' VAL . . . . . 0.566 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 21.2 t -95.73 -59.68 3.02 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.443 0 N-CA-C 108.223 -1.029 . . . . 72.23 108.223 -174.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 186' ' ' PHE . . . . . 0.508 ' HD2' HD13 ' C' ' 127' ' ' LEU . 53.8 m-85 -100.11 125.32 46.2 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.725 0.81 . . . . 61.44 110.787 -168.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 187' ' ' ARG . . . . . 0.414 ' HG2' ' HB3' ' C' ' 155' ' ' GLU . 0.0 OUTLIER -126.23 109.35 12.21 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 107.256 -1.387 . . . . 75.14 107.256 178.906 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 188' ' ' LEU . . . . . 0.468 HD13 ' HD2' ' C' ' 240' ' ' PHE . 52.3 tp -77.48 154.13 32.83 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.617 0.969 . . . . 74.14 113.617 -169.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 189' ' ' GLU . . . . . 0.416 ' HA ' ' HE ' ' C' ' 154' ' ' ARG . 7.9 tp10 -142.25 103.47 4.29 Favored 'General case' 0 C--O 1.248 1.01 0 N-CA-C 107.06 -1.459 . . . . 71.33 107.06 158.58 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 75.13 -88.39 0.79 Allowed Glycine 0 C--N 1.349 1.253 0 CA-C-N 115.471 -0.786 . . . . 74.2 112.526 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 191' ' ' GLN . . . . . 0.517 ' HB3' ' HA3' ' C' ' 247' ' ' GLY . 49.5 mt-30 -123.83 -23.05 4.75 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.659 1.184 . . . . 60.21 110.303 176.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -93.23 127.26 38.74 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 123.756 0.822 . . . . 65.13 110.79 -171.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 193' ' ' LEU . . . . . . . . . . . . . 84.3 mt -86.64 165.72 15.92 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.849 0.86 . . . . 52.2 111.316 -177.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 194' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -126.96 103.69 7.61 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.56 -1.274 . . . . 75.43 107.56 165.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 195' ' ' ALA . . . . . 0.566 ' HA ' ' O ' ' C' ' 185' ' ' VAL . . . -98.41 -177.08 3.58 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 124.024 0.93 . . . . 65.11 109.843 172.12 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 88.6 m -132.41 106.67 8.02 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 107.9 -1.148 . . . . 51.32 107.9 168.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 197' ' ' LEU . . . . . . . . . . . . . 43.3 tp -78.12 122.22 25.34 Favored 'General case' 0 C--N 1.35 0.596 0 N-CA-C 109.327 -0.62 . . . . 73.5 109.327 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -96.18 100.44 12.08 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 108.396 -0.965 . . . . 44.52 108.396 -177.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 199' ' ' VAL . . . . . . . . . . . . . 25.6 t -108.25 124.58 34.18 Favored Pre-proline 0 N--CA 1.481 1.11 0 C-N-CA 123.285 0.634 . . . . 61.21 109.649 -176.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 200' ' ' PRO . . . . . 0.556 ' HG2' HD12 ' C' ' 203' ' ' ILE . 4.5 Cg_exo -63.31 145.92 93.26 Favored 'Trans proline' 0 C--N 1.37 1.673 0 C-N-CA 121.961 1.774 . . . . 71.34 110.834 170.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 201' ' ' ALA . . . . . . . . . . . . . . . -53.37 -47.4 96.33 Favored Pre-proline 0 CA--C 1.558 1.262 0 N-CA-C 113.834 1.05 . . . . 74.35 113.834 -179.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 202' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -63.77 -41.88 22.44 Favored 'Trans proline' 0 C--N 1.384 2.444 0 C-N-CA 121.509 1.473 . . . . 63.15 112.523 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 203' ' ' ILE . . . . . 0.556 HD12 ' HG2' ' C' ' 200' ' ' PRO . 39.5 mt -65.73 -36.04 76.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.009 0.524 . . . . 63.4 110.324 179.043 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 204' ' ' ALA . . . . . 0.454 ' HA ' HG11 ' C' ' 223' ' ' VAL . . . -62.05 -43.01 99.75 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.33 0.652 . . . . 75.02 110.897 176.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 205' ' ' VAL . . . . . . . . . . . . . 70.0 t -67.97 -45.35 83.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.659 0.784 . . . . 63.41 112.529 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 206' ' ' VAL . . . . . 0.615 ' HA ' ' HE3' ' A' ' 270' ' ' LYS . 14.8 p -78.9 -31.15 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 CA-C-O 121.021 0.438 . . . . 52.12 110.98 -176.19 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 82.12 52.06 4.2 Favored Glycine 0 C--N 1.336 0.546 0 CA-C-N 115.345 -0.843 . . . . 63.21 111.701 -172.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -84.22 -135.83 3.08 Favored Glycine 0 C--N 1.346 1.099 0 N-CA-C 111.868 -0.493 . . . . 51.32 111.868 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 209' ' ' LYS . . . . . 0.519 ' HG2' ' HA ' ' C' ' 222' ' ' ALA . 9.7 mtmp? -137.01 139.84 41.69 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 117.509 0.654 . . . . 72.12 111.397 175.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 210' ' ' VAL . . . . . 0.486 HG13 HG21 ' C' ' 203' ' ' ILE . 22.3 m -128.33 135.59 62.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.399 1.08 . . . . 62.05 109.216 175.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 211' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -84.62 112.51 20.51 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 120.852 0.358 . . . . 72.44 110.833 -176.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -81.69 114.58 20.46 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.07 0.948 . . . . 74.43 108.607 170.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 213' ' ' MET . . . . . . . . . . . . . 4.1 tmm? -74.87 116.08 15.19 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 107.311 -1.366 . . . . 63.12 107.311 178.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 214' ' ' THR . . . . . 0.443 ' OG1' HG12 ' C' ' 219' ' ' VAL . 0.2 OUTLIER -116.96 174.4 6.11 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.286 0.565 . . . . 54.24 110.478 -174.167 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 215' ' ' LEU . . . . . 0.423 HD13 ' HB2' ' C' ' 131' ' ' PHE . 27.1 mt -64.47 -29.89 70.93 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.107 1.363 . . . . 44.41 112.067 -177.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -91.65 1.4 57.18 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 114.78 -1.1 . . . . 71.0 110.826 -177.043 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 110.77 -170.06 13.72 Favored Glycine 0 C--N 1.341 0.843 0 N-CA-C 110.693 -0.963 . . . . 64.11 110.693 -169.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -80.5 119.12 3.67 Favored 'Trans proline' 0 CA--C 1.554 1.524 0 C-N-CA 122.566 2.178 . . . . 52.13 113.506 -173.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 219' ' ' VAL . . . . . 0.443 HG12 ' OG1' ' C' ' 214' ' ' THR . 14.8 p -97.82 148.05 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 N-CA-C 107.728 -1.212 . . . . 52.53 107.728 165.566 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 220' ' ' GLU . . . . . 0.484 ' HG2' ' HB3' ' C' ' 209' ' ' LYS . 13.3 tt0 -96.93 155.94 16.56 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 108.574 -0.899 . . . . 72.32 108.574 175.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 221' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' C' ' 209' ' ' LYS . 41.9 t -122.5 116.88 50.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 124.094 0.958 . . . . 74.03 110.154 -178.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 222' ' ' ALA . . . . . 0.519 ' HA ' ' HG2' ' C' ' 209' ' ' LYS . . . -78.74 102.64 8.2 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 108.965 -0.754 . . . . 73.3 108.965 171.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 223' ' ' VAL . . . . . 0.454 HG11 ' HA ' ' C' ' 204' ' ' ALA . 58.2 t -76.43 142.81 71.57 Favored Pre-proline 0 CA--C 1.566 1.574 0 C-N-CA 124.643 1.177 . . . . 73.11 110.372 -177.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 224' ' ' PRO . . . . . 0.649 ' HB3' ' HA ' ' B' ' 245' ' ' LYS . 71.7 Cg_endo -78.69 154.49 26.93 Favored 'Trans proline' 0 C--N 1.38 2.186 0 C-N-CA 122.957 2.438 . . . . 54.33 113.073 168.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -58.89 119.59 6.94 Favored 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 123.496 2.797 . . . . 74.0 112.674 175.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 226' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.0 82.92 0.13 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.275 1.43 . . . . 70.15 110.795 -175.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 227' ' ' THR . . . . . 0.414 HG22 HG11 ' C' ' 253' ' ' VAL . 97.8 m -93.31 133.08 36.92 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 114.295 -1.32 . . . . 70.3 109.482 174.168 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 228' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -100.09 147.75 25.32 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 121.24 0.543 . . . . 74.32 110.65 176.219 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 229' ' ' ALA . . . . . 0.41 ' HB2' ' H ' ' C' ' 255' ' ' ILE . . . -67.83 140.44 56.59 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 114.967 -1.015 . . . . 62.12 109.521 173.538 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 105.83 -18.37 40.45 Favored Glycine 0 C--N 1.333 0.37 0 N-CA-C 111.471 -0.652 . . . . 62.04 111.471 -171.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 231' ' ' ARG . . . . . . . . . . . . . 36.1 mtt85 -62.69 168.35 3.84 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 117.105 0.452 . . . . 74.12 111.697 169.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 232' ' ' LYS . . . . . 0.644 ' HD3' ' HB3' ' C' ' 250' ' ' TYR . 3.9 ttmp? -150.18 131.76 14.86 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.33 0.586 . . . . 71.45 111.117 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 233' ' ' LEU . . . . . 0.595 HD13 ' HB2' ' C' ' 251' ' ' LEU . 4.7 mp -88.03 158.44 18.61 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.65 1.18 . . . . 74.21 110.214 178.024 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 234' ' ' ARG . . . . . 0.509 ' NH2' ' HA ' ' B' ' 243' ' ' GLN . 3.1 ptt85 -128.17 87.89 2.67 Favored 'General case' 0 CA--C 1.55 0.96 0 O-C-N 125.171 1.544 . . . . 72.34 108.19 164.055 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 54.4 mt -77.29 120.46 22.36 Favored 'General case' 0 C--N 1.361 1.071 0 CA-C-N 115.468 -0.787 . . . . 73.43 109.008 174.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -80.94 127.28 32.39 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.686 0.795 . . . . 71.55 111.48 -172.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 72.95 36.17 57.49 Favored Glycine 0 C--N 1.347 1.154 0 O-C-N 123.853 0.721 . . . . 71.42 113.028 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 24.0 mmtm -129.01 21.52 5.8 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.561 0.745 . . . . 72.03 110.987 176.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -92.78 -164.08 37.74 Favored Glycine 0 C--N 1.353 1.505 0 O-C-N 123.559 0.537 . . . . 31.21 112.975 175.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 240' ' ' PHE . . . . . 0.468 ' HD2' HD13 ' C' ' 188' ' ' LEU . 2.5 m-85 -80.89 157.58 71.43 Favored Pre-proline 0 CA--C 1.557 1.244 0 CA-C-O 119.352 -0.356 . . . . 75.14 110.065 177.601 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 241' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -59.26 114.52 2.06 Favored 'Trans proline' 0 C--N 1.387 2.565 0 C-N-CA 123.415 2.744 . . . . 70.21 112.786 -177.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -99.53 168.3 21.65 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-N 115.217 -0.901 . . . . 70.14 112.812 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -67.46 -23.0 44.32 Favored 'Trans proline' 0 C--N 1.374 1.89 0 C-N-CA 123.116 2.544 . . . . 71.42 112.302 176.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -95.33 -4.18 45.93 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.837 0.855 . . . . 71.42 111.3 177.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 141.55 -85.55 0.2 Allowed Glycine 0 C--N 1.349 1.274 0 N-CA-C 111.311 -0.716 . . . . 51.32 111.311 -178.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 246' ' ' ARG . . . . . . . . . . . . . 85.6 mtm180 -138.61 175.26 9.71 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.657 1.183 . . . . 61.31 110.119 178.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 247' ' ' GLY . . . . . 0.517 ' HA3' ' HB3' ' C' ' 191' ' ' GLN . . . -104.08 -158.46 24.25 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 115.201 -0.909 . . . . 63.23 111.926 165.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -118.79 174.66 6.15 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.295 0.638 . . . . 73.54 109.492 -178.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 249' ' ' LEU . . . . . 0.463 ' HG ' HD11 ' C' ' 251' ' ' LEU . 20.6 tp -126.93 118.03 23.71 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.576 0.751 . . . . 74.23 110.841 -173.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 250' ' ' TYR . . . . . 0.644 ' HB3' ' HD3' ' C' ' 232' ' ' LYS . 22.3 m-30 -100.89 106.47 17.83 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.47 0.708 . . . . 71.43 110.715 178.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 251' ' ' LEU . . . . . 0.595 ' HB2' HD13 ' C' ' 233' ' ' LEU . 2.9 mp -105.3 124.32 49.34 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-N 118.836 0.744 . . . . 64.53 111.2 -174.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -76.7 120.2 21.55 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 109.068 -0.716 . . . . 73.41 109.068 174.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 253' ' ' VAL . . . . . 0.414 HG11 HG22 ' C' ' 227' ' ' THR . 72.1 t -77.16 128.16 38.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 C-N-CA 123.235 0.614 . . . . 73.5 111.289 -176.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 254' ' ' ARG . . . . . . . . . . . . . 28.2 mtm180 -107.04 137.22 45.52 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.391 -0.966 . . . . 74.13 108.391 164.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 255' ' ' ILE . . . . . 0.485 ' O ' ' HB ' ' A' ' 255' ' ' ILE . 30.2 mm -98.64 109.61 24.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 105.843 -1.91 . . . . 75.24 105.843 165.529 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 256' ' ' THR . . . . . . . . . . . . . 7.5 t -131.15 176.87 7.9 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 124.09 0.956 . . . . 53.32 109.793 -170.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 49.6 pt -126.81 155.65 75.01 Favored Pre-proline 0 CA--C 1.557 1.226 0 C-N-CA 123.356 0.662 . . . . 64.54 110.254 -177.043 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 258' ' ' PRO . . . . . 0.514 ' HG3' ' HE2' ' A' ' 276' ' ' TYR . 49.6 Cg_endo -80.86 41.4 1.14 Allowed 'Trans proline' 0 C--N 1.377 2.051 0 C-N-CA 123.625 2.883 . . . . 73.21 113.945 -175.494 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 259' ' ' GLU . . . . . 0.404 ' O ' ' HD3' ' A' ' 226' ' ' ARG . 60.8 mm-40 60.51 -93.63 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.882 1.273 . . . . 72.3 110.015 -171.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 260' ' ' ARG . . . . . 0.775 ' HA ' HH11 ' A' ' 226' ' ' ARG . 0.0 OUTLIER -115.03 164.1 14.66 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.514 1.126 . . . . 73.41 110.197 -178.16 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 261' ' ' LEU . . . . . . . . . . . . . 45.6 mt -126.96 173.15 9.85 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.023 0.929 . . . . 71.21 111.398 -171.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 73.4 p -84.27 148.6 53.32 Favored Pre-proline 0 CA--C 1.552 1.051 0 CA-C-N 114.942 -1.026 . . . . 61.23 108.801 168.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -43.34 -36.78 6.75 Favored 'Trans proline' 0 C--N 1.382 2.324 0 C-N-CA 124.478 3.452 . . . . 74.2 115.114 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -64.23 -60.94 2.6 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.251 0.62 . . . . 71.04 110.905 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -53.32 -51.1 63.44 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.448 -0.796 . . . . 65.11 109.874 178.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 266' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -55.99 -36.17 67.6 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 114.547 -1.206 . . . . 64.21 111.706 -178.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -63.76 -48.89 75.13 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.2 0.6 . . . . 70.32 111.259 176.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 268' ' ' LEU . . . . . 0.622 ' HB2' HD21 ' A' ' 272' ' ' LEU . 8.0 mp -63.94 -38.17 90.09 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 123.033 0.208 . . . . 52.44 111.379 178.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 77.1 m95 -64.78 -33.36 75.79 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.054 0.542 . . . . 61.11 111.017 175.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -70.87 -31.78 68.56 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.109 0.564 . . . . 75.43 111.74 175.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -69.76 -38.79 76.88 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 120.567 0.223 . . . . 75.33 110.903 175.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 92.9 mt -60.63 -44.91 95.81 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 115.723 -0.671 . . . . 74.33 109.581 170.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -62.12 -41.69 98.48 Favored 'General case' 0 C--O 1.216 -0.709 0 CA-C-N 115.42 -0.809 . . . . 34.13 111.401 -178.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -69.54 -33.71 73.19 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.386 0.675 . . . . 63.21 111.021 178.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -60.55 -33.77 73.16 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 121.243 0.544 . . . . 70.04 110.398 171.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 276' ' ' TYR . . . . . 0.706 ' HA ' ' HD3' ' C' ' 279' ' ' ARG . 16.4 m-85 -80.91 -31.39 35.13 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.251 -0.886 . . . . 75.52 112.839 174.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 18.6 m-30 -73.17 -22.2 60.53 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 118.391 0.541 . . . . 44.24 109.886 178.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -64.94 -23.43 67.22 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.474 0.71 . . . . 55.2 111.109 171.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 279' ' ' ARG . . . . . 0.706 ' HD3' ' HA ' ' C' ' 276' ' ' TYR . 17.2 mtp-105 -78.63 -21.37 48.51 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.498 0.719 . . . . 71.52 110.515 174.473 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.137 0 C-N-CA 123.507 0.723 . . . . 75.14 109.231 -178.857 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.8 ttpp . . . . . 0 N--CA 1.486 1.328 0 N-CA-C 114.103 1.149 . . . . 62.43 114.103 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -77.57 131.18 37.71 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.205 1.002 . . . . 74.32 110.427 177.071 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -83.76 86.84 7.08 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 107.022 -1.474 . . . . 61.41 107.022 166.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.453 ' CD1' ' HA ' ' A' ' 53' ' ' ALA . 66.6 m-85 -61.2 -31.11 70.87 Favored 'General case' 0 C--O 1.249 1.063 0 CA-C-N 115.094 -0.957 . . . . 73.34 112.144 -174.264 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -57.37 -55.38 35.51 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.241 0.617 . . . . 73.33 109.494 172.474 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.73 -33.66 74.43 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.816 0.847 . . . . 60.32 111.764 -177.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 78.1 mt -62.89 -40.14 87.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.287 0.635 . . . . 74.23 110.477 175.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 93.3 mt -80.03 -2.81 45.82 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 112.49 0.552 . . . . 51.33 112.49 173.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.26 18.03 72.63 Favored Glycine 0 C--N 1.351 1.394 0 O-C-N 123.3 0.375 . . . . 53.33 113.67 177.1 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.607 HG21 HG12 ' A' ' 22' ' ' ILE . 22.8 m -111.55 142.06 25.79 Favored Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 123.209 0.604 . . . . 71.43 110.185 177.353 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -82.94 169.78 12.89 Favored 'Trans proline' 0 C--N 1.366 1.453 0 C-N-CA 122.255 1.97 . . . . 50.12 112.048 174.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.6 mmt85 -67.92 80.43 0.21 Allowed 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 114.969 -1.014 . . . . 75.43 110.422 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -174.96 -32.75 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.166 1.387 . . . . 64.11 108.399 -177.133 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.28 122.07 17.08 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.831 -0.622 . . . . 64.31 110.56 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 72.8 p -76.58 175.13 9.57 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.14 0.976 . . . . 71.11 110.236 178.159 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -50.41 -38.63 43.99 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 124.424 1.09 . . . . 64.21 112.484 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.455 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 1.8 tm-20 -74.05 -41.76 61.26 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.397 1.079 . . . . 72.43 110.265 -175.154 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -67.86 -37.51 81.92 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 123.871 0.869 . . . . 64.03 110.623 177.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.666 HD13 HD13 ' A' ' 57' ' ' LEU . 45.0 mt -68.06 -33.06 58.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 C-N-CA 125.342 1.457 . . . . 73.31 110.612 175.288 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.2 ttmm -69.76 -38.99 76.98 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.733 0.813 . . . . 71.24 109.63 177.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.455 ' HG3' ' O ' ' A' ' 20' ' ' GLU . 48.9 mtt180 -61.36 -45.67 93.41 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 123.582 0.551 . . . . 54.12 109.97 174.237 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.72 -46.02 84.98 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 124.262 0.976 . . . . 64.0 111.302 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -60.6 -49.81 76.02 Favored 'General case' 0 C--N 1.348 0.534 0 O-C-N 123.693 0.621 . . . . 73.1 111.02 177.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -61.43 -35.95 78.99 Favored 'General case' 0 N--CA 1.484 1.229 0 O-C-N 124.078 0.861 . . . . 74.22 111.601 -178.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.8 ttt180 -58.52 -51.11 71.27 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.642 1.177 . . . . 71.15 110.355 174.226 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.704 ' HB3' HD13 ' A' ' 50' ' ' ILE . 54.2 mt -73.94 -21.07 60.17 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 114.843 -1.071 . . . . 74.11 110.708 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -88.4 -9.57 52.17 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.361 1.064 . . . . 63.3 111.392 179.22 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 48.4 mtm105 -93.5 -46.68 7.2 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.08 0.552 . . . . 72.33 109.967 166.289 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -69.75 -60.12 2.51 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.451 0.7 . . . . 63.33 111.423 -174.062 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.428 ' HE2' HD22 ' A' ' 29' ' ' LEU . 26.4 m-85 -92.97 19.52 7.68 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.371 0.668 . . . . 63.25 111.541 -174.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 -57.52 102.91 0.33 Allowed Pre-proline 0 N--CA 1.48 1.025 0 C-N-CA 125.147 1.379 . . . . 63.41 111.323 -172.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -62.17 -25.08 76.81 Favored 'Trans proline' 0 C--N 1.375 1.935 0 C-N-CA 123.164 2.576 . . . . 74.13 113.367 -177.045 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -59.66 -31.11 69.25 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.446 0.698 . . . . 72.45 111.416 175.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.9 t -102.2 -63.18 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 N-CA-C 109.254 -0.647 . . . . 65.53 109.254 176.343 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -97.95 86.07 3.65 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.397 1.079 . . . . 61.35 109.869 -174.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -77.13 71.46 3.63 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 115.382 -0.826 . . . . 73.11 109.707 174.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 43.7 m -118.19 117.57 34.9 Favored Pre-proline 0 N--CA 1.471 0.606 0 N-CA-C 108.287 -1.005 . . . . 54.41 108.287 178.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -41.22 -50.47 4.37 Favored 'Trans proline' 0 C--N 1.388 2.637 0 C-N-CA 124.291 3.327 . . . . 72.23 113.955 -171.068 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -53.98 -48.51 70.29 Favored 'General case' 0 CA--C 1.549 0.922 0 O-C-N 124.583 1.177 . . . . 64.43 111.323 -179.338 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.3 -28.74 67.44 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.384 -0.826 . . . . 72.14 111.237 -178.058 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.458 ' O ' ' HD3' ' A' ' 48' ' ' LYS . 49.2 mt-10 -84.84 -36.74 21.39 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.334 0.654 . . . . 62.01 110.321 -172.417 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -70.29 -42.68 71.73 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.842 0.857 . . . . 62.44 109.336 177.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -57.73 -41.48 81.91 Favored 'General case' 0 C--N 1.35 0.593 0 CA-C-N 114.857 -1.065 . . . . 74.03 109.689 169.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.426 ' HA ' HD12 ' A' ' 50' ' ' ILE . 35.1 t80 -70.47 -23.2 62.65 Favored 'General case' 0 CA--C 1.547 0.845 0 O-C-N 123.468 0.48 . . . . 73.24 111.836 179.204 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.458 ' HD3' ' O ' ' A' ' 44' ' ' GLU . 1.9 mptm? -68.98 -41.22 78.16 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 109.702 -0.481 . . . . 75.14 109.702 171.397 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -65.25 -37.37 87.01 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 123.629 0.58 . . . . 71.44 110.537 176.068 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.704 HD13 ' HB3' ' A' ' 29' ' ' LEU . 79.9 mt -69.14 -39.43 79.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.783 1.233 . . . . 70.53 110.565 177.538 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -67.95 -36.14 79.61 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.606 -0.724 . . . . 73.43 110.396 175.369 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.443 ' O ' HG23 ' A' ' 56' ' ' VAL . 32.4 tt0 -63.78 -53.39 51.57 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.551 1.141 . . . . 63.42 110.138 179.142 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.453 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . . . -60.41 -44.15 96.02 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 113.372 -1.74 . . . . 65.45 112.063 -177.535 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -82.54 -18.28 42.02 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 115.994 -0.548 . . . . 72.32 111.629 177.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.431 ' HB1' ' CD2' ' A' ' 85' ' ' PHE . . . -61.55 -36.62 81.1 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.8 0.809 . . . . 53.01 109.663 172.036 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.474 HG22 ' CE1' ' A' ' 101' ' ' PHE . 38.0 t -69.77 -61.73 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 CA-C-N 113.439 -1.709 . . . . 74.52 110.433 170.27 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.666 HD13 HD13 ' A' ' 22' ' ' ILE . 52.8 mt -86.45 12.78 9.52 Favored 'General case' 0 CA--C 1.559 1.322 0 CA-C-N 114.864 -1.062 . . . . 62.04 113.166 -165.446 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.6 t -67.88 -56.24 9.86 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.774 0.83 . . . . 74.34 110.664 174.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -95.04 148.05 34.04 Favored Pre-proline 0 N--CA 1.47 0.547 0 CA-C-N 115.095 -0.957 . . . . 74.34 110.286 -177.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.75 -41.15 57.65 Favored 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 123.266 2.644 . . . . 72.41 111.207 169.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -60.57 -54.69 42.35 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 123.97 0.908 . . . . 72.3 111.527 -178.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.436 ' HA ' HD12 ' A' ' 65' ' ' ILE . 37.6 mtpt -73.39 -32.04 64.24 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.625 0.77 . . . . 74.54 112.386 -174.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.462 HH21 HD12 ' A' ' 22' ' ' ILE . 7.6 ptm180 -67.31 -38.94 85.78 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.636 -0.505 . . . . 74.11 109.636 175.292 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -65.05 -35.91 82.68 Favored 'General case' 0 C--N 1.362 1.134 0 O-C-N 123.593 0.558 . . . . 74.25 110.904 174.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.436 HD12 ' HA ' ' A' ' 62' ' ' LYS . 83.4 mt -55.58 -47.14 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 C-N-CA 123.366 0.666 . . . . 64.42 110.469 174.736 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -58.04 -55.61 32.68 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 115.578 -0.737 . . . . 75.4 111.274 170.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -58.75 -31.8 68.67 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.467 0.707 . . . . 64.04 112.135 -173.252 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 67.8 p -86.98 -18.3 31.02 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.301 0.64 . . . . 75.13 111.338 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -72.47 134.64 45.42 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 106.839 -1.541 . . . . 63.45 106.839 164.228 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.63 26.77 49.52 Favored Glycine 0 N--CA 1.471 1.0 0 N-CA-C 111.201 -0.76 . . . . 52.54 111.201 -171.045 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 52.8 m -144.42 -56.45 0.36 Allowed 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 102.587 -3.116 . . . . 71.23 102.587 172.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.5 m -84.2 140.95 31.37 Favored 'General case' 0 C--O 1.25 1.098 0 N-CA-C 104.782 -2.303 . . . . 74.23 104.782 157.126 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.23 -41.84 63.27 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.08 0.552 . . . . 74.04 110.539 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.78 151.8 53.04 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 123.731 0.812 . . . . 75.1 110.134 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -63.0 133.8 43.11 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.214 1.943 . . . . 75.41 110.58 172.22 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.404 ' HG2' ' HA ' ' A' ' 65' ' ' ILE . 67.8 Cg_exo -47.26 150.44 3.3 Favored 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 124.373 3.382 . . . . 74.25 115.207 -178.643 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -55.82 113.35 1.39 Allowed 'Trans proline' 0 C--N 1.389 2.662 0 C-N-CA 123.302 2.668 . . . . 62.44 112.46 -178.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -62.58 146.45 95.39 Favored 'Trans proline' 0 C--N 1.382 2.297 0 C-N-CA 123.397 2.731 . . . . 43.51 113.283 -178.128 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -66.21 150.24 84.98 Favored 'Trans proline' 0 C--N 1.373 1.844 0 C-N-CA 122.819 2.346 . . . . 71.05 111.566 174.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.478 ' HD2' ' HA3' ' A' ' 142' ' ' GLY . 74.1 Cg_endo -72.75 64.89 3.94 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 123.576 2.851 . . . . 51.35 112.124 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -178.51 -31.98 0.05 OUTLIER Glycine 0 CA--C 1.522 0.484 0 CA-C-N 114.502 -1.227 . . . . 62.41 110.047 -170.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.77 -169.03 18.8 Favored Glycine 0 C--N 1.356 1.674 0 C-N-CA 122.993 0.33 . . . . 53.03 113.115 176.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -108.0 111.76 24.0 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.326 1.05 . . . . 74.41 110.165 -178.07 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -67.76 155.5 39.14 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.76 1.224 . . . . 71.31 110.944 172.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.523 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 64.8 m-85 -144.39 77.64 1.55 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.894 0.878 . . . . 70.22 110.517 -177.229 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.462 ' HB3' ' HG2' ' A' ' 162' ' ' PRO . 6.0 m -49.42 85.06 0.0 OUTLIER 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 125.446 1.499 . . . . 74.44 113.667 -179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.33 20.71 79.96 Favored Glycine 0 CA--C 1.535 1.299 0 CA-C-N 116.118 -0.492 . . . . 70.11 113.772 -179.177 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.523 ' HB2' ' HB3' ' A' ' 85' ' ' PHE . 24.2 m-85 -114.09 106.86 14.89 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 117.41 0.605 . . . . 72.34 109.502 -176.552 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -83.73 80.52 9.11 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 121.686 0.755 . . . . 71.44 109.907 -177.037 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.439 ' HA ' ' CD2' ' A' ' 93' ' ' PHE . 3.4 p -39.94 -32.94 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 C-N-CA 126.635 1.974 . . . . 75.21 114.688 174.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -53.47 -38.55 63.73 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.557 1.143 . . . . 75.33 111.783 -176.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -97.18 0.68 48.74 Favored 'General case' 0 CA--C 1.554 1.126 0 CA-C-N 115.332 -0.849 . . . . 45.35 111.495 -173.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.439 ' CD2' ' HA ' ' A' ' 90' ' ' VAL . 10.3 m-30 -88.68 -178.12 5.72 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.588 0.755 . . . . 71.01 110.555 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 89.6 p -77.47 163.74 26.07 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 113.595 0.961 . . . . 74.5 113.595 -168.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.413 ' O ' ' HG3' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -61.57 -40.34 94.38 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 114.312 -1.313 . . . . 74.31 112.123 175.889 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -63.33 -39.31 94.2 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 110.085 -0.339 . . . . 75.03 110.085 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -62.14 -40.33 95.61 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.529 -0.759 . . . . 63.23 109.654 176.158 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -81.16 -1.61 45.24 Favored 'General case' 0 CA--C 1.558 1.272 0 CA-C-N 114.801 -1.091 . . . . 73.05 112.288 177.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 95' ' ' GLU . 51.8 mt-10 -96.6 -46.46 6.31 Favored 'General case' 0 N--CA 1.503 2.224 0 C-N-CA 123.278 0.631 . . . . 70.02 111.62 167.666 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 33.5 tp -65.41 -45.55 83.5 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.678 1.191 . . . . 55.03 110.215 -177.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.474 ' CE1' HG22 ' A' ' 56' ' ' VAL . 97.5 m-85 -95.71 -7.97 35.89 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.544 -0.753 . . . . 72.11 111.033 176.489 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -45.16 -58.58 4.98 Favored Glycine 0 CA--C 1.541 1.67 0 CA-C-O 118.656 -1.08 . . . . 72.43 115.625 -177.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -62.3 -8.21 12.01 Favored 'Trans proline' 0 C--N 1.386 2.512 0 C-N-CA 123.169 2.58 . . . . 23.1 113.86 -175.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -142.01 33.49 1.93 Allowed Glycine 0 C--N 1.357 1.731 0 CA-C-O 119.551 -0.583 . . . . 44.4 112.771 175.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.5 mt -66.79 20.92 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.305 0 N-CA-C 114.864 1.431 . . . . 74.25 114.864 -178.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.571 ' HD1' ' H ' ' A' ' 108' ' ' GLY . 0.2 OUTLIER 57.06 -107.26 0.37 Allowed 'General case' 0 CA--C 1.564 1.486 0 C-N-CA 124.182 0.993 . . . . 72.25 110.541 165.123 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 66.22 15.36 63.11 Favored Glycine 0 C--N 1.362 1.975 0 CA-C-N 118.044 0.384 . . . . 44.0 113.414 -176.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.571 ' H ' ' HD1' ' A' ' 106' ' ' PHE . . . . . . . . 0 C--N 1.353 1.5 0 N-CA-C 111.482 -0.647 . . . . 71.34 111.482 -170.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 170' ' ' PRO . 39.2 ttmt . . . . . 0 N--CA 1.476 0.855 0 N-CA-C 112.365 0.506 . . . . 72.15 112.365 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -97.18 -168.21 33.07 Favored Glycine 0 CA--C 1.549 2.196 0 CA-C-N 115.643 -0.708 . . . . 55.22 113.29 179.199 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -112.95 139.06 48.92 Favored 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 124.374 1.07 . . . . 71.34 109.766 177.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -50.61 113.92 1.02 Allowed 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.962 0.887 . . . . 74.23 112.724 -176.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.431 ' O ' HD12 ' A' ' 174' ' ' LEU . 5.4 tt -105.81 148.65 27.28 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 114.652 -1.158 . . . . 70.23 108.795 -168.041 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.447 ' HD2' ' HB2' ' A' ' 175' ' ' LEU . 14.8 tpt180 -98.21 143.13 29.04 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 108.586 -0.894 . . . . 74.51 108.586 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.557 ' HB2' HD11 ' A' ' 174' ' ' LEU . . . -138.93 166.19 25.12 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 118.768 0.713 . . . . 41.51 111.45 -178.658 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.544 ' HB2' ' HB3' ' B' ' 9' ' ' ALA . 18.0 mm-40 -116.61 98.4 6.52 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 106.874 -1.528 . . . . 61.0 106.874 179.024 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.496 ' HB2' HD22 ' A' ' 176' ' ' LEU . 11.7 tp -98.25 103.57 18.65 Favored Pre-proline 0 C--O 1.213 -0.86 0 N-CA-C 107.392 -1.336 . . . . 54.05 107.392 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.489 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 55.2 Cg_endo -66.81 151.22 82.83 Favored 'Trans proline' 0 C--N 1.362 1.276 0 C-N-CA 121.253 1.302 . . . . 75.33 108.847 169.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.649 ' HA ' HG21 ' B' ' 6' ' ' ILE . 17.9 tp -150.91 148.2 28.14 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 119.283 0.947 . . . . 64.01 112.016 177.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 33.8 m -76.21 127.05 32.13 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 114.436 -1.256 . . . . 71.34 109.341 175.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.578 ' HB3' HD22 ' A' ' 215' ' ' LEU . 3.5 mm? -44.61 -57.73 3.46 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 125.516 1.526 . . . . 70.54 112.452 -178.465 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 17.5 mp0 -59.13 -44.56 92.05 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 114.33 -1.304 . . . . 75.32 109.632 -176.031 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -76.63 -12.28 59.99 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 115.185 -0.916 . . . . 64.33 111.856 -178.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.603 ' HB1' ' O ' ' A' ' 153' ' ' VAL . . . -79.45 -38.5 34.48 Favored 'General case' 0 C--O 1.252 1.223 0 CA-C-O 121.772 0.796 . . . . 41.43 109.206 176.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.461 ' HB2' HH21 ' A' ' 154' ' ' ARG . 89.2 t80 -70.57 -41.87 71.85 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 114.564 -1.198 . . . . 74.51 110.762 171.3 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 33.6 m170 -77.22 -36.46 54.68 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.149 0.579 . . . . 75.25 112.065 -172.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.513 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 70.21 -150.35 48.58 Favored Glycine 0 CA--C 1.531 1.087 0 O-C-N 123.411 0.444 . . . . 71.54 114.009 -179.425 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 91.57 -174.29 37.87 Favored Glycine 0 C--N 1.352 1.461 0 C-N-CA 123.483 0.563 . . . . 70.42 112.571 178.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 21.5 mp0 -67.95 113.16 5.42 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.823 0.849 . . . . 73.14 109.231 179.165 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 13.1 tpp180 -108.67 122.77 47.81 Favored 'General case' 0 C--O 1.244 0.806 0 C-N-CA 123.626 0.771 . . . . 74.4 109.626 -175.01 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 48.7 t -73.45 114.86 13.57 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 O-C-N 124.01 0.819 . . . . 71.24 109.156 175.039 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.466 HG13 HG13 ' A' ' 145' ' ' VAL . 5.5 p -142.39 134.64 26.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 124.65 1.18 . . . . 73.14 107.889 177.582 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -123.43 144.38 49.54 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 121.973 -0.454 . . . . 71.3 110.732 -175.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.518 ' HB ' ' HB3' ' B' ' 8' ' ' LEU . 11.9 p -159.32 141.09 4.69 Favored 'Isoleucine or valine' 0 C--O 1.243 0.715 0 C-N-CA 124.646 1.178 . . . . 75.1 108.111 173.297 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 58.92 31.71 21.57 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.911 0.885 . . . . 74.24 110.795 -177.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.478 ' HA3' ' HD2' ' A' ' 80' ' ' PRO . . . 73.05 0.15 50.09 Favored Glycine 0 C--N 1.355 1.598 0 CA-C-N 115.399 -0.818 . . . . 31.1 114.282 -178.378 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.75 99.08 10.41 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.317 1.047 . . . . 72.12 108.311 -174.719 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 27.1 ttt-85 -74.82 92.38 2.51 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.464 1.106 . . . . 74.41 109.702 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.466 HG13 HG13 ' A' ' 138' ' ' VAL . 7.5 p -95.62 136.76 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 123.217 0.607 . . . . 73.53 110.899 -177.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 40.3 t -102.02 85.2 2.64 Favored 'General case' 0 C--O 1.243 0.718 0 N-CA-C 108.523 -0.917 . . . . 31.45 108.523 177.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 89.0 t -81.16 113.17 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 108.598 -0.89 . . . . 73.42 108.598 -176.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 40.4 ttt85 -68.79 93.04 0.51 Allowed 'General case' 0 C--O 1.242 0.692 0 N-CA-C 108.552 -0.907 . . . . 74.14 108.552 173.386 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.513 HG13 ' HA2' ' A' ' 133' ' ' GLY . 41.2 pt -72.91 133.16 82.24 Favored Pre-proline 0 CA--C 1.553 1.084 0 CA-C-N 114.481 -1.236 . . . . 74.13 108.832 177.538 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -59.87 128.52 27.03 Favored 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 122.527 2.152 . . . . 60.34 111.701 177.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.09 92.78 0.09 OUTLIER 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 122.5 2.134 . . . . 74.15 110.519 172.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 126.29 60.59 0.15 Allowed Glycine 0 C--N 1.339 0.698 0 CA-C-O 121.721 0.623 . . . . 75.51 111.709 -168.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.603 ' O ' ' HB1' ' A' ' 130' ' ' ALA . 7.5 p -137.46 138.02 45.26 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.754 0 N-CA-C 107.068 -1.456 . . . . 75.43 107.068 169.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.622 HH21 HD12 ' A' ' 215' ' ' LEU . 57.6 mtt180 -151.13 175.12 12.44 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.627 0.771 . . . . 73.23 109.102 173.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.561 ' HB3' ' H ' ' A' ' 188' ' ' LEU . 17.3 tp10 -34.7 128.16 0.47 Allowed 'General case' 0 N--CA 1.502 2.162 0 C-N-CA 126.442 1.897 . . . . 72.32 114.852 -166.608 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.72 -9.98 66.51 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 114.823 0.689 . . . . 14.21 114.823 175.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 15.3 t -73.18 153.56 40.65 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 117.329 0.564 . . . . 74.23 109.562 174.338 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 85.6 t -119.94 108.16 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.749 0.82 . . . . 72.34 109.846 -175.201 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.568 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 59.5 mt -86.7 113.85 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 N-CA-C 108.718 -0.845 . . . . 75.24 108.718 174.139 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -76.27 107.08 8.27 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 108.691 -0.855 . . . . 61.32 108.691 171.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 15.0 p -117.14 114.9 38.62 Favored Pre-proline 0 CA--C 1.554 1.106 0 N-CA-C 109.281 -0.637 . . . . 61.33 109.281 174.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.462 ' HG2' ' HB3' ' A' ' 86' ' ' SER . 50.4 Cg_endo -69.22 140.83 45.72 Favored 'Trans proline' 0 C--N 1.369 1.633 0 C-N-CA 122.368 2.045 . . . . 74.53 112.62 178.188 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.533 ' N ' ' HB3' ' A' ' 171' ' ' PRO . . . 116.2 -26.52 8.66 Favored Glycine 0 N--CA 1.477 1.409 0 C-N-CA 123.519 0.58 . . . . 70.43 113.355 166.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.538 ' HB2' HD22 ' A' ' 174' ' ' LEU . 1.0 OUTLIER -102.37 -33.25 9.63 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.213 0.605 . . . . 64.15 110.245 -174.798 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.471 ' N ' ' HB2' ' A' ' 174' ' ' LEU . . . -89.86 151.97 22.06 Favored Glycine 0 CA--C 1.493 -1.343 0 N-CA-C 108.801 -1.72 . . . . 73.33 108.801 170.627 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.701 ' HA3' ' HA3' ' A' ' 172' ' ' GLY . . . 53.13 79.16 0.09 OUTLIER Glycine 0 CA--C 1.48 -2.129 0 CA-C-O 118.67 -1.072 . . . . 74.5 112.335 -161.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.497 HE22 HD13 ' B' ' 10' ' ' LEU . 13.0 mm-40 -55.59 104.09 0.12 Allowed 'General case' 0 C--N 1.353 0.725 0 O-C-N 128.275 2.986 . . . . 75.42 109.27 -177.4 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -174.46 -135.95 2.15 Favored Glycine 0 N--CA 1.435 -1.414 0 N-CA-C 109.32 -1.512 . . . . 64.21 109.32 -172.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' ASN . . . . . 0.547 ' ND2' ' HB3' ' A' ' 106' ' ' PHE . 0.5 OUTLIER -134.31 -57.01 0.02 OUTLIER Pre-proline 0 CA--C 1.552 1.039 0 CA-C-O 118.518 -0.753 . . . . 63.11 109.204 176.344 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.462 ' O ' ' HA ' ' A' ' 115' ' ' LYS . 17.2 Cg_exo -67.98 124.1 11.43 Favored 'Trans proline' 0 C--N 1.39 2.751 0 N-CA-C 106.461 -2.169 . . . . 71.13 106.461 160.161 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.533 ' HB3' ' N ' ' A' ' 163' ' ' GLY . 57.2 Cg_endo -67.46 143.08 61.85 Favored 'Trans proline' 0 C--O 1.244 0.777 0 C-N-CA 122.067 1.845 . . . . 71.25 114.612 -164.412 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.701 ' HA3' ' HA3' ' A' ' 166' ' ' GLY . . . -74.68 -29.54 61.24 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 119.597 -1.287 . . . . 72.4 110.872 158.686 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 92.58 138.79 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 127.975 2.51 . . . . 71.14 109.635 -177.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.557 HD11 ' HB2' ' A' ' 121' ' ' ALA . 26.4 tp -109.05 141.02 41.8 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 122.678 0.391 . . . . 64.32 110.343 -173.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.447 ' HB2' ' HD2' ' A' ' 120' ' ' ARG . 65.8 mt -107.98 83.2 1.75 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.332 1.053 . . . . 72.12 108.686 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.568 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 92.1 mt -66.62 101.33 0.77 Allowed 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.174 -0.921 . . . . 70.05 110.283 179.007 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 64.0 t -84.29 102.81 10.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 N-CA-C 107.677 -1.231 . . . . 61.43 107.677 173.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 7.3 p -66.88 128.43 30.05 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 CA-C-N 115.358 -0.837 . . . . 70.33 110.592 -177.507 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.489 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 33.3 mmt180 -124.09 91.82 3.54 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.255 1.422 . . . . 53.32 107.272 -174.234 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.569 HD13 HD13 ' A' ' 127' ' ' LEU . 27.9 mt -70.17 147.52 49.77 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.597 -0.729 . . . . 72.4 112.181 -171.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 61.9 mt -58.95 149.14 67.33 Favored Pre-proline 0 N--CA 1.479 1.024 0 C-N-CA 124.362 1.065 . . . . 73.14 110.814 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -58.86 79.42 0.05 OUTLIER 'Trans proline' 0 C--N 1.383 2.381 0 C-N-CA 123.413 2.742 . . . . 71.42 112.703 176.002 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 66.5 t-80 -129.39 103.5 18.01 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 105.917 -1.882 . . . . 73.35 105.917 -175.21 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -73.58 25.39 0.32 Allowed 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 123.638 2.892 . . . . 61.24 116.227 -163.069 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 71.5 t -97.57 -61.21 2.32 Favored 'Isoleucine or valine' 0 C--N 1.351 0.669 0 CA-C-N 118.425 0.557 . . . . 64.21 110.465 -177.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 15.5 m-30 -124.34 147.92 47.85 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-O 121.829 0.823 . . . . 72.31 112.714 -171.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -144.8 150.28 36.89 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.328 1.851 . . . . 75.51 106.665 172.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.632 HD12 ' HA ' ' A' ' 193' ' ' LEU . 6.3 tp -121.17 173.43 7.31 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 107.177 -1.416 . . . . 74.21 107.177 178.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -159.56 128.98 5.34 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 109.076 -0.713 . . . . 70.31 109.076 165.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 68.6 -74.55 0.31 Allowed Glycine 0 C--N 1.347 1.169 0 N-CA-C 110.979 -0.848 . . . . 65.41 110.979 -170.124 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -164.17 -0.68 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 123.758 0.823 . . . . 72.32 111.547 172.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -95.89 146.49 24.54 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.914 -0.491 . . . . 72.32 109.685 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.632 ' HA ' HD12 ' A' ' 188' ' ' LEU . 0.8 OUTLIER -89.69 157.2 18.1 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.473 1.109 . . . . 63.44 111.486 -165.765 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -142.96 154.9 44.51 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.648 1.579 . . . . 73.14 107.631 175.099 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.439 ' HB3' HD23 ' A' ' 251' ' ' LEU . . . -158.84 127.16 5.21 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.902 0.881 . . . . 74.34 109.122 -176.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 31.1 m -75.66 127.23 32.62 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 118.163 0.438 . . . . 70.21 110.128 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 38.5 tp -130.7 104.32 7.12 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.522 0.729 . . . . 72.21 110.032 -175.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -89.85 124.59 34.82 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 109.261 -0.644 . . . . 61.43 109.261 171.278 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 8.9 p -138.06 137.62 21.53 Favored Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 123.874 0.869 . . . . 64.4 109.16 -174.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.85 155.16 53.69 Favored 'Trans proline' 0 C--N 1.378 2.086 0 C-N-CA 121.765 1.643 . . . . 64.51 111.327 174.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -52.2 -49.66 83.5 Favored Pre-proline 0 CA--C 1.552 1.043 0 N-CA-C 114.633 1.346 . . . . 71.34 114.633 -172.25 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.443 ' HG2' ' HE1' ' C' ' 276' ' ' TYR . 54.3 Cg_exo -58.75 -41.28 64.83 Favored 'Trans proline' 0 C--N 1.386 2.541 0 C-N-CA 121.912 1.741 . . . . 63.54 113.997 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.485 HD11 ' HB3' ' C' ' 276' ' ' TYR . 44.0 mt -68.29 -35.57 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 109.907 -0.405 . . . . 64.32 109.907 178.203 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.16 -45.82 79.59 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.46 0.704 . . . . 71.51 111.751 176.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 53.0 t -68.26 -48.75 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 124.194 0.998 . . . . 63.23 111.522 -176.108 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 54.7 t -83.13 -37.59 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.042 0.937 . . . . 74.41 111.613 -172.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 92.22 70.61 1.17 Allowed Glycine 0 C--O 1.24 0.48 0 CA-C-N 115.765 -0.652 . . . . 72.35 111.493 -174.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -92.18 -154.23 30.7 Favored Glycine 0 C--N 1.34 0.793 0 CA-C-N 115.055 -0.572 . . . . 55.24 113.312 -177.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 36.3 mtmt -130.02 132.84 46.39 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.327 -0.62 . . . . 45.21 109.327 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 29.0 m -132.52 160.37 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 N-CA-C 108.678 -0.86 . . . . 63.11 108.678 172.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -97.68 115.36 27.8 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.358 -0.979 . . . . 71.41 108.358 177.243 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.89 165.65 11.24 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.936 0.894 . . . . 62.04 110.326 -174.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 213' ' ' MET . . . . . 0.456 ' N ' ' SD ' ' A' ' 213' ' ' MET . 0.0 OUTLIER -98.98 137.04 38.08 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.241 -0.89 . . . . 71.23 109.211 -174.941 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 67.6 p -124.53 177.51 5.89 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 107.934 -1.135 . . . . 74.1 107.934 163.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.622 HD12 HH21 ' A' ' 154' ' ' ARG . 33.0 mt -78.26 -23.14 47.42 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.81 -0.632 . . . . 63.31 110.395 -177.484 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -83.62 -12.84 55.49 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.148 0.979 . . . . 64.44 111.175 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 138.28 -164.62 25.6 Favored Glycine 0 C--N 1.346 1.137 0 N-CA-C 111.564 -0.614 . . . . 33.0 111.564 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -79.09 134.8 11.87 Favored 'Trans proline' 0 C--N 1.363 1.303 0 C-N-CA 122.262 1.974 . . . . 70.23 111.693 175.306 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 34.8 m -130.89 168.14 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 107.681 -1.229 . . . . 73.4 107.681 171.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -106.54 152.84 23.17 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 121.856 -0.528 . . . . 75.04 111.894 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 10.2 p -142.63 141.65 27.41 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 CA-C-N 114.868 -1.06 . . . . 74.13 109.319 -173.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -106.83 104.77 14.53 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 109.608 -0.515 . . . . 60.25 109.608 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 66.7 t -58.53 142.78 82.27 Favored Pre-proline 0 CA--C 1.569 1.68 0 C-N-CA 125.262 1.425 . . . . 63.14 110.472 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -84.31 167.36 12.13 Favored 'Trans proline' 0 C--N 1.386 2.515 0 C-N-CA 122.863 2.375 . . . . 75.51 111.195 175.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.12 145.91 28.26 Favored 'Trans proline' 0 C--N 1.367 1.546 0 C-N-CA 121.495 1.463 . . . . 72.53 112.681 174.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 71.9 mtt85 65.76 34.18 7.66 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 125.341 1.456 . . . . 74.04 111.642 175.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.503 HG22 HG11 ' A' ' 253' ' ' VAL . 89.3 m -63.15 108.67 1.31 Allowed 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 113.657 -1.611 . . . . 64.32 110.705 174.109 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -98.71 150.89 21.34 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.597 0.759 . . . . 75.32 110.824 -169.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -63.86 128.04 34.05 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.896 0.879 . . . . 62.31 110.742 177.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 97.0 -26.18 23.71 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-N 116.377 -0.374 . . . . 73.32 112.53 -178.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 55.8 mtt180 -74.36 135.3 42.47 Favored 'General case' 0 C--N 1.36 1.057 0 CA-C-O 121.623 0.725 . . . . 74.0 111.094 -178.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.634 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 33.6 mttm -102.71 112.37 25.12 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 114.219 -1.355 . . . . 72.22 109.03 -178.496 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.548 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 45.6 mt -75.33 99.5 4.12 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.031 0.932 . . . . 71.4 109.755 -172.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 58.9 ttt180 -73.64 123.89 24.91 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.59 1.156 . . . . 64.14 110.958 -173.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.491 HD12 HD23 ' A' ' 249' ' ' LEU . 67.3 mt -116.64 109.41 17.16 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.964 0.905 . . . . 61.12 109.889 -179.637 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -62.5 125.31 23.5 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 123.668 0.787 . . . . 64.43 112.767 -173.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 73.08 30.65 62.79 Favored Glycine 0 C--N 1.352 1.43 0 O-C-N 124.036 0.835 . . . . 74.2 113.881 174.184 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -115.77 -12.38 11.49 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.333 0.653 . . . . 73.01 111.65 -178.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -87.17 -168.77 45.14 Favored Glycine 0 C--N 1.348 1.205 0 O-C-N 123.311 0.382 . . . . 74.43 112.323 171.311 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 240' ' ' PHE . . . . . 0.494 ' HE2' ' HG3' ' A' ' 154' ' ' ARG . 13.2 m-30 -95.0 154.29 39.69 Favored Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 123.039 0.536 . . . . 73.13 111.903 -169.257 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.521 ' HA ' ' HA ' ' A' ' 246' ' ' ARG . 59.5 Cg_endo -70.16 120.54 7.25 Favored 'Trans proline' 0 C--N 1.386 2.544 0 C-N-CA 123.339 2.692 . . . . 73.33 113.62 -176.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -157.05 -138.78 2.58 Favored Glycine 0 C--N 1.35 1.327 0 CA-C-O 119.208 -0.773 . . . . 73.52 112.645 -178.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -70.57 -16.31 34.12 Favored 'Trans proline' 0 C--N 1.385 2.493 0 C-N-CA 123.24 2.627 . . . . 70.45 113.549 -173.157 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -100.18 20.43 14.62 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.737 0.815 . . . . 70.11 110.643 177.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 79.09 -80.19 1.53 Allowed Glycine 0 C--N 1.351 1.398 0 N-CA-C 109.503 -1.439 . . . . 62.24 109.503 -171.066 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.521 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 44.8 mtm180 -125.6 159.36 32.33 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.476 1.11 . . . . 75.41 108.514 164.374 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -87.64 -176.81 48.3 Favored Glycine 0 C--N 1.339 0.696 0 CA-C-N 116.14 -0.482 . . . . 42.24 112.285 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -123.2 151.6 42.07 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.027 0.931 . . . . 75.44 109.648 178.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.491 HD23 HD12 ' A' ' 235' ' ' LEU . 53.8 tp -96.84 111.31 23.55 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 109.434 -0.58 . . . . 70.31 109.434 -178.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.634 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 18.7 m-85 -96.82 105.91 18.12 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.323 1.049 . . . . 52.51 109.539 -179.197 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.548 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 12.1 mt -81.63 97.4 7.86 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.949 0.5 . . . . 72.24 109.739 176.021 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -77.47 105.74 8.79 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.988 0.915 . . . . 75.41 108.726 -174.373 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.503 HG11 HG22 ' A' ' 227' ' ' THR . 55.0 t -88.79 144.35 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 N-CA-C 114.192 1.182 . . . . 24.43 114.192 -165.148 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -128.65 111.47 13.23 Favored 'General case' 0 C--N 1.351 0.666 0 C-N-CA 125.838 1.655 . . . . 73.14 108.01 168.237 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 58.2 mt -76.8 138.6 20.28 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 122.955 0.502 . . . . 74.34 109.769 178.371 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 48.2 p -122.87 173.48 7.75 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.588 1.155 . . . . 73.43 109.307 176.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 257' ' ' ILE . . . . . 0.455 HG13 ' H ' ' A' ' 259' ' ' GLU . 27.3 pt -117.82 162.18 30.42 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 123.301 0.64 . . . . 73.4 109.68 175.287 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -66.65 5.98 0.65 Allowed 'Trans proline' 0 N--CA 1.502 1.979 0 C-N-CA 123.263 2.642 . . . . 74.45 115.609 176.316 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 259' ' ' GLU . . . . . 0.477 ' HG3' ' NE2' ' C' ' 228' ' ' GLN . 2.4 mp0 48.52 -97.68 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.692 0.797 . . . . 63.24 109.659 -161.47 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.7 160.95 17.9 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.062 0.945 . . . . 75.12 111.003 -172.598 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 79.7 mt -138.51 157.38 46.29 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.673 0.789 . . . . 55.32 110.446 -175.069 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 78.4 p -102.67 151.19 38.24 Favored Pre-proline 0 CA--C 1.554 1.133 0 N-CA-C 108.394 -0.965 . . . . 44.34 108.394 169.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -25.79 -46.29 0.06 OUTLIER 'Trans proline' 0 C--N 1.394 2.958 1 C-N-CA 126.58 4.854 . . . . 74.33 117.932 -170.581 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -66.64 -62.73 1.3 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 122.935 0.494 . . . . 71.44 111.445 -176.105 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -66.12 -25.81 67.16 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 122.509 0.324 . . . . 64.2 110.5 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 266' ' ' GLU . . . . . 0.404 ' O ' ' HD3' ' A' ' 270' ' ' LYS . 7.8 tp10 -56.75 -52.12 66.22 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 124.179 0.924 . . . . 73.45 109.455 173.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -62.39 -42.42 99.41 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.698 -1.137 . . . . 64.12 111.653 176.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 10.4 mp -58.04 -55.46 34.63 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 122.971 0.508 . . . . 73.14 111.955 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 66.4 m95 -60.12 -39.79 87.46 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.487 0.715 . . . . 75.0 111.647 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 270' ' ' LYS . . . . . 0.569 ' HE2' HG23 ' C' ' 206' ' ' VAL . 1.1 mptm? -64.34 -44.03 92.78 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 123.62 0.575 . . . . 62.43 111.585 177.293 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -63.72 -43.02 97.78 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 122.993 0.517 . . . . 70.22 110.608 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 272' ' ' LEU . . . . . 0.492 ' O ' ' HB2' ' A' ' 276' ' ' TYR . 75.6 mt -56.53 -46.01 80.83 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 124.422 1.076 . . . . 63.4 110.57 174.188 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -74.69 -37.99 62.49 Favored 'General case' 0 C--O 1.244 0.797 0 O-C-N 124.468 1.105 . . . . 64.51 113.63 -171.168 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -77.3 -39.11 49.1 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.072 0.549 . . . . 74.35 109.566 -179.086 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 275' ' ' ALA . . . . . 0.445 ' HB1' ' NH2' ' A' ' 279' ' ' ARG . . . -74.19 -20.49 60.18 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.162 0.585 . . . . 71.44 111.034 174.086 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 276' ' ' TYR . . . . . 0.492 ' HB2' ' O ' ' A' ' 272' ' ' LEU . 14.7 t80 -65.16 -63.63 1.06 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.079 0.951 . . . . 75.02 108.762 172.772 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -64.94 -38.64 91.64 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 114.987 -1.006 . . . . 70.12 110.406 -173.06 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -62.85 -26.15 68.62 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.236 0.614 . . . . 75.41 112.093 176.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 279' ' ' ARG . . . . . 0.445 ' NH2' ' HB1' ' A' ' 275' ' ' ALA . 27.5 mtm180 -117.4 31.2 6.86 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.477 0.711 . . . . 74.13 109.938 179.424 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.393 0 N-CA-C 109.087 -0.708 . . . . 72.21 109.087 171.984 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.481 1.081 0 N-CA-C 109.872 -0.418 . . . . 71.44 109.872 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 57.6 tttp 70.97 135.11 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.931 1.292 . . . . 54.1 113.594 176.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 63.08 30.14 16.21 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 125.62 1.568 . . . . 74.04 112.168 171.563 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 11.9 m -66.63 -34.96 79.04 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.769 0.428 . . . . 52.14 110.448 175.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 1.8 m 69.14 152.03 0.09 Allowed 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 125.593 1.557 . . . . 70.11 112.167 177.092 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.649 HG21 ' HA ' ' A' ' 125' ' ' LEU . 31.4 pt -136.83 171.2 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 N-CA-C 113.044 0.757 . . . . 64.44 113.044 -158.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -146.05 123.58 11.75 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.169 0.988 . . . . 72.01 110.187 -178.204 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 8' ' ' LEU . . . . . 0.538 HD11 ' HB1' ' A' ' 121' ' ' ALA . 36.3 tp -77.75 145.37 36.53 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.119 0.968 . . . . 75.22 110.908 -173.445 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 9' ' ' ALA . . . . . 0.544 ' HB3' ' HB2' ' A' ' 122' ' ' GLU . . . -88.79 -50.39 6.26 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.052 0.541 . . . . 62.4 111.828 178.791 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 10' ' ' LEU . . . . . 0.497 HD13 HE22 ' A' ' 167' ' ' GLN . 86.9 mt 68.0 122.57 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 124.872 1.269 . . . . 74.1 111.283 -166.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 N--CA 1.481 1.078 0 N-CA-C 108.046 -1.094 . . . . 45.35 108.046 171.664 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.879 0 N-CA-C 108.97 -0.752 . . . . 61.34 108.97 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . -162.14 -28.84 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 115.127 -0.942 . . . . 74.4 110.292 175.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 181' ' ' LEU . . . . . 0.573 HD22 ' HB2' ' C' ' 136' ' ' ARG . 29.3 tp -153.45 -68.7 0.15 Allowed 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 107.636 -1.246 . . . . 62.04 107.636 168.149 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 182' ' ' VAL . . . . . . . . . . . . . 62.6 t -76.43 131.81 34.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 108.123 -1.066 . . . . 71.31 108.123 168.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.1 -48.79 74.77 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 123.726 0.641 . . . . 65.24 110.695 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 179.9 -170.44 0.14 Allowed 'General case' 0 N--CA 1.485 1.301 0 O-C-N 124.2 0.938 . . . . 74.15 110.738 173.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 185' ' ' VAL . . . . . 0.507 HG23 ' HA ' ' C' ' 121' ' ' ALA . 1.8 p . . . . . 0 N--CA 1.47 0.548 0 N-CA-C 106.557 -1.645 . . . . 71.33 106.557 160.171 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 238' ' ' THR . . . . . 0.475 HG22 HG23 ' C' ' 219' ' ' VAL . 6.2 m . . . . . 0 CA--C 1.545 0.753 0 N-CA-C 109.946 -0.391 . . . . 71.31 109.946 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -165.63 -98.84 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 123.337 0.655 . . . . 74.42 110.44 171.563 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . 173.32 -148.52 10.36 Favored Glycine 0 C--N 1.35 1.334 0 N-CA-C 111.615 -0.594 . . . . 71.23 111.615 -176.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -86.38 -167.96 2.06 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.516 0.726 . . . . 71.21 111.144 -176.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 242' ' ' TRP . . . . . 0.59 ' HZ3' ' HD3' ' C' ' 231' ' ' ARG . 0.0 OUTLIER 86.59 -26.82 0.08 Allowed 'General case' 0 N--CA 1.504 2.231 0 C-N-CA 127.191 2.197 . . . . 70.32 111.66 175.872 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 243' ' ' GLN . . . . . 0.409 ' H ' ' HG2' ' B' ' 243' ' ' GLN . 0.6 OUTLIER -102.24 120.69 40.89 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 124.054 0.942 . . . . 74.22 110.676 -168.461 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -60.35 -40.73 97.91 Favored Glycine 0 C--N 1.353 1.49 0 N-CA-C 110.458 -1.057 . . . . 63.11 110.458 165.092 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 5.5 ttpp . . . . . 0 N--CA 1.478 0.934 0 C-N-CA 125.148 1.379 . . . . 75.34 112.755 162.928 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.809 0 CA-C-O 120.267 0.079 . . . . 52.01 111.055 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -37.47 95.1 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 125.693 1.597 . . . . 70.52 114.197 -176.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -67.19 107.73 2.44 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 108.288 -1.004 . . . . 63.2 108.288 166.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -77.74 92.73 4.2 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 106.739 -1.578 . . . . 63.22 106.739 171.104 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 7' ' ' TYR . . . . . 0.438 ' CD1' ' HA ' ' C' ' 53' ' ' ALA . 75.8 m-85 -62.73 -25.9 68.42 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 114.51 -1.223 . . . . 73.43 112.128 -172.249 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -64.91 -46.49 81.46 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.382 0.673 . . . . 72.53 110.408 174.077 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.64 -39.44 94.36 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.266 0.626 . . . . 52.31 111.011 178.147 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 66.7 mt -59.75 -41.1 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 123.797 0.686 . . . . 63.34 110.475 175.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 98.0 mt -85.57 -3.55 58.9 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 112.265 0.469 . . . . 45.45 112.265 176.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 61.27 44.6 97.89 Favored Glycine 0 C--N 1.354 1.54 0 N-CA-C 114.063 0.385 . . . . 64.33 114.063 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 11.0 m -133.13 148.56 69.71 Favored Pre-proline 0 N--CA 1.487 1.423 0 C-N-CA 124.795 1.238 . . . . 64.04 109.823 177.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -75.29 161.36 38.03 Favored 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 122.721 2.281 . . . . 74.43 111.844 170.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 -77.07 20.17 0.27 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.806 0.842 . . . . 71.52 112.518 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -119.0 -15.39 9.29 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.243 1.017 . . . . 71.24 109.079 177.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.08 131.98 51.36 Favored 'General case' 0 C--N 1.355 0.828 0 C-N-CA 123.246 0.618 . . . . 71.14 109.595 175.103 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 59.8 p -65.59 161.8 19.57 Favored 'General case' 0 C--O 1.246 0.872 0 C-N-CA 123.047 0.539 . . . . 74.41 109.866 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 19' ' ' GLN . . . . . 0.525 ' HG2' ' HD3' ' C' ' 60' ' ' PRO . 25.1 tp60 -54.26 -38.82 66.25 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.586 0.754 . . . . 74.45 111.978 -173.007 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 20' ' ' GLU . . . . . 0.443 ' O ' ' HG3' ' C' ' 24' ' ' ARG . 0.4 OUTLIER -68.72 -35.6 77.35 Favored 'General case' 0 C--O 1.211 -0.933 0 CA-C-O 119.182 -0.437 . . . . 64.05 111.128 -179.058 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 21' ' ' GLU . . . . . 0.747 ' HG2' HH21 ' C' ' 24' ' ' ARG . 37.4 mt-10 -68.92 -38.11 79.32 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-O 121.006 0.431 . . . . 73.42 110.76 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 66.6 mt -66.15 -38.58 82.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 124.188 0.995 . . . . 61.32 109.889 174.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 23' ' ' LYS . . . . . 0.438 ' O ' ' HD3' ' C' ' 27' ' ' LYS . 6.6 ttpt -71.4 -33.85 69.85 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 114.68 -1.145 . . . . 74.13 109.972 178.707 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 24' ' ' ARG . . . . . 0.747 HH21 ' HG2' ' C' ' 21' ' ' GLU . 40.8 mtm180 -75.84 -24.21 55.8 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.305 0.642 . . . . 73.52 110.478 176.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.67 -43.96 87.73 Favored 'General case' 0 C--N 1.345 0.41 0 O-C-N 123.711 0.632 . . . . 75.32 109.636 170.157 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 26' ' ' TYR . . . . . 0.466 ' HD1' HG22 ' C' ' 50' ' ' ILE . 81.6 t80 -58.01 -52.42 65.58 Favored 'General case' 0 C--N 1.36 1.04 0 O-C-N 123.624 0.578 . . . . 72.31 110.865 171.462 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 27' ' ' LYS . . . . . 0.441 ' HE2' ' HA ' ' C' ' 24' ' ' ARG . 4.8 mppt? -61.0 -31.8 71.41 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 122.878 0.471 . . . . 74.1 111.487 -177.531 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 28' ' ' ARG . . . . . 0.493 HH21 HD21 ' C' ' 29' ' ' LEU . 38.9 ttp180 -62.28 -48.19 81.01 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.908 0.883 . . . . 71.15 109.602 174.251 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 29' ' ' LEU . . . . . 0.721 HD13 HD12 ' C' ' 50' ' ' ILE . 49.9 mt -74.55 -19.09 60.47 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 114.738 -1.119 . . . . 60.22 111.487 178.337 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.11 -22.49 33.37 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.409 0.684 . . . . 75.32 110.197 178.063 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 31' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' C' ' 27' ' ' LYS . 58.6 mtm180 -86.85 -31.78 20.61 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.252 0.621 . . . . 73.5 110.318 170.234 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -70.27 -60.58 2.19 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.827 0.851 . . . . 71.12 109.493 -178.112 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -90.61 24.52 2.63 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.028 0.931 . . . . 70.15 110.934 -177.139 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 34' ' ' HIS . . . . . 0.474 ' NE2' ' HB3' ' C' ' 36' ' ' ASP . 55.0 t60 -55.12 96.42 0.09 OUTLIER Pre-proline 0 N--CA 1.486 1.345 0 C-N-CA 124.963 1.305 . . . . 72.34 112.84 -164.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 35' ' ' PRO . . . . . 0.518 ' O ' ' HG2' ' C' ' 39' ' ' LYS . 57.9 Cg_endo -76.55 -2.24 12.42 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 123.429 2.753 . . . . 71.32 112.758 -167.257 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 36' ' ' ASP . . . . . 0.474 ' HB3' ' NE2' ' C' ' 34' ' ' HIS . 32.7 t70 -75.88 -38.03 58.28 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.949 0.899 . . . . 60.34 110.81 173.492 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 59.6 t -117.32 -52.69 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 122.89 0.476 . . . . 75.33 109.835 -174.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -97.51 79.29 2.73 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.701 0.762 . . . . 54.22 108.945 178.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 39' ' ' LYS . . . . . 0.518 ' HG2' ' O ' ' C' ' 35' ' ' PRO . 9.8 mtmp? -81.14 69.37 7.73 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 115.189 -0.914 . . . . 62.24 109.815 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 40' ' ' SER . . . . . 0.551 ' HB2' ' HB3' ' C' ' 43' ' ' ALA . 49.6 m -92.5 111.66 51.77 Favored Pre-proline 0 CA--C 1.546 0.81 0 CA-C-O 118.317 -0.849 . . . . 74.14 108.99 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -38.93 -61.09 0.42 Allowed 'Trans proline' 0 C--N 1.387 2.596 0 C-N-CA 124.571 3.514 . . . . 63.44 114.905 -174.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -61.18 -33.94 74.27 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.857 0.863 . . . . 65.44 111.397 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 43' ' ' ALA . . . . . 0.551 ' HB3' ' HB2' ' C' ' 40' ' ' SER . . . -77.35 -20.52 54.7 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.248 0.619 . . . . 62.05 110.659 -178.529 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -84.06 -28.44 27.6 Favored 'General case' 0 C--N 1.351 0.659 0 N-CA-C 109.127 -0.694 . . . . 74.04 109.127 176.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -70.62 -42.19 71.24 Favored 'General case' 0 C--O 1.25 1.125 0 C-N-CA 123.676 0.79 . . . . 42.53 109.602 173.237 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 46' ' ' LYS . . . . . 0.523 ' O ' HG12 ' C' ' 50' ' ' ILE . 63.5 mttp -58.12 -45.65 86.96 Favored 'General case' 0 C--N 1.355 0.832 0 CA-C-N 114.789 -1.096 . . . . 72.32 109.429 168.552 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -62.66 -30.31 71.29 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.926 0.89 . . . . 62.23 110.963 -178.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 2.7 mptm? -63.54 -50.37 69.82 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 109.07 -0.715 . . . . 72.04 109.07 171.131 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -67.57 -17.34 64.6 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 112.791 0.663 . . . . 72.33 112.791 176.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 50' ' ' ILE . . . . . 0.721 HD12 HD13 ' C' ' 29' ' ' LEU . 28.2 mm -78.36 -38.03 22.51 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 N-CA-C 108.832 -0.803 . . . . 75.43 108.832 173.067 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 51' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -78.85 -11.87 60.01 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.799 0.84 . . . . 74.04 111.399 174.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 52' ' ' GLU . . . . . 0.448 ' O ' HG23 ' C' ' 56' ' ' VAL . 30.0 tt0 -77.83 -53.07 7.92 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 108.064 -1.088 . . . . 63.42 108.064 169.658 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 53' ' ' ALA . . . . . 0.438 ' HA ' ' CD1' ' C' ' 7' ' ' TYR . . . -57.8 -34.14 69.31 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 114.432 -1.258 . . . . 63.1 111.399 175.315 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 54' ' ' TYR . . . . . 0.467 ' O ' ' HB2' ' C' ' 58' ' ' SER . 22.9 t80 -82.9 -32.45 27.28 Favored 'General case' 0 C--O 1.216 -0.68 0 C-N-CA 123.79 0.836 . . . . 75.01 110.378 177.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.39 -31.66 66.03 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 118.277 0.489 . . . . 60.54 110.537 173.125 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 56' ' ' VAL . . . . . 0.465 HG12 ' HB2' ' C' ' 66' ' ' TYR . 10.1 t -100.06 -21.3 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.245 0 CA-C-N 115.129 -0.941 . . . . 72.43 112.598 -179.233 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 57' ' ' LEU . . . . . 0.547 HD22 ' HG3' ' C' ' 63' ' ' ARG . 71.0 mt -127.4 29.3 5.56 Favored 'General case' 0 N--CA 1.501 2.122 0 CA-C-N 119.424 1.011 . . . . 75.02 112.655 -179.03 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 58' ' ' SER . . . . . 0.467 ' HB2' ' O ' ' C' ' 54' ' ' TYR . 21.4 t -68.62 -60.81 2.15 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.297 0.57 . . . . 62.42 112.221 177.557 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -125.9 158.98 63.8 Favored Pre-proline 0 N--CA 1.481 1.097 0 C-N-CA 124.393 1.077 . . . . 72.03 109.117 -171.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 60' ' ' PRO . . . . . 0.525 ' HD3' ' HG2' ' C' ' 19' ' ' GLN . 10.3 Cg_endo -48.89 -30.46 17.53 Favored 'Trans proline' 0 C--N 1.388 2.631 0 C-N-CA 123.162 2.574 . . . . 33.23 113.299 178.631 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 61' ' ' GLU . . . . . 0.441 ' O ' HG12 ' C' ' 65' ' ' ILE . 18.4 tt0 -50.79 -69.34 0.11 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.306 1.042 . . . . 62.13 110.625 170.555 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -60.22 -44.81 94.86 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-N 114.724 -1.125 . . . . 75.23 111.357 -174.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 63' ' ' ARG . . . . . 0.547 ' HG3' HD22 ' C' ' 57' ' ' LEU . 31.7 ttp-105 -62.77 -46.14 89.41 Favored 'General case' 0 C--N 1.349 0.544 0 CA-C-N 114.865 -1.062 . . . . 64.42 110.595 -174.14 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -72.57 -25.95 61.54 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 123.744 0.652 . . . . 74.15 111.552 -178.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 65' ' ' ILE . . . . . 0.441 HG12 ' O ' ' C' ' 61' ' ' GLU . 46.1 mm -60.13 -46.61 94.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 109.351 -0.611 . . . . 62.34 109.351 168.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 66' ' ' TYR . . . . . 0.465 ' HB2' HG12 ' C' ' 56' ' ' VAL . 18.3 t80 -63.63 -46.26 86.51 Favored 'General case' 0 C--N 1.353 0.723 0 CA-C-N 115.664 -0.698 . . . . 74.22 110.677 176.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -62.44 -33.67 75.28 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.219 0.607 . . . . 73.14 111.461 -176.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 44.5 p -78.14 -20.27 52.41 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.362 -0.381 . . . . 63.2 111.001 175.482 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -75.02 133.65 41.6 Favored 'General case' 0 CA--C 1.556 1.181 0 N-CA-C 108.415 -0.957 . . . . 75.22 108.415 165.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 91.28 15.6 55.25 Favored Glycine 0 N--CA 1.476 1.345 0 N-CA-C 111.225 -0.75 . . . . 62.51 111.225 -167.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 99.9 m -141.27 -60.34 0.49 Allowed 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 103.601 -2.74 . . . . 72.34 103.601 175.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 91.0 m -78.15 139.09 39.0 Favored 'General case' 0 C--O 1.251 1.155 0 N-CA-C 104.268 -2.493 . . . . 73.35 104.268 155.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.38 -45.93 4.34 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.62 0.768 . . . . 73.23 109.659 -172.691 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -73.87 144.32 82.5 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 123.435 0.694 . . . . 53.23 109.979 178.172 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.82 120.78 8.69 Favored 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 122.738 2.292 . . . . 75.14 110.989 173.052 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -54.27 159.59 7.79 Favored 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 123.685 2.924 . . . . 63.14 114.444 -176.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.57 127.75 14.37 Favored 'Trans proline' 0 C--N 1.381 2.242 0 C-N-CA 122.249 1.966 . . . . 51.51 110.839 172.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 78' ' ' PRO . . . . . 0.46 ' HB3' ' HA3' ' C' ' 104' ' ' GLY . 18.1 Cg_endo -59.02 129.91 34.06 Favored 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 122.609 2.206 . . . . 74.44 112.75 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.07 156.02 66.43 Favored 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 122.749 2.299 . . . . 61.04 111.45 174.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_exo -53.78 87.47 0.03 OUTLIER 'Trans proline' 0 C--N 1.385 2.494 0 C-N-CA 123.314 2.676 . . . . 51.5 112.707 176.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 159.55 -45.45 0.43 Allowed Glycine 0 C--N 1.342 0.894 0 CA-C-N 114.673 -1.149 . . . . 75.2 111.179 178.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 109.45 167.87 20.27 Favored Glycine 0 C--N 1.352 1.433 0 C-N-CA 123.669 0.652 . . . . 74.45 111.987 -175.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -78.03 112.15 14.65 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 109.293 -0.632 . . . . 70.14 109.293 176.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -63.56 146.22 54.13 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.808 0.843 . . . . 63.13 112.801 -178.355 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 85' ' ' PHE . . . . . 0.47 ' O ' ' HB3' ' C' ' 171' ' ' PRO . 75.9 m-85 -138.62 71.33 1.39 Allowed 'General case' 0 C--N 1.356 0.878 0 C-N-CA 124.299 1.039 . . . . 74.41 110.207 171.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 37.0 m -51.0 86.75 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 125.05 1.34 . . . . 45.43 112.744 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 75.68 -5.54 37.66 Favored Glycine 0 CA--C 1.535 1.294 0 CA-C-N 116.067 -0.515 . . . . 74.33 113.493 -176.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 88' ' ' PHE . . . . . 0.451 ' HB2' ' HB3' ' C' ' 85' ' ' PHE . 12.8 m-85 -81.19 118.52 22.64 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.829 -0.804 . . . . 74.44 108.829 -171.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -76.86 81.4 3.44 Favored 'General case' 0 C--O 1.243 0.745 0 CA-C-O 121.204 0.526 . . . . 72.23 110.483 -173.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 90' ' ' VAL . . . . . 0.652 HG23 ' HE2' ' C' ' 97' ' ' PHE . 1.5 p -44.41 -40.96 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 125.46 1.504 . . . . 54.41 111.852 175.561 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -48.12 -40.0 22.2 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.716 1.606 . . . . 74.21 112.961 -178.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -85.1 -29.37 24.91 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.583 0.753 . . . . 75.53 112.165 -173.016 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 17.1 m-30 -68.98 170.39 9.9 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 113.143 0.794 . . . . 72.45 113.143 -164.017 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 81.0 p -71.95 172.77 9.37 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 124.77 1.228 . . . . 45.51 113.779 -164.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 95' ' ' GLU . . . . . 0.49 ' O ' ' HG3' ' C' ' 99' ' ' GLU . 4.7 mp0 -71.6 -34.0 69.5 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 115.275 -0.875 . . . . 55.43 110.953 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -61.19 -44.2 97.67 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-O 121.494 0.664 . . . . 65.02 110.33 174.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 97' ' ' PHE . . . . . 0.652 ' HE2' HG23 ' C' ' 90' ' ' VAL . 47.9 t80 -56.93 -43.77 81.8 Favored 'General case' 0 CA--C 1.554 1.103 0 CA-C-N 114.148 -1.387 . . . . 64.25 109.884 172.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -70.6 -18.97 62.88 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.055 0.542 . . . . 51.52 112.459 177.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 99' ' ' GLU . . . . . 0.49 ' HG3' ' O ' ' C' ' 95' ' ' GLU . 43.2 mt-10 -74.27 -55.35 6.13 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.127 0.489 . . . . 74.43 110.015 173.597 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 27.3 tp -74.91 -45.22 44.17 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.819 -1.082 . . . . 73.23 111.643 -170.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -97.24 -19.1 18.82 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.599 0.76 . . . . 73.25 112.257 -175.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -47.42 -57.96 6.93 Favored Glycine 0 CA--C 1.545 1.913 0 CA-C-O 118.947 -0.918 . . . . 54.11 115.119 -178.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -59.07 -9.41 7.97 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 123.788 2.992 . . . . 62.02 114.621 -179.058 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 104' ' ' GLY . . . . . 0.46 ' HA3' ' HB3' ' C' ' 78' ' ' PRO . . . -136.8 34.29 2.23 Favored Glycine 0 C--N 1.351 1.414 0 CA-C-O 119.985 -0.342 . . . . 43.23 113.116 178.24 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 105' ' ' LEU . . . . . 0.414 ' HB3' ' OD1' ' C' ' 169' ' ' ASN . 43.1 mt . . . . . 0 N--CA 1.485 1.282 0 C-N-CA 123.314 0.645 . . . . 73.03 111.474 172.085 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 116' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' C' ' 170' ' ' PRO . . . . . . . . 0 C--O 1.239 0.42 0 CA-C-O 120.399 -0.112 . . . . 45.25 113.102 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 117' ' ' ARG . . . . . 0.557 HH21 ' HB3' ' C' ' 167' ' ' GLN . 69.4 mtm180 -110.41 163.86 13.26 Favored 'General case' 0 C--O 1.265 1.891 0 CA-C-O 122.154 0.978 . . . . 64.44 110.534 -177.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.09 117.74 5.06 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 112.589 -2.096 . . . . 75.42 108.353 165.668 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 119' ' ' LEU . . . . . 0.505 ' HG ' ' HG2' ' C' ' 167' ' ' GLN . 3.3 tt -92.23 116.18 28.73 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 104.59 -2.374 . . . . 75.21 104.59 178.286 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.423 ' HA ' ' O ' ' C' ' 175' ' ' LEU . 63.0 ttt180 -117.98 118.84 33.04 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.35 -0.982 . . . . 72.31 108.35 -164.387 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 121' ' ' ALA . . . . . 0.507 ' HA ' HG23 ' B' ' 185' ' ' VAL . . . -108.58 170.03 8.28 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 113.847 1.055 . . . . 63.21 113.847 -164.544 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -127.79 108.14 10.47 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 114.16 -1.382 . . . . 73.22 110.288 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -139.12 111.68 7.94 Favored Pre-proline 0 N--CA 1.487 1.42 0 CA-C-N 118.535 0.607 . . . . 73.3 112.431 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -65.74 121.59 9.0 Favored 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 122.037 1.824 . . . . 72.51 109.692 162.087 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 125' ' ' LEU . . . . . 0.484 ' O ' ' HA ' ' C' ' 180' ' ' LEU . 12.7 tp -145.56 167.93 21.85 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 107.585 -1.265 . . . . 74.03 107.585 -169.561 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 126' ' ' THR . . . . . . . . . . . . . 14.5 t -128.26 176.99 7.25 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 119.366 0.985 . . . . 61.53 110.911 173.151 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 127' ' ' LEU . . . . . 0.469 HD11 ' H ' ' C' ' 185' ' ' VAL . 6.3 mt -60.73 -43.54 97.76 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.485 1.514 . . . . 62.25 109.696 -177.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -60.96 -39.67 90.43 Favored 'General case' 0 C--O 1.213 -0.836 0 CA-C-N 114.133 -1.394 . . . . 75.24 110.031 179.066 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 129' ' ' GLU . . . . . 0.532 ' HA ' ' HB2' ' C' ' 132' ' ' HIS . 50.3 mm-40 -77.2 -22.85 51.74 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.783 0.833 . . . . 73.53 111.225 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 130' ' ' ALA . . . . . 0.487 ' HB1' ' HA2' ' C' ' 152' ' ' GLY . . . -72.26 -35.26 68.73 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 109.297 -0.631 . . . . 64.34 109.297 175.035 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 131' ' ' PHE . . . . . 0.546 ' HB2' HD13 ' C' ' 215' ' ' LEU . 10.5 t80 -71.09 -43.56 67.47 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 114.131 -1.395 . . . . 75.55 110.855 168.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 132' ' ' HIS . . . . . 0.532 ' HB2' ' HA ' ' C' ' 129' ' ' GLU . 32.4 m170 -75.32 -6.82 51.88 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.854 0.461 . . . . 60.22 110.378 -178.028 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -59.57 77.81 0.01 OUTLIER Glycine 0 C--N 1.356 1.648 0 C-N-CA 123.815 0.721 . . . . 65.31 112.904 168.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . -113.94 -152.61 10.78 Favored Glycine 0 C--N 1.342 0.884 0 N-CA-C 109.417 -1.473 . . . . 53.24 109.417 174.033 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -71.55 92.99 1.17 Allowed 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 108.409 -0.96 . . . . 71.2 108.409 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 136' ' ' ARG . . . . . 0.573 ' HB2' HD22 ' B' ' 181' ' ' LEU . 78.3 mtp180 -139.55 159.48 42.06 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.116 0.966 . . . . 72.12 109.589 -173.564 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 137' ' ' VAL . . . . . . . . . . . . . 93.5 t -70.78 98.87 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.887 0 CA-C-O 121.978 0.894 . . . . 71.12 110.664 -175.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 138' ' ' VAL . . . . . . . . . . . . . 72.9 t -79.17 112.16 16.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 CA-C-N 113.853 -1.521 . . . . 72.14 107.831 169.229 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 139' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -115.69 82.22 1.72 Allowed 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 108.092 -1.077 . . . . 74.31 108.092 -170.293 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 140' ' ' VAL . . . . . 0.503 HG11 HD11 ' C' ' 174' ' ' LEU . 67.4 t -122.86 104.65 14.82 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 C-N-CA 124.292 1.037 . . . . 63.22 110.833 -169.359 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 69.21 15.01 8.64 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 125.145 1.378 . . . . 15.23 113.388 168.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 116.8 -30.15 6.51 Favored Glycine 0 C--N 1.339 0.746 0 N-CA-C 110.987 -0.845 . . . . 45.25 110.987 -175.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 143' ' ' ARG . . . . . 0.489 ' CZ ' ' HB ' ' C' ' 145' ' ' VAL . 13.0 tpt180 -70.73 114.32 8.7 Favored 'General case' 0 C--N 1.361 1.092 0 N-CA-C 109.055 -0.72 . . . . 73.04 109.055 177.005 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 7.5 ttt-85 -114.27 99.26 7.47 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 115.339 -0.846 . . . . 71.51 108.95 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 145' ' ' VAL . . . . . 0.551 HG22 ' HB ' ' C' ' 147' ' ' VAL . 3.1 p -124.85 124.41 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.473 1.109 . . . . 75.03 110.028 -178.199 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 29.2 m -87.13 86.41 7.29 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 108.906 -0.775 . . . . 54.21 108.906 177.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 147' ' ' VAL . . . . . 0.551 ' HB ' HG22 ' C' ' 145' ' ' VAL . 7.3 p -134.81 160.56 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 124.114 0.966 . . . . 72.53 110.59 -169.214 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 28.5 ttm-85 -90.18 104.89 17.41 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 108.11 -1.071 . . . . 74.22 108.11 168.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 149' ' ' ILE . . . . . . . . . . . . . 29.6 pt -69.34 150.73 97.09 Favored Pre-proline 0 CA--C 1.548 0.872 0 CA-C-O 117.755 -1.117 . . . . 71.41 108.438 165.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 150' ' ' PRO . . . . . 0.564 ' HD2' HG22 ' C' ' 161' ' ' VAL . 28.4 Cg_exo -38.68 107.97 0.07 OUTLIER 'Trans proline' 0 C--N 1.393 2.88 0 C-N-CA 123.415 2.743 . . . . 61.44 113.124 178.504 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -69.71 130.66 19.79 Favored 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 122.671 2.247 . . . . 73.2 111.541 -171.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 152' ' ' GLY . . . . . 0.538 ' HA3' HD23 ' C' ' 188' ' ' LEU . . . 91.71 112.01 1.8 Allowed Glycine 0 C--N 1.342 0.905 0 CA-C-N 115.645 -0.707 . . . . 54.32 113.091 -177.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 153' ' ' VAL . . . . . 0.71 HG21 HG21 ' C' ' 178' ' ' VAL . 3.0 m -123.64 177.66 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 C-N-CA 123.745 0.818 . . . . 71.13 109.595 -173.256 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 154' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -135.03 155.48 50.69 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 123.429 0.692 . . . . 75.32 110.775 -178.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 155' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -67.88 102.53 1.27 Allowed 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.911 1.284 . . . . 74.51 112.036 -176.306 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 97.36 3.5 58.66 Favored Glycine 0 C--N 1.348 1.236 0 CA-C-N 115.354 -0.839 . . . . 64.51 113.009 179.038 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 157' ' ' SER . . . . . . . . . . . . . 52.0 m -95.75 169.82 9.74 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 117.205 0.502 . . . . 75.43 111.394 -175.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 158' ' ' VAL . . . . . 0.435 HG12 HG22 ' C' ' 177' ' ' VAL . 27.6 m -105.68 127.87 60.27 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 CA-C-O 121.604 0.716 . . . . 64.44 111.038 178.54 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 159' ' ' ILE . . . . . 0.594 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 15.2 mt -78.07 98.21 2.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 107.995 -1.113 . . . . 52.25 107.995 168.562 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 36.5 ttp180 -78.74 99.64 6.74 Favored 'General case' 0 C--O 1.239 0.51 0 O-C-N 123.794 0.684 . . . . 72.21 109.683 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 161' ' ' VAL . . . . . 0.613 ' HB ' ' HB3' ' C' ' 174' ' ' LEU . 19.3 t -95.99 113.11 61.52 Favored Pre-proline 0 C--O 1.251 1.15 0 N-CA-C 108.223 -1.028 . . . . 75.24 108.223 175.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -53.31 106.95 0.17 Allowed 'Trans proline' 0 C--N 1.381 2.277 0 C-N-CA 123.848 3.032 . . . . 63.42 114.476 -174.384 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 71.44 16.4 75.61 Favored Glycine 0 C--N 1.347 1.189 0 N-CA-C 115.694 1.038 . . . . 53.31 115.694 168.034 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 164' ' ' MET . . . . . 0.435 ' SD ' HG11 ' C' ' 145' ' ' VAL . 37.5 ttp -105.28 21.76 16.58 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 118.143 0.972 . . . . 73.35 110.939 -178.131 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . -78.12 -121.81 0.26 Allowed Glycine 0 C--N 1.35 1.345 0 CA-C-O 119.42 -0.656 . . . . 64.24 112.311 174.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . 150.98 -80.1 0.2 Allowed Glycine 0 C--N 1.356 1.639 0 C-N-CA 118.909 -1.615 . . . . 75.44 114.442 170.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 167' ' ' GLN . . . . . 0.557 ' HB3' HH21 ' C' ' 117' ' ' ARG . 31.6 mm-40 -14.91 101.18 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.491 0 C-N-CA 126.244 1.818 . . . . 64.31 114.043 -161.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . 115.1 143.57 8.11 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 109.078 -1.609 . . . . 13.44 109.078 -162.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 169' ' ' ASN . . . . . 0.455 ' HB3' ' HD3' ' C' ' 170' ' ' PRO . 34.5 t30 -54.76 -57.61 18.36 Favored Pre-proline 0 CA--C 1.572 1.812 0 N-CA-C 114.597 1.332 . . . . 62.44 114.597 -164.041 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 170' ' ' PRO . . . . . 0.455 ' HD3' ' HB3' ' C' ' 169' ' ' ASN . 33.1 Cg_exo -62.18 154.16 64.72 Favored 'Trans proline' 0 C--N 1.393 2.905 0 CA-C-N 121.93 1.725 . . . . 51.41 112.208 172.564 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 171' ' ' PRO . . . . . 0.47 ' HB3' ' O ' ' C' ' 85' ' ' PHE . 22.7 Cg_endo -62.08 129.88 28.75 Favored 'Trans proline' 0 C--N 1.368 1.553 0 C-N-CA 122.234 1.956 . . . . 74.02 112.828 175.183 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -99.39 -175.23 31.37 Favored Glycine 0 N--CA 1.474 1.174 0 N-CA-C 110.51 -1.036 . . . . 74.42 110.51 166.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 173' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -98.91 152.97 19.19 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 117.993 0.896 . . . . 74.51 109.302 178.039 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 174' ' ' LEU . . . . . 0.613 ' HB3' ' HB ' ' C' ' 161' ' ' VAL . 26.5 tp -99.25 121.74 41.47 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 121.946 -0.472 . . . . 75.22 110.585 -176.039 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 175' ' ' LEU . . . . . 0.423 ' O ' ' HA ' ' C' ' 120' ' ' ARG . 81.3 mt -117.74 87.71 2.77 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.281 0.632 . . . . 71.32 109.9 176.574 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 176' ' ' LEU . . . . . 0.594 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 48.6 mt -76.22 108.46 9.17 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 116.232 -0.44 . . . . 43.02 109.949 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 177' ' ' VAL . . . . . 0.435 HG22 HG12 ' C' ' 158' ' ' VAL . 61.5 t -81.82 106.46 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 N-CA-C 108.256 -1.016 . . . . 74.43 108.256 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 178' ' ' VAL . . . . . 0.71 HG21 HG21 ' C' ' 153' ' ' VAL . 4.0 p -95.64 138.83 20.24 Favored 'Isoleucine or valine' 0 C--O 1.242 0.69 0 CA-C-N 114.344 -1.298 . . . . 74.01 110.344 -177.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 179' ' ' ARG . . . . . . . . . . . . . 52.4 mmm-85 -121.68 109.9 15.31 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 107.73 -1.211 . . . . 72.33 107.73 175.383 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 180' ' ' LEU . . . . . 0.484 ' HA ' ' O ' ' C' ' 125' ' ' LEU . 87.6 mt -71.11 147.87 48.02 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.199 0.6 . . . . 70.51 111.843 -176.014 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 181' ' ' LEU . . . . . . . . . . . . . 30.5 mt -62.01 167.83 4.42 Favored Pre-proline 0 CA--C 1.559 1.316 0 C-N-CA 124.892 1.277 . . . . 74.2 112.106 -179.044 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -42.43 -1.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.398 3.157 1 C-N-CA 125.364 4.043 . . . . 64.12 118.557 175.458 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 183' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -127.2 81.2 70.42 Favored Pre-proline 0 CA--C 1.562 1.438 0 CA-C-N 118.971 0.805 . . . . 62.13 109.792 166.017 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 184' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -85.51 69.6 5.23 Favored 'Trans proline' 0 C--N 1.371 1.713 0 C-N-CA 123.628 2.886 . . . . 71.54 110.485 174.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 185' ' ' VAL . . . . . 0.469 ' H ' HD11 ' C' ' 127' ' ' LEU . 3.9 t -89.89 -42.37 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 109.843 -0.429 . . . . 72.23 109.843 -165.297 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 186' ' ' PHE . . . . . 0.598 ' HB3' HD22 ' C' ' 193' ' ' LEU . 20.9 m-85 -99.38 116.05 30.65 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.369 0.604 . . . . 61.44 112.425 -170.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 187' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -102.51 101.77 11.99 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.312 1.445 . . . . 75.14 107.339 171.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 188' ' ' LEU . . . . . 0.538 HD23 ' HA3' ' C' ' 152' ' ' GLY . 57.8 tp -92.55 141.16 28.8 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 113.301 0.852 . . . . 74.14 113.301 -169.495 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -125.23 101.25 6.9 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 107.857 -1.164 . . . . 71.33 107.857 160.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 72.2 -81.12 0.59 Allowed Glycine 0 C--N 1.353 1.504 0 CA-C-N 115.18 -0.918 . . . . 74.2 113.51 176.336 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 191' ' ' GLN . . . . . 0.584 ' HA ' ' HB2' ' C' ' 240' ' ' PHE . 69.6 mt-30 -132.64 -9.94 3.16 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.318 0.647 . . . . 60.21 111.746 178.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -105.49 115.38 30.16 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 121.23 0.538 . . . . 65.13 110.587 -176.22 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 193' ' ' LEU . . . . . 0.598 HD22 ' HB3' ' C' ' 186' ' ' PHE . 72.2 mt -86.0 152.27 23.06 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.932 1.293 . . . . 52.2 111.132 -178.061 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 194' ' ' TYR . . . . . 0.47 ' O ' ' HA ' ' C' ' 186' ' ' PHE . 49.7 t80 -111.98 148.96 32.68 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 107.25 -1.389 . . . . 75.43 107.25 162.211 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 195' ' ' ALA . . . . . 0.42 ' HA ' ' O ' ' C' ' 185' ' ' VAL . . . -154.42 -176.95 6.14 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.078 0.551 . . . . 65.11 111.177 -177.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 40.2 m -128.36 139.05 52.59 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.049 -0.978 . . . . 51.32 108.893 168.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 197' ' ' LEU . . . . . 0.431 HD13 HD22 ' C' ' 251' ' ' LEU . 35.9 tp -115.53 143.46 45.28 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.522 1.129 . . . . 73.5 108.473 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -113.04 102.1 10.09 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.388 -0.597 . . . . 44.52 109.388 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 199' ' ' VAL . . . . . 0.605 ' HA ' HG11 ' C' ' 210' ' ' VAL . 95.2 t -108.08 119.36 50.17 Favored Pre-proline 0 N--CA 1.473 0.698 0 C-N-CA 123.901 0.88 . . . . 61.21 109.005 176.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 200' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.94 149.54 65.91 Favored 'Trans proline' 0 C--N 1.371 1.751 0 C-N-CA 121.858 1.705 . . . . 71.34 110.934 175.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 201' ' ' ALA . . . . . . . . . . . . . . . -56.02 -43.44 99.23 Favored Pre-proline 0 CA--C 1.553 1.093 0 N-CA-C 114.093 1.145 . . . . 74.35 114.093 -174.117 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 202' ' ' PRO . . . . . 0.427 ' O ' HG12 ' C' ' 206' ' ' VAL . 77.0 Cg_exo -54.18 -53.44 6.31 Favored 'Trans proline' 0 C--N 1.398 3.156 0 C-N-CA 121.752 1.635 . . . . 63.15 112.286 175.526 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 203' ' ' ILE . . . . . . . . . . . . . 41.0 mt -62.73 -32.99 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 124.554 1.142 . . . . 63.4 111.209 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.96 -43.9 81.92 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.756 0.822 . . . . 75.02 112.013 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 205' ' ' VAL . . . . . . . . . . . . . 87.9 t -71.7 -47.95 54.38 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 123.256 0.622 . . . . 63.41 111.199 -179.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 206' ' ' VAL . . . . . 0.569 HG23 ' HE2' ' A' ' 270' ' ' LYS . 14.7 p -80.1 -34.74 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 112.761 0.652 . . . . 52.12 112.761 -171.556 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 90.57 104.5 1.25 Allowed Glycine 0 C--N 1.343 0.92 0 N-CA-C 111.069 -0.812 . . . . 63.21 111.069 -167.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -143.44 -126.71 2.03 Favored Glycine 0 C--N 1.343 0.927 0 N-CA-C 111.679 -0.568 . . . . 51.32 111.679 -176.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 209' ' ' LYS . . . . . 0.478 ' HG2' ' HG2' ' C' ' 220' ' ' GLU . 34.1 ttmt -157.21 137.18 12.53 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 117.633 0.717 . . . . 72.12 110.85 -176.508 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 210' ' ' VAL . . . . . 0.605 HG11 ' HA ' ' C' ' 199' ' ' VAL . 23.4 m -129.95 177.03 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 125.501 1.52 . . . . 62.05 109.526 174.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 211' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.46 149.99 28.76 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 118.436 0.562 . . . . 72.44 111.204 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -129.5 118.55 22.26 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 107.45 -1.315 . . . . 74.43 107.45 166.182 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 213' ' ' MET . . . . . . . . . . . . . 1.4 tmm? -73.82 117.79 16.02 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.344 -0.984 . . . . 63.12 108.344 -179.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 214' ' ' THR . . . . . 0.429 ' OG1' HG12 ' C' ' 219' ' ' VAL . 0.2 OUTLIER -122.8 175.76 6.36 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 119.014 0.824 . . . . 54.24 112.095 -173.521 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 215' ' ' LEU . . . . . 0.546 HD13 ' HB2' ' C' ' 131' ' ' PHE . 41.7 mt -75.82 -29.8 58.78 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.459 1.503 . . . . 44.41 112.012 -171.717 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -87.11 3.28 46.86 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 114.803 -1.09 . . . . 71.0 110.272 176.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 118.26 -178.22 16.75 Favored Glycine 0 C--N 1.348 1.208 0 N-CA-C 110.433 -1.067 . . . . 64.11 110.433 -172.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -75.26 125.2 9.0 Favored 'Trans proline' 0 CA--C 1.554 1.477 0 C-N-CA 121.954 1.769 . . . . 52.13 111.97 178.463 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 219' ' ' VAL . . . . . 0.475 HG23 HG22 ' B' ' 238' ' ' THR . 14.0 p -100.56 157.51 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 N-CA-C 106.865 -1.531 . . . . 52.53 106.865 171.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 220' ' ' GLU . . . . . 0.478 ' HG2' ' HG2' ' C' ' 209' ' ' LYS . 16.5 tt0 -126.63 108.33 11.01 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.859 -0.793 . . . . 72.32 108.859 -177.646 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 221' ' ' VAL . . . . . 0.423 HG22 HD21 ' C' ' 235' ' ' LEU . 32.1 t -68.9 123.99 23.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 125.858 1.663 . . . . 74.03 111.2 -174.55 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -84.67 108.49 17.42 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 109.413 -0.588 . . . . 73.3 109.413 172.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 61.1 t -84.25 127.64 65.54 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 123.744 0.818 . . . . 73.11 110.508 -176.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 224' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -79.76 161.83 24.33 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 123.233 2.622 . . . . 54.33 111.082 168.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -63.12 159.05 40.7 Favored 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 122.427 2.084 . . . . 74.0 113.483 177.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 226' ' ' ARG . . . . . 0.444 ' HD2' ' O ' ' A' ' 259' ' ' GLU . 9.5 mmt180 55.3 63.0 2.24 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.514 1.526 . . . . 70.15 111.894 177.078 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 227' ' ' THR . . . . . . . . . . . . . 52.4 m -96.92 128.93 44.36 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 123.815 0.846 . . . . 70.3 110.97 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 228' ' ' GLN . . . . . 0.477 ' NE2' ' HG3' ' A' ' 259' ' ' GLU . 27.8 mp0 -105.23 147.67 27.8 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 124.545 1.138 . . . . 74.32 111.893 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -73.28 123.4 23.65 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 115.43 -0.805 . . . . 62.12 109.264 177.107 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 116.12 -7.41 18.99 Favored Glycine 0 C--N 1.337 0.599 0 O-C-N 123.522 0.514 . . . . 62.04 112.064 -176.437 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 231' ' ' ARG . . . . . 0.59 ' HD3' ' HZ3' ' B' ' 242' ' ' TRP . 36.0 mtt180 -63.02 169.57 3.27 Favored 'General case' 0 C--N 1.354 0.79 0 CA-C-N 116.846 0.323 . . . . 74.12 110.925 171.072 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 232' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' C' ' 251' ' ' LEU . 3.7 ttmp? -139.29 147.06 41.13 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.567 -0.531 . . . . 71.45 109.567 176.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 233' ' ' LEU . . . . . 0.468 ' O ' ' HA ' ' C' ' 250' ' ' TYR . 1.7 tt -133.01 125.01 28.77 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.693 0.797 . . . . 74.21 109.308 -166.73 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -93.19 104.22 16.43 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-O 121.065 0.459 . . . . 72.34 110.614 170.12 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 235' ' ' LEU . . . . . 0.423 HD21 HG22 ' C' ' 221' ' ' VAL . 75.8 mt -85.11 123.88 31.14 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.391 -0.966 . . . . 73.43 108.391 166.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -85.32 131.75 34.36 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 123.349 0.66 . . . . 71.55 111.541 -171.012 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 80.83 -1.28 84.45 Favored Glycine 0 C--N 1.351 1.402 0 O-C-N 124.033 0.833 . . . . 71.42 113.687 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 238' ' ' LYS . . . . . 0.405 ' HG3' ' HB3' ' C' ' 235' ' ' LEU . 14.0 mmtm -95.11 9.05 41.03 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.19 0.996 . . . . 72.03 112.019 -172.568 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -86.29 -133.01 3.27 Favored Glycine 0 C--N 1.346 1.085 0 N-CA-C 111.723 -0.551 . . . . 31.21 111.723 172.577 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 240' ' ' PHE . . . . . 0.584 ' HB2' ' HA ' ' C' ' 191' ' ' GLN . 1.9 m-85 -103.37 128.45 27.48 Favored Pre-proline 0 N--CA 1.47 0.558 0 C-N-CA 123.105 0.562 . . . . 75.14 110.132 177.452 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 241' ' ' PRO . . . . . 0.454 ' HA ' ' HG2' ' C' ' 246' ' ' ARG . 31.4 Cg_exo -61.98 105.21 0.37 Allowed 'Trans proline' 0 C--N 1.37 1.688 0 C-N-CA 123.405 2.736 . . . . 70.21 112.916 173.115 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -75.67 173.16 53.58 Favored Glycine 0 CA--C 1.531 1.081 0 CA-C-N 115.195 -0.911 . . . . 70.14 112.798 174.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -64.86 -17.17 58.69 Favored 'Trans proline' 0 C--N 1.367 1.545 0 C-N-CA 123.184 2.589 . . . . 71.42 113.955 -170.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -130.84 1.07 4.34 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.631 0.773 . . . . 71.42 111.907 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . -173.19 -136.66 2.22 Favored Glycine 0 C--N 1.35 1.349 0 CA-C-O 119.648 -0.529 . . . . 51.32 113.09 -178.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 246' ' ' ARG . . . . . 0.454 ' HG2' ' HA ' ' C' ' 241' ' ' PRO . 77.8 mtm180 -150.04 165.06 33.89 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.826 0.851 . . . . 61.31 110.891 -176.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -102.35 -166.66 26.63 Favored Glycine 0 C--N 1.35 1.322 0 CA-C-N 114.801 -1.091 . . . . 63.23 111.951 174.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -129.44 164.12 24.36 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 121.114 0.483 . . . . 73.54 110.359 -171.269 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 249' ' ' LEU . . . . . 0.413 HD23 HD12 ' C' ' 235' ' ' LEU . 17.7 tp -120.18 127.62 52.63 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.167 0.987 . . . . 74.23 109.401 -174.627 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 250' ' ' TYR . . . . . 0.468 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 79.0 m-85 -117.24 100.78 7.93 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.704 0.802 . . . . 71.43 110.323 -177.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 251' ' ' LEU . . . . . 0.447 ' O ' ' HA ' ' C' ' 232' ' ' LYS . 0.6 OUTLIER -100.97 134.29 44.19 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 109.932 -0.395 . . . . 64.53 109.932 -176.133 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -76.68 107.73 9.19 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.145 -1.057 . . . . 73.41 108.145 168.02 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 253' ' ' VAL . . . . . . . . . . . . . 46.2 t -75.07 113.78 14.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 115.199 -0.91 . . . . 73.5 110.2 -176.482 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 254' ' ' ARG . . . . . . . . . . . . . 39.1 mtm180 -97.13 155.46 16.81 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.297 0.639 . . . . 74.13 110.882 177.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 255' ' ' ILE . . . . . . . . . . . . . 36.9 mm -101.56 124.88 55.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 114.764 -1.107 . . . . 75.24 108.052 166.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 256' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.07 175.97 8.46 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.138 1.375 . . . . 53.32 108.536 -178.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 35.4 pt -131.16 147.88 67.99 Favored Pre-proline 0 N--CA 1.484 1.243 0 C-N-CA 123.491 0.716 . . . . 64.54 110.047 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -62.56 -12.89 30.3 Favored 'Trans proline' 0 C--N 1.377 2.07 0 C-N-CA 122.862 2.375 . . . . 73.21 113.858 -172.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 54.24 -67.58 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 125.481 1.512 . . . . 72.3 112.194 -164.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 8.0 ppt_? -60.07 132.7 54.76 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.264 0.626 . . . . 73.41 110.433 174.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 261' ' ' LEU . . . . . . . . . . . . . 92.4 mt -139.9 147.86 41.2 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.728 0.811 . . . . 71.21 109.978 -174.317 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 74.4 p -81.89 160.45 63.56 Favored Pre-proline 0 CA--C 1.553 1.084 0 N-CA-C 107.97 -1.122 . . . . 61.23 107.97 168.371 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -45.84 -44.08 18.67 Favored 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 122.782 2.322 . . . . 74.2 112.538 172.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -60.97 -54.18 48.14 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-N 114.18 -1.373 . . . . 71.04 111.514 176.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -50.02 -58.45 5.46 Favored 'General case' 0 C--N 1.359 0.994 0 O-C-N 124.284 0.99 . . . . 65.11 109.992 -177.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 266' ' ' GLU . . . . . 0.468 ' O ' ' HG2' ' C' ' 270' ' ' LYS . 26.8 tt0 -61.34 -38.21 86.09 Favored 'General case' 0 C--N 1.349 0.574 0 CA-C-N 114.719 -1.128 . . . . 64.21 111.336 -175.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -57.28 -46.43 83.11 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.201 0.6 . . . . 70.32 112.351 177.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 268' ' ' LEU . . . . . 0.477 ' HB2' HD21 ' A' ' 272' ' ' LEU . 10.4 mp -66.15 -39.97 90.21 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 116.407 -0.36 . . . . 52.44 110.89 177.437 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -60.44 -36.0 77.17 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 123.266 0.354 . . . . 61.11 111.277 174.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 270' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' C' ' 266' ' ' GLU . 34.2 mmtp -64.08 -45.94 86.49 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.397 0.679 . . . . 75.43 110.439 178.707 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -56.29 -47.42 78.69 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 124.036 0.835 . . . . 75.33 111.577 176.02 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 91.3 mt -61.42 -42.09 98.19 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 114.834 -1.075 . . . . 74.33 110.803 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -61.47 -40.4 94.39 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.373 0.669 . . . . 34.13 111.046 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -68.16 -34.06 75.62 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.715 0.806 . . . . 63.21 111.634 177.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -62.67 -31.43 72.32 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 115.838 -0.619 . . . . 70.04 110.331 172.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 276' ' ' TYR . . . . . 0.485 ' HB3' HD11 ' A' ' 203' ' ' ILE . 53.6 m-85 -79.82 -30.99 40.61 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.084 0.554 . . . . 75.52 112.437 171.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 19.0 m-30 -68.11 -24.23 65.0 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 118.517 0.599 . . . . 44.24 110.205 178.406 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -61.32 -8.3 3.74 Favored 'General case' 0 CA--C 1.559 1.326 0 C-N-CA 124.193 0.997 . . . . 55.2 113.425 172.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 279' ' ' ARG . . . . . . . . . . . . . 81.3 mtt180 -73.59 -24.07 60.01 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 122.739 0.416 . . . . 71.52 112.005 174.343 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.556 1.186 0 O-C-N 124.417 1.073 . . . . 75.14 112.781 -167.514 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp . . . . . 0 CA--C 1.553 1.07 0 N-CA-C 113.789 1.033 . . . . 62.43 113.789 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.417 ' HB3' HD11 ' A' ' 10' ' ' ILE . 51.3 mtmt -87.96 128.18 35.38 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 108.565 -0.902 . . . . 74.32 108.565 169.328 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.492 ' HA ' ' OH ' ' A' ' 66' ' ' TYR . 10.7 t70 -76.48 105.81 7.75 Favored 'General case' 0 C--N 1.347 0.491 0 N-CA-C 109.187 -0.672 . . . . 61.41 109.187 -177.589 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -68.44 -33.31 73.98 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.692 0.797 . . . . 73.34 112.531 -170.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -64.12 -45.62 87.77 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 109.634 -0.506 . . . . 73.33 109.634 174.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.48 -42.1 95.59 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.632 -0.713 . . . . 60.32 111.375 178.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.417 HD11 ' HB3' ' A' ' 5' ' ' LYS . 81.4 mt -58.79 -42.22 84.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 123.676 0.79 . . . . 74.23 110.231 176.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.2 mt -76.14 -11.81 60.0 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 112.912 0.708 . . . . 51.33 112.912 178.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.56 35.09 56.12 Favored Glycine 0 C--N 1.351 1.385 0 O-C-N 122.972 0.17 . . . . 53.33 112.709 -178.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.5 m -127.1 154.5 76.67 Favored Pre-proline 0 CA--C 1.552 1.028 0 C-N-CA 124.916 1.286 . . . . 71.43 109.608 178.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -74.57 168.56 24.52 Favored 'Trans proline' 0 C--N 1.374 1.914 0 C-N-CA 122.282 1.988 . . . . 50.12 112.25 177.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 83.7 mtt180 -75.12 17.36 0.24 Allowed 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 113.142 0.793 . . . . 75.43 113.142 -178.169 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -124.78 15.42 8.67 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.101 0.96 . . . . 64.11 108.974 173.5 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.11 112.08 2.84 Favored 'General case' 0 C--N 1.349 0.566 0 CA-C-N 115.069 -0.969 . . . . 64.31 110.437 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 62.1 p -72.31 169.76 15.57 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.59 0.756 . . . . 71.11 109.708 176.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -54.03 -41.06 67.62 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.954 0.902 . . . . 64.21 112.07 -177.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -65.69 -41.28 92.6 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.187 0.595 . . . . 72.43 110.598 -177.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -69.29 -40.81 77.51 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.36 0.664 . . . . 64.03 111.014 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.554 HD13 ' HB3' ' A' ' 57' ' ' LEU . 60.9 mt -68.68 -32.86 56.74 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 C-N-CA 124.271 1.028 . . . . 73.31 110.721 178.655 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp -73.49 -37.88 65.57 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.177 0.991 . . . . 71.24 110.341 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -75.72 -29.25 58.86 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.044 0.538 . . . . 54.12 110.909 175.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.87 -33.85 71.01 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.351 0.66 . . . . 64.0 110.073 174.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -64.96 -53.05 52.36 Favored 'General case' 0 C--O 1.201 -1.466 0 CA-C-N 114.916 -1.038 . . . . 73.1 109.369 173.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -54.08 -40.14 66.96 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.643 0.777 . . . . 74.22 111.703 178.072 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.419 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 61.0 ttt180 -55.08 -68.19 0.21 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.174 1.39 . . . . 71.15 110.79 177.105 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.745 ' HB3' HD13 ' A' ' 50' ' ' ILE . 96.2 mt -74.43 -16.71 60.86 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.411 -0.813 . . . . 74.11 111.745 -174.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.21 -56.71 8.75 Favored 'General case' 0 C--O 1.204 -1.306 0 N-CA-C 108.177 -1.046 . . . . 63.3 108.177 174.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 69.2 mtp180 -55.22 -51.88 65.17 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 124.127 0.892 . . . . 72.33 110.768 177.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.419 ' HG2' ' O ' ' A' ' 28' ' ' ARG . 14.5 mm100 -54.28 -47.13 72.68 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 124.303 1.002 . . . . 63.33 111.728 -178.333 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.404 ' HE2' HD22 ' A' ' 29' ' ' LEU . 27.7 m-85 -117.82 29.54 7.77 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.36 0.664 . . . . 63.25 111.775 -168.481 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -75.84 111.79 16.56 Favored Pre-proline 0 N--CA 1.485 1.281 0 CA-C-O 117.795 -1.098 . . . . 63.41 109.705 -179.026 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.4 -26.86 83.71 Favored 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 122.516 2.144 . . . . 74.13 111.759 176.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -59.81 -37.39 79.04 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.126 1.37 . . . . 72.45 111.572 175.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 73.5 t -101.97 -58.66 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 CA-C-O 121.478 0.656 . . . . 65.53 109.74 -178.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -97.0 98.96 10.51 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.122 1.369 . . . . 61.35 109.739 -177.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -74.36 82.76 1.91 Allowed 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.953 -0.758 . . . . 73.11 108.953 177.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.412 ' O ' ' HG3' ' A' ' 44' ' ' GLU . 53.7 m -139.64 113.52 7.87 Favored Pre-proline 0 N--CA 1.474 0.753 0 CA-C-O 118.492 -0.765 . . . . 54.41 109.281 177.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -48.19 -40.95 34.97 Favored 'Trans proline' 0 C--N 1.385 2.48 0 C-N-CA 123.606 2.87 . . . . 72.23 113.437 178.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -55.15 -47.03 75.68 Favored 'General case' 0 C--O 1.248 0.999 0 C-N-CA 124.578 1.151 . . . . 64.43 110.696 175.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.64 -23.04 63.43 Favored 'General case' 0 C--N 1.354 0.787 0 CA-C-N 115.077 -0.965 . . . . 72.14 110.782 -178.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.526 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 33.5 mt-10 -76.31 -49.11 17.8 Favored 'General case' 0 C--N 1.358 0.957 0 O-C-N 123.511 0.507 . . . . 62.01 109.781 -176.533 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -67.95 -39.68 83.38 Favored 'General case' 0 C--O 1.251 1.166 0 O-C-N 123.801 0.688 . . . . 62.44 110.927 -179.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 42.8 mttp -56.94 -48.95 77.1 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 116.168 -0.469 . . . . 74.03 110.177 170.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -59.71 -32.91 70.97 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.101 0.96 . . . . 73.24 110.84 179.478 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.526 ' HG2' ' O ' ' A' ' 44' ' ' GLU . 33.5 mmtp -66.66 -43.41 84.63 Favored 'General case' 0 C--N 1.349 0.548 0 CA-C-O 119.245 -0.407 . . . . 75.14 110.662 177.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -68.17 -26.56 65.81 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 123.706 0.629 . . . . 71.44 112.278 176.22 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.745 HD13 ' HB3' ' A' ' 29' ' ' LEU . 59.5 mt -76.76 -35.2 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 124.106 0.962 . . . . 70.53 110.242 175.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -79.3 -21.61 45.73 Favored 'General case' 0 C--O 1.212 -0.891 0 C-N-CA 123.889 0.875 . . . . 73.43 110.621 175.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -77.27 -45.64 25.71 Favored 'General case' 0 C--O 1.247 0.924 0 C-N-CA 124.977 1.311 . . . . 63.42 108.726 176.088 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.78 -47.45 82.51 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-N 113.672 -1.604 . . . . 65.45 110.184 174.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.488 ' HD2' ' HZ ' ' A' ' 88' ' ' PHE . 16.6 t80 -76.48 -23.27 53.8 Favored 'General case' 0 C--O 1.207 -1.166 0 CA-C-N 115.435 -0.802 . . . . 72.32 110.713 177.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.408 ' HB1' ' HD2' ' A' ' 85' ' ' PHE . . . -60.97 -36.16 78.69 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 118.833 0.742 . . . . 53.01 110.875 175.634 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.532 HG11 ' HB2' ' A' ' 66' ' ' TYR . 19.2 t -76.04 -57.66 5.79 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 CA-C-N 115.363 -0.835 . . . . 74.52 110.099 171.584 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.554 ' HB3' HD13 ' A' ' 22' ' ' ILE . 49.2 mt -87.31 12.0 12.99 Favored 'General case' 0 CA--C 1.561 1.397 0 CA-C-N 115.003 -0.999 . . . . 62.04 112.964 -164.664 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.463 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 26.0 t -69.06 -38.61 79.17 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 123.933 0.893 . . . . 74.34 111.228 176.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.481 ' HB2' ' HD3' ' A' ' 62' ' ' LYS . 8.8 m-20 -124.6 142.07 39.57 Favored Pre-proline 0 N--CA 1.475 0.813 0 N-CA-C 108.96 -0.755 . . . . 74.34 108.96 -177.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.423 ' O ' ' HG2' ' A' ' 64' ' ' ARG . 40.0 Cg_exo -58.04 -27.45 79.57 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 122.972 2.448 . . . . 72.41 113.115 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -59.43 -58.72 7.39 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.012 0.925 . . . . 72.3 110.817 176.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.481 ' HD3' ' HB2' ' A' ' 59' ' ' ASP . 20.8 mtpt -73.07 -29.56 63.04 Favored 'General case' 0 C--O 1.249 1.078 0 CA-C-N 114.53 -1.214 . . . . 74.54 111.029 -175.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.432 ' HG3' HD22 ' A' ' 57' ' ' LEU . 61.6 ttt-85 -60.05 -43.92 95.05 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.204 -0.907 . . . . 74.11 109.462 172.215 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.423 ' HG2' ' O ' ' A' ' 60' ' ' PRO . 22.8 mmt180 -68.93 -31.34 70.17 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 123.736 0.648 . . . . 74.25 112.029 177.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.448 HD12 ' HA ' ' A' ' 62' ' ' LYS . 87.3 mt -54.38 -46.5 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 CA-C-O 121.255 0.55 . . . . 64.42 109.653 169.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.532 ' HB2' HG11 ' A' ' 56' ' ' VAL . 7.7 t80 -63.82 -49.99 70.7 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 115.532 -0.758 . . . . 75.4 111.377 175.6 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -57.68 -36.07 71.43 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.997 0.919 . . . . 64.04 111.323 -176.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 60.8 p -79.31 -28.08 42.18 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 119.054 -0.498 . . . . 75.13 110.922 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -67.88 102.78 1.32 Allowed 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 109.455 -0.572 . . . . 63.45 109.455 176.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 119.68 17.63 4.64 Favored Glycine 0 N--CA 1.473 1.124 0 C-N-CA 124.053 0.835 . . . . 52.54 111.346 -170.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 67.8 m -150.61 -55.75 0.16 Allowed 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 104.208 -2.516 . . . . 71.23 104.208 177.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 34.0 m -78.98 138.45 38.06 Favored 'General case' 0 C--O 1.251 1.146 0 N-CA-C 104.466 -2.42 . . . . 74.23 104.466 156.095 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.75 -31.58 12.17 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.015 0.526 . . . . 74.04 110.122 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.72 152.15 87.04 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 123.923 0.889 . . . . 75.1 110.314 175.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -62.32 116.58 3.59 Favored 'Trans proline' 0 C--N 1.375 1.934 0 C-N-CA 122.262 1.975 . . . . 75.41 109.952 168.05 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -51.02 144.99 26.33 Favored 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 123.653 2.902 . . . . 74.25 114.07 -177.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.438 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 11.0 Cg_endo -50.54 124.46 13.36 Favored 'Trans proline' 0 C--N 1.389 2.705 0 C-N-CA 123.828 3.019 . . . . 62.44 113.279 -174.504 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 77' ' ' PRO . 25.4 Cg_exo -63.87 135.33 47.59 Favored 'Trans proline' 0 C--N 1.379 2.152 0 C-N-CA 122.627 2.218 . . . . 43.51 112.227 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.402 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 85.3 Cg_exo -51.16 149.91 15.07 Favored 'Trans proline' 0 C--N 1.378 2.091 0 C-N-CA 122.932 2.422 . . . . 71.05 112.281 168.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 79' ' ' PRO . 38.9 Cg_exo -61.3 85.23 0.09 OUTLIER 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 123.183 2.589 . . . . 51.35 113.266 -175.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 150.03 -34.29 1.02 Allowed Glycine 0 N--CA 1.466 0.674 0 N-CA-C 109.963 -1.255 . . . . 62.41 109.963 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 140.76 -152.73 23.27 Favored Glycine 0 C--N 1.35 1.32 0 C-N-CA 124.151 0.882 . . . . 53.03 110.955 175.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -99.01 113.22 25.29 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.152 0.981 . . . . 74.41 108.897 175.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -55.1 141.76 33.32 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.638 1.175 . . . . 71.31 111.47 174.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.429 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 55.8 m-85 -140.58 77.99 1.63 Allowed 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 124.429 1.092 . . . . 70.22 110.215 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.592 ' HA ' ' HA3' ' A' ' 163' ' ' GLY . 1.7 m -45.62 82.86 0.0 OUTLIER 'General case' 0 CA--C 1.561 1.392 0 C-N-CA 125.892 1.677 . . . . 74.44 113.225 -177.359 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 62.4 28.48 71.15 Favored Glycine 0 C--N 1.349 1.282 0 CA-C-N 116.044 -0.525 . . . . 70.11 114.306 -176.327 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.488 ' HZ ' ' HD2' ' A' ' 54' ' ' TYR . 30.1 m-85 -112.23 117.66 33.16 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.034 0.534 . . . . 72.34 110.031 -176.257 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.494 ' HA ' ' HB3' ' A' ' 170' ' ' PRO . 5.7 m-20 -82.89 74.75 9.83 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 122.405 1.097 . . . . 71.44 110.225 178.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.512 HG21 HD22 ' A' ' 105' ' ' LEU . 1.6 p -50.13 -30.0 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 126.613 1.965 . . . . 75.21 113.11 171.292 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -63.59 -4.99 3.33 Favored 'General case' 0 CA--C 1.566 1.595 0 C-N-CA 124.651 1.18 . . . . 75.33 111.989 177.046 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -119.03 -15.49 9.27 Favored 'General case' 0 CA--C 1.562 1.433 0 C-N-CA 124.652 1.181 . . . . 45.35 111.559 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 18.7 m-30 -74.94 -170.06 1.03 Allowed 'General case' 0 N--CA 1.503 2.212 0 C-N-CA 123.75 0.82 . . . . 71.01 112.625 -173.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 82.5 p -77.76 167.3 21.77 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 113.693 0.997 . . . . 74.5 113.693 -169.008 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.02 -49.02 77.72 Favored 'General case' 0 C--N 1.365 1.276 0 CA-C-N 115.455 -0.793 . . . . 74.31 111.665 179.165 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -56.35 -40.87 75.2 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.592 0.757 . . . . 75.03 110.258 -177.12 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -65.27 -45.88 82.74 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 114.606 -1.179 . . . . 63.23 110.228 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.503 ' HA ' HD11 ' A' ' 105' ' ' LEU . 41.1 mt-30 -80.82 1.73 29.35 Favored 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 114.994 -1.003 . . . . 73.05 111.868 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -99.64 -51.09 3.85 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 124.074 0.95 . . . . 70.02 111.748 170.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 43.0 tp -66.61 -46.92 74.31 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.548 0.739 . . . . 55.03 110.382 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -90.76 -5.05 56.19 Favored 'General case' 0 CA--C 1.55 0.981 0 CA-C-N 115.766 -0.652 . . . . 72.11 110.694 176.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -44.99 -59.39 4.47 Favored Glycine 0 CA--C 1.541 1.681 0 CA-C-O 118.651 -1.083 . . . . 72.43 114.975 178.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -59.6 -1.72 1.18 Allowed 'Trans proline' 0 C--N 1.387 2.564 0 C-N-CA 123.711 2.941 . . . . 23.1 115.126 -177.211 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -149.49 36.32 1.01 Allowed Glycine 0 C--N 1.354 1.574 0 CA-C-N 118.549 0.613 . . . . 44.4 112.82 173.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.512 HD22 HG21 ' A' ' 90' ' ' VAL . 18.3 mt -71.94 62.51 0.45 Allowed 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 117.705 0.753 . . . . 74.25 112.348 172.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 35.47 -112.07 0.07 Allowed 'General case' 0 CA--C 1.561 1.378 0 C-N-CA 126.403 1.881 . . . . 72.25 114.214 173.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 56.86 18.88 27.24 Favored Glycine 0 C--N 1.369 2.397 0 N-CA-C 111.77 -0.532 . . . . 44.0 111.77 -163.594 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.361 1.972 0 O-C-N 124.604 0.826 . . . . 71.34 111.96 -166.583 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.532 ' HA ' ' HD2' ' A' ' 170' ' ' PRO . 37.4 tttp . . . . . 0 N--CA 1.482 1.169 0 N-CA-C 112.637 0.606 . . . . 72.15 112.637 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -80.47 165.75 48.64 Favored Glycine 0 C--N 1.348 1.239 0 O-C-N 124.108 0.88 . . . . 55.22 115.094 -168.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.436 ' O ' ' HA3' ' A' ' 172' ' ' GLY . 24.3 ttt180 -59.99 143.93 50.54 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.819 1.248 . . . . 71.34 111.495 176.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -78.68 126.92 31.38 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 108.733 -0.84 . . . . 74.23 108.733 166.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 53.9 tp -119.25 132.56 55.94 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 109.386 -0.598 . . . . 70.23 109.386 -176.056 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 67.9 ttp85 -90.8 110.97 22.17 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 108.36 -0.978 . . . . 74.51 108.36 171.308 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -114.72 150.97 34.47 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.637 0.775 . . . . 41.51 109.131 178.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -106.95 118.63 37.21 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 107.134 -1.432 . . . . 61.0 107.134 -170.165 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.41 HD11 ' HE ' ' A' ' 136' ' ' ARG . 13.2 tp -99.79 100.14 10.48 Favored Pre-proline 0 N--CA 1.472 0.67 0 N-CA-C 108.892 -0.781 . . . . 54.05 108.892 -176.244 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.643 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 50.8 Cg_endo -71.75 111.05 3.05 Favored 'Trans proline' 0 C--N 1.374 1.891 0 N-CA-C 108.544 -1.368 . . . . 75.33 108.544 172.189 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.474 ' HB3' HD23 ' A' ' 180' ' ' LEU . 60.6 tp -115.78 140.22 49.43 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.438 0.637 . . . . 64.01 110.263 -171.043 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 93.3 m -74.87 134.4 41.66 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 114.068 -1.423 . . . . 71.34 111.078 179.048 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.429 HD13 ' HB2' ' A' ' 186' ' ' PHE . 91.0 mt -57.96 -38.36 75.87 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.939 0.895 . . . . 70.54 111.134 -177.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -56.2 -42.6 77.44 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 114.492 -1.231 . . . . 75.32 110.045 176.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -73.26 -34.61 65.91 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.583 0.753 . . . . 64.33 111.412 178.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -67.23 -25.94 66.35 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 121.128 0.49 . . . . 41.43 110.326 178.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -78.49 -42.75 28.78 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 114.657 -1.156 . . . . 74.51 110.538 173.211 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 36.6 m170 -68.32 -66.69 0.54 Allowed 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.14 0.576 . . . . 75.25 111.055 -177.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.588 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 81.97 56.48 2.89 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-N 116.068 -0.515 . . . . 71.54 112.789 177.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -126.42 -170.11 12.89 Favored Glycine 0 N--CA 1.471 1.017 0 N-CA-C 111.584 -0.606 . . . . 70.42 111.584 178.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 30.1 mp0 -71.37 104.71 3.27 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.447 0.699 . . . . 73.14 109.69 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.738 HH22 HD12 ' A' ' 159' ' ' ILE . 0.0 OUTLIER -90.93 147.08 23.37 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.298 -1.001 . . . . 74.4 108.298 174.843 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 62.3 t -102.68 132.44 48.78 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 N-CA-C 107.923 -1.139 . . . . 71.24 107.923 171.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.492 HG13 HG13 ' A' ' 145' ' ' VAL . 2.2 p -139.08 113.0 6.98 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 124.362 1.065 . . . . 73.14 108.389 -177.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -95.97 142.6 28.0 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 115.599 -0.728 . . . . 71.3 109.76 -176.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.2 p -168.97 138.59 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 123.617 0.767 . . . . 75.1 109.939 173.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 57.2 32.07 21.11 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 124.404 1.082 . . . . 74.24 112.548 175.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 78.41 0.37 78.27 Favored Glycine 0 C--N 1.35 1.349 0 CA-C-N 116.538 -0.301 . . . . 31.1 113.333 -178.219 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.92 104.39 14.36 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 124.266 1.026 . . . . 72.12 108.233 178.153 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 27.9 ttp-105 -92.67 104.4 16.68 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 125.135 1.374 . . . . 74.41 108.775 175.55 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.492 HG13 HG13 ' A' ' 138' ' ' VAL . 3.4 p -107.23 131.69 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 CA-C-O 120.935 0.398 . . . . 73.53 112.045 -175.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 37.6 t -100.4 110.55 22.76 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 108.249 -1.019 . . . . 31.45 108.249 170.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -136.37 140.53 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.8 1.24 . . . . 73.42 108.593 -178.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.488 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 52.7 ttt85 -83.41 144.55 29.54 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.354 0.662 . . . . 74.14 110.9 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.588 HG13 ' HA2' ' A' ' 133' ' ' GLY . 6.3 pt -106.56 145.62 31.41 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 124.609 1.164 . . . . 74.13 108.359 167.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -70.95 143.12 44.27 Favored 'Trans proline' 0 C--N 1.369 1.647 0 C-N-CA 122.272 1.981 . . . . 60.34 111.428 170.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.4 97.5 0.12 Allowed 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 122.606 2.204 . . . . 74.15 110.485 170.351 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 106.03 66.21 0.66 Allowed Glycine 0 C--N 1.339 0.74 0 CA-C-N 115.675 -0.693 . . . . 75.51 111.837 -168.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.432 HG22 HG11 ' A' ' 178' ' ' VAL . 2.1 p -111.89 110.91 33.94 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 N-CA-C 107.999 -1.112 . . . . 75.43 107.999 175.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.51 ' HG3' ' HG ' ' A' ' 188' ' ' LEU . 0.0 OUTLIER -93.87 159.5 15.16 Favored 'General case' 0 C--O 1.205 -1.278 0 C-N-CA 124.09 0.956 . . . . 73.23 110.704 -165.633 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -50.89 119.01 3.52 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.934 1.294 . . . . 72.32 110.357 175.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 93.46 1.19 66.56 Favored Glycine 0 CA--C 1.534 1.252 0 CA-C-O 119.296 -0.725 . . . . 14.21 113.875 -179.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 12.7 t -72.19 126.53 30.02 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 108.458 -0.941 . . . . 74.23 108.458 178.035 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.572 HG22 HG22 ' A' ' 177' ' ' VAL . 48.4 t -102.38 105.46 18.14 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 C-N-CA 123.552 0.741 . . . . 72.34 110.416 -172.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.738 HD12 HH22 ' A' ' 136' ' ' ARG . 57.2 mt -76.3 102.23 3.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 107.777 -1.194 . . . . 75.24 107.777 166.488 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 58.1 ttt180 -74.42 101.06 3.99 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 107.798 -1.186 . . . . 61.32 107.798 172.154 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 6.2 p -124.41 95.57 42.98 Favored Pre-proline 0 CA--C 1.547 0.856 0 N-CA-C 109.448 -0.575 . . . . 61.33 109.448 177.33 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.507 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 28.9 Cg_endo -63.91 152.55 80.27 Favored 'Trans proline' 0 C--N 1.369 1.616 0 C-N-CA 121.963 1.776 . . . . 74.53 111.667 172.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.592 ' HA3' ' HA ' ' A' ' 86' ' ' SER . . . 105.12 -25.9 23.73 Favored Glycine 0 C--N 1.335 0.514 0 CA-C-N 116.043 -0.526 . . . . 70.43 113.628 176.542 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -103.61 0.05 30.28 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 117.331 0.566 . . . . 64.15 110.949 178.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.576 ' HA2' HD13 ' A' ' 174' ' ' LEU . . . -82.71 -129.65 1.36 Allowed Glycine 0 C--N 1.35 1.315 0 O-C-N 123.286 0.366 . . . . 73.33 113.904 -174.077 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -73.95 158.27 52.0 Favored Glycine 0 C--N 1.338 0.683 0 CA-C-N 115.507 -0.346 . . . . 74.5 113.089 -176.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -71.7 111.53 7.06 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.955 1.302 . . . . 75.42 112.09 -169.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -174.7 159.56 28.34 Favored Glycine 0 C--O 1.221 -0.661 0 CA-C-O 118.327 -1.263 . . . . 64.21 110.723 176.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' ASN . . . . . 0.597 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . 55.3 t30 -55.35 -56.64 26.69 Favored Pre-proline 0 N--CA 1.496 1.872 0 CA-C-N 118.262 1.031 . . . . 63.11 111.36 -169.266 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.597 ' HD3' ' HB3' ' A' ' 169' ' ' ASN . 3.3 Cg_endo -88.55 94.4 0.38 Allowed 'Trans proline' 0 C--N 1.386 2.545 0 N-CA-C 107.403 -1.807 . . . . 71.13 107.403 157.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -65.45 154.5 73.39 Favored 'Trans proline' 0 C--N 1.378 2.086 0 C-N-CA 122.111 1.874 . . . . 71.25 111.805 -167.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.436 ' HA3' ' O ' ' A' ' 117' ' ' ARG . . . -74.28 -179.55 41.08 Favored Glycine 0 C--O 1.241 0.559 0 N-CA-C 115.372 0.909 . . . . 72.4 115.372 -164.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.507 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 7.0 m-20 -74.59 108.58 7.44 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.105 0.962 . . . . 71.14 110.425 -173.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.576 HD13 ' HA2' ' A' ' 165' ' ' GLY . 21.9 tp -82.9 99.84 10.01 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 108.759 -0.83 . . . . 64.32 108.759 176.13 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 77.0 mt -74.77 89.15 2.28 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.206 -0.906 . . . . 72.12 109.188 174.142 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.473 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 65.9 mt -75.46 90.17 2.7 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.474 -0.784 . . . . 70.05 110.025 177.362 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.572 HG22 HG22 ' A' ' 158' ' ' VAL . 46.3 t -84.33 103.71 11.83 Favored 'Isoleucine or valine' 0 C--O 1.244 0.809 0 N-CA-C 107.234 -1.395 . . . . 61.43 107.234 175.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.432 HG11 HG22 ' A' ' 153' ' ' VAL . 11.6 p -70.27 118.63 15.06 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 CA-C-N 115.136 -0.938 . . . . 70.33 111.396 -173.093 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.643 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 35.4 mmt180 -98.94 104.52 16.57 Favored 'General case' 0 C--O 1.216 -0.706 0 N-CA-C 108.263 -1.014 . . . . 53.32 108.263 170.109 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.474 HD23 ' HB3' ' A' ' 125' ' ' LEU . 77.1 mt -69.23 142.48 54.19 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 118.7 0.682 . . . . 72.4 109.534 178.48 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 82.9 mt -54.17 161.56 1.86 Allowed Pre-proline 0 N--CA 1.486 1.348 0 C-N-CA 124.19 0.996 . . . . 73.14 112.939 -170.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -76.34 30.72 0.4 Allowed 'Trans proline' 0 C--N 1.383 2.382 0 C-N-CA 122.791 2.327 . . . . 71.42 111.982 164.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -64.59 115.49 20.73 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 125.976 1.71 . . . . 73.35 107.283 175.207 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -76.5 24.73 0.45 Allowed 'Trans proline' 0 N--CA 1.497 1.709 0 C-N-CA 123.474 2.783 . . . . 61.24 115.832 -161.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.419 HG12 ' CD1' ' A' ' 186' ' ' PHE . 51.0 t -106.99 -61.01 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 122.841 0.457 . . . . 64.21 110.446 -176.557 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 186' ' ' PHE . . . . . 0.552 ' HE2' HD13 ' A' ' 193' ' ' LEU . 2.9 m-30 -131.42 165.78 22.75 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.939 0.895 . . . . 72.31 110.792 -172.051 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 22.8 ttp85 -150.4 87.73 1.46 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 114.362 -1.29 . . . . 75.51 108.338 169.5 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.51 ' HG ' ' HG3' ' A' ' 154' ' ' ARG . 51.5 tp -62.23 104.81 0.52 Allowed 'General case' 0 C--O 1.207 -1.157 0 CA-C-N 115.141 -0.936 . . . . 74.21 108.776 174.205 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -136.44 132.93 36.08 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.068 1.347 . . . . 70.31 109.02 -171.195 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 82.72 -84.81 1.52 Allowed Glycine 0 C--N 1.35 1.32 0 N-CA-C 110.757 -0.937 . . . . 65.41 110.757 -177.153 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.61 ' HG2' ' HD2' ' A' ' 243' ' ' PRO . 0.9 OUTLIER -153.89 3.73 0.27 Allowed 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 125.158 1.383 . . . . 72.32 109.962 165.917 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.413 ' HB3' ' H ' ' A' ' 248' ' ' ASP . 2.5 p-10 -118.74 175.29 5.81 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.246 1.419 . . . . 72.32 109.809 -169.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.552 HD13 ' HE2' ' A' ' 186' ' ' PHE . 41.3 mt -114.75 126.16 54.53 Favored 'General case' 0 C--O 1.215 -0.762 0 C-N-CA 123.276 0.63 . . . . 63.44 110.544 -171.402 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -105.21 102.23 11.73 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.469 0.707 . . . . 73.14 109.437 174.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.58 ' HB3' HD23 ' A' ' 251' ' ' LEU . . . -108.28 156.46 19.35 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.946 -0.761 . . . . 74.34 108.946 172.13 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 57.0 m -93.6 123.57 37.01 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 109.036 -0.727 . . . . 70.21 109.036 178.125 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.514 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 32.5 tp -113.09 94.62 4.98 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 108.662 -0.866 . . . . 72.21 108.662 178.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -79.5 122.09 26.02 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 107.026 -1.472 . . . . 61.43 107.026 169.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 9.2 p -133.48 137.47 29.06 Favored Pre-proline 0 CA--C 1.545 0.765 0 N-CA-C 108.156 -1.053 . . . . 64.4 108.156 -177.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.75 159.51 48.34 Favored 'Trans proline' 0 C--N 1.36 1.183 0 C-N-CA 121.796 1.664 . . . . 64.51 111.5 173.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -56.32 -52.94 69.08 Favored Pre-proline 0 CA--C 1.555 1.146 0 CA-C-O 117.715 -1.136 . . . . 71.34 113.242 -172.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -59.3 -40.97 63.34 Favored 'Trans proline' 0 C--N 1.391 2.804 0 C-N-CA 122.03 1.82 . . . . 63.54 113.417 -179.176 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.534 HD11 ' HB3' ' C' ' 276' ' ' TYR . 36.0 mt -71.93 -31.42 40.65 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.962 0 C-N-CA 122.782 0.433 . . . . 64.32 110.368 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.71 -40.73 84.26 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-O 121.155 0.502 . . . . 71.51 110.606 174.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.521 HG13 HD11 ' C' ' 261' ' ' LEU . 48.4 t -71.21 -46.92 63.45 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 C-N-CA 124.189 0.995 . . . . 63.23 112.167 -176.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.503 HG21 ' HA ' ' C' ' 270' ' ' LYS . 94.6 t -98.92 -26.38 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 123.698 0.799 . . . . 74.41 111.574 -170.032 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 99.03 160.29 29.46 Favored Glycine 0 C--O 1.241 0.554 0 N-CA-C 110.941 -0.864 . . . . 72.35 110.941 -170.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.469 ' O ' HG12 ' A' ' 223' ' ' VAL . . . 162.18 168.37 23.99 Favored Glycine 0 N--CA 1.467 0.73 0 N-CA-C 111.84 -0.504 . . . . 55.24 111.84 177.545 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -99.62 117.65 34.46 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 117.068 0.434 . . . . 45.21 110.519 -175.333 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 35.9 m -121.71 162.46 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 124.136 0.974 . . . . 63.11 109.055 177.293 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -70.39 115.29 9.41 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 120.635 0.255 . . . . 71.41 110.96 -177.099 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -103.12 112.54 25.44 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 108.176 -1.046 . . . . 62.04 108.176 168.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -76.48 116.57 17.29 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 107.382 -1.34 . . . . 71.23 107.382 173.316 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 214' ' ' THR . . . . . 0.408 ' HA ' ' CE1' ' A' ' 186' ' ' PHE . 72.8 p -118.79 167.92 11.24 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.804 0.442 . . . . 74.1 110.354 178.172 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 72.1 mt -66.2 -20.77 66.23 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.278 0.631 . . . . 63.31 111.595 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -91.29 -18.31 24.55 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 123.555 0.742 . . . . 64.44 111.562 177.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 147.34 170.63 15.73 Favored Glycine 0 C--N 1.36 1.909 0 CA-C-O 119.97 -0.35 . . . . 33.0 113.594 174.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.79 103.98 1.67 Allowed 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 122.482 2.122 . . . . 70.23 111.404 176.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 33.6 m -106.9 179.83 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 124.25 1.02 . . . . 73.4 110.444 -177.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -110.99 119.54 39.4 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.357 0.663 . . . . 75.04 109.248 173.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 7.2 p -96.85 121.0 46.91 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 N-CA-C 108.979 -0.749 . . . . 74.13 108.979 175.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -80.09 96.68 6.57 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.662 -0.866 . . . . 60.25 108.662 172.314 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.469 HG12 ' O ' ' A' ' 208' ' ' GLY . 10.7 p -68.35 132.72 91.4 Favored Pre-proline 0 CA--C 1.554 1.102 0 N-CA-C 108.916 -0.772 . . . . 63.14 108.916 178.151 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.39 163.55 26.3 Favored 'Trans proline' 0 C--N 1.374 1.875 0 C-N-CA 122.483 2.122 . . . . 75.51 112.455 174.016 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -64.77 163.9 26.21 Favored 'Trans proline' 0 C--N 1.37 1.664 0 C-N-CA 121.993 1.795 . . . . 72.53 112.95 169.247 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 226' ' ' ARG . . . . . 0.423 ' HE ' ' N ' ' A' ' 226' ' ' ARG . 0.0 OUTLIER 41.25 67.78 0.5 Allowed 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 126.057 1.743 . . . . 74.04 112.824 -173.207 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.532 HG23 HD21 ' A' ' 233' ' ' LEU . 95.0 m -101.68 103.01 13.77 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 114.407 -1.27 . . . . 64.32 109.224 177.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 228' ' ' GLN . . . . . 0.813 ' HB3' ' HD3' ' A' ' 231' ' ' ARG . 5.5 tp-100 -87.18 145.96 26.2 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.166 0.986 . . . . 75.32 111.784 -172.726 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -73.15 143.42 47.29 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.975 0.91 . . . . 62.31 111.267 179.131 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 85.26 -0.59 88.73 Favored Glycine 0 C--N 1.348 1.233 0 CA-C-N 115.787 -0.642 . . . . 73.32 113.103 -178.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.813 ' HD3' ' HB3' ' A' ' 228' ' ' GLN . 78.7 mtp180 -112.03 162.49 15.33 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.536 1.134 . . . . 74.0 108.949 176.017 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.414 ' HB3' ' HG2' ' A' ' 252' ' ' GLU . 49.6 pttt -129.63 136.31 49.6 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 122.902 0.481 . . . . 72.22 110.389 -171.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.532 HD21 HG23 ' A' ' 227' ' ' THR . 26.3 mt -86.72 110.97 20.26 Favored 'General case' 0 C--O 1.212 -0.882 0 CA-C-N 115.281 -0.872 . . . . 71.4 110.133 -172.321 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -77.22 106.94 9.26 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.01 0.524 . . . . 64.14 110.25 175.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.497 HD12 HD23 ' A' ' 249' ' ' LEU . 8.5 mt -101.68 93.54 5.39 Favored 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 108.454 -0.943 . . . . 61.12 108.454 172.458 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 4.5 tmtm? -73.67 117.97 16.06 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.437 0.695 . . . . 64.43 111.939 -164.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 101.45 32.16 5.27 Favored Glycine 0 C--N 1.347 1.157 0 CA-C-N 115.813 -0.63 . . . . 74.2 112.614 175.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 2.8 mmmt -117.26 -28.19 6.23 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.941 0.896 . . . . 73.01 111.229 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -79.0 -166.87 32.04 Favored Glycine 0 C--N 1.342 0.915 0 O-C-N 123.663 0.602 . . . . 74.43 113.256 174.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -97.59 158.97 32.15 Favored Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 123.565 0.746 . . . . 73.13 110.333 -173.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -58.64 151.92 59.57 Favored 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 122.656 2.237 . . . . 73.33 113.322 -173.161 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -173.88 -163.42 27.32 Favored Glycine 0 C--N 1.341 0.816 0 CA-C-N 115.65 -0.705 . . . . 73.52 113.761 177.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 243' ' ' PRO . . . . . 0.61 ' HD2' ' HG2' ' A' ' 191' ' ' GLN . 73.4 Cg_endo -70.8 -5.86 17.81 Favored 'Trans proline' 0 C--N 1.373 1.862 0 C-N-CA 123.708 2.939 . . . . 70.45 113.613 -179.132 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -103.94 23.12 13.38 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.74 0.816 . . . . 70.11 109.954 171.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 82.37 -84.44 1.51 Allowed Glycine 0 C--N 1.351 1.4 0 N-CA-C 110.78 -0.928 . . . . 62.24 110.78 -177.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 50.2 mtm180 -125.68 144.64 50.51 Favored 'General case' 0 C--O 1.246 0.871 0 N-CA-C 108.348 -0.982 . . . . 75.41 108.348 171.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -65.79 166.82 35.11 Favored Glycine 0 N--CA 1.448 -0.552 0 O-C-N 123.979 0.799 . . . . 42.24 113.457 176.138 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 248' ' ' ASP . . . . . 0.413 ' H ' ' HB3' ' A' ' 192' ' ' ASP . 4.1 m-20 -110.91 -178.31 3.44 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 123.776 0.831 . . . . 75.44 108.89 -179.004 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.497 HD23 HD12 ' A' ' 235' ' ' LEU . 31.1 tp -118.63 96.53 5.32 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 107.875 -1.157 . . . . 70.31 107.875 169.519 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -79.69 109.52 14.17 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.285 1.034 . . . . 52.51 109.79 175.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.58 HD23 ' HB3' ' A' ' 195' ' ' ALA . 89.7 mt -97.88 97.86 9.31 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.5 -0.773 . . . . 72.24 109.483 177.29 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 252' ' ' GLU . . . . . 0.414 ' HG2' ' HB3' ' A' ' 232' ' ' LYS . 28.7 mt-10 -75.61 115.97 15.84 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.374 0.67 . . . . 75.41 109.611 -176.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 91.7 t -86.43 132.89 31.11 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 C-N-CA 125.468 1.507 . . . . 24.43 113.06 -163.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -130.07 107.04 9.03 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.19 1.396 . . . . 73.14 108.565 173.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.538 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 73.4 mt -84.01 130.74 35.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 123.257 0.623 . . . . 74.34 111.016 -176.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 20.3 p -119.1 174.15 6.49 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.497 1.119 . . . . 73.43 109.844 173.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 257' ' ' ILE . . . . . 0.418 ' HB ' ' HD2' ' A' ' 258' ' ' PRO . 2.9 pp -136.13 154.91 77.72 Favored Pre-proline 0 CA--C 1.566 1.576 0 C-N-CA 123.696 0.798 . . . . 73.4 109.938 -179.34 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 258' ' ' PRO . . . . . 0.418 ' HD2' ' HB ' ' A' ' 257' ' ' ILE . 49.1 Cg_endo -64.67 -5.56 10.53 Favored 'Trans proline' 0 C--N 1.385 2.493 0 C-N-CA 123.457 2.771 . . . . 74.45 116.1 -163.689 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 259' ' ' GLU . . . . . 0.503 ' HG2' ' NE2' ' C' ' 228' ' ' GLN . 31.4 mt-10 52.42 -87.37 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.422 0 C-N-CA 124.122 0.969 . . . . 63.24 112.728 -170.6 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.27 132.84 47.83 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 109.935 -0.394 . . . . 75.12 109.935 -177.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.401 HD21 ' HG2' ' A' ' 258' ' ' PRO . 97.5 mt -130.93 134.62 46.91 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.702 0.801 . . . . 55.32 110.575 -177.488 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 19.1 p -84.16 146.26 47.87 Favored Pre-proline 0 CA--C 1.545 0.788 0 CA-C-O 117.874 -1.06 . . . . 44.34 108.841 169.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -30.94 -42.98 0.11 Allowed 'Trans proline' 0 C--N 1.39 2.731 1 C-N-CA 126.062 4.508 . . . . 74.33 116.569 -172.65 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -64.59 -64.3 0.91 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.25 0.62 . . . . 71.44 110.99 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -61.48 -32.49 72.5 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.086 0.954 . . . . 64.2 110.866 -178.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -53.48 -52.95 57.89 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.779 1.231 . . . . 73.45 109.847 174.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 267' ' ' ALA . . . . . 0.406 ' O ' ' HG3' ' A' ' 271' ' ' LYS . . . -65.69 -41.72 92.07 Favored 'General case' 0 C--O 1.214 -0.795 0 CA-C-N 114.923 -1.035 . . . . 64.12 111.585 178.63 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 10.9 mp -57.24 -47.0 82.47 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 123.071 0.548 . . . . 73.14 111.544 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -64.89 -40.76 95.6 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 123.755 0.659 . . . . 75.0 111.091 178.217 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 270' ' ' LYS . . . . . 0.469 ' HE2' ' HA ' ' C' ' 206' ' ' VAL . 1.5 mptm? -71.68 -25.33 62.06 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.093 0.557 . . . . 62.43 111.98 178.38 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 271' ' ' LYS . . . . . 0.406 ' HG3' ' O ' ' A' ' 267' ' ' ALA . 97.1 mttt -73.75 -48.82 28.99 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.873 -0.788 . . . . 70.22 108.873 176.618 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 72.6 mt -55.28 -40.96 71.62 Favored 'General case' 0 C--O 1.198 -1.641 0 O-C-N 124.774 1.296 . . . . 63.4 109.992 172.049 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -65.79 -55.51 16.8 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.056 0.942 . . . . 64.51 113.105 -174.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -66.57 -43.75 84.16 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 123.787 0.679 . . . . 74.35 110.76 -176.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -62.59 -47.95 81.59 Favored 'General case' 0 C--N 1.355 0.82 0 O-C-N 123.944 0.778 . . . . 71.44 110.285 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -62.75 -45.77 91.14 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.729 0.812 . . . . 75.02 110.945 -177.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -66.82 -40.04 87.89 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 123.519 0.512 . . . . 70.12 110.103 -176.027 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -66.62 -17.86 65.06 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 115.824 -0.625 . . . . 75.41 111.579 174.345 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 82.6 mtt180 -117.76 20.05 13.56 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.134 0.974 . . . . 74.13 109.733 178.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.845 0 N-CA-C 109.173 -0.677 . . . . 72.21 109.173 179.193 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 63.7 mtt . . . . . 0 N--CA 1.483 1.182 0 N-CA-C 109.104 -0.702 . . . . 71.44 109.104 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -82.06 126.65 32.25 Favored 'General case' 0 C--N 1.353 0.733 0 N-CA-C 108.649 -0.871 . . . . 54.1 108.649 172.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -106.34 37.49 2.28 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.137 0.575 . . . . 74.04 110.095 -176.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 55.2 m -53.89 -3.51 0.04 OUTLIER 'General case' 0 CA--C 1.565 1.535 0 N-CA-C 117.31 2.337 . . . . 52.14 117.31 -162.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 16.9 m -132.27 147.6 52.41 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 119.316 0.962 . . . . 70.11 110.291 171.282 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 15.1 pt -138.23 169.59 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 123.85 0.86 . . . . 64.44 112.384 -164.293 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -131.51 147.68 52.56 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 124.21 1.004 . . . . 72.01 109.672 176.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 15.2 tp -85.51 157.0 20.54 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.863 0.865 . . . . 75.22 110.918 -172.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.44 -59.52 2.67 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.322 0.649 . . . . 62.4 111.81 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 66.1 mt 61.12 18.1 8.72 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.863 1.265 . . . . 74.1 111.911 -165.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 64.5 mt . . . . . 0 N--CA 1.485 1.309 0 C-N-CA 124.771 1.228 . . . . 45.35 112.116 179.477 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.776 0 N-CA-C 108.843 -0.799 . . . . 61.34 108.843 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . -66.11 -35.22 79.91 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 109.368 -0.604 . . . . 74.4 109.368 166.051 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 181' ' ' LEU . . . . . 0.527 ' HB2' ' HB3' ' C' ' 136' ' ' ARG . 58.0 tp -159.79 -69.95 0.08 Allowed 'General case' 0 C--N 1.353 0.726 0 CA-C-N 115.816 -0.629 . . . . 62.04 111.186 -176.553 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 182' ' ' VAL . . . . . 0.523 HG11 ' H ' ' C' ' 139' ' ' GLU . 8.2 p -79.93 150.43 4.96 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 CA-C-N 115.355 -0.839 . . . . 71.31 112.711 -163.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -119.67 38.17 3.98 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.909 0.883 . . . . 65.24 109.278 171.249 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 184' ' ' HIS . . . . . 0.401 ' H ' HG22 ' B' ' 182' ' ' VAL . 74.4 m-70 56.85 -87.11 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.723 1.209 . . . . 74.15 110.589 -171.623 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 185' ' ' VAL . . . . . 0.559 HG23 ' HA ' ' C' ' 121' ' ' ALA . 1.5 p . . . . . 0 N--CA 1.469 0.489 0 C-N-CA 124.382 1.073 . . . . 71.33 108.71 173.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 238' ' ' THR . . . . . 0.479 HG21 ' H ' ' C' ' 220' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 113.599 0.962 . . . . 71.31 113.599 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -163.81 174.38 11.64 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.803 0.729 . . . . 74.42 111.113 -165.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . -79.51 -106.29 0.24 Allowed Glycine 0 C--N 1.345 1.051 0 CA-C-N 115.409 -0.814 . . . . 71.23 111.804 174.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.29 -179.52 5.62 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.41 0.684 . . . . 71.21 111.132 -178.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 242' ' ' TRP . . . . . 0.485 ' CZ3' HG21 ' C' ' 253' ' ' VAL . 7.8 m0 -94.18 -60.54 1.71 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.198 0.999 . . . . 70.32 109.375 -175.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -172.25 -33.16 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 113.472 -1.694 . . . . 74.22 109.097 -167.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -162.15 101.7 0.2 Allowed Glycine 0 C--N 1.347 1.185 0 N-CA-C 111.375 -0.69 . . . . 63.11 111.375 174.118 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 39.1 tptt . . . . . 0 N--CA 1.476 0.867 0 C-N-CA 124.13 0.972 . . . . 75.34 109.976 179.301 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.835 0 CA-C-O 120.632 0.253 . . . . 52.01 110.534 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -36.89 117.52 0.52 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.891 1.676 . . . . 70.52 114.288 -176.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 5' ' ' LYS . . . . . 0.462 ' HB3' HD11 ' C' ' 10' ' ' ILE . 14.1 mmmm -93.93 108.59 20.37 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 108.355 -0.98 . . . . 63.2 108.355 167.552 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -71.94 93.97 1.41 Allowed 'General case' 0 C--O 1.238 0.487 0 N-CA-C 107.583 -1.265 . . . . 63.22 107.583 175.39 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 7' ' ' TYR . . . . . 0.483 ' HA ' HD12 ' C' ' 10' ' ' ILE . 30.9 m-85 -60.41 -30.36 69.56 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 115.004 -0.998 . . . . 73.43 112.158 -171.363 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -66.76 -45.04 79.78 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.572 -0.74 . . . . 72.53 110.521 177.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.9 -42.58 99.25 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.088 0.555 . . . . 52.31 110.685 177.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 10' ' ' ILE . . . . . 0.483 HD12 ' HA ' ' C' ' 7' ' ' TYR . 69.5 mt -55.3 -50.95 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 123.72 0.808 . . . . 63.34 111.144 178.513 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 83.4 mt -74.48 -12.0 60.37 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.528 -0.76 . . . . 45.45 112.371 -179.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 69.99 33.82 70.35 Favored Glycine 0 C--N 1.351 1.384 0 O-C-N 123.045 0.216 . . . . 64.33 112.754 -176.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 13' ' ' VAL . . . . . 0.447 ' HB ' ' HD2' ' C' ' 14' ' ' PRO . 11.6 m -108.46 164.39 14.86 Favored Pre-proline 0 N--CA 1.479 1.021 0 C-N-CA 124.46 1.104 . . . . 64.04 109.615 174.184 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 14' ' ' PRO . . . . . 0.447 ' HD2' ' HB ' ' C' ' 13' ' ' VAL . 35.5 Cg_endo -60.12 162.79 15.76 Favored 'Trans proline' 0 C--N 1.384 2.4 0 C-N-CA 122.095 1.863 . . . . 74.43 112.596 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 8.8 mmm180 -77.18 14.31 0.94 Allowed 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.042 0.937 . . . . 71.52 112.413 -170.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -148.99 14.75 0.92 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.692 1.197 . . . . 71.24 108.716 -176.39 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.04 137.5 56.81 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 123.923 0.889 . . . . 71.14 112.914 -170.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 78.8 p -70.77 161.87 30.13 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.798 0.839 . . . . 74.41 110.649 178.333 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -57.52 -29.34 64.26 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.519 0.728 . . . . 74.45 111.541 -177.204 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -65.68 -47.92 73.84 Favored 'General case' 0 C--O 1.215 -0.733 0 CA-C-O 119.33 -0.367 . . . . 64.05 110.486 176.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -61.24 -35.62 77.73 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 123.711 0.632 . . . . 73.42 110.821 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.46 -44.04 97.85 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.928 0 C-N-CA 123.671 0.788 . . . . 61.32 110.756 173.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 6.5 ttpm? -73.02 -31.43 64.46 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.539 0.736 . . . . 74.13 111.304 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 40.0 mtt180 -69.08 -45.47 70.21 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.124 0.97 . . . . 73.52 110.083 178.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -71.77 -31.81 67.01 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 124.522 1.139 . . . . 75.32 111.183 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 26' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -58.0 -60.3 3.94 Favored 'General case' 0 C--O 1.21 -0.995 0 O-C-N 124.191 0.932 . . . . 72.31 109.323 171.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 27' ' ' LYS . . . . . 0.423 ' O ' ' HG3' ' C' ' 31' ' ' ARG . 53.4 mtmt -63.07 -35.08 79.04 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 124.366 1.041 . . . . 74.1 111.336 -178.001 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 28' ' ' ARG . . . . . 0.613 ' HA ' HH21 ' C' ' 31' ' ' ARG . 63.7 ttt180 -58.11 -51.88 67.86 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.071 0.948 . . . . 71.15 110.244 177.584 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 29' ' ' LEU . . . . . 0.517 ' HA ' ' HB3' ' C' ' 32' ' ' GLN . 83.2 mt -90.62 -0.02 57.54 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 113.983 -1.462 . . . . 60.22 111.195 -177.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.15 -10.96 29.05 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.778 0.831 . . . . 75.32 110.003 169.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 31' ' ' ARG . . . . . 0.613 HH21 ' HA ' ' C' ' 28' ' ' ARG . 32.7 mtm105 -93.66 -35.81 12.66 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.261 0.624 . . . . 73.5 109.454 165.514 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 32' ' ' GLN . . . . . 0.517 ' HB3' ' HA ' ' C' ' 29' ' ' LEU . 49.7 tt0 -67.69 -60.55 2.45 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 122.489 0.316 . . . . 71.12 110.386 176.25 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -92.38 31.71 1.28 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.287 0.635 . . . . 70.15 109.781 178.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 34' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -58.91 106.46 0.72 Allowed Pre-proline 0 N--CA 1.481 1.078 0 C-N-CA 124.184 0.993 . . . . 72.34 109.059 -179.236 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -58.37 -29.45 88.25 Favored 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 123.041 2.494 . . . . 71.32 113.146 -165.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -72.28 -33.15 67.22 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.042 0.937 . . . . 60.34 112.442 178.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 61.8 t -97.73 -23.15 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 123.457 0.703 . . . . 75.33 110.689 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -128.86 83.61 2.17 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.74 0.816 . . . . 54.22 109.504 -168.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -81.85 36.05 0.44 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.134 0.973 . . . . 62.24 111.374 178.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 40' ' ' SER . . . . . 0.47 ' HB2' ' HB3' ' C' ' 43' ' ' ALA . 20.0 m -93.02 107.71 26.97 Favored Pre-proline 0 CA--C 1.544 0.742 0 N-CA-C 108.63 -0.878 . . . . 74.14 108.63 -178.056 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -43.39 -54.67 3.4 Favored 'Trans proline' 0 C--N 1.386 2.507 0 C-N-CA 124.437 3.425 . . . . 63.44 114.439 -171.244 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -67.29 -31.14 71.25 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.974 0.91 . . . . 65.44 110.777 -176.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 43' ' ' ALA . . . . . 0.47 ' HB3' ' HB2' ' C' ' 40' ' ' SER . . . -77.31 -19.13 56.84 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.021 0.528 . . . . 62.05 110.68 177.491 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -82.9 -28.06 30.23 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.11 0.564 . . . . 74.04 109.504 176.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -75.63 -32.74 60.36 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.542 0.737 . . . . 42.53 109.832 173.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 46' ' ' LYS . . . . . . . . . . . . . 41.1 mmtm -65.17 -44.02 89.87 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.73 -0.668 . . . . 72.32 109.992 168.27 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -56.71 -37.01 70.32 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.529 0.732 . . . . 62.23 110.171 174.351 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -62.41 -44.33 96.71 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 123.745 0.653 . . . . 72.04 111.72 174.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -66.35 -33.87 76.69 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 122.334 0.253 . . . . 72.33 111.628 176.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 50' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.56 -39.44 85.05 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 C-N-CA 123.77 0.828 . . . . 75.43 109.751 173.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 51' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -72.08 -29.29 63.97 Favored 'General case' 0 C--O 1.212 -0.88 0 C-N-CA 124.034 0.934 . . . . 74.04 110.785 177.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -67.51 -57.53 6.33 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.566 1.146 . . . . 63.42 109.966 177.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.57 -47.12 85.32 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-N 113.158 -1.837 . . . . 63.1 111.629 -176.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -60.22 -57.76 11.4 Favored 'General case' 0 C--O 1.203 -1.362 0 CA-C-N 115.051 -0.977 . . . . 75.01 110.567 174.45 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.97 -30.77 64.38 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 113.174 0.805 . . . . 60.54 113.174 -170.283 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 94.3 t -73.78 -60.06 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 N-CA-C 109.843 -0.429 . . . . 72.43 109.843 170.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 57' ' ' LEU . . . . . 0.432 HD11 ' HB2' ' C' ' 7' ' ' TYR . 79.7 mt -81.64 4.6 21.06 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 113.454 0.909 . . . . 75.02 113.454 -169.661 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 41.8 t -74.62 -36.53 62.92 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.447 1.099 . . . . 62.42 109.717 177.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -82.96 127.78 68.16 Favored Pre-proline 0 C--N 1.331 -0.206 0 N-CA-C 108.399 -0.963 . . . . 72.03 108.399 174.203 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 60' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -54.71 -32.91 78.05 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.571 2.181 . . . . 33.23 111.073 165.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -55.4 -64.64 0.78 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.957 1.303 . . . . 62.13 110.864 174.041 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 36.8 mtpt -76.45 -16.0 59.78 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.13 0.972 . . . . 75.23 112.197 -173.05 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -71.37 -45.15 63.57 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 107.816 -1.179 . . . . 64.42 107.816 171.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -72.13 -24.06 61.41 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.199 0.599 . . . . 74.15 111.861 175.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 90.3 mt -66.06 -42.93 92.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 N-CA-C 109.204 -0.665 . . . . 62.34 109.204 171.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -60.58 -48.89 79.77 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 115.486 -0.779 . . . . 74.22 109.5 174.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -57.39 -42.73 82.76 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.801 0.84 . . . . 73.14 112.112 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 35.8 p -74.13 -23.18 59.25 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.659 0.384 . . . . 63.2 111.431 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -74.11 142.93 45.56 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 109.133 -0.692 . . . . 75.22 109.133 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.64 11.99 65.18 Favored Glycine 0 N--CA 1.476 1.351 0 N-CA-C 112.072 -0.411 . . . . 62.51 112.072 -171.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 36.2 m -144.75 -54.26 0.32 Allowed 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 104.259 -2.497 . . . . 72.34 104.259 175.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 55.0 m -88.73 151.98 22.08 Favored 'General case' 0 C--O 1.246 0.88 0 N-CA-C 104.949 -2.241 . . . . 73.35 104.949 156.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.56 -17.33 2.27 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.872 0.869 . . . . 73.23 110.29 -176.622 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.88 132.55 77.28 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 123.572 0.749 . . . . 53.23 110.466 174.024 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -61.46 156.87 44.17 Favored 'Trans proline' 0 C--N 1.377 2.071 0 C-N-CA 123.413 2.742 . . . . 75.14 112.48 175.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -63.21 169.08 9.87 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 123.421 2.748 . . . . 63.14 112.81 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.85 122.58 5.92 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 121.86 1.707 . . . . 51.51 111.305 171.124 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 78' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.81 122.8 7.53 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 122.51 2.14 . . . . 74.44 112.043 175.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -82.72 159.55 16.4 Favored 'Trans proline' 0 CA--C 1.557 1.672 0 C-N-CA 122.72 2.28 . . . . 61.04 112.109 173.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.27 84.77 0.04 OUTLIER 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 123.123 2.549 . . . . 51.5 112.18 169.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 81' ' ' GLY . . . . . 0.564 ' HA3' ' HB1' ' C' ' 141' ' ' ALA . . . 160.21 -30.18 0.37 Allowed Glycine 0 C--O 1.239 0.43 0 CA-C-N 114.559 -1.2 . . . . 75.2 110.316 -178.523 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 92.14 178.86 41.58 Favored Glycine 0 C--N 1.35 1.311 0 CA-C-N 115.196 -0.502 . . . . 74.45 112.314 173.042 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -80.68 102.16 9.71 Favored 'General case' 0 C--O 1.243 0.761 0 N-CA-C 106.927 -1.508 . . . . 70.14 106.927 168.274 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -53.73 132.69 41.56 Favored 'General case' 0 C--O 1.248 0.978 0 O-C-N 124.769 1.293 . . . . 63.13 111.42 -174.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 85' ' ' PHE . . . . . 0.495 ' CD1' ' HB ' ' C' ' 90' ' ' VAL . 2.1 t80 -156.18 24.02 0.36 Allowed 'General case' 0 C--O 1.243 0.761 0 CA-C-N 114.624 -1.171 . . . . 74.41 110.697 -173.159 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 52.3 m -58.45 128.38 36.85 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.274 -0.876 . . . . 45.43 111.01 -176.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 91.47 -30.31 6.55 Favored Glycine 0 C--N 1.342 0.906 0 CA-C-O 119.591 -0.561 . . . . 74.33 113.175 -179.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 88' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -94.44 137.74 33.22 Favored 'General case' 0 C--N 1.355 0.823 0 N-CA-C 108.443 -0.947 . . . . 74.44 108.443 -177.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -86.64 70.45 10.41 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.244 0.618 . . . . 72.23 111.142 -169.097 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 90' ' ' VAL . . . . . 0.495 ' HB ' ' CD1' ' C' ' 85' ' ' PHE . 1.3 p -39.59 -47.13 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 C-N-CA 125.138 1.375 . . . . 54.41 113.446 178.239 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -69.93 -23.38 63.2 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 114.695 -1.139 . . . . 74.21 111.753 -167.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -100.77 -7.18 23.96 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.293 0.637 . . . . 75.53 111.1 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 8.1 m-30 -78.73 -172.12 2.85 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 109.869 -0.419 . . . . 72.45 109.869 176.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 88.0 p -68.27 148.81 50.26 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 112.332 0.493 . . . . 45.51 112.332 -170.312 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.63 -38.26 89.55 Favored 'General case' 0 CA--C 1.551 1.009 0 CA-C-N 114.871 -1.059 . . . . 55.43 110.869 175.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -49.05 -52.45 25.38 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.658 1.183 . . . . 65.02 111.375 171.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 97' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -62.37 -43.68 98.25 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 114.409 -1.268 . . . . 64.25 110.626 178.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -73.3 -5.06 37.15 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.428 0.691 . . . . 51.52 112.341 -178.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -100.08 -41.96 6.93 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.267 0.627 . . . . 74.43 111.712 167.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 26.6 tp -67.24 -42.86 83.28 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.329 0.652 . . . . 73.23 111.573 -173.155 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -109.91 5.13 22.18 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-O 121.062 0.458 . . . . 73.25 109.875 173.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -44.96 -52.56 7.87 Favored Glycine 0 CA--C 1.538 1.514 0 CA-C-O 118.416 -1.213 . . . . 54.11 115.153 -177.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -35.03 -29.05 0.05 OUTLIER 'Trans proline' 0 C--N 1.389 2.658 0 C-N-CA 125.045 3.83 . . . . 62.02 117.142 175.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -145.73 21.79 1.82 Allowed Glycine 0 C--N 1.36 1.91 0 CA-C-N 118.552 0.615 . . . . 43.23 113.891 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 6.9 mt . . . . . 0 N--CA 1.48 1.039 0 N-CA-C 113.284 0.846 . . . . 73.03 113.284 -179.859 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.401 0 CA-C-O 120.084 -0.287 . . . . 45.25 113.573 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 16.2 mtm180 -58.21 124.53 19.73 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.43 0.692 . . . . 64.44 109.25 174.157 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -57.92 135.22 56.87 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 123.836 0.71 . . . . 75.42 109.249 176.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 119' ' ' LEU . . . . . . . . . . . . . 4.9 tt -95.28 121.34 36.83 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 107.57 -1.27 . . . . 75.21 107.57 -172.145 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.76 94.78 5.26 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 107.668 -1.234 . . . . 72.31 107.668 -168.147 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 121' ' ' ALA . . . . . 0.559 ' HA ' HG23 ' B' ' 185' ' ' VAL . . . -108.58 113.0 25.65 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 108.308 -0.997 . . . . 63.21 108.308 -176.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 122' ' ' GLU . . . . . 0.456 ' HA ' ' O ' ' C' ' 177' ' ' VAL . 0.0 OUTLIER -94.15 110.52 22.23 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 106.959 -1.497 . . . . 73.22 106.959 -178.649 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 123' ' ' LEU . . . . . 0.432 ' H ' HD23 ' C' ' 123' ' ' LEU . 2.4 pt? -129.82 133.32 24.89 Favored Pre-proline 0 N--CA 1.48 1.031 0 C-N-CA 122.481 0.313 . . . . 73.3 111.801 -165.573 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 124' ' ' PRO . . . . . 0.434 ' HA ' ' O ' ' C' ' 179' ' ' ARG . 10.7 Cg_exo -73.53 119.57 6.01 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 123.077 2.518 . . . . 72.51 111.172 170.378 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 125' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' C' ' 180' ' ' LEU . 47.1 tp -128.97 165.32 21.34 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.187 0.995 . . . . 74.03 108.631 -177.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.61 170.9 7.62 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 121.541 0.686 . . . . 61.53 111.686 179.405 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 127' ' ' LEU . . . . . 0.478 HD22 ' CD2' ' C' ' 183' ' ' HIS . 2.4 mt -81.46 -56.69 3.87 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 114.583 -1.189 . . . . 62.25 109.698 -162.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -49.07 -47.13 45.27 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 112.756 -2.02 . . . . 75.24 110.33 170.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -67.88 -33.0 73.88 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 115.707 -0.679 . . . . 73.53 111.456 -177.038 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 130' ' ' ALA . . . . . 0.477 ' HB1' HG22 ' C' ' 153' ' ' VAL . . . -68.17 -31.95 71.87 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 123.698 0.623 . . . . 64.34 110.721 173.598 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 131' ' ' PHE . . . . . 0.405 ' HB2' HD13 ' C' ' 215' ' ' LEU . 74.0 t80 -75.28 -31.85 60.85 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 124.029 0.932 . . . . 75.55 111.37 174.758 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 132' ' ' HIS . . . . . . . . . . . . . 34.6 m170 -79.62 -55.64 4.88 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 112.335 0.495 . . . . 60.22 112.335 -173.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.07 -111.41 3.34 Favored Glycine 0 C--N 1.345 1.068 0 N-CA-C 110.253 -1.139 . . . . 65.31 110.253 -167.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.41 168.2 35.53 Favored Glycine 0 C--N 1.356 1.645 0 CA-C-N 117.426 0.613 . . . . 53.24 113.511 177.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -71.05 93.65 1.04 Allowed 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 108.932 -0.766 . . . . 71.2 108.932 175.092 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 136' ' ' ARG . . . . . 0.527 ' HB3' ' HB2' ' B' ' 181' ' ' LEU . 9.6 mpt_? -117.47 133.5 55.9 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.452 1.101 . . . . 72.12 109.493 -174.372 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 137' ' ' VAL . . . . . . . . . . . . . 27.8 m -71.91 131.12 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-O 121.346 0.593 . . . . 71.12 111.616 -176.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 138' ' ' VAL . . . . . 0.523 HG11 ' SD ' ' C' ' 164' ' ' MET . 13.2 p -115.3 130.12 70.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 C-N-CA 124.684 1.194 . . . . 72.14 107.808 170.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 139' ' ' GLU . . . . . 0.523 ' H ' HG11 ' B' ' 182' ' ' VAL . 42.4 mt-10 -126.61 86.52 2.52 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 108.117 -1.068 . . . . 74.31 108.117 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 140' ' ' VAL . . . . . . . . . . . . . 11.0 m -125.39 107.59 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 123.25 0.62 . . . . 63.22 111.319 -175.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 141' ' ' ALA . . . . . 0.564 ' HB1' ' HA3' ' C' ' 81' ' ' GLY . . . 56.31 28.74 13.84 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.812 1.245 . . . . 15.23 113.27 173.08 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 119.49 -24.3 8.13 Favored Glycine 0 C--N 1.353 1.475 0 CA-C-N 116.5 -0.318 . . . . 45.25 113.663 177.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 143' ' ' ARG . . . . . 0.563 ' HG2' ' HG3' ' C' ' 164' ' ' MET . 0.3 OUTLIER -76.44 97.63 4.35 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.511 0.724 . . . . 73.04 109.059 178.838 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 40.9 ttp180 -113.42 95.45 5.37 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 109.17 -0.678 . . . . 71.51 109.17 176.333 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 145' ' ' VAL . . . . . . . . . . . . . 7.6 p -142.31 141.62 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 123.438 0.695 . . . . 75.03 111.254 -176.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 28.0 t -80.4 101.4 8.99 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 108.754 -0.832 . . . . 54.21 108.754 170.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 12.4 p -122.79 152.58 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.102 0.961 . . . . 72.53 110.014 -176.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -99.98 98.86 9.57 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 107.488 -1.301 . . . . 74.22 107.488 171.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 149' ' ' ILE . . . . . 0.653 HD12 HG21 ' C' ' 159' ' ' ILE . 45.9 pt -68.72 151.39 97.27 Favored Pre-proline 0 CA--C 1.55 0.961 0 N-CA-C 108.873 -0.788 . . . . 71.41 108.873 173.397 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -43.09 110.53 0.17 Allowed 'Trans proline' 0 C--N 1.387 2.604 0 C-N-CA 123.451 2.767 . . . . 61.44 113.543 -178.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -62.3 131.3 33.61 Favored 'Trans proline' 0 C--N 1.386 2.53 0 C-N-CA 122.786 2.324 . . . . 73.2 110.992 178.435 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 152' ' ' GLY . . . . . . . . . . . . . . . 102.13 61.57 0.74 Allowed Glycine 0 C--N 1.334 0.422 0 N-CA-C 110.396 -1.082 . . . . 54.32 110.396 -171.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 153' ' ' VAL . . . . . 0.501 ' HB ' HG12 ' C' ' 159' ' ' ILE . 0.9 OUTLIER -77.98 158.64 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 108.679 -0.86 . . . . 71.13 108.679 -179.691 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 154' ' ' ARG . . . . . 0.752 ' HG2' HD23 ' C' ' 188' ' ' LEU . 33.8 mtp180 -110.52 111.69 23.1 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 118.757 -0.639 . . . . 75.32 110.179 -170.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 155' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -43.29 120.29 1.84 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.735 1.214 . . . . 74.51 112.853 173.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.12 -7.8 20.47 Favored Glycine 0 C--N 1.354 1.551 0 C-N-CA 124.395 0.997 . . . . 64.51 114.182 177.058 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 157' ' ' SER . . . . . 0.522 ' HB2' ' HB2' ' C' ' 154' ' ' ARG . 69.4 m -109.91 -172.78 2.11 Favored 'General case' 0 C--O 1.246 0.905 0 C-N-CA 124.461 1.105 . . . . 75.43 110.735 -175.711 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 158' ' ' VAL . . . . . 0.448 HG21 HD22 ' C' ' 175' ' ' LEU . 12.1 p -88.25 138.99 18.07 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 CA-C-N 114.346 -1.297 . . . . 64.44 112.894 -170.762 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 159' ' ' ILE . . . . . 0.678 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 8.7 mt -108.31 93.25 2.41 Favored 'Isoleucine or valine' 0 C--O 1.245 0.819 0 N-CA-C 105.428 -2.064 . . . . 52.25 105.428 161.098 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -82.27 123.65 29.24 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 108.951 -0.759 . . . . 72.21 108.951 178.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 161' ' ' VAL . . . . . 0.653 HG13 ' HB3' ' C' ' 174' ' ' LEU . 2.0 p -126.47 95.9 37.22 Favored Pre-proline 0 C--O 1.247 0.966 0 N-CA-C 107.694 -1.225 . . . . 75.24 107.694 170.185 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.26 147.75 88.12 Favored 'Trans proline' 0 C--N 1.381 2.268 0 C-N-CA 122.499 2.133 . . . . 63.42 110.836 175.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 87.64 25.73 31.88 Favored Glycine 0 C--N 1.338 0.686 0 CA-C-O 119.372 -0.682 . . . . 53.31 112.039 -171.018 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 164' ' ' MET . . . . . 0.563 ' HG3' ' HG2' ' C' ' 143' ' ' ARG . 34.4 ttm -156.44 23.26 0.35 Allowed 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 117.373 0.586 . . . . 73.35 112.144 -177.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . -86.77 -160.94 35.46 Favored Glycine 0 N--CA 1.48 1.604 0 N-CA-C 114.36 0.504 . . . . 64.24 114.36 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . -96.63 -175.46 35.45 Favored Glycine 0 C--N 1.357 1.733 0 C-N-CA 123.02 0.343 . . . . 75.44 113.514 -177.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 167' ' ' GLN . . . . . . . . . . . . . 19.6 mm-40 -43.42 122.01 2.46 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 126.036 1.734 . . . . 64.31 113.334 -176.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . 177.07 -126.46 1.11 Allowed Glycine 0 C--N 1.349 1.288 0 CA-C-O 118.889 -0.951 . . . . 13.44 112.003 -175.038 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 169' ' ' ASN . . . . . 0.55 ' HB3' ' HD3' ' C' ' 170' ' ' PRO . 31.4 t30 -174.53 -66.57 0.0 OUTLIER Pre-proline 0 CA--C 1.565 1.532 0 CA-C-O 117.759 -1.115 . . . . 62.44 110.731 163.364 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 170' ' ' PRO . . . . . 0.55 ' HD3' ' HB3' ' C' ' 169' ' ' ASN . 6.9 Cg_exo -69.31 -70.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.403 3.439 0 CA-C-N 122.015 1.755 . . . . 51.41 113.685 -177.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 171' ' ' PRO . . . . . 0.51 ' HD3' ' HB2' ' C' ' 170' ' ' PRO . 85.0 Cg_endo -93.85 126.08 0.53 Allowed 'Trans proline' 0 C--N 1.405 3.542 0 CA-C-N 123.901 2.429 . . . . 74.02 111.521 178.512 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -154.43 107.79 0.34 Allowed Glycine 0 C--N 1.331 0.25 0 N-CA-C 109.293 -1.523 . . . . 74.42 109.293 176.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 173' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -126.06 121.99 34.53 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 123.447 0.699 . . . . 74.51 109.473 -166.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 174' ' ' LEU . . . . . 0.653 ' HB3' HG13 ' C' ' 161' ' ' VAL . 61.8 tp -81.96 107.3 14.57 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 109.467 -0.568 . . . . 75.22 109.467 177.412 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 175' ' ' LEU . . . . . 0.448 HD22 HG21 ' C' ' 158' ' ' VAL . 11.4 mt -89.76 87.91 7.16 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 115.632 -0.713 . . . . 71.32 109.641 174.502 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 176' ' ' LEU . . . . . 0.678 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 98.5 mt -73.8 98.12 2.89 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 108.431 -0.951 . . . . 43.02 108.431 171.211 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 177' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' C' ' 122' ' ' GLU . 23.7 t -81.24 97.96 3.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 106.585 -1.635 . . . . 74.43 106.585 178.253 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 178' ' ' VAL . . . . . 0.432 HG21 HG21 ' C' ' 153' ' ' VAL . 3.5 p -87.86 129.95 38.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.012 -0.994 . . . . 74.01 110.756 -169.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 179' ' ' ARG . . . . . 0.434 ' O ' ' HA ' ' C' ' 124' ' ' PRO . 7.4 mmm180 -115.26 107.05 14.76 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 106.216 -1.772 . . . . 72.33 106.216 169.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 180' ' ' LEU . . . . . 0.413 ' HA ' ' O ' ' C' ' 125' ' ' LEU . 80.8 mt -68.38 138.51 55.42 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 109.147 -0.686 . . . . 70.51 109.147 175.325 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 181' ' ' LEU . . . . . . . . . . . . . 86.7 mt -50.55 129.76 26.36 Favored Pre-proline 0 N--CA 1.495 1.817 0 CA-C-O 117.848 -1.072 . . . . 74.2 108.672 -173.016 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER 11.42 -67.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.39 2.723 1 C-N-CA 126.135 4.557 . . . . 64.12 116.329 -153.024 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 183' ' ' HIS . . . . . 0.478 ' CD2' HD22 ' C' ' 127' ' ' LEU . 37.7 t-80 57.29 73.33 0.79 Allowed Pre-proline 0 N--CA 1.479 0.992 0 C-N-CA 124.18 0.992 . . . . 62.13 111.964 168.667 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 184' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -93.22 59.22 0.44 Allowed 'Trans proline' 0 C--N 1.358 1.042 0 N-CA-C 107.678 -1.701 . . . . 71.54 107.678 163.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 185' ' ' VAL . . . . . 0.626 HG11 ' SD ' ' C' ' 213' ' ' MET . 2.2 t -119.5 -59.01 2.95 Favored 'Isoleucine or valine' 0 C--N 1.362 1.133 0 N-CA-C 108.652 -0.87 . . . . 72.23 108.652 178.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 186' ' ' PHE . . . . . 0.495 ' HZ ' ' HA ' ' C' ' 214' ' ' THR . 40.8 m-85 -128.82 173.02 10.73 Favored 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 113.564 0.95 . . . . 61.44 113.564 -172.447 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 187' ' ' ARG . . . . . 0.442 ' NH1' ' HB2' ' C' ' 189' ' ' GLU . 2.1 tmt_? -152.61 120.92 6.3 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.983 1.313 . . . . 75.14 108.138 167.377 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 188' ' ' LEU . . . . . 0.752 HD23 ' HG2' ' C' ' 154' ' ' ARG . 48.7 tp -85.59 129.9 34.7 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 118.765 0.711 . . . . 74.14 112.797 -175.578 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 189' ' ' GLU . . . . . 0.442 ' HB2' ' NH1' ' C' ' 187' ' ' ARG . 14.6 tp10 -133.8 122.41 23.24 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 107.618 -1.253 . . . . 71.33 107.618 165.647 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 67.27 -107.98 2.25 Favored Glycine 0 C--N 1.344 1.025 0 N-CA-C 111.473 -0.651 . . . . 74.2 111.473 -172.237 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 191' ' ' GLN . . . . . 0.442 ' NE2' ' HA3' ' C' ' 242' ' ' GLY . 24.7 mt-30 -122.93 -16.93 6.92 Favored 'General case' 0 C--O 1.258 1.513 0 C-N-CA 124.506 1.123 . . . . 60.21 109.446 174.247 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -81.37 135.8 35.69 Favored 'General case' 0 C--N 1.355 0.816 0 C-N-CA 124.76 1.224 . . . . 65.13 110.295 -178.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 193' ' ' LEU . . . . . 0.523 HD21 ' CD2' ' C' ' 240' ' ' PHE . 95.4 mt -92.9 154.04 18.44 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.771 0.428 . . . . 52.2 110.67 177.404 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 194' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -116.64 105.75 12.77 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.076 -1.453 . . . . 75.43 107.076 167.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 195' ' ' ALA . . . . . 0.527 ' HB3' ' HG ' ' C' ' 251' ' ' LEU . . . -103.07 -177.5 3.39 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 124.017 0.927 . . . . 65.11 110.536 177.569 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 46.7 m -134.64 110.83 9.55 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 108.702 -0.851 . . . . 51.32 108.702 168.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 197' ' ' LEU . . . . . 0.446 HD22 HD12 ' C' ' 233' ' ' LEU . 47.9 tp -85.22 146.13 27.23 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 109.139 -0.689 . . . . 73.5 109.139 174.707 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 198' ' ' ASP . . . . . 0.508 ' HA ' ' HB2' ' C' ' 254' ' ' ARG . 28.4 t70 -117.89 105.88 12.39 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 108.661 -0.866 . . . . 44.52 108.661 -179.395 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 199' ' ' VAL . . . . . 0.428 HG22 HG21 ' C' ' 210' ' ' VAL . 44.7 t -115.05 122.12 33.99 Favored Pre-proline 0 N--CA 1.48 1.046 0 C-N-CA 124.095 0.958 . . . . 61.21 109.435 -176.322 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 200' ' ' PRO . . . . . 0.451 ' HA ' ' O ' ' C' ' 256' ' ' THR . 55.3 Cg_endo -70.36 148.91 62.24 Favored 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 122.021 1.814 . . . . 71.34 111.341 175.278 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 201' ' ' ALA . . . . . . . . . . . . . . . -53.9 -45.41 98.92 Favored Pre-proline 0 CA--C 1.559 1.318 0 C-N-CA 124.844 1.258 . . . . 74.35 113.763 -172.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 202' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -55.49 -49.27 16.63 Favored 'Trans proline' 0 C--N 1.396 3.064 0 C-N-CA 121.879 1.719 . . . . 63.15 112.847 175.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 203' ' ' ILE . . . . . . . . . . . . . 58.0 mt -68.12 -33.14 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.721 0.808 . . . . 63.4 110.869 -178.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 204' ' ' ALA . . . . . 0.401 ' HA ' HG11 ' C' ' 223' ' ' VAL . . . -64.25 -44.07 92.93 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.653 0.781 . . . . 75.02 110.856 178.443 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 205' ' ' VAL . . . . . 0.503 ' HA ' ' HA ' ' C' ' 226' ' ' ARG . 87.0 t -75.4 -39.16 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 115.508 -0.769 . . . . 63.41 112.131 -176.719 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 206' ' ' VAL . . . . . 0.469 ' HA ' ' HE2' ' A' ' 270' ' ' LYS . 14.6 p -77.34 -37.04 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 CA-C-N 118.078 0.399 . . . . 52.12 110.635 -178.32 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 86.57 57.68 2.05 Favored Glycine 0 C--N 1.337 0.631 0 N-CA-C 111.384 -0.687 . . . . 63.21 111.384 -168.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -89.49 -131.61 4.36 Favored Glycine 0 C--N 1.345 1.075 0 N-CA-C 110.915 -0.874 . . . . 51.32 110.915 177.075 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 209' ' ' LYS . . . . . 0.513 ' HG2' ' HG2' ' C' ' 220' ' ' GLU . 4.6 ttmp? -150.44 143.35 24.72 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.345 0.658 . . . . 72.12 110.123 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 210' ' ' VAL . . . . . 0.428 HG21 HG22 ' C' ' 199' ' ' VAL . 30.4 m -134.34 167.98 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 C-N-CA 124.824 1.25 . . . . 62.05 109.486 177.491 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 211' ' ' ARG . . . . . 0.452 ' HA ' ' HA ' ' C' ' 220' ' ' GLU . 36.2 ttm180 -92.24 127.77 37.85 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 122.608 0.363 . . . . 72.44 111.027 179.247 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -102.47 122.99 45.41 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 107.817 -1.179 . . . . 74.43 107.817 164.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 213' ' ' MET . . . . . 0.626 ' SD ' HG11 ' C' ' 185' ' ' VAL . 1.3 tmt? -77.63 136.63 38.26 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.757 -0.831 . . . . 63.12 108.757 175.195 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 214' ' ' THR . . . . . 0.495 ' HA ' ' HZ ' ' C' ' 186' ' ' PHE . 0.1 OUTLIER -134.32 166.8 21.98 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.014 0.526 . . . . 54.24 110.932 178.15 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 215' ' ' LEU . . . . . 0.405 HD13 ' HB2' ' C' ' 131' ' ' PHE . 52.1 mt -60.12 -38.77 84.03 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.752 1.221 . . . . 44.41 112.851 -171.159 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.41 14.64 22.55 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.044 0.938 . . . . 71.0 111.844 -174.268 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 148.77 169.2 15.28 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-O 119.645 -0.531 . . . . 64.11 112.735 176.165 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -91.73 118.3 0.49 Allowed 'Trans proline' 0 CA--C 1.56 1.815 0 C-N-CA 122.829 2.353 . . . . 52.13 113.004 176.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 219' ' ' VAL . . . . . 0.491 HG12 ' OG1' ' C' ' 214' ' ' THR . 2.9 p -100.01 115.26 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.13 0.572 . . . . 52.53 110.174 178.512 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 220' ' ' GLU . . . . . 0.513 ' HG2' ' HG2' ' C' ' 209' ' ' LYS . 24.8 tt0 -82.93 103.79 12.66 Favored 'General case' 0 CA--C 1.556 1.173 0 N-CA-C 108.015 -1.106 . . . . 72.32 108.015 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 221' ' ' VAL . . . . . 0.469 HG21 HD11 ' C' ' 233' ' ' LEU . 7.6 p -101.79 138.87 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.648 0.779 . . . . 74.03 112.513 -168.543 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -81.45 117.58 21.99 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.839 1.256 . . . . 73.3 112.424 -173.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 223' ' ' VAL . . . . . 0.401 HG11 ' HA ' ' C' ' 204' ' ' ALA . 59.7 t -77.7 142.09 65.39 Favored Pre-proline 0 CA--C 1.564 1.491 0 C-N-CA 125.801 1.64 . . . . 73.11 110.423 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 224' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -84.47 155.26 12.26 Favored 'Trans proline' 0 C--N 1.384 2.444 0 C-N-CA 123.408 2.739 . . . . 54.33 113.188 174.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.88 117.67 4.33 Favored 'Trans proline' 0 C--N 1.382 2.306 0 C-N-CA 123.49 2.793 . . . . 74.0 113.3 176.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 226' ' ' ARG . . . . . 0.503 ' HA ' ' HA ' ' C' ' 205' ' ' VAL . 0.0 OUTLIER 65.35 88.69 0.1 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.652 1.581 . . . . 70.15 112.224 -177.917 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 227' ' ' THR . . . . . . . . . . . . . 58.4 m -106.5 131.57 53.53 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 114.337 -1.301 . . . . 70.3 110.345 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 228' ' ' GLN . . . . . 0.503 ' NE2' ' HG2' ' A' ' 259' ' ' GLU . 22.8 mp0 -103.81 152.68 21.61 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.833 0.853 . . . . 74.32 110.816 177.412 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -69.27 140.71 54.46 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.032 -0.985 . . . . 62.12 109.523 177.277 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 93.28 -3.88 73.14 Favored Glycine 0 C--N 1.338 0.654 0 CA-C-O 119.639 -0.534 . . . . 62.04 112.942 -174.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 231' ' ' ARG . . . . . 0.439 ' HD2' ' H ' ' C' ' 228' ' ' GLN . 54.3 mtt180 -64.81 174.51 1.82 Allowed 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 117.564 0.682 . . . . 74.12 111.376 168.157 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 232' ' ' LYS . . . . . 0.467 ' HA ' ' O ' ' C' ' 251' ' ' LEU . 2.6 ttmp? -143.29 151.43 40.51 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.641 0.734 . . . . 71.45 111.064 179.32 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 233' ' ' LEU . . . . . 0.553 HD13 HD13 ' C' ' 251' ' ' LEU . 1.9 tt -127.97 142.35 51.27 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.049 1.74 . . . . 74.21 107.873 -169.18 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 234' ' ' ARG . . . . . 0.424 ' HA ' ' O ' ' C' ' 249' ' ' LEU . 36.3 ptt180 -115.22 116.78 28.91 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 121.577 0.703 . . . . 72.34 111.379 173.492 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 235' ' ' LEU . . . . . 0.456 ' HB2' ' HB3' ' C' ' 249' ' ' LEU . 67.9 mt -109.63 99.42 8.61 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 108.839 -0.8 . . . . 73.43 108.839 171.593 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -69.4 126.19 28.99 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 114.335 -1.302 . . . . 71.55 110.949 -172.487 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 87.56 7.06 76.2 Favored Glycine 0 C--N 1.349 1.269 0 O-C-N 123.749 0.656 . . . . 71.42 113.956 -177.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 238' ' ' LYS . . . . . 0.43 ' HD2' HG21 ' C' ' 214' ' ' THR . 74.5 mmtt -109.91 17.16 21.43 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.469 0.708 . . . . 72.03 111.412 -178.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 239' ' ' GLY . . . . . 0.423 ' HA2' ' HG ' ' C' ' 193' ' ' LEU . . . -86.78 -166.11 42.06 Favored Glycine 0 C--N 1.348 1.239 0 N-CA-C 112.081 -0.408 . . . . 31.21 112.081 174.03 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 240' ' ' PHE . . . . . 0.523 ' CD2' HD21 ' C' ' 193' ' ' LEU . 2.2 m-85 -86.79 152.61 54.23 Favored Pre-proline 0 CA--C 1.558 1.261 0 N-CA-C 108.845 -0.798 . . . . 75.14 108.845 175.092 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 241' ' ' PRO . . . . . 0.43 ' HA ' ' HG2' ' C' ' 246' ' ' ARG . 31.5 Cg_exo -43.34 141.07 3.49 Favored 'Trans proline' 0 C--N 1.382 2.309 0 C-N-CA 124.622 3.548 . . . . 70.21 115.674 178.54 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 242' ' ' GLY . . . . . 0.442 ' HA3' ' NE2' ' C' ' 191' ' ' GLN . . . -133.88 148.95 19.61 Favored Glycine 0 C--N 1.348 1.217 0 CA-C-O 119.097 -0.835 . . . . 70.14 112.422 -176.528 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -60.09 -40.36 61.48 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 123.729 2.953 . . . . 71.42 113.462 -169.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -118.45 19.46 13.34 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.865 0.866 . . . . 71.42 110.787 -175.336 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 142.16 136.3 3.21 Favored Glycine 0 C--N 1.344 1.022 0 N-CA-C 110.063 -1.215 . . . . 51.32 110.063 -175.124 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 246' ' ' ARG . . . . . 0.43 ' HG2' ' HA ' ' C' ' 241' ' ' PRO . 90.5 mtt180 -78.25 150.72 33.37 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 117.349 0.575 . . . . 61.31 110.918 -172.352 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -72.76 -170.47 17.03 Favored Glycine 0 C--N 1.35 1.311 0 O-C-N 124.29 0.993 . . . . 63.23 114.831 -171.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -129.9 155.1 46.59 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.761 0.824 . . . . 73.54 109.017 -170.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 249' ' ' LEU . . . . . 0.486 HD11 ' HB2' ' C' ' 195' ' ' ALA . 24.0 tp -100.27 133.37 44.77 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.934 0.894 . . . . 74.23 110.89 -171.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 250' ' ' TYR . . . . . 0.488 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 1.0 OUTLIER -122.7 100.56 6.98 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.236 1.014 . . . . 71.43 111.084 178.662 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 251' ' ' LEU . . . . . 0.553 HD13 HD13 ' C' ' 233' ' ' LEU . 1.6 mp -97.0 125.69 41.6 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 118.9 -0.572 . . . . 64.53 110.586 -176.016 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -82.6 136.22 34.86 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 108.852 -0.795 . . . . 73.41 108.852 167.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 253' ' ' VAL . . . . . 0.485 HG21 ' CZ3' ' B' ' 242' ' ' TRP . 47.0 t -92.71 138.03 20.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 123.887 0.875 . . . . 73.5 112.82 -168.46 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 254' ' ' ARG . . . . . 0.508 ' HB2' ' HA ' ' C' ' 198' ' ' ASP . 20.6 mmt85 -102.65 136.07 43.15 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.2 1.4 . . . . 74.13 108.49 168.106 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 255' ' ' ILE . . . . . . . . . . . . . 32.7 mm -102.14 104.45 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 107.188 -1.412 . . . . 75.24 107.188 163.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 256' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' C' ' 200' ' ' PRO . 1.7 t -107.82 148.25 29.79 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.365 1.066 . . . . 53.32 109.902 -175.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 2.9 pp -111.9 145.73 33.31 Favored Pre-proline 0 N--CA 1.476 0.853 0 N-CA-C 109.393 -0.595 . . . . 64.54 109.393 176.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -60.4 -8.41 8.66 Favored 'Trans proline' 0 N--CA 1.507 2.268 0 C-N-CA 123.036 2.49 . . . . 73.21 115.36 -169.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 58.61 -68.5 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.572 1.549 . . . . 72.3 112.38 -168.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.17 149.68 44.75 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.771 0.829 . . . . 73.41 109.377 170.33 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 261' ' ' LEU . . . . . 0.521 HD11 HG13 ' A' ' 205' ' ' VAL . 77.6 mt -141.41 148.39 39.52 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.077 0.465 . . . . 71.21 111.089 -178.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 69.2 p -94.28 154.66 40.38 Favored Pre-proline 0 CA--C 1.554 1.129 0 N-CA-C 108.544 -0.91 . . . . 61.23 108.544 168.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -45.27 -45.06 15.52 Favored 'Trans proline' 0 C--N 1.391 2.798 0 C-N-CA 123.553 2.836 . . . . 74.2 114.188 -176.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -61.37 -52.59 64.01 Favored 'General case' 0 C--O 1.249 1.045 0 CA-C-N 115.1 -0.955 . . . . 71.04 110.856 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -52.06 -60.32 3.33 Favored 'General case' 0 C--N 1.362 1.129 0 O-C-N 124.537 1.148 . . . . 65.11 110.373 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 266' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -61.43 -33.82 74.35 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 124.179 0.924 . . . . 64.21 111.732 -172.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -59.63 -51.52 69.44 Favored 'General case' 0 CA--C 1.552 1.042 0 O-C-N 123.273 0.358 . . . . 70.32 111.359 173.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 268' ' ' LEU . . . . . . . . . . . . . 11.1 mp -66.61 -41.74 87.92 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 119.327 -0.368 . . . . 52.44 111.766 179.372 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -58.76 -38.57 78.74 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.654 0.782 . . . . 61.11 110.716 177.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 270' ' ' LYS . . . . . 0.503 ' HA ' HG21 ' A' ' 206' ' ' VAL . 9.6 mtpm? -66.51 -46.38 76.4 Favored 'General case' 0 C--N 1.361 1.091 0 C-N-CA 122.997 0.519 . . . . 75.43 111.139 176.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.83 -37.59 74.11 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 123.66 0.6 . . . . 75.33 111.405 178.366 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 82.5 mt -68.35 -42.48 79.16 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.537 -0.756 . . . . 74.33 110.356 174.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -67.58 -25.6 65.86 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.408 0.683 . . . . 34.13 111.369 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -81.31 -36.34 29.91 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.252 1.021 . . . . 63.21 109.879 176.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -61.02 -28.36 68.99 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.522 -0.763 . . . . 70.04 110.327 168.259 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 276' ' ' TYR . . . . . 0.534 ' HB3' HD11 ' A' ' 203' ' ' ILE . 7.9 m-85 -82.08 -32.4 30.32 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.419 1.088 . . . . 75.52 111.863 175.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 23.0 m-30 -64.68 -30.16 71.17 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 109.483 -0.562 . . . . 44.24 109.483 172.195 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -66.38 -15.48 63.32 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 123.784 0.834 . . . . 55.2 112.41 175.023 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 279' ' ' ARG . . . . . . . . . . . . . 26.3 mtp-105 -82.47 -15.67 51.66 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.1 0.56 . . . . 71.52 111.091 175.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.065 0 C-N-CA 122.938 0.495 . . . . 75.14 109.718 178.317 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 76.6 tttt . . . . . 0 N--CA 1.485 1.293 0 N-CA-C 114.312 1.227 . . . . 62.43 114.312 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -87.9 102.77 15.04 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 107.479 -1.304 . . . . 74.32 107.479 163.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.485 ' HA ' ' OH ' ' A' ' 66' ' ' TYR . 7.3 t0 -71.37 92.7 1.08 Allowed 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 108.455 -0.943 . . . . 61.41 108.455 178.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -62.93 -36.28 82.89 Favored 'General case' 0 C--O 1.244 0.796 0 C-N-CA 123.613 0.765 . . . . 73.34 111.979 -171.083 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.419 ' CE1' HD11 ' A' ' 22' ' ' ILE . 77.7 m-85 -62.98 -44.49 95.9 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.595 -0.73 . . . . 73.33 110.674 175.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.91 -36.91 83.33 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.965 0.506 . . . . 60.32 111.431 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 6' ' ' ASP . 76.3 mt -61.61 -41.69 91.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.134 0.574 . . . . 74.23 110.086 176.314 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.1 mt -75.28 -14.12 60.48 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-N 116.145 -0.48 . . . . 51.33 111.955 175.22 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.49 24.13 76.77 Favored Glycine 0 C--N 1.353 1.476 0 CA-C-N 116.745 -0.207 . . . . 53.33 113.256 -177.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.5 m -108.48 152.38 42.04 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 124.128 0.971 . . . . 71.43 110.008 178.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -58.87 152.51 57.08 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.904 2.402 . . . . 50.12 112.602 174.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -69.49 7.34 0.84 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 112.664 0.616 . . . . 75.43 112.664 178.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -128.44 28.5 5.44 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.025 1.33 . . . . 64.11 107.786 177.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.6 168.7 2.75 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.96 0.904 . . . . 64.31 111.436 176.236 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 67.2 p -114.08 172.91 6.71 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.275 0.63 . . . . 71.11 109.642 175.477 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -58.02 -36.53 72.82 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.327 0.651 . . . . 64.21 110.393 176.396 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -66.59 -43.96 83.48 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.474 0.709 . . . . 72.43 111.433 177.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -67.42 -40.2 85.54 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.204 0.602 . . . . 64.03 111.743 -178.454 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.601 HD13 ' HB3' ' A' ' 57' ' ' LEU . 69.0 mt -71.59 -38.78 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.135 0.974 . . . . 73.31 110.748 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -65.25 -50.94 63.85 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.198 -0.91 . . . . 71.24 110.295 177.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 31.9 mtm180 -67.52 -33.12 74.42 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.352 0.661 . . . . 54.12 111.565 -178.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.32 -49.91 73.74 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 123.902 0.751 . . . . 64.0 109.588 174.046 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -60.58 -44.02 96.68 Favored 'General case' 0 C--O 1.206 -1.19 0 O-C-N 124.088 0.868 . . . . 73.1 110.589 178.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -58.69 -46.74 86.58 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.846 0.859 . . . . 74.22 110.833 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 47.4 ttt180 -57.14 -53.85 53.42 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.134 0.974 . . . . 71.15 110.671 177.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.643 ' HB3' HD13 ' A' ' 50' ' ' ILE . 73.6 mt -77.35 -21.66 53.01 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 115.274 -0.875 . . . . 74.11 111.368 -172.476 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -80.29 -32.09 38.17 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.443 0.697 . . . . 63.3 110.785 178.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 78.3 mtp180 -81.08 -39.99 24.83 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 122.938 0.495 . . . . 72.33 110.245 174.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -70.12 -50.13 43.75 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.297 0.639 . . . . 63.33 111.34 -175.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.51 ' HE2' HD22 ' A' ' 29' ' ' LEU . 15.6 m-85 -100.21 30.19 3.94 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.153 0.581 . . . . 63.25 109.628 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -65.71 111.44 6.32 Favored Pre-proline 0 C--N 1.354 0.763 0 N-CA-C 108.59 -0.893 . . . . 63.41 108.59 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -53.87 -38.37 85.79 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 123.186 2.591 . . . . 74.13 113.778 -168.033 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -70.24 -28.94 65.65 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.055 0.942 . . . . 72.45 112.3 -179.006 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 46.9 t -88.51 -61.58 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 N-CA-C 109.122 -0.696 . . . . 65.53 109.122 177.194 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -100.13 90.26 4.31 Favored 'General case' 0 C--O 1.243 0.759 0 C-N-CA 124.384 1.074 . . . . 61.35 108.881 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -81.04 69.93 7.75 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 108.67 -0.863 . . . . 73.11 108.67 178.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.2 m -125.03 106.04 28.8 Favored Pre-proline 0 C--O 1.237 0.4 0 N-CA-C 107.883 -1.154 . . . . 54.41 107.883 178.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_exo -43.89 -44.7 11.78 Favored 'Trans proline' 0 C--N 1.388 2.626 0 C-N-CA 123.749 2.966 . . . . 72.23 112.979 -177.026 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -50.81 -52.43 41.24 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.395 1.078 . . . . 64.43 111.31 176.138 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.7 -28.45 69.08 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 114.434 -1.257 . . . . 72.14 110.426 -177.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -82.19 -33.6 29.37 Favored 'General case' 0 C--O 1.219 -0.55 0 O-C-N 123.936 0.772 . . . . 62.01 110.293 -175.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.651 ' HA ' ' HD3' ' A' ' 48' ' ' LYS . 44.0 mt-10 -66.89 -46.35 75.19 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.961 0.905 . . . . 62.44 109.983 176.266 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -62.22 -42.64 99.49 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 114.224 -1.353 . . . . 74.03 109.875 174.359 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -56.99 -40.53 76.73 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.302 1.041 . . . . 73.24 110.725 176.032 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.651 ' HD3' ' HA ' ' A' ' 45' ' ' GLU . 24.0 mtpp -60.68 -48.75 80.38 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.703 0.801 . . . . 75.14 109.982 177.291 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -65.57 -26.5 67.89 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 123.38 0.425 . . . . 71.44 111.848 177.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.643 HD13 ' HB3' ' A' ' 29' ' ' LEU . 72.7 mt -74.5 -29.49 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 124.241 1.016 . . . . 70.53 110.058 175.178 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -73.27 -35.08 66.12 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.126 0.57 . . . . 73.43 110.444 172.165 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -67.86 -45.31 74.93 Favored 'General case' 0 C--O 1.256 1.443 0 C-N-CA 124.76 1.224 . . . . 63.42 110.302 175.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.13 -51.31 70.15 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 113.762 -1.563 . . . . 65.45 110.186 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 92.5 t80 -63.26 -35.26 79.75 Favored 'General case' 0 C--O 1.205 -1.267 0 CA-C-N 114.7 -1.136 . . . . 72.32 110.691 174.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.04 -51.34 66.61 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.298 0.639 . . . . 53.01 111.838 -177.25 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 94.4 t -75.39 -38.78 40.7 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 CA-C-N 115.121 -0.945 . . . . 74.52 110.893 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.601 ' HB3' HD13 ' A' ' 22' ' ' ILE . 73.1 mt -89.02 3.97 49.88 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 113.43 0.9 . . . . 62.04 113.43 -174.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.2 t -68.18 -73.12 0.15 Allowed 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.751 0.821 . . . . 74.34 110.497 -179.326 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -83.41 120.54 75.75 Favored Pre-proline 0 C--O 1.25 1.095 0 N-CA-C 108.346 -0.983 . . . . 74.34 108.346 178.558 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.553 ' O ' ' HG3' ' A' ' 64' ' ' ARG . 9.5 Cg_endo -53.82 -19.76 15.76 Favored 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 123.582 2.855 . . . . 72.41 115.187 -172.179 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -72.63 -53.14 12.63 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 119.397 0.999 . . . . 72.3 111.183 178.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -56.25 -41.16 75.32 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 122.417 1.103 . . . . 74.54 110.112 173.31 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.477 ' HB3' ' HA ' ' A' ' 60' ' ' PRO . 32.6 ttt180 -60.12 -43.09 95.91 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 113.273 -1.785 . . . . 74.11 111.142 175.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.553 ' HG3' ' O ' ' A' ' 60' ' ' PRO . 42.1 mtm180 -62.04 -37.23 84.16 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-O 118.974 -0.536 . . . . 74.25 110.314 177.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 84.9 mt -57.65 -44.55 85.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 O-C-N 123.982 0.801 . . . . 64.42 109.655 176.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.485 ' OH ' ' HA ' ' A' ' 6' ' ' ASP . 35.1 t80 -61.13 -50.51 72.89 Favored 'General case' 0 CA--C 1.558 1.25 0 CA-C-N 115.912 -0.585 . . . . 75.4 111.163 175.126 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -65.26 -23.85 67.16 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.857 0.863 . . . . 64.04 112.425 -179.009 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 81.5 p -97.0 -7.3 33.32 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 122.855 0.462 . . . . 75.13 110.601 176.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -73.28 103.76 4.09 Favored 'General case' 0 C--N 1.353 0.737 0 N-CA-C 106.997 -1.483 . . . . 63.45 106.997 168.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 110.15 23.95 5.9 Favored Glycine 0 CA--C 1.531 1.055 0 N-CA-C 110.947 -0.861 . . . . 52.54 110.947 -164.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 94.3 m -145.69 -56.33 0.3 Allowed 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 104.633 -2.358 . . . . 71.23 104.633 172.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 85.8 m -89.85 148.22 23.31 Favored 'General case' 0 C--O 1.252 1.235 0 N-CA-C 105.23 -2.137 . . . . 74.23 105.23 157.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.78 -42.32 4.53 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 123.405 0.682 . . . . 74.04 110.895 -178.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.25 134.98 51.13 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 123.346 0.658 . . . . 75.1 109.315 177.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.414 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 75.0 Cg_exo -52.28 126.16 19.7 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.718 2.279 . . . . 75.41 111.749 175.537 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 75' ' ' PRO . 43.4 Cg_exo -57.51 160.99 12.76 Favored 'Trans proline' 0 C--N 1.375 1.974 0 C-N-CA 123.305 2.67 . . . . 74.25 113.562 -177.088 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -64.48 121.25 8.78 Favored 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 122.195 1.93 . . . . 62.44 111.523 173.035 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.479 ' HG3' ' HA3' ' A' ' 104' ' ' GLY . 35.9 Cg_endo -63.25 136.43 55.63 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 122.871 2.38 . . . . 43.51 111.702 177.466 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -57.89 157.07 25.61 Favored 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 123.183 2.589 . . . . 71.05 112.626 175.052 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -60.37 84.46 0.07 OUTLIER 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 122.801 2.334 . . . . 51.35 111.411 172.045 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.21 -32.3 0.32 Allowed Glycine 0 CA--C 1.525 0.672 0 CA-C-N 114.312 -1.313 . . . . 62.41 109.824 -176.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.92 156.32 31.37 Favored Glycine 0 C--N 1.351 1.366 0 C-N-CA 123.413 0.53 . . . . 53.03 113.072 171.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -63.06 94.47 0.07 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.809 0.843 . . . . 74.41 110.169 170.011 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -76.78 157.89 31.28 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 109.002 -0.74 . . . . 71.31 109.002 169.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.521 ' HE2' ' HD2' ' A' ' 93' ' ' PHE . 16.1 t80 -127.49 50.46 2.01 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.567 0.699 . . . . 70.22 109.563 -178.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 57.8 m -0.41 83.69 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.484 0 C-N-CA 127.288 2.235 . . . . 74.44 116.475 -174.056 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.86 -13.94 2.94 Favored Glycine 0 N--CA 1.482 1.748 0 N-CA-C 116.655 1.422 . . . . 70.11 116.655 168.257 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.502 ' HB3' ' HE2' ' A' ' 93' ' ' PHE . 63.5 m-85 -90.34 136.98 32.72 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 118.158 0.979 . . . . 72.34 110.179 -174.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -66.17 92.51 0.18 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.091 0.556 . . . . 71.44 110.695 -170.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.568 HG13 ' HG3' ' A' ' 91' ' ' GLU . 2.3 p -40.9 -51.49 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 125.12 1.368 . . . . 75.21 113.0 171.478 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.568 ' HG3' HG13 ' A' ' 90' ' ' VAL . 40.3 mt-10 -71.87 -12.1 61.11 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.614 0.766 . . . . 75.33 111.528 -173.139 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -87.09 -34.35 19.17 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.518 0.727 . . . . 45.35 110.632 174.095 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.521 ' HD2' ' HE2' ' A' ' 85' ' ' PHE . 26.5 m-85 -91.49 174.14 7.53 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.158 0.799 . . . . 71.01 113.158 -168.197 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 88.5 p -58.76 151.39 21.32 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 115.395 1.628 . . . . 74.5 115.395 -162.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.91 -42.87 80.72 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.028 -1.442 . . . . 74.31 110.877 170.316 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -50.61 -50.99 52.76 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.185 0.994 . . . . 75.03 111.042 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.478 ' HE2' HG23 ' A' ' 90' ' ' VAL . 1.4 t80 -59.69 -50.56 73.35 Favored 'General case' 0 CA--C 1.555 1.172 0 O-C-N 124.226 0.954 . . . . 63.23 109.829 174.147 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -66.56 -6.6 15.71 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.207 0.603 . . . . 73.05 112.249 -176.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -103.0 -30.95 10.47 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.168 0.987 . . . . 70.02 111.831 170.16 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 26.3 tp -73.59 -56.19 5.33 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.341 0.657 . . . . 55.03 110.842 -177.26 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -93.51 -6.55 46.54 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.115 0.566 . . . . 72.11 110.662 174.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -47.48 -55.75 8.93 Favored Glycine 0 C--N 1.351 1.394 0 CA-C-O 118.767 -1.018 . . . . 72.43 115.579 -177.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -46.4 -13.83 0.11 Allowed 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 124.792 3.661 . . . . 23.1 116.746 176.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.479 ' HA3' ' HG3' ' A' ' 78' ' ' PRO . . . -149.93 29.03 1.14 Allowed Glycine 0 C--N 1.355 1.585 0 CA-C-O 118.599 -1.112 . . . . 44.4 114.215 174.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.526 HD13 HD21 ' A' ' 169' ' ' ASN . 15.1 mt -60.99 79.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 113.005 0.743 . . . . 74.25 113.005 177.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.77 ' HB3' ' HA ' ' A' ' 169' ' ' ASN . 0.5 OUTLIER 24.72 -100.9 0.01 OUTLIER 'General case' 0 CA--C 1.569 1.7 0 C-N-CA 127.249 2.219 . . . . 72.25 113.956 170.175 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 80.06 6.28 89.23 Favored Glycine 0 C--N 1.363 2.046 0 CA-C-N 117.896 0.317 . . . . 44.0 113.431 -176.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.348 1.231 0 N-CA-C 111.317 -0.713 . . . . 71.34 111.317 -172.436 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 88.3 tttt . . . . . 0 CA--C 1.554 1.102 0 N-CA-C 111.756 0.28 . . . . 72.15 111.756 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -88.65 169.98 37.87 Favored Glycine 0 C--N 1.353 1.478 0 CA-C-N 116.337 -0.392 . . . . 55.22 112.961 178.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.418 ' H ' ' HD3' ' A' ' 117' ' ' ARG . 0.0 OUTLIER -113.95 -178.25 3.33 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.523 0.729 . . . . 71.34 110.353 -179.839 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -77.07 142.54 39.77 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 109.04 -0.726 . . . . 74.23 109.04 170.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.472 HD11 ' HB3' ' B' ' 10' ' ' LEU . 7.7 tt -144.18 125.75 14.98 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 107.658 -1.238 . . . . 70.23 107.658 -175.254 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.5 ' NH2' ' HB ' ' A' ' 177' ' ' VAL . 0.0 OUTLIER -97.58 126.44 42.88 Favored 'General case' 0 C--O 1.217 -0.625 0 N-CA-C 107.293 -1.373 . . . . 74.51 107.293 175.903 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.475 ' HB3' HD23 ' A' ' 176' ' ' LEU . . . -120.42 155.7 32.93 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-N 118.39 0.541 . . . . 41.51 111.534 -177.07 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.549 ' HB2' ' HB3' ' B' ' 9' ' ' ALA . 1.2 mm-40 -92.8 111.7 23.41 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 106.244 -1.761 . . . . 61.0 106.244 175.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.487 ' HB3' ' HA ' ' A' ' 178' ' ' VAL . 61.1 tp -101.35 96.17 5.79 Favored Pre-proline 0 N--CA 1.476 0.854 0 N-CA-C 108.29 -1.004 . . . . 54.05 108.29 177.153 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.645 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 58.5 Cg_endo -73.23 112.37 3.51 Favored 'Trans proline' 0 C--N 1.376 2.016 0 C-N-CA 121.406 1.404 . . . . 75.33 110.001 178.198 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.5 ' HB3' HD23 ' A' ' 180' ' ' LEU . 52.8 tp -116.73 138.9 51.13 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.413 0.625 . . . . 64.01 111.536 -168.526 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.633 ' HB ' ' HG2' ' A' ' 129' ' ' GLU . 93.3 m -72.3 125.73 28.06 Favored 'General case' 0 CA--C 1.553 1.072 0 CA-C-N 113.856 -1.52 . . . . 71.34 109.369 174.573 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.449 ' HB3' HD22 ' A' ' 215' ' ' LEU . 48.9 mt -53.4 -39.7 64.48 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 124.032 0.933 . . . . 70.54 112.249 -171.085 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -69.03 -33.85 74.28 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 115.465 -0.789 . . . . 75.32 110.628 -177.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.633 ' HG2' ' HB ' ' A' ' 126' ' ' THR . 12.2 mm-40 -72.99 -26.42 61.33 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 109.949 -0.389 . . . . 64.33 109.949 175.13 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.433 ' HB1' ' O ' ' A' ' 153' ' ' VAL . . . -66.7 -37.62 85.08 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 123.393 0.433 . . . . 41.43 110.54 174.109 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -65.38 -50.52 65.22 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 115.025 -0.989 . . . . 74.51 111.287 173.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 30.9 m170 -70.74 -45.19 65.29 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.183 0.593 . . . . 75.25 111.624 -171.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.07 -163.27 54.11 Favored Glycine 0 C--N 1.339 0.742 0 O-C-N 123.465 0.478 . . . . 71.54 112.834 -175.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 96.93 -173.84 29.64 Favored Glycine 0 C--N 1.345 1.051 0 N-CA-C 112.554 -0.219 . . . . 70.42 112.554 179.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 2.0 mp0 -78.88 109.53 13.24 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 122.655 -0.321 . . . . 73.14 110.357 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -90.97 126.46 36.08 Favored 'General case' 0 C--O 1.248 1.022 0 N-CA-C 109.317 -0.623 . . . . 74.4 109.317 173.117 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.412 HG13 ' HG3' ' A' ' 144' ' ' ARG . 76.3 t -80.31 116.31 24.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 114.742 -1.117 . . . . 71.24 108.483 168.047 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.638 ' HB ' HG13 ' A' ' 145' ' ' VAL . 62.2 t -124.75 129.21 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.08 0.952 . . . . 73.14 109.042 -175.683 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -98.03 142.92 29.15 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 122.996 0.518 . . . . 71.3 110.941 -177.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.549 ' HB ' ' HB3' ' B' ' 8' ' ' LEU . 8.1 p -160.67 121.86 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 C-N-CA 123.515 0.726 . . . . 75.1 111.023 174.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 65.51 14.3 9.4 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.471 1.108 . . . . 74.24 113.911 169.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 84.6 28.04 33.69 Favored Glycine 0 N--CA 1.479 1.518 0 N-CA-C 111.9 -0.48 . . . . 31.1 111.9 -174.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 17.9 tpt85 -152.62 97.31 2.23 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 107.737 -1.208 . . . . 72.12 107.737 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.549 ' NH1' ' HB2' ' A' ' 146' ' ' SER . 0.0 OUTLIER -64.54 129.96 41.86 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 114.908 -1.042 . . . . 74.41 111.424 179.375 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.638 HG13 ' HB ' ' A' ' 138' ' ' VAL . 1.4 p -91.79 130.09 41.46 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 C-N-CA 124.346 1.058 . . . . 73.53 109.223 165.388 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.549 ' HB2' ' NH1' ' A' ' 144' ' ' ARG . 47.5 t -92.96 132.03 37.43 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 108.317 -0.994 . . . . 31.45 108.317 167.531 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 2.1 p -139.81 118.01 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 O-C-N 123.65 0.594 . . . . 73.42 109.919 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.443 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 47.8 ttt85 -74.37 93.41 2.41 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 107.864 -1.162 . . . . 74.14 107.864 167.398 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.554 ' HB ' HG11 ' A' ' 153' ' ' VAL . 34.2 pt -71.75 125.23 91.7 Favored Pre-proline 0 CA--C 1.55 0.956 0 N-CA-C 108.408 -0.96 . . . . 74.13 108.408 175.463 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -59.39 138.28 83.3 Favored 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 122.371 2.048 . . . . 60.34 111.951 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -62.84 93.02 0.14 Allowed 'Trans proline' 0 C--N 1.374 1.877 0 C-N-CA 121.996 1.797 . . . . 74.15 110.116 171.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.503 ' HA2' ' CD2' ' A' ' 240' ' ' PHE . . . 125.02 24.21 1.69 Allowed Glycine 0 C--N 1.345 1.046 0 CA-C-N 115.1 -0.954 . . . . 75.51 113.084 -173.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.581 HG21 HD11 ' A' ' 159' ' ' ILE . 2.6 p -75.38 149.67 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 123.626 0.77 . . . . 75.43 110.366 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.467 ' O ' HG13 ' A' ' 178' ' ' VAL . 0.1 OUTLIER -119.24 -165.35 1.14 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.507 0.723 . . . . 73.23 112.099 -161.043 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.549 ' HB3' ' O ' ' A' ' 188' ' ' LEU . 3.0 tp10 -86.6 141.36 29.06 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 105.481 -2.044 . . . . 72.32 105.481 160.252 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 65.71 9.03 43.46 Favored Glycine 0 CA--C 1.535 1.311 0 N-CA-C 115.322 0.889 . . . . 14.21 115.322 177.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.501 ' O ' HG12 ' A' ' 178' ' ' VAL . 23.2 t -74.64 117.89 16.98 Favored 'General case' 0 C--N 1.355 0.833 0 N-CA-C 107.949 -1.13 . . . . 74.23 107.949 175.506 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.521 HG22 HG22 ' A' ' 177' ' ' VAL . 41.7 t -84.84 88.63 2.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.577 -0.898 . . . . 72.34 108.577 -178.025 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.581 HD11 HG21 ' A' ' 153' ' ' VAL . 30.0 mt -72.3 98.82 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 107.704 -1.221 . . . . 75.24 107.704 174.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -79.61 98.19 6.81 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 114.581 -1.19 . . . . 61.32 108.687 -176.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 3.4 p -123.51 94.92 45.81 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 123.649 0.78 . . . . 61.33 109.473 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.613 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 10.8 Cg_endo -56.65 143.67 88.47 Favored 'Trans proline' 0 C--N 1.363 1.336 0 C-N-CA 123.025 2.483 . . . . 74.53 112.874 167.475 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 95.51 20.37 27.27 Favored Glycine 0 N--CA 1.445 -0.764 0 CA-C-N 114.658 -1.155 . . . . 70.43 115.056 172.327 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.458 ' HG3' HG23 ' A' ' 145' ' ' VAL . 24.9 mmt -143.99 7.96 1.43 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.16 0.584 . . . . 64.15 110.433 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.563 ' HA2' HD13 ' A' ' 174' ' ' LEU . . . -90.55 -121.13 2.31 Favored Glycine 0 C--N 1.346 1.115 0 CA-C-N 115.672 -0.694 . . . . 73.33 114.436 -168.129 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.492 ' O ' ' HA ' ' A' ' 171' ' ' PRO . . . -60.94 115.71 8.25 Favored Glycine 0 C--N 1.362 2.007 0 CA-C-O 119.493 -0.615 . . . . 74.5 113.494 -169.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -59.59 146.25 41.5 Favored 'General case' 0 C--N 1.35 0.615 0 O-C-N 125.087 1.11 . . . . 75.42 111.034 -175.029 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 169.18 -125.25 1.24 Allowed Glycine 0 CA--C 1.495 -1.197 0 N-CA-C 106.816 -2.514 . . . . 64.21 106.816 -174.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' ASN . . . . . 0.77 ' HA ' ' HB3' ' A' ' 106' ' ' PHE . 43.4 t-20 -98.31 -57.09 0.17 Allowed Pre-proline 0 CA--C 1.55 0.981 0 N-CA-C 107.415 -1.328 . . . . 63.11 107.415 170.149 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.668 ' HD3' ' HB3' ' A' ' 169' ' ' ASN . 59.5 Cg_endo -95.03 109.18 0.13 Allowed 'Trans proline' 0 C--N 1.382 2.341 0 C-N-CA 122.033 1.822 . . . . 71.13 110.937 165.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.492 ' HA ' ' O ' ' A' ' 166' ' ' GLY . 29.6 Cg_endo -61.59 113.58 1.87 Allowed 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 121.74 1.627 . . . . 71.25 108.936 174.657 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -63.94 -142.06 0.02 OUTLIER Glycine 0 N--CA 1.484 1.841 0 N-CA-C 116.096 1.198 . . . . 72.4 116.096 -166.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.613 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 38.9 t70 -80.85 124.71 29.32 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 122.177 -0.602 . . . . 71.14 109.427 -177.368 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.563 HD13 ' HA2' ' A' ' 165' ' ' GLY . 26.9 tp -106.88 118.36 36.48 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.148 0.499 . . . . 64.32 110.5 -174.766 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.479 ' HB2' ' HA ' ' A' ' 120' ' ' ARG . 47.5 mt -94.58 85.53 4.54 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 124.061 0.944 . . . . 72.12 108.764 176.175 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.538 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 43.1 mt -72.73 84.37 1.19 Allowed 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.025 -0.534 . . . . 70.05 109.852 178.211 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.521 HG22 HG22 ' A' ' 158' ' ' VAL . 46.6 t -82.9 98.71 5.13 Favored 'Isoleucine or valine' 0 C--O 1.248 1.026 0 N-CA-C 104.917 -2.253 . . . . 61.43 104.917 176.225 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.501 HG12 ' O ' ' A' ' 157' ' ' SER . 10.0 p -76.27 113.29 15.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 112.108 -2.315 . . . . 70.33 111.001 -166.531 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.645 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 30.8 mmm-85 -90.16 106.45 18.49 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-N 115.499 -0.773 . . . . 53.32 108.989 178.19 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.5 HD23 ' HB3' ' A' ' 125' ' ' LEU . 23.3 mt -68.66 147.36 51.98 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 118.76 0.709 . . . . 72.4 110.29 177.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 125' ' ' LEU . 83.9 mt -55.37 159.1 4.8 Favored Pre-proline 0 N--CA 1.484 1.261 0 C-N-CA 124.17 0.988 . . . . 73.14 112.289 -176.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -74.87 24.01 0.39 Allowed 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 122.991 2.46 . . . . 71.42 112.689 170.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' HIS . . . . . 0.418 ' ND1' HD12 ' A' ' 127' ' ' LEU . 65.5 t-80 -61.62 116.09 18.67 Favored Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 125.231 1.412 . . . . 73.35 108.327 174.116 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -75.51 24.89 0.4 Allowed 'Trans proline' 0 C--N 1.371 1.727 0 C-N-CA 124.146 3.23 . . . . 61.24 116.902 -160.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 97.0 t -97.24 -57.82 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 119.168 0.895 . . . . 64.21 109.695 -179.297 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 186' ' ' PHE . . . . . 0.501 ' CE1' ' HB2' ' A' ' 195' ' ' ALA . 19.1 m-85 -132.87 143.61 49.63 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 112.551 0.574 . . . . 72.31 112.551 -171.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 187' ' ' ARG . . . . . 0.686 ' HB3' ' HB2' ' A' ' 194' ' ' TYR . 0.0 OUTLIER -114.12 83.33 1.85 Allowed 'General case' 0 C--O 1.239 0.508 0 N-CA-C 106.735 -1.58 . . . . 75.51 106.735 163.389 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.549 ' O ' ' HB3' ' A' ' 155' ' ' GLU . 48.1 tp -75.07 131.1 40.32 Favored 'General case' 0 C--O 1.202 -1.395 0 CA-C-N 114.465 -1.243 . . . . 74.21 109.367 177.076 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -147.2 129.89 16.05 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.089 -1.078 . . . . 70.31 108.089 171.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 66.26 -81.86 0.1 Allowed Glycine 0 C--N 1.344 0.98 0 O-C-N 124.352 1.032 . . . . 65.41 112.564 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.5 ' HB2' ' HA2' ' A' ' 247' ' ' GLY . 0.3 OUTLIER -129.97 -32.63 1.83 Allowed 'General case' 0 C--O 1.249 1.071 0 C-N-CA 123.834 0.853 . . . . 72.32 109.867 179.268 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -88.26 149.38 23.85 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.625 -0.716 . . . . 72.32 111.776 -166.285 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.478 HD23 ' HB2' ' A' ' 188' ' ' LEU . 88.6 mt -103.25 158.99 15.94 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.532 1.133 . . . . 63.44 108.97 173.05 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.686 ' HB2' ' HB3' ' A' ' 187' ' ' ARG . 28.5 m-85 -131.35 101.33 5.5 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 108.707 -0.849 . . . . 73.14 108.707 168.254 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.501 ' HB2' ' CE1' ' A' ' 186' ' ' PHE . . . -105.4 131.48 52.78 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 109.145 -0.687 . . . . 74.34 109.145 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 196' ' ' THR . . . . . 0.586 ' HA ' ' HB2' ' A' ' 252' ' ' GLU . 30.4 m -71.72 110.75 6.47 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 109.308 -0.627 . . . . 70.21 109.308 177.549 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.568 HD22 HD13 ' A' ' 251' ' ' LEU . 50.1 tp -103.15 101.14 11.09 Favored 'General case' 0 C--N 1.347 0.487 0 N-CA-C 110.111 -0.329 . . . . 72.21 110.111 -178.317 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -73.6 127.7 33.47 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.562 -1.273 . . . . 61.43 107.562 164.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.581 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 7.1 p -142.18 135.35 14.14 Favored Pre-proline 0 CA--C 1.539 0.545 0 N-CA-C 107.889 -1.152 . . . . 64.4 107.889 178.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.3 158.72 37.0 Favored 'Trans proline' 0 C--N 1.361 1.222 0 C-N-CA 121.475 1.45 . . . . 64.51 112.196 172.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.411 ' HB3' ' HD3' ' A' ' 202' ' ' PRO . . . -56.83 -49.66 92.57 Favored Pre-proline 0 N--CA 1.481 1.109 0 N-CA-C 113.233 0.827 . . . . 71.34 113.233 -178.08 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.411 ' HD3' ' HB3' ' A' ' 201' ' ' ALA . 57.1 Cg_exo -57.28 -45.42 35.14 Favored 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 121.953 1.768 . . . . 63.54 113.802 178.694 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 55.4 mt -71.39 -29.69 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 122.953 0.501 . . . . 64.32 110.86 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.89 -42.2 85.92 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.715 0.406 . . . . 71.51 110.391 175.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 46.0 t -68.85 -55.66 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.593 0.757 . . . . 63.23 111.292 -178.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.653 HG21 ' HA ' ' C' ' 270' ' ' LYS . 61.4 t -83.06 -41.69 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-O 120.872 0.367 . . . . 74.41 111.173 -172.05 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 88.96 168.89 44.27 Favored Glycine 0 C--N 1.338 0.692 0 CA-C-N 115.968 -0.56 . . . . 72.35 111.973 -174.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 161.32 -125.34 1.43 Allowed Glycine 0 C--O 1.224 -0.495 0 N-CA-C 110.149 -1.18 . . . . 55.24 110.149 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -137.97 135.74 36.29 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 118.099 0.95 . . . . 45.21 110.882 175.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 28.4 m -129.34 -176.71 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 124.181 0.993 . . . . 63.11 109.276 170.084 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -80.86 133.24 35.55 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.32 0.648 . . . . 71.41 110.765 176.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -119.92 111.94 18.57 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.542 -1.281 . . . . 62.04 107.542 165.137 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -71.81 129.16 37.96 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.055 -0.72 . . . . 71.23 109.055 177.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 43.4 p -109.27 179.82 4.05 Favored 'General case' 0 C--O 1.243 0.763 0 N-CA-C 107.744 -1.206 . . . . 74.1 107.744 171.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.449 HD22 ' HB3' ' A' ' 127' ' ' LEU . 72.2 mt -61.21 -22.11 64.46 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 114.021 1.119 . . . . 63.31 114.021 -170.166 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -142.64 28.7 1.6 Allowed 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 112.705 0.632 . . . . 64.44 112.705 -177.087 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 155.89 159.67 9.51 Favored Glycine 0 N--CA 1.477 1.419 0 N-CA-C 114.28 0.472 . . . . 33.0 114.28 173.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -87.69 130.39 2.7 Favored 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 123.199 2.599 . . . . 70.23 113.305 178.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 30.9 m -110.99 175.59 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 123.749 0.82 . . . . 73.4 110.262 175.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -101.82 111.22 23.4 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.803 0.841 . . . . 75.04 109.355 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 14.7 p -100.15 133.81 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 123.156 0.582 . . . . 74.13 109.584 177.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -86.64 104.47 16.08 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 122.955 0.502 . . . . 60.25 110.49 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 60.2 t -71.24 128.74 89.95 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 123.914 0.886 . . . . 63.14 109.857 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -74.62 167.02 28.07 Favored 'Trans proline' 0 C--N 1.373 1.835 0 C-N-CA 122.743 2.295 . . . . 75.51 111.636 172.11 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 225' ' ' PRO . . . . . 0.466 ' HB2' ' HE ' ' A' ' 226' ' ' ARG . 58.8 Cg_endo -70.35 159.99 51.07 Favored 'Trans proline' 0 C--N 1.365 1.418 0 C-N-CA 122.712 2.274 . . . . 72.53 113.441 171.02 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 226' ' ' ARG . . . . . 0.466 ' HE ' ' HB2' ' A' ' 225' ' ' PRO 0.266 0.0 OUTLIER 38.03 55.96 1.64 Allowed 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 126.428 1.891 . . . . 74.04 113.378 -175.913 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.522 HG23 HD21 ' A' ' 233' ' ' LEU . 64.2 m -84.2 90.44 7.51 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 113.06 -1.882 . . . . 64.32 108.953 173.198 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -86.15 146.45 26.58 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.766 0.826 . . . . 75.32 111.545 -171.159 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -64.8 148.45 51.23 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.846 0.858 . . . . 62.31 112.333 -176.046 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 230' ' ' GLY . . . . . 0.405 ' HA3' ' NH2' ' C' ' 254' ' ' ARG . . . 90.78 -21.16 34.71 Favored Glycine 0 C--N 1.345 1.041 0 CA-C-N 115.434 -0.803 . . . . 73.32 113.311 -178.609 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -81.2 170.81 15.64 Favored 'General case' 0 C--O 1.245 0.821 0 C-N-CA 123.757 0.823 . . . . 74.0 110.993 -179.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.444 ' HG3' ' HB3' ' A' ' 250' ' ' TYR . 0.3 OUTLIER -129.02 117.28 20.65 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 114.601 -1.181 . . . . 72.22 109.03 -178.892 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.522 HD21 HG23 ' A' ' 227' ' ' THR . 58.2 mt -78.33 110.86 13.73 Favored 'General case' 0 C--O 1.218 -0.558 0 N-CA-C 108.034 -1.098 . . . . 71.4 108.034 175.591 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -80.99 106.51 13.05 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.974 0.909 . . . . 64.14 109.974 175.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.598 HD12 ' HG3' ' A' ' 238' ' ' LYS . 0.2 OUTLIER -118.68 107.22 13.43 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.229 0.537 . . . . 61.12 109.757 171.912 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 248' ' ' ASP . 25.6 mtpp -76.52 159.75 30.08 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.36 1.064 . . . . 64.43 111.079 -177.632 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 66.37 18.56 67.63 Favored Glycine 0 C--N 1.348 1.207 0 CA-C-N 115.688 -0.687 . . . . 74.2 113.279 -176.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.598 ' HG3' HD12 ' A' ' 235' ' ' LEU . 45.5 mmtm -114.32 -29.93 6.76 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.229 1.011 . . . . 73.01 109.805 -179.065 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -79.04 -154.98 8.56 Favored Glycine 0 C--N 1.343 0.95 0 CA-C-N 115.001 -1.0 . . . . 74.43 111.107 169.033 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 240' ' ' PHE . . . . . 0.503 ' CD2' ' HA2' ' A' ' 152' ' ' GLY . 35.3 m-85 -95.35 123.44 56.72 Favored Pre-proline 0 C--O 1.239 0.504 0 N-CA-C 109.519 -0.548 . . . . 73.13 109.519 -173.383 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.728 ' HA ' ' HA ' ' A' ' 246' ' ' ARG . 73.8 Cg_endo -73.24 132.16 17.52 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 122.721 2.281 . . . . 73.33 113.116 -170.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -101.65 -167.48 27.44 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 110.757 -0.937 . . . . 73.52 110.757 167.225 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -60.07 -62.54 0.15 Allowed 'Trans proline' 0 C--N 1.377 2.037 0 C-N-CA 122.915 2.41 . . . . 70.45 111.649 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -106.34 -25.31 11.98 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.449 0.7 . . . . 70.11 110.104 170.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -89.84 67.42 2.7 Favored Glycine 0 C--N 1.352 1.447 0 CA-C-N 115.759 -0.655 . . . . 62.24 112.457 -175.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.728 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 52.3 mtm-85 -69.92 118.24 12.51 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 123.529 0.732 . . . . 75.41 109.853 175.592 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 247' ' ' GLY . . . . . 0.5 ' HA2' ' HB2' ' A' ' 191' ' ' GLN . . . -52.85 149.86 10.4 Favored Glycine 0 C--N 1.351 1.376 0 N-CA-C 117.346 1.698 . . . . 42.24 117.346 -167.678 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 248' ' ' ASP . . . . . 0.488 ' HA ' ' HA ' ' A' ' 236' ' ' LYS . 0.8 OUTLIER -98.46 172.87 7.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 113.858 -1.171 . . . . 75.44 109.173 -179.228 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.503 ' HB3' ' HG ' ' A' ' 235' ' ' LEU . 17.5 tp -137.06 101.78 4.65 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 106.21 -1.774 . . . . 70.31 106.21 170.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.444 ' HB3' ' HG3' ' A' ' 232' ' ' LYS . 84.6 m-85 -85.98 112.14 20.93 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 123.553 0.741 . . . . 52.51 109.219 174.535 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.568 HD13 HD22 ' A' ' 197' ' ' LEU . 94.0 mt -88.92 121.12 30.96 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.152 -0.931 . . . . 72.24 110.065 178.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 252' ' ' GLU . . . . . 0.586 ' HB2' ' HA ' ' A' ' 196' ' ' THR . 45.9 mm-40 -75.15 91.49 2.6 Favored 'General case' 0 C--N 1.352 0.711 0 N-CA-C 108.132 -1.062 . . . . 75.41 108.132 177.431 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 42.0 t -65.41 115.59 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 O-C-N 123.705 0.628 . . . . 24.43 110.239 -178.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 254' ' ' ARG . . . . . 0.478 ' HD3' ' HA ' ' A' ' 254' ' ' ARG . 7.2 mmt180 -129.23 102.22 6.36 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.703 0.801 . . . . 73.14 108.921 172.149 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.581 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 60.9 mt -77.38 134.04 29.4 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-N 114.174 -1.375 . . . . 74.34 110.706 -179.14 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 28.4 p -127.7 174.5 9.05 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.638 1.175 . . . . 73.43 109.503 173.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.9 pp -134.98 152.89 78.08 Favored Pre-proline 0 CA--C 1.567 1.625 0 C-N-CA 123.583 0.753 . . . . 73.4 110.768 -177.007 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -65.95 -6.77 15.06 Favored 'Trans proline' 0 N--CA 1.51 2.448 0 C-N-CA 123.854 3.036 . . . . 74.45 115.58 -166.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 259' ' ' GLU . . . . . 0.446 ' O ' ' HG2' ' C' ' 226' ' ' ARG . 39.1 mt-10 48.16 -83.62 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.751 1.221 . . . . 63.24 112.368 -164.63 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 7.1 ppt_? -61.02 137.86 58.21 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.388 0.675 . . . . 75.12 110.115 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.473 HD13 ' HA ' ' A' ' 266' ' ' GLU . 74.1 mt -137.86 140.92 40.68 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.321 0.581 . . . . 55.32 111.1 -172.072 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 37.0 p -83.4 138.74 41.57 Favored Pre-proline 0 CA--C 1.554 1.097 0 CA-C-O 117.683 -1.151 . . . . 44.34 108.745 175.014 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 263' ' ' PRO . . . . . 0.403 ' O ' ' HB3' ' A' ' 266' ' ' GLU . 24.6 Cg_exo -24.79 -56.02 0.07 OUTLIER 'Trans proline' 0 C--N 1.386 2.55 1 C-N-CA 126.309 4.673 . . . . 74.33 117.382 -169.481 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -80.94 -33.22 34.14 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 112.481 0.548 . . . . 71.44 112.481 -173.454 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -69.95 -35.61 74.64 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 122.833 0.453 . . . . 64.2 110.066 174.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 266' ' ' GLU . . . . . 0.473 ' HA ' HD13 ' A' ' 261' ' ' LEU . 8.1 tp10 -54.36 -52.98 59.9 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 124.119 0.968 . . . . 73.45 109.091 169.065 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 267' ' ' ALA . . . . . 0.538 ' O ' ' HG3' ' A' ' 271' ' ' LYS . . . -57.42 -43.96 84.24 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 114.291 -1.322 . . . . 64.12 111.486 177.484 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 4.7 mp -59.55 -53.23 60.53 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 123.983 0.913 . . . . 73.14 111.286 -176.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -53.88 -48.15 70.35 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 124.198 0.937 . . . . 75.0 110.608 175.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 270' ' ' LYS . . . . . 0.533 ' HG3' HG23 ' C' ' 206' ' ' VAL . 1.0 OUTLIER -62.76 -34.82 78.03 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 123.875 0.735 . . . . 62.43 112.715 -179.327 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 271' ' ' LYS . . . . . 0.538 ' HG3' ' O ' ' A' ' 267' ' ' ALA . 64.2 mttm -62.33 -59.03 5.58 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.814 -0.81 . . . . 70.22 108.814 177.307 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 272' ' ' LEU . . . . . 0.534 ' O ' ' HB2' ' A' ' 276' ' ' TYR . 82.2 mt -49.2 -46.19 45.35 Favored 'General case' 0 C--N 1.358 0.963 0 O-C-N 125.564 1.79 . . . . 63.4 110.366 178.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 273' ' ' ALA . . . . . 0.488 ' HA ' ' HB2' ' C' ' 202' ' ' PRO . . . -79.12 -47.73 15.57 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 114.556 1.317 . . . . 64.51 114.556 -165.219 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -74.48 -31.4 62.2 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 110.123 -0.325 . . . . 74.35 110.123 -178.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 275' ' ' ALA . . . . . 0.449 ' O ' ' HG3' ' A' ' 279' ' ' ARG . . . -68.19 -42.04 80.51 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 109.756 -0.461 . . . . 71.44 109.756 169.663 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 276' ' ' TYR . . . . . 0.534 ' HB2' ' O ' ' A' ' 272' ' ' LEU . 32.7 t80 -56.26 -49.99 72.64 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 124.906 1.283 . . . . 75.02 110.683 178.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -64.18 -41.57 97.05 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 114.556 -1.202 . . . . 70.12 109.54 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -68.99 -10.42 57.39 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 123.432 0.693 . . . . 75.41 112.599 176.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 279' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 275' ' ' ALA . 74.4 mtt180 -89.51 -11.28 43.34 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.377 0.671 . . . . 74.13 111.23 175.328 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.302 0 N-CA-C 109.206 -0.664 . . . . 72.21 109.206 177.851 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.41 ' HB2' ' HB2' ' B' ' 4' ' ' SER . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.407 0 N-CA-C 108.683 -0.858 . . . . 71.44 108.683 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -81.16 -46.96 14.11 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 108.352 -0.981 . . . . 54.1 108.352 170.233 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 20.6 mm-40 -138.43 91.38 2.54 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.395 1.478 . . . . 74.04 108.531 173.108 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 4' ' ' SER . . . . . 0.41 ' HB2' ' HB2' ' B' ' 1' ' ' MET . 47.6 t -108.35 151.69 25.66 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 123.991 0.916 . . . . 52.14 108.774 174.237 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 4.5 m -123.87 156.19 36.68 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 123.121 0.568 . . . . 70.11 110.813 -172.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.444 HG21 ' HA ' ' A' ' 125' ' ' LEU . 25.8 pt -139.32 174.21 9.81 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 C-N-CA 124.325 1.05 . . . . 64.44 111.449 -165.325 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -115.15 -163.31 0.87 Allowed 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.113 0.965 . . . . 72.01 110.295 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 8' ' ' LEU . . . . . 0.57 HD22 HG11 ' A' ' 145' ' ' VAL . 14.9 tp -148.09 178.89 8.16 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.129 0.571 . . . . 75.22 110.66 -178.388 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 9' ' ' ALA . . . . . 0.549 ' HB3' ' HB2' ' A' ' 122' ' ' GLU . . . -156.91 105.51 2.18 Favored 'General case' 0 C--N 1.358 0.937 0 C-N-CA 124.576 1.15 . . . . 62.4 108.389 178.161 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 10' ' ' LEU . . . . . 0.472 ' HB3' HD11 ' A' ' 119' ' ' LEU . 93.6 mt -79.59 121.27 25.05 Favored 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 123.997 0.919 . . . . 74.1 111.522 -173.475 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.459 ' O ' ' HG ' ' A' ' 119' ' ' LEU . 2.9 mt . . . . . 0 N--CA 1.506 2.357 0 C-N-CA 124.679 1.191 . . . . 45.35 109.195 -178.236 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.823 0 N-CA-C 109.618 -0.512 . . . . 61.34 109.618 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 180' ' ' ALA . . . . . 0.514 ' HB1' ' HB ' ' C' ' 137' ' ' VAL . . . 61.5 -79.19 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 124.461 1.104 . . . . 74.4 109.881 -165.63 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 181' ' ' LEU . . . . . 0.578 HD22 ' HB2' ' C' ' 136' ' ' ARG . 15.4 tp -168.29 21.48 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.315 0 C-N-CA 123.587 0.755 . . . . 62.04 110.364 172.508 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 182' ' ' VAL . . . . . . . . . . . . . 26.2 t -136.16 148.98 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.403 -0.81 . . . . 71.31 110.701 -173.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -149.07 -72.38 0.19 Allowed 'General case' 0 C--N 1.359 0.999 0 C-N-CA 123.376 0.67 . . . . 65.24 110.933 169.151 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 56.0 p-80 -150.52 161.37 42.67 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 122.402 0.281 . . . . 74.15 111.548 -174.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 185' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 CA--C 1.561 1.379 0 C-N-CA 124.389 1.076 . . . . 71.33 109.065 175.844 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 20.8 m . . . . . 0 CA--C 1.553 1.081 0 CA-C-O 120.974 0.416 . . . . 71.31 111.206 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -75.86 145.57 40.46 Favored 'General case' 0 C--N 1.348 0.532 0 C-N-CA 123.833 0.853 . . . . 74.42 112.262 -177.294 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 240' ' ' GLY . . . . . 0.508 ' H ' HD22 ' C' ' 235' ' ' LEU . . . -74.93 -138.78 0.59 Allowed Glycine 0 CA--C 1.533 1.158 0 CA-C-N 114.656 -1.157 . . . . 71.23 111.984 168.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -158.93 172.65 17.82 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.068 0.547 . . . . 71.21 111.221 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 242' ' ' TRP . . . . . 0.543 ' HH2' HG21 ' C' ' 227' ' ' THR . 0.0 OUTLIER -157.2 -46.65 0.07 Allowed 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.247 1.419 . . . . 70.32 108.514 -172.147 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 243' ' ' GLN . . . . . 0.593 ' HB2' ' HG2' ' C' ' 224' ' ' PRO . 35.8 mt-30 -117.76 -170.06 1.8 Allowed 'General case' 0 C--O 1.247 0.928 0 N-CA-C 107.71 -1.218 . . . . 74.22 107.71 166.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -78.37 89.4 1.11 Allowed Glycine 0 C--N 1.345 1.036 0 N-CA-C 111.147 -0.781 . . . . 63.11 111.147 171.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 1.7 pptp? . . . . . 0 N--CA 1.478 0.971 0 C-N-CA 123.05 0.54 . . . . 75.34 111.513 -177.802 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.916 0 N-CA-C 110.257 -0.275 . . . . 52.01 110.257 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 5.0 ttmp? -38.33 99.43 0.02 OUTLIER 'General case' 0 C--N 1.364 1.2 0 C-N-CA 124.691 1.196 . . . . 70.52 113.536 -176.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 5' ' ' LYS . . . . . 0.453 ' HG3' ' OG ' ' C' ' 94' ' ' SER . 1.3 mmmp? -67.64 96.87 0.57 Allowed 'General case' 0 C--O 1.241 0.651 0 N-CA-C 107.319 -1.363 . . . . 63.2 107.319 165.497 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 6' ' ' ASP . . . . . 0.481 ' HA ' ' OH ' ' C' ' 66' ' ' TYR . 38.4 t70 -70.42 96.56 1.16 Allowed 'General case' 0 C--N 1.348 0.539 0 N-CA-C 108.453 -0.943 . . . . 63.22 108.453 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 7' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -58.36 -34.32 70.54 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 113.835 -1.53 . . . . 73.43 111.737 -173.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -62.0 -47.22 85.76 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 115.777 -0.647 . . . . 72.53 110.42 175.031 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.99 -40.32 93.0 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.252 0.621 . . . . 52.31 111.288 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 10' ' ' ILE . . . . . 0.411 HG22 HD13 ' C' ' 50' ' ' ILE . 58.6 mt -60.93 -39.59 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.079 0.552 . . . . 63.34 110.227 176.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 11' ' ' LEU . . . . . 0.417 ' HB2' HG22 ' C' ' 13' ' ' VAL . 87.0 mt -80.26 -6.97 58.77 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 112.785 0.661 . . . . 45.45 112.785 177.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 69.2 31.39 71.85 Favored Glycine 0 C--N 1.353 1.5 0 O-C-N 123.055 0.222 . . . . 64.33 113.189 -178.458 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 13' ' ' VAL . . . . . 0.417 HG22 ' HB2' ' C' ' 11' ' ' LEU . 26.9 m -126.34 154.67 74.78 Favored Pre-proline 0 N--CA 1.481 1.107 0 C-N-CA 124.932 1.293 . . . . 64.04 109.268 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -80.36 167.56 19.23 Favored 'Trans proline' 0 C--N 1.371 1.743 0 C-N-CA 122.401 2.067 . . . . 74.43 112.754 178.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -72.85 74.29 1.14 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.12 0.968 . . . . 71.52 109.652 173.145 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -178.3 -19.3 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.164 1.386 . . . . 71.24 108.538 -176.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -49.42 112.04 0.58 Allowed 'General case' 0 C--N 1.354 0.782 0 C-N-CA 125.176 1.391 . . . . 71.14 112.345 175.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 77.9 p -73.62 -177.94 2.91 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.011 0.925 . . . . 74.41 111.429 -178.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -51.74 -52.25 50.06 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.307 0.643 . . . . 74.45 111.846 -176.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -67.18 -32.01 72.81 Favored 'General case' 0 C--O 1.206 -1.227 0 CA-C-O 118.679 -0.677 . . . . 64.05 112.107 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -68.92 -40.77 78.87 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 119.014 0.824 . . . . 73.42 110.767 -179.221 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 22' ' ' ILE . . . . . 0.884 HD13 ' HB3' ' C' ' 57' ' ' LEU . 96.6 mt -69.62 -37.77 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.553 1.141 . . . . 61.32 110.199 174.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 23' ' ' LYS . . . . . 0.475 ' O ' ' HG3' ' C' ' 27' ' ' LYS . 10.4 tppt? -65.41 -42.86 92.08 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 114.942 -1.026 . . . . 74.13 109.636 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 24' ' ' ARG . . . . . 0.438 ' HA ' ' HD2' ' C' ' 27' ' ' LYS . 97.3 mtt180 -77.71 -28.23 50.84 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 124.607 1.163 . . . . 73.52 110.669 -177.608 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.72 -43.65 95.9 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 123.895 0.747 . . . . 75.32 109.065 172.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 26' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -65.08 -45.36 85.55 Favored 'General case' 0 C--O 1.213 -0.818 0 CA-C-N 114.939 -1.028 . . . . 72.31 110.886 176.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 27' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' C' ' 23' ' ' LYS . 83.9 mttt -55.57 -46.19 77.22 Favored 'General case' 0 N--CA 1.502 2.14 0 C-N-CA 123.824 0.85 . . . . 74.1 110.143 178.569 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 25.0 ttm180 -56.07 -56.58 19.1 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 114.338 -1.301 . . . . 71.15 110.203 178.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 29' ' ' LEU . . . . . 0.622 HD13 HD12 ' C' ' 50' ' ' ILE . 66.1 mt -80.46 -9.61 59.76 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 114.543 -1.208 . . . . 60.22 111.636 -172.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.77 -27.52 26.83 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.702 0.801 . . . . 75.32 110.248 173.282 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 81.9 mtm180 -90.9 -21.71 21.26 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 123.56 0.537 . . . . 73.5 111.107 171.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -82.55 -55.67 4.33 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.363 0.665 . . . . 71.12 110.187 -178.355 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -89.63 17.08 6.8 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.221 0.609 . . . . 70.15 110.984 178.225 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 34' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -47.14 94.8 0.08 OUTLIER Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 125.151 1.38 . . . . 72.34 112.365 -169.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -75.35 -8.87 20.02 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 123.313 2.675 . . . . 71.32 112.817 -164.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -65.05 -41.32 95.26 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.62 1.168 . . . . 60.34 110.107 171.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 88.5 t -97.06 -48.11 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 115.683 -0.69 . . . . 75.33 109.868 -178.238 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -97.0 75.02 2.62 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 108.152 -1.055 . . . . 54.22 108.152 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 10.5 mtmp? -75.8 75.83 2.75 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 114.377 -1.283 . . . . 62.24 109.247 177.416 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 49.7 m -139.42 132.72 15.59 Favored Pre-proline 0 C--O 1.245 0.831 0 CA-C-N 115.027 -0.988 . . . . 74.14 109.847 -176.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 41' ' ' PRO . . . . . 0.548 ' HA ' ' HB2' ' C' ' 44' ' ' GLU . 81.7 Cg_exo -47.37 -33.16 16.22 Favored 'Trans proline' 0 C--N 1.389 2.709 0 C-N-CA 124.049 3.166 . . . . 63.44 113.059 174.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -45.17 -59.62 2.54 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.418 1.087 . . . . 65.44 110.494 171.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.6 -7.93 59.65 Favored 'General case' 0 C--O 1.211 -0.923 0 CA-C-N 114.339 -1.301 . . . . 62.05 110.646 -177.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 44' ' ' GLU . . . . . 0.548 ' HB2' ' HA ' ' C' ' 41' ' ' PRO . 22.0 mm-40 -78.26 -60.57 2.32 Favored 'General case' 0 C--O 1.213 -0.825 0 N-CA-C 108.422 -0.955 . . . . 74.04 108.422 175.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -53.28 -47.89 68.79 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.147 0.979 . . . . 42.53 110.925 176.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 46' ' ' LYS . . . . . 0.509 ' O ' HG12 ' C' ' 50' ' ' ILE . 49.4 mttp -65.48 -52.28 53.99 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.301 -0.863 . . . . 72.32 112.32 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -68.98 -23.1 64.08 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 118.511 0.596 . . . . 62.23 111.624 -178.225 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 48' ' ' LYS . . . . . 0.436 ' HD3' ' O ' ' C' ' 44' ' ' GLU . 13.1 mptt -75.85 -35.89 59.78 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 122.59 0.356 . . . . 72.04 110.27 177.174 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -67.28 -33.23 74.87 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 117.763 0.256 . . . . 72.33 110.351 170.102 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 50' ' ' ILE . . . . . 0.622 HD12 HD13 ' C' ' 29' ' ' LEU . 22.8 mm -66.34 -38.88 82.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 N-CA-C 109.538 -0.542 . . . . 75.43 109.538 173.523 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 51' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -65.3 -42.29 93.2 Favored 'General case' 0 C--O 1.204 -1.335 0 C-N-CA 123.637 0.775 . . . . 74.04 110.08 178.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -61.82 -52.73 62.97 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.329 1.052 . . . . 63.42 110.097 177.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.13 -56.56 19.41 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-N 113.582 -1.644 . . . . 63.1 111.571 -176.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -64.51 -35.82 82.2 Favored 'General case' 0 C--O 1.204 -1.318 0 CA-C-N 114.19 -1.368 . . . . 75.01 111.226 177.159 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.78 -39.72 92.66 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 118.779 0.718 . . . . 60.54 111.747 -176.046 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 78.8 t -72.94 -50.34 33.27 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 O-C-N 123.597 0.56 . . . . 72.43 109.715 174.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 57' ' ' LEU . . . . . 0.884 ' HB3' HD13 ' C' ' 22' ' ' ILE . 60.9 mt -88.12 1.43 54.36 Favored 'General case' 0 CA--C 1.56 1.362 0 N-CA-C 114.582 1.327 . . . . 75.02 114.582 -168.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 41.5 t -55.8 -38.08 69.47 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 124.599 1.16 . . . . 62.42 112.719 -173.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -121.41 137.91 27.54 Favored Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 107.409 -1.33 . . . . 72.03 107.409 -168.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 60' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -48.9 -36.64 34.75 Favored 'Trans proline' 0 C--N 1.381 2.261 0 C-N-CA 123.839 3.026 . . . . 33.23 113.441 -177.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -58.12 -66.76 0.43 Allowed 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 114.261 -1.336 . . . . 62.13 111.398 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 1.8 mtpm? -72.4 -23.31 61.08 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.54 0.736 . . . . 75.23 111.7 -174.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 -57.24 -50.13 73.85 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.276 -0.874 . . . . 64.42 109.153 169.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 64' ' ' ARG . . . . . 0.514 ' HA ' ' HB2' ' C' ' 67' ' ' ASP . 27.4 mmt180 -72.7 -21.81 60.99 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.636 -0.711 . . . . 74.15 112.117 178.701 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 1.6 mp -58.86 -46.92 90.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-N 118.556 0.616 . . . . 62.34 109.417 167.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 66' ' ' TYR . . . . . 0.481 ' OH ' ' HA ' ' C' ' 6' ' ' ASP . 37.0 t80 -62.41 -51.41 67.65 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 115.78 -0.646 . . . . 74.22 110.52 174.607 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 67' ' ' ASP . . . . . 0.514 ' HB2' ' HA ' ' C' ' 64' ' ' ARG . 27.4 m-20 -59.83 -31.14 69.46 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.704 0.802 . . . . 73.14 112.021 -176.619 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 39.9 p -81.31 -26.93 35.26 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 119.269 -0.396 . . . . 63.2 110.986 176.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 69' ' ' TYR . . . . . 0.402 ' HE2' ' HE1' ' C' ' 96' ' ' PHE . 71.2 t80 -72.6 133.52 44.73 Favored 'General case' 0 C--N 1.359 1.019 0 N-CA-C 108.518 -0.919 . . . . 75.22 108.518 173.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.46 16.94 41.11 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.286 -0.726 . . . . 62.51 111.286 -164.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 63.1 m -146.76 -61.42 0.3 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 103.497 -2.779 . . . . 72.34 103.497 172.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 28.3 m -76.5 142.08 41.04 Favored 'General case' 0 C--O 1.25 1.099 0 N-CA-C 104.997 -2.223 . . . . 73.35 104.997 157.116 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.46 -10.74 8.39 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.342 0.657 . . . . 73.23 110.82 177.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -77.5 138.61 63.26 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 123.242 0.617 . . . . 53.23 109.529 171.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -63.16 136.66 57.2 Favored 'Trans proline' 0 C--N 1.373 1.836 0 C-N-CA 122.602 2.201 . . . . 75.14 111.808 174.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.04 159.37 53.31 Favored 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 123.323 2.682 . . . . 63.14 112.229 -178.282 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -59.51 116.38 3.25 Favored 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 122.693 2.262 . . . . 51.51 112.637 174.151 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 78' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -68.48 136.5 36.8 Favored 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 122.675 2.25 . . . . 74.44 111.82 175.262 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 79' ' ' PRO . . . . . 0.621 ' HB3' ' HA3' ' C' ' 142' ' ' GLY . 38.5 Cg_exo -45.77 159.46 0.21 Allowed 'Trans proline' 0 CA--C 1.567 2.134 0 C-N-CA 123.955 3.103 . . . . 61.04 114.303 166.27 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -66.02 84.21 0.25 Allowed 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 123.075 2.516 . . . . 51.5 111.892 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 146.67 -28.19 1.62 Allowed Glycine 0 C--N 1.336 0.567 0 CA-C-N 114.668 -1.151 . . . . 75.2 110.799 -178.149 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 146.93 173.77 18.43 Favored Glycine 0 C--N 1.344 1.026 0 C-N-CA 123.857 0.741 . . . . 74.45 112.004 172.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 83' ' ' TYR . . . . . 0.478 ' HA ' ' HD2' ' C' ' 79' ' ' PRO . 76.5 m-85 -52.05 120.34 5.29 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.009 0.924 . . . . 70.14 110.591 176.535 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 84' ' ' ASP . . . . . 0.604 ' HB2' ' HG2' ' C' ' 79' ' ' PRO . 44.3 t0 -60.65 124.83 21.55 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 124.502 1.126 . . . . 63.13 110.385 -176.251 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 85' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -169.34 17.94 0.02 OUTLIER 'General case' 0 C--O 1.257 1.492 0 CA-C-N 114.185 -1.37 . . . . 74.41 107.493 -167.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 19.6 m -59.08 116.44 3.84 Favored 'General case' 0 C--N 1.361 1.09 0 CA-C-N 113.755 -1.566 . . . . 45.43 110.781 -166.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 87' ' ' GLY . . . . . 0.504 ' HA2' ' HA ' ' C' ' 171' ' ' PRO . . . 124.1 -20.57 7.1 Favored Glycine 0 C--N 1.342 0.867 0 O-C-N 123.732 0.645 . . . . 74.33 112.936 179.229 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 88' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -123.32 131.96 53.84 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 117.599 0.7 . . . . 74.44 111.804 -169.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -75.42 86.16 2.56 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.553 0.741 . . . . 72.23 111.154 -171.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 90' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -39.8 -43.72 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 C-N-CA 125.901 1.68 . . . . 54.41 114.74 174.228 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -65.07 -18.52 65.37 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.327 0.651 . . . . 74.21 112.149 -174.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -79.3 -30.44 42.89 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 122.848 0.459 . . . . 75.53 110.693 177.274 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -85.47 174.64 9.36 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.484 0.714 . . . . 72.45 112.908 -164.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 94' ' ' SER . . . . . 0.453 ' OG ' ' HG3' ' C' ' 5' ' ' LYS . 93.7 p -78.88 178.24 8.11 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 114.363 1.246 . . . . 45.51 114.363 -163.184 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -62.61 -54.02 45.91 Favored 'General case' 0 C--N 1.355 0.818 0 CA-C-N 113.888 -1.505 . . . . 55.43 111.2 -176.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 96' ' ' PHE . . . . . 0.402 ' HE1' ' HE2' ' C' ' 69' ' ' TYR . 48.6 t80 -48.44 -50.19 32.28 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 123.629 0.772 . . . . 65.02 111.626 -176.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 97' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -60.14 -52.01 67.14 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 114.592 -1.186 . . . . 64.25 110.116 175.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 98' ' ' GLN . . . . . 0.632 ' HA ' HD11 ' C' ' 105' ' ' LEU . 73.5 mt-30 -73.13 3.78 5.18 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 112.753 0.649 . . . . 51.52 112.753 -178.354 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -100.47 -54.5 2.83 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.879 0.872 . . . . 74.43 111.796 168.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 28.9 tp -63.84 -44.76 92.19 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.215 0.606 . . . . 73.23 110.809 -176.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 101' ' ' PHE . . . . . 0.458 ' O ' ' HG ' ' C' ' 105' ' ' LEU . 42.3 m-85 -94.78 -5.76 44.53 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.387 -0.824 . . . . 73.25 110.152 177.334 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -42.61 -60.97 2.67 Favored Glycine 0 CA--C 1.541 1.669 0 CA-C-O 118.553 -1.137 . . . . 54.11 115.076 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -41.42 -24.49 0.23 Allowed 'Trans proline' 0 C--N 1.391 2.785 0 C-N-CA 125.05 3.833 . . . . 62.02 116.584 -179.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -149.29 38.92 0.94 Allowed Glycine 0 C--N 1.35 1.352 0 CA-C-O 119.226 -0.763 . . . . 43.23 112.706 -176.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 105' ' ' LEU . . . . . 0.632 HD11 ' HA ' ' C' ' 98' ' ' GLN . 38.5 mt . . . . . 0 N--CA 1.496 1.863 0 N-CA-C 114.647 1.351 . . . . 73.03 114.647 176.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 116' ' ' GLY . . . . . 0.412 ' HA2' ' HA3' ' C' ' 168' ' ' GLY . . . . . . . . 0 C--O 1.241 0.585 0 CA-C-O 118.822 -0.988 . . . . 45.25 110.653 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 37.8 ttp180 -57.24 101.99 0.08 Allowed 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.401 -0.963 . . . . 64.44 108.401 -177.083 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -47.05 100.55 0.02 OUTLIER 'General case' 0 C--N 1.351 0.653 0 O-C-N 124.739 1.274 . . . . 75.42 107.734 172.068 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 119' ' ' LEU . . . . . . . . . . . . . 23.3 tp -91.15 119.21 31.07 Favored 'General case' 0 C--N 1.338 0.095 0 CA-C-N 114.466 -1.243 . . . . 75.21 109.441 -161.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 10.6 mtt180 -112.22 88.56 2.84 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 114.312 -1.313 . . . . 72.31 107.734 -169.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 121' ' ' ALA . . . . . 0.484 ' HB3' HD23 ' C' ' 176' ' ' LEU . . . -109.46 142.38 40.55 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 109.363 -0.606 . . . . 63.21 109.363 -174.494 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -126.97 127.81 45.4 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 107.152 -1.425 . . . . 73.22 107.152 178.093 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -138.51 147.32 54.6 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 123.249 0.62 . . . . 73.3 110.992 -167.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 124' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' C' ' 179' ' ' ARG . 6.1 Cg_exo -80.78 122.73 4.47 Favored 'Trans proline' 0 C--N 1.368 1.576 0 C-N-CA 123.184 2.59 . . . . 72.51 110.445 166.579 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 125' ' ' LEU . . . . . 0.463 ' HB3' HG13 ' C' ' 178' ' ' VAL . 18.1 tp -132.23 151.97 51.56 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 108.995 -0.743 . . . . 74.03 108.995 -177.501 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 126' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -95.04 152.61 18.18 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-O 120.734 0.302 . . . . 61.53 110.47 -178.054 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 127' ' ' LEU . . . . . 0.548 HD13 ' HD2' ' C' ' 186' ' ' PHE . 89.4 mt -60.51 -49.16 78.67 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.272 1.029 . . . . 62.25 111.029 177.504 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 22.1 mp0 -66.32 -33.45 75.76 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 115.564 -0.743 . . . . 75.24 110.564 179.358 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -68.83 -29.09 67.35 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.423 0.689 . . . . 73.53 111.363 176.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -75.18 -40.95 59.01 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 109.256 -0.646 . . . . 64.34 109.256 176.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 131' ' ' PHE . . . . . 0.596 ' HB2' HD13 ' C' ' 215' ' ' LEU . 84.6 t80 -55.06 -40.12 69.95 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.044 0.937 . . . . 75.55 110.744 174.585 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 132' ' ' HIS . . . . . . . . . . . . . 35.4 m170 -64.75 -59.52 4.14 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 115.545 -0.752 . . . . 60.22 109.676 174.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 62.77 -132.59 43.82 Favored Glycine 0 C--N 1.352 1.434 0 CA-C-N 115.719 -0.673 . . . . 65.31 111.925 -176.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 134' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' C' ' 148' ' ' ARG . . . 63.52 -151.65 48.52 Favored Glycine 0 C--N 1.351 1.41 0 O-C-N 123.956 0.445 . . . . 53.24 112.905 175.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -70.82 107.96 4.25 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.268 0.627 . . . . 71.2 109.784 178.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 136' ' ' ARG . . . . . 0.578 ' HB2' HD22 ' B' ' 181' ' ' LEU . 5.6 mmp_? -106.48 145.51 31.72 Favored 'General case' 0 C--O 1.249 1.029 0 C-N-CA 123.942 0.897 . . . . 72.12 109.185 171.503 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 137' ' ' VAL . . . . . 0.514 ' HB ' ' HB1' ' B' ' 180' ' ' ALA . 82.9 t -72.07 106.57 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.175 0.99 . . . . 71.12 110.412 -178.168 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 138' ' ' VAL . . . . . 0.56 ' HB ' HD23 ' B' ' 181' ' ' LEU . 12.1 p -119.54 111.73 34.26 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 CA-C-O 121.534 0.683 . . . . 72.14 110.173 176.695 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 139' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' C' ' 143' ' ' ARG . 1.4 tm-20 -119.32 99.85 6.95 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 106.882 -1.525 . . . . 74.31 106.882 169.289 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 140' ' ' VAL . . . . . . . . . . . . . 7.3 p -139.03 134.83 42.15 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 109.128 -0.693 . . . . 63.22 109.128 -179.097 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 141' ' ' ALA . . . . . 0.589 ' HB1' ' HG2' ' C' ' 167' ' ' GLN . . . 68.7 6.81 5.72 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.759 1.223 . . . . 15.23 112.713 -179.176 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 142' ' ' GLY . . . . . 0.621 ' HA3' ' HB3' ' C' ' 79' ' ' PRO . . . 105.49 -8.1 43.64 Favored Glycine 0 C--N 1.349 1.304 0 N-CA-C 112.611 -0.196 . . . . 45.25 112.611 -176.55 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 143' ' ' ARG . . . . . 0.459 ' O ' ' HA ' ' C' ' 139' ' ' GLU . 23.9 ttt85 -86.42 104.21 15.7 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.403 0.681 . . . . 73.04 110.615 179.249 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 39.8 ttt180 -98.18 107.76 20.31 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.684 0.794 . . . . 71.51 109.9 177.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 145' ' ' VAL . . . . . . . . . . . . . 7.2 p -150.94 157.14 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 123.914 0.886 . . . . 75.03 109.787 177.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 41.3 m -100.83 105.1 16.37 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.106 -1.072 . . . . 54.21 108.106 168.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 147' ' ' VAL . . . . . 0.477 HG21 HG13 ' C' ' 161' ' ' VAL . 7.6 p -104.67 146.26 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 N-CA-C 110.311 -0.255 . . . . 72.53 110.311 -173.173 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 148' ' ' ARG . . . . . 0.408 ' HA ' ' O ' ' C' ' 134' ' ' GLY . 12.6 ttm180 -85.78 109.73 18.86 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 116.224 -0.444 . . . . 74.22 110.318 177.033 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 149' ' ' ILE . . . . . . . . . . . . . 31.3 pt -91.99 150.08 39.94 Favored Pre-proline 0 C--O 1.245 0.846 0 CA-C-N 114.971 -1.013 . . . . 71.41 108.334 169.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 150' ' ' PRO . . . . . 0.513 ' HD2' HG23 ' C' ' 159' ' ' ILE . 19.3 Cg_endo -56.04 125.76 20.13 Favored 'Trans proline' 0 C--N 1.383 2.359 0 C-N-CA 122.744 2.296 . . . . 61.44 110.974 178.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 151' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' C' ' 150' ' ' PRO . 46.8 Cg_exo -57.07 93.77 0.05 OUTLIER 'Trans proline' 0 C--N 1.383 2.346 0 C-N-CA 123.187 2.592 . . . . 73.2 111.971 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 152' ' ' GLY . . . . . . . . . . . . . . . 114.25 131.44 5.21 Favored Glycine 0 C--N 1.342 0.9 0 CA-C-N 115.259 -0.882 . . . . 54.32 112.633 -174.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 p -145.66 158.95 12.5 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.11 0 C-N-CA 123.694 0.797 . . . . 71.13 110.664 -177.091 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 154' ' ' ARG . . . . . . . . . . . . . 16.7 mtt85 -101.98 153.19 20.11 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 124.399 1.08 . . . . 75.32 110.335 -173.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 155' ' ' GLU . . . . . 0.432 ' HB2' HD12 ' C' ' 180' ' ' LEU . 12.7 tp10 -65.59 127.25 31.14 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.891 0.877 . . . . 74.51 110.372 169.515 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 76.18 6.08 82.4 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-N 115.576 -0.738 . . . . 64.51 114.566 178.28 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 157' ' ' SER . . . . . . . . . . . . . 26.7 t -107.38 156.41 18.96 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 117.337 0.569 . . . . 75.43 111.229 -175.408 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 158' ' ' VAL . . . . . 0.406 ' HB ' ' HB3' ' C' ' 175' ' ' LEU . 18.4 m -93.31 134.25 31.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-N 114.83 -1.077 . . . . 64.44 111.772 -176.535 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 159' ' ' ILE . . . . . 0.564 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 80.9 mt -86.88 132.04 33.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 C-N-CA 124.187 0.995 . . . . 52.25 108.53 166.331 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 21.3 ttm180 -82.49 99.97 9.8 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 109.084 -0.71 . . . . 72.21 109.084 171.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 161' ' ' VAL . . . . . 0.477 HG13 HG21 ' C' ' 147' ' ' VAL . 63.5 t -96.24 95.37 1.96 Allowed Pre-proline 0 CA--C 1.548 0.866 0 N-CA-C 106.432 -1.692 . . . . 75.24 106.432 169.016 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -94.86 165.68 1.7 Allowed 'Trans proline' 0 C--N 1.361 1.232 0 C-N-CA 123.05 2.5 . . . . 63.42 115.226 -162.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 65.83 13.41 59.18 Favored Glycine 0 C--N 1.345 1.044 0 CA-C-N 114.114 -1.403 . . . . 53.31 114.829 172.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 164' ' ' MET . . . . . 0.432 ' SD ' ' NH2' ' C' ' 143' ' ' ARG . 35.1 mtm -136.81 -88.68 0.29 Allowed 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 117.468 0.634 . . . . 73.35 110.067 -175.67 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . 79.85 -152.56 35.24 Favored Glycine 0 C--N 1.351 1.412 0 CA-C-N 116.762 -0.199 . . . . 64.24 113.369 -172.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . -98.77 -159.64 29.68 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-N 115.307 -0.447 . . . . 75.44 112.819 -178.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 167' ' ' GLN . . . . . 0.589 ' HG2' ' HB1' ' C' ' 141' ' ' ALA . 27.4 mm-40 -70.66 118.91 14.05 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.899 0.88 . . . . 64.31 111.533 -174.035 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 168' ' ' GLY . . . . . 0.412 ' HA3' ' HA2' ' C' ' 116' ' ' GLY . . . 161.77 162.48 13.13 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 109.929 -1.269 . . . . 13.44 109.929 178.071 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 169' ' ' ASN . . . . . 0.723 ' HB2' ' HD3' ' C' ' 170' ' ' PRO . 1.7 m-20 -73.57 -68.41 0.36 Allowed Pre-proline 0 CA--C 1.578 2.051 0 CA-C-O 117.846 -1.073 . . . . 62.44 112.97 -166.372 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 170' ' ' PRO . . . . . 0.723 ' HD3' ' HB2' ' C' ' 169' ' ' ASN . 34.1 Cg_exo -63.73 176.17 2.48 Favored 'Trans proline' 0 C--N 1.401 3.298 0 C-N-CA 122.475 2.117 . . . . 51.41 113.281 172.419 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 171' ' ' PRO . . . . . 0.504 ' HA ' ' HA2' ' C' ' 87' ' ' GLY . 29.7 Cg_endo -62.28 139.23 76.35 Favored 'Trans proline' 0 C--N 1.389 2.666 0 C-N-CA 122.551 2.167 . . . . 74.02 111.76 172.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -116.18 -34.03 1.41 Allowed Glycine 0 C--N 1.336 0.574 0 CA-C-N 116.089 -0.505 . . . . 74.42 112.56 177.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 173' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 71.04 147.97 0.08 Allowed 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 125.089 1.355 . . . . 74.51 111.273 -179.111 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 174' ' ' LEU . . . . . . . . . . . . . 11.0 tp -121.97 128.55 51.61 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.904 0.882 . . . . 75.22 108.853 -174.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 175' ' ' LEU . . . . . 0.439 ' HA ' ' O ' ' C' ' 159' ' ' ILE . 71.8 mt -110.49 130.58 55.53 Favored 'General case' 0 C--O 1.243 0.721 0 C-N-CA 123.597 0.759 . . . . 71.32 109.23 172.142 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 176' ' ' LEU . . . . . 0.564 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 95.7 mt -108.33 107.97 18.77 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.373 0.669 . . . . 43.02 110.884 178.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 177' ' ' VAL . . . . . . . . . . . . . 56.0 t -81.53 101.12 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 107.147 -1.427 . . . . 74.43 107.147 173.237 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 178' ' ' VAL . . . . . 0.463 HG13 ' HB3' ' C' ' 125' ' ' LEU . 39.7 t -76.65 128.87 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 114.599 -1.182 . . . . 74.01 110.755 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 179' ' ' ARG . . . . . 0.466 ' O ' ' HA ' ' C' ' 124' ' ' PRO . 36.6 mmt180 -111.94 101.03 9.36 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 105.325 -2.102 . . . . 72.33 105.325 171.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 180' ' ' LEU . . . . . 0.454 ' HA ' ' O ' ' C' ' 125' ' ' LEU . 28.9 mt -68.93 133.03 47.65 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 108.922 -0.77 . . . . 70.51 108.922 -176.651 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 181' ' ' LEU . . . . . . . . . . . . . 85.0 mt -54.05 163.01 1.29 Allowed Pre-proline 0 N--CA 1.493 1.717 0 C-N-CA 125.31 1.444 . . . . 74.2 113.317 -167.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -51.52 77.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.391 2.813 0 C-N-CA 123.744 2.963 . . . . 64.12 111.982 164.261 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 183' ' ' HIS . . . . . . . . . . . . . 75.3 t60 -174.08 53.92 0.15 Allowed Pre-proline 0 CA--C 1.553 1.059 0 N-CA-C 104.112 -2.551 . . . . 62.13 104.112 -170.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 184' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -86.67 65.79 4.68 Favored 'Trans proline' 0 C--N 1.388 2.65 0 C-N-CA 123.535 2.823 . . . . 71.54 112.079 -164.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 185' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 11.7 t -95.89 -50.24 11.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 108.047 -1.094 . . . . 72.23 108.047 -178.169 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 186' ' ' PHE . . . . . 0.548 ' HD2' HD13 ' C' ' 127' ' ' LEU . 34.0 m-85 -117.67 156.39 28.28 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.488 0.715 . . . . 61.44 111.956 -174.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 187' ' ' ARG . . . . . 0.49 ' O ' ' HB3' ' C' ' 194' ' ' TYR . 33.8 ttp180 -153.64 112.11 3.64 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.476 1.51 . . . . 75.14 107.742 177.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 188' ' ' LEU . . . . . 0.431 HD21 ' O ' ' C' ' 190' ' ' GLY . 47.9 tp -80.73 153.1 28.02 Favored 'General case' 0 CA--C 1.558 1.263 0 N-CA-C 115.392 1.627 . . . . 74.14 115.392 -163.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -126.92 99.59 5.8 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.889 1.675 . . . . 71.33 107.182 159.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 190' ' ' GLY . . . . . 0.431 ' O ' HD21 ' C' ' 188' ' ' LEU . . . 63.61 -80.09 0.04 OUTLIER Glycine 0 CA--C 1.539 1.575 0 N-CA-C 114.194 0.438 . . . . 74.2 114.194 175.724 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 191' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -122.42 -34.86 3.2 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.877 1.271 . . . . 60.21 109.635 177.439 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -83.63 125.12 31.5 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.189 0.995 . . . . 65.13 110.983 -174.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 193' ' ' LEU . . . . . 0.439 ' HG ' ' HA2' ' C' ' 239' ' ' GLY . 91.7 mt -80.65 159.09 25.44 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.253 0.621 . . . . 52.2 112.017 -179.083 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 194' ' ' TYR . . . . . 0.49 ' HB3' ' O ' ' C' ' 187' ' ' ARG . 43.7 t80 -119.12 106.94 12.88 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 108.112 -1.07 . . . . 75.43 108.112 165.139 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 195' ' ' ALA . . . . . 0.549 ' HB2' HD11 ' C' ' 249' ' ' LEU . . . -108.2 -174.9 2.63 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.553 0.741 . . . . 65.11 110.099 175.49 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 29.3 m -138.47 119.06 13.93 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.586 -0.733 . . . . 51.32 109.604 174.045 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 197' ' ' LEU . . . . . 0.491 HD13 ' HB2' ' C' ' 212' ' ' ALA . 53.5 tp -98.78 118.21 35.01 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.292 0.637 . . . . 73.5 109.375 -179.073 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 198' ' ' ASP . . . . . 0.584 ' HA ' ' HB2' ' C' ' 254' ' ' ARG . 26.4 t70 -85.69 99.97 11.67 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.501 0.721 . . . . 44.52 109.087 -178.102 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 199' ' ' VAL . . . . . 0.482 HG22 HG21 ' C' ' 210' ' ' VAL . 21.4 t -110.59 123.6 35.26 Favored Pre-proline 0 N--CA 1.479 0.989 0 N-CA-C 108.661 -0.866 . . . . 61.21 108.661 -178.178 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 200' ' ' PRO . . . . . 0.439 ' HD2' HG11 ' C' ' 210' ' ' VAL . 46.2 Cg_endo -69.09 147.22 66.72 Favored 'Trans proline' 0 C--N 1.367 1.546 0 C-N-CA 121.565 1.51 . . . . 71.34 110.553 173.688 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 201' ' ' ALA . . . . . 0.476 ' HB3' ' HH2' ' C' ' 269' ' ' TRP . . . -52.59 -45.46 96.06 Favored Pre-proline 0 CA--C 1.555 1.158 0 C-N-CA 124.638 1.175 . . . . 74.35 113.467 -176.035 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 202' ' ' PRO . . . . . 0.488 ' HB2' ' HA ' ' A' ' 273' ' ' ALA . 23.7 Cg_endo -57.99 -49.71 12.09 Favored 'Trans proline' 0 C--N 1.391 2.774 0 C-N-CA 121.384 1.389 . . . . 63.15 112.304 177.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 203' ' ' ILE . . . . . . . . . . . . . 29.2 mt -64.42 -32.34 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 123.218 0.607 . . . . 63.4 111.145 178.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.8 -37.6 84.87 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.134 0.574 . . . . 75.02 111.512 179.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 205' ' ' VAL . . . . . 0.425 ' HA ' ' HA ' ' C' ' 226' ' ' ARG . 91.2 t -82.09 -37.24 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 123.233 0.613 . . . . 63.41 111.972 -178.363 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 206' ' ' VAL . . . . . 0.533 HG23 ' HG3' ' A' ' 270' ' ' LYS . 8.3 p -87.61 -33.58 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 N-CA-C 111.975 0.361 . . . . 52.12 111.975 -175.158 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 90.33 126.44 3.22 Favored Glycine 0 C--N 1.344 0.98 0 N-CA-C 111.076 -0.81 . . . . 63.21 111.076 -167.285 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -159.93 -137.3 2.2 Favored Glycine 0 C--N 1.336 0.57 0 CA-C-N 117.81 0.805 . . . . 51.32 111.466 179.02 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 209' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' C' ' 221' ' ' VAL . 7.6 mtmp? -139.26 134.75 33.06 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 123.43 0.692 . . . . 72.12 110.603 171.674 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 210' ' ' VAL . . . . . 0.482 HG21 HG22 ' C' ' 199' ' ' VAL . 27.7 m -134.3 140.57 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 107.754 -1.202 . . . . 62.05 107.754 169.021 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 211' ' ' ARG . . . . . 0.53 ' HA ' ' HA ' ' C' ' 220' ' ' GLU . 32.4 ttm105 -80.5 133.12 35.78 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 122.975 0.51 . . . . 72.44 111.66 -175.242 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 212' ' ' ALA . . . . . 0.491 ' HB2' HD13 ' C' ' 197' ' ' LEU . . . -104.18 130.36 51.94 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.785 1.234 . . . . 74.43 107.704 164.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 213' ' ' MET . . . . . 0.407 ' HG2' ' N ' ' C' ' 214' ' ' THR . 6.6 ttt -70.39 149.49 47.24 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 109.264 -0.643 . . . . 63.12 109.264 168.11 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 214' ' ' THR . . . . . 0.528 HG21 ' HD2' ' C' ' 238' ' ' LYS . 0.1 OUTLIER -139.92 169.14 18.26 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.173 0.511 . . . . 54.24 110.415 168.101 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 215' ' ' LEU . . . . . 0.596 HD13 ' HB2' ' C' ' 131' ' ' PHE . 54.4 mt -61.82 -36.05 80.02 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.144 1.378 . . . . 44.41 112.667 -172.482 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.78 -2.67 27.63 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.396 0.679 . . . . 71.0 112.11 -177.395 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 155.69 171.41 22.14 Favored Glycine 0 C--O 1.212 -1.274 0 CA-C-O 119.556 -0.58 . . . . 64.11 112.492 -178.274 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -88.26 126.01 1.91 Allowed 'Trans proline' 0 CA--C 1.556 1.618 0 C-N-CA 122.998 2.465 . . . . 52.13 112.748 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 219' ' ' VAL . . . . . 0.44 HG13 ' HB3' ' C' ' 212' ' ' ALA . 3.3 p -103.2 115.12 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 123.925 0.89 . . . . 52.53 109.696 177.459 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 220' ' ' GLU . . . . . 0.53 ' HA ' ' HA ' ' C' ' 211' ' ' ARG . 23.6 tt0 -84.43 109.38 17.83 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 109.491 -0.559 . . . . 72.32 109.491 -179.012 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 221' ' ' VAL . . . . . 0.458 HG11 HD21 ' C' ' 233' ' ' LEU . 47.7 t -74.13 127.88 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 124.491 1.116 . . . . 74.03 111.957 -174.672 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 222' ' ' ALA . . . . . 0.421 ' HA ' ' HG2' ' C' ' 209' ' ' LYS . . . -80.97 103.52 10.85 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 124.199 0.937 . . . . 73.3 109.05 167.162 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 62.1 t -79.04 129.47 72.91 Favored Pre-proline 0 CA--C 1.553 1.079 0 C-N-CA 123.744 0.818 . . . . 73.11 109.721 176.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 224' ' ' PRO . . . . . 0.593 ' HG2' ' HB2' ' B' ' 243' ' ' GLN . 3.1 Cg_exo -78.68 160.64 28.01 Favored 'Trans proline' 0 C--N 1.371 1.722 0 C-N-CA 123.925 3.084 . . . . 54.33 112.103 169.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.51 143.49 98.02 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 122.944 2.429 . . . . 74.0 112.93 176.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 226' ' ' ARG . . . . . 0.446 ' HG2' ' O ' ' A' ' 259' ' ' GLU . 0.6 OUTLIER 55.18 86.02 0.06 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.468 1.907 . . . . 70.15 113.79 173.748 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 227' ' ' THR . . . . . 0.543 HG21 ' HH2' ' B' ' 242' ' ' TRP . 82.1 m -123.93 133.36 53.74 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 114.828 -1.078 . . . . 70.3 111.143 -178.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 228' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -104.77 155.71 18.65 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.712 0.768 . . . . 74.32 110.702 176.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -72.23 145.59 47.86 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.328 -0.851 . . . . 62.12 109.936 176.271 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 95.42 -9.34 69.36 Favored Glycine 0 N--CA 1.464 0.561 0 CA-C-N 115.746 -0.661 . . . . 62.04 112.118 -171.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 231' ' ' ARG . . . . . 0.404 ' NH1' ' HA ' ' C' ' 227' ' ' THR . 81.8 mtt180 -69.55 178.34 2.54 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 117.339 0.569 . . . . 74.12 110.761 167.24 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 232' ' ' LYS . . . . . 0.571 ' HD3' ' HB3' ' C' ' 250' ' ' TYR . 1.9 ttmp? -153.93 126.86 8.29 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 112.258 0.466 . . . . 71.45 112.258 -174.295 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 233' ' ' LEU . . . . . 0.615 ' O ' ' HA ' ' C' ' 250' ' ' TYR . 5.1 mp -86.39 158.66 19.57 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.488 1.115 . . . . 74.21 110.437 175.435 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 19.1 ptt-85 -128.92 88.46 2.72 Favored 'General case' 0 CA--C 1.556 1.204 0 O-C-N 124.712 1.257 . . . . 72.34 109.513 170.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 235' ' ' LEU . . . . . 0.508 HD22 ' H ' ' B' ' 240' ' ' GLY . 56.9 mt -86.55 105.99 17.22 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 108.213 -1.032 . . . . 73.43 108.213 174.264 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -67.71 132.75 48.05 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.36 0.664 . . . . 71.55 111.639 -168.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 80.95 1.38 89.79 Favored Glycine 0 C--N 1.349 1.254 0 N-CA-C 115.018 0.767 . . . . 71.42 115.018 174.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 238' ' ' LYS . . . . . 0.528 ' HD2' HG21 ' C' ' 214' ' ' THR . 73.8 mmtt -92.8 13.18 21.09 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 123.588 0.755 . . . . 72.03 111.116 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 239' ' ' GLY . . . . . 0.439 ' HA2' ' HG ' ' C' ' 193' ' ' LEU . . . -95.17 -169.6 36.3 Favored Glycine 0 C--N 1.358 1.772 0 C-N-CA 122.977 0.322 . . . . 31.21 113.205 177.537 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 240' ' ' PHE . . . . . 0.41 ' HD2' HD13 ' C' ' 188' ' ' LEU . 3.8 m-85 -78.73 148.28 72.49 Favored Pre-proline 0 N--CA 1.481 1.102 0 C-N-CA 123.027 0.531 . . . . 75.14 110.397 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 241' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -63.64 137.31 58.5 Favored 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 123.43 2.753 . . . . 70.21 112.103 -178.25 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -131.71 168.6 22.26 Favored Glycine 0 C--N 1.342 0.911 0 CA-C-O 120.169 -0.24 . . . . 70.14 113.678 -175.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -73.91 -2.38 12.17 Favored 'Trans proline' 0 C--N 1.38 2.206 0 C-N-CA 123.642 2.894 . . . . 71.42 114.553 -173.383 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -137.62 11.8 2.95 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.655 0.782 . . . . 71.42 111.118 178.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 137.43 167.79 11.17 Favored Glycine 0 C--N 1.348 1.214 0 N-CA-C 111.111 -0.795 . . . . 51.32 111.111 -176.274 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 246' ' ' ARG . . . . . . . . . . . . . 26.8 mtm-85 -81.85 151.32 27.38 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-N 117.275 0.537 . . . . 61.31 109.914 176.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -78.13 -169.93 35.31 Favored Glycine 0 C--N 1.34 0.798 0 O-C-N 123.872 0.733 . . . . 63.23 113.48 -178.102 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -123.79 142.66 50.89 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.122 -1.066 . . . . 73.54 108.122 -173.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 249' ' ' LEU . . . . . 0.549 HD11 ' HB2' ' C' ' 195' ' ' ALA . 25.6 tp -83.89 109.52 17.65 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.95 -0.568 . . . . 74.23 109.797 -179.525 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 250' ' ' TYR . . . . . 0.615 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 22.0 m-30 -101.02 100.53 11.15 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 109.498 -0.556 . . . . 71.43 109.498 179.203 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 251' ' ' LEU . . . . . 0.578 ' HB2' HD13 ' C' ' 233' ' ' LEU . 2.2 mp -100.39 121.91 42.29 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 119.166 -0.445 . . . . 64.53 110.338 -172.671 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 252' ' ' GLU . . . . . 0.454 ' HB2' ' HE1' ' C' ' 194' ' ' TYR . 25.3 tt0 -75.07 129.7 38.04 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-O 121.129 0.49 . . . . 73.41 109.681 170.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 253' ' ' VAL . . . . . 0.52 HG11 HG22 ' C' ' 227' ' ' THR . 60.4 t -76.23 135.19 27.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 115.166 -0.925 . . . . 73.5 111.012 -175.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 254' ' ' ARG . . . . . 0.584 ' HB2' ' HA ' ' C' ' 198' ' ' ASP . 11.4 mmt85 -103.8 135.19 45.8 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.321 1.448 . . . . 74.13 108.32 165.193 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 255' ' ' ILE . . . . . . . . . . . . . 33.0 mm -106.94 105.34 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 107.028 -1.471 . . . . 75.24 107.028 165.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 256' ' ' THR . . . . . . . . . . . . . 3.5 t -115.76 171.72 7.58 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.037 0.935 . . . . 53.32 110.067 -173.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 10.7 pt -134.95 152.93 78.18 Favored Pre-proline 0 CA--C 1.552 1.037 0 C-N-CA 123.987 0.915 . . . . 64.54 109.876 -173.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -80.79 20.98 0.91 Allowed 'Trans proline' 0 C--N 1.381 2.274 0 C-N-CA 123.372 2.715 . . . . 73.21 113.737 -168.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 57.3 -89.81 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.778 1.231 . . . . 72.3 111.18 -174.01 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 260' ' ' ARG . . . . . 0.594 ' H ' ' HD2' ' C' ' 260' ' ' ARG . 0.0 OUTLIER -80.39 145.86 31.78 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 123.214 0.606 . . . . 73.41 109.473 -179.317 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 261' ' ' LEU . . . . . . . . . . . . . 96.4 mt -128.73 154.69 46.1 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.89 0.876 . . . . 71.21 109.566 176.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 45.1 p -84.92 155.72 61.11 Favored Pre-proline 0 CA--C 1.555 1.142 0 N-CA-C 109.252 -0.647 . . . . 61.23 109.252 170.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -34.35 -51.81 0.62 Allowed 'Trans proline' 0 C--N 1.382 2.302 1 C-N-CA 125.684 4.256 . . . . 74.2 115.836 -178.606 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -62.94 -55.05 29.33 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.954 0.501 . . . . 71.04 110.259 -177.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -49.31 -55.14 13.77 Favored 'General case' 0 C--N 1.356 0.866 0 O-C-N 124.451 1.094 . . . . 65.11 109.675 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 266' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' C' ' 270' ' ' LYS . 15.4 tp10 -54.62 -43.27 72.09 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 124.655 1.222 . . . . 64.21 110.997 -177.446 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -60.6 -45.42 94.07 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.508 0.723 . . . . 70.32 112.217 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 268' ' ' LEU . . . . . 0.511 ' HB2' HD21 ' A' ' 272' ' ' LEU . 10.3 mp -66.35 -50.99 61.69 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 116.729 -0.214 . . . . 52.44 110.93 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 269' ' ' TRP . . . . . 0.476 ' HH2' ' HB3' ' C' ' 201' ' ' ALA . 92.5 m95 -56.95 -32.41 65.99 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.292 0.637 . . . . 61.11 111.039 177.354 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 270' ' ' LYS . . . . . 0.653 ' HA ' HG21 ' A' ' 206' ' ' VAL . 10.2 tmtt? -67.76 -46.46 72.02 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.987 0.915 . . . . 75.43 110.336 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -63.2 -37.21 86.32 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 122.73 0.412 . . . . 75.33 111.486 177.068 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 272' ' ' LEU . . . . . 0.416 HD12 ' HA ' ' C' ' 269' ' ' TRP . 75.1 mt -64.9 -37.11 86.54 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.295 0.638 . . . . 74.33 110.125 176.46 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -63.43 -45.39 91.16 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.438 0.695 . . . . 34.13 111.055 177.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -65.72 -36.71 84.38 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.289 0.636 . . . . 63.21 111.036 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -62.7 -33.07 74.33 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 115.596 -0.729 . . . . 70.04 110.584 174.22 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 276' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -73.46 -42.34 62.06 Favored 'General case' 0 CA--C 1.554 1.114 0 CA-C-N 115.36 -0.836 . . . . 75.52 111.939 174.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -68.05 -22.61 64.94 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.949 -0.469 . . . . 44.24 111.403 178.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -59.77 -22.53 62.26 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.504 0.722 . . . . 55.2 112.131 174.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 279' ' ' ARG . . . . . . . . . . . . . 39.0 mtm180 -72.66 -29.84 63.77 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 122.743 0.417 . . . . 71.52 110.738 178.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.044 0 C-N-CA 123.7 0.8 . . . . 75.14 109.378 -173.402 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.484 1.245 0 N-CA-C 113.039 0.755 . . . . 62.43 113.039 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -77.68 109.34 11.57 Favored 'General case' 0 C--O 1.245 0.863 0 C-N-CA 124.031 0.932 . . . . 74.32 109.413 171.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -82.34 94.53 7.39 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 108.459 -0.941 . . . . 61.41 108.459 177.207 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -60.54 -37.46 81.3 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.191 0.997 . . . . 73.34 111.672 -174.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.497 ' HB3' ' O ' ' A' ' 13' ' ' VAL . 95.1 m-85 -67.28 -35.74 80.12 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 114.609 -1.178 . . . . 73.33 111.324 178.618 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.86 -40.13 72.51 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 122.897 0.479 . . . . 60.32 111.014 177.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 77.0 mt -56.0 -42.75 72.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 123.613 0.765 . . . . 74.23 109.455 174.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 87.7 mt -81.06 -17.47 50.0 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 115.212 -0.903 . . . . 51.33 112.392 176.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.09 18.74 78.06 Favored Glycine 0 CA--C 1.536 1.398 0 N-CA-C 114.71 0.644 . . . . 53.33 114.71 -178.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.497 ' O ' ' HB3' ' A' ' 8' ' ' TYR . 19.6 m -103.89 144.07 27.94 Favored Pre-proline 0 N--CA 1.484 1.228 0 C-N-CA 123.666 0.787 . . . . 71.43 109.252 173.459 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -54.58 151.01 32.81 Favored 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 122.889 2.393 . . . . 50.12 113.282 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.33 69.48 1.61 Allowed 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.692 0.797 . . . . 75.43 110.561 179.253 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 170.92 -24.36 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.805 1.242 . . . . 64.11 109.422 -173.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.09 138.85 19.12 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.283 1.033 . . . . 64.31 111.761 -177.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 67.2 p -63.49 166.08 7.1 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.17 0.988 . . . . 71.11 111.033 -175.042 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -56.64 -33.37 66.25 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.985 0.914 . . . . 64.21 111.384 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -69.72 -36.1 75.6 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 122.89 0.476 . . . . 72.43 111.062 -178.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -72.02 -42.06 66.83 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.629 0.772 . . . . 64.03 110.664 177.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 73.7 mt -58.59 -39.53 76.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 124.558 1.143 . . . . 73.31 110.241 173.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.734 ' HG2' ' HE3' ' A' ' 27' ' ' LYS . 33.9 ttmt -71.67 -37.94 70.71 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 114.555 -1.202 . . . . 71.24 110.259 -177.627 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 49.1 mtp180 -57.36 -52.46 65.25 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.503 0.721 . . . . 54.12 110.319 173.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.33 -38.47 91.14 Favored 'General case' 0 C--O 1.246 0.899 0 CA-C-N 114.435 -1.257 . . . . 64.0 111.653 -177.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -61.87 -60.75 3.18 Favored 'General case' 0 C--O 1.209 -1.067 0 CA-C-N 115.433 -0.803 . . . . 73.1 109.487 177.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.734 ' HE3' ' HG2' ' A' ' 23' ' ' LYS . 10.1 mtmp? -58.71 -33.58 70.36 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 124.266 0.979 . . . . 74.22 111.913 -177.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 14.6 ttt180 -52.74 -58.72 5.94 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.299 1.04 . . . . 71.15 109.856 171.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.662 ' HB3' HD13 ' A' ' 50' ' ' ILE . 88.1 mt -81.21 -10.28 59.64 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 115.172 -0.922 . . . . 74.11 111.991 -178.269 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.489 ' HB3' ' HA ' ' A' ' 27' ' ' LYS . . . -94.53 -14.59 24.92 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.772 0.829 . . . . 63.3 111.34 -178.282 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.4 mtm105 -97.96 -38.09 9.53 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.957 -0.757 . . . . 72.33 108.957 168.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -65.43 -47.36 76.48 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.26 0.624 . . . . 63.33 111.092 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -107.4 29.21 7.37 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.515 0.726 . . . . 63.25 110.734 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -68.23 101.51 0.31 Allowed Pre-proline 0 N--CA 1.483 1.204 0 C-N-CA 123.979 0.911 . . . . 63.41 110.547 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.528 ' O ' ' HG3' ' A' ' 39' ' ' LYS . 46.6 Cg_exo -55.07 -39.82 89.0 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 123.073 2.516 . . . . 74.13 113.306 -169.176 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -46.89 -36.94 8.11 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.799 1.239 . . . . 72.45 112.786 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 48.7 t -101.79 -49.25 10.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 C-N-CA 123.657 0.783 . . . . 65.53 109.28 178.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -107.27 75.26 1.01 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 125.121 1.368 . . . . 61.35 110.665 -176.059 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.528 ' HG3' ' O ' ' A' ' 35' ' ' PRO . 9.0 mtmp? -78.02 72.47 4.56 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 109.636 -0.505 . . . . 73.11 109.636 172.597 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 70.4 m -116.9 113.31 39.85 Favored Pre-proline 0 N--CA 1.471 0.621 0 N-CA-C 107.906 -1.146 . . . . 54.41 107.906 176.283 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -42.8 -53.29 4.01 Favored 'Trans proline' 0 C--N 1.387 2.591 0 C-N-CA 124.58 3.52 . . . . 72.23 114.191 -170.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -52.12 -46.82 65.49 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.221 1.009 . . . . 64.43 111.817 176.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.82 -29.16 69.01 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.597 0.759 . . . . 72.14 110.982 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.503 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 46.1 mt-10 -84.47 -29.7 25.83 Favored 'General case' 0 C--N 1.352 0.707 0 C-N-CA 123.423 0.689 . . . . 62.01 110.461 -175.062 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -72.31 -43.45 64.16 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.929 0.892 . . . . 62.44 109.791 176.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.422 ' HD3' ' HA ' ' A' ' 46' ' ' LYS . 40.2 mmtm -62.65 -39.7 94.72 Favored 'General case' 0 C--N 1.345 0.405 0 CA-C-N 115.038 -0.983 . . . . 74.03 109.631 171.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.485 ' HE1' ' HA ' ' A' ' 30' ' ' ALA . 60.0 t80 -63.08 -30.14 71.36 Favored 'General case' 0 C--N 1.356 0.866 0 O-C-N 123.867 0.729 . . . . 73.24 110.656 176.449 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.503 ' HG2' ' O ' ' A' ' 44' ' ' GLU . 34.3 mmtp -62.98 -47.36 83.49 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 109.893 -0.41 . . . . 75.14 109.893 171.682 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -67.95 -25.88 65.67 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 112.384 0.513 . . . . 71.44 112.384 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.662 HD13 ' HB3' ' A' ' 29' ' ' LEU . 63.0 mt -79.47 -33.46 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 C-N-CA 124.515 1.126 . . . . 70.53 110.102 176.42 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -70.22 -39.14 75.29 Favored 'General case' 0 C--O 1.208 -1.08 0 CA-C-N 115.265 -0.879 . . . . 73.43 109.81 173.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -61.01 -48.75 80.37 Favored 'General case' 0 C--O 1.247 0.952 0 C-N-CA 124.986 1.314 . . . . 63.42 109.541 176.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.32 -60.42 3.36 Favored 'General case' 0 C--N 1.352 0.69 0 CA-C-N 113.52 -1.673 . . . . 65.45 111.188 177.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -63.92 -35.73 81.62 Favored 'General case' 0 C--O 1.214 -0.771 0 CA-C-N 115.686 -0.688 . . . . 72.32 111.412 -179.293 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.14 -53.34 58.29 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.579 0.752 . . . . 53.01 110.831 -177.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 66.4 t -62.84 -50.86 78.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 114.533 -1.212 . . . . 74.52 110.352 177.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 67.2 mt -76.07 -8.3 56.67 Favored 'General case' 0 CA--C 1.557 1.242 0 N-CA-C 113.152 0.797 . . . . 62.04 113.152 -172.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.2 t -65.42 -58.46 5.8 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.405 1.082 . . . . 74.34 111.853 -176.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.491 ' HB2' ' HD3' ' A' ' 62' ' ' LYS . 13.4 m-20 -99.31 142.33 24.41 Favored Pre-proline 0 C--O 1.244 0.778 0 C-N-CA 123.419 0.688 . . . . 74.34 109.432 -174.318 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.515 ' O ' ' HG2' ' A' ' 64' ' ' ARG . 48.7 Cg_exo -54.55 -47.23 27.92 Favored 'Trans proline' 0 C--N 1.385 2.447 0 C-N-CA 123.167 2.578 . . . . 72.41 112.941 -172.114 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.485 ' O ' HG12 ' A' ' 65' ' ' ILE . 3.1 mp0 -58.78 -58.2 9.64 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.505 0.722 . . . . 72.3 111.213 -174.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.491 ' HD3' ' HB2' ' A' ' 59' ' ' ASP . 37.9 mtpt -58.28 -43.52 88.05 Favored 'General case' 0 C--O 1.257 1.492 0 C-N-CA 124.29 1.036 . . . . 74.54 111.135 -178.197 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -59.04 -46.81 87.3 Favored 'General case' 0 C--N 1.349 0.581 0 CA-C-N 114.667 -1.152 . . . . 74.11 110.793 178.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.515 ' HG2' ' O ' ' A' ' 60' ' ' PRO . 30.2 mmm180 -77.6 -18.66 56.61 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 123.677 0.61 . . . . 74.25 111.305 -175.228 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.485 HG12 ' O ' ' A' ' 61' ' ' GLU . 28.3 mm -62.29 -50.93 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 N-CA-C 108.081 -1.081 . . . . 64.42 108.081 168.217 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -60.35 -52.25 66.07 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 114.908 -1.042 . . . . 75.4 111.001 175.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -63.31 -31.22 72.31 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.457 0.703 . . . . 64.04 112.059 -172.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.3 p -76.65 -31.55 57.41 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 119.166 -0.445 . . . . 75.13 110.773 173.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -64.06 115.12 4.63 Favored 'General case' 0 CA--C 1.556 1.2 0 N-CA-C 109.492 -0.559 . . . . 63.45 109.492 178.217 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 115.38 5.66 18.82 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 123.562 0.601 . . . . 52.54 111.969 -169.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 86.2 m -147.59 -56.62 0.24 Allowed 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 104.823 -2.288 . . . . 71.23 104.823 178.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.4 m -82.79 141.92 31.95 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 104.446 -2.427 . . . . 74.23 104.446 156.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.79 -35.08 10.25 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 118.617 0.644 . . . . 74.04 111.145 -179.373 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -93.24 134.18 27.41 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 123.393 0.677 . . . . 75.1 109.412 179.284 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.92 116.93 3.61 Favored 'Trans proline' 0 C--N 1.373 1.833 0 C-N-CA 122.299 1.999 . . . . 75.41 110.532 171.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -52.14 142.32 45.58 Favored 'Trans proline' 0 C--N 1.38 2.19 0 C-N-CA 123.035 2.49 . . . . 74.25 112.611 177.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -43.4 129.86 6.58 Favored 'Trans proline' 0 C--N 1.388 2.642 0 C-N-CA 123.969 3.113 . . . . 62.44 113.424 -174.231 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.421 ' HG3' ' HA3' ' A' ' 104' ' ' GLY . 28.2 Cg_endo -58.41 144.02 96.98 Favored 'Trans proline' 0 C--N 1.387 2.579 0 C-N-CA 122.84 2.36 . . . . 43.51 112.705 -171.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.404 ' HB2' HH21 ' A' ' 143' ' ' ARG . 58.9 Cg_endo -65.89 167.49 17.59 Favored 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 122.876 2.384 . . . . 71.05 112.59 -177.329 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.84 88.45 0.07 OUTLIER 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 122.665 2.244 . . . . 51.35 111.694 176.104 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 149.91 -40.88 0.84 Allowed Glycine 0 CA--C 1.524 0.611 0 CA-C-N 113.728 -1.578 . . . . 62.41 109.525 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 110.63 -169.51 13.46 Favored Glycine 0 C--N 1.351 1.383 0 C-N-CA 123.594 0.616 . . . . 53.03 111.686 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -84.72 88.36 7.37 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 123.431 0.692 . . . . 74.41 109.867 176.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -58.11 157.96 7.49 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 114.407 -1.269 . . . . 71.31 111.828 175.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -154.56 72.44 0.86 Allowed 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 108.597 -0.89 . . . . 70.22 108.597 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.4 m -43.58 84.99 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 126.134 1.774 . . . . 74.44 115.218 -165.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.451 ' N ' ' HA3' ' A' ' 163' ' ' GLY . . . 67.78 10.81 59.23 Favored Glycine 0 C--N 1.352 1.449 0 CA-C-N 115.815 -0.629 . . . . 70.11 114.008 175.208 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -93.23 122.95 36.15 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.231 -1.396 . . . . 72.34 107.231 178.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -69.74 90.39 0.59 Allowed 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 110.177 -0.305 . . . . 71.44 110.177 -173.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.491 HG23 ' HE2' ' A' ' 97' ' ' PHE . 2.4 p -34.81 -50.31 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 125.578 1.551 . . . . 75.21 114.084 175.227 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -59.84 -34.22 72.81 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.255 1.022 . . . . 75.33 111.297 -173.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -78.08 -30.84 49.87 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.218 1.007 . . . . 45.35 111.753 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -82.14 172.19 13.48 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 122.746 0.419 . . . . 71.01 110.161 -173.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 83.8 p -57.56 150.06 19.94 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 114.093 1.145 . . . . 74.5 114.093 -164.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.96 -41.8 71.58 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 114.568 -1.196 . . . . 74.31 110.881 170.135 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -59.76 -43.06 94.5 Favored 'General case' 0 C--N 1.354 0.769 0 C-N-CA 123.226 0.61 . . . . 75.03 110.755 -177.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.491 ' HE2' HG23 ' A' ' 90' ' ' VAL . 26.5 t80 -58.58 -49.99 75.42 Favored 'General case' 0 CA--C 1.548 0.895 0 O-C-N 123.761 0.663 . . . . 63.23 109.242 173.476 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.524 ' HA ' HD11 ' A' ' 105' ' ' LEU . 46.4 mt-30 -71.97 -5.6 36.04 Favored 'General case' 0 CA--C 1.557 1.237 0 CA-C-N 115.347 -0.842 . . . . 73.05 112.291 -178.47 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -97.65 -47.61 5.55 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 124.239 1.015 . . . . 70.02 111.903 173.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 37.2 tp -70.86 -52.75 18.34 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.655 0.782 . . . . 55.03 109.739 -176.346 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -86.16 -11.64 52.01 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 115.718 -0.674 . . . . 72.11 110.745 178.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -39.27 -58.82 1.94 Allowed Glycine 0 CA--C 1.543 1.792 0 CA-C-O 118.623 -1.098 . . . . 72.43 114.742 177.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -35.02 -36.92 0.13 Allowed 'Trans proline' 0 C--N 1.394 2.937 0 C-N-CA 125.289 3.993 . . . . 23.1 116.362 176.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.421 ' HA3' ' HG3' ' A' ' 78' ' ' PRO . . . -145.77 42.38 0.97 Allowed Glycine 0 C--N 1.354 1.53 0 CA-C-O 119.224 -0.764 . . . . 44.4 112.117 -178.621 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.524 HD11 ' HA ' ' A' ' 98' ' ' GLN . 8.1 mt -63.2 71.73 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.071 0.948 . . . . 74.25 112.867 177.718 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.72 ' HB3' ' HA ' ' A' ' 169' ' ' ASN . 1.5 t80 32.4 -105.13 0.02 OUTLIER 'General case' 0 CA--C 1.562 1.413 0 C-N-CA 126.3 1.84 . . . . 72.25 111.738 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 80.48 -40.03 2.38 Favored Glycine 0 C--N 1.359 1.844 0 CA-C-O 119.213 -0.77 . . . . 44.0 113.204 179.106 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.686 ' HA3' ' HB3' ' A' ' 167' ' ' GLN . . . . . . . . 0 C--N 1.359 1.839 0 C-N-CA 123.514 0.578 . . . . 71.34 113.519 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.586 ' HA ' ' HD2' ' A' ' 170' ' ' PRO . 21.9 ttmm . . . . . 0 CA--C 1.548 0.886 0 N-CA-C 109.842 -0.429 . . . . 72.15 109.842 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -89.36 161.18 29.86 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-N 116.65 -0.25 . . . . 55.22 113.7 -177.003 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -100.97 145.59 28.47 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.797 1.239 . . . . 71.34 108.174 175.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -58.6 144.95 41.25 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 118.717 0.69 . . . . 74.23 112.014 -175.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.416 ' O ' HD12 ' A' ' 174' ' ' LEU . 7.8 tt -144.5 137.13 26.68 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 109.049 -0.723 . . . . 70.23 109.049 -173.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -93.19 130.56 38.83 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.306 0.642 . . . . 74.51 109.364 174.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.619 ' HB1' HD11 ' B' ' 8' ' ' LEU . . . -141.31 140.86 33.9 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.415 -0.957 . . . . 41.51 108.415 176.209 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.461 ' HG3' HD11 ' B' ' 11' ' ' LEU . 42.6 mt-10 -123.11 109.27 13.83 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 108.704 -0.85 . . . . 61.0 108.704 -166.494 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.797 HD23 HD22 ' A' ' 176' ' ' LEU . 3.8 pp -101.27 114.84 65.71 Favored Pre-proline 0 N--CA 1.484 1.252 0 N-CA-C 110.293 -0.262 . . . . 54.05 110.293 -169.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.659 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 40.4 Cg_endo -67.24 109.56 1.79 Allowed 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 120.7 0.933 . . . . 75.33 110.309 173.507 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.722 ' HA ' HG21 ' B' ' 6' ' ' ILE . 57.7 tp -110.25 144.25 39.21 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 123.555 0.742 . . . . 64.01 110.829 -171.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 40.5 m -71.43 136.71 47.8 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 114.908 -1.042 . . . . 71.34 110.892 178.27 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.875 ' HB3' HD22 ' A' ' 215' ' ' LEU . 59.4 mt -54.37 -49.5 69.68 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.109 0.963 . . . . 70.54 111.688 -177.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -54.99 -46.51 75.14 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 114.646 -1.161 . . . . 75.32 111.452 175.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -65.66 -29.43 69.99 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 122.743 0.417 . . . . 64.33 111.451 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -66.75 -47.54 71.91 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.878 0.471 . . . . 41.43 110.503 178.084 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -63.96 -44.51 92.55 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 114.762 -1.108 . . . . 74.51 111.518 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 30.8 m170 -76.64 -45.58 29.39 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 115.709 -0.678 . . . . 75.25 111.404 -174.319 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.487 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 74.49 -153.25 45.85 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 123.54 0.525 . . . . 71.54 112.689 -177.348 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 81.72 -153.12 32.66 Favored Glycine 0 C--N 1.348 1.245 0 C-N-CA 123.223 0.439 . . . . 70.42 112.935 178.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -72.22 97.4 1.97 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.286 0.635 . . . . 73.14 110.09 -177.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.668 HH11 HD13 ' A' ' 125' ' ' LEU . 5.2 tmm_? -96.05 120.4 36.28 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 107.365 -1.346 . . . . 74.4 107.365 173.371 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 59.6 t -85.75 134.61 26.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 108.945 -0.761 . . . . 71.24 108.945 178.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.504 ' HB ' HG13 ' A' ' 145' ' ' VAL . 85.9 t -116.41 133.44 62.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 C-N-CA 124.007 0.923 . . . . 73.14 108.627 176.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -106.81 114.16 28.09 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 107.719 -1.215 . . . . 71.3 107.719 171.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.554 ' HB ' ' HB3' ' B' ' 8' ' ' LEU . 3.1 p -147.09 108.44 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 122.81 0.444 . . . . 75.1 111.845 -170.365 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 62.5 20.67 12.1 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.31 1.044 . . . . 74.24 112.198 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 92.64 4.87 65.31 Favored Glycine 0 C--N 1.352 1.428 0 CA-C-N 116.257 -0.429 . . . . 31.1 112.782 -175.023 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.468 ' HA ' ' NE ' ' A' ' 143' ' ' ARG . 3.7 tpm_? -98.59 106.67 18.97 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.567 0.747 . . . . 72.12 109.998 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 49.5 ttp180 -85.32 98.75 10.71 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.716 0.806 . . . . 74.41 109.252 174.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.504 HG13 ' HB ' ' A' ' 138' ' ' VAL . 2.5 p -110.8 131.93 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 123.458 0.703 . . . . 73.53 110.906 -177.184 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 48.3 t -89.35 93.28 9.48 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.705 0.802 . . . . 31.45 109.501 177.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 43.4 t -93.95 111.17 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 109.353 -0.61 . . . . 73.42 109.353 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 58.9 ttt85 -77.84 105.18 8.86 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 109.432 -0.581 . . . . 74.14 109.432 175.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.487 HG13 ' HA2' ' A' ' 133' ' ' GLY . 33.2 pt -90.71 149.17 40.04 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 123.766 0.826 . . . . 74.13 110.409 177.741 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -63.73 132.14 33.97 Favored 'Trans proline' 0 C--N 1.379 2.158 0 C-N-CA 122.843 2.362 . . . . 60.34 111.794 175.062 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.24 95.54 0.06 OUTLIER 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 123.155 2.57 . . . . 74.15 112.184 171.215 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 107.81 47.32 0.97 Allowed Glycine 0 C--N 1.341 0.828 0 N-CA-C 111.255 -0.738 . . . . 75.51 111.255 -172.009 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 5.2 p -86.25 141.39 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 108.219 -1.03 . . . . 75.43 108.219 175.042 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.529 ' HG2' ' HA ' ' A' ' 191' ' ' GLN . 0.0 OUTLIER -118.97 135.76 54.44 Favored 'General case' 0 C--O 1.198 -1.62 0 CA-C-O 117.116 -1.421 . . . . 73.23 110.146 -160.839 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.469 ' HB3' ' HB3' ' A' ' 188' ' ' LEU . 5.0 tp10 -43.62 129.94 5.35 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 119.386 0.994 . . . . 72.32 111.381 174.759 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 88.3 -7.47 81.49 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-O 119.062 -0.855 . . . . 14.21 113.594 -175.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.423 ' O ' HG12 ' A' ' 178' ' ' VAL . 8.2 t -66.26 113.53 4.65 Favored 'General case' 0 C--N 1.362 1.129 0 N-CA-C 107.247 -1.39 . . . . 74.23 107.247 176.549 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 58.9 t -85.12 91.27 3.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 107.696 -1.224 . . . . 72.34 107.696 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.599 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 32.8 mt -70.71 82.82 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 107.3 -1.37 . . . . 75.24 107.3 174.687 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 63.2 ttt-85 -74.57 97.93 3.26 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 107.804 -1.184 . . . . 61.32 107.804 179.26 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.401 ' HA ' ' HD2' ' A' ' 162' ' ' PRO . 2.5 p -106.82 104.71 52.67 Favored Pre-proline 0 C--O 1.242 0.707 0 N-CA-C 108.834 -0.802 . . . . 61.33 108.834 -178.624 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 161' ' ' VAL . 29.0 Cg_endo -62.03 104.16 0.32 Allowed 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 122.055 1.836 . . . . 74.53 109.956 173.132 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.451 ' HA3' ' N ' ' A' ' 87' ' ' GLY . . . 124.56 26.82 1.38 Allowed Glycine 0 C--N 1.341 0.843 0 N-CA-C 115.759 1.063 . . . . 70.43 115.759 174.573 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 22.5 mmt -138.63 1.75 2.15 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 117.999 0.899 . . . . 64.15 111.33 172.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.639 ' HA2' HD13 ' A' ' 174' ' ' LEU . . . -84.01 -123.09 0.98 Allowed Glycine 0 C--N 1.351 1.38 0 N-CA-C 114.252 0.461 . . . . 73.33 114.252 -171.004 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -58.54 143.95 43.96 Favored Glycine 0 C--N 1.351 1.37 0 O-C-N 124.122 0.542 . . . . 74.5 111.864 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.686 ' HB3' ' HA3' ' A' ' 108' ' ' GLY . 27.1 mm-40 -68.47 103.98 1.8 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.956 0.902 . . . . 75.42 111.937 -164.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -156.05 168.62 33.52 Favored Glycine 0 C--N 1.338 0.69 0 N-CA-C 109.759 -1.337 . . . . 64.21 109.759 177.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' ASN . . . . . 0.72 ' HA ' ' HB3' ' A' ' 106' ' ' PHE . 0.3 OUTLIER -62.14 -53.62 57.32 Favored Pre-proline 0 N--CA 1.485 1.289 0 CA-C-N 118.401 1.1 . . . . 63.11 110.032 -179.198 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.659 ' HD3' ' HB3' ' A' ' 169' ' ' ASN . 24.4 Cg_endo -95.99 90.79 0.09 OUTLIER 'Trans proline' 0 C--N 1.387 2.558 0 C-N-CA 122.089 1.86 . . . . 71.13 108.079 159.303 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.428 ' HD3' ' O ' ' A' ' 169' ' ' ASN . 25.3 Cg_exo -60.58 174.82 1.42 Allowed 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 122.786 2.324 . . . . 71.25 113.857 -171.164 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -66.35 175.15 21.01 Favored Glycine 0 N--CA 1.472 1.052 0 N-CA-C 115.397 0.919 . . . . 72.4 115.397 -175.214 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -69.79 97.43 1.09 Allowed 'General case' 0 C--O 1.242 0.693 0 N-CA-C 108.225 -1.028 . . . . 71.14 108.225 172.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.639 HD13 ' HA2' ' A' ' 165' ' ' GLY . 21.4 tp -78.47 104.0 8.78 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 109.518 -0.549 . . . . 64.32 109.518 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 68.4 mt -71.67 81.58 0.85 Allowed 'General case' 0 C--O 1.242 0.67 0 C-N-CA 124.1 0.96 . . . . 72.12 109.07 173.17 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.797 HD22 HD23 ' A' ' 123' ' ' LEU . 34.8 mt -76.02 90.06 3.01 Favored 'General case' 0 C--N 1.35 0.627 0 CA-C-N 115.978 -0.556 . . . . 70.05 110.133 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.446 ' HB ' ' HG2' ' A' ' 122' ' ' GLU . 17.4 t -82.22 105.04 11.65 Favored 'Isoleucine or valine' 0 C--O 1.246 0.886 0 N-CA-C 106.954 -1.498 . . . . 61.43 106.954 179.086 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.423 HG12 ' O ' ' A' ' 157' ' ' SER . 7.1 p -71.21 106.42 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.037 0 CA-C-N 114.924 -1.034 . . . . 70.33 110.963 -174.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.659 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 33.7 mmt180 -91.89 94.46 9.32 Favored 'General case' 0 C--O 1.208 -1.089 0 C-N-CA 123.233 0.613 . . . . 53.32 110.215 179.188 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.536 HD23 ' HB3' ' A' ' 125' ' ' LEU . 17.6 mt -67.12 143.73 56.48 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 121.379 -0.826 . . . . 72.4 110.564 -177.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.41 ' HA ' ' HD3' ' A' ' 182' ' ' PRO . 82.5 mt -54.37 144.62 41.01 Favored Pre-proline 0 N--CA 1.476 0.835 0 O-C-N 124.367 1.042 . . . . 73.14 111.329 -172.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 182' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 181' ' ' LEU . 8.0 Cg_exo -75.17 36.52 0.45 Allowed 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 123.041 2.494 . . . . 71.42 113.073 176.429 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 183' ' ' HIS . . . . . 0.488 ' HB3' HD11 ' A' ' 127' ' ' LEU . 24.1 t-80 -61.45 126.26 86.16 Favored Pre-proline 0 CA--C 1.549 0.929 0 N-CA-C 107.636 -1.246 . . . . 73.35 107.636 171.079 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 183' ' ' HIS . 21.2 Cg_exo -66.16 24.06 0.1 OUTLIER 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 124.078 3.185 . . . . 61.24 118.689 -160.662 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 16.2 t -102.93 -59.99 3.1 Favored 'Isoleucine or valine' 0 C--N 1.367 1.366 0 CA-C-N 121.23 1.832 . . . . 64.21 109.362 175.217 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 186' ' ' PHE . . . . . 0.543 ' CD1' ' HB2' ' A' ' 195' ' ' ALA . 49.0 m-85 -120.09 140.6 50.8 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.006 0.743 . . . . 72.31 113.006 -168.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -117.49 92.18 3.78 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 104.604 -2.369 . . . . 75.51 104.604 162.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.579 ' HA ' ' HA ' ' A' ' 193' ' ' LEU . 13.9 tp -73.33 162.14 29.68 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.468 1.107 . . . . 74.21 109.897 -177.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 189' ' ' GLU . . . . . 0.466 ' H ' HD12 ' A' ' 188' ' ' LEU . 11.4 tp10 -163.99 129.53 2.95 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.766 0.827 . . . . 70.31 109.464 171.399 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 75.25 -77.99 1.15 Allowed Glycine 0 C--N 1.348 1.237 0 O-C-N 123.388 0.43 . . . . 65.41 112.986 175.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.529 ' HA ' ' HG2' ' A' ' 154' ' ' ARG . 0.5 OUTLIER -153.26 -0.8 0.24 Allowed 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 124.708 1.203 . . . . 72.32 110.364 170.28 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.47 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 6.4 p-10 -117.95 133.19 56.16 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.998 1.319 . . . . 72.32 111.566 -172.352 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.579 ' HA ' ' HA ' ' A' ' 188' ' ' LEU . 18.2 mt -88.43 155.11 19.86 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.611 1.165 . . . . 63.44 110.126 -171.687 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -126.2 99.13 5.75 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 108.489 -0.93 . . . . 73.14 108.489 167.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.544 ' HB3' HD23 ' A' ' 251' ' ' LEU . . . -103.02 173.19 6.42 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.021 0.929 . . . . 74.34 109.325 175.005 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 30.7 m -110.88 149.06 31.15 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 108.457 -0.942 . . . . 70.21 108.457 171.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.424 HD22 HD13 ' A' ' 251' ' ' LEU . 49.5 tp -142.44 109.53 5.55 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 109.248 -0.649 . . . . 72.21 109.248 -176.228 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -86.35 121.93 29.61 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 108.296 -1.002 . . . . 61.43 108.296 173.098 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 7.5 p -140.36 133.25 14.8 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 123.987 0.915 . . . . 64.4 108.588 -176.215 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.69 156.55 48.93 Favored 'Trans proline' 0 C--N 1.369 1.645 0 C-N-CA 121.858 1.705 . . . . 64.51 111.911 175.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -57.51 -46.64 99.77 Favored Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 124.725 1.21 . . . . 71.34 114.038 -170.168 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -57.86 -45.04 35.28 Favored 'Trans proline' 0 C--N 1.39 2.75 0 C-N-CA 121.643 1.562 . . . . 63.54 113.082 175.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.471 HD11 ' HB3' ' C' ' 276' ' ' TYR . 33.8 mt -71.33 -27.19 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.087 0.555 . . . . 64.32 110.273 -179.435 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -71.52 -47.33 55.93 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.359 0.663 . . . . 71.51 111.08 177.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 53.0 t -65.71 -49.94 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 123.629 0.772 . . . . 63.23 111.309 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 59.0 t -88.74 -43.47 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.588 0.755 . . . . 74.41 111.509 -170.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 96.19 121.75 3.98 Favored Glycine 0 C--N 1.338 0.666 0 CA-C-N 115.947 -0.569 . . . . 72.35 112.683 -174.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.451 ' H ' ' HB ' ' A' ' 223' ' ' VAL . . . -141.98 -137.2 3.34 Favored Glycine 0 C--N 1.341 0.827 0 N-CA-C 111.095 -0.802 . . . . 55.24 111.095 178.041 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -136.24 137.71 41.07 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 118.006 0.903 . . . . 45.21 109.739 174.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 26.9 m -133.74 149.47 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 N-CA-C 108.59 -0.893 . . . . 63.11 108.59 172.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 21.3 ttm105 -75.36 107.58 7.57 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 121.101 0.477 . . . . 71.41 110.12 177.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -105.78 144.81 31.99 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.348 1.059 . . . . 62.04 109.181 175.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 213' ' ' MET . . . . . 0.514 ' N ' ' SD ' ' A' ' 213' ' ' MET . 0.5 OUTLIER -87.02 151.82 22.92 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 123.07 0.548 . . . . 71.23 109.898 -177.998 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 81.3 p -122.05 -162.67 1.01 Allowed 'General case' 0 C--O 1.243 0.732 0 N-CA-C 108.36 -0.978 . . . . 74.1 108.36 170.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.875 HD22 ' HB3' ' A' ' 127' ' ' LEU . 34.1 mt -65.36 -42.63 92.57 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.159 0.584 . . . . 63.31 110.781 177.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -129.3 30.35 5.0 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 115.331 -0.85 . . . . 64.44 112.351 -165.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 155.45 158.2 8.65 Favored Glycine 0 C--N 1.352 1.457 0 CA-C-O 119.75 -0.472 . . . . 33.0 113.888 173.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -94.25 101.67 0.13 Allowed 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 123.277 2.651 . . . . 70.23 112.716 178.166 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 29.7 m -90.63 173.67 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 123.822 0.849 . . . . 73.4 109.771 -176.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 25.9 pt-20 -100.74 124.01 45.76 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 108.47 -0.937 . . . . 75.04 108.47 169.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 14.4 p -100.22 129.21 51.29 Favored 'Isoleucine or valine' 0 C--O 1.245 0.867 0 N-CA-C 108.493 -0.928 . . . . 74.13 108.493 173.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -84.43 101.24 11.87 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 109.379 -0.6 . . . . 60.25 109.379 178.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.451 ' HB ' ' H ' ' A' ' 208' ' ' GLY . 62.4 t -58.33 136.49 85.16 Favored Pre-proline 0 CA--C 1.553 1.067 0 CA-C-N 113.677 -1.601 . . . . 63.14 110.064 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -81.8 176.32 8.5 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 122.987 2.458 . . . . 75.51 110.716 177.021 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -71.53 159.09 52.27 Favored 'Trans proline' 0 C--N 1.359 1.131 0 C-N-CA 120.607 0.871 . . . . 72.53 110.844 165.231 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 226' ' ' ARG . . . . . 0.572 ' HD2' ' O ' ' C' ' 259' ' ' GLU . 11.1 mmt180 65.81 26.95 11.16 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 124.56 1.144 . . . . 74.04 113.195 168.227 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.529 HG23 HD21 ' A' ' 233' ' ' LEU . 31.4 m -65.1 84.43 0.05 OUTLIER 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 124.969 1.308 . . . . 64.32 109.568 175.599 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -86.39 138.89 31.44 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.291 1.036 . . . . 75.32 110.713 -171.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -50.11 127.26 16.42 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.39 1.476 . . . . 62.31 112.112 -176.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 88.29 -25.06 9.6 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-N 115.543 -0.753 . . . . 73.32 114.462 172.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.432 ' O ' HG23 ' A' ' 253' ' ' VAL . 70.8 mtt180 -67.5 156.01 37.69 Favored 'General case' 0 C--N 1.345 0.408 0 N-CA-C 109.323 -0.621 . . . . 74.0 109.323 172.666 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? -110.46 123.29 49.63 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.558 -0.904 . . . . 72.22 108.558 -176.428 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.529 HD21 HG23 ' A' ' 227' ' ' THR . 80.7 mt -72.42 111.53 7.69 Favored 'General case' 0 C--O 1.217 -0.645 0 N-CA-C 107.525 -1.287 . . . . 71.4 107.525 179.296 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -95.21 100.28 12.11 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 123.462 0.476 . . . . 64.14 110.185 -178.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.568 HD12 ' HG3' ' A' ' 238' ' ' LYS . 0.2 OUTLIER -107.31 107.02 17.74 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.547 0.739 . . . . 61.12 109.455 -179.659 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.609 ' HA ' ' HB3' ' A' ' 248' ' ' ASP . 14.2 mmmm -67.54 148.91 50.84 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.702 0.801 . . . . 64.43 111.73 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.475 ' HA2' ' HB2' ' A' ' 246' ' ' ARG . . . 73.55 23.79 76.2 Favored Glycine 0 C--N 1.352 1.45 0 CA-C-N 116.164 -0.471 . . . . 74.2 113.566 177.307 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.568 ' HG3' HD12 ' A' ' 235' ' ' LEU . 46.6 mmtm -123.05 -26.23 4.4 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.873 0.869 . . . . 73.01 110.985 -174.153 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -80.19 -155.19 10.58 Favored Glycine 0 C--N 1.345 1.079 0 CA-C-N 115.948 -0.569 . . . . 74.43 113.009 171.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 240' ' ' PHE . . . . . 0.5 ' HZ ' HD11 ' A' ' 215' ' ' LEU . 3.9 m-85 -94.92 139.03 21.98 Favored Pre-proline 0 N--CA 1.478 0.95 0 CA-C-O 118.893 -0.575 . . . . 73.13 111.175 -168.713 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.597 ' HA ' ' HA ' ' A' ' 246' ' ' ARG . 59.6 Cg_exo -42.4 129.04 4.75 Favored 'Trans proline' 0 C--N 1.391 2.79 0 C-N-CA 124.437 3.425 . . . . 73.33 114.585 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -165.23 -147.15 5.04 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-O 119.334 -0.703 . . . . 73.52 112.586 -176.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 243' ' ' PRO . . . . . 0.465 ' HD2' ' HG2' ' A' ' 191' ' ' GLN . 28.1 Cg_exo -62.71 -28.42 76.51 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 123.761 2.974 . . . . 70.45 113.138 -177.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -90.82 21.28 4.2 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.964 0.906 . . . . 70.11 111.524 -179.107 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 78.28 -70.11 2.65 Favored Glycine 0 C--N 1.35 1.346 0 N-CA-C 109.762 -1.335 . . . . 62.24 109.762 -170.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.597 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 64.0 mtm180 -122.65 144.82 48.88 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 107.154 -1.425 . . . . 75.41 107.154 164.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -69.55 -165.81 4.81 Favored Glycine 0 C--N 1.335 0.514 0 CA-C-O 121.435 0.464 . . . . 42.24 113.919 172.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 248' ' ' ASP . . . . . 0.609 ' HB3' ' HA ' ' A' ' 236' ' ' LYS . 0.9 OUTLIER -121.0 173.53 7.2 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.589 0.755 . . . . 75.44 111.492 -174.049 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.467 HD23 HD11 ' A' ' 235' ' ' LEU . 16.2 tp -126.56 136.25 52.32 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.297 -1.001 . . . . 70.31 108.297 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.443 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 56.5 m-85 -111.78 113.94 26.61 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.352 1.061 . . . . 52.51 109.112 176.041 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.544 HD23 ' HB3' ' A' ' 195' ' ' ALA . 78.2 mt -102.39 106.85 17.67 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 109.262 -0.644 . . . . 72.24 109.262 178.123 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -76.79 117.94 18.9 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 109.435 -0.58 . . . . 75.41 109.435 -178.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 231' ' ' ARG . 49.2 t -71.61 134.19 30.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-N 114.477 -1.238 . . . . 24.43 111.31 -171.657 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -130.94 91.23 3.02 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 106.82 -1.548 . . . . 73.14 106.82 177.113 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.492 HD13 HG23 ' C' ' 257' ' ' ILE . 62.0 mt -77.52 127.88 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 122.767 0.427 . . . . 74.34 111.243 -173.408 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 25.6 p -116.11 165.16 13.46 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.738 1.215 . . . . 73.43 110.263 175.392 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 257' ' ' ILE . . . . . 0.486 ' HB ' ' HD2' ' A' ' 258' ' ' PRO . 2.9 pp -134.17 154.54 80.13 Favored Pre-proline 0 N--CA 1.486 1.363 0 C-N-CA 123.519 0.728 . . . . 73.4 109.079 174.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 258' ' ' PRO . . . . . 0.486 ' HD2' ' HB ' ' A' ' 257' ' ' ILE . 18.4 Cg_endo -54.28 -17.84 12.89 Favored 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 123.705 2.937 . . . . 74.45 116.336 -164.729 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 259' ' ' GLU . . . . . 0.413 ' H ' HD12 ' A' ' 257' ' ' ILE . 7.7 mm-40 59.18 -64.49 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 125.234 1.414 . . . . 63.24 113.119 -167.585 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -79.24 129.68 34.7 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.792 -0.568 . . . . 75.12 111.013 178.529 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.413 HD12 ' HD2' ' C' ' 226' ' ' ARG . 67.4 mt -143.29 154.59 43.94 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.412 1.085 . . . . 55.32 109.852 177.662 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 262' ' ' THR . . . . . 0.445 ' HB ' ' HD2' ' A' ' 263' ' ' PRO . 18.0 p -132.33 159.3 72.84 Favored Pre-proline 0 CA--C 1.564 1.515 0 C-N-CA 124.791 1.236 . . . . 44.34 108.787 174.066 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 263' ' ' PRO . . . . . 0.445 ' HD2' ' HB ' ' A' ' 262' ' ' THR . 39.2 Cg_exo -17.21 -58.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.398 3.155 1 C-N-CA 127.317 5.344 . . . . 74.33 119.167 -170.921 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -70.9 -47.51 58.76 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 118.056 0.389 . . . . 71.44 111.861 -173.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 265' ' ' GLU . . . . . 0.4 ' HB3' HD22 ' A' ' 261' ' ' LEU . 5.5 mp0 -66.05 -36.97 84.67 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 109.506 -0.553 . . . . 64.2 109.506 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 266' ' ' GLU . . . . . 0.461 ' O ' ' HG3' ' A' ' 270' ' ' LYS . 4.2 tp10 -52.55 -48.97 65.81 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 124.509 1.131 . . . . 73.45 109.238 172.481 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -58.65 -51.16 71.11 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.697 1.199 . . . . 64.12 112.835 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 11.0 mp -59.94 -46.62 88.81 Favored 'General case' 0 N--CA 1.483 1.223 0 O-C-N 123.717 0.636 . . . . 73.14 110.689 -178.2 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -65.61 -34.93 79.37 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 123.58 0.752 . . . . 75.0 112.385 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 270' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' A' ' 266' ' ' GLU . 9.1 mtpm? -63.06 -55.31 26.6 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 122.961 0.504 . . . . 62.43 110.793 176.462 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 30.7 mmtm -62.98 -27.99 69.78 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 124.085 0.865 . . . . 70.22 111.634 -178.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 272' ' ' LEU . . . . . 0.434 ' O ' ' HB2' ' A' ' 276' ' ' TYR . 40.9 mt -60.12 -55.42 34.05 Favored 'General case' 0 C--O 1.207 -1.158 0 O-C-N 123.836 0.71 . . . . 63.4 109.887 167.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -63.34 -33.42 75.48 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.874 0.87 . . . . 64.51 113.184 -176.31 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -69.57 -55.34 10.39 Favored 'General case' 0 C--O 1.252 1.203 0 C-N-CA 123.957 0.903 . . . . 74.35 109.736 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -77.26 -2.86 36.86 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-N 115.032 -0.985 . . . . 71.44 111.668 178.11 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 276' ' ' TYR . . . . . 0.434 ' HB2' ' O ' ' A' ' 272' ' ' LEU . 33.4 t80 -79.53 -61.79 1.89 Allowed 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.236 -1.024 . . . . 75.02 108.236 171.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 277' ' ' TYR . . . . . 0.472 ' HA ' ' HB2' ' A' ' 280' ' ' ALA . 2.6 t80 -58.03 -38.76 76.84 Favored 'General case' 0 C--N 1.356 0.877 0 O-C-N 124.988 1.43 . . . . 70.12 109.53 -175.6 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -48.03 -38.05 16.31 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.67 1.188 . . . . 75.41 113.7 175.106 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.55 37.85 3.47 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 109.319 -0.623 . . . . 74.13 109.319 179.139 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 280' ' ' ALA . . . . . 0.472 ' HB2' ' HA ' ' A' ' 277' ' ' TYR . . . . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 118.89 -0.576 . . . . 72.21 112.102 -175.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 61.1 mtm . . . . . 0 N--CA 1.483 1.18 0 N-CA-C 109.488 -0.56 . . . . 71.44 109.488 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt 67.09 -77.42 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 125.335 1.454 . . . . 54.1 111.552 177.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 36.6 tp60 -154.51 128.01 8.57 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 107.258 -1.386 . . . . 74.04 107.258 -177.27 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 39.4 m -141.75 100.65 3.8 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 108.763 -0.828 . . . . 52.14 108.763 -178.201 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 8.6 m -64.09 153.34 37.86 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.353 0.661 . . . . 70.11 112.428 -168.375 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.722 HG21 ' HA ' ' A' ' 125' ' ' LEU . 19.1 pt -117.55 -177.64 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 N-CA-C 113.12 0.785 . . . . 64.44 113.12 -167.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -135.76 143.66 45.39 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 114.572 -1.194 . . . . 72.01 110.322 177.398 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 8' ' ' LEU . . . . . 0.619 HD11 ' HB1' ' A' ' 121' ' ' ALA . 36.9 tp -115.76 157.72 23.91 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.842 1.257 . . . . 75.22 108.494 173.498 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -103.73 -35.66 8.14 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.016 0.526 . . . . 62.4 111.926 178.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 10' ' ' LEU . . . . . 0.424 ' HG ' HG21 ' A' ' 140' ' ' VAL . 88.4 mt 76.68 2.58 3.4 Favored 'General case' 0 N--CA 1.502 2.145 0 C-N-CA 125.556 1.543 . . . . 74.1 110.726 -162.293 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.461 HD11 ' HG3' ' A' ' 122' ' ' GLU . 65.0 mt . . . . . 0 CA--C 1.578 2.043 0 N-CA-C 116.383 1.994 . . . . 45.35 116.383 177.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.214 0 N-CA-C 109.042 -0.725 . . . . 61.34 109.042 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 180' ' ' ALA . . . . . 0.635 ' HB1' HG23 ' C' ' 137' ' ' VAL . . . -161.77 -69.81 0.06 Allowed 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 108.505 -0.924 . . . . 74.4 108.505 172.441 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 20.1 tp -88.35 -68.72 0.75 Allowed 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 107.171 -1.418 . . . . 62.04 107.171 160.216 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 182' ' ' VAL . . . . . . . . . . . . . 78.4 t -135.64 -70.95 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.705 0.802 . . . . 71.31 109.644 175.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -171.64 -89.44 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.257 0.623 . . . . 65.24 110.537 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 26.7 p-80 -168.01 -167.58 0.85 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.481 0.712 . . . . 74.15 110.869 -173.052 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 185' ' ' VAL . . . . . . . . . . . . . 89.6 t . . . . . 0 N--CA 1.482 1.165 0 C-N-CA 124.1 0.96 . . . . 71.33 111.011 -179.267 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 33.0 m . . . . . 0 CA--C 1.544 0.713 0 CA-C-O 121.48 0.657 . . . . 71.31 110.016 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 239' ' ' ALA . . . . . 0.417 ' HA ' HD22 ' C' ' 235' ' ' LEU . . . -68.96 137.96 54.18 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 114.671 -1.15 . . . . 74.42 111.16 172.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . -70.34 -101.57 0.04 OUTLIER Glycine 0 C--N 1.355 1.586 0 N-CA-C 110.923 -0.871 . . . . 71.23 110.923 172.128 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 241' ' ' GLU . . . . . 0.496 ' HB3' ' HG3' ' B' ' 245' ' ' LYS . 24.0 pt-20 -175.31 171.58 2.87 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.847 0.859 . . . . 71.21 111.462 169.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 242' ' ' TRP . . . . . 0.424 ' CZ3' HG21 ' C' ' 253' ' ' VAL . 0.7 OUTLIER -98.27 -66.11 0.92 Allowed 'General case' 0 C--O 1.237 0.408 0 N-CA-C 107.094 -1.447 . . . . 70.32 107.094 -175.773 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -141.72 19.49 2.17 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 112.586 -2.097 . . . . 74.22 106.974 -175.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 114.41 164.88 15.09 Favored Glycine 0 CA--C 1.535 1.341 0 N-CA-C 109.75 -1.34 . . . . 63.11 109.75 -156.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 245' ' ' LYS . . . . . 0.496 ' HG3' ' HB3' ' B' ' 241' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.374 0 C-N-CA 123.727 0.811 . . . . 75.34 111.019 177.223 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.838 0 N-CA-C 110.308 -0.256 . . . . 52.01 110.308 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? -37.64 96.2 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 125.616 1.566 . . . . 70.52 113.179 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 5' ' ' LYS . . . . . 0.484 ' HB3' HD11 ' C' ' 10' ' ' ILE . 97.4 mttt -96.86 106.93 19.34 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.72 0.808 . . . . 63.2 109.561 174.359 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -73.83 97.62 2.79 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 107.076 -1.453 . . . . 63.22 107.076 166.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 7' ' ' TYR . . . . . 0.41 ' HA ' HD12 ' C' ' 10' ' ' ILE . 61.1 m-85 -61.16 -26.04 67.42 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 114.451 -1.249 . . . . 73.43 112.257 -172.607 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -68.67 -46.77 68.22 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.851 0.461 . . . . 72.53 109.792 176.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.3 -42.88 92.35 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.366 0.666 . . . . 52.31 110.678 178.29 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 10' ' ' ILE . . . . . 0.484 HD11 ' HB3' ' C' ' 5' ' ' LYS . 83.3 mt -54.17 -47.39 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 C-N-CA 124.023 0.929 . . . . 63.34 110.615 174.162 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 11' ' ' LEU . . . . . 0.4 ' HB2' HG22 ' C' ' 13' ' ' VAL . 85.8 mt -75.79 -13.6 60.29 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 115.397 -0.82 . . . . 45.45 112.787 179.081 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.66 21.29 75.06 Favored Glycine 0 C--N 1.351 1.393 0 CA-C-N 117.903 0.32 . . . . 64.33 113.655 -177.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 13' ' ' VAL . . . . . 0.4 HG22 ' HB2' ' C' ' 11' ' ' LEU . 12.5 m -106.19 160.58 25.7 Favored Pre-proline 0 N--CA 1.483 1.187 0 C-N-CA 124.291 1.036 . . . . 64.04 110.271 176.332 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -56.82 153.37 37.47 Favored 'Trans proline' 0 C--N 1.388 2.65 0 C-N-CA 122.714 2.276 . . . . 74.43 112.152 177.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 63.6 mtp180 -70.67 7.21 1.16 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 113.661 0.985 . . . . 71.52 113.661 -174.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -135.93 21.94 3.29 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.276 1.031 . . . . 71.24 108.594 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.04 128.07 34.99 Favored 'General case' 0 C--N 1.35 0.608 0 CA-C-N 114.684 -1.144 . . . . 71.14 111.089 -176.183 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 70.8 p -71.44 169.22 15.84 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 123.662 0.785 . . . . 74.41 110.252 177.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -50.98 -38.59 51.89 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.052 0.941 . . . . 74.45 111.615 -178.326 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 20' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' C' ' 24' ' ' ARG . 0.3 OUTLIER -69.68 -45.56 68.04 Favored 'General case' 0 CA--C 1.553 1.061 0 O-C-N 123.952 0.783 . . . . 64.05 110.539 -176.14 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -63.47 -43.41 97.42 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.724 0.773 . . . . 73.42 110.741 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 22' ' ' ILE . . . . . 0.755 HD13 ' HB3' ' C' ' 57' ' ' LEU . 89.8 mt -63.13 -34.3 65.88 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 CA-C-N 114.044 -1.435 . . . . 61.32 110.75 175.486 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -72.67 -29.95 63.86 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.928 0.891 . . . . 74.13 111.223 176.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 24' ' ' ARG . . . . . 0.431 ' HG3' ' O ' ' C' ' 20' ' ' GLU . 94.6 mtt180 -64.81 -53.05 52.94 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.142 0.577 . . . . 73.52 109.541 175.398 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.93 -40.96 97.32 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 114.704 -1.135 . . . . 75.32 111.24 178.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 26' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -52.48 -64.43 0.82 Allowed 'General case' 0 C--O 1.212 -0.877 0 O-C-N 124.789 1.306 . . . . 72.31 110.309 176.085 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -59.01 -38.73 79.9 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 124.339 1.025 . . . . 74.1 111.45 -174.566 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 -55.03 -53.68 52.67 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 123.715 0.634 . . . . 71.15 110.588 177.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 29' ' ' LEU . . . . . 0.526 ' HB3' HD13 ' C' ' 50' ' ' ILE . 72.4 mt -82.65 -17.14 45.66 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 115.009 -0.996 . . . . 60.22 111.941 -176.405 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -85.84 -16.6 38.17 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.738 0.815 . . . . 75.32 110.472 179.305 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -95.19 -37.7 10.92 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.525 0.73 . . . . 73.5 109.954 170.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 25.8 tp60 -65.07 -47.76 76.17 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.393 0.677 . . . . 71.12 111.187 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -108.69 22.7 15.57 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.333 0.653 . . . . 70.15 111.069 -175.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 34' ' ' HIS . . . . . 0.527 ' CD2' ' HB3' ' C' ' 36' ' ' ASP . 54.3 t60 -60.51 99.39 0.18 Allowed Pre-proline 0 N--CA 1.487 1.412 0 C-N-CA 124.913 1.285 . . . . 72.34 111.547 -174.716 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -61.97 -22.37 74.15 Favored 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 123.51 2.806 . . . . 71.32 113.916 -167.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 36' ' ' ASP . . . . . 0.527 ' HB3' ' CD2' ' C' ' 34' ' ' HIS . 9.4 t70 -56.44 -43.88 79.91 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.38 1.072 . . . . 60.34 111.603 174.542 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 37' ' ' VAL . . . . . 0.432 HG23 ' HD2' ' C' ' 34' ' ' HIS . 51.7 t -99.94 -46.24 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-O 121.762 0.791 . . . . 75.33 109.754 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -100.93 84.5 2.7 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.391 1.476 . . . . 54.22 109.921 -175.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -83.37 54.88 2.96 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.402 0.681 . . . . 62.24 110.663 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 44.3 m -104.37 108.33 60.14 Favored Pre-proline 0 N--CA 1.475 0.791 0 CA-C-O 118.572 -0.728 . . . . 74.14 109.136 -178.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -40.75 -52.12 3.34 Favored 'Trans proline' 0 C--N 1.387 2.6 0 C-N-CA 124.655 3.57 . . . . 63.44 114.707 -174.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 42' ' ' GLU . . . . . 0.404 ' O ' ' HD3' ' C' ' 46' ' ' LYS . 41.8 tt0 -56.81 -47.39 80.35 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 124.043 0.839 . . . . 65.44 110.813 178.384 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.05 -20.87 66.32 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 115.966 -0.561 . . . . 62.05 110.901 -178.268 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 44' ' ' GLU . . . . . 0.406 ' O ' ' HD3' ' C' ' 48' ' ' LYS . 45.7 mt-10 -86.29 -28.87 23.47 Favored 'General case' 0 C--N 1.355 0.814 0 C-N-CA 123.21 0.604 . . . . 74.04 109.995 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -60.85 -50.26 74.17 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.753 -0.832 . . . . 42.53 108.753 171.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 46' ' ' LYS . . . . . 0.404 ' HD3' ' O ' ' C' ' 42' ' ' GLU . 12.3 mptt -62.5 -48.79 78.04 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 113.811 -1.541 . . . . 72.32 110.07 179.092 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -56.25 -39.19 72.18 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.809 0.844 . . . . 62.23 110.79 178.135 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 48' ' ' LYS . . . . . 0.406 ' HD3' ' O ' ' C' ' 44' ' ' GLU . 1.2 mptm? -62.02 -49.19 77.01 Favored 'General case' 0 C--O 1.214 -0.794 0 O-C-N 123.841 0.713 . . . . 72.04 109.97 179.217 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -70.68 -22.02 62.53 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 112.557 0.577 . . . . 72.33 112.557 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 50' ' ' ILE . . . . . 0.526 HD13 ' HB3' ' C' ' 29' ' ' LEU . 73.2 mt -80.11 -36.78 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 124.423 1.089 . . . . 75.43 110.69 176.657 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 51' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -89.63 -8.64 52.07 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.031 0.932 . . . . 74.04 110.521 177.18 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 52' ' ' GLU . . . . . 0.413 ' O ' HG23 ' C' ' 56' ' ' VAL . 29.4 tt0 -79.0 -47.19 16.71 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.93 1.292 . . . . 63.42 107.928 166.759 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.42 -44.34 80.29 Favored 'General case' 0 C--N 1.346 0.431 0 CA-C-N 114.243 -1.344 . . . . 63.1 110.684 173.076 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -80.93 -22.84 39.31 Favored 'General case' 0 CA--C 1.553 1.06 0 CA-C-N 115.501 -0.772 . . . . 75.01 111.125 178.007 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.85 -38.24 78.28 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 118.839 0.745 . . . . 60.54 110.22 171.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 56' ' ' VAL . . . . . 0.413 HG23 ' O ' ' C' ' 52' ' ' GLU . 26.1 t -77.34 -47.69 26.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-N 114.891 -1.049 . . . . 72.43 110.501 174.667 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 57' ' ' LEU . . . . . 0.755 ' HB3' HD13 ' C' ' 22' ' ' ILE . 85.1 mt -103.72 20.8 17.36 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 113.569 0.952 . . . . 75.02 113.569 -166.362 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 33.6 t -55.89 -43.1 76.92 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 124.161 0.984 . . . . 62.42 113.275 177.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -140.71 156.91 68.82 Favored Pre-proline 0 N--CA 1.472 0.664 0 C-N-CA 124.379 1.072 . . . . 72.03 109.559 -170.205 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 60' ' ' PRO . . . . . 0.472 ' O ' ' HG2' ' C' ' 64' ' ' ARG . 19.6 Cg_endo -54.62 -29.21 59.8 Favored 'Trans proline' 0 C--N 1.394 2.959 0 C-N-CA 123.408 2.739 . . . . 33.23 112.454 179.176 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -54.04 -63.16 1.24 Allowed 'General case' 0 C--O 1.252 1.199 0 C-N-CA 124.823 1.249 . . . . 62.13 111.801 177.461 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 44.0 mtpt -81.55 -24.64 36.45 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 113.94 -1.482 . . . . 75.23 110.152 -171.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -54.3 -50.13 68.05 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.763 1.225 . . . . 64.42 109.595 166.463 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 64' ' ' ARG . . . . . 0.472 ' HG2' ' O ' ' C' ' 60' ' ' PRO . 20.9 mmt180 -71.11 -29.02 64.74 Favored 'General case' 0 C--N 1.358 0.967 0 CA-C-O 119.13 -0.462 . . . . 74.15 111.801 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 65' ' ' ILE . . . . . 0.401 HG23 ' HG2' ' C' ' 76' ' ' PRO . 69.4 mt -56.86 -44.92 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-O 121.296 0.57 . . . . 62.34 110.317 168.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -63.19 -48.15 79.6 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.994 -0.548 . . . . 74.22 110.969 176.049 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -58.84 -41.4 86.86 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 123.581 0.551 . . . . 73.14 111.725 -177.37 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 64.9 p -67.8 -28.99 68.06 Favored 'General case' 0 C--N 1.349 0.574 0 O-C-N 123.341 0.4 . . . . 63.2 110.671 176.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -77.26 142.71 39.36 Favored 'General case' 0 C--N 1.359 0.989 0 N-CA-C 109.052 -0.721 . . . . 75.22 109.052 171.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.69 13.3 82.6 Favored Glycine 0 C--N 1.346 1.102 0 N-CA-C 112.009 -0.436 . . . . 62.51 112.009 -177.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 28.8 m -136.93 -54.5 0.71 Allowed 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 103.749 -2.686 . . . . 72.34 103.749 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 82.2 m -97.51 150.17 21.37 Favored 'General case' 0 C--O 1.255 1.354 0 N-CA-C 104.532 -2.395 . . . . 73.35 104.532 156.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.12 -34.16 11.8 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.844 0.858 . . . . 73.23 110.258 -178.505 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -70.64 128.1 91.31 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 123.742 0.817 . . . . 53.23 110.732 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -67.13 150.38 82.12 Favored 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 122.647 2.231 . . . . 75.14 111.176 172.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 76' ' ' PRO . . . . . 0.401 ' HG2' HG23 ' C' ' 65' ' ' ILE . 48.1 Cg_exo -58.75 147.39 88.44 Favored 'Trans proline' 0 C--N 1.373 1.856 0 C-N-CA 122.645 2.23 . . . . 63.14 112.123 173.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 77' ' ' PRO . . . . . 0.401 ' HA ' ' HD3' ' C' ' 78' ' ' PRO . 50.5 Cg_exo -56.43 147.42 68.55 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 122.388 2.059 . . . . 51.51 112.113 171.602 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 78' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' C' ' 77' ' ' PRO . 43.3 Cg_exo -59.05 123.05 12.63 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.975 2.45 . . . . 74.44 112.618 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -71.91 170.68 18.25 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 122.872 2.382 . . . . 61.04 112.178 178.13 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 80' ' ' PRO . . . . . 0.49 ' HB2' ' HB1' ' C' ' 141' ' ' ALA . 82.4 Cg_exo -48.8 89.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.393 2.911 0 C-N-CA 123.468 2.779 . . . . 51.5 113.607 178.443 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 118.29 -40.1 2.4 Favored Glycine 0 C--O 1.225 -0.464 0 CA-C-N 114.651 -1.158 . . . . 75.2 110.255 177.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 126.5 -176.04 17.68 Favored Glycine 0 C--N 1.347 1.18 0 N-CA-C 111.249 -0.741 . . . . 74.45 111.249 -172.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -73.98 124.13 25.63 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.839 0.856 . . . . 70.14 111.152 -176.411 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 84' ' ' ASP . . . . . 0.662 ' HB3' HH21 ' C' ' 143' ' ' ARG . 6.9 p-10 -70.77 149.15 47.18 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.616 0.766 . . . . 63.13 110.506 177.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 85' ' ' PHE . . . . . 0.543 ' HB3' ' HB2' ' C' ' 88' ' ' PHE . 53.6 m-85 -148.37 74.86 1.3 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.641 0.777 . . . . 74.41 110.056 -179.147 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 16.5 m -54.98 86.57 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 125.131 1.373 . . . . 45.43 113.645 -175.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 85.49 13.45 70.45 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-N 115.686 -0.688 . . . . 74.33 112.829 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 88' ' ' PHE . . . . . 0.543 ' HB2' ' HB3' ' C' ' 85' ' ' PHE . 18.5 m-85 -115.34 108.15 16.16 Favored 'General case' 0 C--N 1.355 0.815 0 C-N-CA 123.135 0.574 . . . . 74.44 109.641 -174.071 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -74.46 88.13 2.1 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 108.042 -1.095 . . . . 72.23 108.042 177.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 90' ' ' VAL . . . . . 0.715 HG21 HD22 ' C' ' 105' ' ' LEU . 2.1 p -47.35 -40.65 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 CA-C-N 114.317 -1.311 . . . . 54.41 113.151 176.366 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 91' ' ' GLU . . . . . 0.443 ' HB2' ' ND2' ' C' ' 169' ' ' ASN . 33.7 tt0 -65.99 -21.3 66.4 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.863 0.865 . . . . 74.21 111.43 -175.62 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -86.42 -21.59 27.03 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 123.728 0.811 . . . . 75.53 111.239 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -77.24 -177.72 4.72 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.339 0.656 . . . . 72.45 112.338 -175.072 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 94' ' ' SER . . . . . 0.404 ' CB ' ' HZ2' ' C' ' 5' ' ' LYS . 92.4 p -78.14 173.31 12.38 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 113.307 0.854 . . . . 45.51 113.307 -168.757 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.21 -51.07 71.59 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 114.333 -1.303 . . . . 55.43 111.557 178.038 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -56.17 -40.51 74.0 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.984 0.914 . . . . 65.02 111.087 -175.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 97' ' ' PHE . . . . . 0.427 ' HE2' HG23 ' C' ' 90' ' ' VAL . 60.1 t80 -64.72 -50.36 67.22 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 114.519 -1.219 . . . . 64.25 110.04 177.113 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -80.06 2.69 22.89 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 115.213 -0.903 . . . . 51.52 112.56 -177.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -100.07 -45.12 5.77 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.568 0.747 . . . . 74.43 110.507 170.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 13.2 tp -62.74 -58.29 7.96 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.242 0.617 . . . . 73.23 110.127 176.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -81.87 -11.36 58.97 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 115.71 -0.677 . . . . 73.25 111.408 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -37.38 -63.18 0.84 Allowed Glycine 0 C--N 1.358 1.767 0 C-N-CA 124.807 1.194 . . . . 54.11 115.679 -177.445 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_exo -46.21 -34.13 13.08 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 123.841 3.028 . . . . 62.02 115.282 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -119.05 27.88 6.87 Favored Glycine 0 C--N 1.356 1.647 0 CA-C-O 119.318 -0.712 . . . . 43.23 113.823 -175.135 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 105' ' ' LEU . . . . . 0.715 HD22 HG21 ' C' ' 90' ' ' VAL . 29.0 mt . . . . . 0 N--CA 1.482 1.17 0 CA-C-N 117.761 0.78 . . . . 73.03 112.706 176.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 116' ' ' GLY . . . . . 0.514 ' HA2' ' HA3' ' C' ' 168' ' ' GLY . . . . . . . . 0 CA--C 1.516 0.121 0 N-CA-C 113.902 0.321 . . . . 45.25 113.902 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.09 -176.82 2.99 Favored 'General case' 0 C--O 1.26 1.621 0 C-N-CA 124.301 1.041 . . . . 64.44 108.907 168.619 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 118' ' ' ASP . . . . . 0.471 ' HA ' ' O ' ' C' ' 173' ' ' ASP . 4.8 p-10 -60.62 152.99 24.9 Favored 'General case' 0 C--O 1.244 0.764 0 CA-C-N 115.127 -0.942 . . . . 75.42 112.828 -171.549 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 119' ' ' LEU . . . . . 0.469 ' O ' HD12 ' C' ' 174' ' ' LEU . 20.0 tp -110.85 118.28 35.71 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 106.57 -1.641 . . . . 75.21 106.57 173.538 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 21.8 ttm180 -112.37 106.03 14.45 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 121.207 0.527 . . . . 72.31 110.761 -167.371 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 121' ' ' ALA . . . . . . . . . . . . . . . -124.13 117.28 24.3 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.445 -0.798 . . . . 63.21 109.314 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -82.14 125.44 30.89 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 108.478 -0.934 . . . . 73.22 108.478 170.001 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 123' ' ' LEU . . . . . 0.434 HD13 HD22 ' C' ' 176' ' ' LEU . 2.2 pt? -130.33 115.3 17.34 Favored Pre-proline 0 CA--C 1.554 1.134 0 C-N-CA 123.03 0.532 . . . . 73.3 110.461 -171.256 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 124' ' ' PRO . . . . . 0.461 ' HA ' ' O ' ' C' ' 179' ' ' ARG . 53.6 Cg_exo -62.78 115.69 3.08 Favored 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 123.301 2.667 . . . . 72.51 113.707 170.44 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 125' ' ' LEU . . . . . 0.592 HD23 HG11 ' C' ' 153' ' ' VAL . 19.0 tp -131.32 166.52 21.05 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 106.308 -1.738 . . . . 74.03 106.308 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 126' ' ' THR . . . . . 0.443 ' H ' ' HB2' ' C' ' 129' ' ' GLU . 11.7 t -129.54 176.03 8.31 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 120.833 1.651 . . . . 61.53 112.1 175.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 127' ' ' LEU . . . . . 0.483 HD23 HD13 ' C' ' 180' ' ' LEU . 7.4 mt -60.79 -41.67 96.07 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.003 1.721 . . . . 62.25 110.069 -177.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -65.02 -43.63 91.83 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 113.867 -1.515 . . . . 75.24 110.716 176.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 129' ' ' GLU . . . . . 0.443 ' HB2' ' H ' ' C' ' 126' ' ' THR . 38.8 mm-40 -72.59 -21.17 61.17 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-N 115.47 -0.786 . . . . 73.53 111.224 -179.321 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 130' ' ' ALA . . . . . 0.555 ' HB2' HG12 ' C' ' 153' ' ' VAL . . . -78.57 -46.25 19.84 Favored 'General case' 0 C--O 1.22 -0.456 0 O-C-N 124.139 0.899 . . . . 64.34 109.194 174.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 131' ' ' PHE . . . . . 0.623 ' HB2' HD13 ' C' ' 215' ' ' LEU . 88.1 t80 -50.68 -42.99 57.42 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.709 1.204 . . . . 75.55 110.796 173.074 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 132' ' ' HIS . . . . . . . . . . . . . 28.0 m170 -67.44 -67.43 0.46 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.187 -0.915 . . . . 60.22 108.754 175.415 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 50.51 -139.28 22.04 Favored Glycine 0 C--N 1.358 1.791 0 O-C-N 124.198 0.936 . . . . 65.31 113.662 175.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.86 -152.97 37.58 Favored Glycine 0 C--N 1.342 0.913 0 O-C-N 123.958 0.446 . . . . 53.24 113.27 177.278 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -79.15 94.4 5.37 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 108.554 -0.906 . . . . 71.2 108.554 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 136' ' ' ARG . . . . . . . . . . . . . 28.1 mmm-85 -103.39 125.35 49.95 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.778 0.831 . . . . 72.12 109.382 -177.157 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 137' ' ' VAL . . . . . 0.635 HG23 ' HB1' ' B' ' 180' ' ' ALA . 31.6 m -77.43 135.96 25.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 N-CA-C 109.361 -0.607 . . . . 71.12 109.361 174.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 138' ' ' VAL . . . . . . . . . . . . . 7.3 p -136.28 126.42 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.607 0.763 . . . . 72.14 109.35 -176.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 139' ' ' GLU . . . . . 0.496 ' HG3' ' HB2' ' C' ' 144' ' ' ARG . 1.6 mp0 -86.72 75.81 9.6 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.543 -0.539 . . . . 74.31 109.543 -176.292 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 140' ' ' VAL . . . . . . . . . . . . . 87.0 t -86.04 113.02 23.41 Favored 'Isoleucine or valine' 0 C--O 1.246 0.891 0 N-CA-C 108.396 -0.964 . . . . 63.22 108.396 -178.295 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 141' ' ' ALA . . . . . 0.49 ' HB1' ' HB2' ' C' ' 80' ' ' PRO . . . 62.78 37.01 12.75 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 124.565 1.165 . . . . 15.23 110.914 176.319 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 101.55 -34.81 5.36 Favored Glycine 0 C--N 1.351 1.363 0 CA-C-N 114.856 -1.065 . . . . 45.25 112.803 177.02 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 143' ' ' ARG . . . . . 0.662 HH21 ' HB3' ' C' ' 84' ' ' ASP . 0.2 OUTLIER -92.4 118.96 31.47 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 117.179 0.489 . . . . 73.04 111.324 -171.508 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 144' ' ' ARG . . . . . 0.523 ' HG3' ' HB ' ' C' ' 137' ' ' VAL . 35.4 ttm180 -73.92 115.95 13.97 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.194 -0.912 . . . . 71.51 109.638 171.6 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 145' ' ' VAL . . . . . . . . . . . . . 4.2 p -131.51 128.87 61.46 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 C-N-CA 124.049 0.94 . . . . 75.03 109.775 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 36.1 t -75.45 93.02 2.9 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 123.977 0.911 . . . . 54.21 110.582 -177.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 8.8 p -88.15 119.12 35.04 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 N-CA-C 109.241 -0.652 . . . . 72.53 109.241 175.253 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -75.53 104.33 6.04 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 109.513 -0.551 . . . . 74.22 109.513 174.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 149' ' ' ILE . . . . . 0.422 HG21 HG21 ' C' ' 159' ' ' ILE . 36.0 pt -120.29 95.46 49.07 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 107.133 -1.432 . . . . 71.41 107.133 165.59 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -49.78 161.14 0.96 Allowed 'Trans proline' 0 C--N 1.395 2.994 0 C-N-CA 124.271 3.314 . . . . 61.44 114.205 -174.16 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -43.56 94.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.389 2.7 0 C-N-CA 123.345 2.697 . . . . 73.2 112.247 174.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 152' ' ' GLY . . . . . 0.449 ' HA2' ' CD2' ' C' ' 240' ' ' PHE . . . 151.44 132.76 1.93 Allowed Glycine 0 C--N 1.348 1.222 0 CA-C-N 115.073 -0.967 . . . . 54.32 113.637 -174.623 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 153' ' ' VAL . . . . . 0.612 HG22 HG11 ' C' ' 178' ' ' VAL . 0.6 OUTLIER -153.59 160.23 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.028 0 CA-C-N 116.745 0.273 . . . . 71.13 110.948 169.696 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 154' ' ' ARG . . . . . 0.457 ' HG2' ' HB3' ' C' ' 188' ' ' LEU . 22.1 mtp180 -121.36 123.49 42.26 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.206 1.002 . . . . 75.32 110.447 -170.198 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 155' ' ' GLU . . . . . 0.47 ' HB2' HD12 ' C' ' 180' ' ' LEU . 13.3 tp10 -51.18 124.74 12.26 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.439 0.696 . . . . 74.51 112.241 171.082 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 76.28 12.39 84.23 Favored Glycine 0 C--N 1.348 1.241 0 O-C-N 124.394 1.059 . . . . 64.51 114.008 170.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 157' ' ' SER . . . . . . . . . . . . . 55.4 m -101.94 156.1 17.74 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.202 0.525 . . . . 75.43 110.829 -178.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 158' ' ' VAL . . . . . 0.643 HG12 HG22 ' C' ' 177' ' ' VAL . 27.1 m -96.56 111.71 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 CA-C-N 115.103 -0.953 . . . . 64.44 109.161 175.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 159' ' ' ILE . . . . . 0.714 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 57.1 mt -71.39 94.95 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 107.903 -1.147 . . . . 52.25 107.903 170.565 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 12.1 ttp180 -86.87 100.75 12.78 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 109.336 -0.616 . . . . 72.21 109.336 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 161' ' ' VAL . . . . . 0.601 HG13 ' HB3' ' C' ' 174' ' ' LEU . 2.1 p -101.03 102.46 20.19 Favored Pre-proline 0 CA--C 1.553 1.076 0 N-CA-C 108.866 -0.79 . . . . 75.24 108.866 172.6 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -63.76 136.34 53.07 Favored 'Trans proline' 0 C--N 1.386 2.52 0 C-N-CA 122.921 2.414 . . . . 63.42 112.855 -175.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 163' ' ' GLY . . . . . 0.418 ' O ' ' HB2' ' C' ' 171' ' ' PRO . . . 98.29 -6.82 61.69 Favored Glycine 0 C--N 1.341 0.847 0 CA-C-N 115.317 -0.856 . . . . 53.31 113.512 177.625 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 164' ' ' MET . . . . . . . . . . . . . 82.7 mtp -103.26 30.68 4.74 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 118.016 0.908 . . . . 73.35 110.883 178.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 165' ' ' GLY . . . . . 0.499 ' HA2' ' O ' ' C' ' 173' ' ' ASP . . . -57.34 162.8 7.73 Favored Glycine 0 C--N 1.351 1.393 0 CA-C-N 114.932 -1.031 . . . . 64.24 114.82 177.38 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . -117.85 -59.55 0.29 Allowed Glycine 0 C--N 1.346 1.101 0 C-N-CA 121.532 -0.366 . . . . 75.44 112.764 -170.55 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 167' ' ' GLN . . . . . 0.41 ' O ' ' HA2' ' C' ' 116' ' ' GLY . 29.9 mm-40 -88.46 99.07 12.0 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 110.164 -0.31 . . . . 64.31 110.164 -173.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 168' ' ' GLY . . . . . 0.514 ' HA3' ' HA2' ' C' ' 116' ' ' GLY . . . 123.04 147.96 7.5 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-O 119.564 -0.575 . . . . 13.44 112.9 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 169' ' ' ASN . . . . . 0.465 ' OD1' ' HB3' ' C' ' 105' ' ' LEU . 7.3 t30 -61.04 -59.41 13.91 Favored Pre-proline 0 N--CA 1.491 1.607 0 CA-C-O 117.621 -1.18 . . . . 62.44 113.781 -169.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 170' ' ' PRO . . . . . 0.453 ' HD3' ' HB3' ' C' ' 169' ' ' ASN . 6.6 Cg_exo -75.12 106.08 2.21 Favored 'Trans proline' 0 C--N 1.39 2.76 0 C-N-CA 122.01 1.807 . . . . 51.41 109.792 170.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 171' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' C' ' 170' ' ' PRO . 17.0 Cg_exo -66.58 126.02 14.79 Favored 'Trans proline' 0 C--N 1.372 1.798 0 C-N-CA 122.75 2.3 . . . . 74.02 113.229 -167.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -71.37 -74.94 0.68 Allowed Glycine 0 C--N 1.355 1.619 0 O-C-N 123.797 0.686 . . . . 74.42 113.464 -177.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 173' ' ' ASP . . . . . 0.499 ' O ' ' HA2' ' C' ' 165' ' ' GLY . 4.6 p-10 -164.05 166.64 21.21 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.04 0.936 . . . . 74.51 109.746 175.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 174' ' ' LEU . . . . . 0.601 ' HB3' HG13 ' C' ' 161' ' ' VAL . 31.6 tp -113.48 113.76 25.6 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.901 -0.778 . . . . 75.22 108.901 176.099 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 175' ' ' LEU . . . . . 0.469 HD22 ' HB ' ' C' ' 158' ' ' VAL . 70.4 mt -87.72 93.54 9.47 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 123.882 0.873 . . . . 71.32 109.879 170.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 176' ' ' LEU . . . . . 0.714 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 82.3 mt -82.92 100.44 10.4 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 108.989 -0.745 . . . . 43.02 108.989 170.294 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 177' ' ' VAL . . . . . 0.643 HG22 HG12 ' C' ' 158' ' ' VAL . 41.4 t -81.49 93.35 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 108.49 -0.93 . . . . 74.43 108.49 -178.122 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 178' ' ' VAL . . . . . 0.612 HG11 HG22 ' C' ' 153' ' ' VAL . 2.1 p -76.77 125.29 36.43 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 CA-C-N 115.329 -0.85 . . . . 74.01 110.996 -172.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 179' ' ' ARG . . . . . 0.461 ' O ' ' HA ' ' C' ' 124' ' ' PRO . 34.8 mmt180 -120.29 112.9 19.62 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 114.355 -1.293 . . . . 72.33 108.308 178.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 180' ' ' LEU . . . . . 0.545 ' HA ' ' O ' ' C' ' 125' ' ' LEU . 80.5 mt -69.48 143.32 53.54 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 116.561 -0.291 . . . . 70.51 111.579 -178.578 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 181' ' ' LEU . . . . . . . . . . . . . 36.6 mt -60.94 156.49 47.07 Favored Pre-proline 0 N--CA 1.482 1.17 0 CA-C-O 117.731 -1.128 . . . . 74.2 109.92 -179.594 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -49.02 79.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.395 2.987 0 C-N-CA 124.205 3.27 . . . . 64.12 115.516 -174.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 183' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 171.87 76.78 0.04 OUTLIER Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 128.456 2.702 . . . . 62.13 106.82 172.405 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 184' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.22 68.86 4.99 Favored 'Trans proline' 0 C--N 1.38 2.19 0 C-N-CA 123.686 2.924 . . . . 71.54 111.533 178.015 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 185' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 13.1 t -90.48 -41.16 13.32 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.702 0 N-CA-C 109.326 -0.62 . . . . 72.23 109.326 -168.042 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 186' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -122.25 111.03 16.44 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 120.9 0.381 . . . . 61.44 111.718 -172.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 187' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -95.98 112.9 24.51 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 106.562 -1.644 . . . . 75.14 106.562 170.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 188' ' ' LEU . . . . . 0.457 ' HB3' ' HG2' ' C' ' 154' ' ' ARG . 62.0 tp -80.75 144.8 31.88 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-O 121.272 0.558 . . . . 74.14 112.465 -175.64 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -136.9 101.52 4.6 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.634 1.574 . . . . 71.33 107.124 169.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 72.41 -97.27 0.77 Allowed Glycine 0 C--N 1.349 1.263 0 N-CA-C 112.084 -0.406 . . . . 74.2 112.084 -175.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 191' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -119.86 -18.57 8.21 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 124.323 1.049 . . . . 60.21 110.321 175.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -94.53 140.94 29.18 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.168 0.987 . . . . 65.13 110.467 -172.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 193' ' ' LEU . . . . . 0.55 HD21 ' CE2' ' C' ' 240' ' ' PHE . 88.5 mt -100.25 170.18 8.62 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 113.119 0.785 . . . . 52.2 113.119 -169.083 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 194' ' ' TYR . . . . . 0.423 ' HA ' ' O ' ' C' ' 250' ' ' TYR . 52.1 t80 -127.97 108.42 10.66 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.787 0.835 . . . . 75.43 110.197 167.669 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 195' ' ' ALA . . . . . 0.522 ' HA ' ' O ' ' C' ' 185' ' ' VAL . . . -110.68 -175.85 2.82 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.823 0.849 . . . . 65.11 109.125 168.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 17.9 m -121.8 132.15 54.44 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 108.432 -0.951 . . . . 51.32 108.432 167.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 197' ' ' LEU . . . . . 0.476 HD22 HD12 ' C' ' 233' ' ' LEU . 53.7 tp -102.1 145.68 29.01 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.459 0.704 . . . . 73.5 110.444 -177.58 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -116.61 101.61 8.75 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.274 -1.01 . . . . 44.52 108.274 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 199' ' ' VAL . . . . . . . . . . . . . 39.5 t -115.13 126.29 27.98 Favored Pre-proline 0 N--CA 1.476 0.872 0 N-CA-C 108.826 -0.805 . . . . 61.21 108.826 177.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 200' ' ' PRO . . . . . 0.635 ' HG2' HD12 ' C' ' 203' ' ' ILE . 24.0 Cg_exo -60.73 150.01 84.81 Favored 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 122.588 2.192 . . . . 71.34 112.204 168.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 201' ' ' ALA . . . . . 0.454 ' O ' HG23 ' C' ' 205' ' ' VAL . . . -51.84 -57.92 13.02 Favored Pre-proline 0 CA--C 1.56 1.358 0 C-N-CA 124.756 1.222 . . . . 74.35 113.409 177.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 202' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -71.46 -30.68 14.9 Favored 'Trans proline' 0 C--N 1.389 2.71 0 CA-C-N 121.585 1.602 . . . . 63.15 112.544 -174.168 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 203' ' ' ILE . . . . . 0.635 HD12 ' HG2' ' C' ' 200' ' ' PRO . 20.4 mt -64.43 -40.48 89.21 Favored 'Isoleucine or valine' 0 C--N 1.361 1.085 0 N-CA-C 109.307 -0.627 . . . . 63.4 109.307 172.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 204' ' ' ALA . . . . . 0.534 ' HB1' ' HB ' ' C' ' 227' ' ' THR . . . -62.06 -39.06 91.1 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.24 -0.891 . . . . 75.02 110.816 176.447 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 205' ' ' VAL . . . . . 0.454 HG23 ' O ' ' C' ' 201' ' ' ALA . 53.4 t -74.06 -48.86 36.27 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 N-CA-C 114.027 1.121 . . . . 63.41 114.027 -173.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 206' ' ' VAL . . . . . . . . . . . . . 9.0 p -92.73 -33.55 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 CA-C-N 119.551 1.069 . . . . 52.12 111.453 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 105.58 121.69 4.9 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.399 -0.68 . . . . 63.21 111.399 -173.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 208' ' ' GLY . . . . . 0.405 ' H ' ' HB ' ' C' ' 223' ' ' VAL . . . -145.41 -136.22 2.95 Favored Glycine 0 C--N 1.339 0.709 0 N-CA-C 110.833 -0.907 . . . . 51.32 110.833 178.449 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 209' ' ' LYS . . . . . 0.425 ' HA ' ' O ' ' C' ' 221' ' ' VAL . 20.2 ttpp -151.7 118.48 5.78 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 117.523 0.661 . . . . 72.12 109.903 175.46 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 210' ' ' VAL . . . . . . . . . . . . . 19.1 m -111.35 170.0 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 124.829 1.252 . . . . 62.05 109.671 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 211' ' ' ARG . . . . . . . . . . . . . 8.1 tmm_? -103.25 125.35 49.87 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 120.922 0.391 . . . . 72.44 110.909 -179.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 212' ' ' ALA . . . . . 0.463 ' HB3' HG13 ' C' ' 219' ' ' VAL . . . -105.72 152.36 23.27 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.849 1.26 . . . . 74.43 109.728 168.337 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 213' ' ' MET . . . . . . . . . . . . . 17.8 mmm -85.15 142.06 29.74 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.439 0.695 . . . . 63.12 110.017 174.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 214' ' ' THR . . . . . 0.523 HG21 ' HD3' ' C' ' 238' ' ' LYS . 0.2 OUTLIER -141.23 175.05 9.96 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.114 0.566 . . . . 54.24 111.204 172.619 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 215' ' ' LEU . . . . . 0.623 HD13 ' HB2' ' C' ' 131' ' ' PHE . 23.9 mt -61.92 -48.46 80.33 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.246 1.018 . . . . 44.41 111.394 -173.735 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -91.21 13.62 16.61 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 114.399 -1.273 . . . . 71.0 111.416 -176.112 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 124.39 -171.21 16.56 Favored Glycine 0 C--N 1.351 1.392 0 N-CA-C 111.824 -0.51 . . . . 64.11 111.824 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -81.7 129.55 6.44 Favored 'Trans proline' 0 CA--C 1.558 1.719 0 C-N-CA 122.675 2.25 . . . . 52.13 113.848 -178.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 219' ' ' VAL . . . . . 0.463 HG13 ' HB3' ' C' ' 212' ' ' ALA . 5.1 p -97.5 140.32 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 N-CA-C 108.361 -0.978 . . . . 52.53 108.361 172.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 220' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -98.44 107.98 20.56 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 118.583 0.629 . . . . 72.32 109.651 179.168 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 221' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' C' ' 209' ' ' LYS . 37.9 t -69.8 116.04 10.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 126.058 1.743 . . . . 74.03 112.708 -179.284 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -76.01 113.67 13.78 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.493 0.717 . . . . 73.3 109.146 168.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 223' ' ' VAL . . . . . 0.405 ' HB ' ' H ' ' C' ' 208' ' ' GLY . 47.0 t -92.17 138.08 24.61 Favored Pre-proline 0 CA--C 1.561 1.371 0 C-N-CA 124.136 0.975 . . . . 73.11 110.646 -174.206 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 224' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -86.22 164.19 9.86 Favored 'Trans proline' 0 C--N 1.387 2.6 0 C-N-CA 123.377 2.718 . . . . 54.33 112.103 173.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.07 128.48 21.87 Favored 'Trans proline' 0 C--N 1.377 2.079 0 C-N-CA 122.751 2.3 . . . . 74.0 113.705 177.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 226' ' ' ARG . . . . . 0.452 ' HA ' ' HA ' ' C' ' 205' ' ' VAL . 0.0 OUTLIER 59.43 89.09 0.07 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.814 2.045 . . . . 70.15 110.988 179.886 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 227' ' ' THR . . . . . 0.534 ' HB ' ' HB1' ' C' ' 204' ' ' ALA . 24.7 m -106.63 135.68 47.73 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 113.789 -1.551 . . . . 70.3 110.221 178.058 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 228' ' ' GLN . . . . . 0.44 ' H ' ' NE ' ' C' ' 231' ' ' ARG . 3.9 tp-100 -110.35 142.83 41.47 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 124.291 1.036 . . . . 74.32 110.479 -175.384 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -71.23 137.46 48.67 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.677 -0.86 . . . . 62.12 108.677 174.14 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 100.99 0.68 54.97 Favored Glycine 0 CA--C 1.521 0.411 0 CA-C-N 116.08 -0.509 . . . . 62.04 112.286 -170.054 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 231' ' ' ARG . . . . . 0.509 ' HD2' HG23 ' C' ' 227' ' ' THR . 86.2 mtt180 -76.08 172.4 12.85 Favored 'General case' 0 C--N 1.359 1.018 0 CA-C-N 117.115 0.458 . . . . 74.12 110.142 164.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 232' ' ' LYS . . . . . 0.65 ' HD3' ' HB3' ' C' ' 250' ' ' TYR . 4.0 ttmp? -148.07 109.4 4.35 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.394 0.616 . . . . 71.45 110.164 175.17 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 233' ' ' LEU . . . . . 0.607 ' O ' ' HA ' ' C' ' 250' ' ' TYR . 0.5 OUTLIER -72.14 144.75 48.5 Favored 'General case' 0 C--O 1.209 -1.075 0 C-N-CA 125.781 1.632 . . . . 74.21 109.429 -178.02 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 10.1 ptt180 -118.37 90.48 3.34 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 124.912 1.285 . . . . 72.34 110.108 173.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 235' ' ' LEU . . . . . 0.55 ' HB2' ' HB3' ' C' ' 249' ' ' LEU . 66.4 mt -77.79 116.41 18.29 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.509 0.723 . . . . 73.43 111.057 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -63.02 117.03 5.88 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.089 0.956 . . . . 71.55 112.65 -176.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 77.78 11.79 85.08 Favored Glycine 0 C--N 1.351 1.399 0 CA-C-N 115.223 -0.899 . . . . 71.42 114.688 175.362 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 238' ' ' LYS . . . . . 0.527 ' NZ ' ' HA ' ' C' ' 238' ' ' LYS . 0.1 OUTLIER -99.96 8.53 43.99 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.008 0.523 . . . . 72.03 111.053 178.447 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -86.44 -151.25 18.26 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 110.852 -0.899 . . . . 31.21 110.852 164.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 240' ' ' PHE . . . . . 0.55 ' CE2' HD21 ' C' ' 193' ' ' LEU . 48.3 m-85 -90.57 137.02 27.46 Favored Pre-proline 0 N--CA 1.476 0.856 0 CA-C-N 117.036 0.418 . . . . 75.14 110.65 175.368 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 241' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -57.39 120.98 9.25 Favored 'Trans proline' 0 C--N 1.383 2.382 0 C-N-CA 123.254 2.636 . . . . 70.21 111.353 175.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 242' ' ' GLY . . . . . 0.407 ' H ' ' HA ' ' C' ' 246' ' ' ARG . . . -100.28 157.77 19.48 Favored Glycine 0 C--N 1.348 1.246 0 CA-C-O 119.612 -0.549 . . . . 70.14 113.096 -173.171 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -65.62 -21.98 58.61 Favored 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 123.036 2.491 . . . . 71.42 113.61 -176.128 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -132.06 25.56 4.58 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.778 0.831 . . . . 71.42 110.57 178.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 164.25 -137.78 4.92 Favored Glycine 0 C--N 1.346 1.124 0 N-CA-C 111.549 -0.62 . . . . 51.32 111.549 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 246' ' ' ARG . . . . . 0.407 ' HA ' ' H ' ' C' ' 242' ' ' GLY . 0.0 OUTLIER -157.12 163.07 39.33 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.037 0.935 . . . . 61.31 109.664 173.546 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -86.87 170.53 41.84 Favored Glycine 0 C--O 1.242 0.613 0 CA-C-N 116.088 -0.506 . . . . 63.23 111.986 178.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -124.32 136.42 54.09 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 107.763 -1.199 . . . . 73.54 107.763 -178.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 249' ' ' LEU . . . . . 0.55 ' HB3' ' HB2' ' C' ' 235' ' ' LEU . 19.4 tp -81.57 117.86 22.3 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.18 0.592 . . . . 74.23 109.877 -176.742 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 250' ' ' TYR . . . . . 0.65 ' HB3' ' HD3' ' C' ' 232' ' ' LYS . 19.4 m-30 -99.68 101.76 13.05 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 122.799 0.439 . . . . 71.43 109.915 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 251' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' C' ' 232' ' ' LYS . 2.0 mp -101.44 124.4 47.05 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 119.375 -0.345 . . . . 64.53 110.303 -175.265 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -70.97 109.31 5.0 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.544 -0.91 . . . . 73.41 108.544 173.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 253' ' ' VAL . . . . . 0.424 HG21 ' CZ3' ' B' ' 242' ' ' TRP . 57.0 t -77.52 128.96 37.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 123.427 0.691 . . . . 73.5 111.655 -169.07 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 254' ' ' ARG . . . . . . . . . . . . . 20.9 mtm180 -108.64 147.26 32.13 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.125 0.97 . . . . 74.13 109.568 170.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 255' ' ' ILE . . . . . 0.471 HD11 HG22 ' C' ' 227' ' ' THR . 36.5 mm -107.05 125.56 63.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 C-N-CA 124.452 1.101 . . . . 75.24 108.065 171.002 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 256' ' ' THR . . . . . . . . . . . . . 60.2 p -122.94 -175.59 3.21 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.855 0.862 . . . . 53.32 111.69 -171.522 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 257' ' ' ILE . . . . . 0.544 ' HB ' ' HD2' ' C' ' 258' ' ' PRO . 44.9 pt -135.48 161.58 62.32 Favored Pre-proline 0 CA--C 1.571 1.756 0 C-N-CA 123.53 0.732 . . . . 64.54 111.233 -179.081 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 258' ' ' PRO . . . . . 0.544 ' HD2' ' HB ' ' C' ' 257' ' ' ILE . 61.3 Cg_endo -69.43 11.26 0.37 Allowed 'Trans proline' 0 C--N 1.395 3.021 0 C-N-CA 123.733 2.956 . . . . 73.21 116.696 -170.601 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 259' ' ' GLU . . . . . 0.572 ' O ' ' HD2' ' A' ' 226' ' ' ARG . 5.5 mm-40 60.85 -84.29 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.607 0.763 . . . . 72.3 109.775 -170.287 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.47 172.02 8.66 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.45 0.7 . . . . 73.41 110.771 175.333 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 261' ' ' LEU . . . . . 0.47 ' HB2' HH12 ' A' ' 226' ' ' ARG . 11.3 mt -149.47 163.33 38.08 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 121.604 0.716 . . . . 71.21 111.919 176.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 1.2 p -104.36 147.62 34.66 Favored Pre-proline 0 CA--C 1.562 1.404 0 CA-C-N 113.494 -1.685 . . . . 61.23 108.997 171.544 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -45.51 -48.8 11.37 Favored 'Trans proline' 0 C--N 1.39 2.758 0 C-N-CA 125.038 3.825 . . . . 74.2 115.868 -166.15 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -64.62 -51.2 63.91 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-O 121.303 0.573 . . . . 71.04 111.242 -173.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 11.4 mp0 -60.98 -45.53 94.4 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 114.502 -1.226 . . . . 65.11 109.44 -177.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 266' ' ' GLU . . . . . 0.433 ' HG2' ' HE3' ' C' ' 270' ' ' LYS . 42.4 tt0 -61.42 -37.44 83.5 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 114.934 -1.03 . . . . 64.21 111.076 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -63.71 -38.55 91.54 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.591 0.756 . . . . 70.32 111.52 177.381 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 268' ' ' LEU . . . . . . . . . . . . . 11.1 mp -62.23 -43.38 98.96 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 123.242 0.339 . . . . 52.44 110.72 172.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 92.9 m95 -58.34 -36.11 72.94 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 122.904 0.482 . . . . 61.11 111.104 174.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 270' ' ' LYS . . . . . 0.433 ' HE3' ' HG2' ' C' ' 266' ' ' GLU . 99.5 mttt -70.75 -39.35 73.32 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.543 0.737 . . . . 75.43 111.442 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.64 -38.35 89.11 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.954 0.502 . . . . 75.33 110.611 178.009 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 88.8 mt -73.49 -31.31 63.68 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.618 0.767 . . . . 74.33 110.891 176.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -66.24 -40.93 90.57 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.295 0.638 . . . . 34.13 110.021 175.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -69.3 -37.84 77.99 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.13 0.972 . . . . 63.21 110.97 178.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -62.85 -30.76 71.75 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.298 0.639 . . . . 70.04 110.43 172.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 276' ' ' TYR . . . . . 0.471 ' HB3' HD11 ' A' ' 203' ' ' ILE . 1.6 m-85 -75.25 -38.04 60.73 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.705 0.802 . . . . 75.52 111.492 173.758 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -69.56 -24.26 63.68 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 122.456 0.302 . . . . 44.24 110.254 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -63.45 -20.1 65.28 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.922 0.889 . . . . 55.2 112.176 173.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 279' ' ' ARG . . . . . 0.459 ' HD3' ' HA ' ' C' ' 276' ' ' TYR . 14.9 mtp-105 -75.22 -9.64 58.74 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.251 0.62 . . . . 71.52 111.8 176.098 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.151 0 CA-C-O 118.252 -0.88 . . . . 75.14 108.673 174.149 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt . . . . . 0 N--CA 1.472 0.672 0 N-CA-C 113.357 0.873 . . . . 62.43 113.357 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.527 ' HB3' HD11 ' A' ' 10' ' ' ILE . 14.3 mmmm -63.4 110.86 2.07 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.29 -1.004 . . . . 74.32 108.29 170.421 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -73.39 93.64 1.97 Allowed 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 107.638 -1.245 . . . . 61.41 107.638 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.42 ' CD1' ' HA ' ' A' ' 53' ' ' ALA . 62.4 m-85 -63.82 -30.13 71.26 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 114.88 -1.055 . . . . 73.34 112.291 -168.311 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -66.4 -44.47 82.92 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 116.215 -0.448 . . . . 73.33 109.961 173.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.47 -37.58 87.85 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.943 0.497 . . . . 60.32 111.421 178.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.527 HD11 ' HB3' ' A' ' 5' ' ' LYS . 72.9 mt -64.13 -36.22 76.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 123.452 0.701 . . . . 74.23 110.462 176.398 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.0 mt -81.05 -10.36 59.7 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 112.331 0.493 . . . . 51.33 112.331 173.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.02 32.4 60.71 Favored Glycine 0 C--N 1.35 1.352 0 N-CA-C 113.888 0.315 . . . . 53.33 113.888 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.4 m -126.07 155.21 73.77 Favored Pre-proline 0 N--CA 1.482 1.148 0 C-N-CA 124.346 1.058 . . . . 71.43 110.377 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.2 158.98 55.16 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 122.491 2.128 . . . . 50.12 112.335 173.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 35.3 mtm180 -82.02 64.37 6.67 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.068 0.947 . . . . 75.43 110.347 -177.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -179.7 -14.81 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.257 1.423 . . . . 64.11 109.032 -175.056 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.52 131.15 29.1 Favored 'General case' 0 C--N 1.36 1.061 0 C-N-CA 123.604 0.762 . . . . 64.31 111.325 176.052 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 58.1 p -63.37 164.6 8.85 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 123.867 0.729 . . . . 71.11 111.148 -175.331 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 47.6 tp60 -61.32 -27.39 68.45 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.376 0.671 . . . . 64.21 111.538 -176.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -67.97 -46.29 71.78 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.47 -0.786 . . . . 72.43 109.771 175.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -67.24 -35.96 80.65 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.209 0.604 . . . . 64.03 111.012 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.449 HG21 ' HB3' ' A' ' 57' ' ' LEU . 70.9 mt -66.06 -47.13 86.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.361 1.064 . . . . 73.31 110.586 178.021 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 51.4 tttt -55.65 -48.43 75.02 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.597 1.159 . . . . 71.24 110.533 173.073 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 63.9 mtt180 -75.94 -15.97 60.08 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 115.805 -0.634 . . . . 54.12 111.763 -177.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -77.26 -40.13 45.8 Favored 'General case' 0 C--O 1.251 1.17 0 C-N-CA 123.356 0.663 . . . . 64.0 110.262 173.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.546 ' HD1' HG22 ' A' ' 50' ' ' ILE . 64.6 t80 -55.45 -56.79 16.09 Favored 'General case' 0 C--N 1.352 0.702 0 CA-C-N 114.83 -1.077 . . . . 73.1 108.984 169.736 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.425 ' O ' ' HG3' ' A' ' 31' ' ' ARG . 55.5 mtpt -60.7 -38.98 86.84 Favored 'General case' 0 N--CA 1.483 1.208 0 O-C-N 124.248 0.967 . . . . 74.22 111.701 -177.592 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 45.6 ttt180 -52.04 -60.23 3.44 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 125.122 1.369 . . . . 71.15 110.913 175.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 95.9 mt -79.22 -13.5 59.65 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 114.876 -1.056 . . . . 74.11 111.314 -178.333 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.89 -14.72 46.93 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.309 0.643 . . . . 63.3 110.934 175.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.425 ' HG3' ' O ' ' A' ' 27' ' ' LYS . 82.7 mtm180 -89.63 -39.55 13.16 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.248 0.619 . . . . 72.33 109.734 168.417 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -67.28 -59.73 3.18 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.272 0.558 . . . . 63.33 111.447 178.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.689 ' HD2' HD11 ' A' ' 50' ' ' ILE . 21.3 m-85 -91.0 25.83 2.31 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.958 0.903 . . . . 63.25 110.718 -178.441 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -62.61 108.57 1.73 Allowed Pre-proline 0 C--N 1.358 0.955 0 CA-C-O 118.439 -0.791 . . . . 63.41 110.215 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.466 ' HB3' ' HG2' ' A' ' 44' ' ' GLU . 16.5 Cg_endo -53.64 -40.17 80.41 Favored 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 123.281 2.654 . . . . 74.13 113.447 -167.193 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -60.65 -40.7 93.01 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.553 0.741 . . . . 72.45 112.551 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 64.8 t -89.8 -30.08 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 CA-C-O 121.184 0.516 . . . . 65.53 110.28 -175.61 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 53.6 t-20 -108.44 97.29 6.98 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 124.397 1.079 . . . . 61.35 108.845 -172.225 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -81.1 71.11 8.07 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.618 0.767 . . . . 73.11 109.795 -177.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 62.2 m -152.07 112.55 2.88 Favored Pre-proline 0 N--CA 1.476 0.86 0 C-N-CA 123.88 0.872 . . . . 54.41 109.156 178.161 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -51.31 -36.02 55.76 Favored 'Trans proline' 0 C--N 1.388 2.633 0 C-N-CA 123.347 2.698 . . . . 72.23 111.662 176.188 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -47.34 -51.15 20.3 Favored 'General case' 0 C--N 1.35 0.596 0 C-N-CA 124.993 1.317 . . . . 64.43 111.339 174.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.79 -20.05 61.23 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.004 -0.998 . . . . 72.14 111.307 -175.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.466 ' HG2' ' HB3' ' A' ' 35' ' ' PRO . 40.4 mt-10 -86.03 -33.34 21.05 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.594 0.758 . . . . 62.01 110.777 -177.22 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -70.62 -42.7 70.57 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.831 -0.803 . . . . 62.44 108.831 174.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.528 ' O ' HG13 ' A' ' 50' ' ' ILE . 13.2 mptt -65.55 -32.87 74.7 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 114.76 -1.109 . . . . 74.03 110.685 171.569 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.686 ' HA ' HD12 ' A' ' 50' ' ' ILE . 86.9 t80 -62.86 -40.3 97.06 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.402 0.681 . . . . 73.24 110.453 175.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.473 ' HB3' ' HE1' ' A' ' 93' ' ' PHE . 48.2 mtmt -69.11 -33.43 73.48 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.929 -0.578 . . . . 75.14 110.799 176.231 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -65.37 -30.79 71.66 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-N 117.734 0.243 . . . . 71.44 111.577 172.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.689 HD11 ' HD2' ' A' ' 33' ' ' TYR . 31.1 mt -65.18 -43.48 95.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 109.012 -0.736 . . . . 70.53 109.012 172.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.429 ' HB3' ' HD1' ' A' ' 88' ' ' PHE . 43.7 m-80 -69.11 -21.53 64.03 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 115.282 -0.872 . . . . 73.43 111.716 175.576 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -73.37 -51.79 16.11 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-O 122.244 1.021 . . . . 63.42 108.974 175.445 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.42 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . . . -57.24 -41.75 80.15 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 113.35 -1.75 . . . . 65.45 111.032 175.629 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.441 ' O ' ' HB2' ' A' ' 58' ' ' SER . 13.0 t80 -79.15 -22.93 44.38 Favored 'General case' 0 C--O 1.212 -0.887 0 CA-C-N 114.887 -1.051 . . . . 72.32 110.279 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.93 -26.54 65.13 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.815 -0.553 . . . . 53.01 110.789 173.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.57 HG22 ' HE1' ' A' ' 101' ' ' PHE . 20.6 t -95.68 -23.12 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 115.8 -0.636 . . . . 74.52 111.778 173.774 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.498 HD22 ' HG2' ' A' ' 63' ' ' ARG . 62.3 mt -123.72 26.07 7.86 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.575 -0.703 . . . . 62.04 112.292 -174.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.441 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 16.5 t -66.24 -48.24 71.17 Favored 'General case' 0 N--CA 1.502 2.16 0 CA-C-O 121.45 0.643 . . . . 74.34 111.801 176.407 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -110.28 154.32 42.94 Favored Pre-proline 0 N--CA 1.475 0.798 0 CA-C-N 114.697 -1.138 . . . . 74.34 109.109 -176.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.12 -28.26 83.07 Favored 'Trans proline' 0 C--N 1.382 2.333 0 C-N-CA 122.637 2.225 . . . . 72.41 111.818 173.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -70.68 -53.73 14.59 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.269 1.028 . . . . 72.3 111.534 -179.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -58.48 -40.15 81.93 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 121.692 0.758 . . . . 74.54 110.475 175.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.498 ' HG2' HD22 ' A' ' 57' ' ' LEU . 4.5 tmt_? -58.39 -42.19 86.55 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 113.92 -1.491 . . . . 74.11 109.762 178.231 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -72.19 -27.28 62.46 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 118.601 -0.714 . . . . 74.25 112.721 175.335 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 78.9 mt -62.66 -45.97 97.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 CA-C-N 118.754 0.706 . . . . 64.42 109.456 174.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -64.87 -45.39 86.22 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 115.688 -0.687 . . . . 75.4 110.503 176.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -54.61 -42.8 71.58 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 122.892 0.477 . . . . 64.04 111.194 176.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 80.8 p -82.28 -12.68 57.88 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 118.889 -0.577 . . . . 75.13 111.58 -178.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -65.72 120.46 13.03 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 108.305 -0.998 . . . . 63.45 108.305 172.19 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 109.14 8.3 27.58 Favored Glycine 0 C--N 1.344 1.021 0 CA-C-N 115.948 -0.569 . . . . 52.54 111.929 -164.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 85.9 m -147.27 -57.94 0.26 Allowed 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 103.862 -2.644 . . . . 71.23 103.862 176.069 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 27.1 m -71.37 123.83 23.2 Favored 'General case' 0 C--O 1.246 0.874 0 N-CA-C 103.402 -2.814 . . . . 74.23 103.402 154.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.32 -35.0 6.19 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 117.934 0.334 . . . . 74.04 110.628 -178.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.35 138.91 74.88 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 123.232 0.613 . . . . 75.1 109.832 173.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -57.0 149.9 59.27 Favored 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 122.769 2.312 . . . . 75.41 110.994 171.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.46 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 22.7 Cg_endo -57.3 136.18 74.7 Favored 'Trans proline' 0 CA--C 1.564 1.984 0 C-N-CA 122.695 2.263 . . . . 74.25 112.249 -176.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 76' ' ' PRO . 50.0 Cg_exo -55.43 123.24 13.32 Favored 'Trans proline' 0 C--N 1.386 2.538 0 C-N-CA 123.668 2.912 . . . . 62.44 113.916 -173.076 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -67.39 120.15 7.19 Favored 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 122.766 2.311 . . . . 43.51 112.842 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -78.97 167.12 22.46 Favored 'Trans proline' 0 C--N 1.378 2.108 0 C-N-CA 122.826 2.351 . . . . 71.05 111.621 173.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.24 82.89 0.05 OUTLIER 'Trans proline' 0 C--N 1.388 2.605 0 C-N-CA 123.415 2.743 . . . . 51.35 112.131 175.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 147.37 -44.8 0.79 Allowed Glycine 0 C--N 1.337 0.637 0 CA-C-N 114.74 -1.118 . . . . 62.41 110.331 -176.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 104.39 -160.52 15.73 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 116.478 0.139 . . . . 53.03 113.134 -176.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -106.77 128.68 54.44 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.993 0.917 . . . . 74.41 111.486 -175.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.412 ' HA ' ' HD2' ' A' ' 106' ' ' PHE . 13.2 t70 -70.14 144.58 51.98 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.017 1.327 . . . . 71.31 112.811 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.594 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 54.0 m-85 -136.54 72.18 1.43 Allowed 'General case' 0 C--N 1.358 0.977 0 CA-C-O 121.998 0.904 . . . . 70.22 111.453 -178.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 51.3 m -52.93 105.59 0.13 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 113.398 -1.728 . . . . 74.44 113.314 177.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.667 ' H ' ' HA3' ' A' ' 163' ' ' GLY . . . 67.9 2.3 23.02 Favored Glycine 0 C--N 1.343 0.938 0 C-N-CA 123.187 0.423 . . . . 70.11 113.976 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.594 ' HB2' ' HB3' ' A' ' 85' ' ' PHE . 19.0 m-85 -95.78 121.77 37.86 Favored 'General case' 0 C--N 1.349 0.569 0 N-CA-C 108.948 -0.76 . . . . 72.34 108.948 -174.285 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -82.85 60.06 5.16 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 122.119 0.962 . . . . 71.44 109.899 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.499 ' HA ' ' CD2' ' A' ' 93' ' ' PHE . 1.3 p -47.97 -38.69 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 126.532 1.933 . . . . 75.21 113.531 -179.492 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -55.61 -31.66 62.45 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 124.048 0.939 . . . . 75.33 112.236 -178.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -108.7 0.64 20.66 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.39 0.676 . . . . 45.35 112.111 -176.401 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.499 ' CD2' ' HA ' ' A' ' 90' ' ' VAL . 20.9 m-30 -72.05 178.97 3.48 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.907 -0.495 . . . . 71.01 110.697 177.712 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 77.5 p -58.94 155.72 12.84 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.637 0.775 . . . . 74.5 113.007 -173.287 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.464 ' O ' ' HG3' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -58.85 -41.67 87.52 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.165 -0.925 . . . . 74.31 110.631 173.381 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -57.92 -44.18 86.68 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.79 0.436 . . . . 75.03 111.286 175.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.43 ' HE2' HG23 ' A' ' 90' ' ' VAL . 47.2 t80 -59.92 -44.39 94.34 Favored 'General case' 0 C--O 1.244 0.805 0 CA-C-O 121.424 0.631 . . . . 63.23 109.814 177.654 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -75.44 -2.6 29.45 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 114.314 -1.312 . . . . 73.05 111.753 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.464 ' HG3' ' O ' ' A' ' 95' ' ' GLU . 48.8 mt-10 -93.88 -47.61 6.66 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 123.011 0.525 . . . . 70.02 110.949 163.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 48.8 tp -63.45 -32.16 73.52 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.54 1.136 . . . . 55.03 111.679 -171.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.57 ' HE1' HG22 ' A' ' 56' ' ' VAL . 93.7 m-85 -120.13 9.24 11.08 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.979 0.512 . . . . 72.11 110.477 173.458 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.41 ' HA2' ' HG ' ' A' ' 105' ' ' LEU . . . -48.47 -62.2 4.56 Favored Glycine 0 C--N 1.352 1.458 0 C-N-CA 124.702 1.144 . . . . 72.43 115.894 -172.196 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -56.63 -17.34 22.14 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 123.366 2.711 . . . . 23.1 113.474 178.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -129.57 43.22 1.33 Allowed Glycine 0 C--N 1.35 1.329 0 CA-C-O 119.679 -0.512 . . . . 44.4 112.287 178.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.496 HD22 HG21 ' A' ' 90' ' ' VAL . 33.7 mt -78.95 56.98 2.06 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 117.855 0.827 . . . . 74.25 111.065 170.424 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.686 ' HD1' ' H ' ' A' ' 108' ' ' GLY . 0.2 OUTLIER 35.05 -108.55 0.04 OUTLIER 'General case' 0 CA--C 1.568 1.651 0 C-N-CA 126.29 1.836 . . . . 72.25 112.565 178.215 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 72.06 12.2 75.34 Favored Glycine 0 C--N 1.357 1.701 0 CA-C-N 118.485 0.584 . . . . 44.0 112.722 -173.148 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.686 ' H ' ' HD1' ' A' ' 106' ' ' PHE . . . . . . . . 0 C--N 1.342 0.865 0 C-N-CA 124.058 0.837 . . . . 71.34 113.446 -178.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.451 ' HG3' ' O ' ' A' ' 170' ' ' PRO . 87.1 tttt . . . . . 0 N--CA 1.493 1.676 0 N-CA-C 112.789 0.663 . . . . 72.15 112.789 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -81.31 171.94 53.55 Favored Glycine 0 C--N 1.345 1.05 0 CA-C-N 115.438 -0.801 . . . . 55.22 113.371 174.062 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.8 tmm_? -87.19 140.43 29.55 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 108.568 -0.901 . . . . 71.34 108.568 176.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -53.68 116.9 2.74 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.949 0.9 . . . . 74.23 111.383 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.0 tt -109.86 140.99 43.18 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 121.833 -0.542 . . . . 70.23 109.953 -167.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 29.6 ttt-85 -99.01 107.52 19.97 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.992 0.917 . . . . 74.51 108.755 -178.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.441 ' HB2' HD11 ' A' ' 174' ' ' LEU . . . -111.14 165.14 12.15 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.275 0.63 . . . . 41.51 109.425 178.065 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.455 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 19.4 mm-40 -123.78 111.41 16.1 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 107.49 -1.3 . . . . 61.0 107.49 -174.565 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.406 ' O ' ' HA ' ' A' ' 178' ' ' VAL . 60.0 tp -99.71 96.66 4.85 Favored Pre-proline 0 N--CA 1.487 1.398 0 CA-C-N 118.869 0.759 . . . . 54.05 109.55 -172.548 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.46 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 39.3 Cg_endo -74.92 112.19 3.5 Favored 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 121.189 1.259 . . . . 75.33 110.067 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.616 ' HA ' HG21 ' B' ' 6' ' ' ILE . 38.2 tp -117.26 141.71 47.96 Favored 'General case' 0 C--N 1.338 0.08 0 C-N-CA 123.856 0.863 . . . . 64.01 110.113 -169.668 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.415 ' HB ' ' HG2' ' A' ' 129' ' ' GLU . 27.0 m -74.78 130.17 38.98 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.177 0.991 . . . . 71.34 110.199 178.298 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.4 HD23 HD22 ' A' ' 180' ' ' LEU . 64.9 mt -53.84 -52.87 58.99 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.225 1.01 . . . . 70.54 111.852 -177.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.448 ' HA ' ' HB3' ' A' ' 215' ' ' LEU . 5.7 mp0 -58.83 -38.17 78.06 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.938 0.895 . . . . 75.32 110.377 -176.447 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.415 ' HB3' ' CZ ' ' A' ' 136' ' ' ARG . 16.0 mm-40 -74.95 -28.4 60.56 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 114.925 -1.034 . . . . 64.33 110.837 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -68.79 -35.64 77.29 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.969 0.508 . . . . 41.43 111.182 176.077 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.431 ' HB2' HD12 ' A' ' 215' ' ' LEU . 77.6 t80 -67.19 -49.56 64.18 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 123.481 0.488 . . . . 74.51 110.815 173.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 34.6 m170 -70.35 -36.49 74.23 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 123.526 0.516 . . . . 75.25 111.789 -175.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.437 ' HA3' ' HG3' ' A' ' 151' ' ' PRO . . . 72.7 -171.37 50.13 Favored Glycine 0 CA--C 1.528 0.889 0 O-C-N 123.451 0.469 . . . . 71.54 113.574 -176.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.15 172.95 25.25 Favored Glycine 0 N--CA 1.476 1.347 0 C-N-CA 122.704 0.193 . . . . 70.42 112.788 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.422 ' HG3' ' HB2' ' A' ' 148' ' ' ARG . 1.8 mp0 -71.68 108.82 5.21 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.362 0.665 . . . . 73.14 111.112 -174.432 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.415 ' CZ ' ' HB3' ' A' ' 129' ' ' GLU . 6.5 tpp180 -92.84 122.11 34.89 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 108.628 -0.878 . . . . 74.4 108.628 -177.434 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 94.6 t -78.39 96.71 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 109.237 -0.653 . . . . 71.24 109.237 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.579 ' HB ' HG13 ' B' ' 6' ' ' ILE . 0.2 OUTLIER -112.27 118.37 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 108.294 -1.002 . . . . 73.14 108.294 176.388 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 144' ' ' ARG . 30.5 mt-10 -101.29 133.99 45.04 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.092 0.557 . . . . 71.3 111.152 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.585 HG11 HD23 ' B' ' 8' ' ' LEU . 15.0 p -170.64 139.08 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.039 0 O-C-N 123.628 0.58 . . . . 75.1 111.613 -178.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 55.43 26.28 8.67 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 115.696 1.739 . . . . 74.24 115.696 163.029 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 98.22 10.15 52.08 Favored Glycine 0 N--CA 1.476 1.301 0 C-N-CA 121.694 -0.289 . . . . 31.1 113.02 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 34.0 ttm105 -144.07 106.58 4.42 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 123.343 0.657 . . . . 72.12 110.958 -171.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.438 ' HA ' ' HA ' ' A' ' 139' ' ' GLU . 32.4 ttm180 -78.48 93.57 4.79 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 107.173 -1.418 . . . . 74.41 107.173 162.15 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.452 ' O ' HG13 ' A' ' 138' ' ' VAL . 1.5 p -84.83 107.82 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 108.306 -0.998 . . . . 73.53 108.306 175.299 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 26.9 t -84.53 83.03 8.15 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 107.586 -1.265 . . . . 31.45 107.586 172.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.6 p -87.86 109.65 19.87 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 CA-C-O 121.422 0.629 . . . . 73.42 110.343 -173.254 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.422 ' HB2' ' HG3' ' A' ' 135' ' ' GLU . 20.3 ttm180 -57.47 93.42 0.01 OUTLIER 'General case' 0 C--O 1.24 0.565 0 CA-C-N 115.232 -0.895 . . . . 74.14 108.924 166.224 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.623 ' HB ' HG11 ' A' ' 153' ' ' VAL . 28.8 pt -72.88 118.64 70.01 Favored Pre-proline 0 CA--C 1.547 0.85 0 CA-C-N 114.068 -1.424 . . . . 74.13 108.192 173.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -63.52 128.69 23.02 Favored 'Trans proline' 0 C--N 1.368 1.578 0 C-N-CA 122.248 1.965 . . . . 60.34 110.723 177.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.437 ' HG3' ' HA3' ' A' ' 133' ' ' GLY . 52.1 Cg_exo -53.36 100.37 0.06 OUTLIER 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 122.579 2.186 . . . . 74.15 111.272 177.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.444 ' HA2' ' CD2' ' A' ' 240' ' ' PHE . . . 116.75 36.44 1.06 Allowed Glycine 0 C--N 1.342 0.914 0 CA-C-N 115.532 -0.758 . . . . 75.51 112.647 -173.343 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.623 HG11 ' HB ' ' A' ' 149' ' ' ILE . 2.1 p -91.66 132.8 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 123.843 0.857 . . . . 75.43 108.737 176.606 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.401 ' HB3' ' HA ' ' A' ' 189' ' ' GLU . 0.1 OUTLIER -101.97 168.1 9.62 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.983 0.913 . . . . 73.23 113.047 -161.09 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.579 ' HB3' ' O ' ' A' ' 188' ' ' LEU . 9.0 tp10 -68.37 127.1 31.75 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 108.747 -0.835 . . . . 72.32 108.747 167.504 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 73.07 14.59 78.81 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-N 115.378 -0.828 . . . . 14.21 113.362 -174.282 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 46.5 t -66.34 109.76 2.82 Favored 'General case' 0 C--N 1.359 0.999 0 N-CA-C 107.721 -1.214 . . . . 74.23 107.721 171.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.45 HG13 ' HB3' ' A' ' 175' ' ' LEU . 58.6 t -84.86 87.13 2.37 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 N-CA-C 108.59 -0.893 . . . . 72.34 108.59 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.66 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 54.6 mt -74.01 91.89 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.642 0 N-CA-C 107.763 -1.199 . . . . 75.24 107.763 174.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -74.87 105.25 5.82 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 115.566 -0.743 . . . . 61.32 109.528 179.14 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 4.3 p -115.05 110.36 45.97 Favored Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 123.68 0.792 . . . . 61.33 108.94 173.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.467 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 46.5 Cg_endo -66.61 153.8 76.69 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 122.698 2.265 . . . . 74.53 111.684 177.281 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.667 ' HA3' ' H ' ' A' ' 87' ' ' GLY . . . 76.93 15.9 81.25 Favored Glycine 0 C--N 1.34 0.756 0 CA-C-N 115.827 -0.624 . . . . 70.43 113.892 178.241 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 49.2 mtt -125.46 -3.13 7.37 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 117.954 0.877 . . . . 64.15 111.465 177.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.488 ' HA2' HD13 ' A' ' 174' ' ' LEU . . . -85.15 -124.12 1.29 Allowed Glycine 0 C--N 1.343 0.956 0 N-CA-C 113.739 0.256 . . . . 73.33 113.739 -168.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -65.13 164.54 36.36 Favored Glycine 0 C--N 1.348 1.225 0 O-C-N 123.97 0.453 . . . . 74.5 113.422 -176.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.417 ' HB3' ' HA3' ' A' ' 108' ' ' GLY . 29.3 mm-40 -65.47 105.65 1.23 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.47 1.108 . . . . 75.42 111.581 -171.534 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -169.96 167.21 40.34 Favored Glycine 0 C--N 1.354 1.563 0 CA-C-O 118.96 -0.911 . . . . 64.21 112.124 -178.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' ASN . . . . . 0.639 ' HA ' ' HB3' ' A' ' 106' ' ' PHE . 48.3 t30 -63.74 -59.04 12.57 Favored Pre-proline 0 N--CA 1.493 1.694 0 CA-C-N 118.077 0.938 . . . . 63.11 110.752 -173.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.556 ' HD3' ' HB3' ' A' ' 169' ' ' ASN . 27.1 Cg_endo -94.64 95.13 0.11 Allowed 'Trans proline' 0 C--N 1.381 2.247 0 N-CA-C 106.181 -2.276 . . . . 71.13 106.181 156.429 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_exo -51.9 175.73 0.06 OUTLIER 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 123.391 2.727 . . . . 71.25 115.205 -170.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -62.72 -178.6 4.01 Favored Glycine 0 N--CA 1.474 1.229 0 CA-C-O 121.844 0.691 . . . . 72.4 114.499 -176.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.467 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 3.5 m-20 -79.9 104.76 10.7 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.441 -0.948 . . . . 71.14 108.441 171.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.488 HD13 ' HA2' ' A' ' 165' ' ' GLY . 18.2 tp -78.95 124.64 28.44 Favored 'General case' 0 C--N 1.346 0.421 0 N-CA-C 109.29 -0.633 . . . . 64.32 109.29 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.45 ' HB3' HG13 ' A' ' 158' ' ' VAL . 42.8 mt -101.28 88.88 3.59 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 106.661 -1.607 . . . . 72.12 106.661 -177.244 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.66 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 91.2 mt -72.66 83.18 1.15 Allowed 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 109.357 -0.608 . . . . 70.05 109.357 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.442 HG22 HG22 ' A' ' 158' ' ' VAL . 23.3 t -84.36 98.89 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 107.97 -1.122 . . . . 61.43 107.97 -176.533 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 98.6 t -56.58 140.46 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 N-CA-C 113.046 0.758 . . . . 70.33 113.046 -172.318 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.46 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 62.5 mmt-85 -114.52 89.92 3.21 Favored 'General case' 0 C--N 1.343 0.296 0 N-CA-C 107.463 -1.31 . . . . 53.32 107.463 163.473 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.4 HD22 HD23 ' A' ' 127' ' ' LEU . 10.7 mt -66.63 125.01 24.43 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 107.675 -1.232 . . . . 72.4 107.675 178.118 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 44.4 mt -51.85 152.9 4.82 Favored Pre-proline 0 N--CA 1.485 1.279 0 O-C-N 124.639 1.212 . . . . 73.14 113.628 -162.195 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -72.36 23.41 0.27 Allowed 'Trans proline' 0 C--N 1.382 2.321 0 C-N-CA 123.311 2.674 . . . . 71.42 113.366 178.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' HIS . . . . . 0.467 ' HA ' ' HD3' ' A' ' 184' ' ' PRO . 59.7 t-80 -59.84 105.49 0.57 Allowed Pre-proline 0 CA--C 1.556 1.179 0 N-CA-C 106.399 -1.704 . . . . 73.35 106.399 164.564 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 183' ' ' HIS . 13.7 Cg_exo -69.2 25.31 0.16 Allowed 'Trans proline' 0 C--N 1.375 1.921 0 C-N-CA 124.049 3.166 . . . . 61.24 117.534 -161.256 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 87.5 t -97.02 -58.92 3.49 Favored 'Isoleucine or valine' 0 C--N 1.35 0.623 0 CA-C-N 119.524 1.056 . . . . 64.21 110.422 -175.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -121.51 121.4 37.41 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 118.373 0.533 . . . . 72.31 112.22 -174.458 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.57 92.15 4.99 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 107.215 -1.402 . . . . 75.51 107.215 165.36 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.579 ' O ' ' HB3' ' A' ' 155' ' ' GLU . 53.7 tp -87.91 139.97 29.97 Favored 'General case' 0 C--O 1.207 -1.157 0 C-N-CA 123.769 0.828 . . . . 74.21 109.855 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 189' ' ' GLU . . . . . 0.401 ' HA ' ' HB3' ' A' ' 154' ' ' ARG . 40.0 tt0 -162.22 125.47 3.0 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 118.482 0.583 . . . . 70.31 110.003 177.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 73.59 -65.37 1.74 Allowed Glycine 0 C--N 1.356 1.691 0 O-C-N 123.586 0.554 . . . . 65.41 112.223 -173.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.428 ' HB3' ' HA3' ' A' ' 242' ' ' GLY . 4.3 pm0 -164.45 -19.42 0.03 OUTLIER 'General case' 0 C--O 1.249 1.037 0 C-N-CA 125.694 1.598 . . . . 72.32 109.104 177.073 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.422 ' H ' ' H ' ' A' ' 191' ' ' GLN . 2.0 p30 -94.65 134.81 36.83 Favored 'General case' 0 C--N 1.358 0.968 0 C-N-CA 123.908 0.883 . . . . 72.32 112.005 -169.134 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.555 ' HB2' ' HA ' ' A' ' 249' ' ' LEU . 66.8 mt -95.91 150.12 20.79 Favored 'General case' 0 C--O 1.22 -0.463 0 C-N-CA 125.788 1.635 . . . . 63.44 110.368 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -133.74 105.27 6.72 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 106.944 -1.502 . . . . 73.14 106.944 169.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.502 ' HB3' HD23 ' A' ' 251' ' ' LEU . . . -118.6 119.33 34.16 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.658 1.183 . . . . 74.34 109.906 -172.711 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 31.8 m -69.83 129.41 39.47 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 123.358 0.411 . . . . 70.21 109.912 -175.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 54.6 tp -128.79 99.99 5.53 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 109.001 -0.74 . . . . 72.21 109.001 -170.076 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -80.21 121.43 25.6 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.955 -0.757 . . . . 61.43 108.955 176.002 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 6.3 p -138.68 135.58 18.02 Favored Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 124.714 1.206 . . . . 64.4 108.374 -175.34 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -74.12 152.73 45.86 Favored 'Trans proline' 0 C--N 1.368 1.553 0 C-N-CA 121.923 1.748 . . . . 64.51 111.081 173.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -53.35 -50.57 82.0 Favored Pre-proline 0 CA--C 1.553 1.07 0 N-CA-C 113.93 1.085 . . . . 71.34 113.93 -173.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -55.52 -46.25 33.58 Favored 'Trans proline' 0 C--N 1.38 2.19 0 C-N-CA 121.902 1.735 . . . . 63.54 113.581 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 19.6 mt -70.32 -32.32 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 CA-C-N 116.141 -0.481 . . . . 64.32 110.927 -176.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.89 -42.4 85.58 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.004 0.522 . . . . 71.51 111.301 175.084 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.419 ' CG1' HD11 ' C' ' 261' ' ' LEU . 53.9 t -73.17 -40.85 58.43 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.037 0 C-N-CA 124.082 0.953 . . . . 63.23 112.577 -174.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 65.0 t -95.58 -34.77 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 122.614 0.366 . . . . 74.41 111.694 -175.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 93.42 108.84 1.94 Allowed Glycine 0 C--N 1.335 0.508 0 CA-C-N 116.354 -0.384 . . . . 72.35 112.166 -178.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -141.45 -161.94 8.93 Favored Glycine 0 N--CA 1.469 0.841 0 N-CA-C 110.741 -0.943 . . . . 55.24 110.741 177.421 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 44.5 mtmt -100.43 124.11 45.52 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 118.426 1.113 . . . . 45.21 110.814 176.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 31.4 m -108.89 166.07 4.75 Favored 'Isoleucine or valine' 0 C--O 1.247 0.924 0 C-N-CA 125.014 1.326 . . . . 63.11 108.973 170.383 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 211' ' ' ARG . . . . . 0.651 HH21 ' HA ' ' A' ' 220' ' ' GLU . 0.0 OUTLIER -95.16 117.41 30.18 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.022 -0.733 . . . . 71.41 109.022 174.501 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -119.71 130.97 55.27 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 107.481 -1.303 . . . . 62.04 107.481 172.45 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 213' ' ' MET . . . . . 0.546 ' HA ' ' HA ' ' A' ' 218' ' ' PRO . 0.8 OUTLIER -80.27 148.62 30.69 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 122.46 0.304 . . . . 71.23 110.505 -176.497 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 71.5 p -117.67 -177.81 3.33 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 108.808 -0.812 . . . . 74.1 108.808 168.008 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.448 ' HB3' ' HA ' ' A' ' 128' ' ' GLU . 86.0 mt -76.89 -1.98 31.23 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.642 -0.708 . . . . 63.31 112.098 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -126.89 -2.17 6.56 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.145 0.578 . . . . 64.44 111.805 177.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 149.17 167.31 13.82 Favored Glycine 0 N--CA 1.481 1.635 0 N-CA-C 114.626 0.61 . . . . 33.0 114.626 173.059 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 218' ' ' PRO . . . . . 0.546 ' HA ' ' HA ' ' A' ' 213' ' ' MET . 2.7 Cg_exo -76.19 116.59 4.4 Favored 'Trans proline' 0 C--N 1.374 1.888 0 C-N-CA 123.662 2.908 . . . . 70.23 111.968 -177.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.412 HG23 HG23 ' A' ' 221' ' ' VAL . 34.7 m -106.42 162.29 5.32 Favored 'Isoleucine or valine' 0 C--O 1.254 1.317 0 C-N-CA 123.98 0.912 . . . . 73.4 112.03 -172.404 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.651 ' HA ' HH21 ' A' ' 211' ' ' ARG . 29.4 mt-10 -86.49 103.12 14.72 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 114.213 -1.358 . . . . 75.04 109.889 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.412 HG23 HG23 ' A' ' 219' ' ' VAL . 39.7 t -106.93 116.9 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.172 0.589 . . . . 74.13 109.48 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -77.88 99.36 5.95 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 109.255 -0.646 . . . . 60.25 109.255 174.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 14.3 p -64.9 134.0 95.93 Favored Pre-proline 0 CA--C 1.559 1.326 0 N-CA-C 109.491 -0.559 . . . . 63.14 109.491 177.377 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -61.44 168.71 7.64 Favored 'Trans proline' 0 C--N 1.38 2.227 0 C-N-CA 122.735 2.29 . . . . 75.51 112.654 176.225 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.77 150.96 31.34 Favored 'Trans proline' 0 C--N 1.374 1.904 0 C-N-CA 121.624 1.549 . . . . 72.53 112.474 172.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 45.3 mtt-85 66.29 27.34 10.17 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 125.692 1.597 . . . . 74.04 110.963 169.117 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.651 HG23 HD21 ' A' ' 233' ' ' LEU . 80.6 m -63.59 104.87 0.7 Allowed 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 113.06 -1.882 . . . . 64.32 110.843 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -85.14 139.83 31.4 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 123.945 0.898 . . . . 75.32 110.647 -176.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -62.24 157.4 19.59 Favored 'General case' 0 C--N 1.356 0.863 0 C-N-CA 124.152 0.981 . . . . 62.31 111.082 177.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 81.1 -38.74 2.41 Favored Glycine 0 C--N 1.346 1.088 0 CA-C-N 116.637 -0.256 . . . . 73.32 112.606 177.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -69.07 166.94 17.06 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 123.686 0.794 . . . . 74.0 110.26 173.318 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.705 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 2.7 mptp? -124.85 131.87 53.39 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 115.13 -0.941 . . . . 72.22 108.772 -178.719 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.651 HD21 HG23 ' A' ' 227' ' ' THR . 59.4 mt -76.62 97.54 4.44 Favored 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 107.903 -1.147 . . . . 71.4 107.903 176.163 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 234' ' ' ARG . . . . . 0.419 ' HG3' ' HB3' ' A' ' 248' ' ' ASP . 40.7 ttp180 -78.73 103.52 8.73 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 123.599 0.562 . . . . 64.14 109.737 -176.365 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.46 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 10.7 mt -100.04 89.33 4.0 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.217 -1.031 . . . . 61.12 108.217 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -71.0 139.08 50.42 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.751 0.42 . . . . 64.43 110.977 -173.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 79.32 2.6 87.76 Favored Glycine 0 CA--C 1.536 1.346 0 O-C-N 123.533 0.521 . . . . 74.2 113.271 -174.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.493 ' HA ' ' HE3' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -105.83 -16.45 14.66 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 117.47 0.635 . . . . 73.01 111.73 -179.395 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -72.32 -163.29 6.63 Favored Glycine 0 CA--C 1.534 1.238 0 O-C-N 123.412 0.445 . . . . 74.43 112.87 173.207 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 240' ' ' PHE . . . . . 0.444 ' CD2' ' HA2' ' A' ' 152' ' ' GLY . 58.6 m-85 -95.01 166.26 15.29 Favored Pre-proline 0 N--CA 1.485 1.284 0 CA-C-O 118.282 -0.866 . . . . 73.13 109.869 -177.496 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -49.69 146.26 15.86 Favored 'Trans proline' 0 C--N 1.392 2.868 0 C-N-CA 123.399 2.733 . . . . 73.33 113.943 -177.062 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.428 ' HA3' ' HB3' ' A' ' 191' ' ' GLN . . . -168.65 -158.68 12.91 Favored Glycine 0 C--N 1.338 0.657 0 CA-C-N 114.928 -1.033 . . . . 73.52 112.002 -178.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -78.46 -5.52 14.95 Favored 'Trans proline' 0 C--N 1.369 1.626 0 C-N-CA 123.284 2.656 . . . . 70.45 112.749 -173.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -113.51 22.0 14.57 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.003 0.921 . . . . 70.11 110.309 177.428 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 90.84 -75.28 1.63 Allowed Glycine 0 C--N 1.345 1.031 0 N-CA-C 109.996 -1.241 . . . . 62.24 109.996 -174.013 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 73.9 mtp180 -119.94 175.29 5.98 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.994 0.918 . . . . 75.41 109.279 168.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -105.58 -161.03 23.14 Favored Glycine 0 C--N 1.341 0.85 0 CA-C-N 115.988 -0.551 . . . . 42.24 114.306 -177.264 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 248' ' ' ASP . . . . . 0.419 ' HB3' ' HG3' ' A' ' 234' ' ' ARG . 19.3 m-20 -110.7 134.75 52.18 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 124.032 0.933 . . . . 75.44 108.813 -174.185 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.555 ' HA ' ' HB2' ' A' ' 193' ' ' LEU . 12.3 tp -98.95 95.51 7.21 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.0 -1.111 . . . . 70.31 108.0 176.21 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.705 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 84.4 m-85 -82.27 108.28 15.6 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 109.523 -0.547 . . . . 52.51 109.523 178.392 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.512 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 86.7 mt -86.8 105.7 17.19 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 109.298 -0.63 . . . . 72.24 109.298 172.408 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -76.54 106.99 8.5 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.358 0.663 . . . . 75.41 109.504 -174.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.454 HG11 HG22 ' A' ' 227' ' ' THR . 23.9 t -69.27 127.93 31.91 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 124.252 1.021 . . . . 24.43 112.089 -170.627 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -127.5 93.93 3.85 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 107.365 -1.346 . . . . 73.14 107.365 178.605 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.409 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 69.6 mt -83.25 136.11 23.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 C-N-CA 122.641 0.377 . . . . 74.34 110.762 -177.591 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 22.5 p -124.93 169.57 11.95 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.594 1.157 . . . . 73.43 109.497 172.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 257' ' ' ILE . . . . . 0.554 HD12 ' H ' ' A' ' 259' ' ' GLU . 2.3 pp -109.58 141.18 23.07 Favored Pre-proline 0 N--CA 1.484 1.25 0 C-N-CA 122.928 0.491 . . . . 73.4 109.92 178.598 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 258' ' ' PRO . . . . . 0.539 ' HB3' ' HE1' ' C' ' 276' ' ' TYR . 12.7 Cg_endo -52.53 -20.95 13.03 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 124.598 3.532 . . . . 74.45 115.615 -170.389 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 259' ' ' GLU . . . . . 0.554 ' H ' HD12 ' A' ' 257' ' ' ILE . 23.2 mt-10 50.85 -78.93 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.561 1.144 . . . . 63.24 110.576 -160.509 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.59 129.34 16.26 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.271 1.029 . . . . 75.12 111.713 176.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.43 HD22 ' HB3' ' A' ' 265' ' ' GLU . 89.1 mt -154.99 144.85 21.6 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.555 1.142 . . . . 55.32 109.096 -179.073 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 64.2 p -93.86 156.72 39.06 Favored Pre-proline 0 CA--C 1.555 1.151 0 CA-C-O 118.06 -0.971 . . . . 44.34 109.101 171.21 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -34.98 -48.07 0.69 Allowed 'Trans proline' 0 C--N 1.388 2.639 0 C-N-CA 124.843 3.695 . . . . 74.33 116.532 -177.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -68.46 -49.47 59.6 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.05 0.54 . . . . 71.44 111.406 -178.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 265' ' ' GLU . . . . . 0.43 ' HB3' HD22 ' A' ' 261' ' ' LEU . 49.9 mt-10 -56.95 -43.77 81.91 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.077 0.551 . . . . 64.2 110.344 178.408 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -57.12 -45.81 83.18 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 114.483 -1.235 . . . . 73.45 110.513 177.596 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -60.93 -41.67 96.65 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.162 -0.926 . . . . 64.12 111.685 178.331 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 268' ' ' LEU . . . . . 0.406 ' HG ' ' HG ' ' C' ' 268' ' ' LEU . 9.7 mp -64.78 -48.53 74.17 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.296 0.638 . . . . 73.14 111.193 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 68.5 m95 -57.86 -45.58 86.08 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.142 0.577 . . . . 75.0 111.583 178.013 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 270' ' ' LYS . . . . . 0.619 ' HE3' HG23 ' C' ' 206' ' ' VAL . 44.9 mttp -65.16 -42.95 93.22 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-N 115.536 -0.756 . . . . 62.43 111.547 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 34.4 mmtm -63.31 -42.94 99.05 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 122.88 0.472 . . . . 70.22 111.789 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 272' ' ' LEU . . . . . 0.44 ' O ' ' HB2' ' A' ' 276' ' ' TYR . 67.5 mt -54.93 -49.28 71.69 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 124.251 0.97 . . . . 63.4 109.435 172.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -70.06 -33.22 71.66 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.076 1.139 . . . . 64.51 114.076 -175.152 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.428 ' HG3' ' O ' ' A' ' 270' ' ' LYS . 40.6 mt-10 -65.08 -53.94 37.81 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.373 -0.973 . . . . 74.35 108.373 176.535 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -69.87 -20.83 63.38 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 113.567 -1.651 . . . . 71.44 112.161 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 276' ' ' TYR . . . . . 0.554 ' HE2' ' HB3' ' C' ' 258' ' ' PRO . 23.8 t80 -75.49 -64.07 1.15 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.188 0.995 . . . . 75.02 109.4 178.705 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -72.09 -23.06 61.28 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 114.799 -1.091 . . . . 70.12 111.848 -170.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -59.24 -26.99 65.37 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 112.762 0.653 . . . . 75.41 112.762 172.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -77.58 -15.14 59.42 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 116.429 -0.351 . . . . 74.13 110.497 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.131 0 C-N-CA 123.857 0.863 . . . . 72.21 109.042 175.507 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 14.6 tpt . . . . . 0 N--CA 1.479 0.979 0 N-CA-C 109.391 -0.596 . . . . 71.44 109.391 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt 59.86 33.94 21.69 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 124.568 1.147 . . . . 54.1 112.126 175.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 59.22 72.94 0.5 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.736 1.214 . . . . 74.04 109.814 -173.715 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 11.1 p -82.87 -17.51 43.57 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 115.029 -0.987 . . . . 52.14 111.864 -176.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 4.5 m 68.94 158.72 0.16 Allowed 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 125.234 1.413 . . . . 70.11 113.252 174.161 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.616 HG21 ' HA ' ' A' ' 125' ' ' LEU . 14.5 pt -138.57 175.08 8.93 Favored 'Isoleucine or valine' 0 C--N 1.364 1.199 0 C-N-CA 123.316 0.646 . . . . 64.44 111.117 -172.028 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -150.38 141.81 23.39 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.074 0.95 . . . . 72.01 109.017 172.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 8' ' ' LEU . . . . . 0.585 HD23 HG11 ' A' ' 140' ' ' VAL . 52.7 tp -75.76 143.03 42.22 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.263 1.025 . . . . 75.22 109.91 -174.559 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.93 -68.1 0.35 Allowed 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 109.513 -0.551 . . . . 62.4 109.513 172.323 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 6.6 tt 53.39 101.23 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 125.365 1.466 . . . . 74.1 110.527 -176.292 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 31.0 mt . . . . . 0 CA--C 1.556 1.209 0 C-N-CA 124.732 1.213 . . . . 45.35 110.769 -179.6 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.023 0 N-CA-C 109.57 -0.53 . . . . 61.34 109.57 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . 58.37 -79.24 0.02 OUTLIER 'General case' 0 C--N 1.359 1.0 0 C-N-CA 124.953 1.301 . . . . 74.4 110.472 -164.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 181' ' ' LEU . . . . . 0.503 HD22 ' HB3' ' C' ' 136' ' ' ARG . 12.8 tp -162.94 26.61 0.09 Allowed 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.699 0.762 . . . . 62.04 109.505 174.618 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 182' ' ' VAL . . . . . 0.464 HG13 ' HB3' ' C' ' 139' ' ' GLU . 76.7 t -83.44 147.45 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.505 1.122 . . . . 71.31 110.761 -174.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 183' ' ' ALA . . . . . 0.457 ' HB2' HD13 ' C' ' 123' ' ' LEU . . . -134.05 -13.69 2.43 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.54 0.736 . . . . 65.24 112.222 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 55.53 -138.77 1.02 Allowed 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.995 0.918 . . . . 74.15 108.836 -174.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 185' ' ' VAL . . . . . . . . . . . . . 61.0 t . . . . . 0 N--CA 1.47 0.554 0 N-CA-C 106.997 -1.483 . . . . 71.33 106.997 158.528 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 238' ' ' THR . . . . . 0.461 HG22 HG23 ' C' ' 219' ' ' VAL . 6.9 m . . . . . 0 CA--C 1.553 1.081 0 CA-C-O 121.046 0.45 . . . . 71.31 110.197 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 239' ' ' ALA . . . . . 0.658 ' HB2' ' HA ' ' C' ' 221' ' ' VAL . . . -60.79 -177.09 0.07 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.032 1.333 . . . . 74.42 114.117 -178.726 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . -103.21 -95.48 2.33 Favored Glycine 0 C--N 1.341 0.837 0 N-CA-C 110.32 -1.112 . . . . 71.23 110.32 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -166.07 157.12 13.29 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.506 0.723 . . . . 71.21 110.789 -179.451 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -170.58 -69.37 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.17 0.988 . . . . 70.32 109.971 174.46 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -136.74 -6.97 1.91 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.389 1.076 . . . . 74.22 110.505 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 142.74 -163.79 27.21 Favored Glycine 0 C--N 1.352 1.468 0 N-CA-C 113.472 0.149 . . . . 63.11 113.472 174.249 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.544 0.748 0 C-N-CA 124.322 1.049 . . . . 75.34 109.526 -174.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.783 0 N-CA-C 109.693 -0.484 . . . . 52.01 109.693 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -37.72 101.63 0.02 OUTLIER 'General case' 0 C--N 1.354 0.773 0 C-N-CA 125.765 1.626 . . . . 70.52 113.756 -176.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 5' ' ' LYS . . . . . 0.477 ' HE2' HD11 ' C' ' 10' ' ' ILE . 14.6 mmmm -73.32 98.94 2.78 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.46 -1.311 . . . . 63.2 107.46 164.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -71.15 92.78 1.01 Allowed 'General case' 0 C--O 1.234 0.258 0 N-CA-C 107.759 -1.2 . . . . 63.22 107.759 177.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 7' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -58.64 -29.96 66.94 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 114.668 -1.151 . . . . 73.43 112.17 -170.116 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -67.33 -48.75 66.63 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.112 -0.949 . . . . 72.53 110.002 176.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.12 -38.52 86.66 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.978 0.511 . . . . 52.31 110.941 178.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 10' ' ' ILE . . . . . 0.477 HD11 ' HE2' ' C' ' 5' ' ' LYS . 59.5 mt -61.79 -39.36 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.335 0.654 . . . . 63.34 110.185 176.196 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 96.0 mt -80.44 -7.47 59.16 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 112.586 0.587 . . . . 45.45 112.586 176.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.37 35.84 51.41 Favored Glycine 0 C--N 1.352 1.454 0 CA-C-N 117.917 0.326 . . . . 64.33 113.636 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 6.3 m -133.55 155.89 80.15 Favored Pre-proline 0 N--CA 1.483 1.206 0 C-N-CA 125.109 1.364 . . . . 64.04 109.576 177.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -81.98 155.42 17.49 Favored 'Trans proline' 0 C--N 1.371 1.714 0 C-N-CA 122.195 1.93 . . . . 74.43 112.306 174.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 90.1 mtm-85 -67.35 75.98 0.16 Allowed 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.747 0.819 . . . . 71.52 110.311 174.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -177.48 -31.63 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.572 1.149 . . . . 71.24 108.779 -175.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.68 134.22 56.52 Favored 'General case' 0 C--N 1.353 0.748 0 CA-C-N 115.578 -0.737 . . . . 71.14 110.401 177.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 75.0 p -71.36 173.46 7.8 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.319 0.648 . . . . 74.41 111.671 -175.556 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.24 -39.55 87.09 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.347 1.059 . . . . 74.45 110.376 -176.005 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 20' ' ' GLU . . . . . 0.42 ' O ' ' HG3' ' C' ' 24' ' ' ARG . 7.8 tm-20 -66.64 -34.94 78.98 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 123.148 0.579 . . . . 64.05 110.015 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -70.97 -36.95 72.73 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 122.734 0.414 . . . . 73.42 110.773 176.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 1.4 mp -63.87 -34.52 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.333 1.053 . . . . 61.32 110.078 173.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 23' ' ' LYS . . . . . 0.534 ' O ' ' HG3' ' C' ' 27' ' ' LYS . 13.7 tppt? -66.55 -45.18 80.22 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.295 0.638 . . . . 74.13 109.305 178.075 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 24' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' C' ' 20' ' ' GLU . 63.1 mtm-85 -63.49 -41.99 98.55 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 123.459 0.475 . . . . 73.52 110.839 178.211 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.95 -38.45 86.14 Favored 'General case' 0 C--O 1.253 1.251 0 CA-C-N 115.257 -0.883 . . . . 75.32 110.987 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 26' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -57.14 -55.78 30.25 Favored 'General case' 0 C--O 1.216 -0.685 0 CA-C-N 114.541 -1.208 . . . . 72.31 109.13 173.203 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 27' ' ' LYS . . . . . 0.534 ' HG3' ' O ' ' C' ' 23' ' ' LYS . 33.2 mtmt -57.39 -41.56 80.47 Favored 'General case' 0 N--CA 1.483 1.186 0 O-C-N 124.424 1.078 . . . . 74.1 110.824 -177.474 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -55.32 -51.45 66.69 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.004 0.921 . . . . 71.15 110.961 178.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 82.3 mt -86.07 -6.02 59.1 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.724 -0.671 . . . . 60.22 111.498 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.41 -0.09 49.75 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.934 0.893 . . . . 75.32 110.011 171.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 31' ' ' ARG . . . . . 0.402 ' HG3' ' O ' ' C' ' 27' ' ' LYS . 95.7 mtt180 -100.94 -41.89 6.64 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.26 1.024 . . . . 73.5 109.208 165.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.33 -50.16 49.07 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 115.637 -0.71 . . . . 71.12 109.629 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 33' ' ' TYR . . . . . 0.422 ' HB3' ' O ' ' C' ' 43' ' ' ALA . 37.2 m-85 -95.4 14.94 20.9 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.924 0.49 . . . . 70.15 111.52 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 34' ' ' HIS . . . . . 0.422 ' CD2' HG23 ' C' ' 37' ' ' VAL . 12.4 t60 -61.4 107.82 1.27 Allowed Pre-proline 0 N--CA 1.489 1.48 0 C-N-CA 124.36 1.064 . . . . 72.34 110.792 -177.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -61.74 -21.31 71.87 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 123.018 2.479 . . . . 71.32 114.16 -172.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.05 -26.31 36.44 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.951 0.9 . . . . 60.34 111.668 178.423 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 37' ' ' VAL . . . . . 0.422 HG23 ' CD2' ' C' ' 34' ' ' HIS . 90.2 t -97.39 -58.33 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 109.046 -0.724 . . . . 75.33 109.046 176.322 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -98.12 84.21 3.24 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 114.801 -1.09 . . . . 54.22 108.907 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.26 79.21 0.99 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 114.866 -1.061 . . . . 62.24 108.635 175.449 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 67.1 m -140.38 114.9 7.53 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-O 118.301 -0.857 . . . . 74.14 109.387 -178.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -52.12 -41.85 62.61 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 123.326 2.684 . . . . 63.44 112.774 -176.113 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -48.62 -50.62 31.94 Favored 'General case' 0 N--CA 1.483 1.18 0 O-C-N 124.078 0.861 . . . . 65.44 110.85 173.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 43' ' ' ALA . . . . . 0.422 ' O ' ' HB3' ' C' ' 33' ' ' TYR . . . -71.55 -23.55 61.78 Favored 'General case' 0 C--O 1.216 -0.679 0 CA-C-N 114.768 -1.105 . . . . 62.05 110.931 -176.359 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 44' ' ' GLU . . . . . 0.469 ' O ' ' HG3' ' C' ' 48' ' ' LYS . 47.9 mt-10 -80.72 -33.48 35.22 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 122.992 0.517 . . . . 74.04 110.672 -176.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 45' ' ' GLU . . . . . 0.418 ' HA ' ' HD2' ' C' ' 48' ' ' LYS . 40.3 mt-10 -76.36 -39.4 53.95 Favored 'General case' 0 C--O 1.244 0.763 0 C-N-CA 123.316 0.647 . . . . 42.53 109.643 178.015 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 46' ' ' LYS . . . . . 0.535 ' O ' HG12 ' C' ' 50' ' ' ILE . 99.6 mttt -64.26 -34.7 78.71 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.008 -0.997 . . . . 72.32 110.131 170.615 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -66.34 -35.87 81.45 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.919 0.888 . . . . 62.23 110.297 175.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 48' ' ' LYS . . . . . 0.469 ' HG3' ' O ' ' C' ' 44' ' ' GLU . 95.1 mttt -60.67 -42.32 96.83 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 109.773 -0.454 . . . . 72.04 109.773 173.541 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -66.67 -33.8 76.45 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 123.653 0.596 . . . . 72.33 111.578 174.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 50' ' ' ILE . . . . . 0.535 HG12 ' O ' ' C' ' 46' ' ' LYS . 32.8 mm -65.72 -33.93 66.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 109.005 -0.739 . . . . 75.43 109.005 175.626 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 51' ' ' ASN . . . . . 0.555 ' HA ' ' HB3' ' C' ' 54' ' ' TYR . 36.3 m-80 -93.0 -3.98 53.46 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.123 0.969 . . . . 74.04 112.333 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -81.53 -51.45 8.25 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 107.243 -1.391 . . . . 63.42 107.243 165.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.14 -37.29 71.82 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 112.503 -2.135 . . . . 63.1 111.304 173.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 54' ' ' TYR . . . . . 0.555 ' HB3' ' HA ' ' C' ' 51' ' ' ASN . 58.1 t80 -78.18 -39.21 41.51 Favored 'General case' 0 C--O 1.215 -0.724 0 CA-C-N 115.5 -0.773 . . . . 75.01 110.411 174.405 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.52 -28.32 44.46 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 118.751 0.705 . . . . 60.54 111.56 177.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 56' ' ' VAL . . . . . 0.462 ' O ' ' HB2' ' C' ' 62' ' ' LYS . 47.3 t -83.28 -67.09 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 CA-C-O 121.288 0.566 . . . . 72.43 110.443 169.513 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 57' ' ' LEU . . . . . . . . . . . . . 52.1 mt -84.47 15.5 3.67 Favored 'General case' 0 CA--C 1.565 1.538 0 N-CA-C 113.066 0.765 . . . . 75.02 113.066 -164.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 45.5 t -61.2 -45.8 93.09 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 124.188 0.995 . . . . 62.42 112.291 -178.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -123.31 149.83 58.82 Favored Pre-proline 0 C--O 1.242 0.69 0 CA-C-N 114.897 -1.047 . . . . 72.03 108.639 -173.058 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 60' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -51.43 -26.97 22.9 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 123.299 2.666 . . . . 33.23 113.088 174.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -62.56 -70.28 0.21 Allowed 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.439 -0.8 . . . . 62.13 111.272 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 62' ' ' LYS . . . . . 0.486 ' HD3' ' H ' ' C' ' 62' ' ' LYS . 0.0 OUTLIER -70.64 -20.66 62.71 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 122.117 0.167 . . . . 75.23 110.857 -175.568 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -53.59 -62.11 1.87 Allowed 'General case' 0 C--N 1.354 0.776 0 O-C-N 124.002 0.814 . . . . 64.42 109.864 168.119 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -70.1 -27.56 64.69 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 112.249 0.463 . . . . 74.15 112.249 -176.223 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 88.5 mt -57.71 -50.27 78.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 109.68 -0.489 . . . . 62.34 109.68 172.218 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -61.74 -47.61 84.45 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.112 0.565 . . . . 74.22 111.691 174.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -53.94 -32.16 52.75 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.119 0.568 . . . . 73.14 111.979 -178.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 68' ' ' THR . . . . . 0.446 ' O ' ' HB ' ' C' ' 72' ' ' THR . 40.1 p -97.02 -24.09 15.96 Favored 'General case' 0 CA--C 1.553 1.069 0 N-CA-C 112.512 0.56 . . . . 63.2 112.512 176.343 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 69' ' ' TYR . . . . . 0.444 ' HE2' ' HD3' ' C' ' 78' ' ' PRO . 3.4 t80 -118.25 120.29 37.22 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.31 -0.869 . . . . 75.22 110.763 -172.648 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.94 23.58 66.25 Favored Glycine 0 C--N 1.346 1.136 0 N-CA-C 111.616 -0.594 . . . . 62.51 111.616 -173.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 54.8 m -142.18 -53.58 0.42 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 103.745 -2.687 . . . . 72.34 103.745 175.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 72' ' ' THR . . . . . 0.446 ' HB ' ' O ' ' C' ' 68' ' ' THR . 21.1 m -105.25 173.3 6.36 Favored 'General case' 0 CA--C 1.564 1.498 0 N-CA-C 104.969 -2.234 . . . . 73.35 104.969 158.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -90.85 11.41 22.67 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 118.999 0.818 . . . . 73.23 111.081 173.739 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 74' ' ' ALA . . . . . 0.45 ' HB1' ' HD2' ' C' ' 75' ' ' PRO . . . -62.12 -163.35 0.0 OUTLIER Pre-proline 0 CA--C 1.594 2.646 0 C-N-CA 125.728 1.611 . . . . 53.23 112.305 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 75' ' ' PRO . . . . . 0.523 ' HA ' ' HD2' ' C' ' 76' ' ' PRO . 0.2 OUTLIER 8.2 109.24 0.0 OUTLIER 'Trans proline' 1 C--N 1.419 4.25 0 C-N-CA 125.153 3.902 . . . . 75.14 118.512 -156.134 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' C' C ' 76' ' ' PRO . . . . . 0.523 ' HD2' ' HA ' ' C' ' 75' ' ' PRO . 42.5 Cg_endo -62.12 165.96 13.59 Favored 'Trans proline' 0 C--N 1.387 2.556 0 C-N-CA 123.52 2.813 . . . . 63.14 113.321 -179.27 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -21.39 106.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.405 3.517 1 C-N-CA 126.157 4.572 . . . . 51.51 116.029 178.528 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 78' ' ' PRO . . . . . 0.624 ' HG2' ' HA ' ' C' ' 101' ' ' PHE . 1.3 Cg_exo -37.59 146.45 0.11 Allowed 'Trans proline' 0 C--N 1.379 2.133 1 C-N-CA 126.277 4.651 . . . . 74.44 117.639 -171.781 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -58.87 119.43 6.68 Favored 'Trans proline' 0 C--N 1.391 2.813 0 C-N-CA 123.555 2.837 . . . . 61.04 113.411 -178.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -62.12 75.49 0.1 OUTLIER 'Trans proline' 0 C--N 1.391 2.811 0 C-N-CA 123.56 2.84 . . . . 51.5 110.321 169.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -167.48 -24.89 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 113.704 -1.589 . . . . 75.2 110.281 -166.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.41 ' HA2' ' O ' ' C' ' 104' ' ' GLY . . . 118.21 141.73 6.81 Favored Glycine 0 C--N 1.361 1.969 0 N-CA-C 116.377 1.311 . . . . 74.45 116.377 163.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 83' ' ' TYR . . . . . 0.505 ' CE1' ' HB3' ' C' ' 78' ' ' PRO . 22.7 m-85 -110.03 92.93 4.24 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 107.311 -1.366 . . . . 70.14 107.311 165.437 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -27.67 135.29 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 127.471 2.308 . . . . 63.13 116.157 -175.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 85' ' ' PHE . . . . . 0.564 ' HZ ' HD22 ' C' ' 105' ' ' LEU . 16.0 m-85 -135.49 74.21 1.5 Allowed 'General case' 0 C--N 1.346 0.451 0 CA-C-N 115.167 -0.924 . . . . 74.41 110.999 -177.594 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 86' ' ' SER . . . . . 0.521 ' OG ' ' HA2' ' C' ' 163' ' ' GLY . 1.4 m -55.82 83.21 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 123.715 0.806 . . . . 45.43 110.523 177.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 62.65 16.0 54.92 Favored Glycine 0 CA--C 1.54 1.637 0 CA-C-O 119.007 -0.885 . . . . 74.33 114.624 -170.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 88' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -86.46 120.81 28.19 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 118.536 1.168 . . . . 74.44 109.772 -174.208 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -76.56 88.67 3.28 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 120.856 0.36 . . . . 72.23 110.604 -174.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 90' ' ' VAL . . . . . . . . . . . . . 6.0 p -45.43 -43.96 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 124.333 1.053 . . . . 54.41 113.06 175.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -61.48 -31.2 71.17 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.745 0.818 . . . . 74.21 111.381 -176.128 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -79.08 -24.89 43.18 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.275 -0.875 . . . . 75.53 111.083 -176.041 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 19.1 m-30 -73.83 165.51 24.98 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 122.637 0.375 . . . . 72.45 110.787 -175.459 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 86.3 p -67.62 163.45 21.33 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 113.509 0.929 . . . . 45.51 113.509 -167.102 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.11 -42.91 95.72 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.027 -0.988 . . . . 55.43 110.645 172.422 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -58.44 -43.53 88.82 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.161 0.584 . . . . 65.02 110.653 178.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 97' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -61.51 -43.67 98.45 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.203 -0.908 . . . . 64.25 109.691 177.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 98' ' ' GLN . . . . . 0.541 ' HA ' HD12 ' C' ' 105' ' ' LEU . 48.6 mt-30 -82.58 -5.21 58.65 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 115.091 -0.958 . . . . 51.52 113.306 -177.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -101.4 -35.95 9.03 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.412 0.685 . . . . 74.43 110.947 172.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 46.3 tp -74.2 -61.4 1.87 Allowed 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 109.067 -0.716 . . . . 73.23 109.067 -178.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 101' ' ' PHE . . . . . 0.624 ' HA ' ' HG2' ' C' ' 78' ' ' PRO . 65.6 m-85 -92.08 8.72 36.54 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 115.389 -0.823 . . . . 73.25 111.55 -177.002 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -46.52 -58.28 6.05 Favored Glycine 0 CA--C 1.544 1.895 0 N-CA-C 117.629 1.811 . . . . 54.11 117.629 -169.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 103' ' ' PRO . . . . . 0.433 ' HD2' ' HD2' ' C' ' 78' ' ' PRO . 52.9 Cg_exo -58.49 -18.55 39.84 Favored 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 123.359 2.706 . . . . 62.02 114.41 179.408 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 104' ' ' GLY . . . . . 0.41 ' O ' ' HA2' ' C' ' 82' ' ' GLY . . . -105.35 -1.71 41.05 Favored Glycine 0 C--N 1.348 1.197 0 CA-C-O 119.501 -0.61 . . . . 43.23 113.814 179.106 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 105' ' ' LEU . . . . . 0.564 HD22 ' HZ ' ' C' ' 85' ' ' PHE . 15.3 mt . . . . . 0 N--CA 1.494 1.761 0 CA-C-N 119.284 1.542 . . . . 73.03 113.595 -175.194 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 116' ' ' GLY . . . . . 0.431 ' HA3' ' HB3' ' C' ' 171' ' ' PRO . . . . . . . . 0 C--O 1.24 0.518 0 N-CA-C 111.965 -0.454 . . . . 45.25 111.965 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 60.4 mtt180 -80.26 174.91 11.13 Favored 'General case' 0 C--O 1.247 0.947 0 N-CA-C 108.963 -0.755 . . . . 64.44 108.963 175.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.39 130.91 43.19 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-O 120.865 0.364 . . . . 75.42 110.293 174.667 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 119' ' ' LEU . . . . . . . . . . . . . 5.1 tt -90.47 137.35 32.43 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 105.15 -2.167 . . . . 75.21 105.15 -179.114 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.443 ' H ' ' HD2' ' C' ' 120' ' ' ARG . 0.0 OUTLIER -127.48 148.88 50.31 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 110.14 -0.318 . . . . 72.31 110.14 -172.765 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.27 118.56 6.84 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.525 -0.761 . . . . 63.21 109.45 177.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 122' ' ' GLU . . . . . 0.417 ' HA ' ' O ' ' C' ' 177' ' ' VAL . 38.5 tt0 -83.93 132.54 34.76 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 109.772 -0.455 . . . . 73.22 109.772 178.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 123' ' ' LEU . . . . . 0.457 HD13 ' HB2' ' B' ' 183' ' ' ALA . 2.6 pt? -144.69 129.88 9.38 Favored Pre-proline 0 N--CA 1.481 1.1 0 C-N-CA 122.646 0.378 . . . . 73.3 110.185 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 124' ' ' PRO . . . . . 0.478 ' HA ' ' O ' ' C' ' 179' ' ' ARG . 17.3 Cg_exo -72.14 124.83 10.33 Favored 'Trans proline' 0 C--N 1.366 1.452 0 C-N-CA 122.218 1.945 . . . . 72.51 111.281 165.105 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 125' ' ' LEU . . . . . . . . . . . . . 38.0 tp -142.64 155.05 44.89 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.199 1.0 . . . . 74.03 109.015 -170.027 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 126' ' ' THR . . . . . 0.587 ' HB ' ' HG2' ' C' ' 129' ' ' GLU . 1.8 m -101.45 158.04 16.36 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 122.965 0.506 . . . . 61.53 110.289 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 127' ' ' LEU . . . . . 0.565 HD21 HD13 ' C' ' 180' ' ' LEU . 56.1 mt -64.45 -44.69 90.33 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.581 1.153 . . . . 62.25 110.92 178.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -59.93 -36.98 78.19 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 114.954 -1.021 . . . . 75.24 110.505 175.227 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 129' ' ' GLU . . . . . 0.587 ' HG2' ' HB ' ' C' ' 126' ' ' THR . 6.8 mm-40 -78.54 -22.08 47.81 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.105 0.562 . . . . 73.53 111.401 -179.59 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -73.79 -31.68 63.39 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 121.118 0.485 . . . . 64.34 109.935 174.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 131' ' ' PHE . . . . . 0.421 ' CZ ' ' HB3' ' C' ' 216' ' ' GLU . 49.4 t80 -69.19 -46.84 66.5 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 114.575 -1.193 . . . . 75.55 110.186 167.655 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 132' ' ' HIS . . . . . . . . . . . . . 28.1 m170 -78.03 -6.32 54.17 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.152 0.581 . . . . 60.22 111.608 -176.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -55.45 -94.29 0.01 OUTLIER Glycine 0 C--N 1.355 1.631 0 O-C-N 123.977 0.798 . . . . 65.31 113.259 175.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . 55.06 -137.0 45.1 Favored Glycine 0 C--N 1.355 1.636 0 CA-C-N 117.306 0.553 . . . . 53.24 112.799 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 135' ' ' GLU . . . . . 0.499 ' HG3' ' HB2' ' C' ' 148' ' ' ARG . 2.5 mp0 -76.29 96.4 3.96 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 108.839 -0.8 . . . . 71.2 108.839 172.721 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 136' ' ' ARG . . . . . 0.515 ' HA ' ' HE ' ' C' ' 136' ' ' ARG . 2.4 tpm_? -140.43 160.2 40.52 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-O 120.842 0.353 . . . . 72.12 110.296 -175.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 137' ' ' VAL . . . . . . . . . . . . . 19.9 m -74.73 96.19 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.191 0 CA-C-O 122.249 1.023 . . . . 71.12 111.741 -177.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 138' ' ' VAL . . . . . . . . . . . . . 42.8 t -90.36 136.54 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 114.621 -1.172 . . . . 72.14 108.758 172.484 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 139' ' ' GLU . . . . . 0.487 ' HA ' ' O ' ' C' ' 143' ' ' ARG . 1.4 tm-20 -124.09 115.89 21.89 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 108.165 -1.05 . . . . 74.31 108.165 174.286 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 140' ' ' VAL . . . . . . . . . . . . . 66.8 t -137.64 109.13 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 124.187 0.995 . . . . 63.22 109.148 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 63.59 25.75 14.45 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.265 1.026 . . . . 15.23 113.186 173.321 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 108.68 -8.24 34.29 Favored Glycine 0 N--CA 1.473 1.153 0 CA-C-N 116.666 -0.243 . . . . 45.25 113.006 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 143' ' ' ARG . . . . . 0.705 HH12 ' HA ' ' C' ' 164' ' ' MET . 27.4 mmm-85 -87.85 95.98 10.3 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.135 0.574 . . . . 73.04 110.718 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 47.1 ttp180 -96.9 98.84 10.44 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 108.631 -0.878 . . . . 71.51 108.631 175.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 145' ' ' VAL . . . . . 0.536 HG21 ' NH2' ' C' ' 143' ' ' ARG . 69.8 t -132.38 133.09 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.061 0.944 . . . . 75.03 110.525 -169.228 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 15.7 m -85.59 85.03 7.44 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 108.455 -0.943 . . . . 54.21 108.455 170.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 147' ' ' VAL . . . . . 0.404 ' HB ' HG12 ' C' ' 145' ' ' VAL . 10.4 p -118.54 145.35 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 123.232 0.613 . . . . 72.53 110.428 -171.159 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 148' ' ' ARG . . . . . 0.499 ' HB2' ' HG3' ' C' ' 135' ' ' GLU . 42.3 ttm180 -78.25 105.76 9.7 Favored 'General case' 0 C--N 1.348 0.518 0 N-CA-C 108.468 -0.938 . . . . 74.22 108.468 169.409 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 149' ' ' ILE . . . . . 0.633 HD12 HG21 ' C' ' 159' ' ' ILE . 6.9 pt -80.82 152.71 72.33 Favored Pre-proline 0 C--O 1.246 0.869 0 N-CA-C 107.299 -1.371 . . . . 71.41 107.299 165.048 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -39.79 108.91 0.08 OUTLIER 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 122.828 2.352 . . . . 61.44 112.12 168.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -63.98 107.91 0.85 Allowed 'Trans proline' 0 C--N 1.382 2.32 0 C-N-CA 122.928 2.419 . . . . 73.2 110.662 -176.152 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 152' ' ' GLY . . . . . . . . . . . . . . . 105.11 137.61 9.11 Favored Glycine 0 C--N 1.34 0.803 0 CA-C-N 115.837 -0.62 . . . . 54.32 113.955 -170.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 153' ' ' VAL . . . . . 0.704 HG21 HG21 ' C' ' 178' ' ' VAL . 1.9 m -134.57 171.84 17.13 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.192 0 C-N-CA 123.029 0.532 . . . . 71.13 110.922 -175.604 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 154' ' ' ARG . . . . . . . . . . . . . 8.7 mtp180 -135.34 145.06 47.03 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.176 0.99 . . . . 75.32 108.906 -174.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 155' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -56.17 126.07 24.51 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 118.601 0.637 . . . . 74.51 111.766 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 60.84 24.04 62.01 Favored Glycine 0 C--N 1.351 1.364 0 CA-C-N 115.305 -0.861 . . . . 64.51 114.01 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 157' ' ' SER . . . . . . . . . . . . . 37.7 m -107.91 163.59 13.0 Favored 'General case' 0 C--O 1.246 0.87 0 CA-C-O 121.209 0.528 . . . . 75.43 110.275 178.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 20.7 m -102.67 110.42 29.3 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 CA-C-N 114.997 -1.001 . . . . 64.44 110.528 -174.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 159' ' ' ILE . . . . . 0.633 HG21 HD12 ' C' ' 149' ' ' ILE . 7.4 mt -71.51 97.9 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.791 0 N-CA-C 108.251 -1.018 . . . . 52.25 108.251 172.047 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 160' ' ' ARG . . . . . 0.456 ' HA ' ' O ' ' C' ' 174' ' ' LEU . 15.3 ttp180 -79.62 102.63 9.02 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.591 -0.732 . . . . 72.21 110.572 -177.565 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 161' ' ' VAL . . . . . 0.645 HG22 ' HB3' ' C' ' 174' ' ' LEU . 0.7 OUTLIER -109.2 130.34 22.86 Favored Pre-proline 0 CA--C 1.548 0.892 0 N-CA-C 108.221 -1.029 . . . . 75.24 108.221 178.05 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -76.67 147.35 27.81 Favored 'Trans proline' 0 C--N 1.369 1.617 0 C-N-CA 122.528 2.152 . . . . 63.42 111.014 169.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 163' ' ' GLY . . . . . 0.521 ' HA2' ' OG ' ' C' ' 86' ' ' SER . . . 112.53 24.88 4.84 Favored Glycine 0 N--CA 1.47 0.917 0 CA-C-O 119.38 -0.678 . . . . 53.31 114.015 174.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 164' ' ' MET . . . . . 0.705 ' HA ' HH12 ' C' ' 143' ' ' ARG . 26.4 mmt -130.2 -79.75 0.54 Allowed 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 118.002 0.901 . . . . 73.35 110.769 -179.005 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 165' ' ' GLY . . . . . 0.611 ' H ' ' HA ' ' C' ' 173' ' ' ASP . . . 84.13 139.36 4.12 Favored Glycine 0 C--N 1.349 1.3 0 N-CA-C 114.033 0.373 . . . . 64.24 114.033 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . -76.37 -170.93 31.9 Favored Glycine 0 C--N 1.363 2.045 0 CA-C-N 117.213 0.507 . . . . 75.44 112.5 167.1 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 167' ' ' GLN . . . . . 0.607 ' HA ' HE21 ' C' ' 167' ' ' GLN . 0.0 OUTLIER -77.08 105.78 8.38 Favored 'General case' 0 N--CA 1.479 0.982 0 O-C-N 122.18 -0.6 . . . . 64.31 111.841 -174.192 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . 149.85 171.38 18.25 Favored Glycine 0 C--N 1.346 1.138 0 CA-C-O 121.492 0.496 . . . . 13.44 113.713 177.295 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 169' ' ' ASN . . . . . 0.503 ' HB3' ' HD2' ' C' ' 170' ' ' PRO . 1.0 OUTLIER -60.2 158.98 24.33 Favored Pre-proline 0 CA--C 1.559 1.317 0 C-N-CA 126.642 1.977 . . . . 62.44 109.498 175.537 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 170' ' ' PRO . . . . . 0.503 ' HD2' ' HB3' ' C' ' 169' ' ' ASN . 6.5 Cg_exo -0.05 75.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.403 3.415 1 C-N-CA 126.326 4.684 . . . . 51.41 115.511 -162.054 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 171' ' ' PRO . . . . . 0.522 ' HD2' ' O ' ' C' ' 85' ' ' PHE . 93.9 Cg_endo -81.97 176.54 8.18 Favored 'Trans proline' 0 C--N 1.37 1.708 0 C-N-CA 123.065 2.51 . . . . 74.02 114.965 -165.654 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 172' ' ' GLY . . . . . 0.436 ' O ' ' HA2' ' C' ' 165' ' ' GLY . . . -95.49 127.82 9.29 Favored Glycine 0 C--N 1.342 0.882 0 CA-C-N 114.247 -1.342 . . . . 74.42 110.118 -178.038 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 173' ' ' ASP . . . . . 0.611 ' HA ' ' H ' ' C' ' 165' ' ' GLY . 50.0 m-20 -72.85 -162.05 0.1 Allowed 'General case' 0 CA--C 1.555 1.15 0 N-CA-C 114.038 1.125 . . . . 74.51 114.038 -169.113 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 174' ' ' LEU . . . . . 0.645 ' HB3' HG22 ' C' ' 161' ' ' VAL . 38.2 tp -87.99 142.29 27.91 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 112.621 0.6 . . . . 75.22 112.621 -164.55 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 49.8 mt -129.21 95.23 3.99 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.681 1.592 . . . . 71.32 107.95 177.4 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 176' ' ' LEU . . . . . 0.582 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 95.4 mt -82.24 109.04 16.16 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 110.037 -0.357 . . . . 43.02 110.037 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 177' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' C' ' 122' ' ' GLU . 57.8 t -83.52 95.63 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 107.657 -1.238 . . . . 74.43 107.657 -179.057 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 178' ' ' VAL . . . . . 0.704 HG21 HG21 ' C' ' 153' ' ' VAL . 3.3 p -87.26 140.19 16.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 121.342 0.591 . . . . 74.01 112.117 -172.129 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 179' ' ' ARG . . . . . 0.478 ' O ' ' HA ' ' C' ' 124' ' ' PRO . 36.7 mmt180 -117.65 105.5 12.1 Favored 'General case' 0 C--N 1.342 0.276 0 C-N-CA 124.939 1.296 . . . . 72.33 107.872 177.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 180' ' ' LEU . . . . . 0.565 HD13 HD21 ' C' ' 127' ' ' LEU . 96.2 mt -73.45 143.02 46.84 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 122.547 0.339 . . . . 70.51 111.47 -175.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 181' ' ' LEU . . . . . . . . . . . . . 16.8 mt -61.19 166.86 4.47 Favored Pre-proline 0 CA--C 1.56 1.359 0 C-N-CA 124.66 1.184 . . . . 74.2 112.27 -178.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 99.4 Cg_exo -52.71 12.59 0.02 OUTLIER 'Trans proline' 0 C--N 1.39 2.755 0 C-N-CA 124.305 3.337 . . . . 64.12 118.361 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 183' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -129.38 74.24 81.08 Favored Pre-proline 0 CA--C 1.564 1.51 0 CA-C-N 119.069 0.85 . . . . 62.13 108.779 163.349 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 184' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -86.43 66.08 4.9 Favored 'Trans proline' 0 C--N 1.378 2.091 0 C-N-CA 123.099 2.532 . . . . 71.54 110.484 178.58 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 185' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 26.2 t -91.47 -45.25 14.53 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.552 0 CA-C-N 115.623 -0.717 . . . . 72.23 109.331 -166.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 186' ' ' PHE . . . . . 0.491 ' HB3' HD13 ' C' ' 193' ' ' LEU . 42.8 m-85 -103.95 101.45 11.23 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.534 0.734 . . . . 61.44 110.058 -173.015 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 187' ' ' ARG . . . . . . . . . . . . . 18.1 ttt180 -103.61 129.51 50.89 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.403 0.681 . . . . 75.14 109.298 -177.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 188' ' ' LEU . . . . . 0.557 HD13 ' HD2' ' C' ' 240' ' ' PHE . 53.7 tp -79.93 144.73 33.1 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 112.421 0.526 . . . . 74.14 112.421 -173.583 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -143.75 116.75 8.86 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 107.176 -1.416 . . . . 71.33 107.176 163.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 63.1 -97.08 0.18 Allowed Glycine 0 C--N 1.345 1.075 0 N-CA-C 111.436 -0.666 . . . . 74.2 111.436 -172.076 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 191' ' ' GLN . . . . . 0.421 ' HA ' HD11 ' C' ' 188' ' ' LEU . 45.8 mt-30 -129.01 -10.34 4.82 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.992 0.917 . . . . 60.21 110.675 171.051 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 192' ' ' ASP . . . . . 0.413 ' O ' HD12 ' C' ' 188' ' ' LEU . 22.2 m-20 -82.86 161.91 21.77 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.706 0.802 . . . . 65.13 110.448 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 193' ' ' LEU . . . . . 0.619 HD21 ' CD2' ' C' ' 240' ' ' PHE . 79.6 mt -123.03 161.33 24.5 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 122.885 0.474 . . . . 52.2 111.901 -176.619 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 194' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -124.27 128.99 49.98 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 107.824 -1.176 . . . . 75.43 107.824 168.317 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 195' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' C' ' 185' ' ' VAL . . . -136.33 -176.65 4.4 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.576 1.15 . . . . 65.11 109.305 -177.612 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 87.9 m -137.98 119.93 15.42 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 108.594 -0.891 . . . . 51.32 108.594 171.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 197' ' ' LEU . . . . . . . . . . . . . 55.8 tp -96.66 124.1 40.55 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.066 0.546 . . . . 73.5 110.606 -175.031 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -77.75 104.59 8.39 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.42 1.088 . . . . 44.52 109.64 179.516 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 199' ' ' VAL . . . . . 0.577 HG22 HG21 ' C' ' 210' ' ' VAL . 41.1 t -121.53 120.4 28.84 Favored Pre-proline 0 N--CA 1.481 1.105 0 C-N-CA 124.413 1.085 . . . . 61.21 109.196 -178.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 200' ' ' PRO . . . . . 0.504 ' HG2' HD12 ' C' ' 203' ' ' ILE . 12.9 Cg_exo -66.3 150.53 84.6 Favored 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 122.534 2.156 . . . . 71.34 112.12 173.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 201' ' ' ALA . . . . . . . . . . . . . . . -57.09 -48.42 97.44 Favored Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 123.746 0.819 . . . . 74.35 113.068 178.272 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 202' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -57.13 -49.34 14.42 Favored 'Trans proline' 0 C--N 1.383 2.369 0 C-N-CA 121.631 1.554 . . . . 63.15 112.856 175.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 203' ' ' ILE . . . . . 0.504 HD12 ' HG2' ' C' ' 200' ' ' PRO . 27.2 mt -63.11 -29.53 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 123.276 0.631 . . . . 63.4 111.055 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -74.45 -36.59 63.36 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.612 0.765 . . . . 75.02 112.217 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 205' ' ' VAL . . . . . . . . . . . . . 69.1 t -76.73 -41.15 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 122.909 0.483 . . . . 63.41 111.984 -179.408 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 206' ' ' VAL . . . . . 0.619 HG23 ' HE3' ' A' ' 270' ' ' LYS . 12.4 p -90.88 -34.61 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 112.218 0.451 . . . . 52.12 112.218 -176.202 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 94.03 127.65 4.86 Favored Glycine 0 C--N 1.344 0.999 0 N-CA-C 111.644 -0.582 . . . . 63.21 111.644 -167.047 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -156.81 -131.18 1.32 Allowed Glycine 0 C--N 1.346 1.108 0 N-CA-C 111.042 -0.823 . . . . 51.32 111.042 177.52 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 209' ' ' LYS . . . . . 0.492 ' HG2' ' HA ' ' C' ' 222' ' ' ALA . 8.2 mtmp? -147.07 140.77 25.71 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.486 0.714 . . . . 72.12 111.072 173.132 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 210' ' ' VAL . . . . . 0.577 HG21 HG22 ' C' ' 199' ' ' VAL . 17.8 m -136.6 138.92 45.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 125.216 1.406 . . . . 62.05 108.32 172.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 211' ' ' ARG . . . . . . . . . . . . . 36.0 ttm180 -86.82 126.82 34.88 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.376 0.51 . . . . 72.44 112.376 -173.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 212' ' ' ALA . . . . . 0.503 ' HB3' HG13 ' C' ' 219' ' ' VAL . . . -92.56 114.84 27.5 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 123.97 0.908 . . . . 74.43 108.568 164.531 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 213' ' ' MET . . . . . . . . . . . . . 5.4 tmm? -77.31 105.8 8.65 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 107.895 -1.15 . . . . 63.12 107.895 175.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 214' ' ' THR . . . . . 0.526 ' OG1' HG12 ' C' ' 219' ' ' VAL . 0.2 OUTLIER -100.75 173.09 6.68 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.49 0.662 . . . . 54.24 110.594 -176.269 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 215' ' ' LEU . . . . . 0.408 HD13 ' CE1' ' C' ' 240' ' ' PHE . 25.9 mt -69.91 -26.72 64.29 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 114.488 -1.233 . . . . 44.41 112.836 -169.358 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 216' ' ' GLU . . . . . 0.421 ' HB3' ' CZ ' ' C' ' 131' ' ' PHE . 0.0 OUTLIER -111.52 8.69 21.13 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.206 1.002 . . . . 71.0 111.614 -178.985 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 137.92 172.67 12.63 Favored Glycine 0 C--N 1.341 0.833 0 CA-C-O 119.803 -0.443 . . . . 64.11 112.607 179.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -87.62 119.48 1.36 Allowed 'Trans proline' 0 CA--C 1.555 1.562 0 C-N-CA 123.178 2.586 . . . . 52.13 113.099 -174.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 219' ' ' VAL . . . . . 0.526 HG12 ' OG1' ' C' ' 214' ' ' THR . 3.8 p -98.71 115.4 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 108.961 -0.755 . . . . 52.53 108.961 173.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 220' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -80.99 106.6 13.12 Favored 'General case' 0 C--O 1.244 0.77 0 N-CA-C 108.716 -0.846 . . . . 72.32 108.716 178.253 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 221' ' ' VAL . . . . . 0.658 ' HA ' ' HB2' ' B' ' 239' ' ' ALA . 88.3 t -77.85 127.34 38.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 114.786 -1.097 . . . . 74.03 110.589 -176.396 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 222' ' ' ALA . . . . . 0.492 ' HA ' ' HG2' ' C' ' 209' ' ' LYS . . . -95.58 130.51 42.41 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.585 0.754 . . . . 73.3 111.099 177.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 94.8 t -108.35 140.31 21.62 Favored Pre-proline 0 CA--C 1.558 1.28 0 C-N-CA 125.328 1.451 . . . . 73.11 110.065 -173.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 224' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -89.47 168.59 5.0 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 123.556 2.838 . . . . 54.33 111.958 169.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -58.35 142.66 97.82 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.386 2.057 . . . . 74.0 112.428 170.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 226' ' ' ARG . . . . . . . . . . . . . 30.8 mmt-85 66.44 95.12 0.06 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.531 1.533 . . . . 70.15 111.073 -176.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 227' ' ' THR . . . . . 0.435 HG22 HG11 ' C' ' 253' ' ' VAL . 25.7 m -137.29 116.78 12.84 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.637 0.775 . . . . 70.3 111.32 173.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 228' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -101.8 155.88 17.86 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.842 0.857 . . . . 74.32 111.17 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 229' ' ' ALA . . . . . 0.484 ' HB2' ' H ' ' C' ' 255' ' ' ILE . . . -70.37 144.0 51.75 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 115.197 -0.91 . . . . 62.12 109.986 175.035 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 97.02 -11.85 65.75 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-O 119.2 -0.778 . . . . 62.04 113.024 -172.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 231' ' ' ARG . . . . . . . . . . . . . 54.9 mtt180 -69.37 174.34 4.93 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 118.348 1.074 . . . . 74.12 111.04 170.325 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 232' ' ' LYS . . . . . 0.425 ' HD3' ' HB3' ' C' ' 250' ' ' TYR . 28.0 ttmt -147.75 141.95 26.15 Favored 'General case' 0 C--N 1.355 0.819 0 CA-C-O 121.371 0.605 . . . . 71.45 112.222 -176.687 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 233' ' ' LEU . . . . . 0.539 ' O ' ' HA ' ' C' ' 250' ' ' TYR . 3.3 mp -114.63 154.53 28.21 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.945 1.298 . . . . 74.21 109.519 -179.24 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -122.95 120.72 34.23 Favored 'General case' 0 C--O 1.243 0.744 0 N-CA-C 109.19 -0.67 . . . . 72.34 109.19 167.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 44.5 mt -107.54 125.35 51.19 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.418 -0.956 . . . . 73.43 108.418 177.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -74.3 130.11 39.08 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.848 0.859 . . . . 71.55 112.192 -171.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 77.87 -0.69 71.03 Favored Glycine 0 C--N 1.35 1.336 0 CA-C-N 115.16 -0.927 . . . . 71.42 114.013 178.034 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -92.11 8.6 37.11 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.361 0.664 . . . . 72.03 112.06 -173.122 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -81.63 -168.29 40.5 Favored Glycine 0 C--N 1.349 1.303 0 N-CA-C 111.367 -0.693 . . . . 31.21 111.367 167.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 240' ' ' PHE . . . . . 0.619 ' CD2' HD21 ' C' ' 193' ' ' LEU . 18.4 m-85 -78.86 149.59 74.16 Favored Pre-proline 0 CA--C 1.558 1.287 0 CA-C-N 117.105 0.452 . . . . 75.14 110.249 178.019 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 241' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -82.65 142.18 11.38 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 123.492 2.794 . . . . 70.21 112.501 -173.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -132.63 165.06 23.91 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-O 119.422 -0.654 . . . . 70.14 112.69 -178.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -67.79 -1.81 7.48 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 123.527 2.818 . . . . 71.42 113.768 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -121.82 -15.45 7.88 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.657 0.783 . . . . 71.42 111.299 174.213 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 154.7 174.7 24.99 Favored Glycine 0 C--N 1.357 1.703 0 CA-C-O 120.16 -0.244 . . . . 51.32 113.474 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 246' ' ' ARG . . . . . . . . . . . . . 59.3 mtm180 -91.94 157.32 16.89 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 123.983 0.913 . . . . 61.31 111.049 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -85.38 -161.19 34.14 Favored Glycine 0 C--N 1.353 1.493 0 CA-C-O 120.137 -0.257 . . . . 63.23 113.705 176.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -127.41 136.47 51.89 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 117.458 0.629 . . . . 73.54 109.906 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 249' ' ' LEU . . . . . 0.447 HD11 ' HB2' ' C' ' 195' ' ' ALA . 31.0 tp -86.22 119.87 26.97 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.6 0.76 . . . . 74.23 110.59 -177.539 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 250' ' ' TYR . . . . . 0.539 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 14.3 m-85 -100.84 102.79 13.93 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 109.372 -0.603 . . . . 71.43 109.372 176.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 251' ' ' LEU . . . . . 0.435 ' HB2' HD13 ' C' ' 233' ' ' LEU . 1.3 mp -97.52 135.93 38.66 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.58 -0.896 . . . . 64.53 108.58 -178.668 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -98.17 121.07 39.64 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 108.906 -0.776 . . . . 73.41 108.906 175.35 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 253' ' ' VAL . . . . . 0.435 HG11 HG22 ' C' ' 227' ' ' THR . 92.0 t -58.48 138.32 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 124.403 1.081 . . . . 73.5 111.897 -176.325 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 254' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -131.72 109.06 9.9 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.22 1.008 . . . . 74.13 108.295 -178.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 255' ' ' ILE . . . . . 0.484 ' H ' ' HB2' ' C' ' 229' ' ' ALA . 41.4 mm -81.34 123.05 37.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 122.759 0.423 . . . . 75.24 110.186 179.321 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 256' ' ' THR . . . . . 0.431 ' O ' ' HA ' ' C' ' 200' ' ' PRO . 0.0 OUTLIER -125.79 151.78 46.29 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.157 1.383 . . . . 53.32 109.177 -179.565 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 2.8 pp -114.77 153.14 46.9 Favored Pre-proline 0 N--CA 1.49 1.532 0 C-N-CA 122.883 0.473 . . . . 64.54 111.137 -176.543 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 258' ' ' PRO . . . . . 0.554 ' HB3' ' HE2' ' A' ' 276' ' ' TYR . 37.7 Cg_endo -62.01 -2.9 3.28 Favored 'Trans proline' 0 C--N 1.385 2.46 0 C-N-CA 123.451 2.767 . . . . 73.21 115.119 -173.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 58.38 -83.33 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.111 1.364 . . . . 72.3 111.567 -173.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 260' ' ' ARG . . . . . 0.475 HH21 ' HB2' ' C' ' 258' ' ' PRO . 0.0 OUTLIER -66.41 158.09 30.24 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 122.878 0.471 . . . . 73.41 110.631 -177.178 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 261' ' ' LEU . . . . . 0.653 HD13 ' HA ' ' C' ' 266' ' ' GLU . 95.7 mt -145.96 130.86 18.15 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.542 -0.54 . . . . 71.21 109.542 175.381 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 58.3 p -82.84 154.69 67.97 Favored Pre-proline 0 N--CA 1.479 0.988 0 CA-C-O 117.264 -1.351 . . . . 61.23 107.729 170.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -34.66 -40.59 0.23 Allowed 'Trans proline' 0 N--CA 1.508 2.353 0 C-N-CA 124.314 3.343 . . . . 74.2 116.52 -175.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -76.58 -54.95 5.99 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.83 0.452 . . . . 71.04 110.963 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 265' ' ' GLU . . . . . 0.469 ' HB3' HD22 ' C' ' 261' ' ' LEU . 16.0 mm-40 -44.56 -51.88 8.55 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 124.1 0.875 . . . . 65.11 109.84 173.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 266' ' ' GLU . . . . . 0.653 ' HA ' HD13 ' C' ' 261' ' ' LEU . 7.9 tp10 -48.82 -60.29 2.86 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 112.856 -1.974 . . . . 64.21 111.007 176.26 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -53.23 -43.43 67.29 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 124.131 0.894 . . . . 70.32 112.92 -175.195 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 268' ' ' LEU . . . . . 0.418 ' O ' ' HG ' ' C' ' 272' ' ' LEU . 10.5 mp -65.13 -54.12 34.63 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 116.564 -0.289 . . . . 52.44 111.123 179.286 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 93.3 m95 -60.36 -31.51 70.41 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 111.76 0.281 . . . . 61.11 111.76 178.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 270' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' C' ' 266' ' ' GLU . 4.5 mmmp? -61.4 -52.63 63.81 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.483 0.713 . . . . 75.43 109.801 176.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 42.3 mtpt -59.8 -38.9 83.25 Favored 'General case' 0 N--CA 1.481 1.102 0 O-C-N 123.858 0.724 . . . . 75.33 111.848 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 272' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' C' ' 268' ' ' LEU . 78.1 mt -63.0 -41.88 99.7 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 123.823 0.702 . . . . 74.33 111.174 178.473 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -71.81 -41.13 68.61 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 115.599 -0.728 . . . . 34.13 112.257 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -67.84 -34.07 76.0 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.263 0.625 . . . . 63.21 110.084 179.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -62.87 -37.53 87.24 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 114.974 -1.012 . . . . 70.04 110.451 172.103 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 276' ' ' TYR . . . . . 0.539 ' HE1' ' HB3' ' A' ' 258' ' ' PRO . 0.2 OUTLIER -66.72 -44.84 80.54 Favored 'General case' 0 CA--C 1.554 1.107 0 CA-C-N 115.184 -0.916 . . . . 75.52 111.612 173.903 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -69.04 -22.61 64.04 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 122.707 0.403 . . . . 44.24 110.15 -178.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -69.49 0.34 5.4 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.982 0.913 . . . . 55.2 113.012 175.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 279' ' ' ARG . . . . . . . . . . . . . 73.3 mtm180 -82.24 -31.25 30.31 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 117.945 0.339 . . . . 71.52 110.335 168.104 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.98 0 C-N-CA 123.763 0.825 . . . . 75.14 109.246 -177.252 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.416 ' HE2' ' HD2' ' A' ' 69' ' ' TYR . 40.9 ttmt . . . . . 0 N--CA 1.483 1.224 0 N-CA-C 113.255 0.835 . . . . 62.43 113.255 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.411 ' HE2' HD11 ' A' ' 10' ' ' ILE . 49.5 mtpt -80.93 120.17 24.4 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 108.061 -1.088 . . . . 74.32 108.061 168.089 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -71.22 94.92 1.21 Allowed 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 108.23 -1.026 . . . . 61.41 108.23 178.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -63.39 -28.7 70.17 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 114.513 -1.221 . . . . 73.34 112.016 -172.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -67.01 -43.48 82.79 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 122.888 0.475 . . . . 73.33 110.14 176.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.05 -43.66 98.0 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 123.65 0.594 . . . . 60.32 110.467 177.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.411 HD11 ' HE2' ' A' ' 5' ' ' LYS . 65.8 mt -57.4 -40.62 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 123.917 0.761 . . . . 74.23 110.662 176.619 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 87.2 mt -79.4 -21.09 46.11 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 112.448 0.536 . . . . 51.33 112.448 177.321 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.62 49.59 8.91 Favored Glycine 0 CA--C 1.539 1.56 0 CA-C-N 117.688 0.222 . . . . 53.33 113.35 -175.2 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.547 HG13 ' HB2' ' A' ' 25' ' ' ALA . 3.4 m -134.25 161.45 63.64 Favored Pre-proline 0 N--CA 1.491 1.602 0 C-N-CA 125.226 1.41 . . . . 71.43 109.581 175.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -46.73 147.76 4.31 Favored 'Trans proline' 0 C--N 1.392 2.862 0 C-N-CA 123.104 2.536 . . . . 50.12 113.032 173.269 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 61.7 mtp180 -80.88 27.32 0.39 Allowed 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 113.359 0.874 . . . . 75.43 113.359 -166.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -161.08 20.74 0.13 Allowed 'General case' 0 CA--C 1.559 1.319 0 C-N-CA 124.894 1.278 . . . . 64.11 108.646 172.163 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.58 147.25 51.95 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.762 1.225 . . . . 64.31 112.731 -171.186 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.2 p -79.89 176.95 9.27 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.806 0.843 . . . . 71.11 112.658 -175.216 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -52.2 -47.09 65.79 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.492 1.517 . . . . 64.21 113.09 -172.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.453 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 17.2 tp10 -75.42 -28.16 59.27 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 111.656 0.243 . . . . 72.43 111.656 -174.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -65.81 -46.78 77.36 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 121.031 0.443 . . . . 64.03 109.973 174.175 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.628 HG12 ' HB3' ' A' ' 57' ' ' LEU . 1.7 mp -61.33 -36.39 72.57 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 CA-C-N 114.632 -1.167 . . . . 73.31 110.912 174.595 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.494 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 1.6 tppp? -63.12 -47.98 80.48 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.937 0.895 . . . . 71.24 109.639 179.376 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 20' ' ' GLU . 52.8 mtm180 -67.76 -38.22 83.16 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.166 0.987 . . . . 54.12 111.424 -177.328 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.547 ' HB2' HG13 ' A' ' 13' ' ' VAL . . . -61.72 -43.88 98.01 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.725 0.81 . . . . 64.0 110.49 176.649 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -59.07 -49.24 78.65 Favored 'General case' 0 C--O 1.202 -1.404 0 CA-C-N 114.335 -1.302 . . . . 73.1 110.238 174.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 88.2 mttt -52.63 -50.33 63.35 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.732 0.813 . . . . 74.22 110.854 -178.581 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 54.1 ttp180 -55.8 -55.88 27.11 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 114.501 -1.227 . . . . 71.15 111.571 178.121 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.614 ' HB3' HD13 ' A' ' 50' ' ' ILE . 96.8 mt -76.64 -18.97 58.28 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.476 0.711 . . . . 74.11 112.527 -174.549 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -86.33 -29.16 23.21 Favored 'General case' 0 C--O 1.211 -0.93 0 C-N-CA 123.134 0.574 . . . . 63.3 110.153 -178.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 45.7 mtp180 -83.94 -35.01 24.33 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 122.446 0.298 . . . . 72.33 110.397 173.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -71.79 -45.49 61.42 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.332 0.653 . . . . 63.33 110.72 -179.563 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -107.56 35.98 2.89 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.516 0.726 . . . . 63.25 109.829 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -66.11 114.72 17.88 Favored Pre-proline 0 N--CA 1.476 0.866 0 N-CA-C 108.63 -0.878 . . . . 63.41 108.63 178.484 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.404 ' O ' ' HG2' ' A' ' 39' ' ' LYS . 32.1 Cg_exo -58.04 -15.2 21.64 Favored 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 123.249 2.633 . . . . 74.13 114.564 -168.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -94.66 -32.1 13.54 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.814 0.846 . . . . 72.45 111.882 177.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 99.3 t -85.46 -59.97 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 CA-C-O 121.679 0.752 . . . . 65.53 109.084 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -98.7 75.64 2.15 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 114.507 -1.224 . . . . 61.35 108.745 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.404 ' HG2' ' O ' ' A' ' 35' ' ' PRO . 45.4 mtmt -78.04 79.6 4.49 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 114.538 -1.21 . . . . 73.11 108.891 177.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.2 m -131.59 125.62 20.66 Favored Pre-proline 0 N--CA 1.471 0.623 0 N-CA-C 108.812 -0.811 . . . . 54.41 108.812 176.094 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -43.09 -45.73 9.33 Favored 'Trans proline' 0 C--N 1.383 2.392 0 C-N-CA 123.498 2.798 . . . . 72.23 113.281 171.567 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -51.27 -47.53 62.47 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.893 1.277 . . . . 64.43 111.194 174.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.23 -23.67 62.05 Favored 'General case' 0 C--N 1.35 0.623 0 CA-C-N 114.498 -1.228 . . . . 72.14 111.13 -177.036 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.457 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 46.9 mt-10 -78.82 -41.27 30.64 Favored 'General case' 0 C--N 1.359 0.989 0 O-C-N 123.623 0.577 . . . . 62.01 109.651 -178.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -64.58 -46.89 80.79 Favored 'General case' 0 C--O 1.251 1.174 0 C-N-CA 124.25 1.02 . . . . 62.44 110.622 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -61.9 -44.0 97.69 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 114.951 -1.022 . . . . 74.03 110.087 173.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -61.56 -31.36 71.39 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.717 0.807 . . . . 73.24 110.867 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' A' ' 44' ' ' GLU . 33.0 mmtp -65.16 -50.64 65.18 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.072 0.549 . . . . 75.14 109.993 175.642 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -64.51 -29.88 70.91 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 123.247 0.342 . . . . 71.44 111.56 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.614 HD13 ' HB3' ' A' ' 29' ' ' LEU . 84.6 mt -74.1 -31.89 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.577 1.151 . . . . 70.53 110.208 175.34 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -72.59 -36.64 68.19 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.579 0.752 . . . . 73.43 110.522 175.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -66.88 -49.46 65.58 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.286 1.034 . . . . 63.42 109.976 176.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.1 -52.06 66.98 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 114.558 -1.201 . . . . 65.45 111.138 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -63.52 -33.65 76.04 Favored 'General case' 0 C--O 1.209 -1.026 0 CA-C-N 115.166 -0.924 . . . . 72.32 110.615 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.54 -56.46 20.99 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.798 0.439 . . . . 53.01 110.861 177.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.415 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 48.5 t -66.28 -33.42 63.43 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 CA-C-N 114.595 -1.184 . . . . 74.52 111.303 -176.271 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.628 ' HB3' HG12 ' A' ' 22' ' ' ILE . 75.4 mt -102.38 -5.02 24.63 Favored 'General case' 0 CA--C 1.555 1.163 0 N-CA-C 114.416 1.265 . . . . 62.04 114.416 -172.295 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 34.8 t -75.03 -56.82 4.36 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 118.497 0.59 . . . . 74.34 109.916 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.5 ' HB2' ' HE3' ' A' ' 62' ' ' LYS . 12.9 m-20 -80.62 127.38 75.67 Favored Pre-proline 0 C--O 1.255 1.35 0 CA-C-N 115.372 -0.831 . . . . 74.34 110.041 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.464 ' O ' ' HG2' ' A' ' 64' ' ' ARG . 64.6 Cg_exo -53.11 -26.43 32.93 Favored 'Trans proline' 0 C--N 1.387 2.575 0 C-N-CA 123.57 2.847 . . . . 72.41 113.02 177.091 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -54.13 -65.72 0.52 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.006 1.322 . . . . 72.3 111.688 174.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.58 ' HE2' ' HB3' ' A' ' 84' ' ' ASP . 21.9 mttt -72.08 -26.14 62.04 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 115.667 -0.697 . . . . 74.54 110.117 -173.752 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.6 tpt180 -55.34 -51.34 67.1 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 124.015 0.822 . . . . 74.11 109.802 168.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.464 ' HG2' ' O ' ' A' ' 60' ' ' PRO . 1.7 mmp_? -63.67 -36.56 84.24 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.889 0.476 . . . . 74.25 111.392 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.622 HD11 ' HG3' ' A' ' 79' ' ' PRO . 79.5 mt -60.73 -40.19 84.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 123.753 0.658 . . . . 64.42 110.535 175.009 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -69.18 -41.83 76.66 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.827 -0.624 . . . . 75.4 109.462 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -61.36 -43.09 99.46 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.222 0.609 . . . . 64.04 110.899 177.221 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 50.9 p -72.07 -20.44 61.66 Favored 'General case' 0 C--N 1.348 0.537 0 CA-C-N 115.701 -0.682 . . . . 75.13 110.653 177.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.416 ' HD2' ' HE2' ' A' ' 4' ' ' LYS . 46.2 t80 -86.01 101.18 12.69 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 108.243 -1.021 . . . . 63.45 108.243 173.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 115.2 17.63 6.63 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.894 -0.882 . . . . 52.54 110.894 -166.159 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 90.6 m -142.17 -61.39 0.45 Allowed 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 103.822 -2.659 . . . . 71.23 103.822 173.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 50.9 m -79.92 146.35 32.17 Favored 'General case' 0 C--O 1.251 1.178 0 N-CA-C 105.032 -2.211 . . . . 74.23 105.032 157.219 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.36 -39.85 10.26 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.025 0.53 . . . . 74.04 111.375 -177.163 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.47 155.9 56.65 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 123.633 0.773 . . . . 75.1 110.528 -176.047 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -57.08 119.71 7.14 Favored 'Trans proline' 0 C--N 1.384 2.4 0 C-N-CA 122.673 2.249 . . . . 75.41 111.266 175.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.45 155.99 23.53 Favored 'Trans proline' 0 C--N 1.384 2.431 0 C-N-CA 122.909 2.406 . . . . 74.25 112.841 178.195 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -56.12 135.45 69.93 Favored 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 122.512 2.141 . . . . 62.44 111.123 174.169 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -42.61 118.69 1.2 Allowed 'Trans proline' 0 C--N 1.383 2.36 0 C-N-CA 123.687 2.925 . . . . 43.51 113.821 177.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.622 ' HG3' HD11 ' A' ' 65' ' ' ILE . 52.2 Cg_endo -62.31 166.58 12.7 Favored 'Trans proline' 0 C--N 1.383 2.391 0 C-N-CA 123.723 2.949 . . . . 71.05 112.342 -176.337 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -49.45 83.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.398 3.155 0 C-N-CA 124.095 3.197 . . . . 51.35 114.007 -175.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 136.26 -61.81 0.61 Allowed Glycine 0 N--CA 1.445 -0.701 0 CA-C-N 113.905 -1.498 . . . . 62.41 109.551 -176.175 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.407 ' O ' ' HG2' ' A' ' 79' ' ' PRO . . . 144.86 -157.75 27.39 Favored Glycine 0 N--CA 1.468 0.812 0 N-CA-C 110.579 -1.008 . . . . 53.03 110.579 -169.612 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.407 ' HE1' HD13 ' A' ' 65' ' ' ILE . 96.3 m-85 -105.1 106.54 17.08 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.489 0.716 . . . . 74.41 109.884 -177.061 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.58 ' HB3' ' HE2' ' A' ' 62' ' ' LYS . 5.0 t70 -78.98 138.59 38.12 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.298 1.039 . . . . 71.31 112.313 -177.469 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -136.59 68.98 1.42 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.802 0.841 . . . . 70.22 109.812 170.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 59.0 m -53.32 94.71 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 125.104 1.362 . . . . 74.44 113.766 -176.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.34 9.14 63.76 Favored Glycine 0 C--N 1.352 1.436 0 CA-C-N 115.901 -0.591 . . . . 70.11 114.144 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -96.23 130.59 43.27 Favored 'General case' 0 C--O 1.241 0.63 0 N-CA-C 107.71 -1.218 . . . . 72.34 107.71 -179.387 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -75.32 81.56 2.42 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 121.668 0.747 . . . . 71.44 111.134 -171.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.568 HG23 ' HZ ' ' A' ' 97' ' ' PHE . 0.9 OUTLIER -40.02 -41.19 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 126.633 1.973 . . . . 75.21 112.4 171.66 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -69.51 -5.85 26.84 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.328 1.051 . . . . 75.33 113.167 -172.119 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -115.45 -12.08 11.74 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.997 0.519 . . . . 45.35 111.753 -177.062 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 20.8 m-30 -85.53 168.57 14.39 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 112.919 0.711 . . . . 71.01 112.919 -167.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 98.7 p -65.69 168.51 7.59 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 124.919 1.288 . . . . 74.5 114.233 -164.033 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.24 -35.9 82.34 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 115.308 -0.86 . . . . 74.31 111.148 174.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -58.29 -47.08 84.79 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.96 0.904 . . . . 75.03 109.901 177.067 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.568 ' HZ ' HG23 ' A' ' 90' ' ' VAL . 5.3 t80 -56.94 -52.28 65.83 Favored 'General case' 0 CA--C 1.554 1.126 0 O-C-N 124.348 1.03 . . . . 63.23 110.114 172.226 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -65.59 -17.23 64.43 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 112.81 0.67 . . . . 73.05 112.81 -173.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -99.9 -36.5 9.38 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 112.93 0.715 . . . . 70.02 112.93 178.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 50.6 tp -78.23 -41.91 32.82 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-O 121.392 0.615 . . . . 55.03 110.355 -179.183 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -97.18 -24.88 15.51 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.213 1.005 . . . . 72.11 111.278 -175.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -44.17 -56.13 5.47 Favored Glycine 0 CA--C 1.545 1.958 0 CA-C-O 118.807 -0.996 . . . . 72.43 115.193 -178.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_exo -47.32 -25.8 5.13 Favored 'Trans proline' 0 C--N 1.391 2.769 0 C-N-CA 124.039 3.16 . . . . 23.1 115.53 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -133.11 28.96 3.27 Favored Glycine 0 C--N 1.354 1.581 0 CA-C-O 119.53 -0.594 . . . . 44.4 113.427 -177.383 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 44.6 mt -72.19 72.25 0.9 Allowed 'General case' 0 CA--C 1.563 1.477 0 CA-C-N 117.316 0.558 . . . . 74.25 112.151 170.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 11.8 p90 32.4 -130.76 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 127.27 2.228 . . . . 72.25 116.199 163.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.443 ' HA2' ' H ' ' A' ' 169' ' ' ASN . . . 92.2 36.36 6.32 Favored Glycine 0 C--N 1.354 1.541 0 N-CA-C 111.49 -0.644 . . . . 44.0 111.49 -165.683 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.359 1.838 0 CA-C-O 121.434 0.463 . . . . 71.34 112.847 167.84 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 48.6 tptt . . . . . 0 N--CA 1.505 2.284 0 N-CA-C 115.85 1.796 . . . . 72.15 115.85 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.714 ' H ' ' HA3' ' A' ' 172' ' ' GLY . . . -121.29 -155.56 9.53 Favored Glycine 0 CA--C 1.548 2.152 0 C-N-CA 127.317 2.389 . . . . 55.22 112.76 162.692 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.437 ' H ' ' HA ' ' A' ' 171' ' ' PRO . 0.0 OUTLIER -67.06 143.46 56.7 Favored 'General case' 0 C--O 1.285 2.97 0 N-CA-C 116.361 1.985 . . . . 71.34 116.361 178.926 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.598 ' HA ' ' O ' ' A' ' 173' ' ' ASP . 14.8 p-10 -76.16 104.57 6.75 Favored 'General case' 0 CA--C 1.552 1.052 0 CA-C-N 112.175 -2.284 . . . . 74.23 113.151 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.462 ' O ' HD12 ' A' ' 174' ' ' LEU . 6.4 tt -93.37 165.36 12.82 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.1 1.36 . . . . 70.23 107.556 174.122 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 30.4 ttp85 -112.66 130.82 55.91 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 118.503 0.592 . . . . 74.51 110.127 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.641 ' HB3' HD11 ' A' ' 174' ' ' LEU . . . -146.33 176.54 9.69 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.998 0.919 . . . . 41.51 110.886 -175.668 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -107.89 139.88 41.83 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-N 114.533 -1.212 . . . . 61.0 109.197 -171.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.587 ' HB2' HD13 ' A' ' 176' ' ' LEU . 45.7 tp -100.18 96.97 5.55 Favored Pre-proline 0 N--CA 1.473 0.71 0 N-CA-C 107.368 -1.345 . . . . 54.05 107.368 170.552 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.512 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 53.0 Cg_endo -75.54 107.31 2.44 Favored 'Trans proline' 0 C--N 1.37 1.704 0 N-CA-C 106.923 -1.991 . . . . 75.33 106.923 171.335 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.524 ' HB3' HD23 ' A' ' 180' ' ' LEU . 59.5 tp -116.54 127.47 54.55 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 109.241 -0.651 . . . . 64.01 109.241 -167.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.634 HG21 ' HB2' ' B' ' 4' ' ' SER . 50.6 m -57.03 130.55 46.58 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 124.66 1.225 . . . . 71.34 110.965 -178.679 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 35.4 mt -47.62 -47.22 29.01 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.358 1.063 . . . . 70.54 111.232 -178.398 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -56.23 -49.53 73.87 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 114.391 -1.277 . . . . 75.32 110.695 178.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -64.26 -33.71 76.45 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.298 0.639 . . . . 64.33 111.7 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.474 ' HB2' HD22 ' A' ' 180' ' ' LEU . . . -62.46 -38.68 90.76 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.459 0.704 . . . . 41.43 110.825 177.757 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -66.33 -46.02 78.26 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 114.874 -1.057 . . . . 74.51 111.071 173.377 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.499 ' HE1' ' HA ' ' B' ' 2' ' ' LYS . 24.0 m170 -66.55 -65.52 0.67 Allowed 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.282 0.633 . . . . 75.25 111.378 -173.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.509 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 90.82 179.76 43.15 Favored Glycine 0 C--N 1.346 1.117 0 CA-C-N 116.14 -0.482 . . . . 71.54 112.421 -177.029 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.59 -157.45 27.67 Favored Glycine 0 C--N 1.345 1.038 0 C-N-CA 123.298 0.475 . . . . 70.42 112.313 179.181 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 13.7 mp0 -70.98 98.77 1.67 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.929 0.892 . . . . 73.14 111.091 -176.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 7.1 tpp180 -94.01 119.95 33.59 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.872 0.869 . . . . 74.4 109.295 172.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.489 ' O ' HG23 ' B' ' 5' ' ' THR . 76.2 t -79.44 106.01 9.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 114.749 -1.114 . . . . 71.24 109.218 172.307 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.441 HG23 HG13 ' B' ' 6' ' ' ILE . 3.6 p -111.32 125.1 68.63 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 N-CA-C 108.86 -0.793 . . . . 73.14 108.86 172.406 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.553 ' HB3' ' HG3' ' A' ' 144' ' ' ARG . 6.4 pt-20 -124.97 116.46 22.19 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.547 0.739 . . . . 71.3 111.426 -166.296 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.476 HG11 ' HB2' ' B' ' 8' ' ' LEU . 9.2 p -159.92 155.19 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.166 0.986 . . . . 75.1 108.963 177.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 61.63 22.68 13.13 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 124.274 1.03 . . . . 74.24 112.757 174.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 87.42 -13.05 61.15 Favored Glycine 0 C--N 1.353 1.486 0 CA-C-N 116.369 -0.378 . . . . 31.1 113.285 -177.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 22.7 tpt180 -95.81 115.09 26.92 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.395 0.678 . . . . 72.12 110.251 178.556 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.553 ' HG3' ' HB3' ' A' ' 139' ' ' GLU . 13.1 ttt180 -100.55 88.22 3.57 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.081 0.952 . . . . 74.41 108.726 173.413 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 11.2 p -94.88 144.99 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 123.083 0.553 . . . . 73.53 110.909 -173.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 22.9 t -107.64 86.97 2.39 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 109.226 -0.657 . . . . 31.45 109.226 176.33 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.7 p -85.02 124.17 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 123.305 0.642 . . . . 73.42 110.003 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 61.6 ttt85 -75.88 95.74 3.58 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.311 0.577 . . . . 74.14 109.652 177.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.509 HG13 ' HA2' ' A' ' 133' ' ' GLY . 33.6 pt -77.37 140.2 64.76 Favored Pre-proline 0 CA--C 1.557 1.225 0 CA-C-N 115.255 -0.884 . . . . 74.13 109.977 175.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -61.86 130.83 32.54 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.547 2.164 . . . . 60.34 112.301 174.029 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -61.96 112.11 1.42 Allowed 'Trans proline' 0 C--N 1.377 2.065 0 C-N-CA 122.389 2.059 . . . . 74.15 111.45 170.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 84.37 46.3 5.87 Favored Glycine 0 C--N 1.343 0.951 0 N-CA-C 111.128 -0.789 . . . . 75.51 111.128 -171.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -80.36 153.1 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 N-CA-C 109.525 -0.546 . . . . 75.43 109.525 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.542 ' HG2' ' HA ' ' A' ' 191' ' ' GLN . 0.0 OUTLIER -124.91 159.46 31.09 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 123.448 0.699 . . . . 73.23 110.926 -174.629 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.437 ' HB2' ' HB3' ' A' ' 188' ' ' LEU . 10.4 tp10 -57.73 126.29 26.71 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.222 1.409 . . . . 72.32 110.998 -179.347 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 103.52 -10.32 53.46 Favored Glycine 0 C--N 1.347 1.148 0 CA-C-O 119.175 -0.792 . . . . 14.21 113.993 178.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 33.6 t -63.63 112.18 2.71 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 117.693 0.746 . . . . 74.23 109.962 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.471 HG22 HG22 ' A' ' 177' ' ' VAL . 41.8 t -89.51 115.96 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.156 0.582 . . . . 72.34 110.672 -176.32 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 55.2 mt -108.22 108.14 24.54 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 123.967 0.907 . . . . 75.24 108.684 175.405 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -75.39 101.17 4.67 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 108.68 -0.859 . . . . 61.32 108.68 174.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.438 HG11 HD12 ' A' ' 176' ' ' LEU . 7.6 p -124.15 113.58 27.99 Favored Pre-proline 0 CA--C 1.541 0.62 0 N-CA-C 108.26 -1.015 . . . . 61.33 108.26 -173.095 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.414 ' HA ' ' H ' ' A' ' 174' ' ' LEU . 10.1 Cg_exo -71.66 146.43 48.94 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 121.106 1.204 . . . . 74.53 111.839 178.573 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.538 ' H ' ' HA ' ' A' ' 173' ' ' ASP . . . 131.36 -23.91 4.24 Favored Glycine 0 C--N 1.344 0.977 0 N-CA-C 116.646 1.418 . . . . 70.43 116.646 170.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -124.47 -3.8 7.84 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 113.498 0.925 . . . . 64.15 113.498 -165.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.691 ' HA2' HD13 ' A' ' 174' ' ' LEU . . . -74.7 -100.23 0.1 OUTLIER Glycine 0 N--CA 1.474 1.202 0 CA-C-O 118.653 -1.082 . . . . 73.33 113.836 -174.299 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.659 ' HA3' ' HB2' ' A' ' 171' ' ' PRO . . . -70.04 167.17 49.19 Favored Glycine 0 C--N 1.377 2.808 0 C-N-CA 118.079 -2.01 . . . . 74.5 111.333 172.387 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -104.32 102.85 12.52 Favored 'General case' 0 CA--C 1.56 1.359 0 CA-C-N 118.675 1.238 . . . . 75.42 114.095 -177.434 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 122.1 -161.64 16.17 Favored Glycine 0 C--N 1.369 2.392 0 N-CA-C 115.653 1.021 . . . . 64.21 115.653 164.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' ASN . . . . . 0.443 ' H ' ' HA2' ' A' ' 107' ' ' GLY . 20.4 m120 -63.88 -45.91 81.27 Favored Pre-proline 0 CA--C 1.576 1.953 0 CA-C-O 118.494 -0.765 . . . . 63.11 111.023 174.497 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.472 ' HB2' ' HD3' ' A' ' 171' ' ' PRO . 12.6 Cg_exo -72.67 -56.7 0.09 OUTLIER 'Trans proline' 0 CA--C 1.593 3.451 0 CA-C-N 121.973 1.74 . . . . 71.13 116.001 175.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.659 ' HB2' ' HA3' ' A' ' 166' ' ' GLY . 18.8 Cg_endo -98.75 155.27 0.7 Allowed 'Trans proline' 0 C--N 1.399 3.189 0 C-N-CA 122.647 2.231 . . . . 71.25 111.24 167.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.714 ' HA3' ' H ' ' A' ' 116' ' ' GLY . . . -170.13 -80.04 0.05 OUTLIER Glycine 0 C--N 1.379 2.951 0 N-CA-C 120.489 2.956 . . . . 72.4 120.489 -164.598 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.598 ' O ' ' HA ' ' A' ' 118' ' ' ASP . 59.0 m-20 -63.08 162.96 10.71 Favored 'General case' 0 N--CA 1.509 2.476 0 CA-C-N 118.054 0.927 . . . . 71.14 112.179 -168.592 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.691 HD13 ' HA2' ' A' ' 165' ' ' GLY . 20.1 tp -128.42 147.85 50.68 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 120.132 1.333 . . . . 64.32 113.608 -177.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 8.4 mt -111.09 92.75 4.17 Favored 'General case' 0 CA--C 1.555 1.145 0 N-CA-C 106.774 -1.565 . . . . 72.12 106.774 168.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.587 HD13 ' HB2' ' A' ' 123' ' ' LEU . 15.0 mt -76.19 138.51 40.71 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 118.132 0.424 . . . . 70.05 111.607 178.681 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.471 HG22 HG22 ' A' ' 158' ' ' VAL . 47.4 t -119.71 116.0 49.25 Favored 'Isoleucine or valine' 0 C--O 1.242 0.677 0 N-CA-C 106.017 -1.846 . . . . 61.43 106.017 164.378 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.449 ' HA ' ' HB3' ' A' ' 123' ' ' LEU . 10.1 p -72.12 120.32 20.3 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 CA-C-O 121.848 0.832 . . . . 70.33 111.314 -171.557 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.512 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 32.3 mmt180 -106.82 99.53 9.09 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 107.849 -1.167 . . . . 53.32 107.849 172.109 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.794 HD12 ' HG ' ' A' ' 188' ' ' LEU . 80.4 mt -70.12 131.22 43.96 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 109.162 -0.681 . . . . 72.4 109.162 179.362 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.486 HD12 ' HA ' ' A' ' 126' ' ' THR . 54.7 mt -53.38 150.5 11.92 Favored Pre-proline 0 N--CA 1.481 1.084 0 O-C-N 124.606 1.191 . . . . 73.14 113.666 -163.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -83.21 49.1 2.9 Favored 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 122.796 2.331 . . . . 71.42 108.488 160.357 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 26.6 t-80 -69.97 131.5 89.08 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 107.254 -1.387 . . . . 73.35 107.254 178.531 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_exo -16.84 -34.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.386 2.522 1 C-N-CA 127.977 5.784 . . . . 61.24 120.623 -164.466 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 4.8 t -95.06 -59.57 3.05 Favored 'Isoleucine or valine' 0 C--N 1.353 0.744 0 CA-C-N 120.011 1.278 . . . . 64.21 108.728 -172.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 186' ' ' PHE . . . . . 0.487 ' CD1' ' HB2' ' A' ' 195' ' ' ALA . 49.2 m-85 -115.76 154.62 29.28 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 121.177 0.513 . . . . 72.31 111.333 -169.384 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 26.6 ttp180 -138.6 129.57 26.77 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 107.032 -1.47 . . . . 75.51 107.032 165.102 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.794 ' HG ' HD12 ' A' ' 180' ' ' LEU . 4.5 mm? -79.51 166.16 22.24 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.96 0.886 . . . . 74.21 112.3 -176.429 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -163.83 96.86 0.83 Allowed 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 105.663 -1.976 . . . . 70.31 105.663 174.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 62.02 -122.6 29.11 Favored Glycine 0 CA--C 1.531 1.075 0 N-CA-C 111.413 -0.675 . . . . 65.41 111.413 -168.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.542 ' HA ' ' HG2' ' A' ' 154' ' ' ARG . 2.2 mp0 -86.39 -13.89 45.0 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.793 0.837 . . . . 72.32 111.512 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -107.98 156.57 19.08 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 121.718 0.771 . . . . 72.32 112.684 -168.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.536 HD21 ' HE1' ' A' ' 240' ' ' PHE . 59.5 mt -103.61 155.7 18.35 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.781 1.633 . . . . 63.44 111.06 -170.83 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -132.04 100.13 4.95 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 107.845 -1.168 . . . . 73.14 107.845 169.233 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.571 ' HB3' HD23 ' A' ' 251' ' ' LEU . . . -105.32 116.0 31.2 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.429 1.091 . . . . 74.34 110.656 -176.463 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 38.3 m -71.4 102.62 2.68 Favored 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 109.409 -0.589 . . . . 70.21 109.409 176.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.582 HD22 HD13 ' A' ' 251' ' ' LEU . 33.2 tp -101.26 104.42 15.45 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 108.727 -0.842 . . . . 72.21 108.727 -174.455 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -84.4 108.68 17.35 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.891 -0.781 . . . . 61.43 108.891 175.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.53 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 6.2 p -120.76 137.27 26.2 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 124.71 1.204 . . . . 64.4 108.316 -177.365 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.29 156.84 33.28 Favored 'Trans proline' 0 C--N 1.363 1.327 0 C-N-CA 121.485 1.457 . . . . 64.51 111.605 173.51 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.411 ' HB3' ' HH2' ' A' ' 269' ' ' TRP . . . -56.46 -48.82 96.35 Favored Pre-proline 0 CA--C 1.557 1.227 0 N-CA-C 114.701 1.371 . . . . 71.34 114.701 -168.637 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -57.5 -42.71 58.25 Favored 'Trans proline' 0 C--N 1.395 2.995 0 CA-C-N 121.526 1.581 . . . . 63.54 112.079 178.222 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.438 HG12 ' HE1' ' C' ' 277' ' ' TYR . 20.2 mt -73.21 -28.74 26.51 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 CA-C-N 115.262 -0.881 . . . . 64.32 110.634 -176.74 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -72.05 -48.64 42.89 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.348 0.659 . . . . 71.51 111.371 178.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.479 HG11 HD11 ' C' ' 261' ' ' LEU . 95.6 t -72.03 -41.54 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.469 0.708 . . . . 63.23 111.747 -175.716 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 70.3 t -87.32 -41.9 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 116.07 -0.513 . . . . 74.41 111.384 -176.266 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 91.73 83.81 1.46 Allowed Glycine 0 CA--C 1.525 0.711 0 CA-C-N 116.097 -0.501 . . . . 72.35 112.83 -177.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -126.22 -172.42 13.35 Favored Glycine 0 N--CA 1.473 1.149 0 N-CA-C 111.363 -0.695 . . . . 55.24 111.363 173.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 221' ' ' VAL . 50.2 mtmt -85.06 133.16 34.24 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 117.75 0.775 . . . . 45.21 112.522 -174.281 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 34.8 m -121.55 170.55 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 124.253 1.021 . . . . 63.11 108.726 166.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 22.2 ttm180 -82.43 109.36 16.6 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 109.473 -0.566 . . . . 71.41 109.473 172.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -103.18 132.32 49.52 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 108.426 -0.953 . . . . 62.04 108.426 173.049 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 213' ' ' MET . . . . . 0.444 ' N ' ' SD ' ' A' ' 213' ' ' MET . 1.5 mpt? -92.38 135.75 33.77 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.494 -0.558 . . . . 71.23 109.494 -175.448 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 55.8 p -111.79 -176.45 2.94 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.379 0.672 . . . . 74.1 109.517 174.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 58.5 mt -80.41 -4.17 52.59 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.658 0.783 . . . . 63.31 111.949 -177.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.428 ' HA ' ' HE2' ' B' ' 2' ' ' LYS . 56.3 mm-40 -115.65 -17.93 10.99 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.356 0.662 . . . . 64.44 111.507 176.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 156.16 175.35 27.04 Favored Glycine 0 C--N 1.354 1.536 0 C-N-CA 121.465 -0.398 . . . . 33.0 114.012 176.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -77.93 124.41 6.76 Favored 'Trans proline' 0 C--N 1.372 1.795 0 C-N-CA 122.934 2.423 . . . . 70.23 112.349 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 30.9 m -121.11 179.92 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 124.451 1.1 . . . . 73.4 109.429 177.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -102.58 150.27 23.58 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.356 0.662 . . . . 75.04 109.584 172.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 209' ' ' LYS . 2.8 p -145.98 141.36 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 N-CA-C 108.972 -0.751 . . . . 74.13 108.972 176.144 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -86.45 100.81 12.62 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.045 0.538 . . . . 60.25 110.47 -178.291 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 91.8 t -53.9 143.29 41.88 Favored Pre-proline 0 N--CA 1.494 1.734 0 C-N-CA 125.204 1.402 . . . . 63.14 111.136 -179.306 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -62.11 162.83 21.59 Favored 'Trans proline' 0 C--N 1.386 2.534 0 C-N-CA 122.627 2.218 . . . . 75.51 112.406 172.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.54 155.47 35.92 Favored 'Trans proline' 0 C--N 1.367 1.521 0 C-N-CA 121.408 1.405 . . . . 72.53 111.134 166.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 226' ' ' ARG . . . . . 0.404 ' HD2' ' O ' ' C' ' 259' ' ' GLU . 21.1 mmt180 65.33 20.59 11.87 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 125.305 1.442 . . . . 74.04 112.244 173.371 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.437 HG23 HD21 ' A' ' 233' ' ' LEU . 96.5 m -59.19 104.52 0.25 Allowed 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 124.715 1.206 . . . . 64.32 111.202 -176.028 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 5.3 tp60 -98.11 133.97 41.83 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.689 1.196 . . . . 75.32 111.994 -168.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -62.48 140.32 58.6 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.833 1.253 . . . . 62.31 112.892 -173.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 92.37 -35.69 3.94 Favored Glycine 0 C--N 1.349 1.291 0 O-C-N 123.877 0.736 . . . . 73.32 112.005 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -74.04 161.76 29.71 Favored 'General case' 0 C--N 1.349 0.555 0 C-N-CA 123.867 0.867 . . . . 74.0 111.352 -177.22 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.723 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 3.4 mptp? -113.34 118.46 34.65 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.909 0.884 . . . . 72.22 109.065 -175.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.486 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 39.0 mt -76.79 100.25 5.41 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.764 -0.828 . . . . 71.4 108.764 178.466 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 54.3 ttm-85 -71.86 105.86 3.97 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 110.245 -0.279 . . . . 64.14 110.245 179.246 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.531 HD12 HD23 ' A' ' 249' ' ' LEU . 9.1 mt -95.31 104.06 15.94 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 107.508 -1.293 . . . . 61.12 107.508 173.648 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 18.0 tptp -71.47 118.82 14.76 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.353 0.661 . . . . 64.43 111.181 -172.221 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 85.47 32.21 19.92 Favored Glycine 0 C--N 1.35 1.347 0 O-C-N 123.418 0.449 . . . . 74.2 113.251 177.277 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -125.62 5.69 7.52 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.68 0.792 . . . . 73.01 112.443 -175.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -93.86 -157.5 33.15 Favored Glycine 0 N--CA 1.469 0.868 0 C-N-CA 123.378 0.513 . . . . 74.43 112.451 171.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 240' ' ' PHE . . . . . 0.536 ' HE1' HD21 ' A' ' 193' ' ' LEU . 27.2 m-85 -83.38 140.44 41.9 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 122.954 0.502 . . . . 73.13 111.136 -175.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 240' ' ' PHE . 3.6 Cg_exo -77.41 138.09 17.26 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 123.558 2.839 . . . . 73.33 112.587 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 178.19 -138.52 3.75 Favored Glycine 0 CA--C 1.534 1.275 0 CA-C-O 119.056 -0.858 . . . . 73.52 112.449 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -67.69 -12.52 35.8 Favored 'Trans proline' 0 C--N 1.382 2.337 0 C-N-CA 123.844 3.03 . . . . 70.45 114.086 -177.049 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -103.96 21.77 15.78 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.744 0.418 . . . . 70.11 110.37 175.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 71.88 -93.74 0.58 Allowed Glycine 0 C--N 1.353 1.483 0 N-CA-C 110.329 -1.108 . . . . 62.24 110.329 -173.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 -126.18 131.46 52.0 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 107.626 -1.25 . . . . 75.41 107.626 167.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -70.35 -168.0 7.0 Favored Glycine 0 C--N 1.352 1.419 0 O-C-N 123.266 0.354 . . . . 42.24 112.871 178.103 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -111.55 173.34 6.4 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 117.513 0.656 . . . . 75.44 111.112 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.531 HD23 HD12 ' A' ' 235' ' ' LEU . 23.5 tp -128.9 104.07 7.39 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.556 -0.905 . . . . 70.31 108.556 176.505 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.723 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 0.4 OUTLIER -89.81 105.65 17.94 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.701 -0.852 . . . . 52.51 108.701 -178.881 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.582 HD13 HD22 ' A' ' 197' ' ' LEU . 66.3 mt -84.93 101.95 12.75 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.906 -0.775 . . . . 72.24 108.906 177.375 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 252' ' ' GLU . . . . . 0.588 ' HG2' ' HG3' ' A' ' 232' ' ' LYS . 26.0 mt-10 -76.36 104.47 6.89 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.025 0.93 . . . . 75.41 108.743 -177.629 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 40.6 t -67.11 127.68 29.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 114.316 -1.311 . . . . 24.43 112.145 -167.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.49 91.93 3.4 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 107.516 -1.291 . . . . 73.14 107.516 175.576 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.53 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 66.7 mt -79.4 133.55 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 109.777 -0.453 . . . . 74.34 109.777 -178.402 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 19.6 p -130.52 175.26 9.13 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.144 0.978 . . . . 73.43 110.481 174.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 257' ' ' ILE . . . . . 0.513 HD12 ' H ' ' A' ' 259' ' ' GLU . 2.7 pp -132.38 152.45 80.09 Favored Pre-proline 0 CA--C 1.558 1.26 0 C-N-CA 123.843 0.857 . . . . 73.4 109.557 -178.544 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -76.55 8.63 2.91 Favored 'Trans proline' 0 N--CA 1.507 2.301 0 C-N-CA 123.157 2.571 . . . . 74.45 115.03 -165.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 259' ' ' GLU . . . . . 0.579 ' HG2' ' NE2' ' C' ' 228' ' ' GLN . 33.3 mt-10 53.11 -85.53 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.616 1.166 . . . . 63.24 111.219 -163.715 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.83 158.93 5.86 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.163 0.985 . . . . 75.12 111.878 179.135 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.619 HD22 ' HB3' ' A' ' 265' ' ' GLU . 74.7 mt -143.39 151.22 40.15 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.416 0.686 . . . . 55.32 110.558 178.448 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 58.3 p -83.67 161.57 55.74 Favored Pre-proline 0 CA--C 1.559 1.303 0 N-CA-C 108.689 -0.856 . . . . 44.34 108.689 166.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -42.06 -47.03 6.95 Favored 'Trans proline' 0 C--N 1.385 2.45 0 C-N-CA 123.779 2.986 . . . . 74.33 115.217 177.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -67.14 -47.42 71.15 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.017 0.527 . . . . 71.44 109.856 -179.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 265' ' ' GLU . . . . . 0.619 ' HB3' HD22 ' A' ' 261' ' ' LEU . 43.6 mt-10 -56.83 -42.46 79.67 Favored 'General case' 0 C--N 1.352 0.693 0 O-C-N 123.873 0.733 . . . . 64.2 110.866 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -62.58 -50.13 72.53 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 123.195 0.31 . . . . 73.45 110.292 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -54.97 -51.61 65.65 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 124.158 0.912 . . . . 64.12 111.569 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 268' ' ' LEU . . . . . 0.478 ' HB2' HD21 ' C' ' 272' ' ' LEU . 10.1 mp -73.67 -43.62 58.89 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.291 0.637 . . . . 73.14 111.935 -173.049 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 269' ' ' TRP . . . . . 0.411 ' HH2' ' HB3' ' A' ' 201' ' ' ALA . 62.5 m95 -58.68 -45.79 88.66 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 123.358 0.663 . . . . 75.0 111.086 177.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 270' ' ' LYS . . . . . 0.417 ' NZ ' ' HB3' ' A' ' 270' ' ' LYS . 8.7 mtpm? -63.34 -50.06 71.48 Favored 'General case' 0 C--N 1.352 0.693 0 CA-C-N 115.842 -0.617 . . . . 62.43 111.012 178.787 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -64.38 -29.66 70.72 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.045 0.538 . . . . 70.22 111.979 -179.087 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 272' ' ' LEU . . . . . 0.424 ' O ' ' HB2' ' A' ' 276' ' ' TYR . 31.5 mt -61.62 -52.41 64.48 Favored 'General case' 0 C--O 1.211 -0.943 0 N-CA-C 109.377 -0.601 . . . . 63.4 109.377 172.238 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -64.68 -37.04 86.23 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 123.904 0.752 . . . . 64.51 112.824 -178.099 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -67.18 -47.65 70.3 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.823 0.849 . . . . 74.35 110.485 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 275' ' ' ALA . . . . . 0.514 ' O ' ' HG2' ' A' ' 279' ' ' ARG . . . -59.68 -60.13 4.34 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.546 0.738 . . . . 71.44 109.767 175.32 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 276' ' ' TYR . . . . . 0.424 ' HB2' ' O ' ' A' ' 272' ' ' LEU . 24.5 t80 -39.24 -58.96 1.1 Allowed 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 127.45 2.3 . . . . 75.02 111.939 178.072 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -62.45 -46.02 90.44 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 114.572 -1.195 . . . . 70.12 109.963 -176.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -69.81 -8.9 52.24 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.005 0.742 . . . . 75.41 113.005 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 279' ' ' ARG . . . . . 0.514 ' HG2' ' O ' ' A' ' 275' ' ' ALA . 8.7 mmm180 -93.26 -7.45 45.02 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 117.902 0.319 . . . . 74.13 111.63 177.164 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 1.163 0 CA-C-O 118.309 -0.853 . . . . 72.21 109.811 179.676 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.2 mmt . . . . . 0 N--CA 1.475 0.796 0 N-CA-C 110.135 -0.321 . . . . 71.44 110.135 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 2' ' ' LYS . . . . . 0.499 ' HA ' ' HE1' ' A' ' 132' ' ' HIS . 0.2 OUTLIER -78.68 1.45 22.86 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.934 0.894 . . . . 54.1 113.286 -165.996 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.62 10.04 4.71 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.811 0.845 . . . . 74.04 111.118 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 4' ' ' SER . . . . . 0.634 ' HB2' HG21 ' A' ' 126' ' ' THR . 60.8 m -70.81 101.11 2.04 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-O 121.599 0.714 . . . . 52.14 110.703 -176.172 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 5' ' ' THR . . . . . 0.489 HG23 ' O ' ' A' ' 137' ' ' VAL . 92.9 m -85.85 154.78 21.3 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 114.337 -1.301 . . . . 70.11 110.986 -179.501 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.493 HD13 ' HA ' ' A' ' 125' ' ' LEU . 21.9 pt -126.61 178.44 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 C-N-CA 124.509 1.124 . . . . 64.44 111.487 -167.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -147.19 134.5 20.66 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.805 1.242 . . . . 72.01 108.448 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 8' ' ' LEU . . . . . 0.502 HD12 ' HA ' ' A' ' 123' ' ' LEU . 1.5 mm? -63.59 150.9 43.04 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 118.575 0.625 . . . . 75.22 111.569 -178.404 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.04 -43.17 79.33 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 114.787 -1.097 . . . . 62.4 110.054 173.363 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 29.9 mt 74.34 -40.76 0.46 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 126.477 1.911 . . . . 74.1 113.525 -179.398 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 53.1 mt . . . . . 0 CA--C 1.565 1.533 0 C-N-CA 124.566 1.146 . . . . 45.35 110.714 -173.121 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.849 0 CA-C-O 120.787 0.327 . . . . 61.34 110.726 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 180' ' ' ALA . . . . . 0.495 ' HB1' HG23 ' C' ' 137' ' ' VAL . . . -63.71 -63.68 1.1 Allowed 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 109.16 -0.681 . . . . 74.4 109.16 170.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 181' ' ' LEU . . . . . 0.574 HD13 ' HB2' ' C' ' 136' ' ' ARG . 45.1 tp -143.85 -67.28 0.34 Allowed 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 106.727 -1.582 . . . . 62.04 106.727 167.607 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 182' ' ' VAL . . . . . 0.559 HG23 ' HB2' ' C' ' 125' ' ' LEU . 14.7 p -151.4 153.78 9.34 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 N-CA-C 107.185 -1.413 . . . . 71.31 107.185 -177.137 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -83.08 63.97 7.41 Favored 'General case' 0 CA--C 1.562 1.438 0 N-CA-C 115.266 1.58 . . . . 65.24 115.266 -158.177 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 12.3 m170 60.79 -176.16 0.11 Allowed 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 114.379 1.252 . . . . 74.15 114.379 161.209 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 185' ' ' VAL . . . . . . . . . . . . . 2.6 p . . . . . 0 N--CA 1.476 0.869 0 C-N-CA 122.816 0.446 . . . . 71.33 110.509 173.238 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 238' ' ' THR . . . . . 0.571 HG22 HG23 ' C' ' 219' ' ' VAL . 3.0 m . . . . . 0 N--CA 1.474 0.736 0 N-CA-C 107.527 -1.286 . . . . 71.31 107.527 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -84.09 169.13 15.21 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.746 -0.661 . . . . 74.42 110.204 175.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 240' ' ' GLY . . . . . 0.515 ' H ' HD22 ' C' ' 235' ' ' LEU . . . -109.91 -93.08 2.22 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 110.778 -0.929 . . . . 71.23 110.778 -173.296 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 241' ' ' GLU . . . . . 0.413 ' HG3' ' HG3' ' C' ' 234' ' ' ARG . 8.5 pt-20 -165.34 161.2 18.89 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.7 0.8 . . . . 71.21 110.097 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 13.8 m95 -108.19 -82.08 0.56 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.655 0.782 . . . . 70.32 108.944 177.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -153.12 -162.21 1.44 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.765 1.626 . . . . 74.22 107.772 -171.045 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -73.7 79.53 0.83 Allowed Glycine 0 C--N 1.349 1.274 0 N-CA-C 111.199 -0.76 . . . . 63.11 111.199 170.228 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 2.1 pptp? . . . . . 0 N--CA 1.479 0.993 0 C-N-CA 123.946 0.898 . . . . 75.34 111.55 -174.685 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.903 0 CA-C-O 121.006 0.431 . . . . 52.01 111.304 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -36.86 117.51 0.51 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.974 1.71 . . . . 70.52 114.133 173.305 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -76.07 102.58 5.75 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.849 -0.796 . . . . 63.2 108.849 165.516 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 6' ' ' ASP . . . . . 0.432 ' HA ' ' OH ' ' C' ' 66' ' ' TYR . 8.6 t70 -75.01 94.24 2.83 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.184 -1.043 . . . . 63.22 108.184 176.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 7' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -61.44 -35.51 77.78 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-N 115.264 -0.88 . . . . 73.43 112.361 -171.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -60.12 -50.24 74.49 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 116.121 -0.49 . . . . 72.53 110.179 175.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.7 -39.16 93.62 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.899 -0.591 . . . . 52.31 111.506 -178.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 81.5 mt -58.14 -42.13 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 C-N-CA 123.665 0.786 . . . . 63.34 110.163 176.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 95.9 mt -74.35 -24.01 59.11 Favored 'General case' 0 N--CA 1.48 1.075 0 CA-C-N 116.19 -0.459 . . . . 45.45 112.025 175.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.99 38.31 10.44 Favored Glycine 0 C--N 1.345 1.079 0 CA-C-N 116.93 -0.123 . . . . 64.33 113.187 -176.056 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 6.0 m -125.78 157.14 69.87 Favored Pre-proline 0 N--CA 1.481 1.116 0 C-N-CA 124.786 1.235 . . . . 64.04 110.226 176.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -67.77 165.38 27.95 Favored 'Trans proline' 0 C--N 1.383 2.386 0 C-N-CA 122.782 2.321 . . . . 74.43 112.423 177.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -77.54 16.38 0.66 Allowed 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 123.18 0.592 . . . . 71.52 111.982 -179.137 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -119.18 -0.15 11.1 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.786 1.635 . . . . 71.24 108.406 178.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.46 133.01 47.99 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.406 0.682 . . . . 71.14 111.94 -171.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 68.4 p -87.69 175.47 7.86 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.452 1.101 . . . . 74.41 110.862 -178.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -51.5 -39.14 57.01 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.183 0.993 . . . . 74.45 111.527 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -62.59 -47.46 83.72 Favored 'General case' 0 C--N 1.349 0.584 0 O-C-N 123.811 0.694 . . . . 64.05 111.258 178.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -66.77 -37.99 85.69 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.659 0.784 . . . . 73.42 111.322 -177.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 22' ' ' ILE . . . . . 0.629 HG12 ' HB3' ' C' ' 57' ' ' LEU . 1.7 mp -62.28 -42.56 95.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.323 1.049 . . . . 61.32 110.439 175.405 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -69.24 -39.65 78.37 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 114.853 -1.067 . . . . 74.13 110.891 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -70.27 -33.63 71.81 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.737 0.815 . . . . 73.52 110.572 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -74.65 -36.26 62.85 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.777 0.831 . . . . 75.32 110.624 177.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 26' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -60.03 -48.28 82.35 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 115.447 -0.797 . . . . 72.31 108.988 172.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -60.1 -44.76 94.6 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.317 1.047 . . . . 74.1 111.203 178.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 22.6 ttt180 -51.25 -52.16 47.38 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.744 1.217 . . . . 71.15 110.963 177.177 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 29' ' ' LEU . . . . . 0.454 ' HB3' HD13 ' C' ' 50' ' ' ILE . 83.3 mt -83.6 -12.47 56.02 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 114.585 -1.189 . . . . 60.22 111.506 -178.374 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.19 -2.65 55.01 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.684 0.793 . . . . 75.32 110.41 173.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 76.6 mtp180 -95.89 -45.35 6.99 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.6 0.76 . . . . 73.5 109.045 166.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -68.31 -52.84 29.08 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 115.343 -0.844 . . . . 71.12 111.188 -178.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 33' ' ' TYR . . . . . 0.448 ' HE2' HD22 ' C' ' 29' ' ' LEU . 37.3 m-85 -100.97 26.26 7.16 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.577 0.751 . . . . 70.15 110.464 -178.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 34' ' ' HIS . . . . . . . . . . . . . 13.0 t60 -55.12 99.16 0.19 Allowed Pre-proline 0 N--CA 1.488 1.46 0 C-N-CA 124.765 1.226 . . . . 72.34 110.738 -177.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -59.58 -27.88 86.05 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 123.088 2.525 . . . . 71.32 113.97 -167.175 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -72.1 -25.86 61.92 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.357 0.663 . . . . 60.34 111.929 -177.335 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 67.2 t -113.22 -25.59 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 CA-C-O 121.352 0.596 . . . . 75.33 110.783 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -105.43 83.98 2.03 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 106.807 -1.553 . . . . 54.22 106.807 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.96 76.5 7.9 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.89 -0.782 . . . . 62.24 108.89 -178.684 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 67.4 m -143.08 108.43 5.37 Favored Pre-proline 0 C--O 1.235 0.329 0 N-CA-C 107.004 -1.48 . . . . 74.14 107.004 172.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 41' ' ' PRO . . . . . 0.44 ' O ' ' HG2' ' C' ' 45' ' ' GLU . 76.9 Cg_exo -46.79 -30.59 9.53 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 123.548 2.832 . . . . 63.44 114.161 175.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -57.14 -45.53 83.48 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.752 0.821 . . . . 65.44 111.216 175.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.54 -19.19 62.91 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.508 -0.769 . . . . 62.05 110.84 178.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 44' ' ' GLU . . . . . 0.411 ' O ' ' HG3' ' C' ' 48' ' ' LYS . 36.5 mt-10 -87.6 -30.36 20.54 Favored 'General case' 0 C--N 1.358 0.95 0 C-N-CA 123.184 0.594 . . . . 74.04 110.409 -178.488 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 45' ' ' GLU . . . . . 0.44 ' HG2' ' O ' ' C' ' 41' ' ' PRO . 11.8 mm-40 -72.39 -40.09 67.51 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 108.895 -0.78 . . . . 42.53 108.895 174.128 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 46' ' ' LYS . . . . . 0.41 ' O ' HG13 ' C' ' 50' ' ' ILE . 48.4 mttp -63.25 -38.11 89.88 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-N 114.587 -1.188 . . . . 72.32 110.413 170.217 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 47' ' ' PHE . . . . . 0.813 ' HA ' HD12 ' C' ' 50' ' ' ILE . 26.8 t80 -62.45 -35.28 78.81 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 123.526 0.516 . . . . 62.23 110.387 175.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 48' ' ' LYS . . . . . 0.428 ' HB3' ' CE1' ' C' ' 93' ' ' PHE . 98.3 mttt -63.16 -44.74 94.64 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.099 0.56 . . . . 72.04 111.009 174.659 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -61.13 -36.38 79.6 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 120.997 0.427 . . . . 72.33 111.407 177.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 50' ' ' ILE . . . . . 0.813 HD12 ' HA ' ' C' ' 47' ' ' PHE . 52.5 mt -65.89 -40.28 87.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 124.051 0.94 . . . . 75.43 109.887 174.761 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 51' ' ' ASN . . . . . 0.413 ' HB3' ' CD1' ' C' ' 88' ' ' PHE . 28.5 m-80 -75.93 -16.68 59.98 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.067 0.947 . . . . 74.04 111.757 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -73.18 -53.39 11.08 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 108.939 -0.763 . . . . 63.42 108.939 170.364 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.29 -42.88 82.57 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 113.852 -1.522 . . . . 63.1 111.051 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -68.44 -40.67 81.06 Favored 'General case' 0 C--O 1.204 -1.307 0 CA-C-N 114.655 -1.157 . . . . 75.01 110.129 175.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.55 -35.04 73.46 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 112.373 0.508 . . . . 60.54 112.373 -179.232 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 56' ' ' VAL . . . . . 0.414 HG13 ' HZ ' ' C' ' 101' ' ' PHE . 15.6 t -96.39 -16.48 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 O-C-N 123.47 0.482 . . . . 72.43 111.882 -177.365 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 57' ' ' LEU . . . . . 0.629 ' HB3' HG12 ' C' ' 22' ' ' ILE . 92.9 mt -118.81 11.01 12.52 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.086 -1.009 . . . . 75.02 113.153 177.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 58' ' ' SER . . . . . 0.474 ' HB3' ' HD2' ' C' ' 62' ' ' LYS . 43.1 t -52.7 -34.21 51.2 Favored 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 124.749 1.219 . . . . 62.42 113.315 -176.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -134.28 155.93 79.45 Favored Pre-proline 0 N--CA 1.474 0.763 0 C-N-CA 124.803 1.241 . . . . 72.03 108.891 -174.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 60' ' ' PRO . . . . . 0.407 ' O ' ' HG2' ' C' ' 64' ' ' ARG . 50.3 Cg_exo -55.5 -29.73 70.61 Favored 'Trans proline' 0 C--N 1.383 2.347 0 C-N-CA 122.79 2.327 . . . . 33.23 112.354 169.509 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -56.8 -61.84 2.15 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.738 0.815 . . . . 62.13 110.278 174.268 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 62' ' ' LYS . . . . . 0.474 ' HD2' ' HB3' ' C' ' 58' ' ' SER . 56.1 mttp -64.31 -37.79 88.75 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 114.527 -1.215 . . . . 75.23 110.785 -176.342 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -56.28 -49.61 73.75 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 114.072 -1.422 . . . . 64.42 110.389 178.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 64' ' ' ARG . . . . . 0.407 ' HG2' ' O ' ' C' ' 60' ' ' PRO . 29.9 mmt180 -73.1 -27.54 61.77 Favored 'General case' 0 C--N 1.35 0.595 0 CA-C-O 118.591 -0.718 . . . . 74.15 111.755 -177.708 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 81.3 mt -58.73 -47.29 89.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-O 121.215 0.531 . . . . 62.34 109.585 170.257 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 66' ' ' TYR . . . . . 0.432 ' OH ' ' HA ' ' C' ' 6' ' ' ASP . 25.2 t80 -60.17 -52.75 63.98 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.028 -0.987 . . . . 74.22 110.323 175.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -62.05 -34.38 76.15 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.356 0.662 . . . . 73.14 111.831 -175.052 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 72.0 p -77.24 -24.97 51.12 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 119.223 -0.418 . . . . 63.2 110.634 176.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -66.7 128.95 38.23 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 108.816 -0.809 . . . . 75.22 108.816 173.237 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 93.79 15.55 48.91 Favored Glycine 0 C--N 1.344 1.021 0 N-CA-C 111.498 -0.641 . . . . 62.51 111.498 -168.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 86.3 m -143.95 -62.46 0.39 Allowed 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 102.959 -2.978 . . . . 72.34 102.959 174.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 27.1 m -70.41 132.93 46.35 Favored 'General case' 0 C--O 1.25 1.115 0 N-CA-C 104.615 -2.365 . . . . 73.35 104.615 155.083 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.16 -43.83 6.18 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 122.853 0.461 . . . . 73.23 111.316 -173.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -90.89 136.95 27.05 Favored Pre-proline 0 N--CA 1.477 0.886 0 C-N-CA 123.653 0.781 . . . . 53.23 109.834 -179.027 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.33 138.43 86.19 Favored 'Trans proline' 0 C--N 1.376 2.02 0 C-N-CA 122.761 2.308 . . . . 75.14 111.856 171.281 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -59.73 152.63 61.78 Favored 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 122.604 2.202 . . . . 63.14 112.417 176.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -51.67 136.77 50.3 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 122.98 2.454 . . . . 51.51 111.848 178.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 78' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.87 124.03 15.28 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 123.052 2.501 . . . . 74.44 112.565 -176.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.87 173.91 2.02 Favored 'Trans proline' 0 N--CA 1.51 2.46 0 C-N-CA 123.727 2.951 . . . . 61.04 114.447 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -57.11 88.62 0.04 OUTLIER 'Trans proline' 0 C--N 1.392 2.856 0 C-N-CA 122.857 2.372 . . . . 51.5 112.628 171.128 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 130.34 -23.93 4.51 Favored Glycine 0 N--CA 1.467 0.738 0 CA-C-N 114.442 -1.254 . . . . 75.2 110.729 178.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 107.75 -171.1 15.92 Favored Glycine 0 C--N 1.349 1.289 0 C-N-CA 124.852 1.215 . . . . 74.45 111.006 176.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -65.0 90.18 0.08 Allowed 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.59 -0.893 . . . . 70.14 108.59 165.433 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 84' ' ' ASP . . . . . 0.602 ' HB3' ' HG3' ' C' ' 143' ' ' ARG . 18.4 t0 -62.36 139.79 58.54 Favored 'General case' 0 C--O 1.241 0.652 0 O-C-N 124.1 0.875 . . . . 63.13 109.624 178.429 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 85' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -153.74 6.49 0.33 Allowed 'General case' 0 C--O 1.243 0.73 0 CA-C-N 115.447 -0.797 . . . . 74.41 110.273 -175.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 86' ' ' SER . . . . . 0.488 ' HB3' ' O ' ' C' ' 163' ' ' GLY . 74.8 m -64.41 146.75 53.99 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.315 -0.857 . . . . 45.43 110.859 -177.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 97.9 -28.03 16.35 Favored Glycine 0 C--N 1.339 0.719 0 N-CA-C 110.765 -0.934 . . . . 74.33 110.765 -165.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 88' ' ' PHE . . . . . 0.413 ' CD1' ' HB3' ' C' ' 51' ' ' ASN . 23.2 m-85 -116.07 138.03 51.59 Favored 'General case' 0 C--N 1.356 0.882 0 N-CA-C 108.684 -0.858 . . . . 74.44 108.684 -178.699 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -74.73 81.85 2.08 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.638 0.775 . . . . 72.23 110.589 -174.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 90' ' ' VAL . . . . . 0.438 HG13 ' HG2' ' C' ' 91' ' ' GLU . 6.5 p -41.54 -43.69 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 C-N-CA 125.119 1.368 . . . . 54.41 112.845 177.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 91' ' ' GLU . . . . . 0.438 ' HG2' HG13 ' C' ' 90' ' ' VAL . 51.5 mm-40 -74.97 8.09 2.76 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.653 1.181 . . . . 74.21 113.288 -172.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -120.38 -27.35 5.23 Favored 'General case' 0 C--O 1.243 0.753 0 C-N-CA 123.811 0.844 . . . . 75.53 110.929 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 93' ' ' PHE . . . . . 0.428 ' CE1' ' HB3' ' C' ' 48' ' ' LYS . 2.3 m-30 -77.73 170.95 15.7 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 120.864 0.364 . . . . 72.45 111.726 -165.022 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 87.1 p -63.02 164.21 8.65 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 114.964 1.468 . . . . 45.51 114.964 -162.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 95' ' ' GLU . . . . . 0.458 ' O ' ' HG3' ' C' ' 99' ' ' GLU . 0.0 OUTLIER -66.59 -33.02 74.74 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 113.749 -1.568 . . . . 55.43 111.401 173.767 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -66.61 -40.08 88.67 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 120.938 0.399 . . . . 65.02 110.469 176.204 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 97' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -58.85 -44.13 90.92 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 115.415 -0.811 . . . . 64.25 109.73 170.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 98' ' ' GLN . . . . . 0.426 ' O ' ' HA3' ' C' ' 102' ' ' GLY . 69.4 mt-30 -66.78 -18.62 65.46 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 123.463 0.705 . . . . 51.52 112.05 177.675 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 99' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' C' ' 95' ' ' GLU . 47.5 mt-10 -81.14 -48.15 12.52 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.156 0.583 . . . . 74.43 112.123 171.557 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 19.3 tp -82.14 -49.42 10.17 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 116.149 -0.478 . . . . 73.23 111.517 -168.257 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 101' ' ' PHE . . . . . 0.414 ' HZ ' HG13 ' C' ' 56' ' ' VAL . 93.2 m-85 -100.12 -25.11 14.4 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.117 0.567 . . . . 73.25 111.474 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 102' ' ' GLY . . . . . 0.426 ' HA3' ' O ' ' C' ' 98' ' ' GLN . . . -43.08 -58.27 3.83 Favored Glycine 0 CA--C 1.546 2.02 0 CA-C-O 118.961 -0.911 . . . . 54.11 115.325 -178.157 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -54.68 -22.35 28.5 Favored 'Trans proline' 0 C--N 1.387 2.583 0 C-N-CA 123.843 3.029 . . . . 62.02 113.957 -177.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -126.29 16.17 6.74 Favored Glycine 0 C--N 1.356 1.658 0 CA-C-O 118.756 -1.024 . . . . 43.23 113.95 -177.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 34.4 mt . . . . . 0 N--CA 1.487 1.402 0 CA-C-N 117.829 0.814 . . . . 73.03 111.607 176.849 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.625 0 CA-C-O 120.034 -0.315 . . . . 45.25 112.473 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 74.9 mtt85 -89.86 173.17 8.39 Favored 'General case' 0 C--O 1.253 1.261 0 C-N-CA 123.422 0.689 . . . . 64.44 111.51 -178.077 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -66.93 133.93 50.99 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 107.69 -1.226 . . . . 75.42 107.69 169.363 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 119' ' ' LEU . . . . . 0.435 HD11 ' HB2' ' C' ' 141' ' ' ALA . 3.9 tt -93.61 137.49 32.82 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 106.607 -1.627 . . . . 75.21 106.607 -177.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.405 ' N ' HD23 ' C' ' 119' ' ' LEU . 6.0 mmm-85 -128.0 104.02 7.56 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.194 0.521 . . . . 72.31 109.682 -172.346 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 121' ' ' ALA . . . . . 0.468 ' HB3' HD23 ' C' ' 176' ' ' LEU . . . -109.29 115.52 30.15 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.206 -1.405 . . . . 63.21 107.206 172.58 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -104.42 88.93 3.08 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 105.174 -2.158 . . . . 73.22 105.174 174.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 123' ' ' LEU . . . . . 0.438 ' H ' HD23 ' C' ' 123' ' ' LEU . 1.7 pt? -125.52 136.21 27.98 Favored Pre-proline 0 N--CA 1.485 1.294 0 N-CA-C 114.252 1.204 . . . . 73.3 114.252 -158.443 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 124' ' ' PRO . . . . . 0.527 ' HA ' ' O ' ' C' ' 179' ' ' ARG . 53.2 Cg_exo -57.42 140.41 93.06 Favored 'Trans proline' 0 C--N 1.39 2.753 0 C-N-CA 123.816 3.01 . . . . 72.51 114.519 175.127 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 125' ' ' LEU . . . . . 0.559 ' HB2' HG23 ' B' ' 182' ' ' VAL . 54.3 tp -158.38 155.56 28.9 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.071 0.948 . . . . 74.03 109.791 176.633 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 126' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -102.49 153.7 19.8 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.122 0.569 . . . . 61.53 110.427 178.53 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 127' ' ' LEU . . . . . 0.67 HD13 ' HD2' ' C' ' 186' ' ' PHE . 98.0 mt -63.15 -44.46 95.46 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.237 1.015 . . . . 62.25 111.353 176.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 12.2 mp0 -62.04 -37.27 84.29 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 114.729 -1.123 . . . . 75.24 110.553 177.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -67.95 -37.82 82.06 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.68 0.792 . . . . 73.53 111.283 177.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -68.27 -33.58 74.62 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 123.748 0.655 . . . . 64.34 109.972 178.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 131' ' ' PHE . . . . . 0.442 ' HB2' HD13 ' C' ' 215' ' ' LEU . 83.0 t80 -67.21 -42.46 84.05 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.412 1.085 . . . . 75.55 111.007 174.282 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 132' ' ' HIS . . . . . . . . . . . . . 35.3 m170 -61.89 -40.96 97.23 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 123.585 0.553 . . . . 60.22 110.076 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 64.09 -108.37 2.22 Favored Glycine 0 C--N 1.355 1.588 0 N-CA-C 111.04 -0.824 . . . . 65.31 111.04 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . 70.49 147.09 0.37 Allowed Glycine 0 C--N 1.354 1.568 0 O-C-N 124.23 0.606 . . . . 53.24 114.535 173.385 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -80.19 92.94 5.76 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 107.359 -1.349 . . . . 71.2 107.359 176.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 136' ' ' ARG . . . . . 0.574 ' HB2' HD13 ' B' ' 181' ' ' LEU . 72.7 mtp180 -123.82 155.89 37.16 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 124.08 0.952 . . . . 72.12 109.501 -168.678 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 137' ' ' VAL . . . . . 0.495 HG23 ' HB1' ' B' ' 180' ' ' ALA . 31.3 m -78.97 122.52 34.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 CA-C-O 121.242 0.544 . . . . 71.12 111.893 -172.754 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 138' ' ' VAL . . . . . 0.533 ' HB ' HD23 ' B' ' 181' ' ' LEU . 12.9 p -111.56 140.8 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 107.681 -1.229 . . . . 72.14 107.681 169.102 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 139' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -109.83 100.77 9.7 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 108.131 -1.063 . . . . 74.31 108.131 179.069 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 140' ' ' VAL . . . . . . . . . . . . . 11.7 p -143.62 134.88 22.65 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.111 0 C-N-CA 123.484 0.714 . . . . 63.22 109.579 -173.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 141' ' ' ALA . . . . . 0.435 ' HB2' HD11 ' C' ' 119' ' ' LEU . . . 67.26 -1.67 1.43 Allowed 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 125.301 1.44 . . . . 15.23 114.173 178.263 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 119.55 -2.13 13.86 Favored Glycine 0 C--N 1.348 1.238 0 CA-C-O 119.23 -0.761 . . . . 45.25 114.231 179.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 143' ' ' ARG . . . . . 0.602 ' HG3' ' HB3' ' C' ' 84' ' ' ASP . 64.2 mtm180 -119.41 130.7 55.42 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 118.367 1.083 . . . . 73.04 111.744 175.181 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -83.76 103.61 13.19 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 107.709 -1.219 . . . . 71.51 107.709 164.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 145' ' ' VAL . . . . . . . . . . . . . 7.3 p -125.18 130.41 73.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.162 0.585 . . . . 75.03 111.733 -174.118 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 46.2 m -74.5 95.94 2.84 Favored 'General case' 0 C--N 1.353 0.736 0 C-N-CA 123.602 0.761 . . . . 54.21 110.369 176.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 35.1 m -123.42 152.29 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.538 0.735 . . . . 72.53 109.564 177.118 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 45.5 ttp180 -107.1 105.7 15.84 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 107.594 -1.262 . . . . 74.22 107.594 170.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 149' ' ' ILE . . . . . . . . . . . . . 31.6 pt -69.52 147.43 96.76 Favored Pre-proline 0 CA--C 1.55 0.946 0 CA-C-O 118.235 -0.888 . . . . 71.41 108.647 170.489 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -35.9 115.75 0.12 Allowed 'Trans proline' 0 C--N 1.394 2.925 0 C-N-CA 124.185 3.256 . . . . 61.44 113.578 -178.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -57.21 95.58 0.06 OUTLIER 'Trans proline' 0 C--N 1.39 2.715 0 C-N-CA 123.052 2.501 . . . . 73.2 111.886 -176.393 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 152' ' ' GLY . . . . . . . . . . . . . . . 109.64 136.11 7.4 Favored Glycine 0 C--N 1.345 1.08 0 CA-C-N 114.785 -1.098 . . . . 54.32 114.873 -174.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 153' ' ' VAL . . . . . 0.442 HG11 HD11 ' C' ' 159' ' ' ILE . 7.0 m -146.61 174.47 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 124.613 1.165 . . . . 71.13 111.077 172.656 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 154' ' ' ARG . . . . . 0.543 ' HB3' ' H ' ' C' ' 188' ' ' LEU . 11.7 ptt180 -124.72 168.74 12.77 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.495 1.118 . . . . 75.32 109.11 174.06 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 155' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -60.03 119.88 8.62 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.319 0.648 . . . . 74.51 111.104 176.102 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 82.27 15.05 75.26 Favored Glycine 0 C--N 1.351 1.368 0 CA-C-N 115.649 -0.705 . . . . 64.51 113.476 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 157' ' ' SER . . . . . . . . . . . . . 34.1 t -75.63 125.59 29.34 Favored 'General case' 0 C--N 1.353 0.736 0 N-CA-C 109.162 -0.681 . . . . 75.43 109.162 176.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 6.0 p -98.5 97.06 5.62 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 CA-C-O 121.844 0.83 . . . . 64.44 109.714 -177.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 159' ' ' ILE . . . . . 0.666 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 58.0 mt -70.71 113.17 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-N 115.179 -0.919 . . . . 52.25 109.678 175.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 160' ' ' ARG . . . . . 0.417 ' HA ' ' O ' ' C' ' 174' ' ' LEU . 61.8 ttt180 -99.22 101.25 12.51 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 109.696 -0.483 . . . . 72.21 109.696 179.006 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 161' ' ' VAL . . . . . 0.682 ' HB ' ' HB3' ' C' ' 174' ' ' LEU . 97.7 t -82.95 119.7 74.79 Favored Pre-proline 0 C--O 1.25 1.116 0 N-CA-C 108.455 -0.943 . . . . 75.24 108.455 174.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -60.64 106.04 0.34 Allowed 'Trans proline' 0 C--N 1.384 2.42 0 C-N-CA 123.335 2.69 . . . . 63.42 113.163 -173.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 163' ' ' GLY . . . . . 0.488 ' O ' ' HB3' ' C' ' 86' ' ' SER . . . 91.06 -25.34 14.5 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 118.581 -1.122 . . . . 53.31 114.927 169.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 164' ' ' MET . . . . . 0.433 ' O ' ' HB2' ' C' ' 174' ' ' LEU . 39.6 ttp -87.39 50.66 2.05 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 118.536 1.168 . . . . 73.35 112.783 -165.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . -125.69 -96.11 1.03 Allowed Glycine 0 N--CA 1.472 1.041 0 N-CA-C 110.665 -0.974 . . . . 64.24 110.665 171.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . 61.98 40.29 98.69 Favored Glycine 0 C--N 1.353 1.475 0 N-CA-C 115.61 1.004 . . . . 75.44 115.61 162.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 167' ' ' GLN . . . . . 0.4 HE22 ' HA ' ' C' ' 141' ' ' ALA . 15.3 mm-40 -64.96 105.26 0.99 Allowed 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 117.155 0.477 . . . . 64.31 110.126 177.689 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . 159.0 -67.91 0.27 Allowed Glycine 0 C--O 1.219 -0.827 0 N-CA-C 110.867 -0.893 . . . . 13.44 110.867 -178.348 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 169' ' ' ASN . . . . . 0.604 ' HB3' ' HD3' ' C' ' 170' ' ' PRO . 26.6 t-20 -173.7 -62.21 0.0 OUTLIER Pre-proline 0 CA--C 1.575 1.916 0 C-N-CA 124.172 0.989 . . . . 62.44 111.569 172.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 170' ' ' PRO . . . . . 0.604 ' HD3' ' HB3' ' C' ' 169' ' ' ASN . 13.4 Cg_exo -72.63 160.34 46.7 Favored 'Trans proline' 0 C--N 1.4 3.259 0 C-N-CA 121.802 1.668 . . . . 51.41 111.618 172.696 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 171' ' ' PRO . . . . . 0.403 ' HB3' ' HA ' ' C' ' 86' ' ' SER . 30.7 Cg_endo -62.79 152.47 78.4 Favored 'Trans proline' 0 C--N 1.374 1.875 0 C-N-CA 122.163 1.909 . . . . 74.02 113.073 177.493 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -130.96 -103.48 0.97 Allowed Glycine 0 C--N 1.341 0.855 0 N-CA-C 109.29 -1.524 . . . . 74.42 109.29 174.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 173' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -170.68 162.91 7.98 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 124.72 1.208 . . . . 74.51 109.474 165.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 174' ' ' LEU . . . . . 0.682 ' HB3' ' HB ' ' C' ' 161' ' ' VAL . 28.3 tp -104.86 137.47 42.58 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.425 0.69 . . . . 75.22 110.523 -175.378 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 96.8 mt -124.08 92.02 3.58 Favored 'General case' 0 C--O 1.246 0.88 0 C-N-CA 124.62 1.168 . . . . 71.32 109.538 177.325 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 176' ' ' LEU . . . . . 0.666 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 74.3 mt -83.21 92.38 7.45 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 108.817 -0.808 . . . . 43.02 108.817 173.311 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 177' ' ' VAL . . . . . . . . . . . . . 96.0 t -83.45 102.24 9.16 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 N-CA-C 107.642 -1.244 . . . . 74.43 107.642 174.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 178' ' ' VAL . . . . . . . . . . . . . 5.9 p -74.83 132.14 33.84 Favored 'Isoleucine or valine' 0 C--O 1.249 1.039 0 CA-C-N 114.433 -1.258 . . . . 74.01 111.693 -173.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 179' ' ' ARG . . . . . 0.527 ' O ' ' HA ' ' C' ' 124' ' ' PRO . 23.0 mmt180 -110.74 103.27 11.79 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 106.844 -1.539 . . . . 72.33 106.844 170.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 180' ' ' LEU . . . . . 0.609 HD13 HD21 ' C' ' 127' ' ' LEU . 83.9 mt -69.92 148.33 49.11 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 116.006 -0.543 . . . . 70.51 111.059 -179.328 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 181' ' ' LEU . . . . . . . . . . . . . 63.5 mt -66.83 166.91 15.77 Favored Pre-proline 0 CA--C 1.552 1.045 0 CA-C-N 115.083 -0.962 . . . . 74.2 111.299 -175.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -57.33 78.1 0.04 OUTLIER 'Trans proline' 0 C--N 1.394 2.936 0 C-N-CA 122.99 2.46 . . . . 64.12 111.815 170.186 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 183' ' ' HIS . . . . . 0.413 ' N ' ' HD3' ' C' ' 184' ' ' PRO . 62.6 t60 176.68 51.65 0.03 OUTLIER Pre-proline 0 CA--C 1.556 1.202 0 C-N-CA 127.772 2.429 . . . . 62.13 105.591 -173.659 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 184' ' ' PRO . . . . . 0.413 ' HD3' ' N ' ' C' ' 183' ' ' HIS . 79.8 Cg_endo -94.47 65.12 0.31 Allowed 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 122.919 2.413 . . . . 71.54 110.903 -169.539 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 185' ' ' VAL . . . . . 0.605 HG12 ' HB1' ' C' ' 195' ' ' ALA . 6.7 t -94.09 -52.64 9.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 108.951 -0.759 . . . . 72.23 108.951 -167.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 186' ' ' PHE . . . . . 0.67 ' HD2' HD13 ' C' ' 127' ' ' LEU . 67.1 m-85 -99.79 121.35 41.15 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.437 0.695 . . . . 61.44 110.288 -169.287 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 187' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -114.99 107.59 15.58 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.066 0.946 . . . . 75.14 108.699 179.525 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 188' ' ' LEU . . . . . 0.543 ' H ' ' HB3' ' C' ' 154' ' ' ARG . 58.8 tp -77.12 140.69 40.31 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.479 1.112 . . . . 74.14 112.964 -171.428 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -142.0 123.58 15.02 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 106.925 -1.509 . . . . 71.33 106.925 163.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 68.02 -111.54 4.1 Favored Glycine 0 CA--C 1.536 1.377 0 N-CA-C 111.526 -0.629 . . . . 74.2 111.526 -172.012 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 191' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -113.89 -10.95 12.89 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 124.086 0.954 . . . . 60.21 110.057 172.454 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -95.96 147.45 23.68 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.029 0.932 . . . . 65.13 109.98 -168.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 193' ' ' LEU . . . . . 0.504 HD21 ' CD2' ' C' ' 240' ' ' PHE . 84.6 mt -104.21 158.25 16.57 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.018 0.527 . . . . 52.2 111.115 -176.15 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 194' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -131.46 106.67 8.38 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 108.119 -1.067 . . . . 75.43 108.119 165.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 195' ' ' ALA . . . . . 0.605 ' HB1' HG12 ' C' ' 185' ' ' VAL . . . -116.15 -177.75 3.24 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.159 0.984 . . . . 65.11 109.549 176.676 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 25.2 m -128.73 111.42 13.13 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 109.32 -0.622 . . . . 51.32 109.32 178.367 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 197' ' ' LEU . . . . . 0.504 HD13 ' HB2' ' C' ' 212' ' ' ALA . 55.2 tp -85.18 130.88 34.52 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.289 1.036 . . . . 73.5 110.497 -179.515 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -89.8 112.14 23.37 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.359 0.663 . . . . 44.52 109.386 174.153 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 199' ' ' VAL . . . . . 0.55 ' HA ' HG11 ' C' ' 210' ' ' VAL . 59.3 t -117.77 113.55 38.04 Favored Pre-proline 0 N--CA 1.471 0.612 0 C-N-CA 124.347 1.059 . . . . 61.21 108.621 177.456 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 200' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' C' ' 256' ' ' THR . 39.7 Cg_endo -68.3 146.25 68.57 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 121.788 1.659 . . . . 71.34 110.907 176.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 201' ' ' ALA . . . . . . . . . . . . . . . -53.23 -46.18 97.98 Favored Pre-proline 0 CA--C 1.56 1.357 0 C-N-CA 124.917 1.287 . . . . 74.35 114.271 -172.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 202' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -59.3 -45.51 26.63 Favored 'Trans proline' 0 C--N 1.397 3.09 0 CA-C-N 121.212 1.469 . . . . 63.15 111.977 178.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 203' ' ' ILE . . . . . . . . . . . . . 42.4 mt -66.1 -30.54 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 123.84 0.856 . . . . 63.4 110.675 178.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.32 -42.69 79.01 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.332 0.653 . . . . 75.02 111.799 178.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 205' ' ' VAL . . . . . 0.515 HG11 HD11 ' A' ' 261' ' ' LEU . 57.5 t -75.71 -46.84 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 116.016 -0.538 . . . . 63.41 111.942 -176.243 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 206' ' ' VAL . . . . . . . . . . . . . 14.1 p -81.14 -28.9 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 CA-C-O 120.743 0.306 . . . . 52.12 111.118 -179.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 80.12 83.13 0.71 Allowed Glycine 0 C--N 1.337 0.624 0 N-CA-C 111.431 -0.668 . . . . 63.21 111.431 -174.2 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -105.92 -127.83 5.98 Favored Glycine 0 C--N 1.34 0.78 0 N-CA-C 110.365 -1.094 . . . . 51.32 110.365 176.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 209' ' ' LYS . . . . . 0.493 ' HG2' ' HA ' ' C' ' 222' ' ' ALA . 8.2 mtmp? -139.19 145.32 39.17 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.494 0.664 . . . . 72.12 110.545 172.343 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 210' ' ' VAL . . . . . 0.55 HG11 ' HA ' ' C' ' 199' ' ' VAL . 34.1 m -126.87 178.6 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.299 1.44 . . . . 62.05 107.671 173.306 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 211' ' ' ARG . . . . . 0.497 ' HD3' ' HB2' ' C' ' 218' ' ' PRO . 33.6 ttm-85 -128.65 124.01 34.65 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 118.522 0.601 . . . . 72.44 112.167 -178.124 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 212' ' ' ALA . . . . . 0.504 ' HB2' HD13 ' C' ' 197' ' ' LEU . . . -97.81 114.24 26.23 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 107.756 -1.202 . . . . 74.43 107.756 166.032 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 213' ' ' MET . . . . . . . . . . . . . 2.3 tmm? -77.06 98.53 5.03 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 107.112 -1.44 . . . . 63.12 107.112 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 214' ' ' THR . . . . . 0.485 ' OG1' HG12 ' C' ' 219' ' ' VAL . 1.0 OUTLIER -100.98 170.67 8.13 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.359 0.599 . . . . 54.24 109.746 -172.991 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' C' C ' 215' ' ' LEU . . . . . 0.442 HD13 ' HB2' ' C' ' 131' ' ' PHE . 8.4 mt -61.94 -43.55 98.61 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.24 1.416 . . . . 44.41 110.956 -173.695 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -93.35 17.83 10.65 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 113.824 -1.535 . . . . 71.0 111.627 -177.089 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 125.44 152.86 8.32 Favored Glycine 0 C--N 1.344 0.982 0 CA-C-N 116.006 -0.543 . . . . 64.11 111.744 178.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 218' ' ' PRO . . . . . 0.497 ' HB2' ' HD3' ' C' ' 211' ' ' ARG . 68.8 Cg_endo -74.98 103.29 1.7 Allowed 'Trans proline' 0 CA--C 1.554 1.507 0 C-N-CA 122.377 2.051 . . . . 52.13 112.517 175.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 219' ' ' VAL . . . . . 0.571 HG23 HG22 ' B' ' 238' ' ' THR . 1.5 p -75.43 127.4 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 122.938 0.495 . . . . 52.53 109.667 178.553 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 220' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -87.0 104.62 16.48 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 107.383 -1.339 . . . . 72.32 107.383 171.203 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 221' ' ' VAL . . . . . . . . . . . . . 47.6 t -71.22 125.96 30.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 125.733 1.613 . . . . 74.03 111.631 -177.414 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 222' ' ' ALA . . . . . 0.493 ' HA ' ' HG2' ' C' ' 209' ' ' LYS . . . -78.55 106.94 10.85 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.174 0.59 . . . . 73.3 109.821 171.504 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 223' ' ' VAL . . . . . 0.407 ' HA ' ' HD3' ' C' ' 224' ' ' PRO . 60.4 t -83.05 132.69 49.95 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 123.906 0.882 . . . . 73.11 109.179 178.491 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 224' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' C' ' 223' ' ' VAL . 2.2 Cg_endo -83.13 156.76 15.0 Favored 'Trans proline' 0 C--N 1.379 2.179 0 C-N-CA 123.271 2.647 . . . . 54.33 110.979 172.612 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -57.64 134.52 63.63 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 122.309 2.006 . . . . 74.0 112.012 174.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 226' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? 70.97 82.16 0.15 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.617 1.167 . . . . 70.15 110.374 177.717 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 227' ' ' THR . . . . . . . . . . . . . 53.2 m -115.91 123.23 47.58 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.775 0.83 . . . . 70.3 110.612 179.447 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 228' ' ' GLN . . . . . 0.579 ' NE2' ' HG2' ' A' ' 259' ' ' GLU . 24.7 mp0 -102.33 150.8 22.96 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.307 1.043 . . . . 74.32 111.197 -179.013 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -72.47 134.11 45.16 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 114.559 -1.2 . . . . 62.12 109.563 176.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 102.88 -6.45 51.75 Favored Glycine 0 C--N 1.339 0.712 0 O-C-N 123.681 0.613 . . . . 62.04 112.375 -173.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 231' ' ' ARG . . . . . 0.411 ' HD2' ' H ' ' C' ' 228' ' ' GLN . 59.6 mtt180 -65.38 171.97 3.54 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 117.266 0.533 . . . . 74.12 110.85 167.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 232' ' ' LYS . . . . . 0.45 ' HA ' ' O ' ' C' ' 251' ' ' LEU . 37.1 ttmt -148.51 124.74 10.83 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.2 -0.455 . . . . 71.45 110.849 -177.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 233' ' ' LEU . . . . . 0.582 ' O ' ' HA ' ' C' ' 250' ' ' TYR . 6.3 mp -84.66 156.9 21.3 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.444 1.098 . . . . 74.21 110.254 174.713 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 234' ' ' ARG . . . . . 0.413 ' HG3' ' HG3' ' B' ' 241' ' ' GLU . 18.2 ptt-85 -128.0 85.2 2.32 Favored 'General case' 0 CA--C 1.553 1.08 0 O-C-N 124.966 1.416 . . . . 72.34 108.527 166.725 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 235' ' ' LEU . . . . . 0.515 HD22 ' H ' ' B' ' 240' ' ' GLY . 49.8 mt -79.0 116.02 19.04 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.434 -0.803 . . . . 73.43 108.849 176.242 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -77.28 129.62 36.12 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 123.219 0.607 . . . . 71.55 111.835 -169.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 76.18 14.74 82.0 Favored Glycine 0 C--N 1.346 1.088 0 O-C-N 124.451 1.095 . . . . 71.42 114.731 177.198 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 14.2 mmtm -98.87 9.65 43.0 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.386 0.674 . . . . 72.03 111.493 -179.228 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 239' ' ' GLY . . . . . 0.417 ' HA2' ' HG ' ' C' ' 193' ' ' LEU . . . -86.88 -169.55 46.0 Favored Glycine 0 C--N 1.346 1.113 0 O-C-N 123.447 0.467 . . . . 31.21 112.763 177.298 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 240' ' ' PHE . . . . . 0.504 ' CD2' HD21 ' C' ' 193' ' ' LEU . 12.8 m-85 -81.35 150.7 67.99 Favored Pre-proline 0 C--O 1.247 0.968 0 CA-C-O 119.167 -0.444 . . . . 75.14 110.005 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 241' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_exo -71.44 96.14 0.72 Allowed 'Trans proline' 0 C--N 1.388 2.647 0 C-N-CA 123.418 2.745 . . . . 70.21 112.341 -175.379 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -83.03 177.52 53.2 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 115.255 -0.884 . . . . 70.14 113.278 178.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -69.82 -18.93 36.46 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 123.134 2.556 . . . . 71.42 112.602 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -111.21 15.51 21.46 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.052 0.941 . . . . 71.42 110.563 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 109.42 177.26 21.33 Favored Glycine 0 C--N 1.354 1.534 0 N-CA-C 111.712 -0.555 . . . . 51.32 111.712 -175.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 246' ' ' ARG . . . . . . . . . . . . . 34.2 mtm180 -71.72 147.81 47.02 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.124 0.569 . . . . 61.31 111.393 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -78.64 -159.0 12.97 Favored Glycine 0 N--CA 1.48 1.59 0 O-C-N 123.43 0.456 . . . . 63.23 113.329 176.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -124.47 135.96 53.64 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 108.944 -0.761 . . . . 73.54 108.944 -175.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 249' ' ' LEU . . . . . 0.5 HD23 HD12 ' C' ' 235' ' ' LEU . 18.7 tp -83.89 121.9 27.98 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.0 0.92 . . . . 74.23 110.397 -179.058 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 250' ' ' TYR . . . . . 0.582 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 23.1 m-85 -101.64 109.94 21.83 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.221 -0.659 . . . . 71.43 109.221 175.655 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 251' ' ' LEU . . . . . 0.558 HD23 ' HB3' ' C' ' 195' ' ' ALA . 68.5 mt -102.64 112.85 25.8 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 116.402 -0.363 . . . . 64.53 110.917 -175.403 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -70.4 128.46 36.27 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 108.537 -0.912 . . . . 73.41 108.537 168.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 253' ' ' VAL . . . . . . . . . . . . . 84.6 t -82.01 122.53 36.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.014 -0.539 . . . . 73.5 110.944 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 254' ' ' ARG . . . . . . . . . . . . . 13.8 mmt180 -102.1 114.42 28.54 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 107.853 -1.166 . . . . 74.13 107.853 164.343 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 255' ' ' ILE . . . . . 0.513 ' O ' ' HB ' ' A' ' 255' ' ' ILE . 34.2 mm -76.7 119.16 24.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 106.455 -1.683 . . . . 75.24 106.455 164.596 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 256' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' C' ' 200' ' ' PRO . 2.3 t -134.4 172.32 13.06 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.594 1.158 . . . . 53.32 109.416 -171.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 257' ' ' ILE . . . . . 0.434 HD12 ' H ' ' C' ' 259' ' ' GLU . 2.9 pp -135.2 156.11 78.38 Favored Pre-proline 0 N--CA 1.482 1.137 0 C-N-CA 123.273 0.629 . . . . 64.54 109.793 -176.242 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -77.43 22.31 0.59 Allowed 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 122.835 2.357 . . . . 73.21 114.952 -170.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 259' ' ' GLU . . . . . 0.434 ' H ' HD12 ' C' ' 257' ' ' ILE . 43.5 mt-10 61.55 -78.49 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.98 1.312 . . . . 72.3 111.098 -174.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.11 178.23 8.2 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.389 0.675 . . . . 73.41 110.026 179.495 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 261' ' ' LEU . . . . . 0.552 HD22 ' HB3' ' C' ' 265' ' ' GLU . 85.6 mt -142.57 151.36 41.48 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.888 0.875 . . . . 71.21 109.504 169.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 66.2 p -82.76 155.36 68.21 Favored Pre-proline 0 N--CA 1.479 0.981 0 N-CA-C 107.689 -1.226 . . . . 61.23 107.689 166.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -39.21 -44.27 2.71 Favored 'Trans proline' 0 C--N 1.381 2.285 0 C-N-CA 123.814 3.009 . . . . 74.2 115.592 178.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -67.43 -50.4 59.55 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.298 0.639 . . . . 71.04 110.826 -178.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 265' ' ' GLU . . . . . 0.552 ' HB3' HD22 ' C' ' 261' ' ' LEU . 47.8 mt-10 -55.31 -52.08 64.64 Favored 'General case' 0 C--N 1.358 0.968 0 O-C-N 123.927 0.767 . . . . 65.11 109.943 176.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 266' ' ' GLU . . . . . 0.444 ' O ' ' HG2' ' C' ' 270' ' ' LYS . 3.7 tp10 -43.98 -56.08 4.2 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.596 1.558 . . . . 64.21 111.209 176.384 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -59.97 -48.85 80.01 Favored 'General case' 0 CA--C 1.549 0.93 0 O-C-N 124.217 0.948 . . . . 70.32 112.503 -176.01 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 268' ' ' LEU . . . . . . . . . . . . . 11.1 mp -65.37 -44.19 88.41 Favored 'General case' 0 N--CA 1.481 1.12 0 O-C-N 123.392 0.433 . . . . 52.44 111.319 -178.372 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 78.3 m95 -61.26 -37.68 83.99 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.558 0.743 . . . . 61.11 111.221 177.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 270' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' C' ' 266' ' ' GLU . 31.1 mmtp -64.73 -47.23 79.03 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.142 0.577 . . . . 75.43 110.695 178.553 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -64.15 -41.46 97.16 Favored 'General case' 0 N--CA 1.484 1.234 0 O-C-N 123.534 0.521 . . . . 75.33 111.486 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 272' ' ' LEU . . . . . 0.478 HD21 ' HB2' ' A' ' 268' ' ' LEU . 69.2 mt -57.92 -45.85 85.88 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 123.92 0.763 . . . . 74.33 110.146 174.336 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -60.67 -44.2 96.74 Favored 'General case' 0 C--O 1.209 -1.063 0 O-C-N 124.4 1.062 . . . . 34.13 111.718 -176.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -63.13 -49.92 72.48 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-O 121.437 0.637 . . . . 63.21 110.428 178.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -61.17 -23.25 65.43 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 114.493 -1.231 . . . . 70.04 111.342 176.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 276' ' ' TYR . . . . . 0.457 ' HB2' ' O ' ' C' ' 272' ' ' LEU . 6.7 t80 -89.46 -31.69 17.57 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.416 1.086 . . . . 75.52 110.665 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 277' ' ' TYR . . . . . 0.438 ' HE1' HG12 ' A' ' 203' ' ' ILE . 22.7 m-85 -68.24 -25.61 65.27 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 109.176 -0.676 . . . . 44.24 109.176 176.318 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -53.48 -26.61 21.25 Favored 'General case' 0 CA--C 1.554 1.13 0 O-C-N 124.331 1.019 . . . . 55.2 112.954 171.18 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 279' ' ' ARG . . . . . . . . . . . . . 26.4 mtm180 -73.5 -16.45 61.28 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 117.898 0.317 . . . . 71.52 111.726 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.087 0 C-N-CA 123.289 0.636 . . . . 75.14 109.764 -177.231 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 114.869 1.433 . . . . 62.43 114.869 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.54 ' HB3' HD11 ' A' ' 10' ' ' ILE . 99.5 mttt -81.21 123.23 28.29 Favored 'General case' 0 C--O 1.245 0.85 0 N-CA-C 108.924 -0.769 . . . . 74.32 108.924 167.642 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.459 ' HA ' ' OH ' ' A' ' 66' ' ' TYR . 37.2 t70 -75.53 103.97 5.89 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 107.58 -1.267 . . . . 61.41 107.58 167.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.404 ' HB2' HD11 ' A' ' 57' ' ' LEU . 38.4 m-85 -61.83 -27.57 68.86 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 114.876 -1.056 . . . . 73.34 111.873 -173.547 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.548 ' HE1' HD11 ' A' ' 22' ' ' ILE . 30.7 m-85 -68.12 -42.26 80.5 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 116.355 -0.384 . . . . 73.33 110.038 175.221 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.21 -45.58 92.69 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.13 0.572 . . . . 60.32 110.403 177.056 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.54 HD11 ' HB3' ' A' ' 5' ' ' LYS . 64.0 mt -52.91 -47.78 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 123.236 0.614 . . . . 74.23 110.41 175.144 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.465 ' HB3' ' HB1' ' A' ' 25' ' ' ALA . 88.6 mt -81.16 -9.47 59.79 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 115.159 -0.928 . . . . 51.33 113.16 -178.164 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.71 27.7 68.66 Favored Glycine 0 CA--C 1.543 1.824 0 N-CA-C 114.412 0.525 . . . . 53.33 114.412 179.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.407 HG13 ' HB2' ' A' ' 25' ' ' ALA . 5.9 m -114.49 162.08 25.28 Favored Pre-proline 0 N--CA 1.486 1.345 0 C-N-CA 124.507 1.123 . . . . 71.43 110.087 176.359 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -64.3 163.72 25.43 Favored 'Trans proline' 0 C--N 1.389 2.688 0 C-N-CA 122.38 2.053 . . . . 50.12 112.769 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 41.1 mtp180 -83.23 41.43 0.76 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.065 0.946 . . . . 75.43 112.135 -170.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.44 ' H ' ' H ' ' A' ' 17' ' ' ALA . 24.7 t-20 -172.86 -5.24 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.053 1.341 . . . . 64.11 109.355 -171.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.44 ' H ' ' H ' ' A' ' 16' ' ' ASN . . . -40.8 131.43 2.42 Favored 'General case' 0 C--N 1.364 1.229 0 C-N-CA 125.879 1.672 . . . . 64.31 112.674 178.284 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 63.2 p -78.29 -178.94 5.96 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.2 0.6 . . . . 71.11 112.249 -174.116 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -46.44 -58.72 3.49 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 124.915 1.286 . . . . 64.21 112.778 -177.045 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -71.1 -33.36 70.1 Favored 'General case' 0 C--O 1.211 -0.966 0 CA-C-O 119.111 -0.471 . . . . 72.43 111.114 -174.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -62.12 -49.29 76.48 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.137 0.494 . . . . 64.03 110.959 179.041 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.548 HD11 ' HE1' ' A' ' 8' ' ' TYR . 71.9 mt -61.76 -42.41 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.123 0.969 . . . . 73.31 110.518 177.205 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -70.85 -28.17 64.38 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.121 -0.945 . . . . 71.24 111.624 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -73.06 -36.94 66.97 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.331 0.653 . . . . 54.12 110.12 175.076 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.465 ' HB1' ' HB3' ' A' ' 11' ' ' LEU . . . -66.95 -39.95 87.42 Favored 'General case' 0 C--O 1.246 0.909 0 O-C-N 124.028 0.83 . . . . 64.0 110.874 175.006 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.472 ' HD1' HG22 ' A' ' 50' ' ' ILE . 48.8 t80 -57.03 -66.87 0.38 Allowed 'General case' 0 C--O 1.203 -1.391 0 CA-C-N 114.398 -1.273 . . . . 73.1 109.08 172.516 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -50.74 -40.93 55.88 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.567 1.147 . . . . 74.22 111.888 -178.245 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.8 ttt180 -57.5 -67.54 0.32 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.247 0.619 . . . . 71.15 110.59 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 83.9 mt -71.72 -22.79 61.58 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.499 -0.773 . . . . 74.11 111.577 -173.29 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.9 -26.14 29.62 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.466 0.707 . . . . 63.3 110.782 -178.386 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 85.0 mtt180 -83.82 -26.48 29.5 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 122.951 0.501 . . . . 72.33 110.551 172.223 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -70.58 -52.18 23.32 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 121.004 0.431 . . . . 63.33 110.393 173.091 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.465 ' HD2' HD11 ' A' ' 50' ' ' ILE . 14.4 m-85 -97.97 35.51 1.71 Allowed 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.988 0.915 . . . . 63.25 109.843 -177.313 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.488 ' CD2' ' HB3' ' A' ' 36' ' ' ASP . 18.3 t60 -76.63 109.91 10.07 Favored Pre-proline 0 N--CA 1.473 0.695 0 C-N-CA 124.763 1.225 . . . . 63.41 110.156 -172.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -52.21 -37.22 69.73 Favored 'Trans proline' 0 C--N 1.379 2.148 0 C-N-CA 123.584 2.856 . . . . 74.13 113.274 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.488 ' HB3' ' CD2' ' A' ' 34' ' ' HIS . 15.9 t70 -64.28 -31.49 72.71 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.93 0.892 . . . . 72.45 111.778 178.76 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 85.3 t -84.79 -54.25 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 122.868 0.467 . . . . 65.53 109.876 176.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -133.9 110.05 9.46 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.319 1.048 . . . . 61.35 109.762 -174.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -85.97 63.7 8.18 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.376 0.671 . . . . 73.11 109.983 -178.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 66.9 m -99.8 112.56 64.0 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-O 117.654 -1.165 . . . . 54.41 108.459 174.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -38.61 -53.54 1.79 Allowed 'Trans proline' 0 C--N 1.39 2.732 0 C-N-CA 124.411 3.408 . . . . 72.23 114.044 -177.37 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -63.12 -35.04 78.96 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.671 0.788 . . . . 64.43 111.816 -178.003 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.451 ' O ' ' HB3' ' A' ' 33' ' ' TYR . . . -71.2 -29.78 65.58 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 122.829 0.452 . . . . 72.14 110.157 176.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -82.54 -26.74 32.16 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 109.422 -0.585 . . . . 62.01 109.422 -178.36 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -69.01 -41.83 77.25 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.913 0.885 . . . . 62.44 109.653 172.457 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 9.7 mptt -64.66 -41.02 96.39 Favored 'General case' 0 C--O 1.212 -0.903 0 CA-C-N 115.315 -0.857 . . . . 74.03 110.271 174.507 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.491 ' HA ' HD12 ' A' ' 50' ' ' ILE . 90.7 t80 -55.78 -45.42 78.18 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.794 0.838 . . . . 73.24 109.684 174.562 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.466 ' HB3' ' HE1' ' A' ' 93' ' ' PHE . 52.4 mtpt -60.25 -41.26 92.84 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.866 0.866 . . . . 75.14 111.435 176.569 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -67.61 -34.47 77.07 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.479 0.712 . . . . 71.44 111.717 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.491 HD12 ' HA ' ' A' ' 47' ' ' PHE . 53.8 mt -69.33 -35.93 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.496 1.118 . . . . 70.53 109.499 174.451 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -83.43 -13.55 54.54 Favored 'General case' 0 C--O 1.206 -1.222 0 C-N-CA 124.224 1.01 . . . . 73.43 111.401 178.506 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -74.27 -56.8 4.47 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 107.646 -1.242 . . . . 63.42 107.646 169.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -52.94 -50.64 63.6 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-N 113.152 -1.84 . . . . 65.45 110.515 177.231 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -66.35 -41.91 88.86 Favored 'General case' 0 C--O 1.205 -1.247 0 CA-C-N 115.296 -0.865 . . . . 72.32 110.857 178.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.62 -39.65 65.11 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 118.76 0.709 . . . . 53.01 111.986 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 61.1 t -70.8 -51.06 39.31 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 CA-C-N 115.794 -0.639 . . . . 74.52 110.748 174.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.454 HD13 HD13 ' A' ' 22' ' ' ILE . 48.6 mt -89.81 -0.1 57.34 Favored 'General case' 0 CA--C 1.568 1.657 0 N-CA-C 113.806 1.039 . . . . 62.04 113.806 -167.069 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 48.0 t -71.07 -51.15 26.89 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 124.091 0.956 . . . . 74.34 111.411 -173.02 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -86.59 125.19 68.07 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 114.613 -1.176 . . . . 74.34 107.87 177.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -53.21 -26.01 32.21 Favored 'Trans proline' 0 C--N 1.374 1.921 0 C-N-CA 123.322 2.681 . . . . 72.41 113.335 178.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -70.93 -56.26 6.61 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.957 0.903 . . . . 72.3 110.911 177.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.496 ' HA ' HD12 ' A' ' 65' ' ' ILE . 46.4 mtpt -66.96 -27.7 67.67 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 123.829 0.852 . . . . 74.54 111.477 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -60.92 -55.5 32.17 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 114.48 -1.236 . . . . 74.11 109.713 171.614 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -54.21 -40.61 67.78 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 124.165 0.916 . . . . 74.25 111.159 177.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.665 HD13 ' HE1' ' A' ' 83' ' ' TYR . 77.3 mt -51.92 -63.78 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.025 0 O-C-N 124.404 1.065 . . . . 64.42 109.265 174.757 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.459 ' OH ' ' HA ' ' A' ' 6' ' ' ASP . 32.6 t80 -50.19 -54.66 19.41 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 119.024 -0.512 . . . . 75.4 112.071 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -43.27 -55.22 4.13 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 124.433 1.083 . . . . 64.04 110.585 -178.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.425 ' HB ' ' HB3' ' A' ' 74' ' ' ALA . 69.1 p -98.47 -2.53 38.73 Favored 'General case' 0 CA--C 1.551 1.019 0 CA-C-N 115.071 -0.968 . . . . 75.13 113.258 -171.271 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -117.78 118.72 32.82 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 118.754 0.706 . . . . 63.45 109.428 -178.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.08 21.81 72.81 Favored Glycine 0 C--N 1.344 0.991 0 CA-C-O 121.6 0.556 . . . . 52.54 112.781 177.398 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 90.6 m -146.67 -51.81 0.22 Allowed 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 103.969 -2.604 . . . . 71.23 103.969 178.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 60.6 m -102.2 161.43 13.7 Favored 'General case' 0 C--O 1.258 1.533 0 CA-C-N 112.198 -2.273 . . . . 74.23 105.165 158.119 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.89 12.3 17.77 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.409 0.683 . . . . 74.04 112.203 179.18 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.425 ' HB3' ' HB ' ' A' ' 68' ' ' THR . . . -70.3 -152.05 0.0 OUTLIER Pre-proline 0 CA--C 1.589 2.456 0 CA-C-O 116.775 -1.583 . . . . 75.1 111.333 176.375 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.427 ' HA ' ' HD2' ' A' ' 76' ' ' PRO . 6.2 Cg_exo 7.76 107.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.412 3.909 0 C-N-CA 124.384 3.39 . . . . 75.41 117.835 -153.026 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 75' ' ' PRO . 28.9 Cg_endo -57.98 -177.44 0.09 OUTLIER 'Trans proline' 0 N--CA 1.518 2.961 0 C-N-CA 124.519 3.48 . . . . 74.25 113.217 174.369 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -39.11 131.49 1.36 Allowed 'Trans proline' 0 C--N 1.402 3.351 0 C-N-CA 123.111 2.54 . . . . 62.44 114.056 173.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.473 ' HG3' ' HE2' ' A' ' 83' ' ' TYR . 0.5 OUTLIER -29.03 123.31 0.05 OUTLIER 'Trans proline' 0 C--N 1.382 2.324 1 C-N-CA 126.105 4.537 . . . . 43.51 117.314 -172.433 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -78.39 156.45 28.96 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 123.137 2.558 . . . . 71.05 114.07 -176.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -56.35 80.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.393 2.915 0 C-N-CA 124.384 3.389 . . . . 51.35 113.191 175.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -178.15 -34.85 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 N-CA-C 109.903 -1.279 . . . . 62.41 109.903 -177.406 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 75.63 168.82 25.41 Favored Glycine 0 C--N 1.353 1.52 0 N-CA-C 115.194 0.838 . . . . 53.03 115.194 171.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.665 ' HE1' HD13 ' A' ' 65' ' ' ILE . 27.0 m-85 -111.06 102.25 10.72 Favored 'General case' 0 C--O 1.243 0.731 0 C-N-CA 124.789 1.236 . . . . 74.41 109.406 178.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -89.49 152.79 21.26 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.148 0.579 . . . . 71.31 110.819 175.267 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -127.65 77.89 1.78 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.386 1.074 . . . . 70.22 108.367 175.153 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 9.0 m -38.37 86.67 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 126.982 2.113 . . . . 74.44 115.505 -172.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 76.03 -7.27 29.8 Favored Glycine 0 C--N 1.35 1.32 0 CA-C-N 116.041 -0.527 . . . . 70.11 113.789 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -89.71 125.29 35.22 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.609 1.164 . . . . 72.34 108.208 -178.331 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -71.71 88.68 0.99 Allowed 'General case' 0 N--CA 1.482 1.139 0 CA-C-O 121.52 0.676 . . . . 71.44 110.082 -175.263 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -47.13 -43.05 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 126.112 1.765 . . . . 75.21 111.949 177.677 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -73.88 -6.5 47.55 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 115.214 -0.903 . . . . 75.33 111.889 -173.229 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -91.64 -27.93 17.81 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.976 0.911 . . . . 45.35 110.787 172.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.466 ' HE1' ' HB3' ' A' ' 48' ' ' LYS . 23.8 m-85 -76.78 -176.2 3.76 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 112.802 0.667 . . . . 71.01 112.802 -170.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 67.8 p -56.86 145.28 30.22 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.194 0.998 . . . . 74.5 112.944 -167.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.63 -41.26 85.55 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.0 -1.0 . . . . 74.31 111.428 177.575 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -58.91 -44.3 91.25 Favored 'General case' 0 C--N 1.355 0.812 0 C-N-CA 123.038 0.535 . . . . 75.03 110.145 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -58.08 -49.64 76.21 Favored 'General case' 0 CA--C 1.555 1.16 0 CA-C-N 116.077 -0.51 . . . . 63.23 109.963 174.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -73.98 -3.92 32.08 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 112.428 0.529 . . . . 73.05 112.428 -178.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -95.73 -60.15 1.71 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.427 0.691 . . . . 70.02 110.398 171.337 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.4 HD23 ' CE2' ' A' ' 101' ' ' PHE . 24.2 tp -58.5 -56.77 17.9 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.916 1.286 . . . . 55.03 110.785 -177.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.4 ' CE2' HD23 ' A' ' 100' ' ' LEU . 92.2 m-85 -84.25 -8.13 59.13 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 114.251 -1.341 . . . . 72.11 111.043 178.497 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -40.65 -66.28 0.88 Allowed Glycine 0 C--N 1.351 1.376 0 N-CA-C 116.114 1.206 . . . . 72.43 116.114 -174.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.452 ' HB2' ' HG2' ' A' ' 78' ' ' PRO . 23.7 Cg_exo -62.6 -14.86 42.43 Favored 'Trans proline' 0 C--N 1.373 1.864 0 C-N-CA 122.749 2.299 . . . . 23.1 114.06 -175.12 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -103.36 -2.23 47.58 Favored Glycine 0 C--N 1.358 1.773 0 CA-C-O 118.91 -0.939 . . . . 44.4 113.825 -177.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.43 ' HB3' ' OD1' ' A' ' 169' ' ' ASN . 86.6 mt -63.32 77.11 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 124.065 0.946 . . . . 74.25 113.007 -177.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 19.65 -105.14 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.256 0 C-N-CA 127.9 2.48 . . . . 72.25 116.36 174.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 71.85 2.88 53.59 Favored Glycine 0 C--N 1.35 1.353 0 CA-C-O 119.576 -0.569 . . . . 44.0 112.664 -164.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.355 1.584 0 O-C-N 123.923 0.425 . . . . 71.34 112.763 -172.631 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 51.7 tttm . . . . . 0 N--CA 1.484 1.228 0 N-CA-C 112.906 0.706 . . . . 72.15 112.906 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -85.99 -178.3 50.0 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 115.7 -0.682 . . . . 55.22 113.646 177.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.437 ' O ' ' HA3' ' A' ' 172' ' ' GLY . 13.4 ptt180 -96.05 173.43 7.43 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.796 0.838 . . . . 71.34 111.061 179.578 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -78.82 138.76 38.33 Favored 'General case' 0 CA--C 1.549 0.941 0 N-CA-C 109.267 -0.642 . . . . 74.23 109.267 166.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 9.3 tt -144.95 139.33 27.48 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 107.966 -1.124 . . . . 70.23 107.966 -173.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.543 ' HA ' ' HB2' ' A' ' 175' ' ' LEU . 2.8 tmm_? -100.26 119.04 37.78 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 108.891 -0.781 . . . . 74.51 108.891 175.2 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.488 ' HB2' HD11 ' A' ' 174' ' ' LEU . . . -111.73 169.87 8.53 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-O 121.7 0.762 . . . . 41.51 110.41 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.413 ' HB2' ' HB3' ' B' ' 9' ' ' ALA . 7.4 mm-40 -120.26 113.42 20.39 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 106.497 -1.668 . . . . 61.0 106.497 -176.427 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 51.1 tp -98.64 98.02 5.53 Favored Pre-proline 0 N--CA 1.473 0.682 0 N-CA-C 108.194 -1.039 . . . . 54.05 108.194 -178.374 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.647 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 73.4 Cg_endo -77.05 114.24 3.77 Favored 'Trans proline' 0 C--N 1.372 1.789 0 C-N-CA 121.32 1.347 . . . . 75.33 108.958 177.194 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.524 ' HA ' HG21 ' B' ' 6' ' ' ILE . 61.6 tp -123.06 139.56 53.95 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.075 0.55 . . . . 64.01 110.687 -169.005 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 27.2 m -68.56 128.86 38.14 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.861 0.864 . . . . 71.34 109.99 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.526 HD23 ' HB3' ' A' ' 180' ' ' LEU . 75.7 mt -50.93 -49.88 58.8 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 124.187 0.995 . . . . 70.54 111.21 -174.178 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -55.93 -49.4 73.59 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.239 -1.346 . . . . 75.32 109.911 -178.057 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -75.06 -19.84 59.82 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 114.631 -1.168 . . . . 64.33 111.677 -176.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -68.86 -43.69 74.88 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.334 0.653 . . . . 41.43 109.723 174.347 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -70.8 -35.51 72.57 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 115.126 -0.943 . . . . 74.51 111.364 176.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -73.65 -39.95 64.09 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 116.202 -0.453 . . . . 75.25 111.885 -178.533 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.581 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 77.29 -166.44 53.67 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-N 116.513 -0.312 . . . . 71.54 113.42 -176.206 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 100.08 179.04 30.32 Favored Glycine 0 C--N 1.35 1.311 0 C-N-CA 122.828 0.251 . . . . 70.42 113.161 176.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.432 ' HB3' ' OG ' ' A' ' 146' ' ' SER . 2.1 mp0 -74.75 100.63 4.07 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 122.96 0.504 . . . . 73.14 110.2 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -90.57 123.99 34.67 Favored 'General case' 0 C--O 1.244 0.8 0 N-CA-C 109.307 -0.627 . . . . 74.4 109.307 -177.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 98.3 t -72.39 108.41 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 N-CA-C 109.043 -0.725 . . . . 71.24 109.043 173.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.557 HG13 HG13 ' A' ' 145' ' ' VAL . 3.1 p -121.57 133.16 68.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 124.752 1.221 . . . . 73.14 108.312 175.737 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -122.42 146.59 47.22 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.037 0.535 . . . . 71.3 110.243 -170.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 10.7 p -163.89 135.03 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 123.26 0.624 . . . . 75.1 110.06 175.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 61.9 19.89 11.05 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.727 1.211 . . . . 74.24 112.871 176.517 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 96.87 -19.91 52.84 Favored Glycine 0 C--N 1.348 1.226 0 CA-C-N 116.386 -0.37 . . . . 31.1 112.844 -176.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -80.31 115.8 20.04 Favored 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 108.58 -0.896 . . . . 72.12 108.58 -179.213 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 42.2 ttt180 -98.38 99.53 10.73 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.187 0.995 . . . . 74.41 109.781 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.557 HG13 HG13 ' A' ' 138' ' ' VAL . 6.7 p -104.37 153.01 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 C-N-CA 123.231 0.612 . . . . 73.53 110.446 -177.357 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.432 ' OG ' ' HB3' ' A' ' 135' ' ' GLU . 32.0 t -124.61 103.99 8.44 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.599 0.759 . . . . 31.45 109.6 -179.057 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 4.8 p -101.38 121.99 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 123.169 0.588 . . . . 73.42 110.646 -175.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -73.84 99.36 3.19 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.422 0.629 . . . . 74.14 109.969 173.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.581 HG13 ' HA2' ' A' ' 133' ' ' GLY . 24.1 pt -80.96 142.89 52.48 Favored Pre-proline 0 CA--C 1.558 1.25 0 CA-C-N 114.608 -1.178 . . . . 74.13 109.622 173.715 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -66.43 136.28 42.63 Favored 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 122.538 2.159 . . . . 60.34 113.24 174.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -56.36 96.9 0.06 OUTLIER 'Trans proline' 0 C--N 1.385 2.45 0 C-N-CA 123.084 2.523 . . . . 74.15 112.409 168.257 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 104.57 39.63 2.35 Favored Glycine 0 C--N 1.339 0.713 0 CA-C-N 115.298 -0.865 . . . . 75.51 111.675 -174.287 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 11.6 p -78.56 140.94 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 N-CA-C 109.158 -0.682 . . . . 75.43 109.158 177.395 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.414 ' NH1' ' HD3' ' A' ' 243' ' ' PRO . 9.5 mtm105 -115.23 147.15 40.7 Favored 'General case' 0 C--O 1.205 -1.264 0 CA-C-N 115.937 -0.574 . . . . 73.23 111.77 -164.775 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -53.77 120.01 5.7 Favored 'General case' 0 CA--C 1.551 0.984 0 O-C-N 124.266 0.979 . . . . 72.32 110.355 175.267 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 105.09 -8.34 45.23 Favored Glycine 0 C--N 1.347 1.14 0 CA-C-N 115.536 -0.757 . . . . 14.21 113.425 -176.292 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 44.1 m -68.32 105.09 2.03 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 117.447 0.623 . . . . 74.23 110.253 177.314 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.444 HG22 HG22 ' A' ' 177' ' ' VAL . 41.5 t -85.17 90.81 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-N 115.117 -0.947 . . . . 72.34 109.31 -178.588 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.599 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 56.9 mt -70.44 91.64 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 108.404 -0.961 . . . . 75.24 108.404 175.333 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 67.9 ttt-85 -78.38 100.05 6.62 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.778 -0.647 . . . . 61.32 109.273 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.6 p -106.6 105.39 54.56 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 123.662 0.785 . . . . 61.33 109.266 177.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.478 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 23.8 Cg_exo -65.25 104.18 0.59 Allowed 'Trans proline' 0 C--N 1.377 2.058 0 C-N-CA 122.551 2.168 . . . . 74.53 111.283 175.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' A' ' 171' ' ' PRO . . . 126.99 25.77 1.18 Allowed Glycine 0 C--N 1.342 0.873 0 N-CA-C 115.801 1.081 . . . . 70.43 115.801 175.513 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 24.7 mmt -137.57 0.44 2.26 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 119.013 1.406 . . . . 64.15 112.057 177.332 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.695 ' HA2' HD13 ' A' ' 174' ' ' LEU . . . -75.85 -108.22 0.12 Allowed Glycine 0 N--CA 1.477 1.404 0 C-N-CA 123.685 0.66 . . . . 73.33 114.274 -170.602 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -58.22 119.05 15.25 Favored Glycine 0 C--N 1.344 0.992 0 N-CA-C 110.051 -1.22 . . . . 74.5 110.051 168.069 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -64.45 109.09 1.83 Allowed 'General case' 0 CA--C 1.538 0.503 0 O-C-N 124.67 0.865 . . . . 75.42 110.056 -175.548 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -146.77 174.14 26.71 Favored Glycine 0 C--N 1.339 0.739 0 N-CA-C 110.1 -1.2 . . . . 64.21 110.1 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' ASN . . . . . 0.447 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . 50.4 t30 -59.61 -61.05 8.66 Favored Pre-proline 0 CA--C 1.565 1.525 0 CA-C-O 118.629 -0.7 . . . . 63.11 109.742 -176.646 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.447 ' HD3' ' HB3' ' A' ' 169' ' ' ASN . 19.6 Cg_endo -94.81 96.16 0.11 Allowed 'Trans proline' 0 C--N 1.382 2.314 0 CA-C-N 121.44 1.55 . . . . 71.13 108.16 154.453 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.44 ' O ' ' HA2' ' A' ' 163' ' ' GLY . 18.1 Cg_exo -61.59 167.41 9.95 Favored 'Trans proline' 0 C--N 1.385 2.473 0 C-N-CA 122.361 2.041 . . . . 71.25 112.638 -169.553 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.437 ' HA3' ' O ' ' A' ' 117' ' ' ARG . . . -85.81 -168.83 45.25 Favored Glycine 0 C--O 1.216 -0.989 0 C-N-CA 121.172 -0.537 . . . . 72.4 113.247 -177.678 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.478 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 13.6 m-20 -72.59 138.69 46.99 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 122.94 0.496 . . . . 71.14 110.467 -176.12 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.695 HD13 ' HA2' ' A' ' 165' ' ' GLY . 25.6 tp -119.21 132.05 55.9 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 110.0 -0.37 . . . . 64.32 110.0 177.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.543 ' HB2' ' HA ' ' A' ' 120' ' ' ARG . 44.6 mt -102.09 85.74 2.73 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 107.999 -1.112 . . . . 72.12 107.999 176.083 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.599 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 79.8 mt -71.72 85.83 0.92 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 109.543 -0.539 . . . . 70.05 109.543 176.679 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.444 HG22 HG22 ' A' ' 158' ' ' VAL . 18.9 t -82.64 102.22 8.33 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 N-CA-C 106.787 -1.56 . . . . 61.43 106.787 178.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 8.2 p -67.92 107.7 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.961 0 CA-C-O 122.516 1.151 . . . . 70.33 110.705 -171.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.647 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 36.0 mmt180 -95.18 100.08 11.95 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.116 -1.402 . . . . 53.32 108.953 175.122 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.526 ' HB3' HD23 ' A' ' 127' ' ' LEU . 26.3 mt -68.98 142.91 54.53 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 109.753 -0.462 . . . . 72.4 109.753 -179.329 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 55.2 mt -53.97 159.06 3.02 Favored Pre-proline 0 N--CA 1.486 1.336 0 C-N-CA 124.281 1.032 . . . . 73.14 113.142 -168.181 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -74.8 28.72 0.35 Allowed 'Trans proline' 0 C--N 1.38 2.215 0 C-N-CA 123.488 2.792 . . . . 71.42 112.485 167.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 64.8 t-80 -60.1 104.83 0.48 Allowed Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 125.722 1.609 . . . . 73.35 106.881 169.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -70.03 24.53 0.18 Allowed 'Trans proline' 0 C--N 1.382 2.34 0 C-N-CA 124.513 3.475 . . . . 61.24 116.801 -160.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 49.1 t -98.92 -50.94 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 118.721 0.691 . . . . 64.21 109.349 178.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 186' ' ' PHE . . . . . 0.485 ' HB3' HD22 ' A' ' 193' ' ' LEU . 82.9 m-85 -127.74 124.8 38.65 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.045 0.538 . . . . 72.31 110.864 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 52.1 ttp85 -103.5 87.96 2.98 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 107.007 -1.479 . . . . 75.51 107.007 164.13 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.459 ' HA ' ' HA ' ' A' ' 193' ' ' LEU . 16.3 tp -66.9 155.84 37.37 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.29 0.636 . . . . 74.21 109.601 177.089 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 189' ' ' GLU . . . . . 0.404 ' H ' HD12 ' A' ' 188' ' ' LEU . 44.7 tt0 -163.92 121.07 1.73 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.236 0.614 . . . . 70.31 109.384 178.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 74.62 -79.23 0.97 Allowed Glycine 0 C--N 1.348 1.238 0 N-CA-C 112.239 -0.344 . . . . 65.41 112.239 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.538 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 3.8 pm0 -146.25 -13.3 0.46 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.567 1.147 . . . . 72.32 110.251 173.514 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -112.03 140.31 46.81 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.285 1.034 . . . . 72.32 111.503 -169.087 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.485 HD22 ' HB3' ' A' ' 186' ' ' PHE . 35.5 mt -90.2 153.88 20.17 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.312 1.445 . . . . 63.44 111.027 -172.354 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -128.2 98.89 5.24 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 107.738 -1.208 . . . . 73.14 107.738 170.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.459 ' HB3' HD23 ' A' ' 251' ' ' LEU . . . -113.08 130.1 56.28 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.755 0.822 . . . . 74.34 109.932 -176.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 41.2 m -77.25 131.43 38.18 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 109.579 -0.526 . . . . 70.21 109.579 -176.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.422 HD22 HD13 ' A' ' 251' ' ' LEU . 57.1 tp -124.91 108.03 11.47 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 123.216 0.606 . . . . 72.21 109.704 -170.642 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -80.72 107.74 13.79 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 108.513 -0.921 . . . . 61.43 108.513 173.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 6.7 p -126.51 130.59 23.85 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 124.055 0.942 . . . . 64.4 108.58 -179.209 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 200' ' ' PRO . . . . . 0.401 ' HB2' ' HE1' ' C' ' 276' ' ' TYR . 72.9 Cg_endo -75.45 157.44 40.88 Favored 'Trans proline' 0 C--N 1.365 1.409 0 C-N-CA 121.627 1.551 . . . . 64.51 111.96 173.334 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.425 ' HB3' ' HD3' ' A' ' 202' ' ' PRO . . . -54.09 -53.29 60.21 Favored Pre-proline 0 CA--C 1.559 1.295 0 N-CA-C 114.177 1.177 . . . . 71.34 114.177 -169.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.425 ' HD3' ' HB3' ' A' ' 201' ' ' ALA . 50.4 Cg_exo -58.5 -35.63 98.43 Favored 'Trans proline' 0 C--N 1.382 2.292 0 C-N-CA 122.02 1.813 . . . . 63.54 113.682 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 46.2 mt -74.51 -33.89 34.03 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 N-CA-C 109.966 -0.383 . . . . 64.32 109.966 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 204' ' ' ALA . . . . . 0.508 ' HA ' HG11 ' A' ' 223' ' ' VAL . . . -67.92 -41.32 82.78 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.303 0.641 . . . . 71.51 111.275 175.036 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.534 HG13 HD11 ' C' ' 261' ' ' LEU . 55.1 t -78.94 -42.16 24.02 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 C-N-CA 123.865 0.866 . . . . 63.23 112.466 -172.697 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 84.6 t -84.17 -33.0 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 122.793 0.437 . . . . 74.41 110.288 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 88.04 48.5 4.08 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-N 115.551 -0.749 . . . . 72.35 111.796 -177.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -76.93 173.86 54.62 Favored Glycine 0 C--N 1.341 0.853 0 N-CA-C 111.334 -0.706 . . . . 55.24 111.334 173.46 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.528 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 46.8 mtmt -84.76 129.92 34.76 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 117.694 0.747 . . . . 45.21 111.915 -178.262 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.42 HG21 HD11 ' A' ' 197' ' ' LEU . 30.2 m -111.56 -172.12 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.961 0 N-CA-C 106.237 -1.764 . . . . 63.11 106.237 161.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 211' ' ' ARG . . . . . 0.508 ' HD3' ' HB2' ' A' ' 218' ' ' PRO . 15.5 ttm180 -127.39 132.16 50.2 Favored 'General case' 0 C--O 1.237 0.432 0 O-C-N 121.954 -0.466 . . . . 71.41 110.353 177.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -99.51 111.75 24.05 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 108.29 -1.004 . . . . 62.04 108.29 174.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 213' ' ' MET . . . . . 0.5 ' HA ' ' HA ' ' A' ' 218' ' ' PRO . 3.5 mpp? -71.93 123.78 23.46 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 108.602 -0.888 . . . . 71.23 108.602 173.584 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 214' ' ' THR . . . . . 0.453 ' HA ' ' HE1' ' A' ' 186' ' ' PHE . 24.5 p -108.81 -177.74 3.4 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 109.405 -0.591 . . . . 74.1 109.405 179.314 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.437 HD11 ' HZ ' ' A' ' 240' ' ' PHE . 61.5 mt -58.82 -27.21 64.88 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.661 1.184 . . . . 63.31 113.141 -171.615 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -142.34 28.84 1.64 Allowed 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 116.323 -0.399 . . . . 64.44 111.222 -175.316 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 155.72 146.59 4.48 Favored Glycine 0 C--N 1.35 1.346 0 O-C-N 121.513 -0.742 . . . . 33.0 114.612 171.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 218' ' ' PRO . . . . . 0.508 ' HB2' ' HD3' ' A' ' 211' ' ' ARG . 72.9 Cg_endo -85.94 108.82 0.98 Allowed 'Trans proline' 0 C--N 1.369 1.613 0 C-N-CA 122.962 2.441 . . . . 70.23 112.567 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 30.1 m -103.05 150.28 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 123.592 0.757 . . . . 73.4 109.648 -178.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -79.36 142.32 36.14 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 117.802 0.273 . . . . 75.04 110.613 -177.272 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 3.9 m -134.1 110.87 14.34 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 C-N-CA 124.163 0.985 . . . . 74.13 108.578 174.719 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.528 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -72.61 114.53 10.85 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 109.145 -0.687 . . . . 60.25 109.145 174.315 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.508 HG11 ' HA ' ' A' ' 204' ' ' ALA . 50.5 t -59.53 146.63 79.46 Favored Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 124.357 1.063 . . . . 63.14 109.425 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -70.75 158.9 54.36 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 121.592 1.528 . . . . 75.51 109.316 169.401 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -72.34 151.46 54.14 Favored 'Trans proline' 0 CA--C 1.549 1.25 0 CA-C-N 119.925 1.009 . . . . 72.53 111.969 171.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 46.1 mtt180 64.82 39.26 6.22 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 125.331 1.452 . . . . 74.04 110.894 169.184 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.604 HG23 HD21 ' A' ' 233' ' ' LEU . 53.2 m -74.42 109.58 8.01 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 112.989 -1.914 . . . . 64.32 111.716 -177.74 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 228' ' ' GLN . . . . . 0.401 ' HB3' ' HD2' ' A' ' 231' ' ' ARG . 5.8 tp60 -84.86 140.96 30.78 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.618 1.167 . . . . 75.32 111.521 -177.642 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -63.31 145.56 55.29 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.061 0.944 . . . . 62.31 112.184 -179.048 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 86.29 -24.89 7.58 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-N 116.334 -0.394 . . . . 73.32 113.355 178.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.401 ' HD2' ' HB3' ' A' ' 228' ' ' GLN . 93.7 mtt180 -69.15 160.83 30.37 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-O 121.46 0.648 . . . . 74.0 110.905 176.162 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.623 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 2.8 mppt? -115.16 114.87 25.85 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.112 -1.07 . . . . 72.22 108.112 178.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.604 HD21 HG23 ' A' ' 227' ' ' THR . 87.9 mt -76.16 103.44 6.2 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 115.46 -0.791 . . . . 71.4 109.905 -175.491 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -76.14 105.09 6.99 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 123.712 0.632 . . . . 64.14 109.982 177.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.5 ' HG ' ' HB3' ' A' ' 249' ' ' LEU . 0.4 OUTLIER -108.45 115.45 30.13 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.006 -1.109 . . . . 61.12 108.006 167.772 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -69.73 141.44 53.46 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 114.651 -1.159 . . . . 64.43 111.978 -167.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 69.98 17.42 73.58 Favored Glycine 0 C--N 1.348 1.221 0 O-C-N 123.936 0.773 . . . . 74.2 113.922 174.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.451 ' HG3' HD12 ' A' ' 235' ' ' LEU . 33.7 mmtp -107.62 5.15 26.65 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.225 0.61 . . . . 73.01 111.086 -176.075 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -101.74 -156.3 26.42 Favored Glycine 0 C--N 1.347 1.19 0 C-N-CA 123.194 0.426 . . . . 74.43 112.659 173.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 240' ' ' PHE . . . . . 0.437 ' HZ ' HD11 ' A' ' 215' ' ' LEU . 3.4 m-85 -94.23 145.18 29.28 Favored Pre-proline 0 N--CA 1.481 1.079 0 C-N-CA 123.136 0.575 . . . . 73.13 111.065 -172.553 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' A' ' 246' ' ' ARG . 37.4 Cg_exo -60.56 119.09 6.07 Favored 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 123.52 2.813 . . . . 73.33 112.85 178.295 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -156.42 -148.19 4.99 Favored Glycine 0 C--N 1.35 1.323 0 CA-C-O 118.548 -1.14 . . . . 73.52 113.746 -173.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 243' ' ' PRO . . . . . 0.538 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 74.2 Cg_exo -51.92 -38.52 68.82 Favored 'Trans proline' 0 C--N 1.39 2.747 0 C-N-CA 124.138 3.225 . . . . 70.45 113.84 -176.752 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -82.98 15.33 2.8 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.821 0.848 . . . . 70.11 112.207 -178.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 81.16 -71.57 2.89 Favored Glycine 0 C--N 1.345 1.048 0 N-CA-C 109.814 -1.314 . . . . 62.24 109.814 -169.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.41 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 23.1 mtp180 -122.12 147.49 46.08 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.491 1.117 . . . . 75.41 108.723 168.493 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -86.14 -177.44 49.89 Favored Glycine 0 C--N 1.339 0.706 0 CA-C-N 116.303 -0.408 . . . . 42.24 112.346 175.525 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -111.45 170.93 7.79 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.29 0.636 . . . . 75.44 110.072 -179.069 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.5 ' HB3' ' HG ' ' A' ' 235' ' ' LEU . 34.0 tp -114.91 134.39 55.19 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.361 -1.348 . . . . 70.31 107.361 170.588 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.623 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 62.0 m-85 -116.38 106.28 13.45 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 107.945 -1.131 . . . . 52.51 107.945 175.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.459 HD23 ' HB3' ' A' ' 195' ' ' ALA . 49.5 mt -90.23 108.2 19.61 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 109.51 -0.552 . . . . 72.24 109.51 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 252' ' ' GLU . . . . . 0.516 ' HG2' ' HG3' ' A' ' 232' ' ' LYS . 30.6 mt-10 -76.33 111.5 11.84 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.663 1.185 . . . . 75.41 109.068 -172.389 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 27.5 t -69.81 119.24 15.49 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 C-N-CA 123.827 0.851 . . . . 24.43 111.902 -168.031 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.28 91.67 3.59 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 107.433 -1.321 . . . . 73.14 107.433 174.268 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.475 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 62.4 mt -78.61 129.68 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 O-C-N 123.204 0.315 . . . . 74.34 110.305 -177.446 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 51.9 p -113.94 166.46 11.57 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.939 0.895 . . . . 73.43 109.703 173.57 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 257' ' ' ILE . . . . . 0.632 HG23 HG21 ' C' ' 255' ' ' ILE . 2.6 pp -118.17 157.52 48.67 Favored Pre-proline 0 CA--C 1.56 1.329 0 C-N-CA 123.735 0.814 . . . . 73.4 110.378 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 258' ' ' PRO . . . . . 0.503 ' HD2' ' HB ' ' A' ' 257' ' ' ILE . 25.7 Cg_endo -56.23 -17.2 19.65 Favored 'Trans proline' 0 N--CA 1.513 2.631 0 C-N-CA 124.42 3.413 . . . . 74.45 115.165 -168.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 50.01 -81.61 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 124.859 1.264 . . . . 63.24 111.659 -166.383 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.6 161.49 29.52 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 120.114 1.325 . . . . 75.12 109.806 173.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.697 HD22 ' HB3' ' A' ' 265' ' ' GLU . 54.6 mt -147.47 146.5 29.55 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.37 0.668 . . . . 55.32 109.936 173.717 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 72.5 p -83.97 161.35 55.67 Favored Pre-proline 0 CA--C 1.551 1.011 0 N-CA-C 107.958 -1.127 . . . . 44.34 107.958 165.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -50.24 -40.25 52.08 Favored 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 123.279 2.653 . . . . 74.33 113.562 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -63.1 -56.99 12.16 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.745 -0.661 . . . . 71.44 110.53 177.585 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 265' ' ' GLU . . . . . 0.697 ' HB3' HD22 ' A' ' 261' ' ' LEU . 53.0 mt-10 -57.38 -35.97 70.66 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 123.626 0.579 . . . . 64.2 111.102 -179.032 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 266' ' ' GLU . . . . . 0.54 ' HA ' HD13 ' A' ' 261' ' ' LEU . 7.3 tp10 -59.69 -50.41 73.96 Favored 'General case' 0 C--O 1.248 0.984 0 C-N-CA 123.985 0.914 . . . . 73.45 109.519 178.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -60.71 -41.54 95.45 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 114.627 -1.169 . . . . 64.12 111.814 177.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 10.1 mp -69.85 -45.28 68.11 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.42 0.688 . . . . 73.14 111.786 -176.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 63.1 m95 -66.68 -35.38 80.02 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.563 0.745 . . . . 75.0 111.62 -179.267 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 270' ' ' LYS . . . . . 0.455 ' HE2' HG23 ' C' ' 206' ' ' VAL . 96.2 mttt -85.22 -16.79 39.09 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 116.216 -0.447 . . . . 62.43 112.142 177.678 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 4.0 mmmp? -74.47 -32.79 62.69 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 110.029 -0.36 . . . . 70.22 110.029 166.533 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 91.6 mt -61.87 -58.24 8.7 Favored 'General case' 0 C--O 1.212 -0.892 0 N-CA-C 108.338 -0.986 . . . . 63.4 108.338 170.459 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -57.5 -32.59 67.16 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.52 1.128 . . . . 64.51 112.793 -177.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -65.17 -62.68 1.4 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.443 0.697 . . . . 74.35 109.35 172.389 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -70.6 -6.35 36.02 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.276 0.631 . . . . 71.44 112.564 -175.105 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -93.64 -80.51 0.39 Allowed 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 107.612 -1.255 . . . . 75.02 107.612 174.066 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -73.27 -38.1 66.06 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.33 -0.85 . . . . 70.12 112.005 -166.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -73.37 -4.54 34.05 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 122.345 -0.222 . . . . 75.41 111.1 178.322 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -120.96 10.74 10.88 Favored 'General case' 0 C--N 1.358 0.961 0 C-N-CA 123.451 0.7 . . . . 74.13 110.059 176.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.142 0 C-N-CA 123.603 0.761 . . . . 72.21 111.314 -178.502 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.435 ' HB3' ' HB3' ' B' ' 4' ' ' SER . 1.5 mpt? . . . . . 0 N--CA 1.477 0.898 0 N-CA-C 110.238 -0.282 . . . . 71.44 110.238 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -79.77 -49.43 12.04 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.189 0.596 . . . . 54.1 110.608 176.11 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -93.88 19.89 8.37 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.312 0.645 . . . . 74.04 112.3 -171.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 4' ' ' SER . . . . . 0.435 ' HB3' ' HB3' ' B' ' 1' ' ' MET . 13.9 p -65.97 -56.31 12.33 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-O 120.945 0.403 . . . . 52.14 110.156 178.393 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 4.1 m 67.78 151.8 0.08 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.501 1.52 . . . . 70.11 112.328 174.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.524 HG21 ' HA ' ' A' ' 125' ' ' LEU . 46.2 pt -130.93 159.99 42.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 123.019 0.527 . . . . 64.44 111.645 -162.267 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -131.93 134.74 45.99 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.828 0.851 . . . . 72.01 110.104 178.447 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 32.7 tp -73.15 144.69 46.81 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.429 0.691 . . . . 75.22 110.378 -176.058 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 9' ' ' ALA . . . . . 0.413 ' HB3' ' HB2' ' A' ' 122' ' ' GLU . . . -80.39 -50.03 10.67 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 122.477 0.311 . . . . 62.4 111.345 178.666 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 31.4 mt 71.22 -25.09 0.17 Allowed 'General case' 0 N--CA 1.504 2.251 0 C-N-CA 125.295 1.438 . . . . 74.1 113.282 -172.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 61.0 mt . . . . . 0 CA--C 1.558 1.278 0 C-N-CA 124.468 1.107 . . . . 45.35 109.649 -168.391 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.13 0 CA-C-O 121.378 0.608 . . . . 61.34 109.979 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . -176.92 -57.57 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 105.869 -1.9 . . . . 74.4 105.869 170.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 46.1 tp -142.75 123.18 13.95 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 106.35 -1.722 . . . . 62.04 106.35 163.196 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 182' ' ' VAL . . . . . 0.7 ' HB ' ' HB2' ' C' ' 123' ' ' LEU . 69.5 t -68.67 131.94 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.064 0.546 . . . . 71.31 110.817 -172.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -119.54 16.78 12.91 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.767 0.827 . . . . 65.24 112.264 -172.134 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -62.18 100.39 0.17 Allowed 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 122.789 0.436 . . . . 74.15 111.138 -178.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 185' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' C' ' 121' ' ' ALA . 60.6 t . . . . . 0 N--CA 1.48 1.048 0 C-N-CA 123.826 0.851 . . . . 71.33 110.102 177.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 90.8 m . . . . . 0 CA--C 1.56 1.348 0 N-CA-C 110.148 -0.316 . . . . 71.31 110.148 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -88.95 168.1 12.66 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 113.88 1.067 . . . . 74.42 113.88 -176.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 240' ' ' GLY . . . . . 0.567 ' H ' HD22 ' C' ' 235' ' ' LEU . . . -102.44 -118.79 4.48 Favored Glycine 0 C--N 1.34 0.766 0 CA-C-N 112.94 -1.936 . . . . 71.23 110.543 176.484 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -161.11 -179.49 7.53 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-O 121.705 0.764 . . . . 71.21 110.334 174.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 242' ' ' TRP . . . . . 0.438 ' CZ3' HG21 ' C' ' 253' ' ' VAL . 2.6 m0 -106.17 -52.57 2.78 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 106.468 -1.678 . . . . 70.32 106.468 174.286 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 243' ' ' GLN . . . . . 0.403 ' CD ' HH21 ' C' ' 231' ' ' ARG . 8.7 pt20 179.76 -152.13 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.139 0 CA-C-N 112.987 -1.915 . . . . 74.22 107.802 -167.041 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -62.02 116.31 9.18 Favored Glycine 0 CA--C 1.542 1.751 0 CA-C-N 117.785 0.266 . . . . 63.11 113.629 175.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? . . . . . 0 CA--C 1.55 0.98 0 C-N-CA 124.052 0.941 . . . . 75.34 108.886 179.181 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.808 0 CA-C-O 121.185 0.517 . . . . 52.01 109.798 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -37.91 123.8 1.1 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.237 1.815 . . . . 70.52 114.951 -174.16 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 22.3 mmtp -93.53 122.68 36.22 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.6 -0.727 . . . . 63.2 109.591 166.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -82.65 86.18 6.89 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 107.48 -1.304 . . . . 63.22 107.48 170.2 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 7' ' ' TYR . . . . . 0.437 ' HB3' ' HA ' ' C' ' 53' ' ' ALA . 73.9 m-85 -61.61 -35.12 76.95 Favored 'General case' 0 C--O 1.244 0.764 0 CA-C-N 114.341 -1.299 . . . . 73.43 111.198 -176.164 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -60.26 -46.86 88.34 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.584 -0.735 . . . . 72.53 110.113 175.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.55 -39.19 92.83 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.888 0.475 . . . . 52.31 111.27 179.204 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 69.0 mt -57.86 -39.79 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 122.984 0.513 . . . . 63.34 110.704 174.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 11' ' ' LEU . . . . . 0.509 HD13 HG23 ' C' ' 22' ' ' ILE . 67.9 mt -79.92 -17.13 53.85 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 122.898 0.479 . . . . 45.45 112.068 176.059 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.66 26.7 45.22 Favored Glycine 0 CA--C 1.537 1.445 0 N-CA-C 113.887 0.315 . . . . 64.33 113.887 -178.175 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 12.3 m -120.0 156.83 54.11 Favored Pre-proline 0 CA--C 1.555 1.167 0 C-N-CA 124.76 1.224 . . . . 64.04 110.069 178.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.62 164.03 36.79 Favored 'Trans proline' 0 C--N 1.383 2.357 0 C-N-CA 122.85 2.366 . . . . 74.43 112.283 177.032 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -70.03 8.06 0.82 Allowed 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 114.068 1.136 . . . . 71.52 114.068 -174.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -128.01 16.13 6.79 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.508 0.723 . . . . 71.24 109.432 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.5 123.44 19.23 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.354 1.062 . . . . 71.14 110.788 178.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 76.0 p -74.0 177.18 5.83 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.303 0.641 . . . . 74.41 111.003 -177.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.46 -55.44 21.92 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 124.269 1.028 . . . . 74.45 111.191 -171.427 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -67.9 -29.11 68.12 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.393 0.677 . . . . 64.05 112.008 -174.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -71.16 -47.37 58.14 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-O 121.12 0.486 . . . . 73.42 110.682 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 22' ' ' ILE . . . . . 0.767 HD13 ' HB3' ' C' ' 57' ' ' LEU . 82.3 mt -57.89 -44.01 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 124.447 1.099 . . . . 61.32 110.27 172.334 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 23' ' ' LYS . . . . . 0.446 ' HG2' ' HE2' ' C' ' 27' ' ' LYS . 79.1 tttt -66.35 -35.86 81.43 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 113.723 -1.58 . . . . 74.13 111.257 -176.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 27.2 mtm180 -78.95 -33.84 44.96 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 123.323 0.649 . . . . 73.52 111.463 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.98 -44.61 95.56 Favored 'General case' 0 C--O 1.257 1.482 0 CA-C-O 121.812 0.815 . . . . 75.32 110.032 173.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 26' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -60.95 -57.89 10.72 Favored 'General case' 0 C--O 1.201 -1.48 0 CA-C-N 113.797 -1.547 . . . . 72.31 110.125 175.064 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 27' ' ' LYS . . . . . 0.446 ' HE2' ' HG2' ' C' ' 23' ' ' LYS . 49.9 mtmt -54.8 -35.55 64.0 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 123.698 0.799 . . . . 74.1 111.142 -176.741 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 39.7 ttp180 -57.13 -57.77 11.14 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.026 0.531 . . . . 71.15 109.75 172.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 29' ' ' LEU . . . . . 0.623 ' HB3' HD13 ' C' ' 50' ' ' ILE . 95.5 mt -74.71 -14.84 60.78 Favored 'General case' 0 CA--C 1.557 1.229 0 CA-C-N 115.686 -0.688 . . . . 60.22 112.586 -177.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.32 -23.46 19.26 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.376 1.07 . . . . 75.32 111.129 -176.162 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -88.86 -35.98 16.25 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 109.041 -0.726 . . . . 73.5 109.041 171.299 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.45 -50.1 55.01 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 122.996 0.518 . . . . 71.12 109.759 -178.632 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -97.43 25.8 5.39 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.886 0.474 . . . . 70.15 111.178 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 34' ' ' HIS . . . . . . . . . . . . . 13.2 t-160 -59.92 106.87 0.83 Allowed Pre-proline 0 N--CA 1.487 1.406 0 CA-C-O 118.708 -0.663 . . . . 72.34 111.324 -173.252 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.06 -22.49 69.7 Favored 'Trans proline' 0 C--N 1.383 2.355 0 C-N-CA 123.351 2.701 . . . . 71.32 113.233 -172.414 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -70.08 -36.48 74.95 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.782 0.833 . . . . 60.34 111.094 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 62.1 t -98.81 -57.54 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 CA-C-O 121.676 0.75 . . . . 75.33 109.266 -179.081 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -94.0 79.49 4.1 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 124.836 1.254 . . . . 54.22 107.979 -178.494 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -75.59 78.85 2.59 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-N 113.738 -1.574 . . . . 62.24 109.196 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 26.7 m -132.54 107.09 13.1 Favored Pre-proline 0 C--O 1.236 0.352 0 N-CA-C 108.35 -0.981 . . . . 74.14 108.35 178.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 41' ' ' PRO . . . . . 0.431 ' O ' ' HG2' ' C' ' 45' ' ' GLU . 48.0 Cg_exo -42.02 -45.7 7.13 Favored 'Trans proline' 0 C--N 1.386 2.512 0 C-N-CA 123.814 3.009 . . . . 63.44 113.308 178.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -59.92 -41.16 91.14 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.672 0.789 . . . . 65.44 111.481 -179.441 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.89 -27.34 65.7 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 115.678 -0.692 . . . . 62.05 109.956 178.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 44' ' ' GLU . . . . . 0.473 ' O ' ' HG3' ' C' ' 48' ' ' LYS . 38.5 mt-10 -79.2 -27.72 42.58 Favored 'General case' 0 C--O 1.215 -0.759 0 O-C-N 123.827 0.704 . . . . 74.04 109.508 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 45' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' C' ' 41' ' ' PRO . 29.6 mm-40 -70.78 -48.08 56.16 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.636 0.774 . . . . 42.53 110.344 177.214 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 46' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -57.89 -42.77 85.32 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 114.8 -1.091 . . . . 72.32 109.484 172.632 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -65.62 -30.15 70.82 Favored 'General case' 0 C--O 1.213 -0.834 0 CA-C-N 115.04 -0.982 . . . . 62.23 111.202 178.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 48' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' C' ' 44' ' ' GLU . 92.8 mttt -64.89 -43.42 92.94 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.057 0.543 . . . . 72.04 110.384 174.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -61.9 -39.69 92.86 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.595 0.712 . . . . 72.33 111.221 177.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 50' ' ' ILE . . . . . 0.623 HD13 ' HB3' ' C' ' 29' ' ' LEU . 79.0 mt -67.35 -34.1 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 CA-C-N 115.018 -0.992 . . . . 75.43 110.468 173.496 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 51' ' ' ASN . . . . . 0.515 ' HB3' ' CD1' ' C' ' 88' ' ' PHE . 70.8 m-20 -76.92 -17.06 59.17 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.586 1.154 . . . . 74.04 111.408 177.745 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -75.48 -51.27 13.39 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 108.103 -1.073 . . . . 63.42 108.103 171.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 53' ' ' ALA . . . . . 0.437 ' HA ' ' HB3' ' C' ' 7' ' ' TYR . . . -55.3 -38.15 68.29 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 113.752 -1.567 . . . . 63.1 111.518 174.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -80.9 -29.87 35.55 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.132 0.973 . . . . 75.01 110.454 178.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.56 -28.21 66.93 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 123.17 0.588 . . . . 60.54 110.559 174.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 21.1 t -92.02 -45.31 14.34 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.166 0 CA-C-N 115.285 -0.871 . . . . 72.43 112.023 175.065 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 57' ' ' LEU . . . . . 0.767 ' HB3' HD13 ' C' ' 22' ' ' ILE . 87.3 mt -104.52 4.58 33.19 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 115.584 1.698 . . . . 75.02 115.584 -163.677 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 38.6 t -66.71 -74.55 0.11 Allowed 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 118.56 0.618 . . . . 62.42 112.414 -177.103 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -66.6 140.97 96.72 Favored Pre-proline 0 C--N 1.349 0.571 0 N-CA-C 108.7 -0.852 . . . . 72.03 108.7 176.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 60' ' ' PRO . . . . . 0.46 ' O ' ' HG2' ' C' ' 64' ' ' ARG . 18.1 Cg_endo -58.29 -27.75 82.05 Favored 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 122.067 1.845 . . . . 33.23 111.013 174.606 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -65.01 -52.23 57.24 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.541 0.736 . . . . 62.13 111.418 175.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 62' ' ' LYS . . . . . 0.557 ' HD3' ' HB3' ' C' ' 84' ' ' ASP . 46.4 mtmt -66.06 -36.49 83.35 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 121.163 0.506 . . . . 75.23 110.72 -178.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 45.0 ttt-85 -57.44 -46.06 84.0 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.14 -0.936 . . . . 64.42 108.74 175.22 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 64' ' ' ARG . . . . . 0.46 ' HG2' ' O ' ' C' ' 60' ' ' PRO . 24.0 mmt180 -68.75 -24.65 64.47 Favored 'General case' 0 C--O 1.213 -0.823 0 CA-C-N 115.442 -0.799 . . . . 74.15 111.999 177.046 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 65' ' ' ILE . . . . . 0.543 HG12 ' HG2' ' C' ' 76' ' ' PRO . 78.4 mt -60.89 -45.28 98.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 108.906 -0.776 . . . . 62.34 108.906 171.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -60.86 -51.38 69.57 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 115.146 -0.933 . . . . 74.22 109.95 174.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -58.01 -40.0 79.69 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.605 0.762 . . . . 73.14 111.862 -177.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 63.5 p -74.64 -24.83 58.89 Favored 'General case' 0 C--O 1.217 -0.615 0 CA-C-O 119.288 -0.387 . . . . 63.2 110.339 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -75.28 120.12 20.32 Favored 'General case' 0 C--N 1.356 0.868 0 N-CA-C 108.653 -0.869 . . . . 75.22 108.653 174.251 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.55 24.87 22.59 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.293 -0.723 . . . . 62.51 111.293 -169.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 56.8 m -145.62 -62.49 0.33 Allowed 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 103.269 -2.863 . . . . 72.34 103.269 171.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 23.6 m -85.1 148.67 26.02 Favored 'General case' 0 C--O 1.254 1.29 0 N-CA-C 105.458 -2.052 . . . . 73.35 105.458 157.342 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.94 -28.56 15.11 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.273 0.629 . . . . 73.23 110.703 176.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -87.56 136.97 32.43 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 123.594 0.757 . . . . 53.23 110.253 178.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -68.51 127.59 15.85 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.435 2.09 . . . . 75.14 110.495 175.115 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 76' ' ' PRO . . . . . 0.543 ' HG2' HG12 ' C' ' 65' ' ' ILE . 9.8 Cg_endo -51.87 132.87 43.8 Favored 'Trans proline' 0 C--N 1.387 2.602 0 C-N-CA 123.058 2.505 . . . . 63.14 111.741 177.469 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -48.08 128.54 16.94 Favored 'Trans proline' 0 C--N 1.387 2.585 0 C-N-CA 123.877 3.051 . . . . 51.51 114.101 -169.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 78' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -67.95 154.72 72.08 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 122.383 2.055 . . . . 74.44 111.574 178.254 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.97 156.39 39.14 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.398 2.065 . . . . 61.04 111.439 170.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -54.75 85.56 0.03 OUTLIER 'Trans proline' 0 C--N 1.388 2.645 0 C-N-CA 123.367 2.712 . . . . 51.5 113.13 177.121 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 153.17 -42.11 0.66 Allowed Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 114.032 -1.44 . . . . 75.2 110.492 -179.651 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 137.54 169.44 11.63 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-N 115.151 -0.525 . . . . 74.45 112.1 178.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -57.93 148.81 24.52 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.008 0.923 . . . . 70.14 110.36 172.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 84' ' ' ASP . . . . . 0.557 ' HB3' ' HD3' ' C' ' 62' ' ' LYS . 18.0 t0 -57.32 130.82 47.95 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 123.739 0.649 . . . . 63.13 111.88 -179.114 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 85' ' ' PHE . . . . . 0.497 ' CD1' ' HB2' ' C' ' 88' ' ' PHE . 0.3 OUTLIER -148.91 32.97 0.76 Allowed 'General case' 0 C--O 1.241 0.624 0 O-C-N 123.625 0.578 . . . . 74.41 111.543 -170.808 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 86' ' ' SER . . . . . 0.592 ' HA ' ' O ' ' C' ' 169' ' ' ASN . 18.3 m -70.89 93.75 1.0 Allowed 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.286 -0.87 . . . . 45.43 112.721 -169.532 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 86.62 10.02 74.01 Favored Glycine 0 C--N 1.346 1.112 0 CA-C-N 114.796 -1.093 . . . . 74.33 113.306 177.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 88' ' ' PHE . . . . . 0.525 ' HB3' ' HE2' ' C' ' 93' ' ' PHE . 10.2 m-85 -92.62 138.18 31.72 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 108.384 -0.969 . . . . 74.44 108.384 -176.55 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -84.32 76.63 10.1 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 122.029 -0.42 . . . . 72.23 110.799 -168.634 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 90' ' ' VAL . . . . . 0.414 HG23 HD22 ' C' ' 105' ' ' LEU . 4.2 p -43.46 -55.53 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 C-N-CA 125.177 1.391 . . . . 54.41 114.594 -176.286 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -70.76 -19.71 62.69 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.52 0.328 . . . . 74.21 111.813 -173.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -87.64 -23.0 24.38 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 110.221 -0.289 . . . . 75.53 110.221 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 93' ' ' PHE . . . . . 0.525 ' HE2' ' HB3' ' C' ' 88' ' ' PHE . 11.9 m-30 -72.35 171.86 11.42 Favored 'General case' 0 C--N 1.352 0.683 0 N-CA-C 113.314 0.857 . . . . 72.45 113.314 -168.726 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 49.7 m -60.24 150.51 29.93 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 114.288 -1.324 . . . . 45.51 112.463 -172.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 95' ' ' GLU . . . . . 0.425 ' O ' ' HG3' ' C' ' 99' ' ' GLU . 0.0 OUTLIER -66.38 -45.05 81.37 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.448 0.699 . . . . 55.43 110.854 -178.542 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -52.09 -44.41 64.38 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.556 1.142 . . . . 65.02 110.946 172.423 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 97' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -66.56 -39.7 88.65 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 114.118 -1.401 . . . . 64.25 110.605 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -76.66 -9.7 58.85 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.644 0.778 . . . . 51.52 112.037 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 99' ' ' GLU . . . . . 0.425 ' HG3' ' O ' ' C' ' 95' ' ' GLU . 51.1 mt-10 -90.28 -47.02 8.03 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.916 0.486 . . . . 74.43 111.102 169.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 25.6 tp -66.6 -50.0 64.48 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.844 0.858 . . . . 73.23 110.808 -176.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -92.54 -1.23 57.09 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.664 -0.698 . . . . 73.25 111.257 177.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -45.47 -61.42 3.69 Favored Glycine 0 C--N 1.356 1.68 0 CA-C-O 118.769 -1.017 . . . . 54.11 114.704 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -46.66 -18.8 0.57 Allowed 'Trans proline' 0 C--N 1.391 2.808 0 C-N-CA 124.511 3.474 . . . . 62.02 114.735 179.173 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -150.62 53.32 0.5 Allowed Glycine 0 C--N 1.347 1.163 0 CA-C-O 119.894 -0.392 . . . . 43.23 112.728 177.34 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 105' ' ' LEU . . . . . 0.414 HD22 HG23 ' C' ' 90' ' ' VAL . 32.6 mt . . . . . 0 N--CA 1.504 2.268 0 N-CA-C 113.94 1.089 . . . . 73.03 113.94 172.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.887 0 N-CA-C 110.197 -1.161 . . . . 45.25 110.197 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' C' C ' 117' ' ' ARG . . . . . 0.438 ' O ' ' HA2' ' C' ' 166' ' ' GLY . 49.8 ttp180 -88.19 116.62 26.52 Favored 'General case' 0 C--O 1.253 1.246 0 N-CA-C 108.96 -0.755 . . . . 64.44 108.96 177.02 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -40.8 120.58 1.32 Allowed 'General case' 0 N--CA 1.483 1.189 0 O-C-N 124.465 1.103 . . . . 75.42 109.908 175.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 119' ' ' LEU . . . . . . . . . . . . . 13.5 tp -94.81 154.36 17.3 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 118.687 -1.205 . . . . 75.21 108.289 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.49 112.71 6.77 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 105.823 -1.917 . . . . 72.31 105.823 -175.403 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 121' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' B' ' 185' ' ' VAL . . . -132.38 116.52 16.95 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 109.002 -0.74 . . . . 63.21 109.002 -177.303 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 122' ' ' GLU . . . . . 0.504 ' HA ' ' O ' ' C' ' 177' ' ' VAL . 13.8 pt-20 -88.91 131.44 35.13 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 109.357 -0.609 . . . . 73.22 109.357 178.085 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 123' ' ' LEU . . . . . 0.7 ' HB2' ' HB ' ' B' ' 182' ' ' VAL . 2.6 pt? -134.86 124.37 16.63 Favored Pre-proline 0 N--CA 1.478 0.964 0 N-CA-C 111.89 0.33 . . . . 73.3 111.89 -170.212 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 124' ' ' PRO . . . . . 0.451 ' HD2' HG11 ' B' ' 182' ' ' VAL . 16.2 Cg_exo -68.95 117.84 5.29 Favored 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 122.924 2.416 . . . . 72.51 110.314 170.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 125' ' ' LEU . . . . . 0.487 HD23 HG11 ' C' ' 153' ' ' VAL . 42.9 tp -143.68 146.77 33.46 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 122.896 0.479 . . . . 74.03 109.785 -169.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 126' ' ' THR . . . . . 0.486 HG23 HD12 ' C' ' 181' ' ' LEU . 34.0 p -93.93 166.75 12.02 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.753 0.787 . . . . 61.53 110.379 171.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 127' ' ' LEU . . . . . 0.549 HD21 HD13 ' C' ' 180' ' ' LEU . 15.2 mt -71.25 -37.7 71.94 Favored 'General case' 0 C--O 1.249 1.065 0 CA-C-N 114.04 -1.436 . . . . 62.25 109.358 178.141 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 11.2 mp0 -61.36 -49.87 75.19 Favored 'General case' 0 C--O 1.216 -0.696 0 CA-C-N 113.085 -1.871 . . . . 75.24 109.134 178.121 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 129' ' ' GLU . . . . . 0.691 ' HA ' ' HB2' ' C' ' 132' ' ' HIS . 28.7 mm-40 -81.52 -7.48 59.59 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 123.848 0.717 . . . . 73.53 111.562 178.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -68.6 -46.34 69.58 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 109.478 -0.564 . . . . 64.34 109.478 166.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 131' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -67.11 -51.27 56.31 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 115.719 -0.673 . . . . 75.55 110.426 169.103 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 132' ' ' HIS . . . . . 0.691 ' HB2' ' HA ' ' C' ' 129' ' ' GLU . 30.6 m170 -74.06 -1.17 18.95 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.694 0.798 . . . . 60.22 111.604 -174.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -63.3 -101.37 0.01 OUTLIER Glycine 0 C--N 1.352 1.453 0 N-CA-C 111.365 -0.694 . . . . 65.31 111.365 165.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 134' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' C' ' 148' ' ' ARG . . . 53.74 -108.49 0.83 Allowed Glycine 0 C--N 1.349 1.253 0 N-CA-C 111.61 -0.596 . . . . 53.24 111.61 -177.61 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -77.13 95.99 4.38 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.173 -1.047 . . . . 71.2 108.173 174.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 136' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.29 138.53 47.88 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 123.755 0.822 . . . . 72.12 109.291 -174.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 137' ' ' VAL . . . . . . . . . . . . . 34.0 m -86.61 131.54 34.51 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 N-CA-C 109.181 -0.674 . . . . 71.12 109.181 174.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 138' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' C' ' 144' ' ' ARG . 7.6 p -133.96 143.74 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.22 1.008 . . . . 72.14 108.464 -176.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 139' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -123.47 82.99 2.07 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.237 0.541 . . . . 74.31 109.813 176.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 140' ' ' VAL . . . . . 0.563 HG11 ' HG2' ' C' ' 164' ' ' MET . 6.9 p -96.34 137.21 24.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 115.299 -0.864 . . . . 63.22 109.226 176.421 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 55.93 28.27 12.37 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 123.978 0.911 . . . . 15.23 111.701 -177.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 72.2 31.19 64.12 Favored Glycine 0 C--N 1.35 1.338 0 CA-C-N 116.343 -0.39 . . . . 45.25 113.394 -179.183 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 143' ' ' ARG . . . . . . . . . . . . . 55.5 ttt180 -128.03 104.3 7.71 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.561 0.744 . . . . 73.04 109.632 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 144' ' ' ARG . . . . . 0.419 ' HA ' ' O ' ' C' ' 138' ' ' VAL . 49.1 ttt180 -85.35 107.42 17.34 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.618 0.767 . . . . 71.51 110.845 -178.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 145' ' ' VAL . . . . . . . . . . . . . 22.7 t -123.05 140.98 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.534 0.734 . . . . 75.03 110.187 178.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 20.0 m -83.13 96.0 8.26 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 108.88 -0.785 . . . . 54.21 108.88 168.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 29.4 m -98.73 157.93 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 123.528 0.731 . . . . 72.53 109.839 -178.652 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 148' ' ' ARG . . . . . 0.461 HH22 ' HB3' ' C' ' 243' ' ' PRO . 62.8 ttt180 -116.73 94.5 4.63 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 108.638 -0.875 . . . . 74.22 108.638 167.518 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 149' ' ' ILE . . . . . . . . . . . . . 19.4 pt -79.03 150.94 75.54 Favored Pre-proline 0 N--CA 1.476 0.863 0 N-CA-C 107.818 -1.179 . . . . 71.41 107.818 170.434 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -53.82 120.85 8.56 Favored 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 122.092 1.861 . . . . 61.44 110.875 176.151 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -60.04 98.39 0.12 Allowed 'Trans proline' 0 C--N 1.386 2.515 0 C-N-CA 122.509 2.139 . . . . 73.2 110.204 177.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 152' ' ' GLY . . . . . 0.433 ' HA2' ' CZ ' ' C' ' 240' ' ' PHE . . . 147.63 145.34 4.16 Favored Glycine 0 C--N 1.347 1.18 0 CA-C-N 115.943 -0.572 . . . . 54.32 113.35 -172.3 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 153' ' ' VAL . . . . . 0.487 HG11 HD23 ' C' ' 125' ' ' LEU . 2.9 p -159.99 155.07 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.314 0 N-CA-C 112.708 0.633 . . . . 71.13 112.708 172.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 154' ' ' ARG . . . . . . . . . . . . . 16.7 ttm180 -120.72 132.07 54.87 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.626 1.57 . . . . 75.32 109.089 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 155' ' ' GLU . . . . . 0.579 ' HB2' HD12 ' C' ' 180' ' ' LEU . 8.3 tp10 -41.61 127.65 3.14 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 124.779 1.232 . . . . 74.51 112.887 175.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 74.04 0.76 57.6 Favored Glycine 0 C--N 1.352 1.429 0 N-CA-C 114.44 0.536 . . . . 64.51 114.44 173.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 157' ' ' SER . . . . . . . . . . . . . 36.1 t -92.71 155.52 17.65 Favored 'General case' 0 C--O 1.255 1.365 0 CA-C-O 121.519 0.676 . . . . 75.43 109.877 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 158' ' ' VAL . . . . . 0.578 HG12 HG22 ' C' ' 177' ' ' VAL . 29.7 m -99.54 122.0 50.84 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 CA-C-N 114.209 -1.36 . . . . 64.44 110.086 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 159' ' ' ILE . . . . . 0.664 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 31.7 mt -80.22 105.14 9.46 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 N-CA-C 107.198 -1.408 . . . . 52.25 107.198 170.711 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 62.0 ttm-85 -74.33 99.25 3.43 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 107.658 -1.238 . . . . 72.21 107.658 173.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 161' ' ' VAL . . . . . . . . . . . . . 2.4 p -117.48 101.97 52.28 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 124.301 1.041 . . . . 75.24 109.736 -178.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.69 145.46 81.41 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.106 1.87 . . . . 63.42 110.144 168.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 99.36 4.05 56.34 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-O 119.468 -0.629 . . . . 53.31 113.857 -176.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 164' ' ' MET . . . . . 0.588 ' SD ' HD23 ' C' ' 174' ' ' LEU . 19.1 ttm -144.42 5.75 1.25 Allowed 'General case' 0 CA--C 1.559 1.293 0 CA-C-N 117.668 0.734 . . . . 73.35 112.698 -174.236 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . -129.43 177.56 17.93 Favored Glycine 0 N--CA 1.488 2.143 0 CA-C-O 118.421 -1.211 . . . . 64.24 113.203 177.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 166' ' ' GLY . . . . . 0.438 ' HA2' ' O ' ' C' ' 117' ' ' ARG . . . 98.28 106.11 2.54 Favored Glycine 0 C--N 1.364 2.087 0 CA-C-N 119.636 1.718 . . . . 75.44 116.366 176.502 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 167' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -99.98 100.18 11.04 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 105.87 -1.9 . . . . 64.31 105.87 160.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . 163.12 -139.11 5.7 Favored Glycine 0 C--O 1.208 -1.521 0 CA-C-O 119.188 -0.784 . . . . 13.44 112.521 -169.517 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 169' ' ' ASN . . . . . 0.623 ' HB3' ' HD3' ' C' ' 170' ' ' PRO . 2.1 t30 -145.3 -66.05 0.02 OUTLIER Pre-proline 0 CA--C 1.574 1.87 0 CA-C-O 116.846 -1.55 . . . . 62.44 111.254 -176.107 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 170' ' ' PRO . . . . . 0.623 ' HD3' ' HB3' ' C' ' 169' ' ' ASN . 73.9 Cg_exo -54.12 142.45 66.43 Favored 'Trans proline' 0 C--N 1.405 3.528 0 CA-C-N 124.046 2.481 . . . . 51.41 112.897 174.061 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 171' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -85.18 150.55 10.7 Favored 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 123.424 2.749 . . . . 74.02 115.22 -161.013 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -160.96 -109.3 0.24 Allowed Glycine 0 C--N 1.357 1.71 0 CA-C-O 118.629 -1.095 . . . . 74.42 113.495 177.262 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 173' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -173.56 171.94 3.76 Favored 'General case' 0 C--O 1.263 1.785 0 CA-C-O 123.782 1.753 . . . . 74.51 115.19 -168.298 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 174' ' ' LEU . . . . . 0.588 HD23 ' SD ' ' C' ' 164' ' ' MET . 9.9 tp -110.89 143.25 41.81 Favored 'General case' 0 C--N 1.353 0.723 0 CA-C-N 112.008 -2.36 . . . . 75.22 108.934 170.143 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 175' ' ' LEU . . . . . 0.439 ' HB3' ' HB ' ' C' ' 158' ' ' VAL . 72.1 mt -106.97 95.68 5.89 Favored 'General case' 0 C--O 1.249 1.036 0 N-CA-C 108.054 -1.091 . . . . 71.32 108.054 171.691 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 176' ' ' LEU . . . . . 0.664 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 67.5 mt -72.61 101.14 2.95 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.767 -0.651 . . . . 43.02 109.913 175.603 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 177' ' ' VAL . . . . . 0.578 HG22 HG12 ' C' ' 158' ' ' VAL . 25.3 t -82.67 96.94 3.95 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 N-CA-C 107.701 -1.222 . . . . 74.43 107.701 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 178' ' ' VAL . . . . . 0.475 HG21 HG11 ' C' ' 153' ' ' VAL . 8.5 p -72.99 135.45 27.68 Favored 'Isoleucine or valine' 0 C--O 1.248 1.003 0 CA-C-O 121.938 0.875 . . . . 74.01 111.62 -172.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 179' ' ' ARG . . . . . 0.416 ' O ' ' HA ' ' C' ' 124' ' ' PRO . 35.3 mmt180 -110.57 94.55 5.06 Favored 'General case' 0 C--O 1.243 0.717 0 N-CA-C 106.596 -1.631 . . . . 72.33 106.596 171.564 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 180' ' ' LEU . . . . . 0.579 HD12 ' HB2' ' C' ' 155' ' ' GLU . 80.0 mt -69.17 136.5 52.2 Favored 'General case' 0 C--N 1.351 0.631 0 CA-C-O 120.981 0.419 . . . . 70.51 110.462 178.572 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 181' ' ' LEU . . . . . 0.486 HD12 HG23 ' C' ' 126' ' ' THR . 98.7 mt -72.88 165.21 54.51 Favored Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 123.806 0.842 . . . . 74.2 111.234 -173.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -53.84 80.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.391 2.78 0 C-N-CA 123.154 2.569 . . . . 64.12 112.478 169.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 183' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -172.93 60.72 0.26 Allowed Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 126.165 1.786 . . . . 62.13 106.373 -175.268 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 184' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -82.51 65.38 8.21 Favored 'Trans proline' 0 C--N 1.384 2.397 0 C-N-CA 123.066 2.511 . . . . 71.54 111.293 -176.346 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 185' ' ' VAL . . . . . . . . . . . . . 17.8 t -95.45 -36.75 6.94 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.593 0 CA-C-N 115.705 -0.68 . . . . 72.23 109.248 -177.087 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 186' ' ' PHE . . . . . 0.408 ' HD1' ' HB2' ' C' ' 195' ' ' ALA . 38.0 m-85 -133.38 157.39 45.66 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.287 1.035 . . . . 61.44 110.825 -178.554 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 187' ' ' ARG . . . . . 0.434 ' HE ' ' HB3' ' C' ' 155' ' ' GLU . 35.8 ttt180 -150.73 131.82 14.37 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 108.967 -0.753 . . . . 75.14 108.967 168.037 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 188' ' ' LEU . . . . . 0.594 HD13 ' HD2' ' C' ' 240' ' ' PHE . 39.5 tp -79.93 146.83 31.9 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 114.266 1.21 . . . . 74.14 114.266 -168.162 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -139.79 100.6 3.99 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 126.157 1.783 . . . . 71.33 106.907 165.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 70.88 -95.9 0.57 Allowed Glycine 0 N--CA 1.477 1.375 0 CA-C-N 116.495 -0.32 . . . . 74.2 112.597 -176.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 191' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -124.4 -14.08 6.99 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.423 1.089 . . . . 60.21 109.805 169.445 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -84.38 153.53 23.39 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.397 0.679 . . . . 65.13 109.456 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 193' ' ' LEU . . . . . 0.524 HD21 ' CE2' ' C' ' 240' ' ' PHE . 89.1 mt -117.32 156.27 28.11 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.26 0.553 . . . . 52.2 111.636 -173.632 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 194' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -121.44 109.45 14.87 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 107.199 -1.408 . . . . 75.43 107.199 168.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 195' ' ' ALA . . . . . 0.633 ' HB3' ' HG ' ' C' ' 251' ' ' LEU . . . -111.42 -177.56 3.23 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 123.576 0.75 . . . . 65.11 111.578 -175.142 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 38.8 m -136.05 118.48 15.77 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.293 -0.867 . . . . 51.32 109.572 170.272 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 197' ' ' LEU . . . . . 0.431 HD13 ' HB2' ' C' ' 212' ' ' ALA . 51.4 tp -98.25 136.38 38.53 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.428 0.691 . . . . 73.5 109.758 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 198' ' ' ASP . . . . . 0.463 ' HB3' HG21 ' C' ' 256' ' ' THR . 66.9 m-20 -101.83 102.0 12.54 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 109.122 -0.696 . . . . 44.52 109.122 179.229 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 199' ' ' VAL . . . . . 0.401 HG22 HG21 ' C' ' 210' ' ' VAL . 21.4 t -107.05 117.15 57.17 Favored Pre-proline 0 N--CA 1.473 0.72 0 N-CA-C 108.41 -0.959 . . . . 61.21 108.41 178.717 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 200' ' ' PRO . . . . . 0.495 ' HD2' HG11 ' C' ' 210' ' ' VAL . 45.4 Cg_endo -69.49 151.76 70.66 Favored 'Trans proline' 0 C--N 1.371 1.718 0 C-N-CA 122.001 1.801 . . . . 71.34 111.81 175.08 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 201' ' ' ALA . . . . . . . . . . . . . . . -54.65 -47.16 98.74 Favored Pre-proline 0 CA--C 1.564 1.489 0 N-CA-C 114.425 1.268 . . . . 74.35 114.425 -171.289 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 202' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -54.49 -51.37 10.65 Favored 'Trans proline' 0 C--N 1.384 2.41 0 C-N-CA 121.813 1.675 . . . . 63.15 112.916 175.133 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 203' ' ' ILE . . . . . 0.459 HG21 HG13 ' C' ' 210' ' ' VAL . 53.9 mt -64.92 -32.86 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.303 0.641 . . . . 63.4 111.032 -178.783 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -63.72 -48.07 78.55 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.737 0.815 . . . . 75.02 111.187 178.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 205' ' ' VAL . . . . . . . . . . . . . 79.5 t -69.35 -43.26 81.19 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 CA-C-N 115.125 -0.943 . . . . 63.41 112.315 -176.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 206' ' ' VAL . . . . . 0.455 HG23 ' HE2' ' A' ' 270' ' ' LYS . 9.1 p -79.26 -36.19 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 123.248 0.343 . . . . 52.12 111.715 -176.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 82.21 71.77 1.29 Allowed Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.773 -0.649 . . . . 63.21 111.912 -168.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -100.81 -128.32 6.33 Favored Glycine 0 C--N 1.342 0.907 0 N-CA-C 111.249 -0.74 . . . . 51.32 111.249 176.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 209' ' ' LYS . . . . . 0.484 ' HG2' ' HA ' ' C' ' 222' ' ' ALA . 8.5 mtmp? -140.7 143.62 35.15 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.207 0.603 . . . . 72.12 110.424 174.056 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 210' ' ' VAL . . . . . 0.495 HG11 ' HD2' ' C' ' 200' ' ' PRO . 30.4 m -135.18 149.93 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 124.453 1.101 . . . . 62.05 108.207 172.399 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 211' ' ' ARG . . . . . 0.406 HH11 ' HB2' ' C' ' 218' ' ' PRO . 8.1 tmm_? -94.94 126.63 40.41 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 122.74 0.416 . . . . 72.44 111.033 -175.628 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 212' ' ' ALA . . . . . 0.431 ' HB2' HD13 ' C' ' 197' ' ' LEU . . . -96.92 118.73 33.98 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 107.201 -1.407 . . . . 74.43 107.201 167.41 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 213' ' ' MET . . . . . . . . . . . . . 4.3 tmm? -76.68 104.96 7.46 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 108.445 -0.946 . . . . 63.12 108.445 -178.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.49 168.74 10.0 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.857 0.837 . . . . 54.24 110.561 -176.321 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 215' ' ' LEU . . . . . . . . . . . . . 14.6 mt -71.53 -32.34 68.05 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 113.636 -1.62 . . . . 44.41 111.66 -168.298 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.28 17.75 19.93 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 114.813 -1.085 . . . . 71.0 111.366 -177.728 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 144.92 164.51 10.65 Favored Glycine 0 C--N 1.355 1.587 0 CA-C-O 119.685 -0.509 . . . . 64.11 112.521 176.039 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 218' ' ' PRO . . . . . 0.406 ' HB2' HH11 ' C' ' 211' ' ' ARG . 94.6 Cg_endo -84.12 113.37 1.8 Allowed 'Trans proline' 0 CA--C 1.552 1.397 0 C-N-CA 122.633 2.222 . . . . 52.13 112.027 177.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 219' ' ' VAL . . . . . . . . . . . . . 12.1 p -93.62 130.65 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 109.941 -0.392 . . . . 52.53 109.941 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 220' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -98.33 105.74 17.93 Favored 'General case' 0 C--N 1.349 0.559 0 N-CA-C 109.184 -0.673 . . . . 72.32 109.184 176.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 221' ' ' VAL . . . . . 0.511 HG11 HD21 ' C' ' 233' ' ' LEU . 70.7 t -73.14 131.74 34.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 125.236 1.414 . . . . 74.03 112.35 -177.033 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 222' ' ' ALA . . . . . 0.484 ' HA ' ' HG2' ' C' ' 209' ' ' LYS . . . -81.19 108.1 14.55 Favored 'General case' 0 CA--C 1.548 0.887 0 O-C-N 123.91 0.756 . . . . 73.3 110.247 169.617 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 83.7 t -81.85 136.19 48.0 Favored Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 124.87 1.268 . . . . 73.11 109.697 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 224' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -83.81 160.2 14.09 Favored 'Trans proline' 0 C--N 1.383 2.366 0 C-N-CA 123.019 2.479 . . . . 54.33 111.8 172.516 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -62.09 140.3 83.29 Favored 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 122.292 1.995 . . . . 74.0 111.4 174.212 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 226' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? 63.31 68.14 0.62 Allowed 'General case' 0 N--CA 1.477 0.883 0 O-C-N 124.243 0.964 . . . . 70.15 110.635 -178.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 227' ' ' THR . . . . . 0.442 ' O ' HG12 ' A' ' 257' ' ' ILE . 16.8 m -93.44 115.17 27.7 Favored 'General case' 0 C--O 1.219 -0.521 0 C-N-CA 123.051 0.54 . . . . 70.3 109.729 176.522 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 228' ' ' GLN . . . . . 0.546 ' H ' ' HD2' ' C' ' 231' ' ' ARG . 2.8 mp0 -89.57 151.36 21.97 Favored 'General case' 0 C--O 1.246 0.895 0 C-N-CA 124.521 1.128 . . . . 74.32 111.94 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -72.17 108.42 5.34 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 113.914 -1.494 . . . . 62.12 109.016 174.169 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 121.0 1.22 11.53 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 119.215 -0.77 . . . . 62.04 113.569 -176.117 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 231' ' ' ARG . . . . . 0.546 ' HD2' ' H ' ' C' ' 228' ' ' GLN . 19.3 mtp180 -71.53 -179.78 2.68 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 118.107 0.953 . . . . 74.12 110.872 172.34 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 232' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' C' ' 251' ' ' LEU . 31.7 ttmt -143.27 144.88 32.31 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.38 0.609 . . . . 71.45 111.76 -176.115 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 233' ' ' LEU . . . . . 0.683 HD13 ' HB2' ' C' ' 251' ' ' LEU . 5.3 mp -114.05 156.98 23.14 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.198 1.399 . . . . 74.21 109.986 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 20.9 ptt180 -129.92 86.11 2.37 Favored 'General case' 0 CA--C 1.553 1.081 0 O-C-N 124.948 1.405 . . . . 72.34 109.19 170.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 235' ' ' LEU . . . . . 0.567 HD22 ' H ' ' B' ' 240' ' ' GLY . 59.6 mt -83.36 98.62 9.56 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 108.464 -0.939 . . . . 73.43 108.464 173.213 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -65.71 133.38 50.94 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.805 0.842 . . . . 71.55 111.273 -175.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 237' ' ' GLY . . . . . 0.405 ' O ' ' HD3' ' C' ' 246' ' ' ARG . . . 77.24 7.29 86.85 Favored Glycine 0 C--N 1.348 1.207 0 O-C-N 123.444 0.465 . . . . 71.42 114.058 179.246 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -105.95 16.3 25.31 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.279 0.632 . . . . 72.03 111.603 -177.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -78.6 -135.06 0.95 Allowed Glycine 0 C--N 1.348 1.214 0 N-CA-C 111.285 -0.726 . . . . 31.21 111.285 170.18 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 240' ' ' PHE . . . . . 0.594 ' HD2' HD13 ' C' ' 188' ' ' LEU . 48.2 m-85 -97.59 116.53 65.82 Favored Pre-proline 0 C--O 1.247 0.964 0 N-CA-C 109.201 -0.666 . . . . 75.14 109.201 168.237 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 241' ' ' PRO . . . . . 0.432 ' HA ' ' HG2' ' C' ' 246' ' ' ARG . 48.9 Cg_exo -59.13 99.99 0.12 Allowed 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 123.446 2.764 . . . . 70.21 113.071 169.46 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -82.82 159.32 37.87 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-N 114.428 -1.26 . . . . 70.14 111.927 175.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 243' ' ' PRO . . . . . 0.461 ' HB3' HH22 ' C' ' 148' ' ' ARG . 59.4 Cg_endo -70.16 -1.71 9.25 Favored 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 122.89 2.394 . . . . 71.42 113.688 -179.586 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -119.47 -10.98 9.56 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.549 0.74 . . . . 71.42 111.425 176.19 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 158.22 157.86 8.69 Favored Glycine 0 C--N 1.346 1.116 0 N-CA-C 112.147 -0.381 . . . . 51.32 112.147 -178.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 246' ' ' ARG . . . . . 0.432 ' HG2' ' HA ' ' C' ' 241' ' ' PRO . 41.8 mtt180 -85.89 146.47 26.7 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.733 0.813 . . . . 61.31 111.576 -179.074 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -82.78 -172.23 48.1 Favored Glycine 0 C--N 1.35 1.349 0 N-CA-C 111.573 -0.611 . . . . 63.23 111.573 165.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -115.7 164.54 14.21 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 117.567 0.683 . . . . 73.54 109.886 -176.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 249' ' ' LEU . . . . . 0.551 HD23 HD12 ' C' ' 235' ' ' LEU . 34.2 tp -113.12 109.19 18.39 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 123.734 0.814 . . . . 74.23 109.08 177.145 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 250' ' ' TYR . . . . . 0.548 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 39.1 m-85 -102.0 103.14 13.74 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 108.97 -0.752 . . . . 71.43 108.97 177.542 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 251' ' ' LEU . . . . . 0.683 ' HB2' HD13 ' C' ' 233' ' ' LEU . 2.8 mp -96.78 147.56 23.8 Favored 'General case' 0 N--CA 1.505 2.275 0 N-CA-C 109.903 -0.406 . . . . 64.53 109.903 -173.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -107.53 137.67 45.14 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 108.883 -0.784 . . . . 73.41 108.883 169.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 253' ' ' VAL . . . . . 0.438 HG21 ' CZ3' ' B' ' 242' ' ' TRP . 45.8 t -89.68 142.59 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 113.377 0.88 . . . . 73.5 113.377 -169.132 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 254' ' ' ARG . . . . . . . . . . . . . 42.8 mtm180 -119.78 145.27 46.75 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.405 1.082 . . . . 74.13 108.255 163.661 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 255' ' ' ILE . . . . . 0.632 HG21 HG23 ' A' ' 257' ' ' ILE . 29.6 mm -98.32 123.46 50.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 107.958 -1.127 . . . . 75.24 107.958 169.199 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 256' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' C' ' 200' ' ' PRO . 0.5 OUTLIER -127.3 172.71 10.37 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.524 1.13 . . . . 53.32 109.215 -173.569 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 257' ' ' ILE . . . . . 0.448 HD12 ' H ' ' C' ' 259' ' ' GLU . 2.8 pp -136.91 157.53 74.6 Favored Pre-proline 0 CA--C 1.567 1.621 0 C-N-CA 124.124 0.969 . . . . 64.54 109.529 177.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -80.98 17.01 1.51 Allowed 'Trans proline' 0 C--N 1.384 2.404 0 C-N-CA 122.775 2.317 . . . . 73.21 114.209 -167.213 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 259' ' ' GLU . . . . . 0.448 ' H ' HD12 ' C' ' 257' ' ' ILE . 31.8 mt-10 55.32 -83.45 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.507 1.123 . . . . 72.3 110.547 -164.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 260' ' ' ARG . . . . . 0.416 ' H ' ' HG2' ' C' ' 260' ' ' ARG . 2.4 ptp85 -78.68 134.75 37.09 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 124.312 1.045 . . . . 73.41 110.812 -174.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 261' ' ' LEU . . . . . 0.534 HD11 HG13 ' A' ' 205' ' ' VAL . 65.3 mt -113.54 154.17 27.56 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 115.065 -0.971 . . . . 71.21 111.347 -170.381 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 52.7 p -83.74 164.05 46.38 Favored Pre-proline 0 CA--C 1.555 1.14 0 N-CA-C 108.31 -0.996 . . . . 61.23 108.31 169.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -51.05 -42.31 53.36 Favored 'Trans proline' 0 C--N 1.382 2.298 0 C-N-CA 122.417 2.078 . . . . 74.2 112.933 173.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -57.82 -58.14 9.68 Favored 'General case' 0 C--O 1.252 1.213 0 C-N-CA 124.058 0.943 . . . . 71.04 110.316 178.279 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -48.01 -67.22 0.29 Allowed 'General case' 0 C--N 1.357 0.91 0 O-C-N 125.056 1.473 . . . . 65.11 109.999 177.169 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 266' ' ' GLU . . . . . 0.524 ' HG3' ' HE2' ' C' ' 270' ' ' LYS . 8.3 tp10 -49.18 -51.33 33.29 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.2 1.4 . . . . 64.21 111.838 -171.012 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -60.7 -49.11 78.84 Favored 'General case' 0 C--O 1.257 1.479 0 CA-C-N 115.582 -0.736 . . . . 70.32 112.012 -177.528 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 268' ' ' LEU . . . . . 0.412 ' O ' ' HG ' ' C' ' 272' ' ' LEU . 7.6 mp -65.39 -38.3 89.58 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.428 -0.806 . . . . 52.44 110.906 -178.57 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 73.1 m95 -58.41 -41.72 85.58 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.103 0.561 . . . . 61.11 110.693 175.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 270' ' ' LYS . . . . . 0.524 ' HE2' ' HG3' ' C' ' 266' ' ' GLU . 68.3 mmtt -56.08 -51.53 67.53 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 123.327 0.392 . . . . 75.43 110.134 176.464 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -56.45 -43.63 79.69 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 114.872 -1.058 . . . . 75.33 111.541 -178.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 272' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' C' ' 268' ' ' LEU . 82.8 mt -65.83 -41.1 92.2 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.14 -0.937 . . . . 74.33 110.656 -179.065 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -59.17 -42.68 91.37 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.758 0.423 . . . . 34.13 110.431 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -63.26 -38.99 93.32 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.23 0.612 . . . . 63.21 111.28 176.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -61.69 -30.04 70.49 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.037 0.535 . . . . 70.04 111.366 174.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 276' ' ' TYR . . . . . 0.401 ' HE1' ' HB2' ' A' ' 200' ' ' PRO . 2.6 m-85 -78.68 -33.86 46.63 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.04 0.536 . . . . 75.52 112.042 176.273 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -63.14 -32.53 73.94 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 120.993 0.425 . . . . 44.24 109.955 170.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -68.48 -14.21 62.85 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 123.587 0.755 . . . . 55.2 112.066 175.427 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 279' ' ' ARG . . . . . . . . . . . . . 42.4 mtm180 -83.86 -16.26 45.11 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 122.749 0.419 . . . . 71.52 110.394 174.395 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.628 0 N-CA-C 108.268 -1.012 . . . . 75.14 108.268 173.582 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? . . . . . 0 N--CA 1.486 1.371 0 N-CA-C 114.135 1.161 . . . . 62.43 114.135 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.472 ' HG2' ' HB3' ' A' ' 96' ' ' PHE . 70.5 mmtt -93.44 94.32 8.63 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 107.907 -1.145 . . . . 74.32 107.907 171.158 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.41 ' O ' HG13 ' A' ' 10' ' ' ILE . 49.3 t0 -69.37 95.71 0.82 Allowed 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 107.305 -1.368 . . . . 61.41 107.305 173.09 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -61.82 -35.32 77.89 Favored 'General case' 0 C--O 1.244 0.803 0 O-C-N 124.121 0.888 . . . . 73.34 112.252 -171.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -65.04 -45.91 83.47 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.079 -0.51 . . . . 73.33 110.045 177.111 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.01 -37.86 84.02 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 123.435 0.459 . . . . 60.32 111.119 179.145 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.41 HG13 ' O ' ' A' ' 6' ' ' ASP . 68.3 mt -61.7 -39.58 83.73 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 C-N-CA 123.367 0.667 . . . . 74.23 110.318 175.651 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 92.9 mt -80.3 -5.52 56.42 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 112.543 0.572 . . . . 51.33 112.543 176.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.23 34.24 58.23 Favored Glycine 0 C--N 1.354 1.577 0 O-C-N 123.146 0.279 . . . . 53.33 113.396 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 23.8 m -133.23 158.77 74.91 Favored Pre-proline 0 CA--C 1.559 1.295 0 C-N-CA 124.853 1.261 . . . . 71.43 109.622 -177.393 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -75.3 166.55 28.63 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 122.417 2.078 . . . . 50.12 112.145 176.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -70.49 9.84 0.57 Allowed 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 113.706 1.002 . . . . 75.43 113.706 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -116.86 -1.19 12.07 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.493 1.117 . . . . 64.11 108.897 -177.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.63 121.73 14.62 Favored 'General case' 0 C--N 1.347 0.492 0 C-N-CA 124.477 1.111 . . . . 64.31 110.133 176.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.7 p -75.07 173.0 11.35 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.543 0.737 . . . . 71.11 110.931 -176.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -58.02 -33.11 68.61 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.796 0.839 . . . . 64.21 110.801 178.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.448 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 16.9 tp10 -58.0 -49.57 76.37 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.149 0.98 . . . . 72.43 110.567 171.54 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -70.68 -30.01 66.47 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.477 0.711 . . . . 64.03 111.85 -176.435 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.4 mp -69.25 -39.93 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 123.718 0.807 . . . . 73.31 109.213 174.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -64.0 -42.52 97.13 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 124.122 0.889 . . . . 71.24 110.357 178.242 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.52 ' HA ' ' HD3' ' A' ' 27' ' ' LYS . 66.2 mtm180 -68.69 -44.72 73.38 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.087 0.555 . . . . 54.12 110.849 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.2 -40.31 89.6 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.434 -0.803 . . . . 64.0 110.243 177.055 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -64.92 -47.73 76.67 Favored 'General case' 0 C--O 1.201 -1.486 0 CA-C-N 115.164 -0.926 . . . . 73.1 110.6 177.29 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.52 ' HD3' ' HA ' ' A' ' 24' ' ' ARG . 25.4 mtpp -50.07 -47.74 53.47 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 123.674 0.789 . . . . 74.22 110.428 178.401 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.436 ' HA ' ' NH2' ' A' ' 31' ' ' ARG . 8.1 tpt180 -56.52 -56.19 24.39 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 114.326 -1.306 . . . . 71.15 111.285 176.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.621 HD22 ' HE2' ' A' ' 33' ' ' TYR . 64.5 mt -82.62 -12.06 57.94 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.594 0.758 . . . . 74.11 112.297 -171.132 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 34' ' ' HIS . . . -93.37 -18.79 21.99 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.733 0.813 . . . . 63.3 110.015 179.106 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.436 ' NH2' ' HA ' ' A' ' 28' ' ' ARG . 48.8 mtm180 -84.96 -44.98 12.62 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 123.311 0.382 . . . . 72.33 110.204 165.088 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -67.5 -48.29 67.51 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.43 0.692 . . . . 63.33 111.03 -174.12 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.621 ' HE2' HD22 ' A' ' 29' ' ' LEU . 60.6 m-85 -102.9 24.82 10.11 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.169 0.588 . . . . 63.25 111.308 -176.01 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.486 ' CD2' ' HB3' ' A' ' 36' ' ' ASP . 48.8 t60 -71.09 102.05 0.44 Allowed Pre-proline 0 N--CA 1.482 1.141 0 C-N-CA 124.362 1.065 . . . . 63.41 110.726 -177.018 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.507 ' HB3' ' HG2' ' A' ' 44' ' ' GLU . 23.6 Cg_exo -62.06 -25.8 77.78 Favored 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 123.066 2.511 . . . . 74.13 113.29 -168.555 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.486 ' HB3' ' CD2' ' A' ' 34' ' ' HIS . 8.0 t70 -62.92 -40.18 96.83 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.117 1.367 . . . . 72.45 112.208 179.109 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 98.5 t -103.83 -44.7 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-O 121.431 0.634 . . . . 65.53 109.684 -177.559 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -98.44 83.1 2.97 Favored 'General case' 0 C--O 1.243 0.721 0 C-N-CA 124.344 1.057 . . . . 61.35 108.333 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -78.26 79.22 4.71 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.146 -0.934 . . . . 73.11 108.616 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 74.3 m -138.71 115.62 8.9 Favored Pre-proline 0 CA--C 1.542 0.671 0 CA-C-N 115.297 -0.865 . . . . 54.41 108.985 178.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_exo -46.15 -42.83 21.34 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 124.213 3.275 . . . . 72.23 114.353 -178.413 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -51.33 -49.82 60.64 Favored 'General case' 0 N--CA 1.482 1.161 0 O-C-N 124.245 0.966 . . . . 64.43 110.49 175.124 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.26 -26.85 67.54 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-N 114.676 -1.147 . . . . 72.14 111.602 -177.201 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.507 ' HG2' ' HB3' ' A' ' 35' ' ' PRO . 39.8 mt-10 -81.68 -34.48 30.67 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 122.86 0.464 . . . . 62.01 110.964 -173.041 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -82.3 -32.44 29.48 Favored 'General case' 0 C--O 1.246 0.897 0 N-CA-C 110.305 -0.257 . . . . 62.44 110.305 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 36.5 mmtm -62.54 -40.63 97.4 Favored 'General case' 0 C--N 1.348 0.502 0 CA-C-N 115.715 -0.675 . . . . 74.03 109.369 167.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -60.16 -38.63 83.74 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.555 0.742 . . . . 73.24 110.489 175.367 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -56.74 -57.49 12.2 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 120.793 0.33 . . . . 75.14 110.341 174.482 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -58.61 -41.43 85.85 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 115.151 -0.931 . . . . 71.44 111.786 -176.105 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.457 HD13 ' HB3' ' A' ' 29' ' ' LEU . 77.3 mt -74.33 -33.1 32.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.777 1.231 . . . . 70.53 111.217 -176.755 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -88.31 -10.58 49.04 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 119.237 -0.411 . . . . 73.43 111.28 179.357 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -75.89 -49.19 18.59 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 108.06 -1.089 . . . . 63.42 108.06 166.118 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -53.5 -46.9 70.21 Favored 'General case' 0 C--N 1.35 0.623 0 CA-C-N 113.625 -1.625 . . . . 65.45 111.307 174.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -69.05 -44.66 72.21 Favored 'General case' 0 C--O 1.216 -0.662 0 CA-C-N 115.026 -0.988 . . . . 72.32 110.618 177.15 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.409 ' HB2' ' CD2' ' A' ' 88' ' ' PHE . . . -50.1 -37.74 35.32 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.41 0.684 . . . . 53.01 112.224 -179.003 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 88.3 t -76.86 -57.74 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.971 0 CA-C-N 115.267 -0.878 . . . . 74.52 110.943 175.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 65.9 mt -87.22 6.04 35.12 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 113.619 0.97 . . . . 62.04 113.619 -166.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 37.2 t -73.03 -42.15 63.46 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 124.154 0.981 . . . . 74.34 111.349 -178.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -116.25 138.22 24.09 Favored Pre-proline 0 N--CA 1.471 0.579 0 CA-C-N 115.112 -0.949 . . . . 74.34 108.483 -171.022 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -58.61 -20.95 52.81 Favored 'Trans proline' 0 C--N 1.383 2.375 0 C-N-CA 123.844 3.029 . . . . 72.41 113.416 -172.241 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -66.6 -70.01 0.27 Allowed 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.622 0.769 . . . . 72.3 110.867 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt -67.22 -25.28 66.03 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.698 0.799 . . . . 74.54 110.894 -178.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -54.97 -56.92 14.34 Favored 'General case' 0 C--N 1.35 0.614 0 CA-C-N 114.791 -1.095 . . . . 74.11 109.702 169.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -58.13 -37.91 75.5 Favored 'General case' 0 C--N 1.364 1.236 0 O-C-N 123.784 0.677 . . . . 74.25 111.362 178.03 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.564 HG23 ' HG2' ' A' ' 76' ' ' PRO . 1.7 mp -54.31 -48.64 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 123.521 0.513 . . . . 64.42 110.997 175.431 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -69.72 -43.13 73.0 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 119.43 -0.319 . . . . 75.4 110.88 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -57.68 -39.95 78.3 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.156 0.582 . . . . 64.04 111.344 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 63.1 p -74.17 -25.5 59.76 Favored 'General case' 0 C--N 1.347 0.495 0 CA-C-N 115.617 -0.72 . . . . 75.13 110.6 177.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -72.86 136.41 45.32 Favored 'General case' 0 CA--C 1.551 0.983 0 N-CA-C 108.752 -0.833 . . . . 63.45 108.752 169.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.95 18.0 56.88 Favored Glycine 0 N--CA 1.471 1.007 0 N-CA-C 111.513 -0.635 . . . . 52.54 111.513 -171.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 34.9 m -144.33 -58.81 0.38 Allowed 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 103.415 -2.809 . . . . 71.23 103.415 176.419 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 51.3 m -80.93 142.82 33.14 Favored 'General case' 0 C--O 1.25 1.127 0 N-CA-C 105.411 -2.07 . . . . 74.23 105.411 156.17 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.67 -25.22 13.23 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.66 0.784 . . . . 74.04 110.637 178.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.98 143.19 77.29 Favored Pre-proline 0 C--O 1.245 0.843 0 C-N-CA 123.71 0.804 . . . . 75.1 110.094 175.245 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.416 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 34.0 Cg_endo -62.55 143.56 93.06 Favored 'Trans proline' 0 C--N 1.371 1.761 0 C-N-CA 122.224 1.95 . . . . 75.41 109.921 170.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.564 ' HG2' HG23 ' A' ' 65' ' ' ILE . 31.6 Cg_exo -59.98 144.37 99.47 Favored 'Trans proline' 0 C--N 1.371 1.741 0 C-N-CA 122.831 2.354 . . . . 74.25 112.293 -179.132 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.53 119.21 6.27 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 122.647 2.231 . . . . 62.44 111.421 176.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -65.74 134.35 37.45 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 122.76 2.307 . . . . 43.51 112.78 -173.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -72.92 145.49 40.34 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.387 2.058 . . . . 71.05 111.201 174.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -59.88 87.01 0.07 OUTLIER 'Trans proline' 0 C--N 1.384 2.402 0 C-N-CA 122.924 2.416 . . . . 51.35 111.605 178.55 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 155.26 -46.67 0.52 Allowed Glycine 0 C--N 1.332 0.308 0 N-CA-C 109.141 -1.584 . . . . 62.41 109.141 -176.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.489 ' HA3' ' HA ' ' A' ' 106' ' ' PHE . . . 117.01 -174.01 14.99 Favored Glycine 0 C--N 1.346 1.102 0 CA-C-N 115.575 -0.313 . . . . 53.03 113.55 174.803 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -92.78 130.45 38.39 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.825 0.85 . . . . 74.41 110.655 -178.31 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.65 158.19 30.63 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 124.464 1.103 . . . . 71.31 110.432 174.289 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -153.35 75.33 1.06 Allowed 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 107.93 -1.137 . . . . 70.22 107.93 177.504 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.511 ' HA ' ' HE3' ' A' ' 164' ' ' MET . 12.9 m -38.4 84.87 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 127.229 2.212 . . . . 74.44 116.536 -164.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 71.69 20.17 78.42 Favored Glycine 0 C--N 1.342 0.88 0 N-CA-C 114.791 0.676 . . . . 70.11 114.791 174.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.421 ' HB3' ' CE2' ' A' ' 93' ' ' PHE . 35.0 m-85 -122.04 135.87 54.87 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 123.62 0.768 . . . . 72.34 109.454 -174.607 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -74.9 88.47 2.32 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 115.842 -0.617 . . . . 71.44 111.22 -171.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.6 p -33.11 -47.9 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.562 1.426 0 C-N-CA 126.34 1.856 . . . . 75.21 113.529 169.239 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -64.76 -22.85 67.07 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.048 0.939 . . . . 75.33 111.984 -170.372 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -89.38 -27.74 20.24 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.216 0.606 . . . . 45.35 112.437 -178.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.421 ' CE2' ' HB3' ' A' ' 88' ' ' PHE . 40.1 m-85 -75.7 173.93 10.45 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 113.288 0.847 . . . . 71.01 113.288 -166.466 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 53.2 p -71.56 175.43 5.58 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 114.655 1.354 . . . . 74.5 114.655 -161.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -67.23 -50.64 59.95 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 113.562 -1.654 . . . . 74.31 110.374 -174.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.472 ' HB3' ' HG2' ' A' ' 5' ' ' LYS . 72.5 t80 -54.01 -41.06 67.55 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 124.48 1.113 . . . . 75.03 111.729 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -60.46 -51.97 67.2 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 115.384 -0.825 . . . . 63.23 110.121 172.367 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.527 ' HA ' HD11 ' A' ' 105' ' ' LEU . 46.8 mt-30 -70.04 -3.14 14.99 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.609 0.763 . . . . 73.05 112.281 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -98.29 -47.98 5.24 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.191 0.996 . . . . 70.02 111.684 170.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 52.8 tp -73.4 -50.77 20.05 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.394 0.678 . . . . 55.03 110.531 -172.056 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -90.11 -7.44 53.75 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.363 -0.835 . . . . 72.11 110.067 175.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.418 ' HA2' ' HG ' ' A' ' 105' ' ' LEU . . . -44.64 -59.1 4.42 Favored Glycine 0 C--N 1.364 2.096 0 CA-C-O 118.058 -1.412 . . . . 72.43 115.078 -178.078 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -40.56 -25.8 0.2 Allowed 'Trans proline' 0 C--N 1.391 2.809 0 C-N-CA 124.687 3.591 . . . . 23.1 115.739 178.089 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -149.11 54.79 0.5 Allowed Glycine 0 C--N 1.348 1.216 0 N-CA-C 111.461 -0.656 . . . . 44.4 111.461 177.319 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.527 HD11 ' HA ' ' A' ' 98' ' ' GLN . 13.4 mt -69.0 73.3 0.27 Allowed 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 117.468 0.634 . . . . 74.25 110.998 171.142 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.613 ' CG ' ' HA3' ' A' ' 168' ' ' GLY . 0.1 OUTLIER 43.97 -115.02 0.39 Allowed 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 125.639 1.576 . . . . 72.25 113.152 177.769 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.459 ' H ' ' HB3' ' A' ' 106' ' ' PHE . . . 60.8 20.86 57.65 Favored Glycine 0 C--N 1.36 1.863 0 CA-C-O 119.712 -0.493 . . . . 44.0 112.965 -168.61 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.36 1.903 0 N-CA-C 111.577 -0.609 . . . . 71.34 111.577 -171.89 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 22.5 tptm . . . . . 0 N--CA 1.479 1.011 0 CA-C-O 120.498 0.189 . . . . 72.15 110.953 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.602 ' HA2' ' HA ' ' A' ' 170' ' ' PRO . . . -106.37 177.42 22.19 Favored Glycine 0 CA--C 1.5 -0.886 0 N-CA-C 122.751 3.86 . . . . 55.22 122.751 -162.658 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -120.97 150.18 41.51 Favored 'General case' 0 C--O 1.266 1.926 0 CA-C-N 111.197 -2.501 . . . . 71.34 110.034 175.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -66.21 149.95 49.54 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.837 1.255 . . . . 74.23 112.466 -174.235 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 10.0 tt -149.32 147.05 27.87 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.881 -0.785 . . . . 70.23 108.881 178.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.497 HH21 HG21 ' A' ' 177' ' ' VAL . 33.8 mtp-105 -94.26 122.76 37.13 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.011 0.524 . . . . 74.51 109.961 176.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.466 ' HB2' HD11 ' A' ' 174' ' ' LEU . . . -113.57 166.63 11.33 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.549 -0.908 . . . . 41.51 108.549 171.115 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -127.59 118.9 24.79 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.666 -1.235 . . . . 61.0 107.666 -174.085 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 25.4 tp -99.92 99.76 9.84 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 108.611 -0.885 . . . . 54.05 108.611 -169.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.493 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 56.3 Cg_endo -73.61 113.55 3.81 Favored 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 121.69 1.594 . . . . 75.33 108.637 176.04 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.553 ' HA ' HG21 ' B' ' 6' ' ' ILE . 28.0 tp -120.82 138.43 54.05 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 123.44 0.696 . . . . 64.01 109.848 -169.477 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.437 HG21 ' H ' ' B' ' 4' ' ' SER . 96.6 m -67.79 128.85 38.01 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 114.408 -1.269 . . . . 71.34 110.062 176.591 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.898 ' HB3' HD22 ' A' ' 215' ' ' LEU . 8.2 mt -54.8 -47.63 73.78 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 122.264 1.031 . . . . 70.54 111.914 -173.5 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 16.7 mp0 -62.28 -44.04 97.45 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 113.292 -1.776 . . . . 75.32 109.997 -177.019 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -76.57 -20.09 57.2 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 115.577 -0.738 . . . . 64.33 111.798 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.515 ' HB1' ' O ' ' A' ' 153' ' ' VAL . . . -69.26 -39.98 78.1 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.523 0.729 . . . . 41.43 109.636 175.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -75.78 -38.91 57.86 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 115.06 -0.973 . . . . 74.51 111.564 176.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 54.4 m170 -71.25 -35.51 71.45 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 122.565 0.346 . . . . 75.25 111.188 -178.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.94 -141.15 26.83 Favored Glycine 0 C--N 1.344 1.012 0 CA-C-N 116.069 -0.514 . . . . 71.54 113.039 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 84.09 -175.48 51.5 Favored Glycine 0 C--N 1.348 1.249 0 C-N-CA 123.254 0.454 . . . . 70.42 113.036 178.002 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.445 ' HB3' ' OG ' ' A' ' 146' ' ' SER . 1.2 mp0 -72.29 111.87 7.87 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.249 0.62 . . . . 73.14 109.588 174.399 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 8.3 tpp180 -93.65 119.32 32.52 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.246 0.618 . . . . 74.4 109.611 -178.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 74.9 t -81.65 105.37 11.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 108.326 -0.99 . . . . 71.24 108.326 175.404 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.0 p -124.99 123.33 65.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 C-N-CA 124.396 1.078 . . . . 73.14 108.44 176.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -121.2 146.63 46.58 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.119 0.568 . . . . 71.3 109.971 -177.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 11.0 p -160.4 131.66 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-N 115.5 -0.773 . . . . 75.1 109.509 -177.326 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 59.93 24.64 13.75 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 124.319 1.048 . . . . 74.24 112.007 -177.249 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 92.85 -24.65 23.17 Favored Glycine 0 C--N 1.355 1.627 0 CA-C-N 116.13 -0.486 . . . . 31.1 112.387 -176.217 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 66.1 ttp85 -74.52 99.81 3.7 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.772 0.829 . . . . 72.12 110.489 -177.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -89.97 116.13 27.79 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 123.674 0.79 . . . . 74.41 109.977 178.084 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.3 p -121.5 148.39 24.93 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 C-N-CA 123.993 0.917 . . . . 73.53 109.506 177.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.445 ' OG ' ' HB3' ' A' ' 135' ' ' GLU . 34.6 t -113.48 87.56 2.64 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.109 0.963 . . . . 31.45 109.035 179.628 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 29.6 m -83.83 112.51 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-N 116.093 -0.503 . . . . 73.42 109.729 -176.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.442 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 57.4 ttt85 -68.46 95.01 0.59 Allowed 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.329 0.585 . . . . 74.14 109.461 177.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.607 ' HB ' HG11 ' A' ' 153' ' ' VAL . 44.6 pt -81.45 138.13 48.16 Favored Pre-proline 0 CA--C 1.554 1.108 0 CA-C-N 114.896 -1.047 . . . . 74.13 109.506 178.624 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.401 ' HA ' ' HD3' ' A' ' 151' ' ' PRO . 56.2 Cg_endo -69.48 140.38 43.59 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 122.282 1.988 . . . . 60.34 111.525 177.01 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 150' ' ' PRO . 31.7 Cg_exo -61.07 93.53 0.11 Allowed 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 123.076 2.518 . . . . 74.15 111.913 174.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 138.59 -5.74 3.19 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-O 118.946 -0.919 . . . . 75.51 113.22 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.607 HG11 ' HB ' ' A' ' 149' ' ' ILE . 7.5 p -58.8 123.22 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 C-N-CA 123.767 0.827 . . . . 75.43 110.969 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.775 ' HD3' HD21 ' A' ' 193' ' ' LEU . 95.4 mtt180 -140.67 167.97 20.91 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 121.704 -0.622 . . . . 73.23 111.271 -173.228 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.514 ' HB3' ' H ' ' A' ' 188' ' ' LEU . 10.3 tp10 -35.62 118.46 0.48 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 126.977 2.111 . . . . 72.32 114.119 -172.115 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 107.95 -27.25 15.0 Favored Glycine 0 C--N 1.342 0.867 0 CA-C-O 119.398 -0.668 . . . . 14.21 112.92 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 30.7 t -59.6 112.51 1.82 Allowed 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.533 0.733 . . . . 74.23 110.133 -178.002 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 48.4 t -86.67 96.88 5.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 115.633 -0.712 . . . . 72.34 109.266 -179.134 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.593 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 65.8 mt -72.91 102.5 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 N-CA-C 108.409 -0.96 . . . . 75.24 108.409 171.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 51.9 ttt-85 -85.53 103.36 14.32 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.929 -0.578 . . . . 61.32 109.991 -175.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.473 HG13 ' HB3' ' A' ' 174' ' ' LEU . 4.4 p -120.64 116.81 31.64 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 122.895 0.478 . . . . 61.33 109.999 178.018 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.576 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 48.3 Cg_endo -68.86 175.77 6.92 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.573 2.182 . . . . 74.53 112.809 178.277 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 65.05 6.37 25.03 Favored Glycine 0 C--N 1.351 1.404 0 N-CA-C 115.787 1.075 . . . . 70.43 115.787 173.096 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.511 ' HE3' ' HA ' ' A' ' 86' ' ' SER . 64.1 mtt -131.44 -1.7 3.91 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 117.776 0.788 . . . . 64.15 112.796 -173.328 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -54.63 -89.11 0.01 OUTLIER Glycine 0 N--CA 1.487 2.091 0 N-CA-C 110.54 -1.024 . . . . 73.33 110.54 -176.262 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.588 ' O ' ' HA ' ' A' ' 171' ' ' PRO . . . -74.89 161.49 53.43 Favored Glycine 0 CA--C 1.541 1.689 0 N-CA-C 106.185 -2.766 . . . . 74.5 106.185 155.117 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.498 ' HA ' HE21 ' A' ' 167' ' ' GLN . 0.0 OUTLIER -102.7 99.67 9.67 Favored 'General case' 0 CA--C 1.56 1.339 0 CA-C-N 120.153 1.977 . . . . 75.42 113.61 -174.162 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.613 ' HA3' ' CG ' ' A' ' 106' ' ' PHE . . . 75.06 -19.68 2.13 Favored Glycine 0 C--N 1.363 2.076 0 N-CA-C 119.471 2.548 . . . . 64.21 119.471 158.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' ASN . . . . . 0.552 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . 10.8 t30 -107.8 -43.88 0.12 Allowed Pre-proline 0 C--N 1.319 -0.757 0 N-CA-C 105.111 -2.181 . . . . 63.11 105.111 164.122 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.602 ' HA ' ' HA2' ' A' ' 116' ' ' GLY . 97.2 Cg_endo -106.64 52.28 0.02 OUTLIER 'Trans proline' 0 CA--C 1.587 3.126 0 C-N-CA 122.361 2.041 . . . . 71.13 114.687 158.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.588 ' HA ' ' O ' ' A' ' 166' ' ' GLY . 59.0 Cg_endo -63.89 102.61 0.37 Allowed 'Trans proline' 1 C--N 1.43 4.855 0 C-N-CA 122.746 2.297 . . . . 71.25 110.997 -177.771 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -116.75 -169.63 15.24 Favored Glycine 0 N--CA 1.482 1.761 0 C-N-CA 120.665 -0.779 . . . . 72.4 114.677 -169.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.576 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 33.5 m-20 -79.33 105.84 10.93 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 108.725 -0.842 . . . . 71.14 108.725 169.763 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.473 ' HB3' HG13 ' A' ' 161' ' ' VAL . 20.8 tp -82.73 108.67 16.26 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.416 -0.811 . . . . 64.32 110.004 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 82.4 mt -85.93 93.68 9.0 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.764 -0.828 . . . . 72.12 108.764 175.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.593 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 92.2 mt -78.02 93.88 4.55 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-N 115.794 -0.639 . . . . 70.05 109.958 178.3 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.497 HG21 HH21 ' A' ' 120' ' ' ARG . 41.9 t -81.99 98.21 4.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 106.137 -1.801 . . . . 61.43 106.137 174.698 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 12.8 p -65.39 110.77 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-O 121.797 0.808 . . . . 70.33 110.101 -174.06 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.493 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 11.9 mmm-85 -91.32 127.45 36.75 Favored 'General case' 0 C--O 1.219 -0.509 0 N-CA-C 107.636 -1.246 . . . . 53.32 107.636 173.302 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.408 HD13 HD22 ' A' ' 127' ' ' LEU . 15.5 mt -91.16 147.33 23.13 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.806 -0.442 . . . . 72.4 109.806 176.518 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 89.3 mt -55.88 162.77 2.49 Favored Pre-proline 0 N--CA 1.487 1.395 0 C-N-CA 124.979 1.312 . . . . 73.14 113.841 -169.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.23 14.55 0.29 Allowed 'Trans proline' 0 C--N 1.395 2.987 0 C-N-CA 123.052 2.501 . . . . 71.42 113.696 173.6 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' HIS . . . . . 0.414 ' HA ' ' HD3' ' A' ' 184' ' ' PRO . 66.2 t-80 -60.85 105.36 0.57 Allowed Pre-proline 0 CA--C 1.563 1.47 0 N-CA-C 106.317 -1.734 . . . . 73.35 106.317 165.544 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 183' ' ' HIS . 6.6 Cg_exo -72.13 28.24 0.26 Allowed 'Trans proline' 0 N--CA 1.506 2.222 0 C-N-CA 124.764 3.643 . . . . 61.24 118.161 -158.379 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 21.6 t -93.97 -57.95 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-N 119.583 1.083 . . . . 64.21 110.303 -172.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 186' ' ' PHE . . . . . 0.538 ' HB3' HD22 ' A' ' 193' ' ' LEU . 26.8 m-85 -124.81 155.82 38.79 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 112.815 0.672 . . . . 72.31 112.815 -169.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -147.39 99.18 3.1 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 106.076 -1.824 . . . . 75.51 106.076 171.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.514 ' H ' ' HB3' ' A' ' 155' ' ' GLU . 0.7 OUTLIER -78.83 158.03 28.25 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 122.736 0.415 . . . . 74.21 111.429 -175.356 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -148.61 128.64 13.58 Favored 'General case' 0 C--O 1.247 0.937 0 N-CA-C 107.439 -1.319 . . . . 70.31 107.439 166.035 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 70.85 -82.38 0.41 Allowed Glycine 0 C--N 1.349 1.267 0 O-C-N 123.653 0.596 . . . . 65.41 112.716 -178.435 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.403 ' OE1' ' HD2' ' A' ' 243' ' ' PRO . 0.1 OUTLIER -147.63 -5.8 0.47 Allowed 'General case' 0 C--O 1.252 1.222 0 C-N-CA 123.19 0.596 . . . . 72.32 111.776 179.856 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -111.23 147.84 34.13 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 122.886 0.474 . . . . 72.32 111.262 -175.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.775 HD21 ' HD3' ' A' ' 154' ' ' ARG . 83.8 mt -93.54 137.25 33.01 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.191 0.996 . . . . 63.44 111.035 -177.149 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -105.74 103.37 12.86 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 108.063 -1.088 . . . . 73.14 108.063 165.007 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.495 ' HB3' HD23 ' A' ' 251' ' ' LEU . . . -103.15 172.55 6.75 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.285 1.034 . . . . 74.34 110.759 179.617 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 91.1 m -119.81 131.84 55.43 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.625 0.77 . . . . 70.21 108.956 171.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.436 ' HB2' HD22 ' A' ' 251' ' ' LEU . 38.2 tp -113.86 129.05 56.63 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.358 0.663 . . . . 72.21 110.793 -176.359 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -88.15 120.64 29.69 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 107.411 -1.329 . . . . 61.43 107.411 167.159 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.2 p -142.88 120.65 7.11 Favored Pre-proline 0 CA--C 1.544 0.747 0 N-CA-C 109.404 -0.591 . . . . 64.4 109.404 179.089 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.72 151.22 74.69 Favored 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 121.763 1.642 . . . . 64.51 111.038 174.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -51.05 -45.54 88.34 Favored Pre-proline 0 CA--C 1.552 1.021 0 N-CA-C 114.756 1.391 . . . . 71.34 114.756 -173.337 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -55.96 -45.79 35.99 Favored 'Trans proline' 0 C--N 1.388 2.616 0 C-N-CA 122.013 1.809 . . . . 63.54 113.584 175.055 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.566 HD11 ' HB3' ' C' ' 276' ' ' TYR . 27.8 mt -71.4 -28.27 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 123.082 0.553 . . . . 64.32 110.645 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.95 -41.86 77.47 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.043 0.537 . . . . 71.51 110.761 177.148 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 34.1 t -71.18 -48.19 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.602 0.761 . . . . 63.23 111.828 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 86.8 t -94.26 -35.5 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.059 0.544 . . . . 74.41 112.1 -169.075 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 88.68 111.7 1.17 Allowed Glycine 0 CA--C 1.53 0.977 0 CA-C-N 116.366 -0.379 . . . . 72.35 113.569 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -173.62 -158.7 18.54 Favored Glycine 0 C--N 1.351 1.402 0 CA-C-O 120.174 -0.237 . . . . 55.24 112.763 177.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -80.31 119.2 22.73 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.343 0.868 . . . . 45.21 113.343 -167.582 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.426 HG21 HD11 ' A' ' 197' ' ' LEU . 29.2 m -110.84 -172.74 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 114.158 -1.383 . . . . 63.11 107.665 162.771 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 211' ' ' ARG . . . . . 0.457 ' HD2' ' HB2' ' A' ' 218' ' ' PRO . 60.2 ttp180 -126.4 115.93 20.38 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 109.823 -0.436 . . . . 71.41 109.823 172.097 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -105.68 160.06 15.5 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.94 -0.763 . . . . 62.04 108.94 172.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 54.1 ttm -97.09 147.86 23.62 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 109.164 -0.68 . . . . 71.23 109.164 176.499 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 81.4 p -124.86 -173.3 2.77 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 108.455 -0.943 . . . . 74.1 108.455 169.069 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.898 HD22 ' HB3' ' A' ' 127' ' ' LEU . 22.5 mt -72.64 -19.78 61.38 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.044 0.538 . . . . 63.31 110.699 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -110.6 25.95 11.22 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.978 0.911 . . . . 64.44 110.506 178.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 98.94 -175.26 28.53 Favored Glycine 0 C--N 1.351 1.373 0 N-CA-C 114.839 0.696 . . . . 33.0 114.839 173.261 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 218' ' ' PRO . . . . . 0.457 ' HB2' ' HD2' ' A' ' 211' ' ' ARG . 83.8 Cg_endo -76.58 132.07 13.05 Favored 'Trans proline' 0 CA--C 1.557 1.671 0 C-N-CA 123.399 2.733 . . . . 70.23 113.719 -174.294 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 27.2 m -125.7 153.93 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 124.891 1.276 . . . . 73.4 110.257 177.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -79.79 130.08 35.02 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.947 -0.39 . . . . 75.04 109.947 173.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 88.9 t -119.96 121.73 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 123.6 0.76 . . . . 74.13 110.269 -176.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -81.33 103.5 11.14 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.184 0.593 . . . . 60.25 109.812 177.546 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 92.9 t -67.64 146.58 98.58 Favored Pre-proline 0 CA--C 1.56 1.328 0 C-N-CA 125.497 1.519 . . . . 63.14 110.609 177.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -83.04 161.82 15.66 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 122.434 2.09 . . . . 75.51 111.268 172.29 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -70.47 148.4 60.37 Favored 'Trans proline' 0 C--N 1.365 1.44 0 C-N-CA 122.23 1.953 . . . . 72.53 112.647 176.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 57.6 mtt-85 69.32 28.41 4.82 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.578 1.551 . . . . 74.04 111.575 171.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.459 HG23 HD21 ' A' ' 233' ' ' LEU . 19.6 m -69.27 104.45 2.23 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.665 1.586 . . . . 64.32 110.512 174.608 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -101.21 151.61 21.65 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.712 0.805 . . . . 75.32 110.475 -177.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 229' ' ' ALA . . . . . 0.45 ' HA ' ' HB ' ' A' ' 253' ' ' VAL . . . -75.01 152.01 38.74 Favored 'General case' 0 C--N 1.355 0.847 0 N-CA-C 113.19 0.811 . . . . 62.31 113.19 -169.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 85.73 -3.34 87.28 Favored Glycine 0 C--N 1.348 1.209 0 CA-C-N 114.719 -1.128 . . . . 73.32 112.988 -176.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -98.02 156.74 16.5 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.671 0.788 . . . . 74.0 110.563 -178.329 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -104.82 112.39 25.48 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.936 0.895 . . . . 72.22 108.683 176.201 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.459 HD21 HG23 ' A' ' 227' ' ' THR . 65.9 mt -75.8 99.83 4.56 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 107.906 -1.146 . . . . 71.4 107.906 174.533 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -83.58 100.46 10.82 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 109.578 -0.527 . . . . 64.14 109.578 176.38 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.511 ' H ' HD23 ' A' ' 235' ' ' LEU . 0.3 OUTLIER -95.94 115.48 27.49 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 107.838 -1.171 . . . . 61.12 107.838 172.118 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -68.09 136.66 54.1 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 114.577 -1.192 . . . . 64.43 112.203 -171.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 84.99 35.82 12.08 Favored Glycine 0 C--N 1.349 1.282 0 O-C-N 123.807 0.692 . . . . 74.2 114.375 169.019 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.407 ' HE3' HD12 ' A' ' 235' ' ' LEU . 74.5 mmtt -116.04 -23.2 8.62 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.787 0.435 . . . . 73.01 111.68 -177.778 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -89.06 -173.64 46.47 Favored Glycine 0 C--N 1.348 1.211 0 N-CA-C 111.063 -0.815 . . . . 74.43 111.063 171.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -96.27 164.24 18.89 Favored Pre-proline 0 N--CA 1.49 1.563 0 CA-C-N 117.794 0.797 . . . . 73.13 111.398 -173.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.516 ' HA ' ' HA ' ' A' ' 246' ' ' ARG . 96.4 Cg_exo -48.75 135.57 28.03 Favored 'Trans proline' 0 C--N 1.388 2.655 0 C-N-CA 123.356 2.704 . . . . 73.33 114.949 175.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -161.42 -162.42 12.87 Favored Glycine 0 C--N 1.347 1.144 0 CA-C-O 119.253 -0.749 . . . . 73.52 112.601 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 243' ' ' PRO . . . . . 0.403 ' HD2' ' OE1' ' A' ' 191' ' ' GLN . 32.0 Cg_exo -58.15 -23.65 62.6 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 123.399 2.733 . . . . 70.45 113.164 177.105 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -88.09 19.06 3.84 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.777 0.831 . . . . 70.11 111.716 176.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 81.44 -82.41 1.57 Allowed Glycine 0 C--N 1.349 1.26 0 N-CA-C 110.269 -1.132 . . . . 62.24 110.269 -174.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.516 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 70.2 mtm180 -126.51 151.86 47.27 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.709 1.203 . . . . 75.41 108.032 169.149 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -83.74 175.96 52.13 Favored Glycine 0 C--N 1.347 1.185 0 N-CA-C 114.192 0.437 . . . . 42.24 114.192 -174.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -122.83 -175.68 3.22 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.113 0.965 . . . . 75.44 110.906 -174.292 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.487 ' HB3' ' HG ' ' A' ' 235' ' ' LEU . 50.9 tp -127.58 130.44 49.07 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.048 -1.093 . . . . 70.31 108.048 169.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -113.24 105.33 13.29 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 107.429 -1.323 . . . . 52.51 107.429 178.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.495 HD23 ' HB3' ' A' ' 195' ' ' ALA . 36.8 mt -93.6 110.92 22.5 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.129 0.571 . . . . 72.24 110.016 -176.609 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -77.69 109.72 11.92 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.256 0.623 . . . . 75.41 109.491 -177.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.45 ' HB ' ' HA ' ' A' ' 229' ' ' ALA . 31.9 t -68.99 111.25 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 CA-C-N 114.669 -1.151 . . . . 24.43 111.691 -170.531 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -110.8 99.93 8.76 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 107.803 -1.184 . . . . 73.14 107.803 167.237 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.559 HD12 ' HA ' ' C' ' 256' ' ' THR . 72.4 mt -76.9 122.18 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 114.853 -1.067 . . . . 74.34 109.985 179.261 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 61.8 p -107.46 165.36 11.46 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 124.164 0.986 . . . . 73.43 109.667 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.8 pp -130.86 152.24 80.26 Favored Pre-proline 0 CA--C 1.557 1.231 0 C-N-CA 123.517 0.727 . . . . 73.4 110.285 -176.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_exo -53.44 -16.4 7.43 Favored 'Trans proline' 0 C--N 1.383 2.344 0 C-N-CA 123.891 3.061 . . . . 74.45 116.744 -169.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 259' ' ' GLU . . . . . 0.437 ' HA ' ' HB3' ' C' ' 226' ' ' ARG . 64.8 mt-10 50.54 -74.22 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 124.581 1.152 . . . . 63.24 112.947 -167.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.51 139.71 42.35 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 109.814 -0.439 . . . . 75.12 109.814 174.701 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.633 HD22 ' HB2' ' A' ' 265' ' ' GLU . 83.4 mt -134.99 152.25 51.56 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.436 0.694 . . . . 55.32 109.949 174.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.0 155.6 39.74 Favored Pre-proline 0 CA--C 1.552 1.039 0 N-CA-C 106.513 -1.662 . . . . 44.34 106.513 164.137 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -42.95 -27.92 1.06 Allowed 'Trans proline' 0 C--N 1.39 2.74 0 C-N-CA 124.325 3.35 . . . . 74.33 115.515 -174.282 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -60.51 -71.49 0.13 Allowed 'General case' 0 C--O 1.252 1.194 0 C-N-CA 124.28 1.032 . . . . 71.44 111.842 178.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 265' ' ' GLU . . . . . 0.633 ' HB2' HD22 ' A' ' 261' ' ' LEU . 2.1 mp0 -65.83 -30.92 71.62 Favored 'General case' 0 C--N 1.356 0.871 0 N-CA-C 109.265 -0.643 . . . . 64.2 109.265 -177.131 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 266' ' ' GLU . . . . . 0.568 ' HA ' HD13 ' A' ' 261' ' ' LEU . 4.7 tp10 -51.58 -54.77 24.08 Favored 'General case' 0 C--N 1.355 0.815 0 O-C-N 124.294 0.996 . . . . 73.45 109.678 174.122 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -65.71 -37.41 86.36 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.214 0.606 . . . . 64.12 112.108 -177.586 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 268' ' ' LEU . . . . . 0.445 HD21 ' HE3' ' C' ' 271' ' ' LYS . 9.3 mp -59.47 -60.33 4.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 123.452 0.47 . . . . 73.14 110.982 175.298 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -55.65 -38.43 69.54 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.359 1.064 . . . . 75.0 112.465 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 270' ' ' LYS . . . . . 0.676 ' HG3' HG23 ' C' ' 206' ' ' VAL . 0.0 OUTLIER -65.47 -50.17 66.33 Favored 'General case' 0 N--CA 1.478 0.969 0 O-C-N 123.52 0.512 . . . . 62.43 110.181 -179.784 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 3.2 tmpt? -57.64 -48.9 78.18 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 123.68 0.612 . . . . 70.22 109.89 179.089 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 272' ' ' LEU . . . . . 0.502 ' O ' ' HB2' ' A' ' 276' ' ' TYR . 83.9 mt -52.43 -50.5 62.43 Favored 'General case' 0 C--N 1.357 0.916 0 O-C-N 124.413 1.07 . . . . 63.4 110.586 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -72.33 -43.49 64.05 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.019 1.118 . . . . 64.51 114.019 -171.083 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -75.39 -36.16 60.92 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.038 0.535 . . . . 74.35 110.13 -175.472 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -72.33 -32.91 66.92 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 116.293 -0.412 . . . . 71.44 110.414 171.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 276' ' ' TYR . . . . . 0.518 ' HE2' ' HG3' ' C' ' 258' ' ' PRO . 51.4 t80 -55.93 -53.01 62.08 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.344 1.058 . . . . 75.02 109.37 176.686 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 277' ' ' TYR . . . . . 0.413 ' HA ' ' HB3' ' A' ' 280' ' ' ALA . 0.2 OUTLIER -69.37 -34.75 75.02 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 115.401 -0.818 . . . . 70.12 110.391 -179.236 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -63.0 -10.54 14.23 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 112.757 0.651 . . . . 75.41 112.757 173.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 279' ' ' ARG . . . . . 0.46 HH22 ' CD ' ' C' ' 265' ' ' GLU . 49.7 mtm180 -122.95 3.65 9.39 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.777 0.831 . . . . 74.13 111.033 174.672 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 280' ' ' ALA . . . . . 0.413 ' HB3' ' HA ' ' A' ' 277' ' ' TYR . . . . . . . . 0 C--O 1.257 1.465 0 C-N-CA 123.576 0.75 . . . . 72.21 109.775 176.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.297 0 N-CA-C 111.394 0.146 . . . . 71.44 111.394 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -89.62 120.22 30.72 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.727 0.811 . . . . 54.1 110.056 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 17.3 mp0 -82.05 -10.94 59.05 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.743 -0.598 . . . . 74.04 112.154 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 4' ' ' SER . . . . . 0.437 ' H ' HG21 ' A' ' 126' ' ' THR . 19.5 m 58.97 -84.11 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 125.384 1.474 . . . . 52.14 112.838 177.015 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 11.8 m -95.49 150.8 19.92 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.277 0.631 . . . . 70.11 110.139 -175.034 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.553 HG21 ' HA ' ' A' ' 125' ' ' LEU . 38.2 pt -134.13 169.92 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 123.388 0.675 . . . . 64.44 112.329 -163.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -139.44 134.38 32.27 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.314 1.046 . . . . 72.01 109.582 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 52.9 tp -74.32 147.87 41.88 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.213 1.005 . . . . 75.22 111.705 -171.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.35 -57.73 3.96 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.075 0.55 . . . . 62.4 111.559 178.461 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 21.8 mt 67.43 -13.31 0.23 Allowed 'General case' 0 N--CA 1.506 2.367 0 C-N-CA 124.961 1.304 . . . . 74.1 113.449 -169.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 83.9 mt . . . . . 0 CA--C 1.551 1.015 0 C-N-CA 125.155 1.382 . . . . 45.35 112.305 -176.315 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.805 0 N-CA-C 112.669 0.618 . . . . 61.34 112.669 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . 68.3 -67.26 0.2 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.329 1.452 . . . . 74.4 110.541 -169.339 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 35.1 tp -154.63 114.86 3.86 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 109.109 -0.7 . . . . 62.04 109.109 -178.387 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 182' ' ' VAL . . . . . . . . . . . . . 14.4 p 44.53 111.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 C-N-CA 127.033 2.133 . . . . 71.31 116.196 178.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -103.61 84.61 2.31 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 107.579 -1.267 . . . . 65.24 107.579 167.081 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 23.7 p-80 64.85 165.3 0.16 Allowed 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 126.871 2.068 . . . . 74.15 113.841 174.041 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 185' ' ' VAL . . . . . 0.619 HG23 ' HA ' ' C' ' 121' ' ' ALA . 7.7 p . . . . . 0 CA--C 1.55 0.969 0 CA-C-N 115.02 -0.991 . . . . 71.33 111.875 -170.094 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 238' ' ' THR . . . . . 0.604 HG22 HG23 ' C' ' 219' ' ' VAL . 59.3 m . . . . . 0 N--CA 1.465 0.314 0 N-CA-C 107.072 -1.455 . . . . 71.31 107.072 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -162.78 -88.56 0.02 OUTLIER 'General case' 0 C--O 1.236 0.387 0 N-CA-C 109.42 -0.585 . . . . 74.42 109.42 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 240' ' ' GLY . . . . . 0.577 ' HA3' ' HA ' ' C' ' 235' ' ' LEU . . . 162.55 -128.9 1.95 Allowed Glycine 0 C--N 1.339 0.705 0 N-CA-C 110.628 -0.989 . . . . 71.23 110.628 -169.04 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 241' ' ' GLU . . . . . 0.676 ' HG3' ' HG3' ' C' ' 234' ' ' ARG . 6.4 pt-20 -150.24 138.08 20.05 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.412 0.685 . . . . 71.21 109.784 -175.765 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 242' ' ' TRP . . . . . 0.408 ' CD2' ' HG ' ' C' ' 233' ' ' LEU . 1.0 OUTLIER -173.16 117.24 0.29 Allowed 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 107.155 -1.424 . . . . 70.32 107.155 170.628 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 59.69 -82.56 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 124.104 0.962 . . . . 74.22 109.081 -168.151 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 179.83 88.22 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 107.362 -2.295 . . . . 63.11 107.362 177.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 245' ' ' LYS . . . . . 0.427 ' HD3' ' HB3' ' C' ' 222' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.931 0 N-CA-C 112.337 0.495 . . . . 75.34 112.337 -172.721 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.101 0 CA-C-O 120.808 0.337 . . . . 52.01 110.588 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -39.42 100.76 0.02 OUTLIER 'General case' 0 C--N 1.351 0.674 0 C-N-CA 125.301 1.44 . . . . 70.52 112.996 171.245 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -76.42 123.18 25.6 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 106.445 -1.687 . . . . 63.2 106.445 166.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -72.4 96.0 1.83 Allowed 'General case' 0 C--O 1.245 0.818 0 N-CA-C 108.705 -0.85 . . . . 63.22 108.705 -176.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 7' ' ' TYR . . . . . 0.432 ' CE2' HG21 ' C' ' 56' ' ' VAL . 50.2 m-85 -66.89 -24.2 66.08 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 113.893 -1.503 . . . . 73.43 112.083 -169.099 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -66.36 -49.11 68.0 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.803 -0.443 . . . . 72.53 109.803 174.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.09 -41.87 97.47 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 123.635 0.584 . . . . 52.31 110.986 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 58.3 mt -59.05 -41.83 84.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 123.645 0.591 . . . . 63.34 110.715 176.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 11' ' ' LEU . . . . . 0.429 ' HB2' HG22 ' C' ' 13' ' ' VAL . 78.4 mt -69.97 -26.24 64.0 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 115.994 -0.548 . . . . 45.45 111.869 174.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.95 22.31 55.52 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-N 116.694 -0.23 . . . . 64.33 112.953 -173.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 13' ' ' VAL . . . . . 0.429 HG22 ' HB2' ' C' ' 11' ' ' LEU . 19.0 m -107.23 150.5 40.02 Favored Pre-proline 0 N--CA 1.481 1.077 0 C-N-CA 124.184 0.994 . . . . 64.04 109.588 174.156 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -66.38 163.15 33.33 Favored 'Trans proline' 0 C--N 1.371 1.738 0 C-N-CA 122.455 2.103 . . . . 74.43 111.809 178.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -77.27 21.59 0.24 Allowed 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 123.175 0.59 . . . . 71.52 112.326 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -131.49 18.3 4.81 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.1 1.36 . . . . 71.24 107.691 173.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.23 123.72 18.07 Favored 'General case' 0 C--N 1.353 0.74 0 C-N-CA 124.166 0.986 . . . . 71.14 111.322 -178.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 44.0 p -66.72 170.29 6.65 Favored 'General case' 0 C--O 1.251 1.168 0 N-CA-C 109.059 -0.719 . . . . 74.41 109.059 170.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 59.4 tp60 -61.43 -36.42 80.31 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.538 -0.301 . . . . 74.45 111.081 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 20' ' ' GLU . . . . . 0.448 ' HB3' ' NH1' ' C' ' 24' ' ' ARG . 0.1 OUTLIER -73.27 -36.59 66.38 Favored 'General case' 0 C--O 1.212 -0.91 0 CA-C-O 118.869 -0.586 . . . . 64.05 110.171 179.773 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -55.93 -48.79 75.07 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.383 0.611 . . . . 73.42 111.188 174.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 22' ' ' ILE . . . . . 0.544 HD13 ' HB3' ' C' ' 57' ' ' LEU . 71.7 mt -61.6 -43.05 96.36 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-N 114.743 -1.117 . . . . 61.32 110.964 176.616 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 23' ' ' LYS . . . . . 0.542 ' O ' ' HG3' ' C' ' 27' ' ' LYS . 13.1 tppt? -68.76 -25.45 64.73 Favored 'General case' 0 CA--C 1.558 1.287 0 CA-C-N 115.34 -0.845 . . . . 74.13 110.158 179.214 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 24' ' ' ARG . . . . . 0.448 ' NH1' ' HB3' ' C' ' 20' ' ' GLU . 68.5 mtt85 -71.94 -50.95 24.66 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.775 0.83 . . . . 73.52 110.283 178.119 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.87 -37.73 74.45 Favored 'General case' 0 C--O 1.246 0.917 0 O-C-N 124.296 0.997 . . . . 75.32 110.293 177.314 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 26' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -56.31 -71.37 0.09 Allowed 'General case' 0 C--N 1.358 0.968 0 CA-C-O 117.642 -1.171 . . . . 72.31 110.487 172.584 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 27' ' ' LYS . . . . . 0.542 ' HG3' ' O ' ' C' ' 23' ' ' LYS . 39.0 mttp -50.24 -39.59 45.17 Favored 'General case' 0 N--CA 1.504 2.237 0 C-N-CA 123.633 0.773 . . . . 74.1 112.259 -173.365 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -54.75 -62.7 1.49 Allowed 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.691 1.197 . . . . 71.15 110.852 176.354 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 29' ' ' LEU . . . . . 0.514 HD13 HD13 ' C' ' 50' ' ' ILE . 42.3 mt -81.66 -8.81 59.75 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 115.25 -0.886 . . . . 60.22 111.256 -175.351 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 30' ' ' ALA . . . . . 0.463 ' HA ' ' HE1' ' C' ' 47' ' ' PHE . . . -93.36 -14.51 26.79 Favored 'General case' 0 C--O 1.215 -0.763 0 C-N-CA 124.23 1.012 . . . . 75.32 110.579 179.17 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 54.1 mtm180 -92.4 -41.67 10.19 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 109.245 -0.65 . . . . 73.5 109.245 164.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 23.9 tp60 -63.78 -50.61 68.35 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.764 0.826 . . . . 71.12 111.564 -175.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 33' ' ' TYR . . . . . 0.428 ' HE2' HD22 ' C' ' 29' ' ' LEU . 32.6 m-85 -104.26 20.16 18.87 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.235 0.614 . . . . 70.15 110.846 -177.596 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 34' ' ' HIS . . . . . 0.429 ' CD2' ' HB3' ' C' ' 36' ' ' ASP . 5.8 t60 -62.57 114.48 12.17 Favored Pre-proline 0 N--CA 1.475 0.819 0 CA-C-O 118.405 -0.807 . . . . 72.34 109.461 -179.171 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -51.15 -33.47 44.09 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 123.345 2.696 . . . . 71.32 114.414 -173.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 36' ' ' ASP . . . . . 0.429 ' HB3' ' CD2' ' C' ' 34' ' ' HIS . 15.7 t70 -68.51 -44.13 75.32 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.745 0.818 . . . . 60.34 111.639 177.404 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 61.5 t -80.51 -51.14 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 CA-C-O 121.495 0.664 . . . . 75.33 110.05 -173.15 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -112.67 96.79 6.17 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 114.809 -1.087 . . . . 54.22 108.939 177.099 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -84.08 67.03 9.53 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.899 0.479 . . . . 62.24 109.961 178.093 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 49.4 m -124.41 109.77 28.73 Favored Pre-proline 0 N--CA 1.477 0.878 0 C-N-CA 123.645 0.778 . . . . 74.14 108.933 177.393 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -43.82 -47.21 10.09 Favored 'Trans proline' 0 C--N 1.386 2.547 0 C-N-CA 124.197 3.265 . . . . 63.44 113.775 -177.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -55.25 -42.36 73.4 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.913 0.885 . . . . 65.44 111.299 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.68 -27.37 61.19 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 114.972 -1.013 . . . . 62.05 110.754 -178.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -81.51 -24.69 36.51 Favored 'General case' 0 C--N 1.352 0.689 0 O-C-N 123.774 0.671 . . . . 74.04 109.955 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -73.32 -45.07 57.5 Favored 'General case' 0 C--O 1.244 0.774 0 C-N-CA 123.709 0.804 . . . . 42.53 109.688 173.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 46' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -60.83 -41.03 94.99 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 115.605 -0.725 . . . . 72.32 110.36 171.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 47' ' ' PHE . . . . . 0.463 ' HE1' ' HA ' ' C' ' 30' ' ' ALA . 84.6 t80 -57.09 -45.99 82.92 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 124.149 0.906 . . . . 62.23 109.933 176.705 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 48' ' ' LYS . . . . . 0.484 ' HE3' ' HB3' ' C' ' 89' ' ' ASP . 48.5 mtpt -58.98 -46.26 88.54 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 123.965 0.791 . . . . 72.04 111.555 178.286 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -60.56 -43.15 97.56 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.303 0.573 . . . . 72.33 112.099 178.165 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 50' ' ' ILE . . . . . 0.514 HD13 HD13 ' C' ' 29' ' ' LEU . 82.8 mt -70.56 -29.35 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 124.187 0.995 . . . . 75.43 110.526 178.378 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 51' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -90.21 -5.58 56.23 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.802 0.841 . . . . 74.04 111.212 178.164 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -78.0 -48.49 16.06 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 107.319 -1.363 . . . . 63.42 107.319 164.11 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 53' ' ' ALA . . . . . 0.428 ' HA ' ' CD1' ' C' ' 7' ' ' TYR . . . -53.87 -43.6 69.7 Favored 'General case' 0 C--N 1.344 0.331 0 CA-C-N 113.236 -1.802 . . . . 63.1 111.29 174.235 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -79.32 -30.37 42.75 Favored 'General case' 0 C--O 1.214 -0.8 0 CA-C-N 114.934 -1.03 . . . . 75.01 111.111 176.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.82 -36.92 68.01 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 119.01 0.823 . . . . 60.54 111.172 176.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 56' ' ' VAL . . . . . 0.436 HG13 ' HZ ' ' C' ' 101' ' ' PHE . 35.3 t -78.78 -55.02 10.82 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 CA-C-N 114.894 -1.048 . . . . 72.43 110.445 174.024 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 57' ' ' LEU . . . . . 0.544 ' HB3' HD13 ' C' ' 22' ' ' ILE . 79.4 mt -92.56 19.18 7.59 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 113.021 0.749 . . . . 75.02 113.021 -168.455 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 29.9 t -51.31 -61.48 2.21 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.852 1.261 . . . . 62.42 113.657 -177.351 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -133.03 151.59 78.2 Favored Pre-proline 0 N--CA 1.476 0.846 0 N-CA-C 108.422 -0.955 . . . . 72.03 108.422 -172.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 60' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -41.01 -31.53 0.77 Allowed 'Trans proline' 0 C--N 1.386 2.528 0 C-N-CA 124.997 3.798 . . . . 33.23 116.417 -175.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -70.13 -58.97 3.2 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 118.078 0.399 . . . . 62.13 111.242 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -65.23 -28.63 69.5 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.028 0.442 . . . . 75.23 111.544 179.005 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 45.0 tpt85 -54.71 -53.46 54.68 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.371 1.069 . . . . 64.42 110.001 168.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -73.11 -19.16 61.2 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 115.806 -0.634 . . . . 74.15 112.386 -179.165 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 68.0 mt -65.34 -44.46 94.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 N-CA-C 108.869 -0.789 . . . . 62.34 108.869 170.456 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -60.54 -47.76 84.77 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.725 -0.67 . . . . 74.22 110.334 173.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -56.62 -45.79 81.3 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.312 0.645 . . . . 73.14 111.814 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 67.2 p -71.62 -25.48 62.18 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.197 -0.456 . . . . 63.2 110.829 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 69' ' ' TYR . . . . . 0.425 ' CD1' HD13 ' C' ' 100' ' ' LEU . 5.6 t80 -79.68 137.07 36.95 Favored 'General case' 0 C--N 1.358 0.953 0 N-CA-C 109.728 -0.471 . . . . 75.22 109.728 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.48 17.89 53.82 Favored Glycine 0 N--CA 1.473 1.144 0 N-CA-C 111.339 -0.704 . . . . 62.51 111.339 -170.159 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 87.7 m -147.32 -58.98 0.27 Allowed 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 103.615 -2.735 . . . . 72.34 103.615 176.255 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 34.7 m -84.48 148.96 26.26 Favored 'General case' 0 C--O 1.249 1.048 0 N-CA-C 105.403 -2.073 . . . . 73.35 105.403 156.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.96 -16.13 7.65 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.929 0.892 . . . . 73.23 110.202 -176.27 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.92 125.88 87.64 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 123.086 0.554 . . . . 53.23 109.781 174.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -61.57 148.49 92.89 Favored 'Trans proline' 0 C--N 1.372 1.804 0 C-N-CA 122.684 2.256 . . . . 75.14 111.373 169.057 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -65.83 165.24 24.13 Favored 'Trans proline' 0 CA--C 1.56 1.806 0 C-N-CA 122.735 2.29 . . . . 63.14 112.725 -179.277 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -67.37 158.54 56.56 Favored 'Trans proline' 0 C--N 1.374 1.918 0 C-N-CA 122.868 2.379 . . . . 51.51 111.427 167.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 78' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.27 116.83 3.5 Favored 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 122.498 2.132 . . . . 74.44 111.758 175.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -66.7 155.67 69.37 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 122.469 2.112 . . . . 61.04 110.087 177.126 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_exo -46.52 76.27 0.01 OUTLIER 'Trans proline' 0 N--CA 1.509 2.428 0 C-N-CA 124.819 3.68 . . . . 51.5 116.309 -172.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 137.51 -47.06 0.97 Allowed Glycine 0 CA--C 1.53 1.01 0 CA-C-N 115.879 -0.6 . . . . 75.2 112.266 -178.228 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 141.25 164.61 10.03 Favored Glycine 0 N--CA 1.473 1.151 0 N-CA-C 109.799 -1.32 . . . . 74.45 109.799 -174.353 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -70.18 115.15 9.05 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 122.945 0.498 . . . . 70.14 110.028 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -52.09 121.99 7.74 Favored 'General case' 0 C--O 1.242 0.662 0 O-C-N 124.698 1.249 . . . . 63.13 111.661 176.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 85' ' ' PHE . . . . . 0.518 ' HA ' ' HD2' ' C' ' 88' ' ' PHE . 56.3 m-85 -135.39 59.23 1.73 Allowed 'General case' 0 N--CA 1.475 0.789 0 O-C-N 124.074 0.859 . . . . 74.41 110.444 169.649 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 25.0 m -61.0 89.59 0.02 OUTLIER 'General case' 0 C--N 1.354 0.783 0 CA-C-N 114.311 -1.313 . . . . 45.43 113.326 179.143 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 79.74 13.45 82.35 Favored Glycine 0 C--N 1.35 1.36 0 CA-C-N 115.271 -0.877 . . . . 74.33 112.967 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 88' ' ' PHE . . . . . 0.518 ' HD2' ' HA ' ' C' ' 85' ' ' PHE . 5.7 m-85 -100.8 119.77 39.13 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 107.657 -1.238 . . . . 74.44 107.657 -178.05 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 89' ' ' ASP . . . . . 0.484 ' HB3' ' HE3' ' C' ' 48' ' ' LYS . 62.7 t0 -80.19 72.21 6.99 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-O 121.647 0.737 . . . . 72.23 110.622 -176.52 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 90' ' ' VAL . . . . . 0.579 HG23 ' HE2' ' C' ' 97' ' ' PHE . 5.3 p -49.91 -42.53 18.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 125.416 1.486 . . . . 54.41 113.261 -176.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -66.39 -23.07 66.26 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.512 0.725 . . . . 74.21 111.575 -173.273 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -90.38 -19.54 23.86 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.429 0.691 . . . . 75.53 111.112 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 20.1 m-30 -77.81 178.02 7.72 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.138 0.575 . . . . 72.45 111.778 -174.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 94' ' ' SER . . . . . 0.419 ' O ' ' HB3' ' C' ' 97' ' ' PHE . 78.4 p -62.16 153.87 28.94 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.607 0.763 . . . . 45.51 112.323 -171.716 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 95' ' ' GLU . . . . . 0.455 ' O ' ' HG3' ' C' ' 99' ' ' GLU . 0.0 OUTLIER -68.49 -32.14 71.9 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.723 -0.671 . . . . 55.43 111.199 178.582 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -51.38 -53.1 39.84 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.131 0.972 . . . . 65.02 110.556 169.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 97' ' ' PHE . . . . . 0.579 ' HE2' HG23 ' C' ' 90' ' ' VAL . 48.6 t80 -56.6 -47.51 79.46 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-N 113.775 -1.557 . . . . 64.25 110.327 178.35 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -76.58 -9.21 58.49 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 114.753 -1.112 . . . . 51.52 112.988 -176.06 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 99' ' ' GLU . . . . . 0.455 ' HG3' ' O ' ' C' ' 95' ' ' GLU . 61.7 mt-10 -82.61 -51.31 7.87 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.211 0.604 . . . . 74.43 109.563 166.555 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 100' ' ' LEU . . . . . 0.425 HD13 ' CD1' ' C' ' 69' ' ' TYR . 18.7 tp -59.35 -44.84 92.62 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 114.438 -1.256 . . . . 73.23 111.911 -171.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 101' ' ' PHE . . . . . 0.436 ' HZ ' HG13 ' C' ' 56' ' ' VAL . 48.2 m-85 -105.38 11.47 32.69 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.375 0.27 . . . . 73.25 111.03 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -42.23 -64.63 1.48 Allowed Glycine 0 C--N 1.357 1.745 0 C-N-CA 124.823 1.201 . . . . 54.11 114.538 -171.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -29.93 -31.44 0.02 OUTLIER 'Trans proline' 0 C--N 1.389 2.69 1 C-N-CA 126.299 4.666 . . . . 62.02 117.266 176.599 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -156.83 52.67 0.41 Allowed Glycine 0 C--N 1.354 1.538 0 C-N-CA 120.934 -0.651 . . . . 43.23 113.024 179.145 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 105' ' ' LEU . . . . . 0.532 ' HB3' HG21 ' C' ' 90' ' ' VAL . 92.7 mt . . . . . 0 CA--C 1.579 2.065 0 N-CA-C 117.218 2.303 . . . . 73.03 117.218 177.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.637 0 N-CA-C 109.813 -1.315 . . . . 45.25 109.813 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 67.0 mtt180 -97.49 113.13 24.76 Favored 'General case' 0 C--O 1.257 1.463 0 CA-C-O 122.304 1.049 . . . . 64.44 110.903 -172.052 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -74.36 109.28 7.72 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 111.612 -2.54 . . . . 75.42 105.647 162.509 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 119' ' ' LEU . . . . . 0.629 HD12 ' HA2' ' C' ' 165' ' ' GLY . 70.0 mt -91.01 106.84 18.8 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.341 -0.391 . . . . 75.21 110.445 -162.354 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -90.01 94.45 9.8 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 106.604 -1.628 . . . . 72.31 106.604 -178.19 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 121' ' ' ALA . . . . . 0.619 ' HA ' HG23 ' B' ' 185' ' ' VAL . . . -105.44 113.8 27.6 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 109.104 -0.702 . . . . 63.21 109.104 -171.19 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -73.31 107.74 5.79 Favored 'General case' 0 C--O 1.244 0.775 0 N-CA-C 106.981 -1.489 . . . . 73.22 106.981 171.541 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -116.13 137.27 23.31 Favored Pre-proline 0 N--CA 1.474 0.756 0 CA-C-O 120.48 0.181 . . . . 73.3 111.465 -179.024 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.13 116.84 4.54 Favored 'Trans proline' 0 C--N 1.371 1.734 0 C-N-CA 122.984 2.456 . . . . 72.51 110.802 168.511 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 125' ' ' LEU . . . . . 0.484 ' HB3' HG13 ' C' ' 178' ' ' VAL . 13.6 tp -152.63 161.28 42.78 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 109.479 -0.563 . . . . 74.03 109.479 -178.518 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 126' ' ' THR . . . . . 0.462 ' HB ' ' HG ' ' C' ' 181' ' ' LEU . 6.2 t -125.98 175.25 7.84 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.56 0.695 . . . . 61.53 109.96 171.557 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 127' ' ' LEU . . . . . 0.516 HD21 HD13 ' C' ' 180' ' ' LEU . 13.6 mt -60.4 -48.52 81.41 Favored 'General case' 0 C--O 1.245 0.821 0 C-N-CA 125.55 1.54 . . . . 62.25 110.303 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 128' ' ' GLU . . . . . 0.521 ' HG3' ' HA ' ' C' ' 215' ' ' LEU . 8.5 mp0 -63.55 -33.06 74.75 Favored 'General case' 0 C--O 1.215 -0.723 0 CA-C-N 114.009 -1.45 . . . . 75.24 110.748 178.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 129' ' ' GLU . . . . . 0.413 ' HA ' ' HB2' ' C' ' 132' ' ' HIS . 19.4 mm-40 -84.65 -13.65 50.89 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.779 0.832 . . . . 73.53 111.771 178.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 130' ' ' ALA . . . . . 0.516 ' HB2' HG12 ' C' ' 153' ' ' VAL . . . -76.33 -34.61 59.0 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.876 -0.787 . . . . 64.34 108.876 170.115 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 131' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -70.54 -46.28 63.89 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 113.993 -1.458 . . . . 75.55 111.512 168.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 132' ' ' HIS . . . . . 0.413 ' HB2' ' HA ' ' C' ' 129' ' ' GLU . 35.8 m170 -80.65 -9.71 59.77 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 123.365 0.666 . . . . 60.22 111.02 -178.488 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -66.44 -120.16 0.01 OUTLIER Glycine 0 C--N 1.354 1.528 0 O-C-N 123.921 0.763 . . . . 65.31 113.371 177.256 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . 64.85 -103.69 0.81 Allowed Glycine 0 C--N 1.342 0.91 0 N-CA-C 110.852 -0.899 . . . . 53.24 110.852 -173.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 135' ' ' GLU . . . . . 0.71 ' HG3' ' HB2' ' C' ' 148' ' ' ARG . 2.7 mp0 -87.94 94.06 9.66 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.03 0.932 . . . . 71.2 109.277 -177.411 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 136' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -142.41 166.95 23.28 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.502 0.721 . . . . 72.12 110.263 -177.046 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 137' ' ' VAL . . . . . . . . . . . . . 17.7 m -73.89 88.66 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.1 0 CA-C-N 115.251 -0.886 . . . . 71.12 111.202 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 138' ' ' VAL . . . . . 0.53 ' O ' ' HA ' ' C' ' 144' ' ' ARG . 37.4 t -80.21 129.76 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.912 0.885 . . . . 72.14 109.819 175.401 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 139' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -124.95 113.73 18.21 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 108.3 -1.0 . . . . 74.31 108.3 169.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 140' ' ' VAL . . . . . 0.617 HG13 ' HB ' ' B' ' 185' ' ' VAL . 30.7 t -150.02 126.88 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.215 1.006 . . . . 63.22 108.341 167.714 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 65.04 32.4 10.43 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.172 0.989 . . . . 15.23 112.895 172.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 73.03 26.94 69.64 Favored Glycine 0 C--N 1.344 0.991 0 N-CA-C 111.722 -0.551 . . . . 45.25 111.722 -178.156 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 143' ' ' ARG . . . . . . . . . . . . . 45.2 mtp180 -115.74 96.27 5.53 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 107.539 -1.282 . . . . 73.04 107.539 171.17 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 144' ' ' ARG . . . . . 0.53 ' HA ' ' O ' ' C' ' 138' ' ' VAL . 29.2 ttp-105 -114.25 104.22 11.87 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 123.491 0.716 . . . . 71.51 109.539 -178.328 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 145' ' ' VAL . . . . . . . . . . . . . 7.7 p -150.47 146.21 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.34 0.656 . . . . 75.03 110.639 -175.393 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 24.7 m -77.62 88.29 3.92 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 108.601 -0.889 . . . . 54.21 108.601 171.235 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 11.2 p -117.18 154.44 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.656 0.782 . . . . 72.53 109.91 -173.056 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 148' ' ' ARG . . . . . 0.71 ' HB2' ' HG3' ' C' ' 135' ' ' GLU . 31.5 ttt85 -92.54 114.27 26.77 Favored 'General case' 0 C--O 1.242 0.669 0 O-C-N 123.801 0.688 . . . . 74.22 111.02 177.697 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 149' ' ' ILE . . . . . 0.449 HD12 HD13 ' C' ' 159' ' ' ILE . 26.2 pt -94.47 154.26 40.24 Favored Pre-proline 0 CA--C 1.552 1.028 0 N-CA-C 107.493 -1.299 . . . . 71.41 107.493 163.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -51.15 115.6 2.15 Favored 'Trans proline' 0 CA--C 1.565 2.038 0 C-N-CA 122.311 2.007 . . . . 61.44 111.378 174.108 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -61.36 113.45 1.78 Allowed 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 123.359 2.706 . . . . 73.2 111.169 -178.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 152' ' ' GLY . . . . . . . . . . . . . . . 129.28 142.15 5.24 Favored Glycine 0 C--N 1.34 0.779 0 O-C-N 123.449 0.468 . . . . 54.32 114.13 -172.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 153' ' ' VAL . . . . . 0.516 HG12 ' HB2' ' C' ' 130' ' ' ALA . 3.0 p -164.69 168.36 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.39 0 N-CA-C 112.524 0.564 . . . . 71.13 112.524 174.664 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 154' ' ' ARG . . . . . 0.471 ' HB3' ' HB2' ' C' ' 157' ' ' SER . 0.8 OUTLIER -125.81 169.48 12.57 Favored 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 125.806 1.642 . . . . 75.32 108.563 176.96 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' C' C ' 155' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -65.06 128.45 35.83 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.158 0.583 . . . . 74.51 110.289 169.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 71.82 12.0 74.19 Favored Glycine 0 C--N 1.348 1.215 0 O-C-N 123.891 0.744 . . . . 64.51 113.478 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 157' ' ' SER . . . . . 0.471 ' HB2' ' HB3' ' C' ' 154' ' ' ARG . 43.6 t -78.82 140.98 38.1 Favored 'General case' 0 C--O 1.252 1.206 0 C-N-CA 123.117 0.567 . . . . 75.43 109.903 -179.073 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 158' ' ' VAL . . . . . 0.477 HG23 ' HB3' ' C' ' 175' ' ' LEU . 5.4 p -108.78 96.94 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 O-C-N 125.077 1.485 . . . . 64.44 108.956 -174.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 159' ' ' ILE . . . . . 0.616 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 56.4 mt -78.41 111.45 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 108.687 -0.857 . . . . 52.25 108.687 178.394 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 26.4 ttt180 -85.58 107.94 17.73 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 108.826 -0.805 . . . . 72.21 108.826 173.134 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 161' ' ' VAL . . . . . . . . . . . . . 2.2 t -98.17 105.66 30.0 Favored Pre-proline 0 CA--C 1.557 1.228 0 N-CA-C 106.219 -1.771 . . . . 75.24 106.219 171.076 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -64.68 132.02 31.43 Favored 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 123.512 2.808 . . . . 63.42 113.042 -171.028 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 64.83 19.57 65.52 Favored Glycine 0 C--N 1.347 1.194 0 O-C-N 124.01 0.819 . . . . 53.31 113.348 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 164' ' ' MET . . . . . . . . . . . . . 31.8 mmm -110.08 -2.48 16.96 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.583 0.753 . . . . 73.35 111.753 -178.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 165' ' ' GLY . . . . . 0.629 ' HA2' HD12 ' C' ' 119' ' ' LEU . . . -89.5 -111.87 1.33 Allowed Glycine 0 C--N 1.347 1.162 0 N-CA-C 108.293 -1.923 . . . . 64.24 108.293 164.19 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . -156.78 118.11 0.82 Allowed Glycine 0 C--N 1.335 0.498 0 C-N-CA 120.692 -0.766 . . . . 75.44 111.831 161.417 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 167' ' ' GLN . . . . . 0.556 ' HA ' ' HA ' ' C' ' 171' ' ' PRO . 15.0 mm-40 -71.23 101.9 2.42 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 107.792 -1.188 . . . . 64.31 107.792 175.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . -115.77 -125.5 3.88 Favored Glycine 0 N--CA 1.467 0.758 0 N-CA-C 110.275 -1.13 . . . . 13.44 110.275 178.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 169' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -61.41 -67.19 1.15 Allowed Pre-proline 0 CA--C 1.574 1.865 0 CA-C-N 117.956 0.878 . . . . 62.44 110.562 175.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 170' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -93.94 113.82 0.22 Allowed 'Trans proline' 0 C--N 1.393 2.878 0 CA-C-N 122.107 1.788 . . . . 51.41 109.143 163.397 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 171' ' ' PRO . . . . . 0.556 ' HA ' ' HA ' ' C' ' 167' ' ' GLN . 6.5 Cg_exo -33.87 131.78 0.15 Allowed 'Trans proline' 0 C--N 1.372 1.763 0 C-N-CA 124.609 3.54 . . . . 74.02 115.514 -178.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 172' ' ' GLY . . . . . 0.549 ' H ' ' HA ' ' C' ' 167' ' ' GLN . . . -120.85 115.93 3.04 Favored Glycine 0 C--N 1.341 0.828 0 N-CA-C 110.968 -0.853 . . . . 74.42 110.968 -171.337 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 173' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -107.75 158.9 16.91 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 108.512 -0.921 . . . . 74.51 108.512 175.366 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 174' ' ' LEU . . . . . 0.442 HD11 HG21 ' C' ' 140' ' ' VAL . 9.8 tp -81.41 107.56 14.29 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 109.739 -0.467 . . . . 75.22 109.739 -177.252 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 175' ' ' LEU . . . . . 0.477 ' HB3' HG23 ' C' ' 158' ' ' VAL . 78.6 mt -95.12 82.22 3.75 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.43 1.092 . . . . 71.32 110.084 179.505 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 176' ' ' LEU . . . . . 0.616 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 75.7 mt -68.4 100.76 1.12 Allowed 'General case' 0 CA--C 1.546 0.804 0 CA-C-O 121.022 0.439 . . . . 43.02 110.86 178.665 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 177' ' ' VAL . . . . . . . . . . . . . 61.0 t -85.53 101.57 10.11 Favored 'Isoleucine or valine' 0 C--O 1.244 0.784 0 C-N-CA 124.147 0.979 . . . . 74.43 108.398 176.346 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 178' ' ' VAL . . . . . 0.484 HG13 ' HB3' ' C' ' 125' ' ' LEU . 52.1 t -84.93 135.82 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 N-CA-C 112.538 0.57 . . . . 74.01 112.538 -174.256 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 179' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -110.76 113.27 25.73 Favored 'General case' 0 C--O 1.254 1.33 0 C-N-CA 124.981 1.312 . . . . 72.33 108.436 169.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 180' ' ' LEU . . . . . 0.516 HD13 HD21 ' C' ' 127' ' ' LEU . 91.8 mt -76.53 153.76 35.15 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 124.572 1.149 . . . . 70.51 111.445 178.503 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 181' ' ' LEU . . . . . 0.462 ' HG ' ' HB ' ' C' ' 126' ' ' THR . 8.2 mt -65.73 168.4 8.75 Favored Pre-proline 0 N--CA 1.49 1.553 0 C-N-CA 123.105 0.562 . . . . 74.2 110.892 -179.342 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -60.45 70.07 0.07 OUTLIER 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 122.482 2.121 . . . . 64.12 110.793 160.339 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 183' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -160.44 62.39 1.73 Allowed Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 106.753 -1.573 . . . . 62.13 106.753 -167.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 184' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -85.34 64.53 5.97 Favored 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 123.03 2.486 . . . . 71.54 111.217 -170.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 185' ' ' VAL . . . . . 0.618 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 18.1 t -95.55 -56.42 5.22 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.905 0 N-CA-C 107.826 -1.176 . . . . 72.23 107.826 -173.464 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 186' ' ' PHE . . . . . 0.478 ' HD1' ' HB2' ' C' ' 195' ' ' ALA . 33.9 m-85 -114.8 153.66 29.99 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.56 0.744 . . . . 61.44 110.832 -174.642 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 187' ' ' ARG . . . . . . . . . . . . . 7.5 mtm180 -143.42 115.74 8.5 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.569 1.148 . . . . 75.14 108.772 175.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 188' ' ' LEU . . . . . 0.536 HD13 ' HD2' ' C' ' 240' ' ' PHE . 55.6 tp -77.48 143.27 38.63 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.973 0.731 . . . . 74.14 112.973 -171.186 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -141.76 105.22 4.67 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 107.14 -1.429 . . . . 71.33 107.14 166.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 74.32 -101.06 1.21 Allowed Glycine 0 CA--C 1.536 1.37 0 N-CA-C 111.885 -0.486 . . . . 74.2 111.885 -175.273 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 191' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -123.14 -5.13 8.41 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 124.246 1.018 . . . . 60.21 110.744 172.287 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -101.92 140.14 36.61 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.299 0.64 . . . . 65.13 110.088 -174.178 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 193' ' ' LEU . . . . . 0.434 HD21 ' CE2' ' C' ' 240' ' ' PHE . 82.0 mt -99.39 153.24 19.14 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.558 0.743 . . . . 52.2 111.273 -174.134 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 194' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -113.73 107.27 15.52 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 107.418 -1.327 . . . . 75.43 107.418 168.215 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 195' ' ' ALA . . . . . 0.618 ' HA ' ' O ' ' C' ' 185' ' ' VAL . . . -105.09 -178.59 3.7 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.164 0.586 . . . . 65.11 110.119 175.487 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 26.0 m -142.35 99.33 3.48 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 107.457 -1.312 . . . . 51.32 107.457 171.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 197' ' ' LEU . . . . . 0.446 HD13 ' HB2' ' C' ' 212' ' ' ALA . 25.7 tp -80.44 121.31 25.58 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.773 -0.649 . . . . 73.5 111.013 -171.115 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -74.51 100.1 3.78 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 108.166 -1.05 . . . . 44.52 108.166 175.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 199' ' ' VAL . . . . . . . . . . . . . 58.5 t -111.32 117.69 48.97 Favored Pre-proline 0 N--CA 1.474 0.731 0 N-CA-C 108.23 -1.026 . . . . 61.21 108.23 178.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 200' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -72.17 143.96 40.95 Favored 'Trans proline' 0 C--N 1.369 1.625 0 C-N-CA 121.727 1.618 . . . . 71.34 109.81 174.394 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 201' ' ' ALA . . . . . 0.43 ' N ' ' HD2' ' C' ' 202' ' ' PRO . . . -55.0 -44.28 99.52 Favored Pre-proline 0 CA--C 1.552 1.058 0 N-CA-C 114.119 1.155 . . . . 74.35 114.119 -173.708 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 202' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' C' ' 201' ' ' ALA . 17.3 Cg_endo -55.29 -46.99 28.51 Favored 'Trans proline' 0 C--N 1.393 2.906 0 C-N-CA 121.883 1.722 . . . . 63.15 112.67 176.557 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 203' ' ' ILE . . . . . 0.471 ' HA ' HG12 ' C' ' 206' ' ' VAL . 48.0 mt -68.18 -37.52 78.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.14 0.576 . . . . 63.4 110.871 -178.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 204' ' ' ALA . . . . . 0.434 ' HA ' HG11 ' C' ' 223' ' ' VAL . . . -58.53 -44.13 89.44 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.477 0.711 . . . . 75.02 111.338 176.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 205' ' ' VAL . . . . . 0.503 ' HA ' ' HA ' ' C' ' 226' ' ' ARG . 81.7 t -72.74 -42.65 61.87 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 115.156 -0.929 . . . . 63.41 111.786 -177.329 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 206' ' ' VAL . . . . . 0.676 HG23 ' HG3' ' A' ' 270' ' ' LYS . 11.3 p -77.05 -29.38 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 CA-C-O 120.676 0.274 . . . . 52.12 110.74 -174.185 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 77.18 51.91 5.93 Favored Glycine 0 C--N 1.341 0.826 0 N-CA-C 110.634 -0.987 . . . . 63.21 110.634 -171.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -91.78 -120.37 2.55 Favored Glycine 0 C--N 1.344 1.026 0 N-CA-C 111.246 -0.741 . . . . 51.32 111.246 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 209' ' ' LYS . . . . . 0.58 ' HG2' ' HG2' ' C' ' 220' ' ' GLU . 34.6 ttmt -151.72 133.17 14.64 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.619 0.723 . . . . 72.12 111.208 -178.449 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 210' ' ' VAL . . . . . . . . . . . . . 26.8 m -115.16 -175.28 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 126.596 1.958 . . . . 62.05 108.091 174.193 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 211' ' ' ARG . . . . . 0.473 ' HD3' ' HB2' ' C' ' 218' ' ' PRO . 36.9 ttm105 -142.85 127.99 18.61 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 118.236 0.471 . . . . 72.44 111.908 -178.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 212' ' ' ALA . . . . . 0.446 ' HB2' HD13 ' C' ' 197' ' ' LEU . . . -101.68 113.49 26.7 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 108.039 -1.097 . . . . 74.43 108.039 168.689 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 213' ' ' MET . . . . . 0.468 ' HA ' ' HA ' ' C' ' 218' ' ' PRO . 2.9 ttp -69.73 105.87 2.89 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 107.86 -1.163 . . . . 63.12 107.86 174.275 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 214' ' ' THR . . . . . 0.549 ' OG1' HG12 ' C' ' 219' ' ' VAL . 0.2 OUTLIER -101.02 175.63 5.53 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.506 0.669 . . . . 54.24 110.243 -173.144 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' C' C ' 215' ' ' LEU . . . . . 0.521 ' HA ' ' HG3' ' C' ' 128' ' ' GLU . 9.2 mt -63.0 -41.14 99.5 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.711 1.604 . . . . 44.41 111.326 -175.179 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -92.77 0.33 57.4 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 114.32 -1.309 . . . . 71.0 111.15 -177.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 134.36 162.65 9.98 Favored Glycine 0 C--N 1.343 0.931 0 N-CA-C 111.669 -0.572 . . . . 64.11 111.669 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 218' ' ' PRO . . . . . 0.473 ' HB2' ' HD3' ' C' ' 211' ' ' ARG . 59.9 Cg_endo -70.04 107.88 2.01 Favored 'Trans proline' 0 CA--C 1.555 1.575 0 C-N-CA 122.708 2.272 . . . . 52.13 112.952 -178.272 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 219' ' ' VAL . . . . . 0.604 HG23 HG22 ' B' ' 238' ' ' THR . 7.3 p -80.71 120.85 33.12 Favored 'Isoleucine or valine' 0 C--N 1.355 0.832 0 N-CA-C 107.664 -1.236 . . . . 52.53 107.664 174.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 220' ' ' GLU . . . . . 0.58 ' HG2' ' HG2' ' C' ' 209' ' ' LYS . 16.3 tt0 -92.75 103.79 16.12 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 107.583 -1.266 . . . . 72.32 107.583 -179.059 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 221' ' ' VAL . . . . . . . . . . . . . 60.8 t -85.88 123.29 39.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 113.534 -1.666 . . . . 74.03 112.319 -165.28 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 222' ' ' ALA . . . . . 0.427 ' HB3' ' HD3' ' B' ' 245' ' ' LYS . . . -74.84 143.56 43.85 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.311 0.644 . . . . 73.3 110.508 173.429 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 223' ' ' VAL . . . . . 0.434 HG11 ' HA ' ' C' ' 204' ' ' ALA . 98.0 t -116.62 138.11 24.22 Favored Pre-proline 0 N--CA 1.485 1.299 0 C-N-CA 124.316 1.047 . . . . 73.11 109.512 -174.302 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 224' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -78.74 156.02 27.43 Favored 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 123.279 2.653 . . . . 54.33 111.488 170.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.48 124.46 16.31 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 123.346 2.697 . . . . 74.0 113.137 -175.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 226' ' ' ARG . . . . . 0.503 ' HA ' ' HA ' ' C' ' 205' ' ' VAL . 0.0 OUTLIER 58.53 90.87 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.62 1.568 . . . . 70.15 112.378 -179.495 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' C' C ' 227' ' ' THR . . . . . 0.548 HG22 HG11 ' C' ' 253' ' ' VAL . 21.6 m -110.03 127.96 55.13 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 114.817 -1.083 . . . . 70.3 111.378 179.311 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 228' ' ' GLN . . . . . 0.663 HE22 HH21 ' C' ' 231' ' ' ARG . 0.7 OUTLIER -96.54 153.52 17.8 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.11 0.964 . . . . 74.32 111.859 -179.596 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' C' C ' 229' ' ' ALA . . . . . 0.49 ' HB2' ' H ' ' C' ' 255' ' ' ILE . . . -70.45 134.01 47.38 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 114.681 -1.145 . . . . 62.12 109.69 173.525 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 110.45 -19.28 26.77 Favored Glycine 0 C--N 1.339 0.702 0 O-C-N 123.613 0.571 . . . . 62.04 112.088 -173.355 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 231' ' ' ARG . . . . . 0.663 HH21 HE22 ' C' ' 228' ' ' GLN . 71.3 mtt180 -65.78 174.9 2.13 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 117.138 0.469 . . . . 74.12 111.46 173.429 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 232' ' ' LYS . . . . . 0.444 ' HA ' ' O ' ' C' ' 251' ' ' LEU . 30.2 ttmt -142.85 145.71 33.42 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 121.206 0.527 . . . . 71.45 111.525 -178.56 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 233' ' ' LEU . . . . . 0.728 HD13 ' HB2' ' C' ' 251' ' ' LEU . 1.7 mp -113.26 145.33 41.2 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.815 1.246 . . . . 74.21 108.412 178.689 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 234' ' ' ARG . . . . . 0.676 ' HG3' ' HG3' ' B' ' 241' ' ' GLU . 9.2 ptp85 -120.29 95.06 4.59 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 121.957 0.884 . . . . 72.34 109.432 169.414 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 235' ' ' LEU . . . . . 0.577 ' HA ' ' HA3' ' B' ' 240' ' ' GLY . 26.0 mt -84.67 107.66 16.99 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.611 -0.722 . . . . 73.43 109.324 178.397 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -69.07 122.99 19.85 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 123.627 0.771 . . . . 71.55 111.483 -174.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 76.54 32.56 50.6 Favored Glycine 0 C--N 1.344 0.994 0 O-C-N 124.199 0.937 . . . . 71.42 113.192 178.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 33.5 mmtm -123.83 14.99 9.34 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.821 0.848 . . . . 72.03 111.209 175.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -91.62 -147.39 20.02 Favored Glycine 0 C--N 1.353 1.477 0 N-CA-C 111.178 -0.769 . . . . 31.21 111.178 170.263 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 240' ' ' PHE . . . . . 0.536 ' HD2' HD13 ' C' ' 188' ' ' LEU . 39.9 m-85 -94.56 142.12 24.36 Favored Pre-proline 0 N--CA 1.482 1.141 0 CA-C-N 117.572 0.686 . . . . 75.14 111.302 178.473 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 241' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' C' ' 240' ' ' PHE . 3.3 Cg_exo -76.65 113.99 3.76 Favored 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 123.837 3.025 . . . . 70.21 113.69 -172.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -96.78 159.96 21.65 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-O 119.015 -0.88 . . . . 70.14 111.396 170.373 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.58 -13.43 37.27 Favored 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 122.781 2.32 . . . . 71.42 112.857 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -103.25 -16.71 15.6 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.515 0.726 . . . . 71.42 110.935 174.047 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 157.88 158.41 8.96 Favored Glycine 0 C--N 1.356 1.641 0 O-C-N 123.119 0.262 . . . . 51.32 113.702 177.082 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 246' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -73.65 152.62 40.44 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.804 0.842 . . . . 61.31 110.22 174.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.44 -164.69 22.9 Favored Glycine 0 C--N 1.346 1.112 0 O-C-N 123.702 0.626 . . . . 63.23 112.004 173.297 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -119.72 154.48 34.06 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 108.877 -0.786 . . . . 73.54 108.877 -178.118 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 249' ' ' LEU . . . . . 0.561 HD23 HD12 ' C' ' 235' ' ' LEU . 19.0 tp -99.61 109.24 21.76 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.637 -0.71 . . . . 74.23 109.284 175.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 250' ' ' TYR . . . . . 0.593 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 20.2 m-85 -99.44 100.36 11.39 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 109.236 -0.653 . . . . 71.43 109.236 178.702 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 251' ' ' LEU . . . . . 0.728 ' HB2' HD13 ' C' ' 233' ' ' LEU . 0.8 OUTLIER -100.4 140.37 34.74 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.232 -0.655 . . . . 64.53 109.232 -176.716 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -89.54 128.43 36.01 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 108.225 -1.028 . . . . 73.41 108.225 168.113 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 253' ' ' VAL . . . . . 0.548 HG11 HG22 ' C' ' 227' ' ' THR . 80.0 t -67.97 131.97 32.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 123.641 0.776 . . . . 73.5 110.25 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 254' ' ' ARG . . . . . 0.416 HH11 ' HB3' ' C' ' 254' ' ' ARG . 0.0 OUTLIER -126.72 93.06 3.67 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.354 -1.351 . . . . 74.13 107.354 179.226 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' C' C ' 255' ' ' ILE . . . . . 0.49 ' H ' ' HB2' ' C' ' 229' ' ' ALA . 49.8 mm -73.11 127.49 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 O-C-N 123.853 0.721 . . . . 75.24 109.788 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 256' ' ' THR . . . . . 0.559 ' HA ' HD12 ' A' ' 255' ' ' ILE . 1.7 t -144.73 171.04 14.97 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 124.412 1.07 . . . . 53.32 110.396 -171.24 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 257' ' ' ILE . . . . . 0.467 HD12 ' H ' ' C' ' 259' ' ' GLU . 2.7 pp -132.59 148.31 69.06 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 123.735 0.814 . . . . 64.54 109.398 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 258' ' ' PRO . . . . . 0.518 ' HG3' ' HE2' ' A' ' 276' ' ' TYR . 98.5 Cg_endo -74.53 11.14 1.37 Allowed 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 123.323 2.682 . . . . 73.21 114.277 -172.179 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 259' ' ' GLU . . . . . 0.467 ' H ' HD12 ' C' ' 257' ' ' ILE . 18.0 mt-10 62.1 -80.64 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 125.194 1.398 . . . . 72.3 111.101 -171.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 2.8 ptp85 -77.87 143.89 37.41 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.518 1.527 . . . . 73.41 110.928 -173.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 261' ' ' LEU . . . . . . . . . . . . . 75.3 mt -141.7 169.98 16.58 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.046 0.938 . . . . 71.21 110.107 -177.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 23.9 p -84.04 152.02 61.37 Favored Pre-proline 0 CA--C 1.552 1.024 0 N-CA-C 107.765 -1.198 . . . . 61.23 107.765 169.019 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -48.12 -34.64 24.24 Favored 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 123.173 2.582 . . . . 74.2 113.9 176.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.52 -56.14 9.36 Favored 'General case' 0 C--O 1.268 2.037 0 C-N-CA 124.249 1.019 . . . . 71.04 110.624 -178.329 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 265' ' ' GLU . . . . . 0.46 ' CD ' HH22 ' A' ' 279' ' ' ARG . 40.7 mm-40 -51.16 -55.09 19.66 Favored 'General case' 0 C--N 1.359 1.002 0 CA-C-N 114.953 -1.021 . . . . 65.11 110.359 175.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 266' ' ' GLU . . . . . 0.483 ' O ' ' HG2' ' C' ' 270' ' ' LYS . 30.8 tt0 -61.15 -31.46 71.18 Favored 'General case' 0 C--O 1.217 -0.652 0 CA-C-N 114.186 -1.37 . . . . 64.21 111.39 -175.372 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -60.76 -45.15 95.46 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 123.461 0.475 . . . . 70.32 110.866 174.466 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 268' ' ' LEU . . . . . 0.536 ' HA ' ' HE2' ' C' ' 271' ' ' LYS . 11.2 mp -64.18 -42.32 96.74 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 116.202 -0.454 . . . . 52.44 111.465 174.562 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -65.12 -25.36 67.73 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 122.797 0.439 . . . . 61.11 111.296 175.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 270' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' C' ' 266' ' ' GLU . 13.2 mmmm -67.93 -49.66 60.53 Favored 'General case' 0 C--N 1.363 1.175 0 C-N-CA 122.837 0.455 . . . . 75.43 109.867 175.235 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 271' ' ' LYS . . . . . 0.536 ' HE2' ' HA ' ' C' ' 268' ' ' LEU . 52.7 mtmt -57.62 -44.72 85.72 Favored 'General case' 0 N--CA 1.484 1.243 0 O-C-N 123.688 0.618 . . . . 75.33 111.294 178.638 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 88.3 mt -62.08 -41.41 98.16 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.237 0.615 . . . . 74.33 111.189 175.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -64.83 -45.35 86.56 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 115.573 -0.74 . . . . 34.13 111.545 -177.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -70.26 -32.42 70.24 Favored 'General case' 0 C--O 1.242 0.667 0 O-C-N 124.142 0.901 . . . . 63.21 110.62 -178.336 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -61.82 -34.13 75.39 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.684 -0.689 . . . . 70.04 110.678 170.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 276' ' ' TYR . . . . . 0.566 ' HB3' HD11 ' A' ' 203' ' ' ILE . 10.0 m-85 -83.49 -25.48 31.07 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 113.047 0.758 . . . . 75.52 113.047 174.212 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 20.3 m-30 -72.81 -21.23 61.01 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 118.524 0.602 . . . . 44.24 109.933 176.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -61.81 -3.6 1.2 Allowed 'General case' 0 CA--C 1.558 1.266 0 CA-C-N 115.02 -0.991 . . . . 55.2 112.821 169.34 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 279' ' ' ARG . . . . . . . . . . . . . 81.7 mtt180 -72.7 -14.12 61.5 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.255 0.622 . . . . 71.52 112.441 171.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.257 0 C-N-CA 124.452 1.101 . . . . 75.14 112.683 -175.924 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt . . . . . 0 N--CA 1.472 0.627 0 N-CA-C 113.072 0.768 . . . . 62.43 113.072 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.48 ' HE3' ' HB3' ' A' ' 94' ' ' SER . 94.6 mttt -70.84 133.08 46.19 Favored 'General case' 0 C--O 1.244 0.766 0 N-CA-C 108.917 -0.772 . . . . 74.32 108.917 166.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -75.44 86.74 2.58 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 106.388 -1.708 . . . . 61.41 106.388 168.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -60.62 -34.67 74.59 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-N 115.002 -0.999 . . . . 73.34 111.231 -173.523 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.418 ' HE1' HD11 ' A' ' 22' ' ' ILE . 88.9 m-85 -62.56 -45.02 94.87 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.517 -0.765 . . . . 73.33 110.713 175.517 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.81 -42.84 99.52 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.871 0.468 . . . . 60.32 111.254 178.075 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.407 HD11 ' HB3' ' A' ' 5' ' ' LYS . 71.3 mt -55.88 -45.13 79.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 C-N-CA 123.508 0.723 . . . . 74.23 110.311 177.177 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.662 HD13 HG23 ' A' ' 22' ' ' ILE . 83.1 mt -69.43 -29.87 67.68 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 115.898 -0.592 . . . . 51.33 111.674 175.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.3 46.54 5.24 Favored Glycine 0 C--N 1.344 0.995 0 CA-C-O 120.946 0.192 . . . . 53.33 112.737 -173.238 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.528 HG13 ' HB2' ' A' ' 25' ' ' ALA . 3.1 m -141.5 154.76 67.06 Favored Pre-proline 0 N--CA 1.483 1.204 0 C-N-CA 125.166 1.387 . . . . 71.43 109.615 178.724 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -69.07 165.7 29.26 Favored 'Trans proline' 0 N--CA 1.502 1.994 0 C-N-CA 123.239 2.626 . . . . 50.12 113.328 178.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -73.68 14.23 0.39 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 113.855 1.057 . . . . 75.43 113.855 -172.525 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -135.74 19.97 3.3 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 108.954 -0.758 . . . . 64.11 108.954 175.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.36 121.96 15.56 Favored 'General case' 0 C--N 1.343 0.291 0 CA-C-N 115.095 -0.957 . . . . 64.31 110.137 178.769 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 39.9 p -76.88 171.13 15.25 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.554 -0.748 . . . . 71.11 110.166 175.052 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 15.9 mp0 -53.54 -28.98 34.57 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 124.399 1.08 . . . . 64.21 112.359 -177.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -71.95 -48.0 48.37 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.017 0.927 . . . . 72.43 110.869 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -63.88 -41.97 97.6 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 121.742 0.782 . . . . 64.03 110.493 178.473 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.662 HG23 HD13 ' A' ' 11' ' ' LEU . 74.9 mt -68.07 -32.07 54.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 114.093 -1.412 . . . . 73.31 111.174 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -70.53 -35.97 73.46 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.463 0.705 . . . . 71.24 110.907 175.152 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 45.9 mtm105 -61.94 -50.85 70.48 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 109.68 -0.489 . . . . 54.12 109.68 173.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.528 ' HB2' HG13 ' A' ' 13' ' ' VAL . . . -62.08 -37.66 85.88 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 114.891 -1.05 . . . . 64.0 111.764 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -60.26 -64.21 1.03 Allowed 'General case' 0 C--O 1.207 -1.142 0 CA-C-N 114.831 -1.077 . . . . 73.1 109.362 176.287 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -55.15 -30.5 59.97 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 124.167 0.917 . . . . 74.22 112.021 -177.473 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.47 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 50.2 ttp180 -59.46 -67.98 0.32 Allowed 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.567 -0.531 . . . . 71.15 109.567 172.604 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.633 ' HB3' HD13 ' A' ' 50' ' ' ILE . 91.8 mt -70.9 -14.34 62.35 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.171 0.588 . . . . 74.11 112.171 -175.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.638 ' HA ' ' HE1' ' A' ' 47' ' ' PHE . . . -82.96 -38.66 22.43 Favored 'General case' 0 C--O 1.206 -1.229 0 C-N-CA 123.695 0.798 . . . . 63.3 109.864 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.0 mtm180 -78.98 -33.41 45.11 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 122.497 0.319 . . . . 72.33 110.692 176.083 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.47 ' HG2' ' O ' ' A' ' 28' ' ' ARG . 15.1 mm100 -67.46 -62.44 1.42 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 122.962 0.505 . . . . 63.33 110.44 177.523 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.452 ' HE2' HD22 ' A' ' 29' ' ' LEU . 21.7 m-85 -94.83 31.39 1.84 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.288 0.635 . . . . 63.25 110.941 -176.027 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -61.5 105.65 0.65 Allowed Pre-proline 0 N--CA 1.482 1.16 0 C-N-CA 123.877 0.871 . . . . 63.41 109.983 -178.65 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.65 -14.53 36.56 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.423 2.082 . . . . 74.13 111.444 -172.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -62.65 -37.48 86.53 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.399 1.08 . . . . 72.45 111.065 173.175 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 46.7 t -104.58 -51.64 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 CA-C-O 121.356 0.598 . . . . 65.53 109.862 -178.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -99.12 86.13 3.38 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.552 1.141 . . . . 61.35 110.72 -177.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.4 mtmp? -85.78 61.06 6.61 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.352 0.596 . . . . 73.11 110.402 176.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 66.4 m -107.13 110.58 63.46 Favored Pre-proline 0 N--CA 1.476 0.845 0 CA-C-O 118.176 -0.916 . . . . 54.41 109.202 176.358 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.421 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 2.8 Cg_endo -38.07 -53.62 1.57 Allowed 'Trans proline' 0 C--N 1.393 2.911 0 C-N-CA 124.941 3.761 . . . . 72.23 114.151 -172.132 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -47.43 -52.9 15.54 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 124.657 1.183 . . . . 64.43 112.005 177.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.58 -24.89 63.75 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 114.599 -1.182 . . . . 72.14 111.244 -176.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -85.03 -36.46 21.24 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.753 0.821 . . . . 62.01 110.84 -175.441 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 41' ' ' PRO . 28.0 mm-40 -68.74 -47.73 65.53 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 108.854 -0.795 . . . . 62.44 108.854 177.526 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 49.4 mttp -65.87 -33.15 75.18 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 114.856 -1.065 . . . . 74.03 111.38 175.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.638 ' HE1' ' HA ' ' A' ' 30' ' ' ALA . 88.2 t80 -58.6 -44.64 89.94 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.051 0.54 . . . . 73.24 110.292 173.096 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.534 ' HB3' ' HE1' ' A' ' 93' ' ' PHE . 48.5 mtmt -62.45 -39.54 93.7 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.258 -0.428 . . . . 75.14 111.055 177.408 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -65.4 -28.7 69.44 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.044 0.45 . . . . 71.44 111.926 176.261 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.633 HD13 ' HB3' ' A' ' 29' ' ' LEU . 68.2 mt -73.86 -32.9 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.516 0.726 . . . . 70.53 109.834 173.088 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.413 ' O ' ' HB2' ' A' ' 55' ' ' ALA . 25.9 m-80 -81.19 -14.7 57.3 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.541 0.736 . . . . 73.43 111.3 174.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -73.68 -55.56 6.11 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.82 1.248 . . . . 63.42 108.484 170.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.76 -51.47 65.6 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 113.448 -1.705 . . . . 65.45 110.707 175.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -60.82 -45.91 92.59 Favored 'General case' 0 C--O 1.21 -0.984 0 CA-C-N 114.936 -1.029 . . . . 72.32 110.649 177.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 51' ' ' ASN . . . -52.64 -52.58 54.93 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.355 0.662 . . . . 53.01 112.246 -177.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 97.3 t -61.11 -49.44 84.64 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 O-C-N 124.201 0.938 . . . . 74.52 109.782 178.769 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.538 ' HB3' HD13 ' A' ' 22' ' ' ILE . 69.5 mt -87.75 -6.82 58.0 Favored 'General case' 0 CA--C 1.56 1.335 0 N-CA-C 114.6 1.333 . . . . 62.04 114.6 -168.509 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.2 t -79.83 -32.63 40.65 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 123.268 0.627 . . . . 74.34 110.694 -177.274 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -100.55 129.43 27.78 Favored Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 108.296 -1.002 . . . . 74.34 108.296 -176.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.82 -40.18 86.33 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 123.297 2.665 . . . . 72.41 113.499 -172.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.422 ' O ' HG13 ' A' ' 65' ' ' ILE . 13.0 mp0 -64.77 -56.09 15.71 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.055 0.942 . . . . 72.3 110.067 -178.319 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.463 ' HA ' HD12 ' A' ' 65' ' ' ILE . 44.3 mtpt -65.11 -36.49 84.44 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.838 0.855 . . . . 74.54 111.65 -176.166 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 54.2 ttt180 -56.91 -49.98 73.93 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 124.051 0.844 . . . . 74.11 108.967 174.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -69.73 -25.27 63.76 Favored 'General case' 0 C--O 1.214 -0.814 0 CA-C-N 115.091 -0.959 . . . . 74.25 112.354 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.555 HG12 ' HG2' ' A' ' 76' ' ' PRO . 85.1 mt -61.14 -48.08 90.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 108.763 -0.828 . . . . 64.42 108.763 172.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -58.03 -58.26 9.22 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 115.414 -0.812 . . . . 75.4 110.774 173.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -58.13 -38.47 76.6 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.415 1.086 . . . . 64.04 112.381 -172.113 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 73.1 p -76.14 -33.1 59.4 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 118.935 -0.555 . . . . 75.13 110.459 178.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -63.46 120.71 12.2 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-N 118.535 0.607 . . . . 63.45 109.915 -176.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 107.61 5.61 33.79 Favored Glycine 0 CA--C 1.54 1.597 0 C-N-CA 123.443 0.544 . . . . 52.54 112.034 -166.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 91.4 m -146.53 -57.7 0.28 Allowed 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 104.583 -2.377 . . . . 71.23 104.583 175.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 96.4 m -79.14 149.14 32.11 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 105.277 -2.12 . . . . 74.23 105.277 155.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.58 -17.77 3.23 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 122.863 0.465 . . . . 74.04 111.942 -171.445 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -101.98 140.96 21.63 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 123.42 0.688 . . . . 75.1 109.666 177.412 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.13 126.85 13.53 Favored 'Trans proline' 0 C--N 1.374 1.884 0 C-N-CA 122.803 2.335 . . . . 75.41 112.322 177.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.555 ' HG2' HG12 ' A' ' 65' ' ' ILE . 71.4 Cg_exo -53.7 149.28 32.92 Favored 'Trans proline' 0 C--N 1.385 2.495 0 C-N-CA 123.751 2.967 . . . . 74.25 113.419 177.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -55.36 136.83 75.42 Favored 'Trans proline' 0 C--N 1.383 2.39 0 C-N-CA 122.941 2.427 . . . . 62.44 112.181 -176.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -61.27 126.02 18.34 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.907 2.404 . . . . 43.51 112.796 -178.175 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -58.09 157.95 23.41 Favored 'Trans proline' 0 C--N 1.382 2.328 0 C-N-CA 123.415 2.743 . . . . 71.05 113.038 173.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.548 ' HD2' ' HA3' ' A' ' 142' ' ' GLY . 79.8 Cg_exo -48.78 82.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.388 2.64 0 C-N-CA 124.648 3.565 . . . . 51.35 115.42 178.786 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 136.84 -39.55 1.62 Allowed Glycine 0 N--CA 1.467 0.766 0 N-CA-C 109.881 -1.287 . . . . 62.41 109.881 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 144.61 -176.89 23.5 Favored Glycine 0 C--N 1.344 0.982 0 C-N-CA 124.237 0.922 . . . . 53.03 110.969 176.208 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -58.79 98.47 0.04 OUTLIER 'General case' 0 C--O 1.243 0.738 0 N-CA-C 107.604 -1.258 . . . . 74.41 107.604 164.237 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -64.8 110.68 2.49 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.51 0.671 . . . . 71.31 109.307 -173.578 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.417 ' H ' ' HE2' ' A' ' 106' ' ' PHE . 23.0 t80 -133.05 23.9 4.2 Favored 'General case' 0 C--O 1.259 1.567 0 C-N-CA 124.862 1.265 . . . . 70.22 108.664 -168.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.457 ' HA ' ' CG ' ' A' ' 171' ' ' PRO . 73.4 m -58.5 146.28 36.0 Favored 'General case' 0 C--N 1.349 0.559 0 CA-C-N 113.986 -1.461 . . . . 74.44 112.279 -171.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.456 ' H ' ' HG2' ' A' ' 171' ' ' PRO . . . 79.73 -9.08 45.97 Favored Glycine 0 CA--C 1.536 1.382 0 CA-C-O 118.803 -0.998 . . . . 70.11 114.629 -176.795 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.429 ' HB3' ' HE2' ' A' ' 93' ' ' PHE . 51.8 m-85 -112.74 142.63 45.13 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 119.383 1.591 . . . . 72.34 112.575 -176.053 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -82.42 75.89 9.31 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 124.149 0.98 . . . . 71.44 111.126 -172.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.601 HG23 ' HE2' ' A' ' 97' ' ' PHE . 2.5 p -39.4 -48.55 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.62 0 C-N-CA 125.787 1.635 . . . . 75.21 113.904 176.17 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.17 -36.52 70.88 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 124.157 0.983 . . . . 75.33 112.195 -176.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -72.69 -31.7 65.23 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.949 -0.568 . . . . 45.35 110.902 -175.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.534 ' HE1' ' HB3' ' A' ' 48' ' ' LYS . 15.4 m-30 -80.05 174.71 11.32 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.905 -0.589 . . . . 71.01 111.939 -164.436 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.48 ' HB3' ' HE3' ' A' ' 5' ' ' LYS . 78.7 p -57.1 149.41 19.47 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.808 0.843 . . . . 74.5 113.129 -168.251 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.16 -39.61 72.59 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 114.839 -1.073 . . . . 74.31 110.084 168.053 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -54.49 -47.25 73.26 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.384 1.074 . . . . 75.03 110.896 176.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.601 ' HE2' HG23 ' A' ' 90' ' ' VAL . 44.3 t80 -59.42 -50.07 75.35 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 115.338 -0.847 . . . . 63.23 110.092 175.315 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -76.31 -2.18 30.36 Favored 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 112.403 0.52 . . . . 73.05 112.403 -175.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -93.94 -59.3 2.01 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.652 0.781 . . . . 70.02 110.191 169.363 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 33.4 tp -62.46 -46.18 89.68 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.979 0.912 . . . . 55.03 111.24 -176.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.407 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 82.4 m-85 -92.75 -3.65 54.44 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.104 0.562 . . . . 72.11 111.477 177.71 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -46.35 -57.73 6.28 Favored Glycine 0 CA--C 1.544 1.87 0 CA-C-O 118.988 -0.895 . . . . 72.43 115.195 177.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -68.21 11.51 0.26 Allowed 'Trans proline' 0 C--N 1.382 2.317 0 C-N-CA 123.637 2.891 . . . . 23.1 114.635 -178.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -147.05 16.5 1.54 Allowed Glycine 0 C--N 1.348 1.228 0 CA-C-O 119.078 -0.845 . . . . 44.4 113.077 171.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 101' ' ' PHE . 35.5 mt -66.65 79.81 0.11 Allowed 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 118.01 0.905 . . . . 74.25 111.61 174.419 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.417 ' HE2' ' H ' ' A' ' 85' ' ' PHE . 2.7 m-85 38.55 -113.27 0.12 Allowed 'General case' 0 CA--C 1.56 1.34 0 C-N-CA 126.632 1.973 . . . . 72.25 115.813 172.131 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 70.31 0.49 29.96 Favored Glycine 0 C--N 1.368 2.311 0 N-CA-C 112.29 -0.324 . . . . 44.0 112.29 -162.418 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.355 1.604 0 C-N-CA 123.198 0.428 . . . . 71.34 113.284 -171.805 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? . . . . . 0 CA--C 1.55 0.974 0 N-CA-C 109.181 -0.674 . . . . 72.15 109.181 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.429 ' HA2' HH11 ' A' ' 117' ' ' ARG . . . -64.53 160.52 40.4 Favored Glycine 0 C--N 1.343 0.954 0 CA-C-O 121.664 0.591 . . . . 55.22 113.471 178.724 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.527 ' H ' ' HA3' ' A' ' 166' ' ' GLY . 2.7 mpt_? -102.87 165.43 11.05 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.424 1.09 . . . . 71.34 110.923 -168.56 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -76.44 115.75 16.48 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 106.698 -1.593 . . . . 74.23 106.698 163.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.524 HD12 ' HA2' ' A' ' 166' ' ' GLY . 3.6 tt -114.99 136.85 52.67 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 107.756 -1.201 . . . . 70.23 107.756 -174.268 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 29.8 ttt-85 -117.02 135.94 53.33 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 108.554 -0.906 . . . . 74.51 108.554 174.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.97 168.7 23.06 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 121.192 0.52 . . . . 41.51 111.407 -177.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -111.66 112.77 24.7 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.324 1.05 . . . . 61.0 109.439 -169.622 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 37.5 tp -100.92 96.2 5.39 Favored Pre-proline 0 CA--C 1.549 0.909 0 N-CA-C 108.796 -0.816 . . . . 54.05 108.796 -178.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.426 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 1.1 Cg_endo -83.53 114.27 2.07 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 122.695 2.263 . . . . 75.33 110.61 -173.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.521 ' HB3' HD23 ' A' ' 180' ' ' LEU . 46.3 tp -117.41 141.55 48.19 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.152 0.501 . . . . 64.01 111.134 -169.178 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 24.0 m -69.41 142.05 53.96 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 114.908 -1.042 . . . . 71.34 110.277 173.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.586 HD13 ' HB2' ' A' ' 186' ' ' PHE . 84.5 mt -57.65 -46.53 84.1 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.245 0.618 . . . . 70.54 110.389 179.036 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -62.67 -37.51 86.7 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 115.071 -0.968 . . . . 75.32 110.519 -177.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -76.6 -21.4 55.63 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.256 0.622 . . . . 64.33 111.574 178.103 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -71.71 -40.9 69.18 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.023 0.529 . . . . 41.43 110.166 171.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -65.02 -42.43 94.38 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.477 1.111 . . . . 74.51 110.547 177.276 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 41.7 m170 -69.16 -48.3 62.66 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.384 -0.826 . . . . 75.25 111.273 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.46 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 71.3 -141.96 33.36 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 115.941 -0.572 . . . . 71.54 112.496 -175.439 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 71.97 -161.2 54.25 Favored Glycine 0 C--N 1.349 1.297 0 C-N-CA 122.987 0.327 . . . . 70.42 113.141 178.608 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.671 ' HB3' ' HB2' ' A' ' 146' ' ' SER . 26.2 mp0 -69.54 118.46 12.44 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 122.949 0.5 . . . . 73.14 110.146 178.354 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 11.1 tpp180 -101.21 118.91 37.92 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.794 -0.817 . . . . 74.4 108.794 176.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.581 ' HB ' HG21 ' B' ' 5' ' ' THR . 97.2 t -81.74 96.0 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 121.413 0.625 . . . . 71.24 109.465 -178.729 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.1 p -115.47 124.11 71.65 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-N 114.985 -1.007 . . . . 73.14 108.435 173.528 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -85.13 115.11 22.73 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 114.792 -1.095 . . . . 71.3 110.246 178.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 33.9 m -122.58 127.65 75.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 124.226 1.011 . . . . 75.1 110.684 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 63.17 21.26 12.76 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.105 0.962 . . . . 74.24 112.575 177.274 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.548 ' HA3' ' HD2' ' A' ' 80' ' ' PRO . . . 90.2 -17.95 51.04 Favored Glycine 0 C--N 1.35 1.33 0 C-N-CA 122.689 0.185 . . . . 31.1 113.075 -175.409 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -87.83 118.64 27.49 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.201 1.001 . . . . 72.12 108.831 176.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 45.4 ttm105 -82.4 115.46 21.44 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.592 0.757 . . . . 74.41 109.05 178.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 14.7 p -125.47 149.54 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-O 121.4 0.619 . . . . 73.53 110.607 -177.332 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.671 ' HB2' ' HB3' ' A' ' 135' ' ' GLU . 35.9 p -107.55 93.27 4.45 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 124.382 1.073 . . . . 31.45 110.45 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 3.4 p -80.57 112.68 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 123.108 0.563 . . . . 73.42 109.564 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -67.02 95.28 0.38 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.658 0.742 . . . . 74.14 110.378 176.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.46 HG13 ' HA2' ' A' ' 133' ' ' GLY . 44.5 pt -78.15 140.58 61.63 Favored Pre-proline 0 CA--C 1.556 1.186 0 CA-C-N 114.42 -1.264 . . . . 74.13 108.713 170.047 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -66.31 138.48 51.19 Favored 'Trans proline' 0 C--N 1.373 1.833 0 C-N-CA 121.995 1.797 . . . . 60.34 112.187 176.471 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -63.82 92.63 0.17 Allowed 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 122.424 2.083 . . . . 74.15 110.749 171.239 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 123.4 27.35 1.49 Allowed Glycine 0 CA--C 1.526 0.736 0 CA-C-N 114.756 -1.111 . . . . 75.51 110.993 -171.495 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 5.7 p -73.67 137.45 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 123.294 0.637 . . . . 75.43 109.552 179.233 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.56 HH21 ' HG2' ' A' ' 241' ' ' PRO . 0.0 OUTLIER -112.36 154.61 25.47 Favored 'General case' 0 C--O 1.211 -0.941 0 CA-C-N 116.372 -0.376 . . . . 73.23 111.816 -163.704 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -54.0 124.26 15.02 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 124.049 0.843 . . . . 72.32 110.248 171.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.46 4.88 70.13 Favored Glycine 0 C--N 1.342 0.9 0 CA-C-O 119.159 -0.8 . . . . 14.21 113.747 -178.558 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 58.3 m -67.78 102.09 1.17 Allowed 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 118.157 0.979 . . . . 74.23 108.857 170.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 53.9 t -83.94 91.4 2.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 107.34 -1.356 . . . . 72.34 107.34 177.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.653 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 53.0 mt -71.99 85.12 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.801 0 N-CA-C 107.618 -1.253 . . . . 75.24 107.618 174.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -74.17 99.52 3.42 Favored 'General case' 0 C--N 1.353 0.76 0 N-CA-C 107.378 -1.342 . . . . 61.32 107.378 175.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.0 p -110.13 118.75 48.87 Favored Pre-proline 0 CA--C 1.548 0.903 0 CA-C-N 115.076 -0.966 . . . . 61.33 110.872 -169.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -79.06 125.3 6.45 Favored 'Trans proline' 0 C--N 1.369 1.626 0 C-N-CA 122.386 2.057 . . . . 74.53 106.841 160.306 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.421 ' HA2' ' O ' ' A' ' 86' ' ' SER . . . 130.0 -23.75 4.63 Favored Glycine 0 N--CA 1.469 0.9 0 N-CA-C 111.303 -0.719 . . . . 70.43 111.303 -165.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -134.22 144.55 48.5 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 106.152 -1.795 . . . . 64.15 106.152 163.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -175.85 -160.95 24.27 Favored Glycine 0 CA--C 1.498 -0.993 0 N-CA-C 114.596 0.598 . . . . 73.33 114.596 171.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.527 ' HA3' ' H ' ' A' ' 117' ' ' ARG . . . -57.79 135.64 51.56 Favored Glycine 0 C--N 1.356 1.691 0 O-C-N 124.476 0.75 . . . . 74.5 112.322 175.059 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -70.38 105.11 2.91 Favored 'General case' 0 CA--C 1.548 0.899 0 O-C-N 125.686 1.462 . . . . 75.42 110.105 -172.123 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -170.39 155.7 25.51 Favored Glycine 0 C--N 1.339 0.727 0 CA-C-O 118.887 -0.952 . . . . 64.21 111.253 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' ASN . . . . . 0.495 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . 7.3 t30 -64.74 -56.26 22.99 Favored Pre-proline 0 N--CA 1.488 1.438 0 CA-C-O 117.826 -1.083 . . . . 63.11 111.41 -170.102 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.495 ' HD3' ' HB3' ' A' ' 169' ' ' ASN . 1.7 Cg_endo -82.68 91.74 0.96 Allowed 'Trans proline' 0 C--N 1.388 2.649 0 N-CA-C 106.965 -1.975 . . . . 71.13 106.965 162.137 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.457 ' CG ' ' HA ' ' A' ' 86' ' ' SER . 56.0 Cg_endo -76.6 174.58 12.61 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 123.479 2.786 . . . . 71.25 117.232 -156.017 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -95.48 -158.86 32.73 Favored Glycine 0 C--N 1.363 2.05 0 CA-C-N 114.724 -1.125 . . . . 72.4 114.736 -177.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -133.52 146.08 50.73 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 125.386 1.474 . . . . 71.14 108.147 -177.068 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 41.8 tp -118.26 141.63 48.31 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 120.966 0.412 . . . . 64.32 112.015 -172.014 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 68.9 mt -97.2 91.67 5.65 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 124.268 1.027 . . . . 72.12 108.284 171.413 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.653 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 85.4 mt -74.28 85.61 1.93 Allowed 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.392 -0.966 . . . . 70.05 108.392 170.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 46.5 t -83.34 97.82 4.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 107.037 -1.468 . . . . 61.43 107.037 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 8.9 p -68.41 125.88 27.1 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 CA-C-N 115.558 -0.746 . . . . 70.33 110.144 -173.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.426 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 40.4 mmm-85 -116.94 97.61 6.04 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.497 1.119 . . . . 53.32 108.215 -176.446 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.521 HD23 ' HB3' ' A' ' 125' ' ' LEU . 45.3 mt -69.34 141.11 54.31 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 110.067 -0.346 . . . . 72.4 110.067 -179.481 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 79.6 mt -57.52 148.2 56.51 Favored Pre-proline 0 CA--C 1.549 0.929 0 O-C-N 124.066 0.854 . . . . 73.14 111.202 -177.099 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -77.43 48.19 2.49 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 123.084 2.523 . . . . 71.42 110.441 167.194 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' HIS . . . . . 0.431 ' HA ' ' HD3' ' A' ' 184' ' ' PRO . 53.2 t-80 -70.28 136.94 86.54 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 125.27 1.428 . . . . 73.35 109.051 -172.12 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 183' ' ' HIS . 53.1 Cg_exo -58.32 12.09 0.04 OUTLIER 'Trans proline' 0 C--N 1.381 2.253 0 C-N-CA 124.202 3.268 . . . . 61.24 118.127 -168.387 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 40.2 t -106.63 -55.2 5.61 Favored 'Isoleucine or valine' 0 C--N 1.352 0.702 0 CA-C-N 119.43 1.014 . . . . 64.21 109.181 172.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 186' ' ' PHE . . . . . 0.586 ' HB2' HD13 ' A' ' 127' ' ' LEU . 23.1 m-85 -134.49 147.11 50.3 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 115.061 -0.972 . . . . 72.31 111.681 -168.759 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -133.79 90.96 2.77 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 106.177 -1.786 . . . . 75.51 106.177 165.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.49 HD13 ' HG ' ' A' ' 193' ' ' LEU . 60.0 tp -71.47 161.33 31.21 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 124.48 1.112 . . . . 74.21 111.652 -177.129 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -154.28 107.54 2.89 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 122.905 0.482 . . . . 70.31 110.59 174.669 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 82.22 -53.37 4.76 Favored Glycine 0 C--N 1.36 1.861 0 C-N-CA 123.375 0.512 . . . . 65.41 114.216 174.457 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -178.97 -21.43 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 126.917 2.087 . . . . 72.32 107.789 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -85.31 120.37 26.72 Favored 'General case' 0 C--N 1.357 0.923 0 CA-C-N 114.405 -1.271 . . . . 72.32 109.509 -178.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.566 HD13 HD13 ' A' ' 249' ' ' LEU . 0.6 OUTLIER -89.97 142.7 27.46 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.06 0.944 . . . . 63.44 110.112 -170.23 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -119.3 145.18 46.35 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 107.878 -1.156 . . . . 73.14 107.878 166.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.441 ' HB3' HD23 ' A' ' 251' ' ' LEU . . . -144.63 175.84 9.85 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.609 1.164 . . . . 74.34 109.485 -171.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 2.9 m -118.41 139.84 50.77 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.643 -0.873 . . . . 70.21 108.643 172.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.628 HD22 HD13 ' A' ' 251' ' ' LEU . 34.5 tp -145.61 105.87 4.05 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 110.127 -0.323 . . . . 72.21 110.127 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -73.62 133.38 43.46 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 109.285 -0.635 . . . . 61.43 109.285 167.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 7.3 p -143.59 133.03 11.63 Favored Pre-proline 0 CA--C 1.548 0.879 0 N-CA-C 107.781 -1.192 . . . . 64.4 107.781 178.116 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.28 146.15 35.46 Favored 'Trans proline' 0 C--N 1.368 1.586 0 C-N-CA 121.313 1.342 . . . . 64.51 110.404 169.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.477 ' HB3' ' HH2' ' A' ' 269' ' ' TRP . . . -44.13 -52.0 17.16 Favored Pre-proline 0 CA--C 1.568 1.669 0 N-CA-C 115.644 1.72 . . . . 71.34 115.644 -173.608 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.408 ' HD3' ' HB3' ' A' ' 201' ' ' ALA . 50.5 Cg_exo -60.07 -38.55 76.86 Favored 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 121.809 1.673 . . . . 63.54 113.845 -179.49 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 46.3 mt -70.17 -29.4 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 110.016 -0.364 . . . . 64.32 110.016 179.3 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.18 -48.83 61.1 Favored 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 123.069 0.548 . . . . 71.51 111.941 172.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 201' ' ' ALA . 93.4 t -65.54 -43.04 94.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 C-N-CA 123.837 0.855 . . . . 63.23 111.859 -175.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.472 HG21 ' HB2' ' C' ' 273' ' ' ALA . 70.4 t -92.55 -34.68 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.594 0.757 . . . . 74.41 111.458 -173.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 88.09 89.21 1.12 Allowed Glycine 0 C--N 1.341 0.845 0 N-CA-C 111.319 -0.712 . . . . 72.35 111.319 -175.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -107.4 -139.28 9.1 Favored Glycine 0 C--N 1.34 0.798 0 CA-C-O 120.277 -0.18 . . . . 55.24 112.67 -177.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -130.85 128.21 40.16 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.175 0.99 . . . . 45.21 108.917 177.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 29.3 m -129.83 159.24 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 109.038 -0.727 . . . . 63.11 109.038 175.21 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 55.2 ttm-85 -93.93 107.24 19.16 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 109.494 -0.558 . . . . 71.41 109.494 178.04 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -102.25 124.35 47.69 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 124.111 0.964 . . . . 62.04 109.436 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 213' ' ' MET . . . . . 0.413 ' N ' ' SD ' ' A' ' 213' ' ' MET . 1.0 OUTLIER -75.08 126.08 30.27 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.202 0.601 . . . . 71.23 109.747 175.922 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 72.7 p -116.1 -178.01 3.3 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 123.876 0.87 . . . . 74.1 108.726 173.001 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.424 ' HG ' ' HE2' ' A' ' 186' ' ' PHE . 63.8 mt -77.01 -7.6 55.93 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 122.778 0.431 . . . . 63.31 110.727 174.521 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -99.98 -19.66 16.46 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.225 1.01 . . . . 64.44 110.553 176.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 139.53 172.84 12.86 Favored Glycine 0 C--N 1.353 1.504 0 CA-C-O 119.858 -0.412 . . . . 33.0 113.451 175.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -75.9 99.32 1.27 Allowed 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 122.93 2.42 . . . . 70.23 111.285 178.118 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 32.5 m -103.2 159.34 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.208 1.003 . . . . 73.4 110.619 -174.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -93.8 105.07 17.12 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.152 -0.684 . . . . 75.04 109.152 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 8.7 p -101.64 137.52 29.09 Favored 'Isoleucine or valine' 0 C--O 1.253 1.273 0 C-N-CA 123.832 0.853 . . . . 74.13 110.021 -174.588 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -86.42 102.75 14.34 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.784 0.834 . . . . 60.25 110.744 -178.379 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 48.8 t -63.48 137.76 97.17 Favored Pre-proline 0 CA--C 1.56 1.353 0 C-N-CA 124.458 1.103 . . . . 63.14 110.304 179.3 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -79.98 164.01 22.76 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 122.673 2.249 . . . . 75.51 110.612 174.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.99 152.4 46.11 Favored 'Trans proline' 0 C--N 1.369 1.63 0 C-N-CA 121.786 1.657 . . . . 72.53 112.814 178.253 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 226' ' ' ARG . . . . . 0.571 HH12 ' HG ' ' C' ' 261' ' ' LEU . 63.5 mtt-85 67.54 26.06 8.22 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 125.533 1.533 . . . . 74.04 111.873 172.526 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.504 HG23 HD21 ' A' ' 233' ' ' LEU . 10.5 m -61.17 104.01 0.34 Allowed 'General case' 0 CA--C 1.559 1.323 0 C-N-CA 125.699 1.6 . . . . 64.32 111.026 175.316 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 228' ' ' GLN . . . . . 0.562 ' HB3' ' HD2' ' A' ' 231' ' ' ARG . 4.8 tp-100 -97.38 143.89 27.67 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.085 0.954 . . . . 75.32 111.263 -173.252 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -63.57 150.91 42.94 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.588 0.755 . . . . 62.31 112.462 -177.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 83.71 -28.27 4.03 Favored Glycine 0 C--N 1.349 1.271 0 O-C-N 123.684 0.615 . . . . 73.32 112.523 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.562 ' HD2' ' HB3' ' A' ' 228' ' ' GLN . 76.6 mtt180 -77.63 167.11 22.12 Favored 'General case' 0 C--N 1.347 0.492 0 C-N-CA 123.971 0.908 . . . . 74.0 110.469 178.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.443 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 12.5 mptt -121.82 120.55 34.89 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 115.067 -0.97 . . . . 72.22 108.571 -178.078 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.504 HD21 HG23 ' A' ' 227' ' ' THR . 81.8 mt -74.59 110.3 8.77 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 108.595 -0.891 . . . . 71.4 108.595 177.537 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 234' ' ' ARG . . . . . 0.563 ' HG3' ' HB3' ' A' ' 248' ' ' ASP . 39.9 ttp180 -87.63 100.77 13.05 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 122.622 0.369 . . . . 64.14 110.121 178.584 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.503 ' H ' HD23 ' A' ' 235' ' ' LEU . 0.2 OUTLIER -100.84 106.84 18.25 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 106.466 -1.679 . . . . 61.12 106.466 170.662 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -76.18 143.95 40.81 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 115.045 -0.979 . . . . 64.43 111.708 -169.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 71.35 32.62 64.97 Favored Glycine 0 C--N 1.348 1.2 0 O-C-N 123.704 0.627 . . . . 74.2 112.536 -178.1 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.491 ' HG3' HD12 ' A' ' 235' ' ' LEU . 43.9 mmtm -125.32 -17.18 5.71 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.985 0.914 . . . . 73.01 110.453 178.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 239' ' ' GLY . . . . . 0.515 ' HA2' HD12 ' A' ' 193' ' ' LEU . . . -79.6 -151.86 6.85 Favored Glycine 0 C--N 1.353 1.474 0 CA-C-N 116.298 -0.41 . . . . 74.43 112.655 176.354 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -96.72 146.06 30.65 Favored Pre-proline 0 N--CA 1.482 1.169 0 C-N-CA 122.882 0.473 . . . . 73.13 109.857 -179.05 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.728 ' HA ' ' HA ' ' A' ' 246' ' ' ARG . 33.1 Cg_endo -61.27 167.26 9.66 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 123.203 2.602 . . . . 73.33 114.195 -175.577 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -175.2 -176.35 43.4 Favored Glycine 0 CA--C 1.535 1.335 0 CA-C-N 115.213 -0.903 . . . . 73.52 112.18 177.374 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -62.44 -19.31 67.05 Favored 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 123.68 2.92 . . . . 70.45 113.961 -175.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -102.53 22.52 13.4 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 124.027 0.931 . . . . 70.11 110.855 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 90.18 -164.38 30.9 Favored Glycine 0 C--N 1.35 1.338 0 N-CA-C 111.471 -0.651 . . . . 62.24 111.471 -174.051 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.728 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 25.1 ttm180 -73.08 139.37 46.45 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 117.664 0.732 . . . . 75.41 110.383 177.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -70.06 179.11 28.58 Favored Glycine 0 C--N 1.34 0.775 0 CA-C-N 115.709 -0.678 . . . . 42.24 113.379 -176.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 248' ' ' ASP . . . . . 0.563 ' HB3' ' HG3' ' A' ' 234' ' ' ARG . 55.7 m-20 -106.12 140.57 38.89 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.52 0.728 . . . . 75.44 109.493 -173.543 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.566 HD13 HD13 ' A' ' 193' ' ' LEU . 34.4 tp -97.61 120.0 37.19 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.349 -0.982 . . . . 70.31 108.349 178.404 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.443 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 2.9 m-85 -100.93 106.18 17.49 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.363 1.065 . . . . 52.51 108.66 177.562 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.628 HD13 HD22 ' A' ' 197' ' ' LEU . 47.1 mt -87.03 121.45 29.51 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.392 0.677 . . . . 72.24 109.659 177.293 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 252' ' ' GLU . . . . . 0.427 ' HB2' ' O ' ' A' ' 195' ' ' ALA . 2.8 tm-20 -74.38 107.3 6.45 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 107.45 -1.315 . . . . 75.41 107.45 -178.435 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.497 HG12 HG13 ' A' ' 255' ' ' ILE . 42.6 t -67.36 99.67 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.687 0 O-C-N 124.117 0.886 . . . . 24.43 110.223 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.25 92.16 4.39 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 107.181 -1.414 . . . . 73.14 107.181 177.688 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.497 HG13 HG12 ' A' ' 253' ' ' VAL . 70.2 mt -83.8 130.95 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-O 120.779 0.323 . . . . 74.34 110.583 -177.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 51.8 p -128.99 169.38 14.75 Favored 'General case' 0 C--O 1.253 1.265 0 C-N-CA 123.942 0.897 . . . . 73.43 109.585 172.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 257' ' ' ILE . . . . . 0.551 HD13 HG22 ' C' ' 205' ' ' VAL . 2.1 pp -119.14 155.95 52.91 Favored Pre-proline 0 CA--C 1.564 1.513 0 N-CA-C 108.121 -1.066 . . . . 73.4 108.121 173.095 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -76.27 9.21 2.56 Favored 'Trans proline' 0 N--CA 1.512 2.564 0 C-N-CA 123.027 2.485 . . . . 74.45 115.328 -162.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 259' ' ' GLU . . . . . 0.48 ' H ' HD12 ' A' ' 257' ' ' ILE . 5.6 mm-40 56.72 -90.72 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 123.858 0.863 . . . . 63.24 109.925 -164.47 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 260' ' ' ARG . . . . . 0.464 HH22 HG23 ' A' ' 262' ' ' THR . 0.0 OUTLIER -74.33 144.32 44.53 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.589 0.756 . . . . 75.12 111.521 -175.029 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.435 HD11 HG11 ' C' ' 205' ' ' VAL . 49.5 mt -123.41 178.67 5.05 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.046 0.938 . . . . 55.32 111.165 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 262' ' ' THR . . . . . 0.464 HG23 HH22 ' A' ' 260' ' ' ARG . 1.2 p -128.16 143.88 49.61 Favored Pre-proline 0 CA--C 1.556 1.181 0 CA-C-N 114.007 -1.451 . . . . 44.34 108.43 176.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -28.26 -53.91 0.14 Allowed 'Trans proline' 0 C--N 1.39 2.757 1 C-N-CA 126.166 4.577 . . . . 74.33 117.734 -167.712 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 264' ' ' GLU . . . . . 0.406 ' O ' HD13 ' A' ' 268' ' ' LEU . 16.9 tp10 -70.25 -47.52 60.98 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 122.589 0.356 . . . . 71.44 110.68 -174.562 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -64.51 -29.22 70.26 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.284 1.034 . . . . 64.2 110.319 178.218 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -62.76 -50.53 70.69 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.736 0.814 . . . . 73.45 109.047 175.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -62.76 -37.13 85.4 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 114.991 -1.004 . . . . 64.12 112.097 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 268' ' ' LEU . . . . . 0.5 HD21 ' HB3' ' C' ' 271' ' ' LYS . 6.7 mp -64.73 -56.05 16.08 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.704 0.802 . . . . 73.14 111.396 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 269' ' ' TRP . . . . . 0.477 ' HH2' ' HB3' ' A' ' 201' ' ' ALA . 68.1 m95 -58.62 -41.73 86.57 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.431 0.693 . . . . 75.0 111.279 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -60.25 -58.54 8.07 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 123.828 0.705 . . . . 62.43 111.516 178.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 30.8 mmtm -66.34 -33.64 76.18 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 112.418 0.525 . . . . 70.22 112.418 -175.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 13.7 mt -54.25 -53.54 52.3 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 109.224 -0.658 . . . . 63.4 109.224 169.138 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 273' ' ' ALA . . . . . 0.443 ' HA ' ' HB2' ' C' ' 202' ' ' PRO . . . -67.41 -37.84 83.68 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.671 1.188 . . . . 64.51 113.664 -172.665 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -67.81 -53.81 24.08 Favored 'General case' 0 C--O 1.243 0.733 0 C-N-CA 123.956 0.902 . . . . 74.35 109.398 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -66.29 -30.41 70.82 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 115.538 -0.755 . . . . 71.44 111.145 178.441 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -68.57 -44.65 74.0 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.474 0.71 . . . . 75.02 109.945 178.227 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 277' ' ' TYR . . . . . 0.465 ' HA ' ' HB3' ' A' ' 280' ' ' ALA . 70.3 t80 -65.12 -37.53 87.75 Favored 'General case' 0 C--O 1.242 0.674 0 O-C-N 124.06 0.85 . . . . 70.12 110.245 -178.535 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -57.79 -23.83 54.3 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 115.571 -0.74 . . . . 75.41 111.683 173.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 67.7 mtm-85 -102.89 -15.76 16.08 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 124.026 0.93 . . . . 74.13 111.398 176.389 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 280' ' ' ALA . . . . . 0.465 ' HB3' ' HA ' ' A' ' 277' ' ' TYR . . . . . . . . 0 C--O 1.259 1.561 0 C-N-CA 123.851 0.86 . . . . 72.21 110.275 -176.095 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 62.9 mtm . . . . . 0 N--CA 1.482 1.148 0 N-CA-C 109.25 -0.648 . . . . 71.44 109.25 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 61.93 -158.23 0.33 Allowed 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.766 0.826 . . . . 54.1 109.777 -177.221 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -90.47 67.5 6.58 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 108.108 -1.071 . . . . 74.04 108.108 169.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 21.8 p -69.94 97.57 1.15 Allowed 'General case' 0 C--O 1.244 0.776 0 CA-C-N 115.53 -0.759 . . . . 52.14 110.543 -177.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 5' ' ' THR . . . . . 0.581 HG21 ' HB ' ' A' ' 137' ' ' VAL . 0.0 OUTLIER -97.07 166.17 11.72 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.475 -0.784 . . . . 70.11 111.71 -174.59 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 19.7 pt -133.78 166.57 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 115.248 -0.887 . . . . 64.44 112.385 -157.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -128.59 155.31 45.15 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.878 1.271 . . . . 72.01 108.625 173.032 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 45.7 tp -89.36 -98.55 0.1 Allowed 'General case' 0 CA--C 1.55 0.961 0 CA-C-O 119.131 -0.461 . . . . 75.22 110.574 -173.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . 166.31 -55.0 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 125.126 1.371 . . . . 62.4 109.065 -173.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 93.0 mt 57.95 91.29 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.983 1.313 . . . . 74.1 110.459 -168.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 78.7 mt . . . . . 0 CA--C 1.546 0.792 0 C-N-CA 123.526 0.73 . . . . 45.35 109.434 -177.069 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.89 0 N-CA-C 108.46 -0.941 . . . . 61.34 108.46 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 180' ' ' ALA . . . . . 0.565 ' HB1' HG23 ' C' ' 137' ' ' VAL . . . -170.03 -76.97 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.197 1.399 . . . . 74.4 107.553 177.676 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 181' ' ' LEU . . . . . 0.672 HD22 ' HB2' ' C' ' 136' ' ' ARG . 33.9 tp -132.46 -58.01 0.94 Allowed 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 107.518 -1.289 . . . . 62.04 107.518 163.837 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 182' ' ' VAL . . . . . 0.494 HG13 ' H ' ' B' ' 184' ' ' HIS . 11.5 p -74.04 160.51 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-N 114.883 -1.053 . . . . 71.31 110.812 178.163 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -90.33 22.75 3.21 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.888 0.875 . . . . 65.24 111.305 173.027 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 184' ' ' HIS . . . . . 0.494 ' H ' HG13 ' B' ' 182' ' ' VAL . 77.1 t60 64.98 -83.65 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.138 1.375 . . . . 74.15 107.885 -166.767 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 185' ' ' VAL . . . . . 0.439 HG23 ' HA ' ' C' ' 121' ' ' ALA . 1.7 p . . . . . 0 N--CA 1.475 0.813 0 C-N-CA 123.921 0.888 . . . . 71.33 109.002 168.337 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 238' ' ' THR . . . . . 0.455 ' HB ' ' HA ' ' C' ' 219' ' ' VAL . 6.3 m . . . . . 0 CA--C 1.555 1.159 0 CA-C-O 120.599 0.238 . . . . 71.31 110.826 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 239' ' ' ALA . . . . . 0.511 ' HB2' ' HA ' ' C' ' 221' ' ' VAL . . . -77.14 172.95 12.42 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.867 1.062 . . . . 74.42 113.867 -167.125 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 240' ' ' GLY . . . . . 0.439 ' H ' HD22 ' C' ' 235' ' ' LEU . . . -113.05 -101.3 2.5 Favored Glycine 0 C--N 1.339 0.723 0 CA-C-N 114.015 -1.448 . . . . 71.23 109.634 177.712 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -157.51 162.16 38.84 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.588 0.709 . . . . 71.21 111.562 -175.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 242' ' ' TRP . . . . . 0.592 ' HH2' HG21 ' C' ' 199' ' ' VAL . 5.4 m95 -107.04 -47.36 3.71 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 114.106 -1.406 . . . . 70.32 107.478 172.525 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 177.69 -35.78 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 111.532 -2.576 . . . . 74.22 105.504 -166.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -156.5 -176.0 28.1 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 113.487 -1.688 . . . . 63.11 109.459 166.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.476 0.874 0 C-N-CA 123.661 0.784 . . . . 75.34 110.303 175.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.701 0 N-CA-C 109.56 -0.533 . . . . 52.01 109.56 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -40.5 95.67 0.01 OUTLIER 'General case' 0 C--N 1.359 0.99 0 C-N-CA 125.564 1.546 . . . . 70.52 114.045 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 5' ' ' LYS . . . . . 0.416 ' HB3' HD11 ' C' ' 10' ' ' ILE . 48.6 mtmt -87.72 124.52 33.67 Favored 'General case' 0 C--O 1.247 0.942 0 N-CA-C 108.899 -0.778 . . . . 63.2 108.899 170.661 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -75.84 112.88 12.7 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.629 -0.878 . . . . 63.22 108.629 175.285 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 7' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -64.47 -26.16 68.32 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.713 0.805 . . . . 73.43 112.711 -171.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -70.89 -45.07 65.0 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 109.319 -0.623 . . . . 72.53 109.319 178.039 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.57 -36.91 84.16 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.973 -1.012 . . . . 52.31 110.762 176.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 10' ' ' ILE . . . . . 0.416 HD11 ' HB3' ' C' ' 5' ' ' LYS . 56.6 mt -59.46 -46.57 92.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 122.908 0.483 . . . . 63.34 110.06 174.315 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 11' ' ' LEU . . . . . 0.622 ' HB3' ' HB1' ' C' ' 25' ' ' ALA . 56.6 mt -71.39 -6.73 42.36 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 112.639 0.607 . . . . 45.45 112.639 176.498 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.84 21.09 79.66 Favored Glycine 0 C--N 1.355 1.629 0 C-N-CA 122.812 0.244 . . . . 64.33 113.62 178.243 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 13' ' ' VAL . . . . . 0.421 HG11 ' HB2' ' C' ' 25' ' ' ALA . 31.3 m -113.98 161.51 27.57 Favored Pre-proline 0 N--CA 1.477 0.885 0 C-N-CA 124.111 0.964 . . . . 64.04 110.259 -177.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -54.89 148.52 46.32 Favored 'Trans proline' 0 C--N 1.382 2.294 0 C-N-CA 122.617 2.211 . . . . 74.43 113.05 174.121 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 68.4 mtm180 -76.94 19.9 0.28 Allowed 'General case' 0 CA--C 1.559 1.296 0 C-N-CA 123.757 0.823 . . . . 71.52 112.969 -172.319 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -136.97 8.17 2.97 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 125.076 1.35 . . . . 71.24 109.344 179.051 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.07 141.13 58.84 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.851 0.86 . . . . 71.14 112.242 -174.168 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 47.7 p -93.24 176.44 6.4 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.276 1.03 . . . . 74.41 112.335 -174.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -53.41 -36.34 61.39 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 125.288 1.435 . . . . 74.45 112.585 -175.306 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -57.95 -47.98 81.31 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.55 1.14 . . . . 64.05 111.405 175.03 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -76.89 -29.98 56.0 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.042 -1.436 . . . . 73.42 111.194 -174.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 22' ' ' ILE . . . . . 0.452 HG12 ' HB3' ' C' ' 57' ' ' LEU . 1.7 mp -72.28 -34.11 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 C-N-CA 124.119 0.968 . . . . 61.32 110.058 175.46 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 23' ' ' LYS . . . . . 0.534 ' HD3' ' NH2' ' C' ' 148' ' ' ARG . 34.1 ttpt -61.5 -50.64 71.9 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.694 0.798 . . . . 74.13 109.973 173.365 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 50.1 mtm180 -75.5 -20.23 58.89 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 115.582 -0.736 . . . . 73.52 112.423 -178.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 25' ' ' ALA . . . . . 0.622 ' HB1' ' HB3' ' C' ' 11' ' ' LEU . . . -74.23 -38.75 63.45 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.098 0.559 . . . . 75.32 110.238 172.364 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 26' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -63.8 -43.69 95.57 Favored 'General case' 0 C--O 1.216 -0.7 0 CA-C-N 114.846 -1.07 . . . . 72.31 109.524 174.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -55.48 -55.14 35.21 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.886 0.474 . . . . 74.1 109.994 175.316 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -46.5 -62.39 1.39 Allowed 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.047 1.339 . . . . 71.15 111.956 -179.371 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 62.7 mt -74.46 -38.83 62.85 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.385 -0.825 . . . . 60.22 112.168 -173.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.01 2.96 32.25 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 122.573 0.349 . . . . 75.32 111.742 -178.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -95.94 -44.99 7.12 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 108.944 -0.761 . . . . 73.5 108.944 163.14 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 21.3 tp60 -67.65 -55.86 11.63 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 123.501 0.5 . . . . 71.12 112.216 -176.187 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 33' ' ' TYR . . . . . 0.472 ' HD2' HD11 ' C' ' 50' ' ' ILE . 11.1 m-85 -95.66 25.5 4.54 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.699 0.8 . . . . 70.15 110.942 -178.499 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 34' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 -64.9 114.86 16.44 Favored Pre-proline 0 CA--C 1.546 0.813 0 CA-C-O 118.251 -0.881 . . . . 72.34 109.691 -177.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -55.62 -16.14 14.02 Favored 'Trans proline' 0 C--N 1.38 2.211 0 C-N-CA 123.216 2.611 . . . . 71.32 114.314 -177.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -67.75 -53.26 28.79 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.486 0.714 . . . . 60.34 110.391 169.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 77.1 t -77.07 -50.67 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.801 0.84 . . . . 75.33 110.508 -173.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -114.26 86.58 2.45 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.775 1.23 . . . . 54.22 109.011 -178.1 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -75.96 77.21 2.84 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 116.056 -0.52 . . . . 62.24 109.786 178.636 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 22.5 m -135.37 121.06 14.01 Favored Pre-proline 0 N--CA 1.471 0.608 0 CA-C-O 118.284 -0.865 . . . . 74.14 109.278 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -47.99 -37.16 29.22 Favored 'Trans proline' 0 C--N 1.384 2.443 0 C-N-CA 123.346 2.697 . . . . 63.44 112.694 174.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -59.94 -41.84 92.69 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.16 0.984 . . . . 65.44 110.246 177.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.7 -17.98 61.06 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 116.2 -0.455 . . . . 62.05 110.521 177.357 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 44' ' ' GLU . . . . . 0.526 ' HA ' ' HB3' ' C' ' 47' ' ' PHE . 50.1 mt-10 -86.22 -14.88 42.6 Favored 'General case' 0 C--N 1.358 0.953 0 C-N-CA 123.045 0.538 . . . . 74.04 110.371 177.137 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 45' ' ' GLU . . . . . 0.425 ' O ' ' HB2' ' C' ' 48' ' ' LYS . 32.6 mt-10 -82.72 -38.29 23.52 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.924 -0.769 . . . . 42.53 108.924 169.71 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 46' ' ' LYS . . . . . 0.502 ' O ' HG13 ' C' ' 50' ' ' ILE . 59.0 mttp -64.13 -32.04 73.46 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.597 -0.729 . . . . 72.32 110.115 166.659 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 47' ' ' PHE . . . . . 0.526 ' HB3' ' HA ' ' C' ' 44' ' ' GLU . 46.3 t80 -78.29 -21.98 48.91 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.582 0.753 . . . . 62.23 110.533 177.141 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 48' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' C' ' 45' ' ' GLU . 50.6 mttp -60.35 -53.13 61.29 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 107.961 -1.125 . . . . 72.04 107.961 164.033 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -56.81 -40.19 75.53 Favored 'General case' 0 CA--C 1.55 0.954 0 O-C-N 124.447 1.092 . . . . 72.33 112.132 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 50' ' ' ILE . . . . . 0.502 HG13 ' O ' ' C' ' 46' ' ' LYS . 69.9 mt -62.75 -55.13 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 C-N-CA 123.312 0.645 . . . . 75.43 110.082 176.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 51' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -71.67 -20.91 61.87 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 114.823 -1.08 . . . . 74.04 112.174 -173.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -79.52 -54.29 6.05 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.279 1.032 . . . . 63.42 108.548 178.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.71 -33.74 72.0 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 114.125 -1.398 . . . . 63.1 111.732 176.481 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -81.66 -33.74 31.13 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 119.138 -0.458 . . . . 75.01 110.452 177.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 55' ' ' ALA . . . . . 0.417 ' HB1' ' HD2' ' C' ' 85' ' ' PHE . . . -56.6 -35.33 68.12 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 118.023 0.374 . . . . 60.54 110.535 174.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 56' ' ' VAL . . . . . 0.459 ' O ' ' HB2' ' C' ' 62' ' ' LYS . 46.2 t -81.02 -62.2 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 CA-C-N 115.559 -0.746 . . . . 72.43 110.986 176.087 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 57' ' ' LEU . . . . . 0.452 ' HB3' HG12 ' C' ' 22' ' ' ILE . 39.4 mt -79.84 -7.88 58.96 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 114.169 1.174 . . . . 75.02 114.169 -164.117 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 32.6 t -59.92 -51.9 67.69 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.335 0.588 . . . . 62.42 110.433 178.237 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.86 126.39 80.14 Favored Pre-proline 0 C--O 1.246 0.891 0 CA-C-N 114.787 -1.097 . . . . 72.03 108.805 172.485 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 60' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -59.12 -23.77 70.61 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.095 1.863 . . . . 33.23 111.231 168.632 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -64.8 -54.74 26.49 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 124.568 1.147 . . . . 62.13 110.905 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 62' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' C' ' 56' ' ' VAL . 70.3 mttt -69.77 -30.85 68.51 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 115.873 -0.603 . . . . 75.23 110.804 178.325 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 1.3 ttp180 -57.91 -43.6 86.3 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.62 -0.882 . . . . 64.42 108.62 175.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -72.13 -28.4 63.24 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 115.053 -0.976 . . . . 74.15 112.32 177.208 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 65' ' ' ILE . . . . . 0.475 HD13 ' HE1' ' C' ' 83' ' ' TYR . 78.6 mt -59.82 -44.54 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 109.878 -0.416 . . . . 62.34 109.878 170.366 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -67.58 -42.65 82.2 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 116.169 -0.469 . . . . 74.22 110.207 176.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -58.91 -39.96 83.06 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.329 0.652 . . . . 73.14 111.423 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 71.6 p -77.1 -19.33 57.13 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 122.948 0.499 . . . . 63.2 110.983 177.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -74.08 114.29 12.23 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 108.517 -0.92 . . . . 75.22 108.517 170.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 112.26 11.92 14.69 Favored Glycine 0 N--CA 1.472 1.084 0 N-CA-C 111.699 -0.561 . . . . 62.51 111.699 -166.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 95.2 m -144.38 -50.39 0.29 Allowed 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 105.05 -2.204 . . . . 72.34 105.05 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 33.1 m -93.8 137.3 33.19 Favored 'General case' 0 C--O 1.249 1.078 0 N-CA-C 103.527 -2.768 . . . . 73.35 103.527 156.163 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.06 -31.75 13.44 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 118.384 0.538 . . . . 73.23 110.687 177.191 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.94 140.91 74.39 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 123.582 0.753 . . . . 53.23 109.968 176.115 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 75' ' ' PRO . . . . . 0.41 ' HB3' ' O ' ' C' ' 100' ' ' LEU . 10.2 Cg_endo -53.03 115.87 2.56 Favored 'Trans proline' 0 C--N 1.376 2.016 0 C-N-CA 123.173 2.582 . . . . 75.14 112.306 176.129 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -53.44 148.9 32.18 Favored 'Trans proline' 0 C--N 1.391 2.772 0 C-N-CA 123.911 3.074 . . . . 63.14 113.276 -178.512 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -50.87 118.62 4.37 Favored 'Trans proline' 0 C--N 1.389 2.663 0 C-N-CA 123.24 2.627 . . . . 51.51 113.521 -178.175 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 78' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.11 139.48 80.31 Favored 'Trans proline' 0 C--N 1.386 2.511 0 C-N-CA 123.343 2.695 . . . . 74.44 112.943 -178.495 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.58 158.02 17.31 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 123.078 2.519 . . . . 61.04 112.591 177.208 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -74.91 42.48 0.84 Allowed 'Trans proline' 0 C--N 1.382 2.312 0 C-N-CA 123.678 2.918 . . . . 51.5 112.735 174.143 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -159.46 16.86 0.23 Allowed Glycine 0 CA--C 1.529 0.951 0 N-CA-C 108.585 -1.806 . . . . 75.2 108.585 177.006 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 67.6 -171.93 32.86 Favored Glycine 0 C--N 1.365 2.179 0 C-N-CA 124.439 1.019 . . . . 74.45 111.959 -175.271 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 83' ' ' TYR . . . . . 0.475 ' HE1' HD13 ' C' ' 65' ' ' ILE . 58.8 m-85 -83.58 98.15 9.44 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 105.991 -1.855 . . . . 70.14 105.991 162.579 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 84' ' ' ASP . . . . . 0.492 ' OD1' ' HA3' ' C' ' 163' ' ' GLY . 0.3 OUTLIER -56.32 137.18 52.88 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 112.015 0.376 . . . . 63.13 112.015 -175.114 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' C' C ' 85' ' ' PHE . . . . . 0.459 ' HB3' ' HB2' ' C' ' 88' ' ' PHE . 30.7 m-85 -133.06 73.1 1.5 Allowed 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.523 1.129 . . . . 74.41 108.325 177.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 86' ' ' SER . . . . . 0.411 ' HA ' ' HB2' ' C' ' 162' ' ' PRO . 50.4 m -51.64 85.72 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 124.308 1.043 . . . . 45.43 112.345 178.581 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 65.61 19.11 66.7 Favored Glycine 0 CA--C 1.534 1.273 0 CA-C-N 115.566 -0.743 . . . . 74.33 113.672 -175.231 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 88' ' ' PHE . . . . . 0.459 ' HB2' ' HB3' ' C' ' 85' ' ' PHE . 23.0 m-85 -101.81 118.55 37.16 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 109.411 -0.588 . . . . 74.44 109.411 -176.671 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -75.74 90.23 2.86 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.216 0.531 . . . . 72.23 109.686 -178.62 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 90' ' ' VAL . . . . . 0.432 HG23 HD22 ' C' ' 105' ' ' LEU . 1.6 p -41.12 -47.99 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 CA-C-N 113.96 -1.473 . . . . 54.41 113.326 171.229 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -68.78 -19.32 64.31 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.275 0.63 . . . . 74.21 111.635 -175.221 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -93.06 -2.89 55.16 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.354 0.662 . . . . 75.53 111.583 -178.249 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -95.21 174.77 6.89 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 122.714 0.405 . . . . 72.45 111.803 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 90.0 p -66.23 167.15 10.71 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 114.643 1.349 . . . . 45.51 114.643 -168.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 95' ' ' GLU . . . . . 0.403 ' O ' ' HG3' ' C' ' 99' ' ' GLU . 0.0 OUTLIER -59.49 -50.89 72.19 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 114.962 -1.017 . . . . 55.43 112.026 178.744 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -57.13 -46.44 82.66 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.608 0.763 . . . . 65.02 110.502 -176.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 97' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -54.64 -52.29 62.77 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 114.756 -1.111 . . . . 64.25 110.634 175.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 98' ' ' GLN . . . . . 0.576 ' HA ' HD21 ' C' ' 105' ' ' LEU . 98.0 mt-30 -69.0 -18.29 64.03 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.617 -0.719 . . . . 51.52 112.558 -175.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 99' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' C' ' 95' ' ' GLU . 44.3 mt-10 -86.65 -52.42 5.55 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.729 0.411 . . . . 74.43 111.087 176.559 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 100' ' ' LEU . . . . . 0.41 ' O ' ' HB3' ' C' ' 75' ' ' PRO . 54.5 tp -62.09 -39.58 92.94 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.528 0.731 . . . . 73.23 111.012 -178.609 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -96.57 7.49 46.41 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.987 -0.551 . . . . 73.25 110.839 178.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 102' ' ' GLY . . . . . 0.481 ' HA2' ' HG ' ' C' ' 105' ' ' LEU . . . -43.38 -62.34 2.49 Favored Glycine 0 C--N 1.356 1.672 0 C-N-CA 124.906 1.241 . . . . 54.11 114.916 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -49.6 -21.22 5.07 Favored 'Trans proline' 0 C--N 1.384 2.431 0 C-N-CA 123.985 3.123 . . . . 62.02 115.105 -177.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -146.97 41.26 0.97 Allowed Glycine 0 C--N 1.36 1.909 0 CA-C-O 119.576 -0.569 . . . . 43.23 112.823 178.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 105' ' ' LEU . . . . . 0.576 HD21 ' HA ' ' C' ' 98' ' ' GLN . 13.2 mt . . . . . 0 N--CA 1.511 2.59 0 N-CA-C 115.717 1.747 . . . . 73.03 115.717 177.223 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.732 0 CA-C-O 120.09 -0.283 . . . . 45.25 112.901 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 4.6 ppt_? -116.51 137.25 52.32 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.714 -0.847 . . . . 64.44 108.714 167.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 118' ' ' ASP . . . . . 0.894 ' HA ' ' HA2' ' C' ' 166' ' ' GLY . 8.7 p-10 -61.3 134.85 57.41 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 123.851 0.861 . . . . 75.42 111.517 -172.296 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 119' ' ' LEU . . . . . 0.563 ' HB2' ' O ' ' C' ' 165' ' ' GLY . 0.2 OUTLIER -92.81 143.62 26.1 Favored 'General case' 0 N--CA 1.504 2.252 0 C-N-CA 119.293 -0.963 . . . . 75.21 109.697 -176.979 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -128.87 95.44 4.09 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 107.947 -1.131 . . . . 72.31 107.947 175.554 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 121' ' ' ALA . . . . . 0.453 ' HB3' HD23 ' C' ' 176' ' ' LEU . . . -108.33 114.1 27.7 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 108.542 -0.911 . . . . 63.21 108.542 -177.791 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 122' ' ' GLU . . . . . 0.484 ' HA ' ' O ' ' C' ' 177' ' ' VAL . 37.4 mt-10 -95.27 101.44 13.17 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 107.114 -1.439 . . . . 73.22 107.114 172.712 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 123' ' ' LEU . . . . . 0.63 ' H ' HD23 ' C' ' 123' ' ' LEU . 1.7 pt? -105.57 115.52 61.63 Favored Pre-proline 0 N--CA 1.478 0.942 0 CA-C-N 115.702 -0.681 . . . . 73.3 110.896 -168.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 124' ' ' PRO . . . . . 0.535 ' HA ' ' O ' ' C' ' 179' ' ' ARG . 85.8 Cg_exo -52.76 113.46 1.26 Allowed 'Trans proline' 0 C--N 1.384 2.426 0 C-N-CA 122.506 2.138 . . . . 72.51 111.121 164.276 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 125' ' ' LEU . . . . . 0.566 HD23 HG11 ' C' ' 153' ' ' VAL . 37.8 tp -129.99 143.84 51.01 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.648 0.379 . . . . 74.03 110.106 -175.263 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 126' ' ' THR . . . . . . . . . . . . . 2.5 m -85.37 149.49 25.4 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 116.033 -0.531 . . . . 61.53 110.917 -177.39 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 127' ' ' LEU . . . . . 0.476 HD11 ' H ' ' C' ' 185' ' ' VAL . 9.8 mt -70.61 -52.14 23.47 Favored 'General case' 0 C--O 1.247 0.962 0 C-N-CA 124.198 0.999 . . . . 62.25 109.038 -178.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 128' ' ' GLU . . . . . 0.551 ' HG3' ' HA ' ' C' ' 215' ' ' LEU . 1.7 mp0 -59.49 -34.72 72.93 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 113.88 -1.509 . . . . 75.24 111.227 178.026 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 129' ' ' GLU . . . . . 0.518 ' HA ' ' HB2' ' C' ' 132' ' ' HIS . 17.7 mm-40 -84.47 -19.55 33.18 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.616 0.366 . . . . 73.53 111.544 -179.718 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -70.5 -33.68 71.49 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 108.882 -0.785 . . . . 64.34 108.882 171.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 131' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -65.46 -49.06 70.53 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 115.482 -0.781 . . . . 75.55 109.91 167.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 132' ' ' HIS . . . . . 0.518 ' HB2' ' HA ' ' C' ' 129' ' ' GLU . 32.8 m170 -72.18 -3.82 25.62 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 112.704 0.631 . . . . 60.22 112.704 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -54.41 165.13 2.83 Favored Glycine 0 CA--C 1.547 2.047 0 N-CA-C 115.715 1.046 . . . . 65.31 115.715 174.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . 158.52 -130.44 2.53 Favored Glycine 0 C--N 1.348 1.218 0 N-CA-C 110.269 -1.133 . . . . 53.24 110.269 -174.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 17.0 mp0 -81.2 95.53 6.95 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 108.263 -1.014 . . . . 71.2 108.263 169.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 136' ' ' ARG . . . . . 0.672 ' HB2' HD22 ' B' ' 181' ' ' LEU . 26.9 mmt180 -121.83 147.04 46.48 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 122.897 0.479 . . . . 72.12 110.662 -172.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 137' ' ' VAL . . . . . 0.565 HG23 ' HB1' ' B' ' 180' ' ' ALA . 8.0 m -74.42 132.55 33.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 121.69 0.757 . . . . 71.12 110.72 -175.753 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 138' ' ' VAL . . . . . 0.412 HG13 HG11 ' B' ' 182' ' ' VAL . 2.3 t -139.02 133.31 40.64 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 C-N-CA 124.656 1.183 . . . . 72.14 109.269 -175.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 139' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -125.28 109.17 12.49 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 107.898 -1.149 . . . . 74.31 107.898 171.075 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 140' ' ' VAL . . . . . . . . . . . . . 3.2 p -143.32 134.03 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.022 0.929 . . . . 63.22 109.174 178.498 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 64.42 8.17 4.1 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.613 1.165 . . . . 15.23 113.329 177.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 105.29 1.46 41.17 Favored Glycine 0 C--N 1.351 1.37 0 CA-C-O 119.63 -0.539 . . . . 45.25 113.817 -178.525 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 143' ' ' ARG . . . . . 0.425 HH11 ' HG2' ' C' ' 164' ' ' MET . 77.2 ttt180 -100.14 124.98 46.17 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 118.037 0.918 . . . . 73.04 110.708 -179.453 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 49.2 ttt-85 -96.22 116.57 29.22 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.163 0.985 . . . . 71.51 108.944 170.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 145' ' ' VAL . . . . . 0.437 HG11 ' SD ' ' C' ' 164' ' ' MET . 7.7 p -151.74 147.4 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 122.714 0.405 . . . . 75.03 111.104 -177.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 50.8 m -85.39 93.47 8.74 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 108.044 -1.095 . . . . 54.21 108.044 166.241 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 6.2 p -81.33 154.41 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-O 120.853 0.359 . . . . 72.53 110.414 -175.175 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 148' ' ' ARG . . . . . 0.534 ' NH2' ' HD3' ' C' ' 23' ' ' LYS . 53.5 ttm-85 -113.77 95.79 5.51 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 108.275 -1.009 . . . . 74.22 108.275 172.439 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 149' ' ' ILE . . . . . . . . . . . . . 34.8 pt -106.91 150.99 40.45 Favored Pre-proline 0 CA--C 1.548 0.898 0 N-CA-C 108.49 -0.93 . . . . 71.41 108.49 171.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -40.24 111.73 0.15 Allowed 'Trans proline' 0 C--N 1.384 2.409 0 C-N-CA 124.311 3.341 . . . . 61.44 115.042 -179.278 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -64.09 93.78 0.19 Allowed 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.996 2.464 . . . . 73.2 109.856 166.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 152' ' ' GLY . . . . . . . . . . . . . . . 113.17 90.6 1.87 Allowed Glycine 0 C--N 1.341 0.816 0 N-CA-C 110.004 -1.238 . . . . 54.32 110.004 -165.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 153' ' ' VAL . . . . . 0.566 HG11 HD23 ' C' ' 125' ' ' LEU . 2.0 p -115.51 156.74 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 C-N-CA 123.051 0.54 . . . . 71.13 110.152 -174.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 154' ' ' ARG . . . . . 0.517 ' HB2' ' HB3' ' C' ' 157' ' ' SER . 56.7 mtp180 -107.54 135.26 49.3 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.68 0.792 . . . . 75.32 110.675 -174.192 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 155' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -47.04 120.91 3.33 Favored 'General case' 0 CA--C 1.553 1.059 0 CA-C-N 118.663 0.665 . . . . 74.51 111.588 166.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.59 -0.49 88.23 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-O 119.263 -0.743 . . . . 64.51 114.496 176.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 157' ' ' SER . . . . . 0.517 ' HB3' ' HB2' ' C' ' 154' ' ' ARG . 91.5 p -77.83 147.96 34.93 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 118.183 0.991 . . . . 75.43 109.93 177.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 6.1 p -119.63 109.58 26.69 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 CA-C-O 121.668 0.746 . . . . 64.44 109.902 -173.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 159' ' ' ILE . . . . . 0.586 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 17.3 mt -88.24 116.01 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.613 1.165 . . . . 52.25 109.078 -178.127 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -91.01 111.84 23.48 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.521 -0.548 . . . . 72.21 109.521 177.211 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 161' ' ' VAL . . . . . 0.454 HG11 ' HE2' ' C' ' 164' ' ' MET . 1.9 p -122.21 96.4 46.39 Favored Pre-proline 0 CA--C 1.558 1.286 0 C-N-CA 124.254 1.022 . . . . 75.24 108.964 177.046 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 162' ' ' PRO . . . . . 0.83 ' HA ' ' HA ' ' C' ' 173' ' ' ASP . 10.6 Cg_endo -57.05 128.03 28.18 Favored 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 122.847 2.364 . . . . 63.42 113.329 176.023 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 163' ' ' GLY . . . . . 0.492 ' HA3' ' OD1' ' C' ' 84' ' ' ASP . . . 107.31 13.03 22.12 Favored Glycine 0 C--N 1.348 1.209 0 N-CA-C 115.179 0.832 . . . . 53.31 115.179 172.439 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 164' ' ' MET . . . . . 0.454 ' HE2' HG11 ' C' ' 161' ' ' VAL . 5.7 mtm -126.67 32.0 5.23 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 117.991 0.896 . . . . 73.35 112.216 -176.639 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 165' ' ' GLY . . . . . 0.673 ' H ' ' HA2' ' C' ' 172' ' ' GLY . . . 112.35 122.49 4.07 Favored Glycine 0 C--O 1.192 -2.483 0 CA-C-O 115.526 -2.819 . . . . 64.24 107.48 -176.381 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 166' ' ' GLY . . . . . 0.894 ' HA2' ' HA ' ' C' ' 118' ' ' ASP . . . 144.5 -143.57 12.23 Favored Glycine 0 C--O 1.199 -2.035 0 CA-C-N 122.379 3.089 . . . . 75.44 113.239 -161.18 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 167' ' ' GLN . . . . . 0.52 ' H ' ' HB3' ' C' ' 173' ' ' ASP . 22.2 mm-40 -90.07 114.33 26.21 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 118.968 1.384 . . . . 64.31 110.539 177.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . -167.59 -150.97 6.74 Favored Glycine 0 N--CA 1.479 1.502 0 CA-C-O 119.654 -0.526 . . . . 13.44 113.118 -175.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 169' ' ' ASN . . . . . 0.598 ' HB3' ' HD3' ' C' ' 170' ' ' PRO . 25.1 t-20 -72.33 -56.23 4.31 Favored Pre-proline 0 C--N 1.358 0.973 0 N-CA-C 108.354 -0.98 . . . . 62.44 108.354 168.657 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 170' ' ' PRO . . . . . 0.598 ' HD3' ' HB3' ' C' ' 169' ' ' ASN . 57.7 Cg_endo -98.83 -160.11 0.05 OUTLIER 'Trans proline' 0 C--N 1.365 1.409 0 N-CA-C 105.292 -2.619 . . . . 51.41 105.292 159.435 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 171' ' ' PRO . . . . . 0.508 ' HA ' ' O ' ' C' ' 166' ' ' GLY . 22.3 Cg_exo -47.17 119.47 3.52 Favored 'Trans proline' 0 CA--C 1.587 3.13 0 CA-C-N 121.543 1.587 . . . . 74.02 114.733 160.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 172' ' ' GLY . . . . . 0.673 ' HA2' ' H ' ' C' ' 165' ' ' GLY . . . -150.96 84.45 0.16 Allowed Glycine 1 CA--C 1.587 4.575 0 N-CA-C 117.169 1.628 . . . . 74.42 117.169 168.999 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' C' C ' 173' ' ' ASP . . . . . 0.83 ' HA ' ' HA ' ' C' ' 162' ' ' PRO . 29.0 t70 163.05 93.21 0.0 OUTLIER 'General case' 0 N--CA 1.535 3.817 0 C-N-CA 127.58 2.352 . . . . 74.51 108.231 -178.689 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 174' ' ' LEU . . . . . . . . . . . . . 15.1 tp -104.45 139.79 38.87 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 114.724 -1.125 . . . . 75.22 113.035 -162.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 66.9 mt -110.26 92.26 3.98 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.462 1.105 . . . . 71.32 109.398 172.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 176' ' ' LEU . . . . . 0.586 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 68.1 mt -75.29 93.6 2.89 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-N 114.796 -1.093 . . . . 43.02 110.953 175.222 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 177' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' C' ' 122' ' ' GLU . 59.4 t -84.53 101.33 8.91 Favored 'Isoleucine or valine' 0 C--O 1.244 0.777 0 N-CA-C 107.28 -1.378 . . . . 74.43 107.28 172.735 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 178' ' ' VAL . . . . . . . . . . . . . 28.9 m -76.92 122.05 30.58 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 CA-C-O 121.927 0.87 . . . . 74.01 110.18 -176.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 179' ' ' ARG . . . . . 0.535 ' O ' ' HA ' ' C' ' 124' ' ' PRO . 9.9 mmm180 -113.71 111.87 22.52 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 106.376 -1.713 . . . . 72.33 106.376 174.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 180' ' ' LEU . . . . . . . . . . . . . 53.2 mt -67.8 148.19 51.56 Favored 'General case' 0 CA--C 1.558 1.253 0 CA-C-N 117.619 0.191 . . . . 70.51 111.026 -176.259 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 181' ' ' LEU . . . . . . . . . . . . . 41.1 mt -53.23 167.75 0.41 Allowed Pre-proline 0 N--CA 1.5 2.068 0 C-N-CA 125.671 1.588 . . . . 74.2 113.827 -171.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -61.66 68.7 0.1 Allowed 'Trans proline' 0 C--N 1.393 2.9 0 C-N-CA 122.861 2.374 . . . . 64.12 110.252 161.306 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 183' ' ' HIS . . . . . 0.407 ' N ' ' HD3' ' C' ' 184' ' ' PRO . 81.6 t60 172.85 47.52 0.01 OUTLIER Pre-proline 0 CA--C 1.562 1.404 0 C-N-CA 129.031 2.932 . . . . 62.13 104.503 -167.601 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 184' ' ' PRO . . . . . 0.407 ' HD3' ' N ' ' C' ' 183' ' ' HIS . 85.8 Cg_endo -95.05 63.89 0.23 Allowed 'Trans proline' 0 C--N 1.387 2.573 0 C-N-CA 122.395 2.064 . . . . 71.54 109.713 -167.242 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 185' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 9.8 t -92.85 -23.02 5.66 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.476 0 CA-C-N 114.748 -1.114 . . . . 72.23 109.271 -168.301 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 186' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -130.68 101.03 5.51 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 118.746 0.703 . . . . 61.44 110.945 -175.244 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 187' ' ' ARG . . . . . . . . . . . . . 40.7 ttt85 -94.57 117.27 29.86 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 114.494 -1.23 . . . . 75.14 108.066 171.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 188' ' ' LEU . . . . . 0.515 HD13 ' HD2' ' C' ' 240' ' ' PHE . 61.5 tp -82.03 145.95 29.95 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 121.489 0.661 . . . . 74.14 111.824 -179.161 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 189' ' ' GLU . . . . . 0.427 ' HA ' ' NE ' ' C' ' 154' ' ' ARG . 31.2 tt0 -143.71 111.98 6.32 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 107.064 -1.458 . . . . 71.33 107.064 164.024 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 67.49 -100.51 0.61 Allowed Glycine 0 C--N 1.35 1.316 0 N-CA-C 111.271 -0.732 . . . . 74.2 111.271 -171.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 191' ' ' GLN . . . . . 0.482 ' HA ' HD11 ' C' ' 188' ' ' LEU . 48.9 mt-30 -125.61 -6.27 6.93 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.531 0.732 . . . . 60.21 111.136 171.185 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -84.8 138.99 32.26 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 122.892 0.477 . . . . 65.13 110.475 179.209 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 193' ' ' LEU . . . . . 0.494 HD21 ' CD2' ' C' ' 240' ' ' PHE . 90.4 mt -101.49 163.61 12.18 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.408 0.623 . . . . 52.2 111.142 178.548 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 194' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -129.82 115.4 17.19 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 114.59 -1.186 . . . . 75.43 108.915 172.324 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 195' ' ' ALA . . . . . 0.531 ' HA ' ' O ' ' C' ' 185' ' ' VAL . . . -114.59 -178.32 3.34 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.73 0.812 . . . . 65.11 111.242 176.208 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 196' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' C' ' 252' ' ' GLU . 78.1 m -136.32 114.53 11.57 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 108.27 -1.011 . . . . 51.32 108.27 164.101 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 197' ' ' LEU . . . . . . . . . . . . . 45.7 tp -88.85 132.57 34.6 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 123.814 0.846 . . . . 73.5 110.542 -176.133 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -88.22 105.32 17.46 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 108.551 -0.907 . . . . 44.52 108.551 175.364 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 199' ' ' VAL . . . . . 0.592 HG21 ' HH2' ' B' ' 242' ' ' TRP . 51.2 t -115.22 118.5 39.92 Favored Pre-proline 0 N--CA 1.469 0.504 0 N-CA-C 108.019 -1.104 . . . . 61.21 108.019 177.758 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 200' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.69 138.36 31.8 Favored 'Trans proline' 0 C--N 1.372 1.785 0 C-N-CA 121.76 1.64 . . . . 71.34 110.612 175.138 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 201' ' ' ALA . . . . . 0.404 ' O ' HG23 ' C' ' 205' ' ' VAL . . . -41.47 -48.14 9.19 Favored Pre-proline 0 CA--C 1.562 1.411 0 N-CA-C 115.363 1.616 . . . . 74.35 115.363 178.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 202' ' ' PRO . . . . . 0.443 ' HB2' ' HA ' ' A' ' 273' ' ' ALA . 11.9 Cg_endo -53.36 -54.46 4.92 Favored 'Trans proline' 0 C--N 1.386 2.548 0 CA-C-N 121.281 1.493 . . . . 63.15 112.638 176.581 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 203' ' ' ILE . . . . . . . . . . . . . 63.9 mt -63.74 -29.88 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 123.197 0.599 . . . . 63.4 110.703 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.96 -35.79 78.98 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.995 0.918 . . . . 75.02 112.377 179.218 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 205' ' ' VAL . . . . . 0.551 HG22 HD13 ' A' ' 257' ' ' ILE . 46.3 t -80.04 -42.8 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 CA-C-O 119.355 -0.355 . . . . 63.41 111.675 179.002 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 206' ' ' VAL . . . . . . . . . . . . . 10.9 p -80.18 -36.84 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 112.558 0.577 . . . . 52.12 112.558 -172.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 83.31 89.45 0.73 Allowed Glycine 0 C--N 1.344 1.024 0 N-CA-C 111.755 -0.538 . . . . 63.21 111.755 -166.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -127.8 -129.55 3.23 Favored Glycine 0 C--N 1.344 1.006 0 N-CA-C 111.03 -0.828 . . . . 51.32 111.03 177.491 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 209' ' ' LYS . . . . . 0.581 ' HG2' ' HA ' ' C' ' 222' ' ' ALA . 5.9 mtmp? -136.3 146.95 47.19 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 117.711 0.756 . . . . 72.12 111.71 170.406 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 210' ' ' VAL . . . . . 0.429 HG21 HG22 ' C' ' 199' ' ' VAL . 33.4 m -128.67 168.22 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 125.225 1.41 . . . . 62.05 107.678 169.075 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 211' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -106.19 136.43 45.91 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 118.117 0.417 . . . . 72.44 111.391 -177.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 212' ' ' ALA . . . . . 0.532 ' HB3' HG13 ' C' ' 219' ' ' VAL . . . -120.56 120.72 36.64 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 107.6 -1.259 . . . . 74.43 107.6 171.543 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 213' ' ' MET . . . . . 0.426 ' SD ' ' N ' ' C' ' 214' ' ' THR . 8.7 tmm? -71.98 146.38 47.77 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.431 -0.951 . . . . 63.12 108.431 173.258 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 214' ' ' THR . . . . . 0.561 HG21 ' HD2' ' C' ' 238' ' ' LYS . 0.1 OUTLIER -141.79 168.85 18.78 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 119.035 0.834 . . . . 54.24 112.333 178.165 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' C' C ' 215' ' ' LEU . . . . . 0.551 ' HA ' ' HG3' ' C' ' 128' ' ' GLU . 30.8 mt -62.8 -35.78 80.99 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 124.566 1.146 . . . . 44.41 113.444 -166.284 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.48 -2.21 15.61 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 114.546 -1.207 . . . . 71.0 111.495 -171.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 164.37 -168.16 38.61 Favored Glycine 0 C--O 1.21 -1.363 0 CA-C-O 119.6 -0.556 . . . . 64.11 111.786 -174.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -94.41 165.42 1.91 Allowed 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 122.302 2.001 . . . . 52.13 112.554 171.016 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 219' ' ' VAL . . . . . 0.631 ' HB ' ' HE3' ' C' ' 238' ' ' LYS . 2.2 p -142.96 112.9 2.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 108.073 -1.084 . . . . 52.53 108.073 168.171 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 220' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -90.78 108.12 19.62 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 108.277 -1.009 . . . . 72.32 108.277 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 221' ' ' VAL . . . . . 0.511 ' HA ' ' HB2' ' B' ' 239' ' ' ALA . 39.4 t -71.33 127.15 32.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 114.012 -1.449 . . . . 74.03 112.767 -171.163 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 222' ' ' ALA . . . . . 0.581 ' HA ' ' HG2' ' C' ' 209' ' ' LYS . . . -81.41 109.09 15.57 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 123.713 0.633 . . . . 73.3 109.346 169.721 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 58.1 t -82.02 139.6 46.13 Favored Pre-proline 0 CA--C 1.558 1.263 0 C-N-CA 124.282 1.033 . . . . 73.11 110.116 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 224' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -84.93 160.81 11.86 Favored 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 122.929 2.419 . . . . 54.33 111.938 170.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -63.36 140.57 77.33 Favored 'Trans proline' 0 C--N 1.372 1.779 0 C-N-CA 122.247 1.965 . . . . 74.0 110.828 169.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 226' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? 70.0 83.62 0.15 Allowed 'General case' 0 N--CA 1.483 1.189 0 O-C-N 124.403 1.065 . . . . 70.15 111.174 177.298 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 227' ' ' THR . . . . . 0.604 HG22 HD11 ' C' ' 255' ' ' ILE . 52.7 m -128.1 122.05 31.11 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.874 -0.603 . . . . 70.3 112.404 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 228' ' ' GLN . . . . . 0.452 HE21 HG13 ' A' ' 257' ' ' ILE . 26.1 mp0 -108.89 162.28 14.35 Favored 'General case' 0 C--O 1.253 1.259 0 CA-C-O 122.615 1.197 . . . . 74.32 111.152 168.534 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 229' ' ' ALA . . . . . 0.432 ' HB2' ' H ' ' C' ' 255' ' ' ILE . . . -65.64 138.29 57.91 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 112.934 -1.939 . . . . 62.12 109.32 175.613 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 101.56 -4.79 54.21 Favored Glycine 0 CA--C 1.523 0.574 0 CA-C-O 119.616 -0.547 . . . . 62.04 113.012 -174.282 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 231' ' ' ARG . . . . . . . . . . . . . 43.1 mtt85 -70.19 171.3 9.97 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 108.567 -0.901 . . . . 74.12 108.567 162.193 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 232' ' ' LYS . . . . . 0.505 ' HA ' ' O ' ' C' ' 251' ' ' LEU . 32.6 ttmt -155.48 126.18 6.92 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.274 0.559 . . . . 71.45 111.744 -178.39 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 233' ' ' LEU . . . . . 0.631 HD13 ' HB2' ' C' ' 251' ' ' LEU . 4.5 mp -84.92 155.03 21.84 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 114.762 -1.108 . . . . 74.21 110.712 -178.077 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -122.78 100.62 7.0 Favored 'General case' 0 CA--C 1.55 0.953 0 O-C-N 125.099 1.5 . . . . 72.34 108.941 165.155 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 235' ' ' LEU . . . . . 0.448 HD13 HG21 ' C' ' 219' ' ' VAL . 61.3 mt -95.22 114.88 26.72 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.495 0.718 . . . . 73.43 109.165 176.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -71.83 130.82 42.0 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.795 0.838 . . . . 71.55 111.899 -174.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 85.01 -12.81 57.0 Favored Glycine 0 C--N 1.352 1.426 0 CA-C-N 116.029 -0.532 . . . . 71.42 113.123 178.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 238' ' ' LYS . . . . . 0.631 ' HE3' ' HB ' ' C' ' 219' ' ' VAL . 68.5 mmtt -92.25 13.13 20.1 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.743 0.817 . . . . 72.03 112.279 -172.59 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -80.16 -163.25 27.77 Favored Glycine 0 C--N 1.352 1.462 0 N-CA-C 110.992 -0.843 . . . . 31.21 110.992 164.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 240' ' ' PHE . . . . . 0.515 ' HD2' HD13 ' C' ' 188' ' ' LEU . 1.9 m-85 -73.21 124.23 90.36 Favored Pre-proline 0 C--O 1.249 1.036 0 CA-C-N 118.167 0.983 . . . . 75.14 109.141 175.464 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 241' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' C' ' 240' ' ' PHE . 39.4 Cg_exo -63.51 107.28 0.69 Allowed 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 123.353 2.702 . . . . 70.21 114.381 178.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -79.41 158.3 43.44 Favored Glycine 0 C--N 1.341 0.834 0 CA-C-O 118.904 -0.942 . . . . 70.14 111.371 168.16 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -57.31 -30.1 86.43 Favored 'Trans proline' 0 C--N 1.374 1.89 0 C-N-CA 123.53 2.82 . . . . 71.42 113.826 -170.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -134.27 17.55 3.72 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.023 0.529 . . . . 71.42 111.439 -177.294 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 175.77 115.29 0.41 Allowed Glycine 0 C--N 1.346 1.116 0 N-CA-C 111.761 -0.535 . . . . 51.32 111.761 -178.175 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 246' ' ' ARG . . . . . . . . . . . . . 52.4 mtm180 -82.21 156.33 24.46 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.508 0.723 . . . . 61.31 110.264 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -82.24 -160.93 28.17 Favored Glycine 0 N--CA 1.479 1.509 0 N-CA-C 113.825 0.29 . . . . 63.23 113.825 178.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -133.41 133.31 42.2 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 121.539 0.685 . . . . 73.54 110.647 -175.055 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 249' ' ' LEU . . . . . 0.439 HD23 HD12 ' C' ' 235' ' ' LEU . 19.2 tp -88.96 129.5 35.62 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.108 0.963 . . . . 74.23 110.85 -175.47 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 250' ' ' TYR . . . . . 0.588 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 26.8 m-85 -112.38 101.62 9.81 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.856 0.863 . . . . 71.43 110.092 177.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 251' ' ' LEU . . . . . 0.631 ' HB2' HD13 ' C' ' 233' ' ' LEU . 3.3 mp -96.94 117.1 30.4 Favored 'General case' 0 N--CA 1.504 2.249 0 C-N-CA 120.845 -0.342 . . . . 64.53 110.59 -175.363 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 252' ' ' GLU . . . . . 0.424 ' O ' ' HA ' ' C' ' 196' ' ' THR . 6.3 tp10 -70.55 128.94 37.86 Favored 'General case' 0 C--O 1.218 -0.578 0 N-CA-C 108.522 -0.918 . . . . 73.41 108.522 170.795 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 253' ' ' VAL . . . . . . . . . . . . . 78.1 t -85.41 140.27 16.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 O-C-N 121.815 -0.553 . . . . 73.5 111.306 -174.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 254' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 -128.81 121.57 28.59 Favored 'General case' 0 C--N 1.346 0.456 0 C-N-CA 124.337 1.055 . . . . 74.13 108.899 169.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 255' ' ' ILE . . . . . 0.604 HD11 HG22 ' C' ' 227' ' ' THR . 38.7 mm -87.7 125.97 41.28 Favored 'Isoleucine or valine' 0 C--N 1.344 0.328 0 CA-C-N 115.854 -0.612 . . . . 75.24 109.775 178.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 256' ' ' THR . . . . . . . . . . . . . 43.9 p -121.61 -174.8 2.94 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.024 0.93 . . . . 53.32 111.027 -173.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 257' ' ' ILE . . . . . 0.466 HD12 ' H ' ' C' ' 259' ' ' GLU . 2.8 pp -140.0 156.45 70.43 Favored Pre-proline 0 CA--C 1.561 1.381 0 C-N-CA 123.408 0.683 . . . . 64.54 110.815 -176.413 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -56.5 -10.86 5.56 Favored 'Trans proline' 0 C--N 1.387 2.576 0 C-N-CA 124.046 3.164 . . . . 73.21 115.795 -174.371 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 259' ' ' GLU . . . . . 0.466 ' H ' HD12 ' C' ' 257' ' ' ILE . 50.6 mt-10 53.87 -84.62 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 124.772 1.229 . . . . 72.3 110.006 -163.566 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 260' ' ' ARG . . . . . 0.406 ' H ' ' HG3' ' C' ' 260' ' ' ARG . 0.0 OUTLIER -73.28 155.68 39.24 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.012 0.925 . . . . 73.41 110.827 176.765 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' C' C ' 261' ' ' LEU . . . . . 0.571 ' HG ' HH12 ' A' ' 226' ' ' ARG . 85.2 mt -130.97 141.36 50.25 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.297 0.639 . . . . 71.21 110.161 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 80.6 p -84.65 164.66 41.57 Favored Pre-proline 0 CA--C 1.558 1.279 0 N-CA-C 107.812 -1.181 . . . . 61.23 107.812 166.258 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -45.61 -41.87 18.82 Favored 'Trans proline' 0 C--N 1.387 2.574 0 C-N-CA 122.783 2.322 . . . . 74.2 113.776 176.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -55.25 -63.37 1.18 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.037 1.335 . . . . 71.04 111.056 175.081 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -58.4 -41.46 84.95 Favored 'General case' 0 C--N 1.348 0.525 0 CA-C-N 114.442 -1.253 . . . . 65.11 110.719 -176.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 266' ' ' GLU . . . . . 0.568 ' HA ' HD13 ' C' ' 261' ' ' LEU . 11.0 tp10 -56.31 -51.64 67.47 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.908 0.883 . . . . 64.21 110.43 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -59.44 -49.99 75.68 Favored 'General case' 0 CA--C 1.553 1.085 0 CA-C-N 115.747 -0.66 . . . . 70.32 112.114 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 268' ' ' LEU . . . . . . . . . . . . . 10.3 mp -71.4 -38.31 71.47 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 112.536 0.569 . . . . 52.44 112.536 -174.137 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -70.98 -30.21 66.41 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 122.629 0.371 . . . . 61.11 111.09 177.632 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 26.8 mmtp -68.14 -40.45 82.44 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 122.913 0.485 . . . . 75.43 111.172 173.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 271' ' ' LYS . . . . . 0.5 ' HB3' HD21 ' A' ' 268' ' ' LEU . 3.4 mmtm -64.14 -41.3 97.25 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 121.048 0.451 . . . . 75.33 111.256 175.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 72.7 mt -61.41 -42.31 98.54 Favored 'General case' 0 C--O 1.217 -0.649 0 CA-C-N 115.728 -0.669 . . . . 74.33 110.177 172.056 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 273' ' ' ALA . . . . . 0.472 ' HB2' HG21 ' A' ' 206' ' ' VAL . . . -56.51 -43.09 79.41 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.07 0.548 . . . . 34.13 110.899 -179.566 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -58.66 -52.15 66.9 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.177 0.991 . . . . 63.21 110.845 174.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -57.88 -28.92 64.62 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 115.05 -0.977 . . . . 70.04 112.09 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 276' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -95.87 -17.23 21.27 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.532 0.733 . . . . 75.52 111.943 -179.429 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 19.5 m-30 -67.41 -33.88 76.1 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.544 -0.91 . . . . 44.24 108.544 168.104 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -71.66 -1.05 12.37 Favored 'General case' 0 CA--C 1.557 1.228 0 CA-C-N 114.671 -1.15 . . . . 55.2 112.737 173.071 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 279' ' ' ARG . . . . . . . . . . . . . 30.2 mtp-105 -99.63 -1.71 37.37 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.403 0.681 . . . . 71.52 110.973 171.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.051 0 CA-C-O 118.551 -0.738 . . . . 75.14 109.722 175.671 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 88.0 tttt . . . . . 0 N--CA 1.479 1.011 0 N-CA-C 114.288 1.218 . . . . 62.43 114.288 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.442 ' HZ2' ' HB3' ' A' ' 94' ' ' SER . 29.3 mmtp -73.18 97.66 2.46 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 107.766 -1.198 . . . . 74.32 107.766 164.07 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.515 ' HA ' ' OH ' ' A' ' 66' ' ' TYR . 14.3 t70 -74.06 90.55 2.01 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.562 -1.273 . . . . 61.41 107.562 174.264 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.416 ' HB2' HD11 ' A' ' 57' ' ' LEU . 48.9 m-85 -58.16 -31.69 67.49 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 113.919 -1.491 . . . . 73.34 112.264 -170.442 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -66.22 -44.56 83.48 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 122.822 0.449 . . . . 73.33 110.736 177.178 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.73 -41.83 99.36 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 122.992 0.517 . . . . 60.32 110.828 178.473 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.423 HD11 ' HD2' ' A' ' 5' ' ' LYS . 65.6 mt -58.73 -41.19 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 O-C-N 124.071 0.857 . . . . 74.23 110.683 177.096 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 87.6 mt -80.11 -12.21 59.69 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 112.681 0.622 . . . . 51.33 112.681 177.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.86 17.85 78.61 Favored Glycine 0 C--N 1.349 1.267 0 O-C-N 122.958 0.161 . . . . 53.33 113.403 -176.524 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.9 m -101.34 154.4 37.24 Favored Pre-proline 0 N--CA 1.482 1.144 0 C-N-CA 124.075 0.95 . . . . 71.43 109.623 174.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -58.5 154.56 41.21 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 122.695 2.263 . . . . 50.12 113.534 176.07 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 79.0 mtt180 -77.02 66.7 2.89 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.184 0.994 . . . . 75.43 109.797 177.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -178.86 -25.24 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 114.629 -1.169 . . . . 64.11 109.088 -168.18 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.21 133.32 39.48 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 125.098 1.359 . . . . 64.31 113.338 -174.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.439 ' O ' HD13 ' A' ' 22' ' ' ILE . 51.1 p -78.44 172.98 12.85 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.768 0.827 . . . . 71.11 111.16 179.443 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 22.7 tm0? -50.4 -37.26 36.69 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.814 1.246 . . . . 64.21 111.016 176.119 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.446 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 0.3 OUTLIER -61.47 -47.56 85.09 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 124.502 1.121 . . . . 72.43 110.217 -179.522 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -70.32 -34.52 72.78 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.308 1.043 . . . . 64.03 111.211 -178.513 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.439 HD13 ' O ' ' A' ' 18' ' ' THR . 1.5 mp -64.6 -36.96 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.375 1.07 . . . . 73.31 110.04 174.433 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -73.42 -30.47 63.26 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.766 0.826 . . . . 71.24 110.42 179.302 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.446 ' HG3' ' O ' ' A' ' 20' ' ' GLU . 95.3 mtt180 -62.02 -54.67 38.24 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.296 0.57 . . . . 54.12 110.031 172.493 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.8 -34.29 72.84 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 114.541 -1.208 . . . . 64.0 111.61 178.293 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -62.82 -49.95 72.92 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.957 0.903 . . . . 73.1 111.12 176.037 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.438 ' HE2' ' HA ' ' A' ' 24' ' ' ARG . 49.5 mtmt -57.57 -55.15 38.55 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 109.799 -0.445 . . . . 74.22 109.799 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.7 ttp-105 -52.57 -65.89 0.48 Allowed 'General case' 0 N--CA 1.479 1.022 0 O-C-N 123.825 0.703 . . . . 71.15 111.523 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.732 ' HB3' HD13 ' A' ' 50' ' ' ILE . 95.4 mt -72.23 -48.7 40.85 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.186 -0.915 . . . . 74.11 112.434 -170.304 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.75 -15.54 59.73 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 112.872 0.693 . . . . 63.3 112.872 -173.396 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -81.3 -40.24 23.96 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 119.187 0.903 . . . . 72.33 109.57 165.097 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -63.43 -33.94 76.65 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 115.46 -0.791 . . . . 63.33 111.84 -179.185 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.439 ' HB3' ' O ' ' A' ' 43' ' ' ALA . 21.7 m-85 -111.6 15.97 20.85 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.89 0.876 . . . . 63.25 110.474 -175.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -69.8 119.35 70.72 Favored Pre-proline 0 C--N 1.352 0.685 0 C-N-CA 123.492 0.717 . . . . 63.41 109.332 -176.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.453 ' HG3' ' HG2' ' A' ' 44' ' ' GLU . 32.6 Cg_exo -60.51 -8.66 9.34 Favored 'Trans proline' 0 C--N 1.373 1.829 0 C-N-CA 123.12 2.547 . . . . 74.13 114.369 -178.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -73.56 -43.74 59.1 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.965 0.506 . . . . 72.45 110.601 170.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 52.3 t -95.75 -63.66 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 123.286 0.634 . . . . 65.53 110.168 -177.09 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -98.28 80.58 2.67 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 122.303 1.049 . . . . 61.35 109.223 -173.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -76.43 81.45 3.15 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 114.205 -1.361 . . . . 73.11 109.638 178.276 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 69.8 m -140.43 113.94 7.38 Favored Pre-proline 0 N--CA 1.475 0.78 0 C-N-CA 124.152 0.981 . . . . 54.41 108.439 174.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -40.82 -46.17 4.86 Favored 'Trans proline' 0 C--N 1.387 2.568 0 C-N-CA 124.31 3.34 . . . . 72.23 114.05 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.401 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 6.4 tm-20 -54.37 -50.43 67.52 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.679 1.192 . . . . 64.43 109.924 177.028 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.439 ' O ' ' HB3' ' A' ' 33' ' ' TYR . . . -62.55 -31.86 72.73 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 115.121 -0.945 . . . . 72.14 110.691 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.639 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 47.9 mt-10 -77.4 -34.4 54.82 Favored 'General case' 0 C--O 1.217 -0.626 0 O-C-N 123.75 0.656 . . . . 62.01 109.945 -173.149 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -65.59 -44.22 87.32 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.533 0.733 . . . . 62.44 109.932 174.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 42' ' ' GLU . 13.3 mmmm -58.13 -44.94 88.07 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 123.772 0.67 . . . . 74.03 109.869 174.316 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -58.96 -38.97 80.29 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.085 1.354 . . . . 73.24 110.968 178.233 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.639 ' HG2' ' O ' ' A' ' 44' ' ' GLU . 32.9 mmtp -66.55 -43.45 85.04 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 122.688 0.395 . . . . 75.14 110.925 179.233 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -58.59 -42.54 88.3 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 123.855 0.722 . . . . 71.44 111.184 175.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.732 HD13 ' HB3' ' A' ' 29' ' ' LEU . 62.3 mt -76.1 -28.68 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 124.935 1.294 . . . . 70.53 111.321 -176.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.422 ' HA ' ' HB3' ' A' ' 54' ' ' TYR . 13.7 m-80 -93.61 -5.65 48.31 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.587 0.755 . . . . 73.43 111.421 175.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -77.01 -53.47 7.77 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 107.49 -1.3 . . . . 63.42 107.49 164.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.18 -37.09 76.53 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 112.962 -1.927 . . . . 65.45 111.133 176.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.422 ' HB3' ' HA ' ' A' ' 51' ' ' ASN . 61.4 t80 -73.43 -47.27 43.04 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-O 118.811 -0.614 . . . . 72.32 110.537 173.739 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -50.27 -36.18 30.31 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 123.231 0.613 . . . . 53.01 112.368 -178.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.527 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 61.3 t -78.74 -67.48 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 CA-C-N 114.697 -1.138 . . . . 74.52 110.025 175.465 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.466 HD22 ' HG2' ' A' ' 63' ' ' ARG . 46.3 mt -80.09 4.59 16.74 Favored 'General case' 0 CA--C 1.564 1.483 0 N-CA-C 113.484 0.92 . . . . 62.04 113.484 -165.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.5 t -76.24 -25.0 54.57 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 123.875 0.87 . . . . 74.34 110.275 174.204 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -109.99 117.47 51.87 Favored Pre-proline 0 N--CA 1.449 -0.524 0 N-CA-C 107.142 -1.429 . . . . 74.34 107.142 176.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.447 ' O ' ' HG2' ' A' ' 64' ' ' ARG . 84.0 Cg_exo -46.96 -26.47 4.89 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 123.147 2.565 . . . . 72.41 113.318 171.108 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -63.62 -61.21 2.47 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 122.962 0.505 . . . . 72.3 111.274 175.091 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.527 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 34.8 mttp -66.79 -26.72 67.09 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 122.375 0.27 . . . . 74.54 111.029 -178.703 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.466 ' HG2' HD22 ' A' ' 57' ' ' LEU . 4.2 tmt_? -61.58 -48.17 82.2 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.845 1.258 . . . . 74.11 108.826 176.11 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.447 ' HG2' ' O ' ' A' ' 60' ' ' PRO . 19.7 mmm180 -67.1 -33.84 76.33 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.516 -0.765 . . . . 74.25 111.717 176.325 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.436 HD12 ' HA ' ' A' ' 62' ' ' LYS . 84.5 mt -60.49 -42.87 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 C-N-CA 123.077 0.551 . . . . 64.42 110.169 176.298 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.515 ' OH ' ' HA ' ' A' ' 6' ' ' ASP . 32.5 t80 -62.76 -51.92 65.23 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.623 -0.717 . . . . 75.4 110.068 175.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -54.17 -41.48 68.57 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 123.826 0.704 . . . . 64.04 111.271 -178.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 68.7 p -79.07 -22.39 45.37 Favored 'General case' 0 C--N 1.348 0.506 0 CA-C-N 115.637 -0.711 . . . . 75.13 111.931 -178.475 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -70.9 112.46 7.1 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 109.186 -0.672 . . . . 63.45 109.186 177.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 111.34 9.34 21.95 Favored Glycine 0 N--CA 1.473 1.109 0 CA-C-N 115.832 -0.622 . . . . 52.54 111.638 -170.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.8 m -141.44 -59.4 0.48 Allowed 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 104.177 -2.527 . . . . 71.23 104.177 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.5 m -76.64 141.81 40.87 Favored 'General case' 0 C--O 1.252 1.232 0 N-CA-C 104.472 -2.418 . . . . 74.23 104.472 155.622 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.66 -49.38 6.32 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.243 0.617 . . . . 74.04 111.219 -178.095 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -97.08 142.49 24.61 Favored Pre-proline 0 N--CA 1.477 0.893 0 C-N-CA 123.037 0.535 . . . . 75.1 110.441 -174.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.421 ' HB2' ' HG3' ' A' ' 103' ' ' PRO . 37.2 Cg_exo -59.34 151.85 65.03 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 123.114 2.543 . . . . 75.41 112.697 174.343 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.05 158.86 45.52 Favored 'Trans proline' 0 C--N 1.377 2.053 0 C-N-CA 123.216 2.611 . . . . 74.25 114.36 -175.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.96 120.26 7.96 Favored 'Trans proline' 0 C--N 1.386 2.54 0 C-N-CA 123.221 2.614 . . . . 62.44 112.198 171.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.45 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 60.3 Cg_endo -69.18 118.31 5.6 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 122.859 2.372 . . . . 43.51 112.087 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.588 ' HB2' ' HA3' ' A' ' 142' ' ' GLY . 6.5 Cg_exo -74.16 165.62 31.52 Favored 'Trans proline' 0 CA--C 1.566 2.115 0 C-N-CA 122.868 2.378 . . . . 71.05 111.726 178.151 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_exo -51.91 85.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.393 2.913 0 C-N-CA 123.921 3.081 . . . . 51.35 114.428 -176.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 141.29 -44.89 0.99 Allowed Glycine 0 C--N 1.338 0.69 0 N-CA-C 109.767 -1.333 . . . . 62.41 109.767 178.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.42 -168.19 33.27 Favored Glycine 0 C--N 1.351 1.399 0 C-N-CA 123.38 0.514 . . . . 53.03 113.535 176.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -70.14 100.48 1.66 Allowed 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.476 1.11 . . . . 74.41 110.215 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.472 ' HB3' ' NE ' ' A' ' 143' ' ' ARG . 32.6 t0 -60.84 115.82 3.97 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.84 0.856 . . . . 71.31 109.783 173.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -112.9 70.24 0.71 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.458 1.103 . . . . 70.22 108.374 -174.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 16.1 m -44.57 86.56 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 126.232 1.813 . . . . 74.44 115.479 -164.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 65.44 23.39 70.21 Favored Glycine 0 C--N 1.353 1.489 0 CA-C-N 115.496 -0.774 . . . . 70.11 114.741 173.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -102.4 136.25 42.56 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 109.617 -0.512 . . . . 72.34 109.617 -178.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -77.37 91.16 3.83 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 122.111 -0.368 . . . . 71.44 110.033 -175.254 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.4 p -34.69 -56.65 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 115.019 1.488 . . . . 75.21 115.019 175.271 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -64.4 -26.32 68.41 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 118.363 0.529 . . . . 75.33 112.369 -178.233 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -79.85 -21.04 44.6 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.614 0.765 . . . . 45.35 111.006 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -94.82 170.33 9.51 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 107.974 -1.121 . . . . 71.01 107.974 177.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.442 ' HB3' ' HZ2' ' A' ' 5' ' ' LYS . 80.4 p -60.3 149.65 32.84 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 113.826 1.047 . . . . 74.5 113.826 -165.335 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.42 ' O ' ' HG3' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -61.06 -30.16 70.16 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 114.893 -1.049 . . . . 74.31 110.486 168.127 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -57.83 -45.07 86.7 Favored 'General case' 0 C--N 1.355 0.812 0 C-N-CA 124.002 0.921 . . . . 75.03 110.838 172.691 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -63.5 -44.54 94.02 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 115.311 -0.859 . . . . 63.23 109.729 175.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.414 ' HA ' HD11 ' A' ' 105' ' ' LEU . 51.1 mt-30 -68.47 -9.8 51.26 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 115.963 -0.562 . . . . 73.05 111.917 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.42 ' HG3' ' O ' ' A' ' 95' ' ' GLU . 38.7 mt-10 -88.78 -59.29 2.27 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 124.119 0.968 . . . . 70.02 111.208 165.099 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 33.8 tp -60.83 -35.67 77.13 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.943 1.297 . . . . 55.03 112.474 -167.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -116.14 6.43 13.95 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.117 0.567 . . . . 72.11 110.67 176.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -42.84 -57.99 3.81 Favored Glycine 0 C--N 1.357 1.721 0 C-N-CA 124.629 1.109 . . . . 72.43 115.131 177.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.421 ' HG3' ' HB2' ' A' ' 75' ' ' PRO . 28.3 Cg_endo -56.88 -19.08 30.17 Favored 'Trans proline' 0 C--N 1.39 2.752 0 C-N-CA 123.264 2.643 . . . . 23.1 113.377 -173.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -142.1 39.89 1.34 Allowed Glycine 0 C--N 1.354 1.563 0 CA-C-O 119.718 -0.49 . . . . 44.4 112.426 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.466 ' HB3' ' ND2' ' A' ' 169' ' ' ASN . 48.6 mt -61.72 72.61 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 123.026 0.53 . . . . 74.25 111.487 169.47 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.612 ' HB3' ' HA ' ' A' ' 169' ' ' ASN . 2.2 t80 21.09 -106.12 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.432 0 C-N-CA 127.109 2.163 . . . . 72.25 112.774 -170.12 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 58.99 41.41 96.37 Favored Glycine 0 C--N 1.364 2.11 0 CA-C-O 119.744 -0.475 . . . . 44.0 112.644 178.038 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.846 ' HA3' ' HB3' ' A' ' 167' ' ' GLN . . . . . . . . 0 C--N 1.367 2.269 0 C-N-CA 124.896 1.236 . . . . 71.34 114.887 165.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 82.4 tttt . . . . . 0 N--CA 1.479 1.008 0 N-CA-C 114.907 1.447 . . . . 72.15 114.907 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -90.22 -173.47 44.89 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-N 115.129 -0.941 . . . . 55.22 113.601 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -93.86 164.07 13.26 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 124.926 1.29 . . . . 71.34 109.572 -177.658 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -74.25 99.67 3.51 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 121.216 -0.927 . . . . 74.23 109.887 174.457 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 38.3 tp -95.5 141.19 29.32 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 121.039 0.447 . . . . 70.23 111.484 -167.295 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -93.0 122.18 35.09 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 107.184 -1.413 . . . . 74.51 107.184 169.133 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -129.9 168.99 15.77 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.399 -0.593 . . . . 41.51 109.399 176.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -128.91 115.4 17.8 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.482 -0.933 . . . . 61.0 108.482 -175.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 65.3 tp -99.59 100.39 10.71 Favored Pre-proline 0 N--CA 1.472 0.659 0 N-CA-C 108.432 -0.951 . . . . 54.05 108.432 -173.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.555 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 46.4 Cg_endo -67.41 135.86 37.96 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 121.587 1.525 . . . . 75.33 109.535 178.047 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.627 ' HA ' HG21 ' B' ' 6' ' ' ILE . 57.1 tp -146.66 154.93 42.03 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 118.467 0.576 . . . . 64.01 110.311 -176.527 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 48.5 m -84.67 145.24 28.07 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 124.536 1.134 . . . . 71.34 110.337 178.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.736 ' HB3' HD22 ' A' ' 215' ' ' LEU . 18.7 mt -55.83 -60.55 3.3 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.927 0.891 . . . . 70.54 112.233 -175.642 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -51.33 -46.37 62.6 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 114.447 -1.252 . . . . 75.32 110.836 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -70.48 -23.94 62.77 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.138 0.975 . . . . 64.33 111.997 -177.108 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -67.91 -48.01 67.17 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 123.198 0.599 . . . . 41.43 109.596 176.009 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.419 ' HA ' ' HA2' ' A' ' 152' ' ' GLY . 61.0 t80 -71.85 -28.92 63.88 Favored 'General case' 0 CA--C 1.556 1.199 0 O-C-N 124.015 0.822 . . . . 74.51 111.702 178.576 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 49.6 m170 -69.61 -53.43 18.85 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 122.663 0.385 . . . . 75.25 111.039 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.563 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 81.19 -167.7 49.65 Favored Glycine 0 CA--C 1.538 1.474 0 CA-C-N 116.266 -0.425 . . . . 71.54 113.199 -178.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.82 -175.75 23.46 Favored Glycine 0 N--CA 1.477 1.41 0 C-N-CA 123.563 0.601 . . . . 70.42 112.205 -179.213 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.467 ' HB3' ' HB3' ' A' ' 146' ' ' SER . 2.5 mp0 -72.16 108.8 5.53 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.696 -0.853 . . . . 73.14 108.696 176.383 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 17.8 tpt180 -91.47 127.05 36.76 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.625 -0.88 . . . . 74.4 108.625 -177.061 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.44 ' HB ' HG21 ' B' ' 5' ' ' THR . 61.6 t -72.7 118.04 17.2 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 N-CA-C 108.779 -0.822 . . . . 71.24 108.779 176.139 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.512 ' HB ' HG13 ' A' ' 145' ' ' VAL . 59.2 t -132.23 115.8 27.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 124.056 0.942 . . . . 73.14 109.236 -175.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -79.62 124.73 28.8 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 109.04 -0.726 . . . . 71.3 109.04 170.055 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.532 HG21 HD23 ' B' ' 8' ' ' LEU . 12.2 p -167.68 138.13 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 122.899 0.48 . . . . 75.1 110.57 172.563 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 64.66 12.3 7.45 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.933 1.293 . . . . 74.24 112.205 -178.03 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.588 ' HA3' ' HB2' ' A' ' 79' ' ' PRO . . . 76.05 20.41 77.6 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-N 116.562 -0.29 . . . . 31.1 113.132 -172.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.472 ' NE ' ' HB3' ' A' ' 84' ' ' ASP . 1.0 OUTLIER -123.85 114.32 19.71 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 107.926 -1.138 . . . . 72.12 107.926 175.866 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 55.0 ttt-85 -73.16 87.57 1.43 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.3 1.04 . . . . 74.41 109.357 176.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.512 HG13 ' HB ' ' A' ' 138' ' ' VAL . 5.7 p -86.06 134.48 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 123.572 0.749 . . . . 73.53 111.136 -176.566 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.467 ' HB3' ' HB3' ' A' ' 135' ' ' GLU . 15.2 m -94.41 84.86 4.43 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 114.879 -1.055 . . . . 31.45 108.515 174.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 90.0 t -79.92 108.84 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 N-CA-C 108.207 -1.034 . . . . 73.42 108.207 -177.255 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 50.5 ttt180 -76.23 92.87 3.32 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 109.116 -0.698 . . . . 74.14 109.116 -177.045 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.633 ' HB ' HG11 ' A' ' 153' ' ' VAL . 42.2 pt -80.1 137.96 53.04 Favored Pre-proline 0 CA--C 1.555 1.163 0 CA-C-N 114.481 -1.236 . . . . 74.13 109.266 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -62.56 141.58 86.74 Favored 'Trans proline' 0 C--N 1.374 1.888 0 C-N-CA 122.519 2.146 . . . . 60.34 112.245 176.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -58.88 93.79 0.08 OUTLIER 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 122.659 2.24 . . . . 74.15 111.045 170.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . 104.85 77.19 1.13 Allowed Glycine 0 C--N 1.335 0.524 0 CA-C-N 115.032 -0.986 . . . . 75.51 110.85 -172.295 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.633 HG11 ' HB ' ' A' ' 149' ' ' ILE . 5.8 p -135.01 103.37 4.3 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.239 0 C-N-CA 123.899 0.88 . . . . 75.43 109.248 174.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.618 ' HD2' HD11 ' A' ' 193' ' ' LEU . 60.5 mtt180 -113.32 173.74 6.25 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 113.3 0.852 . . . . 73.23 113.3 -166.511 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.53 ' HB2' ' HB2' ' A' ' 180' ' ' LEU . 8.6 tp10 -47.65 94.06 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 127.222 2.209 . . . . 72.32 113.965 -167.206 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 121.49 8.57 7.59 Favored Glycine 0 N--CA 1.478 1.471 0 CA-C-O 119.82 -0.433 . . . . 14.21 114.065 178.222 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 21.8 t -80.9 147.76 30.18 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 109.048 -0.723 . . . . 74.23 109.048 171.022 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 61.2 t -114.49 94.15 2.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 C-N-CA 123.584 0.754 . . . . 72.34 109.072 -178.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.594 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 51.7 mt -74.95 95.13 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 N-CA-C 108.212 -1.033 . . . . 75.24 108.212 173.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -79.94 118.01 21.3 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.395 -0.366 . . . . 61.32 110.127 179.213 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.5 p -118.08 108.89 41.6 Favored Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 123.653 0.781 . . . . 61.33 109.594 175.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -76.37 115.3 4.07 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 123.103 2.536 . . . . 74.53 111.141 175.361 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 125.56 -28.07 5.08 Favored Glycine 0 CA--C 1.507 -0.458 0 N-CA-C 111.205 -0.758 . . . . 70.43 111.205 176.345 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 87.9 mtp -94.77 144.21 25.82 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 105.229 -2.137 . . . . 64.15 105.229 162.226 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 171.4 -124.79 1.14 Allowed Glycine 0 CA--C 1.498 -0.995 0 C-N-CA 121.724 -0.274 . . . . 73.33 112.434 175.306 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -68.93 160.98 52.11 Favored Glycine 0 C--O 1.245 0.787 0 O-C-N 124.508 0.769 . . . . 74.5 111.967 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.846 ' HB3' ' HA3' ' A' ' 108' ' ' GLY . 14.8 mm100 -68.87 104.58 2.09 Favored 'General case' 0 CA--C 1.55 0.972 0 O-C-N 125.142 1.143 . . . . 75.42 111.706 -169.017 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -171.33 162.57 35.24 Favored Glycine 0 C--N 1.344 1.016 0 CA-C-O 118.762 -1.021 . . . . 64.21 112.182 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' ASN . . . . . 0.622 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . 49.5 t-20 -56.54 -58.69 15.43 Favored Pre-proline 0 N--CA 1.503 2.214 0 CA-C-O 118.288 -0.863 . . . . 63.11 110.571 -171.688 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.622 ' HD3' ' HB3' ' A' ' 169' ' ' ASN . 12.8 Cg_endo -91.6 97.21 0.21 Allowed 'Trans proline' 0 C--N 1.383 2.376 0 N-CA-C 107.779 -1.662 . . . . 71.13 107.779 157.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.43 165.3 3.32 Favored 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 122.502 2.134 . . . . 71.25 113.861 -170.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -69.0 -118.34 0.03 OUTLIER Glycine 0 N--CA 1.484 1.881 0 N-CA-C 115.401 0.92 . . . . 72.4 115.401 -170.741 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -135.7 118.89 16.56 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 107.667 -1.234 . . . . 71.14 107.667 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 11.2 tp -105.58 132.46 51.71 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.082 0.467 . . . . 64.32 111.303 -166.654 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 58.9 mt -108.37 94.69 5.2 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 114.915 -1.039 . . . . 72.12 108.445 176.315 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.594 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 72.2 mt -78.5 93.84 4.85 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.564 -0.744 . . . . 70.05 109.732 -179.572 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.0 t -83.4 96.76 4.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 107.498 -1.297 . . . . 61.43 107.498 176.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 12.8 p -65.76 110.37 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.083 0 CA-C-N 115.009 -0.996 . . . . 70.33 111.032 -172.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.555 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 38.8 mmm-85 -96.88 96.14 8.33 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 114.817 -1.083 . . . . 53.32 109.677 179.301 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.53 ' HB2' ' HB2' ' A' ' 155' ' ' GLU . 29.3 mt -69.59 151.21 46.23 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 122.423 -0.173 . . . . 72.4 110.895 178.34 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 99.3 mt -51.63 143.08 21.64 Favored Pre-proline 0 N--CA 1.481 1.076 0 C-N-CA 124.173 0.989 . . . . 73.14 111.489 -175.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.2 86.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.387 2.582 0 C-N-CA 123.475 2.784 . . . . 71.42 112.407 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 183' ' ' HIS . . . . . 0.506 ' HA ' ' HD3' ' A' ' 184' ' ' PRO . 16.3 t-80 -136.96 112.69 9.64 Favored Pre-proline 0 CA--C 1.546 0.823 0 N-CA-C 107.0 -1.482 . . . . 73.35 107.0 -178.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.506 ' HD3' ' HA ' ' A' ' 183' ' ' HIS . 14.2 Cg_exo -70.35 27.05 0.19 Allowed 'Trans proline' 0 CA--C 1.556 1.611 0 C-N-CA 124.42 3.413 . . . . 61.24 117.916 -162.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 14.5 t -94.66 -60.08 2.76 Favored 'Isoleucine or valine' 0 C--N 1.364 1.225 0 CA-C-N 121.102 1.774 . . . . 64.21 109.13 177.767 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 186' ' ' PHE . . . . . 0.434 ' HB3' HD21 ' A' ' 193' ' ' LEU . 48.7 m-85 -109.29 140.92 42.33 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 114.765 1.394 . . . . 72.31 114.765 -164.041 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 7.9 tpp180 -145.13 94.38 2.52 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 126.592 1.957 . . . . 75.51 106.839 172.255 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.519 ' HA ' ' HA ' ' A' ' 193' ' ' LEU . 22.5 tp -75.0 150.24 39.03 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.056 0.942 . . . . 74.21 110.556 173.428 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -131.25 100.15 5.09 Favored 'General case' 0 C--O 1.244 0.805 0 N-CA-C 107.879 -1.156 . . . . 70.31 107.879 167.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 65.92 -87.51 0.11 Allowed Glycine 0 C--N 1.352 1.448 0 CA-C-N 115.522 -0.763 . . . . 65.41 113.412 176.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -107.04 -35.13 6.96 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.078 0.951 . . . . 72.32 110.931 -175.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.448 ' HB2' ' HE1' ' A' ' 250' ' ' TYR . 10.6 p-10 -108.02 125.13 51.19 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-O 121.699 0.762 . . . . 72.32 110.598 -168.524 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.618 HD11 ' HD2' ' A' ' 154' ' ' ARG . 0.4 OUTLIER -91.9 125.7 36.7 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.12 -0.946 . . . . 63.44 108.628 -169.985 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.452 ' HA ' ' HB2' ' A' ' 250' ' ' TYR . 39.3 m-85 -95.97 158.25 15.53 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.837 -0.801 . . . . 73.14 108.837 170.113 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.466 ' HB2' HD11 ' A' ' 249' ' ' LEU . . . -156.05 176.17 13.01 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 123.155 0.582 . . . . 74.34 109.581 -173.559 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 35.6 m -130.51 142.08 50.48 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.824 0.849 . . . . 70.21 108.792 172.207 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 47.6 tp -135.47 125.21 25.41 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 123.796 0.838 . . . . 72.21 109.526 -174.288 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -82.99 126.2 32.26 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 109.186 -0.672 . . . . 61.43 109.186 170.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 7.5 p -141.19 134.08 14.34 Favored Pre-proline 0 CA--C 1.542 0.662 0 N-CA-C 107.508 -1.293 . . . . 64.4 107.508 175.031 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -78.65 161.22 27.91 Favored 'Trans proline' 0 CA--C 1.545 1.047 0 C-N-CA 121.537 1.491 . . . . 64.51 111.377 169.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.524 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -55.55 -53.89 57.35 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 124.621 1.169 . . . . 71.34 113.899 -171.537 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -67.53 -28.98 37.78 Favored 'Trans proline' 0 C--N 1.384 2.421 0 CA-C-N 120.769 1.31 . . . . 63.54 112.032 -173.375 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 17.8 mt -73.74 -34.06 39.75 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 C-N-CA 123.632 0.773 . . . . 64.32 110.318 176.276 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.79 -38.61 80.12 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 122.858 0.463 . . . . 71.51 111.389 176.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 201' ' ' ALA . 39.9 t -78.43 -42.93 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 123.096 0.558 . . . . 63.23 111.941 -175.647 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.421 HG11 ' HD2' ' C' ' 270' ' ' LYS . 56.0 t -89.38 -37.81 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 122.507 0.323 . . . . 74.41 111.45 -177.006 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 101.0 105.45 2.8 Favored Glycine 0 C--N 1.337 0.604 0 CA-C-N 116.413 -0.358 . . . . 72.35 112.421 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.434 ' HA3' ' CE1' ' C' ' 277' ' ' TYR . . . -158.69 178.46 34.88 Favored Glycine 0 C--N 1.347 1.152 0 CA-C-N 116.631 0.215 . . . . 55.24 113.163 -178.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.428 ' HE3' ' HB2' ' A' ' 209' ' ' LYS . 38.1 mtmt -79.98 137.38 36.83 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.945 0.498 . . . . 45.21 111.63 -172.554 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.462 HG11 ' HA ' ' A' ' 199' ' ' VAL . 27.5 m -130.45 151.74 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.83 1.252 . . . . 63.11 108.0 167.637 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 43.3 ttp180 -84.18 115.13 22.26 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 110.054 -0.35 . . . . 71.41 110.054 -179.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.29 132.09 47.0 Favored 'General case' 0 C--O 1.245 0.832 0 C-N-CA 123.502 0.721 . . . . 62.04 109.415 174.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 213' ' ' MET . . . . . 0.509 ' N ' ' SD ' ' A' ' 213' ' ' MET . 1.0 OUTLIER -86.37 101.79 13.43 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 107.64 -1.244 . . . . 71.23 107.64 178.931 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 60.2 p -111.23 168.99 9.09 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 108.896 -0.779 . . . . 74.1 108.896 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.736 HD22 ' HB3' ' A' ' 127' ' ' LEU . 7.2 mt -79.14 -6.76 57.28 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 120.865 0.364 . . . . 63.31 111.183 -172.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -100.31 -4.36 29.39 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.697 1.199 . . . . 64.44 110.92 173.438 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 132.67 -175.36 20.02 Favored Glycine 0 C--N 1.351 1.37 0 CA-C-O 120.038 -0.312 . . . . 33.0 113.312 174.145 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -83.68 101.36 0.92 Allowed 'Trans proline' 0 C--N 1.369 1.628 0 C-N-CA 122.754 2.302 . . . . 70.23 111.155 175.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 34.9 m -101.37 162.2 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 123.151 0.58 . . . . 73.4 109.836 -177.122 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -100.82 112.63 25.09 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 109.397 -0.594 . . . . 75.04 109.397 176.382 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 76.6 t -93.84 106.3 17.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 107.985 -1.117 . . . . 74.13 107.985 177.382 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -71.91 99.65 2.27 Favored 'General case' 0 C--N 1.347 0.495 0 N-CA-C 107.923 -1.14 . . . . 60.25 107.923 172.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 90.6 t -62.77 133.33 95.04 Favored Pre-proline 0 CA--C 1.543 0.705 0 CA-C-N 114.015 -1.448 . . . . 63.14 109.569 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -58.03 155.63 32.89 Favored 'Trans proline' 0 C--N 1.376 1.986 0 C-N-CA 122.493 2.129 . . . . 75.51 112.614 171.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.33 156.77 64.81 Favored 'Trans proline' 0 C--N 1.372 1.771 0 C-N-CA 121.798 1.665 . . . . 72.53 112.33 172.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 226' ' ' ARG . . . . . 0.435 HH21 ' HG ' ' C' ' 261' ' ' LEU . 1.5 ptp85 43.53 48.45 6.3 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 126.484 1.914 . . . . 74.04 113.047 -178.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 20.1 m -86.63 115.68 24.25 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 113.053 -1.885 . . . . 64.32 109.815 175.745 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -87.13 147.3 25.7 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.652 0.781 . . . . 75.32 111.291 -175.257 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -63.65 132.92 52.61 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.884 0.874 . . . . 62.31 110.9 175.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 99.29 -19.82 52.39 Favored Glycine 0 C--N 1.343 0.924 0 CA-C-O 119.612 -0.549 . . . . 73.32 112.902 177.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 30.1 mtm-85 -77.35 158.93 29.87 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 117.289 0.544 . . . . 74.0 110.424 175.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -108.97 123.46 49.15 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.122 0.969 . . . . 72.22 109.883 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.45 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 57.5 mt -77.9 108.3 11.05 Favored 'General case' 0 C--N 1.348 0.542 0 N-CA-C 108.489 -0.93 . . . . 71.4 108.489 173.732 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -88.07 109.37 19.8 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 122.96 0.504 . . . . 64.14 110.927 -178.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.525 ' HG ' ' HB3' ' A' ' 249' ' ' LEU . 0.6 OUTLIER -121.85 111.79 17.55 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.15 0.58 . . . . 61.12 111.577 -179.194 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.456 ' HE3' ' HB3' ' A' ' 248' ' ' ASP . 4.2 mmpt? -52.87 147.92 8.36 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.862 1.265 . . . . 64.43 113.096 174.454 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 101.56 -17.32 55.36 Favored Glycine 0 C--N 1.351 1.377 0 CA-C-N 115.562 -0.745 . . . . 74.2 114.315 173.133 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.407 ' HB2' ' HB2' ' A' ' 249' ' ' LEU . 73.0 mmtt -104.91 5.75 33.12 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 112.567 0.58 . . . . 73.01 112.567 -175.627 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -100.23 174.81 26.59 Favored Glycine 0 C--N 1.349 1.27 0 N-CA-C 112.383 -0.287 . . . . 74.43 112.383 166.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -100.53 163.92 17.24 Favored Pre-proline 0 N--CA 1.48 1.074 0 C-N-CA 125.155 1.382 . . . . 73.13 112.584 -163.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -46.94 140.63 13.07 Favored 'Trans proline' 0 C--N 1.394 2.952 0 C-N-CA 124.23 3.286 . . . . 73.33 114.563 174.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 175.75 -167.48 39.33 Favored Glycine 0 CA--C 1.534 1.271 0 CA-C-N 115.422 -0.808 . . . . 73.52 112.122 179.257 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -56.32 -28.81 73.96 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 123.733 2.956 . . . . 70.45 114.439 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -92.83 22.43 4.85 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.562 0.745 . . . . 70.11 111.843 -178.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 78.18 -93.1 1.19 Allowed Glycine 0 C--N 1.348 1.233 0 N-CA-C 109.762 -1.335 . . . . 62.24 109.762 -172.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 30.3 mtp180 -127.19 148.09 50.19 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.88 0.872 . . . . 75.41 108.904 166.182 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -78.32 -157.03 9.64 Favored Glycine 0 CA--C 1.535 1.33 0 CA-C-O 121.637 0.576 . . . . 42.24 113.902 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 248' ' ' ASP . . . . . 0.456 ' HB3' ' HE3' ' A' ' 236' ' ' LYS . 0.4 OUTLIER -134.49 165.0 26.2 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.404 1.081 . . . . 75.44 111.223 -174.96 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.55 HD13 HD13 ' A' ' 193' ' ' LEU . 61.6 tp -100.39 153.31 19.44 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.493 1.117 . . . . 70.31 109.756 178.749 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.452 ' HB2' ' HA ' ' A' ' 194' ' ' TYR . 62.9 m-85 -128.65 103.6 7.18 Favored 'General case' 0 C--O 1.219 -0.536 0 N-CA-C 108.873 -0.788 . . . . 52.51 108.873 177.441 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.45 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 32.8 mt -90.09 104.16 16.76 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.122 -0.696 . . . . 72.24 109.122 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -77.36 125.27 29.07 Favored 'General case' 0 C--N 1.362 1.141 0 CA-C-O 121.64 0.734 . . . . 75.41 109.933 -176.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 61.1 t -78.76 117.61 24.6 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-N 114.271 -1.331 . . . . 24.43 111.701 -169.211 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 15.8 mmm-85 -114.49 96.17 5.63 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.126 -1.064 . . . . 73.14 108.126 170.031 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.501 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 69.8 mt -75.44 133.95 30.27 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 CA-C-N 114.86 -1.064 . . . . 74.34 110.12 178.81 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 22.6 p -126.09 -177.95 4.13 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.865 1.266 . . . . 73.43 110.144 178.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 257' ' ' ILE . . . . . 0.538 HG23 HG21 ' C' ' 255' ' ' ILE . 2.4 pp -139.01 159.66 65.93 Favored Pre-proline 0 N--CA 1.491 1.589 0 C-N-CA 123.803 0.841 . . . . 73.4 110.655 -177.563 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -60.96 -9.44 12.06 Favored 'Trans proline' 0 C--N 1.393 2.903 0 C-N-CA 123.112 2.541 . . . . 74.45 115.519 -167.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 259' ' ' GLU . . . . . 0.485 ' HA ' ' HB3' ' C' ' 226' ' ' ARG . 42.4 mt-10 57.0 -64.92 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 125.824 1.649 . . . . 63.24 114.288 -174.684 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.15 157.16 16.87 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 109.326 -0.62 . . . . 75.12 109.326 168.157 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.594 HD13 ' HA ' ' A' ' 266' ' ' GLU . 64.2 mt -141.9 131.47 23.95 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 118.287 0.494 . . . . 55.32 111.237 -178.026 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.46 148.35 52.1 Favored Pre-proline 0 CA--C 1.555 1.143 0 N-CA-C 107.702 -1.222 . . . . 44.34 107.702 167.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -40.8 -31.82 0.76 Allowed 'Trans proline' 0 C--N 1.392 2.838 0 C-N-CA 124.939 3.76 . . . . 74.33 116.58 -167.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -61.38 -68.08 0.35 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.448 0.699 . . . . 71.44 110.758 176.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 265' ' ' GLU . . . . . 0.543 ' HB2' HD22 ' A' ' 261' ' ' LEU . 1.7 mp0 -67.17 -28.28 67.98 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 123.487 0.492 . . . . 64.2 110.28 -175.541 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 266' ' ' GLU . . . . . 0.594 ' HA ' HD13 ' A' ' 261' ' ' LEU . 8.3 tp10 -50.38 -58.46 5.65 Favored 'General case' 0 C--O 1.253 1.249 0 C-N-CA 124.258 1.023 . . . . 73.45 109.459 171.574 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 267' ' ' ALA . . . . . 0.447 ' O ' ' HG2' ' A' ' 271' ' ' LYS . . . -59.13 -58.43 8.67 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 114.702 -1.135 . . . . 64.12 111.15 177.405 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 10.2 mp -57.6 -45.92 84.69 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 123.852 0.861 . . . . 73.14 112.854 -170.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 63.3 m95 -60.23 -46.92 88.1 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 123.749 0.655 . . . . 75.0 110.805 175.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 270' ' ' LYS . . . . . 0.625 ' HE2' ' HA ' ' C' ' 206' ' ' VAL . 2.2 mptm? -63.05 -34.33 77.35 Favored 'General case' 0 CA--C 1.548 0.874 0 O-C-N 123.727 0.642 . . . . 62.43 112.03 178.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 271' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' A' ' 267' ' ' ALA . 26.4 mmmt -73.96 -40.31 63.12 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 118.084 0.402 . . . . 70.22 110.366 -177.558 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 39.5 mt -57.72 -39.38 77.11 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 123.467 0.707 . . . . 63.4 110.204 170.621 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -65.97 -45.1 82.92 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 124.129 0.893 . . . . 64.51 112.644 -177.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -67.35 -42.85 82.83 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.811 0.844 . . . . 74.35 110.763 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -62.53 -44.13 97.1 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.38 -0.827 . . . . 71.44 110.231 177.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -63.69 -44.25 94.25 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.415 1.086 . . . . 75.02 109.909 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -62.71 -43.6 98.4 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.82 1.248 . . . . 70.12 109.492 -177.28 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -75.02 -5.03 41.83 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 115.236 -0.893 . . . . 75.41 112.563 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 43.7 mtm180 -115.38 -0.88 13.01 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.808 0.843 . . . . 74.13 110.08 173.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.1 0 N-CA-C 108.546 -0.909 . . . . 72.21 108.546 178.975 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.476 0.874 0 N-CA-C 109.627 -0.509 . . . . 71.44 109.627 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 2' ' ' LYS . . . . . 0.408 ' HG2' ' HG3' ' B' ' 3' ' ' GLN . 85.1 tttt 65.43 143.89 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 125.483 1.513 . . . . 54.1 111.906 -176.428 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 3' ' ' GLN . . . . . 0.408 ' HG3' ' HG2' ' B' ' 2' ' ' LYS . 97.4 mt-30 64.64 1.66 1.43 Allowed 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 125.164 1.386 . . . . 74.04 113.479 -178.632 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 43.3 m -72.57 95.28 1.8 Allowed 'General case' 0 C--N 1.354 0.797 0 C-N-CA 123.468 0.707 . . . . 52.14 109.111 -179.376 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 5' ' ' THR . . . . . 0.44 HG21 ' HB ' ' A' ' 137' ' ' VAL . 0.1 OUTLIER -83.39 160.85 21.53 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.418 -0.81 . . . . 70.11 111.102 -171.879 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.627 HG21 ' HA ' ' A' ' 125' ' ' LEU . 38.5 pt -130.34 168.89 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 112.943 0.72 . . . . 64.44 112.943 -154.291 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -145.25 124.78 13.17 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.82 0.848 . . . . 72.01 108.975 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 8' ' ' LEU . . . . . 0.532 HD23 HG21 ' A' ' 140' ' ' VAL . 60.7 tp -63.53 138.3 58.46 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.066 0.946 . . . . 75.22 110.894 -174.621 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.52 -48.63 80.9 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 124.183 0.927 . . . . 62.4 111.074 177.073 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 6.1 tt 53.67 89.79 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.155 0 O-C-N 124.53 1.144 . . . . 74.1 108.957 -172.047 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 91.7 mt . . . . . 0 CA--C 1.547 0.833 0 N-CA-C 110.045 -0.354 . . . . 45.35 110.045 -176.05 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.319 0 N-CA-C 114.308 1.225 . . . . 61.34 114.308 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . 54.54 48.45 20.41 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.838 0.828 . . . . 74.4 109.088 -168.025 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 31.2 tp 62.25 -77.56 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.28 0 CA-C-N 113.277 -1.783 . . . . 62.04 111.584 -166.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 182' ' ' VAL . . . . . 0.667 ' HA ' ' HB3' ' C' ' 123' ' ' LEU . 91.3 t -96.5 141.3 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 123.839 0.856 . . . . 71.31 111.364 -175.386 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -134.8 8.05 3.52 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.5 0.72 . . . . 65.24 112.708 -176.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -145.44 152.33 39.64 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 118.104 0.411 . . . . 74.15 110.371 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 185' ' ' VAL . . . . . . . . . . . . . 71.4 t . . . . . 0 N--CA 1.501 2.087 0 C-N-CA 126.124 1.77 . . . . 71.33 110.439 -170.83 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 8.9 m . . . . . 0 CA--C 1.555 1.149 0 N-CA-C 109.562 -0.533 . . . . 71.31 109.562 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 239' ' ' ALA . . . . . 0.518 ' HB2' ' HA ' ' C' ' 221' ' ' VAL . . . -67.91 -179.36 1.17 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.345 1.058 . . . . 74.42 111.964 176.426 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 240' ' ' GLY . . . . . 0.469 ' HA3' ' O ' ' C' ' 234' ' ' ARG . . . -103.38 -114.09 3.89 Favored Glycine 0 C--N 1.343 0.956 0 CA-C-O 119.718 -0.49 . . . . 71.23 111.903 -176.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -149.99 142.55 24.47 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.217 0.607 . . . . 71.21 111.087 -178.361 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -179.63 117.25 0.06 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 125.279 1.432 . . . . 70.32 108.971 173.661 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 65.36 -79.48 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 125.068 1.347 . . . . 74.22 113.004 176.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 152.63 100.13 0.19 Allowed Glycine 0 C--N 1.347 1.177 0 N-CA-C 111.699 -0.561 . . . . 63.11 111.699 -177.24 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.552 1.058 0 C-N-CA 123.835 0.854 . . . . 75.34 111.48 -178.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.656 0 N-CA-C 110.008 -0.367 . . . . 52.01 110.008 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -38.72 104.96 0.04 OUTLIER 'General case' 0 C--N 1.358 0.939 0 C-N-CA 125.504 1.522 . . . . 70.52 112.779 178.34 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 5' ' ' LYS . . . . . 0.47 ' HE2' HD11 ' C' ' 10' ' ' ILE . 47.6 mtpt -97.34 112.37 24.22 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.625 -0.88 . . . . 63.2 108.625 173.083 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -71.07 105.01 3.19 Favored 'General case' 0 C--O 1.244 0.788 0 N-CA-C 108.806 -0.813 . . . . 63.22 108.806 174.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 7' ' ' TYR . . . . . 0.421 ' HA ' HD12 ' C' ' 10' ' ' ILE . 75.5 m-85 -63.42 -26.54 68.78 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 114.544 -1.207 . . . . 73.43 112.074 -173.136 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -63.58 -48.23 78.25 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 109.578 -0.527 . . . . 72.53 109.578 173.313 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.95 -37.84 83.77 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.102 0.561 . . . . 52.31 111.544 179.087 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 10' ' ' ILE . . . . . 0.47 HD11 ' HE2' ' C' ' 5' ' ' LYS . 63.8 mt -58.78 -43.9 89.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 C-N-CA 123.225 0.61 . . . . 63.34 110.465 174.621 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 73.4 mt -76.32 -11.83 59.97 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 115.77 -0.65 . . . . 45.45 112.698 177.166 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.32 40.22 55.7 Favored Glycine 0 C--N 1.35 1.353 0 N-CA-C 112.821 -0.112 . . . . 64.33 112.821 -176.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 14.6 m -131.78 156.66 79.83 Favored Pre-proline 0 N--CA 1.485 1.295 0 C-N-CA 124.927 1.291 . . . . 64.04 109.826 178.339 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -80.97 177.16 8.23 Favored 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 122.452 2.101 . . . . 74.43 112.421 176.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 90.5 mtt180 -83.78 36.99 0.57 Allowed 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 122.485 1.136 . . . . 71.52 111.297 176.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -117.34 -15.59 10.35 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.702 2.001 . . . . 71.24 107.417 172.306 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.79 104.69 0.56 Allowed 'General case' 0 C--N 1.35 0.621 0 CA-C-N 114.383 -1.28 . . . . 71.14 112.834 -169.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 76.7 p -71.28 -170.13 0.46 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.894 1.278 . . . . 74.41 110.841 174.328 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.83 -42.89 90.34 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 124.276 1.03 . . . . 74.45 110.152 177.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 20' ' ' GLU . . . . . 0.493 ' O ' ' HG3' ' C' ' 24' ' ' ARG . 0.9 OUTLIER -75.58 -35.74 60.52 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 116.235 -0.438 . . . . 64.05 110.326 -175.582 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -68.52 -38.85 81.26 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-O 121.223 0.535 . . . . 73.42 110.55 178.147 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 1.1 mp -60.14 -39.53 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.397 1.079 . . . . 61.32 109.796 169.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -70.01 -31.39 69.04 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.297 -0.865 . . . . 74.13 110.812 178.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 24' ' ' ARG . . . . . 0.493 ' HG3' ' O ' ' C' ' 20' ' ' GLU . 89.0 mtt180 -65.81 -44.87 84.35 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 109.398 -0.593 . . . . 73.52 109.398 177.435 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.09 -34.9 79.11 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 114.57 -1.196 . . . . 75.32 111.562 176.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 26' ' ' TYR . . . . . 0.418 ' O ' ' HB3' ' C' ' 30' ' ' ALA . 86.6 t80 -67.9 -48.15 66.8 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 123.816 0.698 . . . . 72.31 110.631 177.26 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -59.37 -56.11 26.18 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.381 -0.6 . . . . 74.1 109.381 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 32.3 ttt180 -50.49 -70.76 0.08 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.947 0.899 . . . . 71.15 111.489 177.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 86.7 mt -75.0 -50.31 16.98 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.42 -0.809 . . . . 60.22 112.04 -168.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 30' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' C' ' 26' ' ' TYR . . . -67.57 -28.52 67.85 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-O 117.714 -1.136 . . . . 75.32 112.239 -176.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 31' ' ' ARG . . . . . 0.462 ' HA ' ' HB2' ' C' ' 34' ' ' HIS . 74.5 mtm180 -80.9 -28.24 35.95 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 120.051 1.296 . . . . 73.5 110.842 173.117 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -65.34 -31.33 72.4 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.212 0.605 . . . . 71.12 110.367 171.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 33' ' ' TYR . . . . . 0.453 ' HB3' ' O ' ' C' ' 43' ' ' ALA . 21.7 m-85 -111.02 8.13 21.8 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.884 0.873 . . . . 70.15 112.056 -174.399 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 34' ' ' HIS . . . . . 0.462 ' HB2' ' HA ' ' C' ' 31' ' ' ARG . 9.4 t-160 -75.43 114.33 34.79 Favored Pre-proline 0 N--CA 1.479 1.003 0 CA-C-O 118.26 -0.876 . . . . 72.34 110.152 -174.511 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.52 -20.53 49.9 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 122.423 2.082 . . . . 71.32 112.882 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -53.5 -43.69 68.45 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.773 1.229 . . . . 60.34 112.181 173.277 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 86.5 t -107.53 -52.49 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 123.109 0.564 . . . . 75.33 109.955 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -98.37 90.68 4.88 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.128 0.971 . . . . 54.22 109.898 -176.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -74.84 81.4 2.12 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 109.113 -0.699 . . . . 62.24 109.113 176.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 70.8 m -137.37 117.02 10.31 Favored Pre-proline 0 N--CA 1.48 1.037 0 C-N-CA 123.459 0.704 . . . . 74.14 109.756 176.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -50.52 -43.33 45.52 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 123.882 3.055 . . . . 63.44 114.005 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -58.06 -40.3 80.66 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.406 0.682 . . . . 65.44 110.549 175.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 43' ' ' ALA . . . . . 0.453 ' O ' ' HB3' ' C' ' 33' ' ' TYR . . . -73.41 -17.93 61.21 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 115.661 -0.7 . . . . 62.05 110.259 -178.449 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 44' ' ' GLU . . . . . 0.457 ' O ' ' HD3' ' C' ' 48' ' ' LYS . 44.1 mt-10 -74.87 -43.9 51.9 Favored 'General case' 0 C--N 1.358 0.947 0 N-CA-C 109.217 -0.66 . . . . 74.04 109.217 175.01 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -57.69 -46.03 84.87 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 121.672 0.748 . . . . 42.53 110.048 175.237 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 46' ' ' LYS . . . . . 0.557 ' O ' HG12 ' C' ' 50' ' ' ILE . 99.9 mttt -63.6 -39.56 94.67 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 114.237 -1.347 . . . . 72.32 110.802 176.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -62.94 -32.53 73.86 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.869 0.868 . . . . 62.23 110.476 177.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 48' ' ' LYS . . . . . 0.457 ' HD3' ' O ' ' C' ' 44' ' ' GLU . 2.5 mptm? -65.81 -47.32 75.48 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 122.959 0.504 . . . . 72.04 109.702 173.583 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -58.57 -44.59 89.81 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.13 0.572 . . . . 72.33 111.304 178.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 50' ' ' ILE . . . . . 0.557 HG12 ' O ' ' C' ' 46' ' ' LYS . 20.3 mm -63.21 -49.31 83.7 Favored 'Isoleucine or valine' 0 C--N 1.361 1.078 0 CA-C-N 115.686 -0.688 . . . . 75.43 109.733 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 51' ' ' ASN . . . . . 0.51 ' HA ' ' HB3' ' C' ' 54' ' ' TYR . 22.0 m-80 -79.9 -9.18 59.65 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.703 0.801 . . . . 74.04 112.169 -176.399 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -71.26 -61.37 1.79 Allowed 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 107.842 -1.17 . . . . 63.42 107.842 167.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.65 -41.72 86.71 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 113.626 -1.624 . . . . 63.1 112.216 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 54' ' ' TYR . . . . . 0.51 ' HB3' ' HA ' ' C' ' 51' ' ' ASN . 67.2 t80 -65.1 -52.68 54.04 Favored 'General case' 0 C--O 1.213 -0.837 0 CA-C-N 115.148 -0.933 . . . . 75.01 109.884 177.424 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.68 -38.2 63.95 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 112.199 0.444 . . . . 60.54 112.199 -177.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 98.2 t -64.61 -55.61 20.39 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 O-C-N 123.99 0.807 . . . . 72.43 110.887 173.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 57' ' ' LEU . . . . . . . . . . . . . 68.0 mt -94.27 7.58 44.86 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 113.616 0.969 . . . . 75.02 113.616 -168.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 43.8 t -69.65 -81.03 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.719 0.807 . . . . 62.42 110.919 -175.287 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -83.8 145.4 47.0 Favored Pre-proline 0 C--O 1.248 1.021 0 N-CA-C 109.37 -0.604 . . . . 72.03 109.37 -174.099 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 60' ' ' PRO . . . . . 0.402 ' O ' ' HG2' ' C' ' 64' ' ' ARG . 9.8 Cg_endo -47.13 -33.92 16.4 Favored 'Trans proline' 0 C--N 1.387 2.588 0 C-N-CA 124.546 3.497 . . . . 33.23 113.634 -176.02 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -56.11 -71.03 0.1 Allowed 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 124.492 1.117 . . . . 62.13 111.62 178.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 33.8 mtmt -66.01 -29.08 69.39 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.74 0.816 . . . . 75.23 111.185 -174.358 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 23.8 tpt85 -54.19 -52.47 61.1 Favored 'General case' 0 C--N 1.356 0.876 0 O-C-N 124.277 0.986 . . . . 64.42 109.583 170.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 64' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' C' ' 60' ' ' PRO . 1.7 mmp_? -63.33 -35.99 82.21 Favored 'General case' 0 C--N 1.357 0.896 0 CA-C-O 118.613 -0.708 . . . . 74.15 111.915 178.014 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 1.5 mp -55.98 -45.31 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-N 118.281 0.492 . . . . 62.34 110.363 175.182 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -61.59 -55.17 33.7 Favored 'General case' 0 C--N 1.358 0.957 0 N-CA-C 109.937 -0.394 . . . . 74.22 109.937 176.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -56.48 -36.48 69.15 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.646 0.778 . . . . 73.14 112.586 -176.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 45.5 p -77.35 -30.65 54.0 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 119.085 -0.484 . . . . 63.2 110.92 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -66.82 128.39 36.13 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 118.425 0.557 . . . . 75.22 110.471 -179.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.19 14.85 55.4 Favored Glycine 0 C--N 1.345 1.059 0 N-CA-C 111.582 -0.607 . . . . 62.51 111.582 -176.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 29.8 m -142.48 -57.44 0.44 Allowed 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 103.942 -2.614 . . . . 72.34 103.942 177.09 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 49.5 m -79.73 141.15 36.61 Favored 'General case' 0 C--O 1.257 1.494 0 N-CA-C 104.871 -2.27 . . . . 73.35 104.871 154.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.4 -40.07 10.12 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.486 0.714 . . . . 73.23 109.833 178.679 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -77.88 128.28 79.56 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 123.886 0.874 . . . . 53.23 110.619 -175.142 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -62.48 121.28 9.18 Favored 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 122.642 2.228 . . . . 75.14 110.746 174.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -52.23 131.19 38.67 Favored 'Trans proline' 0 C--N 1.38 2.193 0 C-N-CA 123.328 2.685 . . . . 63.14 113.001 -179.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 77' ' ' PRO . . . . . 0.503 ' HA ' ' HD3' ' C' ' 78' ' ' PRO . 12.2 Cg_endo -53.03 126.79 22.62 Favored 'Trans proline' 0 C--N 1.39 2.743 0 C-N-CA 123.392 2.728 . . . . 51.51 112.232 -175.13 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 78' ' ' PRO . . . . . 0.503 ' HD3' ' HA ' ' C' ' 77' ' ' PRO . 19.7 Cg_exo -64.09 148.53 91.39 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 122.738 2.292 . . . . 74.44 112.317 -172.325 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -57.34 158.1 19.81 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 122.512 2.141 . . . . 61.04 111.251 171.21 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -53.42 80.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.386 2.52 0 C-N-CA 124.069 3.179 . . . . 51.5 115.259 -171.065 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 149.75 -41.91 0.81 Allowed Glycine 0 C--N 1.341 0.826 0 N-CA-C 110.773 -0.931 . . . . 75.2 110.773 -178.537 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 145.86 174.86 18.42 Favored Glycine 0 C--N 1.343 0.921 0 C-N-CA 123.472 0.558 . . . . 74.45 111.881 177.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -53.56 124.32 14.64 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.209 1.004 . . . . 70.14 109.799 169.139 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -58.1 110.85 1.01 Allowed 'General case' 0 N--CA 1.479 0.984 0 O-C-N 123.88 0.737 . . . . 63.13 111.179 175.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 85' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -142.86 31.62 1.42 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.371 1.469 . . . . 74.41 108.736 170.263 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 86' ' ' SER . . . . . 0.462 ' OG ' ' HD2' ' C' ' 143' ' ' ARG . 7.4 m -71.04 106.88 3.86 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 114.216 -1.356 . . . . 45.43 110.191 -173.797 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 100.84 -21.8 42.21 Favored Glycine 0 C--N 1.337 0.626 0 CA-C-N 116.107 -0.497 . . . . 74.33 112.811 -176.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 88' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -88.0 130.65 34.9 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 108.203 -1.036 . . . . 74.44 108.203 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -75.68 69.55 2.39 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.964 0.905 . . . . 72.23 110.664 -170.32 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 90' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -48.34 -43.27 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 125.679 1.592 . . . . 54.41 112.114 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -62.76 -30.78 71.7 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.267 0.627 . . . . 74.21 111.91 -176.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -81.53 -26.02 35.43 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.511 0.324 . . . . 75.53 110.607 177.279 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 15.1 m-30 -68.95 166.75 17.24 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.499 0.319 . . . . 72.45 110.855 -174.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 65.1 p -63.68 162.2 13.6 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 114.3 1.222 . . . . 45.51 114.3 -165.195 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 95' ' ' GLU . . . . . 0.421 ' O ' ' HG3' ' C' ' 99' ' ' GLU . 0.0 OUTLIER -63.39 -44.17 95.47 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 114.988 -1.006 . . . . 55.43 111.931 178.245 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -55.79 -46.95 77.85 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.313 0.645 . . . . 65.02 110.545 177.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 97' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -56.58 -46.85 80.59 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 113.77 -1.559 . . . . 64.25 110.271 175.576 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 98' ' ' GLN . . . . . 0.489 ' HA ' ' CD1' ' C' ' 105' ' ' LEU . 93.1 mt-30 -73.89 -12.71 60.75 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.183 0.808 . . . . 51.52 113.183 -176.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 99' ' ' GLU . . . . . 0.421 ' HG3' ' O ' ' C' ' 95' ' ' GLU . 46.8 mt-10 -87.1 -48.43 8.08 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.19 0.596 . . . . 74.43 111.211 172.195 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 13.3 tp -66.6 -60.1 3.01 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.588 0.755 . . . . 73.23 111.313 -175.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 101' ' ' PHE . . . . . 0.402 ' C ' ' HG ' ' C' ' 105' ' ' LEU . 64.4 m-85 -85.23 -8.98 58.29 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 116.205 -0.452 . . . . 73.25 110.994 -177.043 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -39.0 -55.24 2.34 Favored Glycine 0 C--N 1.365 2.157 0 CA-C-O 118.407 -1.218 . . . . 54.11 114.943 -176.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -29.24 -37.47 0.04 OUTLIER 'Trans proline' 0 C--N 1.391 2.782 1 C-N-CA 125.731 4.287 . . . . 62.02 116.888 173.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -147.52 36.45 1.17 Allowed Glycine 0 C--N 1.352 1.454 0 C-N-CA 121.559 -0.353 . . . . 43.23 112.982 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 105' ' ' LEU . . . . . 0.489 ' CD1' ' HA ' ' C' ' 98' ' ' GLN . 4.1 mt . . . . . 0 N--CA 1.488 1.436 0 N-CA-C 115.629 1.714 . . . . 73.03 115.629 -174.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.969 0 N-CA-C 111.252 -0.739 . . . . 45.25 111.252 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 67.7 mtp180 -93.91 163.55 13.45 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.545 0.738 . . . . 64.44 109.977 177.411 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 118' ' ' ASP . . . . . 0.403 ' HA ' ' O ' ' C' ' 173' ' ' ASP . 9.6 p-10 -73.33 93.52 1.92 Allowed 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 108.57 -0.9 . . . . 75.42 108.57 174.547 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 119' ' ' LEU . . . . . 0.462 HD13 ' HA ' ' C' ' 174' ' ' LEU . 0.0 OUTLIER -95.33 157.08 16.05 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 108.233 -1.025 . . . . 75.21 108.233 -178.544 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.64 126.41 48.97 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.94 -0.392 . . . . 72.31 109.94 -174.596 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 121' ' ' ALA . . . . . . . . . . . . . . . -125.19 118.71 26.65 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 108.747 -0.834 . . . . 63.21 108.747 -178.419 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -94.88 148.16 22.6 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 122.676 0.39 . . . . 73.22 110.839 -171.116 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 123' ' ' LEU . . . . . 0.667 ' HB3' ' HA ' ' B' ' 182' ' ' VAL . 1.0 OUTLIER -144.61 114.82 5.19 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 122.862 0.465 . . . . 73.3 111.137 -177.318 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 124' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' C' ' 179' ' ' ARG . 33.1 Cg_endo -66.18 114.45 3.03 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 121.862 1.708 . . . . 72.51 108.964 162.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 125' ' ' LEU . . . . . 0.583 HD23 HG11 ' C' ' 153' ' ' VAL . 18.4 tp -138.15 155.52 48.64 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.579 0.351 . . . . 74.03 110.846 -164.498 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 126' ' ' THR . . . . . . . . . . . . . 15.0 p -100.09 160.6 14.19 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-O 121.871 0.843 . . . . 61.53 111.218 173.095 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 127' ' ' LEU . . . . . 0.486 HD21 HD13 ' C' ' 180' ' ' LEU . 8.4 mt -67.13 -35.46 79.77 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 113.46 -1.7 . . . . 62.25 108.479 174.127 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -62.88 -47.23 84.2 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 113.145 -1.843 . . . . 75.24 109.605 176.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -66.46 -28.82 68.89 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 122.854 0.462 . . . . 73.53 111.732 176.237 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 130' ' ' ALA . . . . . 0.416 ' HB2' HG12 ' C' ' 153' ' ' VAL . . . -63.85 -41.23 97.85 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 123.463 0.477 . . . . 64.34 110.51 175.339 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 131' ' ' PHE . . . . . 0.439 ' HB2' HD13 ' C' ' 215' ' ' LEU . 52.3 t80 -65.31 -43.0 92.46 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.965 0.906 . . . . 75.55 110.292 172.655 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 132' ' ' HIS . . . . . 0.472 ' O ' ' HD3' ' C' ' 136' ' ' ARG . 23.5 m170 -80.01 -1.8 41.35 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.206 -0.906 . . . . 60.22 110.781 -176.536 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -69.15 65.47 0.52 Allowed Glycine 0 C--N 1.358 1.8 0 C-N-CA 123.977 0.799 . . . . 65.31 114.447 174.259 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . -93.47 -126.23 4.25 Favored Glycine 0 C--N 1.343 0.936 0 N-CA-C 109.442 -1.463 . . . . 53.24 109.442 165.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 13.8 mp0 -71.97 94.79 1.5 Allowed 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 117.667 0.734 . . . . 71.2 109.119 175.156 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 136' ' ' ARG . . . . . 0.472 ' HD3' ' O ' ' C' ' 132' ' ' HIS . 17.9 mmm180 -110.82 147.64 34.07 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.45 0.7 . . . . 72.12 110.313 -175.081 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 137' ' ' VAL . . . . . . . . . . . . . 35.8 m -91.73 144.19 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 108.823 -0.806 . . . . 71.12 108.823 178.165 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 138' ' ' VAL . . . . . 0.432 HG22 HG23 ' C' ' 140' ' ' VAL . 14.7 p -160.64 151.0 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 O-C-N 123.211 0.32 . . . . 72.14 110.936 -177.559 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 139' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -120.1 113.27 20.22 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 107.561 -1.274 . . . . 74.31 107.561 171.238 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 140' ' ' VAL . . . . . 0.512 HG11 HD13 ' C' ' 174' ' ' LEU . 90.0 t -130.14 101.61 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 123.759 0.824 . . . . 63.22 110.794 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 141' ' ' ALA . . . . . 0.652 ' HB3' HH21 ' C' ' 143' ' ' ARG . . . 55.45 44.65 26.69 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.576 1.551 . . . . 15.23 112.562 168.04 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 103.08 6.26 45.72 Favored Glycine 0 C--N 1.347 1.175 0 CA-C-N 115.46 -0.791 . . . . 45.25 113.183 178.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 143' ' ' ARG . . . . . 0.652 HH21 ' HB3' ' C' ' 141' ' ' ALA . 0.0 OUTLIER -120.82 95.39 4.69 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 117.452 0.626 . . . . 73.04 110.19 -176.95 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 52.9 ttt180 -90.49 87.25 6.69 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 107.767 -1.197 . . . . 71.51 107.767 168.53 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 145' ' ' VAL . . . . . . . . . . . . . 27.4 m -119.66 148.77 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 115.4 -0.818 . . . . 75.03 111.574 -176.051 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 16.0 p -99.11 96.9 8.1 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 124.492 1.117 . . . . 54.21 108.433 168.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 14.8 p -124.83 151.52 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.753 0.821 . . . . 72.53 110.471 -173.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 24.2 ttm180 -98.24 110.15 22.78 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 109.952 -0.388 . . . . 74.22 109.952 169.154 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 149' ' ' ILE . . . . . 0.429 HD12 HD13 ' C' ' 159' ' ' ILE . 39.8 pt -78.82 153.88 78.04 Favored Pre-proline 0 CA--C 1.552 1.038 0 N-CA-C 108.085 -1.08 . . . . 71.41 108.085 164.297 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -43.03 111.73 0.24 Allowed 'Trans proline' 0 C--N 1.385 2.45 0 C-N-CA 122.989 2.459 . . . . 61.44 112.879 175.116 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.95 102.6 0.13 Allowed 'Trans proline' 0 C--N 1.389 2.708 0 C-N-CA 123.507 2.805 . . . . 73.2 111.257 -178.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 152' ' ' GLY . . . . . 0.48 ' HA3' HD22 ' C' ' 188' ' ' LEU . . . 132.06 140.33 4.49 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 116.025 -0.534 . . . . 54.32 112.635 -171.288 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 153' ' ' VAL . . . . . 0.657 HG22 HG11 ' C' ' 178' ' ' VAL . 0.3 OUTLIER -152.59 167.26 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 N-CA-C 112.267 0.469 . . . . 71.13 112.267 -174.899 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 154' ' ' ARG . . . . . 0.459 ' HB2' ' OG ' ' C' ' 157' ' ' SER . 19.2 mtt180 -138.61 162.89 33.47 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.529 1.131 . . . . 75.32 109.28 -173.589 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 155' ' ' GLU . . . . . 0.43 ' HB2' HD12 ' C' ' 180' ' ' LEU . 10.2 tp10 -72.76 132.65 43.89 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 123.98 0.912 . . . . 74.51 111.953 178.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 65.17 19.73 66.41 Favored Glycine 0 C--N 1.359 1.839 0 O-C-N 123.745 0.653 . . . . 64.51 113.601 173.16 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 157' ' ' SER . . . . . 0.459 ' OG ' ' HB2' ' C' ' 154' ' ' ARG . 53.4 m -98.18 172.19 7.75 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.241 0.616 . . . . 75.43 111.018 -172.301 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 7.7 p -127.13 118.55 50.46 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.987 0 CA-C-N 115.173 -0.921 . . . . 64.44 110.062 -173.415 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 159' ' ' ILE . . . . . 0.69 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 25.4 mt -94.58 103.56 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 108.281 -1.007 . . . . 52.25 108.281 178.019 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 160' ' ' ARG . . . . . 0.479 HH12 ' HB3' ' C' ' 162' ' ' PRO . 64.4 ttp85 -83.55 100.92 11.09 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 109.819 -0.437 . . . . 72.21 109.819 -179.332 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 161' ' ' VAL . . . . . 0.609 ' HB ' ' HB3' ' C' ' 174' ' ' LEU . 58.2 t -94.59 103.37 11.02 Favored Pre-proline 0 CA--C 1.554 1.13 0 N-CA-C 108.404 -0.961 . . . . 75.24 108.404 175.202 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 162' ' ' PRO . . . . . 0.479 ' HB3' HH12 ' C' ' 160' ' ' ARG . 90.9 Cg_endo -73.87 164.19 35.2 Favored 'Trans proline' 0 C--N 1.373 1.843 0 C-N-CA 122.924 2.416 . . . . 63.42 113.879 -172.737 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.46 -25.14 6.58 Favored Glycine 0 C--N 1.345 1.055 0 CA-C-N 114.886 -1.052 . . . . 53.31 114.294 172.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 164' ' ' MET . . . . . 0.413 ' SD ' ' HG2' ' C' ' 143' ' ' ARG . 23.9 ttp -83.5 -77.7 0.24 Allowed 'General case' 0 C--N 1.356 0.853 0 CA-C-N 117.779 0.789 . . . . 73.35 110.071 -172.674 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . 87.21 -173.27 44.32 Favored Glycine 0 C--N 1.342 0.887 0 CA-C-O 120.116 -0.269 . . . . 64.24 113.664 179.257 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . -83.2 -125.53 1.03 Allowed Glycine 0 C--N 1.345 1.048 0 CA-C-O 119.98 -0.344 . . . . 75.44 112.826 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 167' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -79.64 146.64 32.39 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 117.037 0.419 . . . . 64.31 110.851 -177.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . 78.11 -166.48 52.8 Favored Glycine 0 C--N 1.348 1.216 0 O-C-N 123.876 0.735 . . . . 13.44 112.934 -175.005 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 169' ' ' ASN . . . . . 0.402 ' HB3' ' HD3' ' C' ' 170' ' ' PRO . 23.0 t30 -104.6 -64.35 0.04 OUTLIER Pre-proline 0 CA--C 1.558 1.275 0 CA-C-O 117.214 -1.374 . . . . 62.44 114.421 -164.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 170' ' ' PRO . . . . . 0.402 ' HD3' ' HB3' ' C' ' 169' ' ' ASN . 95.6 Cg_exo -42.67 117.4 0.86 Allowed 'Trans proline' 0 C--N 1.408 3.679 0 C-N-CA 123.3 2.667 . . . . 51.41 114.216 -162.596 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 171' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -36.27 115.72 0.13 Allowed 'Trans proline' 0 C--N 1.397 3.099 1 C-N-CA 125.614 4.21 . . . . 74.02 115.876 -163.372 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -118.87 -150.51 8.8 Favored Glycine 0 C--N 1.345 1.03 0 CA-C-N 115.863 -0.608 . . . . 74.42 112.358 178.171 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 173' ' ' ASP . . . . . 0.403 ' O ' ' HA ' ' C' ' 118' ' ' ASP . 11.6 m-20 -136.43 147.12 47.09 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-O 121.794 0.807 . . . . 74.51 111.189 -178.365 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 174' ' ' LEU . . . . . 0.609 ' HB3' ' HB ' ' C' ' 161' ' ' VAL . 19.0 tp -103.06 136.72 42.34 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 114.194 -1.366 . . . . 75.22 107.71 168.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 66.5 mt -123.44 85.87 2.49 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.321 1.049 . . . . 71.32 108.97 -178.42 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 176' ' ' LEU . . . . . 0.69 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 82.0 mt -71.43 108.15 4.71 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.156 -0.475 . . . . 43.02 110.352 179.384 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 177' ' ' VAL . . . . . . . . . . . . . 25.1 t -84.96 93.46 3.57 Favored 'Isoleucine or valine' 0 C--N 1.347 0.472 0 N-CA-C 108.253 -1.017 . . . . 74.43 108.253 178.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 178' ' ' VAL . . . . . 0.657 HG11 HG22 ' C' ' 153' ' ' VAL . 2.4 p -84.11 117.15 29.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.292 -0.867 . . . . 74.01 110.525 -175.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 179' ' ' ARG . . . . . 0.404 ' O ' ' HA ' ' C' ' 124' ' ' PRO . 6.1 mmm180 -108.2 116.0 31.16 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 107.8 -1.185 . . . . 72.33 107.8 172.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 180' ' ' LEU . . . . . 0.486 HD13 HD21 ' C' ' 127' ' ' LEU . 92.9 mt -74.59 148.33 40.89 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 120.854 0.359 . . . . 70.51 110.499 178.487 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 181' ' ' LEU . . . . . . . . . . . . . 80.9 mt -70.14 166.09 37.12 Favored Pre-proline 0 CA--C 1.552 1.049 0 CA-C-O 118.236 -0.888 . . . . 74.2 109.348 177.043 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -54.2 76.15 0.03 OUTLIER 'Trans proline' 0 C--N 1.393 2.869 0 C-N-CA 123.224 2.616 . . . . 64.12 112.58 170.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 183' ' ' HIS . . . . . 0.432 ' N ' ' HD3' ' C' ' 184' ' ' PRO . 74.5 t60 174.88 54.48 0.03 OUTLIER Pre-proline 0 CA--C 1.561 1.384 0 C-N-CA 126.895 2.078 . . . . 62.13 106.384 -167.78 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 184' ' ' PRO . . . . . 0.432 ' HD3' ' N ' ' C' ' 183' ' ' HIS . 66.3 Cg_endo -93.83 65.1 0.41 Allowed 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.409 2.739 . . . . 71.54 110.628 -174.791 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 185' ' ' VAL . . . . . 0.527 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 16.4 t -93.28 -58.04 3.93 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.559 0 N-CA-C 108.946 -0.761 . . . . 72.23 108.946 -167.249 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 186' ' ' PHE . . . . . 0.405 ' H ' HD13 ' C' ' 127' ' ' LEU . 48.2 m-85 -101.23 104.31 15.35 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 121.201 0.524 . . . . 61.44 111.052 -169.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 187' ' ' ARG . . . . . 0.428 ' NH1' ' HB2' ' C' ' 189' ' ' GLU . 4.0 tmt_? -95.63 122.37 38.32 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 107.79 -1.189 . . . . 75.14 107.79 174.737 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 188' ' ' LEU . . . . . 0.577 HD13 ' HD2' ' C' ' 240' ' ' PHE . 59.2 tp -80.34 147.94 30.87 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.689 0.396 . . . . 74.14 111.861 -177.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 189' ' ' GLU . . . . . 0.428 ' HB2' ' NH1' ' C' ' 187' ' ' ARG . 8.8 tp10 -144.93 110.54 5.33 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 107.756 -1.202 . . . . 71.33 107.756 161.309 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 67.88 -93.12 0.26 Allowed Glycine 0 C--N 1.35 1.345 0 N-CA-C 111.58 -0.608 . . . . 74.2 111.58 -172.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 191' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -128.37 -16.39 4.42 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.383 1.073 . . . . 60.21 110.553 173.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -91.63 134.86 34.33 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.09 0.956 . . . . 65.13 110.249 -173.152 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 193' ' ' LEU . . . . . 0.63 ' HG ' ' HA2' ' C' ' 239' ' ' GLY . 17.4 mt -98.27 173.13 7.15 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 122.878 0.471 . . . . 52.2 112.043 -171.062 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 194' ' ' TYR . . . . . 0.512 ' HA ' ' O ' ' C' ' 250' ' ' TYR . 35.4 t80 -139.05 107.04 5.69 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 114.824 -1.08 . . . . 75.43 108.843 171.73 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 195' ' ' ALA . . . . . 0.527 ' HA ' ' O ' ' C' ' 185' ' ' VAL . . . -106.72 -176.16 3.0 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.322 1.049 . . . . 65.11 109.871 175.634 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 41.0 m -132.31 110.66 10.75 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 108.909 -0.774 . . . . 51.32 108.909 167.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 197' ' ' LEU . . . . . 0.473 ' HB2' HD22 ' C' ' 251' ' ' LEU . 35.6 tp -97.7 109.38 22.14 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.835 0.854 . . . . 73.5 109.169 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -88.94 104.5 17.01 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-O 121.917 0.865 . . . . 44.52 110.071 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 199' ' ' VAL . . . . . 0.405 ' HA ' HG11 ' C' ' 210' ' ' VAL . 42.3 t -92.35 123.22 62.92 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 124.958 1.303 . . . . 61.21 109.148 179.215 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 200' ' ' PRO . . . . . 0.431 ' HA ' ' O ' ' C' ' 256' ' ' THR . 55.6 Cg_endo -69.48 149.44 68.66 Favored 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 121.95 1.767 . . . . 71.34 110.826 176.635 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 201' ' ' ALA . . . . . 0.41 ' HB3' ' HH2' ' C' ' 269' ' ' TRP . . . -54.89 -46.84 99.47 Favored Pre-proline 0 CA--C 1.553 1.061 0 CA-C-O 117.579 -1.2 . . . . 74.35 113.909 -169.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 202' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -54.08 -47.16 28.57 Favored 'Trans proline' 0 C--N 1.395 3.006 0 C-N-CA 121.926 1.751 . . . . 63.15 112.625 176.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 203' ' ' ILE . . . . . . . . . . . . . 48.6 mt -69.77 -37.75 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.152 0.981 . . . . 63.4 111.156 -177.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -61.71 -43.95 97.87 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.507 0.723 . . . . 75.02 110.87 178.334 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 205' ' ' VAL . . . . . . . . . . . . . 78.7 t -74.16 -40.99 51.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 115.024 -0.989 . . . . 63.41 112.378 -176.569 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 206' ' ' VAL . . . . . 0.625 ' HA ' ' HE2' ' A' ' 270' ' ' LYS . 11.1 p -78.15 -33.99 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 CA-C-N 118.047 0.385 . . . . 52.12 110.839 -177.189 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 85.13 52.64 3.37 Favored Glycine 0 C--N 1.338 0.652 0 CA-C-N 115.779 -0.646 . . . . 63.21 111.518 -170.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -90.13 -123.49 2.56 Favored Glycine 0 C--N 1.345 1.055 0 CA-C-N 115.104 -0.548 . . . . 51.32 111.778 -177.202 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 209' ' ' LYS . . . . . 0.516 ' HG2' ' HA ' ' C' ' 222' ' ' ALA . 6.5 mtmp? -147.2 144.13 28.7 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.53 0.681 . . . . 72.12 111.103 175.616 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 210' ' ' VAL . . . . . 0.405 HG11 ' HA ' ' C' ' 199' ' ' VAL . 16.2 m -122.67 178.66 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 113.6 -1.637 . . . . 62.05 107.468 167.073 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 211' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -132.3 130.29 40.64 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.922 0.392 . . . . 72.44 110.542 -178.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 212' ' ' ALA . . . . . 0.566 ' HB3' HG13 ' C' ' 219' ' ' VAL . . . -104.85 113.98 27.91 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 107.171 -1.418 . . . . 74.43 107.171 173.79 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 213' ' ' MET . . . . . . . . . . . . . 5.4 tmm? -67.38 135.51 53.31 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 107.84 -1.17 . . . . 63.12 107.84 171.224 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 214' ' ' THR . . . . . 0.536 HG21 ' HD2' ' C' ' 238' ' ' LYS . 0.1 OUTLIER -134.46 171.42 14.33 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-O 122.088 0.947 . . . . 54.24 111.962 -174.896 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 215' ' ' LEU . . . . . 0.439 HD13 ' HB2' ' C' ' 131' ' ' PHE . 27.4 mt -73.24 -31.16 63.96 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 114.151 -1.386 . . . . 44.41 113.08 -163.144 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.92 8.04 21.97 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.956 -1.02 . . . . 71.0 111.362 -178.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 149.37 -163.11 29.18 Favored Glycine 0 C--N 1.351 1.381 0 CA-C-O 119.479 -0.623 . . . . 64.11 111.938 -177.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -96.44 163.89 1.19 Allowed 'Trans proline' 0 C--N 1.362 1.269 0 C-N-CA 122.984 2.456 . . . . 52.13 113.415 173.621 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 219' ' ' VAL . . . . . 0.744 ' HB ' ' HE3' ' C' ' 238' ' ' LYS . 1.7 p -142.44 114.64 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.099 0 N-CA-C 108.154 -1.054 . . . . 52.53 108.154 166.617 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 220' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -90.84 107.74 19.38 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.081 -1.081 . . . . 72.32 108.081 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 221' ' ' VAL . . . . . 0.518 ' HA ' ' HB2' ' B' ' 239' ' ' ALA . 56.0 t -76.07 129.77 36.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 125.124 1.37 . . . . 74.03 111.798 -172.459 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 222' ' ' ALA . . . . . 0.516 ' HA ' ' HG2' ' C' ' 209' ' ' LYS . . . -90.99 123.77 34.72 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.59 0.756 . . . . 73.3 109.848 173.684 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 58.4 t -99.17 142.0 23.84 Favored Pre-proline 0 CA--C 1.561 1.389 0 C-N-CA 125.149 1.38 . . . . 73.11 110.168 -172.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 224' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -85.6 158.9 10.73 Favored 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 123.958 3.105 . . . . 54.33 112.923 168.388 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -55.95 128.52 30.59 Favored 'Trans proline' 0 C--N 1.385 2.497 0 C-N-CA 123.462 2.775 . . . . 74.0 113.448 178.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 226' ' ' ARG . . . . . 0.554 HH11 HD12 ' A' ' 261' ' ' LEU . 0.0 OUTLIER 52.45 81.14 0.09 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.756 1.622 . . . . 70.15 112.141 -178.82 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 227' ' ' THR . . . . . 0.561 HG22 HG11 ' C' ' 253' ' ' VAL . 54.7 m -93.64 142.27 27.54 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 114.869 -1.06 . . . . 70.3 110.204 176.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 228' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -101.94 146.56 27.69 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.733 0.813 . . . . 74.32 112.271 -173.383 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -69.56 118.14 12.05 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 114.647 -1.16 . . . . 62.12 108.519 169.555 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 113.12 -2.3 25.47 Favored Glycine 0 C--N 1.339 0.717 0 CA-C-O 119.6 -0.556 . . . . 62.04 112.205 -175.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 231' ' ' ARG . . . . . . . . . . . . . 60.0 mtp85 -73.79 -179.49 3.68 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 117.126 0.463 . . . . 74.12 111.273 171.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 232' ' ' LYS . . . . . 0.575 ' HD3' ' HB3' ' C' ' 250' ' ' TYR . 34.4 ttmt -148.61 146.43 28.22 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.891 -0.595 . . . . 71.45 111.225 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 233' ' ' LEU . . . . . 0.649 HD13 ' HB2' ' C' ' 251' ' ' LEU . 0.9 OUTLIER -117.26 155.61 29.17 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.998 1.319 . . . . 74.21 108.495 177.349 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 234' ' ' ARG . . . . . 0.469 ' O ' ' HA3' ' B' ' 240' ' ' GLY . 16.8 ptt180 -127.07 109.6 12.05 Favored 'General case' 0 N--CA 1.475 0.775 0 O-C-N 123.702 0.626 . . . . 72.34 109.583 166.033 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 235' ' ' LEU . . . . . 0.481 HD12 HD23 ' C' ' 249' ' ' LEU . 26.8 mt -95.82 128.08 42.39 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.614 0.765 . . . . 73.43 109.185 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -79.87 125.76 30.13 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.25 0.62 . . . . 71.55 112.284 -168.247 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 77.77 13.71 83.16 Favored Glycine 0 C--N 1.353 1.481 0 O-C-N 124.124 0.89 . . . . 71.42 113.458 178.573 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 238' ' ' LYS . . . . . 0.744 ' HE3' ' HB ' ' C' ' 219' ' ' VAL . 69.6 mmtt -105.05 19.85 19.88 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.592 0.757 . . . . 72.03 111.446 -178.465 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 239' ' ' GLY . . . . . 0.63 ' HA2' ' HG ' ' C' ' 193' ' ' LEU . . . -92.53 -171.08 40.86 Favored Glycine 0 C--N 1.345 1.071 0 CA-C-N 116.217 -0.447 . . . . 31.21 112.749 171.662 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 240' ' ' PHE . . . . . 0.577 ' HD2' HD13 ' C' ' 188' ' ' LEU . 11.9 m-85 -79.04 154.68 77.61 Favored Pre-proline 0 CA--C 1.563 1.447 0 C-N-CA 122.965 0.506 . . . . 75.14 110.221 177.835 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 241' ' ' PRO . . . . . 0.584 ' HA ' ' HG2' ' C' ' 246' ' ' ARG . 18.6 Cg_exo -67.55 136.73 40.4 Favored 'Trans proline' 0 C--N 1.396 3.05 0 C-N-CA 124.183 3.255 . . . . 70.21 114.355 -172.137 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -134.2 171.96 21.97 Favored Glycine 0 C--N 1.35 1.344 0 CA-C-N 115.514 -0.767 . . . . 70.14 113.041 178.425 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.01 -25.06 38.53 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 123.764 2.976 . . . . 71.42 113.321 -177.019 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -112.7 14.52 20.02 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.894 0.878 . . . . 71.42 111.008 178.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 119.45 177.09 16.3 Favored Glycine 0 C--N 1.349 1.299 0 N-CA-C 112.078 -0.409 . . . . 51.32 112.078 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 246' ' ' ARG . . . . . 0.584 ' HG2' ' HA ' ' C' ' 241' ' ' PRO . 72.4 mtm-85 -85.09 158.77 20.33 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.856 0.862 . . . . 61.31 111.005 -177.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.82 -155.03 6.18 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 114.045 0.378 . . . . 63.23 114.045 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -124.96 139.11 54.12 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.363 0.665 . . . . 73.54 109.578 -179.244 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 249' ' ' LEU . . . . . 0.481 HD23 HD12 ' C' ' 235' ' ' LEU . 28.8 tp -85.2 115.27 22.88 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.927 0.891 . . . . 74.23 110.836 -177.523 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 250' ' ' TYR . . . . . 0.587 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 16.0 m-30 -99.91 101.7 12.89 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 110.022 -0.362 . . . . 71.43 110.022 179.163 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 251' ' ' LEU . . . . . 0.649 ' HB2' HD13 ' C' ' 233' ' ' LEU . 0.8 OUTLIER -100.62 138.41 37.72 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.632 -0.668 . . . . 64.53 109.802 -175.716 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -87.57 125.44 34.35 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.895 -0.78 . . . . 73.41 108.895 171.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 253' ' ' VAL . . . . . 0.561 HG11 HG22 ' C' ' 227' ' ' THR . 59.3 t -74.5 136.84 24.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 123.213 0.605 . . . . 73.5 110.899 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 254' ' ' ARG . . . . . . . . . . . . . 40.8 mtm180 -116.12 147.11 41.67 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 107.63 -1.248 . . . . 74.13 107.63 163.034 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 255' ' ' ILE . . . . . 0.538 HG21 HG23 ' A' ' 257' ' ' ILE . 33.4 mm -97.89 119.07 45.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 106.757 -1.571 . . . . 75.24 106.757 164.555 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 256' ' ' THR . . . . . 0.431 ' O ' ' HA ' ' C' ' 200' ' ' PRO . 0.0 OUTLIER -123.4 173.59 7.89 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.031 1.333 . . . . 53.32 108.461 -178.947 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 2.3 pp -144.12 153.27 56.36 Favored Pre-proline 0 N--CA 1.477 0.888 0 C-N-CA 123.181 0.592 . . . . 64.54 110.569 -174.557 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.51 6.1 1.35 Allowed 'Trans proline' 0 C--N 1.385 2.495 0 C-N-CA 122.812 2.341 . . . . 73.21 114.278 -175.366 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 52.43 -84.29 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.858 1.663 . . . . 72.3 112.825 -174.033 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.14 140.1 58.83 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.908 0.883 . . . . 73.41 110.718 -177.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 261' ' ' LEU . . . . . 0.508 HD22 ' HB3' ' C' ' 265' ' ' GLU . 65.1 mt -124.7 152.97 43.04 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.363 0.665 . . . . 71.21 111.101 -176.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 67.6 p -85.05 168.35 21.15 Favored Pre-proline 0 CA--C 1.556 1.202 0 N-CA-C 107.572 -1.27 . . . . 61.23 107.572 164.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -51.16 -37.44 58.61 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 122.799 2.333 . . . . 74.2 112.863 171.246 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -58.71 -64.08 1.06 Allowed 'General case' 0 C--O 1.251 1.138 0 C-N-CA 124.762 1.225 . . . . 71.04 110.845 175.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 265' ' ' GLU . . . . . 0.508 ' HB3' HD22 ' C' ' 261' ' ' LEU . 32.1 mm-40 -53.21 -44.06 67.72 Favored 'General case' 0 C--N 1.352 0.704 0 O-C-N 124.375 1.047 . . . . 65.11 110.493 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 266' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -58.72 -43.02 90.01 Favored 'General case' 0 C--O 1.214 -0.791 0 C-N-CA 123.462 0.705 . . . . 64.21 110.374 -178.148 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -62.22 -51.84 66.17 Favored 'General case' 0 CA--C 1.555 1.157 0 O-C-N 123.726 0.641 . . . . 70.32 111.764 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 268' ' ' LEU . . . . . . . . . . . . . 8.7 mp -66.75 -48.69 68.33 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 116.498 -0.319 . . . . 52.44 111.238 -176.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 269' ' ' TRP . . . . . 0.41 ' HH2' ' HB3' ' C' ' 201' ' ' ALA . 94.6 m95 -61.22 -32.53 72.31 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.511 0.724 . . . . 61.11 111.281 176.392 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 270' ' ' LYS . . . . . 0.421 ' HD2' HG11 ' A' ' 206' ' ' VAL . 1.2 mmmm -61.35 -52.34 65.07 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 123.433 0.693 . . . . 75.43 110.872 176.428 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -63.48 -37.57 87.82 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 123.686 0.616 . . . . 75.33 111.233 -178.215 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 95.5 mt -67.14 -35.1 79.0 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 122.744 0.418 . . . . 74.33 111.586 173.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -64.3 -45.53 87.55 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.35 0.66 . . . . 34.13 110.479 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -69.27 -38.72 78.53 Favored 'General case' 0 C--O 1.245 0.845 0 O-C-N 124.38 1.05 . . . . 63.21 110.931 -179.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -60.91 -30.7 70.34 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.768 -0.651 . . . . 70.04 110.554 172.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 276' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -94.05 -13.73 26.58 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 122.984 0.514 . . . . 75.52 112.304 177.374 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 277' ' ' TYR . . . . . 0.434 ' CE1' ' HA3' ' A' ' 208' ' ' GLY . 22.6 m-30 -70.3 -30.65 67.7 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.001 -1.111 . . . . 44.24 108.001 169.695 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -63.79 2.61 0.46 Allowed 'General case' 0 CA--C 1.557 1.249 0 CA-C-N 114.177 -1.374 . . . . 55.2 113.07 169.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 279' ' ' ARG . . . . . . . . . . . . . 51.9 ttt180 -73.91 -33.54 64.01 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.043 0.537 . . . . 71.52 110.882 171.043 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 1.168 0 O-C-N 123.333 0.396 . . . . 75.14 110.725 -169.499 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.405 ' H3 ' ' CD ' ' A' ' 95' ' ' GLU . 52.6 mtm . . . . . 0 CA--C 1.545 0.778 0 N-CA-C 109.648 -0.501 . . . . 64.12 109.648 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 66.0 43.29 3.02 Favored 'General case' 0 C--N 1.364 1.197 0 C-N-CA 124.907 1.283 . . . . 51.4 112.55 177.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -66.78 78.55 0.12 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.628 0.771 . . . . 74.04 111.368 175.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -35.99 92.89 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 125.703 1.601 . . . . 62.43 113.409 -178.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.8 mmtp -68.07 107.27 2.66 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-N 115.239 -0.891 . . . . 74.32 108.725 168.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -72.83 88.77 1.34 Allowed 'General case' 0 C--O 1.241 0.637 0 N-CA-C 107.415 -1.328 . . . . 61.41 107.415 174.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -60.26 -30.64 69.57 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 114.827 -1.079 . . . . 73.34 111.678 -175.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -64.9 -53.53 45.13 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.958 -0.565 . . . . 73.33 110.357 176.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.16 -34.63 76.78 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 122.72 0.408 . . . . 60.32 111.3 -178.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 76.5 mt -59.96 -43.35 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 N-CA-C 109.865 -0.42 . . . . 74.23 109.865 172.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.445 HD23 HG23 ' A' ' 50' ' ' ILE . 97.0 mt -75.71 -12.24 60.15 Favored 'General case' 0 CA--C 1.555 1.172 0 CA-C-N 116.042 -0.527 . . . . 51.33 112.3 175.118 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.52 36.56 33.41 Favored Glycine 0 C--N 1.349 1.302 0 CA-C-N 117.75 0.25 . . . . 53.33 113.686 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.8 m -131.34 159.8 70.07 Favored Pre-proline 0 N--CA 1.484 1.25 0 C-N-CA 124.935 1.294 . . . . 71.43 109.14 177.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -75.96 166.35 28.19 Favored 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 122.524 2.149 . . . . 50.12 112.846 177.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 43.3 mtm-85 -74.73 21.02 0.11 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 113.309 0.855 . . . . 75.43 113.309 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -122.15 6.67 9.72 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.184 0.993 . . . . 64.11 108.982 174.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.47 136.26 47.54 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.508 0.723 . . . . 64.31 111.936 -175.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.5 p -85.6 176.44 8.19 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.284 1.034 . . . . 71.11 110.691 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.3 tm0? -57.15 -37.65 72.38 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.384 0.674 . . . . 64.21 109.978 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.44 ' HB3' ' NH1' ' A' ' 24' ' ' ARG . 43.3 mm-40 -56.69 -54.33 47.34 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 123.772 0.67 . . . . 72.43 111.054 174.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -63.25 -38.82 92.66 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.994 0.518 . . . . 64.03 111.016 -177.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.6 mp -59.55 -39.52 79.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 124.52 1.128 . . . . 73.31 110.6 173.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -68.25 -56.07 9.96 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.414 -0.812 . . . . 71.24 111.056 -175.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.44 ' NH1' ' HB3' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -66.85 -28.84 68.67 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 122.976 0.172 . . . . 54.12 111.203 -179.204 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.434 ' HB1' ' O ' ' A' ' 11' ' ' LEU . . . -62.66 -51.09 68.63 Favored 'General case' 0 C--O 1.245 0.866 0 O-C-N 123.609 0.568 . . . . 64.0 110.754 173.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -58.75 -45.77 88.93 Favored 'General case' 0 C--O 1.215 -0.711 0 CA-C-N 114.73 -1.123 . . . . 73.1 110.469 178.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.427 ' O ' ' HG3' ' A' ' 31' ' ' ARG . 57.3 mtpt -63.14 -44.01 96.75 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 123.888 0.743 . . . . 74.22 111.128 -177.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.1 ttp85 -54.86 -48.25 73.17 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.609 0.763 . . . . 71.15 110.6 175.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.679 ' HB3' HD13 ' A' ' 50' ' ' ILE . 81.6 mt -77.39 -20.65 54.39 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 115.619 -0.719 . . . . 74.11 111.671 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.535 ' HA ' ' HE1' ' A' ' 47' ' ' PHE . . . -81.21 -22.32 38.92 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.615 0.766 . . . . 63.3 111.118 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.427 ' HG3' ' O ' ' A' ' 27' ' ' LYS . 58.1 mtm180 -91.75 -41.85 10.46 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 122.981 0.512 . . . . 72.33 110.047 174.255 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -69.45 -55.36 10.5 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.319 0.648 . . . . 63.33 111.191 -176.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -96.85 31.25 2.41 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 122.849 0.46 . . . . 63.25 110.27 179.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.492 ' HD2' HG23 ' A' ' 37' ' ' VAL . 44.2 t60 -60.26 101.6 0.26 Allowed Pre-proline 0 N--CA 1.477 0.904 0 C-N-CA 123.99 0.916 . . . . 63.41 110.234 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -70.11 -13.9 34.35 Favored 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 123.061 2.507 . . . . 74.13 113.216 -164.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.409 ' HB3' ' CD2' ' A' ' 34' ' ' HIS . 28.5 t70 -71.53 -35.12 70.58 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.477 0.711 . . . . 72.45 110.526 175.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.492 HG23 ' HD2' ' A' ' 34' ' ' HIS . 99.0 t -94.52 -48.97 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-O 121.309 0.576 . . . . 65.53 109.46 178.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -100.54 71.91 1.54 Allowed 'General case' 0 C--O 1.249 1.035 0 C-N-CA 124.104 0.961 . . . . 61.35 109.486 -177.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -74.36 81.34 1.88 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.049 -0.978 . . . . 73.11 108.873 176.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 67.4 m -138.83 108.67 7.71 Favored Pre-proline 0 C--O 1.24 0.571 0 CA-C-O 118.168 -0.92 . . . . 54.41 108.724 177.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -30.93 -52.43 0.25 Allowed 'Trans proline' 0 C--N 1.392 2.846 0 C-N-CA 125.284 3.989 . . . . 72.23 115.784 -175.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -51.3 -51.39 54.71 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.492 0.717 . . . . 64.43 111.743 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.24 -22.26 62.91 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 115.381 -0.827 . . . . 72.14 111.752 -177.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -88.91 -37.56 15.19 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.372 0.669 . . . . 62.01 110.514 -173.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.515 ' HA ' ' HE2' ' A' ' 48' ' ' LYS . 35.8 mm-40 -70.22 -41.48 73.56 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 108.807 -0.812 . . . . 62.44 108.807 175.247 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 15.4 tppt? -59.35 -45.54 91.1 Favored 'General case' 0 C--N 1.348 0.541 0 CA-C-N 114.641 -1.163 . . . . 74.03 110.011 173.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.59 ' HA ' HD12 ' A' ' 50' ' ' ILE . 71.3 t80 -58.09 -40.69 81.76 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 123.954 0.784 . . . . 73.24 110.984 176.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.524 ' HB3' ' CE1' ' A' ' 93' ' ' PHE . 43.4 mtmt -66.78 -32.83 74.38 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 119.414 -0.327 . . . . 75.14 111.858 178.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.85 -34.58 76.98 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 120.831 0.348 . . . . 71.44 110.439 172.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.679 HD13 ' HB3' ' A' ' 29' ' ' LEU . 73.3 mt -66.97 -30.27 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.049 0.939 . . . . 70.53 109.721 174.087 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.414 ' O ' ' HB2' ' A' ' 55' ' ' ALA . 11.7 m-80 -83.29 -19.89 35.46 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.815 0.846 . . . . 73.43 112.125 174.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -70.98 -52.11 21.69 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 122.509 1.147 . . . . 63.42 108.389 171.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.66 -54.3 45.95 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 112.801 -1.999 . . . . 65.45 111.088 176.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -63.18 -37.84 88.81 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-N 115.262 -0.881 . . . . 72.32 111.176 177.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.414 ' HB2' ' O ' ' A' ' 51' ' ' ASN . . . -51.2 -53.53 34.17 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 122.98 0.512 . . . . 53.01 111.407 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 68.0 t -68.02 -44.11 85.0 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 CA-C-N 114.377 -1.283 . . . . 74.52 110.449 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.492 HD22 ' HD2' ' A' ' 63' ' ' ARG . 41.9 mt -91.48 5.8 48.02 Favored 'General case' 0 CA--C 1.563 1.457 0 N-CA-C 113.875 1.065 . . . . 62.04 113.875 -170.195 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.8 t -80.68 -47.89 13.37 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 123.218 0.607 . . . . 74.34 110.926 177.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -93.35 134.36 26.98 Favored Pre-proline 0 N--CA 1.474 0.768 0 CA-C-O 117.72 -1.133 . . . . 74.34 109.906 -173.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.521 ' O ' ' HG2' ' A' ' 64' ' ' ARG . 9.1 Cg_endo -49.7 -43.98 37.81 Favored 'Trans proline' 0 C--N 1.385 2.492 0 C-N-CA 124.014 3.142 . . . . 72.41 114.027 -177.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.404 ' O ' HG13 ' A' ' 65' ' ' ILE . 3.8 mp0 -67.88 -54.14 21.15 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 122.939 0.496 . . . . 72.3 111.635 -177.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.529 ' HA ' HD12 ' A' ' 65' ' ' ILE . 47.4 mtpt -61.52 -35.17 76.96 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.536 0.734 . . . . 74.54 110.787 -178.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.492 ' HD2' HD22 ' A' ' 57' ' ' LEU . 46.4 tpt85 -54.52 -58.27 8.13 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 114.311 -1.313 . . . . 74.11 108.891 171.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.521 ' HG2' ' O ' ' A' ' 60' ' ' PRO . 1.2 mmp_? -61.58 -28.7 69.53 Favored 'General case' 0 C--O 1.214 -0.801 0 CA-C-N 115.354 -0.839 . . . . 74.25 111.783 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.583 HG23 ' HD2' ' A' ' 76' ' ' PRO . 89.6 mt -61.69 -47.7 92.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 122.931 0.492 . . . . 64.42 109.677 176.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -60.79 -53.77 53.33 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 115.961 -0.563 . . . . 75.4 110.28 175.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -54.13 -44.73 71.61 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.533 0.733 . . . . 64.04 111.801 -176.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 53.7 p -73.77 -27.33 61.1 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.73 0.412 . . . . 75.13 111.332 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -73.37 119.49 17.67 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 109.105 -0.702 . . . . 63.45 109.105 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 101.19 16.22 25.88 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-N 115.964 -0.562 . . . . 52.54 111.964 -168.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 62.9 m -143.29 -59.27 0.42 Allowed 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 104.021 -2.585 . . . . 71.23 104.021 174.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.4 m -83.56 148.85 26.95 Favored 'General case' 0 C--O 1.249 1.061 0 N-CA-C 105.225 -2.139 . . . . 74.23 105.225 157.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.56 -30.15 9.21 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.273 1.029 . . . . 74.04 110.734 -176.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.17 139.9 61.03 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 123.321 0.648 . . . . 75.1 110.005 175.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -62.34 119.02 5.94 Favored 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 122.33 2.02 . . . . 75.41 111.111 175.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.583 ' HD2' HG23 ' A' ' 65' ' ' ILE . 78.6 Cg_exo -51.55 122.14 9.75 Favored 'Trans proline' 0 C--N 1.384 2.42 0 C-N-CA 123.357 2.705 . . . . 74.25 113.183 178.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -44.11 134.51 8.52 Favored 'Trans proline' 0 C--N 1.389 2.703 0 C-N-CA 124.504 3.469 . . . . 62.44 115.176 -168.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -63.15 135.03 48.64 Favored 'Trans proline' 0 C--N 1.386 2.545 0 C-N-CA 122.965 2.444 . . . . 43.51 112.456 -177.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.15 157.66 16.85 Favored 'Trans proline' 0 C--N 1.381 2.268 0 C-N-CA 122.953 2.436 . . . . 71.05 112.1 175.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -60.39 84.45 0.07 OUTLIER 'Trans proline' 0 C--N 1.38 2.222 0 C-N-CA 122.718 2.279 . . . . 51.35 112.185 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 155.01 -42.32 0.59 Allowed Glycine 0 CA--C 1.527 0.785 0 N-CA-C 109.873 -1.291 . . . . 62.41 109.873 -176.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 128.44 -160.5 22.13 Favored Glycine 0 C--N 1.351 1.414 0 CA-C-N 115.103 -0.548 . . . . 53.03 111.79 176.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -97.65 107.55 20.07 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 123.402 0.681 . . . . 74.41 109.166 176.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -54.91 155.09 4.65 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 115.632 -0.713 . . . . 71.31 111.849 170.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -155.98 60.16 0.59 Allowed 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 108.448 -0.945 . . . . 70.22 108.448 174.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 20.4 m -31.93 86.05 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 126.692 1.997 . . . . 74.44 116.39 -169.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 57.13 24.87 52.68 Favored Glycine 0 CA--C 1.536 1.347 0 N-CA-C 114.953 0.741 . . . . 70.11 114.953 176.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -96.58 154.38 17.31 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.412 0.685 . . . . 72.34 110.063 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -82.03 72.05 9.07 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 123.864 0.866 . . . . 71.44 111.476 -168.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.449 HG23 ' HE2' ' A' ' 97' ' ' PHE . 2.1 p -46.31 -50.37 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 C-N-CA 125.171 1.388 . . . . 75.21 113.537 -175.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.41 ' HG2' HG13 ' A' ' 90' ' ' VAL . 11.7 mm-40 -71.64 -4.04 24.99 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 113.55 0.944 . . . . 75.33 113.55 -171.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -107.42 -17.97 13.98 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.157 0.583 . . . . 45.35 111.27 178.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.524 ' CE1' ' HB3' ' A' ' 48' ' ' LYS . 7.6 m-30 -85.64 176.13 8.36 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 122.497 0.319 . . . . 71.01 111.134 -171.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 89.5 p -59.46 151.09 24.86 Favored 'General case' 0 C--O 1.247 0.926 0 N-CA-C 114.163 1.172 . . . . 74.5 114.163 -166.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.405 ' CD ' ' H3 ' ' A' ' 1' ' ' MET . 3.4 pt-20 -53.34 -44.65 68.65 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 114.54 -1.209 . . . . 74.31 110.007 167.136 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.403 ' H ' ' HG3' ' A' ' 95' ' ' GLU . 73.8 t80 -49.79 -51.04 42.44 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.614 1.166 . . . . 75.03 111.331 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.449 ' HE2' HG23 ' A' ' 90' ' ' VAL . 3.5 t80 -58.78 -54.89 42.02 Favored 'General case' 0 CA--C 1.55 0.97 0 O-C-N 123.981 0.801 . . . . 63.23 110.28 174.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -70.8 -6.66 39.45 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 113.371 0.878 . . . . 73.05 113.371 -172.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -101.83 -38.8 7.68 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.275 0.63 . . . . 70.02 111.834 174.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 30.3 tp -69.01 -49.32 58.78 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 121.305 0.574 . . . . 55.03 109.798 177.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -92.04 -8.72 45.16 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 115.231 -0.895 . . . . 72.11 111.42 178.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -45.5 -59.07 4.94 Favored Glycine 0 N--CA 1.482 1.765 0 N-CA-C 115.579 0.991 . . . . 72.43 115.579 178.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -45.37 -23.1 1.12 Allowed 'Trans proline' 0 C--N 1.388 2.635 0 C-N-CA 124.45 3.433 . . . . 23.1 115.441 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.529 ' HA2' ' NH2' ' A' ' 111' ' ' ARG . . . -144.28 39.69 1.22 Allowed Glycine 0 C--N 1.354 1.53 0 CA-C-O 118.989 -0.895 . . . . 44.4 113.399 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 13.1 mt -66.02 38.03 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 114.79 1.404 . . . . 74.25 114.79 178.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.647 ' HB3' ' HA ' ' A' ' 169' ' ' ASN . 0.3 OUTLIER 55.78 -102.81 0.16 Allowed 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 123.888 0.875 . . . . 72.25 110.639 162.433 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 70.2 13.3 70.07 Favored Glycine 0 C--N 1.362 2.003 0 C-N-CA 122.776 0.227 . . . . 44.0 112.811 176.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.569 ' H ' ' HD1' ' A' ' 106' ' ' PHE . . . 61.22 -110.19 2.93 Favored Glycine 0 C--N 1.346 1.104 0 C-N-CA 123.522 0.582 . . . . 71.34 112.568 -173.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -107.64 -5.72 17.31 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.651 0.781 . . . . 64.11 110.351 176.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -81.26 -39.2 13.05 Favored Glycine 0 C--N 1.346 1.121 0 CA-C-N 115.901 -0.59 . . . . 55.25 111.912 174.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.529 ' NH2' ' HA2' ' A' ' 104' ' ' GLY . 11.9 tpt180 75.8 -31.46 0.2 Allowed 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 126.18 1.792 . . . . 71.44 113.415 176.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 17.2 ttt180 -84.71 51.56 2.17 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.08 0.952 . . . . 73.25 110.834 -177.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 70.8 m 58.39 33.0 22.75 Favored 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 114.383 1.253 . . . . 74.21 114.383 169.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -71.44 155.76 40.24 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.305 0.242 . . . . 74.52 110.617 176.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.476 ' HA ' ' HD2' ' A' ' 170' ' ' PRO . 27.1 tptp -80.57 146.7 31.13 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.665 1.186 . . . . 72.15 111.331 -175.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -87.46 144.39 19.06 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-N 115.603 -0.726 . . . . 55.22 112.364 172.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -86.92 160.59 18.64 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.156 0.583 . . . . 71.34 111.821 -177.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -60.26 139.22 57.72 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.147 0.579 . . . . 74.23 111.305 176.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.445 HD23 ' N ' ' A' ' 120' ' ' ARG . 4.8 tt -145.89 160.78 41.33 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 107.994 -1.113 . . . . 70.23 107.994 -179.051 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.445 ' N ' HD23 ' A' ' 119' ' ' LEU . 0.3 OUTLIER -124.77 123.89 40.96 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 109.501 -0.555 . . . . 74.51 109.501 176.794 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.406 ' HB3' HD21 ' A' ' 174' ' ' LEU . . . -129.89 164.95 23.05 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.479 0.712 . . . . 41.51 110.477 -177.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.439 ' O ' HD12 ' B' ' 8' ' ' LEU . 4.2 mm-40 -106.73 120.34 41.73 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 106.976 -1.49 . . . . 61.0 106.976 -172.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.413 HD22 HD13 ' A' ' 176' ' ' LEU . 47.4 tp -97.92 99.84 7.55 Favored Pre-proline 0 CA--C 1.54 0.594 0 N-CA-C 108.191 -1.04 . . . . 54.05 108.191 -176.453 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.599 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 93.3 Cg_endo -77.74 110.99 3.04 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 121.374 1.383 . . . . 75.33 109.407 177.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.63 ' HA ' HG21 ' B' ' 6' ' ' ILE . 44.2 tp -119.57 136.22 54.46 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.87 0.468 . . . . 64.01 110.862 -168.125 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 67.9 m -67.92 129.41 39.84 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.927 0.891 . . . . 71.34 110.221 -179.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.475 HD23 ' HB3' ' A' ' 180' ' ' LEU . 51.5 mt -55.11 -43.37 74.0 Favored 'General case' 0 N--CA 1.481 1.123 0 O-C-N 124.376 1.048 . . . . 70.54 111.163 -174.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -57.34 -46.44 83.28 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 114.76 -1.109 . . . . 75.32 110.442 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -72.39 -29.0 63.35 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 115.339 -0.846 . . . . 64.33 110.719 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -67.12 -33.25 75.04 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.199 0.6 . . . . 41.43 110.564 175.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -66.62 -56.22 11.7 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 123.754 0.659 . . . . 74.51 109.744 172.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -61.27 -50.25 73.77 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 114.895 -1.048 . . . . 75.25 112.162 -169.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.04 131.9 0.28 Allowed Glycine 0 C--N 1.344 0.988 0 O-C-N 123.595 0.559 . . . . 71.54 112.937 -178.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 153.93 -161.34 29.9 Favored Glycine 0 C--N 1.338 0.643 0 N-CA-C 111.693 -0.563 . . . . 70.42 111.693 -177.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -71.23 134.7 47.06 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 109.813 -0.44 . . . . 73.14 109.813 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.556 ' NE ' ' HA ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -120.45 124.68 46.05 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 120.759 0.314 . . . . 74.4 110.634 179.701 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.44 ' HB ' HG23 ' B' ' 5' ' ' THR . 92.6 t -77.9 103.63 5.15 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-N 115.118 -0.947 . . . . 71.24 109.452 175.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 57.4 t -115.98 112.51 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.679 1.191 . . . . 73.14 107.792 177.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -111.97 129.54 56.15 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 120.98 0.419 . . . . 71.3 110.675 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.415 HG11 HD23 ' B' ' 8' ' ' LEU . 7.9 p -169.65 149.94 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.99 0 C-N-CA 124.906 1.282 . . . . 75.1 108.388 -177.514 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 60.68 19.56 9.58 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 113.237 0.828 . . . . 74.24 113.237 174.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 98.68 -31.03 8.59 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 116.402 -0.363 . . . . 31.1 112.607 -178.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.566 ' NH1' ' SD ' ' A' ' 164' ' ' MET . 66.3 ttt180 -86.7 137.62 32.3 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 122.804 0.441 . . . . 72.12 110.811 -178.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 43.1 ttm105 -112.34 97.15 6.43 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 108.189 -1.041 . . . . 74.41 108.189 169.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.6 p -87.21 145.73 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 CA-C-N 115.457 -0.792 . . . . 73.53 111.405 -177.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 39.8 t -103.59 89.05 3.23 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 108.475 -0.935 . . . . 31.45 108.475 170.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 4.9 p -94.45 118.44 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 109.702 -0.481 . . . . 73.42 109.702 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 58.1 ttt85 -72.95 104.16 3.99 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.022 0.439 . . . . 74.14 110.142 177.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 23.6 pt -74.18 143.14 79.81 Favored Pre-proline 0 CA--C 1.554 1.123 0 CA-C-N 115.184 -0.916 . . . . 74.13 110.164 175.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -63.32 138.46 66.27 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.782 2.321 . . . . 60.34 112.315 175.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -62.78 106.38 0.51 Allowed 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.801 2.334 . . . . 74.15 111.837 174.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 90.71 46.68 3.9 Favored Glycine 0 C--N 1.342 0.904 0 CA-C-N 115.508 -0.769 . . . . 75.51 112.184 -176.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.488 HG22 HG11 ' A' ' 178' ' ' VAL . 4.6 p -81.04 126.85 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.314 0.646 . . . . 75.43 110.784 -174.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.707 ' HD2' ' HA ' ' A' ' 191' ' ' GLN . 12.9 mtm180 -108.71 156.98 18.97 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.422 1.089 . . . . 73.23 110.225 -166.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.547 ' HB3' ' HA ' ' A' ' 189' ' ' GLU . 12.9 tp10 -49.62 130.36 20.57 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.011 0.925 . . . . 72.32 112.376 -177.156 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 89.78 0.18 78.85 Favored Glycine 0 C--N 1.347 1.152 0 CA-C-N 115.483 -0.78 . . . . 14.21 114.008 177.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 58.2 m -67.39 115.31 6.89 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 117.717 0.758 . . . . 74.23 109.784 174.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.505 HG22 HG22 ' A' ' 177' ' ' VAL . 90.3 t -95.98 106.02 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 124.164 0.986 . . . . 72.34 110.209 -174.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.515 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 54.1 mt -87.73 100.67 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 108.243 -1.021 . . . . 75.24 108.243 172.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 65.2 ttt-85 -75.15 100.45 4.27 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 109.247 -0.649 . . . . 61.32 109.247 176.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 4.5 p -125.28 117.36 25.28 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 123.927 0.891 . . . . 61.33 109.348 -178.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.19 147.54 79.09 Favored 'Trans proline' 0 C--N 1.371 1.759 0 C-N-CA 121.451 1.434 . . . . 74.53 110.435 169.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.578 ' HA2' ' HD2' ' A' ' 171' ' ' PRO . . . 124.28 -19.72 7.16 Favored Glycine 0 C--N 1.341 0.838 0 N-CA-C 115.213 0.845 . . . . 70.43 115.213 174.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.566 ' SD ' ' NH1' ' A' ' 143' ' ' ARG . 3.6 mpp? -124.12 8.93 8.61 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 117.687 0.744 . . . . 64.15 111.675 -178.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -87.92 -126.14 2.37 Favored Glycine 0 N--CA 1.477 1.382 0 CA-C-N 117.926 0.33 . . . . 73.33 113.32 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -62.71 153.65 43.93 Favored Glycine 0 C--N 1.357 1.72 0 O-C-N 123.481 0.165 . . . . 74.5 112.698 175.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -70.29 123.02 20.67 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.14 0.576 . . . . 75.42 110.903 -173.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -174.48 167.27 39.53 Favored Glycine 0 C--N 1.345 1.066 0 CA-C-O 119.365 -0.686 . . . . 64.21 111.571 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ASN . . . . . 0.647 ' HA ' ' HB3' ' A' ' 106' ' ' PHE . 2.9 t-20 -69.98 -50.78 15.96 Favored Pre-proline 0 N--CA 1.479 0.982 0 CA-C-N 118.281 1.04 . . . . 63.11 110.279 174.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.559 ' HD3' ' HB3' ' A' ' 169' ' ' ASN . 8.3 Cg_endo -90.45 84.69 0.4 Allowed 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 121.703 1.602 . . . . 71.13 108.237 160.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.578 ' HD2' ' HA2' ' A' ' 163' ' ' GLY . 2.7 Cg_exo -71.26 178.99 4.87 Favored 'Trans proline' 0 C--N 1.369 1.657 0 C-N-CA 122.525 2.15 . . . . 71.25 113.007 -163.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -62.85 146.46 50.22 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 117.494 1.758 . . . . 72.4 117.494 -162.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -69.5 89.04 0.5 Allowed 'General case' 0 C--O 1.241 0.658 0 C-N-CA 124.872 1.269 . . . . 71.14 108.547 175.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.406 HD21 ' HB3' ' A' ' 121' ' ' ALA . 22.6 tp -83.14 149.18 27.03 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 114.994 -1.003 . . . . 64.32 111.332 -173.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 80.3 mt -110.56 95.93 5.87 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.037 0.935 . . . . 72.12 108.618 174.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.515 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 93.0 mt -71.21 92.25 1.0 Allowed 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 109.835 -0.431 . . . . 70.05 109.835 175.036 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.505 HG22 HG22 ' A' ' 158' ' ' VAL . 57.5 t -82.7 100.4 6.38 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 N-CA-C 106.923 -1.51 . . . . 61.43 106.923 173.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.488 HG11 HG22 ' A' ' 153' ' ' VAL . 9.9 p -65.87 113.45 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 CA-C-O 122.036 0.922 . . . . 70.33 110.922 -171.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.599 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 37.6 mmt180 -102.51 106.46 17.18 Favored 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 106.705 -1.591 . . . . 53.32 106.705 171.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.719 HD12 ' HB3' ' A' ' 188' ' ' LEU . 33.0 mt -70.09 143.29 52.46 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 118.921 0.782 . . . . 72.4 109.884 178.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 44.0 mt -54.08 158.07 3.91 Favored Pre-proline 0 N--CA 1.49 1.551 0 C-N-CA 124.314 1.046 . . . . 73.14 112.82 -167.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -75.92 44.01 1.22 Allowed 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 123.298 2.665 . . . . 71.42 111.022 163.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 62.0 t-80 -70.73 131.94 87.43 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 125.371 1.469 . . . . 73.35 107.178 177.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -64.34 12.3 0.1 OUTLIER 'Trans proline' 0 C--N 1.37 1.68 0 C-N-CA 123.557 2.838 . . . . 61.24 117.427 -162.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 4.1 t -112.03 -64.54 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.89 0 CA-C-N 120.455 1.479 . . . . 64.21 110.1 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' PHE . . . . . 0.552 ' CD1' ' HB2' ' A' ' 195' ' ' ALA . 39.2 m-85 -126.41 163.57 23.01 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 121.614 0.721 . . . . 72.31 111.869 -168.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 31.5 ttp-105 -141.35 96.07 2.93 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 107.102 -1.444 . . . . 75.51 107.102 161.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.719 ' HB3' HD12 ' A' ' 180' ' ' LEU . 54.5 tp -66.24 117.25 8.25 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.784 0.834 . . . . 74.21 110.465 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.551 ' HB3' ' HE1' ' A' ' 194' ' ' TYR . 35.8 tt0 -138.36 132.76 32.02 Favored 'General case' 0 C--O 1.247 0.925 0 C-N-CA 124.164 0.986 . . . . 70.31 109.084 -177.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 78.0 -82.78 1.2 Allowed Glycine 0 C--N 1.343 0.924 0 CA-C-N 115.687 -0.688 . . . . 65.41 111.56 -177.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.707 ' HA ' ' HD2' ' A' ' 154' ' ' ARG . 4.7 pm0 -147.68 -4.79 0.49 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.978 0.911 . . . . 72.32 110.647 174.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -130.73 156.18 45.37 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 122.997 0.519 . . . . 72.32 112.087 -165.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.495 HD21 ' HE1' ' A' ' 240' ' ' PHE . 68.9 mt -90.4 144.49 25.76 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.999 0.92 . . . . 63.44 110.334 -174.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.551 ' HE1' ' HB3' ' A' ' 189' ' ' GLU . 63.7 m-85 -117.24 110.45 18.13 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 109.049 -0.723 . . . . 73.14 109.049 171.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.604 ' HB3' HD23 ' A' ' 251' ' ' LEU . . . -121.52 -175.02 2.99 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.827 0.851 . . . . 74.34 110.999 178.201 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 22.8 m -125.08 145.63 49.83 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.715 0.806 . . . . 70.21 109.184 175.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.577 HD22 HD13 ' A' ' 251' ' ' LEU . 21.9 tp -133.77 101.16 4.99 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.931 -0.396 . . . . 72.21 109.931 176.168 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -80.67 113.49 18.9 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.321 -0.992 . . . . 61.43 108.321 166.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 6.4 p -133.26 133.21 22.65 Favored Pre-proline 0 N--CA 1.481 1.089 0 C-N-CA 123.652 0.781 . . . . 64.4 109.097 -171.244 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.37 151.89 60.25 Favored 'Trans proline' 0 C--N 1.375 1.941 0 C-N-CA 121.386 1.391 . . . . 64.51 112.146 177.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -55.52 -45.81 99.81 Favored Pre-proline 0 CA--C 1.553 1.083 0 N-CA-C 114.507 1.299 . . . . 71.34 114.507 -171.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -57.73 -45.4 33.46 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 121.442 1.428 . . . . 63.54 112.734 175.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 41.9 mt -71.11 -27.67 30.44 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 CA-C-N 116.117 -0.492 . . . . 64.32 111.12 -178.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -72.38 -45.0 61.74 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.268 0.627 . . . . 71.51 111.428 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 73.7 t -71.5 -49.86 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 123.356 0.662 . . . . 63.23 111.52 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.504 HG21 ' HA ' ' C' ' 270' ' ' LYS . 47.8 t -83.67 -35.18 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.196 0.598 . . . . 74.41 110.907 -172.095 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 91.87 73.96 1.26 Allowed Glycine 0 C--N 1.348 1.202 0 CA-C-N 116.084 -0.507 . . . . 72.35 113.35 176.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -110.42 170.33 13.99 Favored Glycine 0 N--CA 1.473 1.134 0 C-N-CA 122.853 0.263 . . . . 55.24 112.646 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -81.22 128.23 33.56 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.016 0.527 . . . . 45.21 111.921 -175.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.561 HG21 HD11 ' A' ' 197' ' ' LEU . 34.4 m -116.02 168.38 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.124 0.97 . . . . 63.11 108.705 169.186 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 37.9 ttp-105 -88.51 105.69 17.79 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.643 -0.873 . . . . 71.41 108.643 174.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -103.31 123.48 46.86 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.791 -0.818 . . . . 62.04 108.791 176.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 57.6 mtm -68.06 143.8 55.36 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 122.904 0.482 . . . . 71.23 110.72 -177.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 8.5 m -136.71 166.01 24.56 Favored 'General case' 0 CA--C 1.554 1.106 0 N-CA-C 108.762 -0.829 . . . . 74.1 108.762 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.457 HD21 ' HD2' ' A' ' 186' ' ' PHE . 52.6 mt -65.72 -12.85 57.21 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 114.495 1.294 . . . . 63.31 114.495 -170.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -128.2 31.3 5.08 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 109.355 -0.609 . . . . 64.44 109.355 178.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 112.9 160.71 14.61 Favored Glycine 0 C--N 1.351 1.408 0 CA-C-N 114.883 -1.053 . . . . 33.0 112.887 176.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -74.44 142.56 29.93 Favored 'Trans proline' 0 C--N 1.372 1.783 0 C-N-CA 123.141 2.56 . . . . 70.23 111.917 -178.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 34.7 m -128.88 152.0 36.44 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 C-N-CA 124.026 0.93 . . . . 73.4 109.898 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -78.62 117.97 20.28 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-O 121.248 0.547 . . . . 75.04 110.476 176.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 66.2 t -118.11 114.52 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 123.774 0.83 . . . . 74.13 109.063 -177.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -67.78 101.97 1.15 Allowed 'General case' 0 C--N 1.349 0.556 0 N-CA-C 109.525 -0.546 . . . . 60.25 109.525 172.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 96.3 t -53.9 137.58 55.29 Favored Pre-proline 0 CA--C 1.554 1.105 0 C-N-CA 124.354 1.062 . . . . 63.14 109.823 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' PRO . . . . . 0.419 ' HD3' HD13 ' B' ' 441' ' ' ILE . 16.1 Cg_endo -56.22 156.31 21.34 Favored 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 122.522 2.148 . . . . 75.51 111.864 174.02 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -77.97 151.82 27.76 Favored 'Trans proline' 0 C--N 1.366 1.449 0 C-N-CA 121.616 1.544 . . . . 72.53 111.553 177.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 67.4 mtt-85 67.1 26.68 8.82 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 125.056 1.342 . . . . 74.04 111.498 174.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.444 HG23 HD21 ' A' ' 233' ' ' LEU . 28.8 m -64.16 109.01 1.71 Allowed 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 124.581 1.153 . . . . 64.32 111.468 177.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -101.53 146.56 27.5 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.324 1.05 . . . . 75.32 110.572 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -71.01 145.45 49.98 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.225 0.61 . . . . 62.31 112.367 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 95.19 -1.32 64.68 Favored Glycine 0 C--N 1.342 0.901 0 CA-C-N 115.241 -0.89 . . . . 73.32 112.368 -176.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -109.56 167.97 9.75 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.69 0.796 . . . . 74.0 111.449 -176.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -118.59 115.71 25.12 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.079 0.952 . . . . 72.22 109.919 -177.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.516 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 73.9 mt -80.51 110.19 15.74 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 122.76 0.424 . . . . 71.4 110.279 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 234' ' ' ARG . . . . . 0.486 ' HA ' ' O ' ' A' ' 249' ' ' LEU . 42.4 ttm180 -74.18 106.65 5.93 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 124.309 1.006 . . . . 64.14 110.392 175.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.52 HD22 HG12 ' B' ' 441' ' ' ILE . 5.0 mt -112.14 101.57 9.82 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 108.331 -0.988 . . . . 61.12 108.331 173.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -67.43 156.18 37.21 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.399 0.68 . . . . 64.43 111.89 -177.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 81.18 -6.81 62.1 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 116.512 -0.313 . . . . 74.2 113.627 177.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.19 -39.83 20.47 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.651 0.781 . . . . 73.01 109.968 176.233 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -78.98 173.84 55.34 Favored Glycine 0 C--N 1.347 1.153 0 O-C-N 123.676 0.61 . . . . 74.43 111.944 178.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' PHE . . . . . 0.495 ' HE1' HD21 ' A' ' 193' ' ' LEU . 63.2 m-85 -96.45 160.4 29.7 Favored Pre-proline 0 N--CA 1.473 0.703 0 C-N-CA 123.875 0.87 . . . . 73.13 111.472 -167.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' A' ' 245' ' ' GLY . 11.7 Cg_endo -52.7 140.35 56.46 Favored 'Trans proline' 0 C--N 1.387 2.568 0 C-N-CA 122.79 2.327 . . . . 73.33 112.348 175.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 179.94 -153.04 11.45 Favored Glycine 0 C--N 1.341 0.821 0 CA-C-O 118.738 -1.035 . . . . 73.52 111.597 -176.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' PRO . . . . . 0.493 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 85.0 Cg_exo -50.0 -43.52 41.48 Favored 'Trans proline' 0 C--N 1.382 2.342 0 C-N-CA 123.955 3.103 . . . . 70.45 114.482 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -85.29 21.45 1.71 Allowed 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.544 0.738 . . . . 70.11 112.372 -175.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 241' ' ' PRO . . . 81.1 -77.1 2.07 Favored Glycine 0 C--N 1.347 1.192 0 N-CA-C 109.253 -1.539 . . . . 62.24 109.253 -170.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 73.1 mtp180 -126.19 160.64 29.69 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.243 1.017 . . . . 75.41 108.537 163.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -92.18 172.03 34.57 Favored Glycine 0 C--O 1.25 1.124 0 CA-C-O 122.134 0.852 . . . . 42.24 113.589 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -101.2 -170.95 1.91 Allowed 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 114.105 -1.048 . . . . 75.44 110.238 -177.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.486 ' O ' ' HA ' ' A' ' 234' ' ' ARG . 22.3 tp -121.54 144.61 48.62 Favored 'General case' 0 C--O 1.216 -0.704 0 N-CA-C 107.041 -1.466 . . . . 70.31 107.041 164.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -124.84 106.24 9.87 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 108.471 -0.937 . . . . 52.51 108.471 173.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.604 HD23 ' HB3' ' A' ' 195' ' ' ALA . 83.1 mt -90.35 119.3 30.53 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 115.386 -0.825 . . . . 72.24 110.712 -179.117 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -77.21 104.0 7.47 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.011 -0.737 . . . . 75.41 109.011 177.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 38.8 t -73.15 123.53 28.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 115.254 -0.885 . . . . 24.43 111.582 -173.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -125.02 100.96 6.82 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 107.379 -1.341 . . . . 73.14 107.379 166.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.535 ' HB ' ' O ' ' C' ' 255' ' ' ILE . 64.0 mt -75.23 137.15 23.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 115.909 -0.587 . . . . 74.34 109.946 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 39.9 p -119.44 169.49 9.98 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.081 0.952 . . . . 73.43 108.667 173.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 257' ' ' ILE . . . . . 0.517 ' HB ' ' HD2' ' A' ' 258' ' ' PRO . 2.9 pp -134.38 157.0 78.43 Favored Pre-proline 0 CA--C 1.561 1.392 0 N-CA-C 108.547 -0.909 . . . . 73.4 108.547 175.089 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 258' ' ' PRO . . . . . 0.517 ' HD2' ' HB ' ' A' ' 257' ' ' ILE . 37.3 Cg_endo -58.81 -12.34 14.53 Favored 'Trans proline' 0 C--N 1.385 2.481 0 C-N-CA 123.617 2.878 . . . . 74.45 116.147 -162.199 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.58 ' HA ' ' HB3' ' C' ' 226' ' ' ARG . 29.9 tt0 58.25 -70.26 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 125.352 1.461 . . . . 63.24 112.646 -172.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -74.01 131.01 40.96 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 109.285 -0.635 . . . . 75.12 109.285 172.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 19.6 mt -138.58 144.24 39.73 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.78 0.8 . . . . 55.32 111.587 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 24.5 p -96.92 148.9 35.07 Favored Pre-proline 0 CA--C 1.559 1.32 0 CA-C-N 114.167 -1.378 . . . . 44.34 108.954 173.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -39.87 -47.55 3.76 Favored 'Trans proline' 0 C--N 1.387 2.566 0 C-N-CA 125.114 3.876 . . . . 74.33 116.937 -168.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -67.92 -49.16 63.48 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 122.747 0.419 . . . . 71.44 111.417 -175.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -58.48 -44.57 89.39 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 109.91 -0.404 . . . . 64.2 109.91 177.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 266' ' ' GLU . . . . . 0.407 ' OE1' ' HD2' ' C' ' 226' ' ' ARG . 11.8 tp10 -62.65 -33.65 75.47 Favored 'General case' 0 CA--C 1.549 0.92 0 O-C-N 123.754 0.659 . . . . 73.45 111.278 178.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -66.63 -41.71 87.9 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 122.843 0.457 . . . . 64.12 110.782 176.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 10.9 mp -65.54 -47.73 74.87 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.13 0.572 . . . . 73.14 110.7 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 65.9 m95 -58.63 -43.97 89.87 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.925 0.89 . . . . 75.0 111.752 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 270' ' ' LYS . . . . . 0.485 ' O ' ' HG3' ' A' ' 274' ' ' GLU . 42.9 mttp -67.53 -42.78 82.17 Favored 'General case' 0 C--O 1.215 -0.736 0 CA-C-O 119.215 -0.422 . . . . 62.43 111.44 178.202 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 271' ' ' LYS . . . . . 0.417 ' HA ' ' HD3' ' A' ' 271' ' ' LYS . 32.2 mmtm -62.87 -35.62 80.59 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 117.884 0.311 . . . . 70.22 111.706 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 272' ' ' LEU . . . . . 0.652 HD21 ' HB2' ' C' ' 268' ' ' LEU . 86.7 mt -60.31 -50.81 72.14 Favored 'General case' 0 C--O 1.214 -0.768 0 O-C-N 123.909 0.755 . . . . 63.4 109.5 169.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 273' ' ' ALA . . . . . 0.445 ' HA ' ' HB2' ' C' ' 202' ' ' PRO . . . -65.41 -29.93 70.68 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.492 1.117 . . . . 64.51 113.721 -174.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.773 ' HG2' ' HA ' ' B' ' 251' ' ' ALA . 41.1 mt-10 -81.3 -49.09 11.15 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 123.27 0.628 . . . . 74.35 109.311 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -67.7 -18.81 65.05 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 115.605 -0.725 . . . . 71.44 111.156 177.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 276' ' ' TYR . . . . . 0.404 ' HE2' ' HG3' ' C' ' 258' ' ' PRO . 21.0 t80 -77.9 -76.66 0.18 Allowed 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 108.349 -0.982 . . . . 75.02 108.349 171.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -50.05 -60.63 2.76 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.673 1.189 . . . . 70.12 111.543 -171.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 278' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' B' ' 277' ' ' LEU . . . -61.63 -28.65 69.52 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 123.7 0.625 . . . . 75.41 111.795 -174.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 279' ' ' ARG . . . . . 0.487 ' HE ' ' HA ' ' A' ' 279' ' ' ARG . 4.6 mmp_? -117.84 32.48 6.13 Favored 'General case' 0 C--N 1.349 0.548 0 N-CA-C 109.507 -0.553 . . . . 74.13 109.507 -174.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.198 0 N-CA-C 108.709 -0.848 . . . . 72.21 108.709 171.524 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 68.4 mtm . . . . . 0 N--CA 1.483 1.185 0 N-CA-C 109.936 -0.394 . . . . 71.44 109.936 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -104.06 84.96 2.31 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.473 0.709 . . . . 54.1 109.354 -173.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -67.78 -72.34 0.18 Allowed 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 109.44 -0.578 . . . . 74.04 109.44 178.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 22.4 m 64.88 -65.87 0.14 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 125.132 1.373 . . . . 52.14 112.716 176.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 5' ' ' THR . . . . . 0.44 HG23 ' HB ' ' A' ' 137' ' ' VAL . 4.3 m -74.44 153.44 39.18 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 123.635 0.774 . . . . 70.11 111.254 177.126 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.63 HG21 ' HA ' ' A' ' 125' ' ' LEU . 41.6 pt -135.6 -179.84 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 123.173 0.589 . . . . 64.44 112.282 -169.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -130.35 -158.24 0.88 Allowed 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 124.258 1.023 . . . . 72.01 109.612 178.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.439 HD12 ' O ' ' A' ' 122' ' ' GLU . 45.3 tp -141.4 149.75 41.47 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.735 0.814 . . . . 75.22 109.802 179.08 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.84 -51.25 8.81 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 122.747 0.419 . . . . 62.4 111.764 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 27.0 mt 74.71 -22.46 0.26 Allowed 'General case' 0 N--CA 1.499 2.013 0 C-N-CA 125.381 1.472 . . . . 74.1 113.788 -174.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.423 ' N ' ' HD3' ' B' ' 12' ' ' PRO . 79.9 mt 53.38 58.12 13.74 Favored Pre-proline 0 CA--C 1.565 1.549 0 C-N-CA 124.385 1.074 . . . . 45.35 111.877 -172.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.423 ' HD3' ' N ' ' B' ' 11' ' ' LEU . 4.6 Cg_exo -81.51 -26.08 3.41 Favored 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 122.791 2.327 . . . . 61.33 111.868 176.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -159.97 171.34 19.54 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 124.558 1.143 . . . . 75.01 108.251 -174.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 52.3 tp -104.3 117.99 35.55 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.316 -0.994 . . . . 64.54 108.316 172.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -64.89 115.26 5.17 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.257 0.623 . . . . 60.01 109.871 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 47.1 p -82.49 143.38 47.63 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 123.564 0.746 . . . . 51.11 110.133 176.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -76.81 169.01 22.53 Favored 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 122.816 2.344 . . . . 62.42 113.213 178.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 7.3 p -105.93 135.86 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 123.914 0.886 . . . . 61.41 110.347 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 29.3 p -67.29 144.35 55.95 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.137 0.975 . . . . 71.22 112.035 -178.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -123.24 176.51 6.06 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.463 1.105 . . . . 62.34 109.967 -179.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.97 109.99 2.74 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 122.996 0.518 . . . . 75.34 110.036 175.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 22' ' ' ARG . . . . . 0.437 ' NH2' ' HA ' ' B' ' 377' ' ' PHE . 41.1 ttt180 -159.06 153.82 24.66 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.808 0.843 . . . . 73.31 110.027 -171.233 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 23' ' ' THR . . . . . 0.681 ' HA ' ' HG3' ' B' ' 376' ' ' GLU . 85.1 m 70.69 83.65 0.15 Allowed Pre-proline 0 N--CA 1.478 0.967 0 C-N-CA 124.748 1.219 . . . . 72.45 112.185 174.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -91.08 33.47 0.31 Allowed 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 123.418 2.745 . . . . 74.55 111.373 166.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -84.07 75.22 10.18 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 123.976 0.91 . . . . 74.53 110.079 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 26' ' ' MET . . . . . 0.538 ' HB3' ' HD3' ' B' ' 27' ' ' PRO . 1.4 tpt -164.33 -48.24 0.0 OUTLIER Pre-proline 0 CA--C 1.554 1.103 0 CA-C-N 114.808 -1.087 . . . . 75.13 108.931 175.049 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 27' ' ' PRO . . . . . 0.538 ' HD3' ' HB3' ' B' ' 26' ' ' MET . 2.7 Cg_endo -85.92 96.22 0.57 Allowed 'Trans proline' 0 C--N 1.388 2.618 0 C-N-CA 121.687 1.591 . . . . 71.1 108.776 159.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.472 HG21 ' HB2' ' B' ' 139' ' ' ASN . 7.2 p -58.93 122.75 9.67 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 CA-C-N 116.147 -0.478 . . . . 73.51 110.784 -178.08 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.432 HD13 ' H ' ' B' ' 31' ' ' ASN . 1.9 tm? -104.54 115.82 31.02 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 106.401 -1.703 . . . . 62.2 106.401 172.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -64.34 -32.83 74.59 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.026 0.931 . . . . 70.24 112.226 -172.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 31' ' ' ASN . . . . . 0.432 ' H ' HD13 ' B' ' 29' ' ' LEU . 65.5 t30 70.38 13.89 7.49 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 124.873 1.269 . . . . 74.34 111.983 175.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 32' ' ' ARG . . . . . 0.444 ' HB3' ' HB1' ' C' ' 244' ' ' ALA . 4.3 ppt_? -85.99 -1.28 57.19 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.559 0.744 . . . . 72.22 112.603 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.1 118.48 11.32 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 122.975 0.51 . . . . 73.31 110.066 174.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . 59.09 29.7 19.32 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 124.468 1.107 . . . . 53.33 112.182 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 35' ' ' GLN . . . . . 0.663 ' HA ' ' HB3' ' C' ' 236' ' ' LYS . 39.0 tt0 -78.27 -30.9 48.76 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.02 0.928 . . . . 73.13 112.305 -173.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.02 -83.33 0.23 Allowed Glycine 0 CA--C 1.531 1.07 0 N-CA-C 111.647 -0.581 . . . . 74.33 111.647 -173.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 37' ' ' ASP . . . . . 0.491 ' HB2' ' HG2' ' B' ' 35' ' ' GLN . 31.5 t70 60.51 -83.26 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 125.564 1.546 . . . . 61.44 111.995 170.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 7.5 tt -96.78 85.04 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 CA-C-O 122.375 1.083 . . . . 75.44 108.47 173.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 43.7 m -110.51 -43.08 3.93 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 114.856 -1.066 . . . . 64.25 109.108 177.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.08 119.01 72.14 Favored Pre-proline 0 CA--C 1.549 0.911 0 CA-C-N 115.655 -0.702 . . . . 64.0 109.372 172.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -65.97 89.1 0.24 Allowed 'Trans proline' 0 C--N 1.381 2.277 0 C-N-CA 123.107 2.538 . . . . 72.44 112.457 -177.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.78 -80.17 1.08 Allowed Glycine 0 C--N 1.345 1.055 0 CA-C-N 115.529 -0.76 . . . . 45.24 111.642 -176.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.88 -66.62 3.87 Favored Glycine 0 C--N 1.346 1.119 0 N-CA-C 112.044 -0.423 . . . . 42.15 112.044 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . 58.26 -168.99 0.13 Allowed 'General case' 0 C--N 1.36 1.056 0 C-N-CA 124.696 1.198 . . . . 63.2 111.216 -176.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.543 ' HB2' ' HB3' ' B' ' 127' ' ' SER . 0.0 OUTLIER -92.21 128.96 38.25 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 107.467 -1.309 . . . . 74.21 107.467 169.531 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -86.15 81.07 8.57 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 107.637 -1.246 . . . . 75.02 107.637 178.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.429 HD23 ' HA3' ' B' ' 229' ' ' GLY . 2.8 tm? -124.16 101.41 7.19 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 108.021 -1.103 . . . . 53.22 108.021 175.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 10.3 t -179.69 171.76 1.17 Allowed 'General case' 0 C--O 1.245 0.853 0 O-C-N 124.816 1.323 . . . . 51.22 108.104 169.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 145.53 157.96 7.49 Favored Glycine 0 C--N 1.345 1.08 0 N-CA-C 111.841 -0.503 . . . . 74.15 111.841 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -82.73 54.55 2.72 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.997 0.919 . . . . 64.2 110.429 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 51' ' ' GLN . . . . . 0.615 ' HG2' HD22 ' B' ' 55' ' ' LEU . 9.5 tp-100 66.8 128.85 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 125.723 1.609 . . . . 75.3 111.48 -173.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 95.1 m -147.31 103.02 3.53 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 123.298 0.639 . . . . 73.31 109.294 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . 63.65 169.31 0.16 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.932 1.293 . . . . 73.24 113.049 177.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . 72.76 -16.82 0.43 Allowed 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.168 1.387 . . . . 75.51 113.795 176.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.615 HD22 ' HG2' ' B' ' 51' ' ' GLN . 40.5 tp -62.82 128.69 37.08 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 118.772 0.715 . . . . 72.35 109.713 176.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 26.5 mmm180 78.1 -45.49 0.42 Allowed 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 125.76 1.624 . . . . 73.2 112.072 -174.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -69.38 -72.21 0.2 Allowed 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.42 0.688 . . . . 75.31 109.974 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 20.0 m 66.18 4.98 3.36 Favored 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 125.007 1.323 . . . . 62.01 114.028 169.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 60.8 tp 57.94 95.17 0.03 OUTLIER 'General case' 0 C--N 1.36 1.03 0 C-N-CA 124.647 1.179 . . . . 72.44 110.401 -170.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 41.3 m -78.26 90.88 4.35 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 122.869 0.467 . . . . 63.51 109.831 177.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -114.75 148.81 37.84 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.196 0.598 . . . . 71.45 109.79 172.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 62' ' ' LYS . . . . . 0.599 ' HE2' ' HA ' ' B' ' 62' ' ' LYS . 10.8 mmpt? 75.11 141.38 0.08 OUTLIER Pre-proline 0 N--CA 1.484 1.241 0 C-N-CA 125.747 1.619 . . . . 72.3 111.737 -177.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -69.09 90.76 0.45 Allowed 'Trans proline' 0 C--N 1.383 2.344 0 C-N-CA 123.262 2.641 . . . . 72.24 111.641 -177.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 76.32 -48.19 0.56 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 125.647 1.579 . . . . 72.04 111.559 -171.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.402 ' HB2' ' HB2' ' B' ' 62' ' ' LYS . 37.4 ttmt 71.89 -73.28 0.1 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.417 1.487 . . . . 65.32 109.258 -174.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 45.4 t30 54.05 -102.03 0.13 Allowed 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 124.301 1.041 . . . . 72.41 110.589 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 17.3 mm -90.71 95.2 5.34 Favored 'Isoleucine or valine' 0 C--N 1.355 0.843 0 N-CA-C 107.794 -1.188 . . . . 72.03 107.794 177.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 6.4 tp -60.1 117.02 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.23 0 C-N-CA 124.094 0.958 . . . . 73.4 111.94 -175.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 58.6 tp 72.3 -62.89 0.45 Allowed 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 125.868 1.667 . . . . 73.12 112.136 176.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.19 47.86 1.4 Allowed 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 123.915 0.886 . . . . 44.44 111.018 -174.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 9.2 tt -61.41 -43.77 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 123.047 0.539 . . . . 74.32 109.872 172.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.53 -67.61 2.54 Favored Glycine 0 C--N 1.35 1.345 0 CA-C-N 115.798 -0.637 . . . . 62.21 112.157 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 11.5 t70 79.0 -62.5 0.31 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 126.765 2.026 . . . . 63.44 110.789 176.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 74' ' ' GLY . . . . . 0.467 ' H ' ' HB2' ' B' ' 77' ' ' ASP . . . 107.8 -63.94 0.27 Allowed Glycine 0 C--N 1.343 0.961 0 N-CA-C 112.362 -0.295 . . . . 64.42 112.362 176.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 21.2 ptp -87.15 -24.61 24.43 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 122.866 0.466 . . . . 74.01 111.23 -176.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . -111.54 14.04 27.57 Favored Glycine 0 C--N 1.346 1.117 0 N-CA-C 111.54 -0.624 . . . . 71.13 111.54 174.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 77' ' ' ASP . . . . . 0.467 ' HB2' ' H ' ' B' ' 74' ' ' GLY . 15.2 t70 -62.68 135.4 57.35 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.686 1.194 . . . . 73.03 111.927 -178.081 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 22.8 t -166.29 158.39 13.95 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.369 0.668 . . . . 51.1 110.309 178.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 68.55 -71.05 0.12 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 125.678 1.591 . . . . 74.44 112.181 176.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 12.3 tt -53.38 -23.65 7.32 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.295 0 C-N-CA 124.764 1.226 . . . . 72.52 112.936 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -56.71 -47.42 79.99 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.006 0.922 . . . . 71.34 110.958 177.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 82' ' ' ALA . . . . . 0.427 ' HA ' ' HB2' ' B' ' 86' ' ' TYR . . . -66.59 -23.47 66.2 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 114.975 -1.011 . . . . 61.11 112.498 -175.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.9 -41.56 86.92 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.378 0.671 . . . . 71.35 111.229 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 18.4 tpp180 -160.64 140.37 10.97 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.214 0.606 . . . . 73.0 110.363 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 67.46 30.35 6.86 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.493 1.117 . . . . 72.23 112.001 177.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 86' ' ' TYR . . . . . 0.427 ' HB2' ' HA ' ' B' ' 82' ' ' ALA . 50.7 t80 -77.38 77.54 3.91 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 109.198 -0.667 . . . . 63.12 109.198 172.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . 164.03 -34.93 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 126.851 2.061 . . . . 52.24 108.877 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 66.26 -78.04 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 124.806 1.242 . . . . 74.14 108.194 -167.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 89' ' ' GLY . . . . . 0.641 ' HA3' ' HG2' ' B' ' 95' ' ' LYS . . . 151.7 -58.7 0.42 Allowed Glycine 0 C--N 1.343 0.928 0 N-CA-C 110.878 -0.889 . . . . 54.33 110.878 176.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 90' ' ' ALA . . . . . 0.472 ' HB3' ' HB3' ' B' ' 95' ' ' LYS . . . -176.73 113.18 0.1 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.522 1.129 . . . . 62.33 108.836 177.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -66.92 86.87 0.13 Allowed Glycine 0 C--N 1.35 1.352 0 N-CA-C 110.96 -0.856 . . . . 70.11 110.96 174.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 92' ' ' GLY . . . . . 0.563 ' H ' ' HA3' ' B' ' 96' ' ' GLY . . . 92.04 -138.99 14.49 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.961 -0.856 . . . . 23.53 110.961 -167.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 62.73 -75.95 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.911 1.285 . . . . 74.22 111.501 177.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -143.66 -48.78 0.3 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.519 1.128 . . . . 71.21 109.427 176.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 95' ' ' LYS . . . . . 0.641 ' HG2' ' HA3' ' B' ' 89' ' ' GLY . 28.0 tptp -61.95 -47.67 83.82 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.682 0.793 . . . . 74.14 111.31 -177.1 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 96' ' ' GLY . . . . . 0.563 ' HA3' ' H ' ' B' ' 92' ' ' GLY . . . -65.75 82.44 0.09 OUTLIER Glycine 0 C--N 1.345 1.054 0 O-C-N 123.954 0.784 . . . . 72.31 112.638 178.081 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 31.8 pt -84.96 -20.78 8.21 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 124.035 0.934 . . . . 72.22 109.586 176.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -139.67 172.56 12.62 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 125.087 1.355 . . . . 75.21 108.497 168.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -142.84 -40.4 0.33 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.612 0.365 . . . . 61.12 110.629 -177.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 93.5 mt -124.94 81.11 62.71 Favored Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 123.375 0.67 . . . . 74.2 110.767 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -85.09 -8.33 8.96 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 122.345 2.03 . . . . 72.21 112.936 170.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 102' ' ' LEU . . . . . 0.499 ' HB3' ' HA ' ' B' ' 105' ' ' GLN . 3.5 mm? -77.56 -45.03 26.58 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.597 0.759 . . . . 73.12 109.811 177.225 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 14.5 m 65.35 78.47 0.28 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.621 1.169 . . . . 75.52 110.537 178.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 66.96 22.43 72.23 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-N 114.606 -1.179 . . . . 51.35 112.732 -176.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 105' ' ' GLN . . . . . 0.499 ' HA ' ' HB3' ' B' ' 102' ' ' LEU . 8.9 tp-100 57.37 76.36 0.32 Allowed 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 124.462 1.105 . . . . 75.22 109.699 -169.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 64.37 107.62 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 125.682 1.593 . . . . 74.44 113.804 175.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 50.2 p -78.18 -173.63 3.3 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 123.529 0.732 . . . . 63.32 110.497 171.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -79.7 80.34 6.09 Favored 'General case' 0 CA--C 1.558 1.272 0 CA-C-O 122.042 0.925 . . . . 71.44 109.895 177.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -74.28 -41.92 60.43 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 121.785 -0.572 . . . . 53.33 109.86 176.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -169.53 -46.69 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.702 1.201 . . . . 71.24 108.396 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 5.7 tt -170.97 -51.72 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 106.311 -1.737 . . . . 64.15 106.311 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 65.36 -133.73 0.23 Allowed 'General case' 0 CA--C 1.555 1.155 0 CA-C-N 114.149 -1.387 . . . . 73.2 109.474 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 113' ' ' LYS . . . . . 0.542 ' HA ' ' HE2' ' B' ' 113' ' ' LYS . 11.5 mmpt? 69.74 -3.31 1.72 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.115 1.366 . . . . 75.13 113.621 175.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 13.3 mptt 51.2 -92.18 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.525 1.13 . . . . 74.01 110.888 -173.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 115' ' ' THR . . . . . 0.536 HG22 ' HD3' ' B' ' 117' ' ' LYS . 12.1 m 58.13 -74.56 0.02 OUTLIER 'General case' 0 CA--C 1.562 1.408 0 C-N-CA 125.33 1.452 . . . . 73.23 112.755 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.16 47.42 4.7 Favored Glycine 0 C--N 1.354 1.572 0 N-CA-C 111.625 -0.59 . . . . 55.33 111.625 -178.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 117' ' ' LYS . . . . . 0.536 ' HD3' HG22 ' B' ' 115' ' ' THR . 5.1 mptp? -119.68 -52.08 0.04 OUTLIER Pre-proline 0 CA--C 1.569 1.681 0 CA-C-O 117.786 -1.102 . . . . 70.25 112.861 -173.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 118' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -61.72 106.09 0.41 Allowed 'Trans proline' 0 C--N 1.39 2.76 0 C-N-CA 121.985 1.79 . . . . 60.53 113.162 -176.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 119' ' ' ASP . . . . . . . . . . . . . 31.0 t70 76.24 161.6 0.23 Allowed 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 125.207 1.403 . . . . 75.33 112.924 173.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 120' ' ' TYR . . . . . 0.505 ' HA ' ' HB2' ' B' ' 221' ' ' ARG . 0.8 OUTLIER -152.57 -2.77 0.25 Allowed 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 124.36 1.064 . . . . 70.1 111.483 176.1 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 15.9 m -126.94 -31.14 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 113.419 0.896 . . . . 74.32 113.419 -170.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 45.1 m -77.26 91.13 3.75 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.126 0.571 . . . . 75.24 110.284 -174.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -154.5 162.03 41.36 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.146 0.578 . . . . 64.3 109.886 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 46.1 m -101.44 12.93 36.48 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.395 0.678 . . . . 43.31 111.987 -176.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.67 130.35 42.99 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.503 0.721 . . . . 73.02 110.641 177.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.96 -22.73 67.05 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.825 -0.625 . . . . 74.13 110.697 176.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 127' ' ' SER . . . . . 0.543 ' HB3' ' HB2' ' B' ' 45' ' ' ARG . 53.6 m 67.78 26.06 7.83 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.811 1.245 . . . . 70.01 111.906 171.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -104.66 -25.79 12.57 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.55 0.74 . . . . 72.01 110.768 176.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 41.1 p -76.99 89.35 3.54 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 121.105 0.479 . . . . 54.34 110.675 178.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . -85.75 69.58 10.61 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 109.481 -0.562 . . . . 44.22 109.481 175.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 131' ' ' TRP . . . . . 0.436 ' CD1' ' HB3' ' C' ' 132' ' ' HIS . 66.8 t-105 66.23 -76.17 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 125.193 1.397 . . . . 73.51 110.801 -177.028 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 36.4 t -162.88 162.01 26.14 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.102 0.961 . . . . 51.4 109.303 176.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 63.6 m -153.81 141.18 19.67 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 108.993 -0.743 . . . . 62.25 108.993 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . -148.13 135.69 5.63 Favored Glycine 0 C--N 1.343 0.96 0 N-CA-C 111.465 -0.654 . . . . 55.15 111.465 177.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 135' ' ' VAL . . . . . . . . . . . . . 18.9 m -90.76 178.27 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 123.451 0.7 . . . . 73.24 109.857 175.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 136' ' ' LYS . . . . . 0.418 ' O ' ' HA ' ' B' ' 371' ' ' VAL . 18.8 pttp -88.86 47.72 1.54 Allowed 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 121.079 0.466 . . . . 52.43 109.839 173.16 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 45.3 m 56.69 -83.68 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.237 0 C-N-CA 125.381 1.472 . . . . 75.31 113.07 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -134.82 174.43 10.59 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.166 0.987 . . . . 75.52 108.995 -169.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 139' ' ' ASN . . . . . 0.472 ' HB2' HG21 ' B' ' 28' ' ' VAL . 30.0 p-10 -78.5 -41.66 31.79 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 121.747 -0.596 . . . . 73.24 110.638 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 140' ' ' GLY . . . . . 0.835 ' HA3' HG21 ' B' ' 371' ' ' VAL . . . 58.07 -136.41 50.92 Favored Glycine 0 C--N 1.35 1.359 0 N-CA-C 115.068 0.787 . . . . 65.04 115.068 171.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -110.17 -38.38 5.3 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.821 0.849 . . . . 75.34 111.354 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 23.4 mt 73.97 171.57 0.29 Allowed 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 126.103 1.761 . . . . 70.15 111.598 -176.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.63 -172.08 53.18 Favored Glycine 0 C--N 1.346 1.113 0 CA-C-N 115.542 -0.754 . . . . 61.25 113.615 178.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 43.3 t 75.5 -33.98 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 C-N-CA 125.738 1.615 . . . . 75.31 112.183 -178.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -60.96 106.15 0.55 Allowed 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 123.87 0.868 . . . . 64.3 111.215 178.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 82.4 mt -128.05 -74.0 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 107.85 -1.167 . . . . 72.52 107.85 172.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 147' ' ' HIS . . . . . 0.618 ' HA ' HG21 ' B' ' 306' ' ' VAL . 34.1 t-80 72.44 -56.32 0.65 Allowed 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 125.444 1.498 . . . . 72.43 114.678 173.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 148' ' ' GLU . . . . . 0.427 ' HG3' ' O ' ' B' ' 197' ' ' SER . 6.7 mm-40 -46.17 138.88 4.99 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 115.64 1.719 . . . . 73.05 115.64 -155.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 149' ' ' LYS . . . . . 0.461 ' HA ' ' O ' ' B' ' 302' ' ' ASP . 33.2 mtmt -123.48 -93.34 0.51 Allowed 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 114.279 -1.328 . . . . 72.23 109.599 -173.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 38.7 t70 178.45 -123.85 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 125.175 1.39 . . . . 74.11 107.592 172.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 151' ' ' HIS . . . . . 0.41 ' HA ' ' HB2' ' C' ' 118' ' ' ASP . 10.4 p-80 -176.43 113.96 0.26 Allowed Pre-proline 0 C--N 1.356 0.886 0 C-N-CA 124.629 1.171 . . . . 74.43 109.122 -176.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -77.58 -17.9 14.03 Favored 'Trans proline' 0 C--N 1.366 1.499 0 C-N-CA 122.186 1.924 . . . . 42.51 110.862 169.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 21.9 m -111.11 131.55 55.0 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.457 1.103 . . . . 74.2 109.29 -176.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 15.8 tt -142.57 160.77 19.01 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 C-N-CA 124.478 1.111 . . . . 74.25 108.108 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 155' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' B' ' 187' ' ' SER . 58.7 mt 70.47 172.8 0.31 Allowed 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 124.872 1.269 . . . . 72.1 112.628 177.184 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -172.69 -154.22 0.08 Allowed 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 124.698 1.199 . . . . 72.23 108.639 172.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 157' ' ' MET . . . . . . . . . . . . . 60.2 mtt -52.55 -74.83 0.03 OUTLIER 'General case' 0 C--N 1.365 1.27 0 C-N-CA 123.823 0.849 . . . . 53.54 110.994 173.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 158' ' ' ALA . . . . . . . . . . . . . . . 172.17 -71.0 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.561 1.144 . . . . 34.04 108.996 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 32.5 mtmm 46.27 69.07 0.51 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.548 1.539 . . . . 55.45 112.668 -175.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -86.61 59.28 5.54 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.103 0.561 . . . . 70.22 109.578 174.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -69.87 121.66 17.75 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.794 0.837 . . . . 71.1 111.26 -173.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 83.68 -73.64 2.64 Favored Glycine 0 C--N 1.347 1.175 0 N-CA-C 111.718 -0.553 . . . . 73.4 111.718 -177.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 25.4 tp 62.7 8.38 2.98 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 125.173 1.389 . . . . 65.02 112.393 175.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 164' ' ' ALA . . . . . . . . . . . . . . . -170.4 -46.37 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.843 1.257 . . . . 75.34 107.715 -174.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 48.4 p -103.5 -174.55 2.57 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 114.304 -1.316 . . . . 64.15 109.211 169.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . 113.34 -136.02 13.07 Favored Glycine 0 C--N 1.344 0.983 0 N-CA-C 111.111 -0.796 . . . . 71.15 111.111 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 167' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -83.01 68.45 9.51 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 108.742 -0.836 . . . . 72.31 108.742 176.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 168' ' ' VAL . . . . . 0.509 HG23 ' H ' ' B' ' 169' ' ' SER . 17.4 m -108.0 -62.8 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 CA-C-N 115.216 -0.902 . . . . 74.13 110.503 -176.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 169' ' ' SER . . . . . 0.754 ' HA ' ' HB2' ' B' ' 174' ' ' GLN . 20.1 m 49.62 -176.96 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.412 0 N-CA-C 115.427 1.64 . . . . 54.35 115.427 177.193 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 48.0 m -150.25 98.87 2.73 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.692 -0.855 . . . . 63.1 108.692 176.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 171' ' ' ALA . . . . . 0.527 ' H ' ' HG2' ' C' ' 128' ' ' GLU . . . 72.46 -64.8 0.38 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 125.28 1.432 . . . . 53.32 111.209 -178.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 172' ' ' GLU . . . . . . . . . . . . . 15.6 mp0 -105.3 170.89 7.62 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.151 0.981 . . . . 73.22 109.055 168.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 173' ' ' LEU . . . . . 0.553 ' H ' HD13 ' B' ' 173' ' ' LEU . 0.0 OUTLIER -57.25 131.1 49.0 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 123.511 0.724 . . . . 74.23 111.721 178.658 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 174' ' ' GLN . . . . . 0.754 ' HB2' ' HA ' ' B' ' 169' ' ' SER . 8.2 mm100 -131.63 -26.68 2.0 Allowed 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.129 0.972 . . . . 74.45 110.731 -178.23 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 175' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -153.99 149.51 27.3 Favored 'General case' 0 C--O 1.245 0.831 0 O-C-N 123.477 0.485 . . . . 74.1 110.241 174.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -148.27 81.02 1.47 Allowed 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.124 0.97 . . . . 74.11 108.823 172.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 177' ' ' THR . . . . . 0.465 ' N ' ' HD3' ' B' ' 178' ' ' PRO . 2.8 m -130.25 47.5 2.93 Favored Pre-proline 0 CA--C 1.582 2.178 0 CA-C-N 115.951 -0.568 . . . . 64.31 112.248 175.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 178' ' ' PRO . . . . . 0.465 ' HD3' ' N ' ' B' ' 177' ' ' THR . 91.4 Cg_endo -99.1 -152.39 0.03 OUTLIER 'Trans proline' 0 C--N 1.393 2.915 0 C-N-CA 122.319 2.012 . . . . 74.53 110.338 168.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -64.41 -47.21 80.01 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 109.506 -0.553 . . . . 61.34 109.506 167.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . -172.73 -56.06 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 114.527 -1.215 . . . . 74.4 108.482 170.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 181' ' ' LEU . . . . . 0.628 ' HB2' ' HB3' ' C' ' 136' ' ' ARG . 59.3 tp -105.9 -89.38 0.43 Allowed 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 107.602 -1.259 . . . . 62.04 107.602 169.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 182' ' ' VAL . . . . . 0.505 HG11 ' HB2' ' C' ' 123' ' ' LEU . 30.5 m -129.04 -173.04 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.932 0 C-N-CA 124.716 1.206 . . . . 71.31 108.477 170.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -171.94 95.99 0.16 Allowed 'General case' 0 CA--C 1.547 0.865 0 CA-C-O 118.414 -0.803 . . . . 65.24 112.394 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 11.1 p-80 164.56 159.19 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.724 0 C-N-CA 125.551 1.54 . . . . 74.15 112.396 160.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 185' ' ' VAL . . . . . . . . . . . . . 34.8 t -77.45 171.77 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 C-N-CA 124.901 1.28 . . . . 71.33 109.33 169.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 186' ' ' THR . . . . . 0.444 HG22 ' HB3' ' C' ' 122' ' ' GLU . 17.9 p -56.07 86.88 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.461 0.704 . . . . 51.31 110.625 170.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 187' ' ' SER . . . . . 0.445 ' HA ' HD23 ' B' ' 155' ' ' LEU . 10.3 t -111.63 12.65 21.21 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.948 0.899 . . . . 62.14 111.377 -170.246 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 2.4 tpm_? -131.96 -54.8 0.99 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.527 0.731 . . . . 71.52 109.395 177.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -170.55 174.1 5.23 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.788 0.835 . . . . 72.52 111.402 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 190' ' ' CYS . . . . . . . . . . . . . 42.4 t -161.27 124.05 3.15 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.751 0.82 . . . . 70.33 109.511 175.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -64.16 -67.95 0.39 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.238 0.615 . . . . 74.04 111.213 -176.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 179.75 157.5 20.11 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-O 119.142 -0.81 . . . . 64.22 111.215 -177.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 193' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.43 -72.96 0.02 OUTLIER 'Trans proline' 0 C--N 1.366 1.496 0 C-N-CA 122.534 2.156 . . . . 64.32 112.397 -177.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 194' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' B' ' 197' ' ' SER . 19.8 m -81.0 -4.76 56.25 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.037 0.935 . . . . 24.51 111.68 -179.207 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 195' ' ' ALA . . . . . . . . . . . . . . . -67.45 -53.41 29.2 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 122.901 0.48 . . . . 74.32 110.254 174.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 68.9 p -93.27 -23.57 18.46 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.331 -0.85 . . . . 73.32 111.59 -177.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 197' ' ' SER . . . . . 0.444 ' O ' ' HA ' ' B' ' 194' ' ' SER . 22.0 m -146.75 96.32 2.73 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.201 0.6 . . . . 75.11 110.377 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 198' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -70.61 -16.4 62.84 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-O 121.176 0.512 . . . . 51.12 110.718 171.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.93 91.85 1.76 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.672 1.189 . . . . 74.4 109.334 -173.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 200' ' ' CYS . . . . . 0.41 ' SG ' ' HG2' ' B' ' 148' ' ' GLU . 23.8 p -94.24 112.88 59.21 Favored Pre-proline 0 N--CA 1.476 0.826 0 N-CA-C 109.568 -0.53 . . . . 73.31 109.568 177.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 201' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -78.02 162.64 28.93 Favored 'Trans proline' 0 C--N 1.37 1.658 0 C-N-CA 122.385 2.056 . . . . 71.34 111.808 174.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . -165.2 -37.65 0.02 OUTLIER Glycine 0 C--N 1.339 0.72 0 CA-C-N 116.275 -0.42 . . . . 63.04 112.574 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -79.14 78.19 5.61 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.605 -0.887 . . . . 71.33 108.605 174.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -168.86 82.39 0.14 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.854 0.862 . . . . 74.01 109.096 178.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 205' ' ' LEU . . . . . 0.553 HD23 ' H ' ' B' ' 205' ' ' LEU . 1.4 pt? -115.27 21.6 14.0 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.213 0.605 . . . . 51.03 110.585 -178.184 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 206' ' ' GLU . . . . . 0.488 ' HB3' ' NH1' ' C' ' 148' ' ' ARG . 16.6 tt0 56.01 -94.42 0.04 OUTLIER 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 125.415 1.486 . . . . 62.32 112.752 172.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 48.3 tttm -179.66 -64.27 0.01 OUTLIER 'General case' 0 C--N 1.354 0.776 0 C-N-CA 123.553 0.741 . . . . 74.32 109.5 -169.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 75.92 165.01 17.45 Favored Glycine 0 C--N 1.35 1.311 0 CA-C-N 115.704 -0.68 . . . . 71.52 111.911 -169.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 158.17 174.36 27.78 Favored Glycine 0 N--CA 1.468 0.796 0 O-C-N 122.217 -0.578 . . . . 42.21 112.777 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 210' ' ' LYS . . . . . 0.474 ' HG3' ' HB2' ' B' ' 326' ' ' ASP . 53.9 mtpt 65.37 6.25 3.57 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 125.047 1.339 . . . . 74.51 112.238 -178.349 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . -84.49 -100.25 0.62 Allowed Glycine 0 C--N 1.348 1.206 0 N-CA-C 110.859 -0.896 . . . . 74.43 110.859 -177.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 212' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' B' ' 354' ' ' ALA . 19.7 m 61.21 10.3 2.92 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.039 0.936 . . . . 74.04 112.294 -175.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 9.7 tp -160.96 131.08 0.79 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.855 0 N-CA-C 107.404 -1.332 . . . . 64.4 107.404 -175.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 15.0 t -159.76 12.63 0.13 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 122.911 0.484 . . . . 75.43 110.698 -174.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 215' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -70.49 -29.23 65.71 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 122.909 0.483 . . . . 73.31 110.514 -171.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -80.77 84.23 6.35 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 109.412 -0.588 . . . . 61.42 109.412 175.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -78.53 -33.45 47.93 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 108.622 -0.881 . . . . 75.4 108.622 173.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 6.1 mp -68.22 97.31 0.71 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.627 0.771 . . . . 71.43 110.178 -178.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -75.26 -43.85 49.16 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 109.928 -0.397 . . . . 71.24 109.928 174.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -113.27 -72.31 0.71 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.158 0.583 . . . . 61.1 111.496 -178.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 221' ' ' ARG . . . . . 0.505 ' HB2' ' HA ' ' B' ' 120' ' ' TYR . 1.0 OUTLIER -155.72 -81.62 0.07 Allowed 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 119.53 -0.271 . . . . 73.55 111.205 -179.644 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 222' ' ' ALA . . . . . 0.407 ' HA ' HD13 ' B' ' 226' ' ' LEU . . . -169.51 138.99 2.01 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.688 0.395 . . . . 42.52 111.559 -173.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 31.2 t70 50.89 -81.88 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 125.982 1.713 . . . . 61.02 114.352 168.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 7.1 p -61.22 -39.65 83.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.605 0.762 . . . . 74.2 110.885 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 18.5 m -145.05 84.63 1.72 Allowed 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 107.99 -1.115 . . . . 54.34 107.99 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 226' ' ' LEU . . . . . 0.549 ' HB3' ' HA ' ' B' ' 174' ' ' GLN . 58.1 tp -103.81 -14.17 16.15 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.614 0.766 . . . . 74.43 110.212 178.071 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . -151.74 178.79 28.83 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-N 116.32 -0.4 . . . . 51.31 112.539 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 78.11 -72.77 2.25 Favored Glycine 0 C--N 1.346 1.135 0 C-N-CA 122.871 0.272 . . . . 72.41 112.662 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 229' ' ' GLY . . . . . 0.429 ' HA3' HD23 ' B' ' 47' ' ' LEU . . . 77.16 -76.68 1.61 Allowed Glycine 0 C--N 1.344 1.027 0 CA-C-N 115.684 -0.258 . . . . 70.24 112.742 177.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -152.31 113.43 4.23 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.641 0.776 . . . . 70.23 109.944 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 231' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -135.99 84.55 2.09 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.697 0.799 . . . . 73.24 109.269 176.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 41.5 p -76.14 155.77 34.34 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 122.95 0.5 . . . . 74.24 111.11 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -134.88 124.77 25.53 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.659 0.783 . . . . 70.41 109.513 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -171.39 98.6 0.19 Allowed 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 108.138 -1.06 . . . . 72.31 108.138 176.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -154.24 148.9 26.41 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 109.161 -0.681 . . . . 54.41 109.161 -172.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 236' ' ' THR . . . . . . . . . . . . . 5.5 m -50.73 -54.36 23.89 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.638 1.575 . . . . 73.34 113.016 -176.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -161.5 83.45 0.62 Allowed 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.724 -0.671 . . . . 71.12 110.273 -175.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 23.0 m -88.61 -5.76 57.96 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 123.253 0.621 . . . . 71.31 110.639 174.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 239' ' ' ALA . . . . . 0.555 ' HB2' ' HA ' ' C' ' 221' ' ' VAL . . . -55.27 -78.63 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.184 0.994 . . . . 74.42 112.951 -175.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . 152.82 -114.32 0.62 Allowed Glycine 0 C--N 1.339 0.699 0 N-CA-C 110.623 -0.991 . . . . 71.23 110.623 -172.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -151.61 136.07 16.91 Favored 'General case' 0 C--O 1.245 0.855 0 C-N-CA 123.455 0.702 . . . . 71.21 110.012 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 242' ' ' TRP . . . . . 0.528 ' CD2' ' HG ' ' C' ' 233' ' ' LEU . 4.7 p-90 -172.21 138.24 0.96 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.809 0.843 . . . . 70.32 112.106 173.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 71.8 mm-40 62.99 -75.0 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.819 1.648 . . . . 74.22 111.765 175.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 178.96 58.9 0.07 OUTLIER Glycine 0 C--N 1.342 0.9 0 N-CA-C 112.226 -0.35 . . . . 63.11 112.226 177.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 245' ' ' LYS . . . . . 0.771 ' HE2' ' HB1' ' C' ' 222' ' ' ALA . 52.8 tptt -69.23 96.28 0.83 Allowed 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 120.883 0.373 . . . . 75.34 110.767 177.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 4.8 t -68.51 131.88 46.01 Favored 'General case' 0 C--O 1.244 0.815 0 N-CA-C 108.399 -0.963 . . . . 71.02 108.399 164.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 247' ' ' LEU . . . . . . . . . . . . . 46.9 tp -62.45 88.29 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.752 0.821 . . . . 72.51 110.478 -174.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 248' ' ' ARG . . . . . 0.611 ' HD3' HE22 ' B' ' 250' ' ' GLN . 97.2 mtt180 -141.61 121.55 13.64 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.611 1.165 . . . . 75.15 108.574 -178.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.65 -55.17 5.75 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 122.608 0.363 . . . . 71.33 110.414 -178.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 250' ' ' GLN . . . . . 0.611 HE22 ' HD3' ' B' ' 248' ' ' ARG . 0.2 OUTLIER 53.17 -171.62 0.04 OUTLIER 'General case' 0 CA--C 1.561 1.374 0 C-N-CA 125.264 1.426 . . . . 65.4 112.933 -177.444 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 251' ' ' ALA . . . . . 0.773 ' HA ' ' HG2' ' A' ' 274' ' ' GLU . . . 61.03 74.38 0.45 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.548 1.139 . . . . 61.03 112.438 173.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -119.46 -41.19 2.72 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-N 115.791 -0.64 . . . . 72.3 110.934 -177.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . 80.02 -36.31 0.15 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 125.679 1.592 . . . . 51.41 113.144 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -52.58 98.59 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.238 1.015 . . . . 72.51 112.509 -171.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -142.44 -38.97 0.07 OUTLIER Glycine 0 C--N 1.34 0.77 0 CA-C-N 114.579 -1.191 . . . . 54.22 110.877 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 256' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -161.03 -56.73 0.05 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.157 0.583 . . . . 52.52 110.586 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 14.7 mp0 54.44 36.38 25.44 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.531 1.132 . . . . 74.31 112.416 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 258' ' ' LEU . . . . . . . . . . . . . 8.0 mp 67.73 -73.48 0.08 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.856 1.263 . . . . 75.13 110.896 178.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 57.4 t -109.3 -53.91 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 123.204 0.601 . . . . 63.02 110.298 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 260' ' ' SER . . . . . . . . . . . . . 58.4 p -157.12 164.96 37.29 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.07 0.548 . . . . 73.11 110.577 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -87.29 -39.14 15.64 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.376 0.67 . . . . 52.21 111.846 -172.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 262' ' ' ALA . . . . . . . . . . . . . . . -73.68 88.27 1.71 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.286 0.634 . . . . 43.43 110.373 -177.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . 67.34 -74.26 0.07 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 125.225 1.41 . . . . 70.44 111.929 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 31.3 t 69.56 -73.26 0.09 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.569 1.548 . . . . 51.14 111.963 175.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 265' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -66.13 -21.83 66.36 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.939 0.896 . . . . 64.12 111.15 -177.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 266' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -121.91 144.65 48.73 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.749 0.82 . . . . 71.52 109.559 173.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 30.7 t -96.15 -53.28 3.7 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.608 0.763 . . . . 73.13 109.675 177.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 11.9 p -164.3 146.36 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 115.956 -0.566 . . . . 74.44 110.132 -176.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 269' ' ' THR . . . . . . . . . . . . . 33.6 m -142.1 96.07 2.9 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 107.986 -1.116 . . . . 74.31 107.986 173.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 270' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 56.64 -85.81 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 125.423 1.489 . . . . 72.41 112.054 177.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 271' ' ' ALA . . . . . . . . . . . . . . . -141.65 -65.61 0.42 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 106.681 -1.6 . . . . 75.3 106.681 171.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 272' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 60.2 -70.1 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 125.948 1.699 . . . . 54.14 113.559 172.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 65.37 50.99 1.63 Allowed 'General case' 0 C--N 1.355 0.828 0 C-N-CA 125.013 1.325 . . . . 61.32 109.789 -175.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -106.63 157.5 17.65 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 114.04 -1.436 . . . . 71.44 108.923 173.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 275' ' ' LYS . . . . . 0.559 ' N ' ' HD3' ' B' ' 276' ' ' PRO . 3.4 mptp? 60.65 42.58 0.61 Allowed Pre-proline 0 CA--C 1.58 2.099 0 C-N-CA 124.799 1.24 . . . . 71.33 112.412 -168.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 276' ' ' PRO . . . . . 0.559 ' HD3' ' N ' ' B' ' 275' ' ' LYS . 43.7 Cg_endo -109.41 42.35 0.02 OUTLIER 'Trans proline' 0 C--N 1.392 2.866 0 C-N-CA 124.459 3.439 . . . . 62.35 112.112 -177.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 277' ' ' LEU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 278' ' ' ALA . 91.4 mt 81.4 -23.87 0.21 Allowed 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 126.351 1.861 . . . . 63.32 112.5 -174.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -173.22 132.63 0.5 Allowed 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 124.549 1.14 . . . . 62.0 108.725 168.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . 174.52 -103.89 0.19 Allowed Glycine 0 C--N 1.345 1.032 0 CA-C-O 119.875 -0.403 . . . . 75.43 113.04 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 1.5 tm? 56.69 -90.81 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 125.12 1.368 . . . . 53.23 108.912 -170.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -149.11 -63.49 0.23 Allowed 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 106.356 -1.72 . . . . 75.31 106.356 171.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . 54.84 -165.85 0.1 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.684 1.193 . . . . 65.41 112.838 172.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 34.3 t70 61.08 87.99 0.09 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.841 1.256 . . . . 72.33 112.103 174.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . -74.93 -163.32 10.63 Favored Glycine 0 CA--C 1.533 1.187 0 CA-C-N 115.581 -0.736 . . . . 61.45 112.49 171.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 70.06 -75.37 0.07 Allowed 'General case' 0 CA--C 1.558 1.288 0 C-N-CA 124.829 1.251 . . . . 72.41 110.552 -176.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 286' ' ' MET . . . . . . . . . . . . 0.285 58.2 mtt 41.42 -90.04 0.0 OUTLIER Pre-proline 0 CA--C 1.585 2.296 0 C-N-CA 127.328 2.251 . . . . 64.1 114.562 -177.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 287' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -75.91 -26.98 8.99 Favored 'Trans proline' 1 C--N 1.423 4.472 0 CA-C-N 124.905 2.788 . . . . 73.33 112.827 178.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 288' ' ' VAL . . . . . . . . . . . . . 41.4 t 50.91 -91.47 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.564 1.486 0 C-N-CA 124.817 1.247 . . . . 74.32 110.759 -173.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 289' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? 51.55 95.78 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 126.27 1.828 . . . . 72.14 112.715 176.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 290' ' ' TRP . . . . . . . . . . . . . 45.1 p90 -77.64 137.61 38.64 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.132 0.573 . . . . 75.34 110.451 173.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 291' ' ' LEU . . . . . . . . . . . . . 2.8 pp -88.79 -17.9 28.83 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.98 0.512 . . . . 64.34 110.747 175.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . -93.77 103.46 3.04 Favored Glycine 0 C--N 1.35 1.327 0 CA-C-N 115.619 -0.719 . . . . 62.12 111.414 -179.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -85.65 17.6 1.73 Allowed 'Trans proline' 0 C--N 1.374 1.891 0 C-N-CA 123.411 2.741 . . . . 51.12 113.593 -172.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 11.0 mmpt? 63.25 -83.25 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.494 1.518 . . . . 41.23 110.135 -174.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -147.17 157.66 43.68 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.621 0.768 . . . . 34.32 110.128 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 24.9 p -88.86 -59.11 2.32 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.2 0.6 . . . . 65.42 109.638 176.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 73.6 t80 60.27 93.88 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 125.05 1.34 . . . . 64.12 111.596 176.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 41.0 m80 -99.2 71.27 1.8 Allowed 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.696 0.76 . . . . 71.5 109.15 177.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . -139.48 175.32 21.78 Favored Glycine 0 C--N 1.342 0.88 0 CA-C-N 114.466 -1.243 . . . . 63.41 111.898 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 300' ' ' ASN . . . . . 0.436 ' HB3' ' HB2' ' B' ' 194' ' ' SER . 10.9 t-20 62.43 32.95 16.53 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.619 1.168 . . . . 72.23 109.011 -174.018 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 301' ' ' ILE . . . . . . . . . . . . . 2.0 pp -67.26 160.17 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 CA-C-N 113.26 -1.791 . . . . 72.24 112.807 -173.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 302' ' ' ASP . . . . . 0.461 ' O ' ' HA ' ' B' ' 149' ' ' LYS 0.275 6.1 p-10 34.25 -88.91 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 126.128 1.771 . . . . 63.41 113.148 -168.663 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 303' ' ' LYS . . . . . 0.633 ' HZ3' ' HB3' ' B' ' 303' ' ' LYS . 4.7 ttpm? 54.99 70.98 1.41 Allowed Pre-proline 0 CA--C 1.565 1.526 0 CA-C-N 118.332 0.514 . . . . 74.11 109.803 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 304' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -83.77 35.68 0.57 Allowed 'Trans proline' 0 C--N 1.374 1.887 0 C-N-CA 123.162 2.575 . . . . 75.12 111.851 -178.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -74.54 -11.85 60.32 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.66 1.184 . . . . 42.33 112.07 -178.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 306' ' ' VAL . . . . . 0.618 HG21 ' HA ' ' B' ' 147' ' ' HIS . 40.4 t -71.99 95.26 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 C-N-CA 123.342 0.657 . . . . 72.33 109.32 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 23.7 p -69.68 -59.58 2.86 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 114.871 -1.059 . . . . 74.23 110.688 -178.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 308' ' ' CYS . . . . . . . . . . . . . 52.4 t -81.42 119.72 24.08 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 122.925 0.49 . . . . 74.22 110.123 177.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 309' ' ' THR . . . . . 0.418 ' HA ' HD22 ' B' ' 367' ' ' LEU . 13.5 t 177.06 -36.64 0.0 OUTLIER Pre-proline 0 CA--C 1.568 1.645 0 C-N-CA 125.689 1.596 . . . . 72.2 112.366 177.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -95.13 20.98 0.53 Allowed 'Trans proline' 0 C--N 1.408 3.699 0 CA-C-N 122.728 2.01 . . . . 63.14 112.949 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 311' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -97.27 109.86 51.73 Favored Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 123.73 0.812 . . . . 73.13 109.674 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 312' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -87.04 80.63 1.46 Allowed 'Trans proline' 0 C--N 1.372 1.772 0 C-N-CA 122.898 2.399 . . . . 70.14 111.935 176.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 313' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 70.3 138.42 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 125.232 1.413 . . . . 75.13 111.472 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 314' ' ' ARG . . . . . . . . . . . . . 44.4 ttp180 -153.41 -79.09 0.1 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.47 0.708 . . . . 72.01 110.354 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 315' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -112.21 75.41 0.92 Allowed 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 122.13 0.967 . . . . 72.12 109.302 -175.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 316' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -111.45 -178.15 3.38 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 114.528 -1.214 . . . . 74.4 111.08 -173.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 3.8 m -83.4 -67.41 0.79 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.528 -0.76 . . . . 75.41 108.973 -179.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 318' ' ' VAL . . . . . 0.419 ' O ' ' HG3' ' B' ' 363' ' ' GLU . 12.7 p 177.1 137.86 0.22 Allowed Pre-proline 0 CA--C 1.556 1.18 0 C-N-CA 124.861 1.265 . . . . 73.13 109.049 -179.248 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 319' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -73.96 45.06 1.06 Allowed 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 122.581 2.187 . . . . 65.1 113.557 173.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 320' ' ' THR . . . . . . . . . . . . . 11.1 m -144.48 28.79 1.3 Allowed 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 124.764 1.226 . . . . 53.31 108.128 176.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 321' ' ' LEU . . . . . . . . . . . . . 66.3 tp -83.32 -59.64 2.39 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 121.876 -0.515 . . . . 65.14 110.233 176.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 322' ' ' ALA . . . . . . . . . . . . . . . -63.65 100.4 0.28 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.701 0.801 . . . . 64.54 110.726 -177.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 323' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 71.77 -12.49 0.65 Allowed 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 124.934 1.294 . . . . 74.02 112.789 177.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 324' ' ' MET . . . . . . . . . . . . . 91.9 mtp 62.87 -76.04 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 125.065 1.346 . . . . 71.32 110.743 -170.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 325' ' ' THR . . . . . . . . . . . . . 52.5 m -137.09 124.26 21.71 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.444 -0.947 . . . . 72.33 108.444 174.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 326' ' ' ASP . . . . . 0.474 ' HB2' ' HG3' ' B' ' 210' ' ' LYS . 4.8 p-10 -75.75 -37.8 58.99 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.906 0.482 . . . . 72.01 110.8 -178.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -161.13 -69.9 0.06 Allowed 'General case' 0 C--N 1.345 0.402 0 C-N-CA 124.235 1.014 . . . . 54.34 109.306 178.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 328' ' ' ALA . . . . . . . . . . . . . . . -171.0 -70.06 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 108.625 -0.88 . . . . 72.03 108.625 -176.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 329' ' ' ILE . . . . . . . . . . . . . 29.9 mm 65.08 -64.42 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.429 0 C-N-CA 126.003 1.721 . . . . 73.5 112.532 174.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 330' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -55.09 -53.06 60.63 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.176 0.99 . . . . 63.42 111.154 175.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 331' ' ' LEU . . . . . . . . . . . . . 85.2 mt -110.76 90.06 3.22 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.251 -1.018 . . . . 63.34 108.251 172.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 44.5 tp -85.6 -21.96 28.23 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.082 0.553 . . . . 74.41 111.366 -174.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 333' ' ' SER . . . . . . . . . . . . . 36.7 m 52.04 41.3 29.74 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.081 0.952 . . . . 65.04 111.714 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 6.9 tmtm? -73.42 -50.35 22.22 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.405 -0.816 . . . . 63.11 109.935 -174.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 335' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -139.0 149.38 44.62 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.507 0.723 . . . . 73.25 109.745 -176.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -64.92 -27.33 68.78 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.98 0.912 . . . . 61.02 111.64 -176.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 337' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.1 168.19 13.73 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 124.005 0.922 . . . . 62.43 109.737 -177.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 338' ' ' GLY . . . . . . . . . . . . . . . -80.26 62.36 4.28 Favored Glycine 0 C--N 1.349 1.29 0 N-CA-C 111.971 -0.452 . . . . 72.34 111.971 177.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 339' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 61.9 -173.19 0.14 Allowed 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 125.254 1.422 . . . . 74.33 112.243 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 340' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -86.75 -49.2 7.62 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 109.792 -0.448 . . . . 75.24 109.792 174.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 341' ' ' LEU . . . . . 0.499 HD12 ' HG2' ' B' ' 344' ' ' GLU . 54.6 tp 35.66 86.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 126.326 1.85 . . . . 75.34 113.379 178.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 342' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -94.8 -68.82 0.78 Allowed 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 109.06 -0.718 . . . . 64.25 109.06 177.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 343' ' ' VAL . . . . . . . . . . . . . 4.4 p -160.43 87.68 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 107.688 -1.227 . . . . 64.24 107.688 178.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 344' ' ' GLU . . . . . 0.499 ' HG2' HD12 ' B' ' 341' ' ' LEU . 11.8 mm-40 -97.33 32.57 2.19 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-N 115.571 -0.74 . . . . 73.03 109.147 -176.184 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 345' ' ' GLY . . . . . . . . . . . . . . . 84.43 -65.91 3.99 Favored Glycine 0 C--N 1.345 1.066 0 N-CA-C 109.674 -1.37 . . . . 62.31 109.674 -165.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 346' ' ' ALA . . . . . . . . . . . . . . . -134.33 -171.06 2.66 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.552 1.141 . . . . 72.22 108.756 172.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 80.1 p -74.15 165.75 24.62 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 109.49 -0.559 . . . . 72.21 109.49 166.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 8.8 tt -82.1 57.18 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.551 0 CA-C-O 121.945 0.879 . . . . 73.42 109.849 178.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 349' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -62.29 -60.84 2.99 Favored 'General case' 0 C--N 1.359 1.001 0 N-CA-C 108.987 -0.746 . . . . 71.13 108.987 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 350' ' ' LYS . . . . . 0.401 ' O ' ' HB2' ' B' ' 351' ' ' GLN . 71.1 tttt 67.14 -12.25 0.25 Allowed 'General case' 0 CA--C 1.56 1.348 0 C-N-CA 124.747 1.219 . . . . 74.52 114.286 164.14 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 351' ' ' GLN . . . . . 0.401 ' HB2' ' O ' ' B' ' 350' ' ' LYS . 1.5 mp0 72.03 5.68 5.39 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 124.856 1.262 . . . . 71.32 110.951 -160.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -156.21 155.01 31.67 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.501 0.72 . . . . 74.35 110.585 -174.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 353' ' ' HIS . . . . . 0.517 ' HB3' ' HB3' ' C' ' 20' ' ' GLU . 19.5 t-80 -150.17 -41.48 0.13 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.805 1.242 . . . . 74.33 108.338 179.294 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 354' ' ' ALA . . . . . 0.573 ' HB3' HH21 ' C' ' 24' ' ' ARG . . . -161.19 16.04 0.11 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.43 0.692 . . . . 70.11 111.499 176.514 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 355' ' ' ALA . . . . . . . . . . . . . . . 64.59 -78.2 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 125.222 1.409 . . . . 75.44 110.989 -174.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 356' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 62.46 106.96 0.03 OUTLIER Pre-proline 0 CA--C 1.556 1.209 0 C-N-CA 125.566 1.546 . . . . 74.32 112.875 172.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 357' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.19 139.83 86.43 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 123.679 2.919 . . . . 55.22 113.84 -173.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 358' ' ' CYS . . . . . 0.569 ' HA ' ' HD3' ' C' ' 27' ' ' LYS . 74.9 m -67.1 165.3 16.15 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.119 0.968 . . . . 73.32 112.271 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 359' ' ' GLY . . . . . . . . . . . . . . . -68.79 113.67 5.4 Favored Glycine 0 C--N 1.35 1.343 0 CA-C-O 119.422 -0.654 . . . . 62.01 112.07 177.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 360' ' ' GLN . . . . . . . . . . . . . 25.3 tp60 65.59 35.54 7.05 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 124.723 1.209 . . . . 53.34 110.018 -177.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 361' ' ' ILE . . . . . 0.443 HD12 ' H ' ' B' ' 358' ' ' CYS . 19.3 tt -57.91 -32.64 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 C-N-CA 124.337 1.055 . . . . 61.31 112.222 -176.133 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 362' ' ' GLY . . . . . . . . . . . . . . . -159.82 98.11 0.17 Allowed Glycine 0 C--O 1.243 0.686 0 N-CA-C 110.704 -0.958 . . . . 72.35 110.704 176.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 363' ' ' GLU . . . . . 0.419 ' HG3' ' O ' ' B' ' 318' ' ' VAL . 1.9 tm-20 -175.52 86.82 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 107.443 -1.317 . . . . 73.13 107.443 175.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 364' ' ' THR . . . . . . . . . . . . . 89.7 m 65.09 -69.48 0.1 Allowed 'General case' 0 CA--C 1.57 1.741 0 C-N-CA 124.314 1.045 . . . . 74.04 112.537 177.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 22.0 t 64.39 42.52 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 126.195 1.798 . . . . 74.01 109.198 -178.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 34.0 t70 69.62 -60.17 0.48 Allowed 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 126.495 1.918 . . . . 50.12 112.043 179.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 367' ' ' LEU . . . . . 0.418 HD22 ' HA ' ' B' ' 309' ' ' THR . 49.8 tp -54.13 -26.59 28.4 Favored 'General case' 0 CA--C 1.564 1.485 0 C-N-CA 125.4 1.48 . . . . 75.05 113.161 176.056 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 368' ' ' ASP . . . . . 0.578 ' O ' HG22 ' B' ' 371' ' ' VAL . 19.4 t70 80.21 -14.79 0.81 Allowed 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 126.25 1.82 . . . . 71.23 112.154 -178.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 369' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -62.39 -16.04 52.41 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.665 0.786 . . . . 70.1 112.96 -175.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 370' ' ' ALA . . . . . . . . . . . . . . . -58.33 -23.76 57.61 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 122.687 0.395 . . . . 74.25 111.806 175.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 371' ' ' VAL . . . . . 0.835 HG21 ' HA3' ' B' ' 140' ' ' GLY . 11.2 m -107.98 11.97 8.82 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.226 0 C-N-CA 123.83 0.852 . . . . 74.11 111.568 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 372' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -135.13 151.03 50.33 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.993 0.917 . . . . 63.2 110.933 -176.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 373' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -146.91 49.02 1.14 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.264 0.626 . . . . 72.05 109.967 174.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . 66.17 179.21 0.21 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 124.89 1.276 . . . . 71.45 111.872 -173.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 375' ' ' LEU . . . . . 0.443 ' HA ' ' HA3' ' C' ' 190' ' ' GLY . 47.0 tp -163.5 -37.41 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.844 0.458 . . . . 62.01 110.768 175.119 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 376' ' ' GLU . . . . . 0.681 ' HG3' ' HA ' ' B' ' 23' ' ' THR . 12.9 mm-40 -114.89 153.75 29.93 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.496 0.718 . . . . 73.13 112.442 -176.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 377' ' ' PHE . . . . . 0.437 ' HA ' ' NH2' ' B' ' 22' ' ' ARG . 74.6 t80 -168.73 -63.2 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.023 -0.989 . . . . 73.31 108.412 178.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 378' ' ' ALA . . . . . . . . . . . . . . . -174.07 84.89 0.04 OUTLIER 'General case' 0 C--O 1.245 0.819 0 C-N-CA 124.942 1.297 . . . . 61.1 109.003 -178.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm -61.43 -20.51 63.17 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.084 0.553 . . . . 72.01 111.44 176.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 380' ' ' LYS . . . . . . . . . . . . . 65.1 mttm 80.47 -52.13 0.34 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 126.223 1.809 . . . . 53.14 111.474 176.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 381' ' ' GLU . . . . . 0.481 ' HG2' ' H ' ' B' ' 383' ' ' ASN . 25.8 tt0 66.03 -76.59 0.04 OUTLIER 'General case' 0 C--N 1.359 1.0 0 C-N-CA 124.348 1.059 . . . . 74.34 110.243 -176.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . 100.92 -18.72 54.39 Favored Glycine 0 C--N 1.349 1.266 0 CA-C-N 116.043 -0.526 . . . . 73.1 113.567 176.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 383' ' ' ASN . . . . . 0.481 ' H ' ' HG2' ' B' ' 381' ' ' GLU . 2.8 t-20 -67.71 -11.73 58.98 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 123.51 0.724 . . . . 73.1 111.94 -176.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 384' ' ' THR . . . . . . . . . . . . . 40.1 p -63.58 -15.51 58.28 Favored 'General case' 0 CA--C 1.56 1.348 0 C-N-CA 123.71 0.804 . . . . 63.41 112.317 172.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 82.6 mt -75.67 -176.11 3.17 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.615 0.766 . . . . 75.12 111.815 174.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 386' ' ' VAL . . . . . . . . . . . . . 94.2 t 77.91 -41.14 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 C-N-CA 125.595 1.558 . . . . 62.42 112.091 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 387' ' ' ILE . . . . . . . . . . . . . 33.5 mm -76.51 75.38 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 C-N-CA 123.686 0.794 . . . . 74.12 110.766 -174.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 388' ' ' VAL . . . . . 0.516 HG12 ' H ' ' B' ' 391' ' ' ASP . 21.7 t 43.6 91.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 126.444 1.898 . . . . 54.33 112.674 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 389' ' ' THR . . . . . . . . . . . . . 34.6 p -75.87 3.56 9.83 Favored 'General case' 0 CA--C 1.559 1.326 0 N-CA-C 112.328 0.492 . . . . 71.25 112.328 -175.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . -94.8 -69.52 0.75 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.564 0.746 . . . . 70.34 110.677 171.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 391' ' ' ASP . . . . . 0.516 ' H ' HG12 ' B' ' 388' ' ' VAL . 13.2 m-20 -92.11 -12.76 32.11 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.026 0.931 . . . . 64.12 111.566 -169.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 392' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 64.94 18.57 11.55 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 125.114 1.365 . . . . 72.42 111.474 -174.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 393' ' ' ALA . . . . . 0.44 ' HA ' ' OE1' ' B' ' 397' ' ' GLN . . . 66.19 -73.65 0.07 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 125.387 1.475 . . . . 61.53 112.203 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 19.4 t60 56.67 66.56 1.15 Allowed 'General case' 0 C--N 1.359 0.997 0 C-N-CA 124.31 1.044 . . . . 73.31 108.91 -175.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . 60.95 -158.64 0.33 Allowed 'General case' 0 CA--C 1.559 1.32 0 CA-C-N 115.106 -0.952 . . . . 71.44 110.734 -172.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 33.3 t 63.31 -80.43 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.357 1.063 . . . . 75.55 112.497 173.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 397' ' ' GLN . . . . . 0.44 ' OE1' ' HA ' ' B' ' 393' ' ' ALA . 92.2 mt-30 -60.95 -40.3 92.82 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.356 1.062 . . . . 71.41 110.498 178.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 12.6 tt -156.52 116.2 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 N-CA-C 108.216 -1.031 . . . . 75.44 108.216 173.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 399' ' ' VAL . . . . . . . . . . . . . 3.3 p -113.67 -46.47 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 123.354 0.662 . . . . 73.32 112.65 -169.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 400' ' ' ALA . . . . . 0.525 ' HB3' ' HD3' ' B' ' 401' ' ' PRO . . . -69.12 -54.57 11.68 Favored Pre-proline 0 CA--C 1.56 1.338 0 CA-C-O 118.8 -0.619 . . . . 51.41 112.521 -173.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 401' ' ' PRO . . . . . 0.525 ' HD3' ' HB3' ' B' ' 400' ' ' ALA . 59.7 Cg_endo -98.16 112.5 0.09 OUTLIER 'Trans proline' 0 C--N 1.383 2.37 0 C-N-CA 122.03 1.82 . . . . 71.04 112.698 173.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -72.9 -39.77 66.1 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 109.052 -0.721 . . . . 74.34 109.052 172.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 403' ' ' THR . . . . . . . . . . . . . 7.7 t 173.44 172.65 0.15 Allowed 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 126.019 1.728 . . . . 51.3 108.248 170.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 404' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm 74.89 -47.24 0.62 Allowed 'General case' 0 N--CA 1.507 2.404 0 C-N-CA 125.465 1.506 . . . . 70.03 112.514 -176.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 405' ' ' ALA . . . . . . . . . . . . . . . -58.54 -38.62 67.5 Favored Pre-proline 0 CA--C 1.566 1.559 0 N-CA-C 115.008 1.484 . . . . 71.24 115.008 177.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 406' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -44.12 91.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.396 3.048 0 C-N-CA 122.922 2.414 . . . . 44.44 114.85 174.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . -133.77 -40.8 0.18 Allowed Glycine 0 C--N 1.338 0.642 0 CA-C-N 114.762 -1.108 . . . . 55.33 110.715 -178.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 408' ' ' LEU . . . . . . . . . . . . . 61.7 tp -63.75 -39.75 95.05 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.385 0.674 . . . . 72.03 109.616 170.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 70.8 p -72.8 -16.77 61.61 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.04 -0.982 . . . . 73.52 111.057 174.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 410' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 67.37 -144.97 0.14 Allowed 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 125.315 1.446 . . . . 51.32 108.944 -176.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . 79.37 -28.71 0.15 Allowed 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 124.978 1.311 . . . . 63.14 113.091 177.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 1.5 tt 50.9 78.49 0.11 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 125.864 1.665 . . . . 60.41 111.83 172.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 77.43 -54.59 0.54 Allowed 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 125.496 1.518 . . . . 71.14 112.119 177.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 414' ' ' THR . . . . . . . . . . . . . 13.0 m 72.87 -69.02 0.2 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 126.077 1.751 . . . . 73.24 112.089 176.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 415' ' ' LYS . . . . . . . . . . . . 0.269 12.8 ptmm? 59.36 -57.4 0.06 Allowed 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 127.653 2.381 . . . . 73.42 114.145 -175.213 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -79.15 94.38 5.37 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 121.498 -0.751 . . . . 75.33 110.391 175.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 417' ' ' GLY . . . . . . . . . . . . . . . -160.12 67.25 0.26 Allowed Glycine 0 C--N 1.347 1.173 0 CA-C-N 114.323 -1.308 . . . . 43.15 109.853 177.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 418' ' ' ALA . . . . . . . . . . . . . . . -70.65 -31.9 69.0 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.856 0.862 . . . . 70.25 110.647 -177.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 419' ' ' VAL . . . . . . . . . . . . . 46.2 t -101.41 -91.4 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 N-CA-C 107.29 -1.374 . . . . 62.03 107.29 170.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 420' ' ' MET . . . . . . . . . . . . . 26.8 ttt 48.81 -82.49 0.01 OUTLIER 'General case' 0 C--N 1.37 1.477 0 C-N-CA 123.929 0.892 . . . . 73.12 110.385 -167.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 421' ' ' VAL . . . . . . . . . . . . . 69.0 t -110.25 -78.73 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.209 0 N-CA-C 107.035 -1.468 . . . . 72.42 107.035 167.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 422' ' ' MET . . . . . . . . . . . . . 49.1 tpp 55.88 -73.82 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 126.327 1.851 . . . . 74.1 113.215 177.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 423' ' ' SER . . . . . . . . . . . . . 21.2 p -53.4 150.9 6.0 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.112 0.965 . . . . 62.22 112.67 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 424' ' ' TYR . . . . . . . . . . . . . 44.9 t80 74.58 -65.78 0.33 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 125.747 1.619 . . . . 72.42 110.474 -174.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . 58.33 43.3 95.71 Favored Glycine 0 C--N 1.351 1.373 0 N-CA-C 114.181 0.432 . . . . 75.12 114.181 173.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 426' ' ' ASN . . . . . . . . . . . . . 18.8 m120 58.59 23.84 11.34 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 124.064 0.946 . . . . 75.43 112.086 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 427' ' ' SER . . . . . . . . . . . . . 28.5 t -132.46 168.15 18.69 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.84 0.856 . . . . 75.14 109.458 -178.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -77.98 87.95 4.15 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-O 121.338 0.589 . . . . 73.23 110.617 -176.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 429' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -93.57 101.07 13.23 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 106.219 -1.771 . . . . 63.42 106.219 166.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -58.11 -53.91 52.89 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.252 1.021 . . . . 55.41 111.104 -172.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 17.7 m 65.67 -96.29 0.04 OUTLIER 'General case' 0 CA--C 1.561 1.389 0 O-C-N 124.941 1.401 . . . . 73.31 111.867 -177.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 432' ' ' GLN . . . . . . . . . . . . . 23.6 mp0 58.16 176.03 0.06 Allowed 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 124.897 1.279 . . . . 71.1 113.001 -170.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 433' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -81.46 103.06 10.94 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.49 1.116 . . . . 73.43 108.562 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 434' ' ' HIS . . . . . . . . . . . . . 10.5 m170 -126.87 170.07 12.6 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.68 0.792 . . . . 65.13 111.277 -172.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 435' ' ' THR . . . . . . . . . . . . . 15.8 m -71.31 -20.86 62.14 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.109 0.964 . . . . 73.42 112.115 -175.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . -59.18 -20.87 51.82 Favored Glycine 0 N--CA 1.475 1.267 0 N-CA-C 114.599 0.599 . . . . 43.54 114.599 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 72.3 p -55.22 -40.96 71.43 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.978 1.311 . . . . 54.14 112.957 -178.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 438' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -34.13 114.37 0.2 Allowed 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 125.94 1.696 . . . . 71.55 113.976 -172.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 439' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -149.86 152.45 35.13 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.128 0.571 . . . . 74.24 110.793 -176.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 440' ' ' ARG . . . . . . . . . . . . . 7.1 tpp180 -156.81 98.34 1.77 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.518 1.127 . . . . 70.1 108.225 177.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 441' ' ' ILE . . . . . 0.52 HG12 HD22 ' A' ' 235' ' ' LEU . 22.2 mt -69.52 118.83 14.49 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 CA-C-N 115.586 -0.734 . . . . 74.15 111.358 -173.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 442' ' ' ALA . . . . . . . . . . . . . . . -130.75 38.08 3.74 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 114.951 -1.022 . . . . 71.41 109.593 178.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . -80.94 170.18 16.58 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.455 -0.793 . . . . 74.21 110.024 173.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -55.02 142.02 31.83 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.843 0.857 . . . . 65.34 112.123 -178.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . 120.34 -78.69 0.32 Allowed Glycine 0 C--N 1.345 1.079 0 N-CA-C 110.744 -0.943 . . . . 74.34 110.744 -176.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 446' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -77.19 71.62 6.24 Favored 'Trans proline' 0 C--N 1.379 2.15 0 C-N-CA 122.8 2.334 . . . . 63.02 112.144 175.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 447' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -138.75 128.17 24.45 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 124.49 1.116 . . . . 60.0 109.503 175.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . 61.83 -176.07 0.13 Allowed 'General case' 0 CA--C 1.549 0.939 0 O-C-N 124.346 1.029 . . . . 74.31 112.986 175.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 449' ' ' ALA . . . . . 0.617 ' HB1' ' SD ' ' B' ' 464' ' ' MET . . . 62.57 -82.63 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 124.834 1.254 . . . . 61.52 112.753 171.084 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 450' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -79.98 -34.35 38.69 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.067 0.947 . . . . 61.12 111.382 -176.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 61.6 t -62.8 -76.73 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 123.964 0.906 . . . . 63.1 111.746 -170.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 452' ' ' VAL . . . . . . . . . . . . . 4.7 m -137.69 42.74 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 124.193 0.997 . . . . 60.45 108.823 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 72.22 -161.59 54.35 Favored Glycine 0 C--N 1.34 0.768 0 CA-C-N 114.736 -1.12 . . . . 73.44 110.449 -166.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 454' ' ' LEU . . . . . 0.463 ' HG ' ' H ' ' B' ' 461' ' ' PHE . 3.5 mm? -73.31 -64.29 1.01 Allowed 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 117.3 0.55 . . . . 72.5 110.629 -178.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 14.0 t -169.06 176.28 5.39 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 122.806 0.442 . . . . 61.41 110.81 174.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -84.87 63.32 7.98 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-O 122.029 0.919 . . . . 74.3 109.713 178.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 457' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -169.55 166.74 10.0 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 114.948 -1.024 . . . . 42.14 108.46 -177.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 34.1 p -70.25 -5.31 26.76 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.064 0.546 . . . . 72.13 111.578 172.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 459' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -67.86 89.19 0.27 Allowed 'General case' 0 C--N 1.353 0.728 0 N-CA-C 109.054 -0.721 . . . . 73.31 109.054 169.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 2.6 pp -145.47 144.5 30.63 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.05 -0.977 . . . . 65.42 108.864 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 461' ' ' PHE . . . . . 0.463 ' H ' ' HG ' ' B' ' 454' ' ' LEU . 96.6 m-85 -137.92 149.62 46.36 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.612 0.765 . . . . 62.31 109.521 -178.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 24.8 p90 -89.2 12.62 15.39 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.178 0.591 . . . . 72.53 111.207 177.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 41.1 p -74.72 85.05 2.13 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.204 1.002 . . . . 61.35 111.772 -172.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 464' ' ' MET . . . . . 0.617 ' SD ' ' HB1' ' B' ' 449' ' ' ALA . 83.5 mtp -147.98 101.15 3.27 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.3 1.04 . . . . 75.31 108.839 176.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -88.17 134.76 33.7 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 109.261 -0.644 . . . . 72.15 109.261 174.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -100.82 -48.87 4.33 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.25 0.62 . . . . 62.32 112.031 -174.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . -71.14 -30.39 66.42 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.894 0.878 . . . . 75.3 112.009 -175.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 90.7 mt -129.41 142.09 50.88 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 107.678 -1.23 . . . . 45.51 107.678 175.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 469' ' ' GLY . . . . . 0.522 ' HA3' ' HB2' ' C' ' 260' ' ' ARG . . . -72.98 99.41 0.94 Allowed Glycine 0 CA--C 1.527 0.843 0 N-CA-C 111.022 -0.831 . . . . 50.44 111.022 172.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 470' ' ' LEU . . . . . 0.414 HD13 ' N ' ' B' ' 471' ' ' LYS . 0.5 OUTLIER -150.05 147.82 28.28 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 108.113 -1.069 . . . . 73.2 108.113 -179.563 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 471' ' ' LYS . . . . . 0.414 ' N ' HD13 ' B' ' 470' ' ' LEU . 1.2 tmtp? . . . . . 0 C--O 1.247 0.97 0 N-CA-C 108.703 -0.851 . . . . 74.2 108.703 177.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.482 1.146 0 N-CA-C 109.883 -0.414 . . . . 55.23 109.883 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 60.08 19.32 8.54 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 125.357 1.463 . . . . 65.31 114.776 170.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -88.83 49.01 1.71 Allowed 'General case' 0 N--CA 1.485 1.287 0 O-C-N 121.662 -0.649 . . . . 52.01 110.881 178.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -39.11 102.75 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.607 1.563 . . . . 70.52 113.548 177.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 5' ' ' LYS . . . . . 0.484 ' HE2' HD11 ' C' ' 10' ' ' ILE . 48.0 mtpt -84.47 125.44 32.37 Favored 'General case' 0 C--O 1.245 0.832 0 N-CA-C 109.402 -0.592 . . . . 63.2 109.402 173.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -77.16 100.98 5.96 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.627 -0.879 . . . . 63.22 108.627 177.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 7' ' ' TYR . . . . . 0.54 ' HD1' HD12 ' C' ' 10' ' ' ILE . 23.4 m-85 -63.27 -31.17 72.25 Favored 'General case' 0 C--O 1.252 1.185 0 C-N-CA 123.741 0.817 . . . . 73.43 112.158 -172.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 8' ' ' TYR . . . . . 0.422 ' HE1' HD11 ' C' ' 22' ' ' ILE . 89.7 m-85 -60.51 -47.77 84.71 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.828 -0.624 . . . . 72.53 109.846 174.05 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.7 -38.02 88.05 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.546 0.738 . . . . 52.31 111.102 -177.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 10' ' ' ILE . . . . . 0.54 HD12 ' HD1' ' C' ' 7' ' ' TYR . 72.0 mt -58.28 -39.93 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 123.225 0.61 . . . . 63.34 110.41 175.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 11' ' ' LEU . . . . . 0.528 ' O ' ' HB1' ' C' ' 25' ' ' ALA . 86.0 mt -86.3 -11.67 51.57 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 112.654 0.613 . . . . 45.45 112.654 175.005 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.69 24.15 65.58 Favored Glycine 0 CA--C 1.535 1.328 0 N-CA-C 114.347 0.499 . . . . 64.33 114.347 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 5.8 m -105.84 156.19 37.02 Favored Pre-proline 0 N--CA 1.486 1.374 0 C-N-CA 124.056 0.942 . . . . 64.04 109.955 171.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -78.4 168.29 21.71 Favored 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 122.825 2.35 . . . . 74.43 114.427 -178.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 80.2 mtt180 -75.01 72.2 2.13 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.766 0.827 . . . . 71.52 109.87 173.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 175.11 -19.94 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.99 1.316 . . . . 71.24 108.896 -175.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -46.49 133.47 9.98 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 125.484 1.513 . . . . 71.14 113.447 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 18.2 p -74.19 148.2 41.85 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 123.946 0.779 . . . . 74.41 109.074 175.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 19' ' ' GLN . . . . . 0.402 ' HA ' HD12 ' C' ' 22' ' ' ILE . 25.9 tt0 -51.51 -34.11 34.58 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 124.069 0.948 . . . . 74.45 112.131 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 20' ' ' GLU . . . . . 0.517 ' HB3' ' HB3' ' B' ' 353' ' ' HIS . 0.9 OUTLIER -70.11 -44.98 67.86 Favored 'General case' 0 CA--C 1.556 1.201 0 CA-C-N 114.838 -1.074 . . . . 64.05 110.331 -179.461 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -73.38 -27.27 61.39 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 123.023 0.529 . . . . 73.42 111.659 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 22' ' ' ILE . . . . . 0.514 HD13 HD13 ' C' ' 57' ' ' LEU . 76.5 mt -61.97 -44.29 98.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 123.94 0.896 . . . . 61.32 109.073 169.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 23' ' ' LYS . . . . . 0.439 ' O ' ' HG3' ' C' ' 27' ' ' LYS . 5.1 ttpm? -65.02 -32.64 74.46 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 114.922 -1.036 . . . . 74.13 111.388 175.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 24' ' ' ARG . . . . . 0.636 ' HA ' ' HE3' ' C' ' 27' ' ' LYS . 56.1 mtt180 -62.67 -46.91 85.98 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 120.961 0.41 . . . . 73.52 111.118 175.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 25' ' ' ALA . . . . . 0.528 ' HB1' ' O ' ' C' ' 11' ' ' LEU . . . -62.13 -39.17 91.69 Favored 'General case' 0 C--O 1.251 1.14 0 CA-C-N 114.814 -1.084 . . . . 75.32 111.389 177.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 26' ' ' TYR . . . . . 0.477 ' HD1' HG22 ' C' ' 50' ' ' ILE . 38.9 t80 -54.3 -54.7 36.66 Favored 'General case' 0 C--O 1.207 -1.147 0 CA-C-N 115.115 -0.948 . . . . 72.31 109.975 170.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 27' ' ' LYS . . . . . 0.636 ' HE3' ' HA ' ' C' ' 24' ' ' ARG . 10.3 mtmp? -56.85 -40.13 75.54 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 123.319 0.647 . . . . 74.1 111.452 -176.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 28' ' ' ARG . . . . . 0.466 ' HA ' ' NH2' ' C' ' 31' ' ' ARG . 34.8 ttp180 -57.9 -52.25 66.26 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 123.936 0.773 . . . . 71.15 110.606 177.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 29' ' ' LEU . . . . . 0.425 ' HA ' ' HB3' ' C' ' 32' ' ' GLN . 80.6 mt -84.28 -9.72 58.25 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-N 114.905 -1.043 . . . . 60.22 111.756 -176.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -86.85 -23.5 25.26 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.991 0.917 . . . . 75.32 110.214 175.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 31' ' ' ARG . . . . . 0.466 ' NH2' ' HA ' ' C' ' 28' ' ' ARG . 54.7 mtm180 -80.4 -45.88 16.94 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.518 0.727 . . . . 73.5 109.108 167.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 32' ' ' GLN . . . . . 0.425 ' HB3' ' HA ' ' C' ' 29' ' ' LEU . 59.4 tp60 -60.94 -50.97 71.26 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.245 1.018 . . . . 71.12 112.263 -175.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 33' ' ' TYR . . . . . 0.514 ' HB3' ' O ' ' C' ' 43' ' ' ALA . 31.2 m-85 -103.94 20.03 18.92 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.066 0.547 . . . . 70.15 111.843 -172.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 34' ' ' HIS . . . . . 0.478 ' HB3' ' HB ' ' C' ' 37' ' ' VAL . 5.7 t60 -63.87 114.34 13.22 Favored Pre-proline 0 N--CA 1.482 1.16 0 CA-C-O 118.526 -0.75 . . . . 72.34 111.023 -172.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 35' ' ' PRO . . . . . 0.431 ' HA ' ' HG2' ' C' ' 44' ' ' GLU . 34.7 Cg_exo -40.25 -50.43 3.58 Favored 'Trans proline' 0 C--N 1.385 2.488 0 C-N-CA 124.868 3.712 . . . . 71.32 116.111 -166.084 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -91.39 -23.7 19.97 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 111.797 0.295 . . . . 60.34 111.797 -173.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 37' ' ' VAL . . . . . 0.478 ' HB ' ' HB3' ' C' ' 34' ' ' HIS . 69.0 t -74.67 -41.94 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 108.658 -0.867 . . . . 75.33 108.658 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -112.8 96.12 5.79 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.399 -1.334 . . . . 54.22 107.399 175.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -70.61 76.44 0.59 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.801 0.841 . . . . 62.24 110.138 -175.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 62.5 m -152.04 104.62 2.81 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 123.659 0.784 . . . . 74.14 109.306 -176.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -44.64 -38.4 12.33 Favored 'Trans proline' 0 C--N 1.382 2.305 0 C-N-CA 123.882 3.054 . . . . 63.44 113.554 173.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -52.02 -49.94 62.38 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.647 0.779 . . . . 65.44 110.588 174.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 43' ' ' ALA . . . . . 0.514 ' O ' ' HB3' ' C' ' 33' ' ' TYR . . . -71.11 -21.72 62.18 Favored 'General case' 0 C--O 1.213 -0.831 0 CA-C-N 115.143 -0.935 . . . . 62.05 110.805 -178.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 44' ' ' GLU . . . . . 0.471 ' O ' ' HG3' ' C' ' 48' ' ' LYS . 38.0 mt-10 -76.37 -36.06 58.34 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.481 -0.563 . . . . 74.04 109.481 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -73.27 -38.73 65.84 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.756 0.822 . . . . 42.53 110.382 176.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 46' ' ' LYS . . . . . 0.5 ' O ' HG12 ' C' ' 50' ' ' ILE . 0.4 OUTLIER -63.91 -39.16 93.53 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.751 -0.659 . . . . 72.32 109.355 172.711 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -63.52 -34.53 78.0 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.08 0.952 . . . . 62.23 110.317 176.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 48' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' C' ' 44' ' ' GLU . 94.6 mttt -63.28 -43.47 97.83 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.487 -0.324 . . . . 72.04 110.28 174.076 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -64.11 -33.88 76.77 Favored 'General case' 0 CA--C 1.555 1.148 0 O-C-N 122.928 0.142 . . . . 72.33 110.741 176.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 50' ' ' ILE . . . . . 0.5 HG12 ' O ' ' C' ' 46' ' ' LYS . 13.2 mm -65.11 -42.48 94.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 CA-C-O 121.571 0.701 . . . . 75.43 109.441 175.018 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 51' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -76.31 -18.18 59.07 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 114.454 -1.248 . . . . 74.04 111.972 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 52' ' ' GLU . . . . . 0.454 ' O ' HG23 ' C' ' 56' ' ' VAL . 33.6 tt0 -74.86 -56.52 4.68 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.323 1.049 . . . . 63.42 108.611 176.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.95 -44.37 78.37 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 113.823 -1.535 . . . . 63.1 110.781 177.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -67.45 -38.6 84.73 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.33 -0.85 . . . . 75.01 111.152 176.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.32 -36.57 68.87 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 117.891 0.314 . . . . 60.54 111.197 177.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 56' ' ' VAL . . . . . 0.464 HG13 ' HZ ' ' C' ' 101' ' ' PHE . 3.0 t -94.98 -11.82 8.73 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 CA-C-N 115.902 -0.59 . . . . 72.43 111.871 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 57' ' ' LEU . . . . . 0.514 HD13 HD13 ' C' ' 22' ' ' ILE . 86.5 mt -126.37 19.86 7.44 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.98 -1.075 . . . . 75.02 113.654 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 45.9 t -80.74 -56.52 4.09 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 123.22 0.608 . . . . 62.42 112.456 178.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 59' ' ' ASP . . . . . 0.624 ' HB2' ' HD3' ' C' ' 62' ' ' LYS . 3.6 m-20 -108.68 153.6 42.16 Favored Pre-proline 0 N--CA 1.487 1.414 0 CA-C-O 118.086 -0.959 . . . . 72.03 109.904 -168.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 60' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -44.09 -43.47 12.75 Favored 'Trans proline' 0 C--N 1.397 3.106 0 C-N-CA 124.453 3.436 . . . . 33.23 114.192 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -61.89 -60.4 3.7 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.637 -0.71 . . . . 62.13 111.491 -178.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 62' ' ' LYS . . . . . 0.624 ' HD3' ' HB2' ' C' ' 59' ' ' ASP . 0.1 OUTLIER -62.67 -40.12 96.08 Favored 'General case' 0 C--O 1.248 1.01 0 O-C-N 124.244 0.965 . . . . 75.23 109.419 -173.164 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 47.2 tpt85 -51.84 -55.79 17.84 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 114.06 -1.427 . . . . 64.42 109.993 176.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -74.93 -18.07 60.46 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.333 -0.849 . . . . 74.15 112.499 -177.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 69.2 mt -62.94 -48.85 86.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 108.645 -0.872 . . . . 62.34 108.645 170.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -65.7 -43.86 87.88 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.799 -0.637 . . . . 74.22 110.681 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -61.59 -36.13 79.8 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 122.765 0.426 . . . . 73.14 111.578 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 74.4 p -83.9 -15.49 47.84 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 119.144 -0.455 . . . . 63.2 111.165 175.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -71.33 136.25 47.75 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.42 -0.956 . . . . 75.22 108.42 175.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.64 19.21 55.0 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 111.296 -0.721 . . . . 62.51 111.296 -167.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 58.6 m -145.84 -59.07 0.32 Allowed 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 103.274 -2.862 . . . . 72.34 103.274 174.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 13.3 m -79.88 137.47 36.92 Favored 'General case' 0 C--O 1.251 1.168 0 N-CA-C 104.63 -2.359 . . . . 73.35 104.63 156.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.09 -30.9 5.53 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.957 0.903 . . . . 73.23 110.15 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.45 124.86 91.4 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 115.614 -0.721 . . . . 53.23 109.219 174.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -53.31 146.1 41.97 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 122.871 2.381 . . . . 75.14 112.293 173.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -51.89 139.59 50.1 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 123.01 2.473 . . . . 63.14 112.849 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.66 138.9 86.81 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 122.743 2.295 . . . . 51.51 111.705 172.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 78' ' ' PRO . . . . . 0.512 ' HB3' ' HB2' ' C' ' 103' ' ' PRO . 18.0 Cg_endo -59.22 116.45 3.28 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 122.85 2.366 . . . . 74.44 112.581 -176.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -64.21 124.05 12.82 Favored 'Trans proline' 0 C--N 1.376 2.023 0 C-N-CA 122.324 2.016 . . . . 61.04 109.729 171.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -55.32 83.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.392 2.824 0 C-N-CA 123.751 2.967 . . . . 51.5 112.697 -175.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 161.91 -59.99 0.29 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 109.245 -1.542 . . . . 75.2 109.245 -174.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.437 ' HA3' ' HG3' ' C' ' 167' ' ' GLN . . . 143.61 172.69 14.61 Favored Glycine 0 C--N 1.358 1.795 0 C-N-CA 123.069 0.366 . . . . 74.45 112.761 -177.174 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -90.37 119.02 30.31 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.684 -0.858 . . . . 70.14 108.684 171.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 84' ' ' ASP . . . . . 0.612 ' HB2' ' HA ' ' C' ' 164' ' ' MET . 6.6 p-10 -70.29 133.21 46.76 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.509 0.724 . . . . 63.13 111.156 -178.336 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 85' ' ' PHE . . . . . 0.597 ' HB3' ' HB2' ' C' ' 88' ' ' PHE . 54.8 m-85 -139.43 69.81 1.37 Allowed 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.813 0.816 . . . . 74.41 110.796 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 16.7 m -61.5 96.07 0.06 Allowed 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 114.276 -1.329 . . . . 45.43 111.442 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.11 5.11 90.34 Favored Glycine 0 C--N 1.347 1.14 0 CA-C-N 115.807 -0.633 . . . . 74.33 113.317 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 88' ' ' PHE . . . . . 0.597 ' HB2' ' HB3' ' C' ' 85' ' ' PHE . 6.3 m-85 -103.78 118.07 35.83 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 108.154 -1.054 . . . . 74.44 108.154 -179.06 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -83.7 73.32 10.28 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 122.2 1.0 . . . . 72.23 110.766 -176.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 90' ' ' VAL . . . . . 0.666 HG11 ' HB3' ' C' ' 106' ' ' PHE . 2.4 p -41.32 -43.28 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 C-N-CA 126.551 1.94 . . . . 54.41 113.961 175.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -61.78 -32.01 72.26 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.831 0.852 . . . . 74.21 112.049 -175.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -101.26 4.18 41.55 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.482 0.313 . . . . 75.53 111.471 -176.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 93' ' ' PHE . . . . . 0.454 ' CD2' ' HA ' ' C' ' 90' ' ' VAL . 19.4 m-30 -78.04 177.5 8.26 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 110.23 -0.285 . . . . 72.45 110.23 174.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 77.4 p -62.18 158.63 16.49 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.829 0.852 . . . . 45.51 113.269 -173.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 95' ' ' GLU . . . . . 0.465 ' O ' ' HG3' ' C' ' 99' ' ' GLU . 0.0 OUTLIER -64.25 -25.69 68.17 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 123.51 0.507 . . . . 55.43 111.008 170.98 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -62.44 -45.41 93.19 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.694 0.798 . . . . 65.02 110.413 172.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 97' ' ' PHE . . . . . 0.535 ' HE2' HG23 ' C' ' 90' ' ' VAL . 32.5 t80 -64.93 -37.17 86.74 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 115.02 -0.991 . . . . 64.25 109.432 175.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 98' ' ' GLN . . . . . 0.409 ' HB2' ' HA ' ' C' ' 95' ' ' GLU . 70.3 mt-30 -71.12 -17.27 62.57 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.021 -0.99 . . . . 51.52 112.003 178.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 99' ' ' GLU . . . . . 0.465 ' HG3' ' O ' ' C' ' 95' ' ' GLU . 40.2 mt-10 -78.22 -57.9 3.54 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 109.602 -0.518 . . . . 74.43 109.602 167.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 26.6 tp -65.94 -31.26 72.08 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 114.369 -1.287 . . . . 73.23 112.336 -166.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 101' ' ' PHE . . . . . 0.464 ' HZ ' HG13 ' C' ' 56' ' ' VAL . 76.6 m-85 -120.34 13.37 11.88 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.377 0.671 . . . . 73.25 110.885 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -43.55 -63.8 2.05 Favored Glycine 0 C--N 1.352 1.437 0 N-CA-C 116.241 1.256 . . . . 54.11 116.241 -173.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 103' ' ' PRO . . . . . 0.512 ' HB2' ' HB3' ' C' ' 78' ' ' PRO . 38.8 Cg_exo -58.81 -6.3 3.31 Favored 'Trans proline' 0 C--N 1.373 1.837 0 C-N-CA 123.545 2.83 . . . . 62.02 115.225 -174.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -147.28 41.02 0.97 Allowed Glycine 0 C--N 1.351 1.407 0 CA-C-O 119.634 -0.537 . . . . 43.23 112.712 176.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 105' ' ' LEU . . . . . 0.408 HD11 ' HA ' ' C' ' 98' ' ' GLN . 38.0 mt -62.88 21.59 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 116.445 2.017 . . . . 73.03 116.445 -177.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 106' ' ' PHE . . . . . 0.666 ' HB3' HG11 ' C' ' 90' ' ' VAL . 17.2 t80 57.9 -94.34 0.05 OUTLIER 'General case' 0 CA--C 1.568 1.658 0 CA-C-N 120.252 1.387 . . . . 64.24 111.583 164.047 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 107' ' ' GLY . . . . . 0.694 ' HA3' ' HB2' ' C' ' 113' ' ' SER . . . 113.97 17.81 7.16 Favored Glycine 0 C--N 1.344 1.026 0 C-N-CA 125.393 1.473 . . . . 51.05 113.861 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . -9.49 -70.7 0.01 OUTLIER Glycine 0 N--CA 1.479 1.538 0 C-N-CA 127.035 2.255 . . . . 74.41 118.262 172.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 109' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -123.78 25.15 8.17 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.028 0.531 . . . . 74.45 110.274 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 110' ' ' GLY . . . . . . . . . . . . . . . -76.27 -1.78 70.87 Favored Glycine 0 C--N 1.35 1.317 0 CA-C-N 115.593 -0.731 . . . . 54.22 113.11 173.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 9.2 tpp180 81.9 -41.17 0.13 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 127.074 2.15 . . . . 75.25 112.481 171.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 112' ' ' ARG . . . . . 0.468 ' O ' ' N ' ' C' ' 114' ' ' ARG . 9.8 tpp180 -126.88 -39.62 1.95 Allowed 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 117.273 -1.346 . . . . 74.1 113.308 170.216 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 113' ' ' SER . . . . . 0.694 ' HB2' ' HA3' ' C' ' 107' ' ' GLY . 12.7 m -5.63 -33.75 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.469 0 N-CA-C 120.206 3.41 . . . . 72.53 120.206 -168.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 114' ' ' ARG . . . . . 0.518 ' HB3' ' HA2' ' C' ' 168' ' ' GLY . 1.5 tpp180 -159.9 161.96 34.43 Favored 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 107.683 -1.229 . . . . 74.05 107.683 164.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 115' ' ' LYS . . . . . . . . . . . . . 23.4 tptp -85.07 130.12 34.67 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 108.155 -1.054 . . . . 54.14 108.155 165.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 116' ' ' GLY . . . . . 0.592 ' HA2' ' HA3' ' C' ' 168' ' ' GLY . . . -51.92 111.54 1.52 Allowed Glycine 0 C--N 1.358 1.754 0 O-C-N 124.68 1.237 . . . . 45.25 113.302 -178.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 117' ' ' ARG . . . . . 0.452 ' HB2' ' HA3' ' C' ' 166' ' ' GLY . 52.1 mmm-85 -70.03 97.9 1.23 Allowed 'General case' 0 C--O 1.249 1.027 0 N-CA-C 107.314 -1.365 . . . . 64.44 107.314 174.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 118' ' ' ASP . . . . . 0.41 ' HB2' ' HA ' ' B' ' 151' ' ' HIS . 4.5 m-20 -67.09 98.12 0.56 Allowed 'General case' 0 C--O 1.242 0.659 0 CA-C-N 114.767 -1.106 . . . . 75.42 108.166 -178.141 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 119' ' ' LEU . . . . . 0.41 ' O ' HD12 ' C' ' 174' ' ' LEU . 56.0 tp -93.05 98.67 11.49 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 108.134 -1.061 . . . . 75.21 108.134 -168.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.444 HH12 HG21 ' C' ' 158' ' ' VAL . 40.8 ttm-85 -100.48 114.83 28.76 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.58 -0.896 . . . . 72.31 108.58 -177.073 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 121' ' ' ALA . . . . . 0.505 ' HB3' HD23 ' C' ' 176' ' ' LEU . . . -115.46 130.25 56.82 Favored 'General case' 0 C--O 1.219 -0.534 0 C-N-CA 123.644 0.777 . . . . 63.21 110.366 -174.015 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 122' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' C' ' 177' ' ' VAL . 11.5 pt-20 -90.06 147.63 23.53 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 109.413 -0.588 . . . . 73.22 109.413 174.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 123' ' ' LEU . . . . . 0.505 ' HB2' HG11 ' B' ' 182' ' ' VAL . 2.6 pt? -143.81 123.12 7.34 Favored Pre-proline 0 N--CA 1.482 1.173 0 N-CA-C 112.68 0.622 . . . . 73.3 112.68 -176.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 124' ' ' PRO . . . . . 0.445 ' HA ' ' O ' ' C' ' 179' ' ' ARG . 24.3 Cg_exo -65.7 117.67 4.83 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 122.739 2.293 . . . . 72.51 110.905 170.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 125' ' ' LEU . . . . . 0.458 HD23 HG11 ' C' ' 153' ' ' VAL . 44.7 tp -145.32 153.72 41.56 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.92 0.488 . . . . 74.03 110.311 -172.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 126' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.31 166.01 10.68 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.766 0.827 . . . . 61.53 109.873 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 127' ' ' LEU . . . . . 0.5 HD21 HD13 ' C' ' 180' ' ' LEU . 94.4 mt -78.13 -36.79 47.42 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.854 0.862 . . . . 62.25 111.333 -178.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 128' ' ' GLU . . . . . 0.527 ' HG2' ' H ' ' B' ' 171' ' ' ALA . 18.0 mp0 -70.52 -32.18 69.54 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.987 -1.006 . . . . 75.24 109.542 173.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -87.4 -8.71 56.25 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.095 0.558 . . . . 73.53 111.416 176.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -76.56 -43.19 40.04 Favored 'General case' 0 C--O 1.22 -0.461 0 N-CA-C 108.191 -1.04 . . . . 64.34 108.191 164.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 131' ' ' PHE . . . . . 0.461 ' HB2' HD13 ' C' ' 215' ' ' LEU . 77.5 t80 -60.2 -37.99 81.94 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.781 1.233 . . . . 75.55 111.234 174.145 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 132' ' ' HIS . . . . . 0.436 ' HB3' ' CD1' ' B' ' 131' ' ' TRP . 65.7 m170 -78.68 -69.96 0.53 Allowed 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.831 -0.622 . . . . 60.22 110.669 177.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 49.46 -103.81 0.09 OUTLIER Glycine 0 C--N 1.353 1.52 0 O-C-N 124.047 0.842 . . . . 65.31 112.986 -178.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.98 -153.8 34.67 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 114.525 0.57 . . . . 53.24 114.525 170.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -93.42 93.86 8.39 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.152 -1.055 . . . . 71.2 108.152 -167.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 136' ' ' ARG . . . . . 0.628 ' HB3' ' HB2' ' B' ' 181' ' ' LEU . 0.9 OUTLIER -142.19 147.45 36.61 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 122.229 -0.295 . . . . 72.12 110.979 -167.977 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 137' ' ' VAL . . . . . 0.583 ' HA ' ' HA ' ' C' ' 146' ' ' SER . 7.7 p -95.07 129.99 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-O 121.493 0.664 . . . . 71.12 111.364 -177.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 138' ' ' VAL . . . . . . . . . . . . . 3.0 p -114.84 140.72 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.612 1.165 . . . . 72.14 108.953 178.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 139' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -108.0 111.59 23.74 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 107.8 -1.185 . . . . 74.31 107.8 172.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 140' ' ' VAL . . . . . 0.415 HG21 ' HB2' ' C' ' 121' ' ' ALA . 2.7 p -130.63 128.15 62.94 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 C-N-CA 123.896 0.878 . . . . 63.22 109.215 -179.174 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 65.37 33.36 9.03 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.803 0.841 . . . . 15.23 112.388 174.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 78.7 12.5 84.15 Favored Glycine 0 C--N 1.345 1.044 0 CA-C-N 116.399 -0.364 . . . . 45.25 112.302 -176.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 143' ' ' ARG . . . . . . . . . . . . . 29.1 tpt180 -126.32 100.83 6.45 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.445 0.698 . . . . 73.04 109.991 -168.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -83.99 129.33 34.92 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.181 -0.918 . . . . 71.51 109.225 176.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 145' ' ' VAL . . . . . . . . . . . . . 3.7 p -166.34 140.26 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 123.822 0.849 . . . . 75.03 109.854 -174.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 146' ' ' SER . . . . . 0.583 ' HA ' ' HA ' ' C' ' 137' ' ' VAL . 56.8 p -100.7 146.05 27.69 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.075 0.55 . . . . 54.21 111.998 -174.079 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 8.9 p -151.67 150.33 13.22 Favored 'Isoleucine or valine' 0 C--O 1.242 0.711 0 CA-C-N 115.716 -0.674 . . . . 72.53 109.838 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 148' ' ' ARG . . . . . 0.488 ' NH1' ' HB3' ' B' ' 206' ' ' GLU . 20.3 ttt180 -105.36 94.67 5.34 Favored 'General case' 0 C--N 1.347 0.482 0 N-CA-C 107.971 -1.122 . . . . 74.22 107.971 168.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 149' ' ' ILE . . . . . 0.418 HD12 HD13 ' C' ' 159' ' ' ILE . 37.8 pt -75.97 146.68 79.44 Favored Pre-proline 0 CA--C 1.55 0.956 0 CA-C-O 118.603 -0.713 . . . . 71.41 109.513 176.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.37 115.75 2.8 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 122.408 2.072 . . . . 61.44 111.619 177.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -51.72 111.69 0.65 Allowed 'Trans proline' 0 C--N 1.384 2.424 0 C-N-CA 123.633 2.889 . . . . 73.2 114.081 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 152' ' ' GLY . . . . . . . . . . . . . . . 139.77 136.28 3.35 Favored Glycine 0 C--N 1.35 1.324 0 CA-C-N 115.373 -0.83 . . . . 54.32 113.175 -174.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 153' ' ' VAL . . . . . 0.458 HG11 HD23 ' C' ' 125' ' ' LEU . 1.7 p -160.38 160.72 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.777 0 CA-C-N 117.192 0.496 . . . . 71.13 112.2 177.119 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 154' ' ' ARG . . . . . 0.475 ' HD3' ' O ' ' C' ' 188' ' ' LEU . 43.9 ttp180 -128.2 139.68 52.33 Favored 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 125.052 1.341 . . . . 75.32 109.225 177.147 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 155' ' ' GLU . . . . . 0.609 ' HB2' HD12 ' C' ' 180' ' ' LEU . 21.8 tp10 -40.51 123.53 1.83 Allowed 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 125.464 1.506 . . . . 74.51 113.9 176.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 81.09 -13.46 32.02 Favored Glycine 0 C--N 1.353 1.486 0 CA-C-N 115.054 -0.976 . . . . 64.51 113.951 176.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 157' ' ' SER . . . . . . . . . . . . . 17.1 m -83.56 166.28 18.36 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.226 0.61 . . . . 75.43 111.203 -174.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 158' ' ' VAL . . . . . 0.547 HG22 HG22 ' C' ' 177' ' ' VAL . 21.5 t -111.66 136.44 47.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 CA-C-N 115.245 -0.889 . . . . 64.44 110.884 -163.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 159' ' ' ILE . . . . . 0.687 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 27.2 mt -105.99 122.13 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 107.136 -1.431 . . . . 52.25 107.136 172.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 16.8 ttm180 -83.8 141.22 31.54 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 117.947 0.339 . . . . 72.21 110.151 178.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 161' ' ' VAL . . . . . 0.505 ' HB ' ' HB3' ' C' ' 174' ' ' LEU . 39.8 t -128.74 97.65 26.74 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 107.24 -1.393 . . . . 75.24 107.24 164.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -62.92 127.67 21.05 Favored 'Trans proline' 0 C--N 1.377 2.038 0 C-N-CA 122.92 2.413 . . . . 63.42 113.489 -172.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 163' ' ' GLY . . . . . 0.676 ' H ' ' HB3' ' C' ' 173' ' ' ASP . . . 84.67 -18.39 25.61 Favored Glycine 0 CA--C 1.541 1.665 0 N-CA-C 115.135 0.814 . . . . 53.31 115.135 177.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 164' ' ' MET . . . . . 0.612 ' HA ' ' HB2' ' C' ' 84' ' ' ASP . 31.3 ttp -94.77 38.71 1.11 Allowed 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 117.94 0.87 . . . . 73.35 112.317 -167.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . -109.02 -147.01 11.96 Favored Glycine 0 N--CA 1.473 1.132 0 CA-C-N 115.718 -0.674 . . . . 64.24 112.649 174.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 166' ' ' GLY . . . . . 0.452 ' HA3' ' HB2' ' C' ' 117' ' ' ARG . . . -88.88 -177.22 46.53 Favored Glycine 0 C--N 1.351 1.405 0 CA-C-O 119.868 -0.407 . . . . 75.44 112.992 -179.102 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 167' ' ' GLN . . . . . 0.662 ' HA ' ' HA ' ' C' ' 106' ' ' PHE . 28.4 mt-30 -49.97 129.21 20.16 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.168 1.387 . . . . 64.31 112.894 -173.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 168' ' ' GLY . . . . . 0.592 ' HA3' ' HA2' ' C' ' 116' ' ' GLY . . . 165.71 158.07 10.47 Favored Glycine 0 C--N 1.351 1.412 0 N-CA-C 114.984 0.754 . . . . 13.44 114.984 173.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 169' ' ' ASN . . . . . 0.548 ' HB3' ' HD3' ' C' ' 170' ' ' PRO . 5.0 t30 -90.37 -55.43 0.28 Allowed Pre-proline 0 CA--C 1.557 1.213 0 CA-C-N 114.166 -1.017 . . . . 62.44 110.298 165.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 170' ' ' PRO . . . . . 0.548 ' HD3' ' HB3' ' C' ' 169' ' ' ASN . 20.9 Cg_exo -64.44 118.52 5.48 Favored 'Trans proline' 0 C--N 1.399 3.221 0 CA-C-N 120.883 1.351 . . . . 51.41 109.029 175.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 171' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -46.17 107.0 0.1 Allowed 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 123.335 2.69 . . . . 74.02 114.073 -167.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -82.62 -48.15 5.67 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-N 115.154 -0.93 . . . . 74.42 111.154 175.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 173' ' ' ASP . . . . . 0.676 ' HB3' ' H ' ' C' ' 163' ' ' GLY . 2.4 p30 50.84 173.11 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 115.709 1.744 . . . . 74.51 115.709 172.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 174' ' ' LEU . . . . . 0.505 ' HB3' ' HB ' ' C' ' 161' ' ' VAL . 49.5 tp -100.73 132.87 45.91 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 115.488 -0.778 . . . . 75.22 109.759 -177.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 175' ' ' LEU . . . . . 0.506 HD21 ' HE1' ' B' ' 147' ' ' HIS . 90.0 mt -127.54 89.31 2.93 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.924 0.869 . . . . 71.32 110.316 -173.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 176' ' ' LEU . . . . . 0.687 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 96.0 mt -76.36 97.26 4.2 Favored 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 114.262 -1.336 . . . . 43.02 111.945 -175.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 177' ' ' VAL . . . . . 0.547 HG22 HG22 ' C' ' 158' ' ' VAL . 71.5 t -83.56 109.94 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 108.334 -0.987 . . . . 74.43 108.334 174.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 178' ' ' VAL . . . . . 0.433 ' HA ' HD23 ' C' ' 123' ' ' LEU . 8.2 p -75.14 136.03 25.96 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 CA-C-O 121.919 0.866 . . . . 74.01 111.707 -173.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 179' ' ' ARG . . . . . 0.445 ' O ' ' HA ' ' C' ' 124' ' ' PRO . 8.5 mmm180 -109.76 96.1 6.03 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 105.563 -2.014 . . . . 72.33 105.563 171.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 180' ' ' LEU . . . . . 0.609 HD12 ' HB2' ' C' ' 155' ' ' GLU . 77.0 mt -68.97 148.52 50.02 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-O 121.26 0.552 . . . . 70.51 111.046 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 181' ' ' LEU . . . . . . . . . . . . . 56.8 mt -68.97 171.49 6.37 Favored Pre-proline 0 N--CA 1.484 1.235 0 CA-C-N 114.217 -1.356 . . . . 74.2 110.494 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -60.98 67.37 0.09 OUTLIER 'Trans proline' 0 C--N 1.384 2.423 0 C-N-CA 122.543 2.162 . . . . 64.12 111.855 166.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 183' ' ' HIS . . . . . 0.595 ' H ' ' HD3' ' C' ' 184' ' ' PRO . 71.1 t60 -170.25 27.39 0.01 OUTLIER Pre-proline 0 CA--C 1.582 2.195 0 C-N-CA 126.726 2.01 . . . . 62.13 109.894 -177.1 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 184' ' ' PRO . . . . . 0.595 ' HD3' ' H ' ' C' ' 183' ' ' HIS . 12.2 Cg_endo -84.74 68.22 6.2 Favored 'Trans proline' 0 C--N 1.405 3.522 0 C-N-CA 122.542 2.161 . . . . 71.54 110.513 -173.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 185' ' ' VAL . . . . . 0.596 HG12 ' HB1' ' C' ' 195' ' ' ALA . 5.9 t -90.4 -40.95 13.21 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.573 0 N-CA-C 107.658 -1.238 . . . . 72.23 107.658 -172.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 186' ' ' PHE . . . . . 0.415 ' HB2' HD13 ' C' ' 127' ' ' LEU . 74.5 m-85 -99.24 104.56 16.5 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.687 0.795 . . . . 61.44 109.825 -172.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 187' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -94.41 113.3 25.15 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.292 1.437 . . . . 75.14 108.465 -177.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 188' ' ' LEU . . . . . 0.588 HD13 ' HD2' ' C' ' 240' ' ' PHE . 64.7 tp -81.93 146.99 29.5 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 113.233 0.827 . . . . 74.14 113.233 -171.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 189' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' B' ' 375' ' ' LEU . 32.8 tt0 -145.59 101.88 3.62 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.033 1.333 . . . . 71.33 107.55 164.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 190' ' ' GLY . . . . . 0.443 ' HA3' ' HA ' ' B' ' 375' ' ' LEU . . . 74.73 -102.25 1.39 Allowed Glycine 0 C--N 1.346 1.115 0 N-CA-C 112.159 -0.376 . . . . 74.2 112.159 -175.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 191' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -112.24 -13.68 13.45 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.493 0.717 . . . . 60.21 110.363 170.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -87.72 141.06 28.89 Favored 'General case' 0 C--O 1.213 -0.835 0 C-N-CA 123.689 0.796 . . . . 65.13 110.685 -170.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 193' ' ' LEU . . . . . . . . . . . . . 85.6 mt -106.58 167.56 9.77 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 122.899 0.48 . . . . 52.2 110.871 -176.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 194' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -143.2 105.3 4.4 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.567 -0.531 . . . . 75.43 109.567 171.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 195' ' ' ALA . . . . . 0.596 ' HB1' HG12 ' C' ' 185' ' ' VAL . . . -119.52 -176.35 3.14 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.607 1.163 . . . . 65.11 109.324 177.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 30.1 m -123.78 133.58 53.8 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 109.306 -0.628 . . . . 51.32 109.306 176.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 197' ' ' LEU . . . . . 0.458 HD13 ' HB2' ' C' ' 212' ' ' ALA . 32.0 tp -107.2 122.73 47.11 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.403 0.681 . . . . 73.5 109.567 -178.14 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -82.56 98.16 8.83 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 108.566 -0.901 . . . . 44.52 108.566 176.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 199' ' ' VAL . . . . . . . . . . . . . 60.3 t -107.77 121.42 44.11 Favored Pre-proline 0 N--CA 1.478 0.964 0 C-N-CA 123.296 0.639 . . . . 61.21 109.335 -175.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 200' ' ' PRO . . . . . 0.612 ' HG2' HD12 ' C' ' 203' ' ' ILE . 15.9 Cg_exo -63.23 140.69 78.92 Favored 'Trans proline' 0 C--N 1.367 1.541 0 C-N-CA 121.839 1.693 . . . . 71.34 111.181 172.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 201' ' ' ALA . . . . . 0.404 ' N ' ' HD2' ' C' ' 202' ' ' PRO . . . -53.5 -46.43 98.13 Favored Pre-proline 0 CA--C 1.554 1.107 0 N-CA-C 113.49 0.922 . . . . 74.35 113.49 178.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 202' ' ' PRO . . . . . 0.445 ' HB2' ' HA ' ' A' ' 273' ' ' ALA . 39.2 Cg_endo -62.06 -42.64 28.76 Favored 'Trans proline' 0 C--N 1.384 2.407 0 CA-C-N 120.722 1.294 . . . . 63.15 111.946 178.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 203' ' ' ILE . . . . . 0.612 HD12 ' HG2' ' C' ' 200' ' ' PRO . 24.8 mt -64.48 -34.68 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 122.839 0.456 . . . . 63.4 110.958 177.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 204' ' ' ALA . . . . . 0.496 ' HA ' HG11 ' C' ' 223' ' ' VAL . . . -68.13 -35.29 77.87 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.687 0.795 . . . . 75.02 111.913 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 205' ' ' VAL . . . . . 0.535 ' HA ' ' HA ' ' C' ' 226' ' ' ARG . 95.6 t -77.96 -42.09 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-N 115.836 -0.62 . . . . 63.41 112.498 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 206' ' ' VAL . . . . . 0.466 HG23 ' HG2' ' A' ' 270' ' ' LYS . 11.7 p -76.6 -32.73 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 CA-C-O 121.028 0.442 . . . . 52.12 110.009 -177.056 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 84.3 49.95 4.48 Favored Glycine 0 N--CA 1.44 -1.062 0 CA-C-N 115.095 -0.957 . . . . 63.21 111.846 -172.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -84.37 -136.92 3.44 Favored Glycine 0 C--N 1.347 1.187 0 CA-C-O 119.62 -0.545 . . . . 51.32 112.03 177.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 209' ' ' LYS . . . . . 0.493 ' HB3' ' HG2' ' C' ' 220' ' ' GLU . 9.2 mtmp? -139.02 140.89 38.27 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 117.649 0.724 . . . . 72.12 112.83 -178.08 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 210' ' ' VAL . . . . . . . . . . . . . 57.5 t -132.78 129.48 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 124.953 1.301 . . . . 62.05 108.614 178.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 211' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -80.28 125.57 30.04 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 118.16 0.436 . . . . 72.44 111.505 -177.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 212' ' ' ALA . . . . . 0.458 ' HB2' HD13 ' C' ' 197' ' ' LEU . . . -103.12 120.08 40.04 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 108.038 -1.097 . . . . 74.43 108.038 165.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 213' ' ' MET . . . . . . . . . . . . . 5.4 tmm? -79.12 108.53 12.68 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 108.331 -0.989 . . . . 63.12 108.331 -177.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.93 171.85 7.1 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 118.128 0.422 . . . . 54.24 110.772 -173.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 215' ' ' LEU . . . . . 0.461 HD13 ' HB2' ' C' ' 131' ' ' PHE . 25.2 mt -58.41 -37.84 76.15 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 125.302 1.441 . . . . 44.41 113.49 -165.026 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 216' ' ' GLU . . . . . 0.47 ' HG2' HH11 ' C' ' 246' ' ' ARG . 0.0 OUTLIER -110.1 -6.32 15.14 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.057 0.943 . . . . 71.0 111.483 -174.579 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 169.42 156.23 10.62 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-O 119.761 -0.466 . . . . 64.11 113.303 -177.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.74 111.17 3.08 Favored 'Trans proline' 0 CA--C 1.557 1.656 0 C-N-CA 122.933 2.422 . . . . 52.13 112.403 178.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 219' ' ' VAL . . . . . 0.503 ' HB ' ' HE3' ' C' ' 238' ' ' LYS . 9.0 p -84.21 140.16 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 O-C-N 122.07 -0.394 . . . . 52.53 110.019 176.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 220' ' ' GLU . . . . . 0.493 ' HG2' ' HB3' ' C' ' 209' ' ' LYS . 25.5 tt0 -101.23 108.02 19.56 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 107.657 -1.238 . . . . 72.32 107.657 176.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 221' ' ' VAL . . . . . 0.555 ' HA ' ' HB2' ' B' ' 239' ' ' ALA . 42.5 t -77.07 119.48 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 124.055 0.942 . . . . 74.03 111.897 -174.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 222' ' ' ALA . . . . . 0.771 ' HB1' ' HE2' ' B' ' 245' ' ' LYS . . . -80.69 112.71 18.31 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.537 0.735 . . . . 73.3 110.277 169.073 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 223' ' ' VAL . . . . . 0.496 HG11 ' HA ' ' C' ' 204' ' ' ALA . 63.8 t -89.19 138.89 28.65 Favored Pre-proline 0 CA--C 1.559 1.306 0 C-N-CA 124.719 1.208 . . . . 73.11 110.028 -178.077 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 224' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.62 154.38 64.36 Favored 'Trans proline' 0 C--N 1.389 2.705 0 C-N-CA 122.501 2.134 . . . . 54.33 112.147 172.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.31 114.21 1.83 Allowed 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 122.768 2.312 . . . . 74.0 111.906 174.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 226' ' ' ARG . . . . . 0.58 ' HB3' ' HA ' ' A' ' 259' ' ' GLU . 0.0 OUTLIER 70.69 97.91 0.07 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.879 1.672 . . . . 70.15 112.406 -178.186 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 227' ' ' THR . . . . . 0.48 HG22 HG11 ' C' ' 253' ' ' VAL . 50.5 m -120.29 129.28 53.95 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 124.726 1.21 . . . . 70.3 111.562 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 228' ' ' GLN . . . . . 0.424 ' H ' ' HD2' ' C' ' 231' ' ' ARG . 27.0 mp0 -95.14 156.43 16.32 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 124.247 1.019 . . . . 74.32 111.635 175.164 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 229' ' ' ALA . . . . . 0.457 ' HB2' ' H ' ' C' ' 255' ' ' ILE . . . -75.72 131.32 39.77 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 114.84 -1.073 . . . . 62.12 109.742 177.145 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 110.95 -18.96 25.9 Favored Glycine 0 C--N 1.339 0.697 0 CA-C-N 115.711 -0.677 . . . . 62.04 112.085 -170.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 231' ' ' ARG . . . . . 0.424 ' HD2' ' H ' ' C' ' 228' ' ' GLN . 56.4 mtt180 -62.35 161.86 10.9 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 116.754 0.277 . . . . 74.12 110.318 169.16 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 232' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -137.65 138.91 39.93 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.042 0.449 . . . . 71.45 110.76 -174.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 233' ' ' LEU . . . . . 0.64 ' O ' ' HA ' ' C' ' 250' ' ' TYR . 6.1 mp -97.11 153.01 18.22 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 114.366 -1.288 . . . . 74.21 109.431 176.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 17.3 ptt180 -130.78 91.33 3.05 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 107.855 -1.165 . . . . 72.34 107.855 162.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 235' ' ' LEU . . . . . 0.575 HD12 HD23 ' C' ' 249' ' ' LEU . 17.1 mt -71.4 106.41 3.9 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 114.29 -1.323 . . . . 73.43 109.061 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 236' ' ' LYS . . . . . 0.663 ' HB3' ' HA ' ' B' ' 35' ' ' GLN . 26.2 mmmt -69.82 115.25 8.83 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 113.997 -1.456 . . . . 71.55 110.872 -171.099 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 81.39 33.15 29.18 Favored Glycine 0 C--N 1.346 1.1 0 CA-C-N 115.799 -0.637 . . . . 71.42 112.955 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 238' ' ' LYS . . . . . 0.503 ' HE3' ' HB ' ' C' ' 219' ' ' VAL . 64.6 mmtt -125.77 24.41 7.11 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.723 0.809 . . . . 72.03 111.364 177.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -102.32 -156.1 25.77 Favored Glycine 0 C--N 1.344 1.007 0 N-CA-C 111.652 -0.579 . . . . 31.21 111.652 171.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 240' ' ' PHE . . . . . 0.588 ' HD2' HD13 ' C' ' 188' ' ' LEU . 56.8 m-85 -81.67 153.38 70.49 Favored Pre-proline 0 CA--C 1.553 1.086 0 C-N-CA 122.868 0.467 . . . . 75.14 109.915 175.039 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 241' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -66.95 136.05 39.93 Favored 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 123.746 2.964 . . . . 70.21 114.806 -168.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -134.9 173.11 21.71 Favored Glycine 0 C--N 1.351 1.416 0 CA-C-N 115.487 -0.779 . . . . 70.14 112.869 175.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -60.91 -42.8 34.76 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 123.899 3.066 . . . . 71.42 112.796 -174.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 244' ' ' ALA . . . . . 0.444 ' HB1' ' HB3' ' B' ' 32' ' ' ARG . . . -83.53 -17.36 42.1 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.725 0.81 . . . . 71.42 110.698 178.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 143.92 -179.19 21.46 Favored Glycine 0 C--N 1.346 1.108 0 CA-C-N 115.621 -0.718 . . . . 51.32 111.423 -176.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 246' ' ' ARG . . . . . 0.47 HH11 ' HG2' ' C' ' 216' ' ' GLU . 80.8 mtm180 -71.34 159.52 34.42 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.298 0.639 . . . . 61.31 111.192 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -70.42 -164.29 4.99 Favored Glycine 0 C--N 1.353 1.504 0 CA-C-N 116.074 -0.512 . . . . 63.23 113.463 178.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -117.17 124.46 49.18 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 108.803 -0.814 . . . . 73.54 108.803 -173.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 249' ' ' LEU . . . . . 0.575 HD23 HD12 ' C' ' 235' ' ' LEU . 11.0 tp -79.58 119.99 23.31 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.902 -0.777 . . . . 74.23 108.902 177.183 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 250' ' ' TYR . . . . . 0.64 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 20.0 m-85 -96.24 111.93 23.83 Favored 'General case' 0 C--O 1.221 -0.419 0 N-CA-C 108.205 -1.035 . . . . 71.43 108.205 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 251' ' ' LEU . . . . . 0.588 HD12 HD22 ' C' ' 233' ' ' LEU . 77.1 mt -105.32 123.02 47.16 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 109.218 -0.66 . . . . 64.53 109.218 -177.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -81.32 120.27 24.72 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.273 -1.01 . . . . 73.41 108.273 173.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 253' ' ' VAL . . . . . 0.48 HG11 HG22 ' C' ' 227' ' ' THR . 60.3 t -72.29 128.93 35.66 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 C-N-CA 123.018 0.527 . . . . 73.5 110.954 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 254' ' ' ARG . . . . . . . . . . . . . 39.4 mtm105 -112.38 129.77 56.2 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 107.462 -1.31 . . . . 74.13 107.462 162.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 255' ' ' ILE . . . . . 0.535 ' O ' ' HB ' ' A' ' 255' ' ' ILE . 37.9 mm -94.65 114.21 30.75 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.775 0 N-CA-C 106.14 -1.8 . . . . 75.24 106.14 173.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 256' ' ' THR . . . . . 0.486 ' O ' ' HA ' ' C' ' 200' ' ' PRO . 0.1 OUTLIER -132.56 155.28 48.94 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 123.991 0.916 . . . . 53.32 108.93 -170.642 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 2.7 pp -124.0 151.07 64.58 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 109.086 -0.709 . . . . 64.54 109.086 -175.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 258' ' ' PRO . . . . . 0.404 ' HG3' ' HE2' ' A' ' 276' ' ' TYR . 68.9 Cg_endo -75.04 8.88 2.23 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.45 2.1 . . . . 73.21 113.025 -171.064 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 61.37 -79.25 0.02 OUTLIER 'General case' 0 C--N 1.359 0.987 0 C-N-CA 125.718 1.607 . . . . 72.3 110.268 -170.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 260' ' ' ARG . . . . . 0.522 ' HB2' ' HA3' ' B' ' 469' ' ' GLY . 2.6 ptp85 -72.95 142.63 47.82 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.396 1.478 . . . . 73.41 110.671 -178.126 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 261' ' ' LEU . . . . . 0.473 HD22 ' HB3' ' C' ' 265' ' ' GLU . 85.6 mt -139.04 168.25 20.25 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.771 0.829 . . . . 71.21 110.579 -174.403 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 49.4 p -86.53 162.94 43.78 Favored Pre-proline 0 CA--C 1.553 1.063 0 N-CA-C 108.401 -0.963 . . . . 61.23 108.401 168.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -50.49 -40.99 53.85 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 122.738 2.292 . . . . 74.2 113.107 173.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -60.44 -59.21 5.77 Favored 'General case' 0 C--O 1.262 1.73 0 C-N-CA 124.011 0.924 . . . . 71.04 110.846 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 265' ' ' GLU . . . . . 0.473 ' HB3' HD22 ' C' ' 261' ' ' LEU . 49.3 mm-40 -51.04 -63.5 1.11 Allowed 'General case' 0 C--N 1.353 0.724 0 CA-C-N 114.416 -1.265 . . . . 65.11 110.538 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 266' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -55.58 -38.68 69.7 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.365 1.066 . . . . 64.21 111.58 -173.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -58.01 -51.31 70.18 Favored 'General case' 0 C--O 1.248 1.008 0 O-C-N 123.606 0.566 . . . . 70.32 111.427 177.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 268' ' ' LEU . . . . . 0.652 ' HB2' HD21 ' A' ' 272' ' ' LEU . 10.6 mp -64.68 -39.8 94.29 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 119.288 -0.387 . . . . 52.44 111.332 178.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -58.88 -36.64 74.98 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 122.854 0.462 . . . . 61.11 111.683 176.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 270' ' ' LYS . . . . . 0.504 ' HA ' HG21 ' A' ' 206' ' ' VAL . 9.5 mtpm? -72.71 -34.96 67.47 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.244 0.618 . . . . 75.43 111.352 178.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 271' ' ' LYS . . . . . 0.403 ' HA ' ' HD3' ' C' ' 271' ' ' LYS . 69.3 mmtt -68.17 -32.83 73.36 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 123.108 0.255 . . . . 75.33 111.627 175.213 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 272' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' C' ' 268' ' ' LEU . 68.6 mt -67.89 -41.56 82.57 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.202 0.601 . . . . 74.33 109.622 173.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -62.68 -38.61 91.03 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 115.732 -0.667 . . . . 34.13 111.227 176.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -66.22 -37.51 85.71 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.781 0.832 . . . . 63.21 110.756 176.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -62.9 -35.25 79.43 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.891 0.476 . . . . 70.04 111.046 173.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 276' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -69.97 -45.76 66.7 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.559 -0.746 . . . . 75.52 112.179 175.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -63.84 -33.98 76.89 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-O 121.066 0.46 . . . . 44.24 109.801 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -63.29 -17.21 62.28 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 114.882 -1.054 . . . . 55.2 112.659 178.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 279' ' ' ARG . . . . . . . . . . . . . 70.3 mtm180 -73.21 -24.46 60.52 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 122.486 0.314 . . . . 71.52 111.298 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.558 1.255 0 CA-C-O 118.459 -0.781 . . . . 75.14 109.771 -176.481 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.575 ' SD ' ' HG2' ' A' ' 95' ' ' GLU . 1.3 mpt? . . . . . 0 N--CA 1.488 1.451 0 N-CA-C 111.108 0.04 . . . . 64.12 111.108 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 54.23 29.12 10.07 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.318 1.447 . . . . 51.4 112.938 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.32 77.49 4.81 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.13 0.572 . . . . 74.04 110.105 -176.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.5 tmmm? -38.14 105.35 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.93 1.692 . . . . 62.43 112.63 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.638 ' HB3' HD11 ' A' ' 10' ' ' ILE . 48.8 mtpt -97.92 109.32 22.1 Favored 'General case' 0 C--O 1.244 0.782 0 N-CA-C 107.882 -1.155 . . . . 74.32 107.882 172.296 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.516 ' HA ' ' OH ' ' A' ' 66' ' ' TYR . 24.9 t70 -70.98 109.33 5.03 Favored 'General case' 0 C--N 1.351 0.657 0 N-CA-C 108.101 -1.074 . . . . 61.41 108.101 173.133 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -65.65 -32.23 73.68 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-N 115.114 -0.948 . . . . 73.34 111.998 -170.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -63.25 -43.49 97.87 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 109.846 -0.427 . . . . 73.33 109.846 173.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.4 -45.86 90.31 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.52 0.728 . . . . 60.32 111.337 178.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.638 HD11 ' HB3' ' A' ' 5' ' ' LYS . 66.1 mt -56.09 -45.02 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 O-C-N 123.903 0.752 . . . . 74.23 110.613 177.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.514 HD13 HG23 ' A' ' 22' ' ' ILE . 69.1 mt -69.74 -23.19 63.35 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 115.644 -0.707 . . . . 51.33 112.207 176.327 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.78 44.4 7.24 Favored Glycine 0 C--N 1.349 1.253 0 O-C-N 123.182 0.301 . . . . 53.33 112.976 -176.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.0 m -138.17 152.62 72.07 Favored Pre-proline 0 N--CA 1.486 1.326 0 C-N-CA 124.658 1.183 . . . . 71.43 109.839 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -59.26 157.3 30.99 Favored 'Trans proline' 0 C--N 1.384 2.397 0 C-N-CA 122.799 2.333 . . . . 50.12 112.366 177.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 10.9 mtm105 -72.68 8.71 1.35 Allowed 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 113.676 0.991 . . . . 75.43 113.676 -167.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -129.45 14.66 6.06 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.073 0.949 . . . . 64.11 109.474 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.76 131.78 51.79 Favored 'General case' 0 C--N 1.35 0.61 0 C-N-CA 124.273 1.029 . . . . 64.31 111.361 -176.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.1 p -71.98 162.63 29.17 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.568 0.747 . . . . 71.11 110.594 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 8.6 tm0? -55.23 -31.57 61.6 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.096 0.958 . . . . 64.21 110.301 178.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -62.93 -51.11 68.21 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 125.033 1.333 . . . . 72.43 110.481 177.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -71.97 -32.36 67.18 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.613 0.765 . . . . 64.03 111.361 -178.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.599 HD13 ' HB3' ' A' ' 57' ' ' LEU . 61.4 mt -70.66 -30.71 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.269 1.427 . . . . 73.31 110.116 176.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.428 ' HG2' ' HE2' ' A' ' 27' ' ' LYS . 13.7 ttmm -69.74 -44.82 69.46 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.745 0.818 . . . . 71.24 109.114 174.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 71.4 mtp180 -59.62 -42.06 91.81 Favored 'General case' 0 N--CA 1.485 1.275 0 O-C-N 123.981 0.801 . . . . 54.12 111.008 176.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.25 -39.22 75.13 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.783 0.833 . . . . 64.0 111.297 -178.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -60.44 -54.78 41.46 Favored 'General case' 0 C--O 1.216 -0.662 0 CA-C-N 114.917 -1.038 . . . . 73.1 109.361 176.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.428 ' HE2' ' HG2' ' A' ' 23' ' ' LYS . 68.4 mttm -56.75 -42.17 78.86 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.892 0.877 . . . . 74.22 110.964 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -55.7 -55.96 26.03 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.672 0.789 . . . . 71.15 110.855 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.593 ' HB3' HD13 ' A' ' 50' ' ' ILE . 95.3 mt -79.25 -15.17 58.41 Favored 'General case' 0 CA--C 1.555 1.137 0 CA-C-N 115.471 -0.786 . . . . 74.11 111.579 -176.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.66 -20.5 33.46 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.983 0.913 . . . . 63.3 110.985 175.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 28.3 mtm180 -96.55 -25.36 15.65 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.591 0.757 . . . . 72.33 110.164 172.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -69.07 -65.75 0.67 Allowed 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 107.964 -1.124 . . . . 63.33 107.964 176.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -92.89 29.91 1.71 Allowed 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.061 0.544 . . . . 63.25 110.896 -177.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.406 ' CE1' ' HB3' ' A' ' 36' ' ' ASP . 9.4 t-160 -52.71 99.91 0.22 Allowed Pre-proline 0 N--CA 1.486 1.366 0 C-N-CA 125.52 1.528 . . . . 63.41 112.365 -170.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -60.95 -17.88 54.05 Favored 'Trans proline' 0 C--N 1.384 2.415 0 C-N-CA 123.336 2.691 . . . . 74.13 113.914 -171.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.406 ' HB3' ' CE1' ' A' ' 34' ' ' HIS . 32.1 t70 -66.98 -39.17 87.12 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.447 0.699 . . . . 72.45 111.862 176.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 82.2 t -102.28 -52.09 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 123.174 0.589 . . . . 65.53 109.624 -178.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -96.71 87.51 4.36 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 124.166 0.986 . . . . 61.35 109.568 -178.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -84.39 49.19 1.63 Allowed 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 115.439 -0.8 . . . . 73.11 110.653 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 74.0 m -91.94 115.62 64.96 Favored Pre-proline 0 N--CA 1.471 0.59 0 CA-C-O 118.054 -0.974 . . . . 54.41 108.548 176.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.403 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 85.2 Cg_exo -44.77 -49.6 9.34 Favored 'Trans proline' 0 C--N 1.384 2.439 0 C-N-CA 123.756 2.971 . . . . 72.23 113.295 -176.297 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -54.8 -43.32 72.78 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.963 0.905 . . . . 64.43 111.312 178.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.94 -27.68 64.95 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.513 -0.767 . . . . 72.14 110.926 -177.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.441 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 50.1 mt-10 -84.0 -29.98 26.54 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.173 0.589 . . . . 62.01 110.47 -175.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 41' ' ' PRO . 44.6 mt-10 -77.54 -38.45 48.67 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.186 0.595 . . . . 62.44 109.991 177.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -66.14 -34.24 77.59 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.855 -0.611 . . . . 74.03 109.766 170.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.805 ' HA ' HD12 ' A' ' 50' ' ' ILE . 88.0 t80 -62.04 -37.22 84.11 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 122.879 0.472 . . . . 73.24 110.475 172.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 44' ' ' GLU . 97.7 mttt -64.89 -35.12 80.13 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.723 0.409 . . . . 75.14 111.327 174.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -69.88 -29.9 67.22 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 122.421 0.288 . . . . 71.44 111.753 175.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.805 HD12 ' HA ' ' A' ' 47' ' ' PHE . 47.3 mt -70.43 -40.91 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 123.405 0.682 . . . . 70.53 109.794 173.235 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.413 ' HB3' ' HD1' ' A' ' 88' ' ' PHE . 3.2 m-20 -74.25 -20.15 60.26 Favored 'General case' 0 C--O 1.21 -0.99 0 C-N-CA 123.747 0.819 . . . . 73.43 110.934 176.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -74.92 -48.59 23.82 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.682 1.193 . . . . 63.42 109.564 174.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.25 -47.18 87.22 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 113.674 -1.603 . . . . 65.45 110.691 177.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 45.4 t80 -73.92 -23.6 59.56 Favored 'General case' 0 C--O 1.216 -0.661 0 CA-C-N 114.9 -1.045 . . . . 72.32 110.249 176.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.437 ' HA ' ' CD2' ' A' ' 88' ' ' PHE . . . -56.35 -50.82 70.4 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 118.357 0.526 . . . . 53.01 110.272 172.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.405 HG13 ' HZ ' ' A' ' 101' ' ' PHE . 38.3 t -64.46 -51.77 63.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 O-C-N 124.588 1.18 . . . . 74.52 110.409 177.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.599 ' HB3' HD13 ' A' ' 22' ' ' ILE . 45.1 mt -94.05 13.07 24.15 Favored 'General case' 0 CA--C 1.565 1.555 0 N-CA-C 113.095 0.776 . . . . 62.04 113.095 -166.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.1 t -66.77 -63.05 1.15 Allowed 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 123.668 0.787 . . . . 74.34 112.135 175.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.607 ' HB2' ' HD3' ' A' ' 62' ' ' LYS . 9.0 m-20 -100.64 145.53 30.49 Favored Pre-proline 0 N--CA 1.475 0.816 0 CA-C-O 118.478 -0.773 . . . . 74.34 110.046 -173.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.421 ' O ' ' HG2' ' A' ' 64' ' ' ARG . 19.8 Cg_endo -56.65 -32.25 89.96 Favored 'Trans proline' 0 C--N 1.384 2.404 0 C-N-CA 123.427 2.751 . . . . 72.41 113.294 -175.016 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -66.12 -47.67 73.37 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.707 0.803 . . . . 72.3 111.855 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.607 ' HD3' ' HB2' ' A' ' 59' ' ' ASP . 32.1 mtpt -74.59 -33.49 62.65 Favored 'General case' 0 C--O 1.252 1.209 0 C-N-CA 123.958 0.903 . . . . 74.54 110.641 -176.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 22.2 tpt85 -52.9 -51.39 61.35 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 113.922 -1.49 . . . . 74.11 108.827 167.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.421 ' HG2' ' O ' ' A' ' 60' ' ' PRO . 4.7 mmp_? -59.7 -38.97 83.07 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 123.802 0.689 . . . . 74.25 111.644 176.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.577 HG23 ' HD2' ' A' ' 76' ' ' PRO . 87.2 mt -54.96 -45.34 76.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 C-N-CA 122.681 0.392 . . . . 64.42 110.512 178.081 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.516 ' OH ' ' HA ' ' A' ' 6' ' ' ASP . 5.2 t80 -65.44 -49.22 69.96 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 120.77 -0.372 . . . . 75.4 110.813 175.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -57.8 -35.52 70.94 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.347 0.659 . . . . 64.04 112.062 -176.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 61.0 p -75.82 -32.27 59.76 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.044 0.538 . . . . 75.13 110.213 177.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -69.31 110.15 4.5 Favored 'General case' 0 C--N 1.359 0.992 0 N-CA-C 108.865 -0.791 . . . . 63.45 108.865 176.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 108.39 15.4 14.0 Favored Glycine 0 C--N 1.342 0.908 0 CA-C-N 115.905 -0.589 . . . . 52.54 112.151 -171.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 43.7 m -142.83 -57.17 0.43 Allowed 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 104.95 -2.241 . . . . 71.23 104.95 176.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.9 m -89.79 146.72 24.27 Favored 'General case' 0 C--O 1.25 1.121 0 N-CA-C 104.438 -2.43 . . . . 74.23 104.438 156.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.54 -35.56 19.45 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 109.981 -0.377 . . . . 74.04 109.981 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -84.02 131.05 52.47 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 123.85 0.86 . . . . 75.1 110.373 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -64.99 133.48 36.0 Favored 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 122.465 2.11 . . . . 75.41 110.717 173.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.577 ' HD2' HG23 ' A' ' 65' ' ' ILE . 58.7 Cg_exo -44.97 143.89 4.15 Favored 'Trans proline' 0 C--N 1.382 2.298 0 C-N-CA 124.211 3.274 . . . . 74.25 114.404 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -42.97 130.35 5.76 Favored 'Trans proline' 0 C--N 1.387 2.554 0 C-N-CA 124.115 3.21 . . . . 62.44 113.383 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -49.06 119.75 4.76 Favored 'Trans proline' 0 C--N 1.386 2.512 0 C-N-CA 123.378 2.719 . . . . 43.51 112.559 -177.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -51.91 164.15 1.17 Allowed 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 123.648 2.899 . . . . 71.05 113.785 177.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -53.18 88.29 0.03 OUTLIER 'Trans proline' 0 C--N 1.384 2.397 0 C-N-CA 123.379 2.719 . . . . 51.35 113.498 178.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 133.92 -33.53 2.52 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-N 114.541 -1.209 . . . . 62.41 110.33 177.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 139.67 -171.41 23.8 Favored Glycine 0 C--N 1.34 0.752 0 N-CA-C 109.835 -1.306 . . . . 53.03 109.835 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -67.48 105.4 1.82 Allowed 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.274 -1.01 . . . . 74.41 108.274 167.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.465 ' HB3' ' HD2' ' A' ' 62' ' ' LYS . 9.4 t70 -63.87 144.69 56.87 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 122.951 0.5 . . . . 71.31 112.186 -176.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.444 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 67.7 m-85 -139.37 71.11 1.37 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.917 0.887 . . . . 70.22 109.886 174.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.526 ' HA ' ' O ' ' A' ' 162' ' ' PRO . 51.0 m -59.99 85.36 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.244 0 CA-C-N 114.787 -1.097 . . . . 74.44 112.863 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 95.73 11.63 54.84 Favored Glycine 0 C--N 1.35 1.349 0 CA-C-N 115.646 -0.706 . . . . 70.11 113.972 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.444 ' HB2' ' HB3' ' A' ' 85' ' ' PHE . 26.7 m-85 -123.65 114.05 19.47 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 117.951 0.876 . . . . 72.34 110.575 -170.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -80.37 83.25 6.24 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-O 121.401 0.619 . . . . 71.44 110.504 -174.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.825 HG21 HD22 ' A' ' 105' ' ' LEU . 1.6 p -49.21 -42.21 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 N-CA-C 114.543 1.312 . . . . 75.21 114.543 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -66.07 -18.63 65.47 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 120.897 0.379 . . . . 75.33 111.01 -176.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -95.38 -7.24 39.05 Favored 'General case' 0 CA--C 1.559 1.298 0 C-N-CA 123.659 0.783 . . . . 45.35 111.167 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 21.6 m-30 -87.77 -172.46 3.87 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 123.491 0.716 . . . . 71.01 111.87 -177.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 86.1 p -74.78 166.68 23.22 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 113.349 0.87 . . . . 74.5 113.349 -169.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.575 ' HG2' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -61.03 -49.42 77.46 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 114.96 -1.018 . . . . 74.31 111.789 178.097 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -58.94 -40.0 83.3 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.597 0.759 . . . . 75.03 110.718 -175.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -62.63 -49.5 74.94 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.423 -1.262 . . . . 63.23 110.195 176.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.538 ' HA ' HD11 ' A' ' 105' ' ' LEU . 46.3 mt-30 -77.86 -4.37 46.34 Favored 'General case' 0 CA--C 1.552 1.038 0 CA-C-N 115.482 -0.781 . . . . 73.05 112.735 -178.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -92.54 -50.24 5.71 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.628 0.771 . . . . 70.02 109.918 172.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 26.0 tp -58.94 -54.85 42.47 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.1 0.96 . . . . 55.03 110.581 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.405 ' HZ ' HG13 ' A' ' 56' ' ' VAL . 88.5 m-85 -87.48 -1.54 58.0 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 115.801 -0.636 . . . . 72.11 111.098 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -41.28 -58.37 2.87 Favored Glycine 0 N--CA 1.482 1.74 0 N-CA-C 115.879 1.112 . . . . 72.43 115.879 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -50.35 -20.15 5.49 Favored 'Trans proline' 0 C--N 1.385 2.467 0 C-N-CA 124.318 3.346 . . . . 23.1 115.216 -177.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -141.59 31.89 2.09 Favored Glycine 0 C--N 1.355 1.632 0 CA-C-O 119.239 -0.756 . . . . 44.4 113.901 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.825 HD22 HG21 ' A' ' 90' ' ' VAL . 39.8 mt -66.68 78.19 0.11 Allowed 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 117.746 0.773 . . . . 74.25 112.028 171.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.438 ' HB2' ' HA ' ' A' ' 169' ' ' ASN . 24.5 m-85 36.5 -108.68 0.05 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.202 1.401 . . . . 72.25 114.78 177.182 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 59.77 16.12 37.06 Favored Glycine 0 C--N 1.36 1.916 0 N-CA-C 111.256 -0.738 . . . . 44.0 111.256 -160.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 52.61 -123.27 22.55 Favored Glycine 0 C--N 1.36 1.887 0 O-C-N 124.321 0.66 . . . . 71.34 112.612 -164.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -98.69 -1.84 39.71 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.95 0.9 . . . . 64.11 110.599 176.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.12 -30.14 26.36 Favored Glycine 0 C--N 1.346 1.127 0 CA-C-N 116.376 -0.374 . . . . 55.25 112.317 177.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 65.3 -4.0 0.58 Allowed 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 114.704 1.372 . . . . 71.44 114.704 173.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.33 -30.11 68.13 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.946 0.899 . . . . 73.25 110.918 172.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 70.1 m 78.83 68.9 0.04 OUTLIER 'General case' 0 C--N 1.354 0.763 0 C-N-CA 125.102 1.361 . . . . 74.21 111.657 177.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -133.18 161.73 33.65 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 115.464 -0.789 . . . . 74.52 109.887 177.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 43.4 tttp -63.66 145.19 56.19 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 123.902 0.881 . . . . 72.15 113.01 -165.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -85.34 -177.76 50.65 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-N 115.566 -0.743 . . . . 55.22 113.725 178.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.56 ' H ' ' HA3' ' A' ' 166' ' ' GLY . 22.1 ttm180 -94.19 164.52 13.02 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.186 1.394 . . . . 71.34 110.362 176.287 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.421 ' N ' ' HG2' ' A' ' 117' ' ' ARG . 7.9 p-10 -82.95 124.8 30.72 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 108.221 -1.029 . . . . 74.23 108.221 164.448 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 10.5 tt -122.75 121.31 36.02 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.42 -1.326 . . . . 70.23 107.42 -172.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.543 ' HA ' ' HB2' ' A' ' 175' ' ' LEU . 3.7 tmt_? -92.21 110.62 22.01 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 109.001 -0.74 . . . . 74.51 109.001 -177.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -111.21 171.93 7.18 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.265 1.026 . . . . 41.51 109.564 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.463 ' HA ' ' O ' ' A' ' 177' ' ' VAL . 68.0 mt-10 -121.75 125.84 47.51 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 109.0 -0.741 . . . . 61.0 109.0 -177.332 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 46.2 tp -98.79 100.91 10.58 Favored Pre-proline 0 N--CA 1.471 0.614 0 N-CA-C 107.307 -1.368 . . . . 54.05 107.307 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.598 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 55.4 Cg_endo -71.37 113.45 3.62 Favored 'Trans proline' 0 C--N 1.373 1.839 0 N-CA-C 108.587 -1.351 . . . . 75.33 108.587 176.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.494 ' HB3' HD23 ' A' ' 180' ' ' LEU . 47.1 tp -122.85 134.57 54.39 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 119.021 0.828 . . . . 64.01 111.067 -171.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.542 ' HA ' HD12 ' A' ' 181' ' ' LEU . 22.8 m -64.81 134.67 54.59 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 114.275 -1.329 . . . . 71.34 110.333 176.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 47.3 mt -59.55 -38.46 81.13 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 122.927 0.491 . . . . 70.54 111.524 -174.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -59.17 -42.56 91.05 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.385 0.674 . . . . 75.32 109.558 177.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.576 ' HG2' ' HB3' ' B' ' 4' ' ' SER . 50.0 mm-40 -65.78 -37.36 86.1 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.926 0.89 . . . . 64.33 111.768 173.358 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -66.07 -30.22 70.7 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 121.088 0.47 . . . . 41.43 110.838 -177.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -78.58 -59.78 2.64 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 115.016 -0.993 . . . . 74.51 110.551 177.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 44.7 m80 -75.87 -44.55 40.12 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.33 0.652 . . . . 75.25 112.323 -167.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.423 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 85.7 -170.05 43.55 Favored Glycine 0 N--CA 1.477 1.377 0 N-CA-C 114.117 0.407 . . . . 71.54 114.117 176.175 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 108.16 -166.68 13.06 Favored Glycine 0 C--N 1.353 1.51 0 C-N-CA 123.077 0.37 . . . . 70.42 113.019 177.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -70.7 105.83 3.32 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 122.957 0.503 . . . . 73.14 110.598 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 3.1 tpp180 -94.26 120.12 34.04 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 109.124 -0.695 . . . . 74.4 109.124 171.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 58.1 t -84.07 115.02 25.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 N-CA-C 107.889 -1.152 . . . . 71.24 107.889 173.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.443 HG13 HG13 ' A' ' 145' ' ' VAL . 2.7 p -129.44 129.92 67.19 Favored 'Isoleucine or valine' 0 C--O 1.246 0.916 0 C-N-CA 123.593 0.757 . . . . 73.14 109.754 -177.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -92.86 144.5 25.22 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.223 1.009 . . . . 71.3 110.189 -177.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.611 ' HB ' ' HB3' ' B' ' 8' ' ' LEU . 6.6 p -162.68 105.79 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 120.933 0.397 . . . . 75.1 111.07 174.114 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 57.84 34.23 24.13 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.092 0.957 . . . . 74.24 111.473 178.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 95.41 -19.68 53.1 Favored Glycine 0 C--N 1.35 1.311 0 CA-C-N 115.796 -0.638 . . . . 31.1 113.29 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 18.3 tpt85 -76.26 103.26 6.2 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.878 0.871 . . . . 72.12 110.503 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -87.87 97.22 10.81 Favored 'General case' 0 C--O 1.243 0.732 0 C-N-CA 123.873 0.869 . . . . 74.41 109.386 173.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.443 HG13 HG13 ' A' ' 138' ' ' VAL . 3.6 p -102.47 125.3 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-O 121.209 0.528 . . . . 73.53 110.14 177.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 34.6 t -91.48 83.97 5.48 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 108.189 -1.041 . . . . 31.45 108.189 174.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.7 p -92.5 123.56 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 115.703 -0.681 . . . . 73.42 109.705 -176.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 24.2 ttm180 -71.52 107.31 4.35 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.158 0.504 . . . . 74.14 110.037 174.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.423 HG13 ' HA2' ' A' ' 133' ' ' GLY . 20.2 pt -76.96 126.03 86.13 Favored Pre-proline 0 CA--C 1.555 1.172 0 CA-C-N 114.9 -1.045 . . . . 74.13 109.073 170.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -64.12 132.11 32.99 Favored 'Trans proline' 0 C--N 1.37 1.706 0 C-N-CA 122.493 2.128 . . . . 60.34 112.169 176.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -56.91 109.78 0.5 Allowed 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 122.888 2.392 . . . . 74.15 111.499 172.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.42 ' HA3' ' HD2' ' A' ' 241' ' ' PRO . . . 97.2 48.78 1.98 Allowed Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.844 -0.503 . . . . 75.51 111.844 -174.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 4.5 p -96.61 137.85 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.564 0.745 . . . . 75.43 109.507 177.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.414 ' HG2' ' HA ' ' A' ' 191' ' ' GLN . 0.0 OUTLIER -116.48 168.18 10.39 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.613 0.765 . . . . 73.23 111.519 -169.528 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.52 ' HB3' ' HA ' ' A' ' 189' ' ' GLU . 15.9 tp10 -56.61 129.91 42.98 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.594 0.758 . . . . 72.32 111.165 177.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 78.08 10.96 85.83 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-N 115.548 -0.751 . . . . 14.21 114.235 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 10.7 t -75.18 129.85 38.2 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 118.015 0.908 . . . . 74.23 108.665 175.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 21.7 t -108.61 114.78 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 123.199 0.6 . . . . 72.34 110.7 -167.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.553 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 48.4 mt -93.93 92.35 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 107.212 -1.403 . . . . 75.24 107.212 169.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 31.5 ttt180 -74.2 100.39 3.67 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 109.422 -0.584 . . . . 61.32 109.422 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.2 p -126.35 99.35 30.82 Favored Pre-proline 0 CA--C 1.557 1.239 0 C-N-CA 124.129 0.972 . . . . 61.33 110.427 -176.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.526 ' O ' ' HA ' ' A' ' 86' ' ' SER . 65.1 Cg_exo -50.56 158.02 3.04 Favored 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 123.062 2.508 . . . . 74.53 114.186 172.437 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 108.96 -26.82 14.26 Favored Glycine 0 N--CA 1.48 1.571 0 N-CA-C 113.872 0.309 . . . . 70.43 113.872 169.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.425 ' HB2' HD22 ' A' ' 174' ' ' LEU . 63.7 mtm -118.67 -0.04 11.39 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 122.608 0.363 . . . . 64.15 110.891 -177.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -88.17 -106.9 0.99 Allowed Glycine 0 C--N 1.351 1.379 0 N-CA-C 111.025 -0.83 . . . . 73.33 111.025 175.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.56 ' HA3' ' H ' ' A' ' 117' ' ' ARG . . . -69.1 117.73 8.18 Favored Glycine 0 C--O 1.251 1.196 0 N-CA-C 111.589 -0.604 . . . . 74.5 111.589 171.185 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -75.17 104.78 5.88 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 109.218 -0.66 . . . . 75.42 109.218 -175.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -169.92 158.21 30.18 Favored Glycine 0 C--N 1.339 0.725 0 N-CA-C 110.826 -0.91 . . . . 64.21 110.826 -176.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ASN . . . . . 0.527 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . 54.0 t30 -61.59 -62.82 5.15 Favored Pre-proline 0 N--CA 1.488 1.43 0 CA-C-O 117.438 -1.268 . . . . 63.11 110.619 -169.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.527 ' HD3' ' HB3' ' A' ' 169' ' ' ASN . 21.2 Cg_exo -63.1 109.32 0.92 Allowed 'Trans proline' 0 C--N 1.391 2.779 0 CA-C-N 122.487 1.924 . . . . 71.13 107.789 162.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -60.3 128.46 26.31 Favored 'Trans proline' 0 CA--C 1.55 1.301 0 C-N-CA 123.379 2.719 . . . . 71.25 113.622 -163.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -77.34 136.85 19.43 Favored Glycine 0 C--N 1.358 1.752 0 N-CA-C 111.377 -0.689 . . . . 72.4 111.377 175.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.497 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 15.1 m-20 -61.98 128.81 37.94 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.935 0.894 . . . . 71.14 112.034 -172.186 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.425 HD22 ' HB2' ' A' ' 164' ' ' MET . 49.6 tp -102.69 107.84 18.88 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.887 -0.783 . . . . 64.32 108.887 169.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.543 ' HB2' ' HA ' ' A' ' 120' ' ' ARG . 42.7 mt -79.3 94.21 5.43 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 108.663 -0.866 . . . . 72.12 108.663 176.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.553 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 91.8 mt -74.22 82.13 1.83 Allowed 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 109.468 -0.567 . . . . 70.05 109.468 175.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 122' ' ' GLU . 11.8 t -87.87 103.7 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 N-CA-C 107.261 -1.385 . . . . 61.43 107.261 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 8.1 p -73.91 119.15 20.57 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.219 0 N-CA-C 113.39 0.885 . . . . 70.33 113.39 -165.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.598 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 20.8 mmt180 -92.71 102.23 14.64 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.195 0.998 . . . . 53.32 109.437 170.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.494 HD23 ' HB3' ' A' ' 125' ' ' LEU . 96.0 mt -72.91 136.12 45.18 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 122.052 -0.405 . . . . 72.4 110.757 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.542 HD12 ' HA ' ' A' ' 126' ' ' THR . 85.5 mt -55.71 156.25 9.57 Favored Pre-proline 0 N--CA 1.484 1.247 0 C-N-CA 124.649 1.18 . . . . 73.14 112.507 -174.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -82.47 40.72 1.0 Allowed 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 122.943 2.429 . . . . 71.42 111.515 171.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.427 ' HA ' ' HD3' ' A' ' 184' ' ' PRO . 51.9 t-80 -62.24 125.44 85.57 Favored Pre-proline 0 CA--C 1.551 0.997 0 N-CA-C 107.615 -1.254 . . . . 73.35 107.615 172.196 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 183' ' ' HIS . 23.5 Cg_exo -66.17 23.85 0.09 OUTLIER 'Trans proline' 0 N--CA 1.502 2.014 0 C-N-CA 124.239 3.292 . . . . 61.24 118.289 -162.177 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 58.9 t -106.3 -59.32 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 120.294 1.406 . . . . 64.21 109.809 177.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' PHE . . . . . 0.506 ' CE1' ' HB2' ' A' ' 195' ' ' ALA . 21.6 m-85 -127.14 125.6 41.47 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.92 -0.582 . . . . 72.31 111.061 -172.021 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.427 HH22 ' HG2' ' A' ' 155' ' ' GLU . 0.0 OUTLIER -102.31 71.56 1.24 Allowed 'General case' 0 C--O 1.237 0.399 0 N-CA-C 106.452 -1.684 . . . . 75.51 106.452 171.316 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.438 ' HB2' HD23 ' A' ' 193' ' ' LEU . 7.4 tp -64.27 132.95 51.75 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 113.348 -1.751 . . . . 74.21 110.516 -176.288 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.52 ' HA ' ' HB3' ' A' ' 155' ' ' GLU . 11.9 tp10 -138.75 123.6 18.78 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.691 1.196 . . . . 70.31 109.643 -178.07 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 70.73 -75.04 0.58 Allowed Glycine 0 C--N 1.354 1.545 0 O-C-N 123.491 0.495 . . . . 65.41 113.694 175.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.414 ' HA ' ' HG2' ' A' ' 154' ' ' ARG . 2.9 pm0 -145.02 -14.29 0.53 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.669 1.188 . . . . 72.32 110.792 175.006 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.431 ' HB3' ' H ' ' A' ' 248' ' ' ASP . 2.6 p-10 -112.57 137.23 51.1 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.274 1.43 . . . . 72.32 112.708 -165.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.504 HD22 ' HB3' ' A' ' 186' ' ' PHE . 77.3 mt -88.84 159.85 17.51 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.836 1.254 . . . . 63.44 111.003 -173.475 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -130.78 101.59 5.72 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 108.256 -1.016 . . . . 73.14 108.256 169.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.506 ' HB2' ' CE1' ' A' ' 186' ' ' PHE . . . -104.75 148.14 26.93 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 108.806 -0.812 . . . . 74.34 108.806 175.163 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 26.1 m -86.87 141.45 28.77 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 109.601 -0.518 . . . . 70.21 109.601 175.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 56.4 tp -138.88 102.33 4.53 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.15 0.58 . . . . 72.21 109.548 -173.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -79.95 125.75 30.15 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 108.968 -0.753 . . . . 61.43 108.968 173.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.491 HG23 HG11 ' A' ' 210' ' ' VAL . 5.5 p -139.81 136.78 17.68 Favored Pre-proline 0 CA--C 1.55 0.956 0 C-N-CA 124.462 1.105 . . . . 64.4 108.626 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -77.58 155.32 31.57 Favored 'Trans proline' 0 C--N 1.368 1.595 0 C-N-CA 121.714 1.609 . . . . 64.51 112.483 173.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.417 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -58.1 -50.24 89.18 Favored Pre-proline 0 CA--C 1.552 1.038 0 N-CA-C 113.785 1.032 . . . . 71.34 113.785 -169.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.432 ' HG2' ' CE2' ' C' ' 276' ' ' TYR . 86.1 Cg_exo -55.02 -46.64 31.72 Favored 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 121.548 1.499 . . . . 63.54 113.426 176.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.438 HD11 ' HB3' ' C' ' 276' ' ' TYR . 40.5 mt -71.75 -24.03 22.83 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.28 0 C-N-CA 122.375 0.27 . . . . 64.32 110.492 -177.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -74.7 -47.03 33.81 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.121 0.569 . . . . 71.51 111.706 175.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 201' ' ' ALA . 90.3 t -70.91 -38.43 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 C-N-CA 123.736 0.814 . . . . 63.23 111.075 -176.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 55.3 t -89.76 -41.21 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 124.173 0.989 . . . . 74.41 111.782 -175.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 95.45 148.6 24.46 Favored Glycine 0 C--N 1.339 0.739 0 CA-C-N 115.581 -0.736 . . . . 72.35 111.339 -168.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 177.44 -142.67 5.82 Favored Glycine 0 C--N 1.333 0.399 0 N-CA-C 111.235 -0.746 . . . . 55.24 111.235 -177.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -125.76 123.41 38.76 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 117.277 0.538 . . . . 45.21 110.666 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.491 HG11 HG23 ' A' ' 199' ' ' VAL . 22.5 m -124.02 -171.47 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 125.425 1.49 . . . . 63.11 109.207 174.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -126.6 131.9 51.4 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.336 0.654 . . . . 71.41 111.525 178.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -114.02 166.31 11.74 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.395 1.078 . . . . 62.04 109.043 167.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 27.9 ttt -111.49 145.01 39.79 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 122.757 0.423 . . . . 71.23 110.486 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 17.4 p -114.05 -171.07 1.84 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.139 0.976 . . . . 74.1 108.868 171.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 83.5 mt -80.3 -5.24 55.97 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.93 0.715 . . . . 63.31 112.93 -175.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -139.91 9.74 2.38 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 112.848 0.685 . . . . 64.44 112.848 -177.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 154.07 175.83 25.75 Favored Glycine 0 N--CA 1.472 1.046 0 CA-C-O 119.382 -0.677 . . . . 33.0 112.413 177.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -81.65 175.79 9.12 Favored 'Trans proline' 0 C--N 1.362 1.288 0 C-N-CA 122.29 1.993 . . . . 70.23 112.559 178.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 3.2 m -148.77 132.78 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.096 1.358 . . . . 73.4 108.425 178.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.49 ' HB2' ' HA2' ' B' ' 436' ' ' GLY . 6.4 mm-40 -86.72 104.45 16.13 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.418 -0.956 . . . . 75.04 108.418 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 41.1 t -99.78 134.47 39.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 123.968 0.907 . . . . 74.13 110.721 -169.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -83.08 105.24 13.9 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 122.847 0.459 . . . . 60.25 109.815 174.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.558 ' HA ' HD12 ' B' ' 441' ' ' ILE . 11.5 p -79.23 139.97 56.56 Favored Pre-proline 0 CA--C 1.563 1.469 0 C-N-CA 124.35 1.06 . . . . 63.14 109.811 -178.202 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -82.04 178.68 6.18 Favored 'Trans proline' 0 C--N 1.384 2.426 0 C-N-CA 123.094 2.529 . . . . 75.51 111.806 -175.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -80.8 150.99 18.8 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 121.6 1.533 . . . . 72.53 112.387 171.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' ARG . . . . . 0.52 HH21 ' HB2' ' C' ' 261' ' ' LEU . 79.1 mtt85 67.01 25.15 9.34 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 125.159 1.383 . . . . 74.04 112.45 175.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.458 HG23 HD21 ' A' ' 233' ' ' LEU . 37.7 m -61.52 117.11 5.3 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 124.7 1.2 . . . . 64.32 110.466 175.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 228' ' ' GLN . . . . . 0.586 ' HG2' HH12 ' B' ' 221' ' ' ARG . 6.3 tp-100 -110.33 139.7 45.27 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.978 0.911 . . . . 75.32 112.161 -167.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -64.57 133.79 53.05 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.459 1.104 . . . . 62.31 111.772 -177.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' GLY . . . . . 0.521 ' HA3' HH12 ' C' ' 254' ' ' ARG . . . 93.19 -24.63 24.13 Favored Glycine 0 C--N 1.341 0.836 0 CA-C-N 115.85 -0.614 . . . . 73.32 112.803 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 67.6 mtt180 -72.32 147.28 46.49 Favored 'General case' 0 C--N 1.347 0.478 0 CA-C-O 121.41 0.624 . . . . 74.0 109.744 171.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.766 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 2.9 mptp? -106.29 119.34 39.0 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.254 -1.387 . . . . 72.22 107.254 174.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.555 HD13 HD13 ' B' ' 441' ' ' ILE . 70.6 mt -74.38 100.21 3.73 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.32 -0.993 . . . . 71.4 108.32 -177.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 66.1 ttt180 -76.6 104.61 7.19 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 124.07 0.856 . . . . 64.14 110.564 -172.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.675 HD21 HG23 ' B' ' 441' ' ' ILE . 49.2 mt -103.11 96.56 6.87 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.542 0.737 . . . . 61.12 110.694 -178.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 23.8 mtpp -74.52 138.26 43.01 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 122.707 0.403 . . . . 64.43 111.231 -177.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 82.81 16.73 69.55 Favored Glycine 0 C--N 1.346 1.086 0 CA-C-N 115.603 -0.726 . . . . 74.2 112.876 -174.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.623 ' HG3' ' HB3' ' A' ' 235' ' ' LEU . 0.0 OUTLIER -121.05 -17.73 7.7 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.276 0.63 . . . . 73.01 112.572 -174.256 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -78.69 -167.42 32.2 Favored Glycine 0 C--N 1.339 0.722 0 N-CA-C 111.904 -0.478 . . . . 74.43 111.904 171.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -86.01 151.4 54.54 Favored Pre-proline 0 CA--C 1.557 1.239 0 CA-C-O 118.895 -0.574 . . . . 73.13 109.509 -172.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.42 ' HD2' ' HA3' ' A' ' 152' ' ' GLY . 29.7 Cg_exo -38.91 107.92 0.07 OUTLIER 'Trans proline' 0 C--N 1.389 2.673 0 C-N-CA 124.675 3.583 . . . . 73.33 115.52 -179.259 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -133.92 -158.15 8.5 Favored Glycine 0 C--N 1.35 1.354 0 CA-C-O 119.255 -0.747 . . . . 73.52 112.33 -176.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -59.8 -39.65 70.69 Favored 'Trans proline' 0 C--N 1.383 2.357 0 C-N-CA 123.695 2.93 . . . . 70.45 113.595 -174.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -89.25 21.62 3.19 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.417 0.687 . . . . 70.11 111.567 -176.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 97.29 -74.44 0.67 Allowed Glycine 0 C--N 1.346 1.121 0 N-CA-C 109.794 -1.322 . . . . 62.24 109.794 -173.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 17.1 mtp180 -122.55 157.91 31.04 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.124 0.97 . . . . 75.41 108.675 168.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -79.43 -158.54 14.52 Favored Glycine 0 C--N 1.344 0.995 0 O-C-N 123.315 0.384 . . . . 42.24 113.486 176.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' ASP . . . . . 0.431 ' H ' ' HB3' ' A' ' 192' ' ' ASP . 7.4 m-20 -104.44 172.32 6.86 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.142 0.577 . . . . 75.44 110.019 -177.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.577 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 32.5 tp -136.65 97.5 3.56 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 107.831 -1.174 . . . . 70.31 107.831 175.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.766 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 62.2 m-85 -79.45 108.57 13.07 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.266 1.026 . . . . 52.51 110.091 178.247 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.5 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 88.6 mt -93.42 108.31 20.0 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 122.91 0.484 . . . . 72.24 110.061 176.019 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.538 ' HG2' ' HG3' ' A' ' 232' ' ' LYS . 35.5 mt-10 -77.67 102.64 7.17 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.531 1.132 . . . . 75.41 109.708 -172.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.417 HG12 HG13 ' A' ' 255' ' ' ILE . 42.9 t -67.93 126.07 26.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 115.008 -0.997 . . . . 24.43 111.619 -172.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -124.2 92.25 3.63 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 107.275 -1.38 . . . . 73.14 107.275 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.479 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 63.5 mt -82.79 127.69 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 122.815 0.446 . . . . 74.34 111.41 -173.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 69.1 p -111.07 154.68 23.89 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.291 1.036 . . . . 73.43 109.675 175.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 257' ' ' ILE . . . . . 0.488 HD12 ' H ' ' A' ' 259' ' ' GLU . 2.5 pp -103.06 150.08 37.5 Favored Pre-proline 0 CA--C 1.558 1.263 0 C-N-CA 123.069 0.548 . . . . 73.4 109.653 175.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -51.7 -21.98 12.33 Favored 'Trans proline' 0 N--CA 1.509 2.394 0 C-N-CA 124.519 3.48 . . . . 74.45 115.133 -170.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.488 ' H ' HD12 ' A' ' 257' ' ' ILE . 29.3 mt-10 52.17 -78.46 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.991 1.317 . . . . 63.24 111.548 -167.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.9 132.19 46.88 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.566 0.746 . . . . 75.12 111.332 176.342 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.588 HD22 ' HB2' ' A' ' 265' ' ' GLU . 96.2 mt -143.44 150.54 39.17 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.312 1.045 . . . . 55.32 109.723 176.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 20.9 p -118.64 156.69 51.23 Favored Pre-proline 0 CA--C 1.555 1.167 0 CA-C-O 117.774 -1.108 . . . . 44.34 109.204 170.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -21.12 -50.2 0.03 OUTLIER 'Trans proline' 0 C--N 1.401 3.322 1 C-N-CA 126.871 5.047 . . . . 74.33 117.433 -172.137 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -56.56 -69.44 0.15 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.314 0.646 . . . . 71.44 111.289 178.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 265' ' ' GLU . . . . . 0.588 ' HB2' HD22 ' A' ' 261' ' ' LEU . 2.1 mp0 -71.32 -28.75 64.32 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.601 0.36 . . . . 64.2 110.062 -172.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 266' ' ' GLU . . . . . 0.403 ' HA ' HD13 ' A' ' 261' ' ' LEU . 18.8 tp10 -55.86 -60.97 2.7 Favored 'General case' 0 C--O 1.255 1.345 0 C-N-CA 124.22 1.008 . . . . 73.45 110.467 175.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 267' ' ' ALA . . . . . 0.412 ' HB2' HH22 ' B' ' 373' ' ' ARG . . . -60.58 -38.01 83.22 Favored 'General case' 0 C--O 1.22 -0.472 0 CA-C-N 114.38 -1.282 . . . . 64.12 110.675 178.07 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 268' ' ' LEU . . . . . 0.483 HD21 ' HB2' ' C' ' 271' ' ' LYS . 11.8 tp -65.26 -40.1 93.52 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.106 0.962 . . . . 73.14 111.026 -174.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 44.4 m95 -69.41 -37.84 77.65 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.582 -0.736 . . . . 75.0 110.609 176.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 270' ' ' LYS . . . . . 0.666 ' HE2' ' HA ' ' C' ' 206' ' ' VAL . 1.1 mptm? -67.02 -39.47 87.05 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 123.473 0.483 . . . . 62.43 111.632 176.206 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -62.33 -48.83 78.07 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.089 0.556 . . . . 70.22 109.884 177.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 18.5 mt -54.36 -51.46 64.72 Favored 'General case' 0 C--O 1.203 -1.371 0 O-C-N 124.55 1.156 . . . . 63.4 110.446 173.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 273' ' ' ALA . . . . . 0.618 ' HA ' ' HB2' ' C' ' 202' ' ' PRO . . . -67.33 -39.95 85.89 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.697 0.999 . . . . 64.51 113.697 -168.285 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.508 ' HB3' HE21 ' B' ' 250' ' ' GLN . 41.6 mt-10 -86.86 -33.15 19.9 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.589 0.756 . . . . 74.35 110.996 -173.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -71.22 -33.21 69.69 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 109.916 -0.401 . . . . 71.44 109.916 169.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -67.35 -41.54 85.0 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.946 0.898 . . . . 75.02 109.453 174.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 277' ' ' TYR . . . . . 0.459 ' HE1' ' H ' ' C' ' 209' ' ' LYS . 25.2 t80 -62.62 -43.39 98.94 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 124.105 0.878 . . . . 70.12 108.783 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -66.55 -7.88 23.04 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-N 115.199 -0.909 . . . . 75.41 112.647 175.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 73.7 mmt-85 -127.79 13.95 6.91 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 123.885 0.874 . . . . 74.13 111.127 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.658 0 C-N-CA 122.847 0.459 . . . . 72.21 111.309 -173.864 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.0 ttt . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 109.577 -0.527 . . . . 71.44 109.577 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -101.06 -178.05 3.63 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.533 0.733 . . . . 54.1 111.038 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -59.85 103.17 0.19 Allowed 'General case' 0 C--N 1.354 0.777 0 C-N-CA 123.379 0.672 . . . . 74.04 109.375 176.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 4' ' ' SER . . . . . 0.576 ' HB3' ' HG2' ' A' ' 129' ' ' GLU . 50.5 m -83.5 27.25 0.61 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.443 1.097 . . . . 52.14 112.163 -173.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 6.4 m -123.06 145.95 48.1 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 109.011 -0.737 . . . . 70.11 109.011 177.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 29.4 pt -140.18 177.76 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 C-N-CA 123.356 0.662 . . . . 64.44 111.75 -158.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -147.03 127.28 13.86 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.847 0.859 . . . . 72.01 110.053 178.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.611 ' HB3' ' HB ' ' A' ' 140' ' ' VAL . 19.3 tp -65.48 148.85 51.02 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.797 1.239 . . . . 75.22 112.196 -171.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.35 -49.56 33.27 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.522 0.729 . . . . 62.4 111.886 177.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 4.2 tt 60.48 102.6 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 124.594 1.158 . . . . 74.1 110.151 -173.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.413 ' HB2' ' O ' ' A' ' 120' ' ' ARG . 74.8 mt -121.93 122.32 27.75 Favored Pre-proline 0 N--CA 1.481 1.086 0 CA-C-O 118.24 -0.886 . . . . 45.35 109.738 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -37.53 -58.8 0.57 Allowed 'Trans proline' 0 C--N 1.387 2.56 0 C-N-CA 125.268 3.979 . . . . 61.33 114.728 -173.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 13' ' ' LEU . . . . . 0.55 HD13 ' HD3' ' A' ' 117' ' ' ARG . 2.2 pt? -177.44 121.34 0.12 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.853 0.861 . . . . 75.01 109.464 172.437 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -160.69 137.41 8.83 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.122 0.969 . . . . 64.54 109.905 177.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 34.0 p90 30.91 86.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 126.843 2.057 . . . . 60.01 114.623 -176.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 81.3 m -70.07 123.06 88.04 Favored Pre-proline 0 CA--C 1.554 1.105 0 CA-C-N 115.272 -0.876 . . . . 51.11 110.629 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -60.15 137.72 77.07 Favored 'Trans proline' 0 C--N 1.372 1.79 0 C-N-CA 123.201 2.601 . . . . 62.42 112.689 177.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 48.2 t -120.74 -44.66 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 123.422 0.689 . . . . 61.41 110.91 -175.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 46.3 p -70.79 116.0 10.59 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-O 121.004 0.431 . . . . 71.22 111.196 -176.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -79.53 -14.13 59.08 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.799 0.839 . . . . 62.34 110.758 177.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 63.44 68.72 0.59 Allowed 'General case' 0 C--N 1.358 0.968 0 C-N-CA 125.114 1.366 . . . . 75.34 110.967 176.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -91.91 165.53 13.18 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.15 -0.932 . . . . 73.31 109.438 176.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 23' ' ' THR . . . . . . . . . . . . . 48.4 m -66.6 116.8 38.14 Favored Pre-proline 0 CA--C 1.554 1.128 0 C-N-CA 123.036 0.534 . . . . 72.45 111.024 -178.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -90.12 -170.28 0.4 Allowed 'Trans proline' 0 C--N 1.373 1.818 0 C-N-CA 122.772 2.315 . . . . 74.55 111.935 176.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -78.3 154.52 30.83 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 109.395 -0.594 . . . . 74.53 109.395 175.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 61.3 mtt -111.77 98.07 39.97 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 123.229 0.612 . . . . 75.13 109.382 178.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -64.11 154.16 72.13 Favored 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 123.172 2.582 . . . . 71.1 112.796 176.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 14.0 p -65.7 -36.78 78.39 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 C-N-CA 122.756 0.422 . . . . 73.51 109.868 174.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.413 HD21 ' HB2' ' B' ' 32' ' ' ARG . 2.8 tt 59.53 -77.75 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 126.413 1.885 . . . . 62.2 111.726 170.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.462 ' HG2' ' HD2' ' B' ' 337' ' ' LYS . 42.3 mt-10 68.24 78.82 0.22 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.824 1.65 . . . . 70.24 112.39 178.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 31' ' ' ASN . . . . . 0.684 ' HB3' ' HA ' ' B' ' 34' ' ' ALA . 6.1 m120 55.88 97.66 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 125.656 1.582 . . . . 74.34 113.35 176.296 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 32' ' ' ARG . . . . . 0.418 ' NH2' ' HB3' ' B' ' 215' ' ' GLU . 33.6 ttt180 -64.98 99.14 0.33 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.466 1.106 . . . . 72.22 110.355 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 33' ' ' ALA . . . . . 0.579 ' HA ' ' HA2' ' B' ' 211' ' ' GLY . . . 64.25 13.11 7.69 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 125.073 1.349 . . . . 73.31 111.995 -175.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 34' ' ' ALA . . . . . 0.684 ' HA ' ' HB3' ' B' ' 31' ' ' ASN . . . 58.68 -77.18 0.02 OUTLIER 'General case' 0 C--N 1.36 1.043 0 C-N-CA 125.576 1.55 . . . . 53.33 111.698 -168.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -164.44 -46.5 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.152 0.981 . . . . 73.13 109.082 -178.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 138.04 -179.81 17.89 Favored Glycine 0 C--N 1.346 1.121 0 N-CA-C 110.977 -0.849 . . . . 74.33 110.977 -171.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -164.81 157.83 16.82 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.081 0.553 . . . . 61.44 110.668 -175.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 38' ' ' ILE . . . . . 0.551 HG12 ' HB2' ' C' ' 259' ' ' GLU . 36.6 mm -118.81 15.4 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 C-N-CA 123.803 0.841 . . . . 75.44 110.814 -175.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 29.8 p -120.55 -77.55 0.58 Allowed 'General case' 0 N--CA 1.484 1.254 0 O-C-N 120.719 -1.238 . . . . 64.25 109.9 171.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.423 ' HB3' ' HD3' ' B' ' 41' ' ' PRO . . . -176.97 -57.75 0.0 OUTLIER Pre-proline 0 CA--C 1.555 1.147 0 C-N-CA 124.725 1.21 . . . . 64.0 110.762 177.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 41' ' ' PRO . . . . . 0.423 ' HD3' ' HB3' ' B' ' 40' ' ' ALA . 25.4 Cg_endo -89.25 -17.64 1.87 Allowed 'Trans proline' 0 C--N 1.391 2.776 0 C-N-CA 121.714 1.609 . . . . 72.44 113.852 -172.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 130.89 -38.8 1.88 Allowed Glycine 0 C--N 1.342 0.917 0 N-CA-C 110.491 -1.044 . . . . 45.24 110.491 -167.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 43' ' ' GLY . . . . . 0.41 ' H ' ' HG2' ' B' ' 41' ' ' PRO . . . 82.42 -175.54 53.57 Favored Glycine 0 C--N 1.342 0.866 0 N-CA-C 112.174 -0.37 . . . . 42.15 112.174 -177.169 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 44' ' ' ALA . . . . . 0.412 ' HB3' ' HA ' ' C' ' 262' ' ' THR . . . -83.52 65.17 8.28 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.11 0.564 . . . . 63.2 110.953 -173.31 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -73.73 -4.99 37.86 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.357 0.663 . . . . 74.21 112.726 -172.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 46' ' ' ARG . . . . . 0.494 ' HB3' ' H ' ' B' ' 266' ' ' ASN . 0.0 OUTLIER -130.18 -179.1 5.04 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.086 0.954 . . . . 75.02 108.605 174.319 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.4 HD21 ' HB2' ' B' ' 449' ' ' ALA . 1.5 pt? -131.9 175.69 9.0 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.844 0.458 . . . . 53.22 111.199 -177.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 4.4 m -74.37 -28.99 61.36 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.106 -0.952 . . . . 51.22 111.033 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 49' ' ' GLY . . . . . 0.437 ' HA3' ' HB3' ' B' ' 267' ' ' SER . . . 65.76 -103.48 0.84 Allowed Glycine 0 C--N 1.349 1.295 0 CA-C-N 115.537 -0.756 . . . . 74.15 111.861 -176.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -167.98 -78.05 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.77 0.428 . . . . 64.2 110.317 173.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 8.3 tp60 -121.16 -49.69 2.17 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.224 0.61 . . . . 75.3 110.844 -174.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 52' ' ' THR . . . . . 0.434 ' HA ' ' HB3' ' B' ' 287' ' ' PRO . 14.3 t -143.51 170.08 16.5 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.068 0.461 . . . . 73.31 111.591 -176.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -101.28 110.22 22.2 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.973 0.909 . . . . 73.24 109.527 178.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.2 158.02 32.07 Favored 'General case' 0 C--O 1.245 0.847 0 C-N-CA 123.452 0.701 . . . . 75.51 111.161 177.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.578 HD21 ' H ' ' B' ' 113' ' ' LYS . 24.7 tp -102.88 31.61 4.1 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.813 1.245 . . . . 72.35 108.381 -179.167 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 56' ' ' ARG . . . . . 0.724 HH21 ' HA ' ' B' ' 464' ' ' MET . 25.7 ttm180 67.6 164.1 0.21 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.724 1.21 . . . . 73.2 108.561 -155.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 57' ' ' ASP . . . . . 0.496 ' N ' ' HG2' ' B' ' 56' ' ' ARG . 3.9 m-20 -65.1 89.58 0.08 Allowed 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 124.061 0.945 . . . . 75.31 111.542 -177.366 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 58' ' ' SER . . . . . 0.655 ' HA ' ' HB2' ' B' ' 313' ' ' GLN . 19.3 m -82.57 -52.7 6.58 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.971 0.908 . . . . 62.01 111.311 -174.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 59' ' ' LEU . . . . . 0.432 ' HB3' HG21 ' B' ' 306' ' ' VAL . 62.2 tp -75.42 -33.58 60.95 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.988 -0.551 . . . . 72.44 109.987 176.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 22.0 m 58.6 -152.17 0.41 Allowed 'General case' 0 CA--C 1.557 1.25 0 C-N-CA 124.199 1.0 . . . . 63.51 111.201 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 61' ' ' ASP . . . . . 0.405 ' HA ' ' HA ' ' B' ' 308' ' ' CYS . 20.1 t70 -84.19 -68.67 0.7 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.534 0.734 . . . . 71.45 109.134 168.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 62' ' ' LYS . . . . . . . . . . . . . 8.1 mtmp? -124.8 105.4 29.77 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 124.247 1.019 . . . . 72.3 108.314 174.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.25 159.12 54.15 Favored 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 122.742 2.295 . . . . 72.24 111.25 177.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.11 -154.27 0.37 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.537 0.735 . . . . 72.04 110.437 -174.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 42.4 mttp 63.99 92.05 0.07 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 124.132 0.973 . . . . 65.32 110.731 172.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 50.3 t30 72.9 -55.84 0.67 Allowed 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 124.906 1.282 . . . . 72.41 109.583 -170.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 67' ' ' ILE . . . . . 0.501 HG22 HD12 ' B' ' 68' ' ' ILE . 23.6 mm -58.81 141.13 16.19 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.105 0 C-N-CA 124.558 1.143 . . . . 72.03 109.067 168.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 68' ' ' ILE . . . . . 0.501 HD12 HG22 ' B' ' 67' ' ' ILE . 2.2 mp 69.51 132.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 C-N-CA 124.513 1.125 . . . . 73.4 108.587 -163.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.436 ' HB3' ' O ' ' B' ' 96' ' ' GLY . 68.3 mt 66.37 9.75 6.69 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 125.284 1.434 . . . . 73.12 111.86 -169.142 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 7.1 tt -83.15 -44.34 15.18 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 109.482 -0.562 . . . . 44.44 109.482 -176.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 47.1 mm 65.14 -77.12 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.067 0 C-N-CA 124.824 1.25 . . . . 74.32 109.893 -174.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 64.46 31.92 82.49 Favored Glycine 0 C--N 1.355 1.613 0 C-N-CA 122.949 0.309 . . . . 62.21 113.65 177.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -96.32 161.2 14.04 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.532 0.733 . . . . 63.44 110.127 -176.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -70.73 -12.83 71.14 Favored Glycine 0 C--N 1.347 1.174 0 CA-C-N 116.086 -0.506 . . . . 64.42 113.039 176.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 45.0 mtm 65.41 16.82 10.72 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 125.232 1.413 . . . . 74.01 112.126 173.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 66.7 62.74 4.33 Favored Glycine 0 C--N 1.343 0.961 0 CA-C-N 115.961 -0.563 . . . . 71.13 112.89 -178.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 9.3 t70 68.81 -82.04 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.352 1.061 . . . . 73.03 110.811 175.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 78' ' ' SER . . . . . 0.484 ' H ' ' HE1' ' B' ' 424' ' ' TYR . 12.0 t 56.29 50.45 13.3 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 125.089 1.356 . . . . 51.1 112.241 176.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.34 -3.55 8.46 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 123.693 0.797 . . . . 74.44 113.122 178.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 38.8 mm -44.21 -42.66 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 125.509 1.524 . . . . 72.52 111.581 177.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 35.6 m -131.68 94.17 3.47 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-N 115.377 -0.829 . . . . 71.34 109.032 172.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.43 84.16 2.53 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 115.493 -0.776 . . . . 61.11 108.996 172.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.54 84.9 0.61 Allowed 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.254 -0.885 . . . . 71.35 109.556 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 65.0 -75.25 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.531 1.532 . . . . 73.0 109.967 -168.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -133.36 -55.43 0.91 Allowed 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 106.806 -1.553 . . . . 72.23 106.806 170.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -159.44 108.25 1.83 Allowed 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.438 1.495 . . . . 63.12 107.285 174.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -131.98 -75.27 0.51 Allowed 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 108.594 -0.891 . . . . 52.24 108.594 178.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -73.95 141.47 45.93 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 108.719 -0.845 . . . . 74.14 108.719 172.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 89' ' ' GLY . . . . . 0.547 ' HA3' ' HB2' ' B' ' 93' ' ' PHE . . . -89.72 45.91 3.1 Favored Glycine 0 C--N 1.342 0.905 0 CA-C-O 119.4 -0.666 . . . . 54.33 114.005 -171.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . 47.24 -87.13 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 125.69 1.596 . . . . 62.33 113.088 172.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -133.22 -31.96 0.41 Allowed Glycine 0 C--N 1.348 1.211 0 N-CA-C 111.337 -0.705 . . . . 70.11 111.337 175.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -63.45 -29.16 73.75 Favored Glycine 0 C--N 1.35 1.343 0 N-CA-C 114.421 0.528 . . . . 23.53 114.421 -174.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 93' ' ' PHE . . . . . 0.547 ' HB2' ' HA3' ' B' ' 89' ' ' GLY . 93.5 t80 -61.97 -37.66 85.61 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.543 0.737 . . . . 74.22 111.351 177.064 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -70.84 -13.42 62.03 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.373 -0.831 . . . . 71.21 112.169 -174.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 95' ' ' LYS . . . . . 0.497 ' HG3' HD11 ' B' ' 100' ' ' LEU . 0.8 OUTLIER -75.12 -29.88 60.67 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.77 0.828 . . . . 74.14 110.13 174.539 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 96' ' ' GLY . . . . . 0.436 ' O ' ' HB3' ' B' ' 69' ' ' LEU . . . -75.82 -7.81 84.01 Favored Glycine 0 C--N 1.35 1.314 0 CA-C-N 115.507 -0.769 . . . . 72.31 113.848 177.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 71.1 mt -64.77 -56.27 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 117.302 0.551 . . . . 72.22 110.31 176.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -87.9 -84.96 0.19 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.012 0.525 . . . . 75.21 110.511 -178.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . 168.07 -37.07 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.701 1.2 . . . . 61.12 110.106 -172.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 100' ' ' LEU . . . . . 0.497 HD11 ' HG3' ' B' ' 95' ' ' LYS . 83.2 mt 54.6 59.22 11.35 Favored Pre-proline 0 N--CA 1.483 1.198 0 C-N-CA 124.825 1.25 . . . . 74.2 109.911 -167.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 101' ' ' PRO . . . . . 0.547 ' HA ' ' HB2' ' B' ' 105' ' ' GLN . 77.6 Cg_endo -85.24 139.14 6.91 Favored 'Trans proline' 0 C--N 1.369 1.632 0 C-N-CA 122.01 1.807 . . . . 72.21 114.138 -164.233 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 6.6 tt -68.04 -69.06 0.34 Allowed 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 106.809 -1.552 . . . . 73.12 106.809 167.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 88.2 m -159.46 99.35 1.45 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.598 1.159 . . . . 75.52 107.937 173.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 60.65 59.03 10.94 Favored Glycine 0 C--N 1.353 1.486 0 N-CA-C 111.521 -0.631 . . . . 51.35 111.521 -173.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 105' ' ' GLN . . . . . 0.547 ' HB2' ' HA ' ' B' ' 101' ' ' PRO . 55.0 tp60 -58.19 -27.01 63.47 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.776 0.831 . . . . 75.22 112.776 -170.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -56.97 -31.2 64.79 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 125.04 1.336 . . . . 74.44 112.471 -176.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 7.3 m -129.18 4.03 5.24 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.579 0.752 . . . . 63.32 110.857 -179.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 27.9 t60 -74.02 81.93 1.73 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.219 0.608 . . . . 71.44 111.146 -173.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 72.56 -43.54 0.57 Allowed 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 126.213 1.805 . . . . 53.33 112.692 -177.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 110' ' ' ALA . . . . . 0.583 ' HB1' ' HB3' ' B' ' 317' ' ' SER . . . -76.53 75.51 3.25 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.536 1.135 . . . . 71.24 111.398 -178.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 46.4 tp -173.4 -81.71 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 107.229 -1.397 . . . . 64.15 107.229 174.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -81.75 130.61 35.12 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 109.139 -0.689 . . . . 73.2 109.139 176.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 113' ' ' LYS . . . . . 0.578 ' H ' HD21 ' B' ' 55' ' ' LEU . 44.3 mttm -93.97 85.02 4.63 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 122.917 0.487 . . . . 75.13 111.011 -170.19 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 4.5 tmtt? 69.76 -76.98 0.06 Allowed 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 125.85 1.66 . . . . 74.01 112.026 171.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 115' ' ' THR . . . . . 0.7 HG23 ' HB3' ' B' ' 300' ' ' ASN . 54.0 m 71.51 92.19 0.09 Allowed 'General case' 0 C--N 1.361 1.085 0 C-N-CA 125.329 1.452 . . . . 73.23 111.459 -176.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 163.57 -174.92 39.83 Favored Glycine 0 C--N 1.353 1.509 0 N-CA-C 114.375 0.51 . . . . 55.33 114.375 174.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp 57.3 81.5 0.25 Allowed Pre-proline 0 N--CA 1.488 1.439 0 C-N-CA 125.775 1.63 . . . . 70.25 111.949 -178.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 118' ' ' PRO . . . . . 0.465 ' HG3' ' HG3' ' B' ' 294' ' ' LYS . 55.6 Cg_endo -86.16 83.2 1.29 Allowed 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 123.399 2.733 . . . . 60.53 111.927 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 119' ' ' ASP . . . . . 0.472 ' HB2' ' NH2' ' B' ' 289' ' ' ARG . 5.6 m-20 -67.3 127.23 31.88 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.636 -0.711 . . . . 75.33 110.65 -174.534 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 120' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -68.11 150.38 48.46 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.971 0.908 . . . . 70.1 112.363 178.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 121' ' ' VAL . . . . . 0.477 HG11 HD11 ' B' ' 265' ' ' LEU . 30.2 m -110.85 15.38 8.28 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 CA-C-N 114.714 -1.13 . . . . 74.32 110.782 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 11.1 p -105.85 5.86 31.08 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.389 1.076 . . . . 75.24 112.123 -173.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -91.49 -178.78 5.2 Favored 'General case' 0 CA--C 1.561 1.374 0 C-N-CA 123.955 0.902 . . . . 64.3 110.316 -178.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 124' ' ' SER . . . . . 0.662 ' HB2' ' HB3' ' B' ' 207' ' ' LYS . 23.0 t -58.81 124.98 21.63 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.132 0.973 . . . . 43.31 112.538 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 125' ' ' ALA . . . . . 0.437 ' HA ' ' HG2' ' B' ' 342' ' ' GLN . . . -62.64 137.69 58.32 Favored 'General case' 0 C--N 1.352 0.692 0 C-N-CA 123.512 0.725 . . . . 73.02 110.208 172.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 126' ' ' ALA . . . . . 0.606 ' HA ' ' HA3' ' B' ' 211' ' ' GLY . . . -75.37 -67.8 0.62 Allowed 'General case' 0 N--CA 1.471 0.615 0 O-C-N 123.051 0.219 . . . . 74.13 111.091 -176.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 19.8 m 61.68 -167.64 0.2 Allowed 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 124.223 1.009 . . . . 70.01 112.489 176.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -146.85 138.09 24.13 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.41 0.684 . . . . 72.01 109.794 169.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 27.7 p -134.37 145.8 49.31 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.402 1.081 . . . . 54.34 108.961 178.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 130' ' ' ALA . . . . . 0.529 ' HA ' ' HA ' ' B' ' 163' ' ' LEU . . . 63.19 82.95 0.17 Allowed 'General case' 0 C--O 1.243 0.76 0 C-N-CA 124.48 1.112 . . . . 44.22 113.578 171.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 24.1 m-90 -75.38 141.24 43.3 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 115.147 -0.933 . . . . 73.51 109.061 172.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 22.7 m -90.8 31.62 1.05 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.669 0.788 . . . . 51.4 111.741 -173.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 81.4 m -58.55 -49.33 77.8 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.64 1.176 . . . . 62.25 111.981 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . -138.77 72.22 0.43 Allowed Glycine 0 C--N 1.34 0.783 0 CA-C-N 115.434 -0.803 . . . . 55.15 112.266 -174.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 135' ' ' VAL . . . . . . . . . . . . . 10.0 m 51.02 -168.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 C-N-CA 125.867 1.667 . . . . 73.24 113.358 176.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 136' ' ' LYS . . . . . 0.512 ' HD2' ' HB3' ' B' ' 164' ' ' ALA . 75.0 mmtt -127.47 -155.92 0.72 Allowed 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 108.77 -0.826 . . . . 52.43 108.77 176.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 23.3 m 82.61 -40.65 0.11 Allowed 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 125.421 1.488 . . . . 75.31 113.447 173.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -84.93 43.76 1.02 Allowed 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.549 0.74 . . . . 75.52 112.688 -171.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 139' ' ' ASN . . . . . 0.524 ' HB3' ' HA ' ' B' ' 164' ' ' ALA . 37.9 p30 -75.68 -5.67 46.73 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.266 0.626 . . . . 73.24 112.319 178.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -83.64 2.15 87.74 Favored Glycine 0 C--N 1.345 1.063 0 CA-C-O 120.172 -0.238 . . . . 65.04 113.202 173.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -85.41 133.87 34.1 Favored 'General case' 0 C--N 1.349 0.567 0 C-N-CA 123.156 0.582 . . . . 75.34 110.432 176.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 6.4 mp -72.96 147.89 44.78 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 108.722 -0.844 . . . . 70.15 108.722 172.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 128.4 -140.56 11.86 Favored Glycine 0 C--N 1.34 0.788 0 N-CA-C 111.151 -0.78 . . . . 61.25 111.151 -177.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 84.6 t 76.32 -39.0 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 C-N-CA 124.985 1.314 . . . . 75.31 112.55 177.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 22.0 t70 66.09 -83.48 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.389 1.476 . . . . 64.3 109.865 -171.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 8.0 tp 45.25 23.61 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 C-N-CA 126.452 1.901 . . . . 72.52 112.959 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 26.8 t-80 -75.28 -30.96 60.57 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.65 -0.704 . . . . 72.43 110.301 -175.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 70.56 -72.82 0.1 Allowed 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 125.477 1.511 . . . . 73.05 109.87 169.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 149' ' ' LYS . . . . . 0.642 ' HE2' ' HA ' ' B' ' 260' ' ' SER . 63.7 mttp -132.82 -63.19 0.79 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.528 0.731 . . . . 72.23 110.428 172.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -159.71 -66.73 0.08 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.812 0.445 . . . . 74.11 110.43 -170.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 -71.69 -37.88 5.73 Favored Pre-proline 0 CA--C 1.561 1.375 0 CA-C-O 117.767 -1.111 . . . . 74.43 113.886 -174.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -53.79 111.44 0.69 Allowed 'Trans proline' 0 C--N 1.385 2.462 0 C-N-CA 121.814 1.676 . . . . 42.51 112.788 172.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 46.2 m -101.8 151.7 21.75 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.603 1.161 . . . . 74.2 110.295 -175.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 14.6 tt -82.94 115.29 25.17 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 CA-C-O 121.028 0.442 . . . . 74.25 110.106 176.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 155' ' ' LEU . . . . . 0.685 ' HB2' ' HB2' ' B' ' 158' ' ' ALA . 5.4 mp -116.43 138.92 50.98 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 108.627 -0.879 . . . . 72.1 108.627 173.241 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -71.85 -19.86 61.9 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.467 0.707 . . . . 72.23 112.785 -172.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 157' ' ' MET . . . . . 0.513 ' HA ' ' HA ' ' B' ' 161' ' ' ALA . 95.0 mmm -118.72 11.75 12.83 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-O 119.09 -0.481 . . . . 53.54 111.61 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 158' ' ' ALA . . . . . 0.685 ' HB2' ' HB2' ' B' ' 155' ' ' LEU . . . -53.94 95.53 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.829 0.852 . . . . 34.04 112.551 -174.165 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 159' ' ' LYS . . . . . 0.418 ' H ' ' HB2' ' B' ' 198' ' ' GLU . 94.5 mttt 65.54 -76.13 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 125.635 1.574 . . . . 55.45 112.059 175.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -105.95 23.33 14.14 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.633 0.773 . . . . 70.22 110.532 177.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 161' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' B' ' 157' ' ' MET . . . 82.74 24.07 0.17 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 126.023 1.729 . . . . 71.1 112.806 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 76.95 -68.15 2.61 Favored Glycine 0 C--N 1.353 1.522 0 CA-C-N 116.224 -0.444 . . . . 73.4 113.061 170.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 163' ' ' LEU . . . . . 0.529 ' HA ' ' HA ' ' B' ' 130' ' ' ALA . 0.2 OUTLIER -141.98 -40.18 0.36 Allowed 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 107.35 -1.352 . . . . 65.02 107.35 171.537 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 164' ' ' ALA . . . . . 0.524 ' HA ' ' HB3' ' B' ' 139' ' ' ASN . . . 71.24 0.84 3.59 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.453 1.501 . . . . 75.34 112.997 175.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 15.3 t -152.87 169.0 23.91 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 123.406 0.683 . . . . 64.15 109.985 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . -178.08 -49.94 0.07 OUTLIER Glycine 0 C--N 1.339 0.747 0 N-CA-C 109.846 -1.302 . . . . 71.15 109.846 -178.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 167' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -75.58 150.48 38.05 Favored 'General case' 0 C--O 1.245 0.816 0 N-CA-C 108.424 -0.954 . . . . 72.31 108.424 170.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 168' ' ' VAL . . . . . 0.512 HG22 ' HB2' ' B' ' 175' ' ' ASP . 97.0 t 64.23 -87.24 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 C-N-CA 123.809 0.844 . . . . 74.13 108.82 -170.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 58.3 p 44.13 -90.51 0.01 OUTLIER 'General case' 0 CA--C 1.565 1.525 0 C-N-CA 125.311 1.445 . . . . 54.35 114.046 -177.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 28.6 m -82.9 87.33 6.84 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 109.189 -0.671 . . . . 63.1 109.189 -177.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 171' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' C' ' 214' ' ' THR . . . 60.91 -160.88 0.3 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.615 1.166 . . . . 53.32 109.762 -168.306 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 172' ' ' GLU . . . . . 0.442 ' HB3' HG13 ' B' ' 168' ' ' VAL . 0.1 OUTLIER -132.29 150.75 52.09 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.953 -0.758 . . . . 73.22 108.953 169.585 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 173' ' ' LEU . . . . . . . . . . . . . 27.2 tp -88.88 -53.71 4.48 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 108.533 -0.914 . . . . 74.23 108.533 178.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 174' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -165.2 41.82 0.07 Allowed 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 107.724 -1.213 . . . . 74.45 107.724 173.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 175' ' ' ASP . . . . . 0.512 ' HB2' HG22 ' B' ' 168' ' ' VAL . 6.3 m-20 -113.34 -37.29 4.73 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 114.959 -1.019 . . . . 74.1 112.585 -164.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -113.89 114.81 26.75 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 112.932 0.716 . . . . 74.11 112.932 -166.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 8.0 t -156.36 127.94 3.81 Favored Pre-proline 0 CA--C 1.556 1.202 0 C-N-CA 124.21 1.004 . . . . 64.31 109.287 168.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 178' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.88 -61.96 0.04 OUTLIER 'Trans proline' 0 C--N 1.383 2.345 0 C-N-CA 122.475 2.117 . . . . 74.53 112.845 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -152.76 33.03 0.49 Allowed 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.021 0.928 . . . . 61.34 109.263 -178.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . 63.48 -74.98 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.909 1.284 . . . . 74.4 110.67 -164.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 16.8 tp -161.43 13.69 0.09 Allowed 'General case' 0 CA--C 1.56 1.365 0 N-CA-C 111.919 0.341 . . . . 62.04 111.919 -168.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 182' ' ' VAL . . . . . 0.664 ' HA ' ' HB2' ' C' ' 139' ' ' GLU . 12.4 p -117.7 150.09 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 CA-C-O 118.533 -0.746 . . . . 71.31 110.008 178.001 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -169.05 6.57 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 115.21 1.559 . . . . 65.24 115.21 -177.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 79.7 m80 76.4 161.49 0.23 Allowed 'General case' 0 N--CA 1.507 2.399 0 C-N-CA 124.548 1.139 . . . . 74.15 111.437 177.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 185' ' ' VAL . . . . . 0.584 HG23 ' HA ' ' C' ' 141' ' ' ALA . 92.7 t -64.41 106.82 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 122.901 0.48 . . . . 71.33 111.407 -173.534 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 186' ' ' THR . . . . . 0.798 ' HA ' ' HB3' ' C' ' 122' ' ' GLU . 65.2 p 66.43 105.48 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.872 1.669 . . . . 51.31 114.392 163.58 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 187' ' ' SER . . . . . . . . . . . . . 51.5 p -171.82 97.58 0.17 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.658 1.183 . . . . 62.14 109.573 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 188' ' ' ARG . . . . . 0.438 ' HG2' ' HB3' ' C' ' 179' ' ' ARG . 0.0 OUTLIER -73.83 113.22 10.73 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 107.346 -1.353 . . . . 71.52 107.346 173.171 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 189' ' ' LYS . . . . . 0.404 ' HB2' ' HB3' ' C' ' 124' ' ' PRO . 1.2 tmtm? -69.74 98.27 1.18 Allowed 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 109.19 -0.67 . . . . 72.52 109.19 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 190' ' ' CYS . . . . . . . . . . . . . 6.4 p -76.98 112.64 13.83 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-N 115.302 -0.863 . . . . 70.33 109.909 176.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -79.84 124.81 28.97 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.08 0.552 . . . . 74.04 110.621 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -89.83 112.36 4.02 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-O 118.458 -1.19 . . . . 64.22 110.74 168.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 193' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.14 -41.05 82.42 Favored 'Trans proline' 0 C--N 1.385 2.449 0 C-N-CA 122.917 2.412 . . . . 64.32 112.82 177.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 194' ' ' SER . . . . . . . . . . . . . 21.4 t 62.85 20.26 12.07 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 124.839 1.256 . . . . 24.51 111.652 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 195' ' ' ALA . . . . . . . . . . . . . . . -83.7 77.64 9.83 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.538 0.735 . . . . 74.32 111.377 -173.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 72.1 m -70.65 130.3 41.42 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.272 -0.876 . . . . 73.32 108.763 169.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 45.5 m -69.47 83.12 0.4 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.612 0.765 . . . . 75.11 112.765 -169.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 198' ' ' GLU . . . . . 0.418 ' HB2' ' H ' ' B' ' 159' ' ' LYS . 1.0 OUTLIER 55.05 -91.1 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 126.072 1.749 . . . . 51.12 110.728 178.294 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? -155.96 61.23 0.58 Allowed 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 105.762 -1.94 . . . . 74.4 105.762 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 200' ' ' CYS . . . . . . . . . . . . . 54.0 t -59.12 -39.4 73.23 Favored Pre-proline 0 CA--C 1.559 1.293 0 CA-C-N 113.314 -1.766 . . . . 73.31 112.818 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 201' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -63.94 -10.11 21.64 Favored 'Trans proline' 0 C--N 1.39 2.754 0 C-N-CA 121.509 1.472 . . . . 71.34 114.113 171.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . -125.89 67.91 0.53 Allowed Glycine 0 C--N 1.353 1.497 0 C-N-CA 123.002 0.334 . . . . 63.04 112.509 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -120.84 16.23 11.8 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.916 0.886 . . . . 71.33 110.036 177.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . 64.78 17.4 10.95 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.796 1.238 . . . . 74.01 112.163 -174.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 205' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 54.61 78.04 0.18 Allowed 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 125.664 1.586 . . . . 51.03 110.946 175.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -171.92 -54.87 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.608 0.763 . . . . 62.32 109.893 -174.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 207' ' ' LYS . . . . . 0.662 ' HB3' ' HB2' ' B' ' 124' ' ' SER . 13.2 mptt -65.6 -36.0 82.47 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 114.992 -1.003 . . . . 74.32 110.821 -178.21 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 79.27 -78.79 1.69 Allowed Glycine 0 C--N 1.345 1.034 0 CA-C-N 115.788 -0.642 . . . . 71.52 111.96 -178.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 171.42 -65.77 0.14 Allowed Glycine 0 C--N 1.345 1.043 0 N-CA-C 110.296 -1.122 . . . . 42.21 110.296 -177.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 63.92 -78.34 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 125.318 1.447 . . . . 74.51 111.835 169.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 211' ' ' GLY . . . . . 0.606 ' HA3' ' HA ' ' B' ' 126' ' ' ALA . . . -83.88 52.76 4.77 Favored Glycine 0 C--N 1.35 1.346 0 N-CA-C 111.72 -0.552 . . . . 74.43 111.72 173.367 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 70.9 m -149.85 177.27 9.97 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.657 1.183 . . . . 74.04 109.79 -174.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 72.1 mt 71.77 -69.29 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 C-N-CA 125.516 1.526 . . . . 64.4 111.592 178.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 40.7 m 70.51 -67.88 0.23 Allowed 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 125.705 1.602 . . . . 75.43 110.685 -175.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 215' ' ' GLU . . . . . 0.418 ' HB3' ' NH2' ' B' ' 32' ' ' ARG . 33.5 tt0 64.31 107.02 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.183 1.393 . . . . 73.31 112.747 173.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 59.7 81.99 0.16 Allowed 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.0 1.32 . . . . 61.42 112.688 171.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.34 117.18 5.48 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 107.801 -1.185 . . . . 75.4 107.801 173.305 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -72.52 113.66 9.8 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 108.431 -0.951 . . . . 71.43 108.431 178.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 61.8 t30 75.89 -69.65 0.16 Allowed 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 125.526 1.53 . . . . 71.24 112.615 175.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . 70.71 -73.11 0.1 Allowed 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 125.351 1.461 . . . . 61.1 111.87 -175.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 221' ' ' ARG . . . . . 0.586 HH12 ' HG2' ' A' ' 228' ' ' GLN . 0.8 OUTLIER -134.38 131.18 37.94 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.472 1.109 . . . . 73.55 108.486 -178.22 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -157.81 26.19 0.27 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.415 0.686 . . . . 42.52 110.451 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -64.17 100.78 0.35 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.175 0.99 . . . . 61.02 110.26 -171.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 224' ' ' VAL . . . . . 0.427 ' O ' ' HB3' ' C' ' 211' ' ' ARG . 11.3 p -109.74 41.05 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 C-N-CA 124.827 1.251 . . . . 74.2 108.817 -173.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 73.6 p -51.56 -46.92 63.57 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 113.818 -1.537 . . . . 54.34 111.719 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 2.4 tm? 60.85 95.37 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.08 1.352 . . . . 74.43 109.601 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . -107.73 150.0 16.82 Favored Glycine 0 C--N 1.334 0.464 0 CA-C-N 115.819 -0.628 . . . . 51.31 112.859 -177.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . -79.9 101.2 1.92 Allowed Glycine 0 C--N 1.343 0.92 0 N-CA-C 111.207 -0.757 . . . . 72.41 111.207 175.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -62.87 -7.21 15.01 Favored Glycine 0 C--N 1.351 1.411 0 N-CA-C 115.034 0.774 . . . . 70.24 115.034 -178.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 230' ' ' ALA . . . . . 0.451 ' HA ' HE21 ' B' ' 252' ' ' GLN . . . -130.53 147.75 52.26 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 124.775 1.23 . . . . 70.23 108.892 171.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 231' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -61.84 120.92 11.67 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.6 0.36 . . . . 73.24 110.521 177.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 8.6 t -158.04 162.43 38.12 Favored 'General case' 0 C--O 1.246 0.884 0 C-N-CA 124.101 0.961 . . . . 74.24 108.423 174.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -72.71 113.35 9.65 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.939 -1.134 . . . . 70.41 107.939 171.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -74.94 82.23 2.19 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 121.186 0.517 . . . . 72.31 109.946 178.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -76.97 172.29 13.42 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 124.067 0.947 . . . . 54.41 110.148 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 236' ' ' THR . . . . . . . . . . . . . 43.2 m 74.54 86.32 0.1 Allowed 'General case' 0 C--N 1.354 0.768 0 C-N-CA 124.865 1.266 . . . . 73.34 109.524 -176.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -94.37 25.59 3.8 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 114.697 -1.138 . . . . 71.12 110.775 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 238' ' ' THR . . . . . 0.514 HG22 HG23 ' C' ' 219' ' ' VAL . 21.9 m -55.75 105.72 0.2 Allowed 'General case' 0 C--N 1.361 1.108 0 C-N-CA 123.624 0.77 . . . . 71.31 110.132 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 239' ' ' ALA . . . . . 0.425 ' HA ' HG22 ' C' ' 219' ' ' VAL . . . -159.71 -82.8 0.04 OUTLIER 'General case' 0 C--O 1.24 0.593 0 O-C-N 123.837 0.711 . . . . 74.42 109.561 -178.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 240' ' ' GLY . . . . . 0.417 ' HA3' ' HA ' ' C' ' 235' ' ' LEU . . . 161.91 -108.67 0.36 Allowed Glycine 0 C--N 1.333 0.367 0 N-CA-C 109.678 -1.369 . . . . 71.23 109.678 -170.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -159.92 160.45 33.53 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.35 0.66 . . . . 71.21 111.125 178.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 26.7 m95 -123.77 -83.08 0.65 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.165 0.986 . . . . 70.32 108.715 168.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -154.49 -54.87 0.1 Allowed 'General case' 0 C--N 1.362 1.152 0 C-N-CA 125.985 1.714 . . . . 74.22 106.654 -168.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -147.34 -163.28 10.49 Favored Glycine 0 C--N 1.355 1.614 0 CA-C-N 113.843 -1.526 . . . . 63.11 110.628 173.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? -171.69 133.41 0.77 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.89 -0.781 . . . . 75.34 108.89 175.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 246' ' ' THR . . . . . 0.601 HG21 HG12 ' B' ' 371' ' ' VAL . 91.6 m -133.53 151.46 51.75 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.572 1.149 . . . . 71.02 108.759 176.126 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 247' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -132.44 -178.83 5.1 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.458 0.703 . . . . 72.51 110.017 176.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 248' ' ' ARG . . . . . 0.686 ' HD2' ' HA ' ' B' ' 370' ' ' ALA . 2.4 tpm_? -161.68 157.34 24.32 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.975 0.91 . . . . 75.15 109.422 -178.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 249' ' ' GLU . . . . . 0.443 ' HG2' ' NH2' ' B' ' 248' ' ' ARG . 13.4 pt-20 -114.88 160.68 19.21 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.589 0.756 . . . . 71.33 109.274 170.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 250' ' ' GLN . . . . . 0.508 HE21 ' HB3' ' A' ' 274' ' ' GLU . 0.0 OUTLIER -146.41 177.22 9.19 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.454 0.702 . . . . 65.4 109.692 -173.563 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 251' ' ' ALA . . . . . . . . . . . . . . . -88.37 -7.15 57.12 Favored 'General case' 0 N--CA 1.483 1.223 0 O-C-N 122.292 -0.255 . . . . 61.03 111.507 174.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 252' ' ' GLN . . . . . 0.499 ' H ' ' HG2' ' B' ' 250' ' ' GLN . 1.4 tm0? 70.0 -68.73 0.19 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.954 1.701 . . . . 72.3 111.563 172.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -76.44 74.21 3.19 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.012 0.925 . . . . 51.41 110.608 176.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -86.32 -77.84 0.3 Allowed 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 114.667 -1.151 . . . . 72.51 108.106 175.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -84.62 -28.66 31.81 Favored Glycine 0 N--CA 1.47 0.931 0 CA-C-N 117.998 0.363 . . . . 54.22 112.244 169.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 256' ' ' TYR . . . . . . . . . . . . . 78.0 t80 67.4 -76.45 0.05 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.254 1.421 . . . . 52.52 109.616 -171.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 257' ' ' GLN . . . . . 0.619 ' HA ' ' HB1' ' B' ' 355' ' ' ALA . 78.2 mt-30 38.45 88.49 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 126.189 1.796 . . . . 74.31 114.309 171.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 258' ' ' LEU . . . . . . . . . . . . . 2.6 tt -86.0 64.89 8.83 Favored 'General case' 0 CA--C 1.556 1.208 0 N-CA-C 109.243 -0.651 . . . . 75.13 109.243 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 33.4 m 38.2 31.69 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 C-N-CA 127.248 2.219 . . . . 63.02 115.899 172.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 260' ' ' SER . . . . . 0.642 ' HA ' ' HE2' ' B' ' 149' ' ' LYS . 32.4 m -76.96 -29.64 55.65 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 112.425 0.528 . . . . 73.11 112.425 -175.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 28.3 t0 69.31 176.01 0.28 Allowed 'General case' 0 N--CA 1.483 1.193 0 O-C-N 124.36 1.038 . . . . 52.21 111.733 169.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 262' ' ' ALA . . . . . . . . . . . . . . . -137.97 134.97 35.55 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 123.581 0.752 . . . . 43.43 110.062 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 263' ' ' ALA . . . . . 0.449 ' HB2' ' HB ' ' B' ' 348' ' ' ILE . . . -80.65 62.46 4.72 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.566 0.746 . . . . 70.44 111.076 176.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 50.7 m -123.12 -9.45 8.18 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.942 0.897 . . . . 51.14 110.564 176.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 265' ' ' LEU . . . . . 0.477 HD11 HG11 ' B' ' 121' ' ' VAL . 68.9 mt 54.04 58.73 4.77 Favored 'General case' 0 C--N 1.363 1.166 0 C-N-CA 124.446 1.099 . . . . 64.12 110.439 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 266' ' ' ASN . . . . . 0.494 ' H ' ' HB3' ' B' ' 46' ' ' ARG . 29.3 m120 78.13 -63.94 0.3 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 126.574 1.95 . . . . 71.52 111.13 -172.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 267' ' ' SER . . . . . 0.437 ' HB3' ' HA3' ' B' ' 49' ' ' GLY . 32.6 t 56.63 55.82 6.07 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.49 0.716 . . . . 73.13 109.074 -171.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 39.0 t -63.88 102.54 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 115.362 -0.835 . . . . 74.44 110.828 -172.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 269' ' ' THR . . . . . 0.403 ' OG1' ' HB2' ' B' ' 470' ' ' LEU . 14.2 t -159.83 -40.52 0.05 Allowed 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 111.932 0.345 . . . . 74.31 111.932 -175.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 270' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -123.04 132.54 54.16 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 123.414 0.686 . . . . 72.41 110.4 -167.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 271' ' ' ALA . . . . . 0.44 ' HB3' ' HB1' ' B' ' 467' ' ' ALA . . . -174.45 -28.9 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 O-C-N 123.913 0.758 . . . . 75.3 111.937 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 272' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -90.9 61.83 4.79 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-O 121.367 0.603 . . . . 54.14 111.803 -170.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 63.47 -0.51 0.69 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 116.061 1.874 . . . . 61.32 116.061 165.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -68.51 -44.85 73.78 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 118.725 0.693 . . . . 71.44 109.279 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 275' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -105.34 99.04 18.4 Favored Pre-proline 0 N--CA 1.478 0.944 0 N-CA-C 107.24 -1.392 . . . . 71.33 107.24 169.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -61.76 85.94 0.1 OUTLIER 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 123.101 2.534 . . . . 62.35 114.257 -169.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 277' ' ' LEU . . . . . . . . . . . . . 9.7 mp 60.17 -72.47 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 126.977 2.111 . . . . 63.32 114.482 169.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 278' ' ' LEU . . . . . 0.674 HD13 ' H ' ' B' ' 278' ' ' LEU . 0.0 OUTLIER -103.82 0.76 30.73 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.761 0.825 . . . . 62.0 111.78 -175.271 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . -72.28 -78.06 0.52 Allowed Glycine 0 C--N 1.352 1.46 0 O-C-N 123.416 0.448 . . . . 75.43 112.722 179.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 69.51 152.91 0.1 Allowed 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 125.188 1.395 . . . . 53.23 113.728 178.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -114.4 37.45 3.38 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 106.294 -1.743 . . . . 75.31 106.294 165.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -64.59 87.68 0.06 Allowed 'General case' 0 C--N 1.357 0.926 0 CA-C-N 114.561 -1.199 . . . . 65.41 111.856 -171.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -107.34 -13.95 14.99 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.862 1.265 . . . . 72.33 109.442 175.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . -61.94 97.71 0.16 Allowed Glycine 0 C--N 1.345 1.052 0 CA-C-N 115.672 -0.695 . . . . 61.45 113.505 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -67.23 -48.13 68.73 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.021 0.928 . . . . 72.41 110.09 177.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 286' ' ' MET . . . . . . . . . . . . . 44.4 tpp -163.21 108.9 1.0 Allowed Pre-proline 0 CA--C 1.543 0.705 0 N-CA-C 108.729 -0.841 . . . . 64.1 108.729 178.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 287' ' ' PRO . . . . . 0.434 ' HB3' ' HA ' ' B' ' 52' ' ' THR . 28.2 Cg_exo -65.1 78.81 0.21 Allowed 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 123.53 2.82 . . . . 73.33 112.585 178.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 288' ' ' VAL . . . . . 0.551 HG23 ' H ' ' B' ' 289' ' ' ARG 0.269 6.2 m 35.69 -96.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 C-N-CA 125.504 1.521 . . . . 74.32 112.448 -170.071 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 289' ' ' ARG . . . . . 0.551 ' H ' HG23 ' B' ' 288' ' ' VAL . 24.6 tpt180 62.25 -82.5 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.638 1.175 . . . . 72.14 111.152 176.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 290' ' ' TRP . . . . . . . . . . . . . 31.9 t90 -107.01 -31.42 8.3 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.303 1.041 . . . . 75.34 109.221 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 291' ' ' LEU . . . . . . . . . . . . . 47.9 tp -67.66 126.36 29.12 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.469 1.107 . . . . 64.34 110.617 177.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . 90.86 -161.29 28.08 Favored Glycine 0 C--N 1.348 1.213 0 O-C-N 123.633 0.583 . . . . 62.12 112.581 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.84 162.58 41.53 Favored 'Trans proline' 0 C--N 1.371 1.743 0 C-N-CA 122.761 2.308 . . . . 51.12 112.647 176.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 294' ' ' LYS . . . . . 0.465 ' HG3' ' HG3' ' B' ' 118' ' ' PRO . 5.6 ttpm? -57.56 91.28 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.885 1.274 . . . . 41.23 111.384 -177.306 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . 59.09 13.36 2.88 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.863 1.265 . . . . 34.32 112.334 -178.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 296' ' ' THR . . . . . 0.428 ' HB ' ' HA3' ' B' ' 299' ' ' GLY . 6.9 m 51.14 47.69 24.4 Favored 'General case' 0 C--N 1.364 1.221 0 C-N-CA 124.687 1.195 . . . . 65.42 110.103 -169.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 62.68 -78.49 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.431 1.493 . . . . 64.12 110.325 -171.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 298' ' ' HIS . . . . . 0.474 ' HA ' HG21 ' B' ' 115' ' ' THR . 54.6 t-80 -136.7 38.21 2.63 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 108.418 -0.956 . . . . 71.5 108.418 177.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 299' ' ' GLY . . . . . 0.428 ' HA3' ' HB ' ' B' ' 296' ' ' THR . . . -67.04 -29.25 74.31 Favored Glycine 0 C--N 1.349 1.283 0 CA-C-N 115.107 -0.951 . . . . 63.41 112.603 177.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 300' ' ' ASN . . . . . 0.7 ' HB3' HG23 ' B' ' 115' ' ' THR . 24.1 t-20 -71.92 91.77 1.22 Allowed 'General case' 0 CA--C 1.549 0.911 0 CA-C-O 121.682 0.753 . . . . 72.23 109.132 171.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 301' ' ' ILE . . . . . . . . . . . . . 12.7 tt -133.7 -21.26 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 CA-C-N 114.703 -1.135 . . . . 72.24 109.561 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 10.5 t70 71.16 108.1 0.06 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 125.252 1.421 . . . . 63.41 111.688 -178.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 303' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -147.75 -53.78 0.02 OUTLIER Pre-proline 0 CA--C 1.56 1.36 0 C-N-CA 125.155 1.382 . . . . 74.11 110.409 176.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 304' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -72.42 -3.32 13.19 Favored 'Trans proline' 0 C--N 1.401 3.307 0 C-N-CA 122.345 2.03 . . . . 75.12 113.61 -176.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 305' ' ' ALA . . . . . 0.407 ' HB1' ' HB3' ' B' ' 470' ' ' LEU . . . -85.56 -78.03 0.28 Allowed 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 109.703 -0.48 . . . . 42.33 109.703 175.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 306' ' ' VAL . . . . . 0.432 HG21 ' HB3' ' B' ' 59' ' ' LEU . 17.3 m -43.56 -51.0 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 114.918 1.451 . . . . 72.33 114.918 -168.583 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 21.4 m 62.72 -70.02 0.06 Allowed 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 124.784 1.234 . . . . 74.23 111.057 -170.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 308' ' ' CYS . . . . . 0.405 ' HA ' ' HA ' ' B' ' 61' ' ' ASP . 18.8 p -156.13 96.55 1.71 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.035 0.934 . . . . 74.22 109.901 177.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 30.0 p -131.04 135.27 27.03 Favored Pre-proline 0 N--CA 1.484 1.275 0 C-N-CA 123.684 0.794 . . . . 72.2 111.67 -174.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -80.35 -0.98 11.04 Favored 'Trans proline' 0 C--N 1.379 2.157 0 C-N-CA 122.831 2.354 . . . . 63.14 114.454 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 311' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -80.58 122.33 82.27 Favored Pre-proline 0 N--CA 1.481 1.12 0 N-CA-C 109.387 -0.598 . . . . 73.13 109.387 177.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 312' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -83.59 144.18 11.17 Favored 'Trans proline' 0 C--N 1.37 1.692 0 C-N-CA 121.996 1.797 . . . . 70.14 113.503 176.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 313' ' ' GLN . . . . . 0.655 ' HB2' ' HA ' ' B' ' 58' ' ' SER . 6.8 tp60 -62.51 -37.02 84.41 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 115.202 -0.908 . . . . 75.13 110.207 167.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 314' ' ' ARG . . . . . 0.433 HH22 ' HG3' ' B' ' 105' ' ' GLN . 32.6 ttt180 -144.77 118.48 9.22 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 113.839 -1.528 . . . . 72.01 109.047 -173.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 315' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -76.62 -50.85 12.77 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 107.36 -1.348 . . . . 72.12 107.36 170.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 316' ' ' ASP . . . . . . . . . . . . . 32.5 t70 176.13 108.19 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.648 1.579 . . . . 74.4 108.817 158.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 317' ' ' SER . . . . . 0.583 ' HB3' ' HB1' ' B' ' 110' ' ' ALA . 35.1 t -92.73 91.29 7.43 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 121.513 0.673 . . . . 75.41 109.754 175.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 318' ' ' VAL . . . . . . . . . . . . . 14.0 p -91.12 -24.43 0.27 Allowed Pre-proline 0 CA--C 1.583 2.229 0 N-CA-C 114.117 1.154 . . . . 73.13 114.117 173.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 319' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -76.92 25.05 0.46 Allowed 'Trans proline' 0 C--N 1.414 3.986 0 CA-C-N 123.343 2.229 . . . . 65.1 114.883 -170.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 320' ' ' THR . . . . . . . . . . . . . 72.6 m -60.03 -51.71 68.48 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.789 0.836 . . . . 53.31 109.758 170.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 321' ' ' LEU . . . . . 0.586 ' HB3' ' HB3' ' B' ' 434' ' ' HIS . 2.4 tm? 61.19 -78.8 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 125.601 1.561 . . . . 65.14 110.884 176.534 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 322' ' ' ALA . . . . . . . . . . . . . . . -139.64 108.24 5.9 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.857 0.863 . . . . 64.54 109.461 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 323' ' ' GLN . . . . . . . . . . . . . 5.4 pp0? -82.63 7.47 14.64 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.414 0.686 . . . . 74.02 111.731 -178.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 324' ' ' MET . . . . . . . . . . . . . 9.5 ptt? -56.07 -26.16 48.26 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 124.15 0.98 . . . . 71.32 112.057 -177.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 325' ' ' THR . . . . . . . . . . . . . 19.8 m -56.94 154.21 9.89 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 124.438 1.095 . . . . 72.33 110.708 174.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 326' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -57.69 159.22 5.37 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.932 0.893 . . . . 72.01 111.696 -179.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 327' ' ' LYS . . . . . 0.52 ' H ' ' HG ' ' B' ' 331' ' ' LEU . 3.2 mptp? -102.41 3.84 38.23 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.316 0.647 . . . . 54.34 110.426 -179.092 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 328' ' ' ALA . . . . . . . . . . . . . . . 58.81 -85.0 0.02 OUTLIER 'General case' 0 C--N 1.363 1.195 0 C-N-CA 125.293 1.437 . . . . 72.03 109.987 -172.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 329' ' ' ILE . . . . . . . . . . . . . 2.7 pp -61.25 141.96 16.76 Favored 'Isoleucine or valine' 0 C--O 1.244 0.793 0 C-N-CA 123.587 0.755 . . . . 73.5 111.326 176.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 330' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 65.34 4.27 2.62 Favored 'General case' 0 CA--C 1.566 1.592 0 C-N-CA 124.054 0.942 . . . . 63.42 112.166 177.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 331' ' ' LEU . . . . . 0.52 ' HG ' ' H ' ' B' ' 327' ' ' LYS . 2.2 tm? -112.55 89.17 3.0 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 108.966 -0.753 . . . . 63.34 108.966 -174.375 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 51.44 -85.82 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 125.868 1.667 . . . . 74.41 113.493 171.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 333' ' ' SER . . . . . . . . . . . . . 15.3 m -61.1 -58.08 9.84 Favored 'General case' 0 C--N 1.354 0.773 0 C-N-CA 124.253 1.021 . . . . 65.04 109.512 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 23.2 pttm 41.28 -169.92 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 126.618 1.967 . . . . 63.11 115.415 176.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 335' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -124.53 172.15 9.44 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 123.621 0.768 . . . . 73.25 109.203 171.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.75 -47.19 80.62 Favored 'General case' 0 CA--C 1.556 1.194 0 C-N-CA 124.041 0.936 . . . . 61.02 113.264 -173.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 337' ' ' LYS . . . . . 0.462 ' HD2' ' HG2' ' B' ' 30' ' ' GLU . 20.0 ptmt -173.77 -27.07 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.935 0.894 . . . . 62.43 110.26 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 338' ' ' GLY . . . . . . . . . . . . . . . 90.62 -55.39 3.45 Favored Glycine 0 C--N 1.354 1.572 0 O-C-N 123.558 0.537 . . . . 72.34 111.798 177.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 339' ' ' PHE . . . . . 0.533 ' HB2' ' HA ' ' B' ' 446' ' ' PRO . 22.6 p90 -120.12 115.98 24.75 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.624 0.77 . . . . 74.33 109.284 177.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 340' ' ' PHE . . . . . 0.457 ' HD1' ' H ' ' B' ' 340' ' ' PHE . 1.9 p90 -66.77 -51.11 59.58 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.451 0.7 . . . . 75.24 110.968 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 341' ' ' LEU . . . . . 0.505 HD23 HH21 ' B' ' 289' ' ' ARG . 29.4 tp 51.04 77.85 0.12 Allowed 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.906 1.282 . . . . 75.34 110.679 178.129 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 342' ' ' GLN . . . . . 0.437 ' HG2' ' HA ' ' B' ' 125' ' ' ALA . 3.3 tp-100 -109.53 -69.95 0.83 Allowed 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 115.714 -0.675 . . . . 64.25 111.049 -166.17 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 343' ' ' VAL . . . . . . . . . . . . . 12.0 p -160.21 -35.66 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.827 0 C-N-CA 123.317 0.647 . . . . 64.24 109.792 -173.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 54.07 -78.41 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 125.56 1.544 . . . . 73.03 113.277 174.225 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 345' ' ' GLY . . . . . . . . . . . . . . . -70.39 -8.5 62.68 Favored Glycine 0 N--CA 1.484 1.881 0 CA-C-N 118.614 0.643 . . . . 62.31 114.626 -178.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 346' ' ' ALA . . . . . . . . . . . . . . . 77.42 -61.54 0.41 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.69 1.596 . . . . 72.22 112.562 172.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 48.4 p -70.18 -28.75 65.57 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.348 0.659 . . . . 72.21 111.747 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 348' ' ' ILE . . . . . 0.449 ' HB ' ' HB2' ' B' ' 263' ' ' ALA . 2.6 pp 42.02 28.29 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 C-N-CA 126.714 2.005 . . . . 73.42 115.055 177.063 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 349' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -85.8 122.38 29.8 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.786 -0.643 . . . . 71.13 110.437 -171.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 350' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -121.18 26.25 9.07 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.213 1.005 . . . . 74.52 109.764 178.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -143.73 90.25 2.13 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.407 1.083 . . . . 71.32 109.91 -170.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 26.9 t70 83.59 -47.21 0.12 Allowed 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 125.384 1.474 . . . . 74.35 112.828 178.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 353' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -99.24 29.47 3.92 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 123.213 0.605 . . . . 74.33 109.542 -177.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 354' ' ' ALA . . . . . . . . . . . . . . . -82.82 63.7 7.06 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.131 0.972 . . . . 70.11 112.723 -168.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 355' ' ' ALA . . . . . 0.619 ' HB1' ' HA ' ' B' ' 257' ' ' GLN . . . 60.52 11.51 3.06 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.994 1.318 . . . . 75.44 113.445 175.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 356' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 66.7 146.0 0.1 Allowed Pre-proline 0 N--CA 1.487 1.383 0 C-N-CA 125.672 1.589 . . . . 74.32 111.271 -168.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 357' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -62.36 133.72 44.7 Favored 'Trans proline' 0 C--N 1.382 2.32 0 C-N-CA 122.051 1.834 . . . . 55.22 110.698 175.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 358' ' ' CYS . . . . . . . . . . . . . 56.2 m -53.97 127.83 27.92 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 124.075 0.859 . . . . 73.32 111.35 -176.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 359' ' ' GLY . . . . . . . . . . . . . . . -60.14 -27.95 65.84 Favored Glycine 0 C--N 1.353 1.505 0 O-C-N 123.45 0.469 . . . . 62.01 113.004 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 360' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 59.03 -79.14 0.02 OUTLIER 'General case' 0 C--N 1.356 0.857 0 C-N-CA 125.961 1.704 . . . . 53.34 113.023 176.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 361' ' ' ILE . . . . . . . . . . . . . 51.7 mt -59.32 96.97 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 C-N-CA 124.152 0.981 . . . . 61.31 110.076 -174.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 362' ' ' GLY . . . . . . . . . . . . . . . -162.56 22.27 0.19 Allowed Glycine 0 C--N 1.342 0.898 0 CA-C-N 115.216 -0.902 . . . . 72.35 112.656 -173.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 363' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -115.39 131.02 57.06 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.121 0.969 . . . . 73.13 108.633 176.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 364' ' ' THR . . . . . . . . . . . . . 13.7 m -74.2 -29.53 61.78 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 122.925 0.49 . . . . 74.04 111.092 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 21.9 t 65.74 117.93 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 125.402 1.481 . . . . 74.01 110.067 -177.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 73.28 -64.95 0.38 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 125.702 1.601 . . . . 50.12 111.133 -176.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 367' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -67.87 -4.17 11.96 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.564 1.146 . . . . 75.05 112.566 -175.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 368' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -83.08 38.76 0.61 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.698 0.799 . . . . 71.23 109.636 171.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 369' ' ' GLU . . . . . 0.418 ' HB3' ' HA ' ' B' ' 372' ' ' GLN . 35.4 mt-10 -54.0 -28.09 35.85 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 126.023 1.729 . . . . 70.1 112.969 -163.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 370' ' ' ALA . . . . . 0.686 ' HA ' ' HD2' ' B' ' 248' ' ' ARG . . . 77.43 -68.29 0.17 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.603 1.561 . . . . 74.25 111.78 171.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 371' ' ' VAL . . . . . 0.601 HG12 HG21 ' B' ' 246' ' ' THR . 29.1 m -130.36 15.84 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 C-N-CA 123.662 0.785 . . . . 74.11 110.078 171.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 372' ' ' GLN . . . . . 0.418 ' HA ' ' HB3' ' B' ' 369' ' ' GLU . 8.9 tp-100 79.99 147.57 0.09 Allowed 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 125.809 1.644 . . . . 63.2 109.71 -166.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 373' ' ' ARG . . . . . 0.412 HH22 ' HB2' ' A' ' 267' ' ' ALA . 8.4 ptp180 -145.94 171.92 14.12 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.052 0.941 . . . . 72.05 109.627 -173.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . 74.43 -48.55 0.65 Allowed 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 125.248 1.419 . . . . 71.45 112.63 177.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 375' ' ' LEU . . . . . . . . . . . . . 67.8 mt -81.88 55.41 2.74 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.652 1.181 . . . . 62.01 110.036 176.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 53.08 -122.88 2.11 Favored 'General case' 0 CA--C 1.566 1.584 0 C-N-CA 124.603 1.161 . . . . 73.13 110.028 -172.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 377' ' ' PHE . . . . . . . . . . . . . 5.7 t80 56.24 -178.1 0.05 OUTLIER 'General case' 0 CA--C 1.566 1.564 0 C-N-CA 125.165 1.386 . . . . 73.31 111.969 -178.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 378' ' ' ALA . . . . . . . . . . . . . . . 64.84 24.46 12.78 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.077 0.951 . . . . 61.1 111.389 173.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -150.26 155.52 39.85 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.478 -0.783 . . . . 72.01 110.067 -167.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 380' ' ' LYS . . . . . 0.477 ' HD3' ' H ' ' B' ' 380' ' ' LYS . 0.0 OUTLIER -119.29 -177.57 3.38 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.819 0.848 . . . . 53.14 108.955 170.664 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 381' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -82.68 111.71 18.88 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 109.027 -0.731 . . . . 74.34 109.027 175.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . 131.86 151.7 6.94 Favored Glycine 0 N--CA 1.473 1.128 0 N-CA-C 111.949 -0.46 . . . . 73.1 111.949 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 383' ' ' ASN . . . . . 0.404 HD21 ' HB3' ' B' ' 392' ' ' HIS . 32.4 p-10 -165.29 -161.4 0.53 Allowed 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 123.607 0.763 . . . . 73.1 109.88 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 384' ' ' THR . . . . . . . . . . . . . 24.4 m -65.76 153.55 41.49 Favored 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 123.74 0.816 . . . . 63.41 111.998 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 385' ' ' LEU . . . . . 0.469 HD12 ' H ' ' B' ' 392' ' ' HIS . 97.4 mt 79.27 163.52 0.2 Allowed 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 126.16 1.784 . . . . 75.12 111.951 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 386' ' ' VAL . . . . . . . . . . . . . 26.8 m -104.72 -170.2 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 123.678 0.791 . . . . 62.42 111.618 -169.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 387' ' ' ILE . . . . . 0.607 HG21 ' HA ' ' B' ' 405' ' ' ALA . 3.1 mp -70.91 -49.75 47.93 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.962 0 C-N-CA 122.902 0.481 . . . . 74.12 110.137 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 388' ' ' VAL . . . . . . . . . . . . . 96.5 t -68.05 -60.72 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 122.95 0.5 . . . . 54.33 110.687 -177.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 389' ' ' THR . . . . . . . . . . . . . 36.4 m -75.35 90.29 2.64 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.07 -1.085 . . . . 71.25 108.07 169.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . -72.42 -112.84 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.025 0 CA-C-N 114.99 -1.005 . . . . 70.34 111.679 -172.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 391' ' ' ASP . . . . . . . . . . . . . 34.5 t70 58.9 -74.62 0.02 OUTLIER 'General case' 0 CA--C 1.565 1.521 0 C-N-CA 124.624 1.17 . . . . 64.12 111.923 -178.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 392' ' ' HIS . . . . . 0.469 ' H ' HD12 ' B' ' 385' ' ' LEU . 89.5 m-70 67.59 78.3 0.24 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.356 1.462 . . . . 72.42 111.386 175.212 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . 57.12 40.8 28.08 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.187 0.995 . . . . 61.53 110.682 178.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 25.8 m170 74.03 121.15 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.984 1.713 . . . . 73.31 110.299 -174.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . -51.14 103.87 0.07 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.725 1.21 . . . . 71.44 113.149 -172.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 38.5 m -143.5 -164.19 1.81 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.631 1.172 . . . . 75.55 109.505 -179.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 397' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -93.82 32.74 1.39 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.93 0.892 . . . . 71.41 109.872 175.04 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 398' ' ' ILE . . . . . 0.413 HG23 HG23 ' B' ' 399' ' ' VAL . 7.3 tp -64.23 -33.64 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 124.552 1.141 . . . . 75.44 112.316 -173.34 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 399' ' ' VAL . . . . . 0.413 HG23 HG23 ' B' ' 398' ' ' ILE . 36.9 t -122.45 4.95 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 N-CA-C 108.75 -0.833 . . . . 73.32 108.75 174.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 400' ' ' ALA . . . . . 0.475 ' HB1' ' HD2' ' B' ' 401' ' ' PRO . . . 66.63 170.52 0.1 Allowed Pre-proline 0 CA--C 1.567 1.626 0 C-N-CA 124.412 1.085 . . . . 51.41 110.164 -169.537 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 401' ' ' PRO . . . . . 0.475 ' HD2' ' HB1' ' B' ' 400' ' ' ALA . 36.4 Cg_endo -64.87 -1.78 4.63 Favored 'Trans proline' 0 C--N 1.384 2.443 0 C-N-CA 121.507 1.471 . . . . 71.04 114.681 176.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -72.37 90.5 1.29 Allowed 'General case' 0 N--CA 1.481 1.124 0 CA-C-O 121.253 0.549 . . . . 74.34 109.935 174.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 403' ' ' THR . . . . . . . . . . . . . 4.9 t -156.02 122.56 5.18 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.36 1.064 . . . . 51.3 108.563 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 404' ' ' LYS . . . . . . . . . . . . . 7.6 mtmt -137.74 155.33 49.19 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.66 0.784 . . . . 70.03 110.941 -172.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 405' ' ' ALA . . . . . 0.607 ' HA ' HG21 ' B' ' 387' ' ' ILE . . . -70.64 -54.94 7.72 Favored Pre-proline 0 CA--C 1.555 1.15 0 C-N-CA 123.539 0.736 . . . . 71.24 112.552 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 406' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -79.73 8.85 3.76 Favored 'Trans proline' 0 C--N 1.388 2.607 0 C-N-CA 121.438 1.425 . . . . 44.44 113.252 -176.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . 172.28 97.16 0.11 Allowed Glycine 0 C--N 1.34 0.756 0 N-CA-C 110.419 -1.072 . . . . 55.33 110.419 178.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 408' ' ' LEU . . . . . . . . . . . . . 62.3 tp -48.49 -68.1 0.21 Allowed 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 124.775 1.23 . . . . 72.03 111.832 -169.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 50.8 m -113.17 74.76 0.88 Allowed 'General case' 0 C--O 1.237 0.405 0 N-CA-C 107.45 -1.315 . . . . 73.52 107.45 169.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 410' ' ' GLN . . . . . . . . . . . . . 10.4 mm-40 67.85 -70.2 0.13 Allowed 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 125.558 1.543 . . . . 51.32 110.232 -176.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . -72.07 178.86 3.56 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 124.284 1.034 . . . . 63.14 111.278 170.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 1.7 tm? 66.72 83.02 0.17 Allowed 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.765 1.226 . . . . 60.41 109.136 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -77.61 74.57 4.17 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.658 0.783 . . . . 71.14 110.8 -176.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 414' ' ' THR . . . . . . . . . . . . . 15.8 m 76.12 -53.97 0.61 Allowed 'General case' 0 CA--C 1.56 1.341 0 C-N-CA 125.978 1.711 . . . . 73.24 113.28 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 415' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm 74.75 150.65 0.11 Allowed 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 125.177 1.391 . . . . 73.42 110.712 -171.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -57.74 119.88 7.42 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.891 0.476 . . . . 75.33 109.74 171.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 417' ' ' GLY . . . . . . . . . . . . . . . -82.31 62.76 4.53 Favored Glycine 0 C--N 1.342 0.872 0 O-C-N 123.477 0.485 . . . . 43.15 112.653 -178.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 418' ' ' ALA . . . . . . . . . . . . . . . -70.77 -31.56 68.39 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.481 0.712 . . . . 70.25 110.034 173.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 419' ' ' VAL . . . . . . . . . . . . . 27.8 m -87.69 -10.71 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 CA-C-N 115.118 -0.946 . . . . 62.03 111.341 175.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 420' ' ' MET . . . . . . . . . . . . . 22.1 ttt -82.9 -51.92 7.18 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.445 0.698 . . . . 73.12 109.613 175.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 421' ' ' VAL . . . . . . . . . . . . . 11.4 p -64.41 140.36 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 123.047 0.539 . . . . 72.42 111.132 -177.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 422' ' ' MET . . . . . 0.536 ' HG3' HG21 ' B' ' 435' ' ' THR . 6.0 tmm? 63.46 80.99 0.22 Allowed 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 125.123 1.369 . . . . 74.1 109.526 -172.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 423' ' ' SER . . . . . . . . . . . . . 28.3 p 177.39 -72.27 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.636 1.174 . . . . 62.22 110.395 173.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 424' ' ' TYR . . . . . 0.484 ' HE1' ' H ' ' B' ' 78' ' ' SER . 15.5 t80 -78.92 -36.24 42.17 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.342 0.657 . . . . 72.42 111.24 -168.279 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . -90.04 12.46 67.59 Favored Glycine 0 N--CA 1.472 1.081 0 CA-C-O 119.513 -0.604 . . . . 75.12 113.569 178.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 426' ' ' ASN . . . . . . . . . . . . . 15.0 m120 65.45 97.3 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.826 1.251 . . . . 75.43 112.115 173.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 427' ' ' SER . . . . . 0.512 ' O ' ' HG2' ' B' ' 422' ' ' MET . 21.0 t 72.92 -62.09 0.48 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 125.661 1.584 . . . . 75.14 112.65 175.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 56.27 -90.93 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 124.008 0.923 . . . . 73.23 112.856 173.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 429' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -111.17 84.31 1.91 Allowed 'General case' 0 C--N 1.356 0.861 0 C-N-CA 124.162 0.985 . . . . 63.42 108.631 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -94.1 109.66 21.42 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 109.19 -0.67 . . . . 55.41 109.19 -178.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 21.1 m -64.16 108.8 1.65 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.674 0.79 . . . . 73.31 111.357 -176.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 432' ' ' GLN . . . . . 0.409 ' HB2' ' NE2' ' B' ' 438' ' ' GLN . 1.4 mp0 57.92 -87.54 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.429 1.492 . . . . 71.1 111.033 -175.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 433' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -144.67 126.02 14.82 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.751 1.221 . . . . 73.43 108.355 -178.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 434' ' ' HIS . . . . . 0.586 ' HB3' ' HB3' ' B' ' 321' ' ' LEU . 13.5 p-80 51.92 100.85 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 126.501 1.92 . . . . 65.13 113.22 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 435' ' ' THR . . . . . 0.536 HG21 ' HG3' ' B' ' 422' ' ' MET . 15.9 p -64.25 -43.07 96.02 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.211 0.604 . . . . 73.42 111.088 174.113 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 436' ' ' GLY . . . . . 0.49 ' HA2' ' HB2' ' A' ' 220' ' ' GLU . . . -61.68 103.12 0.52 Allowed Glycine 0 C--N 1.35 1.32 0 CA-C-N 115.391 -0.822 . . . . 43.54 112.409 178.387 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 83.5 p 61.84 43.5 9.36 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.798 1.639 . . . . 54.14 111.679 -174.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 438' ' ' GLN . . . . . 0.41 ' HB2' ' O ' ' B' ' 434' ' ' HIS . 5.6 tp60 -63.59 -42.5 98.25 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 115.468 -0.787 . . . . 71.55 110.448 171.174 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 439' ' ' LEU . . . . . 0.418 ' HB2' ' HD3' ' A' ' 238' ' ' LYS . 3.8 pp -134.02 133.61 41.45 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 109.039 -0.726 . . . . 74.24 109.039 176.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 440' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.37 152.13 34.54 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.823 0.849 . . . . 70.1 109.651 -177.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 441' ' ' ILE . . . . . 0.675 HG23 HD21 ' A' ' 235' ' ' LEU . 62.6 mt -105.06 134.69 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.314 0.646 . . . . 74.15 111.348 -175.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 442' ' ' ALA . . . . . . . . . . . . . . . -107.2 -78.83 0.58 Allowed 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 108.522 -0.918 . . . . 71.41 108.522 166.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . 56.83 -83.26 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 125.166 1.386 . . . . 74.21 113.11 176.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -152.25 -177.48 6.21 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.932 0.893 . . . . 65.34 110.207 -178.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . 99.07 103.73 2.45 Favored Glycine 0 C--N 1.349 1.277 0 CA-C-O 118.566 -1.13 . . . . 74.34 110.394 -174.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 446' ' ' PRO . . . . . 0.533 ' HA ' ' HB2' ' B' ' 339' ' ' PHE . 95.4 Cg_endo -74.06 71.35 4.32 Favored 'Trans proline' 0 C--N 1.382 2.327 0 C-N-CA 123.174 2.583 . . . . 63.02 113.593 -173.345 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 447' ' ' HIS . . . . . . . . . . . . . 13.2 t60 67.38 -67.84 0.17 Allowed 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 125.965 1.706 . . . . 60.0 112.812 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . 68.6 164.69 0.24 Allowed 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 125.154 1.382 . . . . 74.31 111.077 -173.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 449' ' ' ALA . . . . . 0.4 ' HB2' HD21 ' B' ' 47' ' ' LEU . . . -82.1 63.46 6.32 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 120.841 0.353 . . . . 61.52 110.705 178.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 450' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -168.79 -75.68 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.824 0.85 . . . . 61.12 109.934 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 61.2 t -71.65 92.57 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 123.531 0.732 . . . . 63.1 111.296 -166.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 452' ' ' VAL . . . . . . . . . . . . . 14.9 p -102.1 -9.78 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.15 0 CA-C-N 114.655 -1.157 . . . . 60.45 109.873 175.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 113.99 -81.3 0.29 Allowed Glycine 0 C--N 1.355 1.62 0 CA-C-N 116.296 -0.411 . . . . 73.44 113.611 169.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 454' ' ' LEU . . . . . 0.545 HD11 ' HA ' ' B' ' 110' ' ' ALA . 3.4 tm? -64.71 106.27 1.15 Allowed 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.539 0.736 . . . . 72.5 109.731 -174.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 30.2 m -94.43 152.74 18.37 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 114.716 -1.129 . . . . 61.41 109.411 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -83.21 -86.37 0.11 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 122.493 0.317 . . . . 74.3 110.401 177.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 457' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 178.62 -68.49 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 108.372 -0.973 . . . . 42.14 108.372 -168.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 35.4 p -101.76 75.74 1.59 Allowed 'General case' 0 C--N 1.35 0.599 0 CA-C-O 122.631 1.205 . . . . 72.13 108.995 178.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 459' ' ' ASP . . . . . 0.454 ' HB3' ' O ' ' B' ' 463' ' ' THR . 9.1 m-20 -87.35 23.62 1.83 Allowed 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 114.195 -1.366 . . . . 73.31 111.144 -173.398 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 460' ' ' LEU . . . . . 0.443 ' H ' ' HG ' ' B' ' 460' ' ' LEU . 1.8 pp -67.4 -12.67 60.81 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 124.306 1.042 . . . . 65.42 112.863 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -75.32 -56.95 4.21 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 122.679 0.392 . . . . 62.31 110.756 -177.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -148.24 29.04 0.89 Allowed 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 123.109 0.563 . . . . 72.53 112.307 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 463' ' ' THR . . . . . 0.454 ' O ' ' HB3' ' B' ' 459' ' ' ASP . 6.1 p 54.16 -71.24 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 126.015 1.726 . . . . 61.35 114.144 -177.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 464' ' ' MET . . . . . 0.724 ' HA ' HH21 ' B' ' 56' ' ' ARG . 41.9 ttm -155.22 -44.58 0.08 Allowed 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.734 -0.604 . . . . 75.31 110.414 178.182 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 465' ' ' LYS . . . . . 0.44 ' HD3' ' H ' ' B' ' 465' ' ' LYS . 0.0 OUTLIER -70.33 138.9 51.83 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 123.529 0.518 . . . . 72.15 110.4 175.702 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -64.81 -67.84 0.41 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.168 0.587 . . . . 62.32 110.492 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 467' ' ' ALA . . . . . 0.44 ' HB1' ' HB3' ' B' ' 271' ' ' ALA . . . 69.52 -11.56 0.5 Allowed 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 115.027 1.492 . . . . 75.3 115.027 168.507 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 53.2 tp -65.66 -30.52 71.23 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.913 0.885 . . . . 45.51 112.07 -172.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 469' ' ' GLY . . . . . . . . . . . . . . . 119.89 56.36 0.25 Allowed Glycine 0 C--N 1.343 0.97 0 N-CA-C 111.232 -0.747 . . . . 50.44 111.232 -178.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 470' ' ' LEU . . . . . 0.407 ' HB3' ' HB1' ' B' ' 305' ' ' ALA . 6.8 mp -79.33 -27.98 42.08 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.172 0.589 . . . . 73.2 110.947 -173.112 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 471' ' ' LYS . . . . . 0.436 ' NZ ' ' HB3' ' B' ' 471' ' ' LYS . 0.2 OUTLIER . . . . . 0 CA--C 1.56 1.346 0 C-N-CA 124.287 1.035 . . . . 74.2 109.219 -172.215 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 110.085 -0.339 . . . . 55.23 110.085 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.42 36.44 17.3 Favored 'General case' 0 C--N 1.351 0.671 0 C-N-CA 125.389 1.476 . . . . 65.31 112.473 176.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.8 73.11 4.37 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 109.825 -0.435 . . . . 52.01 109.825 175.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 4' ' ' LYS . . . . . 0.468 ' HE2' ' HE2' ' C' ' 69' ' ' TYR . 38.7 ttmt -39.42 101.15 0.02 OUTLIER 'General case' 0 C--N 1.353 0.739 0 C-N-CA 125.421 1.488 . . . . 70.52 113.766 -177.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -66.32 95.62 0.31 Allowed 'General case' 0 C--O 1.244 0.807 0 N-CA-C 108.558 -0.905 . . . . 63.2 108.558 164.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -74.7 94.71 2.74 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 106.758 -1.571 . . . . 63.22 106.758 173.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 7' ' ' TYR . . . . . 0.426 ' HB3' ' HA ' ' C' ' 53' ' ' ALA . 50.1 m-85 -56.53 -35.74 68.42 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 114.766 -1.107 . . . . 73.43 111.551 -170.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 8' ' ' TYR . . . . . 0.422 ' HD1' HG23 ' C' ' 13' ' ' VAL . 65.4 m-85 -65.9 -42.65 89.95 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.411 -1.268 . . . . 72.53 111.801 175.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.42 -39.52 94.0 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 122.643 0.377 . . . . 52.31 110.848 177.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 59.2 mt -56.88 -43.14 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.446 0.698 . . . . 63.34 109.939 175.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 11' ' ' LEU . . . . . 0.543 ' HB3' ' HB1' ' C' ' 25' ' ' ALA . 96.2 mt -76.94 -15.15 59.75 Favored 'General case' 0 CA--C 1.556 1.195 0 CA-C-N 115.268 -0.878 . . . . 45.45 113.205 177.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.67 18.86 80.04 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 113.797 0.279 . . . . 64.33 113.797 -176.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 13' ' ' VAL . . . . . 0.422 HG23 ' HD1' ' C' ' 8' ' ' TYR . 30.1 m -111.73 155.03 43.75 Favored Pre-proline 0 N--CA 1.483 1.206 0 C-N-CA 124.442 1.097 . . . . 64.04 110.015 179.412 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -60.59 156.53 41.67 Favored 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 123.155 2.57 . . . . 74.43 113.729 177.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 33.4 mtp-105 -69.95 7.12 1.0 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 113.804 1.038 . . . . 71.52 113.804 -174.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -127.6 9.07 6.47 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.305 1.042 . . . . 71.24 109.302 -177.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.09 130.28 45.45 Favored 'General case' 0 C--N 1.356 0.883 0 C-N-CA 123.97 0.908 . . . . 71.14 110.951 -175.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 71.5 p -68.47 166.86 15.99 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.56 0.744 . . . . 74.41 110.713 -177.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 62.4 tp60 -57.75 -33.62 68.67 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.784 0.833 . . . . 74.45 111.908 -172.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -70.1 -40.53 74.9 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.038 0.535 . . . . 64.05 111.288 177.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -65.64 -39.9 91.92 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 122.757 0.423 . . . . 73.42 110.748 179.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 22' ' ' ILE . . . . . 0.572 HD13 ' HB3' ' C' ' 57' ' ' LEU . 86.1 mt -64.75 -42.57 95.34 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 C-N-CA 124.054 0.942 . . . . 61.32 110.372 176.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -61.99 -47.13 86.17 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.367 1.067 . . . . 74.13 111.326 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 78.7 mtm180 -71.24 -35.53 71.47 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 115.987 -0.551 . . . . 73.52 110.758 -178.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 25' ' ' ALA . . . . . 0.543 ' HB1' ' HB3' ' C' ' 11' ' ' LEU . . . -64.11 -40.39 96.09 Favored 'General case' 0 C--O 1.249 1.031 0 C-N-CA 123.11 0.564 . . . . 75.32 110.457 176.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 26' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -57.91 -60.25 4.0 Favored 'General case' 0 C--O 1.214 -0.778 0 CA-C-N 114.77 -1.105 . . . . 72.31 109.873 175.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -60.49 -41.32 94.01 Favored 'General case' 0 N--CA 1.483 1.183 0 O-C-N 124.068 0.855 . . . . 74.1 111.653 -174.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -53.07 -58.67 6.22 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.456 1.103 . . . . 71.15 110.922 176.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 97.1 mt -80.79 -11.09 59.66 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.521 -0.763 . . . . 60.22 111.06 -176.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -80.43 -26.23 38.54 Favored 'General case' 0 C--O 1.216 -0.684 0 C-N-CA 122.906 0.482 . . . . 75.32 109.731 171.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -81.2 -39.81 24.85 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.929 0.892 . . . . 73.5 110.404 175.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -70.16 -51.15 33.53 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.171 0.588 . . . . 71.12 109.789 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 33' ' ' TYR . . . . . 0.434 ' HB3' ' O ' ' C' ' 43' ' ' ALA . 35.6 m-85 -89.73 14.65 11.27 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 115.739 -0.664 . . . . 70.15 111.798 -176.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 34' ' ' HIS . . . . . 0.493 ' HD2' ' HB3' ' C' ' 36' ' ' ASP . 6.7 t60 -62.15 103.55 0.4 Allowed Pre-proline 0 N--CA 1.487 1.397 0 C-N-CA 123.947 0.899 . . . . 72.34 110.76 -174.392 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 35' ' ' PRO . . . . . 0.571 ' HB3' ' HG2' ' C' ' 44' ' ' GLU . 31.7 Cg_exo -59.55 -26.88 83.48 Favored 'Trans proline' 0 C--N 1.381 2.274 0 C-N-CA 123.285 2.656 . . . . 71.32 113.12 -171.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 36' ' ' ASP . . . . . 0.493 ' HB3' ' HD2' ' C' ' 34' ' ' HIS . 25.2 t70 -64.87 -39.0 92.86 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.25 1.02 . . . . 60.34 111.833 177.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 43.5 t -94.1 -54.34 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-O 121.277 0.56 . . . . 75.33 109.677 -177.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -100.04 92.21 5.14 Favored 'General case' 0 C--O 1.243 0.732 0 C-N-CA 124.558 1.143 . . . . 54.22 109.219 178.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -79.39 76.51 5.96 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 109.346 -0.613 . . . . 62.24 109.346 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 49.5 m -129.27 118.07 19.11 Favored Pre-proline 0 CA--C 1.538 0.491 0 CA-C-O 118.091 -0.957 . . . . 74.14 108.787 177.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -45.04 -45.26 14.47 Favored 'Trans proline' 0 C--N 1.382 2.335 0 C-N-CA 123.917 3.078 . . . . 63.44 113.679 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -60.08 -39.85 87.51 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.482 -0.781 . . . . 65.44 110.94 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 43' ' ' ALA . . . . . 0.434 ' O ' ' HB3' ' C' ' 33' ' ' TYR . . . -74.42 -19.79 60.28 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.885 -0.598 . . . . 62.05 111.447 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 44' ' ' GLU . . . . . 0.571 ' HG2' ' HB3' ' C' ' 35' ' ' PRO . 39.4 mt-10 -78.35 -45.57 22.21 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 109.547 -0.538 . . . . 74.04 109.547 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -68.7 -39.68 80.37 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.258 -0.883 . . . . 42.53 109.915 177.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 46' ' ' LYS . . . . . 0.56 ' O ' HG12 ' C' ' 50' ' ' ILE . 23.1 mmtm -61.7 -42.77 99.39 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.069 -0.514 . . . . 72.32 110.836 174.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -55.93 -43.13 77.09 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.551 0.74 . . . . 62.23 110.027 175.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 48' ' ' LYS . . . . . 0.404 ' HA ' ' HB2' ' C' ' 51' ' ' ASN . 97.1 mttt -72.59 -23.32 60.94 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-N 115.641 -0.709 . . . . 72.04 112.091 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -78.05 -25.61 47.85 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 118.139 0.427 . . . . 72.33 110.342 172.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 50' ' ' ILE . . . . . 0.56 HG12 ' O ' ' C' ' 46' ' ' LYS . 18.2 mm -75.35 -36.13 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 N-CA-C 108.287 -1.005 . . . . 75.43 108.287 172.116 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 51' ' ' ASN . . . . . 0.404 ' HB2' ' HA ' ' C' ' 48' ' ' LYS . 4.0 m-20 -68.27 -36.61 79.66 Favored 'General case' 0 C--O 1.2 -1.548 0 CA-C-N 114.883 -1.053 . . . . 74.04 110.018 173.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -65.52 -47.05 77.26 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.902 1.281 . . . . 63.42 109.986 178.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 53' ' ' ALA . . . . . 0.426 ' HA ' ' HB3' ' C' ' 7' ' ' TYR . . . -57.85 -61.41 2.55 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 113.998 -1.455 . . . . 63.1 111.01 178.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 54' ' ' TYR . . . . . 0.545 ' HD1' HG22 ' C' ' 22' ' ' ILE . 76.6 t80 -71.17 -12.87 61.72 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.745 -0.661 . . . . 75.01 111.533 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.64 -57.69 7.51 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 108.95 -0.759 . . . . 60.54 108.95 171.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 48.4 t -69.04 -22.69 26.41 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 CA-C-N 114.543 -1.208 . . . . 72.43 110.814 -178.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 57' ' ' LEU . . . . . 0.572 ' HB3' HD13 ' C' ' 22' ' ' ILE . 64.7 mt -109.13 9.2 26.2 Favored 'General case' 0 CA--C 1.564 1.484 0 N-CA-C 112.772 0.656 . . . . 75.02 112.772 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 46.6 t -51.69 -45.55 63.54 Favored 'General case' 0 N--CA 1.503 2.215 0 C-N-CA 124.66 1.184 . . . . 62.42 113.292 176.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 59' ' ' ASP . . . . . 0.429 ' HB2' ' HG3' ' C' ' 62' ' ' LYS . 2.0 m-20 -114.85 148.78 41.19 Favored Pre-proline 0 C--O 1.241 0.608 0 CA-C-N 115.492 -0.776 . . . . 72.03 109.145 177.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 60' ' ' PRO . . . . . 0.503 ' O ' ' HG2' ' C' ' 64' ' ' ARG . 69.0 Cg_exo -55.75 -30.6 76.76 Favored 'Trans proline' 0 C--N 1.374 1.921 0 C-N-CA 122.636 2.224 . . . . 33.23 111.984 167.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -64.41 -49.48 71.38 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.925 0.89 . . . . 62.13 111.054 175.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 62' ' ' LYS . . . . . 0.429 ' HG3' ' HB2' ' C' ' 59' ' ' ASP . 28.1 mtpp -66.7 -30.92 71.28 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-O 121.259 0.552 . . . . 75.23 110.07 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 23.0 tpt180 -60.65 -41.68 95.44 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 115.272 -0.876 . . . . 64.42 110.145 168.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 64' ' ' ARG . . . . . 0.503 ' HG2' ' O ' ' C' ' 60' ' ' PRO . 30.5 mmm180 -65.68 -27.09 68.1 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-O 119.305 -0.379 . . . . 74.15 111.525 176.136 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 1.7 mp -63.46 -45.08 98.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 109.581 -0.526 . . . . 62.34 109.581 168.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -58.46 -46.39 86.69 Favored 'General case' 0 CA--C 1.562 1.429 0 N-CA-C 109.312 -0.625 . . . . 74.22 109.312 174.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -61.85 -35.68 78.99 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 124.122 0.969 . . . . 73.14 112.009 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 40.7 p -73.99 -22.55 59.56 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 119.421 -0.323 . . . . 63.2 110.775 177.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 69' ' ' TYR . . . . . 0.468 ' HE2' ' HE2' ' C' ' 4' ' ' LYS . 79.9 t80 -76.11 108.05 8.76 Favored 'General case' 0 C--N 1.355 0.84 0 N-CA-C 107.648 -1.241 . . . . 75.22 107.648 168.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 102.64 27.71 6.63 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.202 -0.759 . . . . 62.51 111.202 -167.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 25.1 m -145.95 -57.64 0.31 Allowed 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 103.494 -2.78 . . . . 72.34 103.494 173.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 5.4 m -81.2 140.18 35.09 Favored 'General case' 0 C--O 1.254 1.32 0 N-CA-C 104.618 -2.364 . . . . 73.35 104.618 157.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.23 -32.63 15.69 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.647 0.779 . . . . 73.23 110.505 -178.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -92.98 159.06 36.47 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 124.056 0.942 . . . . 53.23 109.888 177.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -59.5 150.85 73.08 Favored 'Trans proline' 0 CA--C 1.56 1.786 0 C-N-CA 122.318 2.012 . . . . 75.14 112.141 168.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -68.0 164.16 32.96 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 122.729 2.286 . . . . 63.14 112.788 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -60.64 129.73 30.53 Favored 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 122.973 2.449 . . . . 51.51 111.97 173.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 78' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -59.61 115.17 2.42 Favored 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 123.158 2.572 . . . . 74.44 113.182 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 79' ' ' PRO . . . . . 0.404 ' HA ' ' HD3' ' C' ' 80' ' ' PRO . 38.9 Cg_endo -66.16 130.6 24.55 Favored 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 122.532 2.155 . . . . 61.04 111.332 175.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 80' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' C' ' 79' ' ' PRO . 24.8 Cg_exo -62.0 88.66 0.1 Allowed 'Trans proline' 0 C--N 1.379 2.179 0 C-N-CA 122.733 2.289 . . . . 51.5 111.754 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 155.77 -33.51 0.62 Allowed Glycine 0 N--CA 1.465 0.63 0 N-CA-C 110.238 -1.145 . . . . 75.2 110.238 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 126.96 157.7 9.58 Favored Glycine 0 C--N 1.352 1.47 0 CA-C-N 114.837 -0.682 . . . . 74.45 113.462 173.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -67.69 107.89 2.72 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 107.636 -1.246 . . . . 70.14 107.636 164.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -67.21 130.19 42.31 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.396 0.617 . . . . 63.13 111.719 -169.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 85' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -132.57 52.53 2.07 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.565 1.146 . . . . 74.41 108.122 174.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 50.9 m -64.01 96.38 0.14 Allowed 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 113.295 -1.775 . . . . 45.43 111.862 -174.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 114.95 -13.95 19.56 Favored Glycine 0 C--N 1.348 1.243 0 CA-C-N 115.658 -0.701 . . . . 74.33 113.105 176.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 88' ' ' PHE . . . . . 0.409 ' HB3' ' HZ ' ' C' ' 93' ' ' PHE . 38.8 m-85 -112.3 144.01 42.44 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 117.392 0.596 . . . . 74.44 110.376 -169.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 89' ' ' ASP . . . . . 0.548 ' HA ' ' HG2' ' C' ' 171' ' ' PRO . 46.0 t0 -77.11 74.46 3.69 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.861 0.839 . . . . 72.23 110.746 -175.537 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 90' ' ' VAL . . . . . 0.471 HG12 ' HG3' ' C' ' 171' ' ' PRO . 5.2 p -48.85 -47.46 16.23 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.003 0 C-N-CA 126.128 1.771 . . . . 54.41 113.063 -171.24 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -61.78 -27.2 68.58 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 112.836 0.68 . . . . 74.21 112.836 -173.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -83.74 -11.09 57.61 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 111.796 0.295 . . . . 75.53 111.796 -173.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 93' ' ' PHE . . . . . 0.409 ' HZ ' ' HB3' ' C' ' 88' ' ' PHE . 13.5 m-30 -74.6 171.29 14.12 Favored 'General case' 0 CA--C 1.557 1.233 0 CA-C-O 120.846 0.355 . . . . 72.45 111.581 -174.128 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 93.6 p -76.52 174.34 10.43 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 115.105 1.52 . . . . 45.51 115.105 -164.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -51.87 -47.93 64.29 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.34 1.456 . . . . 55.43 112.644 174.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -56.94 -45.67 82.6 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.547 0.739 . . . . 65.02 110.59 -177.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 97' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.33 -47.76 80.73 Favored 'General case' 0 CA--C 1.56 1.34 0 CA-C-N 114.359 -1.291 . . . . 64.25 110.208 172.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -66.79 -14.09 62.23 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.739 0.815 . . . . 51.52 112.29 -179.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -95.73 -39.2 9.99 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.085 0.554 . . . . 74.43 112.196 177.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 43.8 tp -83.13 -51.28 7.65 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-O 121.403 0.621 . . . . 73.23 110.929 -176.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -87.75 -18.79 28.63 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.001 0.921 . . . . 73.25 110.607 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -40.33 -56.24 2.89 Favored Glycine 0 C--N 1.358 1.781 0 CA-C-O 118.137 -1.369 . . . . 54.11 115.335 177.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 0.8 OUTLIER -28.9 -37.15 0.04 OUTLIER 'Trans proline' 0 C--N 1.389 2.695 1 C-N-CA 125.831 4.354 . . . . 62.02 116.663 174.281 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -149.44 47.3 0.63 Allowed Glycine 0 C--N 1.345 1.056 0 C-N-CA 121.266 -0.492 . . . . 43.23 112.621 -179.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 105' ' ' LEU . . . . . 0.543 ' HB3' HD22 ' C' ' 169' ' ' ASN . 37.1 mt -61.19 80.55 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 121.266 0.555 . . . . 73.03 111.606 170.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 106' ' ' PHE . . . . . 0.524 ' HB3' ' H ' ' C' ' 168' ' ' GLY . 87.0 m-85 45.22 -110.25 0.21 Allowed 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 125.796 1.638 . . . . 64.24 114.159 -178.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 107' ' ' GLY . . . . . 0.4 ' CA ' ' H ' ' C' ' 113' ' ' SER . . . 66.17 15.0 62.48 Favored Glycine 0 C--N 1.362 1.981 0 C-N-CA 121.016 -0.611 . . . . 51.05 112.723 -162.201 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 59.48 -122.02 28.68 Favored Glycine 0 C--N 1.349 1.294 0 N-CA-C 111.072 -0.811 . . . . 74.41 111.072 -167.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 109' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -100.46 -7.77 23.9 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 122.919 0.488 . . . . 74.45 109.961 173.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 110' ' ' GLY . . . . . . . . . . . . . . . -93.11 -6.32 63.26 Favored Glycine 0 C--N 1.353 1.49 0 CA-C-O 119.293 -0.726 . . . . 54.22 114.322 -173.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 51.55 16.78 0.48 Allowed 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 125.016 1.327 . . . . 75.25 112.371 178.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 112' ' ' ARG . . . . . 0.446 ' HD2' ' HB2' ' C' ' 114' ' ' ARG . 1.5 tmt_? -58.27 -33.52 69.49 Favored 'General case' 0 CA--C 1.56 1.346 0 C-N-CA 124.165 0.986 . . . . 74.1 110.045 172.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 113' ' ' SER . . . . . 0.4 ' H ' ' CA ' ' C' ' 107' ' ' GLY . 55.4 m 60.5 34.53 20.4 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.824 1.65 . . . . 72.53 112.382 176.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 114' ' ' ARG . . . . . 0.565 ' NE ' ' HA ' ' C' ' 114' ' ' ARG . 1.1 tpm_? -105.9 -159.32 0.7 Allowed 'General case' 0 C--O 1.209 -1.027 0 CA-C-O 117.847 -1.073 . . . . 74.05 111.023 176.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 115' ' ' LYS . . . . . 0.492 ' H ' ' HG3' ' C' ' 114' ' ' ARG . 5.5 tmtt? -58.24 125.37 22.94 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 120.146 1.339 . . . . 54.14 112.172 -163.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 116' ' ' GLY . . . . . 0.435 ' N ' ' HD3' ' C' ' 115' ' ' LYS . . . -63.48 118.96 14.92 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-N 114.667 -1.151 . . . . 45.25 113.829 177.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -88.5 163.54 15.87 Favored 'General case' 0 C--O 1.244 0.769 0 C-N-CA 124.733 1.213 . . . . 64.44 110.694 178.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -68.87 144.63 54.18 Favored 'General case' 0 C--O 1.245 0.849 0 N-CA-C 108.47 -0.937 . . . . 75.42 108.47 168.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 119' ' ' LEU . . . . . 0.468 HD21 HG23 ' C' ' 140' ' ' VAL . 0.0 OUTLIER -133.53 152.72 51.95 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 121.266 0.555 . . . . 75.21 110.625 175.97 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -105.49 113.52 27.15 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.046 -0.979 . . . . 72.31 108.714 -173.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 121' ' ' ALA . . . . . 0.685 ' HB1' ' HG3' ' C' ' 139' ' ' GLU . . . -111.79 116.84 31.36 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.485 -1.672 . . . . 63.21 106.485 172.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 122' ' ' GLU . . . . . 0.798 ' HB3' ' HA ' ' B' ' 186' ' ' THR . 20.7 tt0 -114.5 138.09 51.03 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 122.638 0.375 . . . . 73.22 110.429 -171.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -142.14 133.38 13.07 Favored Pre-proline 0 CA--C 1.544 0.72 0 CA-C-N 115.403 -0.817 . . . . 73.3 111.164 -168.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 124' ' ' PRO . . . . . 0.404 ' HB3' ' HB2' ' B' ' 189' ' ' LYS . 36.4 Cg_endo -66.93 128.55 18.97 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.383 2.056 . . . . 72.51 110.624 164.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 125' ' ' LEU . . . . . 0.481 ' O ' ' HA ' ' C' ' 180' ' ' LEU . 14.0 tp -153.56 165.48 35.76 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 106.763 -1.569 . . . . 74.03 106.763 -174.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 126' ' ' THR . . . . . 0.422 ' H ' ' HB2' ' C' ' 129' ' ' GLU . 15.1 t -127.69 175.96 7.9 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 119.69 1.132 . . . . 61.53 110.278 173.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 127' ' ' LEU . . . . . 0.438 HD13 ' CD2' ' C' ' 186' ' ' PHE . 33.5 mt -58.89 -47.82 83.61 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.494 1.518 . . . . 62.25 110.876 -178.358 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 128' ' ' GLU . . . . . 0.497 ' HG3' ' HA ' ' C' ' 215' ' ' LEU . 11.4 mp0 -60.92 -36.73 80.07 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 114.904 -1.044 . . . . 75.24 110.281 177.232 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 129' ' ' GLU . . . . . 0.422 ' HB2' ' H ' ' C' ' 126' ' ' THR . 34.7 mm-40 -78.77 -22.67 46.04 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.548 0.739 . . . . 73.53 112.519 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 130' ' ' ALA . . . . . 0.424 ' HB2' HG22 ' C' ' 153' ' ' VAL . . . -74.39 -33.16 62.97 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 108.92 -0.77 . . . . 64.34 108.92 174.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 131' ' ' PHE . . . . . 0.42 ' HB3' ' O ' ' C' ' 128' ' ' GLU . 54.8 t80 -65.64 -48.62 71.54 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 113.922 -1.49 . . . . 75.55 110.07 169.057 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 132' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -73.69 -12.88 60.87 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.331 0.652 . . . . 60.22 112.013 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -37.42 -84.87 0.01 OUTLIER Glycine 0 C--N 1.365 2.176 0 O-C-N 124.649 1.218 . . . . 65.31 114.606 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 134' ' ' GLY . . . . . 0.45 ' O ' ' HA ' ' C' ' 148' ' ' ARG . . . 49.36 -135.31 23.44 Favored Glycine 0 C--N 1.356 1.666 0 O-C-N 124.278 0.634 . . . . 53.24 114.237 174.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 135' ' ' GLU . . . . . 0.522 ' HG3' ' HB2' ' C' ' 148' ' ' ARG . 1.4 mp0 -89.92 91.96 8.81 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 108.044 -1.095 . . . . 71.2 108.044 177.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 136' ' ' ARG . . . . . . . . . . . . . 66.5 mtm180 -140.82 169.29 17.9 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 121.976 0.893 . . . . 72.12 110.751 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 137' ' ' VAL . . . . . 0.623 ' HB ' ' HG2' ' C' ' 144' ' ' ARG . 15.8 m -75.14 95.41 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 CA-C-N 113.769 -1.56 . . . . 71.12 111.122 -176.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 138' ' ' VAL . . . . . 0.471 HG12 ' HB ' ' C' ' 145' ' ' VAL . 2.9 p -79.7 161.24 4.12 Favored 'Isoleucine or valine' 0 C--O 1.251 1.132 0 CA-C-N 114.176 -1.375 . . . . 72.14 112.48 -172.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 139' ' ' GLU . . . . . 0.685 ' HG3' ' HB1' ' C' ' 121' ' ' ALA . 7.7 tp10 -82.5 136.57 34.85 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 113.636 -1.62 . . . . 74.31 111.686 175.1 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 140' ' ' VAL . . . . . 0.468 HG23 HD21 ' C' ' 119' ' ' LEU . 5.5 p -169.76 99.52 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 124.534 1.133 . . . . 63.22 108.821 163.43 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 141' ' ' ALA . . . . . 0.584 ' HA ' HG23 ' B' ' 185' ' ' VAL . . . 66.32 22.64 10.83 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.247 1.019 . . . . 15.23 111.921 -178.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 86.93 -14.17 57.52 Favored Glycine 0 C--N 1.346 1.09 0 CA-C-N 116.208 -0.451 . . . . 45.25 112.726 -174.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 143' ' ' ARG . . . . . 0.62 HH11 HG22 ' C' ' 145' ' ' VAL . 0.0 OUTLIER -74.82 120.94 21.04 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 108.588 -0.893 . . . . 73.04 108.588 -178.688 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 144' ' ' ARG . . . . . 0.623 ' HG2' ' HB ' ' C' ' 137' ' ' VAL . 51.2 ttp180 -87.7 92.36 9.08 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 125.451 1.501 . . . . 71.51 109.918 -169.303 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 145' ' ' VAL . . . . . 0.62 HG22 HH11 ' C' ' 143' ' ' ARG . 65.5 t -98.27 121.03 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 C-N-CA 122.679 0.391 . . . . 75.03 111.067 -174.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 19.8 m -75.02 101.73 4.59 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.165 0.586 . . . . 54.21 109.819 177.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 7.5 p -152.36 158.99 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 122.337 0.255 . . . . 72.53 110.739 -174.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 148' ' ' ARG . . . . . 0.522 ' HB2' ' HG3' ' C' ' 135' ' ' GLU . 42.7 ttm180 -91.44 123.68 35.04 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 109.412 -0.588 . . . . 74.22 109.412 170.361 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 149' ' ' ILE . . . . . . . . . . . . . 34.2 pt -105.03 151.42 39.47 Favored Pre-proline 0 CA--C 1.548 0.904 0 N-CA-C 107.297 -1.371 . . . . 71.41 107.297 163.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -47.95 115.5 1.51 Allowed 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.852 2.368 . . . . 61.44 112.484 175.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 151' ' ' PRO . . . . . 0.537 ' HG2' ' HA2' ' C' ' 242' ' ' GLY . 28.9 Cg_endo -61.87 109.06 0.72 Allowed 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 122.613 2.209 . . . . 73.2 111.155 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 152' ' ' GLY . . . . . . . . . . . . . . . 124.5 122.96 2.7 Favored Glycine 0 C--N 1.343 0.925 0 CA-C-N 115.376 -0.829 . . . . 54.32 113.739 -173.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 153' ' ' VAL . . . . . 0.694 HG21 HG21 ' C' ' 178' ' ' VAL . 5.7 m -141.78 176.04 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 C-N-CA 123.586 0.754 . . . . 71.13 110.658 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 154' ' ' ARG . . . . . 0.718 ' HB2' ' HB2' ' C' ' 157' ' ' SER . 15.6 mtp180 -125.85 169.13 12.95 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 124.378 1.071 . . . . 75.32 109.877 -178.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 155' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -69.81 126.54 30.01 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.744 0.418 . . . . 74.51 110.814 175.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 67.9 11.7 61.14 Favored Glycine 0 C--N 1.349 1.288 0 CA-C-N 115.719 -0.673 . . . . 64.51 113.559 -178.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 157' ' ' SER . . . . . 0.718 ' HB2' ' HB2' ' C' ' 154' ' ' ARG . 33.0 t -74.07 132.8 42.67 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.131 0.572 . . . . 75.43 110.523 -174.021 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 158' ' ' VAL . . . . . 0.54 ' HB ' HD22 ' C' ' 175' ' ' LEU . 16.1 m -86.08 95.94 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 CA-C-N 115.527 -0.761 . . . . 64.44 109.192 171.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 159' ' ' ILE . . . . . 0.775 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 8.3 mt -68.55 90.53 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 107.468 -1.308 . . . . 52.25 107.468 171.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -83.59 100.19 10.65 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.404 -0.591 . . . . 72.21 109.404 -176.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 161' ' ' VAL . . . . . 0.519 HG13 ' HB3' ' C' ' 174' ' ' LEU . 2.6 p -102.84 103.98 36.51 Favored Pre-proline 0 CA--C 1.561 1.391 0 N-CA-C 108.477 -0.935 . . . . 75.24 108.477 175.288 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -62.54 142.55 90.51 Favored 'Trans proline' 0 C--N 1.386 2.534 0 C-N-CA 123.633 2.889 . . . . 63.42 113.805 -175.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 86.15 -24.98 7.32 Favored Glycine 0 C--N 1.347 1.188 0 CA-C-N 115.638 -0.71 . . . . 53.31 113.719 177.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 164' ' ' MET . . . . . . . . . . . . . 41.6 mtp -78.64 -6.47 55.77 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 113.403 0.89 . . . . 73.35 113.403 -174.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . -106.03 -151.5 19.43 Favored Glycine 0 C--N 1.334 0.465 0 N-CA-C 111.856 -0.497 . . . . 64.24 111.856 173.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . 109.27 73.36 0.77 Allowed Glycine 0 C--N 1.342 0.906 0 C-N-CA 121.562 -0.351 . . . . 75.44 112.392 -173.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 167' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -77.32 102.37 6.71 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 105.999 -1.852 . . . . 64.31 105.999 163.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 168' ' ' GLY . . . . . 0.524 ' H ' ' HB3' ' C' ' 106' ' ' PHE . . . 115.51 153.1 10.21 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 108.109 -1.997 . . . . 13.44 108.109 -161.382 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 169' ' ' ASN . . . . . 0.543 HD22 ' HB3' ' C' ' 105' ' ' LEU . 25.0 t-20 -66.07 -66.66 1.22 Allowed Pre-proline 0 CA--C 1.583 2.245 0 CA-C-O 116.74 -1.6 . . . . 62.44 112.833 -168.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 170' ' ' PRO . . . . . 0.46 ' HD3' ' HB3' ' C' ' 169' ' ' ASN . 51.8 Cg_exo -51.08 111.94 0.67 Allowed 'Trans proline' 0 C--N 1.401 3.309 0 CA-C-N 123.076 2.134 . . . . 51.41 113.381 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 171' ' ' PRO . . . . . 0.548 ' HG2' ' HA ' ' C' ' 89' ' ' ASP . 71.6 Cg_exo -47.58 139.9 17.32 Favored 'Trans proline' 0 C--N 1.383 2.377 0 C-N-CA 124.465 3.443 . . . . 74.02 115.698 -164.112 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -108.69 -127.17 5.5 Favored Glycine 0 C--N 1.344 1.004 0 N-CA-C 111.329 -0.708 . . . . 74.42 111.329 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 173' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -151.88 156.47 40.19 Favored 'General case' 0 C--O 1.249 1.077 0 CA-C-O 121.606 0.717 . . . . 74.51 110.423 173.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 174' ' ' LEU . . . . . 0.519 ' HB3' HG13 ' C' ' 161' ' ' VAL . 39.4 tp -104.32 123.48 47.47 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.488 -0.778 . . . . 75.22 110.367 -177.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 175' ' ' LEU . . . . . 0.54 HD22 ' HB ' ' C' ' 158' ' ' VAL . 92.8 mt -101.95 94.87 6.01 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.619 1.167 . . . . 71.32 108.159 173.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 176' ' ' LEU . . . . . 0.775 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 44.2 mt -78.78 101.47 7.62 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.472 -0.566 . . . . 43.02 109.472 174.3 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 177' ' ' VAL . . . . . 0.588 ' HB ' ' HB2' ' C' ' 122' ' ' GLU . 39.5 t -84.32 94.13 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 107.172 -1.418 . . . . 74.43 107.172 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 178' ' ' VAL . . . . . 0.694 HG21 HG21 ' C' ' 153' ' ' VAL . 2.7 p -82.02 125.3 39.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.623 0.725 . . . . 74.01 110.68 -178.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 179' ' ' ARG . . . . . 0.438 ' HB3' ' HG2' ' B' ' 188' ' ' ARG . 39.6 mmt180 -104.81 106.73 17.35 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 114.772 -1.104 . . . . 72.33 108.101 175.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 180' ' ' LEU . . . . . 0.481 ' HA ' ' O ' ' C' ' 125' ' ' LEU . 97.3 mt -70.37 148.93 47.85 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 123.677 0.611 . . . . 70.51 110.505 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 181' ' ' LEU . . . . . 0.416 HD12 ' HB ' ' C' ' 126' ' ' THR . 80.2 mt -72.62 166.58 41.12 Favored Pre-proline 0 N--CA 1.483 1.216 0 C-N-CA 123.443 0.697 . . . . 74.2 110.418 -174.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -55.57 78.74 0.03 OUTLIER 'Trans proline' 0 C--N 1.384 2.426 0 C-N-CA 122.837 2.358 . . . . 64.12 111.867 166.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 183' ' ' HIS . . . . . . . . . . . . . 76.3 t60 -173.11 57.21 0.21 Allowed Pre-proline 0 CA--C 1.559 1.297 0 CA-C-N 113.459 -1.7 . . . . 62.13 107.039 -171.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 184' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -86.16 66.73 5.12 Favored 'Trans proline' 0 C--N 1.385 2.454 0 C-N-CA 123.176 2.584 . . . . 71.54 111.323 -174.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 185' ' ' VAL . . . . . 0.514 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 21.2 t -92.66 -43.17 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 108.595 -0.891 . . . . 72.23 108.595 -173.049 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 186' ' ' PHE . . . . . 0.608 ' HB3' HD22 ' C' ' 193' ' ' LEU . 56.0 m-85 -119.75 119.85 34.83 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.307 0.643 . . . . 61.44 111.738 -171.258 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 187' ' ' ARG . . . . . 0.406 ' HB3' ' HB3' ' C' ' 194' ' ' TYR . 2.2 tmt_? -96.58 109.7 22.25 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 107.03 -1.47 . . . . 75.14 107.03 171.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 188' ' ' LEU . . . . . 0.614 HD13 ' HD2' ' C' ' 240' ' ' PHE . 67.2 tp -82.21 151.25 26.96 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.654 0.74 . . . . 74.14 112.502 -177.06 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -142.02 101.92 4.03 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.252 1.421 . . . . 71.33 107.298 164.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 68.28 -89.53 0.21 Allowed Glycine 0 C--N 1.35 1.354 0 O-C-N 123.205 0.316 . . . . 74.2 113.188 -177.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 191' ' ' GLN . . . . . 0.45 HE21 ' H ' ' C' ' 242' ' ' GLY . 28.4 mt-30 -119.88 -22.91 6.59 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.61 1.164 . . . . 60.21 110.789 175.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -86.45 129.0 35.01 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.574 0.749 . . . . 65.13 110.934 -173.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 193' ' ' LEU . . . . . 0.608 HD22 ' HB3' ' C' ' 186' ' ' PHE . 62.6 mt -93.72 166.71 12.08 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.913 0.485 . . . . 52.2 111.106 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 194' ' ' TYR . . . . . 0.515 ' HA ' ' O ' ' C' ' 250' ' ' TYR . 4.1 t80 -137.82 103.65 5.06 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 109.049 -0.723 . . . . 75.43 109.049 169.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 195' ' ' ALA . . . . . 0.524 ' HB3' ' HG ' ' C' ' 251' ' ' LEU . . . -101.77 -177.38 3.41 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 124.032 0.933 . . . . 65.11 110.093 176.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 56.3 m -132.56 130.17 39.96 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 108.113 -1.069 . . . . 51.32 108.113 168.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 197' ' ' LEU . . . . . . . . . . . . . 51.7 tp -106.54 135.24 48.39 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 123.769 0.828 . . . . 73.5 110.699 -171.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -78.98 101.7 7.92 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.395 0.678 . . . . 44.52 109.619 173.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 199' ' ' VAL . . . . . . . . . . . . . 40.8 t -119.11 109.94 38.54 Favored Pre-proline 0 N--CA 1.473 0.68 0 N-CA-C 108.052 -1.092 . . . . 61.21 108.052 175.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 200' ' ' PRO . . . . . 0.519 ' HA ' ' O ' ' C' ' 256' ' ' THR . 25.6 Cg_exo -60.7 147.2 95.65 Favored 'Trans proline' 0 C--N 1.363 1.325 0 C-N-CA 122.188 1.925 . . . . 71.34 111.546 175.206 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 201' ' ' ALA . . . . . . . . . . . . . . . -50.46 -48.39 81.6 Favored Pre-proline 0 CA--C 1.561 1.384 0 O-C-N 123.885 0.74 . . . . 74.35 112.6 176.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 202' ' ' PRO . . . . . 0.618 ' HB2' ' HA ' ' A' ' 273' ' ' ALA . 20.3 Cg_endo -58.34 -49.81 11.33 Favored 'Trans proline' 0 C--N 1.387 2.584 0 C-N-CA 121.572 1.515 . . . . 63.15 113.161 174.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 203' ' ' ILE . . . . . 0.519 HD12 ' HG2' ' C' ' 200' ' ' PRO . 37.6 mt -63.84 -29.32 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 C-N-CA 122.933 0.493 . . . . 63.4 111.22 -178.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.43 -46.02 67.76 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.166 0.986 . . . . 75.02 111.531 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 205' ' ' VAL . . . . . . . . . . . . . 72.6 t -68.52 -40.42 81.99 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 CA-C-N 115.466 -0.788 . . . . 63.41 111.617 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 206' ' ' VAL . . . . . 0.666 ' HA ' ' HE2' ' A' ' 270' ' ' LYS . 14.3 p -80.13 -38.25 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 112.787 0.662 . . . . 52.12 112.787 -173.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 85.05 71.56 1.31 Allowed Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 116.054 -0.521 . . . . 63.21 112.091 -167.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -98.62 -138.68 10.4 Favored Glycine 0 C--N 1.341 0.813 0 N-CA-C 111.294 -0.722 . . . . 51.32 111.294 176.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 209' ' ' LYS . . . . . 0.591 ' HG2' ' HA ' ' C' ' 222' ' ' ALA . 43.7 mtmt -139.7 146.3 39.45 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.451 0.7 . . . . 72.12 110.221 170.096 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 210' ' ' VAL . . . . . . . . . . . . . 19.9 m -138.15 137.17 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 107.923 -1.14 . . . . 62.05 107.923 173.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 211' ' ' ARG . . . . . 0.427 ' HB3' ' O ' ' B' ' 224' ' ' VAL . 37.2 ttm180 -75.7 127.79 33.8 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 120.685 0.278 . . . . 72.44 110.983 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -95.79 119.19 33.85 Favored 'General case' 0 C--O 1.245 0.854 0 N-CA-C 108.637 -0.875 . . . . 74.43 108.637 165.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 213' ' ' MET . . . . . . . . . . . . . 2.6 tmm? -72.08 121.69 19.66 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 107.583 -1.265 . . . . 63.12 107.583 176.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 214' ' ' THR . . . . . 0.504 ' OG1' HG12 ' C' ' 219' ' ' VAL . 0.2 OUTLIER -126.21 168.13 14.49 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 122.909 0.484 . . . . 54.24 110.568 -174.51 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 215' ' ' LEU . . . . . 0.497 ' HA ' ' HG3' ' C' ' 128' ' ' GLU . 17.0 mt -55.7 -45.27 77.9 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 125.398 1.479 . . . . 44.41 112.043 -176.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -78.64 -28.5 45.52 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 113.547 -1.66 . . . . 71.0 111.416 -176.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 154.98 -164.38 31.78 Favored Glycine 0 C--N 1.343 0.935 0 CA-C-O 119.575 -0.569 . . . . 64.11 112.018 -169.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -84.87 116.49 1.86 Allowed 'Trans proline' 0 CA--C 1.552 1.424 0 C-N-CA 122.691 2.261 . . . . 52.13 113.223 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 219' ' ' VAL . . . . . 0.514 HG23 HG22 ' B' ' 238' ' ' THR . 10.8 p -101.09 117.26 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 108.311 -0.996 . . . . 52.53 108.311 171.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 220' ' ' GLU . . . . . 0.446 ' HG2' ' HD2' ' C' ' 209' ' ' LYS . 27.4 tt0 -91.28 105.36 17.73 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 121.467 0.651 . . . . 72.32 109.986 -171.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 221' ' ' VAL . . . . . 0.413 HG11 HD21 ' C' ' 233' ' ' LEU . 64.4 t -70.23 119.92 17.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 114.846 -1.07 . . . . 74.03 112.019 -174.161 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 222' ' ' ALA . . . . . 0.591 ' HA ' ' HG2' ' C' ' 209' ' ' LYS . . . -76.76 99.13 5.01 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 124.149 0.906 . . . . 73.3 109.806 169.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 98.6 t -73.79 138.54 76.77 Favored Pre-proline 0 CA--C 1.555 1.161 0 C-N-CA 123.651 0.781 . . . . 73.11 109.126 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 224' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -92.35 172.86 2.32 Favored 'Trans proline' 0 C--N 1.368 1.605 0 C-N-CA 123.778 2.985 . . . . 54.33 111.787 174.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -72.85 154.24 53.52 Favored 'Trans proline' 0 C--N 1.371 1.714 0 C-N-CA 121.57 1.513 . . . . 74.0 110.837 174.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 226' ' ' ARG . . . . . 0.517 HH22 ' HB2' ' A' ' 261' ' ' LEU . 10.4 mpt_? 57.95 58.67 3.49 Favored 'General case' 0 N--CA 1.483 1.204 0 O-C-N 124.023 0.827 . . . . 70.15 111.651 177.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 227' ' ' THR . . . . . 0.615 HG22 HG11 ' C' ' 253' ' ' VAL . 90.0 m -97.28 112.23 24.13 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 122.29 -0.256 . . . . 70.3 110.625 178.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 228' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -89.03 163.41 15.53 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.941 0.897 . . . . 74.32 112.206 -178.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -70.36 115.02 9.06 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 113.516 -1.674 . . . . 62.12 109.58 175.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 102.26 8.65 43.67 Favored Glycine 0 C--N 1.336 0.546 0 O-C-N 123.562 0.539 . . . . 62.04 113.449 -178.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 231' ' ' ARG . . . . . 0.402 ' HD3' ' HA ' ' C' ' 227' ' ' THR . 41.4 mtp180 -67.89 169.87 9.11 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 117.502 0.651 . . . . 74.12 109.435 164.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 232' ' ' LYS . . . . . 0.451 ' HA ' ' O ' ' C' ' 251' ' ' LEU . 35.4 ttmt -142.06 142.96 32.88 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.794 0.807 . . . . 71.45 112.288 -173.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 233' ' ' LEU . . . . . 0.678 HD13 ' HB2' ' C' ' 251' ' ' LEU . 3.2 mp -106.72 154.45 20.95 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.766 1.626 . . . . 74.21 108.542 178.006 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 10.5 ptp85 -130.89 88.08 2.57 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 122.268 1.032 . . . . 72.34 108.77 165.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 235' ' ' LEU . . . . . 0.417 ' HA ' ' HA3' ' B' ' 240' ' ' GLY . 30.5 mt -77.59 118.07 19.64 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 114.874 -1.057 . . . . 73.43 109.624 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -81.03 124.71 29.4 Favored 'General case' 0 C--O 1.241 0.605 0 CA-C-N 115.081 -0.963 . . . . 71.55 111.547 -168.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 66.78 29.64 75.0 Favored Glycine 0 C--N 1.345 1.038 0 CA-C-N 115.219 -0.901 . . . . 71.42 112.442 -177.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 34.4 mmtm -118.24 4.42 11.93 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.722 0.809 . . . . 72.03 110.722 178.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 239' ' ' GLY . . . . . 0.466 ' HA2' HD12 ' C' ' 193' ' ' LEU . . . -88.67 -135.4 5.25 Favored Glycine 0 C--N 1.347 1.164 0 N-CA-C 110.625 -0.99 . . . . 31.21 110.625 170.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 240' ' ' PHE . . . . . 0.614 ' HD2' HD13 ' C' ' 188' ' ' LEU . 44.8 m-85 -101.57 108.01 53.8 Favored Pre-proline 0 C--O 1.25 1.093 0 CA-C-N 116.968 0.384 . . . . 75.14 110.092 171.068 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 241' ' ' PRO . . . . . 0.705 ' HA ' ' H ' ' C' ' 246' ' ' ARG . 40.5 Cg_endo -67.51 113.28 2.87 Favored 'Trans proline' 0 C--N 1.366 1.462 0 C-N-CA 122.027 1.818 . . . . 70.21 110.281 170.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 242' ' ' GLY . . . . . 0.537 ' HA2' ' HG2' ' C' ' 151' ' ' PRO . . . -90.45 -162.45 38.27 Favored Glycine 0 N--CA 1.483 1.773 0 CA-C-N 115.347 -0.842 . . . . 70.14 113.217 -169.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -58.95 -33.38 98.69 Favored 'Trans proline' 0 C--N 1.374 1.888 0 C-N-CA 122.677 2.251 . . . . 71.42 112.11 170.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -79.01 -24.43 43.7 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.127 0.571 . . . . 71.42 110.59 169.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 74.89 98.8 0.1 Allowed Glycine 0 C--N 1.343 0.959 0 CA-C-O 119.38 -0.678 . . . . 51.32 114.149 176.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 246' ' ' ARG . . . . . 0.705 ' H ' ' HA ' ' C' ' 241' ' ' PRO . 10.5 ptt180 -162.48 -72.81 0.05 OUTLIER 'General case' 0 CA--C 1.558 1.257 0 N-CA-C 114.187 1.18 . . . . 61.31 114.187 168.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 247' ' ' GLY . . . . . 0.591 ' H ' ' HG3' ' C' ' 246' ' ' ARG . . . 45.62 128.27 0.0 OUTLIER Glycine 0 C--N 1.358 1.758 0 N-CA-C 117.449 1.74 . . . . 63.23 117.449 -159.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -125.95 119.29 27.35 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 108.308 -0.997 . . . . 73.54 108.308 175.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 249' ' ' LEU . . . . . 0.439 ' HG ' HD11 ' C' ' 251' ' ' LEU . 15.4 tp -86.78 118.49 26.22 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.039 -0.982 . . . . 74.23 109.726 -173.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 250' ' ' TYR . . . . . 0.592 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 20.4 m-85 -98.46 119.88 37.93 Favored 'General case' 0 C--O 1.211 -0.948 0 N-CA-C 108.138 -1.06 . . . . 71.43 108.138 175.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 251' ' ' LEU . . . . . 0.678 ' HB2' HD13 ' C' ' 233' ' ' LEU . 2.6 mp -111.24 139.46 46.62 Favored 'General case' 0 N--CA 1.506 2.355 0 CA-C-N 118.706 0.684 . . . . 64.53 110.029 178.363 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -94.2 131.14 40.08 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.984 -0.747 . . . . 73.41 108.984 171.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 253' ' ' VAL . . . . . 0.615 HG11 HG22 ' C' ' 227' ' ' THR . 83.9 t -78.65 123.93 36.28 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 C-N-CA 123.619 0.768 . . . . 73.5 111.557 -175.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 254' ' ' ARG . . . . . 0.521 HH12 ' HA3' ' A' ' 230' ' ' GLY . 9.8 mmt85 -101.36 120.92 41.0 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 109.167 -0.679 . . . . 74.13 109.167 166.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 255' ' ' ILE . . . . . . . . . . . . . 36.0 mm -83.78 94.6 3.49 Favored 'Isoleucine or valine' 0 C--O 1.241 0.636 0 O-C-N 124.265 0.978 . . . . 75.24 108.801 170.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 256' ' ' THR . . . . . 0.519 ' O ' ' HA ' ' C' ' 200' ' ' PRO . 0.0 OUTLIER -97.45 144.11 27.5 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 114.883 -1.053 . . . . 53.32 109.731 -179.799 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 2.8 pp -98.79 153.16 38.0 Favored Pre-proline 0 CA--C 1.558 1.267 0 C-N-CA 122.742 0.417 . . . . 64.54 111.227 -177.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -41.7 -24.34 0.26 Allowed 'Trans proline' 0 C--N 1.389 2.672 1 C-N-CA 125.369 4.046 . . . . 73.21 118.333 -170.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 259' ' ' GLU . . . . . 0.551 ' HB2' HG12 ' B' ' 38' ' ' ILE . 58.1 mm-40 59.88 -73.33 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 124.477 1.111 . . . . 72.3 111.08 -165.1 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.06 159.14 31.43 Favored 'General case' 0 C--N 1.352 0.674 0 N-CA-C 109.026 -0.731 . . . . 73.41 109.026 171.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 261' ' ' LEU . . . . . 0.52 ' HB2' HH21 ' A' ' 226' ' ' ARG . 75.7 mt -145.12 170.9 15.33 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.045 -1.095 . . . . 71.21 108.045 165.354 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 262' ' ' THR . . . . . 0.44 ' H ' ' HB2' ' C' ' 265' ' ' GLU . 45.1 p -122.09 159.96 49.52 Favored Pre-proline 0 CA--C 1.547 0.844 0 N-CA-C 107.587 -1.264 . . . . 61.23 107.587 164.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -38.82 -47.65 2.74 Favored 'Trans proline' 0 C--N 1.387 2.554 0 C-N-CA 123.535 2.823 . . . . 74.2 113.982 175.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -68.82 -53.26 22.54 Favored 'General case' 0 C--N 1.351 0.639 0 CA-C-N 115.886 -0.597 . . . . 71.04 111.344 -178.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 265' ' ' GLU . . . . . 0.44 ' HB2' ' H ' ' C' ' 262' ' ' THR . 47.0 mt-10 -48.24 -56.86 6.91 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 123.806 0.691 . . . . 65.11 109.474 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 266' ' ' GLU . . . . . 0.521 ' O ' ' HG2' ' C' ' 270' ' ' LYS . 33.9 tt0 -57.23 -41.53 79.71 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 114.908 -1.042 . . . . 64.21 111.364 -177.333 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -61.69 -41.81 98.09 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 123.424 0.69 . . . . 70.32 112.784 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 268' ' ' LEU . . . . . 0.418 ' HG ' HD11 ' A' ' 268' ' ' LEU . 10.8 mp -67.14 -40.31 86.71 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.783 0.433 . . . . 52.44 110.177 177.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -59.03 -36.51 75.11 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 116.353 -0.385 . . . . 61.11 110.761 172.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 270' ' ' LYS . . . . . 0.521 ' HG2' ' O ' ' C' ' 266' ' ' GLU . 25.3 mmtp -60.74 -50.65 72.62 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 122.859 0.464 . . . . 75.43 110.276 177.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 271' ' ' LYS . . . . . 0.483 ' HB2' HD21 ' A' ' 268' ' ' LEU . 47.2 mtpt -53.68 -41.37 66.83 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 124.112 0.883 . . . . 75.33 111.326 177.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 95.5 mt -60.96 -45.54 94.32 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 123.799 0.687 . . . . 74.33 111.135 176.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -64.13 -31.01 72.04 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.153 0.581 . . . . 34.13 111.98 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 274' ' ' GLU . . . . . 0.487 ' HG3' ' O ' ' C' ' 270' ' ' LYS . 30.7 mt-10 -77.66 -34.51 53.04 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.143 0.577 . . . . 63.21 110.402 177.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -67.06 -24.23 65.95 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 115.824 -0.625 . . . . 70.04 110.48 171.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 276' ' ' TYR . . . . . 0.444 ' HD1' HH11 ' C' ' 279' ' ' ARG . 4.1 m-85 -80.51 -35.87 34.0 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.281 -0.872 . . . . 75.52 112.077 175.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -66.98 -28.35 68.19 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 109.491 -0.559 . . . . 44.24 109.491 169.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -72.19 3.3 4.7 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 123.8 0.84 . . . . 55.2 112.878 173.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 279' ' ' ARG . . . . . 0.444 HH11 ' HD1' ' C' ' 276' ' ' TYR . 71.9 mtp180 -74.51 -18.85 60.55 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 118.15 0.432 . . . . 71.52 110.4 168.259 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.558 1.269 0 N-CA-C 109.602 -0.518 . . . . 75.14 109.602 175.826 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.4 mtp . . . . . 0 N--CA 1.472 0.631 0 N-CA-C 110.222 -0.288 . . . . 64.12 110.222 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.4 33.55 22.41 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 113.979 1.103 . . . . 51.4 113.979 164.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -85.27 48.36 1.56 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 122.789 0.435 . . . . 74.04 110.193 176.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.416 ' HA ' ' CG ' ' A' ' 96' ' ' PHE . 37.1 ttpt -38.09 108.85 0.09 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.021 1.728 . . . . 62.43 115.37 -172.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.448 ' HD2' HD11 ' A' ' 10' ' ' ILE . 27.7 mmtp -72.26 105.2 3.95 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 108.84 -0.8 . . . . 74.32 108.84 164.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -72.99 96.06 2.09 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 105.905 -1.887 . . . . 61.41 105.905 165.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.433 ' HB2' HD11 ' A' ' 57' ' ' LEU . 67.6 m-85 -61.87 -31.18 71.43 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-N 114.96 -1.018 . . . . 73.34 111.503 -170.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -67.41 -40.23 85.57 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.408 -0.815 . . . . 73.33 109.884 176.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.85 -37.93 89.2 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 122.908 0.483 . . . . 60.32 110.921 177.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.448 HD11 ' HD2' ' A' ' 5' ' ' LYS . 65.3 mt -59.33 -41.46 84.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 123.1 0.56 . . . . 74.23 110.267 173.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.6 mt -80.49 -8.54 59.6 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 115.756 -0.656 . . . . 51.33 112.606 176.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 70.01 18.23 74.37 Favored Glycine 0 C--N 1.353 1.484 0 N-CA-C 114.239 0.455 . . . . 53.33 114.239 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.3 m -103.14 163.3 17.78 Favored Pre-proline 0 N--CA 1.486 1.347 0 C-N-CA 124.374 1.07 . . . . 71.43 110.709 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -47.54 146.75 7.24 Favored 'Trans proline' 0 C--N 1.387 2.577 0 C-N-CA 123.6 2.867 . . . . 50.12 114.043 174.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -71.36 15.78 0.12 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 114.284 1.216 . . . . 75.43 114.284 -170.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -159.8 33.56 0.18 Allowed 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 108.625 -0.88 . . . . 64.11 108.625 173.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.34 149.58 50.16 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.436 1.094 . . . . 64.31 111.834 -177.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 76.1 p -77.8 170.76 16.03 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.516 0.726 . . . . 71.11 111.88 -174.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -55.95 -41.28 74.46 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.673 1.189 . . . . 64.21 112.559 -172.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.36 -32.2 66.25 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 122.629 0.372 . . . . 72.43 110.581 -177.448 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.455 ' HG2' ' NH2' ' A' ' 24' ' ' ARG . 40.1 mt-10 -65.96 -40.97 91.75 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 121.101 0.476 . . . . 64.03 109.771 175.214 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.419 HG12 ' HB3' ' A' ' 57' ' ' LEU . 1.6 mp -65.04 -38.57 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-N 114.763 -1.108 . . . . 73.31 110.416 176.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -75.55 -33.36 60.66 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.567 0.747 . . . . 71.24 111.307 -175.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.461 ' HA ' ' NZ ' ' A' ' 27' ' ' LYS . 85.3 mtm-85 -72.78 -43.64 62.55 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 122.693 0.397 . . . . 54.12 110.566 175.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.04 -31.07 70.48 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.797 -0.638 . . . . 64.0 111.146 177.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -62.55 -58.65 6.79 Favored 'General case' 0 C--O 1.213 -0.856 0 CA-C-O 118.61 -0.709 . . . . 73.1 109.381 173.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.461 ' NZ ' ' HA ' ' A' ' 24' ' ' ARG . 35.5 mtmm -53.97 -39.43 65.98 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 123.949 0.781 . . . . 74.22 111.241 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -54.38 -58.3 7.98 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.182 0.993 . . . . 71.15 110.966 177.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.44 ' HA ' ' HB3' ' A' ' 32' ' ' GLN . 75.4 mt -86.38 -8.99 57.23 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 115.074 -0.967 . . . . 74.11 111.635 -173.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.12 -21.62 25.88 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.686 0.794 . . . . 63.3 109.95 174.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -90.87 -31.76 16.3 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.483 0.713 . . . . 72.33 110.509 170.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.44 ' HB3' ' HA ' ' A' ' 29' ' ' LEU . 29.9 tt0 -73.36 -49.06 29.3 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.999 0.52 . . . . 63.33 111.326 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -98.15 23.78 7.86 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.077 0.551 . . . . 63.25 110.796 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 51.1 t60 -63.2 101.38 0.26 Allowed Pre-proline 0 CA--C 1.554 1.101 0 C-N-CA 124.968 1.307 . . . . 63.41 112.195 -170.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -73.79 -5.44 17.05 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 123.561 2.841 . . . . 74.13 112.552 -172.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -73.73 -27.29 61.11 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 124.571 1.148 . . . . 72.45 111.479 174.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 60.5 t -123.47 -46.71 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 CA-C-O 121.561 0.696 . . . . 65.53 109.716 178.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -98.62 80.96 2.62 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.703 1.201 . . . . 61.35 109.883 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.48 69.4 10.05 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 115.806 -0.633 . . . . 73.11 109.649 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 24.2 m -108.86 134.46 20.34 Favored Pre-proline 0 N--CA 1.479 0.988 0 CA-C-O 118.518 -0.753 . . . . 54.41 109.822 -179.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -48.07 -52.24 8.6 Favored 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 123.88 3.054 . . . . 72.23 113.419 -178.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.411 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 8.2 tp10 -62.42 -32.61 73.48 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 122.85 0.46 . . . . 64.43 110.873 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -82.15 -14.75 55.21 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.928 0.491 . . . . 72.14 110.435 -179.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.425 ' O ' ' HD3' ' A' ' 48' ' ' LYS . 49.0 mm-40 -68.67 -58.9 3.57 Favored 'General case' 0 C--N 1.358 0.94 0 N-CA-C 107.21 -1.404 . . . . 62.01 107.21 170.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -53.23 -47.01 69.35 Favored 'General case' 0 C--N 1.352 0.705 0 CA-C-N 113.842 -1.527 . . . . 62.44 110.396 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.517 ' O ' HG12 ' A' ' 50' ' ' ILE . 0.1 OUTLIER -71.02 -48.9 50.39 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 114.747 -1.115 . . . . 74.03 111.193 -172.385 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -53.45 -46.54 69.91 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 123.849 0.718 . . . . 73.24 110.508 177.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.425 ' HD3' ' O ' ' A' ' 44' ' ' GLU . 2.1 mtpm? -63.3 -36.37 83.46 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 115.37 -0.832 . . . . 75.14 111.525 178.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -69.99 -30.26 67.55 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 122.62 0.368 . . . . 71.44 111.274 173.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.517 HG12 ' O ' ' A' ' 46' ' ' LYS . 18.3 mm -68.95 -36.87 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 108.843 -0.799 . . . . 70.53 108.843 175.322 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.416 ' O ' ' HB2' ' A' ' 55' ' ' ALA . 11.5 m-80 -80.5 -20.09 44.41 Favored 'General case' 0 C--O 1.211 -0.955 0 CA-C-N 114.435 -1.257 . . . . 73.43 111.385 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -71.98 -50.38 29.28 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.328 1.051 . . . . 63.42 109.01 171.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.16 -50.78 71.77 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 113.494 -1.684 . . . . 65.45 111.076 176.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -64.51 -37.96 89.34 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-N 115.068 -0.969 . . . . 72.32 110.525 177.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.416 ' HB2' ' O ' ' A' ' 51' ' ' ASN . . . -54.23 -46.91 72.66 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.289 0.636 . . . . 53.01 112.169 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 67.9 t -72.94 -45.86 53.9 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.116 0 CA-C-N 115.955 -0.566 . . . . 74.52 110.996 177.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.433 HD11 ' HB2' ' A' ' 7' ' ' TYR . 64.2 mt -93.57 0.84 56.77 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 114.206 1.188 . . . . 62.04 114.206 -166.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.1 t -73.58 -52.79 12.25 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.464 0.649 . . . . 74.34 109.85 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -88.89 137.21 29.95 Favored Pre-proline 0 C--O 1.241 0.657 0 CA-C-N 114.737 -1.119 . . . . 74.34 109.745 -176.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.417 ' O ' ' HG2' ' A' ' 64' ' ' ARG . 48.0 Cg_exo -56.19 -26.9 63.14 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 123.346 2.697 . . . . 72.41 112.576 178.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -64.4 -59.88 3.83 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.814 0.846 . . . . 72.3 111.451 -176.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.402 ' HA ' HD12 ' A' ' 65' ' ' ILE . 42.0 mtmt -77.36 -23.62 50.82 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 115.842 -0.617 . . . . 74.54 111.275 -176.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 44.9 tpt85 -54.77 -54.64 39.49 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 108.919 -0.771 . . . . 74.11 108.919 166.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.473 ' HE ' ' HA ' ' A' ' 64' ' ' ARG . 2.2 mmp_? -63.27 -33.37 75.36 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.582 0.753 . . . . 74.25 112.168 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.702 HG23 ' HG3' ' A' ' 76' ' ' PRO . 89.2 mt -59.46 -45.59 93.54 Favored 'Isoleucine or valine' 0 C--O 1.253 1.24 0 C-N-CA 123.105 0.562 . . . . 64.42 110.783 174.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -66.74 -42.03 86.9 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 116.237 -0.438 . . . . 75.4 109.823 178.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -53.93 -45.82 71.32 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 123.161 0.585 . . . . 64.04 110.852 175.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 50.5 p -75.36 -19.3 59.66 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.224 -0.444 . . . . 75.13 112.013 -178.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -70.5 112.33 6.7 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 109.04 -0.726 . . . . 63.45 109.04 174.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 103.36 19.99 11.68 Favored Glycine 0 N--CA 1.474 1.171 0 N-CA-C 111.711 -0.556 . . . . 52.54 111.711 -172.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 97.6 m -142.05 -58.09 0.46 Allowed 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 103.623 -2.732 . . . . 71.23 103.623 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 29.4 m -77.8 134.37 38.03 Favored 'General case' 0 C--O 1.256 1.427 0 N-CA-C 104.399 -2.445 . . . . 74.23 104.399 155.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.18 -29.27 16.55 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.328 0.651 . . . . 74.04 111.15 -177.275 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -94.22 168.35 11.73 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 124.085 0.954 . . . . 75.1 109.929 177.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -53.32 140.36 62.7 Favored 'Trans proline' 0 C--N 1.378 2.108 0 C-N-CA 122.164 1.909 . . . . 75.41 112.621 165.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.702 ' HG3' HG23 ' A' ' 65' ' ' ILE . 91.4 Cg_endo -72.52 175.53 10.01 Favored 'Trans proline' 0 C--N 1.375 1.925 0 C-N-CA 123.644 2.896 . . . . 74.25 112.562 -177.05 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.46 121.15 9.31 Favored 'Trans proline' 0 C--N 1.38 2.2 0 C-N-CA 122.002 1.801 . . . . 62.44 111.186 171.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -63.32 130.2 27.84 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.594 2.196 . . . . 43.51 112.063 176.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -59.5 141.57 97.58 Favored 'Trans proline' 0 C--N 1.381 2.269 0 C-N-CA 122.64 2.227 . . . . 71.05 111.32 172.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.29 78.28 0.45 Allowed 'Trans proline' 0 C--N 1.382 2.298 0 C-N-CA 123.156 2.571 . . . . 51.35 112.694 -177.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 159.29 -35.38 0.48 Allowed Glycine 0 N--CA 1.467 0.713 0 N-CA-C 109.669 -1.372 . . . . 62.41 109.669 -174.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.446 ' HA3' ' HA ' ' A' ' 106' ' ' PHE . . . 130.04 167.22 12.01 Favored Glycine 0 C--N 1.351 1.375 0 CA-C-N 114.899 -0.651 . . . . 53.03 112.926 170.178 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -69.25 100.9 1.38 Allowed 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 108.175 -1.046 . . . . 74.41 108.175 166.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.464 ' O ' ' HD1' ' A' ' 85' ' ' PHE . 12.6 t70 -63.61 152.16 39.65 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.88 0.872 . . . . 71.31 112.969 -174.379 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.464 ' HD1' ' O ' ' A' ' 84' ' ' ASP . 0.3 OUTLIER -148.54 72.43 1.19 Allowed 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 124.699 1.199 . . . . 70.22 107.783 169.882 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.572 ' HA ' ' HA3' ' A' ' 163' ' ' GLY . 44.8 m -55.3 87.75 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 114.562 1.319 . . . . 74.44 114.562 -174.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.608 ' HA2' ' HB3' ' A' ' 171' ' ' PRO . . . 94.56 14.48 50.21 Favored Glycine 0 N--CA 1.47 0.942 0 CA-C-N 116.237 -0.438 . . . . 70.11 113.425 176.309 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -123.19 111.72 16.82 Favored 'General case' 0 C--O 1.245 0.835 0 C-N-CA 122.922 0.489 . . . . 72.34 110.133 -169.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -68.69 92.97 0.49 Allowed 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.077 0.551 . . . . 71.44 110.917 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.489 HG13 ' HG2' ' A' ' 91' ' ' GLU . 2.2 p -31.82 -49.21 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 125.521 1.529 . . . . 75.21 114.311 169.129 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.489 ' HG2' HG13 ' A' ' 90' ' ' VAL . 7.7 mm-40 -68.27 -14.88 63.31 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.992 0.738 . . . . 75.33 112.992 -169.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -78.54 -42.3 29.75 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.504 0.722 . . . . 45.35 111.228 171.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -77.59 178.85 6.94 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 113.46 0.911 . . . . 71.01 113.46 -165.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 67.4 p -58.18 144.4 40.76 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.777 1.231 . . . . 74.5 113.711 -166.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.449 ' O ' ' HG3' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -53.65 -43.02 68.45 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 114.401 -1.272 . . . . 74.31 110.973 172.516 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.416 ' CG ' ' HA ' ' A' ' 4' ' ' LYS . 37.0 t80 -51.18 -52.88 40.01 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.368 1.067 . . . . 75.03 111.479 176.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -57.62 -46.68 83.81 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 114.786 -1.097 . . . . 63.23 110.179 178.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.452 ' HA ' HD11 ' A' ' 105' ' ' LEU . 96.3 mt-30 -70.04 -13.01 62.02 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 115.757 -0.656 . . . . 73.05 112.527 -178.244 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.449 ' HG3' ' O ' ' A' ' 95' ' ' GLU . 52.5 mt-10 -88.87 -52.63 5.01 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 122.982 0.513 . . . . 70.02 111.515 172.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 36.2 tp -65.14 -50.95 64.04 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.368 0.667 . . . . 55.03 111.014 -175.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -87.88 -6.0 58.3 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 115.606 -0.725 . . . . 72.11 110.74 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -42.68 -59.17 3.29 Favored Glycine 0 C--N 1.355 1.585 0 CA-C-O 118.625 -1.097 . . . . 72.43 114.859 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -39.83 -26.89 0.18 Allowed 'Trans proline' 0 C--N 1.393 2.877 0 C-N-CA 124.883 3.722 . . . . 23.1 116.365 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -152.03 37.63 0.81 Allowed Glycine 0 C--N 1.354 1.568 0 CA-C-O 118.975 -0.903 . . . . 44.4 113.427 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.452 HD11 ' HA ' ' A' ' 98' ' ' GLN . 33.9 mt -53.52 85.19 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 117.487 0.644 . . . . 74.25 112.232 174.031 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.446 ' HA ' ' HA3' ' A' ' 82' ' ' GLY . 0.6 OUTLIER 20.99 -110.88 0.01 OUTLIER 'General case' 0 CA--C 1.565 1.533 0 C-N-CA 127.348 2.259 . . . . 72.25 113.526 177.638 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.473 ' HA2' ' HA2' ' A' ' 168' ' ' GLY . . . 58.46 13.74 17.74 Favored Glycine 0 C--N 1.366 2.236 0 N-CA-C 114.388 0.515 . . . . 44.0 114.388 178.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 70.62 -94.22 0.49 Allowed Glycine 0 C--N 1.35 1.342 0 N-CA-C 110.753 -0.939 . . . . 71.34 110.753 -165.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -140.02 17.57 2.46 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.716 1.207 . . . . 64.11 108.853 170.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -62.63 -23.61 65.25 Favored Glycine 0 C--N 1.356 1.667 0 CA-C-N 115.78 -0.645 . . . . 55.25 114.324 -175.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 77.22 -39.19 0.31 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 125.313 1.445 . . . . 71.44 112.982 174.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.32 -15.06 59.1 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.176 0.591 . . . . 73.25 110.463 174.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 2.5 m 73.46 68.6 0.11 Allowed 'General case' 0 C--N 1.36 1.038 0 C-N-CA 124.668 1.187 . . . . 74.21 110.776 172.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.461 ' HD2' ' HA ' ' A' ' 114' ' ' ARG . 0.2 OUTLIER -124.62 170.46 10.92 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 112.379 0.511 . . . . 74.52 112.379 -172.178 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.95 149.39 23.1 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 125.981 1.712 . . . . 72.15 113.374 -164.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -100.97 -164.13 27.81 Favored Glycine 0 CA--C 1.546 1.984 0 CA-C-N 115.573 -0.74 . . . . 55.22 113.304 -178.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.433 ' H ' ' HA3' ' A' ' 166' ' ' GLY . 2.6 tmt_? -108.8 137.61 46.46 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 124.121 0.968 . . . . 71.34 112.257 176.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -57.87 99.04 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 122.194 0.997 . . . . 74.23 111.685 173.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 53.5 tp -103.92 157.54 17.02 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 114.45 -1.25 . . . . 70.23 110.698 -173.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 40.5 ttp180 -109.38 142.25 40.6 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 108.817 -0.809 . . . . 74.51 108.817 170.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.547 ' HB2' HD11 ' A' ' 174' ' ' LEU . . . -128.36 159.33 35.66 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.598 0.713 . . . . 41.51 111.113 177.511 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.4 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 0.7 OUTLIER -116.47 109.73 17.68 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 105.944 -1.873 . . . . 61.0 105.944 -177.311 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.513 ' HB3' ' HA ' ' A' ' 178' ' ' VAL . 37.5 tp -98.86 96.58 4.11 Favored Pre-proline 0 N--CA 1.475 0.805 0 N-CA-C 108.228 -1.027 . . . . 54.05 108.228 -174.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.552 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 97.5 Cg_endo -78.75 107.72 2.31 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 121.065 1.176 . . . . 75.33 109.307 -176.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.438 ' HB3' HD23 ' A' ' 180' ' ' LEU . 43.1 tp -106.76 131.47 53.84 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 122.755 0.422 . . . . 64.01 110.238 -167.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 72.9 m -59.41 124.19 19.25 Favored 'General case' 0 CA--C 1.555 1.171 0 O-C-N 124.609 1.193 . . . . 71.34 109.037 173.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.601 ' HB3' HD22 ' A' ' 215' ' ' LEU . 61.1 mt -53.78 -40.02 65.91 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 124.16 0.984 . . . . 70.54 111.743 -171.088 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 16.0 mp0 -65.02 -35.42 81.14 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 114.228 -1.351 . . . . 75.32 109.683 -178.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -78.67 -22.45 46.77 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.657 0.783 . . . . 64.33 111.165 177.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -68.05 -33.73 75.13 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 109.952 -0.388 . . . . 41.43 109.952 171.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.41 ' HB2' HD12 ' A' ' 215' ' ' LEU . 82.3 t80 -74.75 -47.55 30.54 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 115.236 -0.893 . . . . 74.51 111.488 173.259 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 51.2 m170 -69.87 -53.82 16.28 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.416 0.686 . . . . 75.25 110.921 -173.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.91 -168.42 41.23 Favored Glycine 0 C--N 1.344 1.003 0 CA-C-N 115.78 -0.645 . . . . 71.54 112.84 -178.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 98.44 -164.62 21.17 Favored Glycine 0 C--N 1.349 1.28 0 C-N-CA 123.011 0.339 . . . . 70.42 113.512 175.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -72.06 110.59 6.64 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.535 0.734 . . . . 73.14 110.409 177.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -93.85 122.48 36.38 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 122.861 0.464 . . . . 74.4 110.604 177.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 57.4 t -78.18 113.93 18.08 Favored 'Isoleucine or valine' 0 C--O 1.243 0.728 0 N-CA-C 108.428 -0.953 . . . . 71.24 108.428 169.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.586 HG13 HG13 ' A' ' 145' ' ' VAL . 3.8 p -134.25 136.57 53.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 124.49 1.116 . . . . 73.14 108.683 178.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -123.78 133.32 53.85 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.312 0.645 . . . . 71.3 110.677 -167.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.572 HG11 HD23 ' B' ' 8' ' ' LEU . 12.4 p -166.04 135.34 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.128 0.971 . . . . 75.1 109.318 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 53.23 38.49 27.76 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.196 0.999 . . . . 74.24 112.774 173.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 86.52 -21.82 16.23 Favored Glycine 0 C--N 1.353 1.504 0 CA-C-N 116.551 -0.295 . . . . 31.1 113.323 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.584 HH12 ' HG2' ' A' ' 164' ' ' MET . 12.1 tpt180 -81.82 99.27 8.91 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.138 0.975 . . . . 72.12 111.019 -179.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 38.0 ttp180 -84.65 89.38 7.47 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 107.867 -1.16 . . . . 74.41 107.867 165.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.586 HG13 HG13 ' A' ' 138' ' ' VAL . 3.0 p -97.09 145.58 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 114.783 -1.099 . . . . 73.53 110.877 -175.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 34.2 t -106.04 85.38 2.2 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.425 -0.807 . . . . 31.45 109.1 177.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 35.7 m -84.58 121.88 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 N-CA-C 109.929 -0.397 . . . . 73.42 109.929 -177.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -74.44 97.16 3.02 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.101 0.477 . . . . 74.14 109.817 -178.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 26.9 pt -78.35 123.41 85.8 Favored Pre-proline 0 CA--C 1.557 1.219 0 CA-C-N 115.267 -0.878 . . . . 74.13 109.305 174.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -63.16 135.02 48.58 Favored 'Trans proline' 0 C--N 1.372 1.78 0 C-N-CA 122.642 2.228 . . . . 60.34 112.204 176.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -61.84 96.15 0.14 Allowed 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 122.373 2.048 . . . . 74.15 111.143 171.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.565 ' HA2' ' HD2' ' A' ' 240' ' ' PHE . . . 116.5 35.14 1.21 Allowed Glycine 0 C--N 1.342 0.896 0 CA-C-N 115.481 -0.782 . . . . 75.51 111.536 -172.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.525 HG22 HG11 ' A' ' 178' ' ' VAL . 4.7 p -89.26 135.47 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 123.39 0.676 . . . . 75.43 109.496 -178.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.797 ' HD2' ' HA ' ' A' ' 191' ' ' GLN . 7.9 mtm-85 -123.77 148.72 46.4 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 115.322 -0.854 . . . . 73.23 110.502 -162.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.445 ' HB3' ' O ' ' A' ' 188' ' ' LEU . 6.8 tp10 -52.58 118.82 3.89 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 124.357 1.063 . . . . 72.32 110.464 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 105.78 -2.54 38.86 Favored Glycine 0 C--N 1.344 1.006 0 CA-C-N 115.71 -0.677 . . . . 14.21 113.276 -176.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 26.6 t -72.34 104.31 3.69 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 108.915 -0.772 . . . . 74.23 108.915 177.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.492 HG22 HG22 ' A' ' 177' ' ' VAL . 55.6 t -86.03 95.88 4.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 123.689 0.795 . . . . 72.34 109.558 -178.198 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.531 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 47.7 mt -77.84 92.82 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 N-CA-C 107.809 -1.182 . . . . 75.24 107.809 169.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 65.5 ttt-85 -72.68 114.96 11.39 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 107.928 -1.138 . . . . 61.32 107.928 177.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.497 HG11 ' SD ' ' A' ' 164' ' ' MET . 7.1 p -125.46 129.51 24.4 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 123.523 0.729 . . . . 61.33 109.154 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.488 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 97.8 Cg_endo -73.93 149.3 41.89 Favored 'Trans proline' 0 CA--C 1.552 1.413 0 C-N-CA 122.069 1.846 . . . . 74.53 111.949 177.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.572 ' HA3' ' HA ' ' A' ' 86' ' ' SER . . . 83.43 -25.51 4.98 Favored Glycine 0 N--CA 1.48 1.602 0 N-CA-C 116.244 1.258 . . . . 70.43 116.244 169.156 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.584 ' HG2' HH12 ' A' ' 143' ' ' ARG . 66.5 mtp -75.0 -23.67 58.28 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 117.679 0.74 . . . . 64.15 111.763 -178.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.472 ' HA2' HD13 ' A' ' 174' ' ' LEU . . . -82.37 -103.21 0.44 Allowed Glycine 0 C--N 1.35 1.35 0 CA-C-O 119.747 -0.474 . . . . 73.33 113.255 -175.192 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.433 ' HA3' ' H ' ' A' ' 117' ' ' ARG . . . -54.99 115.61 5.8 Favored Glycine 0 C--O 1.278 2.861 0 O-C-N 124.005 0.473 . . . . 74.5 113.422 173.034 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -56.85 103.45 0.11 Allowed 'General case' 0 C--N 1.355 0.812 0 O-C-N 127.59 2.582 . . . . 75.42 109.088 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.473 ' HA2' ' HA2' ' A' ' 107' ' ' GLY . . . -176.85 139.12 4.29 Favored Glycine 0 N--CA 1.436 -1.32 0 CA-C-N 113.347 -1.751 . . . . 64.21 108.943 -170.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ASN . . . . . 0.512 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . 11.5 t-20 -73.55 -49.46 6.49 Favored Pre-proline 0 CA--C 1.559 1.294 0 N-CA-C 109.04 -0.726 . . . . 63.11 109.04 -173.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.512 ' HD3' ' HB3' ' A' ' 169' ' ' ASN . 28.2 Cg_exo -68.58 146.3 67.08 Favored 'Trans proline' 0 C--N 1.379 2.132 0 N-CA-C 107.991 -1.58 . . . . 71.13 107.991 156.355 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.608 ' HB3' ' HA2' ' A' ' 87' ' ' GLY . 56.4 Cg_endo -64.17 120.99 8.49 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.878 2.385 . . . . 71.25 116.312 -161.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -62.93 -43.0 99.56 Favored Glycine 0 C--N 1.374 2.681 0 C-N-CA 119.169 -1.491 . . . . 72.4 111.927 161.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.488 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 14.1 m-20 95.31 147.74 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 127.396 2.279 . . . . 71.14 108.563 175.35 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.547 HD11 ' HB2' ' A' ' 121' ' ' ALA . 27.9 tp -140.17 143.94 36.38 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.09 0.471 . . . . 64.32 111.162 -171.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 54.0 mt -108.95 90.57 3.33 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 114.746 -1.115 . . . . 72.12 108.254 170.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.531 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 78.7 mt -69.37 87.43 0.44 Allowed 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 109.335 -0.617 . . . . 70.05 109.335 174.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.492 HG22 HG22 ' A' ' 158' ' ' VAL . 11.9 t -84.31 104.67 12.86 Favored 'Isoleucine or valine' 0 C--O 1.245 0.827 0 N-CA-C 106.182 -1.784 . . . . 61.43 106.182 174.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.525 HG11 HG22 ' A' ' 153' ' ' VAL . 9.9 p -67.51 125.67 25.55 Favored 'Isoleucine or valine' 0 C--N 1.349 0.566 0 CA-C-O 121.961 0.886 . . . . 70.33 109.381 -175.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.552 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 28.6 mmt180 -111.94 119.18 37.63 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 107.54 -1.281 . . . . 53.32 107.54 179.285 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.438 HD23 ' HB3' ' A' ' 125' ' ' LEU . 56.7 mt -83.38 144.02 29.92 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-N 118.348 0.522 . . . . 72.4 110.014 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 41.6 mt -54.22 153.54 9.41 Favored Pre-proline 0 N--CA 1.488 1.447 0 C-N-CA 123.898 0.879 . . . . 73.14 112.808 -169.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.93 16.79 0.41 Allowed 'Trans proline' 0 C--N 1.387 2.557 0 C-N-CA 122.97 2.447 . . . . 71.42 113.329 175.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -60.91 101.9 0.28 Allowed Pre-proline 0 CA--C 1.557 1.247 0 N-CA-C 107.213 -1.403 . . . . 73.35 107.213 164.277 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -78.55 25.87 0.53 Allowed 'Trans proline' 0 C--N 1.375 1.932 0 C-N-CA 124.066 3.177 . . . . 61.24 115.478 -161.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 82.3 t -96.88 -32.27 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 109.946 -0.39 . . . . 64.21 109.946 -176.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' PHE . . . . . 0.771 ' HE1' ' HA ' ' A' ' 214' ' ' THR . 35.3 m-85 -145.9 98.87 3.18 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 121.279 0.561 . . . . 72.31 111.935 178.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.625 ' HB3' ' HB2' ' A' ' 194' ' ' TYR . 52.3 ttt180 -85.93 81.63 8.45 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 107.863 -1.162 . . . . 75.51 107.863 164.333 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.453 ' HB2' HD23 ' A' ' 193' ' ' LEU . 35.5 tp -78.1 94.52 4.7 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-N 115.228 -0.896 . . . . 74.21 108.671 175.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -114.26 129.98 56.64 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.185 0.594 . . . . 70.31 109.753 -176.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 77.11 -73.89 1.92 Allowed Glycine 0 C--N 1.351 1.389 0 O-C-N 123.85 0.719 . . . . 65.41 111.98 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.797 ' HA ' ' HD2' ' A' ' 154' ' ' ARG . 13.6 pt20 -154.78 -7.23 0.14 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.655 0.782 . . . . 72.32 111.173 172.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -123.05 152.87 40.57 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.472 -0.785 . . . . 72.32 110.671 -167.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.453 HD23 ' HB2' ' A' ' 188' ' ' LEU . 38.8 mt -95.33 152.52 18.31 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 114.642 -1.163 . . . . 63.44 111.032 -168.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.625 ' HB2' ' HB3' ' A' ' 187' ' ' ARG . 91.8 m-85 -132.61 103.93 6.39 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 107.633 -1.247 . . . . 73.14 107.633 171.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.464 ' HB3' HD23 ' A' ' 251' ' ' LEU . . . -129.9 112.6 13.7 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.472 1.109 . . . . 74.34 110.008 -172.126 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 86.0 m -68.72 122.56 18.81 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-O 120.944 0.402 . . . . 70.21 111.187 -179.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.496 HD22 HD13 ' A' ' 251' ' ' LEU . 44.7 tp -108.97 119.54 39.86 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.861 0.865 . . . . 72.21 110.337 -173.027 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -80.02 116.96 20.44 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 108.296 -1.001 . . . . 61.43 108.296 174.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 2.8 p -144.23 127.66 8.82 Favored Pre-proline 0 N--CA 1.478 0.951 0 C-N-CA 123.335 0.654 . . . . 64.4 110.282 -175.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.408 ' HA ' ' O ' ' A' ' 256' ' ' THR . 55.5 Cg_endo -72.8 150.87 50.59 Favored 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 121.868 1.712 . . . . 64.51 111.88 176.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -42.24 -60.23 2.23 Favored Pre-proline 0 N--CA 1.487 1.406 0 N-CA-C 116.485 2.032 . . . . 71.34 116.485 -173.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -75.07 -18.96 18.15 Favored 'Trans proline' 0 C--N 1.382 2.339 0 CA-C-N 121.524 1.58 . . . . 63.54 113.081 -173.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 16.4 mt -73.37 -34.73 44.21 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 N-CA-C 109.257 -0.646 . . . . 64.32 109.257 172.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.54 -42.87 81.99 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 123.094 0.558 . . . . 71.51 111.482 173.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 71.6 t -72.96 -44.45 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 123.59 0.756 . . . . 63.23 112.513 -174.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 78.7 t -88.76 -37.08 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 122.759 0.424 . . . . 74.41 110.933 -176.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 98.53 77.55 1.33 Allowed Glycine 0 C--N 1.339 0.713 0 N-CA-C 111.651 -0.58 . . . . 72.35 111.651 -176.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -103.44 -144.35 13.73 Favored Glycine 0 C--N 1.34 0.763 0 CA-C-N 115.255 -0.472 . . . . 55.24 112.042 178.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.537 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 43.1 mtmt -127.55 147.03 50.33 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 122.863 0.465 . . . . 45.21 110.614 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 24.8 m -137.14 -177.07 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.634 1.174 . . . . 63.11 108.861 170.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 26.2 ttm180 -116.62 129.24 56.04 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.609 0.763 . . . . 71.41 108.998 171.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -109.03 149.37 29.36 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.444 -0.947 . . . . 62.04 108.444 173.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -88.78 145.95 25.3 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.059 -0.719 . . . . 71.23 109.059 174.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' THR . . . . . 0.771 ' HA ' ' HE1' ' A' ' 186' ' ' PHE . 41.0 p -127.94 174.27 9.32 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 123.914 0.886 . . . . 74.1 109.635 172.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.601 HD22 ' HB3' ' A' ' 127' ' ' LEU . 24.6 mt -59.19 -36.56 75.56 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.001 0.92 . . . . 63.31 110.889 -176.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.423 ' HA ' ' NZ ' ' B' ' 2' ' ' LYS . 15.1 mm-40 -98.87 2.07 46.32 Favored 'General case' 0 CA--C 1.554 1.127 0 CA-C-N 114.714 -1.13 . . . . 64.44 112.539 -172.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 140.8 -173.53 23.12 Favored Glycine 0 N--CA 1.483 1.77 0 CA-C-O 119.253 -0.748 . . . . 33.0 112.785 176.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -79.28 155.67 25.41 Favored 'Trans proline' 0 C--N 1.369 1.643 0 C-N-CA 122.644 2.229 . . . . 70.23 111.8 176.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 18.4 m -148.26 157.08 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 C-N-CA 123.888 0.875 . . . . 73.4 111.066 -177.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -91.24 124.93 35.82 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.951 0.9 . . . . 75.04 109.809 178.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 97.1 t -136.13 123.3 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.22 1.008 . . . . 74.13 109.163 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.537 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -89.98 133.68 34.66 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 118.163 0.438 . . . . 60.25 111.207 178.135 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.562 ' HA ' HD12 ' B' ' 441' ' ' ILE . 44.5 t -78.61 145.42 67.17 Favored Pre-proline 0 CA--C 1.561 1.384 0 C-N-CA 125.571 1.548 . . . . 63.14 110.051 -178.28 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -78.93 172.12 15.45 Favored 'Trans proline' 0 C--N 1.386 2.509 0 C-N-CA 122.767 2.312 . . . . 75.51 111.51 172.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.42 150.74 28.73 Favored 'Trans proline' 0 C--N 1.373 1.829 0 C-N-CA 121.87 1.713 . . . . 72.53 113.274 175.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' ARG . . . . . 0.49 HH12 ' HB2' ' C' ' 261' ' ' LEU . 85.9 mtt-85 64.16 30.04 13.81 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 125.851 1.661 . . . . 74.04 111.477 172.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.578 HG23 HD21 ' A' ' 233' ' ' LEU . 43.7 m -66.15 106.27 1.6 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.516 1.526 . . . . 64.32 111.291 178.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 228' ' ' GLN . . . . . 0.442 ' HB3' ' HD2' ' A' ' 231' ' ' ARG . 6.4 tp-100 -93.16 140.39 29.57 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.021 0.928 . . . . 75.32 110.657 -176.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 229' ' ' ALA . . . . . 0.454 ' HA ' ' HB ' ' A' ' 253' ' ' VAL . . . -66.07 157.59 30.68 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.849 0.86 . . . . 62.31 111.782 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 82.96 -40.19 2.79 Favored Glycine 0 C--N 1.347 1.179 0 CA-C-N 116.189 -0.459 . . . . 73.32 112.043 -177.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.442 ' HD2' ' HB3' ' A' ' 228' ' ' GLN . 92.6 mtt180 -66.4 157.67 31.3 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 124.147 0.979 . . . . 74.0 111.437 175.408 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.752 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 3.3 mptp? -109.94 125.59 53.01 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 114.856 -1.065 . . . . 72.22 108.418 177.13 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.578 HD21 HG23 ' A' ' 227' ' ' THR . 87.4 mt -76.14 104.82 6.85 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.883 -0.784 . . . . 71.4 108.883 177.065 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 18.4 ttp180 -84.95 109.6 18.27 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.27 0.628 . . . . 64.14 110.324 178.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.59 HD22 HG23 ' B' ' 441' ' ' ILE . 0.4 OUTLIER -120.57 117.1 26.73 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.972 0.909 . . . . 61.12 109.75 175.127 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 30.8 mmtm -60.69 151.08 30.18 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.916 1.286 . . . . 64.43 113.277 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 71.23 32.21 65.63 Favored Glycine 0 C--N 1.356 1.656 0 CA-C-N 114.682 -1.145 . . . . 74.2 113.604 172.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.485 ' HG3' HD12 ' A' ' 235' ' ' LEU . 41.8 mmtm -130.32 -30.31 1.94 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.524 0.73 . . . . 73.01 110.565 -174.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -73.04 173.87 47.64 Favored Glycine 0 C--N 1.351 1.396 0 O-C-N 123.301 0.376 . . . . 74.43 112.451 171.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' PHE . . . . . 0.565 ' HD2' ' HA2' ' A' ' 152' ' ' GLY . 5.7 m-85 -91.78 158.15 40.51 Favored Pre-proline 0 N--CA 1.48 1.044 0 C-N-CA 123.204 0.602 . . . . 73.13 110.85 -169.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -61.09 111.05 0.97 Allowed 'Trans proline' 0 C--N 1.387 2.558 0 C-N-CA 123.054 2.503 . . . . 73.33 112.158 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -125.31 -150.34 7.73 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-O 119.337 -0.702 . . . . 73.52 112.212 179.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' PRO . . . . . 0.435 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 32.6 Cg_endo -63.33 -30.77 73.48 Favored 'Trans proline' 0 C--N 1.373 1.848 0 C-N-CA 122.895 2.397 . . . . 70.45 113.07 -177.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.432 ' HB3' HE22 ' A' ' 191' ' ' GLN . . . -107.28 12.7 27.93 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.867 0.867 . . . . 70.11 111.4 178.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 87.66 -161.61 32.37 Favored Glycine 0 C--N 1.345 1.053 0 CA-C-N 116.327 -0.397 . . . . 62.24 112.158 -174.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 66.4 mtt85 -59.46 108.83 0.77 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.337 0.655 . . . . 75.41 110.676 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -70.5 -157.39 2.11 Favored Glycine 0 C--N 1.347 1.142 0 CA-C-N 115.605 -0.725 . . . . 42.24 113.758 -178.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -100.48 166.28 11.01 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.924 0.869 . . . . 75.44 110.641 178.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.441 ' HB3' ' HG ' ' A' ' 235' ' ' LEU . 14.5 tp -102.64 128.36 49.36 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 106.284 -1.746 . . . . 70.31 106.284 164.357 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.752 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 18.6 m-85 -108.77 105.1 14.54 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 107.609 -1.256 . . . . 52.51 107.609 173.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.534 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 40.1 mt -90.7 103.93 16.57 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 109.245 -0.65 . . . . 72.24 109.245 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.498 ' HG2' ' HG3' ' A' ' 232' ' ' LYS . 22.3 mt-10 -76.7 101.69 5.89 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.146 0.978 . . . . 75.41 108.758 -170.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.454 ' HB ' ' HA ' ' A' ' 229' ' ' ALA . 27.0 t -64.31 122.96 16.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-N 114.849 -1.068 . . . . 24.43 112.504 -167.417 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 254' ' ' ARG . . . . . 0.515 ' HD2' ' SD ' ' B' ' 26' ' ' MET . 5.7 mmt180 -122.42 96.29 4.98 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.423 1.089 . . . . 73.14 108.604 169.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.447 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 73.1 mt -72.94 117.09 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 114.171 -1.377 . . . . 74.34 109.57 178.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 256' ' ' THR . . . . . 0.408 ' O ' ' HA ' ' A' ' 200' ' ' PRO . 41.1 p -110.3 174.17 5.99 Favored 'General case' 0 C--O 1.255 1.348 0 C-N-CA 124.445 1.098 . . . . 73.43 110.092 178.374 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 26.1 pt -132.87 151.8 78.68 Favored Pre-proline 0 CA--C 1.554 1.135 0 CA-C-N 114.93 -1.032 . . . . 73.4 108.778 177.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -87.22 22.09 0.97 Allowed 'Trans proline' 0 C--N 1.365 1.429 0 C-N-CA 122.725 2.283 . . . . 74.45 112.962 -171.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 33.83 -87.89 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 125.303 1.441 . . . . 63.24 113.49 -165.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.47 132.52 47.14 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.775 0.83 . . . . 75.12 110.945 -170.21 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.535 HD11 HG11 ' C' ' 205' ' ' VAL . 86.0 mt -127.64 170.42 12.7 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.521 0.728 . . . . 55.32 111.094 -174.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 75.1 p -104.8 159.78 28.21 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-N 114.598 -1.183 . . . . 44.34 110.174 171.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_exo -32.7 -46.92 0.3 Allowed 'Trans proline' 0 C--N 1.383 2.346 0 C-N-CA 124.831 3.687 . . . . 74.33 116.044 172.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -57.62 -64.41 0.91 Allowed 'General case' 0 C--O 1.25 1.114 0 C-N-CA 123.987 0.915 . . . . 71.44 111.197 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -59.5 -48.3 82.17 Favored 'General case' 0 C--N 1.349 0.562 0 CA-C-N 114.54 -1.209 . . . . 64.2 110.2 -176.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 266' ' ' GLU . . . . . 0.536 ' O ' ' HG2' ' A' ' 270' ' ' LYS . 7.1 tp10 -53.03 -52.93 56.88 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 124.617 1.198 . . . . 73.45 111.099 -176.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -63.5 -45.19 91.84 Favored 'General case' 0 C--O 1.254 1.294 0 O-C-N 124.199 0.937 . . . . 64.12 111.94 -178.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 9.4 mp -63.38 -34.09 76.97 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-N 115.826 -0.624 . . . . 73.14 111.358 178.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 269' ' ' TRP . . . . . 0.44 ' O ' HG11 ' C' ' 206' ' ' VAL . 61.7 m95 -75.97 -30.51 58.63 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 118.677 -0.677 . . . . 75.0 111.349 177.149 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 270' ' ' LYS . . . . . 0.536 ' HG2' ' O ' ' A' ' 266' ' ' GLU . 0.0 OUTLIER -57.37 -60.73 3.2 Favored 'General case' 0 C--O 1.267 2.005 0 N-CA-C 108.214 -1.032 . . . . 62.43 108.214 175.103 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? -55.67 -50.24 70.78 Favored 'General case' 0 C--N 1.357 0.928 0 CA-C-N 112.002 -2.363 . . . . 70.22 110.66 -178.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 272' ' ' LEU . . . . . 0.407 HD12 HD12 ' C' ' 272' ' ' LEU . 2.1 tt -58.1 -58.93 6.28 Favored 'General case' 0 C--O 1.191 -2.026 0 O-C-N 124.298 0.999 . . . . 63.4 108.992 -177.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 273' ' ' ALA . . . . . 0.472 ' O ' ' HB3' ' A' ' 276' ' ' TYR . . . -56.21 -48.77 75.77 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 114.236 1.199 . . . . 64.51 114.236 -170.007 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -89.21 -21.85 23.06 Favored 'General case' 0 C--O 1.252 1.189 0 N-CA-C 112.68 0.622 . . . . 74.35 112.68 -172.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -80.47 -26.24 38.4 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.988 -0.445 . . . . 71.44 110.697 168.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 276' ' ' TYR . . . . . 0.472 ' HB3' ' O ' ' A' ' 273' ' ' ALA . 2.2 t80 -58.92 -55.81 30.28 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 125.79 1.636 . . . . 75.02 107.797 170.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -44.91 -66.1 0.44 Allowed 'General case' 0 C--O 1.249 1.077 0 O-C-N 125.538 1.774 . . . . 70.12 109.431 173.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -62.82 -14.24 43.11 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 114.76 -1.109 . . . . 75.41 113.841 -175.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 86.7 mtm180 -132.17 34.16 3.82 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 122.927 0.491 . . . . 74.13 110.228 -175.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.568 1.673 0 O-C-N 124.261 0.976 . . . . 72.21 113.134 175.712 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.443 ' SD ' ' N ' ' B' ' 1' ' ' MET . 1.6 mpt? . . . . . 0 N--CA 1.48 1.073 0 N-CA-C 110.338 -0.245 . . . . 71.44 110.338 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.423 ' NZ ' ' HA ' ' A' ' 216' ' ' GLU . 13.3 mptt -75.16 116.93 16.43 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.668 0.787 . . . . 54.1 110.788 178.085 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -168.58 -38.15 0.02 OUTLIER 'General case' 0 C--O 1.242 0.701 0 C-N-CA 124.361 1.064 . . . . 74.04 109.358 174.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 23.3 t 65.39 -177.59 0.18 Allowed 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.567 1.147 . . . . 52.14 111.027 -179.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 94.6 m 68.69 131.76 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.561 1.144 . . . . 70.11 112.182 177.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 138' ' ' VAL . 42.8 pt -140.5 173.44 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.584 0.754 . . . . 64.44 110.565 -175.111 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -132.82 129.83 39.03 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.544 0.738 . . . . 72.01 110.269 177.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.572 HD23 HG11 ' A' ' 140' ' ' VAL . 50.1 tp -78.51 155.56 29.72 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.036 0.934 . . . . 75.22 110.97 -174.269 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.31 -68.31 0.69 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 122.932 0.493 . . . . 62.4 111.437 176.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 10' ' ' LEU . . . . . 0.499 HD23 ' HB2' ' A' ' 121' ' ' ALA . 51.7 mt 68.32 2.98 3.51 Favored 'General case' 0 N--CA 1.501 2.094 0 C-N-CA 124.871 1.269 . . . . 74.1 111.844 -164.025 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 56.7 mt 55.36 71.07 1.35 Allowed Pre-proline 0 CA--C 1.555 1.169 0 C-N-CA 124.564 1.146 . . . . 45.35 112.137 -175.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -98.66 -145.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 123.922 3.082 . . . . 61.33 111.053 173.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 76.1 mt -59.84 -38.85 83.25 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.444 0.698 . . . . 75.01 111.478 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 3.2 pp -139.55 151.6 46.21 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.561 0.744 . . . . 64.54 110.349 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -144.78 176.51 9.39 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.263 0.625 . . . . 60.01 110.566 -178.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 6.2 t -71.55 135.22 83.91 Favored Pre-proline 0 CA--C 1.556 1.199 0 C-N-CA 123.934 0.894 . . . . 51.11 110.841 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.63 85.55 1.29 Allowed 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 122.167 1.911 . . . . 62.42 112.141 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.533 HG11 ' HD2' ' A' ' 179' ' ' ARG . 35.7 t -80.0 86.13 1.34 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.605 0 N-CA-C 108.607 -0.886 . . . . 61.41 108.607 177.316 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 19' ' ' THR . . . . . 0.452 HG22 ' HD3' ' B' ' 117' ' ' LYS . 1.1 m -85.0 -27.16 26.62 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.405 -0.816 . . . . 71.22 110.587 -175.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 59.5 mttm 67.08 -79.51 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.665 1.186 . . . . 62.34 111.334 -174.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -101.65 75.2 1.56 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.516 0.727 . . . . 75.34 111.683 -169.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 -137.29 118.24 14.26 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 107.786 -1.19 . . . . 73.31 107.786 161.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 23' ' ' THR . . . . . . . . . . . . . 19.7 p -135.2 61.87 48.02 Favored Pre-proline 0 CA--C 1.555 1.139 0 C-N-CA 123.689 0.796 . . . . 72.45 110.12 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -89.92 24.82 0.61 Allowed 'Trans proline' 0 C--N 1.382 2.303 0 C-N-CA 122.809 2.339 . . . . 74.55 112.329 -177.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -84.19 71.83 10.57 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.992 0.917 . . . . 74.53 109.287 -175.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 26' ' ' MET . . . . . 0.515 ' SD ' ' HD2' ' A' ' 254' ' ' ARG . 59.1 mtm -128.41 157.56 74.31 Favored Pre-proline 0 CA--C 1.549 0.93 0 CA-C-N 114.792 -1.094 . . . . 75.13 108.511 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -74.69 65.31 5.77 Favored 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 122.739 2.292 . . . . 71.1 115.418 -173.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.414 HG11 ' HB2' ' B' ' 31' ' ' ASN . 54.4 t 70.43 -49.52 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 C-N-CA 126.504 1.922 . . . . 73.51 114.599 169.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.561 HD12 ' HB3' ' C' ' 228' ' ' GLN . 1.9 mm? 74.31 -64.42 0.39 Allowed 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 125.816 1.646 . . . . 62.2 112.213 170.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -56.59 -65.38 0.62 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.238 0.615 . . . . 70.24 110.383 176.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 31' ' ' ASN . . . . . 0.414 ' HB2' HG11 ' B' ' 28' ' ' VAL . 12.3 m120 -80.95 8.49 8.27 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 112.032 0.382 . . . . 74.34 112.032 -179.273 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 15.9 ttt85 -77.28 -26.07 52.04 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 109.466 -0.568 . . . . 72.22 109.466 170.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -125.7 -86.2 0.62 Allowed 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 123.606 0.763 . . . . 73.31 109.381 168.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . 61.67 11.28 3.84 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 124.562 1.145 . . . . 53.33 113.848 176.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -142.71 144.13 32.57 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 122.825 0.45 . . . . 73.13 110.475 -168.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.78 98.19 0.12 Allowed Glycine 0 C--N 1.341 0.814 0 N-CA-C 109.669 -1.372 . . . . 74.33 109.669 176.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 12.7 t70 62.67 -175.26 0.14 Allowed 'General case' 0 CA--C 1.565 1.551 0 C-N-CA 124.431 1.092 . . . . 61.44 111.21 176.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 36.8 pt -92.72 -12.49 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.575 -0.703 . . . . 75.44 110.692 170.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 39' ' ' THR . . . . . 0.463 ' O ' ' HB2' ' B' ' 155' ' ' LEU . 76.1 p 56.38 -71.09 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 126.795 2.038 . . . . 64.25 113.216 -172.324 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . 69.05 160.29 0.15 Allowed Pre-proline 0 N--CA 1.491 1.593 0 C-N-CA 124.271 1.028 . . . . 64.0 112.234 177.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.66 138.69 35.48 Favored 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 122.188 1.925 . . . . 72.44 112.484 173.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.1 -80.68 0.06 OUTLIER Glycine 0 C--N 1.347 1.14 0 N-CA-C 111.931 -0.468 . . . . 45.24 111.931 177.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 43' ' ' GLY . . . . . 0.637 ' HA2' ' HB2' ' B' ' 159' ' ' LYS . . . -170.88 -170.61 35.29 Favored Glycine 0 C--N 1.343 0.97 0 O-C-N 123.372 0.101 . . . . 42.15 113.075 -176.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 44' ' ' ALA . . . . . 0.614 ' HA ' HG12 ' B' ' 154' ' ' ILE . . . -141.54 -171.0 3.22 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.59 0.756 . . . . 63.2 110.773 -176.14 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -68.86 85.49 0.33 Allowed 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 108.958 -0.756 . . . . 74.21 108.958 173.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 46' ' ' ARG . . . . . 0.433 ' O ' ' HA ' ' B' ' 149' ' ' LYS . 30.6 ttm-85 -57.6 100.5 0.05 Allowed 'General case' 0 C--N 1.359 1.005 0 C-N-CA 124.235 1.014 . . . . 75.02 110.512 -176.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.57 HD12 ' HG3' ' B' ' 148' ' ' GLU . 86.6 mt 52.64 32.23 11.49 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.004 0.922 . . . . 53.22 111.702 177.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 42.5 m -118.24 86.43 2.53 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 115.08 -0.963 . . . . 51.22 108.596 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -62.51 -54.18 36.05 Favored Glycine 0 C--N 1.349 1.294 0 N-CA-C 110.274 -1.13 . . . . 74.15 110.274 172.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -165.97 104.12 0.67 Allowed 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 106.752 -1.573 . . . . 64.2 106.752 162.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 73.03 -67.22 0.28 Allowed 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 125.748 1.619 . . . . 75.3 110.211 -163.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 49.1 p -106.32 163.25 12.98 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.854 0.862 . . . . 73.31 110.272 177.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.07 113.3 2.76 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 108.775 -0.824 . . . . 73.24 108.775 169.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.412 ' HB3' ' HE2' ' B' ' 138' ' ' TYR . . . 58.75 -156.94 0.32 Allowed 'General case' 0 N--CA 1.485 1.309 0 O-C-N 124.123 0.889 . . . . 75.51 110.612 -171.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.424 ' HB3' ' HG2' ' B' ' 235' ' ' GLU . 63.0 tp -156.4 -76.64 0.09 Allowed 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.134 -0.691 . . . . 72.35 109.134 173.085 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 56' ' ' ARG . . . . . 0.524 ' NH1' ' HA ' ' B' ' 290' ' ' TRP . 48.4 ttp85 -168.2 106.58 0.5 Allowed 'General case' 0 C--O 1.24 0.565 0 C-N-CA 124.122 0.969 . . . . 73.2 108.729 -173.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -49.08 -73.4 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 125.302 1.441 . . . . 75.31 112.288 -171.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 9.8 m 75.14 -36.59 0.32 Allowed 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 125.334 1.454 . . . . 62.01 114.2 169.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 51.4 tp -65.71 -34.36 78.02 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.474 1.109 . . . . 72.44 110.819 -176.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 60' ' ' SER . . . . . 0.507 ' HB3' ' HB3' ' B' ' 297' ' ' TYR . 8.0 m 73.57 -67.49 0.26 Allowed 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 125.644 1.578 . . . . 63.51 112.175 171.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 61' ' ' ASP . . . . . 0.442 ' HB2' ' H ' ' B' ' 298' ' ' HIS . 21.3 t70 -108.03 130.84 55.05 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.979 0.912 . . . . 71.45 110.077 -177.255 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 62' ' ' LYS . . . . . . . . . . . . . 8.8 mptt -126.64 77.29 73.87 Favored Pre-proline 0 N--CA 1.493 1.725 0 C-N-CA 123.623 0.769 . . . . 72.3 109.691 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -98.49 -0.09 1.18 Allowed 'Trans proline' 0 C--N 1.37 1.683 0 C-N-CA 123.103 2.536 . . . . 72.24 114.221 178.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 63.04 88.26 0.1 Allowed 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.506 1.122 . . . . 72.04 109.852 -166.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -85.4 22.95 1.41 Allowed 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.541 0.736 . . . . 65.32 111.888 -174.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -85.48 6.17 28.05 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.763 0.825 . . . . 72.41 111.214 -178.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 50.8 mm 74.42 -72.5 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 C-N-CA 125.885 1.674 . . . . 72.03 111.186 177.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 3.9 pt -122.25 125.92 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 123.61 0.764 . . . . 73.4 110.178 -176.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.45 ' HG ' ' HB3' ' B' ' 230' ' ' ALA . 2.8 mm? -112.68 -168.4 1.31 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.494 1.118 . . . . 73.12 109.431 -177.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 70' ' ' LEU . . . . . 0.441 ' HB2' ' O ' ' B' ' 121' ' ' VAL . 3.5 mm? 56.31 -146.67 0.55 Allowed 'General case' 0 CA--C 1.562 1.438 0 C-N-CA 124.115 0.966 . . . . 44.44 111.42 178.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 71' ' ' ILE . . . . . 0.653 HG21 ' HZ1' ' A' ' 232' ' ' LYS . 11.3 tp 58.03 111.2 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 C-N-CA 127.082 2.153 . . . . 74.32 113.192 176.203 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 115.9 -24.34 10.22 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-N 115.43 -0.805 . . . . 62.21 111.801 -175.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -57.07 142.96 40.39 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 124.247 1.019 . . . . 63.44 112.139 -175.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 129.14 -156.38 21.2 Favored Glycine 0 C--N 1.341 0.842 0 N-CA-C 110.781 -0.928 . . . . 64.42 110.781 -177.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 75' ' ' MET . . . . . 0.415 ' HE2' ' O ' ' B' ' 110' ' ' ALA . 19.7 ptm -154.37 132.94 12.08 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 122.967 0.507 . . . . 74.01 109.919 -177.001 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . -129.42 -92.69 0.68 Allowed Glycine 0 C--N 1.342 0.862 0 N-CA-C 110.582 -1.007 . . . . 71.13 110.582 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 77' ' ' ASP . . . . . 0.49 ' HB2' ' HB ' ' B' ' 80' ' ' ILE . 6.5 p-10 -71.05 169.63 14.56 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.301 0.64 . . . . 73.03 112.083 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 78' ' ' SER . . . . . 0.455 ' O ' ' HA2' ' B' ' 104' ' ' GLY . 21.4 m -118.88 93.74 4.2 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 108.095 -1.076 . . . . 51.1 108.095 172.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 66.53 3.47 2.9 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 125.343 1.457 . . . . 74.44 113.249 178.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.49 ' HB ' ' HB2' ' B' ' 77' ' ' ASP . 40.0 mm -75.58 -18.42 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 123.605 0.762 . . . . 72.52 111.058 -172.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 62.1 m -88.37 -64.24 1.18 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 122.854 0.462 . . . . 71.34 110.61 173.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -80.45 -67.04 0.81 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.484 0.714 . . . . 61.11 112.372 -167.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 83' ' ' ALA . . . . . 0.469 ' HB1' HD23 ' B' ' 102' ' ' LEU . . . -92.6 31.32 1.37 Allowed 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.966 0.906 . . . . 71.35 112.523 -165.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -86.87 13.85 8.26 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 113.739 1.014 . . . . 73.0 113.739 -168.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 85' ' ' ASN . . . . . 0.488 ' HA ' HD12 ' B' ' 385' ' ' LEU . 28.7 t-20 -162.46 -58.33 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 119.045 0.838 . . . . 72.23 111.359 -177.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -89.18 164.88 14.8 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.943 0.497 . . . . 63.12 111.312 -173.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 87' ' ' ALA . . . . . 0.719 ' HB2' ' H ' ' B' ' 100' ' ' LEU . . . -91.17 128.73 37.11 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 115.969 -0.56 . . . . 52.24 109.72 174.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -82.35 80.44 8.53 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 121.542 0.687 . . . . 74.14 110.447 -178.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 89' ' ' GLY . . . . . 0.511 ' H ' ' HG2' ' C' ' 279' ' ' ARG . . . 171.96 136.28 2.11 Favored Glycine 0 C--N 1.342 0.906 0 N-CA-C 109.83 -1.308 . . . . 54.33 109.83 175.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -53.58 -44.84 69.7 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.011 0.924 . . . . 62.33 111.401 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -118.36 31.19 5.71 Favored Glycine 0 C--N 1.342 0.908 0 CA-C-N 114.746 -1.116 . . . . 70.11 111.279 172.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -79.04 2.0 71.94 Favored Glycine 0 C--N 1.352 1.457 0 C-N-CA 123.127 0.394 . . . . 23.53 113.168 -175.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -92.65 155.22 17.88 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.179 1.392 . . . . 74.22 108.568 179.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 94' ' ' PHE . . . . . 0.823 ' HB2' ' HB2' ' B' ' 98' ' ' ASP . 25.1 m-85 -68.41 136.06 52.71 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 108.696 -0.853 . . . . 71.21 108.696 169.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 95' ' ' LYS . . . . . 0.427 ' N ' ' HD2' ' B' ' 95' ' ' LYS . 10.4 mptt -71.06 84.67 0.71 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.556 1.143 . . . . 74.14 112.0 -164.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 178.25 -59.34 0.09 OUTLIER Glycine 0 C--N 1.341 0.825 0 CA-C-N 114.181 -1.372 . . . . 72.31 109.953 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 16.2 tt -172.54 -26.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 C-N-CA 124.23 1.012 . . . . 72.22 110.103 175.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 98' ' ' ASP . . . . . 0.823 ' HB2' ' HB2' ' B' ' 94' ' ' PHE . 4.3 m-20 -56.61 112.58 1.32 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.017 1.327 . . . . 75.21 111.792 -169.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.92 159.99 31.15 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.041 0.448 . . . . 61.12 111.024 177.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 100' ' ' LEU . . . . . 0.719 ' H ' ' HB2' ' B' ' 87' ' ' ALA . 4.4 mm? -112.17 77.83 2.25 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 124.217 1.007 . . . . 74.2 108.69 169.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 101' ' ' PRO . . . . . 0.526 ' HB2' HD11 ' B' ' 385' ' ' LEU . 83.7 Cg_endo -81.3 107.78 1.9 Allowed 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 122.072 1.848 . . . . 72.21 110.699 -179.159 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 102' ' ' LEU . . . . . 0.469 HD23 ' HB1' ' B' ' 83' ' ' ALA . 3.0 mm? -56.05 -41.16 74.6 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 122.959 0.504 . . . . 73.12 110.158 -177.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 34.3 m 65.6 -70.09 0.1 Allowed 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 125.706 1.602 . . . . 75.52 112.089 173.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 104' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' B' ' 78' ' ' SER . . . -144.41 -29.54 0.1 Allowed Glycine 0 C--N 1.338 0.674 0 CA-C-N 114.904 -1.043 . . . . 51.35 111.719 174.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 40.09 -74.51 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 126.966 2.106 . . . . 75.22 114.312 -174.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 27.0 p90 -94.29 32.64 1.5 Allowed 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 124.167 0.987 . . . . 74.44 111.625 -178.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 63.1 m -66.97 116.72 8.11 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 122.129 -0.357 . . . . 63.32 110.89 178.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 42.3 p-80 -165.81 87.25 0.38 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.763 1.225 . . . . 71.44 108.052 170.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 67.1 t80 65.74 -84.54 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.622 1.169 . . . . 53.33 110.203 -175.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 110' ' ' ALA . . . . . 0.415 ' O ' ' HE2' ' B' ' 75' ' ' MET . . . 75.16 -54.74 0.65 Allowed 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 125.55 1.54 . . . . 71.24 114.179 171.234 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 1.7 pp -52.21 123.43 10.66 Favored 'General case' 0 CA--C 1.555 1.149 0 N-CA-C 114.042 1.127 . . . . 64.15 114.042 -172.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -129.11 89.42 2.86 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 107.577 -1.268 . . . . 73.2 107.577 172.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 113' ' ' LYS . . . . . 0.554 ' HA ' HG21 ' B' ' 224' ' ' VAL . 56.0 pttt -144.63 30.32 1.22 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 114.166 -1.379 . . . . 75.13 108.925 -176.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -54.8 -69.27 0.13 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 125.16 1.384 . . . . 74.01 110.876 -171.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 7.8 p -147.2 128.06 14.43 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 125.048 1.339 . . . . 73.23 107.451 173.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 177.39 153.91 11.54 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 110.974 -0.851 . . . . 55.33 110.974 -177.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 117' ' ' LYS . . . . . 0.452 ' HD3' HG22 ' B' ' 19' ' ' THR . 27.1 ttpp -162.45 127.45 2.1 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 123.021 0.528 . . . . 70.25 109.893 -178.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 118' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.57 -35.17 17.85 Favored 'Trans proline' 0 C--N 1.381 2.268 0 C-N-CA 122.658 2.239 . . . . 60.53 111.283 167.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 119' ' ' ASP . . . . . . . . . . . . . 27.3 t70 66.23 -81.07 0.03 OUTLIER 'General case' 0 C--N 1.361 1.089 0 C-N-CA 125.589 1.556 . . . . 75.33 111.676 177.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 120' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -59.27 -26.11 64.66 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.73 1.212 . . . . 70.1 112.746 -175.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 121' ' ' VAL . . . . . 0.441 ' O ' ' HB2' ' B' ' 70' ' ' LEU . 51.9 t 67.85 -72.7 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.365 1.269 0 C-N-CA 125.164 1.386 . . . . 74.32 110.881 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 16.5 m -45.9 -60.49 2.22 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.582 1.553 . . . . 75.24 113.067 -177.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 14.9 t0 57.64 -85.13 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 125.19 1.396 . . . . 64.3 110.043 -174.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 30.9 m 60.73 -177.46 0.11 Allowed 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 124.901 1.28 . . . . 43.31 113.4 172.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -170.31 110.29 0.39 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.699 0.8 . . . . 73.02 109.751 172.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -71.28 154.35 41.7 Favored 'General case' 0 C--O 1.246 0.895 0 O-C-N 123.879 0.737 . . . . 74.13 110.826 177.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 17.0 t 67.65 -174.22 0.19 Allowed 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 124.775 1.23 . . . . 70.01 111.586 177.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 128' ' ' ALA . . . . . 0.535 ' HA ' ' SD ' ' C' ' 213' ' ' MET . . . -147.32 152.61 38.52 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.806 0.842 . . . . 72.01 109.695 177.116 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 129' ' ' THR . . . . . 0.412 HG21 ' O ' ' C' ' 215' ' ' LEU . 33.9 m -76.77 85.34 3.38 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 122.915 0.486 . . . . 54.34 110.351 178.27 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . 54.92 -149.21 0.45 Allowed 'General case' 0 CA--C 1.561 1.37 0 C-N-CA 124.521 1.128 . . . . 44.22 112.483 171.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 23.5 m95 58.71 -114.86 0.77 Allowed 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 124.572 1.149 . . . . 73.51 110.841 176.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 49.9 m 51.18 19.45 0.72 Allowed 'General case' 0 C--N 1.372 1.549 0 C-N-CA 124.69 1.196 . . . . 51.4 112.509 -171.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 133' ' ' THR . . . . . 0.435 HG21 HG23 ' B' ' 137' ' ' THR . 68.0 p 48.98 18.45 0.21 Allowed 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 126.197 1.799 . . . . 62.25 113.836 -172.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 61.36 22.88 61.67 Favored Glycine 0 C--N 1.359 1.859 0 CA-C-O 119.342 -0.699 . . . . 55.15 114.022 -176.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 135' ' ' VAL . . . . . . . . . . . . . 89.2 t 74.92 -48.52 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 C-N-CA 125.687 1.595 . . . . 73.24 111.198 -174.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -76.37 91.2 3.25 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.43 1.092 . . . . 52.43 109.557 173.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 137' ' ' THR . . . . . 0.435 HG23 HG21 ' B' ' 133' ' ' THR . 16.6 m -83.04 117.27 22.71 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 123.926 0.89 . . . . 75.31 111.294 -169.44 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 138' ' ' TYR . . . . . 0.412 ' HE2' ' HB3' ' B' ' 54' ' ' ALA . 74.2 m-85 74.58 -47.76 0.64 Allowed 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 125.888 1.675 . . . . 75.52 112.92 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 7.0 t30 74.03 -56.19 0.65 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 125.267 1.427 . . . . 73.24 111.195 -177.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -60.25 -64.55 4.05 Favored Glycine 0 C--N 1.348 1.22 0 CA-C-O 119.678 -0.512 . . . . 65.04 112.14 172.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . 64.79 -64.91 0.15 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 125.735 1.614 . . . . 75.34 111.102 -175.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 7.3 mp -52.91 113.11 0.99 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.378 1.471 . . . . 70.15 110.862 173.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 149.31 132.84 2.13 Favored Glycine 0 C--N 1.336 0.542 0 N-CA-C 111.245 -0.742 . . . . 61.25 111.245 178.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 25.8 t 61.08 32.41 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.564 1.494 0 CA-C-O 122.515 1.15 . . . . 75.31 110.112 -178.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -63.48 -43.62 96.76 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 115.011 -0.995 . . . . 64.3 110.58 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 39.8 mm -73.81 118.93 20.05 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-N 115.247 -0.888 . . . . 72.52 108.785 175.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 60.48 -167.99 0.17 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.301 1.04 . . . . 72.43 113.796 176.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 148' ' ' GLU . . . . . 0.57 ' HG3' HD12 ' B' ' 47' ' ' LEU . 8.9 tp10 67.16 29.95 7.52 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 125.737 1.615 . . . . 73.05 110.404 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 149' ' ' LYS . . . . . 0.433 ' HA ' ' O ' ' B' ' 46' ' ' ARG . 8.3 pttm -158.08 -63.74 0.09 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 114.03 -1.441 . . . . 72.23 107.898 171.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 69.99 0.71 3.19 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 114.226 1.195 . . . . 74.11 114.226 164.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 54.6 p-80 43.21 66.33 4.63 Favored Pre-proline 0 N--CA 1.492 1.644 0 C-N-CA 124.794 1.237 . . . . 74.43 111.438 -168.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -90.36 29.0 0.4 Allowed 'Trans proline' 0 C--N 1.369 1.636 0 C-N-CA 122.86 2.373 . . . . 42.51 111.913 -164.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 1.6 m 54.23 -144.07 0.69 Allowed 'General case' 0 CA--C 1.569 1.678 0 C-N-CA 124.912 1.285 . . . . 74.2 109.236 -167.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 154' ' ' ILE . . . . . 0.614 HG12 ' HA ' ' B' ' 44' ' ' ALA . 0.0 OUTLIER -173.0 139.3 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 N-CA-C 107.746 -1.205 . . . . 74.25 107.746 -177.098 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 155' ' ' LEU . . . . . 0.463 ' HB2' ' O ' ' B' ' 39' ' ' THR . 1.4 pt? -145.28 -59.69 0.34 Allowed 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 122.646 0.378 . . . . 72.1 111.228 176.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 61.6 tt0 -81.24 168.15 18.79 Favored 'General case' 0 CA--C 1.561 1.379 0 C-N-CA 123.705 0.802 . . . . 72.23 111.238 -176.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 157' ' ' MET . . . . . 0.6 ' HG3' ' HG2' ' B' ' 241' ' ' GLU . 4.5 mpp? -45.02 -68.45 0.2 Allowed 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 125.524 1.529 . . . . 53.54 111.932 177.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 158' ' ' ALA . . . . . . . . . . . . . . . -156.29 14.96 0.32 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.969 0.908 . . . . 34.04 110.48 -178.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 159' ' ' LYS . . . . . 0.637 ' HB2' ' HA2' ' B' ' 43' ' ' GLY . 34.0 ttpt 64.52 -77.41 0.04 OUTLIER 'General case' 0 C--N 1.358 0.974 0 C-N-CA 125.074 1.349 . . . . 55.45 111.575 -173.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -163.43 35.39 0.09 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.536 1.134 . . . . 70.22 108.705 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -112.21 152.98 27.77 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.786 0.834 . . . . 71.1 110.097 178.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 84.04 -80.7 1.8 Allowed Glycine 0 C--N 1.347 1.177 0 CA-C-N 116.166 -0.47 . . . . 73.4 111.942 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 8.2 mp 60.75 -80.82 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 125.126 1.371 . . . . 65.02 111.793 -175.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 164' ' ' ALA . . . . . . . . . . . . . . . -69.84 -68.39 0.42 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.264 0.626 . . . . 75.34 111.214 -175.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 26.4 p -138.95 -70.18 0.42 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.417 0.687 . . . . 64.15 110.304 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . -178.86 71.29 0.07 OUTLIER Glycine 0 C--N 1.342 0.868 0 N-CA-C 110.459 -1.057 . . . . 71.15 110.459 -174.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 167' ' ' ASN . . . . . . . . . . . . . 61.7 t30 72.98 -61.92 0.49 Allowed 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 126.302 1.841 . . . . 72.31 111.221 -175.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 7.2 p -138.82 139.29 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.668 0.787 . . . . 74.13 110.304 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 14.3 m -85.33 71.4 10.83 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.868 0.867 . . . . 54.35 109.517 -177.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 35.9 m -70.81 86.08 0.68 Allowed 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 124.282 1.033 . . . . 63.1 110.846 -173.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -133.21 -31.78 1.23 Allowed 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.058 0.543 . . . . 53.32 112.134 -172.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 172' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -83.1 62.7 6.74 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-O 122.381 1.086 . . . . 73.22 110.608 -176.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 173' ' ' LEU . . . . . . . . . . . . . 5.4 mp -109.91 -25.46 10.28 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.569 1.148 . . . . 74.23 108.117 169.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 174' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -132.54 175.65 9.12 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 124.923 1.289 . . . . 74.45 109.189 -178.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 175' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -116.49 160.37 20.7 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.649 0.78 . . . . 74.1 109.972 173.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -118.45 144.2 46.15 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.926 -0.768 . . . . 74.11 108.926 173.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 57.7 m -138.87 103.32 7.53 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 123.689 0.795 . . . . 64.31 109.301 -178.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 178' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.93 -38.73 12.47 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.715 2.277 . . . . 74.53 111.447 175.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -166.98 -63.39 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 107.346 -1.353 . . . . 61.34 107.346 178.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 180' ' ' ALA . . . . . 0.532 ' HB1' HG13 ' C' ' 137' ' ' VAL . . . -145.77 -63.0 0.33 Allowed 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 105.292 -2.114 . . . . 74.4 105.292 169.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 181' ' ' LEU . . . . . 0.583 ' HB3' HG12 ' C' ' 138' ' ' VAL . 37.0 tp -148.37 -32.44 0.25 Allowed 'General case' 0 CA--C 1.553 1.087 0 CA-C-N 114.22 -1.355 . . . . 62.04 108.837 160.234 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 182' ' ' VAL . . . . . 0.662 HG12 HD13 ' C' ' 123' ' ' LEU . 32.6 m -118.6 -176.88 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 C-N-CA 124.53 1.132 . . . . 71.31 111.499 177.11 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 183' ' ' ALA . . . . . 0.517 ' HB2' ' HD2' ' C' ' 124' ' ' PRO . . . -112.21 -95.44 0.44 Allowed 'General case' 0 C--N 1.357 0.92 0 C-N-CA 123.976 0.91 . . . . 65.24 110.163 167.161 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 35.9 m80 -157.58 -171.19 3.47 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 123.689 0.796 . . . . 74.15 110.881 -170.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 185' ' ' VAL . . . . . 0.574 HG22 HD21 ' C' ' 119' ' ' LEU . 25.1 t -68.82 159.78 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 C-N-CA 124.761 1.224 . . . . 71.33 112.853 -171.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 6.7 t -149.6 -171.35 3.87 Favored 'General case' 0 CA--C 1.56 1.364 0 C-N-CA 125.776 1.63 . . . . 51.31 108.583 171.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 187' ' ' SER . . . . . 0.446 ' H ' ' HD2' ' B' ' 188' ' ' ARG . 55.6 m -137.41 12.82 3.01 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.271 0.628 . . . . 62.14 111.521 177.282 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 188' ' ' ARG . . . . . 0.446 ' HD2' ' H ' ' B' ' 187' ' ' SER . 1.8 mpt_? -117.9 153.58 33.32 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 122.688 0.395 . . . . 71.52 110.803 -172.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 189' ' ' LYS . . . . . 0.463 ' HE2' HG11 ' C' ' 177' ' ' VAL . 33.5 mtmm 70.47 125.64 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.487 1.515 . . . . 72.52 113.392 171.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 190' ' ' CYS . . . . . 0.525 ' HA ' HG11 ' C' ' 158' ' ' VAL . 26.0 p -147.98 103.74 3.51 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.301 1.04 . . . . 70.33 109.218 178.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -143.86 -172.29 3.72 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.643 1.577 . . . . 74.04 108.025 -176.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -152.4 65.18 0.35 Allowed Glycine 0 CA--C 1.536 1.386 0 CA-C-O 119.467 -0.63 . . . . 64.22 113.164 173.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 193' ' ' PRO . . . . . 0.572 ' HG2' ' HA ' ' C' ' 157' ' ' SER . 27.7 Cg_endo -98.42 83.84 0.06 OUTLIER 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 123.674 2.916 . . . . 64.32 111.943 175.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 194' ' ' SER . . . . . . . . . . . . . 45.8 t -102.97 146.97 27.53 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.735 0.814 . . . . 24.51 109.844 178.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 195' ' ' ALA . . . . . 0.411 ' HB1' ' HD3' ' C' ' 243' ' ' PRO . . . -150.42 136.64 18.67 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.417 0.687 . . . . 74.32 110.967 -177.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 8.4 m 71.14 160.82 0.22 Allowed 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 124.922 1.289 . . . . 73.32 112.254 175.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 18.7 m -116.47 -62.0 1.65 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.561 0.744 . . . . 75.11 109.74 176.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 198' ' ' GLU . . . . . 0.458 ' HG3' ' H ' ' B' ' 199' ' ' LYS . 6.7 pt-20 -166.23 -59.01 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.886 0.875 . . . . 51.12 110.116 -178.207 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 199' ' ' LYS . . . . . 0.458 ' H ' ' HG3' ' B' ' 198' ' ' GLU . 75.0 mmtt -90.27 87.68 6.92 Favored 'General case' 0 C--N 1.345 0.374 0 C-N-CA 123.646 0.778 . . . . 74.4 109.105 -173.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 200' ' ' CYS . . . . . . . . . . . . . 46.2 t -159.93 79.4 2.59 Favored Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 114.824 -1.08 . . . . 73.31 108.49 175.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 201' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -64.01 -45.84 9.52 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 122.807 2.338 . . . . 71.34 112.576 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 78.65 52.48 5.05 Favored Glycine 0 C--N 1.346 1.131 0 N-CA-C 111.624 -0.591 . . . . 63.04 111.624 -174.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -70.23 -47.8 59.82 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.033 0.933 . . . . 71.33 110.934 -176.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -70.52 89.28 0.7 Allowed 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.868 -0.605 . . . . 74.01 109.635 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 205' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -102.27 118.41 36.81 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-N 115.703 -0.681 . . . . 51.03 109.609 -174.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -76.77 132.65 39.38 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.658 -0.701 . . . . 62.32 109.604 173.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -92.4 -23.94 19.03 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.892 0.877 . . . . 74.32 110.824 177.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 103.67 120.24 4.74 Favored Glycine 0 C--N 1.347 1.172 0 CA-C-N 115.816 -0.629 . . . . 71.52 112.352 175.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . -76.75 -5.53 83.82 Favored Glycine 0 C--N 1.351 1.385 0 CA-C-O 119.874 -0.404 . . . . 42.21 113.148 174.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt 57.53 -67.38 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 127.582 2.353 . . . . 74.51 114.935 171.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . -68.48 99.32 0.58 Allowed Glycine 0 C--N 1.348 1.237 0 CA-C-O 119.557 -0.58 . . . . 74.43 112.528 -178.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 25.9 t 83.02 -10.81 1.0 Allowed 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 126.228 1.811 . . . . 74.04 111.69 -175.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 2.8 mp -92.69 88.49 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 N-CA-C 107.444 -1.317 . . . . 64.4 107.444 176.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 34.2 p -139.24 80.51 1.78 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.74 0.816 . . . . 75.43 109.682 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 215' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -118.77 159.17 24.18 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 109.059 -0.719 . . . . 73.31 109.059 172.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 76.8 mm-40 67.69 116.57 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.09 1.356 . . . . 61.42 111.713 -175.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 217' ' ' LEU . . . . . 0.804 HD12 ' HG2' ' B' ' 221' ' ' ARG . 2.6 mm? 58.78 44.03 17.59 Favored 'General case' 0 C--N 1.36 1.048 0 C-N-CA 124.801 1.241 . . . . 75.4 109.874 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 10.2 tt -61.41 139.51 58.19 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 113.806 -1.543 . . . . 71.43 111.309 -174.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 60.7 26.01 15.78 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 124.836 1.254 . . . . 71.24 112.309 -173.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 220' ' ' ALA . . . . . 0.414 ' O ' ' HG3' ' B' ' 221' ' ' ARG . . . 74.5 -1.98 2.94 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 125.295 1.438 . . . . 61.1 113.177 175.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 221' ' ' ARG . . . . . 0.804 ' HG2' HD12 ' B' ' 217' ' ' LEU 0.251 0.0 OUTLIER 61.61 -21.59 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.337 0 C-N-CA 127.603 2.361 . . . . 73.55 116.734 175.973 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . 71.6 104.86 0.07 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 125.37 1.468 . . . . 42.52 112.521 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -103.14 158.23 16.45 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.036 0.935 . . . . 61.02 110.325 177.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 224' ' ' VAL . . . . . 0.554 HG21 ' HA ' ' B' ' 113' ' ' LYS . 10.7 p -167.15 9.67 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.54 0 C-N-CA 123.848 0.859 . . . . 74.2 110.539 178.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 37.1 p -122.63 146.48 47.41 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.273 0.629 . . . . 54.34 111.922 -169.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 63.64 -88.94 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.655 1.182 . . . . 74.43 113.19 169.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . 121.35 -155.57 16.43 Favored Glycine 0 N--CA 1.475 1.289 0 N-CA-C 110.875 -0.89 . . . . 51.31 110.875 -167.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . -172.61 51.51 0.17 Allowed Glycine 0 C--N 1.345 1.08 0 CA-C-N 117.569 0.685 . . . . 72.41 112.872 178.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . 65.45 -143.14 45.3 Favored Glycine 0 C--N 1.344 1.016 0 CA-C-O 119.901 -0.388 . . . . 70.24 113.818 172.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 230' ' ' ALA . . . . . 0.45 ' HB3' ' HG ' ' B' ' 69' ' ' LEU . . . 178.54 161.54 0.66 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.361 1.465 . . . . 70.23 109.406 172.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 231' ' ' LYS . . . . . 0.476 ' HE3' ' SD ' ' C' ' 213' ' ' MET . 4.0 mptp? -135.02 -153.86 0.54 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.135 0.974 . . . . 73.24 108.575 178.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 6.1 m -144.1 152.68 41.28 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 109.575 -0.528 . . . . 74.24 109.575 176.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 233' ' ' PHE . . . . . 0.44 ' HA ' ' H ' ' C' ' 211' ' ' ARG . 48.2 p90 -83.46 170.32 14.59 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 113.748 1.018 . . . . 70.41 113.748 -169.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 234' ' ' ALA . . . . . 0.591 ' HB3' ' HE ' ' C' ' 211' ' ' ARG . . . -166.07 -148.0 0.09 Allowed 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 125.353 1.461 . . . . 72.31 108.093 173.004 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 235' ' ' GLU . . . . . 0.424 ' HG2' ' HB3' ' B' ' 55' ' ' LEU . 0.0 OUTLIER -126.43 134.27 51.03 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.797 0.839 . . . . 54.41 111.136 -179.891 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 236' ' ' THR . . . . . 0.492 HG22 ' H ' ' B' ' 237' ' ' ALA . 3.5 m -156.18 177.73 11.1 Favored 'General case' 0 CA--C 1.564 1.489 0 C-N-CA 126.545 1.938 . . . . 73.34 107.188 176.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 237' ' ' ALA . . . . . 0.492 ' H ' HG22 ' B' ' 236' ' ' THR . . . -130.31 42.42 3.26 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 119.07 0.85 . . . . 71.12 111.873 -179.418 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 56.8 m -140.98 134.32 29.72 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 118.359 -0.829 . . . . 71.31 110.495 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -173.92 -174.48 0.94 Allowed 'General case' 0 C--N 1.377 1.782 0 N-CA-C 114.028 1.121 . . . . 74.42 114.028 174.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . -116.62 -138.21 6.19 Favored Glycine 0 C--N 1.362 2.004 0 C-N-CA 125.348 1.451 . . . . 71.23 110.902 175.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 241' ' ' GLU . . . . . 0.6 ' HG2' ' HG3' ' B' ' 157' ' ' MET . 11.6 pt-20 -156.65 177.05 11.92 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 117.452 0.626 . . . . 71.21 111.066 174.417 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 242' ' ' TRP . . . . . 0.474 ' CD2' ' HG ' ' C' ' 233' ' ' LEU . 0.0 OUTLIER -158.87 -39.46 0.06 Allowed 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.991 1.316 . . . . 70.32 108.944 179.483 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -126.36 -168.32 1.84 Allowed 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 107.484 -1.302 . . . . 74.22 107.484 162.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -71.87 91.42 0.51 Allowed Glycine 0 C--N 1.344 1.007 0 CA-C-N 116.611 -0.268 . . . . 63.11 112.529 171.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 245' ' ' LYS . . . . . 0.427 ' HE3' ' HB3' ' B' ' 241' ' ' GLU . 0.7 OUTLIER -80.55 51.08 1.4 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.525 1.13 . . . . 75.34 110.592 176.122 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 246' ' ' THR . . . . . 0.579 ' HA ' HG23 ' B' ' 154' ' ' ILE . 55.9 p -112.92 67.25 0.66 Allowed 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.053 -1.43 . . . . 71.02 110.062 -168.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 247' ' ' LEU . . . . . 0.434 HD13 ' N ' ' B' ' 248' ' ' ARG . 2.1 tm? -156.12 140.13 16.35 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.123 -0.695 . . . . 72.51 109.123 -176.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 248' ' ' ARG . . . . . 0.457 ' HD3' ' N ' ' B' ' 249' ' ' GLU . 1.1 tmt_? -159.94 143.34 14.07 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 107.767 -1.197 . . . . 75.15 107.767 169.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 249' ' ' GLU . . . . . 0.457 ' N ' ' HD3' ' B' ' 248' ' ' ARG . 0.3 OUTLIER -144.41 149.5 36.17 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 123.993 0.917 . . . . 71.33 109.437 -179.179 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -142.3 -38.55 0.37 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.947 0.899 . . . . 65.4 111.821 178.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 251' ' ' ALA . . . . . 0.438 ' HB3' ' HB3' ' B' ' 358' ' ' CYS . . . -160.83 54.9 0.31 Allowed 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 112.56 0.578 . . . . 61.03 112.56 -166.284 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 252' ' ' GLN . . . . . 0.527 ' HA ' ' HA ' ' B' ' 363' ' ' GLU . 33.0 tt0 -73.21 -50.54 21.89 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.705 0.802 . . . . 72.3 109.566 174.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -76.17 71.84 2.93 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 114.687 -1.142 . . . . 51.41 108.26 170.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 23.3 tpt180 -82.02 -5.97 58.78 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 114.49 -1.232 . . . . 72.51 110.649 -172.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -59.32 -60.89 7.99 Favored Glycine 0 C--N 1.356 1.646 0 O-C-N 123.511 0.507 . . . . 54.22 111.89 175.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 256' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 72.52 -44.73 0.6 Allowed 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 125.813 1.645 . . . . 52.52 113.115 177.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -63.42 95.44 0.1 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.493 0.717 . . . . 74.31 110.312 177.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 258' ' ' LEU . . . . . . . . . . . . . 31.5 tp -96.62 4.13 52.13 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.129 0.972 . . . . 75.13 109.96 176.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 81.12 -26.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 C-N-CA 126.684 1.994 . . . . 63.02 111.474 -176.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 260' ' ' SER . . . . . . . . . . . . . 14.1 m -68.73 120.61 14.97 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.261 1.024 . . . . 73.11 109.947 173.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 10.0 t70 71.14 -72.06 0.12 Allowed 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 125.068 1.347 . . . . 52.21 112.812 175.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 262' ' ' ALA . . . . . . . . . . . . . . . -60.39 -10.96 5.49 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 114.696 1.369 . . . . 43.43 114.696 -170.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -77.77 -21.29 51.96 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 112.54 0.571 . . . . 70.44 112.54 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 34.0 t -153.78 -51.0 0.1 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 122.665 0.386 . . . . 51.14 110.944 -173.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 265' ' ' LEU . . . . . . . . . . . . . 38.6 tp -72.82 -57.82 3.8 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.383 0.673 . . . . 64.12 111.048 -175.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 266' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 71.87 106.36 0.07 Allowed 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 124.948 1.299 . . . . 71.52 112.273 173.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 94.4 p 56.35 17.4 2.86 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 126.378 1.871 . . . . 73.13 113.774 177.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 46.6 t 56.56 -73.11 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 126.136 1.775 . . . . 74.44 113.425 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 269' ' ' THR . . . . . . . . . . . . . 10.7 m 58.4 52.39 7.25 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.381 1.072 . . . . 74.31 110.238 174.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 270' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -81.13 73.26 8.17 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 114.994 -1.003 . . . . 72.41 109.501 -175.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 271' ' ' ALA . . . . . . . . . . . . . . . 64.65 -70.62 0.08 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 125.38 1.472 . . . . 75.3 111.937 -175.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 272' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -127.28 -34.24 2.31 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.598 1.159 . . . . 54.14 109.864 173.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -66.53 112.97 4.38 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.216 1.006 . . . . 61.32 111.434 -175.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 62.16 104.58 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.75 1.22 . . . . 71.44 112.592 173.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 275' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -155.85 90.9 2.76 Favored Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 123.751 0.821 . . . . 71.33 109.66 175.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -49.47 -61.71 0.53 Allowed 'Trans proline' 0 C--N 1.387 2.589 0 C-N-CA 123.767 2.978 . . . . 62.35 112.714 176.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 277' ' ' LEU . . . . . . . . . . . . . 82.2 mt 50.6 93.1 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 125.192 1.397 . . . . 63.32 113.268 173.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 1.1 pp -80.96 2.91 24.8 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 113.331 0.863 . . . . 62.0 113.331 -171.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . -92.98 48.31 2.47 Favored Glycine 0 C--N 1.348 1.229 0 CA-C-O 120.024 -0.32 . . . . 75.43 113.29 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 4.8 tt 64.48 -88.94 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.083 1.353 . . . . 53.23 110.374 -177.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 63.57 -75.48 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.996 1.318 . . . . 75.31 112.718 -176.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . 63.33 -114.48 0.44 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.987 1.315 . . . . 65.41 111.303 -175.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -61.93 106.58 0.72 Allowed 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.64 0.776 . . . . 72.33 112.503 -169.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . 129.34 -48.43 0.97 Allowed Glycine 0 N--CA 1.47 0.959 0 N-CA-C 110.815 -0.914 . . . . 61.45 110.815 -175.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -100.63 12.29 37.71 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.549 0.74 . . . . 72.41 110.501 173.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 286' ' ' MET . . . . . 0.543 ' HB2' ' HE2' ' B' ' 350' ' ' LYS . 17.0 tpt -161.27 142.13 8.45 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 126.76 2.024 . . . . 64.1 105.795 178.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 287' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -42.98 -52.1 4.99 Favored 'Trans proline' 0 C--N 1.384 2.426 0 C-N-CA 123.532 2.821 . . . . 73.33 113.248 175.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 288' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -145.35 -100.33 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.215 0 C-N-CA 124.489 1.116 . . . . 74.32 108.415 170.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 289' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.58 -30.56 0.76 Allowed 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 106.762 -1.57 . . . . 72.14 106.762 169.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 290' ' ' TRP . . . . . 0.524 ' HA ' ' NH1' ' B' ' 56' ' ' ARG . 30.9 m-90 -67.03 167.74 11.3 Favored 'General case' 0 C--N 1.357 0.911 0 CA-C-N 115.289 -0.869 . . . . 75.34 110.889 164.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 291' ' ' LEU . . . . . 0.407 HD23 ' HB3' ' B' ' 290' ' ' TRP . 1.7 pt? -44.51 -32.33 1.38 Allowed 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 125.288 1.435 . . . . 64.34 113.354 172.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . 174.03 -156.0 22.76 Favored Glycine 0 C--N 1.344 0.991 0 N-CA-C 111.322 -0.711 . . . . 62.12 111.322 177.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.9 3.73 2.21 Favored 'Trans proline' 0 CA--C 1.557 1.626 0 C-N-CA 123.294 2.663 . . . . 51.12 113.913 172.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 294' ' ' LYS . . . . . 0.542 ' HA ' ' HE3' ' B' ' 334' ' ' LYS . 13.7 tmtt? -63.23 113.4 3.16 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.0 0.92 . . . . 41.23 110.721 176.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -126.44 18.59 7.52 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 124.161 0.985 . . . . 34.32 109.734 170.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 32.1 m -67.43 101.88 1.03 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.007 0.923 . . . . 65.42 112.339 -172.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 297' ' ' TYR . . . . . 0.507 ' HB3' ' HB3' ' B' ' 60' ' ' SER . 38.4 p90 -100.82 154.7 18.42 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.685 0.794 . . . . 64.12 108.988 165.346 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 298' ' ' HIS . . . . . 0.442 ' H ' ' HB2' ' B' ' 61' ' ' ASP . 67.2 t60 66.4 111.77 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.581 1.152 . . . . 71.5 109.768 -171.201 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . -58.88 110.96 2.93 Favored Glycine 0 C--N 1.347 1.15 0 CA-C-N 115.824 -0.626 . . . . 63.41 113.624 -178.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 24.5 p30 -70.49 -33.48 71.27 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.933 0.893 . . . . 72.23 111.975 -177.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 301' ' ' ILE . . . . . . . . . . . . . 15.2 tt -90.69 -19.77 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 C-N-CA 123.539 0.735 . . . . 72.24 110.67 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -71.64 -30.69 66.03 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.946 0.899 . . . . 63.41 110.408 177.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 303' ' ' LYS . . . . . 0.512 ' HA ' ' HE2' ' B' ' 303' ' ' LYS . 0.6 OUTLIER -64.24 -54.3 40.12 Favored Pre-proline 0 CA--C 1.562 1.437 0 CA-C-O 118.534 -0.746 . . . . 74.11 111.453 -177.892 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 304' ' ' PRO . . . . . 0.48 ' HA ' ' SG ' ' B' ' 308' ' ' CYS . 91.6 Cg_endo -79.77 165.94 21.91 Favored 'Trans proline' 0 C--N 1.38 2.2 0 CA-C-N 121.443 1.551 . . . . 75.12 111.304 166.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . 66.17 -75.52 0.05 Allowed 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.923 1.289 . . . . 42.33 112.993 177.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 41.3 t -57.88 -55.68 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.864 1.265 . . . . 72.33 111.711 -171.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 80.9 p -89.56 -4.42 57.88 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.58 0.352 . . . . 74.23 111.884 -179.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 308' ' ' CYS . . . . . 0.48 ' SG ' ' HA ' ' B' ' 304' ' ' PRO . 75.3 m -72.82 -31.86 65.11 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.252 0.548 . . . . 74.22 110.322 173.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 39.3 p -90.21 146.95 35.83 Favored Pre-proline 0 CA--C 1.554 1.104 0 CA-C-N 115.202 -0.908 . . . . 72.2 109.285 171.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.34 161.43 40.75 Favored 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 122.764 2.309 . . . . 63.14 112.865 -178.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 311' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -59.96 -39.14 67.23 Favored Pre-proline 0 N--CA 1.491 1.611 0 C-N-CA 123.596 0.758 . . . . 73.13 112.801 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 312' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -74.54 72.33 4.38 Favored 'Trans proline' 0 C--N 1.385 2.474 0 CA-C-N 121.079 1.421 . . . . 70.14 112.056 164.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 313' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -72.03 -45.07 62.24 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 108.426 -0.953 . . . . 75.13 108.426 170.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 314' ' ' ARG . . . . . . . . . . . . . 59.5 mtt85 65.29 -79.0 0.03 OUTLIER 'General case' 0 C--N 1.359 1.0 0 C-N-CA 125.717 1.607 . . . . 72.01 111.29 -178.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 315' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -161.75 -162.61 0.88 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.92 1.288 . . . . 72.12 108.343 -172.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 316' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 70.76 146.09 0.07 Allowed 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 124.434 1.094 . . . . 74.4 112.541 -178.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 61.2 m -142.35 144.98 33.43 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.488 -0.778 . . . . 75.41 109.609 177.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 318' ' ' VAL . . . . . . . . . . . . . 17.0 m -124.82 149.53 63.0 Favored Pre-proline 0 N--CA 1.478 0.945 0 C-N-CA 124.151 0.98 . . . . 73.13 109.168 176.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 319' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -65.67 153.39 78.37 Favored 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 122.209 1.939 . . . . 65.1 111.027 172.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 320' ' ' THR . . . . . . . . . . . . . 6.8 m 68.92 11.44 8.34 Favored 'General case' 0 CA--C 1.561 1.381 0 C-N-CA 123.941 0.897 . . . . 53.31 111.415 177.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 321' ' ' LEU . . . . . . . . . . . . . 52.4 tp -62.33 114.19 3.34 Favored 'General case' 0 C--N 1.359 0.998 0 N-CA-C 109.509 -0.552 . . . . 65.14 109.509 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 322' ' ' ALA . . . . . . . . . . . . . . . 75.39 -66.41 0.29 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.403 1.481 . . . . 64.54 111.34 -175.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 323' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 57.59 56.25 5.06 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 124.432 1.093 . . . . 74.02 109.689 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 324' ' ' MET . . . . . . . . . . . . . 55.7 ttp 77.12 -38.68 0.3 Allowed 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 125.513 1.525 . . . . 71.32 112.189 -176.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 325' ' ' THR . . . . . . . . . . . . . 3.0 m 63.37 20.13 12.08 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 125.03 1.332 . . . . 72.33 110.902 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 326' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 62.21 -174.54 0.14 Allowed 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.386 1.074 . . . . 72.01 111.718 -172.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? 68.34 156.68 0.13 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 124.931 1.293 . . . . 54.34 112.414 -178.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 328' ' ' ALA . . . . . 0.532 ' HB1' ' HA ' ' B' ' 332' ' ' LEU . . . 68.2 -73.08 0.09 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.461 1.505 . . . . 72.03 111.07 -171.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 329' ' ' ILE . . . . . . . . . . . . . 2.0 mp 66.86 125.19 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 C-N-CA 125.218 1.407 . . . . 73.5 111.575 -178.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 330' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 64.51 -74.0 0.05 Allowed 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 125.366 1.466 . . . . 63.42 112.598 168.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 331' ' ' LEU . . . . . 0.407 HD22 ' HA ' ' B' ' 335' ' ' ASN . 61.3 mt -57.36 -45.27 84.58 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.032 1.333 . . . . 63.34 111.285 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 332' ' ' LEU . . . . . 0.532 ' HA ' ' HB1' ' B' ' 328' ' ' ALA . 95.7 mt 59.97 -82.55 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.981 1.312 . . . . 74.41 111.853 179.022 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 333' ' ' SER . . . . . . . . . . . . . 37.9 t -92.31 58.38 3.22 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.86 0.864 . . . . 65.04 109.354 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 334' ' ' LYS . . . . . 0.542 ' HE3' ' HA ' ' B' ' 294' ' ' LYS . 23.9 ttmm 68.42 165.32 0.24 Allowed 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 124.647 1.179 . . . . 63.11 110.949 -175.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 335' ' ' ASN . . . . . 0.407 ' HA ' HD22 ' B' ' 331' ' ' LEU . 2.8 t-20 -67.44 96.15 0.49 Allowed 'General case' 0 C--N 1.355 0.819 0 N-CA-C 109.213 -0.662 . . . . 73.25 109.213 169.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -77.92 -58.15 3.42 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 114.642 -1.163 . . . . 61.02 109.447 176.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 337' ' ' LYS . . . . . . . . . . . . . 28.7 tptp 63.13 -72.87 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 125.378 1.471 . . . . 62.43 109.929 -171.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 338' ' ' GLY . . . . . . . . . . . . . . . -110.68 156.05 15.77 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 111.401 -0.68 . . . . 72.34 111.401 172.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 339' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 67.58 112.53 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 125.109 1.364 . . . . 74.33 112.369 177.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 340' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -56.02 97.39 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.921 1.289 . . . . 75.24 112.049 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 341' ' ' LEU . . . . . . . . . . . . . 7.1 mp 61.76 8.7 2.51 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 125.043 1.337 . . . . 75.34 112.721 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 342' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 61.42 146.87 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 125.889 1.675 . . . . 64.25 112.203 -174.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 343' ' ' VAL . . . . . 0.661 HG22 ' H ' ' B' ' 345' ' ' GLY . 9.9 p -137.86 147.63 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 O-C-N 121.771 -0.581 . . . . 64.24 110.222 -171.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -70.19 -14.62 62.71 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.197 0.599 . . . . 73.03 111.603 178.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 345' ' ' GLY . . . . . 0.661 ' H ' HG22 ' B' ' 343' ' ' VAL . . . -84.19 44.49 3.34 Favored Glycine 0 C--N 1.347 1.139 0 CA-C-N 116.472 -0.331 . . . . 62.31 113.618 174.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 346' ' ' ALA . . . . . . . . . . . . . . . -90.96 -13.36 33.57 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.747 0.819 . . . . 72.22 110.799 176.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 74.8 m -147.01 152.37 38.49 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.477 1.111 . . . . 72.21 109.185 173.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 35.0 mm -86.09 91.8 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 109.36 -0.608 . . . . 73.42 109.36 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 349' ' ' ASP . . . . . . . . . . . . . 15.2 t70 71.59 -66.32 0.3 Allowed 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 125.805 1.642 . . . . 71.13 111.042 178.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 350' ' ' LYS . . . . . 0.543 ' HE2' ' HB2' ' B' ' 286' ' ' MET . 25.0 tttp 76.98 -70.33 0.13 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 126.311 1.844 . . . . 74.52 110.562 171.207 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -174.02 -30.36 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.91 0.884 . . . . 71.32 109.499 177.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -78.83 66.56 4.33 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.917 0.887 . . . . 74.35 109.18 177.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 353' ' ' HIS . . . . . . . . . . . . . 10.2 t-80 164.85 -46.79 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 126.924 2.09 . . . . 74.33 108.176 176.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 354' ' ' ALA . . . . . . . . . . . . . . . 64.71 30.84 12.31 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.835 1.254 . . . . 70.11 112.94 170.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 355' ' ' ALA . . . . . . . . . . . . . . . -91.02 -1.28 57.83 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.37 0.668 . . . . 75.44 111.4 176.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 356' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -58.17 -42.73 96.52 Favored Pre-proline 0 CA--C 1.565 1.549 0 C-N-CA 123.826 0.85 . . . . 74.32 111.915 175.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 357' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -72.83 118.57 5.63 Favored 'Trans proline' 0 C--N 1.39 2.73 0 C-N-CA 121.987 1.791 . . . . 55.22 111.884 166.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 358' ' ' CYS . . . . . 0.438 ' HB3' ' HB3' ' B' ' 251' ' ' ALA . 26.4 p -78.26 138.4 38.6 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.58 0.752 . . . . 73.32 110.014 176.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 359' ' ' GLY . . . . . . . . . . . . . . . -138.54 67.18 0.52 Allowed Glycine 0 C--N 1.339 0.701 0 CA-C-O 119.8 -0.444 . . . . 62.01 112.294 -177.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 360' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 74.15 -61.77 0.48 Allowed 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 125.157 1.383 . . . . 53.34 113.15 170.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 361' ' ' ILE . . . . . . . . . . . . . 45.1 mm -59.45 129.04 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.588 1.155 . . . . 61.31 111.471 -175.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 362' ' ' GLY . . . . . 0.41 ' HA3' ' HA ' ' B' ' 249' ' ' GLU . . . 84.81 -55.18 4.98 Favored Glycine 0 C--N 1.343 0.93 0 CA-C-N 115.384 -0.826 . . . . 72.35 113.371 -173.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 363' ' ' GLU . . . . . 0.527 ' HA ' ' HA ' ' B' ' 252' ' ' GLN . 35.4 tt0 -59.05 -70.21 0.16 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 125.064 1.346 . . . . 73.13 112.893 -174.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 364' ' ' THR . . . . . 0.453 HG23 ' HG2' ' B' ' 363' ' ' GLU . 2.0 p -105.27 0.01 26.74 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.874 0.869 . . . . 74.04 112.815 -167.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 4.8 p -92.95 88.49 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 CA-C-O 121.7 0.762 . . . . 74.01 109.9 177.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 73.74 -19.05 0.36 Allowed 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 125.67 1.588 . . . . 50.12 114.229 175.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 367' ' ' LEU . . . . . . . . . . . . . 5.7 mp 58.08 -83.62 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.979 1.312 . . . . 75.05 110.277 -175.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 368' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -142.31 -64.48 0.42 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.41 1.084 . . . . 71.23 109.026 178.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 369' ' ' GLU . . . . . . . . . . . . . 55.7 tt0 47.39 -85.53 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 125.723 1.609 . . . . 70.1 112.315 -173.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 370' ' ' ALA . . . . . . . . . . . . . . . -167.77 124.11 1.09 Allowed 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.648 1.179 . . . . 74.25 107.964 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 371' ' ' VAL . . . . . . . . . . . . . 58.5 t -68.95 109.08 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 109.064 -0.717 . . . . 74.11 109.064 177.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 372' ' ' GLN . . . . . 0.439 ' HB3' HD21 ' B' ' 375' ' ' LEU . 21.6 tm0? 85.77 -28.55 0.07 Allowed 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 125.897 1.679 . . . . 63.2 111.709 177.112 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 373' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? 78.63 -55.03 0.47 Allowed 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 125.75 1.62 . . . . 72.05 113.277 176.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -88.68 74.51 8.38 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.021 0.528 . . . . 71.45 111.625 -172.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 375' ' ' LEU . . . . . 0.439 HD21 ' HB3' ' B' ' 372' ' ' GLN . 2.9 mm? -117.99 89.4 3.11 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.243 0.617 . . . . 62.01 110.083 179.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -119.27 86.85 2.62 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.664 0.745 . . . . 73.13 108.994 173.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 377' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -125.15 176.16 6.9 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 108.049 -1.093 . . . . 73.31 108.049 177.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 378' ' ' ALA . . . . . . . . . . . . . . . 64.48 14.76 9.12 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 113.199 0.814 . . . . 61.1 113.199 173.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -84.01 86.54 7.18 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.102 0.961 . . . . 72.01 109.423 -171.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 380' ' ' LYS . . . . . . . . . . . . . 47.4 mttp 58.52 22.29 9.51 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 124.903 1.281 . . . . 53.14 112.117 -168.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 381' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -92.38 16.88 10.78 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.656 0.782 . . . . 74.34 111.015 -178.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -79.05 -75.3 1.01 Allowed Glycine 0 C--N 1.35 1.358 0 CA-C-N 115.968 -0.56 . . . . 73.1 112.006 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 383' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 62.7 14.48 7.26 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 124.937 1.295 . . . . 73.1 113.566 174.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 384' ' ' THR . . . . . . . . . . . . . 9.9 p -149.38 -75.86 0.16 Allowed 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.348 1.059 . . . . 63.41 108.981 178.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 385' ' ' LEU . . . . . 0.526 HD11 ' HB2' ' B' ' 101' ' ' PRO . 2.8 mm? 50.58 -84.86 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 125.922 1.689 . . . . 75.12 112.746 -175.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 386' ' ' VAL . . . . . . . . . . . . . 9.2 p -160.21 134.32 1.39 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.666 0 N-CA-C 106.808 -1.553 . . . . 62.42 106.808 177.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 387' ' ' ILE . . . . . 0.591 HG22 HG22 ' B' ' 389' ' ' THR . 31.4 mm 62.81 86.11 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 123.937 0.895 . . . . 74.12 108.664 -170.254 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 388' ' ' VAL . . . . . . . . . . . . . 18.9 m -73.58 72.22 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.291 0 C-N-CA 124.221 1.009 . . . . 54.33 112.662 -169.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 389' ' ' THR . . . . . 0.591 HG22 HG22 ' B' ' 387' ' ' ILE . 10.1 t -156.77 144.76 19.41 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 123.794 0.838 . . . . 71.25 109.175 -178.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . 68.18 -73.64 0.08 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.234 1.413 . . . . 70.34 112.353 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 391' ' ' ASP . . . . . . . . . . . . . 38.0 t70 58.85 45.16 15.74 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.524 1.13 . . . . 64.12 109.9 -174.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 392' ' ' HIS . . . . . . . . . . . . . 20.3 t-160 71.4 143.07 0.06 Allowed 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 114.576 -1.193 . . . . 72.42 110.116 -175.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -56.49 93.57 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.856 0.862 . . . . 61.53 111.005 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 27.4 m170 -72.6 -59.08 2.89 Favored 'General case' 0 C--N 1.351 0.655 0 N-CA-C 108.361 -0.977 . . . . 73.31 108.361 177.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . 57.34 45.61 19.8 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 124.604 1.19 . . . . 71.44 110.394 -175.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 18.8 m 65.74 11.78 7.82 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.101 1.361 . . . . 75.55 112.303 -176.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 397' ' ' GLN . . . . . . . . . . . . . 21.1 tp60 57.01 99.79 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.378 1.471 . . . . 71.41 111.637 -176.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 2.2 mp -70.81 91.58 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 N-CA-C 108.372 -0.973 . . . . 75.44 108.372 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 399' ' ' VAL . . . . . . . . . . . . . 44.6 t 55.45 -88.0 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.158 0 C-N-CA 125.205 1.402 . . . . 73.32 110.657 -173.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 400' ' ' ALA . . . . . . . . . . . . . . . -176.85 88.81 0.26 Allowed Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 124.602 1.161 . . . . 51.41 109.088 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 401' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -66.74 -15.81 48.47 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.704 2.269 . . . . 71.04 111.795 168.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -60.48 -46.58 89.57 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.919 1.288 . . . . 74.34 110.074 172.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 403' ' ' THR . . . . . . . . . . . . . 30.4 p 48.49 -88.05 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.035 1.734 . . . . 51.3 112.574 -173.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 404' ' ' LYS . . . . . 0.588 ' H ' ' HD2' ' B' ' 404' ' ' LYS . 7.0 mptt -74.7 -48.75 24.22 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.545 -0.909 . . . . 70.03 108.545 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 405' ' ' ALA . . . . . . . . . . . . . . . -171.67 -55.51 0.0 OUTLIER Pre-proline 0 CA--C 1.561 1.38 0 CA-C-N 114.644 -1.162 . . . . 71.24 112.374 -169.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 406' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -70.85 105.51 1.68 Allowed 'Trans proline' 0 C--N 1.396 3.032 0 C-N-CA 122.329 2.019 . . . . 44.44 112.917 -171.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . -163.99 -2.53 0.04 OUTLIER Glycine 0 N--CA 1.468 0.803 0 CA-C-N 115.715 -0.675 . . . . 55.33 112.511 178.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 408' ' ' LEU . . . . . . . . . . . . . 5.3 mp -85.99 3.9 40.15 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 124.901 1.281 . . . . 72.03 110.536 176.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 76.4 p -62.53 -164.65 0.01 OUTLIER 'General case' 0 CA--C 1.566 1.567 0 C-N-CA 125.875 1.67 . . . . 73.52 113.684 -178.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 410' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 74.88 -75.38 0.07 Allowed 'General case' 0 C--N 1.367 1.34 0 C-N-CA 125.661 1.584 . . . . 51.32 110.694 175.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . -167.51 134.66 2.29 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.639 0.775 . . . . 63.14 109.21 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 412' ' ' LEU . . . . . 0.456 ' H ' ' HB2' ' B' ' 416' ' ' ASP . 8.1 mp 72.61 168.84 0.32 Allowed 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 125.245 1.418 . . . . 60.41 111.485 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 13.6 m120 70.77 -55.23 0.64 Allowed 'General case' 0 N--CA 1.501 2.089 0 C-N-CA 125.462 1.505 . . . . 71.14 109.633 -164.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 414' ' ' THR . . . . . 0.461 HG22 ' HA ' ' B' ' 98' ' ' ASP . 55.0 p -65.14 170.43 4.55 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.415 1.086 . . . . 73.24 111.079 164.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 415' ' ' LYS . . . . . 0.706 ' HE3' HG23 ' B' ' 419' ' ' VAL . 84.4 tttt -74.7 77.64 2.05 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 108.663 -0.866 . . . . 73.42 108.663 171.213 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 416' ' ' ASP . . . . . 0.456 ' HB2' ' H ' ' B' ' 412' ' ' LEU . 21.9 t70 -88.79 -61.22 1.76 Allowed 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 107.927 -1.138 . . . . 75.33 107.927 176.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 417' ' ' GLY . . . . . . . . . . . . . . . -69.63 88.05 0.28 Allowed Glycine 0 C--N 1.35 1.35 0 N-CA-C 109.897 -1.281 . . . . 43.15 109.897 165.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 418' ' ' ALA . . . . . 0.454 ' HB1' ' HE2' ' B' ' 415' ' ' LYS . . . -77.32 89.07 3.73 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.662 0.785 . . . . 70.25 112.166 -168.026 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 419' ' ' VAL . . . . . 0.706 HG23 ' HE3' ' B' ' 415' ' ' LYS . 72.8 t 47.62 -80.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 126.155 1.782 . . . . 62.03 113.176 178.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 420' ' ' MET . . . . . . . . . . . . . 25.6 ttt -27.89 105.62 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 126.627 1.971 . . . . 73.12 113.86 -171.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 421' ' ' VAL . . . . . . . . . . . . . 7.5 p -60.61 -36.1 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.594 0.757 . . . . 72.42 111.176 -175.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 422' ' ' MET . . . . . . . . . . . . . 5.0 tpt -73.19 89.88 1.55 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.831 0.852 . . . . 74.1 110.458 -175.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 423' ' ' SER . . . . . . . . . . . . . 22.7 t 67.15 -3.23 1.02 Allowed 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 125.006 1.322 . . . . 62.22 113.338 174.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 424' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 54.66 79.58 0.14 Allowed 'General case' 0 C--N 1.365 1.259 0 C-N-CA 124.367 1.067 . . . . 72.42 110.457 -170.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . -65.85 90.09 0.13 Allowed Glycine 0 C--N 1.348 1.232 0 CA-C-N 114.64 -1.164 . . . . 75.12 113.892 -171.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 426' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 61.72 -83.65 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 125.217 1.407 . . . . 75.43 111.378 177.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 427' ' ' SER . . . . . . . . . . . . . 26.9 t -141.46 63.86 1.42 Allowed 'General case' 0 C--O 1.239 0.53 0 N-CA-C 106.877 -1.527 . . . . 75.14 106.877 174.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 71.82 -67.45 0.26 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.761 1.624 . . . . 73.23 110.661 -176.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 429' ' ' GLU . . . . . 0.442 ' HB2' ' CE1' ' B' ' 434' ' ' HIS . 34.4 mm-40 60.74 20.49 10.55 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.379 1.472 . . . . 63.42 112.129 177.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -102.46 145.75 29.1 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.513 0.725 . . . . 55.41 109.984 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 30.2 t -142.36 -50.43 0.38 Allowed 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.696 -0.853 . . . . 73.31 108.696 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 432' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -139.63 -25.15 0.83 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.27 0.628 . . . . 71.1 110.708 176.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 433' ' ' GLU . . . . . 0.606 ' HG2' ' HB2' ' B' ' 438' ' ' GLN . 0.3 OUTLIER -165.3 125.5 1.86 Allowed 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 108.904 -0.776 . . . . 73.43 108.904 176.051 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 434' ' ' HIS . . . . . 0.442 ' CE1' ' HB2' ' B' ' 429' ' ' GLU . 11.8 t-160 -148.76 91.74 1.91 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.361 0.664 . . . . 65.13 109.254 172.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 435' ' ' THR . . . . . . . . . . . . . 5.2 m 61.69 69.55 0.64 Allowed 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 124.541 1.136 . . . . 73.42 111.169 172.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . 70.88 22.8 78.36 Favored Glycine 0 C--N 1.348 1.223 0 CA-C-N 115.61 -0.723 . . . . 43.54 114.18 175.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 98.8 p -107.97 29.26 7.44 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.294 0.638 . . . . 54.14 110.183 177.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 438' ' ' GLN . . . . . 0.606 ' HB2' ' HG2' ' B' ' 433' ' ' GLU . 29.5 tt0 -70.12 -95.38 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 122.802 0.441 . . . . 71.55 110.036 175.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 439' ' ' LEU . . . . . . . . . . . . . 80.6 mt 47.94 31.0 2.17 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 124.36 1.064 . . . . 74.24 112.688 -175.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 440' ' ' ARG . . . . . . . . . . . . . 6.9 mmt180 -72.98 127.9 33.9 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.836 0.854 . . . . 70.1 109.867 -172.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 441' ' ' ILE . . . . . 0.59 HG23 HD22 ' A' ' 235' ' ' LEU . 76.7 mt -69.44 110.63 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 O-C-N 123.924 0.765 . . . . 74.15 111.513 -173.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 442' ' ' ALA . . . . . . . . . . . . . . . -91.06 76.84 6.12 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 109.077 -0.712 . . . . 71.41 109.077 171.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . -122.03 -160.2 0.86 Allowed 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.179 0.991 . . . . 74.21 109.313 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -59.89 103.03 0.18 Allowed 'General case' 0 CA--C 1.555 1.157 0 CA-C-O 121.678 0.751 . . . . 65.34 111.521 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . -167.9 84.79 0.1 OUTLIER Glycine 0 C--N 1.344 0.992 0 N-CA-C 109.38 -1.488 . . . . 74.34 109.38 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 446' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.63 90.38 0.06 OUTLIER 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 123.671 2.914 . . . . 63.02 114.189 -171.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 447' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 58.73 -90.1 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.285 0 C-N-CA 125.662 1.585 . . . . 60.0 111.755 174.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . 51.78 -84.65 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 125.547 1.539 . . . . 74.31 114.792 173.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 449' ' ' ALA . . . . . . . . . . . . . . . -69.51 88.78 0.5 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.045 0.938 . . . . 61.52 112.506 -167.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 450' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -142.18 -72.06 0.32 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.49 1.116 . . . . 61.12 108.396 172.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 7.3 m -128.71 -43.32 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 123.654 0.782 . . . . 63.1 110.359 177.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 452' ' ' VAL . . . . . . . . . . . . . 4.8 t 56.71 30.59 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.412 0 C-N-CA 124.658 1.183 . . . . 60.45 110.37 -176.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 164.32 171.43 30.56 Favored Glycine 0 C--N 1.351 1.399 0 CA-C-N 115.87 -0.605 . . . . 73.44 112.693 -178.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 454' ' ' LEU . . . . . 0.58 ' HA ' ' HB2' ' B' ' 461' ' ' PHE . 3.5 pp -92.79 153.77 18.68 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.377 0.671 . . . . 72.5 111.126 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 30.2 m -112.21 75.87 0.94 Allowed 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 107.221 -1.4 . . . . 61.41 107.221 175.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 456' ' ' ASP . . . . . 0.471 ' HB2' HD13 ' B' ' 454' ' ' LEU . 26.5 t70 -63.22 85.54 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.87 0.868 . . . . 74.3 111.722 -170.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 457' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -136.07 43.16 2.55 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 106.993 -1.484 . . . . 42.14 106.993 177.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 17.3 m 71.85 74.49 0.17 Allowed 'General case' 0 C--N 1.355 0.839 0 C-N-CA 125.225 1.41 . . . . 72.13 107.267 -159.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 459' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -170.08 149.75 3.63 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 114.322 -1.308 . . . . 73.31 109.255 -170.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 37.7 tp -150.46 66.91 0.95 Allowed 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 109.23 -0.656 . . . . 65.42 109.23 178.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 461' ' ' PHE . . . . . 0.58 ' HB2' ' HA ' ' B' ' 454' ' ' LEU . 22.9 m-85 -66.11 102.51 0.83 Allowed 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 108.846 -0.798 . . . . 62.31 108.846 168.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -59.59 -51.85 68.06 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.186 0.594 . . . . 72.53 109.856 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 10.4 m 70.16 -8.87 0.79 Allowed 'General case' 0 CA--C 1.568 1.643 0 C-N-CA 125.341 1.457 . . . . 61.35 112.43 175.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 464' ' ' MET . . . . . . . . . . . . . 3.8 mpp? 50.52 48.34 22.69 Favored 'General case' 0 C--N 1.363 1.172 0 C-N-CA 125.505 1.522 . . . . 75.31 111.797 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -72.98 159.13 34.17 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.704 -1.135 . . . . 72.15 110.871 177.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -154.23 175.4 13.53 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 124.347 1.059 . . . . 62.32 108.897 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . -85.62 44.63 1.12 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.42 0.688 . . . . 75.3 110.757 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 47.5 tp -165.96 -40.47 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.281 1.033 . . . . 45.51 109.597 -176.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 469' ' ' GLY . . . . . . . . . . . . . . . -175.84 -153.51 10.5 Favored Glycine 0 C--N 1.351 1.375 0 CA-C-N 116.412 -0.358 . . . . 50.44 112.454 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 470' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -148.17 161.84 40.65 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.034 0.933 . . . . 73.2 109.298 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 471' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? . . . . . 0 CA--C 1.551 0.987 0 N-CA-C 106.985 -1.487 . . . . 74.2 106.985 174.255 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 67.3 mtm . . . . . 0 N--CA 1.476 0.86 0 N-CA-C 110.485 -0.191 . . . . 55.23 110.485 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 2' ' ' ALA . . . . . 0.4 ' HA ' ' HD1' ' C' ' 96' ' ' PHE . . . 68.11 44.07 1.5 Allowed 'General case' 0 C--N 1.36 1.041 0 C-N-CA 124.306 1.043 . . . . 65.31 111.519 172.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.5 61.66 2.32 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 115.45 -0.795 . . . . 52.01 110.576 176.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -38.52 110.12 0.12 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.129 1.772 . . . . 70.52 113.253 177.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 5' ' ' LYS . . . . . 0.53 ' HB3' HD11 ' C' ' 10' ' ' ILE . 37.7 mtpt -95.71 104.73 16.66 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 108.506 -0.924 . . . . 63.2 108.506 167.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -66.98 104.32 1.35 Allowed 'General case' 0 C--N 1.351 0.658 0 N-CA-C 109.08 -0.711 . . . . 63.22 109.08 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 7' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -63.92 -29.59 70.75 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 124.088 0.868 . . . . 73.43 112.443 -169.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -71.34 -40.43 70.71 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 122.516 0.326 . . . . 72.53 110.38 178.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.11 -37.82 88.69 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 122.825 0.45 . . . . 52.31 110.271 177.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 10' ' ' ILE . . . . . 0.53 HD11 ' HB3' ' C' ' 5' ' ' LYS . 69.4 mt -59.74 -40.25 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 123.186 0.594 . . . . 63.34 110.128 173.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 92.7 mt -82.08 -8.2 59.65 Favored 'General case' 0 CA--C 1.556 1.186 0 N-CA-C 112.935 0.717 . . . . 45.45 112.935 176.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 67.67 35.7 86.36 Favored Glycine 0 C--N 1.352 1.464 0 N-CA-C 113.845 0.298 . . . . 64.33 113.845 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 11.7 m -124.15 160.31 52.89 Favored Pre-proline 0 N--CA 1.486 1.372 0 C-N-CA 125.08 1.352 . . . . 64.04 110.175 178.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -56.91 152.24 44.41 Favored 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 122.933 2.422 . . . . 74.43 113.485 175.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -79.67 28.56 0.26 Allowed 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 113.746 1.017 . . . . 71.52 113.746 -171.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -154.83 27.73 0.43 Allowed 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 108.008 -1.108 . . . . 71.24 108.008 171.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.07 154.24 40.11 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.183 -0.917 . . . . 71.14 111.896 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 69.4 p -95.53 179.42 5.15 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.002 0.921 . . . . 74.41 111.912 -172.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -52.94 -45.0 67.47 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.46 1.104 . . . . 74.45 111.957 -177.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -70.41 -32.85 70.64 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 123.56 0.537 . . . . 64.05 111.746 -177.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -71.57 -43.04 67.05 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 122.907 0.483 . . . . 73.42 110.489 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 1.7 mp -64.86 -38.24 82.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 123.758 0.823 . . . . 61.32 110.221 175.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -64.43 -52.25 59.07 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.124 0.969 . . . . 74.13 111.031 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -69.8 -34.14 73.32 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.467 -0.788 . . . . 73.52 111.087 -177.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -72.38 -35.58 68.5 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.292 0.637 . . . . 75.32 110.979 178.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 26' ' ' TYR . . . . . 0.454 ' HD1' HG22 ' C' ' 50' ' ' ILE . 32.8 t80 -56.75 -61.35 2.49 Favored 'General case' 0 C--O 1.209 -1.065 0 O-C-N 124.261 0.976 . . . . 72.31 108.98 171.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -58.22 -41.67 84.57 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 124.15 0.906 . . . . 74.1 111.929 -177.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 45.7 ttt180 -50.75 -53.89 27.9 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.981 1.312 . . . . 71.15 110.699 176.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 87.1 mt -92.11 -6.2 51.32 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.228 -0.896 . . . . 60.22 111.743 -176.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.65 -4.7 47.18 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.694 0.798 . . . . 75.32 110.145 173.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 58.6 mtp180 -103.96 -35.2 8.21 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.92 0.888 . . . . 73.5 109.53 166.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.98 -55.15 15.73 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 109.506 -0.553 . . . . 71.12 109.506 178.168 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -89.9 7.22 38.39 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 112.046 0.387 . . . . 70.15 112.046 -177.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 34' ' ' HIS . . . . . . . . . . . . . 31.8 t60 -61.28 105.3 0.57 Allowed Pre-proline 0 N--CA 1.478 0.964 0 C-N-CA 124.241 1.016 . . . . 72.34 110.406 -176.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -53.87 -28.36 48.27 Favored 'Trans proline' 0 N--CA 1.507 2.29 0 C-N-CA 123.467 2.778 . . . . 71.32 115.393 -171.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -68.79 -31.81 71.08 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.534 0.734 . . . . 60.34 111.711 178.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 97.9 t -90.96 -50.7 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.402 0.681 . . . . 75.33 109.93 176.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -105.38 92.22 4.11 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.426 1.491 . . . . 54.22 108.605 -173.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -76.36 81.53 3.1 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 108.733 -0.839 . . . . 62.24 108.733 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 45.9 m -147.84 128.63 6.97 Favored Pre-proline 0 N--CA 1.48 1.06 0 C-N-CA 123.244 0.618 . . . . 74.14 110.342 177.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.8 -40.2 86.12 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 122.903 2.402 . . . . 63.44 111.002 174.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -53.0 -46.19 68.22 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 114.871 -1.059 . . . . 65.44 111.004 174.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.71 -16.9 56.69 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 122.616 0.367 . . . . 62.05 110.649 -175.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -73.97 -47.99 33.53 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 107.68 -1.23 . . . . 74.04 107.68 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -70.58 -38.06 74.0 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 114.055 -1.429 . . . . 42.53 111.465 178.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 46' ' ' LYS . . . . . 0.533 ' O ' HG12 ' C' ' 50' ' ' ILE . 34.0 mmtm -64.54 -37.34 87.22 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 116.224 -0.444 . . . . 72.32 110.577 175.095 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -62.2 -40.98 97.9 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.486 0.715 . . . . 62.23 109.665 175.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -60.3 -38.37 83.42 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 123.391 0.432 . . . . 72.04 111.554 173.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -68.48 -33.91 74.99 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 122.744 0.418 . . . . 72.33 111.473 177.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 50' ' ' ILE . . . . . 0.533 HG12 ' O ' ' C' ' 46' ' ' LYS . 26.6 mm -68.77 -32.82 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 N-CA-C 109.246 -0.65 . . . . 75.43 109.246 174.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 51' ' ' ASN . . . . . 0.401 ' HB3' ' HD1' ' C' ' 88' ' ' PHE . 4.3 m-20 -74.12 -32.1 63.04 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 114.998 -1.001 . . . . 74.04 111.05 177.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -66.35 -57.28 7.81 Favored 'General case' 0 C--O 1.248 0.992 0 C-N-CA 123.966 0.906 . . . . 63.42 109.903 175.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -52.15 -54.98 24.03 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 113.632 -1.622 . . . . 63.1 111.194 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -61.19 -46.11 91.84 Favored 'General case' 0 C--O 1.21 -1.024 0 CA-C-N 115.278 -0.874 . . . . 75.01 111.405 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.42 -47.55 72.66 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 122.841 0.456 . . . . 60.54 112.007 -176.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 90.5 t -63.93 -44.08 97.87 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 O-C-N 123.93 0.769 . . . . 72.43 110.331 177.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 57' ' ' LEU . . . . . . . . . . . . . 52.4 mt -88.17 0.17 56.37 Favored 'General case' 0 CA--C 1.564 1.482 0 N-CA-C 113.283 0.846 . . . . 75.02 113.283 -174.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 33.5 t -87.1 -51.31 6.07 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.142 0.977 . . . . 62.42 109.801 -178.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.44 123.06 84.56 Favored Pre-proline 0 C--O 1.217 -0.631 0 N-CA-C 107.845 -1.169 . . . . 72.03 107.845 172.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 60' ' ' PRO . . . . . 0.555 ' HD2' ' HA ' ' C' ' 145' ' ' VAL . 15.0 Cg_endo -55.95 -29.21 72.38 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 122.696 2.264 . . . . 33.23 111.216 170.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -65.39 -64.38 0.88 Allowed 'General case' 0 C--N 1.35 0.595 0 CA-C-N 115.626 -0.715 . . . . 62.13 110.825 176.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 62' ' ' LYS . . . . . 0.501 ' HD3' ' HB3' ' C' ' 83' ' ' TYR . 27.0 mtmm -64.69 -26.62 68.45 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.826 0.45 . . . . 75.23 111.414 -177.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 47.3 tpt85 -57.83 -58.49 8.13 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.642 1.177 . . . . 64.42 109.0 173.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -74.74 -16.79 60.72 Favored 'General case' 0 C--N 1.348 0.518 0 CA-C-N 115.182 -0.917 . . . . 74.15 112.215 -176.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 65' ' ' ILE . . . . . 0.635 HG23 ' HD2' ' C' ' 76' ' ' PRO . 65.2 mt -65.97 -48.26 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 N-CA-C 108.791 -0.818 . . . . 62.34 108.791 169.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -58.61 -51.77 68.49 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.311 -0.859 . . . . 74.22 110.181 176.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -54.44 -51.26 65.53 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.47 0.708 . . . . 73.14 111.643 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 68.0 p -76.0 -13.65 60.23 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 118.958 -0.544 . . . . 63.2 112.376 -177.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -67.52 107.09 2.36 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 109.004 -0.739 . . . . 75.22 109.004 176.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 114.29 17.78 7.01 Favored Glycine 0 C--N 1.343 0.945 0 CA-C-N 115.514 -0.766 . . . . 62.51 111.743 -167.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 98.8 m -148.89 -59.78 0.23 Allowed 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 104.064 -2.569 . . . . 72.34 104.064 176.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 12.4 m -77.9 138.95 39.18 Favored 'General case' 0 C--O 1.256 1.431 0 N-CA-C 104.571 -2.381 . . . . 73.35 104.571 158.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -100.05 -54.82 2.79 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 108.75 -0.833 . . . . 73.23 108.75 -173.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -72.12 151.63 92.54 Favored Pre-proline 0 CA--C 1.546 0.824 0 CA-C-N 114.688 -1.142 . . . . 53.23 109.765 173.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -56.29 123.51 14.01 Favored 'Trans proline' 0 C--N 1.369 1.63 0 C-N-CA 122.338 2.025 . . . . 75.14 110.921 169.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 76' ' ' PRO . . . . . 0.635 ' HD2' HG23 ' C' ' 65' ' ' ILE . 84.3 Cg_exo -50.98 145.79 23.71 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 123.004 2.469 . . . . 63.14 112.817 172.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 77' ' ' PRO . . . . . 0.441 ' HA ' ' HD3' ' C' ' 78' ' ' PRO . 10.8 Cg_endo -51.57 125.79 17.77 Favored 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 123.642 2.894 . . . . 51.51 112.587 -177.126 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 78' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' C' ' 77' ' ' PRO . 14.0 Cg_exo -69.21 141.3 47.05 Favored 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 122.89 2.393 . . . . 74.44 111.95 -177.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 79' ' ' PRO . . . . . 0.417 ' HB2' ' O ' ' C' ' 142' ' ' GLY . 30.9 Cg_endo -61.83 152.68 73.08 Favored 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 122.522 2.148 . . . . 61.04 111.218 174.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -50.73 82.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.392 2.859 0 C-N-CA 124.242 3.295 . . . . 51.5 114.494 -169.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 153.36 -53.05 0.46 Allowed Glycine 0 C--N 1.335 0.481 0 N-CA-C 109.811 -1.315 . . . . 75.2 109.811 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 141.13 -150.76 22.05 Favored Glycine 0 C--N 1.353 1.528 0 CA-C-N 115.615 -0.292 . . . . 74.45 113.662 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 83' ' ' TYR . . . . . 0.501 ' HB3' ' HD3' ' C' ' 62' ' ' LYS . 29.4 m-85 -104.01 122.24 44.83 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.274 1.43 . . . . 70.14 108.855 -177.011 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 84' ' ' ASP . . . . . 0.491 ' HB2' ' NE ' ' C' ' 143' ' ' ARG . 5.5 t70 -80.82 128.38 33.59 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 112.367 0.506 . . . . 63.13 112.367 -169.447 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 85' ' ' PHE . . . . . 0.535 ' HA ' ' HD2' ' C' ' 88' ' ' PHE . 77.0 m-85 -139.46 29.99 2.15 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.263 1.025 . . . . 74.41 109.776 176.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 13.7 m -78.6 84.94 4.68 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 114.89 -1.05 . . . . 45.43 111.39 -173.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 87' ' ' GLY . . . . . 0.591 ' N ' ' HA ' ' C' ' 171' ' ' PRO . . . 130.59 -19.73 5.0 Favored Glycine 0 N--CA 1.47 0.959 0 N-CA-C 110.24 -1.144 . . . . 74.33 110.24 -174.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 88' ' ' PHE . . . . . 0.535 ' HD2' ' HA ' ' C' ' 85' ' ' PHE . 32.5 m-85 -100.0 129.89 46.1 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 107.921 -1.14 . . . . 74.44 107.921 178.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -75.75 78.88 2.69 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.548 0.689 . . . . 72.23 110.804 -175.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 90' ' ' VAL . . . . . 0.451 HG21 ' ND2' ' C' ' 169' ' ' ASN . 5.6 p -50.06 -35.93 11.79 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 C-N-CA 125.981 1.713 . . . . 54.41 113.482 -174.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -65.94 -26.05 67.41 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 123.499 0.72 . . . . 74.21 112.124 -175.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -78.17 -26.56 47.72 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 122.674 0.389 . . . . 75.53 111.88 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 9.3 m-30 -70.13 164.33 24.38 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 123.345 0.403 . . . . 72.45 111.343 -167.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 52.1 p -59.43 149.85 28.25 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 113.969 1.1 . . . . 45.51 113.969 -166.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.71 -35.71 75.07 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 114.738 -1.119 . . . . 55.43 110.525 171.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 96' ' ' PHE . . . . . 0.4 ' HD1' ' HA ' ' C' ' 2' ' ' ALA . 47.1 t80 -53.73 -50.91 64.92 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.542 1.137 . . . . 65.02 110.858 172.104 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 97' ' ' PHE . . . . . 0.414 ' HZ ' HG23 ' C' ' 90' ' ' VAL . 1.1 t80 -58.96 -43.04 91.23 Favored 'General case' 0 CA--C 1.552 1.043 0 CA-C-N 114.511 -1.222 . . . . 64.25 110.767 175.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -69.31 -21.4 63.85 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.077 0.551 . . . . 51.52 112.026 -177.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -82.69 -50.0 9.19 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.293 0.637 . . . . 74.43 110.621 173.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 38.6 tp -67.45 -63.73 1.0 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.775 0.83 . . . . 73.23 110.553 -175.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -80.26 -0.71 37.63 Favored 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 123.091 0.556 . . . . 73.25 112.413 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -45.57 -58.84 5.1 Favored Glycine 0 CA--C 1.544 1.85 0 CA-C-O 118.933 -0.926 . . . . 54.11 115.411 178.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -62.65 -3.38 4.36 Favored 'Trans proline' 0 C--N 1.385 2.466 0 C-N-CA 123.535 2.824 . . . . 62.02 114.528 -176.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -141.71 38.28 1.52 Allowed Glycine 0 C--N 1.354 1.535 0 CA-C-O 119.118 -0.823 . . . . 43.23 112.62 174.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 43.0 mt -70.86 41.24 0.06 Allowed 'General case' 0 N--CA 1.505 2.285 0 CA-C-N 118.58 1.19 . . . . 73.03 113.922 175.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 106' ' ' PHE . . . . . 0.518 ' O ' ' HA ' ' C' ' 111' ' ' ARG . 0.3 OUTLIER 68.59 -108.39 0.09 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.44 1.496 . . . . 64.24 111.926 163.09 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 107' ' ' GLY . . . . . 0.581 ' HA3' ' H ' ' C' ' 113' ' ' SER . . . 65.09 29.75 76.15 Favored Glycine 0 C--N 1.353 1.511 0 CA-C-N 118.534 0.606 . . . . 51.05 113.086 -168.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 60.86 -123.27 32.25 Favored Glycine 0 C--N 1.351 1.375 0 N-CA-C 111.505 -0.638 . . . . 74.41 111.505 -173.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 109' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -99.95 -7.14 25.54 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.443 0.697 . . . . 74.45 110.686 171.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.83 -12.41 66.41 Favored Glycine 0 C--N 1.348 1.224 0 O-C-N 123.603 0.564 . . . . 54.22 112.749 -178.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 111' ' ' ARG . . . . . 0.518 ' HA ' ' O ' ' C' ' 106' ' ' PHE . 77.6 mtm180 56.89 11.79 1.03 Allowed 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 124.539 1.135 . . . . 75.25 113.887 176.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 112' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -48.72 -29.53 4.56 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 126.649 1.98 . . . . 74.1 112.891 173.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 113' ' ' SER . . . . . 0.581 ' H ' ' HA3' ' C' ' 107' ' ' GLY . 38.0 m 63.6 15.54 8.96 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.244 1.418 . . . . 72.53 112.383 -177.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 114' ' ' ARG . . . . . 0.521 ' HG3' ' H ' ' C' ' 115' ' ' LYS . 12.9 tpt180 -117.88 -169.19 1.64 Allowed 'General case' 0 C--O 1.21 -1.01 0 CA-C-O 118.314 -0.851 . . . . 74.05 110.777 -174.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 115' ' ' LYS . . . . . 0.521 ' H ' ' HG3' ' C' ' 114' ' ' ARG . 57.7 tttp -35.82 126.27 0.7 Allowed 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 126.53 1.932 . . . . 54.14 116.123 -161.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 116' ' ' GLY . . . . . 0.432 ' HA2' ' HA3' ' C' ' 168' ' ' GLY . . . -79.94 153.96 36.86 Favored Glycine 0 C--N 1.36 1.9 0 CA-C-N 115.634 -0.712 . . . . 45.25 113.981 -177.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 117' ' ' ARG . . . . . 0.546 ' HB2' ' HB2' ' C' ' 167' ' ' GLN . 2.4 mmp_? -116.29 147.51 41.46 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 124.492 1.117 . . . . 64.44 111.498 177.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -68.9 113.66 6.52 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 108.322 -0.992 . . . . 75.42 108.322 174.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 119' ' ' LEU . . . . . 0.574 HD21 HG22 ' B' ' 185' ' ' VAL . 5.7 tt -92.12 119.34 31.69 Favored 'General case' 0 C--O 1.219 -0.512 0 N-CA-C 105.953 -1.869 . . . . 75.21 105.953 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.418 ' HG2' HD12 ' C' ' 175' ' ' LEU . 98.3 mtt180 -97.48 132.95 42.69 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 107.399 -1.334 . . . . 72.31 107.399 176.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 121' ' ' ALA . . . . . . . . . . . . . . . -143.02 117.37 9.63 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.294 -0.632 . . . . 63.21 109.294 -178.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 122' ' ' GLU . . . . . 0.473 ' HA ' ' O ' ' C' ' 177' ' ' VAL . 12.7 pt-20 -99.17 130.0 45.46 Favored 'General case' 0 C--N 1.348 0.529 0 CA-C-O 120.959 0.409 . . . . 73.22 109.913 177.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 123' ' ' LEU . . . . . 0.662 HD13 HG12 ' B' ' 182' ' ' VAL . 0.4 OUTLIER -122.96 120.9 27.41 Favored Pre-proline 0 N--CA 1.473 0.7 0 C-N-CA 123.447 0.699 . . . . 73.3 111.92 -166.132 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 124' ' ' PRO . . . . . 0.517 ' HD2' ' HB2' ' B' ' 183' ' ' ALA . 80.4 Cg_exo -51.19 116.96 3.0 Favored 'Trans proline' 0 C--N 1.37 1.68 0 C-N-CA 122.82 2.347 . . . . 72.51 111.298 162.082 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 125' ' ' LEU . . . . . . . . . . . . . 26.3 tp -138.64 140.26 38.83 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.373 1.069 . . . . 74.03 108.6 -175.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.4 156.24 21.91 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.069 0.461 . . . . 61.53 111.192 -177.036 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 127' ' ' LEU . . . . . 0.619 ' HB3' HD22 ' C' ' 215' ' ' LEU . 95.9 mt -63.72 -44.99 91.94 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.124 0.97 . . . . 62.25 110.776 177.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -52.84 -46.39 67.77 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 114.885 -1.052 . . . . 75.24 110.513 172.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -67.01 -33.84 76.42 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.092 0.957 . . . . 73.53 111.553 -176.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -72.44 -33.1 66.84 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 123.866 0.729 . . . . 64.34 110.344 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 131' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -68.09 -41.38 81.94 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.2 0.6 . . . . 75.55 110.361 172.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 132' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -66.72 -68.91 0.34 Allowed 'General case' 0 N--CA 1.481 1.118 0 O-C-N 123.653 0.595 . . . . 60.22 111.284 -175.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 62.93 93.25 0.02 OUTLIER Glycine 0 CA--C 1.541 1.678 0 O-C-N 123.735 0.647 . . . . 65.31 113.239 -176.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . -135.89 161.38 24.82 Favored Glycine 0 N--CA 1.479 1.516 0 CA-C-O 119.473 -0.626 . . . . 53.24 111.802 177.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -71.88 95.53 1.56 Allowed 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 108.727 -0.842 . . . . 71.2 108.727 176.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 136' ' ' ARG . . . . . 0.47 ' HB2' HD22 ' B' ' 181' ' ' LEU . 90.0 mtt180 -123.93 163.52 21.16 Favored 'General case' 0 C--O 1.248 1.006 0 C-N-CA 123.563 0.745 . . . . 72.12 109.733 -173.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 137' ' ' VAL . . . . . 0.532 HG13 ' HB1' ' B' ' 180' ' ' ALA . 7.8 p -79.84 125.34 38.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 121.553 0.692 . . . . 71.12 110.621 -169.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 138' ' ' VAL . . . . . 0.583 HG12 ' HB3' ' B' ' 181' ' ' LEU . 8.1 m -112.46 141.84 26.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 124.068 0.947 . . . . 72.14 108.554 173.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 139' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -124.76 100.61 6.7 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 107.742 -1.207 . . . . 74.31 107.742 170.091 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 140' ' ' VAL . . . . . 0.487 HG21 HD21 ' C' ' 174' ' ' LEU . 61.3 t -116.59 100.33 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 109.376 -0.601 . . . . 63.22 109.376 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 63.41 30.69 15.4 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.444 0.698 . . . . 15.23 111.151 177.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 142' ' ' GLY . . . . . 0.417 ' O ' ' HB2' ' C' ' 79' ' ' PRO . . . 101.86 -11.6 57.59 Favored Glycine 0 C--N 1.343 0.917 0 CA-C-N 115.713 -0.676 . . . . 45.25 112.409 -179.237 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 143' ' ' ARG . . . . . 0.491 ' NE ' ' HB2' ' C' ' 84' ' ' ASP . 6.0 tpp180 -76.63 92.87 3.54 Favored 'General case' 0 C--N 1.352 0.699 0 N-CA-C 109.573 -0.529 . . . . 73.04 109.573 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 144' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' C' ' 138' ' ' VAL . 39.3 ttp85 -96.66 94.62 7.42 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 115.083 -0.962 . . . . 71.51 108.778 178.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 145' ' ' VAL . . . . . 0.555 ' HA ' ' HD2' ' C' ' 60' ' ' PRO . 28.6 m -131.5 176.16 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-N 114.978 -1.01 . . . . 75.03 109.879 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 49.0 m -125.12 118.83 26.97 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 109.05 -0.722 . . . . 54.21 109.05 178.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 14.1 p -142.0 150.99 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.103 0.561 . . . . 72.53 110.101 -173.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 45.2 ttp180 -103.34 110.58 22.62 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 108.346 -0.983 . . . . 74.22 108.346 169.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 149' ' ' ILE . . . . . 0.547 ' HB ' HD13 ' C' ' 159' ' ' ILE . 38.0 pt -76.46 148.29 80.04 Favored Pre-proline 0 CA--C 1.557 1.245 0 N-CA-C 109.267 -0.642 . . . . 71.41 109.267 170.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -47.88 119.64 4.03 Favored 'Trans proline' 0 C--N 1.381 2.268 0 C-N-CA 124.033 3.156 . . . . 61.44 113.723 -174.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -63.26 132.72 37.36 Favored 'Trans proline' 0 C--N 1.383 2.364 0 C-N-CA 122.903 2.402 . . . . 73.2 110.969 174.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 152' ' ' GLY . . . . . 0.578 ' HA2' ' HB3' ' C' ' 240' ' ' PHE . . . 86.92 53.92 2.74 Favored Glycine 0 C--N 1.334 0.435 0 N-CA-C 111.338 -0.705 . . . . 54.32 111.338 -173.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 153' ' ' VAL . . . . . 0.588 HG21 HD11 ' C' ' 159' ' ' ILE . 12.5 p -101.99 143.84 14.17 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.245 0 C-N-CA 123.539 0.736 . . . . 71.13 110.531 -172.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 154' ' ' ARG . . . . . 0.626 ' HA ' ' HB3' ' C' ' 188' ' ' LEU . 49.9 mtp180 -96.82 155.2 16.88 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.698 0.799 . . . . 75.32 112.329 -167.231 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 155' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -53.42 108.82 0.37 Allowed 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 123.267 0.627 . . . . 74.51 110.064 162.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 89.25 18.13 53.92 Favored Glycine 0 C--N 1.343 0.959 0 CA-C-O 119.803 -0.443 . . . . 64.51 113.454 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 157' ' ' SER . . . . . 0.572 ' HA ' ' HG2' ' B' ' 193' ' ' PRO . 3.5 m -73.35 107.1 5.47 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 117.148 0.474 . . . . 75.43 110.314 172.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 158' ' ' VAL . . . . . 0.525 HG11 ' HA ' ' B' ' 190' ' ' CYS . 42.1 t -85.02 90.25 2.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-N 114.438 -1.255 . . . . 64.44 108.378 176.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 159' ' ' ILE . . . . . 0.588 HD11 HG21 ' C' ' 153' ' ' VAL . 53.0 mt -75.88 118.96 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 114.972 -1.013 . . . . 52.25 110.179 -178.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 53.1 ttt180 -78.06 119.71 21.87 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 109.918 -0.401 . . . . 72.21 109.918 173.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 161' ' ' VAL . . . . . 0.607 HG11 ' SD ' ' C' ' 164' ' ' MET . 21.2 t -125.97 95.47 39.48 Favored Pre-proline 0 CA--C 1.551 1.017 0 N-CA-C 109.062 -0.718 . . . . 75.24 109.062 176.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.43 119.63 5.85 Favored 'Trans proline' 0 C--N 1.368 1.59 0 C-N-CA 122.388 2.058 . . . . 63.42 111.253 172.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 113.24 23.32 5.23 Favored Glycine 0 C--N 1.341 0.815 0 CA-C-N 115.899 -0.591 . . . . 53.31 112.843 178.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 164' ' ' MET . . . . . 0.607 ' SD ' HG11 ' C' ' 161' ' ' VAL . 28.6 mtp -148.95 3.96 0.63 Allowed 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 112.884 0.698 . . . . 73.35 112.884 -178.211 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 165' ' ' GLY . . . . . 0.414 ' HA3' ' O ' ' C' ' 173' ' ' ASP . . . -126.37 -123.04 2.63 Favored Glycine 0 N--CA 1.48 1.603 0 CA-C-O 118.346 -1.252 . . . . 64.24 111.067 -177.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . 68.57 73.62 0.68 Allowed Glycine 0 C--N 1.363 2.041 0 CA-C-N 118.516 1.158 . . . . 75.44 113.501 165.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 167' ' ' GLN . . . . . 0.546 ' HB2' ' HB2' ' C' ' 117' ' ' ARG . 14.2 mm100 -67.14 98.06 0.57 Allowed 'General case' 0 C--N 1.348 0.502 0 N-CA-C 107.033 -1.469 . . . . 64.31 107.033 170.292 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 168' ' ' GLY . . . . . 0.432 ' HA3' ' HA2' ' C' ' 116' ' ' GLY . . . 136.57 -140.55 11.58 Favored Glycine 0 C--O 1.217 -0.939 0 CA-C-N 112.745 -2.025 . . . . 13.44 108.881 -161.329 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 169' ' ' ASN . . . . . 0.451 ' ND2' HG21 ' C' ' 90' ' ' VAL . 62.6 t30 -153.3 -51.6 0.02 OUTLIER Pre-proline 0 N--CA 1.497 1.894 0 CA-C-N 119.918 1.859 . . . . 62.44 111.952 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 170' ' ' PRO . . . . . 0.431 ' HD3' ' HB3' ' C' ' 169' ' ' ASN . 86.3 Cg_exo -53.81 161.99 4.13 Favored 'Trans proline' 0 C--N 1.393 2.912 0 C-N-CA 122.559 2.173 . . . . 51.41 113.504 164.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 171' ' ' PRO . . . . . 0.591 ' HA ' ' N ' ' C' ' 87' ' ' GLY . 1.5 Cg_exo -28.63 104.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.39 2.759 1 C-N-CA 125.494 4.13 . . . . 74.02 117.854 -174.438 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -121.66 -146.61 7.42 Favored Glycine 0 C--N 1.341 0.819 0 N-CA-C 109.387 -1.485 . . . . 74.42 109.387 170.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 173' ' ' ASP . . . . . 0.414 ' O ' ' HA3' ' C' ' 165' ' ' GLY . 27.2 t70 -171.16 159.5 5.94 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 117.607 0.703 . . . . 74.51 111.053 -176.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 174' ' ' LEU . . . . . 0.487 HD21 HG21 ' C' ' 140' ' ' VAL . 17.5 tp -124.89 115.4 20.56 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.727 0.811 . . . . 75.22 110.166 170.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 175' ' ' LEU . . . . . 0.488 HD22 HG12 ' C' ' 158' ' ' VAL . 76.7 mt -92.05 89.99 7.19 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.172 0.989 . . . . 71.32 110.291 174.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 176' ' ' LEU . . . . . . . . . . . . . 58.1 mt -76.66 93.78 3.69 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.48 0.712 . . . . 43.02 111.002 176.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 177' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' C' ' 122' ' ' GLU . 8.2 t -86.64 100.71 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 123.371 0.668 . . . . 74.43 109.69 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 178' ' ' VAL . . . . . 0.465 HG12 HD11 ' C' ' 123' ' ' LEU . 14.8 m -73.64 112.43 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.199 0 CA-C-O 122.336 1.065 . . . . 74.01 111.154 -174.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 179' ' ' ARG . . . . . 0.403 ' O ' ' HA ' ' C' ' 124' ' ' PRO . 7.0 mmm180 -91.4 115.39 27.99 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 114.291 -1.322 . . . . 72.33 107.687 170.139 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 180' ' ' LEU . . . . . . . . . . . . . 77.4 mt -69.07 135.39 50.71 Favored 'General case' 0 CA--C 1.561 1.398 0 CA-C-N 118.3 0.5 . . . . 70.51 111.436 178.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 181' ' ' LEU . . . . . 0.435 HD23 ' HB3' ' C' ' 124' ' ' PRO . 16.4 mt -53.43 169.65 0.31 Allowed Pre-proline 0 N--CA 1.501 2.102 0 C-N-CA 126.896 2.078 . . . . 74.2 113.965 -175.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -60.86 62.22 0.09 OUTLIER 'Trans proline' 0 C--N 1.397 3.112 0 C-N-CA 123.936 3.09 . . . . 64.12 112.442 161.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 183' ' ' HIS . . . . . 0.513 ' N ' ' HD3' ' C' ' 184' ' ' PRO . 85.7 t60 -162.06 28.17 0.03 OUTLIER Pre-proline 0 CA--C 1.572 1.803 0 C-N-CA 127.82 2.448 . . . . 62.13 107.203 -179.143 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 184' ' ' PRO . . . . . 0.513 ' HD3' ' N ' ' C' ' 183' ' ' HIS . 44.2 Cg_endo -91.81 67.57 1.0 Allowed 'Trans proline' 0 C--N 1.396 3.061 0 C-N-CA 123.719 2.946 . . . . 71.54 111.731 -162.44 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 185' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 2.9 t -87.81 -23.28 6.56 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.788 0 N-CA-C 107.751 -1.203 . . . . 72.23 107.751 -176.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 186' ' ' PHE . . . . . 0.532 ' HD2' HD13 ' C' ' 127' ' ' LEU . 56.7 m-85 -125.57 100.55 6.5 Favored 'General case' 0 C--N 1.346 0.439 0 N-CA-C 108.931 -0.766 . . . . 61.44 108.931 -178.031 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 187' ' ' ARG . . . . . 0.427 ' NH2' ' HB2' ' C' ' 184' ' ' PRO . 32.1 ttm105 -99.89 107.82 19.91 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 107.477 -1.305 . . . . 75.14 107.477 -177.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 188' ' ' LEU . . . . . 0.626 ' HB3' ' HA ' ' C' ' 154' ' ' ARG . 53.3 tp -76.52 127.89 33.71 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.199 0.814 . . . . 74.14 113.199 -163.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -112.97 104.46 12.43 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.9 1.28 . . . . 71.33 108.082 169.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 190' ' ' GLY . . . . . 0.405 ' H ' ' NE ' ' C' ' 154' ' ' ARG . . . 68.2 -103.29 0.98 Allowed Glycine 0 CA--C 1.534 1.247 0 CA-C-N 116.437 -0.347 . . . . 74.2 112.533 -176.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 191' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -113.85 -16.4 12.24 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 124.226 1.01 . . . . 60.21 110.469 175.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -99.52 130.7 45.79 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.409 1.084 . . . . 65.13 110.126 -173.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 193' ' ' LEU . . . . . 0.461 HD22 ' HB3' ' C' ' 186' ' ' PHE . 71.1 mt -74.41 152.55 39.49 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.743 0.817 . . . . 52.2 111.501 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 194' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -120.09 106.66 12.19 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 107.531 -1.285 . . . . 75.43 107.531 167.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 195' ' ' ALA . . . . . 0.48 ' HA ' ' O ' ' C' ' 185' ' ' VAL . . . -109.38 -177.73 3.37 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.264 1.026 . . . . 65.11 110.315 -177.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 95.8 m -137.83 118.42 13.95 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.598 -0.89 . . . . 51.32 108.598 165.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 197' ' ' LEU . . . . . . . . . . . . . 62.3 tp -97.09 139.48 33.03 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.182 -0.917 . . . . 73.5 110.482 -175.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -93.53 100.87 13.07 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 109.015 -0.735 . . . . 44.52 109.015 -178.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 199' ' ' VAL . . . . . 0.552 HG22 HG21 ' C' ' 210' ' ' VAL . 94.7 t -114.41 119.35 40.22 Favored Pre-proline 0 N--CA 1.484 1.232 0 C-N-CA 124.068 0.947 . . . . 61.21 109.226 -178.298 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 200' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -72.68 145.78 42.1 Favored 'Trans proline' 0 C--N 1.366 1.469 0 C-N-CA 121.664 1.576 . . . . 71.34 110.75 174.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 201' ' ' ALA . . . . . 0.435 ' N ' ' HD2' ' C' ' 202' ' ' PRO . . . -58.26 -38.82 70.27 Favored Pre-proline 0 CA--C 1.552 1.037 0 N-CA-C 115.348 1.61 . . . . 74.35 115.348 -173.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 202' ' ' PRO . . . . . 0.552 ' O ' HG13 ' C' ' 206' ' ' VAL . 19.4 Cg_endo -58.45 -52.43 5.54 Favored 'Trans proline' 0 C--N 1.382 2.337 0 CA-C-N 121.547 1.588 . . . . 63.15 111.417 174.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 203' ' ' ILE . . . . . . . . . . . . . 41.7 mt -63.34 -27.6 43.37 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 123.887 0.875 . . . . 63.4 110.793 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.21 -41.59 76.87 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.567 -0.742 . . . . 75.02 112.229 175.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 205' ' ' VAL . . . . . 0.535 HG11 HD11 ' A' ' 261' ' ' LEU . 90.7 t -72.14 -43.65 66.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 122.578 0.351 . . . . 63.41 111.175 -178.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 206' ' ' VAL . . . . . 0.552 HG13 ' O ' ' C' ' 202' ' ' PRO . 0.6 OUTLIER -98.25 -38.08 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 N-CA-C 111.656 0.243 . . . . 52.12 111.656 -168.265 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 106.01 123.62 5.18 Favored Glycine 0 CA--C 1.529 0.914 0 O-C-N 123.122 0.264 . . . . 63.21 112.787 -173.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -158.38 -130.92 1.22 Allowed Glycine 0 C--N 1.34 0.797 0 N-CA-C 110.197 -1.161 . . . . 51.32 110.197 176.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 209' ' ' LYS . . . . . 0.555 ' HG2' ' HA ' ' C' ' 222' ' ' ALA . 8.6 mtmp? -147.65 146.86 29.48 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 117.673 0.737 . . . . 72.12 111.558 176.296 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 210' ' ' VAL . . . . . 0.552 HG21 HG22 ' C' ' 199' ' ' VAL . 31.1 m -141.84 142.59 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 124.417 1.087 . . . . 62.05 109.354 173.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 211' ' ' ARG . . . . . 0.591 ' HE ' ' HB3' ' B' ' 234' ' ' ALA . 45.2 ttm-85 -81.45 127.81 33.2 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.656 0.782 . . . . 72.44 111.801 -172.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -105.98 112.19 25.14 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 107.574 -1.269 . . . . 74.43 107.574 169.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 213' ' ' MET . . . . . 0.578 ' HA ' ' HA ' ' C' ' 218' ' ' PRO . 4.0 ttp -77.97 100.62 6.52 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.812 -0.81 . . . . 63.12 108.812 -176.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.68 177.63 8.8 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 118.02 0.373 . . . . 54.24 110.154 -174.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 215' ' ' LEU . . . . . 0.619 HD22 ' HB3' ' C' ' 127' ' ' LEU . 12.3 mt -51.26 -61.25 2.35 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.295 1.038 . . . . 44.41 111.109 -173.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -92.86 13.36 20.65 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.239 -0.891 . . . . 71.0 111.933 -173.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 144.35 154.86 6.25 Favored Glycine 0 C--N 1.346 1.112 0 CA-C-O 119.831 -0.427 . . . . 64.11 113.128 177.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 218' ' ' PRO . . . . . 0.578 ' HA ' ' HA ' ' C' ' 213' ' ' MET . 52.8 Cg_endo -69.1 125.76 12.89 Favored 'Trans proline' 0 C--N 1.365 1.403 0 C-N-CA 122.896 2.398 . . . . 52.13 114.878 179.199 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 219' ' ' VAL . . . . . . . . . . . . . 9.6 p -100.71 173.21 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.809 0 N-CA-C 106.103 -1.814 . . . . 52.53 106.103 168.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 220' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -118.36 158.18 25.74 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.703 -0.48 . . . . 72.32 109.703 174.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 221' ' ' VAL . . . . . . . . . . . . . 38.0 t -115.31 127.95 72.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 124.801 1.24 . . . . 74.03 109.592 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 222' ' ' ALA . . . . . 0.555 ' HA ' ' HG2' ' C' ' 209' ' ' LYS . . . -80.14 102.32 9.31 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 108.69 -0.856 . . . . 73.3 108.69 170.065 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 48.5 t -76.67 126.58 85.8 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-N 115.294 -0.866 . . . . 73.11 109.344 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 224' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' B' ' 245' ' ' LYS . 6.1 Cg_exo -79.87 163.9 23.12 Favored 'Trans proline' 0 C--N 1.366 1.479 0 C-N-CA 123.715 2.943 . . . . 54.33 112.848 171.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -56.73 146.7 75.89 Favored 'Trans proline' 0 C--N 1.37 1.668 0 C-N-CA 122.128 1.885 . . . . 74.0 112.003 164.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 226' ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? 65.51 71.25 0.44 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.533 1.133 . . . . 70.15 110.929 171.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 227' ' ' THR . . . . . 0.528 HG22 HD11 ' C' ' 255' ' ' ILE . 8.0 m -116.95 125.85 52.05 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 124.287 1.035 . . . . 70.3 111.419 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 228' ' ' GLN . . . . . 0.561 ' HB3' HD12 ' B' ' 29' ' ' LEU . 24.9 mp0 -108.23 157.21 18.53 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.404 1.081 . . . . 74.32 111.017 -177.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 229' ' ' ALA . . . . . 0.533 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -77.03 110.59 11.8 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 114.842 -1.072 . . . . 62.12 110.416 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 108.69 8.95 27.59 Favored Glycine 0 N--CA 1.475 1.25 0 CA-C-O 119.871 -0.405 . . . . 62.04 113.0 -169.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 231' ' ' ARG . . . . . . . . . . . . . 49.9 mtp85 -76.07 168.34 20.22 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 109.223 -0.658 . . . . 74.12 109.223 164.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 232' ' ' LYS . . . . . 0.521 ' HD3' ' HB3' ' C' ' 250' ' ' TYR . 2.4 ttmp? -134.29 146.96 50.51 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-O 121.493 0.663 . . . . 71.45 112.452 178.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 233' ' ' LEU . . . . . 0.728 HD13 ' HB2' ' C' ' 251' ' ' LEU . 5.1 mp -111.27 155.61 22.75 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.323 1.449 . . . . 74.21 111.22 -173.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 29.5 ptt-85 -125.93 91.72 3.44 Favored 'General case' 0 CA--C 1.571 1.769 0 O-C-N 125.477 1.736 . . . . 72.34 110.87 175.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 235' ' ' LEU . . . . . 0.477 ' HB2' ' HB3' ' C' ' 249' ' ' LEU . 79.5 mt -90.96 103.72 16.4 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.876 -0.787 . . . . 73.43 108.876 170.072 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -69.71 129.63 40.13 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.525 0.73 . . . . 71.55 111.863 -175.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 75.13 25.9 67.7 Favored Glycine 0 C--N 1.353 1.507 0 O-C-N 123.882 0.739 . . . . 71.42 114.196 175.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 31.1 mmtm -115.14 13.34 16.79 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.172 0.589 . . . . 72.03 110.621 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 239' ' ' GLY . . . . . 0.433 ' HA2' ' HG ' ' C' ' 193' ' ' LEU . . . -91.3 -163.16 38.47 Favored Glycine 0 C--N 1.353 1.51 0 O-C-N 123.511 0.507 . . . . 31.21 113.323 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 240' ' ' PHE . . . . . 0.578 ' HB3' ' HA2' ' C' ' 152' ' ' GLY . 4.6 m-85 -87.05 154.09 54.78 Favored Pre-proline 0 CA--C 1.552 1.05 0 N-CA-C 110.005 -0.368 . . . . 75.14 110.005 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 241' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.33 113.59 1.67 Allowed 'Trans proline' 0 C--N 1.386 2.513 0 C-N-CA 122.915 2.41 . . . . 70.21 111.382 175.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -111.11 164.54 12.14 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-O 118.945 -0.92 . . . . 70.14 111.714 177.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 243' ' ' PRO . . . . . 0.411 ' HD3' ' HB1' ' B' ' 195' ' ' ALA . 59.8 Cg_endo -68.65 -20.7 40.22 Favored 'Trans proline' 0 C--N 1.37 1.692 0 C-N-CA 122.902 2.401 . . . . 71.42 112.536 -178.139 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -98.18 20.87 11.69 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.1 0.96 . . . . 71.42 110.489 176.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 97.01 177.94 34.79 Favored Glycine 0 C--N 1.348 1.197 0 N-CA-C 111.263 -0.735 . . . . 51.32 111.263 -171.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 246' ' ' ARG . . . . . . . . . . . . . 69.4 mtm180 -71.89 142.6 49.52 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 117.465 0.632 . . . . 61.31 110.593 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -79.42 -158.18 13.79 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 123.846 0.716 . . . . 63.23 112.723 177.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -116.89 -179.86 3.81 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.725 0.81 . . . . 73.54 108.896 -174.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 249' ' ' LEU . . . . . 0.477 ' HB3' ' HB2' ' C' ' 235' ' ' LEU . 10.3 tp -122.41 109.43 14.38 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.48 -0.933 . . . . 74.23 108.48 176.039 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 250' ' ' TYR . . . . . 0.638 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 23.5 m-85 -101.14 105.71 16.89 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.601 -0.727 . . . . 71.43 109.736 178.109 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 251' ' ' LEU . . . . . 0.728 ' HB2' HD13 ' C' ' 233' ' ' LEU . 2.0 mp -98.79 149.89 22.41 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 109.536 -0.542 . . . . 64.53 109.536 -173.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -104.61 128.93 52.76 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 108.16 -1.052 . . . . 73.41 108.16 175.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 253' ' ' VAL . . . . . . . . . . . . . 67.7 t -74.99 134.66 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 112.247 0.462 . . . . 73.5 112.247 -172.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 254' ' ' ARG . . . . . 0.402 ' CZ ' ' HB ' ' C' ' 256' ' ' THR . 1.5 tmm_? -121.69 93.94 4.16 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 107.293 -1.373 . . . . 74.13 107.293 177.122 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 255' ' ' ILE . . . . . 0.528 HD11 HG22 ' C' ' 227' ' ' THR . 46.1 mm -68.49 124.52 24.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 O-C-N 123.264 0.353 . . . . 75.24 110.077 176.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 256' ' ' THR . . . . . 0.402 ' HB ' ' CZ ' ' C' ' 254' ' ' ARG . 0.0 OUTLIER -133.27 170.33 15.6 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.855 1.262 . . . . 53.32 110.772 -174.596 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 257' ' ' ILE . . . . . 0.45 ' HB ' ' HD2' ' C' ' 258' ' ' PRO . 2.9 pp -130.19 157.6 76.67 Favored Pre-proline 0 CA--C 1.556 1.204 0 C-N-CA 124.025 0.93 . . . . 64.54 109.44 178.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 258' ' ' PRO . . . . . 0.45 ' HD2' ' HB ' ' C' ' 257' ' ' ILE . 74.3 Cg_endo -67.14 -8.56 22.24 Favored 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 122.817 2.345 . . . . 73.21 114.031 -166.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 56.94 -71.88 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 125.024 1.329 . . . . 72.3 111.246 -164.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -73.88 152.33 40.21 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.831 0.852 . . . . 73.41 111.483 177.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 261' ' ' LEU . . . . . 0.588 HD13 ' HA ' ' C' ' 266' ' ' GLU . 31.2 mt -146.41 141.04 26.77 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.07 0.548 . . . . 71.21 112.043 179.28 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 53.7 p -87.72 145.33 36.73 Favored Pre-proline 0 CA--C 1.551 0.983 0 CA-C-O 117.914 -1.041 . . . . 61.23 108.369 167.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -45.02 -31.3 5.4 Favored 'Trans proline' 0 C--N 1.382 2.34 0 C-N-CA 124.471 3.448 . . . . 74.2 114.906 -176.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -56.83 -72.45 0.08 Allowed 'General case' 0 C--O 1.257 1.465 0 C-N-CA 124.599 1.159 . . . . 71.04 111.482 174.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -68.36 -24.87 64.85 Favored 'General case' 0 C--O 1.212 -0.888 0 CA-C-N 115.068 -0.969 . . . . 65.11 110.339 -176.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 266' ' ' GLU . . . . . 0.588 ' HA ' HD13 ' C' ' 261' ' ' LEU . 11.3 tp10 -59.09 -48.31 82.08 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.689 0.795 . . . . 64.21 109.95 173.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -63.74 -35.58 81.05 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.18 0.592 . . . . 70.32 111.386 177.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 268' ' ' LEU . . . . . . . . . . . . . 11.2 mp -64.52 -50.88 65.64 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 112.279 0.474 . . . . 52.44 112.279 174.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 269' ' ' TRP . . . . . 0.501 ' HH2' ' HD3' ' C' ' 202' ' ' PRO . 89.6 m95 -60.95 -32.74 72.25 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.46 0.704 . . . . 61.11 110.774 178.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 270' ' ' LYS . . . . . 0.433 ' HB3' ' NZ ' ' C' ' 270' ' ' LYS . 3.7 mmmp? -62.42 -57.75 10.13 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.092 0.957 . . . . 75.43 111.241 175.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 31.1 mmtm -66.39 -24.8 66.54 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.476 0.711 . . . . 75.33 112.475 -177.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 272' ' ' LEU . . . . . 0.407 HD12 HD12 ' A' ' 272' ' ' LEU . 55.4 mt -81.67 -32.46 31.77 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 122.981 0.512 . . . . 74.33 110.744 174.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -63.61 -40.19 96.29 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 109.613 -0.514 . . . . 34.13 109.613 172.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -64.23 -42.48 96.53 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.431 1.092 . . . . 63.21 110.355 175.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -62.17 -28.27 69.55 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.1 0.56 . . . . 70.04 111.316 173.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 276' ' ' TYR . . . . . 0.471 ' HA ' ' HD3' ' C' ' 279' ' ' ARG . 3.0 m-85 -85.05 -25.21 27.76 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.254 0.464 . . . . 75.52 112.254 178.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -68.73 -33.74 74.44 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 108.361 -0.977 . . . . 44.24 108.361 171.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -64.87 -15.63 62.17 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 115.127 -0.942 . . . . 55.2 112.491 172.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 279' ' ' ARG . . . . . 0.511 ' HG2' ' H ' ' B' ' 89' ' ' GLY . 27.0 mtp-105 -82.15 -33.79 29.42 Favored 'General case' 0 C--N 1.357 0.906 0 N-CA-C 109.27 -0.641 . . . . 71.52 109.27 172.268 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.869 0 CA-C-O 118.329 -0.843 . . . . 75.14 109.502 -170.238 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.0 mtt . . . . . 0 N--CA 1.474 0.735 0 N-CA-C 107.716 -1.216 . . . . 64.12 107.716 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 78.54 -39.97 0.26 Allowed 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 125.809 1.644 . . . . 51.4 112.036 -178.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.02 76.28 4.54 Favored 'General case' 0 C--N 1.353 0.74 0 C-N-CA 123.948 0.899 . . . . 74.04 110.641 176.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -40.51 121.11 1.36 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.389 1.076 . . . . 62.43 112.991 166.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.618 ' HD2' HD11 ' A' ' 10' ' ' ILE . 29.0 mmtp -79.28 93.02 5.2 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 108.273 -1.01 . . . . 74.32 108.273 164.125 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -73.93 96.62 2.66 Favored 'General case' 0 C--N 1.352 0.686 0 N-CA-C 107.573 -1.269 . . . . 61.41 107.573 172.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.464 ' CD1' ' HA ' ' A' ' 53' ' ' ALA . 56.2 m-85 -64.39 -22.25 66.9 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 114.954 -1.021 . . . . 73.34 111.726 -171.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -63.48 -50.6 69.03 Favored 'General case' 0 C--N 1.353 0.72 0 O-C-N 123.484 0.49 . . . . 73.33 109.891 171.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.31 -40.25 96.82 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.392 0.677 . . . . 60.32 111.072 -178.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.618 HD11 ' HD2' ' A' ' 5' ' ' LYS . 68.5 mt -58.37 -43.66 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 123.284 0.633 . . . . 74.23 110.261 174.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 92.4 mt -83.26 -2.18 55.0 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 115.845 -0.616 . . . . 51.33 112.586 177.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 67.86 19.41 71.51 Favored Glycine 0 C--N 1.349 1.28 0 N-CA-C 114.639 0.616 . . . . 53.33 114.639 177.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.9 m -102.85 158.49 31.66 Favored Pre-proline 0 N--CA 1.481 1.1 0 C-N-CA 124.06 0.944 . . . . 71.43 110.874 178.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -60.81 158.26 34.1 Favored 'Trans proline' 0 C--N 1.387 2.553 0 C-N-CA 122.77 2.313 . . . . 50.12 112.156 177.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 27.8 mtp180 -74.88 10.85 1.25 Allowed 'General case' 0 CA--C 1.558 1.272 0 O-C-N 121.95 -0.469 . . . . 75.43 112.031 -178.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -119.19 5.63 11.25 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.777 1.631 . . . . 64.11 109.012 -178.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.33 138.53 55.5 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.717 0.807 . . . . 64.31 111.332 -176.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 33.9 p -90.26 -179.71 5.7 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.389 0.676 . . . . 71.11 110.1 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -52.43 -31.95 36.99 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.901 0.88 . . . . 64.21 112.683 179.063 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 19.3 tp10 -87.34 -28.51 22.19 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 112.055 0.391 . . . . 72.43 112.055 -173.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -66.12 -42.94 88.48 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 109.118 -0.697 . . . . 64.03 109.118 168.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.34 -39.85 84.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 O-C-N 124.332 1.02 . . . . 73.31 111.051 174.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -59.89 -56.0 27.2 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.935 0.894 . . . . 71.24 110.521 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 -69.56 -26.77 64.65 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 114.688 -1.142 . . . . 54.12 110.998 -176.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -75.3 -37.26 60.92 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.359 0.663 . . . . 64.0 111.079 178.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -60.06 -54.27 47.91 Favored 'General case' 0 C--O 1.216 -0.66 0 N-CA-C 108.947 -0.76 . . . . 73.1 108.947 173.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.9 mtpt -62.87 -38.02 89.2 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 124.287 0.992 . . . . 74.22 111.526 -178.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.9 ttt180 -53.14 -55.9 20.48 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.615 1.166 . . . . 71.15 110.119 174.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.7 ' HB3' HD13 ' A' ' 50' ' ' ILE . 96.5 mt -79.63 -16.22 56.2 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 115.035 -0.984 . . . . 74.11 111.613 -177.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -81.9 -19.92 39.85 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.717 0.807 . . . . 63.3 110.554 175.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 -89.7 -37.17 14.77 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.186 0.594 . . . . 72.33 110.323 171.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -69.47 -60.45 2.32 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.103 0.478 . . . . 63.33 110.391 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -93.42 34.24 1.18 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.552 0.741 . . . . 63.25 110.286 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.9 t-160 -61.58 102.5 0.31 Allowed Pre-proline 0 C--N 1.356 0.849 0 C-N-CA 124.051 0.94 . . . . 63.41 109.581 178.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -67.89 -19.66 46.16 Favored 'Trans proline' 0 C--N 1.371 1.751 0 C-N-CA 122.879 2.386 . . . . 74.13 112.279 -168.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -59.34 -39.08 82.03 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.453 1.101 . . . . 72.45 111.129 173.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.3 t -101.63 -46.63 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 123.494 0.717 . . . . 65.53 110.466 -176.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -100.51 85.63 2.99 Favored 'General case' 0 C--O 1.245 0.826 0 C-N-CA 124.482 1.113 . . . . 61.35 109.933 -177.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.72 69.94 9.6 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.316 0.646 . . . . 73.11 109.525 178.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.0 m -121.21 110.03 34.74 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-O 118.191 -0.909 . . . . 54.41 108.794 177.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -35.88 -61.9 0.26 Allowed 'Trans proline' 0 C--N 1.389 2.658 0 C-N-CA 125.157 3.904 . . . . 72.23 115.051 -171.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -67.49 -27.01 66.65 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 122.891 0.476 . . . . 64.43 111.957 -175.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.44 -30.46 67.3 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-O 121.001 0.429 . . . . 72.14 109.919 175.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.424 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 35.3 mt-10 -83.29 -28.6 28.98 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.166 -0.925 . . . . 62.01 109.337 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.478 ' HA ' ' HZ2' ' A' ' 48' ' ' LYS . 50.7 mt-10 -66.81 -43.46 83.76 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.325 0.65 . . . . 62.44 109.977 173.121 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 35.0 mmtm -61.61 -42.25 98.61 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 115.057 -0.974 . . . . 74.03 109.939 173.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.597 ' HA ' HD12 ' A' ' 50' ' ' ILE . 91.1 t80 -57.41 -37.16 72.28 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 123.737 0.648 . . . . 73.24 111.112 176.052 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.478 ' HZ2' ' HA ' ' A' ' 45' ' ' GLU . 10.4 mtmp? -70.85 -33.59 70.79 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.947 0.499 . . . . 75.14 111.472 176.081 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -71.14 -23.64 62.11 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 122.741 0.416 . . . . 71.44 111.082 173.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.7 HD13 ' HB3' ' A' ' 29' ' ' LEU . 59.9 mt -79.53 -35.68 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.718 1.207 . . . . 70.53 109.331 174.141 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -65.38 -35.86 82.25 Favored 'General case' 0 C--O 1.209 -1.05 0 CA-C-N 115.628 -0.715 . . . . 73.43 109.827 171.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -65.61 -48.9 70.71 Favored 'General case' 0 C--O 1.247 0.946 0 C-N-CA 125.344 1.458 . . . . 63.42 110.542 177.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.464 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . . . -57.87 -48.28 80.27 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 114.265 -1.334 . . . . 65.45 111.243 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -79.19 -19.87 49.78 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 115.044 -0.98 . . . . 72.32 110.891 177.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.31 -45.72 87.49 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 118.404 0.547 . . . . 53.01 109.865 174.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.594 HG13 ' HZ ' ' A' ' 101' ' ' PHE . 22.7 t -71.43 -56.37 10.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 114.138 -1.392 . . . . 74.52 110.042 175.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.676 HD22 ' HD2' ' A' ' 63' ' ' ARG . 43.5 mt -91.93 15.73 12.53 Favored 'General case' 0 CA--C 1.56 1.346 0 N-CA-C 113.644 0.979 . . . . 62.04 113.644 -164.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.2 t -71.63 -71.54 0.26 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 122.813 0.445 . . . . 74.34 110.798 171.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -79.97 143.18 57.02 Favored Pre-proline 0 N--CA 1.471 0.619 0 CA-C-N 115.439 -0.801 . . . . 74.34 110.113 -176.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -58.47 -27.06 80.73 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 123.155 2.57 . . . . 72.41 112.932 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -67.31 -59.12 3.67 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.711 0.805 . . . . 72.3 111.002 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.504 ' HA ' HD12 ' A' ' 65' ' ' ILE . 27.9 mtpt -70.07 -28.92 65.83 Favored 'General case' 0 C--O 1.248 0.987 0 CA-C-N 114.893 -1.048 . . . . 74.54 110.829 -177.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.676 ' HD2' HD22 ' A' ' 57' ' ' LEU . 31.6 tpt85 -54.21 -55.61 26.28 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 114.635 -1.166 . . . . 74.11 109.401 168.221 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.43 ' HE ' ' HA ' ' A' ' 64' ' ' ARG . 2.8 mmp_? -65.2 -25.68 67.81 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 115.761 -0.654 . . . . 74.25 112.113 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.504 HD12 ' HA ' ' A' ' 62' ' ' LYS . 78.6 mt -59.38 -47.15 91.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 CA-C-N 118.231 0.469 . . . . 64.42 110.138 171.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -58.35 -52.97 63.35 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 116.033 -0.53 . . . . 75.4 110.255 173.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -56.67 -41.85 77.99 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.477 0.711 . . . . 64.04 112.599 -176.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.8 p -74.13 -23.02 59.23 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 122.844 0.458 . . . . 75.13 110.95 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -71.0 126.58 29.96 Favored 'General case' 0 C--N 1.357 0.909 0 N-CA-C 107.42 -1.326 . . . . 63.45 107.42 170.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.82 13.93 41.88 Favored Glycine 0 N--CA 1.471 1.027 0 N-CA-C 112.108 -0.397 . . . . 52.54 112.108 -169.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 42.6 m -140.79 -57.56 0.51 Allowed 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 103.786 -2.672 . . . . 71.23 103.786 173.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 46.7 m -83.82 140.55 31.96 Favored 'General case' 0 C--O 1.247 0.951 0 N-CA-C 104.832 -2.284 . . . . 74.23 104.832 155.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.41 -26.29 17.3 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.027 0.531 . . . . 74.04 110.889 178.226 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -88.82 163.16 36.19 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 123.911 0.884 . . . . 75.1 110.516 176.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -58.23 143.88 96.43 Favored 'Trans proline' 0 C--N 1.371 1.716 0 C-N-CA 122.268 1.979 . . . . 75.41 111.657 163.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.92 159.61 47.73 Favored 'Trans proline' 0 CA--C 1.557 1.665 0 C-N-CA 122.397 2.065 . . . . 74.25 111.341 174.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -51.41 114.57 1.62 Allowed 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 122.927 2.418 . . . . 62.44 112.911 173.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -61.04 140.31 89.13 Favored 'Trans proline' 0 C--N 1.384 2.4 0 C-N-CA 123.311 2.674 . . . . 43.51 112.556 177.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.52 163.86 37.37 Favored 'Trans proline' 0 C--N 1.374 1.896 0 C-N-CA 122.766 2.311 . . . . 71.05 112.445 177.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -58.18 87.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.38 2.186 0 C-N-CA 123.122 2.548 . . . . 51.35 112.648 174.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 150.96 -34.1 0.94 Allowed Glycine 0 C--N 1.338 0.645 0 CA-C-N 114.281 -1.327 . . . . 62.41 110.006 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 106.5 -160.39 14.49 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-N 114.754 -0.723 . . . . 53.03 111.722 178.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -90.89 103.5 16.2 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 123.478 0.711 . . . . 74.41 109.3 178.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -61.63 152.51 30.53 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.728 0.811 . . . . 71.31 111.658 171.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.564 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 70.8 m-85 -142.09 75.04 1.47 Allowed 'General case' 0 C--N 1.353 0.745 0 C-N-CA 124.582 1.153 . . . . 70.22 109.411 172.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.518 ' HA ' ' O ' ' A' ' 162' ' ' PRO . 74.0 m -53.84 84.38 0.0 OUTLIER 'General case' 0 CA--C 1.562 1.405 0 C-N-CA 124.392 1.077 . . . . 74.44 113.316 -178.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 88.32 19.31 53.12 Favored Glycine 0 C--N 1.351 1.369 0 CA-C-N 115.691 -0.686 . . . . 70.11 113.992 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.564 ' HB2' ' HB3' ' A' ' 85' ' ' PHE . 37.4 m-85 -125.95 113.53 17.29 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 118.102 0.951 . . . . 72.34 110.402 -174.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -78.0 86.71 4.18 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.655 0.74 . . . . 71.44 111.008 -176.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.691 HG21 HD22 ' A' ' 105' ' ' LEU . 2.3 p -46.49 -36.31 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 124.926 1.291 . . . . 75.21 113.402 172.325 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.477 ' HB2' ' HG3' ' A' ' 170' ' ' PRO . 16.9 tp10 -54.32 -28.25 41.28 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.197 0.999 . . . . 75.33 111.563 -178.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -84.59 -39.53 18.61 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.654 0.781 . . . . 45.35 112.061 178.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 15.3 m-30 -66.15 162.58 19.46 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 113.404 0.89 . . . . 71.01 113.404 -162.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 92.2 p -65.03 164.55 12.63 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 114.025 1.12 . . . . 74.5 114.025 -165.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.88 -39.33 71.37 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 114.392 -1.276 . . . . 74.31 112.948 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -58.81 -45.59 89.59 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 121.654 0.74 . . . . 75.03 110.302 178.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -64.65 -41.0 96.42 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 113.995 -1.457 . . . . 63.23 110.109 178.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -73.35 -10.67 59.99 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 115.313 -0.858 . . . . 73.05 111.922 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -90.41 -54.48 3.99 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 118.267 0.485 . . . . 70.02 110.507 169.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 29.0 tp -60.47 -28.02 68.0 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.597 1.159 . . . . 55.03 111.786 -174.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.594 ' HZ ' HG13 ' A' ' 56' ' ' VAL . 95.4 m-85 -117.28 -3.97 11.42 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 123.072 0.549 . . . . 72.11 111.72 177.209 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -47.61 -60.63 5.21 Favored Glycine 0 CA--C 1.537 1.438 0 N-CA-C 116.035 1.174 . . . . 72.43 116.035 -175.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -66.1 5.53 0.65 Allowed 'Trans proline' 0 C--N 1.375 1.935 0 C-N-CA 123.303 2.669 . . . . 23.1 114.789 -175.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -150.58 30.92 1.03 Allowed Glycine 0 C--N 1.356 1.639 0 CA-C-O 118.79 -1.006 . . . . 44.4 112.755 170.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.691 HD22 HG21 ' A' ' 90' ' ' VAL . 17.2 mt -60.8 78.64 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 117.421 0.61 . . . . 74.25 112.502 176.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.413 ' HD1' ' H ' ' A' ' 108' ' ' GLY . 0.4 OUTLIER 38.48 -109.05 0.07 Allowed 'General case' 0 CA--C 1.563 1.464 0 C-N-CA 126.628 1.971 . . . . 72.25 113.069 -176.009 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 70.78 15.45 73.68 Favored Glycine 0 C--N 1.366 2.237 0 CA-C-O 119.165 -0.797 . . . . 44.0 114.323 -177.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.738 ' HA3' ' HB3' ' A' ' 167' ' ' GLN . . . -12.76 -69.55 0.01 OUTLIER Glycine 0 C--N 1.366 2.202 0 C-N-CA 125.895 1.712 . . . . 71.34 115.63 166.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -86.04 70.08 10.57 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 109.418 -0.586 . . . . 64.11 109.418 171.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -10.43 -74.28 0.01 OUTLIER Glycine 0 C--N 1.361 1.938 0 C-N-CA 126.534 2.016 . . . . 55.25 116.09 167.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 20.3 ttp180 -5.83 -42.16 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.481 0 C-N-CA 127.379 2.272 . . . . 71.44 116.852 166.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 -122.57 -35.41 3.08 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.194 0.998 . . . . 73.25 110.195 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 49.9 m 64.21 2.29 1.44 Allowed 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 124.775 1.23 . . . . 74.21 113.233 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 39.4 ttt180 -131.43 -148.94 0.37 Allowed 'General case' 0 CA--C 1.555 1.155 0 CA-C-O 118.219 -0.895 . . . . 74.52 109.168 -169.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.603 ' HD2' ' HB2' ' A' ' 170' ' ' PRO . 24.3 tptp -41.23 122.33 1.81 Allowed 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 125.724 1.61 . . . . 72.15 114.533 -163.351 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -83.64 175.79 52.22 Favored Glycine 0 CA--C 1.54 1.637 0 CA-C-N 115.844 -0.616 . . . . 55.22 112.592 175.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.768 ' H ' ' HA3' ' A' ' 166' ' ' GLY . 0.0 OUTLIER -116.72 174.0 6.32 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 124.118 0.967 . . . . 71.34 111.697 -178.359 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -78.46 101.66 7.43 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-O 122.02 0.914 . . . . 74.23 110.089 175.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.524 HD21 ' HD3' ' B' ' 12' ' ' PRO . 10.4 tt -112.2 139.84 47.4 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.938 0.895 . . . . 70.23 108.825 -174.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.4 ' HA ' ' HB2' ' A' ' 175' ' ' LEU . 58.3 ttt180 -94.42 139.02 31.66 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.33 0.652 . . . . 74.51 111.207 -178.129 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.4 ' HB2' HD23 ' B' ' 10' ' ' LEU . . . -134.77 169.43 17.37 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 123.981 0.912 . . . . 41.51 109.368 170.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.408 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 0.3 OUTLIER -117.64 115.74 25.68 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 107.0 -1.482 . . . . 61.0 107.0 -174.082 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 50.5 tp -100.52 100.23 11.74 Favored Pre-proline 0 N--CA 1.476 0.846 0 N-CA-C 108.912 -0.773 . . . . 54.05 108.912 -175.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.559 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 77.4 Cg_endo -84.16 111.73 1.64 Allowed 'Trans proline' 0 C--N 1.374 1.909 0 C-N-CA 121.323 1.348 . . . . 75.33 110.049 176.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.597 ' HA ' HG21 ' B' ' 6' ' ' ILE . 52.3 tp -104.99 137.09 43.28 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.706 0.402 . . . . 64.01 110.338 -176.292 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 90.0 m -68.06 126.69 30.3 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.035 0.934 . . . . 71.34 109.638 177.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 53.9 mt -53.6 -51.88 61.61 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.625 1.17 . . . . 70.54 112.47 -171.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -58.77 -37.39 76.16 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 115.115 -0.948 . . . . 75.32 110.007 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.464 ' HB3' ' NH2' ' A' ' 136' ' ' ARG . 44.6 mm-40 -80.48 -14.81 57.95 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.048 -0.978 . . . . 64.33 112.34 -178.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -70.51 -52.18 23.62 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 107.823 -1.177 . . . . 41.43 107.823 167.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -53.98 -40.1 66.59 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 116.028 -0.533 . . . . 74.51 110.913 175.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 35.9 m170 -78.41 -29.57 47.23 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 122.838 0.455 . . . . 75.25 112.099 -178.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 64.04 -138.05 41.42 Favored Glycine 0 N--CA 1.479 1.531 0 O-C-N 123.271 0.357 . . . . 71.54 113.844 176.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.36 -161.09 46.5 Favored Glycine 0 C--N 1.357 1.696 0 O-C-N 123.781 0.342 . . . . 70.42 113.002 175.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -76.23 119.09 19.65 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 109.255 -0.646 . . . . 73.14 109.255 170.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.464 ' NH2' ' HB3' ' A' ' 129' ' ' GLU . 10.0 tpp180 -93.52 123.35 36.77 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 109.336 -0.616 . . . . 74.4 109.336 175.285 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.411 HG11 ' HE ' ' A' ' 144' ' ' ARG . 98.2 t -88.37 104.07 14.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 109.018 -0.734 . . . . 71.24 109.018 175.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.401 HG22 HD11 ' B' ' 6' ' ' ILE . 15.3 t -102.64 125.36 56.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 CA-C-N 115.041 -0.981 . . . . 73.14 108.598 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -102.98 134.03 47.1 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.554 0.741 . . . . 71.3 109.968 -178.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.416 ' HB ' ' HB3' ' B' ' 8' ' ' LEU . 7.2 p -168.3 113.91 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 122.782 0.433 . . . . 75.1 111.547 178.377 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 61.26 24.78 14.84 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.396 1.078 . . . . 74.24 113.047 170.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 99.38 -11.25 61.59 Favored Glycine 0 C--N 1.349 1.286 0 CA-C-N 116.766 -0.197 . . . . 31.1 112.871 -178.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.417 ' NH2' HG23 ' A' ' 145' ' ' VAL . 16.4 tpt180 -87.9 108.42 19.17 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.872 0.869 . . . . 72.12 109.959 175.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.411 ' HE ' HG11 ' A' ' 137' ' ' VAL . 75.4 ttt180 -105.4 94.87 5.45 Favored 'General case' 0 C--O 1.244 0.794 0 C-N-CA 123.916 0.887 . . . . 74.41 108.864 175.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.418 HG22 HG13 ' A' ' 147' ' ' VAL . 11.5 p -95.58 143.67 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 123.205 0.602 . . . . 73.53 110.959 -176.242 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 33.3 t -118.16 85.6 2.38 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.82 0.848 . . . . 31.45 109.277 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.418 HG13 HG22 ' A' ' 145' ' ' VAL . 11.1 m -92.88 114.04 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 C-N-CA 123.364 0.666 . . . . 73.42 111.745 -173.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -71.32 105.56 3.54 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.449 -0.574 . . . . 74.14 109.449 173.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 21.2 pt -102.14 153.9 37.73 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 124.644 1.178 . . . . 74.13 109.772 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -57.6 -166.34 0.02 OUTLIER 'Trans proline' 0 N--CA 1.519 3.007 0 C-N-CA 124.305 3.337 . . . . 60.34 112.591 170.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -46.13 90.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.399 3.217 0 C-N-CA 121.621 1.547 . . . . 74.15 110.864 162.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 36.52 -94.58 0.01 OUTLIER Glycine 0 C--N 1.346 1.131 0 CA-C-N 113.011 -1.904 . . . . 75.51 114.521 -162.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.73 HG11 HG21 ' A' ' 178' ' ' VAL . 5.5 p 172.71 166.34 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 113.364 -1.418 . . . . 75.43 107.986 -162.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.93 146.64 50.57 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 108.59 -0.892 . . . . 73.23 108.59 177.306 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.56 ' HG2' ' NH1' ' A' ' 187' ' ' ARG . 14.9 tp10 -48.95 129.81 17.67 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.447 1.099 . . . . 72.32 112.263 -177.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 91.08 -4.9 81.58 Favored Glycine 0 C--N 1.346 1.114 0 CA-C-N 115.438 -0.801 . . . . 14.21 113.774 179.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 57.8 m -66.23 113.82 4.85 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 117.499 0.649 . . . . 74.23 110.409 179.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.415 HG22 HG22 ' A' ' 177' ' ' VAL . 61.1 t -90.13 94.93 5.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 C-N-CA 123.892 0.877 . . . . 72.34 108.949 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.595 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 60.1 mt -77.76 108.8 11.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 108.604 -0.887 . . . . 75.24 108.604 175.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 30.1 ttt180 -76.64 107.09 8.68 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.474 -0.565 . . . . 61.32 109.474 178.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.439 HG13 ' HB3' ' A' ' 174' ' ' LEU . 3.8 p -125.93 95.86 38.74 Favored Pre-proline 0 CA--C 1.55 0.958 0 N-CA-C 109.304 -0.628 . . . . 61.33 109.304 174.237 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.518 ' O ' ' HA ' ' A' ' 86' ' ' SER . 30.0 Cg_exo -62.25 142.04 90.04 Favored 'Trans proline' 0 C--N 1.369 1.636 0 C-N-CA 122.524 2.149 . . . . 74.53 111.597 174.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.424 ' N ' ' HB3' ' A' ' 171' ' ' PRO . . . 121.04 -26.36 6.79 Favored Glycine 0 N--CA 1.475 1.299 0 CA-C-N 117.855 0.298 . . . . 70.43 112.759 175.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 68.4 mtm -116.36 2.74 13.24 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 122.761 0.424 . . . . 64.15 110.858 -178.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.406 ' HA2' HD13 ' A' ' 174' ' ' LEU . . . -83.39 -108.99 0.52 Allowed Glycine 0 C--N 1.353 1.505 0 N-CA-C 110.875 -0.89 . . . . 73.33 110.875 175.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.768 ' HA3' ' H ' ' A' ' 117' ' ' ARG . . . -57.69 108.62 1.44 Allowed Glycine 0 C--O 1.263 1.932 0 N-CA-C 110.902 -0.879 . . . . 74.5 110.902 164.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.738 ' HB3' ' HA3' ' A' ' 108' ' ' GLY . 27.1 mm-40 -67.47 105.2 1.75 Allowed 'General case' 0 N--CA 1.446 -0.63 0 O-C-N 125.453 1.325 . . . . 75.42 109.204 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -178.26 169.08 40.67 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 110.871 -0.891 . . . . 64.21 110.871 -176.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ASN . . . . . 0.519 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . 34.3 t30 -63.03 -67.98 0.94 Allowed Pre-proline 0 CA--C 1.57 1.722 0 CA-C-O 117.026 -1.464 . . . . 63.11 111.639 -170.269 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.603 ' HB2' ' HD2' ' A' ' 115' ' ' LYS . 17.0 Cg_exo -66.23 116.01 3.8 Favored 'Trans proline' 0 C--N 1.396 3.066 0 CA-C-N 122.878 2.063 . . . . 71.13 109.922 167.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.424 ' HB3' ' N ' ' A' ' 163' ' ' GLY . 18.8 Cg_exo -40.5 127.27 2.32 Favored 'Trans proline' 0 C--N 1.368 1.592 0 C-N-CA 125.214 3.943 . . . . 71.25 117.131 -171.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -83.11 132.14 10.87 Favored Glycine 0 C--N 1.367 2.289 0 CA-C-O 119.159 -0.801 . . . . 72.4 111.987 164.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.445 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 22.8 m-20 -64.48 108.35 1.63 Allowed 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.166 0.586 . . . . 71.14 110.82 -175.047 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.452 HD21 HD21 ' B' ' 8' ' ' LEU . 38.3 tp -83.64 129.31 34.96 Favored 'General case' 0 C--N 1.349 0.545 0 N-CA-C 109.623 -0.51 . . . . 64.32 109.623 175.108 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.4 ' HB2' ' HA ' ' A' ' 120' ' ' ARG . 55.6 mt -99.1 88.45 3.95 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 107.999 -1.112 . . . . 72.12 107.999 178.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.595 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 75.1 mt -70.62 87.32 0.67 Allowed 'General case' 0 C--N 1.35 0.609 0 N-CA-C 109.06 -0.719 . . . . 70.05 109.06 174.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.415 HG22 HG22 ' A' ' 158' ' ' VAL . 19.7 t -82.62 102.15 8.22 Favored 'Isoleucine or valine' 0 C--O 1.248 1.017 0 N-CA-C 105.749 -1.945 . . . . 61.43 105.749 175.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.73 HG21 HG11 ' A' ' 153' ' ' VAL . 5.4 p -73.42 131.89 34.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 115.034 -0.985 . . . . 70.33 110.865 -169.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.559 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 28.9 mmt180 -112.72 127.27 56.09 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 106.261 -1.755 . . . . 53.32 106.261 167.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.426 HD23 ' HB3' ' A' ' 125' ' ' LEU . 27.7 mt -80.12 147.7 31.28 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.477 -0.935 . . . . 72.4 108.477 169.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 20.2 mt -53.28 152.49 8.17 Favored Pre-proline 0 N--CA 1.482 1.145 0 O-C-N 124.174 0.921 . . . . 73.14 113.021 -167.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' PRO . . . . . 0.446 ' HB3' ' HG2' ' B' ' 149' ' ' LYS . 24.6 Cg_exo -65.16 5.23 0.53 Allowed 'Trans proline' 0 C--N 1.383 2.354 0 C-N-CA 123.566 2.844 . . . . 71.42 113.425 175.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 61.2 t-80 -59.56 104.0 0.41 Allowed Pre-proline 0 CA--C 1.56 1.341 0 C-N-CA 124.894 1.278 . . . . 73.35 107.985 168.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -80.81 26.36 0.6 Allowed 'Trans proline' 0 C--N 1.372 1.773 0 C-N-CA 123.792 2.995 . . . . 61.24 115.537 -162.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.424 HG12 ' HD1' ' A' ' 186' ' ' PHE . 75.5 t -95.22 -61.03 2.28 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.901 0 CA-C-O 118.715 -0.659 . . . . 64.21 110.848 -175.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' PHE . . . . . 0.424 ' HD1' HG12 ' A' ' 185' ' ' VAL . 3.9 m-85 -138.11 92.57 2.67 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 119.064 0.847 . . . . 72.31 110.34 -176.105 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.56 ' NH1' ' HG2' ' A' ' 155' ' ' GLU . 62.1 ttp85 -98.09 98.24 9.58 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.867 0.867 . . . . 75.51 109.391 176.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 193' ' ' LEU . 61.9 tp -68.78 142.15 55.0 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.163 0.985 . . . . 74.21 110.864 178.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -152.7 129.03 10.56 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.792 1.237 . . . . 70.31 109.973 -174.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 68.51 -80.5 0.22 Allowed Glycine 0 C--N 1.351 1.412 0 N-CA-C 111.916 -0.474 . . . . 65.41 111.916 -177.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.573 ' HG3' ' HB3' ' A' ' 244' ' ' ALA . 14.6 mm100 -147.47 -11.18 0.41 Allowed 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 125.069 1.347 . . . . 72.32 110.533 166.06 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -103.7 148.81 25.61 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.492 1.117 . . . . 72.32 110.944 -174.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 188' ' ' LEU . 11.6 mt -90.36 162.67 15.03 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.245 1.018 . . . . 63.44 111.02 -175.192 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -131.16 114.51 15.19 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.303 1.041 . . . . 73.14 109.142 173.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.524 ' HB3' HD23 ' A' ' 251' ' ' LEU . . . -135.68 174.92 10.08 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.64 1.176 . . . . 74.34 110.458 -176.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 27.9 m -120.72 144.87 48.02 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.818 0.847 . . . . 70.21 108.878 173.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.503 HD21 HG21 ' A' ' 210' ' ' VAL . 44.7 tp -129.4 115.92 18.26 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.621 0.768 . . . . 72.21 109.457 -175.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -90.24 121.05 31.92 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 108.092 -1.077 . . . . 61.43 108.092 173.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.5 p -139.5 131.02 14.85 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 124.054 0.942 . . . . 64.4 109.136 -173.09 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -72.35 148.58 49.23 Favored 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 121.602 1.535 . . . . 64.51 110.77 174.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -49.54 -47.4 78.17 Favored Pre-proline 0 CA--C 1.561 1.374 0 N-CA-C 114.131 1.16 . . . . 71.34 114.131 -174.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -51.66 -48.09 23.11 Favored 'Trans proline' 0 C--N 1.384 2.442 0 C-N-CA 122.022 1.815 . . . . 63.54 113.725 176.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 22.9 mt -73.12 -29.36 28.31 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 CA-C-N 115.74 -0.664 . . . . 64.32 110.514 -176.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.4 -41.71 76.06 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.979 0.512 . . . . 71.51 111.493 176.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 54.6 t -74.26 -46.88 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 123.867 0.867 . . . . 63.23 111.875 -175.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 91.5 t -90.56 -31.35 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 122.884 0.473 . . . . 74.41 111.569 -175.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 82.49 111.22 0.45 Allowed Glycine 0 C--N 1.343 0.928 0 N-CA-C 112.37 -0.292 . . . . 72.35 112.37 178.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.465 ' HA3' ' CE1' ' C' ' 277' ' ' TYR . . . -145.47 -132.61 2.47 Favored Glycine 0 C--O 1.217 -0.957 0 CA-C-O 119.178 -0.79 . . . . 55.24 111.719 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -112.05 134.83 53.36 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 118.008 0.904 . . . . 45.21 110.377 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.503 HG21 HD21 ' A' ' 197' ' ' LEU . 12.2 m -132.88 162.34 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 124.796 1.238 . . . . 63.11 108.633 171.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 211' ' ' ARG . . . . . 0.468 ' HG2' HG13 ' B' ' 421' ' ' VAL . 5.8 tpp180 -86.1 126.96 34.58 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 109.314 -0.624 . . . . 71.41 109.314 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.44 109.93 21.84 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.409 -0.96 . . . . 62.04 108.409 170.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 16.9 tpt -83.0 111.82 19.2 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 108.45 -0.944 . . . . 71.23 108.45 177.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 26.5 p -107.55 -174.47 2.54 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 109.502 -0.555 . . . . 74.1 109.502 -174.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 80.7 mt -63.94 -33.9 76.77 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.019 0.927 . . . . 63.31 111.942 -176.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -97.24 -6.63 34.14 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.421 0.688 . . . . 64.44 112.118 -177.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 135.06 -179.03 18.08 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-O 120.054 -0.303 . . . . 33.0 112.61 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -79.6 147.35 19.72 Favored 'Trans proline' 0 CA--C 1.549 1.238 0 C-N-CA 122.94 2.426 . . . . 70.23 113.455 -176.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 31.7 m -136.04 -177.91 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.624 1.569 . . . . 73.4 107.556 172.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.565 ' HB2' ' H ' ' B' ' 437' ' ' SER . 55.5 mt-10 -109.77 127.77 54.85 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 118.499 0.59 . . . . 75.04 109.745 169.259 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.452 ' HB ' HD11 ' B' ' 441' ' ' ILE . 7.0 m -107.52 132.25 55.54 Favored 'Isoleucine or valine' 0 C--O 1.242 0.683 0 C-N-CA 124.178 0.991 . . . . 74.13 108.512 168.014 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -80.24 97.3 6.89 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.572 -0.899 . . . . 60.25 108.572 178.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 14.9 p -65.62 137.39 96.36 Favored Pre-proline 0 N--CA 1.479 1.007 0 C-N-CA 124.186 0.994 . . . . 63.14 109.732 -175.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -72.04 165.93 31.12 Favored 'Trans proline' 0 C--N 1.374 1.9 0 C-N-CA 122.158 1.906 . . . . 75.51 111.931 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -73.58 164.11 35.75 Favored 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 122.214 1.942 . . . . 72.53 112.916 172.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 64.2 mtt-85 61.44 26.94 16.61 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 125.377 1.471 . . . . 74.04 111.812 169.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.525 HG23 HD21 ' A' ' 233' ' ' LEU . 94.6 m -72.06 103.87 3.4 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.19 1.396 . . . . 64.32 110.873 -176.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -87.08 138.11 31.77 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.636 1.174 . . . . 75.32 110.313 -175.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' ALA . . . . . 0.482 ' HA ' ' HB ' ' A' ' 253' ' ' VAL . . . -67.2 156.64 35.76 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.561 0.744 . . . . 62.31 111.973 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 83.51 -14.87 38.48 Favored Glycine 0 N--CA 1.471 0.99 0 CA-C-N 116.024 -0.535 . . . . 73.32 112.892 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -92.42 160.78 14.93 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 123.691 0.796 . . . . 74.0 110.4 177.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -113.49 113.5 25.22 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.783 0.833 . . . . 72.22 108.79 178.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.525 HD21 HG23 ' A' ' 227' ' ' THR . 64.7 mt -76.24 117.21 17.69 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.793 0.837 . . . . 71.4 109.683 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 27.8 ttm-85 -85.97 102.69 14.0 Favored 'General case' 0 CA--C 1.551 1.001 0 N-CA-C 108.679 -0.859 . . . . 64.14 108.679 172.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.532 HD12 HD23 ' A' ' 249' ' ' LEU . 3.1 mt -87.76 110.9 20.81 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 108.581 -0.896 . . . . 61.12 108.581 -178.108 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -59.38 127.84 34.1 Favored 'General case' 0 CA--C 1.555 1.135 0 O-C-N 124.098 0.874 . . . . 64.43 113.254 -177.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 82.59 6.37 88.63 Favored Glycine 0 C--N 1.353 1.5 0 N-CA-C 114.847 0.699 . . . . 74.2 114.847 170.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -95.31 -20.51 19.1 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 117.515 0.657 . . . . 73.01 112.714 -172.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -82.21 -173.01 48.42 Favored Glycine 0 N--CA 1.478 1.451 0 N-CA-C 113.717 0.247 . . . . 74.43 113.717 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -84.87 146.95 47.21 Favored Pre-proline 0 N--CA 1.483 1.213 0 C-N-CA 122.898 0.479 . . . . 73.13 111.811 -167.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -68.98 157.16 62.96 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 123.323 2.682 . . . . 73.33 113.326 173.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 169.84 -156.51 27.38 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 119.305 -0.719 . . . . 73.52 112.07 -178.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -61.99 -28.27 80.43 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 123.786 2.991 . . . . 70.45 113.286 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.573 ' HB3' ' HG3' ' A' ' 191' ' ' GLN . . . -87.38 22.32 2.2 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.252 0.621 . . . . 70.11 111.416 176.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 75.01 -97.32 1.01 Allowed Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.47 -1.052 . . . . 62.24 110.47 -175.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 39.2 mtp180 -128.05 152.4 48.01 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.718 0.807 . . . . 75.41 110.167 166.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -91.57 -175.65 43.07 Favored Glycine 0 C--N 1.342 0.876 0 CA-C-N 116.082 -0.508 . . . . 42.24 112.031 171.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -112.62 -173.25 2.21 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.601 0.76 . . . . 75.44 110.588 178.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.532 HD23 HD12 ' A' ' 235' ' ' LEU . 19.1 tp -125.55 115.6 20.44 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 122.102 -0.374 . . . . 70.31 110.17 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -80.44 123.08 27.74 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.545 -0.539 . . . . 52.51 109.545 172.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.524 HD23 ' HB3' ' A' ' 195' ' ' ALA . 57.8 mt -114.67 119.21 35.93 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.414 0.685 . . . . 72.24 109.415 171.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -77.46 116.94 18.45 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 106.579 -1.637 . . . . 75.41 106.579 176.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.482 ' HB ' ' HA ' ' A' ' 229' ' ' ALA . 24.3 t -75.71 109.68 9.6 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 CA-C-O 121.234 0.54 . . . . 24.43 110.569 -173.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.78 93.36 4.42 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.054 1.341 . . . . 73.14 107.625 177.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.4 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 58.6 mt -83.57 132.41 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-O 120.758 0.313 . . . . 74.34 110.308 -177.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 28.0 p -121.48 172.11 8.3 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.619 1.167 . . . . 73.43 109.889 174.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 257' ' ' ILE . . . . . 0.511 HD12 ' H ' ' A' ' 259' ' ' GLU . 2.1 pp -126.48 154.86 75.15 Favored Pre-proline 0 CA--C 1.562 1.429 0 N-CA-C 107.966 -1.124 . . . . 73.4 107.966 175.125 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 258' ' ' PRO . . . . . 0.461 ' HG3' ' OH ' ' C' ' 276' ' ' TYR . 61.2 Cg_endo -75.96 14.42 1.08 Allowed 'Trans proline' 0 N--CA 1.511 2.549 0 C-N-CA 123.36 2.707 . . . . 74.45 115.713 -164.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.511 ' H ' HD12 ' A' ' 257' ' ' ILE . 5.6 mm-40 54.1 -125.12 2.28 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 124.142 0.977 . . . . 63.24 111.682 -170.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 260' ' ' ARG . . . . . 0.48 ' HD3' ' H ' ' A' ' 260' ' ' ARG . 0.0 OUTLIER -63.61 140.61 58.89 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 118.449 0.568 . . . . 75.12 110.904 -170.443 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.417 HD11 ' CG1' ' C' ' 205' ' ' VAL . 84.9 mt -110.34 160.6 16.42 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.248 0.619 . . . . 55.32 111.584 -171.265 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 21.3 p -103.92 146.85 33.32 Favored Pre-proline 0 CA--C 1.554 1.118 0 C-N-CA 124.652 1.181 . . . . 44.34 108.94 174.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 263' ' ' PRO . . . . . 0.469 ' O ' ' HB3' ' A' ' 266' ' ' GLU . 21.7 Cg_exo -29.46 -58.74 0.14 Allowed 'Trans proline' 0 C--N 1.389 2.692 1 C-N-CA 126.089 4.526 . . . . 74.33 117.948 -163.209 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -72.28 -45.41 60.22 Favored 'General case' 0 C--O 1.211 -0.949 0 CA-C-O 119.217 -0.42 . . . . 71.44 110.711 -176.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -60.17 -31.49 70.16 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 123.955 0.784 . . . . 64.2 109.819 178.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 266' ' ' GLU . . . . . 0.471 ' O ' ' HD3' ' A' ' 270' ' ' LYS . 8.3 tp10 -59.47 -60.58 3.62 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.925 0.89 . . . . 73.45 109.045 171.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -63.99 -21.58 66.56 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 115.235 -0.893 . . . . 64.12 112.198 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 268' ' ' LEU . . . . . 0.418 ' HA ' ' HE2' ' A' ' 271' ' ' LYS . 26.3 tp -79.7 -48.7 13.24 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.548 1.139 . . . . 73.14 110.24 -173.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 70.6 m95 -61.03 -39.07 88.37 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.336 -0.847 . . . . 75.0 110.401 172.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 270' ' ' LYS . . . . . 0.609 ' HG3' HG23 ' C' ' 206' ' ' VAL . 1.0 OUTLIER -63.08 -45.7 90.92 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 123.689 0.618 . . . . 62.43 111.676 176.09 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 271' ' ' LYS . . . . . 0.418 ' HE2' ' HA ' ' A' ' 268' ' ' LEU . 30.3 mtmm -56.63 -50.01 73.28 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 123.082 0.553 . . . . 70.22 110.813 176.345 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 272' ' ' LEU . . . . . 0.418 ' O ' ' HB2' ' A' ' 276' ' ' TYR . 57.8 mt -51.32 -50.97 58.36 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 124.444 1.09 . . . . 63.4 110.4 175.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -72.73 -34.1 66.84 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 114.158 1.17 . . . . 64.51 114.158 -168.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -78.06 -41.68 34.66 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 122.75 0.42 . . . . 74.35 110.105 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -67.39 -30.8 70.67 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 115.98 -0.555 . . . . 71.44 110.52 174.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 276' ' ' TYR . . . . . 0.418 ' HB2' ' O ' ' A' ' 272' ' ' LEU . 35.1 t80 -66.15 -62.76 1.31 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.326 1.051 . . . . 75.02 109.596 176.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -60.43 -44.04 96.19 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.525 1.13 . . . . 70.12 111.168 -172.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -63.13 -17.82 62.75 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 112.467 0.543 . . . . 75.41 112.467 -179.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 -128.27 19.62 6.37 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.668 0.787 . . . . 74.13 111.016 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.08 0 CA-C-O 118.786 -0.626 . . . . 72.21 110.552 -174.956 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.482 1.167 0 N-CA-C 108.866 -0.79 . . . . 71.44 108.866 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.6 ' HE3' ' HA ' ' B' ' 2' ' ' LYS . 0.5 OUTLIER -69.31 129.34 39.52 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 123.656 0.597 . . . . 54.1 110.046 -177.22 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 22.7 tm0? -144.71 145.01 31.5 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 108.462 -0.94 . . . . 74.04 108.462 -173.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 72.5 p 54.86 -85.21 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 125.859 1.663 . . . . 52.14 113.041 -178.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 11.3 m -75.01 157.63 34.58 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.018 0.527 . . . . 70.11 110.218 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.597 HG21 ' HA ' ' A' ' 125' ' ' LEU . 36.3 pt -131.43 170.26 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 123.158 0.583 . . . . 64.44 111.071 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -142.04 132.98 25.88 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.583 0.753 . . . . 72.01 109.955 -177.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.452 HD21 HD21 ' A' ' 174' ' ' LEU . 48.5 tp -79.05 154.42 29.46 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.775 0.83 . . . . 75.22 111.338 -173.326 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -79.17 -63.56 1.39 Allowed 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.349 0.66 . . . . 62.4 112.153 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 10' ' ' LEU . . . . . 0.4 HD23 ' HB2' ' A' ' 121' ' ' ALA . 86.5 mt 62.91 117.43 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 124.865 1.266 . . . . 74.1 110.566 -163.36 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 28.2 mt -89.63 -15.89 0.21 Allowed Pre-proline 0 CA--C 1.584 2.278 0 N-CA-C 116.298 1.962 . . . . 45.35 116.298 -176.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.524 ' HD3' HD21 ' A' ' 119' ' ' LEU . 63.8 Cg_endo -67.11 -4.13 11.02 Favored 'Trans proline' 0 C--N 1.406 3.563 0 CA-C-N 124.068 2.489 . . . . 61.33 114.653 -175.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 13' ' ' LEU . . . . . 0.524 HD23 ' H ' ' B' ' 13' ' ' LEU . 2.1 pt? -128.94 6.54 5.48 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.986 0.915 . . . . 75.01 110.644 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 18.2 tp -102.64 167.49 9.87 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 108.582 -0.896 . . . . 64.54 108.582 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -64.26 115.17 4.78 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 122.677 0.391 . . . . 60.01 110.516 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 16' ' ' THR . . . . . 0.402 ' HB ' ' HD2' ' B' ' 17' ' ' PRO . 63.2 p -128.39 176.94 2.37 Favored Pre-proline 0 CA--C 1.559 1.326 0 C-N-CA 124.746 1.218 . . . . 51.11 108.46 176.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 17' ' ' PRO . . . . . 0.402 ' HD2' ' HB ' ' B' ' 16' ' ' THR . 54.7 Cg_exo -47.07 149.01 3.79 Favored 'Trans proline' 0 C--N 1.384 2.437 0 C-N-CA 122.604 2.202 . . . . 62.42 113.563 166.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 15.4 m -76.28 78.63 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 CA-C-O 122.473 1.13 . . . . 61.41 111.522 -174.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 27.3 p -76.64 91.98 3.47 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 114.663 -1.153 . . . . 71.22 110.403 -177.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp 75.21 -51.21 0.66 Allowed 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 126.075 1.75 . . . . 62.34 112.345 177.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.28 100.47 1.05 Allowed 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.954 -0.758 . . . . 75.34 108.954 167.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 -153.25 9.28 0.42 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.241 0.616 . . . . 73.31 112.036 -172.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 23' ' ' THR . . . . . 0.429 ' HB ' ' HD2' ' B' ' 24' ' ' PRO . 26.9 p 59.58 -176.33 0.03 OUTLIER Pre-proline 0 CA--C 1.576 1.946 0 C-N-CA 124.736 1.215 . . . . 72.45 111.279 177.028 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 24' ' ' PRO . . . . . 0.429 ' HD2' ' HB ' ' B' ' 23' ' ' THR . 81.4 Cg_exo -54.19 -10.64 2.17 Favored 'Trans proline' 0 C--N 1.392 2.844 0 C-N-CA 122.19 1.927 . . . . 74.55 114.822 165.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 78.83 -32.35 0.15 Allowed 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 126.299 1.84 . . . . 74.53 112.218 174.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -124.04 50.45 3.57 Favored Pre-proline 0 CA--C 1.573 1.834 0 C-N-CA 123.547 0.739 . . . . 75.13 112.097 169.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -85.12 -2.23 9.46 Favored 'Trans proline' 0 C--N 1.397 3.087 0 C-N-CA 121.653 1.569 . . . . 71.1 111.215 169.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 16.8 m -125.15 -152.9 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 C-N-CA 125.749 1.62 . . . . 73.51 108.511 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.466 ' O ' ' HG3' ' B' ' 337' ' ' LYS . 83.5 mt 81.72 -49.8 0.24 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 125.938 1.695 . . . . 62.2 111.325 177.001 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.468 ' HG3' ' H ' ' B' ' 32' ' ' ARG . 8.7 tp10 68.83 141.65 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.562 1.145 . . . . 70.24 111.841 177.241 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -87.81 25.1 1.59 Allowed 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.671 0.788 . . . . 74.34 111.704 -179.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 32' ' ' ARG . . . . . 0.468 ' H ' ' HG3' ' B' ' 30' ' ' GLU . 11.1 ptm180 -65.76 -14.14 60.76 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.799 0.84 . . . . 72.22 111.958 174.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 33' ' ' ALA . . . . . 0.407 ' HB3' ' HG2' ' C' ' 162' ' ' PRO . . . -79.71 18.88 0.71 Allowed 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 124.254 1.021 . . . . 73.31 113.476 -174.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -155.24 92.1 1.4 Allowed 'General case' 0 C--O 1.242 0.683 0 C-N-CA 123.666 0.786 . . . . 53.33 109.679 173.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -76.99 -41.8 41.4 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 116.35 -0.386 . . . . 73.13 109.992 173.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 141.97 -31.68 2.07 Favored Glycine 0 C--N 1.342 0.889 0 CA-C-N 115.515 -0.766 . . . . 74.33 112.212 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 37' ' ' ASP . . . . . 0.498 ' HA ' ' HG2' ' C' ' 27' ' ' LYS . 24.2 m-20 -70.71 103.58 2.6 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.417 0.687 . . . . 61.44 111.819 -176.131 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 38' ' ' ILE . . . . . 0.496 HG22 ' HD2' ' C' ' 23' ' ' LYS . 31.6 mt -129.52 80.44 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 N-CA-C 107.61 -1.256 . . . . 75.44 107.61 172.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 59.3 p 56.13 129.89 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 126.93 2.092 . . . . 64.25 114.95 178.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -87.49 -177.35 0.86 Allowed Pre-proline 0 CA--C 1.573 1.841 0 CA-C-O 117.456 -1.259 . . . . 64.0 108.581 175.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -77.72 -168.18 0.57 Allowed 'Trans proline' 0 C--N 1.4 3.279 0 CA-C-N 122.965 2.095 . . . . 72.44 112.986 -168.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 178.79 -139.98 4.26 Favored Glycine 0 C--N 1.339 0.744 0 N-CA-C 110.501 -1.039 . . . . 45.24 110.501 177.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -81.38 72.56 2.74 Favored Glycine 0 C--N 1.342 0.874 0 N-CA-C 111.893 -0.483 . . . . 42.15 111.893 176.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -83.78 59.23 5.07 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.713 0.805 . . . . 63.2 109.462 177.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.656 ' HG2' ' HA ' ' B' ' 48' ' ' THR . 75.8 ttt180 -73.12 84.06 1.32 Allowed 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.304 1.041 . . . . 74.21 110.46 -169.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 29.1 ttm180 -65.46 129.11 38.56 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.731 1.212 . . . . 75.02 110.042 -178.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 10.4 tt 74.52 -14.81 0.68 Allowed 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 124.991 1.317 . . . . 53.22 111.738 -177.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.656 ' HA ' ' HG2' ' B' ' 45' ' ' ARG . 41.2 m 62.44 -78.25 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.247 1.419 . . . . 51.22 111.988 -171.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.37 69.96 1.12 Allowed Glycine 0 C--N 1.343 0.956 0 N-CA-C 111.395 -0.682 . . . . 74.15 111.395 -173.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 68.78 -79.24 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 125.273 1.429 . . . . 64.2 113.181 173.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 15.9 tp60 57.49 -88.83 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 124.696 1.198 . . . . 75.3 111.842 -172.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 5.6 m -109.04 49.21 0.83 Allowed 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 122.517 1.151 . . . . 73.31 109.244 -175.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -94.43 37.04 1.12 Allowed 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 114.988 -1.006 . . . . 73.24 110.197 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . 66.11 29.9 9.68 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.669 1.188 . . . . 75.51 111.697 175.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 59.4 tp -67.24 -65.47 0.68 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.581 0.753 . . . . 72.35 110.005 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -132.11 14.43 4.69 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.34 1.056 . . . . 73.2 109.725 177.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -83.18 81.27 8.77 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 124.235 1.014 . . . . 75.31 110.094 -170.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 22.6 m -83.31 77.64 9.76 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.252 -0.885 . . . . 62.01 110.179 -177.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 59' ' ' LEU . . . . . 0.671 ' HG ' ' HA ' ' B' ' 63' ' ' PRO . 2.9 tt 62.74 72.24 0.5 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.804 1.242 . . . . 72.44 109.924 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 18.5 m -73.9 -35.47 64.65 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-N 115.418 -0.81 . . . . 63.51 109.965 174.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -166.86 -56.57 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.88 1.672 . . . . 71.45 106.5 175.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 62' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -55.79 120.63 34.3 Favored Pre-proline 0 CA--C 1.547 0.862 0 CA-C-N 113.767 -1.56 . . . . 72.3 109.947 168.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 63' ' ' PRO . . . . . 0.671 ' HA ' ' HG ' ' B' ' 59' ' ' LEU . 26.5 Cg_endo -61.02 -46.53 15.51 Favored 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 122.765 2.31 . . . . 72.24 111.86 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 67.46 -8.15 0.5 Allowed 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 125.114 1.365 . . . . 72.04 113.574 177.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm 66.44 5.89 4.03 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 125.326 1.45 . . . . 65.32 111.936 -176.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -85.13 108.28 17.61 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 123.864 0.866 . . . . 72.41 110.847 -171.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 4.3 tt -157.94 100.85 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 124.364 1.065 . . . . 72.03 108.706 176.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 57.8 mt 65.84 -76.47 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 125.716 1.607 . . . . 73.4 111.232 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -145.85 -169.23 3.19 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.042 0.937 . . . . 73.12 108.875 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 70' ' ' LEU . . . . . 0.549 HD23 ' H ' ' B' ' 70' ' ' LEU . 1.5 pt? -55.33 92.04 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.128 0 CA-C-O 121.995 0.902 . . . . 44.44 109.685 167.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 8.3 tp -79.9 -39.09 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 115.115 -0.948 . . . . 74.32 111.087 -172.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.36 106.75 0.43 Allowed Glycine 0 C--O 1.241 0.579 0 N-CA-C 111.309 -0.717 . . . . 62.21 111.309 -169.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -66.98 96.25 0.42 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.761 0.824 . . . . 63.44 109.439 -178.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.85 44.77 60.86 Favored Glycine 0 C--N 1.349 1.301 0 N-CA-C 111.533 -0.627 . . . . 64.42 111.533 -172.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 50.6 mtt 71.01 -63.78 0.41 Allowed 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 125.688 1.595 . . . . 74.01 111.29 -168.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 59.06 38.61 93.25 Favored Glycine 0 C--N 1.355 1.633 0 N-CA-C 112.136 -0.386 . . . . 71.13 112.136 177.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -58.12 -27.64 63.92 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.106 1.363 . . . . 73.03 113.118 -169.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 23.1 t 69.25 59.84 0.32 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.711 1.204 . . . . 51.1 109.263 -175.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -96.6 144.45 26.65 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 114.614 -1.176 . . . . 74.44 111.166 -172.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.478 HG23 ' H ' ' B' ' 81' ' ' THR 0.283 0.0 OUTLIER 49.22 -75.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 C-N-CA 127.242 2.217 . . . . 72.52 114.027 178.634 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' B' B ' 81' ' ' THR . . . . . 0.478 ' H ' HG23 ' B' ' 80' ' ' ILE . 8.7 t -80.63 -21.13 41.78 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.79 0.836 . . . . 71.34 110.23 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 73.15 153.86 0.14 Allowed 'General case' 0 C--N 1.354 0.786 0 C-N-CA 125.611 1.564 . . . . 61.11 111.965 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -87.07 67.36 9.7 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.543 0.737 . . . . 71.35 109.749 -176.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 83.2 mtm180 -79.53 95.82 5.94 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 114.935 -1.029 . . . . 73.0 110.39 -178.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -95.34 130.16 42.21 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 123.839 0.856 . . . . 72.23 109.696 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -73.56 118.6 16.71 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.919 -0.771 . . . . 63.12 108.919 174.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.84 87.54 0.53 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.037 0.935 . . . . 52.24 111.911 -171.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -107.27 -41.86 5.0 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.068 0.947 . . . . 74.14 109.414 176.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -146.94 65.67 0.42 Allowed Glycine 0 C--N 1.341 0.858 0 CA-C-N 115.017 -0.992 . . . . 54.33 110.754 -177.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.21 -172.91 2.6 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 123.69 0.796 . . . . 62.33 110.968 178.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -70.53 6.37 6.11 Favored Glycine 0 C--N 1.351 1.384 0 N-CA-C 115.453 0.941 . . . . 70.11 115.453 -172.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -81.92 31.11 2.84 Favored Glycine 0 C--N 1.356 1.642 0 CA-C-N 117.542 0.671 . . . . 23.53 113.804 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -71.94 100.47 2.46 Favored 'General case' 0 C--N 1.351 0.665 0 N-CA-C 109.59 -0.522 . . . . 74.22 109.59 174.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -153.59 94.29 1.77 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.171 -0.677 . . . . 71.21 109.171 173.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 95' ' ' LYS . . . . . 0.701 ' HG2' ' HB3' ' B' ' 98' ' ' ASP . 24.4 tptm -84.77 -58.41 2.73 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.88 -0.785 . . . . 74.14 108.88 173.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.44 15.91 77.34 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-N 115.707 -0.679 . . . . 72.31 114.076 173.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 10.2 tp -156.1 11.62 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.559 1.311 0 CA-C-O 122.046 0.927 . . . . 72.22 109.535 -178.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 98' ' ' ASP . . . . . 0.701 ' HB3' ' HG2' ' B' ' 95' ' ' LYS . 6.8 p-10 -80.85 114.38 19.7 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 123.465 0.706 . . . . 75.21 110.134 -178.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 99' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' B' ' 323' ' ' GLN . . . -91.44 65.9 5.36 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.528 -0.76 . . . . 61.12 109.098 174.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 100' ' ' LEU . . . . . 0.479 ' HG ' ' HB2' ' B' ' 98' ' ' ASP . 95.7 mt -98.85 123.84 47.98 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 115.619 -0.719 . . . . 74.2 110.135 -176.184 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 101' ' ' PRO . . . . . 0.497 ' HA ' ' HG2' ' B' ' 324' ' ' MET . 89.1 Cg_endo -78.42 133.08 11.6 Favored 'Trans proline' 0 C--N 1.375 1.945 0 C-N-CA 122.98 2.453 . . . . 72.21 112.488 178.394 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 102' ' ' LEU . . . . . 0.584 HD21 ' HB1' ' B' ' 322' ' ' ALA . 2.5 mm? -90.45 -38.41 13.29 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.341 0.656 . . . . 73.12 109.748 176.107 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 15.3 t -151.76 -172.36 4.2 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 115.206 -0.906 . . . . 75.52 109.582 -175.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . -71.34 86.26 0.41 Allowed Glycine 0 C--N 1.351 1.401 0 N-CA-C 112.345 -0.302 . . . . 51.35 112.345 177.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 105' ' ' GLN . . . . . 0.533 ' NE2' ' HA ' ' B' ' 326' ' ' ASP . 24.2 tm0? -68.46 113.72 6.25 Favored 'General case' 0 C--N 1.35 0.625 0 N-CA-C 108.828 -0.804 . . . . 75.22 108.828 176.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 14.5 m-30 60.06 -179.73 0.09 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.678 1.191 . . . . 74.44 113.247 -178.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 71.0 p -96.3 34.02 1.67 Allowed 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.696 0.799 . . . . 63.32 112.063 -174.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 26.5 p80 -90.21 38.13 0.92 Allowed 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.584 0.706 . . . . 71.44 110.552 175.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -120.76 -60.9 1.62 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.71 1.204 . . . . 53.33 107.958 -176.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.75 164.92 20.33 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-N 115.198 -0.91 . . . . 71.24 108.731 166.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 111' ' ' LEU . . . . . 0.743 ' HA ' ' HA ' ' C' ' 243' ' ' PRO . 84.1 mt 64.87 21.58 12.37 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.755 0.822 . . . . 64.15 110.97 -175.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 33.9 t-20 -78.7 135.35 37.15 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.46 0.704 . . . . 73.2 110.258 -170.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 113' ' ' LYS . . . . . 0.517 ' HG2' ' H ' ' B' ' 114' ' ' LYS 0.279 0.0 OUTLIER 32.44 -76.02 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 127.493 2.317 . . . . 75.13 114.129 -166.712 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' B' B ' 114' ' ' LYS . . . . . 0.517 ' H ' ' HG2' ' B' ' 113' ' ' LYS . 1.5 tpmt? -179.45 -162.18 0.04 OUTLIER 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 125.332 1.453 . . . . 74.01 107.232 -174.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 32.0 p -58.82 -63.73 1.19 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.098 0.959 . . . . 73.23 110.496 171.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -94.82 -136.85 8.61 Favored Glycine 0 C--N 1.347 1.141 0 CA-C-N 115.801 -0.636 . . . . 55.33 111.562 175.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 117' ' ' LYS . . . . . 0.577 ' H ' ' HD2' ' B' ' 118' ' ' PRO . 9.5 mtpm? -147.03 -54.14 0.02 OUTLIER Pre-proline 0 CA--C 1.562 1.436 0 C-N-CA 124.85 1.26 . . . . 70.25 110.771 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 118' ' ' PRO . . . . . 0.577 ' HD2' ' H ' ' B' ' 117' ' ' LYS . 73.3 Cg_endo -73.95 -51.71 0.14 Allowed 'Trans proline' 0 C--N 1.396 3.058 0 C-N-CA 121.37 1.38 . . . . 60.53 114.036 -174.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 119' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -154.47 156.01 35.95 Favored 'General case' 0 C--O 1.243 0.751 0 C-N-CA 124.5 1.12 . . . . 75.33 108.202 -173.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 120' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -131.86 3.81 4.13 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 122.907 0.483 . . . . 70.1 111.215 -169.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 121' ' ' VAL . . . . . 0.42 HG23 ' H ' ' B' ' 122' ' ' THR . 3.7 m -137.49 -63.77 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 C-N-CA 123.287 0.635 . . . . 74.32 112.571 -173.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 122' ' ' THR . . . . . 0.42 ' H ' HG23 ' B' ' 121' ' ' VAL . 67.4 m -80.92 -66.35 0.9 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.646 0.778 . . . . 75.24 111.539 -171.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -87.66 -52.01 5.56 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 124.155 0.982 . . . . 64.3 110.676 -174.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 28.8 m 62.01 -107.94 0.27 Allowed 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 125.237 1.415 . . . . 43.31 112.2 177.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . 175.91 138.57 0.06 Allowed 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.196 0.998 . . . . 73.02 109.987 -174.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -155.52 143.14 19.64 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.916 0.886 . . . . 74.13 109.471 177.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 127' ' ' SER . . . . . 0.423 ' HB2' HH22 ' C' ' 154' ' ' ARG . 73.7 p -156.35 179.49 9.2 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 112.485 0.55 . . . . 70.01 112.485 -176.19 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -76.9 145.94 37.94 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.917 0.887 . . . . 72.01 110.552 172.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 129' ' ' THR . . . . . 0.444 ' HB ' HD21 ' B' ' 155' ' ' LEU . 15.5 m -70.5 -16.5 62.91 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 123.345 0.658 . . . . 54.34 111.958 -179.127 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . -66.83 153.49 43.28 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.039 0.535 . . . . 44.22 111.297 176.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 131' ' ' TRP . . . . . 0.483 ' HA ' ' HB2' ' C' ' 187' ' ' ARG . 15.8 p90 -57.31 -29.56 64.03 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.527 1.131 . . . . 73.51 112.812 -172.105 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 132' ' ' SER . . . . . 0.67 ' HB3' HG23 ' B' ' 135' ' ' VAL . 35.6 t -118.56 150.21 40.04 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 123.423 0.689 . . . . 51.4 110.646 178.115 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 7.3 m -68.92 -29.66 67.97 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 115.623 -0.717 . . . . 62.25 109.315 168.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . -72.38 -5.45 63.12 Favored Glycine 0 C--N 1.355 1.634 0 CA-C-N 114.919 -1.037 . . . . 55.15 114.652 -178.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 135' ' ' VAL . . . . . 0.67 HG23 ' HB3' ' B' ' 132' ' ' SER . 47.6 t -74.44 -37.39 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 CA-C-N 117.554 0.677 . . . . 73.24 109.628 174.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt 68.87 10.37 7.88 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 124.76 1.224 . . . . 52.43 113.108 168.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 10.4 p -68.57 106.23 2.51 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 121.783 -0.573 . . . . 75.31 111.095 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 138' ' ' TYR . . . . . 0.602 ' HB2' ' HG3' ' B' ' 148' ' ' GLU . 49.6 t80 65.11 -75.95 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 125.901 1.681 . . . . 75.52 111.177 -176.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 139' ' ' ASN . . . . . 0.614 HD21 HD11 ' B' ' 341' ' ' LEU . 63.3 t30 71.94 155.61 0.15 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 125.367 1.467 . . . . 73.24 112.369 176.514 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . 90.58 50.45 2.93 Favored Glycine 0 C--N 1.348 1.213 0 CA-C-N 116.289 -0.414 . . . . 65.04 113.307 175.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . 75.44 -27.89 0.19 Allowed 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 125.338 1.455 . . . . 75.34 114.781 169.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . 0.261 0.3 OUTLIER 44.56 -81.57 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 125.897 1.679 . . . . 70.15 114.241 -172.369 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 96.23 -44.61 1.99 Allowed Glycine 0 C--N 1.352 1.47 0 N-CA-C 111.87 -0.492 . . . . 61.25 111.87 -175.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 26.1 t -101.18 153.38 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 108.295 -1.002 . . . . 75.31 108.295 173.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -63.43 -49.05 75.26 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 109.683 -0.488 . . . . 64.3 109.683 176.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 68.0 mt 66.28 -12.32 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.56 1.345 0 C-N-CA 125.696 1.599 . . . . 72.52 112.366 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 19.0 p-80 32.88 74.62 0.05 Allowed 'General case' 0 C--N 1.372 1.586 0 C-N-CA 125.482 1.513 . . . . 72.43 111.169 -163.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 148' ' ' GLU . . . . . 0.602 ' HG3' ' HB2' ' B' ' 138' ' ' TYR . 4.4 tm-20 -54.31 132.97 44.89 Favored 'General case' 0 C--N 1.358 0.953 0 CA-C-N 113.875 -1.511 . . . . 73.05 109.56 -172.278 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 149' ' ' LYS . . . . . 0.446 ' HG2' ' HB3' ' A' ' 182' ' ' PRO . 36.0 mtmm 73.54 -77.47 0.05 Allowed 'General case' 0 N--CA 1.478 0.935 0 O-C-N 125.188 1.555 . . . . 72.23 109.388 -163.187 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 25.4 t0 171.84 163.9 0.1 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 125.857 1.663 . . . . 74.11 108.509 174.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 151' ' ' HIS . . . . . 0.439 ' HB3' ' HD2' ' B' ' 152' ' ' PRO . 98.6 m-70 69.92 171.82 0.1 Allowed Pre-proline 0 CA--C 1.565 1.544 0 C-N-CA 124.366 1.066 . . . . 74.43 111.981 173.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 152' ' ' PRO . . . . . 0.439 ' HD2' ' HB3' ' B' ' 151' ' ' HIS . 25.0 Cg_endo -62.47 -177.18 0.28 Allowed 'Trans proline' 0 C--N 1.389 2.692 0 C-N-CA 122.509 2.14 . . . . 42.51 113.47 169.158 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 62.2 m 77.98 -52.37 0.51 Allowed 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 125.668 1.587 . . . . 74.2 110.552 -174.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 60.6 mt 61.58 -83.6 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 125.005 1.322 . . . . 74.25 111.946 170.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 155' ' ' LEU . . . . . 0.444 HD21 ' HB ' ' B' ' 129' ' ' THR . 1.0 OUTLIER -114.68 38.57 3.08 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.807 0.843 . . . . 72.1 110.851 -175.257 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 78.06 -27.32 0.17 Allowed 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 125.701 1.6 . . . . 72.23 112.127 -177.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 157' ' ' MET . . . . . 0.597 ' HB3' ' HG2' ' C' ' 252' ' ' GLU . 53.0 mtt 65.26 23.92 12.2 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.094 0.957 . . . . 53.54 111.394 -174.108 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 158' ' ' ALA . . . . . . . . . . . . . . . 70.34 -65.34 0.33 Allowed 'General case' 0 C--N 1.362 1.145 0 C-N-CA 125.788 1.635 . . . . 34.04 111.582 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 159' ' ' LYS . . . . . 0.405 ' HA ' HG21 ' C' ' 196' ' ' THR . 87.7 mttt 61.46 61.4 1.51 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.023 1.329 . . . . 55.45 111.179 177.163 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -72.17 153.24 41.74 Favored 'General case' 0 C--O 1.247 0.97 0 CA-C-N 114.338 -1.301 . . . . 70.22 108.9 167.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . 75.6 145.15 0.08 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.87 1.268 . . . . 71.1 112.619 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 162' ' ' GLY . . . . . 0.482 ' H ' ' HB2' ' B' ' 356' ' ' ASN . . . 159.39 -45.59 0.44 Allowed Glycine 0 C--N 1.352 1.449 0 CA-C-N 115.918 -0.583 . . . . 73.4 111.908 -176.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 1.6 pp -130.01 141.24 50.77 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.111 0.964 . . . . 65.02 109.739 175.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 164' ' ' ALA . . . . . . . . . . . . . . . -70.97 102.69 2.47 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.468 0.707 . . . . 75.34 111.183 -172.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 11.8 p -88.0 96.25 10.43 Favored 'General case' 0 C--O 1.244 0.769 0 C-N-CA 123.288 0.635 . . . . 64.15 109.857 174.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . -81.44 54.62 4.79 Favored Glycine 0 C--N 1.349 1.303 0 CA-C-N 115.703 -0.68 . . . . 71.15 112.666 178.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 167' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -148.44 2.04 0.63 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.601 1.16 . . . . 72.31 108.765 178.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 10.3 p -166.63 40.12 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.114 0 CA-C-O 122.596 1.189 . . . . 74.13 108.592 -173.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 13.3 m -56.91 -26.46 59.28 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 114.076 -1.42 . . . . 54.35 112.84 -173.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 3.8 m -144.8 -72.31 0.26 Allowed 'General case' 0 C--O 1.24 0.601 0 N-CA-C 107.704 -1.221 . . . . 63.1 107.704 176.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . 174.72 58.19 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.788 1.635 . . . . 53.32 107.193 -174.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 172' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -61.61 97.47 0.07 Allowed 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.636 -0.711 . . . . 73.22 111.002 -175.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 173' ' ' LEU . . . . . . . . . . . . . 1.7 pp -83.24 6.5 19.31 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.957 0.903 . . . . 74.23 111.75 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 174' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -73.12 77.34 1.25 Allowed 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.821 0.848 . . . . 74.45 108.801 173.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 175' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -153.86 158.66 41.12 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-N 114.581 -1.19 . . . . 74.1 108.888 -171.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -151.74 35.06 0.55 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.782 0.833 . . . . 74.11 110.673 -176.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 97.4 m -64.42 126.28 90.22 Favored Pre-proline 0 CA--C 1.555 1.155 0 CA-C-N 115.701 -0.681 . . . . 64.31 109.621 172.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 178' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -81.79 51.38 3.82 Favored 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 123.308 2.672 . . . . 74.53 112.989 -176.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -135.38 96.95 3.57 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.623 0.769 . . . . 61.34 109.441 177.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . -70.81 -36.91 73.19 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.182 0.593 . . . . 74.4 110.547 175.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 13.1 tp -159.72 18.77 0.16 Allowed 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 114.629 -1.169 . . . . 62.04 109.179 176.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 182' ' ' VAL . . . . . 0.602 HG22 ' HA ' ' C' ' 138' ' ' VAL . 55.9 t -76.86 107.0 7.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 116.089 -0.505 . . . . 71.31 111.119 -169.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 183' ' ' ALA . . . . . 0.426 ' HB2' ' HB3' ' C' ' 123' ' ' LEU . . . -86.62 -36.4 18.84 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.13 -0.941 . . . . 65.24 110.214 170.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 184' ' ' HIS . . . . . 0.525 ' HB2' HG12 ' B' ' 182' ' ' VAL . 6.3 t-80 58.42 28.88 17.46 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 125.259 1.424 . . . . 74.15 112.382 171.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 185' ' ' VAL . . . . . . . . . . . . . 53.5 t 59.92 76.83 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 124.226 1.01 . . . . 71.33 109.443 -168.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 186' ' ' THR . . . . . 0.682 HG22 ' HG2' ' C' ' 122' ' ' GLU . 59.6 p 52.64 76.74 0.18 Allowed 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 125.452 1.501 . . . . 51.31 112.422 176.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 187' ' ' SER . . . . . 0.496 ' HB3' ' HB3' ' B' ' 184' ' ' HIS . 32.6 t -148.58 133.46 18.04 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 123.465 0.706 . . . . 62.14 109.4 -177.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -133.14 124.65 27.91 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.659 0.784 . . . . 71.52 110.363 -177.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -109.47 161.05 15.69 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 108.67 -0.863 . . . . 72.52 108.67 164.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 190' ' ' CYS . . . . . . . . . . . . . 77.8 m -148.05 132.83 17.95 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.529 0.732 . . . . 70.33 109.85 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -87.14 130.83 34.36 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 109.376 -0.602 . . . . 74.04 109.376 175.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 192' ' ' GLY . . . . . 0.617 ' H ' ' HG2' ' B' ' 312' ' ' PRO . . . -71.2 127.62 14.91 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-O 117.778 -1.568 . . . . 64.22 110.463 174.478 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 193' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -47.18 -30.11 10.13 Favored 'Trans proline' 0 C--N 1.388 2.656 0 C-N-CA 124.235 3.29 . . . . 64.32 114.993 -169.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 194' ' ' SER . . . . . . . . . . . . . 37.1 m 72.27 -66.48 0.3 Allowed 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.729 1.612 . . . . 24.51 111.547 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 195' ' ' ALA . . . . . . . . . . . . . . . -86.21 154.52 21.24 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 123.256 0.623 . . . . 74.32 109.694 173.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 59.3 m -73.36 -66.04 0.74 Allowed 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.701 0.8 . . . . 73.32 110.2 178.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 42.4 t -170.25 99.74 0.27 Allowed 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 109.045 -0.724 . . . . 75.11 109.045 177.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 198' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -92.47 6.49 46.91 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.324 0.649 . . . . 51.12 111.373 178.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 63.6 mttm 74.11 -63.13 0.44 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 125.9 1.68 . . . . 74.4 109.937 -173.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 200' ' ' CYS . . . . . . . . . . . . . 70.9 m 72.66 108.08 0.03 OUTLIER Pre-proline 0 N--CA 1.481 1.118 0 C-N-CA 125.595 1.558 . . . . 73.31 111.213 178.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 201' ' ' PRO . . . . . 0.539 ' HA ' ' HG2' ' B' ' 363' ' ' GLU . 31.7 Cg_exo -59.86 99.32 0.13 Allowed 'Trans proline' 0 C--N 1.38 2.205 0 C-N-CA 122.769 2.312 . . . . 71.34 112.804 175.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 153.07 26.17 0.04 OUTLIER Glycine 0 C--N 1.351 1.41 0 CA-C-N 115.91 -0.586 . . . . 63.04 113.525 178.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -79.82 -31.78 40.65 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 117.343 0.571 . . . . 71.33 110.663 175.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -146.17 132.04 19.09 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 123.129 0.572 . . . . 74.01 110.212 178.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 205' ' ' LEU . . . . . . . . . . . . . 47.2 tp -71.0 -48.58 52.37 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.766 0.827 . . . . 51.03 109.166 173.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.1 -127.22 0.14 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.468 1.107 . . . . 62.32 109.042 175.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 12.7 mptt 64.5 -75.99 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 124.473 1.109 . . . . 74.32 110.336 -167.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 111.08 147.44 10.99 Favored Glycine 0 C--N 1.349 1.283 0 N-CA-C 111.484 -0.646 . . . . 71.52 111.484 -177.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . -78.6 -31.23 46.0 Favored Glycine 0 N--CA 1.466 0.675 0 N-CA-C 111.774 -0.53 . . . . 42.21 111.774 175.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 210' ' ' LYS . . . . . 0.655 ' HB3' ' HG2' ' B' ' 235' ' ' GLU . 60.5 mttm 60.04 -85.81 0.02 OUTLIER 'General case' 0 C--N 1.365 1.259 0 C-N-CA 124.891 1.277 . . . . 74.51 112.134 168.251 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . -80.17 73.06 2.53 Favored Glycine 0 C--N 1.353 1.519 0 N-CA-C 108.975 -1.65 . . . . 74.43 108.975 167.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 23.1 t -78.12 71.87 4.61 Favored 'General case' 0 C--N 1.357 0.902 0 C-N-CA 124.278 1.031 . . . . 74.04 110.559 -173.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 18.9 pt -112.14 33.02 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.625 1.57 . . . . 64.4 107.976 177.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 76.4 p -70.34 -27.0 64.01 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.905 1.282 . . . . 75.43 112.346 -169.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 215' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -77.79 -24.85 48.73 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 115.799 -0.637 . . . . 73.31 110.176 174.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 19.5 tm0? 77.24 -63.62 0.35 Allowed 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 125.814 1.645 . . . . 61.42 112.667 168.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 217' ' ' LEU . . . . . 0.439 HD23 HD13 ' B' ' 218' ' ' LEU . 3.6 tt -72.19 82.42 1.0 Allowed 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.327 1.051 . . . . 75.4 110.914 -169.117 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 218' ' ' LEU . . . . . 0.439 HD13 HD23 ' B' ' 217' ' ' LEU . 9.2 mp 63.65 -70.98 0.06 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.833 1.653 . . . . 71.43 113.932 167.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 77.24 -35.06 0.21 Allowed 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 126.053 1.741 . . . . 71.24 111.488 -178.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 220' ' ' ALA . . . . . 0.61 ' HA ' HD22 ' B' ' 226' ' ' LEU . . . -68.68 -7.87 37.32 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.366 0.666 . . . . 61.1 111.382 164.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 221' ' ' ARG . . . . . . . . . . . . . 44.7 mtp180 70.99 -80.07 0.04 OUTLIER 'General case' 0 C--N 1.364 1.216 0 C-N-CA 125.814 1.646 . . . . 73.55 110.973 172.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -150.45 0.32 0.43 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.699 0.799 . . . . 42.52 110.487 175.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -73.84 -19.31 60.77 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.827 1.251 . . . . 61.02 111.445 -177.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 58.8 t 66.55 -73.07 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 125.441 1.496 . . . . 74.2 111.253 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 4.3 t -69.8 -43.17 72.64 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.931 0.892 . . . . 54.34 110.947 175.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 226' ' ' LEU . . . . . 0.61 HD22 ' HA ' ' B' ' 220' ' ' ALA . 22.3 tp 58.86 -75.32 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.506 1.522 . . . . 74.43 111.91 -175.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . -170.63 30.57 0.13 Allowed Glycine 0 C--N 1.338 0.659 0 N-CA-C 111.446 -0.662 . . . . 51.31 111.446 176.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 84.62 -46.43 3.67 Favored Glycine 0 C--N 1.348 1.217 0 N-CA-C 112.139 -0.384 . . . . 72.41 112.139 -172.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . 70.21 -91.2 0.37 Allowed Glycine 0 C--N 1.356 1.66 0 C-N-CA 123.175 0.417 . . . . 70.24 112.634 174.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -69.34 -43.63 73.29 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.065 0.546 . . . . 70.23 110.132 174.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 231' ' ' LYS . . . . . . . . . . . . . 45.3 mttp 62.44 -75.87 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 125.893 1.677 . . . . 73.24 111.638 178.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 33.2 m -65.1 98.12 0.28 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.322 1.049 . . . . 74.24 110.789 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -72.66 112.98 9.2 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 115.327 -0.851 . . . . 70.41 108.853 172.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -139.81 -169.95 2.83 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.415 0.686 . . . . 72.31 110.679 -174.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 235' ' ' GLU . . . . . 0.681 ' HG3' ' HE2' ' C' ' 209' ' ' LYS . 17.5 tp10 78.79 134.13 0.06 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.847 1.659 . . . . 54.41 111.517 178.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 236' ' ' THR . . . . . 0.673 HG23 HD21 ' B' ' 247' ' ' LEU . 88.9 m -118.27 -62.78 1.5 Allowed 'General case' 0 C--O 1.241 0.64 0 CA-C-N 115.13 -0.941 . . . . 73.34 110.527 -174.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -170.32 155.08 5.08 Favored 'General case' 0 C--N 1.351 0.652 0 O-C-N 123.538 0.524 . . . . 71.12 111.389 -171.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 41.0 m -146.31 27.72 1.13 Allowed 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 122.986 1.374 . . . . 71.31 107.752 166.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 239' ' ' ALA . . . . . 0.733 ' HB2' ' H ' ' C' ' 222' ' ' ALA . . . -97.32 -173.67 2.73 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 114.329 -1.305 . . . . 74.42 111.945 -173.275 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . -117.1 -151.9 9.49 Favored Glycine 0 C--N 1.341 0.848 0 CA-C-N 114.799 -1.091 . . . . 71.23 111.06 178.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -110.39 141.68 43.12 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.941 0.896 . . . . 71.21 112.026 -165.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 242' ' ' TRP . . . . . 0.428 ' HB3' ' HA ' ' C' ' 233' ' ' LEU . 0.4 OUTLIER -171.09 -39.55 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.584 1.154 . . . . 70.32 109.577 174.231 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 243' ' ' GLN . . . . . 0.766 ' HA ' ' HA ' ' B' ' 378' ' ' ALA . 16.1 pt20 -157.36 162.93 39.08 Favored 'General case' 0 C--O 1.244 0.791 0 C-N-CA 124.47 1.108 . . . . 74.22 108.881 169.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -69.07 116.78 7.46 Favored Glycine 0 C--N 1.351 1.384 0 N-CA-C 111.896 -0.482 . . . . 63.11 111.896 -175.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 245' ' ' LYS . . . . . 0.565 ' HE2' ' HB1' ' C' ' 222' ' ' ALA . 9.2 tmtm? -85.1 112.28 20.52 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 117.245 0.522 . . . . 75.34 110.474 -175.337 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 60.7 p -95.78 149.95 20.94 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.556 0.742 . . . . 71.02 109.005 167.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 247' ' ' LEU . . . . . 0.673 HD21 HG23 ' B' ' 236' ' ' THR . 97.8 mt -83.46 -177.06 6.6 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.845 0.858 . . . . 72.51 112.574 -172.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 248' ' ' ARG . . . . . 0.479 ' HA ' ' HE ' ' B' ' 248' ' ' ARG . 1.5 tpm_? -105.92 148.97 27.03 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.37 1.068 . . . . 75.15 109.035 173.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -130.05 137.32 50.17 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 107.495 -1.298 . . . . 71.33 107.495 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -88.95 40.28 0.97 Allowed 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 124.248 1.019 . . . . 65.4 111.488 -171.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 251' ' ' ALA . . . . . . . . . . . . . . . -59.56 -53.54 56.92 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.047 0.939 . . . . 61.03 111.876 -178.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -101.49 -15.64 17.07 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 124.271 1.028 . . . . 72.3 111.359 -178.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -68.87 -32.99 73.04 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.872 0.469 . . . . 51.41 111.066 174.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -72.09 92.48 1.33 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 122.953 0.501 . . . . 72.51 109.85 175.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . 59.24 -96.45 0.08 OUTLIER Glycine 0 C--N 1.353 1.495 0 O-C-N 123.745 0.653 . . . . 54.22 112.474 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 256' ' ' TYR . . . . . . . . . . . . . 22.9 t80 61.5 -74.7 0.03 OUTLIER 'General case' 0 C--N 1.363 1.156 0 C-N-CA 126.247 1.819 . . . . 52.52 111.16 178.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 257' ' ' GLN . . . . . 0.424 ' NE2' ' H ' ' B' ' 257' ' ' GLN . 2.2 mp0 -64.06 -62.11 1.84 Allowed 'General case' 0 C--N 1.35 0.605 0 C-N-CA 124.163 0.985 . . . . 74.31 108.537 176.154 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 258' ' ' LEU . . . . . . . . . . . . . 1.5 tt 56.11 -84.75 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 125.603 1.561 . . . . 75.13 110.708 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 259' ' ' VAL . . . . . 0.516 ' HA ' ' HB3' ' B' ' 262' ' ' ALA . 62.2 t -85.21 97.23 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 123.199 0.6 . . . . 63.02 109.491 178.114 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 260' ' ' SER . . . . . . . . . . . . . 22.2 m -134.4 96.16 3.53 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 107.159 -1.422 . . . . 73.11 107.159 173.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 61.33 32.28 19.2 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.118 0.967 . . . . 52.21 110.333 -168.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 262' ' ' ALA . . . . . 0.516 ' HB3' ' HA ' ' B' ' 259' ' ' VAL . . . -128.47 39.96 3.73 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.213 1.005 . . . . 43.43 110.536 -174.296 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -63.22 -38.93 93.11 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 116.047 -0.524 . . . . 70.44 110.214 173.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 33.4 t -88.23 168.45 12.72 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 114.8 -1.091 . . . . 51.14 110.168 175.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 265' ' ' LEU . . . . . . . . . . . . . 90.9 mt -90.13 32.03 0.95 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.788 0.835 . . . . 64.12 111.337 -177.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 266' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 69.82 -65.91 0.29 Allowed 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 125.962 1.705 . . . . 71.52 111.25 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 33.5 m -139.8 -63.82 0.5 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.216 1.006 . . . . 73.13 108.4 173.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 11.4 p -174.12 -32.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 124.209 1.003 . . . . 74.44 110.038 -178.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 269' ' ' THR . . . . . . . . . . . . . 35.0 m -68.51 91.24 0.4 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.777 0.831 . . . . 74.31 111.515 -173.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 270' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.48 -175.78 4.98 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.004 1.322 . . . . 72.41 108.436 175.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 271' ' ' ALA . . . . . 0.533 ' HB3' ' HB3' ' B' ' 275' ' ' LYS . . . -120.8 53.49 1.12 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 122.893 0.477 . . . . 75.3 110.786 -175.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 272' ' ' ASN . . . . . 0.536 ' O ' ' HG3' ' B' ' 275' ' ' LYS . 42.7 m-80 61.14 -157.91 0.33 Allowed 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.25 1.02 . . . . 54.14 111.303 176.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -70.14 -7.42 41.54 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.774 -0.579 . . . . 61.32 111.433 170.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -85.09 4.93 31.85 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.094 0.958 . . . . 71.44 112.278 -176.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 275' ' ' LYS . . . . . 0.536 ' HG3' ' O ' ' B' ' 272' ' ' ASN . 2.2 pptp? -94.82 109.42 43.81 Favored Pre-proline 0 CA--C 1.555 1.137 0 CA-C-N 118.31 0.505 . . . . 71.33 111.134 177.102 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -89.12 151.44 5.67 Favored 'Trans proline' 0 C--N 1.377 2.028 0 C-N-CA 122.683 2.256 . . . . 62.35 111.564 170.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 277' ' ' LEU . . . . . . . . . . . . . 4.2 tt -90.78 99.94 12.88 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 107.222 -1.399 . . . . 63.32 107.222 176.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -64.75 -36.09 83.19 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.657 0.783 . . . . 62.0 111.725 -175.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . 92.3 36.03 6.4 Favored Glycine 0 C--N 1.346 1.118 0 CA-C-N 116.263 -0.426 . . . . 75.43 114.05 174.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -155.93 178.49 10.21 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.284 0.634 . . . . 53.23 110.029 172.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -65.47 107.98 1.85 Allowed 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 108.9 -0.778 . . . . 75.31 108.9 176.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -84.41 35.7 0.56 Allowed 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.433 0.901 . . . . 65.41 113.433 -167.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -160.71 -97.08 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 122.785 0.434 . . . . 72.33 110.501 175.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . 144.8 -90.29 0.16 Allowed Glycine 0 C--N 1.355 1.594 0 N-CA-C 111.374 -0.691 . . . . 61.45 111.374 -172.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -146.28 5.92 0.97 Allowed 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 124.15 0.98 . . . . 72.41 111.221 -175.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 286' ' ' MET . . . . . . . . . . . . . 14.8 tpt -60.14 -56.93 30.62 Favored Pre-proline 0 CA--C 1.566 1.576 0 N-CA-C 114.787 1.403 . . . . 64.1 114.787 -165.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 287' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -90.58 35.39 0.32 Allowed 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 122.28 1.987 . . . . 73.33 111.622 -173.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 288' ' ' VAL . . . . . 0.616 HG13 ' H ' ' B' ' 289' ' ' ARG 0.288 7.2 p 41.07 -86.3 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.282 0 C-N-CA 125.941 1.697 . . . . 74.32 111.936 -163.887 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 289' ' ' ARG . . . . . 0.616 ' H ' HG13 ' B' ' 288' ' ' VAL . 7.0 tpm_? 53.41 37.7 26.16 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 122.451 1.119 . . . . 72.14 111.321 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 290' ' ' TRP . . . . . . . . . . . . . 64.7 t90 -63.25 114.72 3.96 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 114.451 -1.25 . . . . 75.34 111.395 -175.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 291' ' ' LEU . . . . . . . . . . . . . 53.9 mt 56.02 -78.25 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 126.799 2.04 . . . . 64.34 113.804 175.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . -176.83 -98.92 0.11 Allowed Glycine 0 CA--C 1.525 0.689 0 CA-C-O 118.741 -1.033 . . . . 62.12 110.777 -178.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.08 87.75 0.24 Allowed 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 122.843 2.362 . . . . 51.12 111.419 172.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 8.2 mtpm? -65.42 -32.33 73.89 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 114.799 -1.091 . . . . 41.23 111.287 -177.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -125.29 113.08 17.13 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 123.869 0.867 . . . . 34.32 109.015 171.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 6.4 t -72.57 150.94 42.68 Favored 'General case' 0 C--O 1.244 0.815 0 N-CA-C 109.336 -0.616 . . . . 65.42 109.336 171.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -73.11 -85.26 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 108.805 -0.813 . . . . 64.12 108.805 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 164.53 -158.15 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 126.786 2.034 . . . . 71.5 107.054 -179.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . 98.42 -73.29 0.58 Allowed Glycine 0 C--N 1.337 0.633 0 N-CA-C 111.705 -0.558 . . . . 63.41 111.705 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -98.48 11.37 38.46 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.303 0.641 . . . . 72.23 111.667 -172.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 301' ' ' ILE . . . . . . . . . . . . . 42.8 pt -119.68 12.3 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 C-N-CA 123.131 0.572 . . . . 72.24 111.058 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -91.95 27.2 2.19 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.737 0.815 . . . . 63.41 111.82 -174.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 303' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -66.2 142.81 98.06 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 124.164 0.985 . . . . 74.11 110.364 177.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 304' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -49.04 -23.89 6.84 Favored 'Trans proline' 0 C--N 1.388 2.606 0 C-N-CA 124.787 3.658 . . . . 75.12 116.032 -171.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -59.55 -43.02 93.66 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.612 0.765 . . . . 42.33 112.0 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 28.1 m -111.97 -33.38 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 123.271 0.628 . . . . 72.33 111.24 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 9.8 m 66.74 -74.3 0.07 Allowed 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 126.325 1.85 . . . . 74.23 110.727 -174.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 308' ' ' CYS . . . . . . . . . . . . . 40.9 m -122.34 -20.39 6.15 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.439 0.695 . . . . 74.22 110.281 175.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 309' ' ' THR . . . . . . . . . . . . 0.25 73.5 m 112.9 -59.43 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.14 0 C-N-CA 128.558 2.743 . . . . 72.2 112.021 177.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -90.92 35.77 0.3 Allowed 'Trans proline' 0 C--N 1.394 2.923 0 C-N-CA 122.614 2.21 . . . . 63.14 113.378 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 311' ' ' ASN . . . . . 0.429 ' HB2' ' HD3' ' B' ' 312' ' ' PRO . 11.7 m120 -76.82 -53.79 1.78 Allowed Pre-proline 0 CA--C 1.561 1.37 0 C-N-CA 123.437 0.695 . . . . 73.13 112.014 -178.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 312' ' ' PRO . . . . . 0.617 ' HG2' ' H ' ' B' ' 192' ' ' GLY . 69.6 Cg_endo -95.47 59.06 0.19 Allowed 'Trans proline' 0 C--N 1.385 2.462 0 C-N-CA 122.204 1.936 . . . . 70.14 112.341 -178.176 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 313' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -71.58 84.4 0.86 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.182 0.593 . . . . 75.13 111.223 178.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 314' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -111.66 75.32 0.91 Allowed 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 107.592 -1.262 . . . . 72.01 107.592 168.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 315' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -155.06 102.55 2.33 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.066 -0.97 . . . . 72.12 108.603 -176.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 316' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -87.49 -49.89 6.9 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.518 -0.919 . . . . 74.4 108.518 172.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 85.0 p 54.64 -74.29 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 126.146 1.778 . . . . 75.41 111.551 -173.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 318' ' ' VAL . . . . . 0.418 HG23 ' HB2' ' B' ' 95' ' ' LYS . 26.5 m 39.79 55.76 6.43 Favored Pre-proline 0 N--CA 1.488 1.448 0 C-N-CA 126.58 1.952 . . . . 73.13 113.724 177.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 319' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -62.81 138.69 70.33 Favored 'Trans proline' 0 C--N 1.387 2.574 0 C-N-CA 122.76 2.307 . . . . 65.1 111.972 -168.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 320' ' ' THR . . . . . . . . . . . . . 52.9 m -149.06 -60.78 0.22 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.411 0.684 . . . . 53.31 110.215 -172.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 321' ' ' LEU . . . . . 0.79 HD12 ' HB2' ' B' ' 323' ' ' GLN . 0.1 OUTLIER -70.26 -56.69 6.14 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.923 0.889 . . . . 65.14 110.305 -171.568 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 322' ' ' ALA . . . . . 0.584 ' HB1' HD21 ' B' ' 102' ' ' LEU . . . 60.16 36.28 21.06 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 124.274 1.03 . . . . 64.54 111.639 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 323' ' ' GLN . . . . . 0.79 ' HB2' HD12 ' B' ' 321' ' ' LEU . 24.2 tp60 -73.91 110.88 8.55 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 108.553 -0.906 . . . . 74.02 108.553 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 324' ' ' MET . . . . . 0.497 ' HG2' ' HA ' ' B' ' 101' ' ' PRO . 76.0 mtm -85.55 41.65 0.91 Allowed 'General case' 0 CA--C 1.556 1.174 0 N-CA-C 113.278 0.844 . . . . 71.32 113.278 -164.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 325' ' ' THR . . . . . . . . . . . . . 57.7 m 70.67 -59.17 0.54 Allowed 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 126.24 1.816 . . . . 72.33 111.654 177.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 326' ' ' ASP . . . . . 0.533 ' HA ' ' NE2' ' B' ' 105' ' ' GLN . 19.7 m-20 75.0 17.33 2.73 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.118 1.367 . . . . 72.01 112.461 171.267 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -105.1 126.56 52.21 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 108.483 -0.932 . . . . 54.34 108.483 173.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 328' ' ' ALA . . . . . 0.432 ' H ' HD12 ' B' ' 329' ' ' ILE . . . -142.0 0.15 1.36 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.373 0.669 . . . . 72.03 111.517 -179.064 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 329' ' ' ILE . . . . . 0.432 HD12 ' H ' ' B' ' 328' ' ' ALA . 3.0 mp -85.17 106.89 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 N-CA-C 108.96 -0.756 . . . . 73.5 108.96 -170.214 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 330' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 69.94 130.94 0.03 OUTLIER 'General case' 0 CA--C 1.561 1.387 0 C-N-CA 126.896 2.078 . . . . 63.42 111.826 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 331' ' ' LEU . . . . . 0.4 HD12 HD22 ' B' ' 332' ' ' LEU . 0.4 OUTLIER -140.85 18.38 2.32 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.345 1.058 . . . . 63.34 110.861 -172.216 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 332' ' ' LEU . . . . . 0.4 HD22 HD12 ' B' ' 331' ' ' LEU . 2.4 pt? -146.12 -163.82 1.82 Allowed 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.324 0.649 . . . . 74.41 111.267 -170.086 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 333' ' ' SER . . . . . . . . . . . . . 16.0 t 68.1 5.66 4.76 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.291 1.036 . . . . 65.04 113.323 164.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 12.6 ptmt -70.16 -40.55 74.65 Favored 'General case' 0 C--N 1.354 0.796 0 C-N-CA 122.691 0.396 . . . . 63.11 110.448 177.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 335' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 68.32 139.28 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 125.56 1.544 . . . . 73.25 111.686 -177.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 336' ' ' GLU . . . . . 0.403 ' HB2' ' HA ' ' B' ' 118' ' ' PRO . 46.7 mt-10 -135.75 -164.37 1.53 Allowed 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.477 1.111 . . . . 61.02 108.542 176.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 337' ' ' LYS . . . . . 0.466 ' HG3' ' O ' ' B' ' 29' ' ' LEU . 7.8 tmtt? -130.32 132.6 45.94 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 107.201 -1.407 . . . . 62.43 107.201 169.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 338' ' ' GLY . . . . . . . . . . . . . . . -82.36 48.15 3.89 Favored Glycine 0 C--N 1.35 1.308 0 O-C-N 123.302 0.376 . . . . 72.34 113.722 -175.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 339' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -89.68 20.81 3.8 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.897 0.879 . . . . 74.33 109.147 173.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 340' ' ' PHE . . . . . 0.406 ' HA ' ' O ' ' C' ' 158' ' ' VAL . 21.9 m-85 -72.0 -2.11 17.03 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.53 1.132 . . . . 75.24 112.06 -177.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 341' ' ' LEU . . . . . 0.614 HD11 HD21 ' B' ' 139' ' ' ASN . 1.8 tm? -73.52 -51.33 17.41 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.824 0.85 . . . . 75.34 109.08 175.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 342' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 60.35 -130.78 0.9 Allowed 'General case' 0 CA--C 1.565 1.548 0 C-N-CA 124.381 1.072 . . . . 64.25 109.44 -178.181 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 343' ' ' VAL . . . . . . . . . . . . . 11.6 p -158.78 41.1 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.243 0 CA-C-O 122.425 1.107 . . . . 64.24 108.895 178.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -63.84 143.58 57.73 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 115.042 -0.981 . . . . 73.03 110.96 177.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 345' ' ' GLY . . . . . . . . . . . . . . . -157.68 47.2 0.46 Allowed Glycine 0 C--N 1.345 1.069 0 CA-C-N 115.821 -0.627 . . . . 62.31 111.77 -178.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 346' ' ' ALA . . . . . . . . . . . . . . . -152.04 -81.66 0.1 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.389 0.676 . . . . 72.22 109.52 176.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 62.1 m 59.06 -80.76 0.02 OUTLIER 'General case' 0 C--N 1.365 1.277 0 C-N-CA 124.795 1.238 . . . . 72.21 112.362 -177.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 348' ' ' ILE . . . . . 0.425 ' O ' ' HG2' ' B' ' 351' ' ' GLN . 2.0 pp -102.56 -3.99 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 123.994 0.917 . . . . 73.42 111.847 -176.438 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 349' ' ' ASP . . . . . . . . . . . . . 31.7 t70 69.54 -78.44 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.698 1.199 . . . . 71.13 109.642 -175.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 350' ' ' LYS . . . . . . . . . . . . . 9.3 mptt -134.17 -67.68 0.58 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.652 -0.869 . . . . 74.52 108.652 167.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 351' ' ' GLN . . . . . 0.425 ' HG2' ' O ' ' B' ' 348' ' ' ILE . 86.7 mm-40 63.4 167.98 0.14 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 125.041 1.336 . . . . 71.32 111.985 -174.292 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -87.47 -23.32 24.49 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.138 -0.69 . . . . 74.35 109.138 174.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 353' ' ' HIS . . . . . . . . . . . . . 14.5 p80 52.54 18.35 0.95 Allowed 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 126.984 2.114 . . . . 74.33 114.017 173.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 354' ' ' ALA . . . . . 0.453 ' HB1' ' HA3' ' B' ' 162' ' ' GLY . . . -101.32 49.43 0.87 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.796 0.838 . . . . 70.11 110.364 -177.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 355' ' ' ALA . . . . . . . . . . . . . . . -71.6 107.45 4.47 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.135 0.574 . . . . 75.44 110.214 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 356' ' ' ASN . . . . . 0.482 ' HB2' ' H ' ' B' ' 162' ' ' GLY . 11.2 t-20 -101.16 120.54 54.8 Favored Pre-proline 0 N--CA 1.48 1.068 0 C-N-CA 123.192 0.597 . . . . 74.32 109.474 -173.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 357' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -67.07 150.54 82.43 Favored 'Trans proline' 0 C--N 1.372 1.813 0 C-N-CA 122.817 2.344 . . . . 55.22 111.588 171.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 358' ' ' CYS . . . . . . . . . . . . . 66.0 m -136.05 11.51 3.33 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.561 0.744 . . . . 73.32 111.54 -177.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 359' ' ' GLY . . . . . . . . . . . . . . . -139.43 156.82 24.82 Favored Glycine 0 C--N 1.347 1.186 0 N-CA-C 111.749 -0.54 . . . . 62.01 111.749 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 360' ' ' GLN . . . . . 0.478 ' HB2' ' HD2' ' C' ' 211' ' ' ARG . 23.5 pt20 -164.68 79.79 0.36 Allowed 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 122.791 0.436 . . . . 53.34 111.705 -175.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 361' ' ' ILE . . . . . . . . . . . . . 66.0 mt 69.07 148.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 C-N-CA 124.659 1.183 . . . . 61.31 111.208 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 362' ' ' GLY . . . . . . . . . . . . . . . -119.3 -20.7 3.91 Favored Glycine 0 N--CA 1.472 1.067 0 O-C-N 122.066 -0.396 . . . . 72.35 113.083 172.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 363' ' ' GLU . . . . . 0.539 ' HG2' ' HA ' ' B' ' 201' ' ' PRO . 1.6 mp0 -84.77 -4.2 58.95 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.072 0.949 . . . . 73.13 111.899 -173.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 364' ' ' THR . . . . . . . . . . . . . 61.6 m 73.59 -63.86 0.42 Allowed 'General case' 0 C--N 1.358 0.956 0 C-N-CA 125.602 1.561 . . . . 74.04 109.93 -169.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 76.7 t 70.18 142.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 C-N-CA 124.865 1.266 . . . . 74.01 110.932 -177.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -58.52 141.69 51.18 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.109 0.964 . . . . 50.12 111.459 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 367' ' ' LEU . . . . . . . . . . . . . 7.7 mp -59.95 -27.0 66.43 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.418 1.087 . . . . 75.05 111.455 -177.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 368' ' ' ASP . . . . . . . . . . . . . 31.8 t70 68.3 -75.92 0.06 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.503 1.521 . . . . 71.23 111.312 176.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 369' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 70.42 143.11 0.05 Allowed 'General case' 0 CA--C 1.56 1.346 0 C-N-CA 125.133 1.373 . . . . 70.1 112.06 174.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 370' ' ' ALA . . . . . . . . . . . . . . . -136.06 -174.5 3.69 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.019 0.928 . . . . 74.25 110.02 -177.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 371' ' ' VAL . . . . . . . . . . . . . 47.7 t -64.21 -37.68 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 C-N-CA 123.687 0.795 . . . . 74.11 110.909 -177.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 372' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 65.97 89.07 0.1 Allowed 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 125.277 1.431 . . . . 63.2 111.115 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 373' ' ' ARG . . . . . 0.653 ' HG3' ' HE2' ' B' ' 377' ' ' PHE . 0.2 OUTLIER -96.06 76.61 3.09 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.591 -0.732 . . . . 72.05 109.605 -177.087 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -160.45 11.18 0.1 Allowed 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.488 -0.778 . . . . 71.45 112.106 -175.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 375' ' ' LEU . . . . . . . . . . . . . 81.9 mt -91.76 9.35 32.99 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.233 0.613 . . . . 62.01 111.341 -174.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -143.86 -22.78 0.57 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.29 1.036 . . . . 73.13 110.362 -178.093 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 377' ' ' PHE . . . . . 0.653 ' HE2' ' HG3' ' B' ' 373' ' ' ARG . 97.6 m-85 -76.1 91.79 3.15 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 109.274 -0.639 . . . . 73.31 109.274 172.194 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 378' ' ' ALA . . . . . 0.766 ' HA ' ' HA ' ' B' ' 243' ' ' GLN . . . -129.29 -88.97 0.51 Allowed 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 116.174 -0.466 . . . . 61.1 111.845 -177.167 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt 60.21 93.46 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.126 0.97 . . . . 72.01 109.194 -168.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 380' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 70.83 171.96 0.31 Allowed 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.774 1.23 . . . . 53.14 110.853 -173.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 381' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -161.07 -53.7 0.05 OUTLIER 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.846 -0.615 . . . . 74.34 111.124 -175.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -166.47 86.89 0.1 OUTLIER Glycine 0 C--N 1.355 1.593 0 C-N-CA 121.596 -0.335 . . . . 73.1 113.872 -175.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 383' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -159.89 -12.27 0.06 Allowed 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 113.615 0.968 . . . . 73.1 113.615 -175.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 384' ' ' THR . . . . . . . . . . . . . 7.0 t -89.53 114.96 26.57 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 118.815 0.734 . . . . 63.41 112.064 -173.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 56.3 mt -93.17 47.51 1.27 Allowed 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.548 0.739 . . . . 75.12 110.093 173.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 386' ' ' VAL . . . . . . . . . . . . . 87.6 t 72.76 -62.64 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 125.44 1.496 . . . . 62.42 111.305 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 387' ' ' ILE . . . . . 0.439 HD13 ' H ' ' B' ' 415' ' ' LYS . 8.0 tp -55.62 -30.13 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 125.128 1.371 . . . . 74.12 112.613 -177.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 388' ' ' VAL . . . . . . . . . . . . . 57.6 t -62.92 -43.89 99.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.421 0.688 . . . . 54.33 110.922 -177.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 389' ' ' THR . . . . . 0.466 ' HB ' ' HB2' ' B' ' 395' ' ' ALA . 35.4 p -97.38 -11.56 23.83 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.476 0.71 . . . . 71.25 111.677 177.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . 55.13 32.1 17.68 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 125.258 1.423 . . . . 70.34 112.471 178.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 391' ' ' ASP . . . . . . . . . . . . . 20.1 t70 65.87 -78.62 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 125.113 1.365 . . . . 64.12 110.725 -171.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 392' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -139.05 179.52 6.45 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 123.892 0.877 . . . . 72.42 109.883 -177.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . 61.32 23.0 13.29 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 124.211 1.004 . . . . 61.53 111.641 -178.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -166.23 -43.18 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.428 1.091 . . . . 73.31 108.792 -170.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 395' ' ' ALA . . . . . 0.466 ' HB2' ' HB ' ' B' ' 389' ' ' THR . . . -66.17 173.97 2.84 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.934 0.893 . . . . 71.44 112.093 178.257 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 49.7 m -65.94 -32.39 73.86 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.068 0.547 . . . . 75.55 111.399 176.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 397' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -93.35 107.36 19.2 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 108.26 -1.015 . . . . 71.41 108.26 176.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 398' ' ' ILE . . . . . 0.404 HG22 HG13 ' B' ' 399' ' ' VAL . 62.3 mt -134.67 -75.23 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 N-CA-C 107.585 -1.265 . . . . 75.44 107.585 172.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 399' ' ' VAL . . . . . 0.404 HG13 HG22 ' B' ' 398' ' ' ILE . 29.2 m -105.39 176.93 0.99 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.699 0 C-N-CA 124.062 0.945 . . . . 73.32 110.046 -177.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 400' ' ' ALA . . . . . . . . . . . . . . . -62.76 -46.27 88.16 Favored Pre-proline 0 CA--C 1.562 1.41 0 CA-C-O 118.285 -0.864 . . . . 51.41 111.327 178.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 401' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.57 53.07 3.86 Favored 'Trans proline' 0 C--N 1.387 2.579 0 C-N-CA 121.939 1.759 . . . . 71.04 112.935 165.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 62.1 -82.06 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 125.644 1.578 . . . . 74.34 112.807 177.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 403' ' ' THR . . . . . . . . . . . . . 18.8 p -129.38 168.44 16.28 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.944 0.898 . . . . 51.3 111.284 -169.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 404' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.32 143.49 42.04 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 114.614 -1.176 . . . . 70.03 108.62 167.401 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 405' ' ' ALA . . . . . . . . . . . . . . . -69.44 -54.68 10.74 Favored Pre-proline 0 CA--C 1.564 1.508 0 CA-C-O 118.532 -0.747 . . . . 71.24 112.241 -177.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 406' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -83.82 113.91 1.94 Allowed 'Trans proline' 0 C--N 1.393 2.896 0 C-N-CA 122.237 1.958 . . . . 44.44 111.081 -176.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . -54.61 -81.75 0.06 OUTLIER Glycine 0 N--CA 1.478 1.462 0 O-C-N 123.628 0.58 . . . . 55.33 113.825 -174.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 408' ' ' LEU . . . . . . . . . . . . . 29.8 tp -176.06 153.69 1.34 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.082 0.953 . . . . 72.03 108.461 176.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 18.6 p -57.96 -38.03 75.28 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.643 0.777 . . . . 73.52 111.297 178.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 410' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 -132.72 101.96 5.49 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 109.156 -0.683 . . . . 51.32 109.156 169.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . -79.78 -59.85 2.57 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.441 -0.578 . . . . 63.14 109.441 177.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 99.2 mt 58.01 -87.68 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.236 1.414 . . . . 60.41 111.38 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 49.35 80.3 0.07 Allowed 'General case' 0 C--N 1.358 0.943 0 C-N-CA 124.769 1.228 . . . . 71.14 111.396 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 414' ' ' THR . . . . . . . . . . . . . 46.7 m -77.82 79.92 4.29 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 109.018 -0.734 . . . . 73.24 109.018 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 415' ' ' LYS . . . . . 0.439 ' H ' HD13 ' B' ' 387' ' ' ILE . 57.2 mttp 52.46 46.66 26.26 Favored 'General case' 0 C--N 1.362 1.128 0 CA-C-N 114.389 -1.278 . . . . 73.42 110.816 -177.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 18.0 t70 75.03 -58.08 0.59 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 125.587 1.555 . . . . 75.33 111.266 -173.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 417' ' ' GLY . . . . . . . . . . . . . . . 144.94 -38.66 1.25 Allowed Glycine 0 C--O 1.246 0.889 0 N-CA-C 110.619 -0.992 . . . . 43.15 110.619 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 418' ' ' ALA . . . . . . . . . . . . . . . -72.67 127.44 32.56 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 123.212 0.605 . . . . 70.25 109.723 175.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 419' ' ' VAL . . . . . . . . . . . . . 14.1 m 48.99 35.36 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 C-N-CA 126.013 1.725 . . . . 62.03 112.768 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 420' ' ' MET . . . . . 0.406 ' O ' ' HD2' ' B' ' 415' ' ' LYS . 0.0 OUTLIER -57.42 -35.64 70.31 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.035 0.934 . . . . 73.12 112.496 -175.005 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 421' ' ' VAL . . . . . 0.468 HG13 ' HG2' ' A' ' 211' ' ' ARG . 3.4 p -83.65 82.33 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 CA-C-O 122.533 1.159 . . . . 72.42 108.319 170.018 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 422' ' ' MET . . . . . . . . . . . . . 15.3 ptp -86.61 -14.4 42.85 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 114.436 -1.256 . . . . 74.1 110.75 177.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 423' ' ' SER . . . . . . . . . . . . . 50.0 m 70.29 -71.33 0.13 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 126.081 1.752 . . . . 62.22 112.393 173.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 424' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 56.41 40.21 29.77 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.012 0.925 . . . . 72.42 109.45 -171.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . 87.91 -79.72 1.71 Allowed Glycine 0 C--N 1.346 1.101 0 CA-C-N 114.577 -1.192 . . . . 75.12 110.95 -171.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 426' ' ' ASN . . . . . . . . . . . . . 6.3 t30 64.34 -69.29 0.09 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 125.299 1.44 . . . . 75.43 110.583 -172.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 427' ' ' SER . . . . . 0.495 ' HB2' ' HB3' ' B' ' 432' ' ' GLN . 19.8 m -90.69 150.3 21.71 Favored 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 108.66 -0.867 . . . . 75.14 108.66 170.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -79.72 -52.05 8.44 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 113.729 1.011 . . . . 73.23 113.729 -162.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 429' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -61.15 83.82 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 123.539 0.736 . . . . 63.42 112.52 -169.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 36.9 t70 47.03 58.33 4.89 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 124.953 1.301 . . . . 55.41 110.819 -177.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 40.5 t 76.77 -46.1 0.5 Allowed 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 125.497 1.519 . . . . 73.31 111.324 -173.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 432' ' ' GLN . . . . . 0.495 ' HB3' ' HB2' ' B' ' 427' ' ' SER . 49.5 tp60 76.08 -49.75 0.6 Allowed 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 126.323 1.849 . . . . 71.1 112.112 178.054 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 433' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -84.1 61.32 6.42 Favored 'General case' 0 C--O 1.243 0.759 0 C-N-CA 123.922 0.889 . . . . 73.43 110.676 -179.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 434' ' ' HIS . . . . . . . . . . . . . 19.9 m170 -74.61 108.18 7.2 Favored 'General case' 0 C--N 1.34 0.193 0 N-CA-C 108.57 -0.9 . . . . 65.13 108.57 175.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 435' ' ' THR . . . . . . . . . . . . . 1.3 m -82.85 1.43 39.3 Favored 'General case' 0 CA--C 1.556 1.182 0 CA-C-N 115.037 -0.983 . . . . 73.42 111.67 -168.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . -176.36 -96.95 0.1 Allowed Glycine 0 C--N 1.352 1.435 0 CA-C-O 119.525 -0.597 . . . . 43.54 111.684 175.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 437' ' ' SER . . . . . 0.565 ' H ' ' HB2' ' A' ' 220' ' ' GLU . 31.1 t 76.48 -9.11 1.54 Allowed 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 125.541 1.536 . . . . 54.14 112.478 178.385 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 438' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -83.06 -27.9 29.95 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.763 0.825 . . . . 71.55 109.955 178.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 439' ' ' LEU . . . . . . . . . . . . . 5.1 mp -76.85 87.68 3.43 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.516 -0.765 . . . . 74.24 109.457 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 440' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -86.5 162.33 18.13 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.205 0.526 . . . . 70.1 110.632 178.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 441' ' ' ILE . . . . . 0.452 HD11 ' HB ' ' A' ' 221' ' ' VAL . 82.3 mt -133.64 149.38 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 124.276 1.031 . . . . 74.15 110.001 -172.176 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 442' ' ' ALA . . . . . . . . . . . . . . . -104.94 -77.35 0.58 Allowed 'General case' 0 CA--C 1.553 1.07 0 N-CA-C 109.251 -0.648 . . . . 71.41 109.251 168.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . 56.14 -88.01 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 125.179 1.392 . . . . 74.21 112.221 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -164.14 170.9 15.8 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.187 1.395 . . . . 65.34 108.375 173.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . 134.82 -61.05 0.64 Allowed Glycine 0 N--CA 1.469 0.881 0 N-CA-C 111.759 -0.537 . . . . 74.34 111.759 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 446' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -58.33 105.8 0.23 Allowed 'Trans proline' 0 C--N 1.382 2.311 0 C-N-CA 122.091 1.86 . . . . 63.02 108.886 164.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 447' ' ' HIS . . . . . . . . . . . . . 11.5 t60 -87.31 -29.03 21.91 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 116.229 -0.442 . . . . 60.0 110.258 -173.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . -153.72 25.17 0.51 Allowed 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.247 1.019 . . . . 74.31 109.555 169.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 449' ' ' ALA . . . . . 0.4 ' HB2' ' HB2' ' B' ' 468' ' ' LEU . . . -107.91 19.02 20.59 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.69 0.796 . . . . 61.52 110.253 178.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 450' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -80.31 89.43 5.52 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.338 -0.846 . . . . 61.12 109.716 -170.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 30.0 m 39.15 70.28 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 C-N-CA 125.807 1.643 . . . . 63.1 113.06 -177.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 452' ' ' VAL . . . . . . . . . . . . . 34.1 m -68.47 -17.73 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 CA-C-N 115.317 -0.856 . . . . 60.45 111.694 -176.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 81.26 60.94 2.16 Favored Glycine 0 C--N 1.348 1.194 0 N-CA-C 110.483 -1.047 . . . . 73.44 110.483 -178.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 454' ' ' LEU . . . . . . . . . . . . . 20.8 tp -94.13 12.27 27.09 Favored 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 123.679 0.792 . . . . 72.5 110.642 -175.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 3.2 m 60.02 21.27 10.39 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 124.592 1.157 . . . . 61.41 110.118 -175.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -78.39 149.27 33.38 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 114.674 -1.148 . . . . 74.3 110.813 -173.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 457' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -143.91 -74.82 0.25 Allowed 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.483 -0.781 . . . . 42.14 109.201 -172.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 17.9 p -147.37 -76.68 0.18 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.523 0.729 . . . . 72.13 111.473 -177.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 459' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -51.5 -93.2 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 125.616 1.566 . . . . 73.31 115.065 -160.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 8.0 mp -89.27 27.14 1.47 Allowed 'General case' 0 N--CA 1.481 1.114 0 O-C-N 121.423 -0.798 . . . . 65.42 109.976 -177.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -101.17 13.07 36.3 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.737 0.815 . . . . 62.31 110.773 -177.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -76.51 87.0 3.22 Favored 'General case' 0 C--N 1.355 0.835 0 N-CA-C 107.958 -1.127 . . . . 72.53 107.958 170.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 34.3 p -106.82 109.58 21.52 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 123.545 0.738 . . . . 61.35 109.835 -178.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 464' ' ' MET . . . . . . . . . . . . . 56.3 ttp -83.82 -59.14 2.52 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 108.717 -0.846 . . . . 75.31 108.717 175.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt 55.31 -83.74 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 125.279 1.432 . . . . 72.15 112.317 178.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -150.17 176.75 10.56 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.657 1.183 . . . . 62.32 109.523 -178.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . -81.31 95.07 6.87 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 109.22 -0.659 . . . . 75.3 109.22 174.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 468' ' ' LEU . . . . . 0.4 ' HB2' ' HB2' ' B' ' 449' ' ' ALA . 3.6 mm? -65.63 92.62 0.15 Allowed 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.072 0.549 . . . . 45.51 109.702 175.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 469' ' ' GLY . . . . . . . . . . . . . . . -155.87 64.76 0.32 Allowed Glycine 0 C--N 1.342 0.897 0 N-CA-C 110.232 -1.147 . . . . 50.44 110.232 -178.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 470' ' ' LEU . . . . . . . . . . . . . 5.6 mp -83.88 63.28 7.45 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.111 0.964 . . . . 73.2 110.5 -175.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 471' ' ' LYS . . . . . . . . . . . . . 88.1 tttt . . . . . 0 CA--C 1.547 0.855 0 N-CA-C 107.97 -1.122 . . . . 74.2 107.97 -178.871 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtm . . . . . 0 N--CA 1.469 0.52 0 N-CA-C 109.029 -0.73 . . . . 55.23 109.029 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 58.02 26.73 13.87 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.482 1.113 . . . . 65.31 112.143 -177.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -89.04 56.25 3.64 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.883 0.873 . . . . 52.01 110.34 -174.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -37.92 100.97 0.02 OUTLIER 'General case' 0 C--N 1.356 0.872 0 C-N-CA 125.778 1.631 . . . . 70.52 113.442 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 5' ' ' LYS . . . . . 0.635 ' HD2' HD11 ' C' ' 10' ' ' ILE . 25.0 mmtp -74.47 101.14 4.04 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 108.943 -0.762 . . . . 63.2 108.943 167.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 6' ' ' ASP . . . . . 0.408 ' HA ' ' OH ' ' C' ' 66' ' ' TYR . 13.5 t70 -73.73 93.12 2.06 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 106.261 -1.755 . . . . 63.22 106.261 168.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 7' ' ' TYR . . . . . 0.453 ' CD1' ' HA ' ' C' ' 53' ' ' ALA . 63.5 m-85 -61.13 -29.37 69.73 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.074 -0.966 . . . . 73.43 111.744 -171.345 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 8' ' ' TYR . . . . . 0.496 ' HD1' HG23 ' C' ' 13' ' ' VAL . 32.1 m-85 -64.05 -46.08 85.97 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.316 -0.856 . . . . 72.53 111.171 173.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.9 -39.39 94.08 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.103 0.561 . . . . 52.31 111.231 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 10' ' ' ILE . . . . . 0.635 HD11 ' HD2' ' C' ' 5' ' ' LYS . 62.2 mt -57.67 -43.81 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 C-N-CA 123.173 0.589 . . . . 63.34 110.042 174.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 11' ' ' LEU . . . . . 0.49 ' HB3' ' HB1' ' C' ' 25' ' ' ALA . 92.0 mt -82.72 -3.05 55.91 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 115.44 -0.8 . . . . 45.45 112.834 178.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 63.03 34.53 90.22 Favored Glycine 0 C--N 1.355 1.592 0 N-CA-C 114.088 0.395 . . . . 64.33 114.088 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 13' ' ' VAL . . . . . 0.496 HG23 ' HD1' ' C' ' 8' ' ' TYR . 8.3 m -129.38 154.33 80.68 Favored Pre-proline 0 N--CA 1.486 1.362 0 C-N-CA 124.776 1.23 . . . . 64.04 109.456 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -77.24 171.18 18.23 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 122.356 2.037 . . . . 74.43 112.778 -179.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 62.6 mtt180 -80.4 29.05 0.3 Allowed 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.518 0.727 . . . . 71.52 111.682 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -117.17 -15.94 10.43 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 125.659 1.583 . . . . 71.24 108.341 175.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.07 110.21 1.52 Allowed 'General case' 0 C--N 1.354 0.77 0 CA-C-N 114.918 -1.037 . . . . 71.14 110.655 -178.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 41.3 p -74.15 174.9 8.06 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 122.936 0.494 . . . . 74.41 109.857 172.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.93 -44.31 29.82 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 124.772 1.229 . . . . 74.45 111.745 -173.557 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 20' ' ' GLU . . . . . 0.668 ' HA ' ' HE3' ' C' ' 23' ' ' LYS . 2.3 tm-20 -65.08 -40.43 94.62 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.241 1.016 . . . . 64.05 110.851 -175.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 21' ' ' GLU . . . . . 0.49 ' HG2' ' NH2' ' C' ' 24' ' ' ARG . 33.6 mt-10 -70.57 -39.39 73.93 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.733 0.813 . . . . 73.42 110.837 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 22' ' ' ILE . . . . . 0.869 HD13 ' HB3' ' C' ' 57' ' ' LEU . 97.0 mt -64.07 -38.18 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.175 1.39 . . . . 61.32 110.368 175.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 23' ' ' LYS . . . . . 0.668 ' HE3' ' HA ' ' C' ' 20' ' ' GLU . 22.1 ttpp -67.76 -35.41 78.67 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.144 1.377 . . . . 74.13 110.438 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 24' ' ' ARG . . . . . 0.49 ' NH2' ' HG2' ' C' ' 21' ' ' GLU . 39.7 mtm180 -73.88 -33.04 63.89 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 115.848 -0.615 . . . . 73.52 112.361 172.337 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 25' ' ' ALA . . . . . 0.49 ' HB1' ' HB3' ' C' ' 11' ' ' LEU . . . -63.18 -38.4 91.04 Favored 'General case' 0 C--O 1.251 1.162 0 CA-C-O 121.465 0.65 . . . . 75.32 110.045 174.395 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 26' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -60.74 -58.46 8.38 Favored 'General case' 0 C--O 1.208 -1.1 0 CA-C-N 113.92 -1.491 . . . . 72.31 109.342 173.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 27' ' ' LYS . . . . . 0.498 ' HG2' ' HA ' ' B' ' 37' ' ' ASP . 27.5 mtpp -42.92 -52.3 5.2 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 124.042 0.839 . . . . 74.1 111.574 178.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -53.95 -62.65 1.52 Allowed 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.375 -1.284 . . . . 71.15 111.423 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 93.4 mt -84.65 -6.48 59.36 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 112.499 0.555 . . . . 60.22 112.499 -171.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.58 -17.07 20.68 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.134 0.574 . . . . 75.32 110.859 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 65.3 mtm180 -94.61 -33.08 13.14 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 123.324 0.39 . . . . 73.5 110.219 167.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -69.91 -52.77 21.83 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.042 0.537 . . . . 71.12 109.766 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 33' ' ' TYR . . . . . 0.417 ' HD1' ' HB1' ' C' ' 43' ' ' ALA . 51.2 m-85 -88.37 10.38 20.11 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 119.504 -0.284 . . . . 70.15 111.013 178.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 34' ' ' HIS . . . . . . . . . . . . . 63.9 t-80 -61.11 116.76 20.68 Favored Pre-proline 0 C--N 1.363 1.173 0 CA-C-O 118.325 -0.845 . . . . 72.34 109.788 -178.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -45.46 -53.43 5.5 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 123.901 3.067 . . . . 71.32 114.272 -172.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -56.14 -40.86 74.47 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.332 0.653 . . . . 60.34 112.63 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 62.1 t -80.13 -31.37 13.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 CA-C-N 115.542 -0.754 . . . . 75.33 110.442 -173.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -143.57 74.85 1.45 Allowed 'General case' 0 C--O 1.243 0.752 0 N-CA-C 108.245 -1.02 . . . . 54.22 108.245 -174.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -69.83 79.54 0.46 Allowed 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 114.919 -1.037 . . . . 62.24 109.975 178.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 16.1 m -136.17 102.17 10.03 Favored Pre-proline 0 CA--C 1.537 0.467 0 N-CA-C 107.486 -1.301 . . . . 74.14 107.486 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -32.83 -55.25 0.36 Allowed 'Trans proline' 0 C--N 1.389 2.703 0 C-N-CA 124.796 3.664 . . . . 63.44 115.256 -175.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.4 -40.57 91.43 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.299 0.64 . . . . 65.44 111.079 -178.129 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 43' ' ' ALA . . . . . 0.417 ' HB1' ' HD1' ' C' ' 33' ' ' TYR . . . -71.54 -24.0 61.86 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.368 0.667 . . . . 62.05 111.205 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -85.81 -28.71 24.31 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.4 -0.592 . . . . 74.04 109.4 -178.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -71.56 -40.87 69.68 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.728 0.811 . . . . 42.53 109.627 170.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 46' ' ' LYS . . . . . 0.529 ' O ' HG12 ' C' ' 50' ' ' ILE . 38.0 mmtm -67.05 -33.18 74.97 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 115.155 -0.93 . . . . 72.32 110.342 173.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -58.58 -46.96 85.84 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.608 0.763 . . . . 62.23 109.376 172.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 48' ' ' LYS . . . . . 0.639 ' HB3' ' HE1' ' C' ' 93' ' ' PHE . 55.4 mtpt -56.58 -42.61 78.95 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 123.894 0.746 . . . . 72.04 110.947 175.335 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -69.68 -24.58 63.62 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 122.936 0.494 . . . . 72.33 112.187 177.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 50' ' ' ILE . . . . . 0.529 HG12 ' O ' ' C' ' 46' ' ' LYS . 27.6 mm -69.71 -41.58 80.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.793 -0.818 . . . . 75.43 108.793 172.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 51' ' ' ASN . . . . . 0.492 ' HB3' ' CD1' ' C' ' 88' ' ' PHE . 58.7 m-80 -68.37 -32.75 73.05 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-N 114.79 -1.096 . . . . 74.04 111.18 177.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -65.84 -54.07 31.57 Favored 'General case' 0 C--O 1.248 0.988 0 C-N-CA 124.677 1.191 . . . . 63.42 110.317 176.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 53' ' ' ALA . . . . . 0.453 ' HA ' ' CD1' ' C' ' 7' ' ' TYR . . . -56.6 -51.04 70.17 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-N 113.627 -1.624 . . . . 63.1 111.297 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -64.35 -35.73 81.83 Favored 'General case' 0 C--O 1.197 -1.664 0 CA-C-N 114.874 -1.057 . . . . 75.01 110.528 177.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 55' ' ' ALA . . . . . 0.441 ' HB2' ' CD2' ' C' ' 88' ' ' PHE . . . -58.97 -44.64 91.55 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 118.378 0.535 . . . . 60.54 111.706 -178.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 86.2 t -68.06 -42.5 85.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 CA-C-O 121.367 0.603 . . . . 72.43 110.432 174.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 57' ' ' LEU . . . . . 0.869 ' HB3' HD13 ' C' ' 22' ' ' ILE . 80.7 mt -93.35 5.13 52.6 Favored 'General case' 0 CA--C 1.563 1.467 0 N-CA-C 113.483 0.92 . . . . 75.02 113.483 -171.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 30.4 t -81.42 -44.24 17.78 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.419 0.688 . . . . 62.42 110.262 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -80.06 128.78 72.47 Favored Pre-proline 0 CA--C 1.515 -0.401 0 CA-C-O 118.246 -0.883 . . . . 72.03 109.08 175.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 60' ' ' PRO . . . . . 0.568 ' O ' ' HG2' ' C' ' 64' ' ' ARG . 87.7 Cg_exo -51.41 -33.11 45.26 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.026 1.817 . . . . 33.23 110.978 162.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 61' ' ' GLU . . . . . 0.47 ' HB2' ' HB3' ' C' ' 144' ' ' ARG . 8.6 tp10 -61.36 -63.97 1.1 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.424 0.689 . . . . 62.13 111.365 176.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -64.81 -23.92 67.39 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 122.886 0.474 . . . . 75.23 111.336 -177.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 63' ' ' ARG . . . . . 0.497 HH21 ' HB3' ' C' ' 66' ' ' TYR . 2.6 tpm_? -63.98 -50.57 68.04 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.827 0.851 . . . . 64.42 110.115 172.394 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 64' ' ' ARG . . . . . 0.568 ' HG2' ' O ' ' C' ' 60' ' ' PRO . 28.5 mmm180 -69.62 -25.02 63.74 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 122.369 0.268 . . . . 74.15 110.894 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 66.6 mt -62.97 -46.52 96.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 N-CA-C 109.46 -0.57 . . . . 62.34 109.46 169.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 66' ' ' TYR . . . . . 0.497 ' HB3' HH21 ' C' ' 63' ' ' ARG . 6.5 t80 -58.78 -46.94 86.36 Favored 'General case' 0 CA--C 1.555 1.142 0 CA-C-N 115.33 -0.85 . . . . 74.22 109.809 176.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -56.23 -46.99 79.34 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.869 0.868 . . . . 73.14 111.265 177.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 27.5 p -78.03 -11.85 59.94 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.144 -0.48 . . . . 63.2 111.809 -177.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -73.82 101.63 3.79 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 107.922 -1.14 . . . . 75.22 107.922 173.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 107.77 22.23 7.42 Favored Glycine 0 C--N 1.347 1.172 0 CA-C-N 116.054 -0.521 . . . . 62.51 111.989 -172.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 92.4 m -144.33 -56.72 0.36 Allowed 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 104.233 -2.506 . . . . 72.34 104.233 175.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 21.9 m -78.74 140.35 38.3 Favored 'General case' 0 C--O 1.256 1.437 0 N-CA-C 104.619 -2.363 . . . . 73.35 104.619 156.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.5 -22.95 15.75 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.63 0.772 . . . . 73.23 111.273 -176.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.64 154.69 38.38 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 123.423 0.689 . . . . 53.23 109.594 174.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -58.82 119.98 7.57 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.194 1.93 . . . . 75.14 110.774 168.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.43 121.25 9.7 Favored 'Trans proline' 0 C--N 1.383 2.376 0 C-N-CA 122.732 2.288 . . . . 63.14 110.918 177.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -41.28 127.54 3.02 Favored 'Trans proline' 0 C--N 1.393 2.887 0 C-N-CA 124.119 3.213 . . . . 51.51 114.091 -169.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 78' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -52.22 142.36 46.21 Favored 'Trans proline' 0 C--N 1.391 2.764 0 C-N-CA 123.8 3.0 . . . . 74.44 113.633 -175.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 79' ' ' PRO . . . . . 0.411 ' HB2' ' HA2' ' C' ' 142' ' ' GLY . 70.8 Cg_exo -54.67 162.87 4.36 Favored 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 123.551 2.834 . . . . 61.04 113.67 176.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -53.97 87.38 0.03 OUTLIER 'Trans proline' 0 C--N 1.387 2.567 0 C-N-CA 123.641 2.894 . . . . 51.5 113.007 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 144.58 -49.51 0.68 Allowed Glycine 0 CA--C 1.524 0.627 0 CA-C-N 113.54 -1.664 . . . . 75.2 109.332 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 142.69 -164.1 27.13 Favored Glycine 0 C--N 1.348 1.237 0 CA-C-N 114.807 -0.697 . . . . 74.45 111.669 -177.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -92.52 111.51 23.13 Favored 'General case' 0 C--O 1.245 0.866 0 C-N-CA 123.907 0.883 . . . . 70.14 108.896 171.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -89.38 -174.4 4.36 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 109.409 -0.589 . . . . 63.13 109.409 170.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 85' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -162.56 71.27 0.3 Allowed 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 107.644 -1.243 . . . . 74.41 107.644 176.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 86' ' ' SER . . . . . 0.412 ' OG ' ' HD3' ' C' ' 143' ' ' ARG . 50.5 m -33.73 96.71 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 118.042 2.608 . . . . 45.43 118.042 -166.006 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 68.16 12.71 63.5 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-N 116.093 -0.503 . . . . 74.33 113.695 173.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 88' ' ' PHE . . . . . 0.492 ' CD1' ' HB3' ' C' ' 51' ' ' ASN . 16.8 m-85 -103.74 150.85 23.67 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 124.271 1.028 . . . . 74.44 108.385 -178.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -83.54 69.31 10.06 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.061 0.458 . . . . 72.23 110.995 -173.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 90' ' ' VAL . . . . . 0.435 HG23 ' CE2' ' C' ' 97' ' ' PHE . 0.8 OUTLIER -43.55 -43.35 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 125.719 1.608 . . . . 54.41 111.945 173.007 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -60.8 -30.77 70.26 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 114.787 -1.097 . . . . 74.21 111.641 -172.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -110.85 4.86 20.16 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.107 0.563 . . . . 75.53 111.289 -176.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 93' ' ' PHE . . . . . 0.639 ' HE1' ' HB3' ' C' ' 48' ' ' LYS . 10.5 m-30 -79.84 -177.14 5.79 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.841 -0.537 . . . . 72.45 112.302 -178.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 96.6 p -67.15 161.18 25.23 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.631 0.975 . . . . 45.51 113.631 -165.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -57.81 -56.08 26.53 Favored 'General case' 0 C--O 1.217 -0.641 0 CA-C-N 113.902 -1.499 . . . . 55.43 110.356 176.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -50.88 -45.27 60.03 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.868 0.867 . . . . 65.02 112.226 -176.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 97' ' ' PHE . . . . . 0.435 ' CE2' HG23 ' C' ' 90' ' ' VAL . 7.5 t80 -58.17 -53.18 61.21 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 115.23 -0.895 . . . . 64.25 110.214 174.111 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -77.49 4.38 11.23 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 122.707 0.403 . . . . 51.52 112.047 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -98.47 -45.54 6.08 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.534 0.733 . . . . 74.43 110.663 170.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 22.9 tp -78.65 -56.34 4.5 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.169 0.588 . . . . 73.23 110.281 -178.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 101' ' ' PHE . . . . . 0.484 ' O ' ' HG ' ' C' ' 105' ' ' LEU . 90.4 m-85 -85.26 -15.52 43.19 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.346 -0.843 . . . . 73.25 111.257 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -46.49 -54.78 8.47 Favored Glycine 0 CA--C 1.545 1.932 0 CA-C-O 118.941 -0.922 . . . . 54.11 114.951 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_exo -45.01 -24.5 1.32 Allowed 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 124.681 3.587 . . . . 62.02 116.434 175.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -128.58 14.56 6.09 Favored Glycine 0 C--N 1.355 1.633 0 CA-C-O 118.605 -1.108 . . . . 43.23 114.237 -178.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 105' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' C' ' 101' ' ' PHE . 49.3 mt -70.54 74.03 0.54 Allowed 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 118.247 1.024 . . . . 73.03 112.246 177.091 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 106' ' ' PHE . . . . . 0.435 ' HD2' HD22 ' C' ' 169' ' ' ASN . 32.1 m-85 35.41 -103.93 0.03 OUTLIER 'General case' 0 CA--C 1.563 1.473 0 C-N-CA 125.496 1.519 . . . . 64.24 114.788 174.323 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 107' ' ' GLY . . . . . 0.412 ' H ' ' HB2' ' C' ' 169' ' ' ASN . . . 61.16 28.74 69.56 Favored Glycine 0 C--N 1.363 2.056 0 N-CA-C 111.266 -0.734 . . . . 51.05 111.266 -163.449 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 68.44 -94.34 0.33 Allowed Glycine 0 C--N 1.348 1.247 0 N-CA-C 108.842 -1.703 . . . . 74.41 108.842 -163.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 109' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -136.47 5.21 2.93 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 124.165 0.986 . . . . 74.45 110.056 168.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 110' ' ' GLY . . . . . . . . . . . . . . . -92.91 -6.3 63.62 Favored Glycine 0 C--N 1.347 1.159 0 CA-C-N 115.857 -0.611 . . . . 54.22 113.449 175.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 52.77 18.47 1.04 Allowed 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 124.962 1.305 . . . . 75.25 113.441 174.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.84 -35.86 71.49 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.534 0.734 . . . . 74.1 110.378 167.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 113' ' ' SER . . . . . . . . . . . . . 50.7 m 75.69 48.85 0.08 Allowed 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 125.976 1.711 . . . . 72.53 110.993 -170.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 114' ' ' ARG . . . . . 0.429 ' HG2' ' N ' ' C' ' 115' ' ' LYS . 64.5 ttt-85 -69.86 159.56 33.42 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 115.565 -0.743 . . . . 74.05 109.733 176.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 115' ' ' LYS . . . . . 0.558 ' HA ' ' HD2' ' C' ' 170' ' ' PRO . 3.9 ttmt -61.15 135.87 57.89 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 118.971 0.805 . . . . 54.14 111.836 -177.027 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -84.18 128.18 8.49 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-N 114.962 -1.017 . . . . 45.25 113.269 -176.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 117' ' ' ARG . . . . . 0.456 ' HG2' ' H ' ' C' ' 118' ' ' ASP . 46.3 ttt-85 -82.98 174.67 10.69 Favored 'General case' 0 C--O 1.25 1.08 0 C-N-CA 123.459 0.704 . . . . 64.44 109.523 175.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 118' ' ' ASP . . . . . 0.456 ' H ' ' HG2' ' C' ' 117' ' ' ARG . 5.0 p-10 -64.52 151.76 43.62 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 121.59 0.709 . . . . 75.42 110.985 173.114 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 119' ' ' LEU . . . . . . . . . . . . . 61.1 tp -108.17 164.04 12.65 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 106.828 -1.545 . . . . 75.21 106.828 172.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 74.0 ttt-85 -138.69 120.94 15.85 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 118.665 0.666 . . . . 72.31 109.654 177.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 121' ' ' ALA . . . . . 0.467 ' HB3' HD11 ' C' ' 174' ' ' LEU . . . -140.84 118.81 11.85 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.28 1.032 . . . . 63.21 108.827 -178.106 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 122' ' ' GLU . . . . . 0.682 ' HG2' HG22 ' B' ' 186' ' ' THR . 13.6 pt-20 -102.05 147.6 26.39 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 110.317 -0.253 . . . . 73.22 110.317 178.405 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 123' ' ' LEU . . . . . 0.426 ' HB3' ' HB2' ' B' ' 183' ' ' ALA . 1.9 pt? -134.98 144.94 52.46 Favored Pre-proline 0 N--CA 1.478 0.954 0 C-N-CA 122.998 0.519 . . . . 73.3 111.237 -173.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.4 116.39 4.1 Favored 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 123.011 2.474 . . . . 72.51 110.076 165.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 125' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' C' ' 180' ' ' LEU . 38.4 tp -133.1 149.55 52.12 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.928 0.891 . . . . 74.03 108.687 -176.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 126' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.26 157.12 16.03 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 122.635 0.374 . . . . 61.53 110.775 -176.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 127' ' ' LEU . . . . . 0.557 HD13 ' HD2' ' C' ' 186' ' ' PHE . 17.9 mt -58.31 -47.02 85.03 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.809 1.244 . . . . 62.25 110.201 173.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 128' ' ' GLU . . . . . 0.463 ' HG3' ' HA ' ' C' ' 215' ' ' LEU . 1.8 mp0 -63.0 -38.08 89.77 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 114.267 -1.333 . . . . 75.24 110.903 178.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -79.54 -17.47 53.94 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 122.749 0.42 . . . . 73.53 111.707 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -75.37 -40.76 57.72 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 109.193 -0.669 . . . . 64.34 109.193 171.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 131' ' ' PHE . . . . . 0.603 ' HB2' HD13 ' C' ' 215' ' ' LEU . 69.2 t80 -62.38 -35.77 80.2 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.61 1.564 . . . . 75.55 111.91 172.007 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 132' ' ' HIS . . . . . . . . . . . . . 43.7 m170 -77.07 -51.31 11.27 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 110.318 -0.253 . . . . 60.22 110.318 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 50.55 -129.29 29.37 Favored Glycine 0 C--N 1.351 1.411 0 O-C-N 124.306 1.004 . . . . 65.31 113.894 177.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.29 -147.51 33.08 Favored Glycine 0 C--N 1.348 1.233 0 C-N-CA 123.128 0.394 . . . . 53.24 113.483 174.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -92.79 110.26 21.7 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.866 0.867 . . . . 71.2 109.898 -177.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 136' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -117.52 135.51 53.89 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.184 0.994 . . . . 72.12 110.152 -174.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 137' ' ' VAL . . . . . . . . . . . . . 35.8 m -76.86 143.98 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 122.644 0.378 . . . . 71.12 111.574 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 138' ' ' VAL . . . . . 0.602 ' HA ' HG22 ' B' ' 182' ' ' VAL . 7.4 p -158.93 139.7 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.28 1.032 . . . . 72.14 108.981 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 139' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' C' ' 143' ' ' ARG . 0.0 OUTLIER -123.8 94.84 4.35 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.559 0.743 . . . . 74.31 110.621 176.112 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 140' ' ' VAL . . . . . . . . . . . . . 11.5 p -147.77 139.85 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 122.977 0.511 . . . . 63.22 111.154 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 61.36 15.58 6.68 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 125.001 1.32 . . . . 15.23 113.72 173.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 142' ' ' GLY . . . . . 0.411 ' HA2' ' HB2' ' C' ' 79' ' ' PRO . . . 114.4 -26.64 9.5 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-N 116.489 -0.323 . . . . 45.25 112.602 -178.439 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 143' ' ' ARG . . . . . 0.457 ' O ' ' HA ' ' C' ' 139' ' ' GLU . 7.7 mmm180 -80.34 101.16 8.79 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.182 0.593 . . . . 73.04 111.593 178.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 144' ' ' ARG . . . . . 0.47 ' HB3' ' HB2' ' C' ' 61' ' ' GLU . 75.2 ttt180 -109.87 89.79 3.12 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 107.402 -1.333 . . . . 71.51 107.402 169.194 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 145' ' ' VAL . . . . . 0.433 HG11 HH21 ' C' ' 143' ' ' ARG . 12.6 p -161.05 163.8 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.904 0 C-N-CA 123.369 0.668 . . . . 75.03 111.26 -166.3 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 20.3 m -85.99 113.26 21.94 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 123.898 0.879 . . . . 54.21 109.972 168.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 3.9 p -89.18 129.45 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.477 0.711 . . . . 72.53 110.192 175.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 148' ' ' ARG . . . . . 0.426 ' HD2' HG23 ' B' ' 38' ' ' ILE . 42.9 ttt180 -86.59 95.07 9.63 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.152 0.581 . . . . 74.22 109.846 178.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 149' ' ' ILE . . . . . . . . . . . . . 40.7 pt -116.53 107.02 47.53 Favored Pre-proline 0 CA--C 1.546 0.827 0 N-CA-C 108.209 -1.034 . . . . 71.41 108.209 165.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -54.2 167.4 1.25 Allowed 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 123.075 2.516 . . . . 61.44 114.005 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -47.69 115.06 1.27 Allowed 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 123.062 2.508 . . . . 73.2 113.063 171.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 152' ' ' GLY . . . . . 0.411 ' HA3' ' HD2' ' B' ' 117' ' ' LYS . . . 150.43 88.45 0.07 OUTLIER Glycine 0 C--N 1.344 1.021 0 C-N-CA 120.441 -0.885 . . . . 54.32 114.527 -178.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 153' ' ' VAL . . . . . 0.594 HG22 HG11 ' C' ' 178' ' ' VAL . 14.0 p -165.26 151.83 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.201 0 C-N-CA 122.885 0.474 . . . . 71.13 110.001 173.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 154' ' ' ARG . . . . . 0.575 ' HD2' ' HG2' ' C' ' 187' ' ' ARG . 37.4 ttp180 -150.55 149.18 29.59 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.182 0.993 . . . . 75.32 109.819 -170.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 155' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -42.3 129.8 3.81 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 125.288 1.435 . . . . 74.51 112.849 -177.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.87 -13.72 58.42 Favored Glycine 0 C--N 1.348 1.219 0 CA-C-N 115.753 -0.658 . . . . 64.51 113.238 177.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 157' ' ' SER . . . . . 0.521 ' O ' HG12 ' C' ' 178' ' ' VAL . 43.8 t -74.8 140.43 43.97 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 108.832 -0.803 . . . . 75.43 108.832 174.162 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 158' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' B' ' 340' ' ' PHE . 58.6 t -119.73 105.84 18.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.629 -0.714 . . . . 64.44 109.266 -173.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 159' ' ' ILE . . . . . 0.689 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 15.3 mt -72.06 97.16 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.66 0 CA-C-N 114.805 -1.089 . . . . 52.25 108.954 -177.091 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 7.2 ttt180 -78.96 97.61 6.11 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 107.673 -1.232 . . . . 72.21 107.673 175.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 161' ' ' VAL . . . . . . . . . . . . . 2.2 p -101.53 103.99 31.22 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 124.457 1.103 . . . . 75.24 108.734 -178.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 162' ' ' PRO . . . . . 0.407 ' HG2' ' HB3' ' B' ' 33' ' ' ALA . 54.1 Cg_exo -55.36 123.98 15.16 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 123.407 2.738 . . . . 63.42 114.207 -173.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 163' ' ' GLY . . . . . 0.725 ' H ' ' HA ' ' C' ' 173' ' ' ASP . . . 89.79 -10.13 74.8 Favored Glycine 0 N--CA 1.441 -1.003 0 N-CA-C 117.236 1.654 . . . . 53.31 117.236 169.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 164' ' ' MET . . . . . 0.495 ' SD ' HD23 ' C' ' 174' ' ' LEU . 46.9 ttm -75.12 -13.23 60.46 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 119.954 1.877 . . . . 73.35 111.028 -177.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . -102.75 -117.12 4.27 Favored Glycine 0 C--N 1.347 1.156 0 CA-C-O 119.368 -0.685 . . . . 64.24 111.691 173.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 166' ' ' GLY . . . . . 0.475 ' HA3' ' HA ' ' C' ' 171' ' ' PRO . . . 87.44 68.86 1.31 Allowed Glycine 0 C--N 1.358 1.766 0 CA-C-N 117.781 0.791 . . . . 75.44 113.7 176.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 167' ' ' GLN . . . . . . . . . . . . . 19.9 mm-40 -80.14 100.21 8.13 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 106.97 -1.493 . . . . 64.31 106.97 173.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . 150.51 -89.23 0.14 Allowed Glycine 0 C--O 1.213 -1.167 0 CA-C-O 118.295 -1.281 . . . . 13.44 110.014 -168.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 169' ' ' ASN . . . . . 0.55 ' HB3' ' HD3' ' C' ' 170' ' ' PRO . 2.9 t-20 -176.36 -59.95 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.706 0 CA-C-O 117.165 -1.398 . . . . 62.44 112.216 164.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 170' ' ' PRO . . . . . 0.558 ' HD2' ' HA ' ' C' ' 115' ' ' LYS . 32.4 Cg_exo -61.52 98.91 0.16 Allowed 'Trans proline' 0 C--N 1.402 3.345 0 CA-C-N 122.446 1.909 . . . . 51.41 110.418 165.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 171' ' ' PRO . . . . . 0.543 ' HB2' ' HA2' ' C' ' 163' ' ' GLY . 7.5 Cg_exo -72.33 120.55 6.83 Favored 'Trans proline' 0 C--N 1.362 1.289 0 C-N-CA 122.34 2.027 . . . . 74.02 113.118 -163.24 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -63.78 -73.3 0.56 Allowed Glycine 0 C--N 1.347 1.164 0 O-C-N 124.029 0.831 . . . . 74.42 111.701 175.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 173' ' ' ASP . . . . . 0.725 ' HA ' ' H ' ' C' ' 163' ' ' GLY . 5.4 p-10 -170.46 175.99 4.56 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.245 0.545 . . . . 74.51 111.828 -179.085 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 174' ' ' LEU . . . . . 0.495 HD23 ' SD ' ' C' ' 164' ' ' MET . 11.2 tp -120.87 136.16 55.0 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 114.633 -1.167 . . . . 75.22 108.254 168.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 175' ' ' LEU . . . . . 0.404 ' N ' HD12 ' C' ' 174' ' ' LEU . 81.7 mt -98.88 88.92 4.14 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.659 1.184 . . . . 71.32 109.449 176.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 176' ' ' LEU . . . . . 0.689 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 78.8 mt -75.3 94.73 3.06 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.303 0.641 . . . . 43.02 110.012 174.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 177' ' ' VAL . . . . . . . . . . . . . 23.5 t -84.62 114.72 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 108.597 -0.89 . . . . 74.43 108.597 -178.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 178' ' ' VAL . . . . . 0.594 HG11 HG22 ' C' ' 153' ' ' VAL . 8.4 p -82.12 126.04 39.88 Favored 'Isoleucine or valine' 0 C--O 1.251 1.15 0 CA-C-O 121.941 0.877 . . . . 74.01 110.822 -176.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 179' ' ' ARG . . . . . . . . . . . . . 24.3 mmt180 -113.82 111.09 21.18 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.188 -1.412 . . . . 72.33 107.188 170.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 180' ' ' LEU . . . . . 0.413 ' HA ' ' O ' ' C' ' 125' ' ' LEU . 93.1 mt -73.29 148.52 43.5 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.86 0.362 . . . . 70.51 110.906 -177.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 181' ' ' LEU . . . . . 0.41 ' HB3' ' HD2' ' C' ' 182' ' ' PRO . 24.9 mt -62.12 166.29 6.84 Favored Pre-proline 0 CA--C 1.564 1.483 0 C-N-CA 124.405 1.082 . . . . 74.2 111.899 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 182' ' ' PRO . . . . . 0.41 ' HD2' ' HB3' ' C' ' 181' ' ' LEU . 12.1 Cg_exo -33.95 -20.84 0.02 OUTLIER 'Trans proline' 0 C--N 1.396 3.068 1 C-N-CA 125.413 4.075 . . . . 64.12 118.26 179.329 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 183' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -104.85 96.8 11.34 Favored Pre-proline 0 CA--C 1.568 1.644 0 CA-C-N 119.14 0.882 . . . . 62.13 110.147 165.296 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 184' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -98.14 65.91 0.09 OUTLIER 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 123.658 2.905 . . . . 71.54 110.575 171.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 185' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 36.9 t -94.02 -43.44 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 CA-C-N 115.952 -0.567 . . . . 72.23 110.611 -164.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 186' ' ' PHE . . . . . 0.557 ' HD2' HD13 ' C' ' 127' ' ' LEU . 68.1 m-85 -99.9 116.55 32.23 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-O 121.205 0.526 . . . . 61.44 111.345 -167.267 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 187' ' ' ARG . . . . . 0.688 ' HB3' ' HB3' ' C' ' 194' ' ' TYR . 3.2 tmt_? -96.12 107.91 20.28 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.997 1.319 . . . . 75.14 108.919 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 188' ' ' LEU . . . . . . . . . . . . . 45.8 tp -84.16 140.92 31.42 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.445 0.535 . . . . 74.14 112.445 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -144.97 106.28 4.21 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 107.069 -1.456 . . . . 71.33 107.069 162.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 74.96 -96.43 0.96 Allowed Glycine 0 C--N 1.355 1.633 0 N-CA-C 112.022 -0.431 . . . . 74.2 112.022 -177.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 191' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -115.19 -31.28 6.06 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.108 0.963 . . . . 60.21 110.154 173.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -76.97 152.66 35.15 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 116.072 -0.513 . . . . 65.13 111.551 -170.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 193' ' ' LEU . . . . . 0.47 HD21 ' CD1' ' C' ' 240' ' ' PHE . 88.1 mt -119.82 165.59 14.38 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.735 0.814 . . . . 52.2 111.257 -176.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 194' ' ' TYR . . . . . 0.688 ' HB3' ' HB3' ' C' ' 187' ' ' ARG . 27.5 t80 -139.47 107.3 5.66 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.097 -0.956 . . . . 75.43 109.585 170.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 195' ' ' ALA . . . . . 0.479 ' HA ' ' O ' ' C' ' 185' ' ' VAL . . . -104.67 -174.99 2.67 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.22 1.008 . . . . 65.11 110.907 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 196' ' ' THR . . . . . 0.405 HG21 ' HA ' ' B' ' 159' ' ' LYS . 65.9 m -132.11 121.09 23.24 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 108.088 -1.079 . . . . 51.32 108.088 164.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 197' ' ' LEU . . . . . . . . . . . . . 41.0 tp -97.53 125.86 42.48 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.292 0.637 . . . . 73.5 111.183 -172.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -73.84 101.85 3.88 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.005 0.922 . . . . 44.52 108.87 176.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 199' ' ' VAL . . . . . 0.572 ' HA ' HG11 ' C' ' 210' ' ' VAL . 26.9 t -121.72 109.28 34.37 Favored Pre-proline 0 N--CA 1.475 0.812 0 N-CA-C 108.62 -0.881 . . . . 61.21 108.62 178.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 200' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -68.45 147.13 70.49 Favored 'Trans proline' 0 C--N 1.37 1.702 0 C-N-CA 121.588 1.526 . . . . 71.34 111.317 175.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 201' ' ' ALA . . . . . 0.505 ' O ' HG23 ' C' ' 205' ' ' VAL . . . -52.44 -49.24 86.65 Favored Pre-proline 0 CA--C 1.553 1.07 0 CA-C-O 118.02 -0.99 . . . . 74.35 112.958 -173.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 202' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -51.12 -47.27 26.58 Favored 'Trans proline' 0 C--N 1.387 2.6 0 C-N-CA 121.649 1.566 . . . . 63.15 112.891 176.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 203' ' ' ILE . . . . . 0.518 ' HA ' HG12 ' C' ' 206' ' ' VAL . 47.0 mt -68.56 -34.18 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 123.044 0.538 . . . . 63.4 111.139 -178.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -70.24 -28.45 65.26 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.659 0.783 . . . . 75.02 112.208 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 205' ' ' VAL . . . . . 0.505 HG23 ' O ' ' C' ' 201' ' ' ALA . 55.0 t -86.39 -40.1 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 116.084 -0.507 . . . . 63.41 111.374 178.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 206' ' ' VAL . . . . . 0.609 HG23 ' HG3' ' A' ' 270' ' ' LYS . 14.0 p -80.16 -37.83 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 O-C-N 123.375 0.422 . . . . 52.12 111.355 -171.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 88.08 61.6 1.48 Allowed Glycine 0 N--CA 1.438 -1.177 0 CA-C-N 115.741 -0.663 . . . . 63.21 112.257 -168.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -101.38 -136.65 9.39 Favored Glycine 0 C--O 1.246 0.882 0 N-CA-C 111.431 -0.668 . . . . 51.32 111.431 176.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 209' ' ' LYS . . . . . 0.681 ' HE2' ' HG3' ' B' ' 235' ' ' GLU . 8.3 mtmp? -140.28 136.3 33.15 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.395 0.617 . . . . 72.12 110.92 178.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 210' ' ' VAL . . . . . 0.572 HG11 ' HA ' ' C' ' 199' ' ' VAL . 34.3 m -119.24 -179.86 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.539 1.535 . . . . 62.05 107.272 169.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 211' ' ' ARG . . . . . 0.62 ' HD3' ' HB2' ' C' ' 218' ' ' PRO . 23.1 ttm105 -132.76 130.6 40.15 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 118.976 0.807 . . . . 72.44 112.095 -178.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -97.0 115.05 26.74 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.32 1.048 . . . . 74.43 108.492 168.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 213' ' ' MET . . . . . . . . . . . . . 4.2 tmm? -71.56 101.91 2.6 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 107.418 -1.327 . . . . 63.12 107.418 171.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 214' ' ' THR . . . . . 0.408 ' OG1' HG12 ' C' ' 219' ' ' VAL . 0.2 OUTLIER -98.88 174.25 6.46 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.348 0.594 . . . . 54.24 110.234 -173.78 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 215' ' ' LEU . . . . . 0.603 HD13 ' HB2' ' C' ' 131' ' ' PHE . 30.7 mt -65.48 -33.89 77.0 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.309 1.444 . . . . 44.41 112.712 -169.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.23 10.71 23.7 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 114.94 -1.027 . . . . 71.0 111.472 -178.149 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 143.65 149.37 5.08 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-O 119.86 -0.411 . . . . 64.11 112.453 176.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 218' ' ' PRO . . . . . 0.62 ' HB2' ' HD3' ' C' ' 211' ' ' ARG . 73.3 Cg_endo -77.24 106.42 2.23 Favored 'Trans proline' 0 CA--C 1.557 1.634 0 C-N-CA 122.606 2.204 . . . . 52.13 113.081 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 219' ' ' VAL . . . . . 0.408 HG12 ' OG1' ' C' ' 214' ' ' THR . 7.2 p -88.32 138.26 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 123.558 0.743 . . . . 52.53 109.903 -178.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 220' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -89.01 111.21 21.88 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 108.734 -0.839 . . . . 72.32 108.734 174.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 221' ' ' VAL . . . . . . . . . . . . . 58.7 t -78.97 128.09 38.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 114.539 -1.209 . . . . 74.03 110.627 -178.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 222' ' ' ALA . . . . . 0.733 ' H ' ' HB2' ' B' ' 239' ' ' ALA . . . -85.42 105.48 16.08 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 124.424 1.09 . . . . 73.3 109.678 176.026 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 59.1 t -85.71 126.73 65.33 Favored Pre-proline 0 C--O 1.213 -0.858 0 N-CA-C 108.105 -1.072 . . . . 73.11 108.105 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 224' ' ' PRO . . . . . 0.725 ' HG2' ' HG3' ' B' ' 243' ' ' GLN . 10.4 Cg_exo -79.09 156.77 26.48 Favored 'Trans proline' 0 CA--C 1.555 1.546 0 C-N-CA 123.847 3.031 . . . . 54.33 112.221 166.325 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.43 148.17 64.02 Favored 'Trans proline' 0 C--N 1.387 2.587 0 C-N-CA 123.208 2.605 . . . . 74.0 113.635 -178.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 226' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.5 91.64 0.08 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.229 1.011 . . . . 70.15 112.215 178.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 227' ' ' THR . . . . . 0.511 HG22 HG11 ' C' ' 253' ' ' VAL . 34.0 m -140.9 124.46 16.85 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 115.37 -0.832 . . . . 70.3 111.869 176.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 228' ' ' GLN . . . . . . . . . . . . . 27.1 mp0 -98.11 161.39 13.74 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-O 122.483 1.135 . . . . 74.32 111.024 170.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 229' ' ' ALA . . . . . 0.437 ' HB2' ' H ' ' C' ' 255' ' ' ILE . . . -67.85 150.04 49.08 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-N 113.729 -1.578 . . . . 62.12 109.375 173.257 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 86.46 -4.17 86.38 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.304 -0.474 . . . . 62.04 113.03 -174.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 231' ' ' ARG . . . . . . . . . . . . . 45.5 mtt180 -76.65 170.34 16.61 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 117.789 0.794 . . . . 74.12 109.334 163.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 232' ' ' LYS . . . . . 0.568 ' HD3' ' HB3' ' C' ' 250' ' ' TYR . 3.9 ttmp? -146.55 139.68 25.58 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.205 0.457 . . . . 71.45 111.921 -173.157 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 233' ' ' LEU . . . . . 0.584 ' O ' ' HA ' ' C' ' 250' ' ' TYR . 2.4 mp -107.77 151.79 25.23 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.625 1.17 . . . . 74.21 109.89 -177.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -118.83 90.18 3.28 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.638 0.775 . . . . 72.34 109.255 171.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 235' ' ' LEU . . . . . 0.558 HD12 HD23 ' C' ' 249' ' ' LEU . 49.1 mt -74.25 108.39 7.01 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 109.13 -0.693 . . . . 73.43 109.13 172.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -71.08 125.57 27.25 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.879 0.872 . . . . 71.55 111.125 -175.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 71.44 37.14 62.66 Favored Glycine 0 C--N 1.349 1.251 0 O-C-N 123.532 0.52 . . . . 71.42 112.968 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 20.4 mmtm -126.07 14.95 7.9 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.913 0.885 . . . . 72.03 111.065 176.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -93.0 -167.48 38.91 Favored Glycine 0 C--N 1.352 1.449 0 N-CA-C 112.002 -0.439 . . . . 31.21 112.002 171.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 240' ' ' PHE . . . . . 0.47 ' CD1' HD21 ' C' ' 193' ' ' LEU . 3.6 m-85 -69.06 153.45 96.06 Favored Pre-proline 0 N--CA 1.478 0.96 0 C-N-CA 123.74 0.816 . . . . 75.14 111.529 176.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 241' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -65.91 118.86 5.85 Favored 'Trans proline' 0 C--N 1.377 2.054 0 C-N-CA 123.75 2.967 . . . . 70.21 112.411 -175.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -126.84 -169.52 12.74 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-N 115.719 -0.673 . . . . 70.14 112.548 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 243' ' ' PRO . . . . . 0.743 ' HA ' ' HA ' ' B' ' 111' ' ' LEU . 2.0 Cg_endo -72.14 -31.61 11.84 Favored 'Trans proline' 0 C--N 1.383 2.344 0 C-N-CA 123.049 2.5 . . . . 71.42 111.006 -178.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -80.35 6.35 12.34 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.82 0.848 . . . . 71.42 111.807 176.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 111.04 -76.56 0.22 Allowed Glycine 0 C--N 1.349 1.285 0 N-CA-C 109.907 -1.277 . . . . 51.32 109.907 -178.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 246' ' ' ARG . . . . . . . . . . . . . 29.4 mtm180 -146.09 166.44 26.12 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.847 1.259 . . . . 61.31 109.468 174.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -80.57 -158.89 19.53 Favored Glycine 0 C--N 1.347 1.172 0 CA-C-N 116.345 -0.388 . . . . 63.23 112.241 172.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -123.82 135.24 53.65 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 117.085 0.443 . . . . 73.54 109.836 -177.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 249' ' ' LEU . . . . . 0.558 HD23 HD12 ' C' ' 235' ' ' LEU . 21.0 tp -88.33 116.15 26.35 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 114.97 -1.014 . . . . 74.23 110.133 -178.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 250' ' ' TYR . . . . . 0.584 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 16.0 m-85 -102.05 99.87 10.07 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 109.838 -0.431 . . . . 71.43 109.838 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 251' ' ' LEU . . . . . 0.564 ' HB2' HD13 ' C' ' 233' ' ' LEU . 1.6 mp -97.15 136.2 38.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.8 -0.563 . . . . 64.53 110.152 -174.383 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 252' ' ' GLU . . . . . 0.597 ' HG2' ' HB3' ' B' ' 157' ' ' MET . 4.9 tp10 -88.14 118.71 27.91 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 108.047 -1.094 . . . . 73.41 108.047 174.146 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 253' ' ' VAL . . . . . 0.511 HG11 HG22 ' C' ' 227' ' ' THR . 94.0 t -60.14 131.14 24.66 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 123.348 0.659 . . . . 73.5 111.066 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 254' ' ' ARG . . . . . 0.47 ' CZ ' ' HB ' ' C' ' 256' ' ' THR . 2.1 tmm_? -124.02 98.32 5.74 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 107.507 -1.294 . . . . 74.13 107.507 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 255' ' ' ILE . . . . . 0.437 ' H ' ' HB2' ' C' ' 229' ' ' ALA . 52.0 mm -72.45 120.4 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 123.356 0.41 . . . . 75.24 109.903 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 256' ' ' THR . . . . . 0.47 ' HB ' ' CZ ' ' C' ' 254' ' ' ARG . 0.0 OUTLIER -125.39 164.46 20.38 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.012 0.925 . . . . 53.32 111.1 -176.131 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 2.8 pp -137.61 149.07 63.76 Favored Pre-proline 0 CA--C 1.554 1.099 0 C-N-CA 124.224 1.01 . . . . 64.54 108.328 175.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -80.11 16.52 1.49 Allowed 'Trans proline' 0 C--N 1.375 1.936 0 C-N-CA 122.599 2.2 . . . . 73.21 113.243 -171.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 57.83 -79.87 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.237 1.415 . . . . 72.3 111.635 -173.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -78.53 148.13 33.52 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.97 0.908 . . . . 73.41 109.901 -178.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 261' ' ' LEU . . . . . . . . . . . . . 82.1 mt -132.88 165.59 24.27 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 121.524 0.678 . . . . 71.21 111.329 -178.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 1.6 p -83.61 147.4 52.27 Favored Pre-proline 0 CA--C 1.552 1.035 0 CA-C-N 114.635 -1.166 . . . . 61.23 108.894 164.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -47.73 -31.63 15.1 Favored 'Trans proline' 0 C--N 1.387 2.558 0 C-N-CA 124.476 3.451 . . . . 74.2 114.988 -173.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -60.43 -65.76 0.63 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.88 0.872 . . . . 71.04 109.73 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -57.67 -42.56 83.82 Favored 'General case' 0 C--O 1.216 -0.697 0 CA-C-N 114.466 -1.243 . . . . 65.11 109.767 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 266' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -51.82 -46.12 64.19 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 123.992 0.917 . . . . 64.21 110.718 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -67.81 -43.67 79.08 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.5 0.72 . . . . 70.32 112.05 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 268' ' ' LEU . . . . . . . . . . . . . 10.6 mp -64.72 -37.35 87.29 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 120.765 0.317 . . . . 52.44 111.295 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 84.5 m95 -70.03 -32.26 70.31 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.536 0.735 . . . . 61.11 110.377 175.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 3.9 mmmp? -57.91 -50.65 72.61 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 122.852 0.461 . . . . 75.43 109.823 171.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 9.7 mmpt? -56.33 -52.53 64.2 Favored 'General case' 0 C--O 1.252 1.223 0 O-C-N 124.183 0.927 . . . . 75.33 111.191 -178.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 57.6 mt -51.99 -60.65 2.94 Favored 'General case' 0 C--N 1.355 0.845 0 CA-C-N 115.323 -0.853 . . . . 74.33 110.216 174.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -51.9 -44.77 63.94 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.927 0.891 . . . . 34.13 112.338 -173.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -62.21 -45.49 93.14 Favored 'General case' 0 C--O 1.252 1.235 0 C-N-CA 123.579 0.752 . . . . 63.21 110.818 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -58.54 -32.03 68.49 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 116.096 -0.502 . . . . 70.04 111.399 175.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 276' ' ' TYR . . . . . 0.703 ' HA ' ' HD3' ' C' ' 279' ' ' ARG . 1.4 m-85 -85.56 -23.09 27.8 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.09 0.556 . . . . 75.52 111.801 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 277' ' ' TYR . . . . . 0.465 ' CE1' ' HA3' ' A' ' 208' ' ' GLY . 20.4 m-30 -70.43 -30.74 67.67 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 109.424 -0.584 . . . . 44.24 109.424 174.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -59.72 -18.74 45.09 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-N 115.361 -0.836 . . . . 55.2 112.384 171.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 279' ' ' ARG . . . . . 0.703 ' HD3' ' HA ' ' C' ' 276' ' ' TYR . 17.5 mtp-105 -87.76 -26.91 22.65 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.784 0.834 . . . . 71.52 110.844 175.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.025 0 C-N-CA 123.243 0.617 . . . . 75.14 110.277 -172.654 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.2 mtp . . . . . 0 N--CA 1.47 0.555 0 N-CA-C 108.463 -0.94 . . . . 64.12 108.463 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.67 30.99 19.73 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.29 1.036 . . . . 51.4 111.999 -179.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.0 64.75 6.83 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.828 0.851 . . . . 74.04 110.458 -175.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -39.3 100.74 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.499 1.52 . . . . 62.43 114.165 -175.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -65.85 109.1 2.36 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 109.278 -0.638 . . . . 74.32 109.278 169.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -73.83 89.35 1.84 Allowed 'General case' 0 C--O 1.246 0.917 0 N-CA-C 107.165 -1.42 . . . . 61.41 107.165 170.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.445 ' HB2' HD11 ' A' ' 57' ' ' LEU . 67.1 m-85 -61.29 -27.94 68.83 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 113.9 -1.5 . . . . 73.34 111.565 -172.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -68.13 -41.7 81.27 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 122.962 0.505 . . . . 73.33 110.255 177.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.13 -41.77 97.07 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.045 0.538 . . . . 60.32 110.497 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 65.2 mt -58.93 -36.73 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 O-C-N 123.804 0.69 . . . . 74.23 110.29 174.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 91.2 mt -84.71 -10.49 57.21 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 113.303 0.853 . . . . 51.33 113.303 177.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 68.74 32.52 74.33 Favored Glycine 0 CA--C 1.537 1.427 0 N-CA-C 114.03 0.372 . . . . 53.33 114.03 -178.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.3 m -118.35 162.67 29.04 Favored Pre-proline 0 N--CA 1.484 1.226 0 C-N-CA 124.609 1.164 . . . . 71.43 109.554 174.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.401 ' HG2' ' HB2' ' A' ' 17' ' ' ALA . 11.9 Cg_endo -54.79 152.35 28.83 Favored 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 122.772 2.315 . . . . 50.12 112.586 175.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 76.1 mtt-85 -74.84 19.43 0.14 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 113.648 0.981 . . . . 75.43 113.648 -172.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -148.79 12.68 0.89 Allowed 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 124.605 1.162 . . . . 64.11 109.128 -177.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.401 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . . . -66.06 145.49 55.79 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.789 1.235 . . . . 64.31 113.457 -171.032 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.1 p -70.45 162.71 28.22 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.363 1.065 . . . . 71.11 111.658 -178.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -57.82 -30.18 65.53 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.145 0.978 . . . . 64.21 111.262 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.499 ' HA ' ' HE2' ' A' ' 23' ' ' LYS . 0.8 OUTLIER -69.07 -40.92 78.17 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.746 0.818 . . . . 72.43 109.899 178.949 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.507 ' HG2' ' NH2' ' A' ' 24' ' ' ARG . 42.7 mt-10 -67.98 -35.96 79.23 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.415 0.686 . . . . 64.03 110.833 176.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.81 -33.76 65.54 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 C-N-CA 124.592 1.157 . . . . 73.31 110.326 175.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.499 ' HE2' ' HA ' ' A' ' 20' ' ' GLU . 37.6 ttpt -76.19 -33.26 59.29 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.74 1.216 . . . . 71.24 110.483 179.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.507 ' NH2' ' HG2' ' A' ' 21' ' ' GLU . 50.2 mtm-85 -70.82 -40.97 72.14 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.156 0.583 . . . . 54.12 110.235 173.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.97 -33.88 75.5 Favored 'General case' 0 C--O 1.237 0.402 0 O-C-N 124.163 0.914 . . . . 64.0 110.719 176.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -60.33 -56.97 15.0 Favored 'General case' 0 C--O 1.215 -0.724 0 O-C-N 123.913 0.758 . . . . 73.1 109.9 176.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.496 ' NZ ' ' HA ' ' A' ' 24' ' ' ARG . 35.1 mtmm -60.32 -44.81 95.12 Favored 'General case' 0 N--CA 1.482 1.164 0 O-C-N 123.869 0.73 . . . . 74.22 111.132 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 46.1 ttt180 -47.25 -52.61 15.55 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 125.087 1.355 . . . . 71.15 111.945 176.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.539 HD13 HD12 ' A' ' 50' ' ' ILE . 62.7 mt -91.74 -13.94 30.78 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.559 -0.746 . . . . 74.11 111.656 -173.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -80.51 -18.51 48.3 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.259 0.624 . . . . 63.3 109.991 172.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 51.1 mtp180 -94.55 -39.11 10.56 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.04 0.936 . . . . 72.33 110.331 172.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -71.22 -40.24 71.24 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 122.537 0.335 . . . . 63.33 111.671 -177.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -106.97 24.62 12.5 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.879 0.472 . . . . 63.25 110.319 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 75.8 t60 -57.18 94.79 0.05 OUTLIER Pre-proline 0 N--CA 1.484 1.259 0 C-N-CA 124.73 1.212 . . . . 63.41 112.105 -171.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -72.02 -22.2 23.22 Favored 'Trans proline' 0 C--N 1.368 1.575 0 C-N-CA 122.652 2.235 . . . . 74.13 111.883 -164.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -53.57 -35.82 61.21 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.473 1.509 . . . . 72.45 111.615 176.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 89.4 t -115.42 -40.32 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 CA-C-O 120.905 0.383 . . . . 65.53 110.113 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -100.5 82.46 2.47 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.23 1.012 . . . . 61.35 110.045 -177.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.99 60.87 6.51 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.043 0.537 . . . . 73.11 110.189 -178.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 63.2 m -105.14 123.85 38.42 Favored Pre-proline 0 N--CA 1.481 1.096 0 CA-C-O 117.81 -1.09 . . . . 54.41 109.706 -177.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -40.88 -51.91 3.51 Favored 'Trans proline' 0 C--N 1.391 2.778 0 C-N-CA 124.767 3.645 . . . . 72.23 114.322 -175.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -51.94 -51.17 58.9 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.067 0.947 . . . . 64.43 110.849 175.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.04 -15.46 60.64 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.403 0.681 . . . . 72.14 111.81 -178.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.6 mm-40 -74.93 -60.77 2.14 Favored 'General case' 0 C--N 1.36 1.024 0 N-CA-C 108.236 -1.024 . . . . 62.01 108.236 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -56.59 -44.45 81.07 Favored 'General case' 0 C--N 1.354 0.793 0 CA-C-N 114.214 -1.357 . . . . 62.44 109.826 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.492 ' O ' HG12 ' A' ' 50' ' ' ILE . 9.6 tppt? -66.89 -43.77 82.61 Favored 'General case' 0 C--N 1.357 0.897 0 O-C-N 124.249 0.968 . . . . 74.03 111.078 -175.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -55.66 -44.39 77.21 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 123.765 0.665 . . . . 73.24 110.523 175.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.7 mtpm? -65.37 -35.64 81.58 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 115.54 -0.754 . . . . 75.14 111.578 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -67.96 -31.24 70.83 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 122.921 0.488 . . . . 71.44 110.747 173.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.539 HD12 HD13 ' A' ' 29' ' ' LEU . 12.0 mm -67.01 -37.54 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 N-CA-C 109.099 -0.704 . . . . 70.53 109.099 173.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.43 ' O ' ' HB2' ' A' ' 55' ' ' ALA . 53.2 m-80 -69.43 -31.54 69.94 Favored 'General case' 0 C--O 1.207 -1.137 0 CA-C-N 115.283 -0.871 . . . . 73.43 111.388 177.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -64.22 -53.77 43.92 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.788 0.804 . . . . 63.42 109.874 174.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.418 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . . . -56.8 -53.27 59.8 Favored 'General case' 0 C--O 1.25 1.096 0 CA-C-N 113.569 -1.651 . . . . 65.45 111.915 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -61.51 -40.35 94.3 Favored 'General case' 0 C--O 1.209 -1.054 0 CA-C-N 115.023 -0.989 . . . . 72.32 110.517 176.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.43 ' HB2' ' O ' ' A' ' 51' ' ' ASN . . . -54.8 -47.51 73.93 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.297 0.639 . . . . 53.01 112.123 -176.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 78.7 t -69.71 -45.36 77.79 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 O-C-N 123.738 0.649 . . . . 74.52 110.671 177.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.445 HD11 ' HB2' ' A' ' 7' ' ' TYR . 58.4 mt -90.84 6.47 44.24 Favored 'General case' 0 CA--C 1.563 1.455 0 N-CA-C 113.603 0.964 . . . . 62.04 113.603 -172.094 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 44.4 t -71.95 -51.87 19.95 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 124.409 1.084 . . . . 74.34 111.339 -178.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -102.29 140.05 20.8 Favored Pre-proline 0 C--O 1.243 0.763 0 CA-C-N 115.209 -0.905 . . . . 74.34 109.172 -176.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.402 ' O ' ' HG2' ' A' ' 64' ' ' ARG . 75.5 Cg_exo -53.25 -26.21 33.25 Favored 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 123.705 2.937 . . . . 72.41 113.142 177.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -61.69 -62.07 2.07 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 124.485 1.114 . . . . 72.3 111.054 -179.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.458 ' HA ' HD12 ' A' ' 65' ' ' ILE . 41.2 mtmt -76.04 -24.0 55.16 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 115.688 -0.687 . . . . 74.54 111.303 -176.269 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 42.1 tpt85 -55.76 -53.33 57.92 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 124.099 0.875 . . . . 74.11 109.005 168.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' A' ' 60' ' ' PRO . 1.8 mmp_? -64.19 -34.91 79.17 Favored 'General case' 0 C--N 1.36 1.05 0 C-N-CA 123.459 0.704 . . . . 74.25 112.172 178.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.458 HD12 ' HA ' ' A' ' 62' ' ' LYS . 94.7 mt -57.09 -44.93 83.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 CA-C-O 121.15 0.5 . . . . 64.42 110.811 174.175 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -63.97 -44.88 91.41 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 115.77 -0.65 . . . . 75.4 110.09 177.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -60.61 -32.58 71.71 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 123.075 0.55 . . . . 64.04 112.019 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 48.6 p -84.4 -15.33 46.67 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.576 0.35 . . . . 75.13 111.571 178.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -72.71 106.4 4.69 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 108.636 -0.876 . . . . 63.45 108.636 170.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 105.54 18.08 12.42 Favored Glycine 0 N--CA 1.472 1.091 0 N-CA-C 111.535 -0.626 . . . . 52.54 111.535 -171.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 85.0 m -137.55 -56.64 0.69 Allowed 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 103.733 -2.691 . . . . 71.23 103.733 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.7 m -82.54 141.32 32.71 Favored 'General case' 0 C--O 1.251 1.156 0 N-CA-C 104.385 -2.45 . . . . 74.23 104.385 155.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.54 -23.13 20.99 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.364 0.665 . . . . 74.04 111.736 -176.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -111.46 169.17 6.6 Favored Pre-proline 0 N--CA 1.478 0.936 0 C-N-CA 124.181 0.993 . . . . 75.1 110.029 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -52.11 135.79 52.66 Favored 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 122.253 1.969 . . . . 75.41 112.386 167.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.455 ' HG3' HG23 ' A' ' 65' ' ' ILE . 73.0 Cg_endo -70.17 173.0 11.98 Favored 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 123.127 2.551 . . . . 74.25 112.259 -178.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -62.58 119.82 7.07 Favored 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 121.759 1.639 . . . . 62.44 111.185 170.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -64.16 145.78 89.63 Favored 'Trans proline' 0 C--N 1.382 2.331 0 C-N-CA 122.848 2.366 . . . . 43.51 112.829 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -63.66 149.62 90.43 Favored 'Trans proline' 0 C--N 1.38 2.205 0 C-N-CA 122.946 2.43 . . . . 71.05 111.954 171.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -67.87 76.35 0.61 Allowed 'Trans proline' 0 C--N 1.382 2.322 0 C-N-CA 123.601 2.867 . . . . 51.35 112.711 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 159.33 -35.47 0.48 Allowed Glycine 0 N--CA 1.462 0.384 0 N-CA-C 109.288 -1.525 . . . . 62.41 109.288 -174.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 128.13 171.36 12.99 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-N 114.804 -0.698 . . . . 53.03 112.331 171.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -67.31 107.36 2.36 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 107.977 -1.119 . . . . 74.41 107.977 166.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.451 ' O ' ' HD1' ' A' ' 85' ' ' PHE . 23.6 t70 -61.86 153.22 29.54 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.802 0.841 . . . . 71.31 112.615 -175.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.451 ' HD1' ' O ' ' A' ' 84' ' ' ASP . 0.1 OUTLIER -153.52 70.77 0.86 Allowed 'General case' 0 CA--C 1.553 1.059 0 N-CA-C 107.761 -1.2 . . . . 70.22 107.761 170.428 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.593 ' HA ' ' HA3' ' A' ' 163' ' ' GLY . 41.5 m -57.9 86.76 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 125.006 1.322 . . . . 74.44 114.367 -174.037 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.572 ' HA2' ' HB3' ' A' ' 171' ' ' PRO . . . 98.16 12.22 46.48 Favored Glycine 0 N--CA 1.47 0.936 0 CA-C-N 116.368 -0.378 . . . . 70.11 113.721 176.035 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.409 ' CD1' ' HB3' ' A' ' 51' ' ' ASN . 30.2 m-85 -123.58 110.32 14.88 Favored 'General case' 0 C--O 1.245 0.846 0 C-N-CA 122.831 0.453 . . . . 72.34 110.16 -170.096 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -70.23 94.8 0.94 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 122.803 0.441 . . . . 71.44 110.066 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.561 HG13 ' HG2' ' A' ' 91' ' ' GLU . 2.3 p -27.41 -50.39 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 126.203 1.801 . . . . 75.21 114.961 166.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.561 ' HG2' HG13 ' A' ' 90' ' ' VAL . 9.7 mm-40 -67.86 -12.89 61.56 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.994 0.918 . . . . 75.33 112.854 -168.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -80.97 -39.17 26.45 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.127 0.971 . . . . 45.35 111.438 175.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.421 ' CD2' ' HE2' ' A' ' 85' ' ' PHE . 22.3 m-85 -83.28 179.73 7.62 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 115.429 -0.805 . . . . 71.01 112.357 -166.031 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 80.1 p -59.14 142.42 51.6 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.446 1.098 . . . . 74.5 112.598 -170.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.4 -28.53 69.85 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.024 -0.989 . . . . 74.31 111.343 174.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -52.32 -55.27 22.58 Favored 'General case' 0 C--N 1.367 1.333 0 C-N-CA 123.026 0.53 . . . . 75.03 110.607 169.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -56.77 -43.53 80.92 Favored 'General case' 0 CA--C 1.548 0.887 0 O-C-N 124.065 0.853 . . . . 63.23 109.586 178.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.578 ' HA ' HD11 ' A' ' 105' ' ' LEU . 92.7 mt-30 -70.87 -12.33 61.48 Favored 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 115.458 -0.792 . . . . 73.05 112.307 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -88.07 -57.71 2.83 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.83 0.852 . . . . 70.02 111.766 171.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 51.0 tp -64.39 -42.51 96.08 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.69 0.796 . . . . 55.03 111.506 -174.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -94.62 -4.75 47.19 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-N 115.811 -0.632 . . . . 72.11 110.331 178.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -43.48 -59.24 3.69 Favored Glycine 0 C--N 1.356 1.663 0 CA-C-O 118.49 -1.172 . . . . 72.43 114.882 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -43.42 -24.15 0.58 Allowed 'Trans proline' 0 C--N 1.392 2.834 0 C-N-CA 124.717 3.612 . . . . 23.1 116.143 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -150.79 36.8 0.9 Allowed Glycine 0 C--N 1.352 1.457 0 CA-C-O 119.241 -0.755 . . . . 44.4 113.016 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.578 HD11 ' HA ' ' A' ' 98' ' ' GLN . 18.1 mt -54.33 84.62 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.147 0.579 . . . . 74.25 111.997 173.206 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.414 ' CD2' ' HA ' ' A' ' 84' ' ' ASP . 0.4 OUTLIER 19.19 -110.18 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 127.938 2.495 . . . . 72.25 113.831 176.192 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 58.46 16.86 30.43 Favored Glycine 0 C--N 1.361 1.931 0 CA-C-O 119.771 -0.461 . . . . 44.0 113.869 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 64.86 -100.04 0.41 Allowed Glycine 0 C--N 1.356 1.664 0 N-CA-C 111.396 -0.682 . . . . 71.34 111.396 -167.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -132.69 7.84 4.13 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.356 1.062 . . . . 64.11 109.842 177.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -69.07 -30.3 72.08 Favored Glycine 0 C--N 1.355 1.633 0 CA-C-N 115.509 -0.769 . . . . 55.25 113.037 178.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 74.52 -30.79 0.21 Allowed 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 124.758 1.223 . . . . 71.44 113.773 176.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.72 -11.7 58.93 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.483 0.713 . . . . 73.25 110.443 175.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 2.9 m 69.69 58.29 0.31 Allowed 'General case' 0 C--N 1.357 0.897 0 C-N-CA 124.218 1.007 . . . . 74.21 109.285 174.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -119.62 169.01 10.46 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.832 -0.622 . . . . 74.52 111.924 -174.103 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.09 132.0 47.5 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.337 1.455 . . . . 72.15 112.188 -164.058 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -77.86 -163.57 21.41 Favored Glycine 0 CA--C 1.543 1.803 0 CA-C-N 115.476 -0.784 . . . . 55.22 114.6 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.455 ' H ' ' HA3' ' A' ' 166' ' ' GLY . 0.9 OUTLIER -112.74 130.33 56.1 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 124.587 1.155 . . . . 71.34 111.751 178.69 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -52.23 120.56 5.61 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.622 0.725 . . . . 74.23 111.487 176.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 67.2 tp -129.1 157.33 42.06 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 115.138 -0.937 . . . . 70.23 110.287 -171.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 34.3 ttp180 -111.18 146.67 36.47 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 108.793 -0.817 . . . . 74.51 108.793 171.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.556 ' HB2' HD11 ' A' ' 174' ' ' LEU . . . -128.35 158.19 38.91 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.604 0.716 . . . . 41.51 110.762 177.228 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.407 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 0.4 OUTLIER -112.76 108.1 16.99 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 105.262 -2.125 . . . . 61.0 105.262 -179.443 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.557 ' HB3' ' HA ' ' A' ' 178' ' ' VAL . 41.9 tp -98.44 97.44 4.68 Favored Pre-proline 0 N--CA 1.476 0.841 0 N-CA-C 108.042 -1.096 . . . . 54.05 108.042 -175.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.584 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 98.5 Cg_endo -79.22 107.62 2.23 Favored 'Trans proline' 0 C--N 1.381 2.237 0 C-N-CA 121.005 1.137 . . . . 75.33 109.309 -177.285 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.517 ' HB3' HD23 ' A' ' 180' ' ' LEU . 54.2 tp -109.63 132.05 54.5 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 122.362 0.265 . . . . 64.01 110.637 -166.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 97.4 m -62.59 124.87 22.11 Favored 'General case' 0 CA--C 1.551 0.986 0 O-C-N 124.496 1.122 . . . . 71.34 109.165 176.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.412 ' HB3' HD22 ' A' ' 215' ' ' LEU . 73.7 mt -52.77 -43.39 65.8 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 124.266 1.027 . . . . 70.54 112.195 -170.154 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -60.12 -35.84 76.14 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 114.36 -1.291 . . . . 75.32 110.241 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -83.01 -20.54 34.86 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.998 0.919 . . . . 64.33 111.314 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -66.64 -35.58 80.52 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 109.86 -0.422 . . . . 41.43 109.86 168.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -74.51 -48.05 29.46 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 115.298 -0.864 . . . . 74.51 111.831 173.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 33.3 m170 -74.03 -40.17 63.05 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 123.221 0.608 . . . . 75.25 111.886 -171.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 74.11 -151.33 43.73 Favored Glycine 0 CA--C 1.531 1.084 0 O-C-N 123.618 0.574 . . . . 71.54 113.092 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 86.34 -167.63 39.51 Favored Glycine 0 N--CA 1.473 1.166 0 C-N-CA 123.117 0.389 . . . . 70.42 112.435 -178.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.424 ' HB3' ' OG ' ' A' ' 146' ' ' SER . 2.6 mp0 -76.65 118.84 19.7 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.908 0.483 . . . . 73.14 110.289 175.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -94.47 119.88 33.85 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.658 0.783 . . . . 74.4 110.083 177.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 77.2 t -75.83 111.56 12.42 Favored 'Isoleucine or valine' 0 C--O 1.244 0.788 0 N-CA-C 108.704 -0.85 . . . . 71.24 108.704 168.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.557 HG13 HG13 ' A' ' 145' ' ' VAL . 3.5 p -135.69 138.09 48.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 124.452 1.101 . . . . 73.14 108.444 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -124.27 141.98 51.63 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.185 0.594 . . . . 71.3 110.974 -170.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.55 HG11 HD23 ' B' ' 8' ' ' LEU . 12.3 p -169.11 137.07 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 124.571 1.149 . . . . 75.1 109.07 176.342 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 55.49 33.21 20.55 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.129 0.972 . . . . 74.24 112.394 174.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 87.25 -23.6 11.32 Favored Glycine 0 C--N 1.352 1.443 0 CA-C-N 116.092 -0.504 . . . . 31.1 113.255 -178.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.548 ' NH1' ' HG2' ' A' ' 164' ' ' MET . 11.5 tpt180 -74.41 100.09 3.71 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.211 1.005 . . . . 72.12 110.543 179.069 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 19.7 ttp180 -84.47 92.53 8.1 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 107.912 -1.144 . . . . 74.41 107.912 165.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.557 HG13 HG13 ' A' ' 138' ' ' VAL . 3.7 p -98.53 143.02 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 115.041 -0.981 . . . . 73.53 110.796 -175.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.424 ' OG ' ' HB3' ' A' ' 135' ' ' GLU . 17.3 t -105.53 84.96 2.16 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 108.46 -0.941 . . . . 31.45 108.46 177.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 34.8 m -83.17 115.4 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 CA-C-O 121.244 0.545 . . . . 73.42 110.192 -177.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 48.5 ttt180 -74.18 103.36 4.58 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 109.426 -0.583 . . . . 74.14 109.426 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.447 ' HB ' HG11 ' A' ' 153' ' ' VAL . 36.3 pt -94.05 139.22 22.51 Favored Pre-proline 0 CA--C 1.557 1.243 0 C-N-CA 123.818 0.847 . . . . 74.13 109.508 176.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -73.26 140.7 31.09 Favored 'Trans proline' 0 C--N 1.372 1.784 0 C-N-CA 122.345 2.03 . . . . 60.34 111.846 176.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -57.85 93.18 0.06 OUTLIER 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 122.653 2.235 . . . . 74.15 111.494 167.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.605 ' HA2' ' HD2' ' A' ' 240' ' ' PHE . . . 124.62 31.48 0.89 Allowed Glycine 0 C--N 1.341 0.847 0 CA-C-N 115.558 -0.746 . . . . 75.51 112.474 -176.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.447 HG11 ' HB ' ' A' ' 149' ' ' ILE . 3.4 p -86.36 137.23 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 123.391 0.676 . . . . 75.43 110.323 -178.269 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.849 ' HD2' ' HA ' ' A' ' 191' ' ' GLN . 2.7 mtm-85 -127.46 151.29 49.03 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.815 0.846 . . . . 73.23 110.908 -163.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -53.24 116.9 2.65 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 124.694 1.246 . . . . 72.32 110.477 178.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 107.16 2.26 35.89 Favored Glycine 0 C--N 1.345 1.081 0 CA-C-N 115.76 -0.654 . . . . 14.21 113.54 -175.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 28.1 t -78.03 104.32 8.53 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 108.091 -1.078 . . . . 74.23 108.091 172.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.442 HG22 HG22 ' A' ' 177' ' ' VAL . 41.8 t -87.06 91.89 3.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 C-N-CA 124.74 1.216 . . . . 72.34 109.585 -178.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.551 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 58.9 mt -76.02 97.04 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 N-CA-C 108.576 -0.898 . . . . 75.24 108.576 173.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 74.0 ttt-85 -75.28 103.91 5.63 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.563 -0.532 . . . . 61.32 109.563 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.483 HG11 ' SD ' ' A' ' 164' ' ' MET . 7.5 p -116.46 123.15 30.95 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 123.505 0.722 . . . . 61.33 109.431 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -65.28 148.68 88.74 Favored 'Trans proline' 0 C--N 1.364 1.359 0 C-N-CA 122.707 2.271 . . . . 74.53 113.113 174.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.593 ' HA3' ' HA ' ' A' ' 86' ' ' SER . . . 83.5 -25.74 4.92 Favored Glycine 0 N--CA 1.479 1.516 0 N-CA-C 116.482 1.353 . . . . 70.43 116.482 166.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.548 ' HG2' ' NH1' ' A' ' 143' ' ' ARG . 66.7 mtp -75.11 -21.68 58.73 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 117.502 0.651 . . . . 64.15 111.691 -179.074 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.531 ' HA2' HD13 ' A' ' 174' ' ' LEU . . . -80.2 -106.62 0.28 Allowed Glycine 0 C--N 1.348 1.236 0 CA-C-O 119.346 -0.697 . . . . 73.33 113.107 -175.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.455 ' HA3' ' H ' ' A' ' 117' ' ' ARG . . . -53.13 109.02 0.86 Allowed Glycine 0 C--O 1.275 2.658 0 O-C-N 123.85 0.382 . . . . 74.5 112.849 168.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -54.29 104.07 0.1 Allowed 'General case' 0 C--N 1.351 0.673 0 O-C-N 127.854 2.737 . . . . 75.42 108.676 177.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -173.26 143.98 7.51 Favored Glycine 0 N--CA 1.44 -1.066 0 N-CA-C 108.556 -1.818 . . . . 64.21 108.556 -171.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ASN . . . . . 0.54 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . 0.2 OUTLIER -73.16 -49.58 7.04 Favored Pre-proline 0 CA--C 1.558 1.27 0 N-CA-C 109.396 -0.594 . . . . 63.11 109.396 -171.688 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.54 ' HD3' ' HB3' ' A' ' 169' ' ' ASN . 18.8 Cg_exo -71.76 149.76 54.92 Favored 'Trans proline' 0 C--N 1.375 1.965 0 N-CA-C 108.19 -1.504 . . . . 71.13 108.19 156.006 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.572 ' HB3' ' HA2' ' A' ' 87' ' ' GLY . 74.1 Cg_endo -69.61 124.12 10.82 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 122.716 2.278 . . . . 71.25 116.247 -162.107 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -62.26 -46.73 93.33 Favored Glycine 0 C--N 1.374 2.641 0 C-N-CA 119.41 -1.376 . . . . 72.4 111.117 161.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 101.8 147.71 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 128.49 2.716 . . . . 71.14 108.438 177.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.556 HD11 ' HB2' ' A' ' 121' ' ' ALA . 28.3 tp -137.14 138.51 40.35 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.115 0.483 . . . . 64.32 110.768 -175.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 48.0 mt -105.34 89.8 3.23 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 114.731 -1.122 . . . . 72.12 108.166 171.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.551 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 64.6 mt -68.39 88.27 0.32 Allowed 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 109.684 -0.487 . . . . 70.05 109.684 175.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.442 HG22 HG22 ' A' ' 158' ' ' VAL . 18.2 t -85.36 104.01 12.89 Favored 'Isoleucine or valine' 0 C--O 1.25 1.1 0 N-CA-C 106.384 -1.71 . . . . 61.43 106.384 174.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.557 ' HA ' ' HB3' ' A' ' 123' ' ' LEU . 8.2 p -67.49 119.55 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 CA-C-N 115.216 -0.902 . . . . 70.33 109.688 -175.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.584 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 36.7 mmt180 -103.07 109.08 20.51 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-N 114.18 -1.373 . . . . 53.32 107.868 176.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.517 HD23 ' HB3' ' A' ' 125' ' ' LEU . 59.6 mt -74.79 143.05 44.17 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.683 -0.636 . . . . 72.4 109.496 177.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 86.2 mt -52.86 154.72 4.72 Favored Pre-proline 0 N--CA 1.486 1.325 0 C-N-CA 123.94 0.896 . . . . 73.14 112.82 -168.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' PRO . . . . . 0.436 ' HD3' HG22 ' B' ' 18' ' ' VAL . 72.2 Cg_endo -74.25 21.43 0.39 Allowed 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 122.695 2.263 . . . . 71.42 112.783 171.178 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 184' ' ' PRO . 36.7 t-80 -61.64 106.7 0.87 Allowed Pre-proline 0 CA--C 1.557 1.215 0 C-N-CA 125.817 1.647 . . . . 73.35 108.114 168.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.453 ' HB3' ' HA ' ' B' ' 23' ' ' THR . 8.0 Cg_exo -73.95 25.04 0.34 Allowed 'Trans proline' 0 C--N 1.373 1.86 0 C-N-CA 124.137 3.225 . . . . 61.24 116.428 -162.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 69.1 t -97.25 -39.08 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 118.569 0.622 . . . . 64.21 109.672 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' PHE . . . . . 0.683 ' HE1' ' HA ' ' A' ' 214' ' ' THR . 35.4 m-85 -146.29 111.59 5.44 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.114 0.483 . . . . 72.31 112.069 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.677 ' HB3' ' HB2' ' A' ' 194' ' ' TYR . 59.4 ttt180 -91.93 82.39 5.14 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 106.889 -1.523 . . . . 75.51 106.889 162.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.499 ' HB2' HD23 ' A' ' 193' ' ' LEU . 40.8 tp -79.5 95.39 5.8 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.438 -0.801 . . . . 74.21 108.872 177.412 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -118.74 131.12 56.12 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.609 0.764 . . . . 70.31 109.951 -174.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 77.62 -77.51 1.59 Allowed Glycine 0 C--N 1.353 1.48 0 N-CA-C 111.497 -0.641 . . . . 65.41 111.497 -178.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.849 ' HA ' ' HD2' ' A' ' 154' ' ' ARG . 13.2 pt20 -153.34 -6.03 0.18 Allowed 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.041 0.936 . . . . 72.32 111.061 173.007 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -122.18 150.43 42.25 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.459 0.704 . . . . 72.32 110.975 -167.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.499 HD23 ' HB2' ' A' ' 188' ' ' LEU . 38.5 mt -92.17 152.31 19.95 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.935 1.294 . . . . 63.44 111.089 -170.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.677 ' HB2' ' HB3' ' A' ' 187' ' ' ARG . 89.0 m-85 -131.34 103.09 6.25 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 107.964 -1.124 . . . . 73.14 107.964 169.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.483 ' HB3' HD23 ' A' ' 251' ' ' LEU . . . -122.93 115.95 22.78 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.464 1.106 . . . . 74.34 110.648 -173.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' THR . . . . . 0.458 ' HA ' ' HB2' ' A' ' 252' ' ' GLU . 93.6 m -71.43 111.63 6.9 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 121.082 0.468 . . . . 70.21 110.686 -177.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.493 HD22 HD13 ' A' ' 251' ' ' LEU . 37.5 tp -99.04 119.85 38.49 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.772 0.829 . . . . 72.21 110.809 -173.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -82.38 115.86 21.6 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 108.363 -0.977 . . . . 61.43 108.363 172.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.1 p -143.62 126.35 8.75 Favored Pre-proline 0 N--CA 1.479 1.022 0 C-N-CA 123.375 0.67 . . . . 64.4 110.138 -175.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 256' ' ' THR . 54.1 Cg_endo -72.11 152.1 56.18 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 121.942 1.762 . . . . 64.51 112.095 176.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -44.22 -59.31 3.89 Favored Pre-proline 0 N--CA 1.484 1.268 0 N-CA-C 116.267 1.951 . . . . 71.34 116.267 -172.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -74.07 -19.82 19.88 Favored 'Trans proline' 0 C--N 1.384 2.411 0 CA-C-N 121.84 1.693 . . . . 63.54 112.76 -174.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 17.7 mt -75.11 -30.27 22.97 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 N-CA-C 109.521 -0.548 . . . . 64.32 109.521 172.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -72.22 -43.03 65.04 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-O 121.129 0.49 . . . . 71.51 111.23 173.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 54.5 t -71.94 -41.77 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 123.803 0.841 . . . . 63.23 112.375 -174.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 97.2 t -93.06 -32.61 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 122.546 0.338 . . . . 74.41 110.747 -178.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 89.83 77.19 1.32 Allowed Glycine 0 C--N 1.343 0.923 0 CA-C-N 116.312 -0.404 . . . . 72.35 112.137 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -96.03 -136.55 8.84 Favored Glycine 0 C--N 1.342 0.867 0 N-CA-C 112.056 -0.418 . . . . 55.24 112.056 178.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 46.0 mtmt -130.47 144.27 51.29 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.12 0.568 . . . . 45.21 110.013 178.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 16.8 m -136.32 176.71 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.533 1.133 . . . . 63.11 109.526 174.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 20.5 ttm180 -109.75 112.2 24.12 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.578 0.751 . . . . 71.41 109.529 175.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -104.6 126.62 51.86 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.721 -0.844 . . . . 62.04 108.721 176.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' MET . . . . . 0.638 ' HA ' ' HA ' ' A' ' 218' ' ' PRO . 3.5 mpp? -74.52 138.92 43.45 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.916 0.486 . . . . 71.23 110.245 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 214' ' ' THR . . . . . 0.683 ' HA ' ' HE1' ' A' ' 186' ' ' PHE . 69.0 p -117.95 179.29 4.13 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 122.999 0.52 . . . . 74.1 110.34 171.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.412 HD22 ' HB3' ' A' ' 127' ' ' LEU . 55.5 mt -67.33 -20.13 65.55 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 115.231 -0.895 . . . . 63.31 111.592 -178.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -109.24 19.71 19.12 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.619 0.767 . . . . 64.44 111.404 179.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 110.47 174.29 20.41 Favored Glycine 0 N--CA 1.474 1.224 0 CA-C-O 119.426 -0.652 . . . . 33.0 113.23 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' PRO . . . . . 0.638 ' HA ' ' HA ' ' A' ' 213' ' ' MET . 83.9 Cg_endo -76.43 145.98 27.26 Favored 'Trans proline' 0 C--N 1.368 1.581 0 C-N-CA 122.744 2.296 . . . . 70.23 112.622 -175.131 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 24.3 m -139.89 163.9 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 C-N-CA 123.777 0.831 . . . . 73.4 111.371 -176.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -91.28 117.54 29.73 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.154 0.982 . . . . 75.04 110.157 -178.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 57.9 t -128.81 126.59 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 124.269 1.027 . . . . 74.13 109.037 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -88.04 131.5 34.63 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.495 0.318 . . . . 60.25 111.372 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.477 ' HA ' HD12 ' B' ' 441' ' ' ILE . 38.4 t -73.5 146.81 86.65 Favored Pre-proline 0 CA--C 1.57 1.744 0 C-N-CA 125.749 1.62 . . . . 63.14 110.602 -178.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -78.91 171.69 16.12 Favored 'Trans proline' 0 C--N 1.388 2.613 0 C-N-CA 122.924 2.416 . . . . 75.51 111.308 169.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -81.06 150.48 17.94 Favored 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 121.92 1.746 . . . . 72.53 113.133 176.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 84.8 mtt-85 63.22 31.16 15.72 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 126.007 1.723 . . . . 74.04 111.527 174.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.595 HG23 HD21 ' A' ' 233' ' ' LEU . 50.2 m -63.26 105.75 0.78 Allowed 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 113.796 -1.547 . . . . 64.32 111.081 177.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -90.18 140.03 30.06 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.291 1.036 . . . . 75.32 110.197 -176.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -66.04 160.19 24.31 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.838 0.855 . . . . 62.31 111.461 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 81.02 -41.38 2.6 Favored Glycine 0 C--N 1.347 1.162 0 CA-C-N 116.382 -0.372 . . . . 73.32 112.405 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -67.19 156.19 36.88 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 124.339 1.056 . . . . 74.0 110.907 177.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.766 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 3.5 mptp? -106.93 124.59 49.84 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-N 114.686 -1.143 . . . . 72.22 108.492 176.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.595 HD21 HG23 ' A' ' 227' ' ' THR . 86.0 mt -74.72 106.43 6.27 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.417 -0.957 . . . . 71.4 108.417 176.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 20.6 ttp180 -87.93 110.92 20.93 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.043 0.537 . . . . 64.14 110.687 178.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.594 HD13 HG12 ' B' ' 441' ' ' ILE . 0.3 OUTLIER -120.26 117.94 29.15 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.101 0.96 . . . . 61.12 109.982 176.154 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 36.0 mmtm -59.68 151.16 25.62 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 125.155 1.382 . . . . 64.43 112.752 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 71.39 34.88 63.54 Favored Glycine 0 C--N 1.354 1.583 0 CA-C-N 114.985 -1.007 . . . . 74.2 113.757 171.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.443 ' HG3' HD12 ' A' ' 235' ' ' LEU . 41.2 mmtm -130.08 -38.87 1.4 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.16 0.584 . . . . 73.01 110.895 -176.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -71.38 168.9 50.43 Favored Glycine 0 C--N 1.35 1.318 0 CA-C-N 116.219 -0.446 . . . . 74.43 112.17 175.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' PHE . . . . . 0.605 ' HD2' ' HA2' ' A' ' 152' ' ' GLY . 4.4 m-85 -87.44 158.15 52.07 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 123.533 0.733 . . . . 73.13 111.067 -165.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -62.6 109.3 0.85 Allowed 'Trans proline' 0 C--N 1.385 2.452 0 C-N-CA 123.051 2.5 . . . . 73.33 111.994 177.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.435 ' HA3' ' HB3' ' A' ' 191' ' ' GLN . . . -122.38 -149.63 7.99 Favored Glycine 0 C--N 1.338 0.644 0 CA-C-O 119.174 -0.792 . . . . 73.52 112.696 -179.159 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 243' ' ' PRO . . . . . 0.455 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 26.1 Cg_endo -60.14 -45.71 22.17 Favored 'Trans proline' 0 C--N 1.375 1.932 0 C-N-CA 123.179 2.586 . . . . 70.45 112.845 -176.097 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -88.43 -19.51 26.45 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.256 0.622 . . . . 70.11 111.073 177.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 126.72 -158.46 20.76 Favored Glycine 0 C--N 1.347 1.166 0 N-CA-C 111.192 -0.763 . . . . 62.24 111.192 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 61.5 mtt180 -57.68 108.41 0.56 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.336 0.654 . . . . 75.41 110.612 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -72.21 -161.82 5.62 Favored Glycine 0 C--O 1.248 1.03 0 CA-C-O 121.977 0.765 . . . . 42.24 113.708 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -102.3 168.31 9.42 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.411 0.684 . . . . 75.44 110.549 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.483 ' HB3' ' HG ' ' A' ' 235' ' ' LEU . 16.0 tp -101.54 128.61 47.71 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 106.794 -1.558 . . . . 70.31 106.794 164.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.766 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 7.0 m-85 -108.93 104.83 14.14 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 107.763 -1.199 . . . . 52.51 107.763 174.265 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.551 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 46.3 mt -90.08 103.94 16.56 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 109.098 -0.705 . . . . 72.24 109.098 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.504 ' HG2' ' HG3' ' A' ' 232' ' ' LYS . 23.2 mt-10 -75.91 100.09 4.72 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.229 1.012 . . . . 75.41 108.866 -171.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 38.4 t -64.97 120.43 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 CA-C-N 114.564 -1.198 . . . . 24.43 112.241 -168.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 254' ' ' ARG . . . . . 0.47 ' HD2' ' SD ' ' B' ' 26' ' ' MET . 10.8 mmt180 -118.33 94.72 4.59 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.489 1.115 . . . . 73.14 108.065 169.029 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.439 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 73.5 mt -70.76 115.67 10.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 114.706 -1.133 . . . . 74.34 109.234 176.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 256' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 200' ' ' PRO . 40.0 p -111.41 173.12 6.5 Favored 'General case' 0 C--O 1.255 1.346 0 C-N-CA 124.248 1.019 . . . . 73.43 109.994 178.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 23.0 pt -134.25 151.72 76.89 Favored Pre-proline 0 CA--C 1.556 1.195 0 CA-C-N 114.918 -1.037 . . . . 73.4 108.523 176.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' PRO . . . . . 0.508 ' HB2' ' HB3' ' B' ' 88' ' ' GLU . 11.1 Cg_endo -87.56 20.12 1.25 Allowed 'Trans proline' 0 C--N 1.37 1.667 0 C-N-CA 122.699 2.266 . . . . 74.45 113.426 -166.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.419 ' HA ' ' HG3' ' C' ' 226' ' ' ARG . 3.4 mp0 40.52 -89.27 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.806 1.242 . . . . 63.24 112.18 -162.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 260' ' ' ARG . . . . . 0.427 ' HD2' ' O ' ' A' ' 258' ' ' PRO . 0.4 OUTLIER -69.62 138.77 53.37 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.072 0.949 . . . . 75.12 111.425 -168.012 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.538 HD11 HG11 ' C' ' 205' ' ' VAL . 98.2 mt -129.28 173.14 10.78 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.016 0.926 . . . . 55.32 110.108 -178.004 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 40.7 p -114.16 156.7 43.83 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 124.252 1.021 . . . . 44.34 109.644 171.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -33.07 -45.22 0.27 Allowed 'Trans proline' 0 C--N 1.396 3.034 1 C-N-CA 125.351 4.034 . . . . 74.33 116.505 -176.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -59.31 -61.27 2.75 Favored 'General case' 0 C--O 1.249 1.045 0 C-N-CA 123.926 0.89 . . . . 71.44 110.778 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -57.71 -47.57 82.02 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-N 114.901 -1.045 . . . . 64.2 110.581 -178.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 266' ' ' GLU . . . . . 0.534 ' O ' ' HG2' ' A' ' 270' ' ' LYS . 7.2 tp10 -55.05 -50.68 68.52 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 124.543 1.152 . . . . 73.45 110.866 -176.099 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -62.45 -46.68 87.4 Favored 'General case' 0 C--O 1.254 1.34 0 O-C-N 124.229 0.956 . . . . 64.12 112.151 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 10.0 mp -63.22 -34.81 78.46 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 116.053 -0.522 . . . . 73.14 111.472 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 269' ' ' TRP . . . . . 0.451 ' O ' HG11 ' C' ' 206' ' ' VAL . 68.6 m95 -74.59 -29.74 61.44 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 118.709 -0.662 . . . . 75.0 111.345 177.205 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 270' ' ' LYS . . . . . 0.534 ' HG2' ' O ' ' A' ' 266' ' ' GLU . 0.0 OUTLIER -58.53 -61.05 2.88 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.442 -0.947 . . . . 62.43 108.442 174.478 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? -54.61 -48.97 71.56 Favored 'General case' 0 C--N 1.364 1.203 0 CA-C-N 112.636 -2.075 . . . . 70.22 110.562 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 272' ' ' LEU . . . . . 0.436 HD12 HD12 ' C' ' 272' ' ' LEU . 1.8 tt -58.01 -66.03 0.54 Allowed 'General case' 0 C--O 1.186 -2.268 0 O-C-N 124.244 0.965 . . . . 63.4 108.846 -179.397 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 273' ' ' ALA . . . . . 0.468 ' HA ' ' HB2' ' C' ' 202' ' ' PRO . . . -50.24 -50.67 49.17 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 114.849 1.426 . . . . 64.51 114.849 -170.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -88.66 -24.52 22.75 Favored 'General case' 0 C--O 1.255 1.379 0 N-CA-C 112.727 0.64 . . . . 74.35 112.727 -170.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -77.7 -36.21 51.34 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 121.846 -0.534 . . . . 71.44 110.631 170.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 276' ' ' TYR . . . . . 0.406 ' HB3' ' O ' ' A' ' 273' ' ' ALA . 2.7 t80 -47.2 -57.47 5.12 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 126.567 1.947 . . . . 75.02 109.66 167.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -44.81 -66.1 0.44 Allowed 'General case' 0 C--O 1.248 1.019 0 O-C-N 125.515 1.759 . . . . 70.12 109.426 174.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -65.14 -9.54 23.78 Favored 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 114.598 -1.183 . . . . 75.41 114.087 -176.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 279' ' ' ARG . . . . . 0.479 ' NH2' ' HG2' ' C' ' 264' ' ' GLU . 77.7 mtm180 -132.92 31.95 3.84 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.308 0.643 . . . . 74.13 110.08 -176.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.566 1.587 0 C-N-CA 124.07 0.948 . . . . 72.21 113.177 177.332 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.48 1.04 0 N-CA-C 109.814 -0.439 . . . . 71.44 109.814 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -72.5 101.04 2.86 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.548 0.739 . . . . 54.1 109.791 174.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -164.39 -40.98 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.312 1.045 . . . . 74.04 109.434 175.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 16.6 t 68.64 -173.45 0.19 Allowed 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.331 1.052 . . . . 52.14 111.225 176.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 17.9 m 70.46 135.62 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.992 1.317 . . . . 70.11 112.346 -178.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 38.7 pt -143.27 176.79 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.392 1.077 . . . . 64.44 109.629 -176.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -137.38 132.64 33.8 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.329 0.652 . . . . 72.01 110.307 177.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.55 HD23 HG11 ' A' ' 140' ' ' VAL . 39.0 tp -81.07 157.02 25.54 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.319 1.048 . . . . 75.22 111.086 -171.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.62 -72.34 0.42 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 122.856 0.462 . . . . 62.4 111.287 176.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 10' ' ' LEU . . . . . 0.455 HD23 ' HB2' ' A' ' 121' ' ' ALA . 33.6 mt 72.35 -7.54 1.35 Allowed 'General case' 0 N--CA 1.503 2.193 0 C-N-CA 125.588 1.555 . . . . 74.1 112.46 -165.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.404 ' N ' ' HD3' ' B' ' 12' ' ' PRO . 28.6 mt 55.87 56.97 10.04 Favored Pre-proline 0 CA--C 1.563 1.473 0 C-N-CA 124.727 1.211 . . . . 45.35 112.257 -176.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.404 ' HD3' ' N ' ' B' ' 11' ' ' LEU . 2.8 Cg_endo -88.78 -67.1 0.01 OUTLIER 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 123.14 2.56 . . . . 61.33 111.926 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 75.7 mt -119.21 -41.83 2.71 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.05 0.94 . . . . 75.01 109.6 177.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 3.4 pp -134.92 -176.94 4.41 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.905 0.882 . . . . 64.54 110.187 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -156.77 -176.13 5.81 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.717 0.807 . . . . 60.01 110.551 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 7.6 t -86.73 141.19 33.63 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 124.02 0.928 . . . . 51.11 110.814 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -83.2 42.68 1.32 Allowed 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 122.896 2.397 . . . . 62.42 113.518 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.505 HG11 ' HB3' ' A' ' 179' ' ' ARG . 98.7 t -74.76 108.7 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 108.842 -0.799 . . . . 61.41 108.842 171.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 2.9 m -101.97 1.21 36.43 Favored 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 123.597 0.759 . . . . 71.22 111.053 -174.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 51.2 mttm 66.11 -81.68 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.803 1.241 . . . . 62.34 111.243 -174.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -100.13 75.84 1.87 Allowed 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.297 0.639 . . . . 75.34 111.883 -169.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -144.89 120.6 10.5 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.368 -0.975 . . . . 73.31 108.368 164.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 23' ' ' THR . . . . . 0.453 ' HA ' ' HB3' ' A' ' 184' ' ' PRO . 17.2 p -135.71 62.49 48.31 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 123.966 0.906 . . . . 72.45 109.935 -177.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -87.06 34.23 0.44 Allowed 'Trans proline' 0 C--N 1.382 2.294 0 C-N-CA 123.273 2.649 . . . . 74.55 112.186 -175.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -93.4 29.42 1.96 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 123.899 0.88 . . . . 74.53 110.504 -173.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 26' ' ' MET . . . . . 0.632 ' HB3' HD21 ' B' ' 29' ' ' LEU . 51.7 mtm -80.4 155.83 73.93 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 123.757 0.823 . . . . 75.13 109.747 177.145 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -75.37 59.68 5.5 Favored 'Trans proline' 0 C--N 1.384 2.436 0 C-N-CA 123.041 2.494 . . . . 71.1 114.611 -177.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.518 HG11 ' HB2' ' B' ' 31' ' ' ASN . 71.9 t 68.03 -61.58 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 125.977 1.711 . . . . 73.51 113.54 172.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.632 HD21 ' HB3' ' B' ' 26' ' ' MET . 2.1 mm? 77.35 -54.83 0.54 Allowed 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 126.164 1.786 . . . . 62.2 112.543 172.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.583 ' HA ' ' HG2' ' C' ' 231' ' ' ARG . 13.3 tp10 -58.68 -68.57 0.25 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 122.777 0.431 . . . . 70.24 110.35 174.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 31' ' ' ASN . . . . . 0.518 ' HB2' HG11 ' B' ' 28' ' ' VAL . 10.8 m120 -71.12 -19.14 62.48 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 122.668 0.387 . . . . 74.34 111.427 -177.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 18.3 ttt85 -61.03 -31.88 71.5 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.736 0.814 . . . . 72.22 111.028 175.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -109.11 -88.7 0.48 Allowed 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 109.119 -0.697 . . . . 73.31 109.119 168.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . 58.66 15.04 3.44 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 125.014 1.326 . . . . 53.33 113.674 176.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -133.51 141.16 47.63 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 122.902 0.481 . . . . 73.13 110.752 -169.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -176.98 61.68 0.1 OUTLIER Glycine 0 C--N 1.341 0.819 0 N-CA-C 110.543 -1.023 . . . . 74.33 110.543 175.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 37.8 t70 68.97 172.82 0.3 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 124.325 1.05 . . . . 61.44 111.116 178.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 45.2 pt -70.99 -18.5 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 123.217 0.607 . . . . 75.44 111.56 173.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 39' ' ' THR . . . . . 0.536 ' O ' ' HB2' ' B' ' 155' ' ' LEU . 69.9 p 62.31 -69.05 0.06 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 126.408 1.883 . . . . 64.25 112.155 -172.003 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . 74.2 161.78 0.15 Allowed Pre-proline 0 N--CA 1.495 1.817 0 C-N-CA 124.394 1.077 . . . . 64.0 112.397 174.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.0 145.29 35.41 Favored 'Trans proline' 0 C--N 1.385 2.457 0 C-N-CA 122.351 2.034 . . . . 72.44 113.02 178.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 178.35 -76.48 0.07 OUTLIER Glycine 0 C--N 1.352 1.459 0 CA-C-N 116.182 -0.463 . . . . 45.24 112.648 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 176.66 -166.77 37.83 Favored Glycine 0 C--N 1.347 1.165 0 N-CA-C 112.314 -0.314 . . . . 42.15 112.314 -176.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 44' ' ' ALA . . . . . 0.562 ' HA ' HG12 ' B' ' 154' ' ' ILE . . . -141.21 178.73 7.2 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 112.598 0.592 . . . . 63.2 112.598 -173.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.556 ' HG3' ' HB ' ' B' ' 154' ' ' ILE . 29.9 mtp180 -69.47 78.9 0.4 Allowed 'General case' 0 C--N 1.357 0.926 0 C-N-CA 123.83 0.852 . . . . 74.21 109.217 175.178 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -63.79 107.87 1.31 Allowed 'General case' 0 C--N 1.353 0.737 0 C-N-CA 124.227 1.011 . . . . 75.02 109.65 -177.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.459 HD12 ' HG3' ' B' ' 148' ' ' GLU . 81.4 mt 52.46 33.44 13.19 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.212 1.005 . . . . 53.22 111.896 177.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 25.8 m -128.11 76.13 1.67 Allowed 'General case' 0 C--O 1.246 0.874 0 C-N-CA 124.07 0.948 . . . . 51.22 108.831 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -67.64 -45.07 79.36 Favored Glycine 0 C--N 1.35 1.349 0 N-CA-C 110.742 -0.943 . . . . 74.15 110.742 173.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -168.96 105.82 0.42 Allowed 'General case' 0 C--O 1.24 0.58 0 N-CA-C 105.54 -2.022 . . . . 64.2 105.54 164.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 67.41 -72.07 0.09 Allowed 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 124.967 1.307 . . . . 75.3 110.381 -166.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 52.6 p -99.21 167.04 10.93 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.331 1.052 . . . . 73.31 110.465 176.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.16 120.49 13.3 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.606 -0.887 . . . . 73.24 108.606 169.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . 57.68 -160.27 0.25 Allowed 'General case' 0 N--CA 1.484 1.25 0 O-C-N 124.031 0.832 . . . . 75.51 111.241 -175.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.401 HD13 ' HA ' ' B' ' 353' ' ' HIS . 60.4 tp -148.47 -82.82 0.11 Allowed 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.842 -0.799 . . . . 72.35 108.842 169.074 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 56' ' ' ARG . . . . . 0.456 ' NH1' ' HA ' ' B' ' 290' ' ' TRP . 48.9 ttp85 -165.85 106.86 0.73 Allowed 'General case' 0 C--N 1.345 0.389 0 N-CA-C 108.969 -0.752 . . . . 73.2 108.969 -173.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -46.66 -71.28 0.07 Allowed 'General case' 0 N--CA 1.479 0.987 0 O-C-N 125.306 1.629 . . . . 75.31 111.9 -171.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 15.1 m 73.44 -35.87 0.33 Allowed 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 125.524 1.53 . . . . 62.01 114.657 169.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 56.9 tp -65.71 -31.51 72.56 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.137 0.975 . . . . 72.44 110.812 -177.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 1.8 m 71.23 -72.45 0.11 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.283 1.433 . . . . 63.51 111.666 172.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 61' ' ' ASP . . . . . 0.413 ' HB2' ' H ' ' B' ' 298' ' ' HIS . 30.8 t70 -101.87 126.28 48.73 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.028 1.331 . . . . 71.45 110.283 -174.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 62' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -124.55 78.41 62.73 Favored Pre-proline 0 N--CA 1.49 1.565 0 C-N-CA 123.606 0.763 . . . . 72.3 109.407 177.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 63' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' B' ' 125' ' ' ALA . 20.4 Cg_endo -93.43 -2.76 3.23 Favored 'Trans proline' 0 C--N 1.371 1.736 0 C-N-CA 122.915 2.41 . . . . 72.24 113.17 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 63.54 89.7 0.09 Allowed 'General case' 0 C--N 1.36 1.047 0 O-C-N 124.798 1.311 . . . . 72.04 109.971 -164.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -86.99 30.14 0.78 Allowed 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.742 0.817 . . . . 65.32 110.235 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 66' ' ' ASN . . . . . 0.483 HD22 ' NH2' ' C' ' 254' ' ' ARG . 2.0 m-20 -91.76 -3.85 55.69 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.978 1.311 . . . . 72.41 110.87 -169.288 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 50.4 mm 75.81 -69.14 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 126.189 1.795 . . . . 72.03 112.013 176.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 3.2 pt -135.77 131.49 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 123.545 0.738 . . . . 73.4 110.072 -177.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.499 ' HG ' ' HB2' ' B' ' 230' ' ' ALA . 3.1 mm? -121.49 -175.09 3.0 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.454 1.102 . . . . 73.12 110.097 -173.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 70' ' ' LEU . . . . . 0.414 ' HB3' ' H ' ' B' ' 71' ' ' ILE . 3.8 mm? 54.2 -144.28 0.68 Allowed 'General case' 0 CA--C 1.562 1.427 0 O-C-N 123.987 0.804 . . . . 44.44 111.204 178.227 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 71' ' ' ILE . . . . . 0.491 ' HA ' ' HG2' ' B' ' 118' ' ' PRO 0.279 10.4 tp 55.66 105.15 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 C-N-CA 127.076 2.15 . . . . 74.32 112.982 177.942 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 119.8 -11.78 10.97 Favored Glycine 0 C--N 1.353 1.506 0 CA-C-N 115.098 -0.956 . . . . 62.21 111.984 -174.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -64.94 149.58 49.43 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 124.218 1.007 . . . . 63.44 111.809 -173.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 123.76 -167.34 16.05 Favored Glycine 0 C--N 1.339 0.73 0 CA-C-N 115.416 -0.811 . . . . 64.42 111.65 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 17.7 ptm -137.58 130.49 30.25 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.925 -0.769 . . . . 74.01 108.925 -177.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . -147.32 -60.65 0.01 OUTLIER Glycine 0 C--N 1.34 0.755 0 N-CA-C 110.372 -1.091 . . . . 71.13 110.372 -177.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -74.0 156.2 37.8 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.401 0.68 . . . . 73.03 110.812 177.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 52.9 m -135.0 79.67 1.8 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.917 0.887 . . . . 51.1 108.714 172.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 79' ' ' GLU . . . . . 0.428 ' HB2' ' HA2' ' B' ' 104' ' ' GLY . 12.1 mm-40 73.54 -8.94 1.26 Allowed 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 125.922 1.689 . . . . 74.44 113.965 174.219 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 24.5 mm -72.41 -24.27 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 123.202 0.601 . . . . 72.52 110.463 -173.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 84.4 m -86.6 -47.06 9.53 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.808 0.443 . . . . 71.34 110.254 173.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.1 -89.87 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 115.638 -0.71 . . . . 61.11 112.09 -171.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -100.02 51.36 0.91 Allowed 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.398 0.679 . . . . 71.35 111.123 -169.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 84' ' ' ARG . . . . . 0.41 ' HA ' ' HA ' ' B' ' 103' ' ' THR . 13.8 ptm180 -78.49 9.76 3.72 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 113.798 1.036 . . . . 73.0 113.798 -171.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 85' ' ' ASN . . . . . 0.518 ' HA ' HD12 ' B' ' 385' ' ' LEU . 29.4 t-20 -167.95 -45.94 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 118.346 0.521 . . . . 72.23 110.889 -178.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -87.74 158.86 18.69 Favored 'General case' 0 C--O 1.244 0.816 0 CA-C-N 116.092 -0.504 . . . . 63.12 111.983 -173.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.76 131.29 34.35 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-N 115.359 -0.837 . . . . 52.24 109.503 171.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 88' ' ' GLU . . . . . 0.508 ' HB3' ' HB2' ' A' ' 258' ' ' PRO . 32.1 mt-10 -83.44 77.29 9.84 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.402 0.62 . . . . 74.14 110.049 178.048 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 89' ' ' GLY . . . . . 0.489 ' H ' ' HG2' ' C' ' 279' ' ' ARG . . . 172.19 137.07 2.26 Favored Glycine 0 C--N 1.342 0.888 0 N-CA-C 110.263 -1.135 . . . . 54.33 110.263 177.435 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.2 -47.2 84.2 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.239 1.015 . . . . 62.33 111.43 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -98.36 31.46 8.02 Favored Glycine 0 C--N 1.345 1.071 0 CA-C-N 115.646 -0.707 . . . . 70.11 112.24 177.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -91.54 25.95 13.85 Favored Glycine 0 C--N 1.355 1.63 0 CA-C-N 116.885 0.342 . . . . 23.53 112.769 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -126.1 116.49 21.46 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.449 1.1 . . . . 74.22 108.953 -175.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 94' ' ' PHE . . . . . 0.49 ' HB2' ' HB2' ' B' ' 98' ' ' ASP . 81.9 m-85 -72.94 171.11 13.39 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 122.612 0.365 . . . . 71.21 110.442 175.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -66.26 -6.55 14.23 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.847 0.859 . . . . 74.14 113.146 -170.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . -80.44 -88.53 0.55 Allowed Glycine 0 C--N 1.348 1.21 0 N-CA-C 110.602 -0.999 . . . . 72.31 110.602 167.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 12.9 tt -163.22 19.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 C-N-CA 124.77 1.228 . . . . 72.22 108.073 174.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 98' ' ' ASP . . . . . 0.548 ' HA ' HG21 ' B' ' 414' ' ' THR . 6.6 m-20 -72.29 82.66 1.03 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.814 0.845 . . . . 75.21 112.904 -160.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -81.8 107.64 14.7 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.898 -1.149 . . . . 61.12 107.898 165.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 100' ' ' LEU . . . . . 0.45 HD21 ' HE1' ' B' ' 94' ' ' PHE . 3.4 mm? -66.88 107.46 1.68 Allowed Pre-proline 0 CA--C 1.55 0.959 0 O-C-N 123.866 0.729 . . . . 74.2 110.321 -178.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -83.02 104.81 1.29 Allowed 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 122.449 2.099 . . . . 72.21 111.257 -178.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -56.63 -42.42 78.8 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.062 0.545 . . . . 73.12 109.743 178.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 103' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' B' ' 84' ' ' ARG . 27.0 m 62.43 -69.81 0.06 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 126.228 1.811 . . . . 75.52 113.341 169.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 104' ' ' GLY . . . . . 0.428 ' HA2' ' HB2' ' B' ' 79' ' ' GLU . . . -142.36 -35.04 0.09 OUTLIER Glycine 0 C--N 1.341 0.826 0 CA-C-O 119.737 -0.48 . . . . 51.35 112.039 175.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 105' ' ' GLN . . . . . 0.446 ' HG3' ' H ' ' B' ' 106' ' ' TYR . 20.9 pt20 41.87 -75.75 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 127.041 2.136 . . . . 75.22 114.29 -177.265 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 106' ' ' TYR . . . . . 0.446 ' H ' ' HG3' ' B' ' 105' ' ' GLN . 51.6 p90 -90.42 33.74 0.9 Allowed 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 123.699 0.8 . . . . 74.44 111.243 -178.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 91.5 m -69.64 107.51 3.46 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 121.155 0.503 . . . . 63.32 110.59 177.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 8.1 p-80 -154.55 63.28 0.67 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.603 1.161 . . . . 71.44 108.726 178.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 92.1 t80 68.68 -82.11 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 124.821 1.248 . . . . 53.33 110.003 -174.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . 71.06 -41.01 0.49 Allowed 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 125.569 1.548 . . . . 71.24 114.821 172.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 3.6 pp -63.69 132.76 52.07 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.624 0.77 . . . . 64.15 112.624 -168.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 13.2 t30 -142.63 91.22 2.29 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 107.431 -1.322 . . . . 73.2 107.431 173.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 113' ' ' LYS . . . . . 0.658 ' HA ' HG21 ' B' ' 224' ' ' VAL . 54.9 pttt -137.14 35.07 2.55 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.544 1.538 . . . . 75.13 108.541 -175.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -55.1 -65.06 0.65 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.45 1.5 . . . . 74.01 111.54 -169.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 2.9 p -152.08 164.86 36.38 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.258 1.423 . . . . 73.23 108.652 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 129.97 162.48 10.81 Favored Glycine 0 C--N 1.338 0.653 0 N-CA-C 111.176 -0.77 . . . . 55.33 111.176 -177.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 22.6 ttpp -166.62 121.57 0.89 Allowed Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 123.711 0.804 . . . . 70.25 109.159 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 118' ' ' PRO . . . . . 0.491 ' HG2' ' HA ' ' B' ' 71' ' ' ILE . 14.7 Cg_exo -70.18 79.14 1.1 Allowed 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 122.433 2.089 . . . . 60.53 109.324 165.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 119' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -67.69 -46.56 71.95 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 114.678 -1.146 . . . . 75.33 110.401 -174.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 120' ' ' TYR . . . . . 0.461 ' HA ' ' HB3' ' B' ' 312' ' ' PRO . 0.5 OUTLIER -70.44 -23.85 62.8 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 114.251 -1.341 . . . . 70.1 112.254 177.977 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 121' ' ' VAL . . . . . 0.481 HG21 ' HA ' ' B' ' 314' ' ' ARG . 98.9 t 62.01 -78.38 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 125.009 1.324 . . . . 74.32 112.043 177.044 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 32.9 m -65.18 -60.56 2.87 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.517 1.127 . . . . 75.24 112.735 -175.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 55.82 -87.86 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.483 1.113 . . . . 64.3 111.42 -166.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 28.5 m 55.77 -158.09 0.23 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.293 1.037 . . . . 43.31 111.992 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 125' ' ' ALA . . . . . 0.628 ' HB3' ' HE2' ' B' ' 231' ' ' LYS . . . -168.11 121.81 0.91 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.344 0.658 . . . . 73.02 109.281 170.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.51 139.58 58.78 Favored 'General case' 0 C--O 1.245 0.817 0 O-C-N 124.183 0.927 . . . . 74.13 110.423 177.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 10.3 t 64.56 -168.97 0.2 Allowed 'General case' 0 CA--C 1.558 1.269 0 C-N-CA 124.902 1.281 . . . . 70.01 111.136 -178.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 128' ' ' ALA . . . . . 0.497 ' HA ' ' SD ' ' C' ' 213' ' ' MET . . . -137.95 149.38 46.11 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.565 0.746 . . . . 72.01 109.495 177.397 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 23.8 m -75.49 82.56 2.55 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.399 0.68 . . . . 54.34 110.224 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . 55.17 -151.08 0.4 Allowed 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 125.195 1.398 . . . . 44.22 112.284 176.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 40.4 m95 58.34 -131.78 1.22 Allowed 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 124.441 1.097 . . . . 73.51 110.149 -178.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 32.2 m 60.3 14.22 4.5 Favored 'General case' 0 C--N 1.374 1.671 0 C-N-CA 124.633 1.173 . . . . 51.4 111.718 -177.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 133' ' ' THR . . . . . 0.429 HG21 HG23 ' B' ' 137' ' ' THR . 70.3 p 48.32 18.15 0.15 Allowed 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 126.128 1.771 . . . . 62.25 114.068 -173.012 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 53.72 34.42 50.52 Favored Glycine 0 C--N 1.357 1.725 0 CA-C-O 119.283 -0.732 . . . . 55.15 113.572 -174.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 135' ' ' VAL . . . . . . . . . . . . . 59.5 t 76.46 -47.09 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 C-N-CA 125.562 1.545 . . . . 73.24 111.639 -175.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -73.95 89.21 1.88 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.894 1.278 . . . . 52.43 109.887 177.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 137' ' ' THR . . . . . 0.429 HG23 HG21 ' B' ' 133' ' ' THR . 12.1 m -83.25 119.76 24.97 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 123.269 0.627 . . . . 75.31 111.455 -170.043 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 75.3 -52.31 0.66 Allowed 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 126.122 1.769 . . . . 75.52 112.744 -178.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 8.2 t30 73.99 -56.86 0.64 Allowed 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 125.447 1.499 . . . . 73.24 110.867 -176.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -64.12 -70.69 1.0 Allowed Glycine 0 C--N 1.353 1.473 0 CA-C-O 119.795 -0.447 . . . . 65.04 112.018 170.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . 71.97 -60.93 0.51 Allowed 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 125.421 1.489 . . . . 75.34 112.646 176.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 7.1 mp -64.85 110.35 2.39 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.869 0.868 . . . . 70.15 109.904 177.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 162.62 132.31 1.32 Allowed Glycine 0 C--N 1.338 0.659 0 N-CA-C 111.021 -0.832 . . . . 61.25 111.021 -178.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 5.1 t 58.48 36.24 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.425 0 C-N-CA 124.641 1.176 . . . . 75.31 109.846 -178.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -66.55 -37.36 84.82 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 114.355 -1.293 . . . . 64.3 110.291 -178.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 44.4 mm -78.16 121.77 31.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 115.03 -0.987 . . . . 72.52 109.231 176.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 58.99 -163.39 0.22 Allowed 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 124.261 1.024 . . . . 72.43 112.307 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 148' ' ' GLU . . . . . 0.459 ' HG3' HD12 ' B' ' 47' ' ' LEU . 11.3 tp10 70.13 23.77 5.16 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 125.131 1.372 . . . . 73.05 110.824 175.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 149' ' ' LYS . . . . . 0.408 ' HG3' ' H ' ' B' ' 150' ' ' ASP . 10.3 pttm -157.86 -71.74 0.09 Allowed 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 107.546 -1.279 . . . . 72.23 107.546 174.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 150' ' ' ASP . . . . . 0.408 ' H ' ' HG3' ' B' ' 149' ' ' LYS . 20.9 m-20 66.25 21.32 11.05 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.244 1.018 . . . . 74.11 113.617 165.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 56.4 p-80 42.32 60.75 9.38 Favored Pre-proline 0 N--CA 1.496 1.861 0 C-N-CA 125.607 1.563 . . . . 74.43 112.443 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -86.51 12.56 2.97 Favored 'Trans proline' 0 C--N 1.37 1.681 0 C-N-CA 122.711 2.274 . . . . 42.51 113.347 -162.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 153' ' ' THR . . . . . 0.564 HG22 ' H ' ' B' ' 154' ' ' ILE . 1.6 m 61.62 -155.46 0.35 Allowed 'General case' 0 CA--C 1.568 1.663 0 C-N-CA 124.487 1.115 . . . . 74.2 109.013 -173.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 154' ' ' ILE . . . . . 0.564 ' H ' HG22 ' B' ' 153' ' ' THR . 0.0 OUTLIER -160.58 148.97 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 N-CA-C 107.82 -1.178 . . . . 74.25 107.82 178.316 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 155' ' ' LEU . . . . . 0.548 ' N ' HD13 ' B' ' 154' ' ' ILE . 2.0 pt? -158.41 -22.95 0.08 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.425 0.69 . . . . 72.1 111.132 173.108 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -122.89 94.29 4.23 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.723 0.809 . . . . 72.23 110.805 -178.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 157' ' ' MET . . . . . 0.577 ' HG3' ' HG2' ' B' ' 241' ' ' GLU . 3.8 mpp? 30.31 -87.95 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.418 0 C-N-CA 127.051 2.141 . . . . 53.54 114.412 174.395 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 158' ' ' ALA . . . . . 0.534 ' HB1' ' HB3' ' B' ' 161' ' ' ALA . . . -141.31 -3.07 1.21 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.539 1.536 . . . . 34.04 109.605 178.038 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt 55.95 -83.29 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 126.043 1.737 . . . . 55.45 112.074 -171.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -123.19 7.06 9.13 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.787 0.835 . . . . 70.22 111.699 -174.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 161' ' ' ALA . . . . . 0.534 ' HB3' ' HB1' ' B' ' 158' ' ' ALA . . . -89.58 119.39 29.97 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.19 0.596 . . . . 71.1 110.208 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 82.36 -90.48 1.5 Allowed Glycine 0 C--N 1.349 1.271 0 CA-C-O 119.792 -0.449 . . . . 73.4 112.561 177.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 10.6 mp 66.28 -71.99 0.08 Allowed 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 125.324 1.45 . . . . 65.02 111.525 -174.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 164' ' ' ALA . . . . . . . . . . . . . . . -65.3 -64.18 0.92 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.218 0.607 . . . . 75.34 111.215 -177.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 165' ' ' THR . . . . . 0.438 ' O ' ' HE3' ' C' ' 238' ' ' LYS . 25.9 p -136.66 -71.55 0.45 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.358 0.663 . . . . 64.15 110.774 -178.236 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . 163.99 74.2 0.03 OUTLIER Glycine 0 C--N 1.338 0.646 0 N-CA-C 111.343 -0.703 . . . . 71.15 111.343 -178.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 167' ' ' ASN . . . . . . . . . . . . . 48.2 t30 74.17 -65.04 0.37 Allowed 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 125.643 1.577 . . . . 72.31 111.323 -178.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 7.3 p -149.54 137.03 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 124.083 0.953 . . . . 74.13 110.101 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 19.2 m -83.08 90.04 7.0 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.642 0.777 . . . . 54.35 109.198 178.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 19.3 m -85.28 73.6 10.55 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.17 0.988 . . . . 63.1 109.448 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -120.68 -49.95 2.21 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 112.666 0.617 . . . . 53.32 112.666 -169.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 172' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -82.63 22.04 0.93 Allowed 'General case' 0 CA--C 1.559 1.296 0 CA-C-O 121.654 0.74 . . . . 73.22 112.139 -169.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 173' ' ' LEU . . . . . . . . . . . . . 7.6 mp -71.29 -23.46 61.96 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.247 0.619 . . . . 74.23 109.622 170.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 174' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -131.85 159.09 39.59 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.811 1.244 . . . . 74.45 108.605 173.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 175' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -100.26 165.8 11.3 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 109.465 -0.568 . . . . 74.1 109.465 172.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -121.56 149.5 43.03 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.781 0.833 . . . . 74.11 108.832 172.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 57.5 m -141.8 106.94 5.87 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 123.3 0.64 . . . . 64.31 109.412 -178.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 178' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -66.05 -44.38 7.48 Favored 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 122.669 2.246 . . . . 74.53 111.465 173.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -168.29 -71.56 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 107.436 -1.32 . . . . 61.34 107.436 -178.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 180' ' ' ALA . . . . . 0.498 ' HB1' HG13 ' C' ' 137' ' ' VAL . . . -135.1 -63.14 0.7 Allowed 'General case' 0 C--O 1.238 0.473 0 N-CA-C 104.791 -2.299 . . . . 74.4 104.791 166.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 181' ' ' LEU . . . . . 0.532 HD22 ' HB2' ' C' ' 136' ' ' ARG . 21.8 tp -152.85 -6.72 0.19 Allowed 'General case' 0 CA--C 1.567 1.611 0 CA-C-N 114.613 -1.176 . . . . 62.04 110.689 158.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 182' ' ' VAL . . . . . 0.643 ' HA ' ' HB2' ' C' ' 123' ' ' LEU . 14.7 m -136.75 178.3 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 C-N-CA 124.583 1.153 . . . . 71.31 112.555 -175.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 183' ' ' ALA . . . . . 0.717 ' HB3' ' HD2' ' C' ' 124' ' ' PRO . . . -143.69 55.37 1.33 Allowed 'General case' 0 CA--C 1.552 1.049 0 CA-C-N 115.118 -0.946 . . . . 65.24 110.401 164.124 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 32.6 m170 70.3 -168.77 0.16 Allowed 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 114.959 1.466 . . . . 74.15 114.959 162.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 185' ' ' VAL . . . . . 0.558 HG22 HD21 ' C' ' 119' ' ' LEU . 45.9 t -79.23 147.34 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 C-N-CA 125.615 1.566 . . . . 71.33 113.263 -164.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 186' ' ' THR . . . . . 0.488 ' HB ' ' HG2' ' C' ' 122' ' ' GLU . 15.2 t -126.02 174.24 8.58 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 125.325 1.45 . . . . 51.31 109.383 166.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 187' ' ' SER . . . . . . . . . . . . . 51.8 m -111.75 -16.85 13.11 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.634 0.774 . . . . 62.14 111.046 173.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -99.96 160.87 13.98 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.425 0.69 . . . . 71.52 111.388 -171.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 31.3 mtmm 70.96 120.42 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 125.48 1.512 . . . . 72.52 112.512 172.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 190' ' ' CYS . . . . . 0.537 ' HA ' HG11 ' C' ' 158' ' ' VAL . 11.6 p -151.82 108.14 3.44 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.507 0.723 . . . . 70.33 109.874 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 191' ' ' TYR . . . . . 0.404 ' H ' HG11 ' C' ' 158' ' ' VAL . 96.1 m-85 -148.48 -165.73 2.35 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 126.273 1.829 . . . . 74.04 108.073 -177.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -150.54 62.04 0.41 Allowed Glycine 0 CA--C 1.539 1.553 0 CA-C-O 119.418 -0.657 . . . . 64.22 113.122 170.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 193' ' ' PRO . . . . . 0.567 ' HG2' ' HA ' ' C' ' 157' ' ' SER . 37.4 Cg_endo -94.82 91.05 0.11 Allowed 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 123.458 2.772 . . . . 64.32 111.339 175.484 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 194' ' ' SER . . . . . . . . . . . . . 35.0 t -128.72 141.65 51.26 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.821 0.849 . . . . 24.51 109.319 -178.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 195' ' ' ALA . . . . . 0.465 ' HB1' ' HD3' ' C' ' 243' ' ' PRO . . . -149.54 156.66 42.33 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.645 0.778 . . . . 74.32 110.445 -176.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 4.4 m 72.6 159.93 0.22 Allowed 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 125.135 1.374 . . . . 73.32 111.772 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 18.9 m -119.52 -68.18 0.93 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.574 0.75 . . . . 75.11 109.598 177.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 198' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -168.86 -55.89 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.96 0.904 . . . . 51.12 109.605 -176.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -93.67 90.13 6.49 Favored 'General case' 0 C--N 1.349 0.544 0 C-N-CA 123.6 0.76 . . . . 74.4 109.266 -178.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 200' ' ' CYS . . . . . . . . . . . . . 53.4 t -164.62 81.84 1.27 Allowed Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 124.013 0.925 . . . . 73.31 108.955 175.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 201' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -73.92 -39.8 1.62 Allowed 'Trans proline' 0 C--N 1.374 1.871 0 C-N-CA 122.457 2.105 . . . . 71.34 113.099 -177.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 69.65 57.79 6.96 Favored Glycine 0 C--N 1.351 1.369 0 N-CA-C 111.724 -0.55 . . . . 63.04 111.724 -173.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -69.82 -49.02 56.73 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.944 0.898 . . . . 71.33 111.483 -174.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.57 124.16 23.21 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.834 -0.432 . . . . 74.01 109.834 176.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 205' ' ' LEU . . . . . 0.471 HD11 ' HB3' ' C' ' 236' ' ' LYS . 3.1 tm? -141.99 130.52 22.56 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 108.503 -0.925 . . . . 51.03 108.503 -176.091 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -77.67 116.76 18.47 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.601 0.76 . . . . 62.32 109.283 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -63.24 -29.83 71.09 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.76 0.824 . . . . 74.32 111.447 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 131.88 96.32 0.67 Allowed Glycine 0 C--N 1.348 1.247 0 N-CA-C 111.796 -0.521 . . . . 71.52 111.796 174.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . -66.03 -18.91 67.34 Favored Glycine 0 C--N 1.352 1.436 0 CA-C-O 119.623 -0.543 . . . . 42.21 114.045 177.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 210' ' ' LYS . . . . . 0.409 ' HG3' ' H ' ' B' ' 211' ' ' GLY . 18.1 ptpt 52.09 -75.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 126.772 2.029 . . . . 74.51 115.07 171.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 211' ' ' GLY . . . . . 0.409 ' H ' ' HG3' ' B' ' 210' ' ' LYS . . . -67.17 96.47 0.33 Allowed Glycine 0 C--N 1.355 1.6 0 CA-C-O 119.7 -0.5 . . . . 74.43 113.26 -173.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 23.0 t 80.79 -8.06 1.49 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 126.018 1.727 . . . . 74.04 112.326 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 2.6 mp -88.54 87.01 2.7 Favored 'Isoleucine or valine' 0 C--N 1.355 0.805 0 N-CA-C 107.497 -1.297 . . . . 64.4 107.497 172.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 29.5 p -131.68 84.41 2.17 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.815 0.846 . . . . 75.43 109.29 178.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 215' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -125.57 145.29 50.19 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 109.178 -0.675 . . . . 73.31 109.178 178.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 19.3 mm100 68.78 132.22 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 125.544 1.538 . . . . 61.42 111.425 -172.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 3.0 mm? 61.4 44.99 8.95 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.613 1.165 . . . . 75.4 110.092 -178.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 10.2 tt -59.8 125.81 25.12 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.965 1.306 . . . . 71.43 110.57 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 3.8 m120 62.37 24.43 14.54 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 124.467 1.107 . . . . 71.24 112.491 -176.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . 62.47 14.11 6.7 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 124.73 1.212 . . . . 61.1 113.024 177.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 221' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 47.7 7.09 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.135 0 C-N-CA 127.195 2.198 . . . . 73.55 116.817 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . 57.23 91.79 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 124.702 1.201 . . . . 42.52 112.27 -178.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -83.77 154.07 23.77 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.648 0.779 . . . . 61.02 110.524 177.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 224' ' ' VAL . . . . . 0.658 HG21 ' HA ' ' B' ' 113' ' ' LYS . 7.3 p -173.81 -35.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 124.862 1.265 . . . . 74.2 110.091 -178.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 40.4 p -74.57 125.22 28.16 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 114.909 -1.041 . . . . 54.34 112.245 -172.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 226' ' ' LEU . . . . . 0.457 ' HB3' ' OH ' ' B' ' 120' ' ' TYR . 4.3 mm? 70.95 -74.79 0.08 Allowed 'General case' 0 CA--C 1.56 1.329 0 C-N-CA 124.812 1.245 . . . . 74.43 113.154 165.056 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . 86.53 -133.9 12.14 Favored Glycine 0 N--CA 1.474 1.194 0 N-CA-C 111.542 -0.623 . . . . 51.31 111.542 -174.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 228' ' ' GLY . . . . . 0.451 ' HA3' HH12 ' C' ' 187' ' ' ARG . . . 110.86 128.41 5.35 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-N 117.016 0.408 . . . . 72.41 113.898 169.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 229' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' C' ' 185' ' ' VAL . . . 126.45 161.86 11.05 Favored Glycine 0 C--N 1.348 1.233 0 CA-C-O 119.738 -0.479 . . . . 70.24 113.193 174.142 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 230' ' ' ALA . . . . . 0.499 ' HB2' ' HG ' ' B' ' 69' ' ' LEU . . . 175.3 145.8 0.07 Allowed 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.635 1.174 . . . . 70.23 110.119 174.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 231' ' ' LYS . . . . . 0.628 ' HE2' ' HB3' ' B' ' 125' ' ' ALA . 4.8 tptp -148.53 -158.09 0.88 Allowed 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.128 0.971 . . . . 73.24 108.457 177.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 3.9 m -143.91 156.09 44.31 Favored 'General case' 0 CA--C 1.56 1.34 0 N-CA-C 109.231 -0.655 . . . . 74.24 109.231 175.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 233' ' ' PHE . . . . . 0.401 ' HA ' ' HB3' ' C' ' 211' ' ' ARG . 50.4 p90 -88.04 155.26 19.9 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 114.07 1.137 . . . . 70.41 114.07 -167.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 234' ' ' ALA . . . . . 0.723 ' HB3' ' HE ' ' C' ' 211' ' ' ARG . . . -174.84 167.05 3.68 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 125.411 1.485 . . . . 72.31 109.839 171.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -76.79 140.91 40.88 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 114.033 1.123 . . . . 54.41 114.033 -168.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 236' ' ' THR . . . . . 0.639 ' HB ' ' HB2' ' C' ' 220' ' ' GLU . 1.7 m -149.29 -150.79 0.36 Allowed 'General case' 0 CA--C 1.577 1.992 0 C-N-CA 125.697 1.599 . . . . 73.34 107.095 174.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 237' ' ' ALA . . . . . 0.468 ' H ' HG22 ' B' ' 236' ' ' THR . . . -155.94 32.21 0.35 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 120.173 1.351 . . . . 71.12 112.084 178.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 95.2 m -146.92 128.33 14.93 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 118.674 -0.679 . . . . 71.31 110.79 -176.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -170.24 -179.35 3.06 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 113.44 0.904 . . . . 74.42 113.44 176.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . -114.89 -142.85 7.95 Favored Glycine 0 C--N 1.36 1.887 0 CA-C-N 114.678 -1.146 . . . . 71.23 111.757 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 241' ' ' GLU . . . . . 0.577 ' HG2' ' HG3' ' B' ' 157' ' ' MET . 11.9 pt-20 -167.31 156.92 10.56 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.753 0.821 . . . . 71.21 110.18 177.189 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 242' ' ' TRP . . . . . 0.472 ' CE2' ' HG ' ' C' ' 233' ' ' LEU . 0.0 OUTLIER -137.53 -35.19 0.67 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.176 1.391 . . . . 70.32 108.75 -172.947 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -123.72 -173.49 2.76 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 106.212 -1.773 . . . . 74.22 106.212 157.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -74.36 103.92 1.58 Allowed Glycine 0 C--N 1.335 0.483 0 C-N-CA 121.417 -0.421 . . . . 63.11 112.556 174.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 245' ' ' LYS . . . . . 0.468 ' HD2' HD12 ' B' ' 154' ' ' ILE . 1.6 pptp? -85.37 41.67 0.9 Allowed 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 122.039 0.923 . . . . 75.34 110.532 174.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 246' ' ' THR . . . . . 0.405 ' HA ' HG23 ' B' ' 154' ' ' ILE . 81.9 p -94.12 55.08 2.0 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.003 1.321 . . . . 71.02 110.062 -173.412 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 247' ' ' LEU . . . . . 0.452 HD11 ' HE2' ' A' ' 270' ' ' LYS . 2.3 tm? -143.91 139.72 29.34 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 108.217 -1.031 . . . . 72.51 108.217 -175.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 248' ' ' ARG . . . . . 0.435 ' N ' HD13 ' B' ' 247' ' ' LEU . 1.6 tmt_? -161.29 149.33 15.49 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 107.526 -1.287 . . . . 75.15 107.526 171.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 249' ' ' GLU . . . . . 0.441 ' HA ' ' HA3' ' B' ' 362' ' ' GLY . 0.4 OUTLIER -151.62 153.42 34.43 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 123.489 0.716 . . . . 71.33 109.854 -179.253 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -149.28 -34.03 0.2 Allowed 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 123.985 0.914 . . . . 65.4 112.18 176.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 251' ' ' ALA . . . . . . . . . . . . . . . -158.24 38.4 0.25 Allowed 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 114.383 1.253 . . . . 61.03 114.383 -163.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -67.56 -47.43 69.82 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.273 0.629 . . . . 72.3 109.728 175.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -79.21 76.99 5.74 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 108.317 -0.994 . . . . 51.41 108.317 168.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 24.0 tpt180 -85.41 -5.17 59.32 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 114.967 -1.015 . . . . 72.51 111.284 -171.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -59.22 -61.01 7.8 Favored Glycine 0 C--N 1.354 1.568 0 N-CA-C 111.914 -0.474 . . . . 54.22 111.914 177.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 256' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 71.94 -50.77 0.7 Allowed 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 125.836 1.655 . . . . 52.52 113.002 178.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -61.5 99.24 0.1 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.957 0.903 . . . . 74.31 110.903 177.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 258' ' ' LEU . . . . . . . . . . . . . 30.1 tp -96.05 23.42 6.48 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 124.081 0.952 . . . . 75.13 109.301 176.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 4.3 p 50.65 21.8 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 C-N-CA 126.537 1.935 . . . . 63.02 112.71 -174.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 260' ' ' SER . . . . . . . . . . . . . 44.8 m -124.68 131.18 53.48 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 107.896 -1.15 . . . . 73.11 107.896 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 15.9 t70 67.68 -73.98 0.08 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.34 1.456 . . . . 52.21 111.704 -176.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 262' ' ' ALA . . . . . 0.465 ' HA ' ' HA ' ' B' ' 266' ' ' ASN . . . -58.05 -13.48 4.81 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.325 1.05 . . . . 43.43 113.114 -178.137 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -59.41 -32.12 69.89 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 124.07 0.948 . . . . 70.44 112.524 174.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 27.2 t -158.2 -41.39 0.06 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.86 0.464 . . . . 51.14 112.227 -178.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 265' ' ' LEU . . . . . . . . . . . . . 40.2 tp -72.64 -47.32 48.55 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.347 0.659 . . . . 64.12 110.823 -176.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 266' ' ' ASN . . . . . 0.465 ' HA ' ' HA ' ' B' ' 262' ' ' ALA . 51.4 m-80 64.71 111.2 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 125.306 1.442 . . . . 71.52 112.655 172.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 267' ' ' SER . . . . . 0.412 ' O ' ' HD2' ' B' ' 276' ' ' PRO . 95.5 p 55.28 25.1 7.05 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 125.266 1.426 . . . . 73.13 112.333 178.306 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 54.2 t 52.3 -82.32 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 C-N-CA 125.853 1.661 . . . . 74.44 112.464 -177.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 269' ' ' THR . . . . . 0.58 HG23 ' HE2' ' B' ' 275' ' ' LYS . 10.9 m 58.24 59.7 2.94 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.502 1.121 . . . . 74.31 109.97 -177.537 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 270' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -83.54 75.65 10.01 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 115.403 -0.817 . . . . 72.41 108.864 -177.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 271' ' ' ALA . . . . . . . . . . . . . . . 65.36 -75.01 0.05 OUTLIER 'General case' 0 CA--C 1.558 1.271 0 C-N-CA 125.072 1.349 . . . . 75.3 111.402 -175.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 272' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -124.55 -31.76 3.2 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.351 1.06 . . . . 54.14 109.689 175.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -73.19 121.88 21.0 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.209 1.003 . . . . 61.32 111.714 -174.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 58.56 102.32 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 125.329 1.452 . . . . 71.44 112.847 173.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 275' ' ' LYS . . . . . 0.58 ' HE2' HG23 ' B' ' 269' ' ' THR . 16.6 ptpt -153.41 95.17 2.94 Favored Pre-proline 0 CA--C 1.553 1.091 0 C-N-CA 123.165 0.586 . . . . 71.33 110.305 178.05 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 276' ' ' PRO . . . . . 0.448 ' HB3' ' HB ' ' B' ' 348' ' ' ILE . 88.7 Cg_exo -49.49 -67.9 0.1 OUTLIER 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 123.442 2.761 . . . . 62.35 112.219 168.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 277' ' ' LEU . . . . . . . . . . . . . 87.8 mt 49.98 89.97 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 125.0 1.32 . . . . 63.32 113.087 176.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 1.8 pp -75.77 6.48 4.9 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 113.665 0.987 . . . . 62.0 113.665 -174.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . -88.46 45.92 3.3 Favored Glycine 0 C--N 1.349 1.25 0 CA-C-O 119.612 -0.549 . . . . 75.43 113.339 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 4.9 tt 61.23 -87.59 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.093 1.357 . . . . 53.23 109.782 -175.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 281' ' ' PHE . . . . . 0.415 ' HB3' HD22 ' B' ' 285' ' ' ASN . 77.8 m-85 58.48 -77.52 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 125.15 1.38 . . . . 75.31 112.441 -176.013 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . 60.75 -98.42 0.08 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.867 1.267 . . . . 65.41 110.732 -176.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -68.44 99.58 0.97 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.229 0.612 . . . . 72.33 109.962 -175.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . 135.9 -38.74 1.74 Allowed Glycine 0 N--CA 1.475 1.28 0 CA-C-N 115.746 -0.661 . . . . 61.45 111.568 -176.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 285' ' ' ASN . . . . . 0.415 HD22 ' HB3' ' B' ' 281' ' ' PHE . 27.7 m-80 -116.03 12.73 15.72 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 124.113 0.965 . . . . 72.41 110.484 178.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 286' ' ' MET . . . . . 0.432 ' SD ' ' HD2' ' B' ' 287' ' ' PRO . 15.7 tpt -161.92 139.2 6.45 Favored Pre-proline 0 C--O 1.247 0.948 0 N-CA-C 105.582 -2.007 . . . . 64.1 105.582 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 287' ' ' PRO . . . . . 0.432 ' HD2' ' SD ' ' B' ' 286' ' ' MET . 55.3 Cg_exo -40.47 -41.82 3.67 Favored 'Trans proline' 0 C--N 1.388 2.637 0 C-N-CA 124.092 3.195 . . . . 73.33 114.152 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 288' ' ' VAL . . . . . 0.486 HG23 ' H ' ' B' ' 289' ' ' ARG . 0.0 OUTLIER -151.25 -86.11 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.233 0 C-N-CA 125.106 1.363 . . . . 74.32 107.81 169.295 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 289' ' ' ARG . . . . . 0.486 ' H ' HG23 ' B' ' 288' ' ' VAL . 0.0 OUTLIER -159.95 -26.64 0.06 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.032 1.733 . . . . 72.14 107.1 170.791 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 290' ' ' TRP . . . . . 0.456 ' HA ' ' NH1' ' B' ' 56' ' ' ARG . 31.8 m-90 -64.44 165.89 9.16 Favored 'General case' 0 C--N 1.357 0.925 0 CA-C-N 115.348 -0.842 . . . . 75.34 110.396 160.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 291' ' ' LEU . . . . . 0.403 HD23 ' HB3' ' B' ' 290' ' ' TRP . 1.8 pt? -44.92 -32.26 1.55 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 125.659 1.584 . . . . 64.34 113.471 175.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . 170.03 -152.8 20.12 Favored Glycine 0 C--N 1.348 1.219 0 CA-C-O 119.547 -0.585 . . . . 62.12 112.094 176.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.14 6.39 1.46 Allowed 'Trans proline' 0 C--N 1.369 1.63 0 C-N-CA 123.366 2.711 . . . . 51.12 113.79 172.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -68.18 106.34 2.39 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.666 0.786 . . . . 41.23 109.849 174.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -119.46 17.69 12.92 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.31 1.044 . . . . 34.32 109.589 167.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 22.5 m -69.95 109.89 4.75 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.041 0.936 . . . . 65.42 112.512 -171.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -107.19 159.03 16.64 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.518 1.127 . . . . 64.12 108.663 165.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 298' ' ' HIS . . . . . 0.413 ' H ' ' HB2' ' B' ' 61' ' ' ASP . 80.1 t60 64.85 113.79 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.496 1.118 . . . . 71.5 110.334 -173.063 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . -60.98 94.99 0.08 OUTLIER Glycine 0 C--N 1.347 1.191 0 CA-C-N 116.232 -0.44 . . . . 63.41 113.092 177.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -71.03 -28.94 64.76 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.106 0.962 . . . . 72.23 111.186 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 301' ' ' ILE . . . . . . . . . . . . . 12.7 tt -87.41 -21.16 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 123.903 0.881 . . . . 72.24 110.622 176.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.54 -29.45 61.38 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.843 0.857 . . . . 63.41 110.652 177.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 303' ' ' LYS . . . . . 0.462 ' HA ' ' HE2' ' B' ' 303' ' ' LYS . 0.6 OUTLIER -62.31 -47.63 89.15 Favored Pre-proline 0 CA--C 1.567 1.598 0 C-N-CA 123.722 0.809 . . . . 74.11 111.551 -178.056 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 304' ' ' PRO . . . . . 0.519 ' HA ' ' SG ' ' B' ' 308' ' ' CYS . 92.2 Cg_endo -79.21 164.12 24.67 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 121.798 1.666 . . . . 75.12 111.452 160.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . 67.55 -78.01 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 124.906 1.282 . . . . 42.33 113.05 177.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 56.2 t -61.76 -58.27 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 124.32 1.048 . . . . 72.33 111.636 -170.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 82.7 p -88.1 4.76 44.17 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.642 0.377 . . . . 74.23 111.723 -177.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 308' ' ' CYS . . . . . 0.519 ' SG ' ' HA ' ' B' ' 304' ' ' PRO . 77.8 m -77.49 -43.35 32.5 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 109.233 -0.655 . . . . 74.22 109.233 171.107 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 41.2 p -83.52 144.14 45.52 Favored Pre-proline 0 CA--C 1.548 0.898 0 CA-C-N 114.775 -1.102 . . . . 72.2 109.59 174.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.36 146.04 89.21 Favored 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 122.738 2.292 . . . . 63.14 111.712 178.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 311' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -57.11 -39.51 78.24 Favored Pre-proline 0 N--CA 1.486 1.375 0 C-N-CA 124.282 1.033 . . . . 73.13 112.582 -178.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 312' ' ' PRO . . . . . 0.461 ' HB3' ' HA ' ' B' ' 120' ' ' TYR . 60.2 Cg_endo -70.76 66.29 2.37 Favored 'Trans proline' 0 C--N 1.399 3.191 0 C-N-CA 122.091 1.861 . . . . 70.14 112.592 164.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 313' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -66.08 -38.99 89.66 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 109.509 -0.552 . . . . 75.13 109.509 174.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 314' ' ' ARG . . . . . 0.481 ' HA ' HG21 ' B' ' 121' ' ' VAL . 91.8 mtt180 67.88 -76.33 0.06 Allowed 'General case' 0 C--N 1.362 1.133 0 C-N-CA 125.526 1.53 . . . . 72.01 111.186 -178.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 315' ' ' ASN . . . . . 0.428 ' HB2' ' CZ ' ' A' ' 194' ' ' TYR . 7.5 p-10 -164.49 -165.47 0.95 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.477 1.111 . . . . 72.12 108.872 -172.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 316' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 68.7 158.79 0.16 Allowed 'General case' 0 N--CA 1.499 2.023 0 C-N-CA 124.345 1.058 . . . . 74.4 112.573 -176.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 67.2 m -152.73 136.73 16.35 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.031 0.932 . . . . 75.41 109.458 175.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 318' ' ' VAL . . . . . . . . . . . . . 30.9 m -113.13 148.13 38.8 Favored Pre-proline 0 N--CA 1.48 1.032 0 C-N-CA 123.978 0.911 . . . . 73.13 109.984 178.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 319' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -69.1 147.83 67.99 Favored 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 122.457 2.105 . . . . 65.1 111.108 173.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 320' ' ' THR . . . . . . . . . . . . . 8.7 m 69.77 15.12 8.04 Favored 'General case' 0 CA--C 1.562 1.405 0 C-N-CA 124.53 1.132 . . . . 53.31 111.162 -179.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 321' ' ' LEU . . . . . . . . . . . . . 56.2 tp -59.35 113.7 2.3 Favored 'General case' 0 C--N 1.358 0.939 0 C-N-CA 123.188 0.595 . . . . 65.14 109.758 177.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 322' ' ' ALA . . . . . . . . . . . . . . . 77.2 -67.06 0.22 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.314 1.446 . . . . 64.54 112.015 -177.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 323' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 60.97 40.96 14.73 Favored 'General case' 0 CA--C 1.561 1.391 0 C-N-CA 124.069 0.948 . . . . 74.02 109.43 -177.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 324' ' ' MET . . . . . . . . . . . . . 63.6 ttp 77.36 -30.98 0.17 Allowed 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 125.684 1.594 . . . . 71.32 112.093 -175.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 325' ' ' THR . . . . . . . . . . . . . 3.2 m 63.5 30.98 15.14 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 124.956 1.302 . . . . 72.33 110.799 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 326' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 66.04 -176.47 0.19 Allowed 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.941 1.297 . . . . 72.01 112.028 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? 65.85 162.2 0.15 Allowed 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 125.424 1.489 . . . . 54.34 112.65 -178.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 328' ' ' ALA . . . . . 0.437 ' HB1' ' HA ' ' B' ' 332' ' ' LEU . . . 72.28 -66.15 0.32 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.731 1.612 . . . . 72.03 111.442 -178.204 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 329' ' ' ILE . . . . . . . . . . . . . 2.0 mp 60.51 112.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 C-N-CA 125.009 1.324 . . . . 73.5 111.546 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 330' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 72.21 -66.8 0.29 Allowed 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.281 1.432 . . . . 63.42 112.69 174.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 331' ' ' LEU . . . . . 0.46 HD22 ' HA ' ' B' ' 335' ' ' ASN . 39.7 mt -62.78 -48.81 77.52 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.196 0.998 . . . . 63.34 111.858 -173.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 332' ' ' LEU . . . . . 0.437 ' HA ' ' HB1' ' B' ' 328' ' ' ALA . 89.4 mt 62.18 -76.05 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 125.272 1.429 . . . . 74.41 112.451 177.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 333' ' ' SER . . . . . . . . . . . . . 38.9 t -100.88 59.0 0.92 Allowed 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.942 0.897 . . . . 65.04 109.081 178.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm 69.83 162.53 0.23 Allowed 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 125.014 1.325 . . . . 63.11 111.29 -175.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 335' ' ' ASN . . . . . 0.46 ' HA ' HD22 ' B' ' 331' ' ' LEU . 27.1 t-20 -63.26 91.52 0.05 Allowed 'General case' 0 C--N 1.361 1.074 0 N-CA-C 107.948 -1.13 . . . . 73.25 107.948 167.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -71.29 -50.0 37.08 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 114.901 -1.045 . . . . 61.02 108.914 176.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 337' ' ' LYS . . . . . . . . . . . . . 26.9 tptp 63.34 -71.97 0.05 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.812 1.645 . . . . 62.43 110.19 -175.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 338' ' ' GLY . . . . . . . . . . . . . . . -125.95 167.58 18.31 Favored Glycine 0 C--N 1.338 0.678 0 N-CA-C 111.385 -0.686 . . . . 72.34 111.385 171.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 339' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 67.11 113.78 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 125.188 1.395 . . . . 74.33 111.318 -178.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 340' ' ' PHE . . . . . 0.509 ' HD1' ' HD2' ' C' ' 260' ' ' ARG . 9.8 p90 -50.9 93.95 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 125.702 1.601 . . . . 75.24 112.917 -179.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 341' ' ' LEU . . . . . . . . . . . . . 6.7 mp 61.31 8.45 2.11 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 124.886 1.274 . . . . 75.34 112.861 -178.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 342' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 61.98 137.44 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 125.893 1.677 . . . . 64.25 111.525 -174.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 343' ' ' VAL . . . . . 0.619 HG22 ' H ' ' B' ' 345' ' ' GLY . 12.7 p -134.49 147.12 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 O-C-N 121.652 -0.655 . . . . 64.24 111.147 -169.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -67.32 -20.18 65.57 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.783 0.833 . . . . 73.03 111.441 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 345' ' ' GLY . . . . . 0.619 ' H ' HG22 ' B' ' 343' ' ' VAL . . . -80.32 24.97 3.35 Favored Glycine 0 C--N 1.348 1.223 0 N-CA-C 114.845 0.698 . . . . 62.31 114.845 177.087 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 346' ' ' ALA . . . . . . . . . . . . . . . -79.04 -19.8 50.5 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.335 0.654 . . . . 72.22 110.792 173.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 73.4 m -128.68 130.38 47.12 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.857 0.863 . . . . 72.21 109.295 173.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 348' ' ' ILE . . . . . 0.448 ' HB ' ' HB3' ' B' ' 276' ' ' PRO . 40.3 mm -77.8 89.15 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.071 0 N-CA-C 109.011 -0.737 . . . . 73.42 109.011 175.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 349' ' ' ASP . . . . . . . . . . . . . 14.5 t70 72.59 -66.23 0.32 Allowed 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 126.002 1.721 . . . . 71.13 112.074 178.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 350' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' B' ' 276' ' ' PRO . 8.2 tttp 72.47 -75.17 0.08 Allowed 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 125.866 1.666 . . . . 74.52 110.027 177.184 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -175.05 -20.88 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.083 1.353 . . . . 71.32 109.627 177.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -81.79 56.22 2.98 Favored 'General case' 0 CA--C 1.558 1.287 0 C-N-CA 123.795 0.838 . . . . 74.35 109.472 178.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 353' ' ' HIS . . . . . 0.401 ' HA ' HD13 ' B' ' 55' ' ' LEU . 11.4 t-80 173.41 -49.04 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 126.091 1.756 . . . . 74.33 108.684 179.1 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 354' ' ' ALA . . . . . . . . . . . . . . . 62.39 37.16 13.87 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.533 1.133 . . . . 70.11 112.743 171.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 355' ' ' ALA . . . . . . . . . . . . . . . -91.84 -0.07 57.5 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.461 0.704 . . . . 75.44 111.729 173.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 356' ' ' ASN . . . . . 0.432 ' HB3' ' HD3' ' B' ' 357' ' ' PRO . 24.3 t-20 -60.98 -45.79 96.6 Favored Pre-proline 0 CA--C 1.565 1.545 0 CA-C-O 118.789 -0.624 . . . . 74.32 111.026 172.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 357' ' ' PRO . . . . . 0.432 ' HD3' ' HB3' ' B' ' 356' ' ' ASN . 24.3 Cg_exo -67.89 114.12 3.25 Favored 'Trans proline' 0 C--N 1.393 2.878 0 C-N-CA 121.972 1.781 . . . . 55.22 112.097 167.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 358' ' ' CYS . . . . . . . . . . . . . 6.8 p -78.02 144.95 36.24 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.629 0.771 . . . . 73.32 110.881 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 359' ' ' GLY . . . . . . . . . . . . . . . -139.35 53.79 0.69 Allowed Glycine 0 C--N 1.35 1.315 0 CA-C-O 119.52 -0.6 . . . . 62.01 113.515 -171.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 360' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 70.49 -63.68 0.4 Allowed 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 125.744 1.618 . . . . 53.34 113.003 176.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 361' ' ' ILE . . . . . . . . . . . . . 39.6 mm -57.46 108.27 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 124.802 1.241 . . . . 61.31 111.053 -173.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 362' ' ' GLY . . . . . 0.441 ' HA3' ' HA ' ' B' ' 249' ' ' GLU . . . 109.56 -55.15 0.52 Allowed Glycine 0 C--N 1.338 0.651 0 CA-C-N 114.649 -1.159 . . . . 72.35 112.395 -176.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 363' ' ' GLU . . . . . 0.535 ' HG2' HG23 ' B' ' 364' ' ' THR . 38.4 tt0 -68.38 -68.93 0.36 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.264 1.026 . . . . 73.13 111.486 -174.198 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 364' ' ' THR . . . . . 0.535 HG23 ' HG2' ' B' ' 363' ' ' GLU . 40.1 p -110.08 68.13 0.66 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.62 0.768 . . . . 74.04 110.576 -174.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 4.5 p -161.12 87.5 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.135 0 CA-C-O 121.635 0.731 . . . . 74.01 110.075 174.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 23.8 t70 76.73 -26.54 0.19 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 126.242 1.817 . . . . 50.12 113.124 177.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 367' ' ' LEU . . . . . . . . . . . . . 7.4 mp 71.0 -97.21 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.37 1.468 . . . . 75.05 111.717 174.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 368' ' ' ASP . . . . . . . . . . . . . 33.4 p-10 -153.41 -2.03 0.22 Allowed 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 113.96 1.096 . . . . 71.23 113.96 -162.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 369' ' ' GLU . . . . . 0.413 ' HB3' ' NH2' ' B' ' 373' ' ' ARG . 36.0 tt0 -53.94 -62.34 1.72 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.419 0.688 . . . . 70.1 112.832 -171.239 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 370' ' ' ALA . . . . . . . . . . . . . . . -169.61 169.9 8.41 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.248 0.619 . . . . 74.25 110.633 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 371' ' ' VAL . . . . . . . . . . . . . 59.7 t -110.46 122.05 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 108.099 -1.074 . . . . 74.11 108.099 173.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 372' ' ' GLN . . . . . 0.434 ' HB3' HD21 ' B' ' 375' ' ' LEU . 17.9 tm0? 81.46 -33.53 0.1 Allowed 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 125.667 1.587 . . . . 63.2 112.824 172.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 373' ' ' ARG . . . . . 0.413 ' NH2' ' HB3' ' B' ' 369' ' ' GLU . 7.0 mpt_? 80.43 -54.53 0.35 Allowed 'General case' 0 N--CA 1.507 2.391 0 C-N-CA 125.448 1.499 . . . . 72.05 113.561 173.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -83.26 69.86 10.02 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.051 0.541 . . . . 71.45 110.894 -174.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 375' ' ' LEU . . . . . 0.434 HD21 ' HB3' ' B' ' 372' ' ' GLN . 3.2 mm? -115.84 101.43 8.79 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.7 0.8 . . . . 62.01 109.365 178.1 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -122.74 92.76 3.78 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.591 -0.892 . . . . 73.13 108.591 172.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 377' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -132.86 162.17 32.26 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.381 1.072 . . . . 73.31 108.897 178.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 378' ' ' ALA . . . . . . . . . . . . . . . 67.87 16.87 9.68 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 124.496 1.119 . . . . 61.1 112.552 176.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -77.6 86.45 3.92 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.058 0.943 . . . . 72.01 109.586 -175.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 380' ' ' LYS . . . . . 0.426 ' H ' HD21 ' B' ' 408' ' ' LEU . 56.3 mttp 59.36 19.57 7.82 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 124.959 1.303 . . . . 53.14 112.037 -169.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 381' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -90.18 18.05 6.39 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.32 0.648 . . . . 74.34 111.265 -176.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -66.16 -69.01 1.46 Allowed Glycine 0 C--N 1.348 1.242 0 N-CA-C 110.996 -0.841 . . . . 73.1 110.996 173.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 383' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 69.31 -20.44 0.17 Allowed 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 125.707 1.603 . . . . 73.1 113.73 175.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 384' ' ' THR . . . . . . . . . . . . . 22.0 p -132.68 -64.93 0.73 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.902 0.881 . . . . 63.41 110.04 -171.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 385' ' ' LEU . . . . . 0.518 HD12 ' HA ' ' B' ' 85' ' ' ASN . 2.1 mm? 53.89 -86.29 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 125.801 1.64 . . . . 75.12 112.177 -178.345 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 386' ' ' VAL . . . . . . . . . . . . . 8.2 p -161.75 139.24 2.13 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 N-CA-C 106.773 -1.566 . . . . 62.42 106.773 178.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 387' ' ' ILE . . . . . . . . . . . . . 29.8 mm 58.91 75.44 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 N-CA-C 107.796 -1.187 . . . . 74.12 107.796 -166.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 388' ' ' VAL . . . . . . . . . . . . . 17.3 m -61.72 88.84 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.259 0 CA-C-N 114.537 -1.211 . . . . 54.33 112.658 -169.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 389' ' ' THR . . . . . . . . . . . . . 11.3 t -173.51 159.62 3.68 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.306 1.042 . . . . 71.25 110.049 178.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . 64.71 -76.61 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 125.572 1.549 . . . . 70.34 113.01 177.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 391' ' ' ASP . . . . . . . . . . . . . 34.3 t70 58.04 51.23 9.05 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 124.536 1.134 . . . . 64.12 109.892 -174.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 392' ' ' HIS . . . . . . . . . . . . . 10.4 t60 70.62 137.36 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 115.274 -0.875 . . . . 72.42 108.852 -172.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -60.5 92.75 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 122.878 0.471 . . . . 61.53 110.09 176.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 29.6 m170 -71.07 -58.9 3.11 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.956 0.903 . . . . 73.31 109.988 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . 60.01 43.47 14.53 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.081 0.952 . . . . 71.44 110.022 -169.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 36.4 m 68.65 4.71 4.5 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 125.782 1.633 . . . . 75.55 112.459 -174.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 397' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 62.43 105.31 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.444 1.498 . . . . 71.41 112.26 -178.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 2.1 mp -69.82 99.46 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 N-CA-C 107.6 -1.259 . . . . 75.44 107.6 174.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 399' ' ' VAL . . . . . . . . . . . . . 39.4 t 54.08 -95.21 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 C-N-CA 125.176 1.39 . . . . 73.32 110.55 -170.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 400' ' ' ALA . . . . . . . . . . . . . . . 172.94 98.04 0.05 OUTLIER Pre-proline 0 C--N 1.364 1.226 0 C-N-CA 124.757 1.223 . . . . 51.41 109.327 178.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 401' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -61.12 -17.05 49.93 Favored 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 123.393 2.728 . . . . 71.04 112.55 174.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -51.5 -48.5 62.91 Favored 'General case' 0 C--N 1.348 0.517 0 C-N-CA 125.301 1.44 . . . . 74.34 110.071 173.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 403' ' ' THR . . . . . . . . . . . . . 55.1 p 52.09 -83.41 0.01 OUTLIER 'General case' 0 C--N 1.36 1.036 0 C-N-CA 126.107 1.763 . . . . 51.3 111.695 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 404' ' ' LYS . . . . . . . . . . . . . 10.1 mptt -75.96 -55.36 5.69 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.352 -0.981 . . . . 70.03 108.352 175.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 405' ' ' ALA . . . . . . . . . . . . . . . -172.79 -47.39 0.0 OUTLIER Pre-proline 0 CA--C 1.561 1.394 0 CA-C-N 114.643 -1.162 . . . . 71.24 111.838 -176.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 406' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -62.06 108.33 0.65 Allowed 'Trans proline' 0 C--N 1.4 3.288 0 C-N-CA 122.201 1.934 . . . . 44.44 113.118 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 407' ' ' GLY . . . . . 0.421 ' H ' ' H ' ' B' ' 408' ' ' LEU . . . -171.2 -10.18 0.02 OUTLIER Glycine 0 N--CA 1.467 0.751 0 CA-C-N 115.549 -0.751 . . . . 55.33 112.555 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 408' ' ' LEU . . . . . 0.426 HD21 ' H ' ' B' ' 380' ' ' LYS . 5.8 mp -81.02 15.12 1.96 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.741 1.217 . . . . 72.03 111.728 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 78.3 p -76.19 -165.17 0.45 Allowed 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 125.181 1.392 . . . . 73.52 112.681 -173.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 410' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 67.83 -85.0 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 125.331 1.452 . . . . 51.32 111.163 175.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . -138.27 138.23 38.24 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.184 0.593 . . . . 63.14 110.505 -174.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 7.0 mp 58.04 -165.5 0.17 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 125.411 1.485 . . . . 60.41 112.353 178.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 14.5 m120 67.2 -71.51 0.1 Allowed 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 125.033 1.333 . . . . 71.14 109.948 -169.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 414' ' ' THR . . . . . 0.548 HG21 ' HA ' ' B' ' 98' ' ' ASP . 81.4 p -84.03 -162.15 0.62 Allowed 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.573 1.549 . . . . 73.24 111.442 -178.138 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 415' ' ' LYS . . . . . 0.598 ' HE3' HG23 ' B' ' 419' ' ' VAL . 68.8 tttt -79.79 34.37 0.28 Allowed 'General case' 0 CA--C 1.571 1.769 0 C-N-CA 123.67 0.788 . . . . 73.42 112.238 -178.296 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -65.02 -46.61 80.6 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 108.651 -0.87 . . . . 75.33 108.651 168.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 417' ' ' GLY . . . . . . . . . . . . . . . -78.09 79.62 1.45 Allowed Glycine 0 C--N 1.351 1.386 0 N-CA-C 109.182 -1.567 . . . . 43.15 109.182 163.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 418' ' ' ALA . . . . . 0.517 ' HA ' ' HG2' ' B' ' 415' ' ' LYS . . . -78.18 86.57 4.3 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.352 0.871 . . . . 70.25 113.352 -163.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 419' ' ' VAL . . . . . 0.598 HG23 ' HE3' ' B' ' 415' ' ' LYS . 66.2 t 52.28 -77.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 C-N-CA 126.392 1.877 . . . . 62.03 113.983 171.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 420' ' ' MET . . . . . . . . . . . . . 23.3 ttt -44.71 122.0 2.96 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.934 1.294 . . . . 73.12 113.652 -167.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 421' ' ' VAL . . . . . . . . . . . . . 13.1 p -64.58 -30.98 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 O-C-N 124.371 1.044 . . . . 72.42 112.361 -174.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 422' ' ' MET . . . . . . . . . . . . . 3.5 tpt -68.03 85.39 0.24 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.308 0.643 . . . . 74.1 109.731 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 423' ' ' SER . . . . . . . . . . . . . 9.5 t 66.49 -5.43 0.61 Allowed 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 125.425 1.49 . . . . 62.22 114.121 173.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 424' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 55.31 30.91 15.63 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 124.493 1.117 . . . . 72.42 110.988 -173.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . -68.13 142.67 39.91 Favored Glycine 0 C--N 1.354 1.54 0 CA-C-N 114.796 -1.093 . . . . 75.12 113.817 -171.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 426' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 55.6 -91.53 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.972 1.309 . . . . 75.43 110.46 -173.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 427' ' ' SER . . . . . . . . . . . . . 36.1 t -170.03 78.26 0.09 Allowed 'General case' 0 C--N 1.353 0.749 0 C-N-CA 123.885 0.874 . . . . 75.14 109.228 176.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 73.56 -68.16 0.23 Allowed 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 125.148 1.379 . . . . 73.23 111.241 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 429' ' ' GLU . . . . . 0.467 ' HB2' ' CE1' ' B' ' 434' ' ' HIS . 15.5 mm-40 62.45 18.95 10.8 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 125.053 1.341 . . . . 63.42 112.779 174.157 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -108.14 138.55 44.22 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.824 0.85 . . . . 55.41 110.778 -176.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 46.3 t -125.97 -78.03 0.59 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 108.63 -0.878 . . . . 73.31 108.63 178.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 432' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -116.85 -11.39 10.88 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.44 0.696 . . . . 71.1 110.198 173.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 433' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -170.78 139.22 1.47 Allowed 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 107.993 -1.114 . . . . 73.43 107.993 178.198 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 434' ' ' HIS . . . . . 0.467 ' CE1' ' HB2' ' B' ' 429' ' ' GLU . 11.2 t-160 -151.35 88.18 1.42 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 122.945 0.498 . . . . 65.13 109.768 172.294 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 435' ' ' THR . . . . . . . . . . . . . 4.1 m 60.24 23.98 13.37 Favored 'General case' 0 CA--C 1.562 1.441 0 C-N-CA 123.957 0.903 . . . . 73.42 112.542 164.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . 144.05 -26.44 2.04 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-O 119.79 -0.45 . . . . 43.54 113.161 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 47.5 p -83.25 70.02 10.05 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-O 121.75 0.786 . . . . 54.14 110.574 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 438' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -101.78 -97.14 0.28 Allowed 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 107.592 -1.262 . . . . 71.55 107.592 175.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 439' ' ' LEU . . . . . . . . . . . . . 95.9 mt 49.89 27.56 2.42 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 124.303 1.041 . . . . 74.24 113.093 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 440' ' ' ARG . . . . . 0.41 ' NH1' ' HB2' ' A' ' 222' ' ' ALA . 8.1 mmt180 -70.34 123.49 21.84 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.699 0.8 . . . . 70.1 109.891 -172.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 441' ' ' ILE . . . . . 0.594 HG12 HD13 ' A' ' 235' ' ' LEU . 71.8 mt -66.6 134.01 30.54 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 124.18 0.992 . . . . 74.15 112.129 -168.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 442' ' ' ALA . . . . . . . . . . . . . . . -107.12 34.04 3.67 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.032 1.333 . . . . 71.41 110.867 -178.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 443' ' ' ALA . . . . . 0.592 ' H ' HG22 ' B' ' 441' ' ' ILE . . . -84.78 -167.48 1.83 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.309 0.644 . . . . 74.21 110.932 177.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -57.34 105.16 0.21 Allowed 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 123.624 0.77 . . . . 65.34 111.923 -177.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . -165.55 83.08 0.1 Allowed Glycine 0 C--N 1.342 0.911 0 N-CA-C 109.616 -1.394 . . . . 74.34 109.616 178.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 446' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -58.15 92.35 0.06 OUTLIER 'Trans proline' 0 C--N 1.383 2.343 0 C-N-CA 123.748 2.965 . . . . 63.02 114.002 -173.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 447' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 57.15 -92.93 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 125.369 1.468 . . . . 60.0 111.169 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 448' ' ' ALA . . . . . 0.67 ' HA ' HD21 ' B' ' 470' ' ' LEU . . . 49.2 -83.89 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.638 1.575 . . . . 74.31 114.394 178.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 449' ' ' ALA . . . . . . . . . . . . . . . -71.83 89.57 1.07 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.345 1.058 . . . . 61.52 112.826 -166.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 450' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -138.35 -68.33 0.45 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.13 0.972 . . . . 61.12 108.443 167.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 7.8 m -137.14 -42.86 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 123.843 0.857 . . . . 63.1 110.834 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 452' ' ' VAL . . . . . . . . . . . . . 6.4 t 57.55 33.72 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.702 0 C-N-CA 124.529 1.132 . . . . 60.45 110.505 -178.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 174.34 170.89 38.1 Favored Glycine 0 C--N 1.346 1.138 0 CA-C-N 115.447 -0.797 . . . . 73.44 112.152 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 454' ' ' LEU . . . . . 0.687 HD22 HD12 ' B' ' 460' ' ' LEU . 3.1 pp -105.38 138.45 41.56 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.164 0.586 . . . . 72.5 111.13 -178.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 13.4 m -96.19 87.46 4.52 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 107.695 -1.224 . . . . 61.41 107.695 172.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -74.2 89.8 2.04 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.376 0.608 . . . . 74.3 111.236 -175.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 457' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -124.18 45.1 2.57 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 107.382 -1.34 . . . . 42.14 107.382 170.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 21.8 m 72.26 71.47 0.15 Allowed 'General case' 0 C--N 1.352 0.684 0 C-N-CA 125.231 1.412 . . . . 72.13 107.926 -159.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 459' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -167.05 153.55 8.35 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 114.496 -1.229 . . . . 73.31 109.296 -172.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 460' ' ' LEU . . . . . 0.687 HD12 HD22 ' B' ' 454' ' ' LEU . 34.3 tp -149.0 73.61 1.22 Allowed 'General case' 0 C--O 1.24 0.576 0 N-CA-C 109.112 -0.699 . . . . 65.42 109.112 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -63.72 99.88 0.25 Allowed 'General case' 0 C--N 1.359 0.994 0 N-CA-C 107.159 -1.423 . . . . 62.31 107.159 165.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -54.96 -49.47 71.33 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 123.923 0.764 . . . . 72.53 109.697 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 21.5 m 71.9 -24.93 0.18 Allowed 'General case' 0 CA--C 1.564 1.518 0 C-N-CA 125.547 1.539 . . . . 61.35 113.192 174.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 464' ' ' MET . . . . . . . . . . . . . 3.9 mpp? 55.17 61.24 3.0 Favored 'General case' 0 C--N 1.361 1.103 0 C-N-CA 125.352 1.461 . . . . 75.31 110.722 -177.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -83.22 136.51 34.38 Favored 'General case' 0 C--N 1.35 0.597 0 CA-C-N 114.998 -1.001 . . . . 72.15 110.288 177.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -125.22 166.87 15.69 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 124.737 1.215 . . . . 62.32 108.533 173.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . -83.58 51.35 1.99 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.643 0.777 . . . . 75.3 110.813 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 52.0 tp -168.66 -44.67 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.623 1.169 . . . . 45.51 108.757 -175.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 469' ' ' GLY . . . . . . . . . . . . . . . -178.56 -144.35 5.6 Favored Glycine 0 C--N 1.347 1.194 0 CA-C-N 115.367 -0.833 . . . . 50.44 111.662 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 470' ' ' LEU . . . . . 0.67 HD21 ' HA ' ' B' ' 448' ' ' ALA . 2.6 pt? -156.62 164.35 38.27 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.821 0.849 . . . . 73.2 109.529 178.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 471' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? . . . . . 0 CA--C 1.553 1.08 0 N-CA-C 107.556 -1.276 . . . . 74.2 107.556 173.128 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 69.2 mtm . . . . . 0 N--CA 1.482 1.169 0 CA-C-O 120.261 0.077 . . . . 55.23 111.192 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 69.29 41.67 1.31 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.546 1.138 . . . . 65.31 112.206 169.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.55 69.94 9.42 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.787 -0.642 . . . . 52.01 109.647 175.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 4' ' ' LYS . . . . . 0.4 ' HE2' ' HB3' ' C' ' 4' ' ' LYS . 31.0 ttpt -38.53 105.73 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.11 1.764 . . . . 70.52 113.589 177.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 5' ' ' LYS . . . . . 0.499 ' HB3' HD11 ' C' ' 10' ' ' ILE . 49.7 mtpt -88.47 104.15 16.53 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 107.425 -1.324 . . . . 63.2 107.425 164.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -67.8 108.35 2.94 Favored 'General case' 0 C--N 1.35 0.595 0 N-CA-C 108.401 -0.962 . . . . 63.22 108.401 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 7' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -64.96 -33.61 76.45 Favored 'General case' 0 C--O 1.244 0.81 0 O-C-N 124.162 0.914 . . . . 73.43 111.814 -169.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -68.11 -41.36 81.87 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.76 -0.654 . . . . 72.53 110.219 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.53 -39.73 94.31 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.274 0.629 . . . . 52.31 110.883 179.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 10' ' ' ILE . . . . . 0.499 HD11 ' HB3' ' C' ' 5' ' ' LYS . 81.7 mt -56.98 -43.17 80.39 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 123.686 0.795 . . . . 63.34 110.027 173.172 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 96.2 mt -76.59 -15.81 59.75 Favored 'General case' 0 CA--C 1.556 1.174 0 N-CA-C 112.952 0.723 . . . . 45.45 112.952 176.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.88 21.29 71.69 Favored Glycine 0 C--N 1.351 1.413 0 N-CA-C 114.021 0.368 . . . . 64.33 114.021 -177.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 23.8 m -112.52 160.26 31.07 Favored Pre-proline 0 N--CA 1.486 1.353 0 C-N-CA 124.463 1.105 . . . . 64.04 110.479 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -55.04 157.58 13.15 Favored 'Trans proline' 0 C--N 1.385 2.46 0 C-N-CA 123.582 2.855 . . . . 74.43 114.509 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 65.1 mtt85 -78.98 28.62 0.22 Allowed 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 124.113 0.965 . . . . 71.52 113.58 -176.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -158.59 15.35 0.19 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.508 1.123 . . . . 71.24 108.631 174.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.28 148.15 33.15 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.371 1.068 . . . . 71.14 112.605 -171.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 74.6 p -87.66 -175.79 5.31 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.831 0.853 . . . . 74.41 112.245 -171.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -53.11 -55.2 25.83 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.155 0.982 . . . . 74.45 111.741 -174.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -63.99 -31.37 72.53 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 123.833 0.708 . . . . 64.05 111.673 -176.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -67.59 -49.77 61.54 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 122.237 0.215 . . . . 73.42 110.516 179.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 1.7 mp -64.0 -42.51 95.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 C-N-CA 123.548 0.739 . . . . 61.32 110.932 177.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -64.41 -52.54 57.64 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.233 1.013 . . . . 74.13 111.008 -176.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -75.29 -26.84 59.04 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.662 -0.699 . . . . 73.52 111.433 -174.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -73.34 -36.49 66.17 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 122.583 0.353 . . . . 75.32 110.893 173.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 26' ' ' TYR . . . . . 0.557 ' HD1' HG22 ' C' ' 50' ' ' ILE . 51.3 t80 -58.63 -56.21 25.13 Favored 'General case' 0 C--O 1.211 -0.973 0 N-CA-C 109.031 -0.729 . . . . 72.31 109.031 173.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -56.23 -45.69 79.84 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 124.614 1.196 . . . . 74.1 111.593 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 44.7 ttt180 -50.47 -55.1 17.4 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.479 1.112 . . . . 71.15 111.245 177.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 84.4 mt -85.26 -12.01 53.47 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 114.929 -1.032 . . . . 60.22 111.558 -175.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -91.75 -4.89 54.47 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.637 0.775 . . . . 75.32 110.155 173.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 36.7 mtp-105 -95.95 -43.47 7.8 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.887 0.875 . . . . 73.5 109.741 166.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.52 -54.29 25.4 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 109.212 -0.662 . . . . 71.12 109.212 -178.268 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -90.5 13.5 15.59 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 116.222 -0.445 . . . . 70.15 111.722 -178.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 34' ' ' HIS . . . . . 0.408 ' HD2' HG23 ' C' ' 37' ' ' VAL . 40.3 t60 -60.61 106.69 0.82 Allowed Pre-proline 0 N--CA 1.479 1.023 0 CA-C-O 118.386 -0.816 . . . . 72.34 109.248 -179.12 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.28 -36.58 47.48 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 123.687 2.925 . . . . 71.32 114.855 -171.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -66.07 -34.63 78.5 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.45 1.1 . . . . 60.34 111.894 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 37' ' ' VAL . . . . . 0.408 HG23 ' HD2' ' C' ' 34' ' ' HIS . 80.0 t -89.15 -50.69 13.06 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 122.916 0.486 . . . . 75.33 110.429 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -102.63 104.0 14.33 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.746 1.219 . . . . 54.22 109.507 -173.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -83.86 35.16 0.51 Allowed 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 123.498 0.719 . . . . 62.24 111.973 -174.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 59.6 m -97.38 132.57 25.13 Favored Pre-proline 0 N--CA 1.488 1.434 0 CA-C-O 119.047 -0.501 . . . . 74.14 110.548 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -49.22 -42.49 39.82 Favored 'Trans proline' 0 C--N 1.384 2.413 0 C-N-CA 123.199 2.599 . . . . 63.44 112.15 168.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -58.32 -37.23 74.68 Favored 'General case' 0 C--N 1.353 0.75 0 CA-C-N 115.542 -0.754 . . . . 65.44 111.025 177.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.56 -21.79 59.33 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 119.431 -0.319 . . . . 62.05 110.768 -178.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -69.59 -51.01 39.13 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 108.987 -0.746 . . . . 74.04 108.987 174.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 45' ' ' GLU . . . . . 0.437 ' O ' ' HG3' ' C' ' 49' ' ' GLU . 42.1 mt-10 -67.88 -47.35 69.09 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 114.103 -1.408 . . . . 42.53 110.793 -175.159 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 46' ' ' LYS . . . . . 0.554 ' O ' HG12 ' C' ' 50' ' ' ILE . 35.8 mmtm -60.35 -43.11 96.81 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-N 115.329 -0.851 . . . . 72.32 111.097 175.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -58.22 -40.96 83.03 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 123.656 0.597 . . . . 62.23 110.546 178.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -64.68 -34.26 77.88 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 123.747 0.654 . . . . 72.04 111.601 175.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 49' ' ' GLU . . . . . 0.437 ' HG3' ' O ' ' C' ' 45' ' ' GLU . 41.6 mt-10 -69.42 -33.0 72.33 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 122.653 0.381 . . . . 72.33 111.139 174.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 50' ' ' ILE . . . . . 0.557 HG22 ' HD1' ' C' ' 26' ' ' TYR . 14.7 mm -71.66 -34.41 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 N-CA-C 108.903 -0.777 . . . . 75.43 108.903 176.153 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 51' ' ' ASN . . . . . 0.449 ' HB3' ' HD1' ' C' ' 88' ' ' PHE . 94.6 m-20 -69.18 -36.71 77.62 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-N 114.642 -1.163 . . . . 74.04 110.662 176.196 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 62.2 tt0 -62.68 -54.34 40.89 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.9 0.88 . . . . 63.42 110.128 177.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -52.64 -60.88 2.71 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-N 113.467 -1.697 . . . . 63.1 111.224 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -61.19 -38.66 87.32 Favored 'General case' 0 C--O 1.21 -1.019 0 CA-C-N 115.072 -0.967 . . . . 75.01 111.895 -178.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.61 -51.26 70.58 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 122.827 0.451 . . . . 60.54 111.463 -177.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 56' ' ' VAL . . . . . 0.511 ' HA ' ' HE3' ' C' ' 62' ' ' LYS . 75.0 t -60.49 -40.63 84.92 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 O-C-N 124.307 1.004 . . . . 72.43 110.394 176.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 57' ' ' LEU . . . . . . . . . . . . . 46.9 mt -89.15 -0.8 57.74 Favored 'General case' 0 CA--C 1.565 1.544 0 N-CA-C 113.025 0.75 . . . . 75.02 113.025 -176.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 32.8 t -77.25 -57.39 3.86 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 124.339 1.056 . . . . 62.42 111.066 -178.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 59' ' ' ASP . . . . . 0.419 ' HA ' HG12 ' C' ' 145' ' ' VAL . 0.9 OUTLIER -65.83 122.83 82.81 Favored Pre-proline 0 C--N 1.354 0.796 0 N-CA-C 107.955 -1.128 . . . . 72.03 107.955 173.231 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 60' ' ' PRO . . . . . 0.54 ' HD2' ' HA ' ' C' ' 145' ' ' VAL . 19.1 Cg_endo -56.17 -27.78 67.34 Favored 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 123.066 2.51 . . . . 33.23 111.177 173.274 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 61' ' ' GLU . . . . . 0.67 ' HG2' ' HD3' ' C' ' 79' ' ' PRO . 3.2 tp10 -58.08 -66.06 0.54 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.249 1.02 . . . . 62.13 110.416 172.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 62' ' ' LYS . . . . . 0.511 ' HE3' ' HA ' ' C' ' 56' ' ' VAL . 17.7 mtmt -70.1 -22.99 62.97 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.426 0.69 . . . . 75.23 111.565 -173.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 48.8 tpt85 -61.18 -55.84 27.61 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.759 1.224 . . . . 64.42 109.233 172.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 -75.24 -19.15 59.9 Favored 'General case' 0 C--N 1.351 0.668 0 CA-C-N 115.26 -0.882 . . . . 74.15 111.523 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 65' ' ' ILE . . . . . 0.493 HG12 ' HB2' ' C' ' 76' ' ' PRO . 36.0 mt -66.03 -46.87 86.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.28 0.632 . . . . 62.34 109.55 171.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -61.46 -46.95 87.93 Favored 'General case' 0 C--N 1.353 0.727 0 O-C-N 123.803 0.689 . . . . 74.22 109.667 177.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -55.05 -48.6 73.22 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 123.675 0.609 . . . . 73.14 111.649 177.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 76.7 p -79.73 -9.15 59.61 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 112.568 0.581 . . . . 63.2 112.568 -178.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -72.38 100.37 2.65 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 108.229 -1.026 . . . . 75.22 108.229 174.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 125.05 10.83 4.54 Favored Glycine 0 N--CA 1.47 0.918 0 CA-C-N 115.348 -0.842 . . . . 62.51 111.704 -165.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 29.5 m -142.61 -55.53 0.43 Allowed 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 104.526 -2.398 . . . . 72.34 104.526 175.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 70.6 m -84.12 135.48 34.38 Favored 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 103.613 -2.736 . . . . 73.35 103.613 154.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.42 -31.09 8.31 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 118.987 0.812 . . . . 73.23 111.147 178.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -72.69 153.18 91.5 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 123.425 0.69 . . . . 53.23 109.254 171.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -54.3 113.55 1.41 Allowed 'Trans proline' 0 C--N 1.373 1.822 0 C-N-CA 122.56 2.173 . . . . 75.14 112.06 171.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 76' ' ' PRO . . . . . 0.493 ' HB2' HG12 ' C' ' 65' ' ' ILE . 45.8 Cg_exo -59.01 148.3 85.91 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 122.979 2.453 . . . . 63.14 111.525 175.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -57.82 124.43 16.0 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.985 2.457 . . . . 51.51 112.963 -169.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 78' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -63.33 153.25 75.61 Favored 'Trans proline' 0 C--N 1.38 2.221 0 C-N-CA 122.541 2.16 . . . . 74.44 111.904 175.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 79' ' ' PRO . . . . . 0.67 ' HD3' ' HG2' ' C' ' 61' ' ' GLU . 37.7 Cg_endo -66.36 147.44 82.94 Favored 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 122.128 1.885 . . . . 61.04 109.531 170.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 80' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' C' ' 79' ' ' PRO . 53.6 Cg_exo -55.22 78.77 0.03 OUTLIER 'Trans proline' 0 C--N 1.384 2.436 0 C-N-CA 124.139 3.226 . . . . 51.5 114.646 -176.028 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 163.7 -51.89 0.3 Allowed Glycine 0 CA--C 1.519 0.283 0 N-CA-C 108.326 -1.909 . . . . 75.2 108.326 -174.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 134.14 -157.63 22.96 Favored Glycine 0 C--N 1.351 1.383 0 C-N-CA 123.09 0.376 . . . . 74.45 113.102 173.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -97.25 121.1 38.76 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.181 0.992 . . . . 70.14 109.007 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 84' ' ' ASP . . . . . 0.499 ' HB2' ' NE ' ' C' ' 143' ' ' ARG . 7.8 t70 -79.5 126.12 30.45 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 112.516 0.562 . . . . 63.13 112.516 -171.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 85' ' ' PHE . . . . . 0.402 ' HA ' ' HD2' ' C' ' 88' ' ' PHE . 87.0 m-85 -137.61 31.7 2.54 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.184 0.994 . . . . 74.41 109.288 173.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 15.5 m -81.07 85.24 6.33 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 114.657 -1.156 . . . . 45.43 110.869 -172.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 87' ' ' GLY . . . . . 0.454 ' N ' ' HA ' ' C' ' 171' ' ' PRO . . . 129.31 -15.85 5.76 Favored Glycine 0 N--CA 1.471 0.971 0 N-CA-C 110.626 -0.99 . . . . 74.33 110.626 -172.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 88' ' ' PHE . . . . . 0.449 ' HD1' ' HB3' ' C' ' 51' ' ' ASN . 33.2 m-85 -108.57 135.87 49.11 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 108.023 -1.102 . . . . 74.44 108.023 178.067 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -77.18 79.26 3.7 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.014 0.525 . . . . 72.23 110.271 -175.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 90' ' ' VAL . . . . . 0.544 HG23 ' HZ ' ' C' ' 97' ' ' PHE . 3.4 p -48.48 -40.85 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 C-N-CA 124.96 1.304 . . . . 54.41 112.574 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -62.92 -29.89 71.13 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.715 0.806 . . . . 74.21 111.42 -177.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -72.32 -33.42 67.34 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.057 0.543 . . . . 75.53 112.023 178.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 93' ' ' PHE . . . . . 0.403 ' HZ ' ' HB3' ' C' ' 88' ' ' PHE . 10.6 m-30 -70.38 166.22 20.76 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 122.72 0.408 . . . . 72.45 111.208 -166.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 75.5 p -57.32 149.65 19.84 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 113.306 0.854 . . . . 45.51 113.306 -168.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.4 -32.94 70.63 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 115.299 -0.864 . . . . 55.43 111.118 170.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -52.97 -52.06 59.43 Favored 'General case' 0 C--N 1.357 0.915 0 C-N-CA 125.016 1.327 . . . . 65.02 109.934 174.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 97' ' ' PHE . . . . . 0.544 ' HZ ' HG23 ' C' ' 90' ' ' VAL . 1.8 t80 -60.35 -44.12 95.86 Favored 'General case' 0 CA--C 1.557 1.22 0 CA-C-N 113.256 -1.793 . . . . 64.25 110.677 174.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -70.79 -12.82 61.78 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 112.568 0.581 . . . . 51.52 112.568 -177.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -93.25 -40.61 10.34 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.298 0.639 . . . . 74.43 110.818 173.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 23.7 tp -75.03 -63.57 1.24 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.021 0.528 . . . . 73.23 110.795 -178.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -80.65 -11.43 59.64 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 122.851 0.46 . . . . 73.25 111.841 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -41.03 -60.91 2.11 Favored Glycine 0 CA--C 1.541 1.715 0 CA-C-O 118.726 -1.041 . . . . 54.11 115.137 178.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -50.14 -28.13 18.91 Favored 'Trans proline' 0 C--N 1.386 2.551 0 C-N-CA 124.113 3.209 . . . . 62.02 114.693 -177.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -126.77 30.55 4.16 Favored Glycine 0 C--N 1.358 1.757 0 CA-C-O 118.516 -1.158 . . . . 43.23 113.145 -175.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 34.5 mt -68.28 72.17 0.19 Allowed 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 118.373 1.086 . . . . 73.03 112.688 177.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 106' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 43.53 -107.99 0.11 Allowed 'General case' 0 CA--C 1.562 1.441 0 C-N-CA 126.494 1.918 . . . . 64.24 113.874 170.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . 70.46 23.4 77.57 Favored Glycine 0 C--N 1.357 1.698 0 CA-C-O 120.002 -0.332 . . . . 51.05 112.943 -169.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 62.2 -104.14 0.7 Allowed Glycine 0 C--N 1.36 1.878 0 N-CA-C 111.668 -0.573 . . . . 74.41 111.668 -174.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 109' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -122.46 -7.28 8.67 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.571 1.148 . . . . 74.45 110.118 172.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 110' ' ' GLY . . . . . . . . . . . . . . . -88.83 -10.05 67.45 Favored Glycine 0 C--N 1.349 1.259 0 C-N-CA 123.48 0.562 . . . . 54.22 113.044 179.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 53.7 mtm-85 58.33 8.11 0.78 Allowed 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 124.642 1.177 . . . . 75.25 113.891 173.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 112' ' ' ARG . . . . . 0.679 ' HE ' ' HB3' ' C' ' 114' ' ' ARG . 44.3 ttp180 -55.7 -23.3 28.02 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 125.192 1.397 . . . . 74.1 112.544 176.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 113' ' ' SER . . . . . . . . . . . . . 27.4 m 65.14 17.5 11.07 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.963 1.305 . . . . 72.53 112.156 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 114' ' ' ARG . . . . . 0.679 ' HB3' ' HE ' ' C' ' 112' ' ' ARG . 14.4 tpt180 -119.57 177.59 4.88 Favored 'General case' 0 CA--C 1.555 1.142 0 CA-C-O 118.509 -0.757 . . . . 74.05 110.829 -170.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 115' ' ' LYS . . . . . 0.471 ' H ' ' HG3' ' C' ' 114' ' ' ARG . 53.9 tttp -25.16 129.24 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.362 0 C-N-CA 127.218 2.207 . . . . 54.14 116.262 -164.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -93.41 158.6 23.71 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-N 115.046 -0.979 . . . . 45.25 113.618 -173.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 117' ' ' ARG . . . . . 0.446 ' HA ' ' NE ' ' C' ' 117' ' ' ARG . 2.2 mmp_? -116.71 155.51 28.75 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.21 1.004 . . . . 64.44 112.156 178.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -66.89 108.61 2.62 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-O 121.756 0.789 . . . . 75.42 109.428 175.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 119' ' ' LEU . . . . . 0.558 HD21 HG22 ' B' ' 185' ' ' VAL . 3.9 tt -89.22 112.74 23.84 Favored 'General case' 0 C--O 1.224 -0.28 0 N-CA-C 105.814 -1.921 . . . . 75.21 105.814 -174.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -93.66 132.68 37.77 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.516 -1.29 . . . . 72.31 107.516 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 121' ' ' ALA . . . . . . . . . . . . . . . -143.52 117.0 9.12 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.161 -0.681 . . . . 63.21 109.161 -177.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 122' ' ' GLU . . . . . 0.539 ' HA ' ' O ' ' C' ' 177' ' ' VAL . 13.1 pt-20 -92.91 125.47 37.52 Favored 'General case' 0 C--N 1.353 0.754 0 N-CA-C 109.036 -0.727 . . . . 73.22 109.036 176.237 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 123' ' ' LEU . . . . . 0.643 ' HB2' ' HA ' ' B' ' 182' ' ' VAL . 0.8 OUTLIER -121.51 105.72 38.49 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 115.873 -0.603 . . . . 73.3 111.63 -170.048 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 124' ' ' PRO . . . . . 0.717 ' HD2' ' HB3' ' B' ' 183' ' ' ALA . 28.2 Cg_exo -42.33 113.77 0.34 Allowed 'Trans proline' 0 C--N 1.374 1.9 0 C-N-CA 123.314 2.676 . . . . 72.51 112.02 161.091 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 125' ' ' LEU . . . . . . . . . . . . . 42.9 tp -140.09 140.78 36.16 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.829 1.252 . . . . 74.03 108.401 -170.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.43 154.11 22.98 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 121.006 0.431 . . . . 61.53 111.156 -176.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 127' ' ' LEU . . . . . 0.665 ' HB3' HD22 ' C' ' 215' ' ' LEU . 96.2 mt -63.22 -44.28 95.72 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.519 1.128 . . . . 62.25 111.067 177.288 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -53.55 -49.03 68.55 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 114.964 -1.016 . . . . 75.24 110.302 172.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -66.19 -32.31 73.67 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.889 0.876 . . . . 73.53 111.484 -176.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -73.05 -31.54 64.48 Favored 'General case' 0 CA--C 1.541 0.596 0 O-C-N 124.087 0.867 . . . . 64.34 110.475 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 131' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -69.45 -43.16 73.85 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.448 0.699 . . . . 75.55 110.395 171.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 132' ' ' HIS . . . . . . . . . . . . . 38.2 m170 -67.11 -67.65 0.44 Allowed 'General case' 0 N--CA 1.485 1.28 0 O-C-N 124.007 0.817 . . . . 60.22 111.924 -172.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 67.52 99.28 0.03 OUTLIER Glycine 0 CA--C 1.542 1.734 0 O-C-N 123.423 0.452 . . . . 65.31 113.607 -178.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . -142.52 162.12 27.33 Favored Glycine 0 N--CA 1.476 1.311 0 CA-C-O 119.244 -0.753 . . . . 53.24 111.272 178.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 53.6 mp0 -71.45 92.81 1.12 Allowed 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 108.565 -0.902 . . . . 71.2 108.565 177.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 136' ' ' ARG . . . . . 0.532 ' HB2' HD22 ' B' ' 181' ' ' LEU . 99.0 mtt180 -124.75 154.71 40.47 Favored 'General case' 0 C--O 1.247 0.941 0 C-N-CA 124.084 0.954 . . . . 72.12 109.302 -173.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 137' ' ' VAL . . . . . 0.498 HG13 ' HB1' ' B' ' 180' ' ' ALA . 7.6 p -81.12 108.8 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-O 121.919 0.866 . . . . 71.12 111.828 -165.117 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 138' ' ' VAL . . . . . 0.415 HG12 HG13 ' B' ' 182' ' ' VAL . 20.8 m -87.78 133.98 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 108.012 -1.107 . . . . 72.14 108.012 165.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 139' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' C' ' 143' ' ' ARG . 1.2 tm-20 -124.7 105.34 9.23 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 108.03 -1.1 . . . . 74.31 108.03 169.215 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 140' ' ' VAL . . . . . . . . . . . . . 67.1 t -127.81 110.41 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 123.796 0.838 . . . . 63.22 109.181 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 63.86 29.32 14.64 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.149 0.979 . . . . 15.23 110.976 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 97.76 -12.96 64.26 Favored Glycine 0 C--N 1.349 1.257 0 CA-C-N 115.003 -0.999 . . . . 45.25 112.738 -178.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 143' ' ' ARG . . . . . 0.499 ' NE ' ' HB2' ' C' ' 84' ' ' ASP . 5.9 tpp180 -75.26 93.92 2.93 Favored 'General case' 0 C--N 1.353 0.717 0 CA-C-N 117.253 0.527 . . . . 73.04 109.84 -177.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 28.8 ttp85 -104.73 96.68 6.74 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 124.373 1.069 . . . . 71.51 109.511 -176.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 145' ' ' VAL . . . . . 0.54 ' HA ' ' HD2' ' C' ' 60' ' ' PRO . 25.7 m -133.02 146.38 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.64 0.776 . . . . 75.03 110.615 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 46.4 m -89.79 92.48 9.06 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.949 -0.76 . . . . 54.21 108.949 174.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 147' ' ' VAL . . . . . 0.599 HG11 ' HE1' ' C' ' 164' ' ' MET . 10.8 p -113.16 145.37 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 122.942 0.497 . . . . 72.53 109.977 -174.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -101.16 101.81 12.61 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 108.499 -0.926 . . . . 74.22 108.499 170.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 149' ' ' ILE . . . . . . . . . . . . . 36.0 pt -73.57 137.1 77.49 Favored Pre-proline 0 CA--C 1.551 1.006 0 N-CA-C 107.734 -1.21 . . . . 71.41 107.734 165.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 150' ' ' PRO . . . . . 0.444 ' HA ' ' HD3' ' C' ' 151' ' ' PRO . 51.5 Cg_endo -63.76 142.66 83.9 Favored 'Trans proline' 0 C--N 1.37 1.702 0 C-N-CA 122.417 2.078 . . . . 61.44 113.136 -167.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 151' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' C' ' 150' ' ' PRO . 26.1 Cg_exo -62.92 149.95 89.94 Favored 'Trans proline' 0 C--N 1.379 2.148 0 C-N-CA 122.843 2.362 . . . . 73.2 111.719 176.075 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 152' ' ' GLY . . . . . 0.71 ' HA2' ' HB3' ' C' ' 240' ' ' PHE . . . 80.59 52.79 4.29 Favored Glycine 0 C--N 1.336 0.557 0 CA-C-N 116.216 -0.447 . . . . 54.32 112.435 -176.472 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 153' ' ' VAL . . . . . 0.527 HG21 HD11 ' C' ' 159' ' ' ILE . 8.3 p -104.14 142.83 16.87 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.312 0 C-N-CA 123.009 0.524 . . . . 71.13 110.26 -177.275 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 154' ' ' ARG . . . . . 0.593 ' HA ' ' HB3' ' C' ' 188' ' ' LEU . 57.5 mtp180 -97.51 161.35 13.82 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.762 0.825 . . . . 75.32 112.094 -168.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 155' ' ' GLU . . . . . 0.473 ' HG2' ' HE ' ' C' ' 187' ' ' ARG . 8.3 tp10 -54.22 115.7 2.21 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.682 0.793 . . . . 74.51 110.102 162.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 78.1 19.67 74.34 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-O 119.536 -0.591 . . . . 64.51 113.862 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 157' ' ' SER . . . . . 0.567 ' HA ' ' HG2' ' B' ' 193' ' ' PRO . 3.4 m -70.62 108.53 4.41 Favored 'General case' 0 C--N 1.355 0.842 0 CA-C-N 117.365 0.583 . . . . 75.43 110.105 172.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 158' ' ' VAL . . . . . 0.537 HG11 ' HA ' ' B' ' 190' ' ' CYS . 22.0 t -84.43 88.46 2.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 114.698 -1.137 . . . . 64.44 108.437 176.395 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 159' ' ' ILE . . . . . 0.527 HD11 HG21 ' C' ' 153' ' ' VAL . 37.5 mt -72.14 118.02 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 115.184 -0.916 . . . . 52.25 109.587 -178.308 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -75.95 118.61 18.91 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 109.091 -0.707 . . . . 72.21 109.091 173.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 161' ' ' VAL . . . . . 0.462 HG11 ' SD ' ' C' ' 164' ' ' MET . 20.6 t -125.85 95.55 39.61 Favored Pre-proline 0 CA--C 1.55 0.96 0 N-CA-C 109.556 -0.535 . . . . 75.24 109.556 174.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.38 128.11 12.5 Favored 'Trans proline' 0 C--N 1.369 1.609 0 C-N-CA 122.264 1.976 . . . . 63.42 111.342 173.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 101.92 23.92 8.93 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-N 115.793 -0.64 . . . . 53.31 113.466 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 164' ' ' MET . . . . . 0.599 ' HE1' HG11 ' C' ' 147' ' ' VAL . 28.2 mtp -151.81 6.9 0.47 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 112.619 0.6 . . . . 73.35 112.619 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 165' ' ' GLY . . . . . 0.415 ' HA3' ' O ' ' C' ' 173' ' ' ASP . . . -121.92 -122.89 2.88 Favored Glycine 0 N--CA 1.478 1.458 0 CA-C-O 118.348 -1.251 . . . . 64.24 111.515 -177.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . 69.4 81.93 0.21 Allowed Glycine 0 C--N 1.359 1.816 0 CA-C-N 118.149 0.974 . . . . 75.44 113.823 165.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 167' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -69.23 99.41 1.16 Allowed 'General case' 0 C--N 1.348 0.512 0 N-CA-C 107.035 -1.469 . . . . 64.31 107.035 166.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . 131.51 -142.51 13.91 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 108.395 -1.882 . . . . 13.44 108.395 -161.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 169' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -145.74 -62.2 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.774 0 CA-C-N 120.226 2.013 . . . . 62.44 111.784 175.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 170' ' ' PRO . . . . . 0.466 ' HG2' ' HA ' ' C' ' 115' ' ' LYS . 26.6 Cg_endo -61.88 162.79 20.97 Favored 'Trans proline' 0 C--N 1.399 3.191 0 C-N-CA 122.174 1.916 . . . . 51.41 112.345 173.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 171' ' ' PRO . . . . . 0.454 ' HA ' ' N ' ' C' ' 87' ' ' GLY . 5.8 Cg_exo -10.38 108.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.396 3.078 1 C-N-CA 127.079 5.186 . . . . 74.02 118.497 -165.189 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -140.32 -156.41 6.87 Favored Glycine 0 C--N 1.342 0.912 0 N-CA-C 109.311 -1.516 . . . . 74.42 109.311 170.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 173' ' ' ASP . . . . . 0.415 ' O ' ' HA3' ' C' ' 165' ' ' GLY . 14.5 t70 -166.3 158.29 13.85 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 117.843 0.822 . . . . 74.51 110.087 -177.018 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 174' ' ' LEU . . . . . 0.434 HD12 ' O ' ' C' ' 119' ' ' LEU . 45.2 tp -118.82 107.53 13.73 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.674 0.79 . . . . 75.22 109.758 175.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 175' ' ' LEU . . . . . 0.451 HD22 HG12 ' C' ' 158' ' ' VAL . 73.8 mt -86.44 85.85 7.33 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.962 0.905 . . . . 71.32 110.273 175.135 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 176' ' ' LEU . . . . . 0.43 ' HG ' ' HG ' ' C' ' 174' ' ' LEU . 47.9 mt -75.3 92.7 2.79 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.594 0.758 . . . . 43.02 110.543 177.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 177' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' C' ' 122' ' ' GLU . 6.5 t -84.92 94.13 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 C-N-CA 123.423 0.689 . . . . 74.43 109.921 179.287 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 178' ' ' VAL . . . . . . . . . . . . . 23.0 m -68.78 119.53 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 O-C-N 121.344 -0.848 . . . . 74.01 110.781 -176.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 179' ' ' ARG . . . . . 0.474 ' O ' ' HA ' ' C' ' 124' ' ' PRO . 7.0 mmm180 -100.93 119.7 39.09 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 107.023 -1.473 . . . . 72.33 107.023 171.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 180' ' ' LEU . . . . . 0.454 HD13 HD21 ' C' ' 127' ' ' LEU . 75.5 mt -68.6 134.99 50.78 Favored 'General case' 0 CA--C 1.559 1.29 0 CA-C-N 118.171 0.441 . . . . 70.51 111.397 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 181' ' ' LEU . . . . . 0.436 HD23 ' HB3' ' C' ' 124' ' ' PRO . 18.5 mt -53.12 169.64 0.29 Allowed Pre-proline 0 N--CA 1.502 2.148 0 C-N-CA 126.521 1.928 . . . . 74.2 113.538 -176.123 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -59.99 64.5 0.07 OUTLIER 'Trans proline' 0 C--N 1.405 3.543 0 C-N-CA 123.486 2.791 . . . . 64.12 112.268 161.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 183' ' ' HIS . . . . . 0.527 ' N ' ' HD3' ' C' ' 184' ' ' PRO . 76.4 t60 -162.37 26.15 0.02 OUTLIER Pre-proline 0 CA--C 1.576 1.957 0 C-N-CA 127.77 2.428 . . . . 62.13 107.705 -176.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 184' ' ' PRO . . . . . 0.527 ' HD3' ' N ' ' C' ' 183' ' ' HIS . 11.0 Cg_endo -88.49 67.67 3.0 Favored 'Trans proline' 0 C--N 1.401 3.341 0 C-N-CA 123.588 2.859 . . . . 71.54 111.377 -163.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 185' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 9.0 t -89.48 -23.93 6.05 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.492 0 N-CA-C 108.146 -1.057 . . . . 72.23 108.146 -177.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 186' ' ' PHE . . . . . 0.484 ' HD2' HD13 ' C' ' 127' ' ' LEU . 48.4 m-85 -127.85 101.82 6.51 Favored 'General case' 0 C--N 1.352 0.704 0 C-N-CA 123.737 0.815 . . . . 61.44 109.266 -178.039 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 187' ' ' ARG . . . . . 0.473 ' HE ' ' HG2' ' C' ' 155' ' ' GLU . 27.9 ttm105 -97.72 110.65 23.17 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 124.557 1.143 . . . . 75.14 108.182 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 188' ' ' LEU . . . . . 0.593 ' HB3' ' HA ' ' C' ' 154' ' ' ARG . 59.5 tp -76.77 131.94 38.99 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.387 0.613 . . . . 74.14 112.6 -166.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -116.08 106.3 13.59 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.147 1.379 . . . . 71.33 108.377 167.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 66.85 -99.8 0.51 Allowed Glycine 0 C--N 1.348 1.239 0 CA-C-N 116.053 -0.521 . . . . 74.2 112.454 -178.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 191' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -117.53 -14.21 10.28 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 124.262 1.025 . . . . 60.21 110.183 175.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -101.32 128.71 47.36 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.678 1.191 . . . . 65.13 110.401 -173.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 193' ' ' LEU . . . . . 0.432 ' HG ' ' HA2' ' C' ' 239' ' ' GLY . 77.8 mt -73.74 153.75 39.89 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.828 0.851 . . . . 52.2 111.883 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 194' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -123.83 106.72 10.7 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 107.266 -1.383 . . . . 75.43 107.266 169.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 195' ' ' ALA . . . . . 0.461 ' HA ' ' O ' ' C' ' 185' ' ' VAL . . . -110.76 -177.91 3.34 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.286 1.034 . . . . 65.11 110.38 -174.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 90.2 m -137.75 121.12 17.05 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 108.638 -0.875 . . . . 51.32 108.638 164.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 197' ' ' LEU . . . . . . . . . . . . . 63.2 tp -100.48 143.5 30.59 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.586 1.155 . . . . 73.5 110.232 -175.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -100.61 101.59 12.53 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 123.656 0.782 . . . . 44.52 109.004 -178.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 199' ' ' VAL . . . . . 0.406 HG22 HG21 ' C' ' 210' ' ' VAL . 94.9 t -114.51 125.58 29.0 Favored Pre-proline 0 N--CA 1.486 1.354 0 C-N-CA 124.404 1.081 . . . . 61.21 109.864 -176.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 200' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -74.06 145.05 34.83 Favored 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 121.675 1.583 . . . . 71.34 111.125 174.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 201' ' ' ALA . . . . . 0.461 ' O ' HG23 ' C' ' 205' ' ' VAL . . . -58.66 -38.89 70.25 Favored Pre-proline 0 CA--C 1.552 1.024 0 N-CA-C 115.263 1.579 . . . . 74.35 115.263 -173.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 202' ' ' PRO . . . . . 0.542 ' O ' HG13 ' C' ' 206' ' ' VAL . 21.2 Cg_endo -59.13 -52.33 5.16 Favored 'Trans proline' 0 C--N 1.388 2.613 0 CA-C-N 121.711 1.647 . . . . 63.15 111.205 175.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 203' ' ' ILE . . . . . . . . . . . . . 43.4 mt -62.49 -28.25 44.36 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 C-N-CA 124.228 1.011 . . . . 63.4 110.737 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.62 -43.4 76.44 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.5 -0.773 . . . . 75.02 112.305 175.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 205' ' ' VAL . . . . . 0.538 HG11 HD11 ' A' ' 261' ' ' LEU . 65.2 t -69.39 -45.42 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 122.373 0.269 . . . . 63.41 110.964 -178.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 206' ' ' VAL . . . . . 0.542 HG13 ' O ' ' C' ' 202' ' ' PRO . 0.7 OUTLIER -96.58 -38.09 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 111.514 0.19 . . . . 52.12 111.514 -167.717 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 106.07 119.49 4.55 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 112.455 -0.258 . . . . 63.21 112.455 -173.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -156.44 -137.64 2.37 Favored Glycine 0 C--N 1.336 0.56 0 N-CA-C 109.79 -1.324 . . . . 51.32 109.79 176.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 209' ' ' LYS . . . . . 0.682 ' HG2' ' HA ' ' C' ' 222' ' ' ALA . 10.2 mtmp? -142.37 151.94 42.38 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 118.08 0.94 . . . . 72.12 111.712 177.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 210' ' ' VAL . . . . . 0.406 HG21 HG22 ' C' ' 199' ' ' VAL . 30.2 m -139.42 174.0 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 125.644 1.577 . . . . 62.05 108.516 174.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 211' ' ' ARG . . . . . 0.723 ' HE ' ' HB3' ' B' ' 234' ' ' ALA . 40.5 ttm-85 -109.66 127.64 54.7 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 118.431 0.56 . . . . 72.44 110.778 -176.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -107.97 113.14 26.11 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 107.335 -1.358 . . . . 74.43 107.335 169.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 213' ' ' MET . . . . . 0.677 ' HA ' ' HA ' ' C' ' 218' ' ' PRO . 4.2 ttp -80.28 98.95 7.63 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 108.954 -0.758 . . . . 63.12 108.954 -176.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.11 177.74 8.58 Favored 'General case' 0 C--O 1.244 0.798 0 O-C-N 123.342 0.401 . . . . 54.24 109.936 -174.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 215' ' ' LEU . . . . . 0.665 HD22 ' HB3' ' C' ' 127' ' ' LEU . 11.9 mt -52.68 -60.81 2.8 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.055 0.942 . . . . 44.41 110.506 -175.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -86.76 8.61 21.94 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.211 -0.904 . . . . 71.0 112.185 -174.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 142.07 157.03 7.0 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-O 119.925 -0.375 . . . . 64.11 113.307 177.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 218' ' ' PRO . . . . . 0.682 ' HB2' HH11 ' C' ' 211' ' ' ARG . 31.8 Cg_endo -63.22 121.99 10.03 Favored 'Trans proline' 0 C--N 1.364 1.389 0 C-N-CA 122.95 2.433 . . . . 52.13 115.322 177.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 219' ' ' VAL . . . . . . . . . . . . . 8.0 p -98.77 167.84 1.8 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.928 0 N-CA-C 107.05 -1.463 . . . . 52.53 107.05 170.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 220' ' ' GLU . . . . . 0.639 ' HB2' ' HB ' ' B' ' 236' ' ' THR . 3.0 tt0 -101.04 158.45 16.0 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 109.338 -0.616 . . . . 72.32 109.338 173.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 221' ' ' VAL . . . . . . . . . . . . . 33.3 t -121.97 123.22 68.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 125.2 1.4 . . . . 74.03 108.309 173.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 222' ' ' ALA . . . . . 0.682 ' HA ' ' HG2' ' C' ' 209' ' ' LYS . . . -84.15 101.92 12.19 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 123.118 0.567 . . . . 73.3 109.565 169.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 61.0 t -75.53 123.39 88.49 Favored Pre-proline 0 CA--C 1.549 0.91 0 CA-C-N 114.409 -1.269 . . . . 73.11 109.222 178.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 224' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -76.37 164.44 30.85 Favored 'Trans proline' 0 C--N 1.369 1.651 0 C-N-CA 123.552 2.835 . . . . 54.33 112.917 172.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -55.96 146.52 68.2 Favored 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 122.361 2.041 . . . . 74.0 112.684 165.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 226' ' ' ARG . . . . . 0.419 ' HG3' ' HA ' ' A' ' 259' ' ' GLU . 8.0 mpt_? 66.65 66.5 0.45 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.764 1.225 . . . . 70.15 110.814 171.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 227' ' ' THR . . . . . 0.533 ' HA ' ' HD3' ' C' ' 231' ' ' ARG . 16.7 m -114.89 121.79 44.29 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 114.697 -1.138 . . . . 70.3 110.779 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 228' ' ' GLN . . . . . 0.401 ' HB3' HD12 ' B' ' 29' ' ' LEU . 24.6 mp0 -111.27 163.01 14.4 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.922 0.889 . . . . 74.32 110.809 -178.177 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -77.18 111.43 12.79 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 114.403 -1.271 . . . . 62.12 109.965 -178.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 110.61 6.2 27.12 Favored Glycine 0 N--CA 1.476 1.311 0 CA-C-O 119.896 -0.391 . . . . 62.04 113.115 -169.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 231' ' ' ARG . . . . . 0.583 ' HG2' ' HA ' ' B' ' 30' ' ' GLU . 39.4 mtp85 -77.84 169.78 17.71 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 109.623 -0.51 . . . . 74.12 109.623 164.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 232' ' ' LYS . . . . . 0.466 ' HB2' ' HZ2' ' C' ' 232' ' ' LYS . 2.1 ttmp? -135.08 151.02 50.36 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.424 0.63 . . . . 71.45 112.461 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 233' ' ' LEU . . . . . 0.715 HD13 ' HB2' ' C' ' 251' ' ' LEU . 5.6 mp -113.96 157.21 22.75 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.672 1.589 . . . . 74.21 110.874 -176.084 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 28.5 ptt-85 -134.57 97.12 3.71 Favored 'General case' 0 CA--C 1.559 1.324 0 O-C-N 125.327 1.642 . . . . 72.34 110.65 173.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 235' ' ' LEU . . . . . 0.478 ' HB2' ' HB3' ' C' ' 249' ' ' LEU . 87.5 mt -93.29 104.44 16.61 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.9 0.88 . . . . 73.43 108.819 171.201 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 236' ' ' LYS . . . . . 0.471 ' HB3' HD11 ' B' ' 205' ' ' LEU . 29.3 mmmt -68.89 132.28 46.48 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.756 0.822 . . . . 71.55 112.184 -174.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 74.37 22.58 77.32 Favored Glycine 0 C--N 1.357 1.711 0 O-C-N 123.925 0.766 . . . . 71.42 113.965 177.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 238' ' ' LYS . . . . . 0.438 ' HE3' ' O ' ' B' ' 165' ' ' THR . 27.9 mmtm -115.79 17.96 15.88 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.462 0.705 . . . . 72.03 111.382 -178.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 239' ' ' GLY . . . . . 0.432 ' HA2' ' HG ' ' C' ' 193' ' ' LEU . . . -91.61 -159.04 35.13 Favored Glycine 0 C--N 1.349 1.252 0 O-C-N 123.421 0.45 . . . . 31.21 112.851 177.209 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 240' ' ' PHE . . . . . 0.71 ' HB3' ' HA2' ' C' ' 152' ' ' GLY . 4.4 m-85 -88.65 154.84 50.82 Favored Pre-proline 0 CA--C 1.551 0.997 0 CA-C-O 119.102 -0.475 . . . . 75.14 109.776 179.038 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 241' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -67.93 101.62 0.7 Allowed 'Trans proline' 0 C--N 1.387 2.596 0 C-N-CA 122.83 2.353 . . . . 70.21 110.66 177.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -94.12 167.86 28.14 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-N 115.623 -0.717 . . . . 70.14 112.152 177.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 243' ' ' PRO . . . . . 0.465 ' HD3' ' HB1' ' B' ' 195' ' ' ALA . 73.8 Cg_endo -70.02 -23.52 29.53 Favored 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 123.023 2.482 . . . . 71.42 111.412 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -99.0 27.34 5.09 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.318 1.047 . . . . 71.42 110.064 175.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 92.07 177.98 41.94 Favored Glycine 0 C--N 1.351 1.377 0 CA-C-N 115.918 -0.583 . . . . 51.32 112.186 -177.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 246' ' ' ARG . . . . . . . . . . . . . 80.1 mtm180 -72.48 138.21 46.87 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 122.699 0.399 . . . . 61.31 110.267 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -79.01 -155.54 9.07 Favored Glycine 0 C--N 1.344 1.025 0 O-C-N 123.857 0.723 . . . . 63.23 112.374 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -120.25 177.6 4.96 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 108.562 -0.903 . . . . 73.54 108.562 -175.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 249' ' ' LEU . . . . . 0.478 ' HB3' ' HB2' ' C' ' 235' ' ' LEU . 12.8 tp -119.7 109.28 15.45 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.877 -0.786 . . . . 74.23 108.877 177.138 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 250' ' ' TYR . . . . . 0.609 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 19.9 m-85 -101.5 105.57 16.58 Favored 'General case' 0 C--N 1.343 0.325 0 CA-C-N 115.901 -0.59 . . . . 71.43 109.605 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 251' ' ' LEU . . . . . 0.715 ' HB2' HD13 ' C' ' 233' ' ' LEU . 2.1 mp -99.71 149.47 23.29 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 109.595 -0.52 . . . . 64.53 109.595 -173.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -103.44 128.17 50.65 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.388 -0.967 . . . . 73.41 108.388 175.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 253' ' ' VAL . . . . . . . . . . . . . 95.1 t -74.15 133.28 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.172 0.589 . . . . 73.5 111.896 -172.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 254' ' ' ARG . . . . . 0.511 ' NH2' ' HB ' ' C' ' 256' ' ' THR . 1.3 tmm_? -122.27 94.98 4.47 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 107.321 -1.363 . . . . 74.13 107.321 176.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 255' ' ' ILE . . . . . 0.482 HD11 HG22 ' C' ' 227' ' ' THR . 46.6 mm -69.17 131.35 34.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 122.634 0.374 . . . . 75.24 110.459 177.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 256' ' ' THR . . . . . 0.511 ' HB ' ' NH2' ' C' ' 254' ' ' ARG . 0.0 OUTLIER -140.8 172.0 13.3 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.538 1.135 . . . . 53.32 111.153 -174.514 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 2.9 pp -130.96 154.18 81.94 Favored Pre-proline 0 CA--C 1.556 1.181 0 C-N-CA 124.351 1.06 . . . . 64.54 109.29 177.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -72.38 -2.62 11.99 Favored 'Trans proline' 0 C--N 1.377 2.065 0 C-N-CA 122.451 2.101 . . . . 73.21 113.631 -166.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 57.14 -72.12 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 125.229 1.412 . . . . 72.3 111.74 -166.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 260' ' ' ARG . . . . . 0.509 ' HD2' ' HD1' ' B' ' 340' ' ' PHE . 27.4 ptt180 -69.75 148.03 49.72 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.597 0.759 . . . . 73.41 111.103 177.251 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 261' ' ' LEU . . . . . 0.472 HD13 ' HA ' ' C' ' 266' ' ' GLU . 72.7 mt -138.35 141.47 39.69 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.243 0.617 . . . . 71.21 111.416 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 46.7 p -82.09 150.8 65.58 Favored Pre-proline 0 CA--C 1.545 0.771 0 N-CA-C 107.995 -1.113 . . . . 61.23 107.995 170.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -47.04 -39.46 25.43 Favored 'Trans proline' 0 N--CA 1.509 2.394 0 C-N-CA 123.77 2.98 . . . . 74.2 113.759 -177.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 264' ' ' GLU . . . . . 0.479 ' HG2' ' NH2' ' A' ' 279' ' ' ARG . 2.8 tp10 -55.89 -67.62 0.27 Allowed 'General case' 0 C--O 1.246 0.877 0 C-N-CA 124.578 1.151 . . . . 71.04 111.093 175.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -66.04 -28.63 69.0 Favored 'General case' 0 C--O 1.212 -0.885 0 CA-C-N 115.176 -0.92 . . . . 65.11 110.847 -173.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 266' ' ' GLU . . . . . 0.472 ' HA ' HD13 ' C' ' 261' ' ' LEU . 11.6 tp10 -57.88 -50.15 74.3 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.025 0.93 . . . . 64.21 109.575 174.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -60.4 -38.53 84.27 Favored 'General case' 0 CA--C 1.548 0.887 0 O-C-N 123.853 0.72 . . . . 70.32 111.592 176.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 268' ' ' LEU . . . . . . . . . . . . . 11.0 mp -65.06 -47.68 76.45 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 112.445 0.535 . . . . 52.44 112.445 177.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 269' ' ' TRP . . . . . 0.444 ' HH2' ' HD3' ' C' ' 202' ' ' PRO . 90.5 m95 -64.74 -33.42 75.92 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.302 0.641 . . . . 61.11 110.603 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 270' ' ' LYS . . . . . 0.4 ' NZ ' ' HB3' ' C' ' 270' ' ' LYS . 4.6 mmmp? -64.9 -48.64 73.47 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.739 0.816 . . . . 75.43 111.547 177.031 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 13.0 mmtm -65.74 -37.96 87.83 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.059 0.543 . . . . 75.33 111.917 179.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 272' ' ' LEU . . . . . 0.436 HD12 HD12 ' A' ' 272' ' ' LEU . 64.3 mt -76.53 -22.46 54.35 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.761 -0.654 . . . . 74.33 111.226 177.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -67.28 -47.04 71.82 Favored 'General case' 0 C--O 1.218 -0.572 0 N-CA-C 109.226 -0.657 . . . . 34.13 109.226 171.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -60.69 -37.36 81.38 Favored 'General case' 0 N--CA 1.483 1.215 0 O-C-N 124.291 0.994 . . . . 63.21 111.099 176.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -63.58 -37.2 86.43 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.625 0.77 . . . . 70.04 111.287 175.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 276' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -83.25 -22.33 33.09 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 116.311 -0.404 . . . . 75.52 112.077 178.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 20.8 m-30 -68.16 -35.93 78.84 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 108.408 -0.96 . . . . 44.24 108.408 172.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -59.39 -27.26 65.83 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 114.898 -1.047 . . . . 55.2 111.439 171.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 279' ' ' ARG . . . . . 0.489 ' HG2' ' H ' ' B' ' 89' ' ' GLY . 25.3 mtp-105 -74.95 -31.54 61.52 Favored 'General case' 0 C--N 1.364 1.236 0 N-CA-C 109.648 -0.501 . . . . 71.52 109.648 175.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 N-CA-C 109.185 -0.672 . . . . 75.14 109.185 -175.233 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.0 mtp . . . . . 0 N--CA 1.473 0.701 0 N-CA-C 109.711 -0.477 . . . . 64.12 109.711 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.93 40.95 28.49 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.904 1.282 . . . . 51.4 112.612 174.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.6 61.47 5.74 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 122.986 0.515 . . . . 74.04 110.146 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -38.49 113.37 0.29 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.88 1.672 . . . . 62.43 112.955 -177.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -89.42 129.12 35.98 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.663 0.785 . . . . 74.32 110.269 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -84.07 86.55 7.19 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 107.007 -1.479 . . . . 61.41 107.007 170.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.435 ' CD1' ' HA ' ' A' ' 53' ' ' ALA . 69.9 m-85 -61.0 -25.96 67.26 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 114.988 -1.005 . . . . 73.34 112.024 -174.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.506 ' HE1' ' HE2' ' A' ' 66' ' ' TYR . 49.3 m-85 -66.69 -52.54 43.58 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.602 -0.726 . . . . 73.33 109.581 175.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.61 -36.54 76.51 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.592 0.757 . . . . 60.32 110.885 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 69.8 mt -59.43 -44.16 92.07 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.097 0 C-N-CA 123.91 0.884 . . . . 74.23 110.943 174.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.5 mt -77.18 -6.95 54.91 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 112.515 0.561 . . . . 51.33 112.515 175.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.92 17.83 76.29 Favored Glycine 0 C--N 1.352 1.434 0 C-N-CA 122.961 0.315 . . . . 53.33 113.561 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.6 m -108.83 152.24 42.22 Favored Pre-proline 0 CA--C 1.554 1.125 0 C-N-CA 124.055 0.942 . . . . 71.43 110.008 176.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -86.41 172.72 6.88 Favored 'Trans proline' 0 C--N 1.368 1.599 0 C-N-CA 122.366 2.044 . . . . 50.12 112.928 178.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 11.9 mmt85 -68.85 78.48 0.31 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.127 -0.942 . . . . 75.43 109.345 172.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -174.37 -31.82 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 114.335 -1.302 . . . . 64.11 108.431 -172.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.43 120.92 15.29 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.624 -0.716 . . . . 64.31 111.304 -178.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 76.2 p -82.62 175.25 10.31 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.989 0.916 . . . . 71.11 110.027 174.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -47.96 -39.81 20.43 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 124.728 1.211 . . . . 64.21 113.033 -176.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.449 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 0.5 OUTLIER -69.35 -44.82 70.83 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.521 0.729 . . . . 72.43 109.796 -175.689 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -67.39 -34.69 77.78 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 124.036 0.935 . . . . 64.03 111.455 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.555 HD13 HD13 ' A' ' 57' ' ' LEU . 77.9 mt -67.23 -36.6 77.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.98 1.312 . . . . 73.31 110.461 175.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -69.84 -38.64 76.56 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.233 -0.894 . . . . 71.24 109.672 178.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 20' ' ' GLU . 94.9 mtt180 -60.25 -48.56 81.22 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.509 0.723 . . . . 54.12 109.896 175.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.81 -43.71 98.31 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 124.541 1.151 . . . . 64.0 111.668 -177.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -61.55 -54.81 38.17 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.55 -0.75 . . . . 73.1 110.638 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.434 ' HA ' ' HB3' ' A' ' 30' ' ' ALA . 57.3 mtpt -62.66 -32.73 73.84 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 124.119 0.887 . . . . 74.22 111.7 -177.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.405 ' HA ' ' NH2' ' A' ' 31' ' ' ARG . 14.9 ttt180 -57.99 -55.38 35.63 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.341 1.056 . . . . 71.15 110.058 174.02 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.635 ' HB3' HD13 ' A' ' 50' ' ' ILE . 78.8 mt -74.94 -15.13 60.7 Favored 'General case' 0 CA--C 1.552 1.026 0 CA-C-N 114.865 -1.061 . . . . 74.11 110.925 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.477 ' HA ' ' HE1' ' A' ' 47' ' ' PHE . . . -89.75 -12.0 40.6 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.032 0.933 . . . . 63.3 111.723 176.469 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.405 ' NH2' ' HA ' ' A' ' 28' ' ' ARG . 47.1 mtm105 -90.68 -42.93 10.45 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 109.714 -0.476 . . . . 72.33 109.714 167.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -68.68 -61.4 1.83 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.491 0.717 . . . . 63.33 111.345 -177.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -92.11 17.5 9.41 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.227 0.611 . . . . 63.25 112.211 -172.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 7.2 t-160 -57.38 101.85 0.28 Allowed Pre-proline 0 CA--C 1.555 1.156 0 C-N-CA 124.645 1.178 . . . . 63.41 111.654 -172.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.87 -32.03 75.78 Favored 'Trans proline' 0 C--N 1.388 2.65 0 C-N-CA 123.883 3.055 . . . . 74.13 113.71 -171.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -47.0 -43.68 19.61 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.609 1.164 . . . . 72.45 112.331 176.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 60.3 t -104.65 -24.77 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.665 0.786 . . . . 65.53 110.069 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -127.48 73.96 1.48 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.259 0.624 . . . . 61.35 110.474 -170.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -79.16 69.19 5.3 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 109.066 -0.716 . . . . 73.11 109.066 171.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.4 m -112.06 105.05 56.43 Favored Pre-proline 0 CA--C 1.535 0.38 0 N-CA-C 107.28 -1.378 . . . . 54.41 107.28 177.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -37.3 -49.38 1.72 Allowed 'Trans proline' 0 C--N 1.389 2.698 0 C-N-CA 124.689 3.593 . . . . 72.23 114.647 -173.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -51.95 -54.32 30.99 Favored 'General case' 0 N--CA 1.48 1.042 0 O-C-N 124.314 1.009 . . . . 64.43 111.086 177.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.09 -21.54 63.12 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 114.798 -1.092 . . . . 72.14 111.385 -177.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.475 ' O ' ' HD3' ' A' ' 48' ' ' LYS . 51.8 mt-10 -83.25 -38.69 21.88 Favored 'General case' 0 C--N 1.355 0.818 0 C-N-CA 122.824 0.45 . . . . 62.01 109.891 -176.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -65.73 -43.98 87.4 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.485 0.714 . . . . 62.44 109.445 175.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -58.62 -41.01 84.94 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 114.696 -1.138 . . . . 74.03 110.265 171.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.477 ' HE1' ' HA ' ' A' ' 30' ' ' ALA . 40.9 t80 -69.51 -25.32 63.99 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 123.407 0.442 . . . . 73.24 111.886 179.076 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.475 ' HD3' ' O ' ' A' ' 44' ' ' GLU . 2.0 mptm? -70.32 -39.13 74.95 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 109.944 -0.391 . . . . 75.14 109.944 174.103 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -63.43 -41.36 98.69 Favored 'General case' 0 CA--C 1.55 0.962 0 O-C-N 123.907 0.754 . . . . 71.44 110.568 174.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.635 HD13 ' HB3' ' A' ' 29' ' ' LEU . 69.4 mt -67.91 -40.53 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 124.621 1.168 . . . . 70.53 110.994 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -63.76 -41.03 98.05 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.261 -0.881 . . . . 73.43 110.379 174.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.426 ' O ' HG23 ' A' ' 56' ' ' VAL . 33.4 tt0 -61.27 -48.85 79.52 Favored 'General case' 0 C--O 1.246 0.906 0 C-N-CA 124.62 1.168 . . . . 63.42 110.591 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.435 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . . . -58.01 -48.07 81.15 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 114.163 -1.38 . . . . 65.45 111.564 -178.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -82.8 -14.52 54.26 Favored 'General case' 0 C--O 1.212 -0.915 0 CA-C-N 115.774 -0.648 . . . . 72.32 111.649 178.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.11 -35.62 81.7 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.777 0.799 . . . . 53.01 109.661 173.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.426 HG22 ' CE1' ' A' ' 101' ' ' PHE . 34.4 t -73.05 -58.7 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 CA-C-N 113.748 -1.569 . . . . 74.52 110.264 170.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.555 HD13 HD13 ' A' ' 22' ' ' ILE . 51.8 mt -90.11 15.09 10.83 Favored 'General case' 0 CA--C 1.558 1.256 0 CA-C-N 115.215 -0.902 . . . . 62.04 113.109 -166.031 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 44.2 t -67.01 -68.07 0.4 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.283 0.633 . . . . 74.34 109.806 173.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -80.95 135.82 51.29 Favored Pre-proline 0 C--O 1.238 0.456 0 CA-C-N 114.799 -1.091 . . . . 74.34 108.792 176.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.465 ' O ' ' HG2' ' A' ' 64' ' ' ARG . 51.3 Cg_exo -56.43 -28.32 72.54 Favored 'Trans proline' 0 C--N 1.369 1.627 0 C-N-CA 123.016 2.477 . . . . 72.41 112.082 170.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -71.29 -48.31 51.52 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.438 0.695 . . . . 72.3 111.285 -178.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.52 ' HA ' HD12 ' A' ' 65' ' ' ILE . 37.6 mtpt -70.87 -27.25 63.68 Favored 'General case' 0 C--O 1.257 1.493 0 CA-C-O 121.36 0.6 . . . . 74.54 110.934 178.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.425 HH21 ' CD1' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -65.58 -41.76 92.5 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 115.382 -0.827 . . . . 74.11 109.436 171.159 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.465 ' HG2' ' O ' ' A' ' 60' ' ' PRO . 4.5 mmp_? -59.22 -41.68 89.22 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.572 0.749 . . . . 74.25 110.734 176.272 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.612 ' HA ' ' HG2' ' A' ' 76' ' ' PRO . 91.0 mt -53.34 -51.12 43.78 Favored 'Isoleucine or valine' 0 C--O 1.251 1.15 0 C-N-CA 124.037 0.935 . . . . 64.42 110.57 175.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.506 ' HE2' ' HE1' ' A' ' 8' ' ' TYR . 37.9 t80 -58.2 -52.16 66.73 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 115.826 -0.624 . . . . 75.4 111.653 173.221 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -56.91 -33.74 67.23 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.144 0.978 . . . . 64.04 112.041 -173.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 40.5 p -91.42 -14.91 29.76 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.133 0.573 . . . . 75.13 112.214 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -72.1 125.41 27.19 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 107.513 -1.291 . . . . 63.45 107.513 166.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.84 23.91 29.11 Favored Glycine 0 N--CA 1.47 0.918 0 N-CA-C 111.281 -0.728 . . . . 52.54 111.281 -171.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 60.0 m -144.88 -57.67 0.35 Allowed 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 103.321 -2.844 . . . . 71.23 103.321 175.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 34.2 m -78.91 134.48 36.88 Favored 'General case' 0 C--O 1.25 1.099 0 N-CA-C 104.348 -2.464 . . . . 74.23 104.348 155.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.27 -31.78 67.9 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.396 0.678 . . . . 74.04 110.733 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -92.17 161.33 33.35 Favored Pre-proline 0 C--O 1.244 0.769 0 C-N-CA 124.177 0.991 . . . . 75.1 110.561 177.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -63.85 138.65 64.35 Favored 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 121.822 1.681 . . . . 75.41 110.172 164.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.612 ' HG2' ' HA ' ' A' ' 65' ' ' ILE . 82.6 Cg_exo -52.99 156.98 8.81 Favored 'Trans proline' 0 N--CA 1.501 1.917 0 C-N-CA 124.062 3.175 . . . . 74.25 114.77 178.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -58.27 124.87 16.86 Favored 'Trans proline' 0 C--N 1.385 2.483 0 C-N-CA 123.065 2.51 . . . . 62.44 112.382 -178.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -70.1 130.67 19.3 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 123.086 2.524 . . . . 43.51 112.245 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -60.91 142.64 98.2 Favored 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 122.827 2.351 . . . . 71.05 111.436 171.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.78 84.47 0.31 Allowed 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 122.83 2.353 . . . . 51.35 111.937 -177.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 165.85 -38.19 0.27 Allowed Glycine 0 C--N 1.333 0.383 0 CA-C-N 114.18 -1.373 . . . . 62.41 109.722 -177.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 113.29 -165.21 12.02 Favored Glycine 0 C--N 1.35 1.346 0 CA-C-N 115.212 -0.494 . . . . 53.03 112.921 176.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -109.58 108.43 18.87 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.125 0.97 . . . . 74.41 109.882 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -66.54 156.09 35.89 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.965 0.906 . . . . 71.31 111.369 173.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.555 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 59.9 m-85 -144.8 77.66 1.54 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.015 0.926 . . . . 70.22 110.491 -175.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.493 ' HB3' ' HG2' ' A' ' 162' ' ' PRO . 7.0 m -48.43 85.61 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.356 0 C-N-CA 125.596 1.558 . . . . 74.44 113.597 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.03 10.95 81.47 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-N 116.013 -0.539 . . . . 70.11 113.628 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.555 ' HB2' ' HB3' ' A' ' 85' ' ' PHE . 25.2 m-85 -104.25 103.57 13.35 Favored 'General case' 0 C--N 1.351 0.652 0 C-N-CA 123.211 0.604 . . . . 72.34 109.492 -175.48 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -82.55 83.29 7.63 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 121.469 0.652 . . . . 71.44 110.034 -174.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.3 p -44.56 -33.27 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 C-N-CA 126.058 1.743 . . . . 75.21 114.36 176.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.481 ' HB2' ' NH2' ' A' ' 114' ' ' ARG . 20.8 tp10 -55.99 -30.91 62.51 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.369 1.068 . . . . 75.33 111.647 -177.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -100.04 -6.65 26.09 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 123.787 0.835 . . . . 45.35 111.334 -175.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 12.8 m-30 -86.41 176.83 7.67 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 123.632 0.773 . . . . 71.01 110.929 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 91.9 p -67.56 161.39 25.7 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 113.161 0.8 . . . . 74.5 113.161 -169.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.85 -39.09 90.64 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 114.788 -1.096 . . . . 74.31 111.437 174.149 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -61.64 -40.39 94.71 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 122.655 0.382 . . . . 75.03 110.343 177.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.418 ' CD1' ' HG3' ' A' ' 52' ' ' GLU . 61.0 t80 -62.0 -41.46 98.08 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-O 121.493 0.663 . . . . 63.23 109.624 176.291 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -80.54 -1.22 41.01 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 114.693 -1.139 . . . . 73.05 112.531 177.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -100.15 -44.35 6.01 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 123.682 0.793 . . . . 70.02 111.872 170.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 24.7 tp -64.58 -47.68 77.81 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.454 1.101 . . . . 55.03 109.803 178.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.426 ' CE1' HG22 ' A' ' 56' ' ' VAL . 98.5 m-85 -92.65 -7.04 48.03 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.375 -0.83 . . . . 72.11 111.272 177.187 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -45.7 -58.89 5.16 Favored Glycine 0 CA--C 1.538 1.492 0 C-N-CA 124.458 1.028 . . . . 72.43 115.668 -177.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -61.9 -8.7 12.22 Favored 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 123.042 2.495 . . . . 23.1 114.046 -176.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -139.85 32.77 2.18 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-O 119.658 -0.523 . . . . 44.4 112.74 175.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.1 mt -68.34 22.47 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 115.007 1.484 . . . . 74.25 115.007 -177.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.511 ' HB3' ' ND2' ' A' ' 169' ' ' ASN . 0.2 OUTLIER 55.83 -107.34 0.38 Allowed 'General case' 0 CA--C 1.566 1.56 0 C-N-CA 124.06 0.944 . . . . 72.25 110.779 164.583 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 67.26 16.68 67.29 Favored Glycine 0 C--N 1.361 1.925 0 CA-C-O 120.043 -0.309 . . . . 44.0 113.479 -179.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.469 ' H ' ' HD1' ' A' ' 106' ' ' PHE . . . 62.35 -98.62 0.21 Allowed Glycine 0 C--N 1.352 1.438 0 N-CA-C 111.414 -0.674 . . . . 71.34 111.414 -171.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -134.34 4.83 3.46 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.973 0.909 . . . . 64.11 110.326 176.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -81.19 -13.86 80.06 Favored Glycine 0 C--N 1.352 1.466 0 CA-C-O 119.914 -0.381 . . . . 55.25 113.128 176.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 52.3 mtt180 75.02 -43.26 0.51 Allowed 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 126.666 1.986 . . . . 71.44 113.655 175.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 43.0 ttt180 -87.94 44.75 1.22 Allowed 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.223 0.609 . . . . 73.25 110.533 -172.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 36.5 m 46.9 57.03 6.0 Favored 'General case' 0 C--N 1.359 1.021 0 C-N-CA 124.648 1.179 . . . . 74.21 112.244 167.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.481 ' NH2' ' HB2' ' A' ' 91' ' ' GLU . 0.0 OUTLIER -116.76 161.83 18.64 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 111.812 0.301 . . . . 74.52 111.812 -168.443 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.432 ' HA ' ' O ' ' A' ' 170' ' ' PRO . 34.8 ttmt -68.9 138.03 54.32 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.687 0.795 . . . . 72.15 113.142 -164.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -97.77 -170.98 32.82 Favored Glycine 0 CA--C 1.544 1.867 0 CA-C-N 115.316 -0.856 . . . . 55.22 113.716 176.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.545 ' NH2' ' HB3' ' B' ' 13' ' ' LEU . 7.2 tmm_? -110.21 140.28 44.5 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.327 1.051 . . . . 71.34 111.049 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -44.09 104.11 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 125.393 1.477 . . . . 74.23 112.953 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.44 ' O ' HD12 ' A' ' 174' ' ' LEU . 5.3 tt -100.39 144.53 29.28 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.209 -0.905 . . . . 70.23 108.788 -171.226 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.57 ' HD2' ' HB2' ' A' ' 175' ' ' LEU . 16.4 tpt180 -96.67 142.64 28.47 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 108.58 -0.896 . . . . 74.51 108.58 -178.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.559 ' HB2' HD11 ' A' ' 174' ' ' LEU . . . -139.62 166.98 23.15 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 118.737 0.698 . . . . 41.51 111.279 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.448 ' HB2' ' HB3' ' B' ' 9' ' ' ALA . 8.1 mm-40 -120.45 101.31 7.69 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 106.193 -1.78 . . . . 61.0 106.193 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.534 HD22 HD13 ' A' ' 176' ' ' LEU . 15.3 tp -99.1 101.87 13.85 Favored Pre-proline 0 C--O 1.215 -0.732 0 N-CA-C 107.918 -1.142 . . . . 54.05 107.918 -177.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.494 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 41.8 Cg_endo -64.63 150.3 88.42 Favored 'Trans proline' 0 C--N 1.368 1.592 0 N-CA-C 108.972 -1.203 . . . . 75.33 108.972 171.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.619 ' HA ' HG21 ' B' ' 6' ' ' ILE . 16.7 tp -152.12 145.99 25.16 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 119.294 0.952 . . . . 64.01 112.152 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 49.2 m -77.47 126.76 31.42 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 114.669 -1.151 . . . . 71.34 109.307 175.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.666 ' HB3' HD22 ' A' ' 215' ' ' LEU . 3.1 mm? -43.86 -55.88 4.24 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 125.955 1.702 . . . . 70.54 112.973 -176.055 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 -59.52 -45.47 91.64 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 114.42 -1.264 . . . . 75.32 109.917 -176.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -77.19 -11.81 59.87 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.376 -0.829 . . . . 64.33 111.976 -177.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.602 ' HB1' ' O ' ' A' ' 153' ' ' VAL . . . -79.24 -41.81 27.39 Favored 'General case' 0 C--O 1.251 1.181 0 CA-C-O 122.0 0.905 . . . . 41.43 109.433 175.293 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -67.99 -40.04 83.14 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 114.204 -1.362 . . . . 74.51 110.813 172.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 38.9 m170 -77.86 -43.74 29.34 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.386 0.674 . . . . 75.25 111.92 -173.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.474 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 74.7 -163.61 54.38 Favored Glycine 0 CA--C 1.533 1.209 0 N-CA-C 114.386 0.514 . . . . 71.54 114.386 178.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 102.42 -168.01 18.31 Favored Glycine 0 N--CA 1.477 1.42 0 C-N-CA 123.612 0.625 . . . . 70.42 112.743 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 11.1 mp0 -68.56 102.82 1.54 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.368 0.667 . . . . 73.14 109.442 176.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 4.2 tpp180 -94.05 122.71 36.84 Favored 'General case' 0 C--O 1.245 0.819 0 C-N-CA 123.413 0.685 . . . . 74.4 109.616 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 59.4 t -78.35 109.45 13.0 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 N-CA-C 108.99 -0.744 . . . . 71.24 108.99 176.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.484 HG13 HG13 ' A' ' 145' ' ' VAL . 3.0 p -133.19 122.43 45.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 124.3 1.04 . . . . 73.14 108.673 178.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -107.56 136.93 46.5 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.262 0.625 . . . . 71.3 109.403 -175.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.589 ' HB ' ' HB3' ' B' ' 8' ' ' LEU . 7.6 p -152.29 132.34 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.445 0.698 . . . . 75.1 109.995 178.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 62.31 22.95 13.55 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.389 1.076 . . . . 74.24 112.091 176.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 87.42 10.78 70.16 Favored Glycine 0 C--N 1.346 1.115 0 CA-C-O 119.872 -0.404 . . . . 31.1 113.181 -178.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.13 99.17 6.44 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 108.359 -0.978 . . . . 72.12 108.359 -176.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 19.2 ttt180 -71.55 92.58 1.14 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.51 1.124 . . . . 74.41 109.969 176.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.484 HG13 HG13 ' A' ' 138' ' ' VAL . 7.7 p -92.94 133.74 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-O 121.065 0.459 . . . . 73.53 110.406 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 32.8 t -98.52 85.45 3.37 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 108.57 -0.9 . . . . 31.45 108.57 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 96.3 t -81.62 113.08 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 109.166 -0.679 . . . . 73.42 109.166 -176.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 60.5 ttt85 -68.41 93.7 0.5 Allowed 'General case' 0 C--O 1.241 0.655 0 N-CA-C 108.894 -0.78 . . . . 74.14 108.894 172.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.474 HG13 ' HA2' ' A' ' 133' ' ' GLY . 47.5 pt -78.68 135.72 59.81 Favored Pre-proline 0 CA--C 1.551 0.99 0 CA-C-N 115.035 -0.984 . . . . 74.13 108.933 178.068 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -58.92 128.7 28.88 Favored 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 122.445 2.097 . . . . 60.34 111.539 174.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.84 92.48 0.05 OUTLIER 'Trans proline' 0 C--N 1.382 2.294 0 C-N-CA 122.655 2.236 . . . . 74.15 110.979 170.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 125.92 66.84 0.17 Allowed Glycine 0 C--N 1.336 0.529 0 C-N-CA 121.127 -0.559 . . . . 75.51 111.851 -167.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.602 ' O ' ' HB1' ' A' ' 130' ' ' ALA . 7.5 p -140.78 139.88 33.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 N-CA-C 107.351 -1.352 . . . . 75.43 107.351 171.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.594 ' HG3' ' HE2' ' A' ' 240' ' ' PHE . 52.0 mtt85 -153.02 173.59 15.23 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.072 0.949 . . . . 73.23 109.194 174.425 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.57 ' HB3' ' H ' ' A' ' 188' ' ' LEU . 16.7 tp10 -35.38 122.31 0.61 Allowed 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 126.505 1.922 . . . . 72.32 114.975 -168.088 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 93.15 -13.38 67.78 Favored Glycine 0 C--N 1.342 0.871 0 CA-C-O 119.655 -0.525 . . . . 14.21 114.174 176.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.464 ' O ' HG12 ' A' ' 178' ' ' VAL . 17.9 t -71.39 139.29 49.72 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 109.274 -0.639 . . . . 74.23 109.274 175.238 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 71.2 t -105.55 119.53 54.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 123.565 0.746 . . . . 72.34 109.131 -178.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.545 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 60.4 mt -98.49 115.19 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 N-CA-C 108.394 -0.965 . . . . 75.24 108.394 174.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -78.3 106.0 9.93 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 109.068 -0.716 . . . . 61.32 109.068 173.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 13.3 p -113.6 113.01 48.09 Favored Pre-proline 0 CA--C 1.556 1.205 0 N-CA-C 109.417 -0.586 . . . . 61.33 109.417 173.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.493 ' HG2' ' HB3' ' A' ' 86' ' ' SER . 43.2 Cg_endo -68.88 139.73 44.15 Favored 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 122.672 2.248 . . . . 74.53 113.042 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.457 ' N ' ' HB3' ' A' ' 171' ' ' PRO . . . 109.67 -26.68 13.75 Favored Glycine 0 N--CA 1.476 1.335 0 C-N-CA 123.442 0.544 . . . . 70.43 113.689 167.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.472 ' SD ' ' N ' ' A' ' 164' ' ' MET . 1.3 mpt? -95.67 -31.06 13.43 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.232 0.613 . . . . 64.15 109.9 -177.304 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.494 ' N ' ' HB2' ' A' ' 174' ' ' LEU . . . -94.32 153.39 21.03 Favored Glycine 0 CA--C 1.492 -1.4 0 N-CA-C 108.742 -1.743 . . . . 73.33 108.742 168.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.826 ' HA3' ' HA3' ' A' ' 172' ' ' GLY . . . 53.44 80.54 0.07 OUTLIER Glycine 0 CA--C 1.475 -2.407 0 CA-C-O 118.872 -0.96 . . . . 74.5 112.968 -162.129 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 10.5 mm-40 -56.52 105.11 0.18 Allowed 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 128.149 2.911 . . . . 75.42 109.059 -178.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -176.89 -140.61 3.66 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.096 -1.602 . . . . 64.21 109.096 -172.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ASN . . . . . 0.511 ' ND2' ' HB3' ' A' ' 106' ' ' PHE . 0.7 OUTLIER -133.04 -54.28 0.02 OUTLIER Pre-proline 0 N--CA 1.484 1.232 0 CA-C-N 117.613 0.707 . . . . 63.11 109.608 176.421 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.432 ' O ' ' HA ' ' A' ' 115' ' ' LYS . 19.1 Cg_exo -67.74 123.44 10.73 Favored 'Trans proline' 0 C--N 1.388 2.625 0 N-CA-C 106.44 -2.177 . . . . 71.13 106.44 159.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.457 ' HB3' ' N ' ' A' ' 163' ' ' GLY . 41.1 Cg_endo -63.43 141.24 80.19 Favored 'Trans proline' 0 N--CA 1.483 0.874 0 C-N-CA 122.508 2.139 . . . . 71.25 114.858 -164.342 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.826 ' HA3' ' HA3' ' A' ' 166' ' ' GLY . . . -79.52 -26.41 56.92 Favored Glycine 0 C--N 1.348 1.217 0 C-N-CA 119.553 -1.308 . . . . 72.4 111.924 159.416 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 89.24 137.37 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 127.385 2.274 . . . . 71.14 110.116 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.559 HD11 ' HB2' ' A' ' 121' ' ' ALA . 24.5 tp -111.21 136.89 49.62 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.26 0.624 . . . . 64.32 110.16 -174.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.57 ' HB2' ' HD2' ' A' ' 120' ' ' ARG . 59.2 mt -105.75 84.79 2.12 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.239 1.015 . . . . 72.12 109.102 -178.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.545 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 95.4 mt -69.03 100.38 1.22 Allowed 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 115.204 -0.907 . . . . 70.05 110.812 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 57.7 t -84.52 102.5 10.56 Favored 'Isoleucine or valine' 0 C--O 1.242 0.69 0 N-CA-C 107.726 -1.213 . . . . 61.43 107.726 173.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 9.1 p -69.37 122.53 21.03 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.211 0 CA-C-N 115.48 -0.782 . . . . 70.33 111.254 -173.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.494 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 23.6 mmt180 -112.44 93.58 4.51 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.449 1.5 . . . . 53.32 108.217 -178.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.561 HD13 HD13 ' A' ' 127' ' ' LEU . 22.4 mt -70.19 149.39 47.56 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.428 0.529 . . . . 72.4 112.428 -175.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 77.9 mt -59.44 159.68 15.95 Favored Pre-proline 0 CA--C 1.554 1.127 0 C-N-CA 124.49 1.116 . . . . 73.14 111.71 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -70.8 32.98 0.23 Allowed 'Trans proline' 0 C--N 1.384 2.439 0 C-N-CA 123.365 2.71 . . . . 71.42 114.7 175.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.493 ' HB3' ' HG ' ' A' ' 127' ' ' LEU . 56.2 t-80 -67.39 106.53 1.26 Allowed Pre-proline 0 CA--C 1.553 1.091 0 C-N-CA 125.165 1.386 . . . . 73.35 107.533 165.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -75.39 24.51 0.4 Allowed 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 123.877 3.051 . . . . 61.24 115.683 -163.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 97.5 t -97.94 -61.76 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 122.595 0.358 . . . . 64.21 111.165 -173.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 14.6 m-30 -124.31 140.52 52.88 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 121.604 0.716 . . . . 72.31 111.937 -171.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -139.02 141.8 38.29 Favored 'General case' 0 C--O 1.215 -0.734 0 C-N-CA 125.883 1.673 . . . . 75.51 106.557 171.012 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.624 HD12 ' HA ' ' A' ' 193' ' ' LEU . 5.4 tp -106.36 176.3 5.21 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 107.211 -1.404 . . . . 74.21 107.211 178.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.598 ' HG3' ' H ' ' B' ' 302' ' ' ASP . 6.9 tp10 -163.16 128.08 3.05 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 109.019 -0.734 . . . . 70.31 109.019 168.219 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 69.0 -74.19 0.36 Allowed Glycine 0 C--N 1.349 1.256 0 N-CA-C 111.005 -0.838 . . . . 65.41 111.005 -169.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -163.81 -2.42 0.03 OUTLIER 'General case' 0 CA--C 1.564 1.495 0 C-N-CA 124.115 0.966 . . . . 72.32 110.996 173.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -98.62 150.88 21.29 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 122.818 0.447 . . . . 72.32 110.599 -178.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.624 ' HA ' HD12 ' A' ' 188' ' ' LEU . 0.4 OUTLIER -88.81 155.93 19.26 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.347 1.059 . . . . 63.44 110.796 -167.112 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -142.57 151.31 41.43 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.642 1.577 . . . . 73.14 108.134 173.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.437 ' HB3' HD23 ' A' ' 251' ' ' LEU . . . -152.72 136.68 16.33 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.168 0.987 . . . . 74.34 108.662 177.014 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 32.2 m -77.79 133.69 38.18 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 118.008 0.367 . . . . 70.21 110.026 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 32.3 tp -134.01 97.59 3.92 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.047 0.539 . . . . 72.21 110.262 -176.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -85.71 121.42 28.35 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 108.723 -0.843 . . . . 61.43 108.723 170.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 7.7 p -138.25 137.37 20.66 Favored Pre-proline 0 N--CA 1.482 1.164 0 C-N-CA 123.754 0.822 . . . . 64.4 109.179 -171.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -72.32 153.97 56.19 Favored 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 121.607 1.538 . . . . 64.51 111.386 177.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.4 ' HB3' ' HH2' ' A' ' 269' ' ' TRP . . . -50.98 -50.91 72.08 Favored Pre-proline 0 CA--C 1.553 1.076 0 N-CA-C 114.696 1.369 . . . . 71.34 114.696 -171.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.563 ' HG2' ' HE1' ' C' ' 276' ' ' TYR . 47.6 Cg_exo -61.2 -37.78 71.53 Favored 'Trans proline' 0 C--N 1.386 2.552 0 C-N-CA 121.851 1.7 . . . . 63.54 113.969 -179.179 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.531 HD11 ' HB3' ' C' ' 276' ' ' TYR . 34.9 mt -67.2 -37.64 79.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 N-CA-C 109.754 -0.462 . . . . 64.32 109.754 176.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.06 -42.83 88.94 Favored 'General case' 0 CA--C 1.554 1.127 0 CA-C-N 115.571 -0.741 . . . . 71.51 111.688 177.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 54.3 t -70.21 -48.49 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 124.081 0.952 . . . . 63.23 111.435 -176.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 57.7 t -85.14 -39.24 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-N 115.137 -0.938 . . . . 74.41 111.781 -170.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 97.67 90.08 1.9 Allowed Glycine 0 C--O 1.242 0.638 0 N-CA-C 110.873 -0.891 . . . . 72.35 110.873 -171.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.524 ' HA3' HG23 ' A' ' 203' ' ' ILE . . . -115.49 -151.48 9.91 Favored Glycine 0 C--N 1.339 0.735 0 CA-C-N 115.468 -0.366 . . . . 55.24 113.54 -175.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.521 ' HD2' ' SD ' ' B' ' 422' ' ' MET . 27.1 mtmt -137.55 132.41 33.12 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.311 -0.625 . . . . 45.21 109.311 -176.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 30.9 m -134.39 149.84 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 108.512 -0.922 . . . . 63.11 108.512 173.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' ARG . . . . . 0.529 ' HD2' ' HA ' ' B' ' 385' ' ' LEU . 30.7 ttm180 -87.12 113.3 22.75 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 109.019 -0.734 . . . . 71.41 109.019 178.002 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.55 165.57 11.17 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.02 0.928 . . . . 62.04 110.052 -176.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' MET . . . . . 0.464 ' SD ' ' N ' ' A' ' 213' ' ' MET . 0.0 OUTLIER -98.21 151.9 19.95 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 115.658 -0.701 . . . . 71.23 109.455 -175.712 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 63.8 p -133.13 -173.82 3.31 Favored 'General case' 0 C--O 1.242 0.697 0 C-N-CA 124.814 1.246 . . . . 74.1 107.721 167.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.666 HD22 ' HB3' ' A' ' 127' ' ' LEU . 28.4 mt -81.12 -26.6 36.04 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.133 0.573 . . . . 63.31 109.901 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -87.64 -17.44 31.86 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 114.977 -1.01 . . . . 64.44 111.723 -176.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 149.34 -156.83 26.98 Favored Glycine 0 C--N 1.344 1.016 0 CA-C-O 119.35 -0.694 . . . . 33.0 111.687 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -87.61 139.92 5.03 Favored 'Trans proline' 0 C--N 1.365 1.395 0 C-N-CA 122.641 2.227 . . . . 70.23 112.055 173.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 35.1 m -132.14 169.66 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.791 1.236 . . . . 73.4 107.796 171.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -111.92 134.46 53.46 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 121.726 -0.609 . . . . 75.04 111.372 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 7.5 p -119.51 140.22 44.23 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 124.745 1.218 . . . . 74.13 109.352 -176.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.525 ' HB3' ' HA ' ' B' ' 440' ' ' ARG . . . -103.62 103.2 13.11 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.971 0.508 . . . . 60.25 110.05 -178.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.592 ' HA ' HD12 ' B' ' 441' ' ' ILE . 70.5 t -58.8 140.78 85.83 Favored Pre-proline 0 CA--C 1.567 1.614 0 C-N-CA 125.432 1.493 . . . . 63.14 110.7 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -84.72 170.47 10.12 Favored 'Trans proline' 0 C--N 1.387 2.604 0 C-N-CA 123.25 2.634 . . . . 75.51 111.549 177.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.16 148.08 30.51 Favored 'Trans proline' 0 C--N 1.368 1.558 0 C-N-CA 121.748 1.632 . . . . 72.53 113.155 174.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 63.3 mtt85 63.62 32.34 14.0 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 125.329 1.451 . . . . 74.04 111.978 175.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.48 HG23 HD21 ' A' ' 233' ' ' LEU . 90.8 m -62.31 106.68 0.78 Allowed 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 113.689 -1.596 . . . . 64.32 110.498 172.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -95.53 151.37 19.37 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.389 0.675 . . . . 75.32 110.888 -170.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -62.27 117.84 6.63 Favored 'General case' 0 C--N 1.351 0.669 0 C-N-CA 123.981 0.912 . . . . 62.31 110.774 177.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 105.51 -23.64 29.46 Favored Glycine 0 C--N 1.34 0.805 0 CA-C-N 115.903 -0.589 . . . . 73.32 112.885 178.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 231' ' ' ARG . 46.5 mtt180 -72.79 136.25 45.4 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-O 121.552 0.691 . . . . 74.0 110.944 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.727 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 39.3 mttm -101.14 112.0 24.36 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 114.09 -1.413 . . . . 72.22 109.299 -179.061 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.536 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 45.9 mt -75.86 100.94 4.95 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.068 0.947 . . . . 71.4 110.175 -172.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 57.1 ttt180 -73.26 125.22 27.28 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.529 1.132 . . . . 64.14 110.895 -172.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.505 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 76.7 mt -118.74 107.25 13.43 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.19 0.996 . . . . 61.12 109.614 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 3.5 mmmp? -60.93 126.06 25.99 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 113.127 0.788 . . . . 64.43 113.127 -172.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 73.6 33.64 57.96 Favored Glycine 0 C--N 1.354 1.543 0 O-C-N 123.852 0.72 . . . . 74.2 114.05 173.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -114.58 -18.31 11.47 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.242 0.617 . . . . 73.01 111.387 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -81.9 -170.14 44.03 Favored Glycine 0 C--N 1.346 1.128 0 N-CA-C 112.004 -0.438 . . . . 74.43 112.004 170.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' PHE . . . . . 0.594 ' HE2' ' HG3' ' A' ' 154' ' ' ARG . 9.9 m-85 -94.69 154.92 39.9 Favored Pre-proline 0 N--CA 1.478 0.965 0 C-N-CA 122.844 0.457 . . . . 73.13 112.149 -170.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -66.65 123.06 10.58 Favored 'Trans proline' 0 C--N 1.387 2.595 0 C-N-CA 123.216 2.611 . . . . 73.33 112.831 -178.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -151.42 -150.03 5.22 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-O 119.368 -0.685 . . . . 73.52 112.426 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -65.06 -29.84 56.56 Favored 'Trans proline' 0 C--N 1.378 2.108 0 C-N-CA 123.249 2.633 . . . . 70.45 113.179 -175.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -87.59 20.77 2.79 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.8 0.84 . . . . 70.11 111.57 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 85.55 -89.76 1.63 Allowed Glycine 0 C--N 1.35 1.332 0 N-CA-C 109.736 -1.346 . . . . 62.24 109.736 -173.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 59.1 mtm180 -127.12 157.56 39.36 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.045 0.938 . . . . 75.41 109.109 165.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -81.38 179.78 53.35 Favored Glycine 0 C--O 1.241 0.561 0 CA-C-N 115.736 -0.665 . . . . 42.24 112.179 178.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -125.27 154.26 41.96 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.725 0.81 . . . . 75.44 109.085 -179.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.562 HD13 HD13 ' A' ' 193' ' ' LEU . 40.1 tp -96.64 112.22 24.05 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 109.466 -0.568 . . . . 70.31 109.466 -179.143 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.727 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 22.0 m-85 -97.79 105.84 18.05 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.577 1.151 . . . . 52.51 109.307 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.536 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 16.4 mt -79.6 98.8 7.04 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 109.67 -0.493 . . . . 72.24 109.67 175.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -77.34 103.52 7.32 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 108.465 -0.939 . . . . 75.41 108.465 -175.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.456 HG11 HG22 ' A' ' 227' ' ' THR . 56.6 t -87.73 144.07 9.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 N-CA-C 114.259 1.207 . . . . 24.43 114.259 -166.04 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 6.7 mmm180 -128.32 113.61 15.83 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.475 1.51 . . . . 73.14 107.619 165.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 62.1 mt -75.96 138.88 19.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 122.986 0.515 . . . . 74.34 109.747 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 46.7 p -124.11 175.82 6.76 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 124.709 1.204 . . . . 73.43 109.304 177.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 257' ' ' ILE . . . . . 0.48 ' HB ' ' HD2' ' A' ' 258' ' ' PRO . 28.6 pt -121.82 164.72 23.41 Favored Pre-proline 0 CA--C 1.556 1.189 0 C-N-CA 123.762 0.825 . . . . 73.4 109.286 175.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 258' ' ' PRO . . . . . 0.48 ' HD2' ' HB ' ' A' ' 257' ' ' ILE . 60.8 Cg_endo -69.65 6.53 1.24 Allowed 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 122.687 2.258 . . . . 74.45 114.851 177.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.478 ' HG3' ' NE2' ' C' ' 228' ' ' GLN . 0.8 OUTLIER 49.35 -96.79 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.615 0.766 . . . . 63.24 109.494 -161.012 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.93 158.56 19.88 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.086 0.954 . . . . 75.12 110.778 -173.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.456 HD13 ' HA ' ' A' ' 266' ' ' GLU . 67.9 mt -135.64 -178.04 4.94 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.732 0.813 . . . . 55.32 110.719 -175.018 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 5.2 p -133.52 146.44 60.6 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 124.697 1.199 . . . . 44.34 109.033 176.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -17.69 -60.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.393 2.918 1 C-N-CA 127.402 5.401 . . . . 74.33 118.037 -168.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -65.03 -59.36 4.23 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.036 0.534 . . . . 71.44 111.197 -175.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -62.91 -29.69 70.97 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.712 0.805 . . . . 64.2 110.659 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 266' ' ' GLU . . . . . 0.456 ' HA ' HD13 ' A' ' 261' ' ' LEU . 8.6 tp10 -57.71 -54.74 43.48 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 124.236 1.015 . . . . 73.45 109.433 175.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -64.34 -33.41 75.77 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 114.681 -1.145 . . . . 64.12 111.691 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 8.8 mp -61.42 -52.22 65.46 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.0 0.52 . . . . 73.14 111.429 177.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 269' ' ' TRP . . . . . 0.4 ' HH2' ' HB3' ' A' ' 201' ' ' ALA . 61.2 m95 -61.7 -38.82 89.27 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.344 0.658 . . . . 75.0 111.805 178.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 270' ' ' LYS . . . . . 0.465 ' HE2' HG23 ' C' ' 206' ' ' VAL . 1.0 OUTLIER -67.55 -40.22 84.99 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.758 -0.655 . . . . 62.43 111.368 179.278 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -64.3 -41.93 96.61 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.071 0.548 . . . . 70.22 110.521 175.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 272' ' ' LEU . . . . . 0.499 ' O ' ' HB2' ' A' ' 276' ' ' TYR . 51.8 mt -55.5 -45.96 77.02 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 124.012 0.82 . . . . 63.4 110.574 175.178 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -77.13 -32.92 56.76 Favored 'General case' 0 C--O 1.246 0.874 0 O-C-N 124.389 1.055 . . . . 64.51 113.005 -173.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -72.47 -48.09 43.61 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.318 0.647 . . . . 74.35 110.061 177.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 275' ' ' ALA . . . . . 0.448 ' HB1' ' NH2' ' A' ' 279' ' ' ARG . . . -71.97 -20.77 61.68 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.51 0.724 . . . . 71.44 111.225 177.041 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 276' ' ' TYR . . . . . 0.499 ' HB2' ' O ' ' A' ' 272' ' ' LEU . 21.7 t80 -63.14 -64.96 0.76 Allowed 'General case' 0 C--N 1.356 0.884 0 C-N-CA 123.803 0.841 . . . . 75.02 108.847 171.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -63.32 -40.6 97.76 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.316 -0.856 . . . . 70.12 110.432 -172.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 278' ' ' ALA . . . . . 0.47 ' HB1' ' HG2' ' B' ' 275' ' ' LYS . . . -59.35 -30.72 68.59 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.659 0.784 . . . . 75.41 111.834 176.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 279' ' ' ARG . . . . . 0.448 ' NH2' ' HB1' ' A' ' 275' ' ' ALA . 23.6 mtm180 -118.22 34.74 5.04 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.347 0.659 . . . . 74.13 109.855 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.386 0 N-CA-C 109.235 -0.654 . . . . 72.21 109.235 174.439 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.478 0.974 0 N-CA-C 109.283 -0.636 . . . . 71.44 109.283 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 59.5 tttp 71.34 115.57 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.772 1.229 . . . . 54.1 112.052 -176.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 66.4 48.34 1.58 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.575 1.55 . . . . 74.04 111.533 170.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 25.5 m -67.5 -22.74 65.44 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 114.816 -1.084 . . . . 52.14 110.574 172.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 2.5 m 71.29 150.37 0.09 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.793 1.637 . . . . 70.11 111.469 176.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.619 HG21 ' HA ' ' A' ' 125' ' ' LEU . 36.5 pt -136.97 167.67 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 113.146 0.795 . . . . 64.44 113.146 -162.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -145.57 124.33 12.61 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.274 1.03 . . . . 72.01 109.647 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.589 ' HB3' ' HB ' ' A' ' 140' ' ' VAL . 44.2 tp -74.26 150.47 40.23 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.168 0.987 . . . . 75.22 111.264 -172.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 9' ' ' ALA . . . . . 0.448 ' HB3' ' HB2' ' A' ' 122' ' ' GLU . . . -90.74 -50.32 5.97 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.192 0.597 . . . . 62.4 112.117 -178.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 84.8 mt 66.65 115.61 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 124.677 1.191 . . . . 74.1 111.678 -170.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 56.2 mt -109.01 102.28 48.07 Favored Pre-proline 0 CA--C 1.553 1.062 0 N-CA-C 108.007 -1.108 . . . . 45.35 108.007 171.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -52.39 -69.21 0.06 OUTLIER 'Trans proline' 0 C--N 1.382 2.301 0 C-N-CA 123.283 2.655 . . . . 61.33 112.461 -175.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 13' ' ' LEU . . . . . 0.545 ' HB3' ' NH2' ' A' ' 117' ' ' ARG . 2.1 pt? -162.59 140.78 8.56 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.93 -0.766 . . . . 75.01 108.93 175.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 94.4 mt 69.96 -16.38 0.29 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.854 1.262 . . . . 64.54 113.981 175.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -80.15 87.66 5.48 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-O 121.612 0.72 . . . . 60.01 109.478 -177.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 61.4 m -134.7 125.22 17.33 Favored Pre-proline 0 CA--C 1.542 0.64 0 N-CA-C 107.549 -1.278 . . . . 51.11 107.549 178.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.12 76.44 0.12 Allowed 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 123.242 2.628 . . . . 62.42 113.986 -176.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 62.0 t -137.55 87.7 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.2 1.0 . . . . 61.41 109.351 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 5.5 m 61.68 12.76 4.81 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 124.665 1.186 . . . . 71.22 113.31 167.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -160.2 -72.0 0.07 Allowed 'General case' 0 N--CA 1.474 0.748 0 O-C-N 121.502 -0.749 . . . . 62.34 111.026 -174.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.26 77.8 3.79 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.22 0.608 . . . . 75.34 111.279 -171.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? 56.25 93.62 0.03 OUTLIER 'General case' 0 C--N 1.356 0.868 0 C-N-CA 125.328 1.451 . . . . 73.31 110.175 -172.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 23' ' ' THR . . . . . 0.619 HG21 HD13 ' B' ' 218' ' ' LEU . 26.8 m -95.95 114.33 63.92 Favored Pre-proline 0 CA--C 1.546 0.824 0 N-CA-C 108.938 -0.764 . . . . 72.45 108.938 176.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -61.26 -38.52 65.1 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 123.091 2.528 . . . . 74.55 112.394 178.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 25' ' ' GLU . . . . . 0.504 ' HG2' ' HB2' ' B' ' 219' ' ' ASN . 10.9 tp10 -72.39 116.03 12.34 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.664 -0.698 . . . . 74.53 109.726 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 27.0 ttt -172.89 -48.23 0.0 OUTLIER Pre-proline 0 CA--C 1.561 1.402 0 C-N-CA 124.461 1.105 . . . . 75.13 110.407 -174.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -70.07 163.1 39.77 Favored 'Trans proline' 0 C--N 1.395 3.026 0 C-N-CA 121.938 1.759 . . . . 71.1 111.957 173.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 61.8 t 76.98 -34.41 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 C-N-CA 125.867 1.667 . . . . 73.51 110.741 -174.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 50.8 mt -68.62 167.92 14.14 Favored 'General case' 0 C--O 1.246 0.912 0 C-N-CA 124.421 1.088 . . . . 62.2 111.517 171.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 62.51 35.23 14.75 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.324 1.049 . . . . 70.24 111.066 -176.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -66.75 108.65 2.58 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.616 0.767 . . . . 74.34 110.905 -177.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 2.9 mpp_? -87.45 -10.33 52.18 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 123.837 0.855 . . . . 72.22 111.666 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -73.14 -72.37 0.26 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.418 0.687 . . . . 73.31 111.204 -174.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -116.99 109.44 17.01 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.834 0.854 . . . . 53.33 109.163 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -165.63 71.36 0.15 Allowed 'General case' 0 C--N 1.356 0.868 0 CA-C-O 121.75 0.786 . . . . 73.13 110.251 -178.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 36' ' ' GLY . . . . . 0.506 ' HA2' ' HA2' ' C' ' 247' ' ' GLY . . . 64.14 -120.61 20.38 Favored Glycine 0 C--N 1.345 1.07 0 CA-C-N 114.753 -1.112 . . . . 74.33 114.195 177.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -62.17 -28.21 69.5 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.016 0.926 . . . . 61.44 113.365 -175.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 11.3 tt -65.87 -27.63 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 CA-C-O 120.74 0.305 . . . . 75.44 111.054 -175.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 12.1 t -103.41 -32.78 9.35 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.532 0.733 . . . . 64.25 110.946 178.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -166.85 105.25 0.64 Allowed Pre-proline 0 N--CA 1.476 0.842 0 C-N-CA 123.839 0.856 . . . . 64.0 109.53 -178.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -71.35 71.5 2.37 Favored 'Trans proline' 0 C--N 1.376 2.001 0 C-N-CA 123.135 2.557 . . . . 72.44 112.348 175.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 63.55 -89.61 0.07 OUTLIER Glycine 0 C--N 1.351 1.381 0 CA-C-N 115.571 -0.74 . . . . 45.24 112.835 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 178.37 21.05 0.03 OUTLIER Glycine 0 CA--C 1.527 0.813 0 C-N-CA 123.356 0.503 . . . . 42.15 112.037 177.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . 61.18 -78.78 0.02 OUTLIER 'General case' 0 C--N 1.363 1.159 0 C-N-CA 125.067 1.347 . . . . 63.2 110.351 -169.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -68.47 127.7 33.95 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.398 0.679 . . . . 74.21 109.207 170.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 5.1 tmm_? -76.78 -28.03 55.51 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 108.629 -0.878 . . . . 75.02 108.629 174.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 29.5 tp 79.63 -35.83 0.15 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 126.377 1.871 . . . . 53.22 112.956 168.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 3.8 m 68.72 9.67 7.47 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 124.329 1.052 . . . . 51.22 111.262 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.58 24.27 63.14 Favored Glycine 0 C--N 1.349 1.281 0 CA-C-N 115.94 -0.573 . . . . 74.15 112.287 -173.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -77.49 146.08 36.65 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.42 0.688 . . . . 64.2 110.764 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -135.2 4.55 3.21 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.998 0.919 . . . . 75.3 110.032 178.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 5.0 m 57.7 30.15 18.44 Favored 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 124.771 1.228 . . . . 73.31 111.514 177.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.42 107.11 2.32 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 122.904 0.481 . . . . 73.24 110.615 -177.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . 68.12 6.26 5.13 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.005 1.322 . . . . 75.51 112.02 -176.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 25.9 tp 57.08 25.18 10.49 Favored 'General case' 0 CA--C 1.564 1.49 0 C-N-CA 124.748 1.219 . . . . 72.35 110.302 -172.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 83.0 mtt85 -134.37 177.53 7.68 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.248 1.019 . . . . 73.2 110.957 -173.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -65.69 -8.63 21.79 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 125.224 1.41 . . . . 75.31 113.058 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 34.9 t -55.37 -22.54 19.99 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 124.602 1.161 . . . . 62.01 113.074 178.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -67.94 -33.78 75.33 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-O 121.02 0.438 . . . . 72.44 111.439 178.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 2.7 t -94.98 114.59 26.43 Favored 'General case' 0 C--O 1.244 0.773 0 N-CA-C 108.255 -1.017 . . . . 63.51 108.255 -171.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -72.28 147.58 46.27 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.777 0.831 . . . . 71.45 111.698 -170.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 62' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm 57.69 75.85 0.52 Allowed Pre-proline 0 CA--C 1.552 1.031 0 C-N-CA 125.476 1.51 . . . . 72.3 112.614 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -70.94 -0.38 7.8 Favored 'Trans proline' 0 C--N 1.38 2.197 0 C-N-CA 123.418 2.745 . . . . 72.24 112.904 168.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 73.33 -76.91 0.06 Allowed 'General case' 0 C--N 1.362 1.135 0 C-N-CA 126.041 1.736 . . . . 72.04 111.66 174.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -112.37 -10.74 13.75 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.546 0.738 . . . . 65.32 111.039 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 71.61 151.51 0.11 Allowed 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 124.758 1.223 . . . . 72.41 111.446 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 12.2 tt 44.59 41.73 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 C-N-CA 126.821 2.048 . . . . 72.03 112.873 176.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 20.2 pt -81.8 67.58 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.111 0 CA-C-N 114.695 -1.139 . . . . 73.4 111.175 -176.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 85.4 mt -77.68 119.88 21.83 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.225 -0.898 . . . . 73.12 109.863 -176.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mp 67.43 -74.81 0.07 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 125.586 1.554 . . . . 44.44 110.663 -178.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 12.9 tt -143.61 102.63 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 124.289 1.036 . . . . 74.32 108.615 177.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -88.32 27.08 7.19 Favored Glycine 0 C--N 1.348 1.232 0 CA-C-N 115.978 -0.555 . . . . 62.21 112.319 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -113.22 -1.73 14.26 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.95 1.3 . . . . 63.44 110.239 -175.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 105.08 169.82 24.11 Favored Glycine 0 C--N 1.352 1.46 0 N-CA-C 111.446 -0.662 . . . . 64.42 111.446 -174.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 75' ' ' MET . . . . . 0.433 ' N ' ' SD ' ' B' ' 75' ' ' MET . 0.4 OUTLIER -91.38 65.35 5.3 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 122.256 1.027 . . . . 74.01 110.459 -177.352 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . -128.99 49.9 0.91 Allowed Glycine 0 C--N 1.334 0.417 0 N-CA-C 109.014 -1.634 . . . . 71.13 109.014 171.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -50.45 -63.19 1.2 Allowed 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.488 1.515 . . . . 73.03 111.977 -170.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 38.7 p 50.98 -74.07 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 125.939 1.695 . . . . 51.1 113.42 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 79' ' ' GLU . . . . . 0.451 ' HG3' HG12 ' B' ' 80' ' ' ILE . 14.2 tp10 71.29 -86.54 0.03 OUTLIER 'General case' 0 C--N 1.357 0.895 0 C-N-CA 125.157 1.383 . . . . 74.44 110.131 176.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.451 HG12 ' HG3' ' B' ' 79' ' ' GLU . 35.8 pt -145.52 -162.78 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 124.708 1.203 . . . . 72.52 107.839 179.026 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 50.0 m -56.96 140.63 48.14 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 108.969 -0.752 . . . . 71.34 108.969 165.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -49.91 93.26 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.175 0.99 . . . . 61.11 111.817 -175.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -159.29 -62.53 0.07 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.723 1.209 . . . . 71.35 108.783 -175.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -84.9 75.78 10.33 Favored 'General case' 0 C--N 1.355 0.837 0 N-CA-C 108.657 -0.868 . . . . 73.0 108.657 172.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -113.73 -68.33 0.93 Allowed 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 107.087 -1.449 . . . . 72.23 107.087 176.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 27.6 t80 63.78 151.88 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 125.19 1.396 . . . . 63.12 112.944 173.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . 62.31 -163.85 0.26 Allowed 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.595 1.158 . . . . 52.24 110.744 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 72.82 -69.79 0.18 Allowed 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 125.156 1.382 . . . . 74.14 110.001 177.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 166.11 -38.36 0.26 Allowed Glycine 0 C--N 1.336 0.538 0 N-CA-C 110.542 -1.023 . . . . 54.33 110.542 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.15 -34.09 73.07 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.767 0.827 . . . . 62.33 111.953 178.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -131.83 77.44 0.39 Allowed Glycine 0 C--N 1.348 1.224 0 N-CA-C 111.776 -0.529 . . . . 70.11 111.776 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.26 -59.71 9.53 Favored Glycine 0 C--N 1.35 1.33 0 CA-C-N 116.761 0.281 . . . . 23.53 112.598 178.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 32.0 t80 50.63 68.74 0.72 Allowed 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.534 1.534 . . . . 74.22 111.274 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -78.12 -9.41 59.15 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 114.479 -1.237 . . . . 71.21 111.357 -178.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 46.9 mttp 75.38 -24.94 0.21 Allowed 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 126.077 1.751 . . . . 74.14 113.281 169.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 80.53 -2.41 78.34 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-O 119.431 -0.649 . . . . 72.31 112.805 -171.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 97' ' ' ILE . . . . . 0.514 ' HA ' HD12 ' B' ' 100' ' ' LEU . 14.0 tt -62.67 -24.83 36.58 Favored 'Isoleucine or valine' 0 C--N 1.362 1.137 0 C-N-CA 124.334 1.053 . . . . 72.22 111.596 -172.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -59.42 132.25 53.42 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.683 0.793 . . . . 75.21 110.357 173.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . 71.88 2.97 4.5 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 124.73 1.212 . . . . 61.12 113.393 175.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 100' ' ' LEU . . . . . 0.514 HD12 ' HA ' ' B' ' 97' ' ' ILE . 79.6 mt -82.41 -41.1 0.93 Allowed Pre-proline 0 CA--C 1.56 1.363 0 CA-C-O 118.079 -0.962 . . . . 74.2 112.268 173.017 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -59.78 108.75 0.5 Allowed 'Trans proline' 0 C--N 1.398 3.134 0 C-N-CA 121.9 1.733 . . . . 72.21 111.861 171.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 59.1 tp -63.92 138.63 58.56 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 115.56 -0.746 . . . . 73.12 109.855 176.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 40.0 m -69.63 91.84 0.62 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.198 0.599 . . . . 75.52 110.148 178.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . -73.85 127.49 10.38 Favored Glycine 0 C--N 1.343 0.953 0 CA-C-N 114.803 -1.089 . . . . 51.35 111.293 176.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 26.3 mp0 -69.06 -29.41 67.53 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.124 0.97 . . . . 75.22 110.427 178.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 85.3 t80 78.11 -36.85 0.22 Allowed 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 125.626 1.571 . . . . 74.44 112.868 171.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 58.7 p -78.91 84.19 4.96 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 124.397 1.079 . . . . 63.32 111.764 -173.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 63.2 m80 68.17 125.58 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.886 1.674 . . . . 71.44 113.298 173.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.448 ' HD2' ' HA3' ' B' ' 202' ' ' GLY . 89.2 m-85 -127.58 40.98 3.6 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.195 0.998 . . . . 53.33 108.859 173.213 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -73.81 90.41 1.88 Allowed 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 114.562 -1.199 . . . . 71.24 110.779 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 4.4 pp -82.54 137.64 34.53 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.112 0.565 . . . . 64.15 110.72 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 67.75 -67.94 0.17 Allowed 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 126.137 1.775 . . . . 73.2 111.792 178.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 113' ' ' LYS . . . . . 0.725 ' HG2' ' HB2' ' C' ' 36' ' ' ASP . 18.5 tppt? 80.69 -63.97 0.19 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.236 1.814 . . . . 75.13 112.542 173.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.93 94.2 2.68 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-O 121.994 0.902 . . . . 74.01 112.105 -174.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 25.5 m -150.31 89.64 1.59 Allowed 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 108.345 -0.983 . . . . 73.23 108.345 174.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 62.06 -114.88 7.22 Favored Glycine 0 C--N 1.362 2.025 0 CA-C-O 118.584 -1.12 . . . . 55.33 110.568 -173.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 107.69 -69.95 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.814 0 C-N-CA 126.766 2.026 . . . . 70.25 115.426 156.264 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 118' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -56.94 -64.04 0.14 Allowed 'Trans proline' 0 C--N 1.402 3.389 0 C-N-CA 122.635 2.223 . . . . 60.53 114.743 -166.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 119' ' ' ASP . . . . . . . . . . . . . 37.9 t70 64.64 -75.88 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.895 1.278 . . . . 75.33 110.73 -173.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 120' ' ' TYR . . . . . 0.405 ' OH ' ' HD2' ' C' ' 160' ' ' ARG . 33.4 m-85 56.81 79.97 0.17 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 125.176 1.39 . . . . 70.1 112.245 177.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 24.9 m -100.86 -20.43 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 CA-C-N 115.427 -0.806 . . . . 74.32 110.182 170.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 33.1 m 55.42 77.13 0.23 Allowed 'General case' 0 C--N 1.358 0.95 0 C-N-CA 125.014 1.326 . . . . 75.24 110.082 -172.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -82.48 152.74 25.95 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 114.642 -1.163 . . . . 64.3 110.997 -175.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 92.4 p 53.32 -160.11 0.13 Allowed 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 125.967 1.707 . . . . 43.31 112.73 176.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -143.98 -67.62 0.34 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.588 0.755 . . . . 73.02 110.165 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -169.57 -168.08 0.75 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.936 0.894 . . . . 74.13 109.888 -179.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 127' ' ' SER . . . . . 0.403 ' OG ' ' HA ' ' B' ' 186' ' ' THR . 66.9 m -134.33 -64.52 0.68 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.179 0.992 . . . . 70.01 109.232 178.002 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -140.86 65.63 1.39 Allowed 'General case' 0 C--O 1.238 0.45 0 N-CA-C 108.295 -1.002 . . . . 72.01 108.295 177.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 9.0 t -63.26 130.9 46.5 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 115.282 -0.872 . . . . 54.34 111.012 -172.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 130' ' ' ALA . . . . . 0.443 ' H ' ' HG3' ' C' ' 179' ' ' ARG . . . 74.85 124.64 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 126.032 1.733 . . . . 44.22 110.214 -165.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 23.3 t90 76.33 -60.15 0.49 Allowed 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 125.546 1.539 . . . . 73.51 111.993 177.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 36.6 m 76.58 -61.82 0.43 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 125.501 1.52 . . . . 51.4 113.996 169.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 26.5 m -68.92 89.57 0.41 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.323 1.049 . . . . 62.25 111.644 -172.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 119.29 -11.93 11.38 Favored Glycine 0 N--CA 1.476 1.334 0 CA-C-N 115.991 -0.55 . . . . 55.15 113.004 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 135' ' ' VAL . . . . . . . . . . . . . 36.2 t 69.25 -79.3 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 125.553 1.541 . . . . 73.24 112.529 174.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 136' ' ' LYS . . . . . 0.427 ' HE3' HG23 ' B' ' 153' ' ' THR . 24.3 ttmm 57.99 47.12 15.39 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.416 1.087 . . . . 52.43 110.76 178.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 68.4 p 61.62 -3.23 0.22 Allowed 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 126.274 1.83 . . . . 75.31 115.127 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 36.1 p90 39.41 -64.4 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.32 0 C-N-CA 127.932 2.493 . . . . 75.52 116.366 -177.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 13.3 m120 66.89 24.43 9.7 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 125.275 1.43 . . . . 73.24 112.093 177.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . 84.72 -63.23 4.44 Favored Glycine 0 C--N 1.341 0.833 0 CA-C-N 115.544 -0.753 . . . . 65.04 112.494 174.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . 66.62 101.51 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.969 1.307 . . . . 75.34 110.263 -174.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -143.53 -167.44 2.57 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.756 0.822 . . . . 70.15 109.23 -175.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 167.86 -47.8 0.24 Allowed Glycine 0 C--N 1.348 1.206 0 N-CA-C 111.928 -0.469 . . . . 61.25 111.928 176.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 72.0 t 76.68 -50.29 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 C-N-CA 125.705 1.602 . . . . 75.31 111.16 178.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -83.11 -34.54 26.07 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.054 0.941 . . . . 64.3 109.775 169.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 2.8 pp -128.95 -169.72 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 124.38 1.072 . . . . 72.52 109.625 175.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 35.3 p-80 -149.72 145.28 26.59 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.213 0.605 . . . . 72.43 110.409 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 63.24 -78.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 125.508 1.523 . . . . 73.05 112.903 170.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 149' ' ' LYS . . . . . . . . . . . . . 56.4 tttm 70.27 -85.29 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 125.71 1.604 . . . . 72.23 113.361 173.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -100.67 -51.92 3.46 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 113.197 0.814 . . . . 74.11 113.197 -165.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -79.36 -55.25 0.91 Allowed Pre-proline 0 CA--C 1.567 1.617 0 N-CA-C 114.605 1.335 . . . . 74.43 114.605 -165.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -57.16 89.93 0.05 OUTLIER 'Trans proline' 0 C--N 1.393 2.885 0 C-N-CA 123.042 2.495 . . . . 42.51 115.014 -166.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 153' ' ' THR . . . . . 0.427 HG23 ' HE3' ' B' ' 136' ' ' LYS . 3.4 m 56.18 27.38 11.53 Favored 'General case' 0 CA--C 1.559 1.3 0 C-N-CA 125.561 1.544 . . . . 74.2 113.38 167.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 50.3 mm -71.87 -33.87 49.39 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 CA-C-N 115.543 -0.753 . . . . 74.25 109.591 176.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 1.8 tt -89.0 54.51 3.02 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 124.362 1.065 . . . . 72.1 108.964 175.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -165.63 -110.26 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.056 0 CA-C-O 119.045 -0.502 . . . . 72.23 109.689 173.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 157' ' ' MET . . . . . . . . . . . . . 24.3 ptt? -172.26 -43.14 0.02 OUTLIER 'General case' 0 C--N 1.363 1.183 0 C-N-CA 123.493 0.717 . . . . 53.54 110.508 -172.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 158' ' ' ALA . . . . . . . . . . . . . . . -83.53 75.24 10.04 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 121.517 0.675 . . . . 34.04 109.462 -176.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -121.8 -71.13 0.74 Allowed 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 106.951 -1.5 . . . . 55.45 106.951 -174.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . 176.77 97.68 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.398 1.479 . . . . 70.22 107.471 177.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -168.31 25.32 0.03 OUTLIER 'General case' 0 C--O 1.246 0.887 0 O-C-N 123.622 0.576 . . . . 71.1 111.08 -171.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . -65.18 -48.03 74.54 Favored Glycine 0 C--N 1.35 1.327 0 N-CA-C 111.409 -0.677 . . . . 73.4 111.409 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 163' ' ' LEU . . . . . 0.463 HD12 ' HB3' ' B' ' 173' ' ' LEU . 49.7 tp 68.21 -78.24 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 124.728 1.211 . . . . 65.02 111.963 166.47 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 164' ' ' ALA . . . . . . . . . . . . . . . -89.26 -12.86 39.51 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.483 0.713 . . . . 75.34 111.229 177.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 15.2 t -129.41 165.9 20.64 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.661 0.784 . . . . 64.15 110.194 -177.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . 134.17 164.35 10.6 Favored Glycine 0 C--N 1.345 1.078 0 N-CA-C 111.425 -0.67 . . . . 71.15 111.425 -177.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 167' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -80.51 119.05 22.67 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.151 0.581 . . . . 72.31 109.89 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 77.8 t 72.75 -69.76 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 125.915 1.686 . . . . 74.13 111.386 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 34.4 t 63.13 -88.74 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 125.024 1.33 . . . . 54.35 110.036 -178.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 42.7 m 71.03 -55.02 0.66 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 125.637 1.575 . . . . 63.1 113.868 174.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 171' ' ' ALA . . . . . 0.401 ' HB2' ' HG2' ' C' ' 128' ' ' GLU . . . -64.37 171.25 3.24 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.758 0.823 . . . . 53.32 111.615 176.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 172' ' ' GLU . . . . . 0.546 ' HB3' ' HG2' ' C' ' 213' ' ' MET . 10.8 tp10 -60.79 87.96 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.058 0.943 . . . . 73.22 111.532 -173.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 173' ' ' LEU . . . . . 0.463 ' HB3' HD12 ' B' ' 163' ' ' LEU . 84.2 mt 62.4 14.4 6.86 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.107 1.363 . . . . 74.23 112.964 177.193 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 174' ' ' GLN . . . . . 0.427 ' NE2' ' SD ' ' B' ' 286' ' ' MET . 27.1 mm-40 -91.97 101.33 13.89 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.367 0.667 . . . . 74.45 109.97 -175.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 175' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -93.06 159.03 15.48 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.861 0.865 . . . . 74.1 111.045 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -169.85 166.28 9.56 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.463 1.105 . . . . 74.11 109.937 175.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 33.5 p -132.54 78.34 67.57 Favored Pre-proline 0 CA--C 1.559 1.323 0 C-N-CA 123.847 0.859 . . . . 64.31 109.862 172.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 178' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -79.46 148.41 20.75 Favored 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 122.425 2.083 . . . . 74.53 111.696 174.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -83.72 65.43 8.52 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.116 0.566 . . . . 61.34 110.111 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . 70.94 -34.77 0.31 Allowed 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 126.438 1.895 . . . . 74.4 113.304 -173.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 181' ' ' LEU . . . . . 0.519 HD22 ' HB2' ' C' ' 136' ' ' ARG . 60.5 tp -161.29 -71.75 0.06 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.139 0.976 . . . . 62.04 108.928 170.206 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 182' ' ' VAL . . . . . . . . . . . . . 49.2 t -86.71 131.08 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 109.263 -0.643 . . . . 71.31 109.263 177.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -66.19 -56.83 9.39 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 123.908 0.755 . . . . 65.24 111.263 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -169.52 178.73 4.08 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-O 121.64 0.733 . . . . 74.15 111.173 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 185' ' ' VAL . . . . . 0.442 ' O ' ' HG2' ' B' ' 188' ' ' ARG . 1.9 p -130.19 122.03 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 107.564 -1.273 . . . . 71.33 107.564 160.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 186' ' ' THR . . . . . 0.403 ' HA ' ' OG ' ' B' ' 127' ' ' SER . 50.0 p 49.04 -96.26 0.03 OUTLIER 'General case' 0 CA--C 1.565 1.526 0 C-N-CA 124.941 1.296 . . . . 51.31 113.389 172.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 187' ' ' SER . . . . . . . . . . . . . 56.7 m -140.51 88.58 2.21 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.592 0.757 . . . . 62.14 109.793 -177.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 188' ' ' ARG . . . . . 0.442 ' HG2' ' O ' ' B' ' 185' ' ' VAL . 13.7 mmt180 -132.34 -178.39 4.89 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.126 0.97 . . . . 71.52 109.571 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -96.98 178.85 5.14 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.879 0.872 . . . . 72.52 110.202 171.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 190' ' ' CYS . . . . . 0.479 ' SG ' ' NZ ' ' B' ' 337' ' ' LYS . 45.6 t -153.52 165.0 37.25 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.899 0.88 . . . . 70.33 109.69 178.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -148.31 168.07 23.52 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.888 0.875 . . . . 74.04 109.746 -170.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -68.78 153.65 53.0 Favored Glycine 0 C--N 1.352 1.439 0 CA-C-O 118.889 -0.95 . . . . 64.22 112.429 174.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 193' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -57.24 150.61 56.9 Favored 'Trans proline' 0 N--CA 1.504 2.13 0 C-N-CA 123.817 3.011 . . . . 64.32 113.896 -169.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 194' ' ' SER . . . . . . . . . . . . . 21.8 m -151.37 118.72 5.98 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.719 0.808 . . . . 24.51 109.821 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 195' ' ' ALA . . . . . . . . . . . . . . . -162.53 164.76 26.73 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.794 0.838 . . . . 74.32 110.093 177.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 99.4 m -106.88 -67.5 0.94 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.353 0.661 . . . . 73.32 110.087 177.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 49.5 m -153.7 -48.85 0.09 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.134 0.974 . . . . 75.11 108.61 -177.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 198' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 60.19 -81.9 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 125.969 1.708 . . . . 51.12 110.237 178.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 199' ' ' LYS . . . . . 0.456 ' HE2' ' HA ' ' B' ' 199' ' ' LYS . 0.6 OUTLIER 70.88 -19.02 0.24 Allowed 'General case' 0 CA--C 1.562 1.411 0 N-CA-C 115.144 1.535 . . . . 74.4 115.144 163.211 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 200' ' ' CYS . . . . . . . . . . . . . 69.2 m -67.09 105.6 0.91 Allowed Pre-proline 0 CA--C 1.56 1.34 0 C-N-CA 124.062 0.945 . . . . 73.31 112.43 -171.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 201' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -105.01 10.3 0.24 Allowed 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 123.591 2.861 . . . . 71.34 114.053 -178.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 202' ' ' GLY . . . . . 0.448 ' HA3' ' HD2' ' B' ' 109' ' ' TYR . . . -79.23 -7.44 88.47 Favored Glycine 0 C--N 1.353 1.492 0 CA-C-O 119.14 -0.811 . . . . 63.04 114.539 -170.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 64.6 t30 66.84 173.18 0.25 Allowed 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.312 1.045 . . . . 71.33 111.766 173.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -61.4 -53.6 54.52 Favored 'General case' 0 C--N 1.351 0.65 0 C-N-CA 123.336 0.654 . . . . 74.01 109.622 167.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 205' ' ' LEU . . . . . . . . . . . . . 4.5 tt 54.5 92.47 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.936 1.294 . . . . 51.03 110.666 173.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.54 -88.41 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.332 0 CA-C-O 119.386 -0.34 . . . . 62.32 110.424 175.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 35.0 mmtm -145.48 -41.88 0.22 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.427 0.691 . . . . 74.32 110.471 177.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . -78.31 -31.1 47.87 Favored Glycine 0 C--N 1.346 1.102 0 O-C-N 123.137 0.273 . . . . 71.52 113.242 -178.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 114.96 -21.37 13.57 Favored Glycine 0 N--CA 1.474 1.184 0 N-CA-C 111.622 -0.591 . . . . 42.21 111.622 -176.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 49.9 tttm -172.12 118.6 0.4 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.306 1.442 . . . . 74.51 107.709 178.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . -156.63 147.68 16.48 Favored Glycine 0 C--N 1.344 0.992 0 CA-C-O 119.535 -0.592 . . . . 74.43 111.739 -179.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 40.6 t 55.93 94.59 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 125.331 1.453 . . . . 74.04 111.918 -176.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 10.1 tp -72.46 -28.64 28.83 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 CA-C-N 116.109 -0.496 . . . . 64.4 110.388 177.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 24.2 m 61.66 -80.79 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 125.509 1.524 . . . . 75.43 111.53 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 215' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -152.12 4.11 0.39 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.692 0.797 . . . . 73.31 111.209 -178.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -70.05 141.91 52.78 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.6 0.76 . . . . 61.42 110.008 176.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 217' ' ' LEU . . . . . 0.584 HD12 ' H ' ' B' ' 218' ' ' LEU 0.324 4.0 pp 51.53 -71.53 0.01 OUTLIER 'General case' 0 CA--C 1.57 1.73 0 C-N-CA 126.772 2.029 . . . . 75.4 114.421 -178.662 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 218' ' ' LEU . . . . . 0.619 HD13 HG21 ' B' ' 23' ' ' THR . 88.8 mt 61.13 -77.75 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 125.857 1.663 . . . . 71.43 111.824 -177.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 219' ' ' ASN . . . . . 0.504 ' HB2' ' HG2' ' B' ' 25' ' ' GLU . 21.7 t-20 -160.47 154.12 22.43 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 108.148 -1.056 . . . . 71.24 108.148 174.022 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -134.89 -171.27 2.75 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.975 0.91 . . . . 61.1 110.214 -175.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 221' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -68.36 -71.01 0.23 Allowed 'General case' 0 C--N 1.351 0.638 0 N-CA-C 107.416 -1.327 . . . . 73.55 107.416 171.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 222' ' ' ALA . . . . . 0.66 ' HB3' ' HE ' ' C' ' 187' ' ' ARG . . . 39.87 66.05 0.64 Allowed 'General case' 0 C--N 1.368 1.39 0 C-N-CA 124.952 1.301 . . . . 42.52 111.228 178.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -86.35 -166.18 1.47 Allowed 'General case' 0 C--O 1.243 0.717 0 CA-C-N 114.09 -1.414 . . . . 61.02 111.948 -163.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 33.6 m -61.73 -31.23 50.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 115.477 -0.783 . . . . 74.2 112.529 -177.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 225' ' ' THR . . . . . 0.411 HG21 HG22 ' C' ' 185' ' ' VAL . 63.1 m 76.22 -53.44 0.61 Allowed 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.896 1.678 . . . . 54.34 113.215 177.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 1.4 tm? 68.38 83.89 0.16 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.205 1.402 . . . . 74.43 107.619 -168.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . -160.65 24.52 0.27 Allowed Glycine 0 C--N 1.344 1.014 0 CA-C-N 115.784 -0.643 . . . . 51.31 112.535 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . -86.98 -106.35 0.84 Allowed Glycine 0 C--N 1.353 1.482 0 N-CA-C 111.535 -0.626 . . . . 72.41 111.535 174.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . 63.8 -130.62 39.74 Favored Glycine 0 C--N 1.355 1.59 0 CA-C-O 119.9 -0.389 . . . . 70.24 113.38 176.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -148.2 153.09 38.3 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.167 0.987 . . . . 70.23 109.106 178.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 231' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -169.45 161.59 9.83 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.13 0.572 . . . . 73.24 110.2 -172.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 232' ' ' THR . . . . . 0.515 HG22 ' HA ' ' B' ' 280' ' ' LEU . 66.0 p -49.54 102.2 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.655 1.582 . . . . 74.24 113.042 -178.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 233' ' ' PHE . . . . . 0.735 ' HB2' HH22 ' C' ' 211' ' ' ARG . 18.6 t80 -156.26 -49.88 0.08 Allowed 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.338 -0.616 . . . . 70.41 109.338 173.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . 79.01 -40.42 0.25 Allowed 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 125.638 1.575 . . . . 72.31 112.338 177.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 235' ' ' GLU . . . . . 0.412 ' CG ' ' HB3' ' C' ' 220' ' ' GLU . 0.3 OUTLIER 73.09 132.31 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.34 1.456 . . . . 54.41 112.386 168.071 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 236' ' ' THR . . . . . 0.457 ' HB ' ' O ' ' B' ' 348' ' ' ILE . 39.7 m -138.54 79.41 1.73 Allowed 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.149 0.98 . . . . 73.34 108.658 172.155 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 237' ' ' ALA . . . . . 0.468 ' HB1' ' H ' ' B' ' 355' ' ' ALA . . . 70.49 79.94 0.17 Allowed 'General case' 0 CA--C 1.56 1.339 0 CA-C-N 113.921 -1.49 . . . . 71.12 112.681 170.28 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 238' ' ' THR . . . . . 0.466 ' OG1' ' HB2' ' B' ' 351' ' ' GLN . 31.4 m -154.1 99.0 2.21 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.877 1.271 . . . . 71.31 110.07 176.373 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -172.47 -179.19 2.16 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.054 0.942 . . . . 74.42 109.815 173.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . -106.0 -125.38 5.49 Favored Glycine 0 C--N 1.346 1.123 0 N-CA-C 112.178 -0.369 . . . . 71.23 112.178 -178.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -104.69 -168.68 1.51 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.895 0.878 . . . . 71.21 110.844 -176.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 242' ' ' TRP . . . . . 0.564 ' HZ3' ' HD3' ' C' ' 231' ' ' ARG . 0.0 OUTLIER 92.43 -13.66 0.18 Allowed 'General case' 0 N--CA 1.508 2.452 0 C-N-CA 128.035 2.534 . . . . 70.32 111.867 176.968 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -124.89 119.34 28.52 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.434 0.635 . . . . 74.22 111.989 -164.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -69.54 -33.83 72.66 Favored Glycine 0 C--N 1.345 1.056 0 N-CA-C 110.16 -1.176 . . . . 63.11 110.16 162.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 8.2 ttpp 61.97 9.33 2.97 Favored 'General case' 0 CA--C 1.558 1.285 0 C-N-CA 124.597 1.159 . . . . 75.34 113.443 161.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 34.0 p -102.42 -8.61 20.98 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.633 0.773 . . . . 71.02 111.092 -177.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 247' ' ' LEU . . . . . 0.566 HD13 ' HG2' ' C' ' 225' ' ' PRO . 4.0 tt -84.55 101.74 12.33 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 109.446 -0.575 . . . . 72.51 109.446 -173.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 248' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 72.44 -75.34 0.08 Allowed 'General case' 0 CA--C 1.558 1.261 0 C-N-CA 125.86 1.664 . . . . 75.15 112.206 174.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 61.54 21.29 11.96 Favored 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 124.672 1.189 . . . . 71.33 111.495 -171.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 250' ' ' GLN . . . . . 0.455 ' OE1' ' HA ' ' B' ' 250' ' ' GLN . 9.2 mm-40 67.24 155.47 0.1 Allowed 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 126.069 1.748 . . . . 65.4 114.57 -178.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 251' ' ' ALA . . . . . . . . . . . . . . . -69.78 138.22 52.55 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 114.546 -1.206 . . . . 61.03 109.537 175.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 -77.36 89.23 3.76 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 109.121 -0.696 . . . . 72.3 109.121 -176.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -60.38 136.73 58.13 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-N 115.31 -0.859 . . . . 51.41 110.112 176.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 68.78 87.56 0.12 Allowed 'General case' 0 N--CA 1.476 0.868 0 O-C-N 124.716 1.26 . . . . 72.51 109.526 -173.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 255' ' ' GLY . . . . . 0.592 ' HA2' ' HA ' ' B' ' 259' ' ' VAL . . . -150.3 54.78 0.48 Allowed Glycine 0 C--N 1.346 1.1 0 CA-C-N 115.597 -0.729 . . . . 54.22 112.83 -173.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 256' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -65.18 99.82 0.41 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.636 0.774 . . . . 52.52 109.597 174.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 15.0 tm0? 58.89 -82.27 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.57 1.548 . . . . 74.31 109.553 -174.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 258' ' ' LEU . . . . . . . . . . . . . 5.1 tt -117.68 85.6 2.37 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 107.633 -1.247 . . . . 75.13 107.633 173.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 259' ' ' VAL . . . . . 0.592 ' HA ' ' HA2' ' B' ' 255' ' ' GLY . 73.4 t 63.77 -74.4 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 C-N-CA 125.711 1.604 . . . . 63.02 112.514 177.421 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 260' ' ' SER . . . . . . . . . . . . . 22.1 p -174.41 -35.38 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 125.662 1.585 . . . . 73.11 107.464 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -167.39 156.99 10.49 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.545 1.138 . . . . 52.21 109.717 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 262' ' ' ALA . . . . . . . . . . . . . . . -80.14 -62.82 1.56 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.561 0.744 . . . . 43.43 109.316 171.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -177.18 101.36 0.05 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.421 1.089 . . . . 70.44 108.685 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 10.9 m 59.42 11.42 2.23 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 125.19 1.396 . . . . 51.14 113.38 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 265' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -75.81 -40.64 54.62 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 108.889 -0.782 . . . . 64.12 108.889 -173.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 266' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -66.09 -16.0 63.56 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 123.567 0.747 . . . . 71.52 110.124 176.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 18.2 m 79.0 -54.87 0.45 Allowed 'General case' 0 C--N 1.365 1.263 0 C-N-CA 126.348 1.859 . . . . 73.13 111.933 171.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 39.7 t -58.88 -48.18 87.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 C-N-CA 124.227 1.011 . . . . 74.44 111.063 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 269' ' ' THR . . . . . . . . . . . . . 26.6 m 50.25 74.5 0.21 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.938 1.295 . . . . 74.31 110.328 -172.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 270' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -66.15 -31.69 72.68 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 113.744 -1.571 . . . . 72.41 111.933 -173.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 271' ' ' ALA . . . . . . . . . . . . . . . 58.49 39.03 25.44 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 124.311 1.007 . . . . 75.3 110.682 -175.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 272' ' ' ASN . . . . . . . . . . . . . 44.5 t-20 -60.62 132.5 54.08 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.167 -0.924 . . . . 54.14 110.922 -173.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.06 93.02 0.99 Allowed 'General case' 0 CA--C 1.54 0.563 0 O-C-N 124.141 0.901 . . . . 61.32 108.959 -177.066 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 -136.02 79.81 1.79 Allowed 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 107.211 -1.403 . . . . 71.44 107.211 171.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 275' ' ' LYS . . . . . 0.47 ' HG2' ' HB1' ' A' ' 278' ' ' ALA . 9.8 mptt 52.06 68.17 3.41 Favored Pre-proline 0 CA--C 1.552 1.037 0 CA-C-N 114.122 -1.399 . . . . 71.33 111.896 -178.343 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -83.81 17.96 1.61 Allowed 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 122.699 2.266 . . . . 62.35 111.954 174.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 277' ' ' LEU . . . . . 0.433 HD22 ' HA ' ' A' ' 279' ' ' ARG . 5.4 mp -81.41 -99.21 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 108.392 -0.966 . . . . 63.32 108.392 175.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 78.3 mt 59.5 22.51 11.08 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 118.918 0.781 . . . . 62.0 112.397 178.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . 108.05 -15.49 36.66 Favored Glycine 0 C--N 1.354 1.545 0 C-N-CA 123.086 0.374 . . . . 75.43 113.177 -176.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 280' ' ' LEU . . . . . 0.515 ' HA ' HG22 ' B' ' 232' ' ' THR . 2.2 tm? -63.77 -43.84 95.21 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.948 0.899 . . . . 53.23 109.622 177.075 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -78.18 -49.76 13.21 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 109.339 -0.615 . . . . 75.31 109.339 174.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . 78.31 -38.83 0.25 Allowed 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 126.063 1.745 . . . . 65.41 112.681 176.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 19.1 t70 66.92 -71.18 0.1 Allowed 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 126.326 1.85 . . . . 72.33 111.429 -176.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . -78.57 66.62 3.26 Favored Glycine 0 C--N 1.347 1.144 0 N-CA-C 111.794 -0.523 . . . . 61.45 111.794 175.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -77.77 88.84 4.0 Favored 'General case' 0 C--O 1.245 0.858 0 N-CA-C 108.08 -1.082 . . . . 72.41 108.08 177.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 286' ' ' MET . . . . . 0.558 ' HB3' ' HD2' ' B' ' 287' ' ' PRO . 65.5 mtm 70.0 176.9 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.533 0 C-N-CA 124.488 1.115 . . . . 64.1 110.611 -175.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 287' ' ' PRO . . . . . 0.558 ' HD2' ' HB3' ' B' ' 286' ' ' MET . 37.9 Cg_endo -65.73 5.37 0.61 Allowed 'Trans proline' 0 C--N 1.389 2.702 0 C-N-CA 121.897 1.731 . . . . 73.33 114.081 172.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 288' ' ' VAL . . . . . . . . . . . . . 26.1 t -74.28 80.29 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 CA-C-O 121.629 0.728 . . . . 74.32 109.206 171.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 289' ' ' ARG . . . . . . . . . . . . . 53.6 ttt180 -116.8 -7.77 11.44 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 124.478 1.111 . . . . 72.14 109.779 177.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 290' ' ' TRP . . . . . . . . . . . . . 72.2 t-105 69.22 116.41 0.04 OUTLIER 'General case' 0 C--N 1.362 1.118 0 C-N-CA 125.02 1.328 . . . . 75.34 110.157 -173.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 291' ' ' LEU . . . . . . . . . . . . . 30.8 tp 72.8 149.99 0.1 Allowed 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 125.712 1.605 . . . . 64.34 111.064 -172.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . 159.07 -65.06 0.29 Allowed Glycine 0 C--N 1.348 1.245 0 CA-C-N 116.007 -0.542 . . . . 62.12 111.907 -179.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -83.96 40.09 0.86 Allowed 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 123.394 2.729 . . . . 51.12 113.201 -178.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -71.44 120.54 17.16 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.383 1.073 . . . . 41.23 111.198 -175.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -163.59 -62.54 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.451 1.1 . . . . 34.32 108.751 169.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 24.8 m 68.79 149.9 0.07 Allowed 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 125.661 1.584 . . . . 65.42 112.417 176.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 84.5 t80 66.2 -82.38 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 124.847 1.259 . . . . 64.12 111.852 175.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 21.5 p80 39.75 85.24 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 125.966 1.707 . . . . 71.5 113.765 -176.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . -79.07 62.86 3.95 Favored Glycine 0 C--N 1.352 1.444 0 CA-C-N 115.934 -0.576 . . . . 63.41 112.841 179.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -171.45 -151.04 0.07 Allowed 'General case' 0 CA--C 1.551 0.999 0 N-CA-C 106.131 -1.803 . . . . 72.23 106.131 -175.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 301' ' ' ILE . . . . . . . . . . . . . 29.7 mm 74.87 142.15 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.562 1.407 0 C-N-CA 124.907 1.283 . . . . 72.24 111.582 174.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 302' ' ' ASP . . . . . 0.598 ' H ' ' HG3' ' A' ' 189' ' ' GLU . 18.5 t0 78.83 161.27 0.2 Allowed 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 125.885 1.674 . . . . 63.41 112.737 171.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 303' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.51 -36.71 24.3 Favored Pre-proline 0 CA--C 1.571 1.778 0 N-CA-C 115.255 1.576 . . . . 74.11 115.255 -165.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 304' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -49.83 -33.79 34.2 Favored 'Trans proline' 0 C--N 1.394 2.944 0 C-N-CA 122.624 2.216 . . . . 75.12 114.13 169.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . 68.53 -72.74 0.1 Allowed 'General case' 0 C--N 1.362 1.142 0 C-N-CA 125.353 1.461 . . . . 42.33 110.558 -175.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 306' ' ' VAL . . . . . 0.427 HG22 ' H ' ' B' ' 308' ' ' CYS . 6.9 p -124.28 139.46 50.56 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 C-N-CA 123.799 0.84 . . . . 72.33 109.372 172.143 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 24.4 m -61.17 -27.71 68.6 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.677 1.191 . . . . 74.23 112.475 -175.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 308' ' ' CYS . . . . . 0.427 ' H ' HG22 ' B' ' 306' ' ' VAL . 20.2 p -70.1 -10.22 58.04 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.309 0.644 . . . . 74.22 111.735 -178.221 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 65.6 p -130.3 88.32 48.08 Favored Pre-proline 0 CA--C 1.554 1.134 0 C-N-CA 123.7 0.8 . . . . 72.2 109.36 174.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -79.68 162.75 24.25 Favored 'Trans proline' 0 C--N 1.376 2.023 0 C-N-CA 122.676 2.251 . . . . 63.14 112.266 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 311' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -83.86 -46.64 0.76 Allowed Pre-proline 0 CA--C 1.564 1.507 0 CA-C-O 119.04 -0.505 . . . . 73.13 111.317 178.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 312' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -92.63 -157.19 0.05 OUTLIER 'Trans proline' 0 C--N 1.386 2.538 0 C-N-CA 122.095 1.863 . . . . 70.14 110.543 166.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 313' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -89.3 9.69 25.07 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.563 0.345 . . . . 75.13 110.78 174.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 314' ' ' ARG . . . . . . . . . . . . . 37.9 ttp-105 72.99 -71.01 0.14 Allowed 'General case' 0 C--N 1.364 1.201 0 C-N-CA 125.922 1.689 . . . . 72.01 111.04 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 315' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 62.44 -81.02 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.921 1.289 . . . . 72.12 112.091 -179.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 316' ' ' ASP . . . . . . . . . . . . . 33.1 t70 64.35 -75.9 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.499 1.52 . . . . 74.4 112.394 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 317' ' ' SER . . . . . 0.623 ' HA ' HG22 ' B' ' 325' ' ' THR . 69.7 m -96.65 -6.95 35.4 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.787 0.835 . . . . 75.41 112.437 -177.146 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 318' ' ' VAL . . . . . 0.671 HG12 ' HA ' ' B' ' 322' ' ' ALA . 29.7 m -118.97 92.11 44.48 Favored Pre-proline 0 CA--C 1.557 1.242 0 C-N-CA 123.181 0.593 . . . . 73.13 110.752 -178.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 319' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -67.98 -37.63 14.73 Favored 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 122.572 2.181 . . . . 65.1 111.312 173.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 320' ' ' THR . . . . . . . . . . . . . 88.5 m -144.08 -58.0 0.38 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.482 1.113 . . . . 53.31 108.292 174.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 321' ' ' LEU . . . . . . . . . . . . . 93.9 mt -112.05 169.58 8.75 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-N 115.325 -0.852 . . . . 65.14 110.016 178.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 322' ' ' ALA . . . . . 0.671 ' HA ' HG12 ' B' ' 318' ' ' VAL . . . -79.63 72.09 6.29 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.61 0.764 . . . . 64.54 110.278 177.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 323' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -88.85 -25.15 22.33 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 115.175 -0.921 . . . . 74.02 109.497 175.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 324' ' ' MET . . . . . 0.44 ' HA ' ' HB3' ' B' ' 317' ' ' SER . 43.1 tpp 73.18 125.65 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.357 1.463 . . . . 71.32 113.441 166.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 325' ' ' THR . . . . . 0.623 HG22 ' HA ' ' B' ' 317' ' ' SER . 4.4 t -104.78 103.39 13.0 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 107.312 -1.366 . . . . 72.33 107.312 163.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 326' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -60.63 147.05 43.25 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.312 0.645 . . . . 72.01 110.019 -177.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 327' ' ' LYS . . . . . 0.439 ' HD2' ' N ' ' B' ' 327' ' ' LYS . 2.9 mptp? -83.45 22.9 0.98 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.685 0.794 . . . . 54.34 113.021 -170.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 328' ' ' ALA . . . . . . . . . . . . . . . 77.71 164.28 0.23 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.127 1.371 . . . . 72.03 113.193 167.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 329' ' ' ILE . . . . . . . . . . . . . 13.6 tt -144.7 173.24 4.51 Favored 'Isoleucine or valine' 0 C--O 1.251 1.144 0 CA-C-N 113.242 -1.799 . . . . 73.5 106.334 175.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 330' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -66.74 -81.33 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 108.134 -1.061 . . . . 63.42 108.134 164.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 331' ' ' LEU . . . . . . . . . . . . . 60.2 tp 48.31 -93.89 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 124.318 1.047 . . . . 63.34 110.585 -174.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 96.9 mt 30.69 -90.62 0.01 OUTLIER 'General case' 0 C--N 1.368 1.382 0 C-N-CA 126.739 2.016 . . . . 74.41 113.84 178.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 333' ' ' SER . . . . . . . . . . . . . 16.5 p -176.64 -66.44 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.491 1.516 . . . . 65.04 107.119 -178.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt 75.21 -45.08 0.55 Allowed 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 125.988 1.715 . . . . 63.11 113.047 172.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 335' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -53.41 109.37 0.43 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.982 1.313 . . . . 73.25 112.426 -176.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 55.73 32.33 19.21 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.865 1.266 . . . . 61.02 113.61 166.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 337' ' ' LYS . . . . . 0.479 ' NZ ' ' SG ' ' B' ' 190' ' ' CYS . 30.8 mtpt -75.94 79.62 2.83 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 121.391 0.615 . . . . 62.43 109.565 173.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 338' ' ' GLY . . . . . . . . . . . . . . . 110.63 157.12 15.27 Favored Glycine 0 C--N 1.342 0.874 0 CA-C-N 114.861 -1.063 . . . . 72.34 110.786 -169.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 339' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -140.4 178.81 7.05 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.623 0.769 . . . . 74.33 109.689 -178.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 340' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -65.36 163.53 15.41 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.672 0.789 . . . . 75.24 112.065 -176.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 341' ' ' LEU . . . . . . . . . . . . . 6.3 tt -146.94 117.59 7.54 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 107.751 -1.203 . . . . 75.34 107.751 176.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 342' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -91.11 127.37 36.51 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 122.944 0.498 . . . . 64.25 110.158 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 343' ' ' VAL . . . . . . . . . . . . . 7.5 p -96.11 -32.59 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.486 0.714 . . . . 64.24 109.618 173.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 63.43 -77.54 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 126.351 1.86 . . . . 73.03 111.384 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 345' ' ' GLY . . . . . . . . . . . . . . . -117.49 148.56 18.72 Favored Glycine 0 C--N 1.342 0.886 0 N-CA-C 112.332 -0.307 . . . . 62.31 112.332 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 346' ' ' ALA . . . . . . . . . . . . . . . -87.84 178.17 6.78 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.956 0.902 . . . . 72.22 110.157 173.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 46.8 t -66.63 -61.7 1.84 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.076 0.55 . . . . 72.21 109.979 177.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 348' ' ' ILE . . . . . 0.457 ' O ' ' HB ' ' B' ' 236' ' ' THR . 61.0 mt 68.02 -62.02 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 125.977 1.711 . . . . 73.42 112.247 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 349' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -52.28 92.35 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 125.41 1.484 . . . . 71.13 112.106 -178.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 350' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? 48.09 73.72 0.2 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 125.317 1.447 . . . . 74.52 111.419 173.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 351' ' ' GLN . . . . . 0.466 ' HB2' ' OG1' ' B' ' 238' ' ' THR . 23.2 mt-30 -78.7 158.08 28.42 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.215 -0.902 . . . . 71.32 112.199 -170.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 7.7 t0 62.0 -99.9 0.09 Allowed 'General case' 0 CA--C 1.563 1.445 0 C-N-CA 124.993 1.317 . . . . 74.35 111.626 169.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 353' ' ' HIS . . . . . . . . . . . . . 44.6 p-80 -135.42 13.04 3.51 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.439 0.695 . . . . 74.33 109.494 -177.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 354' ' ' ALA . . . . . . . . . . . . . . . 72.21 177.07 0.26 Allowed 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 125.522 1.529 . . . . 70.11 110.821 -162.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 355' ' ' ALA . . . . . 0.468 ' H ' ' HB1' ' B' ' 237' ' ' ALA . . . -90.79 168.55 11.65 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.168 0.587 . . . . 75.44 109.591 177.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 356' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -111.52 98.79 42.0 Favored Pre-proline 0 N--CA 1.476 0.873 0 C-N-CA 123.347 0.659 . . . . 74.32 109.538 174.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 357' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -88.12 0.21 6.87 Favored 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 122.97 2.447 . . . . 55.22 111.8 166.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 358' ' ' CYS . . . . . . . . . . . . . 8.9 p -162.96 115.58 1.58 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.435 1.094 . . . . 73.32 108.272 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 359' ' ' GLY . . . . . . . . . . . . . . . -75.73 76.09 1.4 Allowed Glycine 0 C--N 1.349 1.254 0 N-CA-C 110.484 -1.046 . . . . 62.01 110.484 176.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 360' ' ' GLN . . . . . . . . . . . . . 4.2 tm0? 69.89 -67.92 0.22 Allowed 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 125.763 1.625 . . . . 53.34 108.75 -165.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 361' ' ' ILE . . . . . 0.479 HG22 ' H ' ' B' ' 363' ' ' GLU . 45.0 mt -96.38 147.82 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 123.745 0.818 . . . . 61.31 109.208 174.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 362' ' ' GLY . . . . . . . . . . . . . . . -65.36 -37.4 93.83 Favored Glycine 0 C--N 1.352 1.45 0 O-C-N 123.323 0.39 . . . . 72.35 113.053 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 363' ' ' GLU . . . . . 0.479 ' H ' HG22 ' B' ' 361' ' ' ILE . 4.1 mp0 -71.85 -23.31 61.51 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.953 0.901 . . . . 73.13 112.181 -178.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 364' ' ' THR . . . . . . . . . . . . . 69.3 m -59.66 -37.41 78.66 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.445 0.698 . . . . 74.04 111.592 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 17.0 m -108.82 -58.29 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.245 0 CA-C-O 118.751 -0.642 . . . . 74.01 110.504 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 32.4 t70 38.43 -94.23 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 126.024 1.73 . . . . 50.12 113.141 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 367' ' ' LEU . . . . . . . . . . . . . 7.6 mp -133.89 131.35 39.02 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 106.802 -1.555 . . . . 75.05 106.802 167.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 368' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -81.43 177.98 8.64 Favored 'General case' 0 CA--C 1.553 1.069 0 N-CA-C 110.172 -0.307 . . . . 71.23 110.172 177.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 369' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 68.83 -82.38 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 124.86 1.264 . . . . 70.1 111.004 -172.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 370' ' ' ALA . . . . . . . . . . . . . . . 59.12 -83.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 125.01 1.324 . . . . 74.25 111.931 -174.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 371' ' ' VAL . . . . . . . . . . . . . 43.3 t 61.17 -84.43 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 125.807 1.643 . . . . 74.11 112.133 178.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 372' ' ' GLN . . . . . . . . . . . . . 22.0 tp60 -151.18 5.52 0.48 Allowed 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.788 0.835 . . . . 63.2 110.362 -172.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 373' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 61.85 94.1 0.04 OUTLIER 'General case' 0 C--N 1.36 1.028 0 C-N-CA 124.517 1.127 . . . . 72.05 109.66 -171.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -62.35 115.6 4.33 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.523 -0.762 . . . . 71.45 111.468 -172.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 375' ' ' LEU . . . . . . . . . . . . . 53.5 tp -73.99 117.6 15.97 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 108.732 -0.84 . . . . 62.01 108.732 174.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 376' ' ' GLU . . . . . 0.461 ' HB3' ' HA ' ' A' ' 258' ' ' PRO . 0.0 OUTLIER -61.81 -31.09 71.29 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.164 0.985 . . . . 73.13 112.717 -177.98 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 377' ' ' PHE . . . . . 0.488 ' HZ ' ' HB3' ' B' ' 394' ' ' HIS . 79.5 t80 -62.44 -34.88 77.66 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.119 0.968 . . . . 73.31 111.009 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 378' ' ' ALA . . . . . . . . . . . . . . . -66.07 -37.35 85.59 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.446 -0.797 . . . . 61.1 110.158 176.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? 78.42 -28.08 0.16 Allowed 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 125.743 1.617 . . . . 72.01 111.938 170.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 380' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt 72.26 -82.59 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 125.931 1.692 . . . . 53.14 111.927 169.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 381' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -84.83 101.08 11.99 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.088 0.555 . . . . 74.34 111.297 -176.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . 67.35 65.83 2.59 Favored Glycine 0 C--N 1.349 1.303 0 CA-C-N 115.209 -0.905 . . . . 73.1 113.236 175.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 383' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -89.82 -61.54 1.67 Allowed 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 109.555 -0.535 . . . . 73.1 109.555 175.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 384' ' ' THR . . . . . . . . . . . . . 26.2 m 62.88 -79.61 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 125.498 1.519 . . . . 63.41 111.028 -173.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 385' ' ' LEU . . . . . 0.529 ' HA ' ' HD2' ' A' ' 211' ' ' ARG . 96.9 mt 56.95 -89.96 0.03 OUTLIER 'General case' 0 C--N 1.355 0.813 0 C-N-CA 124.604 1.162 . . . . 75.12 109.533 -168.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 386' ' ' VAL . . . . . 0.429 ' HB ' ' HB3' ' B' ' 391' ' ' ASP . 2.9 t -124.87 45.94 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 107.66 -1.237 . . . . 62.42 107.66 174.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 387' ' ' ILE . . . . . . . . . . . . . 1.9 mp 69.96 -65.04 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 C-N-CA 125.664 1.586 . . . . 74.12 109.306 -172.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 388' ' ' VAL . . . . . 0.521 HG23 ' HB2' ' B' ' 391' ' ' ASP . 10.7 m -86.54 135.98 23.91 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 C-N-CA 123.502 0.721 . . . . 54.33 109.584 169.16 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 389' ' ' THR . . . . . . . . . . . . . 14.9 t -79.28 -16.26 56.69 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.364 0.665 . . . . 71.25 111.74 -175.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . -73.78 -20.76 60.39 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.324 0.649 . . . . 70.34 112.098 178.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 391' ' ' ASP . . . . . 0.521 ' HB2' HG23 ' B' ' 388' ' ' VAL . 7.1 t70 -80.79 170.61 16.07 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.298 0.639 . . . . 64.12 111.147 -175.02 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 392' ' ' HIS . . . . . . . . . . . . . 81.2 t60 66.12 35.81 5.98 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.849 1.26 . . . . 72.42 108.445 -169.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . 67.39 22.66 9.38 Favored 'General case' 0 C--N 1.357 0.915 0 CA-C-N 113.938 -1.483 . . . . 61.53 113.069 173.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 394' ' ' HIS . . . . . 0.488 ' HB3' ' HZ ' ' B' ' 377' ' ' PHE . 64.8 m170 -75.46 -11.03 59.95 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 112.25 0.463 . . . . 73.31 112.25 -177.019 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . -66.01 99.18 0.48 Allowed 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 109.134 -0.691 . . . . 71.44 109.134 166.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 32.0 p -72.59 81.5 1.1 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.975 0.91 . . . . 75.55 110.601 -177.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 397' ' ' GLN . . . . . . . . . . . . . 87.5 mm-40 -141.01 88.08 2.15 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.181 0.992 . . . . 71.41 108.875 -176.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 398' ' ' ILE . . . . . 0.652 ' HB ' HG21 ' B' ' 409' ' ' THR . 14.3 tt -111.25 89.57 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 CA-C-O 121.601 0.715 . . . . 75.44 109.508 178.214 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 399' ' ' VAL . . . . . . . . . . . . . 45.4 t -68.9 -75.12 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 CA-C-N 115.792 -0.64 . . . . 73.32 110.222 -174.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 400' ' ' ALA . . . . . . . . . . . . . . . -162.96 80.88 1.64 Allowed Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 123.352 0.661 . . . . 51.41 109.733 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 401' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -81.95 47.04 2.38 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 123.562 2.842 . . . . 71.04 111.712 173.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -64.16 -37.78 88.68 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.387 1.075 . . . . 74.34 111.895 -168.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 403' ' ' THR . . . . . . . . . . . . . 9.3 t -136.39 138.76 41.9 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 108.353 -0.98 . . . . 51.3 108.353 172.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 404' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? 55.8 86.0 0.06 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.364 1.066 . . . . 70.03 110.431 -173.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 405' ' ' ALA . . . . . . . . . . . . . . . -109.65 96.46 23.66 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 123.847 0.859 . . . . 71.24 110.786 -176.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 406' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -83.48 11.9 3.15 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 123.063 2.509 . . . . 44.44 112.852 173.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . 83.18 -84.14 1.57 Allowed Glycine 0 C--N 1.346 1.099 0 CA-C-O 119.693 -0.504 . . . . 55.33 112.058 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 408' ' ' LEU . . . . . . . . . . . . . 82.0 mt 61.54 5.74 1.31 Allowed 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 124.881 1.272 . . . . 72.03 112.814 -178.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 409' ' ' THR . . . . . 0.652 HG21 ' HB ' ' B' ' 398' ' ' ILE . 14.6 t -158.06 157.79 33.56 Favored 'General case' 0 C--O 1.244 0.766 0 C-N-CA 125.14 1.376 . . . . 73.52 107.582 -176.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 410' ' ' GLN . . . . . . . . . . . . . 27.0 pt20 43.69 78.75 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 125.481 1.512 . . . . 51.32 113.391 -178.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . 77.7 -53.92 0.52 Allowed 'General case' 0 N--CA 1.498 1.925 0 C-N-CA 125.55 1.54 . . . . 63.14 113.791 176.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 39.0 tp -73.81 96.35 2.55 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.736 0.814 . . . . 60.41 111.813 -171.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -164.13 -70.9 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 124.435 1.094 . . . . 71.14 108.702 170.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 414' ' ' THR . . . . . . . . . . . . . 36.9 p -112.1 159.45 18.5 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.066 0.946 . . . . 73.24 110.194 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 415' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -104.78 -18.81 14.12 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.066 0.946 . . . . 73.42 111.069 -176.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -78.08 169.37 18.38 Favored 'General case' 0 C--O 1.245 0.852 0 C-N-CA 124.438 1.095 . . . . 75.33 111.841 -171.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 417' ' ' GLY . . . . . . . . . . . . . . . 137.94 -23.42 3.06 Favored Glycine 0 C--N 1.341 0.814 0 CA-C-N 115.127 -0.942 . . . . 43.15 113.308 176.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 418' ' ' ALA . . . . . . . . . . . . . . . -150.22 147.54 27.81 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 117.49 0.645 . . . . 70.25 111.03 -177.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 419' ' ' VAL . . . . . . . . . . . . . 50.2 t -59.04 -43.75 89.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.202 1.001 . . . . 62.03 109.649 172.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 420' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -123.7 115.18 20.99 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 107.512 -1.292 . . . . 73.12 107.512 173.351 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 421' ' ' VAL . . . . . . . . . . . . . 6.3 p -123.65 121.83 63.41 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 C-N-CA 123.657 0.783 . . . . 72.42 110.056 -177.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 422' ' ' MET . . . . . 0.521 ' SD ' ' HD2' ' A' ' 209' ' ' LYS . 0.0 OUTLIER -122.1 10.58 10.08 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.03 0.932 . . . . 74.1 111.117 175.888 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 423' ' ' SER . . . . . . . . . . . . . 19.9 m -108.89 18.76 20.37 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.333 1.053 . . . . 62.22 109.818 169.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 424' ' ' TYR . . . . . 0.411 ' HB3' ' HG2' ' B' ' 429' ' ' GLU . 14.7 t80 -54.16 -58.45 7.31 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.06 1.344 . . . . 72.42 109.709 172.525 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . -105.15 51.01 0.8 Allowed Glycine 0 C--N 1.347 1.148 0 CA-C-N 114.945 -1.025 . . . . 75.12 111.0 172.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 426' ' ' ASN . . . . . . . . . . . . . 21.1 m120 71.79 -66.66 0.29 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.441 1.497 . . . . 75.43 112.534 175.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 427' ' ' SER . . . . . . . . . . . . . 72.9 m -147.53 151.94 37.16 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.49 0.716 . . . . 75.14 111.269 175.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 51.76 93.04 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 125.773 1.629 . . . . 73.23 112.013 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 429' ' ' GLU . . . . . 0.691 ' HG3' ' H ' ' B' ' 431' ' ' SER . 17.0 tp10 -110.9 152.83 26.27 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.864 -0.607 . . . . 63.42 111.589 -171.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -56.86 -35.23 68.65 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.985 1.314 . . . . 55.41 111.009 171.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 431' ' ' SER . . . . . 0.691 ' H ' ' HG3' ' B' ' 429' ' ' GLU . 18.4 m -64.39 81.84 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.092 0.957 . . . . 73.31 110.797 177.165 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 432' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -120.58 26.79 8.93 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.264 1.025 . . . . 71.1 108.989 175.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 433' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -64.17 112.42 3.01 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 115.206 -0.906 . . . . 73.43 109.192 177.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 434' ' ' HIS . . . . . . . . . . . . . 50.3 t60 66.01 34.94 6.67 Favored 'General case' 0 CA--C 1.566 1.558 0 O-C-N 124.409 1.068 . . . . 65.13 110.387 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 435' ' ' THR . . . . . . . . . . . . . 10.6 t -73.31 -8.79 57.36 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.395 0.678 . . . . 73.42 111.622 177.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . -56.2 -31.4 59.2 Favored Glycine 0 C--N 1.357 1.737 0 O-C-N 123.576 0.547 . . . . 43.54 112.187 170.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 68.9 m -70.08 83.08 0.51 Allowed 'General case' 0 C--N 1.354 0.782 0 N-CA-C 107.544 -1.28 . . . . 54.14 107.544 161.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 438' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -66.34 93.94 0.24 Allowed 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 114.44 -1.255 . . . . 71.55 111.762 -170.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 439' ' ' LEU . . . . . . . . . . . . . 86.0 mt -83.21 -5.53 59.16 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 114.943 -1.026 . . . . 74.24 110.604 171.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 440' ' ' ARG . . . . . 0.525 ' HA ' ' HB3' ' A' ' 222' ' ' ALA . 13.1 mtp180 -89.52 108.55 19.72 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.449 -0.945 . . . . 70.1 108.449 177.082 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 441' ' ' ILE . . . . . 0.592 HD12 ' HA ' ' A' ' 223' ' ' VAL . 57.0 mt -69.25 124.03 24.16 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 C-N-CA 123.353 0.661 . . . . 74.15 112.315 -167.17 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 442' ' ' ALA . . . . . . . . . . . . . . . -115.27 32.41 6.07 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.071 0.948 . . . . 71.41 110.15 175.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 443' ' ' ALA . . . . . 0.537 ' H ' HG22 ' B' ' 441' ' ' ILE . . . -68.77 163.64 23.61 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.351 0.66 . . . . 74.21 111.425 178.144 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 15.3 m-30 78.3 -24.72 0.21 Allowed 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 125.744 1.617 . . . . 65.34 111.912 -174.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . 66.89 69.52 1.34 Allowed Glycine 0 C--N 1.352 1.424 0 N-CA-C 110.403 -1.079 . . . . 74.34 110.403 -168.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 446' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -49.08 98.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 124.246 3.297 . . . . 63.02 114.237 -165.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 447' ' ' HIS . . . . . 0.57 ' HD1' HD12 ' B' ' 454' ' ' LEU . 7.8 p-80 -121.4 95.26 4.61 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.937 0.895 . . . . 60.0 109.429 177.252 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . -90.64 -170.72 2.81 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.658 -0.701 . . . . 74.31 109.978 176.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 449' ' ' ALA . . . . . . . . . . . . . . . 63.24 30.82 15.78 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.081 0.952 . . . . 61.52 111.619 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 450' ' ' ASN . . . . . . . . . . . . . 10.8 t30 65.33 15.66 10.13 Favored 'General case' 0 CA--C 1.56 1.355 0 C-N-CA 124.601 1.161 . . . . 61.12 112.153 174.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 40.5 t -78.93 76.91 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 CA-C-O 122.01 0.909 . . . . 63.1 108.756 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 452' ' ' VAL . . . . . . . . . . . . . 8.0 p -75.8 -29.49 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-N 114.334 -1.303 . . . . 60.45 111.68 -172.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . -80.03 67.07 3.49 Favored Glycine 0 C--N 1.349 1.304 0 CA-C-N 115.745 -0.661 . . . . 73.44 112.056 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 454' ' ' LEU . . . . . 0.57 HD12 ' HD1' ' B' ' 447' ' ' HIS . 3.1 tm? -153.55 123.52 6.89 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 106.625 -1.62 . . . . 72.5 106.625 -178.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 58.7 m -79.33 -82.71 0.1 Allowed 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 108.991 -0.744 . . . . 61.41 108.991 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -140.02 155.17 47.2 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.731 0.812 . . . . 74.3 109.057 178.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 457' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 63.26 98.28 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.711 1.204 . . . . 42.14 110.551 -173.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 3.7 m -90.49 3.76 53.01 Favored 'General case' 0 CA--C 1.56 1.344 0 C-N-CA 123.714 0.806 . . . . 72.13 110.738 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 459' ' ' ASP . . . . . . . . . . . . . 28.5 t70 66.5 113.62 0.03 OUTLIER 'General case' 0 C--N 1.362 1.114 0 C-N-CA 125.775 1.63 . . . . 73.31 110.054 -172.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 1.3 tt 66.07 99.69 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 124.845 1.258 . . . . 65.42 108.801 -177.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -73.9 70.55 1.48 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.712 0.805 . . . . 62.31 111.029 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 41.2 t80 -152.66 17.62 0.6 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.231 1.412 . . . . 72.53 107.934 177.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 24.3 p -84.66 54.56 3.08 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.227 1.411 . . . . 61.35 109.978 178.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 464' ' ' MET . . . . . . . . . . . . . 24.6 ptt? -95.03 32.74 1.62 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.959 1.303 . . . . 75.31 110.09 -176.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.15 82.17 0.71 Allowed 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.326 1.05 . . . . 72.15 110.89 -173.146 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -105.17 -172.05 2.03 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.386 1.074 . . . . 62.32 109.368 177.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . -81.46 12.9 3.32 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 123.376 0.67 . . . . 75.3 111.868 178.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 1.4 pp -53.17 151.76 4.84 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.713 1.205 . . . . 45.51 112.675 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 469' ' ' GLY . . . . . . . . . . . . . . . 76.22 -80.46 1.12 Allowed Glycine 0 C--N 1.341 0.825 0 N-CA-C 110.437 -1.065 . . . . 50.44 110.437 -168.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 470' ' ' LEU . . . . . . . . . . . . . 53.1 tp -170.28 -44.25 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.457 1.103 . . . . 73.2 108.813 177.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 471' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? . . . . . 0 CA--C 1.56 1.353 0 C-N-CA 125.351 1.46 . . . . 74.2 109.681 -176.461 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 63.2 mtt . . . . . 0 N--CA 1.475 0.816 0 N-CA-C 109.184 -0.673 . . . . 55.23 109.184 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 63.61 31.55 14.52 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.805 1.242 . . . . 65.31 111.411 -176.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -85.61 35.11 0.6 Allowed 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.334 0.654 . . . . 52.01 111.814 -175.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -37.38 94.95 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.489 1.516 . . . . 70.52 113.862 -175.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -66.49 104.36 1.24 Allowed 'General case' 0 C--O 1.239 0.514 0 N-CA-C 107.915 -1.142 . . . . 63.2 107.915 166.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -74.63 90.98 2.3 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 107.531 -1.285 . . . . 63.22 107.531 172.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 7' ' ' TYR . . . . . 0.423 ' CD1' ' HA ' ' C' ' 53' ' ' ALA . 72.4 m-85 -62.21 -26.01 68.12 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 114.387 -1.279 . . . . 73.43 111.99 -171.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -63.13 -47.86 80.96 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.54 0.736 . . . . 72.53 110.543 173.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.75 -39.58 93.87 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.06 0.544 . . . . 52.31 110.972 178.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 65.9 mt -59.26 -39.93 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 C-N-CA 123.374 0.669 . . . . 63.34 110.737 176.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 11' ' ' LEU . . . . . 0.415 ' O ' ' HB1' ' C' ' 25' ' ' ALA . 95.5 mt -90.14 -0.17 57.47 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 112.497 0.555 . . . . 45.45 112.497 177.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 59.59 37.92 92.93 Favored Glycine 0 C--N 1.352 1.459 0 N-CA-C 114.107 0.403 . . . . 64.33 114.107 178.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 7.2 m -126.03 139.41 34.28 Favored Pre-proline 0 N--CA 1.482 1.141 0 C-N-CA 124.775 1.23 . . . . 64.04 109.209 177.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -76.87 159.83 34.31 Favored 'Trans proline' 0 C--N 1.368 1.605 0 C-N-CA 122.192 1.928 . . . . 74.43 111.976 176.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 53.6 mtt180 -74.08 76.34 1.74 Allowed 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.329 -0.989 . . . . 71.52 108.329 171.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 62.2 t30 176.39 -27.59 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.17 1.388 . . . . 71.24 108.487 -172.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.45 135.93 57.85 Favored 'General case' 0 C--N 1.351 0.664 0 CA-C-N 115.653 -0.703 . . . . 71.14 110.172 172.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 72.0 p -65.99 160.87 22.69 Favored 'General case' 0 C--O 1.246 0.899 0 O-C-N 123.668 0.605 . . . . 74.41 109.671 177.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 19' ' ' GLN . . . . . 0.558 ' HG2' ' HD3' ' C' ' 60' ' ' PRO . 24.8 tp60 -56.57 -33.67 66.38 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.233 0.613 . . . . 74.45 111.808 -176.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -75.0 -28.78 60.67 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 119.121 -0.466 . . . . 64.05 111.698 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 21' ' ' GLU . . . . . 0.527 ' HG2' HH21 ' C' ' 24' ' ' ARG . 46.3 mt-10 -69.36 -41.13 76.97 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 121.109 0.481 . . . . 73.42 110.161 174.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 22' ' ' ILE . . . . . 0.432 HG21 ' HB3' ' C' ' 57' ' ' LEU . 57.2 mt -66.44 -38.3 81.45 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 CA-C-N 114.735 -1.12 . . . . 61.32 110.12 176.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 23' ' ' LYS . . . . . 0.441 ' O ' ' HD3' ' C' ' 27' ' ' LYS . 4.5 ttpt -70.11 -40.49 74.86 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 114.69 -1.141 . . . . 74.13 109.617 179.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 24' ' ' ARG . . . . . 0.527 HH21 ' HG2' ' C' ' 21' ' ' GLU . 46.6 mtm105 -72.57 -22.39 61.0 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.276 0.63 . . . . 73.52 111.283 176.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 25' ' ' ALA . . . . . 0.415 ' HB1' ' O ' ' C' ' 11' ' ' LEU . . . -66.96 -45.2 78.46 Favored 'General case' 0 C--O 1.242 0.661 0 O-C-N 123.537 0.523 . . . . 75.32 109.603 171.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 26' ' ' TYR . . . . . 0.553 ' HD1' HG22 ' C' ' 50' ' ' ILE . 83.4 t80 -57.76 -52.95 63.35 Favored 'General case' 0 C--N 1.355 0.82 0 CA-C-N 115.5 -0.773 . . . . 72.31 110.698 171.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 27' ' ' LYS . . . . . 0.459 ' HE2' ' HA ' ' C' ' 24' ' ' ARG . 6.0 mppt? -60.69 -32.63 71.84 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.433 0.693 . . . . 74.1 111.62 -176.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -61.98 -48.81 78.7 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.974 0.91 . . . . 71.15 109.494 174.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 29' ' ' LEU . . . . . 0.59 HD13 HD12 ' C' ' 50' ' ' ILE . 76.6 mt -77.39 -13.4 59.94 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 114.781 -1.1 . . . . 60.22 111.664 178.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -86.93 -19.68 28.45 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.488 0.715 . . . . 75.32 110.02 176.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 60.4 mtm180 -91.92 -27.23 18.03 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.309 0.644 . . . . 73.5 110.364 169.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -72.84 -59.93 2.48 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.415 0.686 . . . . 71.12 109.218 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -90.25 22.31 3.39 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.92 0.888 . . . . 70.15 110.901 -178.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 34' ' ' HIS . . . . . 0.407 ' NE2' ' HB3' ' C' ' 36' ' ' ASP . 75.8 t60 -53.18 93.97 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.586 0 C-N-CA 125.565 1.546 . . . . 72.34 113.043 -166.007 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 35' ' ' PRO . . . . . 0.423 ' O ' ' HG2' ' C' ' 39' ' ' LYS . 53.3 Cg_endo -76.55 -6.05 16.64 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.901 2.401 . . . . 71.32 111.806 -168.208 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 36' ' ' ASP . . . . . 0.725 ' HB2' ' HG2' ' B' ' 113' ' ' LYS . 24.0 t70 -63.73 -35.91 82.15 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.442 1.097 . . . . 60.34 111.46 172.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 41.1 t -122.92 -46.9 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 CA-C-O 121.191 0.519 . . . . 75.33 109.753 -177.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -98.33 81.85 2.82 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.005 0.922 . . . . 54.22 109.678 -178.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 39' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' C' ' 35' ' ' PRO . 9.7 mtmp? -84.74 70.03 10.76 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 115.641 -0.709 . . . . 62.24 109.919 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 40' ' ' SER . . . . . 0.4 ' HB2' ' HB3' ' C' ' 43' ' ' ALA . 49.4 m -95.22 108.59 39.8 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-O 118.254 -0.879 . . . . 74.14 108.74 175.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -41.35 -53.01 3.33 Favored 'Trans proline' 0 C--N 1.386 2.542 0 C-N-CA 124.457 3.438 . . . . 63.44 115.157 -174.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -65.72 -31.6 72.69 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.302 0.641 . . . . 65.44 111.335 -178.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 43' ' ' ALA . . . . . 0.4 ' HB3' ' HB2' ' C' ' 40' ' ' SER . . . -77.46 -18.93 56.71 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.036 0.534 . . . . 62.05 110.546 176.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 44' ' ' GLU . . . . . 0.452 ' HA ' ' HB3' ' C' ' 47' ' ' PHE . 51.0 mt-10 -89.91 -19.39 24.61 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.797 0.839 . . . . 74.04 109.634 177.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -77.07 -39.82 48.42 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.069 0.947 . . . . 42.53 109.53 168.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 46' ' ' LYS . . . . . 0.531 ' O ' HG12 ' C' ' 50' ' ' ILE . 63.3 mttp -61.35 -48.04 83.11 Favored 'General case' 0 C--N 1.35 0.606 0 CA-C-N 115.094 -0.957 . . . . 72.32 108.847 169.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 47' ' ' PHE . . . . . 0.452 ' HB3' ' HA ' ' C' ' 44' ' ' GLU . 59.5 t80 -64.22 -27.97 69.42 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.179 0.991 . . . . 62.23 110.856 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 48' ' ' LYS . . . . . 0.518 ' HE2' ' HB3' ' C' ' 89' ' ' ASP . 2.9 tptm -62.82 -48.78 77.62 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 108.698 -0.853 . . . . 72.04 108.698 172.203 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -70.79 -19.68 62.67 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 112.557 0.577 . . . . 72.33 112.557 176.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 50' ' ' ILE . . . . . 0.59 HD12 HD13 ' C' ' 29' ' ' LEU . 23.6 mm -78.75 -34.43 17.39 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 N-CA-C 108.787 -0.82 . . . . 75.43 108.787 174.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 51' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -79.1 -18.23 53.66 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 124.069 0.947 . . . . 74.04 111.276 175.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 52' ' ' GLU . . . . . 0.429 ' O ' HG23 ' C' ' 56' ' ' VAL . 32.6 tt0 -76.18 -50.23 15.09 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.569 -0.9 . . . . 63.42 108.569 170.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 53' ' ' ALA . . . . . 0.423 ' HA ' ' CD1' ' C' ' 7' ' ' TYR . . . -60.57 -33.38 72.62 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 114.593 -1.185 . . . . 63.1 111.247 176.243 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 54' ' ' TYR . . . . . 0.458 ' O ' ' HB2' ' C' ' 58' ' ' SER . 20.8 t80 -81.92 -32.9 30.66 Favored 'General case' 0 C--O 1.214 -0.783 0 C-N-CA 123.788 0.835 . . . . 75.01 110.207 176.324 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.81 -34.37 67.63 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 120.915 0.388 . . . . 60.54 110.247 174.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 56' ' ' VAL . . . . . 0.429 HG23 ' O ' ' C' ' 52' ' ' GLU . 14.8 t -97.61 -24.62 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.26 0 CA-C-N 115.065 -0.97 . . . . 72.43 112.308 -178.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 57' ' ' LEU . . . . . 0.432 ' HB3' HG21 ' C' ' 22' ' ' ILE . 61.9 mt -125.46 29.77 5.94 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 119.242 0.928 . . . . 75.02 112.746 -177.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 58' ' ' SER . . . . . 0.458 ' HB2' ' O ' ' C' ' 54' ' ' TYR . 23.1 t -69.8 -56.44 7.13 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.238 0.542 . . . . 62.42 111.8 175.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -130.05 157.19 77.74 Favored Pre-proline 0 N--CA 1.479 0.981 0 C-N-CA 124.313 1.045 . . . . 72.03 109.303 -171.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 60' ' ' PRO . . . . . 0.558 ' HD3' ' HG2' ' C' ' 19' ' ' GLN . 18.2 Cg_endo -54.26 -21.05 21.42 Favored 'Trans proline' 0 C--N 1.391 2.797 0 C-N-CA 122.921 2.414 . . . . 33.23 112.992 -179.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -51.35 -75.62 0.03 OUTLIER 'General case' 0 CA--C 1.565 1.537 0 C-N-CA 124.554 1.142 . . . . 62.13 110.832 170.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.39 -28.68 67.32 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.592 0.757 . . . . 75.23 111.338 -176.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 10.1 ttp180 -66.14 -44.74 83.31 Favored 'General case' 0 C--N 1.351 0.644 0 N-CA-C 109.496 -0.557 . . . . 64.42 109.496 -177.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -71.0 -29.98 66.1 Favored 'General case' 0 C--N 1.359 1.003 0 O-C-N 123.876 0.735 . . . . 74.15 111.015 178.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 47.5 mm -57.19 -48.55 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 CA-C-O 121.196 0.522 . . . . 62.34 110.049 170.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -67.23 -40.72 86.39 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.773 -0.649 . . . . 74.22 111.012 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -59.42 -45.8 90.52 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 122.95 0.5 . . . . 73.14 110.565 178.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 74.2 p -73.14 -15.72 61.47 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.522 -0.763 . . . . 63.2 111.271 178.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -73.05 116.91 14.14 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 106.948 -1.501 . . . . 75.22 106.948 167.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 111.2 9.5 21.95 Favored Glycine 0 N--CA 1.472 1.073 0 N-CA-C 111.475 -0.65 . . . . 62.51 111.475 -165.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 88.3 m -141.57 -59.01 0.48 Allowed 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 103.755 -2.683 . . . . 72.34 103.755 176.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 34.4 m -73.96 134.16 43.09 Favored 'General case' 0 C--O 1.251 1.164 0 N-CA-C 103.88 -2.637 . . . . 73.35 103.88 155.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.03 -37.45 5.36 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.329 0.652 . . . . 73.23 110.8 -170.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -88.86 150.7 46.17 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 123.992 0.917 . . . . 53.23 109.098 174.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -52.37 117.66 3.85 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 122.838 2.359 . . . . 75.14 111.629 172.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.89 156.75 18.41 Favored 'Trans proline' 0 C--N 1.382 2.325 0 C-N-CA 123.494 2.796 . . . . 63.14 113.745 -176.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -66.53 121.38 8.62 Favored 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 122.209 1.939 . . . . 51.51 111.044 172.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 78' ' ' PRO . . . . . 0.449 ' HB3' ' HA3' ' C' ' 104' ' ' GLY . 32.0 Cg_endo -61.82 135.38 55.58 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 122.886 2.391 . . . . 74.44 113.414 -174.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.22 159.06 54.84 Favored 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 123.001 2.467 . . . . 61.04 112.455 176.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.49 85.9 0.04 OUTLIER 'Trans proline' 0 C--N 1.391 2.815 0 C-N-CA 123.553 2.835 . . . . 51.5 112.873 177.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 159.01 -45.33 0.45 Allowed Glycine 0 C--N 1.341 0.856 0 CA-C-N 114.967 -1.015 . . . . 75.2 111.358 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 111.55 175.23 20.02 Favored Glycine 0 C--N 1.351 1.37 0 C-N-CA 123.514 0.578 . . . . 74.45 112.053 -174.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -83.94 113.24 20.84 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.996 -0.742 . . . . 70.14 108.996 177.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 84' ' ' ASP . . . . . 0.424 ' HA ' ' CZ ' ' C' ' 106' ' ' PHE . 2.0 t70 -63.08 144.87 56.52 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 123.928 0.767 . . . . 63.13 112.639 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 85' ' ' PHE . . . . . 0.529 ' O ' ' HG3' ' C' ' 171' ' ' PRO . 78.3 m-85 -137.31 72.24 1.42 Allowed 'General case' 0 C--O 1.212 -0.88 0 C-N-CA 124.567 1.147 . . . . 74.41 109.348 171.087 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 50.7 m -47.49 86.61 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 124.31 1.044 . . . . 45.43 112.924 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 67.64 13.13 62.89 Favored Glycine 0 C--N 1.349 1.275 0 CA-C-N 115.513 -0.767 . . . . 74.33 114.611 -178.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 88' ' ' PHE . . . . . 0.493 ' HB2' ' HB3' ' C' ' 85' ' ' PHE . 18.6 m-85 -92.22 128.97 38.26 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 109.081 -0.711 . . . . 74.44 109.081 -177.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 89' ' ' ASP . . . . . 0.518 ' HB3' ' HE2' ' C' ' 48' ' ' LYS . 27.9 t70 -83.69 78.59 9.67 Favored 'General case' 0 C--O 1.246 0.898 0 CA-C-O 121.665 0.745 . . . . 72.23 110.509 -172.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 90' ' ' VAL . . . . . 0.72 HG23 ' HE2' ' C' ' 97' ' ' PHE . 1.3 p -43.44 -36.43 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.22 0 C-N-CA 125.934 1.694 . . . . 54.41 112.415 172.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -50.21 -36.53 31.16 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.648 1.579 . . . . 74.21 112.891 -178.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -119.26 21.41 12.26 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.524 0.729 . . . . 75.53 111.234 -170.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 21.5 m-30 -94.17 175.49 6.68 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.805 -0.559 . . . . 72.45 111.123 175.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 94' ' ' SER . . . . . 0.408 ' O ' ' HB3' ' C' ' 97' ' ' PHE . 84.5 p -74.4 173.45 10.27 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 113.754 1.02 . . . . 45.51 113.754 -164.099 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 95' ' ' GLU . . . . . 0.455 ' O ' ' HG3' ' C' ' 99' ' ' GLU . 4.0 mp0 -73.21 -36.52 66.52 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 114.71 -1.132 . . . . 55.43 110.617 178.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -60.57 -42.56 96.88 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-O 121.535 0.683 . . . . 65.02 110.289 173.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 97' ' ' PHE . . . . . 0.72 ' HE2' HG23 ' C' ' 90' ' ' VAL . 48.9 t80 -58.46 -43.4 88.85 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 114.282 -1.326 . . . . 64.25 109.933 174.406 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -66.56 -29.21 69.24 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 122.664 0.386 . . . . 51.52 111.814 176.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 99' ' ' GLU . . . . . 0.455 ' HG3' ' O ' ' C' ' 95' ' ' GLU . 45.0 mt-10 -67.21 -56.15 11.09 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 122.752 0.421 . . . . 74.43 110.24 178.424 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 26.7 tp -75.33 -50.18 16.81 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.392 -0.822 . . . . 73.23 111.802 -172.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -91.66 -20.3 21.75 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.299 0.64 . . . . 73.25 112.555 -173.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -46.46 -58.18 6.07 Favored Glycine 0 CA--C 1.541 1.68 0 CA-C-O 118.933 -0.926 . . . . 54.11 115.107 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -63.43 -3.29 5.04 Favored 'Trans proline' 0 C--N 1.385 2.462 0 C-N-CA 123.186 2.591 . . . . 62.02 114.464 -177.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 104' ' ' GLY . . . . . 0.449 ' HA3' ' HB3' ' C' ' 78' ' ' PRO . . . -137.91 32.53 2.35 Favored Glycine 0 C--N 1.349 1.284 0 CA-C-O 119.953 -0.359 . . . . 43.23 113.14 176.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 48.3 mt -73.81 71.2 1.47 Allowed 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.019 0.528 . . . . 73.03 111.733 173.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 106' ' ' PHE . . . . . 0.553 ' HB3' ' H ' ' C' ' 168' ' ' GLY . 34.3 m-85 48.41 -109.3 0.3 Allowed 'General case' 0 CA--C 1.56 1.356 0 C-N-CA 125.05 1.34 . . . . 64.24 113.688 177.07 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . 66.22 6.58 33.8 Favored Glycine 0 C--N 1.369 2.393 0 CA-C-O 119.757 -0.468 . . . . 51.05 114.103 -165.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 56.36 -128.71 46.84 Favored Glycine 0 C--N 1.361 1.929 0 N-CA-C 111.798 -0.521 . . . . 74.41 111.798 -171.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 109' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -107.49 5.61 27.32 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.798 0.839 . . . . 74.45 110.037 168.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 110' ' ' GLY . . . . . . . . . . . . . . . -92.57 -7.93 62.84 Favored Glycine 0 C--N 1.352 1.418 0 O-C-N 123.642 0.588 . . . . 54.22 112.943 -175.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? 57.47 9.2 0.73 Allowed 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 114.246 1.202 . . . . 75.25 114.246 176.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 112' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -55.9 -33.67 64.85 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.628 1.171 . . . . 74.1 111.066 171.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 113' ' ' SER . . . . . . . . . . . . . 20.4 m 55.85 25.67 8.79 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.73 1.212 . . . . 72.53 112.086 175.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 114' ' ' ARG . . . . . 0.422 ' HA ' ' HD2' ' C' ' 114' ' ' ARG . 4.6 tpt180 -137.77 -164.13 1.56 Allowed 'General case' 0 CA--C 1.555 1.138 0 CA-C-O 117.415 -1.279 . . . . 74.05 109.684 -173.051 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 115' ' ' LYS . . . . . . . . . . . . . 11.1 ttpp -22.5 117.96 0.03 OUTLIER 'General case' 0 N--CA 1.509 2.485 0 N-CA-C 115.946 1.832 . . . . 54.14 115.946 -162.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 116' ' ' GLY . . . . . 0.41 ' HA2' ' HA3' ' C' ' 168' ' ' GLY . . . -77.91 147.72 32.42 Favored Glycine 0 C--N 1.343 0.936 0 CA-C-N 115.197 -0.91 . . . . 45.25 113.182 -177.144 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 17.1 mtm180 -116.4 171.88 7.56 Favored 'General case' 0 C--O 1.263 1.81 0 CA-C-O 122.369 1.081 . . . . 64.44 111.397 -173.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 118' ' ' ASP . . . . . 0.459 ' HA ' ' O ' ' C' ' 173' ' ' ASP . 3.4 m-20 -61.3 117.95 6.28 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 112.37 -2.195 . . . . 75.42 109.138 170.286 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 119' ' ' LEU . . . . . 0.637 ' HG ' ' HG2' ' C' ' 167' ' ' GLN . 3.0 tt -92.89 120.72 33.52 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 105.818 -1.919 . . . . 75.21 105.818 -178.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.581 ' HE ' HG21 ' C' ' 177' ' ' VAL . 57.0 ttt180 -117.56 114.19 23.07 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.625 -0.509 . . . . 72.31 109.625 -164.072 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 121' ' ' ALA . . . . . . . . . . . . . . . -108.66 169.95 8.33 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 122.812 0.445 . . . . 63.21 111.805 -171.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -131.86 114.49 14.74 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 123.88 0.872 . . . . 73.22 109.636 -176.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -140.03 115.43 7.88 Favored Pre-proline 0 N--CA 1.483 1.221 0 CA-C-N 117.992 0.36 . . . . 73.3 111.858 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 124' ' ' PRO . . . . . 0.412 ' HA ' ' O ' ' C' ' 179' ' ' ARG . 24.6 Cg_exo -66.88 116.03 3.91 Favored 'Trans proline' 0 C--N 1.378 2.098 0 C-N-CA 122.229 1.952 . . . . 72.51 109.486 162.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 125' ' ' LEU . . . . . 0.462 ' O ' ' HA ' ' C' ' 180' ' ' LEU . 14.8 tp -139.58 166.87 23.43 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 107.392 -1.336 . . . . 74.03 107.392 -170.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 126' ' ' THR . . . . . 0.418 ' HB ' HD12 ' C' ' 181' ' ' LEU . 14.2 t -127.01 175.32 8.18 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 119.1 0.864 . . . . 61.53 110.976 175.038 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 127' ' ' LEU . . . . . 0.458 HD11 ' H ' ' C' ' 185' ' ' VAL . 6.5 mt -59.86 -44.55 94.09 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 126.092 1.757 . . . . 62.25 110.011 -177.12 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 128' ' ' GLU . . . . . 0.401 ' HG2' ' HB2' ' B' ' 171' ' ' ALA . 1.8 mp0 -58.16 -45.25 87.77 Favored 'General case' 0 C--O 1.213 -0.848 0 CA-C-N 113.694 -1.593 . . . . 75.24 109.586 178.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 129' ' ' GLU . . . . . 0.536 ' HA ' ' HB2' ' C' ' 132' ' ' HIS . 20.0 mm-40 -77.74 -18.0 56.98 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 124.446 1.091 . . . . 73.53 111.659 -178.307 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 130' ' ' ALA . . . . . 0.486 ' HB1' ' HA2' ' C' ' 152' ' ' GLY . . . -71.86 -36.67 70.18 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.066 -0.716 . . . . 64.34 109.066 174.359 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 131' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -73.07 -46.71 49.98 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 114.753 -1.112 . . . . 75.55 111.176 167.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 132' ' ' HIS . . . . . 0.536 ' HB2' ' HA ' ' C' ' 129' ' ' GLU . 32.7 m170 -74.79 -7.57 53.81 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 118.998 -0.525 . . . . 60.22 111.24 -172.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -70.28 66.96 0.72 Allowed Glycine 0 C--N 1.354 1.537 0 O-C-N 123.712 0.632 . . . . 65.31 113.482 172.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . -88.45 -139.8 6.88 Favored Glycine 0 C--N 1.348 1.206 0 N-CA-C 109.657 -1.377 . . . . 53.24 109.657 169.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -72.73 93.62 1.67 Allowed 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 108.727 -0.842 . . . . 71.2 108.727 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 136' ' ' ARG . . . . . 0.519 ' HB2' HD22 ' B' ' 181' ' ' LEU . 57.2 mtp180 -141.91 163.11 33.77 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.722 0.809 . . . . 72.12 110.756 -171.17 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 137' ' ' VAL . . . . . . . . . . . . . 54.2 t -71.33 95.48 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 CA-C-N 115.019 -0.991 . . . . 71.12 110.9 -171.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 138' ' ' VAL . . . . . 0.404 ' HB ' HG13 ' C' ' 145' ' ' VAL . 97.9 t -79.01 112.22 16.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 107.055 -1.461 . . . . 72.14 107.055 165.244 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 139' ' ' GLU . . . . . . . . . . . . . 53.7 tt0 -121.48 78.44 1.43 Allowed 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 107.567 -1.272 . . . . 74.31 107.567 -167.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 140' ' ' VAL . . . . . 0.481 HG11 HD11 ' C' ' 174' ' ' LEU . 89.3 t -128.1 104.56 12.04 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 CA-C-N 114.31 -1.313 . . . . 63.22 110.755 -166.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 68.14 24.31 7.7 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.979 1.312 . . . . 15.23 113.045 168.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 107.5 -29.48 10.43 Favored Glycine 0 C--N 1.338 0.689 0 N-CA-C 111.273 -0.731 . . . . 45.25 111.273 -176.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 143' ' ' ARG . . . . . 0.443 ' CZ ' ' HB ' ' C' ' 145' ' ' VAL . 14.0 tpt180 -70.37 106.94 3.57 Favored 'General case' 0 C--N 1.363 1.192 0 N-CA-C 108.8 -0.815 . . . . 73.04 108.8 177.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 11.4 ttt-85 -113.83 96.74 6.0 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-N 114.864 -1.062 . . . . 71.51 108.773 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 145' ' ' VAL . . . . . 0.537 HG22 ' HB ' ' C' ' 147' ' ' VAL . 3.1 p -127.71 130.28 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 124.273 1.029 . . . . 75.03 110.085 -175.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 55.5 m -90.76 86.53 6.36 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 108.803 -0.814 . . . . 54.21 108.803 174.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 147' ' ' VAL . . . . . 0.537 ' HB ' HG22 ' C' ' 145' ' ' VAL . 9.7 p -131.51 159.34 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-N 114.981 -1.008 . . . . 72.53 110.473 -170.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 23.1 ttm180 -88.56 104.52 16.91 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 108.392 -0.966 . . . . 74.22 108.392 170.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 149' ' ' ILE . . . . . 0.415 HD12 HD13 ' C' ' 159' ' ' ILE . 30.5 pt -69.74 151.52 96.4 Favored Pre-proline 0 CA--C 1.548 0.88 0 CA-C-O 118.045 -0.979 . . . . 71.41 108.861 166.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 150' ' ' PRO . . . . . 0.498 ' HD2' HG22 ' C' ' 161' ' ' VAL . 34.8 Cg_exo -39.27 108.66 0.08 OUTLIER 'Trans proline' 0 C--N 1.39 2.74 0 C-N-CA 123.547 2.831 . . . . 61.44 112.864 176.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -66.6 122.09 9.45 Favored 'Trans proline' 0 C--N 1.382 2.302 0 C-N-CA 122.537 2.158 . . . . 73.2 111.447 -171.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 152' ' ' GLY . . . . . 0.599 ' HA3' HD23 ' C' ' 188' ' ' LEU . . . 99.47 122.72 4.84 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-N 115.52 -0.764 . . . . 54.32 113.386 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 153' ' ' VAL . . . . . 0.684 HG21 HG21 ' C' ' 178' ' ' VAL . 3.5 m -129.99 176.13 9.23 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 C-N-CA 123.745 0.818 . . . . 71.13 109.487 -174.014 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 154' ' ' ARG . . . . . 0.482 ' HD2' ' HB2' ' B' ' 217' ' ' LEU . 98.3 mtt180 -133.66 160.05 38.68 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.375 0.67 . . . . 75.32 110.322 177.304 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 155' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -67.25 103.75 1.32 Allowed 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 124.786 1.234 . . . . 74.51 112.125 -176.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 97.89 -0.79 59.29 Favored Glycine 0 C--N 1.354 1.542 0 CA-C-N 115.583 -0.735 . . . . 64.51 113.163 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 157' ' ' SER . . . . . 0.425 ' HB3' ' HA ' ' B' ' 217' ' ' LEU . 55.6 m -90.39 170.34 10.32 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.082 0.553 . . . . 75.43 111.966 -172.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 158' ' ' VAL . . . . . 0.528 HG12 HG22 ' C' ' 177' ' ' VAL . 28.2 m -104.99 125.77 59.97 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 CA-C-N 115.488 -0.778 . . . . 64.44 111.086 178.481 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 159' ' ' ILE . . . . . 0.586 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 17.3 mt -76.04 98.66 1.7 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.6 0 N-CA-C 108.082 -1.081 . . . . 52.25 108.082 166.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 160' ' ' ARG . . . . . 0.405 ' HD2' ' OH ' ' B' ' 120' ' ' TYR . 21.6 ttp180 -81.97 101.25 10.18 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.993 0.917 . . . . 72.21 110.012 -178.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 161' ' ' VAL . . . . . 0.549 ' HB ' ' HB3' ' C' ' 174' ' ' LEU . 16.1 t -100.19 112.87 64.92 Favored Pre-proline 0 CA--C 1.551 1.004 0 N-CA-C 107.83 -1.174 . . . . 75.24 107.83 175.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -50.48 99.11 0.04 OUTLIER 'Trans proline' 0 C--N 1.384 2.418 0 C-N-CA 124.034 3.156 . . . . 63.42 114.745 -172.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 67.29 23.6 73.32 Favored Glycine 0 C--N 1.347 1.143 0 N-CA-C 115.73 1.052 . . . . 53.31 115.73 169.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 164' ' ' MET . . . . . . . . . . . . . 43.6 ttp -98.0 18.67 15.47 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 117.582 0.691 . . . . 73.35 109.795 174.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . -74.94 -120.95 0.1 Allowed Glycine 0 C--N 1.357 1.727 0 CA-C-N 115.81 -0.632 . . . . 64.24 112.248 174.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . 153.03 -82.87 0.17 Allowed Glycine 0 C--N 1.35 1.354 0 C-N-CA 119.057 -1.544 . . . . 75.44 114.669 172.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 167' ' ' GLN . . . . . 0.637 ' HG2' ' HG ' ' C' ' 119' ' ' LEU . 26.2 mm-40 -14.99 102.49 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.479 0 C-N-CA 126.294 1.837 . . . . 64.31 113.933 -160.337 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 168' ' ' GLY . . . . . 0.553 ' H ' ' HB3' ' C' ' 106' ' ' PHE . . . 108.88 145.3 11.22 Favored Glycine 0 CA--C 1.535 1.301 0 N-CA-C 108.996 -1.642 . . . . 13.44 108.996 -161.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 169' ' ' ASN . . . . . 0.539 ' HB3' ' HD3' ' C' ' 170' ' ' PRO . 48.6 t30 -61.42 -59.61 13.02 Favored Pre-proline 0 CA--C 1.576 1.954 0 N-CA-C 114.687 1.365 . . . . 62.44 114.687 -164.204 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 170' ' ' PRO . . . . . 0.539 ' HD3' ' HB3' ' C' ' 169' ' ' ASN . 7.9 Cg_exo -71.41 104.55 1.59 Allowed 'Trans proline' 0 C--N 1.398 3.142 0 C-N-CA 122.303 2.002 . . . . 51.41 110.693 175.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 171' ' ' PRO . . . . . 0.529 ' HG3' ' O ' ' C' ' 85' ' ' PHE . 58.1 Cg_endo -61.35 126.83 20.25 Favored 'Trans proline' 0 N--CA 1.502 1.972 0 C-N-CA 123.736 2.957 . . . . 74.02 114.688 -161.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -80.49 -167.18 36.09 Favored Glycine 0 C--N 1.354 1.538 0 O-C-N 123.48 0.488 . . . . 74.42 112.269 172.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 173' ' ' ASP . . . . . 0.459 ' O ' ' HA ' ' C' ' 118' ' ' ASP . 13.0 t70 -86.62 155.62 20.35 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 123.54 0.736 . . . . 74.51 110.556 -174.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 174' ' ' LEU . . . . . 0.549 ' HB3' ' HB ' ' C' ' 161' ' ' VAL . 27.7 tp -98.24 114.86 27.26 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 121.496 -0.752 . . . . 75.22 110.198 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 175' ' ' LEU . . . . . 0.445 ' O ' ' HA ' ' C' ' 120' ' ' ARG . 79.6 mt -110.97 91.03 3.5 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.316 0.646 . . . . 71.32 109.867 176.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 176' ' ' LEU . . . . . 0.586 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 62.0 mt -81.02 105.88 12.58 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 109.178 -0.675 . . . . 43.02 109.178 178.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 177' ' ' VAL . . . . . 0.581 HG21 ' HE ' ' C' ' 120' ' ' ARG . 60.3 t -81.51 107.68 13.93 Favored 'Isoleucine or valine' 0 C--O 1.249 1.045 0 CA-C-O 121.901 0.857 . . . . 74.43 108.832 -178.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 178' ' ' VAL . . . . . 0.684 HG21 HG21 ' C' ' 153' ' ' VAL . 4.0 p -93.86 140.41 16.58 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 CA-C-N 114.113 -1.403 . . . . 74.01 110.464 -178.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 179' ' ' ARG . . . . . 0.443 ' HG3' ' H ' ' B' ' 130' ' ' ALA . 50.9 mmm-85 -121.92 111.56 17.22 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 107.402 -1.333 . . . . 72.33 107.402 172.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 180' ' ' LEU . . . . . 0.462 ' HA ' ' O ' ' C' ' 125' ' ' LEU . 84.5 mt -70.52 145.88 50.57 Favored 'General case' 0 C--O 1.237 0.432 0 O-C-N 123.543 0.527 . . . . 70.51 111.299 -175.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 181' ' ' LEU . . . . . 0.418 HD12 ' HB ' ' C' ' 126' ' ' THR . 31.1 mt -60.01 168.53 2.06 Favored Pre-proline 0 CA--C 1.555 1.171 0 C-N-CA 124.914 1.286 . . . . 74.2 111.886 -178.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -42.0 -3.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.395 3.023 0 C-N-CA 124.834 3.69 . . . . 64.12 118.14 174.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 183' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -125.3 83.39 61.16 Favored Pre-proline 0 CA--C 1.569 1.69 0 CA-C-N 118.865 0.757 . . . . 62.13 110.499 166.134 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 184' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -85.57 69.57 5.18 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 123.671 2.914 . . . . 71.54 110.311 173.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 185' ' ' VAL . . . . . 0.458 ' H ' HD11 ' C' ' 127' ' ' LEU . 4.3 t -90.83 -43.77 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 N-CA-C 109.993 -0.373 . . . . 72.23 109.993 -166.218 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 186' ' ' PHE . . . . . 0.662 ' HB3' HD22 ' C' ' 193' ' ' LEU . 21.7 m-85 -99.75 113.0 25.21 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.708 0.766 . . . . 61.44 112.151 -170.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 187' ' ' ARG . . . . . 0.66 ' HE ' ' HB3' ' B' ' 222' ' ' ALA . 36.0 ttm180 -96.98 101.23 12.76 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 107.257 -1.386 . . . . 75.14 107.257 171.232 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 188' ' ' LEU . . . . . 0.599 HD23 ' HA3' ' C' ' 152' ' ' GLY . 41.1 tp -93.88 144.73 25.18 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 112.856 0.687 . . . . 74.14 112.856 -171.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -131.42 111.02 11.45 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 107.242 -1.392 . . . . 71.33 107.242 159.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 70.32 -86.37 0.33 Allowed Glycine 0 C--N 1.351 1.362 0 O-C-N 123.704 0.627 . . . . 74.2 113.141 177.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 191' ' ' GLN . . . . . 0.578 ' HA ' ' HB2' ' C' ' 240' ' ' PHE . 20.7 mt-30 -132.51 -10.76 3.18 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.289 0.636 . . . . 60.21 112.028 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -104.66 121.58 43.85 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 121.303 0.573 . . . . 65.13 110.839 -177.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 193' ' ' LEU . . . . . 0.662 HD22 ' HB3' ' C' ' 186' ' ' PHE . 56.7 mt -90.87 153.15 20.42 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.353 1.461 . . . . 52.2 111.034 -177.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 194' ' ' TYR . . . . . 0.493 ' HB3' ' HB3' ' C' ' 187' ' ' ARG . 46.7 t80 -112.05 148.79 33.13 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 106.983 -1.488 . . . . 75.43 106.983 162.099 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 195' ' ' ALA . . . . . 0.4 ' HA ' ' O ' ' C' ' 185' ' ' VAL . . . -154.66 -175.24 5.32 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.253 0.621 . . . . 65.11 110.946 -177.128 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 58.3 m -130.74 145.9 52.07 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.072 0.949 . . . . 51.32 108.813 168.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 197' ' ' LEU . . . . . . . . . . . . . 36.3 tp -127.4 113.64 16.48 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.359 1.064 . . . . 73.5 108.861 -176.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 198' ' ' ASP . . . . . 0.47 ' HB3' HG21 ' C' ' 256' ' ' THR . 19.9 m-20 -86.11 101.76 13.26 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 109.778 -0.453 . . . . 44.52 109.778 -178.245 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 199' ' ' VAL . . . . . 0.553 ' HA ' HG11 ' C' ' 210' ' ' VAL . 88.8 t -105.58 123.22 40.13 Favored Pre-proline 0 N--CA 1.474 0.747 0 C-N-CA 123.775 0.83 . . . . 61.21 109.13 177.549 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 200' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.88 148.03 56.91 Favored 'Trans proline' 0 C--N 1.369 1.655 0 C-N-CA 121.896 1.731 . . . . 71.34 110.929 176.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 201' ' ' ALA . . . . . . . . . . . . . . . -55.0 -43.59 99.14 Favored Pre-proline 0 CA--C 1.553 1.069 0 N-CA-C 114.174 1.176 . . . . 74.35 114.174 -175.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 202' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -54.38 -52.78 7.44 Favored 'Trans proline' 0 C--N 1.394 2.971 0 C-N-CA 121.733 1.622 . . . . 63.15 112.666 175.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 203' ' ' ILE . . . . . . . . . . . . . 44.6 mt -65.18 -31.04 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 124.089 0.956 . . . . 63.4 111.269 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.34 -43.26 81.99 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.736 0.814 . . . . 75.02 111.817 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 205' ' ' VAL . . . . . . . . . . . . . 87.4 t -72.62 -47.81 49.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 115.866 -0.606 . . . . 63.41 111.22 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 206' ' ' VAL . . . . . 0.465 HG23 ' HE2' ' A' ' 270' ' ' LYS . 11.5 p -80.96 -34.12 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 112.842 0.682 . . . . 52.12 112.842 -171.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 89.86 111.77 1.4 Allowed Glycine 0 CA--C 1.531 1.04 0 N-CA-C 111.623 -0.591 . . . . 63.21 111.623 -169.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -153.24 -121.46 0.85 Allowed Glycine 0 C--N 1.348 1.217 0 CA-C-O 119.606 -0.552 . . . . 51.32 111.76 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 209' ' ' LYS . . . . . . . . . . . . . 31.7 mtmt -151.81 153.09 33.57 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.672 0.789 . . . . 72.12 111.6 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 210' ' ' VAL . . . . . 0.553 HG11 ' HA ' ' C' ' 199' ' ' VAL . 29.3 m -139.97 178.06 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 126.764 2.026 . . . . 62.05 108.393 174.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 211' ' ' ARG . . . . . 0.735 HH22 ' HB2' ' B' ' 233' ' ' PHE . 0.0 OUTLIER -111.84 147.93 34.7 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.018 0.527 . . . . 72.44 111.296 177.213 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -127.18 121.29 30.91 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 107.369 -1.345 . . . . 74.43 107.369 164.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 213' ' ' MET . . . . . 0.546 ' HG2' ' HB3' ' B' ' 172' ' ' GLU . 1.4 tmm? -76.02 112.99 13.03 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 108.281 -1.007 . . . . 63.12 108.281 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 214' ' ' THR . . . . . 0.423 HG22 ' H ' ' C' ' 215' ' ' LEU . 0.2 OUTLIER -117.99 175.39 5.69 Favored 'General case' 0 N--CA 1.485 1.325 0 CA-C-N 118.86 0.755 . . . . 54.24 111.962 -173.373 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 215' ' ' LEU . . . . . 0.423 ' H ' HG22 ' C' ' 214' ' ' THR . 35.7 mt -73.82 -33.49 64.18 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.247 1.419 . . . . 44.41 112.384 -171.314 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -83.41 -4.65 58.69 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 115.262 -0.881 . . . . 71.0 110.647 175.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 132.09 173.22 13.26 Favored Glycine 0 C--N 1.342 0.878 0 N-CA-C 110.898 -0.881 . . . . 64.11 110.898 -175.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 218' ' ' PRO . . . . . 0.429 ' HB2' ' NE ' ' C' ' 211' ' ' ARG . 93.5 Cg_endo -75.56 113.22 3.7 Favored 'Trans proline' 0 CA--C 1.55 1.316 0 C-N-CA 122.253 1.969 . . . . 52.13 112.0 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 219' ' ' VAL . . . . . . . . . . . . . 14.6 p -89.03 152.3 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 108.034 -1.099 . . . . 52.53 108.034 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 220' ' ' GLU . . . . . 0.412 ' HB3' ' CG ' ' B' ' 235' ' ' GLU . 18.1 tt0 -111.57 107.69 16.93 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.194 -1.039 . . . . 72.32 108.194 176.119 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 221' ' ' VAL . . . . . 0.429 HG22 HD11 ' C' ' 235' ' ' LEU . 53.9 t -75.86 129.08 37.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 114.281 -1.327 . . . . 74.03 111.415 -174.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -77.95 138.07 38.66 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.016 0.436 . . . . 73.3 110.507 169.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 57.5 t -118.25 124.17 28.82 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 124.066 0.946 . . . . 73.11 108.916 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 224' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -76.47 162.41 33.37 Favored 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 123.065 2.51 . . . . 54.33 111.067 169.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 225' ' ' PRO . . . . . 0.566 ' HG2' HD13 ' B' ' 247' ' ' LEU . 41.7 Cg_exo -60.71 156.14 44.52 Favored 'Trans proline' 0 C--N 1.369 1.632 0 C-N-CA 122.526 2.151 . . . . 74.0 113.333 176.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 226' ' ' ARG . . . . . 0.468 ' HD2' ' O ' ' A' ' 259' ' ' GLU . 11.8 mmt180 59.59 63.52 1.5 Allowed 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 125.269 1.428 . . . . 70.15 111.764 176.123 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 227' ' ' THR . . . . . . . . . . . . . 57.8 m -100.33 132.28 45.79 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.644 0.777 . . . . 70.3 111.51 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 228' ' ' GLN . . . . . 0.478 ' NE2' ' HG3' ' A' ' 259' ' ' GLU . 26.7 mp0 -111.17 150.6 29.27 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 124.562 1.145 . . . . 74.32 112.376 -179.16 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 229' ' ' ALA . . . . . 0.457 ' HB2' ' H ' ' C' ' 255' ' ' ILE . . . -75.1 118.85 18.49 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 114.551 -1.204 . . . . 62.12 109.606 177.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 116.58 -1.35 20.24 Favored Glycine 0 C--N 1.339 0.747 0 O-C-N 123.688 0.617 . . . . 62.04 112.287 -176.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 231' ' ' ARG . . . . . 0.564 ' HD3' ' HZ3' ' B' ' 242' ' ' TRP . 32.4 mtt180 -66.42 172.99 3.55 Favored 'General case' 0 C--N 1.355 0.819 0 CA-C-O 120.843 0.354 . . . . 74.12 110.691 167.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 232' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' C' ' 251' ' ' LEU . 3.6 ttmp? -142.88 146.29 33.94 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 109.582 -0.525 . . . . 71.45 109.582 175.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 233' ' ' LEU . . . . . 0.425 ' O ' ' HA ' ' C' ' 250' ' ' TYR . 3.5 tt -132.91 125.36 29.72 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.726 0.811 . . . . 74.21 108.838 -168.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 35.5 ttp180 -92.31 104.25 16.62 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.776 0.322 . . . . 72.34 110.397 170.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 235' ' ' LEU . . . . . 0.483 HD12 HD23 ' C' ' 249' ' ' LEU . 72.2 mt -81.56 116.41 21.31 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 107.903 -1.147 . . . . 73.43 107.903 164.184 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -80.27 134.08 36.05 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 123.328 0.651 . . . . 71.55 110.963 -176.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 70.9 26.97 73.02 Favored Glycine 0 C--N 1.349 1.269 0 O-C-N 123.933 0.77 . . . . 71.42 113.235 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 21.7 mmtm -120.62 12.15 11.42 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.958 0.903 . . . . 72.03 111.515 -177.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -90.44 -133.1 5.29 Favored Glycine 0 C--N 1.343 0.966 0 N-CA-C 111.316 -0.714 . . . . 31.21 111.316 172.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 240' ' ' PHE . . . . . 0.578 ' HB2' ' HA ' ' C' ' 191' ' ' GLN . 3.5 m-85 -97.35 118.49 64.42 Favored Pre-proline 0 C--O 1.237 0.436 0 C-N-CA 123.068 0.547 . . . . 75.14 109.907 174.028 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 241' ' ' PRO . . . . . 0.515 ' HA ' ' HA ' ' C' ' 246' ' ' ARG . 87.4 Cg_exo -50.94 103.88 0.07 OUTLIER 'Trans proline' 0 C--N 1.365 1.432 0 C-N-CA 123.557 2.838 . . . . 70.21 113.069 166.238 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -77.42 174.0 54.79 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-N 114.707 -1.133 . . . . 70.14 112.974 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -66.82 -11.08 30.61 Favored 'Trans proline' 0 C--N 1.368 1.559 0 C-N-CA 123.123 2.549 . . . . 71.42 114.038 -171.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -137.29 1.72 2.44 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.687 0.795 . . . . 71.42 111.735 179.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . -171.75 -138.38 2.54 Favored Glycine 0 C--N 1.348 1.238 0 CA-C-O 119.706 -0.497 . . . . 51.32 112.949 -177.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 246' ' ' ARG . . . . . 0.515 ' HA ' ' HA ' ' C' ' 241' ' ' PRO . 85.5 mtm180 -148.44 160.87 42.62 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.845 0.858 . . . . 61.31 111.004 -178.197 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 247' ' ' GLY . . . . . 0.506 ' HA2' ' HA2' ' B' ' 36' ' ' GLY . . . -96.46 -169.3 34.32 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 114.879 -1.055 . . . . 63.23 112.173 173.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -126.33 169.94 12.41 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.104 0.562 . . . . 73.54 110.495 -173.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 249' ' ' LEU . . . . . 0.483 HD23 HD12 ' C' ' 235' ' ' LEU . 17.6 tp -129.25 127.14 40.63 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.945 0.898 . . . . 74.23 109.38 -176.022 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 250' ' ' TYR . . . . . 0.425 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 89.5 m-85 -117.06 101.17 8.26 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.695 0.798 . . . . 71.43 110.141 -178.091 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 251' ' ' LEU . . . . . 0.447 ' O ' ' HA ' ' C' ' 232' ' ' LYS . 0.9 OUTLIER -99.23 129.76 45.48 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 119.286 -0.388 . . . . 64.53 110.113 -176.039 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -73.11 108.45 6.0 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.076 -1.083 . . . . 73.41 108.076 166.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 253' ' ' VAL . . . . . 0.43 HG11 ' HH2' ' B' ' 242' ' ' TRP . 46.7 t -78.79 110.69 14.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.732 -0.667 . . . . 73.5 109.977 -176.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 254' ' ' ARG . . . . . . . . . . . . . 41.0 mtm180 -94.06 159.01 15.35 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.498 0.719 . . . . 74.13 111.321 175.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 255' ' ' ILE . . . . . 0.457 ' H ' ' HB2' ' C' ' 229' ' ' ALA . 35.4 mm -105.82 127.23 60.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 114.235 -1.348 . . . . 75.24 107.983 169.184 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 256' ' ' THR . . . . . 0.47 HG21 ' HB3' ' C' ' 198' ' ' ASP . 0.3 OUTLIER -133.49 172.82 12.21 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.917 1.287 . . . . 53.32 108.775 -177.685 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 35.1 pt -127.02 145.55 54.4 Favored Pre-proline 0 N--CA 1.481 1.099 0 C-N-CA 123.434 0.694 . . . . 64.54 110.109 -178.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -63.33 -11.83 27.52 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.698 2.266 . . . . 73.21 113.72 -173.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 53.32 -67.25 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.961 1.704 . . . . 72.3 112.64 -165.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 8.1 ppt_? -59.77 133.65 56.29 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.33 0.652 . . . . 73.41 110.351 174.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 261' ' ' LEU . . . . . 0.556 HD22 ' HB3' ' C' ' 265' ' ' GLU . 91.2 mt -143.34 161.75 37.52 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.73 0.812 . . . . 71.21 110.488 -173.021 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 63.4 p -91.18 165.56 21.17 Favored Pre-proline 0 CA--C 1.55 0.954 0 N-CA-C 108.62 -0.882 . . . . 61.23 108.62 167.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -48.92 -42.13 38.37 Favored 'Trans proline' 0 C--N 1.381 2.281 0 C-N-CA 122.293 1.996 . . . . 74.2 111.988 169.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -64.18 -58.13 7.5 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 114.202 -1.363 . . . . 71.04 111.244 -178.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 265' ' ' GLU . . . . . 0.556 ' HB3' HD22 ' C' ' 261' ' ' LEU . 0.5 OUTLIER -48.85 -58.37 4.93 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.877 0.871 . . . . 65.11 110.924 177.793 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 266' ' ' GLU . . . . . 0.544 ' O ' ' HG2' ' C' ' 270' ' ' LYS . 33.6 tt0 -58.36 -39.49 79.67 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 124.17 0.919 . . . . 64.21 110.939 -175.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -60.2 -44.13 95.36 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.712 0.805 . . . . 70.32 112.408 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 268' ' ' LEU . . . . . . . . . . . . . 11.1 mp -65.65 -40.71 92.78 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 116.709 -0.223 . . . . 52.44 110.745 176.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -59.81 -36.37 76.62 Favored 'General case' 0 N--CA 1.483 1.177 0 O-C-N 123.558 0.536 . . . . 61.11 110.946 174.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 270' ' ' LYS . . . . . 0.544 ' HG2' ' O ' ' C' ' 266' ' ' GLU . 30.5 mmtp -63.9 -46.92 82.68 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.684 0.794 . . . . 75.43 110.368 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -61.68 -45.06 95.6 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.55 0.74 . . . . 75.33 111.708 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 92.7 mt -62.0 -43.75 98.18 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.236 -0.893 . . . . 74.33 110.315 177.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -59.39 -41.21 88.87 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.558 -0.746 . . . . 34.13 110.695 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -69.31 -31.91 70.69 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.185 0.594 . . . . 63.21 111.595 177.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -62.44 -31.95 72.74 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 122.531 0.332 . . . . 70.04 110.473 171.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 276' ' ' TYR . . . . . 0.563 ' HE1' ' HG2' ' A' ' 202' ' ' PRO . 79.2 m-85 -77.35 -34.56 55.15 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 122.887 0.475 . . . . 75.52 112.207 171.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 15.2 m-30 -66.27 -27.48 67.97 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.797 -0.446 . . . . 44.24 109.797 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -65.53 -1.96 3.01 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 124.413 1.085 . . . . 55.2 113.244 175.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 279' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -72.84 -22.89 60.72 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 122.697 0.399 . . . . 71.52 110.917 171.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.077 0 C-N-CA 123.581 0.752 . . . . 75.14 110.154 178.829 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.8 mtt . . . . . 0 N--CA 1.477 0.916 0 N-CA-C 107.625 -1.25 . . . . 64.12 107.625 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 69.12 -9.01 0.63 Allowed 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 125.092 1.357 . . . . 51.4 113.234 -176.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -90.18 64.53 6.13 Favored 'General case' 0 C--N 1.351 0.666 0 C-N-CA 123.843 0.857 . . . . 74.04 109.974 -174.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -41.46 107.67 0.08 Allowed 'General case' 0 C--N 1.352 0.7 0 N-CA-C 113.474 0.916 . . . . 62.43 113.474 172.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -70.74 88.92 0.73 Allowed 'General case' 0 C--O 1.241 0.62 0 N-CA-C 107.584 -1.265 . . . . 74.32 107.584 162.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.466 ' HA ' ' OH ' ' A' ' 66' ' ' TYR . 34.7 t70 -75.45 93.81 3.02 Favored 'General case' 0 C--N 1.354 0.782 0 N-CA-C 107.511 -1.292 . . . . 61.41 107.511 173.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.615 ' HB2' HD11 ' A' ' 57' ' ' LEU . 50.7 m-85 -60.17 -28.61 68.07 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 113.783 -1.553 . . . . 73.34 111.836 -169.558 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.429 ' CD1' HD11 ' A' ' 22' ' ' ILE . 50.3 m-85 -65.47 -47.63 75.45 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.035 0.534 . . . . 73.33 110.454 177.218 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.5 -38.69 91.9 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.871 -0.604 . . . . 60.32 111.427 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 69.6 mt -60.45 -38.98 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 123.733 0.646 . . . . 74.23 110.107 174.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.467 ' HB3' ' HB1' ' A' ' 25' ' ' ALA . 93.7 mt -86.31 2.81 45.98 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 115.36 -0.836 . . . . 51.33 112.505 178.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 63.83 18.23 61.65 Favored Glycine 0 C--N 1.356 1.64 0 N-CA-C 114.771 0.668 . . . . 53.33 114.771 177.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.6 m -107.48 155.35 39.75 Favored Pre-proline 0 N--CA 1.482 1.167 0 C-N-CA 124.389 1.075 . . . . 71.43 110.076 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.88 154.88 30.1 Favored 'Trans proline' 0 C--N 1.383 2.356 0 C-N-CA 123.0 2.466 . . . . 50.12 113.106 177.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 55.7 mtp180 -76.39 13.75 0.89 Allowed 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 112.763 0.653 . . . . 75.43 112.763 -173.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -119.96 -5.41 10.07 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 125.141 1.376 . . . . 64.11 109.402 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.465 ' HB1' ' HB2' ' A' ' 21' ' ' GLU . . . -58.34 127.28 31.35 Favored 'General case' 0 C--N 1.347 0.477 0 C-N-CA 124.75 1.22 . . . . 64.31 111.51 -175.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.563 ' HA ' HH21 ' A' ' 63' ' ' ARG . 79.8 p -84.17 177.05 8.37 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 122.881 0.473 . . . . 71.11 110.658 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -46.71 -32.65 3.72 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 124.982 1.313 . . . . 64.21 113.292 -175.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -81.59 -30.06 33.11 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 112.264 0.468 . . . . 72.43 112.264 -173.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.465 ' HB2' ' HB1' ' A' ' 17' ' ' ALA . 2.5 mp0 -72.92 -33.67 66.12 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 109.601 -0.518 . . . . 64.03 109.601 170.085 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.499 HG21 ' HB2' ' A' ' 57' ' ' LEU . 1.7 mp -67.29 -33.72 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.738 0.815 . . . . 73.31 110.265 173.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.416 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 4.6 tppp? -64.28 -53.5 47.96 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.824 0.85 . . . . 71.24 109.717 176.024 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -59.12 -44.43 92.01 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 124.166 0.916 . . . . 54.12 110.935 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.467 ' HB1' ' HB3' ' A' ' 11' ' ' LEU . . . -66.7 -35.54 80.37 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.792 0.837 . . . . 64.0 111.849 -177.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -64.12 -50.49 68.04 Favored 'General case' 0 C--O 1.215 -0.711 0 CA-C-N 115.403 -0.817 . . . . 73.1 109.784 175.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.416 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 54.8 mtpt -59.07 -42.82 91.27 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 123.947 0.779 . . . . 74.22 110.737 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.0 ttt180 -53.25 -55.55 23.6 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.283 1.433 . . . . 71.15 110.728 176.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.752 ' HB3' HD13 ' A' ' 50' ' ' ILE . 95.5 mt -79.28 -15.63 57.68 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.603 -0.726 . . . . 74.11 111.793 -176.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.21 -18.78 38.06 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.55 0.74 . . . . 63.3 110.595 175.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -86.07 -45.86 11.02 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 122.977 0.511 . . . . 72.33 110.37 169.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -63.86 -57.65 9.2 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.006 0.522 . . . . 63.33 110.434 -177.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -97.35 38.56 1.25 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.556 0.742 . . . . 63.25 110.025 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 7.7 t-160 -63.94 103.58 0.43 Allowed Pre-proline 0 C--N 1.354 0.782 0 C-N-CA 123.769 0.828 . . . . 63.41 109.478 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -68.38 -14.46 40.15 Favored 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 122.534 2.156 . . . . 74.13 112.86 -167.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -67.85 -39.93 83.75 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.502 1.121 . . . . 72.45 111.305 173.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 96.5 t -96.58 -51.18 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 123.291 0.636 . . . . 65.53 110.08 -177.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -102.16 89.86 3.74 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.174 0.989 . . . . 61.35 110.898 -176.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.22 44.83 1.17 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.426 0.69 . . . . 73.11 110.58 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 74.0 m -89.72 130.48 42.93 Favored Pre-proline 0 N--CA 1.474 0.766 0 CA-C-O 117.918 -1.039 . . . . 54.41 108.447 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -38.61 -70.35 0.07 OUTLIER 'Trans proline' 0 C--N 1.392 2.836 0 C-N-CA 124.76 3.64 . . . . 72.23 114.334 -172.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.483 ' HA ' ' HB2' ' A' ' 45' ' ' GLU . 30.9 tt0 -75.81 -7.21 53.89 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 116.61 -0.268 . . . . 64.43 111.642 -174.337 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.37 -35.62 68.53 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 108.929 -0.767 . . . . 72.14 108.929 172.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -86.56 -30.51 21.83 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-N 115.874 -0.603 . . . . 62.01 109.95 -178.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.514 ' HA ' ' HZ2' ' A' ' 48' ' ' LYS . 41.2 mt-10 -67.17 -46.49 73.83 Favored 'General case' 0 C--O 1.244 0.792 0 C-N-CA 123.339 0.656 . . . . 62.44 110.285 174.153 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 32.3 mmtm -61.19 -39.38 89.97 Favored 'General case' 0 C--O 1.214 -0.785 0 CA-C-N 115.633 -0.712 . . . . 74.03 110.383 171.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.457 ' HA ' HD12 ' A' ' 50' ' ' ILE . 85.2 t80 -58.46 -36.69 74.09 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 123.376 0.423 . . . . 73.24 111.179 176.357 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.514 ' HZ2' ' HA ' ' A' ' 45' ' ' GLU . 10.5 mtmp? -69.68 -32.81 71.65 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.009 0.523 . . . . 75.14 111.607 175.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -77.59 -22.65 50.55 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 122.603 0.361 . . . . 71.44 111.873 175.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.752 HD13 ' HB3' ' A' ' 29' ' ' LEU . 60.3 mt -77.82 -34.02 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 124.321 1.048 . . . . 70.53 108.737 172.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -64.89 -39.65 93.87 Favored 'General case' 0 C--O 1.218 -0.582 0 CA-C-N 114.817 -1.083 . . . . 73.43 109.641 171.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -61.04 -51.27 69.9 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.349 1.06 . . . . 63.42 110.603 176.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.18 -55.81 27.03 Favored 'General case' 0 C--O 1.255 1.395 0 CA-C-N 114.465 -1.243 . . . . 65.45 112.105 -178.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -65.01 -38.48 91.05 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.069 -0.968 . . . . 72.32 110.978 178.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.549 ' HB1' ' HD2' ' A' ' 85' ' ' PHE . . . -54.0 -50.07 67.44 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.334 0.654 . . . . 53.01 111.399 -178.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 70.9 t -62.71 -53.15 50.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 CA-C-N 114.706 -1.134 . . . . 74.52 110.74 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.615 HD11 ' HB2' ' A' ' 7' ' ' TYR . 55.1 mt -90.76 6.77 42.8 Favored 'General case' 0 CA--C 1.559 1.318 0 N-CA-C 113.796 1.036 . . . . 62.04 113.796 -168.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.6 t -78.4 -54.15 6.5 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.202 0.601 . . . . 74.34 110.539 176.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -75.89 131.23 76.66 Favored Pre-proline 0 C--O 1.236 0.373 0 CA-C-N 115.322 -0.853 . . . . 74.34 109.393 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.427 ' O ' ' HG2' ' A' ' 64' ' ' ARG . 22.9 Cg_endo -58.35 -32.62 96.51 Favored 'Trans proline' 0 C--N 1.385 2.491 0 C-N-CA 123.201 2.601 . . . . 72.41 112.344 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -66.45 -51.56 55.56 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.557 0.743 . . . . 72.3 110.878 -178.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 36.5 mtpt -73.74 -26.67 60.79 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.042 0.937 . . . . 74.54 111.669 -177.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.563 HH21 ' HA ' ' A' ' 18' ' ' THR . 42.6 tpt85 -59.28 -53.64 55.99 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.959 0.904 . . . . 74.11 108.925 168.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.482 ' HE ' ' HA ' ' A' ' 64' ' ' ARG . 2.4 mmp_? -61.92 -31.89 72.25 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 124.163 0.914 . . . . 74.25 111.611 178.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 64.2 mt -60.16 -47.77 90.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.16 0.584 . . . . 64.42 110.373 174.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.466 ' OH ' ' HA ' ' A' ' 6' ' ' ASP . 21.3 t80 -60.26 -48.14 83.02 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 116.037 -0.529 . . . . 75.4 110.14 177.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -54.06 -47.89 71.18 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.044 0.537 . . . . 64.04 111.546 178.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 72.2 p -72.54 -17.78 61.69 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.799 -0.637 . . . . 75.13 111.824 -177.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -74.84 107.34 6.86 Favored 'General case' 0 C--N 1.361 1.079 0 N-CA-C 107.808 -1.182 . . . . 63.45 107.808 170.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 119.71 10.76 7.53 Favored Glycine 0 N--CA 1.469 0.874 0 N-CA-C 111.744 -0.543 . . . . 52.54 111.744 -167.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 90.6 m -145.13 -56.62 0.33 Allowed 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 105.11 -2.181 . . . . 71.23 105.11 177.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 22.0 m -88.0 143.73 26.93 Favored 'General case' 0 C--O 1.251 1.157 0 N-CA-C 104.421 -2.437 . . . . 74.23 104.421 156.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.22 -31.06 9.29 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.288 0.635 . . . . 74.04 110.728 -178.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -83.85 150.63 59.37 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 123.371 0.669 . . . . 75.1 109.483 173.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.442 ' HG2' ' HG2' ' A' ' 103' ' ' PRO . 55.7 Cg_exo -56.87 135.94 73.63 Favored 'Trans proline' 0 C--N 1.371 1.733 0 C-N-CA 122.864 2.376 . . . . 75.41 112.946 175.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.01 162.98 39.46 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 123.612 2.875 . . . . 74.25 112.801 178.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -50.42 115.62 2.03 Favored 'Trans proline' 0 C--N 1.385 2.449 0 C-N-CA 123.444 2.762 . . . . 62.44 113.678 176.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -68.97 134.17 28.95 Favored 'Trans proline' 0 C--N 1.381 2.251 0 C-N-CA 122.568 2.179 . . . . 43.51 111.895 177.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -61.41 154.46 58.73 Favored 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 122.883 2.388 . . . . 71.05 112.656 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.57 87.8 0.05 OUTLIER 'Trans proline' 0 C--N 1.382 2.326 0 C-N-CA 123.375 2.716 . . . . 51.35 112.943 178.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 148.28 -39.89 0.96 Allowed Glycine 0 N--CA 1.463 0.443 0 N-CA-C 109.492 -1.443 . . . . 62.41 109.492 179.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 117.28 -165.62 12.48 Favored Glycine 0 C--N 1.345 1.068 0 CA-C-N 114.607 -0.796 . . . . 53.03 111.991 178.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -90.99 106.09 18.28 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.629 0.772 . . . . 74.41 108.942 178.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -78.14 149.05 33.86 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.454 0.702 . . . . 71.31 111.725 177.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.549 ' HD2' ' HB1' ' A' ' 55' ' ' ALA . 75.9 m-85 -134.61 75.04 1.56 Allowed 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.311 1.044 . . . . 70.22 110.006 -176.029 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.9 m -49.72 85.59 0.0 OUTLIER 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 125.688 1.595 . . . . 74.44 113.479 -179.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 86.18 12.04 71.46 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-O 119.573 -0.57 . . . . 70.11 114.172 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.616 ' HB3' ' HZ ' ' A' ' 93' ' ' PHE . 45.9 m-85 -119.75 117.45 28.27 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 117.883 0.841 . . . . 72.34 110.334 -174.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -73.77 87.48 1.73 Allowed 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 121.528 0.68 . . . . 71.44 110.391 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.63 HG12 ' HD3' ' A' ' 171' ' ' PRO . 6.0 p -49.45 -32.16 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 125.51 1.524 . . . . 75.21 113.378 173.576 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -56.2 -24.22 40.5 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.45 1.1 . . . . 75.33 111.847 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -86.1 -30.63 22.41 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.932 0.893 . . . . 45.35 112.483 -178.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.616 ' HZ ' ' HB3' ' A' ' 88' ' ' PHE . 10.3 m-30 -65.75 153.27 42.25 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 112.903 0.705 . . . . 71.01 112.903 -165.322 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 84.8 p -64.74 171.1 3.59 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 115.667 1.729 . . . . 74.5 115.667 -165.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.56 -42.4 82.97 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 114.46 -1.246 . . . . 74.31 112.725 177.208 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -57.14 -46.02 83.06 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.984 0.914 . . . . 75.03 109.592 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.429 ' CE2' HG23 ' A' ' 90' ' ' VAL . 48.9 t80 -62.46 -43.52 98.61 Favored 'General case' 0 CA--C 1.553 1.084 0 CA-C-N 113.631 -1.622 . . . . 63.23 110.468 177.199 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -69.26 -13.21 62.27 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.064 0.546 . . . . 73.05 111.64 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -92.59 -30.8 15.44 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.238 0.615 . . . . 70.02 111.408 170.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 25.1 tp -82.25 -63.38 1.39 Allowed 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.491 0.716 . . . . 55.03 111.412 -177.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -93.77 -6.89 45.0 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.7 0.8 . . . . 72.11 112.727 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -43.74 -56.04 5.19 Favored Glycine 0 CA--C 1.545 1.964 0 N-CA-C 116.315 1.286 . . . . 72.43 116.315 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.442 ' HG2' ' HG2' ' A' ' 75' ' ' PRO . 33.4 Cg_exo -63.14 -3.67 5.25 Favored 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 123.625 2.884 . . . . 23.1 115.367 -176.074 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -139.42 26.96 2.65 Favored Glycine 0 C--N 1.352 1.468 0 CA-C-O 119.159 -0.801 . . . . 44.4 112.968 175.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.524 HD22 HG21 ' A' ' 90' ' ' VAL . 23.2 mt -65.38 81.07 0.05 Allowed 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 117.583 0.692 . . . . 74.25 111.708 176.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 43.62 -108.73 0.13 Allowed 'General case' 0 CA--C 1.56 1.327 0 C-N-CA 126.274 1.83 . . . . 72.25 113.072 -178.249 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' A' ' 113' ' ' SER . . . 74.1 5.63 71.57 Favored Glycine 0 C--N 1.368 2.314 0 CA-C-O 118.979 -0.9 . . . . 44.0 114.271 -174.228 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.689 ' HA3' ' HB3' ' A' ' 167' ' ' GLN . . . -13.08 -70.15 0.01 OUTLIER Glycine 0 C--N 1.37 2.422 0 C-N-CA 125.781 1.658 . . . . 71.34 115.905 168.259 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -85.1 65.58 9.31 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.738 0.815 . . . . 64.11 109.741 172.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -10.62 -75.72 0.01 OUTLIER Glycine 0 C--N 1.369 2.37 0 C-N-CA 126.888 2.185 . . . . 55.25 116.914 169.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 24.4 ttp180 -7.05 -43.64 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.604 0 N-CA-C 116.837 2.162 . . . . 71.44 116.837 166.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 51.6 ttp180 -124.28 -36.14 2.7 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.279 1.032 . . . . 73.25 110.289 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.425 ' HA ' ' HA2' ' A' ' 107' ' ' GLY . 75.6 m 65.75 -11.42 0.19 Allowed 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 125.398 1.479 . . . . 74.21 114.81 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 59.3 ttt180 -109.35 -136.23 0.36 Allowed 'General case' 0 CA--C 1.558 1.265 0 CA-C-O 117.776 -1.107 . . . . 74.52 109.287 -171.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -49.7 128.97 19.02 Favored 'General case' 0 C--N 1.367 1.334 0 C-N-CA 124.666 1.187 . . . . 72.15 113.32 -164.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -89.63 176.48 43.0 Favored Glycine 0 CA--C 1.541 1.712 0 O-C-N 123.691 0.619 . . . . 55.22 113.013 175.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.739 ' H ' ' HA3' ' A' ' 166' ' ' GLY . 0.0 OUTLIER -116.24 175.79 5.39 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.451 1.1 . . . . 71.34 111.211 179.537 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -86.84 95.93 10.03 Favored 'General case' 0 CA--C 1.565 1.521 0 CA-C-O 122.035 0.921 . . . . 74.23 111.025 178.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 9.2 tt -100.89 150.62 22.65 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.671 1.189 . . . . 70.23 109.3 -178.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -98.37 138.75 35.15 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.54 0.736 . . . . 74.51 111.376 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.552 ' HB2' HD11 ' A' ' 174' ' ' LEU . . . -128.74 170.5 13.23 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.939 0.895 . . . . 41.51 109.85 170.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -122.21 114.72 21.23 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 106.402 -1.703 . . . . 61.0 106.402 -178.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 53.4 tp -99.25 101.46 12.89 Favored Pre-proline 0 N--CA 1.475 0.796 0 N-CA-C 108.208 -1.034 . . . . 54.05 108.208 -175.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.57 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 7.1 Cg_endo -86.07 111.05 1.09 Allowed 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 121.403 1.402 . . . . 75.33 109.488 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.564 ' HA ' HG21 ' B' ' 6' ' ' ILE . 47.7 tp -106.48 136.95 45.35 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 110.058 -0.349 . . . . 64.01 110.058 -176.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.463 HG21 ' H ' ' B' ' 4' ' ' SER . 99.9 m -65.54 131.09 45.52 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.985 0.914 . . . . 71.34 110.049 175.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 69.3 mt -57.26 -50.81 71.71 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.908 0.883 . . . . 70.54 111.385 -175.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -59.94 -37.55 79.86 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 114.824 -1.08 . . . . 75.32 110.606 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.421 ' HB2' ' HB ' ' A' ' 126' ' ' THR . 45.1 mm-40 -82.06 -12.71 58.11 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 115.425 -0.807 . . . . 64.33 112.056 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -71.29 -54.04 12.21 Favored 'General case' 0 C--N 1.347 0.471 0 N-CA-C 107.719 -1.215 . . . . 41.43 107.719 167.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -51.98 -44.41 64.02 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 116.138 -0.483 . . . . 74.51 110.984 174.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 50.8 m170 -73.51 -30.13 62.91 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 116.468 -0.333 . . . . 75.25 111.786 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 67.9 -129.05 26.72 Favored Glycine 0 C--N 1.349 1.26 0 O-C-N 123.216 0.323 . . . . 71.54 113.257 177.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.445 ' O ' HG12 ' A' ' 149' ' ' ILE . . . 83.24 -175.59 52.74 Favored Glycine 0 C--N 1.35 1.31 0 C-N-CA 123.007 0.337 . . . . 70.42 113.856 175.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.9 111.36 13.66 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 107.783 -1.191 . . . . 73.14 107.783 169.178 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.407 ' NH2' ' HB3' ' A' ' 129' ' ' GLU . 13.8 tpp180 -90.16 121.35 32.12 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 109.186 -0.672 . . . . 74.4 109.186 -175.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.494 HG11 ' HE ' ' A' ' 144' ' ' ARG . 97.6 t -86.68 108.33 17.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 CA-C-N 115.204 -0.907 . . . . 71.24 108.904 177.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.453 HG22 HD11 ' B' ' 6' ' ' ILE . 14.6 t -107.37 113.03 42.52 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 115.005 -0.998 . . . . 73.14 108.417 -178.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -99.05 133.21 43.65 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.586 0.754 . . . . 71.3 109.535 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.447 HG11 HD23 ' B' ' 8' ' ' LEU . 7.3 p -166.14 119.24 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.904 0 C-N-CA 123.595 0.758 . . . . 75.1 110.776 -179.039 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 61.51 19.29 10.2 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.052 1.341 . . . . 74.24 113.741 172.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 102.01 -2.73 51.66 Favored Glycine 0 C--N 1.351 1.376 0 CA-C-N 117.555 0.161 . . . . 31.1 112.993 -177.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 20.7 tpt180 -99.94 112.83 25.09 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.07 0.948 . . . . 72.12 109.589 175.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.494 ' HE ' HG11 ' A' ' 137' ' ' VAL . 74.9 ttt180 -108.02 93.89 4.78 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.122 0.969 . . . . 74.41 108.642 175.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 15.0 p -94.59 149.99 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 123.318 0.647 . . . . 73.53 110.031 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 32.4 t -120.85 98.55 6.06 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.734 0.814 . . . . 31.45 108.872 176.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 19.0 m -103.48 116.63 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.375 0.67 . . . . 73.42 110.951 -176.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -67.41 112.37 4.58 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 109.608 -0.516 . . . . 74.14 109.608 172.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.445 HG12 ' O ' ' A' ' 134' ' ' GLY . 23.7 pt -101.62 152.29 38.04 Favored Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 123.727 0.811 . . . . 74.13 110.283 178.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -58.85 -165.57 0.03 OUTLIER 'Trans proline' 0 N--CA 1.517 2.872 0 C-N-CA 124.568 3.512 . . . . 60.34 112.451 168.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_exo -48.9 89.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.398 3.148 0 CA-C-N 121.025 1.402 . . . . 74.15 109.867 159.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 40.17 -98.01 0.01 OUTLIER Glycine 0 CA--C 1.494 -1.267 0 CA-C-N 112.727 -2.033 . . . . 75.51 114.647 -162.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.708 HG11 HG21 ' A' ' 178' ' ' VAL . 5.5 p 173.43 161.67 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 113.116 -1.542 . . . . 75.43 107.938 -162.203 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.04 152.86 43.72 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.452 -0.944 . . . . 73.23 108.452 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.453 ' HG2' ' NH1' ' A' ' 187' ' ' ARG . 11.3 tp10 -50.76 130.81 25.42 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 124.008 0.923 . . . . 72.32 112.662 -174.312 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.83 9.35 85.07 Favored Glycine 0 C--N 1.346 1.1 0 CA-C-N 115.412 -0.813 . . . . 14.21 114.072 178.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 42.0 m -66.18 109.84 2.78 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-N 118.016 0.908 . . . . 74.23 109.087 173.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 46.7 t -88.65 90.47 3.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 123.801 0.84 . . . . 72.34 109.024 -178.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.545 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 59.6 mt -74.24 104.96 3.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 108.656 -0.868 . . . . 75.24 108.656 175.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 46.7 ttt180 -74.86 108.85 7.87 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 109.32 -0.622 . . . . 61.32 109.32 177.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.482 HG13 ' HB3' ' A' ' 174' ' ' LEU . 3.8 p -119.48 95.58 49.33 Favored Pre-proline 0 CA--C 1.554 1.114 0 C-N-CA 123.898 0.879 . . . . 61.33 108.825 174.075 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.702 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 51.4 Cg_exo -59.74 126.41 20.44 Favored 'Trans proline' 0 C--N 1.372 1.77 0 C-N-CA 122.495 2.13 . . . . 74.53 114.014 175.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 128.05 -30.4 3.92 Favored Glycine 0 N--CA 1.47 0.93 0 CA-C-N 114.852 -1.067 . . . . 70.43 113.774 169.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 69.8 mtm -95.27 3.52 54.44 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 117.191 0.495 . . . . 64.15 111.699 -178.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.518 ' HA2' HD13 ' A' ' 174' ' ' LEU . . . -90.11 -98.32 1.13 Allowed Glycine 0 C--N 1.348 1.227 0 N-CA-C 110.856 -0.898 . . . . 73.33 110.856 175.346 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.739 ' HA3' ' H ' ' A' ' 117' ' ' ARG . . . -61.01 101.4 0.31 Allowed Glycine 0 C--O 1.265 2.089 0 N-CA-C 111.277 -0.729 . . . . 74.5 111.277 164.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.689 ' HB3' ' HA3' ' A' ' 108' ' ' GLY . 12.4 mm100 -64.93 105.87 1.12 Allowed 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 113.151 -1.525 . . . . 75.42 109.066 177.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 174.21 164.9 29.96 Favored Glycine 0 C--O 1.238 0.344 0 N-CA-C 110.393 -1.083 . . . . 64.21 110.393 -175.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ASN . . . . . 0.529 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . 40.1 t30 -60.8 -72.01 0.3 Allowed Pre-proline 0 CA--C 1.563 1.457 0 CA-C-O 116.657 -1.639 . . . . 63.11 112.116 -164.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.529 ' HD3' ' HB3' ' A' ' 169' ' ' ASN . 22.4 Cg_exo -65.65 115.75 3.56 Favored 'Trans proline' 0 C--N 1.389 2.71 0 CA-C-N 123.569 2.31 . . . . 71.13 109.854 171.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.63 ' HD3' HG12 ' A' ' 90' ' ' VAL . 8.7 Cg_exo -38.45 123.0 0.66 Allowed 'Trans proline' 0 C--N 1.375 1.965 1 C-N-CA 125.671 4.247 . . . . 71.25 117.42 -166.48 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -88.0 127.25 8.45 Favored Glycine 0 C--N 1.366 2.225 0 N-CA-C 111.112 -0.795 . . . . 72.4 111.112 164.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.702 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 4.9 m-20 -61.3 136.85 58.19 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.994 0.917 . . . . 71.14 111.792 -169.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.552 HD11 ' HB2' ' A' ' 121' ' ' ALA . 32.3 tp -113.7 126.93 55.79 Favored 'General case' 0 C--N 1.343 0.292 0 N-CA-C 109.786 -0.449 . . . . 64.32 109.786 173.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 83.7 mt -95.36 90.06 5.67 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.296 -0.865 . . . . 72.12 108.879 178.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.545 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 81.9 mt -70.07 88.51 0.6 Allowed 'General case' 0 C--N 1.354 0.799 0 N-CA-C 109.282 -0.636 . . . . 70.05 109.282 174.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 17.1 t -82.22 101.32 6.86 Favored 'Isoleucine or valine' 0 C--O 1.246 0.895 0 N-CA-C 105.54 -2.022 . . . . 61.43 105.54 175.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.708 HG21 HG11 ' A' ' 153' ' ' VAL . 6.0 p -71.2 136.38 25.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 115.217 -0.901 . . . . 70.33 111.01 -171.069 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.57 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 30.7 mmt180 -119.7 120.78 37.6 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.745 -1.576 . . . . 53.32 106.745 169.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 32.7 mt -74.82 147.2 41.39 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 109.062 -0.718 . . . . 72.4 109.062 171.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.421 ' HA ' ' HD3' ' A' ' 182' ' ' PRO . 18.5 mt -53.73 150.46 13.65 Favored Pre-proline 0 N--CA 1.484 1.241 0 C-N-CA 123.662 0.785 . . . . 73.14 112.936 -167.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 181' ' ' LEU . 24.2 Cg_exo -66.95 8.8 0.31 Allowed 'Trans proline' 0 C--N 1.387 2.558 0 C-N-CA 124.312 3.342 . . . . 71.42 113.921 176.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -60.65 103.11 0.34 Allowed Pre-proline 0 CA--C 1.562 1.423 0 C-N-CA 125.377 1.471 . . . . 73.35 107.938 165.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -80.86 26.17 0.61 Allowed 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 123.636 2.89 . . . . 61.24 115.471 -162.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.413 HG12 ' HD1' ' A' ' 186' ' ' PHE . 77.3 t -96.08 -58.94 3.44 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.908 0 CA-C-O 118.644 -0.693 . . . . 64.21 111.15 -173.183 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' PHE . . . . . 0.413 ' HD1' HG12 ' A' ' 185' ' ' VAL . 4.0 m-85 -139.41 91.77 2.52 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 119.191 0.905 . . . . 72.31 110.575 -177.026 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.453 ' NH1' ' HG2' ' A' ' 155' ' ' GLU . 44.8 ttp85 -101.26 103.8 14.82 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.073 0.949 . . . . 75.51 109.526 178.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.433 HD23 ' O ' ' A' ' 153' ' ' VAL . 51.2 tp -71.02 141.47 50.95 Favored 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 124.103 0.961 . . . . 74.21 111.218 179.225 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.417 ' HG3' ' HB3' ' A' ' 155' ' ' GLU . 34.2 tt0 -151.8 126.1 9.33 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.822 1.249 . . . . 70.31 109.825 -175.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 70.15 -81.93 0.35 Allowed Glycine 0 C--N 1.352 1.424 0 N-CA-C 111.625 -0.59 . . . . 65.41 111.625 -176.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -147.88 -10.08 0.4 Allowed 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 125.349 1.46 . . . . 72.32 109.882 166.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -101.06 148.31 25.2 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.325 1.05 . . . . 72.32 111.205 -176.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 14.4 mt -90.92 159.89 15.96 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.26 1.024 . . . . 63.44 110.782 -176.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.505 ' HA ' ' HB2' ' A' ' 250' ' ' TYR . 41.8 m-85 -126.95 110.46 13.02 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.375 1.07 . . . . 73.14 108.919 173.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.527 ' HB3' HD23 ' A' ' 251' ' ' LEU . . . -125.88 166.95 15.95 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.217 1.007 . . . . 74.34 110.796 -178.197 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 24.5 m -112.9 147.42 37.08 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 108.493 -0.928 . . . . 70.21 108.493 171.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.559 HD22 HD13 ' A' ' 251' ' ' LEU . 50.8 tp -139.55 113.37 8.64 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.423 0.689 . . . . 72.21 109.51 -173.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -89.03 124.76 34.59 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 108.402 -0.962 . . . . 61.43 108.402 174.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.9 p -140.47 131.3 13.85 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 124.276 1.031 . . . . 64.4 108.966 -174.155 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -72.74 150.24 49.85 Favored 'Trans proline' 0 C--N 1.379 2.139 0 C-N-CA 121.554 1.503 . . . . 64.51 110.973 173.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -50.94 -46.93 87.73 Favored Pre-proline 0 CA--C 1.558 1.278 0 N-CA-C 114.654 1.353 . . . . 71.34 114.654 -173.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -52.85 -46.58 32.7 Favored 'Trans proline' 0 C--N 1.383 2.394 0 C-N-CA 121.895 1.73 . . . . 63.54 113.754 176.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.41 HG23 ' HE1' ' C' ' 277' ' ' TYR . 20.3 mt -72.54 -30.28 33.65 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 CA-C-N 115.68 -0.691 . . . . 64.32 110.403 -176.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.3 -42.66 75.13 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.205 0.602 . . . . 71.51 111.909 175.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 50.1 t -71.47 -48.62 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 123.903 0.881 . . . . 63.23 111.847 -176.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 53.2 t -87.49 -34.38 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-N 115.731 -0.668 . . . . 74.41 111.472 -173.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 85.21 113.88 0.74 Allowed Glycine 0 C--N 1.337 0.637 0 N-CA-C 111.989 -0.445 . . . . 72.35 111.989 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.44 ' HA3' ' CE1' ' C' ' 277' ' ' TYR . . . -149.7 -136.52 2.62 Favored Glycine 0 C--O 1.219 -0.805 0 CA-C-O 119.386 -0.675 . . . . 55.24 111.747 -178.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? -114.92 129.98 56.82 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 117.684 0.742 . . . . 45.21 110.444 -177.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.461 HG21 HD21 ' A' ' 197' ' ' LEU . 7.1 m -128.31 157.72 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.711 1.205 . . . . 63.11 108.489 171.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 211' ' ' ARG . . . . . 0.616 ' HG2' HG13 ' B' ' 421' ' ' VAL . 7.6 tpp180 -87.98 122.09 31.17 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 109.307 -0.627 . . . . 71.41 109.307 -175.3 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -99.69 110.98 23.36 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.943 -0.762 . . . . 62.04 108.943 176.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 17.0 tpt -82.37 116.48 21.88 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.701 -0.852 . . . . 71.23 108.701 177.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 19.7 p -108.23 -172.29 2.03 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.024 0.53 . . . . 74.1 109.583 -176.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 81.3 mt -67.15 -26.14 66.51 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.861 0.864 . . . . 63.31 112.372 -176.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -105.26 -19.19 13.88 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.15 0.58 . . . . 64.44 111.989 -175.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 152.68 -178.83 29.61 Favored Glycine 0 C--N 1.343 0.933 0 CA-C-O 119.92 -0.378 . . . . 33.0 112.426 -177.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -82.85 149.86 14.12 Favored 'Trans proline' 0 CA--C 1.552 1.423 0 C-N-CA 122.749 2.3 . . . . 70.23 113.545 -176.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 27.9 m -136.22 -178.81 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 125.657 1.583 . . . . 73.4 108.008 172.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.506 ' HG2' HH11 ' A' ' 211' ' ' ARG . 50.2 mt-10 -107.2 131.2 54.43 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 109.483 -0.562 . . . . 75.04 109.483 168.089 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 7.0 m -111.65 128.82 67.95 Favored 'Isoleucine or valine' 0 C--O 1.243 0.738 0 N-CA-C 108.242 -1.022 . . . . 74.13 108.242 167.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -78.23 99.2 6.16 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 109.001 -0.74 . . . . 60.25 109.001 177.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.731 ' HA ' HD12 ' B' ' 441' ' ' ILE . 14.8 p -67.64 137.53 93.09 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 124.066 0.947 . . . . 63.14 109.276 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -76.3 170.86 19.18 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 122.242 1.961 . . . . 75.51 110.958 -177.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.75 161.17 45.96 Favored 'Trans proline' 0 C--N 1.371 1.728 0 C-N-CA 121.378 1.385 . . . . 72.53 112.226 172.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 57.7 mtt-85 64.4 24.19 13.15 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 125.188 1.395 . . . . 74.04 112.02 168.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.537 HG23 HD21 ' A' ' 233' ' ' LEU . 98.6 m -68.27 102.38 1.37 Allowed 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 125.238 1.415 . . . . 64.32 111.162 -178.395 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -87.72 139.16 30.81 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.981 1.312 . . . . 75.32 110.88 -176.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' ALA . . . . . 0.458 ' HA ' ' HB ' ' A' ' 253' ' ' VAL . . . -68.13 156.98 36.33 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.405 0.682 . . . . 62.31 112.197 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 84.42 -19.08 20.66 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-N 115.886 -0.597 . . . . 73.32 112.929 -179.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -90.92 160.96 15.4 Favored 'General case' 0 C--N 1.351 0.672 0 C-N-CA 123.762 0.825 . . . . 74.0 110.654 178.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -115.95 114.44 24.63 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.193 0.997 . . . . 72.22 108.615 -177.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.537 HD21 HG23 ' A' ' 227' ' ' THR . 84.9 mt -75.71 118.67 18.78 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.817 0.847 . . . . 71.4 110.64 -177.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 27.2 ttm-85 -90.48 103.13 15.85 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 109.492 -0.559 . . . . 64.14 109.492 172.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.67 HD13 HG12 ' B' ' 441' ' ' ILE . 0.1 OUTLIER -97.17 123.54 40.97 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.477 0.711 . . . . 61.12 109.174 173.968 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -69.98 132.09 45.4 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 114.592 -1.185 . . . . 64.43 113.48 -169.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 79.44 3.3 88.67 Favored Glycine 0 C--N 1.354 1.575 0 CA-C-N 115.774 -0.648 . . . . 74.2 114.433 171.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.602 ' HG3' HD12 ' A' ' 235' ' ' LEU . 0.0 OUTLIER -90.38 -7.26 53.66 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 112.536 0.569 . . . . 73.01 112.536 -172.406 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -85.91 -166.07 41.6 Favored Glycine 0 C--N 1.351 1.399 0 C-N-CA 123.101 0.382 . . . . 74.43 113.791 175.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -89.64 147.95 38.96 Favored Pre-proline 0 N--CA 1.485 1.308 0 C-N-CA 123.375 0.67 . . . . 73.13 111.429 -171.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -66.3 146.75 81.87 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 123.576 2.851 . . . . 73.33 113.28 174.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -177.87 -155.3 13.79 Favored Glycine 0 CA--C 1.534 1.278 0 CA-C-O 118.969 -0.906 . . . . 73.52 112.138 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -64.49 -33.52 56.8 Favored 'Trans proline' 0 C--N 1.385 2.472 0 C-N-CA 123.746 2.964 . . . . 70.45 113.522 -176.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -89.96 21.03 3.84 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.136 0.574 . . . . 70.11 111.165 176.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 72.38 -152.14 47.69 Favored Glycine 0 C--N 1.35 1.346 0 N-CA-C 110.803 -0.919 . . . . 62.24 110.803 -169.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 27.4 mtp180 -76.29 137.43 39.89 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 109.608 -0.516 . . . . 75.41 109.608 170.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -80.39 -161.5 24.8 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 112.155 -0.378 . . . . 42.24 112.155 173.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -110.92 -174.38 2.46 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 123.734 0.814 . . . . 75.44 110.138 -178.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.526 ' HB3' ' HG ' ' A' ' 235' ' ' LEU . 18.6 tp -127.68 133.22 49.6 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.381 -0.97 . . . . 70.31 108.381 175.066 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.505 ' HB2' ' HA ' ' A' ' 194' ' ' TYR . 3.1 m-85 -96.55 126.34 41.67 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 108.611 -0.885 . . . . 52.51 108.611 173.055 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.559 HD13 HD22 ' A' ' 197' ' ' LEU . 88.7 mt -115.52 108.66 16.74 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.691 -0.855 . . . . 72.24 108.691 172.051 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -76.65 115.87 16.8 Favored 'General case' 0 C--N 1.348 0.529 0 N-CA-C 106.817 -1.549 . . . . 75.41 106.817 -176.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.458 ' HB ' ' HA ' ' A' ' 229' ' ' ALA . 22.7 t -76.25 116.06 18.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 CA-C-N 115.548 -0.751 . . . . 24.43 110.68 -169.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -119.15 91.68 3.61 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 107.091 -1.448 . . . . 73.14 107.091 178.403 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.406 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 62.5 mt -81.23 129.89 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 116.469 -0.332 . . . . 74.34 110.292 -176.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 32.3 p -120.28 173.22 7.26 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.645 1.178 . . . . 73.43 109.618 173.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 257' ' ' ILE . . . . . 0.449 HD12 ' H ' ' A' ' 259' ' ' GLU . 2.1 pp -125.14 155.03 71.64 Favored Pre-proline 0 CA--C 1.562 1.433 0 N-CA-C 107.888 -1.152 . . . . 73.4 107.888 173.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 258' ' ' PRO . . . . . 0.499 ' HG3' ' OH ' ' C' ' 276' ' ' TYR . 37.9 Cg_endo -78.51 18.6 0.94 Allowed 'Trans proline' 0 N--CA 1.512 2.568 0 C-N-CA 123.382 2.721 . . . . 74.45 115.64 -164.145 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.449 ' H ' HD12 ' A' ' 257' ' ' ILE . 5.9 mm-40 51.67 -122.91 2.06 Favored 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 124.015 0.926 . . . . 63.24 111.959 -169.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 260' ' ' ARG . . . . . 0.515 ' HD3' ' H ' ' A' ' 260' ' ' ARG . 0.0 OUTLIER -67.34 149.54 50.19 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 118.679 0.672 . . . . 75.12 111.743 -169.162 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 69.8 mt -120.77 160.67 22.89 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.596 0.758 . . . . 55.32 111.657 -171.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 27.5 p -90.56 148.34 38.47 Favored Pre-proline 0 CA--C 1.556 1.183 0 CA-C-O 117.782 -1.104 . . . . 44.34 108.92 170.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 263' ' ' PRO . . . . . 0.514 ' O ' ' HB3' ' A' ' 266' ' ' GLU . 31.5 Cg_exo -35.23 -54.0 0.7 Allowed 'Trans proline' 0 C--N 1.394 2.932 1 C-N-CA 125.418 4.079 . . . . 74.33 117.298 -167.453 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -77.87 -38.29 46.31 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 121.962 -0.461 . . . . 71.44 111.439 -176.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -64.91 -26.54 68.36 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 122.912 0.485 . . . . 64.2 110.623 173.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 266' ' ' GLU . . . . . 0.514 ' HB3' ' O ' ' A' ' 263' ' ' PRO . 7.9 tp10 -63.14 -58.35 7.51 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 108.353 -0.98 . . . . 73.45 108.353 172.216 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -66.31 -18.31 65.28 Favored 'General case' 0 CA--C 1.553 1.086 0 CA-C-N 115.321 -0.854 . . . . 64.12 112.871 177.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 41.5 tp -78.27 -47.0 18.83 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.691 0.797 . . . . 73.14 110.412 -177.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 68.6 m95 -63.08 -38.13 89.95 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.478 -0.783 . . . . 75.0 110.495 173.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 270' ' ' LYS . . . . . 0.5 ' HG3' HG23 ' C' ' 206' ' ' VAL . 0.9 OUTLIER -63.45 -44.07 95.57 Favored 'General case' 0 CA--C 1.557 1.216 0 O-C-N 123.672 0.607 . . . . 62.43 111.778 175.311 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 29.8 mtmm -57.18 -49.89 74.56 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 123.124 0.57 . . . . 70.22 110.664 175.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 24.7 mt -51.73 -51.0 59.49 Favored 'General case' 0 C--O 1.216 -0.7 0 O-C-N 124.596 1.185 . . . . 63.4 110.862 175.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -68.19 -38.42 81.96 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 113.935 1.087 . . . . 64.51 113.935 -169.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -76.96 -42.79 37.68 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 123.467 0.48 . . . . 74.35 110.154 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 275' ' ' ALA . . . . . 0.414 ' HB1' ' NH2' ' A' ' 279' ' ' ARG . . . -66.02 -30.1 70.58 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.82 -0.627 . . . . 71.44 110.899 175.018 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -67.71 -60.17 2.74 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.377 1.071 . . . . 75.02 109.636 177.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -60.35 -41.72 94.23 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.345 1.058 . . . . 70.12 111.017 -172.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -60.89 -20.59 62.21 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.337 0.655 . . . . 75.41 112.705 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 279' ' ' ARG . . . . . 0.414 ' NH2' ' HB1' ' A' ' 275' ' ' ALA . 87.6 mtm180 -128.99 18.37 6.09 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.8 0.84 . . . . 74.13 111.005 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.022 0 CA-C-O 118.412 -0.804 . . . . 72.21 110.754 -175.734 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.404 ' SD ' ' N ' ' B' ' 1' ' ' MET . 1.0 OUTLIER . . . . . 0 N--CA 1.482 1.171 0 N-CA-C 108.775 -0.824 . . . . 71.44 108.775 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.577 ' HE3' ' HA ' ' B' ' 2' ' ' LYS . 0.4 OUTLIER -70.77 90.03 0.77 Allowed 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 109.425 -0.583 . . . . 54.1 109.425 179.238 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 23.9 tm0? -113.11 160.36 18.27 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.253 1.021 . . . . 74.04 108.95 -173.118 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 4' ' ' SER . . . . . 0.463 ' H ' HG21 ' A' ' 126' ' ' THR . 80.7 p 59.25 -80.45 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 126.785 2.034 . . . . 52.14 111.655 -177.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 6.4 m -76.65 153.88 34.81 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 109.01 -0.737 . . . . 70.11 109.01 172.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.564 HG21 ' HA ' ' A' ' 125' ' ' LEU . 31.7 pt -128.74 173.76 13.14 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 CA-C-O 121.033 0.444 . . . . 64.44 111.207 -174.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -146.54 127.66 14.69 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.395 -0.821 . . . . 72.01 109.458 -177.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.549 HD21 HD21 ' A' ' 174' ' ' LEU . 38.3 tp -73.1 150.73 42.02 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.419 0.688 . . . . 75.22 111.049 -176.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.68 -60.37 2.38 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 122.873 0.469 . . . . 62.4 111.027 176.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 67.3 mt 62.17 127.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 124.584 1.153 . . . . 74.1 110.114 -163.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 24.6 mt -118.35 71.7 9.37 Favored Pre-proline 0 CA--C 1.561 1.383 0 O-C-N 121.706 -0.621 . . . . 45.35 110.318 178.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -91.07 -24.4 0.42 Allowed 'Trans proline' 0 C--N 1.385 2.484 0 C-N-CA 122.44 2.093 . . . . 61.33 113.041 174.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -158.27 13.86 0.2 Allowed 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 112.07 0.396 . . . . 75.01 112.07 -173.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 37.7 tp -63.81 160.5 17.23 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.81 -0.441 . . . . 64.54 109.81 175.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 15' ' ' PHE . . . . . 0.406 ' HE2' HG21 ' B' ' 343' ' ' VAL . 78.3 t80 -53.29 96.57 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 124.203 1.001 . . . . 60.01 111.82 -178.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 54.2 p -116.59 -177.87 0.48 Allowed Pre-proline 0 CA--C 1.556 1.176 0 C-N-CA 125.308 1.443 . . . . 51.11 108.428 176.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -49.25 143.05 20.36 Favored 'Trans proline' 0 C--N 1.383 2.354 0 C-N-CA 121.944 1.762 . . . . 62.42 112.711 162.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 10.7 m -72.21 86.24 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.348 0 CA-C-O 122.205 1.003 . . . . 61.41 112.013 -171.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 37.6 p -89.72 114.02 25.63 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.27 -0.877 . . . . 71.22 111.328 -177.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp 68.66 -68.65 0.17 Allowed 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 126.153 1.781 . . . . 62.34 111.93 174.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.57 93.08 0.48 Allowed 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 107.845 -1.169 . . . . 75.34 107.845 166.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 16.6 ptt180 -146.71 13.86 1.19 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.739 0.815 . . . . 73.31 111.131 -176.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 23' ' ' THR . . . . . 0.629 ' HB ' ' HD2' ' B' ' 24' ' ' PRO . 28.2 p 57.72 -173.89 0.02 OUTLIER Pre-proline 0 CA--C 1.577 2.012 0 C-N-CA 125.195 1.398 . . . . 72.45 111.391 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 24' ' ' PRO . . . . . 0.629 ' HD2' ' HB ' ' B' ' 23' ' ' THR . 26.5 Cg_endo -65.08 -2.01 5.12 Favored 'Trans proline' 0 C--N 1.398 3.166 0 CA-C-N 121.569 1.596 . . . . 74.55 114.075 165.359 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 78.72 -32.87 0.15 Allowed 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 126.004 1.722 . . . . 74.53 113.601 168.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -113.83 27.35 0.1 OUTLIER Pre-proline 0 CA--C 1.582 2.205 0 N-CA-C 114.806 1.41 . . . . 75.13 114.806 176.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -77.69 -10.57 17.07 Favored 'Trans proline' 0 C--N 1.411 3.842 0 CA-C-N 123.508 2.288 . . . . 71.1 110.848 168.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 30.0 m -100.63 -157.72 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 C-N-CA 125.191 1.397 . . . . 73.51 108.967 173.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 76.3 mt 81.98 -50.3 0.23 Allowed 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 126.054 1.742 . . . . 62.2 111.93 174.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 65.63 112.86 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 125.146 1.379 . . . . 70.24 112.152 -178.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 21.3 p-10 -93.28 35.09 1.1 Allowed 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 125.017 1.327 . . . . 74.34 111.278 -177.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 32' ' ' ARG . . . . . 0.609 HH22 ' HB2' ' B' ' 119' ' ' ASP . 27.8 ptt180 -63.39 -20.8 65.85 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.785 0.834 . . . . 72.22 112.221 179.08 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.22 80.86 0.72 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.989 0.916 . . . . 73.31 110.381 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -164.23 35.97 0.08 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.102 0.961 . . . . 53.33 110.238 -175.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -76.87 -44.82 30.58 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 116.407 -0.36 . . . . 73.13 110.187 177.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 126.26 -28.36 4.82 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-O 119.403 -0.665 . . . . 74.33 114.311 171.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 37' ' ' ASP . . . . . 0.546 ' HA ' ' HG2' ' C' ' 27' ' ' LYS . 18.9 m-20 -64.02 94.46 0.1 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.025 0.53 . . . . 61.44 111.839 -174.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 38' ' ' ILE . . . . . 0.512 HG23 ' HD2' ' C' ' 148' ' ' ARG . 39.4 mt -125.12 80.52 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.044 0 N-CA-C 107.583 -1.266 . . . . 75.44 107.583 173.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 75.5 p 56.15 131.79 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 126.931 2.092 . . . . 64.25 115.698 178.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.5 177.65 2.37 Favored Pre-proline 0 CA--C 1.569 1.705 0 CA-C-O 117.482 -1.247 . . . . 64.0 108.494 172.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -82.98 -159.14 0.1 OUTLIER 'Trans proline' 0 C--N 1.4 3.258 0 CA-C-N 122.824 2.044 . . . . 72.44 113.035 -168.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 42' ' ' GLY . . . . . 0.544 ' HA3' ' HA ' ' B' ' 327' ' ' LYS . . . 174.7 -112.81 0.42 Allowed Glycine 0 C--N 1.349 1.285 0 N-CA-C 111.222 -0.751 . . . . 45.24 111.222 179.13 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 43' ' ' GLY . . . . . 0.445 ' HA3' ' HB2' ' B' ' 326' ' ' ASP . . . -97.41 59.09 1.12 Allowed Glycine 0 C--N 1.344 1.02 0 N-CA-C 111.876 -0.49 . . . . 42.15 111.876 178.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.65 75.02 4.21 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.698 0.799 . . . . 63.2 109.39 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.454 ' HG2' ' HA ' ' B' ' 48' ' ' THR . 49.8 ttt180 -84.13 82.62 8.28 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 114.785 -1.098 . . . . 74.21 110.728 -168.156 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 17.6 ttm180 -64.88 134.46 54.08 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.712 0.805 . . . . 75.02 109.688 175.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 9.6 tt 78.83 -30.33 0.15 Allowed 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 125.657 1.583 . . . . 53.22 111.782 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.454 ' HA ' ' HG2' ' B' ' 45' ' ' ARG . 70.9 m 72.4 -63.14 0.44 Allowed 'General case' 0 C--N 1.36 1.028 0 C-N-CA 125.903 1.681 . . . . 51.22 111.362 -176.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.66 47.28 4.89 Favored Glycine 0 C--N 1.342 0.863 0 CA-C-O 120.099 -0.279 . . . . 74.15 112.536 178.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 50' ' ' ASP . . . . . 0.67 ' HB3' ' HB2' ' B' ' 53' ' ' ALA . 10.8 m-20 71.28 -69.51 0.18 Allowed 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 125.567 1.547 . . . . 64.2 111.801 175.216 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 22.8 tp60 63.27 -82.84 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.159 1.383 . . . . 75.3 111.493 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 5.2 m -93.26 52.03 1.72 Allowed 'General case' 0 CA--C 1.55 0.973 0 CA-C-O 121.808 0.813 . . . . 73.31 109.443 -175.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 53' ' ' ALA . . . . . 0.67 ' HB2' ' HB3' ' B' ' 50' ' ' ASP . . . -87.06 22.44 2.04 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.334 0.654 . . . . 73.24 112.697 -172.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.471 ' HA ' ' HB2' ' B' ' 57' ' ' ASP . . . 67.64 25.17 8.28 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 124.869 1.268 . . . . 75.51 110.243 -174.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 50.0 tp -68.53 -67.7 0.45 Allowed 'General case' 0 C--N 1.348 0.533 0 CA-C-N 114.756 -1.111 . . . . 72.35 108.8 -176.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -117.47 12.17 14.08 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.975 0.91 . . . . 73.2 109.709 173.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 57' ' ' ASP . . . . . 0.471 ' HB2' ' HA ' ' B' ' 54' ' ' ALA . 9.6 m-20 -86.07 72.0 10.49 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.588 1.155 . . . . 75.31 110.747 -170.098 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 47.1 m -88.54 81.95 7.03 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.269 -0.878 . . . . 62.01 108.985 178.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 2.5 tt 60.07 70.88 0.6 Allowed 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.871 1.268 . . . . 72.44 110.304 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 18.6 m -74.55 -36.68 63.11 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 121.788 0.804 . . . . 63.51 109.822 173.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -164.81 -56.0 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 105.888 -1.893 . . . . 71.45 105.888 176.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 62' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -49.79 135.97 19.71 Favored Pre-proline 0 CA--C 1.551 0.984 0 CA-C-N 113.156 -1.838 . . . . 72.3 111.067 166.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -49.53 -47.89 21.02 Favored 'Trans proline' 0 C--N 1.394 2.95 0 C-N-CA 123.882 3.054 . . . . 72.24 112.958 -176.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 71.5 -54.89 0.67 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 125.585 1.554 . . . . 72.04 112.587 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm 69.81 15.87 7.89 Favored 'General case' 0 CA--C 1.56 1.346 0 C-N-CA 124.984 1.314 . . . . 65.32 110.327 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -94.12 99.35 11.65 Favored 'General case' 0 C--N 1.351 0.666 0 C-N-CA 124.679 1.191 . . . . 72.41 108.979 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 4.9 tt -151.12 96.04 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 C-N-CA 123.574 0.75 . . . . 72.03 109.13 177.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 61.4 mt 64.4 -76.34 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 C-N-CA 125.434 1.494 . . . . 73.4 110.623 -174.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -144.84 -167.7 2.73 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.065 0.946 . . . . 73.12 109.255 178.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 70' ' ' LEU . . . . . 0.529 HD23 ' H ' ' B' ' 70' ' ' LEU . 2.1 pt? -64.59 83.07 0.04 OUTLIER 'General case' 0 CA--C 1.561 1.392 0 CA-C-O 122.047 0.927 . . . . 44.44 110.387 171.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 8.7 tp -67.12 -29.82 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 123.696 0.798 . . . . 74.32 111.129 -178.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.26 108.92 0.13 Allowed Glycine 0 C--N 1.345 1.074 0 CA-C-N 116.05 -0.523 . . . . 62.21 112.109 -175.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -61.0 102.71 0.22 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.735 0.814 . . . . 63.44 110.152 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.45 55.97 26.01 Favored Glycine 0 C--N 1.356 1.645 0 O-C-N 123.976 0.798 . . . . 64.42 111.934 -177.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 66.9 mtt 67.84 -69.0 0.15 Allowed 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 125.329 1.452 . . . . 74.01 110.085 -166.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 60.07 32.79 76.88 Favored Glycine 0 C--N 1.36 1.916 0 N-CA-C 111.845 -0.502 . . . . 71.13 111.845 -178.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -58.9 -32.96 70.0 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.564 1.145 . . . . 73.03 112.072 -171.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 48.2 t 68.36 47.18 0.98 Allowed 'General case' 0 CA--C 1.55 0.963 0 O-C-N 124.739 1.274 . . . . 51.1 109.335 -177.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -85.66 150.58 24.52 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.45 1.1 . . . . 74.44 111.62 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.492 HG23 ' H ' ' B' ' 81' ' ' THR 0.291 0.0 OUTLIER 50.65 -77.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 C-N-CA 127.631 2.372 . . . . 72.52 113.079 176.02 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' B' B ' 81' ' ' THR . . . . . 0.492 ' H ' HG23 ' B' ' 80' ' ' ILE . 9.4 t -75.88 -18.22 59.49 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.829 0.852 . . . . 71.34 110.627 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 69.02 178.39 0.25 Allowed 'General case' 0 C--N 1.356 0.855 0 C-N-CA 125.052 1.341 . . . . 61.11 111.394 -172.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -100.52 54.7 0.88 Allowed 'General case' 0 C--O 1.243 0.756 0 N-CA-C 108.675 -0.861 . . . . 71.35 108.675 175.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 -69.0 85.7 0.34 Allowed 'General case' 0 C--N 1.353 0.745 0 CA-C-N 115.15 -0.932 . . . . 73.0 109.941 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -116.04 137.16 52.36 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.099 1.359 . . . . 72.23 108.745 -178.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -66.48 116.06 7.05 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 109.239 -0.652 . . . . 63.12 109.239 177.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.83 86.37 0.51 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.549 0.74 . . . . 52.24 111.122 -174.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -109.86 -56.02 2.37 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.803 1.241 . . . . 74.14 108.337 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -88.39 56.69 4.22 Favored Glycine 0 C--N 1.349 1.261 0 CA-C-N 115.154 -0.93 . . . . 54.33 111.224 171.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.88 166.25 22.48 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.591 0.757 . . . . 62.33 110.904 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.2 26.57 1.81 Allowed Glycine 0 CA--C 1.536 1.373 0 N-CA-C 114.448 0.539 . . . . 70.11 114.448 -177.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -97.09 29.89 9.96 Favored Glycine 0 C--N 1.352 1.458 0 C-N-CA 123.493 0.568 . . . . 23.53 112.619 178.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 93' ' ' PHE . . . . . 0.41 ' HA ' ' HB ' ' B' ' 318' ' ' VAL . 87.1 m-85 -68.51 94.82 0.59 Allowed 'General case' 0 C--N 1.352 0.677 0 N-CA-C 109.4 -0.593 . . . . 74.22 109.4 175.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 94' ' ' PHE . . . . . 0.415 ' H ' ' HB ' ' B' ' 318' ' ' VAL . 72.8 t80 -169.69 102.96 0.32 Allowed 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.551 -0.907 . . . . 71.21 108.551 174.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -95.44 -47.93 6.07 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 109.486 -0.561 . . . . 74.14 109.486 174.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.94 -39.54 3.07 Favored Glycine 0 C--N 1.348 1.236 0 CA-C-N 116.142 -0.481 . . . . 72.31 112.718 176.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 9.2 tp -102.79 20.74 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.373 0 CA-C-O 122.036 0.922 . . . . 72.22 109.47 176.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -87.14 155.29 20.18 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 121.83 -0.544 . . . . 75.21 110.925 177.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -142.15 123.86 15.1 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.099 0.96 . . . . 61.12 109.317 -178.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 94.9 mt -127.37 140.82 39.01 Favored Pre-proline 0 N--CA 1.474 0.766 0 C-N-CA 124.122 0.969 . . . . 74.2 108.773 178.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -80.39 98.44 1.09 Allowed 'Trans proline' 0 C--N 1.371 1.728 0 C-N-CA 122.189 1.926 . . . . 72.21 111.001 172.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -68.41 -45.18 73.32 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 109.407 -0.59 . . . . 73.12 109.407 175.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 13.0 t -151.57 -179.17 7.18 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-N 115.117 -0.947 . . . . 75.52 109.723 -176.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . -68.66 90.86 0.25 Allowed Glycine 0 C--N 1.349 1.279 0 N-CA-C 111.313 -0.715 . . . . 51.35 111.313 171.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -65.18 99.24 0.36 Allowed 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 108.407 -0.96 . . . . 75.22 108.407 178.399 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 56.78 -170.45 0.09 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.345 1.058 . . . . 74.44 113.078 -177.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 70.5 p -96.82 24.77 5.8 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 112.878 0.696 . . . . 63.32 112.878 -172.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 31.5 p80 -81.16 69.22 7.72 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-O 122.492 1.139 . . . . 71.44 109.698 173.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -162.74 -62.71 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 106.928 -1.508 . . . . 53.33 106.928 -172.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -79.24 163.41 24.99 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 114.838 -1.074 . . . . 71.24 108.501 164.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 111' ' ' LEU . . . . . 0.588 ' HA ' ' HA ' ' C' ' 243' ' ' PRO . 38.3 mt 62.28 23.94 14.21 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 123.641 0.777 . . . . 64.15 110.874 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 37.0 t-20 -79.32 141.09 37.29 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.749 0.82 . . . . 73.2 110.657 -168.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 113' ' ' LYS . . . . . 0.504 ' HG2' ' H ' ' B' ' 114' ' ' LYS 0.292 0.0 OUTLIER 31.54 -77.64 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 127.802 2.441 . . . . 75.13 114.258 -169.853 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' B' B ' 114' ' ' LYS . . . . . 0.504 ' H ' ' HG2' ' B' ' 113' ' ' LYS . 0.6 OUTLIER -174.83 -165.08 0.18 Allowed 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 107.039 -1.467 . . . . 74.01 107.039 -175.062 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 115' ' ' THR . . . . . 0.446 ' H ' ' HG3' ' B' ' 114' ' ' LYS . 17.1 p -56.1 -70.81 0.1 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.358 0.663 . . . . 73.23 110.324 172.061 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -90.34 -140.0 8.15 Favored Glycine 0 C--N 1.343 0.944 0 N-CA-C 111.458 -0.657 . . . . 55.33 111.458 173.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 117' ' ' LYS . . . . . 0.564 ' H ' ' HD2' ' B' ' 118' ' ' PRO . 10.2 mtpm? -142.0 -58.06 0.02 OUTLIER Pre-proline 0 N--CA 1.485 1.3 0 C-N-CA 124.343 1.057 . . . . 70.25 110.993 176.342 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 118' ' ' PRO . . . . . 0.779 ' HA ' ' HB2' ' B' ' 336' ' ' GLU . 62.7 Cg_endo -70.37 -49.57 0.46 Allowed 'Trans proline' 0 C--N 1.397 3.129 0 C-N-CA 121.217 1.278 . . . . 60.53 113.27 -172.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 119' ' ' ASP . . . . . 0.609 ' HB2' HH22 ' B' ' 32' ' ' ARG . 15.3 t70 -161.07 153.92 20.99 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 124.56 1.144 . . . . 75.33 107.958 -175.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 120' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -122.14 -15.89 7.62 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.126 0.57 . . . . 70.1 111.309 -168.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 6.0 m -134.22 -57.31 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 113.606 0.965 . . . . 74.32 113.606 -170.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 53.6 m -79.96 -67.85 0.73 Allowed 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.17 0.51 . . . . 75.24 111.515 -170.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -88.37 -60.99 1.81 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.85 1.26 . . . . 64.3 111.028 -172.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 124' ' ' SER . . . . . 0.561 ' H ' ' HB3' ' B' ' 119' ' ' ASP . 39.2 m 56.92 -159.36 0.24 Allowed 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 125.329 1.452 . . . . 43.31 112.259 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -157.29 149.41 22.67 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.303 0.641 . . . . 73.02 110.733 178.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -153.08 160.6 42.95 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.269 1.028 . . . . 74.13 109.51 177.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 59.4 p -156.02 -178.22 7.15 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 112.652 0.612 . . . . 70.01 112.652 -171.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -76.85 146.58 37.65 Favored 'General case' 0 C--N 1.354 0.785 0 C-N-CA 123.896 0.878 . . . . 72.01 109.963 171.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 129' ' ' THR . . . . . 0.518 ' HB ' HD21 ' B' ' 155' ' ' LEU . 7.5 m -71.46 -11.27 60.79 Favored 'General case' 0 CA--C 1.556 1.173 0 C-N-CA 123.097 0.559 . . . . 54.34 111.464 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.88 147.98 50.57 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.126 0.57 . . . . 44.22 111.133 172.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 131' ' ' TRP . . . . . 0.41 ' HA ' ' HB2' ' C' ' 187' ' ' ARG . 20.7 p90 -55.43 -25.55 36.72 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 125.045 1.338 . . . . 73.51 113.201 -174.537 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 132' ' ' SER . . . . . 0.623 ' HB3' HG23 ' B' ' 135' ' ' VAL . 39.1 t -122.73 149.12 44.51 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 123.648 0.779 . . . . 51.4 110.557 178.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 6.5 m -68.92 -28.52 66.73 Favored 'General case' 0 CA--C 1.551 0.995 0 N-CA-C 109.194 -0.669 . . . . 62.25 109.194 167.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . -68.86 -8.14 56.94 Favored Glycine 0 C--N 1.357 1.716 0 CA-C-N 114.727 -1.124 . . . . 55.15 115.173 -178.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 135' ' ' VAL . . . . . 0.623 HG23 ' HB3' ' B' ' 132' ' ' SER . 39.6 t -77.36 -32.81 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 CA-C-N 117.568 0.684 . . . . 73.24 109.722 174.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt 66.41 15.25 10.04 Favored 'General case' 0 CA--C 1.572 1.789 0 C-N-CA 125.024 1.33 . . . . 52.43 112.833 170.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 137' ' ' THR . . . . . 0.481 HG23 HG12 ' B' ' 135' ' ' VAL . 11.5 p -69.93 100.7 1.62 Allowed 'General case' 0 N--CA 1.481 1.093 0 O-C-N 121.842 -0.536 . . . . 75.31 111.257 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 55.6 t80 68.08 -80.26 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.553 1.541 . . . . 75.52 110.345 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 4.7 t30 61.56 93.7 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.984 1.314 . . . . 73.24 112.085 176.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . 170.66 42.37 0.03 OUTLIER Glycine 0 C--N 1.354 1.542 0 CA-C-O 119.625 -0.541 . . . . 65.04 114.065 176.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . 76.12 -35.2 0.25 Allowed 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 125.278 1.431 . . . . 75.34 114.114 174.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . 0.265 0.3 OUTLIER 42.85 -86.64 0.01 OUTLIER 'General case' 0 CA--C 1.567 1.622 0 C-N-CA 126.11 1.764 . . . . 70.15 114.026 -176.901 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.32 -35.03 4.83 Favored Glycine 0 C--N 1.356 1.668 0 N-CA-C 112.141 -0.384 . . . . 61.25 112.141 -176.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 42.4 t -102.59 164.12 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 107.581 -1.266 . . . . 75.31 107.581 171.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -64.28 -43.87 93.46 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 118.325 0.511 . . . . 64.3 111.66 -178.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 1.7 mp 72.05 -29.07 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.568 1.654 0 C-N-CA 125.323 1.449 . . . . 72.52 112.308 -176.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 36.6 p-80 37.73 71.86 0.14 Allowed 'General case' 0 C--N 1.373 1.613 0 C-N-CA 125.277 1.431 . . . . 72.43 110.926 -163.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -54.1 131.85 41.71 Favored 'General case' 0 C--N 1.359 0.999 0 CA-C-N 114.163 -1.381 . . . . 73.05 110.763 -168.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 149' ' ' LYS . . . . . . . . . . . . . 31.6 mtmm 71.16 -80.26 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.859 1.664 . . . . 72.23 109.152 -164.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 34.5 t0 178.65 160.48 0.62 Allowed 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.637 1.175 . . . . 74.11 109.127 177.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 69.85 171.66 0.1 Allowed Pre-proline 0 N--CA 1.491 1.598 0 C-N-CA 124.724 1.21 . . . . 74.43 112.073 177.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.86 -173.43 0.2 Allowed 'Trans proline' 0 C--N 1.389 2.677 0 C-N-CA 122.618 2.212 . . . . 42.51 113.721 167.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 47.5 m 76.96 -53.3 0.57 Allowed 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 125.772 1.629 . . . . 74.2 110.391 -172.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 65.2 mt 64.67 -80.72 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.227 0 C-N-CA 125.132 1.373 . . . . 74.25 112.186 169.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 155' ' ' LEU . . . . . 0.518 HD21 ' HB ' ' B' ' 129' ' ' THR . 0.9 OUTLIER -121.63 41.4 3.37 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.894 0.878 . . . . 72.1 111.04 -174.331 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 79.91 -31.14 0.13 Allowed 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 125.77 1.628 . . . . 72.23 112.327 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 157' ' ' MET . . . . . 0.546 ' HB3' ' HG2' ' C' ' 252' ' ' GLU . 51.6 mtt 69.09 25.03 5.93 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.731 1.212 . . . . 53.54 111.618 -173.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 158' ' ' ALA . . . . . . . . . . . . . . . 68.71 -66.7 0.23 Allowed 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 125.931 1.693 . . . . 34.04 112.528 178.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 159' ' ' LYS . . . . . 0.571 ' HA ' HG21 ' C' ' 196' ' ' THR . 89.0 mttt 60.83 61.43 1.66 Allowed 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.833 1.253 . . . . 55.45 110.686 178.24 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -84.31 54.21 2.9 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 114.878 -1.055 . . . . 70.22 109.657 174.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 161' ' ' ALA . . . . . 0.429 ' HA ' ' HA ' ' B' ' 356' ' ' ASN . . . -175.9 132.31 0.26 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.655 1.182 . . . . 71.1 109.495 -174.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 162' ' ' GLY . . . . . 0.511 ' H ' ' HB2' ' B' ' 356' ' ' ASN . . . 170.56 -53.59 0.19 Allowed Glycine 0 C--N 1.354 1.566 0 N-CA-C 112.139 -0.384 . . . . 73.4 112.139 178.168 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 1.5 pp -129.15 138.3 51.7 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.952 0.901 . . . . 65.02 110.642 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 164' ' ' ALA . . . . . . . . . . . . . . . -71.09 102.13 2.4 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.845 0.858 . . . . 75.34 111.854 -171.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 21.5 p -90.03 100.14 13.02 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.345 0.658 . . . . 64.15 110.243 174.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . -84.41 59.39 4.93 Favored Glycine 0 C--N 1.351 1.396 0 CA-C-N 115.965 -0.561 . . . . 71.15 112.596 -177.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 167' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -150.79 -0.93 0.38 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.381 1.072 . . . . 72.31 108.968 178.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 8.1 p -161.85 34.28 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.219 0 CA-C-O 122.254 1.026 . . . . 74.13 108.72 -173.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 10.3 m -55.48 -46.29 76.88 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 114.154 -1.384 . . . . 54.35 111.552 -174.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 6.5 m -112.5 -77.37 0.58 Allowed 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.061 -1.089 . . . . 63.1 108.061 174.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . 174.89 55.36 0.0 OUTLIER 'General case' 0 C--O 1.242 0.665 0 N-CA-C 106.453 -1.684 . . . . 53.32 106.453 -172.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 172' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -54.99 97.7 0.02 OUTLIER 'General case' 0 C--N 1.357 0.903 0 CA-C-N 115.306 -0.861 . . . . 73.22 111.814 -173.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 173' ' ' LEU . . . . . . . . . . . . . 1.2 pp -87.89 21.23 2.74 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.354 1.062 . . . . 74.23 111.413 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 174' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -76.99 -6.78 53.98 Favored 'General case' 0 CA--C 1.562 1.42 0 C-N-CA 124.738 1.215 . . . . 74.45 110.312 178.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 175' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -68.4 154.14 42.38 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.675 1.19 . . . . 74.1 110.015 168.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 176' ' ' ALA . . . . . 0.425 ' H ' ' HB3' ' B' ' 191' ' ' TYR . . . -141.41 26.56 1.96 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.293 0.637 . . . . 74.11 111.911 -174.558 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 92.5 m -60.52 123.66 74.94 Favored Pre-proline 0 CA--C 1.559 1.308 0 C-N-CA 123.158 0.583 . . . . 64.31 110.267 175.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 178' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.44 -3.38 12.9 Favored 'Trans proline' 0 C--N 1.387 2.575 0 C-N-CA 123.241 2.627 . . . . 74.53 113.887 -173.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -70.21 95.89 1.04 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.245 0.618 . . . . 61.34 110.41 176.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.89 -39.57 93.74 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.449 0.699 . . . . 74.4 110.676 176.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 181' ' ' LEU . . . . . 0.459 HD21 HD11 ' C' ' 149' ' ' ILE . 14.8 tp -163.08 27.85 0.09 Allowed 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 114.769 -1.105 . . . . 62.04 108.341 176.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 182' ' ' VAL . . . . . 0.7 HG22 ' HA ' ' C' ' 138' ' ' VAL . 53.9 t -80.58 113.78 20.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 115.768 -0.651 . . . . 71.31 110.892 -171.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -90.21 -40.58 12.1 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.507 -0.769 . . . . 65.24 110.231 170.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 184' ' ' HIS . . . . . 0.671 ' HB3' ' HB3' ' B' ' 187' ' ' SER . 49.7 t-80 52.65 35.86 19.36 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 124.813 1.245 . . . . 74.15 111.599 175.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 185' ' ' VAL . . . . . . . . . . . . . 48.9 t 56.71 82.37 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 124.755 1.222 . . . . 71.33 110.326 -170.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 186' ' ' THR . . . . . 0.67 HG22 ' HG2' ' C' ' 122' ' ' GLU . 38.1 p 61.79 11.88 4.34 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 125.738 1.615 . . . . 51.31 114.059 172.437 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 187' ' ' SER . . . . . 0.671 ' HB3' ' HB3' ' B' ' 184' ' ' HIS . 35.4 t -83.92 143.39 29.88 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.491 0.716 . . . . 62.14 110.328 178.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 188' ' ' ARG . . . . . 0.445 ' HG3' ' HG3' ' C' ' 124' ' ' PRO . 35.9 ttt180 -149.66 137.65 20.39 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.859 0.864 . . . . 71.52 110.291 -174.222 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -127.43 158.43 37.34 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.946 0.898 . . . . 72.52 109.114 169.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 190' ' ' CYS . . . . . . . . . . . . . 74.8 m -144.2 127.82 17.11 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.732 0.813 . . . . 70.33 109.681 178.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 191' ' ' TYR . . . . . 0.425 ' HB3' ' H ' ' B' ' 176' ' ' ALA . 94.0 t80 -85.49 132.34 34.22 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.134 0.974 . . . . 74.04 109.701 178.152 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 192' ' ' GLY . . . . . 0.442 ' H ' ' HG2' ' B' ' 312' ' ' PRO . . . -67.11 134.99 31.74 Favored Glycine 0 C--N 1.349 1.297 0 CA-C-O 118.221 -1.321 . . . . 64.22 111.664 176.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 193' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -50.15 -29.23 21.8 Favored 'Trans proline' 0 C--N 1.388 2.61 0 C-N-CA 124.154 3.236 . . . . 64.32 114.964 -169.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 194' ' ' SER . . . . . . . . . . . . . 31.7 m 71.62 -65.77 0.33 Allowed 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 125.378 1.471 . . . . 24.51 112.107 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 195' ' ' ALA . . . . . . . . . . . . . . . -89.39 166.83 13.48 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.438 0.695 . . . . 74.32 110.613 174.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 31.8 m -86.66 -67.12 0.84 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.693 0.797 . . . . 73.32 109.792 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 39.8 t -167.56 102.63 0.5 Allowed 'General case' 0 C--N 1.35 0.605 0 N-CA-C 108.63 -0.878 . . . . 75.11 108.63 178.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 198' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -106.09 17.84 22.95 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.731 -0.668 . . . . 51.12 111.189 -175.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 64.1 mttm 68.51 -69.2 0.16 Allowed 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 125.24 1.416 . . . . 74.4 110.685 -177.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 200' ' ' CYS . . . . . . . . . . . . . 59.4 m 74.68 96.0 0.04 OUTLIER Pre-proline 0 N--CA 1.482 1.144 0 C-N-CA 125.398 1.479 . . . . 73.31 111.453 173.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 201' ' ' PRO . . . . . 0.554 ' HA ' ' HG2' ' B' ' 363' ' ' GLU . 32.1 Cg_exo -58.72 89.63 0.06 OUTLIER 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 123.317 2.678 . . . . 71.34 112.895 178.202 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 160.63 24.06 0.02 OUTLIER Glycine 0 C--N 1.345 1.07 0 CA-C-N 115.645 -0.707 . . . . 63.04 113.678 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -84.71 -19.24 33.06 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 117.647 0.724 . . . . 71.33 110.553 172.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -147.83 139.82 24.14 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.532 0.733 . . . . 74.01 110.162 176.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 205' ' ' LEU . . . . . . . . . . . . . 59.3 tp -76.41 -54.92 6.06 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.011 -0.737 . . . . 51.03 109.011 173.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.17 -91.04 0.56 Allowed 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.317 1.047 . . . . 62.32 108.983 175.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 207' ' ' LYS . . . . . 0.533 ' HD3' ' HA3' ' C' ' 217' ' ' GLY . 0.2 OUTLIER 61.9 -82.23 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 124.415 1.086 . . . . 74.32 111.442 -178.782 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 112.09 127.0 4.82 Favored Glycine 0 C--N 1.346 1.117 0 N-CA-C 110.604 -0.998 . . . . 71.52 110.604 -172.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 209' ' ' GLY . . . . . 0.527 ' HA3' HG23 ' B' ' 364' ' ' THR . . . -66.41 -48.01 66.48 Favored Glycine 0 C--N 1.352 1.422 0 N-CA-C 111.391 -0.684 . . . . 42.21 111.391 174.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 62.1 mttm 62.59 -81.22 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.547 1.139 . . . . 74.51 111.128 170.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . -72.61 80.3 0.66 Allowed Glycine 0 C--N 1.348 1.219 0 N-CA-C 108.665 -1.774 . . . . 74.43 108.665 159.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 18.4 t -83.39 31.64 0.46 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.685 1.194 . . . . 74.04 111.078 -172.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 19.8 pt -90.16 29.95 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 C-N-CA 125.413 1.485 . . . . 64.4 110.019 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 79.5 p -63.55 -23.16 67.27 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.429 1.092 . . . . 75.43 112.323 -171.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 215' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -80.12 -26.59 39.41 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.656 0.782 . . . . 73.31 111.013 176.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 16.4 tm0? 81.09 -55.26 0.3 Allowed 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 125.936 1.694 . . . . 61.42 113.369 167.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 1.8 tt -84.21 62.97 7.45 Favored 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 123.392 0.677 . . . . 75.4 111.412 -166.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 8.3 mp 74.93 -52.76 0.67 Allowed 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 125.61 1.564 . . . . 71.43 113.755 168.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 73.66 -41.77 0.5 Allowed 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 125.866 1.666 . . . . 71.24 111.698 -174.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 220' ' ' ALA . . . . . 0.591 ' HA ' HD22 ' B' ' 226' ' ' LEU . . . -63.24 -17.77 62.82 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.685 0.794 . . . . 61.1 111.908 166.296 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 221' ' ' ARG . . . . . . . . . . . . . 38.4 mtp-105 70.1 -81.17 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 125.54 1.536 . . . . 73.55 111.275 172.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -135.98 -9.72 2.05 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.845 0.858 . . . . 42.52 111.099 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.02 -35.37 78.16 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.88 1.272 . . . . 61.02 110.326 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 86.0 t 69.0 -68.54 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 125.455 1.502 . . . . 74.2 111.051 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 8.5 t -65.2 -41.95 94.03 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 123.916 0.887 . . . . 54.34 110.94 174.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 226' ' ' LEU . . . . . 0.591 HD22 ' HA ' ' B' ' 220' ' ' ALA . 37.8 tp 50.88 -80.76 0.01 OUTLIER 'General case' 0 C--N 1.366 1.321 0 C-N-CA 125.949 1.7 . . . . 74.43 112.203 -176.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . -167.96 12.03 0.06 OUTLIER Glycine 0 C--N 1.341 0.85 0 CA-C-N 116.485 -0.325 . . . . 51.31 112.476 176.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 88.7 -32.61 4.46 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-O 119.875 -0.403 . . . . 72.41 112.701 -173.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 229' ' ' GLY . . . . . 0.529 ' HA3' ' HA ' ' B' ' 283' ' ' ASP . . . 69.26 -104.05 1.2 Allowed Glycine 0 C--N 1.352 1.456 0 N-CA-C 112.511 -0.236 . . . . 70.24 112.511 175.516 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -64.7 -37.41 87.49 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.489 0.716 . . . . 70.23 110.243 172.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 231' ' ' LYS . . . . . . . . . . . . . 49.1 mttp 63.26 10.86 4.95 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 125.511 1.524 . . . . 73.24 112.169 178.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 86.6 m -121.34 110.59 16.29 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.151 0.581 . . . . 74.24 110.951 -168.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -95.11 95.63 8.69 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 108.408 -0.96 . . . . 70.41 108.408 173.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -144.76 -162.08 1.42 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.186 0.594 . . . . 72.31 110.095 -174.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 235' ' ' GLU . . . . . 0.524 ' HG3' ' HE2' ' C' ' 209' ' ' LYS . 17.9 tp10 76.76 121.27 0.05 OUTLIER 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 125.069 1.348 . . . . 54.41 112.087 173.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 236' ' ' THR . . . . . 0.705 HG23 HD21 ' B' ' 247' ' ' LEU . 49.3 m -96.25 -61.82 1.38 Allowed 'General case' 0 C--O 1.24 0.557 0 C-N-CA 125.614 1.565 . . . . 73.34 110.695 -173.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 237' ' ' ALA . . . . . 0.501 ' HA ' ' HD3' ' C' ' 209' ' ' LYS . . . 179.54 -178.3 0.37 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.574 0.75 . . . . 71.12 111.617 -171.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 94.0 m -152.7 38.46 0.53 Allowed 'General case' 0 N--CA 1.485 1.31 0 CA-C-O 123.722 1.725 . . . . 71.31 106.642 162.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 239' ' ' ALA . . . . . 0.611 ' HB2' ' H ' ' C' ' 222' ' ' ALA . . . -100.31 -178.73 3.91 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.171 -1.377 . . . . 74.42 112.592 -167.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 240' ' ' GLY . . . . . 0.414 ' HA3' ' HA ' ' C' ' 235' ' ' LEU . . . -107.34 -140.08 9.43 Favored Glycine 0 C--N 1.343 0.938 0 CA-C-N 114.589 -1.187 . . . . 71.23 110.629 176.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -133.95 147.93 51.11 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.403 0.681 . . . . 71.21 111.571 -170.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -167.95 -44.21 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.018 1.327 . . . . 70.32 109.193 176.015 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 243' ' ' GLN . . . . . 0.812 ' HG3' ' HG2' ' C' ' 224' ' ' PRO . 6.7 pt20 -159.45 164.1 34.82 Favored 'General case' 0 C--O 1.245 0.82 0 C-N-CA 123.969 0.908 . . . . 74.22 111.17 177.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -67.1 98.15 0.42 Allowed Glycine 0 C--N 1.355 1.633 0 O-C-N 124.179 0.924 . . . . 63.11 113.567 -169.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 245' ' ' LYS . . . . . 0.519 ' HE2' ' HB1' ' C' ' 222' ' ' ALA . 9.2 tmtm? -75.92 130.55 38.66 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.589 0.756 . . . . 75.34 110.009 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 35.1 p -116.25 139.31 50.49 Favored 'General case' 0 C--O 1.244 0.777 0 C-N-CA 124.095 0.958 . . . . 71.02 109.371 174.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 247' ' ' LEU . . . . . 0.705 HD21 HG23 ' B' ' 236' ' ' THR . 89.3 mt -72.71 158.64 35.21 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.839 0.856 . . . . 72.51 112.425 -175.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 248' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -82.88 145.51 29.4 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.069 0.947 . . . . 75.15 110.268 178.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -125.11 133.97 52.65 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 107.434 -1.321 . . . . 71.33 107.434 175.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -93.91 36.48 1.11 Allowed 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.818 0.847 . . . . 65.4 111.654 -170.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.96 -33.51 70.72 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 123.96 0.904 . . . . 61.03 113.301 -177.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -113.63 -23.61 9.65 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.682 0.793 . . . . 72.3 111.173 -176.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -64.08 -36.06 82.77 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.047 0.539 . . . . 51.41 110.872 173.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -70.73 87.51 0.69 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.752 0.821 . . . . 72.51 110.085 176.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 255' ' ' GLY . . . . . 0.507 ' HA2' HD13 ' B' ' 277' ' ' LEU . . . 59.04 -97.17 0.08 OUTLIER Glycine 0 C--N 1.353 1.52 0 O-C-N 123.968 0.793 . . . . 54.22 112.568 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 256' ' ' TYR . . . . . . . . . . . . . 23.0 t80 63.03 -73.78 0.04 OUTLIER 'General case' 0 C--N 1.367 1.364 0 C-N-CA 125.667 1.587 . . . . 52.52 110.547 175.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 257' ' ' GLN . . . . . 0.43 ' NE2' ' H ' ' B' ' 257' ' ' GLN . 2.2 mp0 -62.03 -64.46 0.93 Allowed 'General case' 0 C--N 1.35 0.588 0 C-N-CA 124.436 1.095 . . . . 74.31 108.514 169.065 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 258' ' ' LEU . . . . . . . . . . . . . 2.0 tt 57.35 -81.75 0.02 OUTLIER 'General case' 0 C--N 1.362 1.147 0 C-N-CA 125.775 1.63 . . . . 75.13 110.51 -178.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 45.2 t -90.85 99.32 9.47 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 N-CA-C 108.91 -0.774 . . . . 63.02 108.91 175.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 260' ' ' SER . . . . . . . . . . . . . 56.7 m -138.58 104.32 5.1 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.446 1.098 . . . . 73.11 108.198 176.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 62.3 23.26 13.75 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.59 1.156 . . . . 52.21 111.049 -170.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 262' ' ' ALA . . . . . . . . . . . . . . . -113.49 59.52 0.66 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.897 0.879 . . . . 43.43 109.773 -177.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -68.75 -32.2 71.79 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 115.746 -0.661 . . . . 70.44 110.469 175.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 34.6 t -98.55 161.75 13.5 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.939 0.896 . . . . 51.14 110.03 174.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 265' ' ' LEU . . . . . . . . . . . . . 85.8 mt -93.25 40.21 1.06 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.285 1.034 . . . . 64.12 110.644 -178.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 266' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 70.03 -67.0 0.25 Allowed 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 125.411 1.485 . . . . 71.52 109.999 -173.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 59.6 m -145.63 -57.84 0.32 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.578 1.151 . . . . 73.13 108.224 170.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 12.3 p -176.17 -23.18 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 C-N-CA 124.025 0.93 . . . . 74.44 110.28 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 269' ' ' THR . . . . . . . . . . . . . 12.5 m -66.17 85.05 0.09 Allowed 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.007 0.923 . . . . 74.31 111.822 -174.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 270' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -167.04 173.59 9.09 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.463 1.505 . . . . 72.41 108.749 178.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 271' ' ' ALA . . . . . 0.539 ' HB3' ' HB3' ' B' ' 275' ' ' LYS . . . -109.92 62.36 0.6 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 122.949 0.5 . . . . 75.3 110.688 -176.106 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 272' ' ' ASN . . . . . 0.503 ' O ' ' HG3' ' B' ' 275' ' ' LYS . 34.3 m-80 61.21 -167.91 0.19 Allowed 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 124.536 1.134 . . . . 54.14 111.398 174.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 5.6 pm0 -66.7 -15.92 63.86 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 122.882 0.473 . . . . 61.32 111.103 170.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -62.17 -35.66 79.48 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.515 1.126 . . . . 71.44 112.728 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 275' ' ' LYS . . . . . 0.539 ' HB3' ' HB3' ' B' ' 271' ' ' ALA . 2.2 pptp? -67.1 130.31 93.79 Favored Pre-proline 0 CA--C 1.555 1.172 0 N-CA-C 112.139 0.422 . . . . 71.33 112.139 -176.222 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -95.12 178.03 0.79 Allowed 'Trans proline' 0 C--N 1.371 1.739 0 C-N-CA 122.831 2.354 . . . . 62.35 112.297 171.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 277' ' ' LEU . . . . . 0.507 HD13 ' HA2' ' B' ' 255' ' ' GLY . 4.8 tt -107.0 110.33 22.44 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 106.804 -1.554 . . . . 63.32 106.804 174.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -68.13 -28.43 67.31 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.975 0.91 . . . . 62.0 112.386 -172.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . 84.22 17.98 63.64 Favored Glycine 0 N--CA 1.475 1.277 0 N-CA-C 114.401 0.52 . . . . 75.43 114.401 173.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -150.07 -179.65 7.34 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.468 0.707 . . . . 53.23 109.324 174.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -64.98 109.79 2.24 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 108.772 -0.825 . . . . 75.31 108.772 176.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -83.66 31.78 0.47 Allowed 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.568 0.951 . . . . 65.41 113.568 -166.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 283' ' ' ASP . . . . . 0.529 ' HA ' ' HA3' ' B' ' 229' ' ' GLY . 24.2 t70 -157.35 -93.59 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 122.682 0.393 . . . . 72.33 111.108 176.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . 138.68 -89.82 0.2 Allowed Glycine 0 C--N 1.352 1.446 0 N-CA-C 110.999 -0.84 . . . . 61.45 110.999 -170.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -145.94 3.21 0.93 Allowed 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 123.794 0.838 . . . . 72.41 111.984 -176.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 286' ' ' MET . . . . . . . . . . . . . 17.2 tpt -56.12 -57.29 23.23 Favored Pre-proline 0 CA--C 1.572 1.817 0 N-CA-C 115.424 1.638 . . . . 64.1 115.424 -165.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 287' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -92.65 36.63 0.23 Allowed 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 122.336 2.024 . . . . 73.33 111.633 -171.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 288' ' ' VAL . . . . . 0.611 HG13 ' H ' ' B' ' 289' ' ' ARG 0.299 7.3 p 41.96 -86.99 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.56 1.329 0 C-N-CA 126.005 1.722 . . . . 74.32 111.915 -161.783 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 289' ' ' ARG . . . . . 0.611 ' H ' HG13 ' B' ' 288' ' ' VAL . 6.2 tpm_? 55.14 49.49 17.27 Favored 'General case' 0 CA--C 1.56 1.357 0 CA-C-O 122.382 1.087 . . . . 72.14 110.564 -175.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 290' ' ' TRP . . . . . . . . . . . . . 75.7 t90 -64.7 114.59 4.54 Favored 'General case' 0 CA--C 1.552 1.04 0 CA-C-N 114.273 -1.33 . . . . 75.34 111.045 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 291' ' ' LEU . . . . . . . . . . . . . 74.1 mt 50.02 -81.37 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 126.747 2.019 . . . . 64.34 114.505 172.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . -177.0 -90.56 0.08 OUTLIER Glycine 0 C--N 1.338 0.666 0 N-CA-C 110.616 -0.994 . . . . 62.12 110.616 -177.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -64.44 101.27 0.35 Allowed 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.603 2.202 . . . . 51.12 110.802 173.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -72.67 -1.96 18.31 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.03 0.932 . . . . 41.23 112.026 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -148.52 175.15 11.39 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.072 0.949 . . . . 34.32 110.744 174.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 4.6 t -129.83 133.74 47.12 Favored 'General case' 0 C--O 1.243 0.759 0 N-CA-C 107.834 -1.173 . . . . 65.42 107.834 165.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -82.68 -10.95 58.69 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 122.838 0.455 . . . . 64.12 111.762 -174.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 50.5 m-70 63.64 -156.75 0.32 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.017 0.927 . . . . 71.5 110.388 -173.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . 77.11 18.25 78.74 Favored Glycine 0 C--N 1.35 1.315 0 CA-C-O 120.146 -0.252 . . . . 63.41 112.629 -175.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -162.87 -51.33 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.635 0.774 . . . . 72.23 110.271 -175.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 301' ' ' ILE . . . . . . . . . . . . . 37.3 pt -82.54 7.2 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 N-CA-C 112.829 0.678 . . . . 72.24 112.829 -174.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -80.43 74.37 7.3 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.642 0.777 . . . . 63.41 109.377 -174.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 303' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -95.95 136.36 22.23 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 107.629 -1.249 . . . . 74.11 107.629 178.129 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 304' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -34.1 -37.83 0.12 Allowed 'Trans proline' 0 C--N 1.387 2.579 1 C-N-CA 125.715 4.277 . . . . 75.12 116.946 -170.069 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -58.52 -54.28 48.87 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.821 0.848 . . . . 42.33 111.974 178.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 23.0 m -93.16 -51.07 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 122.859 0.464 . . . . 72.33 111.129 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 52.9 m 56.75 -90.39 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 125.1 1.36 . . . . 74.23 110.98 -175.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 308' ' ' CYS . . . . . . . . . . . . . 34.3 m -92.99 -31.48 14.87 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.437 0.695 . . . . 74.22 110.23 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 309' ' ' THR . . . . . . . . . . . . 0.254 60.5 m 107.84 -59.1 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.773 0 C-N-CA 128.56 2.744 . . . . 72.2 111.757 -178.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -93.19 51.11 0.4 Allowed 'Trans proline' 0 C--N 1.392 2.818 0 CA-C-N 122.018 1.756 . . . . 63.14 112.794 174.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 311' ' ' ASN . . . . . 0.431 ' HB2' ' HD3' ' B' ' 312' ' ' PRO . 13.7 m120 -74.17 -58.3 2.03 Favored Pre-proline 0 CA--C 1.561 1.387 0 CA-C-O 118.823 -0.608 . . . . 73.13 111.586 177.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 312' ' ' PRO . . . . . 0.442 ' HG2' ' H ' ' B' ' 192' ' ' GLY . 55.9 Cg_endo -97.86 63.44 0.09 OUTLIER 'Trans proline' 0 C--N 1.388 2.611 0 C-N-CA 122.398 2.065 . . . . 70.14 111.943 -172.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 313' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -70.35 78.14 0.54 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.606 0.763 . . . . 75.13 111.186 -176.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 314' ' ' ARG . . . . . . . . . . . . . 4.6 mpt_? -124.04 69.46 1.06 Allowed 'General case' 0 C--O 1.238 0.491 0 N-CA-C 106.827 -1.546 . . . . 72.01 106.827 174.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 315' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -160.27 92.44 0.99 Allowed 'General case' 0 C--O 1.242 0.662 0 CA-C-N 114.311 -1.313 . . . . 72.12 107.671 176.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 316' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -74.2 -32.22 62.97 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.23 -0.895 . . . . 74.4 109.365 175.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 85.7 p 56.38 -74.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 126.12 1.768 . . . . 75.41 111.847 -173.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 318' ' ' VAL . . . . . 0.415 ' HB ' ' H ' ' B' ' 94' ' ' PHE . 21.5 m 38.51 58.05 5.32 Favored Pre-proline 0 N--CA 1.493 1.702 0 C-N-CA 126.333 1.853 . . . . 73.13 114.066 175.218 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 319' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -79.77 148.01 19.77 Favored 'Trans proline' 0 C--N 1.373 1.84 0 C-N-CA 122.02 1.814 . . . . 65.1 112.363 -172.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 320' ' ' THR . . . . . . . . . . . . . 33.8 m -151.56 -62.77 0.18 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.257 1.023 . . . . 53.31 110.071 -176.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 321' ' ' LEU . . . . . 0.614 HD12 ' HB2' ' B' ' 323' ' ' GLN . 0.1 OUTLIER -61.42 -55.58 29.78 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 124.14 0.9 . . . . 65.14 110.478 -168.576 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 322' ' ' ALA . . . . . . . . . . . . . . . 63.04 28.86 16.31 Favored 'General case' 0 CA--C 1.55 0.952 0 O-C-N 124.717 1.26 . . . . 64.54 111.696 175.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 323' ' ' GLN . . . . . 0.614 ' HB2' HD12 ' B' ' 321' ' ' LEU . 28.7 tp60 -66.79 114.67 5.84 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 123.387 0.675 . . . . 74.02 109.798 -177.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 324' ' ' MET . . . . . . . . . . . . . 76.9 mtm -80.99 15.52 1.81 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.609 0.763 . . . . 71.32 113.007 -170.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 325' ' ' THR . . . . . . . . . . . . . 31.7 m 77.1 -43.96 0.45 Allowed 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 126.139 1.776 . . . . 72.33 111.4 177.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 326' ' ' ASP . . . . . 0.445 ' HB2' ' HA3' ' B' ' 43' ' ' GLY . 1.5 m-20 69.63 18.4 7.64 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.736 1.214 . . . . 72.01 112.409 166.026 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 327' ' ' LYS . . . . . 0.544 ' HA ' ' HA3' ' B' ' 42' ' ' GLY . 39.9 ttpt -89.41 116.01 27.28 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.49 -0.93 . . . . 54.34 108.49 173.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 328' ' ' ALA . . . . . . . . . . . . . . . -127.42 -9.62 5.74 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.246 0.618 . . . . 72.03 112.541 -172.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 329' ' ' ILE . . . . . . . . . . . . . 3.4 mp -89.41 112.4 24.31 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.177 0 C-N-CA 122.729 0.412 . . . . 73.5 109.985 -169.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 330' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 68.85 135.17 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 127.292 2.237 . . . . 63.42 112.202 178.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 331' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.85 20.45 1.8 Allowed 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.43 1.092 . . . . 63.34 110.918 -172.044 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -144.79 -164.95 2.04 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.348 0.659 . . . . 74.41 111.806 -172.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 333' ' ' SER . . . . . . . . . . . . . 16.5 t 67.18 12.36 8.9 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 124.503 1.121 . . . . 65.04 113.671 164.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 15.5 ptmt -67.87 -32.29 72.69 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 122.84 0.456 . . . . 63.11 110.985 176.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 335' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 69.1 127.85 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 125.349 1.46 . . . . 73.25 111.374 -175.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 336' ' ' GLU . . . . . 0.779 ' HB2' ' HA ' ' B' ' 118' ' ' PRO . 62.5 mt-10 -130.27 -164.4 1.42 Allowed 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.405 1.082 . . . . 61.02 109.025 172.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 337' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -147.88 131.89 17.22 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 107.756 -1.202 . . . . 62.43 107.756 174.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 338' ' ' GLY . . . . . . . . . . . . . . . -75.07 81.11 0.93 Allowed Glycine 0 C--N 1.347 1.166 0 O-C-N 123.535 0.522 . . . . 72.34 112.6 -178.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 339' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -126.55 23.12 6.88 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 107.618 -1.253 . . . . 74.33 107.618 171.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 340' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -78.32 -0.09 27.52 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.04 -0.982 . . . . 75.24 111.989 -176.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 341' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -78.31 -57.29 3.86 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.183 0.993 . . . . 75.34 109.327 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 342' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 60.14 -132.27 0.87 Allowed 'General case' 0 CA--C 1.566 1.589 0 C-N-CA 124.326 1.05 . . . . 64.25 108.536 -177.313 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 343' ' ' VAL . . . . . 0.406 HG21 ' HE2' ' B' ' 15' ' ' PHE . 6.7 p -163.97 74.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.677 0 N-CA-C 107.161 -1.422 . . . . 64.24 107.161 173.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -79.25 157.79 27.71 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 114.234 -1.348 . . . . 73.03 109.968 176.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 345' ' ' GLY . . . . . . . . . . . . . . . -163.4 50.67 0.3 Allowed Glycine 0 C--N 1.336 0.565 0 CA-C-N 115.472 -0.786 . . . . 62.31 112.114 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 346' ' ' ALA . . . . . . . . . . . . . . . -159.93 -88.38 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 109.164 -0.68 . . . . 72.22 109.164 175.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 70.3 m 61.01 -80.27 0.02 OUTLIER 'General case' 0 C--N 1.366 1.299 0 C-N-CA 124.541 1.136 . . . . 72.21 111.94 -178.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 348' ' ' ILE . . . . . 0.447 ' O ' ' HG2' ' B' ' 351' ' ' GLN . 2.4 pp -98.2 -6.96 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 123.959 0.904 . . . . 73.42 111.211 178.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 349' ' ' ASP . . . . . . . . . . . . . 29.3 t70 66.74 -82.36 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.632 1.573 . . . . 71.13 109.642 -174.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 350' ' ' LYS . . . . . . . . . . . . . 8.4 mptt -135.45 -76.46 0.44 Allowed 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.496 -0.927 . . . . 74.52 108.496 167.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 351' ' ' GLN . . . . . 0.447 ' HG2' ' O ' ' B' ' 348' ' ' ILE . 67.1 mm-40 59.73 176.36 0.08 Allowed 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 125.797 1.639 . . . . 71.32 112.843 -175.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -82.43 -28.23 31.46 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.676 -0.693 . . . . 74.35 109.521 175.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 353' ' ' HIS . . . . . . . . . . . . . 13.0 p80 52.54 12.67 0.26 Allowed 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 127.433 2.293 . . . . 74.33 114.706 174.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 354' ' ' ALA . . . . . 0.475 ' HB1' ' HA3' ' B' ' 162' ' ' GLY . . . -96.42 43.52 1.08 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.574 0.75 . . . . 70.11 110.594 -176.214 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 355' ' ' ALA . . . . . . . . . . . . . . . -66.34 99.96 0.59 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.543 0.737 . . . . 75.44 110.179 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 356' ' ' ASN . . . . . 0.511 ' HB2' ' H ' ' B' ' 162' ' ' GLY . 13.3 t-20 -85.14 113.38 49.88 Favored Pre-proline 0 N--CA 1.479 0.994 0 C-N-CA 124.164 0.986 . . . . 74.32 109.951 -171.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 357' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -83.73 149.55 12.67 Favored 'Trans proline' 0 C--N 1.373 1.852 0 C-N-CA 123.134 2.556 . . . . 55.22 111.107 173.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 358' ' ' CYS . . . . . . . . . . . . . 86.1 m -138.05 21.97 2.82 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.903 0.881 . . . . 73.32 109.554 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 359' ' ' GLY . . . . . . . . . . . . . . . -73.81 127.79 10.64 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 115.237 -0.892 . . . . 62.01 113.461 -174.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 360' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -143.36 52.67 1.35 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.96 0.904 . . . . 53.34 110.479 -171.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 361' ' ' ILE . . . . . 0.432 HG22 ' H ' ' B' ' 363' ' ' GLU . 51.4 mt 68.23 -79.09 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 125.24 1.416 . . . . 61.31 110.568 178.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 362' ' ' GLY . . . . . . . . . . . . . . . 118.4 -43.55 1.58 Allowed Glycine 0 C--N 1.346 1.117 0 N-CA-C 111.605 -0.598 . . . . 72.35 111.605 -176.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 363' ' ' GLU . . . . . 0.554 ' HG2' ' HA ' ' B' ' 201' ' ' PRO . 1.7 mp0 -86.84 -8.66 57.1 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.634 0.774 . . . . 73.13 111.245 179.136 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 364' ' ' THR . . . . . 0.527 HG23 ' HA3' ' B' ' 209' ' ' GLY . 72.9 m 74.81 -63.44 0.42 Allowed 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.754 1.622 . . . . 74.04 110.955 -173.28 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 39.5 t 66.02 160.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 C-N-CA 124.401 1.08 . . . . 74.01 110.804 -178.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -52.04 130.45 29.9 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.404 0.682 . . . . 50.12 111.995 178.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 367' ' ' LEU . . . . . . . . . . . . . 8.2 mp -60.73 -32.89 72.13 Favored 'General case' 0 C--N 1.352 0.693 0 O-C-N 124.404 1.065 . . . . 75.05 110.449 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 368' ' ' ASP . . . . . . . . . . . . . 32.5 t70 69.38 -66.54 0.25 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.747 1.619 . . . . 71.23 111.718 173.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 369' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 74.0 117.32 0.05 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.487 1.515 . . . . 70.1 111.861 169.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 370' ' ' ALA . . . . . . . . . . . . . . . -92.27 -179.31 5.2 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.755 0.822 . . . . 74.25 111.347 -176.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 371' ' ' VAL . . . . . . . . . . . . . 85.5 t -74.19 -30.46 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.029 0.932 . . . . 74.11 111.187 -178.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 372' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 64.24 83.45 0.16 Allowed 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 125.092 1.357 . . . . 63.2 111.122 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 373' ' ' ARG . . . . . 0.431 ' HA ' ' NE ' ' B' ' 373' ' ' ARG . 1.3 tpm_? -95.35 68.14 3.0 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.424 -0.807 . . . . 72.05 109.486 -176.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 374' ' ' ALA . . . . . 0.479 ' HA ' ' HD2' ' B' ' 377' ' ' PHE . . . -151.92 13.89 0.62 Allowed 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 115.068 -0.969 . . . . 71.45 111.383 -177.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 375' ' ' LEU . . . . . . . . . . . . . 76.6 mt -81.74 -12.59 58.53 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.208 0.603 . . . . 62.01 111.646 -175.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -111.93 -31.15 7.01 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.272 1.029 . . . . 73.13 110.386 178.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 377' ' ' PHE . . . . . 0.479 ' HD2' ' HA ' ' B' ' 374' ' ' ALA . 71.7 m-85 -72.18 92.29 1.35 Allowed 'General case' 0 C--N 1.352 0.687 0 C-N-CA 123.341 0.656 . . . . 73.31 109.787 -178.199 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 378' ' ' ALA . . . . . . . . . . . . . . . -107.12 -83.64 0.53 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.485 0.714 . . . . 61.1 110.65 -177.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 40.8 mtmt 56.25 72.92 0.47 Allowed 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.728 0.811 . . . . 72.01 109.461 -172.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 380' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 66.21 -173.02 0.19 Allowed 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 124.682 1.193 . . . . 53.14 110.655 -170.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 381' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -165.0 -46.43 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.321 0.649 . . . . 74.34 110.248 -177.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -176.97 93.35 0.09 OUTLIER Glycine 0 C--N 1.346 1.115 0 CA-C-N 116.041 -0.527 . . . . 73.1 112.09 -172.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 383' ' ' ASN . . . . . . . . . . . . . 25.5 p30 -164.88 -10.44 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 112.849 0.685 . . . . 73.1 112.849 -172.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 384' ' ' THR . . . . . . . . . . . . . 6.5 t -97.93 108.56 21.29 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.435 0.636 . . . . 63.41 112.316 -174.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 68.3 mt -88.31 59.34 5.18 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 109.411 -0.589 . . . . 75.12 109.411 171.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 386' ' ' VAL . . . . . . . . . . . . . 98.0 t 70.67 -67.1 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 125.855 1.662 . . . . 62.42 111.929 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 387' ' ' ILE . . . . . . . . . . . . . 8.7 tp -57.91 -29.42 35.8 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.165 0 C-N-CA 125.078 1.351 . . . . 74.12 113.338 -172.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 388' ' ' VAL . . . . . . . . . . . . . 58.1 t -62.9 -48.57 87.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 123.09 0.556 . . . . 54.33 110.965 -177.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 389' ' ' THR . . . . . . . . . . . . . 29.8 p -84.59 -24.37 29.22 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 122.626 0.37 . . . . 71.25 111.182 174.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . 58.99 32.17 22.03 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 124.991 1.317 . . . . 70.34 112.137 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 391' ' ' ASP . . . . . . . . . . . . . 16.9 t70 67.6 -76.69 0.05 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 125.01 1.324 . . . . 64.12 111.112 -176.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 392' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -138.22 177.14 8.1 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.774 0.83 . . . . 72.42 109.185 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . 64.15 15.86 9.62 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 124.345 1.058 . . . . 61.53 112.56 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -164.59 -34.21 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.045 0.938 . . . . 73.31 109.838 -176.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . -65.03 165.46 10.99 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.888 0.875 . . . . 71.44 112.105 176.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 28.8 m -59.94 -32.61 70.95 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.384 0.674 . . . . 75.55 111.231 174.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 397' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -95.28 108.96 21.14 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 108.628 -0.878 . . . . 71.41 108.628 177.179 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 59.3 mt -136.96 -75.24 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 N-CA-C 106.973 -1.491 . . . . 75.44 106.973 171.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 399' ' ' VAL . . . . . . . . . . . . . 27.5 m -102.2 -178.85 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.322 1.049 . . . . 73.32 110.28 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 400' ' ' ALA . . . . . . . . . . . . . . . -70.04 -40.82 13.45 Favored Pre-proline 0 CA--C 1.56 1.35 0 C-N-CA 123.021 0.529 . . . . 51.41 112.386 178.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 401' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -74.61 39.55 0.57 Allowed 'Trans proline' 0 C--N 1.384 2.431 0 C-N-CA 122.234 1.956 . . . . 71.04 113.713 160.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 69.25 -80.06 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 126.14 1.776 . . . . 74.34 112.585 173.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 403' ' ' THR . . . . . . . . . . . . . 40.9 p -122.2 -176.92 3.47 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.111 0.564 . . . . 51.3 111.814 -173.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 404' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.88 142.62 42.77 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.484 1.114 . . . . 70.03 109.101 173.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 405' ' ' ALA . . . . . . . . . . . . . . . -72.99 -50.62 6.68 Favored Pre-proline 0 CA--C 1.557 1.228 0 CA-C-O 118.466 -0.778 . . . . 71.24 112.481 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 406' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -75.04 100.08 1.32 Allowed 'Trans proline' 0 C--N 1.39 2.76 0 CA-C-N 120.925 1.366 . . . . 44.44 111.166 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . -55.26 -87.82 0.01 OUTLIER Glycine 0 C--N 1.352 1.444 0 O-C-N 124.036 0.835 . . . . 55.33 113.995 -172.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 408' ' ' LEU . . . . . . . . . . . . . 21.7 tp -171.81 159.31 5.18 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.352 0.661 . . . . 72.03 109.642 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 16.6 p -64.67 -53.85 41.03 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.133 0.973 . . . . 73.52 111.134 174.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 410' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -139.11 108.01 5.98 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-O 121.456 0.646 . . . . 51.32 109.685 174.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . -94.94 -54.28 3.52 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.42 0.688 . . . . 63.14 110.135 178.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 95.2 mt 63.81 -77.85 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.451 1.5 . . . . 60.41 110.989 -177.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 42.1 t-20 48.52 75.23 0.15 Allowed 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 125.42 1.488 . . . . 71.14 111.863 175.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 414' ' ' THR . . . . . . . . . . . . . 45.4 m -84.76 78.14 9.93 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 109.443 -0.577 . . . . 73.24 109.443 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 415' ' ' LYS . . . . . . . . . . . . . 58.1 mttp 58.04 46.39 16.4 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.562 1.145 . . . . 73.42 111.136 -178.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 21.7 t70 72.04 -74.72 0.08 Allowed 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 125.058 1.343 . . . . 75.33 111.664 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 417' ' ' GLY . . . . . . . . . . . . . . . 163.94 -42.07 0.32 Allowed Glycine 0 C--N 1.339 0.745 0 N-CA-C 110.666 -0.974 . . . . 43.15 110.666 -176.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 418' ' ' ALA . . . . . . . . . . . . . . . -72.02 127.37 32.34 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.428 0.691 . . . . 70.25 109.437 173.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 419' ' ' VAL . . . . . . . . . . . . . 14.1 m 48.52 34.18 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 C-N-CA 126.02 1.728 . . . . 62.03 112.951 -178.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 420' ' ' MET . . . . . 0.402 ' SD ' ' N ' ' B' ' 421' ' ' VAL . 0.0 OUTLIER -58.19 -37.76 75.4 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.725 0.81 . . . . 73.12 111.699 -179.055 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 421' ' ' VAL . . . . . 0.616 HG13 ' HG2' ' A' ' 211' ' ' ARG . 3.9 p -90.23 74.65 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 CA-C-O 122.717 1.246 . . . . 72.42 108.463 168.223 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 422' ' ' MET . . . . . . . . . . . . . 17.8 ptp -80.15 -18.44 49.74 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 114.469 -1.241 . . . . 74.1 110.294 174.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 423' ' ' SER . . . . . . . . . . . . . 37.3 m 74.08 -60.63 0.52 Allowed 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 126.433 1.893 . . . . 62.22 113.237 170.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 424' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 59.03 34.65 23.63 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.066 0.946 . . . . 72.42 110.14 -172.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . 99.05 -64.03 0.72 Allowed Glycine 0 C--N 1.349 1.277 0 CA-C-N 114.23 -1.35 . . . . 75.12 110.862 -172.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 426' ' ' ASN . . . . . . . . . . . . . 6.5 t30 63.81 -67.51 0.1 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 126.259 1.824 . . . . 75.43 111.251 -174.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 427' ' ' SER . . . . . 0.552 ' HB2' ' HB3' ' B' ' 432' ' ' GLN . 20.0 m -90.4 138.85 31.21 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 108.905 -0.776 . . . . 75.14 108.905 171.021 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -88.14 11.53 16.03 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.163 0.585 . . . . 73.23 112.064 -164.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 429' ' ' GLU . . . . . 0.556 ' HB2' ' HB2' ' B' ' 432' ' ' GLN . 11.2 mp0 -95.38 33.22 1.62 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.596 0.758 . . . . 63.42 110.173 178.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 31.9 t70 58.61 93.62 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.848 1.259 . . . . 55.41 110.763 -176.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 44.8 t 66.36 -73.28 0.07 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.963 1.305 . . . . 73.31 110.099 -172.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 432' ' ' GLN . . . . . 0.556 ' HB2' ' HB2' ' B' ' 429' ' ' GLU . 52.7 tp60 73.01 -65.29 0.36 Allowed 'General case' 0 C--N 1.361 1.088 0 C-N-CA 125.866 1.666 . . . . 71.1 111.583 175.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 433' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -73.45 72.61 1.36 Allowed 'General case' 0 C--O 1.242 0.702 0 N-CA-C 108.345 -0.983 . . . . 73.43 108.345 174.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 434' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -82.55 93.8 7.36 Favored 'General case' 0 C--N 1.345 0.382 0 CA-C-N 114.751 -1.113 . . . . 65.13 108.292 -168.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 435' ' ' THR . . . . . 0.43 ' HB ' ' HG3' ' A' ' 220' ' ' GLU . 0.6 OUTLIER -69.56 -10.63 58.96 Favored 'General case' 0 CA--C 1.557 1.244 0 CA-C-N 114.999 -1.0 . . . . 73.42 112.56 -163.595 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . 176.5 -112.18 0.38 Allowed Glycine 0 C--N 1.353 1.525 0 CA-C-O 119.5 -0.611 . . . . 43.54 112.56 175.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 437' ' ' SER . . . . . 0.489 ' N ' ' HB2' ' A' ' 220' ' ' GLU . 16.4 t 84.33 -13.02 0.74 Allowed 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 126.69 1.996 . . . . 54.14 112.141 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 438' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -65.58 -28.81 69.41 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.103 0.561 . . . . 71.55 109.766 169.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 439' ' ' LEU . . . . . . . . . . . . . 4.9 mp -76.68 96.19 4.14 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.151 0.98 . . . . 74.24 109.323 175.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 440' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -90.28 161.41 15.67 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.509 0.724 . . . . 70.1 110.614 176.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 441' ' ' ILE . . . . . 0.731 HD12 ' HA ' ' A' ' 223' ' ' VAL . 44.7 mt -120.66 135.04 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 123.542 0.737 . . . . 74.15 110.564 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 442' ' ' ALA . . . . . . . . . . . . . . . -88.33 -87.08 0.16 Allowed 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 109.542 -0.54 . . . . 71.41 109.542 173.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . 55.99 -86.33 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.239 0 C-N-CA 125.232 1.413 . . . . 74.21 112.801 177.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -170.58 167.31 8.02 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.68 1.592 . . . . 65.34 107.871 178.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . 139.53 -64.33 0.54 Allowed Glycine 0 N--CA 1.469 0.839 0 N-CA-C 111.494 -0.642 . . . . 74.34 111.494 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 446' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -63.14 101.02 0.27 Allowed 'Trans proline' 0 C--N 1.382 2.342 0 C-N-CA 122.345 2.03 . . . . 63.02 108.874 166.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 447' ' ' HIS . . . . . 0.52 ' HB3' ' HA2' ' B' ' 469' ' ' GLY . 12.4 t60 -85.04 -23.97 28.36 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 115.639 -0.71 . . . . 60.0 110.227 -173.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . -156.56 26.86 0.34 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.986 0.914 . . . . 74.31 110.224 174.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 449' ' ' ALA . . . . . 0.479 ' HB2' ' HB2' ' B' ' 468' ' ' LEU . . . -120.93 21.29 11.42 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.305 0.642 . . . . 61.52 111.497 -175.116 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 450' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -78.44 89.08 4.41 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.477 0.711 . . . . 61.12 110.065 -174.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 27.2 m 41.28 81.4 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 C-N-CA 126.227 1.811 . . . . 63.1 113.164 -178.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 452' ' ' VAL . . . . . . . . . . . . . 34.9 m -80.14 5.66 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 CA-C-N 115.582 -0.736 . . . . 60.45 112.454 -176.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 67.61 47.62 61.01 Favored Glycine 0 C--N 1.352 1.45 0 N-CA-C 111.289 -0.724 . . . . 73.44 111.289 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 454' ' ' LEU . . . . . . . . . . . . . 32.1 tp -69.87 -6.62 33.92 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 124.444 1.098 . . . . 72.5 112.714 -170.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 6.1 m 65.45 30.92 10.61 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 122.548 1.166 . . . . 61.41 108.782 -171.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -91.16 174.95 7.13 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 114.417 -1.265 . . . . 74.3 110.966 -175.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 457' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -157.62 -79.77 0.07 Allowed 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.83 -0.623 . . . . 42.14 110.096 179.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 9.1 p -149.85 -48.95 0.14 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.212 0.605 . . . . 72.13 111.416 -170.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 459' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -80.74 -130.22 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 124.561 1.144 . . . . 73.31 112.19 -167.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 6.7 mp -68.44 85.02 0.27 Allowed 'General case' 0 C--N 1.366 1.293 0 CA-C-N 119.044 0.838 . . . . 65.42 110.22 -177.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -147.12 22.94 1.2 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.462 1.505 . . . . 62.31 108.945 177.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 21.9 t80 -69.49 90.35 0.54 Allowed 'General case' 0 C--N 1.359 1.006 0 C-N-CA 123.836 0.854 . . . . 72.53 109.916 -175.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 37.6 p -106.97 89.13 2.91 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.749 0.82 . . . . 61.35 109.569 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 464' ' ' MET . . . . . . . . . . . . . 48.3 ttp -72.22 -60.0 2.45 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.52 -0.919 . . . . 75.31 108.52 173.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt 56.6 -83.43 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 125.955 1.702 . . . . 72.15 112.23 173.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -162.63 173.9 13.3 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.146 1.378 . . . . 62.32 109.398 -177.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . -83.03 99.25 9.73 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 109.502 -0.555 . . . . 75.3 109.502 175.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 468' ' ' LEU . . . . . 0.479 ' HB2' ' HB2' ' B' ' 449' ' ' ALA . 3.4 mm? -66.27 100.33 0.62 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.229 0.612 . . . . 45.51 109.933 177.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 469' ' ' GLY . . . . . 0.52 ' HA2' ' HB3' ' B' ' 447' ' ' HIS . . . -157.1 61.41 0.33 Allowed Glycine 0 C--N 1.34 0.796 0 N-CA-C 110.913 -0.875 . . . . 50.44 110.913 -178.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 470' ' ' LEU . . . . . . . . . . . . . 5.7 mp -80.81 69.52 7.38 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 123.779 0.832 . . . . 73.2 110.619 -174.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 471' ' ' LYS . . . . . . . . . . . . . 88.2 tttt . . . . . 0 CA--C 1.556 1.179 0 C-N-CA 125.152 1.381 . . . . 74.2 107.947 177.335 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 73.1 mtm . . . . . 0 N--CA 1.474 0.736 0 N-CA-C 109.29 -0.633 . . . . 55.23 109.29 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 60.28 33.55 20.91 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.316 1.047 . . . . 65.31 111.442 -175.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -88.5 51.44 2.18 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.055 0.942 . . . . 52.01 110.542 -175.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -38.3 110.38 0.13 Allowed 'General case' 0 C--N 1.363 1.183 0 C-N-CA 125.362 1.465 . . . . 70.52 114.698 -172.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 5' ' ' LYS . . . . . 0.722 ' HD2' HD11 ' C' ' 10' ' ' ILE . 23.2 mmtp -82.57 99.81 9.75 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 115.479 -0.782 . . . . 63.2 109.822 170.055 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -75.04 89.58 2.44 Favored 'General case' 0 C--O 1.246 0.875 0 N-CA-C 107.092 -1.447 . . . . 63.22 107.092 169.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 7' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -61.1 -28.36 69.03 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 114.917 -1.038 . . . . 73.43 112.145 -170.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 8' ' ' TYR . . . . . 0.421 ' HD1' HG23 ' C' ' 13' ' ' VAL . 64.1 m-85 -72.62 -41.44 65.54 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.356 0.662 . . . . 72.53 111.548 177.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.84 -43.05 99.62 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 123.386 0.429 . . . . 52.31 110.497 175.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 10' ' ' ILE . . . . . 0.722 HD11 ' HD2' ' C' ' 5' ' ' LYS . 73.1 mt -59.06 -44.55 91.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 O-C-N 123.956 0.785 . . . . 63.34 110.619 176.107 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 85.1 mt -78.69 -3.33 43.58 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 112.896 0.702 . . . . 45.45 112.896 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 61.29 39.79 97.71 Favored Glycine 0 C--N 1.356 1.655 0 O-C-N 123.302 0.376 . . . . 64.33 113.438 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 13' ' ' VAL . . . . . 0.421 HG23 ' HD1' ' C' ' 8' ' ' TYR . 11.8 m -135.69 158.49 74.09 Favored Pre-proline 0 N--CA 1.48 1.057 0 C-N-CA 125.084 1.354 . . . . 64.04 109.075 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.29 163.66 38.38 Favored 'Trans proline' 0 C--N 1.377 2.071 0 C-N-CA 122.125 1.884 . . . . 74.43 112.49 178.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 58.1 mtt180 -77.81 21.96 0.29 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.004 0.921 . . . . 71.52 111.876 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -117.33 -14.16 10.41 Favored 'General case' 0 C--O 1.243 0.749 0 C-N-CA 125.951 1.7 . . . . 71.24 108.37 178.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.15 114.97 1.34 Allowed 'General case' 0 C--N 1.356 0.879 0 C-N-CA 124.214 1.006 . . . . 71.14 110.538 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 54.4 p -74.21 167.02 22.43 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.596 0.758 . . . . 74.41 109.092 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -50.91 -40.68 57.44 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 124.014 0.926 . . . . 74.45 111.187 -173.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 20' ' ' GLU . . . . . 0.677 ' HA ' ' HE3' ' C' ' 23' ' ' LYS . 3.7 tm-20 -66.04 -40.79 91.27 Favored 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 124.467 1.107 . . . . 64.05 110.685 -178.124 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 21' ' ' GLU . . . . . 0.515 ' HG2' ' NH2' ' C' ' 24' ' ' ARG . 32.7 mt-10 -72.26 -34.44 68.24 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 115.651 -0.704 . . . . 73.42 111.258 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 22' ' ' ILE . . . . . 0.903 HD13 ' HB3' ' C' ' 57' ' ' LEU . 96.1 mt -68.61 -38.98 79.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 124.785 1.234 . . . . 61.32 110.16 176.283 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 23' ' ' LYS . . . . . 0.677 ' HE3' ' HA ' ' C' ' 20' ' ' GLU . 22.2 ttpp -62.98 -35.88 81.64 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 113.896 -1.502 . . . . 74.13 110.063 177.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 24' ' ' ARG . . . . . 0.515 ' NH2' ' HG2' ' C' ' 21' ' ' GLU . 45.6 mtm180 -77.35 -30.07 53.68 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 113.235 0.828 . . . . 73.52 113.235 173.052 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.03 -37.38 86.97 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 121.617 0.723 . . . . 75.32 109.918 171.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 26' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -68.52 -41.93 79.24 Favored 'General case' 0 C--O 1.209 -1.051 0 CA-C-N 113.869 -1.514 . . . . 72.31 110.474 175.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 27' ' ' LYS . . . . . 0.546 ' HG2' ' HA ' ' B' ' 37' ' ' ASP . 27.5 mtpp -50.89 -56.23 13.29 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 118.369 0.531 . . . . 74.1 110.385 173.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -55.61 -58.88 5.95 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 114.944 -1.026 . . . . 71.15 112.138 -177.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 87.1 mt -83.21 -21.28 33.48 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 112.894 0.702 . . . . 60.22 112.894 -169.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 30' ' ' ALA . . . . . 0.478 ' O ' ' HB2' ' C' ' 34' ' ' HIS . . . -78.97 -30.54 44.5 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 118.809 0.732 . . . . 75.32 110.406 176.374 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 65.1 mtm180 -73.59 -45.54 52.6 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 109.997 -0.371 . . . . 73.5 109.997 170.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.63 -46.61 84.89 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.617 0.767 . . . . 71.12 111.023 -174.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 33' ' ' TYR . . . . . 0.5 ' HD1' ' HB1' ' C' ' 43' ' ' ALA . 52.7 m-85 -90.76 4.72 50.84 Favored 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 123.466 0.706 . . . . 70.15 112.071 -178.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 34' ' ' HIS . . . . . 0.478 ' HB2' ' O ' ' C' ' 30' ' ' ALA . 41.8 t60 -60.64 113.35 7.4 Favored Pre-proline 0 N--CA 1.49 1.551 0 CA-C-O 118.206 -0.902 . . . . 72.34 110.959 -177.089 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -48.47 -36.65 31.61 Favored 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 124.283 3.322 . . . . 71.32 115.287 -171.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -69.99 -41.35 74.52 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 122.688 0.395 . . . . 60.34 111.324 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 45.3 t -85.03 -28.71 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-O 121.036 0.446 . . . . 75.33 110.123 -175.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -139.0 80.22 1.77 Allowed 'General case' 0 C--O 1.248 0.981 0 C-N-CA 124.204 1.002 . . . . 54.22 108.83 -174.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -70.31 84.8 0.57 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 114.778 -1.101 . . . . 62.24 109.402 176.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 40' ' ' SER . . . . . 0.576 ' HB2' ' HB3' ' C' ' 43' ' ' ALA . 16.4 m -138.68 103.75 7.65 Favored Pre-proline 0 CA--C 1.542 0.655 0 CA-C-O 117.836 -1.078 . . . . 74.14 108.117 175.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 41' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' C' ' 40' ' ' SER . 5.3 Cg_exo -37.33 -54.23 1.19 Allowed 'Trans proline' 0 C--N 1.393 2.874 0 C-N-CA 124.702 3.601 . . . . 63.44 114.183 -176.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.56 -36.49 83.96 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.973 0.509 . . . . 65.44 110.698 -177.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 43' ' ' ALA . . . . . 0.576 ' HB3' ' HB2' ' C' ' 40' ' ' SER . . . -75.17 -17.51 60.37 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.168 0.587 . . . . 62.05 111.313 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -86.2 -31.93 21.48 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.333 0.653 . . . . 74.04 109.491 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -70.1 -41.74 73.63 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.57 -0.741 . . . . 42.53 109.502 170.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 46' ' ' LYS . . . . . 0.538 ' O ' HG12 ' C' ' 50' ' ' ILE . 33.6 mmtm -63.32 -36.3 83.24 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-N 115.201 -0.908 . . . . 72.32 110.468 173.032 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -57.2 -49.0 77.38 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.604 0.762 . . . . 62.23 109.337 174.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 48' ' ' LYS . . . . . 0.551 ' HB3' ' HE1' ' C' ' 93' ' ' PHE . 52.0 mtpt -57.87 -38.23 75.36 Favored 'General case' 0 CA--C 1.551 1.009 0 O-C-N 123.762 0.663 . . . . 72.04 111.631 175.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -76.31 -19.39 58.29 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.203 0.601 . . . . 72.33 112.267 178.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 50' ' ' ILE . . . . . 0.538 HG12 ' O ' ' C' ' 46' ' ' LYS . 28.4 mm -76.0 -38.96 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 108.474 -0.936 . . . . 75.43 108.474 171.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 51' ' ' ASN . . . . . 0.467 ' HB3' ' CD1' ' C' ' 88' ' ' PHE . 55.7 m-80 -68.42 -30.76 69.73 Favored 'General case' 0 C--O 1.217 -0.645 0 CA-C-N 114.474 -1.239 . . . . 74.04 110.736 176.009 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -68.51 -55.15 12.69 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.845 1.258 . . . . 63.42 110.528 175.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.26 -50.41 69.55 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 114.035 -1.438 . . . . 63.1 111.162 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -63.56 -39.41 94.33 Favored 'General case' 0 C--O 1.198 -1.638 0 CA-C-N 115.023 -0.99 . . . . 75.01 110.775 176.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 55' ' ' ALA . . . . . 0.484 ' HB2' ' CD2' ' C' ' 88' ' ' PHE . . . -56.31 -45.04 80.43 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 118.531 0.605 . . . . 60.54 112.255 -178.082 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 56' ' ' VAL . . . . . 0.443 ' O ' ' HB2' ' C' ' 62' ' ' LYS . 96.1 t -65.7 -46.42 89.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 CA-C-O 121.752 0.786 . . . . 72.43 109.826 173.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 57' ' ' LEU . . . . . 0.903 ' HB3' HD13 ' C' ' 22' ' ' ILE . 81.6 mt -92.37 9.54 33.7 Favored 'General case' 0 CA--C 1.56 1.344 0 N-CA-C 113.365 0.876 . . . . 75.02 113.365 -169.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 21.9 t -86.16 -24.15 26.27 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.54 0.736 . . . . 62.42 110.491 179.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -101.61 131.54 22.82 Favored Pre-proline 0 C--O 1.241 0.633 0 N-CA-C 108.336 -0.987 . . . . 72.03 108.336 174.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 60' ' ' PRO . . . . . 0.494 ' O ' ' HG2' ' C' ' 64' ' ' ARG . 73.7 Cg_exo -53.48 -32.51 63.39 Favored 'Trans proline' 0 C--N 1.375 1.934 0 C-N-CA 122.833 2.356 . . . . 33.23 111.444 164.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -68.09 -49.44 61.26 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.078 0.951 . . . . 62.13 111.561 -177.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 62' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' C' ' 56' ' ' VAL . 62.1 mttp -73.27 -23.98 60.38 Favored 'General case' 0 CA--C 1.559 1.302 0 C-N-CA 122.386 0.274 . . . . 75.23 110.751 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 -61.38 -43.3 99.1 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 109.39 -0.596 . . . . 64.42 109.39 167.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 64' ' ' ARG . . . . . 0.494 ' HG2' ' O ' ' C' ' 60' ' ' PRO . 28.5 mmm180 -68.72 -32.07 71.6 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 119.272 -0.394 . . . . 74.15 111.56 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 65' ' ' ILE . . . . . 0.442 HG23 ' HD2' ' C' ' 76' ' ' PRO . 80.1 mt -62.29 -42.19 94.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 N-CA-C 109.716 -0.475 . . . . 62.34 109.716 171.169 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -63.25 -44.86 93.99 Favored 'General case' 0 CA--C 1.553 1.079 0 CA-C-N 115.573 -0.739 . . . . 74.22 109.756 176.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -58.11 -42.13 85.06 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.184 0.994 . . . . 73.14 111.064 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 68' ' ' THR . . . . . 0.425 ' OG1' ' HG2' ' C' ' 76' ' ' PRO . 39.9 p -83.93 -10.31 58.05 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.602 -0.726 . . . . 63.2 112.013 -178.126 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -71.81 96.7 1.68 Allowed 'General case' 0 C--N 1.36 1.037 0 N-CA-C 108.197 -1.038 . . . . 75.22 108.197 171.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 104.34 30.98 4.81 Favored Glycine 0 C--N 1.346 1.104 0 CA-C-N 116.075 -0.511 . . . . 62.51 111.94 -173.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 84.9 m -146.78 -54.16 0.24 Allowed 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 103.877 -2.638 . . . . 72.34 103.877 174.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 24.7 m -86.24 141.71 29.09 Favored 'General case' 0 C--O 1.256 1.406 0 N-CA-C 104.811 -2.292 . . . . 73.35 104.811 157.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.15 -27.62 20.58 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 123.752 0.821 . . . . 73.23 111.612 -177.389 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -97.24 155.77 37.03 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 123.911 0.884 . . . . 53.23 109.806 176.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_exo -60.12 114.74 2.23 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 122.65 2.234 . . . . 75.14 111.079 168.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 76' ' ' PRO . . . . . 0.442 ' HD2' HG23 ' C' ' 65' ' ' ILE . 50.0 Cg_exo -55.97 122.74 12.3 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 123.091 2.527 . . . . 63.14 111.596 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -43.63 139.85 4.74 Favored 'Trans proline' 0 C--N 1.39 2.725 0 C-N-CA 124.31 3.34 . . . . 51.51 114.849 -166.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 78' ' ' PRO . . . . . 0.494 ' HB2' ' HA2' ' C' ' 82' ' ' GLY . 25.9 Cg_endo -58.86 145.25 97.42 Favored 'Trans proline' 0 C--N 1.387 2.564 0 C-N-CA 123.483 2.788 . . . . 74.44 113.743 -172.245 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 79' ' ' PRO . . . . . 0.595 ' HB2' ' HA2' ' C' ' 142' ' ' GLY . 51.0 Cg_exo -55.93 163.24 6.03 Favored 'Trans proline' 0 C--N 1.385 2.458 0 C-N-CA 123.559 2.84 . . . . 61.04 112.923 176.311 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -55.12 87.07 0.04 OUTLIER 'Trans proline' 0 C--N 1.392 2.832 0 C-N-CA 123.569 2.846 . . . . 51.5 112.855 -177.044 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 145.65 -52.19 0.58 Allowed Glycine 0 C--N 1.339 0.742 0 CA-C-N 113.829 -1.532 . . . . 75.2 109.443 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.494 ' HA2' ' HB2' ' C' ' 78' ' ' PRO . . . 144.34 -170.84 25.95 Favored Glycine 0 C--N 1.344 0.998 0 C-N-CA 123.526 0.584 . . . . 74.45 111.653 -177.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -86.93 104.18 16.01 Favored 'General case' 0 C--O 1.244 0.806 0 C-N-CA 123.653 0.781 . . . . 70.14 109.273 171.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -86.55 -176.21 5.75 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.384 -0.598 . . . . 63.13 109.384 170.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 85' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -161.1 70.98 0.39 Allowed 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 107.507 -1.294 . . . . 74.41 107.507 177.196 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 55.0 m -36.78 95.18 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 117.875 2.546 . . . . 45.43 117.875 -164.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 75.55 6.68 81.65 Favored Glycine 0 C--N 1.355 1.608 0 C-N-CA 123.044 0.354 . . . . 74.33 113.292 174.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 88' ' ' PHE . . . . . 0.484 ' CD2' ' HB2' ' C' ' 55' ' ' ALA . 11.9 m-85 -105.59 131.13 53.35 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 107.489 -1.3 . . . . 74.44 107.489 -177.202 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -80.99 81.97 7.09 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 120.966 0.412 . . . . 72.23 111.337 -170.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 90' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -43.58 -36.14 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 C-N-CA 125.405 1.482 . . . . 54.41 112.74 171.26 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -62.66 -20.09 64.47 Favored 'General case' 0 CA--C 1.561 1.394 0 C-N-CA 124.352 1.061 . . . . 74.21 112.884 -175.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -119.82 7.37 10.97 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 122.865 0.466 . . . . 75.53 111.008 178.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 93' ' ' PHE . . . . . 0.551 ' HE1' ' HB3' ' C' ' 48' ' ' LYS . 13.9 m-30 -83.9 -174.28 5.19 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.129 -0.982 . . . . 72.45 112.114 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 97.6 p -71.3 161.8 30.48 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.839 1.052 . . . . 45.51 113.839 -167.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -59.44 -56.34 23.25 Favored 'General case' 0 C--O 1.215 -0.745 0 CA-C-N 114.249 -1.342 . . . . 55.43 110.837 174.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -51.03 -46.56 61.63 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 124.169 0.918 . . . . 65.02 111.867 -174.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 97' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -58.98 -53.44 58.39 Favored 'General case' 0 CA--C 1.554 1.13 0 CA-C-N 115.406 -0.816 . . . . 64.25 110.158 174.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -74.18 0.84 12.75 Favored 'General case' 0 CA--C 1.56 1.339 0 N-CA-C 112.611 0.597 . . . . 51.52 112.611 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -98.27 -50.74 4.23 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.984 0.914 . . . . 74.43 110.393 172.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 31.3 tp -71.07 -52.83 17.17 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.892 0.877 . . . . 73.23 110.463 -177.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 101' ' ' PHE . . . . . 0.477 ' O ' ' HG ' ' C' ' 105' ' ' LEU . 87.4 m-85 -86.22 -10.02 55.43 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.435 -0.802 . . . . 73.25 110.781 179.148 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -43.04 -55.73 4.79 Favored Glycine 0 CA--C 1.545 1.924 0 CA-C-O 118.479 -1.178 . . . . 54.11 115.026 176.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -37.6 -35.61 0.33 Allowed 'Trans proline' 0 C--N 1.392 2.837 0 C-N-CA 125.136 3.891 . . . . 62.02 116.279 175.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -130.9 24.59 4.27 Favored Glycine 0 C--N 1.349 1.276 0 CA-C-O 118.798 -1.001 . . . . 43.23 113.837 -174.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 105' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' C' ' 101' ' ' PHE . 38.1 mt -74.52 67.04 1.46 Allowed 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 118.038 0.919 . . . . 73.03 111.72 173.228 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 106' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 39.31 -102.85 0.03 OUTLIER 'General case' 0 CA--C 1.562 1.441 0 C-N-CA 125.643 1.577 . . . . 64.24 114.686 172.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . 67.44 26.4 73.6 Favored Glycine 0 C--N 1.362 1.995 0 N-CA-C 111.493 -0.643 . . . . 51.05 111.493 -163.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 70.47 -83.45 0.36 Allowed Glycine 0 C--N 1.347 1.174 0 N-CA-C 109.277 -1.529 . . . . 74.41 109.277 -163.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 109' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -136.45 -8.91 1.94 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.986 0.914 . . . . 74.45 110.321 169.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 110' ' ' GLY . . . . . . . . . . . . . . . -92.09 -2.73 68.44 Favored Glycine 0 C--N 1.352 1.439 0 N-CA-C 114.597 0.599 . . . . 54.22 114.597 -175.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 40.8 ttp180 54.4 16.4 1.26 Allowed 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 124.785 1.234 . . . . 75.25 113.452 176.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.51 -31.24 67.7 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.642 1.177 . . . . 74.1 110.426 166.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 113' ' ' SER . . . . . . . . . . . . . 49.2 m 72.46 49.64 0.2 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 125.78 1.632 . . . . 72.53 111.666 -176.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 42.9 ttt180 -70.6 160.11 33.13 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 115.386 -0.825 . . . . 74.05 110.374 177.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 115' ' ' LYS . . . . . 0.633 ' HE2' ' HB2' ' C' ' 170' ' ' PRO . 3.3 tpmt? -62.15 131.91 51.05 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.279 0.631 . . . . 54.14 111.521 -178.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 116' ' ' GLY . . . . . 0.436 ' HA2' ' HA3' ' C' ' 168' ' ' GLY . . . -82.28 127.81 8.15 Favored Glycine 0 C--N 1.345 1.043 0 CA-C-N 115.373 -0.83 . . . . 45.25 113.963 -174.284 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 117' ' ' ARG . . . . . 0.44 ' HG2' ' H ' ' C' ' 118' ' ' ASP . 56.1 ttt-85 -80.3 175.06 10.99 Favored 'General case' 0 C--O 1.252 1.214 0 C-N-CA 123.615 0.766 . . . . 64.44 109.684 174.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 118' ' ' ASP . . . . . 0.44 ' H ' ' HG2' ' C' ' 117' ' ' ARG . 3.6 p30 -65.38 155.81 34.2 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 121.687 0.756 . . . . 75.42 111.201 172.631 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 119' ' ' LEU . . . . . . . . . . . . . 61.9 tp -109.01 161.67 14.95 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 107.189 -1.411 . . . . 75.21 107.189 172.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 38.8 ttt-85 -131.31 119.84 22.31 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 118.77 0.714 . . . . 72.31 109.322 175.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 121' ' ' ALA . . . . . 0.469 ' HB3' HD11 ' C' ' 174' ' ' LEU . . . -138.09 118.16 13.46 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 124.129 0.972 . . . . 63.21 108.68 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 122' ' ' GLU . . . . . 0.67 ' HG2' HG22 ' B' ' 186' ' ' THR . 13.0 pt-20 -108.03 148.3 29.94 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 122.339 0.255 . . . . 73.22 110.457 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -140.71 145.89 42.08 Favored Pre-proline 0 N--CA 1.481 1.109 0 C-N-CA 122.833 0.453 . . . . 73.3 111.607 -170.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 124' ' ' PRO . . . . . 0.445 ' HG3' ' HG3' ' B' ' 188' ' ' ARG . 97.8 Cg_endo -75.88 130.11 12.13 Favored 'Trans proline' 0 C--N 1.377 2.038 0 C-N-CA 122.509 2.139 . . . . 72.51 110.559 166.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 125' ' ' LEU . . . . . . . . . . . . . 30.2 tp -145.14 148.58 33.76 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 108.668 -0.864 . . . . 74.03 108.668 -175.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 126' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -94.53 158.5 15.51 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 120.911 0.386 . . . . 61.53 110.488 -178.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 127' ' ' LEU . . . . . 0.61 HD13 ' HD2' ' C' ' 186' ' ' PHE . 56.9 mt -62.33 -42.56 99.48 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.656 1.182 . . . . 62.25 110.643 173.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 128' ' ' GLU . . . . . 0.405 ' HG3' ' HA ' ' C' ' 215' ' ' LEU . 2.7 mp0 -62.2 -38.05 87.66 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 114.495 -1.229 . . . . 75.24 110.725 173.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -79.01 -17.93 54.5 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 122.968 0.507 . . . . 73.53 111.592 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -76.63 -40.29 49.71 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-O 121.719 0.771 . . . . 64.34 109.428 172.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 131' ' ' PHE . . . . . 0.622 ' HB2' HD13 ' C' ' 215' ' ' LEU . 76.8 t80 -63.09 -34.89 78.56 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 126.065 1.746 . . . . 75.55 111.873 171.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 132' ' ' HIS . . . . . . . . . . . . . 36.6 m170 -78.35 -59.26 2.85 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 122.381 0.272 . . . . 60.22 110.345 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 53.03 -127.39 35.48 Favored Glycine 0 CA--C 1.537 1.426 0 O-C-N 124.077 0.86 . . . . 65.31 113.955 177.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.51 -146.33 38.72 Favored Glycine 0 C--N 1.349 1.303 0 C-N-CA 123.24 0.448 . . . . 53.24 113.646 177.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -92.01 112.79 24.86 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.337 1.055 . . . . 71.2 109.618 -177.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 136' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -126.64 133.36 51.01 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.389 0.675 . . . . 72.12 110.432 -175.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 137' ' ' VAL . . . . . . . . . . . . . 34.0 m -73.11 138.95 20.32 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 CA-C-O 120.976 0.417 . . . . 71.12 111.479 -176.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 138' ' ' VAL . . . . . 0.7 ' HA ' HG22 ' B' ' 182' ' ' VAL . 7.3 p -152.05 135.53 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.325 1.05 . . . . 72.14 108.986 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 139' ' ' GLU . . . . . 0.5 ' HA ' ' O ' ' C' ' 143' ' ' ARG . 0.0 OUTLIER -117.69 116.25 26.67 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.19 0.596 . . . . 74.31 109.927 170.742 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 140' ' ' VAL . . . . . . . . . . . . . 13.8 p -164.39 138.33 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.823 0.849 . . . . 63.22 110.12 174.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 62.58 13.94 6.68 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 124.869 1.268 . . . . 15.23 113.72 170.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 142' ' ' GLY . . . . . 0.595 ' HA2' ' HB2' ' C' ' 79' ' ' PRO . . . 120.18 -31.63 5.21 Favored Glycine 0 C--N 1.348 1.248 0 CA-C-O 120.103 -0.276 . . . . 45.25 112.814 -178.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 143' ' ' ARG . . . . . 0.5 ' O ' ' HA ' ' C' ' 139' ' ' GLU . 9.8 mmm180 -80.33 108.37 13.89 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.034 0.534 . . . . 73.04 111.954 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 48.6 ttt180 -113.62 91.31 3.6 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 107.635 -1.246 . . . . 71.51 107.635 166.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 145' ' ' VAL . . . . . . . . . . . . . 13.0 p -157.34 159.24 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.142 0.577 . . . . 75.03 111.174 -168.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 20.3 m -78.19 106.89 10.39 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.76 0.824 . . . . 54.21 110.146 168.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 2.6 p -80.52 119.8 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 CA-C-O 121.044 0.45 . . . . 72.53 110.137 174.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 148' ' ' ARG . . . . . 0.512 ' HD2' HG23 ' B' ' 38' ' ' ILE . 48.0 ttt180 -83.82 95.15 8.37 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.595 -0.729 . . . . 74.22 110.068 177.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 149' ' ' ILE . . . . . 0.459 HD11 HD21 ' B' ' 181' ' ' LEU . 38.3 pt -118.71 105.19 46.06 Favored Pre-proline 0 CA--C 1.547 0.861 0 N-CA-C 107.647 -1.242 . . . . 71.41 107.647 164.057 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -53.88 166.78 1.31 Allowed 'Trans proline' 0 C--N 1.384 2.428 0 C-N-CA 123.459 2.772 . . . . 61.44 113.903 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -44.12 108.85 0.13 Allowed 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 123.305 2.67 . . . . 73.2 113.425 171.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 152' ' ' GLY . . . . . . . . . . . . . . . 154.21 87.98 0.06 OUTLIER Glycine 0 C--N 1.349 1.292 0 N-CA-C 114.8 0.68 . . . . 54.32 114.8 -176.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 153' ' ' VAL . . . . . 0.549 HG22 HG11 ' C' ' 178' ' ' VAL . 12.4 p -165.53 155.54 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.617 0 C-N-CA 123.249 0.62 . . . . 71.13 110.656 172.182 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 154' ' ' ARG . . . . . 0.503 ' HD2' ' HG2' ' C' ' 187' ' ' ARG . 30.3 ttp180 -155.64 150.86 26.8 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 124.071 0.948 . . . . 75.32 110.419 -172.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 155' ' ' GLU . . . . . 0.411 ' N ' ' HG2' ' C' ' 154' ' ' ARG . 10.3 tp10 -42.93 130.66 4.3 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 125.589 1.556 . . . . 74.51 113.263 -177.223 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 84.53 -5.79 79.85 Favored Glycine 0 C--N 1.348 1.199 0 CA-C-N 115.827 -0.624 . . . . 64.51 113.252 178.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 157' ' ' SER . . . . . 0.499 ' O ' HG12 ' C' ' 178' ' ' VAL . 37.6 t -78.58 129.5 34.87 Favored 'General case' 0 C--O 1.245 0.82 0 N-CA-C 108.622 -0.881 . . . . 75.43 108.622 173.28 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 97.9 t -105.99 100.44 10.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 N-CA-C 108.261 -1.015 . . . . 64.44 108.261 -177.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 159' ' ' ILE . . . . . 0.665 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 26.1 mt -71.25 96.67 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.672 0 CA-C-N 115.046 -0.979 . . . . 52.25 108.85 -175.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 4.6 ttt180 -79.75 96.58 6.31 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 107.551 -1.277 . . . . 72.21 107.551 175.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 161' ' ' VAL . . . . . . . . . . . . . 2.2 p -97.99 108.44 46.46 Favored Pre-proline 0 C--O 1.247 0.938 0 CA-C-N 114.804 -1.089 . . . . 75.24 108.588 -178.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -52.05 115.97 2.49 Favored 'Trans proline' 0 C--N 1.387 2.572 0 C-N-CA 123.483 2.788 . . . . 63.42 114.55 -173.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 163' ' ' GLY . . . . . 0.671 ' H ' ' HA ' ' C' ' 173' ' ' ASP . . . 91.49 -13.82 65.53 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 117.513 1.765 . . . . 53.31 117.513 168.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 164' ' ' MET . . . . . 0.498 ' HB3' ' HB3' ' C' ' 174' ' ' LEU . 47.7 ttm -68.13 -19.07 64.79 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-N 120.45 2.125 . . . . 73.35 112.659 -170.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . -94.77 -112.54 2.51 Favored Glycine 0 C--N 1.347 1.181 0 CA-C-O 119.332 -0.704 . . . . 64.24 111.886 175.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 166' ' ' GLY . . . . . 0.405 ' HA3' ' HB3' ' C' ' 171' ' ' PRO . . . 86.65 67.23 1.36 Allowed Glycine 0 C--N 1.362 2.007 0 CA-C-N 118.057 0.929 . . . . 75.44 113.866 176.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 167' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -79.65 99.88 7.58 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 107.124 -1.436 . . . . 64.31 107.124 172.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 168' ' ' GLY . . . . . 0.436 ' HA3' ' HA2' ' C' ' 116' ' ' GLY . . . 153.31 -85.61 0.14 Allowed Glycine 0 C--O 1.213 -1.164 0 CA-C-O 118.432 -1.205 . . . . 13.44 110.397 -169.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 169' ' ' ASN . . . . . 0.544 ' HB3' ' HD3' ' C' ' 170' ' ' PRO . 2.9 t-20 179.95 -59.78 0.0 OUTLIER Pre-proline 0 N--CA 1.499 1.985 0 CA-C-O 117.387 -1.292 . . . . 62.44 112.189 163.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 170' ' ' PRO . . . . . 0.633 ' HB2' ' HE2' ' C' ' 115' ' ' LYS . 19.4 Cg_exo -67.77 100.24 0.59 Allowed 'Trans proline' 0 C--N 1.399 3.208 0 CA-C-N 122.623 1.972 . . . . 51.41 109.688 165.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 171' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' C' ' 170' ' ' PRO . 14.2 Cg_exo -71.05 132.06 20.58 Favored 'Trans proline' 0 C--N 1.362 1.267 0 C-N-CA 122.901 2.401 . . . . 74.02 114.469 -162.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -71.44 -72.87 0.86 Allowed Glycine 0 C--N 1.347 1.178 0 O-C-N 124.176 0.922 . . . . 74.42 111.331 173.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 173' ' ' ASP . . . . . 0.671 ' HA ' ' H ' ' C' ' 163' ' ' GLY . 4.9 p-10 -172.67 178.32 2.7 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.201 0.6 . . . . 74.51 111.897 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 174' ' ' LEU . . . . . 0.498 ' HB3' ' HB3' ' C' ' 164' ' ' MET . 12.6 tp -122.09 139.17 54.04 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.169 0.988 . . . . 75.22 109.002 170.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 175' ' ' LEU . . . . . 0.4 ' N ' HD12 ' C' ' 174' ' ' LEU . 85.9 mt -101.39 87.11 3.12 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.67 1.188 . . . . 71.32 109.594 177.058 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 176' ' ' LEU . . . . . 0.665 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 83.9 mt -74.22 92.93 2.28 Favored 'General case' 0 C--N 1.351 0.671 0 C-N-CA 123.09 0.556 . . . . 43.02 109.557 173.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 177' ' ' VAL . . . . . 0.445 ' HB ' ' HB3' ' C' ' 122' ' ' GLU . 22.2 t -84.51 113.52 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 108.619 -0.882 . . . . 74.43 108.619 -177.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 178' ' ' VAL . . . . . 0.549 HG11 HG22 ' C' ' 153' ' ' VAL . 7.5 p -80.76 125.17 39.26 Favored 'Isoleucine or valine' 0 C--O 1.246 0.908 0 CA-C-O 121.798 0.809 . . . . 74.01 111.036 -176.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 179' ' ' ARG . . . . . . . . . . . . . 24.3 mmt180 -110.54 122.9 48.88 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 114.028 -1.442 . . . . 72.33 107.224 169.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 180' ' ' LEU . . . . . 0.556 HD13 HD21 ' C' ' 127' ' ' LEU . 92.5 mt -85.69 149.57 25.21 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 122.774 0.43 . . . . 70.51 111.431 -177.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 181' ' ' LEU . . . . . 0.401 ' HB3' ' HD2' ' C' ' 182' ' ' PRO . 26.4 mt -65.4 165.36 18.52 Favored Pre-proline 0 CA--C 1.565 1.551 0 C-N-CA 124.624 1.17 . . . . 74.2 111.711 -178.369 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 182' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' C' ' 181' ' ' LEU . 12.7 Cg_exo -36.04 -20.88 0.04 OUTLIER 'Trans proline' 0 C--N 1.403 3.423 1 C-N-CA 125.642 4.228 . . . . 64.12 118.701 -177.357 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 183' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -104.94 99.54 19.66 Favored Pre-proline 0 CA--C 1.562 1.44 0 CA-C-N 119.495 1.043 . . . . 62.13 109.123 167.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 184' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -99.26 66.39 0.06 OUTLIER 'Trans proline' 0 C--N 1.38 2.221 0 C-N-CA 123.961 3.107 . . . . 71.54 110.713 174.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 185' ' ' VAL . . . . . 0.549 ' H ' HD11 ' C' ' 127' ' ' LEU . 21.6 t -92.63 -45.06 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-N 115.487 -0.779 . . . . 72.23 110.144 -165.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 186' ' ' PHE . . . . . 0.61 ' HD2' HD13 ' C' ' 127' ' ' LEU . 71.1 m-85 -100.16 114.57 28.05 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.506 0.67 . . . . 61.44 111.354 -167.047 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 187' ' ' ARG . . . . . 0.675 ' HB3' ' HB3' ' C' ' 194' ' ' TYR . 3.2 tmt_? -95.77 107.4 19.63 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.878 1.271 . . . . 75.14 108.72 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 188' ' ' LEU . . . . . . . . . . . . . 41.1 tp -82.32 141.78 32.59 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.835 0.68 . . . . 74.14 112.835 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -145.16 108.68 4.65 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 107.103 -1.443 . . . . 71.33 107.103 161.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 71.36 -92.5 0.5 Allowed Glycine 0 C--N 1.356 1.649 0 O-C-N 123.225 0.328 . . . . 74.2 112.534 -178.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 191' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -117.92 -26.53 6.43 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.874 0.87 . . . . 60.21 110.114 174.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -86.54 153.25 21.97 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.557 -0.747 . . . . 65.13 110.731 -166.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 193' ' ' LEU . . . . . 0.42 HD21 ' CD1' ' C' ' 240' ' ' PHE . 84.1 mt -120.3 163.7 17.42 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.6 -0.727 . . . . 52.2 111.172 -175.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 194' ' ' TYR . . . . . 0.675 ' HB3' ' HB3' ' C' ' 187' ' ' ARG . 33.8 t80 -136.64 107.56 6.67 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 114.723 -1.126 . . . . 75.43 108.884 169.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 195' ' ' ALA . . . . . 0.501 ' HB2' HD11 ' C' ' 249' ' ' LEU . . . -105.01 -175.33 2.76 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.725 0.81 . . . . 65.11 110.822 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 196' ' ' THR . . . . . 0.571 HG21 ' HA ' ' B' ' 159' ' ' LYS . 59.1 m -128.31 124.05 35.54 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 107.912 -1.144 . . . . 51.32 107.912 164.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 197' ' ' LEU . . . . . 0.425 HD13 ' HB2' ' C' ' 212' ' ' ALA . 35.4 tp -98.99 126.74 44.75 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 122.889 0.476 . . . . 73.5 110.743 -176.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -79.15 101.54 7.98 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.038 0.935 . . . . 44.52 108.858 177.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 199' ' ' VAL . . . . . 0.557 ' HA ' HG11 ' C' ' 210' ' ' VAL . 40.3 t -119.38 106.99 41.8 Favored Pre-proline 0 N--CA 1.478 0.936 0 C-N-CA 123.667 0.787 . . . . 61.21 109.307 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 200' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.23 147.94 67.43 Favored 'Trans proline' 0 C--N 1.373 1.836 0 C-N-CA 121.683 1.589 . . . . 71.34 111.45 175.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 201' ' ' ALA . . . . . 0.446 ' O ' HG23 ' C' ' 205' ' ' VAL . . . -55.44 -45.66 99.83 Favored Pre-proline 0 CA--C 1.551 1.016 0 N-CA-C 113.998 1.11 . . . . 74.35 113.998 -171.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 202' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -52.35 -47.32 27.57 Favored 'Trans proline' 0 C--N 1.385 2.468 0 C-N-CA 121.411 1.407 . . . . 63.15 112.569 174.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 203' ' ' ILE . . . . . 0.531 ' HA ' HG12 ' C' ' 206' ' ' VAL . 51.3 mt -69.02 -32.59 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 123.15 0.58 . . . . 63.4 111.195 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.85 -33.84 75.54 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.688 0.795 . . . . 75.02 112.145 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 205' ' ' VAL . . . . . 0.446 HG23 ' O ' ' C' ' 201' ' ' ALA . 43.1 t -85.75 -38.35 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-N 116.072 -0.513 . . . . 63.41 111.693 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 206' ' ' VAL . . . . . 0.531 HG12 ' HA ' ' C' ' 203' ' ' ILE . 14.4 p -79.09 -35.67 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 CA-C-O 120.952 0.406 . . . . 52.12 111.175 -174.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 79.8 66.8 1.63 Allowed Glycine 0 N--CA 1.435 -1.406 0 CA-C-N 115.185 -0.916 . . . . 63.21 111.948 -167.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -98.08 -137.22 9.58 Favored Glycine 0 C--O 1.244 0.766 0 N-CA-C 111.176 -0.769 . . . . 51.32 111.176 174.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 209' ' ' LYS . . . . . 0.524 ' HE2' ' HG3' ' B' ' 235' ' ' GLU . 7.2 mtmp? -134.22 133.15 40.56 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.337 0.655 . . . . 72.12 110.25 174.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 210' ' ' VAL . . . . . 0.557 HG11 ' HA ' ' C' ' 199' ' ' VAL . 35.8 m -114.84 178.49 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.012 1.325 . . . . 62.05 107.936 169.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 211' ' ' ARG . . . . . 0.604 ' HD3' ' HB2' ' C' ' 218' ' ' PRO . 24.8 ttm105 -131.56 130.24 42.01 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 118.454 0.57 . . . . 72.44 112.204 -177.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 212' ' ' ALA . . . . . 0.425 ' HB2' HD13 ' C' ' 197' ' ' LEU . . . -98.59 115.35 28.45 Favored 'General case' 0 C--N 1.348 0.519 0 C-N-CA 124.356 1.062 . . . . 74.43 108.248 169.037 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 213' ' ' MET . . . . . 0.423 ' HA ' ' HA ' ' C' ' 218' ' ' PRO . 2.3 tmm? -71.68 101.59 2.58 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 107.185 -1.413 . . . . 63.12 107.185 172.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 214' ' ' THR . . . . . 0.48 HG22 ' H ' ' C' ' 215' ' ' LEU . 0.6 OUTLIER -101.74 174.63 5.87 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 120.991 0.424 . . . . 54.24 110.348 -171.037 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 215' ' ' LEU . . . . . 0.622 HD13 ' HB2' ' C' ' 131' ' ' PHE . 26.5 mt -61.49 -43.42 98.9 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.793 1.637 . . . . 44.41 112.755 -173.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.86 17.5 19.36 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 115.189 -0.914 . . . . 71.0 110.927 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 217' ' ' GLY . . . . . 0.533 ' HA3' ' HD3' ' B' ' 207' ' ' LYS . . . 127.86 159.73 10.18 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-N 115.492 -0.776 . . . . 64.11 112.567 173.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 218' ' ' PRO . . . . . 0.604 ' HB2' ' HD3' ' C' ' 211' ' ' ARG . 70.3 Cg_endo -75.31 102.88 1.65 Allowed 'Trans proline' 0 CA--C 1.561 1.845 0 C-N-CA 122.764 2.309 . . . . 52.13 114.292 -178.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 219' ' ' VAL . . . . . 0.405 HG12 ' OG1' ' C' ' 214' ' ' THR . 12.6 p -83.87 144.28 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 123.729 0.812 . . . . 52.53 110.097 -178.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 220' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -97.36 109.83 22.5 Favored 'General case' 0 C--O 1.246 0.872 0 CA-C-O 121.66 0.743 . . . . 72.32 109.636 174.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 221' ' ' VAL . . . . . 0.435 HG11 HD22 ' C' ' 233' ' ' LEU . 49.2 t -80.12 138.19 20.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 125.114 1.366 . . . . 74.03 111.136 -178.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 222' ' ' ALA . . . . . 0.611 ' H ' ' HB2' ' B' ' 239' ' ' ALA . . . -89.53 118.01 28.85 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.149 0.979 . . . . 73.3 110.309 173.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 49.0 t -92.72 130.72 35.84 Favored Pre-proline 0 CA--C 1.553 1.092 0 N-CA-C 108.18 -1.044 . . . . 73.11 108.18 174.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 224' ' ' PRO . . . . . 0.812 ' HG2' ' HG3' ' B' ' 243' ' ' GLN . 21.1 Cg_exo -72.48 157.66 52.52 Favored 'Trans proline' 0 C--N 1.37 1.697 0 C-N-CA 123.561 2.84 . . . . 54.33 111.894 164.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -58.67 142.88 98.91 Favored 'Trans proline' 0 C--N 1.382 2.337 0 C-N-CA 122.368 2.045 . . . . 74.0 111.209 174.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 226' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 67.57 95.57 0.06 Allowed 'General case' 0 N--CA 1.484 1.247 0 O-C-N 124.488 1.118 . . . . 70.15 111.331 -179.182 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 227' ' ' THR . . . . . 0.501 HG22 HG11 ' C' ' 253' ' ' VAL . 52.9 m -140.41 123.04 16.24 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 123.222 0.609 . . . . 70.3 112.14 175.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 228' ' ' GLN . . . . . . . . . . . . . 27.7 mp0 -97.74 158.55 15.45 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-O 122.392 1.091 . . . . 74.32 111.172 171.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 229' ' ' ALA . . . . . 0.459 ' HB2' ' H ' ' C' ' 255' ' ' ILE . . . -67.45 148.87 50.98 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-N 113.874 -1.512 . . . . 62.12 109.357 171.133 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 88.71 -5.44 84.62 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-O 119.689 -0.506 . . . . 62.04 112.93 -174.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 231' ' ' ARG . . . . . 0.424 ' NH1' HE22 ' B' ' 243' ' ' GLN . 57.1 mtt180 -76.85 168.97 19.18 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 109.053 -0.721 . . . . 74.12 109.053 163.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 232' ' ' LYS . . . . . 0.562 ' HD3' ' HB3' ' C' ' 250' ' ' TYR . 3.9 ttmp? -143.47 139.82 30.05 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.96 0.41 . . . . 71.45 112.087 -175.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 233' ' ' LEU . . . . . 0.576 HD13 ' HB2' ' C' ' 251' ' ' LEU . 2.4 mp -105.7 155.75 18.95 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.808 1.243 . . . . 74.21 109.724 -179.538 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 41.1 ttp85 -128.01 89.93 3.01 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 109.095 -0.706 . . . . 72.34 109.095 172.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 235' ' ' LEU . . . . . 0.578 HD12 HD23 ' C' ' 249' ' ' LEU . 72.3 mt -73.43 114.14 11.32 Favored 'General case' 0 C--N 1.359 0.995 0 N-CA-C 109.497 -0.557 . . . . 73.43 109.497 174.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 24.7 mmmt -72.55 124.17 24.68 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.956 0.902 . . . . 71.55 111.236 -177.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 72.27 37.52 59.24 Favored Glycine 0 C--N 1.35 1.307 0 O-C-N 123.832 0.708 . . . . 71.42 113.118 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 29.8 mmtm -125.32 14.77 8.32 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.836 0.854 . . . . 72.03 111.322 177.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -96.32 -162.96 33.08 Favored Glycine 0 C--N 1.348 1.245 0 N-CA-C 111.972 -0.451 . . . . 31.21 111.972 172.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 240' ' ' PHE . . . . . 0.42 ' CD1' HD21 ' C' ' 193' ' ' LEU . 3.3 m-85 -72.51 149.59 91.08 Favored Pre-proline 0 N--CA 1.477 0.899 0 C-N-CA 123.588 0.755 . . . . 75.14 111.489 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 241' ' ' PRO . . . . . 0.435 ' HD3' ' CD2' ' C' ' 131' ' ' PHE . 31.6 Cg_exo -59.49 119.25 6.36 Favored 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 124.101 3.201 . . . . 70.21 112.572 -176.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -131.34 -172.76 13.17 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-N 115.488 -0.778 . . . . 70.14 112.822 -174.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 243' ' ' PRO . . . . . 0.588 ' HA ' ' HA ' ' B' ' 111' ' ' LEU . 37.9 Cg_endo -63.56 -40.48 30.18 Favored 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 123.781 2.988 . . . . 71.42 112.652 -178.224 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -84.56 10.81 10.05 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.097 0.559 . . . . 71.42 111.854 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 120.11 -75.45 0.32 Allowed Glycine 0 C--N 1.348 1.207 0 N-CA-C 110.601 -1.0 . . . . 51.32 110.601 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 246' ' ' ARG . . . . . . . . . . . . . 30.5 mtm180 -142.46 -179.97 6.6 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.845 1.258 . . . . 61.31 109.655 175.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -89.02 -161.86 37.93 Favored Glycine 0 C--N 1.346 1.137 0 N-CA-C 112.105 -0.398 . . . . 63.23 112.105 173.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -122.71 137.96 54.75 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 117.358 0.579 . . . . 73.54 109.736 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 249' ' ' LEU . . . . . 0.578 HD23 HD12 ' C' ' 235' ' ' LEU . 21.1 tp -95.04 115.11 27.01 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.198 0.999 . . . . 74.23 110.177 -175.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 250' ' ' TYR . . . . . 0.562 ' HB3' ' HD3' ' C' ' 232' ' ' LYS . 8.6 m-85 -100.91 100.13 10.72 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.253 -0.647 . . . . 71.43 109.253 -179.296 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 251' ' ' LEU . . . . . 0.576 ' HB2' HD13 ' C' ' 233' ' ' LEU . 1.8 mp -96.98 138.65 34.18 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.651 -0.656 . . . . 64.53 109.923 -174.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 252' ' ' GLU . . . . . 0.546 ' HG2' ' HB3' ' B' ' 157' ' ' MET . 4.9 tp10 -89.89 118.83 29.76 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.358 -0.978 . . . . 73.41 108.358 173.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 253' ' ' VAL . . . . . 0.501 HG11 HG22 ' C' ' 227' ' ' THR . 91.7 t -60.27 130.61 24.26 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 123.45 0.7 . . . . 73.5 110.842 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 254' ' ' ARG . . . . . 0.468 ' CZ ' ' HB ' ' C' ' 256' ' ' THR . 2.1 tmm_? -126.27 101.0 6.54 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 107.122 -1.436 . . . . 74.13 107.122 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 255' ' ' ILE . . . . . 0.459 ' H ' ' HB2' ' C' ' 229' ' ' ALA . 46.2 mm -73.45 125.92 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 109.577 -0.527 . . . . 75.24 109.577 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 256' ' ' THR . . . . . 0.468 ' HB ' ' CZ ' ' C' ' 254' ' ' ARG . 0.1 OUTLIER -128.09 163.47 24.55 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.102 0.961 . . . . 53.32 111.003 -175.418 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 2.8 pp -137.08 147.97 60.8 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 124.751 1.221 . . . . 64.54 107.827 173.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -79.17 15.48 1.53 Allowed 'Trans proline' 0 N--CA 1.501 1.943 0 C-N-CA 122.566 2.178 . . . . 73.21 113.089 -170.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 57.59 -84.3 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.406 1.483 . . . . 72.3 111.017 -171.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -73.09 137.83 45.48 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.215 1.006 . . . . 73.41 110.138 -177.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 261' ' ' LEU . . . . . . . . . . . . . 77.3 mt -130.16 165.03 23.17 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.756 0.822 . . . . 71.21 111.361 -178.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 14.9 p -84.09 146.4 48.41 Favored Pre-proline 0 CA--C 1.549 0.918 0 CA-C-N 114.245 -1.343 . . . . 61.23 108.854 167.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -51.38 -26.0 19.95 Favored 'Trans proline' 0 C--N 1.39 2.732 0 C-N-CA 124.256 3.304 . . . . 74.2 114.649 -172.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -66.36 -65.4 0.68 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.753 0.821 . . . . 71.04 109.754 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -56.13 -44.02 78.76 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 114.647 -1.16 . . . . 65.11 109.85 177.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 266' ' ' GLU . . . . . 0.409 ' O ' ' HG2' ' C' ' 270' ' ' LYS . 5.2 tp10 -50.44 -48.42 56.41 Favored 'General case' 0 CA--C 1.548 0.891 0 O-C-N 124.549 1.156 . . . . 64.21 110.529 179.157 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 267' ' ' ALA . . . . . 0.475 ' O ' ' HG2' ' C' ' 271' ' ' LYS . . . -66.57 -41.0 89.27 Favored 'General case' 0 C--N 1.355 0.835 0 CA-C-N 115.481 -0.781 . . . . 70.32 112.22 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 268' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.98 -38.42 91.0 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 120.797 0.332 . . . . 52.44 111.112 176.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -68.01 -32.56 73.03 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.39 0.676 . . . . 61.11 110.43 175.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 270' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' C' ' 266' ' ' GLU . 4.0 mmmp? -58.99 -49.39 78.05 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.048 0.539 . . . . 75.43 109.721 173.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 271' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' C' ' 267' ' ' ALA . 10.8 mmpt? -59.54 -48.76 80.41 Favored 'General case' 0 C--O 1.249 1.033 0 O-C-N 124.252 0.97 . . . . 75.33 111.106 -177.291 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 80.4 mt -54.14 -57.84 9.6 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 124.049 0.843 . . . . 74.33 110.193 173.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -52.95 -45.92 67.93 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.938 0.895 . . . . 34.13 112.339 -173.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -63.56 -43.54 96.76 Favored 'General case' 0 C--O 1.25 1.097 0 C-N-CA 123.789 0.835 . . . . 63.21 110.8 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -56.4 -34.37 66.66 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-O 121.001 0.429 . . . . 70.04 111.444 174.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 276' ' ' TYR . . . . . 0.716 ' HA ' ' HD3' ' C' ' 279' ' ' ARG . 1.0 OUTLIER -85.26 -25.65 27.14 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 115.743 -0.662 . . . . 75.52 111.596 -179.404 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 277' ' ' TYR . . . . . 0.44 ' CE1' ' HA3' ' A' ' 208' ' ' GLY . 22.1 m-30 -68.85 -32.36 71.99 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.938 -0.393 . . . . 44.24 109.938 176.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -55.57 -18.62 7.93 Favored 'General case' 0 CA--C 1.561 1.393 0 O-C-N 123.756 0.66 . . . . 55.2 112.515 173.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 279' ' ' ARG . . . . . 0.716 ' HD3' ' HA ' ' C' ' 276' ' ' TYR . 12.6 mtp-105 -89.87 -28.88 18.94 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.061 0.944 . . . . 71.52 111.833 176.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.963 0 C-N-CA 123.292 0.637 . . . . 75.14 110.671 -174.062 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.485 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.0 OUTLIER . . . . . 0 N--CA 1.482 1.127 0 CA-C-O 119.713 -0.184 . . . . 64.12 110.807 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.38 40.56 27.38 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.41 1.084 . . . . 51.4 111.917 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -73.77 79.19 1.57 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.045 0.538 . . . . 74.04 109.769 177.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -36.0 104.35 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.63 1.572 . . . . 62.43 113.24 -178.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -72.13 112.02 7.86 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.587 -0.894 . . . . 74.32 108.587 166.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -75.98 84.3 2.88 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 107.242 -1.392 . . . . 61.41 107.242 178.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.485 ' HA ' HD12 ' A' ' 10' ' ' ILE . 41.7 m-85 -60.67 -29.98 69.63 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-N 114.59 -1.186 . . . . 73.34 111.996 -173.12 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -66.38 -42.34 88.09 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.833 -0.621 . . . . 73.33 110.432 176.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.09 -40.31 95.95 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.933 0.493 . . . . 60.32 111.19 176.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.485 HD12 ' HA ' ' A' ' 7' ' ' TYR . 62.9 mt -60.79 -39.17 80.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-N 115.807 -0.633 . . . . 74.23 110.727 178.192 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 92.1 mt -86.03 -7.59 58.52 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 112.287 0.477 . . . . 51.33 112.287 176.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.49 18.29 76.93 Favored Glycine 0 C--N 1.351 1.391 0 N-CA-C 114.501 0.56 . . . . 53.33 114.501 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.4 m -103.83 153.88 38.43 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 124.444 1.098 . . . . 71.43 110.041 177.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.23 165.11 20.52 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 122.785 2.323 . . . . 50.12 114.142 -176.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -81.63 61.05 4.86 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.4 1.08 . . . . 75.43 109.658 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -177.42 -26.83 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 114.073 -1.421 . . . . 64.11 108.286 -166.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -47.16 123.58 5.58 Favored 'General case' 0 C--N 1.349 0.579 0 C-N-CA 125.714 1.606 . . . . 64.31 113.137 -174.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 43.7 p -74.42 173.01 10.9 Favored 'General case' 0 C--O 1.243 0.733 0 O-C-N 124.226 0.954 . . . . 71.11 110.901 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.2 tm0? -55.81 -29.19 59.37 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.04 0.936 . . . . 64.21 110.178 179.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -57.22 -58.67 7.19 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.416 1.086 . . . . 72.43 110.845 173.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -66.03 -35.02 79.43 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.135 0.574 . . . . 64.03 111.484 -173.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.51 HG12 ' HB3' ' A' ' 57' ' ' LEU . 1.7 mp -61.76 -45.0 99.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 123.044 0.537 . . . . 73.31 110.296 173.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -61.69 -40.02 93.5 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.575 1.15 . . . . 71.24 111.035 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.613 ' HA ' ' HD3' ' A' ' 27' ' ' LYS . 18.5 mtp180 -77.15 -37.47 53.88 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.997 0.919 . . . . 54.12 111.41 -175.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.92 -37.99 89.43 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.652 -0.704 . . . . 64.0 110.161 173.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -74.97 -28.05 60.42 Favored 'General case' 0 C--O 1.215 -0.732 0 CA-C-N 115.006 -0.997 . . . . 73.1 110.964 176.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.613 ' HD3' ' HA ' ' A' ' 24' ' ' ARG . 22.6 mtpp -55.29 -53.54 54.76 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.414 -0.958 . . . . 74.22 108.414 171.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 -54.2 -67.06 0.29 Allowed 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 114.576 -1.193 . . . . 71.15 111.34 176.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 79.4 mt -70.21 -22.98 62.87 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.04 0.936 . . . . 74.11 112.952 -166.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.81 -54.79 6.66 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 109.252 -0.647 . . . . 63.3 109.252 173.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -64.11 -21.59 66.6 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 120.878 0.37 . . . . 72.33 111.509 -178.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -84.96 -44.33 13.2 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 124.721 1.209 . . . . 63.33 111.113 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -113.78 21.53 14.88 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 112.749 0.648 . . . . 63.25 112.749 -174.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -63.85 113.37 9.81 Favored Pre-proline 0 N--CA 1.484 1.263 0 CA-C-O 118.074 -0.965 . . . . 63.41 108.465 176.321 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.709 ' HB3' ' HG2' ' A' ' 44' ' ' GLU . 19.5 Cg_endo -57.87 -28.08 81.15 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 123.227 2.618 . . . . 74.13 113.647 -174.311 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -73.38 -30.55 63.36 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.881 0.873 . . . . 72.45 111.997 176.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 75.4 t -85.16 -39.23 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.017 0.527 . . . . 65.53 109.889 176.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -132.33 94.5 3.45 Favored 'General case' 0 C--O 1.244 0.793 0 C-N-CA 124.491 1.116 . . . . 61.35 109.088 -175.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.606 ' H ' ' HE3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -76.04 82.91 2.9 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 108.764 -0.828 . . . . 73.11 108.764 -179.581 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.5 m -140.08 116.22 7.99 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-O 117.998 -1.001 . . . . 54.41 108.666 177.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_exo -46.93 -42.22 25.33 Favored 'Trans proline' 0 C--N 1.387 2.579 0 C-N-CA 123.119 2.546 . . . . 72.23 112.419 175.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 34.3 tp10 -48.56 -51.29 28.47 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.05 1.34 . . . . 64.43 111.116 173.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.3 -25.6 65.22 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 115.113 -0.949 . . . . 72.14 111.031 -177.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.709 ' HG2' ' HB3' ' A' ' 35' ' ' PRO . 41.7 mt-10 -84.17 -33.94 24.11 Favored 'General case' 0 C--N 1.354 0.785 0 C-N-CA 123.324 0.65 . . . . 62.01 110.948 -174.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -76.47 -38.68 54.98 Favored 'General case' 0 C--O 1.246 0.905 0 CA-C-O 121.372 0.606 . . . . 62.44 109.459 178.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -66.35 -34.21 77.47 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.411 -0.813 . . . . 74.03 110.083 170.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -62.15 -39.74 93.63 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.361 0.665 . . . . 73.24 109.246 172.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.412 ' HG3' ' O ' ' A' ' 44' ' ' GLU . 67.1 mttm -58.14 -50.93 71.78 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 122.975 0.51 . . . . 75.14 110.688 176.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -60.29 -44.76 95.09 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.474 0.654 . . . . 71.44 111.579 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 96.6 mt -70.82 -26.91 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 124.422 1.089 . . . . 70.53 111.39 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.531 ' HA ' ' HB3' ' A' ' 54' ' ' TYR . 9.7 m-80 -94.82 -6.12 43.57 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.732 0.813 . . . . 73.43 111.474 178.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -75.94 -49.04 18.88 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 106.329 -1.73 . . . . 63.42 106.329 164.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.476 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . . . -57.27 -48.66 78.32 Favored 'General case' 0 C--N 1.349 0.573 0 CA-C-N 113.505 -1.679 . . . . 65.45 111.452 174.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.531 ' HB3' ' HA ' ' A' ' 51' ' ' ASN . 67.2 t80 -67.95 -41.31 82.66 Favored 'General case' 0 C--O 1.209 -1.07 0 CA-C-N 115.689 -0.687 . . . . 72.32 110.602 179.141 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.45 -51.19 60.54 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 118.42 0.554 . . . . 53.01 111.368 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.505 HG13 ' HZ ' ' A' ' 101' ' ' PHE . 47.5 t -73.65 -31.97 33.94 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 CA-C-N 115.122 -0.945 . . . . 74.52 111.204 -177.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.51 ' HB3' HG12 ' A' ' 22' ' ' ILE . 76.4 mt -103.75 3.66 34.36 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 113.961 1.097 . . . . 62.04 113.961 -175.267 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.3 t -63.06 -51.26 67.35 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 123.855 0.862 . . . . 74.34 111.804 -176.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -109.66 144.25 29.5 Favored Pre-proline 0 C--O 1.239 0.513 0 CA-C-N 114.439 -1.255 . . . . 74.34 108.924 -169.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.414 ' O ' ' HG2' ' A' ' 64' ' ' ARG . 48.3 Cg_exo -41.61 -51.09 4.49 Favored 'Trans proline' 0 C--N 1.383 2.379 0 C-N-CA 123.943 3.095 . . . . 72.41 114.983 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.467 ' HB2' ' HB3' ' A' ' 144' ' ' ARG . 18.9 tp10 -79.8 -31.31 40.71 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 112.531 0.567 . . . . 72.3 112.531 -172.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -62.7 -42.2 99.52 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-O 122.084 0.945 . . . . 74.54 108.884 174.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.441 ' HG2' HD22 ' A' ' 57' ' ' LEU . 4.0 tmt_? -61.98 -42.65 99.37 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 113.72 -1.582 . . . . 74.11 108.443 175.064 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.414 ' HG2' ' O ' ' A' ' 60' ' ' PRO . 2.8 mmp_? -62.04 -34.51 76.37 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.615 0.766 . . . . 74.25 111.364 174.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 61' ' ' GLU . 62.4 mt -62.98 -44.24 99.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 109.217 -0.66 . . . . 64.42 109.217 178.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -57.79 -54.22 49.31 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.558 -0.747 . . . . 75.4 110.181 173.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -57.62 -42.52 83.47 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.703 0.801 . . . . 64.04 111.606 -175.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 40.4 p -69.68 -31.22 69.14 Favored 'General case' 0 C--N 1.348 0.535 0 CA-C-N 115.948 -0.569 . . . . 75.13 110.311 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -80.26 137.19 36.59 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 118.212 0.46 . . . . 63.45 110.335 -177.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.15 6.93 77.95 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-N 115.764 -0.653 . . . . 52.54 111.547 -174.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 95.0 m -130.37 -61.28 0.97 Allowed 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 103.671 -2.714 . . . . 71.23 103.671 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 92.0 m -87.72 150.09 23.82 Favored 'General case' 0 C--O 1.255 1.364 0 N-CA-C 105.274 -2.121 . . . . 74.23 105.274 156.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.57 -15.34 11.44 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.768 0.827 . . . . 74.04 111.136 178.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.1 123.99 87.71 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 123.695 0.798 . . . . 75.1 110.919 177.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.455 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 61.2 Cg_endo -71.37 146.26 50.06 Favored 'Trans proline' 0 C--N 1.376 1.995 0 C-N-CA 122.413 2.075 . . . . 75.41 110.77 175.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 75' ' ' PRO . 7.1 Cg_exo -70.76 152.14 63.9 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 122.46 2.107 . . . . 74.25 110.982 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -58.63 148.5 81.77 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 122.809 2.34 . . . . 62.44 112.947 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -50.36 114.15 1.32 Allowed 'Trans proline' 0 C--N 1.391 2.812 0 C-N-CA 123.542 2.828 . . . . 43.51 112.782 177.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.467 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 85.8 Cg_endo -81.73 127.6 5.66 Favored 'Trans proline' 0 CA--C 1.557 1.648 0 C-N-CA 122.467 2.111 . . . . 71.05 112.192 -176.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 79' ' ' PRO . 34.0 Cg_exo -60.33 84.16 0.07 OUTLIER 'Trans proline' 0 C--N 1.384 2.434 0 C-N-CA 123.176 2.584 . . . . 51.35 112.854 -177.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 146.99 -44.32 0.82 Allowed Glycine 0 C--N 1.341 0.834 0 CA-C-N 114.656 -1.156 . . . . 62.41 110.549 -177.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 115.13 144.75 8.45 Favored Glycine 0 C--N 1.359 1.809 0 C-N-CA 123.282 0.468 . . . . 53.03 112.707 178.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -58.24 117.75 4.75 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.693 0.797 . . . . 74.41 109.646 174.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -54.65 108.54 0.4 Allowed 'General case' 0 N--CA 1.476 0.852 0 O-C-N 124.339 1.024 . . . . 71.31 112.967 -171.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.58 ' HA ' ' HD2' ' A' ' 88' ' ' PHE . 14.1 m-85 -134.81 38.7 3.02 Favored 'General case' 0 C--O 1.245 0.862 0 C-N-CA 125.95 1.7 . . . . 70.22 108.068 173.171 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.3 m -67.18 117.75 9.64 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 113.256 -1.793 . . . . 74.44 110.732 177.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 85.24 -12.07 59.25 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-N 116.116 -0.493 . . . . 70.11 113.535 -176.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.58 ' HD2' ' HA ' ' A' ' 85' ' ' PHE . 12.2 m-85 -101.59 135.53 42.96 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 109.426 -0.583 . . . . 72.34 109.426 -172.016 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -79.45 80.41 5.82 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-O 120.909 0.385 . . . . 71.44 110.237 -174.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.422 HG23 ' HZ ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -42.14 -53.64 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 125.692 1.597 . . . . 75.21 112.996 176.841 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -73.85 -5.65 42.31 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 113.374 0.879 . . . . 75.33 113.374 -173.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -95.83 -18.71 20.17 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.209 0.604 . . . . 45.35 110.986 175.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.407 ' HE1' ' HB3' ' A' ' 48' ' ' LYS . 23.2 m-30 -83.62 179.12 7.7 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 113.068 0.766 . . . . 71.01 113.068 -171.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 68.2 p -68.14 151.95 46.23 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.892 1.277 . . . . 74.5 113.236 -170.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.6 -35.23 73.91 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 115.309 -0.86 . . . . 74.31 110.727 172.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -50.08 -51.36 43.33 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.132 1.373 . . . . 75.03 110.297 176.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.422 ' HZ ' HG23 ' A' ' 90' ' ' VAL . 0.3 OUTLIER -64.37 -46.08 84.94 Favored 'General case' 0 CA--C 1.556 1.205 0 CA-C-N 114.257 -1.338 . . . . 63.23 110.831 173.859 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.452 ' HA ' HD21 ' A' ' 105' ' ' LEU . 60.7 mt-30 -70.19 -9.9 57.18 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 112.98 0.733 . . . . 73.05 112.98 -173.015 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -101.96 -44.46 5.48 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.952 0.901 . . . . 70.02 110.929 173.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 17.8 tp -63.66 -56.9 12.21 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.646 0.778 . . . . 55.03 111.042 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.505 ' HZ ' HG13 ' A' ' 56' ' ' VAL . 86.5 m-85 -85.77 6.97 25.53 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 115.392 -0.822 . . . . 72.11 111.073 176.209 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.437 ' HA2' ' HG ' ' A' ' 105' ' ' LEU . . . -41.4 -63.16 1.67 Allowed Glycine 0 C--N 1.358 1.792 0 C-N-CA 124.867 1.223 . . . . 72.43 114.659 178.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -43.55 -23.12 0.47 Allowed 'Trans proline' 0 C--N 1.389 2.689 0 C-N-CA 124.793 3.662 . . . . 23.1 115.849 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.417 ' HA3' ' HD2' ' A' ' 79' ' ' PRO . . . -152.74 51.6 0.49 Allowed Glycine 0 C--N 1.346 1.138 0 O-C-N 121.888 -0.507 . . . . 44.4 112.035 177.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.452 HD21 ' HA ' ' A' ' 98' ' ' GLN . 25.9 mt -57.48 14.05 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.241 0 N-CA-C 116.067 1.877 . . . . 74.25 116.067 177.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER 61.76 -164.66 0.24 Allowed 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.855 0.862 . . . . 72.25 110.417 166.156 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 61.68 45.63 95.88 Favored Glycine 0 N--CA 1.442 -0.925 0 N-CA-C 115.678 1.031 . . . . 44.0 115.678 164.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.736 ' HA3' ' HB2' ' A' ' 114' ' ' ARG . . . 63.18 -69.47 0.03 OUTLIER Glycine 0 CA--C 1.529 0.956 0 N-CA-C 118.692 2.237 . . . . 71.34 118.692 162.069 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.434 ' HE2' HH11 ' A' ' 114' ' ' ARG . 61.4 m-85 -72.49 -8.94 57.72 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.308 0.643 . . . . 64.11 109.656 173.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -84.59 13.51 51.8 Favored Glycine 0 CA--C 1.542 1.776 0 CA-C-N 114.874 -1.057 . . . . 55.25 111.501 161.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? 74.96 -15.29 0.67 Allowed 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 126.942 2.097 . . . . 71.44 112.596 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -97.96 52.26 1.06 Allowed 'General case' 0 CA--C 1.562 1.419 0 N-CA-C 113.443 0.905 . . . . 73.25 113.443 -175.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.531 ' O ' ' HA2' ' A' ' 168' ' ' GLY . 25.7 m 67.53 89.12 0.1 Allowed 'General case' 0 N--CA 1.504 2.258 0 N-CA-C 114.998 1.481 . . . . 74.21 114.998 161.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.736 ' HB2' ' HA3' ' A' ' 108' ' ' GLY . 27.1 ttt180 -72.69 -148.64 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.638 0 CA-C-N 121.266 1.848 . . . . 74.52 111.901 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.404 ' HA ' ' HD2' ' A' ' 170' ' ' PRO . 7.4 tmtt? -10.81 111.23 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.543 0 C-N-CA 126.469 1.908 . . . . 72.15 114.093 -160.03 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.82 129.13 41.36 Favored Glycine 0 CA--C 1.543 1.835 0 CA-C-N 115.549 -0.751 . . . . 55.22 114.7 -175.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.542 ' N ' ' HA3' ' A' ' 166' ' ' GLY . 65.0 mtt180 -77.37 160.4 28.8 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 125.214 1.406 . . . . 71.34 111.576 172.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -85.14 84.86 7.55 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 107.321 -1.362 . . . . 74.23 107.321 163.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 9.5 tt -95.9 144.54 26.14 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.365 1.066 . . . . 70.23 109.45 -171.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.432 ' HA ' ' HB2' ' A' ' 175' ' ' LEU . 53.6 ttt-85 -102.98 143.37 32.64 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.045 0.938 . . . . 74.51 109.924 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.468 ' HB3' HD11 ' A' ' 174' ' ' LEU . . . -147.4 167.46 24.32 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.308 0.575 . . . . 41.51 112.123 -178.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.438 ' O ' HD12 ' B' ' 8' ' ' LEU . 5.7 mm-40 -103.38 107.93 18.96 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 114.49 -1.232 . . . . 61.0 107.741 -175.393 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 24.0 tp -99.24 100.25 9.88 Favored Pre-proline 0 N--CA 1.48 1.05 0 N-CA-C 107.888 -1.153 . . . . 54.05 107.888 177.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.579 ' HG2' ' HB ' ' B' ' 6' ' ' ILE . 43.9 Cg_endo -68.29 139.03 44.63 Favored 'Trans proline' 0 C--N 1.37 1.663 0 C-N-CA 121.323 1.348 . . . . 75.33 109.269 176.008 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.507 HD21 HD12 ' A' ' 149' ' ' ILE . 28.5 tp -142.56 138.7 31.02 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.151 0.887 . . . . 64.01 112.027 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 98.8 m -73.18 131.05 41.55 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 114.233 -1.349 . . . . 71.34 109.189 174.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.57 HD22 HD13 ' A' ' 180' ' ' LEU . 5.4 mt -53.48 -56.74 14.41 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 124.113 0.883 . . . . 70.54 111.085 -172.306 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.628 ' HG2' ' HD3' ' B' ' 2' ' ' LYS . 28.8 mp0 -41.41 -53.06 3.45 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 113.148 -1.842 . . . . 75.32 111.615 176.184 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -65.43 -37.42 86.84 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.454 0.702 . . . . 64.33 111.219 -178.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.585 ' HB1' ' O ' ' A' ' 153' ' ' VAL . . . -60.3 -34.66 74.08 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 124.421 1.075 . . . . 41.43 111.46 178.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -82.68 -37.69 24.46 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.563 0.745 . . . . 74.51 111.527 176.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 41.4 m170 -64.59 -40.12 94.96 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.254 0.622 . . . . 75.25 110.903 -175.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 67.34 77.84 0.3 Allowed Glycine 0 C--N 1.343 0.938 0 CA-C-N 115.452 -0.795 . . . . 71.54 112.804 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.412 ' O ' HG12 ' A' ' 149' ' ' ILE . . . -155.33 -158.99 9.05 Favored Glycine 0 C--N 1.334 0.427 0 N-CA-C 112.141 -0.384 . . . . 70.42 112.141 -179.195 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -68.87 123.89 22.2 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 125.001 1.32 . . . . 73.14 110.401 -175.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.58 HH11 HG23 ' B' ' 5' ' ' THR . 10.1 tpp180 -126.87 120.31 28.9 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.274 -1.01 . . . . 74.4 108.274 169.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.4 t -80.66 128.0 39.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 115.18 -0.918 . . . . 71.24 109.499 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.6 p -142.58 124.03 12.12 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 C-N-CA 124.327 1.051 . . . . 73.14 108.25 -178.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -116.56 123.73 48.09 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.925 0.49 . . . . 71.3 111.695 -171.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.515 HG21 HD23 ' B' ' 8' ' ' LEU . 1.0 OUTLIER -153.69 149.4 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 125.406 1.483 . . . . 75.1 109.598 170.491 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 61.41 20.38 11.1 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.09 0.956 . . . . 74.24 112.33 176.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 85.89 -14.11 53.96 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-N 116.21 -0.45 . . . . 31.1 112.78 -175.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.586 ' HD3' ' SD ' ' A' ' 164' ' ' MET . 59.4 ttt180 -87.82 102.5 14.75 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 123.225 0.61 . . . . 72.12 109.579 177.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.467 ' HB3' ' HB2' ' A' ' 61' ' ' GLU . 41.9 ttt85 -92.41 89.79 6.94 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 107.926 -1.138 . . . . 74.41 107.926 171.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.3 p -96.86 142.95 13.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 115.34 -0.846 . . . . 73.53 109.508 -173.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 23.2 t -108.97 95.81 5.9 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 109.029 -0.73 . . . . 31.45 109.029 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 3.4 p -81.14 116.39 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.005 0.522 . . . . 73.42 110.041 -177.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 38.8 ttt85 -77.61 94.33 4.36 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 107.884 -1.154 . . . . 74.14 107.884 171.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.507 HD12 HD21 ' A' ' 125' ' ' LEU . 9.3 pt -70.45 150.69 95.69 Favored Pre-proline 0 CA--C 1.553 1.064 0 CA-C-N 114.494 -1.23 . . . . 74.13 110.805 -178.412 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.613 ' HB2' ' HZ ' ' A' ' 240' ' ' PHE . 92.9 Cg_endo -75.69 137.73 20.57 Favored 'Trans proline' 0 CA--C 1.566 2.098 0 C-N-CA 122.231 1.954 . . . . 60.34 111.997 178.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.24 101.64 0.36 Allowed 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 123.086 2.524 . . . . 74.15 114.119 -175.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 121.24 5.62 9.42 Favored Glycine 0 C--N 1.345 1.036 0 CA-C-N 115.006 -0.997 . . . . 75.51 112.914 178.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.585 ' O ' ' HB1' ' A' ' 130' ' ' ALA . 7.4 p -62.38 134.71 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 N-CA-C 109.314 -0.624 . . . . 75.43 109.314 175.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.712 ' HD3' ' HB3' ' A' ' 186' ' ' PHE . 70.0 mtt85 -139.17 174.68 10.26 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 122.761 0.424 . . . . 73.23 110.413 -173.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.599 ' HG3' ' HE ' ' A' ' 187' ' ' ARG . 4.2 tp10 -43.62 136.35 3.39 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 126.792 2.037 . . . . 72.32 113.297 -172.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.38 -15.33 46.03 Favored Glycine 0 CA--C 1.534 1.267 0 CA-C-O 118.885 -0.953 . . . . 14.21 114.627 177.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 22.8 t -63.23 151.76 39.53 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-N 118.648 1.224 . . . . 74.23 110.172 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.426 HG22 HG22 ' A' ' 177' ' ' VAL . 57.3 t -123.5 102.08 10.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 123.566 0.747 . . . . 72.34 109.431 -175.194 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.554 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 60.2 mt -83.43 108.57 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 108.282 -1.007 . . . . 75.24 108.282 172.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.433 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 78.1 ttt180 -82.39 110.07 17.2 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 109.381 -0.6 . . . . 61.32 109.381 177.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.402 HG13 ' HB3' ' A' ' 174' ' ' LEU . 3.5 p -121.66 106.52 37.22 Favored Pre-proline 0 CA--C 1.558 1.269 0 C-N-CA 123.164 0.586 . . . . 61.33 110.133 178.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.528 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 24.5 Cg_exo -64.98 129.9 24.41 Favored 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 122.938 2.425 . . . . 74.53 111.89 174.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 102.5 24.97 7.97 Favored Glycine 0 C--N 1.342 0.862 0 CA-C-O 119.713 -0.493 . . . . 70.43 114.055 177.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.586 ' SD ' ' HD3' ' A' ' 143' ' ' ARG . 18.6 tpp -138.77 -40.32 0.49 Allowed 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 117.489 0.645 . . . . 64.15 111.19 -175.333 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.46 ' N ' ' HB2' ' A' ' 174' ' ' LEU . . . -76.98 -85.54 0.43 Allowed Glycine 0 C--N 1.351 1.398 0 O-C-N 123.61 0.569 . . . . 73.33 112.493 -174.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.542 ' HA3' ' N ' ' A' ' 117' ' ' ARG . . . -62.33 105.04 0.86 Allowed Glycine 0 C--O 1.257 1.581 0 N-CA-C 111.697 -0.561 . . . . 74.5 111.697 171.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -60.01 124.46 20.28 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.257 -1.016 . . . . 75.42 108.257 169.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.531 ' HA2' ' O ' ' A' ' 113' ' ' SER . . . 176.47 152.92 10.09 Favored Glycine 0 CA--C 1.499 -0.967 0 O-C-N 123.758 0.661 . . . . 64.21 112.103 -176.329 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ASN . . . . . 0.469 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . 3.6 t-20 -55.19 -45.45 99.85 Favored Pre-proline 0 CA--C 1.569 1.705 0 CA-C-O 118.702 -0.666 . . . . 63.11 110.903 169.553 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.469 ' HD3' ' HB3' ' A' ' 169' ' ' ASN . 15.1 Cg_exo -75.33 140.1 24.18 Favored 'Trans proline' 0 C--N 1.387 2.595 0 C-N-CA 121.911 1.74 . . . . 71.13 110.449 161.523 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.34 112.5 3.54 Favored 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 123.047 2.498 . . . . 71.25 113.159 -170.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -80.57 130.54 9.82 Favored Glycine 0 C--N 1.36 1.87 0 C-N-CA 121.004 -0.617 . . . . 72.4 113.369 177.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.528 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 22.5 m-20 -61.28 137.97 58.24 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.781 0.832 . . . . 71.14 110.392 178.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.468 HD11 ' HB3' ' A' ' 121' ' ' ALA . 43.3 tp -113.3 138.51 49.92 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.766 -0.457 . . . . 64.32 109.766 175.381 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.432 ' HB2' ' HA ' ' A' ' 120' ' ' ARG . 60.3 mt -103.08 86.12 2.64 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 107.947 -1.131 . . . . 72.12 107.947 172.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.554 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 68.3 mt -66.77 89.75 0.16 Allowed 'General case' 0 C--N 1.354 0.792 0 CA-C-N 115.419 -0.81 . . . . 70.05 109.298 174.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.426 HG22 HG22 ' A' ' 158' ' ' VAL . 97.3 t -84.15 99.33 6.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 107.23 -1.396 . . . . 61.43 107.23 175.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.4 p -66.06 102.38 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 CA-C-O 122.294 1.045 . . . . 70.33 111.013 -174.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.548 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 8.1 mmm180 -85.28 96.23 9.45 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 114.137 -1.392 . . . . 53.32 107.797 174.049 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.57 HD13 HD22 ' A' ' 127' ' ' LEU . 19.1 mt -67.91 150.48 48.48 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 109.925 -0.398 . . . . 72.4 109.925 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 74.3 mt -52.75 144.77 24.22 Favored Pre-proline 0 N--CA 1.48 1.026 0 CA-C-O 118.067 -0.968 . . . . 73.14 110.531 178.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -56.2 81.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.388 2.615 0 C-N-CA 124.149 3.232 . . . . 71.42 112.932 -174.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.412 ' CG ' HD11 ' A' ' 127' ' ' LEU . 12.1 t-80 -143.84 96.91 5.46 Favored Pre-proline 0 CA--C 1.547 0.829 0 N-CA-C 105.346 -2.094 . . . . 73.35 105.346 -177.225 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -72.67 27.83 0.28 Allowed 'Trans proline' 0 N--CA 1.498 1.779 0 C-N-CA 124.738 3.625 . . . . 61.24 116.733 -162.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.547 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 61.3 t -93.91 -61.17 2.18 Favored 'Isoleucine or valine' 0 C--N 1.352 0.709 0 CA-C-N 119.648 1.113 . . . . 64.21 110.283 -172.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' PHE . . . . . 0.712 ' HB3' ' HD3' ' A' ' 154' ' ' ARG . 11.7 m-85 -114.52 148.27 38.17 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 114.792 1.404 . . . . 72.31 114.792 -166.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.599 ' HE ' ' HG3' ' A' ' 155' ' ' GLU . 28.5 ttm180 -148.0 134.0 19.21 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.661 1.584 . . . . 75.51 109.192 177.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.48 ' HB2' ' HB2' ' A' ' 154' ' ' ARG . 47.0 tp -97.26 110.27 22.85 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 109.334 -0.617 . . . . 74.21 109.334 174.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.42 92.57 4.75 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 106.983 -1.488 . . . . 70.31 106.983 174.31 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.485 ' HA3' ' HB3' ' B' ' 380' ' ' LYS . . . 68.82 -98.71 0.56 Allowed Glycine 0 C--N 1.346 1.095 0 CA-C-N 115.546 -0.752 . . . . 65.41 111.349 -174.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.44 HE21 ' HD2' ' A' ' 243' ' ' PRO . 0.3 OUTLIER -115.66 -15.42 11.38 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.118 0.567 . . . . 72.32 110.702 172.141 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.403 ' O ' HD12 ' A' ' 188' ' ' LEU . 15.3 m-20 -79.2 163.58 24.89 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.226 0.61 . . . . 72.32 110.061 177.166 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.507 HD22 ' HD2' ' A' ' 154' ' ' ARG . 80.1 mt -125.44 141.12 52.23 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.027 0.931 . . . . 63.44 110.699 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.408 ' HB2' ' HB3' ' A' ' 187' ' ' ARG . 55.3 m-85 -102.26 140.67 36.24 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.862 -1.162 . . . . 73.14 107.862 163.075 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.547 ' HA ' ' O ' ' A' ' 185' ' ' VAL . . . -143.92 155.97 44.26 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.557 1.143 . . . . 74.34 109.314 -173.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 25.4 m -121.27 126.31 49.24 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 108.986 -0.746 . . . . 70.21 108.986 176.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.478 ' HB2' HD22 ' A' ' 251' ' ' LEU . 49.3 tp -117.73 117.89 30.58 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.301 0.641 . . . . 72.21 110.54 -174.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -92.68 113.91 26.31 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.683 -0.858 . . . . 61.43 108.683 169.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 7.4 p -130.46 133.33 24.75 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 124.118 0.967 . . . . 64.4 108.578 -179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -79.8 157.29 24.36 Favored 'Trans proline' 0 C--N 1.366 1.478 0 C-N-CA 121.94 1.76 . . . . 64.51 112.076 171.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -59.3 -48.55 95.89 Favored Pre-proline 0 CA--C 1.558 1.252 0 N-CA-C 114.274 1.213 . . . . 71.34 114.274 -170.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -57.42 -42.64 59.58 Favored 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 121.897 1.731 . . . . 63.54 113.652 178.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 45.3 mt -75.21 -28.24 20.37 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 CA-C-N 116.442 -0.344 . . . . 64.32 110.485 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.44 -42.4 78.92 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.46 0.704 . . . . 71.51 111.101 176.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 42.3 t -71.72 -52.12 27.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 115.184 -0.916 . . . . 63.23 111.583 -178.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 72.5 t -77.29 -31.34 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 122.867 0.467 . . . . 74.41 111.455 -176.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 77.66 71.47 1.21 Allowed Glycine 0 C--N 1.338 0.686 0 CA-C-N 116.242 -0.436 . . . . 72.35 112.015 -177.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -101.19 -123.35 5.17 Favored Glycine 0 C--N 1.346 1.102 0 N-CA-C 111.52 -0.632 . . . . 55.24 111.52 177.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -133.92 139.95 46.48 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.686 0.795 . . . . 45.21 109.395 173.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.427 HG11 HG23 ' A' ' 199' ' ' VAL . 25.1 m -120.96 162.02 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-O 121.33 0.586 . . . . 63.11 110.32 169.361 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 6.8 ttp180 -85.11 114.42 22.23 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.645 -1.161 . . . . 71.41 108.738 171.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -106.26 164.55 11.92 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 109.226 -0.657 . . . . 62.04 109.226 169.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' MET . . . . . 0.414 ' HB2' HG21 ' A' ' 185' ' ' VAL . 71.6 mtp -103.94 139.42 39.11 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 108.729 -0.841 . . . . 71.23 108.729 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 77.8 p -111.42 -165.41 0.99 Allowed 'General case' 0 C--O 1.243 0.755 0 N-CA-C 108.929 -0.767 . . . . 74.1 108.929 174.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.438 HD11 ' HG2' ' A' ' 154' ' ' ARG . 69.9 mt -76.23 -14.69 60.13 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.7 -0.682 . . . . 63.31 112.112 176.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -120.56 -16.61 8.27 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 118.718 0.69 . . . . 64.44 112.071 -175.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 156.82 -165.3 33.06 Favored Glycine 0 N--CA 1.475 1.293 0 CA-C-O 119.776 -0.458 . . . . 33.0 113.694 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -83.67 141.58 9.86 Favored 'Trans proline' 0 C--N 1.367 1.504 0 C-N-CA 122.926 2.417 . . . . 70.23 113.717 -174.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 34.9 m -134.29 169.57 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 124.353 1.061 . . . . 73.4 110.073 176.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.403 ' HB2' ' HB2' ' B' ' 112' ' ' ASN . 49.7 mt-10 -93.53 142.38 27.4 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.361 0.664 . . . . 75.04 110.416 174.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 59.3 t -130.67 119.2 45.02 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 C-N-CA 124.075 0.95 . . . . 74.13 108.452 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.428 ' HB3' ' HA ' ' B' ' 440' ' ' ARG . . . -73.02 102.31 3.47 Favored 'General case' 0 C--N 1.348 0.508 0 N-CA-C 109.181 -0.674 . . . . 60.25 109.181 177.069 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 48.2 t -67.36 141.2 95.64 Favored Pre-proline 0 CA--C 1.555 1.152 0 C-N-CA 124.689 1.196 . . . . 63.14 110.24 -176.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.8 150.86 39.81 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 122.168 1.912 . . . . 75.51 110.448 171.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' PRO . . . . . 0.403 ' O ' ' HG2' ' A' ' 226' ' ' ARG . 21.1 Cg_exo -66.6 138.47 49.76 Favored 'Trans proline' 0 CA--C 1.55 1.291 0 C-N-CA 121.332 1.354 . . . . 72.53 112.021 170.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 226' ' ' ARG . . . . . 0.403 ' HG2' ' O ' ' A' ' 225' ' ' PRO 0.252 7.7 ptp180 52.43 58.77 5.05 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 127.054 2.142 . . . . 74.04 112.544 -177.391 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.498 ' O ' HD11 ' A' ' 255' ' ' ILE . 1.3 m -73.45 105.51 4.85 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 113.989 -1.46 . . . . 64.32 109.146 176.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 228' ' ' GLN . . . . . 0.412 ' HB3' ' HD2' ' A' ' 231' ' ' ARG . 5.9 tp-100 -84.41 132.34 34.59 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.275 0.63 . . . . 75.32 111.03 -174.27 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 229' ' ' ALA . . . . . 0.537 ' HB3' HG22 ' C' ' 256' ' ' THR . . . -66.81 142.04 57.49 Favored 'General case' 0 C--N 1.358 0.97 0 C-N-CA 123.815 0.846 . . . . 62.31 111.916 -177.283 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 88.3 -10.87 69.58 Favored Glycine 0 C--N 1.342 0.906 0 CA-C-N 115.323 -0.853 . . . . 73.32 113.192 -179.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.6 HH11 ' HE1' ' B' ' 444' ' ' TYR . 86.8 mtt180 -87.15 167.07 14.48 Favored 'General case' 0 C--O 1.249 1.062 0 N-CA-C 109.417 -0.586 . . . . 74.0 109.417 172.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.407 ' HD3' ' HA ' ' A' ' 252' ' ' GLU . 0.2 OUTLIER -120.92 126.24 49.5 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.106 -0.952 . . . . 72.22 109.218 -178.168 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.45 HD13 HD13 ' B' ' 441' ' ' ILE . 16.7 mt -83.28 99.16 9.82 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 107.363 -1.347 . . . . 71.4 107.363 177.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 69.6 ttp85 -82.38 100.8 10.21 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.442 -0.947 . . . . 64.14 108.442 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.52 HD12 HD23 ' A' ' 249' ' ' LEU . 21.6 mt -98.41 92.24 5.58 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 108.975 -0.75 . . . . 61.12 108.975 -175.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.519 ' HB3' ' HD2' ' B' ' 434' ' ' HIS . 6.2 tmtm? -60.99 128.51 36.8 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.243 0.617 . . . . 64.43 110.69 -175.143 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 83.16 6.11 88.39 Favored Glycine 0 C--N 1.346 1.103 0 CA-C-N 115.228 -0.896 . . . . 74.2 114.012 175.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.14 6.73 47.21 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 117.715 0.757 . . . . 73.01 111.066 178.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -93.92 -162.04 35.58 Favored Glycine 0 C--N 1.34 0.79 0 CA-C-N 115.662 -0.699 . . . . 74.43 112.095 174.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' PHE . . . . . 0.613 ' HZ ' ' HB2' ' A' ' 150' ' ' PRO . 18.3 t80 -78.07 137.1 61.27 Favored Pre-proline 0 CA--C 1.551 1.016 0 CA-C-O 118.904 -0.569 . . . . 73.13 109.967 -177.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -61.16 106.65 0.4 Allowed 'Trans proline' 0 C--N 1.382 2.336 0 C-N-CA 122.152 1.902 . . . . 73.33 112.1 171.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -137.06 -153.11 6.33 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-O 119.027 -0.874 . . . . 73.52 112.776 -175.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' PRO . . . . . 0.454 ' HA ' HD11 ' B' ' 387' ' ' ILE . 59.2 Cg_exo -54.32 -42.01 71.37 Favored 'Trans proline' 0 C--N 1.384 2.416 0 C-N-CA 123.455 2.77 . . . . 70.45 113.383 176.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -82.24 23.96 0.7 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.965 0.906 . . . . 70.11 112.452 -178.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 83.14 -93.07 1.68 Allowed Glycine 0 C--N 1.35 1.308 0 N-CA-C 109.612 -1.395 . . . . 62.24 109.612 -174.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 20.1 mtm180 -128.12 141.86 51.36 Favored 'General case' 0 C--O 1.247 0.936 0 N-CA-C 107.951 -1.129 . . . . 75.41 107.951 164.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -72.99 -173.51 24.88 Favored Glycine 0 C--N 1.349 1.26 0 O-C-N 123.352 0.408 . . . . 42.24 113.884 -177.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -112.85 135.7 53.31 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.505 0.722 . . . . 75.44 110.498 -174.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.52 HD23 HD12 ' A' ' 235' ' ' LEU . 64.6 tp -97.32 104.96 17.03 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.749 -0.834 . . . . 70.31 108.749 -178.019 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.57 ' HE2' HG13 ' B' ' 154' ' ' ILE . 67.4 m-85 -90.12 105.98 18.18 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.515 0.726 . . . . 52.51 110.05 -177.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.478 HD22 ' HB2' ' A' ' 197' ' ' LEU . 41.5 mt -90.14 119.21 30.28 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 122.874 0.47 . . . . 72.24 109.942 177.068 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 232' ' ' LYS . 0.4 OUTLIER -79.11 116.44 19.4 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 107.973 -1.121 . . . . 75.41 107.973 178.639 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 21.8 t -78.21 102.4 4.46 Favored 'Isoleucine or valine' 0 C--O 1.245 0.841 0 CA-C-O 120.969 0.414 . . . . 24.43 111.402 -174.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -101.85 95.39 6.36 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.642 1.177 . . . . 73.14 109.066 168.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.502 ' HB ' ' O ' ' C' ' 255' ' ' ILE . 63.0 mt -77.18 141.06 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 109.879 -0.415 . . . . 74.34 109.879 175.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 21.6 p -130.03 176.68 7.87 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.777 1.231 . . . . 73.43 109.161 177.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.6 pp -137.71 158.41 71.75 Favored Pre-proline 0 CA--C 1.571 1.779 0 C-N-CA 123.625 0.77 . . . . 73.4 111.208 -175.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -55.96 -14.8 11.98 Favored 'Trans proline' 0 C--N 1.39 2.724 0 C-N-CA 123.843 3.028 . . . . 74.45 116.11 -167.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.453 ' HA ' ' HB3' ' C' ' 226' ' ' ARG . 39.9 mt-10 56.52 -69.98 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 125.53 1.532 . . . . 63.24 113.396 -173.008 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.36 146.19 36.83 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 108.939 -0.763 . . . . 75.12 108.939 169.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.627 HD22 ' HB2' ' A' ' 265' ' ' GLU . 66.6 mt -138.12 167.97 20.71 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.495 0.718 . . . . 55.32 109.23 172.169 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 262' ' ' THR . . . . . 0.562 ' HA ' HD23 ' B' ' 258' ' ' LEU . 71.6 p -129.75 154.13 80.95 Favored Pre-proline 0 CA--C 1.555 1.149 0 N-CA-C 107.596 -1.261 . . . . 44.34 107.596 169.164 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -33.65 -37.2 0.1 OUTLIER 'Trans proline' 0 C--N 1.397 3.128 0 C-N-CA 125.041 3.828 . . . . 74.33 117.221 -169.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -62.51 -68.17 0.35 Allowed 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.377 0.671 . . . . 71.44 111.798 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 265' ' ' GLU . . . . . 0.627 ' HB2' HD22 ' A' ' 261' ' ' LEU . 2.5 mp0 -65.25 -30.29 71.15 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 109.478 -0.564 . . . . 64.2 109.478 -176.254 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 266' ' ' GLU . . . . . 0.474 ' HA ' HD13 ' A' ' 261' ' ' LEU . 5.8 tp10 -53.21 -52.52 58.63 Favored 'General case' 0 CA--C 1.551 0.998 0 O-C-N 124.043 0.839 . . . . 73.45 109.401 174.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -61.83 -49.52 75.97 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 115.28 -0.873 . . . . 64.12 111.714 177.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 9.3 mp -56.78 -54.32 47.7 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.804 0.842 . . . . 73.14 112.145 -176.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 72.5 m95 -56.7 -49.1 76.13 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.949 0.899 . . . . 75.0 111.404 177.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 270' ' ' LYS . . . . . 0.659 ' HG3' HG23 ' C' ' 206' ' ' VAL . 1.1 mptm? -60.48 -34.89 74.69 Favored 'General case' 0 CA--C 1.552 1.039 0 O-C-N 123.678 0.611 . . . . 62.43 111.359 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 7.4 mmpt? -69.91 -46.87 64.45 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 117.993 0.361 . . . . 70.22 111.213 178.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 272' ' ' LEU . . . . . 0.443 HD21 ' HB2' ' C' ' 268' ' ' LEU . 80.9 mt -54.24 -39.83 67.16 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.827 0.851 . . . . 63.4 110.7 174.553 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -80.38 -41.52 24.51 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.786 1.234 . . . . 64.51 113.974 -170.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -64.93 -43.98 90.99 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 108.937 -0.764 . . . . 74.35 108.937 175.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -63.81 -38.57 91.6 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 114.909 -1.041 . . . . 71.44 110.934 173.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -59.91 -56.24 24.22 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.462 0.705 . . . . 75.02 110.109 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -63.67 -37.62 88.03 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.019 0.928 . . . . 70.12 109.967 -175.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -60.12 -26.13 66.0 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 115.463 -0.79 . . . . 75.41 111.89 173.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 49.7 mtm180 -107.38 -1.17 21.83 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.832 0.853 . . . . 74.13 111.72 178.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.248 0 N-CA-C 109.001 -0.74 . . . . 72.21 109.001 -179.231 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 111.437 0.162 . . . . 71.44 111.437 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.628 ' HD3' ' HG2' ' A' ' 128' ' ' GLU . 0.4 OUTLIER -123.25 -1.85 8.64 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.377 0.671 . . . . 54.1 111.934 -178.734 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 3' ' ' GLN . . . . . 0.41 ' HG3' HD21 ' B' ' 413' ' ' ASN . 23.5 tt0 -93.2 0.62 57.18 Favored 'General case' 0 CA--C 1.559 1.307 0 N-CA-C 109.032 -0.729 . . . . 74.04 109.032 168.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 63.4 m -51.56 138.36 22.66 Favored 'General case' 0 C--N 1.357 0.903 0 C-N-CA 125.993 1.717 . . . . 52.14 113.165 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 5' ' ' THR . . . . . 0.58 HG23 HH11 ' A' ' 136' ' ' ARG . 0.3 OUTLIER -110.99 170.04 8.37 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.149 0.98 . . . . 70.11 110.108 -175.583 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.579 ' HB ' ' HG2' ' A' ' 124' ' ' PRO . 45.5 pt -132.64 173.49 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 N-CA-C 113.031 0.752 . . . . 64.44 113.031 -161.006 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -145.1 133.77 22.17 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.571 1.148 . . . . 72.01 108.875 171.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.515 HD23 HG21 ' A' ' 140' ' ' VAL . 34.2 tp -72.83 150.77 42.42 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.868 0.867 . . . . 75.22 110.249 -176.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -79.35 -50.48 10.79 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 119.654 -0.212 . . . . 62.4 111.254 177.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 74.7 mt 62.93 109.2 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 124.338 1.055 . . . . 74.1 110.4 -167.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 85.5 mt -111.41 94.91 24.1 Favored Pre-proline 0 N--CA 1.478 0.936 0 N-CA-C 109.201 -0.666 . . . . 45.35 109.201 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -64.82 -52.71 1.17 Allowed 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 122.863 2.376 . . . . 61.33 111.897 175.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 pp -158.93 -17.6 0.07 Allowed 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 112.912 0.708 . . . . 75.01 112.912 177.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -74.72 100.91 4.12 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 109.014 -0.735 . . . . 64.54 109.014 -177.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -77.67 118.28 19.89 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 108.211 -1.033 . . . . 60.01 108.211 173.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 16' ' ' THR . . . . . 0.478 ' HB ' HG13 ' B' ' 18' ' ' VAL . 30.8 p -80.05 109.53 12.71 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 123.629 0.771 . . . . 51.11 110.899 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -85.42 46.05 1.69 Allowed 'Trans proline' 0 C--N 1.377 2.058 0 C-N-CA 122.904 2.402 . . . . 62.42 111.649 177.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.478 HG13 ' HB ' ' B' ' 16' ' ' THR . 8.1 m -57.34 89.2 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.12 0 C-N-CA 124.968 1.307 . . . . 61.41 112.36 -173.182 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 2.7 m 50.01 50.45 18.48 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.538 1.535 . . . . 71.22 110.217 -176.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -109.79 -10.53 14.77 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 114.825 -1.079 . . . . 62.34 110.21 176.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -172.38 98.7 0.15 Allowed 'General case' 0 C--O 1.24 0.591 0 C-N-CA 124.96 1.304 . . . . 75.34 107.985 173.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 73.9 mtm180 -77.54 -2.8 37.42 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 122.891 0.476 . . . . 73.31 111.071 175.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 23' ' ' THR . . . . . . . . . . . . . 98.5 m -109.13 100.92 42.86 Favored Pre-proline 0 CA--C 1.546 0.813 0 N-CA-C 107.926 -1.139 . . . . 72.45 107.926 158.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 24' ' ' PRO . . . . . 0.408 ' O ' ' HD2' ' B' ' 27' ' ' PRO . 98.1 Cg_endo -80.02 8.11 4.26 Favored 'Trans proline' 0 C--N 1.38 2.193 0 C-N-CA 122.604 2.203 . . . . 74.55 112.467 176.198 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -79.62 82.24 5.76 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.705 0.802 . . . . 74.53 109.157 175.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 25.4 ttt -172.57 -49.02 0.0 OUTLIER Pre-proline 0 CA--C 1.561 1.37 0 CA-C-O 118.05 -0.976 . . . . 75.13 110.831 173.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 27' ' ' PRO . . . . . 0.408 ' HD2' ' O ' ' B' ' 24' ' ' PRO . 65.7 Cg_exo -44.26 122.38 3.68 Favored 'Trans proline' 0 C--N 1.404 3.472 0 C-N-CA 122.942 2.428 . . . . 71.1 113.853 172.048 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 32.4 m -60.17 162.12 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 123.827 0.851 . . . . 73.51 112.091 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.493 HD23 ' H ' ' B' ' 29' ' ' LEU . 2.0 pt? -127.38 -0.83 6.3 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.911 0.884 . . . . 62.2 110.219 179.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.403 ' HG3' ' HG ' ' B' ' 29' ' ' LEU . 38.3 mt-10 -130.04 -169.44 2.13 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.449 1.099 . . . . 70.24 110.523 -172.107 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 26.4 p30 -147.07 -167.63 2.83 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.35 1.06 . . . . 74.34 110.188 -173.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 32' ' ' ARG . . . . . 0.44 ' HB2' ' HB3' ' B' ' 317' ' ' SER . 6.5 ttp180 -109.1 5.79 24.35 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 124.138 0.975 . . . . 72.22 110.14 177.376 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.82 132.23 47.01 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.558 0.743 . . . . 73.31 111.702 -172.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . 67.32 17.41 10.2 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 125.317 1.447 . . . . 53.33 111.951 -175.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -123.32 -87.68 0.63 Allowed 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.409 0.684 . . . . 73.13 109.398 177.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 36' ' ' GLY . . . . . 0.411 ' H ' ' HG2' ' B' ' 32' ' ' ARG . . . 63.45 -85.45 0.05 OUTLIER Glycine 0 C--N 1.354 1.55 0 N-CA-C 111.772 -0.531 . . . . 74.33 111.772 -171.286 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 37' ' ' ASP . . . . . 0.529 ' HA ' ' HA3' ' C' ' 110' ' ' GLY . 3.0 p30 49.97 26.29 1.96 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 126.733 2.013 . . . . 61.44 115.679 170.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 38' ' ' ILE . . . . . 0.485 HG13 ' HD2' ' C' ' 109' ' ' PHE . 7.8 tt -163.33 132.52 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 CA-C-N 118.36 0.527 . . . . 75.44 110.243 173.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 18.1 p -134.96 -62.54 0.72 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.593 0.757 . . . . 64.25 110.436 -173.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.411 ' HA ' ' HD3' ' B' ' 41' ' ' PRO . . . -70.96 133.7 85.97 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 123.662 0.785 . . . . 64.0 111.82 -176.295 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 41' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' B' ' 40' ' ' ALA . 17.4 Cg_exo -68.33 -58.37 0.12 Allowed 'Trans proline' 0 C--N 1.378 2.091 0 C-N-CA 122.728 2.285 . . . . 72.44 112.562 173.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.13 -74.14 1.46 Allowed Glycine 0 C--N 1.345 1.075 0 N-CA-C 111.865 -0.494 . . . . 45.24 111.865 -175.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 43' ' ' GLY . . . . . 0.652 ' HA2' ' HB2' ' B' ' 326' ' ' ASP . . . 137.41 144.94 4.84 Favored Glycine 0 C--N 1.342 0.913 0 N-CA-C 111.751 -0.539 . . . . 42.15 111.751 177.253 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 44' ' ' ALA . . . . . 0.517 ' HB2' ' H ' ' C' ' 142' ' ' GLY . . . -151.68 91.46 1.65 Allowed 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 112.609 0.596 . . . . 63.2 112.609 -171.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.445 ' NH1' ' HB2' ' B' ' 327' ' ' LYS . 0.0 OUTLIER -172.97 173.99 3.61 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 124.729 1.211 . . . . 74.21 109.431 169.07 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 46' ' ' ARG . . . . . 0.579 ' HB3' ' HA ' ' B' ' 179' ' ' ALA . 37.4 ttt-85 -83.53 53.27 2.46 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-O 121.735 0.779 . . . . 75.02 110.666 -178.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 3.1 tt -91.35 70.79 6.07 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 106.39 -1.708 . . . . 53.22 106.39 176.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 9.0 t -172.72 -32.34 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 113.527 -1.669 . . . . 51.22 108.49 -170.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.98 73.78 1.46 Allowed Glycine 0 C--N 1.359 1.823 0 CA-C-N 115.85 -0.614 . . . . 74.15 111.671 176.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -79.89 114.15 18.59 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.284 1.034 . . . . 64.2 110.128 -176.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 51' ' ' GLN . . . . . 0.453 ' HB2' HD22 ' B' ' 55' ' ' LEU . 4.0 pt20 37.45 76.61 0.05 Allowed 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 126.198 1.799 . . . . 75.3 113.747 176.435 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 57.0 p -106.84 104.93 14.73 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.386 0.675 . . . . 73.31 110.784 -176.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . 62.28 -78.25 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 125.193 1.397 . . . . 73.24 112.508 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.72 93.12 0.24 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.077 0.951 . . . . 75.51 110.715 -178.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.453 HD22 ' HB2' ' B' ' 51' ' ' GLN . 46.7 tp -147.05 125.43 12.32 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 107.606 -1.257 . . . . 72.35 107.606 177.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 56.2 ttt180 71.41 -77.65 0.05 Allowed 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 125.199 1.4 . . . . 73.2 111.611 175.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -54.64 -50.58 67.8 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.996 1.318 . . . . 75.31 113.811 -166.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 48.1 t 68.51 -8.56 0.6 Allowed 'General case' 0 CA--C 1.56 1.35 0 C-N-CA 124.155 0.982 . . . . 62.01 113.393 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 72.7 mt 58.28 18.36 5.39 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 124.982 1.313 . . . . 72.44 112.693 -178.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 60' ' ' SER . . . . . 0.495 ' HB2' ' HB2' ' B' ' 346' ' ' ALA . 25.2 t -76.94 -42.4 39.38 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.37 -0.604 . . . . 63.51 109.37 179.252 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 32.7 t70 62.33 97.92 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.783 1.633 . . . . 71.45 110.922 -178.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 62' ' ' LYS . . . . . . . . . . . . . 65.2 mttm 64.86 92.48 0.06 OUTLIER Pre-proline 0 N--CA 1.479 1.024 0 C-N-CA 124.748 1.219 . . . . 72.3 111.409 176.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 63' ' ' PRO . . . . . 0.412 ' HB3' HD21 ' B' ' 173' ' ' LEU . 31.9 Cg_exo -62.48 148.68 92.94 Favored 'Trans proline' 0 C--N 1.369 1.634 0 C-N-CA 122.366 2.044 . . . . 72.24 112.629 172.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 58.91 37.04 24.8 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.121 0.968 . . . . 72.04 111.712 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -84.27 27.87 0.66 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.95 0.9 . . . . 65.32 112.991 -174.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -54.6 -49.99 69.12 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.992 1.317 . . . . 72.41 112.72 -173.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 37.3 pt -123.76 23.32 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 N-CA-C 112.506 0.558 . . . . 72.03 112.506 -173.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 34.9 pt -69.24 117.24 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 CA-C-N 118.351 0.523 . . . . 73.4 109.891 177.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 75.5 mt 63.44 10.11 4.6 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.349 1.06 . . . . 73.12 111.789 -174.14 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 84.0 mt -129.12 18.02 6.05 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.702 1.201 . . . . 44.44 109.944 -176.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 11.8 tt -66.8 118.2 9.6 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 N-CA-C 109.054 -0.721 . . . . 74.32 109.054 175.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 171.28 -165.73 38.8 Favored Glycine 0 C--O 1.243 0.694 0 N-CA-C 111.47 -0.652 . . . . 62.21 111.47 -176.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 61.71 -169.87 0.17 Allowed 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.292 1.037 . . . . 63.44 111.73 -178.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 83.81 -62.35 4.61 Favored Glycine 0 C--N 1.35 1.332 0 N-CA-C 112.323 -0.311 . . . . 64.42 112.323 -178.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 62.1 mtm -71.22 89.05 0.85 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.894 0.878 . . . . 74.01 109.582 178.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 76' ' ' GLY . . . . . 0.602 ' H ' HD21 ' B' ' 265' ' ' LEU . . . 86.6 53.34 2.93 Favored Glycine 0 C--N 1.344 0.973 0 CA-C-N 115.425 -0.807 . . . . 71.13 111.393 -174.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 77' ' ' ASP . . . . . 0.572 ' HB3' ' HB ' ' B' ' 80' ' ' ILE . 22.5 t70 -107.98 157.99 17.75 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.252 0.621 . . . . 73.03 110.683 -175.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 44.1 m -69.24 -37.43 77.97 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.847 0.859 . . . . 51.1 112.279 -177.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 79' ' ' GLU . . . . . 0.416 ' HB3' HH12 ' B' ' 84' ' ' ARG . 41.8 mt-10 -92.01 -47.52 7.24 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.69 0.796 . . . . 74.44 110.474 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.572 ' HB ' ' HB3' ' B' ' 77' ' ' ASP . 2.7 mp -74.52 86.88 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 108.053 -1.091 . . . . 72.52 108.053 175.134 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 11.8 t -178.09 -37.03 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.248 1.419 . . . . 71.34 108.622 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -174.4 -88.87 0.01 OUTLIER 'General case' 0 C--N 1.361 1.081 0 C-N-CA 124.399 1.079 . . . . 61.11 109.575 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . 60.64 -77.67 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 125.579 1.552 . . . . 71.35 112.956 178.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 84' ' ' ARG . . . . . 0.475 ' NH2' ' HA ' ' B' ' 236' ' ' THR . 0.2 OUTLIER -105.51 112.67 25.85 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 108.451 -0.944 . . . . 73.0 108.451 179.896 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 69.58 117.29 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.607 1.163 . . . . 72.23 111.745 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 20.8 p90 -172.6 143.98 1.39 Allowed 'General case' 0 C--O 1.241 0.641 0 C-N-CA 124.912 1.285 . . . . 63.12 109.011 -175.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 87' ' ' ALA . . . . . 0.585 ' H ' ' HA ' ' B' ' 262' ' ' ALA . . . 60.34 81.34 0.18 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.448 1.099 . . . . 52.24 111.796 175.148 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -55.46 173.31 0.12 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.223 1.409 . . . . 74.14 113.179 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -78.23 31.08 1.84 Allowed Glycine 0 CA--C 1.536 1.348 0 CA-C-N 115.866 -0.606 . . . . 54.33 114.081 178.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . 60.47 72.58 0.52 Allowed 'General case' 0 C--N 1.352 0.714 0 C-N-CA 125.392 1.477 . . . . 62.33 111.897 176.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -74.11 -54.43 6.33 Favored Glycine 0 C--N 1.339 0.705 0 N-CA-C 110.306 -1.118 . . . . 70.11 110.306 170.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.72 -129.58 9.37 Favored Glycine 0 C--N 1.348 1.21 0 CA-C-N 115.057 -0.572 . . . . 23.53 113.862 171.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 53.54 -90.48 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.175 1.39 . . . . 74.22 111.384 -174.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 94' ' ' PHE . . . . . 0.461 ' HB2' ' O ' ' B' ' 256' ' ' TYR . 18.1 p90 160.5 -30.7 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 126.783 2.033 . . . . 71.21 108.036 -176.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 95' ' ' LYS . . . . . 0.506 ' HE2' HG21 ' A' ' 262' ' ' THR . 56.0 tttm -137.62 26.19 2.82 Favored 'General case' 0 CA--C 1.556 1.199 0 CA-C-N 114.448 -1.251 . . . . 74.14 109.341 -173.121 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . -66.79 -5.91 33.96 Favored Glycine 0 N--CA 1.482 1.765 0 N-CA-C 115.476 0.95 . . . . 72.31 115.476 -173.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 97' ' ' ILE . . . . . 0.79 HD13 HH22 ' C' ' 226' ' ' ARG . 41.6 mt -76.99 -32.52 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.163 0 C-N-CA 123.346 0.659 . . . . 72.22 110.344 173.194 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -129.86 124.7 33.87 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.811 0.844 . . . . 75.21 110.304 -178.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.95 -59.12 2.91 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.112 0.565 . . . . 61.12 110.555 179.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -144.05 135.13 12.47 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 124.065 0.946 . . . . 74.2 108.992 177.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -51.22 137.38 46.32 Favored 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 122.996 2.464 . . . . 72.21 112.697 175.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -79.69 77.85 6.28 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.093 0.957 . . . . 73.12 110.43 -170.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 70.0 p -90.7 124.71 35.3 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.42 0.688 . . . . 75.52 110.182 -174.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . -79.17 -11.0 85.54 Favored Glycine 0 C--N 1.348 1.216 0 O-C-N 123.198 0.311 . . . . 51.35 113.063 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 19.6 tp60 73.57 13.41 4.45 Favored 'General case' 0 CA--C 1.565 1.519 0 C-N-CA 125.419 1.487 . . . . 75.22 111.479 177.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 62.99 93.98 0.05 Allowed 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.574 1.55 . . . . 74.44 112.822 176.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 107' ' ' THR . . . . . 0.457 HG23 ' H ' ' B' ' 109' ' ' TYR . 2.8 t -107.87 162.84 13.64 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 107.764 -1.199 . . . . 63.32 107.764 165.274 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 45.0 p-80 -75.19 -19.68 59.69 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 122.371 0.268 . . . . 71.44 111.514 -177.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.457 ' H ' HG23 ' B' ' 107' ' ' THR . 85.1 m-85 62.68 -79.16 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.592 1.557 . . . . 53.33 110.505 -174.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -138.86 -81.39 0.31 Allowed 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 108.493 -0.928 . . . . 71.24 108.493 174.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 63.9 tp -175.69 -60.61 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.792 1.237 . . . . 64.15 107.874 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 112' ' ' ASN . . . . . 0.405 ' OD1' ' HB2' ' A' ' 222' ' ' ALA . 26.4 t-20 58.71 -82.78 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 124.698 1.199 . . . . 73.2 110.037 -170.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 113' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? 52.76 89.8 0.03 OUTLIER 'General case' 0 C--N 1.363 1.156 0 C-N-CA 125.078 1.351 . . . . 75.13 110.721 176.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 114' ' ' LYS . . . . . 0.476 ' HA ' ' HD3' ' B' ' 440' ' ' ARG . 24.8 pttm -71.61 -14.94 62.22 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 112.594 0.59 . . . . 74.01 112.594 -171.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 25.3 m 72.46 -55.0 0.68 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 125.938 1.695 . . . . 73.23 111.071 -176.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 114.02 34.98 1.57 Allowed Glycine 0 C--N 1.344 1.026 0 N-CA-C 111.325 -0.71 . . . . 55.33 111.325 177.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 117' ' ' LYS . . . . . 0.536 ' H ' ' HD2' ' B' ' 118' ' ' PRO . 59.9 tttp -162.38 -69.22 0.01 OUTLIER Pre-proline 0 CA--C 1.557 1.242 0 CA-C-O 117.793 -1.098 . . . . 70.25 111.089 -177.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 118' ' ' PRO . . . . . 0.536 ' HD2' ' H ' ' B' ' 117' ' ' LYS . 13.3 Cg_exo -11.49 49.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.404 3.497 1 C-N-CA 127.17 5.247 . . . . 60.53 118.437 -155.262 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 119' ' ' ASP . . . . . . . . . . . . . 20.6 t70 177.12 154.86 0.26 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.671 1.189 . . . . 75.33 109.265 -177.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 120' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -151.67 11.18 0.58 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.46 1.104 . . . . 70.1 110.219 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 56.3 t -132.83 -70.97 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 123.776 0.831 . . . . 74.32 110.666 -172.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 44.7 m -83.19 82.81 8.1 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.018 0.927 . . . . 75.24 111.089 -170.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -170.63 104.48 0.26 Allowed 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 107.627 -1.249 . . . . 64.3 107.627 171.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 44.1 t -90.54 -80.19 0.33 Allowed 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 123.327 0.651 . . . . 43.31 111.538 -173.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . 58.7 25.79 13.79 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 124.399 1.08 . . . . 73.02 111.527 -172.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -69.49 -54.32 14.84 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 123.502 0.721 . . . . 74.13 110.61 -174.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 12.4 p 42.53 35.88 0.72 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 126.019 1.728 . . . . 70.01 113.304 175.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 128' ' ' ALA . . . . . 0.464 ' N ' ' SD ' ' B' ' 157' ' ' MET . . . -67.45 -59.69 3.17 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.779 1.231 . . . . 72.01 111.016 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 33.1 m -75.57 88.99 2.72 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.306 -0.998 . . . . 54.34 108.306 170.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . -69.53 175.48 4.08 Favored 'General case' 0 C--O 1.248 1.002 0 CA-C-N 115.427 -0.806 . . . . 44.22 110.466 177.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 131' ' ' TRP . . . . . 0.451 ' HB2' HG23 ' B' ' 133' ' ' THR . 4.3 m-90 66.02 9.1 5.92 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 124.714 1.205 . . . . 73.51 111.551 -178.278 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 37.9 m 44.89 36.57 1.95 Allowed 'General case' 0 CA--C 1.559 1.326 0 C-N-CA 124.797 1.239 . . . . 51.4 112.151 -174.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 133' ' ' THR . . . . . 0.451 HG23 ' HB2' ' B' ' 131' ' ' TRP . 11.4 p -73.72 86.71 1.68 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.462 0.705 . . . . 62.25 111.074 -177.047 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . -137.9 -141.43 4.19 Favored Glycine 0 C--N 1.343 0.968 0 CA-C-N 115.374 -0.83 . . . . 55.15 111.029 177.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 135' ' ' VAL . . . . . 0.663 HG22 ' H ' ' B' ' 137' ' ' THR . 12.5 p -145.68 147.07 18.86 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 CA-C-N 117.683 0.742 . . . . 73.24 110.446 -177.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 136' ' ' LYS . . . . . 0.52 ' HE3' ' HA ' ' B' ' 215' ' ' GLU . 13.1 ptmm? -80.21 -13.91 58.86 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.304 0.641 . . . . 52.43 111.696 178.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 137' ' ' THR . . . . . 0.663 ' H ' HG22 ' B' ' 135' ' ' VAL . 87.0 m 72.52 102.29 0.07 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.492 1.517 . . . . 75.31 111.626 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 45.4 t80 69.04 151.03 0.08 Allowed 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 125.859 1.664 . . . . 75.52 112.49 177.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 139' ' ' ASN . . . . . 0.563 ' HB3' ' HB3' ' B' ' 188' ' ' ARG . 15.8 m120 -50.38 -48.68 55.79 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.771 1.228 . . . . 73.24 111.885 176.304 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . 90.15 127.54 3.43 Favored Glycine 0 C--N 1.343 0.933 0 CA-C-N 115.483 -0.78 . . . . 65.04 111.306 -176.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -149.85 160.52 43.51 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.795 0.438 . . . . 75.34 111.368 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 142' ' ' LEU . . . . . 0.421 ' HA ' ' SG ' ' B' ' 190' ' ' CYS . 67.2 mt 71.63 -12.71 0.62 Allowed 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 125.607 1.563 . . . . 70.15 113.821 172.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.64 -2.06 64.69 Favored Glycine 0 C--N 1.35 1.319 0 CA-C-N 117.823 0.283 . . . . 61.25 113.366 -173.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 7.3 t -111.06 15.67 8.21 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.308 0 C-N-CA 123.936 0.894 . . . . 75.31 109.777 -176.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -90.76 134.93 34.06 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.156 0.582 . . . . 64.3 109.517 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 10.6 mt 62.52 28.73 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 C-N-CA 125.026 1.33 . . . . 72.52 110.067 -174.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -63.14 -38.68 92.12 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 125.087 1.355 . . . . 72.43 110.994 -178.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -83.05 130.4 35.13 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.601 -0.727 . . . . 73.05 110.895 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 149' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -140.11 88.56 2.23 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.857 0.863 . . . . 72.23 109.441 176.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -81.02 -40.96 23.44 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 108.5 -0.926 . . . . 74.11 108.5 164.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 151' ' ' HIS . . . . . 0.43 ' HA ' ' HD2' ' B' ' 152' ' ' PRO . 62.3 m-70 -111.69 105.73 56.66 Favored Pre-proline 0 C--O 1.242 0.667 0 CA-C-N 114.329 -1.305 . . . . 74.43 108.381 173.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 152' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' B' ' 151' ' ' HIS . 16.5 Cg_endo -55.45 -32.88 84.03 Favored 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 123.367 2.711 . . . . 42.51 111.912 174.011 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 43.8 p 54.32 -87.16 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 126.322 1.849 . . . . 74.2 112.68 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 154' ' ' ILE . . . . . 0.57 HG13 ' HE2' ' A' ' 250' ' ' TYR . 40.2 mm 48.52 74.52 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.359 1.008 0 C-N-CA 124.74 1.216 . . . . 74.25 109.434 -170.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 75.1 mt -74.73 71.69 1.96 Allowed 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 114.915 -1.038 . . . . 72.1 110.647 -174.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 23.5 -72.95 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 127.829 2.451 . . . . 72.23 115.783 170.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 157' ' ' MET . . . . . 0.464 ' SD ' ' N ' ' B' ' 128' ' ' ALA . 45.0 mtm -91.0 -48.1 7.18 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.518 1.127 . . . . 53.54 110.758 -173.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 158' ' ' ALA . . . . . . . . . . . . . . . -74.43 -25.71 59.61 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 114.825 -1.08 . . . . 34.04 112.875 -172.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 159' ' ' LYS . . . . . 0.56 ' HE3' ' HA ' ' B' ' 159' ' ' LYS . 1.0 OUTLIER -97.55 75.37 2.48 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.504 0.669 . . . . 55.45 109.297 -176.369 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.92 157.3 26.26 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 114.685 -1.143 . . . . 70.22 108.779 178.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.56 82.85 2.02 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 122.768 0.427 . . . . 71.1 110.423 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 162' ' ' GLY . . . . . 0.464 ' HA2' ' HA3' ' B' ' 166' ' ' GLY . . . -91.87 -73.02 1.24 Allowed Glycine 0 C--N 1.353 1.501 0 N-CA-C 111.141 -0.784 . . . . 73.4 111.141 177.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 60.29 -78.1 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 125.182 1.393 . . . . 65.02 112.47 173.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 164' ' ' ALA . . . . . . . . . . . . . . . -104.12 -55.32 2.39 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.571 0.748 . . . . 75.34 109.789 178.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 165' ' ' THR . . . . . 0.464 HG22 ' HB3' ' B' ' 174' ' ' GLN . 28.9 p -122.42 -75.2 0.6 Allowed 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 115.404 -0.816 . . . . 64.15 110.162 -176.136 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 166' ' ' GLY . . . . . 0.464 ' HA3' ' HA2' ' B' ' 162' ' ' GLY . . . 92.18 -135.37 12.69 Favored Glycine 0 C--N 1.346 1.123 0 N-CA-C 113.426 0.13 . . . . 71.15 113.426 177.09 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 167' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -92.21 42.01 1.09 Allowed 'General case' 0 CA--C 1.552 1.021 0 CA-C-O 121.811 0.815 . . . . 72.31 109.168 -173.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 168' ' ' VAL . . . . . 0.62 HG23 ' H ' ' B' ' 170' ' ' THR . 23.7 m -76.99 -5.43 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.252 1.021 . . . . 74.13 111.843 177.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 15.1 m 70.21 -0.86 2.65 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 125.428 1.491 . . . . 54.35 112.025 -177.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 170' ' ' THR . . . . . 0.62 ' H ' HG23 ' B' ' 168' ' ' VAL . 57.3 m 56.6 107.76 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 126.035 1.734 . . . . 63.1 112.786 -173.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -97.89 14.66 26.39 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.955 0.902 . . . . 53.32 110.861 174.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 172' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 64.24 14.53 8.74 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 125.847 1.659 . . . . 73.22 112.659 -177.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 173' ' ' LEU . . . . . 0.412 HD21 ' HB3' ' B' ' 63' ' ' PRO . 82.1 mt -116.95 13.63 14.94 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.282 0.633 . . . . 74.23 111.889 -173.076 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 174' ' ' GLN . . . . . 0.464 ' HB3' HG22 ' B' ' 165' ' ' THR . 78.5 mt-30 -138.65 -59.62 0.61 Allowed 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 111.993 0.368 . . . . 74.45 111.993 -168.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 175' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -66.02 119.49 11.46 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.334 1.053 . . . . 74.1 111.772 -170.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -156.2 -175.13 5.27 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.931 0.892 . . . . 74.11 110.668 -174.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 93.7 m -127.58 117.58 21.24 Favored Pre-proline 0 CA--C 1.555 1.167 0 C-N-CA 123.899 0.88 . . . . 64.31 109.923 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 178' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -76.5 -30.35 5.2 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 122.728 2.285 . . . . 74.53 113.846 -178.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 179' ' ' ALA . . . . . 0.579 ' HA ' ' HB3' ' B' ' 46' ' ' ARG . . . -88.04 171.58 10.18 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.3 0.64 . . . . 61.34 110.97 -177.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . -67.91 -46.38 71.74 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-O 121.347 0.594 . . . . 74.4 109.431 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 181' ' ' LEU . . . . . 0.582 ' HB2' ' HB3' ' C' ' 136' ' ' ARG . 33.3 tp -116.61 -96.57 0.46 Allowed 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 105.856 -1.905 . . . . 62.04 105.856 154.025 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 182' ' ' VAL . . . . . 0.585 HG13 ' HB2' ' C' ' 123' ' ' LEU . 7.4 p 156.74 138.6 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.245 0.857 0 C-N-CA 126.777 2.031 . . . . 71.31 105.688 -178.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 183' ' ' ALA . . . . . 0.712 ' HA ' ' HB3' ' C' ' 123' ' ' LEU . . . -160.76 -103.28 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 118.907 -0.568 . . . . 65.24 111.168 176.343 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 59.54 142.86 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 124.142 0.977 . . . . 74.15 111.372 -164.193 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 185' ' ' VAL . . . . . 0.527 ' HA ' ' HA ' ' C' ' 121' ' ' ALA . 50.8 t -69.48 157.24 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.733 0 C-N-CA 123.581 0.752 . . . . 71.33 112.707 -170.209 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 186' ' ' THR . . . . . 0.816 ' HA ' ' HB2' ' C' ' 122' ' ' GLU . 16.3 p -40.94 138.81 0.98 Allowed 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 126.673 1.989 . . . . 51.31 114.587 -177.4 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 187' ' ' SER . . . . . 0.576 ' HA ' ' HG2' ' B' ' 324' ' ' MET . 16.3 m -138.37 -67.93 0.46 Allowed 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 115.472 -0.786 . . . . 62.14 112.231 -170.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 188' ' ' ARG . . . . . 0.563 ' HB3' ' HB3' ' B' ' 139' ' ' ASN . 11.4 ptp180 -91.71 67.81 5.45 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 121.808 0.813 . . . . 71.52 111.95 -166.017 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -142.12 -85.89 0.17 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.063 0.945 . . . . 72.52 109.001 175.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 190' ' ' CYS . . . . . 0.472 ' SG ' ' HA2' ' B' ' 208' ' ' GLY . 84.5 m -154.68 82.43 1.1 Allowed 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 108.362 -0.977 . . . . 70.33 108.362 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 191' ' ' TYR . . . . . 0.481 ' HA ' ' HA ' ' B' ' 320' ' ' THR . 35.5 t80 -99.78 149.73 23.06 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 116.05 -0.523 . . . . 74.04 109.863 -178.284 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -169.75 -164.26 25.16 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 110.767 -0.933 . . . . 64.22 110.767 176.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 193' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.68 -72.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.372 1.807 0 C-N-CA 122.424 2.083 . . . . 64.32 112.753 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 194' ' ' SER . . . . . . . . . . . . . 29.8 t -156.14 37.15 0.34 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.171 0.589 . . . . 24.51 109.771 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 195' ' ' ALA . . . . . . . . . . . . . . . -63.15 -72.56 0.13 Allowed 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.549 -0.75 . . . . 74.32 112.234 -171.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 196' ' ' THR . . . . . 0.546 ' HB ' ' HB3' ' B' ' 200' ' ' CYS . 29.1 p -97.12 1.74 50.32 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.153 0.581 . . . . 73.32 112.092 -176.1 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 197' ' ' SER . . . . . 0.447 ' HA ' HG22 ' B' ' 318' ' ' VAL . 82.3 p -67.47 -37.92 83.63 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.202 0.601 . . . . 75.11 111.386 -177.17 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 198' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -84.59 -36.65 21.92 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.61 -0.723 . . . . 51.12 111.593 -178.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -152.18 123.52 7.72 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 122.882 0.473 . . . . 74.4 110.596 -176.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 200' ' ' CYS . . . . . 0.609 ' SG ' HG11 ' B' ' 318' ' ' VAL . 27.2 p -164.85 154.38 11.7 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 125.053 1.341 . . . . 73.31 108.994 179.182 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 201' ' ' PRO . . . . . 0.457 ' HB2' ' HB2' ' B' ' 204' ' ' ALA . 30.1 Cg_exo -64.95 149.83 88.93 Favored 'Trans proline' 0 C--N 1.37 1.664 0 C-N-CA 121.996 1.797 . . . . 71.34 110.971 164.234 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . -58.59 101.59 0.22 Allowed Glycine 0 C--N 1.349 1.274 0 O-C-N 123.546 0.529 . . . . 63.04 113.852 -174.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 65.61 40.83 4.31 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.828 1.251 . . . . 71.33 111.719 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 204' ' ' ALA . . . . . 0.457 ' HB2' ' HB2' ' B' ' 201' ' ' PRO . . . -73.54 114.3 11.62 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.628 -0.715 . . . . 74.01 109.882 171.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 205' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 60.61 34.35 20.18 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.549 1.14 . . . . 51.03 111.06 -177.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -55.86 -40.57 73.11 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.974 0.91 . . . . 62.32 112.601 -177.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -76.29 -24.58 54.42 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.579 0.752 . . . . 74.32 111.487 -178.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 208' ' ' GLY . . . . . 0.472 ' HA2' ' SG ' ' B' ' 190' ' ' CYS . . . 82.86 -60.72 4.85 Favored Glycine 0 C--N 1.347 1.19 0 O-C-N 123.199 0.312 . . . . 71.52 112.923 179.394 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . -62.46 -13.01 42.44 Favored Glycine 0 C--N 1.351 1.384 0 CA-C-O 119.802 -0.444 . . . . 42.21 113.237 172.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt 76.12 -65.77 0.3 Allowed 'General case' 0 C--N 1.364 1.234 0 C-N-CA 125.348 1.459 . . . . 74.51 111.098 168.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . -91.91 11.42 72.17 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-O 119.895 -0.392 . . . . 74.43 112.498 170.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 49.0 m 58.41 19.43 6.44 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.845 1.258 . . . . 74.04 112.308 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 2.1 pp -87.12 176.21 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 124.299 1.039 . . . . 64.4 110.502 177.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 29.5 m 77.01 -37.73 0.28 Allowed 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 125.234 1.414 . . . . 75.43 112.061 -178.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 215' ' ' GLU . . . . . 0.52 ' HA ' ' HE3' ' B' ' 136' ' ' LYS . 68.6 mm-40 -62.35 -74.41 0.09 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.12 0.968 . . . . 73.31 112.104 174.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 216' ' ' GLN . . . . . 0.448 ' NE2' HH12 ' C' ' 179' ' ' ARG . 12.6 mm-40 -100.76 94.53 6.12 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.014 0.525 . . . . 61.42 110.003 -176.213 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 93.7 mt -97.45 16.33 20.52 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 114.998 -1.001 . . . . 75.4 111.288 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 19.3 mt -109.25 100.41 9.54 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.559 0.743 . . . . 71.43 110.002 -170.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -97.96 53.32 1.09 Allowed 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 123.978 0.911 . . . . 71.24 109.769 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . 68.44 -88.81 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.297 1.439 . . . . 61.1 110.467 -170.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 221' ' ' ARG . . . . . . . . . . . . . 56.6 mtp180 57.67 111.5 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.773 1.229 . . . . 73.55 112.579 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -79.86 81.47 6.12 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 107.548 -1.278 . . . . 42.52 107.548 165.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -67.52 108.74 2.95 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-N 115.354 -0.839 . . . . 61.02 109.847 -170.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 21.4 t 65.07 7.86 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.577 2.01 0 C-N-CA 125.176 1.39 . . . . 74.2 110.504 -175.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 2.5 m 53.69 21.92 2.86 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 125.904 1.682 . . . . 54.34 111.21 -173.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 22.2 tp -90.92 -8.84 48.22 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.861 0.864 . . . . 74.43 110.615 -175.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . -62.73 -54.02 36.83 Favored Glycine 0 C--N 1.358 1.751 0 C-N-CA 123.033 0.349 . . . . 51.31 113.313 178.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 177.07 137.2 2.62 Favored Glycine 0 C--N 1.341 0.822 0 N-CA-C 111.56 -0.616 . . . . 72.41 111.56 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -83.09 -171.69 47.74 Favored Glycine 0 C--N 1.345 1.054 0 N-CA-C 114.015 0.366 . . . . 70.24 114.015 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -144.16 114.01 7.24 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.716 0.807 . . . . 70.23 110.296 -174.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 231' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -154.84 41.64 0.46 Allowed 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 125.04 1.336 . . . . 73.24 110.066 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 33.2 m -80.79 91.65 5.96 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-O 121.089 0.471 . . . . 74.24 110.383 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -79.62 83.36 5.61 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.654 0.781 . . . . 70.41 109.834 176.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -168.71 88.27 0.21 Allowed 'General case' 0 C--O 1.243 0.735 0 C-N-CA 125.148 1.379 . . . . 72.31 107.543 178.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -86.87 -100.64 0.07 Allowed 'General case' 0 CA--C 1.555 1.139 0 CA-C-N 115.668 -0.696 . . . . 54.41 111.416 -169.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 236' ' ' THR . . . . . 0.475 ' HA ' ' NH2' ' B' ' 84' ' ' ARG . 5.2 m 54.51 18.84 2.12 Favored 'General case' 0 CA--C 1.566 1.591 0 C-N-CA 124.815 1.246 . . . . 73.34 112.138 -175.317 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 237' ' ' ALA . . . . . 0.432 ' O ' ' HE3' ' B' ' 294' ' ' LYS . . . 52.92 78.32 0.14 Allowed 'General case' 0 C--N 1.357 0.923 0 C-N-CA 125.17 1.388 . . . . 71.12 111.33 -169.286 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 238' ' ' THR . . . . . 0.456 HG22 HG23 ' C' ' 219' ' ' VAL . 13.3 m -71.13 -36.28 72.04 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 121.488 0.661 . . . . 71.31 109.797 174.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -83.64 173.23 11.56 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 114.518 -1.219 . . . . 74.42 111.15 177.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 240' ' ' GLY . . . . . 0.412 ' H ' HD22 ' C' ' 235' ' ' LEU . . . -83.17 -130.7 1.65 Allowed Glycine 0 C--N 1.346 1.126 0 CA-C-N 115.369 -0.832 . . . . 71.23 112.651 178.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -151.69 156.1 39.68 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.695 0.798 . . . . 71.21 108.96 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 242' ' ' TRP . . . . . 0.471 ' CD2' ' HG ' ' C' ' 233' ' ' LEU . 1.2 p-90 -168.04 115.85 0.73 Allowed 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 113.251 0.834 . . . . 70.32 113.251 -175.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 24.83 74.23 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 128.072 2.549 . . . . 74.22 115.307 166.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 126.58 -142.62 13.72 Favored Glycine 0 C--N 1.341 0.822 0 CA-C-N 115.49 -0.777 . . . . 63.11 112.396 178.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? 89.5 83.74 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 127.159 2.183 . . . . 75.34 110.145 -175.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 246' ' ' THR . . . . . 0.487 HG23 ' HG2' ' C' ' 225' ' ' PRO . 3.5 t -92.25 -168.89 2.09 Favored 'General case' 0 CA--C 1.561 1.37 0 N-CA-C 106.925 -1.509 . . . . 71.02 106.925 155.107 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 247' ' ' LEU . . . . . 0.52 ' HG ' ' H ' ' B' ' 248' ' ' ARG . 12.1 tp -143.84 178.19 8.0 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 119.872 1.215 . . . . 72.51 109.938 173.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 248' ' ' ARG . . . . . 0.52 ' H ' ' HG ' ' B' ' 247' ' ' LEU . 0.0 OUTLIER -132.56 148.75 52.38 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.416 0.687 . . . . 75.15 112.096 -169.136 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 249' ' ' GLU . . . . . 0.686 ' HB3' ' HB2' ' B' ' 260' ' ' SER . 7.5 tp10 -159.95 128.56 4.94 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 114.163 -1.38 . . . . 71.33 108.21 178.477 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -77.54 -50.02 13.47 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 122.826 0.45 . . . . 65.4 110.648 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 251' ' ' ALA . . . . . . . . . . . . . . . 39.3 -100.29 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 125.961 1.704 . . . . 61.03 113.72 -177.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -138.98 27.38 2.4 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.478 1.111 . . . . 72.3 108.64 175.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -79.18 67.16 4.83 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.446 1.098 . . . . 51.41 108.975 172.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 3.5 ptp180 -112.14 97.46 6.67 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 114.82 -1.082 . . . . 72.51 109.173 -174.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . 81.82 -24.62 4.4 Favored Glycine 0 C--N 1.342 0.894 0 CA-C-O 119.66 -0.522 . . . . 54.22 113.329 -177.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 256' ' ' TYR . . . . . 0.461 ' O ' ' HB2' ' B' ' 94' ' ' PHE . 92.8 m-85 -70.75 -95.61 0.01 OUTLIER 'General case' 0 C--N 1.355 0.837 0 C-N-CA 123.328 0.651 . . . . 52.52 109.247 176.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 16.4 pm0 -104.83 167.23 9.85 Favored 'General case' 0 C--N 1.355 0.829 0 CA-C-O 121.478 0.656 . . . . 74.31 110.492 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 258' ' ' LEU . . . . . 0.562 HD23 ' HA ' ' A' ' 262' ' ' THR . 0.3 OUTLIER -91.31 102.96 15.67 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 114.719 -1.128 . . . . 75.13 110.361 178.491 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 259' ' ' VAL . . . . . 0.54 ' HB ' ' H ' ' B' ' 249' ' ' GLU . 34.3 m 46.73 -163.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 C-N-CA 126.187 1.795 . . . . 63.02 113.993 -177.163 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 260' ' ' SER . . . . . 0.686 ' HB2' ' HB3' ' B' ' 249' ' ' GLU . 48.7 m -135.13 121.01 19.71 Favored 'General case' 0 C--N 1.36 1.037 0 O-C-N 121.869 -0.519 . . . . 73.11 111.419 178.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -64.99 -29.11 70.01 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.904 0.882 . . . . 52.21 110.923 171.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 262' ' ' ALA . . . . . 0.585 ' HA ' ' H ' ' B' ' 87' ' ' ALA . . . -57.67 -8.82 0.98 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.208 1.003 . . . . 43.43 113.116 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . 79.94 -69.91 0.1 Allowed 'General case' 0 C--N 1.356 0.851 0 C-N-CA 126.169 1.787 . . . . 70.44 109.796 173.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 45.4 t 67.13 179.27 0.22 Allowed 'General case' 0 CA--C 1.558 1.265 0 O-C-N 124.314 1.008 . . . . 51.14 111.478 173.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 265' ' ' LEU . . . . . 0.602 HD21 ' H ' ' B' ' 76' ' ' GLY . 1.0 OUTLIER -95.16 100.76 12.52 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 109.281 -0.637 . . . . 64.12 109.281 -178.143 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 266' ' ' ASN . . . . . 0.478 ' HA ' ' OG1' ' B' ' 269' ' ' THR . 17.2 t-20 -94.34 175.0 6.85 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 124.007 0.923 . . . . 71.52 111.213 -174.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 21.2 m 86.0 -47.99 0.06 Allowed 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 126.925 2.09 . . . . 73.13 112.191 172.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 7.2 p -112.42 22.11 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 123.097 0.559 . . . . 74.44 109.57 175.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 269' ' ' THR . . . . . 0.478 ' OG1' ' HA ' ' B' ' 266' ' ' ASN . 3.9 m -53.75 -48.91 69.23 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.939 0.895 . . . . 74.31 112.032 -174.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 270' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 60.95 -83.26 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.989 0 O-C-N 124.496 1.122 . . . . 72.41 111.723 -178.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 271' ' ' ALA . . . . . . . . . . . . . . . -152.8 -171.68 4.01 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 124.079 0.952 . . . . 75.3 109.956 -175.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 272' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 61.51 -86.28 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.09 1.356 . . . . 54.14 110.687 -178.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 43.53 65.37 1.01 Allowed 'General case' 0 C--N 1.353 0.734 0 C-N-CA 125.537 1.535 . . . . 61.32 111.395 -174.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -87.43 12.16 12.86 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 114.124 -1.398 . . . . 71.44 110.793 -177.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 275' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -134.98 68.31 70.54 Favored Pre-proline 0 CA--C 1.56 1.347 0 C-N-CA 123.948 0.899 . . . . 71.33 109.955 173.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -84.04 -79.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.382 2.297 0 C-N-CA 122.374 2.049 . . . . 62.35 109.081 164.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 277' ' ' LEU . . . . . 0.445 HD13 ' HB2' ' B' ' 87' ' ' ALA . 1.6 tt 178.76 -60.41 0.01 OUTLIER 'General case' 0 C--N 1.36 1.033 0 C-N-CA 125.184 1.394 . . . . 63.32 107.432 164.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 88.4 mt -112.83 -176.82 2.99 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.471 0.708 . . . . 62.0 110.015 174.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . -138.98 152.0 22.01 Favored Glycine 0 N--CA 1.474 1.204 0 N-CA-C 110.725 -0.95 . . . . 75.43 110.725 175.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 8.6 mp 61.98 101.24 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 124.41 1.084 . . . . 53.23 110.016 -171.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -110.22 148.58 31.57 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 123.65 0.78 . . . . 75.31 109.936 -175.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -174.2 -30.18 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.817 0.847 . . . . 65.41 111.787 -173.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -75.02 -67.96 0.6 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.285 0.634 . . . . 72.33 109.861 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . 70.37 152.12 0.78 Allowed Glycine 0 CA--C 1.534 1.238 0 CA-C-N 115.666 -0.697 . . . . 61.45 114.035 -177.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 76.04 -51.94 0.62 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.753 1.621 . . . . 72.41 115.241 164.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 286' ' ' MET . . . . . . . . . . . . . 23.7 mmt -48.01 -43.17 53.98 Favored Pre-proline 0 N--CA 1.493 1.678 0 N-CA-C 116.441 2.015 . . . . 64.1 116.441 -152.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 287' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -52.04 -45.28 39.9 Favored 'Trans proline' 0 C--N 1.389 2.69 0 C-N-CA 122.125 1.884 . . . . 73.33 112.738 173.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 288' ' ' VAL . . . . . . . . . . . . . 47.2 t 61.87 -78.48 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 C-N-CA 125.893 1.677 . . . . 74.32 111.08 -178.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 289' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 56.41 98.74 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.655 1.182 . . . . 72.14 110.613 -173.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 290' ' ' TRP . . . . . . . . . . . . . 15.5 m-90 -75.28 72.05 2.31 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 121.579 0.704 . . . . 75.34 109.351 177.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 291' ' ' LEU . . . . . . . . . . . . . 3.6 tt -86.84 73.84 9.89 Favored 'General case' 0 C--N 1.352 0.682 0 N-CA-C 107.568 -1.271 . . . . 64.34 107.568 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . -164.44 72.93 0.18 Allowed Glycine 0 C--O 1.244 0.762 0 CA-C-N 115.229 -0.896 . . . . 62.12 111.254 -178.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -59.04 -20.46 53.82 Favored 'Trans proline' 0 C--N 1.382 2.32 0 C-N-CA 123.255 2.637 . . . . 51.12 112.836 175.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 294' ' ' LYS . . . . . 0.432 ' HE3' ' O ' ' B' ' 237' ' ' ALA . 6.3 ptpp? 47.58 -151.24 0.11 Allowed 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 125.954 1.702 . . . . 41.23 112.345 173.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -124.17 103.48 8.28 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 109.279 -0.637 . . . . 34.32 109.279 174.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 33.0 m -92.84 -37.58 12.22 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.288 1.035 . . . . 65.42 110.862 -175.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 67.45 177.5 0.24 Allowed 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 125.525 1.53 . . . . 64.12 113.496 176.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -135.78 -79.1 0.42 Allowed 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.721 -1.127 . . . . 71.5 108.355 170.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . 60.32 -89.06 0.03 OUTLIER Glycine 0 C--N 1.354 1.561 0 CA-C-N 117.598 0.181 . . . . 63.41 113.013 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -93.95 128.38 40.24 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.312 0.645 . . . . 72.23 109.929 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 301' ' ' ILE . . . . . . . . . . . . . 6.5 tt -142.86 145.8 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.939 0.895 . . . . 72.24 109.341 177.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 25.1 t70 68.79 157.64 0.15 Allowed 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.453 1.101 . . . . 63.41 112.409 173.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 303' ' ' LYS . . . . . . . . . . . . . 62.7 tttm 63.89 66.61 1.05 Allowed Pre-proline 0 CA--C 1.565 1.529 0 C-N-CA 125.054 1.342 . . . . 74.11 111.556 175.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 304' ' ' PRO . . . . . 0.553 ' HA ' ' HG2' ' C' ' 243' ' ' PRO . 72.4 Cg_endo -82.0 140.64 11.42 Favored 'Trans proline' 0 C--N 1.38 2.231 0 C-N-CA 122.269 1.98 . . . . 75.12 113.019 178.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -127.22 85.97 2.44 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.545 0.738 . . . . 42.33 110.453 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 54.9 t -123.99 110.56 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 108.346 -0.983 . . . . 72.33 108.346 176.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 14.5 p -113.21 15.52 19.36 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.758 0.823 . . . . 74.23 110.99 177.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 308' ' ' CYS . . . . . . . . . . . . . 59.8 m -87.95 -30.49 20.01 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.587 0.755 . . . . 74.22 111.228 176.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 32.5 p -99.48 -45.52 0.22 Allowed Pre-proline 0 CA--C 1.572 1.808 0 N-CA-C 115.058 1.503 . . . . 72.2 115.058 -174.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -59.92 -63.92 0.11 Allowed 'Trans proline' 0 C--N 1.4 3.241 0 C-N-CA 122.096 1.864 . . . . 63.14 113.973 -168.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 311' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -146.14 90.98 5.61 Favored Pre-proline 0 CA--C 1.548 0.895 0 CA-C-N 117.703 0.229 . . . . 73.13 110.622 -173.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 312' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -91.54 21.86 0.74 Allowed 'Trans proline' 0 CA--C 1.559 1.772 0 C-N-CA 123.096 2.531 . . . . 70.14 113.988 171.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 313' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.74 123.01 22.45 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.583 -0.895 . . . . 75.13 108.583 174.312 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 314' ' ' ARG . . . . . 0.689 ' HG3' HD21 ' C' ' 175' ' ' LEU . 1.5 mmp_? -147.17 176.61 9.83 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.15 1.167 . . . . 72.01 114.15 -166.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 315' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -70.92 -57.65 4.37 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 114.702 -1.135 . . . . 72.12 109.281 173.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 316' ' ' ASP . . . . . . . . . . . . . 6.9 t70 63.66 -68.43 0.09 Allowed 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 126.067 1.747 . . . . 74.4 112.798 -177.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 317' ' ' SER . . . . . 0.44 ' HB3' ' HB2' ' B' ' 32' ' ' ARG . 50.4 m 88.72 16.66 0.06 Allowed 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 126.657 1.983 . . . . 75.41 110.61 -171.109 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 318' ' ' VAL . . . . . 0.609 HG11 ' SG ' ' B' ' 200' ' ' CYS 0.25 2.8 m 63.06 152.94 0.11 Allowed Pre-proline 0 N--CA 1.5 2.031 0 C-N-CA 127.815 2.446 . . . . 73.13 113.258 171.813 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 319' ' ' PRO . . . . . 0.489 ' HD2' ' HB ' ' B' ' 318' ' ' VAL . 18.1 Cg_endo -57.46 -13.72 14.29 Favored 'Trans proline' 0 C--N 1.392 2.86 0 C-N-CA 123.296 2.664 . . . . 65.1 116.484 -170.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 320' ' ' THR . . . . . 0.509 HG22 HG23 ' B' ' 318' ' ' VAL . 9.5 t -87.01 55.7 3.69 Favored 'General case' 0 N--CA 1.486 1.325 0 CA-C-O 122.149 0.976 . . . . 53.31 110.111 175.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 321' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -155.28 120.32 4.86 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.331 -0.85 . . . . 65.14 109.339 -176.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 322' ' ' ALA . . . . . 0.469 ' HB3' HG11 ' B' ' 185' ' ' VAL . . . 82.48 115.87 0.06 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.472 1.509 . . . . 64.54 114.532 163.035 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 323' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 65.61 -77.84 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 126.509 1.923 . . . . 74.02 114.266 164.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 324' ' ' MET . . . . . 0.576 ' HG2' ' HA ' ' B' ' 187' ' ' SER . 0.2 OUTLIER 69.2 -77.79 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 125.259 1.423 . . . . 71.32 109.958 -170.847 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 325' ' ' THR . . . . . . . . . . . . . 3.1 t -95.26 96.22 9.03 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.007 0.923 . . . . 72.33 110.197 -173.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 326' ' ' ASP . . . . . 0.652 ' HB2' ' HA2' ' B' ' 43' ' ' GLY . 3.3 p-10 -79.38 -58.0 3.42 Favored 'General case' 0 CA--C 1.556 1.196 0 CA-C-N 116.248 -0.433 . . . . 72.01 111.202 -173.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 327' ' ' LYS . . . . . 0.486 ' HG2' ' O ' ' B' ' 326' ' ' ASP . 0.0 OUTLIER 178.13 -37.39 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 126.985 2.114 . . . . 54.34 108.753 -176.037 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 328' ' ' ALA . . . . . . . . . . . . . . . -78.16 -51.24 10.54 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.351 0.66 . . . . 72.03 111.396 -177.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 329' ' ' ILE . . . . . 0.419 HG22 ' HG3' ' B' ' 330' ' ' GLU . 2.2 mp 66.63 -80.67 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.563 1.451 0 C-N-CA 124.538 1.135 . . . . 73.5 111.348 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 330' ' ' GLU . . . . . 0.556 ' HG2' ' NH2' ' B' ' 188' ' ' ARG . 44.7 mt-10 -138.53 -4.98 1.6 Allowed 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 123.556 0.743 . . . . 63.42 111.497 -176.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 331' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -139.71 174.7 10.25 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 123.418 0.687 . . . . 63.34 109.787 -173.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 332' ' ' LEU . . . . . 0.704 ' HB3' ' HB3' ' B' ' 335' ' ' ASN . 3.7 mm? -67.79 -29.91 69.21 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.61 0.764 . . . . 74.41 110.99 -178.284 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 333' ' ' SER . . . . . . . . . . . . . 48.9 m 58.42 -84.8 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.38 1.472 . . . . 65.04 112.897 175.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -89.63 -17.96 27.43 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.562 0.745 . . . . 63.11 112.32 -175.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 335' ' ' ASN . . . . . 0.704 ' HB3' ' HB3' ' B' ' 332' ' ' LEU . 7.0 t30 -67.41 97.75 0.59 Allowed 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 108.326 -0.99 . . . . 73.25 108.326 172.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -65.68 -51.16 61.63 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.269 1.027 . . . . 61.02 110.668 -173.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 337' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.13 108.35 4.07 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.774 0.829 . . . . 62.43 111.655 -169.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 338' ' ' GLY . . . . . . . . . . . . . . . -87.94 171.97 41.57 Favored Glycine 0 C--N 1.348 1.216 0 CA-C-N 115.495 -0.775 . . . . 72.34 111.947 170.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 339' ' ' PHE . . . . . . . . . . . . . 53.3 t80 60.19 83.35 0.14 Allowed 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.459 1.104 . . . . 74.33 109.756 -176.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 340' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -94.94 -69.25 0.76 Allowed 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 116.268 -0.424 . . . . 75.24 110.02 -174.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 341' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 61.42 78.81 0.27 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.616 1.167 . . . . 75.34 111.828 178.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 342' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -91.68 -31.4 15.84 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 115.464 -0.789 . . . . 64.25 110.743 175.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 343' ' ' VAL . . . . . . . . . . . . . 94.8 t -135.74 105.48 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.792 0.837 . . . . 64.24 109.368 -177.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -104.73 65.19 0.75 Allowed 'General case' 0 C--O 1.242 0.702 0 C-N-CA 124.01 0.924 . . . . 73.03 109.075 177.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 345' ' ' GLY . . . . . . . . . . . . . . . 73.37 13.37 79.89 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-N 115.335 -0.848 . . . . 62.31 112.762 -173.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 346' ' ' ALA . . . . . 0.495 ' HB2' ' HB2' ' B' ' 60' ' ' SER . . . -72.95 140.62 47.54 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.559 0.743 . . . . 72.22 111.433 -177.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 31.2 t -160.33 142.25 12.74 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 108.229 -1.026 . . . . 72.21 108.229 175.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 2.9 pp -75.4 142.04 15.06 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 N-CA-C 109.888 -0.412 . . . . 73.42 109.888 176.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 349' ' ' ASP . . . . . 0.418 ' HA ' ' HB3' ' B' ' 353' ' ' HIS . 24.7 t70 -89.87 -78.67 0.36 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.311 -0.996 . . . . 71.13 108.311 174.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 350' ' ' LYS . . . . . . . . . . . . . 98.1 mttt 50.81 36.11 13.76 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.461 1.104 . . . . 74.52 111.881 177.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 65.7 -70.25 0.1 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.747 1.619 . . . . 71.32 111.318 -172.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 352' ' ' ASP . . . . . 0.601 ' HB3' ' HB2' ' B' ' 355' ' ' ALA . 12.0 m-20 -79.72 75.06 6.4 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.932 0.893 . . . . 74.35 110.359 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 353' ' ' HIS . . . . . 0.418 ' HB3' ' HA ' ' B' ' 349' ' ' ASP . 2.3 p-80 -83.36 79.12 9.51 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.588 0.755 . . . . 74.33 109.085 174.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 354' ' ' ALA . . . . . . . . . . . . . . . 64.35 86.35 0.13 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 114.574 -1.193 . . . . 70.11 109.052 -164.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 355' ' ' ALA . . . . . 0.601 ' HB2' ' HB3' ' B' ' 352' ' ' ASP . . . -75.07 -97.91 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 118.826 -0.607 . . . . 75.44 110.494 -178.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 356' ' ' ASN . . . . . . . . . . . . . 12.0 m120 50.42 100.16 0.04 OUTLIER Pre-proline 0 CA--C 1.558 1.27 0 C-N-CA 125.131 1.372 . . . . 74.32 112.42 172.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 357' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.53 141.78 56.76 Favored 'Trans proline' 0 C--N 1.37 1.677 0 C-N-CA 122.541 2.16 . . . . 55.22 112.37 -168.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 358' ' ' CYS . . . . . . . . . . . . . 46.5 t -75.15 71.49 2.19 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-O 121.679 0.752 . . . . 73.32 110.044 177.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 359' ' ' GLY . . . . . . . . . . . . . . . -81.24 0.04 88.22 Favored Glycine 0 C--N 1.347 1.187 0 CA-C-N 115.042 -0.981 . . . . 62.01 113.141 -177.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 360' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 61.32 74.67 0.44 Allowed 'General case' 0 C--N 1.357 0.917 0 C-N-CA 124.767 1.227 . . . . 53.34 109.734 -177.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 361' ' ' ILE . . . . . . . . . . . . . 6.6 tt -140.47 135.21 35.33 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 CA-C-N 115.254 -0.884 . . . . 61.31 109.329 -176.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 362' ' ' GLY . . . . . . . . . . . . . . . -162.25 -132.42 1.33 Allowed Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 110.193 -1.163 . . . . 72.35 110.193 176.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 363' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -170.78 139.91 1.58 Allowed 'General case' 0 C--O 1.24 0.561 0 N-CA-C 107.419 -1.326 . . . . 73.13 107.419 175.301 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 364' ' ' THR . . . . . . . . . . . . . 92.7 m -56.41 -59.06 5.51 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.071 0.549 . . . . 74.04 110.195 176.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 36.9 t 53.54 -82.28 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.942 0 C-N-CA 125.404 1.482 . . . . 74.01 110.781 -171.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 22.6 t70 61.96 75.43 0.41 Allowed 'General case' 0 C--O 1.241 0.613 0 C-N-CA 124.589 1.156 . . . . 50.12 109.404 -171.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 367' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.01 -27.01 26.7 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 114.026 -1.443 . . . . 75.05 107.875 166.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 368' ' ' ASP . . . . . . . . . . . . . 26.2 t70 62.47 -77.71 0.03 OUTLIER 'General case' 0 C--N 1.364 1.231 0 C-N-CA 125.808 1.643 . . . . 71.23 110.692 -177.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 369' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 44.4 27.93 0.26 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 126.31 1.844 . . . . 70.1 113.48 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 370' ' ' ALA . . . . . . . . . . . . . . . -111.98 -35.44 5.68 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.028 0.931 . . . . 74.25 110.389 -178.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 371' ' ' VAL . . . . . . . . . . . . . 66.3 t 66.51 -70.94 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 C-N-CA 125.17 1.388 . . . . 74.11 111.921 177.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 372' ' ' GLN . . . . . 0.401 ' HG3' ' H ' ' B' ' 374' ' ' ALA . 7.1 tp-100 -160.87 138.25 9.19 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.727 0.811 . . . . 63.2 109.365 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 373' ' ' ARG . . . . . . . . . . . . . 4.4 ppt_? -58.61 -20.52 48.1 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 124.186 0.994 . . . . 72.05 113.285 -177.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 374' ' ' ALA . . . . . 0.401 ' H ' ' HG3' ' B' ' 372' ' ' GLN . . . -149.09 92.5 1.97 Allowed 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 108.034 -1.098 . . . . 71.45 108.034 172.265 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 375' ' ' LEU . . . . . . . . . . . . . 35.4 tp -77.96 -104.55 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.146 0 CA-C-O 118.981 -0.533 . . . . 62.01 109.821 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -140.62 22.38 2.33 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 119.11 0.868 . . . . 73.13 111.385 -171.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 377' ' ' PHE . . . . . . . . . . . . . 62.7 t80 56.84 -79.79 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.922 1.289 . . . . 73.31 112.831 174.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 378' ' ' ALA . . . . . . . . . . . . . . . -145.79 -17.3 0.46 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.529 0.732 . . . . 61.1 111.465 -176.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? 69.6 125.64 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 125.486 1.514 . . . . 72.01 112.928 178.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 380' ' ' LYS . . . . . 0.485 ' HB3' ' HA3' ' A' ' 190' ' ' GLY . 52.8 tptt -105.81 162.25 13.72 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 125.271 1.429 . . . . 53.14 108.605 173.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 381' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -54.39 125.86 21.07 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.102 0.961 . . . . 74.34 110.934 176.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -91.82 28.83 8.01 Favored Glycine 0 C--N 1.346 1.139 0 O-C-N 123.684 0.615 . . . . 73.1 112.702 177.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 383' ' ' ASN . . . . . . . . . . . . . 20.8 p-10 -63.51 -50.26 70.3 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 109.182 -0.673 . . . . 73.1 109.182 175.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 384' ' ' THR . . . . . . . . . . . . . 62.2 p 40.68 -155.51 0.01 OUTLIER 'General case' 0 C--N 1.361 1.088 0 C-N-CA 126.622 1.969 . . . . 63.41 114.279 174.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 17.1 tp 61.6 39.75 14.21 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.454 1.102 . . . . 75.12 110.527 173.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 386' ' ' VAL . . . . . . . . . . . . . 25.4 t 59.02 49.16 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.542 0 C-N-CA 124.286 1.034 . . . . 62.42 109.45 -176.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 387' ' ' ILE . . . . . 0.454 HD11 ' HA ' ' A' ' 243' ' ' PRO . 2.6 mp 58.3 82.36 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 125.19 1.396 . . . . 74.12 109.989 -175.427 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 388' ' ' VAL . . . . . . . . . . . . . 11.8 p 38.09 68.48 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.63 0 C-N-CA 126.613 1.965 . . . . 54.33 113.609 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 389' ' ' THR . . . . . . . . . . . . . 6.0 m 69.72 -1.26 2.36 Favored 'General case' 0 CA--C 1.57 1.73 0 C-N-CA 125.66 1.584 . . . . 71.25 112.476 177.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . 57.88 28.64 16.36 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 124.71 1.204 . . . . 70.34 110.959 -167.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 391' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -139.69 -77.82 0.33 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.314 1.045 . . . . 64.12 110.467 -172.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 392' ' ' HIS . . . . . . . . . . . . . 48.4 t-80 172.75 -36.53 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.027 0.931 . . . . 72.42 109.411 -164.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . 68.27 -151.12 0.16 Allowed 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.928 1.291 . . . . 61.53 110.845 -177.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 74.43 -63.02 0.44 Allowed 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 125.356 1.463 . . . . 73.31 109.776 -167.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . -167.88 103.91 0.48 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.334 1.054 . . . . 71.44 108.412 174.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 33.5 t -98.34 -90.5 0.28 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.098 0.559 . . . . 75.55 110.593 -176.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 397' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -101.8 -77.65 0.55 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.294 0.637 . . . . 71.41 110.111 -172.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 2.6 pp -101.38 117.9 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 CA-C-O 121.402 0.62 . . . . 75.44 109.987 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 399' ' ' VAL . . . . . . . . . . . . . 3.6 m -134.97 -10.77 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 124.499 1.12 . . . . 73.32 110.284 177.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 400' ' ' ALA . . . . . . . . . . . . . . . -69.23 -44.15 26.28 Favored Pre-proline 0 CA--C 1.56 1.342 0 C-N-CA 124.304 1.042 . . . . 51.41 113.736 176.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 401' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -67.8 102.18 0.73 Allowed 'Trans proline' 0 C--N 1.39 2.744 0 CA-C-N 121.08 1.422 . . . . 71.04 111.352 174.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -80.96 -172.98 4.0 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 122.847 0.459 . . . . 74.34 110.736 -179.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 403' ' ' THR . . . . . 0.603 ' HA ' ' HD2' ' B' ' 415' ' ' LYS . 5.5 m -76.14 -52.76 9.43 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 123.192 0.597 . . . . 51.3 111.802 -171.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 404' ' ' LYS . . . . . 0.666 ' HA ' ' H ' ' B' ' 413' ' ' ASN . 36.1 ttpt -83.88 -37.78 21.97 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 115.32 -0.855 . . . . 70.03 111.874 -171.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 405' ' ' ALA . . . . . 0.486 ' O ' ' HA ' ' B' ' 410' ' ' GLN . . . 63.29 81.42 0.23 Allowed Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 124.549 1.139 . . . . 71.24 110.122 -174.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 406' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -84.14 5.85 6.09 Favored 'Trans proline' 0 C--N 1.373 1.841 0 C-N-CA 123.681 2.921 . . . . 44.44 113.98 -172.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . -61.9 -69.37 1.32 Allowed Glycine 0 C--N 1.351 1.412 0 O-C-N 123.272 0.357 . . . . 55.33 112.645 -177.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 408' ' ' LEU . . . . . . . . . . . . . 43.3 tp -150.59 142.16 23.54 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 108.738 -0.838 . . . . 72.03 108.738 177.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 21.2 m 76.21 -43.8 0.48 Allowed 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 125.46 1.504 . . . . 73.52 112.547 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 410' ' ' GLN . . . . . 0.486 ' HA ' ' O ' ' B' ' 405' ' ' ALA . 76.1 mt-30 66.37 122.03 0.02 OUTLIER 'General case' 0 C--N 1.358 0.956 0 C-N-CA 125.692 1.597 . . . . 51.32 110.974 -174.345 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . -60.62 -26.51 67.07 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.708 0.403 . . . . 63.14 110.23 169.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 1.7 tt 64.44 56.54 1.25 Allowed 'General case' 0 C--N 1.358 0.975 0 C-N-CA 125.198 1.399 . . . . 60.41 107.892 -177.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 413' ' ' ASN . . . . . 0.666 ' H ' ' HA ' ' B' ' 404' ' ' LYS . 3.2 m-20 74.7 -11.91 0.99 Allowed 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 113.014 -1.903 . . . . 71.14 113.485 172.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 414' ' ' THR . . . . . . . . . . . . . 70.2 p -71.75 -5.17 32.11 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 112.899 0.703 . . . . 73.24 112.899 -173.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 415' ' ' LYS . . . . . 0.603 ' HD2' ' HA ' ' B' ' 403' ' ' THR . 13.5 mmmm 77.31 -55.29 0.54 Allowed 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 126.218 1.807 . . . . 73.42 111.36 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 416' ' ' ASP . . . . . 0.519 ' HB3' HG22 ' B' ' 419' ' ' VAL . 16.2 t70 -160.46 -51.62 0.05 Allowed 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.767 1.227 . . . . 75.33 108.337 -176.172 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 417' ' ' GLY . . . . . . . . . . . . . . . 105.41 -50.54 0.82 Allowed Glycine 0 C--N 1.351 1.384 0 CA-C-N 115.106 -0.952 . . . . 43.15 112.293 177.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 418' ' ' ALA . . . . . . . . . . . . . . . -75.59 -21.02 58.18 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.039 0.536 . . . . 70.25 111.859 -175.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 419' ' ' VAL . . . . . 0.519 HG22 ' HB3' ' B' ' 416' ' ' ASP . 24.2 m -74.32 81.79 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.247 0 CA-C-O 122.594 1.187 . . . . 62.03 111.021 176.2 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 420' ' ' MET . . . . . . . . . . . . . 64.7 mtm -94.54 -8.55 37.93 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 114.979 -1.009 . . . . 73.12 111.567 -178.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 421' ' ' VAL . . . . . 0.434 HG12 ' H ' ' B' ' 423' ' ' SER . 88.7 t -74.74 -83.23 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 C-N-CA 122.71 0.404 . . . . 72.42 110.037 176.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 422' ' ' MET . . . . . . . . . . . . . 94.2 mmm 54.1 13.36 0.57 Allowed 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 124.758 1.223 . . . . 74.1 113.889 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 423' ' ' SER . . . . . 0.434 ' H ' HG12 ' B' ' 421' ' ' VAL . 23.0 t -113.03 109.66 19.2 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.214 0.606 . . . . 62.22 110.739 -170.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 424' ' ' TYR . . . . . . . . . . . . . 81.4 t80 67.58 -77.88 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.32 1.448 . . . . 72.42 111.445 176.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . 166.11 145.29 4.39 Favored Glycine 0 C--N 1.339 0.709 0 CA-C-O 119.14 -0.811 . . . . 75.12 111.116 -177.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 426' ' ' ASN . . . . . . . . . . . . . 9.2 p30 45.33 35.27 1.78 Allowed 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 125.699 1.6 . . . . 75.43 112.608 -176.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 427' ' ' SER . . . . . . . . . . . . . 20.3 m 54.73 69.68 0.7 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.629 1.171 . . . . 75.14 110.639 -172.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 46.25 106.72 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 126.274 1.83 . . . . 73.23 113.583 -174.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 429' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -61.05 96.58 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.332 0.653 . . . . 63.42 111.212 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 17.8 t70 35.61 63.78 0.52 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 126.704 2.002 . . . . 55.41 113.511 173.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 29.9 p -110.43 -35.64 5.99 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.527 -0.76 . . . . 73.31 110.698 178.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 432' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 52.82 54.93 9.72 Favored 'General case' 0 CA--C 1.557 1.222 0 CA-C-O 122.349 1.071 . . . . 71.1 110.061 -173.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 433' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -69.2 156.28 39.0 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 114.552 -1.204 . . . . 73.43 108.367 178.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 434' ' ' HIS . . . . . 0.519 ' HD2' ' HB3' ' A' ' 236' ' ' LYS . 53.8 m-70 -50.51 100.55 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.32 1.048 . . . . 65.13 110.371 -176.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 435' ' ' THR . . . . . 0.473 ' HA ' ' HB3' ' B' ' 118' ' ' PRO 0.289 9.7 t 65.58 -15.65 0.11 Allowed 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 128.021 2.528 . . . . 73.42 114.821 -173.972 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . 71.43 -77.04 0.62 Allowed Glycine 0 C--N 1.352 1.472 0 CA-C-N 118.378 0.536 . . . . 43.54 112.2 178.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 32.8 t -129.38 171.09 12.87 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.092 0.957 . . . . 54.14 109.041 172.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 438' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 65.76 114.79 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 124.876 1.27 . . . . 71.55 111.023 -174.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 439' ' ' LEU . . . . . 0.504 HD23 ' H ' ' B' ' 439' ' ' LEU . 1.9 pt? -73.1 87.25 1.39 Allowed 'General case' 0 CA--C 1.558 1.253 0 CA-C-O 122.78 1.276 . . . . 74.24 110.686 -178.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 440' ' ' ARG . . . . . 0.476 ' HD3' ' HA ' ' B' ' 114' ' ' LYS . 57.6 mtt180 -91.9 -10.38 39.81 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 113.915 -1.493 . . . . 70.1 111.028 178.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 441' ' ' ILE . . . . . 0.452 ' HA ' HD22 ' A' ' 235' ' ' LEU . 58.9 mt 69.69 125.46 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.001 0 C-N-CA 125.817 1.647 . . . . 74.15 113.086 174.454 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 442' ' ' ALA . . . . . . . . . . . . . . . -145.37 105.35 4.02 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 107.201 -1.407 . . . . 71.41 107.201 172.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . -158.01 -52.08 0.07 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.506 0.722 . . . . 74.21 109.836 -172.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 444' ' ' TYR . . . . . 0.6 ' HE1' HH11 ' A' ' 231' ' ' ARG . 0.0 OUTLIER -164.71 115.84 1.2 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.595 0.758 . . . . 65.34 110.13 176.409 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . 126.73 -65.19 0.57 Allowed Glycine 0 CA--C 1.54 1.603 0 CA-C-O 118.744 -1.031 . . . . 74.34 114.011 176.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 446' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -43.86 -29.82 2.72 Favored 'Trans proline' 0 C--N 1.397 3.081 0 C-N-CA 124.501 3.467 . . . . 63.02 115.186 178.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 447' ' ' HIS . . . . . . . . . . . . . 18.5 m80 -119.23 -75.22 0.58 Allowed 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 108.343 -0.984 . . . . 60.0 108.343 174.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . 67.24 148.09 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.911 1.284 . . . . 74.31 112.096 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 449' ' ' ALA . . . . . . . . . . . . . . . -77.13 73.68 3.71 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-O 121.565 0.698 . . . . 61.52 110.363 177.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 450' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -157.86 -62.94 0.09 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.223 1.009 . . . . 61.12 109.538 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 7.2 p -77.49 -23.04 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 C-N-CA 122.86 0.464 . . . . 63.1 110.656 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 452' ' ' VAL . . . . . . . . . . . . . 34.5 m -70.31 124.95 27.55 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 C-N-CA 122.972 0.509 . . . . 60.45 110.801 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . -99.33 7.29 59.92 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-N 115.819 -0.628 . . . . 73.44 112.272 177.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 454' ' ' LEU . . . . . . . . . . . . . 63.2 tp -72.26 -81.76 0.05 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.656 0.782 . . . . 72.5 110.131 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 455' ' ' THR . . . . . 0.521 HG21 ' HA ' ' B' ' 461' ' ' PHE . 19.1 m 45.8 70.54 0.36 Allowed 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 124.423 1.089 . . . . 61.41 112.077 -178.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -94.96 13.01 26.37 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 115.216 -0.902 . . . . 74.3 110.721 178.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 457' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -91.66 46.84 1.31 Allowed 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 124.103 0.961 . . . . 42.14 110.114 -178.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 13.7 m 59.35 72.98 0.5 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.39 1.476 . . . . 72.13 112.337 177.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 459' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 58.29 -152.28 0.4 Allowed 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.159 0.984 . . . . 73.31 111.21 171.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 75.2 mt 78.6 -56.7 0.46 Allowed 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 126.022 1.729 . . . . 65.42 112.309 172.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 461' ' ' PHE . . . . . 0.521 ' HA ' HG21 ' B' ' 455' ' ' THR . 76.3 t80 70.15 -73.47 0.09 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.086 1.355 . . . . 62.31 109.634 -172.459 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 462' ' ' TYR . . . . . 0.535 ' HA ' ' SD ' ' B' ' 464' ' ' MET . 14.9 t80 61.54 -171.23 0.15 Allowed 'General case' 0 CA--C 1.561 1.373 0 C-N-CA 124.149 0.979 . . . . 72.53 110.51 175.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 4.0 m 70.79 3.22 4.5 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 124.067 0.947 . . . . 61.35 112.316 177.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 464' ' ' MET . . . . . 0.535 ' SD ' ' HA ' ' B' ' 462' ' ' TYR . 0.0 OUTLIER -78.98 71.33 5.43 Favored 'General case' 0 CA--C 1.557 1.227 0 CA-C-O 122.708 1.242 . . . . 75.31 110.399 -178.557 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -102.38 4.89 39.4 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.668 1.187 . . . . 72.15 111.256 -174.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -61.44 139.56 58.19 Favored 'General case' 0 C--N 1.349 0.571 0 C-N-CA 123.395 0.678 . . . . 62.32 109.573 174.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . -60.54 -24.76 65.63 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 122.98 0.512 . . . . 75.3 111.168 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -82.3 118.96 23.54 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 108.013 -1.106 . . . . 45.51 108.013 167.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 469' ' ' GLY . . . . . . . . . . . . . . . -72.04 86.08 0.48 Allowed Glycine 0 C--N 1.348 1.199 0 N-CA-C 111.286 -0.726 . . . . 50.44 111.286 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 470' ' ' LEU . . . . . . . . . . . . . 63.9 tp -61.42 -59.06 5.83 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.147 0.979 . . . . 73.2 111.195 -177.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 471' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? . . . . . 0 C--O 1.253 1.266 0 N-CA-C 106.796 -1.557 . . . . 74.2 106.796 -175.299 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 1' ' ' MET . . . . . 0.493 ' SD ' ' N ' ' C' ' 1' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.478 0.94 0 N-CA-C 110.165 -0.309 . . . . 55.23 110.165 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 60.54 37.54 19.49 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 125.207 1.403 . . . . 65.31 112.859 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -72.8 80.62 1.15 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 122.508 0.323 . . . . 52.01 110.188 175.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -34.17 93.71 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 127.041 2.137 . . . . 70.52 112.894 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 5' ' ' LYS . . . . . 0.495 ' HE2' HD11 ' C' ' 10' ' ' ILE . 14.5 mmmm -92.84 93.29 8.33 Favored 'General case' 0 C--O 1.243 0.72 0 N-CA-C 107.812 -1.181 . . . . 63.2 107.812 169.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -73.67 97.36 2.66 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 107.193 -1.41 . . . . 63.22 107.193 175.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 7' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -61.54 -37.86 85.32 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.182 -0.917 . . . . 73.43 111.598 -171.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -60.97 -45.02 96.45 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 116.181 -0.463 . . . . 72.53 110.481 175.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.96 -40.95 99.25 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.051 0.54 . . . . 52.31 111.207 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 10' ' ' ILE . . . . . 0.495 HD11 ' HE2' ' C' ' 5' ' ' LYS . 64.6 mt -61.92 -36.07 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.213 0.605 . . . . 63.34 110.576 177.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 11' ' ' LEU . . . . . 0.583 HD13 HG23 ' C' ' 22' ' ' ILE . 68.7 mt -80.61 -13.85 58.69 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 112.46 0.541 . . . . 45.45 112.46 176.128 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.11 35.92 42.27 Favored Glycine 0 C--N 1.351 1.364 0 N-CA-C 113.689 0.235 . . . . 64.33 113.689 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 6.1 m -131.56 153.44 81.55 Favored Pre-proline 0 N--CA 1.482 1.151 0 C-N-CA 124.691 1.196 . . . . 64.04 109.184 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -76.51 161.08 34.7 Favored 'Trans proline' 0 C--N 1.373 1.83 0 C-N-CA 122.432 2.088 . . . . 74.43 112.293 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -67.85 80.53 0.2 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.339 0.655 . . . . 71.52 109.898 176.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -179.19 -30.03 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.673 1.189 . . . . 71.24 109.038 -174.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -47.58 119.72 2.9 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 124.744 1.277 . . . . 71.14 111.688 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 72.3 p -86.25 178.35 7.21 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.802 0.841 . . . . 74.41 110.14 177.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -48.45 -38.28 19.46 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 124.515 1.126 . . . . 74.45 112.195 -177.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 20' ' ' GLU . . . . . 0.402 ' O ' ' HG3' ' C' ' 24' ' ' ARG . 13.9 tp10 -66.72 -52.63 42.25 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.387 0.675 . . . . 64.05 110.953 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 21' ' ' GLU . . . . . 0.662 ' HA ' ' HE ' ' C' ' 24' ' ' ARG . 33.7 mt-10 -65.0 -34.37 78.27 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.636 0.775 . . . . 73.42 111.285 -176.317 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 22' ' ' ILE . . . . . 0.896 HD13 ' HB3' ' C' ' 57' ' ' LEU . 82.1 mt -75.56 -36.08 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.214 1.405 . . . . 61.32 111.268 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -62.87 -44.21 96.74 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.758 0.823 . . . . 74.13 109.77 175.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 24' ' ' ARG . . . . . 0.662 ' HE ' ' HA ' ' C' ' 21' ' ' GLU . 42.8 mtm180 -64.63 -46.05 84.19 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 115.332 -0.849 . . . . 73.52 110.829 178.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 25' ' ' ALA . . . . . 0.42 ' O ' ' HB3' ' C' ' 28' ' ' ARG . . . -61.5 -37.68 84.58 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.461 0.705 . . . . 75.32 111.682 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 26' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -62.97 -52.1 64.33 Favored 'General case' 0 C--O 1.212 -0.882 0 CA-C-N 115.121 -0.945 . . . . 72.31 109.998 176.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -58.02 -37.14 73.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 123.882 0.739 . . . . 74.1 111.369 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 28' ' ' ARG . . . . . 0.42 ' HB3' ' O ' ' C' ' 25' ' ' ALA . 20.8 ttt180 -53.15 -56.03 19.54 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.294 1.037 . . . . 71.15 110.45 172.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 29' ' ' LEU . . . . . 0.671 ' HB3' HD13 ' C' ' 50' ' ' ILE . 91.2 mt -80.9 -11.15 59.63 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 115.769 -0.65 . . . . 60.22 111.879 -177.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -91.31 -10.7 40.39 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.126 0.97 . . . . 75.32 110.535 177.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -93.89 -48.6 6.2 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.216 0.606 . . . . 73.5 110.342 165.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 20.6 tp60 -62.44 -48.52 79.31 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.452 0.701 . . . . 71.12 111.297 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 33' ' ' TYR . . . . . 0.417 ' HE2' HD22 ' C' ' 29' ' ' LEU . 29.4 m-85 -109.01 37.11 2.65 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.218 0.607 . . . . 70.15 109.969 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 34' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -67.89 111.48 7.81 Favored Pre-proline 0 N--CA 1.473 0.719 0 CA-C-O 118.373 -0.823 . . . . 72.34 109.378 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.74 -29.21 76.94 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 122.417 2.078 . . . . 71.32 111.318 -176.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -62.07 -33.03 73.65 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.364 1.466 . . . . 60.34 112.153 176.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 98.6 t -96.71 -62.62 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 N-CA-C 108.988 -0.745 . . . . 75.33 108.988 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -98.72 96.46 7.93 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.263 1.025 . . . . 54.22 110.604 -177.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -80.03 74.66 6.8 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 108.644 -0.873 . . . . 62.24 108.644 173.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 71.1 m -126.8 97.85 32.17 Favored Pre-proline 0 CA--C 1.538 0.506 0 N-CA-C 108.591 -0.892 . . . . 74.14 108.591 175.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -39.16 -44.19 2.64 Favored 'Trans proline' 0 C--N 1.388 2.655 0 C-N-CA 124.76 3.64 . . . . 63.44 114.545 -176.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -48.6 -55.51 10.98 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 124.811 1.244 . . . . 65.44 111.023 174.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.42 -21.21 63.77 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 115.476 -0.784 . . . . 62.05 111.272 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 44' ' ' GLU . . . . . 0.437 ' O ' ' HG3' ' C' ' 48' ' ' LYS . 43.0 mt-10 -88.76 -24.57 22.61 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.529 0.731 . . . . 74.04 110.748 -175.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -81.31 -36.54 29.65 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.615 0.766 . . . . 42.53 109.248 174.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 46' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -65.21 -36.64 84.81 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.05 -0.977 . . . . 72.32 109.167 169.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 47' ' ' PHE . . . . . 0.572 ' HA ' HD12 ' C' ' 50' ' ' ILE . 41.9 t80 -66.68 -32.62 74.06 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.449 0.7 . . . . 62.23 110.408 173.521 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 48' ' ' LYS . . . . . 0.442 ' HB3' ' CE1' ' C' ' 93' ' ' PHE . 95.7 mttt -64.14 -39.79 94.79 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 122.889 0.476 . . . . 72.04 110.808 172.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -69.15 -28.94 66.87 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.65 0.38 . . . . 72.33 110.774 176.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 50' ' ' ILE . . . . . 0.671 HD13 ' HB3' ' C' ' 29' ' ' LEU . 71.2 mt -73.07 -32.79 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 123.856 0.863 . . . . 75.43 110.381 173.014 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 51' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -77.38 -24.73 50.54 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.257 0.623 . . . . 74.04 110.62 175.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -71.09 -52.85 17.02 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 108.369 -0.974 . . . . 63.42 108.369 172.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.22 -44.41 79.53 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 113.533 -1.667 . . . . 63.1 111.467 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -74.18 -38.33 63.68 Favored 'General case' 0 C--O 1.208 -1.112 0 CA-C-N 115.425 -0.807 . . . . 75.01 110.384 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.89 -35.77 75.54 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-O 120.81 0.338 . . . . 60.54 111.469 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 47.5 t -77.84 -44.71 28.55 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 CA-C-N 115.906 -0.588 . . . . 72.43 109.875 175.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 57' ' ' LEU . . . . . 0.896 ' HB3' HD13 ' C' ' 22' ' ' ILE . 52.4 mt -98.74 0.65 44.93 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 115.428 1.64 . . . . 75.02 115.428 -166.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 30.9 t -75.56 -66.12 0.81 Allowed 'General case' 0 N--CA 1.484 1.233 0 CA-C-O 121.733 0.777 . . . . 62.42 109.686 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -86.83 132.36 42.39 Favored Pre-proline 0 C--O 1.255 1.376 0 CA-C-N 114.438 -1.255 . . . . 72.03 108.885 -169.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 60' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_exo -46.6 -30.5 8.9 Favored 'Trans proline' 0 C--N 1.388 2.626 0 C-N-CA 124.218 3.279 . . . . 33.23 114.796 -175.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -57.25 -69.74 0.15 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.572 0.749 . . . . 62.13 111.413 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.28 -25.54 63.39 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 122.773 0.429 . . . . 75.23 110.619 -173.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -61.93 -47.86 83.0 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 108.147 -1.057 . . . . 64.42 108.147 175.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -70.14 -29.34 66.23 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.156 0.582 . . . . 74.15 111.618 177.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 82.0 mt -62.08 -43.8 98.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 C-N-CA 122.72 0.408 . . . . 62.34 110.384 174.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -67.08 -46.55 73.93 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.771 -0.649 . . . . 74.22 109.797 177.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -55.1 -47.58 74.75 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.228 0.611 . . . . 73.14 110.758 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 70.4 p -70.39 -26.81 63.87 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.94 -0.573 . . . . 63.2 111.518 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -69.51 136.17 51.08 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 108.81 -0.811 . . . . 75.22 108.81 178.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.05 15.28 54.5 Favored Glycine 0 N--CA 1.473 1.107 0 N-CA-C 111.632 -0.587 . . . . 62.51 111.632 -169.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 58.2 m -148.4 -60.24 0.24 Allowed 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 103.698 -2.704 . . . . 72.34 103.698 175.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 56.8 m -75.04 140.53 43.61 Favored 'General case' 0 C--O 1.252 1.218 0 N-CA-C 105.147 -2.168 . . . . 73.35 105.147 156.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.87 -36.25 6.7 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.88 0.872 . . . . 73.23 110.873 -176.485 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -93.32 139.17 22.88 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 123.986 0.915 . . . . 53.23 110.096 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -61.7 144.48 97.29 Favored 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 122.691 2.261 . . . . 75.14 112.096 175.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -49.84 144.34 21.07 Favored 'Trans proline' 0 C--N 1.384 2.406 0 C-N-CA 123.826 3.017 . . . . 63.14 113.805 175.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 77' ' ' PRO . . . . . 0.42 ' HA ' ' HD3' ' C' ' 78' ' ' PRO . 18.2 Cg_endo -57.82 131.87 46.52 Favored 'Trans proline' 0 C--N 1.381 2.251 0 C-N-CA 122.697 2.265 . . . . 51.51 111.65 177.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 78' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' C' ' 77' ' ' PRO . 32.2 Cg_exo -57.92 113.61 1.6 Allowed 'Trans proline' 0 C--N 1.388 2.657 0 C-N-CA 122.89 2.393 . . . . 74.44 112.221 -174.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -80.93 178.41 6.94 Favored 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 122.882 2.388 . . . . 61.04 111.902 -178.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -54.51 90.54 0.04 OUTLIER 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 122.279 1.986 . . . . 51.5 112.271 167.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 134.26 -1.64 4.14 Favored Glycine 0 N--CA 1.466 0.662 0 CA-C-N 114.937 -1.029 . . . . 75.2 112.399 175.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 67.01 -149.8 51.51 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 112.39 -0.284 . . . . 74.45 112.39 178.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -99.46 113.63 26.1 Favored 'General case' 0 C--O 1.244 0.803 0 N-CA-C 108.208 -1.034 . . . . 70.14 108.208 168.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 84' ' ' ASP . . . . . 0.554 ' HA ' ' HD2' ' C' ' 106' ' ' PHE . 4.8 p-10 -71.74 134.3 46.14 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-O 121.394 0.616 . . . . 63.13 110.009 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 85' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -159.25 22.24 0.19 Allowed 'General case' 0 C--O 1.248 0.999 0 CA-C-N 114.603 -1.181 . . . . 74.41 107.969 -177.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 86' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' C' ' 169' ' ' ASN . 19.0 m -62.79 128.27 35.14 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 113.141 -1.845 . . . . 45.43 111.273 -170.081 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 87' ' ' GLY . . . . . 0.572 ' HA2' ' HA ' ' C' ' 171' ' ' PRO . . . 99.25 -20.95 47.93 Favored Glycine 0 C--N 1.336 0.569 0 O-C-N 123.775 0.672 . . . . 74.33 112.938 178.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 88' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -93.79 150.64 20.22 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 117.457 0.628 . . . . 74.44 110.224 -178.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -82.56 73.69 9.58 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.113 0.565 . . . . 72.23 110.442 -174.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 90' ' ' VAL . . . . . . . . . . . . . 3.2 p -43.41 -41.72 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 C-N-CA 125.456 1.503 . . . . 54.41 112.486 177.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -56.76 -36.09 69.41 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.902 1.281 . . . . 74.21 111.945 -175.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -88.87 -21.02 23.88 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.02 0.528 . . . . 75.53 111.997 -175.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 93' ' ' PHE . . . . . 0.442 ' CE1' ' HB3' ' C' ' 48' ' ' LYS . 4.5 m-30 -81.75 164.74 21.51 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 122.326 0.251 . . . . 72.45 111.295 -168.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 94.5 p -60.19 152.08 25.51 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.586 1.154 . . . . 45.51 113.598 -165.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 95' ' ' GLU . . . . . 0.451 ' HG2' ' SD ' ' C' ' 1' ' ' MET . 0.0 OUTLIER -60.55 -31.79 70.88 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 114.964 -1.016 . . . . 55.43 111.062 170.96 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -59.88 -44.51 94.14 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.175 0.99 . . . . 65.02 110.426 175.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 97' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -62.1 -43.33 99.07 Favored 'General case' 0 CA--C 1.558 1.28 0 CA-C-N 114.978 -1.01 . . . . 64.25 110.362 170.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -73.68 -1.46 19.13 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.184 0.593 . . . . 51.52 111.758 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -98.95 -41.32 7.64 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.559 0.743 . . . . 74.43 112.092 168.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 23.9 tp -82.02 -35.55 28.73 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.284 0.634 . . . . 73.23 111.83 -174.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -114.14 -17.76 11.82 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.673 0.789 . . . . 73.25 110.956 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -42.72 -58.73 3.47 Favored Glycine 0 CA--C 1.541 1.67 0 CA-C-O 118.689 -1.062 . . . . 54.11 115.466 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.0 -21.19 20.53 Favored 'Trans proline' 0 C--N 1.389 2.658 0 C-N-CA 123.645 2.896 . . . . 62.02 114.224 -176.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -127.68 8.72 6.88 Favored Glycine 0 C--N 1.357 1.7 0 CA-C-O 117.051 -1.972 . . . . 43.23 114.631 -175.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 28.5 mt -46.53 83.0 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.709 0 N-CA-C 114.623 1.342 . . . . 73.03 114.623 -175.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 106' ' ' PHE . . . . . 0.554 ' HD2' ' HA ' ' C' ' 84' ' ' ASP . 0.1 OUTLIER 28.99 -107.95 0.02 OUTLIER 'General case' 0 CA--C 1.568 1.653 0 C-N-CA 127.154 2.182 . . . . 64.24 113.864 171.752 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 107' ' ' GLY . . . . . 0.548 ' HA2' ' HA2' ' C' ' 168' ' ' GLY . . . 57.92 26.49 58.12 Favored Glycine 0 C--N 1.37 2.425 0 CA-C-N 118.889 0.768 . . . . 51.05 112.826 -170.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 108' ' ' GLY . . . . . 0.448 ' HA3' ' O ' ' B' ' 37' ' ' ASP . . . 51.38 -124.35 21.95 Favored Glycine 0 C--N 1.349 1.276 0 O-C-N 124.195 0.585 . . . . 74.41 112.268 -167.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 109' ' ' PHE . . . . . 0.485 ' HD2' HG13 ' B' ' 38' ' ' ILE . 92.6 m-85 -111.19 10.61 21.83 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.124 0.97 . . . . 74.45 109.799 172.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 110' ' ' GLY . . . . . 0.529 ' HA3' ' HA ' ' B' ' 37' ' ' ASP . . . -89.41 -16.44 57.13 Favored Glycine 0 C--N 1.347 1.175 0 N-CA-C 111.029 -0.829 . . . . 54.22 111.029 172.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 58.2 13.35 2.27 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 125.028 1.331 . . . . 75.25 113.592 167.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 112' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -66.16 -20.98 66.31 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 124.864 1.265 . . . . 74.1 111.657 172.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 113' ' ' SER . . . . . 0.416 ' H ' ' HA3' ' C' ' 107' ' ' GLY . 45.4 m 63.98 9.32 4.5 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 124.711 1.204 . . . . 72.53 113.173 177.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 114' ' ' ARG . . . . . 0.453 ' HD2' ' HA ' ' C' ' 114' ' ' ARG . 7.2 tpt180 -100.49 -165.82 1.25 Allowed 'General case' 0 C--O 1.21 -1.01 0 CA-C-O 117.79 -1.1 . . . . 74.05 111.228 -171.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 115' ' ' LYS . . . . . . . . . . . . . 56.7 tttp -30.55 116.91 0.15 Allowed 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 116.185 1.92 . . . . 54.14 116.185 -161.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.18 128.3 30.78 Favored Glycine 0 C--N 1.356 1.676 0 O-C-N 124.486 1.116 . . . . 45.25 111.601 169.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 117' ' ' ARG . . . . . 0.693 ' HB2' ' HB2' ' C' ' 167' ' ' GLN . 50.3 mtm180 -115.46 180.0 3.8 Favored 'General case' 0 C--O 1.254 1.313 0 CA-C-O 122.056 0.931 . . . . 64.44 110.662 -174.03 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 118' ' ' ASP . . . . . 0.484 ' HA ' ' O ' ' C' ' 173' ' ' ASP . 0.8 OUTLIER -57.07 107.24 0.39 Allowed 'General case' 0 C--O 1.243 0.73 0 CA-C-N 112.278 -2.237 . . . . 75.42 110.193 172.124 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 119' ' ' LEU . . . . . 0.576 HD12 ' HA3' ' C' ' 166' ' ' GLY . 0.3 OUTLIER -94.91 113.89 25.67 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 107.647 -1.242 . . . . 75.21 107.647 174.619 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.463 ' HA ' ' O ' ' C' ' 175' ' ' LEU . 0.0 OUTLIER -104.4 124.8 49.88 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 110.125 -0.324 . . . . 72.31 110.125 -173.797 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 121' ' ' ALA . . . . . 0.527 ' HA ' ' HA ' ' B' ' 185' ' ' VAL . . . -111.43 137.15 49.59 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.388 0.675 . . . . 63.21 111.231 -177.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 122' ' ' GLU . . . . . 0.816 ' HB2' ' HA ' ' B' ' 186' ' ' THR . 5.6 tp10 -92.66 90.15 6.97 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 107.665 -1.235 . . . . 73.22 107.665 170.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 123' ' ' LEU . . . . . 0.712 ' HB3' ' HA ' ' B' ' 183' ' ' ALA . 1.1 pt? -105.36 114.28 63.49 Favored Pre-proline 0 N--CA 1.49 1.539 0 CA-C-N 118.474 0.579 . . . . 73.3 112.116 -174.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 124' ' ' PRO . . . . . 0.544 ' HA ' ' O ' ' C' ' 179' ' ' ARG . 36.2 Cg_exo -64.64 112.35 1.94 Allowed 'Trans proline' 0 C--N 1.386 2.528 0 C-N-CA 122.606 2.204 . . . . 72.51 110.489 164.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 125' ' ' LEU . . . . . 0.408 HD23 HG21 ' C' ' 153' ' ' VAL . 51.3 tp -131.79 147.3 52.48 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 122.552 0.341 . . . . 74.03 110.828 -169.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 126' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -92.08 151.47 20.42 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.302 0.641 . . . . 61.53 109.946 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 127' ' ' LEU . . . . . 0.42 ' CD2' HD13 ' C' ' 180' ' ' LEU . 25.2 mt -65.82 -50.99 62.66 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.425 1.09 . . . . 62.25 110.311 -177.355 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -53.69 -42.87 68.44 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 113.165 -1.834 . . . . 75.24 109.896 176.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 129' ' ' GLU . . . . . 0.508 ' HA ' ' HB2' ' C' ' 132' ' ' HIS . 15.1 mm-40 -82.33 -16.93 47.5 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.737 0.815 . . . . 73.53 111.821 -175.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -71.93 -31.53 66.44 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 109.014 -0.735 . . . . 64.34 109.014 172.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 131' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -73.11 -51.12 19.16 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 115.471 -0.786 . . . . 75.55 110.659 164.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 132' ' ' HIS . . . . . 0.508 ' HB2' ' HA ' ' C' ' 129' ' ' GLU . 38.3 m80 -76.32 3.82 10.16 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.005 0.522 . . . . 60.22 112.234 -171.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -58.83 88.26 0.02 OUTLIER Glycine 0 CA--C 1.539 1.544 0 N-CA-C 114.578 0.591 . . . . 65.31 114.578 171.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . -88.03 -143.9 9.12 Favored Glycine 0 C--N 1.355 1.631 0 N-CA-C 111.34 -0.704 . . . . 53.24 111.34 170.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 26.1 mp0 -70.48 93.83 0.92 Allowed 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 107.971 -1.122 . . . . 71.2 107.971 171.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 136' ' ' ARG . . . . . 0.582 ' HB3' ' HB2' ' B' ' 181' ' ' LEU . 78.7 mtt180 -115.58 138.19 51.31 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.024 0.529 . . . . 72.12 110.081 -173.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 137' ' ' VAL . . . . . 0.507 ' HA ' ' HA ' ' C' ' 146' ' ' SER . 21.5 t -76.7 103.57 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-N 116.099 -0.501 . . . . 71.12 109.877 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 138' ' ' VAL . . . . . 0.508 ' HB ' HD23 ' B' ' 181' ' ' LEU . 4.6 p -80.43 123.69 37.45 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 123.659 0.784 . . . . 72.14 109.22 174.15 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 139' ' ' GLU . . . . . 0.642 ' HG2' ' HG3' ' C' ' 144' ' ' ARG . 28.3 mt-10 -118.97 92.01 3.7 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.77 0.828 . . . . 74.31 109.175 -165.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 140' ' ' VAL . . . . . 0.438 ' HB ' ' HB1' ' B' ' 183' ' ' ALA . 7.1 p -143.53 147.39 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 C-N-CA 123.282 0.633 . . . . 63.22 111.435 -168.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 64.53 17.29 10.78 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 125.045 1.338 . . . . 15.23 111.908 -174.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 142' ' ' GLY . . . . . 0.517 ' H ' ' HB2' ' B' ' 44' ' ' ALA . . . 87.37 -8.64 76.29 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-N 115.568 -0.742 . . . . 45.25 112.947 -175.515 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 143' ' ' ARG . . . . . 0.432 ' HD3' ' HA ' ' C' ' 143' ' ' ARG . 6.7 mmt180 -101.47 139.94 36.45 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.446 0.641 . . . . 73.04 111.474 -177.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 144' ' ' ARG . . . . . 0.642 ' HG3' ' HG2' ' C' ' 139' ' ' GLU . 59.7 ttt180 -115.45 93.22 4.19 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-N 114.652 -1.158 . . . . 71.51 110.178 -165.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 145' ' ' VAL . . . . . . . . . . . . . 30.3 m -118.79 142.5 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 123.179 0.591 . . . . 75.03 112.001 -172.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 146' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' C' ' 137' ' ' VAL . 20.3 m -95.0 128.97 42.23 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.266 1.026 . . . . 54.21 111.054 -177.256 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 14.4 p -162.75 148.1 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 123.042 0.537 . . . . 72.53 110.663 175.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 29.8 ttm-85 -84.28 117.22 23.41 Favored 'General case' 0 C--N 1.349 0.571 0 N-CA-C 108.994 -0.743 . . . . 74.22 108.994 166.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 149' ' ' ILE . . . . . 0.452 HD13 HD21 ' B' ' 181' ' ' LEU . 42.2 pt -88.36 150.12 46.12 Favored Pre-proline 0 CA--C 1.548 0.878 0 N-CA-C 108.642 -0.873 . . . . 71.41 108.642 172.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -50.02 112.29 0.69 Allowed 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 123.183 2.589 . . . . 61.44 113.236 179.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -61.5 106.35 0.41 Allowed 'Trans proline' 0 C--N 1.383 2.376 0 C-N-CA 122.958 2.439 . . . . 73.2 112.117 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 152' ' ' GLY . . . . . . . . . . . . . . . 129.19 101.53 1.0 Allowed Glycine 0 C--N 1.343 0.922 0 CA-C-N 115.214 -0.903 . . . . 54.32 111.37 -171.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 153' ' ' VAL . . . . . 0.408 HG21 HD23 ' C' ' 125' ' ' LEU . 1.0 OUTLIER -122.77 159.84 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 CA-C-N 117.145 0.472 . . . . 71.13 110.398 -179.042 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 154' ' ' ARG . . . . . 0.624 ' HB2' ' HB2' ' C' ' 157' ' ' SER . 38.6 mtp180 -119.05 121.77 40.61 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.245 1.018 . . . . 75.32 109.105 -171.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 155' ' ' GLU . . . . . 0.712 ' HB3' ' HG2' ' C' ' 187' ' ' ARG . 9.4 tp10 -45.3 122.94 3.73 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.909 0.883 . . . . 74.51 112.45 174.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 87.52 -21.25 22.86 Favored Glycine 0 C--N 1.351 1.403 0 O-C-N 124.425 1.078 . . . . 64.51 113.276 176.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 157' ' ' SER . . . . . 0.624 ' HB2' ' HB2' ' C' ' 154' ' ' ARG . 33.8 m -88.97 -177.92 5.59 Favored 'General case' 0 C--O 1.247 0.962 0 CA-C-O 121.445 0.641 . . . . 75.43 110.733 -172.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 7.2 p -128.11 127.53 67.78 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 CA-C-N 115.48 -0.782 . . . . 64.44 111.587 -173.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 159' ' ' ILE . . . . . 0.597 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 47.9 mt -73.63 139.04 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.673 1.189 . . . . 52.25 109.194 168.109 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 160' ' ' ARG . . . . . 0.492 HH11 ' HD2' ' B' ' 314' ' ' ARG . 30.1 ttt85 -117.38 111.02 18.76 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 109.098 -0.705 . . . . 72.21 109.098 175.332 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 161' ' ' VAL . . . . . 0.619 HG13 ' HB3' ' C' ' 174' ' ' LEU . 1.6 p -106.03 98.93 20.31 Favored Pre-proline 0 CA--C 1.555 1.166 0 N-CA-C 108.295 -1.002 . . . . 75.24 108.295 168.086 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -76.54 140.17 21.14 Favored 'Trans proline' 0 C--N 1.384 2.433 0 C-N-CA 123.07 2.513 . . . . 63.42 112.141 178.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 110.14 -7.84 30.99 Favored Glycine 0 C--N 1.347 1.157 0 CA-C-O 119.817 -0.435 . . . . 53.31 112.455 178.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 164' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -158.13 124.17 4.65 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.959 0.904 . . . . 73.35 109.383 172.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . -125.68 -116.33 2.1 Favored Glycine 0 C--N 1.346 1.123 0 C-N-CA 123.854 0.74 . . . . 64.24 112.474 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 166' ' ' GLY . . . . . 0.576 ' HA3' HD12 ' C' ' 119' ' ' LEU . . . -169.87 -61.52 0.04 OUTLIER Glycine 0 C--N 1.346 1.103 0 C-N-CA 120.21 -0.995 . . . . 75.44 114.653 175.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 167' ' ' GLN . . . . . 0.693 ' HB2' ' HB2' ' C' ' 117' ' ' ARG . 79.7 mm-40 -66.69 98.58 0.53 Allowed 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 117.09 0.445 . . . . 64.31 110.692 -165.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 168' ' ' GLY . . . . . 0.548 ' HA2' ' HA2' ' C' ' 107' ' ' GLY . . . 110.34 -144.25 17.01 Favored Glycine 0 C--O 1.213 -1.173 0 CA-C-O 118.352 -1.249 . . . . 13.44 111.72 -165.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 169' ' ' ASN . . . . . 0.444 ' HB3' ' HD3' ' C' ' 170' ' ' PRO . 17.9 t-20 -150.21 -51.39 0.02 OUTLIER Pre-proline 0 CA--C 1.594 2.659 0 CA-C-N 119.723 1.762 . . . . 62.44 113.291 -177.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 170' ' ' PRO . . . . . 0.444 ' HD3' ' HB3' ' C' ' 169' ' ' ASN . 49.5 Cg_exo -48.59 177.03 0.02 OUTLIER 'Trans proline' 0 N--CA 1.522 3.188 0 C-N-CA 124.359 3.373 . . . . 51.41 116.765 168.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 171' ' ' PRO . . . . . 0.572 ' HA ' ' HA2' ' C' ' 87' ' ' GLY . 1.1 Cg_exo -31.55 119.25 0.08 OUTLIER 'Trans proline' 0 C--N 1.404 3.483 1 C-N-CA 125.417 4.078 . . . . 74.02 117.272 172.969 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -160.56 -172.24 27.56 Favored Glycine 0 C--N 1.356 1.668 0 C-N-CA 124.276 0.941 . . . . 74.42 111.333 177.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 173' ' ' ASP . . . . . 0.484 ' O ' ' HA ' ' C' ' 118' ' ' ASP . 5.8 p-10 -140.79 147.68 39.44 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.718 0.771 . . . . 74.51 111.209 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 174' ' ' LEU . . . . . 0.619 ' HB3' HG13 ' C' ' 161' ' ' VAL . 43.9 tp -97.83 112.63 24.47 Favored 'General case' 0 C--O 1.245 0.849 0 N-CA-C 109.147 -0.686 . . . . 75.22 109.147 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 175' ' ' LEU . . . . . 0.689 HD21 ' HG3' ' B' ' 314' ' ' ARG . 55.7 mt -87.18 112.25 21.78 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.245 -1.343 . . . . 71.32 109.664 174.162 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 176' ' ' LEU . . . . . 0.597 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 57.7 mt -100.41 97.26 8.02 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 109.355 -0.609 . . . . 43.02 109.355 174.044 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 177' ' ' VAL . . . . . . . . . . . . . 17.1 t -83.61 103.36 10.78 Favored 'Isoleucine or valine' 0 C--O 1.253 1.238 0 N-CA-C 107.904 -1.147 . . . . 74.43 107.904 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 178' ' ' VAL . . . . . . . . . . . . . 6.1 m -84.95 117.43 30.19 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 CA-C-N 114.397 -1.274 . . . . 74.01 112.086 -172.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 179' ' ' ARG . . . . . 0.544 ' O ' ' HA ' ' C' ' 124' ' ' PRO . 6.2 mmm180 -105.36 107.77 18.94 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 106.142 -1.799 . . . . 72.33 106.142 166.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 180' ' ' LEU . . . . . 0.618 HD12 ' HB2' ' C' ' 155' ' ' GLU . 58.4 mt -70.12 148.23 48.99 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 122.35 -0.219 . . . . 70.51 110.583 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 181' ' ' LEU . . . . . . . . . . . . . 67.5 mt -54.28 167.03 0.6 Allowed Pre-proline 0 N--CA 1.494 1.75 0 C-N-CA 125.261 1.425 . . . . 74.2 112.434 -176.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -56.64 71.43 0.04 OUTLIER 'Trans proline' 0 C--N 1.387 2.554 0 C-N-CA 123.029 2.486 . . . . 64.12 111.217 163.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 183' ' ' HIS . . . . . 0.41 ' N ' ' HD3' ' C' ' 184' ' ' PRO . 81.2 t60 -179.2 51.91 0.05 OUTLIER Pre-proline 0 CA--C 1.557 1.249 0 C-N-CA 126.768 2.027 . . . . 62.13 106.237 -164.093 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 184' ' ' PRO . . . . . 0.41 ' HD3' ' N ' ' C' ' 183' ' ' HIS . 61.5 Cg_endo -92.18 65.19 0.87 Allowed 'Trans proline' 0 C--N 1.386 2.537 0 C-N-CA 123.046 2.498 . . . . 71.54 110.662 -170.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 185' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 12.4 t -93.37 -33.86 5.52 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.41 0 CA-C-N 115.284 -0.871 . . . . 72.23 109.035 -171.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 186' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -127.79 106.0 8.83 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 118.809 0.732 . . . . 61.44 111.93 -175.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 187' ' ' ARG . . . . . 0.712 ' HG2' ' HB3' ' C' ' 155' ' ' GLU . 1.6 tmt_? -95.26 116.59 28.95 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 107.352 -1.351 . . . . 75.14 107.352 169.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 188' ' ' LEU . . . . . 0.482 HD13 ' HD2' ' C' ' 240' ' ' PHE . 65.3 tp -80.74 138.89 36.32 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 122.917 0.487 . . . . 74.14 111.762 -178.045 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -142.6 113.09 7.28 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 106.548 -1.649 . . . . 71.33 106.548 169.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 73.92 -109.44 2.8 Favored Glycine 0 N--CA 1.474 1.177 0 N-CA-C 111.413 -0.675 . . . . 74.2 111.413 -170.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 191' ' ' GLN . . . . . 0.455 ' HA ' HD11 ' C' ' 188' ' ' LEU . 78.5 mt-30 -123.85 7.0 8.7 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 123.564 0.745 . . . . 60.21 109.085 167.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 192' ' ' ASP . . . . . 0.481 ' HB3' ' HE1' ' C' ' 250' ' ' TYR . 3.8 m-20 -95.63 142.74 27.59 Favored 'General case' 0 C--N 1.344 0.351 0 C-N-CA 125.176 1.391 . . . . 65.13 109.188 -172.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 193' ' ' LEU . . . . . 0.472 HD21 ' CD2' ' C' ' 240' ' ' PHE . 86.7 mt -112.45 142.34 45.11 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.587 0.355 . . . . 52.2 110.777 -178.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 194' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -108.97 128.05 54.6 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 108.17 -1.048 . . . . 75.43 108.17 165.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 195' ' ' ALA . . . . . 0.584 ' HB3' ' HG ' ' C' ' 251' ' ' LEU . . . -127.03 -178.19 4.32 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.404 0.682 . . . . 65.11 110.768 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 33.0 m -135.54 111.03 9.14 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 107.675 -1.231 . . . . 51.32 107.675 169.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 197' ' ' LEU . . . . . 0.462 HD13 ' HB2' ' C' ' 212' ' ' ALA . 42.2 tp -88.92 136.89 32.77 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 123.436 0.694 . . . . 73.5 110.055 176.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -92.4 117.32 29.8 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 108.616 -0.883 . . . . 44.52 108.616 173.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 199' ' ' VAL . . . . . 0.581 ' HA ' HG11 ' C' ' 210' ' ' VAL . 21.4 t -125.6 106.57 26.7 Favored Pre-proline 0 CA--C 1.544 0.728 0 N-CA-C 108.09 -1.078 . . . . 61.21 108.09 176.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 200' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -67.76 141.69 55.29 Favored 'Trans proline' 0 C--N 1.369 1.613 0 C-N-CA 121.737 1.625 . . . . 71.34 111.33 176.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 201' ' ' ALA . . . . . . . . . . . . . . . -42.65 -49.16 13.3 Favored Pre-proline 0 CA--C 1.559 1.313 0 C-N-CA 125.498 1.519 . . . . 74.35 114.507 -176.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 202' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -55.34 -52.04 8.65 Favored 'Trans proline' 0 C--N 1.388 2.611 0 C-N-CA 121.558 1.505 . . . . 63.15 112.95 175.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 203' ' ' ILE . . . . . 0.483 ' HA ' HG12 ' C' ' 206' ' ' VAL . 53.0 mt -63.45 -34.57 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 122.885 0.474 . . . . 63.4 111.022 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -62.7 -43.27 99.24 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.79 0.836 . . . . 75.02 111.522 178.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 205' ' ' VAL . . . . . 0.48 ' HA ' ' H ' ' C' ' 226' ' ' ARG . 88.5 t -79.29 -34.12 16.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 115.842 -0.617 . . . . 63.41 112.097 -176.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 206' ' ' VAL . . . . . 0.659 HG23 ' HG3' ' A' ' 270' ' ' LYS . 9.9 p -80.24 -32.05 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 122.183 0.193 . . . . 52.12 111.04 -177.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 79.48 56.32 3.42 Favored Glycine 0 C--N 1.336 0.582 0 N-CA-C 111.366 -0.694 . . . . 63.21 111.366 -171.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -92.84 -124.21 3.53 Favored Glycine 0 C--N 1.34 0.786 0 N-CA-C 111.104 -0.798 . . . . 51.32 111.104 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 209' ' ' LYS . . . . . 0.554 ' HB3' ' HG2' ' C' ' 220' ' ' GLU . 40.5 mtmt -148.0 149.35 31.99 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.399 0.679 . . . . 72.12 111.074 176.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 210' ' ' VAL . . . . . 0.581 HG11 ' HA ' ' C' ' 199' ' ' VAL . 15.8 m -137.76 141.68 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-N 114.546 -1.206 . . . . 62.05 108.753 174.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 211' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.73 110.54 19.4 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.264 0.626 . . . . 72.44 111.013 -176.062 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 212' ' ' ALA . . . . . 0.462 ' HB2' HD13 ' C' ' 197' ' ' LEU . . . -90.46 113.56 25.54 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 107.742 -1.207 . . . . 74.43 107.742 165.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 213' ' ' MET . . . . . . . . . . . . . 6.8 tmm? -71.62 132.45 44.64 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 107.79 -1.189 . . . . 63.12 107.79 176.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 214' ' ' THR . . . . . 0.444 ' OG1' HG12 ' C' ' 219' ' ' VAL . 0.2 OUTLIER -127.19 175.18 8.34 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.008 0.523 . . . . 54.24 110.68 -176.93 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 215' ' ' LEU . . . . . . . . . . . . . 20.3 mt -68.17 -23.31 64.85 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.12 0.968 . . . . 44.41 112.074 -172.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -87.36 -26.83 23.16 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 114.684 -1.144 . . . . 71.0 109.735 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 141.47 179.44 18.64 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 109.403 -1.479 . . . . 64.11 109.403 -168.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -75.15 119.11 5.47 Favored 'Trans proline' 0 CA--C 1.559 1.735 0 C-N-CA 122.561 2.174 . . . . 52.13 113.481 -175.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 219' ' ' VAL . . . . . 0.456 HG23 HG22 ' B' ' 238' ' ' THR . 8.6 p -91.66 125.32 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 N-CA-C 108.253 -1.018 . . . . 52.53 108.253 169.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 220' ' ' GLU . . . . . 0.554 ' HG2' ' HB3' ' C' ' 209' ' ' LYS . 15.6 tt0 -90.53 106.33 18.43 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.874 0.845 . . . . 72.32 108.757 177.248 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 221' ' ' VAL . . . . . . . . . . . . . 71.0 t -72.64 126.39 33.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 113.807 -1.542 . . . . 74.03 111.972 -174.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -72.6 117.33 14.15 Favored 'General case' 0 CA--C 1.549 0.919 0 O-C-N 124.314 1.009 . . . . 73.3 110.306 169.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 90.9 t -91.35 140.93 25.68 Favored Pre-proline 0 CA--C 1.555 1.157 0 C-N-CA 124.514 1.125 . . . . 73.11 109.794 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 224' ' ' PRO . . . . . 0.543 ' HG3' HH22 ' C' ' 231' ' ' ARG . 87.3 Cg_endo -81.03 147.54 16.66 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 123.172 2.581 . . . . 54.33 112.089 167.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 225' ' ' PRO . . . . . 0.487 ' HG2' HG23 ' B' ' 246' ' ' THR . 86.7 Cg_exo -52.45 132.45 44.95 Favored 'Trans proline' 0 C--N 1.372 1.793 0 C-N-CA 122.417 2.078 . . . . 74.0 112.793 169.148 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 226' ' ' ARG . . . . . 0.79 HH22 HD13 ' B' ' 97' ' ' ILE . 0.0 OUTLIER 51.31 85.6 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 126.279 1.832 . . . . 70.15 112.583 -171.703 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 227' ' ' THR . . . . . 0.531 HG22 HG11 ' C' ' 253' ' ' VAL . 90.4 m -101.11 130.79 47.21 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 114.406 -1.27 . . . . 70.3 109.854 174.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 228' ' ' GLN . . . . . 0.535 ' NE2' ' HD2' ' C' ' 231' ' ' ARG . 3.6 mp0 -95.4 147.39 23.57 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.499 1.12 . . . . 74.32 111.978 -176.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -72.76 124.25 24.96 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 114.989 -1.005 . . . . 62.12 109.209 173.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 108.32 -9.76 36.03 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-O 119.641 -0.533 . . . . 62.04 112.526 -172.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 231' ' ' ARG . . . . . 0.543 HH22 ' HG3' ' C' ' 224' ' ' PRO . 34.3 mtp180 -64.35 169.92 4.27 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 117.616 0.708 . . . . 74.12 110.465 169.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 232' ' ' LYS . . . . . 0.45 ' HA ' ' O ' ' C' ' 251' ' ' LEU . 33.6 ttmt -142.92 136.96 29.11 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.226 0.536 . . . . 71.45 110.552 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 233' ' ' LEU . . . . . 0.739 HD13 ' HB2' ' C' ' 251' ' ' LEU . 4.0 mp -98.01 145.92 26.02 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 114.478 -1.237 . . . . 74.21 109.759 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 11.5 ptp85 -110.02 90.9 3.45 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 124.628 1.205 . . . . 72.34 108.183 163.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 235' ' ' LEU . . . . . 0.438 HD12 HD23 ' C' ' 249' ' ' LEU . 24.8 mt -78.25 95.95 5.12 Favored 'General case' 0 C--N 1.352 0.686 0 N-CA-C 107.407 -1.331 . . . . 73.43 107.407 169.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -70.75 125.71 27.57 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 114.516 -1.22 . . . . 71.55 111.594 -171.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 75.72 29.23 59.73 Favored Glycine 0 C--N 1.348 1.22 0 O-C-N 123.867 0.73 . . . . 71.42 112.423 -176.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -124.34 17.02 9.04 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.279 0.631 . . . . 72.03 110.535 176.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -77.53 -165.44 24.88 Favored Glycine 0 C--N 1.359 1.811 0 N-CA-C 110.893 -0.883 . . . . 31.21 110.893 167.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 240' ' ' PHE . . . . . 0.482 ' HD2' HD13 ' C' ' 188' ' ' LEU . 1.2 m-85 -70.67 127.29 92.05 Favored Pre-proline 0 C--O 1.257 1.472 0 CA-C-N 118.061 0.93 . . . . 75.14 108.959 176.355 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 241' ' ' PRO . . . . . 0.444 ' HA ' ' HB3' ' C' ' 246' ' ' ARG . 32.0 Cg_exo -61.47 94.94 0.12 Allowed 'Trans proline' 0 C--N 1.385 2.459 0 C-N-CA 123.553 2.836 . . . . 70.21 113.171 177.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 242' ' ' GLY . . . . . 0.517 ' H ' ' HA ' ' C' ' 246' ' ' ARG . . . -77.56 137.94 20.96 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-N 113.838 -1.528 . . . . 70.14 112.126 -179.159 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 243' ' ' PRO . . . . . 0.553 ' HG2' ' HA ' ' B' ' 304' ' ' PRO . 57.9 Cg_endo -68.47 -9.32 25.66 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 123.152 2.568 . . . . 71.42 113.804 -176.175 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -120.78 23.09 10.91 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.393 0.677 . . . . 71.42 110.576 176.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 115.31 143.85 8.14 Favored Glycine 0 C--N 1.341 0.83 0 N-CA-C 109.951 -1.26 . . . . 51.32 109.951 -171.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 246' ' ' ARG . . . . . 0.517 ' HA ' ' H ' ' C' ' 242' ' ' GLY . 15.3 ptp180 -99.42 170.84 8.34 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 118.01 0.905 . . . . 61.31 112.395 -171.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -92.38 -164.92 38.51 Favored Glycine 0 C--N 1.35 1.356 0 CA-C-N 114.932 -1.031 . . . . 63.23 113.581 177.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -130.35 148.11 52.14 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.08 0.952 . . . . 73.54 109.055 -172.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 249' ' ' LEU . . . . . 0.438 HD23 HD12 ' C' ' 235' ' ' LEU . 22.8 tp -101.24 137.16 39.95 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.903 0.881 . . . . 74.23 110.611 -175.101 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 250' ' ' TYR . . . . . 0.589 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 59.3 m-85 -127.46 101.56 6.49 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.443 1.097 . . . . 71.43 109.265 -176.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 251' ' ' LEU . . . . . 0.739 ' HB2' HD13 ' C' ' 233' ' ' LEU . 1.2 mp -101.33 139.13 37.42 Favored 'General case' 0 N--CA 1.508 2.442 0 CA-C-N 118.138 0.426 . . . . 64.53 110.923 -175.197 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -80.09 138.99 37.06 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 108.953 -0.758 . . . . 73.41 108.953 168.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 253' ' ' VAL . . . . . 0.531 HG11 HG22 ' C' ' 227' ' ' THR . 99.0 t -87.29 128.14 40.12 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 CA-C-O 121.079 0.466 . . . . 73.5 111.214 176.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 254' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 -110.18 111.67 23.16 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.465 1.106 . . . . 74.13 108.828 167.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 255' ' ' ILE . . . . . 0.502 ' O ' ' HB ' ' A' ' 255' ' ' ILE . 33.8 mm -80.84 120.51 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 N-CA-C 108.294 -1.002 . . . . 75.24 108.294 171.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 256' ' ' THR . . . . . 0.537 HG22 ' HB3' ' A' ' 229' ' ' ALA . 46.4 p -120.34 -172.78 2.43 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.672 0.789 . . . . 53.32 111.257 -173.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 2.7 pp -141.45 148.79 52.02 Favored Pre-proline 0 N--CA 1.489 1.477 0 C-N-CA 123.39 0.676 . . . . 64.54 110.196 178.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -61.26 -7.69 8.86 Favored 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 123.372 2.715 . . . . 73.21 114.684 -174.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 57.12 -78.35 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.908 1.283 . . . . 72.3 110.846 -166.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 22.5 ptt-85 -60.35 136.58 58.08 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 124.23 1.012 . . . . 73.41 110.26 177.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 261' ' ' LEU . . . . . 0.494 HD22 ' HB3' ' C' ' 265' ' ' GLU . 94.8 mt -143.34 148.21 35.91 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.58 0.752 . . . . 71.21 109.65 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 262' ' ' THR . . . . . 0.467 ' OG1' ' HG2' ' C' ' 265' ' ' GLU . 36.4 p -84.31 162.42 51.39 Favored Pre-proline 0 CA--C 1.548 0.898 0 N-CA-C 108.417 -0.957 . . . . 61.23 108.417 167.506 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -53.4 -35.84 76.94 Favored 'Trans proline' 0 C--N 1.374 1.881 0 C-N-CA 122.267 1.978 . . . . 74.2 114.202 175.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -66.43 -48.11 71.07 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 122.381 0.272 . . . . 71.04 110.514 178.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 265' ' ' GLU . . . . . 0.494 ' HB3' HD22 ' C' ' 261' ' ' LEU . 33.2 mm-40 -52.57 -51.33 60.27 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 123.612 0.57 . . . . 65.11 109.633 175.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 266' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -54.43 -41.57 69.54 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 114.354 -1.294 . . . . 64.21 110.627 -177.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 267' ' ' ALA . . . . . 0.447 ' O ' ' HG3' ' C' ' 271' ' ' LYS . . . -62.13 -46.0 90.95 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.731 -0.668 . . . . 70.32 111.573 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 268' ' ' LEU . . . . . 0.443 ' HB2' HD21 ' A' ' 272' ' ' LEU . 10.4 mp -66.33 -41.94 88.91 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 111.591 0.219 . . . . 52.44 111.591 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -63.48 -33.11 74.86 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 122.988 0.515 . . . . 61.11 111.141 176.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 270' ' ' LYS . . . . . 0.456 ' O ' ' HG2' ' C' ' 274' ' ' GLU . 4.2 mmmp? -61.04 -48.92 79.52 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.631 0.772 . . . . 75.43 110.076 173.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 271' ' ' LYS . . . . . 0.447 ' HG3' ' O ' ' C' ' 267' ' ' ALA . 63.2 mttm -58.55 -43.76 89.41 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.72 0.808 . . . . 75.33 111.568 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 91.2 mt -61.63 -40.36 94.59 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.368 -0.833 . . . . 74.33 110.404 176.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -64.38 -34.69 78.75 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 115.522 -0.763 . . . . 34.13 110.822 177.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 274' ' ' GLU . . . . . 0.456 ' HG2' ' O ' ' C' ' 270' ' ' LYS . 13.5 mm-40 -67.58 -40.3 84.85 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.127 0.571 . . . . 63.21 109.702 177.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -61.71 -30.84 71.02 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.457 0.703 . . . . 70.04 110.662 174.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 276' ' ' TYR . . . . . 0.551 ' HA ' ' HD3' ' C' ' 279' ' ' ARG . 9.6 m-85 -77.27 -31.6 55.0 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.069 -0.968 . . . . 75.52 112.733 172.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -76.3 -19.13 58.56 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 118.526 0.603 . . . . 44.24 110.198 175.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -69.13 -16.58 63.69 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.331 0.652 . . . . 55.2 110.538 169.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 279' ' ' ARG . . . . . 0.551 ' HD3' ' HA ' ' C' ' 276' ' ' TYR . 16.3 mtp-105 -83.52 -14.81 51.46 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.155 0.582 . . . . 71.52 110.978 173.061 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.085 -0.96 . . . . 75.14 110.338 -179.233 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 79.8 mtp . . . . . 0 N--CA 1.476 0.844 0 N-CA-C 111.152 0.056 . . . . 64.12 111.152 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.47 42.99 8.26 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.956 0.902 . . . . 51.4 112.285 170.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -70.54 75.83 0.57 Allowed 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.559 0.744 . . . . 74.04 110.493 177.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.9 ttmp? -38.91 110.02 0.12 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 126.064 1.746 . . . . 62.43 114.472 -174.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -100.26 114.49 27.98 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 123.546 0.739 . . . . 74.32 109.071 164.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.502 ' HA ' ' OH ' ' A' ' 66' ' ' TYR . 23.9 t70 -82.46 102.94 11.65 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 107.729 -1.211 . . . . 61.41 107.729 168.122 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.434 ' HD1' HD12 ' A' ' 10' ' ' ILE . 32.4 m-85 -64.08 -30.44 71.51 Favored 'General case' 0 C--O 1.244 0.811 0 CA-C-N 115.576 -0.738 . . . . 73.34 112.131 -171.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.428 ' CD1' HD11 ' A' ' 22' ' ' ILE . 64.9 m-85 -62.04 -44.34 96.89 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 122.851 0.46 . . . . 73.33 110.394 174.109 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.94 -41.84 97.49 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.285 0.634 . . . . 60.32 111.229 178.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.434 HD12 ' HD1' ' A' ' 7' ' ' TYR . 65.1 mt -55.77 -43.28 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 123.469 0.707 . . . . 74.23 110.976 176.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.6 mt -79.62 -14.12 59.03 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 112.936 0.717 . . . . 51.33 112.936 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.39 36.65 59.25 Favored Glycine 0 C--N 1.351 1.378 0 O-C-N 123.026 0.204 . . . . 53.33 113.485 -176.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.3 m -119.93 157.33 52.96 Favored Pre-proline 0 N--CA 1.482 1.175 0 C-N-CA 124.764 1.226 . . . . 71.43 109.164 175.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.502 ' HG2' ' HB2' ' A' ' 17' ' ' ALA . 12.2 Cg_endo -55.93 153.1 33.05 Favored 'Trans proline' 0 C--N 1.388 2.645 0 C-N-CA 122.771 2.314 . . . . 50.12 112.508 177.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 72.3 mtp180 -81.63 59.53 4.19 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.113 0.965 . . . . 75.43 111.411 -170.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 176.37 -27.96 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.643 1.177 . . . . 64.11 109.273 -168.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.502 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . . . -37.64 138.01 0.4 Allowed 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 126.864 2.065 . . . . 64.31 114.897 -171.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.9 p -61.67 162.26 8.76 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 124.6 1.16 . . . . 71.11 112.455 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -56.05 -35.93 67.47 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.118 0.967 . . . . 64.21 112.279 -175.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.51 -29.49 61.43 Favored 'General case' 0 C--O 1.209 -1.058 0 CA-C-O 118.939 -0.553 . . . . 72.43 110.654 -177.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -69.67 -39.0 77.27 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 118.516 0.598 . . . . 64.03 110.005 173.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.428 HD11 ' CD1' ' A' ' 8' ' ' TYR . 1.6 mp -61.86 -40.91 88.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 C-N-CA 124.199 1.0 . . . . 73.31 110.345 172.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.677 ' HE2' ' HA ' ' B' ' 95' ' ' LYS . 3.8 ttpm? -80.32 -25.76 39.15 Favored 'General case' 0 C--O 1.213 -0.844 0 CA-C-N 114.491 -1.231 . . . . 71.24 110.197 -174.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.454 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 73.5 mtp180 -78.07 -34.85 50.1 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.484 0.714 . . . . 54.12 109.918 173.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.78 -34.36 73.65 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 123.893 0.746 . . . . 64.0 109.982 173.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -63.96 -60.23 3.51 Favored 'General case' 0 C--O 1.209 -1.068 0 CA-C-N 115.672 -0.695 . . . . 73.1 109.533 172.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.454 ' HE3' ' HA ' ' A' ' 24' ' ' ARG . 51.6 mtmt -53.87 -38.2 64.48 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 124.31 1.044 . . . . 74.22 110.686 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.2 ttt180 -59.37 -57.91 10.93 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.521 1.128 . . . . 71.15 110.956 176.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.602 ' HB3' HD13 ' A' ' 50' ' ' ILE . 84.7 mt -76.81 -11.69 59.87 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.702 0.801 . . . . 74.11 111.18 -177.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.06 -20.44 24.36 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.909 0.884 . . . . 63.3 110.535 178.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 75.4 mtm180 -95.68 -31.9 13.02 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.052 0.541 . . . . 72.33 110.673 171.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -77.03 -55.0 5.83 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 108.981 -0.748 . . . . 63.33 108.981 -178.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -93.47 33.55 1.24 Allowed 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 115.879 -0.601 . . . . 63.25 110.531 173.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 7.9 t-80 -61.28 107.75 1.23 Allowed Pre-proline 0 C--N 1.357 0.912 0 N-CA-C 108.564 -0.902 . . . . 63.41 108.564 177.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -57.87 -19.32 38.84 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 122.976 2.451 . . . . 74.13 113.086 -169.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -63.42 -42.69 98.73 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.685 1.194 . . . . 72.45 112.704 178.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.5 t -105.09 -37.46 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 123.173 0.589 . . . . 65.53 109.984 -177.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -98.09 68.13 1.95 Allowed 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 122.634 1.207 . . . . 61.35 108.51 178.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt -79.6 75.88 6.24 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 113.827 -1.533 . . . . 73.11 109.282 -178.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.8 m -135.55 108.29 10.12 Favored Pre-proline 0 N--CA 1.467 0.422 0 CA-C-O 118.124 -0.941 . . . . 54.41 108.622 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -39.31 -45.31 3.03 Favored 'Trans proline' 0 C--N 1.387 2.569 0 C-N-CA 124.23 3.287 . . . . 72.23 114.248 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -56.22 -46.93 79.33 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.408 0.683 . . . . 64.43 111.343 178.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.5 -16.96 61.78 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.527 0.731 . . . . 72.14 111.623 -178.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -92.07 -30.72 15.87 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.532 0.733 . . . . 62.01 110.428 -176.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -72.23 -36.62 69.16 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 109.417 -0.586 . . . . 62.44 109.417 168.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -62.84 -41.28 99.27 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 116.058 -0.519 . . . . 74.03 109.834 170.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.625 ' HA ' HD12 ' A' ' 50' ' ' ILE . 52.1 t80 -63.64 -31.56 72.77 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.583 0.753 . . . . 73.24 110.716 176.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -63.64 -45.14 91.56 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 122.567 0.347 . . . . 75.14 110.975 171.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -65.63 -25.87 67.57 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 111.821 0.304 . . . . 71.44 111.821 178.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.625 HD12 ' HA ' ' A' ' 47' ' ' PHE . 66.1 mt -74.78 -39.28 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 123.847 0.859 . . . . 70.53 110.103 172.315 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.438 ' HB3' ' HD1' ' A' ' 88' ' ' PHE . 94.4 m-20 -71.07 -23.56 62.16 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.684 0.793 . . . . 73.43 110.911 176.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -76.05 -53.35 8.49 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.593 1.557 . . . . 63.42 109.626 177.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.06 -47.19 78.4 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 113.928 -1.487 . . . . 65.45 110.417 176.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -68.87 -37.05 78.82 Favored 'General case' 0 C--O 1.207 -1.14 0 CA-C-N 114.64 -1.164 . . . . 72.32 110.928 176.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -51.93 -53.81 36.78 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 118.658 0.663 . . . . 53.01 110.462 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.477 HG13 ' HZ ' ' A' ' 101' ' ' PHE . 47.0 t -64.1 -55.93 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 113.866 -1.515 . . . . 74.52 110.273 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 78.1 mt -81.61 2.03 31.2 Favored 'General case' 0 CA--C 1.556 1.183 0 N-CA-C 113.745 1.017 . . . . 62.04 113.745 -169.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.0 t -80.19 -75.14 0.27 Allowed 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 109.215 -0.661 . . . . 74.34 109.215 174.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -68.86 116.95 46.5 Favored Pre-proline 0 C--O 1.239 0.549 0 CA-C-O 118.651 -0.69 . . . . 74.34 109.392 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -49.88 -28.0 17.27 Favored 'Trans proline' 0 C--N 1.388 2.621 0 C-N-CA 124.069 3.179 . . . . 72.41 114.294 -175.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -60.34 -62.73 1.65 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.704 0.802 . . . . 72.3 110.735 175.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.448 ' HA ' HD12 ' A' ' 65' ' ' ILE . 29.6 mtmm -64.28 -33.12 75.09 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.176 0.591 . . . . 74.54 110.737 -177.221 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 22.3 ttt85 -61.83 -45.76 92.45 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.065 -0.971 . . . . 74.11 110.703 176.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -70.65 -28.25 64.65 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 119.279 -0.391 . . . . 74.25 111.262 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.448 HD12 ' HA ' ' A' ' 62' ' ' LYS . 73.2 mt -53.24 -52.8 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 N-CA-C 108.86 -0.793 . . . . 64.42 108.86 168.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.502 ' OH ' ' HA ' ' A' ' 6' ' ' ASP . 55.9 t80 -61.97 -52.01 65.76 Favored 'General case' 0 CA--C 1.556 1.179 0 CA-C-N 114.561 -1.2 . . . . 75.4 112.004 178.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -56.37 -40.54 74.73 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.135 0.974 . . . . 64.04 111.848 -175.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 58.6 p -80.35 -22.55 41.31 Favored 'General case' 0 C--O 1.215 -0.728 0 CA-C-N 115.498 -0.774 . . . . 75.13 111.07 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -66.45 109.23 2.66 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 118.909 0.777 . . . . 63.45 108.934 176.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 113.18 13.29 10.98 Favored Glycine 0 CA--C 1.537 1.429 0 CA-C-N 115.337 -0.847 . . . . 52.54 111.565 -166.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 50.7 m -148.4 -61.08 0.25 Allowed 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 103.986 -2.598 . . . . 71.23 103.986 176.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 61.8 m -75.83 139.87 41.97 Favored 'General case' 0 C--O 1.248 1.005 0 N-CA-C 104.549 -2.389 . . . . 74.23 104.549 155.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.14 -25.8 7.94 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 122.792 0.437 . . . . 74.04 111.179 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.08 132.51 90.18 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 123.851 0.86 . . . . 75.1 110.597 176.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -55.51 141.95 81.88 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 122.74 2.294 . . . . 75.41 111.252 168.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -57.72 149.93 65.27 Favored 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 123.501 2.801 . . . . 74.25 113.009 -173.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -66.2 170.81 11.25 Favored 'Trans proline' 0 C--N 1.383 2.393 0 C-N-CA 124.095 3.197 . . . . 62.44 113.742 -173.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -33.71 127.58 0.16 Allowed 'Trans proline' 0 C--N 1.401 3.304 0 C-N-CA 124.818 3.679 . . . . 43.51 114.404 174.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.569 ' HG3' ' HA3' ' A' ' 104' ' ' GLY . 42.2 Cg_endo -77.92 119.8 4.84 Favored 'Trans proline' 0 CA--C 1.559 1.73 0 C-N-CA 123.277 2.651 . . . . 71.05 113.049 -165.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.423 ' HB2' ' HB2' ' B' ' 84' ' ' ARG . 72.0 Cg_endo -73.09 76.23 2.63 Favored 'Trans proline' 0 CA--C 1.554 1.511 0 C-N-CA 122.592 2.195 . . . . 51.35 112.746 -178.299 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 115.22 0.96 22.25 Favored Glycine 0 C--N 1.347 1.152 0 CA-C-N 115.075 -0.966 . . . . 62.41 112.002 -176.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.74 147.14 12.31 Favored Glycine 0 C--N 1.352 1.436 0 N-CA-C 110.713 -0.955 . . . . 53.03 110.713 -167.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -65.53 100.62 0.52 Allowed 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 118.349 1.074 . . . . 74.41 109.029 172.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -54.1 139.75 34.14 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.496 1.118 . . . . 71.31 112.519 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.486 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 65.2 m-85 -143.48 72.85 1.37 Allowed 'General case' 0 N--CA 1.47 0.55 0 O-C-N 124.136 0.897 . . . . 70.22 109.682 171.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 18.2 m -52.7 86.7 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 125.509 1.524 . . . . 74.44 112.68 -179.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.781 ' H ' ' HA3' ' A' ' 163' ' ' GLY . . . 80.7 1.39 89.2 Favored Glycine 0 C--N 1.34 0.767 0 CA-C-N 115.858 -0.61 . . . . 70.11 112.853 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.486 ' HB2' ' HB3' ' A' ' 85' ' ' PHE . 17.4 m-85 -97.24 114.29 26.01 Favored 'General case' 0 C--N 1.344 0.365 0 N-CA-C 107.727 -1.212 . . . . 72.34 107.727 -176.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -80.22 80.92 6.58 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.245 0.545 . . . . 71.44 110.191 -174.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.63 HG21 HD22 ' A' ' 105' ' ' LEU . 1.6 p -42.31 -39.42 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 125.413 1.485 . . . . 75.21 112.936 174.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -57.23 -33.36 67.47 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.008 0.923 . . . . 75.33 112.714 -176.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -105.32 11.6 32.66 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.236 0.541 . . . . 45.35 111.69 -178.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 17.2 m-30 -90.33 173.84 7.9 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 121.967 -0.458 . . . . 71.01 109.881 174.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 86.0 p -65.72 157.89 28.96 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 113.631 0.974 . . . . 74.5 113.631 -167.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.45 -42.77 96.82 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.345 1.058 . . . . 74.31 111.633 176.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -55.63 -49.93 71.52 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.092 0.957 . . . . 75.03 111.2 177.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.526 ' HE2' HG23 ' A' ' 90' ' ' VAL . 37.7 t80 -60.01 -42.84 95.17 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.443 -1.253 . . . . 63.23 110.584 176.09 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -78.27 -4.35 47.42 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.325 -0.852 . . . . 73.05 112.415 -178.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -102.34 -34.05 9.34 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.038 0.535 . . . . 70.02 111.286 169.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 41.6 tp -65.81 -52.13 53.25 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.223 0.609 . . . . 55.03 109.56 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.477 ' HZ ' HG13 ' A' ' 56' ' ' VAL . 88.8 m-85 -92.86 -0.49 57.23 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.529 -0.76 . . . . 72.11 110.745 174.151 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.402 ' N ' ' HD2' ' A' ' 103' ' ' PRO . . . -42.78 -56.65 4.27 Favored Glycine 0 C--N 1.353 1.509 0 CA-C-O 118.213 -1.326 . . . . 72.43 115.188 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.402 ' HD2' ' N ' ' A' ' 102' ' ' GLY . 4.8 Cg_exo -34.76 -32.49 0.07 OUTLIER 'Trans proline' 0 C--N 1.395 3.024 1 C-N-CA 125.697 4.264 . . . . 23.1 115.263 177.17 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.569 ' HA3' ' HG3' ' A' ' 79' ' ' PRO . . . -152.94 49.21 0.52 Allowed Glycine 0 C--N 1.351 1.4 0 C-N-CA 120.547 -0.835 . . . . 44.4 113.786 179.007 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.63 HD22 HG21 ' A' ' 90' ' ' VAL . 29.7 mt -58.22 79.61 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 112.444 0.535 . . . . 74.25 112.444 171.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.51 ' HD1' ' H ' ' A' ' 108' ' ' GLY . 0.1 OUTLIER 42.27 -110.29 0.14 Allowed 'General case' 0 CA--C 1.559 1.326 0 C-N-CA 126.514 1.925 . . . . 72.25 112.819 -179.751 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 70.24 -0.66 23.01 Favored Glycine 0 C--N 1.362 2.011 0 CA-C-N 118.27 0.486 . . . . 44.0 113.663 -172.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.51 ' H ' ' HD1' ' A' ' 106' ' ' PHE . . . 62.63 -109.56 2.73 Favored Glycine 0 C--N 1.352 1.417 0 N-CA-C 112.26 -0.336 . . . . 71.34 112.26 -172.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -126.83 15.67 7.45 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.905 0.882 . . . . 64.11 109.725 176.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -89.34 -23.83 33.12 Favored Glycine 0 C--N 1.346 1.091 0 CA-C-N 115.77 -0.65 . . . . 55.25 112.853 179.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 17.1 tpp180 70.47 -22.59 0.17 Allowed 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 125.55 1.54 . . . . 71.44 113.238 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.13 -12.15 60.79 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.859 0.864 . . . . 73.25 112.156 -173.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 59.6 m 66.34 67.52 0.45 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.436 1.095 . . . . 74.21 110.209 -173.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -73.82 159.53 32.75 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 114.669 -1.151 . . . . 74.52 110.823 -178.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.524 ' HA ' ' HD2' ' A' ' 170' ' ' PRO . 8.0 tmtm? -87.36 123.63 32.52 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 107.226 -1.398 . . . . 72.15 107.226 168.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -73.71 148.71 40.51 Favored Glycine 0 CA--C 1.531 1.086 0 O-C-N 123.373 0.421 . . . . 55.22 113.335 -175.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.417 ' H ' ' HA3' ' A' ' 166' ' ' GLY . 8.0 tmm_? -114.79 155.6 26.43 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 124.081 0.952 . . . . 71.34 110.349 -175.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -58.37 131.42 50.64 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 123.731 0.813 . . . . 74.23 111.694 -178.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.2 tt -145.63 164.77 30.69 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 108.566 -0.901 . . . . 70.23 108.566 -172.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.483 ' NH2' HH21 ' A' ' 179' ' ' ARG . 60.1 ttt180 -129.54 139.22 51.59 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.62 -0.881 . . . . 74.51 108.62 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -135.61 151.51 50.33 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.642 0.777 . . . . 41.51 108.994 177.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.525 ' H ' ' HB3' ' B' ' 9' ' ' ALA . 13.0 mm-40 -102.18 133.78 46.5 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 107.119 -1.437 . . . . 61.0 107.119 -177.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.456 ' HA ' HD12 ' B' ' 8' ' ' LEU . 39.7 tp -102.54 95.15 5.74 Favored Pre-proline 0 CA--C 1.544 0.743 0 N-CA-C 107.991 -1.114 . . . . 54.05 107.991 179.034 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.536 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 52.6 Cg_endo -72.39 112.73 3.52 Favored 'Trans proline' 0 C--N 1.384 2.42 0 C-N-CA 121.532 1.488 . . . . 75.33 109.085 174.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.669 ' HA ' HG21 ' B' ' 6' ' ' ILE . 42.0 tp -123.79 137.49 54.67 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.243 0.544 . . . . 64.01 110.862 -166.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 17.3 m -75.78 133.85 40.58 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 114.984 -1.007 . . . . 71.34 109.72 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 49.5 mt -49.69 -44.01 47.76 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 124.656 1.183 . . . . 70.54 112.103 -169.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -57.58 -54.07 50.97 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.009 -0.996 . . . . 75.32 110.518 -176.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -57.8 -40.29 79.55 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 115.719 -0.673 . . . . 64.33 110.788 177.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -58.76 -48.85 79.79 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 124.291 0.994 . . . . 41.43 112.246 -176.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -74.15 -41.02 62.19 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 123.274 0.359 . . . . 74.51 111.717 -177.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -68.53 -43.54 76.51 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 120.79 0.328 . . . . 75.25 110.87 -178.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.423 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 76.21 177.57 43.44 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-N 115.418 -0.81 . . . . 71.54 113.802 178.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 109.48 -152.41 17.14 Favored Glycine 0 C--N 1.34 0.783 0 C-N-CA 123.48 0.562 . . . . 70.42 112.178 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -77.31 111.52 13.05 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.653 0.781 . . . . 73.14 111.115 -178.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 4.4 tpm_? -101.09 124.12 46.31 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 123.919 0.888 . . . . 74.4 109.81 176.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.0 t -84.33 109.5 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 123.959 0.904 . . . . 71.24 109.308 177.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.9 p -129.56 131.07 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.335 1.054 . . . . 73.14 108.881 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 144' ' ' ARG . 39.3 tt0 -113.93 142.45 46.11 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.035 0.445 . . . . 71.3 110.911 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.7 p -155.31 127.83 1.06 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.59 0 C-N-CA 124.4 1.08 . . . . 75.1 108.622 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 58.81 18.38 6.01 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.025 0.93 . . . . 74.24 112.536 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 103.12 -32.36 7.68 Favored Glycine 0 C--N 1.352 1.453 0 C-N-CA 122.903 0.287 . . . . 31.1 112.463 -176.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.35 105.26 4.02 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 108.898 -0.778 . . . . 72.12 108.898 178.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.494 ' HB3' ' O ' ' B' ' 87' ' ' ALA . 16.1 ttm180 -94.9 98.81 10.98 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.755 0.822 . . . . 74.41 109.51 173.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 6.8 p -95.8 140.75 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.777 0.831 . . . . 73.53 111.303 -177.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 28.7 t -92.62 84.36 5.04 Favored 'General case' 0 C--O 1.243 0.742 0 N-CA-C 108.67 -0.863 . . . . 31.45 108.67 174.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 31.5 m -82.64 122.99 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 N-CA-C 110.257 -0.275 . . . . 73.42 110.257 -177.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -73.73 103.27 4.23 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.565 0.698 . . . . 74.14 109.525 174.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.423 HG13 ' HA2' ' A' ' 133' ' ' GLY . 18.1 pt -82.43 133.7 49.63 Favored Pre-proline 0 CA--C 1.554 1.112 0 CA-C-N 114.565 -1.198 . . . . 74.13 108.206 167.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.588 ' HB2' HG23 ' B' ' 103' ' ' THR . 26.5 Cg_endo -62.78 143.17 91.44 Favored 'Trans proline' 0 C--N 1.371 1.742 0 C-N-CA 121.939 1.759 . . . . 60.34 112.163 175.272 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -57.47 92.14 0.05 OUTLIER 'Trans proline' 0 C--N 1.389 2.695 0 C-N-CA 123.22 2.614 . . . . 74.15 112.563 176.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.687 ' HA3' ' HD2' ' A' ' 241' ' ' PRO . . . 98.65 56.87 1.01 Allowed Glycine 0 C--N 1.335 0.474 0 CA-C-N 114.812 -1.085 . . . . 75.51 111.214 -169.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.449 HG22 HG11 ' A' ' 178' ' ' VAL . 5.4 p -78.38 131.29 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-O 121.73 0.776 . . . . 75.43 109.288 178.214 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.676 ' HA ' HD21 ' A' ' 188' ' ' LEU . 21.8 mtt85 -100.75 149.67 23.58 Favored 'General case' 0 C--O 1.21 -0.98 0 CA-C-N 114.587 -1.188 . . . . 73.23 110.873 -163.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -58.77 118.65 5.95 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.795 0.838 . . . . 72.32 110.916 -178.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 91.66 12.33 59.56 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-N 115.214 -0.903 . . . . 14.21 113.414 -176.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 24.0 t -70.94 113.97 8.53 Favored 'General case' 0 C--N 1.356 0.874 0 N-CA-C 108.319 -0.993 . . . . 74.23 108.319 173.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.488 HG22 HG22 ' A' ' 177' ' ' VAL . 47.2 t -85.57 90.33 2.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 C-N-CA 123.565 0.746 . . . . 72.34 109.09 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 61.6 mt -71.86 93.0 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 107.779 -1.193 . . . . 75.24 107.779 171.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -81.19 109.02 15.33 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.795 -0.639 . . . . 61.32 110.416 -174.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 3.7 p -114.63 108.17 49.73 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 123.606 0.763 . . . . 61.33 109.506 177.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.612 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 52.6 Cg_endo -68.33 155.37 69.49 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 121.95 1.766 . . . . 74.53 110.894 172.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.781 ' HA3' ' H ' ' A' ' 87' ' ' GLY . . . 75.81 27.64 62.39 Favored Glycine 0 C--N 1.345 1.063 0 C-N-CA 121.44 -0.409 . . . . 70.43 114.022 176.289 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 36.6 tpp -134.65 -22.78 1.65 Allowed 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.031 0.532 . . . . 64.15 111.385 -178.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.6 ' HA2' HD13 ' A' ' 174' ' ' LEU . . . -68.65 -99.93 0.03 OUTLIER Glycine 0 C--N 1.354 1.54 0 N-CA-C 114.993 0.757 . . . . 73.33 114.993 -172.063 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.417 ' HA3' ' H ' ' A' ' 117' ' ' ARG . . . -63.69 121.51 23.88 Favored Glycine 0 C--N 1.347 1.182 0 N-CA-C 111.888 -0.485 . . . . 74.5 111.888 178.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -67.96 104.84 1.83 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.506 0.722 . . . . 75.42 110.596 -174.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -165.32 170.52 40.29 Favored Glycine 0 C--N 1.339 0.733 0 CA-C-O 118.785 -1.008 . . . . 64.21 111.242 -178.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ASN . . . . . 0.51 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . 24.4 t-20 -49.52 -65.88 0.74 Allowed Pre-proline 0 CA--C 1.561 1.399 0 CA-C-O 117.247 -1.359 . . . . 63.11 110.858 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.524 ' HD2' ' HA ' ' A' ' 115' ' ' LYS . 71.1 Cg_endo -93.83 94.06 0.13 Allowed 'Trans proline' 0 C--N 1.393 2.869 0 CA-C-N 122.645 1.98 . . . . 71.13 108.881 165.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -69.73 158.26 57.62 Favored 'Trans proline' 0 C--N 1.373 1.848 0 C-N-CA 122.475 2.117 . . . . 71.25 111.765 -164.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -70.1 171.74 42.04 Favored Glycine 0 C--N 1.34 0.802 0 CA-C-N 116.143 -0.48 . . . . 72.4 113.598 -174.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.612 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 31.0 t70 -67.63 142.75 56.31 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 109.329 -0.619 . . . . 71.14 109.329 172.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.6 HD13 ' HA2' ' A' ' 165' ' ' GLY . 23.4 tp -124.57 131.85 53.46 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 120.859 0.362 . . . . 64.32 110.291 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 47.1 mt -102.53 98.37 8.45 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.676 0.791 . . . . 72.12 109.271 176.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.642 HD22 HD11 ' B' ' 8' ' ' LEU . 80.2 mt -83.09 93.98 7.72 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 118.051 0.387 . . . . 70.05 110.577 178.472 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.488 HG22 HG22 ' A' ' 158' ' ' VAL . 24.2 t -85.47 107.43 16.18 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 N-CA-C 107.965 -1.124 . . . . 61.43 107.965 177.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.449 HG11 HG22 ' A' ' 153' ' ' VAL . 7.5 p -69.4 127.7 31.68 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 CA-C-O 121.386 0.613 . . . . 70.33 111.233 -174.117 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.536 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 37.0 mmt180 -116.77 101.7 8.78 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 125.193 1.397 . . . . 53.32 108.278 176.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 4.9 mt -69.92 143.14 52.81 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 118.559 0.618 . . . . 72.4 110.246 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 83.4 mt -61.32 155.47 57.21 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 123.995 0.918 . . . . 73.14 111.755 -175.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -76.95 53.59 4.23 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 122.892 2.395 . . . . 71.42 109.858 163.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 27.8 t-80 -79.19 131.3 66.49 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 125.014 1.326 . . . . 73.35 108.572 -171.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -9.06 -53.6 0.0 OUTLIER 'Trans proline' 0 C--N 1.383 2.379 1 C-N-CA 127.692 5.595 . . . . 61.24 119.748 -163.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 44.2 t -99.76 -59.32 3.35 Favored 'Isoleucine or valine' 0 C--N 1.356 0.855 0 CA-C-N 119.322 0.965 . . . . 64.21 109.993 -168.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' PHE . . . . . 0.631 ' HB3' HD22 ' A' ' 193' ' ' LEU . 51.8 m-85 -101.4 138.78 37.96 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 112.863 0.69 . . . . 72.31 112.863 -165.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 27.2 ttp-105 -116.58 98.51 6.58 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 106.02 -1.844 . . . . 75.51 106.02 164.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.676 HD21 ' HA ' ' A' ' 154' ' ' ARG . 56.0 tp -68.98 144.16 54.2 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.616 -0.513 . . . . 74.21 109.616 176.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -149.15 115.67 5.87 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 107.788 -1.19 . . . . 70.31 107.788 -176.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.432 ' O ' ' HB3' ' A' ' 154' ' ' ARG . . . 73.29 -75.9 0.95 Allowed Glycine 0 C--N 1.349 1.29 0 CA-C-O 119.889 -0.395 . . . . 65.41 113.587 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -153.15 -2.98 0.22 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.976 0.911 . . . . 72.32 110.959 176.191 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -125.21 148.15 48.75 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.961 0.904 . . . . 72.32 110.446 -172.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.631 HD22 ' HB3' ' A' ' 186' ' ' PHE . 81.7 mt -90.83 149.88 21.78 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.856 0.862 . . . . 63.44 111.162 -171.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -128.58 99.59 5.43 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.312 1.045 . . . . 73.14 108.456 171.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.564 ' HB3' HD23 ' A' ' 251' ' ' LEU . . . -110.78 110.86 21.67 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.537 1.135 . . . . 74.34 111.055 -171.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 77.4 m -64.59 121.84 15.4 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 109.299 -0.63 . . . . 70.21 109.299 178.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 54.0 tp -122.62 105.73 10.36 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 123.722 0.809 . . . . 72.21 108.978 -166.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -70.35 126.2 28.96 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.144 0.497 . . . . 61.43 109.917 173.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 7.1 p -142.79 136.96 14.7 Favored Pre-proline 0 CA--C 1.548 0.894 0 N-CA-C 107.179 -1.415 . . . . 64.4 107.179 179.081 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.64 154.56 34.99 Favored 'Trans proline' 0 C--N 1.361 1.19 0 C-N-CA 121.55 1.5 . . . . 64.51 111.718 172.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -53.72 -47.25 97.28 Favored Pre-proline 0 CA--C 1.565 1.52 0 N-CA-C 114.718 1.377 . . . . 71.34 114.718 -174.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -59.11 -39.74 76.69 Favored 'Trans proline' 0 C--N 1.383 2.376 0 C-N-CA 122.088 1.859 . . . . 63.54 114.325 176.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 45.7 mt -75.43 -26.79 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 122.517 0.327 . . . . 64.32 110.609 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.09 -43.68 74.03 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.196 0.598 . . . . 71.51 111.158 173.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 11.1 t -69.23 -52.64 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 123.957 0.903 . . . . 63.23 112.017 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 85.3 t -85.28 -31.7 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 123.231 0.612 . . . . 74.41 111.262 -171.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 83.4 94.66 0.61 Allowed Glycine 0 CA--C 1.53 0.989 0 CA-C-N 116.308 -0.405 . . . . 72.35 113.035 -178.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -123.54 -178.15 15.34 Favored Glycine 0 N--CA 1.476 1.33 0 N-CA-C 111.487 -0.645 . . . . 55.24 111.487 174.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -81.28 134.15 35.55 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 117.963 0.882 . . . . 45.21 110.409 177.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 33.2 m -123.54 143.8 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 106.537 -1.653 . . . . 63.11 106.537 164.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' ARG . . . . . 0.428 ' HE ' ' HG2' ' A' ' 220' ' ' GLU . 29.8 ttm180 -92.87 113.65 25.98 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 121.622 -0.674 . . . . 71.41 109.809 -176.333 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.03 128.8 46.07 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.265 1.026 . . . . 62.04 109.22 -177.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' MET . . . . . 0.409 ' HA ' ' HA ' ' A' ' 218' ' ' PRO . 1.6 mpt? -82.65 124.06 29.84 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.118 -0.697 . . . . 71.23 109.118 -177.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 77.2 p -109.3 -179.61 3.89 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 123.228 0.611 . . . . 74.1 109.784 178.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 49.3 mt -75.83 1.0 16.12 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.388 1.075 . . . . 63.31 111.987 -171.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -133.75 5.17 3.64 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 124.317 1.047 . . . . 64.44 111.592 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 137.49 170.6 11.93 Favored Glycine 0 N--CA 1.482 1.709 0 CA-C-O 119.802 -0.443 . . . . 33.0 113.545 176.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' PRO . . . . . 0.409 ' HA ' ' HA ' ' A' ' 213' ' ' MET . 85.2 Cg_endo -80.49 115.86 3.2 Favored 'Trans proline' 0 C--N 1.372 1.778 0 C-N-CA 122.955 2.437 . . . . 70.23 112.609 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 35.8 m -114.35 147.54 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.637 0.775 . . . . 73.4 109.834 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.428 ' HG2' ' HE ' ' A' ' 211' ' ' ARG . 42.0 mt-10 -73.85 147.18 43.54 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 109.566 -0.531 . . . . 75.04 109.566 175.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 10.1 p -137.24 116.52 15.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-O 121.544 0.688 . . . . 74.13 109.574 175.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -77.39 101.09 6.2 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 123.954 0.902 . . . . 60.25 109.522 -177.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.422 ' HA ' HD12 ' B' ' 441' ' ' ILE . 91.3 t -66.98 131.92 93.83 Favored Pre-proline 0 CA--C 1.556 1.205 0 CA-C-N 114.989 -1.005 . . . . 63.14 109.46 178.297 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.58 165.99 30.96 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.688 2.258 . . . . 75.51 110.922 175.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -69.47 158.62 56.66 Favored 'Trans proline' 0 C--N 1.37 1.695 0 C-N-CA 121.766 1.644 . . . . 72.53 111.857 175.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 15.3 mmt180 69.26 15.62 8.53 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 125.277 1.431 . . . . 74.04 112.046 175.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.429 HG23 HD21 ' A' ' 233' ' ' LEU . 4.0 m -59.89 104.65 0.31 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.188 0.995 . . . . 64.32 111.065 -179.139 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -92.11 139.55 30.52 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 114.418 -1.264 . . . . 75.32 111.671 -173.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' ALA . . . . . 0.635 ' HB1' HD21 ' B' ' 265' ' ' LEU . . . -54.11 153.19 5.27 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.496 1.518 . . . . 62.31 112.337 174.141 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 79.36 -49.15 3.53 Favored Glycine 0 C--N 1.345 1.069 0 N-CA-C 112.269 -0.332 . . . . 73.32 112.269 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -63.73 163.44 11.55 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 124.276 1.03 . . . . 74.0 111.363 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.534 ' HG3' ' HG2' ' A' ' 252' ' ' GLU . 2.9 mppt? -112.12 129.5 56.21 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 114.838 -1.074 . . . . 72.22 110.355 -175.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.585 ' HB3' HG21 ' B' ' 441' ' ' ILE . 79.6 mt -77.59 104.3 8.04 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 108.323 -0.992 . . . . 71.4 108.323 170.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 42.1 ttm105 -82.25 109.3 16.4 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 122.643 0.377 . . . . 64.14 110.247 177.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.519 ' HB3' ' HA ' ' B' ' 441' ' ' ILE . 0.4 OUTLIER -120.83 106.31 11.54 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 108.055 -1.091 . . . . 61.12 108.055 169.866 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -74.56 159.87 31.62 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.069 0.948 . . . . 64.43 112.666 -169.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 73.35 9.51 77.51 Favored Glycine 0 C--N 1.349 1.294 0 CA-C-N 115.496 -0.774 . . . . 74.2 113.369 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.518 ' HD2' HD11 ' B' ' 439' ' ' LEU . 0.0 OUTLIER -108.38 -11.63 15.15 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.295 0.638 . . . . 73.01 111.187 -176.49 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -79.53 -154.34 8.72 Favored Glycine 0 C--N 1.348 1.218 0 N-CA-C 112.515 -0.234 . . . . 74.43 112.515 177.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -92.41 137.69 24.47 Favored Pre-proline 0 N--CA 1.48 1.063 0 CA-C-O 118.918 -0.563 . . . . 73.13 110.132 -175.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.687 ' HD2' ' HA3' ' A' ' 152' ' ' GLY . 89.7 Cg_exo -46.78 107.99 0.14 Allowed 'Trans proline' 0 C--N 1.388 2.61 0 C-N-CA 123.973 3.115 . . . . 73.33 113.83 -178.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -134.56 -145.35 5.21 Favored Glycine 0 C--N 1.35 1.317 0 CA-C-O 119.073 -0.848 . . . . 73.52 112.585 -171.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 243' ' ' PRO . . . . . 0.479 ' HD3' ' HB3' ' B' ' 109' ' ' TYR . 89.3 Cg_endo -72.78 -26.93 15.37 Favored 'Trans proline' 0 C--N 1.385 2.475 0 C-N-CA 123.052 2.501 . . . . 70.45 112.655 -173.005 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -94.2 22.89 5.47 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.19 0.996 . . . . 70.11 111.066 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 90.13 -68.97 2.42 Favored Glycine 0 C--N 1.345 1.077 0 N-CA-C 109.579 -1.408 . . . . 62.24 109.579 -171.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.604 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 75.8 mtp180 -127.23 168.39 14.79 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.53 1.132 . . . . 75.41 109.306 166.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -84.95 -166.2 41.29 Favored Glycine 0 C--N 1.346 1.094 0 CA-C-N 116.171 -0.468 . . . . 42.24 111.973 172.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' ASP . . . . . 0.438 ' HB2' ' CE1' ' A' ' 250' ' ' TYR . 26.6 m-20 -104.39 158.99 16.09 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.371 0.669 . . . . 75.44 109.831 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.426 ' HB3' ' HG ' ' A' ' 235' ' ' LEU . 40.6 tp -106.57 122.74 46.91 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 107.619 -1.252 . . . . 70.31 107.619 167.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.438 ' CE1' ' HB2' ' A' ' 248' ' ' ASP . 42.4 m-85 -108.27 105.69 15.52 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.096 -1.076 . . . . 52.51 108.096 176.003 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.58 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 69.1 mt -84.41 102.83 13.06 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 108.75 -0.833 . . . . 72.24 108.75 176.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.534 ' HG2' ' HG3' ' A' ' 232' ' ' LYS . 27.7 mt-10 -74.96 96.34 3.15 Favored 'General case' 0 C--N 1.356 0.855 0 C-N-CA 123.57 0.748 . . . . 75.41 109.091 -176.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 46.3 t -55.73 133.74 19.55 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 125.571 1.548 . . . . 24.43 112.222 -172.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 254' ' ' ARG . . . . . 0.518 ' HA ' HD22 ' B' ' 265' ' ' LEU . 3.9 tmm_? -133.93 94.42 3.26 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 107.733 -1.21 . . . . 73.14 107.733 -179.151 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.451 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 77.6 mt -79.59 133.9 28.81 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-N 115.961 -0.563 . . . . 74.34 111.144 -176.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 31.1 p -129.87 176.22 8.22 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.548 1.139 . . . . 73.43 109.519 172.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.7 pp -133.23 153.03 80.51 Favored Pre-proline 0 CA--C 1.569 1.703 0 C-N-CA 123.803 0.841 . . . . 73.4 111.116 -174.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' PRO . . . . . 0.422 ' HG2' HD21 ' A' ' 261' ' ' LEU . 23.5 Cg_endo -59.18 -9.68 8.77 Favored 'Trans proline' 0 C--N 1.387 2.597 0 C-N-CA 123.999 3.133 . . . . 74.45 116.278 -166.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.499 ' HA ' ' HB3' ' C' ' 226' ' ' ARG . 36.3 mt-10 56.67 -67.52 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.075 0 C-N-CA 125.415 1.486 . . . . 63.24 113.89 -174.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.03 132.59 39.02 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.55 -0.718 . . . . 75.12 109.66 172.039 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.613 HD22 ' HB2' ' A' ' 265' ' ' GLU . 56.2 mt -123.73 148.92 46.15 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.414 0.686 . . . . 55.32 110.453 173.355 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 21.7 p -127.9 155.09 78.12 Favored Pre-proline 0 CA--C 1.558 1.259 0 C-N-CA 125.06 1.344 . . . . 44.34 108.054 172.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -17.96 -52.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.403 3.44 1 C-N-CA 126.867 5.045 . . . . 74.33 117.989 -170.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 264' ' ' GLU . . . . . 0.442 ' O ' HD13 ' A' ' 268' ' ' LEU . 63.3 mm-40 -55.71 -74.68 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.012 0.525 . . . . 71.44 111.285 177.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 265' ' ' GLU . . . . . 0.613 ' HB2' HD22 ' A' ' 261' ' ' LEU . 1.5 mp0 -64.07 -30.31 71.39 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 122.858 0.463 . . . . 64.2 109.964 -172.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 266' ' ' GLU . . . . . 0.529 ' HA ' HD13 ' A' ' 261' ' ' LEU . 7.6 tp10 -55.51 -62.73 1.49 Allowed 'General case' 0 C--O 1.248 1.01 0 O-C-N 123.79 0.681 . . . . 73.45 109.69 176.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -60.63 -38.86 86.16 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 115.238 -0.892 . . . . 64.12 111.354 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 268' ' ' LEU . . . . . 0.442 HD13 ' O ' ' A' ' 264' ' ' GLU . 2.2 mp -63.46 -48.09 79.13 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.007 0.923 . . . . 73.14 111.921 -176.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 77.9 m95 -68.79 -33.44 73.87 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.315 0.646 . . . . 75.0 111.398 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 270' ' ' LYS . . . . . 0.433 ' HG2' ' O ' ' A' ' 266' ' ' GLU . 29.8 mmtp -70.43 -39.95 74.07 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 122.405 0.282 . . . . 62.43 111.504 175.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -73.44 -30.24 63.08 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.016 0.526 . . . . 70.22 110.574 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 24.0 mt -59.67 -54.4 46.84 Favored 'General case' 0 C--O 1.205 -1.252 0 N-CA-C 108.541 -0.911 . . . . 63.4 108.541 167.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -51.28 -48.57 62.22 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 124.107 0.879 . . . . 64.51 111.948 -177.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.41 ' HG3' ' O ' ' A' ' 270' ' ' LYS . 25.8 mt-10 -62.72 -56.96 12.87 Favored 'General case' 0 CA--C 1.551 0.989 0 O-C-N 123.371 0.419 . . . . 74.35 110.389 178.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -57.71 -65.85 0.57 Allowed 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.726 0.81 . . . . 71.44 111.761 -177.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 276' ' ' TYR . . . . . 0.516 ' HE2' ' HG3' ' C' ' 258' ' ' PRO . 81.9 t80 -45.61 -59.09 2.94 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.703 1.601 . . . . 75.02 112.826 178.165 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 277' ' ' TYR . . . . . 0.572 ' HA ' ' HB2' ' A' ' 280' ' ' ALA . 2.3 t80 -66.86 -35.01 79.07 Favored 'General case' 0 N--CA 1.482 1.132 0 O-C-N 123.59 0.556 . . . . 70.12 110.691 -170.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -61.38 -20.1 62.64 Favored 'General case' 0 CA--C 1.554 1.102 0 N-CA-C 112.761 0.652 . . . . 75.41 112.761 176.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.4 16.29 7.69 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-O 118.437 -0.792 . . . . 74.13 111.479 176.365 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 280' ' ' ALA . . . . . 0.572 ' HB2' ' HA ' ' A' ' 277' ' ' TYR . . . . . . . . 0 N--CA 1.495 1.802 0 N-CA-C 113.135 0.791 . . . . 72.21 113.135 -166.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.479 1.002 0 N-CA-C 109.167 -0.679 . . . . 71.44 109.167 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.4 ' HE3' ' O ' ' B' ' 4' ' ' SER . 58.0 tptt -63.43 108.25 1.3 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.491 0.716 . . . . 54.1 109.645 175.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 61.3 tp60 -82.7 73.92 9.7 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 109.126 -0.694 . . . . 74.04 109.126 177.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 4' ' ' SER . . . . . 0.4 ' O ' ' HE3' ' B' ' 2' ' ' LYS . 61.4 p 45.65 -88.06 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 126.012 1.725 . . . . 52.14 114.062 172.513 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 59.4 m 56.95 133.5 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 126.18 1.792 . . . . 70.11 114.044 -178.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.669 HG21 ' HA ' ' A' ' 125' ' ' LEU . 37.5 pt -137.54 172.43 14.6 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 C-N-CA 122.991 0.517 . . . . 64.44 111.971 -175.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -124.97 -167.6 1.7 Allowed 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.616 1.167 . . . . 72.01 108.991 175.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.642 HD11 HD22 ' A' ' 176' ' ' LEU . 11.0 tp -130.69 167.1 19.35 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 109.428 -0.582 . . . . 75.22 109.428 177.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 9' ' ' ALA . . . . . 0.525 ' HB3' ' H ' ' A' ' 122' ' ' GLU . . . -87.68 -67.11 0.85 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 122.804 0.441 . . . . 62.4 110.864 173.379 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 3.8 tt 64.05 94.27 0.05 Allowed 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.556 1.142 . . . . 74.1 108.834 -169.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 57.2 mt -79.11 114.69 46.69 Favored Pre-proline 0 CA--C 1.553 1.08 0 CA-C-O 118.751 -0.642 . . . . 45.35 109.434 -176.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -58.86 110.36 0.66 Allowed 'Trans proline' 0 C--N 1.384 2.418 0 C-N-CA 123.628 2.885 . . . . 61.33 112.94 -172.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 4.2 pp 50.86 25.47 2.18 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 126.236 1.815 . . . . 75.01 113.863 -178.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 14' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' B' ' 14' ' ' LEU . 62.5 mt 73.46 40.34 0.52 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.815 1.246 . . . . 64.54 112.193 -176.345 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 15' ' ' PHE . . . . . 0.486 ' O ' ' HD3' ' B' ' 17' ' ' PRO . 16.8 m-85 -75.8 85.91 2.79 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 106.385 -1.709 . . . . 60.01 106.385 157.174 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 35.6 p -85.66 104.36 5.02 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 123.741 0.816 . . . . 51.11 111.697 -174.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 17' ' ' PRO . . . . . 0.486 ' HD3' ' O ' ' B' ' 15' ' ' PHE . 18.2 Cg_endo -96.1 8.92 1.6 Allowed 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 123.257 2.638 . . . . 62.42 112.167 176.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.453 HG23 ' HD2' ' B' ' 17' ' ' PRO . 3.8 t -91.64 -1.38 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 C-N-CA 123.42 0.688 . . . . 61.41 110.519 -174.174 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 9.6 t -57.13 -39.28 74.84 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.419 0.688 . . . . 71.22 109.647 170.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 20' ' ' LYS . . . . . 0.463 ' NZ ' ' SG ' ' B' ' 190' ' ' CYS . 58.3 mttp -150.63 119.82 6.78 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 105.567 -2.012 . . . . 62.34 105.567 167.362 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -46.24 106.11 0.07 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 124.413 1.07 . . . . 75.34 111.497 -174.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 22' ' ' ARG . . . . . 0.583 HH21 ' HA3' ' B' ' 209' ' ' GLY . 0.2 OUTLIER -64.75 -78.03 0.05 Allowed 'General case' 0 C--N 1.357 0.898 0 O-C-N 124.289 0.993 . . . . 73.31 109.936 -175.322 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 23' ' ' THR . . . . . 0.458 HG22 ' HB2' ' B' ' 25' ' ' GLU . 21.1 m 51.19 90.79 0.08 OUTLIER Pre-proline 0 CA--C 1.556 1.19 0 C-N-CA 124.586 1.155 . . . . 72.45 111.333 -176.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 24' ' ' PRO . . . . . 0.429 ' HB3' HD13 ' B' ' 68' ' ' ILE . 11.9 Cg_exo -67.8 76.09 0.6 Allowed 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 122.739 2.293 . . . . 74.55 110.3 172.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 25' ' ' GLU . . . . . 0.458 ' HB2' HG22 ' B' ' 23' ' ' THR . 34.1 tt0 -91.42 -4.5 55.57 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 114.508 -1.223 . . . . 74.53 110.947 -172.388 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 26' ' ' MET . . . . . 0.627 ' HB3' ' HB1' ' B' ' 204' ' ' ALA . 99.4 mmm -133.04 154.7 81.44 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 124.324 1.049 . . . . 75.13 109.524 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.82 -46.78 15.13 Favored 'Trans proline' 0 C--N 1.386 2.522 0 C-N-CA 123.285 2.656 . . . . 71.1 114.722 -175.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 43.7 t 69.25 141.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 C-N-CA 124.804 1.241 . . . . 73.51 110.362 -170.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 4.4 mm? 65.72 41.93 3.76 Favored 'General case' 0 N--CA 1.5 2.053 0 C-N-CA 124.519 1.128 . . . . 62.2 110.702 -172.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -91.38 -61.25 1.69 Allowed 'General case' 0 CA--C 1.563 1.442 0 C-N-CA 124.819 1.248 . . . . 70.24 111.778 -174.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 174.02 -50.72 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.507 1.123 . . . . 74.34 111.068 -177.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 32' ' ' ARG . . . . . 0.516 ' HD2' ' HB2' ' B' ' 37' ' ' ASP . 3.8 tmt_? -171.99 -32.34 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 124.247 1.019 . . . . 72.22 108.466 -168.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . 81.44 -69.13 0.08 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 126.138 1.775 . . . . 73.31 112.846 172.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -57.53 131.97 51.78 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.85 0.86 . . . . 53.33 112.13 -172.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 35' ' ' GLN . . . . . 0.462 ' HB3' ' OH ' ' C' ' 250' ' ' TYR . 9.3 pt20 51.97 9.63 0.09 Allowed 'General case' 0 N--CA 1.502 2.171 0 C-N-CA 126.749 2.02 . . . . 73.13 113.773 -174.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 36' ' ' GLY . . . . . 0.506 ' HA3' ' O ' ' B' ' 56' ' ' ARG . . . 75.67 -18.83 2.81 Favored Glycine 0 CA--C 1.539 1.549 0 CA-C-O 119.592 -0.56 . . . . 74.33 113.752 -171.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 37' ' ' ASP . . . . . 0.516 ' HB2' ' HD2' ' B' ' 32' ' ' ARG . 38.3 t70 66.83 109.08 0.04 OUTLIER 'General case' 0 C--N 1.365 1.255 0 C-N-CA 126.359 1.864 . . . . 61.44 111.486 -178.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 38' ' ' ILE . . . . . 0.612 HG12 ' HB2' ' B' ' 56' ' ' ARG . 33.3 mt -75.08 89.02 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 N-CA-C 109.809 -0.441 . . . . 75.44 109.809 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 88.8 m -131.74 106.07 7.89 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.839 -1.171 . . . . 64.25 107.839 171.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . 53.61 93.65 0.05 OUTLIER Pre-proline 0 CA--C 1.555 1.135 0 C-N-CA 124.925 1.29 . . . . 64.0 112.241 -176.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 41' ' ' PRO . . . . . 0.453 ' HB3' ' HD3' ' B' ' 56' ' ' ARG . 15.4 Cg_exo -70.66 -14.8 33.53 Favored 'Trans proline' 0 C--N 1.377 2.038 0 C-N-CA 123.034 2.489 . . . . 72.44 112.983 -179.379 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.81 -71.29 2.75 Favored Glycine 0 C--N 1.347 1.188 0 N-CA-C 109.941 -1.263 . . . . 45.24 109.941 -171.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -115.54 145.63 18.71 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 114.634 -0.783 . . . . 42.15 111.247 171.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -157.75 109.17 2.28 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 108.453 -0.943 . . . . 63.2 108.453 175.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 21.0 tpp180 -59.86 -61.91 2.26 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.227 0.611 . . . . 74.21 110.993 -177.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 32.7 ttm180 73.6 -52.89 0.7 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 125.286 1.434 . . . . 75.02 111.45 -173.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 64.35 -81.75 0.03 OUTLIER 'General case' 0 C--N 1.358 0.976 0 C-N-CA 125.313 1.445 . . . . 53.22 107.615 -170.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 8.2 m -142.62 -62.93 0.43 Allowed 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 109.09 -0.707 . . . . 51.22 109.09 172.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -93.91 46.88 2.26 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 115.378 -0.828 . . . . 74.15 113.143 -175.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 10.1 t70 72.42 -54.8 0.68 Allowed 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 125.653 1.581 . . . . 64.2 112.947 176.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 62.19 33.09 17.04 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 124.415 1.086 . . . . 75.3 111.309 178.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 2.1 m 65.72 33.93 7.92 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.851 1.261 . . . . 73.31 110.586 175.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -85.43 -14.62 45.62 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 115.139 -0.937 . . . . 73.24 111.659 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.426 ' HB2' HG13 ' B' ' 329' ' ' ILE . . . -65.54 -84.07 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 122.779 0.432 . . . . 75.51 110.541 176.147 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 92.5 mt 33.67 -89.41 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 125.575 1.55 . . . . 72.35 114.109 -177.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 56' ' ' ARG . . . . . 0.612 ' HB2' HG12 ' B' ' 38' ' ' ILE . 0.0 OUTLIER 58.61 14.01 2.87 Favored 'General case' 0 C--N 1.366 1.295 0 C-N-CA 124.813 1.245 . . . . 73.2 111.977 -167.177 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -71.61 91.87 1.11 Allowed 'General case' 0 C--N 1.353 0.76 0 C-N-CA 124.217 1.007 . . . . 75.31 108.941 -176.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 44.1 p -161.45 169.55 21.67 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 114.936 -1.029 . . . . 62.01 109.707 -172.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 59' ' ' LEU . . . . . 0.444 HD23 ' H ' ' B' ' 59' ' ' LEU . 1.5 pt? -131.66 128.23 38.62 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 109.078 -0.712 . . . . 72.44 109.078 -179.163 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 16.1 m -65.6 122.84 18.15 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.38 0.672 . . . . 63.51 109.98 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -70.29 78.7 0.53 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.726 0.81 . . . . 71.45 110.734 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 62' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -143.94 78.89 13.69 Favored Pre-proline 0 N--CA 1.468 0.446 0 N-CA-C 106.58 -1.637 . . . . 72.3 106.58 173.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.18 84.71 1.09 Allowed 'Trans proline' 0 C--N 1.374 1.904 0 C-N-CA 121.784 1.656 . . . . 72.24 110.88 177.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 23.55 -82.3 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 127.294 2.238 . . . . 72.04 114.182 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -145.82 88.49 1.83 Allowed 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 105.896 -1.89 . . . . 65.32 105.896 167.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 68.26 -169.07 0.19 Allowed 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 124.717 1.207 . . . . 72.41 108.779 -169.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 12.0 tt -76.97 67.13 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.576 1.959 0 CA-C-O 122.646 1.212 . . . . 72.03 110.661 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 68' ' ' ILE . . . . . 0.429 HD13 ' HB3' ' B' ' 24' ' ' PRO . 2.9 mp 45.12 -81.06 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.559 1.319 0 C-N-CA 128.159 2.583 . . . . 73.4 113.128 -178.181 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -87.37 4.65 42.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.934 -0.479 . . . . 73.12 111.911 -178.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 7.9 mp 64.72 21.22 12.34 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 124.505 1.122 . . . . 44.44 110.705 -173.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 71' ' ' ILE . . . . . 0.655 HG23 ' HA ' ' B' ' 75' ' ' MET . 38.2 mm -103.07 108.49 24.46 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 C-N-CA 123.944 0.898 . . . . 74.32 109.658 -176.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.66 -163.49 36.6 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 111.435 -0.666 . . . . 62.21 111.435 171.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -70.61 111.43 6.1 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 122.772 0.429 . . . . 63.44 109.957 178.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.68 34.42 31.45 Favored Glycine 0 C--N 1.344 0.992 0 CA-C-N 116.229 -0.442 . . . . 64.42 112.13 -174.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 75' ' ' MET . . . . . 0.655 ' HA ' HG23 ' B' ' 71' ' ' ILE . 0.0 OUTLIER 70.31 -69.46 0.17 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.741 1.616 . . . . 74.01 111.46 178.821 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . -146.97 9.01 1.3 Allowed Glycine 0 C--N 1.342 0.886 0 CA-C-O 119.698 -0.501 . . . . 71.13 112.884 176.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 32.4 t70 61.46 -81.45 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 125.265 1.426 . . . . 73.03 111.167 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 78' ' ' SER . . . . . 0.417 ' H ' ' H ' ' B' ' 79' ' ' GLU . 71.6 p -166.73 -15.32 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.536 1.134 . . . . 51.1 109.764 178.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 79' ' ' GLU . . . . . 0.417 ' H ' ' H ' ' B' ' 78' ' ' SER . 50.9 mt-10 -73.11 -15.82 61.48 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.384 0.674 . . . . 74.44 111.667 176.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 15.2 tt -58.57 -39.34 75.31 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.136 0 C-N-CA 123.537 0.735 . . . . 72.52 111.087 175.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 74.1 m -153.29 120.16 5.7 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 107.917 -1.142 . . . . 71.34 107.917 177.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.84 91.73 0.07 Allowed 'General case' 0 N--CA 1.473 0.723 0 O-C-N 123.705 0.628 . . . . 61.11 110.381 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -92.81 -58.41 2.35 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 114.905 -1.043 . . . . 71.35 110.489 -176.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 84' ' ' ARG . . . . . 0.455 ' HG2' ' HB2' ' B' ' 87' ' ' ALA . 6.5 tpm_? -168.4 -51.45 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.184 -0.462 . . . . 73.0 110.097 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 75.89 0.34 3.32 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 125.421 1.488 . . . . 72.23 112.189 -177.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -175.11 91.12 0.06 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.338 1.055 . . . . 63.12 109.251 176.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 87' ' ' ALA . . . . . 0.494 ' O ' ' HB3' ' A' ' 144' ' ' ARG . . . -118.38 107.77 14.26 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 108.69 -0.856 . . . . 52.24 108.69 174.038 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -83.92 48.15 1.41 Allowed 'General case' 0 CA--C 1.563 1.464 0 CA-C-O 121.839 0.828 . . . . 74.14 111.591 -172.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -90.72 59.32 3.28 Favored Glycine 0 C--N 1.351 1.373 0 N-CA-C 110.981 -0.848 . . . . 54.33 110.981 169.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -144.1 -64.11 0.37 Allowed 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.672 -0.862 . . . . 62.33 108.672 -174.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 81.03 -60.17 4.7 Favored Glycine 0 C--N 1.352 1.457 0 CA-C-N 115.776 -0.647 . . . . 70.11 112.868 178.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.29 39.19 4.31 Favored Glycine 0 C--N 1.346 1.136 0 N-CA-C 112.101 -0.4 . . . . 23.53 112.101 -177.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -94.62 131.61 40.21 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.617 0.767 . . . . 74.22 110.311 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -60.95 131.52 50.91 Favored 'General case' 0 N--CA 1.479 1.018 0 O-C-N 124.124 0.89 . . . . 71.21 111.962 -175.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 95' ' ' LYS . . . . . 0.677 ' HA ' ' HE2' ' A' ' 23' ' ' LYS . 82.9 tttt -76.78 -13.25 60.04 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 116.258 -0.428 . . . . 74.14 110.882 172.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.36 -165.87 31.58 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-N 115.922 -0.581 . . . . 72.31 113.115 175.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 21.6 pt -130.61 26.83 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 124.35 1.06 . . . . 72.22 109.281 -176.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -67.48 -55.89 11.74 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.132 1.373 . . . . 75.21 110.593 -171.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 99' ' ' ALA . . . . . 0.463 ' H ' HD12 ' B' ' 100' ' ' LEU . . . -128.1 21.67 6.25 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 114.972 -1.013 . . . . 61.12 109.649 176.418 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 100' ' ' LEU . . . . . 0.491 HD21 ' HD3' ' B' ' 95' ' ' LYS . 4.8 mp -111.48 111.15 55.12 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 123.909 0.884 . . . . 74.2 109.479 -174.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -66.69 146.42 78.86 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 122.966 2.444 . . . . 72.21 112.277 173.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 87.3 mt -70.98 86.79 0.72 Allowed 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.282 0.633 . . . . 73.12 109.857 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 103' ' ' THR . . . . . 0.588 HG23 ' HB2' ' A' ' 150' ' ' PRO . 2.6 m 66.82 10.43 7.56 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 124.67 1.188 . . . . 75.52 111.499 -178.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.13 73.45 2.58 Favored Glycine 0 C--N 1.348 1.22 0 CA-C-N 116.34 -0.391 . . . . 51.35 112.748 -174.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -73.52 88.12 1.63 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.305 0.642 . . . . 75.22 109.648 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 48.1 t80 70.73 -78.03 0.05 Allowed 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 125.054 1.341 . . . . 74.44 111.09 176.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 26.2 p -116.02 45.84 1.67 Allowed 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 124.211 1.004 . . . . 63.32 109.507 177.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 74.0 m80 70.42 -65.54 0.32 Allowed 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 125.399 1.48 . . . . 71.44 109.276 -165.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.479 ' HB3' ' HD3' ' A' ' 243' ' ' PRO . 36.0 t80 -150.65 134.84 16.95 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 124.224 1.009 . . . . 53.33 108.932 174.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.22 90.53 0.91 Allowed 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 107.832 -1.173 . . . . 71.24 107.832 165.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 111' ' ' LEU . . . . . 0.479 ' HB3' ' HG3' ' A' ' 243' ' ' PRO . 0.9 OUTLIER -54.76 145.55 19.23 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.433 1.093 . . . . 64.15 112.789 -173.988 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -71.67 -47.75 52.13 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.524 0.73 . . . . 73.2 110.39 -176.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 113' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -123.06 179.68 4.59 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.393 1.077 . . . . 75.13 109.242 177.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -56.2 -44.34 79.37 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.695 0.798 . . . . 74.01 112.474 -175.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 3.9 m -101.41 31.9 3.54 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 123.411 0.684 . . . . 73.23 109.679 178.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 116' ' ' GLY . . . . . 0.474 ' HA2' ' HB2' ' B' ' 111' ' ' LEU . . . 75.96 -69.84 2.12 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 111.507 -0.637 . . . . 55.33 111.507 -175.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 10.1 tptp -158.41 97.78 1.78 Allowed Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 124.601 1.16 . . . . 70.25 108.236 170.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 118' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -96.22 -154.37 0.04 OUTLIER 'Trans proline' 0 C--N 1.363 1.326 0 C-N-CA 123.404 2.736 . . . . 60.53 111.142 169.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 119' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -77.51 155.85 31.38 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 108.009 -1.108 . . . . 75.33 108.009 165.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 120' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -78.91 83.98 4.98 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-O 121.743 0.782 . . . . 70.1 109.798 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 4.2 t -117.17 29.42 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.234 0 N-CA-C 108.039 -1.097 . . . . 74.32 108.039 176.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 25.9 m -63.97 -37.95 89.3 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.258 1.023 . . . . 75.24 111.178 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -74.53 -10.78 59.88 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.699 0.8 . . . . 64.3 112.053 176.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 80.6 p 59.24 19.47 7.56 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 126.012 1.725 . . . . 43.31 112.532 -175.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -108.3 2.21 22.47 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.967 0.907 . . . . 73.02 110.162 174.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . 62.31 13.13 5.73 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 125.172 1.389 . . . . 74.13 112.54 -176.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 42.2 m 58.5 24.69 12.16 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.673 1.189 . . . . 70.01 112.163 -173.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.6 -47.65 74.97 Favored 'General case' 0 C--N 1.355 0.808 0 C-N-CA 123.918 0.887 . . . . 72.01 111.174 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 21.7 m 78.03 -50.27 0.49 Allowed 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 125.34 1.456 . . . . 54.34 112.994 172.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . 79.21 -40.25 0.24 Allowed 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 126.124 1.77 . . . . 44.22 111.433 -176.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 131' ' ' TRP . . . . . 0.403 ' O ' HD21 ' B' ' 173' ' ' LEU . 24.4 m-90 71.21 -61.85 0.47 Allowed 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 125.857 1.663 . . . . 73.51 111.464 178.009 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 21.5 p -74.83 56.37 0.73 Allowed 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 125.017 1.327 . . . . 51.4 110.865 176.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 12.1 t -140.37 -171.15 3.14 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 125.395 1.478 . . . . 62.25 108.316 -175.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 134' ' ' GLY . . . . . 0.452 ' H ' ' HA ' ' B' ' 137' ' ' THR . . . 99.84 -59.64 0.76 Allowed Glycine 0 N--CA 1.474 1.229 0 N-CA-C 111.71 -0.556 . . . . 55.15 111.71 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 135' ' ' VAL . . . . . . . . . . . . . 2.3 p -67.2 93.35 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.059 0 N-CA-C 108.95 -0.759 . . . . 73.24 108.95 171.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt 85.69 -24.18 0.14 Allowed 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 126.369 1.868 . . . . 52.43 111.136 -173.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 137' ' ' THR . . . . . 0.452 ' HA ' ' H ' ' B' ' 134' ' ' GLY . 5.9 m 61.79 27.43 16.76 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.868 1.267 . . . . 75.31 111.391 178.254 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -95.82 -34.93 11.69 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.355 -0.839 . . . . 75.52 110.246 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 57.1 t30 65.09 174.96 0.21 Allowed 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 125.182 1.393 . . . . 73.24 109.703 -171.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -53.41 -56.69 18.46 Favored Glycine 0 C--N 1.353 1.518 0 N-CA-C 110.827 -0.909 . . . . 65.04 110.827 171.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . 49.36 32.06 4.27 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 125.696 1.598 . . . . 75.34 114.13 164.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 2.3 pp 48.49 19.24 0.22 Allowed 'General case' 0 N--CA 1.502 2.157 0 C-N-CA 125.759 1.624 . . . . 70.15 114.394 -177.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -90.72 27.29 8.99 Favored Glycine 0 C--N 1.342 0.873 0 N-CA-C 115.668 1.027 . . . . 61.25 115.668 -165.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.26 -56.45 12.58 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.282 0 CA-C-N 117.913 0.856 . . . . 75.31 109.374 172.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 4.3 t70 167.27 156.63 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 126.523 1.929 . . . . 64.3 107.94 176.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 21.3 mt 62.88 11.63 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 C-N-CA 124.699 1.2 . . . . 72.52 111.948 177.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 44.8 p-80 43.9 90.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 125.168 1.387 . . . . 72.43 111.708 -166.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 148' ' ' GLU . . . . . 0.404 ' HG3' ' N ' ' B' ' 149' ' ' LYS . 15.6 pt-20 -56.35 -53.46 57.07 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 123.398 0.679 . . . . 73.05 111.64 -175.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 149' ' ' LYS . . . . . 0.576 ' HG2' ' HB3' ' B' ' 163' ' ' LEU . 0.3 OUTLIER -65.55 144.97 56.65 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.213 1.005 . . . . 72.23 109.54 -169.533 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 150' ' ' ASP . . . . . 0.433 ' N ' ' HD2' ' B' ' 149' ' ' LYS . 16.8 t70 95.38 -27.39 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 126.891 2.077 . . . . 74.11 110.695 -178.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 13.6 p-80 -167.72 65.34 0.73 Allowed Pre-proline 0 N--CA 1.492 1.665 0 C-N-CA 123.403 0.681 . . . . 74.43 111.468 175.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -84.44 -9.87 9.03 Favored 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 122.914 2.409 . . . . 42.51 113.462 -176.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 2.4 m 64.55 28.23 13.35 Favored 'General case' 0 CA--C 1.564 1.487 0 C-N-CA 124.319 1.048 . . . . 74.2 110.219 -174.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 9.6 tt -154.54 132.82 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.939 0.896 . . . . 74.25 109.304 176.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 155' ' ' LEU . . . . . 0.506 HD23 HD12 ' B' ' 163' ' ' LEU . 46.8 tp 74.65 -62.43 0.46 Allowed 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 125.615 1.566 . . . . 72.1 111.815 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 156' ' ' GLU . . . . . 0.737 ' HB3' ' HA ' ' B' ' 159' ' ' LYS . 46.9 mt-10 -73.23 99.28 2.82 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.415 0.686 . . . . 72.23 110.163 176.179 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 157' ' ' MET . . . . . . . . . . . . . 14.7 tmm? -58.11 -55.46 34.63 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 124.282 1.033 . . . . 53.54 111.095 -178.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 158' ' ' ALA . . . . . . . . . . . . . . . -100.02 -76.12 0.56 Allowed 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 106.934 -1.506 . . . . 34.04 106.934 166.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 159' ' ' LYS . . . . . 0.737 ' HA ' ' HB3' ' B' ' 156' ' ' GLU . 64.1 pttt -174.52 147.35 1.1 Allowed 'General case' 0 C--N 1.354 0.794 0 O-C-N 124.432 1.083 . . . . 55.45 109.853 163.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -102.63 -8.35 21.01 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.074 -0.966 . . . . 70.22 109.843 171.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . 60.44 24.42 14.0 Favored 'General case' 0 C--N 1.362 1.143 0 C-N-CA 124.463 1.105 . . . . 71.1 110.928 -175.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . -133.21 -59.22 0.08 OUTLIER Glycine 0 C--N 1.352 1.462 0 CA-C-N 115.697 -0.683 . . . . 73.4 112.157 -174.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 163' ' ' LEU . . . . . 0.576 ' HB3' ' HG2' ' B' ' 149' ' ' LYS . 50.6 tp 55.44 -86.58 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 125.063 1.345 . . . . 65.02 112.366 -179.388 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 164' ' ' ALA . . . . . . . . . . . . . . . -177.57 149.85 0.65 Allowed 'General case' 0 C--O 1.243 0.728 0 C-N-CA 124.942 1.297 . . . . 75.34 108.676 -171.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 8.8 t -166.71 7.74 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.805 0.842 . . . . 64.15 110.285 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . 130.03 107.29 1.22 Allowed Glycine 0 C--N 1.342 0.897 0 N-CA-C 109.727 -1.349 . . . . 71.15 109.727 -170.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 167' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -63.94 -31.52 72.73 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.582 0.753 . . . . 72.31 111.908 -176.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 8.0 p 46.64 39.18 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 C-N-CA 125.689 1.596 . . . . 74.13 112.693 178.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 32.5 t -70.52 110.9 5.66 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 113.822 -1.535 . . . . 54.35 109.922 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 170' ' ' THR . . . . . 0.591 ' HA ' ' SD ' ' C' ' 213' ' ' MET . 4.9 m 63.15 33.58 14.29 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.861 1.264 . . . . 63.1 110.19 -177.544 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . 76.63 -45.39 0.5 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 126.164 1.785 . . . . 53.32 111.831 -174.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 172' ' ' GLU . . . . . 0.557 ' HG3' ' H ' ' B' ' 173' ' ' LEU 0.265 10.5 pt-20 45.73 -92.74 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.454 0 C-N-CA 126.094 1.758 . . . . 73.22 114.039 -175.94 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 173' ' ' LEU . . . . . 0.557 ' H ' ' HG3' ' B' ' 172' ' ' GLU . 4.5 mm? 52.34 -91.19 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.925 0.89 . . . . 74.23 110.17 -166.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 174' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 174.74 -64.92 0.01 OUTLIER 'General case' 0 C--N 1.351 0.668 0 C-N-CA 125.374 1.47 . . . . 74.45 107.912 177.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 175' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -100.4 154.79 18.22 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.103 -0.953 . . . . 74.1 110.631 -177.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -162.58 122.87 2.41 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.476 1.11 . . . . 74.11 108.49 174.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 177' ' ' THR . . . . . 0.452 ' HA ' ' HD3' ' B' ' 178' ' ' PRO . 45.5 p -67.14 114.31 17.79 Favored Pre-proline 0 CA--C 1.555 1.166 0 C-N-CA 123.526 0.73 . . . . 64.31 110.131 179.17 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 178' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' B' ' 177' ' ' THR . 4.5 Cg_exo -78.84 67.12 8.6 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 123.391 2.727 . . . . 74.53 112.912 -173.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -85.26 -69.36 0.66 Allowed 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 108.276 -1.009 . . . . 61.34 108.276 173.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . 60.79 -74.69 0.03 OUTLIER 'General case' 0 C--N 1.358 0.963 0 O-C-N 125.111 1.507 . . . . 74.4 113.407 169.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 181' ' ' LEU . . . . . 0.439 ' HG ' ' HB ' ' C' ' 138' ' ' VAL . 30.3 tp -63.06 -30.14 71.36 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.146 1.378 . . . . 62.04 112.176 -177.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 182' ' ' VAL . . . . . 0.58 HG21 ' HB3' ' C' ' 139' ' ' GLU . 2.8 p -99.11 133.93 39.97 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 CA-C-N 116.189 -0.459 . . . . 71.31 110.982 174.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 183' ' ' ALA . . . . . 0.433 ' HB3' ' HA ' ' C' ' 123' ' ' LEU . . . -159.11 39.47 0.21 Allowed 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 114.806 -1.088 . . . . 65.24 108.453 163.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 42.5 p-80 54.49 171.44 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 127.216 2.207 . . . . 74.15 114.731 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 185' ' ' VAL . . . . . 0.478 HG21 HD11 ' C' ' 119' ' ' LEU . 6.9 p -78.65 134.92 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-N 115.638 -0.71 . . . . 71.33 110.469 177.152 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 186' ' ' THR . . . . . 0.505 HG21 ' HG3' ' C' ' 122' ' ' GLU . 8.8 t -79.6 163.89 24.26 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.395 0.678 . . . . 51.31 111.406 -177.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 187' ' ' SER . . . . . . . . . . . . . 11.6 m -81.58 -29.08 33.5 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.418 1.087 . . . . 62.14 111.005 177.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 21.7 mtm180 -88.24 115.71 25.92 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.725 0.81 . . . . 71.52 109.84 -176.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -74.33 85.7 1.96 Allowed 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.454 0.702 . . . . 72.52 109.995 -177.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 190' ' ' CYS . . . . . 0.529 ' HB2' HG21 ' C' ' 177' ' ' VAL . 36.7 m -85.81 90.14 7.96 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 114.735 -1.12 . . . . 70.33 109.64 -179.203 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -64.18 145.47 55.9 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 114.975 -1.011 . . . . 74.04 110.352 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -113.38 158.02 14.56 Favored Glycine 0 N--CA 1.468 0.804 0 CA-C-O 119.508 -0.606 . . . . 64.22 112.532 -178.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 193' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -95.09 -162.95 0.09 OUTLIER 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 123.273 2.649 . . . . 64.32 111.547 175.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 194' ' ' SER . . . . . . . . . . . . . 47.1 m -84.38 155.11 22.47 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 109.807 -0.442 . . . . 24.51 109.807 171.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 195' ' ' ALA . . . . . . . . . . . . . . . -138.35 145.48 41.16 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.544 0.737 . . . . 74.32 110.383 -178.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 196' ' ' THR . . . . . 0.431 ' HB ' ' O ' ' B' ' 202' ' ' GLY . 8.0 m -63.21 -66.98 0.46 Allowed 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 108.767 -0.827 . . . . 73.32 108.767 172.012 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 47.6 m 50.92 28.99 4.09 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.866 1.266 . . . . 75.11 113.03 174.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 198' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.07 89.32 3.01 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 108.749 -0.834 . . . . 51.12 108.749 -174.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 45.9 tttp 71.18 -8.19 1.03 Allowed 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 125.308 1.443 . . . . 74.4 112.595 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 200' ' ' CYS . . . . . . . . . . . . . 34.8 m -138.93 168.89 13.95 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 124.057 0.943 . . . . 73.31 109.897 -167.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 201' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -73.11 3.37 4.62 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 122.107 1.871 . . . . 71.34 112.458 165.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 202' ' ' GLY . . . . . 0.67 ' HA2' ' HA2' ' C' ' 190' ' ' GLY . . . -58.12 117.18 9.66 Favored Glycine 0 C--N 1.359 1.849 0 C-N-CA 123.728 0.68 . . . . 63.04 113.498 175.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 27.3 t30 -170.28 122.68 0.67 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.59 1.156 . . . . 71.33 109.027 -178.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 204' ' ' ALA . . . . . 0.627 ' HB1' ' HB3' ' B' ' 26' ' ' MET . . . -71.68 88.87 0.99 Allowed 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.207 -0.664 . . . . 74.01 109.207 174.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 205' ' ' LEU . . . . . . . . . . . . . 19.4 tp -106.57 -52.74 2.73 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.068 -0.969 . . . . 51.03 108.603 -176.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 58.01 -74.26 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.833 1.653 . . . . 62.32 110.467 -173.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 207' ' ' LYS . . . . . 0.418 ' HD2' ' HB ' ' B' ' 23' ' ' THR . 4.1 ttmp? -103.81 -78.11 0.56 Allowed 'General case' 0 C--O 1.243 0.72 0 N-CA-C 107.349 -1.352 . . . . 74.32 107.349 174.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 52.21 34.06 39.52 Favored Glycine 0 C--N 1.356 1.676 0 O-C-N 124.005 0.816 . . . . 71.52 114.527 173.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 209' ' ' GLY . . . . . 0.583 ' HA3' HH21 ' B' ' 22' ' ' ARG . . . 93.71 75.95 1.31 Allowed Glycine 0 C--N 1.341 0.807 0 N-CA-C 111.316 -0.714 . . . . 42.21 111.316 -174.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 210' ' ' LYS . . . . . 0.515 ' HD3' ' O ' ' C' ' 155' ' ' GLU . 4.8 ttpm? -163.97 -34.22 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.001 0.52 . . . . 74.51 111.394 -178.173 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . -69.38 66.95 0.55 Allowed Glycine 0 C--N 1.362 1.998 0 O-C-N 123.792 0.683 . . . . 74.43 114.067 -171.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 65.4 m -165.77 -44.04 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.641 1.576 . . . . 74.04 107.579 -172.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 49.3 mt 55.67 80.61 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.362 1.14 0 C-N-CA 125.86 1.664 . . . . 64.4 111.047 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 74.0 p -78.15 77.94 4.64 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-O 122.507 1.146 . . . . 75.43 109.443 178.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 215' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -128.06 -52.99 1.31 Allowed 'General case' 0 C--O 1.237 0.408 0 CA-C-N 113.697 -1.592 . . . . 73.31 108.16 -176.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 77.81 -20.63 0.37 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 124.824 1.328 . . . . 61.42 112.401 175.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 5.7 tt -77.21 -64.0 1.24 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.878 0.871 . . . . 75.4 110.253 -169.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 218' ' ' LEU . . . . . 0.541 ' HB3' ' HA ' ' B' ' 222' ' ' ALA . 51.8 mt -80.97 -36.92 30.18 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 110.139 -0.319 . . . . 71.43 110.139 173.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 70.28 103.94 0.06 Allowed 'General case' 0 C--N 1.359 1.014 0 O-C-N 124.771 1.294 . . . . 71.24 112.419 172.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . 64.81 -75.16 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 125.384 1.474 . . . . 61.1 113.42 167.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 221' ' ' ARG . . . . . . . . . . . . . 18.0 tpp180 -60.22 -40.65 90.91 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.47 1.108 . . . . 73.55 111.446 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 222' ' ' ALA . . . . . 0.541 ' HA ' ' HB3' ' B' ' 218' ' ' LEU . . . 60.53 49.55 6.54 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 124.216 0.948 . . . . 42.52 111.327 177.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -46.75 -64.78 0.68 Allowed 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 125.696 1.598 . . . . 61.02 112.774 -172.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 54.6 t -41.53 -62.6 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 125.558 1.543 . . . . 74.2 112.736 -167.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 225' ' ' THR . . . . . 0.575 HG22 ' HD2' ' C' ' 184' ' ' PRO . 60.2 p 50.69 -70.36 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 125.771 1.628 . . . . 54.34 113.726 -175.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 2.7 tm? 72.7 96.05 0.07 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.679 1.192 . . . . 74.43 109.282 175.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . 155.81 -22.16 0.53 Allowed Glycine 0 C--N 1.347 1.14 0 CA-C-O 119.433 -0.648 . . . . 51.31 113.313 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . -56.12 -55.38 29.64 Favored Glycine 0 CA--C 1.536 1.388 0 N-CA-C 114.299 0.48 . . . . 72.41 114.299 -173.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -118.64 50.93 0.78 Allowed Glycine 0 C--N 1.345 1.051 0 N-CA-C 111.037 -0.825 . . . . 70.24 111.037 176.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -58.33 130.99 49.3 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.054 0.942 . . . . 70.23 111.725 -174.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 231' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -68.27 130.64 43.51 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 123.814 0.696 . . . . 73.24 112.116 -169.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 232' ' ' THR . . . . . 0.419 ' H ' HD21 ' B' ' 258' ' ' LEU . 14.7 t -154.95 -178.6 7.35 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.571 1.148 . . . . 74.24 108.859 177.169 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -132.77 94.08 3.33 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 107.795 -1.187 . . . . 70.41 107.795 172.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -148.08 173.39 12.98 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.338 0.655 . . . . 72.31 110.857 -176.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 235' ' ' GLU . . . . . 0.478 ' HA ' ' HZ3' ' C' ' 209' ' ' LYS . 38.1 tt0 -158.87 77.01 0.74 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.3 0.64 . . . . 54.41 110.502 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 236' ' ' THR . . . . . . . . . . . . . 85.6 m -150.77 128.18 11.39 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.761 0.824 . . . . 73.34 109.565 172.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -76.62 85.06 3.28 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.108 0.563 . . . . 71.12 109.58 172.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 4.4 m -93.67 17.29 12.06 Favored 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 123.818 0.847 . . . . 71.31 110.753 -175.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 239' ' ' ALA . . . . . 0.426 ' HA ' HD22 ' C' ' 235' ' ' LEU . . . -83.29 153.29 24.72 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.678 0.791 . . . . 74.42 111.345 -176.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 240' ' ' GLY . . . . . 0.424 ' O ' ' HE3' ' B' ' 245' ' ' LYS . . . -86.86 -60.62 1.67 Allowed Glycine 0 C--N 1.349 1.288 0 CA-C-N 116.008 -0.542 . . . . 71.23 113.708 -164.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 241' ' ' GLU . . . . . 0.422 ' HG2' ' H ' ' C' ' 234' ' ' ARG . 15.4 pt-20 -112.18 -167.41 1.18 Allowed 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 117.49 0.645 . . . . 71.21 110.685 178.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 242' ' ' TRP . . . . . 0.416 ' CH2' HG21 ' C' ' 253' ' ' VAL 0.259 0.0 OUTLIER 59.53 166.33 0.06 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 127.647 2.379 . . . . 70.32 114.567 177.496 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' B' B ' 243' ' ' GLN . . . . . 0.466 ' HG3' ' H ' ' B' ' 245' ' ' LYS . 1.9 pt20 51.99 -166.95 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 126.519 1.928 . . . . 74.22 114.584 170.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -78.98 -43.81 10.58 Favored Glycine 0 C--N 1.362 2.007 0 CA-C-N 115.773 -0.649 . . . . 63.11 112.246 173.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 245' ' ' LYS . . . . . 0.466 ' H ' ' HG3' ' B' ' 243' ' ' GLN . 22.9 pttm 44.74 40.77 4.46 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 126.324 1.85 . . . . 75.34 112.734 -178.022 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 15.3 t -145.45 174.14 11.4 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.63 0.772 . . . . 71.02 110.316 -175.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 247' ' ' LEU . . . . . . . . . . . . . 87.8 mt 64.95 -83.36 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.834 1.254 . . . . 72.51 110.834 -177.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 248' ' ' ARG . . . . . . . . . . . . . 7.4 tpp180 -164.54 11.19 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.155 0.982 . . . . 75.15 109.097 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 51.61 -145.3 0.53 Allowed 'General case' 0 C--N 1.354 0.77 0 C-N-CA 124.794 1.238 . . . . 71.33 112.239 -169.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 250' ' ' GLN . . . . . 0.482 ' HG3' ' HD3' ' C' ' 225' ' ' PRO . 46.5 mm-40 -96.59 51.88 1.19 Allowed 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 111.905 0.335 . . . . 65.4 111.905 -156.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 251' ' ' ALA . . . . . . . . . . . . . . . 75.05 -58.0 0.59 Allowed 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 125.778 1.631 . . . . 61.03 113.149 174.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 19.6 mm100 -86.51 53.26 2.75 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.475 0.71 . . . . 72.3 111.751 -177.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 253' ' ' ALA . . . . . 0.667 ' HB1' ' HE3' ' C' ' 209' ' ' LYS . . . -102.43 40.45 1.35 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.76 0.824 . . . . 51.41 109.356 175.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 42.1 ttp-105 -168.28 -64.83 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.277 0.631 . . . . 72.51 109.957 -178.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . 58.68 -100.85 0.18 Allowed Glycine 0 C--N 1.362 2.024 0 O-C-N 123.568 0.543 . . . . 54.22 111.877 -177.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 256' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -148.04 -57.9 0.24 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.291 1.037 . . . . 52.52 108.7 168.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 25.9 pt20 -143.3 174.97 10.26 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.586 0.755 . . . . 74.31 110.474 -173.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 258' ' ' LEU . . . . . 0.43 ' HB3' ' HE1' ' A' ' 277' ' ' TYR . 2.3 pt? -148.82 148.36 29.83 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.404 0.682 . . . . 75.13 109.745 178.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 15.1 m -119.24 163.56 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.745 0.818 . . . . 63.02 110.163 173.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 260' ' ' SER . . . . . . . . . . . . . 21.3 t -121.13 142.54 49.77 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.855 0.862 . . . . 73.11 108.734 177.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -101.0 -69.26 0.78 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 122.74 0.416 . . . . 52.21 110.873 178.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 262' ' ' ALA . . . . . . . . . . . . . . . -166.67 -149.92 0.11 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.528 0.731 . . . . 43.43 109.258 -169.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 263' ' ' ALA . . . . . 0.447 ' HB3' HG21 ' B' ' 225' ' ' THR . . . -161.64 -167.8 1.81 Allowed 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 118.024 0.375 . . . . 70.44 111.919 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 264' ' ' SER . . . . . 0.769 ' H ' HG21 ' C' ' 196' ' ' THR . 36.1 t 68.31 94.89 0.07 Allowed 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 126.284 1.834 . . . . 51.14 112.553 175.268 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 265' ' ' LEU . . . . . 0.635 HD21 ' HB1' ' A' ' 229' ' ' ALA . 27.8 mt -130.07 -74.63 0.54 Allowed 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 124.098 0.959 . . . . 64.12 109.923 171.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 266' ' ' ASN . . . . . 0.583 HD21 ' HB3' ' B' ' 270' ' ' GLU . 8.5 t-20 69.0 158.72 0.16 Allowed 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 125.345 1.458 . . . . 71.52 110.934 -173.315 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 75.9 p -72.91 -56.72 4.77 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 109.487 -0.56 . . . . 73.13 109.487 175.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 6.2 p 177.37 -40.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.661 1.584 . . . . 74.44 107.532 175.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 269' ' ' THR . . . . . . . . . . . . . 20.0 p -140.27 35.04 1.89 Allowed 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.82 1.248 . . . . 74.31 108.739 177.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 270' ' ' GLU . . . . . 0.583 ' HB3' HD21 ' B' ' 266' ' ' ASN . 8.6 pt-20 46.76 -72.52 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.052 0 C-N-CA 127.363 2.265 . . . . 72.41 114.966 -177.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 271' ' ' ALA . . . . . . . . . . . . . . . -70.2 79.37 0.52 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.934 0.893 . . . . 75.3 111.195 -178.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 272' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -125.62 -63.9 1.1 Allowed 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 107.802 -1.184 . . . . 54.14 107.802 177.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 46.6 mm-40 47.98 -86.05 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 126.542 1.937 . . . . 61.32 114.319 170.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 67.3 126.01 0.02 OUTLIER 'General case' 0 C--N 1.363 1.18 0 C-N-CA 125.265 1.426 . . . . 71.44 111.171 -176.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 275' ' ' LYS . . . . . 0.406 ' HB3' ' NZ ' ' B' ' 275' ' ' LYS . 0.0 OUTLIER 64.84 93.63 0.06 OUTLIER Pre-proline 0 CA--C 1.567 1.618 0 C-N-CA 123.896 0.879 . . . . 71.33 110.294 177.194 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -83.98 3.04 7.88 Favored 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 122.642 2.228 . . . . 62.35 113.245 175.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 277' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -72.74 116.12 12.85 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 122.997 0.519 . . . . 63.32 110.084 -179.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -54.5 -50.98 66.51 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 124.081 0.953 . . . . 62.0 112.104 176.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . 139.28 -99.67 0.27 Allowed Glycine 0 C--N 1.342 0.883 0 N-CA-C 110.92 -0.872 . . . . 75.43 110.92 -171.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.81 -37.38 0.37 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 122.9 0.48 . . . . 53.23 111.542 -178.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 281' ' ' PHE . . . . . 0.4 ' CE1' ' HB3' ' B' ' 250' ' ' GLN . 76.0 t80 63.19 -87.07 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.359 1.064 . . . . 75.31 109.978 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . 60.01 27.65 17.09 Favored 'General case' 0 CA--C 1.565 1.556 0 N-CA-C 115.401 1.63 . . . . 65.41 115.401 168.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -86.02 -52.04 5.96 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.997 -0.439 . . . . 72.33 111.619 -177.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . -78.5 71.98 2.43 Favored Glycine 0 C--N 1.35 1.329 0 CA-C-N 115.571 -0.74 . . . . 61.45 112.85 -173.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 7.0 t30 57.88 91.19 0.04 OUTLIER 'General case' 0 C--N 1.358 0.978 0 C-N-CA 125.058 1.343 . . . . 72.41 111.545 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 286' ' ' MET . . . . . 0.564 ' HG3' ' HD3' ' B' ' 289' ' ' ARG . 44.8 tpp -157.05 68.36 4.3 Favored Pre-proline 0 CA--C 1.555 1.162 0 N-CA-C 109.2 -0.667 . . . . 64.1 109.2 -178.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 287' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -76.87 -68.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.385 2.451 0 C-N-CA 122.549 2.166 . . . . 73.33 112.322 -176.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 288' ' ' VAL . . . . . . . . . . . . . 27.0 m -88.75 20.93 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 123.65 0.78 . . . . 74.32 111.07 176.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 289' ' ' ARG . . . . . 0.564 ' HD3' ' HG3' ' B' ' 286' ' ' MET . 25.2 mmt85 59.6 84.34 0.12 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.155 1.382 . . . . 72.14 111.343 173.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 290' ' ' TRP . . . . . . . . . . . . . 64.6 m95 72.02 118.44 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 125.85 1.66 . . . . 75.34 110.5 -177.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 291' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -153.38 126.79 8.62 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 109.868 -0.419 . . . . 64.34 109.868 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . 63.69 -151.6 48.9 Favored Glycine 0 C--N 1.35 1.308 0 O-C-N 124.091 0.87 . . . . 62.12 113.649 174.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -92.52 15.47 1.52 Allowed 'Trans proline' 0 CA--C 1.556 1.577 0 C-N-CA 123.281 2.654 . . . . 51.12 113.272 177.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 63.0 tttp 70.31 -74.83 0.08 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.911 1.284 . . . . 41.23 112.685 177.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -61.45 -39.28 90.29 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 112.911 0.708 . . . . 34.32 112.911 -172.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 6.2 t 47.57 -178.97 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 126.446 1.898 . . . . 65.42 113.266 -176.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 20.6 t80 41.06 84.43 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 125.778 1.631 . . . . 64.12 113.447 165.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 77.38 -57.2 0.51 Allowed 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 125.731 1.612 . . . . 71.5 111.991 -178.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . -62.99 -30.36 77.18 Favored Glycine 0 C--N 1.354 1.549 0 O-C-N 123.282 0.364 . . . . 63.41 112.854 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 66.07 -74.3 0.06 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.741 1.616 . . . . 72.23 111.902 177.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 301' ' ' ILE . . . . . 0.431 HG23 ' HB2' ' B' ' 303' ' ' LYS . 17.0 tt -145.77 145.21 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 123.124 0.57 . . . . 72.24 110.857 -177.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -79.91 56.21 2.28 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.823 0.849 . . . . 63.41 109.047 171.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 303' ' ' LYS . . . . . 0.431 ' HB2' HG23 ' B' ' 301' ' ' ILE . 11.4 tmtt? -80.19 108.1 8.61 Favored Pre-proline 0 CA--C 1.549 0.916 0 N-CA-C 108.733 -0.84 . . . . 74.11 108.733 -175.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 304' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -87.66 -162.82 0.15 Allowed 'Trans proline' 0 C--N 1.375 1.929 0 C-N-CA 122.681 2.254 . . . . 75.12 111.311 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -63.94 -36.95 85.63 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 122.808 0.443 . . . . 42.33 110.518 172.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 61.8 t 62.71 -76.16 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 125.554 1.542 . . . . 72.33 110.493 -176.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 38.4 m -78.13 103.68 8.23 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.983 0.913 . . . . 74.23 109.462 177.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 308' ' ' CYS . . . . . . . . . . . . . 48.4 t -82.46 -6.63 59.42 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.286 0.634 . . . . 74.22 110.47 175.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 19.6 m -68.12 118.61 60.48 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 124.242 1.017 . . . . 72.2 109.936 173.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -60.51 -46.33 17.99 Favored 'Trans proline' 0 C--N 1.382 2.327 0 C-N-CA 122.573 2.182 . . . . 63.14 111.841 177.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 311' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -163.31 150.86 11.02 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 124.073 0.949 . . . . 73.13 109.538 177.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 312' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -77.51 148.58 26.42 Favored 'Trans proline' 0 C--N 1.377 2.054 0 C-N-CA 122.414 2.076 . . . . 70.14 111.689 175.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 313' ' ' GLN . . . . . . . . . . . . . 26.7 mp0 -79.18 120.11 23.22 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 122.982 0.513 . . . . 75.13 110.252 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 314' ' ' ARG . . . . . . . . . . . . . 2.6 ppt_? -73.98 84.72 1.76 Allowed 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 122.978 0.511 . . . . 72.01 110.823 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 315' ' ' ASN . . . . . . . . . . . . . 7.2 t30 70.33 -74.53 0.08 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.864 1.266 . . . . 72.12 110.22 -175.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 316' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -95.1 -166.77 1.51 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.922 0.889 . . . . 74.4 110.546 -178.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 4.5 m -90.42 -68.28 0.79 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.526 0.731 . . . . 75.41 111.695 -177.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 318' ' ' VAL . . . . . 0.417 ' H ' ' HD2' ' B' ' 319' ' ' PRO . 62.4 t -130.52 -62.87 0.02 OUTLIER Pre-proline 0 CA--C 1.567 1.629 0 CA-C-O 118.414 -0.803 . . . . 73.13 112.664 -164.173 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 319' ' ' PRO . . . . . 0.417 ' HD2' ' H ' ' B' ' 318' ' ' VAL . 76.4 Cg_endo -70.7 -12.0 30.45 Favored 'Trans proline' 0 C--N 1.386 2.528 0 C-N-CA 121.802 1.668 . . . . 65.1 114.514 -165.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 320' ' ' THR . . . . . . . . . . . . . 7.9 m 62.91 76.34 0.37 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.599 1.16 . . . . 53.31 109.73 -175.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 321' ' ' LEU . . . . . . . . . . . . . 28.0 tp -140.77 76.56 1.56 Allowed 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 116.007 -0.542 . . . . 65.14 110.925 -170.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 322' ' ' ALA . . . . . . . . . . . . . . . 63.29 -75.56 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 125.775 1.63 . . . . 64.54 114.743 166.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 323' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -96.99 178.32 5.32 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.677 0.791 . . . . 74.02 110.488 -175.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 324' ' ' MET . . . . . 0.423 ' SD ' ' N ' ' B' ' 324' ' ' MET . 1.4 mpt? -71.51 90.85 1.02 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 109.256 -0.646 . . . . 71.32 109.256 177.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 325' ' ' THR . . . . . . . . . . . . . 50.2 p -55.78 -35.87 66.73 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.155 0.982 . . . . 72.33 113.058 -172.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 326' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -161.36 -94.64 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.52 0.328 . . . . 72.01 110.336 176.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -82.91 101.3 10.93 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.774 -0.578 . . . . 54.34 110.197 -177.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 328' ' ' ALA . . . . . . . . . . . . . . . -82.72 -26.37 32.05 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 115.596 -0.729 . . . . 72.03 109.975 169.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 329' ' ' ILE . . . . . 0.426 HG13 ' HB2' ' B' ' 54' ' ' ALA . 0.2 OUTLIER -136.91 161.04 36.52 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 C-N-CA 124.834 1.254 . . . . 73.5 109.083 -179.618 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 330' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -82.03 -43.35 18.06 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.903 -0.589 . . . . 63.42 110.885 174.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 331' ' ' LEU . . . . . 0.439 HD11 ' HD2' ' C' ' 234' ' ' ARG . 19.5 tp -168.54 172.03 8.47 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.32 0.648 . . . . 63.34 109.897 -167.348 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -65.17 114.13 4.45 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 123.989 0.916 . . . . 74.41 110.089 173.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 333' ' ' SER . . . . . . . . . . . . . 35.6 t -100.12 176.62 5.34 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.546 0.738 . . . . 65.04 110.274 175.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 334' ' ' LYS . . . . . 0.411 ' HZ2' ' HB3' ' B' ' 334' ' ' LYS . 0.0 OUTLIER -137.16 -14.66 1.53 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.54 0.736 . . . . 63.11 110.088 -173.619 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 335' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -83.82 59.51 5.25 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.657 0.783 . . . . 73.25 112.1 -168.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -174.52 -72.68 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.339 1.456 . . . . 61.02 107.201 171.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 337' ' ' LYS . . . . . . . . . . . . . 85.8 tttt 56.1 -81.69 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 125.392 1.477 . . . . 62.43 112.472 175.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 338' ' ' GLY . . . . . . . . . . . . . . . -178.54 -163.13 29.35 Favored Glycine 0 C--O 1.243 0.712 0 N-CA-C 109.817 -1.313 . . . . 72.34 109.817 -176.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 339' ' ' PHE . . . . . . . . . . . . . 40.0 t80 58.05 38.42 26.64 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.603 0.716 . . . . 74.33 109.69 176.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 340' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 63.02 -78.77 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 125.43 1.492 . . . . 75.24 110.304 -169.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 341' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -166.96 -79.15 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 105.339 -2.097 . . . . 75.34 105.339 170.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 342' ' ' GLN . . . . . 0.401 ' HA ' ' HB3' ' B' ' 347' ' ' SER . 49.6 mt-30 58.97 179.98 0.08 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 125.201 1.401 . . . . 64.25 112.829 175.174 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 343' ' ' VAL . . . . . 0.448 HG13 ' H ' ' B' ' 344' ' ' GLU 0.255 6.9 p 47.94 -70.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.467 0 C-N-CA 126.705 2.002 . . . . 64.24 114.215 -179.905 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 344' ' ' GLU . . . . . 0.448 ' H ' HG13 ' B' ' 343' ' ' VAL . 36.6 tt0 -64.37 -40.0 94.97 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.039 0.936 . . . . 73.03 110.25 173.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 345' ' ' GLY . . . . . . . . . . . . . . . -90.13 153.51 22.96 Favored Glycine 0 C--N 1.346 1.096 0 N-CA-C 111.1 -0.8 . . . . 62.31 111.1 174.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 346' ' ' ALA . . . . . . . . . . . . . . . -74.77 86.44 2.2 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.245 0.545 . . . . 72.22 110.622 -178.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 347' ' ' SER . . . . . 0.401 ' HB3' ' HA ' ' B' ' 342' ' ' GLN . 11.1 p -87.19 29.1 0.87 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.139 0.976 . . . . 72.21 112.079 -178.075 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 2.3 mp 60.91 -76.56 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.098 0 C-N-CA 125.332 1.453 . . . . 73.42 109.543 -174.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 349' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -75.46 140.47 42.89 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 120.982 0.42 . . . . 71.13 110.107 172.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 350' ' ' LYS . . . . . 0.425 ' HE3' ' HB2' ' B' ' 350' ' ' LYS . 30.2 mtmt -110.49 105.05 13.87 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 124.557 1.143 . . . . 74.52 108.571 -173.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -70.73 81.44 0.62 Allowed 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.232 0.613 . . . . 71.32 110.336 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -175.71 37.38 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.585 1.154 . . . . 74.35 108.29 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 353' ' ' HIS . . . . . . . . . . . . . 4.9 p80 63.58 -17.45 0.06 Allowed 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 127.499 2.32 . . . . 74.33 115.156 178.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 354' ' ' ALA . . . . . . . . . . . . . . . 52.41 -90.77 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.468 1.107 . . . . 70.11 111.909 -174.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 355' ' ' ALA . . . . . . . . . . . . . . . -116.42 -80.26 0.6 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.543 0.737 . . . . 75.44 109.152 177.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 356' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -164.91 61.58 0.83 Allowed Pre-proline 0 N--CA 1.485 1.315 0 C-N-CA 123.113 0.565 . . . . 74.32 111.347 178.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 357' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.4 -31.43 11.4 Favored 'Trans proline' 0 C--N 1.38 2.222 0 C-N-CA 122.476 2.117 . . . . 55.22 112.97 -177.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 358' ' ' CYS . . . . . . . . . . . . . 67.8 m -78.17 130.62 36.56 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 109.566 -0.531 . . . . 73.32 109.566 177.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 359' ' ' GLY . . . . . . . . . . . . . . . -82.44 55.04 4.96 Favored Glycine 0 C--N 1.347 1.18 0 O-C-N 123.585 0.553 . . . . 62.01 112.555 -179.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 360' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -81.13 128.04 33.31 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.727 0.811 . . . . 53.34 109.159 -179.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 361' ' ' ILE . . . . . . . . . . . . . 58.0 mt -69.66 91.3 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 N-CA-C 107.769 -1.197 . . . . 61.31 107.769 171.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 362' ' ' GLY . . . . . . . . . . . . . . . 73.34 -157.6 52.16 Favored Glycine 0 C--N 1.348 1.205 0 CA-C-N 115.6 -0.727 . . . . 72.35 111.29 -167.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 363' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 62.57 15.41 7.9 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 125.081 1.352 . . . . 73.13 111.433 174.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 364' ' ' THR . . . . . 0.431 HG21 HD12 ' B' ' 367' ' ' LEU . 1.3 m -82.51 10.5 7.15 Favored 'General case' 0 CA--C 1.562 1.424 0 C-N-CA 123.44 0.696 . . . . 74.04 111.064 -174.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 49.1 t 70.44 -75.01 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.361 1.069 0 C-N-CA 126.431 1.892 . . . . 74.01 110.845 173.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -73.65 -42.14 61.78 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.752 0.821 . . . . 50.12 111.611 -177.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 367' ' ' LEU . . . . . 0.431 HD12 HG21 ' B' ' 364' ' ' THR . 64.0 mt -74.52 -77.95 0.11 Allowed 'General case' 0 CA--C 1.546 0.8 0 O-C-N 123.307 0.379 . . . . 75.05 110.441 -176.264 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 368' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -142.25 158.79 43.33 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.151 0.58 . . . . 71.23 111.006 -173.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 369' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -99.1 -80.52 0.46 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.372 1.069 . . . . 70.1 110.298 175.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 370' ' ' ALA . . . . . . . . . . . . . . . -179.19 -60.71 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 108.611 -0.885 . . . . 74.25 108.611 -177.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 371' ' ' VAL . . . . . . . . . . . . . 65.6 t -102.24 -58.44 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 115.119 -0.946 . . . . 74.11 109.291 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 372' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 71.15 -16.23 0.37 Allowed 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 125.299 1.44 . . . . 63.2 114.329 176.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 373' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -74.0 86.31 1.81 Allowed 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 108.695 -0.854 . . . . 72.05 108.695 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . 61.63 18.08 9.22 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.661 0.784 . . . . 71.45 112.628 -178.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 375' ' ' LEU . . . . . . . . . . . . . 46.9 tp 69.51 150.17 0.08 Allowed 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 125.799 1.64 . . . . 62.01 111.659 -172.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -84.18 135.33 34.41 Favored 'General case' 0 CA--C 1.559 1.31 0 C-N-CA 124.232 1.013 . . . . 73.13 109.254 175.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 377' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -132.79 68.62 1.5 Allowed 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.684 0.794 . . . . 73.31 109.741 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 378' ' ' ALA . . . . . 0.429 ' HB3' ' HA ' ' B' ' 383' ' ' ASN . . . 56.54 -74.76 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 125.512 1.525 . . . . 61.1 113.407 177.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 379' ' ' LYS . . . . . 0.484 ' HA ' ' HB3' ' B' ' 400' ' ' ALA . 0.2 OUTLIER -84.57 4.57 31.51 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 124.011 0.924 . . . . 72.01 110.632 171.681 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 380' ' ' LYS . . . . . . . . . . . . . 26.2 tptp 73.88 -63.03 0.44 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.226 1.81 . . . . 53.14 111.567 -172.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 381' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -65.54 -36.76 84.73 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.969 0.908 . . . . 74.34 112.279 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 382' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' B' ' 379' ' ' LYS . . . -155.29 122.89 1.27 Allowed Glycine 0 C--N 1.346 1.115 0 N-CA-C 110.926 -0.87 . . . . 73.1 110.926 -178.355 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 383' ' ' ASN . . . . . 0.429 ' HA ' ' HB3' ' B' ' 378' ' ' ALA . 2.4 p-10 -57.65 -66.82 0.4 Allowed 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.577 0.751 . . . . 73.1 112.502 -175.28 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 384' ' ' THR . . . . . 0.407 ' HB ' ' H ' ' B' ' 385' ' ' LEU . 1.8 p -160.53 -162.85 1.0 Allowed 'General case' 0 C--O 1.246 0.879 0 C-N-CA 125.359 1.464 . . . . 63.41 107.692 -174.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 385' ' ' LEU . . . . . 0.454 ' HB3' ' OE1' ' B' ' 432' ' ' GLN . 4.0 mm? 67.28 -173.19 0.19 Allowed 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 124.443 1.097 . . . . 75.12 111.549 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 386' ' ' VAL . . . . . 0.684 HG22 ' HB3' ' B' ' 391' ' ' ASP . 25.1 t -76.78 88.5 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 123.16 0.584 . . . . 62.42 110.159 -177.218 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 387' ' ' ILE . . . . . . . . . . . . . 8.6 tp -78.4 125.15 37.74 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 N-CA-C 109.557 -0.535 . . . . 74.12 109.557 178.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 388' ' ' VAL . . . . . . . . . . . . . 61.2 t 64.79 -73.84 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 125.653 1.581 . . . . 54.33 111.34 -174.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 389' ' ' THR . . . . . . . . . . . . . 14.5 t -155.74 9.7 0.27 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 122.713 0.405 . . . . 71.25 111.516 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . -144.83 126.8 15.47 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 122.816 0.446 . . . . 70.34 110.522 -176.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 391' ' ' ASP . . . . . 0.684 ' HB3' HG22 ' B' ' 386' ' ' VAL . 5.1 p-10 -85.49 -29.85 23.94 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.617 0.767 . . . . 64.12 110.746 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 392' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 65.25 -82.15 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.067 1.347 . . . . 72.42 112.005 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -158.55 -158.53 0.71 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.941 0.896 . . . . 61.53 109.008 -172.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -57.53 -59.82 4.59 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 109.663 -0.495 . . . . 73.31 109.663 172.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . -69.94 90.72 0.63 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 107.543 -1.28 . . . . 71.44 107.543 166.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 23.9 t -56.44 -29.79 62.07 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.502 1.121 . . . . 75.55 111.565 -175.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 397' ' ' GLN . . . . . 0.599 HE22 ' HB ' ' B' ' 399' ' ' VAL . 0.6 OUTLIER -131.04 144.17 51.25 Favored 'General case' 0 CA--C 1.556 1.175 0 N-CA-C 105.706 -1.961 . . . . 71.41 105.706 169.482 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 8.4 tp -65.9 -42.77 92.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 112.587 0.588 . . . . 75.44 112.587 -167.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 399' ' ' VAL . . . . . 0.599 ' HB ' HE22 ' B' ' 397' ' ' GLN . 79.4 t -64.08 145.53 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 123.449 0.7 . . . . 73.32 110.945 -178.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 400' ' ' ALA . . . . . 0.484 ' HB3' ' HA ' ' B' ' 379' ' ' LYS . . . 72.41 113.66 0.03 OUTLIER Pre-proline 0 C--N 1.357 0.905 0 O-C-N 124.967 1.417 . . . . 51.41 110.47 -178.175 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 401' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' B' ' 400' ' ' ALA . 11.1 Cg_exo -73.1 35.39 0.35 Allowed 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 123.494 2.796 . . . . 71.04 114.42 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 402' ' ' ASP . . . . . 0.575 ' HB3' ' HB3' ' B' ' 405' ' ' ALA . 2.3 m-20 80.36 -10.86 1.21 Allowed 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 125.898 1.679 . . . . 74.34 113.57 169.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 403' ' ' THR . . . . . 0.677 HG22 ' HG3' ' B' ' 404' ' ' LYS . 20.1 m 58.23 -81.16 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.261 0 C-N-CA 124.999 1.32 . . . . 51.3 111.992 -177.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 404' ' ' LYS . . . . . 0.677 ' HG3' HG22 ' B' ' 403' ' ' THR . 66.1 mttm -123.58 17.44 9.61 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.044 0.938 . . . . 70.03 111.285 -175.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 405' ' ' ALA . . . . . 0.575 ' HB3' ' HB3' ' B' ' 402' ' ' ASP . . . -107.92 93.84 11.48 Favored Pre-proline 0 N--CA 1.484 1.245 0 C-N-CA 122.932 0.493 . . . . 71.24 110.768 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 406' ' ' PRO . . . . . 0.419 ' HD3' ' O ' ' B' ' 404' ' ' LYS . 8.7 Cg_exo -74.54 -27.27 11.1 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 122.939 2.426 . . . . 44.44 111.302 172.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . -134.74 -119.07 1.91 Allowed Glycine 0 C--N 1.345 1.064 0 N-CA-C 111.153 -0.779 . . . . 55.33 111.153 175.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 408' ' ' LEU . . . . . . . . . . . . . 83.0 mt 70.04 5.3 5.21 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 125.053 1.341 . . . . 72.03 111.642 -175.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 11.0 t -77.71 -172.68 2.7 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 123.52 0.728 . . . . 73.52 111.716 -171.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 410' ' ' GLN . . . . . 0.488 ' NE2' ' HB2' ' B' ' 391' ' ' ASP . 0.9 OUTLIER -78.55 80.3 4.93 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 124.274 1.03 . . . . 51.32 109.467 -175.019 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . -71.77 146.63 47.96 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.187 -0.915 . . . . 63.14 109.962 177.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 73.2 mt -76.73 72.3 3.35 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.147 0.579 . . . . 60.41 109.724 -177.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 169.17 -44.8 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 126.237 1.815 . . . . 71.14 107.355 -173.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 414' ' ' THR . . . . . . . . . . . . . 55.8 m -64.01 137.06 57.82 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 114.655 -1.157 . . . . 73.24 111.265 178.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 415' ' ' LYS . . . . . 0.499 ' HE3' ' NE2' ' B' ' 432' ' ' GLN . 15.8 tptp 65.41 41.92 4.06 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.964 1.306 . . . . 73.42 110.593 176.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -74.6 84.78 2.07 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 114.994 -1.003 . . . . 75.33 110.82 -177.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 417' ' ' GLY . . . . . . . . . . . . . . . 50.4 67.8 1.72 Allowed Glycine 0 C--N 1.355 1.611 0 C-N-CA 124.232 0.92 . . . . 43.15 115.079 168.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 418' ' ' ALA . . . . . . . . . . . . . . . -66.82 -40.42 88.02 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.092 0.557 . . . . 70.25 110.626 177.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 419' ' ' VAL . . . . . . . . . . . . . 8.9 p -121.57 -27.04 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 C-N-CA 124.142 0.977 . . . . 62.03 109.657 173.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 420' ' ' MET . . . . . . . . . . . . . 16.6 tpt 79.62 -40.75 0.22 Allowed 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 125.968 1.707 . . . . 73.12 112.89 173.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 421' ' ' VAL . . . . . 0.458 ' HB ' ' HB3' ' B' ' 426' ' ' ASN . 4.1 t 59.0 67.47 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.097 0 C-N-CA 124.516 1.126 . . . . 72.42 109.761 -175.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 422' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -83.64 2.44 37.49 Favored 'General case' 0 N--CA 1.486 1.325 0 CA-C-N 115.002 -0.999 . . . . 74.1 111.619 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 423' ' ' SER . . . . . . . . . . . . . 6.7 m -55.6 -36.22 66.7 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.163 1.385 . . . . 62.22 112.512 -176.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 424' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -145.78 18.14 1.46 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.67 0.788 . . . . 72.42 110.453 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . 64.7 70.67 1.02 Allowed Glycine 0 C--N 1.351 1.393 0 CA-C-N 116.11 -0.495 . . . . 75.12 112.087 -176.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 426' ' ' ASN . . . . . 0.458 ' HB3' ' HB ' ' B' ' 421' ' ' VAL . 28.1 t-20 -101.91 -32.13 10.36 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.682 0.793 . . . . 75.43 111.137 -177.161 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 427' ' ' SER . . . . . . . . . . . . . 27.4 m 65.73 29.05 10.89 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.485 1.114 . . . . 75.14 111.997 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 428' ' ' GLU . . . . . 0.407 ' HG3' ' HA ' ' B' ' 432' ' ' GLN . 30.1 tt0 66.47 86.7 0.13 Allowed 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 124.779 1.232 . . . . 73.23 111.128 175.033 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 429' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -157.41 -35.31 0.08 Allowed 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 114.187 -1.37 . . . . 63.42 110.086 -172.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -49.81 -45.81 50.36 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.697 1.199 . . . . 55.41 111.835 -177.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 18.0 p -164.74 20.98 0.06 Allowed 'General case' 0 C--O 1.237 0.427 0 CA-C-N 114.694 -1.139 . . . . 73.31 109.392 176.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 432' ' ' GLN . . . . . 0.499 ' NE2' ' HE3' ' B' ' 415' ' ' LYS . 27.8 mt-30 58.31 -79.92 0.02 OUTLIER 'General case' 0 C--N 1.362 1.15 0 C-N-CA 124.422 1.089 . . . . 71.1 110.044 -165.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 433' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -84.3 71.92 10.61 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.046 0.938 . . . . 73.43 108.696 -178.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 434' ' ' HIS . . . . . . . . . . . . . 55.0 t60 -63.84 96.84 0.14 Allowed 'General case' 0 C--N 1.35 0.616 0 N-CA-C 108.109 -1.071 . . . . 65.13 108.109 176.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 435' ' ' THR . . . . . . . . . . . . . 29.4 m -74.19 82.04 1.82 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 122.04 0.924 . . . . 73.42 109.49 -178.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . -133.85 11.04 4.85 Favored Glycine 0 C--N 1.339 0.747 0 CA-C-N 113.799 -1.546 . . . . 43.54 111.008 176.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 46.8 t -107.42 -52.68 2.73 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.922 0.889 . . . . 54.14 109.288 179.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 438' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 37.03 -77.1 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.323 0 C-N-CA 126.686 1.995 . . . . 71.55 114.406 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 439' ' ' LEU . . . . . 0.518 HD11 ' HD2' ' A' ' 238' ' ' LYS . 49.0 tp 70.4 101.84 0.06 Allowed 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.571 1.148 . . . . 74.24 111.684 173.325 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 440' ' ' ARG . . . . . 0.454 ' N ' ' HD2' ' B' ' 440' ' ' ARG . 5.8 mpt_? -84.6 121.59 27.84 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 109.047 -0.723 . . . . 70.1 109.047 -176.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 441' ' ' ILE . . . . . 0.585 HG21 ' HB3' ' A' ' 233' ' ' LEU . 62.3 mt -76.26 -52.64 17.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 123.346 0.658 . . . . 74.15 109.981 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 442' ' ' ALA . . . . . . . . . . . . . . . 61.5 23.58 13.83 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.649 1.18 . . . . 71.41 112.42 177.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . -70.72 -46.77 62.45 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.244 0.618 . . . . 74.21 110.667 176.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -95.43 104.69 16.6 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.284 -0.871 . . . . 65.34 110.111 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . 174.94 54.4 0.05 OUTLIER Glycine 0 CA--C 1.531 1.057 0 CA-C-N 115.286 -0.87 . . . . 74.34 111.159 170.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 446' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -69.86 -50.1 0.49 Allowed 'Trans proline' 0 C--N 1.386 2.55 0 C-N-CA 122.719 2.28 . . . . 63.02 112.406 -168.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 447' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -163.42 124.16 2.3 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 108.089 -1.078 . . . . 60.0 108.089 178.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . -108.26 73.44 0.88 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.46 0.704 . . . . 74.31 109.849 -179.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 449' ' ' ALA . . . . . . . . . . . . . . . 57.93 -166.83 0.14 Allowed 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.417 1.087 . . . . 61.52 112.275 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 450' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -128.74 149.72 50.58 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 108.814 -0.81 . . . . 61.12 108.814 175.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 11.9 p -76.28 -0.05 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.589 0 C-N-CA 124.742 1.217 . . . . 63.1 111.834 -176.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 452' ' ' VAL . . . . . . . . . . . . . 29.6 m -74.04 82.49 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.22 0 CA-C-O 122.713 1.244 . . . . 60.45 111.656 176.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . -140.65 -86.59 0.11 Allowed Glycine 0 C--N 1.339 0.718 0 CA-C-N 114.695 -1.139 . . . . 73.44 110.97 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 454' ' ' LEU . . . . . . . . . . . . . 83.5 mt 58.84 90.68 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.727 1.211 . . . . 72.5 110.186 -177.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 74.3 p -78.68 18.16 0.62 Allowed 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 124.042 0.937 . . . . 61.41 112.951 -170.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -106.85 139.07 41.85 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.04 0.936 . . . . 74.3 109.165 171.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 457' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 62.28 13.98 6.38 Favored 'General case' 0 CA--C 1.567 1.615 0 C-N-CA 124.76 1.224 . . . . 42.14 111.24 -176.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 9.9 t -71.19 -16.13 62.5 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 124.707 1.203 . . . . 72.13 111.518 -176.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 459' ' ' ASP . . . . . . . . . . . . . 26.2 t70 71.69 -64.84 0.37 Allowed 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 126.046 1.739 . . . . 73.31 111.137 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 460' ' ' LEU . . . . . 0.581 HD23 ' HA ' ' B' ' 464' ' ' MET . 33.9 tp -62.12 154.49 26.95 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.747 0.819 . . . . 65.42 110.629 175.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -57.39 95.46 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 124.502 1.121 . . . . 62.31 111.569 -175.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 35.7 t80 67.61 -79.04 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 125.412 1.485 . . . . 72.53 111.886 175.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 10.0 t -119.74 162.36 19.19 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.216 0.606 . . . . 61.35 110.843 -178.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 464' ' ' MET . . . . . 0.581 ' HA ' HD23 ' B' ' 460' ' ' LEU . 0.0 OUTLIER -86.66 173.89 9.22 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 108.871 -0.788 . . . . 75.31 108.871 175.377 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 465' ' ' LYS . . . . . 0.543 ' N ' ' SD ' ' B' ' 464' ' ' MET . 68.3 mttm -56.55 93.46 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.709 0.804 . . . . 72.15 110.719 173.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -135.53 -38.34 0.74 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.157 0.983 . . . . 62.32 108.66 175.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . -131.67 20.75 4.66 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.101 -0.954 . . . . 75.3 109.755 173.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 94.5 mt -127.11 122.85 35.4 Favored 'General case' 0 C--O 1.246 0.91 0 C-N-CA 124.055 0.942 . . . . 45.51 109.579 -177.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 469' ' ' GLY . . . . . . . . . . . . . . . -133.14 -131.54 3.18 Favored Glycine 0 C--N 1.345 1.044 0 N-CA-C 110.866 -0.894 . . . . 50.44 110.866 173.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 470' ' ' LEU . . . . . . . . . . . . . 53.1 tp -165.67 142.22 5.37 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.692 1.197 . . . . 73.2 108.34 175.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 471' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.555 1.144 0 N-CA-C 107.017 -1.475 . . . . 74.2 107.017 175.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 85.7 mtp . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 119.559 -0.257 . . . . 55.23 111.302 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.13 41.91 19.71 Favored 'General case' 0 C--N 1.355 0.823 0 C-N-CA 124.474 1.11 . . . . 65.31 110.899 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.74 -5.02 0.51 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 114.673 1.36 . . . . 52.01 114.673 -171.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 4.4 ttmp? 46.36 78.46 0.07 Allowed 'General case' 0 C--O 1.244 0.773 0 C-N-CA 125.93 1.692 . . . . 70.52 113.385 178.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -78.42 111.1 14.08 Favored 'General case' 0 C--O 1.246 0.882 0 N-CA-C 107.614 -1.254 . . . . 63.2 107.614 165.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 6' ' ' ASP . . . . . 0.49 ' HA ' ' OH ' ' C' ' 66' ' ' TYR . 13.9 t70 -64.73 113.35 3.72 Favored 'General case' 0 C--N 1.345 0.41 0 O-C-N 123.679 0.612 . . . . 63.22 109.837 177.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 7' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -63.83 -31.6 72.84 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 114.893 -1.049 . . . . 73.43 111.535 -176.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -64.76 -39.71 94.08 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 116.322 -0.399 . . . . 72.53 110.462 174.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.93 -41.5 86.94 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.25 0.62 . . . . 52.31 111.166 176.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 61.3 mt -58.57 -40.15 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 122.988 0.515 . . . . 63.34 110.433 178.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 94.0 mt -83.8 -12.62 55.39 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 112.606 0.595 . . . . 45.45 112.606 177.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.36 22.67 78.8 Favored Glycine 0 CA--C 1.535 1.33 0 N-CA-C 114.196 0.438 . . . . 64.33 114.196 -178.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 14.1 m -104.47 152.76 39.39 Favored Pre-proline 0 N--CA 1.482 1.136 0 C-N-CA 123.916 0.886 . . . . 64.04 110.337 177.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -64.0 157.95 50.24 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.542 2.162 . . . . 74.43 112.436 173.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 71.0 mtt180 -77.47 22.3 0.24 Allowed 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 123.508 0.723 . . . . 71.52 112.262 -179.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -120.9 8.79 10.53 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.965 1.306 . . . . 71.24 108.333 173.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.41 133.92 50.47 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 123.671 0.788 . . . . 71.14 111.328 -178.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 53.0 p -104.24 -176.11 2.99 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.564 1.146 . . . . 74.41 109.993 -178.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -48.41 -52.3 22.64 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 124.623 1.169 . . . . 74.45 112.184 -171.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.79 -48.4 63.73 Favored 'General case' 0 C--O 1.212 -0.912 0 O-C-N 123.746 0.654 . . . . 64.05 109.943 -172.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -63.93 -38.98 93.07 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.003 0.921 . . . . 73.42 111.562 -174.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 22' ' ' ILE . . . . . 0.816 HD13 ' HB3' ' C' ' 57' ' ' LEU . 78.3 mt -67.9 -50.3 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 123.977 0.911 . . . . 61.32 110.325 175.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -66.3 -22.31 66.29 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.195 -0.912 . . . . 74.13 110.017 -178.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 -74.05 -48.4 30.19 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.088 1.355 . . . . 73.52 110.035 176.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.39 -38.35 80.28 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 123.925 0.765 . . . . 75.32 110.678 175.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 26' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -58.96 -62.52 1.82 Allowed 'General case' 0 C--O 1.208 -1.098 0 CA-C-N 115.097 -0.956 . . . . 72.31 109.857 173.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -50.33 -38.59 42.74 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 124.089 0.868 . . . . 74.1 111.582 -177.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 28' ' ' ARG . . . . . 0.405 ' HA ' ' NH2' ' C' ' 31' ' ' ARG . 59.5 ttt180 -57.95 -59.84 4.64 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.138 0.975 . . . . 71.15 110.957 176.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 29' ' ' LEU . . . . . 0.57 HD22 ' HE2' ' C' ' 33' ' ' TYR . 75.9 mt -76.98 -11.9 59.87 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 114.982 -1.008 . . . . 60.22 110.933 -176.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -88.83 -24.56 22.55 Favored 'General case' 0 C--O 1.213 -0.858 0 C-N-CA 124.131 0.973 . . . . 75.32 110.219 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 31' ' ' ARG . . . . . 0.405 ' NH2' ' HA ' ' C' ' 28' ' ' ARG . 45.3 mtm105 -85.12 -39.07 18.34 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.208 0.603 . . . . 73.5 110.204 171.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.72 -56.62 5.45 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 122.871 0.468 . . . . 71.12 110.196 -177.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 33' ' ' TYR . . . . . 0.57 ' HE2' HD22 ' C' ' 29' ' ' LEU . 50.1 m-85 -90.48 23.22 3.07 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 122.986 0.514 . . . . 70.15 111.438 -176.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 34' ' ' HIS . . . . . 0.404 ' HD2' ' HB3' ' C' ' 36' ' ' ASP . 20.6 t60 -68.99 109.1 3.72 Favored Pre-proline 0 N--CA 1.477 0.915 0 CA-C-O 118.265 -0.874 . . . . 72.34 110.114 -178.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 35' ' ' PRO . . . . . 0.505 ' HG3' ' HG2' ' C' ' 44' ' ' GLU . 76.9 Cg_exo -53.12 -25.38 29.04 Favored 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 123.663 2.909 . . . . 71.32 114.932 -173.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 36' ' ' ASP . . . . . 0.404 ' HB3' ' HD2' ' C' ' 34' ' ' HIS . 30.4 t70 -74.49 -35.74 63.25 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.508 0.723 . . . . 60.34 111.687 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 58.0 t -92.29 -56.01 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 109.336 -0.616 . . . . 75.33 109.336 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -100.62 92.17 4.99 Favored 'General case' 0 C--O 1.244 0.795 0 C-N-CA 125.098 1.359 . . . . 54.22 109.616 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.84 76.13 6.53 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.109 0.564 . . . . 62.24 109.722 -178.151 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 40' ' ' SER . . . . . 0.463 ' O ' ' HG3' ' C' ' 44' ' ' GLU . 69.8 m -131.23 111.42 15.45 Favored Pre-proline 0 N--CA 1.475 0.777 0 CA-C-O 118.256 -0.878 . . . . 74.14 110.221 179.102 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -45.1 -40.88 16.1 Favored 'Trans proline' 0 C--N 1.383 2.388 0 C-N-CA 123.718 2.946 . . . . 63.44 113.397 174.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -53.41 -48.83 68.37 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.996 0.919 . . . . 65.44 110.229 175.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 43' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' C' ' 47' ' ' PHE . . . -72.01 -18.72 61.95 Favored 'General case' 0 C--O 1.212 -0.913 0 CA-C-N 113.655 -1.611 . . . . 62.05 111.393 -177.226 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 44' ' ' GLU . . . . . 0.505 ' HG2' ' HG3' ' C' ' 35' ' ' PRO . 44.1 mt-10 -88.43 -40.61 13.36 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.805 0.842 . . . . 74.04 111.139 -174.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -69.93 -40.85 75.27 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 109.974 -0.38 . . . . 42.53 109.974 173.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 46' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -66.43 -35.12 79.51 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.916 -0.584 . . . . 72.32 110.774 173.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 47' ' ' PHE . . . . . 0.468 ' HB2' ' O ' ' C' ' 43' ' ' ALA . 77.3 t80 -57.73 -44.63 86.13 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.364 0.666 . . . . 62.23 109.271 173.186 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -58.87 -46.46 87.76 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 122.878 0.471 . . . . 72.04 111.311 176.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -64.37 -32.27 73.81 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 120.719 0.295 . . . . 72.33 111.756 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 50' ' ' ILE . . . . . 0.536 HD13 ' HB3' ' C' ' 29' ' ' LEU . 80.5 mt -74.03 -31.81 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 124.148 0.979 . . . . 75.43 110.136 175.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 51' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -82.81 -14.65 54.0 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.04 0.936 . . . . 74.04 110.811 176.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -81.48 -50.32 9.55 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.288 1.435 . . . . 63.42 108.429 173.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.95 -40.35 76.26 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 113.276 -1.783 . . . . 63.1 110.567 174.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 54' ' ' TYR . . . . . 0.408 ' O ' ' HB2' ' C' ' 58' ' ' SER . 78.7 t80 -77.61 -33.97 53.57 Favored 'General case' 0 C--O 1.215 -0.72 0 CA-C-N 115.544 -0.753 . . . . 75.01 111.356 174.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 55' ' ' ALA . . . . . 0.713 ' HB1' ' HB3' ' C' ' 85' ' ' PHE . . . -51.01 -46.49 61.54 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.916 0.865 . . . . 60.54 110.266 178.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 47.2 t -76.71 -58.6 4.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-N 113.453 -1.703 . . . . 72.43 110.605 177.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 57' ' ' LEU . . . . . 0.816 ' HB3' HD13 ' C' ' 22' ' ' ILE . 69.6 mt -82.03 1.95 33.28 Favored 'General case' 0 CA--C 1.563 1.45 0 N-CA-C 114.465 1.283 . . . . 75.02 114.465 -166.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 58' ' ' SER . . . . . 0.408 ' HB2' ' O ' ' C' ' 54' ' ' TYR . 48.4 t -50.79 -56.45 12.05 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 124.262 1.025 . . . . 62.42 113.393 -173.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -123.79 150.42 62.05 Favored Pre-proline 0 C--O 1.252 1.207 0 CA-C-N 114.359 -1.291 . . . . 72.03 108.387 -171.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 60' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -47.19 -45.7 21.22 Favored 'Trans proline' 0 C--N 1.384 2.41 0 C-N-CA 123.761 2.974 . . . . 33.23 114.389 -169.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -58.15 -53.38 58.87 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.154 0.582 . . . . 62.13 112.365 -174.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -69.96 -37.24 75.76 Favored 'General case' 0 C--O 1.247 0.948 0 CA-C-N 115.602 -0.726 . . . . 75.23 110.821 -176.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 1.1 ppt_? -64.76 -35.85 82.4 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 115.847 -0.615 . . . . 64.42 109.601 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -73.82 -29.71 62.3 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.107 0.963 . . . . 74.15 111.198 177.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 82.6 mt -62.11 -43.68 98.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 109.57 -0.53 . . . . 62.34 109.57 172.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 66' ' ' TYR . . . . . 0.49 ' OH ' ' HA ' ' C' ' 6' ' ' ASP . 22.2 t80 -57.71 -50.82 71.93 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 116.145 -0.479 . . . . 74.22 110.094 173.229 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -58.45 -40.89 83.86 Favored 'General case' 0 N--CA 1.48 1.074 0 O-C-N 123.813 0.696 . . . . 73.14 112.182 -178.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 40.3 p -69.13 -22.27 63.96 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 119.604 -0.236 . . . . 63.2 110.722 178.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -81.69 142.17 32.94 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 108.678 -0.86 . . . . 75.22 108.678 166.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.72 22.05 62.62 Favored Glycine 0 C--N 1.345 1.071 0 N-CA-C 110.817 -0.913 . . . . 62.51 110.817 -174.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 61.5 m -145.54 -54.72 0.29 Allowed 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 103.045 -2.946 . . . . 72.34 103.045 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 47.3 m -83.41 142.26 31.12 Favored 'General case' 0 C--O 1.26 1.646 0 N-CA-C 105.214 -2.143 . . . . 73.35 105.214 157.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.32 -33.59 28.9 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.72 0.808 . . . . 73.23 111.022 177.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.16 152.89 71.63 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 123.741 0.817 . . . . 53.23 110.521 177.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -58.95 125.77 19.17 Favored 'Trans proline' 0 C--N 1.38 2.211 0 C-N-CA 122.638 2.226 . . . . 75.14 111.162 171.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -58.03 151.02 60.91 Favored 'Trans proline' 0 C--N 1.384 2.429 0 C-N-CA 123.323 2.682 . . . . 63.14 112.215 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -49.28 111.35 0.47 Allowed 'Trans proline' 0 C--N 1.387 2.556 0 C-N-CA 123.492 2.795 . . . . 51.51 113.347 -177.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 78' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.0 133.1 45.37 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.769 2.312 . . . . 74.44 112.493 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 79' ' ' PRO . . . . . 0.413 ' HA ' ' HD3' ' C' ' 80' ' ' PRO . 81.2 Cg_exo -50.16 124.45 12.88 Favored 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 122.399 2.066 . . . . 61.04 110.244 167.23 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 80' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' C' ' 79' ' ' PRO . 32.0 Cg_exo -65.68 37.81 0.13 Allowed 'Trans proline' 0 C--N 1.383 2.385 0 C-N-CA 124.741 3.627 . . . . 51.5 116.746 -172.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -163.24 -10.46 0.03 OUTLIER Glycine 0 CA--C 1.524 0.619 0 C-N-CA 123.51 0.576 . . . . 75.2 112.265 168.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 144.99 168.93 13.11 Favored Glycine 0 C--N 1.35 1.345 0 N-CA-C 114.384 0.513 . . . . 74.45 114.384 173.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -98.5 135.03 40.64 Favored 'General case' 0 C--O 1.219 -0.545 0 N-CA-C 106.744 -1.576 . . . . 70.14 106.744 171.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 84' ' ' ASP . . . . . 0.442 ' HB2' ' NE ' ' C' ' 143' ' ' ARG . 14.2 t70 -72.49 137.18 46.19 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 118.8 0.727 . . . . 63.13 112.333 -178.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 85' ' ' PHE . . . . . 0.713 ' HB3' ' HB1' ' C' ' 55' ' ' ALA . 6.8 p90 -164.49 48.46 0.11 Allowed 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.413 1.485 . . . . 74.41 109.09 170.043 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 86' ' ' SER . . . . . 0.67 ' HA ' ' HG2' ' C' ' 171' ' ' PRO . 68.2 m -63.38 122.89 17.32 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 115.223 -0.898 . . . . 45.43 112.056 -176.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.01 4.52 88.42 Favored Glycine 0 C--N 1.351 1.385 0 CA-C-N 115.29 -0.868 . . . . 74.33 113.401 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 88' ' ' PHE . . . . . 0.496 ' HB3' ' HZ ' ' C' ' 93' ' ' PHE . 11.7 m-85 -108.17 137.67 45.75 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 117.481 0.641 . . . . 74.44 109.579 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -79.92 78.75 6.52 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.52 0.676 . . . . 72.23 111.376 -173.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 90' ' ' VAL . . . . . . . . . . . . . 3.4 p -49.21 -34.83 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 125.478 1.511 . . . . 54.41 113.952 176.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.21 -19.99 64.8 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 123.152 0.581 . . . . 74.21 110.529 -174.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -110.91 16.05 21.46 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-O 121.01 0.433 . . . . 75.53 111.469 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 93' ' ' PHE . . . . . 0.496 ' HZ ' ' HB3' ' C' ' 88' ' ' PHE . 16.7 m-30 -89.13 166.29 13.94 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 109.797 -0.445 . . . . 72.45 109.797 172.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 80.6 p -65.53 164.62 13.71 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.683 0.793 . . . . 45.51 112.91 -170.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.14 -36.81 78.34 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 114.951 -1.022 . . . . 55.43 110.831 170.582 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -58.71 -45.67 89.01 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.189 0.996 . . . . 65.02 110.466 177.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 97' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -62.2 -45.63 92.5 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.936 -0.575 . . . . 64.25 109.661 176.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -81.05 -0.3 39.19 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 115.747 -0.66 . . . . 51.52 112.716 -175.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -101.55 -63.85 1.11 Allowed 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.357 0.663 . . . . 74.43 110.786 168.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 51.3 tp -55.1 -45.08 75.43 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.551 0.74 . . . . 73.23 111.265 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -98.5 -6.1 30.95 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.572 -0.74 . . . . 73.25 111.271 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -45.28 -61.42 3.6 Favored Glycine 0 C--N 1.356 1.647 0 N-CA-C 115.793 1.077 . . . . 54.11 115.793 -176.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -55.37 -27.68 59.37 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 123.097 2.531 . . . . 62.02 112.826 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -115.45 28.2 8.0 Favored Glycine 0 C--N 1.359 1.843 0 CA-C-O 118.937 -0.924 . . . . 43.23 112.815 -177.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 72.2 mt -75.14 47.84 0.38 Allowed 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 119.594 1.697 . . . . 73.03 110.528 170.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 106' ' ' PHE . . . . . 0.637 ' HB3' ' H ' ' C' ' 168' ' ' GLY . 52.6 m-85 52.03 -174.0 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 124.662 1.185 . . . . 64.24 110.396 -169.141 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . 3.29 -44.63 0.0 OUTLIER Glycine 0 N--CA 1.5 2.951 0 N-CA-C 118.469 2.148 . . . . 51.05 118.469 155.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 108' ' ' GLY . . . . . 0.465 ' O ' ' HG3' ' C' ' 114' ' ' ARG . . . 64.1 -145.63 49.81 Favored Glycine 0 C--N 1.356 1.673 0 CA-C-N 114.186 -1.007 . . . . 74.41 110.893 -179.067 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 109' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -108.34 27.31 9.47 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 107.256 -1.387 . . . . 74.45 107.256 164.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 110' ' ' GLY . . . . . . . . . . . . . . . -92.49 11.72 71.44 Favored Glycine 0 C--N 1.361 1.946 0 CA-C-N 115.246 -0.888 . . . . 54.22 114.608 -169.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? 66.11 0.56 1.67 Allowed 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 124.148 0.979 . . . . 75.25 112.357 -176.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 112' ' ' ARG . . . . . . . . . . . . . 54.4 ttp180 -80.17 45.25 0.73 Allowed 'General case' 0 CA--C 1.563 1.47 0 C-N-CA 126.608 1.963 . . . . 74.1 110.449 173.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 113' ' ' SER . . . . . 0.413 ' HB2' ' HB2' ' C' ' 167' ' ' GLN . 19.0 m 70.27 78.59 0.19 Allowed 'General case' 0 C--N 1.36 1.059 0 C-N-CA 123.682 0.793 . . . . 72.53 111.35 -177.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 114' ' ' ARG . . . . . 0.62 ' HG2' ' H ' ' C' ' 115' ' ' LYS . 49.4 ttp180 -66.58 -171.65 0.14 Allowed 'General case' 0 CA--C 1.579 2.076 0 C-N-CA 124.059 0.944 . . . . 74.05 109.768 176.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 115' ' ' LYS . . . . . 0.681 ' HA ' ' HD2' ' C' ' 170' ' ' PRO . 60.8 tttm -5.73 112.78 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.653 0 C-N-CA 127.563 2.345 . . . . 54.14 116.771 -159.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -67.18 140.91 38.44 Favored Glycine 0 C--N 1.355 1.585 0 CA-C-N 114.403 -1.271 . . . . 45.25 115.233 -171.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.04 -175.38 2.78 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.147 1.379 . . . . 64.44 110.18 -177.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -72.44 131.84 43.11 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 109.281 -0.637 . . . . 75.42 109.281 167.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 119' ' ' LEU . . . . . 0.478 HD11 HG21 ' B' ' 185' ' ' VAL . 36.1 tp -110.73 142.21 42.99 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.246 1.018 . . . . 75.21 108.617 -175.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -117.73 104.45 11.0 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 108.719 -0.845 . . . . 72.31 108.719 -169.095 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 121' ' ' ALA . . . . . 0.446 ' HB3' HD23 ' C' ' 176' ' ' LEU . . . -113.41 116.2 29.26 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.077 -0.712 . . . . 63.21 109.077 176.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 122' ' ' GLU . . . . . 0.505 ' HG3' HG21 ' B' ' 186' ' ' THR . 44.5 mt-10 -89.03 110.95 21.58 Favored 'General case' 0 C--N 1.347 0.462 0 N-CA-C 108.26 -1.015 . . . . 73.22 108.26 172.237 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 123' ' ' LEU . . . . . 0.6 HD23 ' H ' ' C' ' 123' ' ' LEU . 1.1 pt? -106.31 113.71 63.03 Favored Pre-proline 0 C--O 1.248 0.976 0 O-C-N 123.781 0.676 . . . . 73.3 109.39 -177.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -58.33 114.45 1.98 Allowed 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 122.205 1.937 . . . . 72.51 110.2 162.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 125' ' ' LEU . . . . . 0.547 ' O ' ' HA ' ' C' ' 180' ' ' LEU . 53.7 tp -142.94 154.94 44.57 Favored 'General case' 0 C--O 1.219 -0.547 0 N-CA-C 106.967 -1.494 . . . . 74.03 106.967 -171.309 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 126' ' ' THR . . . . . 0.452 ' HB ' HD12 ' C' ' 181' ' ' LEU . 11.1 t -119.3 171.62 8.18 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 119.735 1.152 . . . . 61.53 110.795 177.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 127' ' ' LEU . . . . . 0.505 HD11 ' H ' ' C' ' 185' ' ' VAL . 10.0 mt -62.86 -47.48 83.19 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 113.724 -1.58 . . . . 62.25 110.72 -171.224 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -58.32 -44.58 88.69 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 114.219 -1.355 . . . . 75.24 109.896 -177.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -75.25 -24.37 57.64 Favored 'General case' 0 C--O 1.216 -0.703 0 CA-C-N 114.975 -1.011 . . . . 73.53 111.445 178.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 130' ' ' ALA . . . . . 0.422 ' HB1' ' H ' ' C' ' 153' ' ' VAL . . . -71.76 -31.58 66.79 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 109.611 -0.514 . . . . 64.34 109.611 175.297 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 131' ' ' PHE . . . . . 0.551 ' HB2' HD13 ' C' ' 215' ' ' LEU . 75.5 t80 -70.35 -41.88 72.59 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.207 1.003 . . . . 75.55 109.855 172.111 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 132' ' ' HIS . . . . . . . . . . . . . 24.9 m170 -76.62 -8.23 56.83 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 115.19 -0.914 . . . . 60.22 110.99 176.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -54.02 134.1 44.52 Favored Glycine 0 C--N 1.356 1.661 0 O-C-N 123.973 0.796 . . . . 65.31 113.233 176.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . 173.17 -128.37 1.51 Allowed Glycine 0 C--O 1.24 0.526 0 N-CA-C 108.969 -1.652 . . . . 53.24 108.969 -177.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -72.0 95.54 1.61 Allowed 'General case' 0 C--N 1.35 0.587 0 N-CA-C 108.357 -0.979 . . . . 71.2 108.357 175.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 136' ' ' ARG . . . . . . . . . . . . . 19.5 mmt180 -126.1 162.48 25.24 Favored 'General case' 0 C--O 1.243 0.724 0 C-N-CA 123.522 0.729 . . . . 72.12 109.837 -178.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 137' ' ' VAL . . . . . . . . . . . . . 8.6 p -78.85 123.81 36.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 CA-C-N 115.374 -0.83 . . . . 71.12 110.119 177.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 138' ' ' VAL . . . . . 0.439 ' HB ' ' HG ' ' B' ' 181' ' ' LEU . 8.8 p -115.87 131.28 68.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 108.247 -1.02 . . . . 72.14 108.247 169.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 139' ' ' GLU . . . . . 0.58 ' HB3' HG21 ' B' ' 182' ' ' VAL . 9.9 tp10 -124.32 83.31 2.13 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 107.075 -1.454 . . . . 74.31 107.075 174.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 140' ' ' VAL . . . . . . . . . . . . . 54.6 t -140.9 148.67 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 107.214 -1.402 . . . . 63.22 107.214 178.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 68.67 23.39 7.13 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 124.14 0.976 . . . . 15.23 111.524 -177.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 67.14 40.62 92.74 Favored Glycine 0 C--N 1.347 1.167 0 O-C-N 123.931 0.769 . . . . 45.25 112.94 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 143' ' ' ARG . . . . . 0.587 ' NH2' ' HA ' ' C' ' 164' ' ' MET . 25.3 ttp-105 -153.07 124.18 7.49 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-O 120.82 0.343 . . . . 73.04 110.883 179.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 62.9 ttt-85 -88.34 124.0 33.48 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.239 -0.891 . . . . 71.51 109.269 167.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 145' ' ' VAL . . . . . . . . . . . . . 8.0 p -151.52 142.38 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.083 0.553 . . . . 75.03 109.587 173.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 52.9 p -84.33 105.36 15.1 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 109.196 -0.668 . . . . 54.21 109.196 174.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 14.5 p -123.2 146.73 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 N-CA-C 109.663 -0.495 . . . . 72.53 109.663 -178.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -91.16 114.93 27.59 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 122.933 0.493 . . . . 74.22 110.465 174.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 149' ' ' ILE . . . . . . . . . . . . . 31.5 pt -93.24 153.63 41.57 Favored Pre-proline 0 CA--C 1.55 0.953 0 N-CA-C 107.955 -1.128 . . . . 71.41 107.955 164.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -47.52 122.02 6.25 Favored 'Trans proline' 0 C--N 1.384 2.404 0 C-N-CA 123.029 2.486 . . . . 61.44 112.018 177.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -61.25 109.35 0.71 Allowed 'Trans proline' 0 C--N 1.385 2.498 0 C-N-CA 123.043 2.495 . . . . 73.2 111.536 -178.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 152' ' ' GLY . . . . . . . . . . . . . . . 110.58 109.78 3.19 Favored Glycine 0 C--N 1.338 0.673 0 CA-C-N 115.456 -0.793 . . . . 54.32 111.973 -170.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 153' ' ' VAL . . . . . 0.522 ' HB ' HG21 ' C' ' 178' ' ' VAL . 2.1 m -105.27 168.75 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 123.063 0.545 . . . . 71.13 109.647 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 154' ' ' ARG . . . . . 0.44 ' O ' HG23 ' C' ' 178' ' ' VAL . 18.2 mtp180 -115.78 116.26 27.73 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 122.905 0.482 . . . . 75.32 111.258 -174.223 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 155' ' ' GLU . . . . . 0.547 ' HG2' ' HE ' ' C' ' 187' ' ' ARG . 2.9 tp10 -22.7 115.95 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 126.733 2.013 . . . . 74.51 114.234 168.205 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 57.76 10.29 6.23 Favored Glycine 0 C--N 1.351 1.406 0 O-C-N 123.827 0.704 . . . . 64.51 114.752 171.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 157' ' ' SER . . . . . 0.425 ' HB2' ' HB2' ' C' ' 154' ' ' ARG . 49.5 m -106.74 167.28 9.98 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 121.572 0.701 . . . . 75.43 110.466 -173.303 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 18.4 t -103.31 104.75 17.13 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 CA-C-N 114.774 -1.103 . . . . 64.44 110.439 -169.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 159' ' ' ILE . . . . . 0.44 HD11 ' HB ' ' C' ' 153' ' ' VAL . 19.1 mt -72.23 145.87 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 109.287 -0.634 . . . . 52.25 109.287 167.298 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -109.82 108.4 18.71 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 109.148 -0.686 . . . . 72.21 109.148 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 161' ' ' VAL . . . . . 0.576 HG21 HD12 ' C' ' 176' ' ' LEU . 49.4 t -125.87 95.23 40.27 Favored Pre-proline 0 N--CA 1.485 1.283 0 C-N-CA 123.734 0.814 . . . . 75.24 110.967 -171.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -64.53 146.57 89.48 Favored 'Trans proline' 0 C--N 1.363 1.327 0 C-N-CA 121.805 1.67 . . . . 63.42 109.736 165.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 129.78 -16.87 5.54 Favored Glycine 0 N--CA 1.475 1.296 0 C-N-CA 121.715 -0.279 . . . . 53.31 113.569 -176.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 164' ' ' MET . . . . . 0.587 ' HA ' ' NH2' ' C' ' 143' ' ' ARG . 2.9 mpp? -121.58 -79.5 0.61 Allowed 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 109.434 -0.58 . . . . 73.35 109.434 170.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 165' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' C' ' 173' ' ' ASP . . . 68.9 174.18 9.37 Favored Glycine 0 C--N 1.349 1.28 0 N-CA-C 114.436 0.535 . . . . 64.24 114.436 -178.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . -71.11 165.14 53.43 Favored Glycine 0 C--N 1.343 0.934 0 N-CA-C 111.988 -0.445 . . . . 75.44 111.988 172.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 167' ' ' GLN . . . . . 0.413 ' HB2' ' HB2' ' C' ' 113' ' ' SER . 6.8 mm-40 -67.27 144.28 56.01 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 109.828 -0.434 . . . . 64.31 109.828 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 168' ' ' GLY . . . . . 0.637 ' H ' ' HB3' ' C' ' 106' ' ' PHE . . . 144.68 130.85 2.33 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-O 119.084 -0.842 . . . . 13.44 111.37 -174.08 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 169' ' ' ASN . . . . . 0.569 ' HB3' ' HD3' ' C' ' 170' ' ' PRO . 8.5 t30 -49.88 -49.82 71.74 Favored Pre-proline 0 CA--C 1.557 1.224 0 C-N-CA 124.468 1.107 . . . . 62.44 112.46 -172.358 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 170' ' ' PRO . . . . . 0.681 ' HD2' ' HA ' ' C' ' 115' ' ' LYS . 1.5 Cg_endo -86.87 104.71 0.64 Allowed 'Trans proline' 0 C--N 1.383 2.345 0 CA-C-N 121.522 1.579 . . . . 51.41 110.061 162.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 171' ' ' PRO . . . . . 0.67 ' HG2' ' HA ' ' C' ' 86' ' ' SER . 72.4 Cg_endo -72.83 173.09 14.05 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.906 2.404 . . . . 74.02 112.648 -175.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -117.21 -94.76 1.79 Allowed Glycine 0 C--N 1.346 1.09 0 CA-C-N 115.772 -0.649 . . . . 74.42 112.895 -177.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 173' ' ' ASP . . . . . 0.44 ' O ' ' HA2' ' C' ' 165' ' ' GLY . 6.8 t70 -166.26 151.32 8.21 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.906 0.882 . . . . 74.51 109.626 -164.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 174' ' ' LEU . . . . . . . . . . . . . 30.1 tp -117.84 105.15 11.64 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.554 0.741 . . . . 75.22 109.207 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 77.2 mt -74.81 96.18 3.04 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-N 114.523 -1.217 . . . . 71.32 109.744 172.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 176' ' ' LEU . . . . . 0.576 HD12 HG21 ' C' ' 161' ' ' VAL . 41.7 mt -85.77 96.87 9.88 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-N 115.313 -0.858 . . . . 43.02 109.945 178.175 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 177' ' ' VAL . . . . . 0.529 HG21 ' HB2' ' B' ' 190' ' ' CYS . 22.0 t -84.57 101.24 8.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 107.906 -1.146 . . . . 74.43 107.906 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 178' ' ' VAL . . . . . 0.522 HG21 ' HB ' ' C' ' 153' ' ' VAL . 0.8 OUTLIER -84.74 102.66 11.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.059 -0.973 . . . . 74.01 110.632 -171.995 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 179' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -87.95 104.08 16.28 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.291 -1.374 . . . . 72.33 107.291 175.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 180' ' ' LEU . . . . . 0.547 ' HA ' ' O ' ' C' ' 125' ' ' LEU . 96.5 mt -68.83 138.29 54.63 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 109.99 -0.374 . . . . 70.51 109.99 177.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 181' ' ' LEU . . . . . 0.452 HD12 ' HB ' ' C' ' 126' ' ' THR . 51.8 mt -56.87 167.6 1.02 Allowed Pre-proline 0 N--CA 1.493 1.679 0 C-N-CA 125.539 1.536 . . . . 74.2 112.045 -173.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 182' ' ' PRO . . . . . 0.465 ' HB3' HD21 ' B' ' 218' ' ' LEU . 87.1 Cg_exo -54.62 68.38 0.03 OUTLIER 'Trans proline' 0 C--N 1.388 2.654 0 C-N-CA 123.842 3.028 . . . . 64.12 112.58 164.069 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 183' ' ' HIS . . . . . 0.508 ' HA ' ' O ' ' B' ' 225' ' ' THR . 84.3 t60 177.39 48.16 0.03 OUTLIER Pre-proline 0 CA--C 1.567 1.615 0 C-N-CA 128.466 2.707 . . . . 62.13 106.444 -169.472 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 184' ' ' PRO . . . . . 0.575 ' HD2' HG22 ' B' ' 225' ' ' THR . 4.3 Cg_endo -87.95 65.66 3.57 Favored 'Trans proline' 0 C--N 1.398 3.141 0 C-N-CA 123.318 2.679 . . . . 71.54 110.236 -175.299 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 185' ' ' VAL . . . . . 0.505 ' H ' HD11 ' C' ' 127' ' ' LEU . 11.1 t -94.63 -24.77 4.79 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.076 0 CA-C-N 115.0 -1.0 . . . . 72.23 109.938 -170.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 186' ' ' PHE . . . . . 0.426 ' CD1' HD13 ' C' ' 127' ' ' LEU . 32.4 m-85 -124.58 105.51 9.42 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.398 0.618 . . . . 61.44 110.759 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 187' ' ' ARG . . . . . 0.547 ' HE ' ' HG2' ' C' ' 155' ' ' GLU . 35.4 ttm105 -108.3 104.41 13.79 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.708 1.203 . . . . 75.14 108.9 -174.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 188' ' ' LEU . . . . . . . . . . . . . 58.7 tp -77.91 134.89 37.82 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.202 0.815 . . . . 74.14 113.202 -167.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -132.55 119.07 20.03 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 126.008 1.723 . . . . 71.33 107.277 164.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 190' ' ' GLY . . . . . 0.67 ' HA2' ' HA2' ' B' ' 202' ' ' GLY . . . 64.44 -99.21 0.32 Allowed Glycine 0 C--N 1.343 0.954 0 CA-C-N 116.07 -0.514 . . . . 74.2 112.614 -175.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 191' ' ' GLN . . . . . 0.47 ' HB2' ' NH2' ' B' ' 32' ' ' ARG . 50.4 mt-30 -127.3 -12.94 5.63 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.106 0.962 . . . . 60.21 109.336 173.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -86.74 148.49 25.4 Favored 'General case' 0 C--N 1.362 1.111 0 C-N-CA 123.509 0.724 . . . . 65.13 109.516 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 193' ' ' LEU . . . . . 0.458 HD21 ' CD2' ' C' ' 240' ' ' PHE . 90.1 mt -103.48 161.84 13.53 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.325 0.65 . . . . 52.2 110.681 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 194' ' ' TYR . . . . . 0.413 ' HB3' ' HB3' ' C' ' 187' ' ' ARG . 10.5 t80 -125.29 106.73 10.07 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.707 -1.22 . . . . 75.43 107.707 170.298 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 195' ' ' ALA . . . . . 0.496 ' HB2' HD11 ' C' ' 249' ' ' LEU . . . -105.76 -176.81 3.18 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.211 1.004 . . . . 65.11 110.268 177.224 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 196' ' ' THR . . . . . 0.769 HG21 ' H ' ' B' ' 264' ' ' SER . 87.0 m -139.07 120.95 15.48 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 114.953 -1.021 . . . . 51.32 108.836 166.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 197' ' ' LEU . . . . . 0.424 HD13 HD22 ' C' ' 251' ' ' LEU . 27.3 tp -90.69 115.48 27.82 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.886 0.874 . . . . 73.5 110.628 -175.317 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -78.15 104.06 8.49 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.826 0.85 . . . . 44.52 109.76 -178.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 199' ' ' VAL . . . . . 0.535 HG22 HG21 ' C' ' 210' ' ' VAL . 39.4 t -120.35 115.64 32.63 Favored Pre-proline 0 N--CA 1.482 1.145 0 C-N-CA 124.388 1.075 . . . . 61.21 109.481 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 200' ' ' PRO . . . . . 0.4 ' HG2' HD12 ' C' ' 203' ' ' ILE . 38.1 Cg_endo -69.28 149.75 70.33 Favored 'Trans proline' 0 C--N 1.367 1.529 0 C-N-CA 121.71 1.606 . . . . 71.34 111.988 175.1 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 201' ' ' ALA . . . . . 0.427 ' O ' HG23 ' C' ' 205' ' ' VAL . . . -54.73 -47.6 97.68 Favored Pre-proline 0 CA--C 1.562 1.42 0 N-CA-C 114.263 1.209 . . . . 74.35 114.263 -170.296 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 202' ' ' PRO . . . . . 0.436 ' O ' HG12 ' C' ' 206' ' ' VAL . 78.2 Cg_exo -53.3 -45.74 38.85 Favored 'Trans proline' 0 C--N 1.388 2.646 0 C-N-CA 121.763 1.642 . . . . 63.15 112.728 175.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 203' ' ' ILE . . . . . 0.4 HD12 ' HG2' ' C' ' 200' ' ' PRO . 38.7 mt -67.88 -33.86 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 124.048 0.939 . . . . 63.4 111.167 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 204' ' ' ALA . . . . . 0.411 ' HA ' HG11 ' C' ' 223' ' ' VAL . . . -68.73 -34.07 74.98 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.485 0.714 . . . . 75.02 111.654 178.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 205' ' ' VAL . . . . . 0.55 HG13 ' HG3' ' C' ' 226' ' ' ARG . 95.1 t -85.26 -40.42 14.82 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 N-CA-C 112.775 0.658 . . . . 63.41 112.775 -175.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 206' ' ' VAL . . . . . 0.436 HG12 ' O ' ' C' ' 202' ' ' PRO . 6.4 p -81.36 -39.35 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-N 118.959 0.799 . . . . 52.12 110.472 176.3 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 207' ' ' GLY . . . . . 0.423 ' O ' ' HB2' ' B' ' 250' ' ' GLN . . . 97.27 92.49 1.89 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.387 -0.685 . . . . 63.21 111.387 -166.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -113.98 -141.36 7.76 Favored Glycine 0 C--N 1.338 0.694 0 N-CA-C 111.734 -0.546 . . . . 51.32 111.734 176.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 209' ' ' LYS . . . . . 0.667 ' HE3' ' HB1' ' B' ' 253' ' ' ALA . 8.7 mtmp? -140.21 141.28 35.94 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.126 0.571 . . . . 72.12 110.557 171.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 210' ' ' VAL . . . . . 0.535 HG21 HG22 ' C' ' 199' ' ' VAL . 15.1 m -133.59 135.34 55.84 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 C-N-CA 124.912 1.285 . . . . 62.05 107.597 169.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 211' ' ' ARG . . . . . 0.498 ' HA ' ' HA ' ' C' ' 220' ' ' GLU . 0.5 OUTLIER -89.43 122.11 32.32 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 122.279 0.232 . . . . 72.44 110.761 -174.371 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 212' ' ' ALA . . . . . 0.477 ' HB3' HG13 ' C' ' 219' ' ' VAL . . . -81.16 116.35 21.02 Favored 'General case' 0 C--O 1.248 1.023 0 N-CA-C 107.678 -1.23 . . . . 74.43 107.678 173.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 213' ' ' MET . . . . . 0.591 ' SD ' ' HA ' ' B' ' 170' ' ' THR . 4.8 tmm? -70.36 117.25 11.67 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 108.002 -1.11 . . . . 63.12 108.002 174.372 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 214' ' ' THR . . . . . 0.526 HG21 ' HD2' ' C' ' 238' ' ' LYS . 1.0 OUTLIER -115.57 168.12 10.3 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 122.043 0.925 . . . . 54.24 112.406 -176.954 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 215' ' ' LEU . . . . . 0.551 HD13 ' HB2' ' C' ' 131' ' ' PHE . 81.4 mt -65.98 -37.17 85.29 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 114.438 -1.256 . . . . 44.41 113.003 -169.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 216' ' ' GLU . . . . . 0.46 ' HG2' HH11 ' C' ' 246' ' ' ARG . 0.0 OUTLIER -105.23 9.84 33.89 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 114.492 -1.231 . . . . 71.0 110.951 -174.936 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 148.41 -144.81 12.74 Favored Glycine 0 C--N 1.353 1.484 0 CA-C-O 119.925 -0.375 . . . . 64.11 112.4 178.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -105.6 165.14 0.15 Allowed 'Trans proline' 0 CA--C 1.548 1.221 0 C-N-CA 123.61 2.873 . . . . 52.13 113.716 168.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 219' ' ' VAL . . . . . 0.477 HG13 ' HB3' ' C' ' 212' ' ' ALA . 4.5 p -145.7 116.54 1.83 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 107.154 -1.424 . . . . 52.53 107.154 163.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 220' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' C' ' 211' ' ' ARG . 28.2 tt0 -82.78 110.74 18.07 Favored 'General case' 0 C--O 1.247 0.971 0 N-CA-C 108.893 -0.78 . . . . 72.32 108.893 -179.112 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 221' ' ' VAL . . . . . . . . . . . . . 62.1 t -88.38 126.12 41.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 CA-C-N 115.16 -0.927 . . . . 74.03 109.515 -176.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 222' ' ' ALA . . . . . 0.595 ' HA ' ' HG2' ' C' ' 209' ' ' LYS . . . -87.24 143.72 27.15 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.666 -0.697 . . . . 73.3 110.378 176.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 223' ' ' VAL . . . . . 0.411 HG11 ' HA ' ' C' ' 204' ' ' ALA . 56.0 t -112.22 139.41 22.46 Favored Pre-proline 0 CA--C 1.558 1.254 0 C-N-CA 125.155 1.382 . . . . 73.11 108.537 -174.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 224' ' ' PRO . . . . . 0.415 ' HD3' ' CZ2' ' B' ' 242' ' ' TRP . 55.1 Cg_endo -87.76 168.34 6.98 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 123.213 2.609 . . . . 54.33 112.627 175.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 225' ' ' PRO . . . . . 0.482 ' HD3' ' HG3' ' B' ' 250' ' ' GLN . 27.6 Cg_endo -65.77 119.4 6.42 Favored 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 122.197 1.931 . . . . 74.0 112.358 174.14 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 226' ' ' ARG . . . . . 0.55 ' HG3' HG13 ' C' ' 205' ' ' VAL . 0.0 OUTLIER 66.48 89.81 0.1 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.211 1.804 . . . . 70.15 111.679 179.763 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 227' ' ' THR . . . . . . . . . . . . . 40.6 m -112.95 124.91 53.7 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 113.56 -1.654 . . . . 70.3 110.612 -174.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 228' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -90.52 152.02 21.1 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.946 0.898 . . . . 74.32 111.63 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 229' ' ' ALA . . . . . 0.442 ' HA ' ' O ' ' C' ' 253' ' ' VAL . . . -76.16 135.59 39.77 Favored 'General case' 0 C--O 1.243 0.745 0 CA-C-N 115.31 -0.859 . . . . 62.12 109.673 175.169 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 98.06 -2.38 59.75 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 115.774 -0.648 . . . . 62.04 113.339 -169.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 231' ' ' ARG . . . . . . . . . . . . . 68.8 mtt180 -66.35 172.06 4.31 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 117.75 0.775 . . . . 74.12 110.736 167.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 232' ' ' LYS . . . . . 0.559 ' HA ' ' O ' ' C' ' 251' ' ' LEU . 37.7 ttmt -154.32 143.89 21.53 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.243 0.831 . . . . 71.45 113.243 -173.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 233' ' ' LEU . . . . . 0.558 ' O ' ' HA ' ' C' ' 250' ' ' TYR . 3.4 mp -123.88 144.23 49.88 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 115.03 -0.987 . . . . 74.21 109.936 170.108 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 234' ' ' ARG . . . . . 0.439 ' HD2' HD11 ' B' ' 331' ' ' LEU . 16.1 ptp180 -101.66 115.85 31.45 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 108.366 -0.976 . . . . 72.34 108.366 162.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 235' ' ' LEU . . . . . 0.426 HD22 ' HA ' ' B' ' 239' ' ' ALA . 33.7 mt -98.2 119.37 36.74 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 107.913 -1.143 . . . . 73.43 107.913 176.49 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -67.93 128.78 37.76 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.739 0.815 . . . . 71.55 112.087 -172.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 78.8 3.69 87.63 Favored Glycine 0 C--N 1.352 1.448 0 CA-C-N 115.731 -0.668 . . . . 71.42 113.342 176.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 238' ' ' LYS . . . . . 0.526 ' HD2' HG21 ' C' ' 214' ' ' THR . 67.0 mmtt -96.17 8.34 44.07 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.161 0.584 . . . . 72.03 111.518 -177.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -87.42 -170.09 46.17 Favored Glycine 0 C--N 1.352 1.464 0 O-C-N 123.373 0.421 . . . . 31.21 112.802 174.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 240' ' ' PHE . . . . . 0.458 ' CD2' HD21 ' C' ' 193' ' ' LEU . 2.0 m-85 -81.47 150.47 67.09 Favored Pre-proline 0 N--CA 1.48 1.073 0 N-CA-C 110.001 -0.37 . . . . 75.14 110.001 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 241' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -62.08 139.79 80.54 Favored 'Trans proline' 0 C--N 1.385 2.494 0 C-N-CA 123.26 2.64 . . . . 70.21 113.92 -174.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 242' ' ' GLY . . . . . 0.462 ' HA3' HE21 ' C' ' 191' ' ' GLN . . . -132.07 177.28 18.81 Favored Glycine 0 CA--C 1.522 0.485 0 CA-C-N 114.852 -1.067 . . . . 70.14 111.501 177.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.97 -11.25 27.21 Favored 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 122.792 2.328 . . . . 71.42 112.716 -175.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -110.34 -4.83 15.43 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.655 0.782 . . . . 71.42 111.858 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 147.65 -104.86 0.3 Allowed Glycine 0 C--N 1.35 1.342 0 N-CA-C 111.814 -0.514 . . . . 51.32 111.814 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 246' ' ' ARG . . . . . 0.46 HH11 ' HG2' ' C' ' 216' ' ' GLU . 85.0 mtm180 -146.05 167.71 22.71 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 124.78 1.232 . . . . 61.31 109.248 176.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -87.67 -156.8 30.64 Favored Glycine 0 C--N 1.346 1.136 0 N-CA-C 112.21 -0.356 . . . . 63.23 112.21 172.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -115.51 170.01 8.74 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.177 0.591 . . . . 73.54 109.585 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 249' ' ' LEU . . . . . 0.496 HD11 ' HB2' ' C' ' 195' ' ' ALA . 28.4 tp -116.02 115.06 25.46 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.406 0.682 . . . . 74.23 110.857 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 250' ' ' TYR . . . . . 0.558 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 2.1 m-30 -100.83 98.15 8.69 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.231 0.612 . . . . 71.43 109.696 -178.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 251' ' ' LEU . . . . . 0.559 ' O ' ' HA ' ' C' ' 232' ' ' LYS . 1.8 mp -94.53 126.29 39.73 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 119.448 -0.31 . . . . 64.53 110.222 -177.275 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -80.29 113.16 18.26 Favored 'General case' 0 C--O 1.217 -0.619 0 O-C-N 124.887 1.367 . . . . 73.41 108.579 170.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 253' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' C' ' 229' ' ' ALA . 40.5 t -72.36 133.12 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 123.15 0.58 . . . . 73.5 110.335 -174.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 254' ' ' ARG . . . . . 0.445 ' HG2' ' HG ' ' B' ' 265' ' ' LEU . 2.3 tmt_? -122.84 114.82 21.01 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.545 1.138 . . . . 74.13 108.918 -165.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 255' ' ' ILE . . . . . 0.429 HG12 ' HB2' ' C' ' 229' ' ' ALA . 20.8 mm -88.61 115.67 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 109.19 -0.67 . . . . 75.24 109.19 -179.047 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 256' ' ' THR . . . . . . . . . . . . . 1.4 t -124.09 151.43 43.88 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.973 0.909 . . . . 53.32 111.394 -174.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 2.4 pp -121.55 120.49 28.78 Favored Pre-proline 0 N--CA 1.482 1.173 0 N-CA-C 107.55 -1.278 . . . . 64.54 107.55 170.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 258' ' ' PRO . . . . . 0.516 ' HG3' ' HE2' ' A' ' 276' ' ' TYR . 26.6 Cg_endo -78.98 11.68 2.5 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 C-N-CA 122.845 2.364 . . . . 73.21 113.946 -161.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 69.21 -62.24 0.41 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.592 1.557 . . . . 72.3 111.025 -173.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.51 130.43 31.75 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.24 1.016 . . . . 73.41 111.098 176.075 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 261' ' ' LEU . . . . . . . . . . . . . 88.0 mt -156.68 143.78 18.8 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.188 1.395 . . . . 71.21 107.702 177.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 71.8 p -83.41 152.01 63.41 Favored Pre-proline 0 CA--C 1.549 0.936 0 CA-C-O 118.105 -0.95 . . . . 61.23 108.457 172.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_exo -45.6 -33.36 9.66 Favored 'Trans proline' 0 C--N 1.384 2.432 0 C-N-CA 123.486 2.79 . . . . 74.2 114.647 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -63.07 -62.01 2.0 Allowed 'General case' 0 C--O 1.251 1.148 0 C-N-CA 124.258 1.023 . . . . 71.04 110.695 175.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -50.55 -52.0 42.83 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 115.196 -0.911 . . . . 65.11 109.798 178.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 266' ' ' GLU . . . . . 0.467 ' O ' ' HG2' ' C' ' 270' ' ' LYS . 30.6 tt0 -57.75 -38.44 75.37 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.103 1.361 . . . . 64.21 111.249 -178.253 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -59.65 -42.92 93.89 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.386 0.674 . . . . 70.32 110.958 177.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 268' ' ' LEU . . . . . . . . . . . . . 8.2 mp -65.02 -39.13 92.95 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 115.744 -0.662 . . . . 52.44 110.791 175.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -64.19 -29.81 70.9 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 122.582 0.353 . . . . 61.11 111.822 174.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 270' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' C' ' 266' ' ' GLU . 33.9 mmtp -68.91 -44.12 73.82 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 122.967 0.507 . . . . 75.43 109.927 176.256 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 11.0 mmmm -57.27 -45.98 83.52 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 123.92 0.762 . . . . 75.33 111.077 176.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 85.0 mt -62.52 -42.7 99.69 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 114.791 -1.095 . . . . 74.33 110.577 176.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -62.44 -39.16 92.44 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.491 0.716 . . . . 34.13 110.998 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -62.5 -47.82 82.28 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.542 0.737 . . . . 63.21 110.038 176.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -58.91 -30.85 68.13 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 115.319 -0.855 . . . . 70.04 111.368 176.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 276' ' ' TYR . . . . . 0.459 ' HD1' HH11 ' C' ' 279' ' ' ARG . 9.2 m-85 -80.55 -33.32 36.32 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.517 0.727 . . . . 75.52 112.662 178.042 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -73.36 -23.45 60.21 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 118.392 0.542 . . . . 44.24 109.822 177.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -66.79 -11.97 57.13 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 123.754 0.821 . . . . 55.2 112.289 171.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 279' ' ' ARG . . . . . 0.459 HH11 ' HD1' ' C' ' 276' ' ' TYR . 50.8 mtp180 -79.56 -12.8 59.84 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 122.845 0.458 . . . . 71.52 111.055 174.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.904 -0.57 . . . . 75.14 109.971 178.107 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.478 0.961 0 N-CA-C 109.525 -0.546 . . . . 64.12 109.525 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.61 26.01 10.63 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.224 1.409 . . . . 51.4 112.446 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -87.88 60.64 5.99 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.633 0.773 . . . . 74.04 109.99 -175.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -37.59 103.78 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.316 1.446 . . . . 62.43 113.76 -176.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.427 ' HG2' ' HB3' ' A' ' 96' ' ' PHE . 14.5 mmmm -79.7 94.58 5.75 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 107.544 -1.28 . . . . 74.32 107.544 168.179 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.428 ' O ' HG13 ' A' ' 10' ' ' ILE . 11.8 t70 -70.55 92.71 0.86 Allowed 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.154 -1.054 . . . . 61.41 108.154 177.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -58.84 -35.35 72.77 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.765 0.826 . . . . 73.34 112.89 -167.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.407 ' CE1' HD11 ' A' ' 22' ' ' ILE . 88.7 m-85 -63.78 -45.22 90.73 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 116.501 -0.318 . . . . 73.33 110.515 176.366 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.34 -39.42 90.52 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 123.597 0.561 . . . . 60.32 110.964 178.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 6' ' ' ASP . 37.7 mt -65.46 -37.06 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 123.01 0.524 . . . . 74.23 110.55 179.159 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.509 ' HB2' HG22 ' A' ' 13' ' ' VAL . 81.5 mt -73.25 -16.17 61.4 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.114 0.566 . . . . 51.33 111.737 174.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.71 18.0 79.36 Favored Glycine 0 C--N 1.351 1.365 0 O-C-N 123.412 0.445 . . . . 53.33 112.782 -176.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.509 HG22 ' HB2' ' A' ' 11' ' ' LEU . 27.5 m -107.58 158.18 33.95 Favored Pre-proline 0 N--CA 1.479 0.991 0 C-N-CA 124.399 1.08 . . . . 71.43 109.57 179.001 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -64.09 158.15 49.54 Favored 'Trans proline' 0 C--N 1.378 2.117 0 C-N-CA 122.23 1.954 . . . . 50.12 111.998 178.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -72.61 11.78 0.58 Allowed 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 113.418 0.896 . . . . 75.43 113.418 -176.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -135.75 23.34 3.36 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.768 1.227 . . . . 64.11 108.017 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.55 134.22 49.7 Favored 'General case' 0 C--N 1.348 0.518 0 CA-C-N 115.233 -0.894 . . . . 64.31 110.03 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.6 p -68.84 155.93 39.32 Favored 'General case' 0 C--O 1.241 0.646 0 O-C-N 124.053 0.846 . . . . 71.11 109.362 173.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.439 ' HA ' ' HB ' ' A' ' 22' ' ' ILE . 52.1 tt0 -62.68 -19.34 63.77 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 123.026 0.53 . . . . 64.21 110.769 177.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -62.14 -53.55 53.7 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 125.019 1.328 . . . . 72.43 109.773 171.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -64.65 -32.97 74.88 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.846 0.858 . . . . 64.03 111.58 177.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.449 HD13 ' HB3' ' A' ' 57' ' ' LEU . 78.6 mt -69.68 -33.03 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.555 1.142 . . . . 73.31 110.846 177.412 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -72.99 -35.43 66.85 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.494 0.718 . . . . 71.24 110.263 175.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 52.8 mtp180 -66.55 -40.78 89.21 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.383 0.673 . . . . 54.12 110.649 173.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.81 -36.33 82.12 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.508 0.723 . . . . 64.0 110.47 178.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -59.98 -63.18 1.39 Allowed 'General case' 0 C--O 1.21 -0.985 0 CA-C-N 114.847 -1.07 . . . . 73.1 109.918 173.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -52.03 -48.37 64.56 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.066 0.547 . . . . 74.22 111.404 -177.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 50.5 ttt180 -56.38 -68.05 0.25 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.083 0.553 . . . . 71.15 111.784 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.44 ' HB3' HD13 ' A' ' 50' ' ' ILE . 93.8 mt -78.73 -43.38 25.89 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-N 115.74 -0.664 . . . . 74.11 111.753 -168.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.73 -25.35 63.8 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 118.015 -0.993 . . . . 63.3 112.814 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.56 ' HA ' ' HB2' ' A' ' 34' ' ' HIS . 81.7 mtp180 -85.02 -31.57 23.39 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 120.3 1.409 . . . . 72.33 110.969 171.024 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 48.0 tp60 -66.84 -32.57 73.93 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.607 0.363 . . . . 63.33 111.282 174.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.428 ' HB3' ' HB2' ' A' ' 47' ' ' PHE . 23.8 m-85 -111.24 16.53 20.92 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.553 0.741 . . . . 63.25 110.493 -178.009 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.56 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 2.7 t-80 -67.86 116.65 40.49 Favored Pre-proline 0 C--N 1.354 0.781 0 CA-C-O 118.181 -0.914 . . . . 63.41 109.743 -175.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_exo -47.57 -31.94 14.94 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 123.317 2.678 . . . . 74.13 113.534 -178.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -59.91 -53.05 62.41 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.885 0.874 . . . . 72.45 111.493 176.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.6 t -90.44 -56.87 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 122.969 0.508 . . . . 65.53 109.737 -173.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -97.7 84.81 3.44 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 121.808 0.813 . . . . 61.35 108.816 -178.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -79.54 69.23 5.78 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 114.45 -1.25 . . . . 73.11 109.475 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.9 m -134.53 107.68 10.99 Favored Pre-proline 0 N--CA 1.473 0.703 0 CA-C-O 118.386 -0.816 . . . . 54.41 109.475 -177.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.443 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 24.5 Cg_exo -36.81 -56.11 0.78 Allowed 'Trans proline' 0 C--N 1.388 2.62 0 C-N-CA 124.713 3.609 . . . . 72.23 114.597 -177.207 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.476 ' HG2' ' HE3' ' A' ' 46' ' ' LYS . 28.3 tt0 -54.39 -43.48 71.47 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.088 0.955 . . . . 64.43 111.348 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.99 -31.48 69.19 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.023 -0.99 . . . . 72.14 110.375 -178.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.444 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 51.5 mt-10 -78.9 -23.13 44.98 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.224 0.61 . . . . 62.01 109.674 -178.153 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 41' ' ' PRO . 23.6 mm-40 -71.5 -47.9 52.43 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.366 0.666 . . . . 62.44 109.527 172.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.476 ' HE3' ' HG2' ' A' ' 42' ' ' GLU . 97.0 mttt -60.32 -37.02 79.3 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 115.0 -1.0 . . . . 74.03 110.251 175.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.428 ' HB2' ' HB3' ' A' ' 33' ' ' TYR . 85.1 t80 -57.72 -53.88 53.21 Favored 'General case' 0 C--O 1.215 -0.713 0 C-N-CA 124.115 0.966 . . . . 73.24 109.307 173.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 44' ' ' GLU . 91.2 mttt -52.41 -45.86 66.09 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.468 0.707 . . . . 75.14 111.582 -179.113 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -62.47 -51.76 66.17 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 123.575 0.547 . . . . 71.44 111.885 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.44 HD13 ' HB3' ' A' ' 29' ' ' LEU . 86.5 mt -64.13 -31.4 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 124.216 1.006 . . . . 70.53 110.712 -178.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -95.67 -7.78 36.54 Favored 'General case' 0 C--O 1.215 -0.735 0 C-N-CA 123.679 0.792 . . . . 73.43 111.731 -176.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -72.35 -50.25 28.12 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 106.616 -1.624 . . . . 63.42 106.616 163.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.13 -49.8 68.38 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 112.756 -2.02 . . . . 65.45 111.477 175.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -67.31 -43.93 80.44 Favored 'General case' 0 C--O 1.212 -0.883 0 CA-C-N 115.357 -0.838 . . . . 72.32 110.795 177.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.451 ' HB2' ' CD2' ' A' ' 88' ' ' PHE . . . -56.54 -33.1 65.78 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 112.446 0.536 . . . . 53.01 112.446 -176.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 95.4 t -74.06 -53.92 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 CA-C-N 115.809 -0.632 . . . . 74.52 109.894 171.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.449 ' HB3' HD13 ' A' ' 22' ' ' ILE . 82.4 mt -83.99 7.12 19.46 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 113.912 1.079 . . . . 62.04 113.912 -169.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.0 t -87.83 -41.25 13.38 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.104 0.961 . . . . 74.34 110.517 178.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -104.27 107.57 57.83 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 108.593 -0.892 . . . . 74.34 108.593 -174.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -33.75 -32.86 0.06 OUTLIER 'Trans proline' 0 C--N 1.388 2.655 1 C-N-CA 125.613 4.208 . . . . 72.41 116.953 -179.332 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.458 ' HB2' ' HB2' ' A' ' 144' ' ' ARG . 16.3 tp10 -63.61 -65.01 0.74 Allowed 'General case' 0 N--CA 1.485 1.316 0 CA-C-O 121.197 0.522 . . . . 72.3 110.596 179.069 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -65.67 -31.99 73.3 Favored 'General case' 0 C--O 1.247 0.929 0 CA-C-N 114.805 -1.089 . . . . 74.54 110.955 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.496 HH11 ' HG2' ' A' ' 63' ' ' ARG . 26.4 ttt-85 -58.27 -54.59 45.27 Favored 'General case' 0 C--N 1.344 0.345 0 CA-C-N 115.316 -0.856 . . . . 74.11 109.917 176.213 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -71.07 -21.26 62.26 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.527 -0.76 . . . . 74.25 111.787 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.461 HG23 ' HG2' ' A' ' 76' ' ' PRO . 50.9 mt -58.88 -50.13 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 N-CA-C 109.327 -0.62 . . . . 64.42 109.327 168.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.422 ' OH ' ' HA ' ' A' ' 6' ' ' ASP . 34.1 t80 -59.68 -49.98 75.63 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 123.68 0.613 . . . . 75.4 110.534 175.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -57.72 -34.93 69.99 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.457 0.703 . . . . 64.04 112.062 -178.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 69.7 p -89.81 -16.31 30.44 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 119.203 -0.427 . . . . 75.13 111.457 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -74.4 131.34 41.01 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 109.268 -0.642 . . . . 63.45 109.268 178.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 98.34 14.66 37.78 Favored Glycine 0 CA--C 1.53 0.982 0 N-CA-C 110.884 -0.886 . . . . 52.54 110.884 -164.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 37.6 m -146.97 -53.25 0.22 Allowed 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 103.622 -2.733 . . . . 71.23 103.622 177.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.5 m -75.45 135.58 40.71 Favored 'General case' 0 C--O 1.253 1.258 0 N-CA-C 104.408 -2.442 . . . . 74.23 104.408 155.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.23 -34.19 5.99 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.775 0.83 . . . . 74.04 110.917 -173.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -84.71 150.65 56.77 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 123.662 0.785 . . . . 75.1 109.625 176.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.419 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 34.6 Cg_exo -60.28 133.12 47.62 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 122.393 2.062 . . . . 75.41 111.259 175.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.461 ' HG2' HG23 ' A' ' 65' ' ' ILE . 39.3 Cg_exo -60.43 153.86 57.48 Favored 'Trans proline' 0 C--N 1.375 1.934 0 C-N-CA 123.27 2.646 . . . . 74.25 113.174 -173.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.29 128.16 15.16 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.498 2.132 . . . . 62.44 111.415 175.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -62.92 116.02 3.3 Favored 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 123.043 2.495 . . . . 43.51 112.214 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -65.33 169.33 12.59 Favored 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 123.087 2.524 . . . . 71.05 111.979 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.83 86.23 0.03 OUTLIER 'Trans proline' 0 C--N 1.386 2.543 0 C-N-CA 123.394 2.729 . . . . 51.35 112.905 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.429 ' HA3' ' HA ' ' A' ' 141' ' ' ALA . . . 141.99 -37.44 1.58 Allowed Glycine 0 C--N 1.347 1.184 0 CA-C-N 115.021 -0.99 . . . . 62.41 111.411 178.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 114.14 -149.6 18.71 Favored Glycine 0 C--N 1.352 1.436 0 N-CA-C 112.274 -0.33 . . . . 53.03 112.274 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -110.98 73.62 0.83 Allowed 'General case' 0 C--O 1.242 0.66 0 C-N-CA 124.25 1.02 . . . . 74.41 108.283 175.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -57.38 125.11 21.34 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 115.511 -0.768 . . . . 71.31 110.914 177.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -121.92 24.28 9.67 Favored 'General case' 0 C--O 1.248 0.975 0 C-N-CA 123.737 0.815 . . . . 70.22 110.703 -175.234 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.412 ' OG ' ' HA2' ' A' ' 166' ' ' GLY . 74.0 m -50.61 124.9 11.75 Favored 'General case' 0 C--N 1.355 0.815 0 O-C-N 124.116 0.885 . . . . 74.44 111.814 176.3 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 129.0 -40.95 1.62 Allowed Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 109.012 -1.635 . . . . 70.11 109.012 -174.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.451 ' CD2' ' HB2' ' A' ' 55' ' ' ALA . 28.5 m-85 -137.18 143.31 42.32 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.78 0.432 . . . . 72.34 110.041 -170.261 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -75.37 89.37 2.62 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-O 121.515 0.674 . . . . 71.44 110.445 -177.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.557 HG21 ' ND2' ' A' ' 169' ' ' ASN . 2.8 p -38.01 -44.58 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 126.303 1.841 . . . . 75.21 114.068 172.136 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -70.28 -19.53 63.1 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.477 0.711 . . . . 75.33 111.789 -168.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -80.27 -24.8 39.83 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.102 0.561 . . . . 45.35 110.709 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -73.79 173.2 10.2 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 113.572 0.953 . . . . 71.01 113.572 -166.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.401 ' OG ' ' HG3' ' A' ' 5' ' ' LYS . 81.2 p -81.88 178.12 8.48 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 114.564 1.32 . . . . 74.5 114.564 -164.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -62.67 -52.52 62.99 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 113.181 -1.827 . . . . 74.31 112.307 -170.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.427 ' HB3' ' HG2' ' A' ' 5' ' ' LYS . 78.0 t80 -54.28 -41.97 69.47 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 123.501 0.72 . . . . 75.03 111.533 -178.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.511 ' CE2' HG23 ' A' ' 90' ' ' VAL . 36.9 t80 -64.9 -46.2 82.72 Favored 'General case' 0 CA--C 1.555 1.157 0 CA-C-N 114.763 -1.108 . . . . 63.23 110.513 176.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -67.05 -12.89 61.18 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.323 0.649 . . . . 73.05 112.371 178.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -89.82 -53.43 4.5 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.289 0.636 . . . . 70.02 111.36 173.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.2 tp -66.66 -52.78 41.02 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.059 0.944 . . . . 55.03 111.269 -171.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -96.21 -3.04 44.99 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.161 0.584 . . . . 72.11 111.174 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.419 ' N ' ' HD2' ' A' ' 103' ' ' PRO . . . -44.34 -55.83 5.72 Favored Glycine 0 C--N 1.354 1.551 0 CA-C-O 118.724 -1.042 . . . . 72.43 115.366 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.419 ' HD2' ' N ' ' A' ' 102' ' ' GLY . 9.5 Cg_endo -47.69 -28.11 8.93 Favored 'Trans proline' 0 C--N 1.388 2.655 0 C-N-CA 124.211 3.274 . . . . 23.1 114.941 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -134.69 35.08 2.25 Favored Glycine 0 C--N 1.346 1.134 0 CA-C-O 119.487 -0.618 . . . . 44.4 112.888 -176.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.422 ' HB3' ' OG ' ' A' ' 113' ' ' SER . 17.6 mt -67.53 26.2 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 114.683 1.364 . . . . 74.25 114.683 176.19 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER 58.6 -107.39 0.35 Allowed 'General case' 0 CA--C 1.562 1.437 0 C-N-CA 124.46 1.104 . . . . 72.25 110.884 163.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.661 ' H ' ' HB2' ' A' ' 169' ' ' ASN . . . 74.92 8.64 82.92 Favored Glycine 0 C--N 1.354 1.539 0 C-N-CA 123.18 0.419 . . . . 44.0 112.709 -177.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 59.34 -135.7 51.3 Favored Glycine 0 C--N 1.353 1.481 0 N-CA-C 111.854 -0.499 . . . . 71.34 111.854 -170.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -79.9 -4.66 53.28 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.125 0.57 . . . . 64.11 111.278 170.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -80.02 -35.95 26.14 Favored Glycine 0 C--N 1.348 1.242 0 N-CA-C 111.728 -0.549 . . . . 55.25 111.728 177.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 75.04 -26.02 0.2 Allowed 'General case' 0 CA--C 1.566 1.579 0 C-N-CA 125.106 1.362 . . . . 71.44 112.681 174.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 18.8 ttt180 -65.58 -8.23 18.94 Favored 'General case' 0 CA--C 1.563 1.474 0 C-N-CA 125.342 1.457 . . . . 73.25 113.148 -175.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.422 ' OG ' ' HB3' ' A' ' 105' ' ' LEU . 16.4 m 75.05 46.01 0.13 Allowed 'General case' 0 C--N 1.366 1.295 0 C-N-CA 125.018 1.327 . . . . 74.21 108.621 -171.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.423 ' NE ' ' H ' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -103.21 160.09 14.97 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.127 -0.942 . . . . 74.52 111.249 -171.055 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.423 ' H ' ' NE ' ' A' ' 114' ' ' ARG . 27.9 tptp -35.66 137.61 0.19 Allowed 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 127.896 2.478 . . . . 72.15 115.557 -163.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.453 ' HA2' ' HA3' ' A' ' 168' ' ' GLY . . . -84.4 167.88 43.57 Favored Glycine 0 C--N 1.343 0.935 0 N-CA-C 115.587 0.995 . . . . 55.22 115.587 -176.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.519 ' HB3' ' HB2' ' A' ' 167' ' ' GLN . 12.5 ttm180 -115.65 144.32 44.09 Favored 'General case' 0 C--O 1.26 1.628 0 C-N-CA 124.17 0.988 . . . . 71.34 111.31 -174.274 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.467 ' HA ' ' H ' ' A' ' 173' ' ' ASP . 9.3 p-10 -64.6 134.9 55.29 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 114.719 -1.128 . . . . 74.23 109.978 169.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.505 HD11 ' HB2' ' B' ' 11' ' ' LEU . 7.9 tp -144.12 143.67 31.23 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.08 -0.341 . . . . 70.23 110.08 -174.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.424 ' HD2' HG21 ' B' ' 19' ' ' THR . 45.8 ttm180 -97.53 111.13 23.52 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.715 -0.846 . . . . 74.51 108.715 166.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -112.56 167.13 10.71 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 107.957 -1.127 . . . . 41.51 107.957 172.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.497 ' HG2' ' HB ' ' A' ' 177' ' ' VAL . 38.2 mt-10 -127.82 118.55 23.91 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 118.786 0.721 . . . . 61.0 109.648 -172.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.442 HD22 HD13 ' A' ' 176' ' ' LEU . 57.1 tp -100.13 104.62 30.5 Favored Pre-proline 0 N--CA 1.478 0.974 0 C-N-CA 123.985 0.914 . . . . 54.05 111.372 -164.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.653 ' HA ' ' HB2' ' A' ' 179' ' ' ARG . 24.6 Cg_exo -61.68 141.04 89.47 Favored 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 122.428 2.085 . . . . 75.33 110.511 176.077 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 13.4 tp -148.41 149.34 31.57 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.268 0.556 . . . . 64.01 111.975 177.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 97.8 m -85.5 140.26 30.82 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.708 1.203 . . . . 71.34 109.393 175.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.576 ' HB3' HD22 ' A' ' 215' ' ' LEU . 34.0 mt -54.79 -59.88 4.12 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 124.364 1.066 . . . . 70.54 113.359 -171.387 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -58.82 -39.1 80.18 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 114.961 -1.018 . . . . 75.32 110.644 -178.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -72.6 -21.83 61.06 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.06 0.944 . . . . 64.33 111.591 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.593 ' HB1' ' O ' ' A' ' 153' ' ' VAL . . . -74.87 -43.5 54.07 Favored 'General case' 0 C--O 1.247 0.947 0 C-N-CA 123.795 0.838 . . . . 41.43 110.915 178.542 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -72.05 -32.12 66.8 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 116.128 -0.487 . . . . 74.51 110.479 173.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 52.0 m170 -59.69 -48.13 82.88 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 123.4 0.438 . . . . 75.25 110.671 175.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.42 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 81.07 -136.08 15.65 Favored Glycine 0 CA--C 1.526 0.755 0 O-C-N 123.822 0.701 . . . . 71.54 111.583 -176.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 85.34 -172.04 46.6 Favored Glycine 0 C--N 1.344 0.983 0 O-C-N 123.632 0.254 . . . . 70.42 112.75 178.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.487 ' HB3' ' HB3' ' A' ' 146' ' ' SER . 1.8 mp0 -87.96 108.42 19.19 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 108.15 -1.056 . . . . 73.14 108.15 173.15 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 13.8 tpp180 -93.53 122.3 35.82 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 122.85 0.46 . . . . 74.4 110.003 -173.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 95.9 t -78.68 124.36 36.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 123.582 0.753 . . . . 71.24 109.782 -178.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.3 p -151.03 133.04 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 C-N-CA 123.82 0.848 . . . . 73.14 109.873 -174.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -84.93 135.25 34.13 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.196 0.998 . . . . 71.3 110.927 -176.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.66 HG23 ' HB2' ' B' ' 10' ' ' LEU . 2.6 p -166.4 111.56 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.201 0 C-N-CA 123.544 0.738 . . . . 75.1 111.168 -178.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.429 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . 60.25 37.71 20.33 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 113.796 1.035 . . . . 74.24 113.796 168.303 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 77.34 11.87 85.1 Favored Glycine 0 N--CA 1.475 1.298 0 CA-C-N 116.208 -0.451 . . . . 31.1 113.125 -178.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 26.6 ttm-85 -116.78 119.86 36.75 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.775 1.23 . . . . 72.12 108.197 174.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.458 ' HB2' ' HB2' ' A' ' 61' ' ' GLU . 14.1 tpp180 -93.34 89.62 6.44 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 106.707 -1.59 . . . . 74.41 106.707 170.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 11.6 p -89.53 140.16 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-O 121.368 0.604 . . . . 73.53 110.569 -170.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.487 ' HB3' ' HB3' ' A' ' 135' ' ' GLU . 25.2 m -106.01 90.14 3.28 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 107.768 -1.197 . . . . 31.45 107.768 174.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 3.3 p -77.35 112.56 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-O 121.335 0.588 . . . . 73.42 109.44 -174.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 5.8 tpm_? -67.06 92.12 0.24 Allowed 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 108.454 -0.943 . . . . 74.14 108.454 175.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.56 HG22 HD13 ' A' ' 159' ' ' ILE . 33.3 pt -93.44 131.74 31.88 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-N 115.203 -0.908 . . . . 74.13 109.089 -179.06 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -63.25 139.4 71.79 Favored 'Trans proline' 0 C--N 1.37 1.667 0 C-N-CA 122.414 2.076 . . . . 60.34 111.502 175.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -59.23 114.13 1.89 Allowed 'Trans proline' 0 C--N 1.383 2.393 0 C-N-CA 123.068 2.512 . . . . 74.15 111.855 -178.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 98.87 76.43 1.26 Allowed Glycine 0 C--N 1.345 1.066 0 N-CA-C 110.068 -1.213 . . . . 75.51 110.068 -175.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.593 ' O ' ' HB1' ' A' ' 130' ' ' ALA . 4.7 p -126.23 132.02 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 124.315 1.046 . . . . 75.43 108.453 172.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.65 ' HD2' HD12 ' A' ' 215' ' ' LEU . 0.0 OUTLIER -134.71 156.86 48.06 Favored 'General case' 0 N--CA 1.483 1.176 0 O-C-N 121.715 -0.616 . . . . 73.23 110.915 -169.92 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -51.66 117.09 2.45 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 125.222 1.409 . . . . 72.32 112.223 -172.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 114.55 -9.63 21.9 Favored Glycine 0 C--N 1.339 0.748 0 CA-C-N 115.596 -0.729 . . . . 14.21 112.708 -176.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 27.5 t -76.01 144.01 41.14 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.459 -0.941 . . . . 74.23 108.459 171.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 18.6 t -113.75 102.44 13.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 N-CA-C 108.357 -0.979 . . . . 72.34 108.357 174.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.632 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 50.9 mt -70.65 84.48 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.831 0 N-CA-C 107.45 -1.315 . . . . 75.24 107.45 172.055 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 70.9 ttt-85 -75.56 100.63 4.63 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.076 -1.083 . . . . 61.32 108.076 176.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.516 HG13 ' HB3' ' A' ' 174' ' ' LEU . 2.4 p -105.9 102.78 40.99 Favored Pre-proline 0 CA--C 1.546 0.825 0 N-CA-C 108.175 -1.046 . . . . 61.33 108.175 175.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -61.97 140.84 86.92 Favored 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 122.613 2.208 . . . . 74.53 110.582 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.409 ' HA2' ' HB2' ' A' ' 171' ' ' PRO . . . 83.33 26.11 44.96 Favored Glycine 0 CA--C 1.523 0.544 0 CA-C-O 118.984 -0.898 . . . . 70.43 114.557 178.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.435 ' C ' ' HB2' ' A' ' 174' ' ' LEU . 44.0 ttm -139.06 -6.06 1.44 Allowed 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 118.768 1.284 . . . . 64.15 113.423 -177.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.477 ' HA2' HD13 ' A' ' 174' ' ' LEU . . . -49.25 -59.58 6.9 Favored Glycine 0 N--CA 1.499 2.87 0 CA-C-O 122.406 1.003 . . . . 73.33 111.111 -177.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.509 ' H ' ' HA3' ' A' ' 172' ' ' GLY . . . 132.74 -86.66 0.28 Allowed Glycine 0 CA--C 1.48 -2.1 0 CA-C-N 112.227 -1.987 . . . . 74.5 109.554 158.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.519 ' HB2' ' HB3' ' A' ' 117' ' ' ARG . 19.0 mm-40 -23.36 105.32 0.02 OUTLIER 'General case' 0 C--N 1.364 1.207 0 O-C-N 129.193 3.525 . . . . 75.42 115.947 -160.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.453 ' HA3' ' HA2' ' A' ' 116' ' ' GLY . . . 137.86 -118.74 1.71 Allowed Glycine 0 N--CA 1.44 -1.071 0 N-CA-C 105.668 -2.973 . . . . 64.21 105.668 -164.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ASN . . . . . 0.661 ' HB2' ' H ' ' A' ' 107' ' ' GLY . 57.7 t30 -165.37 -43.12 0.0 OUTLIER Pre-proline 0 N--CA 1.481 1.101 0 CA-C-N 117.769 0.784 . . . . 63.11 110.912 165.179 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -61.21 165.32 12.89 Favored 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 121.872 1.715 . . . . 71.13 109.647 160.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.409 ' HB2' ' HA2' ' A' ' 163' ' ' GLY . 18.6 Cg_endo -56.28 113.75 1.59 Allowed 'Trans proline' 0 CA--C 1.548 1.186 0 C-N-CA 122.811 2.34 . . . . 71.25 116.58 -168.055 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.509 ' HA3' ' H ' ' A' ' 166' ' ' GLY . . . -67.46 -142.06 0.07 OUTLIER Glycine 0 C--N 1.371 2.479 0 C-N-CA 118.593 -1.765 . . . . 72.4 113.534 153.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.467 ' H ' ' HA ' ' A' ' 118' ' ' ASP . 45.1 m-20 -152.27 108.53 3.41 Favored 'General case' 0 N--CA 1.51 2.569 0 CA-C-N 118.49 1.145 . . . . 71.14 108.916 176.133 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.516 ' HB3' HG13 ' A' ' 161' ' ' VAL . 7.8 tp -91.55 135.13 34.08 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 118.478 0.581 . . . . 64.32 112.019 -167.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 6.2 mt -115.99 93.94 4.46 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 106.029 -1.841 . . . . 72.12 106.029 177.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.632 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 82.2 mt -88.36 101.89 14.33 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.171 0.588 . . . . 70.05 111.519 -175.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.514 HG21 ' HB3' ' B' ' 392' ' ' HIS . 61.4 t -82.53 97.85 4.41 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 N-CA-C 107.378 -1.341 . . . . 61.43 107.378 174.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.507 HG11 HG22 ' A' ' 153' ' ' VAL . 10.5 p -64.84 124.01 18.84 Favored 'Isoleucine or valine' 0 C--O 1.251 1.158 0 CA-C-N 115.469 -0.787 . . . . 70.33 110.585 -174.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.653 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 8.4 mmt85 -87.94 148.17 24.71 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.03 -1.441 . . . . 53.32 108.526 167.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.488 HD11 ' HA ' ' A' ' 154' ' ' ARG . 29.2 mt -118.54 152.39 36.07 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.878 -0.786 . . . . 72.4 108.878 165.229 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 85.9 mt -53.09 153.87 5.97 Favored Pre-proline 0 CA--C 1.558 1.264 0 O-C-N 124.389 1.056 . . . . 73.14 111.111 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.28 11.66 0.1 Allowed 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 123.456 2.771 . . . . 71.42 115.372 -174.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.57 ' HB3' HD11 ' A' ' 127' ' ' LEU . 4.0 t-80 -61.35 104.54 0.47 Allowed Pre-proline 0 CA--C 1.565 1.529 0 C-N-CA 125.166 1.386 . . . . 73.35 108.17 169.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -80.11 29.28 0.51 Allowed 'Trans proline' 0 C--N 1.368 1.571 0 C-N-CA 124.53 3.486 . . . . 61.24 117.229 -159.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.582 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 23.8 t -89.41 -51.39 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 120.379 1.445 . . . . 64.21 108.703 -172.347 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' PHE . . . . . 0.428 ' CZ ' ' HA ' ' A' ' 214' ' ' THR . 65.1 m-85 -114.2 129.38 56.63 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 112.267 0.469 . . . . 72.31 112.267 -169.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.571 HH22 ' HB2' ' A' ' 189' ' ' GLU . 28.4 ttp85 -127.86 123.91 36.22 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.048 -1.093 . . . . 75.51 108.048 164.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 9.1 tp -93.0 148.05 22.32 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 123.15 0.58 . . . . 74.21 110.475 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.571 ' HB2' HH22 ' A' ' 187' ' ' ARG . 10.0 tp10 -123.5 90.58 3.31 Favored 'General case' 0 C--O 1.246 0.911 0 N-CA-C 107.583 -1.266 . . . . 70.31 107.583 163.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.515 ' HA3' ' HA ' ' B' ' 415' ' ' LYS . . . 64.83 -82.2 0.06 OUTLIER Glycine 0 C--N 1.353 1.506 0 CA-C-N 114.373 -1.285 . . . . 65.41 113.494 176.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 5.3 pm0 -93.18 -45.4 7.89 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.447 0.699 . . . . 72.32 111.362 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -111.09 144.85 39.56 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.38 -0.825 . . . . 72.32 113.009 -163.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.428 ' HB2' ' HA ' ' A' ' 249' ' ' LEU . 86.7 mt -91.46 157.41 17.07 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.491 1.116 . . . . 63.44 110.971 -177.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -131.1 105.22 7.56 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 107.777 -1.194 . . . . 73.14 107.777 170.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.582 ' HA ' ' O ' ' A' ' 185' ' ' VAL . . . -104.7 -175.77 2.89 Favored 'General case' 0 C--O 1.218 -0.567 0 C-N-CA 124.393 1.077 . . . . 74.34 110.67 178.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 34.7 m -125.18 128.66 48.71 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.672 -0.862 . . . . 70.21 108.672 173.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.423 HD22 HD13 ' A' ' 251' ' ' LEU . 48.3 tp -129.55 121.17 26.62 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 109.835 -0.432 . . . . 72.21 109.835 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -85.92 122.12 29.52 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 108.886 -0.783 . . . . 61.43 108.886 169.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 7.1 p -133.19 133.24 22.77 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 107.866 -1.161 . . . . 64.4 107.866 178.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.5 152.19 59.78 Favored 'Trans proline' 0 C--N 1.364 1.372 0 C-N-CA 121.378 1.385 . . . . 64.51 111.192 175.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.64 ' HB3' ' HH2' ' A' ' 269' ' ' TRP . . . -53.92 -44.5 98.29 Favored Pre-proline 0 CA--C 1.557 1.223 0 N-CA-C 114.782 1.401 . . . . 71.34 114.782 -175.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -64.2 -37.28 42.13 Favored 'Trans proline' 0 C--N 1.381 2.266 0 CA-C-N 121.677 1.635 . . . . 63.54 112.994 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 38.0 mt -73.59 -31.52 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.021 0.529 . . . . 64.32 110.21 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.15 -44.71 79.1 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.495 0.718 . . . . 71.51 110.999 177.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 69.5 t -68.32 -63.62 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 123.208 0.603 . . . . 63.23 110.273 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 96.4 t -72.56 -40.12 62.43 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 CA-C-N 115.466 -0.788 . . . . 74.41 111.899 -168.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 96.89 108.32 2.53 Favored Glycine 0 C--N 1.339 0.726 0 N-CA-C 111.1 -0.8 . . . . 72.35 111.1 -173.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -144.33 -157.44 7.2 Favored Glycine 0 C--N 1.342 0.871 0 CA-C-O 120.137 -0.257 . . . . 55.24 112.551 -177.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -117.18 130.41 56.58 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 117.17 0.485 . . . . 45.21 110.897 -176.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 29.8 m -132.94 -172.39 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 N-CA-C 107.591 -1.263 . . . . 63.11 107.591 167.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' ARG . . . . . 0.497 ' HD3' ' HB2' ' A' ' 218' ' ' PRO . 25.7 ttm180 -113.55 126.49 55.35 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 121.897 -0.502 . . . . 71.41 110.663 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -104.57 116.74 32.59 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.868 0.867 . . . . 62.04 109.009 175.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' MET . . . . . 0.421 ' SD ' ' N ' ' A' ' 213' ' ' MET . 3.3 mpp? -82.75 104.72 13.21 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.836 -0.802 . . . . 71.23 108.836 178.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 214' ' ' THR . . . . . 0.428 ' HA ' ' CZ ' ' A' ' 186' ' ' PHE . 82.1 p -116.49 174.09 6.26 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 123.314 0.646 . . . . 74.1 110.364 -178.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.65 HD12 ' HD2' ' A' ' 154' ' ' ARG . 14.6 mt -75.76 -17.64 59.82 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.131 0.573 . . . . 63.31 110.053 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.406 ' HG2' ' OG1' ' A' ' 214' ' ' THR . 1.5 pm0 -88.41 -5.21 58.41 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.772 1.229 . . . . 64.44 110.755 174.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 125.21 162.46 11.35 Favored Glycine 0 C--N 1.35 1.323 0 C-N-CA 123.579 0.609 . . . . 33.0 113.274 172.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' PRO . . . . . 0.497 ' HB2' ' HD3' ' A' ' 211' ' ' ARG . 60.5 Cg_endo -72.06 99.61 1.01 Allowed 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 122.463 2.109 . . . . 70.23 110.143 174.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 35.2 m -102.39 161.26 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.666 0.786 . . . . 73.4 111.466 -172.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -83.04 107.4 15.6 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 108.95 -0.759 . . . . 75.04 108.95 171.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 7.6 p -96.5 116.41 38.45 Favored 'Isoleucine or valine' 0 C--O 1.246 0.907 0 N-CA-C 109.161 -0.681 . . . . 74.13 109.161 178.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -81.97 97.32 8.04 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.646 -0.872 . . . . 60.25 108.646 175.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 97.5 t -58.22 121.82 54.44 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 124.454 1.101 . . . . 63.14 109.308 176.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.67 159.83 51.99 Favored 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 122.416 2.077 . . . . 75.51 111.453 176.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -65.04 156.35 63.19 Favored 'Trans proline' 0 C--N 1.365 1.417 0 C-N-CA 121.91 1.74 . . . . 72.53 111.711 171.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' ARG . . . . . 0.775 HH11 ' HA ' ' C' ' 260' ' ' ARG . 3.2 mmp_? 73.97 11.15 4.47 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.638 1.575 . . . . 74.04 111.89 176.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 13.2 m -59.69 120.78 10.14 Favored 'General case' 0 C--N 1.356 0.861 0 C-N-CA 124.002 0.921 . . . . 64.32 110.588 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' GLN . . . . . 0.523 ' HA ' HD11 ' A' ' 255' ' ' ILE . 48.0 tt0 -128.17 142.49 51.17 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.316 -0.402 . . . . 75.32 111.033 -166.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -60.95 133.85 56.51 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 124.1 0.875 . . . . 62.31 111.079 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 98.89 -38.67 3.01 Favored Glycine 0 C--N 1.34 0.792 0 O-C-N 123.553 0.533 . . . . 73.32 111.92 -177.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 28.5 mtm-85 -70.38 170.04 12.69 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-O 121.214 0.531 . . . . 74.0 111.053 173.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.667 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 2.9 mptp? -124.39 129.52 50.83 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.45 -0.795 . . . . 72.22 109.553 -176.39 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.452 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 54.7 mt -79.63 99.72 7.49 Favored 'General case' 0 C--N 1.346 0.455 0 N-CA-C 109.012 -0.736 . . . . 71.4 109.012 173.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 234' ' ' ARG . . . . . 0.424 ' HB3' ' HA ' ' B' ' 443' ' ' ALA . 32.8 ttp180 -72.09 100.51 2.54 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.042 0.937 . . . . 64.14 110.014 178.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.54 HD22 HG12 ' B' ' 441' ' ' ILE . 5.0 mt -87.75 102.2 14.43 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 107.64 -1.245 . . . . 61.12 107.64 176.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -51.69 126.51 17.92 Favored 'General case' 0 CA--C 1.549 0.932 0 O-C-N 124.148 0.905 . . . . 64.43 113.219 -173.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 75.3 10.22 84.37 Favored Glycine 0 C--N 1.347 1.194 0 CA-C-N 115.051 -0.977 . . . . 74.2 115.47 168.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? -84.37 -11.17 56.78 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 117.615 0.707 . . . . 73.01 110.865 175.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -98.91 -164.94 30.17 Favored Glycine 0 C--N 1.348 1.215 0 N-CA-C 111.206 -0.758 . . . . 74.43 111.206 168.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' PHE . . . . . 0.403 ' N ' ' CD1' ' A' ' 240' ' ' PHE . 2.4 m-30 -96.06 131.6 28.58 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 123.895 0.878 . . . . 73.13 110.326 -168.275 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.13 153.91 62.35 Favored 'Trans proline' 0 CA--C 1.547 1.139 0 C-N-CA 122.742 2.295 . . . . 73.33 112.564 177.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -148.78 -178.14 23.6 Favored Glycine 0 C--N 1.347 1.149 0 CA-C-O 119.396 -0.669 . . . . 73.52 112.876 177.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -52.75 -53.36 6.96 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 123.63 2.886 . . . . 70.45 113.315 175.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -120.46 -28.26 5.01 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 122.963 0.505 . . . . 70.11 111.575 178.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -97.67 99.64 2.27 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 111.837 -0.505 . . . . 62.24 111.837 -176.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -86.03 121.83 29.2 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 108.959 -0.756 . . . . 75.41 108.959 173.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.63 130.1 10.03 Favored Glycine 0 C--O 1.246 0.852 0 N-CA-C 114.851 0.7 . . . . 42.24 114.851 -173.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -123.12 165.38 16.94 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.933 0.893 . . . . 75.44 108.961 176.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.464 HD23 HD12 ' A' ' 235' ' ' LEU . 38.0 tp -99.33 101.68 13.04 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 109.086 -0.709 . . . . 70.31 109.086 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.667 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 14.0 m-85 -87.04 103.58 15.51 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 109.155 -0.683 . . . . 52.51 109.155 -177.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.576 HD23 ' HB3' ' A' ' 195' ' ' ALA . 87.4 mt -83.22 108.63 16.59 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 108.777 -0.823 . . . . 72.24 108.777 177.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.516 ' HG2' ' HG3' ' A' ' 232' ' ' LYS . 40.6 mt-10 -75.11 110.9 9.81 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 108.394 -0.965 . . . . 75.41 108.394 -175.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 59.5 t -67.16 125.57 24.91 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 CA-C-N 114.0 -1.454 . . . . 24.43 111.832 -170.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 3.3 mmm-85 -118.13 94.2 4.41 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 125.066 1.346 . . . . 73.14 107.626 170.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.523 HD11 ' HA ' ' A' ' 228' ' ' GLN . 57.5 mt -70.35 128.81 34.15 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 N-CA-C 109.02 -0.733 . . . . 74.34 109.02 174.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 51.9 p -122.59 146.66 47.23 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 124.434 1.094 . . . . 73.43 108.904 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 257' ' ' ILE . . . . . 0.421 HG23 HG21 ' C' ' 255' ' ' ILE . 2.7 pp -109.75 147.37 36.0 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 123.32 0.648 . . . . 73.4 109.458 175.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -50.49 -18.8 4.08 Favored 'Trans proline' 0 N--CA 1.505 2.16 0 C-N-CA 124.658 3.572 . . . . 74.45 115.906 -168.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 58.51 -80.33 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.761 1.225 . . . . 63.24 110.644 -168.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 12.1 ptm85 -73.93 139.43 44.91 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 109.227 -0.657 . . . . 75.12 109.227 173.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.641 ' HB3' ' HB2' ' A' ' 266' ' ' GLU . 9.3 mt -145.04 138.13 26.51 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.228 0.611 . . . . 55.32 111.403 -169.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 27.0 p -83.04 153.41 66.7 Favored Pre-proline 0 CA--C 1.555 1.15 0 C-N-CA 124.647 1.179 . . . . 44.34 109.572 175.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -39.14 -65.3 0.17 Allowed 'Trans proline' 0 C--N 1.384 2.396 0 C-N-CA 124.878 3.719 . . . . 74.33 116.798 -171.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -68.79 -40.69 79.51 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.016 0.526 . . . . 71.44 111.816 -172.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -68.13 -37.73 81.41 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.063 0.545 . . . . 64.2 110.974 -178.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 266' ' ' GLU . . . . . 0.641 ' HB2' ' HB3' ' A' ' 261' ' ' LEU . 41.3 tt0 -64.2 -48.07 77.29 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 121.487 0.661 . . . . 73.45 109.306 176.347 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 267' ' ' ALA . . . . . 0.427 ' HB1' ' HE3' ' A' ' 271' ' ' LYS . . . -54.66 -41.94 70.73 Favored 'General case' 0 C--O 1.208 -1.123 0 CA-C-N 113.8 -1.545 . . . . 64.12 109.81 175.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 12.4 tp -64.81 -46.47 81.87 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.234 1.014 . . . . 73.14 110.885 -175.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 269' ' ' TRP . . . . . 0.64 ' HH2' ' HB3' ' A' ' 201' ' ' ALA . 73.5 m95 -55.59 -44.94 77.4 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 115.232 -0.894 . . . . 75.0 111.331 173.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 270' ' ' LYS . . . . . 0.615 ' HE3' ' HA ' ' C' ' 206' ' ' VAL . 53.6 mtpt -90.27 -9.31 48.42 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 115.359 -0.837 . . . . 62.43 112.267 -171.264 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 271' ' ' LYS . . . . . 0.427 ' HE3' ' HB1' ' A' ' 267' ' ' ALA . 90.1 mttt -76.05 -45.09 36.0 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.55 -1.278 . . . . 70.22 107.55 166.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 272' ' ' LEU . . . . . 0.622 HD21 ' HB2' ' C' ' 268' ' ' LEU . 46.1 mt -55.57 -47.23 76.73 Favored 'General case' 0 C--O 1.213 -0.831 0 CA-C-N 114.4 -1.273 . . . . 63.4 110.185 169.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 273' ' ' ALA . . . . . 0.532 ' HB3' ' HA ' ' A' ' 270' ' ' LYS . . . -63.75 -47.27 81.7 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 124.258 0.974 . . . . 64.51 112.758 -174.399 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -65.8 -44.2 86.38 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 123.226 0.329 . . . . 74.35 110.909 177.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -67.27 -27.52 67.26 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 122.885 0.474 . . . . 71.44 111.598 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 276' ' ' TYR . . . . . 0.514 ' HE2' ' HG3' ' C' ' 258' ' ' PRO . 24.0 t80 -75.1 -74.95 0.18 Allowed 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 107.974 -1.121 . . . . 75.02 107.974 177.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -49.69 -60.5 2.83 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.307 1.843 . . . . 70.12 112.315 -175.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -70.23 -8.24 48.49 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 112.926 0.713 . . . . 75.41 112.926 -172.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 279' ' ' ARG . . . . . 0.467 ' HE ' ' HA ' ' A' ' 279' ' ' ARG . 1.0 OUTLIER -121.64 1.65 10.04 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-O 118.906 -0.569 . . . . 74.13 111.391 -178.971 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.416 0 O-C-N 124.392 1.058 . . . . 72.21 111.185 -172.514 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mpp? . . . . . 0 N--CA 1.482 1.154 0 N-CA-C 109.302 -0.629 . . . . 71.44 109.302 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -67.33 116.88 8.59 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 108.999 -0.741 . . . . 54.1 108.999 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -86.15 68.9 10.42 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 122.344 1.068 . . . . 74.04 108.91 175.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 18.7 m -104.97 113.28 26.78 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-N 113.881 -1.509 . . . . 52.14 108.415 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.95 174.67 7.79 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 121.094 0.473 . . . . 70.11 110.524 -178.086 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 25.0 pt -138.93 160.13 29.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 123.357 0.663 . . . . 64.44 111.665 -163.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 7' ' ' ALA . . . . . 0.485 ' HB3' ' HG3' ' B' ' 75' ' ' MET . . . -136.17 143.43 44.44 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 107.09 -1.448 . . . . 72.01 107.09 166.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 35.4 tp -71.41 -89.01 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.579 0.752 . . . . 75.22 110.656 -170.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . 159.16 -61.36 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 126.188 1.795 . . . . 62.4 106.761 -175.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 10' ' ' LEU . . . . . 0.66 ' HB2' HG23 ' A' ' 140' ' ' VAL . 3.1 tt 53.49 115.65 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 113.561 -1.654 . . . . 74.1 110.024 -162.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.505 ' HB2' HD11 ' A' ' 119' ' ' LEU . 51.9 mt -73.03 106.28 2.15 Favored Pre-proline 0 CA--C 1.546 0.819 0 N-CA-C 108.874 -0.787 . . . . 45.35 108.874 179.023 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' B' ' 11' ' ' LEU . 16.9 Cg_exo -66.43 151.71 82.52 Favored 'Trans proline' 0 C--N 1.376 1.997 0 C-N-CA 123.198 2.599 . . . . 61.33 114.068 -161.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -50.43 -34.99 26.57 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.395 1.478 . . . . 75.01 111.715 168.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 38.8 tp -62.75 136.06 57.67 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.885 0.874 . . . . 64.54 109.539 175.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 43.7 t80 72.38 -82.38 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.006 1.322 . . . . 60.01 108.923 -172.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 33.4 m -159.37 122.74 2.01 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 123.767 0.827 . . . . 51.11 109.439 176.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.01 76.33 4.21 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 122.892 2.395 . . . . 62.42 112.168 172.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.453 HG22 ' H ' ' B' ' 19' ' ' THR . 4.0 p -159.94 176.65 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.019 0 N-CA-C 107.592 -1.262 . . . . 61.41 107.592 174.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 19' ' ' THR . . . . . 0.453 ' H ' HG22 ' B' ' 18' ' ' VAL . 24.2 p -66.54 87.46 0.12 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.366 0.666 . . . . 71.22 111.938 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -128.71 12.06 6.26 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.573 1.149 . . . . 62.34 110.445 171.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.88 -10.1 59.4 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.314 0.645 . . . . 75.34 111.369 176.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 22' ' ' ARG . . . . . 0.495 ' NH1' HD13 ' B' ' 69' ' ' LEU . 25.0 tpt180 -139.33 47.68 1.88 Allowed 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 122.136 0.969 . . . . 73.31 108.782 176.124 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 23' ' ' THR . . . . . . . . . . . . . 75.5 p -119.01 86.91 32.79 Favored Pre-proline 0 CA--C 1.55 0.969 0 CA-C-N 114.752 -1.113 . . . . 72.45 109.265 176.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -80.03 148.53 19.51 Favored 'Trans proline' 0 C--N 1.374 1.878 0 C-N-CA 122.82 2.347 . . . . 74.55 112.846 -174.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -158.39 101.03 1.69 Allowed 'General case' 0 C--O 1.243 0.75 0 N-CA-C 107.751 -1.203 . . . . 74.53 107.751 177.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 26' ' ' MET . . . . . 0.47 ' H ' HG12 ' B' ' 371' ' ' VAL . 0.0 OUTLIER -164.07 150.75 9.93 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 123.848 0.859 . . . . 75.13 109.096 -174.846 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -89.56 11.64 2.83 Favored 'Trans proline' 0 C--N 1.365 1.395 0 C-N-CA 122.48 2.12 . . . . 71.1 111.79 170.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.539 HG11 ' HB3' ' B' ' 33' ' ' ALA . 13.5 m 48.17 20.31 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 C-N-CA 127.11 2.164 . . . . 73.51 113.861 -174.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 63.13 14.45 7.68 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 125.261 1.424 . . . . 62.2 113.042 178.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -165.88 151.96 9.27 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.334 1.054 . . . . 70.24 109.093 176.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -71.11 97.2 1.45 Allowed 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 108.324 -0.991 . . . . 74.34 108.324 176.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -157.02 -57.56 0.08 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.757 0.823 . . . . 72.22 109.061 -169.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 33' ' ' ALA . . . . . 0.539 ' HB3' HG11 ' B' ' 28' ' ' VAL . . . -134.87 61.23 1.68 Allowed 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.287 -0.869 . . . . 73.31 108.917 178.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -119.02 -112.22 0.34 Allowed 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 114.59 -1.186 . . . . 53.33 108.722 176.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 35' ' ' GLN . . . . . 0.455 ' HB2' HE22 ' B' ' 372' ' ' GLN . 52.1 mt-30 62.92 107.78 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 124.28 1.032 . . . . 73.13 110.576 -171.169 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 36' ' ' GLY . . . . . 0.522 ' HA2' ' HB3' ' B' ' 312' ' ' PRO . . . 165.58 38.48 0.02 OUTLIER Glycine 0 C--N 1.338 0.646 0 CA-C-O 119.386 -0.674 . . . . 74.33 112.715 -179.112 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 1.7 p30 41.73 -80.41 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 125.948 1.699 . . . . 61.44 114.303 -174.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 10.3 tt -151.27 -34.21 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.671 0 C-N-CA 124.597 1.159 . . . . 75.44 109.518 -173.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 12.7 t -149.35 -8.72 0.33 Allowed 'General case' 0 C--O 1.215 -0.737 0 CA-C-O 118.64 -0.695 . . . . 64.25 111.812 -177.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.445 ' HB3' ' HD3' ' B' ' 373' ' ' ARG . . . 51.47 92.14 0.06 OUTLIER Pre-proline 0 N--CA 1.483 1.199 0 C-N-CA 124.549 1.14 . . . . 64.0 112.005 -177.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 41' ' ' PRO . . . . . 0.601 ' HG2' ' HG2' ' B' ' 313' ' ' GLN . 74.3 Cg_endo -72.18 172.86 13.95 Favored 'Trans proline' 0 C--N 1.371 1.757 0 C-N-CA 122.663 2.242 . . . . 72.44 112.861 -178.123 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 42' ' ' GLY . . . . . 0.417 ' HA2' ' HB2' ' B' ' 51' ' ' GLN . . . -79.92 79.49 1.69 Allowed Glycine 0 C--N 1.337 0.595 0 CA-C-N 115.888 -0.596 . . . . 45.24 112.101 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.35 -70.55 1.06 Allowed Glycine 0 C--N 1.349 1.289 0 N-CA-C 111.704 -0.558 . . . . 42.15 111.704 176.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -96.69 97.23 9.19 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 106.34 -1.726 . . . . 63.2 106.34 167.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.0 105.95 0.05 Allowed 'General case' 0 N--CA 1.484 1.239 0 O-C-N 125.037 1.461 . . . . 74.21 111.825 -174.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 18.3 tpt180 -77.31 83.85 3.75 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 114.258 -1.337 . . . . 75.02 108.137 -177.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.408 ' HB2' ' HE1' ' B' ' 377' ' ' PHE . 41.3 tp 65.39 -78.63 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.927 1.291 . . . . 53.22 110.224 -169.176 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 11.6 t -167.99 165.08 13.75 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.855 0.862 . . . . 51.22 110.405 -176.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.53 29.43 13.97 Favored Glycine 0 C--N 1.351 1.406 0 CA-C-N 115.866 -0.606 . . . . 74.15 112.869 175.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 29.0 t70 52.85 74.59 0.28 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.939 1.296 . . . . 64.2 110.274 -173.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 51' ' ' GLN . . . . . 0.417 ' HB2' ' HA2' ' B' ' 42' ' ' GLY . 61.9 tt0 67.69 -82.71 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 125.097 1.359 . . . . 75.3 111.323 -173.055 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 52' ' ' THR . . . . . 0.55 ' HB ' ' HB3' ' B' ' 55' ' ' LEU . 32.5 p -78.72 108.48 12.17 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 122.896 0.478 . . . . 73.31 110.895 -174.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.06 87.52 0.57 Allowed 'General case' 0 C--O 1.244 0.805 0 C-N-CA 123.806 0.842 . . . . 73.24 109.853 176.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . 58.08 72.58 0.51 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.738 1.215 . . . . 75.51 111.219 -178.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.55 ' HB3' ' HB ' ' B' ' 52' ' ' THR . 48.5 tp -157.71 131.5 7.98 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.076 -0.713 . . . . 72.35 109.076 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 6.4 ttp180 -164.25 124.25 2.04 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 108.907 -0.775 . . . . 73.2 108.907 170.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 35.7 t70 54.25 92.66 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.41 1.484 . . . . 75.31 111.513 178.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 50.0 m -143.2 -73.86 0.28 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 122.559 0.343 . . . . 62.01 110.705 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 59' ' ' LEU . . . . . 0.435 HD11 HD11 ' B' ' 69' ' ' LEU . 21.9 tp -104.63 168.46 9.06 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.716 0.406 . . . . 72.44 110.756 -171.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 60' ' ' SER . . . . . 0.439 ' HA ' ' SD ' ' B' ' 26' ' ' MET . 23.6 p -135.18 179.36 6.37 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.589 1.155 . . . . 63.51 110.67 178.414 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 14.6 t70 71.5 141.79 0.05 Allowed 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 125.137 1.375 . . . . 71.45 112.789 177.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 62' ' ' LYS . . . . . 0.409 ' HE2' ' HG ' ' B' ' 375' ' ' LEU . 4.9 mmmp? -119.2 -55.82 0.04 OUTLIER Pre-proline 0 CA--C 1.56 1.364 0 C-N-CA 124.396 1.078 . . . . 72.3 112.505 176.089 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 63' ' ' PRO . . . . . 0.634 ' HG2' ' HB2' ' B' ' 65' ' ' LYS . 48.3 Cg_endo -86.2 8.35 4.53 Favored 'Trans proline' 0 C--N 1.385 2.486 0 C-N-CA 121.63 1.553 . . . . 72.24 114.75 -172.549 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.29 39.75 15.18 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.99 0.916 . . . . 72.04 110.135 -176.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.634 ' HB2' ' HG2' ' B' ' 63' ' ' PRO . 23.6 tptp -71.97 -25.61 61.93 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-N 114.886 -1.052 . . . . 65.32 111.533 -170.103 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -88.2 52.68 2.52 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 123.374 0.67 . . . . 72.41 110.1 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 60.7 mt 64.69 -76.9 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 125.217 1.407 . . . . 72.03 109.627 -172.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 19.3 pt -137.02 172.36 15.11 Favored 'Isoleucine or valine' 0 C--O 1.245 0.862 0 C-N-CA 125.405 1.482 . . . . 73.4 108.46 177.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.571 ' HB3' ' HB2' ' B' ' 73' ' ' ASP . 60.2 tp -63.46 110.92 2.11 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.111 0.565 . . . . 73.12 111.514 -173.411 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 58.7 32.51 22.26 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.911 1.284 . . . . 44.44 110.065 177.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 28.9 pt 44.47 26.58 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 C-N-CA 126.271 1.828 . . . . 74.32 113.823 -174.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -125.79 -84.99 0.57 Allowed Glycine 0 C--N 1.353 1.495 0 N-CA-C 110.176 -1.17 . . . . 62.21 110.176 177.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 73' ' ' ASP . . . . . 0.571 ' HB2' ' HB3' ' B' ' 69' ' ' LEU . 20.4 t70 54.93 -87.33 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.634 1.173 . . . . 63.44 112.033 176.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -89.69 79.13 1.55 Allowed Glycine 0 C--N 1.349 1.262 0 N-CA-C 110.807 -0.917 . . . . 64.42 110.807 177.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 75' ' ' MET . . . . . 0.485 ' HG3' ' HB3' ' B' ' 7' ' ' ALA . 21.6 ptt? -68.67 172.01 6.92 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.327 0.651 . . . . 74.01 111.928 -177.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 137.46 -150.92 20.96 Favored Glycine 0 C--N 1.336 0.579 0 CA-C-N 115.554 -0.748 . . . . 71.13 111.583 -178.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -159.55 138.66 11.06 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 108.502 -0.925 . . . . 73.03 108.502 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 24.9 t -82.77 42.69 0.79 Allowed 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 123.889 0.876 . . . . 51.1 110.818 -176.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 79' ' ' GLU . . . . . 0.4 ' HB3' ' HA ' ' B' ' 84' ' ' ARG . 15.2 tp10 66.18 137.5 0.02 OUTLIER 'General case' 0 C--N 1.362 1.142 0 C-N-CA 125.435 1.494 . . . . 74.44 110.85 -172.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 61.4 mt -69.52 -56.29 12.14 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 123.276 0.631 . . . . 72.52 111.067 -177.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 9.3 t -151.56 -31.85 0.16 Allowed 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 113.307 0.854 . . . . 71.34 113.307 -172.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.8 -27.14 67.81 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 112.641 0.608 . . . . 61.11 112.641 -170.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -167.94 38.24 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.448 1.099 . . . . 71.35 109.335 -176.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 84' ' ' ARG . . . . . 0.4 ' HA ' ' HB3' ' B' ' 79' ' ' GLU . 2.1 ptm180 -58.37 93.26 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.192 0.597 . . . . 73.0 112.325 -170.184 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 4.1 t30 59.83 16.96 6.05 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 124.922 1.289 . . . . 72.23 111.78 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -70.59 117.35 12.01 Favored 'General case' 0 C--N 1.352 0.692 0 CA-C-O 120.961 0.41 . . . . 63.12 110.67 -173.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -123.73 78.7 1.63 Allowed 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.631 1.173 . . . . 52.24 108.4 178.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -141.12 140.07 34.06 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.84 0.856 . . . . 74.14 108.719 -175.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -158.94 59.18 0.33 Allowed Glycine 0 C--N 1.346 1.139 0 N-CA-C 111.546 -0.622 . . . . 54.33 111.546 178.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.84 103.12 1.37 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.599 0.76 . . . . 62.33 110.321 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 75.49 24.22 71.09 Favored Glycine 0 C--N 1.345 1.039 0 CA-C-N 116.046 -0.525 . . . . 70.11 112.48 -175.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -162.72 28.27 0.25 Allowed Glycine 0 C--N 1.346 1.119 0 N-CA-C 112.207 -0.357 . . . . 23.53 112.207 -177.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -81.45 104.74 12.1 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 109.045 -0.724 . . . . 74.22 109.045 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -130.18 145.07 51.69 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.12 0.968 . . . . 71.21 109.706 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -75.23 -30.67 60.62 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.092 0.557 . . . . 74.14 109.647 169.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 112.8 7.46 21.88 Favored Glycine 0 C--N 1.353 1.476 0 CA-C-N 115.947 -0.569 . . . . 72.31 112.562 -179.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 32.5 pt -134.03 21.86 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 C-N-CA 123.96 0.904 . . . . 72.22 109.793 177.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -75.53 97.52 3.74 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.153 0.981 . . . . 75.21 110.753 -169.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -146.8 81.01 1.55 Allowed 'General case' 0 C--O 1.235 0.315 0 N-CA-C 106.548 -1.649 . . . . 61.12 106.548 174.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -79.66 111.27 19.88 Favored Pre-proline 0 N--CA 1.471 0.614 0 C-N-CA 124.069 0.948 . . . . 74.2 110.494 -169.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -90.56 157.29 4.35 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.836 2.357 . . . . 72.21 111.17 172.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -81.91 -2.96 53.07 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 116.541 -0.299 . . . . 73.12 110.464 174.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 13.5 t 52.27 24.83 3.03 Favored 'General case' 0 C--N 1.369 1.435 0 C-N-CA 126.84 2.056 . . . . 75.52 113.76 170.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 137.04 -27.16 2.93 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-O 119.688 -0.506 . . . . 51.35 112.422 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 23.6 tp60 77.7 -45.33 0.44 Allowed 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 126.104 1.762 . . . . 75.22 112.438 177.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -64.08 -17.45 63.42 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.522 1.129 . . . . 74.44 112.089 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 4.2 t -66.72 92.78 0.23 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.808 0.843 . . . . 63.32 110.058 174.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -67.62 -42.3 82.58 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 114.96 -1.018 . . . . 71.44 110.344 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -145.47 -69.62 0.28 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.832 0.853 . . . . 53.33 108.808 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -171.19 173.11 5.07 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.602 1.161 . . . . 71.24 109.721 -177.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 111' ' ' LEU . . . . . 0.412 HD23 ' H ' ' B' ' 111' ' ' LEU . 2.6 pt? -73.96 116.72 14.91 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-O 121.291 0.567 . . . . 64.15 109.997 176.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -81.34 145.5 30.83 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.828 -0.804 . . . . 73.2 108.828 175.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 113' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -168.33 -37.43 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.672 0.789 . . . . 75.13 109.747 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 96.3 mttt 63.78 -72.94 0.05 Allowed 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 125.301 1.441 . . . . 74.01 111.256 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 26.2 p -73.02 153.46 40.89 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.663 0.785 . . . . 73.23 110.124 168.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -111.22 13.88 28.41 Favored Glycine 0 C--N 1.339 0.697 0 CA-C-O 119.683 -0.51 . . . . 55.33 112.078 175.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt 64.91 134.05 0.04 OUTLIER Pre-proline 0 N--CA 1.485 1.293 0 C-N-CA 125.298 1.439 . . . . 70.25 111.633 -173.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 118' ' ' PRO . . . . . 0.544 ' HB2' ' HA ' ' B' ' 121' ' ' VAL . 71.1 Cg_endo -70.72 84.77 0.79 Allowed 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.317 2.011 . . . . 60.53 111.441 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 119' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -58.6 -56.02 27.56 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.894 1.277 . . . . 75.33 110.658 -177.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 120' ' ' TYR . . . . . 0.462 ' CD1' ' HB2' ' B' ' 123' ' ' ASP . 0.1 OUTLIER -80.9 -7.68 59.54 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 114.937 -1.029 . . . . 70.1 112.18 177.857 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 121' ' ' VAL . . . . . 0.544 ' HA ' ' HB2' ' B' ' 118' ' ' PRO . 49.3 t 58.42 -82.71 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.251 0 C-N-CA 125.894 1.678 . . . . 74.32 112.06 -179.236 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 68.2 p -85.29 -31.93 22.8 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.261 0.624 . . . . 75.24 111.531 -176.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 123' ' ' ASP . . . . . 0.466 ' HB3' ' NH1' ' C' ' 260' ' ' ARG . 38.4 t70 61.01 77.82 0.31 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.814 1.246 . . . . 64.3 110.878 -178.014 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 17.6 m 65.99 -78.87 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.985 1.314 . . . . 43.31 111.625 177.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -154.64 163.16 40.64 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.483 0.713 . . . . 73.02 111.061 -177.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -84.25 -20.8 31.62 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 115.124 -0.944 . . . . 74.13 111.234 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 42.1 t -142.02 159.43 42.23 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.075 0.95 . . . . 70.01 108.951 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -138.01 -73.76 0.41 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.921 0.489 . . . . 72.01 110.861 -176.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 12.1 t -74.12 -5.9 44.43 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.605 0.762 . . . . 54.34 112.771 -170.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . 62.06 -156.07 0.34 Allowed 'General case' 0 C--N 1.366 1.293 0 C-N-CA 124.056 0.942 . . . . 44.22 109.537 -173.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 80.4 t90 76.93 -49.07 0.55 Allowed 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 124.911 1.284 . . . . 73.51 111.533 178.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 47.5 p -59.87 149.85 30.29 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.837 1.255 . . . . 51.4 111.28 174.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 5.5 m -66.02 -22.73 66.46 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 124.22 1.008 . . . . 62.25 111.466 -177.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 124.09 50.18 0.21 Allowed Glycine 0 C--N 1.342 0.913 0 CA-C-O 119.349 -0.695 . . . . 55.15 112.27 171.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 135' ' ' VAL . . . . . 0.628 HG13 ' HB2' ' B' ' 468' ' ' LEU . 70.2 t 72.63 -65.09 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 125.333 1.453 . . . . 73.24 111.35 174.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 136' ' ' LYS . . . . . 0.456 ' HA ' ' HB3' ' A' ' 279' ' ' ARG . 35.6 mmtm -126.6 34.9 4.72 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.908 1.283 . . . . 52.43 109.638 174.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 137' ' ' THR . . . . . 0.709 ' HB ' ' HB2' ' B' ' 141' ' ' ALA . 91.5 m 65.78 87.65 0.12 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.231 1.013 . . . . 75.31 110.449 -177.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 63.48 -82.12 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.467 1.507 . . . . 75.52 112.924 174.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -107.81 -15.43 14.56 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.792 0.837 . . . . 73.24 112.518 -170.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . 136.07 -0.66 3.31 Favored Glycine 0 C--N 1.347 1.16 0 CA-C-O 119.342 -0.699 . . . . 65.04 112.882 -175.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 141' ' ' ALA . . . . . 0.709 ' HB2' ' HB ' ' B' ' 137' ' ' THR . . . 59.21 42.37 18.68 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.237 1.015 . . . . 75.34 111.332 177.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 tt -79.82 94.41 5.8 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 108.866 -0.79 . . . . 70.15 108.866 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 178.17 -154.98 15.88 Favored Glycine 0 C--N 1.341 0.858 0 CA-C-N 115.021 -0.99 . . . . 61.25 111.841 178.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 19.8 m -120.68 -57.71 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 CA-C-N 117.298 0.549 . . . . 75.31 110.961 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 145' ' ' ASP . . . . . 0.546 ' O ' ' HG2' ' B' ' 148' ' ' GLU . 14.2 t70 -85.1 -52.65 5.8 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.373 0.669 . . . . 64.3 109.605 -176.074 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 146' ' ' ILE . . . . . 0.515 HD13 ' HB1' ' B' ' 141' ' ' ALA . 20.2 mt 60.87 -86.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 124.91 1.284 . . . . 72.52 110.893 174.057 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -134.06 -81.97 0.45 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.333 1.453 . . . . 72.43 107.126 177.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 148' ' ' GLU . . . . . 0.579 ' HB3' ' HE2' ' B' ' 275' ' ' LYS . 3.4 mm-40 52.84 -80.39 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 126.377 1.871 . . . . 73.05 112.07 -175.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 149' ' ' LYS . . . . . 0.657 ' HA ' ' HB2' ' B' ' 273' ' ' GLN . 2.3 ptpt -73.64 -43.06 60.51 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 124.109 0.964 . . . . 72.23 109.483 176.301 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 150' ' ' ASP . . . . . 0.647 ' HB3' ' HA ' ' B' ' 232' ' ' THR . 5.9 t70 53.24 34.69 18.22 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 125.301 1.441 . . . . 74.11 109.394 -174.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 151' ' ' HIS . . . . . 0.428 ' H ' ' HG3' ' B' ' 149' ' ' LYS . 24.5 m170 65.58 133.38 0.04 OUTLIER Pre-proline 0 CA--C 1.561 1.377 0 C-N-CA 125.279 1.431 . . . . 74.43 109.865 -167.257 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 152' ' ' PRO . . . . . 0.504 ' HB3' ' HB1' ' B' ' 271' ' ' ALA . 12.0 Cg_endo -54.42 -32.48 73.04 Favored 'Trans proline' 0 C--N 1.382 2.301 0 C-N-CA 123.196 2.597 . . . . 42.51 113.541 -173.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 10.3 m 50.99 75.89 0.17 Allowed 'General case' 0 C--O 1.246 0.916 0 C-N-CA 125.605 1.562 . . . . 74.2 111.489 177.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 18.8 pt -87.69 169.98 1.33 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.632 0 CA-C-N 115.51 -0.768 . . . . 74.25 109.437 177.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 75.1 mt 69.98 8.82 6.86 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.797 1.239 . . . . 72.1 111.871 -176.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.81 158.5 28.17 Favored 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 124.396 1.079 . . . . 72.23 109.457 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 157' ' ' MET . . . . . . . . . . . . . 22.2 mmt -53.75 -59.42 4.64 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 124.894 1.278 . . . . 53.54 114.028 -166.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 158' ' ' ALA . . . . . . . . . . . . . . . -137.08 0.42 2.36 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 122.771 0.429 . . . . 34.04 111.705 -177.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 159' ' ' LYS . . . . . 0.548 ' HE3' ' HA ' ' B' ' 159' ' ' LYS . 0.4 OUTLIER 63.21 -80.78 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.486 1.515 . . . . 55.45 111.564 177.697 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -69.37 -55.48 10.26 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.245 0.618 . . . . 70.22 110.273 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -81.19 3.9 22.09 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 122.755 0.422 . . . . 71.1 111.503 175.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . -93.69 -40.78 4.6 Favored Glycine 0 C--N 1.35 1.318 0 O-C-N 123.398 0.436 . . . . 73.4 112.091 177.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 163' ' ' LEU . . . . . 0.507 HD21 ' HA ' ' B' ' 231' ' ' LYS . 3.1 tm? -94.29 -48.27 6.24 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.454 0.701 . . . . 65.02 110.382 -178.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 164' ' ' ALA . . . . . . . . . . . . . . . -70.44 -16.69 62.96 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 112.223 0.453 . . . . 75.34 112.223 -175.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 13.3 t -165.84 -177.95 4.53 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.194 0.997 . . . . 64.15 108.797 175.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . -118.39 54.93 0.6 Allowed Glycine 0 C--N 1.342 0.885 0 N-CA-C 109.62 -1.392 . . . . 71.15 109.62 172.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 167' ' ' ASN . . . . . . . . . . . . . 53.3 t30 65.13 -76.99 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 125.319 1.448 . . . . 72.31 109.988 -169.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 12.9 m -118.0 123.53 71.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 124.95 1.3 . . . . 74.13 107.949 174.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 43.9 m -134.68 111.21 9.8 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.368 0.667 . . . . 54.35 109.446 -175.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 26.1 m 65.57 85.38 0.14 Allowed 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.884 1.274 . . . . 63.1 111.393 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -154.53 -166.49 2.35 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-N 115.033 -0.985 . . . . 53.32 109.15 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 172' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -80.66 44.36 0.72 Allowed 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 112.649 0.611 . . . . 73.22 112.649 -177.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 173' ' ' LEU . . . . . . . . . . . . . 7.1 mp -73.26 -46.58 49.14 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 107.516 -1.29 . . . . 74.23 107.516 165.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 174' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -97.61 69.12 2.16 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 106.854 -1.536 . . . . 74.45 106.854 169.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 175' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -61.5 96.82 0.06 Allowed 'General case' 0 N--CA 1.48 1.04 0 CA-C-O 122.119 0.961 . . . . 74.1 110.844 -173.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -105.47 -20.35 13.51 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 114.806 -1.088 . . . . 74.11 110.676 -177.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 17.1 m -74.8 -43.2 4.93 Favored Pre-proline 0 CA--C 1.568 1.636 0 C-N-CA 123.893 0.877 . . . . 64.31 112.931 -177.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 178' ' ' PRO . . . . . 0.527 ' HG3' ' HG3' ' C' ' 129' ' ' GLU . 12.4 Cg_exo -69.65 127.32 14.52 Favored 'Trans proline' 0 C--N 1.39 2.745 0 C-N-CA 121.698 1.599 . . . . 74.53 111.257 175.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -61.4 -44.41 97.19 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-O 121.671 0.748 . . . . 61.34 110.822 176.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 180' ' ' ALA . . . . . 0.401 ' HB1' HG23 ' C' ' 137' ' ' VAL . . . -174.38 -43.15 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.561 1.544 . . . . 74.4 107.385 -177.011 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 181' ' ' LEU . . . . . 0.738 HD23 ' HB ' ' C' ' 138' ' ' VAL . 41.8 tp -177.25 -63.87 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 126.48 1.912 . . . . 62.04 106.878 169.088 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 182' ' ' VAL . . . . . . . . . . . . . 15.0 p -107.2 149.18 10.83 Favored 'Isoleucine or valine' 0 C--O 1.244 0.787 0 CA-C-N 114.461 -1.245 . . . . 71.31 108.556 175.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -76.33 -62.72 1.52 Allowed 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 109.088 -0.708 . . . . 65.24 109.088 172.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 26.1 t-80 -171.42 -95.06 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.72 0 O-C-N 124.335 1.022 . . . . 74.15 108.437 173.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 185' ' ' VAL . . . . . 0.575 ' HA ' ' HB1' ' C' ' 121' ' ' ALA . 58.5 t -140.0 113.66 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 CA-C-N 118.844 0.747 . . . . 71.33 110.305 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 186' ' ' THR . . . . . 0.517 ' HA ' ' HG2' ' C' ' 122' ' ' GLU . 58.6 p 62.12 4.6 1.25 Allowed 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 116.583 2.068 . . . . 51.31 116.583 162.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 187' ' ' SER . . . . . . . . . . . . . 49.0 m -147.16 107.48 4.06 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 119.378 0.99 . . . . 62.14 111.775 -174.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 18.8 tpt180 -173.02 150.44 1.99 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.468 0.707 . . . . 71.52 110.646 175.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -118.36 139.47 51.31 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.886 0.875 . . . . 72.52 108.992 166.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 190' ' ' CYS . . . . . 0.513 ' HB2' HD21 ' C' ' 181' ' ' LEU . 76.9 m -143.04 -174.39 4.17 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.895 0.878 . . . . 70.33 109.648 176.306 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 28.7 t80 77.13 147.01 0.09 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 125.501 1.52 . . . . 74.04 111.668 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -136.16 101.74 0.38 Allowed Glycine 0 C--N 1.34 0.752 0 N-CA-C 110.718 -0.953 . . . . 64.22 110.718 176.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 193' ' ' PRO . . . . . 0.455 ' HB3' HD22 ' B' ' 454' ' ' LEU . 94.0 Cg_endo -75.72 -10.87 20.18 Favored 'Trans proline' 0 C--N 1.372 1.789 0 C-N-CA 122.307 2.005 . . . . 64.32 113.596 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 194' ' ' SER . . . . . . . . . . . . . 23.0 t 69.05 176.59 0.27 Allowed 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 125.182 1.393 . . . . 24.51 111.142 -178.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 195' ' ' ALA . . . . . . . . . . . . . . . -123.71 29.96 6.37 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.339 1.056 . . . . 74.32 109.993 -179.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 91.3 m 67.84 -69.21 0.15 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.18 1.392 . . . . 73.32 109.898 -169.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 24.7 p -122.24 -81.43 0.64 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.242 1.017 . . . . 75.11 108.543 171.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 198' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -178.75 -40.45 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.583 1.153 . . . . 51.12 108.961 -174.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -163.61 131.58 3.61 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 106.898 -1.519 . . . . 74.4 106.898 177.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 200' ' ' CYS . . . . . . . . . . . . . 52.4 t 61.1 105.74 0.03 OUTLIER Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 124.783 1.233 . . . . 73.31 111.235 -177.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 201' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -75.51 66.82 6.43 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.857 2.371 . . . . 71.34 110.929 175.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . -76.95 119.54 5.43 Favored Glycine 0 C--N 1.346 1.112 0 CA-C-N 115.227 -0.897 . . . . 63.04 112.075 -174.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -159.76 -42.0 0.05 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.961 0.904 . . . . 71.33 108.814 176.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -157.57 119.86 3.81 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 124.046 0.938 . . . . 74.01 109.473 175.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 205' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -136.73 94.28 2.97 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 107.701 -1.222 . . . . 51.03 107.701 175.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 61.7 34.29 17.55 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 124.355 1.062 . . . . 62.32 110.915 175.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 9.1 tmtt? -70.17 112.49 6.56 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 108.978 -0.749 . . . . 74.32 108.978 -179.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 78.54 22.8 66.36 Favored Glycine 0 C--N 1.343 0.94 0 O-C-N 124.102 0.876 . . . . 71.52 112.524 -177.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . -67.83 81.55 0.17 Allowed Glycine 0 C--N 1.352 1.463 0 N-CA-C 111.787 -0.525 . . . . 42.21 111.787 177.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 18.0 tptm -83.12 136.15 34.56 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 123.543 0.737 . . . . 74.51 110.886 -171.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . -167.16 169.13 40.8 Favored Glycine 0 C--N 1.338 0.662 0 O-C-N 123.942 0.776 . . . . 74.43 111.597 174.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 22.9 t 67.84 -75.95 0.06 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.172 1.389 . . . . 74.04 111.356 176.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 46.1 mm -71.81 137.11 24.32 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 123.798 0.839 . . . . 64.4 109.558 178.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 214' ' ' THR . . . . . 0.423 ' O ' ' HA ' ' B' ' 218' ' ' LEU . 10.4 t -88.67 -36.63 16.11 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.528 0.331 . . . . 75.43 110.218 178.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 215' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -66.41 158.91 28.16 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.25 1.02 . . . . 73.31 110.553 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 68.28 90.08 0.1 Allowed 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 124.53 1.132 . . . . 61.42 108.28 -167.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 75.6 mt 62.14 85.1 0.13 Allowed 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 108.328 -0.99 . . . . 75.4 108.328 -166.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 218' ' ' LEU . . . . . 0.423 ' HA ' ' O ' ' B' ' 214' ' ' THR . 36.7 tp -62.36 137.07 58.19 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 114.951 -1.022 . . . . 71.43 111.745 -168.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 66.22 13.47 9.18 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.793 1.237 . . . . 71.24 111.637 -177.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . 61.13 16.06 6.84 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.453 1.101 . . . . 61.1 111.493 -171.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 221' ' ' ARG . . . . . 0.538 ' HD2' HG13 ' B' ' 224' ' ' VAL . 0.0 OUTLIER -82.61 77.45 9.37 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 106.24 -1.763 . . . . 73.55 106.24 -179.175 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -66.93 -33.14 74.94 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 114.579 -1.191 . . . . 42.52 112.619 -167.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 223' ' ' ASP . . . . . 0.513 ' HA ' ' HB2' ' B' ' 226' ' ' LEU . 9.1 p-10 -81.47 13.92 2.77 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 113.24 0.83 . . . . 61.02 113.24 -169.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 224' ' ' VAL . . . . . 0.538 HG13 ' HD2' ' B' ' 221' ' ' ARG . 12.8 m -57.56 -39.53 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 CA-C-O 121.131 0.491 . . . . 74.2 110.528 169.292 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 25.3 p -89.45 -23.51 22.1 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.256 1.022 . . . . 54.34 111.194 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 226' ' ' LEU . . . . . 0.513 ' HB2' ' HA ' ' B' ' 223' ' ' ASP . 3.7 mm? -83.71 -173.65 4.84 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.351 0.66 . . . . 74.43 111.008 178.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . 158.66 48.66 0.01 OUTLIER Glycine 0 C--N 1.332 0.328 0 N-CA-C 107.572 -2.211 . . . . 51.31 107.572 -177.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 228' ' ' GLY . . . . . 0.415 ' HA2' ' HA ' ' B' ' 150' ' ' ASP . . . 118.58 -159.38 14.39 Favored Glycine 0 C--O 1.243 0.707 0 CA-C-N 113.703 -1.248 . . . . 72.41 110.449 -162.082 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -177.59 -57.25 0.07 OUTLIER Glycine 0 C--N 1.341 0.823 0 N-CA-C 112.317 -0.313 . . . . 70.24 112.317 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -175.92 -41.12 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.955 0.902 . . . . 70.23 110.866 -175.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 231' ' ' LYS . . . . . 0.507 ' HA ' HD21 ' B' ' 163' ' ' LEU . 99.6 mttt -88.42 83.09 6.87 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.3 0.64 . . . . 73.24 111.178 -172.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 232' ' ' THR . . . . . 0.647 ' HA ' ' HB3' ' B' ' 150' ' ' ASP . 5.0 t -67.21 86.96 0.16 Allowed 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.873 0.844 . . . . 74.24 109.333 172.405 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 233' ' ' PHE . . . . . 0.43 ' HB2' ' HB2' ' B' ' 274' ' ' GLN . 81.6 m-85 -59.28 101.75 0.11 Allowed 'General case' 0 C--N 1.349 0.561 0 CA-C-N 114.341 -1.3 . . . . 70.41 112.038 -168.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -123.36 105.35 9.76 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 107.705 -1.22 . . . . 72.31 107.705 174.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 235' ' ' GLU . . . . . 0.691 ' HB3' ' HZ3' ' C' ' 209' ' ' LYS . 56.4 mt-10 -80.08 138.75 37.03 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-N 115.788 -0.642 . . . . 54.41 109.601 -176.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 236' ' ' THR . . . . . . . . . . . . . 31.7 p -73.86 96.61 2.62 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.082 0.553 . . . . 73.34 109.91 -178.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -72.13 77.0 0.96 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.708 0.803 . . . . 71.12 110.87 -177.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 30.7 m -152.32 149.69 28.93 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.827 1.251 . . . . 71.31 108.16 -177.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -168.05 -89.65 0.01 OUTLIER 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.059 0.944 . . . . 74.42 109.899 164.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . 159.11 -169.73 35.37 Favored Glycine 0 C--N 1.338 0.692 0 N-CA-C 111.404 -0.678 . . . . 71.23 111.404 -167.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 241' ' ' GLU . . . . . 0.473 ' HG3' ' HG3' ' C' ' 234' ' ' ARG . 9.7 pt-20 -93.04 -13.86 28.09 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 113.376 0.88 . . . . 71.21 113.376 -166.486 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 11.3 m95 55.9 -88.12 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 124.242 1.017 . . . . 70.32 111.706 -177.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 243' ' ' GLN . . . . . 0.509 ' HA ' ' NH2' ' C' ' 234' ' ' ARG . 9.9 pt20 173.67 -37.77 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 126.438 1.895 . . . . 74.22 108.059 -166.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -175.94 128.0 1.32 Allowed Glycine 0 C--N 1.348 1.247 0 N-CA-C 110.033 -1.227 . . . . 63.11 110.033 177.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 245' ' ' LYS . . . . . 0.649 ' HA ' ' HB3' ' C' ' 224' ' ' PRO . 0.0 OUTLIER -158.91 124.96 4.48 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.582 0.753 . . . . 75.34 110.128 -172.336 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 14.9 t -129.5 -166.69 1.69 Allowed 'General case' 0 CA--C 1.563 1.447 0 C-N-CA 123.54 0.736 . . . . 71.02 111.187 -170.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 247' ' ' LEU . . . . . . . . . . . . . 4.7 tt -42.0 126.64 3.26 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 126.738 2.015 . . . . 72.51 114.08 -176.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 248' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.43 116.63 32.77 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.675 0.79 . . . . 75.15 108.965 170.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -169.94 158.98 7.52 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 106.092 -1.818 . . . . 71.33 106.092 178.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 250' ' ' GLN . . . . . 0.474 ' HA ' ' HE2' ' A' ' 270' ' ' LYS . 29.0 tt0 -60.22 -28.88 68.36 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 118.909 0.777 . . . . 65.4 110.749 176.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 251' ' ' ALA . . . . . . . . . . . . . . . 71.85 -64.14 0.4 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.836 1.654 . . . . 61.03 111.491 171.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -88.85 72.26 8.54 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 108.884 -0.784 . . . . 72.3 108.884 170.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 253' ' ' ALA . . . . . 0.541 ' HB1' ' HB3' ' B' ' 256' ' ' TYR . . . -97.04 -48.53 5.36 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.274 -0.875 . . . . 51.41 109.822 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? 61.77 -83.12 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.628 1.571 . . . . 72.51 112.265 176.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -90.91 -38.88 5.94 Favored Glycine 0 C--N 1.345 1.047 0 N-CA-C 111.539 -0.624 . . . . 54.22 111.539 178.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 256' ' ' TYR . . . . . 0.541 ' HB3' ' HB1' ' B' ' 253' ' ' ALA . 33.1 p90 40.7 47.49 2.44 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 125.615 1.566 . . . . 52.52 112.069 -177.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -60.75 118.04 6.13 Favored 'General case' 0 C--N 1.35 0.59 0 CA-C-N 114.659 -1.155 . . . . 74.31 110.731 -173.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 258' ' ' LEU . . . . . 0.576 ' HA ' ' HB3' ' B' ' 263' ' ' ALA . 4.7 tt 74.8 -71.61 0.13 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.769 1.628 . . . . 75.13 109.862 178.055 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 259' ' ' VAL . . . . . 0.536 HG23 ' H ' ' B' ' 260' ' ' SER 0.272 19.6 m 44.25 -76.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 C-N-CA 126.805 2.042 . . . . 63.02 113.849 -176.609 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 260' ' ' SER . . . . . 0.536 ' H ' HG23 ' B' ' 259' ' ' VAL . 61.5 p -163.14 144.72 9.81 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.812 1.245 . . . . 73.11 108.49 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 73.01 -66.43 0.31 Allowed 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.899 1.279 . . . . 52.21 113.719 168.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 262' ' ' ALA . . . . . . . . . . . . . . . -44.58 -59.92 2.23 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.909 1.283 . . . . 43.43 113.121 -176.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 263' ' ' ALA . . . . . 0.576 ' HB3' ' HA ' ' B' ' 258' ' ' LEU . . . -101.02 -4.74 26.89 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 122.623 0.369 . . . . 70.44 111.61 178.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 264' ' ' SER . . . . . 0.451 ' HB2' HD12 ' B' ' 265' ' ' LEU . 12.4 m -85.82 -67.99 0.77 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 122.836 0.455 . . . . 51.14 110.302 -178.023 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 265' ' ' LEU . . . . . 0.451 HD12 ' HB2' ' B' ' 264' ' ' SER . 5.4 mp -95.12 -28.73 14.93 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.332 0.653 . . . . 64.12 111.401 -175.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 266' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 66.15 -72.29 0.08 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 125.12 1.368 . . . . 71.52 109.735 -166.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 24.6 p -75.82 89.18 2.87 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 108.057 -1.09 . . . . 73.13 108.057 167.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 268' ' ' VAL . . . . . 0.506 HG22 ' HB3' ' B' ' 270' ' ' GLU . 4.3 p -53.85 -45.12 62.35 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 124.333 1.053 . . . . 74.44 112.003 -175.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 269' ' ' THR . . . . . . . . . . . . . 30.1 p 44.11 39.44 2.85 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 125.427 1.491 . . . . 74.31 112.259 177.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 270' ' ' GLU . . . . . 0.506 ' HB3' HG22 ' B' ' 268' ' ' VAL . 0.0 OUTLIER -60.35 -19.66 56.42 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.781 1.232 . . . . 72.41 113.254 -169.531 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 271' ' ' ALA . . . . . 0.504 ' HB1' ' HB3' ' B' ' 152' ' ' PRO . . . 63.73 21.8 12.83 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 124.468 1.107 . . . . 75.3 111.753 177.035 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 272' ' ' ASN . . . . . 0.46 ' H ' ' HG2' ' B' ' 270' ' ' GLU . 0.2 OUTLIER 57.85 33.7 23.51 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.924 1.289 . . . . 54.14 110.569 -175.774 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 273' ' ' GLN . . . . . 0.657 ' HB2' ' HA ' ' B' ' 149' ' ' LYS . 27.3 mm-40 -118.85 136.15 54.18 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.47 0.708 . . . . 61.32 109.896 178.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 274' ' ' GLN . . . . . 0.43 ' HB2' ' HB2' ' B' ' 233' ' ' PHE . 17.6 tt0 76.45 -58.85 0.52 Allowed 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 126.449 1.9 . . . . 71.44 113.298 175.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 275' ' ' LYS . . . . . 0.579 ' HE2' ' HB3' ' B' ' 148' ' ' GLU . 74.6 mmtt -54.78 109.48 1.6 Allowed Pre-proline 0 N--CA 1.478 0.938 0 C-N-CA 124.448 1.099 . . . . 71.33 112.566 -164.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -67.02 115.33 3.56 Favored 'Trans proline' 0 C--N 1.383 2.389 0 C-N-CA 122.32 2.013 . . . . 62.35 110.25 176.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 277' ' ' LEU . . . . . . . . . . . . . 96.3 mt -58.36 133.49 55.77 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.608 0.763 . . . . 63.32 111.422 -177.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 1.2 pp -86.2 13.95 7.16 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.894 0.878 . . . . 62.0 112.823 -173.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . -75.13 -110.71 0.1 OUTLIER Glycine 0 C--N 1.351 1.365 0 O-C-N 123.312 0.382 . . . . 75.43 112.432 -178.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 2.6 tt -142.56 -80.88 0.21 Allowed 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 107.117 -1.438 . . . . 53.23 107.117 176.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 68.67 -62.12 0.39 Allowed 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 125.778 1.631 . . . . 75.31 112.791 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 282' ' ' ALA . . . . . 0.5 ' HB1' ' HG3' ' B' ' 245' ' ' LYS . . . 74.68 -74.05 0.09 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.873 1.669 . . . . 65.41 109.0 -174.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -151.24 118.54 5.98 Favored 'General case' 0 C--O 1.245 0.865 0 N-CA-C 107.618 -1.253 . . . . 72.33 107.618 174.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . 61.74 -96.17 0.12 Allowed Glycine 0 C--N 1.351 1.377 0 O-C-N 123.935 0.772 . . . . 61.45 111.297 -174.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -146.88 86.12 1.64 Allowed 'General case' 0 C--O 1.244 0.766 0 N-CA-C 107.897 -1.149 . . . . 72.41 107.897 173.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 286' ' ' MET . . . . . . . . . . . . . 6.3 mmt 68.96 163.81 0.14 Allowed Pre-proline 0 CA--C 1.558 1.256 0 C-N-CA 124.674 1.189 . . . . 64.1 113.099 173.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 287' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -71.04 -2.72 11.52 Favored 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 122.647 2.231 . . . . 73.33 112.761 167.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 288' ' ' VAL . . . . . 0.404 HG12 ' HG3' ' B' ' 289' ' ' ARG . 94.6 t 71.57 -73.35 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.366 1.291 0 C-N-CA 125.591 1.556 . . . . 74.32 110.878 176.044 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 289' ' ' ARG . . . . . 0.404 ' HG3' HG12 ' B' ' 288' ' ' VAL . 98.3 mtt180 -135.19 -53.63 0.79 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.577 0.751 . . . . 72.14 109.839 178.007 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 290' ' ' TRP . . . . . . . . . . . . . 47.4 p90 -66.94 146.06 54.78 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.403 -0.817 . . . . 75.34 111.864 -174.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 291' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -111.15 -52.97 2.75 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 108.516 -0.92 . . . . 64.34 108.516 175.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . -143.71 69.79 0.41 Allowed Glycine 0 C--N 1.348 1.199 0 CA-C-N 115.573 -0.74 . . . . 62.12 112.669 -178.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -80.64 -36.21 0.47 Allowed 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 122.461 2.108 . . . . 51.12 112.956 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 5.4 tmtp? -91.31 85.81 5.94 Favored 'General case' 0 C--N 1.356 0.881 0 N-CA-C 108.329 -0.989 . . . . 41.23 108.329 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -157.13 124.04 5.11 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 114.65 -1.159 . . . . 34.32 108.787 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 14.8 t -151.39 169.86 20.96 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 123.562 0.745 . . . . 65.42 109.906 179.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -125.61 -159.21 0.89 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.285 1.034 . . . . 64.12 109.557 -175.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 42.2 m80 73.96 -76.69 0.06 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.219 1.407 . . . . 71.5 110.477 178.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . 98.06 156.99 29.99 Favored Glycine 0 C--N 1.349 1.263 0 N-CA-C 111.606 -0.597 . . . . 63.41 111.606 -175.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -85.04 -57.48 3.08 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 109.681 -0.488 . . . . 72.23 109.681 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 301' ' ' ILE . . . . . . . . . . . . . 35.1 pt -134.63 -172.66 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 123.838 0.855 . . . . 72.24 110.025 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 26.5 t70 70.33 8.15 6.51 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 125.026 1.33 . . . . 63.41 112.967 174.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 303' ' ' LYS . . . . . 0.464 ' N ' ' HD2' ' B' ' 304' ' ' PRO . 39.7 mtmt -72.52 -29.31 1.17 Allowed Pre-proline 0 CA--C 1.562 1.404 0 C-N-CA 124.581 1.153 . . . . 74.11 112.735 173.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 304' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' B' ' 33' ' ' ALA . 43.7 Cg_endo -67.59 -8.72 23.12 Favored 'Trans proline' 0 C--N 1.397 3.119 0 CA-C-N 121.345 1.516 . . . . 75.12 112.697 164.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . 67.49 26.22 8.27 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 125.07 1.348 . . . . 42.33 111.94 176.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 306' ' ' VAL . . . . . 0.632 HG13 ' H ' ' B' ' 307' ' ' THR . 2.2 p -129.2 -84.77 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 CA-C-N 115.746 -0.661 . . . . 72.33 109.925 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 307' ' ' THR . . . . . 0.632 ' H ' HG13 ' B' ' 306' ' ' VAL . 3.0 m 70.61 -23.91 0.17 Allowed 'General case' 0 CA--C 1.566 1.567 0 C-N-CA 125.786 1.635 . . . . 74.23 113.549 178.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 308' ' ' CYS . . . . . 0.499 ' SG ' HG11 ' C' ' 177' ' ' VAL . 39.7 t -76.79 -115.84 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 124.19 0.996 . . . . 74.22 109.399 177.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 309' ' ' THR . . . . . 0.466 HG22 ' HD3' ' B' ' 312' ' ' PRO . 88.9 m 52.55 98.83 0.04 OUTLIER Pre-proline 0 CA--C 1.561 1.375 0 C-N-CA 124.442 1.097 . . . . 72.2 111.881 -177.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -77.39 56.84 5.68 Favored 'Trans proline' 0 CA--C 1.557 1.648 0 C-N-CA 122.591 2.194 . . . . 63.14 112.628 178.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 311' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -133.67 -52.6 0.03 OUTLIER Pre-proline 0 CA--C 1.567 1.615 0 CA-C-O 117.609 -1.186 . . . . 73.13 112.971 -175.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 312' ' ' PRO . . . . . 0.522 ' HB3' ' HA2' ' B' ' 36' ' ' GLY . 32.4 Cg_exo -58.13 116.03 2.95 Favored 'Trans proline' 0 C--N 1.399 3.216 0 C-N-CA 122.014 1.809 . . . . 70.14 111.954 177.542 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 313' ' ' GLN . . . . . 0.601 ' HG2' ' HG2' ' B' ' 41' ' ' PRO . 2.3 pt20 -165.21 17.12 0.04 OUTLIER 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 113.718 1.006 . . . . 75.13 113.718 -171.001 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 314' ' ' ARG . . . . . 0.584 ' HG2' ' HD3' ' B' ' 41' ' ' PRO . 18.0 mmt85 -61.78 -68.76 0.29 Allowed 'General case' 0 N--CA 1.501 2.108 0 CA-C-N 120.412 1.46 . . . . 72.01 109.887 176.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 315' ' ' ASN . . . . . 0.42 ' HB2' ' NZ ' ' C' ' 115' ' ' LYS . 6.0 t30 -173.04 126.3 0.45 Allowed 'General case' 0 N--CA 1.473 0.677 0 O-C-N 124.025 0.828 . . . . 72.12 109.265 170.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 316' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -79.57 -75.35 0.25 Allowed 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 109.059 -0.719 . . . . 74.4 109.059 169.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 68.6 m -156.41 177.1 11.84 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.52 0.728 . . . . 75.41 110.987 -176.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 318' ' ' VAL . . . . . . . . . . . . . 34.7 m -110.77 146.63 34.8 Favored Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 123.802 0.841 . . . . 73.13 109.356 172.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 319' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -78.7 159.14 28.26 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.593 2.195 . . . . 65.1 112.551 175.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 320' ' ' THR . . . . . . . . . . . . . 22.5 p -138.36 10.63 2.75 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.236 1.014 . . . . 53.31 110.65 178.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 321' ' ' LEU . . . . . . . . . . . . . 58.6 tp -96.81 143.32 27.83 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.393 0.677 . . . . 65.14 111.15 -175.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 322' ' ' ALA . . . . . . . . . . . . . . . -88.87 116.29 27.04 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 107.775 -1.194 . . . . 64.54 107.775 165.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 323' ' ' GLN . . . . . 0.664 ' HG3' ' SD ' ' B' ' 324' ' ' MET . 16.1 pt20 -60.98 -37.79 83.7 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 113.097 0.777 . . . . 74.02 113.097 -170.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 324' ' ' MET . . . . . 0.664 ' SD ' ' HG3' ' B' ' 323' ' ' GLN . 0.1 OUTLIER -162.62 168.8 21.18 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 112.083 0.401 . . . . 71.32 112.083 173.884 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 325' ' ' THR . . . . . 0.714 HG23 HD13 ' B' ' 348' ' ' ILE . 41.9 p -84.75 -107.51 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 124.155 0.982 . . . . 72.33 111.767 -174.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 326' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -174.4 154.27 2.09 Favored 'General case' 0 C--N 1.362 1.13 0 C-N-CA 124.275 1.03 . . . . 72.01 109.436 -175.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 81.8 tttt 176.71 41.84 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.315 0 C-N-CA 125.747 1.619 . . . . 54.34 108.733 170.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 328' ' ' ALA . . . . . . . . . . . . . . . 73.6 91.34 0.09 Allowed 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 125.303 1.441 . . . . 72.03 111.83 177.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 329' ' ' ILE . . . . . 0.419 HG23 ' HG3' ' B' ' 330' ' ' GLU . 10.7 tt -145.09 166.69 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.447 1.099 . . . . 73.5 109.127 173.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 330' ' ' GLU . . . . . 0.419 ' HG3' HG23 ' B' ' 329' ' ' ILE . 44.6 mt-10 71.42 99.22 0.07 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.06 1.344 . . . . 63.42 113.279 170.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 331' ' ' LEU . . . . . 0.43 ' HG ' ' H ' ' B' ' 332' ' ' LEU . 1.2 pt? 41.28 -73.76 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 117.465 2.394 . . . . 63.34 117.465 167.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 332' ' ' LEU . . . . . 0.434 HD23 HG23 ' C' ' 18' ' ' THR . 3.2 tm? 76.63 -66.07 0.27 Allowed 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 125.827 1.651 . . . . 74.41 108.663 -163.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 333' ' ' SER . . . . . . . . . . . . . 27.8 p -111.65 -61.14 1.75 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.634 0.773 . . . . 65.04 110.053 -176.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 334' ' ' LYS . . . . . 0.575 ' HA ' ' HE2' ' B' ' 334' ' ' LYS . 9.9 mmpt? -120.93 132.12 54.75 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.169 0.987 . . . . 63.11 110.387 -176.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 335' ' ' ASN . . . . . 0.504 ' HB2' HD11 ' B' ' 341' ' ' LEU . 2.8 p-10 -92.34 -12.16 33.14 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.877 0.871 . . . . 73.25 111.109 -178.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -80.73 -5.77 57.54 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.069 0.947 . . . . 61.02 110.774 -177.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 337' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -58.9 128.77 38.9 Favored 'General case' 0 C--N 1.36 1.061 0 C-N-CA 123.86 0.864 . . . . 62.43 111.274 -177.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 338' ' ' GLY . . . . . . . . . . . . . . . 79.01 -67.07 3.31 Favored Glycine 0 C--N 1.346 1.116 0 N-CA-C 110.767 -0.933 . . . . 72.34 110.767 -170.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 339' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -166.05 -47.52 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.542 1.137 . . . . 74.33 108.894 172.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 340' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -169.78 91.65 0.21 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.405 -0.961 . . . . 75.24 108.405 -177.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 341' ' ' LEU . . . . . 0.504 HD11 ' HB2' ' B' ' 335' ' ' ASN . 5.1 mp 48.17 52.94 12.51 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.967 1.307 . . . . 75.34 112.962 174.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 342' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -73.56 -13.96 61.12 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 111.575 0.213 . . . . 64.25 111.575 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 343' ' ' VAL . . . . . . . . . . . . . 7.4 p -62.14 142.0 17.04 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 123.257 0.623 . . . . 64.24 109.448 171.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -130.69 144.19 51.26 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.437 1.095 . . . . 73.03 109.106 -178.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 345' ' ' GLY . . . . . . . . . . . . . . . -169.73 -78.74 0.04 OUTLIER Glycine 0 C--N 1.346 1.111 0 CA-C-O 119.845 -0.42 . . . . 62.31 112.927 -176.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 346' ' ' ALA . . . . . 0.408 ' HB1' ' HG2' ' B' ' 324' ' ' MET . . . -57.64 115.69 2.94 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.525 0.73 . . . . 72.22 111.054 177.516 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 347' ' ' SER . . . . . 0.533 ' HB2' ' H ' ' B' ' 352' ' ' ASP . 61.3 p -166.75 21.85 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 113.373 0.879 . . . . 72.21 113.373 -172.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 348' ' ' ILE . . . . . 0.714 HD13 HG23 ' B' ' 325' ' ' THR . 14.9 mm 59.54 43.59 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 CA-C-O 122.346 1.069 . . . . 73.42 108.979 -173.315 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 349' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 60.93 15.06 5.73 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 114.812 -1.085 . . . . 71.13 112.765 173.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 350' ' ' LYS . . . . . . . . . . . . . 4.6 ttmp? -141.65 112.08 7.02 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 107.59 -1.263 . . . . 74.52 107.59 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -62.51 91.76 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.836 0 O-C-N 124.063 0.852 . . . . 71.32 112.392 -163.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 352' ' ' ASP . . . . . 0.533 ' H ' ' HB2' ' B' ' 347' ' ' SER . 21.6 t70 -164.74 -79.2 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.257 1.423 . . . . 74.35 107.238 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 353' ' ' HIS . . . . . . . . . . . . . 4.9 t60 165.47 -39.7 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 125.798 1.639 . . . . 74.33 107.53 -178.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 354' ' ' ALA . . . . . . . . . . . . . . . 67.59 -95.9 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 126.106 1.762 . . . . 70.11 110.749 -175.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 355' ' ' ALA . . . . . . . . . . . . . . . 54.53 25.07 5.85 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 124.248 1.019 . . . . 75.44 112.618 -176.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 356' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -68.31 -46.15 38.5 Favored Pre-proline 0 CA--C 1.562 1.417 0 N-CA-C 113.804 1.038 . . . . 74.32 113.804 -175.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 357' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -72.72 77.82 2.18 Favored 'Trans proline' 0 C--N 1.395 3.004 0 C-N-CA 122.027 1.818 . . . . 55.22 113.175 -175.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 358' ' ' CYS . . . . . . . . . . . . . 85.3 m -103.85 160.16 15.03 Favored 'General case' 0 C--O 1.246 0.886 0 C-N-CA 123.402 0.681 . . . . 73.32 109.64 176.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 359' ' ' GLY . . . . . . . . . . . . . . . -73.12 82.88 0.63 Allowed Glycine 0 C--N 1.347 1.162 0 N-CA-C 110.899 -0.88 . . . . 62.01 110.899 173.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 360' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -48.07 -51.49 24.18 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 124.707 1.203 . . . . 53.34 112.58 -176.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 361' ' ' ILE . . . . . . . . . . . . . 3.6 mp -109.52 78.93 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 N-CA-C 107.011 -1.477 . . . . 61.31 107.011 167.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 362' ' ' GLY . . . . . . . . . . . . . . . -174.06 -73.53 0.05 OUTLIER Glycine 0 C--N 1.344 0.974 0 CA-C-N 115.234 -0.894 . . . . 72.35 111.831 177.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 363' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -82.17 -0.73 46.32 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.954 0.901 . . . . 73.13 112.371 -171.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 364' ' ' THR . . . . . . . . . . . . . 3.0 t -160.84 77.58 0.59 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.703 0.801 . . . . 74.04 110.553 -178.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 31.4 t -125.71 -18.53 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 C-N-CA 123.195 0.598 . . . . 74.01 111.181 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 35.2 t0 68.55 28.37 5.89 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 124.712 1.205 . . . . 50.12 108.372 -167.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 367' ' ' LEU . . . . . . . . . . . . . 2.2 tt 55.74 -105.74 0.29 Allowed 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 126.228 1.811 . . . . 75.05 109.94 -178.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 368' ' ' ASP . . . . . . . . . . . . . 4.6 t70 179.24 -145.16 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.607 -0.886 . . . . 71.23 108.607 -170.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 369' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 73.34 -73.53 0.1 Allowed 'General case' 0 C--N 1.36 1.054 0 C-N-CA 126.174 1.79 . . . . 70.1 111.875 170.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 370' ' ' ALA . . . . . . . . . . . . . . . -94.03 172.38 8.26 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.337 0.655 . . . . 74.25 110.51 177.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 371' ' ' VAL . . . . . 0.47 HG12 ' H ' ' B' ' 26' ' ' MET . 6.1 p -132.12 77.43 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 C-N-CA 122.953 0.501 . . . . 74.11 109.844 177.228 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 372' ' ' GLN . . . . . 0.455 HE22 ' HB2' ' B' ' 35' ' ' GLN . 2.8 mp0 69.73 -63.37 0.39 Allowed 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 125.173 1.389 . . . . 63.2 112.265 176.263 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 373' ' ' ARG . . . . . 0.445 ' HD3' ' HB3' ' B' ' 40' ' ' ALA . 55.9 mtp180 83.82 -4.14 1.13 Allowed 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 126.53 1.932 . . . . 72.05 112.758 169.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 374' ' ' ALA . . . . . 0.445 ' HB2' HG23 ' B' ' 309' ' ' THR . . . -74.82 -8.6 56.93 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.131 0.491 . . . . 71.45 111.023 171.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 375' ' ' LEU . . . . . 0.409 ' HG ' ' HE2' ' B' ' 62' ' ' LYS . 2.9 mm? -70.92 -6.17 36.41 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.775 1.23 . . . . 62.01 110.957 173.205 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.23 -24.11 67.25 Favored 'General case' 0 C--N 1.355 0.84 0 C-N-CA 123.432 0.693 . . . . 73.13 110.437 170.225 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 377' ' ' PHE . . . . . 0.408 ' HE1' ' HB2' ' B' ' 47' ' ' LEU . 3.4 t80 -94.12 57.64 2.41 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.717 0.807 . . . . 73.31 109.868 -179.128 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 378' ' ' ALA . . . . . . . . . . . . . . . -73.41 1.65 9.28 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 115.017 -0.992 . . . . 61.1 110.256 165.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 379' ' ' LYS . . . . . 0.456 ' O ' ' HG3' ' B' ' 380' ' ' LYS . 29.0 mttt -70.66 -9.71 57.68 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 126.424 1.89 . . . . 72.01 110.714 169.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 380' ' ' LYS . . . . . 0.709 ' HD2' ' HB2' ' B' ' 408' ' ' LEU 0.287 0.0 OUTLIER 54.88 140.42 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 127.82 2.448 . . . . 53.14 114.352 -175.783 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' B' B ' 381' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -75.6 165.22 25.41 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.711 0.804 . . . . 74.34 112.607 -175.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . 80.67 -69.82 3.13 Favored Glycine 0 C--N 1.351 1.408 0 CA-C-N 115.501 -0.772 . . . . 73.1 111.478 -176.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 383' ' ' ASN . . . . . . . . . . . . . 7.2 t30 63.4 68.9 0.58 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.895 1.278 . . . . 73.1 111.081 174.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 384' ' ' THR . . . . . 0.573 ' HA ' HG12 ' B' ' 388' ' ' VAL . 3.5 m -150.43 0.31 0.43 Allowed 'General case' 0 CA--C 1.558 1.278 0 CA-C-N 114.913 -1.04 . . . . 63.41 110.109 177.039 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 385' ' ' LEU . . . . . 0.509 HD23 ' HE3' ' B' ' 380' ' ' LYS . 3.3 mm? -51.6 -53.33 39.46 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 126.094 1.758 . . . . 75.12 111.846 -172.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 386' ' ' VAL . . . . . 0.677 ' HB ' ' HB3' ' B' ' 390' ' ' ALA . 18.4 t -125.43 77.76 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 N-CA-C 108.739 -0.838 . . . . 62.42 108.739 176.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 387' ' ' ILE . . . . . . . . . . . . . 20.8 mm 58.48 27.41 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 C-N-CA 124.678 1.191 . . . . 74.12 110.753 173.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 388' ' ' VAL . . . . . 0.573 HG12 ' HA ' ' B' ' 384' ' ' THR . 1.5 m 63.41 -0.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 C-N-CA 126.494 1.917 . . . . 54.33 113.404 -177.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 389' ' ' THR . . . . . . . . . . . . . 9.3 t -128.1 37.64 4.13 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.755 -0.59 . . . . 71.25 111.481 -166.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 390' ' ' ALA . . . . . 0.677 ' HB3' ' HB ' ' B' ' 386' ' ' VAL . . . -153.63 -79.25 0.1 Allowed 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 108.492 -0.929 . . . . 70.34 108.492 170.027 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 391' ' ' ASP . . . . . 0.402 ' O ' ' HB2' ' B' ' 392' ' ' HIS . 1.4 m-20 54.27 78.25 0.17 Allowed 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 116.188 1.921 . . . . 64.12 116.188 155.155 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 392' ' ' HIS . . . . . 0.514 ' HB3' HG21 ' A' ' 177' ' ' VAL . 11.1 t-80 179.32 142.57 0.13 Allowed 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 122.993 0.517 . . . . 72.42 111.059 160.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 393' ' ' ALA . . . . . 0.472 ' HB2' ' HZ3' ' B' ' 415' ' ' LYS . . . -118.06 145.01 45.13 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 107.582 -1.266 . . . . 61.53 107.582 166.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 394' ' ' HIS . . . . . 0.408 ' NE2' ' HB3' ' B' ' 397' ' ' GLN . 30.9 t60 -108.21 -26.74 10.43 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 118.047 0.385 . . . . 73.31 111.423 -175.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . 64.75 31.87 11.51 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.818 1.247 . . . . 71.44 113.104 171.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 23.9 t 62.37 31.19 17.39 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.634 1.174 . . . . 75.55 110.051 177.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 397' ' ' GLN . . . . . 0.408 ' HB3' ' NE2' ' B' ' 394' ' ' HIS . 16.2 pm0 44.25 29.69 0.39 Allowed 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 126.663 1.985 . . . . 71.41 113.987 -174.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 66.9 mt -70.61 93.38 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 107.395 -1.335 . . . . 75.44 107.395 173.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 399' ' ' VAL . . . . . 0.605 ' HA ' ' HA ' ' B' ' 63' ' ' PRO . 73.6 t 65.16 -82.04 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.209 0 C-N-CA 124.848 1.259 . . . . 73.32 109.556 -170.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 400' ' ' ALA . . . . . 0.44 ' HB3' ' HB ' ' B' ' 403' ' ' THR . . . 167.65 145.83 0.06 OUTLIER Pre-proline 0 N--CA 1.484 1.242 0 C-N-CA 126.278 1.831 . . . . 51.41 108.554 175.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 401' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -67.54 -43.94 5.11 Favored 'Trans proline' 0 C--N 1.373 1.84 0 C-N-CA 122.576 2.184 . . . . 71.04 110.844 170.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -86.95 22.82 1.9 Allowed 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.072 1.349 . . . . 74.34 111.55 -177.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 403' ' ' THR . . . . . 0.48 ' O ' ' HB ' ' B' ' 306' ' ' VAL . 15.1 t -64.79 -26.29 68.28 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 112.913 0.709 . . . . 51.3 112.913 -170.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 404' ' ' LYS . . . . . 0.4 ' HD3' ' HA ' ' B' ' 306' ' ' VAL . 46.5 mmtm -86.05 -64.11 1.21 Allowed 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 108.712 -0.847 . . . . 70.03 108.712 172.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 405' ' ' ALA . . . . . 0.52 ' HB3' ' HD3' ' B' ' 406' ' ' PRO . . . -176.03 -56.42 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.342 0 C-N-CA 124.702 1.201 . . . . 71.24 109.966 177.404 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 406' ' ' PRO . . . . . 0.52 ' HD3' ' HB3' ' B' ' 405' ' ' ALA . 59.1 Cg_endo -97.47 98.72 0.07 OUTLIER 'Trans proline' 0 C--N 1.394 2.94 0 C-N-CA 122.464 2.11 . . . . 44.44 111.818 176.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . -73.82 -57.89 4.7 Favored Glycine 0 C--N 1.341 0.86 0 N-CA-C 111.329 -0.708 . . . . 55.33 111.329 175.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 408' ' ' LEU . . . . . 0.709 ' HB2' ' HD2' ' B' ' 380' ' ' LYS . 4.2 mp -110.83 137.64 48.23 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 108.553 -0.906 . . . . 72.03 108.553 178.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 90.0 m -146.76 141.73 27.03 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.601 0.761 . . . . 73.52 109.578 -174.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 410' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 73.44 153.67 0.14 Allowed 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 125.054 1.342 . . . . 51.32 112.09 173.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . -113.08 161.99 16.44 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.415 0.686 . . . . 63.14 111.242 -178.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 68.35 125.64 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 125.341 1.456 . . . . 60.41 111.435 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 69.85 9.29 7.08 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 125.221 1.408 . . . . 71.14 111.405 -173.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 414' ' ' THR . . . . . . . . . . . . . 41.5 p -113.66 -49.61 2.88 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.671 0.788 . . . . 73.24 111.347 -169.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 415' ' ' LYS . . . . . 0.515 ' HA ' ' HA3' ' A' ' 190' ' ' GLY . 35.2 tttp -150.58 36.83 0.65 Allowed 'General case' 0 N--CA 1.485 1.295 0 CA-C-O 121.975 0.893 . . . . 73.42 110.757 -176.326 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.1 -15.85 62.54 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 114.482 -1.236 . . . . 75.33 112.755 -176.134 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 417' ' ' GLY . . . . . . . . . . . . . . . -54.62 102.47 0.14 Allowed Glycine 0 C--N 1.352 1.472 0 O-C-N 123.982 0.801 . . . . 43.15 114.541 -173.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 418' ' ' ALA . . . . . . . . . . . . . . . -90.22 18.6 5.82 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.849 1.26 . . . . 70.25 111.354 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 419' ' ' VAL . . . . . 0.554 HG12 ' H ' ' B' ' 420' ' ' MET . 3.4 t 67.63 179.38 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.57 1.718 0 C-N-CA 125.492 1.517 . . . . 62.03 110.231 175.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 420' ' ' MET . . . . . 0.554 ' H ' HG12 ' B' ' 419' ' ' VAL . 42.2 ttp 77.2 89.98 0.07 Allowed 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.644 1.178 . . . . 73.12 111.285 171.048 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 421' ' ' VAL . . . . . . . . . . . . . 41.2 t -80.89 -19.98 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 C-N-CA 123.744 0.818 . . . . 72.42 111.519 -174.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 422' ' ' MET . . . . . . . . . . . . . 18.2 ptm -63.0 90.78 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.421 0.688 . . . . 74.1 112.48 -173.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 423' ' ' SER . . . . . . . . . . . . . 32.6 t 56.33 -91.16 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.27 1.428 . . . . 62.22 112.202 175.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 424' ' ' TYR . . . . . 0.481 ' HD1' ' HA ' ' B' ' 428' ' ' GLU . 87.1 m-85 -92.0 117.55 29.93 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.963 -0.754 . . . . 72.42 108.963 -178.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . -137.89 144.81 16.23 Favored Glycine 0 C--O 1.241 0.567 0 N-CA-C 110.207 -1.157 . . . . 75.12 110.207 176.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 426' ' ' ASN . . . . . . . . . . . . . 10.4 t30 66.68 -73.21 0.08 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.603 1.161 . . . . 75.43 110.175 -175.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 427' ' ' SER . . . . . . . . . . . . . 22.8 t -161.96 103.14 1.15 Allowed 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 107.805 -1.183 . . . . 75.14 107.805 173.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 428' ' ' GLU . . . . . 0.481 ' HA ' ' HD1' ' B' ' 424' ' ' TYR . 3.4 mp0 59.23 -97.98 0.08 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.59 1.156 . . . . 73.23 111.193 -177.321 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 429' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 56.67 23.39 7.75 Favored 'General case' 0 C--N 1.362 1.117 0 C-N-CA 124.651 1.181 . . . . 63.42 112.984 -177.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -123.46 78.37 1.58 Allowed 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.554 0.692 . . . . 55.41 109.558 -172.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 19.3 m -88.56 -57.75 2.8 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.574 1.15 . . . . 73.31 111.464 177.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 432' ' ' GLN . . . . . . . . . . . . . 4.3 pm0 -146.92 11.25 1.06 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 122.671 0.388 . . . . 71.1 110.824 177.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 433' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -132.7 -171.24 2.61 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.203 0.601 . . . . 73.43 111.014 -170.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 434' ' ' HIS . . . . . . . . . . . . . 41.8 m80 74.84 -102.43 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.327 1.451 . . . . 65.13 111.547 -176.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 435' ' ' THR . . . . . 0.525 ' HB ' ' HB2' ' B' ' 438' ' ' GLN . 28.1 m 48.19 -81.02 0.0 OUTLIER 'General case' 0 CA--C 1.569 1.673 0 C-N-CA 125.234 1.414 . . . . 73.42 112.886 -174.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . -166.73 -80.41 0.04 OUTLIER Glycine 0 C--N 1.348 1.22 0 N-CA-C 109.704 -1.358 . . . . 43.54 109.704 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 44.5 t -78.99 -74.58 0.28 Allowed 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 107.993 -1.114 . . . . 54.14 107.993 170.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 438' ' ' GLN . . . . . 0.525 ' HB2' ' HB ' ' B' ' 435' ' ' THR . 53.7 tp60 61.75 -72.31 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 125.686 1.594 . . . . 71.55 114.409 165.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 439' ' ' LEU . . . . . . . . . . . . 0.313 0.3 OUTLIER 46.66 -92.26 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 126.751 2.02 . . . . 74.24 113.311 -174.304 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 440' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 71.61 -36.11 0.35 Allowed 'General case' 0 N--CA 1.505 2.294 0 C-N-CA 125.453 1.501 . . . . 70.1 112.439 -171.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 441' ' ' ILE . . . . . 0.54 HG12 HD22 ' A' ' 235' ' ' LEU . 67.7 mt 78.2 -81.6 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.347 0.492 0 C-N-CA 125.411 1.484 . . . . 74.15 111.486 165.003 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 442' ' ' ALA . . . . . . . . . . . . . . . 62.38 -70.3 0.05 Allowed 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 124.554 1.142 . . . . 71.41 110.09 -169.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 443' ' ' ALA . . . . . 0.424 ' HA ' ' HB3' ' A' ' 234' ' ' ARG . . . 73.41 -71.5 0.13 Allowed 'General case' 0 C--N 1.357 0.894 0 C-N-CA 125.979 1.712 . . . . 74.21 112.258 170.288 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -87.49 170.64 11.16 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.762 0.825 . . . . 65.34 111.194 -176.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . -144.57 166.47 27.3 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 110.365 -1.094 . . . . 74.34 110.365 173.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 446' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.81 78.87 0.53 Allowed 'Trans proline' 0 C--N 1.369 1.653 0 C-N-CA 123.305 2.67 . . . . 63.02 111.934 178.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 447' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -175.4 -23.06 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.78 1.232 . . . . 60.0 110.245 -177.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . -56.52 101.45 0.06 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.612 0.765 . . . . 74.31 111.221 -178.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 449' ' ' ALA . . . . . . . . . . . . . . . -144.7 125.37 14.14 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 124.804 1.242 . . . . 61.52 108.539 177.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 450' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -134.82 -64.5 0.66 Allowed 'General case' 0 C--O 1.243 0.714 0 C-N-CA 123.745 0.818 . . . . 61.12 110.186 -174.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 99.5 t -80.16 75.85 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 122.411 1.1 . . . . 63.1 108.842 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 452' ' ' VAL . . . . . . . . . . . . . 98.8 t -141.0 -43.18 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 CA-C-N 113.674 -1.603 . . . . 60.45 107.497 177.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . -160.11 158.88 30.23 Favored Glycine 0 C--N 1.35 1.33 0 CA-C-N 114.911 -1.04 . . . . 73.44 112.1 177.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 454' ' ' LEU . . . . . 0.455 HD22 ' HB3' ' B' ' 193' ' ' PRO . 39.6 tp 59.96 -118.47 0.86 Allowed 'General case' 0 CA--C 1.565 1.554 0 C-N-CA 124.829 1.252 . . . . 72.5 110.939 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 62.0 m -167.08 134.29 2.42 Favored 'General case' 0 C--O 1.243 0.72 0 N-CA-C 106.773 -1.565 . . . . 61.41 106.773 -173.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -94.22 171.53 8.78 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 122.044 0.926 . . . . 74.3 112.499 -176.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 457' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -161.32 -155.66 0.41 Allowed 'General case' 0 CA--C 1.555 1.167 0 CA-C-N 113.432 -1.713 . . . . 42.14 108.302 -176.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 25.1 p -55.19 -63.13 1.25 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.079 0.952 . . . . 72.13 113.091 -174.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 459' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -157.51 161.79 38.84 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.62 0.768 . . . . 73.31 109.64 -175.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 7.6 mp 76.58 165.2 0.25 Allowed 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 125.506 1.522 . . . . 65.42 109.747 -167.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 69.34 8.69 6.93 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 124.902 1.281 . . . . 62.31 112.642 176.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -73.04 101.11 3.17 Favored 'General case' 0 C--N 1.359 0.991 0 N-CA-C 108.564 -0.902 . . . . 72.53 108.564 171.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 14.7 t -101.66 -155.26 0.51 Allowed 'General case' 0 CA--C 1.559 1.295 0 CA-C-N 115.265 -0.88 . . . . 61.35 110.823 -167.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 464' ' ' MET . . . . . . . . . . . . . 23.2 mmt -63.92 159.74 19.18 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.414 1.086 . . . . 75.31 111.84 179.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.08 170.09 8.12 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.518 0.727 . . . . 72.15 110.859 -177.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -150.18 148.1 28.52 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 114.95 -1.023 . . . . 62.32 109.022 173.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 467' ' ' ALA . . . . . 0.492 ' HB3' HG21 ' B' ' 135' ' ' VAL . . . -65.03 -19.2 65.88 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.854 0.861 . . . . 75.3 112.201 -178.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 468' ' ' LEU . . . . . 0.628 ' HB2' HG13 ' B' ' 135' ' ' VAL . 8.2 tt -143.41 98.66 3.29 Favored 'General case' 0 C--O 1.245 0.847 0 N-CA-C 106.648 -1.612 . . . . 45.51 106.648 168.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 469' ' ' GLY . . . . . . . . . . . . . . . -79.43 84.58 1.27 Allowed Glycine 0 C--N 1.342 0.896 0 N-CA-C 111.217 -0.753 . . . . 50.44 111.217 175.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 470' ' ' LEU . . . . . 0.493 HD23 ' H ' ' B' ' 470' ' ' LEU . 2.4 pt? -75.76 -38.3 58.49 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.33 0.652 . . . . 73.2 110.299 174.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 471' ' ' LYS . . . . . 0.564 ' HB3' ' HZ3' ' B' ' 471' ' ' LYS . 0.8 OUTLIER . . . . . 0 C--O 1.26 1.646 0 C-N-CA 124.677 1.191 . . . . 74.2 109.885 -177.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 73.3 mtm . . . . . 0 N--CA 1.476 0.856 0 CA-C-O 119.856 -0.116 . . . . 55.23 110.866 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 55.76 25.56 8.49 Favored 'General case' 0 C--N 1.358 0.941 0 C-N-CA 124.692 1.197 . . . . 65.31 112.152 -177.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.92 78.14 4.42 Favored 'General case' 0 C--N 1.35 0.62 0 N-CA-C 108.885 -0.783 . . . . 52.01 108.885 -178.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -36.55 94.54 0.01 OUTLIER 'General case' 0 C--N 1.365 1.241 0 C-N-CA 125.232 1.413 . . . . 70.52 113.371 -175.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 5' ' ' LYS . . . . . 0.433 ' HB3' HD11 ' C' ' 10' ' ' ILE . 29.7 mmtp -65.76 95.84 0.26 Allowed 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.485 -1.234 . . . . 63.2 108.625 169.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 6' ' ' ASP . . . . . 0.478 ' HA ' ' OH ' ' C' ' 66' ' ' TYR . 16.2 t70 -73.14 97.25 2.35 Favored 'General case' 0 C--N 1.343 0.321 0 N-CA-C 106.975 -1.491 . . . . 63.22 106.975 169.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 7' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -63.6 -30.23 71.37 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 114.811 -1.086 . . . . 73.43 112.389 -169.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -61.56 -44.47 96.97 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.593 0.357 . . . . 72.53 110.16 172.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.47 -42.95 98.59 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.177 0.591 . . . . 52.31 110.934 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 10' ' ' ILE . . . . . 0.433 HD11 ' HB3' ' C' ' 5' ' ' LYS . 56.2 mt -59.98 -39.09 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 C-N-CA 123.407 0.683 . . . . 63.34 110.762 178.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 93.0 mt -76.98 -20.84 55.58 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 116.081 -0.509 . . . . 45.45 112.272 175.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.55 39.48 56.18 Favored Glycine 0 C--N 1.346 1.128 0 O-C-N 123.189 0.306 . . . . 64.33 112.549 -176.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 27.2 m -120.32 157.28 53.96 Favored Pre-proline 0 N--CA 1.479 0.976 0 C-N-CA 124.915 1.286 . . . . 64.04 109.097 176.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -51.16 145.76 25.19 Favored 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 122.849 2.366 . . . . 74.43 113.105 177.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 79.2 mtt180 -74.21 18.13 0.16 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 114.105 1.15 . . . . 71.52 114.105 -175.044 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -148.76 21.1 1.02 Allowed 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 124.985 1.314 . . . . 71.24 108.176 177.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.47 156.41 32.53 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.314 1.046 . . . . 71.14 112.883 -170.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 18' ' ' THR . . . . . 0.434 HG23 HD23 ' B' ' 332' ' ' LEU . 70.3 p -65.18 148.39 51.77 Favored 'General case' 0 C--N 1.348 0.534 0 CA-C-N 115.365 -0.834 . . . . 74.41 108.75 170.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 19' ' ' GLN . . . . . 0.447 ' OE1' ' HD2' ' C' ' 63' ' ' ARG . 1.2 mp0 -63.29 -20.01 65.09 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 122.954 0.502 . . . . 74.45 110.477 175.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 20' ' ' GLU . . . . . 0.401 ' HG3' ' HB2' ' B' ' 346' ' ' ALA . 29.1 tt0 -65.4 -44.7 86.64 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.261 -0.881 . . . . 64.05 111.408 168.632 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -63.71 -35.3 80.12 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.114 0.565 . . . . 73.42 110.657 176.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 22' ' ' ILE . . . . . 0.652 HG12 ' HB3' ' C' ' 57' ' ' LEU . 1.7 mp -59.72 -41.33 85.01 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 CA-C-N 115.664 -0.698 . . . . 61.32 109.833 170.307 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 23' ' ' LYS . . . . . 0.468 ' HA ' ' HB3' ' C' ' 26' ' ' TYR . 36.0 mtmm -77.94 -14.96 59.35 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.217 0.607 . . . . 74.13 112.631 175.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -75.18 -37.39 61.24 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 108.622 -0.881 . . . . 73.52 108.622 170.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -76.94 -25.21 52.6 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.246 -0.888 . . . . 75.32 110.936 175.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 26' ' ' TYR . . . . . 0.528 ' O ' ' HB3' ' C' ' 30' ' ' ALA . 87.5 t80 -66.73 -47.43 72.32 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 109.315 -0.624 . . . . 72.31 109.315 169.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 27' ' ' LYS . . . . . 0.521 ' HD3' ' HA ' ' B' ' 325' ' ' THR . 45.0 mtmt -59.04 -53.69 55.52 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 109.29 -0.633 . . . . 74.1 109.29 173.343 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 18.5 ttm180 -50.5 -69.34 0.12 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.9 1.28 . . . . 71.15 110.589 -175.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 29' ' ' LEU . . . . . 0.406 ' HB3' HD13 ' C' ' 50' ' ' ILE . 94.3 mt -82.17 -35.59 28.23 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 114.799 -1.092 . . . . 60.22 112.862 -169.362 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 30' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' C' ' 26' ' ' TYR . . . -87.21 -5.78 58.84 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 118.345 0.521 . . . . 75.32 112.222 -176.408 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 31' ' ' ARG . . . . . 0.506 ' HA ' ' HB2' ' C' ' 34' ' ' HIS . 99.4 mtt180 -96.68 -37.37 10.35 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 118.323 0.51 . . . . 73.5 109.902 163.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -62.02 -43.17 99.4 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.344 0.658 . . . . 71.12 111.148 177.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 33' ' ' TYR . . . . . 0.523 ' HD2' HD11 ' C' ' 50' ' ' ILE . 19.3 m-85 -109.42 26.05 11.09 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.36 1.064 . . . . 70.15 110.044 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 34' ' ' HIS . . . . . 0.506 ' HB2' ' HA ' ' C' ' 31' ' ' ARG . 37.8 t60 -63.68 112.76 7.9 Favored Pre-proline 0 N--CA 1.475 0.79 0 CA-C-O 118.505 -0.76 . . . . 72.34 109.189 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.41 -18.81 15.62 Favored 'Trans proline' 0 N--CA 1.501 1.966 0 C-N-CA 123.392 2.728 . . . . 71.32 114.834 -170.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 36' ' ' ASP . . . . . 0.417 ' HB3' ' HD2' ' C' ' 34' ' ' HIS . 13.0 t70 -80.04 -46.72 16.07 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.041 0.936 . . . . 60.34 110.804 176.025 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 71.0 t -84.15 -54.49 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 123.361 0.664 . . . . 75.33 109.818 -175.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -98.45 83.83 3.09 Favored 'General case' 0 C--O 1.244 0.787 0 N-CA-C 107.991 -1.115 . . . . 54.22 107.991 176.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -79.03 78.09 5.48 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.011 -0.995 . . . . 62.24 109.895 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 71.0 m -139.37 118.55 9.09 Favored Pre-proline 0 CA--C 1.542 0.673 0 C-N-CA 123.882 0.873 . . . . 74.14 108.743 174.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_exo -47.05 -38.74 24.82 Favored 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 123.606 2.871 . . . . 63.44 113.207 176.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -58.05 -44.23 87.3 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.839 0.856 . . . . 65.44 110.211 177.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.47 -21.29 61.96 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.23 -0.896 . . . . 62.05 110.603 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 44' ' ' GLU . . . . . 0.407 ' O ' ' HG2' ' C' ' 48' ' ' LYS . 0.4 OUTLIER -81.54 -33.2 31.9 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.14 0.976 . . . . 74.04 109.2 -178.776 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -68.21 -45.39 73.49 Favored 'General case' 0 C--O 1.261 1.695 0 C-N-CA 124.013 0.925 . . . . 42.53 109.475 174.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 46' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -61.05 -38.61 86.78 Favored 'General case' 0 C--N 1.348 0.518 0 CA-C-N 114.588 -1.187 . . . . 72.32 110.33 172.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 47' ' ' PHE . . . . . 0.676 ' HA ' HD12 ' C' ' 50' ' ' ILE . 65.3 t80 -57.77 -41.13 81.35 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.177 0.991 . . . . 62.23 110.299 176.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 48' ' ' LYS . . . . . 0.407 ' HG2' ' O ' ' C' ' 44' ' ' GLU . 72.3 mmtt -59.01 -49.94 75.97 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 122.383 0.273 . . . . 72.04 110.59 175.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -58.93 -39.43 81.55 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 124.23 0.956 . . . . 72.33 112.097 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 50' ' ' ILE . . . . . 0.676 HD12 ' HA ' ' C' ' 47' ' ' PHE . 55.2 mt -62.76 -47.89 90.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 124.254 1.022 . . . . 75.43 109.628 177.173 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 51' ' ' ASN . . . . . 0.561 ' HA ' ' HB3' ' C' ' 54' ' ' TYR . 64.2 m-80 -79.85 -5.91 56.36 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 115.522 -0.763 . . . . 74.04 112.176 -178.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 52' ' ' GLU . . . . . 0.444 ' HA ' ' CE2' ' C' ' 93' ' ' PHE . 32.0 tt0 -75.3 -56.23 4.92 Favored 'General case' 0 C--O 1.249 1.027 0 CA-C-O 122.166 0.984 . . . . 63.42 108.844 167.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.86 -37.31 73.7 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 113.485 -1.689 . . . . 63.1 111.442 174.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 54' ' ' TYR . . . . . 0.561 ' HB3' ' HA ' ' C' ' 51' ' ' ASN . 70.0 t80 -75.84 -34.32 60.07 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.263 -0.88 . . . . 75.01 110.5 178.258 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.57 -40.71 75.68 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.099 0.476 . . . . 60.54 110.508 175.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 44.4 t -79.95 -37.23 17.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 114.737 -1.12 . . . . 72.43 112.578 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 57' ' ' LEU . . . . . 0.652 ' HB3' HG12 ' C' ' 22' ' ' ILE . 94.6 mt -111.14 12.38 21.89 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 114.033 1.123 . . . . 75.02 114.033 -170.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 47.4 t -57.94 -58.97 6.05 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.239 0.616 . . . . 62.42 111.073 178.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -99.73 150.93 37.26 Favored Pre-proline 0 N--CA 1.47 0.558 0 CA-C-N 114.786 -1.097 . . . . 72.03 110.236 -178.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 60' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -54.31 -34.63 80.94 Favored 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 123.659 2.906 . . . . 33.23 112.513 171.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -66.19 -47.17 74.79 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.912 0.885 . . . . 62.13 110.645 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -66.05 -33.59 76.15 Favored 'General case' 0 C--O 1.249 1.042 0 CA-C-N 115.093 -0.958 . . . . 75.23 111.049 178.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 63' ' ' ARG . . . . . 0.447 ' HD2' ' OE1' ' C' ' 19' ' ' GLN . 13.6 ttt180 -60.94 -47.27 87.21 Favored 'General case' 0 C--O 1.218 -0.585 0 CA-C-N 115.718 -0.674 . . . . 64.42 109.901 173.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -61.83 -34.42 75.92 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 123.603 0.564 . . . . 74.15 111.285 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 72.6 mt -54.2 -57.55 5.73 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.95 0 N-CA-C 108.522 -0.918 . . . . 62.34 108.522 169.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 66' ' ' TYR . . . . . 0.478 ' OH ' ' HA ' ' C' ' 6' ' ' ASP . 10.0 t80 -52.37 -51.52 58.47 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.253 0.621 . . . . 74.22 112.025 176.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -55.22 -36.33 65.87 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.899 0.88 . . . . 73.14 111.257 -174.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 68' ' ' THR . . . . . 0.402 ' O ' ' HB ' ' C' ' 72' ' ' THR . 54.8 p -102.37 -14.29 16.96 Favored 'General case' 0 CA--C 1.556 1.189 0 N-CA-C 112.782 0.66 . . . . 63.2 112.782 -178.386 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -122.05 125.02 45.32 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.023 0.529 . . . . 75.22 109.663 -173.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 74.61 18.93 80.02 Favored Glycine 0 N--CA 1.473 1.155 0 CA-C-O 121.539 0.522 . . . . 62.51 111.937 -175.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 47.8 m -141.31 -50.33 0.42 Allowed 'General case' 0 C--O 1.239 0.505 0 N-CA-C 103.898 -2.63 . . . . 72.34 103.898 178.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 72' ' ' THR . . . . . 0.402 ' HB ' ' O ' ' C' ' 68' ' ' THR . 19.2 m -106.62 163.61 12.76 Favored 'General case' 0 C--O 1.253 1.244 0 N-CA-C 105.192 -2.151 . . . . 73.35 105.192 156.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.09 13.06 27.84 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.511 1.124 . . . . 73.23 111.115 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.42 -152.25 0.0 OUTLIER Pre-proline 0 CA--C 1.607 3.15 0 CA-C-O 115.936 -1.983 . . . . 53.23 113.066 -175.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 75' ' ' PRO . . . . . 0.481 ' HA ' ' HD2' ' C' ' 76' ' ' PRO . 0.8 OUTLIER 0.75 118.32 0.0 OUTLIER 'Trans proline' 1 C--N 1.427 4.684 1 C-N-CA 125.92 4.413 . . . . 75.14 119.796 -158.671 . . . . . . . . 5 4 . 1 . 010 nuclear build full ' C' C ' 76' ' ' PRO . . . . . 0.481 ' HD2' ' HA ' ' C' ' 75' ' ' PRO . 55.7 Cg_endo -63.39 178.22 1.3 Allowed 'Trans proline' 0 N--CA 1.51 2.472 0 C-N-CA 123.864 3.043 . . . . 63.14 112.745 176.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 77' ' ' PRO . . . . . 0.523 ' HA ' ' HD3' ' C' ' 78' ' ' PRO . 0.7 OUTLIER -26.41 116.96 0.03 OUTLIER 'Trans proline' 0 C--N 1.401 3.318 0 C-N-CA 124.929 3.753 . . . . 51.51 115.437 173.631 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 78' ' ' PRO . . . . . 0.523 ' HD3' ' HA ' ' C' ' 77' ' ' PRO . 25.3 Cg_exo -65.68 167.92 16.19 Favored 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 124.111 3.207 . . . . 74.44 114.17 -171.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -54.16 132.91 52.88 Favored 'Trans proline' 0 C--N 1.39 2.712 0 C-N-CA 123.104 2.536 . . . . 61.04 113.227 175.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -58.47 83.76 0.05 OUTLIER 'Trans proline' 0 C--N 1.39 2.726 0 C-N-CA 123.65 2.9 . . . . 51.5 111.879 176.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 81' ' ' GLY . . . . . 0.627 ' HA2' ' HA2' ' C' ' 108' ' ' GLY . . . -175.41 -34.08 0.04 OUTLIER Glycine 0 C--O 1.225 -0.442 0 N-CA-C 109.329 -1.508 . . . . 75.2 109.329 -176.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.561 ' HA3' ' HA ' ' C' ' 106' ' ' PHE . . . 95.09 165.15 35.29 Favored Glycine 0 C--N 1.35 1.339 0 N-CA-C 116.607 1.403 . . . . 74.45 116.607 166.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -69.58 135.84 50.51 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 124.258 1.023 . . . . 70.14 108.318 168.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 84' ' ' ASP . . . . . 0.402 ' HB2' ' HB2' ' C' ' 143' ' ' ARG . 35.6 t70 -66.94 129.22 39.18 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 118.273 0.488 . . . . 63.13 109.728 175.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 85' ' ' PHE . . . . . 0.524 ' HB3' ' HG3' ' C' ' 171' ' ' PRO . 23.5 t80 -116.68 34.77 4.89 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.688 0.795 . . . . 74.41 109.857 -165.287 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 52.8 m -5.74 78.99 0.0 OUTLIER 'General case' 0 CA--C 1.569 1.691 0 N-CA-C 116.836 2.161 . . . . 45.43 116.836 -170.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 53.06 31.71 41.04 Favored Glycine 0 CA--C 1.545 1.959 0 N-CA-C 116.399 1.32 . . . . 74.33 116.399 175.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 88' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -101.67 155.34 18.16 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 119.134 1.467 . . . . 74.44 113.643 -173.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -85.13 79.04 9.72 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.337 0.655 . . . . 72.23 111.128 -178.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 90' ' ' VAL . . . . . . . . . . . . . 2.0 p -42.17 -37.45 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 114.4 1.259 . . . . 54.41 114.4 177.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.11 -14.64 7.21 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 114.19 1.182 . . . . 74.21 114.19 -176.045 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -113.32 -3.49 13.81 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 112.757 0.651 . . . . 75.53 112.757 -175.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 93' ' ' PHE . . . . . 0.444 ' CE2' ' HA ' ' C' ' 52' ' ' GLU . 2.3 m-85 -77.13 153.33 34.33 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 122.741 0.417 . . . . 72.45 110.937 -176.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 97.0 p -82.94 -178.81 7.25 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.768 0.827 . . . . 45.51 113.013 -166.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.38 -61.81 2.33 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 114.552 -1.204 . . . . 55.43 112.911 -175.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 96' ' ' PHE . . . . . 0.413 ' HB3' ' HG2' ' C' ' 5' ' ' LYS . 84.4 t80 -58.07 -38.98 77.38 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 118.753 0.706 . . . . 65.02 110.743 -171.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 97' ' ' PHE . . . . . 0.446 ' CE2' ' HE2' ' C' ' 85' ' ' PHE . 83.4 t80 -60.31 -54.75 41.94 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 114.43 -1.259 . . . . 64.25 110.009 175.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -81.69 5.18 19.19 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 112.478 0.547 . . . . 51.52 112.478 -177.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -100.05 -39.11 8.28 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.836 0.855 . . . . 74.43 109.942 170.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 45.6 tp -78.5 -52.51 8.41 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.892 0.853 . . . . 73.23 109.502 -178.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 101' ' ' PHE . . . . . 0.446 ' HB3' HD13 ' C' ' 105' ' ' LEU . 96.5 m-85 -86.31 -20.72 27.96 Favored 'General case' 0 C--O 1.214 -0.77 0 CA-C-N 113.952 -1.477 . . . . 73.25 111.347 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -49.26 -50.81 27.96 Favored Glycine 0 CA--C 1.549 2.217 0 CA-C-O 118.558 -1.135 . . . . 54.11 115.754 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -49.34 -25.33 9.89 Favored 'Trans proline' 0 C--N 1.387 2.596 0 C-N-CA 124.139 3.226 . . . . 62.02 115.09 175.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 104' ' ' GLY . . . . . 0.438 ' O ' ' HA2' ' C' ' 82' ' ' GLY . . . -137.72 31.68 2.46 Favored Glycine 0 C--N 1.353 1.485 0 CA-C-O 119.401 -0.666 . . . . 43.23 112.188 174.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 105' ' ' LEU . . . . . 0.446 HD13 ' HB3' ' C' ' 101' ' ' PHE . 13.1 tp -78.14 74.51 4.69 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 118.103 0.951 . . . . 73.03 109.128 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 106' ' ' PHE . . . . . 0.561 ' HA ' ' HA3' ' C' ' 82' ' ' GLY . 1.2 m-85 58.96 -148.83 0.47 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.826 1.25 . . . . 64.24 113.586 174.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 107' ' ' GLY . . . . . 0.504 ' HA3' ' HA ' ' C' ' 113' ' ' SER . . . 70.55 42.82 62.67 Favored Glycine 0 C--N 1.359 1.811 0 N-CA-C 111.368 -0.693 . . . . 51.05 111.368 -163.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 108' ' ' GLY . . . . . 0.627 ' HA2' ' HA2' ' C' ' 81' ' ' GLY . . . -13.66 -71.7 0.01 OUTLIER Glycine 0 C--N 1.364 2.108 0 C-N-CA 125.784 1.659 . . . . 74.41 115.791 168.421 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 109' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -92.75 76.68 4.9 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 108.183 -1.043 . . . . 74.45 108.183 168.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 110' ' ' GLY . . . . . . . . . . . . . . . -8.56 -60.31 0.01 OUTLIER Glycine 0 C--N 1.366 2.201 0 C-N-CA 126.471 1.986 . . . . 54.22 116.564 171.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 111' ' ' ARG . . . . . 0.633 ' NE ' ' H ' ' C' ' 111' ' ' ARG . 0.0 OUTLIER -4.62 -43.15 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.366 0 C-N-CA 127.673 2.389 . . . . 75.25 116.394 160.942 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 112' ' ' ARG . . . . . 0.476 ' HG3' ' HB3' ' C' ' 114' ' ' ARG . 14.7 tpt180 -120.14 -38.05 2.98 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.788 0.835 . . . . 74.1 110.972 -173.347 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 113' ' ' SER . . . . . 0.504 ' HA ' ' HA3' ' C' ' 107' ' ' GLY . 29.1 m 47.04 22.12 0.19 Allowed 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 125.122 1.369 . . . . 72.53 113.562 -175.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 114' ' ' ARG . . . . . 0.476 ' HB3' ' HG3' ' C' ' 112' ' ' ARG . 2.6 tpm_? -115.03 -116.28 0.33 Allowed 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 117.686 -1.149 . . . . 74.05 111.476 -169.393 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 115' ' ' LYS . . . . . 0.42 ' NZ ' ' HB2' ' B' ' 315' ' ' ASN . 45.8 tttm -66.19 133.28 50.32 Favored 'General case' 0 C--N 1.361 1.068 0 CA-C-N 119.62 1.1 . . . . 54.14 111.808 -164.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 116' ' ' GLY . . . . . 0.551 ' HA3' ' HA ' ' C' ' 171' ' ' PRO . . . -74.88 109.52 2.81 Favored Glycine 0 CA--C 1.486 -1.734 0 N-CA-C 109.768 -1.333 . . . . 45.25 109.768 169.337 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 117' ' ' ARG . . . . . 0.425 ' HB2' ' O ' ' B' ' 313' ' ' GLN . 37.0 ptt180 -90.5 161.42 15.51 Favored 'General case' 0 C--O 1.264 1.835 0 N-CA-C 108.076 -1.083 . . . . 64.44 108.076 172.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -62.6 155.35 26.3 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 115.031 -0.986 . . . . 75.42 109.416 168.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 119' ' ' LEU . . . . . 0.478 HD13 ' HA ' ' C' ' 174' ' ' LEU . 0.0 OUTLIER -119.64 144.57 47.08 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 108.247 -1.02 . . . . 75.21 108.247 171.562 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.439 ' HA ' ' O ' ' C' ' 175' ' ' LEU . 19.6 ttt180 -138.9 106.77 5.66 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 109.612 -0.514 . . . . 72.31 109.612 -162.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 121' ' ' ALA . . . . . 0.575 ' HB1' ' HA ' ' B' ' 185' ' ' VAL . . . -134.83 127.67 31.24 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 115.492 -0.776 . . . . 63.21 109.835 -172.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 122' ' ' GLU . . . . . 0.517 ' HG2' ' HA ' ' B' ' 186' ' ' THR . 13.2 pt-20 -85.54 141.16 30.07 Favored 'General case' 0 C--O 1.244 0.77 0 N-CA-C 110.13 -0.322 . . . . 73.22 110.13 176.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -142.71 144.28 29.31 Favored Pre-proline 0 N--CA 1.481 1.102 0 CA-C-N 116.182 -0.463 . . . . 73.3 110.937 -170.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -75.44 121.69 6.56 Favored 'Trans proline' 0 C--N 1.368 1.603 0 C-N-CA 123.147 2.565 . . . . 72.51 111.278 173.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 125' ' ' LEU . . . . . 0.521 ' HB3' HG23 ' C' ' 178' ' ' VAL . 55.7 tp -137.37 147.11 45.25 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.279 0.631 . . . . 74.03 110.058 -177.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.73 155.21 18.44 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 123.449 0.7 . . . . 61.53 110.308 -178.169 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 127' ' ' LEU . . . . . 0.508 HD13 ' HD2' ' C' ' 186' ' ' PHE . 96.2 mt -66.3 -44.74 82.62 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.373 1.069 . . . . 62.25 111.234 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 18.4 mp0 -65.09 -33.33 75.77 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.729 1.212 . . . . 75.24 109.733 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 129' ' ' GLU . . . . . 0.527 ' HG3' ' HG3' ' B' ' 178' ' ' PRO . 53.3 mm-40 -77.83 -25.38 48.75 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.712 0.805 . . . . 73.53 112.116 177.18 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -74.3 -32.75 62.99 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 109.142 -0.688 . . . . 64.34 109.142 173.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 131' ' ' PHE . . . . . 0.423 ' HB2' HD13 ' C' ' 215' ' ' LEU . 70.7 t80 -67.46 -44.89 77.51 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.407 1.083 . . . . 75.55 111.088 173.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 132' ' ' HIS . . . . . . . . . . . . . 54.2 m170 -70.72 -49.46 46.7 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 116.261 -0.427 . . . . 60.22 110.685 -176.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 68.39 -90.65 0.23 Allowed Glycine 0 C--N 1.345 1.069 0 N-CA-C 110.664 -0.974 . . . . 65.31 110.664 -170.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.28 161.83 5.7 Favored Glycine 0 C--N 1.353 1.509 0 O-C-N 123.876 0.398 . . . . 53.24 114.008 174.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -71.44 94.69 1.28 Allowed 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 109.105 -0.702 . . . . 71.2 109.105 174.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 136' ' ' ARG . . . . . 0.641 ' HB3' ' HB2' ' B' ' 181' ' ' LEU . 2.7 mpt_? -105.15 158.77 16.35 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.669 1.187 . . . . 72.12 109.051 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 137' ' ' VAL . . . . . 0.401 HG23 ' HB1' ' B' ' 180' ' ' ALA . 23.0 m -104.62 127.77 58.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 109.798 -0.445 . . . . 71.12 109.798 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 138' ' ' VAL . . . . . 0.738 ' HB ' HD23 ' B' ' 181' ' ' LEU . 6.1 p -113.12 114.61 47.44 Favored 'Isoleucine or valine' 0 C--O 1.248 0.986 0 C-N-CA 123.531 0.733 . . . . 72.14 110.052 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 139' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -120.68 93.15 3.94 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 124.829 1.252 . . . . 74.31 108.067 178.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 140' ' ' VAL . . . . . . . . . . . . . 12.7 p -147.61 149.04 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 108.877 -0.786 . . . . 63.22 108.877 -177.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 65.2 19.47 11.74 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 124.75 1.22 . . . . 15.23 112.1 177.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 84.39 -4.03 84.92 Favored Glycine 0 C--N 1.344 0.991 0 CA-C-N 115.675 -0.693 . . . . 45.25 113.553 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 143' ' ' ARG . . . . . 0.526 ' NH2' ' HB3' ' C' ' 164' ' ' MET . 0.0 OUTLIER -111.41 124.37 52.12 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.41 0.684 . . . . 73.04 109.658 -176.722 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 12.9 ttt180 -114.3 121.61 44.18 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.656 1.182 . . . . 71.51 110.859 -171.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 145' ' ' VAL . . . . . 0.549 HG21 ' SD ' ' C' ' 164' ' ' MET . 21.9 m -143.25 177.1 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 C-N-CA 123.922 0.889 . . . . 75.03 110.581 172.193 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 23.0 t -119.36 129.79 55.01 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.761 0.825 . . . . 54.21 108.78 171.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 11.4 p -149.01 154.47 9.6 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 C-N-CA 123.489 0.716 . . . . 72.53 111.003 -178.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 22.0 ttm180 -96.06 116.19 28.58 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 108.082 -1.081 . . . . 74.22 108.082 164.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 149' ' ' ILE . . . . . 0.457 HD13 HD11 ' B' ' 181' ' ' LEU . 31.9 pt -73.22 147.41 87.86 Favored Pre-proline 0 CA--C 1.551 1.001 0 CA-C-O 118.597 -0.716 . . . . 71.41 109.302 172.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -43.07 115.07 0.51 Allowed 'Trans proline' 0 C--N 1.385 2.45 0 C-N-CA 123.698 2.932 . . . . 61.44 113.594 178.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -62.18 95.96 0.15 Allowed 'Trans proline' 0 C--N 1.386 2.533 0 C-N-CA 123.046 2.497 . . . . 73.2 111.636 178.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 152' ' ' GLY . . . . . . . . . . . . . . . 131.28 108.23 1.19 Allowed Glycine 0 C--N 1.343 0.943 0 CA-C-N 114.98 -1.009 . . . . 54.32 112.44 -174.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 153' ' ' VAL . . . . . 0.705 HG21 HG21 ' C' ' 178' ' ' VAL . 1.8 m -131.1 163.53 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 CA-C-N 117.121 0.46 . . . . 71.13 111.067 -179.021 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 154' ' ' ARG . . . . . 0.416 ' HE ' ' HA ' ' C' ' 189' ' ' GLU . 29.6 mtt85 -118.49 144.27 46.14 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.823 0.849 . . . . 75.32 109.443 -178.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 155' ' ' GLU . . . . . 0.497 ' HB2' HD12 ' C' ' 180' ' ' LEU . 4.6 tp10 -56.22 128.32 35.09 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.267 0.627 . . . . 74.51 111.974 173.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 68.29 14.66 66.79 Favored Glycine 0 C--N 1.344 1.024 0 O-C-N 123.882 0.739 . . . . 64.51 113.68 176.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 157' ' ' SER . . . . . . . . . . . . . 34.0 t -104.05 164.53 11.64 Favored 'General case' 0 C--N 1.349 0.566 0 C-N-CA 123.201 0.6 . . . . 75.43 109.534 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 8.8 p -112.48 108.01 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.136 0 CA-C-O 121.738 0.78 . . . . 64.44 111.007 -170.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 159' ' ' ILE . . . . . . . . . . . . . 14.6 mt -71.38 117.2 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.588 1.155 . . . . 52.25 108.91 172.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 48.1 ttt-85 -95.44 119.73 34.45 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 118.532 0.605 . . . . 72.21 109.676 171.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 161' ' ' VAL . . . . . 0.611 ' HB ' ' HB3' ' C' ' 174' ' ' LEU . 92.9 t -99.0 99.02 7.1 Favored Pre-proline 0 C--O 1.246 0.892 0 N-CA-C 107.9 -1.148 . . . . 75.24 107.9 171.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -80.83 153.19 19.58 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.638 2.225 . . . . 63.42 112.002 -178.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 89.92 28.7 17.52 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-O 119.42 -0.656 . . . . 53.31 113.647 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 164' ' ' MET . . . . . 0.549 ' SD ' HG21 ' C' ' 145' ' ' VAL . 20.7 mtm -130.67 -88.14 0.49 Allowed 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 117.888 0.844 . . . . 73.35 111.717 178.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 165' ' ' GLY . . . . . 0.421 ' HA3' ' HB3' ' C' ' 171' ' ' PRO . . . 131.91 147.93 6.02 Favored Glycine 0 N--CA 1.482 1.737 0 CA-C-N 118.686 0.676 . . . . 64.24 114.501 -172.146 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . -108.16 -105.95 3.04 Favored Glycine 0 C--N 1.371 2.494 0 N-CA-C 112.279 -0.328 . . . . 75.44 112.279 172.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 167' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -105.38 107.0 17.76 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.515 0.726 . . . . 64.31 111.642 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . 129.9 159.54 9.81 Favored Glycine 0 C--N 1.357 1.702 0 CA-C-N 117.762 0.256 . . . . 13.44 113.108 171.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 169' ' ' ASN . . . . . 0.471 ' HB2' ' HD3' ' C' ' 170' ' ' PRO . 1.3 m-20 -61.72 -63.18 4.57 Favored Pre-proline 0 CA--C 1.572 1.795 0 C-N-CA 125.008 1.323 . . . . 62.44 114.01 -168.542 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 170' ' ' PRO . . . . . 0.471 ' HD3' ' HB2' ' C' ' 169' ' ' ASN . 73.2 Cg_endo -79.03 98.7 1.2 Allowed 'Trans proline' 0 C--N 1.406 3.569 0 CA-C-N 122.309 1.86 . . . . 51.41 110.335 173.504 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 171' ' ' PRO . . . . . 0.551 ' HA ' ' HA3' ' C' ' 116' ' ' GLY . 10.2 Cg_exo -69.74 142.47 48.13 Favored 'Trans proline' 0 C--N 1.369 1.658 0 C-N-CA 123.704 2.936 . . . . 74.02 116.557 -159.289 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 172' ' ' GLY . . . . . 0.4 ' O ' ' HA2' ' C' ' 165' ' ' GLY . . . -109.01 141.51 15.95 Favored Glycine 0 C--O 1.213 -1.208 0 N-CA-C 106.549 -2.62 . . . . 74.42 106.549 163.345 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 173' ' ' ASP . . . . . 0.444 ' HB3' ' O ' ' C' ' 161' ' ' VAL . 64.8 m-20 -81.12 -161.51 0.41 Allowed 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 115.349 1.611 . . . . 74.51 115.349 -159.124 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 174' ' ' LEU . . . . . 0.611 ' HB3' ' HB ' ' C' ' 161' ' ' VAL . 40.7 tp -94.34 141.95 27.98 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 121.504 -0.747 . . . . 75.22 110.896 -176.069 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 175' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' C' ' 120' ' ' ARG . 76.2 mt -130.06 84.78 2.23 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.416 1.486 . . . . 71.32 109.435 176.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 176' ' ' LEU . . . . . . . . . . . . . 69.5 mt -80.2 107.45 13.0 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.424 0.69 . . . . 43.02 109.644 175.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 177' ' ' VAL . . . . . 0.499 HG11 ' SG ' ' B' ' 308' ' ' CYS . 58.2 t -83.06 95.48 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 107.553 -1.277 . . . . 74.43 107.553 175.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 178' ' ' VAL . . . . . 0.705 HG21 HG21 ' C' ' 153' ' ' VAL . 3.0 p -71.25 122.65 23.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.875 0.845 . . . . 74.01 111.334 -174.5 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 179' ' ' ARG . . . . . . . . . . . . . 17.1 mmm-85 -105.62 111.74 24.55 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 107.277 -1.379 . . . . 72.33 107.277 169.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 180' ' ' LEU . . . . . 0.502 HD13 HD21 ' C' ' 127' ' ' LEU . 97.3 mt -72.12 136.85 46.67 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.35 0.595 . . . . 70.51 111.101 -177.374 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 181' ' ' LEU . . . . . 0.513 HD21 ' HB2' ' B' ' 190' ' ' CYS . 60.3 mt -62.98 167.14 6.51 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 126.016 1.726 . . . . 74.2 113.857 -173.342 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -52.04 71.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.396 3.068 0 C-N-CA 124.208 3.272 . . . . 64.12 113.165 167.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 183' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -178.15 49.0 0.05 OUTLIER Pre-proline 0 CA--C 1.549 0.933 0 N-CA-C 105.153 -2.165 . . . . 62.13 105.153 -171.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 184' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -90.2 65.29 1.88 Allowed 'Trans proline' 0 C--N 1.387 2.586 0 C-N-CA 123.229 2.619 . . . . 71.54 111.655 -163.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 185' ' ' VAL . . . . . 0.566 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 21.2 t -95.73 -59.68 3.02 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.443 0 N-CA-C 108.223 -1.029 . . . . 72.23 108.223 -174.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 186' ' ' PHE . . . . . 0.508 ' HD2' HD13 ' C' ' 127' ' ' LEU . 53.8 m-85 -100.11 125.32 46.2 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.725 0.81 . . . . 61.44 110.787 -168.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 187' ' ' ARG . . . . . 0.414 ' HG2' ' HB3' ' C' ' 155' ' ' GLU . 0.0 OUTLIER -126.23 109.35 12.21 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 107.256 -1.387 . . . . 75.14 107.256 178.906 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 188' ' ' LEU . . . . . 0.468 HD13 ' HD2' ' C' ' 240' ' ' PHE . 52.3 tp -77.48 154.13 32.83 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.617 0.969 . . . . 74.14 113.617 -169.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 189' ' ' GLU . . . . . 0.416 ' HA ' ' HE ' ' C' ' 154' ' ' ARG . 7.9 tp10 -142.25 103.47 4.29 Favored 'General case' 0 C--O 1.248 1.01 0 N-CA-C 107.06 -1.459 . . . . 71.33 107.06 158.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 75.13 -88.39 0.79 Allowed Glycine 0 C--N 1.349 1.253 0 CA-C-N 115.471 -0.786 . . . . 74.2 112.526 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 191' ' ' GLN . . . . . 0.517 ' HB3' ' HA3' ' C' ' 247' ' ' GLY . 49.5 mt-30 -123.83 -23.05 4.75 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.659 1.184 . . . . 60.21 110.303 176.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -93.23 127.26 38.74 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 123.756 0.822 . . . . 65.13 110.79 -171.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 193' ' ' LEU . . . . . . . . . . . . . 84.3 mt -86.64 165.72 15.92 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.849 0.86 . . . . 52.2 111.316 -177.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 194' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -126.96 103.69 7.61 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.56 -1.274 . . . . 75.43 107.56 165.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 195' ' ' ALA . . . . . 0.566 ' HA ' ' O ' ' C' ' 185' ' ' VAL . . . -98.41 -177.08 3.58 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 124.024 0.93 . . . . 65.11 109.843 172.12 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 88.6 m -132.41 106.67 8.02 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 107.9 -1.148 . . . . 51.32 107.9 168.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 197' ' ' LEU . . . . . . . . . . . . . 43.3 tp -78.12 122.22 25.34 Favored 'General case' 0 C--N 1.35 0.596 0 N-CA-C 109.327 -0.62 . . . . 73.5 109.327 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -96.18 100.44 12.08 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 108.396 -0.965 . . . . 44.52 108.396 -177.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 199' ' ' VAL . . . . . . . . . . . . . 25.6 t -108.25 124.58 34.18 Favored Pre-proline 0 N--CA 1.481 1.11 0 C-N-CA 123.285 0.634 . . . . 61.21 109.649 -176.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 200' ' ' PRO . . . . . 0.556 ' HG2' HD12 ' C' ' 203' ' ' ILE . 4.5 Cg_exo -63.31 145.92 93.26 Favored 'Trans proline' 0 C--N 1.37 1.673 0 C-N-CA 121.961 1.774 . . . . 71.34 110.834 170.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 201' ' ' ALA . . . . . . . . . . . . . . . -53.37 -47.4 96.33 Favored Pre-proline 0 CA--C 1.558 1.262 0 N-CA-C 113.834 1.05 . . . . 74.35 113.834 -179.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 202' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -63.77 -41.88 22.44 Favored 'Trans proline' 0 C--N 1.384 2.444 0 C-N-CA 121.509 1.473 . . . . 63.15 112.523 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 203' ' ' ILE . . . . . 0.556 HD12 ' HG2' ' C' ' 200' ' ' PRO . 39.5 mt -65.73 -36.04 76.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.009 0.524 . . . . 63.4 110.324 179.043 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 204' ' ' ALA . . . . . 0.454 ' HA ' HG11 ' C' ' 223' ' ' VAL . . . -62.05 -43.01 99.75 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.33 0.652 . . . . 75.02 110.897 176.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 205' ' ' VAL . . . . . . . . . . . . . 70.0 t -67.97 -45.35 83.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.659 0.784 . . . . 63.41 112.529 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 206' ' ' VAL . . . . . 0.615 ' HA ' ' HE3' ' A' ' 270' ' ' LYS . 14.8 p -78.9 -31.15 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 CA-C-O 121.021 0.438 . . . . 52.12 110.98 -176.19 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 82.12 52.06 4.2 Favored Glycine 0 C--N 1.336 0.546 0 CA-C-N 115.345 -0.843 . . . . 63.21 111.701 -172.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -84.22 -135.83 3.08 Favored Glycine 0 C--N 1.346 1.099 0 N-CA-C 111.868 -0.493 . . . . 51.32 111.868 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 209' ' ' LYS . . . . . 0.691 ' HZ3' ' HB3' ' B' ' 235' ' ' GLU . 9.7 mtmp? -137.01 139.84 41.69 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 117.509 0.654 . . . . 72.12 111.397 175.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 210' ' ' VAL . . . . . 0.486 HG13 HG21 ' C' ' 203' ' ' ILE . 22.3 m -128.33 135.59 62.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.399 1.08 . . . . 62.05 109.216 175.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 211' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -84.62 112.51 20.51 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 120.852 0.358 . . . . 72.44 110.833 -176.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -81.69 114.58 20.46 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.07 0.948 . . . . 74.43 108.607 170.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 213' ' ' MET . . . . . . . . . . . . . 4.1 tmm? -74.87 116.08 15.19 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 107.311 -1.366 . . . . 63.12 107.311 178.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 214' ' ' THR . . . . . 0.443 ' OG1' HG12 ' C' ' 219' ' ' VAL . 0.2 OUTLIER -116.96 174.4 6.11 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.286 0.565 . . . . 54.24 110.478 -174.167 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 215' ' ' LEU . . . . . 0.423 HD13 ' HB2' ' C' ' 131' ' ' PHE . 27.1 mt -64.47 -29.89 70.93 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.107 1.363 . . . . 44.41 112.067 -177.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -91.65 1.4 57.18 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 114.78 -1.1 . . . . 71.0 110.826 -177.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 110.77 -170.06 13.72 Favored Glycine 0 C--N 1.341 0.843 0 N-CA-C 110.693 -0.963 . . . . 64.11 110.693 -169.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -80.5 119.12 3.67 Favored 'Trans proline' 0 CA--C 1.554 1.524 0 C-N-CA 122.566 2.178 . . . . 52.13 113.506 -173.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 219' ' ' VAL . . . . . 0.443 HG12 ' OG1' ' C' ' 214' ' ' THR . 14.8 p -97.82 148.05 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 N-CA-C 107.728 -1.212 . . . . 52.53 107.728 165.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 220' ' ' GLU . . . . . 0.484 ' HG2' ' HB3' ' C' ' 209' ' ' LYS . 13.3 tt0 -96.93 155.94 16.56 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 108.574 -0.899 . . . . 72.32 108.574 175.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 221' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' C' ' 209' ' ' LYS . 41.9 t -122.5 116.88 50.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 124.094 0.958 . . . . 74.03 110.154 -178.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 222' ' ' ALA . . . . . 0.519 ' HA ' ' HG2' ' C' ' 209' ' ' LYS . . . -78.74 102.64 8.2 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 108.965 -0.754 . . . . 73.3 108.965 171.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 223' ' ' VAL . . . . . 0.454 HG11 ' HA ' ' C' ' 204' ' ' ALA . 58.2 t -76.43 142.81 71.57 Favored Pre-proline 0 CA--C 1.566 1.574 0 C-N-CA 124.643 1.177 . . . . 73.11 110.372 -177.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 224' ' ' PRO . . . . . 0.649 ' HB3' ' HA ' ' B' ' 245' ' ' LYS . 71.7 Cg_endo -78.69 154.49 26.93 Favored 'Trans proline' 0 C--N 1.38 2.186 0 C-N-CA 122.957 2.438 . . . . 54.33 113.073 168.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -58.89 119.59 6.94 Favored 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 123.496 2.797 . . . . 74.0 112.674 175.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 226' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.0 82.92 0.13 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.275 1.43 . . . . 70.15 110.795 -175.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 227' ' ' THR . . . . . 0.414 HG22 HG11 ' C' ' 253' ' ' VAL . 97.8 m -93.31 133.08 36.92 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 114.295 -1.32 . . . . 70.3 109.482 174.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 228' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -100.09 147.75 25.32 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 121.24 0.543 . . . . 74.32 110.65 176.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 229' ' ' ALA . . . . . 0.41 ' HB2' ' H ' ' C' ' 255' ' ' ILE . . . -67.83 140.44 56.59 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 114.967 -1.015 . . . . 62.12 109.521 173.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 105.83 -18.37 40.45 Favored Glycine 0 C--N 1.333 0.37 0 N-CA-C 111.471 -0.652 . . . . 62.04 111.471 -171.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 231' ' ' ARG . . . . . . . . . . . . . 36.1 mtt85 -62.69 168.35 3.84 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 117.105 0.452 . . . . 74.12 111.697 169.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 232' ' ' LYS . . . . . 0.644 ' HD3' ' HB3' ' C' ' 250' ' ' TYR . 3.9 ttmp? -150.18 131.76 14.86 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.33 0.586 . . . . 71.45 111.117 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 233' ' ' LEU . . . . . 0.595 HD13 ' HB2' ' C' ' 251' ' ' LEU . 4.7 mp -88.03 158.44 18.61 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.65 1.18 . . . . 74.21 110.214 178.024 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 234' ' ' ARG . . . . . 0.509 ' NH2' ' HA ' ' B' ' 243' ' ' GLN . 3.1 ptt85 -128.17 87.89 2.67 Favored 'General case' 0 CA--C 1.55 0.96 0 O-C-N 125.171 1.544 . . . . 72.34 108.19 164.055 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 54.4 mt -77.29 120.46 22.36 Favored 'General case' 0 C--N 1.361 1.071 0 CA-C-N 115.468 -0.787 . . . . 73.43 109.008 174.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -80.94 127.28 32.39 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.686 0.795 . . . . 71.55 111.48 -172.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 72.95 36.17 57.49 Favored Glycine 0 C--N 1.347 1.154 0 O-C-N 123.853 0.721 . . . . 71.42 113.028 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 24.0 mmtm -129.01 21.52 5.8 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.561 0.745 . . . . 72.03 110.987 176.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -92.78 -164.08 37.74 Favored Glycine 0 C--N 1.353 1.505 0 O-C-N 123.559 0.537 . . . . 31.21 112.975 175.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 240' ' ' PHE . . . . . 0.468 ' HD2' HD13 ' C' ' 188' ' ' LEU . 2.5 m-85 -80.89 157.58 71.43 Favored Pre-proline 0 CA--C 1.557 1.244 0 CA-C-O 119.352 -0.356 . . . . 75.14 110.065 177.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 241' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -59.26 114.52 2.06 Favored 'Trans proline' 0 C--N 1.387 2.565 0 C-N-CA 123.415 2.744 . . . . 70.21 112.786 -177.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -99.53 168.3 21.65 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-N 115.217 -0.901 . . . . 70.14 112.812 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -67.46 -23.0 44.32 Favored 'Trans proline' 0 C--N 1.374 1.89 0 C-N-CA 123.116 2.544 . . . . 71.42 112.302 176.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -95.33 -4.18 45.93 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.837 0.855 . . . . 71.42 111.3 177.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 141.55 -85.55 0.2 Allowed Glycine 0 C--N 1.349 1.274 0 N-CA-C 111.311 -0.716 . . . . 51.32 111.311 -178.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 246' ' ' ARG . . . . . . . . . . . . . 85.6 mtm180 -138.61 175.26 9.71 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.657 1.183 . . . . 61.31 110.119 178.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 247' ' ' GLY . . . . . 0.517 ' HA3' ' HB3' ' C' ' 191' ' ' GLN . . . -104.08 -158.46 24.25 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 115.201 -0.909 . . . . 63.23 111.926 165.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -118.79 174.66 6.15 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.295 0.638 . . . . 73.54 109.492 -178.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 249' ' ' LEU . . . . . 0.463 ' HG ' HD11 ' C' ' 251' ' ' LEU . 20.6 tp -126.93 118.03 23.71 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.576 0.751 . . . . 74.23 110.841 -173.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 250' ' ' TYR . . . . . 0.644 ' HB3' ' HD3' ' C' ' 232' ' ' LYS . 22.3 m-30 -100.89 106.47 17.83 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.47 0.708 . . . . 71.43 110.715 178.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 251' ' ' LEU . . . . . 0.595 ' HB2' HD13 ' C' ' 233' ' ' LEU . 2.9 mp -105.3 124.32 49.34 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-N 118.836 0.744 . . . . 64.53 111.2 -174.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -76.7 120.2 21.55 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 109.068 -0.716 . . . . 73.41 109.068 174.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 253' ' ' VAL . . . . . 0.414 HG11 HG22 ' C' ' 227' ' ' THR . 72.1 t -77.16 128.16 38.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 C-N-CA 123.235 0.614 . . . . 73.5 111.289 -176.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 254' ' ' ARG . . . . . . . . . . . . . 28.2 mtm180 -107.04 137.22 45.52 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.391 -0.966 . . . . 74.13 108.391 164.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 255' ' ' ILE . . . . . 0.485 ' O ' ' HB ' ' A' ' 255' ' ' ILE . 30.2 mm -98.64 109.61 24.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 105.843 -1.91 . . . . 75.24 105.843 165.529 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 256' ' ' THR . . . . . . . . . . . . . 7.5 t -131.15 176.87 7.9 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 124.09 0.956 . . . . 53.32 109.793 -170.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 49.6 pt -126.81 155.65 75.01 Favored Pre-proline 0 CA--C 1.557 1.226 0 C-N-CA 123.356 0.662 . . . . 64.54 110.254 -177.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 258' ' ' PRO . . . . . 0.514 ' HG3' ' HE2' ' A' ' 276' ' ' TYR . 49.6 Cg_endo -80.86 41.4 1.14 Allowed 'Trans proline' 0 C--N 1.377 2.051 0 C-N-CA 123.625 2.883 . . . . 73.21 113.945 -175.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 259' ' ' GLU . . . . . 0.404 ' O ' ' HD3' ' A' ' 226' ' ' ARG . 60.8 mm-40 60.51 -93.63 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.882 1.273 . . . . 72.3 110.015 -171.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 260' ' ' ARG . . . . . 0.775 ' HA ' HH11 ' A' ' 226' ' ' ARG . 0.0 OUTLIER -115.03 164.1 14.66 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.514 1.126 . . . . 73.41 110.197 -178.16 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 261' ' ' LEU . . . . . . . . . . . . . 45.6 mt -126.96 173.15 9.85 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.023 0.929 . . . . 71.21 111.398 -171.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 73.4 p -84.27 148.6 53.32 Favored Pre-proline 0 CA--C 1.552 1.051 0 CA-C-N 114.942 -1.026 . . . . 61.23 108.801 168.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -43.34 -36.78 6.75 Favored 'Trans proline' 0 C--N 1.382 2.324 0 C-N-CA 124.478 3.452 . . . . 74.2 115.114 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -64.23 -60.94 2.6 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.251 0.62 . . . . 71.04 110.905 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -53.32 -51.1 63.44 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.448 -0.796 . . . . 65.11 109.874 178.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 266' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -55.99 -36.17 67.6 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 114.547 -1.206 . . . . 64.21 111.706 -178.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -63.76 -48.89 75.13 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.2 0.6 . . . . 70.32 111.259 176.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 268' ' ' LEU . . . . . 0.622 ' HB2' HD21 ' A' ' 272' ' ' LEU . 8.0 mp -63.94 -38.17 90.09 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 123.033 0.208 . . . . 52.44 111.379 178.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 77.1 m95 -64.78 -33.36 75.79 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.054 0.542 . . . . 61.11 111.017 175.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -70.87 -31.78 68.56 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.109 0.564 . . . . 75.43 111.74 175.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -69.76 -38.79 76.88 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 120.567 0.223 . . . . 75.33 110.903 175.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 92.9 mt -60.63 -44.91 95.81 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 115.723 -0.671 . . . . 74.33 109.581 170.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -62.12 -41.69 98.48 Favored 'General case' 0 C--O 1.216 -0.709 0 CA-C-N 115.42 -0.809 . . . . 34.13 111.401 -178.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -69.54 -33.71 73.19 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.386 0.675 . . . . 63.21 111.021 178.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -60.55 -33.77 73.16 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 121.243 0.544 . . . . 70.04 110.398 171.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 276' ' ' TYR . . . . . 0.706 ' HA ' ' HD3' ' C' ' 279' ' ' ARG . 16.4 m-85 -80.91 -31.39 35.13 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.251 -0.886 . . . . 75.52 112.839 174.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 18.6 m-30 -73.17 -22.2 60.53 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 118.391 0.541 . . . . 44.24 109.886 178.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -64.94 -23.43 67.22 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.474 0.71 . . . . 55.2 111.109 171.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 279' ' ' ARG . . . . . 0.706 ' HD3' ' HA ' ' C' ' 276' ' ' TYR . 17.2 mtp-105 -78.63 -21.37 48.51 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.498 0.719 . . . . 71.52 110.515 174.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.137 0 C-N-CA 123.507 0.723 . . . . 75.14 109.231 -178.857 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.2 mtp . . . . . 0 N--CA 1.473 0.677 0 N-CA-C 109.794 -0.447 . . . . 64.12 109.794 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 60.52 21.83 11.55 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 124.664 1.186 . . . . 51.4 113.98 173.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -88.29 53.89 2.89 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 122.858 0.463 . . . . 74.04 110.744 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.8 ttpp -38.96 105.65 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 125.337 1.455 . . . . 62.43 114.103 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -77.57 131.18 37.71 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.205 1.002 . . . . 74.32 110.427 177.071 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -83.76 86.84 7.08 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 107.022 -1.474 . . . . 61.41 107.022 166.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.453 ' CD1' ' HA ' ' A' ' 53' ' ' ALA . 66.6 m-85 -61.2 -31.11 70.87 Favored 'General case' 0 C--O 1.249 1.063 0 CA-C-N 115.094 -0.957 . . . . 73.34 112.144 -174.264 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -57.37 -55.38 35.51 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.241 0.617 . . . . 73.33 109.494 172.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.73 -33.66 74.43 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.816 0.847 . . . . 60.32 111.764 -177.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 78.1 mt -62.89 -40.14 87.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.287 0.635 . . . . 74.23 110.477 175.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 93.3 mt -80.03 -2.81 45.82 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 112.49 0.552 . . . . 51.33 112.49 173.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.26 18.03 72.63 Favored Glycine 0 C--N 1.351 1.394 0 O-C-N 123.3 0.375 . . . . 53.33 113.67 177.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.607 HG21 HG12 ' A' ' 22' ' ' ILE . 22.8 m -111.55 142.06 25.79 Favored Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 123.209 0.604 . . . . 71.43 110.185 177.353 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -82.94 169.78 12.89 Favored 'Trans proline' 0 C--N 1.366 1.453 0 C-N-CA 122.255 1.97 . . . . 50.12 112.048 174.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.6 mmt85 -67.92 80.43 0.21 Allowed 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 114.969 -1.014 . . . . 75.43 110.422 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -174.96 -32.75 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.166 1.387 . . . . 64.11 108.399 -177.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.28 122.07 17.08 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.831 -0.622 . . . . 64.31 110.56 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 72.8 p -76.58 175.13 9.57 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.14 0.976 . . . . 71.11 110.236 178.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -50.41 -38.63 43.99 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 124.424 1.09 . . . . 64.21 112.484 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.455 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 1.8 tm-20 -74.05 -41.76 61.26 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.397 1.079 . . . . 72.43 110.265 -175.154 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -67.86 -37.51 81.92 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 123.871 0.869 . . . . 64.03 110.623 177.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.666 HD13 HD13 ' A' ' 57' ' ' LEU . 45.0 mt -68.06 -33.06 58.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 C-N-CA 125.342 1.457 . . . . 73.31 110.612 175.288 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.2 ttmm -69.76 -38.99 76.98 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.733 0.813 . . . . 71.24 109.63 177.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.455 ' HG3' ' O ' ' A' ' 20' ' ' GLU . 48.9 mtt180 -61.36 -45.67 93.41 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 123.582 0.551 . . . . 54.12 109.97 174.237 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.72 -46.02 84.98 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 124.262 0.976 . . . . 64.0 111.302 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -60.6 -49.81 76.02 Favored 'General case' 0 C--N 1.348 0.534 0 O-C-N 123.693 0.621 . . . . 73.1 111.02 177.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -61.43 -35.95 78.99 Favored 'General case' 0 N--CA 1.484 1.229 0 O-C-N 124.078 0.861 . . . . 74.22 111.601 -178.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.8 ttt180 -58.52 -51.11 71.27 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.642 1.177 . . . . 71.15 110.355 174.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.704 ' HB3' HD13 ' A' ' 50' ' ' ILE . 54.2 mt -73.94 -21.07 60.17 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 114.843 -1.071 . . . . 74.11 110.708 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -88.4 -9.57 52.17 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.361 1.064 . . . . 63.3 111.392 179.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 48.4 mtm105 -93.5 -46.68 7.2 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.08 0.552 . . . . 72.33 109.967 166.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -69.75 -60.12 2.51 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.451 0.7 . . . . 63.33 111.423 -174.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.428 ' HE2' HD22 ' A' ' 29' ' ' LEU . 26.4 m-85 -92.97 19.52 7.68 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.371 0.668 . . . . 63.25 111.541 -174.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 -57.52 102.91 0.33 Allowed Pre-proline 0 N--CA 1.48 1.025 0 C-N-CA 125.147 1.379 . . . . 63.41 111.323 -172.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -62.17 -25.08 76.81 Favored 'Trans proline' 0 C--N 1.375 1.935 0 C-N-CA 123.164 2.576 . . . . 74.13 113.367 -177.045 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -59.66 -31.11 69.25 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.446 0.698 . . . . 72.45 111.416 175.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.9 t -102.2 -63.18 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 N-CA-C 109.254 -0.647 . . . . 65.53 109.254 176.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -97.95 86.07 3.65 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.397 1.079 . . . . 61.35 109.869 -174.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -77.13 71.46 3.63 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 115.382 -0.826 . . . . 73.11 109.707 174.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 43.7 m -118.19 117.57 34.9 Favored Pre-proline 0 N--CA 1.471 0.606 0 N-CA-C 108.287 -1.005 . . . . 54.41 108.287 178.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -41.22 -50.47 4.37 Favored 'Trans proline' 0 C--N 1.388 2.637 0 C-N-CA 124.291 3.327 . . . . 72.23 113.955 -171.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -53.98 -48.51 70.29 Favored 'General case' 0 CA--C 1.549 0.922 0 O-C-N 124.583 1.177 . . . . 64.43 111.323 -179.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.3 -28.74 67.44 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.384 -0.826 . . . . 72.14 111.237 -178.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.458 ' O ' ' HD3' ' A' ' 48' ' ' LYS . 49.2 mt-10 -84.84 -36.74 21.39 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.334 0.654 . . . . 62.01 110.321 -172.417 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -70.29 -42.68 71.73 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.842 0.857 . . . . 62.44 109.336 177.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -57.73 -41.48 81.91 Favored 'General case' 0 C--N 1.35 0.593 0 CA-C-N 114.857 -1.065 . . . . 74.03 109.689 169.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.426 ' HA ' HD12 ' A' ' 50' ' ' ILE . 35.1 t80 -70.47 -23.2 62.65 Favored 'General case' 0 CA--C 1.547 0.845 0 O-C-N 123.468 0.48 . . . . 73.24 111.836 179.204 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.458 ' HD3' ' O ' ' A' ' 44' ' ' GLU . 1.9 mptm? -68.98 -41.22 78.16 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 109.702 -0.481 . . . . 75.14 109.702 171.397 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -65.25 -37.37 87.01 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 123.629 0.58 . . . . 71.44 110.537 176.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.704 HD13 ' HB3' ' A' ' 29' ' ' LEU . 79.9 mt -69.14 -39.43 79.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.783 1.233 . . . . 70.53 110.565 177.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -67.95 -36.14 79.61 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.606 -0.724 . . . . 73.43 110.396 175.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.443 ' O ' HG23 ' A' ' 56' ' ' VAL . 32.4 tt0 -63.78 -53.39 51.57 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.551 1.141 . . . . 63.42 110.138 179.142 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.453 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . . . -60.41 -44.15 96.02 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 113.372 -1.74 . . . . 65.45 112.063 -177.535 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -82.54 -18.28 42.02 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 115.994 -0.548 . . . . 72.32 111.629 177.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.431 ' HB1' ' CD2' ' A' ' 85' ' ' PHE . . . -61.55 -36.62 81.1 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.8 0.809 . . . . 53.01 109.663 172.036 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.474 HG22 ' CE1' ' A' ' 101' ' ' PHE . 38.0 t -69.77 -61.73 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 CA-C-N 113.439 -1.709 . . . . 74.52 110.433 170.27 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.666 HD13 HD13 ' A' ' 22' ' ' ILE . 52.8 mt -86.45 12.78 9.52 Favored 'General case' 0 CA--C 1.559 1.322 0 CA-C-N 114.864 -1.062 . . . . 62.04 113.166 -165.446 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.6 t -67.88 -56.24 9.86 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.774 0.83 . . . . 74.34 110.664 174.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -95.04 148.05 34.04 Favored Pre-proline 0 N--CA 1.47 0.547 0 CA-C-N 115.095 -0.957 . . . . 74.34 110.286 -177.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.75 -41.15 57.65 Favored 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 123.266 2.644 . . . . 72.41 111.207 169.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -60.57 -54.69 42.35 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 123.97 0.908 . . . . 72.3 111.527 -178.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.436 ' HA ' HD12 ' A' ' 65' ' ' ILE . 37.6 mtpt -73.39 -32.04 64.24 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.625 0.77 . . . . 74.54 112.386 -174.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.462 HH21 HD12 ' A' ' 22' ' ' ILE . 7.6 ptm180 -67.31 -38.94 85.78 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.636 -0.505 . . . . 74.11 109.636 175.292 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -65.05 -35.91 82.68 Favored 'General case' 0 C--N 1.362 1.134 0 O-C-N 123.593 0.558 . . . . 74.25 110.904 174.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.436 HD12 ' HA ' ' A' ' 62' ' ' LYS . 83.4 mt -55.58 -47.14 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 C-N-CA 123.366 0.666 . . . . 64.42 110.469 174.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -58.04 -55.61 32.68 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 115.578 -0.737 . . . . 75.4 111.274 170.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -58.75 -31.8 68.67 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.467 0.707 . . . . 64.04 112.135 -173.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 67.8 p -86.98 -18.3 31.02 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.301 0.64 . . . . 75.13 111.338 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -72.47 134.64 45.42 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 106.839 -1.541 . . . . 63.45 106.839 164.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.63 26.77 49.52 Favored Glycine 0 N--CA 1.471 1.0 0 N-CA-C 111.201 -0.76 . . . . 52.54 111.201 -171.045 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 52.8 m -144.42 -56.45 0.36 Allowed 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 102.587 -3.116 . . . . 71.23 102.587 172.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.5 m -84.2 140.95 31.37 Favored 'General case' 0 C--O 1.25 1.098 0 N-CA-C 104.782 -2.303 . . . . 74.23 104.782 157.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.23 -41.84 63.27 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.08 0.552 . . . . 74.04 110.539 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.78 151.8 53.04 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 123.731 0.812 . . . . 75.1 110.134 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -63.0 133.8 43.11 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.214 1.943 . . . . 75.41 110.58 172.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.404 ' HG2' ' HA ' ' A' ' 65' ' ' ILE . 67.8 Cg_exo -47.26 150.44 3.3 Favored 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 124.373 3.382 . . . . 74.25 115.207 -178.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -55.82 113.35 1.39 Allowed 'Trans proline' 0 C--N 1.389 2.662 0 C-N-CA 123.302 2.668 . . . . 62.44 112.46 -178.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -62.58 146.45 95.39 Favored 'Trans proline' 0 C--N 1.382 2.297 0 C-N-CA 123.397 2.731 . . . . 43.51 113.283 -178.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -66.21 150.24 84.98 Favored 'Trans proline' 0 C--N 1.373 1.844 0 C-N-CA 122.819 2.346 . . . . 71.05 111.566 174.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.478 ' HD2' ' HA3' ' A' ' 142' ' ' GLY . 74.1 Cg_endo -72.75 64.89 3.94 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 123.576 2.851 . . . . 51.35 112.124 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -178.51 -31.98 0.05 OUTLIER Glycine 0 CA--C 1.522 0.484 0 CA-C-N 114.502 -1.227 . . . . 62.41 110.047 -170.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.77 -169.03 18.8 Favored Glycine 0 C--N 1.356 1.674 0 C-N-CA 122.993 0.33 . . . . 53.03 113.115 176.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -108.0 111.76 24.0 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.326 1.05 . . . . 74.41 110.165 -178.07 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -67.76 155.5 39.14 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.76 1.224 . . . . 71.31 110.944 172.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.523 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 64.8 m-85 -144.39 77.64 1.55 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.894 0.878 . . . . 70.22 110.517 -177.229 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.462 ' HB3' ' HG2' ' A' ' 162' ' ' PRO . 6.0 m -49.42 85.06 0.0 OUTLIER 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 125.446 1.499 . . . . 74.44 113.667 -179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.33 20.71 79.96 Favored Glycine 0 CA--C 1.535 1.299 0 CA-C-N 116.118 -0.492 . . . . 70.11 113.772 -179.177 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.523 ' HB2' ' HB3' ' A' ' 85' ' ' PHE . 24.2 m-85 -114.09 106.86 14.89 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 117.41 0.605 . . . . 72.34 109.502 -176.552 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -83.73 80.52 9.11 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 121.686 0.755 . . . . 71.44 109.907 -177.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.439 ' HA ' ' CD2' ' A' ' 93' ' ' PHE . 3.4 p -39.94 -32.94 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 C-N-CA 126.635 1.974 . . . . 75.21 114.688 174.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.478 ' HB2' ' NH2' ' A' ' 114' ' ' ARG . 10.5 tp10 -53.47 -38.55 63.73 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.557 1.143 . . . . 75.33 111.783 -176.575 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -97.18 0.68 48.74 Favored 'General case' 0 CA--C 1.554 1.126 0 CA-C-N 115.332 -0.849 . . . . 45.35 111.495 -173.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.439 ' CD2' ' HA ' ' A' ' 90' ' ' VAL . 10.3 m-30 -88.68 -178.12 5.72 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.588 0.755 . . . . 71.01 110.555 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 89.6 p -77.47 163.74 26.07 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 113.595 0.961 . . . . 74.5 113.595 -168.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.413 ' O ' ' HG3' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -61.57 -40.34 94.38 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 114.312 -1.313 . . . . 74.31 112.123 175.889 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -63.33 -39.31 94.2 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 110.085 -0.339 . . . . 75.03 110.085 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -62.14 -40.33 95.61 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.529 -0.759 . . . . 63.23 109.654 176.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -81.16 -1.61 45.24 Favored 'General case' 0 CA--C 1.558 1.272 0 CA-C-N 114.801 -1.091 . . . . 73.05 112.288 177.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 95' ' ' GLU . 51.8 mt-10 -96.6 -46.46 6.31 Favored 'General case' 0 N--CA 1.503 2.224 0 C-N-CA 123.278 0.631 . . . . 70.02 111.62 167.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 33.5 tp -65.41 -45.55 83.5 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.678 1.191 . . . . 55.03 110.215 -177.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.474 ' CE1' HG22 ' A' ' 56' ' ' VAL . 97.5 m-85 -95.71 -7.97 35.89 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.544 -0.753 . . . . 72.11 111.033 176.489 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -45.16 -58.58 4.98 Favored Glycine 0 CA--C 1.541 1.67 0 CA-C-O 118.656 -1.08 . . . . 72.43 115.625 -177.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -62.3 -8.21 12.01 Favored 'Trans proline' 0 C--N 1.386 2.512 0 C-N-CA 123.169 2.58 . . . . 23.1 113.86 -175.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -142.01 33.49 1.93 Allowed Glycine 0 C--N 1.357 1.731 0 CA-C-O 119.551 -0.583 . . . . 44.4 112.771 175.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.5 mt -66.79 20.92 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.305 0 N-CA-C 114.864 1.431 . . . . 74.25 114.864 -178.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.571 ' HD1' ' H ' ' A' ' 108' ' ' GLY . 0.2 OUTLIER 57.06 -107.26 0.37 Allowed 'General case' 0 CA--C 1.564 1.486 0 C-N-CA 124.182 0.993 . . . . 72.25 110.541 165.123 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 66.22 15.36 63.11 Favored Glycine 0 C--N 1.362 1.975 0 CA-C-N 118.044 0.384 . . . . 44.0 113.414 -176.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.571 ' H ' ' HD1' ' A' ' 106' ' ' PHE . . . 59.22 -113.77 5.48 Favored Glycine 0 C--N 1.353 1.5 0 N-CA-C 111.482 -0.647 . . . . 71.34 111.482 -170.472 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -109.34 -5.61 15.79 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.544 0.737 . . . . 64.11 110.197 169.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -66.96 -27.17 73.31 Favored Glycine 0 C--N 1.351 1.41 0 C-N-CA 123.099 0.381 . . . . 55.25 112.846 177.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 61.8 mtt180 77.01 -40.02 0.35 Allowed 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 126.011 1.724 . . . . 71.44 114.308 169.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 40.3 ttt180 -86.23 46.88 1.38 Allowed 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 118.599 0.636 . . . . 73.25 110.046 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.406 ' HB3' HG11 ' A' ' 90' ' ' VAL . 45.1 m 46.52 52.32 11.03 Favored 'General case' 0 C--N 1.36 1.052 0 C-N-CA 124.712 1.205 . . . . 74.21 112.351 167.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.478 ' NH2' ' HB2' ' A' ' 91' ' ' GLU . 0.3 OUTLIER -110.71 160.8 16.38 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 112.508 0.559 . . . . 74.52 112.508 -166.56 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 170' ' ' PRO . 39.2 ttmt -68.79 135.52 51.34 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.729 0.812 . . . . 72.15 112.365 -170.066 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -97.18 -168.21 33.07 Favored Glycine 0 CA--C 1.549 2.196 0 CA-C-N 115.643 -0.708 . . . . 55.22 113.29 179.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.548 HH22 ' HB3' ' B' ' 13' ' ' LEU . 7.1 tmm_? -112.95 139.06 48.92 Favored 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 124.374 1.07 . . . . 71.34 109.766 177.431 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -50.61 113.92 1.02 Allowed 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.962 0.887 . . . . 74.23 112.724 -176.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.455 HD11 ' HA ' ' B' ' 12' ' ' PRO . 5.4 tt -105.81 148.65 27.28 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 114.652 -1.158 . . . . 70.23 108.795 -168.041 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.447 ' HD2' ' HB2' ' A' ' 175' ' ' LEU . 14.8 tpt180 -98.21 143.13 29.04 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 108.586 -0.894 . . . . 74.51 108.586 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.557 ' HB2' HD11 ' A' ' 174' ' ' LEU . . . -138.93 166.19 25.12 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 118.768 0.713 . . . . 41.51 111.45 -178.658 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.544 ' HB2' ' HB3' ' B' ' 9' ' ' ALA . 18.0 mm-40 -116.61 98.4 6.52 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 106.874 -1.528 . . . . 61.0 106.874 179.024 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.496 ' HB2' HD22 ' A' ' 176' ' ' LEU . 11.7 tp -98.25 103.57 18.65 Favored Pre-proline 0 C--O 1.213 -0.86 0 N-CA-C 107.392 -1.336 . . . . 54.05 107.392 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.489 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 55.2 Cg_endo -66.81 151.22 82.83 Favored 'Trans proline' 0 C--N 1.362 1.276 0 C-N-CA 121.253 1.302 . . . . 75.33 108.847 169.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.649 ' HA ' HG21 ' B' ' 6' ' ' ILE . 17.9 tp -150.91 148.2 28.14 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 119.283 0.947 . . . . 64.01 112.016 177.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 33.8 m -76.21 127.05 32.13 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 114.436 -1.256 . . . . 71.34 109.341 175.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.578 ' HB3' HD22 ' A' ' 215' ' ' LEU . 3.5 mm? -44.61 -57.73 3.46 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 125.516 1.526 . . . . 70.54 112.452 -178.465 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 17.5 mp0 -59.13 -44.56 92.05 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 114.33 -1.304 . . . . 75.32 109.632 -176.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -76.63 -12.28 59.99 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 115.185 -0.916 . . . . 64.33 111.856 -178.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.603 ' HB1' ' O ' ' A' ' 153' ' ' VAL . . . -79.45 -38.5 34.48 Favored 'General case' 0 C--O 1.252 1.223 0 CA-C-O 121.772 0.796 . . . . 41.43 109.206 176.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.461 ' HB2' HH21 ' A' ' 154' ' ' ARG . 89.2 t80 -70.57 -41.87 71.85 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 114.564 -1.198 . . . . 74.51 110.762 171.3 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 33.6 m170 -77.22 -36.46 54.68 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.149 0.579 . . . . 75.25 112.065 -172.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.513 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 70.21 -150.35 48.58 Favored Glycine 0 CA--C 1.531 1.087 0 O-C-N 123.411 0.444 . . . . 71.54 114.009 -179.425 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 91.57 -174.29 37.87 Favored Glycine 0 C--N 1.352 1.461 0 C-N-CA 123.483 0.563 . . . . 70.42 112.571 178.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 21.5 mp0 -67.95 113.16 5.42 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.823 0.849 . . . . 73.14 109.231 179.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 13.1 tpp180 -108.67 122.77 47.81 Favored 'General case' 0 C--O 1.244 0.806 0 C-N-CA 123.626 0.771 . . . . 74.4 109.626 -175.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 48.7 t -73.45 114.86 13.57 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 O-C-N 124.01 0.819 . . . . 71.24 109.156 175.039 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.466 HG13 HG13 ' A' ' 145' ' ' VAL . 5.5 p -142.39 134.64 26.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 124.65 1.18 . . . . 73.14 107.889 177.582 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -123.43 144.38 49.54 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 121.973 -0.454 . . . . 71.3 110.732 -175.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.518 ' HB ' ' HB3' ' B' ' 8' ' ' LEU . 11.9 p -159.32 141.09 4.69 Favored 'Isoleucine or valine' 0 C--O 1.243 0.715 0 C-N-CA 124.646 1.178 . . . . 75.1 108.111 173.297 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 58.92 31.71 21.57 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.911 0.885 . . . . 74.24 110.795 -177.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.478 ' HA3' ' HD2' ' A' ' 80' ' ' PRO . . . 73.05 0.15 50.09 Favored Glycine 0 C--N 1.355 1.598 0 CA-C-N 115.399 -0.818 . . . . 31.1 114.282 -178.378 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.75 99.08 10.41 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.317 1.047 . . . . 72.12 108.311 -174.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 27.1 ttt-85 -74.82 92.38 2.51 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.464 1.106 . . . . 74.41 109.702 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.466 HG13 HG13 ' A' ' 138' ' ' VAL . 7.5 p -95.62 136.76 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 123.217 0.607 . . . . 73.53 110.899 -177.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 40.3 t -102.02 85.2 2.64 Favored 'General case' 0 C--O 1.243 0.718 0 N-CA-C 108.523 -0.917 . . . . 31.45 108.523 177.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 89.0 t -81.16 113.17 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 108.598 -0.89 . . . . 73.42 108.598 -176.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 40.4 ttt85 -68.79 93.04 0.51 Allowed 'General case' 0 C--O 1.242 0.692 0 N-CA-C 108.552 -0.907 . . . . 74.14 108.552 173.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.513 HG13 ' HA2' ' A' ' 133' ' ' GLY . 41.2 pt -72.91 133.16 82.24 Favored Pre-proline 0 CA--C 1.553 1.084 0 CA-C-N 114.481 -1.236 . . . . 74.13 108.832 177.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -59.87 128.52 27.03 Favored 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 122.527 2.152 . . . . 60.34 111.701 177.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.09 92.78 0.09 OUTLIER 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 122.5 2.134 . . . . 74.15 110.519 172.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 126.29 60.59 0.15 Allowed Glycine 0 C--N 1.339 0.698 0 CA-C-O 121.721 0.623 . . . . 75.51 111.709 -168.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.603 ' O ' ' HB1' ' A' ' 130' ' ' ALA . 7.5 p -137.46 138.02 45.26 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.754 0 N-CA-C 107.068 -1.456 . . . . 75.43 107.068 169.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.622 HH21 HD12 ' A' ' 215' ' ' LEU . 57.6 mtt180 -151.13 175.12 12.44 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.627 0.771 . . . . 73.23 109.102 173.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.561 ' HB3' ' H ' ' A' ' 188' ' ' LEU . 17.3 tp10 -34.7 128.16 0.47 Allowed 'General case' 0 N--CA 1.502 2.162 0 C-N-CA 126.442 1.897 . . . . 72.32 114.852 -166.608 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.72 -9.98 66.51 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 114.823 0.689 . . . . 14.21 114.823 175.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 15.3 t -73.18 153.56 40.65 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 117.329 0.564 . . . . 74.23 109.562 174.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 85.6 t -119.94 108.16 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.749 0.82 . . . . 72.34 109.846 -175.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.568 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 59.5 mt -86.7 113.85 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 N-CA-C 108.718 -0.845 . . . . 75.24 108.718 174.139 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -76.27 107.08 8.27 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 108.691 -0.855 . . . . 61.32 108.691 171.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 15.0 p -117.14 114.9 38.62 Favored Pre-proline 0 CA--C 1.554 1.106 0 N-CA-C 109.281 -0.637 . . . . 61.33 109.281 174.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.462 ' HG2' ' HB3' ' A' ' 86' ' ' SER . 50.4 Cg_endo -69.22 140.83 45.72 Favored 'Trans proline' 0 C--N 1.369 1.633 0 C-N-CA 122.368 2.045 . . . . 74.53 112.62 178.188 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.533 ' N ' ' HB3' ' A' ' 171' ' ' PRO . . . 116.2 -26.52 8.66 Favored Glycine 0 N--CA 1.477 1.409 0 C-N-CA 123.519 0.58 . . . . 70.43 113.355 166.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.538 ' HB2' HD22 ' A' ' 174' ' ' LEU . 1.0 OUTLIER -102.37 -33.25 9.63 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.213 0.605 . . . . 64.15 110.245 -174.798 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.471 ' N ' ' HB2' ' A' ' 174' ' ' LEU . . . -89.86 151.97 22.06 Favored Glycine 0 CA--C 1.493 -1.343 0 N-CA-C 108.801 -1.72 . . . . 73.33 108.801 170.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.701 ' HA3' ' HA3' ' A' ' 172' ' ' GLY . . . 53.13 79.16 0.09 OUTLIER Glycine 0 CA--C 1.48 -2.129 0 CA-C-O 118.67 -1.072 . . . . 74.5 112.335 -161.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.497 HE22 HD13 ' B' ' 10' ' ' LEU . 13.0 mm-40 -55.59 104.09 0.12 Allowed 'General case' 0 C--N 1.353 0.725 0 O-C-N 128.275 2.986 . . . . 75.42 109.27 -177.4 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -174.46 -135.95 2.15 Favored Glycine 0 N--CA 1.435 -1.414 0 N-CA-C 109.32 -1.512 . . . . 64.21 109.32 -172.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ASN . . . . . 0.547 ' ND2' ' HB3' ' A' ' 106' ' ' PHE . 0.5 OUTLIER -134.31 -57.01 0.02 OUTLIER Pre-proline 0 CA--C 1.552 1.039 0 CA-C-O 118.518 -0.753 . . . . 63.11 109.204 176.344 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.462 ' O ' ' HA ' ' A' ' 115' ' ' LYS . 17.2 Cg_exo -67.98 124.1 11.43 Favored 'Trans proline' 0 C--N 1.39 2.751 0 N-CA-C 106.461 -2.169 . . . . 71.13 106.461 160.161 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.533 ' HB3' ' N ' ' A' ' 163' ' ' GLY . 57.2 Cg_endo -67.46 143.08 61.85 Favored 'Trans proline' 0 C--O 1.244 0.777 0 C-N-CA 122.067 1.845 . . . . 71.25 114.612 -164.412 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.701 ' HA3' ' HA3' ' A' ' 166' ' ' GLY . . . -74.68 -29.54 61.24 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 119.597 -1.287 . . . . 72.4 110.872 158.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 92.58 138.79 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 127.975 2.51 . . . . 71.14 109.635 -177.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.557 HD11 ' HB2' ' A' ' 121' ' ' ALA . 26.4 tp -109.05 141.02 41.8 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 122.678 0.391 . . . . 64.32 110.343 -173.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.447 ' HB2' ' HD2' ' A' ' 120' ' ' ARG . 65.8 mt -107.98 83.2 1.75 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.332 1.053 . . . . 72.12 108.686 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.568 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 92.1 mt -66.62 101.33 0.77 Allowed 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.174 -0.921 . . . . 70.05 110.283 179.007 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 64.0 t -84.29 102.81 10.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 N-CA-C 107.677 -1.231 . . . . 61.43 107.677 173.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 7.3 p -66.88 128.43 30.05 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 CA-C-N 115.358 -0.837 . . . . 70.33 110.592 -177.507 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.489 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 33.3 mmt180 -124.09 91.82 3.54 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.255 1.422 . . . . 53.32 107.272 -174.234 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.569 HD13 HD13 ' A' ' 127' ' ' LEU . 27.9 mt -70.17 147.52 49.77 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.597 -0.729 . . . . 72.4 112.181 -171.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 61.9 mt -58.95 149.14 67.33 Favored Pre-proline 0 N--CA 1.479 1.024 0 C-N-CA 124.362 1.065 . . . . 73.14 110.814 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -58.86 79.42 0.05 OUTLIER 'Trans proline' 0 C--N 1.383 2.381 0 C-N-CA 123.413 2.742 . . . . 71.42 112.703 176.002 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 66.5 t-80 -129.39 103.5 18.01 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 105.917 -1.882 . . . . 73.35 105.917 -175.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -73.58 25.39 0.32 Allowed 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 123.638 2.892 . . . . 61.24 116.227 -163.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 71.5 t -97.57 -61.21 2.32 Favored 'Isoleucine or valine' 0 C--N 1.351 0.669 0 CA-C-N 118.425 0.557 . . . . 64.21 110.465 -177.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 15.5 m-30 -124.34 147.92 47.85 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-O 121.829 0.823 . . . . 72.31 112.714 -171.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -144.8 150.28 36.89 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.328 1.851 . . . . 75.51 106.665 172.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.632 HD12 ' HA ' ' A' ' 193' ' ' LEU . 6.3 tp -121.17 173.43 7.31 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 107.177 -1.416 . . . . 74.21 107.177 178.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -159.56 128.98 5.34 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 109.076 -0.713 . . . . 70.31 109.076 165.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 68.6 -74.55 0.31 Allowed Glycine 0 C--N 1.347 1.169 0 N-CA-C 110.979 -0.848 . . . . 65.41 110.979 -170.124 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -164.17 -0.68 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 123.758 0.823 . . . . 72.32 111.547 172.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -95.89 146.49 24.54 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.914 -0.491 . . . . 72.32 109.685 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.632 ' HA ' HD12 ' A' ' 188' ' ' LEU . 0.8 OUTLIER -89.69 157.2 18.1 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.473 1.109 . . . . 63.44 111.486 -165.765 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -142.96 154.9 44.51 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.648 1.579 . . . . 73.14 107.631 175.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.439 ' HB3' HD23 ' A' ' 251' ' ' LEU . . . -158.84 127.16 5.21 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.902 0.881 . . . . 74.34 109.122 -176.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 31.1 m -75.66 127.23 32.62 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 118.163 0.438 . . . . 70.21 110.128 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 38.5 tp -130.7 104.32 7.12 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.522 0.729 . . . . 72.21 110.032 -175.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -89.85 124.59 34.82 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 109.261 -0.644 . . . . 61.43 109.261 171.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 8.9 p -138.06 137.62 21.53 Favored Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 123.874 0.869 . . . . 64.4 109.16 -174.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.85 155.16 53.69 Favored 'Trans proline' 0 C--N 1.378 2.086 0 C-N-CA 121.765 1.643 . . . . 64.51 111.327 174.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -52.2 -49.66 83.5 Favored Pre-proline 0 CA--C 1.552 1.043 0 N-CA-C 114.633 1.346 . . . . 71.34 114.633 -172.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.443 ' HG2' ' HE1' ' C' ' 276' ' ' TYR . 54.3 Cg_exo -58.75 -41.28 64.83 Favored 'Trans proline' 0 C--N 1.386 2.541 0 C-N-CA 121.912 1.741 . . . . 63.54 113.997 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.485 HD11 ' HB3' ' C' ' 276' ' ' TYR . 44.0 mt -68.29 -35.57 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 109.907 -0.405 . . . . 64.32 109.907 178.203 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.16 -45.82 79.59 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.46 0.704 . . . . 71.51 111.751 176.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 53.0 t -68.26 -48.75 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 124.194 0.998 . . . . 63.23 111.522 -176.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 54.7 t -83.13 -37.59 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.042 0.937 . . . . 74.41 111.613 -172.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 92.22 70.61 1.17 Allowed Glycine 0 C--O 1.24 0.48 0 CA-C-N 115.765 -0.652 . . . . 72.35 111.493 -174.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -92.18 -154.23 30.7 Favored Glycine 0 C--N 1.34 0.793 0 CA-C-N 115.055 -0.572 . . . . 55.24 113.312 -177.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 36.3 mtmt -130.02 132.84 46.39 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.327 -0.62 . . . . 45.21 109.327 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 29.0 m -132.52 160.37 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 N-CA-C 108.678 -0.86 . . . . 63.11 108.678 172.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -97.68 115.36 27.8 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.358 -0.979 . . . . 71.41 108.358 177.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.89 165.65 11.24 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.936 0.894 . . . . 62.04 110.326 -174.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' MET . . . . . 0.456 ' SD ' ' N ' ' A' ' 213' ' ' MET . 0.0 OUTLIER -98.98 137.04 38.08 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.241 -0.89 . . . . 71.23 109.211 -174.941 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 67.6 p -124.53 177.51 5.89 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 107.934 -1.135 . . . . 74.1 107.934 163.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.622 HD12 HH21 ' A' ' 154' ' ' ARG . 33.0 mt -78.26 -23.14 47.42 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.81 -0.632 . . . . 63.31 110.395 -177.484 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -83.62 -12.84 55.49 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.148 0.979 . . . . 64.44 111.175 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 138.28 -164.62 25.6 Favored Glycine 0 C--N 1.346 1.137 0 N-CA-C 111.564 -0.614 . . . . 33.0 111.564 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' PRO . . . . . 0.487 ' HB3' HG21 ' B' ' 384' ' ' THR . 65.0 Cg_endo -79.09 134.8 11.87 Favored 'Trans proline' 0 C--N 1.363 1.303 0 C-N-CA 122.262 1.974 . . . . 70.23 111.693 175.306 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 34.8 m -130.89 168.14 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 107.681 -1.229 . . . . 73.4 107.681 171.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -106.54 152.84 23.17 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 121.856 -0.528 . . . . 75.04 111.894 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 10.2 p -142.63 141.65 27.41 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 CA-C-N 114.868 -1.06 . . . . 74.13 109.319 -173.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.476 ' HB3' ' HA ' ' B' ' 440' ' ' ARG . . . -106.83 104.77 14.53 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 109.608 -0.515 . . . . 60.25 109.608 -179.207 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.563 ' HA ' HD12 ' B' ' 441' ' ' ILE . 66.7 t -58.53 142.78 82.27 Favored Pre-proline 0 CA--C 1.569 1.68 0 C-N-CA 125.262 1.425 . . . . 63.14 110.472 -179.441 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -84.31 167.36 12.13 Favored 'Trans proline' 0 C--N 1.386 2.515 0 C-N-CA 122.863 2.375 . . . . 75.51 111.195 175.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.12 145.91 28.26 Favored 'Trans proline' 0 C--N 1.367 1.546 0 C-N-CA 121.495 1.463 . . . . 72.53 112.681 174.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 71.9 mtt85 65.76 34.18 7.66 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 125.341 1.456 . . . . 74.04 111.642 175.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.503 HG22 HG11 ' A' ' 253' ' ' VAL . 89.3 m -63.15 108.67 1.31 Allowed 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 113.657 -1.611 . . . . 64.32 110.705 174.109 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -98.71 150.89 21.34 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.597 0.759 . . . . 75.32 110.824 -169.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -63.86 128.04 34.05 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.896 0.879 . . . . 62.31 110.742 177.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 97.0 -26.18 23.71 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-N 116.377 -0.374 . . . . 73.32 112.53 -178.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 55.8 mtt180 -74.36 135.3 42.47 Favored 'General case' 0 C--N 1.36 1.057 0 CA-C-O 121.623 0.725 . . . . 74.0 111.094 -178.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.634 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 33.6 mttm -102.71 112.37 25.12 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 114.219 -1.355 . . . . 72.22 109.03 -178.496 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.548 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 45.6 mt -75.33 99.5 4.12 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.031 0.932 . . . . 71.4 109.755 -172.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 58.9 ttt180 -73.64 123.89 24.91 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.59 1.156 . . . . 64.14 110.958 -173.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.494 HD21 HG23 ' B' ' 441' ' ' ILE . 67.3 mt -116.64 109.41 17.16 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.964 0.905 . . . . 61.12 109.889 -179.637 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -62.5 125.31 23.5 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 123.668 0.787 . . . . 64.43 112.767 -173.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 73.08 30.65 62.79 Favored Glycine 0 C--N 1.352 1.43 0 O-C-N 124.036 0.835 . . . . 74.2 113.881 174.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -115.77 -12.38 11.49 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.333 0.653 . . . . 73.01 111.65 -178.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -87.17 -168.77 45.14 Favored Glycine 0 C--N 1.348 1.205 0 O-C-N 123.311 0.382 . . . . 74.43 112.323 171.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 240' ' ' PHE . . . . . 0.494 ' HE2' ' HG3' ' A' ' 154' ' ' ARG . 13.2 m-30 -95.0 154.29 39.69 Favored Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 123.039 0.536 . . . . 73.13 111.903 -169.257 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.521 ' HA ' ' HA ' ' A' ' 246' ' ' ARG . 59.5 Cg_endo -70.16 120.54 7.25 Favored 'Trans proline' 0 C--N 1.386 2.544 0 C-N-CA 123.339 2.692 . . . . 73.33 113.62 -176.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -157.05 -138.78 2.58 Favored Glycine 0 C--N 1.35 1.327 0 CA-C-O 119.208 -0.773 . . . . 73.52 112.645 -178.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -70.57 -16.31 34.12 Favored 'Trans proline' 0 C--N 1.385 2.493 0 C-N-CA 123.24 2.627 . . . . 70.45 113.549 -173.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -100.18 20.43 14.62 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.737 0.815 . . . . 70.11 110.643 177.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 79.09 -80.19 1.53 Allowed Glycine 0 C--N 1.351 1.398 0 N-CA-C 109.503 -1.439 . . . . 62.24 109.503 -171.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.521 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 44.8 mtm180 -125.6 159.36 32.33 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.476 1.11 . . . . 75.41 108.514 164.374 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -87.64 -176.81 48.3 Favored Glycine 0 C--N 1.339 0.696 0 CA-C-N 116.14 -0.482 . . . . 42.24 112.285 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -123.2 151.6 42.07 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.027 0.931 . . . . 75.44 109.648 178.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.491 HD23 HD12 ' A' ' 235' ' ' LEU . 53.8 tp -96.84 111.31 23.55 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 109.434 -0.58 . . . . 70.31 109.434 -178.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.634 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 18.7 m-85 -96.82 105.91 18.12 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.323 1.049 . . . . 52.51 109.539 -179.197 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.548 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 12.1 mt -81.63 97.4 7.86 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.949 0.5 . . . . 72.24 109.739 176.021 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -77.47 105.74 8.79 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.988 0.915 . . . . 75.41 108.726 -174.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.503 HG11 HG22 ' A' ' 227' ' ' THR . 55.0 t -88.79 144.35 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 N-CA-C 114.192 1.182 . . . . 24.43 114.192 -165.148 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -128.65 111.47 13.23 Favored 'General case' 0 C--N 1.351 0.666 0 C-N-CA 125.838 1.655 . . . . 73.14 108.01 168.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 58.2 mt -76.8 138.6 20.28 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 122.955 0.502 . . . . 74.34 109.769 178.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 48.2 p -122.87 173.48 7.75 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.588 1.155 . . . . 73.43 109.307 176.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 257' ' ' ILE . . . . . 0.455 HG13 ' H ' ' A' ' 259' ' ' GLU . 27.3 pt -117.82 162.18 30.42 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 123.301 0.64 . . . . 73.4 109.68 175.287 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 258' ' ' PRO . . . . . 0.411 ' HA ' ' HB3' ' B' ' 376' ' ' GLU . 47.9 Cg_endo -66.65 5.98 0.65 Allowed 'Trans proline' 0 N--CA 1.502 1.979 0 C-N-CA 123.263 2.642 . . . . 74.45 115.609 176.316 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.477 ' HG3' ' NE2' ' C' ' 228' ' ' GLN . 2.4 mp0 48.52 -97.68 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.692 0.797 . . . . 63.24 109.659 -161.47 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 260' ' ' ARG . . . . . 0.653 ' HG2' ' HB3' ' B' ' 373' ' ' ARG . 0.0 OUTLIER -87.7 160.95 17.9 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.062 0.945 . . . . 75.12 111.003 -172.598 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 79.7 mt -138.51 157.38 46.29 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.673 0.789 . . . . 55.32 110.446 -175.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 78.4 p -102.67 151.19 38.24 Favored Pre-proline 0 CA--C 1.554 1.133 0 N-CA-C 108.394 -0.965 . . . . 44.34 108.394 169.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -25.79 -46.29 0.06 OUTLIER 'Trans proline' 0 C--N 1.394 2.958 1 C-N-CA 126.58 4.854 . . . . 74.33 117.932 -170.581 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -66.64 -62.73 1.3 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 122.935 0.494 . . . . 71.44 111.445 -176.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -66.12 -25.81 67.16 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 122.509 0.324 . . . . 64.2 110.5 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 266' ' ' GLU . . . . . 0.404 ' O ' ' HD3' ' A' ' 270' ' ' LYS . 7.8 tp10 -56.75 -52.12 66.22 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 124.179 0.924 . . . . 73.45 109.455 173.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -62.39 -42.42 99.41 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.698 -1.137 . . . . 64.12 111.653 176.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 10.4 mp -58.04 -55.46 34.63 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 122.971 0.508 . . . . 73.14 111.955 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 66.4 m95 -60.12 -39.79 87.46 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.487 0.715 . . . . 75.0 111.647 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 270' ' ' LYS . . . . . 0.569 ' HE2' HG23 ' C' ' 206' ' ' VAL . 1.1 mptm? -64.34 -44.03 92.78 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 123.62 0.575 . . . . 62.43 111.585 177.293 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -63.72 -43.02 97.78 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 122.993 0.517 . . . . 70.22 110.608 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 272' ' ' LEU . . . . . 0.492 ' O ' ' HB2' ' A' ' 276' ' ' TYR . 75.6 mt -56.53 -46.01 80.83 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 124.422 1.076 . . . . 63.4 110.57 174.188 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 273' ' ' ALA . . . . . 0.583 ' HB1' HE22 ' B' ' 250' ' ' GLN . . . -74.69 -37.99 62.49 Favored 'General case' 0 C--O 1.244 0.797 0 O-C-N 124.468 1.105 . . . . 64.51 113.63 -171.168 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -77.3 -39.11 49.1 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.072 0.549 . . . . 74.35 109.566 -179.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 275' ' ' ALA . . . . . 0.445 ' HB1' ' NH2' ' A' ' 279' ' ' ARG . . . -74.19 -20.49 60.18 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.162 0.585 . . . . 71.44 111.034 174.086 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 276' ' ' TYR . . . . . 0.492 ' HB2' ' O ' ' A' ' 272' ' ' LEU . 14.7 t80 -65.16 -63.63 1.06 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.079 0.951 . . . . 75.02 108.762 172.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -64.94 -38.64 91.64 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 114.987 -1.006 . . . . 70.12 110.406 -173.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 278' ' ' ALA . . . . . 0.495 ' HA ' HD23 ' B' ' 278' ' ' LEU . . . -62.85 -26.15 68.62 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.236 0.614 . . . . 75.41 112.093 176.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 279' ' ' ARG . . . . . 0.445 ' NH2' ' HB1' ' A' ' 275' ' ' ALA . 27.5 mtm180 -117.4 31.2 6.86 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.477 0.711 . . . . 74.13 109.938 179.424 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.393 0 N-CA-C 109.087 -0.708 . . . . 72.21 109.087 171.984 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.481 1.081 0 N-CA-C 109.872 -0.418 . . . . 71.44 109.872 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 57.6 tttp 70.97 135.11 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.931 1.292 . . . . 54.1 113.594 176.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 63.08 30.14 16.21 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 125.62 1.568 . . . . 74.04 112.168 171.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 11.9 m -66.63 -34.96 79.04 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.769 0.428 . . . . 52.14 110.448 175.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 1.8 m 69.14 152.03 0.09 Allowed 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 125.593 1.557 . . . . 70.11 112.167 177.092 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.649 HG21 ' HA ' ' A' ' 125' ' ' LEU . 31.4 pt -136.83 171.2 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 N-CA-C 113.044 0.757 . . . . 64.44 113.044 -158.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -146.05 123.58 11.75 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.169 0.988 . . . . 72.01 110.187 -178.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.538 HD11 ' HB1' ' A' ' 121' ' ' ALA . 36.3 tp -77.75 145.37 36.53 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.119 0.968 . . . . 75.22 110.908 -173.445 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 9' ' ' ALA . . . . . 0.544 ' HB3' ' HB2' ' A' ' 122' ' ' GLU . . . -88.79 -50.39 6.26 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.052 0.541 . . . . 62.4 111.828 178.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 10' ' ' LEU . . . . . 0.497 HD13 HE22 ' A' ' 167' ' ' GLN . 86.9 mt 68.0 122.57 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 124.872 1.269 . . . . 74.1 111.283 -166.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.423 HD22 ' HD2' ' B' ' 15' ' ' PHE . 68.2 mt -111.11 100.84 48.42 Favored Pre-proline 0 N--CA 1.481 1.078 0 N-CA-C 108.046 -1.094 . . . . 45.35 108.046 171.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.455 ' HA ' HD11 ' A' ' 119' ' ' LEU . 13.6 Cg_endo -51.95 -65.77 0.13 Allowed 'Trans proline' 0 C--N 1.384 2.429 0 C-N-CA 123.462 2.775 . . . . 61.33 112.65 -174.47 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 13' ' ' LEU . . . . . 0.548 ' HB3' HH22 ' A' ' 117' ' ' ARG . 2.5 pt? -170.07 147.76 3.28 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.201 1.001 . . . . 75.01 108.87 175.455 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 94.8 mt 70.7 -23.84 0.17 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 125.146 1.378 . . . . 64.54 114.45 174.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 15' ' ' PHE . . . . . 0.423 ' HD2' HD22 ' B' ' 11' ' ' LEU . 69.6 t80 -76.43 96.78 4.12 Favored 'General case' 0 C--N 1.349 0.583 0 CA-C-O 121.447 0.641 . . . . 60.01 109.38 -178.405 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 16' ' ' THR . . . . . 0.402 HG22 HG23 ' B' ' 18' ' ' VAL . 41.4 m -139.57 126.69 12.74 Favored Pre-proline 0 CA--C 1.546 0.811 0 N-CA-C 107.487 -1.301 . . . . 51.11 107.487 178.051 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -66.92 73.85 0.45 Allowed 'Trans proline' 0 C--N 1.379 2.15 0 C-N-CA 123.086 2.524 . . . . 62.42 113.741 -177.092 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.402 HG23 HG22 ' B' ' 16' ' ' THR . 57.5 t -135.47 90.19 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.092 0.957 . . . . 61.41 109.173 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 4.4 m 64.24 10.14 5.34 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 124.335 1.054 . . . . 71.22 113.199 165.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -159.01 -72.24 0.08 Allowed 'General case' 0 N--CA 1.479 1.006 0 O-C-N 121.333 -0.854 . . . . 62.34 111.624 -175.041 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.98 77.44 5.45 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.354 0.661 . . . . 75.34 111.213 -170.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? 54.43 91.35 0.03 OUTLIER 'General case' 0 C--N 1.356 0.869 0 C-N-CA 125.377 1.471 . . . . 73.31 110.972 -177.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 23' ' ' THR . . . . . . . . . . . . . 23.4 m -101.63 107.59 52.16 Favored Pre-proline 0 CA--C 1.554 1.11 0 N-CA-C 108.906 -0.776 . . . . 72.45 108.906 178.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.02 -21.57 68.29 Favored 'Trans proline' 0 C--N 1.381 2.242 0 C-N-CA 123.441 2.761 . . . . 74.55 112.955 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -93.55 97.97 10.86 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 108.369 -0.974 . . . . 74.53 108.369 178.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 26' ' ' MET . . . . . 0.509 ' H ' ' HD2' ' B' ' 27' ' ' PRO . 28.0 ttt -171.26 -38.77 0.0 OUTLIER Pre-proline 0 CA--C 1.567 1.61 0 C-N-CA 124.402 1.081 . . . . 75.13 111.716 -172.442 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 27' ' ' PRO . . . . . 0.509 ' HD2' ' H ' ' B' ' 26' ' ' MET . 30.1 Cg_endo -62.9 168.63 10.13 Favored 'Trans proline' 0 C--N 1.394 2.949 0 C-N-CA 122.167 1.912 . . . . 71.1 112.68 167.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 64.9 t 78.2 -28.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 C-N-CA 126.08 1.752 . . . . 73.51 111.132 -172.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 80.3 mt -68.65 175.88 3.27 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.306 1.042 . . . . 62.2 112.03 173.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 63.42 34.39 12.93 Favored 'General case' 0 C--N 1.357 0.903 0 C-N-CA 124.539 1.136 . . . . 70.24 110.258 -174.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 52.0 t-20 -64.36 93.59 0.1 Allowed 'General case' 0 C--N 1.365 1.281 0 N-CA-C 108.752 -0.833 . . . . 74.34 108.752 176.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 18.5 ttp180 -108.48 11.72 26.68 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 124.99 1.316 . . . . 72.22 109.609 -172.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.56 -51.92 4.89 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.344 1.058 . . . . 73.31 108.923 172.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -119.06 107.88 14.04 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 124.275 1.03 . . . . 53.33 108.69 178.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -166.37 71.21 0.13 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.138 0.975 . . . . 73.13 108.517 -178.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 36' ' ' GLY . . . . . 0.427 ' HA2' ' HA2' ' C' ' 247' ' ' GLY . . . 55.93 -107.78 0.92 Allowed Glycine 0 C--N 1.342 0.866 0 CA-C-N 114.635 -1.166 . . . . 74.33 114.472 178.302 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -65.57 -26.02 67.67 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 114.16 1.17 . . . . 61.44 114.16 -172.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 13.3 tt -74.33 -20.21 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-N 117.816 0.28 . . . . 75.44 111.544 -176.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 10.3 t -107.52 -32.38 7.73 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.021 0.528 . . . . 64.25 110.766 176.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -166.51 103.86 0.67 Allowed Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 123.954 0.902 . . . . 64.0 109.38 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -68.9 72.54 1.04 Allowed 'Trans proline' 0 C--N 1.383 2.386 0 C-N-CA 123.25 2.633 . . . . 72.44 112.563 176.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 60.26 -89.72 0.04 OUTLIER Glycine 0 C--N 1.351 1.413 0 CA-C-N 115.863 -0.608 . . . . 45.24 112.4 -175.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -168.77 18.12 0.07 OUTLIER Glycine 0 CA--C 1.528 0.86 0 CA-C-O 119.599 -0.556 . . . . 42.15 112.291 174.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . 62.61 -75.68 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.654 1.182 . . . . 63.2 109.873 -170.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -65.81 138.75 58.12 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.564 0.746 . . . . 74.21 109.546 166.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -79.01 -27.61 43.27 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 108.22 -1.03 . . . . 75.02 108.22 171.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 44.0 tp 78.56 -36.63 0.2 Allowed 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 126.278 1.831 . . . . 53.22 112.894 171.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 11.8 m 75.13 -3.98 2.48 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 124.918 1.287 . . . . 51.22 111.36 -177.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.62 19.57 61.6 Favored Glycine 0 C--N 1.348 1.215 0 N-CA-C 111.359 -0.696 . . . . 74.15 111.359 -169.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -80.8 151.02 28.96 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 123.569 0.748 . . . . 64.2 110.597 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -134.95 -0.92 2.73 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.388 1.075 . . . . 75.3 110.579 -178.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 4.1 m 60.25 41.05 17.15 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 124.364 1.066 . . . . 73.31 110.621 -177.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.17 95.87 0.6 Allowed 'General case' 0 C--N 1.354 0.799 0 CA-C-N 115.223 -0.899 . . . . 73.24 109.355 177.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.687 ' HB1' HH11 ' B' ' 56' ' ' ARG . . . 65.23 10.1 6.16 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.758 1.223 . . . . 75.51 112.299 -175.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 24.0 tp 58.01 23.56 10.11 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 124.972 1.309 . . . . 72.35 110.893 -172.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 56' ' ' ARG . . . . . 0.687 HH11 ' HB1' ' B' ' 54' ' ' ALA . 79.1 mtt85 -120.59 -167.93 1.55 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.519 1.128 . . . . 73.2 110.043 -175.38 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -82.47 15.73 2.4 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 123.354 0.662 . . . . 75.31 111.601 177.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 31.1 t -64.83 -22.66 67.03 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.478 1.111 . . . . 62.01 112.395 -178.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -66.26 -27.94 68.33 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.988 0.515 . . . . 72.44 110.772 174.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 33.0 t -94.85 95.29 8.58 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.315 1.046 . . . . 63.51 109.168 178.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -66.94 145.14 55.75 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.178 0.591 . . . . 71.45 110.415 176.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 62' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm 62.77 82.01 0.22 Allowed Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 125.056 1.342 . . . . 72.3 111.721 -176.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -68.11 -13.18 37.38 Favored 'Trans proline' 0 C--N 1.382 2.295 0 C-N-CA 123.211 2.607 . . . . 72.24 112.578 170.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 64' ' ' ALA . . . . . 0.517 ' HB1' ' HB1' ' B' ' 262' ' ' ALA . . . 68.25 -78.53 0.04 OUTLIER 'General case' 0 C--N 1.361 1.098 0 C-N-CA 125.577 1.551 . . . . 72.04 111.085 -177.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -107.78 -11.61 15.36 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.255 0.622 . . . . 65.32 111.126 178.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 41.1 t30 70.5 145.93 0.06 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.697 1.199 . . . . 72.41 112.684 177.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 13.7 tt 41.0 60.34 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 C-N-CA 126.65 1.98 . . . . 72.03 112.606 176.234 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 31.6 pt -77.34 77.09 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 CA-C-N 114.607 -1.179 . . . . 73.4 110.783 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.31 99.24 0.9 Allowed 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 114.428 -1.26 . . . . 73.12 109.51 179.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 8.6 mp 68.16 -75.93 0.06 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.84 1.256 . . . . 44.44 110.004 -177.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 71' ' ' ILE . . . . . 0.445 HG12 ' H ' ' B' ' 73' ' ' ASP . 17.7 tt -135.52 123.28 37.03 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 C-N-CA 123.698 0.799 . . . . 74.32 109.256 174.173 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -106.79 26.36 19.76 Favored Glycine 0 N--CA 1.476 1.342 0 N-CA-C 111.296 -0.722 . . . . 62.21 111.296 177.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 73' ' ' ASP . . . . . 0.445 ' H ' HG12 ' B' ' 71' ' ' ILE . 2.7 m-20 -111.5 -40.29 4.4 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.61 1.164 . . . . 63.44 109.805 -172.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 172.45 118.07 0.47 Allowed Glycine 0 C--N 1.337 0.604 0 N-CA-C 109.478 -1.449 . . . . 64.42 109.478 -178.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 75' ' ' MET . . . . . 0.48 ' N ' ' SD ' ' B' ' 75' ' ' MET . 0.7 OUTLIER -74.95 88.04 2.34 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 122.001 0.905 . . . . 74.01 109.29 -174.362 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 161.74 61.04 0.02 OUTLIER Glycine 0 C--N 1.333 0.371 0 N-CA-C 108.3 -1.92 . . . . 71.13 108.3 -173.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -53.07 -49.68 65.89 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 125.064 1.346 . . . . 73.03 111.052 -173.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 95.9 p 60.41 -65.45 0.05 Allowed 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 126.93 2.092 . . . . 51.1 111.745 -178.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 79' ' ' GLU . . . . . 0.587 ' HG3' HG12 ' B' ' 80' ' ' ILE . 10.3 tp10 74.14 -81.6 0.03 OUTLIER 'General case' 0 C--N 1.352 0.702 0 C-N-CA 125.353 1.461 . . . . 74.44 110.37 171.532 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.587 HG12 ' HG3' ' B' ' 79' ' ' GLU . 11.2 pt -144.77 -165.62 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 125.174 1.39 . . . . 72.52 107.896 -178.122 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 23.1 m -69.79 155.81 39.97 Favored 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 108.343 -0.984 . . . . 71.34 108.343 168.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -49.05 95.31 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.751 1.221 . . . . 61.11 112.269 -171.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -161.08 -57.39 0.05 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.469 1.108 . . . . 71.35 108.879 -176.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -102.65 96.15 6.69 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 109.029 -0.73 . . . . 73.0 109.029 174.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -131.58 -68.81 0.64 Allowed 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 107.612 -1.255 . . . . 72.23 107.612 175.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 60.6 t80 65.74 145.49 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 125.461 1.504 . . . . 63.12 112.286 175.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . 58.28 -135.88 0.96 Allowed 'General case' 0 N--CA 1.481 1.123 0 CA-C-O 118.433 -0.794 . . . . 52.24 109.515 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 69.13 -77.11 0.05 Allowed 'General case' 0 C--N 1.364 1.21 0 C-N-CA 124.704 1.202 . . . . 74.14 110.564 168.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 170.6 -32.58 0.15 Allowed Glycine 0 C--N 1.339 0.735 0 N-CA-C 110.564 -1.015 . . . . 54.33 110.564 179.015 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.7 -36.31 83.42 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.262 1.025 . . . . 62.33 112.311 178.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -163.49 88.68 0.1 Allowed Glycine 0 C--N 1.343 0.969 0 N-CA-C 111.256 -0.737 . . . . 70.11 111.256 -179.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.96 -42.83 99.87 Favored Glycine 0 C--N 1.356 1.683 0 N-CA-C 111.936 -0.465 . . . . 23.53 111.936 177.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 23.8 t80 63.26 82.69 0.18 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.219 1.408 . . . . 74.22 111.071 176.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -82.64 -4.42 57.71 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 114.544 -1.207 . . . . 71.21 111.176 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 95' ' ' LYS . . . . . 0.612 ' HB2' HG22 ' B' ' 97' ' ' ILE . 42.1 mttp 73.74 -19.49 0.34 Allowed 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 125.592 1.557 . . . . 74.14 114.064 167.53 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.3 8.78 85.73 Favored Glycine 0 C--N 1.349 1.265 0 CA-C-O 120.035 -0.314 . . . . 72.31 113.609 -176.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 97' ' ' ILE . . . . . 0.612 HG22 ' HB2' ' B' ' 95' ' ' LYS . 9.3 tt -89.48 75.06 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.166 0 CA-C-O 122.599 1.19 . . . . 72.22 109.559 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -157.29 140.18 15.16 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.008 -0.996 . . . . 75.21 109.104 -178.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . 72.03 -11.31 0.79 Allowed 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 125.906 1.683 . . . . 61.12 113.408 -177.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 76.2 mt -76.57 -41.22 2.82 Favored Pre-proline 0 CA--C 1.558 1.257 0 C-N-CA 124.392 1.077 . . . . 74.2 112.089 176.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -60.23 109.78 0.68 Allowed 'Trans proline' 0 C--N 1.405 3.523 0 C-N-CA 121.945 1.764 . . . . 72.21 111.751 172.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 55.1 tp -64.2 126.78 28.85 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.68 0.792 . . . . 73.12 110.217 -178.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 27.5 m -76.03 80.99 2.88 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-O 121.769 0.795 . . . . 75.52 109.684 178.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.86 151.48 30.53 Favored Glycine 0 C--N 1.343 0.965 0 CA-C-N 114.592 -1.186 . . . . 51.35 111.743 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 26.3 mp0 -74.72 -17.74 60.61 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.052 0.941 . . . . 75.22 110.829 178.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 59.9 t80 80.83 -43.87 0.21 Allowed 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 125.245 1.418 . . . . 74.44 112.6 170.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 58.8 p -74.9 95.26 2.93 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.91 0.884 . . . . 63.32 112.183 -173.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 71.49 116.31 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 125.284 1.434 . . . . 71.44 113.115 167.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -136.51 93.6 2.9 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.472 1.109 . . . . 53.33 108.139 174.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -133.56 118.02 17.78 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.435 0.694 . . . . 71.24 110.607 -172.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 3.9 pp -90.03 156.65 18.25 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.446 0.698 . . . . 64.15 109.98 173.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 112' ' ' ASN . . . . . 0.434 ' ND2' ' HB ' ' B' ' 115' ' ' THR . 27.0 t-20 68.62 -73.1 0.09 Allowed 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 124.961 1.304 . . . . 73.2 112.603 174.393 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 113' ' ' LYS . . . . . 0.69 ' HG2' ' HB2' ' C' ' 36' ' ' ASP . 15.7 tppt? 75.08 -69.31 0.18 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 126.232 1.813 . . . . 75.13 111.945 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.64 61.75 1.38 Allowed 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 121.765 0.793 . . . . 74.01 111.8 -173.327 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 115' ' ' THR . . . . . 0.434 ' HB ' ' ND2' ' B' ' 112' ' ' ASN . 69.7 m -137.47 120.84 17.0 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 108.723 -0.843 . . . . 73.23 108.723 174.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 116' ' ' GLY . . . . . 0.462 ' O ' ' HD3' ' B' ' 118' ' ' PRO . . . 63.12 -111.72 4.35 Favored Glycine 0 C--N 1.357 1.742 0 N-CA-C 110.019 -1.232 . . . . 55.33 110.019 -171.038 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . 0.272 4.2 tppp? 99.91 -81.18 0.0 OUTLIER Pre-proline 0 CA--C 1.574 1.877 0 C-N-CA 127.215 2.206 . . . . 70.25 115.102 164.447 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 118' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' B' ' 116' ' ' GLY . 10.8 Cg_endo -84.11 -74.32 0.01 OUTLIER 'Trans proline' 0 C--N 1.4 3.237 0 CA-C-N 122.4 1.893 . . . . 60.53 114.788 -160.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 119' ' ' ASP . . . . . . . . . . . . . 38.3 t70 65.24 -74.85 0.05 Allowed 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 125.071 1.348 . . . . 75.33 110.545 -167.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 120' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 57.3 75.97 0.34 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 124.458 1.103 . . . . 70.1 112.406 177.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 27.9 m -97.54 -20.43 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-N 115.301 -0.863 . . . . 74.32 110.452 170.103 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 35.6 m 56.29 85.71 0.07 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.657 1.183 . . . . 75.24 110.552 -172.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -73.53 177.33 5.4 Favored 'General case' 0 CA--C 1.56 1.333 0 CA-C-N 115.601 -0.727 . . . . 64.3 110.878 -174.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 39.2 p -17.35 -90.94 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 127.75 2.42 . . . . 43.31 115.58 -172.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . 177.48 -74.46 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 124.564 1.146 . . . . 73.02 110.007 176.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -171.01 -166.1 0.46 Allowed 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 114.393 -1.276 . . . . 74.13 109.379 -172.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 63.7 m -104.54 -69.08 0.82 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.64 1.176 . . . . 70.01 110.4 -179.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -131.9 88.48 2.56 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 124.991 1.316 . . . . 72.01 108.63 175.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 15.3 t -67.32 131.43 45.71 Favored 'General case' 0 CA--C 1.559 1.312 0 CA-C-N 116.015 -0.539 . . . . 54.34 110.511 -174.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . 78.44 128.0 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 126.213 1.805 . . . . 44.22 110.976 -169.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 16.9 t90 71.17 -62.23 0.46 Allowed 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 126.054 1.742 . . . . 73.51 111.586 -179.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 20.8 m 79.46 -63.04 0.27 Allowed 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 125.442 1.497 . . . . 51.4 113.099 167.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 26.1 m -69.32 92.83 0.6 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.197 0.999 . . . . 62.25 110.827 -175.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 118.65 -19.99 10.29 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 116.188 -0.46 . . . . 55.15 112.717 -178.012 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 135' ' ' VAL . . . . . . . . . . . . . 62.1 t 66.83 -78.52 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 125.509 1.524 . . . . 73.24 112.439 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm 55.87 48.43 18.07 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.741 1.216 . . . . 52.43 111.288 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 71.3 p 62.89 -4.06 0.28 Allowed 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 126.127 1.771 . . . . 75.31 115.145 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 31.0 p90 37.15 -65.24 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.638 0 C-N-CA 127.896 2.478 . . . . 75.52 116.917 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 14.9 m120 68.08 22.16 8.48 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 125.074 1.35 . . . . 73.24 112.105 176.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . 86.44 -55.87 4.72 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-O 119.57 -0.572 . . . . 65.04 113.657 173.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . 66.81 103.51 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.714 1.206 . . . . 75.34 110.51 -173.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -151.3 -169.65 3.44 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.809 0.844 . . . . 70.15 109.511 -175.012 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 162.48 -20.49 0.18 Allowed Glycine 0 C--N 1.353 1.496 0 CA-C-O 119.607 -0.551 . . . . 61.25 113.919 175.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 58.3 t 71.76 -65.84 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 125.589 1.556 . . . . 75.31 111.417 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -83.14 -29.51 28.59 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.082 0.953 . . . . 64.3 110.678 176.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 2.9 pp -125.52 -177.38 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 123.841 0.856 . . . . 72.52 110.027 175.045 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 43.2 p-80 -143.07 144.23 32.17 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.069 0.548 . . . . 72.43 110.247 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 61.98 -79.63 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 125.221 1.408 . . . . 73.05 112.878 171.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 149' ' ' LYS . . . . . . . . . . . . . 55.6 tttm 69.42 -83.84 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 125.704 1.602 . . . . 72.23 113.259 173.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -100.01 -48.23 4.73 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 113.208 0.818 . . . . 74.11 113.208 -166.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -79.95 -62.94 0.38 Allowed Pre-proline 0 CA--C 1.566 1.561 0 N-CA-C 114.012 1.116 . . . . 74.43 114.012 -168.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.8 91.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.394 2.954 0 C-N-CA 123.352 2.701 . . . . 42.51 115.235 -161.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 153' ' ' THR . . . . . 0.448 ' HB ' ' HA ' ' B' ' 159' ' ' LYS . 4.2 m 60.27 22.96 12.38 Favored 'General case' 0 CA--C 1.56 1.36 0 C-N-CA 125.465 1.506 . . . . 74.2 113.073 168.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 154' ' ' ILE . . . . . 0.409 HD13 ' HG3' ' B' ' 159' ' ' LYS . 35.8 mm -66.44 -40.26 86.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 123.486 0.714 . . . . 74.25 109.523 175.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 3.9 tt -86.97 68.09 9.98 Favored 'General case' 0 CA--C 1.555 1.159 0 N-CA-C 108.557 -0.905 . . . . 72.1 108.557 174.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -173.89 -106.67 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.303 0 C-N-CA 124.046 0.938 . . . . 72.23 109.606 171.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 157' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -176.04 -33.96 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.915 0.886 . . . . 53.54 110.664 -174.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 158' ' ' ALA . . . . . . . . . . . . . . . -88.91 34.41 0.78 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.454 0.702 . . . . 34.04 111.125 -176.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 159' ' ' LYS . . . . . 0.448 ' HA ' ' HB ' ' B' ' 153' ' ' THR . 11.4 tmtt? -60.03 -72.15 0.11 Allowed 'General case' 0 C--N 1.354 0.77 0 C-N-CA 124.444 1.098 . . . . 55.45 108.953 177.333 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 160' ' ' ALA . . . . . 0.427 ' HB3' ' HG2' ' C' ' 182' ' ' PRO . . . 173.49 86.37 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.505 1.522 . . . . 70.22 108.193 175.486 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -163.34 80.28 0.45 Allowed 'General case' 0 C--O 1.24 0.564 0 C-N-CA 124.01 0.924 . . . . 71.1 108.74 178.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . -80.29 -58.28 2.79 Favored Glycine 0 C--N 1.341 0.854 0 N-CA-C 110.194 -1.162 . . . . 73.4 110.194 171.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 49.4 tp 56.59 -85.16 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 125.302 1.441 . . . . 65.02 111.377 175.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 164' ' ' ALA . . . . . . . . . . . . . . . -68.18 -34.48 76.36 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.737 0.815 . . . . 75.34 111.171 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 14.9 t -99.59 38.82 1.38 Allowed 'General case' 0 CA--C 1.558 1.263 0 CA-C-O 121.845 0.831 . . . . 64.15 109.607 173.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . -73.25 89.34 0.6 Allowed Glycine 0 C--N 1.348 1.203 0 CA-C-N 115.466 -0.788 . . . . 71.15 112.375 177.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 167' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -64.34 118.86 9.3 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.567 0.747 . . . . 72.31 109.497 177.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 71.0 t 68.36 -73.82 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.156 0 C-N-CA 125.183 1.393 . . . . 74.13 111.311 -178.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 46.9 t 63.95 -81.37 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.264 1.426 . . . . 54.35 111.313 178.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 2.7 m 59.97 24.13 13.26 Favored 'General case' 0 CA--C 1.565 1.534 0 C-N-CA 124.697 1.199 . . . . 63.1 111.174 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 171' ' ' ALA . . . . . 0.451 ' HB2' ' HG2' ' C' ' 128' ' ' GLU . . . -134.81 -176.03 4.1 Favored 'General case' 0 C--O 1.244 0.779 0 C-N-CA 124.581 1.153 . . . . 53.32 108.925 179.257 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 172' ' ' GLU . . . . . 0.613 ' HB3' ' HG2' ' C' ' 213' ' ' MET . 13.1 tp10 -78.13 80.73 4.54 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 109.749 -0.463 . . . . 73.22 109.749 177.332 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 173' ' ' LEU . . . . . . . . . . . . . 80.1 mt 65.5 9.48 5.84 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 124.896 1.279 . . . . 74.23 112.907 176.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 174' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -92.35 99.74 12.45 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.278 0.631 . . . . 74.45 109.732 -175.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 175' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -85.4 153.99 22.15 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.717 0.807 . . . . 74.1 111.249 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -159.18 125.57 4.52 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.023 0.929 . . . . 74.11 109.651 178.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 35.8 p -121.05 93.28 48.84 Favored Pre-proline 0 CA--C 1.554 1.126 0 C-N-CA 123.696 0.798 . . . . 64.31 110.347 176.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 178' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -83.99 -177.33 3.02 Favored 'Trans proline' 0 C--N 1.377 2.064 0 C-N-CA 122.646 2.231 . . . . 74.53 111.551 170.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -67.32 -53.0 33.61 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 108.97 -0.752 . . . . 61.34 108.97 172.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . -162.14 -28.84 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 115.127 -0.942 . . . . 74.4 110.292 175.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 181' ' ' LEU . . . . . 0.573 HD22 ' HB2' ' C' ' 136' ' ' ARG . 29.3 tp -153.45 -68.7 0.15 Allowed 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 107.636 -1.246 . . . . 62.04 107.636 168.149 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 182' ' ' VAL . . . . . . . . . . . . . 62.6 t -76.43 131.81 34.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 108.123 -1.066 . . . . 71.31 108.123 168.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.1 -48.79 74.77 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 123.726 0.641 . . . . 65.24 110.695 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 179.9 -170.44 0.14 Allowed 'General case' 0 N--CA 1.485 1.301 0 O-C-N 124.2 0.938 . . . . 74.15 110.738 173.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 185' ' ' VAL . . . . . 0.507 HG23 ' HA ' ' C' ' 121' ' ' ALA . 1.8 p -142.24 116.67 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 106.557 -1.645 . . . . 71.33 106.557 160.171 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 25.6 p 56.54 -160.71 0.21 Allowed 'General case' 0 CA--C 1.567 1.622 0 C-N-CA 123.87 0.868 . . . . 51.31 112.342 172.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 187' ' ' SER . . . . . 0.599 ' HB3' ' HA ' ' B' ' 328' ' ' ALA . 16.8 p -74.15 87.24 1.91 Allowed 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 123.414 0.686 . . . . 62.14 111.662 -178.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 188' ' ' ARG . . . . . 0.431 ' HG2' ' O ' ' B' ' 185' ' ' VAL . 7.1 mmt180 -130.73 169.16 16.05 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.648 0.779 . . . . 71.52 109.95 175.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -95.85 162.65 13.5 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.97 0.908 . . . . 72.52 110.086 176.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 190' ' ' CYS . . . . . 0.459 ' SG ' ' NZ ' ' B' ' 337' ' ' LYS . 41.9 t -127.83 150.71 49.71 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.579 0.751 . . . . 70.33 110.402 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -133.84 162.75 31.15 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.66 0.784 . . . . 74.04 110.051 -174.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -68.88 163.53 50.28 Favored Glycine 0 CA--C 1.54 1.6 0 CA-C-O 119.169 -0.795 . . . . 64.22 113.339 177.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 193' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -64.23 135.54 47.31 Favored 'Trans proline' 0 C--N 1.372 1.802 0 C-N-CA 123.25 2.633 . . . . 64.32 112.961 -171.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 194' ' ' SER . . . . . . . . . . . . . 37.9 m -145.72 103.82 3.82 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 123.522 0.729 . . . . 24.51 109.8 -178.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 195' ' ' ALA . . . . . . . . . . . . . . . -158.23 171.17 20.68 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.501 1.12 . . . . 74.32 109.338 177.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 86.6 m -103.89 -65.57 1.01 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 122.967 0.507 . . . . 73.32 110.108 176.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 73.1 m -156.95 -47.2 0.07 Allowed 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.009 -1.108 . . . . 75.11 108.009 -177.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 198' ' ' GLU . . . . . 0.458 ' HG3' ' HB2' ' C' ' 146' ' ' SER . 1.9 mm-40 62.19 -76.91 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 126.184 1.794 . . . . 51.12 109.889 178.529 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 73.83 -29.67 0.2 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 115.179 1.548 . . . . 74.4 115.179 163.371 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 200' ' ' CYS . . . . . . . . . . . . . 86.3 m -62.04 104.09 0.44 Allowed Pre-proline 0 CA--C 1.557 1.242 0 C-N-CA 124.367 1.067 . . . . 73.31 112.986 -169.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 201' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -105.84 18.74 0.13 Allowed 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 123.736 2.958 . . . . 71.34 112.863 -178.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . -74.27 -8.99 80.64 Favored Glycine 0 C--N 1.354 1.536 0 CA-C-O 118.915 -0.936 . . . . 63.04 114.629 -170.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 58.9 t30 70.5 161.81 0.23 Allowed 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 124.643 1.177 . . . . 71.33 111.862 172.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -56.74 -54.01 51.16 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 123.302 0.641 . . . . 74.01 110.065 171.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 205' ' ' LEU . . . . . . . . . . . . . 3.2 tt 48.08 82.53 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 125.365 1.466 . . . . 51.03 111.249 171.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.94 -56.39 22.26 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 123.052 0.541 . . . . 62.32 110.764 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 207' ' ' LYS . . . . . 0.418 ' HD3' ' HA ' ' B' ' 207' ' ' LYS . 36.1 mmtm -156.01 -49.81 0.08 Allowed 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 125.136 1.374 . . . . 74.32 109.244 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . -90.76 -46.29 4.0 Favored Glycine 0 C--N 1.352 1.418 0 CA-C-N 116.365 -0.379 . . . . 71.52 113.311 -172.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 134.26 -47.38 1.0 Allowed Glycine 0 N--CA 1.469 0.862 0 N-CA-C 110.789 -0.924 . . . . 42.21 110.789 -176.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 66.6 tttm -140.48 109.63 6.15 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 108.109 -1.071 . . . . 74.51 108.109 175.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . -154.04 144.84 11.7 Favored Glycine 0 C--N 1.341 0.832 0 N-CA-C 110.811 -0.916 . . . . 74.43 110.811 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 47.9 t 62.2 87.9 0.1 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.577 1.151 . . . . 74.04 110.582 -177.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 10.8 tp -70.21 -33.38 54.34 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 CA-C-N 115.874 -0.603 . . . . 64.4 111.029 -176.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 26.6 m 60.83 -80.89 0.02 OUTLIER 'General case' 0 C--N 1.36 1.029 0 C-N-CA 125.705 1.602 . . . . 75.43 112.273 176.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 215' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -151.24 0.92 0.39 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.576 0.75 . . . . 73.31 111.355 -175.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -72.65 140.76 48.15 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.658 0.783 . . . . 61.42 109.876 177.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 217' ' ' LEU . . . . . 0.497 HD12 ' H ' ' B' ' 218' ' ' LEU 0.329 4.2 pp 54.29 -68.57 0.01 OUTLIER 'General case' 0 CA--C 1.569 1.711 0 C-N-CA 127.043 2.137 . . . . 75.4 114.24 -179.579 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 218' ' ' LEU . . . . . 0.497 ' H ' HD12 ' B' ' 217' ' ' LEU . 82.8 mt 57.59 -81.35 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 125.71 1.604 . . . . 71.43 112.265 -178.514 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 32.1 t-20 -160.21 153.56 22.11 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.342 -0.985 . . . . 71.24 108.342 178.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -144.48 174.65 10.76 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.923 0.889 . . . . 61.1 110.669 -176.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 221' ' ' ARG . . . . . 0.406 ' HD2' ' H ' ' B' ' 221' ' ' ARG . 2.4 mpt_? -58.09 -67.22 0.37 Allowed 'General case' 0 N--CA 1.476 0.848 0 O-C-N 124.23 0.956 . . . . 73.55 109.096 -178.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 222' ' ' ALA . . . . . 0.48 ' HB3' ' HE ' ' C' ' 187' ' ' ARG . . . 36.77 61.09 0.89 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 125.101 1.501 . . . . 42.52 112.013 176.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -85.09 -160.08 0.47 Allowed 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 114.277 -1.329 . . . . 61.02 112.52 -162.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 22.2 m -58.05 -34.98 50.51 Favored 'Isoleucine or valine' 0 C--N 1.361 1.096 0 C-N-CA 123.314 0.646 . . . . 74.2 111.697 -178.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 225' ' ' THR . . . . . 0.624 HG21 HG22 ' C' ' 185' ' ' VAL . 99.3 m 72.02 -59.06 0.57 Allowed 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 126.147 1.779 . . . . 54.34 113.236 179.05 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 1.4 tm? 70.49 85.02 0.14 Allowed 'General case' 0 C--N 1.355 0.811 0 C-N-CA 125.441 1.496 . . . . 74.43 107.736 -170.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . -161.06 25.54 0.26 Allowed Glycine 0 C--N 1.345 1.047 0 CA-C-N 115.882 -0.599 . . . . 51.31 112.558 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . -89.14 -106.6 1.1 Allowed Glycine 0 C--N 1.352 1.458 0 N-CA-C 111.479 -0.648 . . . . 72.41 111.479 175.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . 65.51 -125.74 29.26 Favored Glycine 0 C--N 1.353 1.527 0 CA-C-O 119.549 -0.584 . . . . 70.24 113.404 175.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -157.3 152.01 25.5 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.076 0.95 . . . . 70.23 109.597 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 231' ' ' LYS . . . . . 0.414 ' HA ' ' HB2' ' B' ' 282' ' ' ALA . 27.7 tptp -167.69 165.76 14.15 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.582 0.753 . . . . 73.24 109.655 -172.648 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 232' ' ' THR . . . . . 0.501 HG22 ' HA ' ' B' ' 280' ' ' LEU . 52.7 p -51.68 102.18 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.127 1.371 . . . . 74.24 112.783 -178.204 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 233' ' ' PHE . . . . . 0.78 ' HB2' HH22 ' C' ' 211' ' ' ARG . 33.3 t80 -160.17 -51.91 0.05 Allowed 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.313 0.645 . . . . 70.41 109.668 174.388 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . 79.33 -33.25 0.14 Allowed 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 125.433 1.493 . . . . 72.31 112.59 178.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 235' ' ' GLU . . . . . 0.553 ' HB2' ' HB3' ' C' ' 220' ' ' GLU . 4.1 tm-20 69.94 139.42 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 125.374 1.47 . . . . 54.41 111.778 176.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 236' ' ' THR . . . . . 0.448 ' HB ' ' O ' ' B' ' 348' ' ' ILE . 42.3 m -141.97 84.65 1.89 Allowed 'General case' 0 C--O 1.249 1.04 0 N-CA-C 107.483 -1.303 . . . . 73.34 107.483 171.225 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 237' ' ' ALA . . . . . 0.424 ' HB1' ' H ' ' B' ' 355' ' ' ALA . . . 61.96 66.61 0.81 Allowed 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 114.374 -1.284 . . . . 71.12 111.099 175.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 238' ' ' THR . . . . . 0.475 HG22 HG23 ' C' ' 219' ' ' VAL . 6.2 m -150.33 98.92 2.73 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.141 0.576 . . . . 71.31 109.946 -178.229 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -165.63 -98.84 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 123.337 0.655 . . . . 74.42 110.44 171.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . 173.32 -148.52 10.36 Favored Glycine 0 C--N 1.35 1.334 0 N-CA-C 111.615 -0.594 . . . . 71.23 111.615 -176.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -86.38 -167.96 2.06 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.516 0.726 . . . . 71.21 111.144 -176.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 242' ' ' TRP . . . . . 0.59 ' HZ3' ' HD3' ' C' ' 231' ' ' ARG . 0.0 OUTLIER 86.59 -26.82 0.08 Allowed 'General case' 0 N--CA 1.504 2.231 0 C-N-CA 127.191 2.197 . . . . 70.32 111.66 175.872 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 243' ' ' GLN . . . . . 0.409 ' H ' ' HG2' ' B' ' 243' ' ' GLN . 0.6 OUTLIER -102.24 120.69 40.89 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 124.054 0.942 . . . . 74.22 110.676 -168.461 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -60.35 -40.73 97.91 Favored Glycine 0 C--N 1.353 1.49 0 N-CA-C 110.458 -1.057 . . . . 63.11 110.458 165.092 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 245' ' ' LYS . . . . . 0.43 ' HE3' ' HB3' ' B' ' 357' ' ' PRO . 5.5 ttpp 63.2 13.74 7.16 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.148 1.379 . . . . 75.34 112.755 162.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 22.1 p -126.8 7.56 6.77 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.964 0.905 . . . . 71.02 110.849 -175.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 247' ' ' LEU . . . . . 0.754 HD13 ' HG2' ' C' ' 225' ' ' PRO . 5.5 tt -101.39 100.0 10.42 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 108.266 -1.012 . . . . 72.51 108.266 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 248' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 71.47 -75.41 0.08 Allowed 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 125.841 1.656 . . . . 75.15 112.642 172.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 63.33 33.35 14.05 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.183 0.993 . . . . 71.33 110.509 -173.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 250' ' ' GLN . . . . . 0.583 HE22 ' HB1' ' A' ' 273' ' ' ALA . 8.0 mm-40 69.95 156.02 0.14 Allowed 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 126.391 1.876 . . . . 65.4 113.082 178.403 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 251' ' ' ALA . . . . . . . . . . . . . . . -68.82 123.11 20.05 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.87 -0.789 . . . . 61.03 108.87 169.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -71.06 88.76 0.79 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.588 0.755 . . . . 72.3 109.616 -178.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -62.31 142.47 57.75 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.605 0.762 . . . . 51.41 110.509 179.039 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 30.0 ttt180 70.09 81.94 0.16 Allowed 'General case' 0 N--CA 1.48 1.051 0 O-C-N 124.805 1.315 . . . . 72.51 108.764 -172.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 255' ' ' GLY . . . . . 0.548 ' HA2' ' HA ' ' B' ' 259' ' ' VAL . . . -147.05 48.18 0.66 Allowed Glycine 0 C--N 1.349 1.258 0 CA-C-N 115.252 -0.886 . . . . 54.22 113.126 -172.17 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 256' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -69.82 102.28 1.91 Allowed 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 109.726 -0.472 . . . . 52.52 109.726 173.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 13.9 tm0? 64.57 -73.84 0.05 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.748 1.619 . . . . 74.31 109.957 177.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 258' ' ' LEU . . . . . . . . . . . . . 4.6 tt -131.55 80.89 1.95 Allowed 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 106.888 -1.523 . . . . 75.13 106.888 170.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 259' ' ' VAL . . . . . 0.548 ' HA ' ' HA2' ' B' ' 255' ' ' GLY . 58.6 t 66.81 -71.1 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 C-N-CA 125.87 1.668 . . . . 63.02 111.835 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 260' ' ' SER . . . . . . . . . . . . . 31.2 p -178.57 -38.38 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 126.404 1.882 . . . . 73.11 106.754 175.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -151.45 145.21 25.06 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-N 114.25 -1.341 . . . . 52.21 108.023 175.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 262' ' ' ALA . . . . . 0.517 ' HB1' ' HB1' ' B' ' 64' ' ' ALA . . . -76.78 -61.61 1.91 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.792 0.837 . . . . 43.43 110.17 173.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -170.11 94.39 0.24 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.713 1.205 . . . . 70.44 108.726 175.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 13.9 m 64.68 21.46 12.4 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 124.936 1.294 . . . . 51.14 113.011 175.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 265' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -63.22 -50.86 68.57 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.456 1.102 . . . . 64.12 110.108 -175.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 266' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -75.87 -20.74 57.85 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 116.322 -0.399 . . . . 71.52 110.461 179.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 52.3 m 78.35 -38.93 0.25 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 125.931 1.693 . . . . 73.13 113.252 173.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 59.2 t -68.49 -52.47 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 122.922 0.489 . . . . 74.44 110.008 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 269' ' ' THR . . . . . . . . . . . . . 62.5 m 51.46 90.11 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.052 1.341 . . . . 74.31 111.584 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 270' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -65.86 -29.72 70.22 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.265 1.026 . . . . 72.41 111.509 -177.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 271' ' ' ALA . . . . . . . . . . . . . . . 56.4 36.02 26.85 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 124.292 0.995 . . . . 75.3 111.127 -177.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 272' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -65.58 146.51 54.74 Favored 'General case' 0 C--O 1.247 0.964 0 CA-C-N 114.692 -1.14 . . . . 54.14 110.599 -177.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 20.3 tm0? -67.01 100.49 0.75 Allowed 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.588 -0.733 . . . . 61.32 109.294 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -142.5 87.35 2.0 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 107.88 -1.156 . . . . 71.44 107.88 174.075 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 275' ' ' LYS . . . . . . . . . . . . . 11.7 mptt 50.34 53.37 13.99 Favored Pre-proline 0 CA--C 1.56 1.33 0 CA-C-N 114.331 -1.304 . . . . 71.33 111.911 -178.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 276' ' ' PRO . . . . . 0.415 ' HD2' HD12 ' B' ' 277' ' ' LEU . 51.2 Cg_endo -83.84 14.45 2.4 Favored 'Trans proline' 0 C--N 1.391 2.776 0 C-N-CA 122.435 2.09 . . . . 62.35 112.498 -177.234 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 277' ' ' LEU . . . . . 0.429 HD22 ' HA ' ' A' ' 279' ' ' ARG . 5.2 mp -83.78 -99.36 0.05 Allowed 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 108.468 -0.938 . . . . 63.32 108.468 175.29 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 278' ' ' LEU . . . . . 0.495 HD23 ' HA ' ' A' ' 278' ' ' ALA . 80.9 mt 60.68 20.4 10.39 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-N 118.848 0.749 . . . . 62.0 112.555 177.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . 112.26 -18.72 23.13 Favored Glycine 0 N--CA 1.479 1.514 0 C-N-CA 123.168 0.413 . . . . 75.43 112.992 -175.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 280' ' ' LEU . . . . . 0.501 ' HA ' HG22 ' B' ' 232' ' ' THR . 2.9 tm? -62.92 -48.13 80.27 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.022 0.929 . . . . 53.23 109.778 178.399 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -73.53 -47.74 38.54 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 109.727 -0.471 . . . . 75.31 109.727 175.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 282' ' ' ALA . . . . . 0.414 ' HB2' ' HA ' ' B' ' 231' ' ' LYS . . . 76.95 -33.46 0.2 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 125.901 1.68 . . . . 65.41 113.123 176.076 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 24.2 t70 65.34 -75.32 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 125.609 1.564 . . . . 72.33 111.883 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . -81.44 68.31 3.48 Favored Glycine 0 C--N 1.342 0.914 0 N-CA-C 111.548 -0.621 . . . . 61.45 111.548 175.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -76.02 92.18 3.14 Favored 'General case' 0 C--O 1.244 0.814 0 C-N-CA 124.138 0.975 . . . . 72.41 108.548 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 286' ' ' MET . . . . . 0.431 ' HB3' ' HD2' ' B' ' 287' ' ' PRO . 64.0 mtm 71.7 168.11 0.12 Allowed Pre-proline 0 CA--C 1.564 1.504 0 C-N-CA 124.73 1.212 . . . . 64.1 110.957 -176.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 287' ' ' PRO . . . . . 0.431 ' HD2' ' HB3' ' B' ' 286' ' ' MET . 30.7 Cg_endo -62.0 -3.15 3.51 Favored 'Trans proline' 0 C--N 1.388 2.626 0 C-N-CA 122.611 2.207 . . . . 73.33 114.012 174.12 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 288' ' ' VAL . . . . . . . . . . . . . 21.5 t -78.18 74.39 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 CA-C-O 121.702 0.763 . . . . 74.32 109.438 174.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 289' ' ' ARG . . . . . . . . . . . . . 49.4 ttt180 -101.82 -15.36 16.94 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.212 1.005 . . . . 72.14 110.319 -179.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 290' ' ' TRP . . . . . . . . . . . . . 71.9 t-105 73.29 119.63 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 125.528 1.531 . . . . 75.34 109.889 -170.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 291' ' ' LEU . . . . . 0.421 HD22 HG23 ' B' ' 452' ' ' VAL . 35.4 tp 71.91 144.36 0.06 Allowed 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 125.676 1.59 . . . . 64.34 111.36 -172.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . 151.47 -64.42 0.38 Allowed Glycine 0 C--N 1.35 1.353 0 CA-C-O 119.552 -0.582 . . . . 62.12 112.261 -179.016 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -82.66 42.87 1.38 Allowed 'Trans proline' 0 C--N 1.383 2.382 0 C-N-CA 123.587 2.858 . . . . 51.12 113.078 -179.394 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -82.95 130.08 35.1 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.536 1.134 . . . . 41.23 110.936 -174.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -163.86 -51.69 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.554 1.142 . . . . 34.32 109.133 168.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 18.0 m 70.81 139.1 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 125.84 1.656 . . . . 65.42 112.384 177.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 57.5 t80 68.92 -82.21 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 125.086 1.354 . . . . 64.12 111.376 172.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 29.1 p80 39.21 82.49 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 126.176 1.79 . . . . 71.5 113.788 -175.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . -79.45 65.66 3.61 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-N 115.913 -0.585 . . . . 63.41 113.015 178.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 300' ' ' ASN . . . . . 0.423 HD21 ' HA ' ' B' ' 300' ' ' ASN . 1.0 OUTLIER -172.56 -135.65 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 106.736 -1.579 . . . . 72.23 106.736 -177.992 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 301' ' ' ILE . . . . . . . . . . . . . 8.0 mm 64.57 13.98 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.576 1.945 0 C-N-CA 124.134 0.973 . . . . 72.24 111.561 172.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -140.15 154.53 47.0 Favored 'General case' 0 N--CA 1.485 1.281 0 O-C-N 121.096 -1.003 . . . . 63.41 111.33 -170.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 303' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.86 -47.65 15.45 Favored Pre-proline 0 CA--C 1.568 1.668 0 C-N-CA 124.377 1.071 . . . . 74.11 113.865 -168.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 304' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -57.57 -27.51 77.12 Favored 'Trans proline' 0 C--N 1.39 2.741 0 C-N-CA 122.233 1.955 . . . . 75.12 113.443 170.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . 68.92 -72.36 0.1 Allowed 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 125.257 1.423 . . . . 42.33 110.717 -177.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 7.4 p -104.84 144.38 14.79 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 N-CA-C 108.936 -0.764 . . . . 72.33 108.936 170.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 7.8 m -62.02 -26.76 68.43 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 124.307 1.043 . . . . 74.23 112.367 -172.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 308' ' ' CYS . . . . . . . . . . . . . 29.2 p -72.45 -11.61 60.75 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.574 0.75 . . . . 74.22 112.329 -176.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 52.9 p -119.09 85.5 29.74 Favored Pre-proline 0 CA--C 1.557 1.232 0 C-N-CA 123.403 0.681 . . . . 72.2 110.568 179.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -83.16 168.77 13.24 Favored 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 122.857 2.371 . . . . 63.14 112.582 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 311' ' ' ASN . . . . . 0.445 ' HB3' ' HD3' ' B' ' 312' ' ' PRO . 4.4 t30 -92.93 -50.24 0.28 Allowed Pre-proline 0 CA--C 1.566 1.583 0 CA-C-O 118.866 -0.587 . . . . 73.13 111.423 177.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 312' ' ' PRO . . . . . 0.445 ' HD3' ' HB3' ' B' ' 311' ' ' ASN . 41.0 Cg_endo -95.97 -152.85 0.03 OUTLIER 'Trans proline' 0 C--N 1.391 2.785 0 C-N-CA 122.545 2.163 . . . . 70.14 110.715 170.293 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 313' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -91.98 17.1 9.79 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.717 0.407 . . . . 75.13 111.135 174.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 314' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 69.33 -78.2 0.05 OUTLIER 'General case' 0 C--N 1.353 0.723 0 C-N-CA 125.329 1.452 . . . . 72.01 110.662 -177.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 315' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 57.35 -85.1 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.855 1.262 . . . . 72.12 111.097 -173.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 316' ' ' ASP . . . . . . . . . . . . . 35.6 t70 58.08 -80.53 0.02 OUTLIER 'General case' 0 C--N 1.355 0.837 0 C-N-CA 125.75 1.62 . . . . 74.4 112.556 177.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 317' ' ' SER . . . . . 0.499 ' HA ' HG22 ' B' ' 325' ' ' THR . 19.6 m -78.89 -25.48 43.86 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.721 0.809 . . . . 75.41 111.334 -176.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 318' ' ' VAL . . . . . 0.5 HG12 ' HA ' ' B' ' 322' ' ' ALA . 20.2 m -114.66 96.68 44.69 Favored Pre-proline 0 CA--C 1.563 1.466 0 C-N-CA 124.228 1.011 . . . . 73.13 110.166 -177.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 319' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -62.97 -49.61 4.84 Favored 'Trans proline' 0 C--N 1.382 2.326 0 C-N-CA 122.75 2.3 . . . . 65.1 112.379 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 320' ' ' THR . . . . . . . . . . . . . 24.7 m -132.55 -52.9 0.94 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.637 0.775 . . . . 53.31 109.41 -179.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 321' ' ' LEU . . . . . . . . . . . . . 96.2 mt -114.89 -179.38 3.61 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.195 0.998 . . . . 65.14 109.668 178.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 322' ' ' ALA . . . . . 0.5 ' HA ' HG12 ' B' ' 318' ' ' VAL . . . -83.29 40.48 0.71 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.799 0.84 . . . . 64.54 111.779 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 323' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -62.77 -38.35 90.25 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.481 0.713 . . . . 74.02 110.246 178.117 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 324' ' ' MET . . . . . 0.483 ' SD ' ' HB3' ' B' ' 317' ' ' SER . 46.6 tpp 69.18 110.58 0.05 Allowed 'General case' 0 N--CA 1.478 0.938 0 O-C-N 125.047 1.467 . . . . 71.32 113.055 169.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 325' ' ' THR . . . . . 0.499 HG22 ' HA ' ' B' ' 317' ' ' SER . 10.0 t -77.15 118.3 19.54 Favored 'General case' 0 C--O 1.246 0.88 0 N-CA-C 108.04 -1.096 . . . . 72.33 108.04 164.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 326' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -67.28 145.49 55.11 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.304 0.642 . . . . 72.01 109.593 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 327' ' ' LYS . . . . . 0.439 ' HD2' ' N ' ' B' ' 327' ' ' LYS . 2.3 mptp? -80.78 12.6 3.09 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.318 0.647 . . . . 54.34 112.109 -174.605 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 328' ' ' ALA . . . . . 0.599 ' HA ' ' HB3' ' B' ' 187' ' ' SER . . . 67.92 178.68 0.24 Allowed 'General case' 0 C--N 1.354 0.777 0 C-N-CA 125.096 1.358 . . . . 72.03 113.253 168.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 329' ' ' ILE . . . . . . . . . . . . . 20.4 tt -147.62 173.0 2.3 Favored 'Isoleucine or valine' 0 C--O 1.251 1.158 0 N-CA-C 106.378 -1.712 . . . . 73.5 106.378 173.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 330' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -55.04 -69.4 0.13 Allowed 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 109.278 -0.638 . . . . 63.42 109.278 171.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 331' ' ' LEU . . . . . . . . . . . . . 57.3 tp 45.11 -98.35 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.995 1.318 . . . . 63.34 111.174 -178.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 99.1 mt 34.18 -90.82 0.01 OUTLIER 'General case' 0 C--N 1.361 1.105 0 C-N-CA 126.25 1.82 . . . . 74.41 113.657 -178.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 333' ' ' SER . . . . . . . . . . . . . 15.6 p -167.95 -66.34 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 107.941 -1.133 . . . . 65.04 107.941 -177.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt 74.33 -41.59 0.48 Allowed 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 125.965 1.706 . . . . 63.11 113.126 172.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 335' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -67.31 93.94 0.35 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.322 1.049 . . . . 73.25 111.189 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 58.06 93.9 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.836 1.255 . . . . 61.02 113.796 168.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 337' ' ' LYS . . . . . 0.459 ' NZ ' ' SG ' ' B' ' 190' ' ' CYS . 35.3 mtpt -131.52 15.0 4.97 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.226 0.61 . . . . 62.43 110.994 171.107 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 338' ' ' GLY . . . . . . . . . . . . . . . -156.14 158.98 29.04 Favored Glycine 0 C--N 1.346 1.124 0 N-CA-C 111.495 -0.642 . . . . 72.34 111.495 -179.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 339' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -141.59 165.57 27.14 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.869 0.868 . . . . 74.33 109.773 -177.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 340' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -69.59 153.49 43.38 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.237 0.615 . . . . 75.24 110.933 -178.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 341' ' ' LEU . . . . . . . . . . . . . 5.0 tt -121.46 106.75 11.71 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 107.348 -1.353 . . . . 75.34 107.348 174.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 342' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -82.42 71.25 9.49 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-O 121.894 0.854 . . . . 64.25 111.067 -176.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 343' ' ' VAL . . . . . . . . . . . . . 7.3 p -75.51 -39.0 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-N 115.602 -0.727 . . . . 64.24 109.755 175.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 62.8 -78.79 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.848 1.659 . . . . 73.03 112.243 174.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 345' ' ' GLY . . . . . . . . . . . . . . . -95.47 166.61 25.5 Favored Glycine 0 C--N 1.347 1.163 0 C-N-CA 122.782 0.229 . . . . 62.31 112.765 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 346' ' ' ALA . . . . . . . . . . . . . . . -111.92 174.77 5.72 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.334 1.054 . . . . 72.22 109.907 177.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 41.6 t -63.61 -55.3 24.72 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 122.789 0.436 . . . . 72.21 110.08 178.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 348' ' ' ILE . . . . . 0.448 ' O ' ' HB ' ' B' ' 236' ' ' THR . 62.8 mt 64.01 -70.33 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 125.928 1.691 . . . . 73.42 111.185 -177.367 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 349' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -48.34 100.74 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 125.425 1.49 . . . . 71.13 112.547 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 350' ' ' LYS . . . . . . . . . . . . . 5.9 ttpm? 51.61 67.84 0.89 Allowed 'General case' 0 N--CA 1.483 1.192 0 O-C-N 124.49 1.118 . . . . 74.52 111.68 163.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 351' ' ' GLN . . . . . 0.566 HE22 ' HZ ' ' B' ' 233' ' ' PHE . 25.1 mt-30 -85.52 157.05 20.52 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.267 -0.878 . . . . 71.32 112.225 -172.234 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 7.9 t0 65.66 -92.02 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 125.317 1.447 . . . . 74.35 111.378 172.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 353' ' ' HIS . . . . . . . . . . . . . 49.5 p-80 -143.96 12.41 1.63 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.949 0.9 . . . . 74.33 109.401 -176.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 354' ' ' ALA . . . . . . . . . . . . . . . 74.81 -178.57 0.17 Allowed 'General case' 0 N--CA 1.484 1.27 0 O-C-N 125.133 1.52 . . . . 70.11 110.115 -158.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 355' ' ' ALA . . . . . 0.424 ' H ' ' HB1' ' B' ' 237' ' ' ALA . . . -86.24 -178.08 6.4 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 122.87 0.468 . . . . 75.44 110.027 178.127 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 356' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -116.22 86.79 18.01 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 123.585 0.754 . . . . 74.32 109.036 173.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 357' ' ' PRO . . . . . 0.43 ' HB3' ' HE3' ' B' ' 245' ' ' LYS . 68.1 Cg_endo -81.9 -8.19 12.2 Favored 'Trans proline' 0 C--N 1.384 2.396 0 C-N-CA 122.781 2.321 . . . . 55.22 112.245 175.017 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 358' ' ' CYS . . . . . 0.408 ' HA ' ' CG2' ' B' ' 365' ' ' VAL . 30.4 p -156.21 141.57 17.56 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 124.364 1.066 . . . . 73.32 108.862 178.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 359' ' ' GLY . . . . . . . . . . . . . . . -81.36 68.39 3.46 Favored Glycine 0 C--N 1.34 0.804 0 N-CA-C 109.677 -1.369 . . . . 62.01 109.677 169.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 360' ' ' GLN . . . . . . . . . . . . . 9.0 tm0? 64.84 -68.91 0.1 Allowed 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 125.862 1.665 . . . . 53.34 109.213 -167.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 361' ' ' ILE . . . . . 0.466 HG22 ' H ' ' B' ' 363' ' ' GLU . 73.5 mt -79.69 141.98 14.59 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 C-N-CA 124.186 0.994 . . . . 61.31 109.211 170.45 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 362' ' ' GLY . . . . . . . . . . . . . . . -70.01 -29.49 70.67 Favored Glycine 0 C--N 1.347 1.158 0 C-N-CA 122.93 0.3 . . . . 72.35 113.78 -177.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 363' ' ' GLU . . . . . 0.466 ' H ' HG22 ' B' ' 361' ' ' ILE . 1.7 mp0 -72.55 -20.39 61.34 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.51 0.724 . . . . 73.13 111.699 -179.316 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 364' ' ' THR . . . . . . . . . . . . . 16.6 m -61.76 -27.46 68.75 Favored 'General case' 0 CA--C 1.557 1.22 0 C-N-CA 123.749 0.819 . . . . 74.04 111.44 179.177 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 365' ' ' VAL . . . . . 0.708 HG23 ' H ' ' B' ' 366' ' ' ASP . 5.6 m -110.35 -82.78 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.416 0 CA-C-O 118.758 -0.639 . . . . 74.01 111.155 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 366' ' ' ASP . . . . . 0.708 ' H ' HG23 ' B' ' 365' ' ' VAL . 24.6 t70 47.84 -96.49 0.03 OUTLIER 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 124.743 1.217 . . . . 50.12 111.654 -171.151 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 367' ' ' LEU . . . . . 0.449 HD21 ' HB2' ' C' ' 225' ' ' PRO . 7.1 mp -136.31 130.06 32.36 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 107.048 -1.464 . . . . 75.05 107.048 170.529 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 368' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -84.93 179.82 7.22 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 122.746 0.419 . . . . 71.23 110.462 176.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 369' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 71.23 -72.2 0.12 Allowed 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 125.231 1.412 . . . . 70.1 111.142 -170.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 370' ' ' ALA . . . . . . . . . . . . . . . 68.99 -68.87 0.17 Allowed 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 125.311 1.444 . . . . 74.25 111.527 -177.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 371' ' ' VAL . . . . . . . . . . . . . 43.4 t 65.33 -87.21 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 125.137 1.375 . . . . 74.11 109.881 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 372' ' ' GLN . . . . . . . . . . . . . 20.6 tp60 -172.29 25.83 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.557 1.543 . . . . 63.2 107.082 174.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 373' ' ' ARG . . . . . 0.653 ' HB3' ' HG2' ' A' ' 260' ' ' ARG . 99.4 mtt180 59.46 90.59 0.05 Allowed 'General case' 0 C--N 1.364 1.235 0 C-N-CA 124.787 1.235 . . . . 72.05 109.326 -165.518 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -61.73 116.5 4.85 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.644 -0.707 . . . . 71.45 111.267 -172.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 375' ' ' LEU . . . . . . . . . . . . . 54.7 tp -73.1 118.17 15.73 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 115.468 -0.787 . . . . 62.01 108.88 174.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 376' ' ' GLU . . . . . 0.411 ' HB3' ' HA ' ' A' ' 258' ' ' PRO . 0.0 OUTLIER -61.16 -29.29 69.7 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.069 0.947 . . . . 73.13 112.885 -178.057 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 377' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -57.77 -34.3 69.43 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.154 0.982 . . . . 73.31 111.016 178.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 378' ' ' ALA . . . . . . . . . . . . . . . -64.63 -38.8 92.26 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 115.551 -0.75 . . . . 61.1 110.427 176.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? 78.06 -24.72 0.21 Allowed 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 125.678 1.591 . . . . 72.01 112.37 170.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 380' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt 72.69 -78.95 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 125.48 1.512 . . . . 53.14 112.188 172.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 381' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -99.89 106.76 18.63 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 122.958 0.503 . . . . 74.34 110.562 -170.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . 69.56 53.92 14.75 Favored Glycine 0 C--N 1.348 1.238 0 CA-C-N 115.225 -0.898 . . . . 73.1 113.085 178.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 383' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -76.49 -59.73 2.65 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 109.575 -0.528 . . . . 73.1 109.575 176.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 384' ' ' THR . . . . . 0.487 HG21 ' HB3' ' A' ' 218' ' ' PRO . 18.5 m 61.87 -82.69 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.163 0 CA-C-N 113.883 -1.508 . . . . 63.41 111.515 -176.172 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 83.8 mt 59.87 -82.73 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.627 1.171 . . . . 75.12 109.681 -169.002 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 386' ' ' VAL . . . . . 0.559 ' HA ' ' HA3' ' B' ' 417' ' ' GLY . 9.2 t -121.53 41.23 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 108.037 -1.097 . . . . 62.42 108.037 174.134 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 387' ' ' ILE . . . . . . . . . . . . . 2.1 mp 70.49 -59.81 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 C-N-CA 125.773 1.629 . . . . 74.12 108.804 -168.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 388' ' ' VAL . . . . . 0.507 HG23 ' HB2' ' B' ' 391' ' ' ASP . 35.3 m -87.74 148.11 4.81 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.146 0 C-N-CA 123.93 0.892 . . . . 54.33 109.878 167.4 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 389' ' ' THR . . . . . . . . . . . . . 14.6 t -86.88 -29.38 22.2 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 122.924 0.49 . . . . 71.25 112.049 -175.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . -70.66 -13.08 61.94 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.429 0.691 . . . . 70.34 112.586 -174.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 391' ' ' ASP . . . . . 0.507 ' HB2' HG23 ' B' ' 388' ' ' VAL . 3.9 t70 -76.3 176.24 8.32 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.158 0.983 . . . . 64.12 110.374 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 392' ' ' HIS . . . . . . . . . . . . . 58.7 t60 67.69 21.21 9.35 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.513 1.125 . . . . 72.42 109.508 -175.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . 55.3 39.7 31.35 Favored 'General case' 0 C--N 1.36 1.037 0 C-N-CA 125.156 1.382 . . . . 61.53 111.845 -174.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 26.6 m170 -71.89 74.52 0.88 Allowed 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 122.162 0.982 . . . . 73.31 110.373 177.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . -153.16 113.8 4.06 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 105.989 -1.856 . . . . 71.44 105.989 -177.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 31.1 p -76.33 -8.05 56.27 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.988 0.915 . . . . 75.55 112.002 -174.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 397' ' ' GLN . . . . . . . . . . . . . 76.9 mm-40 -75.3 83.09 2.43 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.964 0.906 . . . . 71.41 110.273 -177.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 398' ' ' ILE . . . . . 0.404 HD12 HG21 ' B' ' 409' ' ' THR . 8.9 tt -97.71 114.54 35.22 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 C-N-CA 124.318 1.047 . . . . 75.44 109.143 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 399' ' ' VAL . . . . . . . . . . . . . 60.0 t -73.19 -75.51 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 123.159 0.584 . . . . 73.32 110.632 -173.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 400' ' ' ALA . . . . . . . . . . . . . . . -173.36 85.75 0.39 Allowed Pre-proline 0 N--CA 1.48 1.032 0 C-N-CA 123.769 0.828 . . . . 51.41 110.755 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 401' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -86.68 57.59 3.7 Favored 'Trans proline' 0 C--N 1.374 1.888 0 C-N-CA 123.512 2.808 . . . . 71.04 110.385 168.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -69.67 -56.29 7.65 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.654 1.182 . . . . 74.34 109.628 -176.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 403' ' ' THR . . . . . . . . . . . . . 3.9 t -101.75 138.79 38.26 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 115.288 -0.869 . . . . 51.3 109.026 170.27 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 404' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? 53.0 91.76 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.114 1.365 . . . . 70.03 110.44 -175.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 405' ' ' ALA . . . . . . . . . . . . . . . -106.86 93.42 8.86 Favored Pre-proline 0 N--CA 1.478 0.935 0 C-N-CA 122.744 0.418 . . . . 71.24 110.916 -177.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 406' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -90.98 22.47 0.72 Allowed 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 122.735 2.29 . . . . 44.44 112.647 176.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . 67.57 -99.02 0.5 Allowed Glycine 0 C--N 1.349 1.255 0 N-CA-C 111.15 -0.78 . . . . 55.33 111.15 -171.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 408' ' ' LEU . . . . . . . . . . . . . 78.6 mt 59.42 13.54 3.27 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 125.356 1.463 . . . . 72.03 113.299 -178.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 409' ' ' THR . . . . . 0.404 HG21 HD12 ' B' ' 398' ' ' ILE . 10.1 t -137.48 149.53 46.89 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 124.542 1.137 . . . . 73.52 108.821 -177.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 410' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 55.47 -66.41 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 127.381 2.273 . . . . 51.32 114.756 176.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 411' ' ' ALA . . . . . 0.464 ' CB ' HD22 ' B' ' 426' ' ' ASN . . . -123.61 -65.53 1.07 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.484 0.713 . . . . 63.14 112.435 -176.022 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 58.4 tp -62.42 104.56 0.52 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.353 0.661 . . . . 60.41 110.859 -173.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -170.4 -79.32 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.858 0.863 . . . . 71.14 109.138 178.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 414' ' ' THR . . . . . . . . . . . . . 77.7 p -116.62 157.71 24.91 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.742 0.817 . . . . 73.24 109.692 -178.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 415' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -119.88 -6.71 10.05 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.787 0.835 . . . . 73.42 111.901 -168.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -76.79 176.55 8.39 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.977 0.911 . . . . 75.33 111.989 -172.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 417' ' ' GLY . . . . . 0.559 ' HA3' ' HA ' ' B' ' 386' ' ' VAL . . . 99.04 14.31 36.8 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 115.213 -0.903 . . . . 43.15 113.561 177.03 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 418' ' ' ALA . . . . . 0.573 ' HB3' ' HB ' ' B' ' 421' ' ' VAL . . . -158.67 135.55 9.68 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 122.855 0.462 . . . . 70.25 110.885 173.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 419' ' ' VAL . . . . . . . . . . . . . 85.3 t -61.58 -43.13 96.46 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 C-N-CA 124.505 1.122 . . . . 62.03 109.965 171.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 420' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -130.01 124.37 32.78 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 107.217 -1.401 . . . . 73.12 107.217 175.047 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 421' ' ' VAL . . . . . 0.573 ' HB ' ' HB3' ' B' ' 418' ' ' ALA . 6.8 p -134.98 112.79 15.22 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.133 0 CA-C-O 121.426 0.631 . . . . 72.42 110.697 -174.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 422' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.35 -3.61 28.49 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.078 0.951 . . . . 74.1 110.655 177.258 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 423' ' ' SER . . . . . . . . . . . . . 15.5 m -102.77 24.16 11.02 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.293 1.037 . . . . 62.22 109.305 171.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 424' ' ' TYR . . . . . 0.45 ' CD1' ' HG2' ' B' ' 429' ' ' GLU . 21.6 t80 -53.59 -37.41 62.94 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 125.986 1.714 . . . . 72.42 110.779 175.683 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . -124.95 47.6 1.01 Allowed Glycine 0 C--N 1.349 1.263 0 N-CA-C 110.785 -0.926 . . . . 75.12 110.785 172.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 426' ' ' ASN . . . . . 0.464 HD22 ' CB ' ' B' ' 411' ' ' ALA . 30.7 m-80 65.69 -82.65 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 125.367 1.467 . . . . 75.43 112.042 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 427' ' ' SER . . . . . . . . . . . . . 20.4 m -102.49 101.65 11.87 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.65 0.78 . . . . 75.14 110.61 -170.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 49.7 79.43 0.08 Allowed 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 125.792 1.637 . . . . 73.23 112.418 171.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 429' ' ' GLU . . . . . 0.45 ' HG2' ' CD1' ' B' ' 424' ' ' TYR . 13.6 tp10 -88.7 162.24 16.38 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 116.467 -0.333 . . . . 63.42 110.923 -177.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -40.91 -39.31 1.12 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 126.419 1.888 . . . . 55.41 112.662 169.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 26.1 m -67.12 81.05 0.13 Allowed 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 124.023 0.929 . . . . 73.31 110.844 -179.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 432' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -119.01 31.34 6.69 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.997 1.319 . . . . 71.1 108.514 174.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 433' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -63.93 131.04 46.48 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 114.62 -1.173 . . . . 73.43 110.429 -178.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 434' ' ' HIS . . . . . . . . . . . . . 76.0 t60 67.27 33.81 5.23 Favored 'General case' 0 CA--C 1.561 1.381 0 C-N-CA 124.529 1.132 . . . . 65.13 110.894 178.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 435' ' ' THR . . . . . . . . . . . . . 15.1 t -73.74 -6.87 49.57 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 122.887 0.475 . . . . 73.42 111.56 176.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . -60.14 -30.91 71.59 Favored Glycine 0 C--N 1.359 1.835 0 C-N-CA 123.084 0.373 . . . . 43.54 112.227 170.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 30.0 m -89.39 81.33 6.62 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 107.479 -1.304 . . . . 54.14 107.479 164.227 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 438' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -67.55 98.01 0.64 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.241 -0.89 . . . . 71.55 111.211 -173.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 439' ' ' LEU . . . . . . . . . . . . . 80.0 mt -80.64 -4.05 52.8 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 115.017 -0.992 . . . . 74.24 110.747 171.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 440' ' ' ARG . . . . . 0.476 ' HA ' ' HB3' ' A' ' 222' ' ' ALA . 40.0 mtp85 -76.58 112.5 13.2 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 107.626 -1.25 . . . . 70.1 107.626 173.43 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 441' ' ' ILE . . . . . 0.563 HD12 ' HA ' ' A' ' 223' ' ' VAL . 63.9 mt -70.97 112.5 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 C-N-CA 123.202 0.601 . . . . 74.15 111.896 -167.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 442' ' ' ALA . . . . . . . . . . . . . . . -102.63 27.1 7.2 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.303 1.041 . . . . 71.41 110.39 177.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 443' ' ' ALA . . . . . 0.404 ' H ' HG22 ' B' ' 441' ' ' ILE . . . -70.2 165.64 21.7 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.404 0.682 . . . . 74.21 111.661 178.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 17.2 m-30 77.43 -18.69 0.48 Allowed 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 125.7 1.6 . . . . 65.34 111.818 -173.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . 61.32 71.58 0.77 Allowed Glycine 0 C--N 1.353 1.494 0 CA-C-O 118.489 -1.173 . . . . 74.34 110.913 -169.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 446' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -45.29 100.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.38 2.211 0 C-N-CA 124.32 3.347 . . . . 63.02 114.662 -168.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 447' ' ' HIS . . . . . . . . . . . . . 10.3 p-80 -131.4 135.19 46.98 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.103 0.961 . . . . 60.0 109.526 175.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . -141.95 -164.38 1.78 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.961 0.904 . . . . 74.31 109.895 -178.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 449' ' ' ALA . . . . . . . . . . . . . . . 67.04 30.84 7.24 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 124.424 1.089 . . . . 61.52 110.992 -175.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 450' ' ' ASN . . . . . . . . . . . . . 9.9 t30 70.49 2.3 4.01 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 125.466 1.506 . . . . 61.12 112.474 -178.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 76.6 t -71.01 89.1 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 N-CA-C 108.82 -0.807 . . . . 63.1 108.82 176.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 452' ' ' VAL . . . . . 0.421 HG23 HD22 ' B' ' 291' ' ' LEU . 7.4 p -90.43 -33.59 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.429 1.091 . . . . 60.45 110.894 -173.618 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . -77.95 74.61 1.98 Allowed Glycine 0 C--N 1.35 1.309 0 CA-C-N 115.542 -0.754 . . . . 73.44 112.052 -178.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 454' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -158.93 129.84 6.13 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 106.561 -1.644 . . . . 72.5 106.561 -177.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 86.1 m -83.22 -82.65 0.15 Allowed 'General case' 0 CA--C 1.553 1.059 0 N-CA-C 109.613 -0.514 . . . . 61.41 109.613 177.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -140.03 152.67 46.42 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.653 0.781 . . . . 74.3 108.931 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 457' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 63.8 99.07 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.912 1.285 . . . . 42.14 110.642 -172.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 5.8 m -95.3 8.67 42.42 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 123.605 0.762 . . . . 72.13 110.346 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 459' ' ' ASP . . . . . . . . . . . . . 12.4 t70 68.62 110.7 0.05 OUTLIER 'General case' 0 C--N 1.362 1.131 0 C-N-CA 124.99 1.316 . . . . 73.31 109.518 -169.329 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 1.5 tt 69.02 109.88 0.05 Allowed 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 125.138 1.375 . . . . 65.42 109.205 178.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -78.46 67.21 4.19 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-O 121.831 0.825 . . . . 62.31 111.305 -177.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -150.54 10.68 0.66 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.955 1.302 . . . . 72.53 108.723 176.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 28.3 p -84.02 54.61 2.98 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.679 1.192 . . . . 61.35 110.398 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 464' ' ' MET . . . . . . . . . . . . . 24.4 ptt? -99.42 36.99 1.64 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.018 1.327 . . . . 75.31 109.33 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 465' ' ' LYS . . . . . 0.562 ' HE3' ' HA ' ' B' ' 465' ' ' LYS . 0.7 OUTLIER -69.46 81.61 0.39 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.07 0.948 . . . . 72.15 110.891 -173.835 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -106.26 -170.56 1.75 Allowed 'General case' 0 C--O 1.239 0.539 0 C-N-CA 124.156 0.982 . . . . 62.32 109.453 -177.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . -82.39 22.97 0.79 Allowed 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 123.726 0.81 . . . . 75.3 111.322 175.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 3.2 pp -57.03 150.53 16.82 Favored 'General case' 0 C--N 1.361 1.076 0 C-N-CA 124.193 0.997 . . . . 45.51 111.172 178.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 469' ' ' GLY . . . . . . . . . . . . . . . 70.38 -91.17 0.38 Allowed Glycine 0 C--N 1.342 0.916 0 N-CA-C 110.833 -0.907 . . . . 50.44 110.833 -171.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 470' ' ' LEU . . . . . . . . . . . . . 40.4 tp -163.48 -41.94 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.03 0.932 . . . . 73.2 109.923 177.094 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 471' ' ' LYS . . . . . . . . . . . . . 6.9 tmtm? . . . . . 0 CA--C 1.559 1.318 0 C-N-CA 125.137 1.375 . . . . 74.2 108.661 -172.244 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 N--CA 1.479 1.003 0 N-CA-C 109.346 -0.613 . . . . 55.23 109.346 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.94 24.38 10.92 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.772 1.229 . . . . 65.31 112.41 178.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -90.91 43.87 1.17 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.971 0.908 . . . . 52.01 111.055 -169.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -37.47 95.1 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 125.693 1.597 . . . . 70.52 114.197 -176.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -67.19 107.73 2.44 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 108.288 -1.004 . . . . 63.2 108.288 166.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -77.74 92.73 4.2 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 106.739 -1.578 . . . . 63.22 106.739 171.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 7' ' ' TYR . . . . . 0.438 ' CD1' ' HA ' ' C' ' 53' ' ' ALA . 75.8 m-85 -62.73 -25.9 68.42 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 114.51 -1.223 . . . . 73.43 112.128 -172.249 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -64.91 -46.49 81.46 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.382 0.673 . . . . 72.53 110.408 174.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.64 -39.44 94.36 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.266 0.626 . . . . 52.31 111.011 178.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 66.7 mt -59.75 -41.1 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 123.797 0.686 . . . . 63.34 110.475 175.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 98.0 mt -85.57 -3.55 58.9 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 112.265 0.469 . . . . 45.45 112.265 176.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 61.27 44.6 97.89 Favored Glycine 0 C--N 1.354 1.54 0 N-CA-C 114.063 0.385 . . . . 64.33 114.063 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 11.0 m -133.13 148.56 69.71 Favored Pre-proline 0 N--CA 1.487 1.423 0 C-N-CA 124.795 1.238 . . . . 64.04 109.823 177.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -75.29 161.36 38.03 Favored 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 122.721 2.281 . . . . 74.43 111.844 170.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 -77.07 20.17 0.27 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.806 0.842 . . . . 71.52 112.518 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -119.0 -15.39 9.29 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.243 1.017 . . . . 71.24 109.079 177.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.08 131.98 51.36 Favored 'General case' 0 C--N 1.355 0.828 0 C-N-CA 123.246 0.618 . . . . 71.14 109.595 175.103 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 59.8 p -65.59 161.8 19.57 Favored 'General case' 0 C--O 1.246 0.872 0 C-N-CA 123.047 0.539 . . . . 74.41 109.866 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 19' ' ' GLN . . . . . 0.525 ' HG2' ' HD3' ' C' ' 60' ' ' PRO . 25.1 tp60 -54.26 -38.82 66.25 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.586 0.754 . . . . 74.45 111.978 -173.007 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 20' ' ' GLU . . . . . 0.443 ' O ' ' HG3' ' C' ' 24' ' ' ARG . 0.4 OUTLIER -68.72 -35.6 77.35 Favored 'General case' 0 C--O 1.211 -0.933 0 CA-C-O 119.182 -0.437 . . . . 64.05 111.128 -179.058 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 21' ' ' GLU . . . . . 0.747 ' HG2' HH21 ' C' ' 24' ' ' ARG . 37.4 mt-10 -68.92 -38.11 79.32 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-O 121.006 0.431 . . . . 73.42 110.76 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 66.6 mt -66.15 -38.58 82.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 124.188 0.995 . . . . 61.32 109.889 174.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 23' ' ' LYS . . . . . 0.438 ' O ' ' HD3' ' C' ' 27' ' ' LYS . 6.6 ttpt -71.4 -33.85 69.85 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 114.68 -1.145 . . . . 74.13 109.972 178.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 24' ' ' ARG . . . . . 0.747 HH21 ' HG2' ' C' ' 21' ' ' GLU . 40.8 mtm180 -75.84 -24.21 55.8 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.305 0.642 . . . . 73.52 110.478 176.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.67 -43.96 87.73 Favored 'General case' 0 C--N 1.345 0.41 0 O-C-N 123.711 0.632 . . . . 75.32 109.636 170.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 26' ' ' TYR . . . . . 0.466 ' HD1' HG22 ' C' ' 50' ' ' ILE . 81.6 t80 -58.01 -52.42 65.58 Favored 'General case' 0 C--N 1.36 1.04 0 O-C-N 123.624 0.578 . . . . 72.31 110.865 171.462 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 27' ' ' LYS . . . . . 0.441 ' HE2' ' HA ' ' C' ' 24' ' ' ARG . 4.8 mppt? -61.0 -31.8 71.41 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 122.878 0.471 . . . . 74.1 111.487 -177.531 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 28' ' ' ARG . . . . . 0.493 HH21 HD21 ' C' ' 29' ' ' LEU . 38.9 ttp180 -62.28 -48.19 81.01 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.908 0.883 . . . . 71.15 109.602 174.251 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 29' ' ' LEU . . . . . 0.721 HD13 HD12 ' C' ' 50' ' ' ILE . 49.9 mt -74.55 -19.09 60.47 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 114.738 -1.119 . . . . 60.22 111.487 178.337 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.11 -22.49 33.37 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.409 0.684 . . . . 75.32 110.197 178.063 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 31' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' C' ' 27' ' ' LYS . 58.6 mtm180 -86.85 -31.78 20.61 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.252 0.621 . . . . 73.5 110.318 170.234 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -70.27 -60.58 2.19 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.827 0.851 . . . . 71.12 109.493 -178.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -90.61 24.52 2.63 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.028 0.931 . . . . 70.15 110.934 -177.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 34' ' ' HIS . . . . . 0.474 ' NE2' ' HB3' ' C' ' 36' ' ' ASP . 55.0 t60 -55.12 96.42 0.09 OUTLIER Pre-proline 0 N--CA 1.486 1.345 0 C-N-CA 124.963 1.305 . . . . 72.34 112.84 -164.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 35' ' ' PRO . . . . . 0.518 ' O ' ' HG2' ' C' ' 39' ' ' LYS . 57.9 Cg_endo -76.55 -2.24 12.42 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 123.429 2.753 . . . . 71.32 112.758 -167.257 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 36' ' ' ASP . . . . . 0.69 ' HB2' ' HG2' ' B' ' 113' ' ' LYS . 32.7 t70 -75.88 -38.03 58.28 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.949 0.899 . . . . 60.34 110.81 173.492 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 59.6 t -117.32 -52.69 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 122.89 0.476 . . . . 75.33 109.835 -174.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -97.51 79.29 2.73 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.701 0.762 . . . . 54.22 108.945 178.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 39' ' ' LYS . . . . . 0.518 ' HG2' ' O ' ' C' ' 35' ' ' PRO . 9.8 mtmp? -81.14 69.37 7.73 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 115.189 -0.914 . . . . 62.24 109.815 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 40' ' ' SER . . . . . 0.551 ' HB2' ' HB3' ' C' ' 43' ' ' ALA . 49.6 m -92.5 111.66 51.77 Favored Pre-proline 0 CA--C 1.546 0.81 0 CA-C-O 118.317 -0.849 . . . . 74.14 108.99 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -38.93 -61.09 0.42 Allowed 'Trans proline' 0 C--N 1.387 2.596 0 C-N-CA 124.571 3.514 . . . . 63.44 114.905 -174.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -61.18 -33.94 74.27 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.857 0.863 . . . . 65.44 111.397 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 43' ' ' ALA . . . . . 0.551 ' HB3' ' HB2' ' C' ' 40' ' ' SER . . . -77.35 -20.52 54.7 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.248 0.619 . . . . 62.05 110.659 -178.529 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -84.06 -28.44 27.6 Favored 'General case' 0 C--N 1.351 0.659 0 N-CA-C 109.127 -0.694 . . . . 74.04 109.127 176.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -70.62 -42.19 71.24 Favored 'General case' 0 C--O 1.25 1.125 0 C-N-CA 123.676 0.79 . . . . 42.53 109.602 173.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 46' ' ' LYS . . . . . 0.523 ' O ' HG12 ' C' ' 50' ' ' ILE . 63.5 mttp -58.12 -45.65 86.96 Favored 'General case' 0 C--N 1.355 0.832 0 CA-C-N 114.789 -1.096 . . . . 72.32 109.429 168.552 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -62.66 -30.31 71.29 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.926 0.89 . . . . 62.23 110.963 -178.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 2.7 mptm? -63.54 -50.37 69.82 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 109.07 -0.715 . . . . 72.04 109.07 171.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -67.57 -17.34 64.6 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 112.791 0.663 . . . . 72.33 112.791 176.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 50' ' ' ILE . . . . . 0.721 HD12 HD13 ' C' ' 29' ' ' LEU . 28.2 mm -78.36 -38.03 22.51 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 N-CA-C 108.832 -0.803 . . . . 75.43 108.832 173.067 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 51' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -78.85 -11.87 60.01 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.799 0.84 . . . . 74.04 111.399 174.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 52' ' ' GLU . . . . . 0.448 ' O ' HG23 ' C' ' 56' ' ' VAL . 30.0 tt0 -77.83 -53.07 7.92 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 108.064 -1.088 . . . . 63.42 108.064 169.658 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 53' ' ' ALA . . . . . 0.438 ' HA ' ' CD1' ' C' ' 7' ' ' TYR . . . -57.8 -34.14 69.31 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 114.432 -1.258 . . . . 63.1 111.399 175.315 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 54' ' ' TYR . . . . . 0.467 ' O ' ' HB2' ' C' ' 58' ' ' SER . 22.9 t80 -82.9 -32.45 27.28 Favored 'General case' 0 C--O 1.216 -0.68 0 C-N-CA 123.79 0.836 . . . . 75.01 110.378 177.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.39 -31.66 66.03 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 118.277 0.489 . . . . 60.54 110.537 173.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 56' ' ' VAL . . . . . 0.465 HG12 ' HB2' ' C' ' 66' ' ' TYR . 10.1 t -100.06 -21.3 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.245 0 CA-C-N 115.129 -0.941 . . . . 72.43 112.598 -179.233 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 57' ' ' LEU . . . . . 0.547 HD22 ' HG3' ' C' ' 63' ' ' ARG . 71.0 mt -127.4 29.3 5.56 Favored 'General case' 0 N--CA 1.501 2.122 0 CA-C-N 119.424 1.011 . . . . 75.02 112.655 -179.03 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 58' ' ' SER . . . . . 0.467 ' HB2' ' O ' ' C' ' 54' ' ' TYR . 21.4 t -68.62 -60.81 2.15 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.297 0.57 . . . . 62.42 112.221 177.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -125.9 158.98 63.8 Favored Pre-proline 0 N--CA 1.481 1.097 0 C-N-CA 124.393 1.077 . . . . 72.03 109.117 -171.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 60' ' ' PRO . . . . . 0.525 ' HD3' ' HG2' ' C' ' 19' ' ' GLN . 10.3 Cg_endo -48.89 -30.46 17.53 Favored 'Trans proline' 0 C--N 1.388 2.631 0 C-N-CA 123.162 2.574 . . . . 33.23 113.299 178.631 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 61' ' ' GLU . . . . . 0.441 ' O ' HG12 ' C' ' 65' ' ' ILE . 18.4 tt0 -50.79 -69.34 0.11 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.306 1.042 . . . . 62.13 110.625 170.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -60.22 -44.81 94.86 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-N 114.724 -1.125 . . . . 75.23 111.357 -174.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 63' ' ' ARG . . . . . 0.547 ' HG3' HD22 ' C' ' 57' ' ' LEU . 31.7 ttp-105 -62.77 -46.14 89.41 Favored 'General case' 0 C--N 1.349 0.544 0 CA-C-N 114.865 -1.062 . . . . 64.42 110.595 -174.14 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -72.57 -25.95 61.54 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 123.744 0.652 . . . . 74.15 111.552 -178.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 65' ' ' ILE . . . . . 0.441 HG12 ' O ' ' C' ' 61' ' ' GLU . 46.1 mm -60.13 -46.61 94.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 109.351 -0.611 . . . . 62.34 109.351 168.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 66' ' ' TYR . . . . . 0.465 ' HB2' HG12 ' C' ' 56' ' ' VAL . 18.3 t80 -63.63 -46.26 86.51 Favored 'General case' 0 C--N 1.353 0.723 0 CA-C-N 115.664 -0.698 . . . . 74.22 110.677 176.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -62.44 -33.67 75.28 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.219 0.607 . . . . 73.14 111.461 -176.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 44.5 p -78.14 -20.27 52.41 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.362 -0.381 . . . . 63.2 111.001 175.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -75.02 133.65 41.6 Favored 'General case' 0 CA--C 1.556 1.181 0 N-CA-C 108.415 -0.957 . . . . 75.22 108.415 165.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 91.28 15.6 55.25 Favored Glycine 0 N--CA 1.476 1.345 0 N-CA-C 111.225 -0.75 . . . . 62.51 111.225 -167.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 99.9 m -141.27 -60.34 0.49 Allowed 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 103.601 -2.74 . . . . 72.34 103.601 175.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 91.0 m -78.15 139.09 39.0 Favored 'General case' 0 C--O 1.251 1.155 0 N-CA-C 104.268 -2.493 . . . . 73.35 104.268 155.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.38 -45.93 4.34 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.62 0.768 . . . . 73.23 109.659 -172.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -73.87 144.32 82.5 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 123.435 0.694 . . . . 53.23 109.979 178.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.82 120.78 8.69 Favored 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 122.738 2.292 . . . . 75.14 110.989 173.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -54.27 159.59 7.79 Favored 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 123.685 2.924 . . . . 63.14 114.444 -176.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.57 127.75 14.37 Favored 'Trans proline' 0 C--N 1.381 2.242 0 C-N-CA 122.249 1.966 . . . . 51.51 110.839 172.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 78' ' ' PRO . . . . . 0.46 ' HB3' ' HA3' ' C' ' 104' ' ' GLY . 18.1 Cg_endo -59.02 129.91 34.06 Favored 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 122.609 2.206 . . . . 74.44 112.75 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.07 156.02 66.43 Favored 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 122.749 2.299 . . . . 61.04 111.45 174.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_exo -53.78 87.47 0.03 OUTLIER 'Trans proline' 0 C--N 1.385 2.494 0 C-N-CA 123.314 2.676 . . . . 51.5 112.707 176.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 159.55 -45.45 0.43 Allowed Glycine 0 C--N 1.342 0.894 0 CA-C-N 114.673 -1.149 . . . . 75.2 111.179 178.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 109.45 167.87 20.27 Favored Glycine 0 C--N 1.352 1.433 0 C-N-CA 123.669 0.652 . . . . 74.45 111.987 -175.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -78.03 112.15 14.65 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 109.293 -0.632 . . . . 70.14 109.293 176.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 84' ' ' ASP . . . . . 0.42 ' HA ' ' CE2' ' C' ' 106' ' ' PHE . 3.1 t70 -63.56 146.22 54.13 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.808 0.843 . . . . 63.13 112.801 -178.355 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 85' ' ' PHE . . . . . 0.47 ' O ' ' HB3' ' C' ' 171' ' ' PRO . 75.9 m-85 -138.62 71.33 1.39 Allowed 'General case' 0 C--N 1.356 0.878 0 C-N-CA 124.299 1.039 . . . . 74.41 110.207 171.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 37.0 m -51.0 86.75 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 125.05 1.34 . . . . 45.43 112.744 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 75.68 -5.54 37.66 Favored Glycine 0 CA--C 1.535 1.294 0 CA-C-N 116.067 -0.515 . . . . 74.33 113.493 -176.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 88' ' ' PHE . . . . . 0.451 ' HB2' ' HB3' ' C' ' 85' ' ' PHE . 12.8 m-85 -81.19 118.52 22.64 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.829 -0.804 . . . . 74.44 108.829 -171.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -76.86 81.4 3.44 Favored 'General case' 0 C--O 1.243 0.745 0 CA-C-O 121.204 0.526 . . . . 72.23 110.483 -173.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 90' ' ' VAL . . . . . 0.652 HG23 ' HE2' ' C' ' 97' ' ' PHE . 1.5 p -44.41 -40.96 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 125.46 1.504 . . . . 54.41 111.852 175.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -48.12 -40.0 22.2 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.716 1.606 . . . . 74.21 112.961 -178.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -85.1 -29.37 24.91 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.583 0.753 . . . . 75.53 112.165 -173.016 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 17.1 m-30 -68.98 170.39 9.9 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 113.143 0.794 . . . . 72.45 113.143 -164.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 81.0 p -71.95 172.77 9.37 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 124.77 1.228 . . . . 45.51 113.779 -164.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 95' ' ' GLU . . . . . 0.49 ' O ' ' HG3' ' C' ' 99' ' ' GLU . 4.7 mp0 -71.6 -34.0 69.5 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 115.275 -0.875 . . . . 55.43 110.953 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -61.19 -44.2 97.67 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-O 121.494 0.664 . . . . 65.02 110.33 174.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 97' ' ' PHE . . . . . 0.652 ' HE2' HG23 ' C' ' 90' ' ' VAL . 47.9 t80 -56.93 -43.77 81.8 Favored 'General case' 0 CA--C 1.554 1.103 0 CA-C-N 114.148 -1.387 . . . . 64.25 109.884 172.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -70.6 -18.97 62.88 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.055 0.542 . . . . 51.52 112.459 177.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 99' ' ' GLU . . . . . 0.49 ' HG3' ' O ' ' C' ' 95' ' ' GLU . 43.2 mt-10 -74.27 -55.35 6.13 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.127 0.489 . . . . 74.43 110.015 173.597 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 27.3 tp -74.91 -45.22 44.17 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.819 -1.082 . . . . 73.23 111.643 -170.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -97.24 -19.1 18.82 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.599 0.76 . . . . 73.25 112.257 -175.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -47.42 -57.96 6.93 Favored Glycine 0 CA--C 1.545 1.913 0 CA-C-O 118.947 -0.918 . . . . 54.11 115.119 -178.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -59.07 -9.41 7.97 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 123.788 2.992 . . . . 62.02 114.621 -179.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 104' ' ' GLY . . . . . 0.46 ' HA3' ' HB3' ' C' ' 78' ' ' PRO . . . -136.8 34.29 2.23 Favored Glycine 0 C--N 1.351 1.414 0 CA-C-O 119.985 -0.342 . . . . 43.23 113.116 178.24 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 105' ' ' LEU . . . . . 0.414 ' HB3' ' OD1' ' C' ' 169' ' ' ASN . 43.1 mt -73.18 68.97 1.03 Allowed 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.314 0.645 . . . . 73.03 111.474 172.085 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 106' ' ' PHE . . . . . 0.504 ' HB3' ' H ' ' C' ' 168' ' ' GLY . 23.2 m-85 48.56 -115.4 0.73 Allowed 'General case' 0 CA--C 1.564 1.482 0 C-N-CA 125.383 1.473 . . . . 64.24 114.36 176.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . 69.07 3.54 37.4 Favored Glycine 0 C--N 1.369 2.4 0 CA-C-O 119.89 -0.394 . . . . 51.05 113.388 -163.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 55.88 -128.13 44.51 Favored Glycine 0 C--N 1.364 2.097 0 N-CA-C 111.83 -0.508 . . . . 74.41 111.83 -171.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 109' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -109.05 9.25 26.36 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.786 0.834 . . . . 74.45 109.633 169.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 110' ' ' GLY . . . . . . . . . . . . . . . -92.0 -13.28 57.94 Favored Glycine 0 C--N 1.349 1.276 0 CA-C-N 115.976 -0.556 . . . . 54.22 112.643 -177.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? 59.16 6.88 0.77 Allowed 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 114.123 1.157 . . . . 75.25 114.123 178.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 112' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -53.54 -35.4 60.7 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.186 1.394 . . . . 74.1 111.572 169.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 113' ' ' SER . . . . . . . . . . . . . 25.0 m 52.79 30.37 8.89 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 125.002 1.321 . . . . 72.53 112.724 176.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 114' ' ' ARG . . . . . 0.482 ' HG3' ' H ' ' C' ' 115' ' ' LYS . 7.7 tpt180 -139.3 -164.66 1.71 Allowed 'General case' 0 CA--C 1.554 1.117 0 CA-C-O 117.713 -1.137 . . . . 74.05 109.646 -177.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 115' ' ' LYS . . . . . 0.482 ' H ' ' HG3' ' C' ' 114' ' ' ARG . 14.8 ttpp -14.41 121.9 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.244 0 C-N-CA 127.236 2.214 . . . . 54.14 116.48 -163.29 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 116' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' C' ' 170' ' ' PRO . . . -67.2 141.21 38.96 Favored Glycine 0 C--N 1.348 1.219 0 CA-C-N 115.024 -0.989 . . . . 45.25 113.102 179.145 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 117' ' ' ARG . . . . . 0.557 HH21 ' HB3' ' C' ' 167' ' ' GLN . 69.4 mtm180 -110.41 163.86 13.26 Favored 'General case' 0 C--O 1.265 1.891 0 CA-C-O 122.154 0.978 . . . . 64.44 110.534 -177.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.09 117.74 5.06 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 112.589 -2.096 . . . . 75.42 108.353 165.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 119' ' ' LEU . . . . . 0.505 ' HG ' ' HG2' ' C' ' 167' ' ' GLN . 3.3 tt -92.23 116.18 28.73 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 104.59 -2.374 . . . . 75.21 104.59 178.286 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.423 ' HA ' ' O ' ' C' ' 175' ' ' LEU . 63.0 ttt180 -117.98 118.84 33.04 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.35 -0.982 . . . . 72.31 108.35 -164.387 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 121' ' ' ALA . . . . . 0.507 ' HA ' HG23 ' B' ' 185' ' ' VAL . . . -108.58 170.03 8.28 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 113.847 1.055 . . . . 63.21 113.847 -164.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -127.79 108.14 10.47 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 114.16 -1.382 . . . . 73.22 110.288 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -139.12 111.68 7.94 Favored Pre-proline 0 N--CA 1.487 1.42 0 CA-C-N 118.535 0.607 . . . . 73.3 112.431 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -65.74 121.59 9.0 Favored 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 122.037 1.824 . . . . 72.51 109.692 162.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 125' ' ' LEU . . . . . 0.484 ' O ' ' HA ' ' C' ' 180' ' ' LEU . 12.7 tp -145.56 167.93 21.85 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 107.585 -1.265 . . . . 74.03 107.585 -169.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 126' ' ' THR . . . . . . . . . . . . . 14.5 t -128.26 176.99 7.25 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 119.366 0.985 . . . . 61.53 110.911 173.151 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 127' ' ' LEU . . . . . 0.469 HD11 ' H ' ' C' ' 185' ' ' VAL . 6.3 mt -60.73 -43.54 97.76 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.485 1.514 . . . . 62.25 109.696 -177.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 128' ' ' GLU . . . . . 0.451 ' HG2' ' HB2' ' B' ' 171' ' ' ALA . 1.9 mp0 -60.96 -39.67 90.43 Favored 'General case' 0 C--O 1.213 -0.836 0 CA-C-N 114.133 -1.394 . . . . 75.24 110.031 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 129' ' ' GLU . . . . . 0.532 ' HA ' ' HB2' ' C' ' 132' ' ' HIS . 50.3 mm-40 -77.2 -22.85 51.74 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.783 0.833 . . . . 73.53 111.225 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 130' ' ' ALA . . . . . 0.487 ' HB1' ' HA2' ' C' ' 152' ' ' GLY . . . -72.26 -35.26 68.73 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 109.297 -0.631 . . . . 64.34 109.297 175.035 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 131' ' ' PHE . . . . . 0.546 ' HB2' HD13 ' C' ' 215' ' ' LEU . 10.5 t80 -71.09 -43.56 67.47 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 114.131 -1.395 . . . . 75.55 110.855 168.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 132' ' ' HIS . . . . . 0.532 ' HB2' ' HA ' ' C' ' 129' ' ' GLU . 32.4 m170 -75.32 -6.82 51.88 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.854 0.461 . . . . 60.22 110.378 -178.028 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -59.57 77.81 0.01 OUTLIER Glycine 0 C--N 1.356 1.648 0 C-N-CA 123.815 0.721 . . . . 65.31 112.904 168.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . -113.94 -152.61 10.78 Favored Glycine 0 C--N 1.342 0.884 0 N-CA-C 109.417 -1.473 . . . . 53.24 109.417 174.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -71.55 92.99 1.17 Allowed 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 108.409 -0.96 . . . . 71.2 108.409 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 136' ' ' ARG . . . . . 0.573 ' HB2' HD22 ' B' ' 181' ' ' LEU . 78.3 mtp180 -139.55 159.48 42.06 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.116 0.966 . . . . 72.12 109.589 -173.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 137' ' ' VAL . . . . . . . . . . . . . 93.5 t -70.78 98.87 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.887 0 CA-C-O 121.978 0.894 . . . . 71.12 110.664 -175.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 138' ' ' VAL . . . . . . . . . . . . . 72.9 t -79.17 112.16 16.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 CA-C-N 113.853 -1.521 . . . . 72.14 107.831 169.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 139' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -115.69 82.22 1.72 Allowed 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 108.092 -1.077 . . . . 74.31 108.092 -170.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 140' ' ' VAL . . . . . 0.503 HG11 HD11 ' C' ' 174' ' ' LEU . 67.4 t -122.86 104.65 14.82 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 C-N-CA 124.292 1.037 . . . . 63.22 110.833 -169.359 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 69.21 15.01 8.64 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 125.145 1.378 . . . . 15.23 113.388 168.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 116.8 -30.15 6.51 Favored Glycine 0 C--N 1.339 0.746 0 N-CA-C 110.987 -0.845 . . . . 45.25 110.987 -175.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 143' ' ' ARG . . . . . 0.489 ' CZ ' ' HB ' ' C' ' 145' ' ' VAL . 13.0 tpt180 -70.73 114.32 8.7 Favored 'General case' 0 C--N 1.361 1.092 0 N-CA-C 109.055 -0.72 . . . . 73.04 109.055 177.005 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 7.5 ttt-85 -114.27 99.26 7.47 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 115.339 -0.846 . . . . 71.51 108.95 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 145' ' ' VAL . . . . . 0.551 HG22 ' HB ' ' C' ' 147' ' ' VAL . 3.1 p -124.85 124.41 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.473 1.109 . . . . 75.03 110.028 -178.199 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 146' ' ' SER . . . . . 0.458 ' HB2' ' HG3' ' B' ' 198' ' ' GLU . 29.2 m -87.13 86.41 7.29 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 108.906 -0.775 . . . . 54.21 108.906 177.614 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 147' ' ' VAL . . . . . 0.551 ' HB ' HG22 ' C' ' 145' ' ' VAL . 7.3 p -134.81 160.56 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 124.114 0.966 . . . . 72.53 110.59 -169.214 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 28.5 ttm-85 -90.18 104.89 17.41 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 108.11 -1.071 . . . . 74.22 108.11 168.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 149' ' ' ILE . . . . . . . . . . . . . 29.6 pt -69.34 150.73 97.09 Favored Pre-proline 0 CA--C 1.548 0.872 0 CA-C-O 117.755 -1.117 . . . . 71.41 108.438 165.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 150' ' ' PRO . . . . . 0.564 ' HD2' HG22 ' C' ' 161' ' ' VAL . 28.4 Cg_exo -38.68 107.97 0.07 OUTLIER 'Trans proline' 0 C--N 1.393 2.88 0 C-N-CA 123.415 2.743 . . . . 61.44 113.124 178.504 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -69.71 130.66 19.79 Favored 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 122.671 2.247 . . . . 73.2 111.541 -171.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 152' ' ' GLY . . . . . 0.538 ' HA3' HD23 ' C' ' 188' ' ' LEU . . . 91.71 112.01 1.8 Allowed Glycine 0 C--N 1.342 0.905 0 CA-C-N 115.645 -0.707 . . . . 54.32 113.091 -177.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 153' ' ' VAL . . . . . 0.71 HG21 HG21 ' C' ' 178' ' ' VAL . 3.0 m -123.64 177.66 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 C-N-CA 123.745 0.818 . . . . 71.13 109.595 -173.256 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 154' ' ' ARG . . . . . 0.456 ' HD2' ' HB2' ' B' ' 217' ' ' LEU . 97.0 mtt180 -135.03 155.48 50.69 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 123.429 0.692 . . . . 75.32 110.775 -178.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 155' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -67.88 102.53 1.27 Allowed 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.911 1.284 . . . . 74.51 112.036 -176.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 97.36 3.5 58.66 Favored Glycine 0 C--N 1.348 1.236 0 CA-C-N 115.354 -0.839 . . . . 64.51 113.009 179.038 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 157' ' ' SER . . . . . 0.422 ' HB3' ' HA ' ' B' ' 217' ' ' LEU . 52.0 m -95.75 169.82 9.74 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 117.205 0.502 . . . . 75.43 111.394 -175.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 158' ' ' VAL . . . . . 0.435 HG12 HG22 ' C' ' 177' ' ' VAL . 27.6 m -105.68 127.87 60.27 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 CA-C-O 121.604 0.716 . . . . 64.44 111.038 178.54 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 159' ' ' ILE . . . . . 0.594 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 15.2 mt -78.07 98.21 2.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 107.995 -1.113 . . . . 52.25 107.995 168.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 36.5 ttp180 -78.74 99.64 6.74 Favored 'General case' 0 C--O 1.239 0.51 0 O-C-N 123.794 0.684 . . . . 72.21 109.683 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 161' ' ' VAL . . . . . 0.613 ' HB ' ' HB3' ' C' ' 174' ' ' LEU . 19.3 t -95.99 113.11 61.52 Favored Pre-proline 0 C--O 1.251 1.15 0 N-CA-C 108.223 -1.028 . . . . 75.24 108.223 175.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -53.31 106.95 0.17 Allowed 'Trans proline' 0 C--N 1.381 2.277 0 C-N-CA 123.848 3.032 . . . . 63.42 114.476 -174.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 71.44 16.4 75.61 Favored Glycine 0 C--N 1.347 1.189 0 N-CA-C 115.694 1.038 . . . . 53.31 115.694 168.034 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 164' ' ' MET . . . . . 0.435 ' SD ' HG11 ' C' ' 145' ' ' VAL . 37.5 ttp -105.28 21.76 16.58 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 118.143 0.972 . . . . 73.35 110.939 -178.131 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . -78.12 -121.81 0.26 Allowed Glycine 0 C--N 1.35 1.345 0 CA-C-O 119.42 -0.656 . . . . 64.24 112.311 174.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . 150.98 -80.1 0.2 Allowed Glycine 0 C--N 1.356 1.639 0 C-N-CA 118.909 -1.615 . . . . 75.44 114.442 170.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 167' ' ' GLN . . . . . 0.557 ' HB3' HH21 ' C' ' 117' ' ' ARG . 31.6 mm-40 -14.91 101.18 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.491 0 C-N-CA 126.244 1.818 . . . . 64.31 114.043 -161.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 168' ' ' GLY . . . . . 0.504 ' H ' ' HB3' ' C' ' 106' ' ' PHE . . . 115.1 143.57 8.11 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 109.078 -1.609 . . . . 13.44 109.078 -162.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 169' ' ' ASN . . . . . 0.455 ' HB3' ' HD3' ' C' ' 170' ' ' PRO . 34.5 t30 -54.76 -57.61 18.36 Favored Pre-proline 0 CA--C 1.572 1.812 0 N-CA-C 114.597 1.332 . . . . 62.44 114.597 -164.041 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 170' ' ' PRO . . . . . 0.455 ' HD3' ' HB3' ' C' ' 169' ' ' ASN . 33.1 Cg_exo -62.18 154.16 64.72 Favored 'Trans proline' 0 C--N 1.393 2.905 0 CA-C-N 121.93 1.725 . . . . 51.41 112.208 172.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 171' ' ' PRO . . . . . 0.47 ' HB3' ' O ' ' C' ' 85' ' ' PHE . 22.7 Cg_endo -62.08 129.88 28.75 Favored 'Trans proline' 0 C--N 1.368 1.553 0 C-N-CA 122.234 1.956 . . . . 74.02 112.828 175.183 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -99.39 -175.23 31.37 Favored Glycine 0 N--CA 1.474 1.174 0 N-CA-C 110.51 -1.036 . . . . 74.42 110.51 166.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 173' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -98.91 152.97 19.19 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 117.993 0.896 . . . . 74.51 109.302 178.039 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 174' ' ' LEU . . . . . 0.613 ' HB3' ' HB ' ' C' ' 161' ' ' VAL . 26.5 tp -99.25 121.74 41.47 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 121.946 -0.472 . . . . 75.22 110.585 -176.039 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 175' ' ' LEU . . . . . 0.423 ' O ' ' HA ' ' C' ' 120' ' ' ARG . 81.3 mt -117.74 87.71 2.77 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.281 0.632 . . . . 71.32 109.9 176.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 176' ' ' LEU . . . . . 0.594 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 48.6 mt -76.22 108.46 9.17 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 116.232 -0.44 . . . . 43.02 109.949 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 177' ' ' VAL . . . . . 0.435 HG22 HG12 ' C' ' 158' ' ' VAL . 61.5 t -81.82 106.46 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 N-CA-C 108.256 -1.016 . . . . 74.43 108.256 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 178' ' ' VAL . . . . . 0.71 HG21 HG21 ' C' ' 153' ' ' VAL . 4.0 p -95.64 138.83 20.24 Favored 'Isoleucine or valine' 0 C--O 1.242 0.69 0 CA-C-N 114.344 -1.298 . . . . 74.01 110.344 -177.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 179' ' ' ARG . . . . . . . . . . . . . 52.4 mmm-85 -121.68 109.9 15.31 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 107.73 -1.211 . . . . 72.33 107.73 175.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 180' ' ' LEU . . . . . 0.484 ' HA ' ' O ' ' C' ' 125' ' ' LEU . 87.6 mt -71.11 147.87 48.02 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.199 0.6 . . . . 70.51 111.843 -176.014 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 181' ' ' LEU . . . . . . . . . . . . . 30.5 mt -62.01 167.83 4.42 Favored Pre-proline 0 CA--C 1.559 1.316 0 C-N-CA 124.892 1.277 . . . . 74.2 112.106 -179.044 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 182' ' ' PRO . . . . . 0.427 ' HG2' ' HB3' ' B' ' 160' ' ' ALA . 29.3 Cg_exo -42.43 -1.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.398 3.157 1 C-N-CA 125.364 4.043 . . . . 64.12 118.557 175.458 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 183' ' ' HIS . . . . . 0.428 ' HA ' HG23 ' B' ' 225' ' ' THR . 0.9 OUTLIER -127.2 81.2 70.42 Favored Pre-proline 0 CA--C 1.562 1.438 0 CA-C-N 118.971 0.805 . . . . 62.13 109.792 166.017 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 184' ' ' PRO . . . . . 0.437 ' O ' ' HA ' ' B' ' 222' ' ' ALA . 88.3 Cg_endo -85.51 69.6 5.23 Favored 'Trans proline' 0 C--N 1.371 1.713 0 C-N-CA 123.628 2.886 . . . . 71.54 110.485 174.581 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 185' ' ' VAL . . . . . 0.624 HG22 HG21 ' B' ' 225' ' ' THR . 3.9 t -89.89 -42.37 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 109.843 -0.429 . . . . 72.23 109.843 -165.297 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 186' ' ' PHE . . . . . 0.598 ' HB3' HD22 ' C' ' 193' ' ' LEU . 20.9 m-85 -99.38 116.05 30.65 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.369 0.604 . . . . 61.44 112.425 -170.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 187' ' ' ARG . . . . . 0.48 ' HE ' ' HB3' ' B' ' 222' ' ' ALA . 37.2 ttm180 -102.51 101.77 11.99 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.312 1.445 . . . . 75.14 107.339 171.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 188' ' ' LEU . . . . . 0.538 HD23 ' HA3' ' C' ' 152' ' ' GLY . 57.8 tp -92.55 141.16 28.8 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 113.301 0.852 . . . . 74.14 113.301 -169.495 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -125.23 101.25 6.9 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 107.857 -1.164 . . . . 71.33 107.857 160.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 72.2 -81.12 0.59 Allowed Glycine 0 C--N 1.353 1.504 0 CA-C-N 115.18 -0.918 . . . . 74.2 113.51 176.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 191' ' ' GLN . . . . . 0.584 ' HA ' ' HB2' ' C' ' 240' ' ' PHE . 19.4 mt-30 -132.64 -9.94 3.16 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.318 0.647 . . . . 60.21 111.746 178.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -105.49 115.38 30.16 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 121.23 0.538 . . . . 65.13 110.587 -176.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 193' ' ' LEU . . . . . 0.598 HD22 ' HB3' ' C' ' 186' ' ' PHE . 72.2 mt -86.0 152.27 23.06 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.932 1.293 . . . . 52.2 111.132 -178.061 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 194' ' ' TYR . . . . . 0.47 ' O ' ' HA ' ' C' ' 186' ' ' PHE . 49.7 t80 -111.98 148.96 32.68 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 107.25 -1.389 . . . . 75.43 107.25 162.211 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 195' ' ' ALA . . . . . 0.42 ' HA ' ' O ' ' C' ' 185' ' ' VAL . . . -154.42 -176.95 6.14 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.078 0.551 . . . . 65.11 111.177 -177.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 40.2 m -128.36 139.05 52.59 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.049 -0.978 . . . . 51.32 108.893 168.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 197' ' ' LEU . . . . . 0.431 HD13 HD22 ' C' ' 251' ' ' LEU . 35.9 tp -115.53 143.46 45.28 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.522 1.129 . . . . 73.5 108.473 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -113.04 102.1 10.09 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.388 -0.597 . . . . 44.52 109.388 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 199' ' ' VAL . . . . . 0.605 ' HA ' HG11 ' C' ' 210' ' ' VAL . 95.2 t -108.08 119.36 50.17 Favored Pre-proline 0 N--CA 1.473 0.698 0 C-N-CA 123.901 0.88 . . . . 61.21 109.005 176.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 200' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.94 149.54 65.91 Favored 'Trans proline' 0 C--N 1.371 1.751 0 C-N-CA 121.858 1.705 . . . . 71.34 110.934 175.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 201' ' ' ALA . . . . . . . . . . . . . . . -56.02 -43.44 99.23 Favored Pre-proline 0 CA--C 1.553 1.093 0 N-CA-C 114.093 1.145 . . . . 74.35 114.093 -174.117 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 202' ' ' PRO . . . . . 0.427 ' O ' HG12 ' C' ' 206' ' ' VAL . 77.0 Cg_exo -54.18 -53.44 6.31 Favored 'Trans proline' 0 C--N 1.398 3.156 0 C-N-CA 121.752 1.635 . . . . 63.15 112.286 175.526 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 203' ' ' ILE . . . . . . . . . . . . . 41.0 mt -62.73 -32.99 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 124.554 1.142 . . . . 63.4 111.209 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.96 -43.9 81.92 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.756 0.822 . . . . 75.02 112.013 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 205' ' ' VAL . . . . . . . . . . . . . 87.9 t -71.7 -47.95 54.38 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 123.256 0.622 . . . . 63.41 111.199 -179.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 206' ' ' VAL . . . . . 0.569 HG23 ' HE2' ' A' ' 270' ' ' LYS . 14.7 p -80.1 -34.74 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 112.761 0.652 . . . . 52.12 112.761 -171.556 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 90.57 104.5 1.25 Allowed Glycine 0 C--N 1.343 0.92 0 N-CA-C 111.069 -0.812 . . . . 63.21 111.069 -167.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -143.44 -126.71 2.03 Favored Glycine 0 C--N 1.343 0.927 0 N-CA-C 111.679 -0.568 . . . . 51.32 111.679 -176.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 209' ' ' LYS . . . . . 0.478 ' HG2' ' HG2' ' C' ' 220' ' ' GLU . 34.1 ttmt -157.21 137.18 12.53 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 117.633 0.717 . . . . 72.12 110.85 -176.508 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 210' ' ' VAL . . . . . 0.605 HG11 ' HA ' ' C' ' 199' ' ' VAL . 23.4 m -129.95 177.03 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 125.501 1.52 . . . . 62.05 109.526 174.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 211' ' ' ARG . . . . . 0.78 HH22 ' HB2' ' B' ' 233' ' ' PHE . 0.1 OUTLIER -109.46 149.99 28.76 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 118.436 0.562 . . . . 72.44 111.204 -179.845 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -129.5 118.55 22.26 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 107.45 -1.315 . . . . 74.43 107.45 166.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 213' ' ' MET . . . . . 0.613 ' HG2' ' HB3' ' B' ' 172' ' ' GLU . 1.4 tmm? -73.82 117.79 16.02 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.344 -0.984 . . . . 63.12 108.344 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 214' ' ' THR . . . . . 0.429 ' OG1' HG12 ' C' ' 219' ' ' VAL . 0.2 OUTLIER -122.8 175.76 6.36 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 119.014 0.824 . . . . 54.24 112.095 -173.521 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 215' ' ' LEU . . . . . 0.546 HD13 ' HB2' ' C' ' 131' ' ' PHE . 41.7 mt -75.82 -29.8 58.78 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.459 1.503 . . . . 44.41 112.012 -171.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -87.11 3.28 46.86 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 114.803 -1.09 . . . . 71.0 110.272 176.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 118.26 -178.22 16.75 Favored Glycine 0 C--N 1.348 1.208 0 N-CA-C 110.433 -1.067 . . . . 64.11 110.433 -172.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -75.26 125.2 9.0 Favored 'Trans proline' 0 CA--C 1.554 1.477 0 C-N-CA 121.954 1.769 . . . . 52.13 111.97 178.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 219' ' ' VAL . . . . . 0.475 HG23 HG22 ' B' ' 238' ' ' THR . 14.0 p -100.56 157.51 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 N-CA-C 106.865 -1.531 . . . . 52.53 106.865 171.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 220' ' ' GLU . . . . . 0.553 ' HB3' ' HB2' ' B' ' 235' ' ' GLU . 16.5 tt0 -126.63 108.33 11.01 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.859 -0.793 . . . . 72.32 108.859 -177.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 221' ' ' VAL . . . . . 0.423 HG22 HD21 ' C' ' 235' ' ' LEU . 32.1 t -68.9 123.99 23.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 125.858 1.663 . . . . 74.03 111.2 -174.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -84.67 108.49 17.42 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 109.413 -0.588 . . . . 73.3 109.413 172.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 61.1 t -84.25 127.64 65.54 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 123.744 0.818 . . . . 73.11 110.508 -176.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 224' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -79.76 161.83 24.33 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 123.233 2.622 . . . . 54.33 111.082 168.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 225' ' ' PRO . . . . . 0.754 ' HG2' HD13 ' B' ' 247' ' ' LEU . 39.4 Cg_exo -63.12 159.05 40.7 Favored 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 122.427 2.084 . . . . 74.0 113.483 177.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 226' ' ' ARG . . . . . 0.444 ' HD2' ' O ' ' A' ' 259' ' ' GLU . 9.5 mmt180 55.3 63.0 2.24 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.514 1.526 . . . . 70.15 111.894 177.078 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 227' ' ' THR . . . . . . . . . . . . . 52.4 m -96.92 128.93 44.36 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 123.815 0.846 . . . . 70.3 110.97 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 228' ' ' GLN . . . . . 0.477 ' NE2' ' HG3' ' A' ' 259' ' ' GLU . 27.8 mp0 -105.23 147.67 27.8 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 124.545 1.138 . . . . 74.32 111.893 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -73.28 123.4 23.65 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 115.43 -0.805 . . . . 62.12 109.264 177.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 116.12 -7.41 18.99 Favored Glycine 0 C--N 1.337 0.599 0 O-C-N 123.522 0.514 . . . . 62.04 112.064 -176.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 231' ' ' ARG . . . . . 0.59 ' HD3' ' HZ3' ' B' ' 242' ' ' TRP . 36.0 mtt180 -63.02 169.57 3.27 Favored 'General case' 0 C--N 1.354 0.79 0 CA-C-N 116.846 0.323 . . . . 74.12 110.925 171.072 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 232' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' C' ' 251' ' ' LEU . 3.7 ttmp? -139.29 147.06 41.13 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.567 -0.531 . . . . 71.45 109.567 176.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 233' ' ' LEU . . . . . 0.468 ' O ' ' HA ' ' C' ' 250' ' ' TYR . 1.7 tt -133.01 125.01 28.77 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.693 0.797 . . . . 74.21 109.308 -166.73 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -93.19 104.22 16.43 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-O 121.065 0.459 . . . . 72.34 110.614 170.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 235' ' ' LEU . . . . . 0.423 HD21 HG22 ' C' ' 221' ' ' VAL . 75.8 mt -85.11 123.88 31.14 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.391 -0.966 . . . . 73.43 108.391 166.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -85.32 131.75 34.36 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 123.349 0.66 . . . . 71.55 111.541 -171.012 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 80.83 -1.28 84.45 Favored Glycine 0 C--N 1.351 1.402 0 O-C-N 124.033 0.833 . . . . 71.42 113.687 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 238' ' ' LYS . . . . . 0.405 ' HG3' ' HB3' ' C' ' 235' ' ' LEU . 14.0 mmtm -95.11 9.05 41.03 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.19 0.996 . . . . 72.03 112.019 -172.568 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -86.29 -133.01 3.27 Favored Glycine 0 C--N 1.346 1.085 0 N-CA-C 111.723 -0.551 . . . . 31.21 111.723 172.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 240' ' ' PHE . . . . . 0.584 ' HB2' ' HA ' ' C' ' 191' ' ' GLN . 1.9 m-85 -103.37 128.45 27.48 Favored Pre-proline 0 N--CA 1.47 0.558 0 C-N-CA 123.105 0.562 . . . . 75.14 110.132 177.452 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 241' ' ' PRO . . . . . 0.454 ' HA ' ' HG2' ' C' ' 246' ' ' ARG . 31.4 Cg_exo -61.98 105.21 0.37 Allowed 'Trans proline' 0 C--N 1.37 1.688 0 C-N-CA 123.405 2.736 . . . . 70.21 112.916 173.115 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -75.67 173.16 53.58 Favored Glycine 0 CA--C 1.531 1.081 0 CA-C-N 115.195 -0.911 . . . . 70.14 112.798 174.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -64.86 -17.17 58.69 Favored 'Trans proline' 0 C--N 1.367 1.545 0 C-N-CA 123.184 2.589 . . . . 71.42 113.955 -170.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -130.84 1.07 4.34 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.631 0.773 . . . . 71.42 111.907 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . -173.19 -136.66 2.22 Favored Glycine 0 C--N 1.35 1.349 0 CA-C-O 119.648 -0.529 . . . . 51.32 113.09 -178.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 246' ' ' ARG . . . . . 0.454 ' HG2' ' HA ' ' C' ' 241' ' ' PRO . 77.8 mtm180 -150.04 165.06 33.89 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.826 0.851 . . . . 61.31 110.891 -176.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 247' ' ' GLY . . . . . 0.427 ' HA2' ' HA2' ' B' ' 36' ' ' GLY . . . -102.35 -166.66 26.63 Favored Glycine 0 C--N 1.35 1.322 0 CA-C-N 114.801 -1.091 . . . . 63.23 111.951 174.35 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -129.44 164.12 24.36 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 121.114 0.483 . . . . 73.54 110.359 -171.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 249' ' ' LEU . . . . . 0.413 HD23 HD12 ' C' ' 235' ' ' LEU . 17.7 tp -120.18 127.62 52.63 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.167 0.987 . . . . 74.23 109.401 -174.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 250' ' ' TYR . . . . . 0.468 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 79.0 m-85 -117.24 100.78 7.93 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.704 0.802 . . . . 71.43 110.323 -177.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 251' ' ' LEU . . . . . 0.447 ' O ' ' HA ' ' C' ' 232' ' ' LYS . 0.6 OUTLIER -100.97 134.29 44.19 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 109.932 -0.395 . . . . 64.53 109.932 -176.133 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -76.68 107.73 9.19 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.145 -1.057 . . . . 73.41 108.145 168.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 253' ' ' VAL . . . . . . . . . . . . . 46.2 t -75.07 113.78 14.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 115.199 -0.91 . . . . 73.5 110.2 -176.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 254' ' ' ARG . . . . . . . . . . . . . 39.1 mtm180 -97.13 155.46 16.81 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.297 0.639 . . . . 74.13 110.882 177.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 255' ' ' ILE . . . . . . . . . . . . . 36.9 mm -101.56 124.88 55.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 114.764 -1.107 . . . . 75.24 108.052 166.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 256' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.07 175.97 8.46 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.138 1.375 . . . . 53.32 108.536 -178.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 35.4 pt -131.16 147.88 67.99 Favored Pre-proline 0 N--CA 1.484 1.243 0 C-N-CA 123.491 0.716 . . . . 64.54 110.047 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -62.56 -12.89 30.3 Favored 'Trans proline' 0 C--N 1.377 2.07 0 C-N-CA 122.862 2.375 . . . . 73.21 113.858 -172.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 54.24 -67.58 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 125.481 1.512 . . . . 72.3 112.194 -164.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 8.0 ppt_? -60.07 132.7 54.76 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.264 0.626 . . . . 73.41 110.433 174.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 261' ' ' LEU . . . . . . . . . . . . . 92.4 mt -139.9 147.86 41.2 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.728 0.811 . . . . 71.21 109.978 -174.317 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 74.4 p -81.89 160.45 63.56 Favored Pre-proline 0 CA--C 1.553 1.084 0 N-CA-C 107.97 -1.122 . . . . 61.23 107.97 168.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -45.84 -44.08 18.67 Favored 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 122.782 2.322 . . . . 74.2 112.538 172.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -60.97 -54.18 48.14 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-N 114.18 -1.373 . . . . 71.04 111.514 176.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -50.02 -58.45 5.46 Favored 'General case' 0 C--N 1.359 0.994 0 O-C-N 124.284 0.99 . . . . 65.11 109.992 -177.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 266' ' ' GLU . . . . . 0.468 ' O ' ' HG2' ' C' ' 270' ' ' LYS . 26.8 tt0 -61.34 -38.21 86.09 Favored 'General case' 0 C--N 1.349 0.574 0 CA-C-N 114.719 -1.128 . . . . 64.21 111.336 -175.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -57.28 -46.43 83.11 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.201 0.6 . . . . 70.32 112.351 177.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 268' ' ' LEU . . . . . 0.477 ' HB2' HD21 ' A' ' 272' ' ' LEU . 10.4 mp -66.15 -39.97 90.21 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 116.407 -0.36 . . . . 52.44 110.89 177.437 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -60.44 -36.0 77.17 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 123.266 0.354 . . . . 61.11 111.277 174.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 270' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' C' ' 266' ' ' GLU . 34.2 mmtp -64.08 -45.94 86.49 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.397 0.679 . . . . 75.43 110.439 178.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -56.29 -47.42 78.69 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 124.036 0.835 . . . . 75.33 111.577 176.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 91.3 mt -61.42 -42.09 98.19 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 114.834 -1.075 . . . . 74.33 110.803 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -61.47 -40.4 94.39 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.373 0.669 . . . . 34.13 111.046 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -68.16 -34.06 75.62 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.715 0.806 . . . . 63.21 111.634 177.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -62.67 -31.43 72.32 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 115.838 -0.619 . . . . 70.04 110.331 172.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 276' ' ' TYR . . . . . 0.485 ' HB3' HD11 ' A' ' 203' ' ' ILE . 53.6 m-85 -79.82 -30.99 40.61 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.084 0.554 . . . . 75.52 112.437 171.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 19.0 m-30 -68.11 -24.23 65.0 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 118.517 0.599 . . . . 44.24 110.205 178.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -61.32 -8.3 3.74 Favored 'General case' 0 CA--C 1.559 1.326 0 C-N-CA 124.193 0.997 . . . . 55.2 113.425 172.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 279' ' ' ARG . . . . . . . . . . . . . 81.3 mtt180 -73.59 -24.07 60.01 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 122.739 0.416 . . . . 71.52 112.005 174.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.556 1.186 0 O-C-N 124.417 1.073 . . . . 75.14 112.781 -167.514 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.48 1.065 0 CA-C-O 121.17 0.509 . . . . 64.12 109.806 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.43 27.04 16.07 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 125.212 1.405 . . . . 51.4 113.208 176.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.24 71.26 9.29 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.508 0.723 . . . . 74.04 110.635 -176.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -40.43 100.99 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 125.716 1.606 . . . . 62.43 113.789 176.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.417 ' HB3' HD11 ' A' ' 10' ' ' ILE . 51.3 mtmt -87.96 128.18 35.38 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 108.565 -0.902 . . . . 74.32 108.565 169.328 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.492 ' HA ' ' OH ' ' A' ' 66' ' ' TYR . 10.7 t70 -76.48 105.81 7.75 Favored 'General case' 0 C--N 1.347 0.491 0 N-CA-C 109.187 -0.672 . . . . 61.41 109.187 -177.589 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -68.44 -33.31 73.98 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.692 0.797 . . . . 73.34 112.531 -170.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -64.12 -45.62 87.77 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 109.634 -0.506 . . . . 73.33 109.634 174.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.48 -42.1 95.59 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.632 -0.713 . . . . 60.32 111.375 178.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.417 HD11 ' HB3' ' A' ' 5' ' ' LYS . 81.4 mt -58.79 -42.22 84.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 123.676 0.79 . . . . 74.23 110.231 176.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.2 mt -76.14 -11.81 60.0 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 112.912 0.708 . . . . 51.33 112.912 178.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.56 35.09 56.12 Favored Glycine 0 C--N 1.351 1.385 0 O-C-N 122.972 0.17 . . . . 53.33 112.709 -178.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.5 m -127.1 154.5 76.67 Favored Pre-proline 0 CA--C 1.552 1.028 0 C-N-CA 124.916 1.286 . . . . 71.43 109.608 178.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -74.57 168.56 24.52 Favored 'Trans proline' 0 C--N 1.374 1.914 0 C-N-CA 122.282 1.988 . . . . 50.12 112.25 177.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 83.7 mtt180 -75.12 17.36 0.24 Allowed 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 113.142 0.793 . . . . 75.43 113.142 -178.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -124.78 15.42 8.67 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.101 0.96 . . . . 64.11 108.974 173.5 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.11 112.08 2.84 Favored 'General case' 0 C--N 1.349 0.566 0 CA-C-N 115.069 -0.969 . . . . 64.31 110.437 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 62.1 p -72.31 169.76 15.57 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.59 0.756 . . . . 71.11 109.708 176.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -54.03 -41.06 67.62 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.954 0.902 . . . . 64.21 112.07 -177.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -65.69 -41.28 92.6 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.187 0.595 . . . . 72.43 110.598 -177.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -69.29 -40.81 77.51 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.36 0.664 . . . . 64.03 111.014 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.554 HD13 ' HB3' ' A' ' 57' ' ' LEU . 60.9 mt -68.68 -32.86 56.74 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 C-N-CA 124.271 1.028 . . . . 73.31 110.721 178.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp -73.49 -37.88 65.57 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.177 0.991 . . . . 71.24 110.341 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -75.72 -29.25 58.86 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.044 0.538 . . . . 54.12 110.909 175.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.87 -33.85 71.01 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.351 0.66 . . . . 64.0 110.073 174.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -64.96 -53.05 52.36 Favored 'General case' 0 C--O 1.201 -1.466 0 CA-C-N 114.916 -1.038 . . . . 73.1 109.369 173.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -54.08 -40.14 66.96 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.643 0.777 . . . . 74.22 111.703 178.072 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.419 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 61.0 ttt180 -55.08 -68.19 0.21 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.174 1.39 . . . . 71.15 110.79 177.105 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.745 ' HB3' HD13 ' A' ' 50' ' ' ILE . 96.2 mt -74.43 -16.71 60.86 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.411 -0.813 . . . . 74.11 111.745 -174.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.21 -56.71 8.75 Favored 'General case' 0 C--O 1.204 -1.306 0 N-CA-C 108.177 -1.046 . . . . 63.3 108.177 174.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 69.2 mtp180 -55.22 -51.88 65.17 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 124.127 0.892 . . . . 72.33 110.768 177.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.419 ' HG2' ' O ' ' A' ' 28' ' ' ARG . 14.5 mm100 -54.28 -47.13 72.68 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 124.303 1.002 . . . . 63.33 111.728 -178.333 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.404 ' HE2' HD22 ' A' ' 29' ' ' LEU . 27.7 m-85 -117.82 29.54 7.77 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.36 0.664 . . . . 63.25 111.775 -168.481 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -75.84 111.79 16.56 Favored Pre-proline 0 N--CA 1.485 1.281 0 CA-C-O 117.795 -1.098 . . . . 63.41 109.705 -179.026 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.4 -26.86 83.71 Favored 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 122.516 2.144 . . . . 74.13 111.759 176.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -59.81 -37.39 79.04 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.126 1.37 . . . . 72.45 111.572 175.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 73.5 t -101.97 -58.66 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 CA-C-O 121.478 0.656 . . . . 65.53 109.74 -178.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -97.0 98.96 10.51 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.122 1.369 . . . . 61.35 109.739 -177.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -74.36 82.76 1.91 Allowed 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.953 -0.758 . . . . 73.11 108.953 177.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.412 ' O ' ' HG3' ' A' ' 44' ' ' GLU . 53.7 m -139.64 113.52 7.87 Favored Pre-proline 0 N--CA 1.474 0.753 0 CA-C-O 118.492 -0.765 . . . . 54.41 109.281 177.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -48.19 -40.95 34.97 Favored 'Trans proline' 0 C--N 1.385 2.48 0 C-N-CA 123.606 2.87 . . . . 72.23 113.437 178.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -55.15 -47.03 75.68 Favored 'General case' 0 C--O 1.248 0.999 0 C-N-CA 124.578 1.151 . . . . 64.43 110.696 175.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.64 -23.04 63.43 Favored 'General case' 0 C--N 1.354 0.787 0 CA-C-N 115.077 -0.965 . . . . 72.14 110.782 -178.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.526 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 33.5 mt-10 -76.31 -49.11 17.8 Favored 'General case' 0 C--N 1.358 0.957 0 O-C-N 123.511 0.507 . . . . 62.01 109.781 -176.533 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -67.95 -39.68 83.38 Favored 'General case' 0 C--O 1.251 1.166 0 O-C-N 123.801 0.688 . . . . 62.44 110.927 -179.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 42.8 mttp -56.94 -48.95 77.1 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 116.168 -0.469 . . . . 74.03 110.177 170.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -59.71 -32.91 70.97 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.101 0.96 . . . . 73.24 110.84 179.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.526 ' HG2' ' O ' ' A' ' 44' ' ' GLU . 33.5 mmtp -66.66 -43.41 84.63 Favored 'General case' 0 C--N 1.349 0.548 0 CA-C-O 119.245 -0.407 . . . . 75.14 110.662 177.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -68.17 -26.56 65.81 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 123.706 0.629 . . . . 71.44 112.278 176.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.745 HD13 ' HB3' ' A' ' 29' ' ' LEU . 59.5 mt -76.76 -35.2 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 124.106 0.962 . . . . 70.53 110.242 175.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -79.3 -21.61 45.73 Favored 'General case' 0 C--O 1.212 -0.891 0 C-N-CA 123.889 0.875 . . . . 73.43 110.621 175.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -77.27 -45.64 25.71 Favored 'General case' 0 C--O 1.247 0.924 0 C-N-CA 124.977 1.311 . . . . 63.42 108.726 176.088 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.78 -47.45 82.51 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-N 113.672 -1.604 . . . . 65.45 110.184 174.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.488 ' HD2' ' HZ ' ' A' ' 88' ' ' PHE . 16.6 t80 -76.48 -23.27 53.8 Favored 'General case' 0 C--O 1.207 -1.166 0 CA-C-N 115.435 -0.802 . . . . 72.32 110.713 177.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.408 ' HB1' ' HD2' ' A' ' 85' ' ' PHE . . . -60.97 -36.16 78.69 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 118.833 0.742 . . . . 53.01 110.875 175.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.532 HG11 ' HB2' ' A' ' 66' ' ' TYR . 19.2 t -76.04 -57.66 5.79 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 CA-C-N 115.363 -0.835 . . . . 74.52 110.099 171.584 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.554 ' HB3' HD13 ' A' ' 22' ' ' ILE . 49.2 mt -87.31 12.0 12.99 Favored 'General case' 0 CA--C 1.561 1.397 0 CA-C-N 115.003 -0.999 . . . . 62.04 112.964 -164.664 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.463 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 26.0 t -69.06 -38.61 79.17 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 123.933 0.893 . . . . 74.34 111.228 176.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.481 ' HB2' ' HD3' ' A' ' 62' ' ' LYS . 8.8 m-20 -124.6 142.07 39.57 Favored Pre-proline 0 N--CA 1.475 0.813 0 N-CA-C 108.96 -0.755 . . . . 74.34 108.96 -177.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.423 ' O ' ' HG2' ' A' ' 64' ' ' ARG . 40.0 Cg_exo -58.04 -27.45 79.57 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 122.972 2.448 . . . . 72.41 113.115 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -59.43 -58.72 7.39 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.012 0.925 . . . . 72.3 110.817 176.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.481 ' HD3' ' HB2' ' A' ' 59' ' ' ASP . 20.8 mtpt -73.07 -29.56 63.04 Favored 'General case' 0 C--O 1.249 1.078 0 CA-C-N 114.53 -1.214 . . . . 74.54 111.029 -175.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.432 ' HG3' HD22 ' A' ' 57' ' ' LEU . 61.6 ttt-85 -60.05 -43.92 95.05 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.204 -0.907 . . . . 74.11 109.462 172.215 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.423 ' HG2' ' O ' ' A' ' 60' ' ' PRO . 22.8 mmt180 -68.93 -31.34 70.17 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 123.736 0.648 . . . . 74.25 112.029 177.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.448 HD12 ' HA ' ' A' ' 62' ' ' LYS . 87.3 mt -54.38 -46.5 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 CA-C-O 121.255 0.55 . . . . 64.42 109.653 169.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.532 ' HB2' HG11 ' A' ' 56' ' ' VAL . 7.7 t80 -63.82 -49.99 70.7 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 115.532 -0.758 . . . . 75.4 111.377 175.6 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -57.68 -36.07 71.43 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.997 0.919 . . . . 64.04 111.323 -176.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 60.8 p -79.31 -28.08 42.18 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 119.054 -0.498 . . . . 75.13 110.922 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -67.88 102.78 1.32 Allowed 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 109.455 -0.572 . . . . 63.45 109.455 176.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 119.68 17.63 4.64 Favored Glycine 0 N--CA 1.473 1.124 0 C-N-CA 124.053 0.835 . . . . 52.54 111.346 -170.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 67.8 m -150.61 -55.75 0.16 Allowed 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 104.208 -2.516 . . . . 71.23 104.208 177.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 34.0 m -78.98 138.45 38.06 Favored 'General case' 0 C--O 1.251 1.146 0 N-CA-C 104.466 -2.42 . . . . 74.23 104.466 156.095 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.75 -31.58 12.17 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.015 0.526 . . . . 74.04 110.122 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.72 152.15 87.04 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 123.923 0.889 . . . . 75.1 110.314 175.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -62.32 116.58 3.59 Favored 'Trans proline' 0 C--N 1.375 1.934 0 C-N-CA 122.262 1.975 . . . . 75.41 109.952 168.05 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -51.02 144.99 26.33 Favored 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 123.653 2.902 . . . . 74.25 114.07 -177.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.438 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 11.0 Cg_endo -50.54 124.46 13.36 Favored 'Trans proline' 0 C--N 1.389 2.705 0 C-N-CA 123.828 3.019 . . . . 62.44 113.279 -174.504 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 77' ' ' PRO . 25.4 Cg_exo -63.87 135.33 47.59 Favored 'Trans proline' 0 C--N 1.379 2.152 0 C-N-CA 122.627 2.218 . . . . 43.51 112.227 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.402 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 85.3 Cg_exo -51.16 149.91 15.07 Favored 'Trans proline' 0 C--N 1.378 2.091 0 C-N-CA 122.932 2.422 . . . . 71.05 112.281 168.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 79' ' ' PRO . 38.9 Cg_exo -61.3 85.23 0.09 OUTLIER 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 123.183 2.589 . . . . 51.35 113.266 -175.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 150.03 -34.29 1.02 Allowed Glycine 0 N--CA 1.466 0.674 0 N-CA-C 109.963 -1.255 . . . . 62.41 109.963 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 140.76 -152.73 23.27 Favored Glycine 0 C--N 1.35 1.32 0 C-N-CA 124.151 0.882 . . . . 53.03 110.955 175.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -99.01 113.22 25.29 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.152 0.981 . . . . 74.41 108.897 175.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -55.1 141.76 33.32 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.638 1.175 . . . . 71.31 111.47 174.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.429 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 55.8 m-85 -140.58 77.99 1.63 Allowed 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 124.429 1.092 . . . . 70.22 110.215 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.592 ' HA ' ' HA3' ' A' ' 163' ' ' GLY . 1.7 m -45.62 82.86 0.0 OUTLIER 'General case' 0 CA--C 1.561 1.392 0 C-N-CA 125.892 1.677 . . . . 74.44 113.225 -177.359 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 62.4 28.48 71.15 Favored Glycine 0 C--N 1.349 1.282 0 CA-C-N 116.044 -0.525 . . . . 70.11 114.306 -176.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.488 ' HZ ' ' HD2' ' A' ' 54' ' ' TYR . 30.1 m-85 -112.23 117.66 33.16 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.034 0.534 . . . . 72.34 110.031 -176.257 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.494 ' HA ' ' HB3' ' A' ' 170' ' ' PRO . 5.7 m-20 -82.89 74.75 9.83 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 122.405 1.097 . . . . 71.44 110.225 178.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.512 HG21 HD22 ' A' ' 105' ' ' LEU . 1.6 p -50.13 -30.0 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 126.613 1.965 . . . . 75.21 113.11 171.292 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -63.59 -4.99 3.33 Favored 'General case' 0 CA--C 1.566 1.595 0 C-N-CA 124.651 1.18 . . . . 75.33 111.989 177.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -119.03 -15.49 9.27 Favored 'General case' 0 CA--C 1.562 1.433 0 C-N-CA 124.652 1.181 . . . . 45.35 111.559 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 18.7 m-30 -74.94 -170.06 1.03 Allowed 'General case' 0 N--CA 1.503 2.212 0 C-N-CA 123.75 0.82 . . . . 71.01 112.625 -173.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 82.5 p -77.76 167.3 21.77 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 113.693 0.997 . . . . 74.5 113.693 -169.008 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.02 -49.02 77.72 Favored 'General case' 0 C--N 1.365 1.276 0 CA-C-N 115.455 -0.793 . . . . 74.31 111.665 179.165 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -56.35 -40.87 75.2 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.592 0.757 . . . . 75.03 110.258 -177.12 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -65.27 -45.88 82.74 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 114.606 -1.179 . . . . 63.23 110.228 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.503 ' HA ' HD11 ' A' ' 105' ' ' LEU . 41.1 mt-30 -80.82 1.73 29.35 Favored 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 114.994 -1.003 . . . . 73.05 111.868 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -99.64 -51.09 3.85 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 124.074 0.95 . . . . 70.02 111.748 170.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 43.0 tp -66.61 -46.92 74.31 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.548 0.739 . . . . 55.03 110.382 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -90.76 -5.05 56.19 Favored 'General case' 0 CA--C 1.55 0.981 0 CA-C-N 115.766 -0.652 . . . . 72.11 110.694 176.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -44.99 -59.39 4.47 Favored Glycine 0 CA--C 1.541 1.681 0 CA-C-O 118.651 -1.083 . . . . 72.43 114.975 178.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -59.6 -1.72 1.18 Allowed 'Trans proline' 0 C--N 1.387 2.564 0 C-N-CA 123.711 2.941 . . . . 23.1 115.126 -177.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -149.49 36.32 1.01 Allowed Glycine 0 C--N 1.354 1.574 0 CA-C-N 118.549 0.613 . . . . 44.4 112.82 173.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.512 HD22 HG21 ' A' ' 90' ' ' VAL . 18.3 mt -71.94 62.51 0.45 Allowed 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 117.705 0.753 . . . . 74.25 112.348 172.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 35.47 -112.07 0.07 Allowed 'General case' 0 CA--C 1.561 1.378 0 C-N-CA 126.403 1.881 . . . . 72.25 114.214 173.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 56.86 18.88 27.24 Favored Glycine 0 C--N 1.369 2.397 0 N-CA-C 111.77 -0.532 . . . . 44.0 111.77 -163.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 55.58 -114.13 4.51 Favored Glycine 0 C--N 1.361 1.972 0 O-C-N 124.604 0.826 . . . . 71.34 111.96 -166.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -125.16 16.76 8.43 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.128 0.971 . . . . 64.11 109.554 173.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -91.04 -22.23 33.42 Favored Glycine 0 C--N 1.343 0.926 0 CA-C-N 115.783 -0.644 . . . . 55.25 111.821 172.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.34 9.3 1.38 Allowed 'General case' 0 CA--C 1.565 1.539 0 C-N-CA 125.143 1.377 . . . . 71.44 113.326 174.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 42.7 tpt85 -57.24 -35.29 69.52 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.641 0.377 . . . . 73.25 110.068 164.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 59.4 m 59.99 63.87 1.37 Allowed 'General case' 0 CA--C 1.546 0.806 0 O-C-N 124.295 0.997 . . . . 74.21 110.375 -176.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -125.19 164.68 19.75 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 115.134 -0.939 . . . . 74.52 109.956 177.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.532 ' HA ' ' HD2' ' A' ' 170' ' ' PRO . 37.4 tttp -54.11 128.86 32.53 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 125.26 1.424 . . . . 72.15 112.637 -175.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -80.47 165.75 48.64 Favored Glycine 0 C--N 1.348 1.239 0 O-C-N 124.108 0.88 . . . . 55.22 115.094 -168.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.594 ' HA ' ' HA ' ' B' ' 401' ' ' PRO . 24.3 ttt180 -59.99 143.93 50.54 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.819 1.248 . . . . 71.34 111.495 176.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.624 ' HB3' ' HE3' ' B' ' 404' ' ' LYS . 3.1 p-10 -78.68 126.92 31.38 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 108.733 -0.84 . . . . 74.23 108.733 166.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 53.9 tp -119.25 132.56 55.94 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 109.386 -0.598 . . . . 70.23 109.386 -176.056 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 67.9 ttp85 -90.8 110.97 22.17 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 108.36 -0.978 . . . . 74.51 108.36 171.308 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -114.72 150.97 34.47 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.637 0.775 . . . . 41.51 109.131 178.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -106.95 118.63 37.21 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 107.134 -1.432 . . . . 61.0 107.134 -170.165 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.41 HD11 ' HE ' ' A' ' 136' ' ' ARG . 13.2 tp -99.79 100.14 10.48 Favored Pre-proline 0 N--CA 1.472 0.67 0 N-CA-C 108.892 -0.781 . . . . 54.05 108.892 -176.244 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.643 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 50.8 Cg_endo -71.75 111.05 3.05 Favored 'Trans proline' 0 C--N 1.374 1.891 0 N-CA-C 108.544 -1.368 . . . . 75.33 108.544 172.189 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.474 ' HB3' HD23 ' A' ' 180' ' ' LEU . 60.6 tp -115.78 140.22 49.43 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.438 0.637 . . . . 64.01 110.263 -171.043 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 93.3 m -74.87 134.4 41.66 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 114.068 -1.423 . . . . 71.34 111.078 179.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.429 HD13 ' HB2' ' A' ' 186' ' ' PHE . 91.0 mt -57.96 -38.36 75.87 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.939 0.895 . . . . 70.54 111.134 -177.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -56.2 -42.6 77.44 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 114.492 -1.231 . . . . 75.32 110.045 176.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -73.26 -34.61 65.91 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.583 0.753 . . . . 64.33 111.412 178.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -67.23 -25.94 66.35 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 121.128 0.49 . . . . 41.43 110.326 178.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -78.49 -42.75 28.78 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 114.657 -1.156 . . . . 74.51 110.538 173.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 36.6 m170 -68.32 -66.69 0.54 Allowed 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.14 0.576 . . . . 75.25 111.055 -177.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.588 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 81.97 56.48 2.89 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-N 116.068 -0.515 . . . . 71.54 112.789 177.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -126.42 -170.11 12.89 Favored Glycine 0 N--CA 1.471 1.017 0 N-CA-C 111.584 -0.606 . . . . 70.42 111.584 178.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 30.1 mp0 -71.37 104.71 3.27 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.447 0.699 . . . . 73.14 109.69 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.738 HH22 HD12 ' A' ' 159' ' ' ILE . 0.0 OUTLIER -90.93 147.08 23.37 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.298 -1.001 . . . . 74.4 108.298 174.843 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 62.3 t -102.68 132.44 48.78 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 N-CA-C 107.923 -1.139 . . . . 71.24 107.923 171.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.492 HG13 HG13 ' A' ' 145' ' ' VAL . 2.2 p -139.08 113.0 6.98 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 124.362 1.065 . . . . 73.14 108.389 -177.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -95.97 142.6 28.0 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 115.599 -0.728 . . . . 71.3 109.76 -176.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.2 p -168.97 138.59 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 123.617 0.767 . . . . 75.1 109.939 173.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 57.2 32.07 21.11 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 124.404 1.082 . . . . 74.24 112.548 175.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 78.41 0.37 78.27 Favored Glycine 0 C--N 1.35 1.349 0 CA-C-N 116.538 -0.301 . . . . 31.1 113.333 -178.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.92 104.39 14.36 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 124.266 1.026 . . . . 72.12 108.233 178.153 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 27.9 ttp-105 -92.67 104.4 16.68 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 125.135 1.374 . . . . 74.41 108.775 175.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.492 HG13 HG13 ' A' ' 138' ' ' VAL . 3.4 p -107.23 131.69 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 CA-C-O 120.935 0.398 . . . . 73.53 112.045 -175.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 37.6 t -100.4 110.55 22.76 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 108.249 -1.019 . . . . 31.45 108.249 170.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -136.37 140.53 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.8 1.24 . . . . 73.42 108.593 -178.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.488 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 52.7 ttt85 -83.41 144.55 29.54 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.354 0.662 . . . . 74.14 110.9 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.588 HG13 ' HA2' ' A' ' 133' ' ' GLY . 6.3 pt -106.56 145.62 31.41 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 124.609 1.164 . . . . 74.13 108.359 167.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -70.95 143.12 44.27 Favored 'Trans proline' 0 C--N 1.369 1.647 0 C-N-CA 122.272 1.981 . . . . 60.34 111.428 170.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.4 97.5 0.12 Allowed 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 122.606 2.204 . . . . 74.15 110.485 170.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 106.03 66.21 0.66 Allowed Glycine 0 C--N 1.339 0.74 0 CA-C-N 115.675 -0.693 . . . . 75.51 111.837 -168.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.432 HG22 HG11 ' A' ' 178' ' ' VAL . 2.1 p -111.89 110.91 33.94 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 N-CA-C 107.999 -1.112 . . . . 75.43 107.999 175.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.51 ' HG3' ' HG ' ' A' ' 188' ' ' LEU . 0.0 OUTLIER -93.87 159.5 15.16 Favored 'General case' 0 C--O 1.205 -1.278 0 C-N-CA 124.09 0.956 . . . . 73.23 110.704 -165.633 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -50.89 119.01 3.52 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.934 1.294 . . . . 72.32 110.357 175.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 93.46 1.19 66.56 Favored Glycine 0 CA--C 1.534 1.252 0 CA-C-O 119.296 -0.725 . . . . 14.21 113.875 -179.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 12.7 t -72.19 126.53 30.02 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 108.458 -0.941 . . . . 74.23 108.458 178.035 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.572 HG22 HG22 ' A' ' 177' ' ' VAL . 48.4 t -102.38 105.46 18.14 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 C-N-CA 123.552 0.741 . . . . 72.34 110.416 -172.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.738 HD12 HH22 ' A' ' 136' ' ' ARG . 57.2 mt -76.3 102.23 3.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 107.777 -1.194 . . . . 75.24 107.777 166.488 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 58.1 ttt180 -74.42 101.06 3.99 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 107.798 -1.186 . . . . 61.32 107.798 172.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 6.2 p -124.41 95.57 42.98 Favored Pre-proline 0 CA--C 1.547 0.856 0 N-CA-C 109.448 -0.575 . . . . 61.33 109.448 177.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.507 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 28.9 Cg_endo -63.91 152.55 80.27 Favored 'Trans proline' 0 C--N 1.369 1.616 0 C-N-CA 121.963 1.776 . . . . 74.53 111.667 172.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.592 ' HA3' ' HA ' ' A' ' 86' ' ' SER . . . 105.12 -25.9 23.73 Favored Glycine 0 C--N 1.335 0.514 0 CA-C-N 116.043 -0.526 . . . . 70.43 113.628 176.542 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -103.61 0.05 30.28 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 117.331 0.566 . . . . 64.15 110.949 178.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.576 ' HA2' HD13 ' A' ' 174' ' ' LEU . . . -82.71 -129.65 1.36 Allowed Glycine 0 C--N 1.35 1.315 0 O-C-N 123.286 0.366 . . . . 73.33 113.904 -174.077 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -73.95 158.27 52.0 Favored Glycine 0 C--N 1.338 0.683 0 CA-C-N 115.507 -0.346 . . . . 74.5 113.089 -176.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -71.7 111.53 7.06 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.955 1.302 . . . . 75.42 112.09 -169.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -174.7 159.56 28.34 Favored Glycine 0 C--O 1.221 -0.661 0 CA-C-O 118.327 -1.263 . . . . 64.21 110.723 176.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ASN . . . . . 0.597 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . 55.3 t30 -55.35 -56.64 26.69 Favored Pre-proline 0 N--CA 1.496 1.872 0 CA-C-N 118.262 1.031 . . . . 63.11 111.36 -169.266 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.597 ' HD3' ' HB3' ' A' ' 169' ' ' ASN . 3.3 Cg_endo -88.55 94.4 0.38 Allowed 'Trans proline' 0 C--N 1.386 2.545 0 N-CA-C 107.403 -1.807 . . . . 71.13 107.403 157.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -65.45 154.5 73.39 Favored 'Trans proline' 0 C--N 1.378 2.086 0 C-N-CA 122.111 1.874 . . . . 71.25 111.805 -167.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.436 ' HA3' ' O ' ' A' ' 117' ' ' ARG . . . -74.28 -179.55 41.08 Favored Glycine 0 C--O 1.241 0.559 0 N-CA-C 115.372 0.909 . . . . 72.4 115.372 -164.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.507 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 7.0 m-20 -74.59 108.58 7.44 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.105 0.962 . . . . 71.14 110.425 -173.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.576 HD13 ' HA2' ' A' ' 165' ' ' GLY . 21.9 tp -82.9 99.84 10.01 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 108.759 -0.83 . . . . 64.32 108.759 176.13 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 77.0 mt -74.77 89.15 2.28 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.206 -0.906 . . . . 72.12 109.188 174.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.473 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 65.9 mt -75.46 90.17 2.7 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.474 -0.784 . . . . 70.05 110.025 177.362 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.572 HG22 HG22 ' A' ' 158' ' ' VAL . 46.3 t -84.33 103.71 11.83 Favored 'Isoleucine or valine' 0 C--O 1.244 0.809 0 N-CA-C 107.234 -1.395 . . . . 61.43 107.234 175.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.432 HG11 HG22 ' A' ' 153' ' ' VAL . 11.6 p -70.27 118.63 15.06 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 CA-C-N 115.136 -0.938 . . . . 70.33 111.396 -173.093 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.643 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 35.4 mmt180 -98.94 104.52 16.57 Favored 'General case' 0 C--O 1.216 -0.706 0 N-CA-C 108.263 -1.014 . . . . 53.32 108.263 170.109 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.474 HD23 ' HB3' ' A' ' 125' ' ' LEU . 77.1 mt -69.23 142.48 54.19 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 118.7 0.682 . . . . 72.4 109.534 178.48 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 82.9 mt -54.17 161.56 1.86 Allowed Pre-proline 0 N--CA 1.486 1.348 0 C-N-CA 124.19 0.996 . . . . 73.14 112.939 -170.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -76.34 30.72 0.4 Allowed 'Trans proline' 0 C--N 1.383 2.382 0 C-N-CA 122.791 2.327 . . . . 71.42 111.982 164.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -64.59 115.49 20.73 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 125.976 1.71 . . . . 73.35 107.283 175.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -76.5 24.73 0.45 Allowed 'Trans proline' 0 N--CA 1.497 1.709 0 C-N-CA 123.474 2.783 . . . . 61.24 115.832 -161.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.419 HG12 ' CD1' ' A' ' 186' ' ' PHE . 51.0 t -106.99 -61.01 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 122.841 0.457 . . . . 64.21 110.446 -176.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' PHE . . . . . 0.552 ' HE2' HD13 ' A' ' 193' ' ' LEU . 2.9 m-30 -131.42 165.78 22.75 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.939 0.895 . . . . 72.31 110.792 -172.051 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 22.8 ttp85 -150.4 87.73 1.46 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 114.362 -1.29 . . . . 75.51 108.338 169.5 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.51 ' HG ' ' HG3' ' A' ' 154' ' ' ARG . 51.5 tp -62.23 104.81 0.52 Allowed 'General case' 0 C--O 1.207 -1.157 0 CA-C-N 115.141 -0.936 . . . . 74.21 108.776 174.205 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -136.44 132.93 36.08 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.068 1.347 . . . . 70.31 109.02 -171.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 82.72 -84.81 1.52 Allowed Glycine 0 C--N 1.35 1.32 0 N-CA-C 110.757 -0.937 . . . . 65.41 110.757 -177.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.61 ' HG2' ' HD2' ' A' ' 243' ' ' PRO . 0.9 OUTLIER -153.89 3.73 0.27 Allowed 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 125.158 1.383 . . . . 72.32 109.962 165.917 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.413 ' HB3' ' H ' ' A' ' 248' ' ' ASP . 2.5 p-10 -118.74 175.29 5.81 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.246 1.419 . . . . 72.32 109.809 -169.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.552 HD13 ' HE2' ' A' ' 186' ' ' PHE . 41.3 mt -114.75 126.16 54.53 Favored 'General case' 0 C--O 1.215 -0.762 0 C-N-CA 123.276 0.63 . . . . 63.44 110.544 -171.402 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -105.21 102.23 11.73 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.469 0.707 . . . . 73.14 109.437 174.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.58 ' HB3' HD23 ' A' ' 251' ' ' LEU . . . -108.28 156.46 19.35 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.946 -0.761 . . . . 74.34 108.946 172.13 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 57.0 m -93.6 123.57 37.01 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 109.036 -0.727 . . . . 70.21 109.036 178.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.514 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 32.5 tp -113.09 94.62 4.98 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 108.662 -0.866 . . . . 72.21 108.662 178.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -79.5 122.09 26.02 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 107.026 -1.472 . . . . 61.43 107.026 169.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 9.2 p -133.48 137.47 29.06 Favored Pre-proline 0 CA--C 1.545 0.765 0 N-CA-C 108.156 -1.053 . . . . 64.4 108.156 -177.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.75 159.51 48.34 Favored 'Trans proline' 0 C--N 1.36 1.183 0 C-N-CA 121.796 1.664 . . . . 64.51 111.5 173.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -56.32 -52.94 69.08 Favored Pre-proline 0 CA--C 1.555 1.146 0 CA-C-O 117.715 -1.136 . . . . 71.34 113.242 -172.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -59.3 -40.97 63.34 Favored 'Trans proline' 0 C--N 1.391 2.804 0 C-N-CA 122.03 1.82 . . . . 63.54 113.417 -179.176 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.534 HD11 ' HB3' ' C' ' 276' ' ' TYR . 36.0 mt -71.93 -31.42 40.65 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.962 0 C-N-CA 122.782 0.433 . . . . 64.32 110.368 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.71 -40.73 84.26 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-O 121.155 0.502 . . . . 71.51 110.606 174.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.521 HG13 HD11 ' C' ' 261' ' ' LEU . 48.4 t -71.21 -46.92 63.45 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 C-N-CA 124.189 0.995 . . . . 63.23 112.167 -176.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.503 HG21 ' HA ' ' C' ' 270' ' ' LYS . 94.6 t -98.92 -26.38 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 123.698 0.799 . . . . 74.41 111.574 -170.032 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 99.03 160.29 29.46 Favored Glycine 0 C--O 1.241 0.554 0 N-CA-C 110.941 -0.864 . . . . 72.35 110.941 -170.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.469 ' O ' HG12 ' A' ' 223' ' ' VAL . . . 162.18 168.37 23.99 Favored Glycine 0 N--CA 1.467 0.73 0 N-CA-C 111.84 -0.504 . . . . 55.24 111.84 177.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -99.62 117.65 34.46 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 117.068 0.434 . . . . 45.21 110.519 -175.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 35.9 m -121.71 162.46 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 124.136 0.974 . . . . 63.11 109.055 177.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -70.39 115.29 9.41 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 120.635 0.255 . . . . 71.41 110.96 -177.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -103.12 112.54 25.44 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 108.176 -1.046 . . . . 62.04 108.176 168.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -76.48 116.57 17.29 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 107.382 -1.34 . . . . 71.23 107.382 173.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' THR . . . . . 0.408 ' HA ' ' CE1' ' A' ' 186' ' ' PHE . 72.8 p -118.79 167.92 11.24 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.804 0.442 . . . . 74.1 110.354 178.172 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 72.1 mt -66.2 -20.77 66.23 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.278 0.631 . . . . 63.31 111.595 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -91.29 -18.31 24.55 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 123.555 0.742 . . . . 64.44 111.562 177.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 147.34 170.63 15.73 Favored Glycine 0 C--N 1.36 1.909 0 CA-C-O 119.97 -0.35 . . . . 33.0 113.594 174.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.79 103.98 1.67 Allowed 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 122.482 2.122 . . . . 70.23 111.404 176.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 33.6 m -106.9 179.83 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 124.25 1.02 . . . . 73.4 110.444 -177.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -110.99 119.54 39.4 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.357 0.663 . . . . 75.04 109.248 173.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 7.2 p -96.85 121.0 46.91 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 N-CA-C 108.979 -0.749 . . . . 74.13 108.979 175.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -80.09 96.68 6.57 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.662 -0.866 . . . . 60.25 108.662 172.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.469 HG12 ' O ' ' A' ' 208' ' ' GLY . 10.7 p -68.35 132.72 91.4 Favored Pre-proline 0 CA--C 1.554 1.102 0 N-CA-C 108.916 -0.772 . . . . 63.14 108.916 178.151 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 224' ' ' PRO . . . . . 0.505 ' HG3' ' HB3' ' B' ' 443' ' ' ALA . 37.0 Cg_endo -64.39 163.55 26.3 Favored 'Trans proline' 0 C--N 1.374 1.875 0 C-N-CA 122.483 2.122 . . . . 75.51 112.455 174.016 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -64.77 163.9 26.21 Favored 'Trans proline' 0 C--N 1.37 1.664 0 C-N-CA 121.993 1.795 . . . . 72.53 112.95 169.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' ARG . . . . . 0.429 ' HD2' ' HB3' ' B' ' 446' ' ' PRO . 0.0 OUTLIER 41.25 67.78 0.5 Allowed 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 126.057 1.743 . . . . 74.04 112.824 -173.207 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.532 HG23 HD21 ' A' ' 233' ' ' LEU . 95.0 m -101.68 103.01 13.77 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 114.407 -1.27 . . . . 64.32 109.224 177.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 228' ' ' GLN . . . . . 0.813 ' HB3' ' HD3' ' A' ' 231' ' ' ARG . 5.5 tp-100 -87.18 145.96 26.2 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.166 0.986 . . . . 75.32 111.784 -172.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -73.15 143.42 47.29 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.975 0.91 . . . . 62.31 111.267 179.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 85.26 -0.59 88.73 Favored Glycine 0 C--N 1.348 1.233 0 CA-C-N 115.787 -0.642 . . . . 73.32 113.103 -178.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.813 ' HD3' ' HB3' ' A' ' 228' ' ' GLN . 78.7 mtp180 -112.03 162.49 15.33 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.536 1.134 . . . . 74.0 108.949 176.017 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.414 ' HB3' ' HG2' ' A' ' 252' ' ' GLU . 49.6 pttt -129.63 136.31 49.6 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 122.902 0.481 . . . . 72.22 110.389 -171.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.532 HD21 HG23 ' A' ' 227' ' ' THR . 26.3 mt -86.72 110.97 20.26 Favored 'General case' 0 C--O 1.212 -0.882 0 CA-C-N 115.281 -0.872 . . . . 71.4 110.133 -172.321 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -77.22 106.94 9.26 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.01 0.524 . . . . 64.14 110.25 175.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.706 HD22 ' HA ' ' B' ' 441' ' ' ILE . 8.5 mt -101.68 93.54 5.39 Favored 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 108.454 -0.943 . . . . 61.12 108.454 172.458 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.512 ' HG3' ' HB2' ' B' ' 457' ' ' GLN . 4.5 tmtm? -73.67 117.97 16.06 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.437 0.695 . . . . 64.43 111.939 -164.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 101.45 32.16 5.27 Favored Glycine 0 C--N 1.347 1.157 0 CA-C-N 115.813 -0.63 . . . . 74.2 112.614 175.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 2.8 mmmt -117.26 -28.19 6.23 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.941 0.896 . . . . 73.01 111.229 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -79.0 -166.87 32.04 Favored Glycine 0 C--N 1.342 0.915 0 O-C-N 123.663 0.602 . . . . 74.43 113.256 174.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -97.59 158.97 32.15 Favored Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 123.565 0.746 . . . . 73.13 110.333 -173.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.535 ' HD3' ' HA ' ' B' ' 421' ' ' VAL . 32.0 Cg_endo -58.64 151.92 59.57 Favored 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 122.656 2.237 . . . . 73.33 113.322 -173.161 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -173.88 -163.42 27.32 Favored Glycine 0 C--N 1.341 0.816 0 CA-C-N 115.65 -0.705 . . . . 73.52 113.761 177.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 243' ' ' PRO . . . . . 0.61 ' HD2' ' HG2' ' A' ' 191' ' ' GLN . 73.4 Cg_endo -70.8 -5.86 17.81 Favored 'Trans proline' 0 C--N 1.373 1.862 0 C-N-CA 123.708 2.939 . . . . 70.45 113.613 -179.132 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -103.94 23.12 13.38 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.74 0.816 . . . . 70.11 109.954 171.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 82.37 -84.44 1.51 Allowed Glycine 0 C--N 1.351 1.4 0 N-CA-C 110.78 -0.928 . . . . 62.24 110.78 -177.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 50.2 mtm180 -125.68 144.64 50.51 Favored 'General case' 0 C--O 1.246 0.871 0 N-CA-C 108.348 -0.982 . . . . 75.41 108.348 171.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -65.79 166.82 35.11 Favored Glycine 0 N--CA 1.448 -0.552 0 O-C-N 123.979 0.799 . . . . 42.24 113.457 176.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 248' ' ' ASP . . . . . 0.413 ' H ' ' HB3' ' A' ' 192' ' ' ASP . 4.1 m-20 -110.91 -178.31 3.44 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 123.776 0.831 . . . . 75.44 108.89 -179.004 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.497 HD23 HD12 ' A' ' 235' ' ' LEU . 31.1 tp -118.63 96.53 5.32 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 107.875 -1.157 . . . . 70.31 107.875 169.519 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -79.69 109.52 14.17 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.285 1.034 . . . . 52.51 109.79 175.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.58 HD23 ' HB3' ' A' ' 195' ' ' ALA . 89.7 mt -97.88 97.86 9.31 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.5 -0.773 . . . . 72.24 109.483 177.29 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.414 ' HG2' ' HB3' ' A' ' 232' ' ' LYS . 28.7 mt-10 -75.61 115.97 15.84 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.374 0.67 . . . . 75.41 109.611 -176.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 91.7 t -86.43 132.89 31.11 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 C-N-CA 125.468 1.507 . . . . 24.43 113.06 -163.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -130.07 107.04 9.03 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.19 1.396 . . . . 73.14 108.565 173.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.538 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 73.4 mt -84.01 130.74 35.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 123.257 0.623 . . . . 74.34 111.016 -176.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 20.3 p -119.1 174.15 6.49 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.497 1.119 . . . . 73.43 109.844 173.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 257' ' ' ILE . . . . . 0.418 ' HB ' ' HD2' ' A' ' 258' ' ' PRO . 2.9 pp -136.13 154.91 77.72 Favored Pre-proline 0 CA--C 1.566 1.576 0 C-N-CA 123.696 0.798 . . . . 73.4 109.938 -179.34 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 258' ' ' PRO . . . . . 0.418 ' HD2' ' HB ' ' A' ' 257' ' ' ILE . 49.1 Cg_endo -64.67 -5.56 10.53 Favored 'Trans proline' 0 C--N 1.385 2.493 0 C-N-CA 123.457 2.771 . . . . 74.45 116.1 -163.689 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.503 ' HG2' ' NE2' ' C' ' 228' ' ' GLN . 31.4 mt-10 52.42 -87.37 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.422 0 C-N-CA 124.122 0.969 . . . . 63.24 112.728 -170.6 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.27 132.84 47.83 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 109.935 -0.394 . . . . 75.12 109.935 -177.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.401 HD21 ' HG2' ' A' ' 258' ' ' PRO . 97.5 mt -130.93 134.62 46.91 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.702 0.801 . . . . 55.32 110.575 -177.488 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 19.1 p -84.16 146.26 47.87 Favored Pre-proline 0 CA--C 1.545 0.788 0 CA-C-O 117.874 -1.06 . . . . 44.34 108.841 169.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -30.94 -42.98 0.11 Allowed 'Trans proline' 0 C--N 1.39 2.731 1 C-N-CA 126.062 4.508 . . . . 74.33 116.569 -172.65 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -64.59 -64.3 0.91 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.25 0.62 . . . . 71.44 110.99 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -61.48 -32.49 72.5 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.086 0.954 . . . . 64.2 110.866 -178.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -53.48 -52.95 57.89 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.779 1.231 . . . . 73.45 109.847 174.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 267' ' ' ALA . . . . . 0.406 ' O ' ' HG3' ' A' ' 271' ' ' LYS . . . -65.69 -41.72 92.07 Favored 'General case' 0 C--O 1.214 -0.795 0 CA-C-N 114.923 -1.035 . . . . 64.12 111.585 178.63 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 10.9 mp -57.24 -47.0 82.47 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 123.071 0.548 . . . . 73.14 111.544 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -64.89 -40.76 95.6 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 123.755 0.659 . . . . 75.0 111.091 178.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 270' ' ' LYS . . . . . 0.469 ' HE2' ' HA ' ' C' ' 206' ' ' VAL . 1.5 mptm? -71.68 -25.33 62.06 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.093 0.557 . . . . 62.43 111.98 178.38 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 271' ' ' LYS . . . . . 0.406 ' HG3' ' O ' ' A' ' 267' ' ' ALA . 97.1 mttt -73.75 -48.82 28.99 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.873 -0.788 . . . . 70.22 108.873 176.618 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 72.6 mt -55.28 -40.96 71.62 Favored 'General case' 0 C--O 1.198 -1.641 0 O-C-N 124.774 1.296 . . . . 63.4 109.992 172.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -65.79 -55.51 16.8 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.056 0.942 . . . . 64.51 113.105 -174.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -66.57 -43.75 84.16 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 123.787 0.679 . . . . 74.35 110.76 -176.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -62.59 -47.95 81.59 Favored 'General case' 0 C--N 1.355 0.82 0 O-C-N 123.944 0.778 . . . . 71.44 110.285 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -62.75 -45.77 91.14 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.729 0.812 . . . . 75.02 110.945 -177.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -66.82 -40.04 87.89 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 123.519 0.512 . . . . 70.12 110.103 -176.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -66.62 -17.86 65.06 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 115.824 -0.625 . . . . 75.41 111.579 174.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 279' ' ' ARG . . . . . 0.459 ' HG2' ' HA ' ' B' ' 278' ' ' LEU . 82.6 mtt180 -117.76 20.05 13.56 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.134 0.974 . . . . 74.13 109.733 178.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.845 0 N-CA-C 109.173 -0.677 . . . . 72.21 109.173 179.193 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 63.7 mtt . . . . . 0 N--CA 1.483 1.182 0 N-CA-C 109.104 -0.702 . . . . 71.44 109.104 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -82.06 126.65 32.25 Favored 'General case' 0 C--N 1.353 0.733 0 N-CA-C 108.649 -0.871 . . . . 54.1 108.649 172.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -106.34 37.49 2.28 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.137 0.575 . . . . 74.04 110.095 -176.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 55.2 m -53.89 -3.51 0.04 OUTLIER 'General case' 0 CA--C 1.565 1.535 0 N-CA-C 117.31 2.337 . . . . 52.14 117.31 -162.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 16.9 m -132.27 147.6 52.41 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 119.316 0.962 . . . . 70.11 110.291 171.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 15.1 pt -138.23 169.59 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 123.85 0.86 . . . . 64.44 112.384 -164.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -131.51 147.68 52.56 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 124.21 1.004 . . . . 72.01 109.672 176.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 15.2 tp -85.51 157.0 20.54 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.863 0.865 . . . . 75.22 110.918 -172.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.44 -59.52 2.67 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.322 0.649 . . . . 62.4 111.81 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 66.1 mt 61.12 18.1 8.72 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.863 1.265 . . . . 74.1 111.911 -165.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 64.5 mt 58.69 79.53 0.31 Allowed Pre-proline 0 N--CA 1.485 1.309 0 C-N-CA 124.771 1.228 . . . . 45.35 112.116 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -89.05 -84.17 0.0 OUTLIER 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 122.964 2.443 . . . . 61.33 112.422 176.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 41.8 mt -131.59 -165.26 1.55 Allowed 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 124.406 1.083 . . . . 75.01 109.946 178.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 10.4 tp -95.85 -177.67 4.11 Favored 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 123.763 0.825 . . . . 64.54 109.66 179.09 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -91.32 170.81 9.68 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.611 0.764 . . . . 60.01 111.585 -173.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 61.6 p -85.92 135.65 37.35 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 124.006 0.922 . . . . 51.11 110.132 176.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 17' ' ' PRO . . . . . 0.651 ' HG3' ' HA ' ' B' ' 366' ' ' ASP . 60.4 Cg_endo -66.93 97.36 0.4 Allowed 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 123.26 2.64 . . . . 62.42 113.08 -175.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 47.7 t -77.66 -35.75 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 124.17 0.988 . . . . 61.41 109.713 177.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 50.0 p -70.77 -23.37 62.39 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.865 0.866 . . . . 71.22 111.097 173.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 20' ' ' LYS . . . . . 0.59 ' HA ' ' HE3' ' B' ' 20' ' ' LYS . 0.4 OUTLIER 75.43 -64.04 0.39 Allowed 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 126.411 1.884 . . . . 62.34 111.828 179.551 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 66.34 99.56 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.919 1.288 . . . . 75.34 112.361 175.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 84.0 mmt-85 -131.29 162.48 29.96 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.254 1.022 . . . . 73.31 109.219 173.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 23' ' ' THR . . . . . 0.466 ' HA ' ' HD3' ' B' ' 24' ' ' PRO . 26.1 m -66.52 107.48 1.65 Allowed Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 123.592 0.757 . . . . 72.45 109.394 176.052 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 24' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' B' ' 23' ' ' THR . 5.9 Cg_exo -76.55 -71.47 0.01 OUTLIER 'Trans proline' 0 C--N 1.371 1.756 0 C-N-CA 122.907 2.404 . . . . 74.55 113.886 -166.283 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -85.79 160.09 19.58 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-O 121.27 0.557 . . . . 74.53 110.835 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 13.3 tpt -93.5 116.67 66.79 Favored Pre-proline 0 C--O 1.242 0.681 0 N-CA-C 108.203 -1.036 . . . . 75.13 108.203 169.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -61.73 84.47 0.09 OUTLIER 'Trans proline' 0 C--N 1.374 1.904 0 C-N-CA 123.48 2.787 . . . . 71.1 113.053 178.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 34.0 m -101.81 -13.63 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 124.281 1.032 . . . . 73.51 110.633 176.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 3.5 tt 64.78 -107.06 0.15 Allowed 'General case' 0 CA--C 1.562 1.437 0 C-N-CA 124.718 1.207 . . . . 62.2 108.453 -172.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 58.36 168.63 0.05 Allowed 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 125.039 1.336 . . . . 70.24 112.048 -177.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 12.8 m120 80.3 -49.78 0.34 Allowed 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 126.194 1.798 . . . . 74.34 111.174 177.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 71.81 -52.79 0.69 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 126.736 2.015 . . . . 72.22 110.524 -172.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 33' ' ' ALA . . . . . 0.668 ' HB3' ' HE2' ' C' ' 238' ' ' LYS . . . 72.74 105.93 0.07 Allowed 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 125.217 1.407 . . . . 73.31 110.323 170.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . 76.99 -52.15 0.57 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 126.502 1.921 . . . . 53.33 110.279 -164.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 68.52 -6.16 0.85 Allowed 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 125.286 1.435 . . . . 73.13 112.674 174.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -172.65 157.58 27.1 Favored Glycine 0 C--N 1.34 0.804 0 O-C-N 122.067 -0.396 . . . . 74.33 112.349 -174.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 37' ' ' ASP . . . . . 0.436 ' HB2' HG23 ' B' ' 165' ' ' THR . 36.7 t0 -76.24 157.9 32.14 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 124.584 1.154 . . . . 61.44 109.946 177.078 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 16.8 tt -64.87 -23.46 33.47 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.299 0 C-N-CA 124.432 1.093 . . . . 75.44 111.328 174.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 53.4 m -141.33 -51.89 0.44 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.477 0.711 . . . . 64.25 110.97 -178.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . 0.321 . . 99.57 -72.73 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.678 0 C-N-CA 127.524 2.33 . . . . 64.0 112.6 -176.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.06 114.84 4.03 Favored 'Trans proline' 0 C--N 1.398 3.156 0 CA-C-N 122.793 2.033 . . . . 72.44 112.417 178.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 42' ' ' GLY . . . . . 0.657 ' HA3' HD21 ' B' ' 167' ' ' ASN . . . 179.3 -42.17 0.08 OUTLIER Glycine 0 C--N 1.349 1.271 0 CA-C-N 115.876 -0.602 . . . . 45.24 112.43 -179.399 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.7 -172.02 32.33 Favored Glycine 0 C--N 1.348 1.244 0 C-N-CA 122.754 0.216 . . . . 42.15 113.319 176.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.68 -13.73 59.82 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.306 1.043 . . . . 63.2 112.254 -177.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.741 ' HG2' ' HG3' ' B' ' 46' ' ' ARG . 56.2 ttp180 75.92 -74.06 0.08 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.461 1.504 . . . . 74.21 111.764 176.095 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 46' ' ' ARG . . . . . 0.741 ' HG3' ' HG2' ' B' ' 45' ' ' ARG . 82.3 mtp180 -127.86 -176.55 3.81 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 123.726 0.81 . . . . 75.02 110.501 -177.067 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -159.74 157.77 30.05 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.473 0.709 . . . . 53.22 110.681 -178.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.455 ' OG1' ' HA ' ' B' ' 193' ' ' PRO . 1.4 t -163.25 -64.4 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.731 0.812 . . . . 51.22 110.8 178.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 49' ' ' GLY . . . . . 0.432 ' H ' HG23 ' B' ' 48' ' ' THR . . . 73.98 -77.33 0.98 Allowed Glycine 0 C--N 1.349 1.263 0 CA-C-N 116.607 -0.27 . . . . 74.15 113.186 -176.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -85.24 160.68 19.82 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.017 0.927 . . . . 64.2 111.173 -174.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -99.24 -26.34 14.21 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 114.711 -1.131 . . . . 75.3 109.812 167.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 12.6 t -174.85 170.17 3.35 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.02 0.928 . . . . 73.31 110.319 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 53' ' ' ALA . . . . . 0.582 ' HB3' ' HB2' ' B' ' 190' ' ' CYS . . . -166.56 139.03 3.71 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.5 1.12 . . . . 73.24 108.793 174.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -136.05 -88.6 0.32 Allowed 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 123.558 0.743 . . . . 75.51 111.848 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 1.1 tt -93.58 64.83 3.64 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.423 0.689 . . . . 72.35 110.104 -171.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 56' ' ' ARG . . . . . 0.473 ' HA ' ' HG3' ' B' ' 188' ' ' ARG . 66.0 mtt-85 73.95 -40.1 0.45 Allowed 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 125.655 1.582 . . . . 73.2 113.614 175.006 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 63.53 9.3 4.12 Favored 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 124.914 1.286 . . . . 75.31 112.537 169.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 58' ' ' SER . . . . . 0.631 ' HB2' ' HB3' ' C' ' 122' ' ' GLU . 24.0 p -104.87 85.28 2.27 Favored 'General case' 0 C--O 1.243 0.731 0 C-N-CA 125.123 1.369 . . . . 62.01 109.723 -170.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -123.8 -49.52 1.86 Allowed 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 115.261 -0.881 . . . . 72.44 109.819 -177.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 67.6 m 62.5 -175.49 0.14 Allowed 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 124.473 1.109 . . . . 63.51 111.383 -166.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.19 -10.65 27.59 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.891 0.876 . . . . 71.45 110.487 -178.382 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 62' ' ' LYS . . . . . 0.581 ' HB3' ' HE2' ' B' ' 303' ' ' LYS . 1.2 tmtp? -164.57 142.78 5.54 Favored Pre-proline 0 CA--C 1.555 1.147 0 N-CA-C 106.944 -1.502 . . . . 72.3 106.944 -175.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -66.99 27.32 0.11 Allowed 'Trans proline' 0 C--N 1.39 2.735 0 C-N-CA 123.463 2.775 . . . . 72.24 115.736 175.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 64' ' ' ALA . . . . . 0.657 ' HB1' ' HB ' ' C' ' 158' ' ' VAL . . . 68.89 -86.01 0.03 OUTLIER 'General case' 0 C--N 1.355 0.836 0 C-N-CA 125.718 1.607 . . . . 72.04 112.342 176.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? 52.15 -99.97 0.09 Allowed 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 117.844 -1.074 . . . . 65.32 110.465 -171.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 49.0 -74.08 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 126.144 1.778 . . . . 72.41 115.521 173.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 67' ' ' ILE . . . . . 0.564 HG13 HG12 ' B' ' 68' ' ' ILE . 7.7 pt 61.31 172.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 127.171 2.188 . . . . 72.03 112.413 -174.607 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 68' ' ' ILE . . . . . 0.564 HG12 HG13 ' B' ' 67' ' ' ILE . 49.7 mm 73.77 148.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 C-N-CA 124.73 1.212 . . . . 73.4 111.287 -178.095 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.479 ' HB3' ' HA2' ' C' ' 190' ' ' GLY . 87.5 mt 65.65 75.33 0.35 Allowed 'General case' 0 C--N 1.359 0.979 0 C-N-CA 124.999 1.32 . . . . 73.12 110.925 -178.015 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 70' ' ' LEU . . . . . 0.412 HD23 HE22 ' B' ' 360' ' ' GLN . 46.3 tp -163.46 -62.76 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 114.937 -1.029 . . . . 44.44 108.623 -179.376 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 71' ' ' ILE . . . . . 0.502 HD12 ' HB3' ' C' ' 243' ' ' PRO 0.264 0.0 OUTLIER 39.86 -70.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 C-N-CA 127.737 2.415 . . . . 74.32 115.755 177.09 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 162.18 -162.53 34.32 Favored Glycine 0 C--N 1.341 0.846 0 N-CA-C 111.246 -0.742 . . . . 62.21 111.246 -175.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -124.77 158.59 32.94 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.787 0.835 . . . . 63.44 109.992 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.37 -6.22 61.23 Favored Glycine 0 C--N 1.35 1.331 0 O-C-N 123.848 0.717 . . . . 64.42 113.163 172.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 65.5 mtt 78.01 -56.53 0.49 Allowed 'General case' 0 C--N 1.366 1.291 0 C-N-CA 126.689 1.996 . . . . 74.01 111.452 176.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 86.99 0.23 85.72 Favored Glycine 0 C--N 1.346 1.12 0 CA-C-O 119.738 -0.479 . . . . 71.13 112.85 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 4.7 t70 63.35 -157.84 0.32 Allowed 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 124.759 1.224 . . . . 73.03 109.518 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 17.2 t 67.69 78.17 0.24 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.099 1.36 . . . . 51.1 110.947 176.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.77 167.01 20.83 Favored 'General case' 0 CA--C 1.553 1.096 0 CA-C-N 114.576 -1.193 . . . . 74.44 109.622 177.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.617 HG22 HG22 ' B' ' 81' ' ' THR . 3.4 mp 66.27 -81.28 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.563 1.452 0 C-N-CA 124.842 1.257 . . . . 72.52 110.036 -175.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 81' ' ' THR . . . . . 0.617 HG22 HG22 ' B' ' 80' ' ' ILE . 12.6 t -166.41 175.39 8.19 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.174 0.989 . . . . 71.34 109.697 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -147.75 17.03 1.13 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.124 0.97 . . . . 61.11 110.515 175.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -95.24 178.3 5.57 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.498 0.719 . . . . 71.35 111.479 -175.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 68.2 -78.98 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.796 1.639 . . . . 73.0 111.691 178.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 59.45 -80.91 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 125.045 1.338 . . . . 72.23 111.327 -178.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -142.63 95.03 2.72 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 107.441 -1.318 . . . . 63.12 107.441 -174.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 87' ' ' ALA . . . . . 0.477 ' HA ' HD21 ' B' ' 155' ' ' LEU . . . -143.96 35.45 1.25 Allowed 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.08 0.466 . . . . 52.24 111.231 -171.34 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -155.33 139.67 16.71 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 115.662 -0.699 . . . . 74.14 109.954 -177.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -88.88 -52.24 2.83 Favored Glycine 0 C--N 1.348 1.238 0 CA-C-N 116.225 -0.443 . . . . 54.33 112.101 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . 70.54 -67.04 0.26 Allowed 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 125.233 1.413 . . . . 62.33 112.43 175.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -67.34 -4.26 29.35 Favored Glycine 0 N--CA 1.48 1.623 0 N-CA-C 114.561 0.584 . . . . 70.11 114.561 177.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -63.16 -28.0 71.47 Favored Glycine 0 C--N 1.353 1.516 0 C-N-CA 123.071 0.367 . . . . 23.53 112.72 176.12 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -66.29 -45.66 79.63 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.892 0.477 . . . . 74.22 110.351 177.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -67.19 -39.05 86.3 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.582 -0.735 . . . . 71.21 110.759 -178.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -79.97 6.06 12.32 Favored 'General case' 0 CA--C 1.565 1.528 0 C-N-CA 123.829 0.852 . . . . 74.14 110.87 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . -81.41 24.13 4.39 Favored Glycine 0 C--N 1.357 1.713 0 N-CA-C 114.685 0.634 . . . . 72.31 114.685 177.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 39.4 mm -116.72 -33.99 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 124.217 1.007 . . . . 72.22 109.512 175.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -132.85 138.69 47.14 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.732 0.813 . . . . 75.21 110.229 -175.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -103.71 -4.17 24.06 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.027 0.931 . . . . 61.12 111.35 177.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 59.74 69.83 1.18 Allowed Pre-proline 0 CA--C 1.557 1.24 0 C-N-CA 125.777 1.631 . . . . 74.2 110.152 -169.131 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -91.54 -172.95 0.48 Allowed 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 123.494 2.796 . . . . 72.21 111.071 170.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -66.53 135.44 54.2 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 108.732 -0.84 . . . . 73.12 108.732 173.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 19.7 p -72.11 108.62 5.4 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.741 0.817 . . . . 75.52 110.301 177.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 113.56 -3.12 24.81 Favored Glycine 0 N--CA 1.469 0.851 0 CA-C-N 115.871 -0.604 . . . . 51.35 111.703 -170.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 105' ' ' GLN . . . . . 0.482 HE21 ' HG ' ' B' ' 111' ' ' LEU . 52.8 tt0 -107.76 -82.7 0.55 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.063 0.945 . . . . 75.22 109.121 178.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 47.98 -93.1 0.02 OUTLIER 'General case' 0 C--N 1.367 1.354 0 C-N-CA 124.305 1.042 . . . . 74.44 111.534 -172.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 30.4 p -123.86 119.33 29.33 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.444 -1.317 . . . . 63.32 107.444 171.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -156.71 88.22 1.04 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 122.513 0.325 . . . . 71.44 110.803 -176.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.751 ' HA ' ' HA ' ' B' ' 114' ' ' LYS . 75.8 m-85 47.2 -79.51 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 126.777 2.031 . . . . 53.33 115.501 168.437 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.0 -29.61 70.75 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.145 0.978 . . . . 71.24 112.38 -174.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 111' ' ' LEU . . . . . 0.482 ' HG ' HE21 ' B' ' 105' ' ' GLN . 3.0 mm? -84.84 -5.69 59.34 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.469 0.707 . . . . 64.15 111.595 -178.013 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -135.99 -164.36 1.54 Allowed 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.274 1.03 . . . . 73.2 110.0 -174.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 113' ' ' LYS . . . . . 0.537 ' HE3' ' HA ' ' B' ' 113' ' ' LYS . 0.7 OUTLIER -91.94 36.79 0.97 Allowed 'General case' 0 CA--C 1.555 1.17 0 CA-C-O 121.721 0.772 . . . . 75.13 109.354 170.302 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 114' ' ' LYS . . . . . 0.751 ' HA ' ' HA ' ' B' ' 109' ' ' TYR . 96.6 mttt 58.93 15.06 3.66 Favored 'General case' 0 C--N 1.364 1.201 0 C-N-CA 125.093 1.357 . . . . 74.01 112.745 -177.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 16.3 m 65.48 -8.49 0.28 Allowed 'General case' 0 CA--C 1.566 1.592 0 C-N-CA 125.351 1.46 . . . . 73.23 113.066 -176.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -73.89 -20.79 79.73 Favored Glycine 0 C--N 1.358 1.794 0 O-C-N 122.043 -0.41 . . . . 55.33 112.985 -174.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 4.9 ttmp? -149.13 79.56 8.28 Favored Pre-proline 0 CA--C 1.548 0.901 0 N-CA-C 108.799 -0.815 . . . . 70.25 108.799 176.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 118' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -66.62 -32.46 38.51 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.319 2.013 . . . . 60.53 111.977 179.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 119' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -168.04 162.95 13.48 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.618 0.767 . . . . 75.33 110.228 177.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 120' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -130.7 117.37 19.35 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 106.989 -1.486 . . . . 70.1 106.989 169.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 7.4 p -57.34 -36.17 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 113.727 1.01 . . . . 74.32 113.727 -167.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 14.1 m -73.97 -36.57 64.57 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.871 0.468 . . . . 75.24 111.3 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -105.71 18.61 21.89 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.263 1.025 . . . . 64.3 111.61 -175.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 63.8 p -65.51 116.51 6.86 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.265 0.626 . . . . 43.31 110.045 178.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 125' ' ' ALA . . . . . 0.401 ' HB2' HG22 ' B' ' 259' ' ' VAL . . . -77.59 71.38 4.07 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-O 121.942 0.877 . . . . 73.02 110.285 -178.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -160.95 -68.32 0.06 Allowed 'General case' 0 C--O 1.24 0.569 0 CA-C-N 114.596 -1.184 . . . . 74.13 108.358 -174.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 20.0 m 59.62 -76.28 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.519 1.528 . . . . 70.01 111.425 -176.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -124.1 119.01 28.24 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 124.696 1.198 . . . . 72.01 108.078 173.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 25.1 p -105.71 82.7 1.83 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.602 0.761 . . . . 54.34 111.195 -176.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . 63.03 -168.24 0.2 Allowed 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 124.08 0.952 . . . . 44.22 112.86 175.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 16.8 m-90 -125.14 138.64 54.15 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.574 1.149 . . . . 73.51 108.325 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 59.1 p 53.81 -78.0 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 125.622 1.569 . . . . 51.4 113.796 177.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 5.8 m 70.98 7.18 6.13 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.921 1.288 . . . . 62.25 112.836 171.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 70.68 35.93 67.1 Favored Glycine 0 C--N 1.355 1.607 0 N-CA-C 111.705 -0.558 . . . . 55.15 111.705 -177.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 135' ' ' VAL . . . . . . . . . . . . . 36.6 t 62.24 112.86 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.466 1.506 . . . . 73.24 110.409 -165.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -60.68 -59.1 5.93 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.244 1.018 . . . . 52.43 110.934 -173.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 4.7 m 62.39 -77.38 0.03 OUTLIER 'General case' 0 CA--C 1.56 1.332 0 C-N-CA 125.134 1.374 . . . . 75.31 111.133 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -165.52 26.41 0.05 Allowed 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 124.86 1.264 . . . . 75.52 110.134 174.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -60.59 -38.87 86.06 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.858 0.863 . . . . 73.24 112.646 -168.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -91.91 -1.32 70.51 Favored Glycine 0 C--N 1.347 1.158 0 CA-C-O 119.897 -0.391 . . . . 65.04 113.076 178.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -92.74 -47.29 7.15 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.726 0.81 . . . . 75.34 110.522 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 84.1 mt -100.61 -55.7 2.52 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.263 0.625 . . . . 70.15 110.28 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 67.56 -108.73 2.56 Favored Glycine 0 C--N 1.347 1.15 0 N-CA-C 111.374 -0.69 . . . . 61.25 111.374 -175.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 21.0 m 43.4 33.71 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 C-N-CA 126.778 2.031 . . . . 75.31 113.927 176.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 75.15 -34.93 0.27 Allowed 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 126.023 1.729 . . . . 64.3 112.442 -176.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 146' ' ' ILE . . . . . 0.532 HG13 ' H ' ' B' ' 147' ' ' HIS . 3.5 tp 55.09 -170.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.562 1.405 0 C-N-CA 126.607 1.963 . . . . 72.52 111.982 -177.181 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 147' ' ' HIS . . . . . 0.532 ' H ' HG13 ' B' ' 146' ' ' ILE . 0.2 OUTLIER 83.03 -17.27 0.52 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.084 1.354 . . . . 72.43 112.02 172.81 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 64.83 -84.77 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 125.055 1.342 . . . . 73.05 112.806 168.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 149' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -74.56 -42.77 58.2 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.585 0.754 . . . . 72.23 110.436 -174.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -67.34 -64.1 0.93 Allowed 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.007 -0.997 . . . . 74.11 108.843 174.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 151' ' ' HIS . . . . . 0.416 ' H ' ' HB3' ' B' ' 147' ' ' HIS . 55.6 t-80 51.65 89.73 0.09 OUTLIER Pre-proline 0 CA--C 1.551 1.016 0 O-C-N 124.982 1.426 . . . . 74.43 112.185 178.571 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -88.0 -163.44 0.16 Allowed 'Trans proline' 0 C--N 1.363 1.318 0 C-N-CA 122.295 1.997 . . . . 42.51 109.928 171.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 14.4 m -91.09 153.11 20.32 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 107.639 -1.245 . . . . 74.2 107.639 164.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 23.3 pt -46.77 118.26 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 123.818 0.847 . . . . 74.25 110.957 178.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 155' ' ' LEU . . . . . 0.477 HD21 ' HA ' ' B' ' 87' ' ' ALA . 45.6 tp -63.66 98.7 0.19 Allowed 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.465 -0.789 . . . . 72.1 111.408 -166.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -117.7 161.22 20.04 Favored 'General case' 0 C--O 1.245 0.816 0 CA-C-N 114.816 -1.084 . . . . 72.23 108.713 175.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 157' ' ' MET . . . . . 0.453 ' N ' ' SD ' ' B' ' 157' ' ' MET . 1.4 mpt? -75.92 87.88 2.9 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.884 0.874 . . . . 53.54 109.912 -173.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 158' ' ' ALA . . . . . . . . . . . . . . . -125.54 -77.61 0.59 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.476 0.71 . . . . 34.04 109.715 178.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -98.46 -2.38 39.12 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.021 0.928 . . . . 55.45 110.806 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -129.24 172.2 11.69 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.254 0.621 . . . . 70.22 111.753 -169.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . 69.2 -69.68 0.16 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.929 1.692 . . . . 71.1 111.785 -176.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 81.78 151.38 8.83 Favored Glycine 0 CA--C 1.534 1.254 0 N-CA-C 113.939 0.336 . . . . 73.4 113.939 174.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 91.1 mt -80.08 -168.63 1.71 Allowed 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.686 0.794 . . . . 65.02 110.496 174.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 164' ' ' ALA . . . . . . . . . . . . . . . 68.82 26.43 5.97 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.448 1.099 . . . . 75.34 111.065 -173.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 165' ' ' THR . . . . . 0.436 HG23 ' HB2' ' B' ' 37' ' ' ASP . 9.8 t -172.83 171.62 4.3 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.592 1.157 . . . . 64.15 109.828 -177.22 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . 174.66 52.26 0.05 OUTLIER Glycine 0 C--N 1.343 0.949 0 N-CA-C 110.653 -0.979 . . . . 71.15 110.653 -177.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 167' ' ' ASN . . . . . 0.657 HD21 ' HA3' ' B' ' 42' ' ' GLY . 19.7 p-10 -54.54 132.97 45.99 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.516 1.126 . . . . 72.31 112.84 -165.238 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 39.4 t 73.94 -38.79 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 C-N-CA 126.406 1.883 . . . . 74.13 112.16 -178.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 37.1 m -78.54 -1.84 35.88 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 124.144 0.977 . . . . 54.35 111.169 173.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 8.5 p -67.37 157.63 33.62 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 123.698 0.799 . . . . 63.1 111.453 172.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -123.17 102.21 7.83 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 107.244 -1.391 . . . . 53.32 107.244 171.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 172' ' ' GLU . . . . . 0.413 ' HA ' ' OE1' ' B' ' 174' ' ' GLN . 2.5 mp0 -71.85 89.76 1.08 Allowed 'General case' 0 N--CA 1.472 0.672 0 O-C-N 123.958 0.786 . . . . 73.22 112.575 -169.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 173' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -113.17 8.63 18.29 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 114.4 -1.273 . . . . 74.23 108.459 162.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 174' ' ' GLN . . . . . 0.413 ' OE1' ' HA ' ' B' ' 172' ' ' GLU . 22.7 mp0 -94.95 156.88 16.15 Favored 'General case' 0 C--N 1.352 0.708 0 C-N-CA 125.203 1.401 . . . . 74.45 109.516 -177.086 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 175' ' ' ASP . . . . . 0.58 ' H ' HG21 ' C' ' 126' ' ' THR . 11.5 t70 179.06 105.6 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.418 1.087 . . . . 74.1 109.302 -175.041 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -97.67 25.98 5.4 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.153 0.581 . . . . 74.11 110.96 178.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 177' ' ' THR . . . . . 0.499 ' N ' ' HD2' ' B' ' 178' ' ' PRO . 9.2 m -78.94 -30.8 0.68 Allowed Pre-proline 0 CA--C 1.573 1.838 0 CA-C-O 116.534 -1.698 . . . . 64.31 115.061 -176.551 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 178' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' B' ' 177' ' ' THR . 10.3 Cg_endo -50.57 -42.17 50.44 Favored 'Trans proline' 1 C--N 1.417 4.147 0 CA-C-N 123.023 2.115 . . . . 74.53 112.271 -178.539 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -176.23 -172.22 0.47 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.119 1.368 . . . . 61.34 108.843 173.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . -66.11 -35.22 79.91 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 109.368 -0.604 . . . . 74.4 109.368 166.051 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 181' ' ' LEU . . . . . 0.527 ' HB2' ' HB3' ' C' ' 136' ' ' ARG . 58.0 tp -159.79 -69.95 0.08 Allowed 'General case' 0 C--N 1.353 0.726 0 CA-C-N 115.816 -0.629 . . . . 62.04 111.186 -176.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 182' ' ' VAL . . . . . 0.523 HG11 ' H ' ' C' ' 139' ' ' GLU . 8.2 p -79.93 150.43 4.96 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 CA-C-N 115.355 -0.839 . . . . 71.31 112.711 -163.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -119.67 38.17 3.98 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.909 0.883 . . . . 65.24 109.278 171.249 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 184' ' ' HIS . . . . . 0.401 ' H ' HG22 ' B' ' 182' ' ' VAL . 74.4 m-70 56.85 -87.11 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.723 1.209 . . . . 74.15 110.589 -171.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 185' ' ' VAL . . . . . 0.559 HG23 ' HA ' ' C' ' 121' ' ' ALA . 1.5 p -161.11 121.36 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 124.382 1.073 . . . . 71.33 108.71 173.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 81.9 p 55.04 85.38 0.06 Allowed 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 125.404 1.481 . . . . 51.31 112.795 175.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 187' ' ' SER . . . . . . . . . . . . . 90.1 p -163.38 -170.63 2.31 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.156 0.582 . . . . 62.14 110.534 178.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 188' ' ' ARG . . . . . 0.564 ' HA ' ' HG2' ' C' ' 124' ' ' PRO . 0.0 OUTLIER -145.83 -173.47 4.15 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 113.07 0.767 . . . . 71.52 113.07 -173.863 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 2.4 ttpt -146.7 143.37 28.69 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.449 1.499 . . . . 72.52 107.587 168.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 190' ' ' CYS . . . . . 0.582 ' HB2' ' HB3' ' B' ' 53' ' ' ALA . 35.2 t -126.87 103.59 7.58 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.215 0.531 . . . . 70.33 110.061 175.511 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -95.88 -37.25 10.79 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.567 1.147 . . . . 74.04 108.776 173.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 96.63 153.26 29.53 Favored Glycine 0 C--N 1.348 1.195 0 CA-C-N 115.315 -0.857 . . . . 64.22 112.829 178.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 193' ' ' PRO . . . . . 0.455 ' HA ' ' OG1' ' B' ' 48' ' ' THR . 29.6 Cg_endo -88.71 50.11 1.51 Allowed 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 124.026 3.15 . . . . 64.32 112.548 -173.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 194' ' ' SER . . . . . . . . . . . . . 38.2 m -73.96 14.54 0.39 Allowed 'General case' 0 CA--C 1.555 1.139 0 N-CA-C 114.181 1.178 . . . . 24.51 114.181 -172.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 195' ' ' ALA . . . . . . . . . . . . . . . -56.99 -52.85 63.61 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.073 0.949 . . . . 74.32 111.185 177.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 25.2 m 51.59 109.94 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 125.74 1.616 . . . . 73.32 114.955 168.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 19.4 m -66.29 91.7 0.17 Allowed 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.19 0.596 . . . . 75.11 109.539 171.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 198' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -81.76 111.89 18.41 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.012 0.925 . . . . 51.12 111.334 -170.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt 51.02 83.73 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.844 1.258 . . . . 74.4 112.755 164.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 200' ' ' CYS . . . . . 0.412 ' HB2' ' HD3' ' B' ' 201' ' ' PRO . 81.2 m -139.59 -49.3 0.02 OUTLIER Pre-proline 0 CA--C 1.562 1.411 0 CA-C-O 118.135 -0.936 . . . . 73.31 112.131 -176.479 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 201' ' ' PRO . . . . . 0.412 ' HD3' ' HB2' ' B' ' 200' ' ' CYS . 23.9 Cg_exo -65.51 95.8 0.28 Allowed 'Trans proline' 0 C--N 1.398 3.152 0 C-N-CA 121.622 1.548 . . . . 71.34 111.847 172.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . -80.86 68.11 3.46 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-N 115.739 -0.664 . . . . 63.04 111.673 176.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 203' ' ' ASN . . . . . 0.424 ' ND2' ' HA ' ' B' ' 283' ' ' ASP . 42.2 p30 -138.66 26.13 2.56 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.991 0.916 . . . . 71.33 111.412 -176.249 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -71.96 83.37 0.95 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.265 0.626 . . . . 74.01 111.694 -171.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 205' ' ' LEU . . . . . . . . . . . . . 53.5 tp 56.75 -79.17 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 126.314 1.846 . . . . 51.03 112.935 174.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -56.53 -68.8 0.18 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.134 1.374 . . . . 62.32 111.079 -178.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -93.99 75.6 4.14 Favored 'General case' 0 C--N 1.344 0.344 0 N-CA-C 108.821 -0.807 . . . . 74.32 108.821 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 208' ' ' GLY . . . . . 0.4 ' HA2' ' HA ' ' B' ' 203' ' ' ASN . . . -147.4 34.75 1.26 Allowed Glycine 0 C--N 1.337 0.636 0 CA-C-N 114.389 -1.278 . . . . 71.52 111.476 177.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 82.89 -62.93 4.56 Favored Glycine 0 C--N 1.346 1.108 0 CA-C-N 115.42 -0.39 . . . . 42.21 112.306 -177.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt 67.75 -77.33 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 125.328 1.451 . . . . 74.51 110.169 -177.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . -88.54 -33.06 10.59 Favored Glycine 0 C--N 1.349 1.294 0 N-CA-C 110.863 -0.895 . . . . 74.43 110.863 171.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 36.2 m 63.7 -164.28 0.25 Allowed 'General case' 0 C--N 1.36 1.053 0 C-N-CA 124.568 1.147 . . . . 74.04 110.957 178.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 68.3 mt 75.36 -64.34 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 C-N-CA 125.291 1.437 . . . . 64.4 110.833 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 32.2 m 74.86 -27.63 0.19 Allowed 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 125.527 1.531 . . . . 75.43 112.723 176.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 215' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 75.61 -68.66 0.19 Allowed 'General case' 0 C--N 1.359 1.002 0 C-N-CA 126.378 1.871 . . . . 73.31 111.766 173.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -146.61 -81.09 0.15 Allowed 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 119.657 -0.211 . . . . 61.42 111.061 -176.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 217' ' ' LEU . . . . . 0.594 ' HB2' HE22 ' B' ' 274' ' ' GLN . 10.1 mp 60.18 -157.11 0.34 Allowed 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.987 0.915 . . . . 75.4 110.275 -166.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 218' ' ' LEU . . . . . 0.406 HD23 ' H ' ' B' ' 218' ' ' LEU . 2.6 pt? -133.21 17.41 4.08 Favored 'General case' 0 N--CA 1.483 1.204 0 O-C-N 121.701 -0.624 . . . . 71.43 112.451 -170.52 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 57.3 -142.23 0.74 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.255 -0.646 . . . . 71.24 109.255 -176.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . 84.72 -36.32 0.05 Allowed 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 125.149 1.38 . . . . 61.1 112.316 163.036 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 221' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.21 133.8 1.15 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.314 1.046 . . . . 73.55 108.342 170.361 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -120.5 118.78 31.15 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 108.949 -0.76 . . . . 42.52 108.949 177.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -65.39 -35.03 79.71 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.646 0.778 . . . . 61.02 109.556 178.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 2.0 p -103.53 101.68 12.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 107.281 -1.377 . . . . 74.2 107.281 166.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 5.7 t -72.12 -52.71 15.44 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 122.647 0.379 . . . . 54.34 111.085 -175.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 226' ' ' LEU . . . . . 0.431 HD11 ' HA ' ' B' ' 281' ' ' PHE . 8.4 tt 65.24 150.81 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 125.032 1.333 . . . . 74.43 111.628 -179.385 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . -163.72 137.64 4.87 Favored Glycine 0 C--N 1.341 0.814 0 N-CA-C 111.205 -0.758 . . . . 51.31 111.205 178.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . -120.92 165.73 14.03 Favored Glycine 0 N--CA 1.469 0.848 0 N-CA-C 111.273 -0.731 . . . . 72.41 111.273 177.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . 91.0 119.1 2.18 Favored Glycine 0 C--N 1.341 0.834 0 CA-C-N 116.904 0.352 . . . . 70.24 113.107 177.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -75.22 -14.57 60.54 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.512 0.725 . . . . 70.23 110.114 171.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 231' ' ' LYS . . . . . 0.43 ' HG3' HD22 ' B' ' 265' ' ' LEU . 53.9 tttp 79.38 94.09 0.06 Allowed 'General case' 0 C--N 1.358 0.958 0 C-N-CA 125.81 1.644 . . . . 73.24 110.877 169.085 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 10.0 t -116.66 125.76 52.22 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.955 0.902 . . . . 74.24 111.397 179.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 233' ' ' PHE . . . . . 0.427 ' HE1' ' HE3' ' B' ' 231' ' ' LYS . 34.4 p90 -176.25 132.46 0.23 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.296 1.438 . . . . 70.41 108.403 170.612 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -136.74 -63.03 0.63 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.276 0.63 . . . . 72.31 110.155 177.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 235' ' ' GLU . . . . . 0.521 ' HG3' ' H ' ' B' ' 237' ' ' ALA . 13.5 tp10 -157.23 146.57 20.2 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.237 0.615 . . . . 54.41 110.031 -174.453 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 236' ' ' THR . . . . . . . . . . . . . 13.4 m -66.82 -24.43 66.16 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.191 1.396 . . . . 73.34 112.302 -176.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 237' ' ' ALA . . . . . 0.521 ' H ' ' HG3' ' B' ' 235' ' ' GLU . . . -113.28 -75.34 0.6 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.344 0.658 . . . . 71.12 110.324 175.424 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 238' ' ' THR . . . . . 0.479 HG21 ' H ' ' C' ' 220' ' ' GLU . 0.2 OUTLIER 64.79 -9.57 0.18 Allowed 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 125.945 1.698 . . . . 71.31 113.599 -177.871 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -163.81 174.38 11.64 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.803 0.729 . . . . 74.42 111.113 -165.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . -79.51 -106.29 0.24 Allowed Glycine 0 C--N 1.345 1.051 0 CA-C-N 115.409 -0.814 . . . . 71.23 111.804 174.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.29 -179.52 5.62 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.41 0.684 . . . . 71.21 111.132 -178.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 242' ' ' TRP . . . . . 0.485 ' CZ3' HG21 ' C' ' 253' ' ' VAL . 7.8 m0 -94.18 -60.54 1.71 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.198 0.999 . . . . 70.32 109.375 -175.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -172.25 -33.16 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 113.472 -1.694 . . . . 74.22 109.097 -167.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -162.15 101.7 0.2 Allowed Glycine 0 C--N 1.347 1.185 0 N-CA-C 111.375 -0.69 . . . . 63.11 111.375 174.118 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 39.1 tptt -120.56 110.28 16.27 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.13 0.972 . . . . 75.34 109.976 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 1.9 p -148.16 101.99 3.32 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.859 1.264 . . . . 71.02 108.322 174.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 247' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' C' ' 206' ' ' VAL . 2.5 tm? -165.64 133.0 2.88 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 108.829 -0.804 . . . . 72.51 108.829 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 248' ' ' ARG . . . . . . . . . . . . . 31.9 mtp-105 -68.44 96.72 0.7 Allowed 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.538 0.735 . . . . 75.15 110.07 176.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -81.33 78.3 8.12 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 121.361 0.6 . . . . 71.33 110.403 -176.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -158.58 139.8 13.2 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 115.013 -0.994 . . . . 65.4 109.384 -177.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 251' ' ' ALA . . . . . . . . . . . . . . . -73.1 107.04 5.22 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 108.849 -0.797 . . . . 61.03 108.849 175.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 25.9 tp60 -67.68 -26.0 65.97 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.032 0.933 . . . . 72.3 110.844 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -73.34 77.71 1.36 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.26 0.624 . . . . 51.41 109.487 173.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -71.39 -48.18 51.55 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 115.572 -0.74 . . . . 72.51 111.155 -171.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . 62.62 -84.46 0.04 OUTLIER Glycine 0 C--N 1.352 1.444 0 O-C-N 124.571 1.169 . . . . 54.22 114.006 175.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 256' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 72.61 -61.82 0.49 Allowed 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 126.329 1.852 . . . . 52.52 111.605 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -61.46 126.79 28.61 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 124.22 1.008 . . . . 74.31 110.613 176.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 258' ' ' LEU . . . . . . . . . . . . . 26.5 tp 67.59 10.21 7.6 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 125.263 1.425 . . . . 75.13 111.852 -178.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 259' ' ' VAL . . . . . 0.401 HG22 ' HB2' ' B' ' 125' ' ' ALA . 24.7 t 65.0 148.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 C-N-CA 125.508 1.523 . . . . 63.02 110.941 -173.455 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 260' ' ' SER . . . . . 0.466 ' HA ' HD22 ' B' ' 277' ' ' LEU . 66.7 p -147.5 -179.2 6.69 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 121.593 -0.692 . . . . 73.11 111.123 -175.242 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -79.63 74.34 6.3 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.969 0.907 . . . . 52.21 109.55 175.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 262' ' ' ALA . . . . . . . . . . . . . . . -173.84 -53.06 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.259 1.424 . . . . 43.43 107.915 -178.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -86.79 155.96 20.1 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 114.724 -1.125 . . . . 70.44 110.357 178.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 10.5 m 73.68 -69.29 0.19 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 126.027 1.731 . . . . 51.14 112.649 175.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 265' ' ' LEU . . . . . 0.43 HD22 ' HG3' ' B' ' 231' ' ' LYS . 1.6 tt 72.34 134.26 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 125.46 1.504 . . . . 64.12 109.602 -175.001 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 266' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 77.82 -67.38 0.19 Allowed 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 125.736 1.614 . . . . 71.52 110.907 -176.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 49.7 m 48.13 59.68 4.1 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.42 1.088 . . . . 73.13 112.943 175.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 6.7 p -75.13 73.58 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.287 0 CA-C-O 122.69 1.233 . . . . 74.44 109.832 175.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 269' ' ' THR . . . . . . . . . . . . . 2.7 t -164.54 100.44 0.81 Allowed 'General case' 0 C--O 1.242 0.698 0 CA-C-N 114.356 -1.293 . . . . 74.31 108.574 -177.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 270' ' ' GLU . . . . . 0.409 ' HG2' ' HB2' ' B' ' 274' ' ' GLN . 30.7 tt0 65.41 27.21 11.89 Favored 'General case' 0 CA--C 1.558 1.261 0 C-N-CA 124.036 0.934 . . . . 72.41 111.096 172.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 271' ' ' ALA . . . . . 0.487 ' HB1' ' HA3' ' B' ' 279' ' ' GLY . . . -82.58 4.85 23.01 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.192 0.997 . . . . 75.3 112.751 -175.439 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 272' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -80.72 71.46 7.62 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.387 0.675 . . . . 54.14 109.769 175.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 62.89 -6.76 0.16 Allowed 'General case' 0 CA--C 1.565 1.529 0 C-N-CA 125.797 1.639 . . . . 61.32 114.907 175.094 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 274' ' ' GLN . . . . . 0.594 HE22 ' HB2' ' B' ' 217' ' ' LEU . 26.8 mm-40 -74.44 -50.7 17.36 Favored 'General case' 0 C--N 1.357 0.931 0 N-CA-C 107.534 -1.284 . . . . 71.44 107.534 171.315 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 275' ' ' LYS . . . . . . . . . . . . . 53.6 mttp -106.89 92.27 7.33 Favored Pre-proline 0 CA--C 1.541 0.611 0 N-CA-C 106.778 -1.564 . . . . 71.33 106.778 162.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -84.23 36.67 0.59 Allowed 'Trans proline' 0 C--N 1.372 1.784 0 C-N-CA 122.974 2.449 . . . . 62.35 111.499 -178.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 277' ' ' LEU . . . . . 0.466 HD22 ' HA ' ' B' ' 260' ' ' SER . 26.1 mt -89.71 -97.7 0.1 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.661 1.184 . . . . 63.32 109.072 -173.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 278' ' ' LEU . . . . . 0.459 ' HA ' ' HG2' ' A' ' 279' ' ' ARG . 2.4 mm? -89.8 22.78 2.96 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 122.957 0.503 . . . . 62.0 111.781 -172.074 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 279' ' ' GLY . . . . . 0.487 ' HA3' ' HB1' ' B' ' 271' ' ' ALA . . . -127.76 -83.89 0.43 Allowed Glycine 0 C--N 1.348 1.231 0 CA-C-O 119.945 -0.364 . . . . 75.43 112.674 -177.226 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 86.1 mt 66.75 -76.36 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 125.334 1.454 . . . . 53.23 111.264 -173.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 281' ' ' PHE . . . . . 0.431 ' HA ' HD11 ' B' ' 226' ' ' LEU . 77.3 t80 -140.68 127.17 20.06 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.713 0.805 . . . . 75.31 109.485 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -92.12 123.66 35.63 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.793 0.837 . . . . 65.41 109.908 178.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 283' ' ' ASP . . . . . 0.424 ' HA ' ' ND2' ' B' ' 203' ' ' ASN . 38.1 t0 -166.05 149.48 7.58 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.467 0.707 . . . . 72.33 109.948 174.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . -136.45 -54.98 0.06 OUTLIER Glycine 0 C--N 1.342 0.876 0 CA-C-N 115.893 -0.594 . . . . 61.45 111.986 -178.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 73.54 -57.46 0.63 Allowed 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 125.535 1.534 . . . . 72.41 112.21 -175.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 286' ' ' MET . . . . . 0.429 ' HA ' ' O ' ' B' ' 290' ' ' TRP . 69.3 mtm 63.34 66.57 1.14 Allowed Pre-proline 0 CA--C 1.554 1.105 0 C-N-CA 124.866 1.266 . . . . 64.1 110.655 -173.632 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 287' ' ' PRO . . . . . 0.504 ' HD2' ' HA ' ' B' ' 291' ' ' LEU . 19.9 Cg_exo -68.42 112.31 2.78 Favored 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 123.248 2.632 . . . . 73.33 112.345 -177.39 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 288' ' ' VAL . . . . . 0.572 HG12 ' HG2' ' B' ' 289' ' ' ARG . 41.7 t 59.18 -80.43 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.242 0 C-N-CA 125.101 1.36 . . . . 74.32 111.965 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 289' ' ' ARG . . . . . 0.572 ' HG2' HG12 ' B' ' 288' ' ' VAL . 59.5 mmt-85 -124.68 102.66 7.7 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.647 0.779 . . . . 72.14 110.019 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 290' ' ' TRP . . . . . 0.429 ' O ' ' HA ' ' B' ' 286' ' ' MET . 8.0 m-90 65.82 -83.32 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 125.317 1.447 . . . . 75.34 112.264 176.082 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 291' ' ' LEU . . . . . 0.504 ' HA ' ' HD2' ' B' ' 287' ' ' PRO . 5.9 mp -134.11 49.3 2.27 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.406 -0.961 . . . . 64.34 108.406 177.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . 87.21 153.61 24.88 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-O 118.318 -1.268 . . . . 62.12 111.317 -170.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -38.4 92.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 124.125 3.217 . . . . 51.12 114.624 172.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 294' ' ' LYS . . . . . 0.451 ' HE2' ' HA ' ' B' ' 294' ' ' LYS . 11.4 mmpt? -70.97 -30.49 66.77 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 114.495 -1.229 . . . . 41.23 110.248 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 295' ' ' ALA . . . . . 0.537 ' HB3' ' HB2' ' C' ' 184' ' ' PRO . . . -153.56 163.76 39.41 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 124.944 1.297 . . . . 34.32 108.42 171.571 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 29.1 m -94.31 143.02 26.75 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.206 0.603 . . . . 65.42 109.828 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -61.83 97.13 0.07 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.768 0.827 . . . . 64.12 109.88 178.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 298' ' ' HIS . . . . . 0.491 ' HB3' HD11 ' B' ' 375' ' ' LEU . 36.8 t-80 60.82 23.15 13.15 Favored 'General case' 0 CA--C 1.563 1.475 0 C-N-CA 124.724 1.21 . . . . 71.5 111.442 177.566 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . -85.21 8.41 70.97 Favored Glycine 0 C--N 1.354 1.581 0 CA-C-N 115.928 -0.578 . . . . 63.41 113.151 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -86.83 53.01 2.67 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.698 1.199 . . . . 72.23 109.518 176.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 301' ' ' ILE . . . . . 0.609 HG13 ' H ' ' B' ' 302' ' ' ASP 0.275 21.2 pt 37.82 -82.79 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.564 1.484 0 C-N-CA 127.152 2.181 . . . . 72.24 114.407 -167.942 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 302' ' ' ASP . . . . . 0.609 ' H ' HG13 ' B' ' 301' ' ' ILE . 14.0 t70 65.66 100.55 0.04 OUTLIER 'General case' 0 C--O 1.242 0.701 0 C-N-CA 124.784 1.234 . . . . 63.41 113.076 -177.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 303' ' ' LYS . . . . . 0.581 ' HE2' ' HB3' ' B' ' 62' ' ' LYS . 0.1 OUTLIER 155.09 -56.84 0.0 OUTLIER Pre-proline 0 N--CA 1.486 1.354 0 C-N-CA 126.913 2.085 . . . . 74.11 109.445 158.305 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 304' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -78.38 104.9 1.9 Allowed 'Trans proline' 0 C--N 1.391 2.799 0 C-N-CA 121.849 1.699 . . . . 75.12 112.55 -177.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -166.61 -55.79 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.606 0.762 . . . . 42.33 111.384 175.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 6.3 p -77.63 -36.16 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 113.16 0.8 . . . . 72.33 113.16 -176.056 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 307' ' ' THR . . . . . 0.446 HG21 HD12 ' B' ' 367' ' ' LEU . 63.2 m 59.12 -87.06 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 124.163 0.985 . . . . 74.23 110.241 -158.493 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 308' ' ' CYS . . . . . . . . . . . . . 37.6 t 171.07 119.75 0.01 OUTLIER 'General case' 0 C--N 1.359 1.007 0 C-N-CA 125.325 1.45 . . . . 74.22 108.657 -173.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 309' ' ' THR . . . . . 0.482 ' H ' HG13 ' B' ' 68' ' ' ILE . 23.6 m -90.72 120.14 68.88 Favored Pre-proline 0 N--CA 1.475 0.777 0 C-N-CA 123.298 0.639 . . . . 72.2 109.501 176.103 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -65.48 -35.6 38.22 Favored 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 122.544 2.162 . . . . 63.14 112.556 -176.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 311' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -99.16 146.33 31.53 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 123.565 0.746 . . . . 73.13 110.422 -177.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 312' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -66.58 123.61 11.31 Favored 'Trans proline' 0 C--N 1.367 1.534 0 C-N-CA 122.306 2.004 . . . . 70.14 111.512 167.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 313' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -77.8 109.88 12.19 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.538 -0.912 . . . . 75.13 108.538 170.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 314' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? -65.2 131.18 45.83 Favored 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 109.466 -0.568 . . . . 72.01 109.466 -176.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 315' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -109.66 -55.44 2.43 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 108.585 -0.894 . . . . 72.12 108.585 174.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 316' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -158.69 156.53 30.09 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 115.066 -0.97 . . . . 74.4 108.518 -177.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 78.6 p -69.45 -40.37 77.2 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 122.946 0.498 . . . . 75.41 110.879 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 318' ' ' VAL . . . . . . . . . . . . . 7.6 p -141.1 77.93 19.83 Favored Pre-proline 0 CA--C 1.561 1.371 0 N-CA-C 108.406 -0.961 . . . . 73.13 108.406 176.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 319' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.98 -24.12 39.81 Favored 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 122.89 2.393 . . . . 65.1 112.423 -175.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 320' ' ' THR . . . . . . . . . . . . . 19.0 p -84.1 -9.98 58.17 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 123.956 0.902 . . . . 53.31 111.644 175.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 321' ' ' LEU . . . . . . . . . . . . . 2.8 tt 49.43 -94.17 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 126.138 1.775 . . . . 65.14 112.908 167.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 322' ' ' ALA . . . . . . . . . . . . . . . -142.8 26.74 1.7 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.046 0.938 . . . . 64.54 110.176 -177.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 323' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -84.91 99.15 10.76 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.723 0.809 . . . . 74.02 109.404 177.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 324' ' ' MET . . . . . . . . . . . . . 51.7 ttm -165.81 -22.35 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.175 0.99 . . . . 71.32 110.57 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 325' ' ' THR . . . . . . . . . . . . . 80.6 m 70.76 -83.24 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.363 1.465 . . . . 72.33 110.252 -173.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 326' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -172.31 -80.57 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.43 0.692 . . . . 72.01 109.254 -178.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 327' ' ' LYS . . . . . 0.556 ' HB3' ' NH2' ' C' ' 24' ' ' ARG . 0.1 OUTLIER -146.5 -32.98 0.32 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.547 0.739 . . . . 54.34 109.852 175.612 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 328' ' ' ALA . . . . . . . . . . . . . . . 50.75 -93.97 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 124.93 1.292 . . . . 72.03 112.444 173.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 329' ' ' ILE . . . . . . . . . . . . . 9.6 tp -148.73 -43.64 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.121 0 C-N-CA 122.432 0.293 . . . . 73.5 111.717 178.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 330' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -71.19 -23.2 61.99 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 112.495 0.554 . . . . 63.42 112.495 -173.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 331' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -67.65 148.66 51.07 Favored 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 108.833 -0.803 . . . . 63.34 108.833 176.047 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 332' ' ' LEU . . . . . 0.476 ' HG ' ' NE2' ' C' ' 19' ' ' GLN . 2.7 mm? -78.19 69.02 4.34 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 124.168 0.987 . . . . 74.41 112.95 -159.534 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 333' ' ' SER . . . . . . . . . . . . . 48.8 m -140.25 -76.77 0.32 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.085 0.954 . . . . 65.04 108.802 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 85.9 mttt 65.95 -66.44 0.16 Allowed 'General case' 0 C--N 1.362 1.117 0 C-N-CA 125.943 1.697 . . . . 63.11 113.319 168.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 335' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -70.63 92.45 0.86 Allowed 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 109.495 -0.558 . . . . 73.25 109.495 175.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -81.2 98.02 7.88 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.672 -0.862 . . . . 61.02 108.672 177.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 337' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -105.94 99.45 9.04 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.589 0.756 . . . . 62.43 110.848 -176.318 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 338' ' ' GLY . . . . . . . . . . . . . . . 47.63 -92.6 0.01 OUTLIER Glycine 0 C--N 1.356 1.661 0 C-N-CA 124.341 0.972 . . . . 72.34 114.087 174.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 339' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -87.03 70.93 10.3 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.938 0.895 . . . . 74.33 108.668 173.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 340' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -69.3 -23.21 63.78 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 115.48 -0.782 . . . . 75.24 110.172 171.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 341' ' ' LEU . . . . . . . . . . . . . 2.7 tm? 77.18 -64.2 0.33 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 126.352 1.861 . . . . 75.34 111.107 174.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 342' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -45.24 90.84 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 125.547 1.539 . . . . 64.25 113.332 -175.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 343' ' ' VAL . . . . . 0.447 HG22 ' H ' ' B' ' 344' ' ' GLU . 9.8 p -85.51 179.61 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 CA-C-N 114.278 -1.328 . . . . 64.24 109.265 179.73 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 344' ' ' GLU . . . . . 0.447 ' H ' HG22 ' B' ' 343' ' ' VAL . 9.2 tp10 -42.13 109.84 0.15 Allowed 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.521 1.128 . . . . 73.03 111.332 171.591 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 345' ' ' GLY . . . . . . . . . . . . . . . 151.13 99.15 0.19 Allowed Glycine 0 C--N 1.336 0.536 0 N-CA-C 109.808 -1.317 . . . . 62.31 109.808 -172.17 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 346' ' ' ALA . . . . . . . . . . . . . . . -62.8 -66.81 0.49 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.58 0.752 . . . . 72.22 111.255 -174.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 69.7 m -154.66 13.19 0.41 Allowed 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.921 0.888 . . . . 72.21 110.262 175.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 348' ' ' ILE . . . . . 0.423 ' HB ' ' NH2' ' C' ' 31' ' ' ARG . 21.9 mm 55.79 52.25 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.162 0 CA-C-O 123.584 1.659 . . . . 73.42 107.406 -160.647 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 349' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -79.4 -14.06 59.19 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 112.203 -2.271 . . . . 71.13 113.039 -165.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 350' ' ' LYS . . . . . . . . . . . . . 42.9 mttp -74.77 -19.04 60.37 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.212 0.605 . . . . 74.52 110.96 -177.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 -104.03 116.21 31.83 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 107.813 -1.18 . . . . 71.32 107.813 169.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 18.6 t70 73.89 -56.11 0.65 Allowed 'General case' 0 N--CA 1.503 2.175 0 C-N-CA 125.516 1.526 . . . . 74.35 112.863 173.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 353' ' ' HIS . . . . . . . . . . . . . 6.1 t60 91.48 -34.56 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 126.772 2.029 . . . . 74.33 112.793 167.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 354' ' ' ALA . . . . . . . . . . . . . . . -133.49 -76.64 0.48 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.608 0.363 . . . . 70.11 110.892 -171.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 355' ' ' ALA . . . . . . . . . . . . . . . 174.67 -39.02 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.034 1.334 . . . . 75.44 108.145 -172.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 356' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 54.52 58.94 11.66 Favored Pre-proline 0 CA--C 1.561 1.396 0 CA-C-N 114.249 -1.341 . . . . 74.32 111.874 177.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 357' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -77.92 -44.26 0.18 Allowed 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 122.584 2.189 . . . . 55.22 113.033 -173.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 358' ' ' CYS . . . . . . . . . . . . . 66.9 m -147.32 107.74 4.09 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.092 0.957 . . . . 73.32 108.709 -178.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 359' ' ' GLY . . . . . . . . . . . . . . . -77.79 80.16 1.36 Allowed Glycine 0 C--N 1.344 1.021 0 N-CA-C 111.0 -0.84 . . . . 62.01 111.0 175.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 360' ' ' GLN . . . . . 0.412 HE22 HD23 ' B' ' 70' ' ' LEU . 6.2 pt20 -72.03 80.54 0.94 Allowed 'General case' 0 CA--C 1.553 1.082 0 CA-C-O 121.763 0.792 . . . . 53.34 111.429 -178.061 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 361' ' ' ILE . . . . . . . . . . . . . 1.4 pt -156.07 153.69 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 125.564 1.546 . . . . 61.31 108.68 178.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 362' ' ' GLY . . . . . . . . . . . . . . . 155.67 -163.52 31.73 Favored Glycine 0 C--N 1.341 0.815 0 CA-C-N 115.952 -0.567 . . . . 72.35 112.533 -178.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 363' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -157.68 107.81 2.18 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.689 0.796 . . . . 73.13 108.901 179.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 364' ' ' THR . . . . . . . . . . . . . 77.8 m -104.41 -68.95 0.83 Allowed 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.143 -0.688 . . . . 74.04 109.143 175.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 365' ' ' VAL . . . . . 0.592 HG12 ' H ' ' B' ' 366' ' ' ASP . 3.0 t 60.16 -178.93 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.57 1.734 0 C-N-CA 124.737 1.215 . . . . 74.01 111.238 -178.003 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 366' ' ' ASP . . . . . 0.651 ' HA ' ' HG3' ' B' ' 17' ' ' PRO . 3.7 m-20 82.65 -12.0 0.94 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 125.488 1.515 . . . . 50.12 112.776 166.23 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 367' ' ' LEU . . . . . 0.446 HD12 HG21 ' B' ' 307' ' ' THR . 69.5 mt -102.38 25.76 8.6 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 108.51 -0.922 . . . . 75.05 108.51 169.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 368' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -116.16 -156.76 0.63 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.432 1.493 . . . . 71.23 109.667 -174.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 369' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 72.98 107.51 0.07 Allowed 'General case' 0 C--N 1.357 0.918 0 C-N-CA 125.452 1.501 . . . . 70.1 110.757 176.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 370' ' ' ALA . . . . . . . . . . . . . . . -151.52 166.97 29.49 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.735 0.814 . . . . 74.25 110.37 -177.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 371' ' ' VAL . . . . . . . . . . . . . 57.3 t -72.08 125.38 30.62 Favored 'Isoleucine or valine' 0 C--O 1.245 0.828 0 N-CA-C 107.505 -1.294 . . . . 74.11 107.505 166.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 372' ' ' GLN . . . . . . . . . . . . . 50.9 tp60 -61.86 133.82 55.92 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 123.842 0.714 . . . . 63.2 110.632 -175.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 373' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -68.24 -27.4 66.32 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.356 -0.838 . . . . 72.05 111.183 -175.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . 73.36 173.47 0.29 Allowed 'General case' 0 C--O 1.247 0.923 0 C-N-CA 124.909 1.284 . . . . 71.45 111.329 -177.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 375' ' ' LEU . . . . . 0.491 HD11 ' HB3' ' B' ' 298' ' ' HIS . 2.9 mm? -62.26 133.43 55.15 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 114.906 -1.043 . . . . 62.01 111.095 -171.332 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 64.5 20.46 12.16 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.401 1.08 . . . . 73.13 112.455 173.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 377' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 68.2 100.91 0.05 Allowed 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.979 1.311 . . . . 73.31 111.689 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 378' ' ' ALA . . . . . . . . . . . . . . . 85.38 2.76 0.65 Allowed 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 125.866 1.666 . . . . 61.1 114.228 167.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -81.9 79.23 8.49 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 121.878 0.847 . . . . 72.01 110.267 175.05 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 380' ' ' LYS . . . . . 0.486 ' HE2' ' HA ' ' B' ' 380' ' ' LYS . 0.6 OUTLIER -134.89 57.28 1.81 Allowed 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 106.424 -1.695 . . . . 53.14 106.424 172.203 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 381' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 57.37 -83.5 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 114.026 -1.443 . . . . 74.34 110.756 -172.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . 73.27 -79.21 0.78 Allowed Glycine 0 C--N 1.351 1.366 0 CA-C-O 121.332 0.406 . . . . 73.1 112.099 178.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 383' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -129.92 119.77 23.79 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 106.064 -1.828 . . . . 73.1 106.064 167.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 384' ' ' THR . . . . . . . . . . . . . 23.6 p -82.08 45.55 0.94 Allowed 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.409 0.684 . . . . 63.41 110.888 -178.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 37.9 tp -150.85 -55.0 0.15 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.132 0.973 . . . . 75.12 108.87 -175.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 386' ' ' VAL . . . . . . . . . . . . . 20.8 m -134.9 155.65 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 C-N-CA 124.09 0.956 . . . . 62.42 109.93 177.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 387' ' ' ILE . . . . . 0.444 HG13 HG23 ' B' ' 388' ' ' VAL . 10.9 tp -112.22 146.51 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 123.049 0.539 . . . . 74.12 109.976 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 388' ' ' VAL . . . . . 0.444 HG23 HG13 ' B' ' 387' ' ' ILE . 49.1 t 61.03 -91.34 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 C-N-CA 125.18 1.392 . . . . 54.33 111.049 -178.43 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 389' ' ' THR . . . . . . . . . . . . . 62.3 m -158.73 -64.93 0.08 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.89 0.876 . . . . 71.25 108.694 -177.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . -171.02 -177.19 2.14 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.357 1.063 . . . . 70.34 110.038 -174.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 391' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -63.74 -52.92 58.29 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.377 0.671 . . . . 64.12 110.664 173.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 392' ' ' HIS . . . . . . . . . . . . . 28.1 t-80 63.5 -76.94 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.618 1.167 . . . . 72.42 111.214 -175.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -153.86 74.33 0.98 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.534 0.733 . . . . 61.53 109.273 179.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 62.24 35.58 15.31 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 124.275 1.03 . . . . 73.31 110.164 -178.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . 63.19 9.57 4.03 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.978 1.311 . . . . 71.44 112.976 -177.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 43.5 t -96.46 135.97 37.6 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 123.971 0.909 . . . . 75.55 109.472 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 397' ' ' GLN . . . . . . . . . . . . . 20.4 tp60 -66.49 -48.37 70.03 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.037 0.935 . . . . 71.41 110.793 176.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 398' ' ' ILE . . . . . 0.515 HG12 HG22 ' B' ' 399' ' ' VAL 0.264 7.6 tt 36.61 -95.86 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.571 1.787 0 C-N-CA 125.93 1.692 . . . . 75.44 111.968 -171.048 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 399' ' ' VAL . . . . . 0.515 HG22 HG12 ' B' ' 398' ' ' ILE . 1.4 m -148.49 -61.8 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 124.921 1.288 . . . . 73.32 108.698 171.241 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 400' ' ' ALA . . . . . 0.548 ' HB1' ' HB ' ' B' ' 403' ' ' THR . . . 46.21 53.27 12.73 Favored Pre-proline 0 CA--C 1.567 1.61 0 C-N-CA 125.515 1.526 . . . . 51.41 113.175 -179.392 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 401' ' ' PRO . . . . . 0.594 ' HA ' ' HA ' ' A' ' 117' ' ' ARG . 26.1 Cg_exo -61.95 -58.61 0.36 Allowed 'Trans proline' 0 C--N 1.388 2.606 0 C-N-CA 123.021 2.481 . . . . 71.04 113.491 -169.301 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -95.6 26.29 4.04 Favored 'General case' 0 CA--C 1.554 1.124 0 CA-C-O 121.643 0.735 . . . . 74.34 110.499 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 403' ' ' THR . . . . . 0.548 ' HB ' ' HB1' ' B' ' 400' ' ' ALA . 9.1 m -107.56 87.4 2.49 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 108.579 -0.897 . . . . 51.3 108.579 176.487 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 404' ' ' LYS . . . . . 0.624 ' HE3' ' HB3' ' A' ' 118' ' ' ASP . 43.0 mmtm -129.41 143.53 50.88 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.819 0.848 . . . . 70.03 109.909 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 405' ' ' ALA . . . . . 0.456 ' H ' ' HD2' ' B' ' 406' ' ' PRO . . . -170.38 -41.78 0.0 OUTLIER Pre-proline 0 CA--C 1.563 1.455 0 CA-C-O 118.108 -0.948 . . . . 71.24 112.152 -169.481 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 406' ' ' PRO . . . . . 0.456 ' HD2' ' H ' ' B' ' 405' ' ' ALA . 72.3 Cg_exo -46.74 144.06 8.3 Favored 'Trans proline' 0 C--N 1.406 3.571 0 C-N-CA 122.872 2.381 . . . . 44.44 113.732 171.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . 95.56 -64.22 1.31 Allowed Glycine 0 C--N 1.342 0.916 0 N-CA-C 111.061 -0.815 . . . . 55.33 111.061 -176.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 408' ' ' LEU . . . . . . . . . . . . . 44.9 tp 57.78 -80.15 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 125.392 1.477 . . . . 72.03 112.43 175.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 21.6 m -110.56 68.13 0.66 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.654 0.781 . . . . 73.52 109.977 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 410' ' ' GLN . . . . . . . . . . . . . 43.6 tp60 62.86 21.19 12.68 Favored 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 124.982 1.313 . . . . 51.32 113.503 170.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . -71.53 151.69 43.64 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 121.744 -0.598 . . . . 63.14 110.171 175.064 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 24.8 tp 71.89 10.88 6.23 Favored 'General case' 0 CA--C 1.566 1.595 0 C-N-CA 125.573 1.549 . . . . 60.41 111.817 -179.035 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -66.03 -37.69 86.51 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.06 0.544 . . . . 71.14 110.311 173.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 414' ' ' THR . . . . . . . . . . . . . 49.8 m 78.6 -42.61 0.33 Allowed 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 126.195 1.798 . . . . 73.24 112.191 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 415' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt 69.82 -81.79 0.03 OUTLIER 'General case' 0 C--N 1.352 0.693 0 C-N-CA 125.766 1.626 . . . . 73.42 111.17 -178.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -133.41 -175.11 3.7 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.796 0.838 . . . . 75.33 111.234 -168.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 417' ' ' GLY . . . . . 0.442 ' O ' ' HG3' ' A' ' 241' ' ' PRO . . . 155.99 -21.32 0.51 Allowed Glycine 0 C--N 1.35 1.341 0 CA-C-N 115.58 -0.737 . . . . 43.15 111.695 -177.268 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 418' ' ' ALA . . . . . . . . . . . . . . . -59.59 -31.48 69.5 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.076 0.95 . . . . 70.25 112.035 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 419' ' ' VAL . . . . . 0.467 HG23 ' HG2' ' B' ' 420' ' ' MET . 30.4 m -74.23 -24.1 18.87 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 C-N-CA 123.646 0.779 . . . . 62.03 112.241 178.138 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 420' ' ' MET . . . . . 0.467 ' HG2' HG23 ' B' ' 419' ' ' VAL . 26.6 mmt -99.95 23.64 9.56 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.834 0.854 . . . . 73.12 111.662 -172.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 421' ' ' VAL . . . . . 0.535 ' HA ' ' HD3' ' A' ' 241' ' ' PRO . 18.6 m -69.05 -156.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 C-N-CA 123.793 0.837 . . . . 72.42 111.789 178.484 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 422' ' ' MET . . . . . . . . . . . . . 20.8 ptt? -67.39 67.25 0.08 Allowed 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 122.62 1.2 . . . . 74.1 111.092 173.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 423' ' ' SER . . . . . . . . . . . . . 12.0 t -173.78 -166.66 0.32 Allowed 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 127.142 2.177 . . . . 62.22 106.405 -170.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 424' ' ' TYR . . . . . . . . . . . . . 92.9 t80 67.21 -77.02 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 124.378 1.071 . . . . 72.42 111.857 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . -73.12 165.92 54.69 Favored Glycine 0 C--N 1.35 1.323 0 CA-C-O 119.845 -0.419 . . . . 75.12 112.796 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 426' ' ' ASN . . . . . 0.517 ' HB3' ' HB ' ' B' ' 435' ' ' THR . 3.0 t30 48.6 61.17 3.2 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 125.107 1.363 . . . . 75.43 111.132 -177.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 427' ' ' SER . . . . . . . . . . . . . 16.2 t 60.7 23.55 13.41 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 124.833 1.253 . . . . 75.14 113.112 175.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 50.64 -68.56 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 127.613 2.365 . . . . 73.23 115.339 175.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 429' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -78.03 -60.05 2.53 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 107.872 -1.158 . . . . 63.42 107.872 173.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 11.9 t70 53.4 97.21 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.732 1.613 . . . . 55.41 111.794 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 14.7 m 76.53 -39.7 0.36 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.671 1.588 . . . . 73.31 111.77 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 432' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -169.47 -66.89 0.02 OUTLIER 'General case' 0 C--N 1.35 0.622 0 C-N-CA 123.774 0.829 . . . . 71.1 109.383 -172.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 433' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -166.98 166.21 15.45 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.538 0.735 . . . . 73.43 109.887 -166.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 434' ' ' HIS . . . . . . . . . . . . . 38.9 m80 66.19 18.03 10.87 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 124.652 1.181 . . . . 65.13 111.936 175.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 435' ' ' THR . . . . . 0.517 ' HB ' ' HB3' ' B' ' 426' ' ' ASN . 29.4 p 57.08 34.22 24.55 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.542 1.537 . . . . 73.42 112.381 -176.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . 166.83 27.84 0.02 OUTLIER Glycine 0 C--N 1.348 1.241 0 CA-C-O 119.322 -0.71 . . . . 43.54 113.886 175.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 39.3 t 59.28 -77.55 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.827 1.251 . . . . 54.14 110.918 -169.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 438' ' ' GLN . . . . . 0.418 ' NE2' ' HA2' ' B' ' 453' ' ' GLY . 3.6 pp0? -67.63 -174.94 0.47 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.079 1.352 . . . . 71.55 112.56 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 439' ' ' LEU . . . . . . . . . . . . . 94.9 mt -80.82 26.84 0.4 Allowed 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 113.805 1.039 . . . . 74.24 113.805 -169.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 440' ' ' ARG . . . . . . . . . . . . . 30.6 mmm180 60.81 34.93 19.6 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 123.743 0.817 . . . . 70.1 112.219 174.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 441' ' ' ILE . . . . . 0.706 ' HA ' HD22 ' A' ' 235' ' ' LEU . 39.2 mt -67.34 98.4 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 CA-C-N 115.263 -0.88 . . . . 74.15 112.359 -169.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 442' ' ' ALA . . . . . . . . . . . . . . . -92.25 -88.13 0.21 Allowed 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 114.956 -1.02 . . . . 71.41 108.711 171.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 443' ' ' ALA . . . . . 0.505 ' HB3' ' HG3' ' A' ' 224' ' ' PRO . . . 66.24 -72.16 0.08 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 125.355 1.462 . . . . 74.21 114.013 168.664 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 444' ' ' TYR . . . . . 0.429 ' CE2' ' HA ' ' A' ' 227' ' ' THR . 88.6 m-85 -134.61 158.0 45.14 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.308 1.043 . . . . 65.34 108.512 175.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . -123.78 62.54 0.57 Allowed Glycine 0 CA--C 1.537 1.463 0 CA-C-O 119.196 -0.78 . . . . 74.34 113.086 176.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 446' ' ' PRO . . . . . 0.429 ' HB3' ' HD2' ' A' ' 226' ' ' ARG . 4.0 Cg_exo -84.44 121.19 2.58 Favored 'Trans proline' 0 C--N 1.384 2.396 0 C-N-CA 123.065 2.51 . . . . 63.02 110.316 174.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 447' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 71.87 -58.77 0.57 Allowed 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 125.959 1.704 . . . . 60.0 110.547 -171.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . 75.46 -67.21 0.25 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 125.665 1.586 . . . . 74.31 113.196 168.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 449' ' ' ALA . . . . . . . . . . . . . . . -75.55 75.59 2.58 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.851 0.86 . . . . 61.52 111.92 -173.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 450' ' ' ASN . . . . . . . . . . . . . 65.3 t30 168.73 -35.72 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 126.366 1.867 . . . . 61.12 107.976 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 42.3 t -78.81 125.85 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.268 1.027 . . . . 63.1 109.785 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 452' ' ' VAL . . . . . . . . . . . . . 30.2 m -71.97 159.24 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 123.239 0.615 . . . . 60.45 111.021 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 453' ' ' GLY . . . . . 0.418 ' HA2' ' NE2' ' B' ' 438' ' ' GLN . . . 97.87 -58.64 1.06 Allowed Glycine 0 C--N 1.341 0.813 0 N-CA-C 111.518 -0.633 . . . . 73.44 111.518 -177.03 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 454' ' ' LEU . . . . . . . . . . . . . 97.1 mt 68.05 159.41 0.16 Allowed 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 125.121 1.368 . . . . 72.5 113.171 176.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 12.5 p -77.67 94.73 4.46 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 114.928 -1.033 . . . . 61.41 109.59 172.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -64.58 -52.97 54.84 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.518 -0.764 . . . . 74.3 110.938 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 457' ' ' GLN . . . . . 0.512 ' HB2' ' HG3' ' A' ' 236' ' ' LYS . 0.5 OUTLIER -81.86 96.39 7.62 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.056 -1.09 . . . . 42.14 108.056 179.424 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 43.6 p 51.18 -165.82 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 125.626 1.571 . . . . 72.13 112.802 -176.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 459' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -86.73 -48.7 8.04 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 121.986 -0.446 . . . . 73.31 111.859 -170.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 9.4 mp 49.64 49.52 19.86 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 123.787 0.835 . . . . 65.42 110.344 -171.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -63.33 119.53 9.84 Favored 'General case' 0 CA--C 1.552 1.04 0 CA-C-N 114.231 -1.35 . . . . 62.31 112.069 -171.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -125.93 29.88 5.8 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.702 1.201 . . . . 72.53 108.626 169.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 5.7 t -99.73 90.75 4.57 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 114.872 -1.058 . . . . 61.35 110.142 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 464' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -98.41 29.46 3.61 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.788 0.835 . . . . 75.31 109.065 170.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? 67.27 8.02 5.93 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 125.63 1.572 . . . . 72.15 111.006 -166.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . 54.99 -157.69 0.21 Allowed 'General case' 0 C--N 1.364 1.217 0 C-N-CA 124.735 1.214 . . . . 62.32 110.982 -172.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 467' ' ' ALA . . . . . 0.401 ' HB1' ' HA ' ' C' ' 263' ' ' PRO . . . -96.11 -27.47 15.05 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.181 0.592 . . . . 75.3 110.215 172.073 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 3.3 pp -162.13 -30.13 0.05 OUTLIER 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.598 1.559 . . . . 45.51 109.85 177.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 469' ' ' GLY . . . . . . . . . . . . . . . 72.21 -91.04 0.53 Allowed Glycine 0 C--N 1.35 1.336 0 C-N-CA 123.913 0.768 . . . . 50.44 112.859 177.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 470' ' ' LEU . . . . . . . . . . . . . 16.6 tp 68.08 6.98 5.54 Favored 'General case' 0 CA--C 1.562 1.418 0 C-N-CA 125.774 1.629 . . . . 73.2 112.122 -178.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 471' ' ' LYS . . . . . . . . . . . . . 64.4 tttp . . . . . 0 C--O 1.252 1.215 0 N-CA-C 107.866 -1.161 . . . . 74.2 107.866 176.632 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 77.2 mtm . . . . . 0 N--CA 1.476 0.826 0 CA-C-O 119.745 -0.169 . . . . 55.23 111.108 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.69 41.22 18.87 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.417 1.087 . . . . 65.31 111.63 177.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -72.48 77.6 1.05 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.763 0.825 . . . . 52.01 110.534 178.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -36.89 117.52 0.52 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.891 1.676 . . . . 70.52 114.288 -176.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 5' ' ' LYS . . . . . 0.462 ' HB3' HD11 ' C' ' 10' ' ' ILE . 14.1 mmmm -93.93 108.59 20.37 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 108.355 -0.98 . . . . 63.2 108.355 167.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -71.94 93.97 1.41 Allowed 'General case' 0 C--O 1.238 0.487 0 N-CA-C 107.583 -1.265 . . . . 63.22 107.583 175.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 7' ' ' TYR . . . . . 0.483 ' HA ' HD12 ' C' ' 10' ' ' ILE . 30.9 m-85 -60.41 -30.36 69.56 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 115.004 -0.998 . . . . 73.43 112.158 -171.363 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -66.76 -45.04 79.78 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.572 -0.74 . . . . 72.53 110.521 177.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.9 -42.58 99.25 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.088 0.555 . . . . 52.31 110.685 177.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 10' ' ' ILE . . . . . 0.483 HD12 ' HA ' ' C' ' 7' ' ' TYR . 69.5 mt -55.3 -50.95 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 123.72 0.808 . . . . 63.34 111.144 178.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 83.4 mt -74.48 -12.0 60.37 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.528 -0.76 . . . . 45.45 112.371 -179.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 69.99 33.82 70.35 Favored Glycine 0 C--N 1.351 1.384 0 O-C-N 123.045 0.216 . . . . 64.33 112.754 -176.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 13' ' ' VAL . . . . . 0.447 ' HB ' ' HD2' ' C' ' 14' ' ' PRO . 11.6 m -108.46 164.39 14.86 Favored Pre-proline 0 N--CA 1.479 1.021 0 C-N-CA 124.46 1.104 . . . . 64.04 109.615 174.184 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 14' ' ' PRO . . . . . 0.447 ' HD2' ' HB ' ' C' ' 13' ' ' VAL . 35.5 Cg_endo -60.12 162.79 15.76 Favored 'Trans proline' 0 C--N 1.384 2.4 0 C-N-CA 122.095 1.863 . . . . 74.43 112.596 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 8.8 mmm180 -77.18 14.31 0.94 Allowed 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.042 0.937 . . . . 71.52 112.413 -170.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -148.99 14.75 0.92 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.692 1.197 . . . . 71.24 108.716 -176.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.04 137.5 56.81 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 123.923 0.889 . . . . 71.14 112.914 -170.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 78.8 p -70.77 161.87 30.13 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.798 0.839 . . . . 74.41 110.649 178.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 19' ' ' GLN . . . . . 0.476 ' NE2' ' HG ' ' B' ' 332' ' ' LEU . 0.2 OUTLIER -57.52 -29.34 64.26 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.519 0.728 . . . . 74.45 111.541 -177.204 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -65.68 -47.92 73.84 Favored 'General case' 0 C--O 1.215 -0.733 0 CA-C-O 119.33 -0.367 . . . . 64.05 110.486 176.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -61.24 -35.62 77.73 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 123.711 0.632 . . . . 73.42 110.821 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.46 -44.04 97.85 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.928 0 C-N-CA 123.671 0.788 . . . . 61.32 110.756 173.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 23' ' ' LYS . . . . . 0.481 ' HB3' ' HZ3' ' C' ' 23' ' ' LYS . 6.5 ttpm? -73.02 -31.43 64.46 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.539 0.736 . . . . 74.13 111.304 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 24' ' ' ARG . . . . . 0.556 ' NH2' ' HB3' ' B' ' 327' ' ' LYS . 40.0 mtt180 -69.08 -45.47 70.21 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.124 0.97 . . . . 73.52 110.083 178.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -71.77 -31.81 67.01 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 124.522 1.139 . . . . 75.32 111.183 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 26' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -58.0 -60.3 3.94 Favored 'General case' 0 C--O 1.21 -0.995 0 O-C-N 124.191 0.932 . . . . 72.31 109.323 171.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 27' ' ' LYS . . . . . 0.423 ' O ' ' HG3' ' C' ' 31' ' ' ARG . 53.4 mtmt -63.07 -35.08 79.04 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 124.366 1.041 . . . . 74.1 111.336 -178.001 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 28' ' ' ARG . . . . . 0.613 ' HA ' HH21 ' C' ' 31' ' ' ARG . 63.7 ttt180 -58.11 -51.88 67.86 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.071 0.948 . . . . 71.15 110.244 177.584 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 29' ' ' LEU . . . . . 0.517 ' HA ' ' HB3' ' C' ' 32' ' ' GLN . 83.2 mt -90.62 -0.02 57.54 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 113.983 -1.462 . . . . 60.22 111.195 -177.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.15 -10.96 29.05 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.778 0.831 . . . . 75.32 110.003 169.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 31' ' ' ARG . . . . . 0.613 HH21 ' HA ' ' C' ' 28' ' ' ARG . 32.7 mtm105 -93.66 -35.81 12.66 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.261 0.624 . . . . 73.5 109.454 165.514 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 32' ' ' GLN . . . . . 0.517 ' HB3' ' HA ' ' C' ' 29' ' ' LEU . 49.7 tt0 -67.69 -60.55 2.45 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 122.489 0.316 . . . . 71.12 110.386 176.25 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -92.38 31.71 1.28 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.287 0.635 . . . . 70.15 109.781 178.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 34' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -58.91 106.46 0.72 Allowed Pre-proline 0 N--CA 1.481 1.078 0 C-N-CA 124.184 0.993 . . . . 72.34 109.059 -179.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -58.37 -29.45 88.25 Favored 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 123.041 2.494 . . . . 71.32 113.146 -165.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -72.28 -33.15 67.22 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.042 0.937 . . . . 60.34 112.442 178.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 61.8 t -97.73 -23.15 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 123.457 0.703 . . . . 75.33 110.689 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -128.86 83.61 2.17 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.74 0.816 . . . . 54.22 109.504 -168.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -81.85 36.05 0.44 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.134 0.973 . . . . 62.24 111.374 178.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 40' ' ' SER . . . . . 0.47 ' HB2' ' HB3' ' C' ' 43' ' ' ALA . 20.0 m -93.02 107.71 26.97 Favored Pre-proline 0 CA--C 1.544 0.742 0 N-CA-C 108.63 -0.878 . . . . 74.14 108.63 -178.056 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -43.39 -54.67 3.4 Favored 'Trans proline' 0 C--N 1.386 2.507 0 C-N-CA 124.437 3.425 . . . . 63.44 114.439 -171.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -67.29 -31.14 71.25 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.974 0.91 . . . . 65.44 110.777 -176.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 43' ' ' ALA . . . . . 0.47 ' HB3' ' HB2' ' C' ' 40' ' ' SER . . . -77.31 -19.13 56.84 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.021 0.528 . . . . 62.05 110.68 177.491 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -82.9 -28.06 30.23 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.11 0.564 . . . . 74.04 109.504 176.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -75.63 -32.74 60.36 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.542 0.737 . . . . 42.53 109.832 173.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 46' ' ' LYS . . . . . . . . . . . . . 41.1 mmtm -65.17 -44.02 89.87 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.73 -0.668 . . . . 72.32 109.992 168.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -56.71 -37.01 70.32 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.529 0.732 . . . . 62.23 110.171 174.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -62.41 -44.33 96.71 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 123.745 0.653 . . . . 72.04 111.72 174.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -66.35 -33.87 76.69 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 122.334 0.253 . . . . 72.33 111.628 176.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 50' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.56 -39.44 85.05 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 C-N-CA 123.77 0.828 . . . . 75.43 109.751 173.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 51' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -72.08 -29.29 63.97 Favored 'General case' 0 C--O 1.212 -0.88 0 C-N-CA 124.034 0.934 . . . . 74.04 110.785 177.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -67.51 -57.53 6.33 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.566 1.146 . . . . 63.42 109.966 177.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.57 -47.12 85.32 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-N 113.158 -1.837 . . . . 63.1 111.629 -176.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -60.22 -57.76 11.4 Favored 'General case' 0 C--O 1.203 -1.362 0 CA-C-N 115.051 -0.977 . . . . 75.01 110.567 174.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.97 -30.77 64.38 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 113.174 0.805 . . . . 60.54 113.174 -170.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 94.3 t -73.78 -60.06 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 N-CA-C 109.843 -0.429 . . . . 72.43 109.843 170.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 57' ' ' LEU . . . . . 0.432 HD11 ' HB2' ' C' ' 7' ' ' TYR . 79.7 mt -81.64 4.6 21.06 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 113.454 0.909 . . . . 75.02 113.454 -169.661 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 41.8 t -74.62 -36.53 62.92 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.447 1.099 . . . . 62.42 109.717 177.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -82.96 127.78 68.16 Favored Pre-proline 0 C--N 1.331 -0.206 0 N-CA-C 108.399 -0.963 . . . . 72.03 108.399 174.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 60' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -54.71 -32.91 78.05 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.571 2.181 . . . . 33.23 111.073 165.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -55.4 -64.64 0.78 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.957 1.303 . . . . 62.13 110.864 174.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 36.8 mtpt -76.45 -16.0 59.78 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.13 0.972 . . . . 75.23 112.197 -173.05 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -71.37 -45.15 63.57 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 107.816 -1.179 . . . . 64.42 107.816 171.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -72.13 -24.06 61.41 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.199 0.599 . . . . 74.15 111.861 175.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 90.3 mt -66.06 -42.93 92.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 N-CA-C 109.204 -0.665 . . . . 62.34 109.204 171.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -60.58 -48.89 79.77 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 115.486 -0.779 . . . . 74.22 109.5 174.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -57.39 -42.73 82.76 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.801 0.84 . . . . 73.14 112.112 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 35.8 p -74.13 -23.18 59.25 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.659 0.384 . . . . 63.2 111.431 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -74.11 142.93 45.56 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 109.133 -0.692 . . . . 75.22 109.133 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.64 11.99 65.18 Favored Glycine 0 N--CA 1.476 1.351 0 N-CA-C 112.072 -0.411 . . . . 62.51 112.072 -171.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 36.2 m -144.75 -54.26 0.32 Allowed 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 104.259 -2.497 . . . . 72.34 104.259 175.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 55.0 m -88.73 151.98 22.08 Favored 'General case' 0 C--O 1.246 0.88 0 N-CA-C 104.949 -2.241 . . . . 73.35 104.949 156.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.56 -17.33 2.27 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.872 0.869 . . . . 73.23 110.29 -176.622 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.88 132.55 77.28 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 123.572 0.749 . . . . 53.23 110.466 174.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -61.46 156.87 44.17 Favored 'Trans proline' 0 C--N 1.377 2.071 0 C-N-CA 123.413 2.742 . . . . 75.14 112.48 175.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -63.21 169.08 9.87 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 123.421 2.748 . . . . 63.14 112.81 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.85 122.58 5.92 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 121.86 1.707 . . . . 51.51 111.305 171.124 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 78' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.81 122.8 7.53 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 122.51 2.14 . . . . 74.44 112.043 175.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -82.72 159.55 16.4 Favored 'Trans proline' 0 CA--C 1.557 1.672 0 C-N-CA 122.72 2.28 . . . . 61.04 112.109 173.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.27 84.77 0.04 OUTLIER 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 123.123 2.549 . . . . 51.5 112.18 169.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 81' ' ' GLY . . . . . 0.564 ' HA3' ' HB1' ' C' ' 141' ' ' ALA . . . 160.21 -30.18 0.37 Allowed Glycine 0 C--O 1.239 0.43 0 CA-C-N 114.559 -1.2 . . . . 75.2 110.316 -178.523 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 92.14 178.86 41.58 Favored Glycine 0 C--N 1.35 1.311 0 CA-C-N 115.196 -0.502 . . . . 74.45 112.314 173.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -80.68 102.16 9.71 Favored 'General case' 0 C--O 1.243 0.761 0 N-CA-C 106.927 -1.508 . . . . 70.14 106.927 168.274 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -53.73 132.69 41.56 Favored 'General case' 0 C--O 1.248 0.978 0 O-C-N 124.769 1.293 . . . . 63.13 111.42 -174.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 85' ' ' PHE . . . . . 0.495 ' CD1' ' HB ' ' C' ' 90' ' ' VAL . 2.1 t80 -156.18 24.02 0.36 Allowed 'General case' 0 C--O 1.243 0.761 0 CA-C-N 114.624 -1.171 . . . . 74.41 110.697 -173.159 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 52.3 m -58.45 128.38 36.85 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.274 -0.876 . . . . 45.43 111.01 -176.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 91.47 -30.31 6.55 Favored Glycine 0 C--N 1.342 0.906 0 CA-C-O 119.591 -0.561 . . . . 74.33 113.175 -179.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 88' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -94.44 137.74 33.22 Favored 'General case' 0 C--N 1.355 0.823 0 N-CA-C 108.443 -0.947 . . . . 74.44 108.443 -177.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -86.64 70.45 10.41 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.244 0.618 . . . . 72.23 111.142 -169.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 90' ' ' VAL . . . . . 0.495 ' HB ' ' CD1' ' C' ' 85' ' ' PHE . 1.3 p -39.59 -47.13 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 C-N-CA 125.138 1.375 . . . . 54.41 113.446 178.239 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -69.93 -23.38 63.2 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 114.695 -1.139 . . . . 74.21 111.753 -167.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -100.77 -7.18 23.96 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.293 0.637 . . . . 75.53 111.1 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 8.1 m-30 -78.73 -172.12 2.85 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 109.869 -0.419 . . . . 72.45 109.869 176.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 88.0 p -68.27 148.81 50.26 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 112.332 0.493 . . . . 45.51 112.332 -170.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.63 -38.26 89.55 Favored 'General case' 0 CA--C 1.551 1.009 0 CA-C-N 114.871 -1.059 . . . . 55.43 110.869 175.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -49.05 -52.45 25.38 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.658 1.183 . . . . 65.02 111.375 171.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 97' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -62.37 -43.68 98.25 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 114.409 -1.268 . . . . 64.25 110.626 178.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -73.3 -5.06 37.15 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.428 0.691 . . . . 51.52 112.341 -178.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -100.08 -41.96 6.93 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.267 0.627 . . . . 74.43 111.712 167.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 26.6 tp -67.24 -42.86 83.28 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.329 0.652 . . . . 73.23 111.573 -173.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -109.91 5.13 22.18 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-O 121.062 0.458 . . . . 73.25 109.875 173.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -44.96 -52.56 7.87 Favored Glycine 0 CA--C 1.538 1.514 0 CA-C-O 118.416 -1.213 . . . . 54.11 115.153 -177.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -35.03 -29.05 0.05 OUTLIER 'Trans proline' 0 C--N 1.389 2.658 0 C-N-CA 125.045 3.83 . . . . 62.02 117.142 175.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -145.73 21.79 1.82 Allowed Glycine 0 C--N 1.36 1.91 0 CA-C-N 118.552 0.615 . . . . 43.23 113.891 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 6.9 mt -75.05 76.54 2.24 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 113.284 0.846 . . . . 73.03 113.284 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 106' ' ' PHE . . . . . 0.505 ' HB3' ' O ' ' C' ' 168' ' ' GLY . 3.7 m-30 45.29 -105.73 0.1 Allowed 'General case' 0 CA--C 1.563 1.451 0 O-C-N 124.622 1.202 . . . . 64.24 112.913 162.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . 111.04 28.33 3.92 Favored Glycine 0 C--N 1.36 1.879 0 N-CA-C 116.182 1.233 . . . . 51.05 116.182 164.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 108' ' ' GLY . . . . . 0.705 ' HA2' ' HA ' ' C' ' 114' ' ' ARG . . . -11.14 -89.79 0.01 OUTLIER Glycine 0 N--CA 1.477 1.38 0 N-CA-C 118.165 2.026 . . . . 74.41 118.165 169.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 109' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -75.72 -8.06 55.89 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 117.034 0.417 . . . . 74.45 111.352 -170.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 110' ' ' GLY . . . . . . . . . . . . . . . -90.56 3.57 81.67 Favored Glycine 0 C--N 1.348 1.248 0 N-CA-C 111.206 -0.758 . . . . 54.22 111.206 173.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 64.5 mtm180 57.97 8.92 0.81 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 125.55 1.54 . . . . 75.25 113.21 175.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 112' ' ' ARG . . . . . . . . . . . . . 53.1 ttt180 -81.94 47.48 1.11 Allowed 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 125.694 1.597 . . . . 74.1 109.657 176.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 113' ' ' SER . . . . . 0.437 ' HB3' ' HB3' ' C' ' 167' ' ' GLN . 28.5 m 90.3 75.97 0.01 OUTLIER 'General case' 0 C--N 1.365 1.252 0 C-N-CA 126.17 1.788 . . . . 72.53 110.963 -166.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 114' ' ' ARG . . . . . 0.726 ' HG2' ' H ' ' C' ' 115' ' ' LYS . 18.1 ttm180 -74.48 -163.35 0.2 Allowed 'General case' 0 CA--C 1.581 2.172 0 C-N-CA 123.948 0.899 . . . . 74.05 110.107 170.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 115' ' ' LYS . . . . . 0.726 ' H ' ' HG2' ' C' ' 114' ' ' ARG . 24.3 ttpp -8.0 111.25 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.303 0 C-N-CA 128.058 2.543 . . . . 54.14 116.121 -164.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -63.09 112.83 5.31 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-N 114.626 -1.17 . . . . 45.25 113.573 -171.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 16.2 mtm180 -58.21 124.53 19.73 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.43 0.692 . . . . 64.44 109.25 174.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -57.92 135.22 56.87 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 123.836 0.71 . . . . 75.42 109.249 176.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 119' ' ' LEU . . . . . . . . . . . . . 4.9 tt -95.28 121.34 36.83 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 107.57 -1.27 . . . . 75.21 107.57 -172.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.76 94.78 5.26 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 107.668 -1.234 . . . . 72.31 107.668 -168.147 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 121' ' ' ALA . . . . . 0.559 ' HA ' HG23 ' B' ' 185' ' ' VAL . . . -108.58 113.0 25.65 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 108.308 -0.997 . . . . 63.21 108.308 -176.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 122' ' ' GLU . . . . . 0.631 ' HB3' ' HB2' ' B' ' 58' ' ' SER . 0.0 OUTLIER -94.15 110.52 22.23 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 106.959 -1.497 . . . . 73.22 106.959 -178.649 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 123' ' ' LEU . . . . . 0.432 HD23 ' H ' ' C' ' 123' ' ' LEU . 2.4 pt? -129.82 133.32 24.89 Favored Pre-proline 0 N--CA 1.48 1.031 0 C-N-CA 122.481 0.313 . . . . 73.3 111.801 -165.573 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 124' ' ' PRO . . . . . 0.564 ' HG2' ' HA ' ' B' ' 188' ' ' ARG . 10.7 Cg_exo -73.53 119.57 6.01 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 123.077 2.518 . . . . 72.51 111.172 170.378 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 125' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' C' ' 180' ' ' LEU . 47.1 tp -128.97 165.32 21.34 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.187 0.995 . . . . 74.03 108.631 -177.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 126' ' ' THR . . . . . 0.58 HG21 ' H ' ' B' ' 175' ' ' ASP . 0.2 OUTLIER -105.61 170.9 7.62 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 121.541 0.686 . . . . 61.53 111.686 179.405 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 127' ' ' LEU . . . . . 0.478 HD22 ' CD2' ' C' ' 183' ' ' HIS . 2.4 mt -81.46 -56.69 3.87 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 114.583 -1.189 . . . . 62.25 109.698 -162.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -49.07 -47.13 45.27 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 112.756 -2.02 . . . . 75.24 110.33 170.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -67.88 -33.0 73.88 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 115.707 -0.679 . . . . 73.53 111.456 -177.038 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 130' ' ' ALA . . . . . 0.477 ' HB1' HG22 ' C' ' 153' ' ' VAL . . . -68.17 -31.95 71.87 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 123.698 0.623 . . . . 64.34 110.721 173.598 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 131' ' ' PHE . . . . . 0.405 ' HB2' HD13 ' C' ' 215' ' ' LEU . 74.0 t80 -75.28 -31.85 60.85 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 124.029 0.932 . . . . 75.55 111.37 174.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 132' ' ' HIS . . . . . . . . . . . . . 34.6 m170 -79.62 -55.64 4.88 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 112.335 0.495 . . . . 60.22 112.335 -173.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.07 -111.41 3.34 Favored Glycine 0 C--N 1.345 1.068 0 N-CA-C 110.253 -1.139 . . . . 65.31 110.253 -167.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.41 168.2 35.53 Favored Glycine 0 C--N 1.356 1.645 0 CA-C-N 117.426 0.613 . . . . 53.24 113.511 177.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -71.05 93.65 1.04 Allowed 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 108.932 -0.766 . . . . 71.2 108.932 175.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 136' ' ' ARG . . . . . 0.527 ' HB3' ' HB2' ' B' ' 181' ' ' LEU . 9.6 mpt_? -117.47 133.5 55.9 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.452 1.101 . . . . 72.12 109.493 -174.372 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 137' ' ' VAL . . . . . . . . . . . . . 27.8 m -71.91 131.12 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-O 121.346 0.593 . . . . 71.12 111.616 -176.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 138' ' ' VAL . . . . . 0.523 HG11 ' SD ' ' C' ' 164' ' ' MET . 13.2 p -115.3 130.12 70.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 C-N-CA 124.684 1.194 . . . . 72.14 107.808 170.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 139' ' ' GLU . . . . . 0.523 ' H ' HG11 ' B' ' 182' ' ' VAL . 42.4 mt-10 -126.61 86.52 2.52 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 108.117 -1.068 . . . . 74.31 108.117 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 140' ' ' VAL . . . . . . . . . . . . . 11.0 m -125.39 107.59 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 123.25 0.62 . . . . 63.22 111.319 -175.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 141' ' ' ALA . . . . . 0.564 ' HB1' ' HA3' ' C' ' 81' ' ' GLY . . . 56.31 28.74 13.84 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.812 1.245 . . . . 15.23 113.27 173.08 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 119.49 -24.3 8.13 Favored Glycine 0 C--N 1.353 1.475 0 CA-C-N 116.5 -0.318 . . . . 45.25 113.663 177.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 143' ' ' ARG . . . . . 0.563 ' HG2' ' HG3' ' C' ' 164' ' ' MET . 0.3 OUTLIER -76.44 97.63 4.35 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.511 0.724 . . . . 73.04 109.059 178.838 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 40.9 ttp180 -113.42 95.45 5.37 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 109.17 -0.678 . . . . 71.51 109.17 176.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 145' ' ' VAL . . . . . . . . . . . . . 7.6 p -142.31 141.62 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 123.438 0.695 . . . . 75.03 111.254 -176.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 28.0 t -80.4 101.4 8.99 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 108.754 -0.832 . . . . 54.21 108.754 170.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 12.4 p -122.79 152.58 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.102 0.961 . . . . 72.53 110.014 -176.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -99.98 98.86 9.57 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 107.488 -1.301 . . . . 74.22 107.488 171.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 149' ' ' ILE . . . . . 0.653 HD12 HG21 ' C' ' 159' ' ' ILE . 45.9 pt -68.72 151.39 97.27 Favored Pre-proline 0 CA--C 1.55 0.961 0 N-CA-C 108.873 -0.788 . . . . 71.41 108.873 173.397 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -43.09 110.53 0.17 Allowed 'Trans proline' 0 C--N 1.387 2.604 0 C-N-CA 123.451 2.767 . . . . 61.44 113.543 -178.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -62.3 131.3 33.61 Favored 'Trans proline' 0 C--N 1.386 2.53 0 C-N-CA 122.786 2.324 . . . . 73.2 110.992 178.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 152' ' ' GLY . . . . . . . . . . . . . . . 102.13 61.57 0.74 Allowed Glycine 0 C--N 1.334 0.422 0 N-CA-C 110.396 -1.082 . . . . 54.32 110.396 -171.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 153' ' ' VAL . . . . . 0.501 ' HB ' HG12 ' C' ' 159' ' ' ILE . 0.9 OUTLIER -77.98 158.64 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 108.679 -0.86 . . . . 71.13 108.679 -179.691 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 154' ' ' ARG . . . . . 0.752 ' HG2' HD23 ' C' ' 188' ' ' LEU . 33.8 mtp180 -110.52 111.69 23.1 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 118.757 -0.639 . . . . 75.32 110.179 -170.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 155' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -43.29 120.29 1.84 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.735 1.214 . . . . 74.51 112.853 173.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.12 -7.8 20.47 Favored Glycine 0 C--N 1.354 1.551 0 C-N-CA 124.395 0.997 . . . . 64.51 114.182 177.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 157' ' ' SER . . . . . 0.522 ' HB2' ' HB2' ' C' ' 154' ' ' ARG . 69.4 m -109.91 -172.78 2.11 Favored 'General case' 0 C--O 1.246 0.905 0 C-N-CA 124.461 1.105 . . . . 75.43 110.735 -175.711 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 158' ' ' VAL . . . . . 0.657 ' HB ' ' HB1' ' B' ' 64' ' ' ALA . 12.1 p -88.25 138.99 18.07 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 CA-C-N 114.346 -1.297 . . . . 64.44 112.894 -170.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 159' ' ' ILE . . . . . 0.678 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 8.7 mt -108.31 93.25 2.41 Favored 'Isoleucine or valine' 0 C--O 1.245 0.819 0 N-CA-C 105.428 -2.064 . . . . 52.25 105.428 161.098 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 160' ' ' ARG . . . . . 0.545 ' HD2' ' HB ' ' B' ' 67' ' ' ILE . 6.1 ptm180 -82.27 123.65 29.24 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 108.951 -0.759 . . . . 72.21 108.951 178.579 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 161' ' ' VAL . . . . . 0.653 HG13 ' HB3' ' C' ' 174' ' ' LEU . 2.0 p -126.47 95.9 37.22 Favored Pre-proline 0 C--O 1.247 0.966 0 N-CA-C 107.694 -1.225 . . . . 75.24 107.694 170.185 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.26 147.75 88.12 Favored 'Trans proline' 0 C--N 1.381 2.268 0 C-N-CA 122.499 2.133 . . . . 63.42 110.836 175.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 87.64 25.73 31.88 Favored Glycine 0 C--N 1.338 0.686 0 CA-C-O 119.372 -0.682 . . . . 53.31 112.039 -171.018 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 164' ' ' MET . . . . . 0.563 ' HG3' ' HG2' ' C' ' 143' ' ' ARG . 34.4 ttm -156.44 23.26 0.35 Allowed 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 117.373 0.586 . . . . 73.35 112.144 -177.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . -86.77 -160.94 35.46 Favored Glycine 0 N--CA 1.48 1.604 0 N-CA-C 114.36 0.504 . . . . 64.24 114.36 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . -96.63 -175.46 35.45 Favored Glycine 0 C--N 1.357 1.733 0 C-N-CA 123.02 0.343 . . . . 75.44 113.514 -177.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 167' ' ' GLN . . . . . 0.437 ' HB3' ' HB3' ' C' ' 113' ' ' SER . 19.6 mm-40 -43.42 122.01 2.46 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 126.036 1.734 . . . . 64.31 113.334 -176.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 168' ' ' GLY . . . . . 0.505 ' O ' ' HB3' ' C' ' 106' ' ' PHE . . . 177.07 -126.46 1.11 Allowed Glycine 0 C--N 1.349 1.288 0 CA-C-O 118.889 -0.951 . . . . 13.44 112.003 -175.038 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 169' ' ' ASN . . . . . 0.55 ' HB3' ' HD3' ' C' ' 170' ' ' PRO . 31.4 t30 -174.53 -66.57 0.0 OUTLIER Pre-proline 0 CA--C 1.565 1.532 0 CA-C-O 117.759 -1.115 . . . . 62.44 110.731 163.364 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 170' ' ' PRO . . . . . 0.55 ' HD3' ' HB3' ' C' ' 169' ' ' ASN . 6.9 Cg_exo -69.31 -70.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.403 3.439 0 CA-C-N 122.015 1.755 . . . . 51.41 113.685 -177.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 171' ' ' PRO . . . . . 0.52 ' HG2' ' HG3' ' C' ' 115' ' ' LYS . 85.0 Cg_endo -93.85 126.08 0.53 Allowed 'Trans proline' 0 C--N 1.405 3.542 0 CA-C-N 123.901 2.429 . . . . 74.02 111.521 178.512 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -154.43 107.79 0.34 Allowed Glycine 0 C--N 1.331 0.25 0 N-CA-C 109.293 -1.523 . . . . 74.42 109.293 176.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 173' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -126.06 121.99 34.53 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 123.447 0.699 . . . . 74.51 109.473 -166.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 174' ' ' LEU . . . . . 0.653 ' HB3' HG13 ' C' ' 161' ' ' VAL . 61.8 tp -81.96 107.3 14.57 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 109.467 -0.568 . . . . 75.22 109.467 177.412 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 175' ' ' LEU . . . . . 0.448 HD22 HG21 ' C' ' 158' ' ' VAL . 11.4 mt -89.76 87.91 7.16 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 115.632 -0.713 . . . . 71.32 109.641 174.502 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 176' ' ' LEU . . . . . 0.678 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 98.5 mt -73.8 98.12 2.89 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 108.431 -0.951 . . . . 43.02 108.431 171.211 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 177' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' C' ' 122' ' ' GLU . 23.7 t -81.24 97.96 3.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 106.585 -1.635 . . . . 74.43 106.585 178.253 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 178' ' ' VAL . . . . . 0.432 HG21 HG21 ' C' ' 153' ' ' VAL . 3.5 p -87.86 129.95 38.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.012 -0.994 . . . . 74.01 110.756 -169.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 179' ' ' ARG . . . . . 0.434 ' O ' ' HA ' ' C' ' 124' ' ' PRO . 7.4 mmm180 -115.26 107.05 14.76 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 106.216 -1.772 . . . . 72.33 106.216 169.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 180' ' ' LEU . . . . . 0.413 ' HA ' ' O ' ' C' ' 125' ' ' LEU . 80.8 mt -68.38 138.51 55.42 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 109.147 -0.686 . . . . 70.51 109.147 175.325 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 181' ' ' LEU . . . . . . . . . . . . . 86.7 mt -50.55 129.76 26.36 Favored Pre-proline 0 N--CA 1.495 1.817 0 CA-C-O 117.848 -1.072 . . . . 74.2 108.672 -173.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER 11.42 -67.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.39 2.723 1 C-N-CA 126.135 4.557 . . . . 64.12 116.329 -153.024 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 183' ' ' HIS . . . . . 0.478 ' CD2' HD22 ' C' ' 127' ' ' LEU . 37.7 t-80 57.29 73.33 0.79 Allowed Pre-proline 0 N--CA 1.479 0.992 0 C-N-CA 124.18 0.992 . . . . 62.13 111.964 168.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 184' ' ' PRO . . . . . 0.537 ' HB2' ' HB3' ' B' ' 295' ' ' ALA . 63.8 Cg_endo -93.22 59.22 0.44 Allowed 'Trans proline' 0 C--N 1.358 1.042 0 N-CA-C 107.678 -1.701 . . . . 71.54 107.678 163.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 185' ' ' VAL . . . . . 0.626 HG11 ' SD ' ' C' ' 213' ' ' MET . 2.2 t -119.5 -59.01 2.95 Favored 'Isoleucine or valine' 0 C--N 1.362 1.133 0 N-CA-C 108.652 -0.87 . . . . 72.23 108.652 178.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 186' ' ' PHE . . . . . 0.495 ' HZ ' ' HA ' ' C' ' 214' ' ' THR . 40.8 m-85 -128.82 173.02 10.73 Favored 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 113.564 0.95 . . . . 61.44 113.564 -172.447 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 187' ' ' ARG . . . . . 0.442 ' NH1' ' HB2' ' C' ' 189' ' ' GLU . 2.1 tmt_? -152.61 120.92 6.3 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.983 1.313 . . . . 75.14 108.138 167.377 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 188' ' ' LEU . . . . . 0.752 HD23 ' HG2' ' C' ' 154' ' ' ARG . 48.7 tp -85.59 129.9 34.7 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 118.765 0.711 . . . . 74.14 112.797 -175.578 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 189' ' ' GLU . . . . . 0.442 ' HB2' ' NH1' ' C' ' 187' ' ' ARG . 14.6 tp10 -133.8 122.41 23.24 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 107.618 -1.253 . . . . 71.33 107.618 165.647 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 190' ' ' GLY . . . . . 0.479 ' HA2' ' HB3' ' B' ' 69' ' ' LEU . . . 67.27 -107.98 2.25 Favored Glycine 0 C--N 1.344 1.025 0 N-CA-C 111.473 -0.651 . . . . 74.2 111.473 -172.237 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 191' ' ' GLN . . . . . 0.442 ' NE2' ' HA3' ' C' ' 242' ' ' GLY . 24.7 mt-30 -122.93 -16.93 6.92 Favored 'General case' 0 C--O 1.258 1.513 0 C-N-CA 124.506 1.123 . . . . 60.21 109.446 174.247 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -81.37 135.8 35.69 Favored 'General case' 0 C--N 1.355 0.816 0 C-N-CA 124.76 1.224 . . . . 65.13 110.295 -178.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 193' ' ' LEU . . . . . 0.523 HD21 ' CD2' ' C' ' 240' ' ' PHE . 95.4 mt -92.9 154.04 18.44 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.771 0.428 . . . . 52.2 110.67 177.404 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 194' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -116.64 105.75 12.77 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.076 -1.453 . . . . 75.43 107.076 167.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 195' ' ' ALA . . . . . 0.527 ' HB3' ' HG ' ' C' ' 251' ' ' LEU . . . -103.07 -177.5 3.39 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 124.017 0.927 . . . . 65.11 110.536 177.569 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 46.7 m -134.64 110.83 9.55 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 108.702 -0.851 . . . . 51.32 108.702 168.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 197' ' ' LEU . . . . . 0.446 HD22 HD12 ' C' ' 233' ' ' LEU . 47.9 tp -85.22 146.13 27.23 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 109.139 -0.689 . . . . 73.5 109.139 174.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 198' ' ' ASP . . . . . 0.508 ' HA ' ' HB2' ' C' ' 254' ' ' ARG . 28.4 t70 -117.89 105.88 12.39 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 108.661 -0.866 . . . . 44.52 108.661 -179.395 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 199' ' ' VAL . . . . . 0.428 HG22 HG21 ' C' ' 210' ' ' VAL . 44.7 t -115.05 122.12 33.99 Favored Pre-proline 0 N--CA 1.48 1.046 0 C-N-CA 124.095 0.958 . . . . 61.21 109.435 -176.322 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 200' ' ' PRO . . . . . 0.451 ' HA ' ' O ' ' C' ' 256' ' ' THR . 55.3 Cg_endo -70.36 148.91 62.24 Favored 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 122.021 1.814 . . . . 71.34 111.341 175.278 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 201' ' ' ALA . . . . . . . . . . . . . . . -53.9 -45.41 98.92 Favored Pre-proline 0 CA--C 1.559 1.318 0 C-N-CA 124.844 1.258 . . . . 74.35 113.763 -172.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 202' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -55.49 -49.27 16.63 Favored 'Trans proline' 0 C--N 1.396 3.064 0 C-N-CA 121.879 1.719 . . . . 63.15 112.847 175.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 203' ' ' ILE . . . . . . . . . . . . . 58.0 mt -68.12 -33.14 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.721 0.808 . . . . 63.4 110.869 -178.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 204' ' ' ALA . . . . . 0.401 ' HA ' HG11 ' C' ' 223' ' ' VAL . . . -64.25 -44.07 92.93 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.653 0.781 . . . . 75.02 110.856 178.443 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 205' ' ' VAL . . . . . 0.503 ' HA ' ' HA ' ' C' ' 226' ' ' ARG . 87.0 t -75.4 -39.16 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 115.508 -0.769 . . . . 63.41 112.131 -176.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 206' ' ' VAL . . . . . 0.469 ' HA ' ' HE2' ' A' ' 270' ' ' LYS . 14.6 p -77.34 -37.04 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 CA-C-N 118.078 0.399 . . . . 52.12 110.635 -178.32 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 86.57 57.68 2.05 Favored Glycine 0 C--N 1.337 0.631 0 N-CA-C 111.384 -0.687 . . . . 63.21 111.384 -168.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -89.49 -131.61 4.36 Favored Glycine 0 C--N 1.345 1.075 0 N-CA-C 110.915 -0.874 . . . . 51.32 110.915 177.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 209' ' ' LYS . . . . . 0.513 ' HG2' ' HG2' ' C' ' 220' ' ' GLU . 4.6 ttmp? -150.44 143.35 24.72 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.345 0.658 . . . . 72.12 110.123 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 210' ' ' VAL . . . . . 0.428 HG21 HG22 ' C' ' 199' ' ' VAL . 30.4 m -134.34 167.98 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 C-N-CA 124.824 1.25 . . . . 62.05 109.486 177.491 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 211' ' ' ARG . . . . . 0.452 ' HA ' ' HA ' ' C' ' 220' ' ' GLU . 36.2 ttm180 -92.24 127.77 37.85 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 122.608 0.363 . . . . 72.44 111.027 179.247 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -102.47 122.99 45.41 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 107.817 -1.179 . . . . 74.43 107.817 164.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 213' ' ' MET . . . . . 0.626 ' SD ' HG11 ' C' ' 185' ' ' VAL . 1.3 tmt? -77.63 136.63 38.26 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.757 -0.831 . . . . 63.12 108.757 175.195 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 214' ' ' THR . . . . . 0.495 ' HA ' ' HZ ' ' C' ' 186' ' ' PHE . 0.1 OUTLIER -134.32 166.8 21.98 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.014 0.526 . . . . 54.24 110.932 178.15 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 215' ' ' LEU . . . . . 0.405 HD13 ' HB2' ' C' ' 131' ' ' PHE . 52.1 mt -60.12 -38.77 84.03 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.752 1.221 . . . . 44.41 112.851 -171.159 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.41 14.64 22.55 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.044 0.938 . . . . 71.0 111.844 -174.268 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 148.77 169.2 15.28 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-O 119.645 -0.531 . . . . 64.11 112.735 176.165 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -91.73 118.3 0.49 Allowed 'Trans proline' 0 CA--C 1.56 1.815 0 C-N-CA 122.829 2.353 . . . . 52.13 113.004 176.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 219' ' ' VAL . . . . . 0.491 HG12 ' OG1' ' C' ' 214' ' ' THR . 2.9 p -100.01 115.26 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.13 0.572 . . . . 52.53 110.174 178.512 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 220' ' ' GLU . . . . . 0.513 ' HG2' ' HG2' ' C' ' 209' ' ' LYS . 24.8 tt0 -82.93 103.79 12.66 Favored 'General case' 0 CA--C 1.556 1.173 0 N-CA-C 108.015 -1.106 . . . . 72.32 108.015 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 221' ' ' VAL . . . . . 0.469 HG21 HD11 ' C' ' 233' ' ' LEU . 7.6 p -101.79 138.87 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.648 0.779 . . . . 74.03 112.513 -168.543 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -81.45 117.58 21.99 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.839 1.256 . . . . 73.3 112.424 -173.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 223' ' ' VAL . . . . . 0.401 HG11 ' HA ' ' C' ' 204' ' ' ALA . 59.7 t -77.7 142.09 65.39 Favored Pre-proline 0 CA--C 1.564 1.491 0 C-N-CA 125.801 1.64 . . . . 73.11 110.423 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 224' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -84.47 155.26 12.26 Favored 'Trans proline' 0 C--N 1.384 2.444 0 C-N-CA 123.408 2.739 . . . . 54.33 113.188 174.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.88 117.67 4.33 Favored 'Trans proline' 0 C--N 1.382 2.306 0 C-N-CA 123.49 2.793 . . . . 74.0 113.3 176.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 226' ' ' ARG . . . . . 0.503 ' HA ' ' HA ' ' C' ' 205' ' ' VAL . 0.0 OUTLIER 65.35 88.69 0.1 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.652 1.581 . . . . 70.15 112.224 -177.917 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 227' ' ' THR . . . . . . . . . . . . . 58.4 m -106.5 131.57 53.53 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 114.337 -1.301 . . . . 70.3 110.345 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 228' ' ' GLN . . . . . 0.503 ' NE2' ' HG2' ' A' ' 259' ' ' GLU . 22.8 mp0 -103.81 152.68 21.61 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.833 0.853 . . . . 74.32 110.816 177.412 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -69.27 140.71 54.46 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.032 -0.985 . . . . 62.12 109.523 177.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 93.28 -3.88 73.14 Favored Glycine 0 C--N 1.338 0.654 0 CA-C-O 119.639 -0.534 . . . . 62.04 112.942 -174.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 231' ' ' ARG . . . . . 0.439 ' HD2' ' H ' ' C' ' 228' ' ' GLN . 54.3 mtt180 -64.81 174.51 1.82 Allowed 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 117.564 0.682 . . . . 74.12 111.376 168.157 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 232' ' ' LYS . . . . . 0.467 ' HA ' ' O ' ' C' ' 251' ' ' LEU . 2.6 ttmp? -143.29 151.43 40.51 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.641 0.734 . . . . 71.45 111.064 179.32 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 233' ' ' LEU . . . . . 0.553 HD13 HD13 ' C' ' 251' ' ' LEU . 1.9 tt -127.97 142.35 51.27 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.049 1.74 . . . . 74.21 107.873 -169.18 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 234' ' ' ARG . . . . . 0.424 ' HA ' ' O ' ' C' ' 249' ' ' LEU . 36.3 ptt180 -115.22 116.78 28.91 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 121.577 0.703 . . . . 72.34 111.379 173.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 235' ' ' LEU . . . . . 0.456 ' HB2' ' HB3' ' C' ' 249' ' ' LEU . 67.9 mt -109.63 99.42 8.61 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 108.839 -0.8 . . . . 73.43 108.839 171.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -69.4 126.19 28.99 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 114.335 -1.302 . . . . 71.55 110.949 -172.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 87.56 7.06 76.2 Favored Glycine 0 C--N 1.349 1.269 0 O-C-N 123.749 0.656 . . . . 71.42 113.956 -177.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 238' ' ' LYS . . . . . 0.668 ' HE2' ' HB3' ' B' ' 33' ' ' ALA . 74.5 mmtt -109.91 17.16 21.43 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.469 0.708 . . . . 72.03 111.412 -178.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 239' ' ' GLY . . . . . 0.423 ' HA2' ' HG ' ' C' ' 193' ' ' LEU . . . -86.78 -166.11 42.06 Favored Glycine 0 C--N 1.348 1.239 0 N-CA-C 112.081 -0.408 . . . . 31.21 112.081 174.03 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 240' ' ' PHE . . . . . 0.523 ' CD2' HD21 ' C' ' 193' ' ' LEU . 2.2 m-85 -86.79 152.61 54.23 Favored Pre-proline 0 CA--C 1.558 1.261 0 N-CA-C 108.845 -0.798 . . . . 75.14 108.845 175.092 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 241' ' ' PRO . . . . . 0.43 ' HA ' ' HG2' ' C' ' 246' ' ' ARG . 31.5 Cg_exo -43.34 141.07 3.49 Favored 'Trans proline' 0 C--N 1.382 2.309 0 C-N-CA 124.622 3.548 . . . . 70.21 115.674 178.54 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 242' ' ' GLY . . . . . 0.442 ' HA3' ' NE2' ' C' ' 191' ' ' GLN . . . -133.88 148.95 19.61 Favored Glycine 0 C--N 1.348 1.217 0 CA-C-O 119.097 -0.835 . . . . 70.14 112.422 -176.528 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 243' ' ' PRO . . . . . 0.502 ' HB3' HD12 ' B' ' 71' ' ' ILE . 36.3 Cg_endo -60.09 -40.36 61.48 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 123.729 2.953 . . . . 71.42 113.462 -169.432 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -118.45 19.46 13.34 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.865 0.866 . . . . 71.42 110.787 -175.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 142.16 136.3 3.21 Favored Glycine 0 C--N 1.344 1.022 0 N-CA-C 110.063 -1.215 . . . . 51.32 110.063 -175.124 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 246' ' ' ARG . . . . . 0.43 ' HG2' ' HA ' ' C' ' 241' ' ' PRO . 90.5 mtt180 -78.25 150.72 33.37 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 117.349 0.575 . . . . 61.31 110.918 -172.352 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -72.76 -170.47 17.03 Favored Glycine 0 C--N 1.35 1.311 0 O-C-N 124.29 0.993 . . . . 63.23 114.831 -171.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -129.9 155.1 46.59 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.761 0.824 . . . . 73.54 109.017 -170.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 249' ' ' LEU . . . . . 0.486 HD11 ' HB2' ' C' ' 195' ' ' ALA . 24.0 tp -100.27 133.37 44.77 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.934 0.894 . . . . 74.23 110.89 -171.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 250' ' ' TYR . . . . . 0.488 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 1.0 OUTLIER -122.7 100.56 6.98 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.236 1.014 . . . . 71.43 111.084 178.662 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 251' ' ' LEU . . . . . 0.553 HD13 HD13 ' C' ' 233' ' ' LEU . 1.6 mp -97.0 125.69 41.6 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 118.9 -0.572 . . . . 64.53 110.586 -176.016 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -82.6 136.22 34.86 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 108.852 -0.795 . . . . 73.41 108.852 167.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 253' ' ' VAL . . . . . 0.485 HG21 ' CZ3' ' B' ' 242' ' ' TRP . 47.0 t -92.71 138.03 20.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 123.887 0.875 . . . . 73.5 112.82 -168.46 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 254' ' ' ARG . . . . . 0.508 ' HB2' ' HA ' ' C' ' 198' ' ' ASP . 20.6 mmt85 -102.65 136.07 43.15 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.2 1.4 . . . . 74.13 108.49 168.106 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 255' ' ' ILE . . . . . . . . . . . . . 32.7 mm -102.14 104.45 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 107.188 -1.412 . . . . 75.24 107.188 163.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 256' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' C' ' 200' ' ' PRO . 1.7 t -107.82 148.25 29.79 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.365 1.066 . . . . 53.32 109.902 -175.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 2.9 pp -111.9 145.73 33.31 Favored Pre-proline 0 N--CA 1.476 0.853 0 N-CA-C 109.393 -0.595 . . . . 64.54 109.393 176.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -60.4 -8.41 8.66 Favored 'Trans proline' 0 N--CA 1.507 2.268 0 C-N-CA 123.036 2.49 . . . . 73.21 115.36 -169.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 58.61 -68.5 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.572 1.549 . . . . 72.3 112.38 -168.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.17 149.68 44.75 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.771 0.829 . . . . 73.41 109.377 170.33 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 261' ' ' LEU . . . . . 0.521 HD11 HG13 ' A' ' 205' ' ' VAL . 77.6 mt -141.41 148.39 39.52 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.077 0.465 . . . . 71.21 111.089 -178.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 69.2 p -94.28 154.66 40.38 Favored Pre-proline 0 CA--C 1.554 1.129 0 N-CA-C 108.544 -0.91 . . . . 61.23 108.544 168.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 263' ' ' PRO . . . . . 0.401 ' HA ' ' HB1' ' B' ' 467' ' ' ALA . 86.0 Cg_exo -45.27 -45.06 15.52 Favored 'Trans proline' 0 C--N 1.391 2.798 0 C-N-CA 123.553 2.836 . . . . 74.2 114.188 -176.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -61.37 -52.59 64.01 Favored 'General case' 0 C--O 1.249 1.045 0 CA-C-N 115.1 -0.955 . . . . 71.04 110.856 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -52.06 -60.32 3.33 Favored 'General case' 0 C--N 1.362 1.129 0 O-C-N 124.537 1.148 . . . . 65.11 110.373 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 266' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -61.43 -33.82 74.35 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 124.179 0.924 . . . . 64.21 111.732 -172.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -59.63 -51.52 69.44 Favored 'General case' 0 CA--C 1.552 1.042 0 O-C-N 123.273 0.358 . . . . 70.32 111.359 173.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 268' ' ' LEU . . . . . . . . . . . . . 11.1 mp -66.61 -41.74 87.92 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 119.327 -0.368 . . . . 52.44 111.766 179.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -58.76 -38.57 78.74 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.654 0.782 . . . . 61.11 110.716 177.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 270' ' ' LYS . . . . . 0.503 ' HA ' HG21 ' A' ' 206' ' ' VAL . 9.6 mtpm? -66.51 -46.38 76.4 Favored 'General case' 0 C--N 1.361 1.091 0 C-N-CA 122.997 0.519 . . . . 75.43 111.139 176.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.83 -37.59 74.11 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 123.66 0.6 . . . . 75.33 111.405 178.366 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 82.5 mt -68.35 -42.48 79.16 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.537 -0.756 . . . . 74.33 110.356 174.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -67.58 -25.6 65.86 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.408 0.683 . . . . 34.13 111.369 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -81.31 -36.34 29.91 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.252 1.021 . . . . 63.21 109.879 176.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -61.02 -28.36 68.99 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.522 -0.763 . . . . 70.04 110.327 168.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 276' ' ' TYR . . . . . 0.534 ' HB3' HD11 ' A' ' 203' ' ' ILE . 7.9 m-85 -82.08 -32.4 30.32 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.419 1.088 . . . . 75.52 111.863 175.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 23.0 m-30 -64.68 -30.16 71.17 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 109.483 -0.562 . . . . 44.24 109.483 172.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -66.38 -15.48 63.32 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 123.784 0.834 . . . . 55.2 112.41 175.023 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 279' ' ' ARG . . . . . . . . . . . . . 26.3 mtp-105 -82.47 -15.67 51.66 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.1 0.56 . . . . 71.52 111.091 175.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.065 0 C-N-CA 122.938 0.495 . . . . 75.14 109.718 178.317 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 80.5 mtp . . . . . 0 N--CA 1.48 1.035 0 N-CA-C 110.586 -0.153 . . . . 64.12 110.586 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.29 40.77 11.04 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.574 1.149 . . . . 51.4 112.059 177.028 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -74.66 77.56 2.03 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.523 0.729 . . . . 74.04 110.229 177.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -35.82 110.79 0.11 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 125.489 1.515 . . . . 62.43 114.312 -177.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -87.9 102.77 15.04 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 107.479 -1.304 . . . . 74.32 107.479 163.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.485 ' HA ' ' OH ' ' A' ' 66' ' ' TYR . 7.3 t0 -71.37 92.7 1.08 Allowed 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 108.455 -0.943 . . . . 61.41 108.455 178.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -62.93 -36.28 82.89 Favored 'General case' 0 C--O 1.244 0.796 0 C-N-CA 123.613 0.765 . . . . 73.34 111.979 -171.083 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.419 ' CE1' HD11 ' A' ' 22' ' ' ILE . 77.7 m-85 -62.98 -44.49 95.9 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.595 -0.73 . . . . 73.33 110.674 175.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.91 -36.91 83.33 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.965 0.506 . . . . 60.32 111.431 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 6' ' ' ASP . 76.3 mt -61.61 -41.69 91.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.134 0.574 . . . . 74.23 110.086 176.314 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.1 mt -75.28 -14.12 60.48 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-N 116.145 -0.48 . . . . 51.33 111.955 175.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.49 24.13 76.77 Favored Glycine 0 C--N 1.353 1.476 0 CA-C-N 116.745 -0.207 . . . . 53.33 113.256 -177.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.5 m -108.48 152.38 42.04 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 124.128 0.971 . . . . 71.43 110.008 178.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -58.87 152.51 57.08 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.904 2.402 . . . . 50.12 112.602 174.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -69.49 7.34 0.84 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 112.664 0.616 . . . . 75.43 112.664 178.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -128.44 28.5 5.44 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.025 1.33 . . . . 64.11 107.786 177.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.6 168.7 2.75 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.96 0.904 . . . . 64.31 111.436 176.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 67.2 p -114.08 172.91 6.71 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.275 0.63 . . . . 71.11 109.642 175.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -58.02 -36.53 72.82 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.327 0.651 . . . . 64.21 110.393 176.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -66.59 -43.96 83.48 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.474 0.709 . . . . 72.43 111.433 177.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -67.42 -40.2 85.54 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.204 0.602 . . . . 64.03 111.743 -178.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.601 HD13 ' HB3' ' A' ' 57' ' ' LEU . 69.0 mt -71.59 -38.78 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.135 0.974 . . . . 73.31 110.748 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -65.25 -50.94 63.85 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.198 -0.91 . . . . 71.24 110.295 177.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 31.9 mtm180 -67.52 -33.12 74.42 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.352 0.661 . . . . 54.12 111.565 -178.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.32 -49.91 73.74 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 123.902 0.751 . . . . 64.0 109.588 174.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -60.58 -44.02 96.68 Favored 'General case' 0 C--O 1.206 -1.19 0 O-C-N 124.088 0.868 . . . . 73.1 110.589 178.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -58.69 -46.74 86.58 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.846 0.859 . . . . 74.22 110.833 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 47.4 ttt180 -57.14 -53.85 53.42 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.134 0.974 . . . . 71.15 110.671 177.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.643 ' HB3' HD13 ' A' ' 50' ' ' ILE . 73.6 mt -77.35 -21.66 53.01 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 115.274 -0.875 . . . . 74.11 111.368 -172.476 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -80.29 -32.09 38.17 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.443 0.697 . . . . 63.3 110.785 178.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 78.3 mtp180 -81.08 -39.99 24.83 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 122.938 0.495 . . . . 72.33 110.245 174.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -70.12 -50.13 43.75 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.297 0.639 . . . . 63.33 111.34 -175.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.51 ' HE2' HD22 ' A' ' 29' ' ' LEU . 15.6 m-85 -100.21 30.19 3.94 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.153 0.581 . . . . 63.25 109.628 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -65.71 111.44 6.32 Favored Pre-proline 0 C--N 1.354 0.763 0 N-CA-C 108.59 -0.893 . . . . 63.41 108.59 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -53.87 -38.37 85.79 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 123.186 2.591 . . . . 74.13 113.778 -168.033 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -70.24 -28.94 65.65 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.055 0.942 . . . . 72.45 112.3 -179.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 46.9 t -88.51 -61.58 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 N-CA-C 109.122 -0.696 . . . . 65.53 109.122 177.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -100.13 90.26 4.31 Favored 'General case' 0 C--O 1.243 0.759 0 C-N-CA 124.384 1.074 . . . . 61.35 108.881 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -81.04 69.93 7.75 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 108.67 -0.863 . . . . 73.11 108.67 178.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.2 m -125.03 106.04 28.8 Favored Pre-proline 0 C--O 1.237 0.4 0 N-CA-C 107.883 -1.154 . . . . 54.41 107.883 178.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_exo -43.89 -44.7 11.78 Favored 'Trans proline' 0 C--N 1.388 2.626 0 C-N-CA 123.749 2.966 . . . . 72.23 112.979 -177.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -50.81 -52.43 41.24 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.395 1.078 . . . . 64.43 111.31 176.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.7 -28.45 69.08 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 114.434 -1.257 . . . . 72.14 110.426 -177.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -82.19 -33.6 29.37 Favored 'General case' 0 C--O 1.219 -0.55 0 O-C-N 123.936 0.772 . . . . 62.01 110.293 -175.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.651 ' HA ' ' HD3' ' A' ' 48' ' ' LYS . 44.0 mt-10 -66.89 -46.35 75.19 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.961 0.905 . . . . 62.44 109.983 176.266 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -62.22 -42.64 99.49 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 114.224 -1.353 . . . . 74.03 109.875 174.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -56.99 -40.53 76.73 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.302 1.041 . . . . 73.24 110.725 176.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.651 ' HD3' ' HA ' ' A' ' 45' ' ' GLU . 24.0 mtpp -60.68 -48.75 80.38 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.703 0.801 . . . . 75.14 109.982 177.291 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -65.57 -26.5 67.89 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 123.38 0.425 . . . . 71.44 111.848 177.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.643 HD13 ' HB3' ' A' ' 29' ' ' LEU . 72.7 mt -74.5 -29.49 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 124.241 1.016 . . . . 70.53 110.058 175.178 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -73.27 -35.08 66.12 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.126 0.57 . . . . 73.43 110.444 172.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -67.86 -45.31 74.93 Favored 'General case' 0 C--O 1.256 1.443 0 C-N-CA 124.76 1.224 . . . . 63.42 110.302 175.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.13 -51.31 70.15 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 113.762 -1.563 . . . . 65.45 110.186 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 92.5 t80 -63.26 -35.26 79.75 Favored 'General case' 0 C--O 1.205 -1.267 0 CA-C-N 114.7 -1.136 . . . . 72.32 110.691 174.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.04 -51.34 66.61 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.298 0.639 . . . . 53.01 111.838 -177.25 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 94.4 t -75.39 -38.78 40.7 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 CA-C-N 115.121 -0.945 . . . . 74.52 110.893 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.601 ' HB3' HD13 ' A' ' 22' ' ' ILE . 73.1 mt -89.02 3.97 49.88 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 113.43 0.9 . . . . 62.04 113.43 -174.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.2 t -68.18 -73.12 0.15 Allowed 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.751 0.821 . . . . 74.34 110.497 -179.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -83.41 120.54 75.75 Favored Pre-proline 0 C--O 1.25 1.095 0 N-CA-C 108.346 -0.983 . . . . 74.34 108.346 178.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.553 ' O ' ' HG3' ' A' ' 64' ' ' ARG . 9.5 Cg_endo -53.82 -19.76 15.76 Favored 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 123.582 2.855 . . . . 72.41 115.187 -172.179 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -72.63 -53.14 12.63 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 119.397 0.999 . . . . 72.3 111.183 178.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -56.25 -41.16 75.32 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 122.417 1.103 . . . . 74.54 110.112 173.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.477 ' HB3' ' HA ' ' A' ' 60' ' ' PRO . 32.6 ttt180 -60.12 -43.09 95.91 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 113.273 -1.785 . . . . 74.11 111.142 175.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.553 ' HG3' ' O ' ' A' ' 60' ' ' PRO . 42.1 mtm180 -62.04 -37.23 84.16 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-O 118.974 -0.536 . . . . 74.25 110.314 177.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 84.9 mt -57.65 -44.55 85.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 O-C-N 123.982 0.801 . . . . 64.42 109.655 176.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.485 ' OH ' ' HA ' ' A' ' 6' ' ' ASP . 35.1 t80 -61.13 -50.51 72.89 Favored 'General case' 0 CA--C 1.558 1.25 0 CA-C-N 115.912 -0.585 . . . . 75.4 111.163 175.126 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -65.26 -23.85 67.16 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.857 0.863 . . . . 64.04 112.425 -179.009 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 81.5 p -97.0 -7.3 33.32 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 122.855 0.462 . . . . 75.13 110.601 176.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -73.28 103.76 4.09 Favored 'General case' 0 C--N 1.353 0.737 0 N-CA-C 106.997 -1.483 . . . . 63.45 106.997 168.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 110.15 23.95 5.9 Favored Glycine 0 CA--C 1.531 1.055 0 N-CA-C 110.947 -0.861 . . . . 52.54 110.947 -164.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 94.3 m -145.69 -56.33 0.3 Allowed 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 104.633 -2.358 . . . . 71.23 104.633 172.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 85.8 m -89.85 148.22 23.31 Favored 'General case' 0 C--O 1.252 1.235 0 N-CA-C 105.23 -2.137 . . . . 74.23 105.23 157.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.78 -42.32 4.53 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 123.405 0.682 . . . . 74.04 110.895 -178.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.25 134.98 51.13 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 123.346 0.658 . . . . 75.1 109.315 177.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.414 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 75.0 Cg_exo -52.28 126.16 19.7 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.718 2.279 . . . . 75.41 111.749 175.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 75' ' ' PRO . 43.4 Cg_exo -57.51 160.99 12.76 Favored 'Trans proline' 0 C--N 1.375 1.974 0 C-N-CA 123.305 2.67 . . . . 74.25 113.562 -177.088 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -64.48 121.25 8.78 Favored 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 122.195 1.93 . . . . 62.44 111.523 173.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.479 ' HG3' ' HA3' ' A' ' 104' ' ' GLY . 35.9 Cg_endo -63.25 136.43 55.63 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 122.871 2.38 . . . . 43.51 111.702 177.466 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.567 ' HB3' HD11 ' B' ' 29' ' ' LEU . 51.8 Cg_exo -57.89 157.07 25.61 Favored 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 123.183 2.589 . . . . 71.05 112.626 175.052 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -60.37 84.46 0.07 OUTLIER 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 122.801 2.334 . . . . 51.35 111.411 172.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.21 -32.3 0.32 Allowed Glycine 0 CA--C 1.525 0.672 0 CA-C-N 114.312 -1.313 . . . . 62.41 109.824 -176.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.92 156.32 31.37 Favored Glycine 0 C--N 1.351 1.366 0 C-N-CA 123.413 0.53 . . . . 53.03 113.072 171.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -63.06 94.47 0.07 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.809 0.843 . . . . 74.41 110.169 170.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -76.78 157.89 31.28 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 109.002 -0.74 . . . . 71.31 109.002 169.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.521 ' HE2' ' HD2' ' A' ' 93' ' ' PHE . 16.1 t80 -127.49 50.46 2.01 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.567 0.699 . . . . 70.22 109.563 -178.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.428 ' HB3' HH22 ' B' ' 22' ' ' ARG . 57.8 m -0.41 83.69 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.484 0 C-N-CA 127.288 2.235 . . . . 74.44 116.475 -174.056 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.86 -13.94 2.94 Favored Glycine 0 N--CA 1.482 1.748 0 N-CA-C 116.655 1.422 . . . . 70.11 116.655 168.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.502 ' HB3' ' HE2' ' A' ' 93' ' ' PHE . 63.5 m-85 -90.34 136.98 32.72 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 118.158 0.979 . . . . 72.34 110.179 -174.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -66.17 92.51 0.18 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.091 0.556 . . . . 71.44 110.695 -170.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.568 HG13 ' HG3' ' A' ' 91' ' ' GLU . 2.3 p -40.9 -51.49 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 125.12 1.368 . . . . 75.21 113.0 171.478 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.568 ' HG3' HG13 ' A' ' 90' ' ' VAL . 40.3 mt-10 -71.87 -12.1 61.11 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.614 0.766 . . . . 75.33 111.528 -173.139 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -87.09 -34.35 19.17 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.518 0.727 . . . . 45.35 110.632 174.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.521 ' HD2' ' HE2' ' A' ' 85' ' ' PHE . 26.5 m-85 -91.49 174.14 7.53 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.158 0.799 . . . . 71.01 113.158 -168.197 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 88.5 p -58.76 151.39 21.32 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 115.395 1.628 . . . . 74.5 115.395 -162.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.91 -42.87 80.72 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.028 -1.442 . . . . 74.31 110.877 170.316 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -50.61 -50.99 52.76 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.185 0.994 . . . . 75.03 111.042 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.478 ' HE2' HG23 ' A' ' 90' ' ' VAL . 1.4 t80 -59.69 -50.56 73.35 Favored 'General case' 0 CA--C 1.555 1.172 0 O-C-N 124.226 0.954 . . . . 63.23 109.829 174.147 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -66.56 -6.6 15.71 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.207 0.603 . . . . 73.05 112.249 -176.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -103.0 -30.95 10.47 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.168 0.987 . . . . 70.02 111.831 170.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 26.3 tp -73.59 -56.19 5.33 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.341 0.657 . . . . 55.03 110.842 -177.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -93.51 -6.55 46.54 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.115 0.566 . . . . 72.11 110.662 174.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -47.48 -55.75 8.93 Favored Glycine 0 C--N 1.351 1.394 0 CA-C-O 118.767 -1.018 . . . . 72.43 115.579 -177.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -46.4 -13.83 0.11 Allowed 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 124.792 3.661 . . . . 23.1 116.746 176.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.479 ' HA3' ' HG3' ' A' ' 78' ' ' PRO . . . -149.93 29.03 1.14 Allowed Glycine 0 C--N 1.355 1.585 0 CA-C-O 118.599 -1.112 . . . . 44.4 114.215 174.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.526 HD13 HD21 ' A' ' 169' ' ' ASN . 15.1 mt -60.99 79.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 113.005 0.743 . . . . 74.25 113.005 177.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.77 ' HB3' ' HA ' ' A' ' 169' ' ' ASN . 0.5 OUTLIER 24.72 -100.9 0.01 OUTLIER 'General case' 0 CA--C 1.569 1.7 0 C-N-CA 127.249 2.219 . . . . 72.25 113.956 170.175 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 80.06 6.28 89.23 Favored Glycine 0 C--N 1.363 2.046 0 CA-C-N 117.896 0.317 . . . . 44.0 113.431 -176.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 59.61 -129.51 48.74 Favored Glycine 0 C--N 1.348 1.231 0 N-CA-C 111.317 -0.713 . . . . 71.34 111.317 -172.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -97.82 -2.13 41.64 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.35 0.66 . . . . 64.11 110.294 169.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -81.09 -26.96 51.43 Favored Glycine 0 C--N 1.355 1.597 0 N-CA-C 111.896 -0.482 . . . . 55.25 111.896 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? 60.15 3.65 0.55 Allowed 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 115.248 1.573 . . . . 71.44 115.248 170.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.86 -15.67 60.18 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 122.795 0.438 . . . . 73.25 109.994 174.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.421 ' HB3' HD22 ' A' ' 169' ' ' ASN . 40.4 m 70.23 46.4 0.61 Allowed 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.622 1.169 . . . . 74.21 110.518 -177.372 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -86.17 159.22 19.57 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 114.948 -1.024 . . . . 74.52 112.369 -174.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -59.11 146.1 39.9 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 124.826 1.251 . . . . 72.15 111.756 174.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -88.65 169.98 37.87 Favored Glycine 0 C--N 1.353 1.478 0 CA-C-N 116.337 -0.392 . . . . 55.22 112.961 178.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.418 ' HD3' ' H ' ' A' ' 117' ' ' ARG . 0.0 OUTLIER -113.95 -178.25 3.33 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.523 0.729 . . . . 71.34 110.353 -179.839 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -77.07 142.54 39.77 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 109.04 -0.726 . . . . 74.23 109.04 170.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.472 HD11 ' HB3' ' B' ' 10' ' ' LEU . 7.7 tt -144.18 125.75 14.98 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 107.658 -1.238 . . . . 70.23 107.658 -175.254 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.5 ' NH2' ' HB ' ' A' ' 177' ' ' VAL . 0.0 OUTLIER -97.58 126.44 42.88 Favored 'General case' 0 C--O 1.217 -0.625 0 N-CA-C 107.293 -1.373 . . . . 74.51 107.293 175.903 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.475 ' HB3' HD23 ' A' ' 176' ' ' LEU . . . -120.42 155.7 32.93 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-N 118.39 0.541 . . . . 41.51 111.534 -177.07 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.549 ' HB2' ' HB3' ' B' ' 9' ' ' ALA . 1.2 mm-40 -92.8 111.7 23.41 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 106.244 -1.761 . . . . 61.0 106.244 175.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.487 ' HB3' ' HA ' ' A' ' 178' ' ' VAL . 61.1 tp -101.35 96.17 5.79 Favored Pre-proline 0 N--CA 1.476 0.854 0 N-CA-C 108.29 -1.004 . . . . 54.05 108.29 177.153 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.645 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 58.5 Cg_endo -73.23 112.37 3.51 Favored 'Trans proline' 0 C--N 1.376 2.016 0 C-N-CA 121.406 1.404 . . . . 75.33 110.001 178.198 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.5 ' HB3' HD23 ' A' ' 180' ' ' LEU . 52.8 tp -116.73 138.9 51.13 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.413 0.625 . . . . 64.01 111.536 -168.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.633 ' HB ' ' HG2' ' A' ' 129' ' ' GLU . 93.3 m -72.3 125.73 28.06 Favored 'General case' 0 CA--C 1.553 1.072 0 CA-C-N 113.856 -1.52 . . . . 71.34 109.369 174.573 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.449 ' HB3' HD22 ' A' ' 215' ' ' LEU . 48.9 mt -53.4 -39.7 64.48 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 124.032 0.933 . . . . 70.54 112.249 -171.085 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -69.03 -33.85 74.28 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 115.465 -0.789 . . . . 75.32 110.628 -177.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.633 ' HG2' ' HB ' ' A' ' 126' ' ' THR . 12.2 mm-40 -72.99 -26.42 61.33 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 109.949 -0.389 . . . . 64.33 109.949 175.13 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.433 ' HB1' ' O ' ' A' ' 153' ' ' VAL . . . -66.7 -37.62 85.08 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 123.393 0.433 . . . . 41.43 110.54 174.109 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -65.38 -50.52 65.22 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 115.025 -0.989 . . . . 74.51 111.287 173.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 30.9 m170 -70.74 -45.19 65.29 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.183 0.593 . . . . 75.25 111.624 -171.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.07 -163.27 54.11 Favored Glycine 0 C--N 1.339 0.742 0 O-C-N 123.465 0.478 . . . . 71.54 112.834 -175.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 96.93 -173.84 29.64 Favored Glycine 0 C--N 1.345 1.051 0 N-CA-C 112.554 -0.219 . . . . 70.42 112.554 179.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 2.0 mp0 -78.88 109.53 13.24 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 122.655 -0.321 . . . . 73.14 110.357 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -90.97 126.46 36.08 Favored 'General case' 0 C--O 1.248 1.022 0 N-CA-C 109.317 -0.623 . . . . 74.4 109.317 173.117 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.412 HG13 ' HG3' ' A' ' 144' ' ' ARG . 76.3 t -80.31 116.31 24.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 114.742 -1.117 . . . . 71.24 108.483 168.047 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.638 ' HB ' HG13 ' A' ' 145' ' ' VAL . 62.2 t -124.75 129.21 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.08 0.952 . . . . 73.14 109.042 -175.683 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.429 ' HG2' ' HB3' ' B' ' 30' ' ' GLU . 14.7 tp10 -98.03 142.92 29.15 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 122.996 0.518 . . . . 71.3 110.941 -177.497 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.549 ' HB ' ' HB3' ' B' ' 8' ' ' LEU . 8.1 p -160.67 121.86 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 C-N-CA 123.515 0.726 . . . . 75.1 111.023 174.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 65.51 14.3 9.4 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.471 1.108 . . . . 74.24 113.911 169.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 84.6 28.04 33.69 Favored Glycine 0 N--CA 1.479 1.518 0 N-CA-C 111.9 -0.48 . . . . 31.1 111.9 -174.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 17.9 tpt85 -152.62 97.31 2.23 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 107.737 -1.208 . . . . 72.12 107.737 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.611 ' HB3' ' HA ' ' B' ' 28' ' ' VAL . 0.0 OUTLIER -64.54 129.96 41.86 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 114.908 -1.042 . . . . 74.41 111.424 179.375 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.638 HG13 ' HB ' ' A' ' 138' ' ' VAL . 1.4 p -91.79 130.09 41.46 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 C-N-CA 124.346 1.058 . . . . 73.53 109.223 165.388 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.549 ' HB2' ' NH1' ' A' ' 144' ' ' ARG . 47.5 t -92.96 132.03 37.43 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 108.317 -0.994 . . . . 31.45 108.317 167.531 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 2.1 p -139.81 118.01 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 O-C-N 123.65 0.594 . . . . 73.42 109.919 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.443 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 47.8 ttt85 -74.37 93.41 2.41 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 107.864 -1.162 . . . . 74.14 107.864 167.398 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.554 ' HB ' HG11 ' A' ' 153' ' ' VAL . 34.2 pt -71.75 125.23 91.7 Favored Pre-proline 0 CA--C 1.55 0.956 0 N-CA-C 108.408 -0.96 . . . . 74.13 108.408 175.463 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -59.39 138.28 83.3 Favored 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 122.371 2.048 . . . . 60.34 111.951 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -62.84 93.02 0.14 Allowed 'Trans proline' 0 C--N 1.374 1.877 0 C-N-CA 121.996 1.797 . . . . 74.15 110.116 171.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.503 ' HA2' ' CD2' ' A' ' 240' ' ' PHE . . . 125.02 24.21 1.69 Allowed Glycine 0 C--N 1.345 1.046 0 CA-C-N 115.1 -0.954 . . . . 75.51 113.084 -173.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.581 HG21 HD11 ' A' ' 159' ' ' ILE . 2.6 p -75.38 149.67 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 123.626 0.77 . . . . 75.43 110.366 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.467 ' O ' HG13 ' A' ' 178' ' ' VAL . 0.1 OUTLIER -119.24 -165.35 1.14 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.507 0.723 . . . . 73.23 112.099 -161.043 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.549 ' HB3' ' O ' ' A' ' 188' ' ' LEU . 3.0 tp10 -86.6 141.36 29.06 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 105.481 -2.044 . . . . 72.32 105.481 160.252 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 65.71 9.03 43.46 Favored Glycine 0 CA--C 1.535 1.311 0 N-CA-C 115.322 0.889 . . . . 14.21 115.322 177.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.501 ' O ' HG12 ' A' ' 178' ' ' VAL . 23.2 t -74.64 117.89 16.98 Favored 'General case' 0 C--N 1.355 0.833 0 N-CA-C 107.949 -1.13 . . . . 74.23 107.949 175.506 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.521 HG22 HG22 ' A' ' 177' ' ' VAL . 41.7 t -84.84 88.63 2.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.577 -0.898 . . . . 72.34 108.577 -178.025 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.581 HD11 HG21 ' A' ' 153' ' ' VAL . 30.0 mt -72.3 98.82 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 107.704 -1.221 . . . . 75.24 107.704 174.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -79.61 98.19 6.81 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 114.581 -1.19 . . . . 61.32 108.687 -176.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 3.4 p -123.51 94.92 45.81 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 123.649 0.78 . . . . 61.33 109.473 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.628 ' HG2' ' HG2' ' B' ' 20' ' ' LYS . 10.8 Cg_endo -56.65 143.67 88.47 Favored 'Trans proline' 0 C--N 1.363 1.336 0 C-N-CA 123.025 2.483 . . . . 74.53 112.874 167.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 95.51 20.37 27.27 Favored Glycine 0 N--CA 1.445 -0.764 0 CA-C-N 114.658 -1.155 . . . . 70.43 115.056 172.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.458 ' HG3' HG23 ' A' ' 145' ' ' VAL . 24.9 mmt -143.99 7.96 1.43 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.16 0.584 . . . . 64.15 110.433 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.563 ' HA2' HD13 ' A' ' 174' ' ' LEU . . . -90.55 -121.13 2.31 Favored Glycine 0 C--N 1.346 1.115 0 CA-C-N 115.672 -0.694 . . . . 73.33 114.436 -168.129 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.492 ' O ' ' HA ' ' A' ' 171' ' ' PRO . . . -60.94 115.71 8.25 Favored Glycine 0 C--N 1.362 2.007 0 CA-C-O 119.493 -0.615 . . . . 74.5 113.494 -169.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -59.59 146.25 41.5 Favored 'General case' 0 C--N 1.35 0.615 0 O-C-N 125.087 1.11 . . . . 75.42 111.034 -175.029 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 169.18 -125.25 1.24 Allowed Glycine 0 CA--C 1.495 -1.197 0 N-CA-C 106.816 -2.514 . . . . 64.21 106.816 -174.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ASN . . . . . 0.77 ' HA ' ' HB3' ' A' ' 106' ' ' PHE . 43.4 t-20 -98.31 -57.09 0.17 Allowed Pre-proline 0 CA--C 1.55 0.981 0 N-CA-C 107.415 -1.328 . . . . 63.11 107.415 170.149 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.668 ' HD3' ' HB3' ' A' ' 169' ' ' ASN . 59.5 Cg_endo -95.03 109.18 0.13 Allowed 'Trans proline' 0 C--N 1.382 2.341 0 C-N-CA 122.033 1.822 . . . . 71.13 110.937 165.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.492 ' HA ' ' O ' ' A' ' 166' ' ' GLY . 29.6 Cg_endo -61.59 113.58 1.87 Allowed 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 121.74 1.627 . . . . 71.25 108.936 174.657 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -63.94 -142.06 0.02 OUTLIER Glycine 0 N--CA 1.484 1.841 0 N-CA-C 116.096 1.198 . . . . 72.4 116.096 -166.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.613 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 38.9 t70 -80.85 124.71 29.32 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 122.177 -0.602 . . . . 71.14 109.427 -177.368 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.563 HD13 ' HA2' ' A' ' 165' ' ' GLY . 26.9 tp -106.88 118.36 36.48 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.148 0.499 . . . . 64.32 110.5 -174.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.65 HD11 ' HB2' ' B' ' 15' ' ' PHE . 47.5 mt -94.58 85.53 4.54 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 124.061 0.944 . . . . 72.12 108.764 176.175 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.538 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 43.1 mt -72.73 84.37 1.19 Allowed 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.025 -0.534 . . . . 70.05 109.852 178.211 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.521 HG22 HG22 ' A' ' 158' ' ' VAL . 46.6 t -82.9 98.71 5.13 Favored 'Isoleucine or valine' 0 C--O 1.248 1.026 0 N-CA-C 104.917 -2.253 . . . . 61.43 104.917 176.225 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.501 HG12 ' O ' ' A' ' 157' ' ' SER . 10.0 p -76.27 113.29 15.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 112.108 -2.315 . . . . 70.33 111.001 -166.531 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.645 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 30.8 mmm-85 -90.16 106.45 18.49 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-N 115.499 -0.773 . . . . 53.32 108.989 178.19 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.5 HD23 ' HB3' ' A' ' 125' ' ' LEU . 23.3 mt -68.66 147.36 51.98 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 118.76 0.709 . . . . 72.4 110.29 177.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 125' ' ' LEU . 83.9 mt -55.37 159.1 4.8 Favored Pre-proline 0 N--CA 1.484 1.261 0 C-N-CA 124.17 0.988 . . . . 73.14 112.289 -176.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -74.87 24.01 0.39 Allowed 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 122.991 2.46 . . . . 71.42 112.689 170.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.418 ' ND1' HD12 ' A' ' 127' ' ' LEU . 65.5 t-80 -61.62 116.09 18.67 Favored Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 125.231 1.412 . . . . 73.35 108.327 174.116 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -75.51 24.89 0.4 Allowed 'Trans proline' 0 C--N 1.371 1.727 0 C-N-CA 124.146 3.23 . . . . 61.24 116.902 -160.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 97.0 t -97.24 -57.82 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 119.168 0.895 . . . . 64.21 109.695 -179.297 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' PHE . . . . . 0.501 ' CE1' ' HB2' ' A' ' 195' ' ' ALA . 19.1 m-85 -132.87 143.61 49.63 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 112.551 0.574 . . . . 72.31 112.551 -171.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.736 HH22 ' HB2' ' B' ' 411' ' ' ALA . 0.0 OUTLIER -114.12 83.33 1.85 Allowed 'General case' 0 C--O 1.239 0.508 0 N-CA-C 106.735 -1.58 . . . . 75.51 106.735 163.389 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.549 ' O ' ' HB3' ' A' ' 155' ' ' GLU . 48.1 tp -75.07 131.1 40.32 Favored 'General case' 0 C--O 1.202 -1.395 0 CA-C-N 114.465 -1.243 . . . . 74.21 109.367 177.076 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.404 ' HG3' ' HA ' ' B' ' 410' ' ' GLN . 0.4 OUTLIER -147.2 129.89 16.05 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.089 -1.078 . . . . 70.31 108.089 171.94 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 66.26 -81.86 0.1 Allowed Glycine 0 C--N 1.344 0.98 0 O-C-N 124.352 1.032 . . . . 65.41 112.564 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.5 ' HB2' ' HA2' ' A' ' 247' ' ' GLY . 0.7 OUTLIER -129.97 -32.63 1.83 Allowed 'General case' 0 C--O 1.249 1.071 0 C-N-CA 123.834 0.853 . . . . 72.32 109.867 179.268 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -88.26 149.38 23.85 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.625 -0.716 . . . . 72.32 111.776 -166.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.478 HD23 ' HB2' ' A' ' 188' ' ' LEU . 88.6 mt -103.25 158.99 15.94 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.532 1.133 . . . . 63.44 108.97 173.05 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.686 ' HB2' ' HB3' ' A' ' 187' ' ' ARG . 28.5 m-85 -131.35 101.33 5.5 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 108.707 -0.849 . . . . 73.14 108.707 168.254 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.501 ' HB2' ' CE1' ' A' ' 186' ' ' PHE . . . -105.4 131.48 52.78 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 109.145 -0.687 . . . . 74.34 109.145 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 196' ' ' THR . . . . . 0.586 ' HA ' ' HB2' ' A' ' 252' ' ' GLU . 30.4 m -71.72 110.75 6.47 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 109.308 -0.627 . . . . 70.21 109.308 177.549 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.568 HD22 HD13 ' A' ' 251' ' ' LEU . 50.1 tp -103.15 101.14 11.09 Favored 'General case' 0 C--N 1.347 0.487 0 N-CA-C 110.111 -0.329 . . . . 72.21 110.111 -178.317 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -73.6 127.7 33.47 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.562 -1.273 . . . . 61.43 107.562 164.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.581 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 7.1 p -142.18 135.35 14.14 Favored Pre-proline 0 CA--C 1.539 0.545 0 N-CA-C 107.889 -1.152 . . . . 64.4 107.889 178.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.3 158.72 37.0 Favored 'Trans proline' 0 C--N 1.361 1.222 0 C-N-CA 121.475 1.45 . . . . 64.51 112.196 172.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.411 ' HB3' ' HD3' ' A' ' 202' ' ' PRO . . . -56.83 -49.66 92.57 Favored Pre-proline 0 N--CA 1.481 1.109 0 N-CA-C 113.233 0.827 . . . . 71.34 113.233 -178.08 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.411 ' HD3' ' HB3' ' A' ' 201' ' ' ALA . 57.1 Cg_exo -57.28 -45.42 35.14 Favored 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 121.953 1.768 . . . . 63.54 113.802 178.694 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 55.4 mt -71.39 -29.69 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 122.953 0.501 . . . . 64.32 110.86 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.89 -42.2 85.92 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.715 0.406 . . . . 71.51 110.391 175.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 46.0 t -68.85 -55.66 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.593 0.757 . . . . 63.23 111.292 -178.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.653 HG21 ' HA ' ' C' ' 270' ' ' LYS . 61.4 t -83.06 -41.69 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-O 120.872 0.367 . . . . 74.41 111.173 -172.05 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 88.96 168.89 44.27 Favored Glycine 0 C--N 1.338 0.692 0 CA-C-N 115.968 -0.56 . . . . 72.35 111.973 -174.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 161.32 -125.34 1.43 Allowed Glycine 0 C--O 1.224 -0.495 0 N-CA-C 110.149 -1.18 . . . . 55.24 110.149 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -137.97 135.74 36.29 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 118.099 0.95 . . . . 45.21 110.882 175.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 28.4 m -129.34 -176.71 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 124.181 0.993 . . . . 63.11 109.276 170.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -80.86 133.24 35.55 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.32 0.648 . . . . 71.41 110.765 176.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -119.92 111.94 18.57 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.542 -1.281 . . . . 62.04 107.542 165.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -71.81 129.16 37.96 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.055 -0.72 . . . . 71.23 109.055 177.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 43.4 p -109.27 179.82 4.05 Favored 'General case' 0 C--O 1.243 0.763 0 N-CA-C 107.744 -1.206 . . . . 74.1 107.744 171.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.449 HD22 ' HB3' ' A' ' 127' ' ' LEU . 72.2 mt -61.21 -22.11 64.46 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 114.021 1.119 . . . . 63.31 114.021 -170.166 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -142.64 28.7 1.6 Allowed 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 112.705 0.632 . . . . 64.44 112.705 -177.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 155.89 159.67 9.51 Favored Glycine 0 N--CA 1.477 1.419 0 N-CA-C 114.28 0.472 . . . . 33.0 114.28 173.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -87.69 130.39 2.7 Favored 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 123.199 2.599 . . . . 70.23 113.305 178.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 30.9 m -110.99 175.59 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 123.749 0.82 . . . . 73.4 110.262 175.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -101.82 111.22 23.4 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.803 0.841 . . . . 75.04 109.355 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 14.7 p -100.15 133.81 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 123.156 0.582 . . . . 74.13 109.584 177.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -86.64 104.47 16.08 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 122.955 0.502 . . . . 60.25 110.49 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 60.2 t -71.24 128.74 89.95 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 123.914 0.886 . . . . 63.14 109.857 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' PRO . . . . . 0.558 ' HD3' HD12 ' B' ' 441' ' ' ILE . 79.0 Cg_endo -74.62 167.02 28.07 Favored 'Trans proline' 0 C--N 1.373 1.835 0 C-N-CA 122.743 2.295 . . . . 75.51 111.636 172.11 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 225' ' ' PRO . . . . . 0.466 ' HB2' ' HE ' ' A' ' 226' ' ' ARG . 58.8 Cg_endo -70.35 159.99 51.07 Favored 'Trans proline' 0 C--N 1.365 1.418 0 C-N-CA 122.712 2.274 . . . . 72.53 113.441 171.02 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 226' ' ' ARG . . . . . 0.466 ' HE ' ' HB2' ' A' ' 225' ' ' PRO 0.266 0.0 OUTLIER 38.03 55.96 1.64 Allowed 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 126.428 1.891 . . . . 74.04 113.378 -175.913 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.522 HG23 HD21 ' A' ' 233' ' ' LEU . 64.2 m -84.2 90.44 7.51 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 113.06 -1.882 . . . . 64.32 108.953 173.198 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -86.15 146.45 26.58 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.766 0.826 . . . . 75.32 111.545 -171.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -64.8 148.45 51.23 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.846 0.858 . . . . 62.31 112.333 -176.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 230' ' ' GLY . . . . . 0.405 ' HA3' ' NH2' ' C' ' 254' ' ' ARG . . . 90.78 -21.16 34.71 Favored Glycine 0 C--N 1.345 1.041 0 CA-C-N 115.434 -0.803 . . . . 73.32 113.311 -178.609 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.53 ' HD3' ' OH ' ' B' ' 444' ' ' TYR . 99.8 mtt180 -81.2 170.81 15.64 Favored 'General case' 0 C--O 1.245 0.821 0 C-N-CA 123.757 0.823 . . . . 74.0 110.993 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.444 ' HG3' ' HB3' ' A' ' 250' ' ' TYR . 0.3 OUTLIER -129.02 117.28 20.65 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 114.601 -1.181 . . . . 72.22 109.03 -178.892 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.522 HD21 HG23 ' A' ' 227' ' ' THR . 58.2 mt -78.33 110.86 13.73 Favored 'General case' 0 C--O 1.218 -0.558 0 N-CA-C 108.034 -1.098 . . . . 71.4 108.034 175.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -80.99 106.51 13.05 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.974 0.909 . . . . 64.14 109.974 175.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.672 ' HB3' ' HA ' ' B' ' 441' ' ' ILE . 0.2 OUTLIER -118.68 107.22 13.43 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.229 0.537 . . . . 61.12 109.757 171.912 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 248' ' ' ASP . 25.6 mtpp -76.52 159.75 30.08 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.36 1.064 . . . . 64.43 111.079 -177.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 66.37 18.56 67.63 Favored Glycine 0 C--N 1.348 1.207 0 CA-C-N 115.688 -0.687 . . . . 74.2 113.279 -176.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.598 ' HG3' HD12 ' A' ' 235' ' ' LEU . 45.5 mmtm -114.32 -29.93 6.76 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.229 1.011 . . . . 73.01 109.805 -179.065 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -79.04 -154.98 8.56 Favored Glycine 0 C--N 1.343 0.95 0 CA-C-N 115.001 -1.0 . . . . 74.43 111.107 169.033 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 240' ' ' PHE . . . . . 0.503 ' CD2' ' HA2' ' A' ' 152' ' ' GLY . 35.3 m-85 -95.35 123.44 56.72 Favored Pre-proline 0 C--O 1.239 0.504 0 N-CA-C 109.519 -0.548 . . . . 73.13 109.519 -173.383 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.728 ' HA ' ' HA ' ' A' ' 246' ' ' ARG . 73.8 Cg_endo -73.24 132.16 17.52 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 122.721 2.281 . . . . 73.33 113.116 -170.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -101.65 -167.48 27.44 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 110.757 -0.937 . . . . 73.52 110.757 167.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -60.07 -62.54 0.15 Allowed 'Trans proline' 0 C--N 1.377 2.037 0 C-N-CA 122.915 2.41 . . . . 70.45 111.649 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -106.34 -25.31 11.98 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.449 0.7 . . . . 70.11 110.104 170.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -89.84 67.42 2.7 Favored Glycine 0 C--N 1.352 1.447 0 CA-C-N 115.759 -0.655 . . . . 62.24 112.457 -175.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.728 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 52.3 mtm-85 -69.92 118.24 12.51 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 123.529 0.732 . . . . 75.41 109.853 175.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.5 ' HA2' ' HB2' ' A' ' 191' ' ' GLN . . . -52.85 149.86 10.4 Favored Glycine 0 C--N 1.351 1.376 0 N-CA-C 117.346 1.698 . . . . 42.24 117.346 -167.678 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 248' ' ' ASP . . . . . 0.488 ' HA ' ' HA ' ' A' ' 236' ' ' LYS . 0.8 OUTLIER -98.46 172.87 7.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 113.858 -1.171 . . . . 75.44 109.173 -179.228 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.503 ' HB3' ' HG ' ' A' ' 235' ' ' LEU . 17.5 tp -137.06 101.78 4.65 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 106.21 -1.774 . . . . 70.31 106.21 170.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.444 ' HB3' ' HG3' ' A' ' 232' ' ' LYS . 84.6 m-85 -85.98 112.14 20.93 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 123.553 0.741 . . . . 52.51 109.219 174.535 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.568 HD13 HD22 ' A' ' 197' ' ' LEU . 94.0 mt -88.92 121.12 30.96 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.152 -0.931 . . . . 72.24 110.065 178.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.586 ' HB2' ' HA ' ' A' ' 196' ' ' THR . 45.9 mm-40 -75.15 91.49 2.6 Favored 'General case' 0 C--N 1.352 0.711 0 N-CA-C 108.132 -1.062 . . . . 75.41 108.132 177.431 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 42.0 t -65.41 115.59 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 O-C-N 123.705 0.628 . . . . 24.43 110.239 -178.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 254' ' ' ARG . . . . . 0.478 ' HA ' ' HD3' ' A' ' 254' ' ' ARG . 7.2 mmt180 -129.23 102.22 6.36 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.703 0.801 . . . . 73.14 108.921 172.149 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.581 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 60.9 mt -77.38 134.04 29.4 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-N 114.174 -1.375 . . . . 74.34 110.706 -179.14 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 28.4 p -127.7 174.5 9.05 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.638 1.175 . . . . 73.43 109.503 173.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.9 pp -134.98 152.89 78.08 Favored Pre-proline 0 CA--C 1.567 1.625 0 C-N-CA 123.583 0.753 . . . . 73.4 110.768 -177.007 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -65.95 -6.77 15.06 Favored 'Trans proline' 0 N--CA 1.51 2.448 0 C-N-CA 123.854 3.036 . . . . 74.45 115.58 -166.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.446 ' O ' ' HG2' ' C' ' 226' ' ' ARG . 39.1 mt-10 48.16 -83.62 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.751 1.221 . . . . 63.24 112.368 -164.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 7.1 ppt_? -61.02 137.86 58.21 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.388 0.675 . . . . 75.12 110.115 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.473 HD13 ' HA ' ' A' ' 266' ' ' GLU . 74.1 mt -137.86 140.92 40.68 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.321 0.581 . . . . 55.32 111.1 -172.072 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 37.0 p -83.4 138.74 41.57 Favored Pre-proline 0 CA--C 1.554 1.097 0 CA-C-O 117.683 -1.151 . . . . 44.34 108.745 175.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 263' ' ' PRO . . . . . 0.403 ' O ' ' HB3' ' A' ' 266' ' ' GLU . 24.6 Cg_exo -24.79 -56.02 0.07 OUTLIER 'Trans proline' 0 C--N 1.386 2.55 1 C-N-CA 126.309 4.673 . . . . 74.33 117.382 -169.481 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -80.94 -33.22 34.14 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 112.481 0.548 . . . . 71.44 112.481 -173.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -69.95 -35.61 74.64 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 122.833 0.453 . . . . 64.2 110.066 174.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 266' ' ' GLU . . . . . 0.473 ' HA ' HD13 ' A' ' 261' ' ' LEU . 8.1 tp10 -54.36 -52.98 59.9 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 124.119 0.968 . . . . 73.45 109.091 169.065 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 267' ' ' ALA . . . . . 0.538 ' O ' ' HG3' ' A' ' 271' ' ' LYS . . . -57.42 -43.96 84.24 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 114.291 -1.322 . . . . 64.12 111.486 177.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 4.7 mp -59.55 -53.23 60.53 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 123.983 0.913 . . . . 73.14 111.286 -176.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -53.88 -48.15 70.35 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 124.198 0.937 . . . . 75.0 110.608 175.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 270' ' ' LYS . . . . . 0.533 ' HG3' HG23 ' C' ' 206' ' ' VAL . 1.0 OUTLIER -62.76 -34.82 78.03 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 123.875 0.735 . . . . 62.43 112.715 -179.327 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 271' ' ' LYS . . . . . 0.538 ' HG3' ' O ' ' A' ' 267' ' ' ALA . 64.2 mttm -62.33 -59.03 5.58 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.814 -0.81 . . . . 70.22 108.814 177.307 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 272' ' ' LEU . . . . . 0.534 ' O ' ' HB2' ' A' ' 276' ' ' TYR . 82.2 mt -49.2 -46.19 45.35 Favored 'General case' 0 C--N 1.358 0.963 0 O-C-N 125.564 1.79 . . . . 63.4 110.366 178.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 273' ' ' ALA . . . . . 0.488 ' HA ' ' HB2' ' C' ' 202' ' ' PRO . . . -79.12 -47.73 15.57 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 114.556 1.317 . . . . 64.51 114.556 -165.219 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -74.48 -31.4 62.2 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 110.123 -0.325 . . . . 74.35 110.123 -178.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 275' ' ' ALA . . . . . 0.449 ' O ' ' HG3' ' A' ' 279' ' ' ARG . . . -68.19 -42.04 80.51 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 109.756 -0.461 . . . . 71.44 109.756 169.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 276' ' ' TYR . . . . . 0.534 ' HB2' ' O ' ' A' ' 272' ' ' LEU . 32.7 t80 -56.26 -49.99 72.64 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 124.906 1.283 . . . . 75.02 110.683 178.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -64.18 -41.57 97.05 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 114.556 -1.202 . . . . 70.12 109.54 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -68.99 -10.42 57.39 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 123.432 0.693 . . . . 75.41 112.599 176.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 279' ' ' ARG . . . . . 0.585 ' HA ' HD22 ' B' ' 278' ' ' LEU . 74.4 mtt180 -89.51 -11.28 43.34 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.377 0.671 . . . . 74.13 111.23 175.328 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.302 0 N-CA-C 109.206 -0.664 . . . . 72.21 109.206 177.851 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.41 ' HB2' ' HB2' ' B' ' 4' ' ' SER . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.407 0 N-CA-C 108.683 -0.858 . . . . 71.44 108.683 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -81.16 -46.96 14.11 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 108.352 -0.981 . . . . 54.1 108.352 170.233 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 20.6 mm-40 -138.43 91.38 2.54 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.395 1.478 . . . . 74.04 108.531 173.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 4' ' ' SER . . . . . 0.41 ' HB2' ' HB2' ' B' ' 1' ' ' MET . 47.6 t -108.35 151.69 25.66 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 123.991 0.916 . . . . 52.14 108.774 174.237 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 4.5 m -123.87 156.19 36.68 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 123.121 0.568 . . . . 70.11 110.813 -172.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.444 HG21 ' HA ' ' A' ' 125' ' ' LEU . 25.8 pt -139.32 174.21 9.81 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 C-N-CA 124.325 1.05 . . . . 64.44 111.449 -165.325 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -115.15 -163.31 0.87 Allowed 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.113 0.965 . . . . 72.01 110.295 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.57 HD22 HG11 ' A' ' 145' ' ' VAL . 14.9 tp -148.09 178.89 8.16 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.129 0.571 . . . . 75.22 110.66 -178.388 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 9' ' ' ALA . . . . . 0.549 ' HB3' ' HB2' ' A' ' 122' ' ' GLU . . . -156.91 105.51 2.18 Favored 'General case' 0 C--N 1.358 0.937 0 C-N-CA 124.576 1.15 . . . . 62.4 108.389 178.161 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 10' ' ' LEU . . . . . 0.472 ' HB3' HD11 ' A' ' 119' ' ' LEU . 93.6 mt -79.59 121.27 25.05 Favored 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 123.997 0.919 . . . . 74.1 111.522 -173.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.539 HD22 ' HA ' ' B' ' 370' ' ' ALA . 2.9 mt -126.82 168.03 15.77 Favored Pre-proline 0 N--CA 1.506 2.357 0 C-N-CA 124.679 1.191 . . . . 45.35 109.195 -178.236 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -74.84 -137.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.394 2.968 0 C-N-CA 123.222 2.615 . . . . 61.33 113.513 -174.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 90.4 mt 89.88 179.22 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.49 0 C-N-CA 126.138 1.775 . . . . 75.01 113.249 172.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 63.1 tp -134.15 148.52 50.95 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 124.338 1.055 . . . . 64.54 111.623 -165.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 15' ' ' PHE . . . . . 0.65 ' HB2' HD11 ' A' ' 175' ' ' LEU . 0.5 OUTLIER -170.59 -151.85 0.08 Allowed 'General case' 0 CA--C 1.569 1.697 0 C-N-CA 124.133 0.973 . . . . 60.01 110.153 174.733 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 16' ' ' THR . . . . . 0.419 ' HA ' ' HD3' ' B' ' 17' ' ' PRO . 97.9 m -146.48 135.2 11.05 Favored Pre-proline 0 CA--C 1.567 1.605 0 C-N-CA 124.317 1.047 . . . . 51.11 110.119 -175.331 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 17' ' ' PRO . . . . . 0.569 ' HB3' ' HB3' ' A' ' 162' ' ' PRO . 17.9 Cg_exo -70.09 129.4 17.19 Favored 'Trans proline' 0 C--N 1.384 2.42 0 C-N-CA 123.473 2.782 . . . . 62.42 114.076 -179.106 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 88.0 t -136.53 -81.68 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 C-N-CA 123.362 0.665 . . . . 61.41 112.171 174.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 19' ' ' THR . . . . . 0.448 ' O ' ' HD2' ' A' ' 162' ' ' PRO . 56.4 m -84.96 120.99 27.13 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.468 0.707 . . . . 71.22 112.884 -163.519 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 20' ' ' LYS . . . . . 0.628 ' HG2' ' HG2' ' A' ' 162' ' ' PRO . 52.5 mttp -124.88 119.83 29.92 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.499 0.72 . . . . 62.34 110.524 -173.065 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -160.91 119.61 2.53 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.775 0.83 . . . . 75.34 109.914 176.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 22' ' ' ARG . . . . . 0.428 HH22 ' HB3' ' A' ' 86' ' ' SER . 2.5 mpt_? -123.68 -178.28 3.98 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.836 0.826 . . . . 73.31 112.054 -176.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 23' ' ' THR . . . . . . . . . . . . . 2.2 t -135.47 160.49 67.68 Favored Pre-proline 0 CA--C 1.563 1.458 0 C-N-CA 125.472 1.509 . . . . 72.45 107.973 175.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 24' ' ' PRO . . . . . 0.465 ' HA ' ' HG2' ' A' ' 60' ' ' PRO . 11.5 Cg_exo -36.4 119.27 0.21 Allowed 'Trans proline' 0 C--N 1.387 2.557 0 C-N-CA 124.156 3.237 . . . . 74.55 115.66 171.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -90.97 45.88 1.28 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.842 0.857 . . . . 74.53 111.17 174.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 14.2 tmm? -69.36 -44.39 26.03 Favored Pre-proline 0 CA--C 1.568 1.639 0 CA-C-N 115.723 -0.671 . . . . 75.13 110.069 167.036 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -87.38 49.97 1.95 Allowed 'Trans proline' 0 C--N 1.397 3.118 0 C-N-CA 122.314 2.009 . . . . 71.1 111.945 171.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.627 HG13 ' HG ' ' B' ' 29' ' ' LEU . 11.5 p -80.32 -17.41 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 C-N-CA 123.27 0.628 . . . . 73.51 112.241 -175.236 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.627 ' HG ' HG13 ' B' ' 28' ' ' VAL . 60.2 mt -121.92 111.26 16.86 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.531 0.732 . . . . 62.2 110.352 -175.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.429 ' HB3' ' HG2' ' A' ' 139' ' ' GLU . 13.0 tp10 -147.13 146.62 29.97 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.492 0.717 . . . . 70.24 109.252 171.275 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -106.35 -24.83 12.15 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.612 0.765 . . . . 74.34 110.416 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 11.8 tpp180 -73.52 99.82 3.12 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 121.538 0.685 . . . . 72.22 110.459 178.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -103.71 132.01 50.35 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 114.291 -1.322 . . . . 73.31 107.796 168.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -160.68 -174.13 4.29 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.39 0.676 . . . . 53.33 110.581 -176.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 73.18 -74.3 0.09 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.968 1.707 . . . . 73.13 111.371 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 36' ' ' GLY . . . . . 0.402 ' HA3' ' HB2' ' A' ' 124' ' ' PRO . . . -99.35 161.78 19.83 Favored Glycine 0 C--N 1.341 0.837 0 CA-C-N 116.163 -0.471 . . . . 74.33 113.221 -174.371 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -155.75 178.51 10.17 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 123.683 0.793 . . . . 61.44 108.996 -178.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 38' ' ' ILE . . . . . 0.562 HD13 ' HA ' ' B' ' 367' ' ' LEU . 2.3 mp -60.75 -22.99 27.71 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.404 0 C-N-CA 125.594 1.558 . . . . 75.44 111.263 170.386 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 8.3 m 76.72 32.2 0.53 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 125.342 1.457 . . . . 64.25 108.189 -162.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.716 ' HB1' HG21 ' B' ' 309' ' ' THR . . . -64.99 -36.34 15.77 Favored Pre-proline 0 CA--C 1.561 1.404 0 CA-C-N 113.645 -1.616 . . . . 64.0 111.834 171.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 41' ' ' PRO . . . . . 0.672 ' HB3' ' HB ' ' B' ' 361' ' ' ILE . 44.0 Cg_exo -47.4 -32.87 15.81 Favored 'Trans proline' 0 C--N 1.397 3.099 0 C-N-CA 122.872 2.381 . . . . 72.44 114.62 164.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -77.28 -7.38 86.9 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-O 119.616 -0.546 . . . . 45.24 113.99 -176.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -133.14 177.3 19.04 Favored Glycine 0 C--N 1.353 1.484 0 CA-C-N 117.552 0.676 . . . . 42.15 113.544 -175.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -162.57 120.87 2.13 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.647 1.179 . . . . 63.2 109.045 174.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' B' ' 45' ' ' ARG . 2.1 mpt_? 45.46 -88.59 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 126.272 1.829 . . . . 74.21 111.232 -170.232 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.33 67.05 0.71 Allowed 'General case' 0 C--O 1.24 0.554 0 N-CA-C 105.173 -2.158 . . . . 75.02 105.173 177.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 35.2 tp 78.12 152.9 0.13 Allowed 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 126.053 1.741 . . . . 53.22 109.866 -169.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 33.1 p -80.59 50.99 1.4 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.042 0.937 . . . . 51.22 112.401 -176.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -82.31 63.96 4.34 Favored Glycine 0 C--N 1.343 0.967 0 N-CA-C 109.285 -1.526 . . . . 74.15 109.285 165.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 50' ' ' ASP . . . . . 0.47 ' O ' HD21 ' B' ' 111' ' ' LEU . 15.3 t70 -89.16 -64.44 1.14 Allowed 'General case' 0 C--N 1.351 0.643 0 C-N-CA 124.245 1.018 . . . . 64.2 109.027 -177.243 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 59.27 -83.46 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 125.105 1.362 . . . . 75.3 110.578 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 9.5 m 50.85 77.4 0.13 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 125.352 1.461 . . . . 73.31 112.404 176.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -157.8 -53.2 0.07 Allowed 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 121.117 0.484 . . . . 73.24 109.951 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -158.37 -179.23 7.91 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.426 -0.806 . . . . 75.51 110.809 -175.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 2.8 pp -121.81 25.6 9.12 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.177 0.991 . . . . 72.35 109.619 175.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 78.29 -47.15 0.44 Allowed 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 125.936 1.694 . . . . 73.2 112.425 -179.021 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 22.8 t70 78.74 -49.88 0.45 Allowed 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 125.766 1.627 . . . . 75.31 111.967 177.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 42.3 m -72.11 74.93 0.95 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 123.842 0.857 . . . . 62.01 111.047 -178.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 59' ' ' LEU . . . . . 0.604 HD13 HG21 ' B' ' 196' ' ' THR . 60.4 mt -91.45 71.24 6.0 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 124.028 0.931 . . . . 72.44 108.736 -177.543 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 31.0 m -139.56 -31.63 0.67 Allowed 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 114.814 -1.084 . . . . 63.51 110.169 -177.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 63.46 77.28 0.33 Allowed 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 125.065 1.346 . . . . 71.45 109.631 175.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 62' ' ' LYS . . . . . . . . . . . . . 41.6 mtpt -90.66 124.62 61.9 Favored Pre-proline 0 N--CA 1.472 0.673 0 CA-C-N 115.538 -0.755 . . . . 72.3 111.172 -169.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -76.55 -11.41 18.74 Favored 'Trans proline' 0 C--N 1.38 2.214 0 C-N-CA 122.85 2.366 . . . . 72.24 113.031 176.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 69.85 -70.24 0.15 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 125.388 1.475 . . . . 72.04 110.482 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.521 ' HG2' ' H ' ' B' ' 66' ' ' ASN . 75.2 tttt -76.41 177.35 7.42 Favored 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 124.449 1.1 . . . . 65.32 108.835 170.225 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 66' ' ' ASN . . . . . 0.521 ' H ' ' HG2' ' B' ' 65' ' ' LYS . 4.1 m-20 72.97 13.72 4.89 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.79 1.236 . . . . 72.41 112.967 173.018 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 67' ' ' ILE . . . . . 0.459 ' H ' HD13 ' B' ' 67' ' ' ILE . 0.2 OUTLIER -80.74 -23.96 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 122.999 0.52 . . . . 72.03 110.997 176.778 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 22.8 pt -95.97 -39.66 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 123.663 0.785 . . . . 73.4 110.775 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 95.7 mt -127.99 126.98 42.41 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 107.3 -1.37 . . . . 73.12 107.3 177.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 82.2 mt -49.76 -43.78 48.3 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.384 1.074 . . . . 44.44 113.005 -171.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 71' ' ' ILE . . . . . 0.458 HG13 ' HB3' ' B' ' 73' ' ' ASP . 38.3 pt -111.82 2.84 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 123.109 0.564 . . . . 74.32 111.957 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 64.0 33.12 86.39 Favored Glycine 0 C--N 1.357 1.723 0 CA-C-O 121.047 0.248 . . . . 62.21 112.614 178.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 73' ' ' ASP . . . . . 0.458 ' HB3' HG13 ' B' ' 71' ' ' ILE . 17.1 p-10 -74.03 -61.1 1.97 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.655 1.182 . . . . 63.44 112.925 -170.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.23 45.62 85.21 Favored Glycine 0 CA--C 1.535 1.291 0 N-CA-C 111.825 -0.51 . . . . 64.42 111.825 -168.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -62.64 123.83 19.42 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.845 0.858 . . . . 74.01 110.337 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . -150.31 56.76 0.46 Allowed Glycine 0 C--N 1.338 0.664 0 N-CA-C 110.024 -1.23 . . . . 71.13 110.024 175.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 77' ' ' ASP . . . . . 0.564 ' HA ' ' HB2' ' B' ' 88' ' ' GLU . 11.5 t70 -75.55 136.71 40.55 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 122.655 0.382 . . . . 73.03 110.882 -174.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 78' ' ' SER . . . . . 0.641 ' HA ' ' HB3' ' B' ' 84' ' ' ARG . 48.9 m 70.69 37.17 1.44 Allowed 'General case' 0 N--CA 1.477 0.907 0 O-C-N 124.723 1.264 . . . . 51.1 111.207 -176.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 79' ' ' GLU . . . . . 0.415 ' HG2' HG12 ' B' ' 80' ' ' ILE . 40.0 tt0 -116.41 121.68 42.61 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.215 -0.902 . . . . 74.44 110.069 177.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.415 HG12 ' HG2' ' B' ' 79' ' ' GLU . 31.2 mm 53.63 -91.69 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.56 1.331 0 C-N-CA 125.778 1.631 . . . . 72.52 112.417 173.2 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 20.5 p 21.32 -86.53 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 127.201 2.2 . . . . 71.34 115.124 -178.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -152.78 56.99 0.8 Allowed 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 106.293 -1.743 . . . . 61.11 106.293 174.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . 73.63 -61.15 0.51 Allowed 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 125.329 1.452 . . . . 71.35 107.475 -157.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 84' ' ' ARG . . . . . 0.641 ' HB3' ' HA ' ' B' ' 78' ' ' SER . 7.8 ptm180 -153.34 -174.6 5.0 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.602 1.161 . . . . 73.0 108.951 163.075 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -133.14 -83.51 0.47 Allowed 'General case' 0 N--CA 1.479 1.025 0 CA-C-O 119.108 -0.472 . . . . 72.23 109.87 -178.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -149.4 -55.57 0.18 Allowed 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 112.884 0.698 . . . . 63.12 112.884 -176.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -122.53 29.1 7.06 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 113.07 0.767 . . . . 52.24 113.07 -162.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 88' ' ' GLU . . . . . 0.564 ' HB2' ' HA ' ' B' ' 77' ' ' ASP . 5.3 mp0 -74.36 -21.51 59.64 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.156 0.583 . . . . 74.14 109.995 -178.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -62.05 -15.56 50.34 Favored Glycine 0 C--N 1.356 1.66 0 CA-C-O 119.205 -0.775 . . . . 54.33 113.493 173.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . 74.84 -66.07 0.31 Allowed 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.545 1.538 . . . . 62.33 112.993 167.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -71.29 -105.12 0.05 OUTLIER Glycine 0 C--N 1.351 1.381 0 O-C-N 123.639 0.587 . . . . 70.11 112.431 179.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 107.05 -175.48 20.61 Favored Glycine 0 C--N 1.344 1.016 0 CA-C-N 116.978 0.389 . . . . 23.53 112.631 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -60.12 99.71 0.08 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.659 1.184 . . . . 74.22 111.11 -176.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 66.17 -71.53 0.09 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 125.536 1.534 . . . . 71.21 112.376 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? 61.15 103.52 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.738 1.215 . . . . 74.14 111.55 173.256 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . -81.94 46.74 3.55 Favored Glycine 0 N--CA 1.475 1.28 0 CA-C-O 120.947 0.193 . . . . 72.31 112.876 178.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 49.9 mm -121.04 -35.86 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 124.85 1.26 . . . . 72.22 108.832 177.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -145.02 159.93 42.17 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.899 0.88 . . . . 75.21 109.649 -176.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . 77.08 -50.52 0.55 Allowed 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 125.912 1.685 . . . . 61.12 112.844 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 100' ' ' LEU . . . . . 0.498 ' HB2' ' HD3' ' B' ' 101' ' ' PRO . 5.5 mp -84.25 -57.45 0.4 Allowed Pre-proline 0 CA--C 1.566 1.595 0 C-N-CA 123.802 0.841 . . . . 74.2 110.76 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 101' ' ' PRO . . . . . 0.498 ' HD3' ' HB2' ' B' ' 100' ' ' LEU . 76.2 Cg_endo -91.4 96.35 0.22 Allowed 'Trans proline' 0 C--N 1.393 2.879 0 C-N-CA 121.793 1.662 . . . . 72.21 113.42 -177.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 8.5 mp -90.33 160.98 15.84 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 108.549 -0.908 . . . . 73.12 108.549 168.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 34.9 p -50.56 -68.4 0.17 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.28 1.032 . . . . 75.52 112.165 -174.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . -159.67 150.72 21.23 Favored Glycine 0 C--N 1.343 0.971 0 N-CA-C 111.845 -0.502 . . . . 51.35 111.845 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -151.65 139.57 19.99 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 123.68 0.792 . . . . 75.22 109.455 -178.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 106' ' ' TYR . . . . . 0.501 ' O ' ' HD3' ' C' ' 148' ' ' ARG . 6.5 p90 -159.77 -54.17 0.06 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.886 0.874 . . . . 74.44 110.15 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 1.4 m 64.41 -1.99 0.68 Allowed 'General case' 0 N--CA 1.509 2.514 0 C-N-CA 125.304 1.442 . . . . 63.32 112.911 -176.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 71.9 t60 -164.99 97.03 0.73 Allowed 'General case' 0 C--O 1.243 0.742 0 N-CA-C 107.249 -1.389 . . . . 71.44 107.249 -171.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -76.88 103.01 6.59 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 107.718 -1.215 . . . . 53.33 107.718 173.079 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -81.7 15.8 2.02 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.82 0.848 . . . . 71.24 111.996 -176.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 111' ' ' LEU . . . . . 0.47 HD21 ' O ' ' B' ' 50' ' ' ASP . 4.8 tt 73.67 -64.24 0.4 Allowed 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.897 1.679 . . . . 64.15 111.077 174.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -74.65 83.73 2.08 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.695 0.76 . . . . 73.2 110.016 176.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 113' ' ' LYS . . . . . 0.4 ' HD3' ' HB2' ' C' ' 150' ' ' PRO . 52.9 tptt -144.75 30.42 1.2 Allowed 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 107.452 -1.314 . . . . 75.13 107.452 177.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.63 142.98 29.57 Favored 'General case' 0 C--N 1.349 0.545 0 CA-C-N 114.895 -1.048 . . . . 74.01 110.578 -176.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 4.1 m 64.58 154.82 0.07 Allowed 'General case' 0 CA--C 1.563 1.452 0 C-N-CA 125.449 1.499 . . . . 73.23 113.605 170.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 116' ' ' GLY . . . . . 0.464 ' O ' ' HD3' ' B' ' 118' ' ' PRO . . . 116.04 67.11 0.4 Allowed Glycine 0 C--N 1.347 1.162 0 CA-C-N 115.783 -0.644 . . . . 55.33 112.174 174.255 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -90.06 105.8 12.48 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 123.431 0.692 . . . . 70.25 110.439 172.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 118' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' B' ' 116' ' ' GLY . 1.8 Cg_endo -85.02 94.71 0.66 Allowed 'Trans proline' 0 C--N 1.366 1.453 0 C-N-CA 122.403 2.068 . . . . 60.53 108.281 165.315 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 119' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -77.52 -97.35 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 115.662 -0.699 . . . . 75.33 110.54 -174.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 120' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -130.61 97.53 4.4 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 109.129 -0.693 . . . . 70.1 109.129 -178.126 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 3.3 t -118.11 39.47 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.037 0 N-CA-C 107.947 -1.131 . . . . 74.32 107.947 176.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 47.6 p 55.58 58.48 4.51 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 125.369 1.467 . . . . 75.24 111.264 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 123' ' ' ASP . . . . . 0.464 ' HB3' ' H ' ' B' ' 405' ' ' ALA . 6.9 m-20 -88.06 48.74 1.68 Allowed 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 114.85 -1.068 . . . . 64.3 111.126 -173.532 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 20.4 t -104.06 112.73 25.85 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 107.496 -1.298 . . . . 43.31 107.496 175.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 125' ' ' ALA . . . . . 0.683 ' HB1' ' H ' ' B' ' 299' ' ' GLY . . . -155.77 31.02 0.36 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.22 0.608 . . . . 73.02 110.595 -177.287 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . 50.94 72.32 0.36 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.647 1.179 . . . . 74.13 112.249 -177.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 38.5 t -77.32 -26.96 52.67 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 115.543 -0.753 . . . . 70.01 110.627 177.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 128' ' ' ALA . . . . . 0.598 ' HB1' ' HB2' ' B' ' 131' ' ' TRP . . . -145.26 110.7 5.31 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.879 0.871 . . . . 72.01 109.353 -179.006 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 23.1 p -98.91 -62.06 1.29 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.738 0.815 . . . . 54.34 110.98 -178.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . -78.25 -22.95 47.58 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.27 0.628 . . . . 44.22 111.416 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 131' ' ' TRP . . . . . 0.598 ' HB2' ' HB1' ' B' ' 128' ' ' ALA . 22.8 m-90 -76.43 92.45 3.39 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.032 0.933 . . . . 73.51 109.296 -177.021 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 28.7 p -139.04 -66.39 0.47 Allowed 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 115.446 -0.797 . . . . 51.4 110.826 -175.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 43.1 p -88.44 48.05 1.58 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.963 0.905 . . . . 62.25 111.38 -173.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 64.24 -116.16 8.76 Favored Glycine 0 C--N 1.348 1.238 0 N-CA-C 111.739 -0.544 . . . . 55.15 111.739 -179.259 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 135' ' ' VAL . . . . . . . . . . . . . 21.6 t -95.43 58.97 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.055 0 N-CA-C 108.707 -0.849 . . . . 73.24 108.707 177.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 85.0 tttt 53.7 57.6 5.93 Favored 'General case' 0 CA--C 1.561 1.379 0 C-N-CA 124.749 1.219 . . . . 52.43 111.724 177.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 36.8 m -81.66 89.08 6.22 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.249 0.547 . . . . 75.31 110.2 -177.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -143.82 143.21 31.23 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 115.108 -0.951 . . . . 75.52 108.787 173.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 69.72 -74.88 0.08 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.181 1.392 . . . . 73.24 111.364 -176.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . 67.38 -100.67 0.61 Allowed Glycine 0 C--N 1.346 1.129 0 O-C-N 123.211 0.319 . . . . 65.04 112.649 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 141' ' ' ALA . . . . . 0.489 ' HB1' ' HB3' ' B' ' 145' ' ' ASP . . . -111.7 -10.42 14.07 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.808 0.843 . . . . 75.34 111.128 177.684 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 64.31 -76.62 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 125.493 1.517 . . . . 70.15 110.229 -175.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 177.54 32.03 0.05 OUTLIER Glycine 0 C--N 1.338 0.66 0 N-CA-C 110.027 -1.229 . . . . 61.25 110.027 175.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 16.0 m -133.99 22.99 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.089 1.356 . . . . 75.31 109.965 -176.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 145' ' ' ASP . . . . . 0.489 ' HB3' ' HB1' ' B' ' 141' ' ' ALA . 10.0 p-10 -51.9 -42.48 62.77 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.448 1.099 . . . . 64.3 110.79 178.271 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 146' ' ' ILE . . . . . 0.481 HG23 ' HG3' ' B' ' 148' ' ' GLU . 15.6 tt 157.97 -10.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 C-N-CA 127.644 2.377 . . . . 72.52 107.792 -175.114 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 51.3 m170 82.23 25.12 0.19 Allowed 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 126.328 1.851 . . . . 72.43 112.334 177.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 148' ' ' GLU . . . . . 0.481 ' HG3' HG23 ' B' ' 146' ' ' ILE . 55.9 mt-10 -76.64 -41.83 44.32 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 109.009 -0.737 . . . . 73.05 109.009 165.625 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 149' ' ' LYS . . . . . . . . . . . . . 18.0 mmtp -100.52 -53.75 3.02 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.675 -0.861 . . . . 72.23 108.675 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 29.8 t70 62.22 -86.14 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.344 1.458 . . . . 74.11 111.16 177.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 151' ' ' HIS . . . . . 0.643 ' H ' ' HD2' ' B' ' 152' ' ' PRO . 42.4 m80 -149.88 -48.15 0.02 OUTLIER Pre-proline 0 CA--C 1.565 1.552 0 C-N-CA 124.817 1.247 . . . . 74.43 112.261 -172.562 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 152' ' ' PRO . . . . . 0.643 ' HD2' ' H ' ' B' ' 151' ' ' HIS . 55.2 Cg_endo -66.09 85.5 0.25 Allowed 'Trans proline' 0 C--N 1.402 3.368 0 CA-C-N 121.972 1.74 . . . . 42.51 112.638 178.624 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 60.7 m -86.85 92.97 9.17 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 107.863 -1.162 . . . . 74.2 107.863 174.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 154' ' ' ILE . . . . . 0.438 HG22 ' O ' ' B' ' 262' ' ' ALA . 2.3 pp -102.81 128.73 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 115.286 -0.87 . . . . 74.25 110.401 -170.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 155' ' ' LEU . . . . . 0.507 ' HG ' ' H ' ' B' ' 156' ' ' GLU . 20.7 tp 59.67 -170.93 0.13 Allowed 'General case' 0 CA--C 1.571 1.765 0 C-N-CA 124.621 1.168 . . . . 72.1 111.593 170.695 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 156' ' ' GLU . . . . . 0.507 ' H ' ' HG ' ' B' ' 155' ' ' LEU . 56.6 mm-40 -57.99 -36.96 73.37 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.503 0.721 . . . . 72.23 110.34 166.183 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 157' ' ' MET . . . . . . . . . . . . . 1.5 tmt? 75.21 -14.64 0.74 Allowed 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 125.728 1.611 . . . . 53.54 111.813 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 158' ' ' ALA . . . . . . . . . . . . . . . 76.45 -60.16 0.48 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 126.371 1.868 . . . . 34.04 111.816 179.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -76.12 -37.12 58.44 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.833 0.853 . . . . 55.45 110.746 -175.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -61.76 -49.96 74.27 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.767 -0.651 . . . . 70.22 109.502 175.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -64.49 -29.46 70.5 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.144 0.978 . . . . 71.1 111.952 177.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . -66.99 -36.9 91.66 Favored Glycine 0 C--N 1.352 1.448 0 O-C-N 123.49 0.494 . . . . 73.4 112.919 179.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 67.2 tp -77.91 -51.41 10.46 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.338 0.655 . . . . 65.02 109.578 175.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 164' ' ' ALA . . . . . . . . . . . . . . . -158.29 117.4 3.14 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 114.902 -1.045 . . . . 75.34 108.428 -173.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 9.7 t -57.43 -35.35 69.96 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 123.282 0.633 . . . . 64.15 111.794 -177.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . 61.71 29.41 72.04 Favored Glycine 0 C--N 1.355 1.62 0 O-C-N 123.652 0.595 . . . . 71.15 112.524 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 167' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -76.94 142.41 40.06 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.014 0.926 . . . . 72.31 110.351 -173.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 9.3 p -67.04 135.19 29.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 122.512 0.325 . . . . 74.13 110.217 -178.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 94.3 p 55.86 33.15 21.03 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.259 1.424 . . . . 54.35 112.4 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 15.3 t -68.35 -19.87 64.68 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.759 0.424 . . . . 63.1 111.115 174.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . 70.51 -73.82 0.09 Allowed 'General case' 0 C--N 1.361 1.069 0 C-N-CA 126.034 1.734 . . . . 53.32 111.483 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 172' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 65.31 102.07 0.04 OUTLIER 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 125.196 1.398 . . . . 73.22 109.216 -176.287 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 173' ' ' LEU . . . . . 0.502 HD21 ' HG2' ' C' ' 128' ' ' GLU . 3.4 mm? -73.65 -39.94 64.09 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.686 0.795 . . . . 74.23 111.18 -172.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 174' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 69.96 -67.83 0.22 Allowed 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 125.343 1.457 . . . . 74.45 110.69 -176.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 175' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -106.25 139.83 40.14 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.038 0.935 . . . . 74.1 108.779 171.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -115.31 70.06 0.74 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.509 0.723 . . . . 74.11 109.721 -178.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 39.3 m -158.65 111.78 1.64 Allowed Pre-proline 0 CA--C 1.553 1.082 0 C-N-CA 124.197 0.999 . . . . 64.31 108.423 175.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 178' ' ' PRO . . . . . 0.562 ' HD3' ' HG3' ' C' ' 129' ' ' GLU . 90.6 Cg_endo -83.7 -42.51 0.08 OUTLIER 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 122.752 2.301 . . . . 74.53 113.25 179.194 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -167.79 27.37 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.405 1.082 . . . . 61.34 109.618 -174.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 180' ' ' ALA . . . . . 0.514 ' HB1' ' HB ' ' C' ' 137' ' ' VAL . . . 61.5 -79.19 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 124.461 1.104 . . . . 74.4 109.881 -165.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 181' ' ' LEU . . . . . 0.578 HD22 ' HB2' ' C' ' 136' ' ' ARG . 15.4 tp -168.29 21.48 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.315 0 C-N-CA 123.587 0.755 . . . . 62.04 110.364 172.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 182' ' ' VAL . . . . . . . . . . . . . 26.2 t -136.16 148.98 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.403 -0.81 . . . . 71.31 110.701 -173.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -149.07 -72.38 0.19 Allowed 'General case' 0 C--N 1.359 0.999 0 C-N-CA 123.376 0.67 . . . . 65.24 110.933 169.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 56.0 p-80 -150.52 161.37 42.67 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 122.402 0.281 . . . . 74.15 111.548 -174.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 185' ' ' VAL . . . . . . . . . . . . . 21.3 t -98.73 161.38 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.379 0 C-N-CA 124.389 1.076 . . . . 71.33 109.065 175.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 11.1 t -153.12 -171.25 3.86 Favored 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 123.871 0.868 . . . . 51.31 110.098 -176.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 187' ' ' SER . . . . . . . . . . . . . 45.8 m -92.89 130.94 38.32 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.28 1.032 . . . . 62.14 110.24 178.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 188' ' ' ARG . . . . . 0.506 ' HG2' ' H ' ' B' ' 189' ' ' LYS . 21.5 ttm180 178.55 -163.96 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 124.69 1.196 . . . . 71.52 108.335 -176.398 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 189' ' ' LYS . . . . . 0.506 ' H ' ' HG2' ' B' ' 188' ' ' ARG . 15.0 ptpt -147.63 152.22 37.51 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.673 1.189 . . . . 72.52 108.52 170.511 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 190' ' ' CYS . . . . . . . . . . . . . 51.2 m -140.27 137.82 34.52 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.308 0.643 . . . . 70.33 111.211 -173.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -166.88 143.71 4.66 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.265 1.026 . . . . 74.04 109.896 173.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 148.2 66.92 0.01 OUTLIER Glycine 0 C--N 1.352 1.462 0 CA-C-O 119.298 -0.723 . . . . 64.22 112.34 173.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 193' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -70.75 134.69 26.43 Favored 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 123.455 2.77 . . . . 64.32 113.889 -174.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 194' ' ' SER . . . . . 0.534 ' H ' ' HB2' ' C' ' 162' ' ' PRO . 52.2 p -162.35 171.83 16.58 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.861 1.264 . . . . 24.51 109.121 172.533 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 195' ' ' ALA . . . . . . . . . . . . . . . -136.39 -165.42 1.72 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.188 0.595 . . . . 74.32 111.227 -174.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 196' ' ' THR . . . . . 0.604 HG21 HD13 ' B' ' 59' ' ' LEU . 81.2 m 76.84 129.54 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 125.836 1.654 . . . . 73.32 111.645 -179.145 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 70.5 p -163.08 -175.85 4.55 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 124.172 0.989 . . . . 75.11 109.367 178.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 198' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 74.56 135.23 0.05 Allowed 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 125.299 1.439 . . . . 51.12 112.016 168.464 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 199' ' ' LYS . . . . . 0.439 ' HB3' HH22 ' C' ' 148' ' ' ARG . 52.8 tttp -161.23 90.86 0.83 Allowed 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 115.301 -0.863 . . . . 74.4 108.997 -176.314 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 200' ' ' CYS . . . . . . . . . . . . . 66.1 m -60.38 -46.71 97.57 Favored Pre-proline 0 CA--C 1.563 1.454 0 N-CA-C 113.289 0.848 . . . . 73.31 113.289 -178.015 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 201' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -75.06 3.16 5.9 Favored 'Trans proline' 0 C--N 1.39 2.747 0 C-N-CA 121.974 1.783 . . . . 71.34 113.23 178.145 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . -86.47 46.95 3.66 Favored Glycine 0 C--N 1.351 1.362 0 C-N-CA 122.804 0.24 . . . . 63.04 112.694 178.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -141.12 136.97 32.44 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.769 1.227 . . . . 71.33 108.64 -178.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -74.51 127.79 33.94 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.556 0.743 . . . . 74.01 109.813 177.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 205' ' ' LEU . . . . . . . . . . . . . 56.0 tp -62.81 -67.89 0.38 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.062 0.945 . . . . 51.03 110.932 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -156.42 -89.07 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 106.541 -1.651 . . . . 62.32 106.541 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 4.2 tmtm? 179.69 -75.84 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 107.785 -1.191 . . . . 74.32 107.785 178.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 121.59 51.29 0.24 Allowed Glycine 0 C--N 1.343 0.957 0 N-CA-C 109.143 -1.583 . . . . 71.52 109.143 -163.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . -66.98 -33.93 85.4 Favored Glycine 0 C--N 1.35 1.337 0 CA-C-N 114.769 -0.716 . . . . 42.21 114.109 -171.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -90.68 143.11 27.07 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.436 0.694 . . . . 74.51 110.096 177.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . 179.19 -65.19 0.08 OUTLIER Glycine 0 C--N 1.339 0.746 0 N-CA-C 109.898 -1.281 . . . . 74.43 109.898 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 46.5 m -82.77 95.64 7.94 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 123.93 0.892 . . . . 74.04 109.771 174.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 213' ' ' ILE . . . . . 0.558 ' HB ' HD23 ' B' ' 218' ' ' LEU . 61.0 mt -72.61 131.48 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 N-CA-C 108.746 -0.835 . . . . 64.4 108.746 175.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 214' ' ' THR . . . . . 0.669 ' HA ' ' HB2' ' B' ' 219' ' ' ASN . 11.1 t -127.22 151.64 48.43 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 123.685 0.794 . . . . 75.43 109.937 -179.298 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 215' ' ' GLU . . . . . 0.474 ' O ' ' HA ' ' B' ' 220' ' ' ALA . 36.8 tt0 72.8 -68.31 0.23 Allowed 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.794 1.638 . . . . 73.31 112.676 177.189 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -76.54 109.05 9.96 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.375 0.67 . . . . 61.42 110.175 -173.071 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 86.6 mt 67.68 -73.65 0.08 Allowed 'General case' 0 N--CA 1.478 0.974 0 O-C-N 124.896 1.372 . . . . 75.4 111.182 -179.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 218' ' ' LEU . . . . . 0.558 HD23 ' HB ' ' B' ' 213' ' ' ILE . 26.8 tp -78.8 133.57 37.05 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.692 0.797 . . . . 71.43 109.361 177.136 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 219' ' ' ASN . . . . . 0.669 ' HB2' ' HA ' ' B' ' 214' ' ' THR . 93.6 m-20 58.51 49.08 11.07 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.924 0.89 . . . . 71.24 109.94 -172.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 220' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' B' ' 215' ' ' GLU . . . -52.36 103.22 0.06 Allowed 'General case' 0 C--N 1.353 0.749 0 C-N-CA 124.567 1.147 . . . . 61.1 112.569 -168.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 221' ' ' ARG . . . . . . . . . . . . . 65.1 mtm180 64.9 -78.31 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 125.412 1.485 . . . . 73.55 110.287 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -166.98 134.01 2.41 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 125.115 1.366 . . . . 42.52 107.706 172.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -67.91 -34.16 76.09 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.456 0.702 . . . . 61.02 111.301 -179.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 12.9 t -83.76 -8.63 11.33 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.175 0 CA-C-N 115.797 -0.638 . . . . 74.2 110.14 176.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 16.5 m 71.9 108.01 0.07 Allowed 'General case' 0 C--N 1.361 1.083 0 C-N-CA 125.564 1.546 . . . . 54.34 110.006 -178.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 63.2 mt 69.77 166.87 0.28 Allowed 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.953 1.301 . . . . 74.43 111.117 -172.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . -84.34 62.25 4.6 Favored Glycine 0 CA--C 1.532 1.127 0 CA-C-N 116.242 -0.435 . . . . 51.31 112.573 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . -126.26 7.21 7.61 Favored Glycine 0 N--CA 1.476 1.348 0 C-N-CA 123.124 0.392 . . . . 72.41 112.534 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -87.63 -173.02 47.98 Favored Glycine 0 C--N 1.344 1.015 0 C-N-CA 122.836 0.255 . . . . 70.24 112.881 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . 74.54 -53.84 0.67 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.704 1.602 . . . . 70.23 111.179 -173.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 231' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? 65.14 19.19 11.72 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 124.943 1.297 . . . . 73.24 111.188 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 9.8 t -143.3 137.83 29.11 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.709 1.203 . . . . 74.24 109.122 -179.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -130.01 72.64 1.49 Allowed 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 108.645 -0.872 . . . . 70.41 108.645 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -149.62 122.2 8.57 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.045 -0.979 . . . . 72.31 108.963 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -120.47 -168.86 1.71 Allowed 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.822 0.849 . . . . 54.41 110.436 -176.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 236' ' ' THR . . . . . . . . . . . . . 8.0 m -64.43 -26.55 68.5 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.963 0.905 . . . . 73.34 111.549 177.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . 70.21 121.33 0.03 OUTLIER 'General case' 0 C--N 1.361 1.085 0 C-N-CA 125.423 1.489 . . . . 71.12 110.748 -174.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 20.8 m -69.27 -24.66 64.0 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 123.529 0.732 . . . . 71.31 111.206 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -75.86 145.57 40.46 Favored 'General case' 0 C--N 1.348 0.532 0 C-N-CA 123.833 0.853 . . . . 74.42 112.262 -177.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 240' ' ' GLY . . . . . 0.508 ' H ' HD22 ' C' ' 235' ' ' LEU . . . -74.93 -138.78 0.59 Allowed Glycine 0 CA--C 1.533 1.158 0 CA-C-N 114.656 -1.157 . . . . 71.23 111.984 168.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -158.93 172.65 17.82 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.068 0.547 . . . . 71.21 111.221 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 242' ' ' TRP . . . . . 0.543 ' HH2' HG21 ' C' ' 227' ' ' THR . 0.0 OUTLIER -157.2 -46.65 0.07 Allowed 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.247 1.419 . . . . 70.32 108.514 -172.147 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 243' ' ' GLN . . . . . 0.593 ' HB2' ' HG2' ' C' ' 224' ' ' PRO . 35.8 mt-30 -117.76 -170.06 1.8 Allowed 'General case' 0 C--O 1.247 0.928 0 N-CA-C 107.71 -1.218 . . . . 74.22 107.71 166.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -78.37 89.4 1.11 Allowed Glycine 0 C--N 1.345 1.036 0 N-CA-C 111.147 -0.781 . . . . 63.11 111.147 171.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 1.7 pptp? -77.11 141.74 40.07 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.05 0.54 . . . . 75.34 111.513 -177.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 72.8 m -151.02 140.2 21.21 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.059 0.944 . . . . 71.02 109.446 -178.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 247' ' ' LEU . . . . . . . . . . . . . 74.9 mt -84.46 130.05 34.8 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.449 0.7 . . . . 72.51 109.53 176.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 248' ' ' ARG . . . . . 0.625 ' HG3' HG22 ' C' ' 206' ' ' VAL . 25.0 mmm180 -85.14 -173.47 4.72 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.69 0.796 . . . . 75.15 111.187 177.111 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -109.99 153.98 23.8 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.728 0.811 . . . . 71.33 109.757 -176.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -76.49 89.75 3.27 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 107.09 -1.448 . . . . 65.4 107.09 166.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 251' ' ' ALA . . . . . . . . . . . . . . . -72.38 74.25 1.01 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.506 0.723 . . . . 61.03 109.605 -177.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 59.71 110.16 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 125.546 1.538 . . . . 72.3 110.5 -164.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -70.69 -20.15 62.7 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.553 0.741 . . . . 51.41 111.231 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 66.1 mtp180 72.06 81.01 0.15 Allowed 'General case' 0 C--N 1.359 1.01 0 C-N-CA 125.263 1.425 . . . . 72.51 111.742 170.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -174.14 -102.9 0.16 Allowed Glycine 0 C--N 1.346 1.112 0 CA-C-N 114.937 -1.029 . . . . 54.22 111.908 178.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 256' ' ' TYR . . . . . . . . . . . . . 41.2 t80 55.12 41.22 31.84 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.845 1.307 . . . . 52.52 109.759 -172.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -156.67 -53.48 0.08 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 114.527 -1.215 . . . . 74.31 108.999 -174.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 258' ' ' LEU . . . . . . . . . . . . . 29.8 tp -166.83 -37.78 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 115.499 -0.773 . . . . 75.13 110.795 -175.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 39.1 t -65.67 -65.89 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.711 0.804 . . . . 63.02 112.208 -164.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 260' ' ' SER . . . . . 0.457 ' HA ' HD21 ' B' ' 278' ' ' LEU . 32.6 p -102.27 33.97 2.91 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 121.948 0.88 . . . . 73.11 110.884 -178.045 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -103.08 59.65 0.77 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-N 114.613 -1.176 . . . . 52.21 108.35 -177.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 262' ' ' ALA . . . . . 0.438 ' O ' HG22 ' B' ' 154' ' ' ILE . . . 58.74 72.78 0.51 Allowed 'General case' 0 C--N 1.356 0.863 0 CA-C-N 114.274 -1.33 . . . . 43.43 110.001 -174.295 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . 59.69 -92.29 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.632 1.173 . . . . 70.44 111.271 -175.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 45.6 m 51.47 33.07 9.63 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.419 1.088 . . . . 51.14 113.882 177.029 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 265' ' ' LEU . . . . . 0.406 HD11 ' HA ' ' B' ' 278' ' ' LEU . 10.6 mp -61.24 160.0 11.23 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.271 0.628 . . . . 64.12 111.333 175.039 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 266' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -68.56 89.04 0.36 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.297 0.639 . . . . 71.52 110.152 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 26.2 m 59.68 -84.41 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 125.251 1.421 . . . . 73.13 111.918 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 49.0 t 67.16 131.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 C-N-CA 125.245 1.418 . . . . 74.44 111.221 -177.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 269' ' ' THR . . . . . 0.402 HG22 ' H ' ' B' ' 270' ' ' GLU . 1.3 m -92.37 -144.8 0.21 Allowed 'General case' 0 CA--C 1.563 1.448 0 N-CA-C 108.124 -1.065 . . . . 74.31 108.124 -178.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 270' ' ' GLU . . . . . 0.402 ' H ' HG22 ' B' ' 269' ' ' THR . 35.0 tt0 68.14 33.88 4.23 Favored 'General case' 0 CA--C 1.563 1.452 0 C-N-CA 123.806 0.842 . . . . 72.41 111.087 168.5 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 271' ' ' ALA . . . . . 0.443 ' O ' ' HE3' ' B' ' 275' ' ' LYS . . . 66.46 -79.17 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.861 1.265 . . . . 75.3 112.0 178.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 272' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -167.58 32.22 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.801 0.84 . . . . 54.14 109.573 -177.221 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.82 -62.95 1.49 Allowed 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 109.308 -0.627 . . . . 61.32 109.308 -177.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -94.5 -4.08 48.75 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 116.321 -0.4 . . . . 71.44 111.965 -177.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 275' ' ' LYS . . . . . 0.443 ' HE3' ' O ' ' B' ' 271' ' ' ALA . 6.8 mtmp? -61.34 -44.83 94.24 Favored Pre-proline 0 CA--C 1.562 1.411 0 CA-C-O 118.535 -0.745 . . . . 71.33 112.468 178.111 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -88.0 6.32 5.01 Favored 'Trans proline' 0 C--N 1.389 2.689 0 C-N-CA 122.342 2.028 . . . . 62.35 113.472 176.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 277' ' ' LEU . . . . . . . . . . . . . 67.0 tp -113.0 108.36 17.23 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 108.829 -0.804 . . . . 63.32 108.829 178.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 278' ' ' LEU . . . . . 0.585 HD22 ' HA ' ' A' ' 279' ' ' ARG . 5.1 mp -59.24 -65.67 0.63 Allowed 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.741 0.816 . . . . 62.0 110.263 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . 58.85 18.91 41.58 Favored Glycine 0 C--N 1.356 1.664 0 CA-C-N 115.045 -0.98 . . . . 75.43 113.122 -174.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 280' ' ' LEU . . . . . 0.625 ' HB3' HG21 ' C' ' 262' ' ' THR . 6.5 tt 75.19 -40.7 0.44 Allowed 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 126.337 1.855 . . . . 53.23 110.126 -169.669 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 80.0 t80 74.04 105.68 0.07 Allowed 'General case' 0 C--N 1.36 1.044 0 C-N-CA 125.672 1.589 . . . . 75.31 110.744 176.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -163.73 -83.42 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.713 0.805 . . . . 65.41 109.061 177.088 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -101.93 31.98 3.65 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-O 121.663 0.745 . . . . 72.33 109.638 176.25 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 284' ' ' GLY . . . . . 0.719 ' HA2' ' HG3' ' C' ' 260' ' ' ARG . . . -84.9 69.11 3.37 Favored Glycine 0 C--N 1.351 1.363 0 CA-C-N 114.944 -1.025 . . . . 61.45 110.838 173.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -155.97 176.61 12.42 Favored 'General case' 0 C--O 1.244 0.786 0 C-N-CA 123.604 0.762 . . . . 72.41 110.348 -177.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 286' ' ' MET . . . . . . . . . . . . . 12.7 tmm? 64.21 84.63 0.18 Allowed Pre-proline 0 CA--C 1.553 1.089 0 C-N-CA 124.961 1.304 . . . . 64.1 110.825 178.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 287' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -91.65 118.55 0.51 Allowed 'Trans proline' 0 C--N 1.368 1.602 0 C-N-CA 123.07 2.513 . . . . 73.33 111.215 166.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 288' ' ' VAL . . . . . . . . . . . . . 44.3 t -70.14 91.51 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 108.429 -0.952 . . . . 74.32 108.429 177.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 289' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -115.68 146.06 42.19 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.153 0.981 . . . . 72.14 109.408 -172.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 290' ' ' TRP . . . . . . . . . . . . . 6.3 m0 75.18 -49.41 0.64 Allowed 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 125.618 1.567 . . . . 75.34 112.27 178.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 291' ' ' LEU . . . . . . . . . . . . . 58.4 tp -52.89 -51.09 62.43 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.456 1.103 . . . . 64.34 111.355 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . -94.54 -69.41 1.07 Allowed Glycine 0 CA--C 1.535 1.288 0 CA-C-N 115.441 -0.799 . . . . 62.12 111.35 174.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.05 88.21 0.83 Allowed 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 123.26 2.64 . . . . 51.12 112.645 -178.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 4.9 ttpm? 179.06 -26.34 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 125.175 1.39 . . . . 41.23 109.391 179.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -79.84 36.02 0.32 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.137 0.975 . . . . 34.32 112.766 -175.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 9.8 t -167.74 150.36 5.82 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.053 0.941 . . . . 65.42 110.795 178.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -179.11 118.5 0.07 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 126.046 1.738 . . . . 64.12 106.81 174.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 56.5 t60 67.6 107.65 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.083 0.953 . . . . 71.5 111.094 -178.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 299' ' ' GLY . . . . . 0.683 ' H ' ' HB1' ' B' ' 125' ' ' ALA . . . -87.91 176.59 45.91 Favored Glycine 0 N--CA 1.469 0.869 0 N-CA-C 110.99 -0.844 . . . . 63.41 110.99 166.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 54.7 t30 70.17 156.44 0.15 Allowed 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 124.354 1.062 . . . . 72.23 111.784 178.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 301' ' ' ILE . . . . . . . . . . . . . 18.3 pt -60.92 -33.91 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.252 0.621 . . . . 72.24 111.285 175.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -161.23 -106.17 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.924 0 CA-C-O 119.094 -0.479 . . . . 63.41 110.505 174.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 303' ' ' LYS . . . . . 0.413 ' H ' ' HD2' ' B' ' 304' ' ' PRO . 7.6 mtmp? -157.22 -42.96 0.0 OUTLIER Pre-proline 0 CA--C 1.578 2.023 0 CA-C-O 117.382 -1.294 . . . . 74.11 114.174 -164.494 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 304' ' ' PRO . . . . . 0.413 ' HD2' ' H ' ' B' ' 303' ' ' LYS . 82.1 Cg_exo -49.19 141.42 23.62 Favored 'Trans proline' 0 C--N 1.402 3.346 0 C-N-CA 122.838 2.359 . . . . 75.12 114.766 177.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -133.33 160.24 37.92 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.117 0.967 . . . . 42.33 110.133 -178.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 306' ' ' VAL . . . . . 0.469 ' HB ' ' HD3' ' B' ' 373' ' ' ARG . 2.8 p -61.63 111.07 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.916 0.887 . . . . 72.33 112.307 -175.207 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -161.36 99.66 1.18 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.42 1.088 . . . . 74.23 109.105 176.108 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 308' ' ' CYS . . . . . 0.543 ' HB3' ' HG2' ' B' ' 369' ' ' GLU . 51.6 t -164.83 -30.98 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.44 0.696 . . . . 74.22 110.728 175.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 309' ' ' THR . . . . . 0.716 HG21 ' HB1' ' B' ' 40' ' ' ALA . 97.9 m -56.71 130.04 77.39 Favored Pre-proline 0 N--CA 1.481 1.093 0 CA-C-O 117.928 -1.034 . . . . 72.2 111.55 176.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -53.32 -67.12 0.09 OUTLIER 'Trans proline' 0 C--N 1.393 2.898 0 C-N-CA 123.708 2.939 . . . . 63.14 112.799 -176.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 311' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -175.06 147.96 1.07 Allowed Pre-proline 0 N--CA 1.479 0.986 0 C-N-CA 123.31 0.644 . . . . 73.13 110.328 175.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 312' ' ' PRO . . . . . 0.594 ' HG3' ' HA ' ' B' ' 41' ' ' PRO . 21.4 Cg_endo -92.4 -147.22 0.03 OUTLIER 'Trans proline' 0 C--N 1.365 1.433 0 C-N-CA 123.351 2.701 . . . . 70.14 110.636 170.264 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 313' ' ' GLN . . . . . 0.624 HE22 ' HB2' ' B' ' 316' ' ' ASP . 0.5 OUTLIER -64.92 105.17 0.97 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.332 0.653 . . . . 75.13 109.439 175.544 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 314' ' ' ARG . . . . . . . . . . . . . 35.1 mmt180 -124.69 79.3 1.76 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.588 1.155 . . . . 72.01 108.564 177.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 315' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -156.26 -57.76 0.09 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.524 0.73 . . . . 72.12 109.316 -177.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 316' ' ' ASP . . . . . 0.624 ' HB2' HE22 ' B' ' 313' ' ' GLN . 2.8 m-20 -81.93 69.81 8.71 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.893 0.877 . . . . 74.4 108.664 176.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 25.6 t -117.85 87.64 2.76 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.149 -0.932 . . . . 75.41 109.096 -176.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 318' ' ' VAL . . . . . . . . . . . . . 34.1 m 39.59 62.08 5.49 Favored Pre-proline 0 CA--C 1.57 1.743 0 C-N-CA 126.597 1.959 . . . . 73.13 114.112 -178.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 319' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -86.34 -179.13 3.0 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 122.587 2.191 . . . . 65.1 112.627 -178.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 320' ' ' THR . . . . . . . . . . . . . 57.8 m 74.02 -56.7 0.64 Allowed 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 126.404 1.882 . . . . 53.31 111.936 -173.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 321' ' ' LEU . . . . . . . . . . . . . 34.9 tp -83.32 64.67 7.91 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 124.122 0.969 . . . . 65.14 110.125 -177.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 322' ' ' ALA . . . . . . . . . . . . . . . -89.6 -59.42 2.21 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.497 -0.774 . . . . 64.54 110.431 -178.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 323' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 58.38 76.55 0.33 Allowed 'General case' 0 CA--C 1.553 1.096 0 CA-C-O 121.816 0.817 . . . . 74.02 109.658 -178.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 324' ' ' MET . . . . . . . . . . . . . 41.9 ttp 59.61 -105.9 0.26 Allowed 'General case' 0 CA--C 1.561 1.403 0 CA-C-N 113.783 -1.553 . . . . 71.32 109.426 -168.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 325' ' ' THR . . . . . . . . . . . . . 31.5 m 63.5 -63.41 0.13 Allowed 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 125.81 1.644 . . . . 72.33 113.838 178.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 326' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -48.96 132.51 18.61 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 125.097 1.359 . . . . 72.01 112.812 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 1.7 tmmt? 64.6 -77.25 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.881 0 O-C-N 125.451 1.72 . . . . 54.34 110.59 176.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 328' ' ' ALA . . . . . . . . . . . . . . . 64.55 -72.18 0.07 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 125.69 1.596 . . . . 72.03 111.244 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 329' ' ' ILE . . . . . . . . . . . . . 17.4 pt 53.0 125.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 C-N-CA 127.652 2.381 . . . . 73.5 113.624 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 330' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 50.72 16.49 0.32 Allowed 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 125.975 1.71 . . . . 63.42 113.669 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 331' ' ' LEU . . . . . . . . . . . . . 6.9 mp -107.93 179.29 4.27 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.072 1.349 . . . . 63.34 108.681 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 67.62 -72.9 0.09 Allowed 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 125.127 1.371 . . . . 74.41 110.729 -176.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 333' ' ' SER . . . . . 0.465 ' HB3' ' HB2' ' B' ' 336' ' ' GLU . 18.8 m 74.63 -10.27 1.2 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 125.948 1.699 . . . . 65.04 112.147 -177.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 61.3 mttm 63.84 -77.12 0.03 OUTLIER 'General case' 0 C--N 1.365 1.267 0 C-N-CA 125.263 1.425 . . . . 63.11 112.025 178.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 335' ' ' ASN . . . . . 0.401 ' HB2' ' CA ' ' C' ' 237' ' ' GLY . 8.0 t30 -76.75 -48.92 17.24 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 122.871 0.468 . . . . 73.25 111.517 -178.474 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 336' ' ' GLU . . . . . 0.465 ' HB2' ' HB3' ' B' ' 333' ' ' SER . 4.0 mp0 -66.19 86.82 0.1 Allowed 'General case' 0 C--N 1.353 0.718 0 O-C-N 124.236 0.96 . . . . 61.02 109.374 -177.219 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 337' ' ' LYS . . . . . . . . . . . . . 44.8 tttp 64.72 -77.01 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 126.549 1.939 . . . . 62.43 111.434 -171.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 338' ' ' GLY . . . . . . . . . . . . . . . 135.17 -36.81 2.01 Favored Glycine 0 C--N 1.343 0.936 0 N-CA-C 110.813 -0.915 . . . . 72.34 110.813 -174.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 339' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 60.45 -80.76 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.567 1.547 . . . . 74.33 112.175 176.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 340' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -88.76 102.64 15.2 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 108.563 -0.903 . . . . 75.24 108.563 174.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 341' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -101.74 130.24 48.09 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 108.655 -0.868 . . . . 75.34 108.655 172.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 342' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -63.34 94.23 0.08 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.612 0.765 . . . . 64.25 109.447 178.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 343' ' ' VAL . . . . . . . . . . . . . 14.5 p -63.16 -33.85 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.242 1.017 . . . . 64.24 112.233 -170.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -97.26 119.53 35.96 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.258 0.623 . . . . 73.03 110.305 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 345' ' ' GLY . . . . . . . . . . . . . . . 78.28 -75.35 1.94 Allowed Glycine 0 C--N 1.344 1.016 0 O-C-N 124.189 0.931 . . . . 62.31 113.567 173.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 346' ' ' ALA . . . . . . . . . . . . . . . 64.22 16.93 10.4 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.813 1.245 . . . . 72.22 111.82 -177.088 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 28.2 t -92.39 27.66 2.18 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.279 1.031 . . . . 72.21 110.731 -175.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 348' ' ' ILE . . . . . 0.482 HG22 ' HB2' ' B' ' 351' ' ' GLN . 10.9 mt 55.03 47.02 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 107.633 -1.247 . . . . 73.42 107.633 -171.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 349' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -59.75 -36.8 77.35 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 113.163 -1.835 . . . . 71.13 113.066 -160.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 350' ' ' LYS . . . . . 0.644 ' HD2' ' H ' ' B' ' 350' ' ' LYS . 0.0 OUTLIER -74.38 -25.45 59.5 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.312 -0.858 . . . . 74.52 111.866 -175.349 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 351' ' ' GLN . . . . . 0.482 ' HB2' HG22 ' B' ' 348' ' ' ILE . 21.0 tp60 -63.58 167.21 5.89 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.551 0.74 . . . . 71.32 110.271 -179.37 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -47.5 105.96 0.08 Allowed 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 125.332 1.453 . . . . 74.35 111.737 -171.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 353' ' ' HIS . . . . . . . . . . . . . 44.6 p-80 -141.18 173.37 11.55 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.56 0.744 . . . . 74.33 110.768 -171.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 354' ' ' ALA . . . . . . . . . . . . . . . 57.92 43.13 21.87 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.959 1.304 . . . . 70.11 111.911 176.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 355' ' ' ALA . . . . . . . . . . . . . . . 65.09 19.12 11.73 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.499 1.12 . . . . 75.44 112.744 173.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 356' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -133.73 140.64 37.26 Favored Pre-proline 0 N--CA 1.479 1.024 0 C-N-CA 123.009 0.524 . . . . 74.32 110.509 177.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 357' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -89.27 42.66 0.6 Allowed 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 123.564 2.843 . . . . 55.22 111.304 173.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 358' ' ' CYS . . . . . . . . . . . . . 47.9 t 69.82 -0.96 2.49 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 124.679 1.192 . . . . 73.32 111.984 -177.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 359' ' ' GLY . . . . . . . . . . . . . . . 66.98 -95.53 0.28 Allowed Glycine 0 C--N 1.353 1.507 0 N-CA-C 109.892 -1.283 . . . . 62.01 109.892 -166.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 360' ' ' GLN . . . . . 0.407 ' HA ' ' NE2' ' B' ' 313' ' ' GLN . 8.6 tt0 55.64 -80.16 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 126.322 1.849 . . . . 53.34 113.239 167.317 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 361' ' ' ILE . . . . . 0.672 ' HB ' ' HB3' ' B' ' 41' ' ' PRO . 2.8 pp -72.22 -20.56 20.04 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 125.107 1.363 . . . . 61.31 111.905 -175.54 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 362' ' ' GLY . . . . . . . . . . . . . . . -70.72 -17.21 74.82 Favored Glycine 0 C--N 1.354 1.562 0 O-C-N 123.76 0.663 . . . . 72.35 113.224 178.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 363' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -81.98 -16.25 51.02 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.551 0.74 . . . . 73.13 111.439 -178.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 364' ' ' THR . . . . . . . . . . . . . 17.3 p -126.17 118.31 24.94 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.847 0.859 . . . . 74.04 111.181 -177.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 3.0 m -123.54 84.22 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 N-CA-C 107.598 -1.26 . . . . 74.01 107.598 168.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -76.46 -37.11 57.42 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 115.285 -0.871 . . . . 50.12 112.499 -162.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 367' ' ' LEU . . . . . 0.562 ' HA ' HD13 ' B' ' 38' ' ' ILE . 3.1 tt 61.85 73.51 0.47 Allowed 'General case' 0 CA--C 1.553 1.08 0 N-CA-C 108.343 -0.984 . . . . 75.05 108.343 -171.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 368' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -107.69 -72.18 0.73 Allowed 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 116.085 -0.507 . . . . 71.23 111.975 -171.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 369' ' ' GLU . . . . . 0.543 ' HG2' ' HB3' ' B' ' 308' ' ' CYS . 0.3 OUTLIER -55.97 134.87 52.55 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.684 1.194 . . . . 70.1 111.241 -164.497 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 370' ' ' ALA . . . . . 0.539 ' HA ' HD22 ' B' ' 11' ' ' LEU . . . -153.3 40.61 0.53 Allowed 'General case' 0 CA--C 1.557 1.231 0 N-CA-C 113.11 0.782 . . . . 74.25 113.11 -170.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 371' ' ' VAL . . . . . . . . . . . . . 9.9 p -144.79 -25.83 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.575 -0.703 . . . . 74.11 112.889 175.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 372' ' ' GLN . . . . . 0.403 ' HG2' ' N ' ' B' ' 373' ' ' ARG . 55.7 tt0 -112.21 175.55 5.39 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.174 0.99 . . . . 63.2 110.176 -173.055 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 373' ' ' ARG . . . . . 0.469 ' HD3' ' HB ' ' B' ' 306' ' ' VAL . 33.2 mtm180 89.15 122.09 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 126.525 1.93 . . . . 72.05 112.278 170.089 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 374' ' ' ALA . . . . . 0.471 ' HB1' HG11 ' A' ' 177' ' ' VAL . . . 61.2 121.43 0.01 OUTLIER 'General case' 0 C--N 1.359 1.007 0 C-N-CA 126.088 1.755 . . . . 71.45 113.71 163.431 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 375' ' ' LEU . . . . . 0.462 ' HA ' ' HA ' ' B' ' 378' ' ' ALA . 85.5 mt 70.43 15.07 7.34 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.891 1.276 . . . . 62.01 112.338 -178.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.84 -29.77 66.0 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.246 0.618 . . . . 73.13 109.605 171.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 377' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -103.92 -25.91 12.86 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.22 1.008 . . . . 73.31 110.579 167.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 378' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' B' ' 375' ' ' LEU . . . 74.95 -166.01 0.08 Allowed 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 124.972 1.309 . . . . 61.1 112.688 172.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? 71.39 109.28 0.06 Allowed 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 125.469 1.508 . . . . 72.01 111.191 -173.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 380' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -157.04 -56.34 0.08 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.013 0.925 . . . . 53.14 108.815 176.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 381' ' ' GLU . . . . . 0.404 ' HG3' ' HG2' ' B' ' 415' ' ' LYS . 14.8 tt0 -74.64 113.85 12.38 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.624 -0.716 . . . . 74.34 109.639 176.182 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -74.27 -46.21 21.8 Favored Glycine 0 C--N 1.342 0.906 0 N-CA-C 110.637 -0.985 . . . . 73.1 110.637 168.145 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 383' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -168.18 -179.07 3.9 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.817 1.247 . . . . 73.1 108.696 176.128 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 384' ' ' THR . . . . . . . . . . . . . 14.4 t -119.61 11.66 12.08 Favored 'General case' 0 CA--C 1.558 1.269 0 C-N-CA 123.313 0.645 . . . . 63.41 111.296 -175.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 5.0 mp -101.25 -73.4 0.65 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.588 0.755 . . . . 75.12 109.096 -178.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 386' ' ' VAL . . . . . . . . . . . . . 2.5 m -139.41 116.77 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.023 1.329 . . . . 62.42 108.037 175.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 387' ' ' ILE . . . . . 0.666 HG21 ' HA ' ' B' ' 414' ' ' THR . 8.6 tp -83.21 -155.55 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.572 1.805 0 C-N-CA 123.783 0.833 . . . . 74.12 110.622 -174.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 388' ' ' VAL . . . . . 0.621 ' H ' HG13 ' B' ' 387' ' ' ILE . 19.2 t 72.26 2.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 C-N-CA 125.507 1.523 . . . . 54.33 110.502 -174.354 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 389' ' ' THR . . . . . . . . . . . . . 8.1 m -66.6 -36.41 82.55 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.648 1.179 . . . . 71.25 110.421 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . -84.55 114.86 22.27 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 124.117 0.967 . . . . 70.34 110.018 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 391' ' ' ASP . . . . . . . . . . . . . 32.0 t70 65.29 -102.6 0.09 Allowed 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 124.71 1.204 . . . . 64.12 111.943 173.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 392' ' ' HIS . . . . . 0.455 ' H ' ' H ' ' B' ' 393' ' ' ALA . 48.3 p-80 171.56 10.36 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 125.852 1.661 . . . . 72.42 109.624 -173.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 393' ' ' ALA . . . . . 0.455 ' H ' ' H ' ' B' ' 392' ' ' HIS . . . 65.15 78.73 0.27 Allowed 'General case' 0 C--N 1.363 1.155 0 C-N-CA 124.98 1.312 . . . . 61.53 111.33 -174.25 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -135.89 170.14 16.47 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.218 -1.031 . . . . 73.31 108.218 168.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . 65.57 15.31 9.98 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.812 0.845 . . . . 71.44 111.827 -178.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 29.8 t -78.51 85.0 4.61 Favored 'General case' 0 C--N 1.348 0.529 0 N-CA-C 107.2 -1.407 . . . . 75.55 107.2 171.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 397' ' ' GLN . . . . . 0.44 ' HB2' ' OH ' ' A' ' 194' ' ' TYR . 2.7 mp0 57.62 -148.88 0.47 Allowed 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 124.297 1.039 . . . . 71.41 110.778 178.141 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 398' ' ' ILE . . . . . 0.408 ' H ' ' HB3' ' B' ' 397' ' ' GLN . 2.9 pt 68.72 155.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 C-N-CA 126.767 2.027 . . . . 75.44 114.0 168.408 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 399' ' ' VAL . . . . . . . . . . . . . 53.6 t 68.43 155.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 C-N-CA 125.177 1.391 . . . . 73.32 111.778 177.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 400' ' ' ALA . . . . . . . . . . . . . . . 74.62 172.29 0.1 OUTLIER Pre-proline 0 N--CA 1.48 1.027 0 C-N-CA 125.326 1.451 . . . . 51.41 110.348 -177.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 401' ' ' PRO . . . . . 0.479 ' HG2' ' HG2' ' C' ' 184' ' ' PRO . 41.2 Cg_exo -44.19 119.98 2.33 Favored 'Trans proline' 0 C--N 1.384 2.405 0 C-N-CA 122.472 2.114 . . . . 71.04 112.673 167.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 22.5 p-10 -82.16 11.35 5.38 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.824 1.25 . . . . 74.34 111.561 -178.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 403' ' ' THR . . . . . . . . . . . . . 34.0 p -115.98 2.58 13.51 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.734 1.614 . . . . 51.3 111.099 -172.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 404' ' ' LYS . . . . . . . . . . . . . 52.6 tttm -168.86 103.71 0.4 Allowed 'General case' 0 C--N 1.355 0.821 0 C-N-CA 122.904 0.481 . . . . 70.03 110.387 176.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 405' ' ' ALA . . . . . 0.464 ' H ' ' HB3' ' B' ' 123' ' ' ASP . . . -177.17 124.18 0.28 Allowed Pre-proline 0 N--CA 1.476 0.829 0 C-N-CA 124.954 1.302 . . . . 71.24 108.529 171.105 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 406' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -65.74 86.49 0.22 Allowed 'Trans proline' 0 C--N 1.383 2.376 0 C-N-CA 122.719 2.279 . . . . 44.44 112.241 177.031 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . -124.75 -93.95 1.01 Allowed Glycine 0 C--N 1.348 1.208 0 N-CA-C 109.41 -1.476 . . . . 55.33 109.41 174.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 408' ' ' LEU . . . . . . . . . . . . . 5.8 mp 61.47 -90.12 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.6 1.16 . . . . 72.03 111.067 174.306 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 77.9 m -83.65 151.93 25.04 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.761 0.824 . . . . 73.52 109.173 178.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 410' ' ' GLN . . . . . 0.404 ' HA ' ' HG3' ' A' ' 189' ' ' GLU . 10.1 mm100 70.72 153.69 0.12 Allowed 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 125.049 1.34 . . . . 51.32 112.361 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 411' ' ' ALA . . . . . 0.736 ' HB2' HH22 ' A' ' 187' ' ' ARG . . . -141.3 -87.58 0.17 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.189 -0.914 . . . . 63.14 108.774 178.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 43.0 tp 174.68 139.75 0.05 OUTLIER 'General case' 0 C--N 1.359 1.0 0 C-N-CA 124.57 1.148 . . . . 60.41 109.736 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 17.2 t30 72.88 164.17 0.28 Allowed 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.735 1.214 . . . . 71.14 113.944 163.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 414' ' ' THR . . . . . 0.666 ' HA ' HG21 ' B' ' 387' ' ' ILE . 11.8 m 82.91 124.32 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 126.956 2.102 . . . . 73.24 112.865 172.066 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 415' ' ' LYS . . . . . 0.443 ' HE3' ' O ' ' A' ' 158' ' ' VAL . 22.1 tptm -130.68 -54.12 1.07 Allowed 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.208 1.403 . . . . 73.42 108.762 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -88.16 -178.13 5.87 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.754 0.822 . . . . 75.33 109.971 174.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 417' ' ' GLY . . . . . . . . . . . . . . . -151.84 174.11 30.96 Favored Glycine 0 C--N 1.346 1.084 0 C-N-CA 121.899 -0.191 . . . . 43.15 113.063 -176.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 418' ' ' ALA . . . . . . . . . . . . . . . -97.6 175.46 6.19 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.448 1.099 . . . . 70.25 110.462 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 419' ' ' VAL . . . . . . . . . . . . . 68.9 t -77.5 108.86 11.36 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 C-N-CA 123.322 0.649 . . . . 62.03 109.846 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 420' ' ' MET . . . . . 0.543 ' HG3' ' H ' ' B' ' 421' ' ' VAL . 23.2 ptm 46.31 -79.11 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 127.267 2.227 . . . . 73.12 114.678 177.091 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 421' ' ' VAL . . . . . 0.543 ' H ' ' HG3' ' B' ' 420' ' ' MET . 27.2 m -119.36 -38.02 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 123.702 0.801 . . . . 72.42 110.9 -176.269 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 422' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER 61.89 -72.64 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 125.682 1.593 . . . . 74.1 111.708 -174.383 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 423' ' ' SER . . . . . . . . . . . . . 38.0 m -82.48 111.35 18.42 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.871 0.868 . . . . 62.22 110.876 -178.029 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 424' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 62.07 -161.48 0.29 Allowed 'General case' 0 N--CA 1.477 0.878 0 O-C-N 124.36 1.038 . . . . 72.42 112.525 170.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . 157.1 -84.94 0.13 Allowed Glycine 0 C--N 1.338 0.684 0 N-CA-C 109.593 -1.403 . . . . 75.12 109.593 173.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 426' ' ' ASN . . . . . 0.835 ' HB2' ' HB2' ' B' ' 432' ' ' GLN . 0.0 OUTLIER -173.28 102.57 0.12 Allowed 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 107.819 -1.178 . . . . 75.43 107.819 -179.89 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 427' ' ' SER . . . . . . . . . . . . . 44.0 m 62.54 20.05 11.68 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 124.237 1.015 . . . . 75.14 110.552 -167.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 50.93 25.99 2.46 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 125.024 1.33 . . . . 73.23 112.061 -168.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 429' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -149.57 -90.39 0.07 Allowed 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 109.082 -0.71 . . . . 63.42 109.082 -176.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -168.82 -171.22 1.32 Allowed 'General case' 0 CA--C 1.555 1.155 0 N-CA-C 109.141 -0.689 . . . . 55.41 109.141 -171.11 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 28.4 t 80.95 -1.83 1.79 Allowed 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 125.37 1.468 . . . . 73.31 113.249 168.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 432' ' ' GLN . . . . . 0.835 ' HB2' ' HB2' ' B' ' 426' ' ' ASN . 14.7 mm100 -101.89 -47.84 4.46 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 118.418 0.554 . . . . 71.1 110.033 173.486 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 433' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 64.79 -80.25 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.681 1.192 . . . . 73.43 110.116 -176.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 434' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -78.26 81.43 4.62 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 107.733 -1.21 . . . . 65.13 107.733 167.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 435' ' ' THR . . . . . . . . . . . . . 3.1 t -68.41 -48.82 63.67 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.02 -0.991 . . . . 73.42 109.652 175.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . 56.9 16.61 18.55 Favored Glycine 0 C--N 1.356 1.671 0 N-CA-C 114.503 0.561 . . . . 43.54 114.503 175.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 37.5 p -71.65 -44.01 65.08 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 123.987 0.915 . . . . 54.14 110.396 -176.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 438' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -152.71 -81.46 0.09 Allowed 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.916 -1.038 . . . . 71.55 109.554 -174.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 439' ' ' LEU . . . . . . . . . . . . . 5.9 mp 53.62 -85.27 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.955 0.902 . . . . 74.24 109.121 -164.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 440' ' ' ARG . . . . . . . . . . . . . 18.4 mmt180 65.73 171.66 0.22 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 124.967 1.307 . . . . 70.1 113.148 172.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 441' ' ' ILE . . . . . 0.672 ' HA ' ' HB3' ' A' ' 235' ' ' LEU . 27.5 mt -114.72 121.96 67.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 114.842 -1.072 . . . . 74.15 109.802 179.249 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 442' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' B' ' 458' ' ' THR . . . -60.9 -39.6 89.94 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.746 0.818 . . . . 71.41 110.7 178.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . -73.54 142.16 46.69 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.378 0.671 . . . . 74.21 110.7 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 444' ' ' TYR . . . . . 0.565 ' HB3' ' ND2' ' B' ' 450' ' ' ASN . 84.0 m-85 64.43 -86.11 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.311 1.044 . . . . 65.34 110.97 175.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . 64.23 -136.26 39.99 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-O 119.462 -0.632 . . . . 74.34 112.671 -176.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 446' ' ' PRO . . . . . 0.54 ' HD3' ' HA ' ' B' ' 459' ' ' ASP . 71.9 Cg_endo -99.71 47.94 0.06 OUTLIER 'Trans proline' 0 CA--C 1.555 1.554 0 C-N-CA 123.309 2.673 . . . . 63.02 112.089 168.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 447' ' ' HIS . . . . . . . . . . . . . 70.5 t60 -77.49 76.76 4.02 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.522 0.729 . . . . 60.0 111.13 -175.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . 65.33 -77.59 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.085 1.354 . . . . 74.31 112.009 177.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 449' ' ' ALA . . . . . . . . . . . . . . . -142.83 7.43 1.65 Allowed 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.729 0.812 . . . . 61.52 111.422 178.169 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 450' ' ' ASN . . . . . 0.565 ' ND2' ' HB3' ' B' ' 444' ' ' TYR . 5.4 m-20 55.5 17.07 2.08 Favored 'General case' 0 N--CA 1.502 2.125 0 C-N-CA 125.331 1.453 . . . . 61.12 114.5 173.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 65.0 t -69.37 96.05 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 122.934 0.494 . . . . 63.1 109.943 -174.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 452' ' ' VAL . . . . . . . . . . . . . 7.1 t 62.32 25.71 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.564 1.482 0 C-N-CA 125.2 1.4 . . . . 60.45 109.942 -177.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . -91.13 68.54 2.21 Favored Glycine 0 C--N 1.35 1.327 0 CA-C-N 115.456 -0.793 . . . . 73.44 113.348 -170.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 454' ' ' LEU . . . . . . . . . . . . . 2.2 tt -78.15 70.82 4.57 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.068 -1.086 . . . . 72.5 108.068 175.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 55.8 p -127.47 144.26 51.09 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 124.508 1.123 . . . . 61.41 109.917 -171.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -77.49 82.94 3.91 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.632 0.773 . . . . 74.3 110.07 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 457' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -101.78 -29.57 11.8 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.07 1.348 . . . . 42.14 110.957 -179.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 458' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' B' ' 442' ' ' ALA . 62.2 m 71.64 120.98 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.675 1.59 . . . . 72.13 110.837 -174.304 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 459' ' ' ASP . . . . . 0.54 ' HA ' ' HD3' ' B' ' 446' ' ' PRO . 34.7 t70 -68.97 138.66 54.75 Favored 'General case' 0 C--N 1.352 0.704 0 C-N-CA 123.189 0.595 . . . . 73.31 111.321 -175.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 30.6 tp -123.71 -12.01 7.67 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.387 1.075 . . . . 65.42 108.73 176.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 72.5 t80 55.04 88.57 0.04 OUTLIER 'General case' 0 C--N 1.36 1.063 0 C-N-CA 125.227 1.411 . . . . 62.31 111.102 -172.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -110.68 -14.48 14.03 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 115.313 -0.858 . . . . 72.53 110.397 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 26.0 m -78.26 92.81 4.54 Favored 'General case' 0 C--N 1.35 0.621 0 CA-C-O 121.676 0.75 . . . . 61.35 110.5 -175.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 464' ' ' MET . . . . . . . . . . . . . 19.2 ptp -147.02 20.71 1.25 Allowed 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 114.33 -1.304 . . . . 75.31 109.308 177.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -149.4 146.59 27.55 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 124.597 1.159 . . . . 72.15 109.589 -174.423 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -90.31 1.61 56.36 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.77 0.828 . . . . 62.32 110.663 173.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . 67.74 -76.61 0.05 Allowed 'General case' 0 C--N 1.368 1.374 0 C-N-CA 125.709 1.604 . . . . 75.3 111.399 176.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 5.0 tt -78.08 -26.74 48.33 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 124.119 0.967 . . . . 45.51 109.494 178.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 469' ' ' GLY . . . . . 0.404 ' N ' ' HB3' ' C' ' 263' ' ' PRO . . . -85.55 66.65 3.74 Favored Glycine 0 C--N 1.349 1.274 0 CA-C-N 116.086 -0.506 . . . . 50.44 113.449 -176.596 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 470' ' ' LEU . . . . . . . . . . . . . 3.2 pp -131.29 -6.58 3.8 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.433 0.693 . . . . 73.2 111.249 175.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 471' ' ' LYS . . . . . . . . . . . . . 61.5 tttp . . . . . 0 C--O 1.252 1.186 0 N-CA-C 108.907 -0.775 . . . . 74.2 108.907 -175.643 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 67.2 mtt . . . . . 0 N--CA 1.479 1.001 0 N-CA-C 109.315 -0.624 . . . . 55.23 109.315 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.03 24.08 12.3 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.368 1.467 . . . . 65.31 112.885 178.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.0 76.56 3.55 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.262 0.625 . . . . 52.01 110.257 -178.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 5.0 ttmp? -38.33 99.43 0.02 OUTLIER 'General case' 0 C--N 1.364 1.2 0 C-N-CA 124.691 1.196 . . . . 70.52 113.536 -176.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 5' ' ' LYS . . . . . 0.453 ' HG3' ' OG ' ' C' ' 94' ' ' SER . 1.3 mmmp? -67.64 96.87 0.57 Allowed 'General case' 0 C--O 1.241 0.651 0 N-CA-C 107.319 -1.363 . . . . 63.2 107.319 165.497 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 6' ' ' ASP . . . . . 0.481 ' HA ' ' OH ' ' C' ' 66' ' ' TYR . 38.4 t70 -70.42 96.56 1.16 Allowed 'General case' 0 C--N 1.348 0.539 0 N-CA-C 108.453 -0.943 . . . . 63.22 108.453 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 7' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -58.36 -34.32 70.54 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 113.835 -1.53 . . . . 73.43 111.737 -173.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -62.0 -47.22 85.76 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 115.777 -0.647 . . . . 72.53 110.42 175.031 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.99 -40.32 93.0 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.252 0.621 . . . . 52.31 111.288 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 10' ' ' ILE . . . . . 0.411 HG22 HD13 ' C' ' 50' ' ' ILE . 58.6 mt -60.93 -39.59 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.079 0.552 . . . . 63.34 110.227 176.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 11' ' ' LEU . . . . . 0.417 ' HB2' HG22 ' C' ' 13' ' ' VAL . 87.0 mt -80.26 -6.97 58.77 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 112.785 0.661 . . . . 45.45 112.785 177.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 69.2 31.39 71.85 Favored Glycine 0 C--N 1.353 1.5 0 O-C-N 123.055 0.222 . . . . 64.33 113.189 -178.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 13' ' ' VAL . . . . . 0.417 HG22 ' HB2' ' C' ' 11' ' ' LEU . 26.9 m -126.34 154.67 74.78 Favored Pre-proline 0 N--CA 1.481 1.107 0 C-N-CA 124.932 1.293 . . . . 64.04 109.268 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -80.36 167.56 19.23 Favored 'Trans proline' 0 C--N 1.371 1.743 0 C-N-CA 122.401 2.067 . . . . 74.43 112.754 178.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -72.85 74.29 1.14 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.12 0.968 . . . . 71.52 109.652 173.145 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -178.3 -19.3 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.164 1.386 . . . . 71.24 108.538 -176.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -49.42 112.04 0.58 Allowed 'General case' 0 C--N 1.354 0.782 0 C-N-CA 125.176 1.391 . . . . 71.14 112.345 175.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 77.9 p -73.62 -177.94 2.91 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.011 0.925 . . . . 74.41 111.429 -178.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -51.74 -52.25 50.06 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.307 0.643 . . . . 74.45 111.846 -176.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -67.18 -32.01 72.81 Favored 'General case' 0 C--O 1.206 -1.227 0 CA-C-O 118.679 -0.677 . . . . 64.05 112.107 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -68.92 -40.77 78.87 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 119.014 0.824 . . . . 73.42 110.767 -179.221 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 22' ' ' ILE . . . . . 0.884 HD13 ' HB3' ' C' ' 57' ' ' LEU . 96.6 mt -69.62 -37.77 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.553 1.141 . . . . 61.32 110.199 174.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 23' ' ' LYS . . . . . 0.475 ' O ' ' HG3' ' C' ' 27' ' ' LYS . 10.4 tppt? -65.41 -42.86 92.08 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 114.942 -1.026 . . . . 74.13 109.636 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 24' ' ' ARG . . . . . 0.438 ' HA ' ' HD2' ' C' ' 27' ' ' LYS . 97.3 mtt180 -77.71 -28.23 50.84 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 124.607 1.163 . . . . 73.52 110.669 -177.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.72 -43.65 95.9 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 123.895 0.747 . . . . 75.32 109.065 172.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 26' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -65.08 -45.36 85.55 Favored 'General case' 0 C--O 1.213 -0.818 0 CA-C-N 114.939 -1.028 . . . . 72.31 110.886 176.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 27' ' ' LYS . . . . . 0.491 ' HE2' ' HA ' ' B' ' 196' ' ' THR . 83.9 mttt -55.57 -46.19 77.22 Favored 'General case' 0 N--CA 1.502 2.14 0 C-N-CA 123.824 0.85 . . . . 74.1 110.143 178.569 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 25.0 ttm180 -56.07 -56.58 19.1 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 114.338 -1.301 . . . . 71.15 110.203 178.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 29' ' ' LEU . . . . . 0.622 HD13 HD12 ' C' ' 50' ' ' ILE . 66.1 mt -80.46 -9.61 59.76 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 114.543 -1.208 . . . . 60.22 111.636 -172.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.77 -27.52 26.83 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.702 0.801 . . . . 75.32 110.248 173.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 81.9 mtm180 -90.9 -21.71 21.26 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 123.56 0.537 . . . . 73.5 111.107 171.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -82.55 -55.67 4.33 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.363 0.665 . . . . 71.12 110.187 -178.355 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -89.63 17.08 6.8 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.221 0.609 . . . . 70.15 110.984 178.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 34' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -47.14 94.8 0.08 OUTLIER Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 125.151 1.38 . . . . 72.34 112.365 -169.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -75.35 -8.87 20.02 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 123.313 2.675 . . . . 71.32 112.817 -164.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -65.05 -41.32 95.26 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.62 1.168 . . . . 60.34 110.107 171.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 88.5 t -97.06 -48.11 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 115.683 -0.69 . . . . 75.33 109.868 -178.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -97.0 75.02 2.62 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 108.152 -1.055 . . . . 54.22 108.152 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 10.5 mtmp? -75.8 75.83 2.75 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 114.377 -1.283 . . . . 62.24 109.247 177.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 49.7 m -139.42 132.72 15.59 Favored Pre-proline 0 C--O 1.245 0.831 0 CA-C-N 115.027 -0.988 . . . . 74.14 109.847 -176.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 41' ' ' PRO . . . . . 0.548 ' HA ' ' HB2' ' C' ' 44' ' ' GLU . 81.7 Cg_exo -47.37 -33.16 16.22 Favored 'Trans proline' 0 C--N 1.389 2.709 0 C-N-CA 124.049 3.166 . . . . 63.44 113.059 174.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -45.17 -59.62 2.54 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.418 1.087 . . . . 65.44 110.494 171.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.6 -7.93 59.65 Favored 'General case' 0 C--O 1.211 -0.923 0 CA-C-N 114.339 -1.301 . . . . 62.05 110.646 -177.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 44' ' ' GLU . . . . . 0.548 ' HB2' ' HA ' ' C' ' 41' ' ' PRO . 22.0 mm-40 -78.26 -60.57 2.32 Favored 'General case' 0 C--O 1.213 -0.825 0 N-CA-C 108.422 -0.955 . . . . 74.04 108.422 175.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -53.28 -47.89 68.79 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.147 0.979 . . . . 42.53 110.925 176.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 46' ' ' LYS . . . . . 0.509 ' O ' HG12 ' C' ' 50' ' ' ILE . 49.4 mttp -65.48 -52.28 53.99 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.301 -0.863 . . . . 72.32 112.32 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -68.98 -23.1 64.08 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 118.511 0.596 . . . . 62.23 111.624 -178.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 48' ' ' LYS . . . . . 0.436 ' HD3' ' O ' ' C' ' 44' ' ' GLU . 13.1 mptt -75.85 -35.89 59.78 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 122.59 0.356 . . . . 72.04 110.27 177.174 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -67.28 -33.23 74.87 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 117.763 0.256 . . . . 72.33 110.351 170.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 50' ' ' ILE . . . . . 0.622 HD12 HD13 ' C' ' 29' ' ' LEU . 22.8 mm -66.34 -38.88 82.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 N-CA-C 109.538 -0.542 . . . . 75.43 109.538 173.523 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 51' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -65.3 -42.29 93.2 Favored 'General case' 0 C--O 1.204 -1.335 0 C-N-CA 123.637 0.775 . . . . 74.04 110.08 178.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -61.82 -52.73 62.97 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.329 1.052 . . . . 63.42 110.097 177.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.13 -56.56 19.41 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-N 113.582 -1.644 . . . . 63.1 111.571 -176.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -64.51 -35.82 82.2 Favored 'General case' 0 C--O 1.204 -1.318 0 CA-C-N 114.19 -1.368 . . . . 75.01 111.226 177.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.78 -39.72 92.66 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 118.779 0.718 . . . . 60.54 111.747 -176.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 78.8 t -72.94 -50.34 33.27 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 O-C-N 123.597 0.56 . . . . 72.43 109.715 174.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 57' ' ' LEU . . . . . 0.884 ' HB3' HD13 ' C' ' 22' ' ' ILE . 60.9 mt -88.12 1.43 54.36 Favored 'General case' 0 CA--C 1.56 1.362 0 N-CA-C 114.582 1.327 . . . . 75.02 114.582 -168.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 41.5 t -55.8 -38.08 69.47 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 124.599 1.16 . . . . 62.42 112.719 -173.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -121.41 137.91 27.54 Favored Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 107.409 -1.33 . . . . 72.03 107.409 -168.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 60' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -48.9 -36.64 34.75 Favored 'Trans proline' 0 C--N 1.381 2.261 0 C-N-CA 123.839 3.026 . . . . 33.23 113.441 -177.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -58.12 -66.76 0.43 Allowed 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 114.261 -1.336 . . . . 62.13 111.398 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 1.8 mtpm? -72.4 -23.31 61.08 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.54 0.736 . . . . 75.23 111.7 -174.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 -57.24 -50.13 73.85 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.276 -0.874 . . . . 64.42 109.153 169.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 64' ' ' ARG . . . . . 0.514 ' HA ' ' HB2' ' C' ' 67' ' ' ASP . 27.4 mmt180 -72.7 -21.81 60.99 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.636 -0.711 . . . . 74.15 112.117 178.701 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 1.6 mp -58.86 -46.92 90.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-N 118.556 0.616 . . . . 62.34 109.417 167.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 66' ' ' TYR . . . . . 0.481 ' OH ' ' HA ' ' C' ' 6' ' ' ASP . 37.0 t80 -62.41 -51.41 67.65 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 115.78 -0.646 . . . . 74.22 110.52 174.607 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 67' ' ' ASP . . . . . 0.514 ' HB2' ' HA ' ' C' ' 64' ' ' ARG . 27.4 m-20 -59.83 -31.14 69.46 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.704 0.802 . . . . 73.14 112.021 -176.619 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 39.9 p -81.31 -26.93 35.26 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 119.269 -0.396 . . . . 63.2 110.986 176.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 69' ' ' TYR . . . . . 0.402 ' HE2' ' HE1' ' C' ' 96' ' ' PHE . 71.2 t80 -72.6 133.52 44.73 Favored 'General case' 0 C--N 1.359 1.019 0 N-CA-C 108.518 -0.919 . . . . 75.22 108.518 173.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.46 16.94 41.11 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.286 -0.726 . . . . 62.51 111.286 -164.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 63.1 m -146.76 -61.42 0.3 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 103.497 -2.779 . . . . 72.34 103.497 172.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 28.3 m -76.5 142.08 41.04 Favored 'General case' 0 C--O 1.25 1.099 0 N-CA-C 104.997 -2.223 . . . . 73.35 104.997 157.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.46 -10.74 8.39 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.342 0.657 . . . . 73.23 110.82 177.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -77.5 138.61 63.26 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 123.242 0.617 . . . . 53.23 109.529 171.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -63.16 136.66 57.2 Favored 'Trans proline' 0 C--N 1.373 1.836 0 C-N-CA 122.602 2.201 . . . . 75.14 111.808 174.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.04 159.37 53.31 Favored 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 123.323 2.682 . . . . 63.14 112.229 -178.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -59.51 116.38 3.25 Favored 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 122.693 2.262 . . . . 51.51 112.637 174.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 78' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -68.48 136.5 36.8 Favored 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 122.675 2.25 . . . . 74.44 111.82 175.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 79' ' ' PRO . . . . . 0.621 ' HB3' ' HA3' ' C' ' 142' ' ' GLY . 38.5 Cg_exo -45.77 159.46 0.21 Allowed 'Trans proline' 0 CA--C 1.567 2.134 0 C-N-CA 123.955 3.103 . . . . 61.04 114.303 166.27 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -66.02 84.21 0.25 Allowed 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 123.075 2.516 . . . . 51.5 111.892 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 146.67 -28.19 1.62 Allowed Glycine 0 C--N 1.336 0.567 0 CA-C-N 114.668 -1.151 . . . . 75.2 110.799 -178.149 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 146.93 173.77 18.43 Favored Glycine 0 C--N 1.344 1.026 0 C-N-CA 123.857 0.741 . . . . 74.45 112.004 172.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 83' ' ' TYR . . . . . 0.478 ' HA ' ' HD2' ' C' ' 79' ' ' PRO . 76.5 m-85 -52.05 120.34 5.29 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.009 0.924 . . . . 70.14 110.591 176.535 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 84' ' ' ASP . . . . . 0.604 ' HB2' ' HG2' ' C' ' 79' ' ' PRO . 44.3 t0 -60.65 124.83 21.55 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 124.502 1.126 . . . . 63.13 110.385 -176.251 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 85' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -169.34 17.94 0.02 OUTLIER 'General case' 0 C--O 1.257 1.492 0 CA-C-N 114.185 -1.37 . . . . 74.41 107.493 -167.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 19.6 m -59.08 116.44 3.84 Favored 'General case' 0 C--N 1.361 1.09 0 CA-C-N 113.755 -1.566 . . . . 45.43 110.781 -166.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 87' ' ' GLY . . . . . 0.504 ' HA2' ' HA ' ' C' ' 171' ' ' PRO . . . 124.1 -20.57 7.1 Favored Glycine 0 C--N 1.342 0.867 0 O-C-N 123.732 0.645 . . . . 74.33 112.936 179.229 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 88' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -123.32 131.96 53.84 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 117.599 0.7 . . . . 74.44 111.804 -169.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -75.42 86.16 2.56 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.553 0.741 . . . . 72.23 111.154 -171.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 90' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -39.8 -43.72 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 C-N-CA 125.901 1.68 . . . . 54.41 114.74 174.228 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -65.07 -18.52 65.37 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.327 0.651 . . . . 74.21 112.149 -174.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -79.3 -30.44 42.89 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 122.848 0.459 . . . . 75.53 110.693 177.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -85.47 174.64 9.36 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.484 0.714 . . . . 72.45 112.908 -164.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 94' ' ' SER . . . . . 0.453 ' OG ' ' HG3' ' C' ' 5' ' ' LYS . 93.7 p -78.88 178.24 8.11 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 114.363 1.246 . . . . 45.51 114.363 -163.184 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -62.61 -54.02 45.91 Favored 'General case' 0 C--N 1.355 0.818 0 CA-C-N 113.888 -1.505 . . . . 55.43 111.2 -176.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 96' ' ' PHE . . . . . 0.402 ' HE1' ' HE2' ' C' ' 69' ' ' TYR . 48.6 t80 -48.44 -50.19 32.28 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 123.629 0.772 . . . . 65.02 111.626 -176.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 97' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -60.14 -52.01 67.14 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 114.592 -1.186 . . . . 64.25 110.116 175.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 98' ' ' GLN . . . . . 0.632 ' HA ' HD11 ' C' ' 105' ' ' LEU . 73.5 mt-30 -73.13 3.78 5.18 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 112.753 0.649 . . . . 51.52 112.753 -178.354 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -100.47 -54.5 2.83 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.879 0.872 . . . . 74.43 111.796 168.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 28.9 tp -63.84 -44.76 92.19 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.215 0.606 . . . . 73.23 110.809 -176.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 101' ' ' PHE . . . . . 0.458 ' O ' ' HG ' ' C' ' 105' ' ' LEU . 42.3 m-85 -94.78 -5.76 44.53 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.387 -0.824 . . . . 73.25 110.152 177.334 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -42.61 -60.97 2.67 Favored Glycine 0 CA--C 1.541 1.669 0 CA-C-O 118.553 -1.137 . . . . 54.11 115.076 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -41.42 -24.49 0.23 Allowed 'Trans proline' 0 C--N 1.391 2.785 0 C-N-CA 125.05 3.833 . . . . 62.02 116.584 -179.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -149.29 38.92 0.94 Allowed Glycine 0 C--N 1.35 1.352 0 CA-C-O 119.226 -0.763 . . . . 43.23 112.706 -176.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 105' ' ' LEU . . . . . 0.632 HD11 ' HA ' ' C' ' 98' ' ' GLN . 38.5 mt -64.2 80.66 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 114.647 1.351 . . . . 73.03 114.647 176.308 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 106' ' ' PHE . . . . . 0.46 ' HB3' ' H ' ' C' ' 107' ' ' GLY . 0.6 OUTLIER 48.23 -150.79 0.14 Allowed 'General case' 0 CA--C 1.556 1.202 0 N-CA-C 117.158 2.281 . . . . 64.24 117.158 162.893 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 107' ' ' GLY . . . . . 0.46 ' H ' ' HB3' ' C' ' 106' ' ' PHE . . . 93.15 -1.19 69.83 Favored Glycine 0 C--N 1.353 1.494 0 N-CA-C 111.766 -0.534 . . . . 51.05 111.766 -165.333 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 108' ' ' GLY . . . . . 0.408 ' HA2' ' HB3' ' C' ' 167' ' ' GLN . . . 61.76 -136.65 46.61 Favored Glycine 0 C--N 1.35 1.353 0 N-CA-C 111.776 -0.53 . . . . 74.41 111.776 -175.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 109' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -86.62 -0.9 57.11 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.162 0.585 . . . . 74.45 110.61 176.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 110' ' ' GLY . . . . . . . . . . . . . . . -93.98 -28.41 11.02 Favored Glycine 0 C--N 1.356 1.663 0 CA-C-N 116.417 -0.356 . . . . 54.22 112.768 178.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 13.7 mmm180 67.76 -11.49 0.33 Allowed 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 114.477 1.288 . . . . 75.25 114.477 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 112' ' ' ARG . . . . . . . . . . . . . 39.1 ttp180 -78.6 12.96 1.79 Allowed 'General case' 0 CA--C 1.565 1.547 0 C-N-CA 123.988 0.915 . . . . 74.1 112.423 -178.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 113' ' ' SER . . . . . . . . . . . . . 66.4 m 66.6 36.97 4.61 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.743 1.217 . . . . 72.53 112.113 175.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 114' ' ' ARG . . . . . 0.504 ' HG2' ' H ' ' C' ' 115' ' ' LYS . 2.1 ttp180 -70.3 174.35 5.72 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 115.55 -0.75 . . . . 74.05 111.608 -174.428 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 115' ' ' LYS . . . . . 0.635 ' HA ' ' HD2' ' C' ' 170' ' ' PRO . 61.8 tttp -47.1 143.25 3.21 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.336 1.054 . . . . 54.14 110.441 168.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 116' ' ' GLY . . . . . 0.412 ' HA2' ' HA3' ' C' ' 168' ' ' GLY . . . -44.01 124.51 5.23 Favored Glycine 0 C--N 1.359 1.809 0 CA-C-O 118.822 -0.988 . . . . 45.25 110.653 169.113 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 37.8 ttp180 -57.24 101.99 0.08 Allowed 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.401 -0.963 . . . . 64.44 108.401 -177.083 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -47.05 100.55 0.02 OUTLIER 'General case' 0 C--N 1.351 0.653 0 O-C-N 124.739 1.274 . . . . 75.42 107.734 172.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 119' ' ' LEU . . . . . . . . . . . . . 23.3 tp -91.15 119.21 31.07 Favored 'General case' 0 C--N 1.338 0.095 0 CA-C-N 114.466 -1.243 . . . . 75.21 109.441 -161.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.439 ' HD3' ' N ' ' B' ' 188' ' ' ARG . 10.6 mtt180 -112.22 88.56 2.84 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 114.312 -1.313 . . . . 72.31 107.734 -169.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 121' ' ' ALA . . . . . 0.484 ' HB3' HD23 ' C' ' 176' ' ' LEU . . . -109.46 142.38 40.55 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 109.363 -0.606 . . . . 63.21 109.363 -174.494 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -126.97 127.81 45.4 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 107.152 -1.425 . . . . 73.22 107.152 178.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -138.51 147.32 54.6 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 123.249 0.62 . . . . 73.3 110.992 -167.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 124' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' C' ' 179' ' ' ARG . 6.1 Cg_exo -80.78 122.73 4.47 Favored 'Trans proline' 0 C--N 1.368 1.576 0 C-N-CA 123.184 2.59 . . . . 72.51 110.445 166.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 125' ' ' LEU . . . . . 0.463 ' HB3' HG13 ' C' ' 178' ' ' VAL . 18.1 tp -132.23 151.97 51.56 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 108.995 -0.743 . . . . 74.03 108.995 -177.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 126' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -95.04 152.61 18.18 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-O 120.734 0.302 . . . . 61.53 110.47 -178.054 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 127' ' ' LEU . . . . . 0.548 HD13 ' HD2' ' C' ' 186' ' ' PHE . 89.4 mt -60.51 -49.16 78.67 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.272 1.029 . . . . 62.25 111.029 177.504 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 128' ' ' GLU . . . . . 0.502 ' HG2' HD21 ' B' ' 173' ' ' LEU . 22.1 mp0 -66.32 -33.45 75.76 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 115.564 -0.743 . . . . 75.24 110.564 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 129' ' ' GLU . . . . . 0.562 ' HG3' ' HD3' ' B' ' 178' ' ' PRO . 13.5 mm-40 -68.83 -29.09 67.35 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.423 0.689 . . . . 73.53 111.363 176.059 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -75.18 -40.95 59.01 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 109.256 -0.646 . . . . 64.34 109.256 176.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 131' ' ' PHE . . . . . 0.596 ' HB2' HD13 ' C' ' 215' ' ' LEU . 84.6 t80 -55.06 -40.12 69.95 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.044 0.937 . . . . 75.55 110.744 174.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 132' ' ' HIS . . . . . . . . . . . . . 35.4 m170 -64.75 -59.52 4.14 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 115.545 -0.752 . . . . 60.22 109.676 174.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 62.77 -132.59 43.82 Favored Glycine 0 C--N 1.352 1.434 0 CA-C-N 115.719 -0.673 . . . . 65.31 111.925 -176.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 134' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' C' ' 148' ' ' ARG . . . 63.52 -151.65 48.52 Favored Glycine 0 C--N 1.351 1.41 0 O-C-N 123.956 0.445 . . . . 53.24 112.905 175.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -70.82 107.96 4.25 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.268 0.627 . . . . 71.2 109.784 178.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 136' ' ' ARG . . . . . 0.578 ' HB2' HD22 ' B' ' 181' ' ' LEU . 5.6 mmp_? -106.48 145.51 31.72 Favored 'General case' 0 C--O 1.249 1.029 0 C-N-CA 123.942 0.897 . . . . 72.12 109.185 171.503 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 137' ' ' VAL . . . . . 0.514 ' HB ' ' HB1' ' B' ' 180' ' ' ALA . 82.9 t -72.07 106.57 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.175 0.99 . . . . 71.12 110.412 -178.168 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 138' ' ' VAL . . . . . 0.56 ' HB ' HD23 ' B' ' 181' ' ' LEU . 12.1 p -119.54 111.73 34.26 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 CA-C-O 121.534 0.683 . . . . 72.14 110.173 176.695 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 139' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' C' ' 143' ' ' ARG . 1.4 tm-20 -119.32 99.85 6.95 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 106.882 -1.525 . . . . 74.31 106.882 169.289 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 140' ' ' VAL . . . . . . . . . . . . . 7.3 p -139.03 134.83 42.15 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 109.128 -0.693 . . . . 63.22 109.128 -179.097 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 141' ' ' ALA . . . . . 0.589 ' HB1' ' HG2' ' C' ' 167' ' ' GLN . . . 68.7 6.81 5.72 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.759 1.223 . . . . 15.23 112.713 -179.176 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 142' ' ' GLY . . . . . 0.621 ' HA3' ' HB3' ' C' ' 79' ' ' PRO . . . 105.49 -8.1 43.64 Favored Glycine 0 C--N 1.349 1.304 0 N-CA-C 112.611 -0.196 . . . . 45.25 112.611 -176.55 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 143' ' ' ARG . . . . . 0.459 ' O ' ' HA ' ' C' ' 139' ' ' GLU . 23.9 ttt85 -86.42 104.21 15.7 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.403 0.681 . . . . 73.04 110.615 179.249 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 39.8 ttt180 -98.18 107.76 20.31 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.684 0.794 . . . . 71.51 109.9 177.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 145' ' ' VAL . . . . . . . . . . . . . 7.2 p -150.94 157.14 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 123.914 0.886 . . . . 75.03 109.787 177.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 41.3 m -100.83 105.1 16.37 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.106 -1.072 . . . . 54.21 108.106 168.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 147' ' ' VAL . . . . . 0.477 HG21 HG13 ' C' ' 161' ' ' VAL . 7.6 p -104.67 146.26 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 N-CA-C 110.311 -0.255 . . . . 72.53 110.311 -173.173 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 148' ' ' ARG . . . . . 0.501 ' HD3' ' O ' ' B' ' 106' ' ' TYR . 12.6 ttm180 -85.78 109.73 18.86 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 116.224 -0.444 . . . . 74.22 110.318 177.033 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 149' ' ' ILE . . . . . . . . . . . . . 31.3 pt -91.99 150.08 39.94 Favored Pre-proline 0 C--O 1.245 0.846 0 CA-C-N 114.971 -1.013 . . . . 71.41 108.334 169.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 150' ' ' PRO . . . . . 0.513 ' HD2' HG23 ' C' ' 159' ' ' ILE . 19.3 Cg_endo -56.04 125.76 20.13 Favored 'Trans proline' 0 C--N 1.383 2.359 0 C-N-CA 122.744 2.296 . . . . 61.44 110.974 178.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 151' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' C' ' 150' ' ' PRO . 46.8 Cg_exo -57.07 93.77 0.05 OUTLIER 'Trans proline' 0 C--N 1.383 2.346 0 C-N-CA 123.187 2.592 . . . . 73.2 111.971 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 152' ' ' GLY . . . . . . . . . . . . . . . 114.25 131.44 5.21 Favored Glycine 0 C--N 1.342 0.9 0 CA-C-N 115.259 -0.882 . . . . 54.32 112.633 -174.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 p -145.66 158.95 12.5 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.11 0 C-N-CA 123.694 0.797 . . . . 71.13 110.664 -177.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 154' ' ' ARG . . . . . . . . . . . . . 16.7 mtt85 -101.98 153.19 20.11 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 124.399 1.08 . . . . 75.32 110.335 -173.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 155' ' ' GLU . . . . . 0.432 ' HB2' HD12 ' C' ' 180' ' ' LEU . 12.7 tp10 -65.59 127.25 31.14 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.891 0.877 . . . . 74.51 110.372 169.515 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 76.18 6.08 82.4 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-N 115.576 -0.738 . . . . 64.51 114.566 178.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 157' ' ' SER . . . . . . . . . . . . . 26.7 t -107.38 156.41 18.96 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 117.337 0.569 . . . . 75.43 111.229 -175.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 158' ' ' VAL . . . . . 0.406 ' HB ' ' HB3' ' C' ' 175' ' ' LEU . 18.4 m -93.31 134.25 31.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-N 114.83 -1.077 . . . . 64.44 111.772 -176.535 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 159' ' ' ILE . . . . . 0.564 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 80.9 mt -86.88 132.04 33.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 C-N-CA 124.187 0.995 . . . . 52.25 108.53 166.331 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 160' ' ' ARG . . . . . 0.454 ' NH1' HD13 ' B' ' 111' ' ' LEU . 21.3 ttm180 -82.49 99.97 9.8 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 109.084 -0.71 . . . . 72.21 109.084 171.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 161' ' ' VAL . . . . . 0.477 HG13 HG21 ' C' ' 147' ' ' VAL . 63.5 t -96.24 95.37 1.96 Allowed Pre-proline 0 CA--C 1.548 0.866 0 N-CA-C 106.432 -1.692 . . . . 75.24 106.432 169.016 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 162' ' ' PRO . . . . . 0.534 ' HB2' ' H ' ' B' ' 194' ' ' SER . 26.9 Cg_endo -94.86 165.68 1.7 Allowed 'Trans proline' 0 C--N 1.361 1.232 0 C-N-CA 123.05 2.5 . . . . 63.42 115.226 -162.431 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 65.83 13.41 59.18 Favored Glycine 0 C--N 1.345 1.044 0 CA-C-N 114.114 -1.403 . . . . 53.31 114.829 172.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 164' ' ' MET . . . . . 0.432 ' SD ' ' NH2' ' C' ' 143' ' ' ARG . 35.1 mtm -136.81 -88.68 0.29 Allowed 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 117.468 0.634 . . . . 73.35 110.067 -175.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . 79.85 -152.56 35.24 Favored Glycine 0 C--N 1.351 1.412 0 CA-C-N 116.762 -0.199 . . . . 64.24 113.369 -172.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . -98.77 -159.64 29.68 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-N 115.307 -0.447 . . . . 75.44 112.819 -178.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 167' ' ' GLN . . . . . 0.589 ' HG2' ' HB1' ' C' ' 141' ' ' ALA . 27.4 mm-40 -70.66 118.91 14.05 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.899 0.88 . . . . 64.31 111.533 -174.035 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 168' ' ' GLY . . . . . 0.412 ' HA3' ' HA2' ' C' ' 116' ' ' GLY . . . 161.77 162.48 13.13 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 109.929 -1.269 . . . . 13.44 109.929 178.071 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 169' ' ' ASN . . . . . 0.723 ' HB2' ' HD3' ' C' ' 170' ' ' PRO . 1.7 m-20 -73.57 -68.41 0.36 Allowed Pre-proline 0 CA--C 1.578 2.051 0 CA-C-O 117.846 -1.073 . . . . 62.44 112.97 -166.372 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 170' ' ' PRO . . . . . 0.723 ' HD3' ' HB2' ' C' ' 169' ' ' ASN . 34.1 Cg_exo -63.73 176.17 2.48 Favored 'Trans proline' 0 C--N 1.401 3.298 0 C-N-CA 122.475 2.117 . . . . 51.41 113.281 172.419 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 171' ' ' PRO . . . . . 0.504 ' HA ' ' HA2' ' C' ' 87' ' ' GLY . 29.7 Cg_endo -62.28 139.23 76.35 Favored 'Trans proline' 0 C--N 1.389 2.666 0 C-N-CA 122.551 2.167 . . . . 74.02 111.76 172.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -116.18 -34.03 1.41 Allowed Glycine 0 C--N 1.336 0.574 0 CA-C-N 116.089 -0.505 . . . . 74.42 112.56 177.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 173' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 71.04 147.97 0.08 Allowed 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 125.089 1.355 . . . . 74.51 111.273 -179.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 174' ' ' LEU . . . . . . . . . . . . . 11.0 tp -121.97 128.55 51.61 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.904 0.882 . . . . 75.22 108.853 -174.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 175' ' ' LEU . . . . . 0.478 ' HB2' HH11 ' B' ' 188' ' ' ARG . 71.8 mt -110.49 130.58 55.53 Favored 'General case' 0 C--O 1.243 0.721 0 C-N-CA 123.597 0.759 . . . . 71.32 109.23 172.142 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 176' ' ' LEU . . . . . 0.564 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 95.7 mt -108.33 107.97 18.77 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.373 0.669 . . . . 43.02 110.884 178.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 177' ' ' VAL . . . . . . . . . . . . . 56.0 t -81.53 101.12 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 107.147 -1.427 . . . . 74.43 107.147 173.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 178' ' ' VAL . . . . . 0.463 HG13 ' HB3' ' C' ' 125' ' ' LEU . 39.7 t -76.65 128.87 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 114.599 -1.182 . . . . 74.01 110.755 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 179' ' ' ARG . . . . . 0.466 ' O ' ' HA ' ' C' ' 124' ' ' PRO . 36.6 mmt180 -111.94 101.03 9.36 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 105.325 -2.102 . . . . 72.33 105.325 171.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 180' ' ' LEU . . . . . 0.454 ' HA ' ' O ' ' C' ' 125' ' ' LEU . 28.9 mt -68.93 133.03 47.65 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 108.922 -0.77 . . . . 70.51 108.922 -176.651 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 181' ' ' LEU . . . . . . . . . . . . . 85.0 mt -54.05 163.01 1.29 Allowed Pre-proline 0 N--CA 1.493 1.717 0 C-N-CA 125.31 1.444 . . . . 74.2 113.317 -167.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -51.52 77.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.391 2.813 0 C-N-CA 123.744 2.963 . . . . 64.12 111.982 164.261 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 183' ' ' HIS . . . . . . . . . . . . . 75.3 t60 -174.08 53.92 0.15 Allowed Pre-proline 0 CA--C 1.553 1.059 0 N-CA-C 104.112 -2.551 . . . . 62.13 104.112 -170.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 184' ' ' PRO . . . . . 0.479 ' HG2' ' HG2' ' B' ' 401' ' ' PRO . 92.1 Cg_endo -86.67 65.79 4.68 Favored 'Trans proline' 0 C--N 1.388 2.65 0 C-N-CA 123.535 2.823 . . . . 71.54 112.079 -164.059 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 185' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 11.7 t -95.89 -50.24 11.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 108.047 -1.094 . . . . 72.23 108.047 -178.169 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 186' ' ' PHE . . . . . 0.548 ' HD2' HD13 ' C' ' 127' ' ' LEU . 34.0 m-85 -117.67 156.39 28.28 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.488 0.715 . . . . 61.44 111.956 -174.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 187' ' ' ARG . . . . . 0.49 ' O ' ' HB3' ' C' ' 194' ' ' TYR . 33.8 ttp180 -153.64 112.11 3.64 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.476 1.51 . . . . 75.14 107.742 177.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 188' ' ' LEU . . . . . 0.431 HD21 ' O ' ' C' ' 190' ' ' GLY . 47.9 tp -80.73 153.1 28.02 Favored 'General case' 0 CA--C 1.558 1.263 0 N-CA-C 115.392 1.627 . . . . 74.14 115.392 -163.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -126.92 99.59 5.8 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.889 1.675 . . . . 71.33 107.182 159.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 190' ' ' GLY . . . . . 0.431 ' O ' HD21 ' C' ' 188' ' ' LEU . . . 63.61 -80.09 0.04 OUTLIER Glycine 0 CA--C 1.539 1.575 0 N-CA-C 114.194 0.438 . . . . 74.2 114.194 175.724 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 191' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -122.42 -34.86 3.2 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.877 1.271 . . . . 60.21 109.635 177.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -83.63 125.12 31.5 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.189 0.995 . . . . 65.13 110.983 -174.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 193' ' ' LEU . . . . . 0.439 ' HG ' ' HA2' ' C' ' 239' ' ' GLY . 91.7 mt -80.65 159.09 25.44 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.253 0.621 . . . . 52.2 112.017 -179.083 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 194' ' ' TYR . . . . . 0.49 ' HB3' ' O ' ' C' ' 187' ' ' ARG . 43.7 t80 -119.12 106.94 12.88 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 108.112 -1.07 . . . . 75.43 108.112 165.139 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 195' ' ' ALA . . . . . 0.549 ' HB2' HD11 ' C' ' 249' ' ' LEU . . . -108.2 -174.9 2.63 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.553 0.741 . . . . 65.11 110.099 175.49 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 29.3 m -138.47 119.06 13.93 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.586 -0.733 . . . . 51.32 109.604 174.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 197' ' ' LEU . . . . . 0.491 HD13 ' HB2' ' C' ' 212' ' ' ALA . 53.5 tp -98.78 118.21 35.01 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.292 0.637 . . . . 73.5 109.375 -179.073 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 198' ' ' ASP . . . . . 0.584 ' HA ' ' HB2' ' C' ' 254' ' ' ARG . 26.4 t70 -85.69 99.97 11.67 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.501 0.721 . . . . 44.52 109.087 -178.102 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 199' ' ' VAL . . . . . 0.482 HG22 HG21 ' C' ' 210' ' ' VAL . 21.4 t -110.59 123.6 35.26 Favored Pre-proline 0 N--CA 1.479 0.989 0 N-CA-C 108.661 -0.866 . . . . 61.21 108.661 -178.178 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 200' ' ' PRO . . . . . 0.439 ' HD2' HG11 ' C' ' 210' ' ' VAL . 46.2 Cg_endo -69.09 147.22 66.72 Favored 'Trans proline' 0 C--N 1.367 1.546 0 C-N-CA 121.565 1.51 . . . . 71.34 110.553 173.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 201' ' ' ALA . . . . . 0.476 ' HB3' ' HH2' ' C' ' 269' ' ' TRP . . . -52.59 -45.46 96.06 Favored Pre-proline 0 CA--C 1.555 1.158 0 C-N-CA 124.638 1.175 . . . . 74.35 113.467 -176.035 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 202' ' ' PRO . . . . . 0.488 ' HB2' ' HA ' ' A' ' 273' ' ' ALA . 23.7 Cg_endo -57.99 -49.71 12.09 Favored 'Trans proline' 0 C--N 1.391 2.774 0 C-N-CA 121.384 1.389 . . . . 63.15 112.304 177.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 203' ' ' ILE . . . . . . . . . . . . . 29.2 mt -64.42 -32.34 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 123.218 0.607 . . . . 63.4 111.145 178.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.8 -37.6 84.87 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.134 0.574 . . . . 75.02 111.512 179.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 205' ' ' VAL . . . . . 0.425 ' HA ' ' HA ' ' C' ' 226' ' ' ARG . 91.2 t -82.09 -37.24 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 123.233 0.613 . . . . 63.41 111.972 -178.363 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 206' ' ' VAL . . . . . 0.625 HG22 ' HG3' ' B' ' 248' ' ' ARG . 8.3 p -87.61 -33.58 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 N-CA-C 111.975 0.361 . . . . 52.12 111.975 -175.158 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 90.33 126.44 3.22 Favored Glycine 0 C--N 1.344 0.98 0 N-CA-C 111.076 -0.81 . . . . 63.21 111.076 -167.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -159.93 -137.3 2.2 Favored Glycine 0 C--N 1.336 0.57 0 CA-C-N 117.81 0.805 . . . . 51.32 111.466 179.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 209' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' C' ' 221' ' ' VAL . 7.6 mtmp? -139.26 134.75 33.06 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 123.43 0.692 . . . . 72.12 110.603 171.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 210' ' ' VAL . . . . . 0.482 HG21 HG22 ' C' ' 199' ' ' VAL . 27.7 m -134.3 140.57 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 107.754 -1.202 . . . . 62.05 107.754 169.021 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 211' ' ' ARG . . . . . 0.53 ' HA ' ' HA ' ' C' ' 220' ' ' GLU . 32.4 ttm105 -80.5 133.12 35.78 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 122.975 0.51 . . . . 72.44 111.66 -175.242 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 212' ' ' ALA . . . . . 0.491 ' HB2' HD13 ' C' ' 197' ' ' LEU . . . -104.18 130.36 51.94 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.785 1.234 . . . . 74.43 107.704 164.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 213' ' ' MET . . . . . 0.407 ' HG2' ' N ' ' C' ' 214' ' ' THR . 6.6 ttt -70.39 149.49 47.24 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 109.264 -0.643 . . . . 63.12 109.264 168.11 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 214' ' ' THR . . . . . 0.528 HG21 ' HD2' ' C' ' 238' ' ' LYS . 0.1 OUTLIER -139.92 169.14 18.26 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.173 0.511 . . . . 54.24 110.415 168.101 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 215' ' ' LEU . . . . . 0.596 HD13 ' HB2' ' C' ' 131' ' ' PHE . 54.4 mt -61.82 -36.05 80.02 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.144 1.378 . . . . 44.41 112.667 -172.482 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.78 -2.67 27.63 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.396 0.679 . . . . 71.0 112.11 -177.395 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 155.69 171.41 22.14 Favored Glycine 0 C--O 1.212 -1.274 0 CA-C-O 119.556 -0.58 . . . . 64.11 112.492 -178.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -88.26 126.01 1.91 Allowed 'Trans proline' 0 CA--C 1.556 1.618 0 C-N-CA 122.998 2.465 . . . . 52.13 112.748 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 219' ' ' VAL . . . . . 0.44 HG13 ' HB3' ' C' ' 212' ' ' ALA . 3.3 p -103.2 115.12 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 123.925 0.89 . . . . 52.53 109.696 177.459 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 220' ' ' GLU . . . . . 0.53 ' HA ' ' HA ' ' C' ' 211' ' ' ARG . 23.6 tt0 -84.43 109.38 17.83 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 109.491 -0.559 . . . . 72.32 109.491 -179.012 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 221' ' ' VAL . . . . . 0.458 HG11 HD21 ' C' ' 233' ' ' LEU . 47.7 t -74.13 127.88 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 124.491 1.116 . . . . 74.03 111.957 -174.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 222' ' ' ALA . . . . . 0.421 ' HA ' ' HG2' ' C' ' 209' ' ' LYS . . . -80.97 103.52 10.85 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 124.199 0.937 . . . . 73.3 109.05 167.162 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 62.1 t -79.04 129.47 72.91 Favored Pre-proline 0 CA--C 1.553 1.079 0 C-N-CA 123.744 0.818 . . . . 73.11 109.721 176.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 224' ' ' PRO . . . . . 0.593 ' HG2' ' HB2' ' B' ' 243' ' ' GLN . 3.1 Cg_exo -78.68 160.64 28.01 Favored 'Trans proline' 0 C--N 1.371 1.722 0 C-N-CA 123.925 3.084 . . . . 54.33 112.103 169.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.51 143.49 98.02 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 122.944 2.429 . . . . 74.0 112.93 176.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 226' ' ' ARG . . . . . 0.446 ' HG2' ' O ' ' A' ' 259' ' ' GLU . 0.6 OUTLIER 55.18 86.02 0.06 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.468 1.907 . . . . 70.15 113.79 173.748 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 227' ' ' THR . . . . . 0.543 HG21 ' HH2' ' B' ' 242' ' ' TRP . 82.1 m -123.93 133.36 53.74 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 114.828 -1.078 . . . . 70.3 111.143 -178.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 228' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -104.77 155.71 18.65 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.712 0.768 . . . . 74.32 110.702 176.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -72.23 145.59 47.86 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.328 -0.851 . . . . 62.12 109.936 176.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 95.42 -9.34 69.36 Favored Glycine 0 N--CA 1.464 0.561 0 CA-C-N 115.746 -0.661 . . . . 62.04 112.118 -171.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 231' ' ' ARG . . . . . 0.404 ' NH1' ' HA ' ' C' ' 227' ' ' THR . 81.8 mtt180 -69.55 178.34 2.54 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 117.339 0.569 . . . . 74.12 110.761 167.24 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 232' ' ' LYS . . . . . 0.571 ' HD3' ' HB3' ' C' ' 250' ' ' TYR . 1.9 ttmp? -153.93 126.86 8.29 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 112.258 0.466 . . . . 71.45 112.258 -174.295 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 233' ' ' LEU . . . . . 0.615 ' O ' ' HA ' ' C' ' 250' ' ' TYR . 5.1 mp -86.39 158.66 19.57 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.488 1.115 . . . . 74.21 110.437 175.435 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 19.1 ptt-85 -128.92 88.46 2.72 Favored 'General case' 0 CA--C 1.556 1.204 0 O-C-N 124.712 1.257 . . . . 72.34 109.513 170.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 235' ' ' LEU . . . . . 0.508 HD22 ' H ' ' B' ' 240' ' ' GLY . 56.9 mt -86.55 105.99 17.22 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 108.213 -1.032 . . . . 73.43 108.213 174.264 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -67.71 132.75 48.05 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.36 0.664 . . . . 71.55 111.639 -168.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 237' ' ' GLY . . . . . 0.401 ' CA ' ' HB2' ' B' ' 335' ' ' ASN . . . 80.95 1.38 89.79 Favored Glycine 0 C--N 1.349 1.254 0 N-CA-C 115.018 0.767 . . . . 71.42 115.018 174.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 238' ' ' LYS . . . . . 0.528 ' HD2' HG21 ' C' ' 214' ' ' THR . 73.8 mmtt -92.8 13.18 21.09 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 123.588 0.755 . . . . 72.03 111.116 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 239' ' ' GLY . . . . . 0.439 ' HA2' ' HG ' ' C' ' 193' ' ' LEU . . . -95.17 -169.6 36.3 Favored Glycine 0 C--N 1.358 1.772 0 C-N-CA 122.977 0.322 . . . . 31.21 113.205 177.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 240' ' ' PHE . . . . . 0.41 ' HD2' HD13 ' C' ' 188' ' ' LEU . 3.8 m-85 -78.73 148.28 72.49 Favored Pre-proline 0 N--CA 1.481 1.102 0 C-N-CA 123.027 0.531 . . . . 75.14 110.397 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 241' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -63.64 137.31 58.5 Favored 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 123.43 2.753 . . . . 70.21 112.103 -178.25 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -131.71 168.6 22.26 Favored Glycine 0 C--N 1.342 0.911 0 CA-C-O 120.169 -0.24 . . . . 70.14 113.678 -175.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -73.91 -2.38 12.17 Favored 'Trans proline' 0 C--N 1.38 2.206 0 C-N-CA 123.642 2.894 . . . . 71.42 114.553 -173.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -137.62 11.8 2.95 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.655 0.782 . . . . 71.42 111.118 178.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 137.43 167.79 11.17 Favored Glycine 0 C--N 1.348 1.214 0 N-CA-C 111.111 -0.795 . . . . 51.32 111.111 -176.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 246' ' ' ARG . . . . . . . . . . . . . 26.8 mtm-85 -81.85 151.32 27.38 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-N 117.275 0.537 . . . . 61.31 109.914 176.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -78.13 -169.93 35.31 Favored Glycine 0 C--N 1.34 0.798 0 O-C-N 123.872 0.733 . . . . 63.23 113.48 -178.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -123.79 142.66 50.89 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.122 -1.066 . . . . 73.54 108.122 -173.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 249' ' ' LEU . . . . . 0.549 HD11 ' HB2' ' C' ' 195' ' ' ALA . 25.6 tp -83.89 109.52 17.65 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.95 -0.568 . . . . 74.23 109.797 -179.525 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 250' ' ' TYR . . . . . 0.615 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 22.0 m-30 -101.02 100.53 11.15 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 109.498 -0.556 . . . . 71.43 109.498 179.203 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 251' ' ' LEU . . . . . 0.578 ' HB2' HD13 ' C' ' 233' ' ' LEU . 2.2 mp -100.39 121.91 42.29 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 119.166 -0.445 . . . . 64.53 110.338 -172.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 252' ' ' GLU . . . . . 0.454 ' HB2' ' HE1' ' C' ' 194' ' ' TYR . 25.3 tt0 -75.07 129.7 38.04 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-O 121.129 0.49 . . . . 73.41 109.681 170.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 253' ' ' VAL . . . . . 0.52 HG11 HG22 ' C' ' 227' ' ' THR . 60.4 t -76.23 135.19 27.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 115.166 -0.925 . . . . 73.5 111.012 -175.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 254' ' ' ARG . . . . . 0.584 ' HB2' ' HA ' ' C' ' 198' ' ' ASP . 11.4 mmt85 -103.8 135.19 45.8 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.321 1.448 . . . . 74.13 108.32 165.193 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 255' ' ' ILE . . . . . . . . . . . . . 33.0 mm -106.94 105.34 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 107.028 -1.471 . . . . 75.24 107.028 165.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 256' ' ' THR . . . . . . . . . . . . . 3.5 t -115.76 171.72 7.58 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.037 0.935 . . . . 53.32 110.067 -173.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 10.7 pt -134.95 152.93 78.18 Favored Pre-proline 0 CA--C 1.552 1.037 0 C-N-CA 123.987 0.915 . . . . 64.54 109.876 -173.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -80.79 20.98 0.91 Allowed 'Trans proline' 0 C--N 1.381 2.274 0 C-N-CA 123.372 2.715 . . . . 73.21 113.737 -168.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 57.3 -89.81 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.778 1.231 . . . . 72.3 111.18 -174.01 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 260' ' ' ARG . . . . . 0.719 ' HG3' ' HA2' ' B' ' 284' ' ' GLY . 0.0 OUTLIER -80.39 145.86 31.78 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 123.214 0.606 . . . . 73.41 109.473 -179.317 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 261' ' ' LEU . . . . . . . . . . . . . 96.4 mt -128.73 154.69 46.1 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.89 0.876 . . . . 71.21 109.566 176.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 262' ' ' THR . . . . . 0.625 HG21 ' HB3' ' B' ' 280' ' ' LEU . 45.1 p -84.92 155.72 61.11 Favored Pre-proline 0 CA--C 1.555 1.142 0 N-CA-C 109.252 -0.647 . . . . 61.23 109.252 170.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 263' ' ' PRO . . . . . 0.404 ' HB3' ' N ' ' B' ' 469' ' ' GLY . 3.8 Cg_exo -34.35 -51.81 0.62 Allowed 'Trans proline' 0 C--N 1.382 2.302 1 C-N-CA 125.684 4.256 . . . . 74.2 115.836 -178.606 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -62.94 -55.05 29.33 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.954 0.501 . . . . 71.04 110.259 -177.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -49.31 -55.14 13.77 Favored 'General case' 0 C--N 1.356 0.866 0 O-C-N 124.451 1.094 . . . . 65.11 109.675 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 266' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' C' ' 270' ' ' LYS . 15.4 tp10 -54.62 -43.27 72.09 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 124.655 1.222 . . . . 64.21 110.997 -177.446 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -60.6 -45.42 94.07 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.508 0.723 . . . . 70.32 112.217 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 268' ' ' LEU . . . . . 0.511 ' HB2' HD21 ' A' ' 272' ' ' LEU . 10.3 mp -66.35 -50.99 61.69 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 116.729 -0.214 . . . . 52.44 110.93 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 269' ' ' TRP . . . . . 0.476 ' HH2' ' HB3' ' C' ' 201' ' ' ALA . 92.5 m95 -56.95 -32.41 65.99 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.292 0.637 . . . . 61.11 111.039 177.354 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 270' ' ' LYS . . . . . 0.653 ' HA ' HG21 ' A' ' 206' ' ' VAL . 10.2 tmtt? -67.76 -46.46 72.02 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.987 0.915 . . . . 75.43 110.336 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -63.2 -37.21 86.32 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 122.73 0.412 . . . . 75.33 111.486 177.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 272' ' ' LEU . . . . . 0.416 HD12 ' HA ' ' C' ' 269' ' ' TRP . 75.1 mt -64.9 -37.11 86.54 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.295 0.638 . . . . 74.33 110.125 176.46 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -63.43 -45.39 91.16 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.438 0.695 . . . . 34.13 111.055 177.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -65.72 -36.71 84.38 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.289 0.636 . . . . 63.21 111.036 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -62.7 -33.07 74.33 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 115.596 -0.729 . . . . 70.04 110.584 174.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 276' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -73.46 -42.34 62.06 Favored 'General case' 0 CA--C 1.554 1.114 0 CA-C-N 115.36 -0.836 . . . . 75.52 111.939 174.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -68.05 -22.61 64.94 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.949 -0.469 . . . . 44.24 111.403 178.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -59.77 -22.53 62.26 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.504 0.722 . . . . 55.2 112.131 174.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 279' ' ' ARG . . . . . . . . . . . . . 39.0 mtm180 -72.66 -29.84 63.77 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 122.743 0.417 . . . . 71.52 110.738 178.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.044 0 C-N-CA 123.7 0.8 . . . . 75.14 109.378 -173.402 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.47 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.1 mpt? . . . . . 0 N--CA 1.475 0.786 0 N-CA-C 109.87 -0.418 . . . . 64.12 109.87 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.76 16.06 7.54 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 125.333 1.453 . . . . 51.4 113.649 175.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -80.72 76.76 7.6 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.256 0.622 . . . . 74.04 110.224 -174.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -37.28 105.22 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 126.722 2.009 . . . . 62.43 113.039 -178.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -77.68 109.34 11.57 Favored 'General case' 0 C--O 1.245 0.863 0 C-N-CA 124.031 0.932 . . . . 74.32 109.413 171.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -82.34 94.53 7.39 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 108.459 -0.941 . . . . 61.41 108.459 177.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -60.54 -37.46 81.3 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.191 0.997 . . . . 73.34 111.672 -174.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.497 ' HB3' ' O ' ' A' ' 13' ' ' VAL . 95.1 m-85 -67.28 -35.74 80.12 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 114.609 -1.178 . . . . 73.33 111.324 178.618 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.86 -40.13 72.51 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 122.897 0.479 . . . . 60.32 111.014 177.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 77.0 mt -56.0 -42.75 72.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 123.613 0.765 . . . . 74.23 109.455 174.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 87.7 mt -81.06 -17.47 50.0 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 115.212 -0.903 . . . . 51.33 112.392 176.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.09 18.74 78.06 Favored Glycine 0 CA--C 1.536 1.398 0 N-CA-C 114.71 0.644 . . . . 53.33 114.71 -178.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.497 ' O ' ' HB3' ' A' ' 8' ' ' TYR . 19.6 m -103.89 144.07 27.94 Favored Pre-proline 0 N--CA 1.484 1.228 0 C-N-CA 123.666 0.787 . . . . 71.43 109.252 173.459 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -54.58 151.01 32.81 Favored 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 122.889 2.393 . . . . 50.12 113.282 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.33 69.48 1.61 Allowed 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.692 0.797 . . . . 75.43 110.561 179.253 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 170.92 -24.36 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.805 1.242 . . . . 64.11 109.422 -173.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.09 138.85 19.12 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.283 1.033 . . . . 64.31 111.761 -177.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 67.2 p -63.49 166.08 7.1 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.17 0.988 . . . . 71.11 111.033 -175.042 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -56.64 -33.37 66.25 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.985 0.914 . . . . 64.21 111.384 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -69.72 -36.1 75.6 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 122.89 0.476 . . . . 72.43 111.062 -178.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -72.02 -42.06 66.83 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.629 0.772 . . . . 64.03 110.664 177.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 73.7 mt -58.59 -39.53 76.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 124.558 1.143 . . . . 73.31 110.241 173.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.734 ' HG2' ' HE3' ' A' ' 27' ' ' LYS . 33.9 ttmt -71.67 -37.94 70.71 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 114.555 -1.202 . . . . 71.24 110.259 -177.627 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 49.1 mtp180 -57.36 -52.46 65.25 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.503 0.721 . . . . 54.12 110.319 173.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.33 -38.47 91.14 Favored 'General case' 0 C--O 1.246 0.899 0 CA-C-N 114.435 -1.257 . . . . 64.0 111.653 -177.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -61.87 -60.75 3.18 Favored 'General case' 0 C--O 1.209 -1.067 0 CA-C-N 115.433 -0.803 . . . . 73.1 109.487 177.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.734 ' HE3' ' HG2' ' A' ' 23' ' ' LYS . 10.1 mtmp? -58.71 -33.58 70.36 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 124.266 0.979 . . . . 74.22 111.913 -177.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 14.6 ttt180 -52.74 -58.72 5.94 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.299 1.04 . . . . 71.15 109.856 171.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.662 ' HB3' HD13 ' A' ' 50' ' ' ILE . 88.1 mt -81.21 -10.28 59.64 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 115.172 -0.922 . . . . 74.11 111.991 -178.269 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.489 ' HB3' ' HA ' ' A' ' 27' ' ' LYS . . . -94.53 -14.59 24.92 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.772 0.829 . . . . 63.3 111.34 -178.282 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.4 mtm105 -97.96 -38.09 9.53 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.957 -0.757 . . . . 72.33 108.957 168.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -65.43 -47.36 76.48 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.26 0.624 . . . . 63.33 111.092 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -107.4 29.21 7.37 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.515 0.726 . . . . 63.25 110.734 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -68.23 101.51 0.31 Allowed Pre-proline 0 N--CA 1.483 1.204 0 C-N-CA 123.979 0.911 . . . . 63.41 110.547 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.528 ' O ' ' HG3' ' A' ' 39' ' ' LYS . 46.6 Cg_exo -55.07 -39.82 89.0 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 123.073 2.516 . . . . 74.13 113.306 -169.176 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -46.89 -36.94 8.11 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.799 1.239 . . . . 72.45 112.786 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 48.7 t -101.79 -49.25 10.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 C-N-CA 123.657 0.783 . . . . 65.53 109.28 178.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -107.27 75.26 1.01 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 125.121 1.368 . . . . 61.35 110.665 -176.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.528 ' HG3' ' O ' ' A' ' 35' ' ' PRO . 9.0 mtmp? -78.02 72.47 4.56 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 109.636 -0.505 . . . . 73.11 109.636 172.597 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 70.4 m -116.9 113.31 39.85 Favored Pre-proline 0 N--CA 1.471 0.621 0 N-CA-C 107.906 -1.146 . . . . 54.41 107.906 176.283 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -42.8 -53.29 4.01 Favored 'Trans proline' 0 C--N 1.387 2.591 0 C-N-CA 124.58 3.52 . . . . 72.23 114.191 -170.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -52.12 -46.82 65.49 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.221 1.009 . . . . 64.43 111.817 176.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.82 -29.16 69.01 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.597 0.759 . . . . 72.14 110.982 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.503 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 46.1 mt-10 -84.47 -29.7 25.83 Favored 'General case' 0 C--N 1.352 0.707 0 C-N-CA 123.423 0.689 . . . . 62.01 110.461 -175.062 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -72.31 -43.45 64.16 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.929 0.892 . . . . 62.44 109.791 176.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.422 ' HD3' ' HA ' ' A' ' 46' ' ' LYS . 40.2 mmtm -62.65 -39.7 94.72 Favored 'General case' 0 C--N 1.345 0.405 0 CA-C-N 115.038 -0.983 . . . . 74.03 109.631 171.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.485 ' HE1' ' HA ' ' A' ' 30' ' ' ALA . 60.0 t80 -63.08 -30.14 71.36 Favored 'General case' 0 C--N 1.356 0.866 0 O-C-N 123.867 0.729 . . . . 73.24 110.656 176.449 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.503 ' HG2' ' O ' ' A' ' 44' ' ' GLU . 34.3 mmtp -62.98 -47.36 83.49 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 109.893 -0.41 . . . . 75.14 109.893 171.682 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -67.95 -25.88 65.67 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 112.384 0.513 . . . . 71.44 112.384 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.662 HD13 ' HB3' ' A' ' 29' ' ' LEU . 63.0 mt -79.47 -33.46 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 C-N-CA 124.515 1.126 . . . . 70.53 110.102 176.42 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -70.22 -39.14 75.29 Favored 'General case' 0 C--O 1.208 -1.08 0 CA-C-N 115.265 -0.879 . . . . 73.43 109.81 173.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -61.01 -48.75 80.37 Favored 'General case' 0 C--O 1.247 0.952 0 C-N-CA 124.986 1.314 . . . . 63.42 109.541 176.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.32 -60.42 3.36 Favored 'General case' 0 C--N 1.352 0.69 0 CA-C-N 113.52 -1.673 . . . . 65.45 111.188 177.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -63.92 -35.73 81.62 Favored 'General case' 0 C--O 1.214 -0.771 0 CA-C-N 115.686 -0.688 . . . . 72.32 111.412 -179.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.14 -53.34 58.29 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.579 0.752 . . . . 53.01 110.831 -177.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 66.4 t -62.84 -50.86 78.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 114.533 -1.212 . . . . 74.52 110.352 177.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 67.2 mt -76.07 -8.3 56.67 Favored 'General case' 0 CA--C 1.557 1.242 0 N-CA-C 113.152 0.797 . . . . 62.04 113.152 -172.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.2 t -65.42 -58.46 5.8 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.405 1.082 . . . . 74.34 111.853 -176.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.491 ' HB2' ' HD3' ' A' ' 62' ' ' LYS . 13.4 m-20 -99.31 142.33 24.41 Favored Pre-proline 0 C--O 1.244 0.778 0 C-N-CA 123.419 0.688 . . . . 74.34 109.432 -174.318 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.515 ' O ' ' HG2' ' A' ' 64' ' ' ARG . 48.7 Cg_exo -54.55 -47.23 27.92 Favored 'Trans proline' 0 C--N 1.385 2.447 0 C-N-CA 123.167 2.578 . . . . 72.41 112.941 -172.114 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.485 ' O ' HG12 ' A' ' 65' ' ' ILE . 3.1 mp0 -58.78 -58.2 9.64 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.505 0.722 . . . . 72.3 111.213 -174.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.491 ' HD3' ' HB2' ' A' ' 59' ' ' ASP . 37.9 mtpt -58.28 -43.52 88.05 Favored 'General case' 0 C--O 1.257 1.492 0 C-N-CA 124.29 1.036 . . . . 74.54 111.135 -178.197 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -59.04 -46.81 87.3 Favored 'General case' 0 C--N 1.349 0.581 0 CA-C-N 114.667 -1.152 . . . . 74.11 110.793 178.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.515 ' HG2' ' O ' ' A' ' 60' ' ' PRO . 30.2 mmm180 -77.6 -18.66 56.61 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 123.677 0.61 . . . . 74.25 111.305 -175.228 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.485 HG12 ' O ' ' A' ' 61' ' ' GLU . 28.3 mm -62.29 -50.93 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 N-CA-C 108.081 -1.081 . . . . 64.42 108.081 168.217 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -60.35 -52.25 66.07 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 114.908 -1.042 . . . . 75.4 111.001 175.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -63.31 -31.22 72.31 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.457 0.703 . . . . 64.04 112.059 -172.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.3 p -76.65 -31.55 57.41 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 119.166 -0.445 . . . . 75.13 110.773 173.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -64.06 115.12 4.63 Favored 'General case' 0 CA--C 1.556 1.2 0 N-CA-C 109.492 -0.559 . . . . 63.45 109.492 178.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 115.38 5.66 18.82 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 123.562 0.601 . . . . 52.54 111.969 -169.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 86.2 m -147.59 -56.62 0.24 Allowed 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 104.823 -2.288 . . . . 71.23 104.823 178.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.4 m -82.79 141.92 31.95 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 104.446 -2.427 . . . . 74.23 104.446 156.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.79 -35.08 10.25 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 118.617 0.644 . . . . 74.04 111.145 -179.373 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -93.24 134.18 27.41 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 123.393 0.677 . . . . 75.1 109.412 179.284 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.92 116.93 3.61 Favored 'Trans proline' 0 C--N 1.373 1.833 0 C-N-CA 122.299 1.999 . . . . 75.41 110.532 171.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -52.14 142.32 45.58 Favored 'Trans proline' 0 C--N 1.38 2.19 0 C-N-CA 123.035 2.49 . . . . 74.25 112.611 177.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -43.4 129.86 6.58 Favored 'Trans proline' 0 C--N 1.388 2.642 0 C-N-CA 123.969 3.113 . . . . 62.44 113.424 -174.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.421 ' HG3' ' HA3' ' A' ' 104' ' ' GLY . 28.2 Cg_endo -58.41 144.02 96.98 Favored 'Trans proline' 0 C--N 1.387 2.579 0 C-N-CA 122.84 2.36 . . . . 43.51 112.705 -171.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.404 ' HB2' HH21 ' A' ' 143' ' ' ARG . 58.9 Cg_endo -65.89 167.49 17.59 Favored 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 122.876 2.384 . . . . 71.05 112.59 -177.329 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.84 88.45 0.07 OUTLIER 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 122.665 2.244 . . . . 51.35 111.694 176.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 149.91 -40.88 0.84 Allowed Glycine 0 CA--C 1.524 0.611 0 CA-C-N 113.728 -1.578 . . . . 62.41 109.525 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 110.63 -169.51 13.46 Favored Glycine 0 C--N 1.351 1.383 0 C-N-CA 123.594 0.616 . . . . 53.03 111.686 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -84.72 88.36 7.37 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 123.431 0.692 . . . . 74.41 109.867 176.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -58.11 157.96 7.49 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 114.407 -1.269 . . . . 71.31 111.828 175.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -154.56 72.44 0.86 Allowed 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 108.597 -0.89 . . . . 70.22 108.597 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.4 m -43.58 84.99 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 126.134 1.774 . . . . 74.44 115.218 -165.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.451 ' N ' ' HA3' ' A' ' 163' ' ' GLY . . . 67.78 10.81 59.23 Favored Glycine 0 C--N 1.352 1.449 0 CA-C-N 115.815 -0.629 . . . . 70.11 114.008 175.208 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -93.23 122.95 36.15 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.231 -1.396 . . . . 72.34 107.231 178.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -69.74 90.39 0.59 Allowed 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 110.177 -0.305 . . . . 71.44 110.177 -173.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.491 HG23 ' HE2' ' A' ' 97' ' ' PHE . 2.4 p -34.81 -50.31 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 125.578 1.551 . . . . 75.21 114.084 175.227 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -59.84 -34.22 72.81 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.255 1.022 . . . . 75.33 111.297 -173.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -78.08 -30.84 49.87 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.218 1.007 . . . . 45.35 111.753 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -82.14 172.19 13.48 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 122.746 0.419 . . . . 71.01 110.161 -173.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 83.8 p -57.56 150.06 19.94 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 114.093 1.145 . . . . 74.5 114.093 -164.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.96 -41.8 71.58 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 114.568 -1.196 . . . . 74.31 110.881 170.135 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -59.76 -43.06 94.5 Favored 'General case' 0 C--N 1.354 0.769 0 C-N-CA 123.226 0.61 . . . . 75.03 110.755 -177.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.491 ' HE2' HG23 ' A' ' 90' ' ' VAL . 26.5 t80 -58.58 -49.99 75.42 Favored 'General case' 0 CA--C 1.548 0.895 0 O-C-N 123.761 0.663 . . . . 63.23 109.242 173.476 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.524 ' HA ' HD11 ' A' ' 105' ' ' LEU . 46.4 mt-30 -71.97 -5.6 36.04 Favored 'General case' 0 CA--C 1.557 1.237 0 CA-C-N 115.347 -0.842 . . . . 73.05 112.291 -178.47 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -97.65 -47.61 5.55 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 124.239 1.015 . . . . 70.02 111.903 173.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 37.2 tp -70.86 -52.75 18.34 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.655 0.782 . . . . 55.03 109.739 -176.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -86.16 -11.64 52.01 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 115.718 -0.674 . . . . 72.11 110.745 178.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -39.27 -58.82 1.94 Allowed Glycine 0 CA--C 1.543 1.792 0 CA-C-O 118.623 -1.098 . . . . 72.43 114.742 177.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -35.02 -36.92 0.13 Allowed 'Trans proline' 0 C--N 1.394 2.937 0 C-N-CA 125.289 3.993 . . . . 23.1 116.362 176.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.421 ' HA3' ' HG3' ' A' ' 78' ' ' PRO . . . -145.77 42.38 0.97 Allowed Glycine 0 C--N 1.354 1.53 0 CA-C-O 119.224 -0.764 . . . . 44.4 112.117 -178.621 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.524 HD11 ' HA ' ' A' ' 98' ' ' GLN . 8.1 mt -63.2 71.73 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.071 0.948 . . . . 74.25 112.867 177.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.72 ' HB3' ' HA ' ' A' ' 169' ' ' ASN . 1.5 t80 32.4 -105.13 0.02 OUTLIER 'General case' 0 CA--C 1.562 1.413 0 C-N-CA 126.3 1.84 . . . . 72.25 111.738 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 80.48 -40.03 2.38 Favored Glycine 0 C--N 1.359 1.844 0 CA-C-O 119.213 -0.77 . . . . 44.0 113.204 179.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.686 ' HA3' ' HB3' ' A' ' 167' ' ' GLN . . . 51.06 -121.21 10.73 Favored Glycine 0 C--N 1.359 1.839 0 C-N-CA 123.514 0.578 . . . . 71.34 113.519 179.445 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -84.37 -8.53 58.96 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.468 0.707 . . . . 64.11 111.313 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -77.54 -35.74 35.81 Favored Glycine 0 C--N 1.35 1.308 0 N-CA-C 110.639 -0.984 . . . . 55.25 110.639 168.05 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 20.1 tpp180 73.51 -40.79 0.47 Allowed 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 126.707 2.003 . . . . 71.44 114.203 171.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.01 21.54 1.94 Allowed 'General case' 0 CA--C 1.565 1.548 0 C-N-CA 125.182 1.393 . . . . 73.25 110.859 -168.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 48.1 m 60.28 41.94 15.76 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-O 122.175 0.988 . . . . 74.21 109.013 -167.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 17.2 ttp180 -80.48 162.42 24.39 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 114.006 -1.452 . . . . 74.52 110.836 -173.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.586 ' HA ' ' HD2' ' A' ' 170' ' ' PRO . 21.9 ttmm -70.52 149.69 46.9 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.223 0.609 . . . . 72.15 109.842 174.138 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -89.36 161.18 29.86 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-N 116.65 -0.25 . . . . 55.22 113.7 -177.003 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -100.97 145.59 28.47 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.797 1.239 . . . . 71.34 108.174 175.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -58.6 144.95 41.25 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 118.717 0.69 . . . . 74.23 112.014 -175.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.416 ' O ' HD12 ' A' ' 174' ' ' LEU . 7.8 tt -144.5 137.13 26.68 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 109.049 -0.723 . . . . 70.23 109.049 -173.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -93.19 130.56 38.83 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.306 0.642 . . . . 74.51 109.364 174.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.619 ' HB1' HD11 ' B' ' 8' ' ' LEU . . . -141.31 140.86 33.9 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.415 -0.957 . . . . 41.51 108.415 176.209 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.461 ' HG3' HD11 ' B' ' 11' ' ' LEU . 42.6 mt-10 -123.11 109.27 13.83 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 108.704 -0.85 . . . . 61.0 108.704 -166.494 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.797 HD23 HD22 ' A' ' 176' ' ' LEU . 3.8 pp -101.27 114.84 65.71 Favored Pre-proline 0 N--CA 1.484 1.252 0 N-CA-C 110.293 -0.262 . . . . 54.05 110.293 -169.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.659 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 40.4 Cg_endo -67.24 109.56 1.79 Allowed 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 120.7 0.933 . . . . 75.33 110.309 173.507 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.722 ' HA ' HG21 ' B' ' 6' ' ' ILE . 57.7 tp -110.25 144.25 39.21 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 123.555 0.742 . . . . 64.01 110.829 -171.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 40.5 m -71.43 136.71 47.8 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 114.908 -1.042 . . . . 71.34 110.892 178.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.875 ' HB3' HD22 ' A' ' 215' ' ' LEU . 59.4 mt -54.37 -49.5 69.68 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.109 0.963 . . . . 70.54 111.688 -177.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -54.99 -46.51 75.14 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 114.646 -1.161 . . . . 75.32 111.452 175.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -65.66 -29.43 69.99 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 122.743 0.417 . . . . 64.33 111.451 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -66.75 -47.54 71.91 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.878 0.471 . . . . 41.43 110.503 178.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -63.96 -44.51 92.55 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 114.762 -1.108 . . . . 74.51 111.518 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 30.8 m170 -76.64 -45.58 29.39 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 115.709 -0.678 . . . . 75.25 111.404 -174.319 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.487 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 74.49 -153.25 45.85 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 123.54 0.525 . . . . 71.54 112.689 -177.348 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 81.72 -153.12 32.66 Favored Glycine 0 C--N 1.348 1.245 0 C-N-CA 123.223 0.439 . . . . 70.42 112.935 178.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -72.22 97.4 1.97 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.286 0.635 . . . . 73.14 110.09 -177.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.668 HH11 HD13 ' A' ' 125' ' ' LEU . 5.2 tmm_? -96.05 120.4 36.28 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 107.365 -1.346 . . . . 74.4 107.365 173.371 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 59.6 t -85.75 134.61 26.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 108.945 -0.761 . . . . 71.24 108.945 178.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.504 ' HB ' HG13 ' A' ' 145' ' ' VAL . 85.9 t -116.41 133.44 62.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 C-N-CA 124.007 0.923 . . . . 73.14 108.627 176.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -106.81 114.16 28.09 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 107.719 -1.215 . . . . 71.3 107.719 171.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.554 ' HB ' ' HB3' ' B' ' 8' ' ' LEU . 3.1 p -147.09 108.44 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 122.81 0.444 . . . . 75.1 111.845 -170.365 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 62.5 20.67 12.1 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.31 1.044 . . . . 74.24 112.198 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 92.64 4.87 65.31 Favored Glycine 0 C--N 1.352 1.428 0 CA-C-N 116.257 -0.429 . . . . 31.1 112.782 -175.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.468 ' HA ' ' NE ' ' A' ' 143' ' ' ARG . 3.7 tpm_? -98.59 106.67 18.97 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.567 0.747 . . . . 72.12 109.998 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 49.5 ttp180 -85.32 98.75 10.71 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.716 0.806 . . . . 74.41 109.252 174.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.504 HG13 ' HB ' ' A' ' 138' ' ' VAL . 2.5 p -110.8 131.93 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 123.458 0.703 . . . . 73.53 110.906 -177.184 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 48.3 t -89.35 93.28 9.48 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.705 0.802 . . . . 31.45 109.501 177.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 43.4 t -93.95 111.17 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 109.353 -0.61 . . . . 73.42 109.353 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 58.9 ttt85 -77.84 105.18 8.86 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 109.432 -0.581 . . . . 74.14 109.432 175.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.487 HG13 ' HA2' ' A' ' 133' ' ' GLY . 33.2 pt -90.71 149.17 40.04 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 123.766 0.826 . . . . 74.13 110.409 177.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -63.73 132.14 33.97 Favored 'Trans proline' 0 C--N 1.379 2.158 0 C-N-CA 122.843 2.362 . . . . 60.34 111.794 175.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.24 95.54 0.06 OUTLIER 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 123.155 2.57 . . . . 74.15 112.184 171.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 107.81 47.32 0.97 Allowed Glycine 0 C--N 1.341 0.828 0 N-CA-C 111.255 -0.738 . . . . 75.51 111.255 -172.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 5.2 p -86.25 141.39 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 108.219 -1.03 . . . . 75.43 108.219 175.042 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.529 ' HG2' ' HA ' ' A' ' 191' ' ' GLN . 0.0 OUTLIER -118.97 135.76 54.44 Favored 'General case' 0 C--O 1.198 -1.62 0 CA-C-O 117.116 -1.421 . . . . 73.23 110.146 -160.839 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.469 ' HB3' ' HB3' ' A' ' 188' ' ' LEU . 5.0 tp10 -43.62 129.94 5.35 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 119.386 0.994 . . . . 72.32 111.381 174.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 88.3 -7.47 81.49 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-O 119.062 -0.855 . . . . 14.21 113.594 -175.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.423 ' O ' HG12 ' A' ' 178' ' ' VAL . 8.2 t -66.26 113.53 4.65 Favored 'General case' 0 C--N 1.362 1.129 0 N-CA-C 107.247 -1.39 . . . . 74.23 107.247 176.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 58.9 t -85.12 91.27 3.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 107.696 -1.224 . . . . 72.34 107.696 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.599 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 32.8 mt -70.71 82.82 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 107.3 -1.37 . . . . 75.24 107.3 174.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 63.2 ttt-85 -74.57 97.93 3.26 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 107.804 -1.184 . . . . 61.32 107.804 179.26 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.401 ' HA ' ' HD2' ' A' ' 162' ' ' PRO . 2.5 p -106.82 104.71 52.67 Favored Pre-proline 0 C--O 1.242 0.707 0 N-CA-C 108.834 -0.802 . . . . 61.33 108.834 -178.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 161' ' ' VAL . 29.0 Cg_endo -62.03 104.16 0.32 Allowed 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 122.055 1.836 . . . . 74.53 109.956 173.132 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.451 ' HA3' ' N ' ' A' ' 87' ' ' GLY . . . 124.56 26.82 1.38 Allowed Glycine 0 C--N 1.341 0.843 0 N-CA-C 115.759 1.063 . . . . 70.43 115.759 174.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 22.5 mmt -138.63 1.75 2.15 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 117.999 0.899 . . . . 64.15 111.33 172.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.639 ' HA2' HD13 ' A' ' 174' ' ' LEU . . . -84.01 -123.09 0.98 Allowed Glycine 0 C--N 1.351 1.38 0 N-CA-C 114.252 0.461 . . . . 73.33 114.252 -171.004 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -58.54 143.95 43.96 Favored Glycine 0 C--N 1.351 1.37 0 O-C-N 124.122 0.542 . . . . 74.5 111.864 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.686 ' HB3' ' HA3' ' A' ' 108' ' ' GLY . 27.1 mm-40 -68.47 103.98 1.8 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.956 0.902 . . . . 75.42 111.937 -164.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -156.05 168.62 33.52 Favored Glycine 0 C--N 1.338 0.69 0 N-CA-C 109.759 -1.337 . . . . 64.21 109.759 177.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ASN . . . . . 0.72 ' HA ' ' HB3' ' A' ' 106' ' ' PHE . 0.3 OUTLIER -62.14 -53.62 57.32 Favored Pre-proline 0 N--CA 1.485 1.289 0 CA-C-N 118.401 1.1 . . . . 63.11 110.032 -179.198 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.659 ' HD3' ' HB3' ' A' ' 169' ' ' ASN . 24.4 Cg_endo -95.99 90.79 0.09 OUTLIER 'Trans proline' 0 C--N 1.387 2.558 0 C-N-CA 122.089 1.86 . . . . 71.13 108.079 159.303 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.428 ' HD3' ' O ' ' A' ' 169' ' ' ASN . 25.3 Cg_exo -60.58 174.82 1.42 Allowed 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 122.786 2.324 . . . . 71.25 113.857 -171.164 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -66.35 175.15 21.01 Favored Glycine 0 N--CA 1.472 1.052 0 N-CA-C 115.397 0.919 . . . . 72.4 115.397 -175.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -69.79 97.43 1.09 Allowed 'General case' 0 C--O 1.242 0.693 0 N-CA-C 108.225 -1.028 . . . . 71.14 108.225 172.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.639 HD13 ' HA2' ' A' ' 165' ' ' GLY . 21.4 tp -78.47 104.0 8.78 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 109.518 -0.549 . . . . 64.32 109.518 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 68.4 mt -71.67 81.58 0.85 Allowed 'General case' 0 C--O 1.242 0.67 0 C-N-CA 124.1 0.96 . . . . 72.12 109.07 173.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.797 HD22 HD23 ' A' ' 123' ' ' LEU . 34.8 mt -76.02 90.06 3.01 Favored 'General case' 0 C--N 1.35 0.627 0 CA-C-N 115.978 -0.556 . . . . 70.05 110.133 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.446 ' HB ' ' HG2' ' A' ' 122' ' ' GLU . 17.4 t -82.22 105.04 11.65 Favored 'Isoleucine or valine' 0 C--O 1.246 0.886 0 N-CA-C 106.954 -1.498 . . . . 61.43 106.954 179.086 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.423 HG12 ' O ' ' A' ' 157' ' ' SER . 7.1 p -71.21 106.42 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.037 0 CA-C-N 114.924 -1.034 . . . . 70.33 110.963 -174.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.659 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 33.7 mmt180 -91.89 94.46 9.32 Favored 'General case' 0 C--O 1.208 -1.089 0 C-N-CA 123.233 0.613 . . . . 53.32 110.215 179.188 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.536 HD23 ' HB3' ' A' ' 125' ' ' LEU . 17.6 mt -67.12 143.73 56.48 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 121.379 -0.826 . . . . 72.4 110.564 -177.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.41 ' HA ' ' HD3' ' A' ' 182' ' ' PRO . 82.5 mt -54.37 144.62 41.01 Favored Pre-proline 0 N--CA 1.476 0.835 0 O-C-N 124.367 1.042 . . . . 73.14 111.329 -172.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 181' ' ' LEU . 8.0 Cg_exo -75.17 36.52 0.45 Allowed 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 123.041 2.494 . . . . 71.42 113.073 176.429 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.488 ' HB3' HD11 ' A' ' 127' ' ' LEU . 24.1 t-80 -61.45 126.26 86.16 Favored Pre-proline 0 CA--C 1.549 0.929 0 N-CA-C 107.636 -1.246 . . . . 73.35 107.636 171.079 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 183' ' ' HIS . 21.2 Cg_exo -66.16 24.06 0.1 OUTLIER 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 124.078 3.185 . . . . 61.24 118.689 -160.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 16.2 t -102.93 -59.99 3.1 Favored 'Isoleucine or valine' 0 C--N 1.367 1.366 0 CA-C-N 121.23 1.832 . . . . 64.21 109.362 175.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' PHE . . . . . 0.543 ' CD1' ' HB2' ' A' ' 195' ' ' ALA . 49.0 m-85 -120.09 140.6 50.8 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.006 0.743 . . . . 72.31 113.006 -168.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -117.49 92.18 3.78 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 104.604 -2.369 . . . . 75.51 104.604 162.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.579 ' HA ' ' HA ' ' A' ' 193' ' ' LEU . 13.9 tp -73.33 162.14 29.68 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.468 1.107 . . . . 74.21 109.897 -177.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.466 ' H ' HD12 ' A' ' 188' ' ' LEU . 11.4 tp10 -163.99 129.53 2.95 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.766 0.827 . . . . 70.31 109.464 171.399 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 75.25 -77.99 1.15 Allowed Glycine 0 C--N 1.348 1.237 0 O-C-N 123.388 0.43 . . . . 65.41 112.986 175.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.529 ' HA ' ' HG2' ' A' ' 154' ' ' ARG . 0.5 OUTLIER -153.26 -0.8 0.24 Allowed 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 124.708 1.203 . . . . 72.32 110.364 170.28 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.47 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 6.4 p-10 -117.95 133.19 56.16 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.998 1.319 . . . . 72.32 111.566 -172.352 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.579 ' HA ' ' HA ' ' A' ' 188' ' ' LEU . 18.2 mt -88.43 155.11 19.86 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.611 1.165 . . . . 63.44 110.126 -171.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -126.2 99.13 5.75 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 108.489 -0.93 . . . . 73.14 108.489 167.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.544 ' HB3' HD23 ' A' ' 251' ' ' LEU . . . -103.02 173.19 6.42 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.021 0.929 . . . . 74.34 109.325 175.005 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 196' ' ' THR . . . . . 0.538 HG21 ' HD3' ' B' ' 293' ' ' PRO . 30.7 m -110.88 149.06 31.15 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 108.457 -0.942 . . . . 70.21 108.457 171.439 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.424 HD22 HD13 ' A' ' 251' ' ' LEU . 49.5 tp -142.44 109.53 5.55 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 109.248 -0.649 . . . . 72.21 109.248 -176.228 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -86.35 121.93 29.61 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 108.296 -1.002 . . . . 61.43 108.296 173.098 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 7.5 p -140.36 133.25 14.8 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 123.987 0.915 . . . . 64.4 108.588 -176.215 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.69 156.55 48.93 Favored 'Trans proline' 0 C--N 1.369 1.645 0 C-N-CA 121.858 1.705 . . . . 64.51 111.911 175.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -57.51 -46.64 99.77 Favored Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 124.725 1.21 . . . . 71.34 114.038 -170.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -57.86 -45.04 35.28 Favored 'Trans proline' 0 C--N 1.39 2.75 0 C-N-CA 121.643 1.562 . . . . 63.54 113.082 175.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.471 HD11 ' HB3' ' C' ' 276' ' ' TYR . 33.8 mt -71.33 -27.19 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.087 0.555 . . . . 64.32 110.273 -179.435 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -71.52 -47.33 55.93 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.359 0.663 . . . . 71.51 111.08 177.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 53.0 t -65.71 -49.94 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 123.629 0.772 . . . . 63.23 111.309 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 59.0 t -88.74 -43.47 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.588 0.755 . . . . 74.41 111.509 -170.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 96.19 121.75 3.98 Favored Glycine 0 C--N 1.338 0.666 0 CA-C-N 115.947 -0.569 . . . . 72.35 112.683 -174.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.451 ' H ' ' HB ' ' A' ' 223' ' ' VAL . . . -141.98 -137.2 3.34 Favored Glycine 0 C--N 1.341 0.827 0 N-CA-C 111.095 -0.802 . . . . 55.24 111.095 178.041 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -136.24 137.71 41.07 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 118.006 0.903 . . . . 45.21 109.739 174.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 26.9 m -133.74 149.47 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 N-CA-C 108.59 -0.893 . . . . 63.11 108.59 172.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' ARG . . . . . 0.417 ' HD2' ' O ' ' B' ' 408' ' ' LEU . 21.3 ttm105 -75.36 107.58 7.57 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 121.101 0.477 . . . . 71.41 110.12 177.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -105.78 144.81 31.99 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.348 1.059 . . . . 62.04 109.181 175.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 213' ' ' MET . . . . . 0.514 ' SD ' ' N ' ' A' ' 213' ' ' MET . 0.5 OUTLIER -87.02 151.82 22.92 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 123.07 0.548 . . . . 71.23 109.898 -177.998 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 81.3 p -122.05 -162.67 1.01 Allowed 'General case' 0 C--O 1.243 0.732 0 N-CA-C 108.36 -0.978 . . . . 74.1 108.36 170.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.875 HD22 ' HB3' ' A' ' 127' ' ' LEU . 34.1 mt -65.36 -42.63 92.57 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.159 0.584 . . . . 63.31 110.781 177.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -129.3 30.35 5.0 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 115.331 -0.85 . . . . 64.44 112.351 -165.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 155.45 158.2 8.65 Favored Glycine 0 C--N 1.352 1.457 0 CA-C-O 119.75 -0.472 . . . . 33.0 113.888 173.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -94.25 101.67 0.13 Allowed 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 123.277 2.651 . . . . 70.23 112.716 178.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 29.7 m -90.63 173.67 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 123.822 0.849 . . . . 73.4 109.771 -176.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.551 ' HG3' ' HA ' ' B' ' 438' ' ' GLN . 25.9 pt-20 -100.74 124.01 45.76 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 108.47 -0.937 . . . . 75.04 108.47 169.564 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 14.4 p -100.22 129.21 51.29 Favored 'Isoleucine or valine' 0 C--O 1.245 0.867 0 N-CA-C 108.493 -0.928 . . . . 74.13 108.493 173.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.509 ' HB3' ' HA ' ' B' ' 440' ' ' ARG . . . -84.43 101.24 11.87 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 109.379 -0.6 . . . . 60.25 109.379 178.374 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.451 ' HB ' ' H ' ' A' ' 208' ' ' GLY . 62.4 t -58.33 136.49 85.16 Favored Pre-proline 0 CA--C 1.553 1.067 0 CA-C-N 113.677 -1.601 . . . . 63.14 110.064 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 224' ' ' PRO . . . . . 0.594 ' HG3' HD11 ' B' ' 441' ' ' ILE . 32.0 Cg_endo -81.8 176.32 8.5 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 122.987 2.458 . . . . 75.51 110.716 177.021 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -71.53 159.09 52.27 Favored 'Trans proline' 0 C--N 1.359 1.131 0 C-N-CA 120.607 0.871 . . . . 72.53 110.844 165.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 226' ' ' ARG . . . . . 0.572 ' HD2' ' O ' ' C' ' 259' ' ' GLU . 11.1 mmt180 65.81 26.95 11.16 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 124.56 1.144 . . . . 74.04 113.195 168.227 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.529 HG23 HD21 ' A' ' 233' ' ' LEU . 31.4 m -65.1 84.43 0.05 OUTLIER 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 124.969 1.308 . . . . 64.32 109.568 175.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -86.39 138.89 31.44 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.291 1.036 . . . . 75.32 110.713 -171.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -50.11 127.26 16.42 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.39 1.476 . . . . 62.31 112.112 -176.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 230' ' ' GLY . . . . . 0.459 ' HA3' ' HB3' ' B' ' 290' ' ' TRP . . . 88.29 -25.06 9.6 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-N 115.543 -0.753 . . . . 73.32 114.462 172.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.432 ' O ' HG23 ' A' ' 253' ' ' VAL . 70.8 mtt180 -67.5 156.01 37.69 Favored 'General case' 0 C--N 1.345 0.408 0 N-CA-C 109.323 -0.621 . . . . 74.0 109.323 172.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? -110.46 123.29 49.63 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.558 -0.904 . . . . 72.22 108.558 -176.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.529 HD21 HG23 ' A' ' 227' ' ' THR . 80.7 mt -72.42 111.53 7.69 Favored 'General case' 0 C--O 1.217 -0.645 0 N-CA-C 107.525 -1.287 . . . . 71.4 107.525 179.296 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -95.21 100.28 12.11 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 123.462 0.476 . . . . 64.14 110.185 -178.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.731 ' HB3' ' HB ' ' B' ' 441' ' ' ILE . 0.2 OUTLIER -107.31 107.02 17.74 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.547 0.739 . . . . 61.12 109.455 -179.659 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.609 ' HA ' ' HB3' ' A' ' 248' ' ' ASP . 14.2 mmmm -67.54 148.91 50.84 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.702 0.801 . . . . 64.43 111.73 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.475 ' HA2' ' HB2' ' A' ' 246' ' ' ARG . . . 73.55 23.79 76.2 Favored Glycine 0 C--N 1.352 1.45 0 CA-C-N 116.164 -0.471 . . . . 74.2 113.566 177.307 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.568 ' HG3' HD12 ' A' ' 235' ' ' LEU . 46.6 mmtm -123.05 -26.23 4.4 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.873 0.869 . . . . 73.01 110.985 -174.153 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -80.19 -155.19 10.58 Favored Glycine 0 C--N 1.345 1.079 0 CA-C-N 115.948 -0.569 . . . . 74.43 113.009 171.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 240' ' ' PHE . . . . . 0.5 ' HZ ' HD11 ' A' ' 215' ' ' LEU . 3.9 m-85 -94.92 139.03 21.98 Favored Pre-proline 0 N--CA 1.478 0.95 0 CA-C-O 118.893 -0.575 . . . . 73.13 111.175 -168.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.597 ' HA ' ' HA ' ' A' ' 246' ' ' ARG . 59.6 Cg_exo -42.4 129.04 4.75 Favored 'Trans proline' 0 C--N 1.391 2.79 0 C-N-CA 124.437 3.425 . . . . 73.33 114.585 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -165.23 -147.15 5.04 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-O 119.334 -0.703 . . . . 73.52 112.586 -176.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 243' ' ' PRO . . . . . 0.465 ' HD2' ' HG2' ' A' ' 191' ' ' GLN . 28.1 Cg_exo -62.71 -28.42 76.51 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 123.761 2.974 . . . . 70.45 113.138 -177.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -90.82 21.28 4.2 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.964 0.906 . . . . 70.11 111.524 -179.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 78.28 -70.11 2.65 Favored Glycine 0 C--N 1.35 1.346 0 N-CA-C 109.762 -1.335 . . . . 62.24 109.762 -170.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.597 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 64.0 mtm180 -122.65 144.82 48.88 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 107.154 -1.425 . . . . 75.41 107.154 164.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -69.55 -165.81 4.81 Favored Glycine 0 C--N 1.335 0.514 0 CA-C-O 121.435 0.464 . . . . 42.24 113.919 172.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 248' ' ' ASP . . . . . 0.609 ' HB3' ' HA ' ' A' ' 236' ' ' LYS . 0.9 OUTLIER -121.0 173.53 7.2 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.589 0.755 . . . . 75.44 111.492 -174.049 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.467 HD23 HD11 ' A' ' 235' ' ' LEU . 16.2 tp -126.56 136.25 52.32 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.297 -1.001 . . . . 70.31 108.297 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.443 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 56.5 m-85 -111.78 113.94 26.61 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.352 1.061 . . . . 52.51 109.112 176.041 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.544 HD23 ' HB3' ' A' ' 195' ' ' ALA . 78.2 mt -102.39 106.85 17.67 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 109.262 -0.644 . . . . 72.24 109.262 178.123 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -76.79 117.94 18.9 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 109.435 -0.58 . . . . 75.41 109.435 -178.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 231' ' ' ARG . 49.2 t -71.61 134.19 30.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-N 114.477 -1.238 . . . . 24.43 111.31 -171.657 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -130.94 91.23 3.02 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 106.82 -1.548 . . . . 73.14 106.82 177.113 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.492 HD13 HG23 ' C' ' 257' ' ' ILE . 62.0 mt -77.52 127.88 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 122.767 0.427 . . . . 74.34 111.243 -173.408 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 25.6 p -116.11 165.16 13.46 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.738 1.215 . . . . 73.43 110.263 175.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 257' ' ' ILE . . . . . 0.486 ' HB ' ' HD2' ' A' ' 258' ' ' PRO . 2.9 pp -134.17 154.54 80.13 Favored Pre-proline 0 N--CA 1.486 1.363 0 C-N-CA 123.519 0.728 . . . . 73.4 109.079 174.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 258' ' ' PRO . . . . . 0.486 ' HD2' ' HB ' ' A' ' 257' ' ' ILE . 18.4 Cg_endo -54.28 -17.84 12.89 Favored 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 123.705 2.937 . . . . 74.45 116.336 -164.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.413 ' H ' HD12 ' A' ' 257' ' ' ILE . 7.7 mm-40 59.18 -64.49 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 125.234 1.414 . . . . 63.24 113.119 -167.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -79.24 129.68 34.7 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.792 -0.568 . . . . 75.12 111.013 178.529 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.413 HD12 ' HD2' ' C' ' 226' ' ' ARG . 67.4 mt -143.29 154.59 43.94 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.412 1.085 . . . . 55.32 109.852 177.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 262' ' ' THR . . . . . 0.445 ' HB ' ' HD2' ' A' ' 263' ' ' PRO . 18.0 p -132.33 159.3 72.84 Favored Pre-proline 0 CA--C 1.564 1.515 0 C-N-CA 124.791 1.236 . . . . 44.34 108.787 174.066 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 263' ' ' PRO . . . . . 0.445 ' HD2' ' HB ' ' A' ' 262' ' ' THR . 39.2 Cg_exo -17.21 -58.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.398 3.155 1 C-N-CA 127.317 5.344 . . . . 74.33 119.167 -170.921 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -70.9 -47.51 58.76 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 118.056 0.389 . . . . 71.44 111.861 -173.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 265' ' ' GLU . . . . . 0.4 ' HB3' HD22 ' A' ' 261' ' ' LEU . 5.5 mp0 -66.05 -36.97 84.67 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 109.506 -0.553 . . . . 64.2 109.506 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 266' ' ' GLU . . . . . 0.461 ' O ' ' HG3' ' A' ' 270' ' ' LYS . 4.2 tp10 -52.55 -48.97 65.81 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 124.509 1.131 . . . . 73.45 109.238 172.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -58.65 -51.16 71.11 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.697 1.199 . . . . 64.12 112.835 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 11.0 mp -59.94 -46.62 88.81 Favored 'General case' 0 N--CA 1.483 1.223 0 O-C-N 123.717 0.636 . . . . 73.14 110.689 -178.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -65.61 -34.93 79.37 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 123.58 0.752 . . . . 75.0 112.385 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 270' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' A' ' 266' ' ' GLU . 9.1 mtpm? -63.06 -55.31 26.6 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 122.961 0.504 . . . . 62.43 110.793 176.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 30.7 mmtm -62.98 -27.99 69.78 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 124.085 0.865 . . . . 70.22 111.634 -178.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 272' ' ' LEU . . . . . 0.434 ' O ' ' HB2' ' A' ' 276' ' ' TYR . 40.9 mt -60.12 -55.42 34.05 Favored 'General case' 0 C--O 1.207 -1.158 0 O-C-N 123.836 0.71 . . . . 63.4 109.887 167.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -63.34 -33.42 75.48 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.874 0.87 . . . . 64.51 113.184 -176.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.439 ' HA ' ' HB3' ' B' ' 250' ' ' GLN . 43.9 mt-10 -69.57 -55.34 10.39 Favored 'General case' 0 C--O 1.252 1.203 0 C-N-CA 123.957 0.903 . . . . 74.35 109.736 179.199 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -77.26 -2.86 36.86 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-N 115.032 -0.985 . . . . 71.44 111.668 178.11 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 276' ' ' TYR . . . . . 0.434 ' HB2' ' O ' ' A' ' 272' ' ' LEU . 33.4 t80 -79.53 -61.79 1.89 Allowed 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.236 -1.024 . . . . 75.02 108.236 171.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 277' ' ' TYR . . . . . 0.472 ' HA ' ' HB2' ' A' ' 280' ' ' ALA . 2.6 t80 -58.03 -38.76 76.84 Favored 'General case' 0 C--N 1.356 0.877 0 O-C-N 124.988 1.43 . . . . 70.12 109.53 -175.6 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -48.03 -38.05 16.31 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.67 1.188 . . . . 75.41 113.7 175.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 279' ' ' ARG . . . . . 0.536 ' HA ' HD21 ' B' ' 277' ' ' LEU . 0.1 OUTLIER -132.55 37.85 3.47 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 109.319 -0.623 . . . . 74.13 109.319 179.139 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 280' ' ' ALA . . . . . 0.472 ' HB2' ' HA ' ' A' ' 277' ' ' TYR . . . . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 118.89 -0.576 . . . . 72.21 112.102 -175.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 61.1 mtm . . . . . 0 N--CA 1.483 1.18 0 N-CA-C 109.488 -0.56 . . . . 71.44 109.488 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt 67.09 -77.42 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 125.335 1.454 . . . . 54.1 111.552 177.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 36.6 tp60 -154.51 128.01 8.57 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 107.258 -1.386 . . . . 74.04 107.258 -177.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 39.4 m -141.75 100.65 3.8 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 108.763 -0.828 . . . . 52.14 108.763 -178.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 8.6 m -64.09 153.34 37.86 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.353 0.661 . . . . 70.11 112.428 -168.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.722 HG21 ' HA ' ' A' ' 125' ' ' LEU . 19.1 pt -117.55 -177.64 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 N-CA-C 113.12 0.785 . . . . 64.44 113.12 -167.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -135.76 143.66 45.39 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 114.572 -1.194 . . . . 72.01 110.322 177.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.619 HD11 ' HB1' ' A' ' 121' ' ' ALA . 36.9 tp -115.76 157.72 23.91 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.842 1.257 . . . . 75.22 108.494 173.498 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -103.73 -35.66 8.14 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.016 0.526 . . . . 62.4 111.926 178.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 10' ' ' LEU . . . . . 0.424 ' HG ' HG21 ' A' ' 140' ' ' VAL . 88.4 mt 76.68 2.58 3.4 Favored 'General case' 0 N--CA 1.502 2.145 0 C-N-CA 125.556 1.543 . . . . 74.1 110.726 -162.293 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.461 HD11 ' HG3' ' A' ' 122' ' ' GLU . 65.0 mt 64.43 36.32 0.2 Allowed Pre-proline 0 CA--C 1.578 2.043 0 N-CA-C 116.383 1.994 . . . . 45.35 116.383 177.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.77 -23.87 13.9 Favored 'Trans proline' 0 C--N 1.402 3.344 0 CA-C-N 122.511 1.933 . . . . 61.33 109.661 160.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 2.2 pp -136.31 153.43 51.16 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 126.027 1.731 . . . . 75.01 107.218 169.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -148.02 145.72 28.61 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 122.436 0.294 . . . . 64.54 110.509 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -119.37 103.56 9.58 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.013 0.925 . . . . 60.01 108.712 176.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 40.2 p -82.46 157.48 67.54 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 123.573 0.749 . . . . 51.11 109.181 172.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -59.37 95.85 0.09 OUTLIER 'Trans proline' 0 C--N 1.384 2.404 0 C-N-CA 122.379 2.053 . . . . 62.42 111.464 176.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 6.3 p -69.35 91.14 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.139 0 CA-C-O 122.203 1.001 . . . . 61.41 110.721 -178.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 10.1 t -160.84 159.51 29.93 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 114.789 -1.096 . . . . 71.22 109.325 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 45.7 tptt -153.69 -45.33 0.09 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.167 0.587 . . . . 62.34 109.827 -178.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -147.19 -29.98 0.35 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.215 0.606 . . . . 75.34 111.153 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 68.33 -73.5 0.08 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 125.02 1.328 . . . . 73.31 110.135 -172.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 23' ' ' THR . . . . . . . . . . . . . 29.0 m -123.33 96.2 44.42 Favored Pre-proline 0 CA--C 1.546 0.789 0 N-CA-C 107.634 -1.247 . . . . 72.45 107.634 173.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.87 84.0 0.86 Allowed 'Trans proline' 0 C--N 1.38 2.227 0 C-N-CA 122.618 2.212 . . . . 74.55 110.825 176.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -73.98 90.86 1.98 Allowed 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 114.803 -1.089 . . . . 74.53 109.598 178.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 52.5 mtp -155.47 -49.04 0.01 OUTLIER Pre-proline 0 N--CA 1.499 2.02 0 C-N-CA 124.641 1.177 . . . . 75.13 111.67 175.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -80.17 42.4 1.31 Allowed 'Trans proline' 0 C--N 1.402 3.391 0 C-N-CA 122.772 2.314 . . . . 71.1 112.527 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 34.9 m -107.6 -2.7 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 123.948 0.899 . . . . 73.51 111.607 -176.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 30.6 tp -53.25 -53.86 44.7 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 125.221 1.408 . . . . 62.2 112.464 -173.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' B' ' 371' ' ' VAL . 0.0 OUTLIER -105.52 2.98 28.91 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 114.143 -1.39 . . . . 70.24 111.376 -169.631 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.64 -20.42 59.9 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 123.068 0.547 . . . . 74.34 110.501 -178.163 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 32' ' ' ARG . . . . . 0.561 ' HB3' ' HA ' ' B' ' 375' ' ' LEU . 4.9 tpm_? -146.93 -60.05 0.29 Allowed 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 122.83 0.452 . . . . 72.22 111.337 175.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 33' ' ' ALA . . . . . 0.56 ' HA ' ' HB3' ' B' ' 373' ' ' ARG . . . 56.03 80.02 0.15 Allowed 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.675 1.19 . . . . 73.31 111.59 -167.429 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.48 12.21 2.11 Favored 'General case' 0 CA--C 1.555 1.173 0 N-CA-C 113.168 0.803 . . . . 53.33 113.168 -175.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -157.99 -63.8 0.09 Allowed 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 118.499 0.591 . . . . 73.13 111.363 174.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 122.87 -71.9 0.41 Allowed Glycine 0 C--N 1.339 0.732 0 N-CA-C 110.563 -1.015 . . . . 74.33 110.563 -175.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 37' ' ' ASP . . . . . 0.433 ' HB2' HH22 ' C' ' 234' ' ' ARG . 11.9 m-20 58.55 94.29 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 125.288 1.435 . . . . 61.44 111.124 -179.309 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 45.7 pt -127.67 13.96 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.981 0 C-N-CA 123.955 0.902 . . . . 75.44 112.262 -172.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 7.6 m -52.46 107.12 0.19 Allowed 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 123.607 0.763 . . . . 64.25 111.171 -170.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -48.31 107.04 0.68 Allowed Pre-proline 0 N--CA 1.482 1.128 0 O-C-N 125.267 1.605 . . . . 64.0 113.779 -166.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -78.19 -46.4 0.12 Allowed 'Trans proline' 0 C--N 1.37 1.671 0 C-N-CA 122.346 2.031 . . . . 72.44 109.654 167.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.6 113.87 0.25 Allowed Glycine 0 C--N 1.351 1.396 0 CA-C-N 114.901 -1.045 . . . . 45.24 112.466 176.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.67 103.15 0.92 Allowed Glycine 0 CA--C 1.532 1.108 0 CA-C-O 119.692 -0.504 . . . . 42.15 111.854 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . 62.89 96.4 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 125.223 1.409 . . . . 63.2 111.269 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.56 ' HG2' HG23 ' B' ' 236' ' ' THR . 4.9 mmp_? -82.37 98.92 9.09 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 122.677 0.391 . . . . 74.21 110.851 -174.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.24 23.57 1.23 Allowed 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 126.609 1.964 . . . . 75.02 113.797 178.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 68.6 tp -58.15 -42.75 86.58 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.515 1.126 . . . . 53.22 111.556 -174.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 29.1 m 70.36 -64.1 0.38 Allowed 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 125.933 1.693 . . . . 51.22 111.29 -178.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -166.32 -90.54 0.08 OUTLIER Glycine 0 C--N 1.339 0.711 0 N-CA-C 110.517 -1.033 . . . . 74.15 110.517 173.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -105.79 91.54 3.79 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 107.548 -1.279 . . . . 64.2 107.548 172.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 9.7 pm0 -64.38 -28.58 69.79 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.036 0.935 . . . . 75.3 111.485 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 3.3 m -104.49 150.03 24.93 Favored 'General case' 0 CA--C 1.554 1.127 0 N-CA-C 108.303 -0.999 . . . . 73.31 108.303 177.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.22 145.32 55.33 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 112.888 0.699 . . . . 73.24 112.888 -165.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.507 ' HA ' ' HA3' ' B' ' 162' ' ' GLY . . . -80.92 170.94 15.63 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.493 1.117 . . . . 75.51 110.844 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.417 HD22 ' N ' ' B' ' 56' ' ' ARG . 0.0 OUTLIER -51.15 -37.6 47.24 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.722 1.209 . . . . 72.35 112.983 -175.451 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 56' ' ' ARG . . . . . 0.56 ' HD3' ' SD ' ' B' ' 157' ' ' MET . 44.3 ttt180 52.15 -82.73 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 125.231 1.412 . . . . 73.2 113.374 175.209 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -78.9 -84.75 0.08 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.472 0.709 . . . . 75.31 110.371 -174.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 22.3 t 63.75 26.29 14.41 Favored 'General case' 0 CA--C 1.565 1.547 0 C-N-CA 124.404 1.082 . . . . 62.01 112.498 176.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -81.78 137.69 35.28 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.481 0.712 . . . . 72.44 110.209 172.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 79.9 p -85.9 2.65 45.19 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.792 0.837 . . . . 63.51 111.649 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -77.14 -11.17 59.78 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 124.092 0.957 . . . . 71.45 111.922 178.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 62' ' ' LYS . . . . . 0.414 ' HB3' HD11 ' B' ' 155' ' ' LEU . 27.8 mmtp -78.03 154.52 80.17 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 123.934 0.894 . . . . 72.3 110.84 -174.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -47.87 -33.09 18.88 Favored 'Trans proline' 0 C--N 1.391 2.768 0 C-N-CA 124.511 3.474 . . . . 72.24 113.953 -174.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 57.25 -89.56 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.096 1.359 . . . . 72.04 111.503 174.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -91.04 -49.23 6.52 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.704 0.801 . . . . 65.32 110.509 -176.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -79.6 96.7 6.24 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.181 -0.674 . . . . 72.41 109.181 -178.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 67' ' ' ILE . . . . . 0.594 HG13 ' H ' ' B' ' 69' ' ' LEU . 7.0 tp -161.55 143.3 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.103 0.961 . . . . 72.03 108.476 -174.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 43.6 pt -61.4 -20.57 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 123.322 0.649 . . . . 73.4 112.55 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.594 ' H ' HG13 ' B' ' 67' ' ' ILE . 1.4 tt 55.47 -103.11 0.17 Allowed 'General case' 0 CA--C 1.559 1.293 0 C-N-CA 124.775 1.23 . . . . 73.12 109.788 176.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 70' ' ' LEU . . . . . 0.419 ' H ' ' HB3' ' B' ' 69' ' ' LEU . 95.2 mt -147.88 26.56 1.0 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.428 1.491 . . . . 44.44 107.6 176.505 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 50.9 mm -64.99 121.74 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 124.865 1.266 . . . . 74.32 111.121 -171.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 142.73 61.41 0.03 OUTLIER Glycine 0 C--N 1.341 0.819 0 N-CA-C 110.114 -1.194 . . . . 62.21 110.114 -176.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 65.7 -76.86 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 125.437 1.495 . . . . 63.44 110.221 -172.395 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -156.35 53.04 0.42 Allowed Glycine 0 C--N 1.342 0.878 0 N-CA-C 110.445 -1.062 . . . . 64.42 110.445 177.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 7.8 tpt -74.15 93.82 2.35 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 109.15 -0.685 . . . . 74.01 109.15 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 123.4 -41.18 1.82 Allowed Glycine 0 N--CA 1.47 0.952 0 N-CA-C 111.351 -0.699 . . . . 71.13 111.351 -175.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -76.15 -62.49 1.59 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.833 0.853 . . . . 73.03 109.9 178.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 19.7 t 61.39 24.15 14.3 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 125.034 1.333 . . . . 51.1 111.405 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 79' ' ' GLU . . . . . 0.644 ' HG3' HG23 ' B' ' 80' ' ' ILE . 11.2 tp10 -97.52 153.82 17.91 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 124.452 1.101 . . . . 74.44 110.12 -177.415 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.644 HG23 ' HG3' ' B' ' 79' ' ' GLU . 22.6 pt 50.5 21.53 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 C-N-CA 126.813 2.045 . . . . 72.52 114.5 176.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 81' ' ' THR . . . . . 0.486 HG23 ' H ' ' B' ' 82' ' ' ALA . 0.6 OUTLIER -108.11 -68.5 0.9 Allowed 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.438 0.695 . . . . 71.34 109.685 173.87 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 82' ' ' ALA . . . . . 0.486 ' H ' HG23 ' B' ' 81' ' ' THR . . . 62.5 6.43 1.98 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.632 1.173 . . . . 61.11 113.39 -178.49 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . 65.07 -69.27 0.1 Allowed 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.881 1.273 . . . . 71.35 111.607 -171.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? 69.28 -84.97 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 125.26 1.424 . . . . 73.0 109.596 176.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 50.98 -87.45 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 125.633 1.573 . . . . 72.23 111.642 -177.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -111.91 88.23 2.75 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.137 -1.06 . . . . 63.12 108.137 177.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.83 -174.98 4.68 Favored 'General case' 0 C--O 1.247 0.925 0 C-N-CA 124.904 1.282 . . . . 52.24 108.967 -178.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 63.37 28.26 15.52 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 124.039 0.936 . . . . 74.14 110.897 175.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -87.18 -125.93 2.1 Favored Glycine 0 C--N 1.344 1.016 0 CA-C-O 119.33 -0.706 . . . . 54.33 111.338 179.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . 65.63 -71.47 0.08 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 125.196 1.398 . . . . 62.33 111.737 178.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.68 -8.63 78.78 Favored Glycine 0 C--N 1.347 1.192 0 CA-C-O 119.66 -0.522 . . . . 70.11 113.193 175.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -84.84 45.61 3.54 Favored Glycine 0 C--N 1.356 1.643 0 CA-C-N 116.977 0.388 . . . . 23.53 112.385 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -161.59 119.18 2.26 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.632 1.173 . . . . 74.22 108.67 178.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -89.48 63.14 6.23 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 121.561 0.696 . . . . 71.21 109.301 177.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -110.55 153.24 25.41 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.537 -0.756 . . . . 74.14 110.315 -178.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 69.67 -92.85 0.36 Allowed Glycine 0 C--N 1.345 1.072 0 O-C-N 123.979 0.8 . . . . 72.31 111.682 -176.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 97' ' ' ILE . . . . . 0.421 HG12 ' HB3' ' B' ' 100' ' ' LEU . 0.7 OUTLIER 74.78 -29.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 C-N-CA 126.319 1.848 . . . . 72.22 112.79 178.386 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 69.33 -78.7 0.04 OUTLIER 'General case' 0 C--N 1.361 1.079 0 C-N-CA 125.84 1.656 . . . . 75.21 111.79 171.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -157.64 30.85 0.27 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.66 0.784 . . . . 61.12 110.142 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 100' ' ' LEU . . . . . 0.512 ' HB3' ' HD3' ' B' ' 101' ' ' PRO . 2.8 tm? -59.83 -56.53 34.75 Favored Pre-proline 0 CA--C 1.566 1.561 0 C-N-CA 124.189 0.996 . . . . 74.2 111.038 -178.524 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 101' ' ' PRO . . . . . 0.512 ' HD3' ' HB3' ' B' ' 100' ' ' LEU . 40.7 Cg_endo -96.18 22.23 0.4 Allowed 'Trans proline' 0 C--N 1.392 2.839 0 C-N-CA 122.144 1.896 . . . . 72.21 112.73 -179.279 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 63.6 tp -80.14 -51.39 9.04 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 109.707 -0.479 . . . . 73.12 109.707 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 103' ' ' THR . . . . . 0.627 HG22 ' H ' ' B' ' 105' ' ' GLN . 18.1 m 68.68 151.99 0.09 Allowed 'General case' 0 N--CA 1.483 1.215 0 O-C-N 124.92 1.387 . . . . 75.52 111.222 -173.497 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . -63.75 -34.06 88.91 Favored Glycine 0 C--N 1.352 1.422 0 N-CA-C 111.846 -0.502 . . . . 51.35 111.846 173.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 105' ' ' GLN . . . . . 0.627 ' H ' HG22 ' B' ' 103' ' ' THR . 87.8 mt-30 68.7 99.08 0.06 Allowed 'General case' 0 C--N 1.36 1.058 0 C-N-CA 125.523 1.529 . . . . 75.22 110.473 176.475 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 69.93 166.95 0.29 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.126 1.37 . . . . 74.44 111.624 -179.373 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 66.8 p -79.17 102.24 8.39 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 109.053 -0.721 . . . . 63.32 109.053 178.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 25.8 m170 -68.8 106.5 2.7 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 109.436 -0.579 . . . . 71.44 109.436 177.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -60.96 -25.51 66.88 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.206 -0.906 . . . . 53.33 111.114 176.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . 66.79 -163.8 0.23 Allowed 'General case' 0 C--O 1.247 0.928 0 C-N-CA 124.594 1.158 . . . . 71.24 110.356 -177.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 2.9 mm? 61.67 34.88 17.32 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 124.119 0.967 . . . . 64.15 109.914 -177.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -73.02 101.21 3.18 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.621 0.769 . . . . 73.2 110.004 -175.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 113' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt 58.78 37.71 24.91 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.427 1.091 . . . . 75.13 109.747 -179.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 40.7 tptt -66.83 95.04 0.34 Allowed 'General case' 0 C--O 1.246 0.905 0 CA-C-N 114.249 -1.341 . . . . 74.01 111.509 -168.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 47.9 p 45.72 64.78 1.32 Allowed 'General case' 0 C--O 1.242 0.665 0 O-C-N 124.623 1.202 . . . . 73.23 111.617 -175.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -56.87 -41.71 91.62 Favored Glycine 0 C--N 1.353 1.505 0 N-CA-C 109.785 -1.326 . . . . 55.33 109.785 168.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 117' ' ' LYS . . . . . 0.495 ' HG3' ' HG2' ' B' ' 464' ' ' MET . 24.6 mmtp -136.04 156.36 77.08 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-N 113.269 -1.466 . . . . 70.25 107.826 161.099 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 118' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.5 -15.19 48.56 Favored 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 122.695 2.263 . . . . 60.53 111.839 170.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 119' ' ' ASP . . . . . . . . . . . . . 23.6 t0 77.0 155.14 0.16 Allowed 'General case' 0 C--N 1.359 0.982 0 C-N-CA 126.369 1.867 . . . . 75.33 111.024 174.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 120' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -78.54 134.87 37.21 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.006 0.922 . . . . 70.1 109.636 177.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 14.0 p -82.5 1.89 3.41 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.493 0 C-N-CA 123.874 0.869 . . . . 74.32 110.237 174.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 82.8 p -71.41 85.19 0.82 Allowed 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 124.864 1.266 . . . . 75.24 112.268 -171.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.03 -52.98 3.66 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.052 1.341 . . . . 64.3 108.955 178.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 9.4 t 61.18 21.18 11.66 Favored 'General case' 0 CA--C 1.56 1.328 0 C-N-CA 125.529 1.532 . . . . 43.31 113.463 170.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -70.46 103.06 2.35 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.169 0.588 . . . . 73.02 109.486 175.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -156.27 -63.82 0.11 Allowed 'General case' 0 C--O 1.24 0.605 0 C-N-CA 123.768 0.827 . . . . 74.13 109.432 -176.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 41.2 m 56.86 -157.06 0.28 Allowed 'General case' 0 CA--C 1.563 1.472 0 C-N-CA 124.205 1.002 . . . . 70.01 110.998 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -81.06 -11.17 59.57 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 118.668 0.667 . . . . 72.01 110.884 174.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 16.3 m -63.85 -23.97 67.56 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.561 0.744 . . . . 54.34 110.505 171.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 130' ' ' ALA . . . . . 0.557 ' HB1' HG12 ' B' ' 135' ' ' VAL . . . -56.33 -29.49 61.37 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.453 1.101 . . . . 44.22 113.031 177.117 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 18.6 m95 -88.68 -4.92 58.43 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.192 0.597 . . . . 73.51 111.841 -175.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 132' ' ' SER . . . . . 0.534 ' HA ' ' HB2' ' B' ' 167' ' ' ASN . 48.1 t -76.38 99.35 4.81 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 108.423 -0.954 . . . . 51.4 108.423 172.458 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 8.7 m 78.84 -40.05 0.25 Allowed 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 125.768 1.627 . . . . 62.25 112.11 -176.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 136.69 168.94 11.57 Favored Glycine 0 C--N 1.351 1.376 0 N-CA-C 112.123 -0.391 . . . . 55.15 112.123 176.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 135' ' ' VAL . . . . . 0.593 HG22 ' SG ' ' B' ' 200' ' ' CYS . 27.0 m -86.57 21.01 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 C-N-CA 123.642 0.777 . . . . 73.24 111.837 -176.084 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 136' ' ' LYS . . . . . 0.541 ' HB2' HD13 ' B' ' 205' ' ' LEU . 2.5 pptp? -132.96 175.13 9.64 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.497 0.719 . . . . 52.43 111.656 -168.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 13.2 t -137.9 -170.25 2.73 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.145 0.978 . . . . 75.31 108.431 175.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -145.4 111.93 5.81 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.046 0.538 . . . . 75.52 110.47 175.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 4.4 m120 63.06 -87.13 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.934 1.694 . . . . 73.24 112.474 167.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -151.13 50.76 0.53 Allowed Glycine 0 C--N 1.346 1.115 0 N-CA-C 111.013 -0.835 . . . . 65.04 111.013 -175.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.03 76.49 1.71 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.847 0.859 . . . . 75.34 109.7 177.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 87.2 mt -122.79 1.27 9.36 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.064 0.945 . . . . 70.15 111.745 -171.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 143' ' ' GLY . . . . . 0.432 ' HA2' ' HA ' ' B' ' 147' ' ' HIS . . . -79.09 81.33 1.43 Allowed Glycine 0 C--N 1.347 1.176 0 O-C-N 123.145 0.278 . . . . 61.25 113.34 -176.377 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 20.3 t -89.81 -58.42 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 N-CA-C 108.868 -0.79 . . . . 75.31 108.868 175.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 145' ' ' ASP . . . . . 0.524 ' HB3' ' HA ' ' B' ' 350' ' ' LYS . 8.7 p-10 -132.59 -41.9 0.95 Allowed 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 108.28 -1.007 . . . . 64.3 108.28 169.633 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 11.2 tt -85.27 105.24 13.99 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 N-CA-C 107.295 -1.372 . . . . 72.52 107.295 171.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 147' ' ' HIS . . . . . 0.432 ' HA ' ' HA2' ' B' ' 143' ' ' GLY . 5.8 p80 -80.34 142.72 34.2 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.841 -0.618 . . . . 72.43 110.436 -171.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 148' ' ' GLU . . . . . 0.433 ' HB3' ' HA ' ' B' ' 212' ' ' SER . 12.3 tp10 -82.46 138.62 34.32 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 107.226 -1.398 . . . . 73.05 107.226 163.612 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 149' ' ' LYS . . . . . . . . . . . . . 42.1 pttt -89.28 -27.46 20.55 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.177 0.591 . . . . 72.23 110.243 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 27.8 t70 61.56 -81.62 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 125.557 1.543 . . . . 74.11 112.006 169.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 68.5 m80 -149.67 -62.64 0.02 OUTLIER Pre-proline 0 CA--C 1.562 1.425 0 C-N-CA 124.492 1.117 . . . . 74.43 111.347 -177.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 152' ' ' PRO . . . . . 0.604 ' HB2' ' HB2' ' B' ' 155' ' ' LEU . 65.5 Cg_endo -75.66 2.56 6.81 Favored 'Trans proline' 0 C--N 1.395 3.007 0 C-N-CA 121.698 1.599 . . . . 42.51 114.923 -162.47 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 24.4 m 67.11 -77.8 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 125.384 1.474 . . . . 74.2 111.537 177.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 45.1 pt -123.45 -35.41 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.942 0.897 . . . . 74.25 110.681 178.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 155' ' ' LEU . . . . . 0.604 ' HB2' ' HB2' ' B' ' 152' ' ' PRO . 13.0 tp 49.71 -148.99 0.26 Allowed 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 124.514 1.125 . . . . 72.1 109.957 -175.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 156' ' ' GLU . . . . . 0.501 ' H ' ' HG ' ' B' ' 155' ' ' LEU . 16.9 mp0 -67.39 -58.13 5.33 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 107.108 -1.442 . . . . 72.23 107.108 158.429 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 157' ' ' MET . . . . . 0.56 ' SD ' ' HD3' ' B' ' 56' ' ' ARG . 1.9 mpp? -130.51 129.3 42.71 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 106.153 -1.795 . . . . 53.54 106.153 165.238 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 158' ' ' ALA . . . . . 0.642 ' HB3' ' HB ' ' B' ' 214' ' ' THR . . . -70.06 77.19 0.5 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 108.784 -0.821 . . . . 34.04 108.784 172.432 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 159' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' B' ' 210' ' ' LYS . 8.9 tmtt? 56.72 110.29 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 126.354 1.862 . . . . 55.45 111.443 -168.247 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -80.37 138.93 36.74 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 123.362 0.665 . . . . 70.22 110.512 177.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -69.23 -21.46 63.93 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.608 0.763 . . . . 71.1 111.783 -178.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 162' ' ' GLY . . . . . 0.507 ' HA3' ' HA ' ' B' ' 54' ' ' ALA . . . -82.38 56.56 5.0 Favored Glycine 0 C--N 1.351 1.397 0 O-C-N 123.369 0.418 . . . . 73.4 112.067 173.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 4.4 tt -158.26 77.89 0.8 Allowed 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 106.219 -1.771 . . . . 65.02 106.219 -176.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 164' ' ' ALA . . . . . . . . . . . . . . . -161.46 161.08 29.99 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.072 0.949 . . . . 75.34 109.477 -177.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 49.6 p -88.35 -50.33 6.4 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 123.57 0.748 . . . . 64.15 110.373 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . 74.32 -152.51 45.1 Favored Glycine 0 C--N 1.349 1.28 0 CA-C-N 116.031 -0.531 . . . . 71.15 112.158 -177.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 167' ' ' ASN . . . . . 0.534 ' HB2' ' HA ' ' B' ' 132' ' ' SER . 28.3 t-20 -126.38 -69.9 0.75 Allowed 'General case' 0 C--O 1.243 0.718 0 N-CA-C 108.697 -0.853 . . . . 72.31 108.697 176.035 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 88.4 t 68.13 -65.58 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 C-N-CA 125.491 1.516 . . . . 74.13 111.624 -177.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 169' ' ' SER . . . . . 0.605 ' HB3' ' HA ' ' B' ' 173' ' ' LEU . 43.4 m -71.28 79.18 0.72 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.981 0.912 . . . . 54.35 110.966 176.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 9.6 m -90.9 -45.15 8.94 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.156 0.982 . . . . 63.1 110.212 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -110.95 -55.63 2.47 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.929 0.892 . . . . 53.32 109.278 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 172' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -81.95 95.81 7.5 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.212 1.005 . . . . 73.22 109.473 175.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 173' ' ' LEU . . . . . 0.605 ' HA ' ' HB3' ' B' ' 169' ' ' SER . 11.1 mp -83.14 -67.95 0.75 Allowed 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 122.675 0.39 . . . . 74.23 111.109 -178.14 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 174' ' ' GLN . . . . . 0.45 ' HB3' ' HG3' ' B' ' 193' ' ' PRO . 7.4 tp-100 -168.73 141.82 2.91 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 107.934 -1.136 . . . . 74.45 107.934 -175.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 175' ' ' ASP . . . . . . . . . . . . . 13.0 t70 73.37 107.73 0.07 Allowed 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 125.264 1.425 . . . . 74.1 109.476 -173.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -113.79 21.93 14.49 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.07 0.948 . . . . 74.11 108.964 173.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 19.0 p -123.08 92.66 48.95 Favored Pre-proline 0 C--O 1.244 0.764 0 C-N-CA 124.063 0.945 . . . . 64.31 110.456 -169.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 178' ' ' PRO . . . . . 0.746 ' HA ' ' HD2' ' B' ' 189' ' ' LYS . 19.2 Cg_exo -68.78 -48.33 1.02 Allowed 'Trans proline' 0 C--N 1.371 1.759 0 C-N-CA 122.089 1.859 . . . . 74.53 111.414 170.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -163.34 -42.88 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.905 0.882 . . . . 61.34 109.042 172.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 180' ' ' ALA . . . . . 0.635 ' HB1' HG23 ' C' ' 137' ' ' VAL . . . -161.77 -69.81 0.06 Allowed 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 108.505 -0.924 . . . . 74.4 108.505 172.441 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 20.1 tp -88.35 -68.72 0.75 Allowed 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 107.171 -1.418 . . . . 62.04 107.171 160.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 182' ' ' VAL . . . . . 0.495 ' HA ' ' HB2' ' B' ' 178' ' ' PRO . 78.4 t -135.64 -70.95 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.705 0.802 . . . . 71.31 109.644 175.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -171.64 -89.44 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.257 0.623 . . . . 65.24 110.537 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 26.7 p-80 -168.01 -167.58 0.85 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.481 0.712 . . . . 74.15 110.869 -173.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 185' ' ' VAL . . . . . . . . . . . . . 89.6 t -56.6 113.81 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 124.1 0.96 . . . . 71.33 111.011 -179.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 186' ' ' THR . . . . . 0.411 HG22 ' HG2' ' C' ' 122' ' ' GLU . 75.3 p 47.04 69.52 0.49 Allowed 'General case' 0 C--N 1.358 0.951 0 C-N-CA 125.688 1.595 . . . . 51.31 112.114 -178.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 187' ' ' SER . . . . . . . . . . . . . 47.3 t -145.46 145.27 31.03 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.201 1.0 . . . . 62.14 109.508 -177.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 188' ' ' ARG . . . . . 0.477 ' HB2' ' HG2' ' C' ' 124' ' ' PRO . 0.0 OUTLIER -128.64 146.91 50.73 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.8 0.44 . . . . 71.52 111.731 -173.271 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 189' ' ' LYS . . . . . 0.746 ' HD2' ' HA ' ' B' ' 178' ' ' PRO . 10.2 tmtt? -163.98 96.85 0.82 Allowed 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 107.432 -1.322 . . . . 72.52 107.432 171.217 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 190' ' ' CYS . . . . . . . . . . . . . 27.7 p -94.93 -179.75 4.95 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 123.687 0.795 . . . . 70.33 109.159 173.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 48.3 p90 -125.53 153.67 43.27 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 120.77 0.319 . . . . 74.04 110.596 175.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -167.11 77.53 0.12 Allowed Glycine 0 C--N 1.338 0.683 0 N-CA-C 110.615 -0.994 . . . . 64.22 110.615 178.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 193' ' ' PRO . . . . . 0.45 ' HG3' ' HB3' ' B' ' 174' ' ' GLN . 92.0 Cg_endo -75.44 -7.61 18.9 Favored 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 123.13 2.553 . . . . 64.32 114.131 -170.152 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 194' ' ' SER . . . . . . . . . . . . . 41.3 t 75.79 -61.33 0.47 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.481 1.513 . . . . 24.51 111.698 -175.227 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 195' ' ' ALA . . . . . . . . . . . . . . . 67.98 11.49 8.39 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.813 1.245 . . . . 74.32 112.3 -177.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 2.2 t 53.1 8.12 0.1 Allowed 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 127.017 2.127 . . . . 73.32 115.246 177.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 36.9 m 53.77 24.69 4.56 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.576 1.151 . . . . 75.11 112.702 -177.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 198' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 68.35 145.26 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 125.361 1.464 . . . . 51.12 112.063 -173.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -90.89 88.5 7.06 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 107.624 -1.251 . . . . 74.4 107.624 166.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 200' ' ' CYS . . . . . 0.593 ' SG ' HG22 ' B' ' 135' ' ' VAL . 67.1 m -59.73 -43.62 95.6 Favored Pre-proline 0 CA--C 1.565 1.54 0 N-CA-C 115.032 1.493 . . . . 73.31 115.032 -168.38 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 201' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -76.64 64.49 7.45 Favored 'Trans proline' 0 C--N 1.397 3.089 0 CA-C-N 121.589 1.603 . . . . 71.34 111.758 173.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . -126.7 143.42 14.32 Favored Glycine 0 C--N 1.346 1.136 0 CA-C-N 115.507 -0.77 . . . . 63.04 112.012 -177.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 66.06 -78.72 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 125.651 1.58 . . . . 71.33 111.882 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -139.86 158.21 44.46 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.88 0.872 . . . . 74.01 110.212 -177.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 205' ' ' LEU . . . . . 0.541 HD13 ' HB2' ' B' ' 136' ' ' LYS . 21.1 tp -161.11 -63.84 0.06 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.224 0.61 . . . . 51.03 109.789 -177.262 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -111.34 -56.35 2.39 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.503 -0.925 . . . . 62.32 108.503 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 207' ' ' LYS . . . . . 0.442 ' HD3' ' N ' ' B' ' 208' ' ' GLY . 1.1 tmtp? -78.4 139.81 38.74 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 108.432 -0.951 . . . . 74.32 108.432 175.459 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 208' ' ' GLY . . . . . 0.442 ' N ' ' HD3' ' B' ' 207' ' ' LYS . . . 174.68 -99.19 0.13 Allowed Glycine 0 C--N 1.343 0.932 0 N-CA-C 111.748 -0.541 . . . . 71.52 111.748 173.135 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 124.05 33.72 0.77 Allowed Glycine 0 C--N 1.343 0.959 0 N-CA-C 111.17 -0.772 . . . . 42.21 111.17 -173.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 210' ' ' LYS . . . . . 0.46 ' O ' ' HG3' ' B' ' 159' ' ' LYS . 0.0 OUTLIER -149.9 45.17 0.92 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.889 0.876 . . . . 74.51 109.763 -179.574 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . -78.58 -89.96 0.39 Allowed Glycine 0 C--N 1.343 0.972 0 N-CA-C 110.793 -0.923 . . . . 74.43 110.793 175.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 212' ' ' SER . . . . . 0.433 ' HA ' ' HB3' ' B' ' 148' ' ' GLU . 13.3 p 41.31 -86.26 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.22 0 C-N-CA 126.536 1.934 . . . . 74.04 115.589 172.368 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 213' ' ' ILE . . . . . 0.406 ' H ' ' HB3' ' B' ' 159' ' ' LYS . 50.9 mt 59.19 87.85 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 125.148 1.379 . . . . 64.4 108.947 -163.456 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 214' ' ' THR . . . . . 0.642 ' HB ' ' HB3' ' B' ' 158' ' ' ALA . 88.0 m -141.49 -56.86 0.48 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.833 0.853 . . . . 75.43 109.022 -174.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 215' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 71.32 -65.58 0.34 Allowed 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 125.744 1.617 . . . . 73.31 110.922 -173.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.4 136.69 43.5 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.463 1.105 . . . . 61.42 109.126 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 3.3 pp -117.94 152.29 35.74 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.813 0.445 . . . . 75.4 110.635 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 218' ' ' LEU . . . . . 0.552 HD23 ' H ' ' B' ' 218' ' ' LEU . 2.2 pt? -124.14 22.59 8.65 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.986 0.914 . . . . 71.43 109.684 -177.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -72.78 -10.48 59.84 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 124.551 1.141 . . . . 71.24 112.378 -175.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -65.29 -35.06 79.87 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.258 0.623 . . . . 61.1 110.112 171.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 221' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 71.49 -60.84 0.5 Allowed 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 126.573 1.949 . . . . 73.55 111.462 176.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -53.7 -32.55 52.27 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.37 0.668 . . . . 42.52 110.732 168.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -114.44 138.74 50.2 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 108.507 -0.923 . . . . 61.02 108.507 165.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 3.2 p -134.69 134.19 54.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 124.097 0.959 . . . . 74.2 108.757 -176.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 35.7 p -92.19 -166.41 1.54 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.062 0.545 . . . . 54.34 110.396 175.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 76.87 -48.6 0.54 Allowed 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 126.028 1.731 . . . . 74.43 111.502 -176.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . 83.12 5.09 89.46 Favored Glycine 0 C--N 1.346 1.099 0 CA-C-N 116.423 -0.353 . . . . 51.31 113.115 179.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 87.89 -24.23 11.48 Favored Glycine 0 C--N 1.355 1.59 0 CA-C-O 119.552 -0.582 . . . . 72.41 113.866 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -71.25 -61.25 4.02 Favored Glycine 0 C--N 1.356 1.654 0 CA-C-N 117.367 0.584 . . . . 70.24 111.835 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -73.01 103.11 3.68 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.157 0.583 . . . . 70.23 110.24 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 231' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -123.59 132.89 54.0 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.142 0.977 . . . . 73.24 109.285 177.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 30.2 p -74.04 104.13 4.76 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.487 0.715 . . . . 74.24 109.616 176.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -71.97 160.02 33.24 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 109.84 -0.43 . . . . 70.41 109.84 174.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -69.44 165.76 20.19 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.151 0.58 . . . . 72.31 110.845 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -58.78 118.48 5.76 Favored 'General case' 0 N--CA 1.48 1.066 0 O-C-N 123.499 0.5 . . . . 54.41 109.908 178.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 236' ' ' THR . . . . . 0.56 HG23 ' HG2' ' B' ' 45' ' ' ARG . 98.5 m -61.83 116.14 4.59 Favored 'General case' 0 C--O 1.242 0.694 0 O-C-N 124.433 1.083 . . . . 73.34 109.989 177.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -63.8 94.17 0.09 Allowed 'General case' 0 C--N 1.348 0.527 0 O-C-N 124.076 0.86 . . . . 71.12 108.946 173.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 33.0 m -71.02 -25.02 62.49 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.047 -0.979 . . . . 71.31 110.016 175.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 239' ' ' ALA . . . . . 0.417 ' HA ' HD22 ' C' ' 235' ' ' LEU . . . -68.96 137.96 54.18 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 114.671 -1.15 . . . . 74.42 111.16 172.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . -70.34 -101.57 0.04 OUTLIER Glycine 0 C--N 1.355 1.586 0 N-CA-C 110.923 -0.871 . . . . 71.23 110.923 172.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 241' ' ' GLU . . . . . 0.496 ' HB3' ' HG3' ' B' ' 245' ' ' LYS . 24.0 pt-20 -175.31 171.58 2.87 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.847 0.859 . . . . 71.21 111.462 169.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 242' ' ' TRP . . . . . 0.424 ' CZ3' HG21 ' C' ' 253' ' ' VAL . 0.7 OUTLIER -98.27 -66.11 0.92 Allowed 'General case' 0 C--O 1.237 0.408 0 N-CA-C 107.094 -1.447 . . . . 70.32 107.094 -175.773 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 243' ' ' GLN . . . . . 0.684 ' HG2' HH22 ' B' ' 373' ' ' ARG . 44.9 mt-30 -141.72 19.49 2.17 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 112.586 -2.097 . . . . 74.22 106.974 -175.266 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 114.41 164.88 15.09 Favored Glycine 0 CA--C 1.535 1.341 0 N-CA-C 109.75 -1.34 . . . . 63.11 109.75 -156.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 245' ' ' LYS . . . . . 0.496 ' HG3' ' HB3' ' B' ' 241' ' ' GLU . 0.2 OUTLIER -150.05 164.64 35.03 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.727 0.811 . . . . 75.34 111.019 177.223 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 34.0 m -138.8 134.99 34.15 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.488 0.715 . . . . 71.02 110.397 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 247' ' ' LEU . . . . . . . . . . . . . 95.9 mt -118.29 109.61 16.53 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.313 1.045 . . . . 72.51 108.885 175.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 248' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -129.57 140.73 51.13 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.813 0.845 . . . . 75.15 109.328 177.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -67.3 135.02 52.67 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.993 0.917 . . . . 71.33 110.544 178.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 250' ' ' GLN . . . . . 0.439 ' HB3' ' HA ' ' A' ' 274' ' ' GLU . 8.8 mp0 -102.17 -77.8 0.55 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.606 0.762 . . . . 65.4 110.207 -172.029 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 251' ' ' ALA . . . . . . . . . . . . . . . -84.54 4.86 30.06 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.425 0.69 . . . . 61.03 112.421 -172.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 252' ' ' GLN . . . . . 0.403 ' NE2' ' H ' ' B' ' 250' ' ' GLN . 2.8 mp0 -72.21 145.28 48.1 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.485 1.114 . . . . 72.3 111.805 -171.173 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 253' ' ' ALA . . . . . 0.469 ' HB2' ' NE2' ' B' ' 351' ' ' GLN . . . 67.85 -75.76 0.06 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.843 1.657 . . . . 51.41 111.833 -177.502 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 254' ' ' ARG . . . . . 0.401 ' HB2' HG23 ' B' ' 320' ' ' THR . 11.9 tpt180 -137.08 6.14 2.83 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.263 0.625 . . . . 72.51 111.098 -176.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -67.84 -23.43 74.18 Favored Glycine 0 C--N 1.355 1.621 0 O-C-N 122.389 -0.194 . . . . 54.22 112.644 178.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 256' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -64.16 -40.59 96.46 Favored 'General case' 0 C--N 1.357 0.917 0 C-N-CA 123.264 0.626 . . . . 52.52 110.442 172.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 257' ' ' GLN . . . . . 0.597 ' HB2' HG21 ' B' ' 325' ' ' THR . 12.5 pt20 41.95 103.57 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 126.549 1.94 . . . . 74.31 113.289 -177.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 258' ' ' LEU . . . . . . . . . . . . . 86.6 mt -33.38 112.92 0.14 Allowed 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 126.192 1.797 . . . . 75.13 113.922 -169.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 9.0 p -133.87 158.91 42.6 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 124.041 0.937 . . . . 63.02 109.925 -174.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 260' ' ' SER . . . . . . . . . . . . . 22.5 p -95.68 16.7 16.63 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.552 0.741 . . . . 73.11 110.351 174.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 27.5 t70 62.5 178.3 0.14 Allowed 'General case' 0 C--N 1.37 1.492 0 C-N-CA 124.846 1.258 . . . . 52.21 110.391 179.032 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 262' ' ' ALA . . . . . . . . . . . . . . . -60.47 -39.15 86.59 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.959 0.504 . . . . 43.43 110.795 171.031 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -143.13 -51.93 0.36 Allowed 'General case' 0 C--N 1.349 0.545 0 C-N-CA 123.125 0.57 . . . . 70.44 111.878 -176.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 66.1 m 72.21 -57.36 0.62 Allowed 'General case' 0 N--CA 1.504 2.259 0 C-N-CA 125.595 1.558 . . . . 51.14 111.669 -172.12 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 265' ' ' LEU . . . . . . . . . . . . . 19.7 tp -58.97 -17.25 23.05 Favored 'General case' 0 CA--C 1.56 1.331 0 C-N-CA 125.762 1.625 . . . . 64.12 112.258 178.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 266' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -79.5 79.61 5.95 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.734 0.814 . . . . 71.52 109.554 175.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 33.5 p -167.03 178.66 5.61 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.053 0.941 . . . . 73.13 110.369 -178.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 57.7 t -66.15 -70.07 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 124.009 0.923 . . . . 74.44 111.553 -173.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 269' ' ' THR . . . . . . . . . . . . . 6.9 m -73.28 -24.28 60.41 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.167 0.587 . . . . 74.31 110.011 178.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 270' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 57.53 16.39 3.29 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 126.547 1.939 . . . . 72.41 114.352 173.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 271' ' ' ALA . . . . . . . . . . . . . . . -65.5 -50.22 66.08 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.788 0.835 . . . . 75.3 111.121 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 272' ' ' ASN . . . . . 0.641 HD21 ' HB ' ' B' ' 343' ' ' VAL . 22.3 p-10 -156.38 -52.37 0.08 Allowed 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 111.969 0.359 . . . . 54.14 111.969 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -157.42 76.97 0.84 Allowed 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 121.657 0.741 . . . . 61.32 110.032 -170.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -114.5 18.45 16.78 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.946 0.898 . . . . 71.44 109.266 173.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 275' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -68.18 150.5 97.71 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 123.73 0.812 . . . . 71.33 111.805 -175.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -81.15 58.27 6.89 Favored 'Trans proline' 0 C--N 1.372 1.783 0 C-N-CA 123.054 2.502 . . . . 62.35 109.737 163.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 277' ' ' LEU . . . . . 0.536 HD21 ' HA ' ' A' ' 279' ' ' ARG . 22.9 tp -83.0 159.15 22.26 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.421 1.089 . . . . 63.32 109.668 -174.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 278' ' ' LEU . . . . . 0.42 HD22 ' HA ' ' B' ' 278' ' ' LEU . 1.0 OUTLIER 70.28 86.97 0.12 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.495 1.518 . . . . 62.0 109.105 -173.941 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . -159.13 -172.57 26.41 Favored Glycine 0 C--N 1.347 1.171 0 CA-C-N 115.86 -0.609 . . . . 75.43 113.348 -178.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 280' ' ' LEU . . . . . 0.482 HD11 ' HB3' ' C' ' 198' ' ' ASP . 17.1 tp -97.17 136.52 37.57 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 108.999 -0.741 . . . . 53.23 108.999 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -80.19 -60.39 2.35 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.491 0.716 . . . . 75.31 112.166 -165.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -73.25 -35.58 66.25 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 109.55 -0.537 . . . . 65.41 109.55 174.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 283' ' ' ASP . . . . . 0.426 ' HA ' HD23 ' B' ' 280' ' ' LEU . 6.1 t0 70.2 -71.62 0.12 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 126.064 1.746 . . . . 72.33 112.209 169.106 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . -81.51 39.98 2.56 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 123.489 0.566 . . . . 61.45 112.971 177.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -79.28 85.93 5.08 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 107.484 -1.302 . . . . 72.41 107.484 173.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 286' ' ' MET . . . . . 0.592 ' H ' ' HD2' ' B' ' 287' ' ' PRO . 47.6 mtm -131.6 -53.97 0.03 OUTLIER Pre-proline 0 CA--C 1.561 1.394 0 CA-C-N 115.395 -0.821 . . . . 64.1 112.261 -168.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 287' ' ' PRO . . . . . 0.592 ' HD2' ' H ' ' B' ' 286' ' ' MET . 62.8 Cg_endo -70.04 161.22 46.8 Favored 'Trans proline' 0 C--N 1.403 3.425 0 C-N-CA 121.778 1.652 . . . . 73.33 112.75 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 288' ' ' VAL . . . . . . . . . . . . . 4.9 p -76.33 81.66 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.301 0 CA-C-O 123.01 1.386 . . . . 74.32 109.89 177.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 289' ' ' ARG . . . . . 0.459 ' NE ' ' H ' ' B' ' 290' ' ' TRP . 1.2 tpm_? -151.47 174.32 13.53 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 113.959 -1.473 . . . . 72.14 107.207 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 290' ' ' TRP . . . . . 0.46 ' HB3' HH11 ' C' ' 254' ' ' ARG . 5.2 m-90 79.94 -5.01 1.89 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.764 1.225 . . . . 75.34 112.39 171.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 291' ' ' LEU . . . . . . . . . . . . . 5.2 mp -123.4 95.76 4.72 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 107.993 -1.114 . . . . 64.34 107.993 172.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . -53.63 -60.48 8.23 Favored Glycine 0 CA--C 1.539 1.54 0 O-C-N 123.879 0.737 . . . . 62.12 114.755 179.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 293' ' ' PRO . . . . . 0.538 ' HD3' HG21 ' A' ' 196' ' ' THR . 43.6 Cg_endo -86.76 32.91 0.44 Allowed 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 123.13 2.553 . . . . 51.12 113.087 -177.068 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 30.0 tttm 64.42 -85.88 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.69 1.196 . . . . 41.23 111.122 -177.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . 176.03 42.79 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.299 1.04 . . . . 34.32 108.666 -169.315 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 2.9 t 51.49 -169.82 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 125.718 1.607 . . . . 65.42 111.828 -172.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -128.43 91.34 3.22 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 108.087 -1.079 . . . . 64.12 108.087 170.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -87.24 -24.29 24.44 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.086 -0.961 . . . . 71.5 110.997 -176.11 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . 100.26 -11.9 60.16 Favored Glycine 0 C--N 1.345 1.057 0 O-C-N 123.466 0.479 . . . . 63.41 112.548 -173.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 300' ' ' ASN . . . . . 0.53 ' HB2' ' HB1' ' B' ' 374' ' ' ALA . 3.7 p-10 -165.1 26.79 0.06 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.843 0.857 . . . . 72.23 110.315 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 301' ' ' ILE . . . . . 0.584 HG12 ' HZ3' ' C' ' 232' ' ' LYS . 0.3 OUTLIER 49.44 -78.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 C-N-CA 127.099 2.16 . . . . 72.24 113.277 -174.73 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -62.04 158.12 17.27 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 125.51 1.524 . . . . 63.41 111.99 -171.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 303' ' ' LYS . . . . . 0.508 ' N ' ' HD3' ' B' ' 304' ' ' PRO . 8.2 tmtt? 66.39 57.67 1.01 Allowed Pre-proline 0 CA--C 1.567 1.623 0 C-N-CA 125.967 1.707 . . . . 74.11 111.386 -169.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 304' ' ' PRO . . . . . 0.508 ' HD3' ' N ' ' B' ' 303' ' ' LYS . 1.7 Cg_endo -87.38 95.58 0.46 Allowed 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 123.119 2.546 . . . . 75.12 110.518 169.247 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . 73.7 -68.92 0.2 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.803 1.641 . . . . 42.33 110.265 -177.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 306' ' ' VAL . . . . . 0.456 HG21 ' HA ' ' B' ' 303' ' ' LYS . 62.5 t 64.38 90.77 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 125.281 1.432 . . . . 72.33 111.789 176.06 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 307' ' ' THR . . . . . 0.702 HG22 ' HB2' ' C' ' 226' ' ' ARG . 39.3 p 68.3 -24.3 0.13 Allowed 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 126.535 1.934 . . . . 74.23 114.105 177.28 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 308' ' ' CYS . . . . . . . . . . . . . 59.3 m 56.93 -74.8 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 124.903 1.281 . . . . 74.22 110.256 -170.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 54.6 p -84.64 118.38 70.91 Favored Pre-proline 0 CA--C 1.55 0.978 0 N-CA-C 107.799 -1.186 . . . . 72.2 107.799 163.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -59.49 152.94 58.03 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 122.625 2.216 . . . . 63.14 112.137 -177.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 311' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -58.65 109.59 1.97 Allowed Pre-proline 0 N--CA 1.479 1.004 0 C-N-CA 123.855 0.862 . . . . 73.13 110.75 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 312' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -85.46 -17.01 4.53 Favored 'Trans proline' 0 C--N 1.373 1.818 0 C-N-CA 121.867 1.712 . . . . 70.14 112.706 176.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 313' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 53.34 167.34 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 C-N-CA 127.127 2.171 . . . . 75.13 114.278 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 314' ' ' ARG . . . . . 0.581 ' NH1' ' HA ' ' B' ' 316' ' ' ASP . 0.0 OUTLIER -167.19 150.4 6.4 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.285 0.634 . . . . 72.01 110.609 178.805 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 315' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -86.26 144.06 27.61 Favored 'General case' 0 C--O 1.245 0.845 0 N-CA-C 107.953 -1.129 . . . . 72.12 107.953 170.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 316' ' ' ASP . . . . . 0.581 ' HA ' ' NH1' ' B' ' 314' ' ' ARG . 10.7 m-20 -86.99 68.28 10.02 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 122.975 0.51 . . . . 74.4 110.955 -172.142 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 24.8 m 54.19 -82.89 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 125.778 1.631 . . . . 75.41 112.414 -178.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 318' ' ' VAL . . . . . . . . . . . . . 7.4 m -101.6 106.62 47.37 Favored Pre-proline 0 CA--C 1.558 1.258 0 C-N-CA 124.411 1.084 . . . . 73.13 110.402 -176.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 319' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.58 94.77 0.85 Allowed 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 122.736 2.291 . . . . 65.1 111.501 176.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 320' ' ' THR . . . . . 0.401 HG23 ' HB2' ' B' ' 254' ' ' ARG . 26.1 m 65.44 86.8 0.12 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.672 1.189 . . . . 53.31 110.683 -179.016 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 321' ' ' LEU . . . . . . . . . . . . . 45.0 tp -101.85 -23.82 14.12 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.919 0.887 . . . . 65.14 110.166 176.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 322' ' ' ALA . . . . . . . . . . . . . . . 67.19 -169.74 0.2 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.783 1.233 . . . . 64.54 110.986 -173.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 323' ' ' GLN . . . . . 0.548 ' HG2' ' H ' ' B' ' 324' ' ' MET . 26.1 tt0 66.07 -170.46 0.19 Allowed 'General case' 0 CA--C 1.57 1.745 0 C-N-CA 124.461 1.104 . . . . 74.02 110.253 178.528 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 324' ' ' MET . . . . . 0.548 ' H ' ' HG2' ' B' ' 323' ' ' GLN . 50.3 ttm 79.59 -56.35 0.4 Allowed 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 125.44 1.496 . . . . 71.32 112.113 174.376 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 325' ' ' THR . . . . . 0.597 HG21 ' HB2' ' B' ' 257' ' ' GLN . 47.3 p -80.7 70.55 7.48 Favored 'General case' 0 CA--C 1.553 1.078 0 CA-C-O 121.718 0.771 . . . . 72.33 110.463 178.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 326' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -75.73 -63.64 1.25 Allowed 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.246 1.018 . . . . 72.01 110.187 -178.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 39.51 40.33 0.59 Allowed 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 126.31 1.844 . . . . 54.34 113.796 -178.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 328' ' ' ALA . . . . . . . . . . . . . . . -64.16 -51.31 64.43 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.166 0.587 . . . . 72.03 111.097 -178.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 329' ' ' ILE . . . . . . . . . . . . . 33.4 pt -137.24 -175.54 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 123.797 0.839 . . . . 73.5 111.03 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 330' ' ' GLU . . . . . 0.417 ' O ' ' HB2' ' B' ' 331' ' ' LEU . 8.0 tp10 64.8 99.56 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 125.736 1.615 . . . . 63.42 113.331 176.383 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 331' ' ' LEU . . . . . 0.471 ' HG ' ' H ' ' B' ' 332' ' ' LEU . 13.3 tp 175.2 -145.22 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 125.52 1.528 . . . . 63.34 107.344 168.21 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 332' ' ' LEU . . . . . 0.471 ' H ' ' HG ' ' B' ' 331' ' ' LEU . 7.1 mp -80.81 -176.1 5.67 Favored 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 124.117 0.967 . . . . 74.41 109.87 170.197 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 333' ' ' SER . . . . . . . . . . . . . 41.7 t -61.58 -30.17 70.5 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.312 1.045 . . . . 65.04 112.225 -177.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -79.78 4.84 15.17 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.479 0.712 . . . . 63.11 112.667 -176.05 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 335' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -116.94 -170.47 1.84 Allowed 'General case' 0 CA--C 1.553 1.07 0 N-CA-C 107.371 -1.344 . . . . 73.25 107.371 167.101 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 77.47 -3.33 2.45 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 125.01 1.324 . . . . 61.02 112.62 168.018 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 337' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -75.52 -8.26 56.3 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.573 0.749 . . . . 62.43 109.966 162.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 338' ' ' GLY . . . . . . . . . . . . . . . 107.83 -146.66 16.33 Favored Glycine 0 C--N 1.353 1.507 0 N-CA-C 111.282 -0.727 . . . . 72.34 111.282 -179.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 339' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -114.89 158.1 22.43 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.049 1.34 . . . . 74.33 108.804 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 340' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -79.42 85.66 5.2 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 121.22 0.533 . . . . 75.24 110.858 -172.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 341' ' ' LEU . . . . . . . . . . . . . 51.3 mt -128.92 5.48 5.43 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.17 0.988 . . . . 75.34 110.03 169.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 342' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -92.33 106.6 18.57 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 107.774 -1.195 . . . . 64.25 107.774 176.02 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 343' ' ' VAL . . . . . 0.641 ' HB ' HD21 ' B' ' 272' ' ' ASN . 39.2 t 53.65 84.37 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 C-N-CA 124.686 1.195 . . . . 64.24 109.363 -167.235 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 344' ' ' GLU . . . . . 0.624 ' HG2' ' H ' ' B' ' 345' ' ' GLY . 0.1 OUTLIER -94.86 -103.8 0.15 Allowed 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 123.926 0.89 . . . . 73.03 110.912 -166.703 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 345' ' ' GLY . . . . . 0.624 ' H ' ' HG2' ' B' ' 344' ' ' GLU . . . 79.52 -61.75 4.19 Favored Glycine 0 C--N 1.357 1.695 0 CA-C-N 119.601 1.091 . . . . 62.31 112.905 -177.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 346' ' ' ALA . . . . . . . . . . . . . . . -67.65 92.74 0.34 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.244 1.018 . . . . 72.22 110.643 178.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 32.3 t -170.94 -49.45 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.936 1.294 . . . . 72.21 108.996 178.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 348' ' ' ILE . . . . . 0.448 ' HA ' ' H ' ' B' ' 253' ' ' ALA . 30.7 mm -94.85 -58.39 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 123.158 0.583 . . . . 73.42 109.683 -175.368 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 349' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 48.0 74.92 0.15 Allowed 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 125.5 1.52 . . . . 71.13 113.367 171.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 350' ' ' LYS . . . . . 0.524 ' HA ' ' HB3' ' B' ' 145' ' ' ASP . 28.3 ttpt 75.59 -61.91 0.46 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 125.563 1.545 . . . . 74.52 111.132 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 351' ' ' GLN . . . . . 0.469 ' NE2' ' HB2' ' B' ' 253' ' ' ALA . 6.5 tp60 67.26 -171.48 0.19 Allowed 'General case' 0 CA--C 1.561 1.376 0 C-N-CA 123.689 0.795 . . . . 71.32 109.305 -178.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 352' ' ' ASP . . . . . 0.455 ' N ' ' HG3' ' B' ' 351' ' ' GLN . 4.5 m-20 -73.37 43.79 0.14 Allowed 'General case' 0 CA--C 1.562 1.408 0 C-N-CA 124.344 1.058 . . . . 74.35 110.926 166.008 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 353' ' ' HIS . . . . . . . . . . . . . 19.8 t-80 -141.26 92.79 2.51 Favored 'General case' 0 C--N 1.355 0.834 0 C-N-CA 125.294 1.438 . . . . 74.33 108.567 -171.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 354' ' ' ALA . . . . . . . . . . . . . . . -170.36 -67.82 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.925 0.89 . . . . 70.11 109.404 -178.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 355' ' ' ALA . . . . . 0.451 ' HB1' ' HD2' ' B' ' 357' ' ' PRO . . . -170.76 169.6 6.92 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.293 1.037 . . . . 75.44 109.641 -178.536 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 356' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -83.24 -49.37 0.73 Allowed Pre-proline 0 CA--C 1.56 1.346 0 CA-C-O 118.162 -0.923 . . . . 74.32 112.336 177.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 357' ' ' PRO . . . . . 0.451 ' HD2' ' HB1' ' B' ' 355' ' ' ALA . 74.0 Cg_endo -72.05 93.49 0.72 Allowed 'Trans proline' 0 C--N 1.404 3.477 0 C-N-CA 121.709 1.606 . . . . 55.22 112.993 -172.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 358' ' ' CYS . . . . . . . . . . . . . 57.7 m -74.54 -50.64 17.29 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 107.82 -1.178 . . . . 73.32 107.82 168.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 359' ' ' GLY . . . . . . . . . . . . . . . -107.59 87.38 0.49 Allowed Glycine 0 C--N 1.345 1.054 0 N-CA-C 109.817 -1.313 . . . . 62.01 109.817 171.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 360' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 -50.85 132.91 26.93 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.318 1.047 . . . . 53.34 110.599 175.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 361' ' ' ILE . . . . . 0.523 HG22 ' H ' ' B' ' 363' ' ' GLU . 71.2 mt 74.39 -59.79 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 C-N-CA 125.657 1.583 . . . . 61.31 110.35 -172.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 362' ' ' GLY . . . . . . . . . . . . . . . 82.81 -12.15 49.75 Favored Glycine 0 C--N 1.348 1.238 0 C-N-CA 122.788 0.232 . . . . 72.35 113.668 175.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 363' ' ' GLU . . . . . 0.523 ' H ' HG22 ' B' ' 361' ' ' ILE . 36.9 mt-10 -101.43 8.43 42.15 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.26 1.024 . . . . 73.13 110.207 176.654 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 364' ' ' THR . . . . . . . . . . . . . 24.1 p -83.68 60.32 5.66 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.207 1.003 . . . . 74.04 109.978 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 35.8 m -89.24 156.41 3.07 Favored 'Isoleucine or valine' 0 C--O 1.245 0.838 0 CA-C-N 114.625 -1.17 . . . . 74.01 110.073 -178.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -80.75 85.09 6.15 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 109.172 -0.677 . . . . 50.12 109.172 177.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 367' ' ' LEU . . . . . . . . . . . . . 56.9 mt 62.51 -166.34 0.22 Allowed 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 124.511 1.125 . . . . 75.05 111.236 177.056 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 368' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -70.93 -47.23 60.18 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.782 -0.822 . . . . 71.23 108.782 172.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 369' ' ' GLU . . . . . 0.668 ' HG2' ' H ' ' B' ' 371' ' ' VAL . 0.0 OUTLIER -170.79 -33.54 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 114.34 -1.3 . . . . 70.1 109.282 170.218 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 370' ' ' ALA . . . . . 0.553 ' HB3' HE21 ' B' ' 372' ' ' GLN . . . 56.77 31.36 19.32 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 125.022 1.329 . . . . 74.25 111.56 -175.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 371' ' ' VAL . . . . . 0.668 ' H ' ' HG2' ' B' ' 369' ' ' GLU . 4.6 t 53.39 38.16 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.786 0 C-N-CA 124.839 1.255 . . . . 74.11 110.907 -175.173 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 372' ' ' GLN . . . . . 0.553 HE21 ' HB3' ' B' ' 370' ' ' ALA . 43.4 mt-30 -102.74 100.23 10.24 Favored 'General case' 0 N--CA 1.483 1.217 0 O-C-N 121.181 -0.95 . . . . 63.2 110.402 178.396 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 373' ' ' ARG . . . . . 0.684 HH22 ' HG2' ' B' ' 243' ' ' GLN . 0.2 OUTLIER -157.75 -82.17 0.06 Allowed 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 109.133 -0.691 . . . . 72.05 109.133 171.758 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 374' ' ' ALA . . . . . 0.53 ' HB1' ' HB2' ' B' ' 300' ' ' ASN . . . 170.39 179.4 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 125.606 1.562 . . . . 71.45 108.693 -171.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 375' ' ' LEU . . . . . 0.561 ' HA ' ' HB3' ' B' ' 32' ' ' ARG . 79.9 mt -68.78 -175.38 0.69 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 122.565 0.346 . . . . 62.01 111.236 170.436 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -60.88 97.02 0.05 Allowed 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 121.446 0.641 . . . . 73.13 110.74 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 377' ' ' PHE . . . . . 0.406 ' HB2' ' HB3' ' B' ' 303' ' ' LYS . 42.0 p90 -79.69 7.09 9.12 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.462 1.105 . . . . 73.31 112.515 -177.294 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 378' ' ' ALA . . . . . . . . . . . . . . . -77.57 23.28 0.23 Allowed 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 124.243 1.017 . . . . 61.1 112.056 178.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -99.57 164.12 12.21 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 124.775 1.23 . . . . 72.01 109.401 177.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 380' ' ' LYS . . . . . 0.438 ' NZ ' HD12 ' B' ' 385' ' ' LEU . 25.2 tttt -70.31 -88.47 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.097 0 O-C-N 123.76 0.662 . . . . 53.14 110.416 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 381' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 179.37 -75.88 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 106.593 -1.632 . . . . 74.34 106.593 -166.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 382' ' ' GLY . . . . . 0.421 ' HA3' ' HG ' ' B' ' 385' ' ' LEU . . . -99.74 75.22 0.47 Allowed Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 108.679 -1.768 . . . . 73.1 108.679 172.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 383' ' ' ASN . . . . . . . . . . . . . 49.7 m-20 -64.2 -27.33 68.99 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 113.868 -1.166 . . . . 73.1 111.036 -175.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 384' ' ' THR . . . . . . . . . . . . . 14.7 t -121.9 28.72 7.44 Favored 'General case' 0 CA--C 1.56 1.349 0 C-N-CA 123.574 0.749 . . . . 63.41 111.585 -174.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 385' ' ' LEU . . . . . 0.603 HD13 ' H ' ' B' ' 418' ' ' ALA . 70.3 mt -63.17 135.71 57.31 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 122.4 0.28 . . . . 75.12 111.107 177.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 386' ' ' VAL . . . . . . . . . . . . . 42.3 t 66.04 -75.59 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 125.343 1.457 . . . . 62.42 110.457 -172.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 387' ' ' ILE . . . . . . . . . . . . . 35.9 pt -119.7 162.85 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.365 1.066 . . . . 74.12 109.574 178.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 388' ' ' VAL . . . . . . . . . . . . . 11.8 p -70.9 109.66 3.34 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 CA-C-O 121.602 0.715 . . . . 54.33 109.681 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 389' ' ' THR . . . . . . . . . . . . . 9.1 m -136.18 28.85 3.1 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.121 0.969 . . . . 71.25 109.002 -173.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . -83.82 -91.68 0.08 Allowed 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 115.59 -0.732 . . . . 70.34 111.771 -171.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 391' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 53.94 -88.36 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 125.077 1.351 . . . . 64.12 112.266 -175.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 392' ' ' HIS . . . . . . . . . . . . . 32.0 m-70 -114.51 95.28 5.18 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 107.272 -1.381 . . . . 72.42 107.272 178.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . 65.39 -86.37 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.023 1.329 . . . . 61.53 110.782 -174.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -163.05 127.52 3.0 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 107.058 -1.46 . . . . 73.31 107.058 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . -62.14 98.97 0.12 Allowed 'General case' 0 CA--C 1.542 0.657 0 O-C-N 123.792 0.682 . . . . 71.44 110.196 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 45.7 t -123.84 -49.88 1.85 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.499 1.12 . . . . 75.55 108.833 178.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 397' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 66.31 65.07 0.5 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.999 1.32 . . . . 71.41 110.3 177.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 1.7 mp 77.45 -33.63 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 124.889 1.276 . . . . 75.44 112.874 171.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 399' ' ' VAL . . . . . . . . . . . . . 15.5 m -59.24 -42.29 86.59 Favored 'Isoleucine or valine' 0 C--N 1.36 1.043 0 C-N-CA 122.962 0.505 . . . . 73.32 111.64 -170.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 400' ' ' ALA . . . . . . . . . . . . . . . 55.79 103.53 0.03 OUTLIER Pre-proline 0 N--CA 1.483 1.179 0 C-N-CA 125.09 1.356 . . . . 51.41 112.131 175.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 401' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -49.8 98.44 0.04 OUTLIER 'Trans proline' 0 C--N 1.386 2.516 0 C-N-CA 123.261 2.641 . . . . 71.04 112.969 -178.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -76.06 -62.47 1.59 Allowed 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 114.5 -1.227 . . . . 74.34 109.702 -173.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 403' ' ' THR . . . . . . . . . . . . . 15.1 t -160.45 -155.03 0.41 Allowed 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 124.301 1.04 . . . . 51.3 108.3 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 404' ' ' LYS . . . . . . . . . . . . . 64.7 mttp 76.32 -62.74 0.41 Allowed 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 125.288 1.435 . . . . 70.03 111.74 176.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 405' ' ' ALA . . . . . . . . . . . . . . . -114.41 89.28 17.49 Favored Pre-proline 0 N--CA 1.477 0.902 0 C-N-CA 123.552 0.741 . . . . 71.24 111.003 178.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 406' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -83.33 10.27 3.74 Favored 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 122.566 2.177 . . . . 44.44 112.495 164.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 407' ' ' GLY . . . . . 0.627 ' HA3' ' HA3' ' B' ' 417' ' ' GLY . . . 91.03 -42.77 2.85 Favored Glycine 0 C--N 1.358 1.794 0 C-N-CA 122.954 0.311 . . . . 55.33 113.639 172.418 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 408' ' ' LEU . . . . . 0.417 ' O ' ' HD2' ' A' ' 211' ' ' ARG . 3.3 pp -68.74 -18.0 64.15 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.486 0.714 . . . . 72.03 111.691 177.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 53.3 m -65.14 140.27 58.77 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.655 1.182 . . . . 73.52 111.771 178.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 410' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -63.96 128.75 37.18 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.923 0.889 . . . . 51.32 109.305 173.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . 74.74 -60.04 0.53 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 125.493 1.517 . . . . 63.14 112.208 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -74.68 88.96 2.23 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 122.084 0.945 . . . . 60.41 109.82 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 27.3 p30 -151.57 -161.53 1.34 Allowed 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 114.108 -1.406 . . . . 71.14 109.663 -174.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 414' ' ' THR . . . . . . . . . . . . . 4.0 m 69.49 165.66 0.27 Allowed 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 124.968 1.307 . . . . 73.24 110.583 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 415' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 77.77 -46.59 0.46 Allowed 'General case' 0 N--CA 1.505 2.307 0 C-N-CA 125.748 1.619 . . . . 73.42 111.561 -178.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -160.12 -170.69 2.93 Favored 'General case' 0 CA--C 1.557 1.239 0 N-CA-C 107.707 -1.22 . . . . 75.33 107.707 -179.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 417' ' ' GLY . . . . . 0.627 ' HA3' ' HA3' ' B' ' 407' ' ' GLY . . . 104.18 52.31 0.89 Allowed Glycine 0 N--CA 1.468 0.823 0 C-N-CA 122.715 0.198 . . . . 43.15 112.877 174.327 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 418' ' ' ALA . . . . . 0.603 ' H ' HD13 ' B' ' 385' ' ' LEU . . . 60.6 -88.7 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.171 1.388 . . . . 70.25 111.997 178.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 419' ' ' VAL . . . . . 0.424 HG12 ' HB2' ' B' ' 423' ' ' SER . 31.5 m -136.72 -17.26 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 C-N-CA 123.868 0.867 . . . . 62.03 110.806 -176.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 420' ' ' MET . . . . . . . . . . . . . 23.4 mtp 69.02 -67.64 0.21 Allowed 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 125.525 1.53 . . . . 73.12 111.178 -173.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 421' ' ' VAL . . . . . 0.543 HG22 ' HG2' ' B' ' 422' ' ' MET . 1.4 p -147.83 -53.89 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 125.731 1.612 . . . . 72.42 107.527 175.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 422' ' ' MET . . . . . 0.543 ' HG2' HG22 ' B' ' 421' ' ' VAL . 25.6 mmt -132.34 129.65 39.74 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 106.997 -1.482 . . . . 74.1 106.997 176.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 423' ' ' SER . . . . . 0.424 ' HB2' HG12 ' B' ' 419' ' ' VAL . 13.6 t -85.88 46.95 1.37 Allowed 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 123.583 0.753 . . . . 62.22 110.923 -178.245 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 424' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -157.42 101.26 1.86 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.205 1.002 . . . . 72.42 108.828 -178.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . 55.03 39.42 69.15 Favored Glycine 0 C--N 1.354 1.537 0 O-C-N 124.113 0.883 . . . . 75.12 113.982 175.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 426' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 69.46 -73.44 0.09 Allowed 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 125.137 1.375 . . . . 75.43 111.015 -178.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 427' ' ' SER . . . . . 0.506 ' HB2' ' HB2' ' B' ' 422' ' ' MET . 40.3 m 57.6 30.79 19.36 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 125.12 1.368 . . . . 75.14 111.669 -177.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 428' ' ' GLU . . . . . 0.43 ' HA ' HG11 ' B' ' 421' ' ' VAL . 8.6 pt-20 -78.48 79.99 4.89 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.283 1.033 . . . . 73.23 109.848 179.308 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 429' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -58.44 136.54 57.5 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 114.324 -1.307 . . . . 63.42 111.789 -176.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 18.9 t70 63.32 -82.37 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.87 1.268 . . . . 55.41 112.005 175.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 18.8 t -161.37 19.91 0.12 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.174 0.59 . . . . 73.31 110.535 -175.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 432' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 42.42 47.16 4.25 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 125.757 1.623 . . . . 71.1 112.739 -178.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 433' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -53.08 141.87 21.6 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.555 1.142 . . . . 73.43 113.498 -170.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 434' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -82.38 52.17 1.99 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.48 1.112 . . . . 65.13 109.88 177.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 435' ' ' THR . . . . . . . . . . . . . 15.3 t -88.59 -166.23 1.54 Allowed 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 123.701 0.8 . . . . 73.42 110.259 -170.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . 92.27 11.27 59.97 Favored Glycine 0 C--N 1.347 1.169 0 CA-C-O 119.75 -0.472 . . . . 43.54 112.977 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 49.5 m 58.57 30.75 20.24 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.255 1.022 . . . . 54.14 111.029 -178.324 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 438' ' ' GLN . . . . . 0.551 ' HA ' ' HG3' ' A' ' 220' ' ' GLU . 7.8 pt20 58.41 9.29 1.02 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 126.887 2.075 . . . . 71.55 113.741 -175.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 439' ' ' LEU . . . . . 0.415 HD12 ' HD2' ' A' ' 238' ' ' LYS . 4.0 mm? 60.12 -78.52 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 125.021 1.328 . . . . 74.24 111.714 -175.6 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 440' ' ' ARG . . . . . 0.509 ' HA ' ' HB3' ' A' ' 222' ' ' ALA . 27.2 tpt180 59.25 95.86 0.03 OUTLIER 'General case' 0 C--N 1.355 0.836 0 C-N-CA 125.457 1.503 . . . . 70.1 108.839 -168.296 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 441' ' ' ILE . . . . . 0.731 ' HB ' ' HB3' ' A' ' 235' ' ' LEU . 6.1 pt -75.24 -41.29 43.96 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 N-CA-C 114.422 1.268 . . . . 74.15 114.422 -151.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 442' ' ' ALA . . . . . 0.432 ' N ' HG13 ' B' ' 441' ' ' ILE . . . 56.1 82.29 0.11 Allowed 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 124.441 1.096 . . . . 71.41 112.075 -168.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . -130.66 -57.68 1.05 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.317 1.047 . . . . 74.21 108.375 173.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -81.55 78.37 8.31 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 114.829 -1.078 . . . . 65.34 108.639 169.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 445' ' ' GLY . . . . . 0.406 ' O ' ' HE3' ' B' ' 465' ' ' LYS . . . -61.18 -55.84 27.12 Favored Glycine 0 C--N 1.349 1.268 0 CA-C-N 114.559 -1.2 . . . . 74.34 112.271 172.354 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 446' ' ' PRO . . . . . 0.604 ' HG2' ' HB2' ' B' ' 471' ' ' LYS . 39.4 Cg_exo -60.25 145.34 98.77 Favored 'Trans proline' 0 C--N 1.381 2.251 0 C-N-CA 122.373 2.049 . . . . 63.02 112.276 175.58 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 447' ' ' HIS . . . . . . . . . . . . . 31.3 t-80 -65.98 -42.81 89.36 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.581 0.752 . . . . 60.0 111.828 -175.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 448' ' ' ALA . . . . . 0.49 ' HB1' ' HB3' ' C' ' 260' ' ' ARG . . . -93.23 -25.74 17.67 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 122.993 0.517 . . . . 74.31 111.179 178.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 449' ' ' ALA . . . . . 0.511 ' O ' ' HA ' ' B' ' 470' ' ' LEU . . . 61.48 -77.41 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.158 1.383 . . . . 61.52 112.482 177.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 450' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 65.6 -60.4 0.27 Allowed 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 125.261 1.425 . . . . 61.12 111.898 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 451' ' ' VAL . . . . . 0.82 HG11 HE22 ' B' ' 457' ' ' GLN . 62.0 t 83.02 139.52 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 125.789 1.636 . . . . 63.1 111.493 166.424 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 452' ' ' VAL . . . . . 0.451 ' O ' HG12 ' B' ' 451' ' ' VAL . 8.5 p -62.72 165.3 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.545 0 C-N-CA 124.559 1.144 . . . . 60.45 110.126 172.012 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . -62.88 87.48 0.05 OUTLIER Glycine 0 CA--C 1.538 1.469 0 O-C-N 122.282 -0.261 . . . . 73.44 112.917 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 454' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.85 107.76 5.16 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.08 0.952 . . . . 72.5 108.861 -177.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 8.5 t -75.89 -40.92 53.46 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.628 0.771 . . . . 61.41 112.192 -173.079 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -85.67 -11.43 53.8 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 112.398 0.518 . . . . 74.3 112.398 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 457' ' ' GLN . . . . . 0.82 HE22 HG11 ' B' ' 451' ' ' VAL . 6.1 tp-100 54.62 43.54 30.04 Favored 'General case' 0 CA--C 1.558 1.271 0 CA-C-O 122.266 1.032 . . . . 42.14 111.374 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 5.2 t -84.46 59.09 5.23 Favored 'General case' 0 CA--C 1.553 1.092 0 CA-C-O 122.47 1.129 . . . . 72.13 110.138 175.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 459' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -169.3 150.42 4.31 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 114.446 -1.252 . . . . 73.31 109.242 -173.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 460' ' ' LEU . . . . . 0.701 ' HA ' ' HD2' ' B' ' 471' ' ' LYS . 2.5 pt? -156.74 139.72 15.35 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.831 0.852 . . . . 65.42 109.949 173.249 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -129.32 146.93 51.12 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.877 0.871 . . . . 62.31 109.488 176.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -110.02 78.1 1.1 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.621 1.168 . . . . 72.53 109.32 -178.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 81.2 p -92.55 -177.23 4.53 Favored 'General case' 0 C--O 1.247 0.929 0 CA-C-N 116.045 -0.525 . . . . 61.35 109.775 174.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 464' ' ' MET . . . . . 0.495 ' HG2' ' HG3' ' B' ' 117' ' ' LYS . 1.3 tpt -71.08 138.12 49.5 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 123.215 0.606 . . . . 75.31 110.467 177.379 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 465' ' ' LYS . . . . . 0.406 ' HE3' ' O ' ' B' ' 445' ' ' GLY . 11.5 mptt -87.41 65.56 8.72 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.058 0.943 . . . . 72.15 108.62 177.368 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -82.94 -146.97 0.08 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.143 0.977 . . . . 62.32 109.973 -178.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . -80.35 -32.13 37.81 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 118.91 0.777 . . . . 75.3 110.067 175.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 11.1 mp -117.17 -124.35 0.29 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 124.407 1.083 . . . . 45.51 109.767 176.154 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 469' ' ' GLY . . . . . . . . . . . . . . . 100.86 121.13 4.72 Favored Glycine 0 C--N 1.354 1.557 0 N-CA-C 111.393 -0.683 . . . . 50.44 111.393 -171.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 470' ' ' LEU . . . . . 0.511 ' HA ' ' O ' ' B' ' 449' ' ' ALA . 6.8 tt -114.65 147.74 39.15 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.058 0.943 . . . . 73.2 109.376 175.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 471' ' ' LYS . . . . . 0.701 ' HD2' ' HA ' ' B' ' 460' ' ' LEU . 9.3 ttpp . . . . . 0 CA--C 1.561 1.4 0 C-N-CA 123.179 0.592 . . . . 74.2 110.538 -177.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 61.9 mtm . . . . . 0 N--CA 1.485 1.282 0 CA-C-O 119.651 -0.214 . . . . 55.23 111.094 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.56 40.89 32.03 Favored 'General case' 0 C--N 1.359 0.985 0 C-N-CA 124.286 1.034 . . . . 65.31 111.437 -176.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -73.99 77.79 1.68 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.163 0.585 . . . . 52.01 110.308 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? -37.64 96.2 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 125.616 1.566 . . . . 70.52 113.179 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 5' ' ' LYS . . . . . 0.484 ' HB3' HD11 ' C' ' 10' ' ' ILE . 97.4 mttt -96.86 106.93 19.34 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.72 0.808 . . . . 63.2 109.561 174.359 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -73.83 97.62 2.79 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 107.076 -1.453 . . . . 63.22 107.076 166.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 7' ' ' TYR . . . . . 0.41 ' HA ' HD12 ' C' ' 10' ' ' ILE . 61.1 m-85 -61.16 -26.04 67.42 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 114.451 -1.249 . . . . 73.43 112.257 -172.607 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -68.67 -46.77 68.22 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.851 0.461 . . . . 72.53 109.792 176.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.3 -42.88 92.35 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.366 0.666 . . . . 52.31 110.678 178.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 10' ' ' ILE . . . . . 0.484 HD11 ' HB3' ' C' ' 5' ' ' LYS . 83.3 mt -54.17 -47.39 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 C-N-CA 124.023 0.929 . . . . 63.34 110.615 174.162 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 11' ' ' LEU . . . . . 0.4 ' HB2' HG22 ' C' ' 13' ' ' VAL . 85.8 mt -75.79 -13.6 60.29 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 115.397 -0.82 . . . . 45.45 112.787 179.081 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.66 21.29 75.06 Favored Glycine 0 C--N 1.351 1.393 0 CA-C-N 117.903 0.32 . . . . 64.33 113.655 -177.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 13' ' ' VAL . . . . . 0.4 HG22 ' HB2' ' C' ' 11' ' ' LEU . 12.5 m -106.19 160.58 25.7 Favored Pre-proline 0 N--CA 1.483 1.187 0 C-N-CA 124.291 1.036 . . . . 64.04 110.271 176.332 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -56.82 153.37 37.47 Favored 'Trans proline' 0 C--N 1.388 2.65 0 C-N-CA 122.714 2.276 . . . . 74.43 112.152 177.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 63.6 mtp180 -70.67 7.21 1.16 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 113.661 0.985 . . . . 71.52 113.661 -174.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -135.93 21.94 3.29 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.276 1.031 . . . . 71.24 108.594 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.04 128.07 34.99 Favored 'General case' 0 C--N 1.35 0.608 0 CA-C-N 114.684 -1.144 . . . . 71.14 111.089 -176.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 70.8 p -71.44 169.22 15.84 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 123.662 0.785 . . . . 74.41 110.252 177.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -50.98 -38.59 51.89 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.052 0.941 . . . . 74.45 111.615 -178.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 20' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' C' ' 24' ' ' ARG . 0.3 OUTLIER -69.68 -45.56 68.04 Favored 'General case' 0 CA--C 1.553 1.061 0 O-C-N 123.952 0.783 . . . . 64.05 110.539 -176.14 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -63.47 -43.41 97.42 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.724 0.773 . . . . 73.42 110.741 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 22' ' ' ILE . . . . . 0.755 HD13 ' HB3' ' C' ' 57' ' ' LEU . 89.8 mt -63.13 -34.3 65.88 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 CA-C-N 114.044 -1.435 . . . . 61.32 110.75 175.486 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -72.67 -29.95 63.86 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.928 0.891 . . . . 74.13 111.223 176.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 24' ' ' ARG . . . . . 0.431 ' HG3' ' O ' ' C' ' 20' ' ' GLU . 94.6 mtt180 -64.81 -53.05 52.94 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.142 0.577 . . . . 73.52 109.541 175.398 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.93 -40.96 97.32 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 114.704 -1.135 . . . . 75.32 111.24 178.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 26' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -52.48 -64.43 0.82 Allowed 'General case' 0 C--O 1.212 -0.877 0 O-C-N 124.789 1.306 . . . . 72.31 110.309 176.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -59.01 -38.73 79.9 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 124.339 1.025 . . . . 74.1 111.45 -174.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 -55.03 -53.68 52.67 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 123.715 0.634 . . . . 71.15 110.588 177.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 29' ' ' LEU . . . . . 0.526 ' HB3' HD13 ' C' ' 50' ' ' ILE . 72.4 mt -82.65 -17.14 45.66 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 115.009 -0.996 . . . . 60.22 111.941 -176.405 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -85.84 -16.6 38.17 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.738 0.815 . . . . 75.32 110.472 179.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -95.19 -37.7 10.92 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.525 0.73 . . . . 73.5 109.954 170.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 25.8 tp60 -65.07 -47.76 76.17 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.393 0.677 . . . . 71.12 111.187 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -108.69 22.7 15.57 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.333 0.653 . . . . 70.15 111.069 -175.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 34' ' ' HIS . . . . . 0.527 ' CD2' ' HB3' ' C' ' 36' ' ' ASP . 54.3 t60 -60.51 99.39 0.18 Allowed Pre-proline 0 N--CA 1.487 1.412 0 C-N-CA 124.913 1.285 . . . . 72.34 111.547 -174.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -61.97 -22.37 74.15 Favored 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 123.51 2.806 . . . . 71.32 113.916 -167.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 36' ' ' ASP . . . . . 0.527 ' HB3' ' CD2' ' C' ' 34' ' ' HIS . 9.4 t70 -56.44 -43.88 79.91 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.38 1.072 . . . . 60.34 111.603 174.542 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 37' ' ' VAL . . . . . 0.432 HG23 ' HD2' ' C' ' 34' ' ' HIS . 51.7 t -99.94 -46.24 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-O 121.762 0.791 . . . . 75.33 109.754 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -100.93 84.5 2.7 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.391 1.476 . . . . 54.22 109.921 -175.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -83.37 54.88 2.96 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.402 0.681 . . . . 62.24 110.663 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 44.3 m -104.37 108.33 60.14 Favored Pre-proline 0 N--CA 1.475 0.791 0 CA-C-O 118.572 -0.728 . . . . 74.14 109.136 -178.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -40.75 -52.12 3.34 Favored 'Trans proline' 0 C--N 1.387 2.6 0 C-N-CA 124.655 3.57 . . . . 63.44 114.707 -174.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 42' ' ' GLU . . . . . 0.404 ' O ' ' HD3' ' C' ' 46' ' ' LYS . 41.8 tt0 -56.81 -47.39 80.35 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 124.043 0.839 . . . . 65.44 110.813 178.384 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.05 -20.87 66.32 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 115.966 -0.561 . . . . 62.05 110.901 -178.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 44' ' ' GLU . . . . . 0.406 ' O ' ' HD3' ' C' ' 48' ' ' LYS . 45.7 mt-10 -86.29 -28.87 23.47 Favored 'General case' 0 C--N 1.355 0.814 0 C-N-CA 123.21 0.604 . . . . 74.04 109.995 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -60.85 -50.26 74.17 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.753 -0.832 . . . . 42.53 108.753 171.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 46' ' ' LYS . . . . . 0.404 ' HD3' ' O ' ' C' ' 42' ' ' GLU . 12.3 mptt -62.5 -48.79 78.04 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 113.811 -1.541 . . . . 72.32 110.07 179.092 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -56.25 -39.19 72.18 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.809 0.844 . . . . 62.23 110.79 178.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 48' ' ' LYS . . . . . 0.406 ' HD3' ' O ' ' C' ' 44' ' ' GLU . 1.2 mptm? -62.02 -49.19 77.01 Favored 'General case' 0 C--O 1.214 -0.794 0 O-C-N 123.841 0.713 . . . . 72.04 109.97 179.217 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -70.68 -22.02 62.53 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 112.557 0.577 . . . . 72.33 112.557 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 50' ' ' ILE . . . . . 0.526 HD13 ' HB3' ' C' ' 29' ' ' LEU . 73.2 mt -80.11 -36.78 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 124.423 1.089 . . . . 75.43 110.69 176.657 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 51' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -89.63 -8.64 52.07 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.031 0.932 . . . . 74.04 110.521 177.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 52' ' ' GLU . . . . . 0.413 ' O ' HG23 ' C' ' 56' ' ' VAL . 29.4 tt0 -79.0 -47.19 16.71 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.93 1.292 . . . . 63.42 107.928 166.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.42 -44.34 80.29 Favored 'General case' 0 C--N 1.346 0.431 0 CA-C-N 114.243 -1.344 . . . . 63.1 110.684 173.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -80.93 -22.84 39.31 Favored 'General case' 0 CA--C 1.553 1.06 0 CA-C-N 115.501 -0.772 . . . . 75.01 111.125 178.007 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.85 -38.24 78.28 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 118.839 0.745 . . . . 60.54 110.22 171.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 56' ' ' VAL . . . . . 0.413 HG23 ' O ' ' C' ' 52' ' ' GLU . 26.1 t -77.34 -47.69 26.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-N 114.891 -1.049 . . . . 72.43 110.501 174.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 57' ' ' LEU . . . . . 0.755 ' HB3' HD13 ' C' ' 22' ' ' ILE . 85.1 mt -103.72 20.8 17.36 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 113.569 0.952 . . . . 75.02 113.569 -166.362 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 33.6 t -55.89 -43.1 76.92 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 124.161 0.984 . . . . 62.42 113.275 177.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -140.71 156.91 68.82 Favored Pre-proline 0 N--CA 1.472 0.664 0 C-N-CA 124.379 1.072 . . . . 72.03 109.559 -170.205 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 60' ' ' PRO . . . . . 0.472 ' O ' ' HG2' ' C' ' 64' ' ' ARG . 19.6 Cg_endo -54.62 -29.21 59.8 Favored 'Trans proline' 0 C--N 1.394 2.959 0 C-N-CA 123.408 2.739 . . . . 33.23 112.454 179.176 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -54.04 -63.16 1.24 Allowed 'General case' 0 C--O 1.252 1.199 0 C-N-CA 124.823 1.249 . . . . 62.13 111.801 177.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 44.0 mtpt -81.55 -24.64 36.45 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 113.94 -1.482 . . . . 75.23 110.152 -171.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -54.3 -50.13 68.05 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.763 1.225 . . . . 64.42 109.595 166.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 64' ' ' ARG . . . . . 0.472 ' HG2' ' O ' ' C' ' 60' ' ' PRO . 20.9 mmt180 -71.11 -29.02 64.74 Favored 'General case' 0 C--N 1.358 0.967 0 CA-C-O 119.13 -0.462 . . . . 74.15 111.801 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 65' ' ' ILE . . . . . 0.401 HG23 ' HG2' ' C' ' 76' ' ' PRO . 69.4 mt -56.86 -44.92 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-O 121.296 0.57 . . . . 62.34 110.317 168.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -63.19 -48.15 79.6 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.994 -0.548 . . . . 74.22 110.969 176.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -58.84 -41.4 86.86 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 123.581 0.551 . . . . 73.14 111.725 -177.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 64.9 p -67.8 -28.99 68.06 Favored 'General case' 0 C--N 1.349 0.574 0 O-C-N 123.341 0.4 . . . . 63.2 110.671 176.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -77.26 142.71 39.36 Favored 'General case' 0 C--N 1.359 0.989 0 N-CA-C 109.052 -0.721 . . . . 75.22 109.052 171.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.69 13.3 82.6 Favored Glycine 0 C--N 1.346 1.102 0 N-CA-C 112.009 -0.436 . . . . 62.51 112.009 -177.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 28.8 m -136.93 -54.5 0.71 Allowed 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 103.749 -2.686 . . . . 72.34 103.749 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 82.2 m -97.51 150.17 21.37 Favored 'General case' 0 C--O 1.255 1.354 0 N-CA-C 104.532 -2.395 . . . . 73.35 104.532 156.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.12 -34.16 11.8 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.844 0.858 . . . . 73.23 110.258 -178.505 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -70.64 128.1 91.31 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 123.742 0.817 . . . . 53.23 110.732 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -67.13 150.38 82.12 Favored 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 122.647 2.231 . . . . 75.14 111.176 172.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 76' ' ' PRO . . . . . 0.401 ' HG2' HG23 ' C' ' 65' ' ' ILE . 48.1 Cg_exo -58.75 147.39 88.44 Favored 'Trans proline' 0 C--N 1.373 1.856 0 C-N-CA 122.645 2.23 . . . . 63.14 112.123 173.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 77' ' ' PRO . . . . . 0.401 ' HA ' ' HD3' ' C' ' 78' ' ' PRO . 50.5 Cg_exo -56.43 147.42 68.55 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 122.388 2.059 . . . . 51.51 112.113 171.602 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 78' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' C' ' 77' ' ' PRO . 43.3 Cg_exo -59.05 123.05 12.63 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.975 2.45 . . . . 74.44 112.618 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -71.91 170.68 18.25 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 122.872 2.382 . . . . 61.04 112.178 178.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 80' ' ' PRO . . . . . 0.49 ' HB2' ' HB1' ' C' ' 141' ' ' ALA . 82.4 Cg_exo -48.8 89.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.393 2.911 0 C-N-CA 123.468 2.779 . . . . 51.5 113.607 178.443 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 118.29 -40.1 2.4 Favored Glycine 0 C--O 1.225 -0.464 0 CA-C-N 114.651 -1.158 . . . . 75.2 110.255 177.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.508 ' HA3' ' HA ' ' C' ' 106' ' ' PHE . . . 126.5 -176.04 17.68 Favored Glycine 0 C--N 1.347 1.18 0 N-CA-C 111.249 -0.741 . . . . 74.45 111.249 -172.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -73.98 124.13 25.63 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.839 0.856 . . . . 70.14 111.152 -176.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 84' ' ' ASP . . . . . 0.662 ' HB3' HH21 ' C' ' 143' ' ' ARG . 6.9 p-10 -70.77 149.15 47.18 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.616 0.766 . . . . 63.13 110.506 177.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 85' ' ' PHE . . . . . 0.543 ' HB3' ' HB2' ' C' ' 88' ' ' PHE . 53.6 m-85 -148.37 74.86 1.3 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.641 0.777 . . . . 74.41 110.056 -179.147 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 16.5 m -54.98 86.57 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 125.131 1.373 . . . . 45.43 113.645 -175.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 85.49 13.45 70.45 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-N 115.686 -0.688 . . . . 74.33 112.829 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 88' ' ' PHE . . . . . 0.543 ' HB2' ' HB3' ' C' ' 85' ' ' PHE . 18.5 m-85 -115.34 108.15 16.16 Favored 'General case' 0 C--N 1.355 0.815 0 C-N-CA 123.135 0.574 . . . . 74.44 109.641 -174.071 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -74.46 88.13 2.1 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 108.042 -1.095 . . . . 72.23 108.042 177.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 90' ' ' VAL . . . . . 0.715 HG21 HD22 ' C' ' 105' ' ' LEU . 2.1 p -47.35 -40.65 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 CA-C-N 114.317 -1.311 . . . . 54.41 113.151 176.366 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 91' ' ' GLU . . . . . 0.443 ' HB2' ' ND2' ' C' ' 169' ' ' ASN . 33.7 tt0 -65.99 -21.3 66.4 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.863 0.865 . . . . 74.21 111.43 -175.62 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -86.42 -21.59 27.03 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 123.728 0.811 . . . . 75.53 111.239 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -77.24 -177.72 4.72 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.339 0.656 . . . . 72.45 112.338 -175.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 92.4 p -78.14 173.31 12.38 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 113.307 0.854 . . . . 45.51 113.307 -168.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.21 -51.07 71.59 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 114.333 -1.303 . . . . 55.43 111.557 178.038 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -56.17 -40.51 74.0 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.984 0.914 . . . . 65.02 111.087 -175.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 97' ' ' PHE . . . . . 0.427 ' HE2' HG23 ' C' ' 90' ' ' VAL . 60.1 t80 -64.72 -50.36 67.22 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 114.519 -1.219 . . . . 64.25 110.04 177.113 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -80.06 2.69 22.89 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 115.213 -0.903 . . . . 51.52 112.56 -177.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -100.07 -45.12 5.77 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.568 0.747 . . . . 74.43 110.507 170.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 13.2 tp -62.74 -58.29 7.96 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.242 0.617 . . . . 73.23 110.127 176.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -81.87 -11.36 58.97 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 115.71 -0.677 . . . . 73.25 111.408 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -37.38 -63.18 0.84 Allowed Glycine 0 C--N 1.358 1.767 0 C-N-CA 124.807 1.194 . . . . 54.11 115.679 -177.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_exo -46.21 -34.13 13.08 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 123.841 3.028 . . . . 62.02 115.282 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -119.05 27.88 6.87 Favored Glycine 0 C--N 1.356 1.647 0 CA-C-O 119.318 -0.712 . . . . 43.23 113.823 -175.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 105' ' ' LEU . . . . . 0.715 HD22 HG21 ' C' ' 90' ' ' VAL . 29.0 mt -68.67 81.79 0.28 Allowed 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 117.761 0.78 . . . . 73.03 112.706 176.133 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 106' ' ' PHE . . . . . 0.539 ' HB2' ' HA ' ' C' ' 169' ' ' ASN . 0.2 OUTLIER 36.61 -113.84 0.1 Allowed 'General case' 0 CA--C 1.558 1.269 0 C-N-CA 126.864 2.066 . . . . 64.24 115.464 174.928 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . 68.48 2.2 26.31 Favored Glycine 0 C--N 1.359 1.861 0 N-CA-C 112.219 -0.353 . . . . 51.05 112.219 -162.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 108' ' ' GLY . . . . . 0.629 ' HA3' ' HA ' ' C' ' 167' ' ' GLN . . . 55.56 -142.59 36.82 Favored Glycine 0 C--N 1.36 1.898 0 N-CA-C 111.389 -0.684 . . . . 74.41 111.389 -168.323 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 109' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -85.05 -0.58 54.95 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 122.797 0.439 . . . . 74.45 109.988 170.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 110' ' ' GLY . . . . . . . . . . . . . . . -90.1 -15.41 57.61 Favored Glycine 0 C--N 1.361 1.95 0 CA-C-O 119.832 -0.427 . . . . 54.22 112.36 -178.26 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 52.8 15.22 0.51 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 114.694 1.368 . . . . 75.25 114.694 174.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 112' ' ' ARG . . . . . . . . . . . . . 38.2 ttp-105 -56.93 -32.59 66.12 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.147 0.979 . . . . 74.1 111.366 169.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 113' ' ' SER . . . . . . . . . . . . . 31.7 m 58.12 32.28 21.81 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.714 1.206 . . . . 72.53 111.246 -176.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 18.2 mtp85 -135.38 -178.69 5.22 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.791 0.836 . . . . 74.05 110.782 177.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 115' ' ' LYS . . . . . 0.543 ' HA ' ' HD2' ' C' ' 170' ' ' PRO . 56.6 tttp -28.73 129.02 0.08 Allowed 'General case' 0 N--CA 1.503 2.18 0 C-N-CA 126.207 1.803 . . . . 54.14 115.378 -163.059 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 116' ' ' GLY . . . . . 0.514 ' HA2' ' HA3' ' C' ' 168' ' ' GLY . . . -89.72 144.91 18.02 Favored Glycine 0 C--N 1.344 1.004 0 O-C-N 123.986 0.804 . . . . 45.25 113.902 -174.209 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.09 -176.82 2.99 Favored 'General case' 0 C--O 1.26 1.621 0 C-N-CA 124.301 1.041 . . . . 64.44 108.907 168.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 118' ' ' ASP . . . . . 0.471 ' HA ' ' O ' ' C' ' 173' ' ' ASP . 4.8 p-10 -60.62 152.99 24.9 Favored 'General case' 0 C--O 1.244 0.764 0 CA-C-N 115.127 -0.942 . . . . 75.42 112.828 -171.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 119' ' ' LEU . . . . . 0.469 ' O ' HD12 ' C' ' 174' ' ' LEU . 20.0 tp -110.85 118.28 35.71 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 106.57 -1.641 . . . . 75.21 106.57 173.538 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 21.8 ttm180 -112.37 106.03 14.45 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 121.207 0.527 . . . . 72.31 110.761 -167.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 121' ' ' ALA . . . . . . . . . . . . . . . -124.13 117.28 24.3 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.445 -0.798 . . . . 63.21 109.314 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 122' ' ' GLU . . . . . 0.411 ' HG2' HG22 ' B' ' 186' ' ' THR . 9.1 pt-20 -82.14 125.44 30.89 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 108.478 -0.934 . . . . 73.22 108.478 170.001 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 123' ' ' LEU . . . . . 0.434 HD13 HD22 ' C' ' 176' ' ' LEU . 2.2 pt? -130.33 115.3 17.34 Favored Pre-proline 0 CA--C 1.554 1.134 0 C-N-CA 123.03 0.532 . . . . 73.3 110.461 -171.256 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 124' ' ' PRO . . . . . 0.477 ' HG2' ' HB2' ' B' ' 188' ' ' ARG . 53.6 Cg_exo -62.78 115.69 3.08 Favored 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 123.301 2.667 . . . . 72.51 113.707 170.44 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 125' ' ' LEU . . . . . 0.592 HD23 HG11 ' C' ' 153' ' ' VAL . 19.0 tp -131.32 166.52 21.05 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 106.308 -1.738 . . . . 74.03 106.308 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 126' ' ' THR . . . . . 0.443 ' H ' ' HB2' ' C' ' 129' ' ' GLU . 11.7 t -129.54 176.03 8.31 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 120.833 1.651 . . . . 61.53 112.1 175.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 127' ' ' LEU . . . . . 0.483 HD23 HD13 ' C' ' 180' ' ' LEU . 7.4 mt -60.79 -41.67 96.07 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.003 1.721 . . . . 62.25 110.069 -177.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -65.02 -43.63 91.83 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 113.867 -1.515 . . . . 75.24 110.716 176.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 129' ' ' GLU . . . . . 0.443 ' HB2' ' H ' ' C' ' 126' ' ' THR . 38.8 mm-40 -72.59 -21.17 61.17 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-N 115.47 -0.786 . . . . 73.53 111.224 -179.321 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 130' ' ' ALA . . . . . 0.555 ' HB2' HG12 ' C' ' 153' ' ' VAL . . . -78.57 -46.25 19.84 Favored 'General case' 0 C--O 1.22 -0.456 0 O-C-N 124.139 0.899 . . . . 64.34 109.194 174.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 131' ' ' PHE . . . . . 0.623 ' HB2' HD13 ' C' ' 215' ' ' LEU . 88.1 t80 -50.68 -42.99 57.42 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.709 1.204 . . . . 75.55 110.796 173.074 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 132' ' ' HIS . . . . . . . . . . . . . 28.0 m170 -67.44 -67.43 0.46 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.187 -0.915 . . . . 60.22 108.754 175.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 50.51 -139.28 22.04 Favored Glycine 0 C--N 1.358 1.791 0 O-C-N 124.198 0.936 . . . . 65.31 113.662 175.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.86 -152.97 37.58 Favored Glycine 0 C--N 1.342 0.913 0 O-C-N 123.958 0.446 . . . . 53.24 113.27 177.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -79.15 94.4 5.37 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 108.554 -0.906 . . . . 71.2 108.554 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 136' ' ' ARG . . . . . . . . . . . . . 28.1 mmm-85 -103.39 125.35 49.95 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.778 0.831 . . . . 72.12 109.382 -177.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 137' ' ' VAL . . . . . 0.635 HG23 ' HB1' ' B' ' 180' ' ' ALA . 31.6 m -77.43 135.96 25.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 N-CA-C 109.361 -0.607 . . . . 71.12 109.361 174.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 138' ' ' VAL . . . . . . . . . . . . . 7.3 p -136.28 126.42 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.607 0.763 . . . . 72.14 109.35 -176.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 139' ' ' GLU . . . . . 0.496 ' HG3' ' HB2' ' C' ' 144' ' ' ARG . 1.6 mp0 -86.72 75.81 9.6 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.543 -0.539 . . . . 74.31 109.543 -176.292 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 140' ' ' VAL . . . . . . . . . . . . . 87.0 t -86.04 113.02 23.41 Favored 'Isoleucine or valine' 0 C--O 1.246 0.891 0 N-CA-C 108.396 -0.964 . . . . 63.22 108.396 -178.295 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 141' ' ' ALA . . . . . 0.49 ' HB1' ' HB2' ' C' ' 80' ' ' PRO . . . 62.78 37.01 12.75 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 124.565 1.165 . . . . 15.23 110.914 176.319 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 101.55 -34.81 5.36 Favored Glycine 0 C--N 1.351 1.363 0 CA-C-N 114.856 -1.065 . . . . 45.25 112.803 177.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 143' ' ' ARG . . . . . 0.662 HH21 ' HB3' ' C' ' 84' ' ' ASP . 0.2 OUTLIER -92.4 118.96 31.47 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 117.179 0.489 . . . . 73.04 111.324 -171.508 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 144' ' ' ARG . . . . . 0.523 ' HG3' ' HB ' ' C' ' 137' ' ' VAL . 35.4 ttm180 -73.92 115.95 13.97 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.194 -0.912 . . . . 71.51 109.638 171.6 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 145' ' ' VAL . . . . . . . . . . . . . 4.2 p -131.51 128.87 61.46 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 C-N-CA 124.049 0.94 . . . . 75.03 109.775 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 36.1 t -75.45 93.02 2.9 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 123.977 0.911 . . . . 54.21 110.582 -177.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 8.8 p -88.15 119.12 35.04 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 N-CA-C 109.241 -0.652 . . . . 72.53 109.241 175.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -75.53 104.33 6.04 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 109.513 -0.551 . . . . 74.22 109.513 174.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 149' ' ' ILE . . . . . 0.422 HG21 HG21 ' C' ' 159' ' ' ILE . 36.0 pt -120.29 95.46 49.07 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 107.133 -1.432 . . . . 71.41 107.133 165.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -49.78 161.14 0.96 Allowed 'Trans proline' 0 C--N 1.395 2.994 0 C-N-CA 124.271 3.314 . . . . 61.44 114.205 -174.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -43.56 94.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.389 2.7 0 C-N-CA 123.345 2.697 . . . . 73.2 112.247 174.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 152' ' ' GLY . . . . . 0.449 ' HA2' ' CD2' ' C' ' 240' ' ' PHE . . . 151.44 132.76 1.93 Allowed Glycine 0 C--N 1.348 1.222 0 CA-C-N 115.073 -0.967 . . . . 54.32 113.637 -174.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 153' ' ' VAL . . . . . 0.612 HG22 HG11 ' C' ' 178' ' ' VAL . 0.6 OUTLIER -153.59 160.23 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.028 0 CA-C-N 116.745 0.273 . . . . 71.13 110.948 169.696 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 154' ' ' ARG . . . . . 0.457 ' HG2' ' HB3' ' C' ' 188' ' ' LEU . 22.1 mtp180 -121.36 123.49 42.26 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.206 1.002 . . . . 75.32 110.447 -170.198 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 155' ' ' GLU . . . . . 0.47 ' HB2' HD12 ' C' ' 180' ' ' LEU . 13.3 tp10 -51.18 124.74 12.26 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.439 0.696 . . . . 74.51 112.241 171.082 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 76.28 12.39 84.23 Favored Glycine 0 C--N 1.348 1.241 0 O-C-N 124.394 1.059 . . . . 64.51 114.008 170.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 157' ' ' SER . . . . . . . . . . . . . 55.4 m -101.94 156.1 17.74 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.202 0.525 . . . . 75.43 110.829 -178.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 158' ' ' VAL . . . . . 0.643 HG12 HG22 ' C' ' 177' ' ' VAL . 27.1 m -96.56 111.71 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 CA-C-N 115.103 -0.953 . . . . 64.44 109.161 175.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 159' ' ' ILE . . . . . 0.714 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 57.1 mt -71.39 94.95 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 107.903 -1.147 . . . . 52.25 107.903 170.565 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 12.1 ttp180 -86.87 100.75 12.78 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 109.336 -0.616 . . . . 72.21 109.336 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 161' ' ' VAL . . . . . 0.601 HG13 ' HB3' ' C' ' 174' ' ' LEU . 2.1 p -101.03 102.46 20.19 Favored Pre-proline 0 CA--C 1.553 1.076 0 N-CA-C 108.866 -0.79 . . . . 75.24 108.866 172.6 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -63.76 136.34 53.07 Favored 'Trans proline' 0 C--N 1.386 2.52 0 C-N-CA 122.921 2.414 . . . . 63.42 112.855 -175.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 163' ' ' GLY . . . . . 0.418 ' O ' ' HB2' ' C' ' 171' ' ' PRO . . . 98.29 -6.82 61.69 Favored Glycine 0 C--N 1.341 0.847 0 CA-C-N 115.317 -0.856 . . . . 53.31 113.512 177.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 164' ' ' MET . . . . . . . . . . . . . 82.7 mtp -103.26 30.68 4.74 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 118.016 0.908 . . . . 73.35 110.883 178.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 165' ' ' GLY . . . . . 0.499 ' HA2' ' O ' ' C' ' 173' ' ' ASP . . . -57.34 162.8 7.73 Favored Glycine 0 C--N 1.351 1.393 0 CA-C-N 114.932 -1.031 . . . . 64.24 114.82 177.38 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . -117.85 -59.55 0.29 Allowed Glycine 0 C--N 1.346 1.101 0 C-N-CA 121.532 -0.366 . . . . 75.44 112.764 -170.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 167' ' ' GLN . . . . . 0.629 ' HA ' ' HA3' ' C' ' 108' ' ' GLY . 29.9 mm-40 -88.46 99.07 12.0 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 110.164 -0.31 . . . . 64.31 110.164 -173.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 168' ' ' GLY . . . . . 0.514 ' HA3' ' HA2' ' C' ' 116' ' ' GLY . . . 123.04 147.96 7.5 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-O 119.564 -0.575 . . . . 13.44 112.9 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 169' ' ' ASN . . . . . 0.539 ' HA ' ' HB2' ' C' ' 106' ' ' PHE . 7.3 t30 -61.04 -59.41 13.91 Favored Pre-proline 0 N--CA 1.491 1.607 0 CA-C-O 117.621 -1.18 . . . . 62.44 113.781 -169.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 170' ' ' PRO . . . . . 0.543 ' HD2' ' HA ' ' C' ' 115' ' ' LYS . 6.6 Cg_exo -75.12 106.08 2.21 Favored 'Trans proline' 0 C--N 1.39 2.76 0 C-N-CA 122.01 1.807 . . . . 51.41 109.792 170.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 171' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' C' ' 170' ' ' PRO . 17.0 Cg_exo -66.58 126.02 14.79 Favored 'Trans proline' 0 C--N 1.372 1.798 0 C-N-CA 122.75 2.3 . . . . 74.02 113.229 -167.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -71.37 -74.94 0.68 Allowed Glycine 0 C--N 1.355 1.619 0 O-C-N 123.797 0.686 . . . . 74.42 113.464 -177.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 173' ' ' ASP . . . . . 0.499 ' O ' ' HA2' ' C' ' 165' ' ' GLY . 4.6 p-10 -164.05 166.64 21.21 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.04 0.936 . . . . 74.51 109.746 175.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 174' ' ' LEU . . . . . 0.601 ' HB3' HG13 ' C' ' 161' ' ' VAL . 31.6 tp -113.48 113.76 25.6 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.901 -0.778 . . . . 75.22 108.901 176.099 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 175' ' ' LEU . . . . . 0.469 HD22 ' HB ' ' C' ' 158' ' ' VAL . 70.4 mt -87.72 93.54 9.47 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 123.882 0.873 . . . . 71.32 109.879 170.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 176' ' ' LEU . . . . . 0.714 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 82.3 mt -82.92 100.44 10.4 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 108.989 -0.745 . . . . 43.02 108.989 170.294 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 177' ' ' VAL . . . . . 0.643 HG22 HG12 ' C' ' 158' ' ' VAL . 41.4 t -81.49 93.35 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 108.49 -0.93 . . . . 74.43 108.49 -178.122 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 178' ' ' VAL . . . . . 0.612 HG11 HG22 ' C' ' 153' ' ' VAL . 2.1 p -76.77 125.29 36.43 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 CA-C-N 115.329 -0.85 . . . . 74.01 110.996 -172.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 179' ' ' ARG . . . . . 0.461 ' O ' ' HA ' ' C' ' 124' ' ' PRO . 34.8 mmt180 -120.29 112.9 19.62 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 114.355 -1.293 . . . . 72.33 108.308 178.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 180' ' ' LEU . . . . . 0.545 ' HA ' ' O ' ' C' ' 125' ' ' LEU . 80.5 mt -69.48 143.32 53.54 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 116.561 -0.291 . . . . 70.51 111.579 -178.578 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 181' ' ' LEU . . . . . . . . . . . . . 36.6 mt -60.94 156.49 47.07 Favored Pre-proline 0 N--CA 1.482 1.17 0 CA-C-O 117.731 -1.128 . . . . 74.2 109.92 -179.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -49.02 79.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.395 2.987 0 C-N-CA 124.205 3.27 . . . . 64.12 115.516 -174.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 183' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 171.87 76.78 0.04 OUTLIER Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 128.456 2.702 . . . . 62.13 106.82 172.405 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 184' ' ' PRO . . . . . 0.532 ' HG2' ' HB3' ' B' ' 287' ' ' PRO . 71.9 Cg_endo -74.22 68.86 4.99 Favored 'Trans proline' 0 C--N 1.38 2.19 0 C-N-CA 123.686 2.924 . . . . 71.54 111.533 178.015 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 185' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 13.1 t -90.48 -41.16 13.32 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.702 0 N-CA-C 109.326 -0.62 . . . . 72.23 109.326 -168.042 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 186' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -122.25 111.03 16.44 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 120.9 0.381 . . . . 61.44 111.718 -172.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 187' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -95.98 112.9 24.51 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 106.562 -1.644 . . . . 75.14 106.562 170.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 188' ' ' LEU . . . . . 0.457 ' HB3' ' HG2' ' C' ' 154' ' ' ARG . 62.0 tp -80.75 144.8 31.88 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-O 121.272 0.558 . . . . 74.14 112.465 -175.64 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -136.9 101.52 4.6 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.634 1.574 . . . . 71.33 107.124 169.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 72.41 -97.27 0.77 Allowed Glycine 0 C--N 1.349 1.263 0 N-CA-C 112.084 -0.406 . . . . 74.2 112.084 -175.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 191' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -119.86 -18.57 8.21 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 124.323 1.049 . . . . 60.21 110.321 175.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -94.53 140.94 29.18 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.168 0.987 . . . . 65.13 110.467 -172.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 193' ' ' LEU . . . . . 0.55 HD21 ' CE2' ' C' ' 240' ' ' PHE . 88.5 mt -100.25 170.18 8.62 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 113.119 0.785 . . . . 52.2 113.119 -169.083 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 194' ' ' TYR . . . . . 0.423 ' HA ' ' O ' ' C' ' 250' ' ' TYR . 52.1 t80 -127.97 108.42 10.66 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.787 0.835 . . . . 75.43 110.197 167.669 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 195' ' ' ALA . . . . . 0.522 ' HA ' ' O ' ' C' ' 185' ' ' VAL . . . -110.68 -175.85 2.82 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.823 0.849 . . . . 65.11 109.125 168.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 17.9 m -121.8 132.15 54.44 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 108.432 -0.951 . . . . 51.32 108.432 167.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 197' ' ' LEU . . . . . 0.476 HD22 HD12 ' C' ' 233' ' ' LEU . 53.7 tp -102.1 145.68 29.01 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.459 0.704 . . . . 73.5 110.444 -177.58 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 198' ' ' ASP . . . . . 0.482 ' HB3' HD11 ' B' ' 280' ' ' LEU . 6.0 t70 -116.61 101.61 8.75 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.274 -1.01 . . . . 44.52 108.274 -179.398 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 199' ' ' VAL . . . . . . . . . . . . . 39.5 t -115.13 126.29 27.98 Favored Pre-proline 0 N--CA 1.476 0.872 0 N-CA-C 108.826 -0.805 . . . . 61.21 108.826 177.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 200' ' ' PRO . . . . . 0.635 ' HG2' HD12 ' C' ' 203' ' ' ILE . 24.0 Cg_exo -60.73 150.01 84.81 Favored 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 122.588 2.192 . . . . 71.34 112.204 168.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 201' ' ' ALA . . . . . 0.454 ' O ' HG23 ' C' ' 205' ' ' VAL . . . -51.84 -57.92 13.02 Favored Pre-proline 0 CA--C 1.56 1.358 0 C-N-CA 124.756 1.222 . . . . 74.35 113.409 177.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 202' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -71.46 -30.68 14.9 Favored 'Trans proline' 0 C--N 1.389 2.71 0 CA-C-N 121.585 1.602 . . . . 63.15 112.544 -174.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 203' ' ' ILE . . . . . 0.635 HD12 ' HG2' ' C' ' 200' ' ' PRO . 20.4 mt -64.43 -40.48 89.21 Favored 'Isoleucine or valine' 0 C--N 1.361 1.085 0 N-CA-C 109.307 -0.627 . . . . 63.4 109.307 172.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 204' ' ' ALA . . . . . 0.534 ' HB1' ' HB ' ' C' ' 227' ' ' THR . . . -62.06 -39.06 91.1 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.24 -0.891 . . . . 75.02 110.816 176.447 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 205' ' ' VAL . . . . . 0.454 HG23 ' O ' ' C' ' 201' ' ' ALA . 53.4 t -74.06 -48.86 36.27 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 N-CA-C 114.027 1.121 . . . . 63.41 114.027 -173.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 206' ' ' VAL . . . . . . . . . . . . . 9.0 p -92.73 -33.55 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 CA-C-N 119.551 1.069 . . . . 52.12 111.453 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 105.58 121.69 4.9 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.399 -0.68 . . . . 63.21 111.399 -173.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 208' ' ' GLY . . . . . 0.405 ' H ' ' HB ' ' C' ' 223' ' ' VAL . . . -145.41 -136.22 2.95 Favored Glycine 0 C--N 1.339 0.709 0 N-CA-C 110.833 -0.907 . . . . 51.32 110.833 178.449 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 209' ' ' LYS . . . . . 0.425 ' HA ' ' O ' ' C' ' 221' ' ' VAL . 20.2 ttpp -151.7 118.48 5.78 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 117.523 0.661 . . . . 72.12 109.903 175.46 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 210' ' ' VAL . . . . . . . . . . . . . 19.1 m -111.35 170.0 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 124.829 1.252 . . . . 62.05 109.671 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 211' ' ' ARG . . . . . . . . . . . . . 8.1 tmm_? -103.25 125.35 49.87 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 120.922 0.391 . . . . 72.44 110.909 -179.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 212' ' ' ALA . . . . . 0.463 ' HB3' HG13 ' C' ' 219' ' ' VAL . . . -105.72 152.36 23.27 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.849 1.26 . . . . 74.43 109.728 168.337 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 213' ' ' MET . . . . . . . . . . . . . 17.8 mmm -85.15 142.06 29.74 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.439 0.695 . . . . 63.12 110.017 174.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 214' ' ' THR . . . . . 0.523 HG21 ' HD3' ' C' ' 238' ' ' LYS . 0.2 OUTLIER -141.23 175.05 9.96 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.114 0.566 . . . . 54.24 111.204 172.619 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 215' ' ' LEU . . . . . 0.623 HD13 ' HB2' ' C' ' 131' ' ' PHE . 23.9 mt -61.92 -48.46 80.33 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.246 1.018 . . . . 44.41 111.394 -173.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -91.21 13.62 16.61 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 114.399 -1.273 . . . . 71.0 111.416 -176.112 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 124.39 -171.21 16.56 Favored Glycine 0 C--N 1.351 1.392 0 N-CA-C 111.824 -0.51 . . . . 64.11 111.824 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -81.7 129.55 6.44 Favored 'Trans proline' 0 CA--C 1.558 1.719 0 C-N-CA 122.675 2.25 . . . . 52.13 113.848 -178.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 219' ' ' VAL . . . . . 0.463 HG13 ' HB3' ' C' ' 212' ' ' ALA . 5.1 p -97.5 140.32 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 N-CA-C 108.361 -0.978 . . . . 52.53 108.361 172.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 220' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -98.44 107.98 20.56 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 118.583 0.629 . . . . 72.32 109.651 179.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 221' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' C' ' 209' ' ' LYS . 37.9 t -69.8 116.04 10.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 126.058 1.743 . . . . 74.03 112.708 -179.284 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -76.01 113.67 13.78 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.493 0.717 . . . . 73.3 109.146 168.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 223' ' ' VAL . . . . . 0.405 ' HB ' ' H ' ' C' ' 208' ' ' GLY . 47.0 t -92.17 138.08 24.61 Favored Pre-proline 0 CA--C 1.561 1.371 0 C-N-CA 124.136 0.975 . . . . 73.11 110.646 -174.206 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 224' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -86.22 164.19 9.86 Favored 'Trans proline' 0 C--N 1.387 2.6 0 C-N-CA 123.377 2.718 . . . . 54.33 112.103 173.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.07 128.48 21.87 Favored 'Trans proline' 0 C--N 1.377 2.079 0 C-N-CA 122.751 2.3 . . . . 74.0 113.705 177.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 226' ' ' ARG . . . . . 0.702 ' HB2' HG22 ' B' ' 307' ' ' THR . 0.0 OUTLIER 59.43 89.09 0.07 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.814 2.045 . . . . 70.15 110.988 179.886 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 227' ' ' THR . . . . . 0.534 ' HB ' ' HB1' ' C' ' 204' ' ' ALA . 24.7 m -106.63 135.68 47.73 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 113.789 -1.551 . . . . 70.3 110.221 178.058 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 228' ' ' GLN . . . . . 0.44 ' H ' ' NE ' ' C' ' 231' ' ' ARG . 3.9 tp-100 -110.35 142.83 41.47 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 124.291 1.036 . . . . 74.32 110.479 -175.384 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -71.23 137.46 48.67 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.677 -0.86 . . . . 62.12 108.677 174.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 100.99 0.68 54.97 Favored Glycine 0 CA--C 1.521 0.411 0 CA-C-N 116.08 -0.509 . . . . 62.04 112.286 -170.054 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 231' ' ' ARG . . . . . 0.509 ' HD2' HG23 ' C' ' 227' ' ' THR . 86.2 mtt180 -76.08 172.4 12.85 Favored 'General case' 0 C--N 1.359 1.018 0 CA-C-N 117.115 0.458 . . . . 74.12 110.142 164.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 232' ' ' LYS . . . . . 0.65 ' HD3' ' HB3' ' C' ' 250' ' ' TYR . 4.0 ttmp? -148.07 109.4 4.35 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.394 0.616 . . . . 71.45 110.164 175.17 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 233' ' ' LEU . . . . . 0.607 ' O ' ' HA ' ' C' ' 250' ' ' TYR . 0.5 OUTLIER -72.14 144.75 48.5 Favored 'General case' 0 C--O 1.209 -1.075 0 C-N-CA 125.781 1.632 . . . . 74.21 109.429 -178.02 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 234' ' ' ARG . . . . . 0.433 HH22 ' HB2' ' B' ' 37' ' ' ASP . 10.1 ptt180 -118.37 90.48 3.34 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 124.912 1.285 . . . . 72.34 110.108 173.185 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 235' ' ' LEU . . . . . 0.55 ' HB2' ' HB3' ' C' ' 249' ' ' LEU . 66.4 mt -77.79 116.41 18.29 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.509 0.723 . . . . 73.43 111.057 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -63.02 117.03 5.88 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.089 0.956 . . . . 71.55 112.65 -176.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 77.78 11.79 85.08 Favored Glycine 0 C--N 1.351 1.399 0 CA-C-N 115.223 -0.899 . . . . 71.42 114.688 175.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 238' ' ' LYS . . . . . 0.527 ' HA ' ' NZ ' ' C' ' 238' ' ' LYS . 0.1 OUTLIER -99.96 8.53 43.99 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.008 0.523 . . . . 72.03 111.053 178.447 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -86.44 -151.25 18.26 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 110.852 -0.899 . . . . 31.21 110.852 164.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 240' ' ' PHE . . . . . 0.55 ' CE2' HD21 ' C' ' 193' ' ' LEU . 48.3 m-85 -90.57 137.02 27.46 Favored Pre-proline 0 N--CA 1.476 0.856 0 CA-C-N 117.036 0.418 . . . . 75.14 110.65 175.368 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 241' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -57.39 120.98 9.25 Favored 'Trans proline' 0 C--N 1.383 2.382 0 C-N-CA 123.254 2.636 . . . . 70.21 111.353 175.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 242' ' ' GLY . . . . . 0.407 ' H ' ' HA ' ' C' ' 246' ' ' ARG . . . -100.28 157.77 19.48 Favored Glycine 0 C--N 1.348 1.246 0 CA-C-O 119.612 -0.549 . . . . 70.14 113.096 -173.171 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -65.62 -21.98 58.61 Favored 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 123.036 2.491 . . . . 71.42 113.61 -176.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -132.06 25.56 4.58 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.778 0.831 . . . . 71.42 110.57 178.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 164.25 -137.78 4.92 Favored Glycine 0 C--N 1.346 1.124 0 N-CA-C 111.549 -0.62 . . . . 51.32 111.549 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 246' ' ' ARG . . . . . 0.407 ' HA ' ' H ' ' C' ' 242' ' ' GLY . 0.0 OUTLIER -157.12 163.07 39.33 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.037 0.935 . . . . 61.31 109.664 173.546 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -86.87 170.53 41.84 Favored Glycine 0 C--O 1.242 0.613 0 CA-C-N 116.088 -0.506 . . . . 63.23 111.986 178.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -124.32 136.42 54.09 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 107.763 -1.199 . . . . 73.54 107.763 -178.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 249' ' ' LEU . . . . . 0.55 ' HB3' ' HB2' ' C' ' 235' ' ' LEU . 19.4 tp -81.57 117.86 22.3 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.18 0.592 . . . . 74.23 109.877 -176.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 250' ' ' TYR . . . . . 0.65 ' HB3' ' HD3' ' C' ' 232' ' ' LYS . 19.4 m-30 -99.68 101.76 13.05 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 122.799 0.439 . . . . 71.43 109.915 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 251' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' C' ' 232' ' ' LYS . 2.0 mp -101.44 124.4 47.05 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 119.375 -0.345 . . . . 64.53 110.303 -175.265 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -70.97 109.31 5.0 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.544 -0.91 . . . . 73.41 108.544 173.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 253' ' ' VAL . . . . . 0.424 HG21 ' CZ3' ' B' ' 242' ' ' TRP . 57.0 t -77.52 128.96 37.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 123.427 0.691 . . . . 73.5 111.655 -169.07 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 254' ' ' ARG . . . . . 0.46 HH11 ' HB3' ' B' ' 290' ' ' TRP . 20.9 mtm180 -108.64 147.26 32.13 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.125 0.97 . . . . 74.13 109.568 170.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 255' ' ' ILE . . . . . 0.471 HD11 HG22 ' C' ' 227' ' ' THR . 36.5 mm -107.05 125.56 63.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 C-N-CA 124.452 1.101 . . . . 75.24 108.065 171.002 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 256' ' ' THR . . . . . . . . . . . . . 60.2 p -122.94 -175.59 3.21 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.855 0.862 . . . . 53.32 111.69 -171.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 257' ' ' ILE . . . . . 0.544 ' HB ' ' HD2' ' C' ' 258' ' ' PRO . 44.9 pt -135.48 161.58 62.32 Favored Pre-proline 0 CA--C 1.571 1.756 0 C-N-CA 123.53 0.732 . . . . 64.54 111.233 -179.081 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 258' ' ' PRO . . . . . 0.544 ' HD2' ' HB ' ' C' ' 257' ' ' ILE . 61.3 Cg_endo -69.43 11.26 0.37 Allowed 'Trans proline' 0 C--N 1.395 3.021 0 C-N-CA 123.733 2.956 . . . . 73.21 116.696 -170.601 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 259' ' ' GLU . . . . . 0.572 ' O ' ' HD2' ' A' ' 226' ' ' ARG . 5.5 mm-40 60.85 -84.29 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.607 0.763 . . . . 72.3 109.775 -170.287 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 260' ' ' ARG . . . . . 0.49 ' HB3' ' HB1' ' B' ' 448' ' ' ALA . 0.1 OUTLIER -92.47 172.02 8.66 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.45 0.7 . . . . 73.41 110.771 175.333 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 261' ' ' LEU . . . . . 0.47 ' HB2' HH12 ' A' ' 226' ' ' ARG . 11.3 mt -149.47 163.33 38.08 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 121.604 0.716 . . . . 71.21 111.919 176.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 1.2 p -104.36 147.62 34.66 Favored Pre-proline 0 CA--C 1.562 1.404 0 CA-C-N 113.494 -1.685 . . . . 61.23 108.997 171.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -45.51 -48.8 11.37 Favored 'Trans proline' 0 C--N 1.39 2.758 0 C-N-CA 125.038 3.825 . . . . 74.2 115.868 -166.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -64.62 -51.2 63.91 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-O 121.303 0.573 . . . . 71.04 111.242 -173.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 11.4 mp0 -60.98 -45.53 94.4 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 114.502 -1.226 . . . . 65.11 109.44 -177.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 266' ' ' GLU . . . . . 0.433 ' HG2' ' HE3' ' C' ' 270' ' ' LYS . 42.4 tt0 -61.42 -37.44 83.5 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 114.934 -1.03 . . . . 64.21 111.076 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -63.71 -38.55 91.54 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.591 0.756 . . . . 70.32 111.52 177.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 268' ' ' LEU . . . . . . . . . . . . . 11.1 mp -62.23 -43.38 98.96 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 123.242 0.339 . . . . 52.44 110.72 172.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 92.9 m95 -58.34 -36.11 72.94 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 122.904 0.482 . . . . 61.11 111.104 174.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 270' ' ' LYS . . . . . 0.433 ' HE3' ' HG2' ' C' ' 266' ' ' GLU . 99.5 mttt -70.75 -39.35 73.32 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.543 0.737 . . . . 75.43 111.442 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.64 -38.35 89.11 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.954 0.502 . . . . 75.33 110.611 178.009 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 88.8 mt -73.49 -31.31 63.68 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.618 0.767 . . . . 74.33 110.891 176.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -66.24 -40.93 90.57 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.295 0.638 . . . . 34.13 110.021 175.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -69.3 -37.84 77.99 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.13 0.972 . . . . 63.21 110.97 178.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -62.85 -30.76 71.75 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.298 0.639 . . . . 70.04 110.43 172.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 276' ' ' TYR . . . . . 0.471 ' HB3' HD11 ' A' ' 203' ' ' ILE . 1.6 m-85 -75.25 -38.04 60.73 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.705 0.802 . . . . 75.52 111.492 173.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -69.56 -24.26 63.68 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 122.456 0.302 . . . . 44.24 110.254 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -63.45 -20.1 65.28 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.922 0.889 . . . . 55.2 112.176 173.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 279' ' ' ARG . . . . . 0.459 ' HD3' ' HA ' ' C' ' 276' ' ' TYR . 14.9 mtp-105 -75.22 -9.64 58.74 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.251 0.62 . . . . 71.52 111.8 176.098 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.151 0 CA-C-O 118.252 -0.88 . . . . 75.14 108.673 174.149 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.3 mtm . . . . . 0 C--O 1.234 0.282 0 N-CA-C 108.934 -0.765 . . . . 64.12 108.934 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.15 22.28 13.02 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 114.417 -1.265 . . . . 51.4 113.892 169.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -86.96 44.83 1.2 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.926 0.491 . . . . 74.04 110.485 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -37.81 97.12 0.01 OUTLIER 'General case' 0 C--N 1.364 1.229 0 C-N-CA 125.786 1.634 . . . . 62.43 113.357 -176.267 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.527 ' HB3' HD11 ' A' ' 10' ' ' ILE . 14.3 mmmm -63.4 110.86 2.07 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.29 -1.004 . . . . 74.32 108.29 170.421 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -73.39 93.64 1.97 Allowed 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 107.638 -1.245 . . . . 61.41 107.638 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.42 ' CD1' ' HA ' ' A' ' 53' ' ' ALA . 62.4 m-85 -63.82 -30.13 71.26 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 114.88 -1.055 . . . . 73.34 112.291 -168.311 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -66.4 -44.47 82.92 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 116.215 -0.448 . . . . 73.33 109.961 173.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.47 -37.58 87.85 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.943 0.497 . . . . 60.32 111.421 178.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.527 HD11 ' HB3' ' A' ' 5' ' ' LYS . 72.9 mt -64.13 -36.22 76.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 123.452 0.701 . . . . 74.23 110.462 176.398 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.0 mt -81.05 -10.36 59.7 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 112.331 0.493 . . . . 51.33 112.331 173.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.02 32.4 60.71 Favored Glycine 0 C--N 1.35 1.352 0 N-CA-C 113.888 0.315 . . . . 53.33 113.888 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.4 m -126.07 155.21 73.77 Favored Pre-proline 0 N--CA 1.482 1.148 0 C-N-CA 124.346 1.058 . . . . 71.43 110.377 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.2 158.98 55.16 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 122.491 2.128 . . . . 50.12 112.335 173.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 35.3 mtm180 -82.02 64.37 6.67 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.068 0.947 . . . . 75.43 110.347 -177.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -179.7 -14.81 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.257 1.423 . . . . 64.11 109.032 -175.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.52 131.15 29.1 Favored 'General case' 0 C--N 1.36 1.061 0 C-N-CA 123.604 0.762 . . . . 64.31 111.325 176.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 58.1 p -63.37 164.6 8.85 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 123.867 0.729 . . . . 71.11 111.148 -175.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 47.6 tp60 -61.32 -27.39 68.45 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.376 0.671 . . . . 64.21 111.538 -176.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -67.97 -46.29 71.78 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.47 -0.786 . . . . 72.43 109.771 175.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -67.24 -35.96 80.65 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.209 0.604 . . . . 64.03 111.012 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.449 HG21 ' HB3' ' A' ' 57' ' ' LEU . 70.9 mt -66.06 -47.13 86.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.361 1.064 . . . . 73.31 110.586 178.021 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 51.4 tttt -55.65 -48.43 75.02 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.597 1.159 . . . . 71.24 110.533 173.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 63.9 mtt180 -75.94 -15.97 60.08 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 115.805 -0.634 . . . . 54.12 111.763 -177.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -77.26 -40.13 45.8 Favored 'General case' 0 C--O 1.251 1.17 0 C-N-CA 123.356 0.663 . . . . 64.0 110.262 173.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.546 ' HD1' HG22 ' A' ' 50' ' ' ILE . 64.6 t80 -55.45 -56.79 16.09 Favored 'General case' 0 C--N 1.352 0.702 0 CA-C-N 114.83 -1.077 . . . . 73.1 108.984 169.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.425 ' O ' ' HG3' ' A' ' 31' ' ' ARG . 55.5 mtpt -60.7 -38.98 86.84 Favored 'General case' 0 N--CA 1.483 1.208 0 O-C-N 124.248 0.967 . . . . 74.22 111.701 -177.592 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 45.6 ttt180 -52.04 -60.23 3.44 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 125.122 1.369 . . . . 71.15 110.913 175.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 95.9 mt -79.22 -13.5 59.65 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 114.876 -1.056 . . . . 74.11 111.314 -178.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.89 -14.72 46.93 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.309 0.643 . . . . 63.3 110.934 175.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.425 ' HG3' ' O ' ' A' ' 27' ' ' LYS . 82.7 mtm180 -89.63 -39.55 13.16 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.248 0.619 . . . . 72.33 109.734 168.417 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -67.28 -59.73 3.18 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.272 0.558 . . . . 63.33 111.447 178.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.689 ' HD2' HD11 ' A' ' 50' ' ' ILE . 21.3 m-85 -91.0 25.83 2.31 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.958 0.903 . . . . 63.25 110.718 -178.441 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 40.1 t60 -62.61 108.57 1.73 Allowed Pre-proline 0 C--N 1.358 0.955 0 CA-C-O 118.439 -0.791 . . . . 63.41 110.215 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.466 ' HB3' ' HG2' ' A' ' 44' ' ' GLU . 16.5 Cg_endo -53.64 -40.17 80.41 Favored 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 123.281 2.654 . . . . 74.13 113.447 -167.193 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -60.65 -40.7 93.01 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.553 0.741 . . . . 72.45 112.551 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 64.8 t -89.8 -30.08 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 CA-C-O 121.184 0.516 . . . . 65.53 110.28 -175.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 53.6 t-20 -108.44 97.29 6.98 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 124.397 1.079 . . . . 61.35 108.845 -172.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -81.1 71.11 8.07 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.618 0.767 . . . . 73.11 109.795 -177.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 62.2 m -152.07 112.55 2.88 Favored Pre-proline 0 N--CA 1.476 0.86 0 C-N-CA 123.88 0.872 . . . . 54.41 109.156 178.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -51.31 -36.02 55.76 Favored 'Trans proline' 0 C--N 1.388 2.633 0 C-N-CA 123.347 2.698 . . . . 72.23 111.662 176.188 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -47.34 -51.15 20.3 Favored 'General case' 0 C--N 1.35 0.596 0 C-N-CA 124.993 1.317 . . . . 64.43 111.339 174.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.79 -20.05 61.23 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.004 -0.998 . . . . 72.14 111.307 -175.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.466 ' HG2' ' HB3' ' A' ' 35' ' ' PRO . 40.4 mt-10 -86.03 -33.34 21.05 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.594 0.758 . . . . 62.01 110.777 -177.22 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -70.62 -42.7 70.57 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.831 -0.803 . . . . 62.44 108.831 174.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.528 ' O ' HG13 ' A' ' 50' ' ' ILE . 13.2 mptt -65.55 -32.87 74.7 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 114.76 -1.109 . . . . 74.03 110.685 171.569 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.686 ' HA ' HD12 ' A' ' 50' ' ' ILE . 86.9 t80 -62.86 -40.3 97.06 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.402 0.681 . . . . 73.24 110.453 175.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.473 ' HB3' ' HE1' ' A' ' 93' ' ' PHE . 48.2 mtmt -69.11 -33.43 73.48 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.929 -0.578 . . . . 75.14 110.799 176.231 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -65.37 -30.79 71.66 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-N 117.734 0.243 . . . . 71.44 111.577 172.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.689 HD11 ' HD2' ' A' ' 33' ' ' TYR . 31.1 mt -65.18 -43.48 95.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 109.012 -0.736 . . . . 70.53 109.012 172.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.429 ' HB3' ' HD1' ' A' ' 88' ' ' PHE . 43.7 m-80 -69.11 -21.53 64.03 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 115.282 -0.872 . . . . 73.43 111.716 175.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -73.37 -51.79 16.11 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-O 122.244 1.021 . . . . 63.42 108.974 175.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.42 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . . . -57.24 -41.75 80.15 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 113.35 -1.75 . . . . 65.45 111.032 175.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.441 ' O ' ' HB2' ' A' ' 58' ' ' SER . 13.0 t80 -79.15 -22.93 44.38 Favored 'General case' 0 C--O 1.212 -0.887 0 CA-C-N 114.887 -1.051 . . . . 72.32 110.279 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.93 -26.54 65.13 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.815 -0.553 . . . . 53.01 110.789 173.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.57 HG22 ' HE1' ' A' ' 101' ' ' PHE . 20.6 t -95.68 -23.12 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 115.8 -0.636 . . . . 74.52 111.778 173.774 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.498 HD22 ' HG2' ' A' ' 63' ' ' ARG . 62.3 mt -123.72 26.07 7.86 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.575 -0.703 . . . . 62.04 112.292 -174.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.441 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 16.5 t -66.24 -48.24 71.17 Favored 'General case' 0 N--CA 1.502 2.16 0 CA-C-O 121.45 0.643 . . . . 74.34 111.801 176.407 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -110.28 154.32 42.94 Favored Pre-proline 0 N--CA 1.475 0.798 0 CA-C-N 114.697 -1.138 . . . . 74.34 109.109 -176.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.12 -28.26 83.07 Favored 'Trans proline' 0 C--N 1.382 2.333 0 C-N-CA 122.637 2.225 . . . . 72.41 111.818 173.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -70.68 -53.73 14.59 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.269 1.028 . . . . 72.3 111.534 -179.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -58.48 -40.15 81.93 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 121.692 0.758 . . . . 74.54 110.475 175.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.498 ' HG2' HD22 ' A' ' 57' ' ' LEU . 4.5 tmt_? -58.39 -42.19 86.55 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 113.92 -1.491 . . . . 74.11 109.762 178.231 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -72.19 -27.28 62.46 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 118.601 -0.714 . . . . 74.25 112.721 175.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 78.9 mt -62.66 -45.97 97.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 CA-C-N 118.754 0.706 . . . . 64.42 109.456 174.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -64.87 -45.39 86.22 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 115.688 -0.687 . . . . 75.4 110.503 176.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -54.61 -42.8 71.58 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 122.892 0.477 . . . . 64.04 111.194 176.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 80.8 p -82.28 -12.68 57.88 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 118.889 -0.577 . . . . 75.13 111.58 -178.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -65.72 120.46 13.03 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 108.305 -0.998 . . . . 63.45 108.305 172.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 109.14 8.3 27.58 Favored Glycine 0 C--N 1.344 1.021 0 CA-C-N 115.948 -0.569 . . . . 52.54 111.929 -164.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 85.9 m -147.27 -57.94 0.26 Allowed 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 103.862 -2.644 . . . . 71.23 103.862 176.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 27.1 m -71.37 123.83 23.2 Favored 'General case' 0 C--O 1.246 0.874 0 N-CA-C 103.402 -2.814 . . . . 74.23 103.402 154.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.32 -35.0 6.19 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 117.934 0.334 . . . . 74.04 110.628 -178.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.35 138.91 74.88 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 123.232 0.613 . . . . 75.1 109.832 173.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -57.0 149.9 59.27 Favored 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 122.769 2.312 . . . . 75.41 110.994 171.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.46 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 22.7 Cg_endo -57.3 136.18 74.7 Favored 'Trans proline' 0 CA--C 1.564 1.984 0 C-N-CA 122.695 2.263 . . . . 74.25 112.249 -176.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 76' ' ' PRO . 50.0 Cg_exo -55.43 123.24 13.32 Favored 'Trans proline' 0 C--N 1.386 2.538 0 C-N-CA 123.668 2.912 . . . . 62.44 113.916 -173.076 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -67.39 120.15 7.19 Favored 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 122.766 2.311 . . . . 43.51 112.842 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.534 ' HG3' HG21 ' B' ' 18' ' ' VAL . 84.7 Cg_endo -78.97 167.12 22.46 Favored 'Trans proline' 0 C--N 1.378 2.108 0 C-N-CA 122.826 2.351 . . . . 71.05 111.621 173.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.24 82.89 0.05 OUTLIER 'Trans proline' 0 C--N 1.388 2.605 0 C-N-CA 123.415 2.743 . . . . 51.35 112.131 175.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 147.37 -44.8 0.79 Allowed Glycine 0 C--N 1.337 0.637 0 CA-C-N 114.74 -1.118 . . . . 62.41 110.331 -176.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 104.39 -160.52 15.73 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 116.478 0.139 . . . . 53.03 113.134 -176.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -106.77 128.68 54.44 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.993 0.917 . . . . 74.41 111.486 -175.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.412 ' HA ' ' HD2' ' A' ' 106' ' ' PHE . 13.2 t70 -70.14 144.58 51.98 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.017 1.327 . . . . 71.31 112.811 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.594 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 54.0 m-85 -136.54 72.18 1.43 Allowed 'General case' 0 C--N 1.358 0.977 0 CA-C-O 121.998 0.904 . . . . 70.22 111.453 -178.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.438 ' O ' HG21 ' B' ' 23' ' ' THR . 51.3 m -52.93 105.59 0.13 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 113.398 -1.728 . . . . 74.44 113.314 177.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.667 ' H ' ' HA3' ' A' ' 163' ' ' GLY . . . 67.9 2.3 23.02 Favored Glycine 0 C--N 1.343 0.938 0 C-N-CA 123.187 0.423 . . . . 70.11 113.976 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.594 ' HB2' ' HB3' ' A' ' 85' ' ' PHE . 19.0 m-85 -95.78 121.77 37.86 Favored 'General case' 0 C--N 1.349 0.569 0 N-CA-C 108.948 -0.76 . . . . 72.34 108.948 -174.285 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -82.85 60.06 5.16 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 122.119 0.962 . . . . 71.44 109.899 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.499 ' HA ' ' CD2' ' A' ' 93' ' ' PHE . 1.3 p -47.97 -38.69 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 126.532 1.933 . . . . 75.21 113.531 -179.492 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -55.61 -31.66 62.45 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 124.048 0.939 . . . . 75.33 112.236 -178.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -108.7 0.64 20.66 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.39 0.676 . . . . 45.35 112.111 -176.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.499 ' CD2' ' HA ' ' A' ' 90' ' ' VAL . 20.9 m-30 -72.05 178.97 3.48 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.907 -0.495 . . . . 71.01 110.697 177.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 77.5 p -58.94 155.72 12.84 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.637 0.775 . . . . 74.5 113.007 -173.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.464 ' O ' ' HG3' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -58.85 -41.67 87.52 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.165 -0.925 . . . . 74.31 110.631 173.381 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -57.92 -44.18 86.68 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.79 0.436 . . . . 75.03 111.286 175.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.43 ' HE2' HG23 ' A' ' 90' ' ' VAL . 47.2 t80 -59.92 -44.39 94.34 Favored 'General case' 0 C--O 1.244 0.805 0 CA-C-O 121.424 0.631 . . . . 63.23 109.814 177.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -75.44 -2.6 29.45 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 114.314 -1.312 . . . . 73.05 111.753 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.464 ' HG3' ' O ' ' A' ' 95' ' ' GLU . 48.8 mt-10 -93.88 -47.61 6.66 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 123.011 0.525 . . . . 70.02 110.949 163.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 48.8 tp -63.45 -32.16 73.52 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.54 1.136 . . . . 55.03 111.679 -171.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.57 ' HE1' HG22 ' A' ' 56' ' ' VAL . 93.7 m-85 -120.13 9.24 11.08 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.979 0.512 . . . . 72.11 110.477 173.458 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.41 ' HA2' ' HG ' ' A' ' 105' ' ' LEU . . . -48.47 -62.2 4.56 Favored Glycine 0 C--N 1.352 1.458 0 C-N-CA 124.702 1.144 . . . . 72.43 115.894 -172.196 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -56.63 -17.34 22.14 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 123.366 2.711 . . . . 23.1 113.474 178.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -129.57 43.22 1.33 Allowed Glycine 0 C--N 1.35 1.329 0 CA-C-O 119.679 -0.512 . . . . 44.4 112.287 178.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.496 HD22 HG21 ' A' ' 90' ' ' VAL . 33.7 mt -78.95 56.98 2.06 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 117.855 0.827 . . . . 74.25 111.065 170.424 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.686 ' HD1' ' H ' ' A' ' 108' ' ' GLY . 0.2 OUTLIER 35.05 -108.55 0.04 OUTLIER 'General case' 0 CA--C 1.568 1.651 0 C-N-CA 126.29 1.836 . . . . 72.25 112.565 178.215 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 72.06 12.2 75.34 Favored Glycine 0 C--N 1.357 1.701 0 CA-C-N 118.485 0.584 . . . . 44.0 112.722 -173.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.686 ' H ' ' HD1' ' A' ' 106' ' ' PHE . . . 64.38 -112.65 5.18 Favored Glycine 0 C--N 1.342 0.865 0 C-N-CA 124.058 0.837 . . . . 71.34 113.446 -178.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -114.33 -5.32 12.94 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.912 0.885 . . . . 64.11 109.636 173.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -80.84 -29.32 42.98 Favored Glycine 0 C--N 1.357 1.71 0 N-CA-C 111.547 -0.621 . . . . 55.25 111.547 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.8 tpp180 63.39 2.18 1.12 Allowed 'General case' 0 CA--C 1.566 1.566 0 C-N-CA 125.39 1.476 . . . . 71.44 113.503 171.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 75.2 ttt180 -65.78 -23.89 66.81 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.16 0.984 . . . . 73.25 111.463 171.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.403 ' HA ' ' HB2' ' A' ' 169' ' ' ASN . 69.5 m 74.02 46.97 0.16 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.777 1.231 . . . . 74.21 111.227 -178.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -111.09 160.53 16.8 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 115.089 -0.96 . . . . 74.52 109.265 174.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.451 ' HG3' ' O ' ' A' ' 170' ' ' PRO . 87.1 tttt -57.57 148.69 23.32 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 125.047 1.339 . . . . 72.15 112.789 -175.357 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -81.31 171.94 53.55 Favored Glycine 0 C--N 1.345 1.05 0 CA-C-N 115.438 -0.801 . . . . 55.22 113.371 174.062 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.8 tmm_? -87.19 140.43 29.55 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 108.568 -0.901 . . . . 71.34 108.568 176.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -53.68 116.9 2.74 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.949 0.9 . . . . 74.23 111.383 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.0 tt -109.86 140.99 43.18 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 121.833 -0.542 . . . . 70.23 109.953 -167.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 29.6 ttt-85 -99.01 107.52 19.97 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.992 0.917 . . . . 74.51 108.755 -178.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.441 ' HB2' HD11 ' A' ' 174' ' ' LEU . . . -111.14 165.14 12.15 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.275 0.63 . . . . 41.51 109.425 178.065 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.455 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 19.4 mm-40 -123.78 111.41 16.1 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 107.49 -1.3 . . . . 61.0 107.49 -174.565 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.406 ' O ' ' HA ' ' A' ' 178' ' ' VAL . 60.0 tp -99.71 96.66 4.85 Favored Pre-proline 0 N--CA 1.487 1.398 0 CA-C-N 118.869 0.759 . . . . 54.05 109.55 -172.548 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.46 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 39.3 Cg_endo -74.92 112.19 3.5 Favored 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 121.189 1.259 . . . . 75.33 110.067 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.616 ' HA ' HG21 ' B' ' 6' ' ' ILE . 38.2 tp -117.26 141.71 47.96 Favored 'General case' 0 C--N 1.338 0.08 0 C-N-CA 123.856 0.863 . . . . 64.01 110.113 -169.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.415 ' HB ' ' HG2' ' A' ' 129' ' ' GLU . 27.0 m -74.78 130.17 38.98 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.177 0.991 . . . . 71.34 110.199 178.298 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.4 HD23 HD22 ' A' ' 180' ' ' LEU . 64.9 mt -53.84 -52.87 58.99 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.225 1.01 . . . . 70.54 111.852 -177.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.448 ' HA ' ' HB3' ' A' ' 215' ' ' LEU . 5.7 mp0 -58.83 -38.17 78.06 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.938 0.895 . . . . 75.32 110.377 -176.447 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.415 ' HG2' ' HB ' ' A' ' 126' ' ' THR . 16.0 mm-40 -74.95 -28.4 60.56 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 114.925 -1.034 . . . . 64.33 110.837 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -68.79 -35.64 77.29 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.969 0.508 . . . . 41.43 111.182 176.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.431 ' HB2' HD12 ' A' ' 215' ' ' LEU . 77.6 t80 -67.19 -49.56 64.18 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 123.481 0.488 . . . . 74.51 110.815 173.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 34.6 m170 -70.35 -36.49 74.23 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 123.526 0.516 . . . . 75.25 111.789 -175.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.437 ' HA3' ' HG3' ' A' ' 151' ' ' PRO . . . 72.7 -171.37 50.13 Favored Glycine 0 CA--C 1.528 0.889 0 O-C-N 123.451 0.469 . . . . 71.54 113.574 -176.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.15 172.95 25.25 Favored Glycine 0 N--CA 1.476 1.347 0 C-N-CA 122.704 0.193 . . . . 70.42 112.788 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.769 ' HG2' HH21 ' B' ' 22' ' ' ARG . 1.8 mp0 -71.68 108.82 5.21 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.362 0.665 . . . . 73.14 111.112 -174.432 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.415 ' CZ ' ' HB3' ' A' ' 129' ' ' GLU . 6.5 tpp180 -92.84 122.11 34.89 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 108.628 -0.878 . . . . 74.4 108.628 -177.434 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 94.6 t -78.39 96.71 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 109.237 -0.653 . . . . 71.24 109.237 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.579 ' HB ' HG13 ' B' ' 6' ' ' ILE . 0.2 OUTLIER -112.27 118.37 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 108.294 -1.002 . . . . 73.14 108.294 176.388 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 144' ' ' ARG . 30.5 mt-10 -101.29 133.99 45.04 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.092 0.557 . . . . 71.3 111.152 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.585 HG11 HD23 ' B' ' 8' ' ' LEU . 15.0 p -170.64 139.08 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.039 0 O-C-N 123.628 0.58 . . . . 75.1 111.613 -178.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.644 ' HA ' ' HA ' ' B' ' 15' ' ' PHE . . . 55.43 26.28 8.67 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 115.696 1.739 . . . . 74.24 115.696 163.029 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 98.22 10.15 52.08 Favored Glycine 0 N--CA 1.476 1.301 0 C-N-CA 121.694 -0.289 . . . . 31.1 113.02 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.425 ' HA ' ' HA ' ' B' ' 20' ' ' LYS . 34.0 ttm105 -144.07 106.58 4.42 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 123.343 0.657 . . . . 72.12 110.958 -171.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.507 ' H ' ' HA ' ' B' ' 20' ' ' LYS . 32.4 ttm180 -78.48 93.57 4.79 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 107.173 -1.418 . . . . 74.41 107.173 162.15 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.452 ' O ' HG13 ' A' ' 138' ' ' VAL . 1.5 p -84.83 107.82 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 108.306 -0.998 . . . . 73.53 108.306 175.299 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.42 ' HB3' ' HG2' ' B' ' 22' ' ' ARG . 26.9 t -84.53 83.03 8.15 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 107.586 -1.265 . . . . 31.45 107.586 172.507 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.6 p -87.86 109.65 19.87 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 CA-C-O 121.422 0.629 . . . . 73.42 110.343 -173.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.422 ' HB2' ' HG3' ' A' ' 135' ' ' GLU . 20.3 ttm180 -57.47 93.42 0.01 OUTLIER 'General case' 0 C--O 1.24 0.565 0 CA-C-N 115.232 -0.895 . . . . 74.14 108.924 166.224 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.623 ' HB ' HG11 ' A' ' 153' ' ' VAL . 28.8 pt -72.88 118.64 70.01 Favored Pre-proline 0 CA--C 1.547 0.85 0 CA-C-N 114.068 -1.424 . . . . 74.13 108.192 173.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.556 ' HB3' ' HG3' ' B' ' 314' ' ' ARG . 31.8 Cg_exo -63.52 128.69 23.02 Favored 'Trans proline' 0 C--N 1.368 1.578 0 C-N-CA 122.248 1.965 . . . . 60.34 110.723 177.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.741 ' HB2' ' HB2' ' B' ' 315' ' ' ASN . 52.1 Cg_exo -53.36 100.37 0.06 OUTLIER 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 122.579 2.186 . . . . 74.15 111.272 177.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.444 ' HA2' ' CD2' ' A' ' 240' ' ' PHE . . . 116.75 36.44 1.06 Allowed Glycine 0 C--N 1.342 0.914 0 CA-C-N 115.532 -0.758 . . . . 75.51 112.647 -173.343 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.623 HG11 ' HB ' ' A' ' 149' ' ' ILE . 2.1 p -91.66 132.8 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 123.843 0.857 . . . . 75.43 108.737 176.606 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.401 ' HB3' ' HA ' ' A' ' 189' ' ' GLU . 0.1 OUTLIER -101.97 168.1 9.62 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.983 0.913 . . . . 73.23 113.047 -161.09 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.579 ' HB3' ' O ' ' A' ' 188' ' ' LEU . 9.0 tp10 -68.37 127.1 31.75 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 108.747 -0.835 . . . . 72.32 108.747 167.504 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 73.07 14.59 78.81 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-N 115.378 -0.828 . . . . 14.21 113.362 -174.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 46.5 t -66.34 109.76 2.82 Favored 'General case' 0 C--N 1.359 0.999 0 N-CA-C 107.721 -1.214 . . . . 74.23 107.721 171.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.524 HG21 ' H ' ' B' ' 34' ' ' ALA . 58.6 t -84.86 87.13 2.37 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 N-CA-C 108.59 -0.893 . . . . 72.34 108.59 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.66 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 54.6 mt -74.01 91.89 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.642 0 N-CA-C 107.763 -1.199 . . . . 75.24 107.763 174.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.444 ' HB2' ' HB2' ' B' ' 31' ' ' ASN . 70.1 ttt180 -74.87 105.25 5.82 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 115.566 -0.743 . . . . 61.32 109.528 179.14 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 4.3 p -115.05 110.36 45.97 Favored Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 123.68 0.792 . . . . 61.33 108.94 173.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.467 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 46.5 Cg_endo -66.61 153.8 76.69 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 122.698 2.265 . . . . 74.53 111.684 177.281 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.667 ' HA3' ' H ' ' A' ' 87' ' ' GLY . . . 76.93 15.9 81.25 Favored Glycine 0 C--N 1.34 0.756 0 CA-C-N 115.827 -0.624 . . . . 70.43 113.892 178.241 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 49.2 mtt -125.46 -3.13 7.37 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 117.954 0.877 . . . . 64.15 111.465 177.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.488 ' HA2' HD13 ' A' ' 174' ' ' LEU . . . -85.15 -124.12 1.29 Allowed Glycine 0 C--N 1.343 0.956 0 N-CA-C 113.739 0.256 . . . . 73.33 113.739 -168.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -65.13 164.54 36.36 Favored Glycine 0 C--N 1.348 1.225 0 O-C-N 123.97 0.453 . . . . 74.5 113.422 -176.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.417 ' HB3' ' CA ' ' A' ' 108' ' ' GLY . 29.3 mm-40 -65.47 105.65 1.23 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.47 1.108 . . . . 75.42 111.581 -171.534 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -169.96 167.21 40.34 Favored Glycine 0 C--N 1.354 1.563 0 CA-C-O 118.96 -0.911 . . . . 64.21 112.124 -178.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ASN . . . . . 0.639 ' HA ' ' HB3' ' A' ' 106' ' ' PHE . 48.3 t30 -63.74 -59.04 12.57 Favored Pre-proline 0 N--CA 1.493 1.694 0 CA-C-N 118.077 0.938 . . . . 63.11 110.752 -173.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.556 ' HD3' ' HB3' ' A' ' 169' ' ' ASN . 27.1 Cg_endo -94.64 95.13 0.11 Allowed 'Trans proline' 0 C--N 1.381 2.247 0 N-CA-C 106.181 -2.276 . . . . 71.13 106.181 156.429 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_exo -51.9 175.73 0.06 OUTLIER 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 123.391 2.727 . . . . 71.25 115.205 -170.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -62.72 -178.6 4.01 Favored Glycine 0 N--CA 1.474 1.229 0 CA-C-O 121.844 0.691 . . . . 72.4 114.499 -176.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.467 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 3.5 m-20 -79.9 104.76 10.7 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.441 -0.948 . . . . 71.14 108.441 171.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.488 HD13 ' HA2' ' A' ' 165' ' ' GLY . 18.2 tp -78.95 124.64 28.44 Favored 'General case' 0 C--N 1.346 0.421 0 N-CA-C 109.29 -0.633 . . . . 64.32 109.29 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.45 ' HB3' HG13 ' A' ' 158' ' ' VAL . 42.8 mt -101.28 88.88 3.59 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 106.661 -1.607 . . . . 72.12 106.661 -177.244 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.66 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 91.2 mt -72.66 83.18 1.15 Allowed 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 109.357 -0.608 . . . . 70.05 109.357 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.442 HG22 HG22 ' A' ' 158' ' ' VAL . 23.3 t -84.36 98.89 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 107.97 -1.122 . . . . 61.43 107.97 -176.533 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 98.6 t -56.58 140.46 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 N-CA-C 113.046 0.758 . . . . 70.33 113.046 -172.318 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.46 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 62.5 mmt-85 -114.52 89.92 3.21 Favored 'General case' 0 C--N 1.343 0.296 0 N-CA-C 107.463 -1.31 . . . . 53.32 107.463 163.473 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.4 HD22 HD23 ' A' ' 127' ' ' LEU . 10.7 mt -66.63 125.01 24.43 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 107.675 -1.232 . . . . 72.4 107.675 178.118 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 44.4 mt -51.85 152.9 4.82 Favored Pre-proline 0 N--CA 1.485 1.279 0 O-C-N 124.639 1.212 . . . . 73.14 113.628 -162.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -72.36 23.41 0.27 Allowed 'Trans proline' 0 C--N 1.382 2.321 0 C-N-CA 123.311 2.674 . . . . 71.42 113.366 178.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.467 ' HA ' ' HD3' ' A' ' 184' ' ' PRO . 59.7 t-80 -59.84 105.49 0.57 Allowed Pre-proline 0 CA--C 1.556 1.179 0 N-CA-C 106.399 -1.704 . . . . 73.35 106.399 164.564 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 183' ' ' HIS . 13.7 Cg_exo -69.2 25.31 0.16 Allowed 'Trans proline' 0 C--N 1.375 1.921 0 C-N-CA 124.049 3.166 . . . . 61.24 117.534 -161.256 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 87.5 t -97.02 -58.92 3.49 Favored 'Isoleucine or valine' 0 C--N 1.35 0.623 0 CA-C-N 119.524 1.056 . . . . 64.21 110.422 -175.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -121.51 121.4 37.41 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 118.373 0.533 . . . . 72.31 112.22 -174.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.57 92.15 4.99 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 107.215 -1.402 . . . . 75.51 107.215 165.36 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.579 ' O ' ' HB3' ' A' ' 155' ' ' GLU . 53.7 tp -87.91 139.97 29.97 Favored 'General case' 0 C--O 1.207 -1.157 0 C-N-CA 123.769 0.828 . . . . 74.21 109.855 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.418 ' HG2' ' HA ' ' B' ' 307' ' ' THR . 40.0 tt0 -162.22 125.47 3.0 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 118.482 0.583 . . . . 70.31 110.003 177.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 73.59 -65.37 1.74 Allowed Glycine 0 C--N 1.356 1.691 0 O-C-N 123.586 0.554 . . . . 65.41 112.223 -173.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.556 ' NE2' ' HB2' ' B' ' 304' ' ' PRO . 4.3 pm0 -164.45 -19.42 0.03 OUTLIER 'General case' 0 C--O 1.249 1.037 0 C-N-CA 125.694 1.598 . . . . 72.32 109.104 177.073 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.422 ' H ' ' H ' ' A' ' 191' ' ' GLN . 2.0 p30 -94.65 134.81 36.83 Favored 'General case' 0 C--N 1.358 0.968 0 C-N-CA 123.908 0.883 . . . . 72.32 112.005 -169.134 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.555 ' HB2' ' HA ' ' A' ' 249' ' ' LEU . 66.8 mt -95.91 150.12 20.79 Favored 'General case' 0 C--O 1.22 -0.463 0 C-N-CA 125.788 1.635 . . . . 63.44 110.368 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -133.74 105.27 6.72 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 106.944 -1.502 . . . . 73.14 106.944 169.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.502 ' HB3' HD23 ' A' ' 251' ' ' LEU . . . -118.6 119.33 34.16 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.658 1.183 . . . . 74.34 109.906 -172.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 31.8 m -69.83 129.41 39.47 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 123.358 0.411 . . . . 70.21 109.912 -175.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 54.6 tp -128.79 99.99 5.53 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 109.001 -0.74 . . . . 72.21 109.001 -170.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -80.21 121.43 25.6 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.955 -0.757 . . . . 61.43 108.955 176.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 6.3 p -138.68 135.58 18.02 Favored Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 124.714 1.206 . . . . 64.4 108.374 -175.34 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -74.12 152.73 45.86 Favored 'Trans proline' 0 C--N 1.368 1.553 0 C-N-CA 121.923 1.748 . . . . 64.51 111.081 173.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -53.35 -50.57 82.0 Favored Pre-proline 0 CA--C 1.553 1.07 0 N-CA-C 113.93 1.085 . . . . 71.34 113.93 -173.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -55.52 -46.25 33.58 Favored 'Trans proline' 0 C--N 1.38 2.19 0 C-N-CA 121.902 1.735 . . . . 63.54 113.581 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 19.6 mt -70.32 -32.32 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 CA-C-N 116.141 -0.481 . . . . 64.32 110.927 -176.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.89 -42.4 85.58 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.004 0.522 . . . . 71.51 111.301 175.084 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.419 ' CG1' HD11 ' C' ' 261' ' ' LEU . 53.9 t -73.17 -40.85 58.43 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.037 0 C-N-CA 124.082 0.953 . . . . 63.23 112.577 -174.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 65.0 t -95.58 -34.77 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 122.614 0.366 . . . . 74.41 111.694 -175.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 93.42 108.84 1.94 Allowed Glycine 0 C--N 1.335 0.508 0 CA-C-N 116.354 -0.384 . . . . 72.35 112.166 -178.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -141.45 -161.94 8.93 Favored Glycine 0 N--CA 1.469 0.841 0 N-CA-C 110.741 -0.943 . . . . 55.24 110.741 177.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 44.5 mtmt -100.43 124.11 45.52 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 118.426 1.113 . . . . 45.21 110.814 176.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 31.4 m -108.89 166.07 4.75 Favored 'Isoleucine or valine' 0 C--O 1.247 0.924 0 C-N-CA 125.014 1.326 . . . . 63.11 108.973 170.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' ARG . . . . . 0.656 ' HG2' HG21 ' B' ' 421' ' ' VAL . 0.0 OUTLIER -95.16 117.41 30.18 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.022 -0.733 . . . . 71.41 109.022 174.501 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -119.71 130.97 55.27 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 107.481 -1.303 . . . . 62.04 107.481 172.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 213' ' ' MET . . . . . 0.546 ' HA ' ' HA ' ' A' ' 218' ' ' PRO . 0.8 OUTLIER -80.27 148.62 30.69 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 122.46 0.304 . . . . 71.23 110.505 -176.497 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 71.5 p -117.67 -177.81 3.33 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 108.808 -0.812 . . . . 74.1 108.808 168.008 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.448 ' HB3' ' HA ' ' A' ' 128' ' ' GLU . 86.0 mt -76.89 -1.98 31.23 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.642 -0.708 . . . . 63.31 112.098 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -126.89 -2.17 6.56 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.145 0.578 . . . . 64.44 111.805 177.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 149.17 167.31 13.82 Favored Glycine 0 N--CA 1.481 1.635 0 N-CA-C 114.626 0.61 . . . . 33.0 114.626 173.059 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' PRO . . . . . 0.546 ' HA ' ' HA ' ' A' ' 213' ' ' MET . 2.7 Cg_exo -76.19 116.59 4.4 Favored 'Trans proline' 0 C--N 1.374 1.888 0 C-N-CA 123.662 2.908 . . . . 70.23 111.968 -177.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.655 HG12 HG22 ' B' ' 435' ' ' THR . 34.7 m -106.42 162.29 5.32 Favored 'Isoleucine or valine' 0 C--O 1.254 1.317 0 C-N-CA 123.98 0.912 . . . . 73.4 112.03 -172.404 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.651 ' HA ' HH21 ' A' ' 211' ' ' ARG . 29.4 mt-10 -86.49 103.12 14.72 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 114.213 -1.358 . . . . 75.04 109.889 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.479 HG13 HD11 ' B' ' 441' ' ' ILE . 39.7 t -106.93 116.9 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.172 0.589 . . . . 74.13 109.48 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.451 ' O ' HG13 ' B' ' 441' ' ' ILE . . . -77.88 99.36 5.95 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 109.255 -0.646 . . . . 60.25 109.255 174.461 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 14.3 p -64.9 134.0 95.93 Favored Pre-proline 0 CA--C 1.559 1.326 0 N-CA-C 109.491 -0.559 . . . . 63.14 109.491 177.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -61.44 168.71 7.64 Favored 'Trans proline' 0 C--N 1.38 2.227 0 C-N-CA 122.735 2.29 . . . . 75.51 112.654 176.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.77 150.96 31.34 Favored 'Trans proline' 0 C--N 1.374 1.904 0 C-N-CA 121.624 1.549 . . . . 72.53 112.474 172.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 45.3 mtt-85 66.29 27.34 10.17 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 125.692 1.597 . . . . 74.04 110.963 169.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.651 HG23 HD21 ' A' ' 233' ' ' LEU . 80.6 m -63.59 104.87 0.7 Allowed 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 113.06 -1.882 . . . . 64.32 110.843 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -85.14 139.83 31.4 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 123.945 0.898 . . . . 75.32 110.647 -176.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -62.24 157.4 19.59 Favored 'General case' 0 C--N 1.356 0.863 0 C-N-CA 124.152 0.981 . . . . 62.31 111.082 177.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 81.1 -38.74 2.41 Favored Glycine 0 C--N 1.346 1.088 0 CA-C-N 116.637 -0.256 . . . . 73.32 112.606 177.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -69.07 166.94 17.06 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 123.686 0.794 . . . . 74.0 110.26 173.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.705 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 2.7 mptp? -124.85 131.87 53.39 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 115.13 -0.941 . . . . 72.22 108.772 -178.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.651 HD21 HG23 ' A' ' 227' ' ' THR . 59.4 mt -76.62 97.54 4.44 Favored 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 107.903 -1.147 . . . . 71.4 107.903 176.163 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 234' ' ' ARG . . . . . 0.419 ' HG3' ' HB3' ' A' ' 248' ' ' ASP . 40.7 ttp180 -78.73 103.52 8.73 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 123.599 0.562 . . . . 64.14 109.737 -176.365 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.46 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 10.7 mt -100.04 89.33 4.0 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.217 -1.031 . . . . 61.12 108.217 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -71.0 139.08 50.42 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.751 0.42 . . . . 64.43 110.977 -173.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 79.32 2.6 87.76 Favored Glycine 0 CA--C 1.536 1.346 0 O-C-N 123.533 0.521 . . . . 74.2 113.271 -174.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.493 ' HE3' ' HA ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -105.83 -16.45 14.66 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 117.47 0.635 . . . . 73.01 111.73 -179.395 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -72.32 -163.29 6.63 Favored Glycine 0 CA--C 1.534 1.238 0 O-C-N 123.412 0.445 . . . . 74.43 112.87 173.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 240' ' ' PHE . . . . . 0.444 ' CD2' ' HA2' ' A' ' 152' ' ' GLY . 58.6 m-85 -95.01 166.26 15.29 Favored Pre-proline 0 N--CA 1.485 1.284 0 CA-C-O 118.282 -0.866 . . . . 73.13 109.869 -177.496 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -49.69 146.26 15.86 Favored 'Trans proline' 0 C--N 1.392 2.868 0 C-N-CA 123.399 2.733 . . . . 73.33 113.943 -177.062 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.428 ' HA3' ' HB3' ' A' ' 191' ' ' GLN . . . -168.65 -158.68 12.91 Favored Glycine 0 C--N 1.338 0.657 0 CA-C-N 114.928 -1.033 . . . . 73.52 112.002 -178.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -78.46 -5.52 14.95 Favored 'Trans proline' 0 C--N 1.369 1.626 0 C-N-CA 123.284 2.656 . . . . 70.45 112.749 -173.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -113.51 22.0 14.57 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.003 0.921 . . . . 70.11 110.309 177.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 90.84 -75.28 1.63 Allowed Glycine 0 C--N 1.345 1.031 0 N-CA-C 109.996 -1.241 . . . . 62.24 109.996 -174.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 73.9 mtp180 -119.94 175.29 5.98 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.994 0.918 . . . . 75.41 109.279 168.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -105.58 -161.03 23.14 Favored Glycine 0 C--N 1.341 0.85 0 CA-C-N 115.988 -0.551 . . . . 42.24 114.306 -177.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 248' ' ' ASP . . . . . 0.419 ' HB3' ' HG3' ' A' ' 234' ' ' ARG . 19.3 m-20 -110.7 134.75 52.18 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 124.032 0.933 . . . . 75.44 108.813 -174.185 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.555 ' HA ' ' HB2' ' A' ' 193' ' ' LEU . 12.3 tp -98.95 95.51 7.21 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.0 -1.111 . . . . 70.31 108.0 176.21 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.705 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 84.4 m-85 -82.27 108.28 15.6 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 109.523 -0.547 . . . . 52.51 109.523 178.392 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.512 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 86.7 mt -86.8 105.7 17.19 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 109.298 -0.63 . . . . 72.24 109.298 172.408 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -76.54 106.99 8.5 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.358 0.663 . . . . 75.41 109.504 -174.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.454 HG11 HG22 ' A' ' 227' ' ' THR . 23.9 t -69.27 127.93 31.91 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 124.252 1.021 . . . . 24.43 112.089 -170.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -127.5 93.93 3.85 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 107.365 -1.346 . . . . 73.14 107.365 178.605 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.409 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 69.6 mt -83.25 136.11 23.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 C-N-CA 122.641 0.377 . . . . 74.34 110.762 -177.591 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 22.5 p -124.93 169.57 11.95 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.594 1.157 . . . . 73.43 109.497 172.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 257' ' ' ILE . . . . . 0.554 HD12 ' H ' ' A' ' 259' ' ' GLU . 2.3 pp -109.58 141.18 23.07 Favored Pre-proline 0 N--CA 1.484 1.25 0 C-N-CA 122.928 0.491 . . . . 73.4 109.92 178.598 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 258' ' ' PRO . . . . . 0.539 ' HB3' ' HE1' ' C' ' 276' ' ' TYR . 12.7 Cg_endo -52.53 -20.95 13.03 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 124.598 3.532 . . . . 74.45 115.615 -170.389 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.554 ' H ' HD12 ' A' ' 257' ' ' ILE . 23.2 mt-10 50.85 -78.93 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.561 1.144 . . . . 63.24 110.576 -160.509 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 260' ' ' ARG . . . . . 0.415 ' HG3' ' HG3' ' B' ' 381' ' ' GLU . 0.0 OUTLIER -48.59 129.34 16.26 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.271 1.029 . . . . 75.12 111.713 176.973 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.43 HD22 ' HB3' ' A' ' 265' ' ' GLU . 89.1 mt -154.99 144.85 21.6 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.555 1.142 . . . . 55.32 109.096 -179.073 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 64.2 p -93.86 156.72 39.06 Favored Pre-proline 0 CA--C 1.555 1.151 0 CA-C-O 118.06 -0.971 . . . . 44.34 109.101 171.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 263' ' ' PRO . . . . . 0.477 ' HG2' HD12 ' B' ' 375' ' ' LEU . 11.3 Cg_exo -34.98 -48.07 0.69 Allowed 'Trans proline' 0 C--N 1.388 2.639 0 C-N-CA 124.843 3.695 . . . . 74.33 116.532 -177.224 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -68.46 -49.47 59.6 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.05 0.54 . . . . 71.44 111.406 -178.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 265' ' ' GLU . . . . . 0.43 ' HB3' HD22 ' A' ' 261' ' ' LEU . 49.9 mt-10 -56.95 -43.77 81.91 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.077 0.551 . . . . 64.2 110.344 178.408 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -57.12 -45.81 83.18 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 114.483 -1.235 . . . . 73.45 110.513 177.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -60.93 -41.67 96.65 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.162 -0.926 . . . . 64.12 111.685 178.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 268' ' ' LEU . . . . . 0.406 ' HG ' ' HG ' ' C' ' 268' ' ' LEU . 9.7 mp -64.78 -48.53 74.17 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.296 0.638 . . . . 73.14 111.193 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 68.5 m95 -57.86 -45.58 86.08 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.142 0.577 . . . . 75.0 111.583 178.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 270' ' ' LYS . . . . . 0.619 ' HE3' HG23 ' C' ' 206' ' ' VAL . 44.9 mttp -65.16 -42.95 93.22 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-N 115.536 -0.756 . . . . 62.43 111.547 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 34.4 mmtm -63.31 -42.94 99.05 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 122.88 0.472 . . . . 70.22 111.789 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 272' ' ' LEU . . . . . 0.44 ' O ' ' HB2' ' A' ' 276' ' ' TYR . 67.5 mt -54.93 -49.28 71.69 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 124.251 0.97 . . . . 63.4 109.435 172.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -70.06 -33.22 71.66 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.076 1.139 . . . . 64.51 114.076 -175.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.428 ' HG3' ' O ' ' A' ' 270' ' ' LYS . 40.6 mt-10 -65.08 -53.94 37.81 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.373 -0.973 . . . . 74.35 108.373 176.535 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -69.87 -20.83 63.38 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 113.567 -1.651 . . . . 71.44 112.161 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 276' ' ' TYR . . . . . 0.554 ' HE2' ' HB3' ' C' ' 258' ' ' PRO . 23.8 t80 -75.49 -64.07 1.15 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.188 0.995 . . . . 75.02 109.4 178.705 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -72.09 -23.06 61.28 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 114.799 -1.091 . . . . 70.12 111.848 -170.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -59.24 -26.99 65.37 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 112.762 0.653 . . . . 75.41 112.762 172.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -77.58 -15.14 59.42 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 116.429 -0.351 . . . . 74.13 110.497 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.131 0 C-N-CA 123.857 0.863 . . . . 72.21 109.042 175.507 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 14.6 tpt . . . . . 0 N--CA 1.479 0.979 0 N-CA-C 109.391 -0.596 . . . . 71.44 109.391 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt 59.86 33.94 21.69 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 124.568 1.147 . . . . 54.1 112.126 175.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 59.22 72.94 0.5 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.736 1.214 . . . . 74.04 109.814 -173.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 11.1 p -82.87 -17.51 43.57 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 115.029 -0.987 . . . . 52.14 111.864 -176.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 4.5 m 68.94 158.72 0.16 Allowed 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 125.234 1.413 . . . . 70.11 113.252 174.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.616 HG21 ' HA ' ' A' ' 125' ' ' LEU . 14.5 pt -138.57 175.08 8.93 Favored 'Isoleucine or valine' 0 C--N 1.364 1.199 0 C-N-CA 123.316 0.646 . . . . 64.44 111.117 -172.028 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -150.38 141.81 23.39 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.074 0.95 . . . . 72.01 109.017 172.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.585 HD23 HG11 ' A' ' 140' ' ' VAL . 52.7 tp -75.76 143.03 42.22 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.263 1.025 . . . . 75.22 109.91 -174.559 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.93 -68.1 0.35 Allowed 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 109.513 -0.551 . . . . 62.4 109.513 172.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 6.6 tt 53.39 101.23 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 125.365 1.466 . . . . 74.1 110.527 -176.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 31.0 mt -49.68 120.9 11.52 Favored Pre-proline 0 CA--C 1.556 1.209 0 C-N-CA 124.732 1.213 . . . . 45.35 110.769 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -54.21 136.4 68.07 Favored 'Trans proline' 0 C--N 1.383 2.348 0 C-N-CA 124.139 3.226 . . . . 61.33 114.634 -155.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 41.4 mt -150.0 -47.62 0.13 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.415 1.486 . . . . 75.01 108.801 177.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -155.84 162.9 40.38 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.717 0.807 . . . . 64.54 109.766 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 15' ' ' PHE . . . . . 0.644 ' HA ' ' HA ' ' A' ' 141' ' ' ALA . 62.6 t80 -154.26 117.31 4.48 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.307 0.643 . . . . 60.01 109.83 173.144 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 1.3 p -146.88 169.84 8.77 Favored Pre-proline 0 CA--C 1.558 1.26 0 C-N-CA 125.649 1.58 . . . . 51.11 108.283 174.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -105.06 23.57 0.1 Allowed 'Trans proline' 0 CA--C 1.557 1.663 0 C-N-CA 122.934 2.423 . . . . 62.42 112.656 164.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.534 HG21 ' HG3' ' A' ' 79' ' ' PRO . 4.8 p -66.57 -66.67 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 N-CA-C 114.941 1.46 . . . . 61.41 114.941 -163.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 25.4 m -87.8 -53.6 4.68 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 122.523 0.329 . . . . 71.22 111.55 -163.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 20' ' ' LYS . . . . . 0.507 ' HA ' ' H ' ' A' ' 144' ' ' ARG . 92.4 mttt 70.56 178.89 0.25 Allowed 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 124.771 1.228 . . . . 62.34 110.367 -171.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -179.79 151.63 0.45 Allowed 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.539 0.685 . . . . 75.34 112.494 178.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 22' ' ' ARG . . . . . 0.769 HH21 ' HG2' ' A' ' 135' ' ' GLU . 26.0 mtp-105 -141.86 104.51 4.52 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.491 1.116 . . . . 73.31 108.766 172.035 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 23' ' ' THR . . . . . 0.438 HG21 ' O ' ' A' ' 86' ' ' SER . 17.8 p -139.43 52.86 4.3 Favored Pre-proline 0 N--CA 1.497 1.915 0 CA-C-N 118.806 0.73 . . . . 72.45 112.583 168.435 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 24' ' ' PRO . . . . . 0.44 ' HD2' ' HG2' ' B' ' 25' ' ' GLU . 8.7 Cg_endo -101.15 0.19 0.57 Allowed 'Trans proline' 0 C--N 1.371 1.745 0 C-N-CA 122.444 2.096 . . . . 74.55 113.859 176.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 25' ' ' GLU . . . . . 0.44 ' HG2' ' HD2' ' B' ' 24' ' ' PRO . 69.8 mm-40 -75.22 -20.32 59.31 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.573 0.749 . . . . 74.53 112.634 -167.213 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 26' ' ' MET . . . . . 0.493 ' H ' ' HD2' ' B' ' 27' ' ' PRO . 51.2 ttm -170.89 -50.35 0.0 OUTLIER Pre-proline 0 CA--C 1.567 1.611 0 CA-C-O 118.264 -0.874 . . . . 75.13 112.542 -171.284 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 27' ' ' PRO . . . . . 0.493 ' HD2' ' H ' ' B' ' 26' ' ' MET . 72.7 Cg_endo -71.07 10.51 0.66 Allowed 'Trans proline' 0 C--N 1.399 3.214 0 C-N-CA 122.212 1.941 . . . . 71.1 115.355 -172.148 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 29.0 m -70.51 142.77 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 N-CA-C 109.146 -0.687 . . . . 73.51 109.146 166.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 32.0 tp -141.93 166.94 23.34 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.119 0.568 . . . . 62.2 110.64 -171.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -76.29 155.27 34.43 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.093 0.957 . . . . 70.24 110.104 173.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 31' ' ' ASN . . . . . 0.444 ' HB2' ' HB2' ' A' ' 160' ' ' ARG . 28.7 t-20 -129.41 168.5 16.21 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.992 0.917 . . . . 74.34 109.738 -175.302 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 21.5 ptt-85 -65.68 -0.63 2.2 Favored 'General case' 0 CA--C 1.561 1.392 0 C-N-CA 125.02 1.328 . . . . 72.22 113.372 173.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 33' ' ' ALA . . . . . 0.404 ' O ' ' HG3' ' B' ' 35' ' ' GLN . . . 75.41 118.15 0.05 Allowed 'General case' 0 C--N 1.365 1.242 0 C-N-CA 126.535 1.934 . . . . 73.31 108.482 -166.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 34' ' ' ALA . . . . . 0.524 ' H ' HG21 ' A' ' 158' ' ' VAL . . . -64.53 99.01 0.28 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.211 0.529 . . . . 53.33 110.082 178.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 35' ' ' GLN . . . . . 0.404 ' HG3' ' O ' ' B' ' 33' ' ' ALA . 65.3 mt-30 -87.28 170.75 11.17 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.081 0.952 . . . . 73.13 110.673 -178.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -132.33 178.42 18.03 Favored Glycine 0 C--N 1.34 0.792 0 CA-C-N 116.004 -0.544 . . . . 74.33 112.148 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -76.01 -53.7 7.98 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.601 0.76 . . . . 61.44 110.235 179.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 48.7 mm 76.03 -59.8 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 C-N-CA 125.483 1.513 . . . . 75.44 113.277 168.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 54.6 m -59.11 -67.18 0.4 Allowed 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.054 0.942 . . . . 64.25 112.642 -173.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.478 ' HB3' ' HD3' ' B' ' 41' ' ' PRO . . . -112.2 -54.37 0.05 OUTLIER Pre-proline 0 N--CA 1.489 1.511 0 CA-C-O 118.286 -0.864 . . . . 64.0 112.13 -174.387 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 41' ' ' PRO . . . . . 0.478 ' HD3' ' HB3' ' B' ' 40' ' ' ALA . 15.1 Cg_exo -71.81 107.98 2.33 Favored 'Trans proline' 0 C--N 1.388 2.642 0 CA-C-N 121.795 1.677 . . . . 72.44 111.662 172.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -167.84 -125.18 0.76 Allowed Glycine 0 C--N 1.344 1.016 0 N-CA-C 110.974 -0.85 . . . . 45.24 110.974 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -159.99 -152.82 6.66 Favored Glycine 0 C--N 1.344 1.025 0 N-CA-C 111.852 -0.499 . . . . 42.15 111.852 179.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . 59.31 87.07 0.08 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.817 1.247 . . . . 63.2 109.837 -172.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 20.2 mtp180 64.86 -142.68 0.24 Allowed 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 124.128 0.971 . . . . 74.21 109.172 -171.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 82.9 mtt180 70.82 103.34 0.06 Allowed 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.485 1.114 . . . . 75.02 111.026 176.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 79.4 mt 62.06 23.42 13.81 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.989 0.915 . . . . 53.22 112.004 172.136 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 28.1 m -80.27 -41.48 24.93 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 114.762 -1.108 . . . . 51.22 109.58 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -161.95 31.25 0.31 Allowed Glycine 0 C--N 1.338 0.649 0 CA-C-N 114.58 -1.191 . . . . 74.15 110.375 175.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 50' ' ' ASP . . . . . 0.403 ' HB3' ' HD3' ' C' ' 160' ' ' ARG . 2.1 m-20 -85.71 -2.27 58.03 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.513 1.125 . . . . 64.2 112.447 -167.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -116.41 -63.29 1.47 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 122.94 0.496 . . . . 75.3 111.86 -175.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 41.2 p -109.51 -45.89 3.62 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.108 0.563 . . . . 73.31 111.761 -173.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.7 -55.36 35.83 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.693 0.797 . . . . 73.24 112.138 -170.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -99.53 4.46 45.95 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.232 0.613 . . . . 75.51 110.642 175.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 94.0 mt 65.52 -167.38 0.22 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 125.194 1.398 . . . . 72.35 110.644 -170.131 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 92.4 mtt-85 -113.14 107.71 16.3 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.283 0.633 . . . . 73.2 109.575 176.116 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 9.3 t70 66.38 -176.4 0.19 Allowed 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 124.39 1.076 . . . . 75.31 110.467 175.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 51.1 m -143.1 39.6 1.46 Allowed 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.743 -0.598 . . . . 62.01 110.228 177.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 45.9 tp -60.35 102.6 0.18 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.423 0.689 . . . . 72.44 110.641 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 29.4 m -91.61 84.07 5.43 Favored 'General case' 0 C--O 1.244 0.779 0 C-N-CA 123.853 0.861 . . . . 63.51 109.882 -177.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 14.3 t70 62.57 -94.75 0.04 OUTLIER 'General case' 0 CA--C 1.563 1.462 0 O-C-N 124.309 1.006 . . . . 71.45 111.267 169.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 62' ' ' LYS . . . . . . . . . . . . . 87.9 tttt 162.21 91.09 0.01 OUTLIER Pre-proline 0 C--N 1.359 0.981 0 C-N-CA 126.854 2.061 . . . . 72.3 106.64 -176.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -68.75 -36.4 14.06 Favored 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 122.557 2.172 . . . . 72.24 113.055 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -97.97 105.31 17.44 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.703 0.801 . . . . 72.04 111.029 -173.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.402 ' HE2' ' HD3' ' C' ' 24' ' ' ARG . 7.6 tmtt? -92.32 69.88 5.14 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 106.996 -1.483 . . . . 65.32 106.996 170.104 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -127.57 155.14 44.3 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.247 0.619 . . . . 72.41 110.135 -177.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 16.1 tt -124.88 140.79 46.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 124.051 0.941 . . . . 72.03 108.742 176.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 8.3 tt -64.13 102.04 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.118 0 CA-C-O 121.398 0.618 . . . . 73.4 109.812 177.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 57.1 tp -67.85 -59.7 3.09 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.767 -0.651 . . . . 73.12 110.099 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 57.8 tp -162.54 147.43 12.17 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.176 0.59 . . . . 44.44 109.935 -177.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 29.4 pt -72.04 134.15 30.43 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 C-N-CA 123.462 0.705 . . . . 74.32 110.613 173.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -82.13 135.0 13.61 Favored Glycine 0 C--N 1.344 1.024 0 CA-C-O 119.327 -0.707 . . . . 62.21 112.318 -178.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 4.1 t70 69.98 175.73 0.28 Allowed 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 125.224 1.409 . . . . 63.44 110.825 177.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -125.51 -103.03 1.38 Allowed Glycine 0 C--N 1.352 1.432 0 O-C-N 121.864 -0.522 . . . . 64.42 112.625 178.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 75' ' ' MET . . . . . 0.487 ' HA ' ' HB2' ' B' ' 79' ' ' GLU . 1.0 OUTLIER 62.41 -84.31 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 125.276 1.43 . . . . 74.01 110.169 -172.272 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 59.01 -85.47 0.01 OUTLIER Glycine 0 C--N 1.355 1.6 0 N-CA-C 114.55 0.58 . . . . 71.13 114.55 175.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -88.53 21.64 2.86 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.784 1.234 . . . . 73.03 111.767 -176.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 17.0 m 76.71 -0.72 2.97 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 125.796 1.638 . . . . 51.1 111.411 -168.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 79' ' ' GLU . . . . . 0.487 ' HB2' ' HA ' ' B' ' 75' ' ' MET . 32.3 tt0 54.01 44.95 28.59 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 125.149 1.38 . . . . 74.44 111.49 176.018 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 2.2 pp 48.29 16.03 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 C-N-CA 126.41 1.884 . . . . 72.52 114.638 -177.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 20.4 m -75.79 -26.85 57.69 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.716 0.806 . . . . 71.34 110.414 -178.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.13 -29.93 65.85 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 115.423 -0.808 . . . . 61.11 110.494 172.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -77.42 119.35 20.91 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.156 0.583 . . . . 71.35 110.311 177.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 61.1 mtp85 -92.57 35.42 1.02 Allowed 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.871 0.868 . . . . 73.0 111.427 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 9.1 t30 61.05 -79.72 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.936 1.294 . . . . 72.23 111.232 -174.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -61.24 -72.19 0.12 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.673 0.789 . . . . 63.12 110.963 -177.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . 175.26 -72.47 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.897 1.279 . . . . 52.24 107.976 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -102.45 -78.44 0.54 Allowed 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 114.743 -1.117 . . . . 74.14 108.487 -177.139 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 145.89 -92.32 0.16 Allowed Glycine 0 C--N 1.349 1.261 0 N-CA-C 112.303 -0.319 . . . . 54.33 112.303 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -162.12 30.11 0.12 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.578 0.751 . . . . 62.33 110.305 -174.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.18 -78.93 0.78 Allowed Glycine 0 C--N 1.344 1.022 0 CA-C-N 115.769 -0.651 . . . . 70.11 112.199 -175.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 92' ' ' GLY . . . . . 0.498 ' HA2' ' HA ' ' B' ' 210' ' ' LYS . . . -175.66 -152.54 9.53 Favored Glycine 0 C--N 1.339 0.709 0 N-CA-C 111.615 -0.594 . . . . 23.53 111.615 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -93.34 -18.62 22.2 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.286 0.635 . . . . 74.22 111.346 178.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -56.33 -62.67 1.56 Allowed 'General case' 0 N--CA 1.479 1.02 0 CA-C-O 119.115 -0.469 . . . . 71.21 110.817 -178.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 6.8 tmtm? 60.53 -77.85 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 O-C-N 124.33 1.019 . . . . 74.14 108.906 -174.208 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . -171.04 42.82 0.19 Allowed Glycine 0 C--N 1.346 1.121 0 N-CA-C 110.199 -1.16 . . . . 72.31 110.199 172.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 13.7 pt -70.13 -31.56 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 123.58 0.752 . . . . 72.22 112.051 -173.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -147.7 -153.68 0.51 Allowed 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 109.327 -0.62 . . . . 75.21 109.327 -172.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . 69.59 24.89 5.43 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.156 1.383 . . . . 61.12 112.346 -175.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 5.9 mp -58.91 -46.36 99.54 Favored Pre-proline 0 N--CA 1.484 1.255 0 CA-C-O 118.511 -0.757 . . . . 74.2 110.809 167.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -67.19 -5.83 14.7 Favored 'Trans proline' 0 C--N 1.4 3.262 0 C-N-CA 121.896 1.731 . . . . 72.21 113.268 177.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 102' ' ' LEU . . . . . 0.535 ' HB3' ' H ' ' B' ' 114' ' ' LYS . 69.3 mt 71.05 -69.54 0.18 Allowed 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 125.902 1.681 . . . . 73.12 111.156 173.223 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 3.6 t -88.04 -46.32 9.44 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.472 1.109 . . . . 75.52 110.445 171.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 71.96 12.05 74.82 Favored Glycine 0 C--N 1.35 1.345 0 CA-C-O 119.512 -0.605 . . . . 51.35 114.539 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -162.38 -63.81 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 117.553 0.677 . . . . 75.22 111.253 -175.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -93.59 107.09 19.0 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.076 0.551 . . . . 74.44 110.931 -171.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 83.8 m -137.14 -63.46 0.6 Allowed 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.217 -1.031 . . . . 63.32 108.217 176.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 57.72 -77.15 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 126.024 1.73 . . . . 71.44 113.107 173.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -129.61 -63.98 0.9 Allowed 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 108.893 -0.781 . . . . 53.33 108.893 173.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -136.6 121.58 18.87 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.159 0.984 . . . . 71.24 109.666 179.014 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 111' ' ' LEU . . . . . 0.436 HD13 ' N ' ' B' ' 112' ' ' ASN . 1.5 tm? -150.92 151.54 32.32 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.637 -0.875 . . . . 64.15 108.637 -178.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 112' ' ' ASN . . . . . 0.436 ' N ' HD13 ' B' ' 111' ' ' LEU . 19.7 m120 -74.79 113.14 11.74 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.041 0.537 . . . . 73.2 109.978 178.305 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 113' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.72 -165.08 0.33 Allowed 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 123.657 0.783 . . . . 75.13 110.357 176.133 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 114' ' ' LYS . . . . . 0.535 ' H ' ' HB3' ' B' ' 102' ' ' LEU . 1.4 tpmt? -58.22 -35.55 71.83 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.358 0.663 . . . . 74.01 111.378 -177.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 11.9 m 65.6 -76.06 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.86 1.664 . . . . 73.23 110.269 -176.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -161.42 174.7 38.0 Favored Glycine 0 C--O 1.242 0.65 0 N-CA-C 109.961 -1.256 . . . . 55.33 109.961 172.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 117' ' ' LYS . . . . . 0.433 ' N ' ' HE3' ' B' ' 117' ' ' LYS . 0.8 OUTLIER 68.4 136.96 0.05 OUTLIER Pre-proline 0 CA--C 1.57 1.744 0 C-N-CA 124.538 1.135 . . . . 70.25 111.01 -175.928 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 118' ' ' PRO . . . . . 0.646 ' HD2' ' HB ' ' B' ' 121' ' ' VAL . 19.4 Cg_exo -67.62 72.67 0.65 Allowed 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 123.196 2.597 . . . . 60.53 111.21 169.623 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 119' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 56.19 -92.01 0.03 OUTLIER 'General case' 0 C--N 1.352 0.711 0 C-N-CA 125.609 1.564 . . . . 75.33 110.955 -170.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 120' ' ' TYR . . . . . 0.676 ' HB2' ' HG ' ' B' ' 280' ' ' LEU . 41.4 t80 -104.61 -19.85 13.85 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.402 0.681 . . . . 70.1 110.874 -175.246 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 121' ' ' VAL . . . . . 0.646 ' HB ' ' HD2' ' B' ' 118' ' ' PRO 0.288 8.3 p 52.05 -68.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 C-N-CA 127.385 2.274 . . . . 74.32 114.336 -174.433 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 32.5 m -55.55 95.67 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 124.44 1.096 . . . . 75.24 112.538 -174.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -98.21 4.84 48.88 Favored 'General case' 0 CA--C 1.553 1.07 0 CA-C-N 115.345 -0.843 . . . . 64.3 109.904 172.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 44.5 t 60.98 -100.74 0.1 Allowed 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 125.646 1.579 . . . . 43.31 112.265 171.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 125' ' ' ALA . . . . . 0.558 ' HA ' ' HE2' ' B' ' 210' ' ' LYS . . . -163.96 -58.4 0.04 OUTLIER 'General case' 0 C--N 1.36 1.023 0 CA-C-N 118.852 0.751 . . . . 73.02 112.872 -172.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -71.65 163.41 27.82 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 122.745 0.418 . . . . 74.13 111.893 -172.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 35.5 m 65.1 -175.37 0.18 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.68 1.192 . . . . 70.01 112.541 177.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . 66.38 -68.68 0.13 Allowed 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 125.127 1.371 . . . . 72.01 111.669 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 129' ' ' THR . . . . . 0.634 HG23 ' HA2' ' B' ' 209' ' ' GLY . 34.1 p -67.81 -40.09 83.88 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.178 0.591 . . . . 54.34 109.533 166.355 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . -79.93 -164.34 0.66 Allowed 'General case' 0 CA--C 1.553 1.065 0 CA-C-N 115.334 -0.848 . . . . 44.22 109.526 169.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 131' ' ' TRP . . . . . 0.521 ' HH2' HD23 ' B' ' 205' ' ' LEU . 25.1 m0 69.7 27.0 4.8 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 124.249 1.02 . . . . 73.51 110.375 -166.401 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 132' ' ' SER . . . . . 0.587 ' HB2' ' HD2' ' B' ' 231' ' ' LYS . 12.8 p -155.37 -83.97 0.06 Allowed 'General case' 0 CA--C 1.541 0.635 0 N-CA-C 106.558 -1.645 . . . . 51.4 106.558 172.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 31.9 m -154.0 -84.46 0.07 Allowed 'General case' 0 CA--C 1.551 0.983 0 N-CA-C 108.249 -1.019 . . . . 62.25 108.249 170.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . -151.02 37.74 0.86 Allowed Glycine 0 C--N 1.35 1.347 0 N-CA-C 110.266 -1.133 . . . . 55.15 110.266 178.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 135' ' ' VAL . . . . . . . . . . . . . 8.3 p -158.78 160.21 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.32 1.048 . . . . 73.24 108.51 -173.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 136' ' ' LYS . . . . . 0.458 ' HG3' ' H ' ' B' ' 137' ' ' THR . 0.5 OUTLIER -131.41 176.73 8.05 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 122.736 0.414 . . . . 52.43 110.325 -179.846 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 137' ' ' THR . . . . . 0.458 ' H ' ' HG3' ' B' ' 136' ' ' LYS . 5.5 t -55.34 92.88 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 125.171 1.388 . . . . 75.31 112.889 -176.143 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 58.9 t80 73.68 -74.41 0.09 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.797 1.639 . . . . 75.52 112.295 172.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 139' ' ' ASN . . . . . 0.437 ' OD1' ' HA ' ' B' ' 212' ' ' SER . 12.7 t30 70.05 154.29 0.12 Allowed 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 125.242 1.417 . . . . 73.24 112.609 -177.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . 91.15 -3.88 80.56 Favored Glycine 0 C--N 1.348 1.229 0 CA-C-N 115.559 -0.746 . . . . 65.04 112.272 -176.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -91.51 -0.3 57.59 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.007 0.923 . . . . 75.34 111.447 -178.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -79.6 109.33 13.89 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.115 -1.069 . . . . 70.15 108.115 176.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -108.68 -34.46 2.63 Favored Glycine 0 C--N 1.342 0.91 0 O-C-N 123.61 0.569 . . . . 61.25 111.907 174.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 5.0 p -104.53 131.34 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.886 0.874 . . . . 75.31 110.175 -179.116 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -95.52 -36.97 11.09 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.702 0.801 . . . . 64.3 110.47 176.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 44.0 mm -62.74 127.57 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 123.753 0.821 . . . . 72.52 111.334 -178.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 61.57 4.27 0.98 Allowed 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 125.832 1.653 . . . . 72.43 113.561 175.383 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -92.88 163.82 13.56 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.444 0.698 . . . . 73.05 110.9 -171.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 149' ' ' LYS . . . . . 0.441 ' HE2' ' HA ' ' B' ' 260' ' ' SER . 20.5 tptp -75.47 97.48 3.69 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 123.327 0.651 . . . . 72.23 112.19 -172.04 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -85.15 142.95 29.12 Favored 'General case' 0 CA--C 1.553 1.072 0 CA-C-N 115.362 -0.836 . . . . 74.11 109.553 165.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 58.2 m80 66.26 116.1 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.593 0 C-N-CA 125.569 1.548 . . . . 74.43 112.619 -175.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 152' ' ' PRO . . . . . 0.459 ' HD2' ' HA3' ' B' ' 209' ' ' GLY . 57.9 Cg_endo -72.08 166.78 28.62 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.094 1.863 . . . . 42.51 110.723 163.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 12.7 t -160.43 -31.74 0.06 Allowed 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 112.429 0.529 . . . . 74.2 112.429 -174.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 9.8 tt -94.41 76.25 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 CA-C-O 121.859 0.838 . . . . 74.25 110.615 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 7.3 mp 51.28 -86.13 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 125.82 1.648 . . . . 72.1 113.397 174.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -159.73 -79.25 0.06 Allowed 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 107.505 -1.294 . . . . 72.23 107.505 -177.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 157' ' ' MET . . . . . 0.544 ' HB3' HD21 ' B' ' 218' ' ' LEU . 26.8 ptm 167.34 164.61 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 126.292 1.837 . . . . 53.54 108.511 179.022 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 158' ' ' ALA . . . . . . . . . . . . . . . -163.32 -171.34 2.56 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.278 1.031 . . . . 34.04 108.473 174.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 54.6 tptt -102.67 -15.0 16.47 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 123.148 0.579 . . . . 55.45 109.558 169.312 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -151.98 -75.09 0.14 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.734 0.814 . . . . 70.22 110.398 177.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -156.71 -82.87 0.06 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.433 0.693 . . . . 71.1 109.976 178.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 162' ' ' GLY . . . . . 0.683 ' HA2' ' HB2' ' B' ' 235' ' ' GLU . . . 76.81 -71.38 2.16 Favored Glycine 0 C--N 1.352 1.432 0 C-N-CA 122.71 0.195 . . . . 73.4 113.077 -178.393 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 71.5 mt 67.33 23.9 9.13 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.93 1.292 . . . . 65.02 112.48 173.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 164' ' ' ALA . . . . . . . . . . . . . . . -90.63 -100.77 0.1 Allowed 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 122.868 0.467 . . . . 75.34 111.06 178.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 87.0 m 63.22 -69.96 0.07 Allowed 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 124.721 1.209 . . . . 64.15 111.441 -167.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . -87.82 -167.79 43.82 Favored Glycine 0 C--N 1.346 1.132 0 N-CA-C 112.129 -0.388 . . . . 71.15 112.129 174.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 167' ' ' ASN . . . . . 0.456 HD21 ' HB3' ' B' ' 75' ' ' MET . 38.0 p30 -70.3 -26.56 63.85 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 117.375 0.588 . . . . 72.31 110.694 175.344 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 26.9 m 39.86 42.27 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 126.616 1.966 . . . . 74.13 113.574 176.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 169' ' ' SER . . . . . 0.711 ' HB2' ' HB3' ' B' ' 172' ' ' GLU . 55.7 p -63.51 -32.67 74.2 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-N 115.177 -0.919 . . . . 54.35 111.62 -177.137 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 32.4 m 58.31 88.92 0.06 Allowed 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.817 1.247 . . . . 63.1 111.834 170.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . 77.4 -19.62 0.42 Allowed 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 125.342 1.457 . . . . 53.32 112.299 -178.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 172' ' ' GLU . . . . . 0.711 ' HB3' ' HB2' ' B' ' 169' ' ' SER . 3.0 tm-20 -74.75 103.36 4.99 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 108.823 -0.806 . . . . 73.22 108.823 173.625 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 173' ' ' LEU . . . . . 0.584 ' HG ' ' HG2' ' B' ' 174' ' ' GLN . 2.4 pt? -168.34 -41.08 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 107.594 -1.262 . . . . 74.23 107.594 166.475 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 174' ' ' GLN . . . . . 0.584 ' HG2' ' HG ' ' B' ' 173' ' ' LEU . 27.0 pt20 -172.95 -175.23 1.2 Allowed 'General case' 0 C--O 1.244 0.77 0 C-N-CA 125.251 1.421 . . . . 74.45 108.377 177.399 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 175' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -70.86 -82.21 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 116.021 -0.536 . . . . 74.1 110.21 169.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . 171.91 -42.26 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.123 1.369 . . . . 74.11 108.006 -171.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 16.1 p -139.58 73.46 35.3 Favored Pre-proline 0 CA--C 1.557 1.233 0 C-N-CA 125.141 1.376 . . . . 64.31 108.576 172.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 178' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.85 169.27 22.49 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 122.665 2.244 . . . . 74.53 112.778 -175.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -119.08 21.32 12.4 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.836 0.854 . . . . 61.34 109.57 176.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . 58.37 -79.24 0.02 OUTLIER 'General case' 0 C--N 1.359 1.0 0 C-N-CA 124.953 1.301 . . . . 74.4 110.472 -164.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 181' ' ' LEU . . . . . 0.503 HD22 ' HB3' ' C' ' 136' ' ' ARG . 12.8 tp -162.94 26.61 0.09 Allowed 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.699 0.762 . . . . 62.04 109.505 174.618 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 182' ' ' VAL . . . . . 0.464 HG13 ' HB3' ' C' ' 139' ' ' GLU . 76.7 t -83.44 147.45 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.505 1.122 . . . . 71.31 110.761 -174.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 183' ' ' ALA . . . . . 0.457 ' HB2' HD13 ' C' ' 123' ' ' LEU . . . -134.05 -13.69 2.43 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.54 0.736 . . . . 65.24 112.222 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 55.53 -138.77 1.02 Allowed 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.995 0.918 . . . . 74.15 108.836 -174.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 185' ' ' VAL . . . . . . . . . . . . . 61.0 t -114.76 102.17 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 106.997 -1.483 . . . . 71.33 106.997 158.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 66.6 p 55.79 84.97 0.07 Allowed 'General case' 0 CA--C 1.56 1.364 0 C-N-CA 125.456 1.503 . . . . 51.31 112.798 177.113 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 187' ' ' SER . . . . . . . . . . . . . 64.5 p -116.95 172.48 7.23 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.7 1.2 . . . . 62.14 111.036 -178.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -136.34 152.15 50.35 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.52 0.728 . . . . 71.52 111.358 -179.087 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 189' ' ' LYS . . . . . 0.557 ' H ' ' HG2' ' C' ' 124' ' ' PRO . 55.1 tttp -115.81 116.63 28.36 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.796 1.238 . . . . 72.52 109.633 -174.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 190' ' ' CYS . . . . . . . . . . . . . 8.1 p -99.91 151.39 21.37 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.634 0.774 . . . . 70.33 109.994 174.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -153.85 136.8 15.44 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.225 0.61 . . . . 74.04 110.195 -176.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -93.85 105.62 3.31 Favored Glycine 0 C--N 1.348 1.239 0 CA-C-O 118.79 -1.006 . . . . 64.22 111.201 173.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 193' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -69.17 157.43 61.56 Favored 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 122.593 2.195 . . . . 64.32 112.611 178.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 194' ' ' SER . . . . . . . . . . . . . 32.7 t -73.87 151.48 40.46 Favored 'General case' 0 C--O 1.244 0.802 0 C-N-CA 123.457 0.703 . . . . 24.51 111.132 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 195' ' ' ALA . . . . . . . . . . . . . . . -64.18 105.04 0.82 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.634 0.773 . . . . 74.32 110.889 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 88.4 m -102.11 116.03 31.8 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.91 0.884 . . . . 73.32 109.907 -179.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 30.4 t -108.63 128.59 54.98 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.999 -0.741 . . . . 75.11 108.999 176.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 198' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 55.68 -94.11 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.725 1.21 . . . . 51.12 111.358 176.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 4.3 mmmp? -140.47 -63.25 0.48 Allowed 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 106.79 -1.559 . . . . 74.4 106.79 171.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 200' ' ' CYS . . . . . . . . . . . . . 97.5 m -161.1 73.55 2.63 Favored Pre-proline 0 CA--C 1.562 1.442 0 C-N-CA 125.388 1.475 . . . . 73.31 108.984 173.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 201' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -78.41 -23.49 8.6 Favored 'Trans proline' 0 C--N 1.374 1.891 0 C-N-CA 122.452 2.101 . . . . 71.34 113.039 -175.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . -85.39 93.52 1.84 Allowed Glycine 0 C--N 1.346 1.093 0 CA-C-N 115.88 -0.6 . . . . 63.04 111.701 -178.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 203' ' ' ASN . . . . . 0.424 HD22 ' HB2' ' B' ' 207' ' ' LYS . 2.1 t-20 70.36 7.77 6.35 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 124.922 1.289 . . . . 71.33 112.414 174.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . 59.25 -84.98 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 125.744 1.618 . . . . 74.01 113.389 174.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 205' ' ' LEU . . . . . 0.56 ' H ' HD13 ' B' ' 205' ' ' LEU . 0.0 OUTLIER -110.39 8.83 23.42 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.532 0.733 . . . . 51.03 111.88 -174.488 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 67.14 118.52 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.396 1.078 . . . . 62.32 111.192 -173.139 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 207' ' ' LYS . . . . . 0.424 ' HB2' HD22 ' B' ' 203' ' ' ASN . 9.6 mtpm? -123.79 34.25 5.12 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.796 1.239 . . . . 74.32 110.493 -174.011 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . -67.94 80.67 0.19 Allowed Glycine 0 C--N 1.357 1.707 0 O-C-N 123.385 0.428 . . . . 71.52 114.167 -174.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 209' ' ' GLY . . . . . 0.634 ' HA2' HG23 ' B' ' 129' ' ' THR . . . -120.7 68.98 0.4 Allowed Glycine 0 C--N 1.342 0.886 0 N-CA-C 112.006 -0.437 . . . . 42.21 112.006 -175.261 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 210' ' ' LYS . . . . . 0.558 ' HE2' ' HA ' ' B' ' 125' ' ' ALA . 3.4 mptp? -72.83 -28.3 62.46 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.768 0.827 . . . . 74.51 110.937 -174.418 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . -153.43 -168.48 17.27 Favored Glycine 0 C--O 1.248 0.982 0 N-CA-C 110.136 -1.186 . . . . 74.43 110.136 175.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 212' ' ' SER . . . . . 0.437 ' HA ' ' OD1' ' B' ' 139' ' ' ASN . 67.5 m 58.18 31.74 21.14 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.47 0.708 . . . . 74.04 111.902 -179.197 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 24.8 pt -68.57 -36.26 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 CA-C-N 115.984 -0.553 . . . . 64.4 110.475 -179.023 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 214' ' ' THR . . . . . 0.511 HG22 ' HG3' ' B' ' 215' ' ' GLU . 6.8 m 57.56 -77.46 0.02 OUTLIER 'General case' 0 C--N 1.36 1.056 0 C-N-CA 126.194 1.798 . . . . 75.43 111.702 -176.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 215' ' ' GLU . . . . . 0.511 ' HG3' HG22 ' B' ' 214' ' ' THR . 0.0 OUTLIER -174.22 -25.26 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 126.029 1.732 . . . . 73.31 109.044 178.393 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 216' ' ' GLN . . . . . 0.416 HE21 ' HG2' ' B' ' 149' ' ' LYS . 8.9 tt0 62.68 79.65 0.25 Allowed 'General case' 0 C--N 1.359 1.018 0 C-N-CA 125.685 1.594 . . . . 61.42 110.824 177.484 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 217' ' ' LEU . . . . . 0.535 ' HA ' ' HB2' ' B' ' 221' ' ' ARG . 0.0 OUTLIER -59.54 -29.3 67.81 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 115.007 -0.997 . . . . 75.4 113.664 -176.557 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 218' ' ' LEU . . . . . 0.544 HD21 ' HB3' ' B' ' 157' ' ' MET . 2.6 mm? -62.73 -38.97 92.59 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.525 0.33 . . . . 71.43 110.821 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -103.78 86.77 2.66 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.181 0.592 . . . . 71.24 110.456 -173.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . 72.05 7.99 5.87 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.94 1.296 . . . . 61.1 114.382 168.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 221' ' ' ARG . . . . . 0.535 ' HB2' ' HA ' ' B' ' 217' ' ' LEU . 7.8 mpt_? -110.46 6.03 21.8 Favored 'General case' 0 N--CA 1.499 2.002 0 CA-C-N 118.472 0.578 . . . . 73.55 111.241 173.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -162.81 -47.54 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.431 1.092 . . . . 42.52 109.111 175.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 70.4 -53.09 0.65 Allowed 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 126.968 2.107 . . . . 61.02 114.2 170.409 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 11.4 p -64.95 -16.02 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 124.681 1.192 . . . . 74.2 112.336 177.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 225' ' ' THR . . . . . 0.426 HG21 HD23 ' B' ' 217' ' ' LEU . 23.8 p -66.53 87.55 0.12 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.725 0.81 . . . . 54.34 111.443 177.074 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 8.5 tt -81.71 105.75 13.1 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-N 115.119 -0.946 . . . . 74.43 108.501 176.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . -173.54 64.6 0.12 Allowed Glycine 0 C--N 1.342 0.869 0 CA-C-N 115.775 -0.648 . . . . 51.31 111.545 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . -76.88 90.57 0.98 Allowed Glycine 0 C--N 1.342 0.897 0 N-CA-C 111.491 -0.643 . . . . 72.41 111.491 177.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -155.5 169.2 33.33 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-O 121.044 0.247 . . . . 70.24 113.624 -176.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -99.63 69.12 1.6 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.039 0.936 . . . . 70.23 110.288 -176.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 231' ' ' LYS . . . . . 0.587 ' HD2' ' HB2' ' B' ' 132' ' ' SER . 31.5 tttp 67.72 9.58 7.18 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 125.387 1.475 . . . . 73.24 113.015 173.078 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -93.31 169.91 10.02 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.009 0.524 . . . . 74.24 110.274 -172.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -69.26 -91.45 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.496 0.718 . . . . 70.41 112.52 -168.405 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -150.19 21.27 0.86 Allowed 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 118.723 0.692 . . . . 72.31 112.557 -168.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 235' ' ' GLU . . . . . 0.683 ' HB2' ' HA2' ' B' ' 162' ' ' GLY . 12.8 mp0 -74.21 127.85 34.03 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.23 0.612 . . . . 54.41 109.869 -173.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 236' ' ' THR . . . . . . . . . . . . . 26.2 m -114.61 -79.69 0.59 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.311 0.644 . . . . 73.34 109.529 -178.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -83.72 89.56 7.17 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.08 0.552 . . . . 71.12 111.125 -172.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 238' ' ' THR . . . . . 0.461 HG22 HG23 ' C' ' 219' ' ' VAL . 6.9 m -75.62 -16.56 60.2 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-N 115.594 -0.73 . . . . 71.31 110.197 172.137 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 239' ' ' ALA . . . . . 0.658 ' HB2' ' HA ' ' C' ' 221' ' ' VAL . . . -60.79 -177.09 0.07 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.032 1.333 . . . . 74.42 114.117 -178.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . -103.21 -95.48 2.33 Favored Glycine 0 C--N 1.341 0.837 0 N-CA-C 110.32 -1.112 . . . . 71.23 110.32 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -166.07 157.12 13.29 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.506 0.723 . . . . 71.21 110.789 -179.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -170.58 -69.37 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.17 0.988 . . . . 70.32 109.971 174.46 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -136.74 -6.97 1.91 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.389 1.076 . . . . 74.22 110.505 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 142.74 -163.79 27.21 Favored Glycine 0 C--N 1.352 1.468 0 N-CA-C 113.472 0.149 . . . . 63.11 113.472 174.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -167.48 131.33 1.79 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.322 1.049 . . . . 75.34 109.526 -174.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 246' ' ' THR . . . . . 0.537 ' HB ' ' HG ' ' B' ' 247' ' ' LEU . 0.6 OUTLIER -163.15 151.39 13.82 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 112.848 0.684 . . . . 71.02 112.848 -179.626 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 247' ' ' LEU . . . . . 0.537 ' HG ' ' HB ' ' B' ' 246' ' ' THR . 85.2 mt 75.44 154.02 0.15 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 126.585 1.954 . . . . 72.51 115.374 159.254 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 248' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.98 60.84 0.13 Allowed 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 106.082 -1.821 . . . . 75.15 106.082 -177.019 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -77.22 163.93 26.08 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 113.638 0.977 . . . . 71.33 113.638 -163.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -115.45 175.71 5.4 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 114.58 -1.191 . . . . 65.4 112.491 -167.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 251' ' ' ALA . . . . . 0.555 ' HB1' ' HB3' ' B' ' 254' ' ' ARG . . . -138.11 94.04 2.83 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.59 1.156 . . . . 61.03 108.217 175.067 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -58.01 -32.19 67.69 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 114.068 1.136 . . . . 72.3 114.068 -170.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -154.08 7.26 0.33 Allowed 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.261 0.624 . . . . 51.41 110.772 175.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 254' ' ' ARG . . . . . 0.555 ' HB3' ' HB1' ' B' ' 251' ' ' ALA . 0.0 OUTLIER -80.14 102.37 9.34 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 109.013 -0.736 . . . . 72.51 109.013 -173.114 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . 90.51 71.54 1.23 Allowed Glycine 0 C--N 1.35 1.345 0 O-C-N 123.823 0.702 . . . . 54.22 111.408 -177.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 256' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -155.25 -48.48 0.08 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.28 0.632 . . . . 52.52 110.114 -175.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 257' ' ' GLN . . . . . 0.567 ' HG3' ' HG ' ' B' ' 258' ' ' LEU . 8.7 tp-100 63.86 -83.29 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.923 1.289 . . . . 74.31 109.702 -171.33 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 258' ' ' LEU . . . . . 0.567 ' HG ' ' HG3' ' B' ' 257' ' ' GLN . 3.3 pp -159.67 -8.15 0.06 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.531 1.132 . . . . 75.13 110.636 175.541 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 259' ' ' VAL . . . . . 0.554 HG23 ' H ' ' B' ' 260' ' ' SER . 5.6 m -87.62 -70.41 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 C-N-CA 123.452 0.701 . . . . 63.02 111.772 -174.443 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 260' ' ' SER . . . . . 0.554 ' H ' HG23 ' B' ' 259' ' ' VAL . 74.9 m -167.38 -56.0 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.355 1.062 . . . . 73.11 109.748 -174.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -144.78 -71.54 0.27 Allowed 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 114.58 -1.191 . . . . 52.21 108.839 -167.402 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 262' ' ' ALA . . . . . 0.428 ' HB1' ' H ' ' B' ' 280' ' ' LEU . . . 64.87 7.36 3.88 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.754 1.222 . . . . 43.43 113.392 178.151 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -109.76 -30.6 7.79 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.788 0.835 . . . . 70.44 112.036 -171.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 78.7 p -58.64 -50.34 74.22 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.124 0.97 . . . . 51.14 113.384 -167.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 265' ' ' LEU . . . . . 0.437 HD12 ' HB3' ' B' ' 280' ' ' LEU . 95.9 mt -59.94 -38.21 81.78 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.196 0.598 . . . . 64.12 112.006 -176.193 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 266' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -66.19 -29.52 69.81 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 115.749 -0.66 . . . . 71.52 110.581 176.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 267' ' ' SER . . . . . 0.481 ' HA ' ' HG3' ' C' ' 260' ' ' ARG . 49.5 m -89.44 -26.88 20.73 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.111 0.964 . . . . 73.13 112.642 -177.007 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 268' ' ' VAL . . . . . 0.503 HG12 HG23 ' B' ' 269' ' ' THR . 41.0 t -77.48 -48.75 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 123.576 0.75 . . . . 74.44 110.257 -178.089 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 269' ' ' THR . . . . . 0.503 HG23 HG12 ' B' ' 268' ' ' VAL . 36.7 p -119.69 -172.9 2.42 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.667 0.787 . . . . 74.31 110.703 -176.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 270' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 79.28 -53.97 0.43 Allowed 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 126.216 1.806 . . . . 72.41 112.949 172.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 271' ' ' ALA . . . . . . . . . . . . . . . 75.55 -13.41 0.87 Allowed 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 125.173 1.389 . . . . 75.3 114.158 175.1 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 272' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -172.53 -168.68 0.54 Allowed 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 118.446 0.566 . . . . 54.14 111.415 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 72.31 43.53 0.49 Allowed 'General case' 0 C--N 1.364 1.206 0 C-N-CA 125.662 1.585 . . . . 61.32 109.502 -177.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 62.84 -79.4 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 125.216 1.407 . . . . 71.44 111.064 -177.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 275' ' ' LYS . . . . . . . . . . . . . 25.3 mmtp 58.39 73.54 0.72 Allowed Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 124.312 1.045 . . . . 71.33 109.634 -176.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.53 157.31 51.76 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 123.103 2.536 . . . . 62.35 113.36 -178.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 277' ' ' LEU . . . . . . . . . . . . . 1.5 pp -86.38 35.98 0.68 Allowed 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 115.126 -0.943 . . . . 63.32 110.965 177.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 61.7 tp -65.35 -52.43 53.79 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.137 1.375 . . . . 62.0 110.875 -173.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . -171.46 72.43 0.11 Allowed Glycine 0 C--N 1.339 0.721 0 CA-C-N 114.77 -1.105 . . . . 75.43 110.465 -177.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 280' ' ' LEU . . . . . 0.676 ' HG ' ' HB2' ' B' ' 120' ' ' TYR . 3.7 mm? 72.45 -66.99 0.28 Allowed 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 125.697 1.599 . . . . 53.23 110.97 178.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 281' ' ' PHE . . . . . 0.4 ' HA ' ' HB2' ' B' ' 286' ' ' MET . 14.3 t80 58.91 -164.67 0.2 Allowed 'General case' 0 CA--C 1.566 1.59 0 C-N-CA 124.712 1.205 . . . . 75.31 111.804 170.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . 76.48 -74.07 0.08 Allowed 'General case' 0 C--N 1.361 1.074 0 C-N-CA 125.304 1.441 . . . . 65.41 111.522 167.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -146.01 -15.42 0.46 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.626 0.77 . . . . 72.33 110.666 -175.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . -73.83 -91.66 0.14 Allowed Glycine 0 C--N 1.356 1.647 0 C-N-CA 123.108 0.385 . . . . 61.45 113.937 -172.037 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -86.17 -35.51 20.07 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 117.095 0.448 . . . . 72.41 110.8 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 286' ' ' MET . . . . . 0.4 ' HB2' ' HA ' ' B' ' 281' ' ' PHE . 89.7 mtp -110.83 97.6 34.34 Favored Pre-proline 0 N--CA 1.475 0.807 0 C-N-CA 123.92 0.888 . . . . 64.1 108.769 177.296 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 287' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -76.44 82.88 2.15 Favored 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 122.475 2.117 . . . . 73.33 111.265 174.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 288' ' ' VAL . . . . . . . . . . . . . 11.5 p -76.19 157.49 5.64 Favored 'Isoleucine or valine' 0 C--O 1.243 0.719 0 CA-C-N 115.441 -0.799 . . . . 74.32 109.001 173.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 289' ' ' ARG . . . . . . . . . . . . . 63.1 mtp180 -63.71 132.98 52.72 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 109.974 -0.38 . . . . 72.14 109.974 176.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 290' ' ' TRP . . . . . . . . . . . . . 2.6 m-90 -86.69 4.1 42.04 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 115.356 -0.838 . . . . 75.34 112.441 -166.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 291' ' ' LEU . . . . . . . . . . . . . 28.9 tp 71.21 -71.56 0.13 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.975 1.71 . . . . 64.34 111.044 -176.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . -167.55 -62.26 0.03 OUTLIER Glycine 0 CA--C 1.534 1.244 0 CA-C-O 119.06 -0.856 . . . . 62.12 113.075 -174.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -55.95 -47.88 22.67 Favored 'Trans proline' 0 C--N 1.383 2.392 0 C-N-CA 123.624 2.883 . . . . 51.12 113.697 -175.116 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 6.0 tmtm? 57.44 -80.92 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 125.656 1.583 . . . . 41.23 111.16 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -81.25 12.95 3.14 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.735 0.814 . . . . 34.32 112.272 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 11.3 m 78.75 34.39 0.24 Allowed 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 125.697 1.599 . . . . 65.42 111.314 175.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 82.8 t80 60.37 99.33 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 124.356 1.062 . . . . 64.12 112.693 169.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 67.8 m-70 -125.88 114.81 19.03 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.774 0.83 . . . . 71.5 108.855 176.116 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . -163.4 21.56 0.17 Allowed Glycine 0 C--N 1.341 0.847 0 CA-C-O 119.768 -0.462 . . . . 63.41 113.379 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -64.87 -24.46 67.54 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.341 0.656 . . . . 72.23 111.188 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 301' ' ' ILE . . . . . . . . . . . . . 48.6 mm 68.93 -75.42 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.207 0 C-N-CA 125.608 1.563 . . . . 72.24 109.601 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -173.87 -47.77 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.648 1.179 . . . . 63.41 107.952 170.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 303' ' ' LYS . . . . . . . . . . . . . 24.3 tptp -177.32 115.49 0.25 Allowed Pre-proline 0 CA--C 1.547 0.828 0 N-CA-C 107.442 -1.318 . . . . 74.11 107.442 -176.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 304' ' ' PRO . . . . . 0.556 ' HB2' ' NE2' ' A' ' 191' ' ' GLN . 42.4 Cg_exo -56.33 -34.33 93.75 Favored 'Trans proline' 0 C--N 1.386 2.514 0 C-N-CA 122.881 2.388 . . . . 75.12 112.579 -177.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 305' ' ' ALA . . . . . 0.598 ' HB1' ' HB ' ' B' ' 309' ' ' THR . . . -153.87 136.13 14.88 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.065 -1.087 . . . . 42.33 108.065 168.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 58.1 t -54.43 -70.57 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 124.314 1.046 . . . . 72.33 111.731 -170.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 307' ' ' THR . . . . . 0.418 ' HA ' ' HG2' ' A' ' 189' ' ' GLU . 39.1 m -148.73 -60.98 0.24 Allowed 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 120.987 0.422 . . . . 74.23 110.447 -175.338 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 308' ' ' CYS . . . . . . . . . . . . . 42.1 t -127.06 36.73 4.39 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.682 0.793 . . . . 74.22 109.146 176.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 309' ' ' THR . . . . . 0.598 ' HB ' ' HB1' ' B' ' 305' ' ' ALA . 9.0 m -65.86 -44.85 64.0 Favored Pre-proline 0 CA--C 1.571 1.767 0 CA-C-N 115.003 -0.999 . . . . 72.2 111.723 177.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 310' ' ' PRO . . . . . 0.475 ' HD3' ' HB1' ' B' ' 305' ' ' ALA . 48.6 Cg_endo -92.72 160.38 2.83 Favored 'Trans proline' 0 C--N 1.391 2.814 0 C-N-CA 121.87 1.713 . . . . 63.14 112.282 171.124 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 311' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -81.81 157.91 68.64 Favored Pre-proline 0 CA--C 1.549 0.911 0 N-CA-C 107.891 -1.152 . . . . 73.13 107.891 167.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 312' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -71.6 125.91 11.62 Favored 'Trans proline' 0 C--N 1.363 1.327 0 C-N-CA 121.759 1.639 . . . . 70.14 111.476 173.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 313' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -85.75 4.23 37.75 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.468 0.707 . . . . 75.13 111.031 179.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 314' ' ' ARG . . . . . 0.556 ' HG3' ' HB3' ' A' ' 150' ' ' PRO . 9.4 mpt_? 61.8 -164.48 0.24 Allowed 'General case' 0 C--N 1.373 1.606 0 C-N-CA 124.763 1.225 . . . . 72.01 109.91 -176.056 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 315' ' ' ASN . . . . . 0.741 ' HB2' ' HB2' ' A' ' 151' ' ' PRO . 1.6 m120 -146.07 151.81 38.32 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.411 0.684 . . . . 72.12 109.309 165.441 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 316' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -127.85 172.6 10.71 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 107.223 -1.399 . . . . 74.4 107.223 175.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 100.0 p 54.98 52.34 12.03 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.532 1.133 . . . . 75.41 110.947 -174.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 318' ' ' VAL . . . . . 0.468 ' N ' ' HD2' ' B' ' 319' ' ' PRO . 25.4 m -69.78 -22.55 0.65 Allowed Pre-proline 0 CA--C 1.568 1.64 0 N-CA-C 115.207 1.558 . . . . 73.13 115.207 -173.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 319' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' B' ' 318' ' ' VAL . 10.7 Cg_endo -55.53 -33.11 85.39 Favored 'Trans proline' 0 C--N 1.403 3.412 0 CA-C-N 122.784 2.03 . . . . 65.1 112.375 166.465 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 320' ' ' THR . . . . . . . . . . . . . 41.3 m 62.21 -79.34 0.03 OUTLIER 'General case' 0 C--N 1.359 0.985 0 C-N-CA 124.892 1.277 . . . . 53.31 111.25 179.131 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 321' ' ' LEU . . . . . . . . . . . . . 49.7 tp -103.58 83.86 2.21 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 108.324 -0.991 . . . . 65.14 108.324 175.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 322' ' ' ALA . . . . . . . . . . . . . . . -82.33 -30.24 30.55 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 115.778 -0.646 . . . . 64.54 110.484 177.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 323' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -119.23 101.01 7.68 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.251 1.02 . . . . 74.02 110.529 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 324' ' ' MET . . . . . . . . . . . . . 23.7 ptp -105.96 15.98 25.75 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.944 0.898 . . . . 71.32 109.884 171.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 325' ' ' THR . . . . . . . . . . . . . 3.5 m 62.07 28.81 17.4 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.711 1.204 . . . . 72.33 110.251 -174.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 326' ' ' ASP . . . . . . . . . . . . . 36.7 t70 64.1 -73.01 0.05 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.308 1.443 . . . . 72.01 109.788 -171.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -87.62 133.4 33.82 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 107.899 -1.149 . . . . 54.34 107.899 168.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 328' ' ' ALA . . . . . . . . . . . . . . . -64.42 -57.6 8.83 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.854 0.462 . . . . 72.03 110.746 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 329' ' ' ILE . . . . . 0.604 ' HB ' ' HB3' ' B' ' 431' ' ' SER . 4.0 mp -123.93 -68.35 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 107.985 -1.117 . . . . 73.5 107.985 172.39 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 330' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 72.45 -38.02 0.41 Allowed 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 125.807 1.643 . . . . 63.42 113.047 -175.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 331' ' ' LEU . . . . . . . . . . . . . 33.6 tp -55.84 -38.94 70.73 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.443 1.097 . . . . 63.34 112.305 -178.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 332' ' ' LEU . . . . . 0.503 ' HG ' HG21 ' B' ' 329' ' ' ILE . 96.9 mt -72.71 -10.87 60.3 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 113.196 0.813 . . . . 74.41 113.196 -178.171 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 333' ' ' SER . . . . . . . . . . . . . 10.4 t -67.28 112.48 4.55 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 122.992 0.517 . . . . 65.04 109.84 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -166.46 -155.29 0.2 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.725 1.21 . . . . 63.11 108.203 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 335' ' ' ASN . . . . . . . . . . . . . 52.3 t30 86.38 -47.21 0.05 Allowed 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 125.366 1.466 . . . . 73.25 111.439 176.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.29 -23.3 62.3 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 124.153 0.981 . . . . 61.02 112.702 -175.122 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 337' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -59.56 -39.18 83.19 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.58 1.152 . . . . 62.43 110.836 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 338' ' ' GLY . . . . . . . . . . . . . . . 150.17 33.77 0.04 OUTLIER Glycine 0 C--N 1.348 1.237 0 C-N-CA 121.645 -0.312 . . . . 72.34 113.548 176.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 339' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -91.77 89.29 7.02 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 122.935 0.494 . . . . 74.33 109.852 -178.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 340' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -88.76 174.63 7.89 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.524 0.73 . . . . 75.24 111.304 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 341' ' ' LEU . . . . . . . . . . . . . 54.9 tp -71.84 105.73 3.91 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 124.308 1.043 . . . . 75.34 110.792 -175.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 342' ' ' GLN . . . . . . . . . . . . . 48.1 tp60 -95.98 -40.08 9.45 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.121 0.968 . . . . 64.25 111.534 -178.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 343' ' ' VAL . . . . . . . . . . . . . 59.6 t -64.09 -24.23 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 123.443 0.697 . . . . 64.24 111.469 -175.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -134.98 143.47 46.85 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 108.682 -0.858 . . . . 73.03 108.682 178.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 345' ' ' GLY . . . . . . . . . . . . . . . -166.25 106.15 0.26 Allowed Glycine 0 C--N 1.353 1.515 0 CA-C-O 119.395 -0.67 . . . . 62.31 111.686 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 346' ' ' ALA . . . . . . . . . . . . . . . 65.98 11.29 7.62 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 124.785 1.234 . . . . 72.22 113.164 175.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 14.0 m -99.06 0.81 44.47 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.274 1.029 . . . . 72.21 110.844 -178.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 70.2 mt 67.91 -77.35 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 125.964 1.706 . . . . 73.42 110.801 -177.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 349' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -72.01 -83.31 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.21 0.604 . . . . 71.13 110.41 -176.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 350' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -139.36 146.53 40.34 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.97 0.908 . . . . 74.52 108.803 177.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -97.5 136.5 37.84 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 108.0 -1.111 . . . . 71.32 108.0 170.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 26.6 t70 76.2 -59.43 0.51 Allowed 'General case' 0 CA--C 1.55 0.967 0 O-C-N 124.713 1.258 . . . . 74.35 111.106 179.08 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 353' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -86.03 164.69 17.2 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.473 0.709 . . . . 74.33 111.64 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 354' ' ' ALA . . . . . . . . . . . . . . . 64.95 8.5 4.71 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 124.546 1.139 . . . . 70.11 112.871 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 355' ' ' ALA . . . . . . . . . . . . . . . -92.76 5.95 49.31 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.039 0.935 . . . . 75.44 110.759 174.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 356' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -63.94 -45.04 80.48 Favored Pre-proline 0 CA--C 1.554 1.099 0 C-N-CA 125.049 1.34 . . . . 74.32 112.667 -178.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 357' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -68.08 -17.09 45.74 Favored 'Trans proline' 0 C--N 1.388 2.609 0 C-N-CA 121.899 1.733 . . . . 55.22 112.714 171.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 358' ' ' CYS . . . . . . . . . . . . . 56.9 m 65.5 18.39 11.26 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.721 1.209 . . . . 73.32 111.698 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 359' ' ' GLY . . . . . . . . . . . . . . . 65.02 -86.78 0.08 OUTLIER Glycine 0 C--N 1.353 1.474 0 N-CA-C 111.302 -0.719 . . . . 62.01 111.302 -172.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 360' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -79.49 93.97 5.51 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 108.966 -0.753 . . . . 53.34 108.966 174.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 361' ' ' ILE . . . . . 0.41 HG23 ' H ' ' B' ' 363' ' ' GLU . 7.9 tp -86.54 -20.56 7.74 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.227 0 C-N-CA 124.1 0.96 . . . . 61.31 110.264 177.156 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 362' ' ' GLY . . . . . . . . . . . . . . . 118.29 -10.78 13.04 Favored Glycine 0 C--N 1.347 1.192 0 CA-C-N 116.089 -0.505 . . . . 72.35 112.52 -178.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 363' ' ' GLU . . . . . 0.41 ' H ' HG23 ' B' ' 361' ' ' ILE . 20.3 mm-40 -81.25 97.48 7.66 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.333 0.653 . . . . 73.13 109.466 179.183 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 364' ' ' THR . . . . . . . . . . . . . 26.7 p -103.81 93.73 5.05 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.25 1.02 . . . . 74.04 110.758 -176.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 97.9 t -101.26 -56.67 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 N-CA-C 108.457 -0.942 . . . . 74.01 108.457 175.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -128.64 158.3 38.91 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 107.931 -1.137 . . . . 50.12 107.931 177.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 367' ' ' LEU . . . . . . . . . . . . . 81.4 mt -112.93 22.05 14.82 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.114 0.966 . . . . 75.05 110.607 178.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 368' ' ' ASP . . . . . 0.561 ' HA ' HG12 ' B' ' 371' ' ' VAL . 11.0 p-10 -69.0 -10.11 55.86 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 113.932 1.086 . . . . 71.23 113.932 -175.01 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 369' ' ' GLU . . . . . 0.466 ' HA ' ' NH1' ' B' ' 373' ' ' ARG . 16.9 tp10 -97.66 12.23 34.33 Favored 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 123.587 0.755 . . . . 70.1 110.542 177.48 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 370' ' ' ALA . . . . . . . . . . . . . . . -147.84 -23.84 0.36 Allowed 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 112.751 0.649 . . . . 74.25 112.751 178.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 371' ' ' VAL . . . . . 0.561 HG12 ' HA ' ' B' ' 368' ' ' ASP . 7.3 p -60.78 -66.55 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.333 0 N-CA-C 112.967 0.729 . . . . 74.11 112.967 -167.332 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 372' ' ' GLN . . . . . 0.434 ' H ' HG13 ' B' ' 371' ' ' VAL . 0.3 OUTLIER -175.6 107.32 0.09 Allowed 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 108.67 -0.863 . . . . 63.2 108.67 -174.117 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 373' ' ' ARG . . . . . 0.466 ' NH1' ' HA ' ' B' ' 369' ' ' GLU . 1.9 mpp_? -119.99 -11.37 9.3 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 123.219 0.608 . . . . 72.05 111.32 174.323 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . 73.85 -55.59 0.66 Allowed 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 125.883 1.673 . . . . 71.45 112.223 -175.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 375' ' ' LEU . . . . . 0.477 HD12 ' HG2' ' A' ' 263' ' ' PRO . 8.4 tt 75.77 -7.18 1.85 Allowed 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 125.228 1.411 . . . . 62.01 111.395 178.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -69.89 81.18 0.47 Allowed 'General case' 0 C--N 1.357 0.897 0 CA-C-O 121.969 0.89 . . . . 73.13 109.579 173.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 377' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -163.37 -44.35 0.03 OUTLIER 'General case' 0 C--O 1.224 -0.272 0 CA-C-N 113.92 -1.491 . . . . 73.31 107.933 -175.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 378' ' ' ALA . . . . . 0.484 ' HA ' ' HB3' ' B' ' 381' ' ' GLU . . . -55.51 -24.48 31.89 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 124.741 1.216 . . . . 61.1 113.249 -178.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -65.37 -51.57 59.58 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.882 0.873 . . . . 72.01 110.36 175.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 380' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -84.84 -15.28 45.3 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.66 0.784 . . . . 53.14 110.86 -178.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 381' ' ' GLU . . . . . 0.484 ' HB3' ' HA ' ' B' ' 378' ' ' ALA . 23.9 tt0 -72.06 -34.47 68.76 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.399 1.08 . . . . 74.34 109.999 175.234 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 382' ' ' GLY . . . . . 0.443 ' HA2' HG23 ' B' ' 403' ' ' THR . . . -73.82 66.39 1.75 Allowed Glycine 0 C--N 1.345 1.079 0 N-CA-C 111.666 -0.574 . . . . 73.1 111.666 176.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 383' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -73.87 -46.14 46.61 Favored 'General case' 0 C--N 1.351 0.633 0 C-N-CA 123.988 0.915 . . . . 73.1 109.368 -176.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 384' ' ' THR . . . . . . . . . . . . . 5.2 m 69.63 1.13 3.24 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 124.442 1.097 . . . . 63.41 112.473 173.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 1.3 pp -100.99 165.04 11.53 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.692 0.797 . . . . 75.12 111.728 -177.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 386' ' ' VAL . . . . . . . . . . . . . 10.0 p -94.74 27.41 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 C-N-CA 124.352 1.061 . . . . 62.42 109.884 -179.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 387' ' ' ILE . . . . . . . . . . . . . 48.8 mm 72.49 -66.34 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 126.418 1.887 . . . . 74.12 110.767 -171.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 388' ' ' VAL . . . . . . . . . . . . . 90.4 t 75.31 -49.56 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 C-N-CA 125.564 1.546 . . . . 54.33 111.464 -178.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 389' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 78.58 -12.09 1.13 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 126.914 2.086 . . . . 71.25 113.193 173.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . 53.11 73.74 0.34 Allowed 'General case' 0 C--N 1.363 1.164 0 C-N-CA 124.406 1.082 . . . . 70.34 111.352 176.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 391' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 68.48 -76.3 0.06 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.153 1.381 . . . . 64.12 110.628 -172.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 392' ' ' HIS . . . . . . . . . . . . . 30.1 p-80 -157.1 16.77 0.28 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.013 0.925 . . . . 72.42 110.859 -177.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -68.17 -55.98 10.41 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.552 0.741 . . . . 61.53 110.837 -175.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 44.0 t-80 68.41 -71.47 0.11 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 126.126 1.77 . . . . 73.31 111.579 179.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . 54.42 -100.57 0.11 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.315 1.046 . . . . 71.44 109.308 -169.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 16.5 m 63.71 -17.79 0.07 Allowed 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 124.947 1.299 . . . . 75.55 114.344 177.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 397' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 62.2 -68.83 0.06 Allowed 'General case' 0 C--N 1.356 0.852 0 C-N-CA 126.591 1.956 . . . . 71.41 111.226 -171.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 20.9 pt -85.59 155.17 3.46 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.209 0 C-N-CA 124.213 1.005 . . . . 75.44 110.639 172.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 399' ' ' VAL . . . . . . . . . . . . . 11.5 p -78.65 -25.62 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 122.553 0.341 . . . . 73.32 110.86 -175.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 400' ' ' ALA . . . . . . . . . . . . . . . -123.31 83.3 52.19 Favored Pre-proline 0 CA--C 1.557 1.219 0 C-N-CA 124.017 0.927 . . . . 51.41 110.247 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 401' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -69.78 -52.82 0.3 Allowed 'Trans proline' 0 C--N 1.386 2.552 0 C-N-CA 122.818 2.345 . . . . 71.04 111.868 176.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 402' ' ' ASP . . . . . 0.409 ' HB3' ' HD3' ' A' ' 260' ' ' ARG . 6.6 t70 59.15 -179.64 0.08 Allowed 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 125.128 1.371 . . . . 74.34 112.478 174.027 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 403' ' ' THR . . . . . 0.443 HG23 ' HA2' ' B' ' 382' ' ' GLY . 85.8 m -147.61 106.22 3.8 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.992 0.917 . . . . 51.3 108.968 172.185 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 404' ' ' LYS . . . . . 0.421 ' HE2' ' HB1' ' C' ' 275' ' ' ALA . 24.6 tptp -84.89 -29.81 24.93 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 122.699 0.4 . . . . 70.03 109.997 177.094 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 405' ' ' ALA . . . . . . . . . . . . . . . -50.3 105.6 0.54 Allowed Pre-proline 0 CA--C 1.558 1.262 0 C-N-CA 124.727 1.211 . . . . 71.24 112.286 -177.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 406' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -72.1 1.33 6.07 Favored 'Trans proline' 0 C--N 1.384 2.413 0 C-N-CA 123.281 2.654 . . . . 44.44 114.224 -174.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . -74.36 -24.9 71.94 Favored Glycine 0 C--N 1.344 1.016 0 N-CA-C 111.957 -0.457 . . . . 55.33 111.957 169.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 408' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -105.94 26.78 9.25 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.283 1.033 . . . . 72.03 109.993 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 9.5 t -64.41 -25.32 67.96 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 124.195 0.998 . . . . 73.52 112.827 -178.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 410' ' ' GLN . . . . . . . . . . . . . 71.0 mm-40 67.33 -77.27 0.05 OUTLIER 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.609 1.564 . . . . 51.32 110.362 -174.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . 60.45 -76.84 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 125.3 1.44 . . . . 63.14 112.435 174.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 5.8 mp -64.5 -37.58 88.04 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.195 0.998 . . . . 60.41 110.09 178.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -76.99 85.2 3.51 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.103 -0.953 . . . . 71.14 109.012 175.118 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 414' ' ' THR . . . . . . . . . . . . . 12.9 p -98.52 82.15 2.82 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.067 0.947 . . . . 73.24 108.879 174.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 415' ' ' LYS . . . . . . . . . . . . . 5.0 ttmp? -133.25 -44.01 0.85 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.521 0.728 . . . . 73.42 109.867 -175.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 70.43 138.28 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.968 1.707 . . . . 75.33 111.5 -177.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 417' ' ' GLY . . . . . . . . . . . . . . . -65.82 -36.53 92.32 Favored Glycine 0 C--N 1.346 1.126 0 N-CA-C 110.663 -0.975 . . . . 43.15 110.663 169.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 418' ' ' ALA . . . . . . . . . . . . . . . -139.27 114.5 9.64 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.091 0.957 . . . . 70.25 108.481 171.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 419' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.5 140.89 18.96 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 C-N-CA 123.668 0.787 . . . . 62.03 109.487 175.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 420' ' ' MET . . . . . 0.476 ' SD ' ' N ' ' B' ' 421' ' ' VAL . 9.5 tmm? 72.66 153.97 0.14 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 124.813 1.245 . . . . 73.12 109.111 -169.313 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 421' ' ' VAL . . . . . 0.656 HG21 ' HG2' ' A' ' 211' ' ' ARG . 15.9 m -67.96 91.2 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.331 0 CA-C-O 122.115 0.96 . . . . 72.42 112.63 -174.559 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 422' ' ' MET . . . . . . . . . . . . . 13.6 tpt -63.6 -48.99 75.11 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 115.175 -0.921 . . . . 74.1 108.67 166.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 423' ' ' SER . . . . . . . . . . . . . 46.2 m -148.8 -57.02 0.21 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 107.282 -1.377 . . . . 62.22 107.282 170.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 424' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -140.51 107.63 5.47 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.49 1.116 . . . . 72.42 108.407 172.023 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . -171.12 152.36 18.08 Favored Glycine 0 C--N 1.344 0.987 0 N-CA-C 110.787 -0.925 . . . . 75.12 110.787 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 426' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 64.53 87.77 0.11 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.717 1.207 . . . . 75.43 111.012 -177.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 427' ' ' SER . . . . . . . . . . . . . 34.6 p -74.09 86.88 1.87 Allowed 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 115.213 -0.903 . . . . 75.14 110.925 -176.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 58.56 28.0 16.45 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 125.197 1.399 . . . . 73.23 112.385 175.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 429' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 62.39 -89.76 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 124.718 1.207 . . . . 63.42 110.738 -172.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 18.5 t70 177.12 -86.93 0.0 OUTLIER 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.176 1.39 . . . . 55.41 108.102 -174.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 431' ' ' SER . . . . . 0.604 ' HB3' ' HB ' ' B' ' 329' ' ' ILE . 51.4 m -167.68 10.88 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 124.452 1.101 . . . . 73.31 111.564 -174.243 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 432' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -71.9 -49.34 38.72 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.387 0.675 . . . . 71.1 110.882 -173.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 433' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -135.51 -40.92 0.71 Allowed 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.245 -0.889 . . . . 73.43 109.758 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 434' ' ' HIS . . . . . . . . . . . . . 59.6 t-80 66.89 102.54 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.284 1.034 . . . . 65.13 110.68 177.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 435' ' ' THR . . . . . 0.655 HG22 HG12 ' A' ' 219' ' ' VAL . 1.7 m -69.1 -25.47 64.43 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.65 0.78 . . . . 73.42 112.649 -167.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . -66.01 94.72 0.22 Allowed Glycine 0 C--N 1.349 1.283 0 N-CA-C 111.49 -0.644 . . . . 43.54 111.49 174.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 24.9 p -79.93 -85.98 0.08 Allowed 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 123.319 0.648 . . . . 54.14 111.74 -172.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 438' ' ' GLN . . . . . . . . . . . . . 13.9 tm0? -107.74 -76.39 0.61 Allowed 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 108.05 -1.092 . . . . 71.55 108.05 -177.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 439' ' ' LEU . . . . . . . . . . . . . 1.7 pp 34.79 45.58 0.16 Allowed 'General case' 0 N--CA 1.502 2.138 0 C-N-CA 126.347 1.859 . . . . 74.24 114.96 169.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 440' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -75.1 -4.1 36.63 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 115.964 -0.562 . . . . 70.1 112.327 -169.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 441' ' ' ILE . . . . . 0.616 HG22 ' H ' ' B' ' 443' ' ' ALA . 46.2 mm 76.42 -83.87 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 125.355 1.462 . . . . 74.15 111.673 170.274 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 442' ' ' ALA . . . . . . . . . . . . . . . 67.63 2.34 2.95 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 124.654 1.182 . . . . 71.41 114.176 -177.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 443' ' ' ALA . . . . . 0.616 ' H ' HG22 ' B' ' 441' ' ' ILE . . . -89.23 154.6 19.99 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.641 0.776 . . . . 74.21 110.709 178.351 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 65.08 -80.26 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.865 1.266 . . . . 65.34 110.787 -174.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . 168.28 78.72 0.04 OUTLIER Glycine 0 C--N 1.341 0.816 0 N-CA-C 110.717 -0.953 . . . . 74.34 110.717 -177.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 446' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -79.58 0.11 10.28 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 122.544 2.163 . . . . 63.02 111.536 175.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 447' ' ' HIS . . . . . . . . . . . . . 26.9 m80 -123.32 87.8 2.81 Favored 'General case' 0 C--N 1.35 0.623 0 C-N-CA 124.407 1.083 . . . . 60.0 108.453 178.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . -124.72 117.05 23.35 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.963 1.305 . . . . 74.31 109.238 -177.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 449' ' ' ALA . . . . . . . . . . . . . . . 57.82 67.22 0.99 Allowed 'General case' 0 CA--C 1.549 0.906 0 O-C-N 124.207 0.942 . . . . 61.52 110.467 -174.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 450' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -64.11 -68.68 0.33 Allowed 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 114.774 -1.103 . . . . 61.12 111.354 -174.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 46.8 t 62.16 -74.07 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 C-N-CA 125.038 1.335 . . . . 63.1 111.365 -178.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 452' ' ' VAL . . . . . . . . . . . . . 29.8 m -85.49 172.59 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 123.585 0.754 . . . . 60.45 109.786 171.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . -148.18 44.05 0.79 Allowed Glycine 0 N--CA 1.466 0.687 0 N-CA-C 110.924 -0.87 . . . . 73.44 110.924 175.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 454' ' ' LEU . . . . . . . . . . . . . 42.4 tp -146.7 120.39 9.2 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.32 0.648 . . . . 72.5 109.664 -176.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 11.1 t -154.54 13.49 0.42 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.115 0.966 . . . . 61.41 109.753 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -82.22 -19.59 39.41 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.327 1.051 . . . . 74.3 112.65 -165.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 457' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -65.6 154.72 37.95 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.348 0.659 . . . . 42.14 111.114 -179.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 46.8 p -57.76 -26.56 62.04 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.443 1.097 . . . . 72.13 112.855 -178.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 459' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -62.15 -37.76 86.43 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.772 0.829 . . . . 73.31 110.602 174.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 94.1 mt 66.87 99.12 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.497 1.519 . . . . 65.42 110.672 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -76.13 -176.32 3.48 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.675 0.79 . . . . 62.31 110.578 178.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 462' ' ' TYR . . . . . 0.472 ' HB3' ' HA3' ' B' ' 469' ' ' GLY . 39.7 m-85 -74.96 107.48 7.06 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 109.247 -0.649 . . . . 72.53 109.247 174.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 463' ' ' THR . . . . . 0.595 HG22 ' HA ' ' B' ' 470' ' ' LEU . 12.5 t -68.96 -179.35 1.46 Allowed 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 122.95 0.5 . . . . 61.35 111.104 -179.397 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 464' ' ' MET . . . . . . . . . . . . . 21.7 mmt -76.98 20.37 0.26 Allowed 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 123.933 0.893 . . . . 75.31 113.203 -168.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt -80.28 140.26 36.28 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 109.37 -0.604 . . . . 72.15 109.37 169.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -73.79 147.27 43.57 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 122.791 0.436 . . . . 62.32 109.911 170.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . 72.38 111.96 0.06 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.299 1.439 . . . . 75.3 111.825 -178.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 39.3 tp 66.04 -73.37 0.07 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 125.4 1.48 . . . . 45.51 110.724 -177.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 469' ' ' GLY . . . . . 0.472 ' HA3' ' HB3' ' B' ' 462' ' ' TYR . . . 142.73 -96.13 0.19 Allowed Glycine 0 C--N 1.345 1.058 0 N-CA-C 112.202 -0.359 . . . . 50.44 112.202 172.467 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 470' ' ' LEU . . . . . 0.595 ' HA ' HG22 ' B' ' 463' ' ' THR . 46.5 tp -62.58 -55.09 30.44 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.421 0.688 . . . . 73.2 111.157 -175.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 471' ' ' LYS . . . . . . . . . . . . . 5.3 mtpm? . . . . . 0 CA--C 1.55 0.966 0 CA-C-N 115.04 -0.982 . . . . 74.2 108.772 179.697 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 68.3 mtm . . . . . 0 N--CA 1.481 1.082 0 N-CA-C 110.426 -0.213 . . . . 55.23 110.426 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.39 29.4 18.96 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.932 1.293 . . . . 65.31 112.69 175.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -74.68 76.9 2.04 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.382 0.673 . . . . 52.01 109.693 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -37.72 101.63 0.02 OUTLIER 'General case' 0 C--N 1.354 0.773 0 C-N-CA 125.765 1.626 . . . . 70.52 113.756 -176.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 5' ' ' LYS . . . . . 0.477 ' HE2' HD11 ' C' ' 10' ' ' ILE . 14.6 mmmm -73.32 98.94 2.78 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.46 -1.311 . . . . 63.2 107.46 164.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -71.15 92.78 1.01 Allowed 'General case' 0 C--O 1.234 0.258 0 N-CA-C 107.759 -1.2 . . . . 63.22 107.759 177.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 7' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -58.64 -29.96 66.94 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 114.668 -1.151 . . . . 73.43 112.17 -170.116 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -67.33 -48.75 66.63 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.112 -0.949 . . . . 72.53 110.002 176.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.12 -38.52 86.66 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.978 0.511 . . . . 52.31 110.941 178.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 10' ' ' ILE . . . . . 0.477 HD11 ' HE2' ' C' ' 5' ' ' LYS . 59.5 mt -61.79 -39.36 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.335 0.654 . . . . 63.34 110.185 176.196 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 96.0 mt -80.44 -7.47 59.16 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 112.586 0.587 . . . . 45.45 112.586 176.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.37 35.84 51.41 Favored Glycine 0 C--N 1.352 1.454 0 CA-C-N 117.917 0.326 . . . . 64.33 113.636 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 6.3 m -133.55 155.89 80.15 Favored Pre-proline 0 N--CA 1.483 1.206 0 C-N-CA 125.109 1.364 . . . . 64.04 109.576 177.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -81.98 155.42 17.49 Favored 'Trans proline' 0 C--N 1.371 1.714 0 C-N-CA 122.195 1.93 . . . . 74.43 112.306 174.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 90.1 mtm-85 -67.35 75.98 0.16 Allowed 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.747 0.819 . . . . 71.52 110.311 174.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -177.48 -31.63 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.572 1.149 . . . . 71.24 108.779 -175.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.68 134.22 56.52 Favored 'General case' 0 C--N 1.353 0.748 0 CA-C-N 115.578 -0.737 . . . . 71.14 110.401 177.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 75.0 p -71.36 173.46 7.8 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.319 0.648 . . . . 74.41 111.671 -175.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.24 -39.55 87.09 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.347 1.059 . . . . 74.45 110.376 -176.005 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 20' ' ' GLU . . . . . 0.42 ' O ' ' HG3' ' C' ' 24' ' ' ARG . 7.8 tm-20 -66.64 -34.94 78.98 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 123.148 0.579 . . . . 64.05 110.015 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -70.97 -36.95 72.73 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 122.734 0.414 . . . . 73.42 110.773 176.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 1.4 mp -63.87 -34.52 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.333 1.053 . . . . 61.32 110.078 173.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 23' ' ' LYS . . . . . 0.534 ' O ' ' HG3' ' C' ' 27' ' ' LYS . 13.7 tppt? -66.55 -45.18 80.22 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.295 0.638 . . . . 74.13 109.305 178.075 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 24' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' C' ' 20' ' ' GLU . 63.1 mtm-85 -63.49 -41.99 98.55 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 123.459 0.475 . . . . 73.52 110.839 178.211 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.95 -38.45 86.14 Favored 'General case' 0 C--O 1.253 1.251 0 CA-C-N 115.257 -0.883 . . . . 75.32 110.987 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 26' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -57.14 -55.78 30.25 Favored 'General case' 0 C--O 1.216 -0.685 0 CA-C-N 114.541 -1.208 . . . . 72.31 109.13 173.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 27' ' ' LYS . . . . . 0.534 ' HG3' ' O ' ' C' ' 23' ' ' LYS . 33.2 mtmt -57.39 -41.56 80.47 Favored 'General case' 0 N--CA 1.483 1.186 0 O-C-N 124.424 1.078 . . . . 74.1 110.824 -177.474 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -55.32 -51.45 66.69 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.004 0.921 . . . . 71.15 110.961 178.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 82.3 mt -86.07 -6.02 59.1 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.724 -0.671 . . . . 60.22 111.498 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.41 -0.09 49.75 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.934 0.893 . . . . 75.32 110.011 171.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 31' ' ' ARG . . . . . 0.402 ' HG3' ' O ' ' C' ' 27' ' ' LYS . 95.7 mtt180 -100.94 -41.89 6.64 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.26 1.024 . . . . 73.5 109.208 165.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.33 -50.16 49.07 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 115.637 -0.71 . . . . 71.12 109.629 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 33' ' ' TYR . . . . . 0.422 ' HB3' ' O ' ' C' ' 43' ' ' ALA . 37.2 m-85 -95.4 14.94 20.9 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.924 0.49 . . . . 70.15 111.52 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 34' ' ' HIS . . . . . 0.422 ' CD2' HG23 ' C' ' 37' ' ' VAL . 12.4 t60 -61.4 107.82 1.27 Allowed Pre-proline 0 N--CA 1.489 1.48 0 C-N-CA 124.36 1.064 . . . . 72.34 110.792 -177.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -61.74 -21.31 71.87 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 123.018 2.479 . . . . 71.32 114.16 -172.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.05 -26.31 36.44 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.951 0.9 . . . . 60.34 111.668 178.423 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 37' ' ' VAL . . . . . 0.422 HG23 ' CD2' ' C' ' 34' ' ' HIS . 90.2 t -97.39 -58.33 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 109.046 -0.724 . . . . 75.33 109.046 176.322 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -98.12 84.21 3.24 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 114.801 -1.09 . . . . 54.22 108.907 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.26 79.21 0.99 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 114.866 -1.061 . . . . 62.24 108.635 175.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 67.1 m -140.38 114.9 7.53 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-O 118.301 -0.857 . . . . 74.14 109.387 -178.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -52.12 -41.85 62.61 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 123.326 2.684 . . . . 63.44 112.774 -176.113 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -48.62 -50.62 31.94 Favored 'General case' 0 N--CA 1.483 1.18 0 O-C-N 124.078 0.861 . . . . 65.44 110.85 173.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 43' ' ' ALA . . . . . 0.422 ' O ' ' HB3' ' C' ' 33' ' ' TYR . . . -71.55 -23.55 61.78 Favored 'General case' 0 C--O 1.216 -0.679 0 CA-C-N 114.768 -1.105 . . . . 62.05 110.931 -176.359 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 44' ' ' GLU . . . . . 0.469 ' O ' ' HG3' ' C' ' 48' ' ' LYS . 47.9 mt-10 -80.72 -33.48 35.22 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 122.992 0.517 . . . . 74.04 110.672 -176.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 45' ' ' GLU . . . . . 0.418 ' HA ' ' HD2' ' C' ' 48' ' ' LYS . 40.3 mt-10 -76.36 -39.4 53.95 Favored 'General case' 0 C--O 1.244 0.763 0 C-N-CA 123.316 0.647 . . . . 42.53 109.643 178.015 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 46' ' ' LYS . . . . . 0.535 ' O ' HG12 ' C' ' 50' ' ' ILE . 99.6 mttt -64.26 -34.7 78.71 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.008 -0.997 . . . . 72.32 110.131 170.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -66.34 -35.87 81.45 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.919 0.888 . . . . 62.23 110.297 175.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 48' ' ' LYS . . . . . 0.469 ' HG3' ' O ' ' C' ' 44' ' ' GLU . 95.1 mttt -60.67 -42.32 96.83 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 109.773 -0.454 . . . . 72.04 109.773 173.541 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -66.67 -33.8 76.45 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 123.653 0.596 . . . . 72.33 111.578 174.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 50' ' ' ILE . . . . . 0.535 HG12 ' O ' ' C' ' 46' ' ' LYS . 32.8 mm -65.72 -33.93 66.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 109.005 -0.739 . . . . 75.43 109.005 175.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 51' ' ' ASN . . . . . 0.555 ' HA ' ' HB3' ' C' ' 54' ' ' TYR . 36.3 m-80 -93.0 -3.98 53.46 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.123 0.969 . . . . 74.04 112.333 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -81.53 -51.45 8.25 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 107.243 -1.391 . . . . 63.42 107.243 165.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.14 -37.29 71.82 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 112.503 -2.135 . . . . 63.1 111.304 173.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 54' ' ' TYR . . . . . 0.555 ' HB3' ' HA ' ' C' ' 51' ' ' ASN . 58.1 t80 -78.18 -39.21 41.51 Favored 'General case' 0 C--O 1.215 -0.724 0 CA-C-N 115.5 -0.773 . . . . 75.01 110.411 174.405 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.52 -28.32 44.46 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 118.751 0.705 . . . . 60.54 111.56 177.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 56' ' ' VAL . . . . . 0.462 ' O ' ' HB2' ' C' ' 62' ' ' LYS . 47.3 t -83.28 -67.09 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 CA-C-O 121.288 0.566 . . . . 72.43 110.443 169.513 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 57' ' ' LEU . . . . . . . . . . . . . 52.1 mt -84.47 15.5 3.67 Favored 'General case' 0 CA--C 1.565 1.538 0 N-CA-C 113.066 0.765 . . . . 75.02 113.066 -164.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 45.5 t -61.2 -45.8 93.09 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 124.188 0.995 . . . . 62.42 112.291 -178.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -123.31 149.83 58.82 Favored Pre-proline 0 C--O 1.242 0.69 0 CA-C-N 114.897 -1.047 . . . . 72.03 108.639 -173.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 60' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -51.43 -26.97 22.9 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 123.299 2.666 . . . . 33.23 113.088 174.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -62.56 -70.28 0.21 Allowed 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.439 -0.8 . . . . 62.13 111.272 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 62' ' ' LYS . . . . . 0.486 ' HD3' ' H ' ' C' ' 62' ' ' LYS . 0.0 OUTLIER -70.64 -20.66 62.71 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 122.117 0.167 . . . . 75.23 110.857 -175.568 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -53.59 -62.11 1.87 Allowed 'General case' 0 C--N 1.354 0.776 0 O-C-N 124.002 0.814 . . . . 64.42 109.864 168.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -70.1 -27.56 64.69 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 112.249 0.463 . . . . 74.15 112.249 -176.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 88.5 mt -57.71 -50.27 78.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 109.68 -0.489 . . . . 62.34 109.68 172.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -61.74 -47.61 84.45 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.112 0.565 . . . . 74.22 111.691 174.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -53.94 -32.16 52.75 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.119 0.568 . . . . 73.14 111.979 -178.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 68' ' ' THR . . . . . 0.446 ' O ' ' HB ' ' C' ' 72' ' ' THR . 40.1 p -97.02 -24.09 15.96 Favored 'General case' 0 CA--C 1.553 1.069 0 N-CA-C 112.512 0.56 . . . . 63.2 112.512 176.343 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 69' ' ' TYR . . . . . 0.444 ' HE2' ' HD3' ' C' ' 78' ' ' PRO . 3.4 t80 -118.25 120.29 37.22 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.31 -0.869 . . . . 75.22 110.763 -172.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.94 23.58 66.25 Favored Glycine 0 C--N 1.346 1.136 0 N-CA-C 111.616 -0.594 . . . . 62.51 111.616 -173.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 54.8 m -142.18 -53.58 0.42 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 103.745 -2.687 . . . . 72.34 103.745 175.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 72' ' ' THR . . . . . 0.446 ' HB ' ' O ' ' C' ' 68' ' ' THR . 21.1 m -105.25 173.3 6.36 Favored 'General case' 0 CA--C 1.564 1.498 0 N-CA-C 104.969 -2.234 . . . . 73.35 104.969 158.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -90.85 11.41 22.67 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 118.999 0.818 . . . . 73.23 111.081 173.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 74' ' ' ALA . . . . . 0.45 ' HB1' ' HD2' ' C' ' 75' ' ' PRO . . . -62.12 -163.35 0.0 OUTLIER Pre-proline 0 CA--C 1.594 2.646 0 C-N-CA 125.728 1.611 . . . . 53.23 112.305 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 75' ' ' PRO . . . . . 0.523 ' HA ' ' HD2' ' C' ' 76' ' ' PRO . 0.2 OUTLIER 8.2 109.24 0.0 OUTLIER 'Trans proline' 1 C--N 1.419 4.25 0 C-N-CA 125.153 3.902 . . . . 75.14 118.512 -156.134 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' C' C ' 76' ' ' PRO . . . . . 0.523 ' HD2' ' HA ' ' C' ' 75' ' ' PRO . 42.5 Cg_endo -62.12 165.96 13.59 Favored 'Trans proline' 0 C--N 1.387 2.556 0 C-N-CA 123.52 2.813 . . . . 63.14 113.321 -179.27 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -21.39 106.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.405 3.517 1 C-N-CA 126.157 4.572 . . . . 51.51 116.029 178.528 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 78' ' ' PRO . . . . . 0.624 ' HG2' ' HA ' ' C' ' 101' ' ' PHE . 1.3 Cg_exo -37.59 146.45 0.11 Allowed 'Trans proline' 0 C--N 1.379 2.133 1 C-N-CA 126.277 4.651 . . . . 74.44 117.639 -171.781 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -58.87 119.43 6.68 Favored 'Trans proline' 0 C--N 1.391 2.813 0 C-N-CA 123.555 2.837 . . . . 61.04 113.411 -178.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -62.12 75.49 0.1 OUTLIER 'Trans proline' 0 C--N 1.391 2.811 0 C-N-CA 123.56 2.84 . . . . 51.5 110.321 169.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -167.48 -24.89 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 113.704 -1.589 . . . . 75.2 110.281 -166.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.41 ' HA2' ' O ' ' C' ' 104' ' ' GLY . . . 118.21 141.73 6.81 Favored Glycine 0 C--N 1.361 1.969 0 N-CA-C 116.377 1.311 . . . . 74.45 116.377 163.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 83' ' ' TYR . . . . . 0.505 ' CE1' ' HB3' ' C' ' 78' ' ' PRO . 22.7 m-85 -110.03 92.93 4.24 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 107.311 -1.366 . . . . 70.14 107.311 165.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -27.67 135.29 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 127.471 2.308 . . . . 63.13 116.157 -175.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 85' ' ' PHE . . . . . 0.564 ' HZ ' HD22 ' C' ' 105' ' ' LEU . 16.0 m-85 -135.49 74.21 1.5 Allowed 'General case' 0 C--N 1.346 0.451 0 CA-C-N 115.167 -0.924 . . . . 74.41 110.999 -177.594 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 86' ' ' SER . . . . . 0.521 ' OG ' ' HA2' ' C' ' 163' ' ' GLY . 1.4 m -55.82 83.21 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 123.715 0.806 . . . . 45.43 110.523 177.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 62.65 16.0 54.92 Favored Glycine 0 CA--C 1.54 1.637 0 CA-C-O 119.007 -0.885 . . . . 74.33 114.624 -170.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 88' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -86.46 120.81 28.19 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 118.536 1.168 . . . . 74.44 109.772 -174.208 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -76.56 88.67 3.28 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 120.856 0.36 . . . . 72.23 110.604 -174.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 90' ' ' VAL . . . . . . . . . . . . . 6.0 p -45.43 -43.96 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 124.333 1.053 . . . . 54.41 113.06 175.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -61.48 -31.2 71.17 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.745 0.818 . . . . 74.21 111.381 -176.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -79.08 -24.89 43.18 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.275 -0.875 . . . . 75.53 111.083 -176.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 19.1 m-30 -73.83 165.51 24.98 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 122.637 0.375 . . . . 72.45 110.787 -175.459 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 86.3 p -67.62 163.45 21.33 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 113.509 0.929 . . . . 45.51 113.509 -167.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.11 -42.91 95.72 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.027 -0.988 . . . . 55.43 110.645 172.422 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -58.44 -43.53 88.82 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.161 0.584 . . . . 65.02 110.653 178.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 97' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -61.51 -43.67 98.45 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.203 -0.908 . . . . 64.25 109.691 177.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 98' ' ' GLN . . . . . 0.541 ' HA ' HD12 ' C' ' 105' ' ' LEU . 48.6 mt-30 -82.58 -5.21 58.65 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 115.091 -0.958 . . . . 51.52 113.306 -177.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -101.4 -35.95 9.03 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.412 0.685 . . . . 74.43 110.947 172.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 46.3 tp -74.2 -61.4 1.87 Allowed 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 109.067 -0.716 . . . . 73.23 109.067 -178.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 101' ' ' PHE . . . . . 0.624 ' HA ' ' HG2' ' C' ' 78' ' ' PRO . 65.6 m-85 -92.08 8.72 36.54 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 115.389 -0.823 . . . . 73.25 111.55 -177.002 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -46.52 -58.28 6.05 Favored Glycine 0 CA--C 1.544 1.895 0 N-CA-C 117.629 1.811 . . . . 54.11 117.629 -169.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 103' ' ' PRO . . . . . 0.433 ' HD2' ' HD2' ' C' ' 78' ' ' PRO . 52.9 Cg_exo -58.49 -18.55 39.84 Favored 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 123.359 2.706 . . . . 62.02 114.41 179.408 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 104' ' ' GLY . . . . . 0.41 ' O ' ' HA2' ' C' ' 82' ' ' GLY . . . -105.35 -1.71 41.05 Favored Glycine 0 C--N 1.348 1.197 0 CA-C-O 119.501 -0.61 . . . . 43.23 113.814 179.106 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 105' ' ' LEU . . . . . 0.564 HD22 ' HZ ' ' C' ' 85' ' ' PHE . 15.3 mt -83.56 32.97 0.46 Allowed 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 119.284 1.542 . . . . 73.03 113.595 -175.194 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 106' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 53.03 -117.64 1.22 Allowed 'General case' 0 CA--C 1.557 1.216 0 N-CA-C 107.846 -1.168 . . . . 64.24 107.846 -177.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.48 54.68 1.22 Allowed Glycine 0 C--N 1.368 2.344 0 N-CA-C 120.815 3.086 . . . . 51.05 120.815 155.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 61.82 -77.1 0.02 OUTLIER Glycine 0 CA--C 1.554 2.483 0 N-CA-C 115.95 1.14 . . . . 74.41 115.95 162.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 109' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -77.0 -7.54 55.81 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 124.757 1.223 . . . . 74.45 111.049 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 110' ' ' GLY . . . . . . . . . . . . . . . -65.91 13.45 0.33 Allowed Glycine 0 CA--C 1.556 2.656 0 N-CA-C 116.574 1.389 . . . . 54.22 116.574 176.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 47.8 ttp180 87.79 -42.03 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 125.745 1.618 . . . . 75.25 113.399 167.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 112' ' ' ARG . . . . . . . . . . . . . 7.5 tpm_? -114.7 -44.55 3.06 Favored 'General case' 0 N--CA 1.503 2.192 0 CA-C-N 119.104 0.866 . . . . 74.1 108.895 168.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 113' ' ' SER . . . . . . . . . . . . . 22.9 m -4.28 80.23 0.0 OUTLIER 'General case' 0 C--O 1.205 -1.278 0 C-N-CA 127.271 2.228 . . . . 72.53 115.821 154.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 114' ' ' ARG . . . . . 0.444 ' HA ' ' HD3' ' C' ' 114' ' ' ARG . 18.4 mmt180 -133.12 -131.4 0.18 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.75 -1.219 . . . . 74.05 111.524 176.013 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 115' ' ' LYS . . . . . 0.4 ' H ' ' HB3' ' C' ' 114' ' ' ARG . 7.6 tmtt? -82.25 106.05 13.83 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 103.441 -2.8 . . . . 54.14 103.441 161.554 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 116' ' ' GLY . . . . . 0.431 ' HA3' ' HB3' ' C' ' 171' ' ' PRO . . . -63.28 132.06 42.06 Favored Glycine 0 C--N 1.344 1.022 0 O-C-N 123.858 0.724 . . . . 45.25 111.965 -171.622 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 60.4 mtt180 -80.26 174.91 11.13 Favored 'General case' 0 C--O 1.247 0.947 0 N-CA-C 108.963 -0.755 . . . . 64.44 108.963 175.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.39 130.91 43.19 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-O 120.865 0.364 . . . . 75.42 110.293 174.667 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 119' ' ' LEU . . . . . . . . . . . . . 5.1 tt -90.47 137.35 32.43 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 105.15 -2.167 . . . . 75.21 105.15 -179.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.443 ' H ' ' HD2' ' C' ' 120' ' ' ARG . 0.0 OUTLIER -127.48 148.88 50.31 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 110.14 -0.318 . . . . 72.31 110.14 -172.765 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.27 118.56 6.84 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.525 -0.761 . . . . 63.21 109.45 177.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 122' ' ' GLU . . . . . 0.417 ' HA ' ' O ' ' C' ' 177' ' ' VAL . 38.5 tt0 -83.93 132.54 34.76 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 109.772 -0.455 . . . . 73.22 109.772 178.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 123' ' ' LEU . . . . . 0.457 HD13 ' HB2' ' B' ' 183' ' ' ALA . 2.6 pt? -144.69 129.88 9.38 Favored Pre-proline 0 N--CA 1.481 1.1 0 C-N-CA 122.646 0.378 . . . . 73.3 110.185 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 124' ' ' PRO . . . . . 0.557 ' HG2' ' H ' ' B' ' 189' ' ' LYS . 17.3 Cg_exo -72.14 124.83 10.33 Favored 'Trans proline' 0 C--N 1.366 1.452 0 C-N-CA 122.218 1.945 . . . . 72.51 111.281 165.105 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 125' ' ' LEU . . . . . . . . . . . . . 38.0 tp -142.64 155.05 44.89 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.199 1.0 . . . . 74.03 109.015 -170.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 126' ' ' THR . . . . . 0.587 ' HB ' ' HG2' ' C' ' 129' ' ' GLU . 1.8 m -101.45 158.04 16.36 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 122.965 0.506 . . . . 61.53 110.289 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 127' ' ' LEU . . . . . 0.565 HD21 HD13 ' C' ' 180' ' ' LEU . 56.1 mt -64.45 -44.69 90.33 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.581 1.153 . . . . 62.25 110.92 178.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -59.93 -36.98 78.19 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 114.954 -1.021 . . . . 75.24 110.505 175.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 129' ' ' GLU . . . . . 0.587 ' HG2' ' HB ' ' C' ' 126' ' ' THR . 6.8 mm-40 -78.54 -22.08 47.81 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.105 0.562 . . . . 73.53 111.401 -179.59 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -73.79 -31.68 63.39 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 121.118 0.485 . . . . 64.34 109.935 174.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 131' ' ' PHE . . . . . 0.421 ' CZ ' ' HB3' ' C' ' 216' ' ' GLU . 49.4 t80 -69.19 -46.84 66.5 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 114.575 -1.193 . . . . 75.55 110.186 167.655 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 132' ' ' HIS . . . . . . . . . . . . . 28.1 m170 -78.03 -6.32 54.17 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.152 0.581 . . . . 60.22 111.608 -176.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -55.45 -94.29 0.01 OUTLIER Glycine 0 C--N 1.355 1.631 0 O-C-N 123.977 0.798 . . . . 65.31 113.259 175.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . 55.06 -137.0 45.1 Favored Glycine 0 C--N 1.355 1.636 0 CA-C-N 117.306 0.553 . . . . 53.24 112.799 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 135' ' ' GLU . . . . . 0.499 ' HG3' ' HB2' ' C' ' 148' ' ' ARG . 2.5 mp0 -76.29 96.4 3.96 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 108.839 -0.8 . . . . 71.2 108.839 172.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 136' ' ' ARG . . . . . 0.515 ' HA ' ' HE ' ' C' ' 136' ' ' ARG . 2.4 tpm_? -140.43 160.2 40.52 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-O 120.842 0.353 . . . . 72.12 110.296 -175.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 137' ' ' VAL . . . . . . . . . . . . . 19.9 m -74.73 96.19 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.191 0 CA-C-O 122.249 1.023 . . . . 71.12 111.741 -177.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 138' ' ' VAL . . . . . . . . . . . . . 42.8 t -90.36 136.54 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 114.621 -1.172 . . . . 72.14 108.758 172.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 139' ' ' GLU . . . . . 0.487 ' HA ' ' O ' ' C' ' 143' ' ' ARG . 1.4 tm-20 -124.09 115.89 21.89 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 108.165 -1.05 . . . . 74.31 108.165 174.286 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 140' ' ' VAL . . . . . . . . . . . . . 66.8 t -137.64 109.13 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 124.187 0.995 . . . . 63.22 109.148 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 63.59 25.75 14.45 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.265 1.026 . . . . 15.23 113.186 173.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 108.68 -8.24 34.29 Favored Glycine 0 N--CA 1.473 1.153 0 CA-C-N 116.666 -0.243 . . . . 45.25 113.006 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 143' ' ' ARG . . . . . 0.705 HH12 ' HA ' ' C' ' 164' ' ' MET . 27.4 mmm-85 -87.85 95.98 10.3 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.135 0.574 . . . . 73.04 110.718 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 47.1 ttp180 -96.9 98.84 10.44 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 108.631 -0.878 . . . . 71.51 108.631 175.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 145' ' ' VAL . . . . . 0.536 HG21 ' NH2' ' C' ' 143' ' ' ARG . 69.8 t -132.38 133.09 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.061 0.944 . . . . 75.03 110.525 -169.228 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 15.7 m -85.59 85.03 7.44 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 108.455 -0.943 . . . . 54.21 108.455 170.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 147' ' ' VAL . . . . . 0.404 ' HB ' HG12 ' C' ' 145' ' ' VAL . 10.4 p -118.54 145.35 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 123.232 0.613 . . . . 72.53 110.428 -171.159 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 148' ' ' ARG . . . . . 0.499 ' HB2' ' HG3' ' C' ' 135' ' ' GLU . 42.3 ttm180 -78.25 105.76 9.7 Favored 'General case' 0 C--N 1.348 0.518 0 N-CA-C 108.468 -0.938 . . . . 74.22 108.468 169.409 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 149' ' ' ILE . . . . . 0.633 HD12 HG21 ' C' ' 159' ' ' ILE . 6.9 pt -80.82 152.71 72.33 Favored Pre-proline 0 C--O 1.246 0.869 0 N-CA-C 107.299 -1.371 . . . . 71.41 107.299 165.048 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -39.79 108.91 0.08 OUTLIER 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 122.828 2.352 . . . . 61.44 112.12 168.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -63.98 107.91 0.85 Allowed 'Trans proline' 0 C--N 1.382 2.32 0 C-N-CA 122.928 2.419 . . . . 73.2 110.662 -176.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 152' ' ' GLY . . . . . . . . . . . . . . . 105.11 137.61 9.11 Favored Glycine 0 C--N 1.34 0.803 0 CA-C-N 115.837 -0.62 . . . . 54.32 113.955 -170.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 153' ' ' VAL . . . . . 0.704 HG21 HG21 ' C' ' 178' ' ' VAL . 1.9 m -134.57 171.84 17.13 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.192 0 C-N-CA 123.029 0.532 . . . . 71.13 110.922 -175.604 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 154' ' ' ARG . . . . . . . . . . . . . 8.7 mtp180 -135.34 145.06 47.03 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.176 0.99 . . . . 75.32 108.906 -174.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 155' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -56.17 126.07 24.51 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 118.601 0.637 . . . . 74.51 111.766 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 60.84 24.04 62.01 Favored Glycine 0 C--N 1.351 1.364 0 CA-C-N 115.305 -0.861 . . . . 64.51 114.01 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 157' ' ' SER . . . . . . . . . . . . . 37.7 m -107.91 163.59 13.0 Favored 'General case' 0 C--O 1.246 0.87 0 CA-C-O 121.209 0.528 . . . . 75.43 110.275 178.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 20.7 m -102.67 110.42 29.3 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 CA-C-N 114.997 -1.001 . . . . 64.44 110.528 -174.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 159' ' ' ILE . . . . . 0.633 HG21 HD12 ' C' ' 149' ' ' ILE . 7.4 mt -71.51 97.9 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.791 0 N-CA-C 108.251 -1.018 . . . . 52.25 108.251 172.047 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 160' ' ' ARG . . . . . 0.456 ' HA ' ' O ' ' C' ' 174' ' ' LEU . 15.3 ttp180 -79.62 102.63 9.02 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.591 -0.732 . . . . 72.21 110.572 -177.565 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 161' ' ' VAL . . . . . 0.645 HG22 ' HB3' ' C' ' 174' ' ' LEU . 0.7 OUTLIER -109.2 130.34 22.86 Favored Pre-proline 0 CA--C 1.548 0.892 0 N-CA-C 108.221 -1.029 . . . . 75.24 108.221 178.05 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -76.67 147.35 27.81 Favored 'Trans proline' 0 C--N 1.369 1.617 0 C-N-CA 122.528 2.152 . . . . 63.42 111.014 169.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 163' ' ' GLY . . . . . 0.521 ' HA2' ' OG ' ' C' ' 86' ' ' SER . . . 112.53 24.88 4.84 Favored Glycine 0 N--CA 1.47 0.917 0 CA-C-O 119.38 -0.678 . . . . 53.31 114.015 174.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 164' ' ' MET . . . . . 0.705 ' HA ' HH12 ' C' ' 143' ' ' ARG . 26.4 mmt -130.2 -79.75 0.54 Allowed 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 118.002 0.901 . . . . 73.35 110.769 -179.005 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 165' ' ' GLY . . . . . 0.611 ' H ' ' HA ' ' C' ' 173' ' ' ASP . . . 84.13 139.36 4.12 Favored Glycine 0 C--N 1.349 1.3 0 N-CA-C 114.033 0.373 . . . . 64.24 114.033 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . -76.37 -170.93 31.9 Favored Glycine 0 C--N 1.363 2.045 0 CA-C-N 117.213 0.507 . . . . 75.44 112.5 167.1 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 167' ' ' GLN . . . . . 0.607 HE21 ' HA ' ' C' ' 167' ' ' GLN . 0.0 OUTLIER -77.08 105.78 8.38 Favored 'General case' 0 N--CA 1.479 0.982 0 O-C-N 122.18 -0.6 . . . . 64.31 111.841 -174.192 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . 149.85 171.38 18.25 Favored Glycine 0 C--N 1.346 1.138 0 CA-C-O 121.492 0.496 . . . . 13.44 113.713 177.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 169' ' ' ASN . . . . . 0.503 ' HB3' ' HD2' ' C' ' 170' ' ' PRO . 1.0 OUTLIER -60.2 158.98 24.33 Favored Pre-proline 0 CA--C 1.559 1.317 0 C-N-CA 126.642 1.977 . . . . 62.44 109.498 175.537 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 170' ' ' PRO . . . . . 0.503 ' HD2' ' HB3' ' C' ' 169' ' ' ASN . 6.5 Cg_exo -0.05 75.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.403 3.415 1 C-N-CA 126.326 4.684 . . . . 51.41 115.511 -162.054 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 171' ' ' PRO . . . . . 0.522 ' HD2' ' O ' ' C' ' 85' ' ' PHE . 93.9 Cg_endo -81.97 176.54 8.18 Favored 'Trans proline' 0 C--N 1.37 1.708 0 C-N-CA 123.065 2.51 . . . . 74.02 114.965 -165.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 172' ' ' GLY . . . . . 0.436 ' O ' ' HA2' ' C' ' 165' ' ' GLY . . . -95.49 127.82 9.29 Favored Glycine 0 C--N 1.342 0.882 0 CA-C-N 114.247 -1.342 . . . . 74.42 110.118 -178.038 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 173' ' ' ASP . . . . . 0.611 ' HA ' ' H ' ' C' ' 165' ' ' GLY . 50.0 m-20 -72.85 -162.05 0.1 Allowed 'General case' 0 CA--C 1.555 1.15 0 N-CA-C 114.038 1.125 . . . . 74.51 114.038 -169.113 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 174' ' ' LEU . . . . . 0.645 ' HB3' HG22 ' C' ' 161' ' ' VAL . 38.2 tp -87.99 142.29 27.91 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 112.621 0.6 . . . . 75.22 112.621 -164.55 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 49.8 mt -129.21 95.23 3.99 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.681 1.592 . . . . 71.32 107.95 177.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 176' ' ' LEU . . . . . 0.582 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 95.4 mt -82.24 109.04 16.16 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 110.037 -0.357 . . . . 43.02 110.037 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 177' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' C' ' 122' ' ' GLU . 57.8 t -83.52 95.63 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 107.657 -1.238 . . . . 74.43 107.657 -179.057 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 178' ' ' VAL . . . . . 0.704 HG21 HG21 ' C' ' 153' ' ' VAL . 3.3 p -87.26 140.19 16.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 121.342 0.591 . . . . 74.01 112.117 -172.129 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 179' ' ' ARG . . . . . 0.478 ' O ' ' HA ' ' C' ' 124' ' ' PRO . 36.7 mmt180 -117.65 105.5 12.1 Favored 'General case' 0 C--N 1.342 0.276 0 C-N-CA 124.939 1.296 . . . . 72.33 107.872 177.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 180' ' ' LEU . . . . . 0.565 HD13 HD21 ' C' ' 127' ' ' LEU . 96.2 mt -73.45 143.02 46.84 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 122.547 0.339 . . . . 70.51 111.47 -175.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 181' ' ' LEU . . . . . . . . . . . . . 16.8 mt -61.19 166.86 4.47 Favored Pre-proline 0 CA--C 1.56 1.359 0 C-N-CA 124.66 1.184 . . . . 74.2 112.27 -178.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 99.4 Cg_exo -52.71 12.59 0.02 OUTLIER 'Trans proline' 0 C--N 1.39 2.755 0 C-N-CA 124.305 3.337 . . . . 64.12 118.361 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 183' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -129.38 74.24 81.08 Favored Pre-proline 0 CA--C 1.564 1.51 0 CA-C-N 119.069 0.85 . . . . 62.13 108.779 163.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 184' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -86.43 66.08 4.9 Favored 'Trans proline' 0 C--N 1.378 2.091 0 C-N-CA 123.099 2.532 . . . . 71.54 110.484 178.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 185' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 26.2 t -91.47 -45.25 14.53 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.552 0 CA-C-N 115.623 -0.717 . . . . 72.23 109.331 -166.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 186' ' ' PHE . . . . . 0.491 ' HB3' HD13 ' C' ' 193' ' ' LEU . 42.8 m-85 -103.95 101.45 11.23 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.534 0.734 . . . . 61.44 110.058 -173.015 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 187' ' ' ARG . . . . . . . . . . . . . 18.1 ttt180 -103.61 129.51 50.89 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.403 0.681 . . . . 75.14 109.298 -177.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 188' ' ' LEU . . . . . 0.557 HD13 ' HD2' ' C' ' 240' ' ' PHE . 53.7 tp -79.93 144.73 33.1 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 112.421 0.526 . . . . 74.14 112.421 -173.583 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -143.75 116.75 8.86 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 107.176 -1.416 . . . . 71.33 107.176 163.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 63.1 -97.08 0.18 Allowed Glycine 0 C--N 1.345 1.075 0 N-CA-C 111.436 -0.666 . . . . 74.2 111.436 -172.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 191' ' ' GLN . . . . . 0.421 ' HA ' HD11 ' C' ' 188' ' ' LEU . 45.8 mt-30 -129.01 -10.34 4.82 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.992 0.917 . . . . 60.21 110.675 171.051 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 192' ' ' ASP . . . . . 0.413 ' O ' HD12 ' C' ' 188' ' ' LEU . 22.2 m-20 -82.86 161.91 21.77 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.706 0.802 . . . . 65.13 110.448 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 193' ' ' LEU . . . . . 0.619 HD21 ' CD2' ' C' ' 240' ' ' PHE . 79.6 mt -123.03 161.33 24.5 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 122.885 0.474 . . . . 52.2 111.901 -176.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 194' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -124.27 128.99 49.98 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 107.824 -1.176 . . . . 75.43 107.824 168.317 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 195' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' C' ' 185' ' ' VAL . . . -136.33 -176.65 4.4 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.576 1.15 . . . . 65.11 109.305 -177.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 87.9 m -137.98 119.93 15.42 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 108.594 -0.891 . . . . 51.32 108.594 171.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 197' ' ' LEU . . . . . . . . . . . . . 55.8 tp -96.66 124.1 40.55 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.066 0.546 . . . . 73.5 110.606 -175.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -77.75 104.59 8.39 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.42 1.088 . . . . 44.52 109.64 179.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 199' ' ' VAL . . . . . 0.577 HG22 HG21 ' C' ' 210' ' ' VAL . 41.1 t -121.53 120.4 28.84 Favored Pre-proline 0 N--CA 1.481 1.105 0 C-N-CA 124.413 1.085 . . . . 61.21 109.196 -178.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 200' ' ' PRO . . . . . 0.504 ' HG2' HD12 ' C' ' 203' ' ' ILE . 12.9 Cg_exo -66.3 150.53 84.6 Favored 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 122.534 2.156 . . . . 71.34 112.12 173.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 201' ' ' ALA . . . . . . . . . . . . . . . -57.09 -48.42 97.44 Favored Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 123.746 0.819 . . . . 74.35 113.068 178.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 202' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -57.13 -49.34 14.42 Favored 'Trans proline' 0 C--N 1.383 2.369 0 C-N-CA 121.631 1.554 . . . . 63.15 112.856 175.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 203' ' ' ILE . . . . . 0.504 HD12 ' HG2' ' C' ' 200' ' ' PRO . 27.2 mt -63.11 -29.53 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 123.276 0.631 . . . . 63.4 111.055 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -74.45 -36.59 63.36 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.612 0.765 . . . . 75.02 112.217 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 205' ' ' VAL . . . . . . . . . . . . . 69.1 t -76.73 -41.15 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 122.909 0.483 . . . . 63.41 111.984 -179.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 206' ' ' VAL . . . . . 0.619 HG23 ' HE3' ' A' ' 270' ' ' LYS . 12.4 p -90.88 -34.61 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 112.218 0.451 . . . . 52.12 112.218 -176.202 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 94.03 127.65 4.86 Favored Glycine 0 C--N 1.344 0.999 0 N-CA-C 111.644 -0.582 . . . . 63.21 111.644 -167.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -156.81 -131.18 1.32 Allowed Glycine 0 C--N 1.346 1.108 0 N-CA-C 111.042 -0.823 . . . . 51.32 111.042 177.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 209' ' ' LYS . . . . . 0.492 ' HG2' ' HA ' ' C' ' 222' ' ' ALA . 8.2 mtmp? -147.07 140.77 25.71 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.486 0.714 . . . . 72.12 111.072 173.132 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 210' ' ' VAL . . . . . 0.577 HG21 HG22 ' C' ' 199' ' ' VAL . 17.8 m -136.6 138.92 45.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 125.216 1.406 . . . . 62.05 108.32 172.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 211' ' ' ARG . . . . . . . . . . . . . 36.0 ttm180 -86.82 126.82 34.88 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.376 0.51 . . . . 72.44 112.376 -173.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 212' ' ' ALA . . . . . 0.503 ' HB3' HG13 ' C' ' 219' ' ' VAL . . . -92.56 114.84 27.5 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 123.97 0.908 . . . . 74.43 108.568 164.531 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 213' ' ' MET . . . . . . . . . . . . . 5.4 tmm? -77.31 105.8 8.65 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 107.895 -1.15 . . . . 63.12 107.895 175.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 214' ' ' THR . . . . . 0.526 ' OG1' HG12 ' C' ' 219' ' ' VAL . 0.2 OUTLIER -100.75 173.09 6.68 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.49 0.662 . . . . 54.24 110.594 -176.269 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 215' ' ' LEU . . . . . 0.408 HD13 ' CE1' ' C' ' 240' ' ' PHE . 25.9 mt -69.91 -26.72 64.29 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 114.488 -1.233 . . . . 44.41 112.836 -169.358 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 216' ' ' GLU . . . . . 0.421 ' HB3' ' CZ ' ' C' ' 131' ' ' PHE . 0.0 OUTLIER -111.52 8.69 21.13 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.206 1.002 . . . . 71.0 111.614 -178.985 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 137.92 172.67 12.63 Favored Glycine 0 C--N 1.341 0.833 0 CA-C-O 119.803 -0.443 . . . . 64.11 112.607 179.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -87.62 119.48 1.36 Allowed 'Trans proline' 0 CA--C 1.555 1.562 0 C-N-CA 123.178 2.586 . . . . 52.13 113.099 -174.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 219' ' ' VAL . . . . . 0.526 HG12 ' OG1' ' C' ' 214' ' ' THR . 3.8 p -98.71 115.4 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 108.961 -0.755 . . . . 52.53 108.961 173.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 220' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -80.99 106.6 13.12 Favored 'General case' 0 C--O 1.244 0.77 0 N-CA-C 108.716 -0.846 . . . . 72.32 108.716 178.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 221' ' ' VAL . . . . . 0.658 ' HA ' ' HB2' ' B' ' 239' ' ' ALA . 88.3 t -77.85 127.34 38.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 114.786 -1.097 . . . . 74.03 110.589 -176.396 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 222' ' ' ALA . . . . . 0.492 ' HA ' ' HG2' ' C' ' 209' ' ' LYS . . . -95.58 130.51 42.41 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.585 0.754 . . . . 73.3 111.099 177.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 94.8 t -108.35 140.31 21.62 Favored Pre-proline 0 CA--C 1.558 1.28 0 C-N-CA 125.328 1.451 . . . . 73.11 110.065 -173.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 224' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -89.47 168.59 5.0 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 123.556 2.838 . . . . 54.33 111.958 169.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -58.35 142.66 97.82 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.386 2.057 . . . . 74.0 112.428 170.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 226' ' ' ARG . . . . . . . . . . . . . 30.8 mmt-85 66.44 95.12 0.06 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.531 1.533 . . . . 70.15 111.073 -176.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 227' ' ' THR . . . . . 0.435 HG22 HG11 ' C' ' 253' ' ' VAL . 25.7 m -137.29 116.78 12.84 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.637 0.775 . . . . 70.3 111.32 173.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 228' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -101.8 155.88 17.86 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.842 0.857 . . . . 74.32 111.17 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 229' ' ' ALA . . . . . 0.484 ' HB2' ' H ' ' C' ' 255' ' ' ILE . . . -70.37 144.0 51.75 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 115.197 -0.91 . . . . 62.12 109.986 175.035 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 97.02 -11.85 65.75 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-O 119.2 -0.778 . . . . 62.04 113.024 -172.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 231' ' ' ARG . . . . . . . . . . . . . 54.9 mtt180 -69.37 174.34 4.93 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 118.348 1.074 . . . . 74.12 111.04 170.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 232' ' ' LYS . . . . . 0.425 ' HD3' ' HB3' ' C' ' 250' ' ' TYR . 28.0 ttmt -147.75 141.95 26.15 Favored 'General case' 0 C--N 1.355 0.819 0 CA-C-O 121.371 0.605 . . . . 71.45 112.222 -176.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 233' ' ' LEU . . . . . 0.539 ' O ' ' HA ' ' C' ' 250' ' ' TYR . 3.3 mp -114.63 154.53 28.21 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.945 1.298 . . . . 74.21 109.519 -179.24 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -122.95 120.72 34.23 Favored 'General case' 0 C--O 1.243 0.744 0 N-CA-C 109.19 -0.67 . . . . 72.34 109.19 167.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 44.5 mt -107.54 125.35 51.19 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.418 -0.956 . . . . 73.43 108.418 177.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -74.3 130.11 39.08 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.848 0.859 . . . . 71.55 112.192 -171.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 77.87 -0.69 71.03 Favored Glycine 0 C--N 1.35 1.336 0 CA-C-N 115.16 -0.927 . . . . 71.42 114.013 178.034 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -92.11 8.6 37.11 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.361 0.664 . . . . 72.03 112.06 -173.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -81.63 -168.29 40.5 Favored Glycine 0 C--N 1.349 1.303 0 N-CA-C 111.367 -0.693 . . . . 31.21 111.367 167.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 240' ' ' PHE . . . . . 0.619 ' CD2' HD21 ' C' ' 193' ' ' LEU . 18.4 m-85 -78.86 149.59 74.16 Favored Pre-proline 0 CA--C 1.558 1.287 0 CA-C-N 117.105 0.452 . . . . 75.14 110.249 178.019 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 241' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -82.65 142.18 11.38 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 123.492 2.794 . . . . 70.21 112.501 -173.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -132.63 165.06 23.91 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-O 119.422 -0.654 . . . . 70.14 112.69 -178.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -67.79 -1.81 7.48 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 123.527 2.818 . . . . 71.42 113.768 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -121.82 -15.45 7.88 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.657 0.783 . . . . 71.42 111.299 174.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 154.7 174.7 24.99 Favored Glycine 0 C--N 1.357 1.703 0 CA-C-O 120.16 -0.244 . . . . 51.32 113.474 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 246' ' ' ARG . . . . . . . . . . . . . 59.3 mtm180 -91.94 157.32 16.89 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 123.983 0.913 . . . . 61.31 111.049 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -85.38 -161.19 34.14 Favored Glycine 0 C--N 1.353 1.493 0 CA-C-O 120.137 -0.257 . . . . 63.23 113.705 176.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -127.41 136.47 51.89 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 117.458 0.629 . . . . 73.54 109.906 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 249' ' ' LEU . . . . . 0.447 HD11 ' HB2' ' C' ' 195' ' ' ALA . 31.0 tp -86.22 119.87 26.97 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.6 0.76 . . . . 74.23 110.59 -177.539 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 250' ' ' TYR . . . . . 0.539 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 14.3 m-85 -100.84 102.79 13.93 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 109.372 -0.603 . . . . 71.43 109.372 176.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 251' ' ' LEU . . . . . 0.435 ' HB2' HD13 ' C' ' 233' ' ' LEU . 1.3 mp -97.52 135.93 38.66 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.58 -0.896 . . . . 64.53 108.58 -178.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -98.17 121.07 39.64 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 108.906 -0.776 . . . . 73.41 108.906 175.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 253' ' ' VAL . . . . . 0.435 HG11 HG22 ' C' ' 227' ' ' THR . 92.0 t -58.48 138.32 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 124.403 1.081 . . . . 73.5 111.897 -176.325 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 254' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -131.72 109.06 9.9 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.22 1.008 . . . . 74.13 108.295 -178.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 255' ' ' ILE . . . . . 0.484 ' H ' ' HB2' ' C' ' 229' ' ' ALA . 41.4 mm -81.34 123.05 37.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 122.759 0.423 . . . . 75.24 110.186 179.321 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 256' ' ' THR . . . . . 0.431 ' O ' ' HA ' ' C' ' 200' ' ' PRO . 0.0 OUTLIER -125.79 151.78 46.29 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.157 1.383 . . . . 53.32 109.177 -179.565 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 2.8 pp -114.77 153.14 46.9 Favored Pre-proline 0 N--CA 1.49 1.532 0 C-N-CA 122.883 0.473 . . . . 64.54 111.137 -176.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 258' ' ' PRO . . . . . 0.554 ' HB3' ' HE2' ' A' ' 276' ' ' TYR . 37.7 Cg_endo -62.01 -2.9 3.28 Favored 'Trans proline' 0 C--N 1.385 2.46 0 C-N-CA 123.451 2.767 . . . . 73.21 115.119 -173.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 58.38 -83.33 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.111 1.364 . . . . 72.3 111.567 -173.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 260' ' ' ARG . . . . . 0.481 ' HG3' ' HA ' ' B' ' 267' ' ' SER . 0.0 OUTLIER -66.41 158.09 30.24 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 122.878 0.471 . . . . 73.41 110.631 -177.178 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 261' ' ' LEU . . . . . 0.653 HD13 ' HA ' ' C' ' 266' ' ' GLU . 95.7 mt -145.96 130.86 18.15 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.542 -0.54 . . . . 71.21 109.542 175.381 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 58.3 p -82.84 154.69 67.97 Favored Pre-proline 0 N--CA 1.479 0.988 0 CA-C-O 117.264 -1.351 . . . . 61.23 107.729 170.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -34.66 -40.59 0.23 Allowed 'Trans proline' 0 N--CA 1.508 2.353 0 C-N-CA 124.314 3.343 . . . . 74.2 116.52 -175.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -76.58 -54.95 5.99 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.83 0.452 . . . . 71.04 110.963 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 265' ' ' GLU . . . . . 0.469 ' HB3' HD22 ' C' ' 261' ' ' LEU . 16.0 mm-40 -44.56 -51.88 8.55 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 124.1 0.875 . . . . 65.11 109.84 173.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 266' ' ' GLU . . . . . 0.653 ' HA ' HD13 ' C' ' 261' ' ' LEU . 7.9 tp10 -48.82 -60.29 2.86 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 112.856 -1.974 . . . . 64.21 111.007 176.26 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -53.23 -43.43 67.29 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 124.131 0.894 . . . . 70.32 112.92 -175.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 268' ' ' LEU . . . . . 0.418 ' O ' ' HG ' ' C' ' 272' ' ' LEU . 10.5 mp -65.13 -54.12 34.63 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 116.564 -0.289 . . . . 52.44 111.123 179.286 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 93.3 m95 -60.36 -31.51 70.41 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 111.76 0.281 . . . . 61.11 111.76 178.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 270' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' C' ' 266' ' ' GLU . 4.5 mmmp? -61.4 -52.63 63.81 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.483 0.713 . . . . 75.43 109.801 176.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 42.3 mtpt -59.8 -38.9 83.25 Favored 'General case' 0 N--CA 1.481 1.102 0 O-C-N 123.858 0.724 . . . . 75.33 111.848 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 272' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' C' ' 268' ' ' LEU . 78.1 mt -63.0 -41.88 99.7 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 123.823 0.702 . . . . 74.33 111.174 178.473 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -71.81 -41.13 68.61 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 115.599 -0.728 . . . . 34.13 112.257 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -67.84 -34.07 76.0 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.263 0.625 . . . . 63.21 110.084 179.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 275' ' ' ALA . . . . . 0.421 ' HB1' ' HE2' ' B' ' 404' ' ' LYS . . . -62.87 -37.53 87.24 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 114.974 -1.012 . . . . 70.04 110.451 172.103 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 276' ' ' TYR . . . . . 0.539 ' HE1' ' HB3' ' A' ' 258' ' ' PRO . 0.2 OUTLIER -66.72 -44.84 80.54 Favored 'General case' 0 CA--C 1.554 1.107 0 CA-C-N 115.184 -0.916 . . . . 75.52 111.612 173.903 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -69.04 -22.61 64.04 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 122.707 0.403 . . . . 44.24 110.15 -178.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -69.49 0.34 5.4 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.982 0.913 . . . . 55.2 113.012 175.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 279' ' ' ARG . . . . . . . . . . . . . 73.3 mtm180 -82.24 -31.25 30.31 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 117.945 0.339 . . . . 71.52 110.335 168.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.98 0 C-N-CA 123.763 0.825 . . . . 75.14 109.246 -177.252 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.3 mtm . . . . . 0 N--CA 1.479 1.015 0 CA-C-O 119.532 -0.27 . . . . 64.12 111.433 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.43 36.84 24.15 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.362 1.065 . . . . 51.4 111.331 -178.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.61 79.14 4.11 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 114.646 -1.161 . . . . 74.04 111.066 -171.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.416 ' HE2' ' HD2' ' A' ' 69' ' ' TYR . 40.9 ttmt -36.89 103.0 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.351 1.06 . . . . 62.43 113.255 176.617 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.411 ' HE2' HD11 ' A' ' 10' ' ' ILE . 49.5 mtpt -80.93 120.17 24.4 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 108.061 -1.088 . . . . 74.32 108.061 168.089 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -71.22 94.92 1.21 Allowed 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 108.23 -1.026 . . . . 61.41 108.23 178.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -63.39 -28.7 70.17 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 114.513 -1.221 . . . . 73.34 112.016 -172.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -67.01 -43.48 82.79 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 122.888 0.475 . . . . 73.33 110.14 176.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.05 -43.66 98.0 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 123.65 0.594 . . . . 60.32 110.467 177.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.411 HD11 ' HE2' ' A' ' 5' ' ' LYS . 65.8 mt -57.4 -40.62 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 123.917 0.761 . . . . 74.23 110.662 176.619 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 87.2 mt -79.4 -21.09 46.11 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 112.448 0.536 . . . . 51.33 112.448 177.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.62 49.59 8.91 Favored Glycine 0 CA--C 1.539 1.56 0 CA-C-N 117.688 0.222 . . . . 53.33 113.35 -175.2 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.547 HG13 ' HB2' ' A' ' 25' ' ' ALA . 3.4 m -134.25 161.45 63.64 Favored Pre-proline 0 N--CA 1.491 1.602 0 C-N-CA 125.226 1.41 . . . . 71.43 109.581 175.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -46.73 147.76 4.31 Favored 'Trans proline' 0 C--N 1.392 2.862 0 C-N-CA 123.104 2.536 . . . . 50.12 113.032 173.269 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 61.7 mtp180 -80.88 27.32 0.39 Allowed 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 113.359 0.874 . . . . 75.43 113.359 -166.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -161.08 20.74 0.13 Allowed 'General case' 0 CA--C 1.559 1.319 0 C-N-CA 124.894 1.278 . . . . 64.11 108.646 172.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.58 147.25 51.95 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.762 1.225 . . . . 64.31 112.731 -171.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.2 p -79.89 176.95 9.27 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.806 0.843 . . . . 71.11 112.658 -175.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -52.2 -47.09 65.79 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.492 1.517 . . . . 64.21 113.09 -172.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.453 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 17.2 tp10 -75.42 -28.16 59.27 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 111.656 0.243 . . . . 72.43 111.656 -174.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -65.81 -46.78 77.36 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 121.031 0.443 . . . . 64.03 109.973 174.175 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.628 HG12 ' HB3' ' A' ' 57' ' ' LEU . 1.7 mp -61.33 -36.39 72.57 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 CA-C-N 114.632 -1.167 . . . . 73.31 110.912 174.595 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.494 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 1.6 tppp? -63.12 -47.98 80.48 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.937 0.895 . . . . 71.24 109.639 179.376 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 20' ' ' GLU . 52.8 mtm180 -67.76 -38.22 83.16 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.166 0.987 . . . . 54.12 111.424 -177.328 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.547 ' HB2' HG13 ' A' ' 13' ' ' VAL . . . -61.72 -43.88 98.01 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.725 0.81 . . . . 64.0 110.49 176.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -59.07 -49.24 78.65 Favored 'General case' 0 C--O 1.202 -1.404 0 CA-C-N 114.335 -1.302 . . . . 73.1 110.238 174.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 88.2 mttt -52.63 -50.33 63.35 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.732 0.813 . . . . 74.22 110.854 -178.581 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 54.1 ttp180 -55.8 -55.88 27.11 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 114.501 -1.227 . . . . 71.15 111.571 178.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.614 ' HB3' HD13 ' A' ' 50' ' ' ILE . 96.8 mt -76.64 -18.97 58.28 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.476 0.711 . . . . 74.11 112.527 -174.549 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -86.33 -29.16 23.21 Favored 'General case' 0 C--O 1.211 -0.93 0 C-N-CA 123.134 0.574 . . . . 63.3 110.153 -178.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 45.7 mtp180 -83.94 -35.01 24.33 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 122.446 0.298 . . . . 72.33 110.397 173.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -71.79 -45.49 61.42 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.332 0.653 . . . . 63.33 110.72 -179.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -107.56 35.98 2.89 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.516 0.726 . . . . 63.25 109.829 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -66.11 114.72 17.88 Favored Pre-proline 0 N--CA 1.476 0.866 0 N-CA-C 108.63 -0.878 . . . . 63.41 108.63 178.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.404 ' O ' ' HG2' ' A' ' 39' ' ' LYS . 32.1 Cg_exo -58.04 -15.2 21.64 Favored 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 123.249 2.633 . . . . 74.13 114.564 -168.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -94.66 -32.1 13.54 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.814 0.846 . . . . 72.45 111.882 177.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 99.3 t -85.46 -59.97 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 CA-C-O 121.679 0.752 . . . . 65.53 109.084 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -98.7 75.64 2.15 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 114.507 -1.224 . . . . 61.35 108.745 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.404 ' HG2' ' O ' ' A' ' 35' ' ' PRO . 45.4 mtmt -78.04 79.6 4.49 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 114.538 -1.21 . . . . 73.11 108.891 177.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.2 m -131.59 125.62 20.66 Favored Pre-proline 0 N--CA 1.471 0.623 0 N-CA-C 108.812 -0.811 . . . . 54.41 108.812 176.094 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -43.09 -45.73 9.33 Favored 'Trans proline' 0 C--N 1.383 2.392 0 C-N-CA 123.498 2.798 . . . . 72.23 113.281 171.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -51.27 -47.53 62.47 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.893 1.277 . . . . 64.43 111.194 174.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.23 -23.67 62.05 Favored 'General case' 0 C--N 1.35 0.623 0 CA-C-N 114.498 -1.228 . . . . 72.14 111.13 -177.036 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.457 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 46.9 mt-10 -78.82 -41.27 30.64 Favored 'General case' 0 C--N 1.359 0.989 0 O-C-N 123.623 0.577 . . . . 62.01 109.651 -178.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -64.58 -46.89 80.79 Favored 'General case' 0 C--O 1.251 1.174 0 C-N-CA 124.25 1.02 . . . . 62.44 110.622 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -61.9 -44.0 97.69 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 114.951 -1.022 . . . . 74.03 110.087 173.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -61.56 -31.36 71.39 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.717 0.807 . . . . 73.24 110.867 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' A' ' 44' ' ' GLU . 33.0 mmtp -65.16 -50.64 65.18 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.072 0.549 . . . . 75.14 109.993 175.642 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -64.51 -29.88 70.91 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 123.247 0.342 . . . . 71.44 111.56 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.614 HD13 ' HB3' ' A' ' 29' ' ' LEU . 84.6 mt -74.1 -31.89 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.577 1.151 . . . . 70.53 110.208 175.34 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -72.59 -36.64 68.19 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.579 0.752 . . . . 73.43 110.522 175.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -66.88 -49.46 65.58 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.286 1.034 . . . . 63.42 109.976 176.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.1 -52.06 66.98 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 114.558 -1.201 . . . . 65.45 111.138 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -63.52 -33.65 76.04 Favored 'General case' 0 C--O 1.209 -1.026 0 CA-C-N 115.166 -0.924 . . . . 72.32 110.615 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.54 -56.46 20.99 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.798 0.439 . . . . 53.01 110.861 177.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.415 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 48.5 t -66.28 -33.42 63.43 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 CA-C-N 114.595 -1.184 . . . . 74.52 111.303 -176.271 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.628 ' HB3' HG12 ' A' ' 22' ' ' ILE . 75.4 mt -102.38 -5.02 24.63 Favored 'General case' 0 CA--C 1.555 1.163 0 N-CA-C 114.416 1.265 . . . . 62.04 114.416 -172.295 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 34.8 t -75.03 -56.82 4.36 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 118.497 0.59 . . . . 74.34 109.916 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.5 ' HB2' ' HE3' ' A' ' 62' ' ' LYS . 12.9 m-20 -80.62 127.38 75.67 Favored Pre-proline 0 C--O 1.255 1.35 0 CA-C-N 115.372 -0.831 . . . . 74.34 110.041 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.464 ' O ' ' HG2' ' A' ' 64' ' ' ARG . 64.6 Cg_exo -53.11 -26.43 32.93 Favored 'Trans proline' 0 C--N 1.387 2.575 0 C-N-CA 123.57 2.847 . . . . 72.41 113.02 177.091 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -54.13 -65.72 0.52 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.006 1.322 . . . . 72.3 111.688 174.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.58 ' HE2' ' HB3' ' A' ' 84' ' ' ASP . 21.9 mttt -72.08 -26.14 62.04 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 115.667 -0.697 . . . . 74.54 110.117 -173.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.6 tpt180 -55.34 -51.34 67.1 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 124.015 0.822 . . . . 74.11 109.802 168.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.464 ' HG2' ' O ' ' A' ' 60' ' ' PRO . 1.7 mmp_? -63.67 -36.56 84.24 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.889 0.476 . . . . 74.25 111.392 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.622 HD11 ' HG3' ' A' ' 79' ' ' PRO . 79.5 mt -60.73 -40.19 84.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 123.753 0.658 . . . . 64.42 110.535 175.009 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -69.18 -41.83 76.66 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.827 -0.624 . . . . 75.4 109.462 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -61.36 -43.09 99.46 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.222 0.609 . . . . 64.04 110.899 177.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 50.9 p -72.07 -20.44 61.66 Favored 'General case' 0 C--N 1.348 0.537 0 CA-C-N 115.701 -0.682 . . . . 75.13 110.653 177.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.416 ' HD2' ' HE2' ' A' ' 4' ' ' LYS . 46.2 t80 -86.01 101.18 12.69 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 108.243 -1.021 . . . . 63.45 108.243 173.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 115.2 17.63 6.63 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.894 -0.882 . . . . 52.54 110.894 -166.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 90.6 m -142.17 -61.39 0.45 Allowed 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 103.822 -2.659 . . . . 71.23 103.822 173.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 50.9 m -79.92 146.35 32.17 Favored 'General case' 0 C--O 1.251 1.178 0 N-CA-C 105.032 -2.211 . . . . 74.23 105.032 157.219 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.36 -39.85 10.26 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.025 0.53 . . . . 74.04 111.375 -177.163 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.47 155.9 56.65 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 123.633 0.773 . . . . 75.1 110.528 -176.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -57.08 119.71 7.14 Favored 'Trans proline' 0 C--N 1.384 2.4 0 C-N-CA 122.673 2.249 . . . . 75.41 111.266 175.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.45 155.99 23.53 Favored 'Trans proline' 0 C--N 1.384 2.431 0 C-N-CA 122.909 2.406 . . . . 74.25 112.841 178.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -56.12 135.45 69.93 Favored 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 122.512 2.141 . . . . 62.44 111.123 174.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -42.61 118.69 1.2 Allowed 'Trans proline' 0 C--N 1.383 2.36 0 C-N-CA 123.687 2.925 . . . . 43.51 113.821 177.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.622 ' HG3' HD11 ' A' ' 65' ' ' ILE . 52.2 Cg_endo -62.31 166.58 12.7 Favored 'Trans proline' 0 C--N 1.383 2.391 0 C-N-CA 123.723 2.949 . . . . 71.05 112.342 -176.337 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -49.45 83.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.398 3.155 0 C-N-CA 124.095 3.197 . . . . 51.35 114.007 -175.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.541 ' HA2' ' HG2' ' A' ' 111' ' ' ARG . . . 136.26 -61.81 0.61 Allowed Glycine 0 N--CA 1.445 -0.701 0 CA-C-N 113.905 -1.498 . . . . 62.41 109.551 -176.175 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.407 ' O ' ' HG2' ' A' ' 79' ' ' PRO . . . 144.86 -157.75 27.39 Favored Glycine 0 N--CA 1.468 0.812 0 N-CA-C 110.579 -1.008 . . . . 53.03 110.579 -169.612 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.407 ' HE1' HD13 ' A' ' 65' ' ' ILE . 96.3 m-85 -105.1 106.54 17.08 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.489 0.716 . . . . 74.41 109.884 -177.061 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.58 ' HB3' ' HE2' ' A' ' 62' ' ' LYS . 5.0 t70 -78.98 138.59 38.12 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.298 1.039 . . . . 71.31 112.313 -177.469 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -136.59 68.98 1.42 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.802 0.841 . . . . 70.22 109.812 170.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 59.0 m -53.32 94.71 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 125.104 1.362 . . . . 74.44 113.766 -176.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.654 ' H ' ' NH2' ' A' ' 114' ' ' ARG . . . 70.34 9.14 63.76 Favored Glycine 0 C--N 1.352 1.436 0 CA-C-N 115.901 -0.591 . . . . 70.11 114.144 178.514 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -96.23 130.59 43.27 Favored 'General case' 0 C--O 1.241 0.63 0 N-CA-C 107.71 -1.218 . . . . 72.34 107.71 -179.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -75.32 81.56 2.42 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 121.668 0.747 . . . . 71.44 111.134 -171.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.568 HG23 ' HZ ' ' A' ' 97' ' ' PHE . 0.9 OUTLIER -40.02 -41.19 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 126.633 1.973 . . . . 75.21 112.4 171.66 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -69.51 -5.85 26.84 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.328 1.051 . . . . 75.33 113.167 -172.119 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -115.45 -12.08 11.74 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.997 0.519 . . . . 45.35 111.753 -177.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 20.8 m-30 -85.53 168.57 14.39 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 112.919 0.711 . . . . 71.01 112.919 -167.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 98.7 p -65.69 168.51 7.59 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 124.919 1.288 . . . . 74.5 114.233 -164.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.24 -35.9 82.34 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 115.308 -0.86 . . . . 74.31 111.148 174.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -58.29 -47.08 84.79 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.96 0.904 . . . . 75.03 109.901 177.067 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.568 ' HZ ' HG23 ' A' ' 90' ' ' VAL . 5.3 t80 -56.94 -52.28 65.83 Favored 'General case' 0 CA--C 1.554 1.126 0 O-C-N 124.348 1.03 . . . . 63.23 110.114 172.226 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -65.59 -17.23 64.43 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 112.81 0.67 . . . . 73.05 112.81 -173.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -99.9 -36.5 9.38 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 112.93 0.715 . . . . 70.02 112.93 178.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 50.6 tp -78.23 -41.91 32.82 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-O 121.392 0.615 . . . . 55.03 110.355 -179.183 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -97.18 -24.88 15.51 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.213 1.005 . . . . 72.11 111.278 -175.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -44.17 -56.13 5.47 Favored Glycine 0 CA--C 1.545 1.958 0 CA-C-O 118.807 -0.996 . . . . 72.43 115.193 -178.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_exo -47.32 -25.8 5.13 Favored 'Trans proline' 0 C--N 1.391 2.769 0 C-N-CA 124.039 3.16 . . . . 23.1 115.53 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -133.11 28.96 3.27 Favored Glycine 0 C--N 1.354 1.581 0 CA-C-O 119.53 -0.594 . . . . 44.4 113.427 -177.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 44.6 mt -72.19 72.25 0.9 Allowed 'General case' 0 CA--C 1.563 1.477 0 CA-C-N 117.316 0.558 . . . . 74.25 112.151 170.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.727 ' HB3' ' HB3' ' A' ' 112' ' ' ARG . 11.8 p90 32.4 -130.76 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 127.27 2.228 . . . . 72.25 116.199 163.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.443 ' HA2' ' H ' ' A' ' 169' ' ' ASN . . . 92.2 36.36 6.32 Favored Glycine 0 C--N 1.354 1.541 0 N-CA-C 111.49 -0.644 . . . . 44.0 111.49 -165.683 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 71.39 -74.29 0.71 Allowed Glycine 0 C--N 1.359 1.838 0 CA-C-O 121.434 0.463 . . . . 71.34 112.847 167.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -73.47 -8.01 54.15 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.4 1.08 . . . . 64.11 109.601 169.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -77.32 8.39 32.97 Favored Glycine 0 CA--C 1.544 1.884 0 CA-C-N 115.774 -0.648 . . . . 55.25 113.788 164.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.541 ' HG2' ' HA2' ' A' ' 81' ' ' GLY . 31.3 ttp180 83.86 -38.14 0.07 Allowed 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 125.539 1.536 . . . . 71.44 114.224 163.327 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.727 ' HB3' ' HB3' ' A' ' 106' ' ' PHE . 16.3 tpp85 -78.29 -35.77 47.46 Favored 'General case' 0 N--CA 1.506 2.325 0 CA-C-N 119.286 0.948 . . . . 73.25 111.994 178.267 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.519 ' HB3' ' HA ' ' A' ' 167' ' ' GLN . 69.0 m 58.14 67.54 0.94 Allowed 'General case' 0 CA--C 1.557 1.213 0 O-C-N 124.116 0.885 . . . . 74.21 112.277 177.382 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.654 ' NH2' ' H ' ' A' ' 87' ' ' GLY . 0.6 OUTLIER -110.49 -118.32 0.29 Allowed 'General case' 0 C--O 1.19 -2.064 0 N-CA-C 116.443 2.016 . . . . 74.52 116.443 -167.618 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 48.6 tptt -70.33 81.57 0.54 Allowed 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 115.85 1.796 . . . . 72.15 115.85 -159.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.714 ' H ' ' HA3' ' A' ' 172' ' ' GLY . . . -121.29 -155.56 9.53 Favored Glycine 0 CA--C 1.548 2.152 0 C-N-CA 127.317 2.389 . . . . 55.22 112.76 162.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.437 ' H ' ' HA ' ' A' ' 171' ' ' PRO . 0.0 OUTLIER -67.06 143.46 56.7 Favored 'General case' 0 C--O 1.285 2.97 0 N-CA-C 116.361 1.985 . . . . 71.34 116.361 178.926 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.598 ' HA ' ' O ' ' A' ' 173' ' ' ASP . 14.8 p-10 -76.16 104.57 6.75 Favored 'General case' 0 CA--C 1.552 1.052 0 CA-C-N 112.175 -2.284 . . . . 74.23 113.151 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.462 ' O ' HD12 ' A' ' 174' ' ' LEU . 6.4 tt -93.37 165.36 12.82 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.1 1.36 . . . . 70.23 107.556 174.122 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 30.4 ttp85 -112.66 130.82 55.91 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 118.503 0.592 . . . . 74.51 110.127 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.641 ' HB3' HD11 ' A' ' 174' ' ' LEU . . . -146.33 176.54 9.69 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.998 0.919 . . . . 41.51 110.886 -175.668 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -107.89 139.88 41.83 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-N 114.533 -1.212 . . . . 61.0 109.197 -171.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.587 ' HB2' HD13 ' A' ' 176' ' ' LEU . 45.7 tp -100.18 96.97 5.55 Favored Pre-proline 0 N--CA 1.473 0.71 0 N-CA-C 107.368 -1.345 . . . . 54.05 107.368 170.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.512 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 53.0 Cg_endo -75.54 107.31 2.44 Favored 'Trans proline' 0 C--N 1.37 1.704 0 N-CA-C 106.923 -1.991 . . . . 75.33 106.923 171.335 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.524 ' HB3' HD23 ' A' ' 180' ' ' LEU . 59.5 tp -116.54 127.47 54.55 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 109.241 -0.651 . . . . 64.01 109.241 -167.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.634 HG21 ' HB2' ' B' ' 4' ' ' SER . 50.6 m -57.03 130.55 46.58 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 124.66 1.225 . . . . 71.34 110.965 -178.679 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 35.4 mt -47.62 -47.22 29.01 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.358 1.063 . . . . 70.54 111.232 -178.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -56.23 -49.53 73.87 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 114.391 -1.277 . . . . 75.32 110.695 178.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -64.26 -33.71 76.45 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.298 0.639 . . . . 64.33 111.7 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.474 ' HB2' HD22 ' A' ' 180' ' ' LEU . . . -62.46 -38.68 90.76 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.459 0.704 . . . . 41.43 110.825 177.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -66.33 -46.02 78.26 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 114.874 -1.057 . . . . 74.51 111.071 173.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.499 ' HE1' ' HA ' ' B' ' 2' ' ' LYS . 24.0 m170 -66.55 -65.52 0.67 Allowed 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.282 0.633 . . . . 75.25 111.378 -173.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.509 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 90.82 179.76 43.15 Favored Glycine 0 C--N 1.346 1.117 0 CA-C-N 116.14 -0.482 . . . . 71.54 112.421 -177.029 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.59 -157.45 27.67 Favored Glycine 0 C--N 1.345 1.038 0 C-N-CA 123.298 0.475 . . . . 70.42 112.313 179.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 13.7 mp0 -70.98 98.77 1.67 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.929 0.892 . . . . 73.14 111.091 -176.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 7.1 tpp180 -94.01 119.95 33.59 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.872 0.869 . . . . 74.4 109.295 172.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.489 ' O ' HG23 ' B' ' 5' ' ' THR . 76.2 t -79.44 106.01 9.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 114.749 -1.114 . . . . 71.24 109.218 172.307 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.441 HG23 HG13 ' B' ' 6' ' ' ILE . 3.6 p -111.32 125.1 68.63 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 N-CA-C 108.86 -0.793 . . . . 73.14 108.86 172.406 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.553 ' HB3' ' HG3' ' A' ' 144' ' ' ARG . 6.4 pt-20 -124.97 116.46 22.19 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.547 0.739 . . . . 71.3 111.426 -166.296 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.476 HG11 ' HB2' ' B' ' 8' ' ' LEU . 9.2 p -159.92 155.19 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.166 0.986 . . . . 75.1 108.963 177.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 61.63 22.68 13.13 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 124.274 1.03 . . . . 74.24 112.757 174.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 87.42 -13.05 61.15 Favored Glycine 0 C--N 1.353 1.486 0 CA-C-N 116.369 -0.378 . . . . 31.1 113.285 -177.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 22.7 tpt180 -95.81 115.09 26.92 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.395 0.678 . . . . 72.12 110.251 178.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.553 ' HG3' ' HB3' ' A' ' 139' ' ' GLU . 13.1 ttt180 -100.55 88.22 3.57 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.081 0.952 . . . . 74.41 108.726 173.413 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 11.2 p -94.88 144.99 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 123.083 0.553 . . . . 73.53 110.909 -173.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 22.9 t -107.64 86.97 2.39 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 109.226 -0.657 . . . . 31.45 109.226 176.33 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.7 p -85.02 124.17 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 123.305 0.642 . . . . 73.42 110.003 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 61.6 ttt85 -75.88 95.74 3.58 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.311 0.577 . . . . 74.14 109.652 177.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.509 HG13 ' HA2' ' A' ' 133' ' ' GLY . 33.6 pt -77.37 140.2 64.76 Favored Pre-proline 0 CA--C 1.557 1.225 0 CA-C-N 115.255 -0.884 . . . . 74.13 109.977 175.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -61.86 130.83 32.54 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.547 2.164 . . . . 60.34 112.301 174.029 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -61.96 112.11 1.42 Allowed 'Trans proline' 0 C--N 1.377 2.065 0 C-N-CA 122.389 2.059 . . . . 74.15 111.45 170.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 84.37 46.3 5.87 Favored Glycine 0 C--N 1.343 0.951 0 N-CA-C 111.128 -0.789 . . . . 75.51 111.128 -171.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -80.36 153.1 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 N-CA-C 109.525 -0.546 . . . . 75.43 109.525 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.542 ' HG2' ' HA ' ' A' ' 191' ' ' GLN . 0.0 OUTLIER -124.91 159.46 31.09 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 123.448 0.699 . . . . 73.23 110.926 -174.629 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.437 ' HB2' ' HB3' ' A' ' 188' ' ' LEU . 10.4 tp10 -57.73 126.29 26.71 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.222 1.409 . . . . 72.32 110.998 -179.347 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 103.52 -10.32 53.46 Favored Glycine 0 C--N 1.347 1.148 0 CA-C-O 119.175 -0.792 . . . . 14.21 113.993 178.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 33.6 t -63.63 112.18 2.71 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 117.693 0.746 . . . . 74.23 109.962 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.471 HG22 HG22 ' A' ' 177' ' ' VAL . 41.8 t -89.51 115.96 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.156 0.582 . . . . 72.34 110.672 -176.32 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 55.2 mt -108.22 108.14 24.54 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 123.967 0.907 . . . . 75.24 108.684 175.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -75.39 101.17 4.67 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 108.68 -0.859 . . . . 61.32 108.68 174.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.438 HG11 HD12 ' A' ' 176' ' ' LEU . 7.6 p -124.15 113.58 27.99 Favored Pre-proline 0 CA--C 1.541 0.62 0 N-CA-C 108.26 -1.015 . . . . 61.33 108.26 -173.095 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.414 ' HA ' ' H ' ' A' ' 174' ' ' LEU . 10.1 Cg_exo -71.66 146.43 48.94 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 121.106 1.204 . . . . 74.53 111.839 178.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.538 ' H ' ' HA ' ' A' ' 173' ' ' ASP . . . 131.36 -23.91 4.24 Favored Glycine 0 C--N 1.344 0.977 0 N-CA-C 116.646 1.418 . . . . 70.43 116.646 170.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -124.47 -3.8 7.84 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 113.498 0.925 . . . . 64.15 113.498 -165.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.691 ' HA2' HD13 ' A' ' 174' ' ' LEU . . . -74.7 -100.23 0.1 OUTLIER Glycine 0 N--CA 1.474 1.202 0 CA-C-O 118.653 -1.082 . . . . 73.33 113.836 -174.299 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.659 ' HA3' ' HB2' ' A' ' 171' ' ' PRO . . . -70.04 167.17 49.19 Favored Glycine 0 C--N 1.377 2.808 0 C-N-CA 118.079 -2.01 . . . . 74.5 111.333 172.387 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.519 ' HA ' ' HB3' ' A' ' 113' ' ' SER . 7.1 mm-40 -104.32 102.85 12.52 Favored 'General case' 0 CA--C 1.56 1.359 0 CA-C-N 118.675 1.238 . . . . 75.42 114.095 -177.434 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 122.1 -161.64 16.17 Favored Glycine 0 C--N 1.369 2.392 0 N-CA-C 115.653 1.021 . . . . 64.21 115.653 164.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' ASN . . . . . 0.443 ' H ' ' HA2' ' A' ' 107' ' ' GLY . 20.4 m120 -63.88 -45.91 81.27 Favored Pre-proline 0 CA--C 1.576 1.953 0 CA-C-O 118.494 -0.765 . . . . 63.11 111.023 174.497 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.472 ' HB2' ' HD3' ' A' ' 171' ' ' PRO . 12.6 Cg_exo -72.67 -56.7 0.09 OUTLIER 'Trans proline' 0 CA--C 1.593 3.451 0 CA-C-N 121.973 1.74 . . . . 71.13 116.001 175.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.659 ' HB2' ' HA3' ' A' ' 166' ' ' GLY . 18.8 Cg_endo -98.75 155.27 0.7 Allowed 'Trans proline' 0 C--N 1.399 3.189 0 C-N-CA 122.647 2.231 . . . . 71.25 111.24 167.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.714 ' HA3' ' H ' ' A' ' 116' ' ' GLY . . . -170.13 -80.04 0.05 OUTLIER Glycine 0 C--N 1.379 2.951 0 N-CA-C 120.489 2.956 . . . . 72.4 120.489 -164.598 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.598 ' O ' ' HA ' ' A' ' 118' ' ' ASP . 59.0 m-20 -63.08 162.96 10.71 Favored 'General case' 0 N--CA 1.509 2.476 0 CA-C-N 118.054 0.927 . . . . 71.14 112.179 -168.592 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.691 HD13 ' HA2' ' A' ' 165' ' ' GLY . 20.1 tp -128.42 147.85 50.68 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 120.132 1.333 . . . . 64.32 113.608 -177.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 8.4 mt -111.09 92.75 4.17 Favored 'General case' 0 CA--C 1.555 1.145 0 N-CA-C 106.774 -1.565 . . . . 72.12 106.774 168.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.587 HD13 ' HB2' ' A' ' 123' ' ' LEU . 15.0 mt -76.19 138.51 40.71 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 118.132 0.424 . . . . 70.05 111.607 178.681 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.471 HG22 HG22 ' A' ' 158' ' ' VAL . 47.4 t -119.71 116.0 49.25 Favored 'Isoleucine or valine' 0 C--O 1.242 0.677 0 N-CA-C 106.017 -1.846 . . . . 61.43 106.017 164.378 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.449 ' HA ' ' HB3' ' A' ' 123' ' ' LEU . 10.1 p -72.12 120.32 20.3 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 CA-C-O 121.848 0.832 . . . . 70.33 111.314 -171.557 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.512 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 32.3 mmt180 -106.82 99.53 9.09 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 107.849 -1.167 . . . . 53.32 107.849 172.109 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.794 HD12 ' HG ' ' A' ' 188' ' ' LEU . 80.4 mt -70.12 131.22 43.96 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 109.162 -0.681 . . . . 72.4 109.162 179.362 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.486 HD12 ' HA ' ' A' ' 126' ' ' THR . 54.7 mt -53.38 150.5 11.92 Favored Pre-proline 0 N--CA 1.481 1.084 0 O-C-N 124.606 1.191 . . . . 73.14 113.666 -163.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -83.21 49.1 2.9 Favored 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 122.796 2.331 . . . . 71.42 108.488 160.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 26.6 t-80 -69.97 131.5 89.08 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 107.254 -1.387 . . . . 73.35 107.254 178.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_exo -16.84 -34.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.386 2.522 1 C-N-CA 127.977 5.784 . . . . 61.24 120.623 -164.466 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 4.8 t -95.06 -59.57 3.05 Favored 'Isoleucine or valine' 0 C--N 1.353 0.744 0 CA-C-N 120.011 1.278 . . . . 64.21 108.728 -172.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' PHE . . . . . 0.487 ' CD1' ' HB2' ' A' ' 195' ' ' ALA . 49.2 m-85 -115.76 154.62 29.28 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 121.177 0.513 . . . . 72.31 111.333 -169.384 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 26.6 ttp180 -138.6 129.57 26.77 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 107.032 -1.47 . . . . 75.51 107.032 165.102 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.794 ' HG ' HD12 ' A' ' 180' ' ' LEU . 4.5 mm? -79.51 166.16 22.24 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.96 0.886 . . . . 74.21 112.3 -176.429 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -163.83 96.86 0.83 Allowed 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 105.663 -1.976 . . . . 70.31 105.663 174.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 62.02 -122.6 29.11 Favored Glycine 0 CA--C 1.531 1.075 0 N-CA-C 111.413 -0.675 . . . . 65.41 111.413 -168.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.542 ' HA ' ' HG2' ' A' ' 154' ' ' ARG . 2.2 mp0 -86.39 -13.89 45.0 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.793 0.837 . . . . 72.32 111.512 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -107.98 156.57 19.08 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 121.718 0.771 . . . . 72.32 112.684 -168.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.536 HD21 ' HE1' ' A' ' 240' ' ' PHE . 59.5 mt -103.61 155.7 18.35 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.781 1.633 . . . . 63.44 111.06 -170.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -132.04 100.13 4.95 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 107.845 -1.168 . . . . 73.14 107.845 169.233 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.571 ' HB3' HD23 ' A' ' 251' ' ' LEU . . . -105.32 116.0 31.2 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.429 1.091 . . . . 74.34 110.656 -176.463 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 38.3 m -71.4 102.62 2.68 Favored 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 109.409 -0.589 . . . . 70.21 109.409 176.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.582 HD22 HD13 ' A' ' 251' ' ' LEU . 33.2 tp -101.26 104.42 15.45 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 108.727 -0.842 . . . . 72.21 108.727 -174.455 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -84.4 108.68 17.35 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.891 -0.781 . . . . 61.43 108.891 175.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.53 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 6.2 p -120.76 137.27 26.2 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 124.71 1.204 . . . . 64.4 108.316 -177.365 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.29 156.84 33.28 Favored 'Trans proline' 0 C--N 1.363 1.327 0 C-N-CA 121.485 1.457 . . . . 64.51 111.605 173.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.411 ' HB3' ' HH2' ' A' ' 269' ' ' TRP . . . -56.46 -48.82 96.35 Favored Pre-proline 0 CA--C 1.557 1.227 0 N-CA-C 114.701 1.371 . . . . 71.34 114.701 -168.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -57.5 -42.71 58.25 Favored 'Trans proline' 0 C--N 1.395 2.995 0 CA-C-N 121.526 1.581 . . . . 63.54 112.079 178.222 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.438 HG12 ' HE1' ' C' ' 277' ' ' TYR . 20.2 mt -73.21 -28.74 26.51 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 CA-C-N 115.262 -0.881 . . . . 64.32 110.634 -176.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -72.05 -48.64 42.89 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.348 0.659 . . . . 71.51 111.371 178.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.479 HG11 HD11 ' C' ' 261' ' ' LEU . 95.6 t -72.03 -41.54 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.469 0.708 . . . . 63.23 111.747 -175.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 70.3 t -87.32 -41.9 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 116.07 -0.513 . . . . 74.41 111.384 -176.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 91.73 83.81 1.46 Allowed Glycine 0 CA--C 1.525 0.711 0 CA-C-N 116.097 -0.501 . . . . 72.35 112.83 -177.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -126.22 -172.42 13.35 Favored Glycine 0 N--CA 1.473 1.149 0 N-CA-C 111.363 -0.695 . . . . 55.24 111.363 173.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 221' ' ' VAL . 50.2 mtmt -85.06 133.16 34.24 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 117.75 0.775 . . . . 45.21 112.522 -174.281 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 34.8 m -121.55 170.55 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 124.253 1.021 . . . . 63.11 108.726 166.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 22.2 ttm180 -82.43 109.36 16.6 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 109.473 -0.566 . . . . 71.41 109.473 172.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -103.18 132.32 49.52 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 108.426 -0.953 . . . . 62.04 108.426 173.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 213' ' ' MET . . . . . 0.444 ' SD ' ' N ' ' A' ' 213' ' ' MET . 1.5 mpt? -92.38 135.75 33.77 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.494 -0.558 . . . . 71.23 109.494 -175.448 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 55.8 p -111.79 -176.45 2.94 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.379 0.672 . . . . 74.1 109.517 174.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 58.5 mt -80.41 -4.17 52.59 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.658 0.783 . . . . 63.31 111.949 -177.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.428 ' HA ' ' HE2' ' B' ' 2' ' ' LYS . 56.3 mm-40 -115.65 -17.93 10.99 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.356 0.662 . . . . 64.44 111.507 176.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 156.16 175.35 27.04 Favored Glycine 0 C--N 1.354 1.536 0 C-N-CA 121.465 -0.398 . . . . 33.0 114.012 176.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -77.93 124.41 6.76 Favored 'Trans proline' 0 C--N 1.372 1.795 0 C-N-CA 122.934 2.423 . . . . 70.23 112.349 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 30.9 m -121.11 179.92 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 124.451 1.1 . . . . 73.4 109.429 177.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -102.58 150.27 23.58 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.356 0.662 . . . . 75.04 109.584 172.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 209' ' ' LYS . 2.8 p -145.98 141.36 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 N-CA-C 108.972 -0.751 . . . . 74.13 108.972 176.144 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -86.45 100.81 12.62 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.045 0.538 . . . . 60.25 110.47 -178.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 91.8 t -53.9 143.29 41.88 Favored Pre-proline 0 N--CA 1.494 1.734 0 C-N-CA 125.204 1.402 . . . . 63.14 111.136 -179.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 224' ' ' PRO . . . . . 0.416 ' HG3' ' O ' ' B' ' 441' ' ' ILE . 32.7 Cg_exo -62.11 162.83 21.59 Favored 'Trans proline' 0 C--N 1.386 2.534 0 C-N-CA 122.627 2.218 . . . . 75.51 112.406 172.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.54 155.47 35.92 Favored 'Trans proline' 0 C--N 1.367 1.521 0 C-N-CA 121.408 1.405 . . . . 72.53 111.134 166.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 226' ' ' ARG . . . . . 0.404 ' HD2' ' O ' ' C' ' 259' ' ' GLU . 21.1 mmt180 65.33 20.59 11.87 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 125.305 1.442 . . . . 74.04 112.244 173.371 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.437 HG23 HD21 ' A' ' 233' ' ' LEU . 96.5 m -59.19 104.52 0.25 Allowed 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 124.715 1.206 . . . . 64.32 111.202 -176.028 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 5.3 tp60 -98.11 133.97 41.83 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.689 1.196 . . . . 75.32 111.994 -168.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -62.48 140.32 58.6 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.833 1.253 . . . . 62.31 112.892 -173.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 92.37 -35.69 3.94 Favored Glycine 0 C--N 1.349 1.291 0 O-C-N 123.877 0.736 . . . . 73.32 112.005 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -74.04 161.76 29.71 Favored 'General case' 0 C--N 1.349 0.555 0 C-N-CA 123.867 0.867 . . . . 74.0 111.352 -177.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.723 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 3.4 mptp? -113.34 118.46 34.65 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.909 0.884 . . . . 72.22 109.065 -175.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.486 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 39.0 mt -76.79 100.25 5.41 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.764 -0.828 . . . . 71.4 108.764 178.466 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 54.3 ttm-85 -71.86 105.86 3.97 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 110.245 -0.279 . . . . 64.14 110.245 179.246 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.637 HD22 ' HA ' ' B' ' 441' ' ' ILE . 9.1 mt -95.31 104.06 15.94 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 107.508 -1.293 . . . . 61.12 107.508 173.648 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 18.0 tptp -71.47 118.82 14.76 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.353 0.661 . . . . 64.43 111.181 -172.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 85.47 32.21 19.92 Favored Glycine 0 C--N 1.35 1.347 0 O-C-N 123.418 0.449 . . . . 74.2 113.251 177.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -125.62 5.69 7.52 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.68 0.792 . . . . 73.01 112.443 -175.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -93.86 -157.5 33.15 Favored Glycine 0 N--CA 1.469 0.868 0 C-N-CA 123.378 0.513 . . . . 74.43 112.451 171.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 240' ' ' PHE . . . . . 0.536 ' HE1' HD21 ' A' ' 193' ' ' LEU . 27.2 m-85 -83.38 140.44 41.9 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 122.954 0.502 . . . . 73.13 111.136 -175.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 240' ' ' PHE . 3.6 Cg_exo -77.41 138.09 17.26 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 123.558 2.839 . . . . 73.33 112.587 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 178.19 -138.52 3.75 Favored Glycine 0 CA--C 1.534 1.275 0 CA-C-O 119.056 -0.858 . . . . 73.52 112.449 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -67.69 -12.52 35.8 Favored 'Trans proline' 0 C--N 1.382 2.337 0 C-N-CA 123.844 3.03 . . . . 70.45 114.086 -177.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -103.96 21.77 15.78 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.744 0.418 . . . . 70.11 110.37 175.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 71.88 -93.74 0.58 Allowed Glycine 0 C--N 1.353 1.483 0 N-CA-C 110.329 -1.108 . . . . 62.24 110.329 -173.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 -126.18 131.46 52.0 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 107.626 -1.25 . . . . 75.41 107.626 167.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -70.35 -168.0 7.0 Favored Glycine 0 C--N 1.352 1.419 0 O-C-N 123.266 0.354 . . . . 42.24 112.871 178.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -111.55 173.34 6.4 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 117.513 0.656 . . . . 75.44 111.112 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.531 HD23 HD12 ' A' ' 235' ' ' LEU . 23.5 tp -128.9 104.07 7.39 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.556 -0.905 . . . . 70.31 108.556 176.505 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.723 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 0.4 OUTLIER -89.81 105.65 17.94 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.701 -0.852 . . . . 52.51 108.701 -178.881 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.582 HD13 HD22 ' A' ' 197' ' ' LEU . 66.3 mt -84.93 101.95 12.75 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.906 -0.775 . . . . 72.24 108.906 177.375 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.588 ' HG2' ' HG3' ' A' ' 232' ' ' LYS . 26.0 mt-10 -76.36 104.47 6.89 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.025 0.93 . . . . 75.41 108.743 -177.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 40.6 t -67.11 127.68 29.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 114.316 -1.311 . . . . 24.43 112.145 -167.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.49 91.93 3.4 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 107.516 -1.291 . . . . 73.14 107.516 175.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.53 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 66.7 mt -79.4 133.55 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 109.777 -0.453 . . . . 74.34 109.777 -178.402 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 19.6 p -130.52 175.26 9.13 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.144 0.978 . . . . 73.43 110.481 174.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 257' ' ' ILE . . . . . 0.513 HD12 ' H ' ' A' ' 259' ' ' GLU . 2.7 pp -132.38 152.45 80.09 Favored Pre-proline 0 CA--C 1.558 1.26 0 C-N-CA 123.843 0.857 . . . . 73.4 109.557 -178.544 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -76.55 8.63 2.91 Favored 'Trans proline' 0 N--CA 1.507 2.301 0 C-N-CA 123.157 2.571 . . . . 74.45 115.03 -165.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.579 ' HG2' ' NE2' ' C' ' 228' ' ' GLN . 33.3 mt-10 53.11 -85.53 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.616 1.166 . . . . 63.24 111.219 -163.715 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.83 158.93 5.86 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.163 0.985 . . . . 75.12 111.878 179.135 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.619 HD22 ' HB3' ' A' ' 265' ' ' GLU . 74.7 mt -143.39 151.22 40.15 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.416 0.686 . . . . 55.32 110.558 178.448 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 58.3 p -83.67 161.57 55.74 Favored Pre-proline 0 CA--C 1.559 1.303 0 N-CA-C 108.689 -0.856 . . . . 44.34 108.689 166.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -42.06 -47.03 6.95 Favored 'Trans proline' 0 C--N 1.385 2.45 0 C-N-CA 123.779 2.986 . . . . 74.33 115.217 177.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -67.14 -47.42 71.15 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.017 0.527 . . . . 71.44 109.856 -179.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 265' ' ' GLU . . . . . 0.619 ' HB3' HD22 ' A' ' 261' ' ' LEU . 43.6 mt-10 -56.83 -42.46 79.67 Favored 'General case' 0 C--N 1.352 0.693 0 O-C-N 123.873 0.733 . . . . 64.2 110.866 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -62.58 -50.13 72.53 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 123.195 0.31 . . . . 73.45 110.292 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -54.97 -51.61 65.65 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 124.158 0.912 . . . . 64.12 111.569 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 268' ' ' LEU . . . . . 0.478 ' HB2' HD21 ' C' ' 272' ' ' LEU . 10.1 mp -73.67 -43.62 58.89 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.291 0.637 . . . . 73.14 111.935 -173.049 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 269' ' ' TRP . . . . . 0.411 ' HH2' ' HB3' ' A' ' 201' ' ' ALA . 62.5 m95 -58.68 -45.79 88.66 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 123.358 0.663 . . . . 75.0 111.086 177.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 270' ' ' LYS . . . . . 0.417 ' NZ ' ' HB3' ' A' ' 270' ' ' LYS . 8.7 mtpm? -63.34 -50.06 71.48 Favored 'General case' 0 C--N 1.352 0.693 0 CA-C-N 115.842 -0.617 . . . . 62.43 111.012 178.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -64.38 -29.66 70.72 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.045 0.538 . . . . 70.22 111.979 -179.087 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 272' ' ' LEU . . . . . 0.424 ' O ' ' HB2' ' A' ' 276' ' ' TYR . 31.5 mt -61.62 -52.41 64.48 Favored 'General case' 0 C--O 1.211 -0.943 0 N-CA-C 109.377 -0.601 . . . . 63.4 109.377 172.238 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -64.68 -37.04 86.23 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 123.904 0.752 . . . . 64.51 112.824 -178.099 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -67.18 -47.65 70.3 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.823 0.849 . . . . 74.35 110.485 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 275' ' ' ALA . . . . . 0.514 ' O ' ' HG2' ' A' ' 279' ' ' ARG . . . -59.68 -60.13 4.34 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.546 0.738 . . . . 71.44 109.767 175.32 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 276' ' ' TYR . . . . . 0.424 ' HB2' ' O ' ' A' ' 272' ' ' LEU . 24.5 t80 -39.24 -58.96 1.1 Allowed 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 127.45 2.3 . . . . 75.02 111.939 178.072 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -62.45 -46.02 90.44 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 114.572 -1.195 . . . . 70.12 109.963 -176.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -69.81 -8.9 52.24 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.005 0.742 . . . . 75.41 113.005 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 279' ' ' ARG . . . . . 0.514 ' HG2' ' O ' ' A' ' 275' ' ' ALA . 8.7 mmm180 -93.26 -7.45 45.02 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 117.902 0.319 . . . . 74.13 111.63 177.164 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 280' ' ' ALA . . . . . 0.555 ' HA ' HD21 ' B' ' 59' ' ' LEU . . . . . . . . 0 CA--C 1.555 1.163 0 CA-C-O 118.309 -0.853 . . . . 72.21 109.811 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.2 mmt . . . . . 0 N--CA 1.475 0.796 0 N-CA-C 110.135 -0.321 . . . . 71.44 110.135 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.499 ' HA ' ' HE1' ' A' ' 132' ' ' HIS . 0.2 OUTLIER -78.68 1.45 22.86 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.934 0.894 . . . . 54.1 113.286 -165.996 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.62 10.04 4.71 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.811 0.845 . . . . 74.04 111.118 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 4' ' ' SER . . . . . 0.634 ' HB2' HG21 ' A' ' 126' ' ' THR . 60.8 m -70.81 101.11 2.04 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-O 121.599 0.714 . . . . 52.14 110.703 -176.172 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 5' ' ' THR . . . . . 0.489 HG23 ' O ' ' A' ' 137' ' ' VAL . 92.9 m -85.85 154.78 21.3 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 114.337 -1.301 . . . . 70.11 110.986 -179.501 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.493 HD13 ' HA ' ' A' ' 125' ' ' LEU . 21.9 pt -126.61 178.44 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 C-N-CA 124.509 1.124 . . . . 64.44 111.487 -167.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -147.19 134.5 20.66 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.805 1.242 . . . . 72.01 108.448 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.502 HD12 ' HA ' ' A' ' 123' ' ' LEU . 1.5 mm? -63.59 150.9 43.04 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 118.575 0.625 . . . . 75.22 111.569 -178.404 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.04 -43.17 79.33 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 114.787 -1.097 . . . . 62.4 110.054 173.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 29.9 mt 74.34 -40.76 0.46 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 126.477 1.911 . . . . 74.1 113.525 -179.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.426 ' N ' ' HD3' ' B' ' 12' ' ' PRO . 53.1 mt 55.53 53.26 8.5 Favored Pre-proline 0 CA--C 1.565 1.533 0 C-N-CA 124.566 1.146 . . . . 45.35 110.714 -173.121 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.742 ' HD2' ' HB3' ' B' ' 15' ' ' PHE . 11.2 Cg_exo -68.59 122.55 9.52 Favored 'Trans proline' 0 C--N 1.392 2.818 0 C-N-CA 122.571 2.181 . . . . 61.33 111.068 -175.099 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 45.43 -76.16 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 126.47 1.908 . . . . 75.01 113.775 -173.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 18.6 tp -145.76 29.59 1.11 Allowed 'General case' 0 N--CA 1.484 1.255 0 CA-C-O 121.569 0.699 . . . . 64.54 110.201 -175.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 15' ' ' PHE . . . . . 0.742 ' HB3' ' HD2' ' B' ' 12' ' ' PRO . 87.3 t80 -92.04 101.94 14.49 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.147 0.579 . . . . 60.01 109.454 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 3.1 t -167.21 150.29 5.95 Favored Pre-proline 0 N--CA 1.478 0.971 0 C-N-CA 125.171 1.388 . . . . 51.11 108.521 -178.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -58.87 -18.34 41.55 Favored 'Trans proline' 0 C--N 1.375 1.964 0 C-N-CA 122.478 2.119 . . . . 62.42 113.722 171.148 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 5.2 t -96.63 14.34 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.494 0 C-N-CA 123.826 0.85 . . . . 61.41 110.327 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 19' ' ' THR . . . . . 0.537 HG23 ' HD2' ' B' ' 20' ' ' LYS . 9.8 t -59.67 -39.09 83.33 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.49 0.716 . . . . 71.22 111.654 -178.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 20' ' ' LYS . . . . . 0.537 ' HD2' HG23 ' B' ' 19' ' ' THR . 2.6 mptp? -140.11 161.95 36.4 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.483 1.113 . . . . 62.34 108.711 172.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.85 80.18 5.22 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 109.119 -0.697 . . . . 75.34 109.119 174.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 34.7 mtm180 -80.43 -50.96 9.39 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.183 -0.917 . . . . 73.31 110.184 -176.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 23' ' ' THR . . . . . . . . . . . . . 10.6 m 57.34 87.82 0.13 Allowed Pre-proline 0 CA--C 1.556 1.201 0 O-C-N 124.746 1.279 . . . . 72.45 110.225 -170.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -81.67 42.46 1.33 Allowed 'Trans proline' 0 C--N 1.372 1.787 0 C-N-CA 123.163 2.575 . . . . 74.55 112.617 -179.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -62.5 -54.62 37.27 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.254 1.021 . . . . 74.53 110.59 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 26' ' ' MET . . . . . 0.529 ' HB3' HG21 ' B' ' 296' ' ' THR . 65.9 mtt -119.04 164.8 19.25 Favored Pre-proline 0 CA--C 1.544 0.722 0 CA-C-N 114.847 -1.07 . . . . 75.13 110.091 -174.602 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 27' ' ' PRO . . . . . 0.403 ' HD2' HG21 ' B' ' 296' ' ' THR . 61.7 Cg_exo -47.54 -31.49 13.93 Favored 'Trans proline' 0 C--N 1.382 2.305 0 C-N-CA 123.385 2.723 . . . . 71.1 114.198 165.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 84.0 t 71.73 -70.49 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 C-N-CA 125.317 1.447 . . . . 73.51 111.212 176.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -109.97 104.3 13.18 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 108.616 -0.883 . . . . 62.2 108.616 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -96.64 -19.96 18.64 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.549 0.74 . . . . 70.24 109.577 170.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 70.15 -80.07 0.04 OUTLIER 'General case' 0 C--N 1.357 0.902 0 C-N-CA 126.234 1.813 . . . . 74.34 111.229 175.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -80.59 85.31 6.01 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.262 0.553 . . . . 72.22 110.406 -173.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -129.68 84.81 2.24 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.436 -0.949 . . . . 73.31 108.436 174.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -127.52 92.94 3.59 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.18 0.992 . . . . 53.33 109.333 -178.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 67.19 91.48 0.09 Allowed 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.654 1.182 . . . . 73.13 110.609 -179.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.72 89.96 0.1 Allowed Glycine 0 C--N 1.343 0.97 0 N-CA-C 110.846 -0.902 . . . . 74.33 110.846 -178.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 61.99 95.46 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.297 1.439 . . . . 61.44 111.262 -173.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 2.8 mp -67.26 106.98 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 N-CA-C 107.343 -1.354 . . . . 75.44 107.343 172.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 14.7 t -68.3 -22.26 64.73 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 123.571 0.749 . . . . 64.25 112.473 -173.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . 58.3 78.13 0.37 Allowed Pre-proline 0 N--CA 1.48 1.042 0 C-N-CA 124.521 1.128 . . . . 64.0 110.577 -174.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.94 -158.27 0.09 OUTLIER 'Trans proline' 0 C--N 1.372 1.811 0 C-N-CA 122.895 2.397 . . . . 72.44 112.039 -177.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 42' ' ' GLY . . . . . 0.579 ' HA3' ' HB2' ' C' ' 246' ' ' ARG . . . -82.7 76.01 2.29 Favored Glycine 0 C--N 1.344 1.026 0 N-CA-C 114.074 0.39 . . . . 45.24 114.074 -174.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -93.52 -114.77 2.41 Favored Glycine 0 C--N 1.342 0.891 0 N-CA-C 111.141 -0.784 . . . . 42.15 111.141 171.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.81 124.36 24.66 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.587 0.755 . . . . 63.2 110.461 178.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.441 ' NE ' ' HB ' ' B' ' 232' ' ' THR . 14.1 mtp180 -86.22 -176.34 5.88 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.805 0.842 . . . . 74.21 110.645 -178.292 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 16.3 tpt180 -113.7 141.11 47.64 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.674 0.789 . . . . 75.02 109.168 176.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -137.68 67.4 1.43 Allowed 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.872 0.844 . . . . 53.22 109.335 175.425 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 9.8 m -56.75 -33.39 66.53 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 114.769 -1.105 . . . . 51.22 111.842 -178.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 159.53 61.2 0.01 OUTLIER Glycine 0 C--N 1.341 0.851 0 N-CA-C 109.762 -1.335 . . . . 74.15 109.762 177.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 28.9 t70 68.49 -97.41 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.785 1.234 . . . . 64.2 109.203 -165.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 51' ' ' GLN . . . . . 0.479 ' HG3' ' HB2' ' B' ' 53' ' ' ALA . 36.4 tp60 175.38 -30.66 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.929 1.292 . . . . 75.3 110.222 177.026 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 6.9 m 59.32 40.27 21.39 Favored 'General case' 0 CA--C 1.557 1.213 0 CA-C-O 122.187 0.994 . . . . 73.31 109.326 -174.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 53' ' ' ALA . . . . . 0.479 ' HB2' ' HG3' ' B' ' 51' ' ' GLN . . . -80.06 66.3 5.51 Favored 'General case' 0 C--N 1.354 0.786 0 CA-C-N 114.715 -1.13 . . . . 73.24 109.766 179.106 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.449 ' HB1' ' O ' ' B' ' 161' ' ' ALA . . . -97.56 166.86 11.31 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-N 114.533 -1.212 . . . . 75.51 109.952 -176.065 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.489 ' HB3' ' HB3' ' B' ' 58' ' ' SER . 8.1 mp 75.49 -36.57 0.3 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 125.555 1.542 . . . . 72.35 112.063 -173.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 54.3 ttp85 73.4 -74.9 0.08 Allowed 'General case' 0 C--N 1.365 1.243 0 C-N-CA 125.411 1.484 . . . . 73.2 110.07 179.128 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -131.26 -14.89 3.32 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.947 0.899 . . . . 75.31 110.951 172.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 58' ' ' SER . . . . . 0.489 ' HB3' ' HB3' ' B' ' 55' ' ' LEU . 89.8 p 59.6 12.91 3.06 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 125.944 1.698 . . . . 62.01 113.659 -177.583 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 59' ' ' LEU . . . . . 0.555 HD21 ' HA ' ' A' ' 280' ' ' ALA . 97.8 mt -90.06 125.34 35.38 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 123.898 0.879 . . . . 72.44 109.147 176.099 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 60' ' ' SER . . . . . 0.406 ' HB3' ' HG ' ' B' ' 142' ' ' LEU . 73.9 p -75.49 168.13 20.59 Favored 'General case' 0 C--O 1.24 0.588 0 O-C-N 123.722 0.638 . . . . 63.51 110.866 174.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -69.88 155.04 41.16 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 114.853 -1.067 . . . . 71.45 110.603 174.025 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 62' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -140.48 93.54 8.75 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 124.462 1.105 . . . . 72.3 108.115 171.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -72.46 -16.03 27.59 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 122.593 2.195 . . . . 72.24 112.435 176.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 70.41 -70.7 0.14 Allowed 'General case' 0 C--N 1.365 1.259 0 C-N-CA 125.955 1.702 . . . . 72.04 111.734 179.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 56.1 pttt -124.5 -1.08 8.08 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.984 0.914 . . . . 65.32 111.27 178.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 60.1 t30 73.98 -63.11 0.44 Allowed 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 125.761 1.624 . . . . 72.41 111.227 -176.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 1.8 pp -78.42 68.86 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.278 0 C-N-CA 124.221 1.008 . . . . 72.03 111.913 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 10.3 tt -48.28 -40.75 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 C-N-CA 125.205 1.402 . . . . 73.4 113.834 -173.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 44.5 tp -125.17 -10.96 7.04 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.16 0.584 . . . . 73.12 111.263 -176.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 2.9 tt 61.59 87.26 0.1 Allowed 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 108.003 -1.11 . . . . 44.44 108.003 -166.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 15.1 tt -92.62 142.31 13.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 C-N-CA 123.798 0.839 . . . . 74.32 109.749 -178.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -83.5 179.93 52.39 Favored Glycine 0 C--N 1.347 1.161 0 N-CA-C 112.266 -0.334 . . . . 62.21 112.266 176.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -72.27 118.91 15.74 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.122 0.569 . . . . 63.44 109.531 177.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.55 24.83 73.94 Favored Glycine 0 C--N 1.353 1.519 0 O-C-N 123.682 0.614 . . . . 64.42 112.111 -172.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 75' ' ' MET . . . . . 0.6 ' HG3' ' HB2' ' B' ' 193' ' ' PRO . 0.6 OUTLIER 69.33 -67.48 0.22 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 126.01 1.724 . . . . 74.01 110.936 -171.796 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 107.08 67.06 0.64 Allowed Glycine 0 C--N 1.343 0.928 0 N-CA-C 110.616 -0.994 . . . . 71.13 110.616 -176.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 77' ' ' ASP . . . . . 0.404 ' HB2' ' SD ' ' B' ' 75' ' ' MET . 25.0 t70 -140.96 156.67 46.02 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.532 0.733 . . . . 73.03 109.826 -174.358 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 92.7 p 58.39 -78.86 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 127.036 2.135 . . . . 51.1 112.706 179.134 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 68.16 -73.08 0.09 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.375 1.47 . . . . 74.44 110.661 -174.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 14.8 pt -136.33 30.33 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 124.885 1.274 . . . . 72.52 108.494 174.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 56.4 m 74.49 -48.48 0.65 Allowed 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 126.411 1.884 . . . . 71.34 110.369 -170.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.56 127.79 32.91 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 109.047 -0.723 . . . . 61.11 109.047 164.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -177.04 -47.99 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.305 1.442 . . . . 71.35 107.424 -176.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -81.21 -168.47 1.84 Allowed 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 114.144 -1.389 . . . . 73.0 109.504 176.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -75.08 81.33 2.25 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 108.538 -0.912 . . . . 72.23 108.538 176.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 66.55 170.63 0.24 Allowed 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 125.631 1.572 . . . . 63.12 112.25 -179.134 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.38 137.57 9.3 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.263 0.625 . . . . 52.24 110.013 -177.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -79.97 104.5 10.59 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.812 0.845 . . . . 74.14 109.443 178.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.49 91.66 0.28 Allowed Glycine 0 C--N 1.345 1.053 0 O-C-N 123.454 0.471 . . . . 54.33 111.939 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.8 -30.57 70.03 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.539 0.736 . . . . 62.33 111.748 -178.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.63 -78.97 0.59 Allowed Glycine 0 C--N 1.348 1.208 0 CA-C-N 116.06 -0.518 . . . . 70.11 111.906 -177.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 68.86 -88.4 0.22 Allowed Glycine 0 C--N 1.351 1.41 0 N-CA-C 111.298 -0.721 . . . . 23.53 111.298 -178.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -161.19 48.88 0.22 Allowed 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 107.508 -1.293 . . . . 74.22 107.508 174.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -58.37 -42.11 86.25 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 115.666 -0.697 . . . . 71.21 110.237 178.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 95' ' ' LYS . . . . . 0.468 ' HB3' ' HB2' ' B' ' 98' ' ' ASP . 14.5 mmmm -132.75 -44.4 0.89 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.85 0.86 . . . . 74.14 110.235 176.487 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.16 -98.87 2.26 Favored Glycine 0 C--N 1.348 1.234 0 N-CA-C 111.552 -0.619 . . . . 72.31 111.552 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 3.2 mp -92.24 -66.94 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 108.391 -0.966 . . . . 72.22 108.391 175.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 98' ' ' ASP . . . . . 0.468 ' HB2' ' HB3' ' B' ' 95' ' ' LYS . 26.7 t70 61.06 -82.26 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 125.127 1.371 . . . . 75.21 112.409 174.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -159.97 92.76 1.03 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 106.652 -1.61 . . . . 61.12 106.652 179.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 6.5 tt -64.54 114.64 15.15 Favored Pre-proline 0 CA--C 1.55 0.957 0 C-N-CA 123.966 0.906 . . . . 74.2 110.218 -175.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -56.29 121.3 9.77 Favored 'Trans proline' 0 C--N 1.386 2.504 0 C-N-CA 122.715 2.276 . . . . 72.21 110.871 172.17 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 102' ' ' LEU . . . . . 0.599 HD13 ' HB2' ' C' ' 118' ' ' ASP . 62.3 mt -76.75 10.4 2.24 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.191 0.996 . . . . 73.12 113.083 -166.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 26.7 m -72.49 -43.3 63.83 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.905 0.882 . . . . 75.52 110.458 170.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . -151.85 -167.67 15.33 Favored Glycine 0 C--N 1.346 1.089 0 CA-C-N 115.508 -0.769 . . . . 51.35 112.339 -175.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 105' ' ' GLN . . . . . 0.564 ' HB3' ' HA ' ' B' ' 110' ' ' ALA . 32.2 tt0 -77.74 80.17 4.2 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 108.888 -0.782 . . . . 75.22 108.888 175.129 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 32.7 t80 77.11 -55.62 0.54 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 126.081 1.752 . . . . 74.44 112.312 177.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 15.0 p -129.54 103.31 6.8 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.188 0.595 . . . . 63.32 110.574 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 61.9 m80 66.1 -77.46 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 125.283 1.433 . . . . 71.44 113.289 171.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -128.34 167.59 16.74 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.954 1.301 . . . . 53.33 108.329 -175.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 110' ' ' ALA . . . . . 0.564 ' HA ' ' HB3' ' B' ' 105' ' ' GLN . . . -64.04 149.46 47.43 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.369 0.604 . . . . 71.24 111.394 175.394 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 8.3 mp -74.73 -8.3 55.98 Favored 'General case' 0 CA--C 1.554 1.099 0 CA-C-N 115.537 -0.756 . . . . 64.15 110.139 172.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -70.37 84.47 0.58 Allowed 'General case' 0 C--N 1.362 1.128 0 C-N-CA 124.15 0.98 . . . . 73.2 109.641 170.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 113' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -166.12 -168.66 1.29 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.176 1.39 . . . . 75.13 108.049 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -81.07 13.32 2.82 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 113.072 0.767 . . . . 74.01 113.072 -174.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 10.9 t -165.49 153.29 10.98 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.896 0.879 . . . . 73.23 109.741 168.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 107.19 -41.74 2.11 Favored Glycine 0 N--CA 1.472 1.051 0 CA-C-O 119.95 -0.361 . . . . 55.33 112.713 176.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -141.45 94.48 7.53 Favored Pre-proline 0 N--CA 1.48 1.052 0 C-N-CA 123.267 0.627 . . . . 70.25 109.965 176.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 118' ' ' PRO . . . . . 0.524 ' HA ' ' HD2' ' B' ' 193' ' ' PRO . 91.5 Cg_endo -82.99 162.34 15.76 Favored 'Trans proline' 0 C--N 1.367 1.549 0 C-N-CA 122.564 2.176 . . . . 60.53 111.206 165.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 119' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -150.03 -179.27 7.03 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 108.704 -0.851 . . . . 75.33 108.704 178.319 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 120' ' ' TYR . . . . . . . . . . . . . 29.7 p90 -143.47 177.48 8.43 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.034 0.934 . . . . 70.1 109.674 -171.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 121' ' ' VAL . . . . . 0.557 HG13 ' H ' ' B' ' 122' ' ' THR . 2.1 p -164.02 -68.74 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 N-CA-C 107.902 -1.147 . . . . 74.32 107.902 166.146 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 122' ' ' THR . . . . . 0.557 ' H ' HG13 ' B' ' 121' ' ' VAL . 39.8 p 47.72 14.7 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 115.69 1.737 . . . . 75.24 115.69 171.027 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -177.99 143.51 0.31 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.271 1.029 . . . . 64.3 108.813 -175.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 46.8 m 58.99 24.95 13.22 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.244 1.018 . . . . 43.31 111.94 178.369 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -68.28 -15.08 63.43 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.672 1.189 . . . . 73.02 112.35 -176.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . 63.63 -167.69 0.21 Allowed 'General case' 0 C--N 1.365 1.26 0 C-N-CA 124.535 1.134 . . . . 74.13 109.638 -171.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 127' ' ' SER . . . . . 0.645 ' H ' HD23 ' B' ' 218' ' ' LEU . 16.0 m 59.99 -156.02 0.35 Allowed 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 123.299 0.64 . . . . 70.01 110.771 177.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -170.13 93.37 0.23 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.297 1.039 . . . . 72.01 108.475 165.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 73.8 p 49.86 -93.48 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.249 0 C-N-CA 125.644 1.578 . . . . 54.34 112.747 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 130' ' ' ALA . . . . . 0.411 ' HA ' ' HB2' ' B' ' 222' ' ' ALA . . . 173.77 81.98 0.0 OUTLIER 'General case' 0 C--O 1.238 0.481 0 N-CA-C 105.451 -2.055 . . . . 44.22 105.451 -178.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 131' ' ' TRP . . . . . 0.593 ' HE1' ' HB3' ' B' ' 164' ' ' ALA . 87.1 t90 80.09 -37.48 0.16 Allowed 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 125.424 1.49 . . . . 73.51 112.527 -174.259 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 32.0 t -70.0 78.85 0.49 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.626 1.17 . . . . 51.4 113.229 -166.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 12.0 t 177.91 172.96 0.61 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 125.179 1.391 . . . . 62.25 109.216 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 134' ' ' GLY . . . . . 0.496 ' HA3' HG21 ' B' ' 165' ' ' THR . . . 80.39 -73.82 2.44 Favored Glycine 0 C--N 1.349 1.273 0 N-CA-C 110.999 -0.841 . . . . 55.15 110.999 -178.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 135' ' ' VAL . . . . . 0.587 HG11 HD21 ' B' ' 155' ' ' LEU . 11.8 m -73.74 123.83 29.71 Favored 'Isoleucine or valine' 0 C--O 1.242 0.662 0 N-CA-C 108.342 -0.984 . . . . 73.24 108.342 169.546 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? 76.18 -10.59 1.27 Allowed 'General case' 0 CA--C 1.559 1.318 0 C-N-CA 125.737 1.615 . . . . 52.43 111.731 -174.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 26.8 m 69.7 -67.54 0.22 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 125.891 1.677 . . . . 75.31 112.157 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -68.26 -55.31 12.62 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.739 1.216 . . . . 75.52 112.17 -172.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -152.86 125.38 8.22 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 108.788 -0.819 . . . . 73.24 108.788 -172.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -68.73 -81.17 0.21 Allowed Glycine 0 C--N 1.35 1.311 0 O-C-N 123.544 0.528 . . . . 65.04 112.726 -179.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . 64.14 -1.49 0.69 Allowed 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 125.326 1.451 . . . . 75.34 114.628 175.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 142' ' ' LEU . . . . . 0.516 ' HB3' HG12 ' B' ' 144' ' ' VAL . 32.4 mt 52.96 94.66 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.854 1.262 . . . . 70.15 111.855 -170.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -79.32 58.86 4.38 Favored Glycine 0 C--N 1.351 1.415 0 N-CA-C 112.052 -0.419 . . . . 61.25 112.052 174.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 144' ' ' VAL . . . . . 0.516 HG12 ' HB3' ' B' ' 142' ' ' LEU . 11.4 p -143.7 158.28 16.49 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 C-N-CA 124.274 1.03 . . . . 75.31 108.874 -174.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -69.75 84.69 0.47 Allowed 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 124.311 1.045 . . . . 64.3 111.955 -175.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 146' ' ' ILE . . . . . 0.418 HG22 HH21 ' A' ' 279' ' ' ARG . 3.7 mp 60.32 9.92 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.586 2.36 0 C-N-CA 125.427 1.491 . . . . 72.52 112.157 174.684 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 49.5 p-80 46.8 88.11 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 126.148 1.779 . . . . 72.43 113.061 -174.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -95.55 -44.78 7.35 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.46 -0.775 . . . . 73.05 112.821 -172.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 149' ' ' LYS . . . . . 0.489 ' HB2' HG23 ' B' ' 153' ' ' THR . 0.8 OUTLIER -80.94 123.61 28.45 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 122.793 0.437 . . . . 72.23 110.352 -174.439 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 24.6 t70 57.34 -92.67 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.696 1.198 . . . . 74.11 110.222 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 151' ' ' HIS . . . . . 0.475 ' HB2' ' HD3' ' B' ' 152' ' ' PRO . 91.2 m-70 -144.97 -61.7 0.02 OUTLIER Pre-proline 0 CA--C 1.561 1.383 0 CA-C-O 118.044 -0.979 . . . . 74.43 110.309 176.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 152' ' ' PRO . . . . . 0.475 ' HD3' ' HB2' ' B' ' 151' ' ' HIS . 43.5 Cg_endo -85.97 -0.89 8.64 Favored 'Trans proline' 0 C--N 1.399 3.205 0 CA-C-N 122.3 1.857 . . . . 42.51 113.139 178.099 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 153' ' ' THR . . . . . 0.489 HG23 ' HB2' ' B' ' 149' ' ' LYS . 72.9 m 62.28 79.63 0.25 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 125.291 1.436 . . . . 74.2 111.876 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 9.5 tt 48.97 24.42 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 C-N-CA 126.698 1.999 . . . . 74.25 113.087 175.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 155' ' ' LEU . . . . . 0.587 HD21 HG11 ' B' ' 135' ' ' VAL . 4.8 tt -66.21 -49.97 65.44 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 107.704 -1.221 . . . . 72.1 107.704 178.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -98.69 111.01 23.52 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 108.2 -1.037 . . . . 72.23 108.2 165.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 157' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -68.54 -45.82 71.14 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 108.31 -0.996 . . . . 53.54 108.31 173.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 158' ' ' ALA . . . . . . . . . . . . . . . -74.15 96.38 2.73 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 108.52 -0.918 . . . . 34.04 108.52 167.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -72.87 87.93 1.32 Allowed 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 108.752 -0.833 . . . . 55.45 108.752 177.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -97.97 2.12 48.65 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 114.882 -1.054 . . . . 70.22 110.15 176.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 161' ' ' ALA . . . . . 0.449 ' O ' ' HB1' ' B' ' 54' ' ' ALA . . . 67.68 16.55 9.82 Favored 'General case' 0 C--N 1.359 1.009 0 C-N-CA 124.896 1.279 . . . . 71.1 112.449 176.201 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . -70.82 -29.35 69.42 Favored Glycine 0 C--N 1.347 1.163 0 CA-C-O 120.053 -0.304 . . . . 73.4 112.555 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 35.4 tp 73.63 84.27 0.11 Allowed 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.652 1.581 . . . . 65.02 109.379 -172.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 164' ' ' ALA . . . . . 0.593 ' HB3' ' HE1' ' B' ' 131' ' ' TRP . . . 63.07 -78.95 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 126.142 1.777 . . . . 75.34 112.972 176.312 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 165' ' ' THR . . . . . 0.508 HG23 HG13 ' B' ' 135' ' ' VAL . 10.9 p -112.03 14.96 20.81 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.214 1.005 . . . . 64.15 112.042 -175.347 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . 78.31 67.76 1.58 Allowed Glycine 0 C--N 1.344 0.997 0 N-CA-C 111.559 -0.617 . . . . 71.15 111.559 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 167' ' ' ASN . . . . . 0.418 ' HB2' ' HD1' ' B' ' 131' ' ' TRP . 2.9 t-20 -54.77 -50.17 69.12 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.613 0.765 . . . . 72.31 110.294 176.141 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 20.1 m 43.74 22.7 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 C-N-CA 126.398 1.879 . . . . 74.13 114.76 174.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 169' ' ' SER . . . . . 0.474 ' HB3' HD13 ' B' ' 226' ' ' LEU . 50.6 m -70.27 113.82 7.81 Favored 'General case' 0 C--N 1.352 0.676 0 N-CA-C 108.303 -0.999 . . . . 54.35 108.303 176.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 170' ' ' THR . . . . . 0.514 ' O ' ' HD2' ' B' ' 231' ' ' LYS . 24.5 m 82.17 -50.05 0.21 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 126.472 1.909 . . . . 63.1 110.479 -171.686 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -50.4 -36.9 34.88 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.844 1.258 . . . . 53.32 113.702 -177.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 172' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -65.52 -45.05 84.99 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.89 0.876 . . . . 73.22 111.444 -178.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 173' ' ' LEU . . . . . 0.532 HD13 ' HB3' ' B' ' 231' ' ' LYS . 33.3 tp 77.4 -17.17 0.58 Allowed 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 125.224 1.41 . . . . 74.23 112.715 176.607 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 174' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -98.52 101.17 12.53 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 121.811 -0.556 . . . . 74.45 111.963 -170.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 175' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 70.8 172.79 0.31 Allowed 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 114.236 1.199 . . . . 74.1 114.236 163.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -164.65 -175.31 3.77 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-N 113.501 -1.681 . . . . 74.11 107.85 176.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 60.5 m -108.14 95.25 14.86 Favored Pre-proline 0 N--CA 1.479 0.979 0 N-CA-C 108.533 -0.914 . . . . 64.31 108.533 166.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 178' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -87.64 -176.75 1.82 Allowed 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 123.05 2.5 . . . . 74.53 112.362 175.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -84.02 -177.76 6.77 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.68 0.792 . . . . 61.34 110.726 175.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 180' ' ' ALA . . . . . 0.495 ' HB1' HG23 ' C' ' 137' ' ' VAL . . . -63.71 -63.68 1.1 Allowed 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 109.16 -0.681 . . . . 74.4 109.16 170.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 181' ' ' LEU . . . . . 0.574 HD13 ' HB2' ' C' ' 136' ' ' ARG . 45.1 tp -143.85 -67.28 0.34 Allowed 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 106.727 -1.582 . . . . 62.04 106.727 167.607 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 182' ' ' VAL . . . . . 0.559 HG23 ' HB2' ' C' ' 125' ' ' LEU . 14.7 p -151.4 153.78 9.34 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 N-CA-C 107.185 -1.413 . . . . 71.31 107.185 -177.137 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -83.08 63.97 7.41 Favored 'General case' 0 CA--C 1.562 1.438 0 N-CA-C 115.266 1.58 . . . . 65.24 115.266 -158.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 12.3 m170 60.79 -176.16 0.11 Allowed 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 114.379 1.252 . . . . 74.15 114.379 161.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 185' ' ' VAL . . . . . . . . . . . . . 2.6 p -99.72 112.6 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 122.816 0.446 . . . . 71.33 110.509 173.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 72.6 p 62.56 -67.8 0.07 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 126.76 2.024 . . . . 51.31 114.467 168.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 187' ' ' SER . . . . . . . . . . . . . 16.2 m -53.69 96.23 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.584 1.154 . . . . 62.14 111.353 177.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 19.1 mmm180 -138.66 139.76 38.6 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.538 0.735 . . . . 71.52 111.077 -177.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -115.35 80.61 1.45 Allowed 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.068 -1.086 . . . . 72.52 108.068 170.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 190' ' ' CYS . . . . . . . . . . . . . 25.6 p -169.45 149.54 4.02 Favored 'General case' 0 C--O 1.245 0.832 0 CA-C-N 115.012 -0.995 . . . . 70.33 109.194 178.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 43.9 t80 69.68 160.78 0.2 Allowed 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 124.876 1.27 . . . . 74.04 112.154 174.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 157.07 -161.18 30.97 Favored Glycine 0 C--N 1.347 1.152 0 CA-C-O 119.258 -0.745 . . . . 64.22 113.227 174.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 193' ' ' PRO . . . . . 0.6 ' HB2' ' HG3' ' B' ' 75' ' ' MET . 58.0 Cg_exo -48.36 100.95 0.04 OUTLIER 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 124.155 3.237 . . . . 64.32 112.878 171.27 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 194' ' ' SER . . . . . . . . . . . . . 33.0 m -107.63 149.58 27.91 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.374 -0.83 . . . . 24.51 109.579 178.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 195' ' ' ALA . . . . . . . . . . . . . . . -83.69 1.78 40.86 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.654 0.782 . . . . 74.32 111.72 179.152 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 196' ' ' THR . . . . . 0.654 HG21 ' HA2' ' B' ' 202' ' ' GLY . 35.7 m 80.88 -52.24 0.31 Allowed 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 126.451 1.9 . . . . 73.32 112.165 179.468 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 24.4 m 72.15 10.07 5.99 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 125.005 1.322 . . . . 75.11 112.906 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 198' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -96.01 81.61 3.41 Favored 'General case' 0 CA--C 1.551 0.983 0 N-CA-C 107.744 -1.206 . . . . 51.12 107.744 176.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 25.9 pttm 47.45 -69.4 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.152 0 C-N-CA 127.409 2.284 . . . . 74.4 115.724 179.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 200' ' ' CYS . . . . . 0.419 ' H ' ' HD2' ' B' ' 201' ' ' PRO . 83.2 m -140.66 -54.84 0.02 OUTLIER Pre-proline 0 CA--C 1.569 1.711 0 C-N-CA 124.511 1.124 . . . . 73.31 111.686 -178.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 201' ' ' PRO . . . . . 0.419 ' HD2' ' H ' ' B' ' 200' ' ' CYS . 56.2 Cg_endo -82.7 -179.16 4.34 Favored 'Trans proline' 0 C--N 1.403 3.412 0 CA-C-N 121.747 1.66 . . . . 71.34 113.751 -177.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 202' ' ' GLY . . . . . 0.654 ' HA2' HG21 ' B' ' 196' ' ' THR . . . -97.34 46.56 1.66 Allowed Glycine 0 C--N 1.351 1.375 0 CA-C-N 115.068 -0.969 . . . . 63.04 111.976 178.273 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -87.13 73.75 9.74 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.82 0.848 . . . . 71.33 109.393 -176.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . 65.6 158.55 0.11 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.819 1.248 . . . . 74.01 111.483 -175.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 205' ' ' LEU . . . . . 0.523 ' HB3' HG23 ' B' ' 196' ' ' THR . 2.2 pt? -155.14 165.04 37.93 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.081 0.467 . . . . 51.03 111.241 -173.519 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -95.01 -13.4 25.27 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 124.329 1.052 . . . . 62.32 110.226 173.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 207' ' ' LYS . . . . . 0.623 ' HB2' ' HG3' ' C' ' 182' ' ' PRO . 4.5 tmtm? 85.4 -36.96 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 126.612 1.965 . . . . 74.32 110.172 -166.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 98.56 69.38 0.94 Allowed Glycine 0 C--N 1.344 1.02 0 N-CA-C 111.517 -0.633 . . . . 71.52 111.517 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . -102.47 -57.84 0.79 Allowed Glycine 0 C--N 1.344 1.025 0 N-CA-C 110.963 -0.855 . . . . 42.21 110.963 174.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -105.01 -22.56 13.1 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.014 0.925 . . . . 74.51 111.275 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . -72.62 148.24 41.56 Favored Glycine 0 C--N 1.347 1.193 0 O-C-N 123.586 0.554 . . . . 74.43 112.265 -177.071 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 34.5 t 75.05 -56.8 0.62 Allowed 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 125.992 1.717 . . . . 74.04 111.078 -174.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 6.5 tt -67.19 112.37 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 C-N-CA 123.454 0.701 . . . . 64.4 111.366 177.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 85.0 m -79.39 84.43 5.29 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 108.233 -1.025 . . . . 75.43 108.233 167.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 215' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -63.08 -30.06 71.3 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 114.649 -1.16 . . . . 73.31 110.913 -178.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 64.08 83.36 0.17 Allowed 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.72 1.208 . . . . 61.42 109.5 176.644 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 23.7 tp -160.44 -77.76 0.06 Allowed 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 109.242 -0.651 . . . . 75.4 109.242 176.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 218' ' ' LEU . . . . . 0.645 HD23 ' H ' ' B' ' 127' ' ' SER . 2.7 mm? -86.56 67.18 9.8 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 107.44 -1.318 . . . . 71.43 107.44 172.618 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -62.41 122.53 15.94 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 114.697 -1.138 . . . . 71.24 111.331 -171.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . 78.09 -42.49 0.35 Allowed 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 125.641 1.576 . . . . 61.1 112.968 177.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 221' ' ' ARG . . . . . . . . . . . . . 45.3 ttt180 -48.05 -43.69 30.61 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.272 1.429 . . . . 73.55 111.911 176.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 222' ' ' ALA . . . . . 0.411 ' HB2' ' HA ' ' B' ' 130' ' ' ALA . . . 70.53 7.74 6.33 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 125.133 1.373 . . . . 42.52 112.017 -175.023 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 19.6 t70 67.29 -68.25 0.16 Allowed 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 126.188 1.795 . . . . 61.02 113.817 174.158 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 11.3 p -50.2 -34.63 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 125.14 1.376 . . . . 74.2 112.828 -178.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 225' ' ' THR . . . . . 0.433 ' HB ' ' H ' ' B' ' 170' ' ' THR . 69.5 p 50.37 27.41 2.73 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 125.335 1.454 . . . . 54.34 113.631 177.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 226' ' ' LEU . . . . . 0.474 HD13 ' HB3' ' B' ' 169' ' ' SER . 6.8 mp 51.19 79.24 0.1 Allowed 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.762 1.225 . . . . 74.43 111.799 173.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . 96.32 -45.75 1.88 Allowed Glycine 0 C--N 1.346 1.133 0 CA-C-N 116.033 -0.531 . . . . 51.31 111.973 -177.366 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 64.95 -99.3 0.35 Allowed Glycine 0 C--N 1.354 1.54 0 C-N-CA 123.402 0.525 . . . . 72.41 112.638 178.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -83.78 71.0 3.07 Favored Glycine 0 C--N 1.346 1.096 0 N-CA-C 111.405 -0.678 . . . . 70.24 111.405 178.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -163.33 -30.69 0.04 OUTLIER 'General case' 0 C--O 1.244 0.769 0 C-N-CA 124.054 0.942 . . . . 70.23 110.115 -176.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 231' ' ' LYS . . . . . 0.532 ' HB3' HD13 ' B' ' 173' ' ' LEU . 34.1 tttt -54.54 107.32 0.27 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.121 0.969 . . . . 73.24 111.25 177.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 232' ' ' THR . . . . . 0.441 ' HB ' ' NE ' ' B' ' 45' ' ' ARG . 5.4 m -143.67 148.1 35.27 Favored 'General case' 0 C--O 1.244 0.789 0 N-CA-C 107.374 -1.343 . . . . 74.24 107.374 170.309 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -68.93 141.74 54.91 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 108.876 -0.787 . . . . 70.41 108.876 -179.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -73.77 166.55 23.1 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 112.919 0.711 . . . . 72.31 112.919 -165.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -65.5 -48.41 72.66 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 113.964 -1.471 . . . . 54.41 109.685 -171.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 236' ' ' THR . . . . . . . . . . . . . 25.4 p -72.07 -69.83 0.37 Allowed 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.198 -0.91 . . . . 73.34 109.631 172.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -160.14 -76.86 0.06 Allowed 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 107.824 -1.176 . . . . 71.12 107.824 175.081 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 238' ' ' THR . . . . . 0.571 HG22 HG23 ' C' ' 219' ' ' VAL . 3.0 m -132.36 -66.75 0.68 Allowed 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 107.527 -1.286 . . . . 71.31 107.527 171.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -84.09 169.13 15.21 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.746 -0.661 . . . . 74.42 110.204 175.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 240' ' ' GLY . . . . . 0.515 ' H ' HD22 ' C' ' 235' ' ' LEU . . . -109.91 -93.08 2.22 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 110.778 -0.929 . . . . 71.23 110.778 -173.296 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 241' ' ' GLU . . . . . 0.413 ' HG3' ' HG3' ' C' ' 234' ' ' ARG . 8.5 pt-20 -165.34 161.2 18.89 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.7 0.8 . . . . 71.21 110.097 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 13.8 m95 -108.19 -82.08 0.56 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.655 0.782 . . . . 70.32 108.944 177.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -153.12 -162.21 1.44 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.765 1.626 . . . . 74.22 107.772 -171.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -73.7 79.53 0.83 Allowed Glycine 0 C--N 1.349 1.274 0 N-CA-C 111.199 -0.76 . . . . 63.11 111.199 170.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 2.1 pptp? -74.72 155.0 38.16 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.946 0.898 . . . . 75.34 111.55 -174.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 9.7 t -165.03 158.69 17.15 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.413 0.685 . . . . 71.02 110.434 -175.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 247' ' ' LEU . . . . . . . . . . . . . 34.2 tp -101.56 127.5 48.24 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.077 0.951 . . . . 72.51 109.43 -179.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 248' ' ' ARG . . . . . 0.49 ' HG3' ' HG2' ' C' ' 226' ' ' ARG . 9.9 ptp180 -133.15 71.52 1.47 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 122.319 1.057 . . . . 75.15 109.17 -178.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -86.65 -43.74 12.39 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 113.62 -1.627 . . . . 71.33 112.52 -170.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -66.35 -57.5 7.32 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 123.555 0.534 . . . . 65.4 112.307 -164.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 251' ' ' ALA . . . . . 0.527 ' H ' ' HG ' ' B' ' 280' ' ' LEU . . . 54.7 -78.88 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 125.058 1.343 . . . . 61.03 112.163 -175.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -84.49 64.21 8.29 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 124.493 1.117 . . . . 72.3 108.09 172.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -69.95 -31.77 69.68 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.378 -0.828 . . . . 51.41 110.336 178.337 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -142.44 -72.18 0.32 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 107.657 -1.238 . . . . 72.51 107.657 177.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . 70.08 -76.6 0.45 Allowed Glycine 0 C--N 1.357 1.747 0 O-C-N 123.766 0.666 . . . . 54.22 113.676 172.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 256' ' ' TYR . . . . . 0.702 ' HA ' ' HA ' ' B' ' 266' ' ' ASN . 92.3 m-85 -75.74 -0.6 21.47 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.448 1.099 . . . . 52.52 112.73 -178.725 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 64.44 -88.65 0.03 OUTLIER 'General case' 0 C--N 1.356 0.866 0 C-N-CA 125.38 1.472 . . . . 74.31 109.586 -176.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 258' ' ' LEU . . . . . . . . . . . . . 53.9 tp -176.21 -69.71 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.32 1.048 . . . . 75.13 108.724 169.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 13.0 m -139.14 135.04 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.196 0.998 . . . . 63.02 108.963 178.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 260' ' ' SER . . . . . . . . . . . . . 58.1 m -151.82 80.64 1.27 Allowed 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 106.79 -1.559 . . . . 73.11 106.79 173.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 66.4 -69.43 0.12 Allowed 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 125.009 1.324 . . . . 52.21 109.99 -166.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 262' ' ' ALA . . . . . . . . . . . . . . . -82.17 145.53 30.04 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.478 0.711 . . . . 43.43 110.55 171.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -74.11 131.79 41.65 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.127 0.571 . . . . 70.44 109.726 175.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 80.1 p 49.92 46.07 24.57 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.631 1.572 . . . . 51.14 111.35 -175.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 265' ' ' LEU . . . . . . . . . . . . . 61.1 tp -59.39 -31.19 69.01 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.929 0.892 . . . . 64.12 111.425 -179.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 266' ' ' ASN . . . . . 0.702 ' HA ' ' HA ' ' B' ' 256' ' ' TYR . 64.6 t30 81.6 -70.49 0.07 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.154 1.382 . . . . 71.52 111.458 170.57 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 21.8 m 65.13 -76.16 0.04 OUTLIER 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 125.019 1.328 . . . . 73.13 112.959 173.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 10.2 p -59.32 -32.72 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.668 0.787 . . . . 74.44 112.485 -173.101 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 269' ' ' THR . . . . . 0.458 ' HB ' ' ND2' ' B' ' 266' ' ' ASN . 16.4 m -84.47 -11.83 55.44 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 123.259 0.624 . . . . 74.31 112.345 -176.171 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 270' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -139.51 -60.01 0.56 Allowed 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.486 -0.759 . . . . 72.41 112.585 -177.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 271' ' ' ALA . . . . . . . . . . . . . . . -70.54 112.14 6.58 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.75 0.82 . . . . 75.3 110.911 -174.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 272' ' ' ASN . . . . . . . . . . . . . 8.9 t30 70.91 -74.82 0.08 Allowed 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 126.103 1.761 . . . . 54.14 112.021 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 17.3 mp0 -60.41 -48.13 83.08 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.406 0.682 . . . . 61.32 111.072 -175.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 57.29 22.94 8.24 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.823 1.249 . . . . 71.44 112.272 178.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 275' ' ' LYS . . . . . 0.52 ' HD2' HD12 ' B' ' 278' ' ' LEU . 37.1 ttpt -157.78 99.2 1.85 Allowed Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 123.699 0.8 . . . . 71.33 109.797 -169.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 276' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' B' ' 269' ' ' THR . 85.5 Cg_endo -85.22 -59.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 122.541 2.161 . . . . 62.35 112.742 173.252 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 277' ' ' LEU . . . . . . . . . . . . . 97.9 mt -137.74 94.77 2.95 Favored 'General case' 0 C--N 1.356 0.87 0 C-N-CA 124.573 1.149 . . . . 63.32 109.536 -170.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 278' ' ' LEU . . . . . 0.52 HD12 ' HD2' ' B' ' 275' ' ' LYS . 0.7 OUTLIER -86.05 -13.19 48.12 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 124.287 1.035 . . . . 62.0 109.871 178.648 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . -64.06 -20.91 65.3 Favored Glycine 0 N--CA 1.478 1.466 0 N-CA-C 114.165 0.426 . . . . 75.43 114.165 -178.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 280' ' ' LEU . . . . . 0.527 ' HG ' ' H ' ' B' ' 251' ' ' ALA . 2.4 mm? -90.7 11.79 21.11 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.773 0.829 . . . . 53.23 111.318 178.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -147.87 111.19 4.92 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.935 0.894 . . . . 75.31 108.613 -176.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -83.99 33.21 0.48 Allowed 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 124.178 0.991 . . . . 65.41 112.422 -176.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 16.3 t70 64.57 26.86 13.33 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.56 1.144 . . . . 72.33 110.366 -179.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . 82.71 53.95 3.4 Favored Glycine 0 C--N 1.35 1.346 0 N-CA-C 111.245 -0.742 . . . . 61.45 111.245 -174.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 9.1 t30 68.36 110.32 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 125.034 1.333 . . . . 72.41 110.885 -172.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 286' ' ' MET . . . . . . . . . . . . . 47.8 tpp -74.22 119.68 77.58 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 123.651 0.78 . . . . 64.1 110.212 -179.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 287' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -67.67 112.5 2.66 Favored 'Trans proline' 0 C--N 1.377 2.071 0 C-N-CA 122.77 2.313 . . . . 73.33 111.18 178.077 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 288' ' ' VAL . . . . . . . . . . . . . 33.8 m -111.99 158.19 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.385 0.674 . . . . 74.32 109.785 177.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 289' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -107.47 171.44 7.38 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.103 0.961 . . . . 72.14 109.531 179.109 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 290' ' ' TRP . . . . . . . . . . . . . 60.6 m95 56.73 27.49 12.8 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 124.715 1.206 . . . . 75.34 111.275 -178.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 291' ' ' LEU . . . . . 0.505 HD23 ' H ' ' B' ' 291' ' ' LEU . 2.7 pt? -90.23 1.08 56.85 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.1 0.96 . . . . 64.34 112.703 -169.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . -168.46 -102.41 0.16 Allowed Glycine 0 C--N 1.344 1.008 0 CA-C-O 119.008 -0.885 . . . . 62.12 111.609 178.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 293' ' ' PRO . . . . . 0.581 ' HB2' HG22 ' B' ' 296' ' ' THR . 96.5 Cg_endo -77.39 80.79 2.81 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.789 2.326 . . . . 51.12 112.403 -176.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -83.24 -27.19 30.08 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 115.681 -0.691 . . . . 41.23 110.703 177.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -128.21 89.85 2.98 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 107.763 -1.199 . . . . 34.32 107.763 173.134 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 296' ' ' THR . . . . . 0.581 HG22 ' HB2' ' B' ' 293' ' ' PRO . 29.0 p -74.37 90.55 2.16 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 124.017 0.927 . . . . 65.42 110.195 -173.198 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 297' ' ' TYR . . . . . 0.548 ' HD2' ' HA ' ' B' ' 300' ' ' ASN . 77.7 t80 66.73 1.79 2.35 Favored 'General case' 0 CA--C 1.562 1.426 0 C-N-CA 124.824 1.25 . . . . 64.12 111.264 -173.299 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 3.6 t60 53.01 84.8 0.05 Allowed 'General case' 0 C--N 1.361 1.086 0 C-N-CA 125.029 1.332 . . . . 71.5 110.64 -167.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . 71.01 63.16 3.24 Favored Glycine 0 C--N 1.344 0.98 0 CA-C-N 114.912 -1.04 . . . . 63.41 111.751 -178.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 300' ' ' ASN . . . . . 0.548 ' HA ' ' HD2' ' B' ' 297' ' ' TYR . 53.8 t30 -58.02 89.83 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.572 1.149 . . . . 72.23 110.902 -177.475 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 301' ' ' ILE . . . . . . . . . . . . . 50.2 mm 74.89 -34.15 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.559 1.32 0 C-N-CA 125.77 1.628 . . . . 72.24 112.751 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 31.6 t70 57.54 87.28 0.07 Allowed 'General case' 0 C--N 1.361 1.069 0 C-N-CA 124.353 1.061 . . . . 63.41 109.162 -172.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 303' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -154.38 130.88 5.7 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 109.287 -0.634 . . . . 74.11 109.287 -169.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 304' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -69.82 -163.56 0.11 Allowed 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 122.842 2.361 . . . . 75.12 110.899 166.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -81.58 60.96 4.79 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 122.827 0.451 . . . . 42.33 110.276 174.081 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 78.4 t 66.89 -54.34 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 C-N-CA 126.399 1.88 . . . . 72.33 113.145 -178.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 51.3 m 83.77 -53.58 0.14 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 126.518 1.927 . . . . 74.23 111.143 173.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 308' ' ' CYS . . . . . . . . . . . . . 24.6 p -81.13 20.01 0.86 Allowed 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.697 0.799 . . . . 74.22 113.082 -172.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 18.4 p -120.79 82.5 35.01 Favored Pre-proline 0 CA--C 1.556 1.209 0 C-N-CA 123.201 0.601 . . . . 72.2 110.258 171.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -84.59 -168.43 0.53 Allowed 'Trans proline' 0 C--N 1.375 1.925 0 C-N-CA 122.536 2.157 . . . . 63.14 112.199 170.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 311' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -136.03 101.14 10.49 Favored Pre-proline 0 N--CA 1.48 1.028 0 C-N-CA 123.957 0.903 . . . . 73.13 108.877 173.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 312' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -76.73 102.28 1.6 Allowed 'Trans proline' 0 C--N 1.374 1.88 0 C-N-CA 121.975 1.783 . . . . 70.14 111.481 170.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 313' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -95.83 156.33 16.37 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.899 0.48 . . . . 75.13 109.796 175.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 314' ' ' ARG . . . . . 0.462 ' NH1' ' H ' ' B' ' 322' ' ' ALA . 13.3 ptp180 -123.42 72.72 1.14 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.128 0.971 . . . . 72.01 109.023 -178.09 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 315' ' ' ASN . . . . . . . . . . . . . 7.9 t30 71.22 -61.4 0.48 Allowed 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 125.507 1.523 . . . . 72.12 109.759 -167.079 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 316' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -87.51 148.43 24.92 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.491 1.116 . . . . 74.4 109.685 172.07 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 31.3 p -83.07 -70.97 0.52 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.101 0.56 . . . . 75.41 109.925 175.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 318' ' ' VAL . . . . . . . . . . . . . 41.7 t -81.31 -47.66 1.08 Allowed Pre-proline 0 CA--C 1.568 1.647 0 CA-C-O 118.453 -0.784 . . . . 73.13 111.38 -179.108 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 319' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -65.38 157.71 56.5 Favored 'Trans proline' 0 C--N 1.398 3.147 0 C-N-CA 121.936 1.757 . . . . 65.1 112.404 173.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 320' ' ' THR . . . . . 0.571 ' HA ' ' HA ' ' B' ' 325' ' ' THR . 6.7 m 69.67 -11.53 0.51 Allowed 'General case' 0 CA--C 1.566 1.572 0 C-N-CA 125.595 1.558 . . . . 53.31 113.16 178.556 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 321' ' ' LEU . . . . . . . . . . . . . 56.1 tp -70.42 98.14 1.38 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.813 0.845 . . . . 65.14 111.054 -172.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 322' ' ' ALA . . . . . 0.462 ' H ' ' NH1' ' B' ' 314' ' ' ARG . . . 76.63 -34.77 0.23 Allowed 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 126.267 1.827 . . . . 64.54 112.961 178.261 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 323' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -161.82 -171.66 2.99 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 125.861 1.664 . . . . 74.02 107.68 178.242 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 324' ' ' MET . . . . . . . . . . . . . 18.6 ptp 44.44 79.99 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 125.642 1.577 . . . . 71.32 112.642 177.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 325' ' ' THR . . . . . 0.571 ' HA ' ' HA ' ' B' ' 320' ' ' THR . 35.3 p -60.45 -58.04 10.17 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 115.243 -0.889 . . . . 72.33 112.995 -171.017 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 326' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -109.37 -63.77 1.32 Allowed 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 122.91 0.484 . . . . 72.01 109.996 178.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -160.04 98.14 1.3 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.938 0.895 . . . . 54.34 108.908 -171.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 328' ' ' ALA . . . . . . . . . . . . . . . -114.98 89.92 3.21 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 108.658 -0.867 . . . . 72.03 108.658 177.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 329' ' ' ILE . . . . . . . . . . . . . 48.2 pt -121.74 175.46 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.077 0.951 . . . . 73.5 111.373 -171.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 330' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -94.04 144.4 25.51 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.898 0.879 . . . . 63.42 108.739 169.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 331' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -66.89 -49.9 64.14 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.793 0.837 . . . . 63.34 110.212 176.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 5.4 tt -165.92 109.83 0.81 Allowed 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 109.231 -0.655 . . . . 74.41 109.231 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 333' ' ' SER . . . . . . . . . . . . . 17.2 m -86.79 125.45 33.95 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 108.335 -0.987 . . . . 65.04 108.335 169.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 23.4 mtpp -81.93 71.69 8.97 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-O 121.671 0.748 . . . . 63.11 111.246 177.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 335' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -74.34 -34.8 63.53 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 114.542 -1.208 . . . . 73.25 110.935 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.19 -20.43 60.2 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.769 0.828 . . . . 61.02 111.182 176.195 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 337' ' ' LYS . . . . . . . . . . . . . 23.3 tptm 76.91 -23.84 0.24 Allowed 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 125.862 1.665 . . . . 62.43 112.592 174.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 338' ' ' GLY . . . . . . . . . . . . . . . 68.26 47.86 55.9 Favored Glycine 0 C--N 1.345 1.058 0 N-CA-C 110.931 -0.868 . . . . 72.34 110.931 -170.079 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 339' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -72.93 82.13 1.2 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.618 0.767 . . . . 74.33 110.29 -177.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 340' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 56.85 16.39 2.72 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 125.585 1.554 . . . . 75.24 112.959 178.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 341' ' ' LEU . . . . . . . . . . . . . 72.2 mt 57.29 46.79 17.93 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.63 1.172 . . . . 75.34 110.968 -173.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 342' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -111.74 153.7 26.1 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.595 0.758 . . . . 64.25 111.273 -178.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 343' ' ' VAL . . . . . . . . . . . . . 6.7 t 63.72 3.46 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.576 1.947 0 C-N-CA 126.18 1.792 . . . . 64.24 112.717 175.105 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.53 -15.66 30.29 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.447 0.699 . . . . 73.03 112.269 -175.388 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 345' ' ' GLY . . . . . . . . . . . . . . . 140.5 -44.01 1.08 Allowed Glycine 0 C--N 1.348 1.247 0 CA-C-N 117.624 0.193 . . . . 62.31 112.628 174.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 346' ' ' ALA . . . . . . . . . . . . . . . -103.28 29.29 5.68 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.709 0.804 . . . . 72.22 111.2 -175.074 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 9.6 m -62.66 93.05 0.05 Allowed 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.392 1.077 . . . . 72.21 112.404 -172.063 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 2.7 mp 69.97 -61.53 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 C-N-CA 125.848 1.659 . . . . 73.42 111.373 -179.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 349' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -70.5 166.92 19.47 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.972 0.909 . . . . 71.13 112.495 177.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 350' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -158.44 156.19 29.92 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 114.466 -1.243 . . . . 74.52 108.106 -178.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -63.43 150.69 43.02 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.634 0.373 . . . . 71.32 110.649 177.56 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -118.24 108.43 15.13 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 122.8 0.44 . . . . 74.35 110.812 -177.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 353' ' ' HIS . . . . . . . . . . . . . 51.9 m80 54.08 39.24 30.43 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.735 1.214 . . . . 74.33 111.988 174.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 354' ' ' ALA . . . . . . . . . . . . . . . 69.04 -72.21 0.11 Allowed 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 125.109 1.364 . . . . 70.11 110.068 -168.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 355' ' ' ALA . . . . . . . . . . . . . . . -148.8 -64.98 0.24 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.4 0.68 . . . . 75.44 109.685 179.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 356' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -163.1 127.27 1.91 Allowed Pre-proline 0 N--CA 1.477 0.888 0 N-CA-C 108.079 -1.082 . . . . 74.32 108.079 178.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 357' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -54.85 -51.62 9.92 Favored 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 123.09 2.527 . . . . 55.22 113.381 -176.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 358' ' ' CYS . . . . . . . . . . . . . 67.3 m -70.41 -24.33 62.91 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.04 0.536 . . . . 73.32 111.457 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 359' ' ' GLY . . . . . . . . . . . . . . . -74.1 -31.96 59.05 Favored Glycine 0 C--N 1.347 1.174 0 CA-C-N 116.256 -0.429 . . . . 62.01 112.7 178.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 360' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -96.14 38.9 1.16 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.181 0.592 . . . . 53.34 111.217 -176.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 361' ' ' ILE . . . . . . . . . . . . . 2.7 pp -70.64 -7.83 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 C-N-CA 123.4 0.68 . . . . 61.31 112.177 174.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 362' ' ' GLY . . . . . . . . . . . . . . . -145.48 -168.72 13.23 Favored Glycine 0 C--N 1.342 0.89 0 N-CA-C 111.196 -0.762 . . . . 72.35 111.196 172.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 363' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 63.22 -80.84 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 125.413 1.485 . . . . 73.13 112.189 176.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 364' ' ' THR . . . . . . . . . . . . . 66.6 p -96.38 27.37 3.8 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.76 0.824 . . . . 74.04 111.849 -173.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 8.1 m -65.76 -29.76 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 123.492 0.717 . . . . 74.01 111.784 173.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -84.0 -10.47 57.87 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.276 0.63 . . . . 50.12 111.191 174.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 367' ' ' LEU . . . . . . . . . . . . . 9.2 mp 64.98 169.47 0.19 Allowed 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 124.787 1.235 . . . . 75.05 112.449 178.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 368' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -84.89 86.25 7.38 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 122.203 1.002 . . . . 71.23 108.549 170.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 369' ' ' GLU . . . . . 0.446 ' HB3' ' HB3' ' B' ' 372' ' ' GLN . 50.7 mt-10 -75.03 -64.35 1.07 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 114.412 -1.267 . . . . 70.1 111.084 -176.466 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 370' ' ' ALA . . . . . . . . . . . . . . . 66.13 -73.36 0.07 Allowed 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.307 1.443 . . . . 74.25 111.452 -175.054 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 371' ' ' VAL . . . . . . . . . . . . . 9.2 p -74.81 -30.0 23.64 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.085 0 C-N-CA 124.472 1.109 . . . . 74.11 112.582 -177.198 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 372' ' ' GLN . . . . . 0.446 ' HB3' ' HB3' ' B' ' 369' ' ' GLU . 0.2 OUTLIER -66.28 -61.73 1.86 Allowed 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.19 0.596 . . . . 63.2 110.881 -170.381 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 373' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -111.75 148.31 33.77 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 122.961 0.504 . . . . 72.05 111.014 178.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . 65.76 -82.84 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 125.47 1.508 . . . . 71.45 112.177 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 375' ' ' LEU . . . . . . . . . . . . . 44.4 tp 50.16 -102.18 0.1 Allowed 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.882 1.273 . . . . 62.01 111.356 -175.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -127.43 -7.67 5.78 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.004 0.921 . . . . 73.13 110.345 176.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 377' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -59.47 -65.41 0.68 Allowed 'General case' 0 C--N 1.355 0.832 0 O-C-N 124.098 0.874 . . . . 73.31 109.217 -177.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 378' ' ' ALA . . . . . . . . . . . . . . . 60.54 -1.38 0.22 Allowed 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 114.741 1.385 . . . . 61.1 114.741 171.106 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -77.14 86.56 3.61 Favored 'General case' 0 C--N 1.351 0.639 0 N-CA-C 108.751 -0.833 . . . . 72.01 108.751 -176.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 380' ' ' LYS . . . . . . . . . . . . . 88.8 tttt 48.8 91.42 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.402 1.481 . . . . 53.14 112.752 177.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 381' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -61.66 -45.52 93.68 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 108.52 -0.918 . . . . 74.34 108.52 171.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -166.29 -162.42 17.7 Favored Glycine 0 C--N 1.34 0.798 0 CA-C-N 114.118 -1.401 . . . . 73.1 109.624 171.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 383' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -74.82 169.41 17.95 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 109.289 -0.634 . . . . 73.1 109.289 170.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 384' ' ' THR . . . . . . . . . . . . . 48.3 p -80.94 76.04 7.9 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-O 121.898 0.856 . . . . 63.41 111.627 -173.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -159.67 109.04 1.83 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.901 1.28 . . . . 75.12 107.943 171.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 386' ' ' VAL . . . . . . . . . . . . . 4.4 m -86.79 67.19 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.694 0.798 . . . . 62.42 110.572 -175.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 387' ' ' ILE . . . . . 0.503 HG12 HG23 ' B' ' 388' ' ' VAL . 9.8 tt -65.49 129.09 29.39 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.094 0 CA-C-N 115.317 -0.856 . . . . 74.12 109.824 177.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 388' ' ' VAL . . . . . 0.503 HG23 HG12 ' B' ' 387' ' ' ILE . 65.9 t 77.02 -51.91 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 C-N-CA 125.882 1.673 . . . . 54.33 111.997 -178.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 389' ' ' THR . . . . . . . . . . . . . 35.2 p -85.02 16.92 3.14 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 123.652 0.781 . . . . 71.25 112.713 -176.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . -66.36 -66.42 0.55 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.635 0.774 . . . . 70.34 111.317 177.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 391' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -145.25 -87.78 0.11 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.468 0.707 . . . . 64.12 109.876 -173.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 392' ' ' HIS . . . . . . . . . . . . . 40.0 m80 52.46 83.16 0.06 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.331 1.052 . . . . 72.42 111.218 -168.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -76.17 69.17 2.69 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.203 0.601 . . . . 61.53 109.762 173.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 33.1 m80 56.2 -84.88 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 126.176 1.79 . . . . 73.31 112.361 -178.002 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . -153.51 -0.9 0.22 Allowed 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 112.884 0.698 . . . . 71.44 112.884 -174.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 66.3 m -96.75 19.62 12.21 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 112.118 0.414 . . . . 75.55 112.118 -177.222 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 397' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 67.8 -73.99 0.08 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.84 1.256 . . . . 71.41 109.679 -174.115 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 12.6 tt -157.87 135.26 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 C-N-CA 124.261 1.024 . . . . 75.44 108.567 176.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 399' ' ' VAL . . . . . 0.597 HG23 ' H ' ' B' ' 400' ' ' ALA 0.26 29.8 m 44.6 -79.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 C-N-CA 126.699 2.0 . . . . 73.32 114.599 -178.919 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 400' ' ' ALA . . . . . 0.597 ' H ' HG23 ' B' ' 399' ' ' VAL . . . -113.3 129.38 24.64 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 123.802 0.841 . . . . 51.41 108.843 -177.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 401' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -70.63 81.58 1.02 Allowed 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 122.745 2.297 . . . . 71.04 112.126 -179.198 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 25.8 t70 65.35 107.71 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.859 1.264 . . . . 74.34 111.162 -178.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 403' ' ' THR . . . . . 0.49 ' H ' ' HG3' ' B' ' 406' ' ' PRO . 89.0 m -140.94 101.16 3.99 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 122.909 0.484 . . . . 51.3 110.575 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 404' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp 63.3 -75.57 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.551 1.54 . . . . 70.03 113.195 169.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 405' ' ' ALA . . . . . . . . . . . . . . . -125.56 76.5 69.57 Favored Pre-proline 0 CA--C 1.555 1.135 0 C-N-CA 123.656 0.782 . . . . 71.24 110.832 179.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 406' ' ' PRO . . . . . 0.49 ' HG3' ' H ' ' B' ' 403' ' ' THR . 9.8 Cg_endo -94.1 115.58 0.24 Allowed 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 123.25 2.633 . . . . 44.44 110.586 169.545 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . -64.99 137.94 38.98 Favored Glycine 0 CA--C 1.535 1.324 0 CA-C-N 116.741 -0.208 . . . . 55.33 113.114 -177.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 408' ' ' LEU . . . . . . . . . . . . . 3.9 tt -139.62 99.73 3.79 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 107.573 -1.269 . . . . 72.03 107.573 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 93.4 m 73.86 -66.25 0.31 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 125.236 1.414 . . . . 73.52 112.187 176.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 410' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -111.94 104.7 12.99 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.942 0.897 . . . . 51.32 109.692 -179.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . -148.87 -83.65 0.1 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.677 0.791 . . . . 63.14 109.023 174.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 96.2 mt -142.33 -60.78 0.45 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.879 0.871 . . . . 60.41 109.881 -177.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -118.6 5.16 11.64 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.953 0.901 . . . . 71.14 110.62 -174.092 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 414' ' ' THR . . . . . . . . . . . . . 11.8 p -75.52 118.38 18.31 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.661 0.784 . . . . 73.24 110.538 -177.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 415' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt 67.09 -72.47 0.09 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.856 1.262 . . . . 73.42 111.46 -176.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -68.94 129.03 38.79 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.639 0.776 . . . . 75.33 109.422 173.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 417' ' ' GLY . . . . . . . . . . . . . . . 97.24 -28.66 13.05 Favored Glycine 0 C--N 1.346 1.086 0 N-CA-C 111.899 -0.48 . . . . 43.15 111.899 -174.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 418' ' ' ALA . . . . . . . . . . . . . . . -80.78 70.76 7.62 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 108.858 -0.793 . . . . 70.25 108.858 173.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 419' ' ' VAL . . . . . . . . . . . . . 29.3 m -77.18 160.74 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 114.693 -1.139 . . . . 62.03 110.441 -177.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 420' ' ' MET . . . . . . . . . . . . . 14.9 tpt 75.82 -20.62 0.34 Allowed 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 125.707 1.603 . . . . 73.12 111.924 -175.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 421' ' ' VAL . . . . . . . . . . . . . 26.3 t -78.27 73.57 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.073 0 C-N-CA 123.966 0.906 . . . . 72.42 109.274 176.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 422' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -175.7 -72.63 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 107.1 -1.445 . . . . 74.1 107.1 -178.709 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 423' ' ' SER . . . . . . . . . . . . . 28.3 t 61.77 -79.43 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.348 0 C-N-CA 125.629 1.572 . . . . 62.22 112.214 -179.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 424' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -138.49 21.82 2.73 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 123.588 0.755 . . . . 72.42 110.766 176.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . -168.88 -145.08 4.45 Favored Glycine 0 C--N 1.336 0.549 0 N-CA-C 110.87 -0.892 . . . . 75.12 110.87 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 426' ' ' ASN . . . . . 0.437 ' H ' ' H ' ' B' ' 427' ' ' SER . 8.3 t30 -166.26 -1.57 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.548 0.739 . . . . 75.43 109.875 175.448 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 427' ' ' SER . . . . . 0.437 ' H ' ' H ' ' B' ' 426' ' ' ASN . 16.3 m 70.1 11.58 7.63 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 125.198 1.399 . . . . 75.14 111.015 -171.147 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 163.85 96.47 0.0 OUTLIER 'General case' 0 C--N 1.359 1.018 0 C-N-CA 127.553 2.341 . . . . 73.23 105.814 -179.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 429' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -87.42 31.28 0.75 Allowed 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.273 0.629 . . . . 63.42 111.68 -169.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -76.95 90.34 3.54 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 108.365 -0.976 . . . . 55.41 108.365 176.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 52.9 m 63.19 17.49 10.24 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.868 1.267 . . . . 73.31 112.121 -172.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 432' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 51.57 40.31 26.79 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 124.628 1.171 . . . . 71.1 111.255 -172.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 433' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -77.87 87.56 4.08 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 115.36 -0.836 . . . . 73.43 110.302 -175.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 434' ' ' HIS . . . . . . . . . . . . . 39.3 p-80 -98.81 73.61 2.01 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.579 -0.897 . . . . 65.13 108.579 172.106 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 435' ' ' THR . . . . . . . . . . . . . 55.0 m -44.64 -46.61 10.26 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 125.473 1.509 . . . . 73.42 113.133 -173.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . -108.3 154.55 16.49 Favored Glycine 0 C--N 1.344 0.997 0 N-CA-C 111.423 -0.671 . . . . 43.54 111.423 174.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 58.6 p -74.25 -29.73 61.82 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.392 0.677 . . . . 54.14 110.261 173.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 438' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 62.36 22.9 13.53 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 125.37 1.468 . . . . 71.55 112.066 178.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 439' ' ' LEU . . . . . . . . . . . . . 88.5 mt -75.29 93.49 2.88 Favored 'General case' 0 C--N 1.352 0.678 0 N-CA-C 109.197 -0.668 . . . . 74.24 109.197 175.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 440' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -56.44 110.72 0.82 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.492 0.717 . . . . 70.1 110.73 177.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 441' ' ' ILE . . . . . 0.637 ' HA ' HD22 ' A' ' 235' ' ' LEU . 18.0 tt -134.11 19.58 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 CA-C-O 122.514 1.15 . . . . 74.15 109.904 175.464 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 442' ' ' ALA . . . . . . . . . . . . . . . -80.78 79.07 7.49 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.509 -0.768 . . . . 71.41 109.754 175.133 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . -93.31 -56.8 2.81 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.837 0.855 . . . . 74.21 109.463 176.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 3.1 m-30 -89.95 86.65 6.67 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.41 -0.814 . . . . 65.34 109.257 176.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . -79.24 115.01 4.01 Favored Glycine 0 C--N 1.342 0.883 0 N-CA-C 109.976 -1.25 . . . . 74.34 109.976 169.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 446' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -66.9 83.31 0.32 Allowed 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 122.66 2.24 . . . . 63.02 112.124 -178.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 447' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -82.21 85.34 6.83 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.089 -0.96 . . . . 60.0 109.988 -178.003 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . -106.86 -153.66 0.5 Allowed 'General case' 0 C--O 1.245 0.82 0 CA-C-N 114.634 -1.166 . . . . 74.31 108.39 172.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 449' ' ' ALA . . . . . 0.514 ' O ' ' HA ' ' B' ' 461' ' ' PHE . . . 67.6 -81.23 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.31 1.044 . . . . 61.52 111.372 175.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 450' ' ' ASN . . . . . 0.417 ' HB3' HG13 ' B' ' 452' ' ' VAL . 73.6 m-20 -155.33 166.15 34.42 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.018 0.927 . . . . 61.12 110.871 -178.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 7.4 p -100.21 20.76 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 123.926 0.89 . . . . 63.1 110.689 175.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 452' ' ' VAL . . . . . 0.417 HG13 ' HB3' ' B' ' 450' ' ' ASN . 15.8 m -57.58 116.86 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 C-N-CA 124.296 1.038 . . . . 60.45 111.682 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 100.09 -31.79 8.04 Favored Glycine 0 C--N 1.343 0.968 0 CA-C-N 115.691 -0.686 . . . . 73.44 113.282 179.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 454' ' ' LEU . . . . . 0.478 HD22 ' HB2' ' B' ' 456' ' ' ASP . 0.5 OUTLIER -78.81 -40.95 31.55 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.237 0.615 . . . . 72.5 110.588 -175.035 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 9.4 m 69.5 0.9 3.11 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 124.529 1.131 . . . . 61.41 112.658 179.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 456' ' ' ASP . . . . . 0.478 ' HB2' HD22 ' B' ' 454' ' ' LEU . 30.6 t70 -73.81 -16.66 61.14 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.869 0.868 . . . . 74.3 111.86 -175.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 457' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 69.18 15.52 8.62 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 125.185 1.394 . . . . 42.14 112.742 -176.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 7.4 t -77.99 63.25 2.94 Favored 'General case' 0 CA--C 1.556 1.207 0 CA-C-O 122.703 1.24 . . . . 72.13 109.495 171.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 459' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -102.02 128.37 48.49 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.216 -0.902 . . . . 73.31 110.192 -171.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 95.9 mt -128.02 82.34 2.08 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 106.996 -1.483 . . . . 65.42 106.996 166.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 461' ' ' PHE . . . . . 0.514 ' HA ' ' O ' ' B' ' 449' ' ' ALA . 44.8 p90 -61.93 -36.77 82.36 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 115.205 -0.907 . . . . 62.31 111.788 -178.39 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 462' ' ' TYR . . . . . 0.473 ' HD2' ' H ' ' B' ' 465' ' ' LYS . 39.2 p90 -81.24 -14.33 57.59 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.193 0.997 . . . . 72.53 111.566 176.542 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 94.3 m 65.08 -77.8 0.04 OUTLIER 'General case' 0 C--N 1.36 1.047 0 C-N-CA 125.215 1.406 . . . . 61.35 110.432 -172.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 464' ' ' MET . . . . . 0.584 ' HB3' HD21 ' B' ' 468' ' ' LEU . 6.3 tpt -151.48 92.07 1.73 Allowed 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 107.519 -1.289 . . . . 75.31 107.519 171.699 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 465' ' ' LYS . . . . . 0.473 ' H ' ' HD2' ' B' ' 462' ' ' TYR . 83.4 tttt 63.65 -80.01 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 125.119 1.367 . . . . 72.15 110.665 -170.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -177.1 149.33 0.68 Allowed 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.105 0.962 . . . . 62.32 110.197 178.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . 56.23 88.61 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.283 1.433 . . . . 75.3 113.338 170.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 468' ' ' LEU . . . . . 0.584 HD21 ' HB3' ' B' ' 464' ' ' MET . 6.0 mp -115.7 17.57 16.12 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.303 0.641 . . . . 45.51 110.538 175.053 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 469' ' ' GLY . . . . . . . . . . . . . . . 80.32 -1.12 82.56 Favored Glycine 0 C--N 1.347 1.19 0 CA-C-N 116.827 -0.17 . . . . 50.44 113.44 -176.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 470' ' ' LEU . . . . . . . . . . . . . 1.3 pp -124.18 -164.99 1.3 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.947 1.299 . . . . 73.2 108.976 178.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 471' ' ' LYS . . . . . 0.45 ' HE2' ' HA ' ' B' ' 471' ' ' LYS . 0.6 OUTLIER . . . . . 0 CA--C 1.56 1.359 0 C-N-CA 123.202 0.601 . . . . 74.2 109.604 178.012 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 62.9 mtm . . . . . 0 N--CA 1.481 1.107 0 N-CA-C 109.309 -0.626 . . . . 55.23 109.309 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 74.72 -33.56 0.25 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 126.081 1.752 . . . . 65.31 113.575 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -74.64 79.41 2.01 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.206 1.002 . . . . 52.01 111.304 -177.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -36.86 117.51 0.51 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.974 1.71 . . . . 70.52 114.133 173.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -76.07 102.58 5.75 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.849 -0.796 . . . . 63.2 108.849 165.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 6' ' ' ASP . . . . . 0.432 ' HA ' ' OH ' ' C' ' 66' ' ' TYR . 8.6 t70 -75.01 94.24 2.83 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.184 -1.043 . . . . 63.22 108.184 176.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 7' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -61.44 -35.51 77.78 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-N 115.264 -0.88 . . . . 73.43 112.361 -171.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -60.12 -50.24 74.49 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 116.121 -0.49 . . . . 72.53 110.179 175.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.7 -39.16 93.62 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.899 -0.591 . . . . 52.31 111.506 -178.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 81.5 mt -58.14 -42.13 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 C-N-CA 123.665 0.786 . . . . 63.34 110.163 176.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 95.9 mt -74.35 -24.01 59.11 Favored 'General case' 0 N--CA 1.48 1.075 0 CA-C-N 116.19 -0.459 . . . . 45.45 112.025 175.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.99 38.31 10.44 Favored Glycine 0 C--N 1.345 1.079 0 CA-C-N 116.93 -0.123 . . . . 64.33 113.187 -176.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 6.0 m -125.78 157.14 69.87 Favored Pre-proline 0 N--CA 1.481 1.116 0 C-N-CA 124.786 1.235 . . . . 64.04 110.226 176.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -67.77 165.38 27.95 Favored 'Trans proline' 0 C--N 1.383 2.386 0 C-N-CA 122.782 2.321 . . . . 74.43 112.423 177.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -77.54 16.38 0.66 Allowed 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 123.18 0.592 . . . . 71.52 111.982 -179.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -119.18 -0.15 11.1 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.786 1.635 . . . . 71.24 108.406 178.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.46 133.01 47.99 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.406 0.682 . . . . 71.14 111.94 -171.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 68.4 p -87.69 175.47 7.86 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.452 1.101 . . . . 74.41 110.862 -178.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -51.5 -39.14 57.01 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.183 0.993 . . . . 74.45 111.527 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -62.59 -47.46 83.72 Favored 'General case' 0 C--N 1.349 0.584 0 O-C-N 123.811 0.694 . . . . 64.05 111.258 178.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -66.77 -37.99 85.69 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.659 0.784 . . . . 73.42 111.322 -177.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 22' ' ' ILE . . . . . 0.629 HG12 ' HB3' ' C' ' 57' ' ' LEU . 1.7 mp -62.28 -42.56 95.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.323 1.049 . . . . 61.32 110.439 175.405 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -69.24 -39.65 78.37 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 114.853 -1.067 . . . . 74.13 110.891 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -70.27 -33.63 71.81 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.737 0.815 . . . . 73.52 110.572 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -74.65 -36.26 62.85 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.777 0.831 . . . . 75.32 110.624 177.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 26' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -60.03 -48.28 82.35 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 115.447 -0.797 . . . . 72.31 108.988 172.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -60.1 -44.76 94.6 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.317 1.047 . . . . 74.1 111.203 178.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 22.6 ttt180 -51.25 -52.16 47.38 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.744 1.217 . . . . 71.15 110.963 177.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 29' ' ' LEU . . . . . 0.454 ' HB3' HD13 ' C' ' 50' ' ' ILE . 83.3 mt -83.6 -12.47 56.02 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 114.585 -1.189 . . . . 60.22 111.506 -178.374 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.19 -2.65 55.01 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.684 0.793 . . . . 75.32 110.41 173.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 76.6 mtp180 -95.89 -45.35 6.99 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.6 0.76 . . . . 73.5 109.045 166.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -68.31 -52.84 29.08 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 115.343 -0.844 . . . . 71.12 111.188 -178.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 33' ' ' TYR . . . . . 0.448 ' HE2' HD22 ' C' ' 29' ' ' LEU . 37.3 m-85 -100.97 26.26 7.16 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.577 0.751 . . . . 70.15 110.464 -178.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 34' ' ' HIS . . . . . . . . . . . . . 13.0 t60 -55.12 99.16 0.19 Allowed Pre-proline 0 N--CA 1.488 1.46 0 C-N-CA 124.765 1.226 . . . . 72.34 110.738 -177.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -59.58 -27.88 86.05 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 123.088 2.525 . . . . 71.32 113.97 -167.175 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -72.1 -25.86 61.92 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.357 0.663 . . . . 60.34 111.929 -177.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 67.2 t -113.22 -25.59 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 CA-C-O 121.352 0.596 . . . . 75.33 110.783 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -105.43 83.98 2.03 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 106.807 -1.553 . . . . 54.22 106.807 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.96 76.5 7.9 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.89 -0.782 . . . . 62.24 108.89 -178.684 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 67.4 m -143.08 108.43 5.37 Favored Pre-proline 0 C--O 1.235 0.329 0 N-CA-C 107.004 -1.48 . . . . 74.14 107.004 172.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 41' ' ' PRO . . . . . 0.44 ' O ' ' HG2' ' C' ' 45' ' ' GLU . 76.9 Cg_exo -46.79 -30.59 9.53 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 123.548 2.832 . . . . 63.44 114.161 175.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -57.14 -45.53 83.48 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.752 0.821 . . . . 65.44 111.216 175.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.54 -19.19 62.91 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.508 -0.769 . . . . 62.05 110.84 178.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 44' ' ' GLU . . . . . 0.411 ' O ' ' HG3' ' C' ' 48' ' ' LYS . 36.5 mt-10 -87.6 -30.36 20.54 Favored 'General case' 0 C--N 1.358 0.95 0 C-N-CA 123.184 0.594 . . . . 74.04 110.409 -178.488 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 45' ' ' GLU . . . . . 0.44 ' HG2' ' O ' ' C' ' 41' ' ' PRO . 11.8 mm-40 -72.39 -40.09 67.51 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 108.895 -0.78 . . . . 42.53 108.895 174.128 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 46' ' ' LYS . . . . . 0.41 ' O ' HG13 ' C' ' 50' ' ' ILE . 48.4 mttp -63.25 -38.11 89.88 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-N 114.587 -1.188 . . . . 72.32 110.413 170.217 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 47' ' ' PHE . . . . . 0.813 ' HA ' HD12 ' C' ' 50' ' ' ILE . 26.8 t80 -62.45 -35.28 78.81 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 123.526 0.516 . . . . 62.23 110.387 175.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 48' ' ' LYS . . . . . 0.428 ' HB3' ' CE1' ' C' ' 93' ' ' PHE . 98.3 mttt -63.16 -44.74 94.64 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.099 0.56 . . . . 72.04 111.009 174.659 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -61.13 -36.38 79.6 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 120.997 0.427 . . . . 72.33 111.407 177.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 50' ' ' ILE . . . . . 0.813 HD12 ' HA ' ' C' ' 47' ' ' PHE . 52.5 mt -65.89 -40.28 87.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 124.051 0.94 . . . . 75.43 109.887 174.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 51' ' ' ASN . . . . . 0.413 ' HB3' ' CD1' ' C' ' 88' ' ' PHE . 28.5 m-80 -75.93 -16.68 59.98 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.067 0.947 . . . . 74.04 111.757 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -73.18 -53.39 11.08 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 108.939 -0.763 . . . . 63.42 108.939 170.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.29 -42.88 82.57 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 113.852 -1.522 . . . . 63.1 111.051 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -68.44 -40.67 81.06 Favored 'General case' 0 C--O 1.204 -1.307 0 CA-C-N 114.655 -1.157 . . . . 75.01 110.129 175.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.55 -35.04 73.46 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 112.373 0.508 . . . . 60.54 112.373 -179.232 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 56' ' ' VAL . . . . . 0.414 HG13 ' HZ ' ' C' ' 101' ' ' PHE . 15.6 t -96.39 -16.48 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 O-C-N 123.47 0.482 . . . . 72.43 111.882 -177.365 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 57' ' ' LEU . . . . . 0.629 ' HB3' HG12 ' C' ' 22' ' ' ILE . 92.9 mt -118.81 11.01 12.52 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.086 -1.009 . . . . 75.02 113.153 177.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 58' ' ' SER . . . . . 0.474 ' HB3' ' HD2' ' C' ' 62' ' ' LYS . 43.1 t -52.7 -34.21 51.2 Favored 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 124.749 1.219 . . . . 62.42 113.315 -176.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -134.28 155.93 79.45 Favored Pre-proline 0 N--CA 1.474 0.763 0 C-N-CA 124.803 1.241 . . . . 72.03 108.891 -174.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 60' ' ' PRO . . . . . 0.407 ' O ' ' HG2' ' C' ' 64' ' ' ARG . 50.3 Cg_exo -55.5 -29.73 70.61 Favored 'Trans proline' 0 C--N 1.383 2.347 0 C-N-CA 122.79 2.327 . . . . 33.23 112.354 169.509 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -56.8 -61.84 2.15 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.738 0.815 . . . . 62.13 110.278 174.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 62' ' ' LYS . . . . . 0.474 ' HD2' ' HB3' ' C' ' 58' ' ' SER . 56.1 mttp -64.31 -37.79 88.75 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 114.527 -1.215 . . . . 75.23 110.785 -176.342 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -56.28 -49.61 73.75 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 114.072 -1.422 . . . . 64.42 110.389 178.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 64' ' ' ARG . . . . . 0.407 ' HG2' ' O ' ' C' ' 60' ' ' PRO . 29.9 mmt180 -73.1 -27.54 61.77 Favored 'General case' 0 C--N 1.35 0.595 0 CA-C-O 118.591 -0.718 . . . . 74.15 111.755 -177.708 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 81.3 mt -58.73 -47.29 89.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-O 121.215 0.531 . . . . 62.34 109.585 170.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 66' ' ' TYR . . . . . 0.432 ' OH ' ' HA ' ' C' ' 6' ' ' ASP . 25.2 t80 -60.17 -52.75 63.98 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.028 -0.987 . . . . 74.22 110.323 175.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -62.05 -34.38 76.15 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.356 0.662 . . . . 73.14 111.831 -175.052 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 72.0 p -77.24 -24.97 51.12 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 119.223 -0.418 . . . . 63.2 110.634 176.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -66.7 128.95 38.23 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 108.816 -0.809 . . . . 75.22 108.816 173.237 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 93.79 15.55 48.91 Favored Glycine 0 C--N 1.344 1.021 0 N-CA-C 111.498 -0.641 . . . . 62.51 111.498 -168.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 86.3 m -143.95 -62.46 0.39 Allowed 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 102.959 -2.978 . . . . 72.34 102.959 174.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 27.1 m -70.41 132.93 46.35 Favored 'General case' 0 C--O 1.25 1.115 0 N-CA-C 104.615 -2.365 . . . . 73.35 104.615 155.083 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.16 -43.83 6.18 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 122.853 0.461 . . . . 73.23 111.316 -173.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -90.89 136.95 27.05 Favored Pre-proline 0 N--CA 1.477 0.886 0 C-N-CA 123.653 0.781 . . . . 53.23 109.834 -179.027 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.33 138.43 86.19 Favored 'Trans proline' 0 C--N 1.376 2.02 0 C-N-CA 122.761 2.308 . . . . 75.14 111.856 171.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -59.73 152.63 61.78 Favored 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 122.604 2.202 . . . . 63.14 112.417 176.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -51.67 136.77 50.3 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 122.98 2.454 . . . . 51.51 111.848 178.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 78' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.87 124.03 15.28 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 123.052 2.501 . . . . 74.44 112.565 -176.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.87 173.91 2.02 Favored 'Trans proline' 0 N--CA 1.51 2.46 0 C-N-CA 123.727 2.951 . . . . 61.04 114.447 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -57.11 88.62 0.04 OUTLIER 'Trans proline' 0 C--N 1.392 2.856 0 C-N-CA 122.857 2.372 . . . . 51.5 112.628 171.128 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 130.34 -23.93 4.51 Favored Glycine 0 N--CA 1.467 0.738 0 CA-C-N 114.442 -1.254 . . . . 75.2 110.729 178.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.641 ' HA3' ' HA ' ' C' ' 106' ' ' PHE . . . 107.75 -171.1 15.92 Favored Glycine 0 C--N 1.349 1.289 0 C-N-CA 124.852 1.215 . . . . 74.45 111.006 176.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -65.0 90.18 0.08 Allowed 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.59 -0.893 . . . . 70.14 108.59 165.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 84' ' ' ASP . . . . . 0.602 ' HB3' ' HG3' ' C' ' 143' ' ' ARG . 18.4 t0 -62.36 139.79 58.54 Favored 'General case' 0 C--O 1.241 0.652 0 O-C-N 124.1 0.875 . . . . 63.13 109.624 178.429 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 85' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -153.74 6.49 0.33 Allowed 'General case' 0 C--O 1.243 0.73 0 CA-C-N 115.447 -0.797 . . . . 74.41 110.273 -175.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 86' ' ' SER . . . . . 0.488 ' HB3' ' O ' ' C' ' 163' ' ' GLY . 74.8 m -64.41 146.75 53.99 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.315 -0.857 . . . . 45.43 110.859 -177.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 97.9 -28.03 16.35 Favored Glycine 0 C--N 1.339 0.719 0 N-CA-C 110.765 -0.934 . . . . 74.33 110.765 -165.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 88' ' ' PHE . . . . . 0.413 ' CD1' ' HB3' ' C' ' 51' ' ' ASN . 23.2 m-85 -116.07 138.03 51.59 Favored 'General case' 0 C--N 1.356 0.882 0 N-CA-C 108.684 -0.858 . . . . 74.44 108.684 -178.699 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -74.73 81.85 2.08 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.638 0.775 . . . . 72.23 110.589 -174.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 90' ' ' VAL . . . . . 0.438 HG13 ' HG2' ' C' ' 91' ' ' GLU . 6.5 p -41.54 -43.69 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 C-N-CA 125.119 1.368 . . . . 54.41 112.845 177.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 91' ' ' GLU . . . . . 0.438 ' HG2' HG13 ' C' ' 90' ' ' VAL . 51.5 mm-40 -74.97 8.09 2.76 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.653 1.181 . . . . 74.21 113.288 -172.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -120.38 -27.35 5.23 Favored 'General case' 0 C--O 1.243 0.753 0 C-N-CA 123.811 0.844 . . . . 75.53 110.929 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 93' ' ' PHE . . . . . 0.428 ' CE1' ' HB3' ' C' ' 48' ' ' LYS . 2.3 m-30 -77.73 170.95 15.7 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 120.864 0.364 . . . . 72.45 111.726 -165.022 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 87.1 p -63.02 164.21 8.65 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 114.964 1.468 . . . . 45.51 114.964 -162.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 95' ' ' GLU . . . . . 0.458 ' O ' ' HG3' ' C' ' 99' ' ' GLU . 0.0 OUTLIER -66.59 -33.02 74.74 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 113.749 -1.568 . . . . 55.43 111.401 173.767 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -66.61 -40.08 88.67 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 120.938 0.399 . . . . 65.02 110.469 176.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 97' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -58.85 -44.13 90.92 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 115.415 -0.811 . . . . 64.25 109.73 170.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 98' ' ' GLN . . . . . 0.426 ' O ' ' HA3' ' C' ' 102' ' ' GLY . 69.4 mt-30 -66.78 -18.62 65.46 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 123.463 0.705 . . . . 51.52 112.05 177.675 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 99' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' C' ' 95' ' ' GLU . 47.5 mt-10 -81.14 -48.15 12.52 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.156 0.583 . . . . 74.43 112.123 171.557 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 19.3 tp -82.14 -49.42 10.17 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 116.149 -0.478 . . . . 73.23 111.517 -168.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 101' ' ' PHE . . . . . 0.414 ' HZ ' HG13 ' C' ' 56' ' ' VAL . 93.2 m-85 -100.12 -25.11 14.4 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.117 0.567 . . . . 73.25 111.474 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 102' ' ' GLY . . . . . 0.426 ' HA3' ' O ' ' C' ' 98' ' ' GLN . . . -43.08 -58.27 3.83 Favored Glycine 0 CA--C 1.546 2.02 0 CA-C-O 118.961 -0.911 . . . . 54.11 115.325 -178.157 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -54.68 -22.35 28.5 Favored 'Trans proline' 0 C--N 1.387 2.583 0 C-N-CA 123.843 3.029 . . . . 62.02 113.957 -177.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -126.29 16.17 6.74 Favored Glycine 0 C--N 1.356 1.658 0 CA-C-O 118.756 -1.024 . . . . 43.23 113.95 -177.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 34.4 mt -57.76 89.15 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 117.829 0.814 . . . . 73.03 111.607 176.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 106' ' ' PHE . . . . . 0.641 ' HA ' ' HA3' ' C' ' 82' ' ' GLY . 50.7 m-85 60.05 -108.2 0.36 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.138 1.375 . . . . 64.24 113.142 175.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 107' ' ' GLY . . . . . 0.449 ' HA2' ' HA ' ' C' ' 113' ' ' SER . . . 73.61 5.79 69.44 Favored Glycine 0 CA--C 1.549 2.209 0 N-CA-C 110.846 -0.902 . . . . 51.05 110.846 -160.26 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . -13.11 -74.77 0.01 OUTLIER Glycine 0 C--N 1.387 3.371 0 C-N-CA 127.302 2.382 . . . . 74.41 115.953 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 109' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -100.76 75.65 1.73 Allowed 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 108.349 -0.982 . . . . 74.45 108.349 172.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 110' ' ' GLY . . . . . . . . . . . . . . . -10.04 -69.99 0.01 OUTLIER Glycine 0 N--CA 1.493 2.469 0 C-N-CA 126.126 1.822 . . . . 54.22 115.407 171.369 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -5.76 -41.4 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.885 0 C-N-CA 126.927 2.091 . . . . 75.25 116.607 161.251 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 112' ' ' ARG . . . . . 0.401 ' HA ' ' NE ' ' C' ' 112' ' ' ARG . 1.0 OUTLIER -122.65 -38.26 2.67 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.009 1.324 . . . . 74.1 109.638 179.062 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 113' ' ' SER . . . . . 0.449 ' HA ' ' HA2' ' C' ' 107' ' ' GLY . 67.6 m 55.19 14.56 1.05 Allowed 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 125.198 1.399 . . . . 72.53 112.728 -173.482 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 26.9 tpt180 -144.96 -112.61 0.1 Allowed 'General case' 0 C--O 1.194 -1.816 0 CA-C-O 117.297 -1.335 . . . . 74.05 110.412 -163.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 115' ' ' LYS . . . . . . . . . . . . . 25.3 tptp -38.15 111.88 0.19 Allowed 'General case' 0 N--CA 1.507 2.395 0 CA-C-N 121.248 1.84 . . . . 54.14 114.193 -167.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -67.59 121.86 15.97 Favored Glycine 0 C--N 1.362 1.99 0 O-C-N 124.257 0.973 . . . . 45.25 112.473 -174.183 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 74.9 mtt85 -89.86 173.17 8.39 Favored 'General case' 0 C--O 1.253 1.261 0 C-N-CA 123.422 0.689 . . . . 64.44 111.51 -178.077 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 118' ' ' ASP . . . . . 0.599 ' HB2' HD13 ' B' ' 102' ' ' LEU . 4.0 m-20 -66.93 133.93 50.99 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 107.69 -1.226 . . . . 75.42 107.69 169.363 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 119' ' ' LEU . . . . . 0.435 HD11 ' HB2' ' C' ' 141' ' ' ALA . 3.9 tt -93.61 137.49 32.82 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 106.607 -1.627 . . . . 75.21 106.607 -177.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.405 ' N ' HD23 ' C' ' 119' ' ' LEU . 6.0 mmm-85 -128.0 104.02 7.56 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.194 0.521 . . . . 72.31 109.682 -172.346 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 121' ' ' ALA . . . . . 0.468 ' HB3' HD23 ' C' ' 176' ' ' LEU . . . -109.29 115.52 30.15 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.206 -1.405 . . . . 63.21 107.206 172.58 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -104.42 88.93 3.08 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 105.174 -2.158 . . . . 73.22 105.174 174.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 123' ' ' LEU . . . . . 0.438 HD23 ' H ' ' C' ' 123' ' ' LEU . 1.7 pt? -125.52 136.21 27.98 Favored Pre-proline 0 N--CA 1.485 1.294 0 N-CA-C 114.252 1.204 . . . . 73.3 114.252 -158.443 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 124' ' ' PRO . . . . . 0.527 ' HA ' ' O ' ' C' ' 179' ' ' ARG . 53.2 Cg_exo -57.42 140.41 93.06 Favored 'Trans proline' 0 C--N 1.39 2.753 0 C-N-CA 123.816 3.01 . . . . 72.51 114.519 175.127 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 125' ' ' LEU . . . . . 0.559 ' HB2' HG23 ' B' ' 182' ' ' VAL . 54.3 tp -158.38 155.56 28.9 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.071 0.948 . . . . 74.03 109.791 176.633 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 126' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -102.49 153.7 19.8 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.122 0.569 . . . . 61.53 110.427 178.53 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 127' ' ' LEU . . . . . 0.67 HD13 ' HD2' ' C' ' 186' ' ' PHE . 98.0 mt -63.15 -44.46 95.46 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.237 1.015 . . . . 62.25 111.353 176.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 12.2 mp0 -62.04 -37.27 84.29 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 114.729 -1.123 . . . . 75.24 110.553 177.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -67.95 -37.82 82.06 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.68 0.792 . . . . 73.53 111.283 177.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -68.27 -33.58 74.62 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 123.748 0.655 . . . . 64.34 109.972 178.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 131' ' ' PHE . . . . . 0.442 ' HB2' HD13 ' C' ' 215' ' ' LEU . 83.0 t80 -67.21 -42.46 84.05 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.412 1.085 . . . . 75.55 111.007 174.282 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 132' ' ' HIS . . . . . . . . . . . . . 35.3 m170 -61.89 -40.96 97.23 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 123.585 0.553 . . . . 60.22 110.076 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 64.09 -108.37 2.22 Favored Glycine 0 C--N 1.355 1.588 0 N-CA-C 111.04 -0.824 . . . . 65.31 111.04 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . 70.49 147.09 0.37 Allowed Glycine 0 C--N 1.354 1.568 0 O-C-N 124.23 0.606 . . . . 53.24 114.535 173.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -80.19 92.94 5.76 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 107.359 -1.349 . . . . 71.2 107.359 176.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 136' ' ' ARG . . . . . 0.574 ' HB2' HD13 ' B' ' 181' ' ' LEU . 72.7 mtp180 -123.82 155.89 37.16 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 124.08 0.952 . . . . 72.12 109.501 -168.678 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 137' ' ' VAL . . . . . 0.495 HG23 ' HB1' ' B' ' 180' ' ' ALA . 31.3 m -78.97 122.52 34.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 CA-C-O 121.242 0.544 . . . . 71.12 111.893 -172.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 138' ' ' VAL . . . . . 0.533 ' HB ' HD23 ' B' ' 181' ' ' LEU . 12.9 p -111.56 140.8 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 107.681 -1.229 . . . . 72.14 107.681 169.102 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 139' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -109.83 100.77 9.7 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 108.131 -1.063 . . . . 74.31 108.131 179.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 140' ' ' VAL . . . . . . . . . . . . . 11.7 p -143.62 134.88 22.65 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.111 0 C-N-CA 123.484 0.714 . . . . 63.22 109.579 -173.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 141' ' ' ALA . . . . . 0.435 ' HB2' HD11 ' C' ' 119' ' ' LEU . . . 67.26 -1.67 1.43 Allowed 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 125.301 1.44 . . . . 15.23 114.173 178.263 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 119.55 -2.13 13.86 Favored Glycine 0 C--N 1.348 1.238 0 CA-C-O 119.23 -0.761 . . . . 45.25 114.231 179.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 143' ' ' ARG . . . . . 0.602 ' HG3' ' HB3' ' C' ' 84' ' ' ASP . 64.2 mtm180 -119.41 130.7 55.42 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 118.367 1.083 . . . . 73.04 111.744 175.181 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -83.76 103.61 13.19 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 107.709 -1.219 . . . . 71.51 107.709 164.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 145' ' ' VAL . . . . . . . . . . . . . 7.3 p -125.18 130.41 73.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.162 0.585 . . . . 75.03 111.733 -174.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 46.2 m -74.5 95.94 2.84 Favored 'General case' 0 C--N 1.353 0.736 0 C-N-CA 123.602 0.761 . . . . 54.21 110.369 176.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 35.1 m -123.42 152.29 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.538 0.735 . . . . 72.53 109.564 177.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 45.5 ttp180 -107.1 105.7 15.84 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 107.594 -1.262 . . . . 74.22 107.594 170.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 149' ' ' ILE . . . . . . . . . . . . . 31.6 pt -69.52 147.43 96.76 Favored Pre-proline 0 CA--C 1.55 0.946 0 CA-C-O 118.235 -0.888 . . . . 71.41 108.647 170.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -35.9 115.75 0.12 Allowed 'Trans proline' 0 C--N 1.394 2.925 0 C-N-CA 124.185 3.256 . . . . 61.44 113.578 -178.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -57.21 95.58 0.06 OUTLIER 'Trans proline' 0 C--N 1.39 2.715 0 C-N-CA 123.052 2.501 . . . . 73.2 111.886 -176.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 152' ' ' GLY . . . . . . . . . . . . . . . 109.64 136.11 7.4 Favored Glycine 0 C--N 1.345 1.08 0 CA-C-N 114.785 -1.098 . . . . 54.32 114.873 -174.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 153' ' ' VAL . . . . . 0.442 HG11 HD11 ' C' ' 159' ' ' ILE . 7.0 m -146.61 174.47 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 124.613 1.165 . . . . 71.13 111.077 172.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 154' ' ' ARG . . . . . 0.543 ' HB3' ' H ' ' C' ' 188' ' ' LEU . 11.7 ptt180 -124.72 168.74 12.77 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.495 1.118 . . . . 75.32 109.11 174.06 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 155' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -60.03 119.88 8.62 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.319 0.648 . . . . 74.51 111.104 176.102 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 82.27 15.05 75.26 Favored Glycine 0 C--N 1.351 1.368 0 CA-C-N 115.649 -0.705 . . . . 64.51 113.476 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 157' ' ' SER . . . . . . . . . . . . . 34.1 t -75.63 125.59 29.34 Favored 'General case' 0 C--N 1.353 0.736 0 N-CA-C 109.162 -0.681 . . . . 75.43 109.162 176.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 6.0 p -98.5 97.06 5.62 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 CA-C-O 121.844 0.83 . . . . 64.44 109.714 -177.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 159' ' ' ILE . . . . . 0.666 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 58.0 mt -70.71 113.17 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-N 115.179 -0.919 . . . . 52.25 109.678 175.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 160' ' ' ARG . . . . . 0.417 ' HA ' ' O ' ' C' ' 174' ' ' LEU . 61.8 ttt180 -99.22 101.25 12.51 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 109.696 -0.483 . . . . 72.21 109.696 179.006 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 161' ' ' VAL . . . . . 0.682 ' HB ' ' HB3' ' C' ' 174' ' ' LEU . 97.7 t -82.95 119.7 74.79 Favored Pre-proline 0 C--O 1.25 1.116 0 N-CA-C 108.455 -0.943 . . . . 75.24 108.455 174.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -60.64 106.04 0.34 Allowed 'Trans proline' 0 C--N 1.384 2.42 0 C-N-CA 123.335 2.69 . . . . 63.42 113.163 -173.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 163' ' ' GLY . . . . . 0.488 ' O ' ' HB3' ' C' ' 86' ' ' SER . . . 91.06 -25.34 14.5 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 118.581 -1.122 . . . . 53.31 114.927 169.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 164' ' ' MET . . . . . 0.433 ' O ' ' HB2' ' C' ' 174' ' ' LEU . 39.6 ttp -87.39 50.66 2.05 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 118.536 1.168 . . . . 73.35 112.783 -165.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . -125.69 -96.11 1.03 Allowed Glycine 0 N--CA 1.472 1.041 0 N-CA-C 110.665 -0.974 . . . . 64.24 110.665 171.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . 61.98 40.29 98.69 Favored Glycine 0 C--N 1.353 1.475 0 N-CA-C 115.61 1.004 . . . . 75.44 115.61 162.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 167' ' ' GLN . . . . . 0.4 HE22 ' HA ' ' C' ' 141' ' ' ALA . 15.3 mm-40 -64.96 105.26 0.99 Allowed 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 117.155 0.477 . . . . 64.31 110.126 177.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . 159.0 -67.91 0.27 Allowed Glycine 0 C--O 1.219 -0.827 0 N-CA-C 110.867 -0.893 . . . . 13.44 110.867 -178.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 169' ' ' ASN . . . . . 0.604 ' HB3' ' HD3' ' C' ' 170' ' ' PRO . 26.6 t-20 -173.7 -62.21 0.0 OUTLIER Pre-proline 0 CA--C 1.575 1.916 0 C-N-CA 124.172 0.989 . . . . 62.44 111.569 172.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 170' ' ' PRO . . . . . 0.604 ' HD3' ' HB3' ' C' ' 169' ' ' ASN . 13.4 Cg_exo -72.63 160.34 46.7 Favored 'Trans proline' 0 C--N 1.4 3.259 0 C-N-CA 121.802 1.668 . . . . 51.41 111.618 172.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 171' ' ' PRO . . . . . 0.403 ' HB3' ' HA ' ' C' ' 86' ' ' SER . 30.7 Cg_endo -62.79 152.47 78.4 Favored 'Trans proline' 0 C--N 1.374 1.875 0 C-N-CA 122.163 1.909 . . . . 74.02 113.073 177.493 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -130.96 -103.48 0.97 Allowed Glycine 0 C--N 1.341 0.855 0 N-CA-C 109.29 -1.524 . . . . 74.42 109.29 174.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 173' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -170.68 162.91 7.98 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 124.72 1.208 . . . . 74.51 109.474 165.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 174' ' ' LEU . . . . . 0.682 ' HB3' ' HB ' ' C' ' 161' ' ' VAL . 28.3 tp -104.86 137.47 42.58 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.425 0.69 . . . . 75.22 110.523 -175.378 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 96.8 mt -124.08 92.02 3.58 Favored 'General case' 0 C--O 1.246 0.88 0 C-N-CA 124.62 1.168 . . . . 71.32 109.538 177.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 176' ' ' LEU . . . . . 0.666 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 74.3 mt -83.21 92.38 7.45 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 108.817 -0.808 . . . . 43.02 108.817 173.311 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 177' ' ' VAL . . . . . . . . . . . . . 96.0 t -83.45 102.24 9.16 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 N-CA-C 107.642 -1.244 . . . . 74.43 107.642 174.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 178' ' ' VAL . . . . . . . . . . . . . 5.9 p -74.83 132.14 33.84 Favored 'Isoleucine or valine' 0 C--O 1.249 1.039 0 CA-C-N 114.433 -1.258 . . . . 74.01 111.693 -173.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 179' ' ' ARG . . . . . 0.527 ' O ' ' HA ' ' C' ' 124' ' ' PRO . 23.0 mmt180 -110.74 103.27 11.79 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 106.844 -1.539 . . . . 72.33 106.844 170.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 180' ' ' LEU . . . . . 0.609 HD13 HD21 ' C' ' 127' ' ' LEU . 83.9 mt -69.92 148.33 49.11 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 116.006 -0.543 . . . . 70.51 111.059 -179.328 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 181' ' ' LEU . . . . . . . . . . . . . 63.5 mt -66.83 166.91 15.77 Favored Pre-proline 0 CA--C 1.552 1.045 0 CA-C-N 115.083 -0.962 . . . . 74.2 111.299 -175.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 182' ' ' PRO . . . . . 0.623 ' HG3' ' HB2' ' B' ' 207' ' ' LYS . 18.1 Cg_endo -57.33 78.1 0.04 OUTLIER 'Trans proline' 0 C--N 1.394 2.936 0 C-N-CA 122.99 2.46 . . . . 64.12 111.815 170.186 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 183' ' ' HIS . . . . . 0.413 ' N ' ' HD3' ' C' ' 184' ' ' PRO . 62.6 t60 176.68 51.65 0.03 OUTLIER Pre-proline 0 CA--C 1.556 1.202 0 C-N-CA 127.772 2.429 . . . . 62.13 105.591 -173.659 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 184' ' ' PRO . . . . . 0.413 ' HD3' ' N ' ' C' ' 183' ' ' HIS . 79.8 Cg_endo -94.47 65.12 0.31 Allowed 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 122.919 2.413 . . . . 71.54 110.903 -169.539 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 185' ' ' VAL . . . . . 0.605 HG12 ' HB1' ' C' ' 195' ' ' ALA . 6.7 t -94.09 -52.64 9.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 108.951 -0.759 . . . . 72.23 108.951 -167.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 186' ' ' PHE . . . . . 0.67 ' HD2' HD13 ' C' ' 127' ' ' LEU . 67.1 m-85 -99.79 121.35 41.15 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.437 0.695 . . . . 61.44 110.288 -169.287 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 187' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -114.99 107.59 15.58 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.066 0.946 . . . . 75.14 108.699 179.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 188' ' ' LEU . . . . . 0.543 ' H ' ' HB3' ' C' ' 154' ' ' ARG . 58.8 tp -77.12 140.69 40.31 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.479 1.112 . . . . 74.14 112.964 -171.428 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -142.0 123.58 15.02 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 106.925 -1.509 . . . . 71.33 106.925 163.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 68.02 -111.54 4.1 Favored Glycine 0 CA--C 1.536 1.377 0 N-CA-C 111.526 -0.629 . . . . 74.2 111.526 -172.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 191' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -113.89 -10.95 12.89 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 124.086 0.954 . . . . 60.21 110.057 172.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -95.96 147.45 23.68 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.029 0.932 . . . . 65.13 109.98 -168.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 193' ' ' LEU . . . . . 0.504 HD21 ' CD2' ' C' ' 240' ' ' PHE . 84.6 mt -104.21 158.25 16.57 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.018 0.527 . . . . 52.2 111.115 -176.15 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 194' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -131.46 106.67 8.38 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 108.119 -1.067 . . . . 75.43 108.119 165.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 195' ' ' ALA . . . . . 0.605 ' HB1' HG12 ' C' ' 185' ' ' VAL . . . -116.15 -177.75 3.24 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.159 0.984 . . . . 65.11 109.549 176.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 25.2 m -128.73 111.42 13.13 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 109.32 -0.622 . . . . 51.32 109.32 178.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 197' ' ' LEU . . . . . 0.504 HD13 ' HB2' ' C' ' 212' ' ' ALA . 55.2 tp -85.18 130.88 34.52 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.289 1.036 . . . . 73.5 110.497 -179.515 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -89.8 112.14 23.37 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.359 0.663 . . . . 44.52 109.386 174.153 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 199' ' ' VAL . . . . . 0.55 ' HA ' HG11 ' C' ' 210' ' ' VAL . 59.3 t -117.77 113.55 38.04 Favored Pre-proline 0 N--CA 1.471 0.612 0 C-N-CA 124.347 1.059 . . . . 61.21 108.621 177.456 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 200' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' C' ' 256' ' ' THR . 39.7 Cg_endo -68.3 146.25 68.57 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 121.788 1.659 . . . . 71.34 110.907 176.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 201' ' ' ALA . . . . . . . . . . . . . . . -53.23 -46.18 97.98 Favored Pre-proline 0 CA--C 1.56 1.357 0 C-N-CA 124.917 1.287 . . . . 74.35 114.271 -172.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 202' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -59.3 -45.51 26.63 Favored 'Trans proline' 0 C--N 1.397 3.09 0 CA-C-N 121.212 1.469 . . . . 63.15 111.977 178.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 203' ' ' ILE . . . . . . . . . . . . . 42.4 mt -66.1 -30.54 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 123.84 0.856 . . . . 63.4 110.675 178.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.32 -42.69 79.01 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.332 0.653 . . . . 75.02 111.799 178.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 205' ' ' VAL . . . . . 0.515 HG11 HD11 ' A' ' 261' ' ' LEU . 57.5 t -75.71 -46.84 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 116.016 -0.538 . . . . 63.41 111.942 -176.243 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 206' ' ' VAL . . . . . . . . . . . . . 14.1 p -81.14 -28.9 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 CA-C-O 120.743 0.306 . . . . 52.12 111.118 -179.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 80.12 83.13 0.71 Allowed Glycine 0 C--N 1.337 0.624 0 N-CA-C 111.431 -0.668 . . . . 63.21 111.431 -174.2 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -105.92 -127.83 5.98 Favored Glycine 0 C--N 1.34 0.78 0 N-CA-C 110.365 -1.094 . . . . 51.32 110.365 176.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 209' ' ' LYS . . . . . 0.493 ' HG2' ' HA ' ' C' ' 222' ' ' ALA . 8.2 mtmp? -139.19 145.32 39.17 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.494 0.664 . . . . 72.12 110.545 172.343 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 210' ' ' VAL . . . . . 0.55 HG11 ' HA ' ' C' ' 199' ' ' VAL . 34.1 m -126.87 178.6 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.299 1.44 . . . . 62.05 107.671 173.306 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 211' ' ' ARG . . . . . 0.497 ' HD3' ' HB2' ' C' ' 218' ' ' PRO . 33.6 ttm-85 -128.65 124.01 34.65 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 118.522 0.601 . . . . 72.44 112.167 -178.124 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 212' ' ' ALA . . . . . 0.504 ' HB2' HD13 ' C' ' 197' ' ' LEU . . . -97.81 114.24 26.23 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 107.756 -1.202 . . . . 74.43 107.756 166.032 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 213' ' ' MET . . . . . . . . . . . . . 2.3 tmm? -77.06 98.53 5.03 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 107.112 -1.44 . . . . 63.12 107.112 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 214' ' ' THR . . . . . 0.485 ' OG1' HG12 ' C' ' 219' ' ' VAL . 1.0 OUTLIER -100.98 170.67 8.13 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.359 0.599 . . . . 54.24 109.746 -172.991 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 215' ' ' LEU . . . . . 0.442 HD13 ' HB2' ' C' ' 131' ' ' PHE . 8.4 mt -61.94 -43.55 98.61 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.24 1.416 . . . . 44.41 110.956 -173.695 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -93.35 17.83 10.65 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 113.824 -1.535 . . . . 71.0 111.627 -177.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 125.44 152.86 8.32 Favored Glycine 0 C--N 1.344 0.982 0 CA-C-N 116.006 -0.543 . . . . 64.11 111.744 178.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 218' ' ' PRO . . . . . 0.497 ' HB2' ' HD3' ' C' ' 211' ' ' ARG . 68.8 Cg_endo -74.98 103.29 1.7 Allowed 'Trans proline' 0 CA--C 1.554 1.507 0 C-N-CA 122.377 2.051 . . . . 52.13 112.517 175.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 219' ' ' VAL . . . . . 0.571 HG23 HG22 ' B' ' 238' ' ' THR . 1.5 p -75.43 127.4 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 122.938 0.495 . . . . 52.53 109.667 178.553 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 220' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -87.0 104.62 16.48 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 107.383 -1.339 . . . . 72.32 107.383 171.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 221' ' ' VAL . . . . . . . . . . . . . 47.6 t -71.22 125.96 30.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 125.733 1.613 . . . . 74.03 111.631 -177.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 222' ' ' ALA . . . . . 0.493 ' HA ' ' HG2' ' C' ' 209' ' ' LYS . . . -78.55 106.94 10.85 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.174 0.59 . . . . 73.3 109.821 171.504 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 223' ' ' VAL . . . . . 0.407 ' HA ' ' HD3' ' C' ' 224' ' ' PRO . 60.4 t -83.05 132.69 49.95 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 123.906 0.882 . . . . 73.11 109.179 178.491 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 224' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' C' ' 223' ' ' VAL . 2.2 Cg_endo -83.13 156.76 15.0 Favored 'Trans proline' 0 C--N 1.379 2.179 0 C-N-CA 123.271 2.647 . . . . 54.33 110.979 172.612 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -57.64 134.52 63.63 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 122.309 2.006 . . . . 74.0 112.012 174.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 226' ' ' ARG . . . . . 0.49 ' HG2' ' HG3' ' B' ' 248' ' ' ARG . 9.8 mpt_? 70.97 82.16 0.15 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.617 1.167 . . . . 70.15 110.374 177.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 227' ' ' THR . . . . . . . . . . . . . 53.2 m -115.91 123.23 47.58 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.775 0.83 . . . . 70.3 110.612 179.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 228' ' ' GLN . . . . . 0.579 ' NE2' ' HG2' ' A' ' 259' ' ' GLU . 24.7 mp0 -102.33 150.8 22.96 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.307 1.043 . . . . 74.32 111.197 -179.013 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -72.47 134.11 45.16 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 114.559 -1.2 . . . . 62.12 109.563 176.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 102.88 -6.45 51.75 Favored Glycine 0 C--N 1.339 0.712 0 O-C-N 123.681 0.613 . . . . 62.04 112.375 -173.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 231' ' ' ARG . . . . . 0.411 ' HD2' ' H ' ' C' ' 228' ' ' GLN . 59.6 mtt180 -65.38 171.97 3.54 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 117.266 0.533 . . . . 74.12 110.85 167.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 232' ' ' LYS . . . . . 0.45 ' HA ' ' O ' ' C' ' 251' ' ' LEU . 37.1 ttmt -148.51 124.74 10.83 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.2 -0.455 . . . . 71.45 110.849 -177.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 233' ' ' LEU . . . . . 0.582 ' O ' ' HA ' ' C' ' 250' ' ' TYR . 6.3 mp -84.66 156.9 21.3 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.444 1.098 . . . . 74.21 110.254 174.713 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 234' ' ' ARG . . . . . 0.413 ' HG3' ' HG3' ' B' ' 241' ' ' GLU . 18.2 ptt-85 -128.0 85.2 2.32 Favored 'General case' 0 CA--C 1.553 1.08 0 O-C-N 124.966 1.416 . . . . 72.34 108.527 166.725 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 235' ' ' LEU . . . . . 0.515 HD22 ' H ' ' B' ' 240' ' ' GLY . 49.8 mt -79.0 116.02 19.04 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.434 -0.803 . . . . 73.43 108.849 176.242 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -77.28 129.62 36.12 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 123.219 0.607 . . . . 71.55 111.835 -169.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 76.18 14.74 82.0 Favored Glycine 0 C--N 1.346 1.088 0 O-C-N 124.451 1.095 . . . . 71.42 114.731 177.198 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 14.2 mmtm -98.87 9.65 43.0 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.386 0.674 . . . . 72.03 111.493 -179.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 239' ' ' GLY . . . . . 0.417 ' HA2' ' HG ' ' C' ' 193' ' ' LEU . . . -86.88 -169.55 46.0 Favored Glycine 0 C--N 1.346 1.113 0 O-C-N 123.447 0.467 . . . . 31.21 112.763 177.298 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 240' ' ' PHE . . . . . 0.504 ' CD2' HD21 ' C' ' 193' ' ' LEU . 12.8 m-85 -81.35 150.7 67.99 Favored Pre-proline 0 C--O 1.247 0.968 0 CA-C-O 119.167 -0.444 . . . . 75.14 110.005 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 241' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_exo -71.44 96.14 0.72 Allowed 'Trans proline' 0 C--N 1.388 2.647 0 C-N-CA 123.418 2.745 . . . . 70.21 112.341 -175.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -83.03 177.52 53.2 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 115.255 -0.884 . . . . 70.14 113.278 178.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -69.82 -18.93 36.46 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 123.134 2.556 . . . . 71.42 112.602 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -111.21 15.51 21.46 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.052 0.941 . . . . 71.42 110.563 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 109.42 177.26 21.33 Favored Glycine 0 C--N 1.354 1.534 0 N-CA-C 111.712 -0.555 . . . . 51.32 111.712 -175.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 246' ' ' ARG . . . . . 0.579 ' HB2' ' HA3' ' B' ' 42' ' ' GLY . 34.2 mtm180 -71.72 147.81 47.02 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.124 0.569 . . . . 61.31 111.393 -179.674 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -78.64 -159.0 12.97 Favored Glycine 0 N--CA 1.48 1.59 0 O-C-N 123.43 0.456 . . . . 63.23 113.329 176.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -124.47 135.96 53.64 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 108.944 -0.761 . . . . 73.54 108.944 -175.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 249' ' ' LEU . . . . . 0.5 HD23 HD12 ' C' ' 235' ' ' LEU . 18.7 tp -83.89 121.9 27.98 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.0 0.92 . . . . 74.23 110.397 -179.058 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 250' ' ' TYR . . . . . 0.582 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 23.1 m-85 -101.64 109.94 21.83 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.221 -0.659 . . . . 71.43 109.221 175.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 251' ' ' LEU . . . . . 0.558 HD23 ' HB3' ' C' ' 195' ' ' ALA . 68.5 mt -102.64 112.85 25.8 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 116.402 -0.363 . . . . 64.53 110.917 -175.403 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -70.4 128.46 36.27 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 108.537 -0.912 . . . . 73.41 108.537 168.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 253' ' ' VAL . . . . . . . . . . . . . 84.6 t -82.01 122.53 36.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.014 -0.539 . . . . 73.5 110.944 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 254' ' ' ARG . . . . . . . . . . . . . 13.8 mmt180 -102.1 114.42 28.54 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 107.853 -1.166 . . . . 74.13 107.853 164.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 255' ' ' ILE . . . . . 0.513 ' O ' ' HB ' ' A' ' 255' ' ' ILE . 34.2 mm -76.7 119.16 24.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 106.455 -1.683 . . . . 75.24 106.455 164.596 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 256' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' C' ' 200' ' ' PRO . 2.3 t -134.4 172.32 13.06 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.594 1.158 . . . . 53.32 109.416 -171.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 257' ' ' ILE . . . . . 0.434 HD12 ' H ' ' C' ' 259' ' ' GLU . 2.9 pp -135.2 156.11 78.38 Favored Pre-proline 0 N--CA 1.482 1.137 0 C-N-CA 123.273 0.629 . . . . 64.54 109.793 -176.242 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -77.43 22.31 0.59 Allowed 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 122.835 2.357 . . . . 73.21 114.952 -170.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 259' ' ' GLU . . . . . 0.434 ' H ' HD12 ' C' ' 257' ' ' ILE . 43.5 mt-10 61.55 -78.49 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.98 1.312 . . . . 72.3 111.098 -174.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.11 178.23 8.2 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.389 0.675 . . . . 73.41 110.026 179.495 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 261' ' ' LEU . . . . . 0.552 HD22 ' HB3' ' C' ' 265' ' ' GLU . 85.6 mt -142.57 151.36 41.48 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.888 0.875 . . . . 71.21 109.504 169.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 66.2 p -82.76 155.36 68.21 Favored Pre-proline 0 N--CA 1.479 0.981 0 N-CA-C 107.689 -1.226 . . . . 61.23 107.689 166.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -39.21 -44.27 2.71 Favored 'Trans proline' 0 C--N 1.381 2.285 0 C-N-CA 123.814 3.009 . . . . 74.2 115.592 178.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -67.43 -50.4 59.55 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.298 0.639 . . . . 71.04 110.826 -178.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 265' ' ' GLU . . . . . 0.552 ' HB3' HD22 ' C' ' 261' ' ' LEU . 47.8 mt-10 -55.31 -52.08 64.64 Favored 'General case' 0 C--N 1.358 0.968 0 O-C-N 123.927 0.767 . . . . 65.11 109.943 176.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 266' ' ' GLU . . . . . 0.444 ' O ' ' HG2' ' C' ' 270' ' ' LYS . 3.7 tp10 -43.98 -56.08 4.2 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.596 1.558 . . . . 64.21 111.209 176.384 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -59.97 -48.85 80.01 Favored 'General case' 0 CA--C 1.549 0.93 0 O-C-N 124.217 0.948 . . . . 70.32 112.503 -176.01 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 268' ' ' LEU . . . . . . . . . . . . . 11.1 mp -65.37 -44.19 88.41 Favored 'General case' 0 N--CA 1.481 1.12 0 O-C-N 123.392 0.433 . . . . 52.44 111.319 -178.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 78.3 m95 -61.26 -37.68 83.99 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.558 0.743 . . . . 61.11 111.221 177.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 270' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' C' ' 266' ' ' GLU . 31.1 mmtp -64.73 -47.23 79.03 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.142 0.577 . . . . 75.43 110.695 178.553 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -64.15 -41.46 97.16 Favored 'General case' 0 N--CA 1.484 1.234 0 O-C-N 123.534 0.521 . . . . 75.33 111.486 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 272' ' ' LEU . . . . . 0.478 HD21 ' HB2' ' A' ' 268' ' ' LEU . 69.2 mt -57.92 -45.85 85.88 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 123.92 0.763 . . . . 74.33 110.146 174.336 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -60.67 -44.2 96.74 Favored 'General case' 0 C--O 1.209 -1.063 0 O-C-N 124.4 1.062 . . . . 34.13 111.718 -176.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -63.13 -49.92 72.48 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-O 121.437 0.637 . . . . 63.21 110.428 178.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -61.17 -23.25 65.43 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 114.493 -1.231 . . . . 70.04 111.342 176.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 276' ' ' TYR . . . . . 0.457 ' HB2' ' O ' ' C' ' 272' ' ' LEU . 6.7 t80 -89.46 -31.69 17.57 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.416 1.086 . . . . 75.52 110.665 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 277' ' ' TYR . . . . . 0.438 ' HE1' HG12 ' A' ' 203' ' ' ILE . 22.7 m-85 -68.24 -25.61 65.27 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 109.176 -0.676 . . . . 44.24 109.176 176.318 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -53.48 -26.61 21.25 Favored 'General case' 0 CA--C 1.554 1.13 0 O-C-N 124.331 1.019 . . . . 55.2 112.954 171.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 279' ' ' ARG . . . . . . . . . . . . . 26.4 mtm180 -73.5 -16.45 61.28 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 117.898 0.317 . . . . 71.52 111.726 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.087 0 C-N-CA 123.289 0.636 . . . . 75.14 109.764 -177.231 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.6 mtm . . . . . 0 N--CA 1.474 0.742 0 N-CA-C 109.59 -0.522 . . . . 64.12 109.59 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.511 ' HA ' ' HD1' ' A' ' 96' ' ' PHE . . . 63.11 34.37 13.74 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.692 1.197 . . . . 51.4 113.68 173.681 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -86.78 49.68 1.86 Allowed 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.109 0.564 . . . . 74.04 111.079 -179.068 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -37.0 113.27 0.24 Allowed 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 125.398 1.479 . . . . 62.43 114.869 -174.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.54 ' HB3' HD11 ' A' ' 10' ' ' ILE . 99.5 mttt -81.21 123.23 28.29 Favored 'General case' 0 C--O 1.245 0.85 0 N-CA-C 108.924 -0.769 . . . . 74.32 108.924 167.642 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.459 ' HA ' ' OH ' ' A' ' 66' ' ' TYR . 37.2 t70 -75.53 103.97 5.89 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 107.58 -1.267 . . . . 61.41 107.58 167.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.404 ' HB2' HD11 ' A' ' 57' ' ' LEU . 38.4 m-85 -61.83 -27.57 68.86 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 114.876 -1.056 . . . . 73.34 111.873 -173.547 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.548 ' HE1' HD11 ' A' ' 22' ' ' ILE . 30.7 m-85 -68.12 -42.26 80.5 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 116.355 -0.384 . . . . 73.33 110.038 175.221 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.21 -45.58 92.69 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.13 0.572 . . . . 60.32 110.403 177.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.54 HD11 ' HB3' ' A' ' 5' ' ' LYS . 64.0 mt -52.91 -47.78 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 123.236 0.614 . . . . 74.23 110.41 175.144 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.465 ' HB3' ' HB1' ' A' ' 25' ' ' ALA . 88.6 mt -81.16 -9.47 59.79 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 115.159 -0.928 . . . . 51.33 113.16 -178.164 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.71 27.7 68.66 Favored Glycine 0 CA--C 1.543 1.824 0 N-CA-C 114.412 0.525 . . . . 53.33 114.412 179.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.407 HG13 ' HB2' ' A' ' 25' ' ' ALA . 5.9 m -114.49 162.08 25.28 Favored Pre-proline 0 N--CA 1.486 1.345 0 C-N-CA 124.507 1.123 . . . . 71.43 110.087 176.359 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -64.3 163.72 25.43 Favored 'Trans proline' 0 C--N 1.389 2.688 0 C-N-CA 122.38 2.053 . . . . 50.12 112.769 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 41.1 mtp180 -83.23 41.43 0.76 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.065 0.946 . . . . 75.43 112.135 -170.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.44 ' H ' ' H ' ' A' ' 17' ' ' ALA . 24.7 t-20 -172.86 -5.24 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.053 1.341 . . . . 64.11 109.355 -171.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.44 ' H ' ' H ' ' A' ' 16' ' ' ASN . . . -40.8 131.43 2.42 Favored 'General case' 0 C--N 1.364 1.229 0 C-N-CA 125.879 1.672 . . . . 64.31 112.674 178.284 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 63.2 p -78.29 -178.94 5.96 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.2 0.6 . . . . 71.11 112.249 -174.116 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -46.44 -58.72 3.49 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 124.915 1.286 . . . . 64.21 112.778 -177.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -71.1 -33.36 70.1 Favored 'General case' 0 C--O 1.211 -0.966 0 CA-C-O 119.111 -0.471 . . . . 72.43 111.114 -174.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -62.12 -49.29 76.48 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.137 0.494 . . . . 64.03 110.959 179.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.548 HD11 ' HE1' ' A' ' 8' ' ' TYR . 71.9 mt -61.76 -42.41 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.123 0.969 . . . . 73.31 110.518 177.205 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -70.85 -28.17 64.38 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.121 -0.945 . . . . 71.24 111.624 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -73.06 -36.94 66.97 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.331 0.653 . . . . 54.12 110.12 175.076 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.465 ' HB1' ' HB3' ' A' ' 11' ' ' LEU . . . -66.95 -39.95 87.42 Favored 'General case' 0 C--O 1.246 0.909 0 O-C-N 124.028 0.83 . . . . 64.0 110.874 175.006 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.472 ' HD1' HG22 ' A' ' 50' ' ' ILE . 48.8 t80 -57.03 -66.87 0.38 Allowed 'General case' 0 C--O 1.203 -1.391 0 CA-C-N 114.398 -1.273 . . . . 73.1 109.08 172.516 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -50.74 -40.93 55.88 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.567 1.147 . . . . 74.22 111.888 -178.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.8 ttt180 -57.5 -67.54 0.32 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.247 0.619 . . . . 71.15 110.59 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 83.9 mt -71.72 -22.79 61.58 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.499 -0.773 . . . . 74.11 111.577 -173.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.9 -26.14 29.62 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.466 0.707 . . . . 63.3 110.782 -178.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 85.0 mtt180 -83.82 -26.48 29.5 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 122.951 0.501 . . . . 72.33 110.551 172.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -70.58 -52.18 23.32 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 121.004 0.431 . . . . 63.33 110.393 173.091 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.465 ' HD2' HD11 ' A' ' 50' ' ' ILE . 14.4 m-85 -97.97 35.51 1.71 Allowed 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.988 0.915 . . . . 63.25 109.843 -177.313 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.488 ' CD2' ' HB3' ' A' ' 36' ' ' ASP . 18.3 t60 -76.63 109.91 10.07 Favored Pre-proline 0 N--CA 1.473 0.695 0 C-N-CA 124.763 1.225 . . . . 63.41 110.156 -172.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -52.21 -37.22 69.73 Favored 'Trans proline' 0 C--N 1.379 2.148 0 C-N-CA 123.584 2.856 . . . . 74.13 113.274 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.488 ' HB3' ' CD2' ' A' ' 34' ' ' HIS . 15.9 t70 -64.28 -31.49 72.71 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.93 0.892 . . . . 72.45 111.778 178.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 85.3 t -84.79 -54.25 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 122.868 0.467 . . . . 65.53 109.876 176.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -133.9 110.05 9.46 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.319 1.048 . . . . 61.35 109.762 -174.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -85.97 63.7 8.18 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.376 0.671 . . . . 73.11 109.983 -178.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 66.9 m -99.8 112.56 64.0 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-O 117.654 -1.165 . . . . 54.41 108.459 174.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -38.61 -53.54 1.79 Allowed 'Trans proline' 0 C--N 1.39 2.732 0 C-N-CA 124.411 3.408 . . . . 72.23 114.044 -177.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -63.12 -35.04 78.96 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.671 0.788 . . . . 64.43 111.816 -178.003 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.451 ' O ' ' HB3' ' A' ' 33' ' ' TYR . . . -71.2 -29.78 65.58 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 122.829 0.452 . . . . 72.14 110.157 176.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -82.54 -26.74 32.16 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 109.422 -0.585 . . . . 62.01 109.422 -178.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -69.01 -41.83 77.25 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.913 0.885 . . . . 62.44 109.653 172.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 9.7 mptt -64.66 -41.02 96.39 Favored 'General case' 0 C--O 1.212 -0.903 0 CA-C-N 115.315 -0.857 . . . . 74.03 110.271 174.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.491 ' HA ' HD12 ' A' ' 50' ' ' ILE . 90.7 t80 -55.78 -45.42 78.18 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.794 0.838 . . . . 73.24 109.684 174.562 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.466 ' HB3' ' HE1' ' A' ' 93' ' ' PHE . 52.4 mtpt -60.25 -41.26 92.84 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.866 0.866 . . . . 75.14 111.435 176.569 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -67.61 -34.47 77.07 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.479 0.712 . . . . 71.44 111.717 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.491 HD12 ' HA ' ' A' ' 47' ' ' PHE . 53.8 mt -69.33 -35.93 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.496 1.118 . . . . 70.53 109.499 174.451 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -83.43 -13.55 54.54 Favored 'General case' 0 C--O 1.206 -1.222 0 C-N-CA 124.224 1.01 . . . . 73.43 111.401 178.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -74.27 -56.8 4.47 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 107.646 -1.242 . . . . 63.42 107.646 169.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -52.94 -50.64 63.6 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-N 113.152 -1.84 . . . . 65.45 110.515 177.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -66.35 -41.91 88.86 Favored 'General case' 0 C--O 1.205 -1.247 0 CA-C-N 115.296 -0.865 . . . . 72.32 110.857 178.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.62 -39.65 65.11 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 118.76 0.709 . . . . 53.01 111.986 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 61.1 t -70.8 -51.06 39.31 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 CA-C-N 115.794 -0.639 . . . . 74.52 110.748 174.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.454 HD13 HD13 ' A' ' 22' ' ' ILE . 48.6 mt -89.81 -0.1 57.34 Favored 'General case' 0 CA--C 1.568 1.657 0 N-CA-C 113.806 1.039 . . . . 62.04 113.806 -167.069 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 48.0 t -71.07 -51.15 26.89 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 124.091 0.956 . . . . 74.34 111.411 -173.02 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -86.59 125.19 68.07 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 114.613 -1.176 . . . . 74.34 107.87 177.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -53.21 -26.01 32.21 Favored 'Trans proline' 0 C--N 1.374 1.921 0 C-N-CA 123.322 2.681 . . . . 72.41 113.335 178.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -70.93 -56.26 6.61 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.957 0.903 . . . . 72.3 110.911 177.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.496 ' HA ' HD12 ' A' ' 65' ' ' ILE . 46.4 mtpt -66.96 -27.7 67.67 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 123.829 0.852 . . . . 74.54 111.477 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -60.92 -55.5 32.17 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 114.48 -1.236 . . . . 74.11 109.713 171.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -54.21 -40.61 67.78 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 124.165 0.916 . . . . 74.25 111.159 177.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.665 HD13 ' HE1' ' A' ' 83' ' ' TYR . 77.3 mt -51.92 -63.78 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.025 0 O-C-N 124.404 1.065 . . . . 64.42 109.265 174.757 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.459 ' OH ' ' HA ' ' A' ' 6' ' ' ASP . 32.6 t80 -50.19 -54.66 19.41 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 119.024 -0.512 . . . . 75.4 112.071 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -43.27 -55.22 4.13 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 124.433 1.083 . . . . 64.04 110.585 -178.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.425 ' HB ' ' HB3' ' A' ' 74' ' ' ALA . 69.1 p -98.47 -2.53 38.73 Favored 'General case' 0 CA--C 1.551 1.019 0 CA-C-N 115.071 -0.968 . . . . 75.13 113.258 -171.271 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -117.78 118.72 32.82 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 118.754 0.706 . . . . 63.45 109.428 -178.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.08 21.81 72.81 Favored Glycine 0 C--N 1.344 0.991 0 CA-C-O 121.6 0.556 . . . . 52.54 112.781 177.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 90.6 m -146.67 -51.81 0.22 Allowed 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 103.969 -2.604 . . . . 71.23 103.969 178.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 60.6 m -102.2 161.43 13.7 Favored 'General case' 0 C--O 1.258 1.533 0 CA-C-N 112.198 -2.273 . . . . 74.23 105.165 158.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.89 12.3 17.77 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.409 0.683 . . . . 74.04 112.203 179.18 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.425 ' HB3' ' HB ' ' A' ' 68' ' ' THR . . . -70.3 -152.05 0.0 OUTLIER Pre-proline 0 CA--C 1.589 2.456 0 CA-C-O 116.775 -1.583 . . . . 75.1 111.333 176.375 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.427 ' HA ' ' HD2' ' A' ' 76' ' ' PRO . 6.2 Cg_exo 7.76 107.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.412 3.909 0 C-N-CA 124.384 3.39 . . . . 75.41 117.835 -153.026 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 75' ' ' PRO . 28.9 Cg_endo -57.98 -177.44 0.09 OUTLIER 'Trans proline' 0 N--CA 1.518 2.961 0 C-N-CA 124.519 3.48 . . . . 74.25 113.217 174.369 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -39.11 131.49 1.36 Allowed 'Trans proline' 0 C--N 1.402 3.351 0 C-N-CA 123.111 2.54 . . . . 62.44 114.056 173.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.473 ' HG3' ' HE2' ' A' ' 83' ' ' TYR . 0.5 OUTLIER -29.03 123.31 0.05 OUTLIER 'Trans proline' 0 C--N 1.382 2.324 1 C-N-CA 126.105 4.537 . . . . 43.51 117.314 -172.433 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -78.39 156.45 28.96 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 123.137 2.558 . . . . 71.05 114.07 -176.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -56.35 80.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.393 2.915 0 C-N-CA 124.384 3.389 . . . . 51.35 113.191 175.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -178.15 -34.85 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 N-CA-C 109.903 -1.279 . . . . 62.41 109.903 -177.406 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 75.63 168.82 25.41 Favored Glycine 0 C--N 1.353 1.52 0 N-CA-C 115.194 0.838 . . . . 53.03 115.194 171.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.665 ' HE1' HD13 ' A' ' 65' ' ' ILE . 27.0 m-85 -111.06 102.25 10.72 Favored 'General case' 0 C--O 1.243 0.731 0 C-N-CA 124.789 1.236 . . . . 74.41 109.406 178.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -89.49 152.79 21.26 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.148 0.579 . . . . 71.31 110.819 175.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -127.65 77.89 1.78 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.386 1.074 . . . . 70.22 108.367 175.153 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 9.0 m -38.37 86.67 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 126.982 2.113 . . . . 74.44 115.505 -172.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 76.03 -7.27 29.8 Favored Glycine 0 C--N 1.35 1.32 0 CA-C-N 116.041 -0.527 . . . . 70.11 113.789 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -89.71 125.29 35.22 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.609 1.164 . . . . 72.34 108.208 -178.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -71.71 88.68 0.99 Allowed 'General case' 0 N--CA 1.482 1.139 0 CA-C-O 121.52 0.676 . . . . 71.44 110.082 -175.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -47.13 -43.05 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 126.112 1.765 . . . . 75.21 111.949 177.677 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -73.88 -6.5 47.55 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 115.214 -0.903 . . . . 75.33 111.889 -173.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -91.64 -27.93 17.81 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.976 0.911 . . . . 45.35 110.787 172.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.466 ' HE1' ' HB3' ' A' ' 48' ' ' LYS . 23.8 m-85 -76.78 -176.2 3.76 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 112.802 0.667 . . . . 71.01 112.802 -170.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 67.8 p -56.86 145.28 30.22 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.194 0.998 . . . . 74.5 112.944 -167.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.63 -41.26 85.55 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.0 -1.0 . . . . 74.31 111.428 177.575 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.511 ' HD1' ' HA ' ' A' ' 2' ' ' ALA . 74.2 t80 -58.91 -44.3 91.25 Favored 'General case' 0 C--N 1.355 0.812 0 C-N-CA 123.038 0.535 . . . . 75.03 110.145 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -58.08 -49.64 76.21 Favored 'General case' 0 CA--C 1.555 1.16 0 CA-C-N 116.077 -0.51 . . . . 63.23 109.963 174.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -73.98 -3.92 32.08 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 112.428 0.529 . . . . 73.05 112.428 -178.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -95.73 -60.15 1.71 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.427 0.691 . . . . 70.02 110.398 171.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.4 HD23 ' CE2' ' A' ' 101' ' ' PHE . 24.2 tp -58.5 -56.77 17.9 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.916 1.286 . . . . 55.03 110.785 -177.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.4 ' CE2' HD23 ' A' ' 100' ' ' LEU . 92.2 m-85 -84.25 -8.13 59.13 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 114.251 -1.341 . . . . 72.11 111.043 178.497 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -40.65 -66.28 0.88 Allowed Glycine 0 C--N 1.351 1.376 0 N-CA-C 116.114 1.206 . . . . 72.43 116.114 -174.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.452 ' HB2' ' HG2' ' A' ' 78' ' ' PRO . 23.7 Cg_exo -62.6 -14.86 42.43 Favored 'Trans proline' 0 C--N 1.373 1.864 0 C-N-CA 122.749 2.299 . . . . 23.1 114.06 -175.12 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -103.36 -2.23 47.58 Favored Glycine 0 C--N 1.358 1.773 0 CA-C-O 118.91 -0.939 . . . . 44.4 113.825 -177.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.43 ' HB3' ' OD1' ' A' ' 169' ' ' ASN . 86.6 mt -63.32 77.11 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 124.065 0.946 . . . . 74.25 113.007 -177.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 19.65 -105.14 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.256 0 C-N-CA 127.9 2.48 . . . . 72.25 116.36 174.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 71.85 2.88 53.59 Favored Glycine 0 C--N 1.35 1.353 0 CA-C-O 119.576 -0.569 . . . . 44.0 112.664 -164.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 53.9 -125.73 33.7 Favored Glycine 0 C--N 1.355 1.584 0 O-C-N 123.923 0.425 . . . . 71.34 112.763 -172.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -88.21 -6.96 57.53 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.125 0.97 . . . . 64.11 111.194 177.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -80.51 -38.85 16.08 Favored Glycine 0 C--N 1.345 1.058 0 CA-C-N 116.387 -0.37 . . . . 55.25 112.651 179.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? 65.68 -7.46 0.35 Allowed 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 114.572 1.323 . . . . 71.44 114.572 176.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.57 -20.24 66.13 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.321 1.049 . . . . 73.25 110.632 171.609 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 46.2 m 71.83 70.61 0.16 Allowed 'General case' 0 C--N 1.351 0.671 0 C-N-CA 124.529 1.132 . . . . 74.21 110.673 177.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.412 ' HG3' ' H ' ' A' ' 115' ' ' LYS . 2.2 tpm_? -135.28 172.75 12.56 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.515 0.726 . . . . 74.52 110.453 178.13 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.412 ' H ' ' HG3' ' A' ' 114' ' ' ARG . 51.7 tttm -60.87 142.87 55.87 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.396 1.078 . . . . 72.15 112.906 -177.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -85.99 -178.3 50.0 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 115.7 -0.682 . . . . 55.22 113.646 177.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.437 ' O ' ' HA3' ' A' ' 172' ' ' GLY . 13.4 ptt180 -96.05 173.43 7.43 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.796 0.838 . . . . 71.34 111.061 179.578 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -78.82 138.76 38.33 Favored 'General case' 0 CA--C 1.549 0.941 0 N-CA-C 109.267 -0.642 . . . . 74.23 109.267 166.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 9.3 tt -144.95 139.33 27.48 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 107.966 -1.124 . . . . 70.23 107.966 -173.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.543 ' HA ' ' HB2' ' A' ' 175' ' ' LEU . 2.8 tmm_? -100.26 119.04 37.78 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 108.891 -0.781 . . . . 74.51 108.891 175.2 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.488 ' HB2' HD11 ' A' ' 174' ' ' LEU . . . -111.73 169.87 8.53 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-O 121.7 0.762 . . . . 41.51 110.41 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.413 ' HB2' ' HB3' ' B' ' 9' ' ' ALA . 7.4 mm-40 -120.26 113.42 20.39 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 106.497 -1.668 . . . . 61.0 106.497 -176.427 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 51.1 tp -98.64 98.02 5.53 Favored Pre-proline 0 N--CA 1.473 0.682 0 N-CA-C 108.194 -1.039 . . . . 54.05 108.194 -178.374 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.647 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 73.4 Cg_endo -77.05 114.24 3.77 Favored 'Trans proline' 0 C--N 1.372 1.789 0 C-N-CA 121.32 1.347 . . . . 75.33 108.958 177.194 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.524 ' HA ' HG21 ' B' ' 6' ' ' ILE . 61.6 tp -123.06 139.56 53.95 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.075 0.55 . . . . 64.01 110.687 -169.005 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 27.2 m -68.56 128.86 38.14 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.861 0.864 . . . . 71.34 109.99 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.526 HD23 ' HB3' ' A' ' 180' ' ' LEU . 75.7 mt -50.93 -49.88 58.8 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 124.187 0.995 . . . . 70.54 111.21 -174.178 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -55.93 -49.4 73.59 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.239 -1.346 . . . . 75.32 109.911 -178.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -75.06 -19.84 59.82 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 114.631 -1.168 . . . . 64.33 111.677 -176.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -68.86 -43.69 74.88 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.334 0.653 . . . . 41.43 109.723 174.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -70.8 -35.51 72.57 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 115.126 -0.943 . . . . 74.51 111.364 176.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -73.65 -39.95 64.09 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 116.202 -0.453 . . . . 75.25 111.885 -178.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.581 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 77.29 -166.44 53.67 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-N 116.513 -0.312 . . . . 71.54 113.42 -176.206 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 100.08 179.04 30.32 Favored Glycine 0 C--N 1.35 1.311 0 C-N-CA 122.828 0.251 . . . . 70.42 113.161 176.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.432 ' HB3' ' OG ' ' A' ' 146' ' ' SER . 2.1 mp0 -74.75 100.63 4.07 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 122.96 0.504 . . . . 73.14 110.2 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -90.57 123.99 34.67 Favored 'General case' 0 C--O 1.244 0.8 0 N-CA-C 109.307 -0.627 . . . . 74.4 109.307 -177.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 98.3 t -72.39 108.41 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 N-CA-C 109.043 -0.725 . . . . 71.24 109.043 173.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.557 HG13 HG13 ' A' ' 145' ' ' VAL . 3.1 p -121.57 133.16 68.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 124.752 1.221 . . . . 73.14 108.312 175.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -122.42 146.59 47.22 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.037 0.535 . . . . 71.3 110.243 -170.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 10.7 p -163.89 135.03 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 123.26 0.624 . . . . 75.1 110.06 175.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 61.9 19.89 11.05 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.727 1.211 . . . . 74.24 112.871 176.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 96.87 -19.91 52.84 Favored Glycine 0 C--N 1.348 1.226 0 CA-C-N 116.386 -0.37 . . . . 31.1 112.844 -176.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -80.31 115.8 20.04 Favored 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 108.58 -0.896 . . . . 72.12 108.58 -179.213 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 42.2 ttt180 -98.38 99.53 10.73 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.187 0.995 . . . . 74.41 109.781 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.557 HG13 HG13 ' A' ' 138' ' ' VAL . 6.7 p -104.37 153.01 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 C-N-CA 123.231 0.612 . . . . 73.53 110.446 -177.357 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.432 ' OG ' ' HB3' ' A' ' 135' ' ' GLU . 32.0 t -124.61 103.99 8.44 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.599 0.759 . . . . 31.45 109.6 -179.057 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 4.8 p -101.38 121.99 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 123.169 0.588 . . . . 73.42 110.646 -175.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -73.84 99.36 3.19 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.422 0.629 . . . . 74.14 109.969 173.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.581 HG13 ' HA2' ' A' ' 133' ' ' GLY . 24.1 pt -80.96 142.89 52.48 Favored Pre-proline 0 CA--C 1.558 1.25 0 CA-C-N 114.608 -1.178 . . . . 74.13 109.622 173.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -66.43 136.28 42.63 Favored 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 122.538 2.159 . . . . 60.34 113.24 174.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -56.36 96.9 0.06 OUTLIER 'Trans proline' 0 C--N 1.385 2.45 0 C-N-CA 123.084 2.523 . . . . 74.15 112.409 168.257 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 104.57 39.63 2.35 Favored Glycine 0 C--N 1.339 0.713 0 CA-C-N 115.298 -0.865 . . . . 75.51 111.675 -174.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 11.6 p -78.56 140.94 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 N-CA-C 109.158 -0.682 . . . . 75.43 109.158 177.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.414 ' NH1' ' HD3' ' A' ' 243' ' ' PRO . 9.5 mtm105 -115.23 147.15 40.7 Favored 'General case' 0 C--O 1.205 -1.264 0 CA-C-N 115.937 -0.574 . . . . 73.23 111.77 -164.775 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -53.77 120.01 5.7 Favored 'General case' 0 CA--C 1.551 0.984 0 O-C-N 124.266 0.979 . . . . 72.32 110.355 175.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 105.09 -8.34 45.23 Favored Glycine 0 C--N 1.347 1.14 0 CA-C-N 115.536 -0.757 . . . . 14.21 113.425 -176.292 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 44.1 m -68.32 105.09 2.03 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 117.447 0.623 . . . . 74.23 110.253 177.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.444 HG22 HG22 ' A' ' 177' ' ' VAL . 41.5 t -85.17 90.81 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-N 115.117 -0.947 . . . . 72.34 109.31 -178.588 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.599 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 56.9 mt -70.44 91.64 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 108.404 -0.961 . . . . 75.24 108.404 175.333 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 67.9 ttt-85 -78.38 100.05 6.62 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.778 -0.647 . . . . 61.32 109.273 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.6 p -106.6 105.39 54.56 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 123.662 0.785 . . . . 61.33 109.266 177.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.478 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 23.8 Cg_exo -65.25 104.18 0.59 Allowed 'Trans proline' 0 C--N 1.377 2.058 0 C-N-CA 122.551 2.168 . . . . 74.53 111.283 175.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' A' ' 171' ' ' PRO . . . 126.99 25.77 1.18 Allowed Glycine 0 C--N 1.342 0.873 0 N-CA-C 115.801 1.081 . . . . 70.43 115.801 175.513 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 24.7 mmt -137.57 0.44 2.26 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 119.013 1.406 . . . . 64.15 112.057 177.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.695 ' HA2' HD13 ' A' ' 174' ' ' LEU . . . -75.85 -108.22 0.12 Allowed Glycine 0 N--CA 1.477 1.404 0 C-N-CA 123.685 0.66 . . . . 73.33 114.274 -170.602 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -58.22 119.05 15.25 Favored Glycine 0 C--N 1.344 0.992 0 N-CA-C 110.051 -1.22 . . . . 74.5 110.051 168.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -64.45 109.09 1.83 Allowed 'General case' 0 CA--C 1.538 0.503 0 O-C-N 124.67 0.865 . . . . 75.42 110.056 -175.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -146.77 174.14 26.71 Favored Glycine 0 C--N 1.339 0.739 0 N-CA-C 110.1 -1.2 . . . . 64.21 110.1 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' ASN . . . . . 0.447 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . 50.4 t30 -59.61 -61.05 8.66 Favored Pre-proline 0 CA--C 1.565 1.525 0 CA-C-O 118.629 -0.7 . . . . 63.11 109.742 -176.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.447 ' HD3' ' HB3' ' A' ' 169' ' ' ASN . 19.6 Cg_endo -94.81 96.16 0.11 Allowed 'Trans proline' 0 C--N 1.382 2.314 0 CA-C-N 121.44 1.55 . . . . 71.13 108.16 154.453 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.44 ' O ' ' HA2' ' A' ' 163' ' ' GLY . 18.1 Cg_exo -61.59 167.41 9.95 Favored 'Trans proline' 0 C--N 1.385 2.473 0 C-N-CA 122.361 2.041 . . . . 71.25 112.638 -169.553 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.437 ' HA3' ' O ' ' A' ' 117' ' ' ARG . . . -85.81 -168.83 45.25 Favored Glycine 0 C--O 1.216 -0.989 0 C-N-CA 121.172 -0.537 . . . . 72.4 113.247 -177.678 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.478 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 13.6 m-20 -72.59 138.69 46.99 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 122.94 0.496 . . . . 71.14 110.467 -176.12 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.695 HD13 ' HA2' ' A' ' 165' ' ' GLY . 25.6 tp -119.21 132.05 55.9 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 110.0 -0.37 . . . . 64.32 110.0 177.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.543 ' HB2' ' HA ' ' A' ' 120' ' ' ARG . 44.6 mt -102.09 85.74 2.73 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 107.999 -1.112 . . . . 72.12 107.999 176.083 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.599 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 79.8 mt -71.72 85.83 0.92 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 109.543 -0.539 . . . . 70.05 109.543 176.679 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.444 HG22 HG22 ' A' ' 158' ' ' VAL . 18.9 t -82.64 102.22 8.33 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 N-CA-C 106.787 -1.56 . . . . 61.43 106.787 178.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 8.2 p -67.92 107.7 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.961 0 CA-C-O 122.516 1.151 . . . . 70.33 110.705 -171.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.647 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 36.0 mmt180 -95.18 100.08 11.95 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.116 -1.402 . . . . 53.32 108.953 175.122 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.526 ' HB3' HD23 ' A' ' 127' ' ' LEU . 26.3 mt -68.98 142.91 54.53 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 109.753 -0.462 . . . . 72.4 109.753 -179.329 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 55.2 mt -53.97 159.06 3.02 Favored Pre-proline 0 N--CA 1.486 1.336 0 C-N-CA 124.281 1.032 . . . . 73.14 113.142 -168.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -74.8 28.72 0.35 Allowed 'Trans proline' 0 C--N 1.38 2.215 0 C-N-CA 123.488 2.792 . . . . 71.42 112.485 167.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 64.8 t-80 -60.1 104.83 0.48 Allowed Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 125.722 1.609 . . . . 73.35 106.881 169.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -70.03 24.53 0.18 Allowed 'Trans proline' 0 C--N 1.382 2.34 0 C-N-CA 124.513 3.475 . . . . 61.24 116.801 -160.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 49.1 t -98.92 -50.94 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 118.721 0.691 . . . . 64.21 109.349 178.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' PHE . . . . . 0.485 ' HB3' HD22 ' A' ' 193' ' ' LEU . 82.9 m-85 -127.74 124.8 38.65 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.045 0.538 . . . . 72.31 110.864 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 52.1 ttp85 -103.5 87.96 2.98 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 107.007 -1.479 . . . . 75.51 107.007 164.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.459 ' HA ' ' HA ' ' A' ' 193' ' ' LEU . 16.3 tp -66.9 155.84 37.37 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.29 0.636 . . . . 74.21 109.601 177.089 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.404 ' H ' HD12 ' A' ' 188' ' ' LEU . 44.7 tt0 -163.92 121.07 1.73 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.236 0.614 . . . . 70.31 109.384 178.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 74.62 -79.23 0.97 Allowed Glycine 0 C--N 1.348 1.238 0 N-CA-C 112.239 -0.344 . . . . 65.41 112.239 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.538 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 3.8 pm0 -146.25 -13.3 0.46 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.567 1.147 . . . . 72.32 110.251 173.514 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -112.03 140.31 46.81 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.285 1.034 . . . . 72.32 111.503 -169.087 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.485 HD22 ' HB3' ' A' ' 186' ' ' PHE . 35.5 mt -90.2 153.88 20.17 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.312 1.445 . . . . 63.44 111.027 -172.354 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -128.2 98.89 5.24 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 107.738 -1.208 . . . . 73.14 107.738 170.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.459 ' HB3' HD23 ' A' ' 251' ' ' LEU . . . -113.08 130.1 56.28 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.755 0.822 . . . . 74.34 109.932 -176.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 41.2 m -77.25 131.43 38.18 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 109.579 -0.526 . . . . 70.21 109.579 -176.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.422 HD22 HD13 ' A' ' 251' ' ' LEU . 57.1 tp -124.91 108.03 11.47 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 123.216 0.606 . . . . 72.21 109.704 -170.642 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -80.72 107.74 13.79 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 108.513 -0.921 . . . . 61.43 108.513 173.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 6.7 p -126.51 130.59 23.85 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 124.055 0.942 . . . . 64.4 108.58 -179.209 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.401 ' HB2' ' HE1' ' C' ' 276' ' ' TYR . 72.9 Cg_endo -75.45 157.44 40.88 Favored 'Trans proline' 0 C--N 1.365 1.409 0 C-N-CA 121.627 1.551 . . . . 64.51 111.96 173.334 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.425 ' HB3' ' HD3' ' A' ' 202' ' ' PRO . . . -54.09 -53.29 60.21 Favored Pre-proline 0 CA--C 1.559 1.295 0 N-CA-C 114.177 1.177 . . . . 71.34 114.177 -169.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.425 ' HD3' ' HB3' ' A' ' 201' ' ' ALA . 50.4 Cg_exo -58.5 -35.63 98.43 Favored 'Trans proline' 0 C--N 1.382 2.292 0 C-N-CA 122.02 1.813 . . . . 63.54 113.682 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 46.2 mt -74.51 -33.89 34.03 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 N-CA-C 109.966 -0.383 . . . . 64.32 109.966 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.508 ' HA ' HG11 ' A' ' 223' ' ' VAL . . . -67.92 -41.32 82.78 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.303 0.641 . . . . 71.51 111.275 175.036 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.534 HG13 HD11 ' C' ' 261' ' ' LEU . 55.1 t -78.94 -42.16 24.02 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 C-N-CA 123.865 0.866 . . . . 63.23 112.466 -172.697 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 84.6 t -84.17 -33.0 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 122.793 0.437 . . . . 74.41 110.288 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 88.04 48.5 4.08 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-N 115.551 -0.749 . . . . 72.35 111.796 -177.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -76.93 173.86 54.62 Favored Glycine 0 C--N 1.341 0.853 0 N-CA-C 111.334 -0.706 . . . . 55.24 111.334 173.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.528 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 46.8 mtmt -84.76 129.92 34.76 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 117.694 0.747 . . . . 45.21 111.915 -178.262 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.42 HG21 HD11 ' A' ' 197' ' ' LEU . 30.2 m -111.56 -172.12 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.961 0 N-CA-C 106.237 -1.764 . . . . 63.11 106.237 161.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 211' ' ' ARG . . . . . 0.508 ' HD3' ' HB2' ' A' ' 218' ' ' PRO . 15.5 ttm180 -127.39 132.16 50.2 Favored 'General case' 0 C--O 1.237 0.432 0 O-C-N 121.954 -0.466 . . . . 71.41 110.353 177.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -99.51 111.75 24.05 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 108.29 -1.004 . . . . 62.04 108.29 174.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 213' ' ' MET . . . . . 0.5 ' HA ' ' HA ' ' A' ' 218' ' ' PRO . 3.5 mpp? -71.93 123.78 23.46 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 108.602 -0.888 . . . . 71.23 108.602 173.584 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 214' ' ' THR . . . . . 0.453 ' HA ' ' HE1' ' A' ' 186' ' ' PHE . 24.5 p -108.81 -177.74 3.4 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 109.405 -0.591 . . . . 74.1 109.405 179.314 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.437 HD11 ' HZ ' ' A' ' 240' ' ' PHE . 61.5 mt -58.82 -27.21 64.88 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.661 1.184 . . . . 63.31 113.141 -171.615 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -142.34 28.84 1.64 Allowed 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 116.323 -0.399 . . . . 64.44 111.222 -175.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 155.72 146.59 4.48 Favored Glycine 0 C--N 1.35 1.346 0 O-C-N 121.513 -0.742 . . . . 33.0 114.612 171.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 218' ' ' PRO . . . . . 0.508 ' HB2' ' HD3' ' A' ' 211' ' ' ARG . 72.9 Cg_endo -85.94 108.82 0.98 Allowed 'Trans proline' 0 C--N 1.369 1.613 0 C-N-CA 122.962 2.441 . . . . 70.23 112.567 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 30.1 m -103.05 150.28 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 123.592 0.757 . . . . 73.4 109.648 -178.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -79.36 142.32 36.14 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 117.802 0.273 . . . . 75.04 110.613 -177.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 3.9 m -134.1 110.87 14.34 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 C-N-CA 124.163 0.985 . . . . 74.13 108.578 174.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.528 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -72.61 114.53 10.85 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 109.145 -0.687 . . . . 60.25 109.145 174.315 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.609 ' HA ' HD12 ' B' ' 441' ' ' ILE . 50.5 t -59.53 146.63 79.46 Favored Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 124.357 1.063 . . . . 63.14 109.425 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 224' ' ' PRO . . . . . 0.599 ' HD3' ' HB ' ' B' ' 441' ' ' ILE . 60.4 Cg_endo -70.75 158.9 54.36 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 121.592 1.528 . . . . 75.51 109.316 169.401 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 225' ' ' PRO . . . . . 0.411 ' HG2' ' HD3' ' B' ' 446' ' ' PRO . 33.2 Cg_endo -72.34 151.46 54.14 Favored 'Trans proline' 0 CA--C 1.549 1.25 0 CA-C-N 119.925 1.009 . . . . 72.53 111.969 171.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 46.1 mtt180 64.82 39.26 6.22 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 125.331 1.452 . . . . 74.04 110.894 169.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.604 HG23 HD21 ' A' ' 233' ' ' LEU . 53.2 m -74.42 109.58 8.01 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 112.989 -1.914 . . . . 64.32 111.716 -177.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 228' ' ' GLN . . . . . 0.401 ' HB3' ' HD2' ' A' ' 231' ' ' ARG . 5.8 tp60 -84.86 140.96 30.78 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.618 1.167 . . . . 75.32 111.521 -177.642 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -63.31 145.56 55.29 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.061 0.944 . . . . 62.31 112.184 -179.048 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 86.29 -24.89 7.58 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-N 116.334 -0.394 . . . . 73.32 113.355 178.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.401 ' HD2' ' HB3' ' A' ' 228' ' ' GLN . 93.7 mtt180 -69.15 160.83 30.37 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-O 121.46 0.648 . . . . 74.0 110.905 176.162 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.623 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 2.8 mppt? -115.16 114.87 25.85 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.112 -1.07 . . . . 72.22 108.112 178.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.604 HD21 HG23 ' A' ' 227' ' ' THR . 87.9 mt -76.16 103.44 6.2 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 115.46 -0.791 . . . . 71.4 109.905 -175.491 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -76.14 105.09 6.99 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 123.712 0.632 . . . . 64.14 109.982 177.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.577 ' HB3' ' HA ' ' B' ' 441' ' ' ILE . 0.4 OUTLIER -108.45 115.45 30.13 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.006 -1.109 . . . . 61.12 108.006 167.772 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -69.73 141.44 53.46 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 114.651 -1.159 . . . . 64.43 111.978 -167.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 69.98 17.42 73.58 Favored Glycine 0 C--N 1.348 1.221 0 O-C-N 123.936 0.773 . . . . 74.2 113.922 174.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.451 ' HG3' HD12 ' A' ' 235' ' ' LEU . 33.7 mmtp -107.62 5.15 26.65 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.225 0.61 . . . . 73.01 111.086 -176.075 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -101.74 -156.3 26.42 Favored Glycine 0 C--N 1.347 1.19 0 C-N-CA 123.194 0.426 . . . . 74.43 112.659 173.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 240' ' ' PHE . . . . . 0.437 ' HZ ' HD11 ' A' ' 215' ' ' LEU . 3.4 m-85 -94.23 145.18 29.28 Favored Pre-proline 0 N--CA 1.481 1.079 0 C-N-CA 123.136 0.575 . . . . 73.13 111.065 -172.553 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' A' ' 246' ' ' ARG . 37.4 Cg_exo -60.56 119.09 6.07 Favored 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 123.52 2.813 . . . . 73.33 112.85 178.295 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -156.42 -148.19 4.99 Favored Glycine 0 C--N 1.35 1.323 0 CA-C-O 118.548 -1.14 . . . . 73.52 113.746 -173.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 243' ' ' PRO . . . . . 0.538 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 74.2 Cg_exo -51.92 -38.52 68.82 Favored 'Trans proline' 0 C--N 1.39 2.747 0 C-N-CA 124.138 3.225 . . . . 70.45 113.84 -176.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -82.98 15.33 2.8 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.821 0.848 . . . . 70.11 112.207 -178.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 81.16 -71.57 2.89 Favored Glycine 0 C--N 1.345 1.048 0 N-CA-C 109.814 -1.314 . . . . 62.24 109.814 -169.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.41 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 23.1 mtp180 -122.12 147.49 46.08 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.491 1.117 . . . . 75.41 108.723 168.493 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -86.14 -177.44 49.89 Favored Glycine 0 C--N 1.339 0.706 0 CA-C-N 116.303 -0.408 . . . . 42.24 112.346 175.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -111.45 170.93 7.79 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.29 0.636 . . . . 75.44 110.072 -179.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.5 ' HB3' ' HG ' ' A' ' 235' ' ' LEU . 34.0 tp -114.91 134.39 55.19 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.361 -1.348 . . . . 70.31 107.361 170.588 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.623 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 62.0 m-85 -116.38 106.28 13.45 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 107.945 -1.131 . . . . 52.51 107.945 175.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.459 HD23 ' HB3' ' A' ' 195' ' ' ALA . 49.5 mt -90.23 108.2 19.61 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 109.51 -0.552 . . . . 72.24 109.51 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.516 ' HG2' ' HG3' ' A' ' 232' ' ' LYS . 30.6 mt-10 -76.33 111.5 11.84 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.663 1.185 . . . . 75.41 109.068 -172.389 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 27.5 t -69.81 119.24 15.49 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 C-N-CA 123.827 0.851 . . . . 24.43 111.902 -168.031 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.28 91.67 3.59 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 107.433 -1.321 . . . . 73.14 107.433 174.268 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.475 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 62.4 mt -78.61 129.68 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 O-C-N 123.204 0.315 . . . . 74.34 110.305 -177.446 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 51.9 p -113.94 166.46 11.57 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.939 0.895 . . . . 73.43 109.703 173.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 257' ' ' ILE . . . . . 0.632 HG23 HG21 ' C' ' 255' ' ' ILE . 2.6 pp -118.17 157.52 48.67 Favored Pre-proline 0 CA--C 1.56 1.329 0 C-N-CA 123.735 0.814 . . . . 73.4 110.378 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 258' ' ' PRO . . . . . 0.503 ' HD2' ' HB ' ' A' ' 257' ' ' ILE . 25.7 Cg_endo -56.23 -17.2 19.65 Favored 'Trans proline' 0 N--CA 1.513 2.631 0 C-N-CA 124.42 3.413 . . . . 74.45 115.165 -168.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 50.01 -81.61 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 124.859 1.264 . . . . 63.24 111.659 -166.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.6 161.49 29.52 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 120.114 1.325 . . . . 75.12 109.806 173.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.697 HD22 ' HB3' ' A' ' 265' ' ' GLU . 54.6 mt -147.47 146.5 29.55 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.37 0.668 . . . . 55.32 109.936 173.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 72.5 p -83.97 161.35 55.67 Favored Pre-proline 0 CA--C 1.551 1.011 0 N-CA-C 107.958 -1.127 . . . . 44.34 107.958 165.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 263' ' ' PRO . . . . . 0.425 ' HG3' ' HA ' ' B' ' 376' ' ' GLU . 10.4 Cg_endo -50.24 -40.25 52.08 Favored 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 123.279 2.653 . . . . 74.33 113.562 -179.448 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -63.1 -56.99 12.16 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.745 -0.661 . . . . 71.44 110.53 177.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 265' ' ' GLU . . . . . 0.697 ' HB3' HD22 ' A' ' 261' ' ' LEU . 53.0 mt-10 -57.38 -35.97 70.66 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 123.626 0.579 . . . . 64.2 111.102 -179.032 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 266' ' ' GLU . . . . . 0.54 ' HA ' HD13 ' A' ' 261' ' ' LEU . 7.3 tp10 -59.69 -50.41 73.96 Favored 'General case' 0 C--O 1.248 0.984 0 C-N-CA 123.985 0.914 . . . . 73.45 109.519 178.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -60.71 -41.54 95.45 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 114.627 -1.169 . . . . 64.12 111.814 177.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 10.1 mp -69.85 -45.28 68.11 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.42 0.688 . . . . 73.14 111.786 -176.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 63.1 m95 -66.68 -35.38 80.02 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.563 0.745 . . . . 75.0 111.62 -179.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 270' ' ' LYS . . . . . 0.455 ' HE2' HG23 ' C' ' 206' ' ' VAL . 96.2 mttt -85.22 -16.79 39.09 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 116.216 -0.447 . . . . 62.43 112.142 177.678 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 4.0 mmmp? -74.47 -32.79 62.69 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 110.029 -0.36 . . . . 70.22 110.029 166.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 91.6 mt -61.87 -58.24 8.7 Favored 'General case' 0 C--O 1.212 -0.892 0 N-CA-C 108.338 -0.986 . . . . 63.4 108.338 170.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -57.5 -32.59 67.16 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.52 1.128 . . . . 64.51 112.793 -177.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -65.17 -62.68 1.4 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.443 0.697 . . . . 74.35 109.35 172.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -70.6 -6.35 36.02 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.276 0.631 . . . . 71.44 112.564 -175.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -93.64 -80.51 0.39 Allowed 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 107.612 -1.255 . . . . 75.02 107.612 174.066 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -73.27 -38.1 66.06 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.33 -0.85 . . . . 70.12 112.005 -166.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -73.37 -4.54 34.05 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 122.345 -0.222 . . . . 75.41 111.1 178.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -120.96 10.74 10.88 Favored 'General case' 0 C--N 1.358 0.961 0 C-N-CA 123.451 0.7 . . . . 74.13 110.059 176.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.142 0 C-N-CA 123.603 0.761 . . . . 72.21 111.314 -178.502 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.435 ' HB3' ' HB3' ' B' ' 4' ' ' SER . 1.5 mpt? . . . . . 0 N--CA 1.477 0.898 0 N-CA-C 110.238 -0.282 . . . . 71.44 110.238 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -79.77 -49.43 12.04 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.189 0.596 . . . . 54.1 110.608 176.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -93.88 19.89 8.37 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.312 0.645 . . . . 74.04 112.3 -171.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 4' ' ' SER . . . . . 0.435 ' HB3' ' HB3' ' B' ' 1' ' ' MET . 13.9 p -65.97 -56.31 12.33 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-O 120.945 0.403 . . . . 52.14 110.156 178.393 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 4.1 m 67.78 151.8 0.08 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.501 1.52 . . . . 70.11 112.328 174.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.524 HG21 ' HA ' ' A' ' 125' ' ' LEU . 46.2 pt -130.93 159.99 42.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 123.019 0.527 . . . . 64.44 111.645 -162.267 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -131.93 134.74 45.99 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.828 0.851 . . . . 72.01 110.104 178.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 32.7 tp -73.15 144.69 46.81 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.429 0.691 . . . . 75.22 110.378 -176.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 9' ' ' ALA . . . . . 0.413 ' HB3' ' HB2' ' A' ' 122' ' ' GLU . . . -80.39 -50.03 10.67 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 122.477 0.311 . . . . 62.4 111.345 178.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 31.4 mt 71.22 -25.09 0.17 Allowed 'General case' 0 N--CA 1.504 2.251 0 C-N-CA 125.295 1.438 . . . . 74.1 113.282 -172.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 61.0 mt 56.56 69.47 1.76 Allowed Pre-proline 0 CA--C 1.558 1.278 0 C-N-CA 124.468 1.107 . . . . 45.35 109.649 -168.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -91.03 -151.01 0.04 OUTLIER 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 123.17 2.58 . . . . 61.33 112.368 -176.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -59.21 -30.53 68.29 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.071 0.948 . . . . 75.01 112.676 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 3.2 pp -135.37 153.98 51.65 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.405 0.682 . . . . 64.54 110.183 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -156.82 132.0 9.11 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 108.767 -0.827 . . . . 60.01 108.767 177.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 36.6 p -110.94 98.62 39.35 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 123.659 0.784 . . . . 51.11 110.065 178.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -91.61 -163.01 0.11 Allowed 'Trans proline' 0 C--N 1.373 1.86 0 C-N-CA 123.015 2.476 . . . . 62.42 112.119 174.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 34.6 m -71.48 -6.85 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 C-N-CA 123.81 0.844 . . . . 61.41 112.7 179.221 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 11.8 m -58.1 -44.05 87.44 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.618 0.767 . . . . 71.22 110.678 175.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -76.82 -73.94 0.26 Allowed 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 115.751 -0.659 . . . . 62.34 110.317 178.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.87 88.78 7.13 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.358 -0.608 . . . . 75.34 109.358 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 37.5 mtp85 -65.64 -60.5 2.85 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 114.573 -1.194 . . . . 73.31 109.093 -178.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 23' ' ' THR . . . . . 0.424 ' HB ' ' HD3' ' B' ' 24' ' ' PRO 0.276 18.0 m 98.05 -84.22 0.0 OUTLIER Pre-proline 0 CA--C 1.57 1.748 0 C-N-CA 127.219 2.208 . . . . 72.45 114.85 164.626 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 24' ' ' PRO . . . . . 0.424 ' HD3' ' HB ' ' B' ' 23' ' ' THR . 27.5 Cg_endo -85.41 26.13 0.66 Allowed 'Trans proline' 0 C--N 1.392 2.844 0 CA-C-N 122.47 1.918 . . . . 74.55 114.935 -154.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -79.95 83.22 5.9 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 122.889 0.476 . . . . 74.53 110.215 179.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 59.0 mtm -75.61 -44.01 4.15 Favored Pre-proline 0 CA--C 1.561 1.393 0 CA-C-N 115.083 -0.962 . . . . 75.13 111.662 174.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -59.22 108.11 0.41 Allowed 'Trans proline' 0 C--N 1.397 3.095 0 C-N-CA 121.982 1.788 . . . . 71.1 112.689 176.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 5.8 m -73.67 99.73 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 CA-C-N 115.38 -0.827 . . . . 73.51 109.781 176.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 66.4 mt 71.19 -72.41 0.11 Allowed 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 125.949 1.7 . . . . 62.2 111.096 -178.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.96 -4.16 3.57 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.27 1.028 . . . . 70.24 110.522 178.578 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 7.2 t30 64.28 65.62 0.66 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.492 1.517 . . . . 74.34 109.654 -172.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 32' ' ' ARG . . . . . 0.563 ' HG3' ' H ' ' B' ' 33' ' ' ALA . 14.9 ptp180 -63.99 -73.82 0.11 Allowed 'General case' 0 CA--C 1.558 1.286 0 CA-C-N 113.944 -1.48 . . . . 72.22 113.175 -175.201 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 33' ' ' ALA . . . . . 0.563 ' H ' ' HG3' ' B' ' 32' ' ' ARG . . . 165.78 -61.05 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 126.11 1.764 . . . . 73.31 108.548 -174.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -157.28 -73.76 0.09 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.81 0.844 . . . . 53.33 111.215 -177.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -77.83 -69.26 0.56 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.257 0.623 . . . . 73.13 110.423 -172.223 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 36' ' ' GLY . . . . . 0.401 ' HA2' ' HD3' ' B' ' 32' ' ' ARG . . . -170.65 140.98 6.25 Favored Glycine 0 C--N 1.342 0.889 0 CA-C-O 118.718 -1.045 . . . . 74.33 111.292 -175.36 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 20.4 t70 69.28 156.46 0.14 Allowed 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 124.342 1.057 . . . . 61.44 111.478 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 50.5 mm -60.92 -59.47 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 123.528 0.731 . . . . 75.44 112.043 -172.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 9.7 t -163.14 179.41 7.49 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.123 0.569 . . . . 64.25 109.959 -177.484 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.8 114.17 8.98 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 123.576 0.75 . . . . 64.0 110.571 177.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -68.6 102.59 0.87 Allowed 'Trans proline' 0 C--N 1.382 2.32 0 C-N-CA 122.741 2.294 . . . . 72.44 111.605 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -73.2 -64.44 2.52 Favored Glycine 0 C--N 1.34 0.79 0 CA-C-N 115.62 -0.718 . . . . 45.24 112.812 -177.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 62.13 41.72 99.71 Favored Glycine 0 C--N 1.349 1.293 0 N-CA-C 111.134 -0.787 . . . . 42.15 111.134 -172.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -84.84 -173.87 4.96 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.218 1.007 . . . . 63.2 111.356 -175.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.59 32.59 7.08 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.591 1.156 . . . . 74.21 110.353 -179.362 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 46' ' ' ARG . . . . . 0.52 ' HG3' ' HA ' ' B' ' 236' ' ' THR . 19.6 ttm180 -91.59 45.37 1.23 Allowed 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.857 0.863 . . . . 75.02 110.706 -174.643 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -86.04 96.71 9.95 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 107.986 -1.116 . . . . 53.22 107.986 177.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 22.6 m 79.65 -45.89 0.33 Allowed 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 125.981 1.713 . . . . 51.22 111.578 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.5 -60.81 4.67 Favored Glycine 0 C--N 1.343 0.943 0 N-CA-C 111.11 -0.796 . . . . 74.15 111.11 -175.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 18.9 t70 61.08 -87.72 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.243 1.417 . . . . 64.2 110.576 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 62.41 16.61 8.76 Favored 'General case' 0 CA--C 1.559 1.324 0 C-N-CA 124.684 1.194 . . . . 75.3 111.782 173.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 52' ' ' THR . . . . . 0.455 ' HB ' ' HB1' ' B' ' 158' ' ' ALA . 22.2 p -134.95 -13.35 2.16 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 112.784 0.661 . . . . 73.31 112.784 -171.31 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.98 81.92 4.36 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 122.907 0.483 . . . . 73.24 111.337 -178.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . 52.42 53.59 12.08 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.962 1.305 . . . . 75.51 112.768 174.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 44.7 tp -75.18 109.41 8.65 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 109.037 -0.727 . . . . 72.35 109.037 175.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 56' ' ' ARG . . . . . 0.53 HH21 ' HB3' ' B' ' 64' ' ' ALA . 0.3 OUTLIER -64.47 121.03 13.42 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.637 0.775 . . . . 73.2 110.833 -179.839 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -168.25 -79.34 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.467 1.107 . . . . 75.31 108.411 170.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 21.3 m -81.9 89.52 6.37 Favored 'General case' 0 C--N 1.347 0.47 0 N-CA-C 108.599 -0.889 . . . . 62.01 108.599 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 59' ' ' LEU . . . . . 0.575 ' HA ' ' HB3' ' B' ' 63' ' ' PRO . 57.7 mt 64.5 -78.38 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.053 0 O-C-N 124.646 1.216 . . . . 72.44 111.451 175.268 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 14.4 m 72.41 -67.65 0.25 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.93 1.692 . . . . 63.51 111.89 172.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 61' ' ' ASP . . . . . 0.575 ' HB3' ' HB2' ' B' ' 272' ' ' ASN . 10.0 t0 -151.4 -68.61 0.18 Allowed 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 107.974 -1.121 . . . . 71.45 107.974 176.263 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 62' ' ' LYS . . . . . 0.414 ' HB2' ' HB3' ' B' ' 273' ' ' GLN . 11.3 mptt -118.53 118.24 33.82 Favored Pre-proline 0 N--CA 1.481 1.082 0 N-CA-C 107.645 -1.243 . . . . 72.3 107.645 162.369 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 63' ' ' PRO . . . . . 0.575 ' HB3' ' HA ' ' B' ' 59' ' ' LEU . 65.9 Cg_endo -82.24 28.19 0.57 Allowed 'Trans proline' 0 C--N 1.38 2.205 0 C-N-CA 123.277 2.651 . . . . 72.24 113.165 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 64' ' ' ALA . . . . . 0.611 ' HA ' ' HG2' ' B' ' 273' ' ' GLN . . . 70.92 -15.94 0.37 Allowed 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 125.435 1.494 . . . . 72.04 113.894 -177.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 85.0 tttt 56.31 63.74 1.9 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.964 1.306 . . . . 65.32 110.394 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -85.46 12.41 8.5 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 114.567 -1.197 . . . . 72.41 111.573 -177.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 9.4 tt -69.78 86.53 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.342 0 CA-C-O 121.695 0.759 . . . . 72.03 110.311 178.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 2.2 mp 61.63 -83.77 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.181 0 C-N-CA 125.567 1.547 . . . . 73.4 110.784 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 56.2 tp -178.93 148.35 0.39 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.937 1.295 . . . . 73.12 108.894 -177.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 7.4 mp -69.1 95.1 0.71 Allowed 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 108.614 -0.884 . . . . 44.44 108.614 170.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 2.8 pp -73.05 -23.7 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.747 0.819 . . . . 74.32 111.883 -177.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 131.89 99.05 0.76 Allowed Glycine 0 C--N 1.348 1.243 0 N-CA-C 111.912 -0.475 . . . . 62.21 111.912 178.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -101.21 158.68 15.85 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.149 0.58 . . . . 63.44 109.734 175.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -158.39 61.73 0.32 Allowed Glycine 0 C--N 1.333 0.412 0 N-CA-C 109.774 -1.33 . . . . 64.42 109.774 174.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 24.8 ttt 63.31 36.18 11.89 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-O 122.496 1.141 . . . . 74.01 109.08 -174.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . -91.11 62.86 2.85 Favored Glycine 0 C--N 1.348 1.222 0 CA-C-N 114.699 -1.137 . . . . 71.13 111.973 -175.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -70.62 -33.81 71.42 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.074 0.55 . . . . 73.03 109.74 177.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 92.6 p 50.84 38.35 19.61 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 125.933 1.693 . . . . 51.1 113.172 174.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 79' ' ' GLU . . . . . 0.51 ' HG3' ' HA ' ' B' ' 111' ' ' LEU . 9.0 tp10 -130.3 90.19 2.9 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 108.732 -0.84 . . . . 74.44 108.732 177.528 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 33.4 mm 56.01 67.28 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 125.326 1.45 . . . . 72.52 110.581 -177.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 81' ' ' THR . . . . . 0.517 ' HA ' ' CE1' ' B' ' 108' ' ' HIS . 41.2 p -71.74 -29.43 64.52 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 115.744 -0.662 . . . . 71.34 112.161 -176.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 60.9 15.61 6.18 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.559 1.143 . . . . 61.11 112.151 -177.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -104.83 115.17 29.85 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 123.591 0.757 . . . . 71.35 110.225 -172.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 41.4 mmt180 -94.63 132.05 39.76 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.558 0.743 . . . . 73.0 110.482 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 85' ' ' ASN . . . . . 0.491 HD22 ' HA ' ' B' ' 99' ' ' ALA . 49.4 t-20 -74.25 -83.61 0.05 Allowed 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 107.754 -1.202 . . . . 72.23 107.754 169.395 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 4.7 t80 60.5 -174.86 0.12 Allowed 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.824 0.849 . . . . 63.12 112.07 169.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.03 -15.91 52.0 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 122.827 0.451 . . . . 52.24 110.496 168.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -74.07 -63.79 1.15 Allowed 'General case' 0 C--N 1.351 0.636 0 C-N-CA 123.78 0.832 . . . . 74.14 110.38 177.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -70.61 -42.48 62.89 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 115.773 -0.649 . . . . 54.33 112.441 -177.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . 56.21 19.26 3.75 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.77 1.228 . . . . 62.33 113.075 176.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -89.78 61.25 3.46 Favored Glycine 0 C--N 1.35 1.325 0 N-CA-C 112.134 -0.386 . . . . 70.11 112.134 -176.039 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -160.86 -169.82 24.63 Favored Glycine 0 C--N 1.34 0.759 0 N-CA-C 111.953 -0.459 . . . . 23.53 111.953 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -105.64 9.12 33.33 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.406 1.082 . . . . 74.22 111.984 -174.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 54.9 t80 66.91 6.11 4.45 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 124.827 1.251 . . . . 71.21 112.756 174.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -69.87 -12.69 61.81 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 124.376 1.071 . . . . 74.14 113.714 -172.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 94.08 -34.12 4.86 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 112.563 -0.215 . . . . 72.31 112.563 -176.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 14.3 tt -105.76 -0.54 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 123.643 0.777 . . . . 72.22 110.17 178.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -78.18 1.58 20.93 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 125.181 1.392 . . . . 75.21 112.617 -176.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 99' ' ' ALA . . . . . 0.491 ' HA ' HD22 ' B' ' 85' ' ' ASN . . . -81.03 31.49 0.32 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.015 0.926 . . . . 61.12 111.894 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 91.9 mt -73.15 154.73 90.47 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 124.838 1.255 . . . . 74.2 110.798 -177.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -67.05 83.37 0.34 Allowed 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 122.837 2.358 . . . . 72.21 111.718 173.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 38.4 tp -95.29 -11.22 28.24 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.101 -0.954 . . . . 73.12 109.867 176.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 13.6 t -156.07 170.66 21.66 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.315 0.646 . . . . 75.52 110.399 -176.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . -152.52 146.55 15.25 Favored Glycine 0 C--N 1.344 0.973 0 N-CA-C 111.192 -0.763 . . . . 51.35 111.192 177.068 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -75.87 89.9 2.92 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.326 0.65 . . . . 75.22 110.084 -178.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 44.1 t80 61.76 -177.24 0.12 Allowed 'General case' 0 CA--C 1.568 1.662 0 C-N-CA 124.348 1.059 . . . . 74.44 111.654 177.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 40.1 m -49.82 121.02 4.77 Favored 'General case' 0 C--N 1.355 0.831 0 C-N-CA 123.847 0.859 . . . . 63.32 110.428 170.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 108' ' ' HIS . . . . . 0.517 ' CE1' ' HA ' ' B' ' 81' ' ' THR . 2.8 m-70 -79.44 98.37 6.76 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 107.069 -1.456 . . . . 71.44 107.069 -176.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -77.61 -30.13 52.2 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 122.455 0.302 . . . . 53.33 110.972 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.35 -69.07 0.24 Allowed 'General case' 0 N--CA 1.477 0.911 0 O-C-N 123.776 0.673 . . . . 71.24 111.11 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 111' ' ' LEU . . . . . 0.51 ' HA ' ' HG3' ' B' ' 79' ' ' GLU . 94.5 mt 48.67 -87.59 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.955 1.302 . . . . 64.15 111.818 -179.147 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -169.18 114.72 0.57 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.159 1.384 . . . . 73.2 107.721 177.067 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 113' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp 70.65 7.34 6.18 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 124.749 1.22 . . . . 75.13 112.207 -175.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt 62.42 -76.96 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.501 1.521 . . . . 74.01 112.514 -178.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 14.2 t -129.6 12.26 5.85 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.402 0.681 . . . . 73.23 110.498 -177.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -91.17 13.44 66.31 Favored Glycine 0 C--N 1.35 1.312 0 CA-C-N 116.616 -0.266 . . . . 55.33 113.087 177.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 117' ' ' LYS . . . . . 0.534 ' HB3' ' HD3' ' B' ' 118' ' ' PRO . 6.6 tmtm? -164.03 -52.12 0.01 OUTLIER Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 124.55 1.14 . . . . 70.25 108.118 -178.344 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 118' ' ' PRO . . . . . 0.534 ' HD3' ' HB3' ' B' ' 117' ' ' LYS . 12.1 Cg_endo -94.08 66.83 0.38 Allowed 'Trans proline' 0 C--N 1.385 2.464 0 C-N-CA 122.265 1.977 . . . . 60.53 109.368 169.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 119' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -56.62 99.41 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 113.957 -1.474 . . . . 75.33 112.265 -167.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 120' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -90.33 -43.3 10.44 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.561 0.745 . . . . 70.1 110.498 -176.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 7.9 p -63.16 -42.37 96.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 123.003 0.521 . . . . 74.32 111.297 -176.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 81.7 p -88.63 94.33 9.86 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 108.976 -0.749 . . . . 75.24 108.976 173.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 54.56 -85.81 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 125.542 1.537 . . . . 64.3 112.815 178.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 57.1 p -172.85 28.64 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.1 0.96 . . . . 43.31 109.993 -172.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . 63.54 30.52 15.12 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.741 1.217 . . . . 73.02 110.955 -173.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -82.11 143.37 31.53 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.956 0.902 . . . . 74.13 111.52 -177.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 50.2 m -139.03 143.16 38.31 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.816 0.846 . . . . 70.01 109.956 176.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -139.39 179.15 6.71 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.791 0.836 . . . . 72.01 111.102 -172.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 20.2 m 76.63 -51.75 0.58 Allowed 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 126.027 1.731 . . . . 54.34 112.106 -178.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . -55.94 142.29 36.23 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.3 1.04 . . . . 44.22 112.078 177.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 66.4 p-90 -63.57 -22.86 67.13 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.48 0.712 . . . . 73.51 112.286 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 50.1 p -77.76 -54.18 6.65 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.034 0.934 . . . . 51.4 112.326 -175.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 73.7 p -104.67 -24.84 12.9 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.434 0.694 . . . . 62.25 112.0 -173.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . -72.96 -0.77 53.43 Favored Glycine 0 N--CA 1.476 1.309 0 CA-C-N 115.921 -0.581 . . . . 55.15 114.281 -177.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 135' ' ' VAL . . . . . 0.414 HG23 ' HB2' ' B' ' 59' ' ' LEU . 16.8 m -97.14 21.02 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.118 0 C-N-CA 124.214 1.006 . . . . 73.24 110.286 170.638 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 136' ' ' LYS . . . . . 0.471 ' O ' ' HB3' ' B' ' 59' ' ' LEU . 87.1 tttt 67.98 108.99 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 125.448 1.499 . . . . 52.43 111.683 177.352 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 137' ' ' THR . . . . . 0.508 ' HA ' HD13 ' B' ' 59' ' ' LEU . 11.0 p -80.04 50.84 1.27 Allowed 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.119 0.968 . . . . 75.31 112.245 -179.388 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 62.2 t80 62.98 -76.3 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.442 1.497 . . . . 75.52 110.306 -175.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 59.18 -82.82 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 125.111 1.364 . . . . 73.24 113.321 171.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . 98.07 -149.18 19.12 Favored Glycine 0 C--N 1.351 1.406 0 N-CA-C 111.049 -0.82 . . . . 65.04 111.049 -170.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -80.43 85.92 5.83 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 122.961 0.504 . . . . 75.34 109.887 178.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 142' ' ' LEU . . . . . 0.472 HD11 HD12 ' B' ' 146' ' ' ILE . 0.7 OUTLIER -86.64 20.57 2.47 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.868 0.867 . . . . 70.15 112.468 -174.153 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 101.71 -46.79 1.23 Allowed Glycine 0 C--N 1.346 1.098 0 N-CA-C 111.576 -0.61 . . . . 61.25 111.576 -178.073 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 3.6 t -92.8 34.57 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 CA-C-O 121.817 0.818 . . . . 75.31 109.479 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 60.61 -98.4 0.08 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.271 1.428 . . . . 64.3 111.427 -178.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 146' ' ' ILE . . . . . 0.472 HD12 HD11 ' B' ' 142' ' ' LEU . 34.1 mt 50.91 52.39 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 CA-C-O 122.51 1.148 . . . . 72.52 109.702 -175.48 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -67.94 -80.5 0.04 OUTLIER 'General case' 0 C--N 1.358 0.965 0 CA-C-N 114.116 -1.402 . . . . 72.43 110.769 -176.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -176.74 121.39 0.14 Allowed 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 107.491 -1.3 . . . . 73.05 107.491 -174.515 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 149' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm 54.99 31.21 15.59 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 123.692 0.797 . . . . 72.23 110.307 -163.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -130.6 129.55 42.87 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.633 1.173 . . . . 74.11 108.635 -173.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 39.1 m80 69.38 165.22 0.13 Allowed Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 124.452 1.095 . . . . 74.43 111.267 -170.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -58.88 -171.82 0.05 OUTLIER 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 122.55 2.167 . . . . 42.51 112.767 166.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 1.4 t 56.45 -159.55 0.23 Allowed 'General case' 0 CA--C 1.568 1.637 0 C-N-CA 124.698 1.199 . . . . 74.2 110.916 -176.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 154' ' ' ILE . . . . . 0.457 ' HA ' ' HB2' ' B' ' 136' ' ' LYS . 64.5 mt 74.76 -75.55 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 C-N-CA 124.747 1.219 . . . . 74.25 110.157 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 155' ' ' LEU . . . . . 0.675 HD23 ' H ' ' B' ' 155' ' ' LEU . 2.1 pt? -90.54 -27.52 19.11 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 108.765 -0.828 . . . . 72.1 108.765 172.156 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 64.84 28.79 12.76 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 125.084 1.353 . . . . 72.23 111.63 168.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 157' ' ' MET . . . . . . . . . . . . . 84.9 mtp 58.62 24.05 11.62 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 124.19 0.996 . . . . 53.54 111.21 -176.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 158' ' ' ALA . . . . . 0.455 ' HB1' ' HB ' ' B' ' 52' ' ' THR . . . 68.43 -69.92 0.14 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.003 1.721 . . . . 34.04 113.268 179.136 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 12.0 mptt 66.1 -166.51 0.22 Allowed 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 124.681 1.192 . . . . 55.45 110.047 -166.061 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 160' ' ' ALA . . . . . 0.676 ' HA ' ' HA ' ' B' ' 230' ' ' ALA . . . 65.84 -156.98 0.27 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.912 0.885 . . . . 70.22 111.588 176.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . 78.35 -60.99 0.39 Allowed 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 125.333 1.453 . . . . 71.1 112.503 176.091 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . -74.78 -5.81 75.74 Favored Glycine 0 CA--C 1.535 1.309 0 N-CA-C 114.902 0.721 . . . . 73.4 114.902 -175.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 163' ' ' LEU . . . . . 0.537 ' HG ' HD13 ' B' ' 226' ' ' LEU . 2.7 tm? -167.13 155.67 9.88 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 108.981 -0.748 . . . . 65.02 108.981 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 164' ' ' ALA . . . . . . . . . . . . . . . -131.68 133.54 44.98 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.112 0.965 . . . . 75.34 109.82 -178.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 20.1 p -119.79 -66.31 1.08 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.015 0.526 . . . . 64.15 111.084 176.044 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.35 -178.59 53.83 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-O 119.775 -0.458 . . . . 71.15 112.826 -174.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 167' ' ' ASN . . . . . . . . . . . . . 7.5 t30 57.05 95.47 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 125.361 1.464 . . . . 72.31 112.062 -178.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 168' ' ' VAL . . . . . 0.58 HG22 ' H ' ' B' ' 174' ' ' GLN . 7.5 t 59.62 50.17 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 C-N-CA 124.991 1.316 . . . . 74.13 109.507 -177.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 31.3 t -142.95 -45.38 0.3 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.456 -0.793 . . . . 54.35 111.9 -172.078 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 170' ' ' THR . . . . . 0.641 ' HB ' ' HB3' ' B' ' 231' ' ' LYS . 9.4 t -110.13 -43.43 3.95 Favored 'General case' 0 N--CA 1.478 0.969 0 O-C-N 122.163 -0.336 . . . . 63.1 111.848 -175.229 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -164.29 -42.57 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 122.425 0.29 . . . . 53.32 111.382 -173.237 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 172' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.34 120.95 12.0 Favored 'General case' 0 CA--C 1.555 1.142 0 O-C-N 123.69 0.619 . . . . 73.22 110.614 -178.421 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 173' ' ' LEU . . . . . . . . . . . . . 4.6 tt -107.67 102.51 11.74 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 108.492 -0.929 . . . . 74.23 108.492 -173.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 174' ' ' GLN . . . . . 0.58 ' H ' HG22 ' B' ' 168' ' ' VAL . 0.9 OUTLIER -102.29 99.03 9.08 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 107.584 -1.265 . . . . 74.45 107.584 177.415 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 175' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -122.67 18.12 10.34 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.688 0.795 . . . . 74.1 109.723 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . 57.94 87.05 0.07 Allowed 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.665 1.186 . . . . 74.11 110.715 -172.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 177' ' ' THR . . . . . 0.416 HG22 ' HG3' ' C' ' 129' ' ' GLU . 15.2 t -71.8 -31.9 1.94 Allowed Pre-proline 0 CA--C 1.574 1.889 0 CA-C-O 117.287 -1.339 . . . . 64.31 113.923 -178.689 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 178' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -86.29 -163.81 0.19 Allowed 'Trans proline' 0 C--N 1.402 3.373 0 CA-C-N 122.875 2.062 . . . . 74.53 111.957 174.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -52.24 -51.61 57.33 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.465 0.706 . . . . 61.34 109.979 171.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . -176.92 -57.57 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 105.869 -1.9 . . . . 74.4 105.869 170.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 46.1 tp -142.75 123.18 13.95 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 106.35 -1.722 . . . . 62.04 106.35 163.196 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 182' ' ' VAL . . . . . 0.7 ' HB ' ' HB2' ' C' ' 123' ' ' LEU . 69.5 t -68.67 131.94 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.064 0.546 . . . . 71.31 110.817 -172.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -119.54 16.78 12.91 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.767 0.827 . . . . 65.24 112.264 -172.134 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -62.18 100.39 0.17 Allowed 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 122.789 0.436 . . . . 74.15 111.138 -178.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 185' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' C' ' 121' ' ' ALA . 60.6 t -68.04 151.63 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.826 0.851 . . . . 71.33 110.102 177.422 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 186' ' ' THR . . . . . 0.452 ' HB ' ' HG2' ' C' ' 122' ' ' GLU . 15.0 t -125.87 172.25 10.04 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.889 0.875 . . . . 51.31 110.576 -177.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 187' ' ' SER . . . . . . . . . . . . . 20.7 m -83.93 134.35 34.67 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.824 0.85 . . . . 62.14 112.437 -170.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 188' ' ' ARG . . . . . 0.451 ' HD3' ' HD2' ' C' ' 120' ' ' ARG . 59.8 ttt85 -173.61 160.95 3.87 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.828 1.251 . . . . 71.52 108.739 177.073 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -141.31 112.9 7.61 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 108.726 -0.842 . . . . 72.52 108.726 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 190' ' ' CYS . . . . . . . . . . . . . 6.8 p -177.35 -176.89 0.66 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.806 1.242 . . . . 70.33 109.878 173.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -163.79 168.97 18.96 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.654 1.182 . . . . 74.04 109.511 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -80.79 147.67 28.11 Favored Glycine 0 CA--C 1.54 1.624 0 CA-C-O 118.835 -0.981 . . . . 64.22 113.025 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 193' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -52.63 -44.55 46.69 Favored 'Trans proline' 0 C--N 1.382 2.34 0 C-N-CA 124.609 3.539 . . . . 64.32 115.491 -173.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 194' ' ' SER . . . . . . . . . . . . . 9.0 m 78.33 88.16 0.07 Allowed 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 125.382 1.473 . . . . 24.51 112.509 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 195' ' ' ALA . . . . . . . . . . . . . . . -162.05 106.19 1.2 Allowed 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 123.606 0.762 . . . . 74.32 110.613 178.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 196' ' ' THR . . . . . 0.602 HG22 ' H ' ' B' ' 197' ' ' SER . 2.2 m 60.86 -150.06 0.41 Allowed 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 124.821 1.248 . . . . 73.32 110.793 174.309 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 197' ' ' SER . . . . . 0.602 ' H ' HG22 ' B' ' 196' ' ' THR . 37.3 m -58.0 104.6 0.21 Allowed 'General case' 0 C--N 1.363 1.186 0 CA-C-N 119.245 0.93 . . . . 75.11 109.676 172.528 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 198' ' ' GLU . . . . . 0.558 ' HG3' ' HD3' ' B' ' 201' ' ' PRO . 35.8 tp10 -69.8 -24.45 63.49 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 113.714 1.005 . . . . 51.12 113.714 -163.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt 69.43 2.64 3.81 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 124.265 1.026 . . . . 74.4 112.925 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 200' ' ' CYS . . . . . 0.456 ' HB3' ' HA2' ' C' ' 172' ' ' GLY . 69.8 m 60.71 79.36 0.29 Allowed Pre-proline 0 CA--C 1.566 1.59 0 C-N-CA 124.261 1.024 . . . . 73.31 112.453 177.457 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 201' ' ' PRO . . . . . 0.558 ' HD3' ' HG3' ' B' ' 198' ' ' GLU . 29.1 Cg_endo -97.88 16.96 0.56 Allowed 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 123.788 2.992 . . . . 71.34 112.963 177.228 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 116.95 79.59 0.74 Allowed Glycine 0 C--N 1.338 0.672 0 N-CA-C 110.745 -0.942 . . . . 63.04 110.745 -173.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 203' ' ' ASN . . . . . 0.556 ' H ' ' HA3' ' C' ' 172' ' ' GLY . 80.4 m-20 -144.41 -138.52 0.1 Allowed 'General case' 0 CA--C 1.572 1.822 0 C-N-CA 123.942 0.897 . . . . 71.33 109.441 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 204' ' ' ALA . . . . . 0.954 ' HA ' ' HA3' ' C' ' 166' ' ' GLY . . . -74.34 -172.13 1.36 Allowed 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 115.585 1.698 . . . . 74.01 115.585 -169.401 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 205' ' ' LEU . . . . . 0.551 ' HG ' ' NH1' ' C' ' 143' ' ' ARG . 0.5 OUTLIER -83.76 -92.73 0.07 Allowed 'General case' 0 CA--C 1.578 2.021 0 C-N-CA 124.962 1.305 . . . . 51.03 112.047 -165.182 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 206' ' ' GLU . . . . . 0.407 ' HG2' ' HZ ' ' C' ' 88' ' ' PHE . 6.0 tp10 2.47 93.32 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 128.346 2.658 . . . . 62.32 117.193 -157.265 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm 52.3 -176.87 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 125.574 1.55 . . . . 74.32 114.613 165.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . -115.99 -59.53 0.33 Allowed Glycine 0 C--N 1.339 0.697 0 N-CA-C 110.258 -1.137 . . . . 71.52 110.258 169.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 124.73 -168.41 16.85 Favored Glycine 0 C--N 1.341 0.842 0 CA-C-O 119.372 -0.682 . . . . 42.21 111.582 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp 69.07 -64.28 0.34 Allowed 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 125.492 1.517 . . . . 74.51 113.113 176.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . -53.92 103.64 0.18 Allowed Glycine 0 C--N 1.356 1.662 0 O-C-N 123.409 0.443 . . . . 74.43 112.62 177.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 48.9 m -110.76 -2.87 16.02 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.788 1.235 . . . . 74.04 111.635 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 21.8 pt -82.05 116.98 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-O 121.219 0.533 . . . . 64.4 110.661 179.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 37.0 p -143.05 -38.79 0.34 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.624 1.17 . . . . 75.43 109.085 174.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 215' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -58.98 -48.69 80.64 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.709 0.804 . . . . 73.31 110.45 179.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 46.32 29.84 0.92 Allowed 'General case' 0 N--CA 1.5 2.044 0 C-N-CA 126.238 1.815 . . . . 61.42 113.588 172.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 64.3 tp -71.57 88.89 0.95 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.541 0.736 . . . . 75.4 111.029 -173.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 218' ' ' LEU . . . . . 0.476 HD22 ' N ' ' B' ' 221' ' ' ARG . 1.8 tt 75.58 -48.76 0.61 Allowed 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 126.336 1.854 . . . . 71.43 111.086 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 39.4 t30 76.92 -66.3 0.25 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 126.2 1.8 . . . . 71.24 110.164 178.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -60.06 -23.93 64.15 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.884 0.874 . . . . 61.1 112.473 177.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 221' ' ' ARG . . . . . 0.476 ' N ' HD22 ' B' ' 218' ' ' LEU . 26.1 mmt180 67.62 6.34 4.94 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 124.69 1.196 . . . . 73.55 112.819 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -172.71 165.85 5.39 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.72 1.208 . . . . 42.52 109.999 -178.086 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 71.15 -69.02 0.19 Allowed 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 125.737 1.615 . . . . 61.02 112.485 173.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 41.0 t 70.07 -73.45 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 125.777 1.631 . . . . 74.2 110.217 -175.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 8.8 t -144.81 13.85 1.51 Allowed 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.936 0.895 . . . . 54.34 110.043 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 226' ' ' LEU . . . . . 0.537 HD13 ' HG ' ' B' ' 163' ' ' LEU . 8.4 mp 67.83 -74.97 0.07 Allowed 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 125.647 1.579 . . . . 74.43 110.56 -177.163 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . -133.35 -5.14 3.03 Favored Glycine 0 N--CA 1.476 1.303 0 C-N-CA 122.946 0.308 . . . . 51.31 113.249 177.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 90.64 165.93 40.66 Favored Glycine 0 C--N 1.345 1.063 0 CA-C-N 116.562 0.181 . . . . 72.41 112.998 -179.414 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . 61.9 60.63 7.75 Favored Glycine 0 C--N 1.347 1.175 0 O-C-N 123.881 0.401 . . . . 70.24 112.489 -178.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 230' ' ' ALA . . . . . 0.676 ' HA ' ' HA ' ' B' ' 160' ' ' ALA . . . -147.05 104.62 3.7 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.261 0.625 . . . . 70.23 109.555 -172.24 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 231' ' ' LYS . . . . . 0.641 ' HB3' ' HB ' ' B' ' 170' ' ' THR . 0.0 OUTLIER -120.37 -51.38 2.19 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.247 0.619 . . . . 73.24 112.466 -165.039 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 72.9 p -66.62 129.14 38.86 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.312 0.645 . . . . 74.24 112.2 -168.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -77.28 129.72 36.24 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.87 0.868 . . . . 70.41 109.431 178.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -110.29 81.86 1.5 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.131 0.572 . . . . 72.31 112.517 -171.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -134.79 76.96 1.66 Allowed 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 106.779 -1.563 . . . . 54.41 106.779 165.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 236' ' ' THR . . . . . 0.52 ' HA ' ' HG3' ' B' ' 46' ' ' ARG . 63.5 m 71.04 -67.14 0.26 Allowed 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 124.837 1.255 . . . . 73.34 109.014 -164.169 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -133.07 -163.73 1.39 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.849 1.26 . . . . 71.12 107.628 170.355 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 90.8 m -75.14 -16.24 60.54 Favored 'General case' 0 CA--C 1.56 1.348 0 C-N-CA 123.185 0.594 . . . . 71.31 110.148 170.011 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -88.95 168.1 12.66 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 113.88 1.067 . . . . 74.42 113.88 -176.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 240' ' ' GLY . . . . . 0.567 ' H ' HD22 ' C' ' 235' ' ' LEU . . . -102.44 -118.79 4.48 Favored Glycine 0 C--N 1.34 0.766 0 CA-C-N 112.94 -1.936 . . . . 71.23 110.543 176.484 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -161.11 -179.49 7.53 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-O 121.705 0.764 . . . . 71.21 110.334 174.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 242' ' ' TRP . . . . . 0.438 ' CZ3' HG21 ' C' ' 253' ' ' VAL . 2.6 m0 -106.17 -52.57 2.78 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 106.468 -1.678 . . . . 70.32 106.468 174.286 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 243' ' ' GLN . . . . . 0.403 ' CD ' HH21 ' C' ' 231' ' ' ARG . 8.7 pt20 179.76 -152.13 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.139 0 CA-C-N 112.987 -1.915 . . . . 74.22 107.802 -167.041 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -62.02 116.31 9.18 Favored Glycine 0 CA--C 1.542 1.751 0 CA-C-N 117.785 0.266 . . . . 63.11 113.629 175.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? -105.8 105.59 15.69 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.052 0.941 . . . . 75.34 108.886 179.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 21.8 m -76.71 143.71 39.81 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 109.116 -0.698 . . . . 71.02 109.116 171.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 247' ' ' LEU . . . . . . . . . . . . . 3.9 pp -116.41 137.24 52.32 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 119.464 1.029 . . . . 72.51 111.861 178.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 248' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 177.12 94.73 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 126.433 1.893 . . . . 75.15 107.236 172.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.77 -39.22 90.89 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.563 1.145 . . . . 71.33 112.66 -179.251 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 172.29 -76.95 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.519 1.128 . . . . 65.4 109.913 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 251' ' ' ALA . . . . . . . . . . . . . . . -168.46 49.71 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.437 1.095 . . . . 61.03 108.766 -170.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 252' ' ' GLN . . . . . 0.595 HE21 ' HB3' ' B' ' 367' ' ' LEU . 22.9 tt0 -68.45 -10.92 58.57 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 114.636 -1.165 . . . . 72.3 111.582 -178.568 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 253' ' ' ALA . . . . . 0.541 ' HA ' HD13 ' B' ' 367' ' ' LEU . . . -56.56 -33.51 66.21 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.405 0.682 . . . . 51.41 110.709 172.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 28.6 tpt180 -84.97 141.93 29.99 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 123.031 0.532 . . . . 72.51 110.489 173.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . 141.05 -86.94 0.19 Allowed Glycine 0 C--N 1.351 1.374 0 N-CA-C 111.465 -0.654 . . . . 54.22 111.465 177.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 256' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 63.12 -78.02 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 125.569 1.548 . . . . 52.52 112.36 177.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -68.2 -27.22 66.2 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.644 0.778 . . . . 74.31 110.545 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 258' ' ' LEU . . . . . . . . . . . . . 6.0 tt 68.55 -77.92 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 125.67 1.588 . . . . 75.13 108.37 -175.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 259' ' ' VAL . . . . . 0.522 ' HA ' ' HG3' ' B' ' 357' ' ' PRO . 8.3 p -88.85 155.3 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 C-N-CA 123.55 0.74 . . . . 63.02 110.016 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 260' ' ' SER . . . . . . . . . . . . . 48.0 m -73.91 85.65 1.75 Allowed 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 122.665 0.386 . . . . 73.11 110.633 176.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 26.7 t70 59.46 -86.52 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 125.306 1.442 . . . . 52.21 112.502 176.133 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 262' ' ' ALA . . . . . . . . . . . . . . . -118.82 131.1 56.08 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.903 0.881 . . . . 43.43 110.659 -174.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 263' ' ' ALA . . . . . 0.424 ' HB3' HG21 ' B' ' 259' ' ' VAL . . . -162.24 -32.19 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.79 0.836 . . . . 70.44 110.486 179.229 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 20.6 t 74.88 -69.62 0.17 Allowed 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 125.41 1.484 . . . . 51.14 111.327 174.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 265' ' ' LEU . . . . . . . . . . . . . 2.9 pp -122.19 5.34 9.75 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.977 0.911 . . . . 64.12 110.444 173.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 266' ' ' ASN . . . . . 0.419 ' HA ' ' HB1' ' B' ' 263' ' ' ALA 0.255 7.0 p30 47.35 -76.87 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 126.634 1.974 . . . . 71.52 113.374 -166.092 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 36.8 p -164.41 22.39 0.06 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.651 0.78 . . . . 73.13 109.71 -173.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 28.7 m -140.36 162.94 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.684 0.794 . . . . 74.44 110.106 -174.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 269' ' ' THR . . . . . . . . . . . . . 12.1 p -140.84 22.61 2.28 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.838 0.855 . . . . 74.31 109.744 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 270' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -102.76 101.38 11.46 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.404 0.681 . . . . 72.41 111.306 -175.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 271' ' ' ALA . . . . . . . . . . . . . . . -78.29 -35.14 48.34 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.312 0.645 . . . . 75.3 110.432 169.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 272' ' ' ASN . . . . . 0.575 ' HB2' ' HB3' ' B' ' 61' ' ' ASP . 41.3 m-80 -127.47 137.64 52.73 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.775 0.83 . . . . 54.14 109.722 178.051 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 273' ' ' GLN . . . . . 0.611 ' HG2' ' HA ' ' B' ' 64' ' ' ALA . 7.3 tp-100 63.82 138.13 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 125.533 1.533 . . . . 61.32 112.413 -173.154 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 72.7 -61.83 0.49 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.439 1.496 . . . . 71.44 109.997 -176.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 275' ' ' LYS . . . . . 0.43 ' HE3' ' HA ' ' B' ' 272' ' ' ASN . 92.4 mttt 45.79 47.66 4.32 Favored Pre-proline 0 N--CA 1.486 1.326 0 C-N-CA 125.264 1.426 . . . . 71.33 111.471 175.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 276' ' ' PRO . . . . . 0.406 ' O ' ' HB2' ' B' ' 355' ' ' ALA . 4.8 Cg_exo -74.09 90.53 0.97 Allowed 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 122.357 2.038 . . . . 62.35 111.106 -166.308 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 277' ' ' LEU . . . . . . . . . . . . . 75.3 mt -106.29 7.9 31.58 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 114.719 -1.128 . . . . 63.32 109.311 175.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 90.8 mt -98.87 131.7 44.77 Favored 'General case' 0 C--N 1.351 0.634 0 C-N-CA 123.962 0.905 . . . . 62.0 109.655 177.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . -129.44 38.12 2.06 Favored Glycine 0 C--N 1.332 0.343 0 N-CA-C 109.276 -1.53 . . . . 75.43 109.276 176.311 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 88.5 mt -55.8 -40.72 73.08 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.622 1.169 . . . . 53.23 110.523 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -136.38 144.27 44.46 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 108.365 -0.976 . . . . 75.31 108.365 172.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -126.24 167.48 15.39 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.505 0.722 . . . . 65.41 111.258 -176.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 70.01 -72.99 0.1 Allowed 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 125.6 1.56 . . . . 72.33 111.726 175.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . -78.38 74.27 2.1 Favored Glycine 0 C--N 1.351 1.38 0 C-N-CA 122.546 0.117 . . . . 61.45 113.35 -177.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -135.16 -71.02 0.48 Allowed 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.765 -0.828 . . . . 72.41 108.765 178.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 286' ' ' MET . . . . . . . . . . . . . 96.5 mmm -92.61 -45.48 0.33 Allowed Pre-proline 0 N--CA 1.486 1.342 0 CA-C-O 118.788 -0.625 . . . . 64.1 110.647 175.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 287' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -87.06 -170.05 0.57 Allowed 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 121.673 1.582 . . . . 73.33 112.012 165.093 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 288' ' ' VAL . . . . . . . . . . . . . 38.6 t 62.05 -84.53 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 125.198 1.399 . . . . 74.32 110.096 -174.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 289' ' ' ARG . . . . . . . . . . . . . 52.5 ttp180 53.81 87.14 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.085 1.354 . . . . 72.14 111.735 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 290' ' ' TRP . . . . . . . . . . . . . 42.9 p90 -76.81 159.0 30.45 Favored 'General case' 0 C--O 1.246 0.878 0 C-N-CA 122.779 0.432 . . . . 75.34 110.006 175.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 291' ' ' LEU . . . . . . . . . . . . . 9.2 mp -77.86 -47.72 18.13 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.967 0.507 . . . . 64.34 109.852 -178.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . 121.46 -73.33 0.36 Allowed Glycine 0 CA--C 1.533 1.17 0 CA-C-O 119.42 -0.656 . . . . 62.12 111.994 -176.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 293' ' ' PRO . . . . . 0.48 ' HG3' ' SD ' ' B' ' 464' ' ' MET . 6.2 Cg_exo -75.78 108.45 2.69 Favored 'Trans proline' 0 C--N 1.383 2.381 0 C-N-CA 122.405 2.07 . . . . 51.12 111.247 179.175 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -61.64 -41.13 97.07 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 109.109 -0.701 . . . . 41.23 109.109 173.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -129.26 113.41 14.98 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.24 -0.891 . . . . 34.32 108.605 168.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 75.2 m -73.51 83.78 1.51 Allowed 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 109.11 -0.7 . . . . 65.42 109.11 175.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -158.13 140.7 14.55 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 114.825 -1.08 . . . . 64.12 108.734 -179.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 22.3 m170 -135.93 -172.24 3.06 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.741 1.216 . . . . 71.5 109.456 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . 72.37 34.36 60.76 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.074 -0.81 . . . . 63.41 111.074 -168.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -149.72 -42.48 0.14 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.076 0.55 . . . . 72.23 111.954 -175.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 301' ' ' ILE . . . . . . . . . . . . . 14.9 tt -128.61 16.55 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-O 121.974 0.892 . . . . 72.24 110.833 -170.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -81.27 -24.88 37.0 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.805 0.842 . . . . 63.41 111.737 -172.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 303' ' ' LYS . . . . . . . . . . . . . 4.7 ttmp? 62.13 83.34 0.21 Allowed Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 124.791 1.237 . . . . 74.11 110.49 -175.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 304' ' ' PRO . . . . . 0.741 ' HA ' ' HB ' ' B' ' 307' ' ' THR . 33.5 Cg_exo -61.37 -10.44 15.96 Favored 'Trans proline' 0 C--N 1.383 2.367 0 C-N-CA 123.533 2.822 . . . . 75.12 113.939 178.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -62.05 -40.07 94.5 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.586 0.755 . . . . 42.33 111.24 172.078 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 34.7 m -121.67 33.02 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 123.619 0.768 . . . . 72.33 110.054 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 307' ' ' THR . . . . . 0.741 ' HB ' ' HA ' ' B' ' 304' ' ' PRO . 8.9 t -58.01 -31.68 67.2 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.512 1.125 . . . . 74.23 113.424 -176.763 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 308' ' ' CYS . . . . . . . . . . . . . 49.7 t -86.84 -28.7 22.74 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.185 0.594 . . . . 74.22 110.562 177.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 309' ' ' THR . . . . . 0.454 ' HB ' ' HD3' ' B' ' 310' ' ' PRO 0.261 36.5 m 105.1 -62.93 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.867 0 C-N-CA 128.19 2.596 . . . . 72.2 111.825 -174.405 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 310' ' ' PRO . . . . . 0.454 ' HD3' ' HB ' ' B' ' 309' ' ' THR . 37.5 Cg_exo -60.98 114.97 2.4 Favored 'Trans proline' 0 C--N 1.393 2.908 0 CA-C-N 122.232 1.833 . . . . 63.14 113.612 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 311' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -78.7 -34.02 0.95 Allowed Pre-proline 0 CA--C 1.57 1.742 0 CA-C-O 116.949 -1.5 . . . . 73.13 114.644 176.18 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 312' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -75.78 75.57 3.99 Favored 'Trans proline' 0 C--N 1.404 3.474 0 CA-C-N 123.186 2.173 . . . . 70.14 112.465 -175.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 313' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -50.15 -46.87 54.35 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.892 1.677 . . . . 75.13 112.049 -171.487 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 314' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 -70.56 82.54 0.59 Allowed 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.159 0.984 . . . . 72.01 112.18 -176.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 315' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -161.86 43.96 0.15 Allowed 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 122.593 1.187 . . . . 72.12 107.858 178.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 316' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -148.53 -42.79 0.15 Allowed 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 114.439 -1.255 . . . . 74.4 112.087 -164.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 51.1 m 56.99 33.88 24.04 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 124.144 0.978 . . . . 75.41 111.446 -176.017 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 318' ' ' VAL . . . . . . . . . . . . 0.253 7.4 p 36.83 87.21 0.12 Allowed Pre-proline 0 CA--C 1.564 1.493 0 C-N-CA 126.706 2.002 . . . . 73.13 112.281 -167.592 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 319' ' ' PRO . . . . . 0.415 ' HG2' ' H ' ' B' ' 423' ' ' SER . 24.3 Cg_exo -64.77 -26.1 60.5 Favored 'Trans proline' 0 C--N 1.388 2.655 0 C-N-CA 123.274 2.649 . . . . 65.1 113.293 -173.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 320' ' ' THR . . . . . . . . . . . . . 19.3 m 59.74 80.76 0.19 Allowed 'General case' 0 C--N 1.354 0.768 0 O-C-N 124.612 1.195 . . . . 53.31 109.363 -173.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 321' ' ' LEU . . . . . . . . . . . . . 60.4 mt -64.25 -55.8 19.0 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 114.858 -1.065 . . . . 65.14 110.213 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 322' ' ' ALA . . . . . . . . . . . . . . . 56.75 22.66 7.13 Favored 'General case' 0 CA--C 1.553 1.091 0 CA-C-N 114.677 -1.147 . . . . 64.54 110.933 -172.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 323' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -77.45 76.46 3.99 Favored 'General case' 0 C--N 1.359 0.991 0 C-N-CA 123.834 0.854 . . . . 74.02 109.554 -178.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 324' ' ' MET . . . . . . . . . . . . . 21.9 ptp -103.54 -21.94 13.69 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.147 0.979 . . . . 71.32 110.366 -178.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 325' ' ' THR . . . . . . . . . . . . . 31.9 m -75.98 97.06 3.9 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.137 0.575 . . . . 72.33 110.224 178.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 326' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -67.34 136.09 54.28 Favored 'General case' 0 C--N 1.351 0.649 0 C-N-CA 123.272 0.629 . . . . 72.01 110.091 175.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -134.43 17.48 3.67 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.062 0.945 . . . . 54.34 109.541 178.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 328' ' ' ALA . . . . . 0.409 ' HB2' HD23 ' B' ' 439' ' ' LEU . . . -99.95 -44.43 6.04 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.405 -0.816 . . . . 72.03 111.173 -175.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 329' ' ' ILE . . . . . . . . . . . . . 35.5 mm 61.73 81.8 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 C-N-CA 124.776 1.23 . . . . 73.5 109.348 -175.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 330' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 71.41 137.81 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 126.189 1.796 . . . . 63.42 111.211 -176.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 331' ' ' LEU . . . . . 0.494 HD13 ' HA ' ' B' ' 438' ' ' GLN . 50.3 tp -70.0 -58.68 3.55 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.564 -0.744 . . . . 63.34 110.227 -179.689 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 332' ' ' LEU . . . . . 0.443 HD22 ' HG ' ' B' ' 331' ' ' LEU . 4.1 mm? -106.86 -147.47 0.41 Allowed 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 108.348 -0.982 . . . . 74.41 108.348 171.267 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 333' ' ' SER . . . . . 0.433 ' HB2' ' OE1' ' B' ' 457' ' ' GLN . 8.7 t 82.92 24.84 0.14 Allowed 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 125.361 1.464 . . . . 65.04 110.867 174.425 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -97.43 24.96 6.04 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.045 0.938 . . . . 63.11 110.419 178.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 335' ' ' ASN . . . . . . . . . . . . . 60.7 t30 57.19 69.58 0.73 Allowed 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.853 0.861 . . . . 73.25 109.726 179.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 17.0 mp0 -57.56 -68.1 0.27 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.595 1.158 . . . . 61.02 110.884 -170.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 337' ' ' LYS . . . . . 0.43 ' HG2' ' H ' ' B' ' 339' ' ' PHE . 22.3 ttmm 174.0 141.13 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 125.352 1.461 . . . . 62.43 108.798 167.596 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 338' ' ' GLY . . . . . . . . . . . . . . . -79.38 5.98 58.65 Favored Glycine 0 CA--C 1.536 1.355 0 CA-C-O 119.234 -0.759 . . . . 72.34 114.96 -177.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 339' ' ' PHE . . . . . 0.43 ' H ' ' HG2' ' B' ' 337' ' ' LYS . 49.1 p90 -156.28 147.22 22.07 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 118.289 1.044 . . . . 74.33 111.019 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 340' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -131.56 -71.22 0.56 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.156 0.582 . . . . 75.24 111.091 -175.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 341' ' ' LEU . . . . . . . . . . . . . 1.7 pp -64.58 -25.8 68.13 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 112.473 0.545 . . . . 75.34 112.473 -171.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 342' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 74.2 -15.48 0.6 Allowed 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 125.565 1.546 . . . . 64.25 112.171 172.208 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 343' ' ' VAL . . . . . . . . . . . . . 13.3 t 60.46 32.92 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.42 0 C-N-CA 124.444 1.098 . . . . 64.24 108.394 -167.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -62.66 130.68 46.08 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.312 1.045 . . . . 73.03 110.786 -176.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 345' ' ' GLY . . . . . . . . . . . . . . . -147.55 -21.03 0.09 OUTLIER Glycine 0 C--N 1.345 1.043 0 O-C-N 123.406 0.441 . . . . 62.31 113.161 -175.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 346' ' ' ALA . . . . . . . . . . . . . . . -73.77 151.94 40.48 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 117.362 0.581 . . . . 72.22 111.784 -177.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 19.9 t 77.29 -43.88 0.43 Allowed 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 126.068 1.747 . . . . 72.21 112.239 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 61.1 mt -85.2 -42.73 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.829 0.852 . . . . 73.42 110.312 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 349' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 64.67 -82.51 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.676 1.59 . . . . 71.13 110.881 -173.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 350' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -129.23 -87.41 0.53 Allowed 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.001 -0.74 . . . . 74.52 109.001 178.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 48.26 85.16 0.03 OUTLIER 'General case' 0 C--N 1.362 1.151 0 C-N-CA 124.452 1.101 . . . . 71.32 110.526 -171.216 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -53.74 -25.68 19.85 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.186 0.995 . . . . 74.35 113.352 -171.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 353' ' ' HIS . . . . . . . . . . . . . 49.8 m80 76.41 -35.35 0.24 Allowed 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 125.416 1.486 . . . . 74.33 111.568 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 354' ' ' ALA . . . . . . . . . . . . . . . -62.87 97.05 0.1 Allowed 'General case' 0 C--O 1.242 0.686 0 C-N-CA 124.149 0.98 . . . . 70.11 110.26 168.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 355' ' ' ALA . . . . . 0.406 ' HB2' ' O ' ' B' ' 276' ' ' PRO . . . -72.42 -77.85 0.09 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.523 -0.762 . . . . 75.44 110.825 -179.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 356' ' ' ASN . . . . . 0.506 ' HB3' ' HD3' ' B' ' 357' ' ' PRO . 27.4 t-20 173.78 -58.76 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.336 0 C-N-CA 125.045 1.338 . . . . 74.32 109.31 -176.514 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 357' ' ' PRO . . . . . 0.522 ' HG3' ' HA ' ' B' ' 259' ' ' VAL . 4.5 Cg_endo -102.07 -174.22 0.1 Allowed 'Trans proline' 0 C--N 1.393 2.92 0 C-N-CA 122.678 2.252 . . . . 55.22 113.5 -175.025 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 358' ' ' CYS . . . . . . . . . . . . . 60.3 m -99.82 60.81 1.11 Allowed 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 108.978 -0.749 . . . . 73.32 108.978 170.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 359' ' ' GLY . . . . . . . . . . . . . . . -76.71 77.71 1.42 Allowed Glycine 0 C--N 1.349 1.254 0 CA-C-N 114.813 -1.085 . . . . 62.01 112.968 -176.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 360' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -117.93 149.68 40.49 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.43 0.692 . . . . 53.34 110.58 -178.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 361' ' ' ILE . . . . . . . . . . . . . 16.4 tt -159.16 155.26 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.931 0.892 . . . . 61.31 108.629 -178.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 362' ' ' GLY . . . . . . . . . . . . . . . -127.26 -106.12 1.38 Allowed Glycine 0 C--N 1.348 1.23 0 C-N-CA 121.6 -0.333 . . . . 72.35 113.296 -178.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 363' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -75.07 -19.78 59.82 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.831 0.852 . . . . 73.13 112.327 -171.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 364' ' ' THR . . . . . 0.52 HG23 HG23 ' B' ' 365' ' ' VAL . 3.8 t 55.34 168.28 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 126.484 1.914 . . . . 74.04 113.862 -173.492 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 365' ' ' VAL . . . . . 0.52 HG23 HG23 ' B' ' 364' ' ' THR . 58.6 t 70.05 140.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 125.475 1.51 . . . . 74.01 111.896 -178.389 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 2.3 p30 32.78 53.34 0.35 Allowed 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 126.47 1.908 . . . . 50.12 114.428 178.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 367' ' ' LEU . . . . . 0.595 ' HB3' HE21 ' B' ' 252' ' ' GLN . 3.1 pp -57.08 -16.7 8.02 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 124.0 0.92 . . . . 75.05 113.367 179.049 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 368' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -58.2 -60.92 3.0 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.982 1.713 . . . . 71.23 111.397 178.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 369' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 52.62 -100.7 0.1 Allowed 'General case' 0 CA--C 1.564 1.49 0 C-N-CA 124.988 1.315 . . . . 70.1 109.34 -168.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 370' ' ' ALA . . . . . . . . . . . . . . . 176.43 -70.65 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 124.668 1.187 . . . . 74.25 110.551 176.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 371' ' ' VAL . . . . . . . . . . . . . 29.5 t -110.71 -18.25 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 C-N-CA 123.519 0.728 . . . . 74.11 112.266 -167.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 372' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -71.96 86.31 1.0 Allowed 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 120.959 0.409 . . . . 63.2 111.751 -176.125 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 373' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -162.37 157.71 23.0 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.499 1.12 . . . . 72.05 108.715 170.704 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -78.16 156.74 29.7 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.312 0.645 . . . . 71.45 112.554 -170.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 375' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -144.81 160.01 41.95 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.65 1.18 . . . . 62.01 108.932 -177.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 376' ' ' GLU . . . . . 0.425 ' HA ' ' HG3' ' A' ' 263' ' ' PRO . 2.9 mp0 -64.07 -32.39 73.93 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.371 0.669 . . . . 73.13 111.218 -174.458 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 377' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -65.26 100.65 0.48 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.829 0.852 . . . . 73.31 110.067 177.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 378' ' ' ALA . . . . . . . . . . . . . . . -87.53 0.75 55.13 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 115.353 -0.839 . . . . 61.1 111.602 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt 75.34 -57.65 0.59 Allowed 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 125.831 1.652 . . . . 72.01 111.095 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 380' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.21 157.37 29.36 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 108.974 -0.75 . . . . 53.14 108.974 170.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 381' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -84.18 22.24 1.25 Allowed 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 123.702 0.801 . . . . 74.34 110.908 -176.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . 71.81 3.58 55.69 Favored Glycine 0 C--N 1.352 1.467 0 C-N-CA 122.84 0.257 . . . . 73.1 112.741 -171.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 383' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -93.69 99.1 11.58 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.015 0.926 . . . . 73.1 110.487 -173.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 384' ' ' THR . . . . . . . . . . . . . 35.8 p -108.12 -56.48 2.24 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.522 -0.918 . . . . 63.41 108.522 174.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 62.59 150.35 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 126.029 1.731 . . . . 75.12 113.589 178.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 386' ' ' VAL . . . . . 0.654 HG21 ' HD2' ' B' ' 415' ' ' LYS . 7.7 p 47.05 23.78 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.606 0 C-N-CA 126.774 2.03 . . . . 62.42 113.609 178.12 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 387' ' ' ILE . . . . . . . . . . . . . 34.8 mm 57.37 -74.35 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 125.21 1.404 . . . . 74.12 110.867 -172.076 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 388' ' ' VAL . . . . . 0.52 HG13 HG13 ' B' ' 386' ' ' VAL 0.285 4.3 m 46.47 -102.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 125.856 1.662 . . . . 54.33 111.979 -171.371 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 389' ' ' THR . . . . . 0.452 ' H ' HG23 ' B' ' 388' ' ' VAL . 45.2 p -94.89 -34.87 12.26 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 109.348 -0.612 . . . . 71.25 109.348 173.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . 57.51 69.69 0.72 Allowed 'General case' 0 C--O 1.245 0.825 0 C-N-CA 125.418 1.487 . . . . 70.34 109.794 -174.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 391' ' ' ASP . . . . . . . . . . . . . 14.4 t70 74.08 -66.01 0.32 Allowed 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 113.35 -1.75 . . . . 64.12 109.319 -170.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 392' ' ' HIS . . . . . 0.526 ' HD2' ' HB3' ' B' ' 404' ' ' LYS . 16.2 t-80 -157.21 -21.72 0.09 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.19 0.596 . . . . 72.42 110.478 174.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -69.44 76.12 0.39 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.302 1.041 . . . . 61.53 113.502 -167.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 81.5 t60 173.08 126.14 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 126.287 1.835 . . . . 73.31 107.5 177.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . 54.97 60.88 3.21 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 124.085 0.866 . . . . 71.44 110.096 -174.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 78.5 p -70.21 83.47 0.54 Allowed 'General case' 0 CA--C 1.555 1.152 0 CA-C-N 114.089 -1.414 . . . . 75.55 112.128 -169.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 397' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -174.62 -28.93 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 125.024 1.33 . . . . 71.41 108.425 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 9.1 tt -42.57 -46.41 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 C-N-CA 125.085 1.354 . . . . 75.44 113.089 -174.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 399' ' ' VAL . . . . . . . . . . . . . 13.9 t -132.29 72.56 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 N-CA-C 107.888 -1.152 . . . . 73.32 107.888 170.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 400' ' ' ALA . . . . . . . . . . . . . . . -71.0 -43.41 13.4 Favored Pre-proline 0 CA--C 1.563 1.455 0 N-CA-C 114.103 1.149 . . . . 51.41 114.103 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 401' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -52.31 114.01 1.46 Allowed 'Trans proline' 0 C--N 1.397 3.083 0 C-N-CA 122.335 2.023 . . . . 71.04 113.254 179.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 12.9 t70 66.89 -85.15 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 125.058 1.343 . . . . 74.34 110.775 -179.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 403' ' ' THR . . . . . . . . . . . . . 34.4 p -150.25 -156.98 0.77 Allowed 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 125.601 1.56 . . . . 51.3 107.73 178.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 404' ' ' LYS . . . . . 0.526 ' HB3' ' HD2' ' B' ' 392' ' ' HIS . 0.0 OUTLIER -84.09 -9.37 58.66 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.53 0.332 . . . . 70.03 111.733 168.697 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 405' ' ' ALA . . . . . . . . . . . . . . . -60.81 -32.31 10.86 Favored Pre-proline 0 CA--C 1.563 1.472 0 N-CA-C 114.237 1.199 . . . . 71.24 114.237 -177.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 406' ' ' PRO . . . . . . . . . . . . . 0.7 OUTLIER -33.85 -39.41 0.14 Allowed 'Trans proline' 0 C--N 1.393 2.883 0 C-N-CA 123.734 2.956 . . . . 44.44 115.472 163.459 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . 130.67 142.22 5.06 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-N 116.495 -0.32 . . . . 55.33 112.912 172.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 408' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -156.08 136.82 13.38 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 124.299 1.039 . . . . 72.03 108.539 177.116 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 9.7 t -134.8 -29.35 1.16 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.469 0.708 . . . . 73.52 110.881 -178.086 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 410' ' ' GLN . . . . . . . . . . . . . 65.2 tp60 -121.74 81.76 1.86 Allowed 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.217 0.607 . . . . 51.32 110.371 -175.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . -95.4 -82.93 0.37 Allowed 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 106.985 -1.487 . . . . 63.14 106.985 164.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 54.9 tp 54.73 -78.41 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.357 1.463 . . . . 60.41 112.642 176.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 17.8 m120 60.91 -161.26 0.29 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 125.176 1.39 . . . . 71.14 110.591 -177.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 414' ' ' THR . . . . . . . . . . . . . 52.6 p -84.22 38.21 0.65 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.645 0.778 . . . . 73.24 109.93 171.019 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 415' ' ' LYS . . . . . 0.654 ' HD2' HG21 ' B' ' 386' ' ' VAL . 55.3 mtmt 52.47 46.2 27.13 Favored 'General case' 0 C--N 1.356 0.856 0 C-N-CA 124.846 1.259 . . . . 73.42 110.792 -164.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 31.5 t70 58.22 -97.98 0.08 Allowed 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 112.781 -2.009 . . . . 75.33 110.686 -178.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 417' ' ' GLY . . . . . 0.43 ' O ' ' HD2' ' A' ' 211' ' ' ARG . . . -105.85 34.46 5.74 Favored Glycine 0 C--N 1.345 1.03 0 N-CA-C 111.894 -0.482 . . . . 43.15 111.894 179.559 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 418' ' ' ALA . . . . . . . . . . . . . . . 72.68 -66.74 0.29 Allowed 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 125.535 1.534 . . . . 70.25 110.926 -175.125 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 419' ' ' VAL . . . . . . . . . . . . . 57.4 t 64.45 -71.86 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 C-N-CA 125.652 1.581 . . . . 62.03 112.32 176.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 420' ' ' MET . . . . . 0.552 ' HB2' HG23 ' B' ' 386' ' ' VAL . 27.2 ttt -46.21 -26.62 0.82 Allowed 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 125.823 1.649 . . . . 73.12 113.175 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 421' ' ' VAL . . . . . . . . . . . . . 21.2 t -77.26 63.13 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.347 0 CA-C-O 121.906 0.86 . . . . 72.42 109.777 175.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 422' ' ' MET . . . . . 0.46 ' HB3' ' NH2' ' A' ' 211' ' ' ARG . 19.6 ptp -141.97 -4.22 1.06 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.087 1.355 . . . . 74.1 109.795 176.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 423' ' ' SER . . . . . 0.44 ' HB3' ' HB3' ' B' ' 426' ' ' ASN . 16.3 m 76.46 -24.99 0.21 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 125.919 1.688 . . . . 62.22 112.559 -176.339 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 424' ' ' TYR . . . . . . . . . . . . . 31.0 t80 73.16 -71.65 0.13 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.948 1.299 . . . . 72.42 109.948 173.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . -150.91 16.67 0.93 Allowed Glycine 0 CA--C 1.532 1.115 0 CA-C-N 116.265 -0.425 . . . . 75.12 112.358 172.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 426' ' ' ASN . . . . . 0.44 ' HB3' ' HB3' ' B' ' 423' ' ' SER . 29.2 t-20 -66.15 -45.13 82.06 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.275 1.03 . . . . 75.43 112.263 -172.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 427' ' ' SER . . . . . 0.666 ' HB3' ' HA ' ' B' ' 431' ' ' SER . 26.8 t -71.7 121.68 19.29 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 109.003 -0.74 . . . . 75.14 109.003 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -55.26 -61.13 2.53 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.228 1.411 . . . . 73.23 113.889 -161.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 429' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -84.0 79.45 9.49 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.056 0.542 . . . . 63.42 110.658 -174.195 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 38.7 t70 54.94 37.93 29.6 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 124.068 0.947 . . . . 55.41 111.457 171.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 431' ' ' SER . . . . . 0.666 ' HA ' ' HB3' ' B' ' 427' ' ' SER . 29.7 t 66.63 -79.18 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.379 1.072 . . . . 73.31 110.27 -166.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 432' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 64.67 7.68 3.96 Favored 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 124.018 0.927 . . . . 71.1 111.995 179.085 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 433' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -69.67 -22.73 63.42 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.687 0.795 . . . . 73.43 111.47 -177.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 434' ' ' HIS . . . . . . . . . . . . . 61.3 t-80 72.13 168.71 0.31 Allowed 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 124.953 1.301 . . . . 65.13 112.113 171.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 435' ' ' THR . . . . . 0.507 ' O ' ' HG ' ' B' ' 439' ' ' LEU . 53.2 m 82.38 -54.54 0.21 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.344 1.858 . . . . 73.42 111.861 174.489 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . -53.54 -67.41 2.15 Favored Glycine 0 N--CA 1.481 1.695 0 CA-C-N 118.519 0.599 . . . . 43.54 113.994 -174.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 23.9 m -64.84 -23.33 67.2 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.279 0.632 . . . . 54.14 111.82 177.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 438' ' ' GLN . . . . . 0.494 ' HA ' HD13 ' B' ' 331' ' ' LEU . 22.8 mp0 -79.7 -23.3 42.48 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.2 1.0 . . . . 71.55 111.248 -172.502 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 439' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' B' ' 435' ' ' THR . 93.8 mt -79.85 35.83 0.32 Allowed 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.651 0.781 . . . . 74.24 111.205 177.321 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 440' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -67.7 169.7 9.07 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 123.643 0.777 . . . . 70.1 112.108 -174.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 441' ' ' ILE . . . . . 0.609 HD12 ' HA ' ' A' ' 223' ' ' VAL . 47.2 mt -95.02 140.33 17.0 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 CA-C-N 114.748 -1.115 . . . . 74.15 109.731 177.477 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 442' ' ' ALA . . . . . . . . . . . . . . . -83.76 -80.99 0.18 Allowed 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 108.751 -0.833 . . . . 71.41 108.751 172.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 443' ' ' ALA . . . . . 0.498 ' HB3' ' HG3' ' A' ' 224' ' ' PRO . . . 56.73 -85.08 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 125.464 1.506 . . . . 74.21 113.173 173.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 31.4 p90 -167.49 -160.78 0.37 Allowed 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.959 0.904 . . . . 65.34 110.32 -177.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . 137.72 -89.05 0.21 Allowed Glycine 0 C--N 1.347 1.163 0 CA-C-O 119.75 -0.472 . . . . 74.34 111.972 174.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 446' ' ' PRO . . . . . 0.411 ' HD3' ' HG2' ' A' ' 225' ' ' PRO . 48.6 Cg_endo -97.77 -163.34 0.07 OUTLIER 'Trans proline' 0 C--N 1.368 1.578 0 C-N-CA 123.151 2.567 . . . . 63.02 110.616 168.341 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 447' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -144.92 51.17 1.24 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 122.274 1.035 . . . . 60.0 108.997 170.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . 176.24 142.61 0.07 Allowed 'General case' 0 C--O 1.24 0.569 0 CA-C-N 112.416 -2.174 . . . . 74.31 106.822 172.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 449' ' ' ALA . . . . . . . . . . . . . . . -169.63 -58.16 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 122.078 0.942 . . . . 61.52 108.721 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 450' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -120.32 172.11 8.04 Favored 'General case' 0 CA--C 1.552 1.042 0 CA-C-N 113.681 -1.599 . . . . 61.12 108.228 178.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 67.4 t 78.45 -57.58 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 C-N-CA 125.598 1.559 . . . . 63.1 110.771 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 452' ' ' VAL . . . . . . . . . . . . . 28.3 m -62.88 -26.89 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 123.853 0.861 . . . . 60.45 112.168 175.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . -69.74 -27.48 73.21 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-O 119.905 -0.386 . . . . 73.44 113.074 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 454' ' ' LEU . . . . . . . . . . . . . 87.2 mt 61.85 21.39 12.22 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 124.499 1.119 . . . . 72.5 110.691 -175.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 455' ' ' THR . . . . . 0.417 ' HB ' HD23 ' B' ' 460' ' ' LEU . 38.5 p -100.14 151.8 20.99 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 124.288 1.035 . . . . 61.41 110.566 -176.139 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -70.32 146.59 50.43 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.372 0.669 . . . . 74.3 109.982 -177.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 457' ' ' GLN . . . . . 0.433 ' OE1' ' HB2' ' B' ' 333' ' ' SER . 47.8 mt-30 -100.44 4.14 43.56 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.274 0.842 . . . . 42.14 113.274 -166.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 36.2 p -66.3 -56.02 13.21 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 118.445 0.566 . . . . 72.13 109.563 177.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 459' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -161.28 82.05 0.62 Allowed 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.21 -0.905 . . . . 73.31 109.921 178.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 460' ' ' LEU . . . . . 0.417 HD23 ' HB ' ' B' ' 455' ' ' THR . 23.9 tp -163.98 -86.71 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.49 -0.777 . . . . 65.42 109.535 175.224 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 65.94 -63.9 0.22 Allowed 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 125.08 1.352 . . . . 62.31 111.899 -175.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 20.8 t80 66.09 54.51 0.98 Allowed 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 125.465 1.506 . . . . 72.53 110.728 174.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 62.1 m -74.42 86.15 2.01 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 115.147 -0.933 . . . . 61.35 110.199 174.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 464' ' ' MET . . . . . 0.48 ' SD ' ' HG3' ' B' ' 293' ' ' PRO . 24.9 ttt -120.76 144.05 48.48 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 107.974 -1.121 . . . . 75.31 107.974 178.165 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? 77.12 -38.87 0.31 Allowed 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 125.342 1.457 . . . . 72.15 112.525 -177.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -67.82 -20.31 65.16 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.726 0.81 . . . . 62.32 112.248 178.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . -84.62 0.87 48.6 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 123.883 0.873 . . . . 75.3 111.613 175.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 468' ' ' LEU . . . . . 0.616 ' HA ' ' HG2' ' C' ' 266' ' ' GLU . 67.5 tp -113.19 112.07 23.14 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.619 1.168 . . . . 45.51 108.761 179.183 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 469' ' ' GLY . . . . . . . . . . . . . . . 74.3 144.38 0.89 Allowed Glycine 0 C--N 1.351 1.394 0 O-C-N 123.311 0.382 . . . . 50.44 112.887 -176.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 470' ' ' LEU . . . . . . . . . . . . . 6.6 tt -85.98 -48.25 8.85 Favored 'General case' 0 N--CA 1.485 1.275 0 O-C-N 121.868 -0.783 . . . . 73.2 109.081 176.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 471' ' ' LYS . . . . . . . . . . . . . 11.1 tmtt? . . . . . 0 CA--C 1.557 1.218 0 N-CA-C 107.119 -1.437 . . . . 74.2 107.119 -165.295 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 70.8 mtm . . . . . 0 N--CA 1.477 0.882 0 N-CA-C 110.738 -0.097 . . . . 55.23 110.738 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' C' C ' 2' ' ' ALA . . . . . 0.451 ' HA ' ' HD1' ' C' ' 96' ' ' PHE . . . 65.33 41.32 4.38 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.714 1.206 . . . . 65.31 112.039 174.293 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -75.79 72.83 2.72 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.554 0.741 . . . . 52.01 109.798 175.001 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -37.91 123.8 1.1 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.237 1.815 . . . . 70.52 114.951 -174.16 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 22.3 mmtp -93.53 122.68 36.22 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.6 -0.727 . . . . 63.2 109.591 166.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -82.65 86.18 6.89 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 107.48 -1.304 . . . . 63.22 107.48 170.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 7' ' ' TYR . . . . . 0.437 ' HB3' ' HA ' ' C' ' 53' ' ' ALA . 73.9 m-85 -61.61 -35.12 76.95 Favored 'General case' 0 C--O 1.244 0.764 0 CA-C-N 114.341 -1.299 . . . . 73.43 111.198 -176.164 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -60.26 -46.86 88.34 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.584 -0.735 . . . . 72.53 110.113 175.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.55 -39.19 92.83 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.888 0.475 . . . . 52.31 111.27 179.204 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 69.0 mt -57.86 -39.79 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 122.984 0.513 . . . . 63.34 110.704 174.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 11' ' ' LEU . . . . . 0.509 HD13 HG23 ' C' ' 22' ' ' ILE . 67.9 mt -79.92 -17.13 53.85 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 122.898 0.479 . . . . 45.45 112.068 176.059 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.66 26.7 45.22 Favored Glycine 0 CA--C 1.537 1.445 0 N-CA-C 113.887 0.315 . . . . 64.33 113.887 -178.175 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 12.3 m -120.0 156.83 54.11 Favored Pre-proline 0 CA--C 1.555 1.167 0 C-N-CA 124.76 1.224 . . . . 64.04 110.069 178.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.62 164.03 36.79 Favored 'Trans proline' 0 C--N 1.383 2.357 0 C-N-CA 122.85 2.366 . . . . 74.43 112.283 177.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -70.03 8.06 0.82 Allowed 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 114.068 1.136 . . . . 71.52 114.068 -174.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -128.01 16.13 6.79 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.508 0.723 . . . . 71.24 109.432 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.5 123.44 19.23 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.354 1.062 . . . . 71.14 110.788 178.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 76.0 p -74.0 177.18 5.83 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.303 0.641 . . . . 74.41 111.003 -177.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.46 -55.44 21.92 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 124.269 1.028 . . . . 74.45 111.191 -171.427 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -67.9 -29.11 68.12 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.393 0.677 . . . . 64.05 112.008 -174.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -71.16 -47.37 58.14 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-O 121.12 0.486 . . . . 73.42 110.682 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 22' ' ' ILE . . . . . 0.767 HD13 ' HB3' ' C' ' 57' ' ' LEU . 82.3 mt -57.89 -44.01 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 124.447 1.099 . . . . 61.32 110.27 172.334 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 23' ' ' LYS . . . . . 0.446 ' HG2' ' HE2' ' C' ' 27' ' ' LYS . 79.1 tttt -66.35 -35.86 81.43 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 113.723 -1.58 . . . . 74.13 111.257 -176.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 27.2 mtm180 -78.95 -33.84 44.96 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 123.323 0.649 . . . . 73.52 111.463 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.98 -44.61 95.56 Favored 'General case' 0 C--O 1.257 1.482 0 CA-C-O 121.812 0.815 . . . . 75.32 110.032 173.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 26' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -60.95 -57.89 10.72 Favored 'General case' 0 C--O 1.201 -1.48 0 CA-C-N 113.797 -1.547 . . . . 72.31 110.125 175.064 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 27' ' ' LYS . . . . . 0.446 ' HE2' ' HG2' ' C' ' 23' ' ' LYS . 49.9 mtmt -54.8 -35.55 64.0 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 123.698 0.799 . . . . 74.1 111.142 -176.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 39.7 ttp180 -57.13 -57.77 11.14 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.026 0.531 . . . . 71.15 109.75 172.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 29' ' ' LEU . . . . . 0.623 ' HB3' HD13 ' C' ' 50' ' ' ILE . 95.5 mt -74.71 -14.84 60.78 Favored 'General case' 0 CA--C 1.557 1.229 0 CA-C-N 115.686 -0.688 . . . . 60.22 112.586 -177.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.32 -23.46 19.26 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.376 1.07 . . . . 75.32 111.129 -176.162 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -88.86 -35.98 16.25 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 109.041 -0.726 . . . . 73.5 109.041 171.299 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.45 -50.1 55.01 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 122.996 0.518 . . . . 71.12 109.759 -178.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -97.43 25.8 5.39 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.886 0.474 . . . . 70.15 111.178 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 34' ' ' HIS . . . . . . . . . . . . . 13.2 t-160 -59.92 106.87 0.83 Allowed Pre-proline 0 N--CA 1.487 1.406 0 CA-C-O 118.708 -0.663 . . . . 72.34 111.324 -173.252 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.06 -22.49 69.7 Favored 'Trans proline' 0 C--N 1.383 2.355 0 C-N-CA 123.351 2.701 . . . . 71.32 113.233 -172.414 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -70.08 -36.48 74.95 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.782 0.833 . . . . 60.34 111.094 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 62.1 t -98.81 -57.54 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 CA-C-O 121.676 0.75 . . . . 75.33 109.266 -179.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -94.0 79.49 4.1 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 124.836 1.254 . . . . 54.22 107.979 -178.494 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -75.59 78.85 2.59 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-N 113.738 -1.574 . . . . 62.24 109.196 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 26.7 m -132.54 107.09 13.1 Favored Pre-proline 0 C--O 1.236 0.352 0 N-CA-C 108.35 -0.981 . . . . 74.14 108.35 178.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 41' ' ' PRO . . . . . 0.431 ' O ' ' HG2' ' C' ' 45' ' ' GLU . 48.0 Cg_exo -42.02 -45.7 7.13 Favored 'Trans proline' 0 C--N 1.386 2.512 0 C-N-CA 123.814 3.009 . . . . 63.44 113.308 178.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -59.92 -41.16 91.14 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.672 0.789 . . . . 65.44 111.481 -179.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.89 -27.34 65.7 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 115.678 -0.692 . . . . 62.05 109.956 178.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 44' ' ' GLU . . . . . 0.473 ' O ' ' HG3' ' C' ' 48' ' ' LYS . 38.5 mt-10 -79.2 -27.72 42.58 Favored 'General case' 0 C--O 1.215 -0.759 0 O-C-N 123.827 0.704 . . . . 74.04 109.508 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 45' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' C' ' 41' ' ' PRO . 29.6 mm-40 -70.78 -48.08 56.16 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.636 0.774 . . . . 42.53 110.344 177.214 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 46' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -57.89 -42.77 85.32 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 114.8 -1.091 . . . . 72.32 109.484 172.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -65.62 -30.15 70.82 Favored 'General case' 0 C--O 1.213 -0.834 0 CA-C-N 115.04 -0.982 . . . . 62.23 111.202 178.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 48' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' C' ' 44' ' ' GLU . 92.8 mttt -64.89 -43.42 92.94 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.057 0.543 . . . . 72.04 110.384 174.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -61.9 -39.69 92.86 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.595 0.712 . . . . 72.33 111.221 177.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 50' ' ' ILE . . . . . 0.623 HD13 ' HB3' ' C' ' 29' ' ' LEU . 79.0 mt -67.35 -34.1 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 CA-C-N 115.018 -0.992 . . . . 75.43 110.468 173.496 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 51' ' ' ASN . . . . . 0.515 ' HB3' ' CD1' ' C' ' 88' ' ' PHE . 70.8 m-20 -76.92 -17.06 59.17 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.586 1.154 . . . . 74.04 111.408 177.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -75.48 -51.27 13.39 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 108.103 -1.073 . . . . 63.42 108.103 171.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 53' ' ' ALA . . . . . 0.437 ' HA ' ' HB3' ' C' ' 7' ' ' TYR . . . -55.3 -38.15 68.29 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 113.752 -1.567 . . . . 63.1 111.518 174.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -80.9 -29.87 35.55 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.132 0.973 . . . . 75.01 110.454 178.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.56 -28.21 66.93 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 123.17 0.588 . . . . 60.54 110.559 174.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 21.1 t -92.02 -45.31 14.34 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.166 0 CA-C-N 115.285 -0.871 . . . . 72.43 112.023 175.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 57' ' ' LEU . . . . . 0.767 ' HB3' HD13 ' C' ' 22' ' ' ILE . 87.3 mt -104.52 4.58 33.19 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 115.584 1.698 . . . . 75.02 115.584 -163.677 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 38.6 t -66.71 -74.55 0.11 Allowed 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 118.56 0.618 . . . . 62.42 112.414 -177.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -66.6 140.97 96.72 Favored Pre-proline 0 C--N 1.349 0.571 0 N-CA-C 108.7 -0.852 . . . . 72.03 108.7 176.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 60' ' ' PRO . . . . . 0.46 ' O ' ' HG2' ' C' ' 64' ' ' ARG . 18.1 Cg_endo -58.29 -27.75 82.05 Favored 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 122.067 1.845 . . . . 33.23 111.013 174.606 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -65.01 -52.23 57.24 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.541 0.736 . . . . 62.13 111.418 175.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 62' ' ' LYS . . . . . 0.557 ' HD3' ' HB3' ' C' ' 84' ' ' ASP . 46.4 mtmt -66.06 -36.49 83.35 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 121.163 0.506 . . . . 75.23 110.72 -178.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 45.0 ttt-85 -57.44 -46.06 84.0 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.14 -0.936 . . . . 64.42 108.74 175.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 64' ' ' ARG . . . . . 0.46 ' HG2' ' O ' ' C' ' 60' ' ' PRO . 24.0 mmt180 -68.75 -24.65 64.47 Favored 'General case' 0 C--O 1.213 -0.823 0 CA-C-N 115.442 -0.799 . . . . 74.15 111.999 177.046 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 65' ' ' ILE . . . . . 0.543 HG12 ' HG2' ' C' ' 76' ' ' PRO . 78.4 mt -60.89 -45.28 98.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 108.906 -0.776 . . . . 62.34 108.906 171.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -60.86 -51.38 69.57 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 115.146 -0.933 . . . . 74.22 109.95 174.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -58.01 -40.0 79.69 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.605 0.762 . . . . 73.14 111.862 -177.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 63.5 p -74.64 -24.83 58.89 Favored 'General case' 0 C--O 1.217 -0.615 0 CA-C-O 119.288 -0.387 . . . . 63.2 110.339 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -75.28 120.12 20.32 Favored 'General case' 0 C--N 1.356 0.868 0 N-CA-C 108.653 -0.869 . . . . 75.22 108.653 174.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.55 24.87 22.59 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.293 -0.723 . . . . 62.51 111.293 -169.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 56.8 m -145.62 -62.49 0.33 Allowed 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 103.269 -2.863 . . . . 72.34 103.269 171.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 23.6 m -85.1 148.67 26.02 Favored 'General case' 0 C--O 1.254 1.29 0 N-CA-C 105.458 -2.052 . . . . 73.35 105.458 157.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.94 -28.56 15.11 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.273 0.629 . . . . 73.23 110.703 176.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -87.56 136.97 32.43 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 123.594 0.757 . . . . 53.23 110.253 178.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -68.51 127.59 15.85 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.435 2.09 . . . . 75.14 110.495 175.115 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 76' ' ' PRO . . . . . 0.543 ' HG2' HG12 ' C' ' 65' ' ' ILE . 9.8 Cg_endo -51.87 132.87 43.8 Favored 'Trans proline' 0 C--N 1.387 2.602 0 C-N-CA 123.058 2.505 . . . . 63.14 111.741 177.469 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -48.08 128.54 16.94 Favored 'Trans proline' 0 C--N 1.387 2.585 0 C-N-CA 123.877 3.051 . . . . 51.51 114.101 -169.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 78' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -67.95 154.72 72.08 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 122.383 2.055 . . . . 74.44 111.574 178.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.97 156.39 39.14 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.398 2.065 . . . . 61.04 111.439 170.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -54.75 85.56 0.03 OUTLIER 'Trans proline' 0 C--N 1.388 2.645 0 C-N-CA 123.367 2.712 . . . . 51.5 113.13 177.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 153.17 -42.11 0.66 Allowed Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 114.032 -1.44 . . . . 75.2 110.492 -179.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 137.54 169.44 11.63 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-N 115.151 -0.525 . . . . 74.45 112.1 178.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -57.93 148.81 24.52 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.008 0.923 . . . . 70.14 110.36 172.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 84' ' ' ASP . . . . . 0.557 ' HB3' ' HD3' ' C' ' 62' ' ' LYS . 18.0 t0 -57.32 130.82 47.95 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 123.739 0.649 . . . . 63.13 111.88 -179.114 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 85' ' ' PHE . . . . . 0.497 ' CD1' ' HB2' ' C' ' 88' ' ' PHE . 0.3 OUTLIER -148.91 32.97 0.76 Allowed 'General case' 0 C--O 1.241 0.624 0 O-C-N 123.625 0.578 . . . . 74.41 111.543 -170.808 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 86' ' ' SER . . . . . 0.592 ' HA ' ' O ' ' C' ' 169' ' ' ASN . 18.3 m -70.89 93.75 1.0 Allowed 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.286 -0.87 . . . . 45.43 112.721 -169.532 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 86.62 10.02 74.01 Favored Glycine 0 C--N 1.346 1.112 0 CA-C-N 114.796 -1.093 . . . . 74.33 113.306 177.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 88' ' ' PHE . . . . . 0.525 ' HB3' ' HE2' ' C' ' 93' ' ' PHE . 10.2 m-85 -92.62 138.18 31.72 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 108.384 -0.969 . . . . 74.44 108.384 -176.55 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -84.32 76.63 10.1 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 122.029 -0.42 . . . . 72.23 110.799 -168.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 90' ' ' VAL . . . . . 0.414 HG23 HD22 ' C' ' 105' ' ' LEU . 4.2 p -43.46 -55.53 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 C-N-CA 125.177 1.391 . . . . 54.41 114.594 -176.286 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -70.76 -19.71 62.69 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.52 0.328 . . . . 74.21 111.813 -173.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -87.64 -23.0 24.38 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 110.221 -0.289 . . . . 75.53 110.221 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 93' ' ' PHE . . . . . 0.525 ' HE2' ' HB3' ' C' ' 88' ' ' PHE . 11.9 m-30 -72.35 171.86 11.42 Favored 'General case' 0 C--N 1.352 0.683 0 N-CA-C 113.314 0.857 . . . . 72.45 113.314 -168.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 49.7 m -60.24 150.51 29.93 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 114.288 -1.324 . . . . 45.51 112.463 -172.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 95' ' ' GLU . . . . . 0.425 ' O ' ' HG3' ' C' ' 99' ' ' GLU . 0.0 OUTLIER -66.38 -45.05 81.37 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.448 0.699 . . . . 55.43 110.854 -178.542 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 96' ' ' PHE . . . . . 0.451 ' HD1' ' HA ' ' C' ' 2' ' ' ALA . 33.2 t80 -52.09 -44.41 64.38 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.556 1.142 . . . . 65.02 110.946 172.423 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 97' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -66.56 -39.7 88.65 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 114.118 -1.401 . . . . 64.25 110.605 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -76.66 -9.7 58.85 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.644 0.778 . . . . 51.52 112.037 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 99' ' ' GLU . . . . . 0.425 ' HG3' ' O ' ' C' ' 95' ' ' GLU . 51.1 mt-10 -90.28 -47.02 8.03 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.916 0.486 . . . . 74.43 111.102 169.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 25.6 tp -66.6 -50.0 64.48 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.844 0.858 . . . . 73.23 110.808 -176.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -92.54 -1.23 57.09 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.664 -0.698 . . . . 73.25 111.257 177.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -45.47 -61.42 3.69 Favored Glycine 0 C--N 1.356 1.68 0 CA-C-O 118.769 -1.017 . . . . 54.11 114.704 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -46.66 -18.8 0.57 Allowed 'Trans proline' 0 C--N 1.391 2.808 0 C-N-CA 124.511 3.474 . . . . 62.02 114.735 179.173 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -150.62 53.32 0.5 Allowed Glycine 0 C--N 1.347 1.163 0 CA-C-O 119.894 -0.392 . . . . 43.23 112.728 177.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 105' ' ' LEU . . . . . 0.414 HD22 HG23 ' C' ' 90' ' ' VAL . 32.6 mt -67.4 20.74 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.268 0 N-CA-C 113.94 1.089 . . . . 73.03 113.94 172.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 69.99 -167.03 0.17 Allowed 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 126.687 1.995 . . . . 64.24 113.132 169.162 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . 106.54 -6.18 38.39 Favored Glycine 0 C--N 1.346 1.098 0 CA-C-N 115.958 -0.565 . . . . 51.05 111.775 -163.221 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 67.58 -125.86 23.81 Favored Glycine 0 C--N 1.347 1.17 0 N-CA-C 112.035 -0.426 . . . . 74.41 112.035 177.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 109' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -82.12 -8.2 59.65 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 122.88 0.472 . . . . 74.45 110.981 175.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 110' ' ' GLY . . . . . . . . . . . . . . . -89.95 -32.02 10.39 Favored Glycine 0 C--N 1.345 1.061 0 N-CA-C 111.929 -0.468 . . . . 54.22 111.929 177.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 111' ' ' ARG . . . . . 0.427 ' HD3' ' O ' ' C' ' 111' ' ' ARG . 0.5 OUTLIER 69.7 -18.03 0.22 Allowed 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 125.404 1.482 . . . . 75.25 112.908 176.749 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 112' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -78.98 18.19 0.66 Allowed 'General case' 0 CA--C 1.563 1.46 0 C-N-CA 123.985 0.914 . . . . 74.1 111.65 -174.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 113' ' ' SER . . . . . . . . . . . . . 53.5 m 50.32 38.04 16.73 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.514 0.725 . . . . 72.53 111.685 -177.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.03 -168.39 2.21 Favored 'General case' 0 C--O 1.21 -1.004 0 CA-C-N 115.491 -0.777 . . . . 74.05 110.816 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 115' ' ' LYS . . . . . 0.496 ' HA ' ' HD2' ' C' ' 170' ' ' PRO . 15.4 tptm -53.81 141.86 25.73 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.231 1.012 . . . . 54.14 112.892 -170.634 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 116' ' ' GLY . . . . . 0.429 ' HA3' ' N ' ' B' ' 204' ' ' ALA . . . -55.45 128.89 45.54 Favored Glycine 0 C--N 1.367 2.258 0 N-CA-C 110.197 -1.161 . . . . 45.25 110.197 167.311 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 117' ' ' ARG . . . . . 0.438 ' O ' ' HA2' ' C' ' 166' ' ' GLY . 49.8 ttp180 -88.19 116.62 26.52 Favored 'General case' 0 C--O 1.253 1.246 0 N-CA-C 108.96 -0.755 . . . . 64.44 108.96 177.02 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -40.8 120.58 1.32 Allowed 'General case' 0 N--CA 1.483 1.189 0 O-C-N 124.465 1.103 . . . . 75.42 109.908 175.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 119' ' ' LEU . . . . . . . . . . . . . 13.5 tp -94.81 154.36 17.3 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 118.687 -1.205 . . . . 75.21 108.289 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.451 ' HD2' ' HD3' ' B' ' 188' ' ' ARG . 0.0 OUTLIER -143.49 112.71 6.77 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 105.823 -1.917 . . . . 72.31 105.823 -175.403 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 121' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' B' ' 185' ' ' VAL . . . -132.38 116.52 16.95 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 109.002 -0.74 . . . . 63.21 109.002 -177.303 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 122' ' ' GLU . . . . . 0.504 ' HA ' ' O ' ' C' ' 177' ' ' VAL . 13.8 pt-20 -88.91 131.44 35.13 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 109.357 -0.609 . . . . 73.22 109.357 178.085 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 123' ' ' LEU . . . . . 0.7 ' HB2' ' HB ' ' B' ' 182' ' ' VAL . 2.6 pt? -134.86 124.37 16.63 Favored Pre-proline 0 N--CA 1.478 0.964 0 N-CA-C 111.89 0.33 . . . . 73.3 111.89 -170.212 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 124' ' ' PRO . . . . . 0.451 ' HD2' HG11 ' B' ' 182' ' ' VAL . 16.2 Cg_exo -68.95 117.84 5.29 Favored 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 122.924 2.416 . . . . 72.51 110.314 170.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 125' ' ' LEU . . . . . 0.487 HD23 HG11 ' C' ' 153' ' ' VAL . 42.9 tp -143.68 146.77 33.46 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 122.896 0.479 . . . . 74.03 109.785 -169.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 126' ' ' THR . . . . . 0.486 HG23 HD12 ' C' ' 181' ' ' LEU . 34.0 p -93.93 166.75 12.02 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.753 0.787 . . . . 61.53 110.379 171.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 127' ' ' LEU . . . . . 0.549 HD21 HD13 ' C' ' 180' ' ' LEU . 15.2 mt -71.25 -37.7 71.94 Favored 'General case' 0 C--O 1.249 1.065 0 CA-C-N 114.04 -1.436 . . . . 62.25 109.358 178.141 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 11.2 mp0 -61.36 -49.87 75.19 Favored 'General case' 0 C--O 1.216 -0.696 0 CA-C-N 113.085 -1.871 . . . . 75.24 109.134 178.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 129' ' ' GLU . . . . . 0.691 ' HA ' ' HB2' ' C' ' 132' ' ' HIS . 28.7 mm-40 -81.52 -7.48 59.59 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 123.848 0.717 . . . . 73.53 111.562 178.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -68.6 -46.34 69.58 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 109.478 -0.564 . . . . 64.34 109.478 166.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 131' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -67.11 -51.27 56.31 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 115.719 -0.673 . . . . 75.55 110.426 169.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 132' ' ' HIS . . . . . 0.691 ' HB2' ' HA ' ' C' ' 129' ' ' GLU . 30.6 m170 -74.06 -1.17 18.95 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.694 0.798 . . . . 60.22 111.604 -174.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -63.3 -101.37 0.01 OUTLIER Glycine 0 C--N 1.352 1.453 0 N-CA-C 111.365 -0.694 . . . . 65.31 111.365 165.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 134' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' C' ' 148' ' ' ARG . . . 53.74 -108.49 0.83 Allowed Glycine 0 C--N 1.349 1.253 0 N-CA-C 111.61 -0.596 . . . . 53.24 111.61 -177.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -77.13 95.99 4.38 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.173 -1.047 . . . . 71.2 108.173 174.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 136' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.29 138.53 47.88 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 123.755 0.822 . . . . 72.12 109.291 -174.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 137' ' ' VAL . . . . . . . . . . . . . 34.0 m -86.61 131.54 34.51 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 N-CA-C 109.181 -0.674 . . . . 71.12 109.181 174.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 138' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' C' ' 144' ' ' ARG . 7.6 p -133.96 143.74 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.22 1.008 . . . . 72.14 108.464 -176.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 139' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -123.47 82.99 2.07 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.237 0.541 . . . . 74.31 109.813 176.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 140' ' ' VAL . . . . . 0.563 HG11 ' HG2' ' C' ' 164' ' ' MET . 6.9 p -96.34 137.21 24.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 115.299 -0.864 . . . . 63.22 109.226 176.421 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 55.93 28.27 12.37 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 123.978 0.911 . . . . 15.23 111.701 -177.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 72.2 31.19 64.12 Favored Glycine 0 C--N 1.35 1.338 0 CA-C-N 116.343 -0.39 . . . . 45.25 113.394 -179.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 143' ' ' ARG . . . . . 0.551 ' NH1' ' HG ' ' B' ' 205' ' ' LEU . 55.5 ttt180 -128.03 104.3 7.71 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.561 0.744 . . . . 73.04 109.632 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 144' ' ' ARG . . . . . 0.419 ' HA ' ' O ' ' C' ' 138' ' ' VAL . 49.1 ttt180 -85.35 107.42 17.34 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.618 0.767 . . . . 71.51 110.845 -178.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 145' ' ' VAL . . . . . . . . . . . . . 22.7 t -123.05 140.98 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.534 0.734 . . . . 75.03 110.187 178.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 20.0 m -83.13 96.0 8.26 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 108.88 -0.785 . . . . 54.21 108.88 168.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 29.4 m -98.73 157.93 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 123.528 0.731 . . . . 72.53 109.839 -178.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 148' ' ' ARG . . . . . 0.461 HH22 ' HB3' ' C' ' 243' ' ' PRO . 62.8 ttt180 -116.73 94.5 4.63 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 108.638 -0.875 . . . . 74.22 108.638 167.518 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 149' ' ' ILE . . . . . . . . . . . . . 19.4 pt -79.03 150.94 75.54 Favored Pre-proline 0 N--CA 1.476 0.863 0 N-CA-C 107.818 -1.179 . . . . 71.41 107.818 170.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -53.82 120.85 8.56 Favored 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 122.092 1.861 . . . . 61.44 110.875 176.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -60.04 98.39 0.12 Allowed 'Trans proline' 0 C--N 1.386 2.515 0 C-N-CA 122.509 2.139 . . . . 73.2 110.204 177.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 152' ' ' GLY . . . . . 0.433 ' HA2' ' CZ ' ' C' ' 240' ' ' PHE . . . 147.63 145.34 4.16 Favored Glycine 0 C--N 1.347 1.18 0 CA-C-N 115.943 -0.572 . . . . 54.32 113.35 -172.3 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 153' ' ' VAL . . . . . 0.487 HG11 HD23 ' C' ' 125' ' ' LEU . 2.9 p -159.99 155.07 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.314 0 N-CA-C 112.708 0.633 . . . . 71.13 112.708 172.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 154' ' ' ARG . . . . . . . . . . . . . 16.7 ttm180 -120.72 132.07 54.87 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.626 1.57 . . . . 75.32 109.089 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 155' ' ' GLU . . . . . 0.579 ' HB2' HD12 ' C' ' 180' ' ' LEU . 8.3 tp10 -41.61 127.65 3.14 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 124.779 1.232 . . . . 74.51 112.887 175.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 74.04 0.76 57.6 Favored Glycine 0 C--N 1.352 1.429 0 N-CA-C 114.44 0.536 . . . . 64.51 114.44 173.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 157' ' ' SER . . . . . . . . . . . . . 36.1 t -92.71 155.52 17.65 Favored 'General case' 0 C--O 1.255 1.365 0 CA-C-O 121.519 0.676 . . . . 75.43 109.877 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 158' ' ' VAL . . . . . 0.578 HG12 HG22 ' C' ' 177' ' ' VAL . 29.7 m -99.54 122.0 50.84 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 CA-C-N 114.209 -1.36 . . . . 64.44 110.086 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 159' ' ' ILE . . . . . 0.664 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 31.7 mt -80.22 105.14 9.46 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 N-CA-C 107.198 -1.408 . . . . 52.25 107.198 170.711 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 62.0 ttm-85 -74.33 99.25 3.43 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 107.658 -1.238 . . . . 72.21 107.658 173.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 161' ' ' VAL . . . . . . . . . . . . . 2.4 p -117.48 101.97 52.28 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 124.301 1.041 . . . . 75.24 109.736 -178.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.69 145.46 81.41 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.106 1.87 . . . . 63.42 110.144 168.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 99.36 4.05 56.34 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-O 119.468 -0.629 . . . . 53.31 113.857 -176.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 164' ' ' MET . . . . . 0.588 ' SD ' HD23 ' C' ' 174' ' ' LEU . 19.1 ttm -144.42 5.75 1.25 Allowed 'General case' 0 CA--C 1.559 1.293 0 CA-C-N 117.668 0.734 . . . . 73.35 112.698 -174.236 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . -129.43 177.56 17.93 Favored Glycine 0 N--CA 1.488 2.143 0 CA-C-O 118.421 -1.211 . . . . 64.24 113.203 177.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 166' ' ' GLY . . . . . 0.954 ' HA3' ' HA ' ' B' ' 204' ' ' ALA . . . 98.28 106.11 2.54 Favored Glycine 0 C--N 1.364 2.087 0 CA-C-N 119.636 1.718 . . . . 75.44 116.366 176.502 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 167' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -99.98 100.18 11.04 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 105.87 -1.9 . . . . 64.31 105.87 160.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . 163.12 -139.11 5.7 Favored Glycine 0 C--O 1.208 -1.521 0 CA-C-O 119.188 -0.784 . . . . 13.44 112.521 -169.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 169' ' ' ASN . . . . . 0.623 ' HB3' ' HD3' ' C' ' 170' ' ' PRO . 2.1 t30 -145.3 -66.05 0.02 OUTLIER Pre-proline 0 CA--C 1.574 1.87 0 CA-C-O 116.846 -1.55 . . . . 62.44 111.254 -176.107 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 170' ' ' PRO . . . . . 0.623 ' HD3' ' HB3' ' C' ' 169' ' ' ASN . 73.9 Cg_exo -54.12 142.45 66.43 Favored 'Trans proline' 0 C--N 1.405 3.528 0 CA-C-N 124.046 2.481 . . . . 51.41 112.897 174.061 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 171' ' ' PRO . . . . . 0.541 ' HA ' ' HB3' ' B' ' 204' ' ' ALA . 60.9 Cg_endo -85.18 150.55 10.7 Favored 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 123.424 2.749 . . . . 74.02 115.22 -161.013 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 172' ' ' GLY . . . . . 0.556 ' HA3' ' H ' ' B' ' 203' ' ' ASN . . . -160.96 -109.3 0.24 Allowed Glycine 0 C--N 1.357 1.71 0 CA-C-O 118.629 -1.095 . . . . 74.42 113.495 177.262 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 173' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -173.56 171.94 3.76 Favored 'General case' 0 C--O 1.263 1.785 0 CA-C-O 123.782 1.753 . . . . 74.51 115.19 -168.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 174' ' ' LEU . . . . . 0.588 HD23 ' SD ' ' C' ' 164' ' ' MET . 9.9 tp -110.89 143.25 41.81 Favored 'General case' 0 C--N 1.353 0.723 0 CA-C-N 112.008 -2.36 . . . . 75.22 108.934 170.143 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 175' ' ' LEU . . . . . 0.439 ' HB3' ' HB ' ' C' ' 158' ' ' VAL . 72.1 mt -106.97 95.68 5.89 Favored 'General case' 0 C--O 1.249 1.036 0 N-CA-C 108.054 -1.091 . . . . 71.32 108.054 171.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 176' ' ' LEU . . . . . 0.664 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 67.5 mt -72.61 101.14 2.95 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.767 -0.651 . . . . 43.02 109.913 175.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 177' ' ' VAL . . . . . 0.578 HG22 HG12 ' C' ' 158' ' ' VAL . 25.3 t -82.67 96.94 3.95 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 N-CA-C 107.701 -1.222 . . . . 74.43 107.701 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 178' ' ' VAL . . . . . 0.475 HG21 HG11 ' C' ' 153' ' ' VAL . 8.5 p -72.99 135.45 27.68 Favored 'Isoleucine or valine' 0 C--O 1.248 1.003 0 CA-C-O 121.938 0.875 . . . . 74.01 111.62 -172.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 179' ' ' ARG . . . . . 0.416 ' O ' ' HA ' ' C' ' 124' ' ' PRO . 35.3 mmt180 -110.57 94.55 5.06 Favored 'General case' 0 C--O 1.243 0.717 0 N-CA-C 106.596 -1.631 . . . . 72.33 106.596 171.564 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 180' ' ' LEU . . . . . 0.579 HD12 ' HB2' ' C' ' 155' ' ' GLU . 80.0 mt -69.17 136.5 52.2 Favored 'General case' 0 C--N 1.351 0.631 0 CA-C-O 120.981 0.419 . . . . 70.51 110.462 178.572 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 181' ' ' LEU . . . . . 0.486 HD12 HG23 ' C' ' 126' ' ' THR . 98.7 mt -72.88 165.21 54.51 Favored Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 123.806 0.842 . . . . 74.2 111.234 -173.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -53.84 80.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.391 2.78 0 C-N-CA 123.154 2.569 . . . . 64.12 112.478 169.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 183' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -172.93 60.72 0.26 Allowed Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 126.165 1.786 . . . . 62.13 106.373 -175.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 184' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -82.51 65.38 8.21 Favored 'Trans proline' 0 C--N 1.384 2.397 0 C-N-CA 123.066 2.511 . . . . 71.54 111.293 -176.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 185' ' ' VAL . . . . . . . . . . . . . 17.8 t -95.45 -36.75 6.94 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.593 0 CA-C-N 115.705 -0.68 . . . . 72.23 109.248 -177.087 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 186' ' ' PHE . . . . . 0.408 ' HD1' ' HB2' ' C' ' 195' ' ' ALA . 38.0 m-85 -133.38 157.39 45.66 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.287 1.035 . . . . 61.44 110.825 -178.554 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 187' ' ' ARG . . . . . 0.434 ' HE ' ' HB3' ' C' ' 155' ' ' GLU . 35.8 ttt180 -150.73 131.82 14.37 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 108.967 -0.753 . . . . 75.14 108.967 168.037 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 188' ' ' LEU . . . . . 0.594 HD13 ' HD2' ' C' ' 240' ' ' PHE . 39.5 tp -79.93 146.83 31.9 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 114.266 1.21 . . . . 74.14 114.266 -168.162 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -139.79 100.6 3.99 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 126.157 1.783 . . . . 71.33 106.907 165.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 70.88 -95.9 0.57 Allowed Glycine 0 N--CA 1.477 1.375 0 CA-C-N 116.495 -0.32 . . . . 74.2 112.597 -176.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 191' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -124.4 -14.08 6.99 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.423 1.089 . . . . 60.21 109.805 169.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -84.38 153.53 23.39 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.397 0.679 . . . . 65.13 109.456 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 193' ' ' LEU . . . . . 0.524 HD21 ' CE2' ' C' ' 240' ' ' PHE . 89.1 mt -117.32 156.27 28.11 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.26 0.553 . . . . 52.2 111.636 -173.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 194' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -121.44 109.45 14.87 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 107.199 -1.408 . . . . 75.43 107.199 168.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 195' ' ' ALA . . . . . 0.633 ' HB3' ' HG ' ' C' ' 251' ' ' LEU . . . -111.42 -177.56 3.23 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 123.576 0.75 . . . . 65.11 111.578 -175.142 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 38.8 m -136.05 118.48 15.77 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.293 -0.867 . . . . 51.32 109.572 170.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 197' ' ' LEU . . . . . 0.431 HD13 ' HB2' ' C' ' 212' ' ' ALA . 51.4 tp -98.25 136.38 38.53 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.428 0.691 . . . . 73.5 109.758 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 198' ' ' ASP . . . . . 0.463 ' HB3' HG21 ' C' ' 256' ' ' THR . 66.9 m-20 -101.83 102.0 12.54 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 109.122 -0.696 . . . . 44.52 109.122 179.229 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 199' ' ' VAL . . . . . 0.401 HG22 HG21 ' C' ' 210' ' ' VAL . 21.4 t -107.05 117.15 57.17 Favored Pre-proline 0 N--CA 1.473 0.72 0 N-CA-C 108.41 -0.959 . . . . 61.21 108.41 178.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 200' ' ' PRO . . . . . 0.495 ' HD2' HG11 ' C' ' 210' ' ' VAL . 45.4 Cg_endo -69.49 151.76 70.66 Favored 'Trans proline' 0 C--N 1.371 1.718 0 C-N-CA 122.001 1.801 . . . . 71.34 111.81 175.08 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 201' ' ' ALA . . . . . . . . . . . . . . . -54.65 -47.16 98.74 Favored Pre-proline 0 CA--C 1.564 1.489 0 N-CA-C 114.425 1.268 . . . . 74.35 114.425 -171.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 202' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -54.49 -51.37 10.65 Favored 'Trans proline' 0 C--N 1.384 2.41 0 C-N-CA 121.813 1.675 . . . . 63.15 112.916 175.133 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 203' ' ' ILE . . . . . 0.459 HG21 HG13 ' C' ' 210' ' ' VAL . 53.9 mt -64.92 -32.86 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.303 0.641 . . . . 63.4 111.032 -178.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -63.72 -48.07 78.55 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.737 0.815 . . . . 75.02 111.187 178.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 205' ' ' VAL . . . . . . . . . . . . . 79.5 t -69.35 -43.26 81.19 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 CA-C-N 115.125 -0.943 . . . . 63.41 112.315 -176.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 206' ' ' VAL . . . . . 0.455 HG23 ' HE2' ' A' ' 270' ' ' LYS . 9.1 p -79.26 -36.19 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 123.248 0.343 . . . . 52.12 111.715 -176.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 82.21 71.77 1.29 Allowed Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.773 -0.649 . . . . 63.21 111.912 -168.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -100.81 -128.32 6.33 Favored Glycine 0 C--N 1.342 0.907 0 N-CA-C 111.249 -0.74 . . . . 51.32 111.249 176.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 209' ' ' LYS . . . . . 0.484 ' HG2' ' HA ' ' C' ' 222' ' ' ALA . 8.5 mtmp? -140.7 143.62 35.15 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.207 0.603 . . . . 72.12 110.424 174.056 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 210' ' ' VAL . . . . . 0.495 HG11 ' HD2' ' C' ' 200' ' ' PRO . 30.4 m -135.18 149.93 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 124.453 1.101 . . . . 62.05 108.207 172.399 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 211' ' ' ARG . . . . . 0.406 HH11 ' HB2' ' C' ' 218' ' ' PRO . 8.1 tmm_? -94.94 126.63 40.41 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 122.74 0.416 . . . . 72.44 111.033 -175.628 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 212' ' ' ALA . . . . . 0.431 ' HB2' HD13 ' C' ' 197' ' ' LEU . . . -96.92 118.73 33.98 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 107.201 -1.407 . . . . 74.43 107.201 167.41 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 213' ' ' MET . . . . . . . . . . . . . 4.3 tmm? -76.68 104.96 7.46 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 108.445 -0.946 . . . . 63.12 108.445 -178.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.49 168.74 10.0 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.857 0.837 . . . . 54.24 110.561 -176.321 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 215' ' ' LEU . . . . . . . . . . . . . 14.6 mt -71.53 -32.34 68.05 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 113.636 -1.62 . . . . 44.41 111.66 -168.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.28 17.75 19.93 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 114.813 -1.085 . . . . 71.0 111.366 -177.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 144.92 164.51 10.65 Favored Glycine 0 C--N 1.355 1.587 0 CA-C-O 119.685 -0.509 . . . . 64.11 112.521 176.039 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 218' ' ' PRO . . . . . 0.406 ' HB2' HH11 ' C' ' 211' ' ' ARG . 94.6 Cg_endo -84.12 113.37 1.8 Allowed 'Trans proline' 0 CA--C 1.552 1.397 0 C-N-CA 122.633 2.222 . . . . 52.13 112.027 177.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 219' ' ' VAL . . . . . . . . . . . . . 12.1 p -93.62 130.65 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 109.941 -0.392 . . . . 52.53 109.941 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 220' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -98.33 105.74 17.93 Favored 'General case' 0 C--N 1.349 0.559 0 N-CA-C 109.184 -0.673 . . . . 72.32 109.184 176.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 221' ' ' VAL . . . . . 0.511 HG11 HD21 ' C' ' 233' ' ' LEU . 70.7 t -73.14 131.74 34.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 125.236 1.414 . . . . 74.03 112.35 -177.033 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 222' ' ' ALA . . . . . 0.484 ' HA ' ' HG2' ' C' ' 209' ' ' LYS . . . -81.19 108.1 14.55 Favored 'General case' 0 CA--C 1.548 0.887 0 O-C-N 123.91 0.756 . . . . 73.3 110.247 169.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 83.7 t -81.85 136.19 48.0 Favored Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 124.87 1.268 . . . . 73.11 109.697 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 224' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -83.81 160.2 14.09 Favored 'Trans proline' 0 C--N 1.383 2.366 0 C-N-CA 123.019 2.479 . . . . 54.33 111.8 172.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -62.09 140.3 83.29 Favored 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 122.292 1.995 . . . . 74.0 111.4 174.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 226' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? 63.31 68.14 0.62 Allowed 'General case' 0 N--CA 1.477 0.883 0 O-C-N 124.243 0.964 . . . . 70.15 110.635 -178.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 227' ' ' THR . . . . . 0.442 ' O ' HG12 ' A' ' 257' ' ' ILE . 16.8 m -93.44 115.17 27.7 Favored 'General case' 0 C--O 1.219 -0.521 0 C-N-CA 123.051 0.54 . . . . 70.3 109.729 176.522 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 228' ' ' GLN . . . . . 0.546 ' H ' ' HD2' ' C' ' 231' ' ' ARG . 2.8 mp0 -89.57 151.36 21.97 Favored 'General case' 0 C--O 1.246 0.895 0 C-N-CA 124.521 1.128 . . . . 74.32 111.94 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -72.17 108.42 5.34 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 113.914 -1.494 . . . . 62.12 109.016 174.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 121.0 1.22 11.53 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 119.215 -0.77 . . . . 62.04 113.569 -176.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 231' ' ' ARG . . . . . 0.546 ' HD2' ' H ' ' C' ' 228' ' ' GLN . 19.3 mtp180 -71.53 -179.78 2.68 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 118.107 0.953 . . . . 74.12 110.872 172.34 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 232' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' C' ' 251' ' ' LEU . 31.7 ttmt -143.27 144.88 32.31 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.38 0.609 . . . . 71.45 111.76 -176.115 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 233' ' ' LEU . . . . . 0.683 HD13 ' HB2' ' C' ' 251' ' ' LEU . 5.3 mp -114.05 156.98 23.14 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.198 1.399 . . . . 74.21 109.986 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 20.9 ptt180 -129.92 86.11 2.37 Favored 'General case' 0 CA--C 1.553 1.081 0 O-C-N 124.948 1.405 . . . . 72.34 109.19 170.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 235' ' ' LEU . . . . . 0.567 HD22 ' H ' ' B' ' 240' ' ' GLY . 59.6 mt -83.36 98.62 9.56 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 108.464 -0.939 . . . . 73.43 108.464 173.213 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -65.71 133.38 50.94 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.805 0.842 . . . . 71.55 111.273 -175.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 237' ' ' GLY . . . . . 0.405 ' O ' ' HD3' ' C' ' 246' ' ' ARG . . . 77.24 7.29 86.85 Favored Glycine 0 C--N 1.348 1.207 0 O-C-N 123.444 0.465 . . . . 71.42 114.058 179.246 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -105.95 16.3 25.31 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.279 0.632 . . . . 72.03 111.603 -177.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -78.6 -135.06 0.95 Allowed Glycine 0 C--N 1.348 1.214 0 N-CA-C 111.285 -0.726 . . . . 31.21 111.285 170.18 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 240' ' ' PHE . . . . . 0.594 ' HD2' HD13 ' C' ' 188' ' ' LEU . 48.2 m-85 -97.59 116.53 65.82 Favored Pre-proline 0 C--O 1.247 0.964 0 N-CA-C 109.201 -0.666 . . . . 75.14 109.201 168.237 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 241' ' ' PRO . . . . . 0.432 ' HA ' ' HG2' ' C' ' 246' ' ' ARG . 48.9 Cg_exo -59.13 99.99 0.12 Allowed 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 123.446 2.764 . . . . 70.21 113.071 169.46 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -82.82 159.32 37.87 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-N 114.428 -1.26 . . . . 70.14 111.927 175.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 243' ' ' PRO . . . . . 0.461 ' HB3' HH22 ' C' ' 148' ' ' ARG . 59.4 Cg_endo -70.16 -1.71 9.25 Favored 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 122.89 2.394 . . . . 71.42 113.688 -179.586 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -119.47 -10.98 9.56 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.549 0.74 . . . . 71.42 111.425 176.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 158.22 157.86 8.69 Favored Glycine 0 C--N 1.346 1.116 0 N-CA-C 112.147 -0.381 . . . . 51.32 112.147 -178.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 246' ' ' ARG . . . . . 0.432 ' HG2' ' HA ' ' C' ' 241' ' ' PRO . 41.8 mtt180 -85.89 146.47 26.7 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.733 0.813 . . . . 61.31 111.576 -179.074 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -82.78 -172.23 48.1 Favored Glycine 0 C--N 1.35 1.349 0 N-CA-C 111.573 -0.611 . . . . 63.23 111.573 165.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -115.7 164.54 14.21 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 117.567 0.683 . . . . 73.54 109.886 -176.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 249' ' ' LEU . . . . . 0.551 HD23 HD12 ' C' ' 235' ' ' LEU . 34.2 tp -113.12 109.19 18.39 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 123.734 0.814 . . . . 74.23 109.08 177.145 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 250' ' ' TYR . . . . . 0.548 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 39.1 m-85 -102.0 103.14 13.74 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 108.97 -0.752 . . . . 71.43 108.97 177.542 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 251' ' ' LEU . . . . . 0.683 ' HB2' HD13 ' C' ' 233' ' ' LEU . 2.8 mp -96.78 147.56 23.8 Favored 'General case' 0 N--CA 1.505 2.275 0 N-CA-C 109.903 -0.406 . . . . 64.53 109.903 -173.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -107.53 137.67 45.14 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 108.883 -0.784 . . . . 73.41 108.883 169.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 253' ' ' VAL . . . . . 0.438 HG21 ' CZ3' ' B' ' 242' ' ' TRP . 45.8 t -89.68 142.59 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 113.377 0.88 . . . . 73.5 113.377 -169.132 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 254' ' ' ARG . . . . . . . . . . . . . 42.8 mtm180 -119.78 145.27 46.75 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.405 1.082 . . . . 74.13 108.255 163.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 255' ' ' ILE . . . . . 0.632 HG21 HG23 ' A' ' 257' ' ' ILE . 29.6 mm -98.32 123.46 50.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 107.958 -1.127 . . . . 75.24 107.958 169.199 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 256' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' C' ' 200' ' ' PRO . 0.5 OUTLIER -127.3 172.71 10.37 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.524 1.13 . . . . 53.32 109.215 -173.569 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 257' ' ' ILE . . . . . 0.448 HD12 ' H ' ' C' ' 259' ' ' GLU . 2.8 pp -136.91 157.53 74.6 Favored Pre-proline 0 CA--C 1.567 1.621 0 C-N-CA 124.124 0.969 . . . . 64.54 109.529 177.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -80.98 17.01 1.51 Allowed 'Trans proline' 0 C--N 1.384 2.404 0 C-N-CA 122.775 2.317 . . . . 73.21 114.209 -167.213 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 259' ' ' GLU . . . . . 0.448 ' H ' HD12 ' C' ' 257' ' ' ILE . 31.8 mt-10 55.32 -83.45 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.507 1.123 . . . . 72.3 110.547 -164.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 260' ' ' ARG . . . . . 0.416 ' HG2' ' H ' ' C' ' 260' ' ' ARG . 2.4 ptp85 -78.68 134.75 37.09 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 124.312 1.045 . . . . 73.41 110.812 -174.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 261' ' ' LEU . . . . . 0.534 HD11 HG13 ' A' ' 205' ' ' VAL . 65.3 mt -113.54 154.17 27.56 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 115.065 -0.971 . . . . 71.21 111.347 -170.381 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 52.7 p -83.74 164.05 46.38 Favored Pre-proline 0 CA--C 1.555 1.14 0 N-CA-C 108.31 -0.996 . . . . 61.23 108.31 169.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -51.05 -42.31 53.36 Favored 'Trans proline' 0 C--N 1.382 2.298 0 C-N-CA 122.417 2.078 . . . . 74.2 112.933 173.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -57.82 -58.14 9.68 Favored 'General case' 0 C--O 1.252 1.213 0 C-N-CA 124.058 0.943 . . . . 71.04 110.316 178.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -48.01 -67.22 0.29 Allowed 'General case' 0 C--N 1.357 0.91 0 O-C-N 125.056 1.473 . . . . 65.11 109.999 177.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 266' ' ' GLU . . . . . 0.616 ' HG2' ' HA ' ' B' ' 468' ' ' LEU . 8.3 tp10 -49.18 -51.33 33.29 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.2 1.4 . . . . 64.21 111.838 -171.012 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -60.7 -49.11 78.84 Favored 'General case' 0 C--O 1.257 1.479 0 CA-C-N 115.582 -0.736 . . . . 70.32 112.012 -177.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 268' ' ' LEU . . . . . 0.412 ' O ' ' HG ' ' C' ' 272' ' ' LEU . 7.6 mp -65.39 -38.3 89.58 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.428 -0.806 . . . . 52.44 110.906 -178.57 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 73.1 m95 -58.41 -41.72 85.58 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.103 0.561 . . . . 61.11 110.693 175.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 270' ' ' LYS . . . . . 0.524 ' HE2' ' HG3' ' C' ' 266' ' ' GLU . 68.3 mmtt -56.08 -51.53 67.53 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 123.327 0.392 . . . . 75.43 110.134 176.464 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -56.45 -43.63 79.69 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 114.872 -1.058 . . . . 75.33 111.541 -178.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 272' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' C' ' 268' ' ' LEU . 82.8 mt -65.83 -41.1 92.2 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.14 -0.937 . . . . 74.33 110.656 -179.065 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -59.17 -42.68 91.37 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.758 0.423 . . . . 34.13 110.431 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -63.26 -38.99 93.32 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.23 0.612 . . . . 63.21 111.28 176.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -61.69 -30.04 70.49 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.037 0.535 . . . . 70.04 111.366 174.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 276' ' ' TYR . . . . . 0.401 ' HE1' ' HB2' ' A' ' 200' ' ' PRO . 2.6 m-85 -78.68 -33.86 46.63 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.04 0.536 . . . . 75.52 112.042 176.273 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -63.14 -32.53 73.94 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 120.993 0.425 . . . . 44.24 109.955 170.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -68.48 -14.21 62.85 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 123.587 0.755 . . . . 55.2 112.066 175.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 279' ' ' ARG . . . . . . . . . . . . . 42.4 mtm180 -83.86 -16.26 45.11 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 122.749 0.419 . . . . 71.52 110.394 174.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.628 0 N-CA-C 108.268 -1.012 . . . . 75.14 108.268 173.582 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.0 mmt . . . . . 0 N--CA 1.478 0.971 0 N-CA-C 108.594 -0.891 . . . . 64.12 108.594 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.66 33.04 21.84 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.707 1.203 . . . . 51.4 111.603 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -86.14 57.23 4.37 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.272 0.629 . . . . 74.04 111.0 -176.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -36.48 100.74 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 125.6 1.56 . . . . 62.43 114.135 -175.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.472 ' HG2' ' HB3' ' A' ' 96' ' ' PHE . 70.5 mmtt -93.44 94.32 8.63 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 107.907 -1.145 . . . . 74.32 107.907 171.158 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.41 ' O ' HG13 ' A' ' 10' ' ' ILE . 49.3 t0 -69.37 95.71 0.82 Allowed 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 107.305 -1.368 . . . . 61.41 107.305 173.09 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -61.82 -35.32 77.89 Favored 'General case' 0 C--O 1.244 0.803 0 O-C-N 124.121 0.888 . . . . 73.34 112.252 -171.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -65.04 -45.91 83.47 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.079 -0.51 . . . . 73.33 110.045 177.111 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.01 -37.86 84.02 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 123.435 0.459 . . . . 60.32 111.119 179.145 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.41 HG13 ' O ' ' A' ' 6' ' ' ASP . 68.3 mt -61.7 -39.58 83.73 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 C-N-CA 123.367 0.667 . . . . 74.23 110.318 175.651 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 92.9 mt -80.3 -5.52 56.42 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 112.543 0.572 . . . . 51.33 112.543 176.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.23 34.24 58.23 Favored Glycine 0 C--N 1.354 1.577 0 O-C-N 123.146 0.279 . . . . 53.33 113.396 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 23.8 m -133.23 158.77 74.91 Favored Pre-proline 0 CA--C 1.559 1.295 0 C-N-CA 124.853 1.261 . . . . 71.43 109.622 -177.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -75.3 166.55 28.63 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 122.417 2.078 . . . . 50.12 112.145 176.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -70.49 9.84 0.57 Allowed 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 113.706 1.002 . . . . 75.43 113.706 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -116.86 -1.19 12.07 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.493 1.117 . . . . 64.11 108.897 -177.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.63 121.73 14.62 Favored 'General case' 0 C--N 1.347 0.492 0 C-N-CA 124.477 1.111 . . . . 64.31 110.133 176.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.7 p -75.07 173.0 11.35 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.543 0.737 . . . . 71.11 110.931 -176.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -58.02 -33.11 68.61 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.796 0.839 . . . . 64.21 110.801 178.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.448 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 16.9 tp10 -58.0 -49.57 76.37 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.149 0.98 . . . . 72.43 110.567 171.54 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -70.68 -30.01 66.47 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.477 0.711 . . . . 64.03 111.85 -176.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.4 mp -69.25 -39.93 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 123.718 0.807 . . . . 73.31 109.213 174.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -64.0 -42.52 97.13 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 124.122 0.889 . . . . 71.24 110.357 178.242 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.52 ' HA ' ' HD3' ' A' ' 27' ' ' LYS . 66.2 mtm180 -68.69 -44.72 73.38 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.087 0.555 . . . . 54.12 110.849 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.2 -40.31 89.6 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.434 -0.803 . . . . 64.0 110.243 177.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -64.92 -47.73 76.67 Favored 'General case' 0 C--O 1.201 -1.486 0 CA-C-N 115.164 -0.926 . . . . 73.1 110.6 177.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.52 ' HD3' ' HA ' ' A' ' 24' ' ' ARG . 25.4 mtpp -50.07 -47.74 53.47 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 123.674 0.789 . . . . 74.22 110.428 178.401 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.436 ' HA ' ' NH2' ' A' ' 31' ' ' ARG . 8.1 tpt180 -56.52 -56.19 24.39 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 114.326 -1.306 . . . . 71.15 111.285 176.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.621 HD22 ' HE2' ' A' ' 33' ' ' TYR . 64.5 mt -82.62 -12.06 57.94 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.594 0.758 . . . . 74.11 112.297 -171.132 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 34' ' ' HIS . . . -93.37 -18.79 21.99 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.733 0.813 . . . . 63.3 110.015 179.106 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.436 ' NH2' ' HA ' ' A' ' 28' ' ' ARG . 48.8 mtm180 -84.96 -44.98 12.62 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 123.311 0.382 . . . . 72.33 110.204 165.088 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -67.5 -48.29 67.51 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.43 0.692 . . . . 63.33 111.03 -174.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.621 ' HE2' HD22 ' A' ' 29' ' ' LEU . 60.6 m-85 -102.9 24.82 10.11 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.169 0.588 . . . . 63.25 111.308 -176.01 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.486 ' CD2' ' HB3' ' A' ' 36' ' ' ASP . 48.8 t60 -71.09 102.05 0.44 Allowed Pre-proline 0 N--CA 1.482 1.141 0 C-N-CA 124.362 1.065 . . . . 63.41 110.726 -177.018 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.507 ' HB3' ' HG2' ' A' ' 44' ' ' GLU . 23.6 Cg_exo -62.06 -25.8 77.78 Favored 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 123.066 2.511 . . . . 74.13 113.29 -168.555 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.486 ' HB3' ' CD2' ' A' ' 34' ' ' HIS . 8.0 t70 -62.92 -40.18 96.83 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.117 1.367 . . . . 72.45 112.208 179.109 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 98.5 t -103.83 -44.7 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-O 121.431 0.634 . . . . 65.53 109.684 -177.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -98.44 83.1 2.97 Favored 'General case' 0 C--O 1.243 0.721 0 C-N-CA 124.344 1.057 . . . . 61.35 108.333 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -78.26 79.22 4.71 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.146 -0.934 . . . . 73.11 108.616 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 74.3 m -138.71 115.62 8.9 Favored Pre-proline 0 CA--C 1.542 0.671 0 CA-C-N 115.297 -0.865 . . . . 54.41 108.985 178.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_exo -46.15 -42.83 21.34 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 124.213 3.275 . . . . 72.23 114.353 -178.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -51.33 -49.82 60.64 Favored 'General case' 0 N--CA 1.482 1.161 0 O-C-N 124.245 0.966 . . . . 64.43 110.49 175.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.26 -26.85 67.54 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-N 114.676 -1.147 . . . . 72.14 111.602 -177.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.507 ' HG2' ' HB3' ' A' ' 35' ' ' PRO . 39.8 mt-10 -81.68 -34.48 30.67 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 122.86 0.464 . . . . 62.01 110.964 -173.041 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -82.3 -32.44 29.48 Favored 'General case' 0 C--O 1.246 0.897 0 N-CA-C 110.305 -0.257 . . . . 62.44 110.305 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 36.5 mmtm -62.54 -40.63 97.4 Favored 'General case' 0 C--N 1.348 0.502 0 CA-C-N 115.715 -0.675 . . . . 74.03 109.369 167.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -60.16 -38.63 83.74 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.555 0.742 . . . . 73.24 110.489 175.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -56.74 -57.49 12.2 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 120.793 0.33 . . . . 75.14 110.341 174.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -58.61 -41.43 85.85 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 115.151 -0.931 . . . . 71.44 111.786 -176.105 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.457 HD13 ' HB3' ' A' ' 29' ' ' LEU . 77.3 mt -74.33 -33.1 32.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.777 1.231 . . . . 70.53 111.217 -176.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -88.31 -10.58 49.04 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 119.237 -0.411 . . . . 73.43 111.28 179.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -75.89 -49.19 18.59 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 108.06 -1.089 . . . . 63.42 108.06 166.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -53.5 -46.9 70.21 Favored 'General case' 0 C--N 1.35 0.623 0 CA-C-N 113.625 -1.625 . . . . 65.45 111.307 174.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -69.05 -44.66 72.21 Favored 'General case' 0 C--O 1.216 -0.662 0 CA-C-N 115.026 -0.988 . . . . 72.32 110.618 177.15 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.409 ' HB2' ' CD2' ' A' ' 88' ' ' PHE . . . -50.1 -37.74 35.32 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.41 0.684 . . . . 53.01 112.224 -179.003 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 88.3 t -76.86 -57.74 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.971 0 CA-C-N 115.267 -0.878 . . . . 74.52 110.943 175.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 65.9 mt -87.22 6.04 35.12 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 113.619 0.97 . . . . 62.04 113.619 -166.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 37.2 t -73.03 -42.15 63.46 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 124.154 0.981 . . . . 74.34 111.349 -178.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -116.25 138.22 24.09 Favored Pre-proline 0 N--CA 1.471 0.579 0 CA-C-N 115.112 -0.949 . . . . 74.34 108.483 -171.022 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -58.61 -20.95 52.81 Favored 'Trans proline' 0 C--N 1.383 2.375 0 C-N-CA 123.844 3.029 . . . . 72.41 113.416 -172.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -66.6 -70.01 0.27 Allowed 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.622 0.769 . . . . 72.3 110.867 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt -67.22 -25.28 66.03 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.698 0.799 . . . . 74.54 110.894 -178.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -54.97 -56.92 14.34 Favored 'General case' 0 C--N 1.35 0.614 0 CA-C-N 114.791 -1.095 . . . . 74.11 109.702 169.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -58.13 -37.91 75.5 Favored 'General case' 0 C--N 1.364 1.236 0 O-C-N 123.784 0.677 . . . . 74.25 111.362 178.03 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.564 HG23 ' HG2' ' A' ' 76' ' ' PRO . 1.7 mp -54.31 -48.64 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 123.521 0.513 . . . . 64.42 110.997 175.431 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -69.72 -43.13 73.0 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 119.43 -0.319 . . . . 75.4 110.88 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -57.68 -39.95 78.3 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.156 0.582 . . . . 64.04 111.344 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 63.1 p -74.17 -25.5 59.76 Favored 'General case' 0 C--N 1.347 0.495 0 CA-C-N 115.617 -0.72 . . . . 75.13 110.6 177.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -72.86 136.41 45.32 Favored 'General case' 0 CA--C 1.551 0.983 0 N-CA-C 108.752 -0.833 . . . . 63.45 108.752 169.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.95 18.0 56.88 Favored Glycine 0 N--CA 1.471 1.007 0 N-CA-C 111.513 -0.635 . . . . 52.54 111.513 -171.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 34.9 m -144.33 -58.81 0.38 Allowed 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 103.415 -2.809 . . . . 71.23 103.415 176.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 51.3 m -80.93 142.82 33.14 Favored 'General case' 0 C--O 1.25 1.127 0 N-CA-C 105.411 -2.07 . . . . 74.23 105.411 156.17 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.67 -25.22 13.23 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.66 0.784 . . . . 74.04 110.637 178.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.98 143.19 77.29 Favored Pre-proline 0 C--O 1.245 0.843 0 C-N-CA 123.71 0.804 . . . . 75.1 110.094 175.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.416 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 34.0 Cg_endo -62.55 143.56 93.06 Favored 'Trans proline' 0 C--N 1.371 1.761 0 C-N-CA 122.224 1.95 . . . . 75.41 109.921 170.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.564 ' HG2' HG23 ' A' ' 65' ' ' ILE . 31.6 Cg_exo -59.98 144.37 99.47 Favored 'Trans proline' 0 C--N 1.371 1.741 0 C-N-CA 122.831 2.354 . . . . 74.25 112.293 -179.132 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.53 119.21 6.27 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 122.647 2.231 . . . . 62.44 111.421 176.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -65.74 134.35 37.45 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 122.76 2.307 . . . . 43.51 112.78 -173.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -72.92 145.49 40.34 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.387 2.058 . . . . 71.05 111.201 174.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -59.88 87.01 0.07 OUTLIER 'Trans proline' 0 C--N 1.384 2.402 0 C-N-CA 122.924 2.416 . . . . 51.35 111.605 178.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 155.26 -46.67 0.52 Allowed Glycine 0 C--N 1.332 0.308 0 N-CA-C 109.141 -1.584 . . . . 62.41 109.141 -176.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.489 ' HA3' ' HA ' ' A' ' 106' ' ' PHE . . . 117.01 -174.01 14.99 Favored Glycine 0 C--N 1.346 1.102 0 CA-C-N 115.575 -0.313 . . . . 53.03 113.55 174.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -92.78 130.45 38.39 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.825 0.85 . . . . 74.41 110.655 -178.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.65 158.19 30.63 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 124.464 1.103 . . . . 71.31 110.432 174.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -153.35 75.33 1.06 Allowed 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 107.93 -1.137 . . . . 70.22 107.93 177.504 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.511 ' HA ' ' HE3' ' A' ' 164' ' ' MET . 12.9 m -38.4 84.87 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 127.229 2.212 . . . . 74.44 116.536 -164.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 71.69 20.17 78.42 Favored Glycine 0 C--N 1.342 0.88 0 N-CA-C 114.791 0.676 . . . . 70.11 114.791 174.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.421 ' HB3' ' CE2' ' A' ' 93' ' ' PHE . 35.0 m-85 -122.04 135.87 54.87 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 123.62 0.768 . . . . 72.34 109.454 -174.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -74.9 88.47 2.32 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 115.842 -0.617 . . . . 71.44 111.22 -171.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.6 p -33.11 -47.9 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.562 1.426 0 C-N-CA 126.34 1.856 . . . . 75.21 113.529 169.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -64.76 -22.85 67.07 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.048 0.939 . . . . 75.33 111.984 -170.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -89.38 -27.74 20.24 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.216 0.606 . . . . 45.35 112.437 -178.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.421 ' CE2' ' HB3' ' A' ' 88' ' ' PHE . 40.1 m-85 -75.7 173.93 10.45 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 113.288 0.847 . . . . 71.01 113.288 -166.466 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 53.2 p -71.56 175.43 5.58 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 114.655 1.354 . . . . 74.5 114.655 -161.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -67.23 -50.64 59.95 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 113.562 -1.654 . . . . 74.31 110.374 -174.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.472 ' HB3' ' HG2' ' A' ' 5' ' ' LYS . 72.5 t80 -54.01 -41.06 67.55 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 124.48 1.113 . . . . 75.03 111.729 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -60.46 -51.97 67.2 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 115.384 -0.825 . . . . 63.23 110.121 172.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.527 ' HA ' HD11 ' A' ' 105' ' ' LEU . 46.8 mt-30 -70.04 -3.14 14.99 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.609 0.763 . . . . 73.05 112.281 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -98.29 -47.98 5.24 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.191 0.996 . . . . 70.02 111.684 170.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 52.8 tp -73.4 -50.77 20.05 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.394 0.678 . . . . 55.03 110.531 -172.056 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -90.11 -7.44 53.75 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.363 -0.835 . . . . 72.11 110.067 175.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.418 ' HA2' ' HG ' ' A' ' 105' ' ' LEU . . . -44.64 -59.1 4.42 Favored Glycine 0 C--N 1.364 2.096 0 CA-C-O 118.058 -1.412 . . . . 72.43 115.078 -178.078 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -40.56 -25.8 0.2 Allowed 'Trans proline' 0 C--N 1.391 2.809 0 C-N-CA 124.687 3.591 . . . . 23.1 115.739 178.089 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -149.11 54.79 0.5 Allowed Glycine 0 C--N 1.348 1.216 0 N-CA-C 111.461 -0.656 . . . . 44.4 111.461 177.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.527 HD11 ' HA ' ' A' ' 98' ' ' GLN . 13.4 mt -69.0 73.3 0.27 Allowed 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 117.468 0.634 . . . . 74.25 110.998 171.142 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.613 ' CG ' ' HA3' ' A' ' 168' ' ' GLY . 0.1 OUTLIER 43.97 -115.02 0.39 Allowed 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 125.639 1.576 . . . . 72.25 113.152 177.769 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.459 ' H ' ' HB3' ' A' ' 106' ' ' PHE . . . 60.8 20.86 57.65 Favored Glycine 0 C--N 1.36 1.863 0 CA-C-O 119.712 -0.493 . . . . 44.0 112.965 -168.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 57.19 -133.66 52.6 Favored Glycine 0 C--N 1.36 1.903 0 N-CA-C 111.577 -0.609 . . . . 71.34 111.577 -171.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -83.25 -7.51 59.59 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.715 0.406 . . . . 64.11 110.469 174.106 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -92.24 -10.99 60.34 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-O 119.018 -0.879 . . . . 55.25 114.17 -177.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 45.1 tpt85 58.76 5.55 0.5 Allowed 'General case' 0 N--CA 1.506 2.361 0 CA-C-N 118.137 0.968 . . . . 71.44 113.439 174.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -61.21 -21.42 63.83 Favored 'General case' 0 CA--C 1.562 1.429 0 C-N-CA 124.498 1.119 . . . . 73.25 113.721 -176.162 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 35.3 m 58.46 46.46 15.05 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.324 1.05 . . . . 74.21 110.546 -174.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.416 ' HD2' ' H ' ' A' ' 115' ' ' LYS . 2.0 tmm_? -92.63 156.37 17.14 Favored 'General case' 0 CA--C 1.553 1.072 0 CA-C-N 115.517 -0.765 . . . . 74.52 109.338 -173.487 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.416 ' H ' ' HD2' ' A' ' 114' ' ' ARG . 22.5 tptm -96.11 148.6 22.51 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.547 0.739 . . . . 72.15 110.953 -174.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.602 ' HA2' ' HA ' ' A' ' 170' ' ' PRO . . . -106.37 177.42 22.19 Favored Glycine 0 CA--C 1.5 -0.886 0 N-CA-C 122.751 3.86 . . . . 55.22 122.751 -162.658 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -120.97 150.18 41.51 Favored 'General case' 0 C--O 1.266 1.926 0 CA-C-N 111.197 -2.501 . . . . 71.34 110.034 175.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -66.21 149.95 49.54 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.837 1.255 . . . . 74.23 112.466 -174.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 10.0 tt -149.32 147.05 27.87 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.881 -0.785 . . . . 70.23 108.881 178.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.497 HH21 HG21 ' A' ' 177' ' ' VAL . 33.8 mtp-105 -94.26 122.76 37.13 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.011 0.524 . . . . 74.51 109.961 176.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.466 ' HB2' HD11 ' A' ' 174' ' ' LEU . . . -113.57 166.63 11.33 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.549 -0.908 . . . . 41.51 108.549 171.115 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -127.59 118.9 24.79 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.666 -1.235 . . . . 61.0 107.666 -174.085 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 25.4 tp -99.92 99.76 9.84 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 108.611 -0.885 . . . . 54.05 108.611 -169.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.493 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 56.3 Cg_endo -73.61 113.55 3.81 Favored 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 121.69 1.594 . . . . 75.33 108.637 176.04 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.553 ' HA ' HG21 ' B' ' 6' ' ' ILE . 28.0 tp -120.82 138.43 54.05 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 123.44 0.696 . . . . 64.01 109.848 -169.477 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.437 HG21 ' H ' ' B' ' 4' ' ' SER . 96.6 m -67.79 128.85 38.01 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 114.408 -1.269 . . . . 71.34 110.062 176.591 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.898 ' HB3' HD22 ' A' ' 215' ' ' LEU . 8.2 mt -54.8 -47.63 73.78 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 122.264 1.031 . . . . 70.54 111.914 -173.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.459 ' HG2' ' HA2' ' B' ' 96' ' ' GLY . 16.7 mp0 -62.28 -44.04 97.45 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 113.292 -1.776 . . . . 75.32 109.997 -177.019 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -76.57 -20.09 57.2 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 115.577 -0.738 . . . . 64.33 111.798 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.515 ' HB1' ' O ' ' A' ' 153' ' ' VAL . . . -69.26 -39.98 78.1 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.523 0.729 . . . . 41.43 109.636 175.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -75.78 -38.91 57.86 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 115.06 -0.973 . . . . 74.51 111.564 176.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 54.4 m170 -71.25 -35.51 71.45 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 122.565 0.346 . . . . 75.25 111.188 -178.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.94 -141.15 26.83 Favored Glycine 0 C--N 1.344 1.012 0 CA-C-N 116.069 -0.514 . . . . 71.54 113.039 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 84.09 -175.48 51.5 Favored Glycine 0 C--N 1.348 1.249 0 C-N-CA 123.254 0.454 . . . . 70.42 113.036 178.002 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.445 ' HB3' ' OG ' ' A' ' 146' ' ' SER . 1.2 mp0 -72.29 111.87 7.87 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.249 0.62 . . . . 73.14 109.588 174.399 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 8.3 tpp180 -93.65 119.32 32.52 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.246 0.618 . . . . 74.4 109.611 -178.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 74.9 t -81.65 105.37 11.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 108.326 -0.99 . . . . 71.24 108.326 175.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.0 p -124.99 123.33 65.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 C-N-CA 124.396 1.078 . . . . 73.14 108.44 176.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -121.2 146.63 46.58 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.119 0.568 . . . . 71.3 109.971 -177.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 11.0 p -160.4 131.66 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-N 115.5 -0.773 . . . . 75.1 109.509 -177.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 59.93 24.64 13.75 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 124.319 1.048 . . . . 74.24 112.007 -177.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 92.85 -24.65 23.17 Favored Glycine 0 C--N 1.355 1.627 0 CA-C-N 116.13 -0.486 . . . . 31.1 112.387 -176.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 66.1 ttp85 -74.52 99.81 3.7 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.772 0.829 . . . . 72.12 110.489 -177.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -89.97 116.13 27.79 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 123.674 0.79 . . . . 74.41 109.977 178.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.3 p -121.5 148.39 24.93 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 C-N-CA 123.993 0.917 . . . . 73.53 109.506 177.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.445 ' OG ' ' HB3' ' A' ' 135' ' ' GLU . 34.6 t -113.48 87.56 2.64 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.109 0.963 . . . . 31.45 109.035 179.628 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 29.6 m -83.83 112.51 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-N 116.093 -0.503 . . . . 73.42 109.729 -176.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.442 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 57.4 ttt85 -68.46 95.01 0.59 Allowed 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.329 0.585 . . . . 74.14 109.461 177.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.607 ' HB ' HG11 ' A' ' 153' ' ' VAL . 44.6 pt -81.45 138.13 48.16 Favored Pre-proline 0 CA--C 1.554 1.108 0 CA-C-N 114.896 -1.047 . . . . 74.13 109.506 178.624 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.401 ' HA ' ' HD3' ' A' ' 151' ' ' PRO . 56.2 Cg_endo -69.48 140.38 43.59 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 122.282 1.988 . . . . 60.34 111.525 177.01 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 150' ' ' PRO . 31.7 Cg_exo -61.07 93.53 0.11 Allowed 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 123.076 2.518 . . . . 74.15 111.913 174.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 138.59 -5.74 3.19 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-O 118.946 -0.919 . . . . 75.51 113.22 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.607 HG11 ' HB ' ' A' ' 149' ' ' ILE . 7.5 p -58.8 123.22 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 C-N-CA 123.767 0.827 . . . . 75.43 110.969 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.775 ' HD3' HD21 ' A' ' 193' ' ' LEU . 95.4 mtt180 -140.67 167.97 20.91 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 121.704 -0.622 . . . . 73.23 111.271 -173.228 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.514 ' HB3' ' H ' ' A' ' 188' ' ' LEU . 10.3 tp10 -35.62 118.46 0.48 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 126.977 2.111 . . . . 72.32 114.119 -172.115 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 107.95 -27.25 15.0 Favored Glycine 0 C--N 1.342 0.867 0 CA-C-O 119.398 -0.668 . . . . 14.21 112.92 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 30.7 t -59.6 112.51 1.82 Allowed 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.533 0.733 . . . . 74.23 110.133 -178.002 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 48.4 t -86.67 96.88 5.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 115.633 -0.712 . . . . 72.34 109.266 -179.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.593 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 65.8 mt -72.91 102.5 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 N-CA-C 108.409 -0.96 . . . . 75.24 108.409 171.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 51.9 ttt-85 -85.53 103.36 14.32 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.929 -0.578 . . . . 61.32 109.991 -175.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.473 HG13 ' HB3' ' A' ' 174' ' ' LEU . 4.4 p -120.64 116.81 31.64 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 122.895 0.478 . . . . 61.33 109.999 178.018 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.576 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 48.3 Cg_endo -68.86 175.77 6.92 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.573 2.182 . . . . 74.53 112.809 178.277 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 65.05 6.37 25.03 Favored Glycine 0 C--N 1.351 1.404 0 N-CA-C 115.787 1.075 . . . . 70.43 115.787 173.096 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.511 ' HE3' ' HA ' ' A' ' 86' ' ' SER . 64.1 mtt -131.44 -1.7 3.91 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 117.776 0.788 . . . . 64.15 112.796 -173.328 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -54.63 -89.11 0.01 OUTLIER Glycine 0 N--CA 1.487 2.091 0 N-CA-C 110.54 -1.024 . . . . 73.33 110.54 -176.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.588 ' O ' ' HA ' ' A' ' 171' ' ' PRO . . . -74.89 161.49 53.43 Favored Glycine 0 CA--C 1.541 1.689 0 N-CA-C 106.185 -2.766 . . . . 74.5 106.185 155.117 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.498 HE21 ' HA ' ' A' ' 167' ' ' GLN . 0.0 OUTLIER -102.7 99.67 9.67 Favored 'General case' 0 CA--C 1.56 1.339 0 CA-C-N 120.153 1.977 . . . . 75.42 113.61 -174.162 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.613 ' HA3' ' CG ' ' A' ' 106' ' ' PHE . . . 75.06 -19.68 2.13 Favored Glycine 0 C--N 1.363 2.076 0 N-CA-C 119.471 2.548 . . . . 64.21 119.471 158.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' ASN . . . . . 0.552 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . 10.8 t30 -107.8 -43.88 0.12 Allowed Pre-proline 0 C--N 1.319 -0.757 0 N-CA-C 105.111 -2.181 . . . . 63.11 105.111 164.122 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.602 ' HA ' ' HA2' ' A' ' 116' ' ' GLY . 97.2 Cg_endo -106.64 52.28 0.02 OUTLIER 'Trans proline' 0 CA--C 1.587 3.126 0 C-N-CA 122.361 2.041 . . . . 71.13 114.687 158.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.588 ' HA ' ' O ' ' A' ' 166' ' ' GLY . 59.0 Cg_endo -63.89 102.61 0.37 Allowed 'Trans proline' 1 C--N 1.43 4.855 0 C-N-CA 122.746 2.297 . . . . 71.25 110.997 -177.771 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -116.75 -169.63 15.24 Favored Glycine 0 N--CA 1.482 1.761 0 C-N-CA 120.665 -0.779 . . . . 72.4 114.677 -169.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.576 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 33.5 m-20 -79.33 105.84 10.93 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 108.725 -0.842 . . . . 71.14 108.725 169.763 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.473 ' HB3' HG13 ' A' ' 161' ' ' VAL . 20.8 tp -82.73 108.67 16.26 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.416 -0.811 . . . . 64.32 110.004 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 82.4 mt -85.93 93.68 9.0 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.764 -0.828 . . . . 72.12 108.764 175.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.593 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 92.2 mt -78.02 93.88 4.55 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-N 115.794 -0.639 . . . . 70.05 109.958 178.3 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.497 HG21 HH21 ' A' ' 120' ' ' ARG . 41.9 t -81.99 98.21 4.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 106.137 -1.801 . . . . 61.43 106.137 174.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 12.8 p -65.39 110.77 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-O 121.797 0.808 . . . . 70.33 110.101 -174.06 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.493 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 11.9 mmm-85 -91.32 127.45 36.75 Favored 'General case' 0 C--O 1.219 -0.509 0 N-CA-C 107.636 -1.246 . . . . 53.32 107.636 173.302 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.408 HD13 HD22 ' A' ' 127' ' ' LEU . 15.5 mt -91.16 147.33 23.13 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.806 -0.442 . . . . 72.4 109.806 176.518 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 89.3 mt -55.88 162.77 2.49 Favored Pre-proline 0 N--CA 1.487 1.395 0 C-N-CA 124.979 1.312 . . . . 73.14 113.841 -169.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.23 14.55 0.29 Allowed 'Trans proline' 0 C--N 1.395 2.987 0 C-N-CA 123.052 2.501 . . . . 71.42 113.696 173.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.414 ' HA ' ' HD3' ' A' ' 184' ' ' PRO . 66.2 t-80 -60.85 105.36 0.57 Allowed Pre-proline 0 CA--C 1.563 1.47 0 N-CA-C 106.317 -1.734 . . . . 73.35 106.317 165.544 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 183' ' ' HIS . 6.6 Cg_exo -72.13 28.24 0.26 Allowed 'Trans proline' 0 N--CA 1.506 2.222 0 C-N-CA 124.764 3.643 . . . . 61.24 118.161 -158.379 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 21.6 t -93.97 -57.95 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-N 119.583 1.083 . . . . 64.21 110.303 -172.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' PHE . . . . . 0.538 ' HB3' HD22 ' A' ' 193' ' ' LEU . 26.8 m-85 -124.81 155.82 38.79 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 112.815 0.672 . . . . 72.31 112.815 -169.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -147.39 99.18 3.1 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 106.076 -1.824 . . . . 75.51 106.076 171.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.514 ' H ' ' HB3' ' A' ' 155' ' ' GLU . 0.7 OUTLIER -78.83 158.03 28.25 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 122.736 0.415 . . . . 74.21 111.429 -175.356 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.441 ' HG2' ' HA ' ' B' ' 120' ' ' TYR . 26.6 tt0 -148.61 128.64 13.58 Favored 'General case' 0 C--O 1.247 0.937 0 N-CA-C 107.439 -1.319 . . . . 70.31 107.439 166.035 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.452 ' HA3' ' HB3' ' B' ' 120' ' ' TYR . . . 70.85 -82.38 0.41 Allowed Glycine 0 C--N 1.349 1.267 0 O-C-N 123.653 0.596 . . . . 65.41 112.716 -178.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.403 ' OE1' ' HD2' ' A' ' 243' ' ' PRO . 0.1 OUTLIER -147.63 -5.8 0.47 Allowed 'General case' 0 C--O 1.252 1.222 0 C-N-CA 123.19 0.596 . . . . 72.32 111.776 179.856 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -111.23 147.84 34.13 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 122.886 0.474 . . . . 72.32 111.262 -175.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.775 HD21 ' HD3' ' A' ' 154' ' ' ARG . 83.8 mt -93.54 137.25 33.01 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.191 0.996 . . . . 63.44 111.035 -177.149 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -105.74 103.37 12.86 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 108.063 -1.088 . . . . 73.14 108.063 165.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.495 ' HB3' HD23 ' A' ' 251' ' ' LEU . . . -103.15 172.55 6.75 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.285 1.034 . . . . 74.34 110.759 179.617 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 91.1 m -119.81 131.84 55.43 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.625 0.77 . . . . 70.21 108.956 171.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.436 ' HB2' HD22 ' A' ' 251' ' ' LEU . 38.2 tp -113.86 129.05 56.63 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.358 0.663 . . . . 72.21 110.793 -176.359 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -88.15 120.64 29.69 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 107.411 -1.329 . . . . 61.43 107.411 167.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.2 p -142.88 120.65 7.11 Favored Pre-proline 0 CA--C 1.544 0.747 0 N-CA-C 109.404 -0.591 . . . . 64.4 109.404 179.089 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.72 151.22 74.69 Favored 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 121.763 1.642 . . . . 64.51 111.038 174.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -51.05 -45.54 88.34 Favored Pre-proline 0 CA--C 1.552 1.021 0 N-CA-C 114.756 1.391 . . . . 71.34 114.756 -173.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -55.96 -45.79 35.99 Favored 'Trans proline' 0 C--N 1.388 2.616 0 C-N-CA 122.013 1.809 . . . . 63.54 113.584 175.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.566 HD11 ' HB3' ' C' ' 276' ' ' TYR . 27.8 mt -71.4 -28.27 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 123.082 0.553 . . . . 64.32 110.645 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.95 -41.86 77.47 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.043 0.537 . . . . 71.51 110.761 177.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 34.1 t -71.18 -48.19 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.602 0.761 . . . . 63.23 111.828 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 86.8 t -94.26 -35.5 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.059 0.544 . . . . 74.41 112.1 -169.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 88.68 111.7 1.17 Allowed Glycine 0 CA--C 1.53 0.977 0 CA-C-N 116.366 -0.379 . . . . 72.35 113.569 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -173.62 -158.7 18.54 Favored Glycine 0 C--N 1.351 1.402 0 CA-C-O 120.174 -0.237 . . . . 55.24 112.763 177.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -80.31 119.2 22.73 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.343 0.868 . . . . 45.21 113.343 -167.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.426 HG21 HD11 ' A' ' 197' ' ' LEU . 29.2 m -110.84 -172.74 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 114.158 -1.383 . . . . 63.11 107.665 162.771 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 211' ' ' ARG . . . . . 0.457 ' HD2' ' HB2' ' A' ' 218' ' ' PRO . 60.2 ttp180 -126.4 115.93 20.38 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 109.823 -0.436 . . . . 71.41 109.823 172.097 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -105.68 160.06 15.5 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.94 -0.763 . . . . 62.04 108.94 172.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 54.1 ttm -97.09 147.86 23.62 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 109.164 -0.68 . . . . 71.23 109.164 176.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 81.4 p -124.86 -173.3 2.77 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 108.455 -0.943 . . . . 74.1 108.455 169.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.898 HD22 ' HB3' ' A' ' 127' ' ' LEU . 22.5 mt -72.64 -19.78 61.38 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.044 0.538 . . . . 63.31 110.699 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -110.6 25.95 11.22 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.978 0.911 . . . . 64.44 110.506 178.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 98.94 -175.26 28.53 Favored Glycine 0 C--N 1.351 1.373 0 N-CA-C 114.839 0.696 . . . . 33.0 114.839 173.261 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 218' ' ' PRO . . . . . 0.457 ' HB2' ' HD2' ' A' ' 211' ' ' ARG . 83.8 Cg_endo -76.58 132.07 13.05 Favored 'Trans proline' 0 CA--C 1.557 1.671 0 C-N-CA 123.399 2.733 . . . . 70.23 113.719 -174.294 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.407 ' HA ' HG21 ' B' ' 384' ' ' THR . 27.2 m -125.7 153.93 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 124.891 1.276 . . . . 73.4 110.257 177.688 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -79.79 130.08 35.02 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.947 -0.39 . . . . 75.04 109.947 173.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 88.9 t -119.96 121.73 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 123.6 0.76 . . . . 74.13 110.269 -176.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -81.33 103.5 11.14 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.184 0.593 . . . . 60.25 109.812 177.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.601 ' HA ' HD12 ' B' ' 441' ' ' ILE . 92.9 t -67.64 146.58 98.58 Favored Pre-proline 0 CA--C 1.56 1.328 0 C-N-CA 125.497 1.519 . . . . 63.14 110.609 177.818 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -83.04 161.82 15.66 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 122.434 2.09 . . . . 75.51 111.268 172.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 225' ' ' PRO . . . . . 0.564 ' HD2' ' HD3' ' B' ' 446' ' ' PRO . 11.3 Cg_exo -70.47 148.4 60.37 Favored 'Trans proline' 0 C--N 1.365 1.44 0 C-N-CA 122.23 1.953 . . . . 72.53 112.647 176.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 57.6 mtt-85 69.32 28.41 4.82 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.578 1.551 . . . . 74.04 111.575 171.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.459 HG23 HD21 ' A' ' 233' ' ' LEU . 19.6 m -69.27 104.45 2.23 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.665 1.586 . . . . 64.32 110.512 174.608 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -101.21 151.61 21.65 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.712 0.805 . . . . 75.32 110.475 -177.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 229' ' ' ALA . . . . . 0.45 ' HA ' ' HB ' ' A' ' 253' ' ' VAL . . . -75.01 152.01 38.74 Favored 'General case' 0 C--N 1.355 0.847 0 N-CA-C 113.19 0.811 . . . . 62.31 113.19 -169.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 85.73 -3.34 87.28 Favored Glycine 0 C--N 1.348 1.209 0 CA-C-N 114.719 -1.128 . . . . 73.32 112.988 -176.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -98.02 156.74 16.5 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.671 0.788 . . . . 74.0 110.563 -178.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -104.82 112.39 25.48 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.936 0.895 . . . . 72.22 108.683 176.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.459 HD21 HG23 ' A' ' 227' ' ' THR . 65.9 mt -75.8 99.83 4.56 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 107.906 -1.146 . . . . 71.4 107.906 174.533 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -83.58 100.46 10.82 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 109.578 -0.527 . . . . 64.14 109.578 176.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.511 ' H ' HD23 ' A' ' 235' ' ' LEU . 0.3 OUTLIER -95.94 115.48 27.49 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 107.838 -1.171 . . . . 61.12 107.838 172.118 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -68.09 136.66 54.1 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 114.577 -1.192 . . . . 64.43 112.203 -171.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 84.99 35.82 12.08 Favored Glycine 0 C--N 1.349 1.282 0 O-C-N 123.807 0.692 . . . . 74.2 114.375 169.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.407 ' HE3' HD12 ' A' ' 235' ' ' LEU . 74.5 mmtt -116.04 -23.2 8.62 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.787 0.435 . . . . 73.01 111.68 -177.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -89.06 -173.64 46.47 Favored Glycine 0 C--N 1.348 1.211 0 N-CA-C 111.063 -0.815 . . . . 74.43 111.063 171.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -96.27 164.24 18.89 Favored Pre-proline 0 N--CA 1.49 1.563 0 CA-C-N 117.794 0.797 . . . . 73.13 111.398 -173.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.516 ' HA ' ' HA ' ' A' ' 246' ' ' ARG . 96.4 Cg_exo -48.75 135.57 28.03 Favored 'Trans proline' 0 C--N 1.388 2.655 0 C-N-CA 123.356 2.704 . . . . 73.33 114.949 175.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.413 ' HA2' ' HE3' ' B' ' 117' ' ' LYS . . . -161.42 -162.42 12.87 Favored Glycine 0 C--N 1.347 1.144 0 CA-C-O 119.253 -0.749 . . . . 73.52 112.601 179.346 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 243' ' ' PRO . . . . . 0.51 ' HB2' ' HE1' ' B' ' 120' ' ' TYR . 32.0 Cg_exo -58.15 -23.65 62.6 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 123.399 2.733 . . . . 70.45 113.164 177.105 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -88.09 19.06 3.84 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.777 0.831 . . . . 70.11 111.716 176.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 81.44 -82.41 1.57 Allowed Glycine 0 C--N 1.349 1.26 0 N-CA-C 110.269 -1.132 . . . . 62.24 110.269 -174.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.516 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 70.2 mtm180 -126.51 151.86 47.27 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.709 1.203 . . . . 75.41 108.032 169.149 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -83.74 175.96 52.13 Favored Glycine 0 C--N 1.347 1.185 0 N-CA-C 114.192 0.437 . . . . 42.24 114.192 -174.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -122.83 -175.68 3.22 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.113 0.965 . . . . 75.44 110.906 -174.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.487 ' HB3' ' HG ' ' A' ' 235' ' ' LEU . 50.9 tp -127.58 130.44 49.07 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.048 -1.093 . . . . 70.31 108.048 169.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -113.24 105.33 13.29 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 107.429 -1.323 . . . . 52.51 107.429 178.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.495 HD23 ' HB3' ' A' ' 195' ' ' ALA . 36.8 mt -93.6 110.92 22.5 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.129 0.571 . . . . 72.24 110.016 -176.609 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -77.69 109.72 11.92 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.256 0.623 . . . . 75.41 109.491 -177.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.45 ' HB ' ' HA ' ' A' ' 229' ' ' ALA . 31.9 t -68.99 111.25 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 CA-C-N 114.669 -1.151 . . . . 24.43 111.691 -170.531 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -110.8 99.93 8.76 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 107.803 -1.184 . . . . 73.14 107.803 167.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.559 HD12 ' HA ' ' C' ' 256' ' ' THR . 72.4 mt -76.9 122.18 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 114.853 -1.067 . . . . 74.34 109.985 179.261 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 61.8 p -107.46 165.36 11.46 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 124.164 0.986 . . . . 73.43 109.667 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 257' ' ' ILE . . . . . 0.773 HD11 HE21 ' C' ' 228' ' ' GLN . 2.8 pp -130.86 152.24 80.26 Favored Pre-proline 0 CA--C 1.557 1.231 0 C-N-CA 123.517 0.727 . . . . 73.4 110.285 -176.547 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_exo -53.44 -16.4 7.43 Favored 'Trans proline' 0 C--N 1.383 2.344 0 C-N-CA 123.891 3.061 . . . . 74.45 116.744 -169.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.437 ' HA ' ' HB3' ' C' ' 226' ' ' ARG . 64.8 mt-10 50.54 -74.22 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 124.581 1.152 . . . . 63.24 112.947 -167.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.51 139.71 42.35 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 109.814 -0.439 . . . . 75.12 109.814 174.701 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.633 HD22 ' HB2' ' A' ' 265' ' ' GLU . 83.4 mt -134.99 152.25 51.56 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.436 0.694 . . . . 55.32 109.949 174.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.0 155.6 39.74 Favored Pre-proline 0 CA--C 1.552 1.039 0 N-CA-C 106.513 -1.662 . . . . 44.34 106.513 164.137 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -42.95 -27.92 1.06 Allowed 'Trans proline' 0 C--N 1.39 2.74 0 C-N-CA 124.325 3.35 . . . . 74.33 115.515 -174.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -60.51 -71.49 0.13 Allowed 'General case' 0 C--O 1.252 1.194 0 C-N-CA 124.28 1.032 . . . . 71.44 111.842 178.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 265' ' ' GLU . . . . . 0.633 ' HB2' HD22 ' A' ' 261' ' ' LEU . 2.1 mp0 -65.83 -30.92 71.62 Favored 'General case' 0 C--N 1.356 0.871 0 N-CA-C 109.265 -0.643 . . . . 64.2 109.265 -177.131 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 266' ' ' GLU . . . . . 0.568 ' HA ' HD13 ' A' ' 261' ' ' LEU . 4.7 tp10 -51.58 -54.77 24.08 Favored 'General case' 0 C--N 1.355 0.815 0 O-C-N 124.294 0.996 . . . . 73.45 109.678 174.122 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -65.71 -37.41 86.36 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.214 0.606 . . . . 64.12 112.108 -177.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 268' ' ' LEU . . . . . 0.445 HD21 ' HE3' ' C' ' 271' ' ' LYS . 9.3 mp -59.47 -60.33 4.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 123.452 0.47 . . . . 73.14 110.982 175.298 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -55.65 -38.43 69.54 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.359 1.064 . . . . 75.0 112.465 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 270' ' ' LYS . . . . . 0.676 ' HG3' HG23 ' C' ' 206' ' ' VAL . 0.0 OUTLIER -65.47 -50.17 66.33 Favored 'General case' 0 N--CA 1.478 0.969 0 O-C-N 123.52 0.512 . . . . 62.43 110.181 -179.784 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 3.2 tmpt? -57.64 -48.9 78.18 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 123.68 0.612 . . . . 70.22 109.89 179.089 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 272' ' ' LEU . . . . . 0.502 ' O ' ' HB2' ' A' ' 276' ' ' TYR . 83.9 mt -52.43 -50.5 62.43 Favored 'General case' 0 C--N 1.357 0.916 0 O-C-N 124.413 1.07 . . . . 63.4 110.586 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -72.33 -43.49 64.05 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.019 1.118 . . . . 64.51 114.019 -171.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -75.39 -36.16 60.92 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.038 0.535 . . . . 74.35 110.13 -175.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -72.33 -32.91 66.92 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 116.293 -0.412 . . . . 71.44 110.414 171.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 276' ' ' TYR . . . . . 0.518 ' HE2' ' HG3' ' C' ' 258' ' ' PRO . 51.4 t80 -55.93 -53.01 62.08 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.344 1.058 . . . . 75.02 109.37 176.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 277' ' ' TYR . . . . . 0.413 ' HA ' ' HB3' ' A' ' 280' ' ' ALA . 0.2 OUTLIER -69.37 -34.75 75.02 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 115.401 -0.818 . . . . 70.12 110.391 -179.236 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 278' ' ' ALA . . . . . 0.417 ' HA ' HG23 ' B' ' 232' ' ' THR . . . -63.0 -10.54 14.23 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 112.757 0.651 . . . . 75.41 112.757 173.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 279' ' ' ARG . . . . . 0.46 HH22 ' CD ' ' C' ' 265' ' ' GLU . 49.7 mtm180 -122.95 3.65 9.39 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.777 0.831 . . . . 74.13 111.033 174.672 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 280' ' ' ALA . . . . . 0.413 ' HB3' ' HA ' ' A' ' 277' ' ' TYR . . . . . . . . 0 C--O 1.257 1.465 0 C-N-CA 123.576 0.75 . . . . 72.21 109.775 176.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.297 0 N-CA-C 111.394 0.146 . . . . 71.44 111.394 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.516 ' HB3' ' HB2' ' B' ' 94' ' ' PHE . 74.8 tttt -89.62 120.22 30.72 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.727 0.811 . . . . 54.1 110.056 -179.337 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -82.05 -10.94 59.05 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.743 -0.598 . . . . 74.04 112.154 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 4' ' ' SER . . . . . 0.437 ' H ' HG21 ' A' ' 126' ' ' THR . 19.5 m 58.97 -84.11 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 125.384 1.474 . . . . 52.14 112.838 177.015 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 11.8 m -95.49 150.8 19.92 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.277 0.631 . . . . 70.11 110.139 -175.034 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.553 HG21 ' HA ' ' A' ' 125' ' ' LEU . 38.2 pt -134.13 169.92 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 123.388 0.675 . . . . 64.44 112.329 -163.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -139.44 134.38 32.27 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.314 1.046 . . . . 72.01 109.582 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 52.9 tp -74.32 147.87 41.88 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.213 1.005 . . . . 75.22 111.705 -171.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.35 -57.73 3.96 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.075 0.55 . . . . 62.4 111.559 178.461 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 21.8 mt 67.43 -13.31 0.23 Allowed 'General case' 0 N--CA 1.506 2.367 0 C-N-CA 124.961 1.304 . . . . 74.1 113.449 -169.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 83.9 mt 58.68 71.83 0.93 Allowed Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 125.155 1.382 . . . . 45.35 112.305 -176.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -71.38 -55.7 0.13 Allowed 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 122.84 2.36 . . . . 61.33 110.059 173.244 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -148.82 129.69 14.28 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 108.051 -1.092 . . . . 75.01 108.051 169.121 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -151.0 107.92 3.55 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 107.388 -1.338 . . . . 64.54 107.388 -176.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -133.6 88.67 2.5 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 108.032 -1.099 . . . . 60.01 108.032 176.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 23.8 p -71.36 141.43 85.77 Favored Pre-proline 0 CA--C 1.547 0.861 0 CA-C-N 115.822 -0.626 . . . . 51.11 109.472 172.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.18 86.33 0.79 Allowed 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 122.273 1.982 . . . . 62.42 111.105 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 35.5 m -85.53 -27.81 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 CA-C-N 115.043 -0.981 . . . . 61.41 110.011 176.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 32.5 p -69.84 -33.46 72.32 Favored 'General case' 0 C--N 1.348 0.538 0 CA-C-N 115.089 -0.96 . . . . 71.22 109.682 169.108 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 23.6 mtpp 62.04 -79.43 0.03 OUTLIER 'General case' 0 C--N 1.357 0.905 0 C-N-CA 126.0 1.72 . . . . 62.34 111.332 -179.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -153.44 -95.17 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 108.031 -1.1 . . . . 75.34 108.031 177.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 22' ' ' ARG . . . . . 0.628 ' HB3' HH11 ' C' ' 154' ' ' ARG . 5.0 ppt_? 42.31 27.4 0.08 Allowed 'General case' 0 N--CA 1.508 2.425 0 C-N-CA 126.032 1.733 . . . . 73.31 114.966 176.453 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 23' ' ' THR . . . . . . . . . . . . . 70.6 p -81.14 154.8 72.47 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 123.59 0.756 . . . . 72.45 109.529 177.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -59.34 106.28 0.3 Allowed 'Trans proline' 0 C--N 1.37 1.69 0 C-N-CA 122.322 2.015 . . . . 74.55 110.606 171.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -61.46 -48.17 82.33 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.333 0.587 . . . . 74.53 110.033 178.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 26' ' ' MET . . . . . 0.442 ' SD ' ' HB3' ' B' ' 29' ' ' LEU . 43.0 ttm -132.85 128.95 20.98 Favored Pre-proline 0 CA--C 1.544 0.714 0 N-CA-C 107.512 -1.292 . . . . 75.13 107.512 172.344 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 27' ' ' PRO . . . . . 0.571 ' HG2' ' HB3' ' B' ' 315' ' ' ASN . 83.7 Cg_exo -48.08 -42.19 32.73 Favored 'Trans proline' 0 C--N 1.384 2.437 0 C-N-CA 123.966 3.111 . . . . 71.1 113.5 -179.399 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.518 HG13 ' HD2' ' B' ' 319' ' ' PRO . 4.9 p -171.31 138.29 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 C-N-CA 124.569 1.147 . . . . 73.51 109.048 174.498 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.442 ' HB3' ' SD ' ' B' ' 26' ' ' MET . 0.4 OUTLIER -127.27 134.23 50.08 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.602 1.161 . . . . 62.2 108.789 174.969 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 70.6 151.76 0.1 Allowed 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 125.153 1.381 . . . . 70.24 110.495 -174.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 17.2 p-10 -106.64 -38.72 6.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.939 -0.476 . . . . 74.34 111.623 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -159.36 104.27 1.64 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 122.606 0.363 . . . . 72.22 110.6 178.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -94.08 103.1 15.18 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 106.474 -1.676 . . . . 73.31 106.474 164.021 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.85 -63.1 1.29 Allowed 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.097 0.959 . . . . 53.33 112.298 -166.287 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 57.72 -162.5 0.21 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.816 0.847 . . . . 73.13 111.063 179.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 59.96 63.08 5.39 Favored Glycine 0 C--N 1.355 1.625 0 CA-C-O 119.653 -0.526 . . . . 74.33 112.806 172.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 24.8 t70 65.33 -88.54 0.03 OUTLIER 'General case' 0 C--N 1.355 0.828 0 C-N-CA 124.355 1.062 . . . . 61.44 109.738 -173.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 13.3 tt 171.54 -29.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 124.679 1.192 . . . . 75.44 109.261 -177.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 8.9 t -57.14 -54.49 46.19 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.44 1.096 . . . . 64.25 112.891 -168.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.545 ' HB1' ' HB2' ' B' ' 328' ' ' ALA . . . -178.4 82.22 0.22 Allowed Pre-proline 0 C--N 1.36 1.052 0 C-N-CA 123.324 0.649 . . . . 64.0 111.863 -177.27 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -88.83 -174.71 1.07 Allowed 'Trans proline' 0 C--N 1.365 1.416 0 C-N-CA 122.635 2.223 . . . . 72.44 111.211 162.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 151.98 -72.81 0.27 Allowed Glycine 0 C--N 1.345 1.071 0 C-N-CA 121.844 -0.217 . . . . 45.24 113.146 170.059 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -152.82 137.22 5.74 Favored Glycine 0 C--N 1.335 0.493 0 N-CA-C 111.356 -0.698 . . . . 42.15 111.356 -176.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 44' ' ' ALA . . . . . 0.436 ' HA ' ' HB2' ' B' ' 336' ' ' GLU . . . -75.62 2.6 11.44 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.409 0.684 . . . . 63.2 112.675 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.57 ' HB2' ' HD2' ' B' ' 337' ' ' LYS . 22.0 mmt180 66.81 -68.86 0.14 Allowed 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 126.114 1.766 . . . . 74.21 112.274 176.143 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 46' ' ' ARG . . . . . 0.47 HH12 ' HB3' ' C' ' 139' ' ' GLU . 10.0 ttm180 73.22 -86.93 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 125.325 1.45 . . . . 75.02 110.728 177.458 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.424 ' HG ' ' H ' ' B' ' 48' ' ' THR . 18.4 tp 164.52 -176.17 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 126.187 1.795 . . . . 53.22 106.445 -169.545 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.54 ' HA ' ' HD3' ' C' ' 144' ' ' ARG . 88.5 m -56.52 -55.72 30.26 Favored 'General case' 0 C--N 1.352 0.704 0 CA-C-N 118.431 0.559 . . . . 51.22 109.73 168.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.37 -1.02 78.44 Favored Glycine 0 C--N 1.347 1.148 0 CA-C-O 119.812 -0.438 . . . . 74.15 113.122 177.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 50' ' ' ASP . . . . . 0.502 ' HA ' ' ND1' ' B' ' 184' ' ' HIS . 13.3 t70 -79.11 -75.97 0.22 Allowed 'General case' 0 C--N 1.356 0.86 0 N-CA-C 107.053 -1.462 . . . . 64.2 107.053 172.061 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 59.93 11.37 2.56 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 125.103 1.361 . . . . 75.3 112.816 174.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 44.7 p -134.46 -162.84 1.29 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.231 1.012 . . . . 73.31 109.719 -169.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -127.44 82.12 2.07 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.846 -0.798 . . . . 73.24 108.846 171.023 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.425 ' HB2' ' HD2' ' B' ' 184' ' ' HIS . . . -77.8 113.6 15.83 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 108.989 -0.745 . . . . 75.51 108.989 174.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 88.5 mt -103.53 -14.26 16.26 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.413 0.685 . . . . 72.35 110.842 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 56' ' ' ARG . . . . . 0.591 ' HG3' HD12 ' B' ' 59' ' ' LEU . 0.0 OUTLIER 68.87 106.74 0.05 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.476 1.51 . . . . 73.2 110.585 -176.117 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -63.15 -71.57 0.16 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.62 1.168 . . . . 75.31 110.799 -177.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 27.2 t -90.1 74.48 7.17 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 121.846 0.832 . . . . 62.01 110.298 178.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 59' ' ' LEU . . . . . 0.591 HD12 ' HG3' ' B' ' 56' ' ' ARG . 0.5 OUTLIER -146.95 3.97 0.83 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 113.907 -1.497 . . . . 72.44 108.216 164.079 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 18.7 t -169.88 176.14 4.9 Favored 'General case' 0 C--O 1.248 1.016 0 C-N-CA 125.75 1.62 . . . . 63.51 107.32 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 15.6 t70 66.74 -74.72 0.06 Allowed 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 124.158 0.983 . . . . 71.45 110.893 -177.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 62' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -123.03 85.97 50.99 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 124.366 1.066 . . . . 72.3 109.228 175.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -87.08 123.45 1.97 Allowed 'Trans proline' 0 C--N 1.371 1.713 0 C-N-CA 122.555 2.17 . . . . 72.24 109.699 167.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -79.18 -24.97 42.86 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.303 0.641 . . . . 72.04 111.608 -176.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 64.66 -78.42 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.786 1.234 . . . . 65.32 110.102 -173.649 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 68.75 -66.32 0.25 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 125.403 1.481 . . . . 72.41 111.432 -177.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 67' ' ' ILE . . . . . 0.485 HD11 HD12 ' B' ' 69' ' ' LEU . 16.7 tt 51.34 112.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 C-N-CA 126.948 2.099 . . . . 72.03 113.298 172.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 34.1 mt -70.17 -5.32 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.598 0 C-N-CA 124.007 0.923 . . . . 73.4 112.051 -171.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.631 HD11 ' HG3' ' B' ' 312' ' ' PRO . 63.7 mt -79.92 60.19 3.42 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 124.25 1.02 . . . . 73.12 111.345 177.696 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -143.84 21.88 1.78 Allowed 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 108.088 -1.078 . . . . 44.44 108.088 169.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 61.8 mt 61.38 64.19 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 C-N-CA 124.847 1.259 . . . . 74.32 108.443 -168.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -113.0 4.58 25.61 Favored Glycine 0 C--N 1.349 1.272 0 CA-C-N 113.898 -1.501 . . . . 62.21 112.863 -177.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -106.49 151.52 24.86 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.229 1.012 . . . . 63.44 109.807 -178.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 56.4 -97.56 0.06 OUTLIER Glycine 0 C--N 1.356 1.666 0 O-C-N 123.561 0.538 . . . . 64.42 111.859 -175.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.7 93.95 9.74 Favored 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 108.063 -1.088 . . . . 74.01 108.063 168.47 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . -98.23 95.17 1.59 Allowed Glycine 0 C--N 1.343 0.961 0 CA-C-O 119.023 -0.876 . . . . 71.13 112.238 -176.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 29.5 t70 51.75 -88.91 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 125.423 1.489 . . . . 73.03 111.979 179.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 45.4 m -85.91 66.36 9.57 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.08 0.952 . . . . 51.1 109.525 177.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 79' ' ' GLU . . . . . 0.549 ' HG3' HG22 ' B' ' 80' ' ' ILE . 11.1 pt-20 -64.51 -34.11 77.46 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 114.712 -1.131 . . . . 74.44 111.912 178.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.549 HG22 ' HG3' ' B' ' 79' ' ' GLU . 15.9 tt -169.3 -32.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.802 1.241 . . . . 72.52 108.653 -178.098 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 14.3 m 62.41 73.9 0.45 Allowed 'General case' 0 C--N 1.36 1.046 0 C-N-CA 124.858 1.263 . . . . 71.34 110.433 174.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 61.52 -78.53 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 125.112 1.365 . . . . 61.11 112.073 -175.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . 69.23 109.21 0.05 Allowed 'General case' 0 C--N 1.36 1.024 0 C-N-CA 125.462 1.505 . . . . 71.35 110.47 -174.265 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -69.4 87.13 0.44 Allowed 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 108.381 -0.97 . . . . 73.0 108.381 -179.548 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 75.03 -19.5 0.38 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 125.458 1.503 . . . . 72.23 113.304 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 75.3 t80 66.98 -75.82 0.06 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.978 1.311 . . . . 63.12 111.885 178.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.01 -166.67 2.61 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.884 0.873 . . . . 52.24 110.305 -177.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 60.18 -91.5 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.996 1.318 . . . . 74.14 112.002 175.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -94.8 64.46 1.48 Allowed Glycine 0 C--N 1.348 1.21 0 N-CA-C 111.16 -0.776 . . . . 54.33 111.16 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.26 -45.74 86.8 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.067 0.547 . . . . 62.33 109.966 176.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.3 173.36 36.1 Favored Glycine 0 C--N 1.347 1.173 0 CA-C-N 115.402 -0.817 . . . . 70.11 114.019 171.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.26 -27.49 5.08 Favored Glycine 0 C--N 1.343 0.966 0 CA-C-O 119.064 -0.853 . . . . 23.53 114.576 173.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 34.7 t80 67.6 -71.98 0.1 Allowed 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 125.25 1.42 . . . . 74.22 110.635 -175.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 94' ' ' PHE . . . . . 0.516 ' HB2' ' HB3' ' B' ' 2' ' ' LYS . 81.7 m-85 67.75 40.24 2.49 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 125.403 1.481 . . . . 71.21 111.55 175.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 51.7 mttp 66.73 -82.08 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.965 1.306 . . . . 74.14 111.605 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 96' ' ' GLY . . . . . 0.459 ' HA2' ' HG2' ' A' ' 128' ' ' GLU . . . 90.93 -52.82 3.27 Favored Glycine 0 C--N 1.35 1.331 0 N-CA-C 111.04 -0.824 . . . . 72.31 111.04 -171.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 1.2 pp -94.24 75.36 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 124.395 1.078 . . . . 72.22 110.19 176.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -84.25 73.81 10.4 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 109.011 -0.737 . . . . 75.21 109.011 178.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -81.38 99.48 8.72 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 114.75 -1.114 . . . . 61.12 109.769 -175.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 100' ' ' LEU . . . . . 0.553 ' HG ' ' HD3' ' B' ' 101' ' ' PRO . 4.1 pp -164.79 -36.39 0.0 OUTLIER Pre-proline 0 CA--C 1.572 1.813 0 C-N-CA 124.616 1.166 . . . . 74.2 112.911 176.165 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 101' ' ' PRO . . . . . 0.553 ' HD3' ' HG ' ' B' ' 100' ' ' LEU . 42.4 Cg_endo -91.98 6.8 3.35 Favored 'Trans proline' 0 C--N 1.406 3.592 0 CA-C-N 122.735 2.012 . . . . 72.21 113.569 177.587 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 102' ' ' LEU . . . . . 0.403 HD23 ' H ' ' B' ' 102' ' ' LEU . 2.3 pt? -78.42 83.58 4.63 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 122.191 0.996 . . . . 73.12 109.982 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 9.9 t -166.61 151.49 7.75 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-N 114.81 -1.086 . . . . 75.52 109.563 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 149.12 130.64 1.9 Allowed Glycine 0 C--N 1.337 0.635 0 N-CA-C 110.32 -1.112 . . . . 51.35 110.32 -178.285 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 -73.35 81.99 1.4 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.637 0.775 . . . . 75.22 110.083 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 106' ' ' TYR . . . . . 0.578 ' HB3' HD12 ' B' ' 412' ' ' LEU . 18.4 m-85 62.02 10.47 3.66 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.456 1.502 . . . . 74.44 113.943 171.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 22.7 m -88.71 92.42 9.19 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.635 0.731 . . . . 63.32 110.635 -175.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 23.4 p-80 -114.57 55.41 0.75 Allowed 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 108.078 -1.082 . . . . 71.44 108.078 172.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -73.22 94.85 2.03 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 114.486 -1.234 . . . . 53.33 109.848 -176.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -81.88 -6.39 59.06 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.896 0.879 . . . . 71.24 111.708 178.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 53.6 tp 71.17 -73.85 0.09 Allowed 'General case' 0 C--N 1.362 1.124 0 C-N-CA 125.274 1.429 . . . . 64.15 110.647 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 9.9 t30 61.48 40.04 14.25 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 124.371 1.068 . . . . 73.2 110.365 178.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 113' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -69.59 123.58 21.7 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.12 -0.945 . . . . 75.13 108.745 178.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 52.7 tttm 62.75 23.31 13.89 Favored 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 124.355 1.062 . . . . 74.01 110.032 -177.037 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 20.2 m 65.18 -77.42 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 125.288 1.435 . . . . 73.23 110.57 -171.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 64.23 30.75 78.67 Favored Glycine 0 C--N 1.359 1.848 0 O-C-N 123.221 0.325 . . . . 55.33 113.676 175.447 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 117' ' ' LYS . . . . . 0.493 ' HE2' ' HD3' ' A' ' 243' ' ' PRO . 6.1 ttpm? -129.1 135.2 27.24 Favored Pre-proline 0 CA--C 1.553 1.075 0 C-N-CA 124.151 0.98 . . . . 70.25 109.317 -172.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 118' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -73.88 176.35 9.57 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 123.136 2.558 . . . . 60.53 114.775 -170.085 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 119' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -90.64 169.62 10.84 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 114.288 -1.324 . . . . 75.33 110.487 177.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 120' ' ' TYR . . . . . 0.51 ' HE1' ' HB2' ' A' ' 243' ' ' PRO . 29.6 p90 -133.65 150.2 51.57 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.43 1.092 . . . . 70.1 109.551 -177.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 10.3 t 50.38 46.87 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-O 122.833 1.301 . . . . 74.32 109.507 -178.114 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 3.1 m -97.82 30.68 2.9 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 114.549 -1.205 . . . . 75.24 110.347 -171.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 4.2 p30 46.12 30.74 1.01 Allowed 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 125.368 1.467 . . . . 64.3 112.335 -173.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 46.2 t -71.33 106.19 3.78 Favored 'General case' 0 C--N 1.354 0.765 0 N-CA-C 108.157 -1.053 . . . . 43.31 108.157 178.37 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . 61.63 31.39 18.72 Favored 'General case' 0 CA--C 1.55 0.96 0 O-C-N 124.446 1.091 . . . . 73.02 110.477 -171.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . 62.91 69.23 0.6 Allowed 'General case' 0 C--N 1.358 0.978 0 C-N-CA 125.192 1.397 . . . . 74.13 111.277 -178.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 27.2 p -90.17 106.24 18.35 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.281 0.632 . . . . 70.01 110.561 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . 64.0 37.6 9.18 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 124.642 1.177 . . . . 72.01 112.53 174.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 41.2 p -108.2 0.72 21.64 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.995 0.918 . . . . 54.34 112.257 -178.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . -82.27 155.98 24.56 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 121.074 0.464 . . . . 44.22 111.781 -177.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 24.1 m-90 -104.52 164.61 11.63 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.613 1.165 . . . . 73.51 109.416 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 36.7 p -154.65 138.7 16.43 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.111 0.564 . . . . 51.4 110.707 -176.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 49.8 m 71.55 -71.14 0.14 Allowed 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 125.409 1.484 . . . . 62.25 111.037 -178.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . -141.45 -53.89 0.04 OUTLIER Glycine 0 C--N 1.349 1.283 0 N-CA-C 112.118 -0.393 . . . . 55.15 112.118 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 135' ' ' VAL . . . . . . . . . . . . . 18.5 m -113.18 -167.56 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 N-CA-C 108.7 -0.852 . . . . 73.24 108.7 179.136 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 3.2 tmtp? -71.2 -55.63 7.73 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 108.302 -0.999 . . . . 52.43 108.302 177.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 19.6 m -87.08 69.79 10.2 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-N 115.537 -0.756 . . . . 75.31 110.012 -178.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 61.08 -89.86 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.27 0 C-N-CA 125.123 1.369 . . . . 75.52 112.065 177.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -135.6 -2.33 2.44 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.188 0.995 . . . . 73.24 110.255 -175.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -64.18 84.44 0.06 OUTLIER Glycine 0 C--N 1.353 1.473 0 C-N-CA 123.142 0.401 . . . . 65.04 112.875 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.43 -49.47 48.5 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.024 0.93 . . . . 75.34 110.086 -177.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 35.9 tp -92.73 -16.64 25.21 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 115.319 -0.855 . . . . 70.15 109.885 172.108 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 83.84 -58.39 5.02 Favored Glycine 0 C--N 1.353 1.479 0 N-CA-C 111.819 -0.512 . . . . 61.25 111.819 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 144' ' ' VAL . . . . . 0.669 HG21 ' HB2' ' B' ' 151' ' ' HIS . 58.5 t -76.86 -40.77 31.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 124.665 1.186 . . . . 75.31 109.745 174.621 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 145' ' ' ASP . . . . . 0.419 ' HA ' ' HG ' ' B' ' 218' ' ' LEU . 1.0 OUTLIER 68.47 -79.55 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.131 1.373 . . . . 64.3 113.084 173.904 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 17.1 tt -132.86 -8.17 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 C-N-CA 123.135 0.574 . . . . 72.52 111.236 -175.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 -59.79 -45.13 93.26 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.847 0.859 . . . . 72.43 111.619 -177.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -140.24 163.91 31.5 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.121 1.368 . . . . 73.05 108.154 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 149' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -92.14 -9.58 41.93 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.049 0.54 . . . . 72.23 109.985 170.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -96.61 169.51 9.84 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.375 1.07 . . . . 74.11 109.979 -178.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 151' ' ' HIS . . . . . 0.669 ' HB2' HG21 ' B' ' 144' ' ' VAL . 34.1 m-70 65.73 85.62 0.15 Allowed Pre-proline 0 N--CA 1.485 1.305 0 C-N-CA 125.155 1.382 . . . . 74.43 109.446 -178.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.45 -16.14 24.55 Favored 'Trans proline' 0 C--N 1.374 1.891 0 C-N-CA 122.566 2.178 . . . . 42.51 113.02 -176.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 28.3 m 69.18 -68.55 0.18 Allowed 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 125.455 1.502 . . . . 74.2 110.482 -177.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 8.1 tp -88.3 134.51 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 N-CA-C 108.504 -0.924 . . . . 74.25 108.504 168.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 155' ' ' LEU . . . . . 0.641 HD23 ' H ' ' B' ' 155' ' ' LEU . 2.2 pt? -111.86 -4.41 14.6 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.441 0.696 . . . . 72.1 111.504 -173.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -88.72 -68.61 0.76 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.258 0.623 . . . . 72.23 110.026 -176.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 157' ' ' MET . . . . . . . . . . . . . 19.8 mmt -145.24 174.48 11.05 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.777 1.231 . . . . 53.54 108.691 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 158' ' ' ALA . . . . . . . . . . . . . . . -164.89 94.57 0.67 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.244 0.617 . . . . 34.04 109.543 175.258 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -152.14 80.51 1.25 Allowed 'General case' 0 C--O 1.242 0.679 0 C-N-CA 122.841 0.456 . . . . 55.45 109.973 175.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -172.85 133.46 0.56 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.262 1.025 . . . . 70.22 109.407 173.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.56 -34.27 62.88 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.422 0.689 . . . . 71.1 110.671 177.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 71.57 -155.68 52.35 Favored Glycine 0 C--N 1.352 1.463 0 CA-C-O 119.443 -0.643 . . . . 73.4 112.18 -178.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 9.4 tt 67.32 123.54 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 125.025 1.33 . . . . 65.02 111.889 177.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 164' ' ' ALA . . . . . . . . . . . . . . . -139.8 170.56 15.65 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.607 0.763 . . . . 75.34 109.614 175.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 3.2 t -73.59 75.36 1.49 Allowed 'General case' 0 CA--C 1.553 1.079 0 CA-C-O 121.925 0.869 . . . . 64.15 110.045 176.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . 84.16 -56.14 5.03 Favored Glycine 0 C--N 1.349 1.273 0 CA-C-N 114.988 -1.005 . . . . 71.15 111.98 -176.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 167' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -145.54 153.9 41.6 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 124.101 0.96 . . . . 72.31 109.582 -178.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 168' ' ' VAL . . . . . 0.62 HG21 ' HG3' ' B' ' 193' ' ' PRO . 88.4 t -61.14 104.97 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.952 1.301 . . . . 74.13 111.135 -176.007 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 25.2 m -88.64 -178.62 5.85 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.17 0.988 . . . . 54.35 110.567 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 72.6 p -63.5 -58.06 8.22 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.475 0.71 . . . . 63.1 110.288 178.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . 59.44 -81.21 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 125.389 1.476 . . . . 53.32 113.517 170.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 172' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -83.3 73.33 10.14 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.55 0.74 . . . . 73.22 110.786 -171.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 173' ' ' LEU . . . . . . . . . . . . . 21.7 tp 61.41 22.78 13.13 Favored 'General case' 0 CA--C 1.562 1.419 0 C-N-CA 124.876 1.271 . . . . 74.23 112.128 173.037 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 174' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 73.51 -8.64 1.32 Allowed 'General case' 0 N--CA 1.505 2.324 0 C-N-CA 124.629 1.172 . . . . 74.45 111.456 -173.091 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 175' ' ' ASP . . . . . . . . . . . . . 28.2 t70 71.56 135.05 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 127.159 2.184 . . . . 74.1 112.44 -177.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -96.34 -8.03 33.68 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.964 0.905 . . . . 74.11 112.154 -175.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 16.7 m -64.23 -40.77 55.59 Favored Pre-proline 0 CA--C 1.568 1.647 0 CA-C-O 118.377 -0.821 . . . . 64.31 112.843 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 178' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -58.56 156.31 32.33 Favored 'Trans proline' 0 C--N 1.399 3.231 0 C-N-CA 121.858 1.705 . . . . 74.53 112.568 172.181 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 179' ' ' ALA . . . . . 0.415 ' HB1' ' NE ' ' B' ' 46' ' ' ARG . . . -88.9 24.93 1.92 Allowed 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.997 0.919 . . . . 61.34 112.669 -170.615 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . 68.3 -67.26 0.2 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.329 1.452 . . . . 74.4 110.541 -169.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 35.1 tp -154.63 114.86 3.86 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 109.109 -0.7 . . . . 62.04 109.109 -178.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 182' ' ' VAL . . . . . . . . . . . . . 14.4 p 44.53 111.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 C-N-CA 127.033 2.133 . . . . 71.31 116.196 178.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -103.61 84.61 2.31 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 107.579 -1.267 . . . . 65.24 107.579 167.081 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 184' ' ' HIS . . . . . 0.509 ' NE2' ' HB3' ' B' ' 187' ' ' SER . 23.7 p-80 64.85 165.3 0.16 Allowed 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 126.871 2.068 . . . . 74.15 113.841 174.041 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 185' ' ' VAL . . . . . 0.619 HG23 ' HA ' ' C' ' 121' ' ' ALA . 7.7 p -84.94 116.18 28.05 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.969 0 CA-C-N 115.02 -0.991 . . . . 71.33 111.875 -170.094 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 80.4 p 48.45 79.72 0.07 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 125.868 1.667 . . . . 51.31 114.09 166.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 187' ' ' SER . . . . . 0.509 ' HB3' ' NE2' ' B' ' 184' ' ' HIS . 29.9 t -179.16 -33.19 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.359 0.663 . . . . 62.14 110.556 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.01 -78.17 0.12 Allowed 'General case' 0 CA--C 1.542 0.671 0 O-C-N 123.564 0.54 . . . . 71.52 109.687 -174.243 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 189' ' ' LYS . . . . . 0.542 ' HZ1' ' CD ' ' C' ' 122' ' ' GLU . 4.5 ttmp? 54.08 91.5 0.03 OUTLIER 'General case' 0 CA--C 1.56 1.364 0 C-N-CA 124.204 1.002 . . . . 72.52 111.906 -175.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 190' ' ' CYS . . . . . 0.866 ' HA ' ' HA ' ' B' ' 294' ' ' LYS . 54.0 t -142.58 92.71 2.44 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.054 0.541 . . . . 70.33 110.338 178.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 191' ' ' TYR . . . . . 0.623 ' HB2' HD22 ' C' ' 181' ' ' LEU . 49.7 p90 -157.79 149.71 22.05 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 111.991 0.367 . . . . 74.04 111.991 -174.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 63.04 174.12 2.41 Favored Glycine 0 C--N 1.35 1.34 0 O-C-N 124.387 1.054 . . . . 64.22 114.73 172.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 193' ' ' PRO . . . . . 0.62 ' HG3' HG21 ' B' ' 168' ' ' VAL . 73.0 Cg_endo -71.07 162.6 42.09 Favored 'Trans proline' 0 C--N 1.366 1.465 0 C-N-CA 122.531 2.154 . . . . 64.32 111.833 178.612 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 194' ' ' SER . . . . . . . . . . . . . 46.6 m -87.07 41.91 1.0 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.371 0.668 . . . . 24.51 111.174 178.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.05 -23.08 64.0 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.754 0.822 . . . . 74.32 110.805 175.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 196' ' ' THR . . . . . 0.47 HG23 ' HB ' ' B' ' 296' ' ' THR . 5.2 t -89.63 23.28 2.7 Favored 'General case' 0 CA--C 1.561 1.39 0 C-N-CA 124.698 1.199 . . . . 73.32 110.946 174.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 22.7 m 71.55 103.07 0.07 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.327 1.451 . . . . 75.11 112.599 169.093 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 198' ' ' GLU . . . . . 0.713 ' HB2' ' HA ' ' B' ' 296' ' ' THR . 6.5 tm-20 -160.31 -79.34 0.05 Allowed 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 107.267 -1.383 . . . . 51.12 107.267 172.501 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.59 -34.79 40.47 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.892 -0.781 . . . . 74.4 108.892 171.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 200' ' ' CYS . . . . . . . . . . . . . 55.3 m 68.93 154.19 0.14 Allowed Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 125.74 1.616 . . . . 73.31 113.2 168.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 201' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -83.5 164.28 14.47 Favored 'Trans proline' 0 C--N 1.369 1.617 0 C-N-CA 122.393 2.062 . . . . 71.34 111.789 170.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 150.86 -121.33 1.21 Allowed Glycine 0 C--N 1.335 0.48 0 N-CA-C 110.29 -1.124 . . . . 63.04 110.29 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -91.88 -162.23 0.9 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.3 0.64 . . . . 71.33 109.372 174.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 204' ' ' ALA . . . . . 0.491 ' H ' HD21 ' B' ' 217' ' ' LEU . . . -96.14 28.24 3.29 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.204 0.602 . . . . 74.01 110.846 177.002 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 205' ' ' LEU . . . . . . . . . . . . . 41.2 tp 64.36 -75.15 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.352 1.461 . . . . 51.03 110.126 -171.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 206' ' ' GLU . . . . . 0.509 ' HG2' ' HA2' ' B' ' 211' ' ' GLY . 0.5 OUTLIER -131.73 125.91 33.19 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 106.871 -1.529 . . . . 62.32 106.871 176.692 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 207' ' ' LYS . . . . . 0.447 ' HA ' ' HE2' ' B' ' 207' ' ' LYS . 0.6 OUTLIER -64.49 -37.86 89.01 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.881 0.873 . . . . 74.32 112.139 -173.197 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 137.09 10.85 1.1 Allowed Glycine 0 N--CA 1.469 0.897 0 CA-C-N 116.016 -0.538 . . . . 71.52 111.944 -174.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . -170.94 132.01 2.36 Favored Glycine 0 C--N 1.342 0.915 0 N-CA-C 110.723 -0.951 . . . . 42.21 110.723 -177.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 77.5 tttt 70.59 -78.01 0.05 Allowed 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 125.049 1.34 . . . . 74.51 111.393 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 211' ' ' GLY . . . . . 0.509 ' HA2' ' HG2' ' B' ' 206' ' ' GLU . . . 166.63 53.89 0.03 OUTLIER Glycine 0 C--N 1.335 0.492 0 N-CA-C 107.55 -2.22 . . . . 74.43 107.55 -169.036 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 50.3 m 65.58 88.38 0.11 Allowed 'General case' 0 C--N 1.354 0.78 0 C-N-CA 125.257 1.423 . . . . 74.04 108.738 -162.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 8.7 tp -68.54 -21.43 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 124.065 0.946 . . . . 64.4 111.413 -179.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 51.1 p -81.64 -1.49 46.84 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.332 0.653 . . . . 75.43 110.817 173.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 215' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 68.66 -69.45 0.15 Allowed 'General case' 0 C--N 1.366 1.285 0 C-N-CA 126.179 1.791 . . . . 73.31 109.916 -178.15 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -112.8 168.55 9.59 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.139 0.976 . . . . 61.42 109.133 169.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 217' ' ' LEU . . . . . 0.491 HD21 ' H ' ' B' ' 204' ' ' ALA . 3.5 pp -145.15 21.66 1.56 Allowed 'General case' 0 N--CA 1.484 1.229 0 CA-C-O 121.674 0.75 . . . . 75.4 109.639 173.71 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 218' ' ' LEU . . . . . 0.419 ' HG ' ' HA ' ' B' ' 145' ' ' ASP . 3.7 mm? -79.91 179.26 7.67 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 114.628 -1.169 . . . . 71.43 110.136 -177.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 12.2 t30 61.71 32.5 18.33 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 122.587 1.184 . . . . 71.24 108.809 -171.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -64.04 -24.49 67.72 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 114.332 -1.303 . . . . 61.1 112.484 -174.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 221' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -90.29 44.33 1.2 Allowed 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.861 0.864 . . . . 73.55 110.053 178.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -87.55 147.83 25.15 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 123.34 0.656 . . . . 42.52 109.419 175.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 223' ' ' ASP . . . . . 0.571 ' HA ' HG21 ' B' ' 269' ' ' THR . 28.7 t70 66.74 -82.82 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.692 1.197 . . . . 61.02 110.88 -177.139 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 45.2 t -84.41 84.11 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 108.194 -1.039 . . . . 74.2 108.194 173.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 15.0 m -74.84 -11.28 60.1 Favored 'General case' 0 CA--C 1.553 1.095 0 CA-C-N 114.902 -1.044 . . . . 54.34 111.255 -179.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 31.5 mt 73.2 108.65 0.07 Allowed 'General case' 0 C--N 1.366 1.302 0 C-N-CA 125.451 1.5 . . . . 74.43 109.765 178.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . -67.59 -18.37 69.92 Favored Glycine 0 C--N 1.351 1.397 0 O-C-N 123.461 0.476 . . . . 51.31 112.822 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 80.32 29.94 43.15 Favored Glycine 0 C--N 1.35 1.349 0 O-C-N 124.045 0.497 . . . . 72.41 112.002 177.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -166.01 -146.56 4.87 Favored Glycine 0 C--N 1.342 0.915 0 O-C-N 123.564 0.214 . . . . 70.24 112.753 -176.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -159.22 16.13 0.17 Allowed 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.761 0.824 . . . . 70.23 111.393 -171.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 231' ' ' LYS . . . . . . . . . . . . . 5.3 mptt 65.9 95.61 0.06 Allowed 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.484 1.114 . . . . 73.24 111.82 171.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 232' ' ' THR . . . . . 0.417 HG23 ' HA ' ' A' ' 278' ' ' ALA . 70.8 p 77.52 -41.4 0.36 Allowed 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 127.693 2.397 . . . . 74.24 112.709 177.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 65.19 -174.93 0.18 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.215 1.006 . . . . 70.41 110.323 -170.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -140.71 48.17 1.73 Allowed 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.084 0.469 . . . . 72.31 110.12 -173.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -101.92 126.2 48.77 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 108.335 -0.987 . . . . 54.41 108.335 178.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 236' ' ' THR . . . . . . . . . . . . . 45.1 m -80.65 -63.42 1.41 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.838 0.855 . . . . 73.34 111.3 -176.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -166.95 90.31 0.38 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.452 0.701 . . . . 71.12 110.4 -175.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 238' ' ' THR . . . . . 0.604 HG22 HG23 ' C' ' 219' ' ' VAL . 59.3 m -132.58 109.18 9.57 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 107.072 -1.455 . . . . 71.31 107.072 169.477 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 239' ' ' ALA . . . . . 0.418 ' H ' ' HA3' ' B' ' 359' ' ' GLY . . . -162.78 -88.56 0.02 OUTLIER 'General case' 0 C--O 1.236 0.387 0 N-CA-C 109.42 -0.585 . . . . 74.42 109.42 179.199 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 240' ' ' GLY . . . . . 0.577 ' HA3' ' HA ' ' C' ' 235' ' ' LEU . . . 162.55 -128.9 1.95 Allowed Glycine 0 C--N 1.339 0.705 0 N-CA-C 110.628 -0.989 . . . . 71.23 110.628 -169.04 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 241' ' ' GLU . . . . . 0.676 ' HG3' ' HG3' ' C' ' 234' ' ' ARG . 6.4 pt-20 -150.24 138.08 20.05 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.412 0.685 . . . . 71.21 109.784 -175.765 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 242' ' ' TRP . . . . . 0.408 ' CD2' ' HG ' ' C' ' 233' ' ' LEU . 1.0 OUTLIER -173.16 117.24 0.29 Allowed 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 107.155 -1.424 . . . . 70.32 107.155 170.628 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 243' ' ' GLN . . . . . 0.512 ' HA ' ' HB2' ' B' ' 367' ' ' LEU . 30.6 mt-30 59.69 -82.56 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 124.104 0.962 . . . . 74.22 109.081 -168.151 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 179.83 88.22 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 107.362 -2.295 . . . . 63.11 107.362 177.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 245' ' ' LYS . . . . . 0.427 ' HD3' ' HB3' ' C' ' 222' ' ' ALA . 0.0 OUTLIER -64.29 155.64 31.45 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 112.337 0.495 . . . . 75.34 112.337 -172.721 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 12.3 t -147.53 157.49 43.59 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.137 0.575 . . . . 71.02 111.075 -179.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 247' ' ' LEU . . . . . 0.481 HD13 ' HE3' ' C' ' 209' ' ' LYS . 40.7 tp -113.72 95.64 5.44 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 107.537 -1.282 . . . . 72.51 107.537 171.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 248' ' ' ARG . . . . . 0.512 ' HB3' HG22 ' C' ' 206' ' ' VAL . 0.9 OUTLIER -87.99 120.15 29.04 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 107.856 -1.164 . . . . 75.15 107.856 179.436 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -160.25 114.21 2.18 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 107.832 -1.173 . . . . 71.33 107.832 -170.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -123.7 85.94 2.5 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.41 0.684 . . . . 65.4 109.827 -174.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 251' ' ' ALA . . . . . . . . . . . . . . . 62.13 -86.94 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.13 1.372 . . . . 61.03 112.065 178.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 252' ' ' GLN . . . . . 0.564 ' NE2' ' HB2' ' B' ' 278' ' ' LEU . 59.6 tt0 172.24 -179.41 0.07 Allowed 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.98 0.912 . . . . 72.3 109.183 -168.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -58.17 159.5 5.85 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.993 0.917 . . . . 51.41 110.387 162.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 4.1 ppt_? -62.46 -22.04 65.92 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 112.956 0.725 . . . . 72.51 112.956 -170.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 255' ' ' GLY . . . . . 0.534 ' HA3' HD22 ' B' ' 277' ' ' LEU . . . -62.87 -25.0 67.26 Favored Glycine 0 C--N 1.357 1.746 0 O-C-N 123.43 0.456 . . . . 54.22 113.042 178.187 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 256' ' ' TYR . . . . . 0.458 ' HD2' HD23 ' B' ' 258' ' ' LEU . 36.1 t80 62.54 16.25 8.59 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.797 1.239 . . . . 52.52 112.895 166.261 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 257' ' ' GLN . . . . . 0.491 ' HG3' HD23 ' B' ' 278' ' ' LEU . 24.5 tm0? 67.01 3.27 3.05 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 124.747 1.219 . . . . 74.31 111.994 178.128 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 258' ' ' LEU . . . . . 0.458 HD23 ' HD2' ' B' ' 256' ' ' TYR . 2.5 pp -83.43 24.91 0.79 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.258 -0.901 . . . . 75.13 112.039 -177.502 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 30.1 m -63.56 -15.91 17.27 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 C-N-CA 124.765 1.226 . . . . 63.02 112.372 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 260' ' ' SER . . . . . . . . . . . . . 49.2 m 65.37 33.2 9.16 Favored 'General case' 0 C--N 1.366 1.299 0 C-N-CA 124.615 1.166 . . . . 73.11 111.816 172.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 30.6 t70 71.47 147.78 0.08 Allowed 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 125.431 1.492 . . . . 52.21 111.385 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 262' ' ' ALA . . . . . . . . . . . . . . . 75.95 -49.23 0.6 Allowed 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 125.651 1.581 . . . . 43.43 111.487 -175.011 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . 73.64 -69.83 0.18 Allowed 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 125.326 1.45 . . . . 70.44 110.967 177.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 47.3 t -137.33 -22.89 1.13 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.047 0.939 . . . . 51.14 110.027 176.136 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 265' ' ' LEU . . . . . . . . . . . . . 56.9 tp 57.29 94.99 0.02 OUTLIER 'General case' 0 C--N 1.357 0.911 0 C-N-CA 125.294 1.438 . . . . 64.12 111.569 178.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 266' ' ' ASN . . . . . 0.685 ' HB3' ' HD2' ' B' ' 275' ' ' LYS . 45.9 t30 -130.7 119.5 22.48 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 107.621 -1.251 . . . . 71.52 107.621 176.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 30.9 m -63.68 -33.65 76.1 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.877 0.871 . . . . 73.13 112.571 -168.142 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 8.5 p -72.66 128.7 35.72 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 N-CA-C 109.545 -0.539 . . . . 74.44 109.545 176.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 269' ' ' THR . . . . . 0.571 HG21 ' HA ' ' B' ' 223' ' ' ASP . 8.3 t -62.73 -42.6 99.74 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.27 0.628 . . . . 74.31 110.532 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 270' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' B' ' 269' ' ' THR . 4.7 pt-20 64.55 -11.32 0.13 Allowed 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 127.62 2.368 . . . . 72.41 115.716 168.152 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 271' ' ' ALA . . . . . . . . . . . . . . . 66.39 -9.32 0.32 Allowed 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 125.392 1.477 . . . . 75.3 114.785 174.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 272' ' ' ASN . . . . . 0.437 ' HA ' HG22 ' C' ' 262' ' ' THR . 96.8 m-20 -99.67 31.86 3.06 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.479 0.711 . . . . 54.14 111.116 -174.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 15.4 tm0? 62.4 -84.0 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.404 1.082 . . . . 61.32 109.901 -178.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 274' ' ' GLN . . . . . 0.44 ' HB3' ' HD3' ' B' ' 275' ' ' LYS . 7.2 tp60 65.63 -72.28 0.08 Allowed 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 126.144 1.778 . . . . 71.44 113.497 178.337 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 275' ' ' LYS . . . . . 0.685 ' HD2' ' HB3' ' B' ' 266' ' ' ASN . 2.2 mppt? -81.16 -60.96 0.41 Allowed Pre-proline 0 CA--C 1.562 1.436 0 CA-C-O 118.705 -0.664 . . . . 71.33 111.727 -172.509 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 276' ' ' PRO . . . . . 0.482 ' HD3' ' HB2' ' B' ' 275' ' ' LYS . 89.4 Cg_endo -88.66 103.93 0.43 Allowed 'Trans proline' 0 C--N 1.393 2.887 0 C-N-CA 121.949 1.766 . . . . 62.35 112.621 -172.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 277' ' ' LEU . . . . . 0.534 HD22 ' HA3' ' B' ' 255' ' ' GLY . 6.5 mp -74.95 -7.65 54.21 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 122.819 0.448 . . . . 63.32 111.388 175.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 278' ' ' LEU . . . . . 0.564 ' HB2' ' NE2' ' B' ' 252' ' ' GLN . 37.3 tp -162.32 -57.33 0.04 OUTLIER 'General case' 0 C--O 1.234 0.27 0 N-CA-C 107.525 -1.287 . . . . 62.0 107.525 172.424 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . 75.47 -77.67 1.21 Allowed Glycine 0 C--N 1.347 1.178 0 CA-C-N 115.082 -0.963 . . . . 75.43 111.651 -176.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 63.79 72.05 0.48 Allowed 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.132 1.373 . . . . 53.23 109.728 178.465 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -160.91 -47.32 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.78 -0.646 . . . . 75.31 110.06 178.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -156.93 148.13 22.05 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.726 0.81 . . . . 65.41 110.042 -178.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -170.9 -59.8 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.799 1.24 . . . . 72.33 108.324 -179.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . 96.28 137.35 9.3 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-N 114.503 -1.226 . . . . 61.45 112.958 176.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -93.54 -159.01 0.66 Allowed 'General case' 0 CA--C 1.551 0.995 0 N-CA-C 107.948 -1.13 . . . . 72.41 107.948 172.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 286' ' ' MET . . . . . . . . . . . . . 57.8 mtt -124.94 74.93 66.43 Favored Pre-proline 0 N--CA 1.488 1.463 0 CA-C-N 118.731 0.696 . . . . 64.1 111.715 -175.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 287' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -86.95 -33.13 0.17 Allowed 'Trans proline' 0 C--N 1.384 2.441 0 C-N-CA 122.732 2.288 . . . . 73.33 113.485 170.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 288' ' ' VAL . . . . . . . . . . . . . 29.3 t 53.22 -89.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 125.614 1.566 . . . . 74.32 111.717 -176.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 289' ' ' ARG . . . . . 0.541 ' NH1' ' HB3' ' B' ' 291' ' ' LEU . 0.4 OUTLIER 169.74 89.14 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 104.755 -2.313 . . . . 72.14 104.755 179.504 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 290' ' ' TRP . . . . . . . . . . . . . 70.0 m95 -93.81 143.71 26.09 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.247 0.546 . . . . 75.34 111.117 -177.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 291' ' ' LEU . . . . . 0.541 ' HB3' ' NH1' ' B' ' 289' ' ' ARG . 2.3 pt? -153.45 174.06 14.87 Favored 'General case' 0 C--O 1.243 0.714 0 CA-C-N 114.633 -1.167 . . . . 64.34 109.893 -179.279 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . -113.9 83.65 0.34 Allowed Glycine 0 C--N 1.344 0.977 0 CA-C-O 118.965 -0.908 . . . . 62.12 112.703 177.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -83.13 65.06 7.9 Favored 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 123.099 2.533 . . . . 51.12 111.31 174.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 294' ' ' LYS . . . . . 0.866 ' HA ' ' HA ' ' B' ' 190' ' ' CYS . 15.0 ptpt 55.4 8.36 0.28 Allowed 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 127.042 2.137 . . . . 41.23 115.709 174.434 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 295' ' ' ALA . . . . . 0.414 ' HB2' ' O ' ' B' ' 191' ' ' TYR . . . 61.63 -75.0 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.986 1.314 . . . . 34.32 111.593 -175.139 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 296' ' ' THR . . . . . 0.713 ' HA ' ' HB2' ' B' ' 198' ' ' GLU . 9.5 t -150.14 -15.25 0.25 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.084 0.953 . . . . 65.42 111.014 -179.007 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 20.5 t80 64.73 20.44 12.13 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 125.23 1.412 . . . . 64.12 111.915 -178.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 298' ' ' HIS . . . . . 0.534 ' H ' HG23 ' B' ' 296' ' ' THR . 65.0 m170 -72.49 85.58 1.14 Allowed 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 108.804 -0.813 . . . . 71.5 108.804 171.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . -60.91 -37.84 94.42 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-N 115.441 -0.799 . . . . 63.41 113.559 -171.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -67.68 -34.58 77.21 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.037 0.935 . . . . 72.23 111.232 176.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 301' ' ' ILE . . . . . . . . . . . . . 16.1 tt 37.32 90.28 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.366 1.315 0 C-N-CA 126.467 1.907 . . . . 72.24 112.09 -172.316 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 302' ' ' ASP . . . . . 0.452 ' O ' ' HG2' ' B' ' 303' ' ' LYS . 18.3 t70 -75.25 81.66 2.37 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.41 -0.814 . . . . 63.41 111.389 -170.404 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 303' ' ' LYS . . . . . 0.687 ' HE3' ' HA ' ' B' ' 303' ' ' LYS . 0.0 OUTLIER -172.0 -61.22 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.36 0 C-N-CA 126.891 2.076 . . . . 74.11 107.758 162.717 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 304' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -92.66 -28.37 0.14 Allowed 'Trans proline' 0 C--N 1.395 3.007 0 C-N-CA 121.863 1.709 . . . . 75.12 114.561 176.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . 50.55 -95.11 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.969 1.308 . . . . 42.33 111.826 -172.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 306' ' ' VAL . . . . . 0.523 HG21 HH12 ' B' ' 56' ' ' ARG . 26.4 m -142.06 156.58 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 125.176 1.391 . . . . 72.33 108.144 170.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 8.7 t -91.66 111.35 22.83 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 108.172 -1.048 . . . . 74.23 108.172 171.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 308' ' ' CYS . . . . . . . . . . . . . 44.3 t -88.76 21.21 3.12 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.025 0.93 . . . . 74.22 111.374 -173.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 42.2 p -77.28 112.63 24.76 Favored Pre-proline 0 CA--C 1.553 1.082 0 C-N-CA 124.166 0.986 . . . . 72.2 110.733 -177.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -74.86 107.66 2.53 Favored 'Trans proline' 0 C--N 1.377 2.037 0 C-N-CA 122.226 1.951 . . . . 63.14 110.673 174.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 311' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -72.63 136.83 80.47 Favored Pre-proline 0 CA--C 1.552 1.052 0 N-CA-C 109.245 -0.65 . . . . 73.13 109.245 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 312' ' ' PRO . . . . . 0.631 ' HG3' HD11 ' B' ' 69' ' ' LEU . 52.8 Cg_exo -57.1 166.65 3.96 Favored 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 123.076 2.518 . . . . 70.14 113.823 178.498 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 313' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -85.58 45.7 1.22 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.866 0.867 . . . . 75.13 110.48 -178.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 314' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -70.18 106.01 3.14 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.009 0.923 . . . . 72.01 108.817 -177.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 315' ' ' ASN . . . . . 0.571 ' HB3' ' HG2' ' B' ' 27' ' ' PRO . 51.8 t30 72.22 125.19 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.471 1.509 . . . . 72.12 112.037 178.225 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 316' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -102.53 -16.97 15.95 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.876 0.87 . . . . 74.4 110.964 176.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 15.2 m -91.63 106.36 18.42 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.706 0.802 . . . . 75.41 111.009 -170.136 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 318' ' ' VAL . . . . . 0.408 HG23 HG11 ' B' ' 28' ' ' VAL . 2.9 p -75.54 117.42 63.23 Favored Pre-proline 0 CA--C 1.556 1.188 0 C-N-CA 123.366 0.666 . . . . 73.13 109.576 171.078 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 319' ' ' PRO . . . . . 0.518 ' HD2' HG13 ' B' ' 28' ' ' VAL . 73.4 Cg_exo -54.55 107.5 0.23 Allowed 'Trans proline' 0 C--N 1.382 2.324 0 C-N-CA 123.07 2.513 . . . . 65.1 112.176 175.026 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 320' ' ' THR . . . . . . . . . . . . . 14.4 t -162.44 170.28 19.01 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.427 0.691 . . . . 53.31 110.328 -178.078 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 321' ' ' LEU . . . . . . . . . . . . . 50.4 tp -108.36 -90.93 0.44 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 122.887 0.475 . . . . 65.14 110.04 -178.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 322' ' ' ALA . . . . . 0.555 ' HA ' ' HB2' ' C' ' 27' ' ' LYS . . . -156.07 -62.35 0.11 Allowed 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 107.203 -1.406 . . . . 64.54 107.203 -179.039 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 323' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -82.2 101.37 10.43 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 114.97 -1.014 . . . . 74.02 108.43 169.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 324' ' ' MET . . . . . 0.514 ' HB2' ' HE2' ' C' ' 27' ' ' LYS . 17.1 tmm? -73.7 -49.14 27.17 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 106.59 -1.633 . . . . 71.32 106.59 169.771 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 325' ' ' THR . . . . . 0.42 ' HA ' ' NH2' ' C' ' 24' ' ' ARG . 91.7 m 75.16 -55.95 0.63 Allowed 'General case' 0 C--N 1.356 0.869 0 C-N-CA 126.46 1.904 . . . . 72.33 113.358 168.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 326' ' ' ASP . . . . . 0.653 ' HB3' HD12 ' B' ' 329' ' ' ILE . 1.4 t70 58.99 -92.1 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.814 0 O-C-N 124.203 0.94 . . . . 72.01 109.216 -170.359 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 327' ' ' LYS . . . . . 0.409 ' HA ' ' HD2' ' B' ' 327' ' ' LYS . 20.2 tptp 174.64 -38.86 0.01 OUTLIER 'General case' 0 C--N 1.36 1.053 0 C-N-CA 124.127 0.971 . . . . 54.34 110.376 -178.315 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 328' ' ' ALA . . . . . 0.545 ' HB2' ' HB1' ' B' ' 40' ' ' ALA . . . -138.64 -12.56 1.32 Allowed 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 115.874 1.805 . . . . 72.03 115.874 -165.357 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 329' ' ' ILE . . . . . 0.653 HD12 ' HB3' ' B' ' 326' ' ' ASP . 0.2 OUTLIER -58.2 -27.06 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.757 0 CA-C-N 120.922 1.692 . . . . 73.5 113.039 -177.197 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 330' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -106.78 -11.73 15.7 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.867 0.867 . . . . 63.42 112.426 -172.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 331' ' ' LEU . . . . . . . . . . . . . 3.4 pp -149.58 -157.33 0.81 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.611 0.764 . . . . 63.34 110.034 -177.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 332' ' ' LEU . . . . . 0.435 HD12 ' HB3' ' B' ' 335' ' ' ASN . 2.0 tm? 81.13 -41.35 0.16 Allowed 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 125.566 1.546 . . . . 74.41 111.973 174.512 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 333' ' ' SER . . . . . . . . . . . . . 19.9 m 78.76 120.91 0.05 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.917 1.687 . . . . 65.04 110.819 -173.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm 65.39 -83.06 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.488 1.515 . . . . 63.11 111.638 -175.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 335' ' ' ASN . . . . . 0.435 ' HB3' HD12 ' B' ' 332' ' ' LEU . 2.0 p-10 50.53 120.81 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 126.013 1.725 . . . . 73.25 112.421 -168.151 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 336' ' ' GLU . . . . . 0.436 ' HB2' ' HA ' ' B' ' 44' ' ' ALA . 46.8 mt-10 74.84 -51.35 0.67 Allowed 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 125.654 1.582 . . . . 61.02 113.024 -179.096 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 337' ' ' LYS . . . . . 0.57 ' HD2' ' HB2' ' B' ' 45' ' ' ARG . 61.9 tttm -52.07 -41.44 62.36 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.709 1.204 . . . . 62.43 113.049 -174.412 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 338' ' ' GLY . . . . . . . . . . . . . . . -147.03 13.06 1.46 Allowed Glycine 0 C--N 1.34 0.761 0 CA-C-N 116.133 -0.485 . . . . 72.34 112.891 177.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 339' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -146.4 125.58 12.96 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.405 0.682 . . . . 74.33 110.174 -177.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 340' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -78.2 -23.24 47.63 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 108.951 -0.759 . . . . 75.24 108.951 165.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 341' ' ' LEU . . . . . . . . . . . . . 31.4 tp 67.63 -78.01 0.04 OUTLIER 'General case' 0 C--N 1.357 0.909 0 C-N-CA 125.734 1.614 . . . . 75.34 110.62 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 342' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -161.32 27.5 0.13 Allowed 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 123.037 0.535 . . . . 64.25 109.81 -176.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 343' ' ' VAL . . . . . . . . . . . . . 7.6 p -71.51 82.45 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.236 0 CA-C-O 122.211 1.005 . . . . 64.24 110.531 -177.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 61.75 10.0 3.18 Favored 'General case' 0 C--N 1.36 1.064 0 CA-C-N 114.221 -1.354 . . . . 73.03 112.679 -177.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 345' ' ' GLY . . . . . . . . . . . . . . . 77.54 -63.18 3.41 Favored Glycine 0 C--N 1.351 1.393 0 N-CA-C 111.305 -0.718 . . . . 62.31 111.305 -170.181 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 346' ' ' ALA . . . . . . . . . . . . . . . -122.19 119.7 32.02 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.246 1.018 . . . . 72.22 109.59 172.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 18.5 m -80.03 89.5 5.36 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.624 0.769 . . . . 72.21 108.949 174.037 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 14.9 tt -155.56 30.95 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.108 0 C-N-CA 123.994 0.917 . . . . 73.42 109.006 -173.114 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 349' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 61.0 69.05 0.7 Allowed 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.64 1.176 . . . . 71.13 108.924 -172.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 350' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.37 84.58 6.62 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.041 -0.981 . . . . 74.52 108.697 -172.155 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 55.85 19.89 3.8 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 125.131 1.372 . . . . 71.32 113.647 171.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -80.55 157.06 26.19 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 122.634 0.374 . . . . 74.35 110.458 -173.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 353' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -55.33 -40.92 71.75 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.026 0.931 . . . . 74.33 111.29 175.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 354' ' ' ALA . . . . . . . . . . . . . . . 76.46 -61.9 0.43 Allowed 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 125.543 1.537 . . . . 70.11 113.738 168.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 355' ' ' ALA . . . . . . . . . . . . . . . 74.2 4.83 4.61 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 125.259 1.424 . . . . 75.44 111.312 -167.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 356' ' ' ASN . . . . . 0.412 ' N ' ' HD2' ' B' ' 357' ' ' PRO . 1.8 m-20 -76.08 -43.77 3.67 Favored Pre-proline 0 CA--C 1.557 1.223 0 C-N-CA 124.574 1.15 . . . . 74.32 111.269 175.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 357' ' ' PRO . . . . . 0.412 ' HD2' ' N ' ' B' ' 356' ' ' ASN . 58.1 Cg_endo -67.8 172.18 11.04 Favored 'Trans proline' 0 C--N 1.403 3.412 0 C-N-CA 121.877 1.718 . . . . 55.22 113.472 177.156 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 358' ' ' CYS . . . . . . . . . . . . . 48.3 t 79.34 158.11 0.17 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 126.012 1.725 . . . . 73.32 111.741 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 359' ' ' GLY . . . . . 0.418 ' HA3' ' H ' ' B' ' 239' ' ' ALA . . . -167.8 78.3 0.11 Allowed Glycine 0 C--N 1.342 0.869 0 CA-C-N 115.301 -0.863 . . . . 62.01 111.635 178.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 360' ' ' GLN . . . . . 0.556 HE21 ' HG3' ' C' ' 236' ' ' LYS . 12.3 mm-40 59.99 -153.63 0.38 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.792 1.237 . . . . 53.34 112.398 175.255 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 361' ' ' ILE . . . . . . . . . . . . . 34.2 mm -53.71 152.22 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 124.609 1.164 . . . . 61.31 111.365 178.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 362' ' ' GLY . . . . . . . . . . . . . . . -65.72 -156.39 0.32 Allowed Glycine 0 C--N 1.352 1.449 0 C-N-CA 123.287 0.47 . . . . 72.35 114.245 178.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 363' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -81.0 82.11 7.06 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 108.753 -0.832 . . . . 73.13 108.753 -175.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 364' ' ' THR . . . . . . . . . . . . . 5.5 t -92.52 -42.7 9.56 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 114.974 -1.012 . . . . 74.04 112.978 -165.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 50.2 t 58.89 105.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 124.37 1.068 . . . . 74.01 110.816 -167.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -153.28 167.61 28.77 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.675 0.79 . . . . 50.12 109.238 -174.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 367' ' ' LEU . . . . . 0.512 ' HB2' ' HA ' ' B' ' 243' ' ' GLN . 96.3 mt 58.97 100.06 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.697 1.199 . . . . 75.05 112.527 175.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 368' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -62.48 126.6 27.89 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.466 0.706 . . . . 71.23 110.738 178.031 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 369' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -137.29 128.63 28.11 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.385 0.674 . . . . 70.1 109.313 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 370' ' ' ALA . . . . . . . . . . . . . . . -162.24 105.29 1.14 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.958 0.903 . . . . 74.25 108.896 -173.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 371' ' ' VAL . . . . . . . . . . . . . 11.7 m -127.29 -48.12 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 112.905 0.706 . . . . 74.11 112.905 -168.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 372' ' ' GLN . . . . . 0.457 ' HB3' ' HG2' ' C' ' 228' ' ' GLN . 49.9 tp60 -95.43 -79.62 0.43 Allowed 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 119.237 -0.411 . . . . 63.2 110.716 -163.028 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 373' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 44.73 16.87 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.417 0 C-N-CA 127.083 2.153 . . . . 72.05 116.067 -179.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 374' ' ' ALA . . . . . 0.477 ' HB3' HH22 ' C' ' 279' ' ' ARG . . . 61.58 12.1 4.28 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.253 1.021 . . . . 71.45 112.165 -170.606 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 375' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 64.58 -77.28 0.04 OUTLIER 'General case' 0 C--N 1.356 0.875 0 C-N-CA 126.615 1.966 . . . . 62.01 110.487 -174.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -91.37 124.6 35.68 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.868 0.867 . . . . 73.13 110.803 -175.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 377' ' ' PHE . . . . . 0.441 ' O ' ' HG2' ' C' ' 279' ' ' ARG . 83.3 m-85 -86.95 -16.05 37.0 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.561 0.744 . . . . 73.31 110.469 169.009 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 378' ' ' ALA . . . . . . . . . . . . . . . -87.39 -63.78 1.25 Allowed 'General case' 0 C--N 1.344 0.352 0 C-N-CA 123.267 0.627 . . . . 61.1 110.936 -178.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 379' ' ' LYS . . . . . 0.517 ' HE2' ' HG2' ' B' ' 381' ' ' GLU 0.263 8.2 ptmm? 48.48 -77.53 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 125.915 1.686 . . . . 72.01 112.504 -164.562 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 380' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? 57.27 79.8 0.18 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.903 0.881 . . . . 53.14 111.563 -176.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 381' ' ' GLU . . . . . 0.517 ' HG2' ' HE2' ' B' ' 379' ' ' LYS . 40.9 mm-40 -90.08 -30.2 17.85 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.236 -0.438 . . . . 74.34 110.006 178.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . 64.58 58.14 10.96 Favored Glycine 0 C--N 1.351 1.39 0 N-CA-C 111.284 -0.727 . . . . 73.1 111.284 -174.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 383' ' ' ASN . . . . . . . . . . . . 0.271 10.7 p30 72.5 -16.25 0.45 Allowed 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 126.994 2.118 . . . . 73.1 114.676 176.292 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 384' ' ' THR . . . . . 0.407 HG21 ' HA ' ' A' ' 219' ' ' VAL . 3.1 m 58.6 44.52 17.48 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 124.747 1.219 . . . . 63.41 110.796 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 96.4 mt 61.77 22.97 13.4 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 124.273 1.029 . . . . 75.12 111.268 -175.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 386' ' ' VAL . . . . . 0.444 ' O ' HG22 ' B' ' 387' ' ' ILE . 3.1 t 53.05 23.19 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 C-N-CA 125.722 1.609 . . . . 62.42 111.121 -173.413 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 387' ' ' ILE . . . . . 0.475 HG23 ' H ' ' B' ' 389' ' ' THR 0.262 6.3 tt 67.33 -41.74 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 C-N-CA 128.031 2.532 . . . . 74.12 114.789 -177.253 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 388' ' ' VAL . . . . . . . . . . . . . 4.8 p 55.61 20.09 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 C-N-CA 126.185 1.794 . . . . 54.33 113.34 175.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 389' ' ' THR . . . . . 0.475 ' H ' HG23 ' B' ' 387' ' ' ILE . 56.0 m -156.02 157.5 36.24 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.162 0.985 . . . . 71.25 109.169 -176.03 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . 68.94 36.19 2.62 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 124.464 1.106 . . . . 70.34 110.695 177.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 391' ' ' ASP . . . . . 0.536 ' HB3' ' HA2' ' B' ' 436' ' ' GLY . 5.0 p-10 -75.48 -163.99 0.3 Allowed 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 114.588 -1.187 . . . . 64.12 111.123 176.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 392' ' ' HIS . . . . . . . . . . . . . 57.4 t60 -63.36 -48.23 78.78 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.144 0.978 . . . . 72.42 111.287 -176.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -99.71 5.37 45.71 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.522 0.729 . . . . 61.53 111.514 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 11.6 m170 66.46 16.91 10.56 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 124.903 1.281 . . . . 73.31 112.002 172.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . -163.11 -56.44 0.04 OUTLIER 'General case' 0 C--O 1.238 0.454 0 C-N-CA 123.633 0.773 . . . . 71.44 109.586 -172.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 77.4 p 51.73 -173.32 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 125.853 1.661 . . . . 75.55 113.572 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 397' ' ' GLN . . . . . 0.545 ' HB2' ' HB3' ' B' ' 401' ' ' PRO . 2.3 mp0 -72.24 116.67 12.95 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.549 -0.908 . . . . 71.41 108.549 170.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 398' ' ' ILE . . . . . 0.604 HG21 ' HD2' ' B' ' 415' ' ' LYS . 14.1 tt -57.71 144.69 9.85 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 O-C-N 123.826 0.704 . . . . 75.44 110.706 176.021 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 399' ' ' VAL . . . . . . . . . . . . . 58.3 t 74.68 -83.93 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 C-N-CA 125.43 1.492 . . . . 73.32 110.661 -176.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 400' ' ' ALA . . . . . . . . . . . . . . . -128.05 91.41 44.77 Favored Pre-proline 0 N--CA 1.492 1.631 0 N-CA-C 113.309 0.855 . . . . 51.41 113.309 -168.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 401' ' ' PRO . . . . . 0.545 ' HB3' ' HB2' ' B' ' 397' ' ' GLN . 68.5 Cg_endo -96.36 -171.67 0.19 Allowed 'Trans proline' 0 C--N 1.371 1.715 0 C-N-CA 123.559 2.839 . . . . 71.04 111.186 160.525 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -166.02 94.21 0.56 Allowed 'General case' 0 N--CA 1.482 1.172 0 CA-C-O 120.922 0.391 . . . . 74.34 110.799 -178.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 403' ' ' THR . . . . . 0.554 ' H ' ' HB2' ' B' ' 433' ' ' GLU . 7.5 m 61.14 12.24 3.95 Favored 'General case' 0 CA--C 1.569 1.695 0 C-N-CA 124.817 1.247 . . . . 51.3 111.897 174.337 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 404' ' ' LYS . . . . . . . . . . . . . 9.3 mtmp? -148.46 86.89 1.55 Allowed 'General case' 0 C--O 1.243 0.724 0 C-N-CA 125.363 1.465 . . . . 70.03 107.259 -171.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 405' ' ' ALA . . . . . . . . . . . . . . . -66.04 -43.66 57.71 Favored Pre-proline 0 CA--C 1.56 1.339 0 CA-C-N 115.261 -0.881 . . . . 71.24 111.944 179.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 406' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -94.02 50.41 0.31 Allowed 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 122.291 1.994 . . . . 44.44 111.386 165.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . -70.22 -71.61 0.99 Allowed Glycine 0 C--N 1.344 1.017 0 CA-C-N 115.867 -0.606 . . . . 55.33 113.741 -176.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 408' ' ' LEU . . . . . 0.458 HD13 ' N ' ' B' ' 409' ' ' THR . 0.8 OUTLIER -148.99 151.7 35.01 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 109.0 -0.741 . . . . 72.03 109.0 -170.75 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 409' ' ' THR . . . . . 0.458 ' N ' HD13 ' B' ' 408' ' ' LEU . 52.8 p 56.06 24.32 7.73 Favored 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 125.591 1.556 . . . . 73.52 111.811 -174.388 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 410' ' ' GLN . . . . . 0.502 ' HA ' ' OG1' ' B' ' 414' ' ' THR . 0.1 OUTLIER -81.06 81.34 7.32 Favored 'General case' 0 C--N 1.35 0.624 0 N-CA-C 108.073 -1.084 . . . . 51.32 108.073 178.616 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . -77.26 -62.14 1.75 Allowed 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 114.753 -1.112 . . . . 63.14 109.523 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 412' ' ' LEU . . . . . 0.578 HD12 ' HB3' ' B' ' 106' ' ' TYR . 1.7 tm? -158.95 93.72 1.18 Allowed 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 106.258 -1.756 . . . . 60.41 106.258 -178.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 78.33 -43.04 0.35 Allowed 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 125.605 1.562 . . . . 71.14 112.791 -179.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 414' ' ' THR . . . . . 0.502 ' OG1' ' HA ' ' B' ' 410' ' ' GLN . 1.7 m 66.03 37.16 5.41 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.86 1.264 . . . . 73.24 109.833 -176.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 415' ' ' LYS . . . . . 0.604 ' HD2' HG21 ' B' ' 398' ' ' ILE . 92.6 mttt 72.42 118.0 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 125.355 1.462 . . . . 73.42 110.313 -178.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -70.96 84.06 0.68 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.293 1.037 . . . . 75.33 111.067 -175.142 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 417' ' ' GLY . . . . . . . . . . . . . . . 78.26 154.02 7.01 Favored Glycine 0 C--N 1.345 1.053 0 CA-C-N 115.418 -0.81 . . . . 43.15 113.395 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 418' ' ' ALA . . . . . . . . . . . . . . . -85.87 73.26 10.38 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.101 -1.074 . . . . 70.25 108.101 170.457 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 419' ' ' VAL . . . . . . . . . . . . . 31.5 m -60.54 131.15 25.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 CA-C-N 114.117 -1.401 . . . . 62.03 112.635 -168.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 420' ' ' MET . . . . . . . . . . . . . 70.6 mtm 72.11 -59.95 0.54 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 126.082 1.753 . . . . 73.12 112.572 177.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 421' ' ' VAL . . . . . . . . . . . . . 19.9 m -58.53 -52.25 61.87 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 C-N-CA 124.235 1.014 . . . . 72.42 112.679 -177.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 422' ' ' MET . . . . . 0.486 ' HG3' ' H ' ' B' ' 424' ' ' TYR . 8.4 tpt 60.99 139.99 0.01 OUTLIER 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 124.65 1.18 . . . . 74.1 112.567 -176.461 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 423' ' ' SER . . . . . . . . . . . . . 34.5 t -81.0 -14.17 58.19 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.445 0.698 . . . . 62.22 111.821 -178.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 424' ' ' TYR . . . . . 0.486 ' H ' ' HG3' ' B' ' 422' ' ' MET . 8.5 m-85 64.87 -153.92 0.29 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.836 1.254 . . . . 72.42 110.83 -178.568 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . 107.14 74.16 0.87 Allowed Glycine 0 C--N 1.345 1.073 0 N-CA-C 109.956 -1.258 . . . . 75.12 109.956 -174.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 426' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -62.11 -35.56 79.07 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.545 0.738 . . . . 75.43 112.236 -174.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 427' ' ' SER . . . . . . . . . . . . . 27.8 t -108.14 36.9 2.62 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.376 0.67 . . . . 75.14 109.354 177.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 69.73 -74.75 0.08 Allowed 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 125.974 1.71 . . . . 73.23 111.046 -177.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 429' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 34.03 -74.45 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 127.846 2.458 . . . . 63.42 117.008 167.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -71.84 -68.05 0.49 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.396 0.678 . . . . 55.41 111.257 -170.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 11.8 p -98.34 -12.03 21.91 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-O 119.124 -0.465 . . . . 73.31 112.052 -175.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 432' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 59.48 -74.24 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 125.288 1.435 . . . . 71.1 113.988 170.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 433' ' ' GLU . . . . . 0.554 ' HB2' ' H ' ' B' ' 403' ' ' THR . 55.2 tt0 -80.76 -16.3 54.19 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.488 0.715 . . . . 73.43 110.585 175.227 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 434' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 67.91 13.42 9.16 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.677 1.191 . . . . 65.13 113.895 166.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 435' ' ' THR . . . . . . . . . . . . . 4.8 m 61.67 26.35 16.04 Favored 'General case' 0 CA--C 1.563 1.463 0 CA-C-O 122.495 1.141 . . . . 73.42 109.371 -174.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 436' ' ' GLY . . . . . 0.536 ' HA2' ' HB3' ' B' ' 391' ' ' ASP . . . 141.54 90.31 0.16 Allowed Glycine 0 C--N 1.348 1.195 0 N-CA-C 109.075 -1.61 . . . . 43.54 109.075 -168.269 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 37.1 p -85.43 70.22 10.77 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.663 0.785 . . . . 54.14 110.22 -177.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 438' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 58.65 169.66 0.06 Allowed 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 126.43 1.892 . . . . 71.55 112.935 -176.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 439' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -85.96 83.12 7.88 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 107.628 -1.249 . . . . 74.24 107.628 177.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 440' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -95.98 146.82 24.3 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.14 0.576 . . . . 70.1 110.789 -179.092 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 441' ' ' ILE . . . . . 0.601 HD12 ' HA ' ' A' ' 223' ' ' VAL . 58.7 mt -97.99 138.08 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.861 0.864 . . . . 74.15 110.58 -179.368 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 442' ' ' ALA . . . . . . . . . . . . . . . -132.87 98.91 4.43 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 107.758 -1.201 . . . . 71.41 107.758 170.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . -133.92 -67.86 0.58 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.551 0.741 . . . . 74.21 110.054 -174.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -151.6 153.12 33.86 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.838 0.855 . . . . 65.34 109.639 174.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . 125.3 -82.99 0.35 Allowed Glycine 0 CA--C 1.53 0.974 0 CA-C-O 119.229 -0.762 . . . . 74.34 111.229 -177.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 446' ' ' PRO . . . . . 0.564 ' HD3' ' HD2' ' A' ' 225' ' ' PRO . 94.5 Cg_endo -80.54 135.5 10.49 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 122.726 2.284 . . . . 63.02 112.379 -176.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 447' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -139.06 152.28 47.43 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.966 0.907 . . . . 60.0 108.998 178.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . -68.11 134.65 50.91 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.103 0.561 . . . . 74.31 109.969 175.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 449' ' ' ALA . . . . . . . . . . . . . . . -109.43 113.16 25.73 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.766 0.826 . . . . 61.52 108.916 177.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 450' ' ' ASN . . . . . 0.541 HD22 ' HG ' ' B' ' 454' ' ' LEU . 28.2 p-10 -72.51 -27.47 62.28 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.341 0.657 . . . . 61.12 111.065 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 451' ' ' VAL . . . . . 0.544 HG12 ' HA ' ' B' ' 464' ' ' MET 0.283 35.1 m 49.52 -76.77 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 C-N-CA 127.26 2.224 . . . . 63.1 114.131 177.72 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 452' ' ' VAL . . . . . 0.514 ' H ' HG23 ' B' ' 451' ' ' VAL . 62.0 t -68.64 -40.72 82.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 123.278 0.631 . . . . 60.45 109.814 -179.498 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 155.4 -163.86 31.76 Favored Glycine 0 C--N 1.338 0.68 0 CA-C-N 115.22 -0.9 . . . . 73.44 111.157 -178.112 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 454' ' ' LEU . . . . . 0.541 ' HG ' HD22 ' B' ' 450' ' ' ASN . 0.4 OUTLIER -156.92 152.01 26.19 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.085 0.554 . . . . 72.5 111.094 -179.421 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 56.8 p -92.6 3.39 55.65 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.318 1.047 . . . . 61.41 111.07 177.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -70.53 -65.8 0.68 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.965 0.906 . . . . 74.3 110.577 -178.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 457' ' ' GLN . . . . . . . . . . . . . 21.5 tm0? -170.97 134.0 0.94 Allowed 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 106.912 -1.514 . . . . 42.14 106.912 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 30.6 p -50.7 95.99 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.166 0.986 . . . . 72.13 111.653 -177.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 459' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -166.79 166.03 15.94 Favored 'General case' 0 C--O 1.243 0.741 0 C-N-CA 124.515 1.126 . . . . 73.31 108.313 -178.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 78.6 mt 62.89 33.12 15.34 Favored 'General case' 0 C--N 1.359 0.984 0 CA-C-O 122.09 0.947 . . . . 65.42 109.9 -175.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -64.67 125.55 25.11 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 114.346 -1.297 . . . . 62.31 109.832 178.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 68.9 t80 68.5 14.0 9.04 Favored 'General case' 0 CA--C 1.567 1.598 0 C-N-CA 124.498 1.119 . . . . 72.53 111.786 -179.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 84.0 m -73.9 83.56 1.7 Allowed 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 122.223 1.011 . . . . 61.35 109.086 172.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 464' ' ' MET . . . . . 0.544 ' HA ' HG12 ' B' ' 451' ' ' VAL . 54.3 mtt -128.05 137.03 52.01 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 113.986 -1.461 . . . . 75.31 108.209 -175.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -75.87 93.49 3.2 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 108.315 -0.995 . . . . 72.15 108.315 172.316 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -71.61 -172.24 0.76 Allowed 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.14 -0.936 . . . . 62.32 110.685 176.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . -60.91 -45.53 94.28 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 109.414 -0.588 . . . . 75.3 109.414 170.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 5.0 mp -109.67 -161.46 0.76 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.056 0.943 . . . . 45.51 108.786 173.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 469' ' ' GLY . . . . . . . . . . . . . . . -84.54 177.62 51.45 Favored Glycine 0 C--N 1.35 1.308 0 N-CA-C 112.334 -0.307 . . . . 50.44 112.334 171.189 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 470' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.47 121.96 14.13 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 122.929 0.492 . . . . 73.2 110.667 -178.315 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 471' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.258 1.537 0 C-N-CA 124.978 1.311 . . . . 74.2 110.394 175.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 64.6 mtm . . . . . 0 N--CA 1.471 0.621 0 N-CA-C 109.481 -0.563 . . . . 55.23 109.481 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.7 21.15 7.03 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.662 1.185 . . . . 65.31 113.026 177.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -86.91 45.28 1.25 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.418 0.687 . . . . 52.01 110.588 -178.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -39.42 100.76 0.02 OUTLIER 'General case' 0 C--N 1.351 0.674 0 C-N-CA 125.301 1.44 . . . . 70.52 112.996 171.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -76.42 123.18 25.6 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 106.445 -1.687 . . . . 63.2 106.445 166.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -72.4 96.0 1.83 Allowed 'General case' 0 C--O 1.245 0.818 0 N-CA-C 108.705 -0.85 . . . . 63.22 108.705 -176.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 7' ' ' TYR . . . . . 0.432 ' CE2' HG21 ' C' ' 56' ' ' VAL . 50.2 m-85 -66.89 -24.2 66.08 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 113.893 -1.503 . . . . 73.43 112.083 -169.099 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -66.36 -49.11 68.0 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.803 -0.443 . . . . 72.53 109.803 174.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.09 -41.87 97.47 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 123.635 0.584 . . . . 52.31 110.986 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 58.3 mt -59.05 -41.83 84.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 123.645 0.591 . . . . 63.34 110.715 176.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 11' ' ' LEU . . . . . 0.429 ' HB2' HG22 ' C' ' 13' ' ' VAL . 78.4 mt -69.97 -26.24 64.0 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 115.994 -0.548 . . . . 45.45 111.869 174.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.95 22.31 55.52 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-N 116.694 -0.23 . . . . 64.33 112.953 -173.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 13' ' ' VAL . . . . . 0.429 HG22 ' HB2' ' C' ' 11' ' ' LEU . 19.0 m -107.23 150.5 40.02 Favored Pre-proline 0 N--CA 1.481 1.077 0 C-N-CA 124.184 0.994 . . . . 64.04 109.588 174.156 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -66.38 163.15 33.33 Favored 'Trans proline' 0 C--N 1.371 1.738 0 C-N-CA 122.455 2.103 . . . . 74.43 111.809 178.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -77.27 21.59 0.24 Allowed 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 123.175 0.59 . . . . 71.52 112.326 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -131.49 18.3 4.81 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.1 1.36 . . . . 71.24 107.691 173.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.23 123.72 18.07 Favored 'General case' 0 C--N 1.353 0.74 0 C-N-CA 124.166 0.986 . . . . 71.14 111.322 -178.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 44.0 p -66.72 170.29 6.65 Favored 'General case' 0 C--O 1.251 1.168 0 N-CA-C 109.059 -0.719 . . . . 74.41 109.059 170.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 59.4 tp60 -61.43 -36.42 80.31 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.538 -0.301 . . . . 74.45 111.081 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 20' ' ' GLU . . . . . 0.448 ' HB3' ' NH1' ' C' ' 24' ' ' ARG . 0.1 OUTLIER -73.27 -36.59 66.38 Favored 'General case' 0 C--O 1.212 -0.91 0 CA-C-O 118.869 -0.586 . . . . 64.05 110.171 179.773 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -55.93 -48.79 75.07 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.383 0.611 . . . . 73.42 111.188 174.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 22' ' ' ILE . . . . . 0.544 HD13 ' HB3' ' C' ' 57' ' ' LEU . 71.7 mt -61.6 -43.05 96.36 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-N 114.743 -1.117 . . . . 61.32 110.964 176.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 23' ' ' LYS . . . . . 0.542 ' O ' ' HG3' ' C' ' 27' ' ' LYS . 13.1 tppt? -68.76 -25.45 64.73 Favored 'General case' 0 CA--C 1.558 1.287 0 CA-C-N 115.34 -0.845 . . . . 74.13 110.158 179.214 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 24' ' ' ARG . . . . . 0.448 ' NH1' ' HB3' ' C' ' 20' ' ' GLU . 68.5 mtt85 -71.94 -50.95 24.66 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.775 0.83 . . . . 73.52 110.283 178.119 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.87 -37.73 74.45 Favored 'General case' 0 C--O 1.246 0.917 0 O-C-N 124.296 0.997 . . . . 75.32 110.293 177.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 26' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -56.31 -71.37 0.09 Allowed 'General case' 0 C--N 1.358 0.968 0 CA-C-O 117.642 -1.171 . . . . 72.31 110.487 172.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 27' ' ' LYS . . . . . 0.555 ' HB2' ' HA ' ' B' ' 322' ' ' ALA . 39.0 mttp -50.24 -39.59 45.17 Favored 'General case' 0 N--CA 1.504 2.237 0 C-N-CA 123.633 0.773 . . . . 74.1 112.259 -173.365 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -54.75 -62.7 1.49 Allowed 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.691 1.197 . . . . 71.15 110.852 176.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 29' ' ' LEU . . . . . 0.514 HD13 HD13 ' C' ' 50' ' ' ILE . 42.3 mt -81.66 -8.81 59.75 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 115.25 -0.886 . . . . 60.22 111.256 -175.351 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 30' ' ' ALA . . . . . 0.463 ' HA ' ' HE1' ' C' ' 47' ' ' PHE . . . -93.36 -14.51 26.79 Favored 'General case' 0 C--O 1.215 -0.763 0 C-N-CA 124.23 1.012 . . . . 75.32 110.579 179.17 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 54.1 mtm180 -92.4 -41.67 10.19 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 109.245 -0.65 . . . . 73.5 109.245 164.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 23.9 tp60 -63.78 -50.61 68.35 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.764 0.826 . . . . 71.12 111.564 -175.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 33' ' ' TYR . . . . . 0.428 ' HE2' HD22 ' C' ' 29' ' ' LEU . 32.6 m-85 -104.26 20.16 18.87 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.235 0.614 . . . . 70.15 110.846 -177.596 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 34' ' ' HIS . . . . . 0.429 ' CD2' ' HB3' ' C' ' 36' ' ' ASP . 5.8 t60 -62.57 114.48 12.17 Favored Pre-proline 0 N--CA 1.475 0.819 0 CA-C-O 118.405 -0.807 . . . . 72.34 109.461 -179.171 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -51.15 -33.47 44.09 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 123.345 2.696 . . . . 71.32 114.414 -173.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 36' ' ' ASP . . . . . 0.429 ' HB3' ' CD2' ' C' ' 34' ' ' HIS . 15.7 t70 -68.51 -44.13 75.32 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.745 0.818 . . . . 60.34 111.639 177.404 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 61.5 t -80.51 -51.14 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 CA-C-O 121.495 0.664 . . . . 75.33 110.05 -173.15 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -112.67 96.79 6.17 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 114.809 -1.087 . . . . 54.22 108.939 177.099 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -84.08 67.03 9.53 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.899 0.479 . . . . 62.24 109.961 178.093 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 49.4 m -124.41 109.77 28.73 Favored Pre-proline 0 N--CA 1.477 0.878 0 C-N-CA 123.645 0.778 . . . . 74.14 108.933 177.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -43.82 -47.21 10.09 Favored 'Trans proline' 0 C--N 1.386 2.547 0 C-N-CA 124.197 3.265 . . . . 63.44 113.775 -177.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -55.25 -42.36 73.4 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.913 0.885 . . . . 65.44 111.299 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.68 -27.37 61.19 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 114.972 -1.013 . . . . 62.05 110.754 -178.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -81.51 -24.69 36.51 Favored 'General case' 0 C--N 1.352 0.689 0 O-C-N 123.774 0.671 . . . . 74.04 109.955 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -73.32 -45.07 57.5 Favored 'General case' 0 C--O 1.244 0.774 0 C-N-CA 123.709 0.804 . . . . 42.53 109.688 173.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 46' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -60.83 -41.03 94.99 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 115.605 -0.725 . . . . 72.32 110.36 171.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 47' ' ' PHE . . . . . 0.463 ' HE1' ' HA ' ' C' ' 30' ' ' ALA . 84.6 t80 -57.09 -45.99 82.92 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 124.149 0.906 . . . . 62.23 109.933 176.705 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 48' ' ' LYS . . . . . 0.484 ' HE3' ' HB3' ' C' ' 89' ' ' ASP . 48.5 mtpt -58.98 -46.26 88.54 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 123.965 0.791 . . . . 72.04 111.555 178.286 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -60.56 -43.15 97.56 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.303 0.573 . . . . 72.33 112.099 178.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 50' ' ' ILE . . . . . 0.514 HD13 HD13 ' C' ' 29' ' ' LEU . 82.8 mt -70.56 -29.35 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 124.187 0.995 . . . . 75.43 110.526 178.378 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 51' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -90.21 -5.58 56.23 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.802 0.841 . . . . 74.04 111.212 178.164 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -78.0 -48.49 16.06 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 107.319 -1.363 . . . . 63.42 107.319 164.11 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 53' ' ' ALA . . . . . 0.428 ' HA ' ' CD1' ' C' ' 7' ' ' TYR . . . -53.87 -43.6 69.7 Favored 'General case' 0 C--N 1.344 0.331 0 CA-C-N 113.236 -1.802 . . . . 63.1 111.29 174.235 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -79.32 -30.37 42.75 Favored 'General case' 0 C--O 1.214 -0.8 0 CA-C-N 114.934 -1.03 . . . . 75.01 111.111 176.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.82 -36.92 68.01 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 119.01 0.823 . . . . 60.54 111.172 176.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 56' ' ' VAL . . . . . 0.436 HG13 ' HZ ' ' C' ' 101' ' ' PHE . 35.3 t -78.78 -55.02 10.82 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 CA-C-N 114.894 -1.048 . . . . 72.43 110.445 174.024 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 57' ' ' LEU . . . . . 0.544 ' HB3' HD13 ' C' ' 22' ' ' ILE . 79.4 mt -92.56 19.18 7.59 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 113.021 0.749 . . . . 75.02 113.021 -168.455 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 29.9 t -51.31 -61.48 2.21 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.852 1.261 . . . . 62.42 113.657 -177.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -133.03 151.59 78.2 Favored Pre-proline 0 N--CA 1.476 0.846 0 N-CA-C 108.422 -0.955 . . . . 72.03 108.422 -172.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 60' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -41.01 -31.53 0.77 Allowed 'Trans proline' 0 C--N 1.386 2.528 0 C-N-CA 124.997 3.798 . . . . 33.23 116.417 -175.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -70.13 -58.97 3.2 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 118.078 0.399 . . . . 62.13 111.242 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -65.23 -28.63 69.5 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.028 0.442 . . . . 75.23 111.544 179.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 45.0 tpt85 -54.71 -53.46 54.68 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.371 1.069 . . . . 64.42 110.001 168.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -73.11 -19.16 61.2 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 115.806 -0.634 . . . . 74.15 112.386 -179.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 68.0 mt -65.34 -44.46 94.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 N-CA-C 108.869 -0.789 . . . . 62.34 108.869 170.456 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -60.54 -47.76 84.77 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.725 -0.67 . . . . 74.22 110.334 173.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -56.62 -45.79 81.3 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.312 0.645 . . . . 73.14 111.814 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 67.2 p -71.62 -25.48 62.18 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.197 -0.456 . . . . 63.2 110.829 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 69' ' ' TYR . . . . . 0.425 ' CD1' HD13 ' C' ' 100' ' ' LEU . 5.6 t80 -79.68 137.07 36.95 Favored 'General case' 0 C--N 1.358 0.953 0 N-CA-C 109.728 -0.471 . . . . 75.22 109.728 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.48 17.89 53.82 Favored Glycine 0 N--CA 1.473 1.144 0 N-CA-C 111.339 -0.704 . . . . 62.51 111.339 -170.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 87.7 m -147.32 -58.98 0.27 Allowed 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 103.615 -2.735 . . . . 72.34 103.615 176.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 34.7 m -84.48 148.96 26.26 Favored 'General case' 0 C--O 1.249 1.048 0 N-CA-C 105.403 -2.073 . . . . 73.35 105.403 156.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.96 -16.13 7.65 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.929 0.892 . . . . 73.23 110.202 -176.27 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.92 125.88 87.64 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 123.086 0.554 . . . . 53.23 109.781 174.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -61.57 148.49 92.89 Favored 'Trans proline' 0 C--N 1.372 1.804 0 C-N-CA 122.684 2.256 . . . . 75.14 111.373 169.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -65.83 165.24 24.13 Favored 'Trans proline' 0 CA--C 1.56 1.806 0 C-N-CA 122.735 2.29 . . . . 63.14 112.725 -179.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -67.37 158.54 56.56 Favored 'Trans proline' 0 C--N 1.374 1.918 0 C-N-CA 122.868 2.379 . . . . 51.51 111.427 167.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 78' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.27 116.83 3.5 Favored 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 122.498 2.132 . . . . 74.44 111.758 175.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -66.7 155.67 69.37 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 122.469 2.112 . . . . 61.04 110.087 177.126 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_exo -46.52 76.27 0.01 OUTLIER 'Trans proline' 0 N--CA 1.509 2.428 0 C-N-CA 124.819 3.68 . . . . 51.5 116.309 -172.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 137.51 -47.06 0.97 Allowed Glycine 0 CA--C 1.53 1.01 0 CA-C-N 115.879 -0.6 . . . . 75.2 112.266 -178.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.406 ' HA3' ' CE1' ' C' ' 106' ' ' PHE . . . 141.25 164.61 10.03 Favored Glycine 0 N--CA 1.473 1.151 0 N-CA-C 109.799 -1.32 . . . . 74.45 109.799 -174.353 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -70.18 115.15 9.05 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 122.945 0.498 . . . . 70.14 110.028 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -52.09 121.99 7.74 Favored 'General case' 0 C--O 1.242 0.662 0 O-C-N 124.698 1.249 . . . . 63.13 111.661 176.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 85' ' ' PHE . . . . . 0.518 ' HA ' ' HD2' ' C' ' 88' ' ' PHE . 56.3 m-85 -135.39 59.23 1.73 Allowed 'General case' 0 N--CA 1.475 0.789 0 O-C-N 124.074 0.859 . . . . 74.41 110.444 169.649 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 25.0 m -61.0 89.59 0.02 OUTLIER 'General case' 0 C--N 1.354 0.783 0 CA-C-N 114.311 -1.313 . . . . 45.43 113.326 179.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 79.74 13.45 82.35 Favored Glycine 0 C--N 1.35 1.36 0 CA-C-N 115.271 -0.877 . . . . 74.33 112.967 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 88' ' ' PHE . . . . . 0.518 ' HD2' ' HA ' ' C' ' 85' ' ' PHE . 5.7 m-85 -100.8 119.77 39.13 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 107.657 -1.238 . . . . 74.44 107.657 -178.05 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 89' ' ' ASP . . . . . 0.484 ' HB3' ' HE3' ' C' ' 48' ' ' LYS . 62.7 t0 -80.19 72.21 6.99 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-O 121.647 0.737 . . . . 72.23 110.622 -176.52 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 90' ' ' VAL . . . . . 0.579 HG23 ' HE2' ' C' ' 97' ' ' PHE . 5.3 p -49.91 -42.53 18.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 125.416 1.486 . . . . 54.41 113.261 -176.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -66.39 -23.07 66.26 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.512 0.725 . . . . 74.21 111.575 -173.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -90.38 -19.54 23.86 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.429 0.691 . . . . 75.53 111.112 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 20.1 m-30 -77.81 178.02 7.72 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.138 0.575 . . . . 72.45 111.778 -174.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 94' ' ' SER . . . . . 0.419 ' O ' ' HB3' ' C' ' 97' ' ' PHE . 78.4 p -62.16 153.87 28.94 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.607 0.763 . . . . 45.51 112.323 -171.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 95' ' ' GLU . . . . . 0.455 ' O ' ' HG3' ' C' ' 99' ' ' GLU . 0.0 OUTLIER -68.49 -32.14 71.9 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.723 -0.671 . . . . 55.43 111.199 178.582 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -51.38 -53.1 39.84 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.131 0.972 . . . . 65.02 110.556 169.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 97' ' ' PHE . . . . . 0.579 ' HE2' HG23 ' C' ' 90' ' ' VAL . 48.6 t80 -56.6 -47.51 79.46 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-N 113.775 -1.557 . . . . 64.25 110.327 178.35 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -76.58 -9.21 58.49 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 114.753 -1.112 . . . . 51.52 112.988 -176.06 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 99' ' ' GLU . . . . . 0.455 ' HG3' ' O ' ' C' ' 95' ' ' GLU . 61.7 mt-10 -82.61 -51.31 7.87 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.211 0.604 . . . . 74.43 109.563 166.555 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 100' ' ' LEU . . . . . 0.425 HD13 ' CD1' ' C' ' 69' ' ' TYR . 18.7 tp -59.35 -44.84 92.62 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 114.438 -1.256 . . . . 73.23 111.911 -171.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 101' ' ' PHE . . . . . 0.436 ' HZ ' HG13 ' C' ' 56' ' ' VAL . 48.2 m-85 -105.38 11.47 32.69 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.375 0.27 . . . . 73.25 111.03 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -42.23 -64.63 1.48 Allowed Glycine 0 C--N 1.357 1.745 0 C-N-CA 124.823 1.201 . . . . 54.11 114.538 -171.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -29.93 -31.44 0.02 OUTLIER 'Trans proline' 0 C--N 1.389 2.69 1 C-N-CA 126.299 4.666 . . . . 62.02 117.266 176.599 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -156.83 52.67 0.41 Allowed Glycine 0 C--N 1.354 1.538 0 C-N-CA 120.934 -0.651 . . . . 43.23 113.024 179.145 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 105' ' ' LEU . . . . . 0.532 ' HB3' HG21 ' C' ' 90' ' ' VAL . 92.7 mt -55.88 13.86 0.0 OUTLIER 'General case' 0 CA--C 1.579 2.065 0 N-CA-C 117.218 2.303 . . . . 73.03 117.218 177.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 106' ' ' PHE . . . . . 0.788 ' HA ' ' HB3' ' C' ' 114' ' ' ARG 0.302 2.2 m-30 46.51 -98.98 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 121.008 1.731 . . . . 64.24 113.444 178.484 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . 112.71 47.83 0.66 Allowed Glycine 0 C--O 1.229 -0.212 0 N-CA-C 115.55 0.98 . . . . 51.05 115.55 170.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . -15.75 -70.76 0.01 OUTLIER Glycine 0 N--CA 1.49 2.296 0 C-N-CA 125.026 1.298 . . . . 74.41 115.115 161.122 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 109' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -97.38 -4.27 38.69 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.075 0.95 . . . . 74.45 111.704 178.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 110' ' ' GLY . . . . . . . . . . . . . . . -73.65 -16.8 79.04 Favored Glycine 0 C--N 1.357 1.706 0 N-CA-C 111.521 -0.632 . . . . 54.22 111.521 175.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 88.0 mtt-85 79.68 -40.52 0.22 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.896 2.078 . . . . 75.25 113.856 166.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 112' ' ' ARG . . . . . . . . . . . . . 3.3 tpp180 -126.75 -39.54 1.97 Allowed 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 119.47 1.032 . . . . 74.1 112.626 174.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 113' ' ' SER . . . . . . . . . . . . . 15.3 m -7.31 -36.23 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.696 0 N-CA-C 120.066 3.358 . . . . 72.53 120.066 -176.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 114' ' ' ARG . . . . . 0.788 ' HB3' ' HA ' ' C' ' 106' ' ' PHE . 1.6 tpm_? -164.17 170.93 15.71 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 125.548 1.539 . . . . 74.05 107.983 169.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 115' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -78.14 114.12 16.72 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 118.59 -0.719 . . . . 54.14 110.469 175.173 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -61.85 109.35 2.49 Favored Glycine 0 C--N 1.359 1.831 0 N-CA-C 109.813 -1.315 . . . . 45.25 109.813 166.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 117' ' ' ARG . . . . . 0.511 ' HD3' HD13 ' B' ' 59' ' ' LEU . 67.0 mtt180 -97.49 113.13 24.76 Favored 'General case' 0 C--O 1.257 1.463 0 CA-C-O 122.304 1.049 . . . . 64.44 110.903 -172.052 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -74.36 109.28 7.72 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 111.612 -2.54 . . . . 75.42 105.647 162.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 119' ' ' LEU . . . . . 0.629 HD12 ' HA2' ' C' ' 165' ' ' GLY . 70.0 mt -91.01 106.84 18.8 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.341 -0.391 . . . . 75.21 110.445 -162.354 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -90.01 94.45 9.8 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 106.604 -1.628 . . . . 72.31 106.604 -178.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 121' ' ' ALA . . . . . 0.619 ' HA ' HG23 ' B' ' 185' ' ' VAL . . . -105.44 113.8 27.6 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 109.104 -0.702 . . . . 63.21 109.104 -171.19 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 122' ' ' GLU . . . . . 0.542 ' CD ' ' HZ1' ' B' ' 189' ' ' LYS . 5.2 tm-20 -73.31 107.74 5.79 Favored 'General case' 0 C--O 1.244 0.775 0 N-CA-C 106.981 -1.489 . . . . 73.22 106.981 171.541 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -116.13 137.27 23.31 Favored Pre-proline 0 N--CA 1.474 0.756 0 CA-C-O 120.48 0.181 . . . . 73.3 111.465 -179.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.13 116.84 4.54 Favored 'Trans proline' 0 C--N 1.371 1.734 0 C-N-CA 122.984 2.456 . . . . 72.51 110.802 168.511 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 125' ' ' LEU . . . . . 0.484 ' HB3' HG13 ' C' ' 178' ' ' VAL . 13.6 tp -152.63 161.28 42.78 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 109.479 -0.563 . . . . 74.03 109.479 -178.518 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 126' ' ' THR . . . . . 0.462 ' HB ' ' HG ' ' C' ' 181' ' ' LEU . 6.2 t -125.98 175.25 7.84 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.56 0.695 . . . . 61.53 109.96 171.557 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 127' ' ' LEU . . . . . 0.516 HD21 HD13 ' C' ' 180' ' ' LEU . 13.6 mt -60.4 -48.52 81.41 Favored 'General case' 0 C--O 1.245 0.821 0 C-N-CA 125.55 1.54 . . . . 62.25 110.303 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 128' ' ' GLU . . . . . 0.521 ' HG3' ' HA ' ' C' ' 215' ' ' LEU . 8.5 mp0 -63.55 -33.06 74.75 Favored 'General case' 0 C--O 1.215 -0.723 0 CA-C-N 114.009 -1.45 . . . . 75.24 110.748 178.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 129' ' ' GLU . . . . . 0.413 ' HA ' ' HB2' ' C' ' 132' ' ' HIS . 19.4 mm-40 -84.65 -13.65 50.89 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.779 0.832 . . . . 73.53 111.771 178.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 130' ' ' ALA . . . . . 0.516 ' HB2' HG12 ' C' ' 153' ' ' VAL . . . -76.33 -34.61 59.0 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.876 -0.787 . . . . 64.34 108.876 170.115 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 131' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -70.54 -46.28 63.89 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 113.993 -1.458 . . . . 75.55 111.512 168.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 132' ' ' HIS . . . . . 0.413 ' HB2' ' HA ' ' C' ' 129' ' ' GLU . 35.8 m170 -80.65 -9.71 59.77 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 123.365 0.666 . . . . 60.22 111.02 -178.488 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -66.44 -120.16 0.01 OUTLIER Glycine 0 C--N 1.354 1.528 0 O-C-N 123.921 0.763 . . . . 65.31 113.371 177.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . 64.85 -103.69 0.81 Allowed Glycine 0 C--N 1.342 0.91 0 N-CA-C 110.852 -0.899 . . . . 53.24 110.852 -173.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 135' ' ' GLU . . . . . 0.71 ' HG3' ' HB2' ' C' ' 148' ' ' ARG . 2.7 mp0 -87.94 94.06 9.66 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.03 0.932 . . . . 71.2 109.277 -177.411 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 136' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -142.41 166.95 23.28 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.502 0.721 . . . . 72.12 110.263 -177.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 137' ' ' VAL . . . . . . . . . . . . . 17.7 m -73.89 88.66 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.1 0 CA-C-N 115.251 -0.886 . . . . 71.12 111.202 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 138' ' ' VAL . . . . . 0.53 ' O ' ' HA ' ' C' ' 144' ' ' ARG . 37.4 t -80.21 129.76 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.912 0.885 . . . . 72.14 109.819 175.401 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 139' ' ' GLU . . . . . 0.47 ' HB3' HH12 ' B' ' 46' ' ' ARG . 8.3 tp10 -124.95 113.73 18.21 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 108.3 -1.0 . . . . 74.31 108.3 169.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 140' ' ' VAL . . . . . 0.617 HG13 ' HB ' ' B' ' 185' ' ' VAL . 30.7 t -150.02 126.88 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.215 1.006 . . . . 63.22 108.341 167.714 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 65.04 32.4 10.43 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.172 0.989 . . . . 15.23 112.895 172.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 73.03 26.94 69.64 Favored Glycine 0 C--N 1.344 0.991 0 N-CA-C 111.722 -0.551 . . . . 45.25 111.722 -178.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 143' ' ' ARG . . . . . . . . . . . . . 45.2 mtp180 -115.74 96.27 5.53 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 107.539 -1.282 . . . . 73.04 107.539 171.17 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 144' ' ' ARG . . . . . 0.54 ' HD3' ' HA ' ' B' ' 48' ' ' THR . 29.2 ttp-105 -114.25 104.22 11.87 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 123.491 0.716 . . . . 71.51 109.539 -178.328 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 145' ' ' VAL . . . . . . . . . . . . . 7.7 p -150.47 146.21 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.34 0.656 . . . . 75.03 110.639 -175.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 24.7 m -77.62 88.29 3.92 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 108.601 -0.889 . . . . 54.21 108.601 171.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 11.2 p -117.18 154.44 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.656 0.782 . . . . 72.53 109.91 -173.056 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 148' ' ' ARG . . . . . 0.71 ' HB2' ' HG3' ' C' ' 135' ' ' GLU . 31.5 ttt85 -92.54 114.27 26.77 Favored 'General case' 0 C--O 1.242 0.669 0 O-C-N 123.801 0.688 . . . . 74.22 111.02 177.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 149' ' ' ILE . . . . . 0.449 HD12 HD13 ' C' ' 159' ' ' ILE . 26.2 pt -94.47 154.26 40.24 Favored Pre-proline 0 CA--C 1.552 1.028 0 N-CA-C 107.493 -1.299 . . . . 71.41 107.493 163.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -51.15 115.6 2.15 Favored 'Trans proline' 0 CA--C 1.565 2.038 0 C-N-CA 122.311 2.007 . . . . 61.44 111.378 174.108 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -61.36 113.45 1.78 Allowed 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 123.359 2.706 . . . . 73.2 111.169 -178.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 152' ' ' GLY . . . . . . . . . . . . . . . 129.28 142.15 5.24 Favored Glycine 0 C--N 1.34 0.779 0 O-C-N 123.449 0.468 . . . . 54.32 114.13 -172.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 153' ' ' VAL . . . . . 0.516 HG12 ' HB2' ' C' ' 130' ' ' ALA . 3.0 p -164.69 168.36 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.39 0 N-CA-C 112.524 0.564 . . . . 71.13 112.524 174.664 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 154' ' ' ARG . . . . . 0.628 HH11 ' HB3' ' B' ' 22' ' ' ARG . 0.8 OUTLIER -125.81 169.48 12.57 Favored 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 125.806 1.642 . . . . 75.32 108.563 176.96 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 155' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -65.06 128.45 35.83 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.158 0.583 . . . . 74.51 110.289 169.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 71.82 12.0 74.19 Favored Glycine 0 C--N 1.348 1.215 0 O-C-N 123.891 0.744 . . . . 64.51 113.478 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 157' ' ' SER . . . . . 0.471 ' HB2' ' HB3' ' C' ' 154' ' ' ARG . 43.6 t -78.82 140.98 38.1 Favored 'General case' 0 C--O 1.252 1.206 0 C-N-CA 123.117 0.567 . . . . 75.43 109.903 -179.073 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 158' ' ' VAL . . . . . 0.477 HG23 ' HB3' ' C' ' 175' ' ' LEU . 5.4 p -108.78 96.94 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 O-C-N 125.077 1.485 . . . . 64.44 108.956 -174.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 159' ' ' ILE . . . . . 0.616 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 56.4 mt -78.41 111.45 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 108.687 -0.857 . . . . 52.25 108.687 178.394 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 26.4 ttt180 -85.58 107.94 17.73 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 108.826 -0.805 . . . . 72.21 108.826 173.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 161' ' ' VAL . . . . . . . . . . . . . 2.2 t -98.17 105.66 30.0 Favored Pre-proline 0 CA--C 1.557 1.228 0 N-CA-C 106.219 -1.771 . . . . 75.24 106.219 171.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -64.68 132.02 31.43 Favored 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 123.512 2.808 . . . . 63.42 113.042 -171.028 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 64.83 19.57 65.52 Favored Glycine 0 C--N 1.347 1.194 0 O-C-N 124.01 0.819 . . . . 53.31 113.348 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 164' ' ' MET . . . . . . . . . . . . . 31.8 mmm -110.08 -2.48 16.96 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.583 0.753 . . . . 73.35 111.753 -178.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 165' ' ' GLY . . . . . 0.629 ' HA2' HD12 ' C' ' 119' ' ' LEU . . . -89.5 -111.87 1.33 Allowed Glycine 0 C--N 1.347 1.162 0 N-CA-C 108.293 -1.923 . . . . 64.24 108.293 164.19 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . -156.78 118.11 0.82 Allowed Glycine 0 C--N 1.335 0.498 0 C-N-CA 120.692 -0.766 . . . . 75.44 111.831 161.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 167' ' ' GLN . . . . . 0.556 ' HA ' ' HA ' ' C' ' 171' ' ' PRO . 15.0 mm-40 -71.23 101.9 2.42 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 107.792 -1.188 . . . . 64.31 107.792 175.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . -115.77 -125.5 3.88 Favored Glycine 0 N--CA 1.467 0.758 0 N-CA-C 110.275 -1.13 . . . . 13.44 110.275 178.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 169' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -61.41 -67.19 1.15 Allowed Pre-proline 0 CA--C 1.574 1.865 0 CA-C-N 117.956 0.878 . . . . 62.44 110.562 175.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 170' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -93.94 113.82 0.22 Allowed 'Trans proline' 0 C--N 1.393 2.878 0 CA-C-N 122.107 1.788 . . . . 51.41 109.143 163.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 171' ' ' PRO . . . . . 0.556 ' HA ' ' HA ' ' C' ' 167' ' ' GLN . 6.5 Cg_exo -33.87 131.78 0.15 Allowed 'Trans proline' 0 C--N 1.372 1.763 0 C-N-CA 124.609 3.54 . . . . 74.02 115.514 -178.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 172' ' ' GLY . . . . . 0.549 ' H ' ' HA ' ' C' ' 167' ' ' GLN . . . -120.85 115.93 3.04 Favored Glycine 0 C--N 1.341 0.828 0 N-CA-C 110.968 -0.853 . . . . 74.42 110.968 -171.337 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 173' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -107.75 158.9 16.91 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 108.512 -0.921 . . . . 74.51 108.512 175.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 174' ' ' LEU . . . . . 0.442 HD11 HG21 ' C' ' 140' ' ' VAL . 9.8 tp -81.41 107.56 14.29 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 109.739 -0.467 . . . . 75.22 109.739 -177.252 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 175' ' ' LEU . . . . . 0.477 ' HB3' HG23 ' C' ' 158' ' ' VAL . 78.6 mt -95.12 82.22 3.75 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.43 1.092 . . . . 71.32 110.084 179.505 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 176' ' ' LEU . . . . . 0.616 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 75.7 mt -68.4 100.76 1.12 Allowed 'General case' 0 CA--C 1.546 0.804 0 CA-C-O 121.022 0.439 . . . . 43.02 110.86 178.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 177' ' ' VAL . . . . . . . . . . . . . 61.0 t -85.53 101.57 10.11 Favored 'Isoleucine or valine' 0 C--O 1.244 0.784 0 C-N-CA 124.147 0.979 . . . . 74.43 108.398 176.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 178' ' ' VAL . . . . . 0.484 HG13 ' HB3' ' C' ' 125' ' ' LEU . 52.1 t -84.93 135.82 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 N-CA-C 112.538 0.57 . . . . 74.01 112.538 -174.256 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 179' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -110.76 113.27 25.73 Favored 'General case' 0 C--O 1.254 1.33 0 C-N-CA 124.981 1.312 . . . . 72.33 108.436 169.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 180' ' ' LEU . . . . . 0.516 HD13 HD21 ' C' ' 127' ' ' LEU . 91.8 mt -76.53 153.76 35.15 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 124.572 1.149 . . . . 70.51 111.445 178.503 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 181' ' ' LEU . . . . . 0.623 HD22 ' HB2' ' B' ' 191' ' ' TYR . 8.2 mt -65.73 168.4 8.75 Favored Pre-proline 0 N--CA 1.49 1.553 0 C-N-CA 123.105 0.562 . . . . 74.2 110.892 -179.342 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -60.45 70.07 0.07 OUTLIER 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 122.482 2.121 . . . . 64.12 110.793 160.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 183' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -160.44 62.39 1.73 Allowed Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 106.753 -1.573 . . . . 62.13 106.753 -167.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 184' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -85.34 64.53 5.97 Favored 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 123.03 2.486 . . . . 71.54 111.217 -170.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 185' ' ' VAL . . . . . 0.618 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 18.1 t -95.55 -56.42 5.22 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.905 0 N-CA-C 107.826 -1.176 . . . . 72.23 107.826 -173.464 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 186' ' ' PHE . . . . . 0.478 ' HD1' ' HB2' ' C' ' 195' ' ' ALA . 33.9 m-85 -114.8 153.66 29.99 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.56 0.744 . . . . 61.44 110.832 -174.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 187' ' ' ARG . . . . . . . . . . . . . 7.5 mtm180 -143.42 115.74 8.5 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.569 1.148 . . . . 75.14 108.772 175.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 188' ' ' LEU . . . . . 0.536 HD13 ' HD2' ' C' ' 240' ' ' PHE . 55.6 tp -77.48 143.27 38.63 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.973 0.731 . . . . 74.14 112.973 -171.186 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -141.76 105.22 4.67 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 107.14 -1.429 . . . . 71.33 107.14 166.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 74.32 -101.06 1.21 Allowed Glycine 0 CA--C 1.536 1.37 0 N-CA-C 111.885 -0.486 . . . . 74.2 111.885 -175.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 191' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -123.14 -5.13 8.41 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 124.246 1.018 . . . . 60.21 110.744 172.287 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -101.92 140.14 36.61 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.299 0.64 . . . . 65.13 110.088 -174.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 193' ' ' LEU . . . . . 0.434 HD21 ' CE2' ' C' ' 240' ' ' PHE . 82.0 mt -99.39 153.24 19.14 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.558 0.743 . . . . 52.2 111.273 -174.134 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 194' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -113.73 107.27 15.52 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 107.418 -1.327 . . . . 75.43 107.418 168.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 195' ' ' ALA . . . . . 0.618 ' HA ' ' O ' ' C' ' 185' ' ' VAL . . . -105.09 -178.59 3.7 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.164 0.586 . . . . 65.11 110.119 175.487 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 26.0 m -142.35 99.33 3.48 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 107.457 -1.312 . . . . 51.32 107.457 171.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 197' ' ' LEU . . . . . 0.446 HD13 ' HB2' ' C' ' 212' ' ' ALA . 25.7 tp -80.44 121.31 25.58 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.773 -0.649 . . . . 73.5 111.013 -171.115 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -74.51 100.1 3.78 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 108.166 -1.05 . . . . 44.52 108.166 175.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 199' ' ' VAL . . . . . . . . . . . . . 58.5 t -111.32 117.69 48.97 Favored Pre-proline 0 N--CA 1.474 0.731 0 N-CA-C 108.23 -1.026 . . . . 61.21 108.23 178.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 200' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -72.17 143.96 40.95 Favored 'Trans proline' 0 C--N 1.369 1.625 0 C-N-CA 121.727 1.618 . . . . 71.34 109.81 174.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 201' ' ' ALA . . . . . 0.43 ' N ' ' HD2' ' C' ' 202' ' ' PRO . . . -55.0 -44.28 99.52 Favored Pre-proline 0 CA--C 1.552 1.058 0 N-CA-C 114.119 1.155 . . . . 74.35 114.119 -173.708 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 202' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' C' ' 201' ' ' ALA . 17.3 Cg_endo -55.29 -46.99 28.51 Favored 'Trans proline' 0 C--N 1.393 2.906 0 C-N-CA 121.883 1.722 . . . . 63.15 112.67 176.557 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 203' ' ' ILE . . . . . 0.471 ' HA ' HG12 ' C' ' 206' ' ' VAL . 48.0 mt -68.18 -37.52 78.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.14 0.576 . . . . 63.4 110.871 -178.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 204' ' ' ALA . . . . . 0.434 ' HA ' HG11 ' C' ' 223' ' ' VAL . . . -58.53 -44.13 89.44 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.477 0.711 . . . . 75.02 111.338 176.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 205' ' ' VAL . . . . . 0.503 ' HA ' ' HA ' ' C' ' 226' ' ' ARG . 81.7 t -72.74 -42.65 61.87 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 115.156 -0.929 . . . . 63.41 111.786 -177.329 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 206' ' ' VAL . . . . . 0.676 HG23 ' HG3' ' A' ' 270' ' ' LYS . 11.3 p -77.05 -29.38 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 CA-C-O 120.676 0.274 . . . . 52.12 110.74 -174.185 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 77.18 51.91 5.93 Favored Glycine 0 C--N 1.341 0.826 0 N-CA-C 110.634 -0.987 . . . . 63.21 110.634 -171.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -91.78 -120.37 2.55 Favored Glycine 0 C--N 1.344 1.026 0 N-CA-C 111.246 -0.741 . . . . 51.32 111.246 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 209' ' ' LYS . . . . . 0.58 ' HG2' ' HG2' ' C' ' 220' ' ' GLU . 34.6 ttmt -151.72 133.17 14.64 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.619 0.723 . . . . 72.12 111.208 -178.449 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 210' ' ' VAL . . . . . . . . . . . . . 26.8 m -115.16 -175.28 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 126.596 1.958 . . . . 62.05 108.091 174.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 211' ' ' ARG . . . . . 0.473 ' HD3' ' HB2' ' C' ' 218' ' ' PRO . 36.9 ttm105 -142.85 127.99 18.61 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 118.236 0.471 . . . . 72.44 111.908 -178.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 212' ' ' ALA . . . . . 0.446 ' HB2' HD13 ' C' ' 197' ' ' LEU . . . -101.68 113.49 26.7 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 108.039 -1.097 . . . . 74.43 108.039 168.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 213' ' ' MET . . . . . 0.468 ' HA ' ' HA ' ' C' ' 218' ' ' PRO . 2.9 ttp -69.73 105.87 2.89 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 107.86 -1.163 . . . . 63.12 107.86 174.275 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 214' ' ' THR . . . . . 0.549 ' OG1' HG12 ' C' ' 219' ' ' VAL . 0.2 OUTLIER -101.02 175.63 5.53 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.506 0.669 . . . . 54.24 110.243 -173.144 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 215' ' ' LEU . . . . . 0.521 ' HA ' ' HG3' ' C' ' 128' ' ' GLU . 9.2 mt -63.0 -41.14 99.5 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.711 1.604 . . . . 44.41 111.326 -175.179 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -92.77 0.33 57.4 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 114.32 -1.309 . . . . 71.0 111.15 -177.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 134.36 162.65 9.98 Favored Glycine 0 C--N 1.343 0.931 0 N-CA-C 111.669 -0.572 . . . . 64.11 111.669 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 218' ' ' PRO . . . . . 0.473 ' HB2' ' HD3' ' C' ' 211' ' ' ARG . 59.9 Cg_endo -70.04 107.88 2.01 Favored 'Trans proline' 0 CA--C 1.555 1.575 0 C-N-CA 122.708 2.272 . . . . 52.13 112.952 -178.272 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 219' ' ' VAL . . . . . 0.604 HG23 HG22 ' B' ' 238' ' ' THR . 7.3 p -80.71 120.85 33.12 Favored 'Isoleucine or valine' 0 C--N 1.355 0.832 0 N-CA-C 107.664 -1.236 . . . . 52.53 107.664 174.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 220' ' ' GLU . . . . . 0.58 ' HG2' ' HG2' ' C' ' 209' ' ' LYS . 16.3 tt0 -92.75 103.79 16.12 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 107.583 -1.266 . . . . 72.32 107.583 -179.059 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 221' ' ' VAL . . . . . . . . . . . . . 60.8 t -85.88 123.29 39.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 113.534 -1.666 . . . . 74.03 112.319 -165.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 222' ' ' ALA . . . . . 0.427 ' HB3' ' HD3' ' B' ' 245' ' ' LYS . . . -74.84 143.56 43.85 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.311 0.644 . . . . 73.3 110.508 173.429 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 223' ' ' VAL . . . . . 0.434 HG11 ' HA ' ' C' ' 204' ' ' ALA . 98.0 t -116.62 138.11 24.22 Favored Pre-proline 0 N--CA 1.485 1.299 0 C-N-CA 124.316 1.047 . . . . 73.11 109.512 -174.302 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 224' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -78.74 156.02 27.43 Favored 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 123.279 2.653 . . . . 54.33 111.488 170.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.48 124.46 16.31 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 123.346 2.697 . . . . 74.0 113.137 -175.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 226' ' ' ARG . . . . . 0.503 ' HA ' ' HA ' ' C' ' 205' ' ' VAL . 0.0 OUTLIER 58.53 90.87 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.62 1.568 . . . . 70.15 112.378 -179.495 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 227' ' ' THR . . . . . 0.548 HG22 HG11 ' C' ' 253' ' ' VAL . 21.6 m -110.03 127.96 55.13 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 114.817 -1.083 . . . . 70.3 111.378 179.311 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 228' ' ' GLN . . . . . 0.773 HE21 HD11 ' A' ' 257' ' ' ILE . 0.8 OUTLIER -96.54 153.52 17.8 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.11 0.964 . . . . 74.32 111.859 -179.596 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 229' ' ' ALA . . . . . 0.49 ' HB2' ' H ' ' C' ' 255' ' ' ILE . . . -70.45 134.01 47.38 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 114.681 -1.145 . . . . 62.12 109.69 173.525 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 110.45 -19.28 26.77 Favored Glycine 0 C--N 1.339 0.702 0 O-C-N 123.613 0.571 . . . . 62.04 112.088 -173.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 231' ' ' ARG . . . . . 0.543 ' NH1' ' HA ' ' C' ' 227' ' ' THR . 71.3 mtt180 -65.78 174.9 2.13 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 117.138 0.469 . . . . 74.12 111.46 173.429 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 232' ' ' LYS . . . . . 0.444 ' HA ' ' O ' ' C' ' 251' ' ' LEU . 30.2 ttmt -142.85 145.71 33.42 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 121.206 0.527 . . . . 71.45 111.525 -178.56 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 233' ' ' LEU . . . . . 0.728 HD13 ' HB2' ' C' ' 251' ' ' LEU . 1.7 mp -113.26 145.33 41.2 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.815 1.246 . . . . 74.21 108.412 178.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 234' ' ' ARG . . . . . 0.676 ' HG3' ' HG3' ' B' ' 241' ' ' GLU . 9.2 ptp85 -120.29 95.06 4.59 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 121.957 0.884 . . . . 72.34 109.432 169.414 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 235' ' ' LEU . . . . . 0.577 ' HA ' ' HA3' ' B' ' 240' ' ' GLY . 26.0 mt -84.67 107.66 16.99 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.611 -0.722 . . . . 73.43 109.324 178.397 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 236' ' ' LYS . . . . . 0.556 ' HG3' HE21 ' B' ' 360' ' ' GLN . 71.1 mmtt -69.07 122.99 19.85 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 123.627 0.771 . . . . 71.55 111.483 -174.714 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 76.54 32.56 50.6 Favored Glycine 0 C--N 1.344 0.994 0 O-C-N 124.199 0.937 . . . . 71.42 113.192 178.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 33.5 mmtm -123.83 14.99 9.34 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.821 0.848 . . . . 72.03 111.209 175.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -91.62 -147.39 20.02 Favored Glycine 0 C--N 1.353 1.477 0 N-CA-C 111.178 -0.769 . . . . 31.21 111.178 170.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 240' ' ' PHE . . . . . 0.536 ' HD2' HD13 ' C' ' 188' ' ' LEU . 39.9 m-85 -94.56 142.12 24.36 Favored Pre-proline 0 N--CA 1.482 1.141 0 CA-C-N 117.572 0.686 . . . . 75.14 111.302 178.473 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 241' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' C' ' 240' ' ' PHE . 3.3 Cg_exo -76.65 113.99 3.76 Favored 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 123.837 3.025 . . . . 70.21 113.69 -172.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -96.78 159.96 21.65 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-O 119.015 -0.88 . . . . 70.14 111.396 170.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.58 -13.43 37.27 Favored 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 122.781 2.32 . . . . 71.42 112.857 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -103.25 -16.71 15.6 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.515 0.726 . . . . 71.42 110.935 174.047 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 157.88 158.41 8.96 Favored Glycine 0 C--N 1.356 1.641 0 O-C-N 123.119 0.262 . . . . 51.32 113.702 177.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 246' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -73.65 152.62 40.44 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.804 0.842 . . . . 61.31 110.22 174.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.44 -164.69 22.9 Favored Glycine 0 C--N 1.346 1.112 0 O-C-N 123.702 0.626 . . . . 63.23 112.004 173.297 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -119.72 154.48 34.06 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 108.877 -0.786 . . . . 73.54 108.877 -178.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 249' ' ' LEU . . . . . 0.561 HD23 HD12 ' C' ' 235' ' ' LEU . 19.0 tp -99.61 109.24 21.76 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.637 -0.71 . . . . 74.23 109.284 175.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 250' ' ' TYR . . . . . 0.593 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 20.2 m-85 -99.44 100.36 11.39 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 109.236 -0.653 . . . . 71.43 109.236 178.702 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 251' ' ' LEU . . . . . 0.728 ' HB2' HD13 ' C' ' 233' ' ' LEU . 0.8 OUTLIER -100.4 140.37 34.74 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.232 -0.655 . . . . 64.53 109.232 -176.716 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -89.54 128.43 36.01 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 108.225 -1.028 . . . . 73.41 108.225 168.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 253' ' ' VAL . . . . . 0.548 HG11 HG22 ' C' ' 227' ' ' THR . 80.0 t -67.97 131.97 32.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 123.641 0.776 . . . . 73.5 110.25 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 254' ' ' ARG . . . . . 0.416 ' HB3' HH11 ' C' ' 254' ' ' ARG . 0.0 OUTLIER -126.72 93.06 3.67 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.354 -1.351 . . . . 74.13 107.354 179.226 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 255' ' ' ILE . . . . . 0.49 ' H ' ' HB2' ' C' ' 229' ' ' ALA . 49.8 mm -73.11 127.49 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 O-C-N 123.853 0.721 . . . . 75.24 109.788 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 256' ' ' THR . . . . . 0.559 ' HA ' HD12 ' A' ' 255' ' ' ILE . 1.7 t -144.73 171.04 14.97 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 124.412 1.07 . . . . 53.32 110.396 -171.24 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 257' ' ' ILE . . . . . 0.467 HD12 ' H ' ' C' ' 259' ' ' GLU . 2.7 pp -132.59 148.31 69.06 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 123.735 0.814 . . . . 64.54 109.398 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 258' ' ' PRO . . . . . 0.518 ' HG3' ' HE2' ' A' ' 276' ' ' TYR . 98.5 Cg_endo -74.53 11.14 1.37 Allowed 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 123.323 2.682 . . . . 73.21 114.277 -172.179 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 259' ' ' GLU . . . . . 0.467 ' H ' HD12 ' C' ' 257' ' ' ILE . 18.0 mt-10 62.1 -80.64 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 125.194 1.398 . . . . 72.3 111.101 -171.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 2.8 ptp85 -77.87 143.89 37.41 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.518 1.527 . . . . 73.41 110.928 -173.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 261' ' ' LEU . . . . . . . . . . . . . 75.3 mt -141.7 169.98 16.58 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.046 0.938 . . . . 71.21 110.107 -177.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 262' ' ' THR . . . . . 0.437 HG22 ' HA ' ' B' ' 272' ' ' ASN . 23.9 p -84.04 152.02 61.37 Favored Pre-proline 0 CA--C 1.552 1.024 0 N-CA-C 107.765 -1.198 . . . . 61.23 107.765 169.019 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -48.12 -34.64 24.24 Favored 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 123.173 2.582 . . . . 74.2 113.9 176.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.52 -56.14 9.36 Favored 'General case' 0 C--O 1.268 2.037 0 C-N-CA 124.249 1.019 . . . . 71.04 110.624 -178.329 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 265' ' ' GLU . . . . . 0.46 ' CD ' HH22 ' A' ' 279' ' ' ARG . 40.7 mm-40 -51.16 -55.09 19.66 Favored 'General case' 0 C--N 1.359 1.002 0 CA-C-N 114.953 -1.021 . . . . 65.11 110.359 175.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 266' ' ' GLU . . . . . 0.483 ' O ' ' HG2' ' C' ' 270' ' ' LYS . 30.8 tt0 -61.15 -31.46 71.18 Favored 'General case' 0 C--O 1.217 -0.652 0 CA-C-N 114.186 -1.37 . . . . 64.21 111.39 -175.372 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -60.76 -45.15 95.46 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 123.461 0.475 . . . . 70.32 110.866 174.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 268' ' ' LEU . . . . . 0.536 ' HA ' ' HE2' ' C' ' 271' ' ' LYS . 11.2 mp -64.18 -42.32 96.74 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 116.202 -0.454 . . . . 52.44 111.465 174.562 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -65.12 -25.36 67.73 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 122.797 0.439 . . . . 61.11 111.296 175.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 270' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' C' ' 266' ' ' GLU . 13.2 mmmm -67.93 -49.66 60.53 Favored 'General case' 0 C--N 1.363 1.175 0 C-N-CA 122.837 0.455 . . . . 75.43 109.867 175.235 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 271' ' ' LYS . . . . . 0.536 ' HE2' ' HA ' ' C' ' 268' ' ' LEU . 52.7 mtmt -57.62 -44.72 85.72 Favored 'General case' 0 N--CA 1.484 1.243 0 O-C-N 123.688 0.618 . . . . 75.33 111.294 178.638 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 88.3 mt -62.08 -41.41 98.16 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.237 0.615 . . . . 74.33 111.189 175.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -64.83 -45.35 86.56 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 115.573 -0.74 . . . . 34.13 111.545 -177.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -70.26 -32.42 70.24 Favored 'General case' 0 C--O 1.242 0.667 0 O-C-N 124.142 0.901 . . . . 63.21 110.62 -178.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -61.82 -34.13 75.39 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.684 -0.689 . . . . 70.04 110.678 170.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 276' ' ' TYR . . . . . 0.566 ' HB3' HD11 ' A' ' 203' ' ' ILE . 10.0 m-85 -83.49 -25.48 31.07 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 113.047 0.758 . . . . 75.52 113.047 174.212 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 20.3 m-30 -72.81 -21.23 61.01 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 118.524 0.602 . . . . 44.24 109.933 176.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -61.81 -3.6 1.2 Allowed 'General case' 0 CA--C 1.558 1.266 0 CA-C-N 115.02 -0.991 . . . . 55.2 112.821 169.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 279' ' ' ARG . . . . . 0.477 HH22 ' HB3' ' B' ' 374' ' ' ALA . 81.7 mtt180 -72.7 -14.12 61.5 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.255 0.622 . . . . 71.52 112.441 171.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.257 0 C-N-CA 124.452 1.101 . . . . 75.14 112.683 -175.924 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.5 mtm . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 119.508 -0.282 . . . . 64.12 111.511 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 49.91 34.22 7.61 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.929 1.292 . . . . 51.4 112.333 -175.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.5 71.57 9.58 Favored 'General case' 0 C--N 1.349 0.559 0 C-N-CA 123.308 0.643 . . . . 74.04 109.957 -176.057 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -38.91 106.53 0.05 Allowed 'General case' 0 C--N 1.353 0.723 0 C-N-CA 124.533 1.133 . . . . 62.43 113.072 176.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.48 ' HE3' ' HB3' ' A' ' 94' ' ' SER . 94.6 mttt -70.84 133.08 46.19 Favored 'General case' 0 C--O 1.244 0.766 0 N-CA-C 108.917 -0.772 . . . . 74.32 108.917 166.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -75.44 86.74 2.58 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 106.388 -1.708 . . . . 61.41 106.388 168.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -60.62 -34.67 74.59 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-N 115.002 -0.999 . . . . 73.34 111.231 -173.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.418 ' HE1' HD11 ' A' ' 22' ' ' ILE . 88.9 m-85 -62.56 -45.02 94.87 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.517 -0.765 . . . . 73.33 110.713 175.517 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.81 -42.84 99.52 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.871 0.468 . . . . 60.32 111.254 178.075 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.407 HD11 ' HB3' ' A' ' 5' ' ' LYS . 71.3 mt -55.88 -45.13 79.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 C-N-CA 123.508 0.723 . . . . 74.23 110.311 177.177 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.662 HD13 HG23 ' A' ' 22' ' ' ILE . 83.1 mt -69.43 -29.87 67.68 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 115.898 -0.592 . . . . 51.33 111.674 175.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.3 46.54 5.24 Favored Glycine 0 C--N 1.344 0.995 0 CA-C-O 120.946 0.192 . . . . 53.33 112.737 -173.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.528 HG13 ' HB2' ' A' ' 25' ' ' ALA . 3.1 m -141.5 154.76 67.06 Favored Pre-proline 0 N--CA 1.483 1.204 0 C-N-CA 125.166 1.387 . . . . 71.43 109.615 178.724 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -69.07 165.7 29.26 Favored 'Trans proline' 0 N--CA 1.502 1.994 0 C-N-CA 123.239 2.626 . . . . 50.12 113.328 178.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -73.68 14.23 0.39 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 113.855 1.057 . . . . 75.43 113.855 -172.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -135.74 19.97 3.3 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 108.954 -0.758 . . . . 64.11 108.954 175.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.36 121.96 15.56 Favored 'General case' 0 C--N 1.343 0.291 0 CA-C-N 115.095 -0.957 . . . . 64.31 110.137 178.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 39.9 p -76.88 171.13 15.25 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.554 -0.748 . . . . 71.11 110.166 175.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 15.9 mp0 -53.54 -28.98 34.57 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 124.399 1.08 . . . . 64.21 112.359 -177.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -71.95 -48.0 48.37 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.017 0.927 . . . . 72.43 110.869 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -63.88 -41.97 97.6 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 121.742 0.782 . . . . 64.03 110.493 178.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.662 HG23 HD13 ' A' ' 11' ' ' LEU . 74.9 mt -68.07 -32.07 54.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 114.093 -1.412 . . . . 73.31 111.174 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -70.53 -35.97 73.46 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.463 0.705 . . . . 71.24 110.907 175.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 45.9 mtm105 -61.94 -50.85 70.48 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 109.68 -0.489 . . . . 54.12 109.68 173.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.528 ' HB2' HG13 ' A' ' 13' ' ' VAL . . . -62.08 -37.66 85.88 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 114.891 -1.05 . . . . 64.0 111.764 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -60.26 -64.21 1.03 Allowed 'General case' 0 C--O 1.207 -1.142 0 CA-C-N 114.831 -1.077 . . . . 73.1 109.362 176.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -55.15 -30.5 59.97 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 124.167 0.917 . . . . 74.22 112.021 -177.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.47 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 50.2 ttp180 -59.46 -67.98 0.32 Allowed 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.567 -0.531 . . . . 71.15 109.567 172.604 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.633 ' HB3' HD13 ' A' ' 50' ' ' ILE . 91.8 mt -70.9 -14.34 62.35 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.171 0.588 . . . . 74.11 112.171 -175.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.638 ' HA ' ' HE1' ' A' ' 47' ' ' PHE . . . -82.96 -38.66 22.43 Favored 'General case' 0 C--O 1.206 -1.229 0 C-N-CA 123.695 0.798 . . . . 63.3 109.864 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.0 mtm180 -78.98 -33.41 45.11 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 122.497 0.319 . . . . 72.33 110.692 176.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.47 ' HG2' ' O ' ' A' ' 28' ' ' ARG . 15.1 mm100 -67.46 -62.44 1.42 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 122.962 0.505 . . . . 63.33 110.44 177.523 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.452 ' HE2' HD22 ' A' ' 29' ' ' LEU . 21.7 m-85 -94.83 31.39 1.84 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.288 0.635 . . . . 63.25 110.941 -176.027 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -61.5 105.65 0.65 Allowed Pre-proline 0 N--CA 1.482 1.16 0 C-N-CA 123.877 0.871 . . . . 63.41 109.983 -178.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.65 -14.53 36.56 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.423 2.082 . . . . 74.13 111.444 -172.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -62.65 -37.48 86.53 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.399 1.08 . . . . 72.45 111.065 173.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 46.7 t -104.58 -51.64 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 CA-C-O 121.356 0.598 . . . . 65.53 109.862 -178.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -99.12 86.13 3.38 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.552 1.141 . . . . 61.35 110.72 -177.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.4 mtmp? -85.78 61.06 6.61 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.352 0.596 . . . . 73.11 110.402 176.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 66.4 m -107.13 110.58 63.46 Favored Pre-proline 0 N--CA 1.476 0.845 0 CA-C-O 118.176 -0.916 . . . . 54.41 109.202 176.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.421 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 2.8 Cg_endo -38.07 -53.62 1.57 Allowed 'Trans proline' 0 C--N 1.393 2.911 0 C-N-CA 124.941 3.761 . . . . 72.23 114.151 -172.132 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -47.43 -52.9 15.54 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 124.657 1.183 . . . . 64.43 112.005 177.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.58 -24.89 63.75 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 114.599 -1.182 . . . . 72.14 111.244 -176.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -85.03 -36.46 21.24 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.753 0.821 . . . . 62.01 110.84 -175.441 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 41' ' ' PRO . 28.0 mm-40 -68.74 -47.73 65.53 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 108.854 -0.795 . . . . 62.44 108.854 177.526 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 49.4 mttp -65.87 -33.15 75.18 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 114.856 -1.065 . . . . 74.03 111.38 175.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.638 ' HE1' ' HA ' ' A' ' 30' ' ' ALA . 88.2 t80 -58.6 -44.64 89.94 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.051 0.54 . . . . 73.24 110.292 173.096 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.534 ' HB3' ' HE1' ' A' ' 93' ' ' PHE . 48.5 mtmt -62.45 -39.54 93.7 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.258 -0.428 . . . . 75.14 111.055 177.408 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -65.4 -28.7 69.44 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.044 0.45 . . . . 71.44 111.926 176.261 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.633 HD13 ' HB3' ' A' ' 29' ' ' LEU . 68.2 mt -73.86 -32.9 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.516 0.726 . . . . 70.53 109.834 173.088 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.413 ' O ' ' HB2' ' A' ' 55' ' ' ALA . 25.9 m-80 -81.19 -14.7 57.3 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.541 0.736 . . . . 73.43 111.3 174.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -73.68 -55.56 6.11 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.82 1.248 . . . . 63.42 108.484 170.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.76 -51.47 65.6 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 113.448 -1.705 . . . . 65.45 110.707 175.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -60.82 -45.91 92.59 Favored 'General case' 0 C--O 1.21 -0.984 0 CA-C-N 114.936 -1.029 . . . . 72.32 110.649 177.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 51' ' ' ASN . . . -52.64 -52.58 54.93 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.355 0.662 . . . . 53.01 112.246 -177.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 97.3 t -61.11 -49.44 84.64 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 O-C-N 124.201 0.938 . . . . 74.52 109.782 178.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.538 ' HB3' HD13 ' A' ' 22' ' ' ILE . 69.5 mt -87.75 -6.82 58.0 Favored 'General case' 0 CA--C 1.56 1.335 0 N-CA-C 114.6 1.333 . . . . 62.04 114.6 -168.509 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.2 t -79.83 -32.63 40.65 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 123.268 0.627 . . . . 74.34 110.694 -177.274 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -100.55 129.43 27.78 Favored Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 108.296 -1.002 . . . . 74.34 108.296 -176.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.82 -40.18 86.33 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 123.297 2.665 . . . . 72.41 113.499 -172.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.422 ' O ' HG13 ' A' ' 65' ' ' ILE . 13.0 mp0 -64.77 -56.09 15.71 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.055 0.942 . . . . 72.3 110.067 -178.319 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.463 ' HA ' HD12 ' A' ' 65' ' ' ILE . 44.3 mtpt -65.11 -36.49 84.44 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.838 0.855 . . . . 74.54 111.65 -176.166 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 54.2 ttt180 -56.91 -49.98 73.93 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 124.051 0.844 . . . . 74.11 108.967 174.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -69.73 -25.27 63.76 Favored 'General case' 0 C--O 1.214 -0.814 0 CA-C-N 115.091 -0.959 . . . . 74.25 112.354 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.555 HG12 ' HG2' ' A' ' 76' ' ' PRO . 85.1 mt -61.14 -48.08 90.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 108.763 -0.828 . . . . 64.42 108.763 172.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -58.03 -58.26 9.22 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 115.414 -0.812 . . . . 75.4 110.774 173.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -58.13 -38.47 76.6 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.415 1.086 . . . . 64.04 112.381 -172.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 73.1 p -76.14 -33.1 59.4 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 118.935 -0.555 . . . . 75.13 110.459 178.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -63.46 120.71 12.2 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-N 118.535 0.607 . . . . 63.45 109.915 -176.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 107.61 5.61 33.79 Favored Glycine 0 CA--C 1.54 1.597 0 C-N-CA 123.443 0.544 . . . . 52.54 112.034 -166.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 91.4 m -146.53 -57.7 0.28 Allowed 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 104.583 -2.377 . . . . 71.23 104.583 175.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 96.4 m -79.14 149.14 32.11 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 105.277 -2.12 . . . . 74.23 105.277 155.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.58 -17.77 3.23 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 122.863 0.465 . . . . 74.04 111.942 -171.445 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -101.98 140.96 21.63 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 123.42 0.688 . . . . 75.1 109.666 177.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.13 126.85 13.53 Favored 'Trans proline' 0 C--N 1.374 1.884 0 C-N-CA 122.803 2.335 . . . . 75.41 112.322 177.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.555 ' HG2' HG12 ' A' ' 65' ' ' ILE . 71.4 Cg_exo -53.7 149.28 32.92 Favored 'Trans proline' 0 C--N 1.385 2.495 0 C-N-CA 123.751 2.967 . . . . 74.25 113.419 177.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -55.36 136.83 75.42 Favored 'Trans proline' 0 C--N 1.383 2.39 0 C-N-CA 122.941 2.427 . . . . 62.44 112.181 -176.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -61.27 126.02 18.34 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.907 2.404 . . . . 43.51 112.796 -178.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -58.09 157.95 23.41 Favored 'Trans proline' 0 C--N 1.382 2.328 0 C-N-CA 123.415 2.743 . . . . 71.05 113.038 173.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.548 ' HD2' ' HA3' ' A' ' 142' ' ' GLY . 79.8 Cg_exo -48.78 82.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.388 2.64 0 C-N-CA 124.648 3.565 . . . . 51.35 115.42 178.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 136.84 -39.55 1.62 Allowed Glycine 0 N--CA 1.467 0.766 0 N-CA-C 109.881 -1.287 . . . . 62.41 109.881 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 144.61 -176.89 23.5 Favored Glycine 0 C--N 1.344 0.982 0 C-N-CA 124.237 0.922 . . . . 53.03 110.969 176.208 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -58.79 98.47 0.04 OUTLIER 'General case' 0 C--O 1.243 0.738 0 N-CA-C 107.604 -1.258 . . . . 74.41 107.604 164.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -64.8 110.68 2.49 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.51 0.671 . . . . 71.31 109.307 -173.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.417 ' H ' ' HE2' ' A' ' 106' ' ' PHE . 23.0 t80 -133.05 23.9 4.2 Favored 'General case' 0 C--O 1.259 1.567 0 C-N-CA 124.862 1.265 . . . . 70.22 108.664 -168.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.457 ' HA ' ' CG ' ' A' ' 171' ' ' PRO . 73.4 m -58.5 146.28 36.0 Favored 'General case' 0 C--N 1.349 0.559 0 CA-C-N 113.986 -1.461 . . . . 74.44 112.279 -171.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.456 ' H ' ' HG2' ' A' ' 171' ' ' PRO . . . 79.73 -9.08 45.97 Favored Glycine 0 CA--C 1.536 1.382 0 CA-C-O 118.803 -0.998 . . . . 70.11 114.629 -176.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.429 ' HB3' ' HE2' ' A' ' 93' ' ' PHE . 51.8 m-85 -112.74 142.63 45.13 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 119.383 1.591 . . . . 72.34 112.575 -176.053 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -82.42 75.89 9.31 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 124.149 0.98 . . . . 71.44 111.126 -172.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.601 HG23 ' HE2' ' A' ' 97' ' ' PHE . 2.5 p -39.4 -48.55 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.62 0 C-N-CA 125.787 1.635 . . . . 75.21 113.904 176.17 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.17 -36.52 70.88 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 124.157 0.983 . . . . 75.33 112.195 -176.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -72.69 -31.7 65.23 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.949 -0.568 . . . . 45.35 110.902 -175.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.534 ' HE1' ' HB3' ' A' ' 48' ' ' LYS . 15.4 m-30 -80.05 174.71 11.32 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.905 -0.589 . . . . 71.01 111.939 -164.436 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.48 ' HB3' ' HE3' ' A' ' 5' ' ' LYS . 78.7 p -57.1 149.41 19.47 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.808 0.843 . . . . 74.5 113.129 -168.251 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.16 -39.61 72.59 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 114.839 -1.073 . . . . 74.31 110.084 168.053 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -54.49 -47.25 73.26 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.384 1.074 . . . . 75.03 110.896 176.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.601 ' HE2' HG23 ' A' ' 90' ' ' VAL . 44.3 t80 -59.42 -50.07 75.35 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 115.338 -0.847 . . . . 63.23 110.092 175.315 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -76.31 -2.18 30.36 Favored 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 112.403 0.52 . . . . 73.05 112.403 -175.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -93.94 -59.3 2.01 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.652 0.781 . . . . 70.02 110.191 169.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 33.4 tp -62.46 -46.18 89.68 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.979 0.912 . . . . 55.03 111.24 -176.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.407 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 82.4 m-85 -92.75 -3.65 54.44 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.104 0.562 . . . . 72.11 111.477 177.71 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -46.35 -57.73 6.28 Favored Glycine 0 CA--C 1.544 1.87 0 CA-C-O 118.988 -0.895 . . . . 72.43 115.195 177.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -68.21 11.51 0.26 Allowed 'Trans proline' 0 C--N 1.382 2.317 0 C-N-CA 123.637 2.891 . . . . 23.1 114.635 -178.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -147.05 16.5 1.54 Allowed Glycine 0 C--N 1.348 1.228 0 CA-C-O 119.078 -0.845 . . . . 44.4 113.077 171.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 101' ' ' PHE . 35.5 mt -66.65 79.81 0.11 Allowed 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 118.01 0.905 . . . . 74.25 111.61 174.419 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.417 ' HE2' ' H ' ' A' ' 85' ' ' PHE . 2.7 m-85 38.55 -113.27 0.12 Allowed 'General case' 0 CA--C 1.56 1.34 0 C-N-CA 126.632 1.973 . . . . 72.25 115.813 172.131 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 70.31 0.49 29.96 Favored Glycine 0 C--N 1.368 2.311 0 N-CA-C 112.29 -0.324 . . . . 44.0 112.29 -162.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 55.46 -122.84 28.1 Favored Glycine 0 C--N 1.355 1.604 0 C-N-CA 123.198 0.428 . . . . 71.34 113.284 -171.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -105.78 -0.05 25.71 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.875 0.87 . . . . 64.11 110.077 175.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -93.56 -25.47 18.22 Favored Glycine 0 C--N 1.353 1.478 0 CA-C-O 119.599 -0.556 . . . . 55.25 113.553 -178.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.6 tpm_? 67.45 -11.01 0.32 Allowed 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 124.972 1.309 . . . . 71.44 112.986 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.42 12.25 0.49 Allowed 'General case' 0 CA--C 1.562 1.424 0 O-C-N 121.184 -0.947 . . . . 73.25 111.636 178.34 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 51.8 m 53.39 37.92 26.65 Favored 'General case' 0 C--N 1.367 1.338 0 C-N-CA 124.308 1.043 . . . . 74.21 111.141 176.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 21.2 tpt180 -76.68 158.05 31.32 Favored 'General case' 0 C--N 1.344 0.359 0 CA-C-N 114.221 -1.354 . . . . 74.52 111.935 -169.095 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -60.7 129.49 41.8 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.061 0.944 . . . . 72.15 109.181 175.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.429 ' HA2' HH11 ' A' ' 117' ' ' ARG . . . -64.53 160.52 40.4 Favored Glycine 0 C--N 1.343 0.954 0 CA-C-O 121.664 0.591 . . . . 55.22 113.471 178.724 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.527 ' H ' ' HA3' ' A' ' 166' ' ' GLY . 2.7 mpt_? -102.87 165.43 11.05 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.424 1.09 . . . . 71.34 110.923 -168.56 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -76.44 115.75 16.48 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 106.698 -1.593 . . . . 74.23 106.698 163.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.524 HD12 ' HA2' ' A' ' 166' ' ' GLY . 3.6 tt -114.99 136.85 52.67 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 107.756 -1.201 . . . . 70.23 107.756 -174.268 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 29.8 ttt-85 -117.02 135.94 53.33 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 108.554 -0.906 . . . . 74.51 108.554 174.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.97 168.7 23.06 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 121.192 0.52 . . . . 41.51 111.407 -177.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -111.66 112.77 24.7 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.324 1.05 . . . . 61.0 109.439 -169.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 37.5 tp -100.92 96.2 5.39 Favored Pre-proline 0 CA--C 1.549 0.909 0 N-CA-C 108.796 -0.816 . . . . 54.05 108.796 -178.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.426 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 1.1 Cg_endo -83.53 114.27 2.07 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 122.695 2.263 . . . . 75.33 110.61 -173.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.521 ' HB3' HD23 ' A' ' 180' ' ' LEU . 46.3 tp -117.41 141.55 48.19 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.152 0.501 . . . . 64.01 111.134 -169.178 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 24.0 m -69.41 142.05 53.96 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 114.908 -1.042 . . . . 71.34 110.277 173.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.586 HD13 ' HB2' ' A' ' 186' ' ' PHE . 84.5 mt -57.65 -46.53 84.1 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.245 0.618 . . . . 70.54 110.389 179.036 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -62.67 -37.51 86.7 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 115.071 -0.968 . . . . 75.32 110.519 -177.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -76.6 -21.4 55.63 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.256 0.622 . . . . 64.33 111.574 178.103 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -71.71 -40.9 69.18 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.023 0.529 . . . . 41.43 110.166 171.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -65.02 -42.43 94.38 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.477 1.111 . . . . 74.51 110.547 177.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 41.7 m170 -69.16 -48.3 62.66 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.384 -0.826 . . . . 75.25 111.273 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.46 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 71.3 -141.96 33.36 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 115.941 -0.572 . . . . 71.54 112.496 -175.439 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 71.97 -161.2 54.25 Favored Glycine 0 C--N 1.349 1.297 0 C-N-CA 122.987 0.327 . . . . 70.42 113.141 178.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.671 ' HB3' ' HB2' ' A' ' 146' ' ' SER . 26.2 mp0 -69.54 118.46 12.44 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 122.949 0.5 . . . . 73.14 110.146 178.354 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 11.1 tpp180 -101.21 118.91 37.92 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.794 -0.817 . . . . 74.4 108.794 176.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.581 ' HB ' HG21 ' B' ' 5' ' ' THR . 97.2 t -81.74 96.0 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 121.413 0.625 . . . . 71.24 109.465 -178.729 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.1 p -115.47 124.11 71.65 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-N 114.985 -1.007 . . . . 73.14 108.435 173.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -85.13 115.11 22.73 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 114.792 -1.095 . . . . 71.3 110.246 178.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 33.9 m -122.58 127.65 75.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 124.226 1.011 . . . . 75.1 110.684 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 63.17 21.26 12.76 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.105 0.962 . . . . 74.24 112.575 177.274 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.548 ' HA3' ' HD2' ' A' ' 80' ' ' PRO . . . 90.2 -17.95 51.04 Favored Glycine 0 C--N 1.35 1.33 0 C-N-CA 122.689 0.185 . . . . 31.1 113.075 -175.409 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -87.83 118.64 27.49 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.201 1.001 . . . . 72.12 108.831 176.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 45.4 ttm105 -82.4 115.46 21.44 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.592 0.757 . . . . 74.41 109.05 178.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 14.7 p -125.47 149.54 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-O 121.4 0.619 . . . . 73.53 110.607 -177.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.671 ' HB2' ' HB3' ' A' ' 135' ' ' GLU . 35.9 p -107.55 93.27 4.45 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 124.382 1.073 . . . . 31.45 110.45 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 3.4 p -80.57 112.68 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 123.108 0.563 . . . . 73.42 109.564 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -67.02 95.28 0.38 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.658 0.742 . . . . 74.14 110.378 176.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.46 HG13 ' HA2' ' A' ' 133' ' ' GLY . 44.5 pt -78.15 140.58 61.63 Favored Pre-proline 0 CA--C 1.556 1.186 0 CA-C-N 114.42 -1.264 . . . . 74.13 108.713 170.047 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -66.31 138.48 51.19 Favored 'Trans proline' 0 C--N 1.373 1.833 0 C-N-CA 121.995 1.797 . . . . 60.34 112.187 176.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -63.82 92.63 0.17 Allowed 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 122.424 2.083 . . . . 74.15 110.749 171.239 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 123.4 27.35 1.49 Allowed Glycine 0 CA--C 1.526 0.736 0 CA-C-N 114.756 -1.111 . . . . 75.51 110.993 -171.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 5.7 p -73.67 137.45 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 123.294 0.637 . . . . 75.43 109.552 179.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.56 HH21 ' HG2' ' A' ' 241' ' ' PRO . 0.0 OUTLIER -112.36 154.61 25.47 Favored 'General case' 0 C--O 1.211 -0.941 0 CA-C-N 116.372 -0.376 . . . . 73.23 111.816 -163.704 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -54.0 124.26 15.02 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 124.049 0.843 . . . . 72.32 110.248 171.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.46 4.88 70.13 Favored Glycine 0 C--N 1.342 0.9 0 CA-C-O 119.159 -0.8 . . . . 14.21 113.747 -178.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 58.3 m -67.78 102.09 1.17 Allowed 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 118.157 0.979 . . . . 74.23 108.857 170.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 53.9 t -83.94 91.4 2.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 107.34 -1.356 . . . . 72.34 107.34 177.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.653 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 53.0 mt -71.99 85.12 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.801 0 N-CA-C 107.618 -1.253 . . . . 75.24 107.618 174.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -74.17 99.52 3.42 Favored 'General case' 0 C--N 1.353 0.76 0 N-CA-C 107.378 -1.342 . . . . 61.32 107.378 175.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.0 p -110.13 118.75 48.87 Favored Pre-proline 0 CA--C 1.548 0.903 0 CA-C-N 115.076 -0.966 . . . . 61.33 110.872 -169.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -79.06 125.3 6.45 Favored 'Trans proline' 0 C--N 1.369 1.626 0 C-N-CA 122.386 2.057 . . . . 74.53 106.841 160.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.421 ' HA2' ' O ' ' A' ' 86' ' ' SER . . . 130.0 -23.75 4.63 Favored Glycine 0 N--CA 1.469 0.9 0 N-CA-C 111.303 -0.719 . . . . 70.43 111.303 -165.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -134.22 144.55 48.5 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 106.152 -1.795 . . . . 64.15 106.152 163.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -175.85 -160.95 24.27 Favored Glycine 0 CA--C 1.498 -0.993 0 N-CA-C 114.596 0.598 . . . . 73.33 114.596 171.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.527 ' HA3' ' H ' ' A' ' 117' ' ' ARG . . . -57.79 135.64 51.56 Favored Glycine 0 C--N 1.356 1.691 0 O-C-N 124.476 0.75 . . . . 74.5 112.322 175.059 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -70.38 105.11 2.91 Favored 'General case' 0 CA--C 1.548 0.899 0 O-C-N 125.686 1.462 . . . . 75.42 110.105 -172.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -170.39 155.7 25.51 Favored Glycine 0 C--N 1.339 0.727 0 CA-C-O 118.887 -0.952 . . . . 64.21 111.253 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' ASN . . . . . 0.495 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . 7.3 t30 -64.74 -56.26 22.99 Favored Pre-proline 0 N--CA 1.488 1.438 0 CA-C-O 117.826 -1.083 . . . . 63.11 111.41 -170.102 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.495 ' HD3' ' HB3' ' A' ' 169' ' ' ASN . 1.7 Cg_endo -82.68 91.74 0.96 Allowed 'Trans proline' 0 C--N 1.388 2.649 0 N-CA-C 106.965 -1.975 . . . . 71.13 106.965 162.137 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.457 ' CG ' ' HA ' ' A' ' 86' ' ' SER . 56.0 Cg_endo -76.6 174.58 12.61 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 123.479 2.786 . . . . 71.25 117.232 -156.017 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -95.48 -158.86 32.73 Favored Glycine 0 C--N 1.363 2.05 0 CA-C-N 114.724 -1.125 . . . . 72.4 114.736 -177.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -133.52 146.08 50.73 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 125.386 1.474 . . . . 71.14 108.147 -177.068 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 41.8 tp -118.26 141.63 48.31 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 120.966 0.412 . . . . 64.32 112.015 -172.014 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 68.9 mt -97.2 91.67 5.65 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 124.268 1.027 . . . . 72.12 108.284 171.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.653 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 85.4 mt -74.28 85.61 1.93 Allowed 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.392 -0.966 . . . . 70.05 108.392 170.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 46.5 t -83.34 97.82 4.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 107.037 -1.468 . . . . 61.43 107.037 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 8.9 p -68.41 125.88 27.1 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 CA-C-N 115.558 -0.746 . . . . 70.33 110.144 -173.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.426 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 40.4 mmm-85 -116.94 97.61 6.04 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.497 1.119 . . . . 53.32 108.215 -176.446 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.521 HD23 ' HB3' ' A' ' 125' ' ' LEU . 45.3 mt -69.34 141.11 54.31 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 110.067 -0.346 . . . . 72.4 110.067 -179.481 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 79.6 mt -57.52 148.2 56.51 Favored Pre-proline 0 CA--C 1.549 0.929 0 O-C-N 124.066 0.854 . . . . 73.14 111.202 -177.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -77.43 48.19 2.49 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 123.084 2.523 . . . . 71.42 110.441 167.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.431 ' HA ' ' HD3' ' A' ' 184' ' ' PRO . 53.2 t-80 -70.28 136.94 86.54 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 125.27 1.428 . . . . 73.35 109.051 -172.12 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 183' ' ' HIS . 53.1 Cg_exo -58.32 12.09 0.04 OUTLIER 'Trans proline' 0 C--N 1.381 2.253 0 C-N-CA 124.202 3.268 . . . . 61.24 118.127 -168.387 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 40.2 t -106.63 -55.2 5.61 Favored 'Isoleucine or valine' 0 C--N 1.352 0.702 0 CA-C-N 119.43 1.014 . . . . 64.21 109.181 172.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' PHE . . . . . 0.586 ' HB2' HD13 ' A' ' 127' ' ' LEU . 23.1 m-85 -134.49 147.11 50.3 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 115.061 -0.972 . . . . 72.31 111.681 -168.759 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -133.79 90.96 2.77 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 106.177 -1.786 . . . . 75.51 106.177 165.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.49 HD13 ' HG ' ' A' ' 193' ' ' LEU . 60.0 tp -71.47 161.33 31.21 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 124.48 1.112 . . . . 74.21 111.652 -177.129 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -154.28 107.54 2.89 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 122.905 0.482 . . . . 70.31 110.59 174.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 82.22 -53.37 4.76 Favored Glycine 0 C--N 1.36 1.861 0 C-N-CA 123.375 0.512 . . . . 65.41 114.216 174.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -178.97 -21.43 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 126.917 2.087 . . . . 72.32 107.789 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -85.31 120.37 26.72 Favored 'General case' 0 C--N 1.357 0.923 0 CA-C-N 114.405 -1.271 . . . . 72.32 109.509 -178.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.566 HD13 HD13 ' A' ' 249' ' ' LEU . 0.6 OUTLIER -89.97 142.7 27.46 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.06 0.944 . . . . 63.44 110.112 -170.23 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -119.3 145.18 46.35 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 107.878 -1.156 . . . . 73.14 107.878 166.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.441 ' HB3' HD23 ' A' ' 251' ' ' LEU . . . -144.63 175.84 9.85 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.609 1.164 . . . . 74.34 109.485 -171.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 196' ' ' THR . . . . . 0.446 ' OG1' ' HA ' ' B' ' 120' ' ' TYR . 2.9 m -118.41 139.84 50.77 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.643 -0.873 . . . . 70.21 108.643 172.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.628 HD22 HD13 ' A' ' 251' ' ' LEU . 34.5 tp -145.61 105.87 4.05 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 110.127 -0.323 . . . . 72.21 110.127 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -73.62 133.38 43.46 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 109.285 -0.635 . . . . 61.43 109.285 167.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 7.3 p -143.59 133.03 11.63 Favored Pre-proline 0 CA--C 1.548 0.879 0 N-CA-C 107.781 -1.192 . . . . 64.4 107.781 178.116 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.28 146.15 35.46 Favored 'Trans proline' 0 C--N 1.368 1.586 0 C-N-CA 121.313 1.342 . . . . 64.51 110.404 169.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.477 ' HB3' ' HH2' ' A' ' 269' ' ' TRP . . . -44.13 -52.0 17.16 Favored Pre-proline 0 CA--C 1.568 1.669 0 N-CA-C 115.644 1.72 . . . . 71.34 115.644 -173.608 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.408 ' HD3' ' HB3' ' A' ' 201' ' ' ALA . 50.5 Cg_exo -60.07 -38.55 76.86 Favored 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 121.809 1.673 . . . . 63.54 113.845 -179.49 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 46.3 mt -70.17 -29.4 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 110.016 -0.364 . . . . 64.32 110.016 179.3 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.18 -48.83 61.1 Favored 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 123.069 0.548 . . . . 71.51 111.941 172.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 201' ' ' ALA . 93.4 t -65.54 -43.04 94.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 C-N-CA 123.837 0.855 . . . . 63.23 111.859 -175.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.472 HG21 ' HB2' ' C' ' 273' ' ' ALA . 70.4 t -92.55 -34.68 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.594 0.757 . . . . 74.41 111.458 -173.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 88.09 89.21 1.12 Allowed Glycine 0 C--N 1.341 0.845 0 N-CA-C 111.319 -0.712 . . . . 72.35 111.319 -175.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -107.4 -139.28 9.1 Favored Glycine 0 C--N 1.34 0.798 0 CA-C-O 120.277 -0.18 . . . . 55.24 112.67 -177.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -130.85 128.21 40.16 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.175 0.99 . . . . 45.21 108.917 177.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 29.3 m -129.83 159.24 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 109.038 -0.727 . . . . 63.11 109.038 175.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 55.2 ttm-85 -93.93 107.24 19.16 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 109.494 -0.558 . . . . 71.41 109.494 178.04 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -102.25 124.35 47.69 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 124.111 0.964 . . . . 62.04 109.436 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 213' ' ' MET . . . . . 0.413 ' SD ' ' N ' ' A' ' 213' ' ' MET . 1.0 OUTLIER -75.08 126.08 30.27 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.202 0.601 . . . . 71.23 109.747 175.922 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 72.7 p -116.1 -178.01 3.3 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 123.876 0.87 . . . . 74.1 108.726 173.001 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.424 ' HG ' ' HE2' ' A' ' 186' ' ' PHE . 63.8 mt -77.01 -7.6 55.93 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 122.778 0.431 . . . . 63.31 110.727 174.521 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -99.98 -19.66 16.46 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.225 1.01 . . . . 64.44 110.553 176.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 139.53 172.84 12.86 Favored Glycine 0 C--N 1.353 1.504 0 CA-C-O 119.858 -0.412 . . . . 33.0 113.451 175.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -75.9 99.32 1.27 Allowed 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 122.93 2.42 . . . . 70.23 111.285 178.118 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 32.5 m -103.2 159.34 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.208 1.003 . . . . 73.4 110.619 -174.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.646 ' HB2' ' HB2' ' B' ' 428' ' ' GLU . 36.8 mt-10 -93.8 105.07 17.12 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.152 -0.684 . . . . 75.04 109.152 179.285 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 8.7 p -101.64 137.52 29.09 Favored 'Isoleucine or valine' 0 C--O 1.253 1.273 0 C-N-CA 123.832 0.853 . . . . 74.13 110.021 -174.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -86.42 102.75 14.34 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.784 0.834 . . . . 60.25 110.744 -178.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.452 ' HA ' HD12 ' B' ' 441' ' ' ILE . 48.8 t -63.48 137.76 97.17 Favored Pre-proline 0 CA--C 1.56 1.353 0 C-N-CA 124.458 1.103 . . . . 63.14 110.304 179.3 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 224' ' ' PRO . . . . . 0.616 ' HB2' ' HB2' ' B' ' 444' ' ' TYR . 65.0 Cg_endo -79.98 164.01 22.76 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 122.673 2.249 . . . . 75.51 110.612 174.611 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.99 152.4 46.11 Favored 'Trans proline' 0 C--N 1.369 1.63 0 C-N-CA 121.786 1.657 . . . . 72.53 112.814 178.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 226' ' ' ARG . . . . . 0.571 HH12 ' HG ' ' C' ' 261' ' ' LEU . 63.5 mtt-85 67.54 26.06 8.22 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 125.533 1.533 . . . . 74.04 111.873 172.526 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.504 HG23 HD21 ' A' ' 233' ' ' LEU . 10.5 m -61.17 104.01 0.34 Allowed 'General case' 0 CA--C 1.559 1.323 0 C-N-CA 125.699 1.6 . . . . 64.32 111.026 175.316 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 228' ' ' GLN . . . . . 0.562 ' HB3' ' HD2' ' A' ' 231' ' ' ARG . 4.8 tp-100 -97.38 143.89 27.67 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.085 0.954 . . . . 75.32 111.263 -173.252 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -63.57 150.91 42.94 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.588 0.755 . . . . 62.31 112.462 -177.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 83.71 -28.27 4.03 Favored Glycine 0 C--N 1.349 1.271 0 O-C-N 123.684 0.615 . . . . 73.32 112.523 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.562 ' HD2' ' HB3' ' A' ' 228' ' ' GLN . 76.6 mtt180 -77.63 167.11 22.12 Favored 'General case' 0 C--N 1.347 0.492 0 C-N-CA 123.971 0.908 . . . . 74.0 110.469 178.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.443 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 12.5 mptt -121.82 120.55 34.89 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 115.067 -0.97 . . . . 72.22 108.571 -178.078 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.504 HD21 HG23 ' A' ' 227' ' ' THR . 81.8 mt -74.59 110.3 8.77 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 108.595 -0.891 . . . . 71.4 108.595 177.537 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 234' ' ' ARG . . . . . 0.563 ' HG3' ' HB3' ' A' ' 248' ' ' ASP . 39.9 ttp180 -87.63 100.77 13.05 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 122.622 0.369 . . . . 64.14 110.121 178.584 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.504 HD13 HG12 ' B' ' 441' ' ' ILE . 0.2 OUTLIER -100.84 106.84 18.25 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 106.466 -1.679 . . . . 61.12 106.466 170.662 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -76.18 143.95 40.81 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 115.045 -0.979 . . . . 64.43 111.708 -169.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 71.35 32.62 64.97 Favored Glycine 0 C--N 1.348 1.2 0 O-C-N 123.704 0.627 . . . . 74.2 112.536 -178.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.491 ' HG3' HD12 ' A' ' 235' ' ' LEU . 43.9 mmtm -125.32 -17.18 5.71 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.985 0.914 . . . . 73.01 110.453 178.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 239' ' ' GLY . . . . . 0.515 ' HA2' HD12 ' A' ' 193' ' ' LEU . . . -79.6 -151.86 6.85 Favored Glycine 0 C--N 1.353 1.474 0 CA-C-N 116.298 -0.41 . . . . 74.43 112.655 176.354 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -96.72 146.06 30.65 Favored Pre-proline 0 N--CA 1.482 1.169 0 C-N-CA 122.882 0.473 . . . . 73.13 109.857 -179.05 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.728 ' HA ' ' HA ' ' A' ' 246' ' ' ARG . 33.1 Cg_endo -61.27 167.26 9.66 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 123.203 2.602 . . . . 73.33 114.195 -175.577 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -175.2 -176.35 43.4 Favored Glycine 0 CA--C 1.535 1.335 0 CA-C-N 115.213 -0.903 . . . . 73.52 112.18 177.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -62.44 -19.31 67.05 Favored 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 123.68 2.92 . . . . 70.45 113.961 -175.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -102.53 22.52 13.4 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 124.027 0.931 . . . . 70.11 110.855 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 90.18 -164.38 30.9 Favored Glycine 0 C--N 1.35 1.338 0 N-CA-C 111.471 -0.651 . . . . 62.24 111.471 -174.051 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.728 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 25.1 ttm180 -73.08 139.37 46.45 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 117.664 0.732 . . . . 75.41 110.383 177.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -70.06 179.11 28.58 Favored Glycine 0 C--N 1.34 0.775 0 CA-C-N 115.709 -0.678 . . . . 42.24 113.379 -176.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 248' ' ' ASP . . . . . 0.563 ' HB3' ' HG3' ' A' ' 234' ' ' ARG . 55.7 m-20 -106.12 140.57 38.89 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.52 0.728 . . . . 75.44 109.493 -173.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.566 HD13 HD13 ' A' ' 193' ' ' LEU . 34.4 tp -97.61 120.0 37.19 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.349 -0.982 . . . . 70.31 108.349 178.404 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.443 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 2.9 m-85 -100.93 106.18 17.49 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.363 1.065 . . . . 52.51 108.66 177.562 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.628 HD13 HD22 ' A' ' 197' ' ' LEU . 47.1 mt -87.03 121.45 29.51 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.392 0.677 . . . . 72.24 109.659 177.293 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.427 ' HB2' ' O ' ' A' ' 195' ' ' ALA . 2.8 tm-20 -74.38 107.3 6.45 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 107.45 -1.315 . . . . 75.41 107.45 -178.435 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.497 HG12 HG13 ' A' ' 255' ' ' ILE . 42.6 t -67.36 99.67 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.687 0 O-C-N 124.117 0.886 . . . . 24.43 110.223 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.25 92.16 4.39 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 107.181 -1.414 . . . . 73.14 107.181 177.688 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.497 HG13 HG12 ' A' ' 253' ' ' VAL . 70.2 mt -83.8 130.95 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-O 120.779 0.323 . . . . 74.34 110.583 -177.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 51.8 p -128.99 169.38 14.75 Favored 'General case' 0 C--O 1.253 1.265 0 C-N-CA 123.942 0.897 . . . . 73.43 109.585 172.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 257' ' ' ILE . . . . . 0.551 HD13 HG22 ' C' ' 205' ' ' VAL . 2.1 pp -119.14 155.95 52.91 Favored Pre-proline 0 CA--C 1.564 1.513 0 N-CA-C 108.121 -1.066 . . . . 73.4 108.121 173.095 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -76.27 9.21 2.56 Favored 'Trans proline' 0 N--CA 1.512 2.564 0 C-N-CA 123.027 2.485 . . . . 74.45 115.328 -162.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.48 ' H ' HD12 ' A' ' 257' ' ' ILE . 5.6 mm-40 56.72 -90.72 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 123.858 0.863 . . . . 63.24 109.925 -164.47 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 260' ' ' ARG . . . . . 0.464 HH22 HG23 ' A' ' 262' ' ' THR . 0.0 OUTLIER -74.33 144.32 44.53 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.589 0.756 . . . . 75.12 111.521 -175.029 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.435 HD11 HG11 ' C' ' 205' ' ' VAL . 49.5 mt -123.41 178.67 5.05 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.046 0.938 . . . . 55.32 111.165 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 262' ' ' THR . . . . . 0.464 HG23 HH22 ' A' ' 260' ' ' ARG . 1.2 p -128.16 143.88 49.61 Favored Pre-proline 0 CA--C 1.556 1.181 0 CA-C-N 114.007 -1.451 . . . . 44.34 108.43 176.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -28.26 -53.91 0.14 Allowed 'Trans proline' 0 C--N 1.39 2.757 1 C-N-CA 126.166 4.577 . . . . 74.33 117.734 -167.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 264' ' ' GLU . . . . . 0.406 ' O ' HD13 ' A' ' 268' ' ' LEU . 16.9 tp10 -70.25 -47.52 60.98 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 122.589 0.356 . . . . 71.44 110.68 -174.562 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -64.51 -29.22 70.26 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.284 1.034 . . . . 64.2 110.319 178.218 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -62.76 -50.53 70.69 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.736 0.814 . . . . 73.45 109.047 175.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -62.76 -37.13 85.4 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 114.991 -1.004 . . . . 64.12 112.097 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 268' ' ' LEU . . . . . 0.5 HD21 ' HB3' ' C' ' 271' ' ' LYS . 6.7 mp -64.73 -56.05 16.08 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.704 0.802 . . . . 73.14 111.396 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 269' ' ' TRP . . . . . 0.477 ' HH2' ' HB3' ' A' ' 201' ' ' ALA . 68.1 m95 -58.62 -41.73 86.57 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.431 0.693 . . . . 75.0 111.279 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -60.25 -58.54 8.07 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 123.828 0.705 . . . . 62.43 111.516 178.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 30.8 mmtm -66.34 -33.64 76.18 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 112.418 0.525 . . . . 70.22 112.418 -175.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 13.7 mt -54.25 -53.54 52.3 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 109.224 -0.658 . . . . 63.4 109.224 169.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 273' ' ' ALA . . . . . 0.443 ' HA ' ' HB2' ' C' ' 202' ' ' PRO . . . -67.41 -37.84 83.68 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.671 1.188 . . . . 64.51 113.664 -172.665 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.466 ' HB3' ' HA ' ' B' ' 250' ' ' GLN . 37.6 mt-10 -67.81 -53.81 24.08 Favored 'General case' 0 C--O 1.243 0.733 0 C-N-CA 123.956 0.902 . . . . 74.35 109.398 -179.463 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -66.29 -30.41 70.82 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 115.538 -0.755 . . . . 71.44 111.145 178.441 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -68.57 -44.65 74.0 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.474 0.71 . . . . 75.02 109.945 178.227 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 277' ' ' TYR . . . . . 0.465 ' HA ' ' HB3' ' A' ' 280' ' ' ALA . 70.3 t80 -65.12 -37.53 87.75 Favored 'General case' 0 C--O 1.242 0.674 0 O-C-N 124.06 0.85 . . . . 70.12 110.245 -178.535 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -57.79 -23.83 54.3 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 115.571 -0.74 . . . . 75.41 111.683 173.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 67.7 mtm-85 -102.89 -15.76 16.08 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 124.026 0.93 . . . . 74.13 111.398 176.389 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 280' ' ' ALA . . . . . 0.465 ' HB3' ' HA ' ' A' ' 277' ' ' TYR . . . . . . . . 0 C--O 1.259 1.561 0 C-N-CA 123.851 0.86 . . . . 72.21 110.275 -176.095 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 62.9 mtm . . . . . 0 N--CA 1.482 1.148 0 N-CA-C 109.25 -0.648 . . . . 71.44 109.25 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 61.93 -158.23 0.33 Allowed 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.766 0.826 . . . . 54.1 109.777 -177.221 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -90.47 67.5 6.58 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 108.108 -1.071 . . . . 74.04 108.108 169.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 21.8 p -69.94 97.57 1.15 Allowed 'General case' 0 C--O 1.244 0.776 0 CA-C-N 115.53 -0.759 . . . . 52.14 110.543 -177.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 5' ' ' THR . . . . . 0.581 HG21 ' HB ' ' A' ' 137' ' ' VAL . 0.0 OUTLIER -97.07 166.17 11.72 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.475 -0.784 . . . . 70.11 111.71 -174.59 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 19.7 pt -133.78 166.57 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 115.248 -0.887 . . . . 64.44 112.385 -157.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -128.59 155.31 45.15 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.878 1.271 . . . . 72.01 108.625 173.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 45.7 tp -89.36 -98.55 0.1 Allowed 'General case' 0 CA--C 1.55 0.961 0 CA-C-O 119.131 -0.461 . . . . 75.22 110.574 -173.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . 166.31 -55.0 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 125.126 1.371 . . . . 62.4 109.065 -173.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 93.0 mt 57.95 91.29 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.983 1.313 . . . . 74.1 110.459 -168.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 78.7 mt -100.82 100.85 13.68 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 123.526 0.73 . . . . 45.35 109.434 -177.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -75.86 72.15 5.27 Favored 'Trans proline' 0 C--N 1.381 2.281 0 C-N-CA 122.974 2.449 . . . . 61.33 111.349 -177.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 7.4 mp 59.75 31.31 20.76 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.637 1.175 . . . . 75.01 110.635 -175.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 29.0 tp -79.48 14.91 1.42 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 124.726 1.211 . . . . 64.54 111.994 -172.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -82.57 69.22 9.29 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.105 0.962 . . . . 60.01 109.742 179.118 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 2.5 t -142.84 68.55 18.83 Favored Pre-proline 0 CA--C 1.56 1.344 0 CA-C-N 115.225 -0.898 . . . . 51.11 110.351 -179.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 17' ' ' PRO . . . . . 0.501 ' HB3' ' HB3' ' B' ' 21' ' ' ALA . 39.6 Cg_exo -64.7 96.39 0.25 Allowed 'Trans proline' 0 C--N 1.385 2.483 0 C-N-CA 122.895 2.397 . . . . 62.42 112.319 172.389 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 12.8 m -76.19 86.3 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.344 0 C-N-CA 123.395 0.678 . . . . 61.41 111.144 -179.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 20.6 m 76.04 -48.16 0.58 Allowed 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 126.202 1.801 . . . . 71.22 112.525 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -69.56 112.15 5.87 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 107.841 -1.17 . . . . 62.34 107.841 170.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 21' ' ' ALA . . . . . 0.501 ' HB3' ' HB3' ' B' ' 17' ' ' PRO . . . 74.28 169.31 0.3 Allowed 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 125.267 1.427 . . . . 75.34 110.68 -164.4 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 72.67 -65.57 0.35 Allowed 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 124.966 1.306 . . . . 73.31 109.823 -165.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 23' ' ' THR . . . . . . . . . . . . . 31.0 m -128.3 88.46 52.55 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 124.036 0.934 . . . . 72.45 108.562 176.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -57.06 112.35 1.08 Allowed 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 123.28 2.654 . . . . 74.55 112.796 -179.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -95.6 111.99 23.8 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.049 0.54 . . . . 74.53 109.721 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 26' ' ' MET . . . . . 0.411 ' SD ' ' N ' ' B' ' 26' ' ' MET . 1.5 mpt? -79.06 158.83 74.29 Favored Pre-proline 0 CA--C 1.557 1.214 0 C-N-CA 123.798 0.839 . . . . 75.13 109.995 176.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -66.87 84.85 0.31 Allowed 'Trans proline' 0 C--N 1.384 2.441 0 C-N-CA 122.373 2.049 . . . . 71.1 110.625 172.091 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.534 HG13 ' H ' ' B' ' 29' ' ' LEU 0.276 5.1 p 39.53 -80.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 C-N-CA 126.42 1.888 . . . . 73.51 113.747 -168.233 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.534 ' H ' HG13 ' B' ' 28' ' ' VAL . 81.8 mt 72.92 -38.59 0.42 Allowed 'General case' 0 N--CA 1.499 2.0 0 C-N-CA 126.387 1.875 . . . . 62.2 113.663 -179.398 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -72.47 84.1 1.11 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.789 0.836 . . . . 70.24 110.817 -174.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -99.13 -20.09 16.84 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.258 0.623 . . . . 74.34 110.994 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -84.24 76.02 10.14 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.543 0.737 . . . . 72.22 110.469 -174.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -91.44 -24.65 19.64 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 115.067 -0.97 . . . . 73.31 111.062 177.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . 76.03 -43.51 0.48 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 126.173 1.789 . . . . 53.33 112.535 178.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 69.74 -73.67 0.09 Allowed 'General case' 0 C--N 1.361 1.074 0 C-N-CA 125.714 1.606 . . . . 73.13 110.955 176.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 161.85 45.14 0.02 OUTLIER Glycine 0 C--N 1.341 0.842 0 N-CA-C 110.253 -1.139 . . . . 74.33 110.253 177.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -68.95 119.89 13.98 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.651 0.78 . . . . 61.44 110.963 -175.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 38.5 mm 57.4 -88.24 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.166 0 C-N-CA 125.407 1.483 . . . . 75.44 110.25 -170.375 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 15.5 p -155.69 12.34 0.32 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 124.759 1.223 . . . . 64.25 109.948 178.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . 51.82 64.87 7.11 Favored Pre-proline 0 CA--C 1.562 1.406 0 C-N-CA 124.078 0.951 . . . . 64.0 111.117 -166.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -75.35 6.6 3.44 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 123.545 2.83 . . . . 72.44 114.185 -176.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -79.75 61.77 4.24 Favored Glycine 0 C--N 1.35 1.324 0 C-N-CA 122.92 0.295 . . . . 45.24 112.735 176.091 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -172.0 14.49 0.05 OUTLIER Glycine 0 C--N 1.345 1.079 0 C-N-CA 123.502 0.573 . . . . 42.15 112.198 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . 66.64 -73.5 0.07 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.668 1.587 . . . . 63.2 111.345 -177.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 20.1 tpp180 -156.54 -60.35 0.1 Allowed 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 106.563 -1.643 . . . . 74.21 106.563 175.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 71.6 mtt180 -131.39 -173.05 3.01 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 114.98 -1.009 . . . . 75.02 109.518 171.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 1.8 pp -83.1 -171.57 3.65 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.278 0.631 . . . . 53.22 111.247 178.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 31.1 m 69.13 80.08 0.19 Allowed 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.101 1.36 . . . . 51.22 109.993 -175.197 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.28 111.04 3.28 Favored Glycine 0 C--N 1.35 1.336 0 CA-C-N 114.904 -1.043 . . . . 74.15 112.804 -176.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -64.36 -45.46 87.66 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.055 0.942 . . . . 64.2 110.26 175.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 51' ' ' GLN . . . . . 0.668 ' HB2' HD21 ' B' ' 55' ' ' LEU . 73.6 mt-30 65.22 -75.86 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 125.399 1.479 . . . . 75.3 111.512 -179.399 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 32.2 m -117.2 -60.44 1.83 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.489 0.715 . . . . 73.31 109.392 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -176.56 -58.68 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.446 1.099 . . . . 73.24 109.385 177.235 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -147.49 103.52 3.55 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.654 0.782 . . . . 75.51 109.419 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.668 HD21 ' HB2' ' B' ' 51' ' ' GLN . 2.8 mm? -87.23 109.2 19.32 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.751 0.82 . . . . 72.35 108.861 -178.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 56' ' ' ARG . . . . . 0.404 ' HA ' ' H ' ' B' ' 233' ' ' PHE . 0.1 OUTLIER 79.17 -16.45 0.67 Allowed 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 125.235 1.414 . . . . 73.2 113.021 176.763 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 48.9 t0 74.3 142.52 0.07 Allowed 'General case' 0 C--N 1.372 1.555 0 C-N-CA 124.887 1.275 . . . . 75.31 109.902 -175.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 23.6 m -107.7 170.52 7.93 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.489 0.716 . . . . 62.01 112.153 -169.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 4.5 mm? 77.53 79.45 0.08 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 125.957 1.703 . . . . 72.44 112.47 -178.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 68.1 m -143.98 23.19 1.72 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.862 1.265 . . . . 63.51 109.134 171.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 61' ' ' ASP . . . . . 0.572 ' HB2' ' HD2' ' B' ' 63' ' ' PRO . 2.2 m-20 -85.68 -59.63 2.25 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.162 0.985 . . . . 71.45 110.082 -168.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 62' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -175.4 -48.32 0.0 OUTLIER Pre-proline 0 CA--C 1.555 1.142 0 C-N-CA 125.424 1.49 . . . . 72.3 108.362 -175.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 63' ' ' PRO . . . . . 0.572 ' HD2' ' HB2' ' B' ' 61' ' ' ASP . 73.2 Cg_endo -71.37 -165.18 0.18 Allowed 'Trans proline' 0 C--N 1.406 3.597 0 C-N-CA 122.08 1.853 . . . . 72.24 113.671 174.208 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 78.66 100.28 0.06 Allowed 'General case' 0 C--N 1.361 1.087 0 C-N-CA 126.0 1.72 . . . . 72.04 109.758 -170.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.431 ' NZ ' HG22 ' B' ' 68' ' ' ILE . 57.0 tttm 84.16 -64.42 0.08 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 126.063 1.745 . . . . 65.32 110.904 175.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 66' ' ' ASN . . . . . 0.446 HD21 ' HA ' ' B' ' 63' ' ' PRO . 20.5 m120 57.69 -88.7 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 124.449 1.099 . . . . 72.41 113.055 175.119 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 60.9 mt -76.76 98.07 1.79 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.69 0 C-N-CA 123.313 0.645 . . . . 72.03 109.31 -175.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 68' ' ' ILE . . . . . 0.541 HD13 ' HG2' ' B' ' 221' ' ' ARG . 2.9 pp -66.08 142.78 16.34 Favored 'Isoleucine or valine' 0 C--O 1.246 0.906 0 CA-C-N 114.995 -1.002 . . . . 73.4 108.462 168.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.61 132.05 44.86 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 107.013 -1.477 . . . . 73.12 107.013 176.431 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 7.6 mp -55.54 -34.11 64.41 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.151 0.98 . . . . 44.44 111.73 -173.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 31.6 pt -136.56 157.25 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 124.906 1.283 . . . . 74.32 108.973 173.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.75 -29.32 3.75 Favored Glycine 0 N--CA 1.478 1.481 0 CA-C-O 119.56 -0.578 . . . . 62.21 114.104 174.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 73' ' ' ASP . . . . . 0.477 ' HB3' ' HG3' ' B' ' 221' ' ' ARG . 15.7 t70 -53.35 -43.61 67.85 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 124.966 1.306 . . . . 63.44 110.499 178.677 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -132.71 124.77 3.92 Favored Glycine 0 C--N 1.334 0.47 0 N-CA-C 108.396 -1.882 . . . . 64.42 108.396 163.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 14.2 tpt -79.69 86.36 5.3 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 117.583 0.691 . . . . 74.01 109.778 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 70.7 -176.24 36.25 Favored Glycine 0 CA--C 1.534 1.252 0 CA-C-N 115.292 -0.867 . . . . 71.13 113.379 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 77' ' ' ASP . . . . . 0.702 ' HA ' HG11 ' B' ' 224' ' ' VAL . 5.8 p-10 -95.91 148.38 22.69 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.826 0.85 . . . . 73.03 109.768 173.233 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 78' ' ' SER . . . . . 0.413 ' H ' HG21 ' B' ' 224' ' ' VAL . 17.9 m -73.18 85.71 1.38 Allowed 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 121.638 0.732 . . . . 51.1 111.239 -174.304 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -75.55 -16.4 60.27 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 114.629 -1.169 . . . . 74.44 111.391 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 6.6 tp -50.08 -39.99 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 124.611 1.165 . . . . 72.52 111.131 175.239 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 26.7 m -116.4 -81.24 0.61 Allowed 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 108.448 -0.945 . . . . 71.34 108.448 170.087 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 58.9 169.47 0.06 Allowed 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 124.585 1.154 . . . . 61.11 112.976 -173.121 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . 70.08 -67.3 0.24 Allowed 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 125.058 1.343 . . . . 71.35 113.101 176.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 30.5 tpt180 65.58 103.74 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.682 1.193 . . . . 73.0 109.124 -175.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 85' ' ' ASN . . . . . 0.458 ' HB2' ' HA2' ' B' ' 89' ' ' GLY . 6.2 m-20 69.18 87.32 0.12 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.045 0.938 . . . . 72.23 108.797 -164.589 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -76.71 -18.32 58.58 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.553 0.741 . . . . 63.12 111.453 -174.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -81.19 -80.74 0.14 Allowed 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 109.201 -0.666 . . . . 52.24 109.201 172.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -112.79 98.24 7.07 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.683 0.793 . . . . 74.14 109.481 177.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 89' ' ' GLY . . . . . 0.458 ' HA2' ' HB2' ' B' ' 85' ' ' ASN . . . -81.78 14.57 30.49 Favored Glycine 0 C--N 1.351 1.397 0 CA-C-N 115.726 -0.67 . . . . 54.33 113.544 178.193 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -87.89 158.98 18.55 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.644 0.778 . . . . 62.33 110.284 176.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -93.83 -32.51 7.54 Favored Glycine 0 C--N 1.341 0.824 0 CA-C-N 115.894 -0.594 . . . . 70.11 111.822 171.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -90.36 126.51 8.37 Favored Glycine 0 C--N 1.343 0.957 0 N-CA-C 111.881 -0.488 . . . . 23.53 111.881 177.264 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 93' ' ' PHE . . . . . 0.479 ' CE2' ' HA ' ' B' ' 304' ' ' PRO . 93.7 m-85 -122.86 138.68 54.58 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.834 0.853 . . . . 74.22 109.646 -178.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 63.66 118.08 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 125.244 1.418 . . . . 71.21 110.891 -175.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -83.63 56.94 3.82 Favored 'General case' 0 CA--C 1.561 1.402 0 CA-C-O 123.122 1.439 . . . . 74.14 109.834 -178.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . -166.21 141.6 7.08 Favored Glycine 0 C--N 1.332 0.309 0 CA-C-N 114.431 -1.259 . . . . 72.31 110.37 -176.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 2.1 pp -120.12 164.44 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-O 121.432 0.634 . . . . 72.22 111.551 -174.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -111.66 24.96 12.14 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.694 1.198 . . . . 75.21 109.549 173.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.76 105.48 0.66 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.768 0.827 . . . . 61.12 111.269 -174.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 3.5 pp -58.54 149.98 58.61 Favored Pre-proline 0 CA--C 1.558 1.258 0 C-N-CA 124.956 1.303 . . . . 74.2 112.503 -178.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -61.77 93.09 0.12 Allowed 'Trans proline' 0 C--N 1.384 2.414 0 C-N-CA 123.27 2.647 . . . . 72.21 112.739 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 102' ' ' LEU . . . . . 0.43 HD23 ' H ' ' B' ' 102' ' ' LEU . 2.3 pt? -113.1 -173.73 2.31 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.02 0.928 . . . . 73.12 110.249 179.079 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 6.2 t 57.62 14.87 2.55 Favored 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 126.718 2.007 . . . . 75.52 114.824 172.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.53 -82.18 1.09 Allowed Glycine 0 C--N 1.347 1.185 0 N-CA-C 111.179 -0.769 . . . . 51.35 111.179 172.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -141.16 153.41 45.34 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 124.478 1.111 . . . . 75.22 108.748 173.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 106' ' ' TYR . . . . . 0.438 ' HA ' ' HA2' ' B' ' 382' ' ' GLY . 60.1 t80 73.21 -13.35 0.71 Allowed 'General case' 0 N--CA 1.501 2.097 0 C-N-CA 124.639 1.176 . . . . 74.44 112.899 174.411 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 49.8 p -107.39 2.13 24.15 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.642 1.177 . . . . 63.32 111.291 -177.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -163.96 151.33 12.23 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.559 0.743 . . . . 71.44 109.69 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -92.82 147.34 22.94 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.903 -0.777 . . . . 53.33 108.903 171.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . 68.08 118.26 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.991 1.316 . . . . 71.24 113.027 173.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 48.3 tp -129.19 85.26 2.3 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.951 0.9 . . . . 64.15 108.742 177.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 57.41 -162.62 0.2 Allowed 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 125.017 1.327 . . . . 73.2 111.69 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 113' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? 69.36 -78.25 0.05 OUTLIER 'General case' 0 C--N 1.357 0.932 0 C-N-CA 125.988 1.715 . . . . 75.13 111.014 173.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -66.82 86.46 0.13 Allowed 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 121.645 0.736 . . . . 74.01 111.442 -173.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 29.5 p -100.02 -91.51 0.3 Allowed 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 108.067 -1.086 . . . . 73.23 108.067 171.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 52.85 -101.23 0.07 OUTLIER Glycine 0 C--N 1.359 1.86 0 N-CA-C 114.681 0.633 . . . . 55.33 114.681 175.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 117' ' ' LYS . . . . . 0.426 ' HE3' ' HD2' ' B' ' 118' ' ' PRO . 32.5 mmmt 70.21 164.79 0.14 Allowed Pre-proline 0 N--CA 1.49 1.555 0 C-N-CA 125.578 1.551 . . . . 70.25 112.079 -177.195 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 118' ' ' PRO . . . . . 0.426 ' HD2' ' HE3' ' B' ' 117' ' ' LYS . 80.2 Cg_endo -73.77 -150.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.389 2.684 0 C-N-CA 122.287 1.992 . . . . 60.53 111.458 171.04 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 119' ' ' ASP . . . . . 0.455 ' HB3' ' HB2' ' B' ' 126' ' ' ALA . 1.8 m-20 80.92 -59.81 0.26 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.245 1.418 . . . . 75.33 111.159 175.149 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 120' ' ' TYR . . . . . 0.446 ' HA ' ' OG1' ' A' ' 196' ' ' THR . 52.9 m-85 64.78 -74.69 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.802 1.241 . . . . 70.1 113.311 168.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 7.3 p -155.98 -30.83 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.559 1.313 0 C-N-CA 123.167 0.587 . . . . 74.32 111.536 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 20.8 m -144.79 7.07 1.23 Allowed 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 123.722 0.809 . . . . 75.24 111.313 -173.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 123' ' ' ASP . . . . . 0.402 ' O ' ' HA ' ' B' ' 119' ' ' ASP . 12.9 t70 -103.88 157.11 17.31 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 124.0 0.92 . . . . 64.3 110.582 -176.823 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 16.2 m 57.6 -82.93 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 125.397 1.479 . . . . 43.31 112.872 176.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 125' ' ' ALA . . . . . 0.414 ' HB2' ' HG2' ' C' ' 252' ' ' GLU . . . -155.01 29.92 0.41 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.822 0.849 . . . . 73.02 110.492 -178.008 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 126' ' ' ALA . . . . . 0.455 ' HB2' ' HB3' ' B' ' 119' ' ' ASP . . . -69.13 138.49 54.27 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 122.962 0.505 . . . . 74.13 110.436 177.141 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 10.9 m 73.1 1.43 4.01 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.729 1.212 . . . . 70.01 112.296 -177.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -95.05 114.66 26.5 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.434 0.694 . . . . 72.01 110.533 -177.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 129' ' ' THR . . . . . 0.562 ' HB ' ' HA ' ' B' ' 133' ' ' THR . 6.7 m -147.02 172.44 13.73 Favored 'General case' 0 CA--C 1.557 1.235 0 N-CA-C 107.94 -1.133 . . . . 54.34 107.94 179.217 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . -61.74 130.76 47.34 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.187 0.595 . . . . 44.22 110.842 175.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 131' ' ' TRP . . . . . 0.501 ' HA ' ' OD1' ' B' ' 167' ' ' ASN . 5.7 m-90 57.9 44.68 19.5 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.566 1.146 . . . . 73.51 110.698 -177.099 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 38.0 t 71.62 -59.94 0.53 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 126.291 1.836 . . . . 51.4 110.696 -173.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 133' ' ' THR . . . . . 0.562 ' HA ' ' HB ' ' B' ' 129' ' ' THR . 10.7 t -159.66 22.16 0.18 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.566 0.746 . . . . 62.25 110.048 178.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.08 23.47 61.34 Favored Glycine 0 C--N 1.348 1.242 0 CA-C-N 115.708 -0.678 . . . . 55.15 111.821 -170.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 135' ' ' VAL . . . . . . . . . . . . . 60.2 t 61.11 -80.39 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.559 1.309 0 C-N-CA 125.912 1.685 . . . . 73.24 112.331 -177.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 8.2 mtpm? -69.47 84.29 0.41 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.02 0.528 . . . . 52.43 112.042 -172.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 55.1 m -162.16 -33.96 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.489 1.516 . . . . 75.31 108.97 179.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -52.96 91.94 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.423 0 C-N-CA 124.629 1.171 . . . . 75.52 111.719 -177.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 56.9 t30 67.47 -67.13 0.18 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 125.464 1.506 . . . . 73.24 110.846 -170.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . 159.65 131.43 1.24 Allowed Glycine 0 C--N 1.341 0.83 0 N-CA-C 111.192 -0.763 . . . . 65.04 111.192 174.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -90.44 -4.9 56.68 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.461 0.705 . . . . 75.34 111.704 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 6.3 tt 79.05 -60.17 0.38 Allowed 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 126.352 1.861 . . . . 70.15 110.088 179.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -72.7 86.4 0.54 Allowed Glycine 0 CA--C 1.533 1.202 0 CA-C-O 119.981 -0.344 . . . . 61.25 113.526 -177.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 144' ' ' VAL . . . . . 0.471 HG22 ' HB2' ' B' ' 148' ' ' GLU . 54.9 t 64.47 80.25 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 125.228 1.411 . . . . 75.31 112.215 171.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -106.79 -47.27 3.77 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.496 0.718 . . . . 64.3 110.403 174.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 26.2 pt -101.25 -42.42 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 122.746 0.418 . . . . 72.52 110.809 177.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -163.65 -75.32 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 122.753 0.421 . . . . 72.43 110.276 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 148' ' ' GLU . . . . . 0.471 ' HB2' HG22 ' B' ' 144' ' ' VAL . 10.0 mm-40 54.41 -170.91 0.06 Allowed 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.842 1.257 . . . . 73.05 111.864 -170.521 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 149' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -160.4 96.85 1.2 Allowed 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.046 0.45 . . . . 72.23 110.734 173.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -96.04 -83.92 0.36 Allowed 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 107.172 -1.418 . . . . 74.11 107.172 167.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 151' ' ' HIS . . . . . 0.733 ' HB2' ' HG3' ' B' ' 206' ' ' GLU . 43.2 t60 -176.18 -57.68 0.0 OUTLIER Pre-proline 0 N--CA 1.486 1.336 0 CA-C-O 118.539 -0.743 . . . . 74.43 111.922 175.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -83.0 161.82 15.75 Favored 'Trans proline' 0 C--N 1.388 2.65 0 C-N-CA 121.533 1.488 . . . . 42.51 112.406 -171.009 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 67.4 p -72.29 -28.09 62.88 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.191 -0.913 . . . . 74.2 111.055 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 154' ' ' ILE . . . . . 0.541 HG22 ' HG ' ' B' ' 155' ' ' LEU . 41.1 mm 67.25 -71.18 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 125.358 1.463 . . . . 74.25 110.004 -176.104 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 155' ' ' LEU . . . . . 0.541 ' HG ' HG22 ' B' ' 154' ' ' ILE . 74.8 mt -122.04 -43.57 2.33 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.813 0.845 . . . . 72.1 110.011 176.382 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 156' ' ' GLU . . . . . 0.473 ' HG3' ' H ' ' B' ' 158' ' ' ALA . 8.4 tp10 -148.5 147.55 29.22 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.041 0.937 . . . . 72.23 109.657 178.571 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 157' ' ' MET . . . . . . . . . . . . . 53.6 ttm -57.25 -30.73 64.88 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 124.849 1.26 . . . . 53.54 112.274 -177.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 158' ' ' ALA . . . . . 0.473 ' H ' ' HG3' ' B' ' 156' ' ' GLU . . . -109.65 107.65 17.78 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.426 0.69 . . . . 34.04 110.751 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 82.8 tttt 67.66 11.38 8.35 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 124.666 1.186 . . . . 55.45 112.993 168.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . 71.63 -54.16 0.68 Allowed 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 125.446 1.498 . . . . 70.22 111.833 -175.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . 75.01 -40.86 0.45 Allowed 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 115.629 1.714 . . . . 71.1 115.629 164.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . -76.58 13.64 8.02 Favored Glycine 0 CA--C 1.538 1.487 0 N-CA-C 114.35 0.5 . . . . 73.4 114.35 -171.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -76.12 -11.73 59.99 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.2 1.0 . . . . 65.02 109.968 175.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 164' ' ' ALA . . . . . . . . . . . . . . . -50.58 -32.05 17.59 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 125.051 1.34 . . . . 75.34 112.162 173.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 26.4 m -54.86 107.3 0.28 Allowed 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.591 1.156 . . . . 64.15 111.199 175.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . 152.91 -47.81 0.55 Allowed Glycine 0 C--N 1.346 1.132 0 N-CA-C 111.259 -0.736 . . . . 71.15 111.259 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 167' ' ' ASN . . . . . 0.501 ' OD1' ' HA ' ' B' ' 131' ' ' TRP . 9.3 p30 -110.1 22.3 15.74 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.473 0.709 . . . . 72.31 110.624 -179.112 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 30.3 m -78.24 -173.4 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.179 0 C-N-CA 123.556 0.742 . . . . 74.13 111.726 -178.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 18.9 m -57.53 103.82 0.15 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.419 1.088 . . . . 54.35 111.058 179.092 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 25.6 m 64.77 -77.99 0.03 OUTLIER 'General case' 0 C--N 1.36 1.026 0 C-N-CA 124.884 1.274 . . . . 63.1 110.591 -172.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . 177.64 175.04 0.48 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.907 1.283 . . . . 53.32 108.992 178.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 172' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.76 147.61 28.31 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 106.429 -1.693 . . . . 73.22 106.429 163.193 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 173' ' ' LEU . . . . . 0.659 ' HB2' ' HB3' ' B' ' 335' ' ' ASN . 6.7 mp -71.21 -0.05 8.97 Favored 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 123.191 0.596 . . . . 74.23 112.168 -173.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 174' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -61.96 78.97 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.946 0.898 . . . . 74.45 110.64 172.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 175' ' ' ASP . . . . . . . . . . . . . 39.2 t70 63.04 148.04 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 125.655 1.582 . . . . 74.1 112.268 -168.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -138.98 34.01 2.15 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.579 0.752 . . . . 74.11 110.139 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 10.7 m -116.98 93.38 41.82 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 123.609 0.763 . . . . 64.31 109.598 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 178' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -81.28 -23.17 5.34 Favored 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 122.524 2.149 . . . . 74.53 112.602 175.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -175.3 -71.78 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.919 1.287 . . . . 61.34 108.46 175.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 180' ' ' ALA . . . . . 0.565 ' HB1' HG23 ' C' ' 137' ' ' VAL . . . -170.03 -76.97 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.197 1.399 . . . . 74.4 107.553 177.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 181' ' ' LEU . . . . . 0.672 HD22 ' HB2' ' C' ' 136' ' ' ARG . 33.9 tp -132.46 -58.01 0.94 Allowed 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 107.518 -1.289 . . . . 62.04 107.518 163.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 182' ' ' VAL . . . . . 0.494 HG13 ' H ' ' B' ' 184' ' ' HIS . 11.5 p -74.04 160.51 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-N 114.883 -1.053 . . . . 71.31 110.812 178.163 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -90.33 22.75 3.21 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.888 0.875 . . . . 65.24 111.305 173.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 184' ' ' HIS . . . . . 0.494 ' H ' HG13 ' B' ' 182' ' ' VAL . 77.1 t60 64.98 -83.65 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.138 1.375 . . . . 74.15 107.885 -166.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 185' ' ' VAL . . . . . 0.439 HG23 ' HA ' ' C' ' 121' ' ' ALA . 1.7 p -165.56 122.33 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 123.921 0.888 . . . . 71.33 109.002 168.337 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 66.7 p 51.95 -74.74 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.283 0 O-C-N 125.52 1.762 . . . . 51.31 113.005 174.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 187' ' ' SER . . . . . . . . . . . . . 21.7 m -59.48 119.13 6.93 Favored 'General case' 0 C--N 1.352 0.717 0 C-N-CA 123.877 0.871 . . . . 62.14 110.396 171.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 188' ' ' ARG . . . . . 0.689 ' HD3' ' SG ' ' B' ' 190' ' ' CYS . 34.6 ttt180 -134.18 149.6 51.04 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.774 -0.824 . . . . 71.52 108.774 178.332 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -83.91 7.74 17.23 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 123.176 0.59 . . . . 72.52 112.312 -176.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 190' ' ' CYS . . . . . 0.689 ' SG ' ' HD3' ' B' ' 188' ' ' ARG . 28.1 p -80.82 75.32 7.76 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 123.077 0.551 . . . . 70.33 110.51 179.036 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -157.98 -178.9 7.65 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.433 0.693 . . . . 74.04 109.917 177.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 114.96 85.4 1.28 Allowed Glycine 0 C--N 1.348 1.217 0 N-CA-C 110.988 -0.845 . . . . 64.22 110.988 -176.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 193' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -56.67 -23.5 49.54 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 123.524 2.816 . . . . 64.32 113.643 175.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 194' ' ' SER . . . . . . . . . . . . . 95.5 p 55.5 26.98 9.61 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 125.611 1.565 . . . . 24.51 112.684 176.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 195' ' ' ALA . . . . . . . . . . . . . . . -147.97 109.99 4.53 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.73 0.812 . . . . 74.32 109.567 -177.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 30.5 p -73.02 -61.0 1.97 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.955 0.902 . . . . 73.32 109.872 177.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 71.8 m -149.79 -177.74 6.06 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.136 1.374 . . . . 75.11 108.003 168.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 198' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -65.01 85.47 0.05 OUTLIER 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 123.446 0.698 . . . . 51.12 110.482 177.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 12.6 mptt 67.11 -73.85 0.07 Allowed 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 126.072 1.749 . . . . 74.4 111.44 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 200' ' ' CYS . . . . . 0.638 ' H ' ' HD2' ' B' ' 201' ' ' PRO . 86.3 m -147.55 -54.57 0.02 OUTLIER Pre-proline 0 CA--C 1.561 1.384 0 C-N-CA 124.385 1.074 . . . . 73.31 111.713 175.615 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 201' ' ' PRO . . . . . 0.638 ' HD2' ' H ' ' B' ' 200' ' ' CYS . 61.7 Cg_endo -67.94 -29.01 35.05 Favored 'Trans proline' 0 C--N 1.395 3.021 0 C-N-CA 122.04 1.827 . . . . 71.34 113.218 -173.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 81.57 -59.3 4.84 Favored Glycine 0 C--N 1.35 1.359 0 N-CA-C 111.985 -0.446 . . . . 63.04 111.985 -177.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -70.38 161.93 29.56 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.452 1.101 . . . . 71.33 110.29 173.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -57.14 112.76 1.46 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.928 0.891 . . . . 74.01 112.094 -178.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 205' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -98.47 -33.07 11.16 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.322 1.049 . . . . 51.03 110.513 -178.218 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 206' ' ' GLU . . . . . 0.733 ' HG3' ' HB2' ' B' ' 151' ' ' HIS . 34.9 tt0 77.52 96.33 0.06 Allowed 'General case' 0 N--CA 1.479 0.989 0 O-C-N 125.1 1.5 . . . . 62.32 110.093 -172.19 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 21.6 pttm -125.1 163.96 21.25 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.848 1.259 . . . . 74.32 109.693 -179.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 82.53 21.0 60.86 Favored Glycine 0 N--CA 1.471 0.995 0 N-CA-C 111.908 -0.477 . . . . 71.52 111.908 -175.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . -74.87 -177.32 39.08 Favored Glycine 0 C--N 1.345 1.047 0 CA-C-N 115.194 -0.503 . . . . 42.21 113.193 175.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 210' ' ' LYS . . . . . 0.501 ' HE3' ' HA ' ' B' ' 210' ' ' LYS . 0.3 OUTLIER 73.03 -62.49 0.47 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.403 1.481 . . . . 74.51 110.171 -173.164 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . -64.78 87.23 0.08 OUTLIER Glycine 0 C--N 1.352 1.453 0 O-C-N 123.164 0.29 . . . . 74.43 112.662 177.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 35.3 t -72.41 92.99 1.49 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.795 0.838 . . . . 74.04 111.113 -173.095 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 213' ' ' ILE . . . . . 0.516 HG13 ' H ' ' B' ' 214' ' ' THR 0.259 18.7 pt 40.42 -74.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 C-N-CA 127.407 2.283 . . . . 64.4 115.026 -176.406 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 214' ' ' THR . . . . . 0.516 ' H ' HG13 ' B' ' 213' ' ' ILE . 8.6 t -171.22 -26.25 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.143 0.977 . . . . 75.43 110.093 178.152 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 215' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 71.24 170.21 0.32 Allowed 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 125.275 1.43 . . . . 73.31 112.121 -176.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 66.24 28.53 9.97 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.054 1.342 . . . . 61.42 112.157 -177.327 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -82.79 73.93 9.79 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 107.989 -1.115 . . . . 75.4 107.989 168.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 22.1 tp -127.24 30.17 5.45 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 108.253 -1.017 . . . . 71.43 108.253 -178.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 56.95 -153.38 0.37 Allowed 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 114.027 -1.442 . . . . 71.24 111.479 -174.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . 73.68 10.47 4.79 Favored 'General case' 0 C--N 1.36 1.043 0 C-N-CA 124.165 0.986 . . . . 61.1 112.25 174.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 221' ' ' ARG . . . . . 0.541 ' HG2' HD13 ' B' ' 68' ' ' ILE . 0.0 OUTLIER -105.59 -71.36 0.75 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.48 0.712 . . . . 73.55 111.328 -177.415 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -141.54 27.2 1.89 Allowed 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.874 0.87 . . . . 42.52 110.883 -170.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -98.0 -52.3 3.75 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 125.617 1.567 . . . . 61.02 109.465 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 224' ' ' VAL . . . . . 0.702 HG11 ' HA ' ' B' ' 77' ' ' ASP . 14.5 p -85.96 -31.79 6.68 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 CA-C-N 114.611 -1.177 . . . . 74.2 110.21 175.37 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 3.8 m -83.8 -43.18 15.68 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.707 0.803 . . . . 54.34 110.602 -172.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 7.4 mp -118.33 166.37 12.72 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.816 0.846 . . . . 74.43 109.69 176.025 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . -177.24 -44.7 0.06 OUTLIER Glycine 0 C--N 1.342 0.9 0 N-CA-C 110.729 -0.949 . . . . 51.31 110.729 178.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . -94.05 -126.6 4.54 Favored Glycine 0 C--N 1.346 1.116 0 CA-C-N 114.863 -0.669 . . . . 72.41 112.052 172.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . 72.6 20.37 79.52 Favored Glycine 0 C--N 1.345 1.07 0 N-CA-C 111.732 -0.547 . . . . 70.24 111.732 -171.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -80.68 136.22 36.15 Favored 'General case' 0 C--N 1.351 0.656 0 C-N-CA 124.385 1.074 . . . . 70.23 110.101 -174.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 231' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -75.45 120.36 20.78 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.259 1.024 . . . . 73.24 109.709 -175.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 3.1 t -170.47 100.1 0.26 Allowed 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 124.166 0.986 . . . . 74.24 110.297 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 233' ' ' PHE . . . . . 0.404 ' H ' ' HA ' ' B' ' 56' ' ' ARG . 19.4 t80 -163.27 73.75 0.33 Allowed 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.865 0.866 . . . . 70.41 109.921 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 234' ' ' ALA . . . . . 0.474 ' H ' ' HA ' ' B' ' 363' ' ' GLU . . . -161.82 134.55 6.0 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 116.513 -0.312 . . . . 72.31 111.091 175.761 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.38 94.72 5.84 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 106.589 -1.634 . . . . 54.41 106.589 171.264 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 236' ' ' THR . . . . . 0.594 ' H ' HD21 ' B' ' 247' ' ' LEU . 33.4 m 76.86 -30.52 0.18 Allowed 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 125.06 1.344 . . . . 73.34 111.961 178.556 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . 72.19 -72.53 0.11 Allowed 'General case' 0 C--N 1.361 1.085 0 C-N-CA 126.305 1.842 . . . . 71.12 112.066 170.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 238' ' ' THR . . . . . 0.455 ' HB ' ' HA ' ' C' ' 219' ' ' VAL . 6.3 m -140.83 -8.46 1.06 Allowed 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 123.357 0.663 . . . . 71.31 110.826 -175.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 239' ' ' ALA . . . . . 0.511 ' HB2' ' HA ' ' C' ' 221' ' ' VAL . . . -77.14 172.95 12.42 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.867 1.062 . . . . 74.42 113.867 -167.125 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 240' ' ' GLY . . . . . 0.439 ' H ' HD22 ' C' ' 235' ' ' LEU . . . -113.05 -101.3 2.5 Favored Glycine 0 C--N 1.339 0.723 0 CA-C-N 114.015 -1.448 . . . . 71.23 109.634 177.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -157.51 162.16 38.84 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.588 0.709 . . . . 71.21 111.562 -175.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 242' ' ' TRP . . . . . 0.592 ' HH2' HG21 ' C' ' 199' ' ' VAL . 5.4 m95 -107.04 -47.36 3.71 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 114.106 -1.406 . . . . 70.32 107.478 172.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 177.69 -35.78 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 111.532 -2.576 . . . . 74.22 105.504 -166.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -156.5 -176.0 28.1 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 113.487 -1.688 . . . . 63.11 109.459 166.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -170.16 153.59 4.63 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.661 0.784 . . . . 75.34 110.303 175.199 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 246' ' ' THR . . . . . 0.538 HG22 ' HD3' ' C' ' 225' ' ' PRO . 11.2 t -167.31 174.43 8.08 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.426 0.691 . . . . 71.02 109.898 168.329 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 247' ' ' LEU . . . . . 0.647 HD13 ' HB3' ' B' ' 363' ' ' GLU . 2.2 pp -159.87 160.17 33.33 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 124.472 1.109 . . . . 72.51 108.868 178.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 248' ' ' ARG . . . . . 0.405 ' HD3' ' O ' ' B' ' 249' ' ' GLU . 0.0 OUTLIER -157.63 174.88 14.68 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.353 0.596 . . . . 75.15 111.221 -179.594 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 249' ' ' GLU . . . . . 0.693 ' HG2' ' HA3' ' B' ' 362' ' ' GLY . 2.5 tm-20 -86.9 163.11 17.34 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 114.751 -1.113 . . . . 71.33 109.943 -171.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 250' ' ' GLN . . . . . 0.466 ' HA ' ' HB3' ' A' ' 274' ' ' GLU . 26.5 mp0 -76.91 11.26 1.82 Allowed 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 124.494 1.118 . . . . 65.4 112.641 -176.298 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 251' ' ' ALA . . . . . . . . . . . . . . . 61.33 28.02 17.58 Favored 'General case' 0 C--N 1.361 1.072 0 C-N-CA 124.953 1.301 . . . . 61.03 110.688 -171.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 69.41 -87.17 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.681 1.992 . . . . 72.3 112.474 173.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . 57.69 -84.91 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 124.096 0.958 . . . . 51.41 111.072 -170.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 12.0 ttp180 174.76 -60.28 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.998 1.719 . . . . 72.51 106.652 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . 177.69 -170.86 43.39 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-N 114.371 -1.286 . . . . 54.22 110.934 -178.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 256' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -94.78 39.55 1.1 Allowed 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 117.492 0.646 . . . . 52.52 110.757 -175.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 69.22 -152.08 0.14 Allowed 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.306 1.043 . . . . 74.31 110.828 -177.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 258' ' ' LEU . . . . . 0.528 HD23 ' HA ' ' B' ' 266' ' ' ASN . 41.9 tp -49.83 134.13 21.17 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.263 1.025 . . . . 75.13 112.684 -178.602 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 2.4 p -124.8 85.83 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 N-CA-C 107.902 -1.147 . . . . 63.02 107.902 172.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 260' ' ' SER . . . . . 0.591 ' HB3' ' HB2' ' B' ' 265' ' ' LEU . 44.6 t -87.8 93.6 9.5 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.192 -0.913 . . . . 73.11 109.971 178.575 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 22.4 t70 65.74 -79.41 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.985 1.314 . . . . 52.21 112.392 174.101 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 262' ' ' ALA . . . . . . . . . . . . . . . -76.79 -76.13 0.18 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.909 0.884 . . . . 43.43 111.341 -176.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -165.82 130.82 2.38 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 123.526 0.73 . . . . 70.44 109.408 -177.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 264' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' B' ' 258' ' ' LEU . 88.0 p 52.33 -93.71 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 125.504 1.522 . . . . 51.14 112.81 -178.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 265' ' ' LEU . . . . . 0.591 ' HB2' ' HB3' ' B' ' 260' ' ' SER . 84.3 mt 52.81 43.6 31.29 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.665 1.186 . . . . 64.12 111.623 -173.31 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 266' ' ' ASN . . . . . 0.528 ' HA ' HD23 ' B' ' 258' ' ' LEU . 13.5 m120 -65.35 150.45 48.26 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 115.243 -0.89 . . . . 71.52 110.535 178.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 33.0 t -72.82 86.56 1.26 Allowed 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 123.107 0.563 . . . . 73.13 110.699 -175.315 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 60.2 t 64.36 -79.84 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 C-N-CA 125.904 1.682 . . . . 74.44 110.211 -175.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 269' ' ' THR . . . . . . . . . . . . . 40.8 p -91.42 -54.87 3.73 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.238 -1.023 . . . . 74.31 108.238 169.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 270' ' ' GLU . . . . . 0.561 ' HB2' HD22 ' B' ' 277' ' ' LEU . 9.0 tp10 -178.02 -35.08 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.325 1.45 . . . . 72.41 109.277 178.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 271' ' ' ALA . . . . . . . . . . . . . . . 79.56 -51.37 0.4 Allowed 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 126.066 1.747 . . . . 75.3 110.248 -169.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 272' ' ' ASN . . . . . 0.447 ' HB2' ' HG3' ' B' ' 270' ' ' GLU . 3.6 m-20 -62.07 144.26 55.49 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 109.415 -0.587 . . . . 54.14 109.415 169.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 65.36 27.26 11.96 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.075 0.95 . . . . 61.32 110.734 -172.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 60.96 -91.37 0.03 OUTLIER 'General case' 0 C--N 1.355 0.827 0 C-N-CA 125.83 1.652 . . . . 71.44 111.735 179.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 275' ' ' LYS . . . . . 0.448 ' HB2' ' HD3' ' B' ' 276' ' ' PRO . 7.8 mtpm? -128.88 -57.87 0.03 OUTLIER Pre-proline 0 CA--C 1.557 1.25 0 CA-C-O 118.243 -0.884 . . . . 71.33 112.013 -169.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 276' ' ' PRO . . . . . 0.448 ' HD3' ' HB2' ' B' ' 275' ' ' LYS . 91.1 Cg_endo -78.73 81.5 2.76 Favored 'Trans proline' 0 C--N 1.395 2.991 0 C-N-CA 121.488 1.459 . . . . 62.35 112.898 -172.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 277' ' ' LEU . . . . . 0.561 HD22 ' HB2' ' B' ' 270' ' ' GLU . 47.2 tp -74.95 94.08 2.78 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.439 -0.8 . . . . 63.32 109.082 175.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 1.6 tm? 77.23 -57.68 0.51 Allowed 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 125.667 1.587 . . . . 62.0 110.845 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . -158.71 -164.06 13.79 Favored Glycine 0 C--N 1.344 1.022 0 O-C-N 122.396 -0.19 . . . . 75.43 112.892 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 280' ' ' LEU . . . . . 0.553 HD11 ' HB2' ' B' ' 456' ' ' ASP . 3.0 tm? -98.17 148.08 23.94 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.286 1.035 . . . . 53.23 109.522 -176.583 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -150.66 -52.72 0.14 Allowed 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 108.645 -0.872 . . . . 75.31 108.645 171.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 282' ' ' ALA . . . . . 0.569 ' HB1' HD21 ' B' ' 454' ' ' LEU . . . -155.22 30.03 0.4 Allowed 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 115.18 -0.918 . . . . 65.41 110.02 -176.619 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -99.36 -18.6 17.44 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.703 0.801 . . . . 72.33 111.49 -172.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 284' ' ' GLY . . . . . 0.532 ' HA3' ' HA ' ' B' ' 456' ' ' ASP . . . -65.83 -48.77 63.68 Favored Glycine 0 CA--C 1.534 1.228 0 CA-C-O 119.707 -0.496 . . . . 61.45 114.077 -176.615 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 60.25 61.41 1.81 Allowed 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 122.002 0.906 . . . . 72.41 111.74 173.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 286' ' ' MET . . . . . . . . . . . . . 44.5 mtt -152.57 173.55 4.44 Favored Pre-proline 0 N--CA 1.489 1.487 0 C-N-CA 124.396 1.078 . . . . 64.1 109.43 -177.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 287' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -45.1 115.18 0.82 Allowed 'Trans proline' 0 C--N 1.388 2.65 0 C-N-CA 122.858 2.372 . . . . 73.33 112.045 166.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 288' ' ' VAL . . . . . 0.423 HG13 ' HB ' ' B' ' 455' ' ' THR . 43.0 t -63.28 86.24 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.17 0 C-N-CA 124.432 1.093 . . . . 74.32 113.315 -160.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 289' ' ' ARG . . . . . 0.45 ' H ' ' HA ' ' B' ' 457' ' ' GLN . 19.9 ptt180 36.56 -154.43 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 127.979 2.511 . . . . 72.14 116.481 163.492 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 290' ' ' TRP . . . . . 0.454 ' HA ' ' HG ' ' B' ' 460' ' ' LEU . 6.0 m0 66.06 22.85 11.13 Favored 'General case' 0 C--N 1.363 1.179 0 C-N-CA 124.684 1.194 . . . . 75.34 111.332 176.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 291' ' ' LEU . . . . . . . . . . . . . 2.3 pp -146.09 -16.67 0.45 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.392 1.077 . . . . 64.34 110.598 176.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . -79.2 155.53 40.36 Favored Glycine 0 C--N 1.355 1.599 0 CA-C-O 119.448 -0.64 . . . . 62.12 113.284 -174.042 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -82.7 174.18 9.82 Favored 'Trans proline' 0 C--N 1.373 1.837 0 C-N-CA 123.32 2.68 . . . . 51.12 112.796 -177.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -78.4 -15.46 58.65 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.924 -0.58 . . . . 41.23 111.822 -179.115 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . 53.64 41.51 32.06 Favored 'General case' 0 C--N 1.36 1.053 0 C-N-CA 124.387 1.075 . . . . 34.32 111.416 172.443 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 31.4 p -79.64 72.41 6.32 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 114.936 -1.029 . . . . 65.42 110.837 -175.405 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -101.0 6.84 43.66 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.154 -0.93 . . . . 64.12 110.625 178.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 69.79 -60.86 0.46 Allowed 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 126.423 1.889 . . . . 71.5 111.852 -176.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . 84.47 -158.5 34.12 Favored Glycine 0 C--N 1.347 1.167 0 N-CA-C 110.865 -0.894 . . . . 63.41 110.865 -177.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -87.31 -33.39 19.23 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.913 -0.773 . . . . 72.23 108.913 172.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 301' ' ' ILE . . . . . . . . . . . . . 76.1 mt 66.19 -64.88 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.059 0 C-N-CA 125.989 1.716 . . . . 72.24 109.271 -165.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 37.3 t70 66.2 76.85 0.3 Allowed 'General case' 0 C--N 1.352 0.702 0 C-N-CA 124.327 1.051 . . . . 63.41 110.39 168.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 303' ' ' LYS . . . . . 0.652 ' HB3' ' HA ' ' B' ' 306' ' ' VAL . 0.1 OUTLIER 57.48 95.73 0.05 OUTLIER Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 125.543 1.537 . . . . 74.11 110.641 -175.698 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 304' ' ' PRO . . . . . 0.479 ' HA ' ' CE2' ' B' ' 93' ' ' PHE . 41.4 Cg_exo -55.65 94.52 0.05 OUTLIER 'Trans proline' 0 C--N 1.383 2.391 0 C-N-CA 123.428 2.752 . . . . 75.12 113.076 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . 59.15 25.91 14.53 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 124.304 1.042 . . . . 42.33 111.21 -174.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 306' ' ' VAL . . . . . 0.652 ' HA ' ' HB3' ' B' ' 303' ' ' LYS . 40.2 t 65.17 -68.37 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.135 0 C-N-CA 126.443 1.897 . . . . 72.33 111.179 -171.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 85.6 m 69.36 -70.54 0.14 Allowed 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 125.428 1.491 . . . . 74.23 111.585 178.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 308' ' ' CYS . . . . . . . . . . . . . 52.3 t -65.68 94.64 0.21 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.51 0.724 . . . . 74.22 110.273 177.333 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 17.2 p -126.44 137.67 30.82 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 124.3 1.04 . . . . 72.2 109.746 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -78.41 -144.66 0.03 OUTLIER 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.66 2.24 . . . . 63.14 110.106 169.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 311' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -111.58 86.58 7.06 Favored Pre-proline 0 N--CA 1.478 0.953 0 N-CA-C 108.534 -0.913 . . . . 73.13 108.534 169.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 312' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -94.68 19.56 0.68 Allowed 'Trans proline' 0 C--N 1.377 2.043 0 C-N-CA 122.868 2.379 . . . . 70.14 113.408 -176.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 313' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -54.01 -67.44 0.26 Allowed 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.95 0.9 . . . . 75.13 111.11 -177.252 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 314' ' ' ARG . . . . . . . . . . . . . 46.9 mtp180 63.21 -84.81 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.86 1.264 . . . . 72.01 110.385 -176.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 315' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -97.46 -28.81 13.82 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.702 0.801 . . . . 72.12 109.894 175.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 316' ' ' ASP . . . . . . . . . . . . . 26.6 t70 68.35 -77.58 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.215 1.806 . . . . 74.4 110.604 -174.214 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 70.4 m -145.19 -58.89 0.34 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.183 0.593 . . . . 75.41 110.506 -174.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 318' ' ' VAL . . . . . 0.584 HG11 HD22 ' B' ' 356' ' ' ASN . 30.8 m -85.71 142.09 36.71 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 123.189 0.596 . . . . 73.13 110.418 -177.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 319' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -49.84 -48.1 20.7 Favored 'Trans proline' 0 C--N 1.384 2.423 0 C-N-CA 123.541 2.827 . . . . 65.1 114.572 -176.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 320' ' ' THR . . . . . 0.545 HG23 ' HA ' ' B' ' 357' ' ' PRO . 28.6 m 59.51 81.78 0.16 Allowed 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.81 0.844 . . . . 53.31 111.131 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 321' ' ' LEU . . . . . 0.486 ' HB3' ' HA ' ' B' ' 354' ' ' ALA . 58.8 tp -83.72 -43.59 15.34 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.45 -0.796 . . . . 65.14 110.255 -179.017 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 322' ' ' ALA . . . . . . . . . . . . . . . -159.76 -162.92 1.07 Allowed 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 116.129 -0.487 . . . . 64.54 111.7 -170.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 323' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -134.47 170.89 15.08 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 124.779 1.232 . . . . 74.02 107.867 169.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 324' ' ' MET . . . . . . . . . . . . . 43.8 mtm 78.05 113.82 0.07 Allowed 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 125.687 1.595 . . . . 71.32 109.451 -174.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 325' ' ' THR . . . . . . . . . . . . . 69.4 p 50.93 60.13 4.1 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 125.245 1.418 . . . . 72.33 109.9 -170.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 326' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -135.12 -3.29 2.48 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 112.841 -1.981 . . . . 72.01 111.899 -158.12 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 33.1 mtmm -110.38 -2.99 16.37 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.757 0.823 . . . . 54.34 111.021 -178.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 328' ' ' ALA . . . . . . . . . . . . . . . 72.17 159.4 0.21 Allowed 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 125.69 1.596 . . . . 72.03 112.727 -175.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 329' ' ' ILE . . . . . . . . . . . . . 19.7 pt 47.63 30.3 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 C-N-CA 126.5 1.92 . . . . 73.5 114.788 178.163 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 330' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -83.58 56.14 3.49 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 123.683 0.793 . . . . 63.42 111.107 179.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 331' ' ' LEU . . . . . . . . . . . . . 2.4 tt -176.31 135.78 0.26 Allowed 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 105.777 -1.934 . . . . 63.34 105.777 -178.208 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 2.7 pp -66.72 145.35 55.64 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 118.555 0.616 . . . . 74.41 111.086 178.234 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 333' ' ' SER . . . . . . . . . . . . . 16.2 t -103.02 66.66 0.92 Allowed 'General case' 0 C--O 1.242 0.709 0 C-N-CA 123.498 0.719 . . . . 65.04 109.56 -176.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 334' ' ' LYS . . . . . 0.494 ' HE2' ' HB3' ' B' ' 337' ' ' LYS . 19.1 tptm 70.15 -71.49 0.13 Allowed 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 125.397 1.479 . . . . 63.11 110.185 -178.384 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 335' ' ' ASN . . . . . 0.659 ' HB3' ' HB2' ' B' ' 173' ' ' LEU . 20.7 m120 58.95 -86.23 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 125.89 1.676 . . . . 73.25 113.269 172.121 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -83.51 -9.96 58.63 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 123.188 0.595 . . . . 61.02 112.127 -175.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 337' ' ' LYS . . . . . 0.494 ' HB3' ' HE2' ' B' ' 334' ' ' LYS . 45.1 mmtm -95.5 18.52 12.55 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.255 0.622 . . . . 62.43 110.385 169.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 338' ' ' GLY . . . . . . . . . . . . . . . -165.37 -157.28 9.73 Favored Glycine 0 C--N 1.344 1.02 0 N-CA-C 111.561 -0.615 . . . . 72.34 111.561 178.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 339' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -108.49 -5.0 16.78 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.699 0.8 . . . . 74.33 110.691 178.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 340' ' ' PHE . . . . . . . . . . . . . 46.3 t80 55.87 62.36 2.43 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 124.966 1.307 . . . . 75.24 110.149 -174.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 341' ' ' LEU . . . . . . . . . . . . . 6.6 tt -72.38 -49.08 36.6 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 114.286 -1.325 . . . . 75.34 109.623 -175.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 342' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -92.9 95.75 9.69 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.871 -0.604 . . . . 64.25 111.002 -176.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 343' ' ' VAL . . . . . . . . . . . . . 42.1 t -76.35 -32.43 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.923 0.889 . . . . 64.24 109.535 175.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -61.27 -34.82 75.81 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.488 0.715 . . . . 73.03 111.075 175.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 345' ' ' GLY . . . . . . . . . . . . . . . -101.37 43.2 1.76 Allowed Glycine 0 C--N 1.349 1.279 0 CA-C-N 115.909 -0.587 . . . . 62.31 111.731 177.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 346' ' ' ALA . . . . . . . . . . . . . . . -78.78 85.07 4.81 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.107 0.563 . . . . 72.22 109.699 176.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 21.2 t 65.7 -162.04 0.26 Allowed 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 124.781 1.232 . . . . 72.21 111.084 177.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 42.9 mm -81.27 79.12 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 C-N-CA 123.633 0.773 . . . . 73.42 110.187 -178.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 349' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -88.55 141.11 28.79 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.07 -0.968 . . . . 71.13 109.679 175.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 350' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? 74.84 -42.86 0.5 Allowed 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 125.586 1.554 . . . . 74.52 113.168 175.308 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -59.82 -77.35 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.469 0.708 . . . . 71.32 110.187 177.309 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 30.2 t70 58.33 -179.26 0.07 Allowed 'General case' 0 CA--C 1.567 1.609 0 C-N-CA 124.156 0.982 . . . . 74.35 111.924 178.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 353' ' ' HIS . . . . . . . . . . . . . 49.0 m80 -108.73 -28.61 9.13 Favored 'General case' 0 N--CA 1.479 1.018 0 O-C-N 121.148 -0.97 . . . . 74.33 112.11 178.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 354' ' ' ALA . . . . . 0.486 ' HA ' ' HB3' ' B' ' 321' ' ' LEU . . . -111.95 -21.89 11.34 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 112.883 0.697 . . . . 70.11 112.883 -175.736 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 355' ' ' ALA . . . . . . . . . . . . . . . 62.56 52.86 2.78 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.242 1.017 . . . . 75.44 109.966 -171.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 356' ' ' ASN . . . . . 0.584 HD22 HG11 ' B' ' 318' ' ' VAL . 33.0 t30 71.07 126.93 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.631 0 C-N-CA 125.114 1.366 . . . . 74.32 111.358 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 357' ' ' PRO . . . . . 0.545 ' HA ' HG23 ' B' ' 320' ' ' THR . 45.0 Cg_endo -79.61 51.99 4.11 Favored 'Trans proline' 0 C--N 1.381 2.242 0 C-N-CA 123.369 2.713 . . . . 55.22 112.664 178.048 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 358' ' ' CYS . . . . . . . . . . . . . 90.3 m 65.08 -73.05 0.06 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 125.165 1.386 . . . . 73.32 111.687 -171.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 359' ' ' GLY . . . . . . . . . . . . . . . 86.56 -12.23 61.71 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 123.168 0.413 . . . . 62.01 112.168 -172.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 360' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -88.39 45.79 1.32 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.393 1.477 . . . . 53.34 111.764 -170.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 361' ' ' ILE . . . . . . . . . . . . . 19.3 mm -85.4 -29.38 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 108.523 -0.918 . . . . 61.31 108.523 174.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 362' ' ' GLY . . . . . 0.693 ' HA3' ' HG2' ' B' ' 249' ' ' GLU . . . 72.25 58.37 5.14 Favored Glycine 0 C--N 1.344 0.979 0 CA-C-N 115.151 -0.931 . . . . 72.35 112.82 176.459 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 363' ' ' GLU . . . . . 0.647 ' HB3' HD13 ' B' ' 247' ' ' LEU . 6.9 mm-40 66.81 -80.92 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.05 1.34 . . . . 73.13 110.615 178.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 364' ' ' THR . . . . . 0.424 ' H ' ' H ' ' B' ' 365' ' ' VAL . 58.0 m -155.33 -23.98 0.11 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.218 1.407 . . . . 74.04 109.287 -177.013 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 365' ' ' VAL . . . . . 0.563 HG22 ' HG3' ' B' ' 249' ' ' GLU . 7.2 t 66.62 168.38 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.568 1.661 0 C-N-CA 124.922 1.289 . . . . 74.01 109.523 -172.573 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 29.5 t70 75.47 -7.77 1.72 Allowed 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 114.045 1.128 . . . . 50.12 114.045 161.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 367' ' ' LEU . . . . . . . . . . . . . 96.5 mt -90.51 -1.87 57.9 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 113.305 0.854 . . . . 75.05 113.305 -174.322 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 368' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -75.38 -159.27 0.1 Allowed 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 122.784 0.434 . . . . 71.23 110.55 174.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 369' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 54.12 52.26 13.05 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.783 0.833 . . . . 70.1 109.403 -167.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 370' ' ' ALA . . . . . . . . . . . . . . . -63.19 -177.01 0.16 Allowed 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 114.407 -1.27 . . . . 74.25 112.65 -176.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 371' ' ' VAL . . . . . . . . . . . . . 8.1 t -69.41 1.09 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.573 1.848 0 C-N-CA 123.176 0.591 . . . . 74.11 110.997 178.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 372' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 83.62 -18.48 0.43 Allowed 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 126.444 1.898 . . . . 63.2 111.966 169.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 373' ' ' ARG . . . . . . . . . . . . . 13.2 tpt180 74.77 -53.61 0.67 Allowed 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 125.811 1.644 . . . . 72.05 110.456 -175.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -67.98 -21.47 65.06 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.129 0.972 . . . . 71.45 112.61 178.09 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 375' ' ' LEU . . . . . . . . . . . . . 91.4 mt 69.89 -70.36 0.15 Allowed 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 125.423 1.489 . . . . 62.01 110.471 -175.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -119.45 -179.59 3.91 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.399 1.08 . . . . 73.13 108.937 174.219 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 377' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -118.87 67.44 0.78 Allowed 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.666 -0.864 . . . . 73.31 108.666 175.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 378' ' ' ALA . . . . . . . . . . . . . . . -79.29 -3.45 46.09 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 115.481 -0.781 . . . . 61.1 111.96 -178.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.21 74.13 0.43 Allowed 'General case' 0 C--N 1.357 0.894 0 C-N-CA 125.09 1.356 . . . . 72.01 109.931 -174.339 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 380' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -84.29 -9.82 58.16 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 114.693 -1.14 . . . . 53.14 110.253 179.183 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 381' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -85.21 179.82 7.15 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.493 1.517 . . . . 74.34 111.251 178.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 382' ' ' GLY . . . . . 0.438 ' HA2' ' HA ' ' B' ' 106' ' ' TYR . . . -175.78 -96.99 0.1 Allowed Glycine 0 C--N 1.346 1.089 0 CA-C-N 115.62 -0.718 . . . . 73.1 111.378 179.199 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 383' ' ' ASN . . . . . . . . . . . . . 58.6 t-20 -163.24 138.81 6.71 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 107.647 -1.242 . . . . 73.1 107.647 178.026 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 384' ' ' THR . . . . . . . . . . . . . 41.6 p -99.29 76.44 2.06 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.115 0.566 . . . . 63.41 109.945 -177.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 5.8 mp -67.63 87.22 0.21 Allowed 'General case' 0 C--N 1.358 0.966 0 N-CA-C 108.356 -0.979 . . . . 75.12 108.356 174.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 386' ' ' VAL . . . . . . . . . . . . . 58.4 t 76.75 -54.94 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 126.574 1.949 . . . . 62.42 110.305 -175.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 387' ' ' ILE . . . . . 0.464 HG21 ' HB2' ' B' ' 395' ' ' ALA . 5.0 tp -149.75 -62.86 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.169 0 C-N-CA 123.558 0.743 . . . . 74.12 110.407 179.032 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 388' ' ' VAL . . . . . 0.444 ' H ' HG23 ' B' ' 387' ' ' ILE . 91.0 t 61.39 123.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 125.62 1.568 . . . . 54.33 112.13 -174.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 389' ' ' THR . . . . . . . . . . . . . 42.8 m -150.09 112.52 4.7 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.968 0.907 . . . . 71.25 108.662 176.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . 68.9 112.28 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.08 1.352 . . . . 70.34 112.194 177.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 391' ' ' ASP . . . . . . . . . . . . . 18.2 t70 67.15 -92.1 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.373 1.069 . . . . 64.12 110.632 176.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 392' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -144.94 1.89 1.01 Allowed 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 124.554 1.142 . . . . 72.42 109.746 178.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -64.83 122.92 18.07 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 123.94 0.896 . . . . 61.53 110.311 -174.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -67.05 88.89 0.16 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.478 0.711 . . . . 73.31 109.386 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 395' ' ' ALA . . . . . 0.464 ' HB2' HG21 ' B' ' 387' ' ' ILE . . . 64.72 5.67 2.89 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 125.122 1.369 . . . . 71.44 113.09 -176.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 37.6 m 54.6 87.66 0.04 OUTLIER 'General case' 0 C--N 1.361 1.095 0 C-N-CA 124.436 1.094 . . . . 75.55 110.995 -172.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 397' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -90.12 24.09 2.61 Favored 'General case' 0 CA--C 1.569 1.686 0 C-N-CA 123.932 0.893 . . . . 71.41 111.041 -170.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . 0.26 12.0 tt 46.88 107.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 C-N-CA 126.565 1.946 . . . . 75.44 113.675 -173.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 399' ' ' VAL . . . . . . . . . . . . . 55.9 t 64.75 -97.72 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 C-N-CA 125.244 1.418 . . . . 73.32 110.697 -178.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 400' ' ' ALA . . . . . . . . . . . . . . . -174.55 63.91 0.26 Allowed Pre-proline 0 CA--C 1.561 1.381 0 C-N-CA 123.003 0.521 . . . . 51.41 111.524 -174.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 401' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -89.66 111.1 0.48 Allowed 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 122.822 2.348 . . . . 71.04 112.822 -178.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 17.8 t70 66.93 11.6 8.44 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 125.613 1.565 . . . . 74.34 112.172 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 403' ' ' THR . . . . . . . . . . . . . 81.0 p -82.21 9.74 8.17 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.391 0.676 . . . . 51.3 110.967 176.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 404' ' ' LYS . . . . . . . . . . . . . 53.4 mmtt 64.16 -93.38 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.285 1.834 . . . . 70.03 109.652 178.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 405' ' ' ALA . . . . . 0.458 ' HB3' ' HD3' ' B' ' 406' ' ' PRO . . . 175.19 -59.81 0.0 OUTLIER Pre-proline 0 CA--C 1.557 1.238 0 C-N-CA 125.376 1.471 . . . . 71.24 109.739 175.353 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 406' ' ' PRO . . . . . 0.458 ' HD3' ' HB3' ' B' ' 405' ' ' ALA . 71.4 Cg_endo -77.0 97.01 1.12 Allowed 'Trans proline' 0 C--N 1.396 3.042 0 C-N-CA 121.874 1.716 . . . . 44.44 112.7 -176.11 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . 63.53 33.79 88.19 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 115.014 -0.994 . . . . 55.33 114.495 170.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 408' ' ' LEU . . . . . . . . . . . . . 73.1 mt 61.19 -79.26 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 125.117 1.367 . . . . 72.03 110.983 -176.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 24.6 m 66.56 -63.69 0.25 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.989 1.716 . . . . 73.52 112.559 175.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 410' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 83.27 -25.1 0.15 Allowed 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 126.398 1.879 . . . . 51.32 113.047 172.367 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . 74.68 -56.62 0.63 Allowed 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 125.877 1.671 . . . . 63.14 112.719 177.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -59.56 172.34 0.7 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 125.191 1.396 . . . . 60.41 112.612 -176.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -68.02 82.14 0.22 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.208 1.003 . . . . 71.14 110.458 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 414' ' ' THR . . . . . . . . . . . . . 6.5 t -170.43 -51.01 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.722 1.209 . . . . 73.24 108.635 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 415' ' ' LYS . . . . . 0.611 ' HD3' ' SD ' ' B' ' 420' ' ' MET . 3.8 mptp? 65.83 -65.55 0.18 Allowed 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 125.502 1.521 . . . . 73.42 111.032 -177.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 37.6 t70 80.06 -56.52 0.36 Allowed 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 125.867 1.667 . . . . 75.33 112.702 166.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 417' ' ' GLY . . . . . . . . . . . . . . . -71.72 72.04 0.86 Allowed Glycine 0 C--N 1.347 1.17 0 N-CA-C 111.487 -0.645 . . . . 43.15 111.487 174.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 418' ' ' ALA . . . . . . . . . . . . . . . 65.69 -166.27 0.22 Allowed 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 125.244 1.418 . . . . 70.25 111.583 -172.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 419' ' ' VAL . . . . . . . . . . . . . 76.6 t 70.02 -80.93 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 125.637 1.575 . . . . 62.03 109.597 -175.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 420' ' ' MET . . . . . 0.611 ' SD ' ' HD3' ' B' ' 415' ' ' LYS . 87.1 mtp -97.82 176.43 5.8 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.404 0.681 . . . . 73.12 109.945 175.773 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 421' ' ' VAL . . . . . . . . . . . . . 60.9 t 74.41 -62.31 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 C-N-CA 125.465 1.506 . . . . 72.42 110.615 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 422' ' ' MET . . . . . . . . . . . . . 91.8 mmm -66.0 -39.33 90.2 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.831 0.852 . . . . 74.1 111.425 172.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 423' ' ' SER . . . . . . . . . . . . . 68.5 m -151.79 -155.13 0.59 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.859 1.263 . . . . 62.22 108.176 -178.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 424' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -157.3 -38.9 0.07 Allowed 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 107.884 -1.154 . . . . 72.42 107.884 162.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . -121.19 -164.03 12.2 Favored Glycine 0 C--N 1.346 1.136 0 N-CA-C 110.664 -0.974 . . . . 75.12 110.664 166.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 426' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -65.29 -44.07 89.13 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.45 0.643 . . . . 75.43 109.411 175.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 427' ' ' SER . . . . . 0.707 ' HB3' ' HB2' ' B' ' 430' ' ' ASP . 36.1 t -156.74 176.46 12.71 Favored 'General case' 0 C--O 1.245 0.834 0 N-CA-C 107.896 -1.15 . . . . 75.14 107.896 170.626 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 428' ' ' GLU . . . . . 0.646 ' HB2' ' HB2' ' A' ' 220' ' ' GLU . 0.4 OUTLIER -71.83 -76.4 0.11 Allowed 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 108.51 -0.922 . . . . 73.23 108.51 179.435 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 429' ' ' GLU . . . . . 0.501 ' HA ' ' HA ' ' B' ' 433' ' ' GLU . 0.0 OUTLIER -85.74 49.88 1.86 Allowed 'General case' 0 N--CA 1.481 1.078 0 CA-C-O 121.897 0.856 . . . . 63.42 109.857 -179.24 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 430' ' ' ASP . . . . . 0.707 ' HB2' ' HB3' ' B' ' 427' ' ' SER . 32.6 t70 -84.6 78.73 9.79 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 125.21 1.404 . . . . 55.41 108.429 178.441 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 19.9 t 78.37 -51.14 0.48 Allowed 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 126.431 1.892 . . . . 73.31 113.373 174.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 432' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -110.54 -2.23 16.56 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 118.837 0.744 . . . . 71.1 112.825 -174.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 433' ' ' GLU . . . . . 0.501 ' HA ' ' HA ' ' B' ' 429' ' ' GLU . 2.1 mp0 58.4 95.06 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 124.05 0.94 . . . . 73.43 109.917 -170.258 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 434' ' ' HIS . . . . . 0.454 ' NE2' ' HB3' ' B' ' 430' ' ' ASP . 22.1 m-70 -65.99 -39.96 90.77 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.952 0.901 . . . . 65.13 112.056 -168.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 435' ' ' THR . . . . . . . . . . . . . 96.7 m -144.65 -69.65 0.3 Allowed 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 111.992 0.367 . . . . 73.42 111.992 177.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . -55.82 -49.05 68.28 Favored Glycine 0 C--N 1.351 1.373 0 O-C-N 123.761 0.663 . . . . 43.54 114.398 -166.209 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 15.8 m 73.2 -55.64 0.67 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.988 1.715 . . . . 54.14 112.589 176.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 438' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.84 -104.89 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 124.576 1.15 . . . . 71.55 109.545 176.13 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 439' ' ' LEU . . . . . 0.542 HD12 ' HG3' ' B' ' 428' ' ' GLU . 65.7 mt 54.42 16.17 1.2 Allowed 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 125.168 1.387 . . . . 74.24 113.878 176.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 440' ' ' ARG . . . . . . . . . . . . . 76.2 mtp180 -92.75 112.5 24.48 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 108.618 -0.882 . . . . 70.1 108.618 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 441' ' ' ILE . . . . . 0.504 HG12 HD13 ' A' ' 235' ' ' LEU . 53.9 mt -76.24 101.79 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 CA-C-O 120.84 0.352 . . . . 74.15 110.456 -178.294 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 442' ' ' ALA . . . . . . . . . . . . . . . -87.88 84.32 7.02 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 108.743 -0.836 . . . . 71.41 108.743 172.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . -131.07 -54.37 1.04 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.747 0.819 . . . . 74.21 109.822 -175.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 444' ' ' TYR . . . . . 0.616 ' HB2' ' HB2' ' A' ' 224' ' ' PRO . 6.4 m-85 -106.6 28.16 8.13 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.913 0.885 . . . . 65.34 109.619 177.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . 100.87 -167.3 19.63 Favored Glycine 0 C--N 1.344 0.98 0 CA-C-N 115.539 -0.755 . . . . 74.34 111.629 -175.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 446' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -79.43 164.65 23.76 Favored 'Trans proline' 0 C--N 1.368 1.579 0 C-N-CA 122.617 2.212 . . . . 63.02 112.45 177.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 447' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -83.22 0.32 45.98 Favored 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 123.587 0.755 . . . . 60.0 110.164 176.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . -63.86 91.47 0.06 Allowed 'General case' 0 C--N 1.359 1.003 0 C-N-CA 124.391 1.076 . . . . 74.31 110.37 174.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 449' ' ' ALA . . . . . . . . . . . . . . . -82.49 -5.08 58.49 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.743 0.817 . . . . 61.52 111.7 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 450' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 67.11 94.24 0.07 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.42 1.488 . . . . 61.12 110.479 177.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 451' ' ' VAL . . . . . 0.742 HG13 ' H ' ' B' ' 464' ' ' MET . 84.2 t -73.15 -45.63 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.684 0.794 . . . . 63.1 111.21 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 452' ' ' VAL . . . . . 0.556 HG13 ' H ' ' B' ' 453' ' ' GLY . 2.5 p -64.23 -75.13 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 O-C-N 123.877 0.736 . . . . 60.45 112.334 -175.106 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 453' ' ' GLY . . . . . 0.556 ' H ' HG13 ' B' ' 452' ' ' VAL . . . 55.91 -102.7 0.19 Allowed Glycine 0 C--N 1.346 1.1 0 CA-C-O 121.025 0.236 . . . . 73.44 112.555 -171.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 454' ' ' LEU . . . . . 0.569 HD21 ' HB1' ' B' ' 282' ' ' ALA . 1.9 pt? -161.14 -41.84 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 107.694 -1.224 . . . . 72.5 107.694 -176.138 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 455' ' ' THR . . . . . 0.423 ' HB ' HG13 ' B' ' 288' ' ' VAL . 4.9 m 49.88 -85.63 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 126.57 1.948 . . . . 61.41 114.166 171.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 456' ' ' ASP . . . . . 0.553 ' HB2' HD11 ' B' ' 280' ' ' LEU . 7.1 t70 -171.19 -162.52 0.25 Allowed 'General case' 0 CA--C 1.554 1.132 0 N-CA-C 107.747 -1.205 . . . . 74.3 107.747 -172.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 457' ' ' GLN . . . . . 0.45 ' HA ' ' H ' ' B' ' 289' ' ' ARG . 9.8 tt0 -146.51 -32.03 0.34 Allowed 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 118.704 0.684 . . . . 42.14 111.205 174.045 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 33.3 p -87.1 -12.21 47.83 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.966 1.098 . . . . 72.13 113.966 -168.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 459' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -95.95 173.93 7.19 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 119.534 1.061 . . . . 73.31 111.466 174.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 460' ' ' LEU . . . . . 0.454 ' HG ' ' HA ' ' B' ' 290' ' ' TRP . 5.8 tt -160.15 104.08 1.48 Allowed 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 107.564 -1.273 . . . . 65.42 107.564 -176.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -132.94 -87.62 0.43 Allowed 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.576 0.75 . . . . 62.31 110.379 177.043 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -149.58 162.76 39.54 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.001 -1.111 . . . . 72.53 108.001 -173.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 41.8 p -63.7 168.66 4.67 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 122.98 0.512 . . . . 61.35 111.587 176.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 464' ' ' MET . . . . . 0.742 ' H ' HG13 ' B' ' 451' ' ' VAL . 1.8 tpt 75.2 131.69 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.865 1.266 . . . . 75.31 110.791 -178.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 36.1 mtmm -69.88 85.98 0.51 Allowed 'General case' 0 C--N 1.355 0.826 0 N-CA-C 108.884 -0.784 . . . . 72.15 108.884 173.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -164.48 -52.5 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.353 -1.294 . . . . 62.32 108.608 -174.315 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 467' ' ' ALA . . . . . 0.456 ' HA ' ' HZ1' ' C' ' 271' ' ' LYS . . . -90.41 69.55 6.94 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.131 -0.94 . . . . 75.3 110.844 179.024 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -91.64 -172.47 3.23 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 123.019 0.527 . . . . 45.51 111.185 -178.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 469' ' ' GLY . . . . . . . . . . . . . . . -115.51 -82.6 1.02 Allowed Glycine 0 C--N 1.356 1.645 0 N-CA-C 112.19 -0.364 . . . . 50.44 112.19 174.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 470' ' ' LEU . . . . . 0.409 HD12 ' N ' ' B' ' 471' ' ' LYS . 3.8 pp -170.67 -38.98 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.636 1.175 . . . . 73.2 108.486 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 471' ' ' LYS . . . . . 0.409 ' N ' HD12 ' B' ' 470' ' ' LEU . 5.2 tmtm? . . . . . 0 C--O 1.252 1.19 0 N-CA-C 104.167 -2.531 . . . . 74.2 104.167 172.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 59.0 mtm . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 119.613 -0.232 . . . . 55.23 110.48 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 52.68 39.82 29.12 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.152 0.981 . . . . 65.31 111.957 -177.033 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -84.46 64.18 8.26 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 109.56 -0.533 . . . . 52.01 109.56 178.051 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -40.5 95.67 0.01 OUTLIER 'General case' 0 C--N 1.359 0.99 0 C-N-CA 125.564 1.546 . . . . 70.52 114.045 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 5' ' ' LYS . . . . . 0.416 ' HB3' HD11 ' C' ' 10' ' ' ILE . 48.6 mtmt -87.72 124.52 33.67 Favored 'General case' 0 C--O 1.247 0.942 0 N-CA-C 108.899 -0.778 . . . . 63.2 108.899 170.661 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -75.84 112.88 12.7 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.629 -0.878 . . . . 63.22 108.629 175.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 7' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -64.47 -26.16 68.32 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.713 0.805 . . . . 73.43 112.711 -171.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -70.89 -45.07 65.0 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 109.319 -0.623 . . . . 72.53 109.319 178.039 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.57 -36.91 84.16 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.973 -1.012 . . . . 52.31 110.762 176.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 10' ' ' ILE . . . . . 0.416 HD11 ' HB3' ' C' ' 5' ' ' LYS . 56.6 mt -59.46 -46.57 92.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 122.908 0.483 . . . . 63.34 110.06 174.315 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 11' ' ' LEU . . . . . 0.622 ' HB3' ' HB1' ' C' ' 25' ' ' ALA . 56.6 mt -71.39 -6.73 42.36 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 112.639 0.607 . . . . 45.45 112.639 176.498 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.84 21.09 79.66 Favored Glycine 0 C--N 1.355 1.629 0 C-N-CA 122.812 0.244 . . . . 64.33 113.62 178.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 13' ' ' VAL . . . . . 0.421 HG11 ' HB2' ' C' ' 25' ' ' ALA . 31.3 m -113.98 161.51 27.57 Favored Pre-proline 0 N--CA 1.477 0.885 0 C-N-CA 124.111 0.964 . . . . 64.04 110.259 -177.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -54.89 148.52 46.32 Favored 'Trans proline' 0 C--N 1.382 2.294 0 C-N-CA 122.617 2.211 . . . . 74.43 113.05 174.121 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 68.4 mtm180 -76.94 19.9 0.28 Allowed 'General case' 0 CA--C 1.559 1.296 0 C-N-CA 123.757 0.823 . . . . 71.52 112.969 -172.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -136.97 8.17 2.97 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 125.076 1.35 . . . . 71.24 109.344 179.051 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.07 141.13 58.84 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.851 0.86 . . . . 71.14 112.242 -174.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 47.7 p -93.24 176.44 6.4 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.276 1.03 . . . . 74.41 112.335 -174.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -53.41 -36.34 61.39 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 125.288 1.435 . . . . 74.45 112.585 -175.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -57.95 -47.98 81.31 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.55 1.14 . . . . 64.05 111.405 175.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -76.89 -29.98 56.0 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.042 -1.436 . . . . 73.42 111.194 -174.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 22' ' ' ILE . . . . . 0.452 HG12 ' HB3' ' C' ' 57' ' ' LEU . 1.7 mp -72.28 -34.11 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 C-N-CA 124.119 0.968 . . . . 61.32 110.058 175.46 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 23' ' ' LYS . . . . . 0.534 ' HD3' ' NH2' ' C' ' 148' ' ' ARG . 34.1 ttpt -61.5 -50.64 71.9 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.694 0.798 . . . . 74.13 109.973 173.365 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 50.1 mtm180 -75.5 -20.23 58.89 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 115.582 -0.736 . . . . 73.52 112.423 -178.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 25' ' ' ALA . . . . . 0.622 ' HB1' ' HB3' ' C' ' 11' ' ' LEU . . . -74.23 -38.75 63.45 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.098 0.559 . . . . 75.32 110.238 172.364 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 26' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -63.8 -43.69 95.57 Favored 'General case' 0 C--O 1.216 -0.7 0 CA-C-N 114.846 -1.07 . . . . 72.31 109.524 174.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -55.48 -55.14 35.21 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.886 0.474 . . . . 74.1 109.994 175.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -46.5 -62.39 1.39 Allowed 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.047 1.339 . . . . 71.15 111.956 -179.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 62.7 mt -74.46 -38.83 62.85 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.385 -0.825 . . . . 60.22 112.168 -173.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.01 2.96 32.25 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 122.573 0.349 . . . . 75.32 111.742 -178.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -95.94 -44.99 7.12 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 108.944 -0.761 . . . . 73.5 108.944 163.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 21.3 tp60 -67.65 -55.86 11.63 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 123.501 0.5 . . . . 71.12 112.216 -176.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 33' ' ' TYR . . . . . 0.472 ' HD2' HD11 ' C' ' 50' ' ' ILE . 11.1 m-85 -95.66 25.5 4.54 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.699 0.8 . . . . 70.15 110.942 -178.499 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 34' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 -64.9 114.86 16.44 Favored Pre-proline 0 CA--C 1.546 0.813 0 CA-C-O 118.251 -0.881 . . . . 72.34 109.691 -177.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -55.62 -16.14 14.02 Favored 'Trans proline' 0 C--N 1.38 2.211 0 C-N-CA 123.216 2.611 . . . . 71.32 114.314 -177.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -67.75 -53.26 28.79 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.486 0.714 . . . . 60.34 110.391 169.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 77.1 t -77.07 -50.67 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.801 0.84 . . . . 75.33 110.508 -173.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -114.26 86.58 2.45 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.775 1.23 . . . . 54.22 109.011 -178.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -75.96 77.21 2.84 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 116.056 -0.52 . . . . 62.24 109.786 178.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 22.5 m -135.37 121.06 14.01 Favored Pre-proline 0 N--CA 1.471 0.608 0 CA-C-O 118.284 -0.865 . . . . 74.14 109.278 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -47.99 -37.16 29.22 Favored 'Trans proline' 0 C--N 1.384 2.443 0 C-N-CA 123.346 2.697 . . . . 63.44 112.694 174.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -59.94 -41.84 92.69 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.16 0.984 . . . . 65.44 110.246 177.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.7 -17.98 61.06 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 116.2 -0.455 . . . . 62.05 110.521 177.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 44' ' ' GLU . . . . . 0.526 ' HA ' ' HB3' ' C' ' 47' ' ' PHE . 50.1 mt-10 -86.22 -14.88 42.6 Favored 'General case' 0 C--N 1.358 0.953 0 C-N-CA 123.045 0.538 . . . . 74.04 110.371 177.137 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 45' ' ' GLU . . . . . 0.425 ' O ' ' HB2' ' C' ' 48' ' ' LYS . 32.6 mt-10 -82.72 -38.29 23.52 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.924 -0.769 . . . . 42.53 108.924 169.71 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 46' ' ' LYS . . . . . 0.502 ' O ' HG13 ' C' ' 50' ' ' ILE . 59.0 mttp -64.13 -32.04 73.46 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.597 -0.729 . . . . 72.32 110.115 166.659 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 47' ' ' PHE . . . . . 0.526 ' HB3' ' HA ' ' C' ' 44' ' ' GLU . 46.3 t80 -78.29 -21.98 48.91 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.582 0.753 . . . . 62.23 110.533 177.141 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 48' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' C' ' 45' ' ' GLU . 50.6 mttp -60.35 -53.13 61.29 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 107.961 -1.125 . . . . 72.04 107.961 164.033 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -56.81 -40.19 75.53 Favored 'General case' 0 CA--C 1.55 0.954 0 O-C-N 124.447 1.092 . . . . 72.33 112.132 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 50' ' ' ILE . . . . . 0.502 HG13 ' O ' ' C' ' 46' ' ' LYS . 69.9 mt -62.75 -55.13 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 C-N-CA 123.312 0.645 . . . . 75.43 110.082 176.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 51' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -71.67 -20.91 61.87 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 114.823 -1.08 . . . . 74.04 112.174 -173.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -79.52 -54.29 6.05 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.279 1.032 . . . . 63.42 108.548 178.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.71 -33.74 72.0 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 114.125 -1.398 . . . . 63.1 111.732 176.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -81.66 -33.74 31.13 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 119.138 -0.458 . . . . 75.01 110.452 177.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 55' ' ' ALA . . . . . 0.417 ' HB1' ' HD2' ' C' ' 85' ' ' PHE . . . -56.6 -35.33 68.12 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 118.023 0.374 . . . . 60.54 110.535 174.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 56' ' ' VAL . . . . . 0.459 ' O ' ' HB2' ' C' ' 62' ' ' LYS . 46.2 t -81.02 -62.2 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 CA-C-N 115.559 -0.746 . . . . 72.43 110.986 176.087 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 57' ' ' LEU . . . . . 0.452 ' HB3' HG12 ' C' ' 22' ' ' ILE . 39.4 mt -79.84 -7.88 58.96 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 114.169 1.174 . . . . 75.02 114.169 -164.117 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 32.6 t -59.92 -51.9 67.69 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.335 0.588 . . . . 62.42 110.433 178.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.86 126.39 80.14 Favored Pre-proline 0 C--O 1.246 0.891 0 CA-C-N 114.787 -1.097 . . . . 72.03 108.805 172.485 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 60' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -59.12 -23.77 70.61 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.095 1.863 . . . . 33.23 111.231 168.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -64.8 -54.74 26.49 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 124.568 1.147 . . . . 62.13 110.905 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 62' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' C' ' 56' ' ' VAL . 70.3 mttt -69.77 -30.85 68.51 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 115.873 -0.603 . . . . 75.23 110.804 178.325 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 1.3 ttp180 -57.91 -43.6 86.3 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.62 -0.882 . . . . 64.42 108.62 175.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -72.13 -28.4 63.24 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 115.053 -0.976 . . . . 74.15 112.32 177.208 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 65' ' ' ILE . . . . . 0.475 HD13 ' HE1' ' C' ' 83' ' ' TYR . 78.6 mt -59.82 -44.54 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 109.878 -0.416 . . . . 62.34 109.878 170.366 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -67.58 -42.65 82.2 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 116.169 -0.469 . . . . 74.22 110.207 176.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -58.91 -39.96 83.06 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.329 0.652 . . . . 73.14 111.423 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 71.6 p -77.1 -19.33 57.13 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 122.948 0.499 . . . . 63.2 110.983 177.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -74.08 114.29 12.23 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 108.517 -0.92 . . . . 75.22 108.517 170.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 112.26 11.92 14.69 Favored Glycine 0 N--CA 1.472 1.084 0 N-CA-C 111.699 -0.561 . . . . 62.51 111.699 -166.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 95.2 m -144.38 -50.39 0.29 Allowed 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 105.05 -2.204 . . . . 72.34 105.05 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 33.1 m -93.8 137.3 33.19 Favored 'General case' 0 C--O 1.249 1.078 0 N-CA-C 103.527 -2.768 . . . . 73.35 103.527 156.163 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.06 -31.75 13.44 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 118.384 0.538 . . . . 73.23 110.687 177.191 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.94 140.91 74.39 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 123.582 0.753 . . . . 53.23 109.968 176.115 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 75' ' ' PRO . . . . . 0.41 ' HB3' ' O ' ' C' ' 100' ' ' LEU . 10.2 Cg_endo -53.03 115.87 2.56 Favored 'Trans proline' 0 C--N 1.376 2.016 0 C-N-CA 123.173 2.582 . . . . 75.14 112.306 176.129 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -53.44 148.9 32.18 Favored 'Trans proline' 0 C--N 1.391 2.772 0 C-N-CA 123.911 3.074 . . . . 63.14 113.276 -178.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -50.87 118.62 4.37 Favored 'Trans proline' 0 C--N 1.389 2.663 0 C-N-CA 123.24 2.627 . . . . 51.51 113.521 -178.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 78' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.11 139.48 80.31 Favored 'Trans proline' 0 C--N 1.386 2.511 0 C-N-CA 123.343 2.695 . . . . 74.44 112.943 -178.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.58 158.02 17.31 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 123.078 2.519 . . . . 61.04 112.591 177.208 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -74.91 42.48 0.84 Allowed 'Trans proline' 0 C--N 1.382 2.312 0 C-N-CA 123.678 2.918 . . . . 51.5 112.735 174.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -159.46 16.86 0.23 Allowed Glycine 0 CA--C 1.529 0.951 0 N-CA-C 108.585 -1.806 . . . . 75.2 108.585 177.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 67.6 -171.93 32.86 Favored Glycine 0 C--N 1.365 2.179 0 C-N-CA 124.439 1.019 . . . . 74.45 111.959 -175.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 83' ' ' TYR . . . . . 0.475 ' HE1' HD13 ' C' ' 65' ' ' ILE . 58.8 m-85 -83.58 98.15 9.44 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 105.991 -1.855 . . . . 70.14 105.991 162.579 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 84' ' ' ASP . . . . . 0.492 ' OD1' ' HA3' ' C' ' 163' ' ' GLY . 0.3 OUTLIER -56.32 137.18 52.88 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 112.015 0.376 . . . . 63.13 112.015 -175.114 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 85' ' ' PHE . . . . . 0.459 ' HB3' ' HB2' ' C' ' 88' ' ' PHE . 30.7 m-85 -133.06 73.1 1.5 Allowed 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.523 1.129 . . . . 74.41 108.325 177.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 86' ' ' SER . . . . . 0.411 ' HA ' ' HB2' ' C' ' 162' ' ' PRO . 50.4 m -51.64 85.72 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 124.308 1.043 . . . . 45.43 112.345 178.581 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 65.61 19.11 66.7 Favored Glycine 0 CA--C 1.534 1.273 0 CA-C-N 115.566 -0.743 . . . . 74.33 113.672 -175.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 88' ' ' PHE . . . . . 0.459 ' HB2' ' HB3' ' C' ' 85' ' ' PHE . 23.0 m-85 -101.81 118.55 37.16 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 109.411 -0.588 . . . . 74.44 109.411 -176.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -75.74 90.23 2.86 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.216 0.531 . . . . 72.23 109.686 -178.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 90' ' ' VAL . . . . . 0.432 HG23 HD22 ' C' ' 105' ' ' LEU . 1.6 p -41.12 -47.99 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 CA-C-N 113.96 -1.473 . . . . 54.41 113.326 171.229 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 91' ' ' GLU . . . . . 0.509 ' HB2' ' HG3' ' C' ' 112' ' ' ARG . 45.5 tt0 -68.78 -19.32 64.31 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.275 0.63 . . . . 74.21 111.635 -175.221 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -93.06 -2.89 55.16 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.354 0.662 . . . . 75.53 111.583 -178.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -95.21 174.77 6.89 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 122.714 0.405 . . . . 72.45 111.803 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 90.0 p -66.23 167.15 10.71 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 114.643 1.349 . . . . 45.51 114.643 -168.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 95' ' ' GLU . . . . . 0.403 ' O ' ' HG3' ' C' ' 99' ' ' GLU . 0.0 OUTLIER -59.49 -50.89 72.19 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 114.962 -1.017 . . . . 55.43 112.026 178.744 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -57.13 -46.44 82.66 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.608 0.763 . . . . 65.02 110.502 -176.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 97' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -54.64 -52.29 62.77 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 114.756 -1.111 . . . . 64.25 110.634 175.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 98' ' ' GLN . . . . . 0.576 ' HA ' HD21 ' C' ' 105' ' ' LEU . 98.0 mt-30 -69.0 -18.29 64.03 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.617 -0.719 . . . . 51.52 112.558 -175.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 99' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' C' ' 95' ' ' GLU . 44.3 mt-10 -86.65 -52.42 5.55 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.729 0.411 . . . . 74.43 111.087 176.559 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 100' ' ' LEU . . . . . 0.41 ' O ' ' HB3' ' C' ' 75' ' ' PRO . 54.5 tp -62.09 -39.58 92.94 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.528 0.731 . . . . 73.23 111.012 -178.609 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -96.57 7.49 46.41 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.987 -0.551 . . . . 73.25 110.839 178.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 102' ' ' GLY . . . . . 0.481 ' HA2' ' HG ' ' C' ' 105' ' ' LEU . . . -43.38 -62.34 2.49 Favored Glycine 0 C--N 1.356 1.672 0 C-N-CA 124.906 1.241 . . . . 54.11 114.916 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -49.6 -21.22 5.07 Favored 'Trans proline' 0 C--N 1.384 2.431 0 C-N-CA 123.985 3.123 . . . . 62.02 115.105 -177.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -146.97 41.26 0.97 Allowed Glycine 0 C--N 1.36 1.909 0 CA-C-O 119.576 -0.569 . . . . 43.23 112.823 178.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 105' ' ' LEU . . . . . 0.576 HD21 ' HA ' ' C' ' 98' ' ' GLN . 13.2 mt -56.77 13.36 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.59 0 N-CA-C 115.717 1.747 . . . . 73.03 115.717 177.223 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 106' ' ' PHE . . . . . 0.545 ' HA ' ' HB2' ' C' ' 169' ' ' ASN . 0.2 OUTLIER 72.35 -104.44 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.044 0.937 . . . . 64.24 111.821 166.077 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 107' ' ' GLY . . . . . 0.472 ' HA2' ' HB2' ' C' ' 112' ' ' ARG . . . 109.56 24.84 5.71 Favored Glycine 0 N--CA 1.466 0.668 0 N-CA-C 111.376 -0.69 . . . . 51.05 111.376 -161.732 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . -15.48 -67.7 0.01 OUTLIER Glycine 0 C--N 1.364 2.111 0 C-N-CA 124.882 1.229 . . . . 74.41 113.343 160.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 109' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -91.01 78.51 5.94 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 107.631 -1.248 . . . . 74.45 107.631 167.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 110' ' ' GLY . . . . . . . . . . . . . . . 0.51 -69.16 0.0 OUTLIER Glycine 0 N--CA 1.498 2.779 0 C-N-CA 127.308 2.385 . . . . 54.22 116.86 -179.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 17.9 mtp180 -7.04 -40.31 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.914 0 C-N-CA 126.432 1.893 . . . . 75.25 116.031 158.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 112' ' ' ARG . . . . . 0.509 ' HG3' ' HB2' ' C' ' 91' ' ' GLU . 5.5 mpt_? -85.96 47.09 1.4 Allowed 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 126.347 1.859 . . . . 74.1 110.213 -174.569 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 113' ' ' SER . . . . . . . . . . . . . 44.4 m 84.76 -0.2 0.87 Allowed 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 117.179 2.289 . . . . 72.53 117.179 162.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 114' ' ' ARG . . . . . 0.701 ' HB3' ' HA ' ' C' ' 169' ' ' ASN . 0.1 OUTLIER -154.75 158.85 40.14 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 120.725 1.602 . . . . 74.05 112.376 174.23 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 115' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -103.47 131.43 50.58 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.762 1.023 . . . . 54.14 113.762 -177.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -109.56 165.88 12.49 Favored Glycine 0 CA--C 1.542 1.732 0 O-C-N 123.456 0.473 . . . . 45.25 112.901 163.092 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 4.6 ppt_? -116.51 137.25 52.32 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.714 -0.847 . . . . 64.44 108.714 167.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 118' ' ' ASP . . . . . 0.894 ' HA ' ' HA2' ' C' ' 166' ' ' GLY . 8.7 p-10 -61.3 134.85 57.41 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 123.851 0.861 . . . . 75.42 111.517 -172.296 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 119' ' ' LEU . . . . . 0.563 ' HB2' ' O ' ' C' ' 165' ' ' GLY . 0.2 OUTLIER -92.81 143.62 26.1 Favored 'General case' 0 N--CA 1.504 2.252 0 C-N-CA 119.293 -0.963 . . . . 75.21 109.697 -176.979 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -128.87 95.44 4.09 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 107.947 -1.131 . . . . 72.31 107.947 175.554 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 121' ' ' ALA . . . . . 0.453 ' HB3' HD23 ' C' ' 176' ' ' LEU . . . -108.33 114.1 27.7 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 108.542 -0.911 . . . . 63.21 108.542 -177.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 122' ' ' GLU . . . . . 0.484 ' HA ' ' O ' ' C' ' 177' ' ' VAL . 37.4 mt-10 -95.27 101.44 13.17 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 107.114 -1.439 . . . . 73.22 107.114 172.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 123' ' ' LEU . . . . . 0.63 HD23 ' H ' ' C' ' 123' ' ' LEU . 1.7 pt? -105.57 115.52 61.63 Favored Pre-proline 0 N--CA 1.478 0.942 0 CA-C-N 115.702 -0.681 . . . . 73.3 110.896 -168.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 124' ' ' PRO . . . . . 0.535 ' HA ' ' O ' ' C' ' 179' ' ' ARG . 85.8 Cg_exo -52.76 113.46 1.26 Allowed 'Trans proline' 0 C--N 1.384 2.426 0 C-N-CA 122.506 2.138 . . . . 72.51 111.121 164.276 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 125' ' ' LEU . . . . . 0.566 HD23 HG11 ' C' ' 153' ' ' VAL . 37.8 tp -129.99 143.84 51.01 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.648 0.379 . . . . 74.03 110.106 -175.263 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 126' ' ' THR . . . . . . . . . . . . . 2.5 m -85.37 149.49 25.4 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 116.033 -0.531 . . . . 61.53 110.917 -177.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 127' ' ' LEU . . . . . 0.476 HD11 ' H ' ' C' ' 185' ' ' VAL . 9.8 mt -70.61 -52.14 23.47 Favored 'General case' 0 C--O 1.247 0.962 0 C-N-CA 124.198 0.999 . . . . 62.25 109.038 -178.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 128' ' ' GLU . . . . . 0.551 ' HG3' ' HA ' ' C' ' 215' ' ' LEU . 1.7 mp0 -59.49 -34.72 72.93 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 113.88 -1.509 . . . . 75.24 111.227 178.026 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 129' ' ' GLU . . . . . 0.518 ' HA ' ' HB2' ' C' ' 132' ' ' HIS . 17.7 mm-40 -84.47 -19.55 33.18 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.616 0.366 . . . . 73.53 111.544 -179.718 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -70.5 -33.68 71.49 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 108.882 -0.785 . . . . 64.34 108.882 171.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 131' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -65.46 -49.06 70.53 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 115.482 -0.781 . . . . 75.55 109.91 167.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 132' ' ' HIS . . . . . 0.518 ' HB2' ' HA ' ' C' ' 129' ' ' GLU . 32.8 m170 -72.18 -3.82 25.62 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 112.704 0.631 . . . . 60.22 112.704 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -54.41 165.13 2.83 Favored Glycine 0 CA--C 1.547 2.047 0 N-CA-C 115.715 1.046 . . . . 65.31 115.715 174.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . 158.52 -130.44 2.53 Favored Glycine 0 C--N 1.348 1.218 0 N-CA-C 110.269 -1.133 . . . . 53.24 110.269 -174.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 17.0 mp0 -81.2 95.53 6.95 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 108.263 -1.014 . . . . 71.2 108.263 169.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 136' ' ' ARG . . . . . 0.672 ' HB2' HD22 ' B' ' 181' ' ' LEU . 26.9 mmt180 -121.83 147.04 46.48 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 122.897 0.479 . . . . 72.12 110.662 -172.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 137' ' ' VAL . . . . . 0.565 HG23 ' HB1' ' B' ' 180' ' ' ALA . 8.0 m -74.42 132.55 33.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 121.69 0.757 . . . . 71.12 110.72 -175.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 138' ' ' VAL . . . . . 0.412 HG13 HG11 ' B' ' 182' ' ' VAL . 2.3 t -139.02 133.31 40.64 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 C-N-CA 124.656 1.183 . . . . 72.14 109.269 -175.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 139' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -125.28 109.17 12.49 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 107.898 -1.149 . . . . 74.31 107.898 171.075 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 140' ' ' VAL . . . . . . . . . . . . . 3.2 p -143.32 134.03 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.022 0.929 . . . . 63.22 109.174 178.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 64.42 8.17 4.1 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.613 1.165 . . . . 15.23 113.329 177.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 105.29 1.46 41.17 Favored Glycine 0 C--N 1.351 1.37 0 CA-C-O 119.63 -0.539 . . . . 45.25 113.817 -178.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 143' ' ' ARG . . . . . 0.425 HH11 ' HG2' ' C' ' 164' ' ' MET . 77.2 ttt180 -100.14 124.98 46.17 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 118.037 0.918 . . . . 73.04 110.708 -179.453 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 49.2 ttt-85 -96.22 116.57 29.22 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.163 0.985 . . . . 71.51 108.944 170.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 145' ' ' VAL . . . . . 0.437 HG11 ' SD ' ' C' ' 164' ' ' MET . 7.7 p -151.74 147.4 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 122.714 0.405 . . . . 75.03 111.104 -177.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 50.8 m -85.39 93.47 8.74 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 108.044 -1.095 . . . . 54.21 108.044 166.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 6.2 p -81.33 154.41 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-O 120.853 0.359 . . . . 72.53 110.414 -175.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 148' ' ' ARG . . . . . 0.534 ' NH2' ' HD3' ' C' ' 23' ' ' LYS . 53.5 ttm-85 -113.77 95.79 5.51 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 108.275 -1.009 . . . . 74.22 108.275 172.439 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 149' ' ' ILE . . . . . . . . . . . . . 34.8 pt -106.91 150.99 40.45 Favored Pre-proline 0 CA--C 1.548 0.898 0 N-CA-C 108.49 -0.93 . . . . 71.41 108.49 171.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -40.24 111.73 0.15 Allowed 'Trans proline' 0 C--N 1.384 2.409 0 C-N-CA 124.311 3.341 . . . . 61.44 115.042 -179.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -64.09 93.78 0.19 Allowed 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.996 2.464 . . . . 73.2 109.856 166.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 152' ' ' GLY . . . . . . . . . . . . . . . 113.17 90.6 1.87 Allowed Glycine 0 C--N 1.341 0.816 0 N-CA-C 110.004 -1.238 . . . . 54.32 110.004 -165.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 153' ' ' VAL . . . . . 0.566 HG11 HD23 ' C' ' 125' ' ' LEU . 2.0 p -115.51 156.74 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 C-N-CA 123.051 0.54 . . . . 71.13 110.152 -174.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 154' ' ' ARG . . . . . 0.517 ' HB2' ' HB3' ' C' ' 157' ' ' SER . 56.7 mtp180 -107.54 135.26 49.3 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.68 0.792 . . . . 75.32 110.675 -174.192 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 155' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -47.04 120.91 3.33 Favored 'General case' 0 CA--C 1.553 1.059 0 CA-C-N 118.663 0.665 . . . . 74.51 111.588 166.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.59 -0.49 88.23 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-O 119.263 -0.743 . . . . 64.51 114.496 176.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 157' ' ' SER . . . . . 0.517 ' HB3' ' HB2' ' C' ' 154' ' ' ARG . 91.5 p -77.83 147.96 34.93 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 118.183 0.991 . . . . 75.43 109.93 177.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 6.1 p -119.63 109.58 26.69 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 CA-C-O 121.668 0.746 . . . . 64.44 109.902 -173.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 159' ' ' ILE . . . . . 0.586 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 17.3 mt -88.24 116.01 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.613 1.165 . . . . 52.25 109.078 -178.127 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -91.01 111.84 23.48 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.521 -0.548 . . . . 72.21 109.521 177.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 161' ' ' VAL . . . . . 0.454 HG11 ' HE2' ' C' ' 164' ' ' MET . 1.9 p -122.21 96.4 46.39 Favored Pre-proline 0 CA--C 1.558 1.286 0 C-N-CA 124.254 1.022 . . . . 75.24 108.964 177.046 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 162' ' ' PRO . . . . . 0.83 ' HA ' ' HA ' ' C' ' 173' ' ' ASP . 10.6 Cg_endo -57.05 128.03 28.18 Favored 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 122.847 2.364 . . . . 63.42 113.329 176.023 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 163' ' ' GLY . . . . . 0.492 ' HA3' ' OD1' ' C' ' 84' ' ' ASP . . . 107.31 13.03 22.12 Favored Glycine 0 C--N 1.348 1.209 0 N-CA-C 115.179 0.832 . . . . 53.31 115.179 172.439 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 164' ' ' MET . . . . . 0.454 ' HE2' HG11 ' C' ' 161' ' ' VAL . 5.7 mtm -126.67 32.0 5.23 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 117.991 0.896 . . . . 73.35 112.216 -176.639 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 165' ' ' GLY . . . . . 0.673 ' H ' ' HA2' ' C' ' 172' ' ' GLY . . . 112.35 122.49 4.07 Favored Glycine 0 C--O 1.192 -2.483 0 CA-C-O 115.526 -2.819 . . . . 64.24 107.48 -176.381 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 166' ' ' GLY . . . . . 0.894 ' HA2' ' HA ' ' C' ' 118' ' ' ASP . . . 144.5 -143.57 12.23 Favored Glycine 0 C--O 1.199 -2.035 0 CA-C-N 122.379 3.089 . . . . 75.44 113.239 -161.18 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 167' ' ' GLN . . . . . 0.52 ' H ' ' HB3' ' C' ' 173' ' ' ASP . 22.2 mm-40 -90.07 114.33 26.21 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 118.968 1.384 . . . . 64.31 110.539 177.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . -167.59 -150.97 6.74 Favored Glycine 0 N--CA 1.479 1.502 0 CA-C-O 119.654 -0.526 . . . . 13.44 113.118 -175.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 169' ' ' ASN . . . . . 0.701 ' HA ' ' HB3' ' C' ' 114' ' ' ARG . 7.3 t30 -72.33 -56.23 4.31 Favored Pre-proline 0 C--N 1.358 0.973 0 N-CA-C 108.354 -0.98 . . . . 62.44 108.354 168.657 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 170' ' ' PRO . . . . . 0.598 ' HD3' ' HB3' ' C' ' 169' ' ' ASN . 57.7 Cg_endo -98.83 -160.11 0.05 OUTLIER 'Trans proline' 0 C--N 1.365 1.409 0 N-CA-C 105.292 -2.619 . . . . 51.41 105.292 159.435 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 171' ' ' PRO . . . . . 0.508 ' HA ' ' O ' ' C' ' 166' ' ' GLY . 22.3 Cg_exo -47.17 119.47 3.52 Favored 'Trans proline' 0 CA--C 1.587 3.13 0 CA-C-N 121.543 1.587 . . . . 74.02 114.733 160.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 172' ' ' GLY . . . . . 0.673 ' HA2' ' H ' ' C' ' 165' ' ' GLY . . . -150.96 84.45 0.16 Allowed Glycine 1 CA--C 1.587 4.575 0 N-CA-C 117.169 1.628 . . . . 74.42 117.169 168.999 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 173' ' ' ASP . . . . . 0.83 ' HA ' ' HA ' ' C' ' 162' ' ' PRO . 29.0 t70 163.05 93.21 0.0 OUTLIER 'General case' 0 N--CA 1.535 3.817 0 C-N-CA 127.58 2.352 . . . . 74.51 108.231 -178.689 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 174' ' ' LEU . . . . . . . . . . . . . 15.1 tp -104.45 139.79 38.87 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 114.724 -1.125 . . . . 75.22 113.035 -162.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 66.9 mt -110.26 92.26 3.98 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.462 1.105 . . . . 71.32 109.398 172.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 176' ' ' LEU . . . . . 0.586 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 68.1 mt -75.29 93.6 2.89 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-N 114.796 -1.093 . . . . 43.02 110.953 175.222 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 177' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' C' ' 122' ' ' GLU . 59.4 t -84.53 101.33 8.91 Favored 'Isoleucine or valine' 0 C--O 1.244 0.777 0 N-CA-C 107.28 -1.378 . . . . 74.43 107.28 172.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 178' ' ' VAL . . . . . . . . . . . . . 28.9 m -76.92 122.05 30.58 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 CA-C-O 121.927 0.87 . . . . 74.01 110.18 -176.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 179' ' ' ARG . . . . . 0.535 ' O ' ' HA ' ' C' ' 124' ' ' PRO . 9.9 mmm180 -113.71 111.87 22.52 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 106.376 -1.713 . . . . 72.33 106.376 174.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 180' ' ' LEU . . . . . . . . . . . . . 53.2 mt -67.8 148.19 51.56 Favored 'General case' 0 CA--C 1.558 1.253 0 CA-C-N 117.619 0.191 . . . . 70.51 111.026 -176.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 181' ' ' LEU . . . . . . . . . . . . . 41.1 mt -53.23 167.75 0.41 Allowed Pre-proline 0 N--CA 1.5 2.068 0 C-N-CA 125.671 1.588 . . . . 74.2 113.827 -171.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -61.66 68.7 0.1 Allowed 'Trans proline' 0 C--N 1.393 2.9 0 C-N-CA 122.861 2.374 . . . . 64.12 110.252 161.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 183' ' ' HIS . . . . . 0.407 ' N ' ' HD3' ' C' ' 184' ' ' PRO . 81.6 t60 172.85 47.52 0.01 OUTLIER Pre-proline 0 CA--C 1.562 1.404 0 C-N-CA 129.031 2.932 . . . . 62.13 104.503 -167.601 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 184' ' ' PRO . . . . . 0.407 ' HD3' ' N ' ' C' ' 183' ' ' HIS . 85.8 Cg_endo -95.05 63.89 0.23 Allowed 'Trans proline' 0 C--N 1.387 2.573 0 C-N-CA 122.395 2.064 . . . . 71.54 109.713 -167.242 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 185' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 9.8 t -92.85 -23.02 5.66 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.476 0 CA-C-N 114.748 -1.114 . . . . 72.23 109.271 -168.301 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 186' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -130.68 101.03 5.51 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 118.746 0.703 . . . . 61.44 110.945 -175.244 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 187' ' ' ARG . . . . . . . . . . . . . 40.7 ttt85 -94.57 117.27 29.86 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 114.494 -1.23 . . . . 75.14 108.066 171.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 188' ' ' LEU . . . . . 0.515 HD13 ' HD2' ' C' ' 240' ' ' PHE . 61.5 tp -82.03 145.95 29.95 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 121.489 0.661 . . . . 74.14 111.824 -179.161 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 189' ' ' GLU . . . . . 0.427 ' HA ' ' NE ' ' C' ' 154' ' ' ARG . 31.2 tt0 -143.71 111.98 6.32 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 107.064 -1.458 . . . . 71.33 107.064 164.024 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 67.49 -100.51 0.61 Allowed Glycine 0 C--N 1.35 1.316 0 N-CA-C 111.271 -0.732 . . . . 74.2 111.271 -171.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 191' ' ' GLN . . . . . 0.482 ' HA ' HD11 ' C' ' 188' ' ' LEU . 48.9 mt-30 -125.61 -6.27 6.93 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.531 0.732 . . . . 60.21 111.136 171.185 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -84.8 138.99 32.26 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 122.892 0.477 . . . . 65.13 110.475 179.209 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 193' ' ' LEU . . . . . 0.494 HD21 ' CD2' ' C' ' 240' ' ' PHE . 90.4 mt -101.49 163.61 12.18 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.408 0.623 . . . . 52.2 111.142 178.548 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 194' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -129.82 115.4 17.19 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 114.59 -1.186 . . . . 75.43 108.915 172.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 195' ' ' ALA . . . . . 0.531 ' HA ' ' O ' ' C' ' 185' ' ' VAL . . . -114.59 -178.32 3.34 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.73 0.812 . . . . 65.11 111.242 176.208 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 196' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' C' ' 252' ' ' GLU . 78.1 m -136.32 114.53 11.57 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 108.27 -1.011 . . . . 51.32 108.27 164.101 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 197' ' ' LEU . . . . . . . . . . . . . 45.7 tp -88.85 132.57 34.6 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 123.814 0.846 . . . . 73.5 110.542 -176.133 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -88.22 105.32 17.46 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 108.551 -0.907 . . . . 44.52 108.551 175.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 199' ' ' VAL . . . . . 0.592 HG21 ' HH2' ' B' ' 242' ' ' TRP . 51.2 t -115.22 118.5 39.92 Favored Pre-proline 0 N--CA 1.469 0.504 0 N-CA-C 108.019 -1.104 . . . . 61.21 108.019 177.758 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 200' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.69 138.36 31.8 Favored 'Trans proline' 0 C--N 1.372 1.785 0 C-N-CA 121.76 1.64 . . . . 71.34 110.612 175.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 201' ' ' ALA . . . . . 0.404 ' O ' HG23 ' C' ' 205' ' ' VAL . . . -41.47 -48.14 9.19 Favored Pre-proline 0 CA--C 1.562 1.411 0 N-CA-C 115.363 1.616 . . . . 74.35 115.363 178.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 202' ' ' PRO . . . . . 0.443 ' HB2' ' HA ' ' A' ' 273' ' ' ALA . 11.9 Cg_endo -53.36 -54.46 4.92 Favored 'Trans proline' 0 C--N 1.386 2.548 0 CA-C-N 121.281 1.493 . . . . 63.15 112.638 176.581 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 203' ' ' ILE . . . . . . . . . . . . . 63.9 mt -63.74 -29.88 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 123.197 0.599 . . . . 63.4 110.703 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.96 -35.79 78.98 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.995 0.918 . . . . 75.02 112.377 179.218 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 205' ' ' VAL . . . . . 0.551 HG22 HD13 ' A' ' 257' ' ' ILE . 46.3 t -80.04 -42.8 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 CA-C-O 119.355 -0.355 . . . . 63.41 111.675 179.002 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 206' ' ' VAL . . . . . . . . . . . . . 10.9 p -80.18 -36.84 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 112.558 0.577 . . . . 52.12 112.558 -172.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 83.31 89.45 0.73 Allowed Glycine 0 C--N 1.344 1.024 0 N-CA-C 111.755 -0.538 . . . . 63.21 111.755 -166.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -127.8 -129.55 3.23 Favored Glycine 0 C--N 1.344 1.006 0 N-CA-C 111.03 -0.828 . . . . 51.32 111.03 177.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 209' ' ' LYS . . . . . 0.581 ' HG2' ' HA ' ' C' ' 222' ' ' ALA . 5.9 mtmp? -136.3 146.95 47.19 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 117.711 0.756 . . . . 72.12 111.71 170.406 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 210' ' ' VAL . . . . . 0.429 HG21 HG22 ' C' ' 199' ' ' VAL . 33.4 m -128.67 168.22 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 125.225 1.41 . . . . 62.05 107.678 169.075 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 211' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -106.19 136.43 45.91 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 118.117 0.417 . . . . 72.44 111.391 -177.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 212' ' ' ALA . . . . . 0.532 ' HB3' HG13 ' C' ' 219' ' ' VAL . . . -120.56 120.72 36.64 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 107.6 -1.259 . . . . 74.43 107.6 171.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 213' ' ' MET . . . . . 0.426 ' SD ' ' N ' ' C' ' 214' ' ' THR . 8.7 tmm? -71.98 146.38 47.77 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.431 -0.951 . . . . 63.12 108.431 173.258 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 214' ' ' THR . . . . . 0.561 HG21 ' HD2' ' C' ' 238' ' ' LYS . 0.1 OUTLIER -141.79 168.85 18.78 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 119.035 0.834 . . . . 54.24 112.333 178.165 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 215' ' ' LEU . . . . . 0.551 ' HA ' ' HG3' ' C' ' 128' ' ' GLU . 30.8 mt -62.8 -35.78 80.99 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 124.566 1.146 . . . . 44.41 113.444 -166.284 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.48 -2.21 15.61 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 114.546 -1.207 . . . . 71.0 111.495 -171.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 164.37 -168.16 38.61 Favored Glycine 0 C--O 1.21 -1.363 0 CA-C-O 119.6 -0.556 . . . . 64.11 111.786 -174.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -94.41 165.42 1.91 Allowed 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 122.302 2.001 . . . . 52.13 112.554 171.016 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 219' ' ' VAL . . . . . 0.631 ' HB ' ' HE3' ' C' ' 238' ' ' LYS . 2.2 p -142.96 112.9 2.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 108.073 -1.084 . . . . 52.53 108.073 168.171 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 220' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -90.78 108.12 19.62 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 108.277 -1.009 . . . . 72.32 108.277 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 221' ' ' VAL . . . . . 0.511 ' HA ' ' HB2' ' B' ' 239' ' ' ALA . 39.4 t -71.33 127.15 32.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 114.012 -1.449 . . . . 74.03 112.767 -171.163 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 222' ' ' ALA . . . . . 0.581 ' HA ' ' HG2' ' C' ' 209' ' ' LYS . . . -81.41 109.09 15.57 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 123.713 0.633 . . . . 73.3 109.346 169.721 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 58.1 t -82.02 139.6 46.13 Favored Pre-proline 0 CA--C 1.558 1.263 0 C-N-CA 124.282 1.033 . . . . 73.11 110.116 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 224' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -84.93 160.81 11.86 Favored 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 122.929 2.419 . . . . 54.33 111.938 170.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 225' ' ' PRO . . . . . 0.538 ' HD3' HG22 ' B' ' 246' ' ' THR . 25.7 Cg_exo -63.36 140.57 77.33 Favored 'Trans proline' 0 C--N 1.372 1.779 0 C-N-CA 122.247 1.965 . . . . 74.0 110.828 169.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 226' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? 70.0 83.62 0.15 Allowed 'General case' 0 N--CA 1.483 1.189 0 O-C-N 124.403 1.065 . . . . 70.15 111.174 177.298 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 227' ' ' THR . . . . . 0.604 HG22 HD11 ' C' ' 255' ' ' ILE . 52.7 m -128.1 122.05 31.11 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.874 -0.603 . . . . 70.3 112.404 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 228' ' ' GLN . . . . . 0.452 HE21 HG13 ' A' ' 257' ' ' ILE . 26.1 mp0 -108.89 162.28 14.35 Favored 'General case' 0 C--O 1.253 1.259 0 CA-C-O 122.615 1.197 . . . . 74.32 111.152 168.534 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 229' ' ' ALA . . . . . 0.432 ' HB2' ' H ' ' C' ' 255' ' ' ILE . . . -65.64 138.29 57.91 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 112.934 -1.939 . . . . 62.12 109.32 175.613 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 101.56 -4.79 54.21 Favored Glycine 0 CA--C 1.523 0.574 0 CA-C-O 119.616 -0.547 . . . . 62.04 113.012 -174.282 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 231' ' ' ARG . . . . . . . . . . . . . 43.1 mtt85 -70.19 171.3 9.97 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 108.567 -0.901 . . . . 74.12 108.567 162.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 232' ' ' LYS . . . . . 0.505 ' HA ' ' O ' ' C' ' 251' ' ' LEU . 32.6 ttmt -155.48 126.18 6.92 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.274 0.559 . . . . 71.45 111.744 -178.39 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 233' ' ' LEU . . . . . 0.631 HD13 ' HB2' ' C' ' 251' ' ' LEU . 4.5 mp -84.92 155.03 21.84 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 114.762 -1.108 . . . . 74.21 110.712 -178.077 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -122.78 100.62 7.0 Favored 'General case' 0 CA--C 1.55 0.953 0 O-C-N 125.099 1.5 . . . . 72.34 108.941 165.155 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 235' ' ' LEU . . . . . 0.448 HD13 HG21 ' C' ' 219' ' ' VAL . 61.3 mt -95.22 114.88 26.72 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.495 0.718 . . . . 73.43 109.165 176.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -71.83 130.82 42.0 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.795 0.838 . . . . 71.55 111.899 -174.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 85.01 -12.81 57.0 Favored Glycine 0 C--N 1.352 1.426 0 CA-C-N 116.029 -0.532 . . . . 71.42 113.123 178.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 238' ' ' LYS . . . . . 0.631 ' HE3' ' HB ' ' C' ' 219' ' ' VAL . 68.5 mmtt -92.25 13.13 20.1 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.743 0.817 . . . . 72.03 112.279 -172.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -80.16 -163.25 27.77 Favored Glycine 0 C--N 1.352 1.462 0 N-CA-C 110.992 -0.843 . . . . 31.21 110.992 164.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 240' ' ' PHE . . . . . 0.515 ' HD2' HD13 ' C' ' 188' ' ' LEU . 1.9 m-85 -73.21 124.23 90.36 Favored Pre-proline 0 C--O 1.249 1.036 0 CA-C-N 118.167 0.983 . . . . 75.14 109.141 175.464 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 241' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' C' ' 240' ' ' PHE . 39.4 Cg_exo -63.51 107.28 0.69 Allowed 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 123.353 2.702 . . . . 70.21 114.381 178.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -79.41 158.3 43.44 Favored Glycine 0 C--N 1.341 0.834 0 CA-C-O 118.904 -0.942 . . . . 70.14 111.371 168.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -57.31 -30.1 86.43 Favored 'Trans proline' 0 C--N 1.374 1.89 0 C-N-CA 123.53 2.82 . . . . 71.42 113.826 -170.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -134.27 17.55 3.72 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.023 0.529 . . . . 71.42 111.439 -177.294 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 175.77 115.29 0.41 Allowed Glycine 0 C--N 1.346 1.116 0 N-CA-C 111.761 -0.535 . . . . 51.32 111.761 -178.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 246' ' ' ARG . . . . . . . . . . . . . 52.4 mtm180 -82.21 156.33 24.46 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.508 0.723 . . . . 61.31 110.264 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -82.24 -160.93 28.17 Favored Glycine 0 N--CA 1.479 1.509 0 N-CA-C 113.825 0.29 . . . . 63.23 113.825 178.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -133.41 133.31 42.2 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 121.539 0.685 . . . . 73.54 110.647 -175.055 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 249' ' ' LEU . . . . . 0.439 HD23 HD12 ' C' ' 235' ' ' LEU . 19.2 tp -88.96 129.5 35.62 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.108 0.963 . . . . 74.23 110.85 -175.47 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 250' ' ' TYR . . . . . 0.588 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 26.8 m-85 -112.38 101.62 9.81 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.856 0.863 . . . . 71.43 110.092 177.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 251' ' ' LEU . . . . . 0.631 ' HB2' HD13 ' C' ' 233' ' ' LEU . 3.3 mp -96.94 117.1 30.4 Favored 'General case' 0 N--CA 1.504 2.249 0 C-N-CA 120.845 -0.342 . . . . 64.53 110.59 -175.363 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 252' ' ' GLU . . . . . 0.424 ' O ' ' HA ' ' C' ' 196' ' ' THR . 6.3 tp10 -70.55 128.94 37.86 Favored 'General case' 0 C--O 1.218 -0.578 0 N-CA-C 108.522 -0.918 . . . . 73.41 108.522 170.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 253' ' ' VAL . . . . . . . . . . . . . 78.1 t -85.41 140.27 16.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 O-C-N 121.815 -0.553 . . . . 73.5 111.306 -174.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 254' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 -128.81 121.57 28.59 Favored 'General case' 0 C--N 1.346 0.456 0 C-N-CA 124.337 1.055 . . . . 74.13 108.899 169.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 255' ' ' ILE . . . . . 0.604 HD11 HG22 ' C' ' 227' ' ' THR . 38.7 mm -87.7 125.97 41.28 Favored 'Isoleucine or valine' 0 C--N 1.344 0.328 0 CA-C-N 115.854 -0.612 . . . . 75.24 109.775 178.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 256' ' ' THR . . . . . . . . . . . . . 43.9 p -121.61 -174.8 2.94 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.024 0.93 . . . . 53.32 111.027 -173.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 257' ' ' ILE . . . . . 0.466 HD12 ' H ' ' C' ' 259' ' ' GLU . 2.8 pp -140.0 156.45 70.43 Favored Pre-proline 0 CA--C 1.561 1.381 0 C-N-CA 123.408 0.683 . . . . 64.54 110.815 -176.413 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -56.5 -10.86 5.56 Favored 'Trans proline' 0 C--N 1.387 2.576 0 C-N-CA 124.046 3.164 . . . . 73.21 115.795 -174.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 259' ' ' GLU . . . . . 0.466 ' H ' HD12 ' C' ' 257' ' ' ILE . 50.6 mt-10 53.87 -84.62 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 124.772 1.229 . . . . 72.3 110.006 -163.566 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 260' ' ' ARG . . . . . 0.406 ' H ' ' HG3' ' C' ' 260' ' ' ARG . 0.0 OUTLIER -73.28 155.68 39.24 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.012 0.925 . . . . 73.41 110.827 176.765 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 261' ' ' LEU . . . . . 0.571 ' HG ' HH12 ' A' ' 226' ' ' ARG . 85.2 mt -130.97 141.36 50.25 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.297 0.639 . . . . 71.21 110.161 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 80.6 p -84.65 164.66 41.57 Favored Pre-proline 0 CA--C 1.558 1.279 0 N-CA-C 107.812 -1.181 . . . . 61.23 107.812 166.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -45.61 -41.87 18.82 Favored 'Trans proline' 0 C--N 1.387 2.574 0 C-N-CA 122.783 2.322 . . . . 74.2 113.776 176.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -55.25 -63.37 1.18 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.037 1.335 . . . . 71.04 111.056 175.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -58.4 -41.46 84.95 Favored 'General case' 0 C--N 1.348 0.525 0 CA-C-N 114.442 -1.253 . . . . 65.11 110.719 -176.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 266' ' ' GLU . . . . . 0.568 ' HA ' HD13 ' C' ' 261' ' ' LEU . 11.0 tp10 -56.31 -51.64 67.47 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.908 0.883 . . . . 64.21 110.43 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -59.44 -49.99 75.68 Favored 'General case' 0 CA--C 1.553 1.085 0 CA-C-N 115.747 -0.66 . . . . 70.32 112.114 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 268' ' ' LEU . . . . . . . . . . . . . 10.3 mp -71.4 -38.31 71.47 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 112.536 0.569 . . . . 52.44 112.536 -174.137 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -70.98 -30.21 66.41 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 122.629 0.371 . . . . 61.11 111.09 177.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 26.8 mmtp -68.14 -40.45 82.44 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 122.913 0.485 . . . . 75.43 111.172 173.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 271' ' ' LYS . . . . . 0.5 ' HB3' HD21 ' A' ' 268' ' ' LEU . 3.4 mmtm -64.14 -41.3 97.25 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 121.048 0.451 . . . . 75.33 111.256 175.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 72.7 mt -61.41 -42.31 98.54 Favored 'General case' 0 C--O 1.217 -0.649 0 CA-C-N 115.728 -0.669 . . . . 74.33 110.177 172.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 273' ' ' ALA . . . . . 0.472 ' HB2' HG21 ' A' ' 206' ' ' VAL . . . -56.51 -43.09 79.41 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.07 0.548 . . . . 34.13 110.899 -179.566 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -58.66 -52.15 66.9 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.177 0.991 . . . . 63.21 110.845 174.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -57.88 -28.92 64.62 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 115.05 -0.977 . . . . 70.04 112.09 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 276' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -95.87 -17.23 21.27 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.532 0.733 . . . . 75.52 111.943 -179.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 19.5 m-30 -67.41 -33.88 76.1 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.544 -0.91 . . . . 44.24 108.544 168.104 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -71.66 -1.05 12.37 Favored 'General case' 0 CA--C 1.557 1.228 0 CA-C-N 114.671 -1.15 . . . . 55.2 112.737 173.071 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 279' ' ' ARG . . . . . . . . . . . . . 30.2 mtp-105 -99.63 -1.71 37.37 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.403 0.681 . . . . 71.52 110.973 171.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.051 0 CA-C-O 118.551 -0.738 . . . . 75.14 109.722 175.671 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.6 mtp . . . . . 0 N--CA 1.476 0.837 0 N-CA-C 109.197 -0.668 . . . . 64.12 109.197 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.8 23.92 14.26 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.465 1.106 . . . . 51.4 111.957 178.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -83.57 65.44 8.45 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.433 0.693 . . . . 74.04 110.672 -174.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -38.46 98.36 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.599 1.56 . . . . 62.43 114.288 -175.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.442 ' HZ2' ' HB3' ' A' ' 94' ' ' SER . 29.3 mmtp -73.18 97.66 2.46 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 107.766 -1.198 . . . . 74.32 107.766 164.07 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.515 ' HA ' ' OH ' ' A' ' 66' ' ' TYR . 14.3 t70 -74.06 90.55 2.01 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.562 -1.273 . . . . 61.41 107.562 174.264 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.416 ' HB2' HD11 ' A' ' 57' ' ' LEU . 48.9 m-85 -58.16 -31.69 67.49 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 113.919 -1.491 . . . . 73.34 112.264 -170.442 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -66.22 -44.56 83.48 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 122.822 0.449 . . . . 73.33 110.736 177.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.73 -41.83 99.36 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 122.992 0.517 . . . . 60.32 110.828 178.473 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.423 HD11 ' HD2' ' A' ' 5' ' ' LYS . 65.6 mt -58.73 -41.19 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 O-C-N 124.071 0.857 . . . . 74.23 110.683 177.096 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 87.6 mt -80.11 -12.21 59.69 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 112.681 0.622 . . . . 51.33 112.681 177.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.86 17.85 78.61 Favored Glycine 0 C--N 1.349 1.267 0 O-C-N 122.958 0.161 . . . . 53.33 113.403 -176.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.9 m -101.34 154.4 37.24 Favored Pre-proline 0 N--CA 1.482 1.144 0 C-N-CA 124.075 0.95 . . . . 71.43 109.623 174.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -58.5 154.56 41.21 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 122.695 2.263 . . . . 50.12 113.534 176.07 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 79.0 mtt180 -77.02 66.7 2.89 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.184 0.994 . . . . 75.43 109.797 177.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -178.86 -25.24 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 114.629 -1.169 . . . . 64.11 109.088 -168.18 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.21 133.32 39.48 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 125.098 1.359 . . . . 64.31 113.338 -174.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.439 ' O ' HD13 ' A' ' 22' ' ' ILE . 51.1 p -78.44 172.98 12.85 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.768 0.827 . . . . 71.11 111.16 179.443 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 22.7 tm0? -50.4 -37.26 36.69 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.814 1.246 . . . . 64.21 111.016 176.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.446 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 0.3 OUTLIER -61.47 -47.56 85.09 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 124.502 1.121 . . . . 72.43 110.217 -179.522 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -70.32 -34.52 72.78 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.308 1.043 . . . . 64.03 111.211 -178.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.439 HD13 ' O ' ' A' ' 18' ' ' THR . 1.5 mp -64.6 -36.96 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.375 1.07 . . . . 73.31 110.04 174.433 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -73.42 -30.47 63.26 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.766 0.826 . . . . 71.24 110.42 179.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.446 ' HG3' ' O ' ' A' ' 20' ' ' GLU . 95.3 mtt180 -62.02 -54.67 38.24 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.296 0.57 . . . . 54.12 110.031 172.493 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.8 -34.29 72.84 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 114.541 -1.208 . . . . 64.0 111.61 178.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -62.82 -49.95 72.92 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.957 0.903 . . . . 73.1 111.12 176.037 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.438 ' HE2' ' HA ' ' A' ' 24' ' ' ARG . 49.5 mtmt -57.57 -55.15 38.55 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 109.799 -0.445 . . . . 74.22 109.799 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.7 ttp-105 -52.57 -65.89 0.48 Allowed 'General case' 0 N--CA 1.479 1.022 0 O-C-N 123.825 0.703 . . . . 71.15 111.523 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.732 ' HB3' HD13 ' A' ' 50' ' ' ILE . 95.4 mt -72.23 -48.7 40.85 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.186 -0.915 . . . . 74.11 112.434 -170.304 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.75 -15.54 59.73 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 112.872 0.693 . . . . 63.3 112.872 -173.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -81.3 -40.24 23.96 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 119.187 0.903 . . . . 72.33 109.57 165.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -63.43 -33.94 76.65 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 115.46 -0.791 . . . . 63.33 111.84 -179.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.439 ' HB3' ' O ' ' A' ' 43' ' ' ALA . 21.7 m-85 -111.6 15.97 20.85 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.89 0.876 . . . . 63.25 110.474 -175.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -69.8 119.35 70.72 Favored Pre-proline 0 C--N 1.352 0.685 0 C-N-CA 123.492 0.717 . . . . 63.41 109.332 -176.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.453 ' HG3' ' HG2' ' A' ' 44' ' ' GLU . 32.6 Cg_exo -60.51 -8.66 9.34 Favored 'Trans proline' 0 C--N 1.373 1.829 0 C-N-CA 123.12 2.547 . . . . 74.13 114.369 -178.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -73.56 -43.74 59.1 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.965 0.506 . . . . 72.45 110.601 170.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 52.3 t -95.75 -63.66 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 123.286 0.634 . . . . 65.53 110.168 -177.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -98.28 80.58 2.67 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 122.303 1.049 . . . . 61.35 109.223 -173.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -76.43 81.45 3.15 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 114.205 -1.361 . . . . 73.11 109.638 178.276 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 69.8 m -140.43 113.94 7.38 Favored Pre-proline 0 N--CA 1.475 0.78 0 C-N-CA 124.152 0.981 . . . . 54.41 108.439 174.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -40.82 -46.17 4.86 Favored 'Trans proline' 0 C--N 1.387 2.568 0 C-N-CA 124.31 3.34 . . . . 72.23 114.05 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.401 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 6.4 tm-20 -54.37 -50.43 67.52 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.679 1.192 . . . . 64.43 109.924 177.028 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.439 ' O ' ' HB3' ' A' ' 33' ' ' TYR . . . -62.55 -31.86 72.73 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 115.121 -0.945 . . . . 72.14 110.691 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.639 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 47.9 mt-10 -77.4 -34.4 54.82 Favored 'General case' 0 C--O 1.217 -0.626 0 O-C-N 123.75 0.656 . . . . 62.01 109.945 -173.149 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -65.59 -44.22 87.32 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.533 0.733 . . . . 62.44 109.932 174.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 42' ' ' GLU . 13.3 mmmm -58.13 -44.94 88.07 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 123.772 0.67 . . . . 74.03 109.869 174.316 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -58.96 -38.97 80.29 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.085 1.354 . . . . 73.24 110.968 178.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.639 ' HG2' ' O ' ' A' ' 44' ' ' GLU . 32.9 mmtp -66.55 -43.45 85.04 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 122.688 0.395 . . . . 75.14 110.925 179.233 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -58.59 -42.54 88.3 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 123.855 0.722 . . . . 71.44 111.184 175.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.732 HD13 ' HB3' ' A' ' 29' ' ' LEU . 62.3 mt -76.1 -28.68 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 124.935 1.294 . . . . 70.53 111.321 -176.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.422 ' HA ' ' HB3' ' A' ' 54' ' ' TYR . 13.7 m-80 -93.61 -5.65 48.31 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.587 0.755 . . . . 73.43 111.421 175.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -77.01 -53.47 7.77 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 107.49 -1.3 . . . . 63.42 107.49 164.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.18 -37.09 76.53 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 112.962 -1.927 . . . . 65.45 111.133 176.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.422 ' HB3' ' HA ' ' A' ' 51' ' ' ASN . 61.4 t80 -73.43 -47.27 43.04 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-O 118.811 -0.614 . . . . 72.32 110.537 173.739 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -50.27 -36.18 30.31 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 123.231 0.613 . . . . 53.01 112.368 -178.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.527 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 61.3 t -78.74 -67.48 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 CA-C-N 114.697 -1.138 . . . . 74.52 110.025 175.465 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.466 HD22 ' HG2' ' A' ' 63' ' ' ARG . 46.3 mt -80.09 4.59 16.74 Favored 'General case' 0 CA--C 1.564 1.483 0 N-CA-C 113.484 0.92 . . . . 62.04 113.484 -165.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.5 t -76.24 -25.0 54.57 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 123.875 0.87 . . . . 74.34 110.275 174.204 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -109.99 117.47 51.87 Favored Pre-proline 0 N--CA 1.449 -0.524 0 N-CA-C 107.142 -1.429 . . . . 74.34 107.142 176.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.447 ' O ' ' HG2' ' A' ' 64' ' ' ARG . 84.0 Cg_exo -46.96 -26.47 4.89 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 123.147 2.565 . . . . 72.41 113.318 171.108 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -63.62 -61.21 2.47 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 122.962 0.505 . . . . 72.3 111.274 175.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.527 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 34.8 mttp -66.79 -26.72 67.09 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 122.375 0.27 . . . . 74.54 111.029 -178.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.466 ' HG2' HD22 ' A' ' 57' ' ' LEU . 4.2 tmt_? -61.58 -48.17 82.2 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.845 1.258 . . . . 74.11 108.826 176.11 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.447 ' HG2' ' O ' ' A' ' 60' ' ' PRO . 19.7 mmm180 -67.1 -33.84 76.33 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.516 -0.765 . . . . 74.25 111.717 176.325 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.436 HD12 ' HA ' ' A' ' 62' ' ' LYS . 84.5 mt -60.49 -42.87 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 C-N-CA 123.077 0.551 . . . . 64.42 110.169 176.298 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.515 ' OH ' ' HA ' ' A' ' 6' ' ' ASP . 32.5 t80 -62.76 -51.92 65.23 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.623 -0.717 . . . . 75.4 110.068 175.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -54.17 -41.48 68.57 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 123.826 0.704 . . . . 64.04 111.271 -178.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 68.7 p -79.07 -22.39 45.37 Favored 'General case' 0 C--N 1.348 0.506 0 CA-C-N 115.637 -0.711 . . . . 75.13 111.931 -178.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -70.9 112.46 7.1 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 109.186 -0.672 . . . . 63.45 109.186 177.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 111.34 9.34 21.95 Favored Glycine 0 N--CA 1.473 1.109 0 CA-C-N 115.832 -0.622 . . . . 52.54 111.638 -170.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.8 m -141.44 -59.4 0.48 Allowed 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 104.177 -2.527 . . . . 71.23 104.177 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.5 m -76.64 141.81 40.87 Favored 'General case' 0 C--O 1.252 1.232 0 N-CA-C 104.472 -2.418 . . . . 74.23 104.472 155.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.66 -49.38 6.32 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.243 0.617 . . . . 74.04 111.219 -178.095 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -97.08 142.49 24.61 Favored Pre-proline 0 N--CA 1.477 0.893 0 C-N-CA 123.037 0.535 . . . . 75.1 110.441 -174.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.421 ' HB2' ' HG3' ' A' ' 103' ' ' PRO . 37.2 Cg_exo -59.34 151.85 65.03 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 123.114 2.543 . . . . 75.41 112.697 174.343 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.05 158.86 45.52 Favored 'Trans proline' 0 C--N 1.377 2.053 0 C-N-CA 123.216 2.611 . . . . 74.25 114.36 -175.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.96 120.26 7.96 Favored 'Trans proline' 0 C--N 1.386 2.54 0 C-N-CA 123.221 2.614 . . . . 62.44 112.198 171.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.45 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 60.3 Cg_endo -69.18 118.31 5.6 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 122.859 2.372 . . . . 43.51 112.087 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.588 ' HB2' ' HA3' ' A' ' 142' ' ' GLY . 6.5 Cg_exo -74.16 165.62 31.52 Favored 'Trans proline' 0 CA--C 1.566 2.115 0 C-N-CA 122.868 2.378 . . . . 71.05 111.726 178.151 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_exo -51.91 85.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.393 2.913 0 C-N-CA 123.921 3.081 . . . . 51.35 114.428 -176.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 141.29 -44.89 0.99 Allowed Glycine 0 C--N 1.338 0.69 0 N-CA-C 109.767 -1.333 . . . . 62.41 109.767 178.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.42 -168.19 33.27 Favored Glycine 0 C--N 1.351 1.399 0 C-N-CA 123.38 0.514 . . . . 53.03 113.535 176.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -70.14 100.48 1.66 Allowed 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.476 1.11 . . . . 74.41 110.215 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.472 ' HB3' ' NE ' ' A' ' 143' ' ' ARG . 32.6 t0 -60.84 115.82 3.97 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.84 0.856 . . . . 71.31 109.783 173.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -112.9 70.24 0.71 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.458 1.103 . . . . 70.22 108.374 -174.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 16.1 m -44.57 86.56 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 126.232 1.813 . . . . 74.44 115.479 -164.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 65.44 23.39 70.21 Favored Glycine 0 C--N 1.353 1.489 0 CA-C-N 115.496 -0.774 . . . . 70.11 114.741 173.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -102.4 136.25 42.56 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 109.617 -0.512 . . . . 72.34 109.617 -178.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -77.37 91.16 3.83 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 122.111 -0.368 . . . . 71.44 110.033 -175.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.4 p -34.69 -56.65 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 115.019 1.488 . . . . 75.21 115.019 175.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -64.4 -26.32 68.41 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 118.363 0.529 . . . . 75.33 112.369 -178.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -79.85 -21.04 44.6 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.614 0.765 . . . . 45.35 111.006 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -94.82 170.33 9.51 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 107.974 -1.121 . . . . 71.01 107.974 177.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.442 ' HB3' ' HZ2' ' A' ' 5' ' ' LYS . 80.4 p -60.3 149.65 32.84 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 113.826 1.047 . . . . 74.5 113.826 -165.335 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.42 ' O ' ' HG3' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -61.06 -30.16 70.16 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 114.893 -1.049 . . . . 74.31 110.486 168.127 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -57.83 -45.07 86.7 Favored 'General case' 0 C--N 1.355 0.812 0 C-N-CA 124.002 0.921 . . . . 75.03 110.838 172.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -63.5 -44.54 94.02 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 115.311 -0.859 . . . . 63.23 109.729 175.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.414 ' HA ' HD11 ' A' ' 105' ' ' LEU . 51.1 mt-30 -68.47 -9.8 51.26 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 115.963 -0.562 . . . . 73.05 111.917 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.42 ' HG3' ' O ' ' A' ' 95' ' ' GLU . 38.7 mt-10 -88.78 -59.29 2.27 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 124.119 0.968 . . . . 70.02 111.208 165.099 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 33.8 tp -60.83 -35.67 77.13 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.943 1.297 . . . . 55.03 112.474 -167.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -116.14 6.43 13.95 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.117 0.567 . . . . 72.11 110.67 176.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -42.84 -57.99 3.81 Favored Glycine 0 C--N 1.357 1.721 0 C-N-CA 124.629 1.109 . . . . 72.43 115.131 177.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.421 ' HG3' ' HB2' ' A' ' 75' ' ' PRO . 28.3 Cg_endo -56.88 -19.08 30.17 Favored 'Trans proline' 0 C--N 1.39 2.752 0 C-N-CA 123.264 2.643 . . . . 23.1 113.377 -173.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -142.1 39.89 1.34 Allowed Glycine 0 C--N 1.354 1.563 0 CA-C-O 119.718 -0.49 . . . . 44.4 112.426 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.466 ' HB3' ' ND2' ' A' ' 169' ' ' ASN . 48.6 mt -61.72 72.61 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 123.026 0.53 . . . . 74.25 111.487 169.47 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.612 ' HB3' ' HA ' ' A' ' 169' ' ' ASN . 2.2 t80 21.09 -106.12 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.432 0 C-N-CA 127.109 2.163 . . . . 72.25 112.774 -170.12 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 58.99 41.41 96.37 Favored Glycine 0 C--N 1.364 2.11 0 CA-C-O 119.744 -0.475 . . . . 44.0 112.644 178.038 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.846 ' HA3' ' HB3' ' A' ' 167' ' ' GLN . . . -14.11 -70.57 0.01 OUTLIER Glycine 0 C--N 1.367 2.269 0 C-N-CA 124.896 1.236 . . . . 71.34 114.887 165.693 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -86.42 72.46 10.3 Favored 'General case' 0 C--O 1.251 1.153 0 N-CA-C 108.783 -0.821 . . . . 64.11 108.783 169.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -13.39 -67.84 0.01 OUTLIER Glycine 0 C--N 1.368 2.319 0 C-N-CA 126.03 1.776 . . . . 55.25 115.324 170.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -4.88 -44.08 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.527 0 C-N-CA 127.447 2.299 . . . . 71.44 116.496 162.688 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.507 ' HG2' ' HB2' ' A' ' 114' ' ' ARG . 59.5 ttt180 -113.77 -35.28 5.21 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.427 0.691 . . . . 73.25 110.755 -172.42 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 33.0 m 54.51 31.46 14.88 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 124.17 0.988 . . . . 74.21 111.443 -176.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.507 ' HB2' ' HG2' ' A' ' 112' ' ' ARG . 7.6 mmt180 -148.11 -175.28 4.83 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.465 0.706 . . . . 74.52 110.922 -173.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -44.4 143.94 1.16 Allowed 'General case' 0 N--CA 1.479 1.008 0 O-C-N 125.45 1.719 . . . . 72.15 114.907 -163.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -90.22 -173.47 44.89 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-N 115.129 -0.941 . . . . 55.22 113.601 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -93.86 164.07 13.26 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 124.926 1.29 . . . . 71.34 109.572 -177.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -74.25 99.67 3.51 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 121.216 -0.927 . . . . 74.23 109.887 174.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 38.3 tp -95.5 141.19 29.32 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 121.039 0.447 . . . . 70.23 111.484 -167.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -93.0 122.18 35.09 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 107.184 -1.413 . . . . 74.51 107.184 169.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -129.9 168.99 15.77 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.399 -0.593 . . . . 41.51 109.399 176.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -128.91 115.4 17.8 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.482 -0.933 . . . . 61.0 108.482 -175.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 65.3 tp -99.59 100.39 10.71 Favored Pre-proline 0 N--CA 1.472 0.659 0 N-CA-C 108.432 -0.951 . . . . 54.05 108.432 -173.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.555 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 46.4 Cg_endo -67.41 135.86 37.96 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 121.587 1.525 . . . . 75.33 109.535 178.047 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.627 ' HA ' HG21 ' B' ' 6' ' ' ILE . 57.1 tp -146.66 154.93 42.03 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 118.467 0.576 . . . . 64.01 110.311 -176.527 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 48.5 m -84.67 145.24 28.07 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 124.536 1.134 . . . . 71.34 110.337 178.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.736 ' HB3' HD22 ' A' ' 215' ' ' LEU . 18.7 mt -55.83 -60.55 3.3 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.927 0.891 . . . . 70.54 112.233 -175.642 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -51.33 -46.37 62.6 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 114.447 -1.252 . . . . 75.32 110.836 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -70.48 -23.94 62.77 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.138 0.975 . . . . 64.33 111.997 -177.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -67.91 -48.01 67.17 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 123.198 0.599 . . . . 41.43 109.596 176.009 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.419 ' HA ' ' HA2' ' A' ' 152' ' ' GLY . 61.0 t80 -71.85 -28.92 63.88 Favored 'General case' 0 CA--C 1.556 1.199 0 O-C-N 124.015 0.822 . . . . 74.51 111.702 178.576 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 49.6 m170 -69.61 -53.43 18.85 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 122.663 0.385 . . . . 75.25 111.039 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.563 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 81.19 -167.7 49.65 Favored Glycine 0 CA--C 1.538 1.474 0 CA-C-N 116.266 -0.425 . . . . 71.54 113.199 -178.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.82 -175.75 23.46 Favored Glycine 0 N--CA 1.477 1.41 0 C-N-CA 123.563 0.601 . . . . 70.42 112.205 -179.213 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.467 ' HB3' ' HB3' ' A' ' 146' ' ' SER . 2.5 mp0 -72.16 108.8 5.53 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.696 -0.853 . . . . 73.14 108.696 176.383 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 17.8 tpt180 -91.47 127.05 36.76 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.625 -0.88 . . . . 74.4 108.625 -177.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.44 ' HB ' HG21 ' B' ' 5' ' ' THR . 61.6 t -72.7 118.04 17.2 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 N-CA-C 108.779 -0.822 . . . . 71.24 108.779 176.139 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.512 ' HB ' HG13 ' A' ' 145' ' ' VAL . 59.2 t -132.23 115.8 27.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 124.056 0.942 . . . . 73.14 109.236 -175.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -79.62 124.73 28.8 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 109.04 -0.726 . . . . 71.3 109.04 170.055 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.532 HG21 HD23 ' B' ' 8' ' ' LEU . 12.2 p -167.68 138.13 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 122.899 0.48 . . . . 75.1 110.57 172.563 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 64.66 12.3 7.45 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.933 1.293 . . . . 74.24 112.205 -178.03 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.588 ' HA3' ' HB2' ' A' ' 79' ' ' PRO . . . 76.05 20.41 77.6 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-N 116.562 -0.29 . . . . 31.1 113.132 -172.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.472 ' NE ' ' HB3' ' A' ' 84' ' ' ASP . 1.0 OUTLIER -123.85 114.32 19.71 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 107.926 -1.138 . . . . 72.12 107.926 175.866 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 55.0 ttt-85 -73.16 87.57 1.43 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.3 1.04 . . . . 74.41 109.357 176.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.512 HG13 ' HB ' ' A' ' 138' ' ' VAL . 5.7 p -86.06 134.48 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 123.572 0.749 . . . . 73.53 111.136 -176.566 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.467 ' HB3' ' HB3' ' A' ' 135' ' ' GLU . 15.2 m -94.41 84.86 4.43 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 114.879 -1.055 . . . . 31.45 108.515 174.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 90.0 t -79.92 108.84 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 N-CA-C 108.207 -1.034 . . . . 73.42 108.207 -177.255 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 50.5 ttt180 -76.23 92.87 3.32 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 109.116 -0.698 . . . . 74.14 109.116 -177.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.633 ' HB ' HG11 ' A' ' 153' ' ' VAL . 42.2 pt -80.1 137.96 53.04 Favored Pre-proline 0 CA--C 1.555 1.163 0 CA-C-N 114.481 -1.236 . . . . 74.13 109.266 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -62.56 141.58 86.74 Favored 'Trans proline' 0 C--N 1.374 1.888 0 C-N-CA 122.519 2.146 . . . . 60.34 112.245 176.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -58.88 93.79 0.08 OUTLIER 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 122.659 2.24 . . . . 74.15 111.045 170.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . 104.85 77.19 1.13 Allowed Glycine 0 C--N 1.335 0.524 0 CA-C-N 115.032 -0.986 . . . . 75.51 110.85 -172.295 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.633 HG11 ' HB ' ' A' ' 149' ' ' ILE . 5.8 p -135.01 103.37 4.3 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.239 0 C-N-CA 123.899 0.88 . . . . 75.43 109.248 174.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.618 ' HD2' HD11 ' A' ' 193' ' ' LEU . 60.5 mtt180 -113.32 173.74 6.25 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 113.3 0.852 . . . . 73.23 113.3 -166.511 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.53 ' HB2' ' HB2' ' A' ' 180' ' ' LEU . 8.6 tp10 -47.65 94.06 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 127.222 2.209 . . . . 72.32 113.965 -167.206 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 121.49 8.57 7.59 Favored Glycine 0 N--CA 1.478 1.471 0 CA-C-O 119.82 -0.433 . . . . 14.21 114.065 178.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 21.8 t -80.9 147.76 30.18 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 109.048 -0.723 . . . . 74.23 109.048 171.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 61.2 t -114.49 94.15 2.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 C-N-CA 123.584 0.754 . . . . 72.34 109.072 -178.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.594 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 51.7 mt -74.95 95.13 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 N-CA-C 108.212 -1.033 . . . . 75.24 108.212 173.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -79.94 118.01 21.3 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.395 -0.366 . . . . 61.32 110.127 179.213 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.5 p -118.08 108.89 41.6 Favored Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 123.653 0.781 . . . . 61.33 109.594 175.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -76.37 115.3 4.07 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 123.103 2.536 . . . . 74.53 111.141 175.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 125.56 -28.07 5.08 Favored Glycine 0 CA--C 1.507 -0.458 0 N-CA-C 111.205 -0.758 . . . . 70.43 111.205 176.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 87.9 mtp -94.77 144.21 25.82 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 105.229 -2.137 . . . . 64.15 105.229 162.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 171.4 -124.79 1.14 Allowed Glycine 0 CA--C 1.498 -0.995 0 C-N-CA 121.724 -0.274 . . . . 73.33 112.434 175.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -68.93 160.98 52.11 Favored Glycine 0 C--O 1.245 0.787 0 O-C-N 124.508 0.769 . . . . 74.5 111.967 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.846 ' HB3' ' HA3' ' A' ' 108' ' ' GLY . 14.8 mm100 -68.87 104.58 2.09 Favored 'General case' 0 CA--C 1.55 0.972 0 O-C-N 125.142 1.143 . . . . 75.42 111.706 -169.017 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -171.33 162.57 35.24 Favored Glycine 0 C--N 1.344 1.016 0 CA-C-O 118.762 -1.021 . . . . 64.21 112.182 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' ASN . . . . . 0.622 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . 49.5 t-20 -56.54 -58.69 15.43 Favored Pre-proline 0 N--CA 1.503 2.214 0 CA-C-O 118.288 -0.863 . . . . 63.11 110.571 -171.688 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.622 ' HD3' ' HB3' ' A' ' 169' ' ' ASN . 12.8 Cg_endo -91.6 97.21 0.21 Allowed 'Trans proline' 0 C--N 1.383 2.376 0 N-CA-C 107.779 -1.662 . . . . 71.13 107.779 157.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.43 165.3 3.32 Favored 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 122.502 2.134 . . . . 71.25 113.861 -170.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -69.0 -118.34 0.03 OUTLIER Glycine 0 N--CA 1.484 1.881 0 N-CA-C 115.401 0.92 . . . . 72.4 115.401 -170.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -135.7 118.89 16.56 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 107.667 -1.234 . . . . 71.14 107.667 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 11.2 tp -105.58 132.46 51.71 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.082 0.467 . . . . 64.32 111.303 -166.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 58.9 mt -108.37 94.69 5.2 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 114.915 -1.039 . . . . 72.12 108.445 176.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.594 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 72.2 mt -78.5 93.84 4.85 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.564 -0.744 . . . . 70.05 109.732 -179.572 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.0 t -83.4 96.76 4.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 107.498 -1.297 . . . . 61.43 107.498 176.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 12.8 p -65.76 110.37 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.083 0 CA-C-N 115.009 -0.996 . . . . 70.33 111.032 -172.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.555 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 38.8 mmm-85 -96.88 96.14 8.33 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 114.817 -1.083 . . . . 53.32 109.677 179.301 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.53 ' HB2' ' HB2' ' A' ' 155' ' ' GLU . 29.3 mt -69.59 151.21 46.23 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 122.423 -0.173 . . . . 72.4 110.895 178.34 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 99.3 mt -51.63 143.08 21.64 Favored Pre-proline 0 N--CA 1.481 1.076 0 C-N-CA 124.173 0.989 . . . . 73.14 111.489 -175.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.2 86.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.387 2.582 0 C-N-CA 123.475 2.784 . . . . 71.42 112.407 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.506 ' HA ' ' HD3' ' A' ' 184' ' ' PRO . 16.3 t-80 -136.96 112.69 9.64 Favored Pre-proline 0 CA--C 1.546 0.823 0 N-CA-C 107.0 -1.482 . . . . 73.35 107.0 -178.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.506 ' HD3' ' HA ' ' A' ' 183' ' ' HIS . 14.2 Cg_exo -70.35 27.05 0.19 Allowed 'Trans proline' 0 CA--C 1.556 1.611 0 C-N-CA 124.42 3.413 . . . . 61.24 117.916 -162.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 14.5 t -94.66 -60.08 2.76 Favored 'Isoleucine or valine' 0 C--N 1.364 1.225 0 CA-C-N 121.102 1.774 . . . . 64.21 109.13 177.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 186' ' ' PHE . . . . . 0.434 ' HB3' HD21 ' A' ' 193' ' ' LEU . 48.7 m-85 -109.29 140.92 42.33 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 114.765 1.394 . . . . 72.31 114.765 -164.041 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 7.9 tpp180 -145.13 94.38 2.52 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 126.592 1.957 . . . . 75.51 106.839 172.255 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.519 ' HA ' ' HA ' ' A' ' 193' ' ' LEU . 22.5 tp -75.0 150.24 39.03 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.056 0.942 . . . . 74.21 110.556 173.428 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -131.25 100.15 5.09 Favored 'General case' 0 C--O 1.244 0.805 0 N-CA-C 107.879 -1.156 . . . . 70.31 107.879 167.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 65.92 -87.51 0.11 Allowed Glycine 0 C--N 1.352 1.448 0 CA-C-N 115.522 -0.763 . . . . 65.41 113.412 176.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -107.04 -35.13 6.96 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.078 0.951 . . . . 72.32 110.931 -175.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.448 ' HB2' ' HE1' ' A' ' 250' ' ' TYR . 10.6 p-10 -108.02 125.13 51.19 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-O 121.699 0.762 . . . . 72.32 110.598 -168.524 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.618 HD11 ' HD2' ' A' ' 154' ' ' ARG . 0.4 OUTLIER -91.9 125.7 36.7 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.12 -0.946 . . . . 63.44 108.628 -169.985 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.452 ' HA ' ' HB2' ' A' ' 250' ' ' TYR . 39.3 m-85 -95.97 158.25 15.53 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.837 -0.801 . . . . 73.14 108.837 170.113 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.466 ' HB2' HD11 ' A' ' 249' ' ' LEU . . . -156.05 176.17 13.01 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 123.155 0.582 . . . . 74.34 109.581 -173.559 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 35.6 m -130.51 142.08 50.48 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.824 0.849 . . . . 70.21 108.792 172.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 47.6 tp -135.47 125.21 25.41 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 123.796 0.838 . . . . 72.21 109.526 -174.288 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -82.99 126.2 32.26 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 109.186 -0.672 . . . . 61.43 109.186 170.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 7.5 p -141.19 134.08 14.34 Favored Pre-proline 0 CA--C 1.542 0.662 0 N-CA-C 107.508 -1.293 . . . . 64.4 107.508 175.031 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -78.65 161.22 27.91 Favored 'Trans proline' 0 CA--C 1.545 1.047 0 C-N-CA 121.537 1.491 . . . . 64.51 111.377 169.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.524 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -55.55 -53.89 57.35 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 124.621 1.169 . . . . 71.34 113.899 -171.537 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -67.53 -28.98 37.78 Favored 'Trans proline' 0 C--N 1.384 2.421 0 CA-C-N 120.769 1.31 . . . . 63.54 112.032 -173.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 17.8 mt -73.74 -34.06 39.75 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 C-N-CA 123.632 0.773 . . . . 64.32 110.318 176.276 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.79 -38.61 80.12 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 122.858 0.463 . . . . 71.51 111.389 176.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 201' ' ' ALA . 39.9 t -78.43 -42.93 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 123.096 0.558 . . . . 63.23 111.941 -175.647 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.421 HG11 ' HD2' ' C' ' 270' ' ' LYS . 56.0 t -89.38 -37.81 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 122.507 0.323 . . . . 74.41 111.45 -177.006 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 101.0 105.45 2.8 Favored Glycine 0 C--N 1.337 0.604 0 CA-C-N 116.413 -0.358 . . . . 72.35 112.421 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.434 ' HA3' ' CE1' ' C' ' 277' ' ' TYR . . . -158.69 178.46 34.88 Favored Glycine 0 C--N 1.347 1.152 0 CA-C-N 116.631 0.215 . . . . 55.24 113.163 -178.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.428 ' HE3' ' HB2' ' A' ' 209' ' ' LYS . 38.1 mtmt -79.98 137.38 36.83 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.945 0.498 . . . . 45.21 111.63 -172.554 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.462 HG11 ' HA ' ' A' ' 199' ' ' VAL . 27.5 m -130.45 151.74 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.83 1.252 . . . . 63.11 108.0 167.637 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 43.3 ttp180 -84.18 115.13 22.26 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 110.054 -0.35 . . . . 71.41 110.054 -179.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.29 132.09 47.0 Favored 'General case' 0 C--O 1.245 0.832 0 C-N-CA 123.502 0.721 . . . . 62.04 109.415 174.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 213' ' ' MET . . . . . 0.509 ' SD ' ' N ' ' A' ' 213' ' ' MET . 1.0 OUTLIER -86.37 101.79 13.43 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 107.64 -1.244 . . . . 71.23 107.64 178.931 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 60.2 p -111.23 168.99 9.09 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 108.896 -0.779 . . . . 74.1 108.896 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.736 HD22 ' HB3' ' A' ' 127' ' ' LEU . 7.2 mt -79.14 -6.76 57.28 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 120.865 0.364 . . . . 63.31 111.183 -172.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -100.31 -4.36 29.39 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.697 1.199 . . . . 64.44 110.92 173.438 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 132.67 -175.36 20.02 Favored Glycine 0 C--N 1.351 1.37 0 CA-C-O 120.038 -0.312 . . . . 33.0 113.312 174.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -83.68 101.36 0.92 Allowed 'Trans proline' 0 C--N 1.369 1.628 0 C-N-CA 122.754 2.302 . . . . 70.23 111.155 175.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 34.9 m -101.37 162.2 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 123.151 0.58 . . . . 73.4 109.836 -177.122 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -100.82 112.63 25.09 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 109.397 -0.594 . . . . 75.04 109.397 176.382 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.495 HG13 HD11 ' B' ' 441' ' ' ILE . 76.6 t -93.84 106.3 17.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 107.985 -1.117 . . . . 74.13 107.985 177.382 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -71.91 99.65 2.27 Favored 'General case' 0 C--N 1.347 0.495 0 N-CA-C 107.923 -1.14 . . . . 60.25 107.923 172.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 90.6 t -62.77 133.33 95.04 Favored Pre-proline 0 CA--C 1.543 0.705 0 CA-C-N 114.015 -1.448 . . . . 63.14 109.569 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -58.03 155.63 32.89 Favored 'Trans proline' 0 C--N 1.376 1.986 0 C-N-CA 122.493 2.129 . . . . 75.51 112.614 171.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.33 156.77 64.81 Favored 'Trans proline' 0 C--N 1.372 1.771 0 C-N-CA 121.798 1.665 . . . . 72.53 112.33 172.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 226' ' ' ARG . . . . . 0.435 HH21 ' HG ' ' C' ' 261' ' ' LEU . 1.5 ptp85 43.53 48.45 6.3 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 126.484 1.914 . . . . 74.04 113.047 -178.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 20.1 m -86.63 115.68 24.25 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 113.053 -1.885 . . . . 64.32 109.815 175.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -87.13 147.3 25.7 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.652 0.781 . . . . 75.32 111.291 -175.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -63.65 132.92 52.61 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.884 0.874 . . . . 62.31 110.9 175.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 99.29 -19.82 52.39 Favored Glycine 0 C--N 1.343 0.924 0 CA-C-O 119.612 -0.549 . . . . 73.32 112.902 177.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 30.1 mtm-85 -77.35 158.93 29.87 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 117.289 0.544 . . . . 74.0 110.424 175.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -108.97 123.46 49.15 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.122 0.969 . . . . 72.22 109.883 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.45 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 57.5 mt -77.9 108.3 11.05 Favored 'General case' 0 C--N 1.348 0.542 0 N-CA-C 108.489 -0.93 . . . . 71.4 108.489 173.732 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -88.07 109.37 19.8 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 122.96 0.504 . . . . 64.14 110.927 -178.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.525 ' HG ' ' HB3' ' A' ' 249' ' ' LEU . 0.6 OUTLIER -121.85 111.79 17.55 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.15 0.58 . . . . 61.12 111.577 -179.194 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.456 ' HE3' ' HB3' ' A' ' 248' ' ' ASP . 4.2 mmpt? -52.87 147.92 8.36 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.862 1.265 . . . . 64.43 113.096 174.454 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 101.56 -17.32 55.36 Favored Glycine 0 C--N 1.351 1.377 0 CA-C-N 115.562 -0.745 . . . . 74.2 114.315 173.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.407 ' HB2' ' HB2' ' A' ' 249' ' ' LEU . 73.0 mmtt -104.91 5.75 33.12 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 112.567 0.58 . . . . 73.01 112.567 -175.627 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -100.23 174.81 26.59 Favored Glycine 0 C--N 1.349 1.27 0 N-CA-C 112.383 -0.287 . . . . 74.43 112.383 166.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -100.53 163.92 17.24 Favored Pre-proline 0 N--CA 1.48 1.074 0 C-N-CA 125.155 1.382 . . . . 73.13 112.584 -163.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -46.94 140.63 13.07 Favored 'Trans proline' 0 C--N 1.394 2.952 0 C-N-CA 124.23 3.286 . . . . 73.33 114.563 174.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 175.75 -167.48 39.33 Favored Glycine 0 CA--C 1.534 1.271 0 CA-C-N 115.422 -0.808 . . . . 73.52 112.122 179.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -56.32 -28.81 73.96 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 123.733 2.956 . . . . 70.45 114.439 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -92.83 22.43 4.85 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.562 0.745 . . . . 70.11 111.843 -178.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 78.18 -93.1 1.19 Allowed Glycine 0 C--N 1.348 1.233 0 N-CA-C 109.762 -1.335 . . . . 62.24 109.762 -172.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 30.3 mtp180 -127.19 148.09 50.19 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.88 0.872 . . . . 75.41 108.904 166.182 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -78.32 -157.03 9.64 Favored Glycine 0 CA--C 1.535 1.33 0 CA-C-O 121.637 0.576 . . . . 42.24 113.902 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 248' ' ' ASP . . . . . 0.456 ' HB3' ' HE3' ' A' ' 236' ' ' LYS . 0.4 OUTLIER -134.49 165.0 26.2 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.404 1.081 . . . . 75.44 111.223 -174.96 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.55 HD13 HD13 ' A' ' 193' ' ' LEU . 61.6 tp -100.39 153.31 19.44 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.493 1.117 . . . . 70.31 109.756 178.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.452 ' HB2' ' HA ' ' A' ' 194' ' ' TYR . 62.9 m-85 -128.65 103.6 7.18 Favored 'General case' 0 C--O 1.219 -0.536 0 N-CA-C 108.873 -0.788 . . . . 52.51 108.873 177.441 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.45 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 32.8 mt -90.09 104.16 16.76 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.122 -0.696 . . . . 72.24 109.122 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -77.36 125.27 29.07 Favored 'General case' 0 C--N 1.362 1.141 0 CA-C-O 121.64 0.734 . . . . 75.41 109.933 -176.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 61.1 t -78.76 117.61 24.6 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-N 114.271 -1.331 . . . . 24.43 111.701 -169.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 15.8 mmm-85 -114.49 96.17 5.63 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.126 -1.064 . . . . 73.14 108.126 170.031 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.501 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 69.8 mt -75.44 133.95 30.27 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 CA-C-N 114.86 -1.064 . . . . 74.34 110.12 178.81 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 22.6 p -126.09 -177.95 4.13 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.865 1.266 . . . . 73.43 110.144 178.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 257' ' ' ILE . . . . . 0.538 HG23 HG21 ' C' ' 255' ' ' ILE . 2.4 pp -139.01 159.66 65.93 Favored Pre-proline 0 N--CA 1.491 1.589 0 C-N-CA 123.803 0.841 . . . . 73.4 110.655 -177.563 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -60.96 -9.44 12.06 Favored 'Trans proline' 0 C--N 1.393 2.903 0 C-N-CA 123.112 2.541 . . . . 74.45 115.519 -167.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.485 ' HA ' ' HB3' ' C' ' 226' ' ' ARG . 42.4 mt-10 57.0 -64.92 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 125.824 1.649 . . . . 63.24 114.288 -174.684 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 260' ' ' ARG . . . . . 0.54 ' HB2' ' HG3' ' B' ' 376' ' ' GLU . 0.0 OUTLIER -92.15 157.16 16.87 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 109.326 -0.62 . . . . 75.12 109.326 168.157 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.594 HD13 ' HA ' ' A' ' 266' ' ' GLU . 64.2 mt -141.9 131.47 23.95 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 118.287 0.494 . . . . 55.32 111.237 -178.026 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.46 148.35 52.1 Favored Pre-proline 0 CA--C 1.555 1.143 0 N-CA-C 107.702 -1.222 . . . . 44.34 107.702 167.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 263' ' ' PRO . . . . . 0.521 ' HG3' HD22 ' B' ' 375' ' ' LEU . 56.0 Cg_exo -40.8 -31.82 0.76 Allowed 'Trans proline' 0 C--N 1.392 2.838 0 C-N-CA 124.939 3.76 . . . . 74.33 116.58 -167.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -61.38 -68.08 0.35 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.448 0.699 . . . . 71.44 110.758 176.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 265' ' ' GLU . . . . . 0.543 ' HB2' HD22 ' A' ' 261' ' ' LEU . 1.7 mp0 -67.17 -28.28 67.98 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 123.487 0.492 . . . . 64.2 110.28 -175.541 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 266' ' ' GLU . . . . . 0.594 ' HA ' HD13 ' A' ' 261' ' ' LEU . 8.3 tp10 -50.38 -58.46 5.65 Favored 'General case' 0 C--O 1.253 1.249 0 C-N-CA 124.258 1.023 . . . . 73.45 109.459 171.574 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 267' ' ' ALA . . . . . 0.447 ' O ' ' HG2' ' A' ' 271' ' ' LYS . . . -59.13 -58.43 8.67 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 114.702 -1.135 . . . . 64.12 111.15 177.405 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 10.2 mp -57.6 -45.92 84.69 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 123.852 0.861 . . . . 73.14 112.854 -170.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 63.3 m95 -60.23 -46.92 88.1 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 123.749 0.655 . . . . 75.0 110.805 175.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 270' ' ' LYS . . . . . 0.625 ' HE2' ' HA ' ' C' ' 206' ' ' VAL . 2.2 mptm? -63.05 -34.33 77.35 Favored 'General case' 0 CA--C 1.548 0.874 0 O-C-N 123.727 0.642 . . . . 62.43 112.03 178.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 271' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' A' ' 267' ' ' ALA . 26.4 mmmt -73.96 -40.31 63.12 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 118.084 0.402 . . . . 70.22 110.366 -177.558 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 39.5 mt -57.72 -39.38 77.11 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 123.467 0.707 . . . . 63.4 110.204 170.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -65.97 -45.1 82.92 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 124.129 0.893 . . . . 64.51 112.644 -177.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -67.35 -42.85 82.83 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.811 0.844 . . . . 74.35 110.763 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -62.53 -44.13 97.1 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.38 -0.827 . . . . 71.44 110.231 177.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -63.69 -44.25 94.25 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.415 1.086 . . . . 75.02 109.909 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -62.71 -43.6 98.4 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.82 1.248 . . . . 70.12 109.492 -177.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -75.02 -5.03 41.83 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 115.236 -0.893 . . . . 75.41 112.563 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 43.7 mtm180 -115.38 -0.88 13.01 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.808 0.843 . . . . 74.13 110.08 173.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.1 0 N-CA-C 108.546 -0.909 . . . . 72.21 108.546 178.975 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.476 0.874 0 N-CA-C 109.627 -0.509 . . . . 71.44 109.627 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.408 ' HG2' ' HG3' ' B' ' 3' ' ' GLN . 85.1 tttt 65.43 143.89 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 125.483 1.513 . . . . 54.1 111.906 -176.428 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 3' ' ' GLN . . . . . 0.408 ' HG3' ' HG2' ' B' ' 2' ' ' LYS . 97.4 mt-30 64.64 1.66 1.43 Allowed 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 125.164 1.386 . . . . 74.04 113.479 -178.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 43.3 m -72.57 95.28 1.8 Allowed 'General case' 0 C--N 1.354 0.797 0 C-N-CA 123.468 0.707 . . . . 52.14 109.111 -179.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 5' ' ' THR . . . . . 0.44 HG21 ' HB ' ' A' ' 137' ' ' VAL . 0.1 OUTLIER -83.39 160.85 21.53 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.418 -0.81 . . . . 70.11 111.102 -171.879 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.627 HG21 ' HA ' ' A' ' 125' ' ' LEU . 38.5 pt -130.34 168.89 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 112.943 0.72 . . . . 64.44 112.943 -154.291 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -145.25 124.78 13.17 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.82 0.848 . . . . 72.01 108.975 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.532 HD23 HG21 ' A' ' 140' ' ' VAL . 60.7 tp -63.53 138.3 58.46 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.066 0.946 . . . . 75.22 110.894 -174.621 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.52 -48.63 80.9 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 124.183 0.927 . . . . 62.4 111.074 177.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 6.1 tt 53.67 89.79 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.155 0 O-C-N 124.53 1.144 . . . . 74.1 108.957 -172.047 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 91.7 mt -66.44 112.06 8.36 Favored Pre-proline 0 CA--C 1.547 0.833 0 N-CA-C 110.045 -0.354 . . . . 45.35 110.045 -176.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -83.85 -152.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.373 1.826 0 C-N-CA 122.839 2.36 . . . . 61.33 111.969 -173.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 13' ' ' LEU . . . . . 0.611 HD23 ' H ' ' B' ' 13' ' ' LEU . 2.6 pt? -87.78 19.86 3.29 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 123.044 0.538 . . . . 75.01 111.079 175.385 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 6.0 tt -153.15 100.09 2.44 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 107.62 -1.252 . . . . 64.54 107.62 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -159.88 17.16 0.15 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.353 0.661 . . . . 60.01 111.122 175.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 16' ' ' THR . . . . . 0.549 HG23 HG22 ' B' ' 18' ' ' VAL . 9.5 t -70.93 140.48 86.13 Favored Pre-proline 0 CA--C 1.561 1.397 0 C-N-CA 123.28 0.632 . . . . 51.11 111.437 -175.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -80.12 24.54 0.64 Allowed 'Trans proline' 0 C--N 1.386 2.531 0 C-N-CA 123.428 2.752 . . . . 62.42 114.234 -175.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.549 HG22 HG23 ' B' ' 16' ' ' THR . 32.7 m -68.01 -14.4 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 123.494 0.718 . . . . 61.41 111.998 176.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 9.9 t -63.63 -21.02 66.14 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.841 0.856 . . . . 71.22 111.814 174.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -111.44 46.21 1.13 Allowed 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 124.155 0.982 . . . . 62.34 108.555 175.155 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.1 -34.46 77.68 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 115.738 -0.665 . . . . 75.34 111.304 177.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.52 75.98 5.86 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 121.616 0.722 . . . . 73.31 109.292 177.656 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 23' ' ' THR . . . . . 0.469 ' HB ' ' HD3' ' B' ' 24' ' ' PRO . 73.7 m -88.86 -47.25 0.43 Allowed Pre-proline 0 CA--C 1.556 1.199 0 N-CA-C 108.605 -0.887 . . . . 72.45 108.605 162.334 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 24' ' ' PRO . . . . . 0.518 ' HA ' ' NH1' ' C' ' 154' ' ' ARG . 84.4 Cg_endo -92.84 101.43 0.16 Allowed 'Trans proline' 0 C--N 1.391 2.814 0 C-N-CA 121.803 1.669 . . . . 74.55 111.578 167.571 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -76.13 -72.76 0.31 Allowed 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.072 -0.714 . . . . 74.53 109.072 175.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 26' ' ' MET . . . . . 0.414 ' HB2' ' NH2' ' C' ' 154' ' ' ARG . 15.4 tmm? 58.92 88.87 0.12 Allowed Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 125.036 1.334 . . . . 75.13 110.844 -178.659 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_exo -47.55 115.61 1.48 Allowed 'Trans proline' 0 C--N 1.372 1.809 0 C-N-CA 122.568 2.179 . . . . 71.1 111.107 164.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 7.7 p -70.95 76.19 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.392 0 CA-C-O 123.221 1.486 . . . . 73.51 111.588 -172.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -121.69 90.32 3.29 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 113.968 -1.469 . . . . 62.2 107.489 177.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -134.71 -74.76 0.47 Allowed 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 107.455 -1.313 . . . . 70.24 107.455 177.443 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 43.7 t30 56.19 -84.33 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 124.576 1.15 . . . . 74.34 111.447 -178.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -137.9 85.94 2.14 Favored 'General case' 0 C--N 1.351 0.636 0 C-N-CA 124.989 1.316 . . . . 72.22 108.157 177.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.42 79.57 8.83 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 109.08 -0.711 . . . . 73.31 109.08 175.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -93.16 -3.3 54.2 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.861 0.865 . . . . 53.33 112.043 -175.002 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -79.35 83.0 5.43 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-O 122.162 0.982 . . . . 73.13 111.121 179.255 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -148.98 -128.78 1.72 Allowed Glycine 0 C--N 1.338 0.666 0 N-CA-C 108.407 -1.877 . . . . 74.33 108.407 172.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 29.8 t70 64.16 -70.81 0.07 Allowed 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 125.068 1.347 . . . . 61.44 113.026 168.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 36.1 mm -67.56 -26.66 36.07 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.968 0 C-N-CA 124.066 0.946 . . . . 75.44 110.902 176.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 42.9 p -62.25 89.76 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 123.588 0.755 . . . . 64.25 112.328 -176.248 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -164.02 98.46 0.94 Allowed Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 124.537 1.135 . . . . 64.0 108.041 -178.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -72.44 85.09 1.11 Allowed 'Trans proline' 0 C--N 1.372 1.783 0 C-N-CA 123.058 2.505 . . . . 72.44 112.566 -178.163 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -78.29 140.12 23.34 Favored Glycine 0 C--N 1.347 1.161 0 CA-C-N 115.641 -0.709 . . . . 45.24 111.904 177.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.27 -24.63 29.42 Favored Glycine 0 C--N 1.346 1.105 0 CA-C-O 119.765 -0.464 . . . . 42.15 112.363 -175.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . 65.45 4.2 2.65 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 124.931 1.293 . . . . 63.2 113.507 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 31.0 tpt180 61.4 -74.22 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 125.392 1.477 . . . . 74.21 111.598 -170.191 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 46' ' ' ARG . . . . . 0.469 ' HG2' ' HB1' ' B' ' 234' ' ' ALA . 17.3 tpp180 -142.9 -81.81 0.19 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.61 0.764 . . . . 75.02 109.628 -171.52 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 8.9 mp 54.8 -88.0 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 123.716 0.806 . . . . 53.22 110.991 -167.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 92.9 m 71.42 -47.0 0.65 Allowed 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 125.632 1.573 . . . . 51.22 112.812 -176.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.94 64.15 3.73 Favored Glycine 0 C--N 1.347 1.175 0 C-N-CA 123.243 0.449 . . . . 74.15 113.542 178.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -136.69 -11.18 1.81 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.618 1.167 . . . . 64.2 109.797 176.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 51' ' ' GLN . . . . . 0.412 HE22 HG21 ' B' ' 122' ' ' THR . 57.0 tp60 67.13 80.38 0.22 Allowed 'General case' 0 C--N 1.362 1.11 0 C-N-CA 124.97 1.308 . . . . 75.3 109.93 -175.551 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 18.3 m -83.23 78.15 9.66 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.399 0.68 . . . . 73.31 110.083 -178.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . 58.41 -82.52 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 125.204 1.402 . . . . 73.24 111.7 -178.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . 55.64 -88.0 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.233 1.413 . . . . 75.51 112.605 174.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.546 ' HB3' ' HG3' ' B' ' 350' ' ' LYS . 0.6 OUTLIER 72.14 -49.58 0.69 Allowed 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 126.071 1.748 . . . . 72.35 111.412 -177.404 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 36.1 ttm180 77.2 144.56 0.08 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 125.18 1.392 . . . . 73.2 110.889 172.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 26.2 t70 66.43 -99.53 0.06 Allowed 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 124.6 1.16 . . . . 75.31 110.745 -174.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 26.2 p -179.39 -79.41 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.226 1.011 . . . . 62.01 109.768 -174.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 92.6 mt -142.68 -77.51 0.25 Allowed 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 107.911 -1.144 . . . . 72.44 107.911 -174.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 49.2 m 51.32 -79.18 0.01 OUTLIER 'General case' 0 C--N 1.366 1.283 0 C-N-CA 125.665 1.586 . . . . 63.51 113.466 -177.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -84.4 170.81 13.19 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.875 0.87 . . . . 71.45 112.243 -171.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 79.5 65.36 0.18 Allowed Pre-proline 0 C--N 1.351 0.668 0 C-N-CA 126.844 2.058 . . . . 72.3 108.578 -178.405 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 63' ' ' PRO . . . . . 0.587 ' HB2' ' HB1' ' B' ' 295' ' ' ALA . 35.6 Cg_endo -86.01 41.2 0.82 Allowed 'Trans proline' 0 C--N 1.378 2.079 0 C-N-CA 123.739 2.959 . . . . 72.24 111.543 -173.311 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -138.94 -24.96 0.89 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.537 1.135 . . . . 72.04 110.769 -172.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.5 ' HG3' ' H ' ' B' ' 66' ' ' ASN 0.257 21.3 ptmt 46.79 -77.48 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.316 0 C-N-CA 125.829 1.652 . . . . 65.32 113.109 -169.211 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 66' ' ' ASN . . . . . 0.5 ' H ' ' HG3' ' B' ' 65' ' ' LYS . 45.6 t30 -80.11 -65.4 1.01 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.638 0.775 . . . . 72.41 109.263 175.259 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 4.0 tt -175.11 34.87 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.563 1.47 0 N-CA-C 107.621 -1.251 . . . . 72.03 107.621 -173.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 78.4 mt 72.56 -58.36 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 C-N-CA 126.01 1.724 . . . . 73.4 109.994 -168.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 67.7 mt -74.02 148.79 41.67 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.287 1.035 . . . . 73.12 110.509 175.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 3.2 tt -166.83 90.8 0.4 Allowed 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 109.434 -0.58 . . . . 44.44 109.434 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 71' ' ' ILE . . . . . 0.638 HG23 ' H ' ' B' ' 73' ' ' ASP . 9.0 tp 175.17 -25.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 C-N-CA 125.535 1.534 . . . . 74.32 108.884 169.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.89 -36.32 3.26 Favored Glycine 0 C--N 1.341 0.819 0 N-CA-C 108.981 -1.648 . . . . 62.21 108.981 -172.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 73' ' ' ASP . . . . . 0.638 ' H ' HG23 ' B' ' 71' ' ' ILE . 5.0 m-20 72.6 23.96 2.93 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.587 1.555 . . . . 63.44 113.608 161.679 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -80.36 55.3 4.62 Favored Glycine 0 C--N 1.349 1.27 0 N-CA-C 110.758 -0.937 . . . . 64.42 110.758 164.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 14.4 tpt -162.42 18.24 0.09 Allowed 'General case' 0 CA--C 1.559 1.318 0 C-N-CA 124.796 1.239 . . . . 74.01 108.657 -170.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . -62.68 -40.56 99.33 Favored Glycine 0 C--N 1.361 1.964 0 CA-C-N 116.055 -0.52 . . . . 71.13 112.493 -177.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 32.0 t70 69.65 -73.05 0.1 Allowed 'General case' 0 C--N 1.357 0.894 0 C-N-CA 125.448 1.499 . . . . 73.03 113.085 167.246 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 34.1 m -90.53 -78.85 0.37 Allowed 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.353 0.661 . . . . 51.1 111.745 -174.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 79' ' ' GLU . . . . . 0.423 ' HA ' ' HB3' ' B' ' 82' ' ' ALA . 0.0 OUTLIER -148.22 -159.02 0.97 Allowed 'General case' 0 N--CA 1.485 1.324 0 CA-C-O 118.704 -0.665 . . . . 74.44 109.712 -174.664 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 80' ' ' ILE . . . . . 0.533 HG13 ' H ' ' B' ' 81' ' ' THR 0.296 49.7 pt 54.14 -69.47 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 C-N-CA 127.372 2.269 . . . . 72.52 114.028 179.987 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 81' ' ' THR . . . . . 0.533 ' H ' HG13 ' B' ' 80' ' ' ILE . 32.7 m -66.43 -36.3 82.46 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.251 0.62 . . . . 71.34 109.63 171.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 82' ' ' ALA . . . . . 0.423 ' HB3' ' HA ' ' B' ' 79' ' ' GLU . . . -67.08 -36.46 82.03 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.094 0.957 . . . . 61.11 111.337 174.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.64 -25.66 64.04 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.543 0.737 . . . . 71.35 111.066 176.166 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 56.7 ttt180 68.48 -79.22 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.214 1.406 . . . . 73.0 111.766 173.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -158.42 19.7 0.23 Allowed 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.227 0.611 . . . . 72.23 110.573 -179.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 61.2 t80 69.96 -70.96 0.13 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.829 1.252 . . . . 63.12 110.443 -169.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . 66.65 -77.9 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.78 1.232 . . . . 52.24 110.987 -179.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -125.5 149.36 48.34 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.901 0.881 . . . . 74.14 109.416 178.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 167.72 -0.42 0.04 OUTLIER Glycine 0 C--N 1.342 0.897 0 CA-C-O 119.242 -0.754 . . . . 54.33 113.423 177.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . 74.94 -60.13 0.53 Allowed 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 125.386 1.474 . . . . 62.33 112.355 177.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 91' ' ' GLY . . . . . 0.471 ' HA2' ' HE1' ' B' ' 94' ' ' PHE . . . -82.23 66.53 3.86 Favored Glycine 0 C--N 1.351 1.368 0 C-N-CA 123.206 0.431 . . . . 70.11 113.516 -178.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -98.96 51.36 1.16 Allowed Glycine 0 C--N 1.342 0.916 0 CA-C-O 119.885 -0.397 . . . . 23.53 112.198 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 66.8 125.59 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 125.277 1.431 . . . . 74.22 112.231 -177.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 94' ' ' PHE . . . . . 0.471 ' HE1' ' HA2' ' B' ' 91' ' ' GLY . 71.3 m-85 -125.98 -170.34 2.17 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.052 0.941 . . . . 71.21 110.278 -178.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt 67.92 -82.45 0.03 OUTLIER 'General case' 0 C--N 1.363 1.158 0 C-N-CA 125.395 1.478 . . . . 74.14 110.561 -178.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 173.58 65.18 0.05 OUTLIER Glycine 0 C--N 1.332 0.36 0 N-CA-C 109.299 -1.521 . . . . 72.31 109.299 -175.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 97' ' ' ILE . . . . . 0.409 HG13 ' H ' ' B' ' 99' ' ' ALA . 10.8 tp -62.72 146.18 12.87 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 C-N-CA 123.706 0.802 . . . . 72.22 110.802 -177.448 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -77.37 3.52 12.99 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.334 1.053 . . . . 75.21 112.361 -179.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 99' ' ' ALA . . . . . 0.409 ' H ' HG13 ' B' ' 97' ' ' ILE . . . -114.39 95.12 5.11 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.022 0.929 . . . . 61.12 109.484 177.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 93.9 mt -77.19 126.24 85.47 Favored Pre-proline 0 N--CA 1.48 1.027 0 C-N-CA 123.261 0.625 . . . . 74.2 109.759 176.183 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -63.77 133.18 37.99 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 122.749 2.299 . . . . 72.21 111.639 175.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 102' ' ' LEU . . . . . 0.558 HD13 ' HE2' ' B' ' 106' ' ' TYR 0.267 0.1 OUTLIER 38.55 -92.08 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.353 0 C-N-CA 126.568 1.947 . . . . 73.12 113.803 -175.22 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 7.2 m 58.71 -80.97 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 125.046 1.339 . . . . 75.52 112.446 -178.168 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . -75.28 -18.61 79.97 Favored Glycine 0 C--N 1.356 1.647 0 CA-C-O 120.117 -0.268 . . . . 51.35 112.86 -179.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -69.31 -5.33 22.48 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.4 0.68 . . . . 75.22 112.149 177.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 106' ' ' TYR . . . . . 0.558 ' HE2' HD13 ' B' ' 102' ' ' LEU . 76.6 m-85 -81.86 -53.01 6.52 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 123.586 0.754 . . . . 74.44 110.154 169.302 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 50.6 m 69.9 -34.69 0.29 Allowed 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 125.369 1.468 . . . . 63.32 114.002 176.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -61.85 93.44 0.04 OUTLIER 'General case' 0 C--N 1.361 1.081 0 C-N-CA 124.958 1.303 . . . . 71.44 109.804 178.101 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.404 ' H ' ' H ' ' B' ' 110' ' ' ALA . 65.8 t80 176.8 -15.95 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.093 1.757 . . . . 53.33 108.547 -170.083 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 110' ' ' ALA . . . . . 0.581 ' HB2' ' HB2' ' B' ' 282' ' ' ALA . . . -58.21 -49.92 75.37 Favored 'General case' 0 C--N 1.353 0.718 0 C-N-CA 124.44 1.096 . . . . 71.24 111.187 179.283 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -99.38 78.41 2.2 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 107.258 -1.386 . . . . 64.15 107.258 169.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -153.72 71.45 0.87 Allowed 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 108.221 -1.029 . . . . 73.2 108.221 173.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 113' ' ' LYS . . . . . 0.432 ' HG2' ' O ' ' B' ' 256' ' ' TYR . 16.5 tppt? -164.62 -82.96 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 114.576 -1.193 . . . . 75.13 109.221 174.406 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -168.19 110.53 0.58 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.128 0.571 . . . . 74.01 109.508 -170.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 8.9 m 63.55 155.69 0.06 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 124.648 1.179 . . . . 73.23 112.424 177.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 125.93 -168.97 17.92 Favored Glycine 0 C--N 1.346 1.088 0 N-CA-C 111.522 -0.631 . . . . 55.33 111.522 179.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 117' ' ' LYS . . . . . 0.575 ' HE2' ' HE2' ' B' ' 120' ' ' TYR . 13.8 mmmm -135.82 -56.57 0.02 OUTLIER Pre-proline 0 CA--C 1.566 1.594 0 N-CA-C 114.079 1.14 . . . . 70.25 114.079 -178.152 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 118' ' ' PRO . . . . . 0.708 ' HB2' ' HA ' ' B' ' 281' ' ' PHE . 71.1 Cg_endo -65.26 128.59 20.77 Favored 'Trans proline' 0 C--N 1.389 2.664 0 C-N-CA 122.195 1.93 . . . . 60.53 112.654 -161.267 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 119' ' ' ASP . . . . . . . . . . . . . 20.7 t70 169.47 -41.04 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 125.258 1.423 . . . . 75.33 109.16 -176.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 120' ' ' TYR . . . . . 0.575 ' HE2' ' HE2' ' B' ' 117' ' ' LYS . 0.2 OUTLIER -76.33 -153.72 0.05 OUTLIER 'General case' 0 CA--C 1.558 1.251 0 CA-C-N 113.654 -1.612 . . . . 70.1 112.455 -175.729 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 121' ' ' VAL . . . . . 0.485 ' HB ' ' H ' ' B' ' 221' ' ' ARG . 7.6 p -135.89 114.3 15.4 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.162 0 C-N-CA 124.075 0.95 . . . . 74.32 109.463 165.142 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 122' ' ' THR . . . . . 0.412 HG21 HE22 ' B' ' 51' ' ' GLN . 1.4 m 64.96 24.57 12.67 Favored 'General case' 0 CA--C 1.566 1.567 0 C-N-CA 124.915 1.286 . . . . 75.24 113.454 168.167 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 67.63 -79.36 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 C-N-CA 124.647 1.179 . . . . 64.3 111.828 174.391 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 41.4 t -70.04 -55.34 9.79 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 125.087 1.355 . . . . 43.31 110.642 -175.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . 68.85 -64.26 0.33 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 125.381 1.473 . . . . 73.02 112.366 178.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -129.94 13.92 5.78 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.772 0.829 . . . . 74.13 111.177 177.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 30.8 t 62.94 86.78 0.11 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.408 1.083 . . . . 70.01 111.357 -179.056 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . 68.69 -73.36 0.09 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 125.247 1.419 . . . . 72.01 111.387 -175.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 12.6 t -156.67 5.33 0.16 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.219 1.008 . . . . 54.34 110.29 176.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . 55.88 -87.29 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.177 1.391 . . . . 44.22 111.327 -168.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 3.6 p90 -164.43 164.38 22.03 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.944 1.297 . . . . 73.51 109.245 -175.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 15.0 m -86.4 92.46 8.84 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.082 0.553 . . . . 51.4 110.083 -179.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 12.9 m 70.79 97.02 0.07 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.915 1.286 . . . . 62.25 111.561 175.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . -167.49 159.54 32.89 Favored Glycine 0 C--N 1.346 1.114 0 CA-C-O 119.763 -0.465 . . . . 55.15 112.788 176.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 135' ' ' VAL . . . . . . . . . . . . . 61.9 t 61.65 -81.46 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 125.113 1.365 . . . . 73.24 111.413 -178.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 136' ' ' LYS . . . . . 0.434 ' HB3' ' HD2' ' B' ' 138' ' ' TYR . 60.8 tttp -79.96 -21.26 43.96 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.064 0.546 . . . . 52.43 110.648 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 19.3 m 77.5 -44.5 0.43 Allowed 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 125.021 1.329 . . . . 75.31 111.09 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 138' ' ' TYR . . . . . 0.434 ' HD2' ' HB3' ' B' ' 136' ' ' LYS 0.25 3.6 p90 47.78 -80.24 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 127.043 2.137 . . . . 75.52 114.756 170.577 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -69.46 -24.44 63.79 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 122.97 0.508 . . . . 73.24 111.272 -176.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . 98.51 -77.32 0.56 Allowed Glycine 0 C--N 1.351 1.362 0 O-C-N 123.974 0.796 . . . . 65.04 112.334 176.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . 64.9 -76.62 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 125.082 1.353 . . . . 75.34 112.009 -178.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 2.0 pp -108.26 -10.07 15.42 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.712 0.805 . . . . 70.15 111.529 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -124.51 167.23 16.87 Favored Glycine 0 C--N 1.353 1.487 0 C-N-CA 123.658 0.647 . . . . 61.25 112.09 178.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 7.8 p 39.6 43.26 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 C-N-CA 126.126 1.77 . . . . 75.31 112.417 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -66.91 104.39 1.35 Allowed 'General case' 0 C--O 1.244 0.782 0 CA-C-N 114.899 -1.046 . . . . 64.3 108.364 -178.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 73.3 mt 72.63 -63.16 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 125.337 1.455 . . . . 72.52 110.794 -174.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 25.7 t-80 -159.39 -61.57 0.07 Allowed 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 121.051 0.453 . . . . 72.43 110.134 -178.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 148' ' ' GLU . . . . . 0.417 ' HA ' ' HB3' ' B' ' 151' ' ' HIS . 40.6 mm-40 -110.59 -117.18 0.3 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.758 0.823 . . . . 73.05 109.424 -175.19 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 149' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt 69.01 -69.31 0.16 Allowed 'General case' 0 C--N 1.369 1.435 0 C-N-CA 125.517 1.527 . . . . 72.23 111.879 175.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -86.08 -37.35 18.93 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.455 0.702 . . . . 74.11 110.94 174.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 151' ' ' HIS . . . . . 0.417 ' HB3' ' HA ' ' B' ' 148' ' ' GLU . 30.9 t-80 -64.78 105.72 0.8 Allowed Pre-proline 0 CA--C 1.557 1.224 0 C-N-CA 124.636 1.174 . . . . 74.43 111.52 -174.563 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -93.7 -31.2 0.07 OUTLIER 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 122.992 2.461 . . . . 42.51 114.452 -175.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 21.7 p -103.82 99.18 8.95 Favored 'General case' 0 C--N 1.349 0.546 0 C-N-CA 123.77 0.828 . . . . 74.2 110.493 -170.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 3.1 mp -90.62 -29.86 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-N 115.294 -0.866 . . . . 74.25 109.51 174.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 93.8 mt -65.32 85.09 0.06 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.5 0.72 . . . . 72.1 111.617 -176.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 60.35 103.18 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.774 1.63 . . . . 72.23 112.423 176.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 157' ' ' MET . . . . . 0.446 ' HB3' ' HG2' ' B' ' 207' ' ' LYS . 1.9 mpt? -71.36 -21.69 62.0 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.626 0.77 . . . . 53.54 110.766 176.023 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 158' ' ' ALA . . . . . . . . . . . . . . . -69.52 -20.59 63.7 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.067 0.947 . . . . 34.04 111.967 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 33.7 mmtm -53.89 -35.83 62.02 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.941 0.896 . . . . 55.45 111.595 174.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -79.03 74.41 5.56 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.447 0.699 . . . . 70.22 110.285 176.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -87.61 81.92 7.58 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.628 -0.714 . . . . 71.1 109.947 179.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 83.96 -72.11 2.87 Favored Glycine 0 C--N 1.347 1.144 0 CA-C-N 115.772 -0.649 . . . . 73.4 112.716 178.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . 0.274 2.4 pp 59.96 -64.53 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 127.813 2.445 . . . . 65.02 114.082 177.402 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 164' ' ' ALA . . . . . . . . . . . . . . . -90.76 -6.36 54.48 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.25 0.62 . . . . 75.34 111.825 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 50.3 p -72.23 86.55 1.09 Allowed 'General case' 0 CA--C 1.548 0.88 0 CA-C-O 121.706 0.765 . . . . 64.15 111.193 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . -153.53 101.62 0.21 Allowed Glycine 0 C--N 1.337 0.609 0 N-CA-C 110.548 -1.021 . . . . 71.15 110.548 179.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 167' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 58.36 27.28 15.14 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.856 1.263 . . . . 72.31 111.864 -178.134 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 9.9 m -72.15 93.69 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-N 115.454 -0.794 . . . . 74.13 109.299 176.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 48.7 m 70.85 11.09 7.1 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.114 1.366 . . . . 54.35 111.907 -174.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 22.6 m 62.22 144.41 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 125.497 1.519 . . . . 63.1 112.591 -176.005 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -63.72 -56.84 12.55 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.877 0.471 . . . . 53.32 110.133 175.134 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 172' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.61 -36.18 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.706 0.802 . . . . 73.22 109.601 173.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 173' ' ' LEU . . . . . . . . . . . . . 28.9 tp -159.3 144.94 16.1 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.808 0.843 . . . . 74.23 109.571 179.031 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 174' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 65.62 -82.41 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.487 1.515 . . . . 74.45 112.907 176.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 175' ' ' ASP . . . . . . . . . . . . . 10.4 t70 57.23 -83.1 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 124.387 1.075 . . . . 74.1 108.853 -164.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . 57.95 19.61 6.01 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 124.952 1.301 . . . . 74.11 113.548 171.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 8.7 m -78.95 -54.79 1.01 Allowed Pre-proline 0 CA--C 1.564 1.509 0 C-N-CA 123.428 0.691 . . . . 64.31 112.648 -172.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 178' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -82.23 174.18 10.19 Favored 'Trans proline' 0 C--N 1.387 2.574 0 C-N-CA 122.097 1.864 . . . . 74.53 114.023 -166.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . 76.66 -39.65 0.35 Allowed 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 126.197 1.799 . . . . 61.34 114.308 169.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . 54.54 48.45 20.41 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.838 0.828 . . . . 74.4 109.088 -168.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 31.2 tp 62.25 -77.56 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.28 0 CA-C-N 113.277 -1.783 . . . . 62.04 111.584 -166.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 182' ' ' VAL . . . . . 0.667 ' HA ' ' HB3' ' C' ' 123' ' ' LEU . 91.3 t -96.5 141.3 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 123.839 0.856 . . . . 71.31 111.364 -175.386 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -134.8 8.05 3.52 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.5 0.72 . . . . 65.24 112.708 -176.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 184' ' ' HIS . . . . . 0.438 ' HD2' ' HB3' ' C' ' 122' ' ' GLU . 80.0 t60 -145.44 152.33 39.64 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 118.104 0.411 . . . . 74.15 110.371 179.534 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 185' ' ' VAL . . . . . . . . . . . . . 71.4 t 76.44 -50.48 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 C-N-CA 126.124 1.77 . . . . 71.33 110.439 -170.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 1.9 t -156.21 123.68 5.47 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.191 0.996 . . . . 51.31 110.529 -174.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 187' ' ' SER . . . . . . . . . . . . . 22.5 t 174.05 166.26 0.21 Allowed 'General case' 0 C--O 1.244 0.77 0 C-N-CA 125.197 1.399 . . . . 62.14 108.539 174.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 52.3 ttt180 -83.33 77.86 9.73 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 107.691 -1.226 . . . . 71.52 107.691 171.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -155.2 137.31 14.7 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 106.743 -1.577 . . . . 72.52 106.743 -170.248 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 190' ' ' CYS . . . . . . . . . . . . . 66.6 m -72.39 94.0 1.59 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 122.982 0.513 . . . . 70.33 110.651 -177.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 191' ' ' TYR . . . . . 0.567 ' HA ' ' HA ' ' B' ' 197' ' ' SER . 7.8 p90 -129.47 164.89 22.72 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.078 0.951 . . . . 74.04 109.958 -175.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 58.06 -103.16 0.3 Allowed Glycine 0 C--N 1.351 1.368 0 O-C-N 124.481 1.113 . . . . 64.22 114.391 165.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 193' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -55.97 -23.37 42.91 Favored 'Trans proline' 0 C--N 1.388 2.636 0 C-N-CA 123.572 2.848 . . . . 64.32 113.082 176.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 194' ' ' SER . . . . . . . . . . . . . 50.5 m -86.55 72.29 10.28 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 109.228 -0.656 . . . . 24.51 109.228 171.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 195' ' ' ALA . . . . . . . . . . . . . . . 61.45 -80.63 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 125.22 1.408 . . . . 74.32 113.157 175.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 97.3 m -127.51 146.54 50.47 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.884 1.274 . . . . 73.32 109.527 -176.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 197' ' ' SER . . . . . 0.567 ' HA ' ' HA ' ' B' ' 191' ' ' TYR . 11.1 t -84.72 -83.12 0.16 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 122.907 0.483 . . . . 75.11 110.99 -178.522 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 198' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -101.3 175.09 5.7 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 122.882 0.473 . . . . 51.12 109.966 -178.043 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp 72.04 -65.74 0.34 Allowed 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 125.354 1.462 . . . . 74.4 112.902 174.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 200' ' ' CYS . . . . . 0.433 ' SG ' ' HB3' ' B' ' 203' ' ' ASN . 42.4 t 58.91 62.07 4.45 Favored Pre-proline 0 CA--C 1.556 1.205 0 C-N-CA 124.469 1.108 . . . . 73.31 109.911 -174.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 201' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.45 -26.18 24.6 Favored 'Trans proline' 0 C--N 1.383 2.342 0 C-N-CA 123.082 2.522 . . . . 71.34 113.29 -166.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . -71.65 -31.0 65.61 Favored Glycine 0 C--N 1.352 1.428 0 O-C-N 123.386 0.429 . . . . 63.04 112.296 178.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 203' ' ' ASN . . . . . 0.433 ' HB3' ' SG ' ' B' ' 200' ' ' CYS . 44.6 t-20 -94.39 64.37 3.13 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 108.417 -0.957 . . . . 71.33 108.417 175.432 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -92.43 86.23 5.6 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 108.431 -0.951 . . . . 74.01 108.431 175.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 205' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -86.97 65.8 9.14 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.949 0.881 . . . . 51.03 109.982 -174.378 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -83.49 136.35 34.32 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 114.24 -1.345 . . . . 62.32 109.611 175.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 207' ' ' LYS . . . . . 0.535 ' HB2' ' HA ' ' B' ' 210' ' ' LYS . 82.8 mttt -91.74 7.26 42.59 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.795 0.838 . . . . 74.32 110.753 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 72.75 -100.03 0.97 Allowed Glycine 0 C--N 1.352 1.441 0 O-C-N 123.385 0.428 . . . . 71.52 112.041 -177.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . -81.08 5.1 67.7 Favored Glycine 0 C--N 1.351 1.39 0 CA-C-O 119.545 -0.586 . . . . 42.21 113.034 177.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 210' ' ' LYS . . . . . 0.535 ' HA ' ' HB2' ' B' ' 207' ' ' LYS . 29.2 mmtp 51.98 75.1 0.23 Allowed 'General case' 0 C--N 1.364 1.203 0 C-N-CA 125.741 1.616 . . . . 74.51 110.904 174.271 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . 68.0 63.19 3.77 Favored Glycine 0 C--N 1.354 1.546 0 N-CA-C 110.787 -0.925 . . . . 74.43 110.787 -172.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 39.5 p -56.38 -72.15 0.08 Allowed 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 124.106 0.962 . . . . 74.04 112.636 -167.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 213' ' ' ILE . . . . . 0.462 ' HA ' HD23 ' B' ' 217' ' ' LEU . 0.2 OUTLIER -137.87 157.04 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 C-N-CA 123.528 0.731 . . . . 64.4 110.531 178.487 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 40.7 p -123.88 -61.35 1.38 Allowed 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 107.573 -1.269 . . . . 75.43 107.573 172.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 215' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -105.13 -61.85 1.42 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.064 0.946 . . . . 73.31 108.565 166.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 216' ' ' GLN . . . . . 0.423 ' HB3' ' HA ' ' B' ' 65' ' ' LYS . 13.0 pt20 -155.31 -45.56 0.08 Allowed 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.055 -0.975 . . . . 61.42 110.945 -173.166 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 217' ' ' LEU . . . . . 0.462 HD23 ' HA ' ' B' ' 213' ' ' ILE . 3.8 mm? 60.67 -179.5 0.1 Allowed 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.254 1.022 . . . . 75.4 110.756 -166.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 63.7 tp 77.1 -40.79 0.37 Allowed 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 125.132 1.373 . . . . 71.43 112.208 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 69.18 -74.49 0.08 Allowed 'General case' 0 C--N 1.359 0.996 0 C-N-CA 125.329 1.452 . . . . 71.24 110.359 -173.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . 65.36 113.86 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.319 1.447 . . . . 61.1 111.508 176.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 221' ' ' ARG . . . . . 0.485 ' H ' ' HB ' ' B' ' 121' ' ' VAL . 44.7 mtm180 65.7 -167.41 0.21 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 124.797 1.239 . . . . 73.55 110.052 -174.125 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . 72.69 -17.6 0.39 Allowed 'General case' 0 N--CA 1.505 2.291 0 C-N-CA 124.801 1.24 . . . . 42.52 113.75 175.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -60.23 -39.12 85.55 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.424 0.689 . . . . 61.02 109.58 177.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 18.7 m 48.67 -154.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 C-N-CA 125.765 1.626 . . . . 74.2 112.257 174.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 19.3 m 83.37 -66.15 0.08 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.166 1.386 . . . . 54.34 111.669 166.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 28.8 mt -73.52 156.86 37.72 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 122.643 0.377 . . . . 74.43 111.823 -170.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 227' ' ' GLY . . . . . 0.451 ' HA2' ' HD3' ' B' ' 118' ' ' PRO . . . -144.02 -71.69 0.02 OUTLIER Glycine 0 C--N 1.341 0.823 0 CA-C-N 115.493 -0.776 . . . . 51.31 111.21 -179.098 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . -103.67 23.27 33.18 Favored Glycine 0 C--N 1.347 1.158 0 CA-C-O 119.846 -0.419 . . . . 72.41 112.48 176.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -79.05 64.88 3.65 Favored Glycine 0 C--N 1.356 1.691 0 C-N-CA 123.108 0.385 . . . . 70.24 112.256 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 230' ' ' ALA . . . . . 0.482 ' HB2' ' HD3' ' B' ' 117' ' ' LYS . . . -122.1 -152.9 0.53 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.893 1.277 . . . . 70.23 108.071 -175.606 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 231' ' ' LYS . . . . . 0.47 ' HD2' ' HB3' ' B' ' 230' ' ' ALA . 0.1 OUTLIER 57.31 46.53 18.32 Favored 'General case' 0 C--N 1.361 1.102 0 C-N-CA 124.143 0.977 . . . . 73.24 110.06 175.025 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 232' ' ' THR . . . . . 0.584 ' HA ' ' SG ' ' B' ' 358' ' ' CYS . 26.4 p -66.23 85.44 0.1 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.144 0.978 . . . . 74.24 112.158 -170.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -91.93 126.1 36.88 Favored 'General case' 0 C--N 1.351 0.631 0 N-CA-C 108.313 -0.995 . . . . 70.41 108.313 175.215 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 234' ' ' ALA . . . . . 0.469 ' HB1' ' HG2' ' B' ' 46' ' ' ARG . . . -177.05 119.84 0.12 Allowed 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 108.547 -0.908 . . . . 72.31 108.547 -176.316 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 235' ' ' GLU . . . . . 0.716 ' HA ' ' HE2' ' C' ' 209' ' ' LYS . 43.4 mt-10 -132.77 169.18 17.08 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 121.475 0.655 . . . . 54.41 112.66 -177.102 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 236' ' ' THR . . . . . . . . . . . . . 5.0 t -167.18 115.89 0.82 Allowed 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 113.831 -1.531 . . . . 73.34 108.116 175.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -89.14 52.68 2.45 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 121.732 0.777 . . . . 71.12 111.02 -177.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 8.9 m -78.69 -17.7 55.51 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-N 115.047 -0.979 . . . . 71.31 109.562 172.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 239' ' ' ALA . . . . . 0.518 ' HB2' ' HA ' ' C' ' 221' ' ' VAL . . . -67.91 -179.36 1.17 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.345 1.058 . . . . 74.42 111.964 176.426 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 240' ' ' GLY . . . . . 0.469 ' HA3' ' O ' ' C' ' 234' ' ' ARG . . . -103.38 -114.09 3.89 Favored Glycine 0 C--N 1.343 0.956 0 CA-C-O 119.718 -0.49 . . . . 71.23 111.903 -176.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -149.99 142.55 24.47 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.217 0.607 . . . . 71.21 111.087 -178.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -179.63 117.25 0.06 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 125.279 1.432 . . . . 70.32 108.971 173.661 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 65.36 -79.48 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 125.068 1.347 . . . . 74.22 113.004 176.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 152.63 100.13 0.19 Allowed Glycine 0 C--N 1.347 1.177 0 N-CA-C 111.699 -0.561 . . . . 63.11 111.699 -177.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.53 110.79 2.43 Favored 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 123.835 0.854 . . . . 75.34 111.48 -178.341 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 6.9 p -145.04 79.83 1.6 Allowed 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 122.885 0.474 . . . . 71.02 111.083 -176.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 247' ' ' LEU . . . . . 0.499 HD23 ' HA2' ' C' ' 208' ' ' GLY . 2.8 pp -68.87 146.12 53.11 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 116.299 -0.41 . . . . 72.51 110.141 169.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 248' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -154.91 109.32 2.97 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.784 -0.45 . . . . 75.15 109.784 177.211 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 177.59 173.07 0.55 Allowed 'General case' 0 N--CA 1.484 1.23 0 O-C-N 125.411 1.695 . . . . 71.33 109.136 161.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -160.93 114.69 2.04 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.027 0.531 . . . . 65.4 109.973 -174.042 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 251' ' ' ALA . . . . . . . . . . . . . . . -100.05 94.4 6.24 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.936 0.895 . . . . 61.03 110.11 175.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 6.0 pm0 -138.28 0.96 2.16 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.219 1.008 . . . . 72.3 109.575 174.074 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -75.8 89.21 2.86 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.617 0.767 . . . . 51.41 110.827 -170.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 28.6 tpt180 70.72 124.98 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 125.624 1.57 . . . . 72.51 111.928 175.109 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -117.38 108.92 1.78 Allowed Glycine 0 C--N 1.355 1.626 0 CA-C-O 119.635 -0.536 . . . . 54.22 113.127 -173.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 256' ' ' TYR . . . . . 0.432 ' O ' ' HG2' ' B' ' 113' ' ' LYS . 56.3 t80 73.91 -26.69 0.19 Allowed 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 125.828 1.651 . . . . 52.52 113.848 173.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 9.5 mp0 60.76 79.02 0.26 Allowed 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 108.798 -0.816 . . . . 74.31 108.798 -169.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 258' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -50.31 131.59 24.18 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.492 1.117 . . . . 75.13 112.445 -175.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 10.9 m 54.26 9.04 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.408 0 C-N-CA 126.775 2.03 . . . . 63.02 114.702 179.199 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 260' ' ' SER . . . . . . . . . . . . . 33.5 t -93.86 -4.29 50.32 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.693 0.797 . . . . 73.11 110.734 -178.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -64.2 -49.84 70.42 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 123.441 0.697 . . . . 52.21 110.684 178.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 262' ' ' ALA . . . . . . . . . . . . . . . 50.6 27.36 2.88 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 124.995 1.318 . . . . 43.43 112.032 -175.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -114.18 -24.95 8.7 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.073 0.949 . . . . 70.44 111.743 -168.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 34.1 t -153.46 126.75 8.55 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 108.947 -0.76 . . . . 51.14 108.947 -179.096 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 265' ' ' LEU . . . . . 0.471 ' HA ' ' HG3' ' B' ' 270' ' ' GLU . 3.4 tm? 67.14 127.44 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 124.681 1.192 . . . . 64.12 109.811 -174.08 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 266' ' ' ASN . . . . . . . . . . . . . 61.3 t30 63.75 45.15 4.62 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 124.473 1.109 . . . . 71.52 108.975 -171.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 44.4 t -158.29 173.62 16.41 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 114.682 -1.145 . . . . 73.13 109.756 -171.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 53.8 t -62.55 -29.12 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 124.54 1.136 . . . . 74.44 110.68 178.184 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 269' ' ' THR . . . . . . . . . . . . . 21.5 p -109.31 55.31 0.64 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.309 1.044 . . . . 74.31 110.287 176.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 270' ' ' GLU . . . . . 0.471 ' HG3' ' HA ' ' B' ' 265' ' ' LEU . 34.4 tt0 -79.31 -23.78 43.27 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 114.969 -1.014 . . . . 72.41 110.731 174.288 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 271' ' ' ALA . . . . . . . . . . . . . . . -70.68 1.92 4.74 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.871 0.868 . . . . 75.3 111.818 176.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 272' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -57.96 -28.61 64.5 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.254 1.422 . . . . 54.14 110.917 167.255 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 76.79 -20.14 0.39 Allowed 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 125.814 1.645 . . . . 61.32 112.188 175.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 274' ' ' GLN . . . . . 0.482 ' HB3' ' O ' ' B' ' 282' ' ' ALA . 50.8 mt-30 -116.91 168.65 10.05 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 125.582 1.553 . . . . 71.44 109.205 -174.593 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 275' ' ' LYS . . . . . . . . . . . . . 55.4 tttp -154.28 130.61 5.6 Favored Pre-proline 0 N--CA 1.475 0.785 0 N-CA-C 109.477 -0.564 . . . . 71.33 109.477 175.02 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 276' ' ' PRO . . . . . 0.417 ' HB3' ' HA ' ' B' ' 110' ' ' ALA . 59.2 Cg_endo -68.63 154.92 70.52 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 122.43 2.087 . . . . 62.35 110.944 169.509 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 277' ' ' LEU . . . . . 0.629 HD21 ' HB3' ' B' ' 280' ' ' LEU . 2.2 pt? -165.62 171.49 13.03 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.911 0.484 . . . . 63.32 111.27 175.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 2.2 pp -72.32 -6.38 42.87 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.937 0.895 . . . . 62.0 112.695 -177.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . -132.87 -160.01 9.39 Favored Glycine 0 C--N 1.348 1.215 0 N-CA-C 110.774 -0.931 . . . . 75.43 110.774 173.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 280' ' ' LEU . . . . . 0.629 ' HB3' HD21 ' B' ' 277' ' ' LEU . 27.1 tp 54.39 -90.11 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.778 1.231 . . . . 53.23 111.166 176.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 281' ' ' PHE . . . . . 0.708 ' HA ' ' HB2' ' B' ' 118' ' ' PRO . 58.5 t80 177.42 -89.87 0.0 OUTLIER 'General case' 0 C--N 1.36 1.052 0 C-N-CA 125.203 1.401 . . . . 75.31 107.784 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 282' ' ' ALA . . . . . 0.581 ' HB2' ' HB2' ' B' ' 110' ' ' ALA . . . 179.75 14.53 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.145 1.378 . . . . 65.41 109.644 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 283' ' ' ASP . . . . . 0.406 ' H ' ' H ' ' B' ' 282' ' ' ALA . 7.6 p-10 -89.64 161.94 15.87 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.949 0.9 . . . . 72.33 110.357 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . -106.91 123.45 7.32 Favored Glycine 0 C--N 1.349 1.275 0 N-CA-C 111.674 -0.57 . . . . 61.45 111.674 -178.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 33.0 p-10 -73.02 -21.33 60.83 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.367 0.667 . . . . 72.41 111.776 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 286' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -91.62 114.05 60.64 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 123.526 0.73 . . . . 64.1 109.497 177.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 287' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -79.72 152.48 22.54 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.684 2.256 . . . . 73.33 111.444 170.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 288' ' ' VAL . . . . . . . . . . . . . 35.1 m -66.65 -19.57 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 122.696 0.398 . . . . 74.32 112.008 179.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 289' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 72.69 150.07 0.1 Allowed 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 124.912 1.285 . . . . 72.14 110.673 -177.444 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 290' ' ' TRP . . . . . . . . . . . . . 49.7 t90 79.47 -24.54 0.21 Allowed 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 125.389 1.476 . . . . 75.34 112.272 -179.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 291' ' ' LEU . . . . . . . . . . . . . 8.1 mp 70.96 -72.82 0.11 Allowed 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 125.035 1.334 . . . . 64.34 111.078 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . 85.93 -100.15 2.46 Favored Glycine 0 C--N 1.351 1.414 0 CA-C-O 119.013 -0.881 . . . . 62.12 111.333 -177.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -57.71 130.91 41.02 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.314 2.01 . . . . 51.12 110.433 164.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -70.64 -61.43 1.77 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 122.57 0.348 . . . . 41.23 110.379 -175.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 295' ' ' ALA . . . . . 0.587 ' HB1' ' HB2' ' B' ' 63' ' ' PRO . . . 63.51 6.9 2.73 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.928 1.291 . . . . 34.32 113.294 -179.347 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 22.6 p -75.82 98.01 4.05 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.315 0.646 . . . . 65.42 109.621 -179.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -73.83 147.29 43.47 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 115.884 -0.598 . . . . 64.12 110.351 -178.06 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 24.5 p-80 -163.48 155.3 17.35 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.189 0.596 . . . . 71.5 110.848 -169.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . -93.29 -35.29 6.33 Favored Glycine 0 C--N 1.339 0.7 0 CA-C-N 116.248 -0.433 . . . . 63.41 112.374 172.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 58.3 t30 -106.4 149.98 26.48 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.923 0.889 . . . . 72.23 110.896 -175.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 301' ' ' ILE . . . . . . . . . . . . 0.262 2.6 pp 48.39 -178.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 C-N-CA 127.267 2.227 . . . . 72.24 114.983 178.066 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 33.0 t70 54.73 48.61 19.83 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 125.009 1.324 . . . . 63.41 111.925 173.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 303' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -110.65 135.09 20.74 Favored Pre-proline 0 N--CA 1.481 1.114 0 C-N-CA 123.894 0.878 . . . . 74.11 110.513 -177.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 304' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -70.72 -21.13 29.43 Favored 'Trans proline' 0 C--N 1.379 2.157 0 C-N-CA 122.902 2.401 . . . . 75.12 112.401 171.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -107.96 164.22 12.46 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.536 0.734 . . . . 42.33 111.219 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 20.6 m -126.3 31.5 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 C-N-CA 124.156 0.982 . . . . 72.33 110.69 -176.184 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 89.0 m 66.61 -74.56 0.06 Allowed 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 125.165 1.386 . . . . 74.23 111.194 -178.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 308' ' ' CYS . . . . . . . . . . . . . 16.5 p -115.49 137.57 51.93 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 124.386 1.075 . . . . 74.22 108.884 176.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 6.6 m -61.34 -47.18 94.64 Favored Pre-proline 0 CA--C 1.563 1.468 0 CA-C-O 118.88 -0.581 . . . . 72.2 111.65 -178.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.35 107.01 2.23 Favored 'Trans proline' 0 C--N 1.386 2.529 0 C-N-CA 121.435 1.424 . . . . 63.14 110.279 163.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 311' ' ' ASN . . . . . 0.426 ' N ' ' HD2' ' B' ' 312' ' ' PRO . 40.9 m-80 -85.0 -48.24 0.62 Allowed Pre-proline 0 CA--C 1.561 1.394 0 CA-C-O 118.148 -0.93 . . . . 73.13 111.646 176.635 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 312' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' B' ' 311' ' ' ASN . 19.8 Cg_endo -57.66 -62.96 0.17 Allowed 'Trans proline' 0 C--N 1.402 3.35 0 C-N-CA 122.545 2.163 . . . . 70.14 112.482 178.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 313' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 73.52 -45.76 0.62 Allowed 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 125.914 1.686 . . . . 75.13 114.238 172.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 314' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 177.52 -31.28 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.313 1.045 . . . . 72.01 108.983 -165.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 315' ' ' ASN . . . . . 0.42 ' O ' ' HG3' ' B' ' 324' ' ' MET . 29.0 m-80 -73.68 -2.73 24.42 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.354 1.062 . . . . 72.12 111.947 -176.239 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 316' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -90.73 -38.34 13.11 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.806 0.842 . . . . 74.4 111.46 -179.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 18.1 t -159.51 -159.07 0.71 Allowed 'General case' 0 CA--C 1.553 1.06 0 N-CA-C 109.624 -0.51 . . . . 75.41 109.624 -168.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 318' ' ' VAL . . . . . . . . . . . . . 5.5 m 63.67 143.93 0.07 OUTLIER Pre-proline 0 N--CA 1.497 1.894 0 C-N-CA 127.603 2.361 . . . . 73.13 113.748 176.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 319' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -61.48 140.42 87.28 Favored 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 122.498 2.132 . . . . 65.1 110.905 174.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 320' ' ' THR . . . . . . . . . . . . . 2.7 m 67.17 83.67 0.16 Allowed 'General case' 0 CA--C 1.557 1.25 0 C-N-CA 124.526 1.13 . . . . 53.31 109.151 -173.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 321' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -91.66 8.27 37.65 Favored 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 124.294 1.037 . . . . 65.14 113.012 -169.053 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 322' ' ' ALA . . . . . . . . . . . . . . . 70.49 -101.67 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.225 1.41 . . . . 64.54 112.298 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 323' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -134.75 28.42 3.57 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.694 0.798 . . . . 74.02 110.901 -171.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 324' ' ' MET . . . . . 0.42 ' HG3' ' O ' ' B' ' 315' ' ' ASN . 1.3 tmt? -63.96 -58.18 7.5 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 109.017 -0.734 . . . . 71.32 109.017 171.45 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 325' ' ' THR . . . . . . . . . . . . . 13.9 p -70.22 103.94 2.5 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 109.059 -0.719 . . . . 72.33 109.059 169.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 326' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -172.01 -48.65 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.867 0.867 . . . . 72.01 109.255 -175.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt 64.63 45.18 3.6 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.633 1.173 . . . . 54.34 111.617 176.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 328' ' ' ALA . . . . . . . . . . . . . . . 64.25 25.35 13.54 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.411 1.084 . . . . 72.03 113.12 167.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 329' ' ' ILE . . . . . . . . . . . . . 3.0 mp 51.85 39.79 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.734 0 CA-C-O 122.6 1.191 . . . . 73.5 110.752 -175.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 330' ' ' GLU . . . . . 0.567 ' HB3' ' HA ' ' B' ' 333' ' ' SER . 46.7 mt-10 -93.29 -67.09 0.88 Allowed 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.522 -0.763 . . . . 63.42 110.054 176.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 331' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 54.52 93.59 0.02 OUTLIER 'General case' 0 C--N 1.365 1.252 0 C-N-CA 125.215 1.406 . . . . 63.34 111.202 178.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 68.0 mt 73.65 0.91 3.78 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 124.977 1.311 . . . . 74.41 111.366 -168.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 333' ' ' SER . . . . . 0.567 ' HA ' ' HB3' ' B' ' 330' ' ' GLU . 19.7 t 54.26 78.8 0.15 Allowed 'General case' 0 C--N 1.356 0.856 0 C-N-CA 125.231 1.412 . . . . 65.04 112.183 -177.03 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.97 16.0 3.05 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 116.289 -0.414 . . . . 63.11 110.519 172.28 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 335' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -57.69 -61.62 2.38 Favored 'General case' 0 C--N 1.361 1.08 0 C-N-CA 123.861 0.865 . . . . 73.25 110.063 173.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 336' ' ' GLU . . . . . 0.561 ' HG2' ' H ' ' B' ' 338' ' ' GLY . 38.9 tt0 -166.78 146.85 5.72 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 124.352 1.061 . . . . 61.02 108.471 174.249 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 337' ' ' LYS . . . . . 0.597 ' HE3' ' HA ' ' B' ' 337' ' ' LYS . 0.6 OUTLIER -81.47 -36.17 29.63 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.312 0.645 . . . . 62.43 110.365 177.084 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 338' ' ' GLY . . . . . 0.561 ' H ' ' HG2' ' B' ' 336' ' ' GLU . . . 72.57 44.92 38.68 Favored Glycine 0 C--N 1.35 1.334 0 N-CA-C 111.161 -0.776 . . . . 72.34 111.161 -174.285 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 339' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -80.87 85.32 6.2 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.265 1.026 . . . . 74.33 109.2 -171.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 340' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -78.46 -40.93 34.15 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 115.689 -0.687 . . . . 75.24 112.063 -173.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 341' ' ' LEU . . . . . . . . . . . . . 98.3 mt 55.21 34.51 22.87 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 124.199 1.0 . . . . 75.34 111.616 -177.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 342' ' ' GLN . . . . . . . . . . . . . 31.7 tp60 -70.47 87.57 0.65 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.186 0.994 . . . . 64.25 110.534 -176.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 343' ' ' VAL . . . . . . . . . . . . . 27.2 m -73.64 162.05 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 122.957 0.503 . . . . 64.24 110.578 176.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -111.61 177.96 4.48 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.985 0.914 . . . . 73.03 110.919 -174.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 345' ' ' GLY . . . . . . . . . . . . . . . 79.3 -85.97 1.22 Allowed Glycine 0 C--N 1.355 1.604 0 O-C-N 123.389 0.43 . . . . 62.31 112.061 179.115 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 346' ' ' ALA . . . . . . . . . . . . . . . -76.87 -39.38 51.27 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.212 -0.662 . . . . 72.22 109.212 171.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 347' ' ' SER . . . . . 0.419 ' HB2' ' HB2' ' B' ' 350' ' ' LYS . 19.6 m 66.9 124.36 0.02 OUTLIER 'General case' 0 C--N 1.361 1.104 0 C-N-CA 125.807 1.643 . . . . 72.21 112.48 174.043 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 11.7 tt -59.53 -33.85 52.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 C-N-CA 123.422 0.689 . . . . 73.42 111.18 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 349' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -68.09 -36.78 80.36 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.87 0.868 . . . . 71.13 110.971 177.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 350' ' ' LYS . . . . . 0.546 ' HG3' ' HB3' ' B' ' 55' ' ' LEU . 11.0 mptt -92.48 -77.65 0.43 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.276 0.631 . . . . 74.52 110.704 -175.182 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 54.68 25.73 6.74 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.713 1.205 . . . . 71.32 112.438 -175.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -65.62 145.57 55.9 Favored 'General case' 0 C--N 1.351 0.666 0 CA-C-O 121.348 0.594 . . . . 74.35 110.755 -178.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 353' ' ' HIS . . . . . . . . . . . . . 11.2 p80 -143.44 -3.74 0.91 Allowed 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 114.856 -1.065 . . . . 74.33 110.356 -175.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 354' ' ' ALA . . . . . . . . . . . . . . . 69.22 -60.13 0.47 Allowed 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 125.47 1.508 . . . . 70.11 112.764 -177.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 355' ' ' ALA . . . . . . . . . . . . . . . 83.25 130.81 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 126.459 1.904 . . . . 75.44 110.673 178.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 356' ' ' ASN . . . . . . . . . . . . . 11.5 m120 68.48 129.05 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.482 0 C-N-CA 125.328 1.451 . . . . 74.32 110.736 -173.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 357' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -61.36 -28.21 83.91 Favored 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 122.228 1.952 . . . . 55.22 111.514 171.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 358' ' ' CYS . . . . . 0.584 ' SG ' ' HA ' ' B' ' 232' ' ' THR . 24.2 t 60.78 38.8 17.89 Favored 'General case' 0 C--N 1.361 1.07 0 C-N-CA 124.924 1.289 . . . . 73.32 111.303 173.588 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 359' ' ' GLY . . . . . . . . . . . . . . . -84.84 55.01 4.97 Favored Glycine 0 C--N 1.348 1.225 0 CA-C-N 115.206 -0.906 . . . . 62.01 113.257 -177.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 360' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 54.27 7.13 0.12 Allowed 'General case' 0 N--CA 1.502 2.154 0 C-N-CA 127.255 2.222 . . . . 53.34 116.351 170.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 361' ' ' ILE . . . . . 0.416 HG23 ' H ' ' B' ' 362' ' ' GLY 0.292 16.3 tt 45.55 -70.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 C-N-CA 126.521 1.928 . . . . 61.31 113.373 -166.547 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 362' ' ' GLY . . . . . 0.416 ' H ' HG23 ' B' ' 361' ' ' ILE . . . -122.26 179.48 16.19 Favored Glycine 0 C--N 1.35 1.325 0 N-CA-C 111.956 -0.458 . . . . 72.35 111.956 175.537 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 363' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -89.27 54.26 2.9 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.986 0.914 . . . . 73.13 109.5 -178.141 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 364' ' ' THR . . . . . . . . . . . . . 32.3 m 52.71 -101.45 0.11 Allowed 'General case' 0 CA--C 1.561 1.392 0 C-N-CA 125.042 1.337 . . . . 74.04 110.624 -169.048 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 74.2 t -143.27 -69.56 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 N-CA-C 107.484 -1.302 . . . . 74.01 107.484 174.037 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 36.6 t70 54.3 85.7 0.05 Allowed 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.148 1.379 . . . . 50.12 112.276 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 367' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -167.91 84.51 0.2 Allowed 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 105.797 -1.927 . . . . 75.05 105.797 176.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 368' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 57.41 40.27 27.53 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 124.111 0.964 . . . . 71.23 109.866 -169.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 369' ' ' GLU . . . . . . . . . . . . . 8.8 tm-20 -137.79 -21.93 1.1 Allowed 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 114.384 -1.28 . . . . 70.1 110.409 -164.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 370' ' ' ALA . . . . . . . . . . . . . . . -54.46 95.57 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.28 1.032 . . . . 74.25 111.935 -176.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 371' ' ' VAL . . . . . 0.493 HG13 HD21 ' B' ' 375' ' ' LEU . 2.4 p 56.31 6.57 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 C-N-CA 126.706 2.002 . . . . 74.11 113.255 -177.211 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 372' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -86.06 75.73 9.89 Favored 'General case' 0 C--N 1.352 0.693 0 N-CA-C 107.863 -1.162 . . . . 63.2 107.863 -175.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 373' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 -127.85 -48.37 1.37 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 114.228 -1.351 . . . . 72.05 109.055 -175.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -126.77 -84.54 0.61 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.365 0.666 . . . . 71.45 109.491 177.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 375' ' ' LEU . . . . . 0.521 HD22 ' HG3' ' A' ' 263' ' ' PRO . 79.1 mt 72.27 -43.31 0.56 Allowed 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 125.381 1.472 . . . . 62.01 113.225 178.291 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 376' ' ' GLU . . . . . 0.54 ' HG3' ' HB2' ' A' ' 260' ' ' ARG . 12.4 mm-40 73.45 -60.59 0.53 Allowed 'General case' 0 N--CA 1.5 2.028 0 C-N-CA 125.92 1.688 . . . . 73.13 113.444 171.298 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 377' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 71.2 -80.22 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.396 1.478 . . . . 73.31 111.302 177.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 378' ' ' ALA . . . . . . . . . . . . . . . -92.34 25.0 3.13 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.663 0.785 . . . . 61.1 111.637 -173.398 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 379' ' ' LYS . . . . . 0.503 ' HE3' ' HG2' ' A' ' 260' ' ' ARG . 63.2 tttp -139.55 102.24 4.41 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.846 0.858 . . . . 72.01 109.104 -177.051 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 380' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -99.99 -50.43 4.0 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.584 0.754 . . . . 53.14 109.392 174.068 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 381' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 60.52 38.26 19.11 Favored 'General case' 0 CA--C 1.555 1.163 0 CA-C-O 122.221 1.01 . . . . 74.34 111.07 172.056 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -147.58 67.38 0.39 Allowed Glycine 0 C--N 1.343 0.919 0 CA-C-N 114.903 -1.044 . . . . 73.1 110.493 -178.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 383' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -137.46 105.69 5.74 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.677 1.191 . . . . 73.1 107.924 -178.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 384' ' ' THR . . . . . 0.402 ' HB ' ' HA ' ' C' ' 280' ' ' ALA . 35.8 m -113.44 -63.05 1.5 Allowed 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 111.977 0.362 . . . . 63.41 111.977 -171.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 86.3 mt -108.56 -86.91 0.51 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.502 0.721 . . . . 75.12 111.615 -171.334 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 386' ' ' VAL . . . . . 0.519 HG13 HD12 ' B' ' 387' ' ' ILE . 14.3 p -97.22 -26.15 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 122.619 0.368 . . . . 62.42 111.548 -169.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 387' ' ' ILE . . . . . 0.527 HG23 ' HB3' ' B' ' 391' ' ' ASP . 2.3 mp -72.51 86.99 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.074 0 CA-C-O 122.414 1.102 . . . . 74.12 109.233 173.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 388' ' ' VAL . . . . . . . . . . . . . 2.7 m -157.67 -42.26 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 127.579 2.352 . . . . 54.33 105.994 174.043 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 389' ' ' THR . . . . . . . . . . . . . 41.5 m -100.69 -35.43 9.48 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 114.361 -1.29 . . . . 71.25 108.584 168.204 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . -77.72 142.21 38.88 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 108.864 -0.791 . . . . 70.34 108.864 167.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 391' ' ' ASP . . . . . 0.527 ' HB3' HG23 ' B' ' 387' ' ' ILE . 30.1 t70 57.03 27.98 14.14 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 122.163 0.983 . . . . 64.12 110.678 -179.318 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 392' ' ' HIS . . . . . . . . . . . . . 29.1 t60 -68.62 94.04 0.55 Allowed 'General case' 0 C--N 1.351 0.641 0 CA-C-N 114.701 -1.136 . . . . 72.42 109.817 -177.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -154.63 117.23 4.34 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 123.828 0.851 . . . . 61.53 109.029 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -71.95 -23.02 61.38 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.096 0.558 . . . . 73.31 111.137 175.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . 64.54 -74.44 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.651 1.58 . . . . 71.44 111.645 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 36.9 t -66.84 120.84 14.23 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.082 0.953 . . . . 75.55 110.614 177.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 397' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 -70.38 -10.37 58.87 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 112.416 0.524 . . . . 71.41 112.416 -177.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 86.6 mt -49.19 -50.45 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 124.244 1.017 . . . . 75.44 110.655 174.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 399' ' ' VAL . . . . . . . . . . . . . 15.3 m -88.74 112.41 23.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-N 115.536 -0.756 . . . . 73.32 110.069 176.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 400' ' ' ALA . . . . . . . . . . . . . . . -77.6 -41.44 2.27 Favored Pre-proline 0 CA--C 1.563 1.443 0 CA-C-O 118.03 -0.986 . . . . 51.41 112.18 176.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 401' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -61.47 88.3 0.1 OUTLIER 'Trans proline' 0 C--N 1.397 3.082 0 C-N-CA 122.075 1.85 . . . . 71.04 113.377 174.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -108.4 -70.88 0.78 Allowed 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 107.866 -1.161 . . . . 74.34 107.866 174.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 403' ' ' THR . . . . . . . . . . . . . 20.1 m -72.95 -30.45 63.86 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.529 0.732 . . . . 51.3 109.94 176.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 404' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -93.15 72.18 4.6 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.984 0.914 . . . . 70.03 109.692 -179.038 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 405' ' ' ALA . . . . . 0.462 ' HB3' ' HD3' ' B' ' 406' ' ' PRO . . . -170.19 -52.2 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.341 0 C-N-CA 124.018 0.927 . . . . 71.24 111.058 177.464 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 406' ' ' PRO . . . . . 0.462 ' HD3' ' HB3' ' B' ' 405' ' ' ALA . 42.0 Cg_endo -107.85 20.07 0.09 OUTLIER 'Trans proline' 0 C--N 1.387 2.567 0 C-N-CA 123.057 2.505 . . . . 44.44 113.835 176.342 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . -75.3 79.5 1.05 Allowed Glycine 0 C--N 1.354 1.548 0 N-CA-C 114.096 0.398 . . . . 55.33 114.096 -171.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 408' ' ' LEU . . . . . 0.553 HD11 HD21 ' B' ' 412' ' ' LEU . 14.7 tp 64.1 41.68 6.16 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 125.074 1.349 . . . . 72.03 110.939 178.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 30.5 p -67.72 -36.17 80.11 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.336 -0.847 . . . . 73.52 111.965 178.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 410' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -73.92 155.78 38.33 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.745 0.818 . . . . 51.32 111.225 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . -85.29 -3.88 58.97 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.558 0.743 . . . . 63.14 112.233 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 412' ' ' LEU . . . . . 0.553 HD21 HD11 ' B' ' 408' ' ' LEU . 3.3 mm? 69.29 -68.93 0.17 Allowed 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 125.62 1.568 . . . . 60.41 110.877 -175.488 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 18.4 m120 67.22 173.72 0.26 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.126 1.37 . . . . 71.14 111.219 -178.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 414' ' ' THR . . . . . . . . . . . . . 30.2 p -67.01 -54.56 20.51 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.028 -1.101 . . . . 73.24 108.028 167.181 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 415' ' ' LYS . . . . . 0.489 ' HG2' ' HB3' ' B' ' 418' ' ' ALA . 35.6 ttmt 59.72 18.61 7.38 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 124.536 1.134 . . . . 73.42 111.483 171.524 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -58.85 -49.18 78.72 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.948 1.299 . . . . 75.33 111.308 -171.055 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 417' ' ' GLY . . . . . . . . . . . . . . . -61.98 -28.78 70.97 Favored Glycine 0 C--N 1.347 1.179 0 O-C-N 123.857 0.723 . . . . 43.15 113.251 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 418' ' ' ALA . . . . . 0.489 ' HB3' ' HG2' ' B' ' 415' ' ' LYS . . . -80.95 -40.34 24.63 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.423 0.689 . . . . 70.25 110.971 178.492 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 419' ' ' VAL . . . . . . . . . . . . . 32.8 m -92.51 32.6 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 123.245 0.618 . . . . 62.03 110.812 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 420' ' ' MET . . . . . . . . . . . . . 26.4 ptm -68.54 -7.6 33.94 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.737 0.815 . . . . 73.12 112.065 176.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 421' ' ' VAL . . . . . . . . . . . . . 34.1 m -76.58 -27.96 17.42 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 C-N-CA 122.752 0.421 . . . . 72.42 110.604 172.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 422' ' ' MET . . . . . 0.441 ' HA ' ' HB ' ' B' ' 435' ' ' THR . 1.7 tmt? -95.04 134.07 38.13 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.374 1.07 . . . . 74.1 109.556 179.336 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 423' ' ' SER . . . . . . . . . . . . . 22.8 t 64.08 -73.88 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 125.503 1.521 . . . . 62.22 112.358 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 424' ' ' TYR . . . . . . . . . . . . 0.259 50.1 p90 50.91 -74.16 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 126.815 2.046 . . . . 72.42 113.993 -178.358 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . -163.39 28.97 0.24 Allowed Glycine 0 N--CA 1.468 0.774 0 N-CA-C 111.17 -0.772 . . . . 75.12 111.17 -177.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 426' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -69.34 -43.23 74.08 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.683 1.193 . . . . 75.43 111.835 -173.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 427' ' ' SER . . . . . . . . . . . . . 22.4 t 78.43 -42.43 0.33 Allowed 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 125.328 1.451 . . . . 75.14 112.054 -178.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -57.4 -39.31 75.83 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.167 0.587 . . . . 73.23 109.952 172.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 429' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 71.12 111.41 0.06 Allowed 'General case' 0 CA--C 1.546 0.794 0 O-C-N 124.862 1.351 . . . . 63.42 110.873 165.369 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 430' ' ' ASP . . . . . 0.563 ' HB2' ' HB3' ' B' ' 433' ' ' GLU . 6.7 p-10 -69.24 -26.67 64.91 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.353 1.061 . . . . 55.41 112.959 -171.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 15.3 m 63.11 44.3 5.88 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.349 1.06 . . . . 73.31 110.792 179.048 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 432' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 70.67 54.46 0.27 Allowed 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 124.668 1.187 . . . . 71.1 109.859 -179.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 433' ' ' GLU . . . . . 0.563 ' HB3' ' HB2' ' B' ' 430' ' ' ASP . 33.1 tt0 -109.85 22.29 15.83 Favored 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 124.273 1.029 . . . . 73.43 109.153 173.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 434' ' ' HIS . . . . . . . . . . . . . 16.4 t60 76.24 -64.35 0.35 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 125.589 1.556 . . . . 65.13 111.569 176.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 435' ' ' THR . . . . . 0.441 ' HB ' ' HA ' ' B' ' 422' ' ' MET . 2.4 m 70.01 146.65 0.06 Allowed 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 125.423 1.489 . . . . 73.42 111.971 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . 95.54 -0.05 63.06 Favored Glycine 0 C--N 1.341 0.811 0 N-CA-C 110.712 -0.955 . . . . 43.54 110.712 -163.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 16.4 m -90.68 121.02 32.22 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.023 1.329 . . . . 54.14 109.16 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 438' ' ' GLN . . . . . . . . . . . . . 47.1 tp60 60.54 90.57 0.06 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.361 1.064 . . . . 71.55 110.024 -172.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 439' ' ' LEU . . . . . 0.443 HD23 ' H ' ' B' ' 439' ' ' LEU . 2.0 pt? -89.49 33.08 0.83 Allowed 'General case' 0 CA--C 1.555 1.16 0 CA-C-N 115.035 -0.984 . . . . 74.24 111.518 -173.326 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 440' ' ' ARG . . . . . . . . . . . . . 52.1 ttp180 70.07 100.81 0.06 Allowed 'General case' 0 C--N 1.367 1.337 0 C-N-CA 124.731 1.212 . . . . 70.1 110.89 178.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 441' ' ' ILE . . . . . 0.495 HD11 HG13 ' A' ' 221' ' ' VAL . 55.1 mt -127.58 116.48 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 124.037 0.935 . . . . 74.15 109.945 -176.156 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 442' ' ' ALA . . . . . . . . . . . . . . . -105.77 37.62 2.2 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.84 0.856 . . . . 71.41 110.235 177.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . -77.78 -65.09 1.01 Allowed 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.538 -0.755 . . . . 74.21 111.193 -177.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -98.33 154.3 17.92 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.414 0.686 . . . . 65.34 109.78 -176.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . -153.01 -161.59 10.41 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-O 119.244 -0.753 . . . . 74.34 111.407 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 446' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -78.08 144.18 20.93 Favored 'Trans proline' 0 C--N 1.37 1.678 0 C-N-CA 122.669 2.246 . . . . 63.02 111.983 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 447' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -73.78 131.15 41.26 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 108.664 -0.865 . . . . 60.0 108.664 179.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . -67.93 84.62 0.22 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 123.552 0.741 . . . . 74.31 109.547 175.088 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 449' ' ' ALA . . . . . . . . . . . . . . . -139.23 129.28 25.14 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 124.859 1.264 . . . . 61.52 108.214 -176.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 450' ' ' ASN . . . . . . . . . . . . . 8.5 p30 46.02 -163.6 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 125.269 1.428 . . . . 61.12 112.681 -176.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 59.2 t 63.28 -79.31 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 124.568 1.147 . . . . 63.1 110.583 -174.158 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 452' ' ' VAL . . . . . 0.464 HG13 ' H ' ' B' ' 453' ' ' GLY 0.279 2.7 p 40.29 -82.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.371 1.54 0 C-N-CA 126.792 2.037 . . . . 60.45 113.575 179.998 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 453' ' ' GLY . . . . . 0.464 ' H ' HG13 ' B' ' 452' ' ' VAL . . . 176.14 -75.11 0.08 OUTLIER Glycine 0 C--N 1.339 0.709 0 CA-C-N 118.42 0.554 . . . . 73.44 112.534 176.526 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 454' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 60.55 -78.41 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.949 1.3 . . . . 72.5 110.423 -171.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 30.8 m 66.37 -79.82 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.342 1.457 . . . . 61.41 111.435 179.07 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -116.24 -25.01 7.73 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.437 1.095 . . . . 74.3 109.91 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 457' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -71.53 127.56 32.98 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.851 0.86 . . . . 42.14 108.818 175.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 18.8 p -108.69 87.78 2.57 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.557 0.743 . . . . 72.13 111.274 -176.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 459' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -115.96 155.41 28.07 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.072 -1.085 . . . . 73.31 108.072 172.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 2.0 pp -73.12 -0.37 13.9 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 113.691 0.997 . . . . 65.42 113.691 -176.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -68.76 0.2 4.59 Favored 'General case' 0 CA--C 1.563 1.476 0 N-CA-C 113.516 0.932 . . . . 62.31 113.516 -175.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 20.4 p90 -78.65 23.35 0.32 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.217 -0.927 . . . . 72.53 111.94 172.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 4.6 m -71.16 77.16 0.7 Allowed 'General case' 0 CA--C 1.56 1.332 0 C-N-CA 125.158 1.383 . . . . 61.35 110.59 173.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 464' ' ' MET . . . . . . . . . . . . . 18.9 ptm -96.93 92.67 6.22 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-O 121.733 0.778 . . . . 75.31 110.212 177.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -123.98 85.39 2.41 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 108.27 -1.011 . . . . 72.15 108.27 170.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -91.43 -173.41 3.58 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 114.974 -1.012 . . . . 62.32 110.189 177.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . 71.93 -69.25 0.19 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 125.438 1.495 . . . . 75.3 111.539 178.082 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 468' ' ' LEU . . . . . 0.4 ' H ' ' HG ' ' B' ' 468' ' ' LEU . 2.2 pp -82.97 -12.04 57.63 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.558 0.743 . . . . 45.51 111.281 173.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 469' ' ' GLY . . . . . . . . . . . . . . . -143.05 -173.65 14.81 Favored Glycine 0 C--N 1.353 1.504 0 C-N-CA 123.436 0.541 . . . . 50.44 111.889 177.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 470' ' ' LEU . . . . . . . . . . . . . 58.5 tp -163.71 139.91 6.7 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.084 0.954 . . . . 73.2 109.666 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 471' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.546 0.805 0 N-CA-C 107.007 -1.479 . . . . 74.2 107.007 173.184 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 1' ' ' MET . . . . . 0.502 ' SD ' ' N ' ' C' ' 1' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.474 0.775 0 N-CA-C 109.197 -0.668 . . . . 55.23 109.197 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.59 25.91 12.19 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 125.908 1.683 . . . . 65.31 113.543 176.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -85.38 66.67 9.81 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.006 0.522 . . . . 52.01 110.008 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -38.72 104.96 0.04 OUTLIER 'General case' 0 C--N 1.358 0.939 0 C-N-CA 125.504 1.522 . . . . 70.52 112.779 178.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 5' ' ' LYS . . . . . 0.47 ' HE2' HD11 ' C' ' 10' ' ' ILE . 47.6 mtpt -97.34 112.37 24.22 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.625 -0.88 . . . . 63.2 108.625 173.083 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -71.07 105.01 3.19 Favored 'General case' 0 C--O 1.244 0.788 0 N-CA-C 108.806 -0.813 . . . . 63.22 108.806 174.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 7' ' ' TYR . . . . . 0.421 ' HA ' HD12 ' C' ' 10' ' ' ILE . 75.5 m-85 -63.42 -26.54 68.78 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 114.544 -1.207 . . . . 73.43 112.074 -173.136 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -63.58 -48.23 78.25 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 109.578 -0.527 . . . . 72.53 109.578 173.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.95 -37.84 83.77 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.102 0.561 . . . . 52.31 111.544 179.087 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 10' ' ' ILE . . . . . 0.47 HD11 ' HE2' ' C' ' 5' ' ' LYS . 63.8 mt -58.78 -43.9 89.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 C-N-CA 123.225 0.61 . . . . 63.34 110.465 174.621 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 73.4 mt -76.32 -11.83 59.97 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 115.77 -0.65 . . . . 45.45 112.698 177.166 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.32 40.22 55.7 Favored Glycine 0 C--N 1.35 1.353 0 N-CA-C 112.821 -0.112 . . . . 64.33 112.821 -176.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 14.6 m -131.78 156.66 79.83 Favored Pre-proline 0 N--CA 1.485 1.295 0 C-N-CA 124.927 1.291 . . . . 64.04 109.826 178.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -80.97 177.16 8.23 Favored 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 122.452 2.101 . . . . 74.43 112.421 176.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 90.5 mtt180 -83.78 36.99 0.57 Allowed 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 122.485 1.136 . . . . 71.52 111.297 176.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -117.34 -15.59 10.35 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.702 2.001 . . . . 71.24 107.417 172.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.79 104.69 0.56 Allowed 'General case' 0 C--N 1.35 0.621 0 CA-C-N 114.383 -1.28 . . . . 71.14 112.834 -169.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 76.7 p -71.28 -170.13 0.46 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.894 1.278 . . . . 74.41 110.841 174.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.83 -42.89 90.34 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 124.276 1.03 . . . . 74.45 110.152 177.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 20' ' ' GLU . . . . . 0.493 ' O ' ' HG3' ' C' ' 24' ' ' ARG . 0.9 OUTLIER -75.58 -35.74 60.52 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 116.235 -0.438 . . . . 64.05 110.326 -175.582 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -68.52 -38.85 81.26 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-O 121.223 0.535 . . . . 73.42 110.55 178.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 1.1 mp -60.14 -39.53 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.397 1.079 . . . . 61.32 109.796 169.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -70.01 -31.39 69.04 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.297 -0.865 . . . . 74.13 110.812 178.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 24' ' ' ARG . . . . . 0.493 ' HG3' ' O ' ' C' ' 20' ' ' GLU . 89.0 mtt180 -65.81 -44.87 84.35 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 109.398 -0.593 . . . . 73.52 109.398 177.435 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.09 -34.9 79.11 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 114.57 -1.196 . . . . 75.32 111.562 176.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 26' ' ' TYR . . . . . 0.418 ' O ' ' HB3' ' C' ' 30' ' ' ALA . 86.6 t80 -67.9 -48.15 66.8 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 123.816 0.698 . . . . 72.31 110.631 177.26 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -59.37 -56.11 26.18 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.381 -0.6 . . . . 74.1 109.381 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 32.3 ttt180 -50.49 -70.76 0.08 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.947 0.899 . . . . 71.15 111.489 177.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 86.7 mt -75.0 -50.31 16.98 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.42 -0.809 . . . . 60.22 112.04 -168.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 30' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' C' ' 26' ' ' TYR . . . -67.57 -28.52 67.85 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-O 117.714 -1.136 . . . . 75.32 112.239 -176.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 31' ' ' ARG . . . . . 0.462 ' HA ' ' HB2' ' C' ' 34' ' ' HIS . 74.5 mtm180 -80.9 -28.24 35.95 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 120.051 1.296 . . . . 73.5 110.842 173.117 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -65.34 -31.33 72.4 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.212 0.605 . . . . 71.12 110.367 171.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 33' ' ' TYR . . . . . 0.453 ' HB3' ' O ' ' C' ' 43' ' ' ALA . 21.7 m-85 -111.02 8.13 21.8 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.884 0.873 . . . . 70.15 112.056 -174.399 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 34' ' ' HIS . . . . . 0.462 ' HB2' ' HA ' ' C' ' 31' ' ' ARG . 9.4 t-160 -75.43 114.33 34.79 Favored Pre-proline 0 N--CA 1.479 1.003 0 CA-C-O 118.26 -0.876 . . . . 72.34 110.152 -174.511 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.52 -20.53 49.9 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 122.423 2.082 . . . . 71.32 112.882 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -53.5 -43.69 68.45 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.773 1.229 . . . . 60.34 112.181 173.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 86.5 t -107.53 -52.49 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 123.109 0.564 . . . . 75.33 109.955 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -98.37 90.68 4.88 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.128 0.971 . . . . 54.22 109.898 -176.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -74.84 81.4 2.12 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 109.113 -0.699 . . . . 62.24 109.113 176.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 70.8 m -137.37 117.02 10.31 Favored Pre-proline 0 N--CA 1.48 1.037 0 C-N-CA 123.459 0.704 . . . . 74.14 109.756 176.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -50.52 -43.33 45.52 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 123.882 3.055 . . . . 63.44 114.005 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -58.06 -40.3 80.66 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.406 0.682 . . . . 65.44 110.549 175.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 43' ' ' ALA . . . . . 0.453 ' O ' ' HB3' ' C' ' 33' ' ' TYR . . . -73.41 -17.93 61.21 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 115.661 -0.7 . . . . 62.05 110.259 -178.449 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 44' ' ' GLU . . . . . 0.457 ' O ' ' HD3' ' C' ' 48' ' ' LYS . 44.1 mt-10 -74.87 -43.9 51.9 Favored 'General case' 0 C--N 1.358 0.947 0 N-CA-C 109.217 -0.66 . . . . 74.04 109.217 175.01 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -57.69 -46.03 84.87 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 121.672 0.748 . . . . 42.53 110.048 175.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 46' ' ' LYS . . . . . 0.557 ' O ' HG12 ' C' ' 50' ' ' ILE . 99.9 mttt -63.6 -39.56 94.67 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 114.237 -1.347 . . . . 72.32 110.802 176.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -62.94 -32.53 73.86 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.869 0.868 . . . . 62.23 110.476 177.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 48' ' ' LYS . . . . . 0.457 ' HD3' ' O ' ' C' ' 44' ' ' GLU . 2.5 mptm? -65.81 -47.32 75.48 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 122.959 0.504 . . . . 72.04 109.702 173.583 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -58.57 -44.59 89.81 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.13 0.572 . . . . 72.33 111.304 178.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 50' ' ' ILE . . . . . 0.557 HG12 ' O ' ' C' ' 46' ' ' LYS . 20.3 mm -63.21 -49.31 83.7 Favored 'Isoleucine or valine' 0 C--N 1.361 1.078 0 CA-C-N 115.686 -0.688 . . . . 75.43 109.733 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 51' ' ' ASN . . . . . 0.51 ' HA ' ' HB3' ' C' ' 54' ' ' TYR . 22.0 m-80 -79.9 -9.18 59.65 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.703 0.801 . . . . 74.04 112.169 -176.399 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -71.26 -61.37 1.79 Allowed 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 107.842 -1.17 . . . . 63.42 107.842 167.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.65 -41.72 86.71 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 113.626 -1.624 . . . . 63.1 112.216 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 54' ' ' TYR . . . . . 0.51 ' HB3' ' HA ' ' C' ' 51' ' ' ASN . 67.2 t80 -65.1 -52.68 54.04 Favored 'General case' 0 C--O 1.213 -0.837 0 CA-C-N 115.148 -0.933 . . . . 75.01 109.884 177.424 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.68 -38.2 63.95 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 112.199 0.444 . . . . 60.54 112.199 -177.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 98.2 t -64.61 -55.61 20.39 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 O-C-N 123.99 0.807 . . . . 72.43 110.887 173.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 57' ' ' LEU . . . . . . . . . . . . . 68.0 mt -94.27 7.58 44.86 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 113.616 0.969 . . . . 75.02 113.616 -168.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 43.8 t -69.65 -81.03 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.719 0.807 . . . . 62.42 110.919 -175.287 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -83.8 145.4 47.0 Favored Pre-proline 0 C--O 1.248 1.021 0 N-CA-C 109.37 -0.604 . . . . 72.03 109.37 -174.099 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 60' ' ' PRO . . . . . 0.402 ' O ' ' HG2' ' C' ' 64' ' ' ARG . 9.8 Cg_endo -47.13 -33.92 16.4 Favored 'Trans proline' 0 C--N 1.387 2.588 0 C-N-CA 124.546 3.497 . . . . 33.23 113.634 -176.02 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -56.11 -71.03 0.1 Allowed 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 124.492 1.117 . . . . 62.13 111.62 178.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 33.8 mtmt -66.01 -29.08 69.39 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.74 0.816 . . . . 75.23 111.185 -174.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 23.8 tpt85 -54.19 -52.47 61.1 Favored 'General case' 0 C--N 1.356 0.876 0 O-C-N 124.277 0.986 . . . . 64.42 109.583 170.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 64' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' C' ' 60' ' ' PRO . 1.7 mmp_? -63.33 -35.99 82.21 Favored 'General case' 0 C--N 1.357 0.896 0 CA-C-O 118.613 -0.708 . . . . 74.15 111.915 178.014 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 1.5 mp -55.98 -45.31 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-N 118.281 0.492 . . . . 62.34 110.363 175.182 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -61.59 -55.17 33.7 Favored 'General case' 0 C--N 1.358 0.957 0 N-CA-C 109.937 -0.394 . . . . 74.22 109.937 176.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -56.48 -36.48 69.15 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.646 0.778 . . . . 73.14 112.586 -176.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 45.5 p -77.35 -30.65 54.0 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 119.085 -0.484 . . . . 63.2 110.92 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -66.82 128.39 36.13 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 118.425 0.557 . . . . 75.22 110.471 -179.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.19 14.85 55.4 Favored Glycine 0 C--N 1.345 1.059 0 N-CA-C 111.582 -0.607 . . . . 62.51 111.582 -176.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 29.8 m -142.48 -57.44 0.44 Allowed 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 103.942 -2.614 . . . . 72.34 103.942 177.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 49.5 m -79.73 141.15 36.61 Favored 'General case' 0 C--O 1.257 1.494 0 N-CA-C 104.871 -2.27 . . . . 73.35 104.871 154.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.4 -40.07 10.12 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.486 0.714 . . . . 73.23 109.833 178.679 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -77.88 128.28 79.56 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 123.886 0.874 . . . . 53.23 110.619 -175.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -62.48 121.28 9.18 Favored 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 122.642 2.228 . . . . 75.14 110.746 174.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -52.23 131.19 38.67 Favored 'Trans proline' 0 C--N 1.38 2.193 0 C-N-CA 123.328 2.685 . . . . 63.14 113.001 -179.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 77' ' ' PRO . . . . . 0.503 ' HA ' ' HD3' ' C' ' 78' ' ' PRO . 12.2 Cg_endo -53.03 126.79 22.62 Favored 'Trans proline' 0 C--N 1.39 2.743 0 C-N-CA 123.392 2.728 . . . . 51.51 112.232 -175.13 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 78' ' ' PRO . . . . . 0.503 ' HD3' ' HA ' ' C' ' 77' ' ' PRO . 19.7 Cg_exo -64.09 148.53 91.39 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 122.738 2.292 . . . . 74.44 112.317 -172.325 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -57.34 158.1 19.81 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 122.512 2.141 . . . . 61.04 111.251 171.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -53.42 80.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.386 2.52 0 C-N-CA 124.069 3.179 . . . . 51.5 115.259 -171.065 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 149.75 -41.91 0.81 Allowed Glycine 0 C--N 1.341 0.826 0 N-CA-C 110.773 -0.931 . . . . 75.2 110.773 -178.537 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 145.86 174.86 18.42 Favored Glycine 0 C--N 1.343 0.921 0 C-N-CA 123.472 0.558 . . . . 74.45 111.881 177.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -53.56 124.32 14.64 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.209 1.004 . . . . 70.14 109.799 169.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -58.1 110.85 1.01 Allowed 'General case' 0 N--CA 1.479 0.984 0 O-C-N 123.88 0.737 . . . . 63.13 111.179 175.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 85' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -142.86 31.62 1.42 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.371 1.469 . . . . 74.41 108.736 170.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 86' ' ' SER . . . . . 0.462 ' OG ' ' HD2' ' C' ' 143' ' ' ARG . 7.4 m -71.04 106.88 3.86 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 114.216 -1.356 . . . . 45.43 110.191 -173.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 100.84 -21.8 42.21 Favored Glycine 0 C--N 1.337 0.626 0 CA-C-N 116.107 -0.497 . . . . 74.33 112.811 -176.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 88' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -88.0 130.65 34.9 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 108.203 -1.036 . . . . 74.44 108.203 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -75.68 69.55 2.39 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.964 0.905 . . . . 72.23 110.664 -170.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 90' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -48.34 -43.27 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 125.679 1.592 . . . . 54.41 112.114 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -62.76 -30.78 71.7 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.267 0.627 . . . . 74.21 111.91 -176.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -81.53 -26.02 35.43 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.511 0.324 . . . . 75.53 110.607 177.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 15.1 m-30 -68.95 166.75 17.24 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.499 0.319 . . . . 72.45 110.855 -174.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 65.1 p -63.68 162.2 13.6 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 114.3 1.222 . . . . 45.51 114.3 -165.195 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 95' ' ' GLU . . . . . 0.421 ' O ' ' HG3' ' C' ' 99' ' ' GLU . 0.0 OUTLIER -63.39 -44.17 95.47 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 114.988 -1.006 . . . . 55.43 111.931 178.245 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -55.79 -46.95 77.85 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.313 0.645 . . . . 65.02 110.545 177.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 97' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -56.58 -46.85 80.59 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 113.77 -1.559 . . . . 64.25 110.271 175.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 98' ' ' GLN . . . . . 0.489 ' HA ' ' CD1' ' C' ' 105' ' ' LEU . 93.1 mt-30 -73.89 -12.71 60.75 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.183 0.808 . . . . 51.52 113.183 -176.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 99' ' ' GLU . . . . . 0.421 ' HG3' ' O ' ' C' ' 95' ' ' GLU . 46.8 mt-10 -87.1 -48.43 8.08 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.19 0.596 . . . . 74.43 111.211 172.195 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 13.3 tp -66.6 -60.1 3.01 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.588 0.755 . . . . 73.23 111.313 -175.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 101' ' ' PHE . . . . . 0.402 ' C ' ' HG ' ' C' ' 105' ' ' LEU . 64.4 m-85 -85.23 -8.98 58.29 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 116.205 -0.452 . . . . 73.25 110.994 -177.043 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -39.0 -55.24 2.34 Favored Glycine 0 C--N 1.365 2.157 0 CA-C-O 118.407 -1.218 . . . . 54.11 114.943 -176.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -29.24 -37.47 0.04 OUTLIER 'Trans proline' 0 C--N 1.391 2.782 1 C-N-CA 125.731 4.287 . . . . 62.02 116.888 173.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -147.52 36.45 1.17 Allowed Glycine 0 C--N 1.352 1.454 0 C-N-CA 121.559 -0.353 . . . . 43.23 112.982 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 105' ' ' LEU . . . . . 0.489 ' CD1' ' HA ' ' C' ' 98' ' ' GLN . 4.1 mt -68.61 14.2 0.08 Allowed 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 115.629 1.714 . . . . 73.03 115.629 -174.078 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 106' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 54.92 -160.13 0.17 Allowed 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 119.21 0.914 . . . . 64.24 110.088 -170.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . 85.73 64.25 1.5 Allowed Glycine 0 C--N 1.36 1.877 0 C-N-CA 118.566 -1.778 . . . . 51.05 117.459 162.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 64.7 -81.57 0.06 OUTLIER Glycine 0 N--CA 1.48 1.606 0 N-CA-C 114.896 0.719 . . . . 74.41 114.896 162.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 109' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -73.07 -5.34 38.31 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.217 1.007 . . . . 74.45 112.093 -177.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 110' ' ' GLY . . . . . . . . . . . . . . . -71.03 9.99 3.53 Favored Glycine 0 CA--C 1.56 2.872 0 N-CA-C 115.879 1.112 . . . . 54.22 115.879 172.104 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 82.06 -40.9 0.12 Allowed 'General case' 0 N--CA 1.503 2.222 0 C-N-CA 125.753 1.621 . . . . 75.25 114.705 170.224 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 112' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -105.75 -46.2 4.2 Favored 'General case' 0 N--CA 1.503 2.189 0 CA-C-N 119.776 1.171 . . . . 74.1 107.991 169.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 113' ' ' SER . . . . . . . . . . . . . 31.3 m -1.09 79.64 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 128.142 2.577 . . . . 72.53 115.662 153.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 114' ' ' ARG . . . . . 0.569 ' HG3' ' H ' ' C' ' 115' ' ' LYS . 0.3 OUTLIER -99.13 -161.87 0.91 Allowed 'General case' 0 CA--C 1.557 1.213 0 O-C-N 121.453 -0.78 . . . . 74.05 111.263 177.696 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 115' ' ' LYS . . . . . 0.777 ' HG3' ' HB2' ' C' ' 170' ' ' PRO . 84.8 tttt -83.68 140.15 32.33 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 106.467 -1.679 . . . . 54.14 106.467 160.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -57.56 109.13 1.61 Allowed Glycine 0 C--N 1.347 1.174 0 N-CA-C 111.252 -0.739 . . . . 45.25 111.252 176.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 67.7 mtp180 -93.91 163.55 13.45 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.545 0.738 . . . . 64.44 109.977 177.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 118' ' ' ASP . . . . . 0.403 ' HA ' ' O ' ' C' ' 173' ' ' ASP . 9.6 p-10 -73.33 93.52 1.92 Allowed 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 108.57 -0.9 . . . . 75.42 108.57 174.547 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 119' ' ' LEU . . . . . 0.462 HD13 ' HA ' ' C' ' 174' ' ' LEU . 0.0 OUTLIER -95.33 157.08 16.05 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 108.233 -1.025 . . . . 75.21 108.233 -178.544 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.64 126.41 48.97 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.94 -0.392 . . . . 72.31 109.94 -174.596 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 121' ' ' ALA . . . . . . . . . . . . . . . -125.19 118.71 26.65 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 108.747 -0.834 . . . . 63.21 108.747 -178.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 122' ' ' GLU . . . . . 0.438 ' HB3' ' HD2' ' B' ' 184' ' ' HIS . 37.2 tt0 -94.88 148.16 22.6 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 122.676 0.39 . . . . 73.22 110.839 -171.116 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 123' ' ' LEU . . . . . 0.667 ' HB3' ' HA ' ' B' ' 182' ' ' VAL . 1.0 OUTLIER -144.61 114.82 5.19 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 122.862 0.465 . . . . 73.3 111.137 -177.318 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 124' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' C' ' 179' ' ' ARG . 33.1 Cg_endo -66.18 114.45 3.03 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 121.862 1.708 . . . . 72.51 108.964 162.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 125' ' ' LEU . . . . . 0.583 HD23 HG11 ' C' ' 153' ' ' VAL . 18.4 tp -138.15 155.52 48.64 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.579 0.351 . . . . 74.03 110.846 -164.498 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 126' ' ' THR . . . . . . . . . . . . . 15.0 p -100.09 160.6 14.19 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-O 121.871 0.843 . . . . 61.53 111.218 173.095 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 127' ' ' LEU . . . . . 0.486 HD21 HD13 ' C' ' 180' ' ' LEU . 8.4 mt -67.13 -35.46 79.77 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 113.46 -1.7 . . . . 62.25 108.479 174.127 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -62.88 -47.23 84.2 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 113.145 -1.843 . . . . 75.24 109.605 176.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -66.46 -28.82 68.89 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 122.854 0.462 . . . . 73.53 111.732 176.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 130' ' ' ALA . . . . . 0.416 ' HB2' HG12 ' C' ' 153' ' ' VAL . . . -63.85 -41.23 97.85 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 123.463 0.477 . . . . 64.34 110.51 175.339 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 131' ' ' PHE . . . . . 0.439 ' HB2' HD13 ' C' ' 215' ' ' LEU . 52.3 t80 -65.31 -43.0 92.46 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.965 0.906 . . . . 75.55 110.292 172.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 132' ' ' HIS . . . . . 0.472 ' O ' ' HD3' ' C' ' 136' ' ' ARG . 6.5 m-70 -80.01 -1.8 41.35 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.206 -0.906 . . . . 60.22 110.781 -176.536 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -69.15 65.47 0.52 Allowed Glycine 0 C--N 1.358 1.8 0 C-N-CA 123.977 0.799 . . . . 65.31 114.447 174.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . -93.47 -126.23 4.25 Favored Glycine 0 C--N 1.343 0.936 0 N-CA-C 109.442 -1.463 . . . . 53.24 109.442 165.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 13.8 mp0 -71.97 94.79 1.5 Allowed 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 117.667 0.734 . . . . 71.2 109.119 175.156 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 136' ' ' ARG . . . . . 0.472 ' HD3' ' O ' ' C' ' 132' ' ' HIS . 17.9 mmm180 -110.82 147.64 34.07 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.45 0.7 . . . . 72.12 110.313 -175.081 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 137' ' ' VAL . . . . . . . . . . . . . 35.8 m -91.73 144.19 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 108.823 -0.806 . . . . 71.12 108.823 178.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 138' ' ' VAL . . . . . 0.432 HG22 HG23 ' C' ' 140' ' ' VAL . 14.7 p -160.64 151.0 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 O-C-N 123.211 0.32 . . . . 72.14 110.936 -177.559 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 139' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -120.1 113.27 20.22 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 107.561 -1.274 . . . . 74.31 107.561 171.238 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 140' ' ' VAL . . . . . 0.512 HG11 HD13 ' C' ' 174' ' ' LEU . 90.0 t -130.14 101.61 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 123.759 0.824 . . . . 63.22 110.794 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 141' ' ' ALA . . . . . 0.652 ' HB3' HH21 ' C' ' 143' ' ' ARG . . . 55.45 44.65 26.69 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.576 1.551 . . . . 15.23 112.562 168.04 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 103.08 6.26 45.72 Favored Glycine 0 C--N 1.347 1.175 0 CA-C-N 115.46 -0.791 . . . . 45.25 113.183 178.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 143' ' ' ARG . . . . . 0.652 HH21 ' HB3' ' C' ' 141' ' ' ALA . 0.0 OUTLIER -120.82 95.39 4.69 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 117.452 0.626 . . . . 73.04 110.19 -176.95 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 52.9 ttt180 -90.49 87.25 6.69 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 107.767 -1.197 . . . . 71.51 107.767 168.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 145' ' ' VAL . . . . . . . . . . . . . 27.4 m -119.66 148.77 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 115.4 -0.818 . . . . 75.03 111.574 -176.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 16.0 p -99.11 96.9 8.1 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 124.492 1.117 . . . . 54.21 108.433 168.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 14.8 p -124.83 151.52 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.753 0.821 . . . . 72.53 110.471 -173.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 24.2 ttm180 -98.24 110.15 22.78 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 109.952 -0.388 . . . . 74.22 109.952 169.154 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 149' ' ' ILE . . . . . 0.429 HD12 HD13 ' C' ' 159' ' ' ILE . 39.8 pt -78.82 153.88 78.04 Favored Pre-proline 0 CA--C 1.552 1.038 0 N-CA-C 108.085 -1.08 . . . . 71.41 108.085 164.297 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -43.03 111.73 0.24 Allowed 'Trans proline' 0 C--N 1.385 2.45 0 C-N-CA 122.989 2.459 . . . . 61.44 112.879 175.116 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.95 102.6 0.13 Allowed 'Trans proline' 0 C--N 1.389 2.708 0 C-N-CA 123.507 2.805 . . . . 73.2 111.257 -178.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 152' ' ' GLY . . . . . 0.48 ' HA3' HD22 ' C' ' 188' ' ' LEU . . . 132.06 140.33 4.49 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 116.025 -0.534 . . . . 54.32 112.635 -171.288 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 153' ' ' VAL . . . . . 0.657 HG22 HG11 ' C' ' 178' ' ' VAL . 0.3 OUTLIER -152.59 167.26 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 N-CA-C 112.267 0.469 . . . . 71.13 112.267 -174.899 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 154' ' ' ARG . . . . . 0.518 ' NH1' ' HA ' ' B' ' 24' ' ' PRO . 19.2 mtt180 -138.61 162.89 33.47 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.529 1.131 . . . . 75.32 109.28 -173.589 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 155' ' ' GLU . . . . . 0.43 ' HB2' HD12 ' C' ' 180' ' ' LEU . 10.2 tp10 -72.76 132.65 43.89 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 123.98 0.912 . . . . 74.51 111.953 178.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 65.17 19.73 66.41 Favored Glycine 0 C--N 1.359 1.839 0 O-C-N 123.745 0.653 . . . . 64.51 113.601 173.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 157' ' ' SER . . . . . 0.459 ' OG ' ' HB2' ' C' ' 154' ' ' ARG . 53.4 m -98.18 172.19 7.75 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.241 0.616 . . . . 75.43 111.018 -172.301 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 7.7 p -127.13 118.55 50.46 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.987 0 CA-C-N 115.173 -0.921 . . . . 64.44 110.062 -173.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 159' ' ' ILE . . . . . 0.69 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 25.4 mt -94.58 103.56 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 108.281 -1.007 . . . . 52.25 108.281 178.019 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 160' ' ' ARG . . . . . 0.479 HH12 ' HB3' ' C' ' 162' ' ' PRO . 64.4 ttp85 -83.55 100.92 11.09 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 109.819 -0.437 . . . . 72.21 109.819 -179.332 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 161' ' ' VAL . . . . . 0.609 ' HB ' ' HB3' ' C' ' 174' ' ' LEU . 58.2 t -94.59 103.37 11.02 Favored Pre-proline 0 CA--C 1.554 1.13 0 N-CA-C 108.404 -0.961 . . . . 75.24 108.404 175.202 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 162' ' ' PRO . . . . . 0.479 ' HB3' HH12 ' C' ' 160' ' ' ARG . 90.9 Cg_endo -73.87 164.19 35.2 Favored 'Trans proline' 0 C--N 1.373 1.843 0 C-N-CA 122.924 2.416 . . . . 63.42 113.879 -172.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.46 -25.14 6.58 Favored Glycine 0 C--N 1.345 1.055 0 CA-C-N 114.886 -1.052 . . . . 53.31 114.294 172.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 164' ' ' MET . . . . . 0.413 ' SD ' ' HG2' ' C' ' 143' ' ' ARG . 23.9 ttp -83.5 -77.7 0.24 Allowed 'General case' 0 C--N 1.356 0.853 0 CA-C-N 117.779 0.789 . . . . 73.35 110.071 -172.674 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . 87.21 -173.27 44.32 Favored Glycine 0 C--N 1.342 0.887 0 CA-C-O 120.116 -0.269 . . . . 64.24 113.664 179.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . -83.2 -125.53 1.03 Allowed Glycine 0 C--N 1.345 1.048 0 CA-C-O 119.98 -0.344 . . . . 75.44 112.826 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 167' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -79.64 146.64 32.39 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 117.037 0.419 . . . . 64.31 110.851 -177.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 168' ' ' GLY . . . . . 0.553 ' HA3' ' O ' ' C' ' 114' ' ' ARG . . . 78.11 -166.48 52.8 Favored Glycine 0 C--N 1.348 1.216 0 O-C-N 123.876 0.735 . . . . 13.44 112.934 -175.005 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 169' ' ' ASN . . . . . 0.402 ' HB3' ' HD3' ' C' ' 170' ' ' PRO . 23.0 t30 -104.6 -64.35 0.04 OUTLIER Pre-proline 0 CA--C 1.558 1.275 0 CA-C-O 117.214 -1.374 . . . . 62.44 114.421 -164.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 170' ' ' PRO . . . . . 0.777 ' HB2' ' HG3' ' C' ' 115' ' ' LYS . 95.6 Cg_exo -42.67 117.4 0.86 Allowed 'Trans proline' 0 C--N 1.408 3.679 0 C-N-CA 123.3 2.667 . . . . 51.41 114.216 -162.596 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 171' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -36.27 115.72 0.13 Allowed 'Trans proline' 0 C--N 1.397 3.099 1 C-N-CA 125.614 4.21 . . . . 74.02 115.876 -163.372 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -118.87 -150.51 8.8 Favored Glycine 0 C--N 1.345 1.03 0 CA-C-N 115.863 -0.608 . . . . 74.42 112.358 178.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 173' ' ' ASP . . . . . 0.403 ' O ' ' HA ' ' C' ' 118' ' ' ASP . 11.6 m-20 -136.43 147.12 47.09 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-O 121.794 0.807 . . . . 74.51 111.189 -178.365 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 174' ' ' LEU . . . . . 0.609 ' HB3' ' HB ' ' C' ' 161' ' ' VAL . 19.0 tp -103.06 136.72 42.34 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 114.194 -1.366 . . . . 75.22 107.71 168.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 66.5 mt -123.44 85.87 2.49 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.321 1.049 . . . . 71.32 108.97 -178.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 176' ' ' LEU . . . . . 0.69 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 82.0 mt -71.43 108.15 4.71 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.156 -0.475 . . . . 43.02 110.352 179.384 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 177' ' ' VAL . . . . . . . . . . . . . 25.1 t -84.96 93.46 3.57 Favored 'Isoleucine or valine' 0 C--N 1.347 0.472 0 N-CA-C 108.253 -1.017 . . . . 74.43 108.253 178.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 178' ' ' VAL . . . . . 0.657 HG11 HG22 ' C' ' 153' ' ' VAL . 2.4 p -84.11 117.15 29.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.292 -0.867 . . . . 74.01 110.525 -175.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 179' ' ' ARG . . . . . 0.404 ' O ' ' HA ' ' C' ' 124' ' ' PRO . 6.1 mmm180 -108.2 116.0 31.16 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 107.8 -1.185 . . . . 72.33 107.8 172.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 180' ' ' LEU . . . . . 0.486 HD13 HD21 ' C' ' 127' ' ' LEU . 92.9 mt -74.59 148.33 40.89 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 120.854 0.359 . . . . 70.51 110.499 178.487 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 181' ' ' LEU . . . . . . . . . . . . . 80.9 mt -70.14 166.09 37.12 Favored Pre-proline 0 CA--C 1.552 1.049 0 CA-C-O 118.236 -0.888 . . . . 74.2 109.348 177.043 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -54.2 76.15 0.03 OUTLIER 'Trans proline' 0 C--N 1.393 2.869 0 C-N-CA 123.224 2.616 . . . . 64.12 112.58 170.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 183' ' ' HIS . . . . . 0.432 ' N ' ' HD3' ' C' ' 184' ' ' PRO . 74.5 t60 174.88 54.48 0.03 OUTLIER Pre-proline 0 CA--C 1.561 1.384 0 C-N-CA 126.895 2.078 . . . . 62.13 106.384 -167.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 184' ' ' PRO . . . . . 0.432 ' HD3' ' N ' ' C' ' 183' ' ' HIS . 66.3 Cg_endo -93.83 65.1 0.41 Allowed 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.409 2.739 . . . . 71.54 110.628 -174.791 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 185' ' ' VAL . . . . . 0.527 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 16.4 t -93.28 -58.04 3.93 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.559 0 N-CA-C 108.946 -0.761 . . . . 72.23 108.946 -167.249 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 186' ' ' PHE . . . . . 0.405 ' H ' HD13 ' C' ' 127' ' ' LEU . 48.2 m-85 -101.23 104.31 15.35 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 121.201 0.524 . . . . 61.44 111.052 -169.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 187' ' ' ARG . . . . . 0.428 ' NH1' ' HB2' ' C' ' 189' ' ' GLU . 4.0 tmt_? -95.63 122.37 38.32 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 107.79 -1.189 . . . . 75.14 107.79 174.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 188' ' ' LEU . . . . . 0.577 HD13 ' HD2' ' C' ' 240' ' ' PHE . 59.2 tp -80.34 147.94 30.87 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.689 0.396 . . . . 74.14 111.861 -177.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 189' ' ' GLU . . . . . 0.428 ' HB2' ' NH1' ' C' ' 187' ' ' ARG . 8.8 tp10 -144.93 110.54 5.33 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 107.756 -1.202 . . . . 71.33 107.756 161.309 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 67.88 -93.12 0.26 Allowed Glycine 0 C--N 1.35 1.345 0 N-CA-C 111.58 -0.608 . . . . 74.2 111.58 -172.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 191' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -128.37 -16.39 4.42 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.383 1.073 . . . . 60.21 110.553 173.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -91.63 134.86 34.33 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.09 0.956 . . . . 65.13 110.249 -173.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 193' ' ' LEU . . . . . 0.63 ' HG ' ' HA2' ' C' ' 239' ' ' GLY . 17.4 mt -98.27 173.13 7.15 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 122.878 0.471 . . . . 52.2 112.043 -171.062 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 194' ' ' TYR . . . . . 0.512 ' HA ' ' O ' ' C' ' 250' ' ' TYR . 35.4 t80 -139.05 107.04 5.69 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 114.824 -1.08 . . . . 75.43 108.843 171.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 195' ' ' ALA . . . . . 0.527 ' HA ' ' O ' ' C' ' 185' ' ' VAL . . . -106.72 -176.16 3.0 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.322 1.049 . . . . 65.11 109.871 175.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 41.0 m -132.31 110.66 10.75 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 108.909 -0.774 . . . . 51.32 108.909 167.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 197' ' ' LEU . . . . . 0.473 ' HB2' HD22 ' C' ' 251' ' ' LEU . 35.6 tp -97.7 109.38 22.14 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.835 0.854 . . . . 73.5 109.169 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -88.94 104.5 17.01 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-O 121.917 0.865 . . . . 44.52 110.071 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 199' ' ' VAL . . . . . 0.405 ' HA ' HG11 ' C' ' 210' ' ' VAL . 42.3 t -92.35 123.22 62.92 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 124.958 1.303 . . . . 61.21 109.148 179.215 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 200' ' ' PRO . . . . . 0.431 ' HA ' ' O ' ' C' ' 256' ' ' THR . 55.6 Cg_endo -69.48 149.44 68.66 Favored 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 121.95 1.767 . . . . 71.34 110.826 176.635 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 201' ' ' ALA . . . . . 0.41 ' HB3' ' HH2' ' C' ' 269' ' ' TRP . . . -54.89 -46.84 99.47 Favored Pre-proline 0 CA--C 1.553 1.061 0 CA-C-O 117.579 -1.2 . . . . 74.35 113.909 -169.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 202' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -54.08 -47.16 28.57 Favored 'Trans proline' 0 C--N 1.395 3.006 0 C-N-CA 121.926 1.751 . . . . 63.15 112.625 176.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 203' ' ' ILE . . . . . . . . . . . . . 48.6 mt -69.77 -37.75 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.152 0.981 . . . . 63.4 111.156 -177.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -61.71 -43.95 97.87 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.507 0.723 . . . . 75.02 110.87 178.334 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 205' ' ' VAL . . . . . . . . . . . . . 78.7 t -74.16 -40.99 51.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 115.024 -0.989 . . . . 63.41 112.378 -176.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 206' ' ' VAL . . . . . 0.625 ' HA ' ' HE2' ' A' ' 270' ' ' LYS . 11.1 p -78.15 -33.99 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 CA-C-N 118.047 0.385 . . . . 52.12 110.839 -177.189 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 85.13 52.64 3.37 Favored Glycine 0 C--N 1.338 0.652 0 CA-C-N 115.779 -0.646 . . . . 63.21 111.518 -170.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 208' ' ' GLY . . . . . 0.499 ' HA2' HD23 ' B' ' 247' ' ' LEU . . . -90.13 -123.49 2.56 Favored Glycine 0 C--N 1.345 1.055 0 CA-C-N 115.104 -0.548 . . . . 51.32 111.778 -177.202 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 209' ' ' LYS . . . . . 0.716 ' HE2' ' HA ' ' B' ' 235' ' ' GLU . 6.5 mtmp? -147.2 144.13 28.7 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.53 0.681 . . . . 72.12 111.103 175.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 210' ' ' VAL . . . . . 0.405 HG11 ' HA ' ' C' ' 199' ' ' VAL . 16.2 m -122.67 178.66 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 113.6 -1.637 . . . . 62.05 107.468 167.073 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 211' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -132.3 130.29 40.64 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.922 0.392 . . . . 72.44 110.542 -178.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 212' ' ' ALA . . . . . 0.566 ' HB3' HG13 ' C' ' 219' ' ' VAL . . . -104.85 113.98 27.91 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 107.171 -1.418 . . . . 74.43 107.171 173.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 213' ' ' MET . . . . . . . . . . . . . 5.4 tmm? -67.38 135.51 53.31 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 107.84 -1.17 . . . . 63.12 107.84 171.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 214' ' ' THR . . . . . 0.536 HG21 ' HD2' ' C' ' 238' ' ' LYS . 0.1 OUTLIER -134.46 171.42 14.33 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-O 122.088 0.947 . . . . 54.24 111.962 -174.896 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 215' ' ' LEU . . . . . 0.439 HD13 ' HB2' ' C' ' 131' ' ' PHE . 27.4 mt -73.24 -31.16 63.96 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 114.151 -1.386 . . . . 44.41 113.08 -163.144 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.92 8.04 21.97 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.956 -1.02 . . . . 71.0 111.362 -178.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 149.37 -163.11 29.18 Favored Glycine 0 C--N 1.351 1.381 0 CA-C-O 119.479 -0.623 . . . . 64.11 111.938 -177.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -96.44 163.89 1.19 Allowed 'Trans proline' 0 C--N 1.362 1.269 0 C-N-CA 122.984 2.456 . . . . 52.13 113.415 173.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 219' ' ' VAL . . . . . 0.744 ' HB ' ' HE3' ' C' ' 238' ' ' LYS . 1.7 p -142.44 114.64 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.099 0 N-CA-C 108.154 -1.054 . . . . 52.53 108.154 166.617 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 220' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -90.84 107.74 19.38 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.081 -1.081 . . . . 72.32 108.081 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 221' ' ' VAL . . . . . 0.518 ' HA ' ' HB2' ' B' ' 239' ' ' ALA . 56.0 t -76.07 129.77 36.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 125.124 1.37 . . . . 74.03 111.798 -172.459 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 222' ' ' ALA . . . . . 0.516 ' HA ' ' HG2' ' C' ' 209' ' ' LYS . . . -90.99 123.77 34.72 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.59 0.756 . . . . 73.3 109.848 173.684 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 58.4 t -99.17 142.0 23.84 Favored Pre-proline 0 CA--C 1.561 1.389 0 C-N-CA 125.149 1.38 . . . . 73.11 110.168 -172.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 224' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -85.6 158.9 10.73 Favored 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 123.958 3.105 . . . . 54.33 112.923 168.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -55.95 128.52 30.59 Favored 'Trans proline' 0 C--N 1.385 2.497 0 C-N-CA 123.462 2.775 . . . . 74.0 113.448 178.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 226' ' ' ARG . . . . . 0.554 HH11 HD12 ' A' ' 261' ' ' LEU . 0.0 OUTLIER 52.45 81.14 0.09 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.756 1.622 . . . . 70.15 112.141 -178.82 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 227' ' ' THR . . . . . 0.561 HG22 HG11 ' C' ' 253' ' ' VAL . 54.7 m -93.64 142.27 27.54 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 114.869 -1.06 . . . . 70.3 110.204 176.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 228' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -101.94 146.56 27.69 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.733 0.813 . . . . 74.32 112.271 -173.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -69.56 118.14 12.05 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 114.647 -1.16 . . . . 62.12 108.519 169.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 113.12 -2.3 25.47 Favored Glycine 0 C--N 1.339 0.717 0 CA-C-O 119.6 -0.556 . . . . 62.04 112.205 -175.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 231' ' ' ARG . . . . . . . . . . . . . 60.0 mtp85 -73.79 -179.49 3.68 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 117.126 0.463 . . . . 74.12 111.273 171.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 232' ' ' LYS . . . . . 0.575 ' HD3' ' HB3' ' C' ' 250' ' ' TYR . 34.4 ttmt -148.61 146.43 28.22 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.891 -0.595 . . . . 71.45 111.225 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 233' ' ' LEU . . . . . 0.649 HD13 ' HB2' ' C' ' 251' ' ' LEU . 0.9 OUTLIER -117.26 155.61 29.17 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.998 1.319 . . . . 74.21 108.495 177.349 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 234' ' ' ARG . . . . . 0.469 ' O ' ' HA3' ' B' ' 240' ' ' GLY . 16.8 ptt180 -127.07 109.6 12.05 Favored 'General case' 0 N--CA 1.475 0.775 0 O-C-N 123.702 0.626 . . . . 72.34 109.583 166.033 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 235' ' ' LEU . . . . . 0.481 HD12 HD23 ' C' ' 249' ' ' LEU . 26.8 mt -95.82 128.08 42.39 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.614 0.765 . . . . 73.43 109.185 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -79.87 125.76 30.13 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.25 0.62 . . . . 71.55 112.284 -168.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 77.77 13.71 83.16 Favored Glycine 0 C--N 1.353 1.481 0 O-C-N 124.124 0.89 . . . . 71.42 113.458 178.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 238' ' ' LYS . . . . . 0.744 ' HE3' ' HB ' ' C' ' 219' ' ' VAL . 69.6 mmtt -105.05 19.85 19.88 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.592 0.757 . . . . 72.03 111.446 -178.465 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 239' ' ' GLY . . . . . 0.63 ' HA2' ' HG ' ' C' ' 193' ' ' LEU . . . -92.53 -171.08 40.86 Favored Glycine 0 C--N 1.345 1.071 0 CA-C-N 116.217 -0.447 . . . . 31.21 112.749 171.662 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 240' ' ' PHE . . . . . 0.577 ' HD2' HD13 ' C' ' 188' ' ' LEU . 11.9 m-85 -79.04 154.68 77.61 Favored Pre-proline 0 CA--C 1.563 1.447 0 C-N-CA 122.965 0.506 . . . . 75.14 110.221 177.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 241' ' ' PRO . . . . . 0.584 ' HA ' ' HG2' ' C' ' 246' ' ' ARG . 18.6 Cg_exo -67.55 136.73 40.4 Favored 'Trans proline' 0 C--N 1.396 3.05 0 C-N-CA 124.183 3.255 . . . . 70.21 114.355 -172.137 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -134.2 171.96 21.97 Favored Glycine 0 C--N 1.35 1.344 0 CA-C-N 115.514 -0.767 . . . . 70.14 113.041 178.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.01 -25.06 38.53 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 123.764 2.976 . . . . 71.42 113.321 -177.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -112.7 14.52 20.02 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.894 0.878 . . . . 71.42 111.008 178.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 119.45 177.09 16.3 Favored Glycine 0 C--N 1.349 1.299 0 N-CA-C 112.078 -0.409 . . . . 51.32 112.078 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 246' ' ' ARG . . . . . 0.584 ' HG2' ' HA ' ' C' ' 241' ' ' PRO . 72.4 mtm-85 -85.09 158.77 20.33 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.856 0.862 . . . . 61.31 111.005 -177.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.82 -155.03 6.18 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 114.045 0.378 . . . . 63.23 114.045 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -124.96 139.11 54.12 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.363 0.665 . . . . 73.54 109.578 -179.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 249' ' ' LEU . . . . . 0.481 HD23 HD12 ' C' ' 235' ' ' LEU . 28.8 tp -85.2 115.27 22.88 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.927 0.891 . . . . 74.23 110.836 -177.523 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 250' ' ' TYR . . . . . 0.587 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 16.0 m-30 -99.91 101.7 12.89 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 110.022 -0.362 . . . . 71.43 110.022 179.163 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 251' ' ' LEU . . . . . 0.649 ' HB2' HD13 ' C' ' 233' ' ' LEU . 0.8 OUTLIER -100.62 138.41 37.72 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.632 -0.668 . . . . 64.53 109.802 -175.716 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -87.57 125.44 34.35 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.895 -0.78 . . . . 73.41 108.895 171.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 253' ' ' VAL . . . . . 0.561 HG11 HG22 ' C' ' 227' ' ' THR . 59.3 t -74.5 136.84 24.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 123.213 0.605 . . . . 73.5 110.899 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 254' ' ' ARG . . . . . . . . . . . . . 40.8 mtm180 -116.12 147.11 41.67 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 107.63 -1.248 . . . . 74.13 107.63 163.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 255' ' ' ILE . . . . . 0.538 HG21 HG23 ' A' ' 257' ' ' ILE . 33.4 mm -97.89 119.07 45.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 106.757 -1.571 . . . . 75.24 106.757 164.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 256' ' ' THR . . . . . 0.431 ' O ' ' HA ' ' C' ' 200' ' ' PRO . 0.0 OUTLIER -123.4 173.59 7.89 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.031 1.333 . . . . 53.32 108.461 -178.947 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 2.3 pp -144.12 153.27 56.36 Favored Pre-proline 0 N--CA 1.477 0.888 0 C-N-CA 123.181 0.592 . . . . 64.54 110.569 -174.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.51 6.1 1.35 Allowed 'Trans proline' 0 C--N 1.385 2.495 0 C-N-CA 122.812 2.341 . . . . 73.21 114.278 -175.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 52.43 -84.29 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.858 1.663 . . . . 72.3 112.825 -174.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.14 140.1 58.83 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.908 0.883 . . . . 73.41 110.718 -177.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 261' ' ' LEU . . . . . 0.508 HD22 ' HB3' ' C' ' 265' ' ' GLU . 65.1 mt -124.7 152.97 43.04 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.363 0.665 . . . . 71.21 111.101 -176.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 67.6 p -85.05 168.35 21.15 Favored Pre-proline 0 CA--C 1.556 1.202 0 N-CA-C 107.572 -1.27 . . . . 61.23 107.572 164.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -51.16 -37.44 58.61 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 122.799 2.333 . . . . 74.2 112.863 171.246 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -58.71 -64.08 1.06 Allowed 'General case' 0 C--O 1.251 1.138 0 C-N-CA 124.762 1.225 . . . . 71.04 110.845 175.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 265' ' ' GLU . . . . . 0.508 ' HB3' HD22 ' C' ' 261' ' ' LEU . 32.1 mm-40 -53.21 -44.06 67.72 Favored 'General case' 0 C--N 1.352 0.704 0 O-C-N 124.375 1.047 . . . . 65.11 110.493 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 266' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -58.72 -43.02 90.01 Favored 'General case' 0 C--O 1.214 -0.791 0 C-N-CA 123.462 0.705 . . . . 64.21 110.374 -178.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -62.22 -51.84 66.17 Favored 'General case' 0 CA--C 1.555 1.157 0 O-C-N 123.726 0.641 . . . . 70.32 111.764 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 268' ' ' LEU . . . . . . . . . . . . . 8.7 mp -66.75 -48.69 68.33 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 116.498 -0.319 . . . . 52.44 111.238 -176.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 269' ' ' TRP . . . . . 0.41 ' HH2' ' HB3' ' C' ' 201' ' ' ALA . 94.6 m95 -61.22 -32.53 72.31 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.511 0.724 . . . . 61.11 111.281 176.392 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 270' ' ' LYS . . . . . 0.421 ' HD2' HG11 ' A' ' 206' ' ' VAL . 1.2 mmmm -61.35 -52.34 65.07 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 123.433 0.693 . . . . 75.43 110.872 176.428 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -63.48 -37.57 87.82 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 123.686 0.616 . . . . 75.33 111.233 -178.215 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 95.5 mt -67.14 -35.1 79.0 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 122.744 0.418 . . . . 74.33 111.586 173.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -64.3 -45.53 87.55 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.35 0.66 . . . . 34.13 110.479 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -69.27 -38.72 78.53 Favored 'General case' 0 C--O 1.245 0.845 0 O-C-N 124.38 1.05 . . . . 63.21 110.931 -179.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -60.91 -30.7 70.34 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.768 -0.651 . . . . 70.04 110.554 172.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 276' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -94.05 -13.73 26.58 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 122.984 0.514 . . . . 75.52 112.304 177.374 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 277' ' ' TYR . . . . . 0.434 ' CE1' ' HA3' ' A' ' 208' ' ' GLY . 22.6 m-30 -70.3 -30.65 67.7 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.001 -1.111 . . . . 44.24 108.001 169.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 278' ' ' ALA . . . . . 0.451 ' HA ' HG12 ' B' ' 387' ' ' ILE . . . -63.79 2.61 0.46 Allowed 'General case' 0 CA--C 1.557 1.249 0 CA-C-N 114.177 -1.374 . . . . 55.2 113.07 169.717 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 279' ' ' ARG . . . . . . . . . . . . . 51.9 ttt180 -73.91 -33.54 64.01 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.043 0.537 . . . . 71.52 110.882 171.043 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 280' ' ' ALA . . . . . 0.402 ' HA ' ' HB ' ' B' ' 384' ' ' THR . . . . . . . . 0 CA--C 1.555 1.168 0 O-C-N 123.333 0.396 . . . . 75.14 110.725 -169.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 113.409 0.892 . . . . 62.43 113.409 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.8 mmtp -68.07 107.27 2.66 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-N 115.239 -0.891 . . . . 74.32 108.725 168.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -72.83 88.77 1.34 Allowed 'General case' 0 C--O 1.241 0.637 0 N-CA-C 107.415 -1.328 . . . . 61.41 107.415 174.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -60.26 -30.64 69.57 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 114.827 -1.079 . . . . 73.34 111.678 -175.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -64.9 -53.53 45.13 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.958 -0.565 . . . . 73.33 110.357 176.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.16 -34.63 76.78 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 122.72 0.408 . . . . 60.32 111.3 -178.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 76.5 mt -59.96 -43.35 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 N-CA-C 109.865 -0.42 . . . . 74.23 109.865 172.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.445 HD23 HG23 ' A' ' 50' ' ' ILE . 97.0 mt -75.71 -12.24 60.15 Favored 'General case' 0 CA--C 1.555 1.172 0 CA-C-N 116.042 -0.527 . . . . 51.33 112.3 175.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.52 36.56 33.41 Favored Glycine 0 C--N 1.349 1.302 0 CA-C-N 117.75 0.25 . . . . 53.33 113.686 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.8 m -131.34 159.8 70.07 Favored Pre-proline 0 N--CA 1.484 1.25 0 C-N-CA 124.935 1.294 . . . . 71.43 109.14 177.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -75.96 166.35 28.19 Favored 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 122.524 2.149 . . . . 50.12 112.846 177.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 43.3 mtm-85 -74.73 21.02 0.11 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 113.309 0.855 . . . . 75.43 113.309 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -122.15 6.67 9.72 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.184 0.993 . . . . 64.11 108.982 174.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.47 136.26 47.54 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.508 0.723 . . . . 64.31 111.936 -175.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.5 p -85.6 176.44 8.19 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.284 1.034 . . . . 71.11 110.691 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.3 tm0? -57.15 -37.65 72.38 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.384 0.674 . . . . 64.21 109.978 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.44 ' HB3' ' NH1' ' A' ' 24' ' ' ARG . 43.3 mm-40 -56.69 -54.33 47.34 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 123.772 0.67 . . . . 72.43 111.054 174.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -63.25 -38.82 92.66 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.994 0.518 . . . . 64.03 111.016 -177.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.6 mp -59.55 -39.52 79.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 124.52 1.128 . . . . 73.31 110.6 173.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -68.25 -56.07 9.96 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.414 -0.812 . . . . 71.24 111.056 -175.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.44 ' NH1' ' HB3' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -66.85 -28.84 68.67 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 122.976 0.172 . . . . 54.12 111.203 -179.204 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.434 ' HB1' ' O ' ' A' ' 11' ' ' LEU . . . -62.66 -51.09 68.63 Favored 'General case' 0 C--O 1.245 0.866 0 O-C-N 123.609 0.568 . . . . 64.0 110.754 173.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -58.75 -45.77 88.93 Favored 'General case' 0 C--O 1.215 -0.711 0 CA-C-N 114.73 -1.123 . . . . 73.1 110.469 178.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.427 ' O ' ' HG3' ' A' ' 31' ' ' ARG . 57.3 mtpt -63.14 -44.01 96.75 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 123.888 0.743 . . . . 74.22 111.128 -177.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.1 ttp85 -54.86 -48.25 73.17 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.609 0.763 . . . . 71.15 110.6 175.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.679 ' HB3' HD13 ' A' ' 50' ' ' ILE . 81.6 mt -77.39 -20.65 54.39 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 115.619 -0.719 . . . . 74.11 111.671 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.535 ' HA ' ' HE1' ' A' ' 47' ' ' PHE . . . -81.21 -22.32 38.92 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.615 0.766 . . . . 63.3 111.118 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.427 ' HG3' ' O ' ' A' ' 27' ' ' LYS . 58.1 mtm180 -91.75 -41.85 10.46 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 122.981 0.512 . . . . 72.33 110.047 174.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -69.45 -55.36 10.5 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.319 0.648 . . . . 63.33 111.191 -176.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -96.85 31.25 2.41 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 122.849 0.46 . . . . 63.25 110.27 179.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.492 ' HD2' HG23 ' A' ' 37' ' ' VAL . 44.2 t60 -60.26 101.6 0.26 Allowed Pre-proline 0 N--CA 1.477 0.904 0 C-N-CA 123.99 0.916 . . . . 63.41 110.234 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -70.11 -13.9 34.35 Favored 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 123.061 2.507 . . . . 74.13 113.216 -164.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.409 ' HB3' ' CD2' ' A' ' 34' ' ' HIS . 28.5 t70 -71.53 -35.12 70.58 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.477 0.711 . . . . 72.45 110.526 175.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.492 HG23 ' HD2' ' A' ' 34' ' ' HIS . 99.0 t -94.52 -48.97 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-O 121.309 0.576 . . . . 65.53 109.46 178.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -100.54 71.91 1.54 Allowed 'General case' 0 C--O 1.249 1.035 0 C-N-CA 124.104 0.961 . . . . 61.35 109.486 -177.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -74.36 81.34 1.88 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.049 -0.978 . . . . 73.11 108.873 176.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 67.4 m -138.83 108.67 7.71 Favored Pre-proline 0 C--O 1.24 0.571 0 CA-C-O 118.168 -0.92 . . . . 54.41 108.724 177.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -30.93 -52.43 0.25 Allowed 'Trans proline' 0 C--N 1.392 2.846 0 C-N-CA 125.284 3.989 . . . . 72.23 115.784 -175.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -51.3 -51.39 54.71 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.492 0.717 . . . . 64.43 111.743 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.24 -22.26 62.91 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 115.381 -0.827 . . . . 72.14 111.752 -177.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -88.91 -37.56 15.19 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.372 0.669 . . . . 62.01 110.514 -173.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.515 ' HA ' ' HE2' ' A' ' 48' ' ' LYS . 35.8 mm-40 -70.22 -41.48 73.56 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 108.807 -0.812 . . . . 62.44 108.807 175.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 15.4 tppt? -59.35 -45.54 91.1 Favored 'General case' 0 C--N 1.348 0.541 0 CA-C-N 114.641 -1.163 . . . . 74.03 110.011 173.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.59 ' HA ' HD12 ' A' ' 50' ' ' ILE . 71.3 t80 -58.09 -40.69 81.76 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 123.954 0.784 . . . . 73.24 110.984 176.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.524 ' HB3' ' CE1' ' A' ' 93' ' ' PHE . 43.4 mtmt -66.78 -32.83 74.38 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 119.414 -0.327 . . . . 75.14 111.858 178.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.85 -34.58 76.98 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 120.831 0.348 . . . . 71.44 110.439 172.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.679 HD13 ' HB3' ' A' ' 29' ' ' LEU . 73.3 mt -66.97 -30.27 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.049 0.939 . . . . 70.53 109.721 174.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.414 ' O ' ' HB2' ' A' ' 55' ' ' ALA . 11.7 m-80 -83.29 -19.89 35.46 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.815 0.846 . . . . 73.43 112.125 174.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -70.98 -52.11 21.69 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 122.509 1.147 . . . . 63.42 108.389 171.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.66 -54.3 45.95 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 112.801 -1.999 . . . . 65.45 111.088 176.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -63.18 -37.84 88.81 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-N 115.262 -0.881 . . . . 72.32 111.176 177.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.414 ' HB2' ' O ' ' A' ' 51' ' ' ASN . . . -51.2 -53.53 34.17 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 122.98 0.512 . . . . 53.01 111.407 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 68.0 t -68.02 -44.11 85.0 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 CA-C-N 114.377 -1.283 . . . . 74.52 110.449 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.492 HD22 ' HD2' ' A' ' 63' ' ' ARG . 41.9 mt -91.48 5.8 48.02 Favored 'General case' 0 CA--C 1.563 1.457 0 N-CA-C 113.875 1.065 . . . . 62.04 113.875 -170.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.8 t -80.68 -47.89 13.37 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 123.218 0.607 . . . . 74.34 110.926 177.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -93.35 134.36 26.98 Favored Pre-proline 0 N--CA 1.474 0.768 0 CA-C-O 117.72 -1.133 . . . . 74.34 109.906 -173.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.521 ' O ' ' HG2' ' A' ' 64' ' ' ARG . 9.1 Cg_endo -49.7 -43.98 37.81 Favored 'Trans proline' 0 C--N 1.385 2.492 0 C-N-CA 124.014 3.142 . . . . 72.41 114.027 -177.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.404 ' O ' HG13 ' A' ' 65' ' ' ILE . 3.8 mp0 -67.88 -54.14 21.15 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 122.939 0.496 . . . . 72.3 111.635 -177.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.529 ' HA ' HD12 ' A' ' 65' ' ' ILE . 47.4 mtpt -61.52 -35.17 76.96 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.536 0.734 . . . . 74.54 110.787 -178.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.492 ' HD2' HD22 ' A' ' 57' ' ' LEU . 46.4 tpt85 -54.52 -58.27 8.13 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 114.311 -1.313 . . . . 74.11 108.891 171.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.521 ' HG2' ' O ' ' A' ' 60' ' ' PRO . 1.2 mmp_? -61.58 -28.7 69.53 Favored 'General case' 0 C--O 1.214 -0.801 0 CA-C-N 115.354 -0.839 . . . . 74.25 111.783 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.583 HG23 ' HD2' ' A' ' 76' ' ' PRO . 89.6 mt -61.69 -47.7 92.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 122.931 0.492 . . . . 64.42 109.677 176.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -60.79 -53.77 53.33 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 115.961 -0.563 . . . . 75.4 110.28 175.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -54.13 -44.73 71.61 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.533 0.733 . . . . 64.04 111.801 -176.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 53.7 p -73.77 -27.33 61.1 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.73 0.412 . . . . 75.13 111.332 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -73.37 119.49 17.67 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 109.105 -0.702 . . . . 63.45 109.105 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 101.19 16.22 25.88 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-N 115.964 -0.562 . . . . 52.54 111.964 -168.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 62.9 m -143.29 -59.27 0.42 Allowed 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 104.021 -2.585 . . . . 71.23 104.021 174.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.4 m -83.56 148.85 26.95 Favored 'General case' 0 C--O 1.249 1.061 0 N-CA-C 105.225 -2.139 . . . . 74.23 105.225 157.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.56 -30.15 9.21 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.273 1.029 . . . . 74.04 110.734 -176.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.17 139.9 61.03 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 123.321 0.648 . . . . 75.1 110.005 175.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -62.34 119.02 5.94 Favored 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 122.33 2.02 . . . . 75.41 111.111 175.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.583 ' HD2' HG23 ' A' ' 65' ' ' ILE . 78.6 Cg_exo -51.55 122.14 9.75 Favored 'Trans proline' 0 C--N 1.384 2.42 0 C-N-CA 123.357 2.705 . . . . 74.25 113.183 178.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -44.11 134.51 8.52 Favored 'Trans proline' 0 C--N 1.389 2.703 0 C-N-CA 124.504 3.469 . . . . 62.44 115.176 -168.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -63.15 135.03 48.64 Favored 'Trans proline' 0 C--N 1.386 2.545 0 C-N-CA 122.965 2.444 . . . . 43.51 112.456 -177.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.15 157.66 16.85 Favored 'Trans proline' 0 C--N 1.381 2.268 0 C-N-CA 122.953 2.436 . . . . 71.05 112.1 175.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -60.39 84.45 0.07 OUTLIER 'Trans proline' 0 C--N 1.38 2.222 0 C-N-CA 122.718 2.279 . . . . 51.35 112.185 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 155.01 -42.32 0.59 Allowed Glycine 0 CA--C 1.527 0.785 0 N-CA-C 109.873 -1.291 . . . . 62.41 109.873 -176.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 128.44 -160.5 22.13 Favored Glycine 0 C--N 1.351 1.414 0 CA-C-N 115.103 -0.548 . . . . 53.03 111.79 176.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -97.65 107.55 20.07 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 123.402 0.681 . . . . 74.41 109.166 176.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -54.91 155.09 4.65 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 115.632 -0.713 . . . . 71.31 111.849 170.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -155.98 60.16 0.59 Allowed 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 108.448 -0.945 . . . . 70.22 108.448 174.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 20.4 m -31.93 86.05 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 126.692 1.997 . . . . 74.44 116.39 -169.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 57.13 24.87 52.68 Favored Glycine 0 CA--C 1.536 1.347 0 N-CA-C 114.953 0.741 . . . . 70.11 114.953 176.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -96.58 154.38 17.31 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.412 0.685 . . . . 72.34 110.063 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -82.03 72.05 9.07 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 123.864 0.866 . . . . 71.44 111.476 -168.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.449 HG23 ' HE2' ' A' ' 97' ' ' PHE . 2.1 p -46.31 -50.37 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 C-N-CA 125.171 1.388 . . . . 75.21 113.537 -175.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.41 ' HG2' HG13 ' A' ' 90' ' ' VAL . 11.7 mm-40 -71.64 -4.04 24.99 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 113.55 0.944 . . . . 75.33 113.55 -171.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -107.42 -17.97 13.98 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.157 0.583 . . . . 45.35 111.27 178.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.524 ' CE1' ' HB3' ' A' ' 48' ' ' LYS . 7.6 m-30 -85.64 176.13 8.36 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 122.497 0.319 . . . . 71.01 111.134 -171.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 89.5 p -59.46 151.09 24.86 Favored 'General case' 0 C--O 1.247 0.926 0 N-CA-C 114.163 1.172 . . . . 74.5 114.163 -166.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.403 ' HG3' ' H ' ' A' ' 96' ' ' PHE . 3.4 pt-20 -53.34 -44.65 68.65 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 114.54 -1.209 . . . . 74.31 110.007 167.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.403 ' H ' ' HG3' ' A' ' 95' ' ' GLU . 73.8 t80 -49.79 -51.04 42.44 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.614 1.166 . . . . 75.03 111.331 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.449 ' HE2' HG23 ' A' ' 90' ' ' VAL . 3.5 t80 -58.78 -54.89 42.02 Favored 'General case' 0 CA--C 1.55 0.97 0 O-C-N 123.981 0.801 . . . . 63.23 110.28 174.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -70.8 -6.66 39.45 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 113.371 0.878 . . . . 73.05 113.371 -172.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -101.83 -38.8 7.68 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.275 0.63 . . . . 70.02 111.834 174.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 30.3 tp -69.01 -49.32 58.78 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 121.305 0.574 . . . . 55.03 109.798 177.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -92.04 -8.72 45.16 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 115.231 -0.895 . . . . 72.11 111.42 178.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -45.5 -59.07 4.94 Favored Glycine 0 N--CA 1.482 1.765 0 N-CA-C 115.579 0.991 . . . . 72.43 115.579 178.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -45.37 -23.1 1.12 Allowed 'Trans proline' 0 C--N 1.388 2.635 0 C-N-CA 124.45 3.433 . . . . 23.1 115.441 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -144.28 39.69 1.22 Allowed Glycine 0 C--N 1.354 1.53 0 CA-C-O 118.989 -0.895 . . . . 44.4 113.399 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 13.1 mt -66.02 38.03 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 114.79 1.404 . . . . 74.25 114.79 178.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.647 ' HB3' ' HA ' ' A' ' 169' ' ' ASN . 0.3 OUTLIER 55.78 -102.81 0.16 Allowed 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 123.888 0.875 . . . . 72.25 110.639 162.433 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 70.2 13.3 70.07 Favored Glycine 0 C--N 1.362 2.003 0 C-N-CA 122.776 0.227 . . . . 44.0 112.811 176.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.569 ' H ' ' HD1' ' A' ' 106' ' ' PHE . . . . . . . . 0 C--N 1.346 1.104 0 C-N-CA 123.522 0.582 . . . . 71.34 112.568 -173.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.476 ' HA ' ' HD2' ' A' ' 170' ' ' PRO . 27.1 tptp . . . . . 0 N--CA 1.475 0.808 0 CA-C-O 120.926 0.393 . . . . 72.15 111.331 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -87.46 144.39 19.06 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-N 115.603 -0.726 . . . . 55.22 112.364 172.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -86.92 160.59 18.64 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.156 0.583 . . . . 71.34 111.821 -177.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -60.26 139.22 57.72 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.147 0.579 . . . . 74.23 111.305 176.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.445 HD23 ' N ' ' A' ' 120' ' ' ARG . 4.8 tt -145.89 160.78 41.33 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 107.994 -1.113 . . . . 70.23 107.994 -179.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.445 ' N ' HD23 ' A' ' 119' ' ' LEU . 0.3 OUTLIER -124.77 123.89 40.96 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 109.501 -0.555 . . . . 74.51 109.501 176.794 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.406 ' HB3' HD21 ' A' ' 174' ' ' LEU . . . -129.89 164.95 23.05 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.479 0.712 . . . . 41.51 110.477 -177.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.439 ' O ' HD12 ' B' ' 8' ' ' LEU . 4.2 mm-40 -106.73 120.34 41.73 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 106.976 -1.49 . . . . 61.0 106.976 -172.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.413 HD22 HD13 ' A' ' 176' ' ' LEU . 47.4 tp -97.92 99.84 7.55 Favored Pre-proline 0 CA--C 1.54 0.594 0 N-CA-C 108.191 -1.04 . . . . 54.05 108.191 -176.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.599 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 93.3 Cg_endo -77.74 110.99 3.04 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 121.374 1.383 . . . . 75.33 109.407 177.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.63 ' HA ' HG21 ' B' ' 6' ' ' ILE . 44.2 tp -119.57 136.22 54.46 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.87 0.468 . . . . 64.01 110.862 -168.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 67.9 m -67.92 129.41 39.84 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.927 0.891 . . . . 71.34 110.221 -179.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.475 HD23 ' HB3' ' A' ' 180' ' ' LEU . 51.5 mt -55.11 -43.37 74.0 Favored 'General case' 0 N--CA 1.481 1.123 0 O-C-N 124.376 1.048 . . . . 70.54 111.163 -174.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -57.34 -46.44 83.28 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 114.76 -1.109 . . . . 75.32 110.442 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -72.39 -29.0 63.35 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 115.339 -0.846 . . . . 64.33 110.719 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -67.12 -33.25 75.04 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.199 0.6 . . . . 41.43 110.564 175.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -66.62 -56.22 11.7 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 123.754 0.659 . . . . 74.51 109.744 172.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -61.27 -50.25 73.77 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 114.895 -1.048 . . . . 75.25 112.162 -169.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.04 131.9 0.28 Allowed Glycine 0 C--N 1.344 0.988 0 O-C-N 123.595 0.559 . . . . 71.54 112.937 -178.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 153.93 -161.34 29.9 Favored Glycine 0 C--N 1.338 0.643 0 N-CA-C 111.693 -0.563 . . . . 70.42 111.693 -177.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -71.23 134.7 47.06 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 109.813 -0.44 . . . . 73.14 109.813 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.556 ' NE ' ' HA ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -120.45 124.68 46.05 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 120.759 0.314 . . . . 74.4 110.634 179.701 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.44 ' HB ' HG23 ' B' ' 5' ' ' THR . 92.6 t -77.9 103.63 5.15 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-N 115.118 -0.947 . . . . 71.24 109.452 175.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 57.4 t -115.98 112.51 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.679 1.191 . . . . 73.14 107.792 177.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -111.97 129.54 56.15 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 120.98 0.419 . . . . 71.3 110.675 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.415 HG11 HD23 ' B' ' 8' ' ' LEU . 7.9 p -169.65 149.94 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.99 0 C-N-CA 124.906 1.282 . . . . 75.1 108.388 -177.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 60.68 19.56 9.58 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 113.237 0.828 . . . . 74.24 113.237 174.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 98.68 -31.03 8.59 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 116.402 -0.363 . . . . 31.1 112.607 -178.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.566 ' NH1' ' SD ' ' A' ' 164' ' ' MET . 66.3 ttt180 -86.7 137.62 32.3 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 122.804 0.441 . . . . 72.12 110.811 -178.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 43.1 ttm105 -112.34 97.15 6.43 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 108.189 -1.041 . . . . 74.41 108.189 169.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.6 p -87.21 145.73 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 CA-C-N 115.457 -0.792 . . . . 73.53 111.405 -177.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 39.8 t -103.59 89.05 3.23 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 108.475 -0.935 . . . . 31.45 108.475 170.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 4.9 p -94.45 118.44 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 109.702 -0.481 . . . . 73.42 109.702 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 58.1 ttt85 -72.95 104.16 3.99 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.022 0.439 . . . . 74.14 110.142 177.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 23.6 pt -74.18 143.14 79.81 Favored Pre-proline 0 CA--C 1.554 1.123 0 CA-C-N 115.184 -0.916 . . . . 74.13 110.164 175.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -63.32 138.46 66.27 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.782 2.321 . . . . 60.34 112.315 175.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -62.78 106.38 0.51 Allowed 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.801 2.334 . . . . 74.15 111.837 174.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 90.71 46.68 3.9 Favored Glycine 0 C--N 1.342 0.904 0 CA-C-N 115.508 -0.769 . . . . 75.51 112.184 -176.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.488 HG22 HG11 ' A' ' 178' ' ' VAL . 4.6 p -81.04 126.85 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.314 0.646 . . . . 75.43 110.784 -174.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.707 ' HD2' ' HA ' ' A' ' 191' ' ' GLN . 12.9 mtm180 -108.71 156.98 18.97 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.422 1.089 . . . . 73.23 110.225 -166.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.547 ' HB3' ' HA ' ' A' ' 189' ' ' GLU . 12.9 tp10 -49.62 130.36 20.57 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.011 0.925 . . . . 72.32 112.376 -177.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 89.78 0.18 78.85 Favored Glycine 0 C--N 1.347 1.152 0 CA-C-N 115.483 -0.78 . . . . 14.21 114.008 177.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 58.2 m -67.39 115.31 6.89 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 117.717 0.758 . . . . 74.23 109.784 174.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.505 HG22 HG22 ' A' ' 177' ' ' VAL . 90.3 t -95.98 106.02 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 124.164 0.986 . . . . 72.34 110.209 -174.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.515 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 54.1 mt -87.73 100.67 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 108.243 -1.021 . . . . 75.24 108.243 172.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 65.2 ttt-85 -75.15 100.45 4.27 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 109.247 -0.649 . . . . 61.32 109.247 176.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 4.5 p -125.28 117.36 25.28 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 123.927 0.891 . . . . 61.33 109.348 -178.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.19 147.54 79.09 Favored 'Trans proline' 0 C--N 1.371 1.759 0 C-N-CA 121.451 1.434 . . . . 74.53 110.435 169.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.578 ' HA2' ' HD2' ' A' ' 171' ' ' PRO . . . 124.28 -19.72 7.16 Favored Glycine 0 C--N 1.341 0.838 0 N-CA-C 115.213 0.845 . . . . 70.43 115.213 174.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.566 ' SD ' ' NH1' ' A' ' 143' ' ' ARG . 3.6 mpp? -124.12 8.93 8.61 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 117.687 0.744 . . . . 64.15 111.675 -178.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -87.92 -126.14 2.37 Favored Glycine 0 N--CA 1.477 1.382 0 CA-C-N 117.926 0.33 . . . . 73.33 113.32 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -62.71 153.65 43.93 Favored Glycine 0 C--N 1.357 1.72 0 O-C-N 123.481 0.165 . . . . 74.5 112.698 175.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -70.29 123.02 20.67 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.14 0.576 . . . . 75.42 110.903 -173.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -174.48 167.27 39.53 Favored Glycine 0 C--N 1.345 1.066 0 CA-C-O 119.365 -0.686 . . . . 64.21 111.571 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . 0.647 ' HA ' ' HB3' ' A' ' 106' ' ' PHE . 2.9 t-20 -69.98 -50.78 15.96 Favored Pre-proline 0 N--CA 1.479 0.982 0 CA-C-N 118.281 1.04 . . . . 63.11 110.279 174.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.559 ' HD3' ' HB3' ' A' ' 169' ' ' ASN . 8.3 Cg_endo -90.45 84.69 0.4 Allowed 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 121.703 1.602 . . . . 71.13 108.237 160.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.578 ' HD2' ' HA2' ' A' ' 163' ' ' GLY . 2.7 Cg_exo -71.26 178.99 4.87 Favored 'Trans proline' 0 C--N 1.369 1.657 0 C-N-CA 122.525 2.15 . . . . 71.25 113.007 -163.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -62.85 146.46 50.22 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 117.494 1.758 . . . . 72.4 117.494 -162.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -69.5 89.04 0.5 Allowed 'General case' 0 C--O 1.241 0.658 0 C-N-CA 124.872 1.269 . . . . 71.14 108.547 175.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.406 HD21 ' HB3' ' A' ' 121' ' ' ALA . 22.6 tp -83.14 149.18 27.03 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 114.994 -1.003 . . . . 64.32 111.332 -173.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 80.3 mt -110.56 95.93 5.87 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.037 0.935 . . . . 72.12 108.618 174.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.515 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 93.0 mt -71.21 92.25 1.0 Allowed 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 109.835 -0.431 . . . . 70.05 109.835 175.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.505 HG22 HG22 ' A' ' 158' ' ' VAL . 57.5 t -82.7 100.4 6.38 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 N-CA-C 106.923 -1.51 . . . . 61.43 106.923 173.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.488 HG11 HG22 ' A' ' 153' ' ' VAL . 9.9 p -65.87 113.45 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 CA-C-O 122.036 0.922 . . . . 70.33 110.922 -171.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.599 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 37.6 mmt180 -102.51 106.46 17.18 Favored 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 106.705 -1.591 . . . . 53.32 106.705 171.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.719 HD12 ' HB3' ' A' ' 188' ' ' LEU . 33.0 mt -70.09 143.29 52.46 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 118.921 0.782 . . . . 72.4 109.884 178.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 44.0 mt -54.08 158.07 3.91 Favored Pre-proline 0 N--CA 1.49 1.551 0 C-N-CA 124.314 1.046 . . . . 73.14 112.82 -167.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -75.92 44.01 1.22 Allowed 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 123.298 2.665 . . . . 71.42 111.022 163.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 62.0 t-80 -70.73 131.94 87.43 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 125.371 1.469 . . . . 73.35 107.178 177.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -64.34 12.3 0.1 OUTLIER 'Trans proline' 0 C--N 1.37 1.68 0 C-N-CA 123.557 2.838 . . . . 61.24 117.427 -162.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 4.1 t -112.03 -64.54 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.89 0 CA-C-N 120.455 1.479 . . . . 64.21 110.1 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . 0.552 ' CD1' ' HB2' ' A' ' 195' ' ' ALA . 39.2 m-85 -126.41 163.57 23.01 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 121.614 0.721 . . . . 72.31 111.869 -168.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 31.5 ttp-105 -141.35 96.07 2.93 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 107.102 -1.444 . . . . 75.51 107.102 161.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.719 ' HB3' HD12 ' A' ' 180' ' ' LEU . 54.5 tp -66.24 117.25 8.25 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.784 0.834 . . . . 74.21 110.465 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . 0.551 ' HB3' ' HE1' ' A' ' 194' ' ' TYR . 35.8 tt0 -138.36 132.76 32.02 Favored 'General case' 0 C--O 1.247 0.925 0 C-N-CA 124.164 0.986 . . . . 70.31 109.084 -177.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 78.0 -82.78 1.2 Allowed Glycine 0 C--N 1.343 0.924 0 CA-C-N 115.687 -0.688 . . . . 65.41 111.56 -177.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.707 ' HA ' ' HD2' ' A' ' 154' ' ' ARG . 4.7 pm0 -147.68 -4.79 0.49 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.978 0.911 . . . . 72.32 110.647 174.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -130.73 156.18 45.37 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 122.997 0.519 . . . . 72.32 112.087 -165.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.495 HD21 ' HE1' ' A' ' 240' ' ' PHE . 68.9 mt -90.4 144.49 25.76 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.999 0.92 . . . . 63.44 110.334 -174.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.551 ' HE1' ' HB3' ' A' ' 189' ' ' GLU . 63.7 m-85 -117.24 110.45 18.13 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 109.049 -0.723 . . . . 73.14 109.049 171.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.604 ' HB3' HD23 ' A' ' 251' ' ' LEU . . . -121.52 -175.02 2.99 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.827 0.851 . . . . 74.34 110.999 178.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 22.8 m -125.08 145.63 49.83 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.715 0.806 . . . . 70.21 109.184 175.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.577 HD22 HD13 ' A' ' 251' ' ' LEU . 21.9 tp -133.77 101.16 4.99 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.931 -0.396 . . . . 72.21 109.931 176.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -80.67 113.49 18.9 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.321 -0.992 . . . . 61.43 108.321 166.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 6.4 p -133.26 133.21 22.65 Favored Pre-proline 0 N--CA 1.481 1.089 0 C-N-CA 123.652 0.781 . . . . 64.4 109.097 -171.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.37 151.89 60.25 Favored 'Trans proline' 0 C--N 1.375 1.941 0 C-N-CA 121.386 1.391 . . . . 64.51 112.146 177.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -55.52 -45.81 99.81 Favored Pre-proline 0 CA--C 1.553 1.083 0 N-CA-C 114.507 1.299 . . . . 71.34 114.507 -171.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -57.73 -45.4 33.46 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 121.442 1.428 . . . . 63.54 112.734 175.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 41.9 mt -71.11 -27.67 30.44 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 CA-C-N 116.117 -0.492 . . . . 64.32 111.12 -178.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -72.38 -45.0 61.74 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.268 0.627 . . . . 71.51 111.428 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 73.7 t -71.5 -49.86 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 123.356 0.662 . . . . 63.23 111.52 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.504 HG21 ' HA ' ' C' ' 270' ' ' LYS . 47.8 t -83.67 -35.18 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.196 0.598 . . . . 74.41 110.907 -172.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 91.87 73.96 1.26 Allowed Glycine 0 C--N 1.348 1.202 0 CA-C-N 116.084 -0.507 . . . . 72.35 113.35 176.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -110.42 170.33 13.99 Favored Glycine 0 N--CA 1.473 1.134 0 C-N-CA 122.853 0.263 . . . . 55.24 112.646 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -81.22 128.23 33.56 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.016 0.527 . . . . 45.21 111.921 -175.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.561 HG21 HD11 ' A' ' 197' ' ' LEU . 34.4 m -116.02 168.38 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.124 0.97 . . . . 63.11 108.705 169.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 37.9 ttp-105 -88.51 105.69 17.79 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.643 -0.873 . . . . 71.41 108.643 174.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -103.31 123.48 46.86 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.791 -0.818 . . . . 62.04 108.791 176.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 57.6 mtm -68.06 143.8 55.36 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 122.904 0.482 . . . . 71.23 110.72 -177.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 8.5 m -136.71 166.01 24.56 Favored 'General case' 0 CA--C 1.554 1.106 0 N-CA-C 108.762 -0.829 . . . . 74.1 108.762 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.457 HD21 ' HD2' ' A' ' 186' ' ' PHE . 52.6 mt -65.72 -12.85 57.21 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 114.495 1.294 . . . . 63.31 114.495 -170.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -128.2 31.3 5.08 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 109.355 -0.609 . . . . 64.44 109.355 178.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 112.9 160.71 14.61 Favored Glycine 0 C--N 1.351 1.408 0 CA-C-N 114.883 -1.053 . . . . 33.0 112.887 176.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -74.44 142.56 29.93 Favored 'Trans proline' 0 C--N 1.372 1.783 0 C-N-CA 123.141 2.56 . . . . 70.23 111.917 -178.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 34.7 m -128.88 152.0 36.44 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 C-N-CA 124.026 0.93 . . . . 73.4 109.898 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -78.62 117.97 20.28 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-O 121.248 0.547 . . . . 75.04 110.476 176.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 66.2 t -118.11 114.52 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 123.774 0.83 . . . . 74.13 109.063 -177.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -67.78 101.97 1.15 Allowed 'General case' 0 C--N 1.349 0.556 0 N-CA-C 109.525 -0.546 . . . . 60.25 109.525 172.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 96.3 t -53.9 137.58 55.29 Favored Pre-proline 0 CA--C 1.554 1.105 0 C-N-CA 124.354 1.062 . . . . 63.14 109.823 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -56.22 156.31 21.34 Favored 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 122.522 2.148 . . . . 75.51 111.864 174.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -77.97 151.82 27.76 Favored 'Trans proline' 0 C--N 1.366 1.449 0 C-N-CA 121.616 1.544 . . . . 72.53 111.553 177.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 67.4 mtt-85 67.1 26.68 8.82 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 125.056 1.342 . . . . 74.04 111.498 174.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.444 HG23 HD21 ' A' ' 233' ' ' LEU . 28.8 m -64.16 109.01 1.71 Allowed 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 124.581 1.153 . . . . 64.32 111.468 177.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -101.53 146.56 27.5 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.324 1.05 . . . . 75.32 110.572 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -71.01 145.45 49.98 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.225 0.61 . . . . 62.31 112.367 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 95.19 -1.32 64.68 Favored Glycine 0 C--N 1.342 0.901 0 CA-C-N 115.241 -0.89 . . . . 73.32 112.368 -176.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -109.56 167.97 9.75 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.69 0.796 . . . . 74.0 111.449 -176.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -118.59 115.71 25.12 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.079 0.952 . . . . 72.22 109.919 -177.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.516 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 73.9 mt -80.51 110.19 15.74 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 122.76 0.424 . . . . 71.4 110.279 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . 0.486 ' HA ' ' O ' ' A' ' 249' ' ' LEU . 42.4 ttm180 -74.18 106.65 5.93 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 124.309 1.006 . . . . 64.14 110.392 175.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.445 HD12 HD23 ' A' ' 249' ' ' LEU . 5.0 mt -112.14 101.57 9.82 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 108.331 -0.988 . . . . 61.12 108.331 173.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -67.43 156.18 37.21 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.399 0.68 . . . . 64.43 111.89 -177.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 81.18 -6.81 62.1 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 116.512 -0.313 . . . . 74.2 113.627 177.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.19 -39.83 20.47 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.651 0.781 . . . . 73.01 109.968 176.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -78.98 173.84 55.34 Favored Glycine 0 C--N 1.347 1.153 0 O-C-N 123.676 0.61 . . . . 74.43 111.944 178.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . 0.495 ' HE1' HD21 ' A' ' 193' ' ' LEU . 63.2 m-85 -96.45 160.4 29.7 Favored Pre-proline 0 N--CA 1.473 0.703 0 C-N-CA 123.875 0.87 . . . . 73.13 111.472 -167.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' A' ' 245' ' ' GLY . 11.7 Cg_endo -52.7 140.35 56.46 Favored 'Trans proline' 0 C--N 1.387 2.568 0 C-N-CA 122.79 2.327 . . . . 73.33 112.348 175.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 179.94 -153.04 11.45 Favored Glycine 0 C--N 1.341 0.821 0 CA-C-O 118.738 -1.035 . . . . 73.52 111.597 -176.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . 0.493 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 85.0 Cg_exo -50.0 -43.52 41.48 Favored 'Trans proline' 0 C--N 1.382 2.342 0 C-N-CA 123.955 3.103 . . . . 70.45 114.482 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -85.29 21.45 1.71 Allowed 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.544 0.738 . . . . 70.11 112.372 -175.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 241' ' ' PRO . . . 81.1 -77.1 2.07 Favored Glycine 0 C--N 1.347 1.192 0 N-CA-C 109.253 -1.539 . . . . 62.24 109.253 -170.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 73.1 mtp180 -126.19 160.64 29.69 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.243 1.017 . . . . 75.41 108.537 163.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -92.18 172.03 34.57 Favored Glycine 0 C--O 1.25 1.124 0 CA-C-O 122.134 0.852 . . . . 42.24 113.589 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -101.2 -170.95 1.91 Allowed 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 114.105 -1.048 . . . . 75.44 110.238 -177.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.486 ' O ' ' HA ' ' A' ' 234' ' ' ARG . 22.3 tp -121.54 144.61 48.62 Favored 'General case' 0 C--O 1.216 -0.704 0 N-CA-C 107.041 -1.466 . . . . 70.31 107.041 164.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -124.84 106.24 9.87 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 108.471 -0.937 . . . . 52.51 108.471 173.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.604 HD23 ' HB3' ' A' ' 195' ' ' ALA . 83.1 mt -90.35 119.3 30.53 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 115.386 -0.825 . . . . 72.24 110.712 -179.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -77.21 104.0 7.47 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.011 -0.737 . . . . 75.41 109.011 177.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 38.8 t -73.15 123.53 28.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 115.254 -0.885 . . . . 24.43 111.582 -173.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -125.02 100.96 6.82 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 107.379 -1.341 . . . . 73.14 107.379 166.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.535 ' HB ' ' O ' ' C' ' 255' ' ' ILE . 64.0 mt -75.23 137.15 23.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 115.909 -0.587 . . . . 74.34 109.946 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 39.9 p -119.44 169.49 9.98 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.081 0.952 . . . . 73.43 108.667 173.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.517 ' HB ' ' HD2' ' A' ' 258' ' ' PRO . 2.9 pp -134.38 157.0 78.43 Favored Pre-proline 0 CA--C 1.561 1.392 0 N-CA-C 108.547 -0.909 . . . . 73.4 108.547 175.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' PRO . . . . . 0.517 ' HD2' ' HB ' ' A' ' 257' ' ' ILE . 37.3 Cg_endo -58.81 -12.34 14.53 Favored 'Trans proline' 0 C--N 1.385 2.481 0 C-N-CA 123.617 2.878 . . . . 74.45 116.147 -162.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . 0.58 ' HA ' ' HB3' ' C' ' 226' ' ' ARG . 29.9 tt0 58.25 -70.26 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 125.352 1.461 . . . . 63.24 112.646 -172.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -74.01 131.01 40.96 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 109.285 -0.635 . . . . 75.12 109.285 172.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 19.6 mt -138.58 144.24 39.73 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.78 0.8 . . . . 55.32 111.587 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 24.5 p -96.92 148.9 35.07 Favored Pre-proline 0 CA--C 1.559 1.32 0 CA-C-N 114.167 -1.378 . . . . 44.34 108.954 173.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -39.87 -47.55 3.76 Favored 'Trans proline' 0 C--N 1.387 2.566 0 C-N-CA 125.114 3.876 . . . . 74.33 116.937 -168.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -67.92 -49.16 63.48 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 122.747 0.419 . . . . 71.44 111.417 -175.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -58.48 -44.57 89.39 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 109.91 -0.404 . . . . 64.2 109.91 177.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' GLU . . . . . 0.407 ' OE1' ' HD2' ' C' ' 226' ' ' ARG . 11.8 tp10 -62.65 -33.65 75.47 Favored 'General case' 0 CA--C 1.549 0.92 0 O-C-N 123.754 0.659 . . . . 73.45 111.278 178.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -66.63 -41.71 87.9 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 122.843 0.457 . . . . 64.12 110.782 176.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 10.9 mp -65.54 -47.73 74.87 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.13 0.572 . . . . 73.14 110.7 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 65.9 m95 -58.63 -43.97 89.87 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.925 0.89 . . . . 75.0 111.752 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . 0.485 ' O ' ' HG3' ' A' ' 274' ' ' GLU . 42.9 mttp -67.53 -42.78 82.17 Favored 'General case' 0 C--O 1.215 -0.736 0 CA-C-O 119.215 -0.422 . . . . 62.43 111.44 178.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . 0.417 ' HA ' ' HD3' ' A' ' 271' ' ' LYS . 32.2 mmtm -62.87 -35.62 80.59 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 117.884 0.311 . . . . 70.22 111.706 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' LEU . . . . . 0.652 HD21 ' HB2' ' C' ' 268' ' ' LEU . 86.7 mt -60.31 -50.81 72.14 Favored 'General case' 0 C--O 1.214 -0.768 0 O-C-N 123.909 0.755 . . . . 63.4 109.5 169.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . 0.445 ' HA ' ' HB2' ' C' ' 202' ' ' PRO . . . -65.41 -29.93 70.68 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.492 1.117 . . . . 64.51 113.721 -174.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.485 ' HG3' ' O ' ' A' ' 270' ' ' LYS . 41.1 mt-10 -81.3 -49.09 11.15 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 123.27 0.628 . . . . 74.35 109.311 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -67.7 -18.81 65.05 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 115.605 -0.725 . . . . 71.44 111.156 177.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . 0.404 ' HE2' ' HG3' ' C' ' 258' ' ' PRO . 21.0 t80 -77.9 -76.66 0.18 Allowed 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 108.349 -0.982 . . . . 75.02 108.349 171.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -50.05 -60.63 2.76 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.673 1.189 . . . . 70.12 111.543 -171.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -61.63 -28.65 69.52 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 123.7 0.625 . . . . 75.41 111.795 -174.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . 0.487 ' HA ' ' HE ' ' A' ' 279' ' ' ARG . 4.6 mmp_? -117.84 32.48 6.13 Favored 'General case' 0 C--N 1.349 0.548 0 N-CA-C 109.507 -0.553 . . . . 74.13 109.507 -174.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.198 0 N-CA-C 108.709 -0.848 . . . . 72.21 108.709 171.524 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 68.4 mtm . . . . . 0 N--CA 1.483 1.185 0 N-CA-C 109.936 -0.394 . . . . 71.44 109.936 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -104.06 84.96 2.31 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.473 0.709 . . . . 54.1 109.354 -173.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -67.78 -72.34 0.18 Allowed 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 109.44 -0.578 . . . . 74.04 109.44 178.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 22.4 m 64.88 -65.87 0.14 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 125.132 1.373 . . . . 52.14 112.716 176.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' THR . . . . . 0.44 HG23 ' HB ' ' A' ' 137' ' ' VAL . 4.3 m -74.44 153.44 39.18 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 123.635 0.774 . . . . 70.11 111.254 177.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.63 HG21 ' HA ' ' A' ' 125' ' ' LEU . 41.6 pt -135.6 -179.84 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 123.173 0.589 . . . . 64.44 112.282 -169.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -130.35 -158.24 0.88 Allowed 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 124.258 1.023 . . . . 72.01 109.612 178.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . 0.439 HD12 ' O ' ' A' ' 122' ' ' GLU . 45.3 tp -141.4 149.75 41.47 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.735 0.814 . . . . 75.22 109.802 179.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.84 -51.25 8.81 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 122.747 0.419 . . . . 62.4 111.764 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 27.0 mt 74.71 -22.46 0.26 Allowed 'General case' 0 N--CA 1.499 2.013 0 C-N-CA 125.381 1.472 . . . . 74.1 113.788 -174.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 79.9 mt . . . . . 0 CA--C 1.565 1.549 0 C-N-CA 124.385 1.074 . . . . 45.35 111.877 -172.442 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.061 0 N-CA-C 109.506 -0.553 . . . . 61.34 109.506 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . -172.73 -56.06 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 114.527 -1.215 . . . . 74.4 108.482 170.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 181' ' ' LEU . . . . . 0.628 ' HB2' ' HB3' ' C' ' 136' ' ' ARG . 59.3 tp -105.9 -89.38 0.43 Allowed 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 107.602 -1.259 . . . . 62.04 107.602 169.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 182' ' ' VAL . . . . . 0.505 HG11 ' HB2' ' C' ' 123' ' ' LEU . 30.5 m -129.04 -173.04 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.932 0 C-N-CA 124.716 1.206 . . . . 71.31 108.477 170.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -171.94 95.99 0.16 Allowed 'General case' 0 CA--C 1.547 0.865 0 CA-C-O 118.414 -0.803 . . . . 65.24 112.394 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 11.1 p-80 164.56 159.19 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.724 0 C-N-CA 125.551 1.54 . . . . 74.15 112.396 160.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 185' ' ' VAL . . . . . . . . . . . . . 34.8 t . . . . . 0 N--CA 1.494 1.737 0 C-N-CA 124.901 1.28 . . . . 71.33 109.33 169.932 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 23.0 m . . . . . 0 CA--C 1.557 1.213 0 CA-C-O 120.796 0.331 . . . . 71.31 110.639 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 239' ' ' ALA . . . . . 0.555 ' HB2' ' HA ' ' C' ' 221' ' ' VAL . . . -55.27 -78.63 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.184 0.994 . . . . 74.42 112.951 -175.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . 152.82 -114.32 0.62 Allowed Glycine 0 C--N 1.339 0.699 0 N-CA-C 110.623 -0.991 . . . . 71.23 110.623 -172.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -151.61 136.07 16.91 Favored 'General case' 0 C--O 1.245 0.855 0 C-N-CA 123.455 0.702 . . . . 71.21 110.012 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 242' ' ' TRP . . . . . 0.528 ' CD2' ' HG ' ' C' ' 233' ' ' LEU . 4.7 p-90 -172.21 138.24 0.96 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.809 0.843 . . . . 70.32 112.106 173.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 71.8 mm-40 62.99 -75.0 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.819 1.648 . . . . 74.22 111.765 175.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 178.96 58.9 0.07 OUTLIER Glycine 0 C--N 1.342 0.9 0 N-CA-C 112.226 -0.35 . . . . 63.11 112.226 177.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 245' ' ' LYS . . . . . 0.771 ' HE2' ' HB1' ' C' ' 222' ' ' ALA . 52.8 tptt . . . . . 0 CA--C 1.541 0.607 0 CA-C-O 120.883 0.373 . . . . 75.34 110.767 177.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.287 0 CA-C-O 120.889 0.376 . . . . 52.01 110.881 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -39.11 102.75 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.607 1.563 . . . . 70.52 113.548 177.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 5' ' ' LYS . . . . . 0.484 ' HE2' HD11 ' C' ' 10' ' ' ILE . 48.0 mtpt -84.47 125.44 32.37 Favored 'General case' 0 C--O 1.245 0.832 0 N-CA-C 109.402 -0.592 . . . . 63.2 109.402 173.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -77.16 100.98 5.96 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.627 -0.879 . . . . 63.22 108.627 177.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 7' ' ' TYR . . . . . 0.54 ' HD1' HD12 ' C' ' 10' ' ' ILE . 23.4 m-85 -63.27 -31.17 72.25 Favored 'General case' 0 C--O 1.252 1.185 0 C-N-CA 123.741 0.817 . . . . 73.43 112.158 -172.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 8' ' ' TYR . . . . . 0.422 ' HE1' HD11 ' C' ' 22' ' ' ILE . 89.7 m-85 -60.51 -47.77 84.71 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.828 -0.624 . . . . 72.53 109.846 174.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.7 -38.02 88.05 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.546 0.738 . . . . 52.31 111.102 -177.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 10' ' ' ILE . . . . . 0.54 HD12 ' HD1' ' C' ' 7' ' ' TYR . 72.0 mt -58.28 -39.93 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 123.225 0.61 . . . . 63.34 110.41 175.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 11' ' ' LEU . . . . . 0.528 ' O ' ' HB1' ' C' ' 25' ' ' ALA . 86.0 mt -86.3 -11.67 51.57 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 112.654 0.613 . . . . 45.45 112.654 175.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.69 24.15 65.58 Favored Glycine 0 CA--C 1.535 1.328 0 N-CA-C 114.347 0.499 . . . . 64.33 114.347 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 5.8 m -105.84 156.19 37.02 Favored Pre-proline 0 N--CA 1.486 1.374 0 C-N-CA 124.056 0.942 . . . . 64.04 109.955 171.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -78.4 168.29 21.71 Favored 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 122.825 2.35 . . . . 74.43 114.427 -178.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 80.2 mtt180 -75.01 72.2 2.13 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.766 0.827 . . . . 71.52 109.87 173.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 175.11 -19.94 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.99 1.316 . . . . 71.24 108.896 -175.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -46.49 133.47 9.98 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 125.484 1.513 . . . . 71.14 113.447 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 18.2 p -74.19 148.2 41.85 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 123.946 0.779 . . . . 74.41 109.074 175.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 19' ' ' GLN . . . . . 0.402 ' HA ' HD12 ' C' ' 22' ' ' ILE . 25.9 tt0 -51.51 -34.11 34.58 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 124.069 0.948 . . . . 74.45 112.131 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.11 -44.98 67.86 Favored 'General case' 0 CA--C 1.556 1.201 0 CA-C-N 114.838 -1.074 . . . . 64.05 110.331 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -73.38 -27.27 61.39 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 123.023 0.529 . . . . 73.42 111.659 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 22' ' ' ILE . . . . . 0.514 HD13 HD13 ' C' ' 57' ' ' LEU . 76.5 mt -61.97 -44.29 98.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 123.94 0.896 . . . . 61.32 109.073 169.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 23' ' ' LYS . . . . . 0.439 ' O ' ' HG3' ' C' ' 27' ' ' LYS . 5.1 ttpm? -65.02 -32.64 74.46 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 114.922 -1.036 . . . . 74.13 111.388 175.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 24' ' ' ARG . . . . . 0.636 ' HA ' ' HE3' ' C' ' 27' ' ' LYS . 56.1 mtt180 -62.67 -46.91 85.98 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 120.961 0.41 . . . . 73.52 111.118 175.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . 0.528 ' HB1' ' O ' ' C' ' 11' ' ' LEU . . . -62.13 -39.17 91.69 Favored 'General case' 0 C--O 1.251 1.14 0 CA-C-N 114.814 -1.084 . . . . 75.32 111.389 177.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 26' ' ' TYR . . . . . 0.477 ' HD1' HG22 ' C' ' 50' ' ' ILE . 38.9 t80 -54.3 -54.7 36.66 Favored 'General case' 0 C--O 1.207 -1.147 0 CA-C-N 115.115 -0.948 . . . . 72.31 109.975 170.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . 0.636 ' HE3' ' HA ' ' C' ' 24' ' ' ARG . 10.3 mtmp? -56.85 -40.13 75.54 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 123.319 0.647 . . . . 74.1 111.452 -176.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 28' ' ' ARG . . . . . 0.466 ' HA ' ' NH2' ' C' ' 31' ' ' ARG . 34.8 ttp180 -57.9 -52.25 66.26 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 123.936 0.773 . . . . 71.15 110.606 177.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . 0.425 ' HA ' ' HB3' ' C' ' 32' ' ' GLN . 80.6 mt -84.28 -9.72 58.25 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-N 114.905 -1.043 . . . . 60.22 111.756 -176.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -86.85 -23.5 25.26 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.991 0.917 . . . . 75.32 110.214 175.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . 0.466 ' NH2' ' HA ' ' C' ' 28' ' ' ARG . 54.7 mtm180 -80.4 -45.88 16.94 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.518 0.727 . . . . 73.5 109.108 167.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 32' ' ' GLN . . . . . 0.425 ' HB3' ' HA ' ' C' ' 29' ' ' LEU . 59.4 tp60 -60.94 -50.97 71.26 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.245 1.018 . . . . 71.12 112.263 -175.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 33' ' ' TYR . . . . . 0.514 ' HB3' ' O ' ' C' ' 43' ' ' ALA . 31.2 m-85 -103.94 20.03 18.92 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.066 0.547 . . . . 70.15 111.843 -172.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 34' ' ' HIS . . . . . 0.478 ' HB3' ' HB ' ' C' ' 37' ' ' VAL . 5.7 t60 -63.87 114.34 13.22 Favored Pre-proline 0 N--CA 1.482 1.16 0 CA-C-O 118.526 -0.75 . . . . 72.34 111.023 -172.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 35' ' ' PRO . . . . . 0.431 ' HA ' ' HG2' ' C' ' 44' ' ' GLU . 34.7 Cg_exo -40.25 -50.43 3.58 Favored 'Trans proline' 0 C--N 1.385 2.488 0 C-N-CA 124.868 3.712 . . . . 71.32 116.111 -166.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -91.39 -23.7 19.97 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 111.797 0.295 . . . . 60.34 111.797 -173.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . 0.478 ' HB ' ' HB3' ' C' ' 34' ' ' HIS . 69.0 t -74.67 -41.94 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 108.658 -0.867 . . . . 75.33 108.658 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -112.8 96.12 5.79 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.399 -1.334 . . . . 54.22 107.399 175.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -70.61 76.44 0.59 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.801 0.841 . . . . 62.24 110.138 -175.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 62.5 m -152.04 104.62 2.81 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 123.659 0.784 . . . . 74.14 109.306 -176.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -44.64 -38.4 12.33 Favored 'Trans proline' 0 C--N 1.382 2.305 0 C-N-CA 123.882 3.054 . . . . 63.44 113.554 173.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -52.02 -49.94 62.38 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.647 0.779 . . . . 65.44 110.588 174.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 43' ' ' ALA . . . . . 0.514 ' O ' ' HB3' ' C' ' 33' ' ' TYR . . . -71.11 -21.72 62.18 Favored 'General case' 0 C--O 1.213 -0.831 0 CA-C-N 115.143 -0.935 . . . . 62.05 110.805 -178.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 44' ' ' GLU . . . . . 0.471 ' O ' ' HG3' ' C' ' 48' ' ' LYS . 38.0 mt-10 -76.37 -36.06 58.34 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.481 -0.563 . . . . 74.04 109.481 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -73.27 -38.73 65.84 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.756 0.822 . . . . 42.53 110.382 176.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 46' ' ' LYS . . . . . 0.5 ' O ' HG12 ' C' ' 50' ' ' ILE . 0.4 OUTLIER -63.91 -39.16 93.53 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.751 -0.659 . . . . 72.32 109.355 172.711 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -63.52 -34.53 78.0 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.08 0.952 . . . . 62.23 110.317 176.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 48' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' C' ' 44' ' ' GLU . 94.6 mttt -63.28 -43.47 97.83 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.487 -0.324 . . . . 72.04 110.28 174.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -64.11 -33.88 76.77 Favored 'General case' 0 CA--C 1.555 1.148 0 O-C-N 122.928 0.142 . . . . 72.33 110.741 176.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 50' ' ' ILE . . . . . 0.5 HG12 ' O ' ' C' ' 46' ' ' LYS . 13.2 mm -65.11 -42.48 94.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 CA-C-O 121.571 0.701 . . . . 75.43 109.441 175.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 51' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -76.31 -18.18 59.07 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 114.454 -1.248 . . . . 74.04 111.972 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 52' ' ' GLU . . . . . 0.454 ' O ' HG23 ' C' ' 56' ' ' VAL . 33.6 tt0 -74.86 -56.52 4.68 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.323 1.049 . . . . 63.42 108.611 176.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.95 -44.37 78.37 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 113.823 -1.535 . . . . 63.1 110.781 177.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -67.45 -38.6 84.73 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.33 -0.85 . . . . 75.01 111.152 176.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.32 -36.57 68.87 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 117.891 0.314 . . . . 60.54 111.197 177.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 56' ' ' VAL . . . . . 0.464 HG13 ' HZ ' ' C' ' 101' ' ' PHE . 3.0 t -94.98 -11.82 8.73 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 CA-C-N 115.902 -0.59 . . . . 72.43 111.871 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 57' ' ' LEU . . . . . 0.514 HD13 HD13 ' C' ' 22' ' ' ILE . 86.5 mt -126.37 19.86 7.44 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.98 -1.075 . . . . 75.02 113.654 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 45.9 t -80.74 -56.52 4.09 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 123.22 0.608 . . . . 62.42 112.456 178.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 59' ' ' ASP . . . . . 0.624 ' HB2' ' HD3' ' C' ' 62' ' ' LYS . 3.6 m-20 -108.68 153.6 42.16 Favored Pre-proline 0 N--CA 1.487 1.414 0 CA-C-O 118.086 -0.959 . . . . 72.03 109.904 -168.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 60' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -44.09 -43.47 12.75 Favored 'Trans proline' 0 C--N 1.397 3.106 0 C-N-CA 124.453 3.436 . . . . 33.23 114.192 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -61.89 -60.4 3.7 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.637 -0.71 . . . . 62.13 111.491 -178.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 62' ' ' LYS . . . . . 0.624 ' HD3' ' HB2' ' C' ' 59' ' ' ASP . 0.1 OUTLIER -62.67 -40.12 96.08 Favored 'General case' 0 C--O 1.248 1.01 0 O-C-N 124.244 0.965 . . . . 75.23 109.419 -173.164 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 47.2 tpt85 -51.84 -55.79 17.84 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 114.06 -1.427 . . . . 64.42 109.993 176.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -74.93 -18.07 60.46 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.333 -0.849 . . . . 74.15 112.499 -177.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 69.2 mt -62.94 -48.85 86.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 108.645 -0.872 . . . . 62.34 108.645 170.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -65.7 -43.86 87.88 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.799 -0.637 . . . . 74.22 110.681 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -61.59 -36.13 79.8 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 122.765 0.426 . . . . 73.14 111.578 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 74.4 p -83.9 -15.49 47.84 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 119.144 -0.455 . . . . 63.2 111.165 175.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -71.33 136.25 47.75 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.42 -0.956 . . . . 75.22 108.42 175.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.64 19.21 55.0 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 111.296 -0.721 . . . . 62.51 111.296 -167.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 58.6 m -145.84 -59.07 0.32 Allowed 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 103.274 -2.862 . . . . 72.34 103.274 174.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 13.3 m -79.88 137.47 36.92 Favored 'General case' 0 C--O 1.251 1.168 0 N-CA-C 104.63 -2.359 . . . . 73.35 104.63 156.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.09 -30.9 5.53 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.957 0.903 . . . . 73.23 110.15 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.45 124.86 91.4 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 115.614 -0.721 . . . . 53.23 109.219 174.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -53.31 146.1 41.97 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 122.871 2.381 . . . . 75.14 112.293 173.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -51.89 139.59 50.1 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 123.01 2.473 . . . . 63.14 112.849 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.66 138.9 86.81 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 122.743 2.295 . . . . 51.51 111.705 172.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 78' ' ' PRO . . . . . 0.512 ' HB3' ' HB2' ' C' ' 103' ' ' PRO . 18.0 Cg_endo -59.22 116.45 3.28 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 122.85 2.366 . . . . 74.44 112.581 -176.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -64.21 124.05 12.82 Favored 'Trans proline' 0 C--N 1.376 2.023 0 C-N-CA 122.324 2.016 . . . . 61.04 109.729 171.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -55.32 83.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.392 2.824 0 C-N-CA 123.751 2.967 . . . . 51.5 112.697 -175.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 161.91 -59.99 0.29 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 109.245 -1.542 . . . . 75.2 109.245 -174.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.437 ' HA3' ' HG3' ' C' ' 167' ' ' GLN . . . 143.61 172.69 14.61 Favored Glycine 0 C--N 1.358 1.795 0 C-N-CA 123.069 0.366 . . . . 74.45 112.761 -177.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -90.37 119.02 30.31 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.684 -0.858 . . . . 70.14 108.684 171.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 84' ' ' ASP . . . . . 0.612 ' HB2' ' HA ' ' C' ' 164' ' ' MET . 6.6 p-10 -70.29 133.21 46.76 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.509 0.724 . . . . 63.13 111.156 -178.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 85' ' ' PHE . . . . . 0.597 ' HB3' ' HB2' ' C' ' 88' ' ' PHE . 54.8 m-85 -139.43 69.81 1.37 Allowed 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.813 0.816 . . . . 74.41 110.796 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 16.7 m -61.5 96.07 0.06 Allowed 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 114.276 -1.329 . . . . 45.43 111.442 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.11 5.11 90.34 Favored Glycine 0 C--N 1.347 1.14 0 CA-C-N 115.807 -0.633 . . . . 74.33 113.317 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 88' ' ' PHE . . . . . 0.597 ' HB2' ' HB3' ' C' ' 85' ' ' PHE . 6.3 m-85 -103.78 118.07 35.83 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 108.154 -1.054 . . . . 74.44 108.154 -179.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -83.7 73.32 10.28 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 122.2 1.0 . . . . 72.23 110.766 -176.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 90' ' ' VAL . . . . . 0.535 HG23 ' HE2' ' C' ' 97' ' ' PHE . 2.4 p -41.32 -43.28 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 C-N-CA 126.551 1.94 . . . . 54.41 113.961 175.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -61.78 -32.01 72.26 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.831 0.852 . . . . 74.21 112.049 -175.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -101.26 4.18 41.55 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.482 0.313 . . . . 75.53 111.471 -176.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 93' ' ' PHE . . . . . 0.454 ' CD2' ' HA ' ' C' ' 90' ' ' VAL . 19.4 m-30 -78.04 177.5 8.26 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 110.23 -0.285 . . . . 72.45 110.23 174.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 77.4 p -62.18 158.63 16.49 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.829 0.852 . . . . 45.51 113.269 -173.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 95' ' ' GLU . . . . . 0.465 ' O ' ' HG3' ' C' ' 99' ' ' GLU . 0.0 OUTLIER -64.25 -25.69 68.17 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 123.51 0.507 . . . . 55.43 111.008 170.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -62.44 -45.41 93.19 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.694 0.798 . . . . 65.02 110.413 172.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 97' ' ' PHE . . . . . 0.535 ' HE2' HG23 ' C' ' 90' ' ' VAL . 32.5 t80 -64.93 -37.17 86.74 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 115.02 -0.991 . . . . 64.25 109.432 175.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 98' ' ' GLN . . . . . 0.409 ' HB2' ' HA ' ' C' ' 95' ' ' GLU . 70.3 mt-30 -71.12 -17.27 62.57 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.021 -0.99 . . . . 51.52 112.003 178.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 99' ' ' GLU . . . . . 0.465 ' HG3' ' O ' ' C' ' 95' ' ' GLU . 40.2 mt-10 -78.22 -57.9 3.54 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 109.602 -0.518 . . . . 74.43 109.602 167.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 26.6 tp -65.94 -31.26 72.08 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 114.369 -1.287 . . . . 73.23 112.336 -166.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 101' ' ' PHE . . . . . 0.464 ' HZ ' HG13 ' C' ' 56' ' ' VAL . 76.6 m-85 -120.34 13.37 11.88 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.377 0.671 . . . . 73.25 110.885 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -43.55 -63.8 2.05 Favored Glycine 0 C--N 1.352 1.437 0 N-CA-C 116.241 1.256 . . . . 54.11 116.241 -173.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . 0.512 ' HB2' ' HB3' ' C' ' 78' ' ' PRO . 38.8 Cg_exo -58.81 -6.3 3.31 Favored 'Trans proline' 0 C--N 1.373 1.837 0 C-N-CA 123.545 2.83 . . . . 62.02 115.225 -174.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -147.28 41.02 0.97 Allowed Glycine 0 C--N 1.351 1.407 0 CA-C-O 119.634 -0.537 . . . . 43.23 112.712 176.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 105' ' ' LEU . . . . . 0.408 HD11 ' HA ' ' C' ' 98' ' ' GLN . 38.0 mt . . . . . 0 N--CA 1.495 1.813 0 N-CA-C 116.445 2.017 . . . . 73.03 116.445 -177.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 116' ' ' GLY . . . . . 0.592 ' HA2' ' HA3' ' C' ' 168' ' ' GLY . . . . . . . . 0 CA--C 1.51 -0.241 0 CA-C-O 120.064 -0.298 . . . . 45.25 113.302 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 117' ' ' ARG . . . . . 0.452 ' HB2' ' HA3' ' C' ' 166' ' ' GLY . 52.1 mmm-85 -70.03 97.9 1.23 Allowed 'General case' 0 C--O 1.249 1.027 0 N-CA-C 107.314 -1.365 . . . . 64.44 107.314 174.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.09 98.12 0.56 Allowed 'General case' 0 C--O 1.242 0.659 0 CA-C-N 114.767 -1.106 . . . . 75.42 108.166 -178.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 119' ' ' LEU . . . . . 0.41 ' O ' HD12 ' C' ' 174' ' ' LEU . 56.0 tp -93.05 98.67 11.49 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 108.134 -1.061 . . . . 75.21 108.134 -168.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.444 HH12 HG21 ' C' ' 158' ' ' VAL . 40.8 ttm-85 -100.48 114.83 28.76 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.58 -0.896 . . . . 72.31 108.58 -177.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 121' ' ' ALA . . . . . 0.505 ' HB3' HD23 ' C' ' 176' ' ' LEU . . . -115.46 130.25 56.82 Favored 'General case' 0 C--O 1.219 -0.534 0 C-N-CA 123.644 0.777 . . . . 63.21 110.366 -174.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 122' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' C' ' 177' ' ' VAL . 11.5 pt-20 -90.06 147.63 23.53 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 109.413 -0.588 . . . . 73.22 109.413 174.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 123' ' ' LEU . . . . . 0.505 ' HB2' HG11 ' B' ' 182' ' ' VAL . 2.6 pt? -143.81 123.12 7.34 Favored Pre-proline 0 N--CA 1.482 1.173 0 N-CA-C 112.68 0.622 . . . . 73.3 112.68 -176.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . 0.445 ' HA ' ' O ' ' C' ' 179' ' ' ARG . 24.3 Cg_exo -65.7 117.67 4.83 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 122.739 2.293 . . . . 72.51 110.905 170.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 125' ' ' LEU . . . . . 0.458 HD23 HG11 ' C' ' 153' ' ' VAL . 44.7 tp -145.32 153.72 41.56 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.92 0.488 . . . . 74.03 110.311 -172.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 126' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.31 166.01 10.68 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.766 0.827 . . . . 61.53 109.873 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 127' ' ' LEU . . . . . 0.5 HD21 HD13 ' C' ' 180' ' ' LEU . 94.4 mt -78.13 -36.79 47.42 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.854 0.862 . . . . 62.25 111.333 -178.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 128' ' ' GLU . . . . . 0.425 ' HG3' ' HA ' ' C' ' 215' ' ' LEU . 18.0 mp0 -70.52 -32.18 69.54 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.987 -1.006 . . . . 75.24 109.542 173.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -87.4 -8.71 56.25 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.095 0.558 . . . . 73.53 111.416 176.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -76.56 -43.19 40.04 Favored 'General case' 0 C--O 1.22 -0.461 0 N-CA-C 108.191 -1.04 . . . . 64.34 108.191 164.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 131' ' ' PHE . . . . . 0.461 ' HB2' HD13 ' C' ' 215' ' ' LEU . 77.5 t80 -60.2 -37.99 81.94 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.781 1.233 . . . . 75.55 111.234 174.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 132' ' ' HIS . . . . . . . . . . . . . 65.7 m170 -78.68 -69.96 0.53 Allowed 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.831 -0.622 . . . . 60.22 110.669 177.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 49.46 -103.81 0.09 OUTLIER Glycine 0 C--N 1.353 1.52 0 O-C-N 124.047 0.842 . . . . 65.31 112.986 -178.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.98 -153.8 34.67 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 114.525 0.57 . . . . 53.24 114.525 170.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -93.42 93.86 8.39 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.152 -1.055 . . . . 71.2 108.152 -167.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 136' ' ' ARG . . . . . 0.628 ' HB3' ' HB2' ' B' ' 181' ' ' LEU . 0.9 OUTLIER -142.19 147.45 36.61 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 122.229 -0.295 . . . . 72.12 110.979 -167.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 137' ' ' VAL . . . . . 0.583 ' HA ' ' HA ' ' C' ' 146' ' ' SER . 7.7 p -95.07 129.99 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-O 121.493 0.664 . . . . 71.12 111.364 -177.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 138' ' ' VAL . . . . . . . . . . . . . 3.0 p -114.84 140.72 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.612 1.165 . . . . 72.14 108.953 178.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 139' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -108.0 111.59 23.74 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 107.8 -1.185 . . . . 74.31 107.8 172.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 140' ' ' VAL . . . . . 0.415 HG21 ' HB2' ' C' ' 121' ' ' ALA . 2.7 p -130.63 128.15 62.94 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 C-N-CA 123.896 0.878 . . . . 63.22 109.215 -179.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 65.37 33.36 9.03 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.803 0.841 . . . . 15.23 112.388 174.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 78.7 12.5 84.15 Favored Glycine 0 C--N 1.345 1.044 0 CA-C-N 116.399 -0.364 . . . . 45.25 112.302 -176.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 143' ' ' ARG . . . . . . . . . . . . . 29.1 tpt180 -126.32 100.83 6.45 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.445 0.698 . . . . 73.04 109.991 -168.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -83.99 129.33 34.92 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.181 -0.918 . . . . 71.51 109.225 176.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 145' ' ' VAL . . . . . . . . . . . . . 3.7 p -166.34 140.26 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 123.822 0.849 . . . . 75.03 109.854 -174.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 146' ' ' SER . . . . . 0.583 ' HA ' ' HA ' ' C' ' 137' ' ' VAL . 56.8 p -100.7 146.05 27.69 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.075 0.55 . . . . 54.21 111.998 -174.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 8.9 p -151.67 150.33 13.22 Favored 'Isoleucine or valine' 0 C--O 1.242 0.711 0 CA-C-N 115.716 -0.674 . . . . 72.53 109.838 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 20.3 ttt180 -105.36 94.67 5.34 Favored 'General case' 0 C--N 1.347 0.482 0 N-CA-C 107.971 -1.122 . . . . 74.22 107.971 168.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 149' ' ' ILE . . . . . 0.418 HD12 HD13 ' C' ' 159' ' ' ILE . 37.8 pt -75.97 146.68 79.44 Favored Pre-proline 0 CA--C 1.55 0.956 0 CA-C-O 118.603 -0.713 . . . . 71.41 109.513 176.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.37 115.75 2.8 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 122.408 2.072 . . . . 61.44 111.619 177.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -51.72 111.69 0.65 Allowed 'Trans proline' 0 C--N 1.384 2.424 0 C-N-CA 123.633 2.889 . . . . 73.2 114.081 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 152' ' ' GLY . . . . . . . . . . . . . . . 139.77 136.28 3.35 Favored Glycine 0 C--N 1.35 1.324 0 CA-C-N 115.373 -0.83 . . . . 54.32 113.175 -174.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 153' ' ' VAL . . . . . 0.458 HG11 HD23 ' C' ' 125' ' ' LEU . 1.7 p -160.38 160.72 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.777 0 CA-C-N 117.192 0.496 . . . . 71.13 112.2 177.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 154' ' ' ARG . . . . . 0.475 ' HD3' ' O ' ' C' ' 188' ' ' LEU . 43.9 ttp180 -128.2 139.68 52.33 Favored 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 125.052 1.341 . . . . 75.32 109.225 177.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 155' ' ' GLU . . . . . 0.609 ' HB2' HD12 ' C' ' 180' ' ' LEU . 21.8 tp10 -40.51 123.53 1.83 Allowed 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 125.464 1.506 . . . . 74.51 113.9 176.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 81.09 -13.46 32.02 Favored Glycine 0 C--N 1.353 1.486 0 CA-C-N 115.054 -0.976 . . . . 64.51 113.951 176.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 157' ' ' SER . . . . . . . . . . . . . 17.1 m -83.56 166.28 18.36 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.226 0.61 . . . . 75.43 111.203 -174.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 158' ' ' VAL . . . . . 0.547 HG22 HG22 ' C' ' 177' ' ' VAL . 21.5 t -111.66 136.44 47.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 CA-C-N 115.245 -0.889 . . . . 64.44 110.884 -163.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 159' ' ' ILE . . . . . 0.687 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 27.2 mt -105.99 122.13 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 107.136 -1.431 . . . . 52.25 107.136 172.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 16.8 ttm180 -83.8 141.22 31.54 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 117.947 0.339 . . . . 72.21 110.151 178.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 161' ' ' VAL . . . . . 0.505 ' HB ' ' HB3' ' C' ' 174' ' ' LEU . 39.8 t -128.74 97.65 26.74 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 107.24 -1.393 . . . . 75.24 107.24 164.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -62.92 127.67 21.05 Favored 'Trans proline' 0 C--N 1.377 2.038 0 C-N-CA 122.92 2.413 . . . . 63.42 113.489 -172.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 163' ' ' GLY . . . . . 0.676 ' H ' ' HB3' ' C' ' 173' ' ' ASP . . . 84.67 -18.39 25.61 Favored Glycine 0 CA--C 1.541 1.665 0 N-CA-C 115.135 0.814 . . . . 53.31 115.135 177.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 164' ' ' MET . . . . . 0.612 ' HA ' ' HB2' ' C' ' 84' ' ' ASP . 31.3 ttp -94.77 38.71 1.11 Allowed 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 117.94 0.87 . . . . 73.35 112.317 -167.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . -109.02 -147.01 11.96 Favored Glycine 0 N--CA 1.473 1.132 0 CA-C-N 115.718 -0.674 . . . . 64.24 112.649 174.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 166' ' ' GLY . . . . . 0.452 ' HA3' ' HB2' ' C' ' 117' ' ' ARG . . . -88.88 -177.22 46.53 Favored Glycine 0 C--N 1.351 1.405 0 CA-C-O 119.868 -0.407 . . . . 75.44 112.992 -179.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 167' ' ' GLN . . . . . 0.437 ' HG3' ' HA3' ' C' ' 82' ' ' GLY . 28.4 mt-30 -49.97 129.21 20.16 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.168 1.387 . . . . 64.31 112.894 -173.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 168' ' ' GLY . . . . . 0.592 ' HA3' ' HA2' ' C' ' 116' ' ' GLY . . . 165.71 158.07 10.47 Favored Glycine 0 C--N 1.351 1.412 0 N-CA-C 114.984 0.754 . . . . 13.44 114.984 173.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 169' ' ' ASN . . . . . 0.548 ' HB3' ' HD3' ' C' ' 170' ' ' PRO . 5.0 t30 -90.37 -55.43 0.28 Allowed Pre-proline 0 CA--C 1.557 1.213 0 CA-C-N 114.166 -1.017 . . . . 62.44 110.298 165.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 170' ' ' PRO . . . . . 0.548 ' HD3' ' HB3' ' C' ' 169' ' ' ASN . 20.9 Cg_exo -64.44 118.52 5.48 Favored 'Trans proline' 0 C--N 1.399 3.221 0 CA-C-N 120.883 1.351 . . . . 51.41 109.029 175.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 171' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -46.17 107.0 0.1 Allowed 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 123.335 2.69 . . . . 74.02 114.073 -167.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -82.62 -48.15 5.67 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-N 115.154 -0.93 . . . . 74.42 111.154 175.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 173' ' ' ASP . . . . . 0.676 ' HB3' ' H ' ' C' ' 163' ' ' GLY . 2.4 p30 50.84 173.11 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 115.709 1.744 . . . . 74.51 115.709 172.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 174' ' ' LEU . . . . . 0.505 ' HB3' ' HB ' ' C' ' 161' ' ' VAL . 49.5 tp -100.73 132.87 45.91 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 115.488 -0.778 . . . . 75.22 109.759 -177.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 90.0 mt -127.54 89.31 2.93 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.924 0.869 . . . . 71.32 110.316 -173.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 176' ' ' LEU . . . . . 0.687 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 96.0 mt -76.36 97.26 4.2 Favored 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 114.262 -1.336 . . . . 43.02 111.945 -175.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 177' ' ' VAL . . . . . 0.547 HG22 HG22 ' C' ' 158' ' ' VAL . 71.5 t -83.56 109.94 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 108.334 -0.987 . . . . 74.43 108.334 174.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 178' ' ' VAL . . . . . 0.433 ' HA ' HD23 ' C' ' 123' ' ' LEU . 8.2 p -75.14 136.03 25.96 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 CA-C-O 121.919 0.866 . . . . 74.01 111.707 -173.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 179' ' ' ARG . . . . . 0.445 ' O ' ' HA ' ' C' ' 124' ' ' PRO . 8.5 mmm180 -109.76 96.1 6.03 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 105.563 -2.014 . . . . 72.33 105.563 171.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 180' ' ' LEU . . . . . 0.609 HD12 ' HB2' ' C' ' 155' ' ' GLU . 77.0 mt -68.97 148.52 50.02 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-O 121.26 0.552 . . . . 70.51 111.046 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 181' ' ' LEU . . . . . . . . . . . . . 56.8 mt -68.97 171.49 6.37 Favored Pre-proline 0 N--CA 1.484 1.235 0 CA-C-N 114.217 -1.356 . . . . 74.2 110.494 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -60.98 67.37 0.09 OUTLIER 'Trans proline' 0 C--N 1.384 2.423 0 C-N-CA 122.543 2.162 . . . . 64.12 111.855 166.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 183' ' ' HIS . . . . . 0.595 ' H ' ' HD3' ' C' ' 184' ' ' PRO . 71.1 t60 -170.25 27.39 0.01 OUTLIER Pre-proline 0 CA--C 1.582 2.195 0 C-N-CA 126.726 2.01 . . . . 62.13 109.894 -177.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 184' ' ' PRO . . . . . 0.595 ' HD3' ' H ' ' C' ' 183' ' ' HIS . 12.2 Cg_endo -84.74 68.22 6.2 Favored 'Trans proline' 0 C--N 1.405 3.522 0 C-N-CA 122.542 2.161 . . . . 71.54 110.513 -173.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 185' ' ' VAL . . . . . 0.596 HG12 ' HB1' ' C' ' 195' ' ' ALA . 5.9 t -90.4 -40.95 13.21 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.573 0 N-CA-C 107.658 -1.238 . . . . 72.23 107.658 -172.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 186' ' ' PHE . . . . . 0.415 ' HB2' HD13 ' C' ' 127' ' ' LEU . 74.5 m-85 -99.24 104.56 16.5 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.687 0.795 . . . . 61.44 109.825 -172.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 187' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -94.41 113.3 25.15 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.292 1.437 . . . . 75.14 108.465 -177.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 188' ' ' LEU . . . . . 0.588 HD13 ' HD2' ' C' ' 240' ' ' PHE . 64.7 tp -81.93 146.99 29.5 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 113.233 0.827 . . . . 74.14 113.233 -171.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -145.59 101.88 3.62 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.033 1.333 . . . . 71.33 107.55 164.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 74.73 -102.25 1.39 Allowed Glycine 0 C--N 1.346 1.115 0 N-CA-C 112.159 -0.376 . . . . 74.2 112.159 -175.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 191' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -112.24 -13.68 13.45 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.493 0.717 . . . . 60.21 110.363 170.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -87.72 141.06 28.89 Favored 'General case' 0 C--O 1.213 -0.835 0 C-N-CA 123.689 0.796 . . . . 65.13 110.685 -170.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 193' ' ' LEU . . . . . . . . . . . . . 85.6 mt -106.58 167.56 9.77 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 122.899 0.48 . . . . 52.2 110.871 -176.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 194' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -143.2 105.3 4.4 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.567 -0.531 . . . . 75.43 109.567 171.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 195' ' ' ALA . . . . . 0.596 ' HB1' HG12 ' C' ' 185' ' ' VAL . . . -119.52 -176.35 3.14 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.607 1.163 . . . . 65.11 109.324 177.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 30.1 m -123.78 133.58 53.8 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 109.306 -0.628 . . . . 51.32 109.306 176.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 197' ' ' LEU . . . . . 0.458 HD13 ' HB2' ' C' ' 212' ' ' ALA . 32.0 tp -107.2 122.73 47.11 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.403 0.681 . . . . 73.5 109.567 -178.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -82.56 98.16 8.83 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 108.566 -0.901 . . . . 44.52 108.566 176.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 199' ' ' VAL . . . . . . . . . . . . . 60.3 t -107.77 121.42 44.11 Favored Pre-proline 0 N--CA 1.478 0.964 0 C-N-CA 123.296 0.639 . . . . 61.21 109.335 -175.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 200' ' ' PRO . . . . . 0.612 ' HG2' HD12 ' C' ' 203' ' ' ILE . 15.9 Cg_exo -63.23 140.69 78.92 Favored 'Trans proline' 0 C--N 1.367 1.541 0 C-N-CA 121.839 1.693 . . . . 71.34 111.181 172.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 201' ' ' ALA . . . . . 0.404 ' N ' ' HD2' ' C' ' 202' ' ' PRO . . . -53.5 -46.43 98.13 Favored Pre-proline 0 CA--C 1.554 1.107 0 N-CA-C 113.49 0.922 . . . . 74.35 113.49 178.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 202' ' ' PRO . . . . . 0.445 ' HB2' ' HA ' ' A' ' 273' ' ' ALA . 39.2 Cg_endo -62.06 -42.64 28.76 Favored 'Trans proline' 0 C--N 1.384 2.407 0 CA-C-N 120.722 1.294 . . . . 63.15 111.946 178.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 203' ' ' ILE . . . . . 0.612 HD12 ' HG2' ' C' ' 200' ' ' PRO . 24.8 mt -64.48 -34.68 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 122.839 0.456 . . . . 63.4 110.958 177.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 204' ' ' ALA . . . . . 0.496 ' HA ' HG11 ' C' ' 223' ' ' VAL . . . -68.13 -35.29 77.87 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.687 0.795 . . . . 75.02 111.913 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 205' ' ' VAL . . . . . 0.535 ' HA ' ' HA ' ' C' ' 226' ' ' ARG . 95.6 t -77.96 -42.09 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-N 115.836 -0.62 . . . . 63.41 112.498 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 206' ' ' VAL . . . . . 0.466 HG23 ' HG2' ' A' ' 270' ' ' LYS . 11.7 p -76.6 -32.73 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 CA-C-O 121.028 0.442 . . . . 52.12 110.009 -177.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 84.3 49.95 4.48 Favored Glycine 0 N--CA 1.44 -1.062 0 CA-C-N 115.095 -0.957 . . . . 63.21 111.846 -172.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -84.37 -136.92 3.44 Favored Glycine 0 C--N 1.347 1.187 0 CA-C-O 119.62 -0.545 . . . . 51.32 112.03 177.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 209' ' ' LYS . . . . . 0.493 ' HB3' ' HG2' ' C' ' 220' ' ' GLU . 9.2 mtmp? -139.02 140.89 38.27 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 117.649 0.724 . . . . 72.12 112.83 -178.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 210' ' ' VAL . . . . . . . . . . . . . 57.5 t -132.78 129.48 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 124.953 1.301 . . . . 62.05 108.614 178.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 211' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -80.28 125.57 30.04 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 118.16 0.436 . . . . 72.44 111.505 -177.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 212' ' ' ALA . . . . . 0.458 ' HB2' HD13 ' C' ' 197' ' ' LEU . . . -103.12 120.08 40.04 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 108.038 -1.097 . . . . 74.43 108.038 165.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 213' ' ' MET . . . . . . . . . . . . . 5.4 tmm? -79.12 108.53 12.68 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 108.331 -0.989 . . . . 63.12 108.331 -177.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.93 171.85 7.1 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 118.128 0.422 . . . . 54.24 110.772 -173.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 215' ' ' LEU . . . . . 0.461 HD13 ' HB2' ' C' ' 131' ' ' PHE . 25.2 mt -58.41 -37.84 76.15 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 125.302 1.441 . . . . 44.41 113.49 -165.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 216' ' ' GLU . . . . . 0.47 ' HG2' HH11 ' C' ' 246' ' ' ARG . 0.0 OUTLIER -110.1 -6.32 15.14 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.057 0.943 . . . . 71.0 111.483 -174.579 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 169.42 156.23 10.62 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-O 119.761 -0.466 . . . . 64.11 113.303 -177.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.74 111.17 3.08 Favored 'Trans proline' 0 CA--C 1.557 1.656 0 C-N-CA 122.933 2.422 . . . . 52.13 112.403 178.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 219' ' ' VAL . . . . . 0.503 ' HB ' ' HE3' ' C' ' 238' ' ' LYS . 9.0 p -84.21 140.16 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 O-C-N 122.07 -0.394 . . . . 52.53 110.019 176.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 220' ' ' GLU . . . . . 0.493 ' HG2' ' HB3' ' C' ' 209' ' ' LYS . 25.5 tt0 -101.23 108.02 19.56 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 107.657 -1.238 . . . . 72.32 107.657 176.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 221' ' ' VAL . . . . . 0.555 ' HA ' ' HB2' ' B' ' 239' ' ' ALA . 42.5 t -77.07 119.48 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 124.055 0.942 . . . . 74.03 111.897 -174.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 222' ' ' ALA . . . . . 0.771 ' HB1' ' HE2' ' B' ' 245' ' ' LYS . . . -80.69 112.71 18.31 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.537 0.735 . . . . 73.3 110.277 169.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 223' ' ' VAL . . . . . 0.496 HG11 ' HA ' ' C' ' 204' ' ' ALA . 63.8 t -89.19 138.89 28.65 Favored Pre-proline 0 CA--C 1.559 1.306 0 C-N-CA 124.719 1.208 . . . . 73.11 110.028 -178.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 224' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.62 154.38 64.36 Favored 'Trans proline' 0 C--N 1.389 2.705 0 C-N-CA 122.501 2.134 . . . . 54.33 112.147 172.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.31 114.21 1.83 Allowed 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 122.768 2.312 . . . . 74.0 111.906 174.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 226' ' ' ARG . . . . . 0.58 ' HB3' ' HA ' ' A' ' 259' ' ' GLU . 0.0 OUTLIER 70.69 97.91 0.07 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.879 1.672 . . . . 70.15 112.406 -178.186 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 227' ' ' THR . . . . . 0.48 HG22 HG11 ' C' ' 253' ' ' VAL . 50.5 m -120.29 129.28 53.95 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 124.726 1.21 . . . . 70.3 111.562 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 228' ' ' GLN . . . . . 0.424 ' H ' ' HD2' ' C' ' 231' ' ' ARG . 27.0 mp0 -95.14 156.43 16.32 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 124.247 1.019 . . . . 74.32 111.635 175.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 229' ' ' ALA . . . . . 0.457 ' HB2' ' H ' ' C' ' 255' ' ' ILE . . . -75.72 131.32 39.77 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 114.84 -1.073 . . . . 62.12 109.742 177.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 110.95 -18.96 25.9 Favored Glycine 0 C--N 1.339 0.697 0 CA-C-N 115.711 -0.677 . . . . 62.04 112.085 -170.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 231' ' ' ARG . . . . . 0.424 ' HD2' ' H ' ' C' ' 228' ' ' GLN . 56.4 mtt180 -62.35 161.86 10.9 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 116.754 0.277 . . . . 74.12 110.318 169.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 232' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -137.65 138.91 39.93 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.042 0.449 . . . . 71.45 110.76 -174.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 233' ' ' LEU . . . . . 0.64 ' O ' ' HA ' ' C' ' 250' ' ' TYR . 6.1 mp -97.11 153.01 18.22 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 114.366 -1.288 . . . . 74.21 109.431 176.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 17.3 ptt180 -130.78 91.33 3.05 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 107.855 -1.165 . . . . 72.34 107.855 162.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 235' ' ' LEU . . . . . 0.575 HD12 HD23 ' C' ' 249' ' ' LEU . 17.1 mt -71.4 106.41 3.9 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 114.29 -1.323 . . . . 73.43 109.061 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 26.2 mmmt -69.82 115.25 8.83 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 113.997 -1.456 . . . . 71.55 110.872 -171.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 81.39 33.15 29.18 Favored Glycine 0 C--N 1.346 1.1 0 CA-C-N 115.799 -0.637 . . . . 71.42 112.955 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 238' ' ' LYS . . . . . 0.503 ' HE3' ' HB ' ' C' ' 219' ' ' VAL . 64.6 mmtt -125.77 24.41 7.11 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.723 0.809 . . . . 72.03 111.364 177.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -102.32 -156.1 25.77 Favored Glycine 0 C--N 1.344 1.007 0 N-CA-C 111.652 -0.579 . . . . 31.21 111.652 171.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 240' ' ' PHE . . . . . 0.588 ' HD2' HD13 ' C' ' 188' ' ' LEU . 56.8 m-85 -81.67 153.38 70.49 Favored Pre-proline 0 CA--C 1.553 1.086 0 C-N-CA 122.868 0.467 . . . . 75.14 109.915 175.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 241' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -66.95 136.05 39.93 Favored 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 123.746 2.964 . . . . 70.21 114.806 -168.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -134.9 173.11 21.71 Favored Glycine 0 C--N 1.351 1.416 0 CA-C-N 115.487 -0.779 . . . . 70.14 112.869 175.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -60.91 -42.8 34.76 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 123.899 3.066 . . . . 71.42 112.796 -174.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -83.53 -17.36 42.1 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.725 0.81 . . . . 71.42 110.698 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 143.92 -179.19 21.46 Favored Glycine 0 C--N 1.346 1.108 0 CA-C-N 115.621 -0.718 . . . . 51.32 111.423 -176.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 246' ' ' ARG . . . . . 0.47 HH11 ' HG2' ' C' ' 216' ' ' GLU . 80.8 mtm180 -71.34 159.52 34.42 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.298 0.639 . . . . 61.31 111.192 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -70.42 -164.29 4.99 Favored Glycine 0 C--N 1.353 1.504 0 CA-C-N 116.074 -0.512 . . . . 63.23 113.463 178.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -117.17 124.46 49.18 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 108.803 -0.814 . . . . 73.54 108.803 -173.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 249' ' ' LEU . . . . . 0.575 HD23 HD12 ' C' ' 235' ' ' LEU . 11.0 tp -79.58 119.99 23.31 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.902 -0.777 . . . . 74.23 108.902 177.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 250' ' ' TYR . . . . . 0.64 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 20.0 m-85 -96.24 111.93 23.83 Favored 'General case' 0 C--O 1.221 -0.419 0 N-CA-C 108.205 -1.035 . . . . 71.43 108.205 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 251' ' ' LEU . . . . . 0.588 HD12 HD22 ' C' ' 233' ' ' LEU . 77.1 mt -105.32 123.02 47.16 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 109.218 -0.66 . . . . 64.53 109.218 -177.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -81.32 120.27 24.72 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.273 -1.01 . . . . 73.41 108.273 173.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 253' ' ' VAL . . . . . 0.48 HG11 HG22 ' C' ' 227' ' ' THR . 60.3 t -72.29 128.93 35.66 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 C-N-CA 123.018 0.527 . . . . 73.5 110.954 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 254' ' ' ARG . . . . . . . . . . . . . 39.4 mtm105 -112.38 129.77 56.2 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 107.462 -1.31 . . . . 74.13 107.462 162.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 255' ' ' ILE . . . . . 0.535 ' O ' ' HB ' ' A' ' 255' ' ' ILE . 37.9 mm -94.65 114.21 30.75 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.775 0 N-CA-C 106.14 -1.8 . . . . 75.24 106.14 173.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 256' ' ' THR . . . . . 0.486 ' O ' ' HA ' ' C' ' 200' ' ' PRO . 0.1 OUTLIER -132.56 155.28 48.94 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 123.991 0.916 . . . . 53.32 108.93 -170.642 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 2.7 pp -124.0 151.07 64.58 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 109.086 -0.709 . . . . 64.54 109.086 -175.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 258' ' ' PRO . . . . . 0.404 ' HG3' ' HE2' ' A' ' 276' ' ' TYR . 68.9 Cg_endo -75.04 8.88 2.23 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.45 2.1 . . . . 73.21 113.025 -171.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 61.37 -79.25 0.02 OUTLIER 'General case' 0 C--N 1.359 0.987 0 C-N-CA 125.718 1.607 . . . . 72.3 110.268 -170.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 2.6 ptp85 -72.95 142.63 47.82 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.396 1.478 . . . . 73.41 110.671 -178.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 261' ' ' LEU . . . . . 0.473 HD22 ' HB3' ' C' ' 265' ' ' GLU . 85.6 mt -139.04 168.25 20.25 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.771 0.829 . . . . 71.21 110.579 -174.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 49.4 p -86.53 162.94 43.78 Favored Pre-proline 0 CA--C 1.553 1.063 0 N-CA-C 108.401 -0.963 . . . . 61.23 108.401 168.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -50.49 -40.99 53.85 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 122.738 2.292 . . . . 74.2 113.107 173.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -60.44 -59.21 5.77 Favored 'General case' 0 C--O 1.262 1.73 0 C-N-CA 124.011 0.924 . . . . 71.04 110.846 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 265' ' ' GLU . . . . . 0.473 ' HB3' HD22 ' C' ' 261' ' ' LEU . 49.3 mm-40 -51.04 -63.5 1.11 Allowed 'General case' 0 C--N 1.353 0.724 0 CA-C-N 114.416 -1.265 . . . . 65.11 110.538 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 266' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -55.58 -38.68 69.7 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.365 1.066 . . . . 64.21 111.58 -173.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -58.01 -51.31 70.18 Favored 'General case' 0 C--O 1.248 1.008 0 O-C-N 123.606 0.566 . . . . 70.32 111.427 177.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 268' ' ' LEU . . . . . 0.652 ' HB2' HD21 ' A' ' 272' ' ' LEU . 10.6 mp -64.68 -39.8 94.29 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 119.288 -0.387 . . . . 52.44 111.332 178.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -58.88 -36.64 74.98 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 122.854 0.462 . . . . 61.11 111.683 176.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 270' ' ' LYS . . . . . 0.504 ' HA ' HG21 ' A' ' 206' ' ' VAL . 9.5 mtpm? -72.71 -34.96 67.47 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.244 0.618 . . . . 75.43 111.352 178.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 271' ' ' LYS . . . . . 0.403 ' HA ' ' HD3' ' C' ' 271' ' ' LYS . 69.3 mmtt -68.17 -32.83 73.36 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 123.108 0.255 . . . . 75.33 111.627 175.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 272' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' C' ' 268' ' ' LEU . 68.6 mt -67.89 -41.56 82.57 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.202 0.601 . . . . 74.33 109.622 173.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -62.68 -38.61 91.03 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 115.732 -0.667 . . . . 34.13 111.227 176.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -66.22 -37.51 85.71 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.781 0.832 . . . . 63.21 110.756 176.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -62.9 -35.25 79.43 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.891 0.476 . . . . 70.04 111.046 173.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 276' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -69.97 -45.76 66.7 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.559 -0.746 . . . . 75.52 112.179 175.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -63.84 -33.98 76.89 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-O 121.066 0.46 . . . . 44.24 109.801 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -63.29 -17.21 62.28 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 114.882 -1.054 . . . . 55.2 112.659 178.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 279' ' ' ARG . . . . . . . . . . . . . 70.3 mtm180 -73.21 -24.46 60.52 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 122.486 0.314 . . . . 71.52 111.298 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.558 1.255 0 CA-C-O 118.459 -0.781 . . . . 75.14 109.771 -176.481 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.5 tmmm? . . . . . 0 N--CA 1.48 1.057 0 N-CA-C 112.63 0.604 . . . . 62.43 112.63 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.638 ' HB3' HD11 ' A' ' 10' ' ' ILE . 48.8 mtpt -97.92 109.32 22.1 Favored 'General case' 0 C--O 1.244 0.782 0 N-CA-C 107.882 -1.155 . . . . 74.32 107.882 172.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.516 ' HA ' ' OH ' ' A' ' 66' ' ' TYR . 24.9 t70 -70.98 109.33 5.03 Favored 'General case' 0 C--N 1.351 0.657 0 N-CA-C 108.101 -1.074 . . . . 61.41 108.101 173.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -65.65 -32.23 73.68 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-N 115.114 -0.948 . . . . 73.34 111.998 -170.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -63.25 -43.49 97.87 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 109.846 -0.427 . . . . 73.33 109.846 173.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.4 -45.86 90.31 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.52 0.728 . . . . 60.32 111.337 178.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.638 HD11 ' HB3' ' A' ' 5' ' ' LYS . 66.1 mt -56.09 -45.02 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 O-C-N 123.903 0.752 . . . . 74.23 110.613 177.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.514 HD13 HG23 ' A' ' 22' ' ' ILE . 69.1 mt -69.74 -23.19 63.35 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 115.644 -0.707 . . . . 51.33 112.207 176.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.78 44.4 7.24 Favored Glycine 0 C--N 1.349 1.253 0 O-C-N 123.182 0.301 . . . . 53.33 112.976 -176.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.0 m -138.17 152.62 72.07 Favored Pre-proline 0 N--CA 1.486 1.326 0 C-N-CA 124.658 1.183 . . . . 71.43 109.839 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -59.26 157.3 30.99 Favored 'Trans proline' 0 C--N 1.384 2.397 0 C-N-CA 122.799 2.333 . . . . 50.12 112.366 177.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 10.9 mtm105 -72.68 8.71 1.35 Allowed 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 113.676 0.991 . . . . 75.43 113.676 -167.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -129.45 14.66 6.06 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.073 0.949 . . . . 64.11 109.474 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.76 131.78 51.79 Favored 'General case' 0 C--N 1.35 0.61 0 C-N-CA 124.273 1.029 . . . . 64.31 111.361 -176.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.1 p -71.98 162.63 29.17 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.568 0.747 . . . . 71.11 110.594 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 8.6 tm0? -55.23 -31.57 61.6 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.096 0.958 . . . . 64.21 110.301 178.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -62.93 -51.11 68.21 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 125.033 1.333 . . . . 72.43 110.481 177.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -71.97 -32.36 67.18 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.613 0.765 . . . . 64.03 111.361 -178.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.599 HD13 ' HB3' ' A' ' 57' ' ' LEU . 61.4 mt -70.66 -30.71 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.269 1.427 . . . . 73.31 110.116 176.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.428 ' HG2' ' HE2' ' A' ' 27' ' ' LYS . 13.7 ttmm -69.74 -44.82 69.46 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.745 0.818 . . . . 71.24 109.114 174.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 71.4 mtp180 -59.62 -42.06 91.81 Favored 'General case' 0 N--CA 1.485 1.275 0 O-C-N 123.981 0.801 . . . . 54.12 111.008 176.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.25 -39.22 75.13 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.783 0.833 . . . . 64.0 111.297 -178.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -60.44 -54.78 41.46 Favored 'General case' 0 C--O 1.216 -0.662 0 CA-C-N 114.917 -1.038 . . . . 73.1 109.361 176.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.428 ' HE2' ' HG2' ' A' ' 23' ' ' LYS . 68.4 mttm -56.75 -42.17 78.86 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.892 0.877 . . . . 74.22 110.964 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -55.7 -55.96 26.03 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.672 0.789 . . . . 71.15 110.855 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.593 ' HB3' HD13 ' A' ' 50' ' ' ILE . 95.3 mt -79.25 -15.17 58.41 Favored 'General case' 0 CA--C 1.555 1.137 0 CA-C-N 115.471 -0.786 . . . . 74.11 111.579 -176.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.66 -20.5 33.46 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.983 0.913 . . . . 63.3 110.985 175.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 28.3 mtm180 -96.55 -25.36 15.65 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.591 0.757 . . . . 72.33 110.164 172.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -69.07 -65.75 0.67 Allowed 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 107.964 -1.124 . . . . 63.33 107.964 176.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -92.89 29.91 1.71 Allowed 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.061 0.544 . . . . 63.25 110.896 -177.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.406 ' CE1' ' HB3' ' A' ' 36' ' ' ASP . 9.4 t-160 -52.71 99.91 0.22 Allowed Pre-proline 0 N--CA 1.486 1.366 0 C-N-CA 125.52 1.528 . . . . 63.41 112.365 -170.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -60.95 -17.88 54.05 Favored 'Trans proline' 0 C--N 1.384 2.415 0 C-N-CA 123.336 2.691 . . . . 74.13 113.914 -171.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.406 ' HB3' ' CE1' ' A' ' 34' ' ' HIS . 32.1 t70 -66.98 -39.17 87.12 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.447 0.699 . . . . 72.45 111.862 176.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 82.2 t -102.28 -52.09 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 123.174 0.589 . . . . 65.53 109.624 -178.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -96.71 87.51 4.36 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 124.166 0.986 . . . . 61.35 109.568 -178.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -84.39 49.19 1.63 Allowed 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 115.439 -0.8 . . . . 73.11 110.653 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 74.0 m -91.94 115.62 64.96 Favored Pre-proline 0 N--CA 1.471 0.59 0 CA-C-O 118.054 -0.974 . . . . 54.41 108.548 176.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.403 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 85.2 Cg_exo -44.77 -49.6 9.34 Favored 'Trans proline' 0 C--N 1.384 2.439 0 C-N-CA 123.756 2.971 . . . . 72.23 113.295 -176.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -54.8 -43.32 72.78 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.963 0.905 . . . . 64.43 111.312 178.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.94 -27.68 64.95 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.513 -0.767 . . . . 72.14 110.926 -177.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.441 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 50.1 mt-10 -84.0 -29.98 26.54 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.173 0.589 . . . . 62.01 110.47 -175.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 41' ' ' PRO . 44.6 mt-10 -77.54 -38.45 48.67 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.186 0.595 . . . . 62.44 109.991 177.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -66.14 -34.24 77.59 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.855 -0.611 . . . . 74.03 109.766 170.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.805 ' HA ' HD12 ' A' ' 50' ' ' ILE . 88.0 t80 -62.04 -37.22 84.11 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 122.879 0.472 . . . . 73.24 110.475 172.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 44' ' ' GLU . 97.7 mttt -64.89 -35.12 80.13 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.723 0.409 . . . . 75.14 111.327 174.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -69.88 -29.9 67.22 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 122.421 0.288 . . . . 71.44 111.753 175.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.805 HD12 ' HA ' ' A' ' 47' ' ' PHE . 47.3 mt -70.43 -40.91 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 123.405 0.682 . . . . 70.53 109.794 173.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.413 ' HB3' ' HD1' ' A' ' 88' ' ' PHE . 3.2 m-20 -74.25 -20.15 60.26 Favored 'General case' 0 C--O 1.21 -0.99 0 C-N-CA 123.747 0.819 . . . . 73.43 110.934 176.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -74.92 -48.59 23.82 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.682 1.193 . . . . 63.42 109.564 174.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.25 -47.18 87.22 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 113.674 -1.603 . . . . 65.45 110.691 177.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 45.4 t80 -73.92 -23.6 59.56 Favored 'General case' 0 C--O 1.216 -0.661 0 CA-C-N 114.9 -1.045 . . . . 72.32 110.249 176.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.437 ' HA ' ' CD2' ' A' ' 88' ' ' PHE . . . -56.35 -50.82 70.4 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 118.357 0.526 . . . . 53.01 110.272 172.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.405 HG13 ' HZ ' ' A' ' 101' ' ' PHE . 38.3 t -64.46 -51.77 63.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 O-C-N 124.588 1.18 . . . . 74.52 110.409 177.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.599 ' HB3' HD13 ' A' ' 22' ' ' ILE . 45.1 mt -94.05 13.07 24.15 Favored 'General case' 0 CA--C 1.565 1.555 0 N-CA-C 113.095 0.776 . . . . 62.04 113.095 -166.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.1 t -66.77 -63.05 1.15 Allowed 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 123.668 0.787 . . . . 74.34 112.135 175.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.607 ' HB2' ' HD3' ' A' ' 62' ' ' LYS . 9.0 m-20 -100.64 145.53 30.49 Favored Pre-proline 0 N--CA 1.475 0.816 0 CA-C-O 118.478 -0.773 . . . . 74.34 110.046 -173.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.421 ' O ' ' HG2' ' A' ' 64' ' ' ARG . 19.8 Cg_endo -56.65 -32.25 89.96 Favored 'Trans proline' 0 C--N 1.384 2.404 0 C-N-CA 123.427 2.751 . . . . 72.41 113.294 -175.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -66.12 -47.67 73.37 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.707 0.803 . . . . 72.3 111.855 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.607 ' HD3' ' HB2' ' A' ' 59' ' ' ASP . 32.1 mtpt -74.59 -33.49 62.65 Favored 'General case' 0 C--O 1.252 1.209 0 C-N-CA 123.958 0.903 . . . . 74.54 110.641 -176.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 22.2 tpt85 -52.9 -51.39 61.35 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 113.922 -1.49 . . . . 74.11 108.827 167.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.421 ' HG2' ' O ' ' A' ' 60' ' ' PRO . 4.7 mmp_? -59.7 -38.97 83.07 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 123.802 0.689 . . . . 74.25 111.644 176.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.577 HG23 ' HD2' ' A' ' 76' ' ' PRO . 87.2 mt -54.96 -45.34 76.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 C-N-CA 122.681 0.392 . . . . 64.42 110.512 178.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.516 ' OH ' ' HA ' ' A' ' 6' ' ' ASP . 5.2 t80 -65.44 -49.22 69.96 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 120.77 -0.372 . . . . 75.4 110.813 175.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -57.8 -35.52 70.94 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.347 0.659 . . . . 64.04 112.062 -176.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 61.0 p -75.82 -32.27 59.76 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.044 0.538 . . . . 75.13 110.213 177.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -69.31 110.15 4.5 Favored 'General case' 0 C--N 1.359 0.992 0 N-CA-C 108.865 -0.791 . . . . 63.45 108.865 176.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 108.39 15.4 14.0 Favored Glycine 0 C--N 1.342 0.908 0 CA-C-N 115.905 -0.589 . . . . 52.54 112.151 -171.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 43.7 m -142.83 -57.17 0.43 Allowed 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 104.95 -2.241 . . . . 71.23 104.95 176.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.9 m -89.79 146.72 24.27 Favored 'General case' 0 C--O 1.25 1.121 0 N-CA-C 104.438 -2.43 . . . . 74.23 104.438 156.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.54 -35.56 19.45 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 109.981 -0.377 . . . . 74.04 109.981 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -84.02 131.05 52.47 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 123.85 0.86 . . . . 75.1 110.373 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -64.99 133.48 36.0 Favored 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 122.465 2.11 . . . . 75.41 110.717 173.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.577 ' HD2' HG23 ' A' ' 65' ' ' ILE . 58.7 Cg_exo -44.97 143.89 4.15 Favored 'Trans proline' 0 C--N 1.382 2.298 0 C-N-CA 124.211 3.274 . . . . 74.25 114.404 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -42.97 130.35 5.76 Favored 'Trans proline' 0 C--N 1.387 2.554 0 C-N-CA 124.115 3.21 . . . . 62.44 113.383 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -49.06 119.75 4.76 Favored 'Trans proline' 0 C--N 1.386 2.512 0 C-N-CA 123.378 2.719 . . . . 43.51 112.559 -177.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -51.91 164.15 1.17 Allowed 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 123.648 2.899 . . . . 71.05 113.785 177.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -53.18 88.29 0.03 OUTLIER 'Trans proline' 0 C--N 1.384 2.397 0 C-N-CA 123.379 2.719 . . . . 51.35 113.498 178.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 133.92 -33.53 2.52 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-N 114.541 -1.209 . . . . 62.41 110.33 177.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 139.67 -171.41 23.8 Favored Glycine 0 C--N 1.34 0.752 0 N-CA-C 109.835 -1.306 . . . . 53.03 109.835 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -67.48 105.4 1.82 Allowed 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.274 -1.01 . . . . 74.41 108.274 167.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.465 ' HB3' ' HD2' ' A' ' 62' ' ' LYS . 9.4 t70 -63.87 144.69 56.87 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 122.951 0.5 . . . . 71.31 112.186 -176.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.444 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 67.7 m-85 -139.37 71.11 1.37 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.917 0.887 . . . . 70.22 109.886 174.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.526 ' HA ' ' O ' ' A' ' 162' ' ' PRO . 51.0 m -59.99 85.36 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.244 0 CA-C-N 114.787 -1.097 . . . . 74.44 112.863 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 95.73 11.63 54.84 Favored Glycine 0 C--N 1.35 1.349 0 CA-C-N 115.646 -0.706 . . . . 70.11 113.972 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.444 ' HB2' ' HB3' ' A' ' 85' ' ' PHE . 26.7 m-85 -123.65 114.05 19.47 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 117.951 0.876 . . . . 72.34 110.575 -170.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -80.37 83.25 6.24 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-O 121.401 0.619 . . . . 71.44 110.504 -174.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.825 HG21 HD22 ' A' ' 105' ' ' LEU . 1.6 p -49.21 -42.21 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 N-CA-C 114.543 1.312 . . . . 75.21 114.543 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -66.07 -18.63 65.47 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 120.897 0.379 . . . . 75.33 111.01 -176.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -95.38 -7.24 39.05 Favored 'General case' 0 CA--C 1.559 1.298 0 C-N-CA 123.659 0.783 . . . . 45.35 111.167 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 21.6 m-30 -87.77 -172.46 3.87 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 123.491 0.716 . . . . 71.01 111.87 -177.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 86.1 p -74.78 166.68 23.22 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 113.349 0.87 . . . . 74.5 113.349 -169.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.03 -49.42 77.46 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 114.96 -1.018 . . . . 74.31 111.789 178.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -58.94 -40.0 83.3 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.597 0.759 . . . . 75.03 110.718 -175.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -62.63 -49.5 74.94 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.423 -1.262 . . . . 63.23 110.195 176.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.538 ' HA ' HD11 ' A' ' 105' ' ' LEU . 46.3 mt-30 -77.86 -4.37 46.34 Favored 'General case' 0 CA--C 1.552 1.038 0 CA-C-N 115.482 -0.781 . . . . 73.05 112.735 -178.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -92.54 -50.24 5.71 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.628 0.771 . . . . 70.02 109.918 172.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 26.0 tp -58.94 -54.85 42.47 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.1 0.96 . . . . 55.03 110.581 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.405 ' HZ ' HG13 ' A' ' 56' ' ' VAL . 88.5 m-85 -87.48 -1.54 58.0 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 115.801 -0.636 . . . . 72.11 111.098 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -41.28 -58.37 2.87 Favored Glycine 0 N--CA 1.482 1.74 0 N-CA-C 115.879 1.112 . . . . 72.43 115.879 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -50.35 -20.15 5.49 Favored 'Trans proline' 0 C--N 1.385 2.467 0 C-N-CA 124.318 3.346 . . . . 23.1 115.216 -177.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -141.59 31.89 2.09 Favored Glycine 0 C--N 1.355 1.632 0 CA-C-O 119.239 -0.756 . . . . 44.4 113.901 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.825 HD22 HG21 ' A' ' 90' ' ' VAL . 39.8 mt -66.68 78.19 0.11 Allowed 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 117.746 0.773 . . . . 74.25 112.028 171.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.438 ' HB2' ' HA ' ' A' ' 169' ' ' ASN . 24.5 m-85 36.5 -108.68 0.05 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.202 1.401 . . . . 72.25 114.78 177.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 59.77 16.12 37.06 Favored Glycine 0 C--N 1.36 1.916 0 N-CA-C 111.256 -0.738 . . . . 44.0 111.256 -160.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.36 1.887 0 O-C-N 124.321 0.66 . . . . 71.34 112.612 -164.876 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 43.4 tttp . . . . . 0 N--CA 1.494 1.746 0 N-CA-C 113.01 0.745 . . . . 72.15 113.01 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -85.34 -177.76 50.65 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-N 115.566 -0.743 . . . . 55.22 113.725 178.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.56 ' H ' ' HA3' ' A' ' 166' ' ' GLY . 22.1 ttm180 -94.19 164.52 13.02 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.186 1.394 . . . . 71.34 110.362 176.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.421 ' N ' ' HG2' ' A' ' 117' ' ' ARG . 7.9 p-10 -82.95 124.8 30.72 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 108.221 -1.029 . . . . 74.23 108.221 164.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 10.5 tt -122.75 121.31 36.02 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.42 -1.326 . . . . 70.23 107.42 -172.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.543 ' HA ' ' HB2' ' A' ' 175' ' ' LEU . 3.7 tmt_? -92.21 110.62 22.01 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 109.001 -0.74 . . . . 74.51 109.001 -177.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -111.21 171.93 7.18 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.265 1.026 . . . . 41.51 109.564 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.463 ' HA ' ' O ' ' A' ' 177' ' ' VAL . 68.0 mt-10 -121.75 125.84 47.51 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 109.0 -0.741 . . . . 61.0 109.0 -177.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 46.2 tp -98.79 100.91 10.58 Favored Pre-proline 0 N--CA 1.471 0.614 0 N-CA-C 107.307 -1.368 . . . . 54.05 107.307 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.598 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 55.4 Cg_endo -71.37 113.45 3.62 Favored 'Trans proline' 0 C--N 1.373 1.839 0 N-CA-C 108.587 -1.351 . . . . 75.33 108.587 176.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.494 ' HB3' HD23 ' A' ' 180' ' ' LEU . 47.1 tp -122.85 134.57 54.39 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 119.021 0.828 . . . . 64.01 111.067 -171.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.542 ' HA ' HD12 ' A' ' 181' ' ' LEU . 22.8 m -64.81 134.67 54.59 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 114.275 -1.329 . . . . 71.34 110.333 176.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 47.3 mt -59.55 -38.46 81.13 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 122.927 0.491 . . . . 70.54 111.524 -174.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -59.17 -42.56 91.05 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.385 0.674 . . . . 75.32 109.558 177.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.576 ' HG2' ' HB3' ' B' ' 4' ' ' SER . 50.0 mm-40 -65.78 -37.36 86.1 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.926 0.89 . . . . 64.33 111.768 173.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -66.07 -30.22 70.7 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 121.088 0.47 . . . . 41.43 110.838 -177.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -78.58 -59.78 2.64 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 115.016 -0.993 . . . . 74.51 110.551 177.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 44.7 m80 -75.87 -44.55 40.12 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.33 0.652 . . . . 75.25 112.323 -167.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.423 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 85.7 -170.05 43.55 Favored Glycine 0 N--CA 1.477 1.377 0 N-CA-C 114.117 0.407 . . . . 71.54 114.117 176.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 108.16 -166.68 13.06 Favored Glycine 0 C--N 1.353 1.51 0 C-N-CA 123.077 0.37 . . . . 70.42 113.019 177.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -70.7 105.83 3.32 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 122.957 0.503 . . . . 73.14 110.598 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 3.1 tpp180 -94.26 120.12 34.04 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 109.124 -0.695 . . . . 74.4 109.124 171.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 58.1 t -84.07 115.02 25.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 N-CA-C 107.889 -1.152 . . . . 71.24 107.889 173.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.443 HG13 HG13 ' A' ' 145' ' ' VAL . 2.7 p -129.44 129.92 67.19 Favored 'Isoleucine or valine' 0 C--O 1.246 0.916 0 C-N-CA 123.593 0.757 . . . . 73.14 109.754 -177.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -92.86 144.5 25.22 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.223 1.009 . . . . 71.3 110.189 -177.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.611 ' HB ' ' HB3' ' B' ' 8' ' ' LEU . 6.6 p -162.68 105.79 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 120.933 0.397 . . . . 75.1 111.07 174.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 57.84 34.23 24.13 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.092 0.957 . . . . 74.24 111.473 178.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 95.41 -19.68 53.1 Favored Glycine 0 C--N 1.35 1.311 0 CA-C-N 115.796 -0.638 . . . . 31.1 113.29 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 18.3 tpt85 -76.26 103.26 6.2 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.878 0.871 . . . . 72.12 110.503 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -87.87 97.22 10.81 Favored 'General case' 0 C--O 1.243 0.732 0 C-N-CA 123.873 0.869 . . . . 74.41 109.386 173.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.443 HG13 HG13 ' A' ' 138' ' ' VAL . 3.6 p -102.47 125.3 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-O 121.209 0.528 . . . . 73.53 110.14 177.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 34.6 t -91.48 83.97 5.48 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 108.189 -1.041 . . . . 31.45 108.189 174.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.7 p -92.5 123.56 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 115.703 -0.681 . . . . 73.42 109.705 -176.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 24.2 ttm180 -71.52 107.31 4.35 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.158 0.504 . . . . 74.14 110.037 174.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.423 HG13 ' HA2' ' A' ' 133' ' ' GLY . 20.2 pt -76.96 126.03 86.13 Favored Pre-proline 0 CA--C 1.555 1.172 0 CA-C-N 114.9 -1.045 . . . . 74.13 109.073 170.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -64.12 132.11 32.99 Favored 'Trans proline' 0 C--N 1.37 1.706 0 C-N-CA 122.493 2.128 . . . . 60.34 112.169 176.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -56.91 109.78 0.5 Allowed 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 122.888 2.392 . . . . 74.15 111.499 172.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.42 ' HA3' ' HD2' ' A' ' 241' ' ' PRO . . . 97.2 48.78 1.98 Allowed Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.844 -0.503 . . . . 75.51 111.844 -174.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 4.5 p -96.61 137.85 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.564 0.745 . . . . 75.43 109.507 177.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.414 ' HG2' ' HA ' ' A' ' 191' ' ' GLN . 0.0 OUTLIER -116.48 168.18 10.39 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.613 0.765 . . . . 73.23 111.519 -169.528 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.52 ' HB3' ' HA ' ' A' ' 189' ' ' GLU . 15.9 tp10 -56.61 129.91 42.98 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.594 0.758 . . . . 72.32 111.165 177.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 78.08 10.96 85.83 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-N 115.548 -0.751 . . . . 14.21 114.235 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 10.7 t -75.18 129.85 38.2 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 118.015 0.908 . . . . 74.23 108.665 175.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 21.7 t -108.61 114.78 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 123.199 0.6 . . . . 72.34 110.7 -167.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.553 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 48.4 mt -93.93 92.35 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 107.212 -1.403 . . . . 75.24 107.212 169.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 31.5 ttt180 -74.2 100.39 3.67 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 109.422 -0.584 . . . . 61.32 109.422 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.2 p -126.35 99.35 30.82 Favored Pre-proline 0 CA--C 1.557 1.239 0 C-N-CA 124.129 0.972 . . . . 61.33 110.427 -176.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.526 ' O ' ' HA ' ' A' ' 86' ' ' SER . 65.1 Cg_exo -50.56 158.02 3.04 Favored 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 123.062 2.508 . . . . 74.53 114.186 172.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 108.96 -26.82 14.26 Favored Glycine 0 N--CA 1.48 1.571 0 N-CA-C 113.872 0.309 . . . . 70.43 113.872 169.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.425 ' HB2' HD22 ' A' ' 174' ' ' LEU . 63.7 mtm -118.67 -0.04 11.39 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 122.608 0.363 . . . . 64.15 110.891 -177.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -88.17 -106.9 0.99 Allowed Glycine 0 C--N 1.351 1.379 0 N-CA-C 111.025 -0.83 . . . . 73.33 111.025 175.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.56 ' HA3' ' H ' ' A' ' 117' ' ' ARG . . . -69.1 117.73 8.18 Favored Glycine 0 C--O 1.251 1.196 0 N-CA-C 111.589 -0.604 . . . . 74.5 111.589 171.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -75.17 104.78 5.88 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 109.218 -0.66 . . . . 75.42 109.218 -175.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -169.92 158.21 30.18 Favored Glycine 0 C--N 1.339 0.725 0 N-CA-C 110.826 -0.91 . . . . 64.21 110.826 -176.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . 0.527 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . 54.0 t30 -61.59 -62.82 5.15 Favored Pre-proline 0 N--CA 1.488 1.43 0 CA-C-O 117.438 -1.268 . . . . 63.11 110.619 -169.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.527 ' HD3' ' HB3' ' A' ' 169' ' ' ASN . 21.2 Cg_exo -63.1 109.32 0.92 Allowed 'Trans proline' 0 C--N 1.391 2.779 0 CA-C-N 122.487 1.924 . . . . 71.13 107.789 162.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -60.3 128.46 26.31 Favored 'Trans proline' 0 CA--C 1.55 1.301 0 C-N-CA 123.379 2.719 . . . . 71.25 113.622 -163.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -77.34 136.85 19.43 Favored Glycine 0 C--N 1.358 1.752 0 N-CA-C 111.377 -0.689 . . . . 72.4 111.377 175.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.497 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 15.1 m-20 -61.98 128.81 37.94 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.935 0.894 . . . . 71.14 112.034 -172.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.425 HD22 ' HB2' ' A' ' 164' ' ' MET . 49.6 tp -102.69 107.84 18.88 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.887 -0.783 . . . . 64.32 108.887 169.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.543 ' HB2' ' HA ' ' A' ' 120' ' ' ARG . 42.7 mt -79.3 94.21 5.43 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 108.663 -0.866 . . . . 72.12 108.663 176.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.553 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 91.8 mt -74.22 82.13 1.83 Allowed 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 109.468 -0.567 . . . . 70.05 109.468 175.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 122' ' ' GLU . 11.8 t -87.87 103.7 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 N-CA-C 107.261 -1.385 . . . . 61.43 107.261 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 8.1 p -73.91 119.15 20.57 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.219 0 N-CA-C 113.39 0.885 . . . . 70.33 113.39 -165.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.598 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 20.8 mmt180 -92.71 102.23 14.64 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.195 0.998 . . . . 53.32 109.437 170.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.494 HD23 ' HB3' ' A' ' 125' ' ' LEU . 96.0 mt -72.91 136.12 45.18 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 122.052 -0.405 . . . . 72.4 110.757 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.542 HD12 ' HA ' ' A' ' 126' ' ' THR . 85.5 mt -55.71 156.25 9.57 Favored Pre-proline 0 N--CA 1.484 1.247 0 C-N-CA 124.649 1.18 . . . . 73.14 112.507 -174.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -82.47 40.72 1.0 Allowed 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 122.943 2.429 . . . . 71.42 111.515 171.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . 0.427 ' HA ' ' HD3' ' A' ' 184' ' ' PRO . 51.9 t-80 -62.24 125.44 85.57 Favored Pre-proline 0 CA--C 1.551 0.997 0 N-CA-C 107.615 -1.254 . . . . 73.35 107.615 172.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 183' ' ' HIS . 23.5 Cg_exo -66.17 23.85 0.09 OUTLIER 'Trans proline' 0 N--CA 1.502 2.014 0 C-N-CA 124.239 3.292 . . . . 61.24 118.289 -162.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 58.9 t -106.3 -59.32 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 120.294 1.406 . . . . 64.21 109.809 177.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . 0.506 ' CE1' ' HB2' ' A' ' 195' ' ' ALA . 21.6 m-85 -127.14 125.6 41.47 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.92 -0.582 . . . . 72.31 111.061 -172.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.427 HH22 ' HG2' ' A' ' 155' ' ' GLU . 0.0 OUTLIER -102.31 71.56 1.24 Allowed 'General case' 0 C--O 1.237 0.399 0 N-CA-C 106.452 -1.684 . . . . 75.51 106.452 171.316 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.438 ' HB2' HD23 ' A' ' 193' ' ' LEU . 7.4 tp -64.27 132.95 51.75 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 113.348 -1.751 . . . . 74.21 110.516 -176.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . 0.52 ' HA ' ' HB3' ' A' ' 155' ' ' GLU . 11.9 tp10 -138.75 123.6 18.78 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.691 1.196 . . . . 70.31 109.643 -178.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 70.73 -75.04 0.58 Allowed Glycine 0 C--N 1.354 1.545 0 O-C-N 123.491 0.495 . . . . 65.41 113.694 175.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.414 ' HA ' ' HG2' ' A' ' 154' ' ' ARG . 2.9 pm0 -145.02 -14.29 0.53 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.669 1.188 . . . . 72.32 110.792 175.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.431 ' HB3' ' H ' ' A' ' 248' ' ' ASP . 2.6 p-10 -112.57 137.23 51.1 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.274 1.43 . . . . 72.32 112.708 -165.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.504 HD22 ' HB3' ' A' ' 186' ' ' PHE . 77.3 mt -88.84 159.85 17.51 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.836 1.254 . . . . 63.44 111.003 -173.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -130.78 101.59 5.72 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 108.256 -1.016 . . . . 73.14 108.256 169.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.506 ' HB2' ' CE1' ' A' ' 186' ' ' PHE . . . -104.75 148.14 26.93 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 108.806 -0.812 . . . . 74.34 108.806 175.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 26.1 m -86.87 141.45 28.77 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 109.601 -0.518 . . . . 70.21 109.601 175.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 56.4 tp -138.88 102.33 4.53 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.15 0.58 . . . . 72.21 109.548 -173.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -79.95 125.75 30.15 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 108.968 -0.753 . . . . 61.43 108.968 173.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.491 HG23 HG11 ' A' ' 210' ' ' VAL . 5.5 p -139.81 136.78 17.68 Favored Pre-proline 0 CA--C 1.55 0.956 0 C-N-CA 124.462 1.105 . . . . 64.4 108.626 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -77.58 155.32 31.57 Favored 'Trans proline' 0 C--N 1.368 1.595 0 C-N-CA 121.714 1.609 . . . . 64.51 112.483 173.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.417 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -58.1 -50.24 89.18 Favored Pre-proline 0 CA--C 1.552 1.038 0 N-CA-C 113.785 1.032 . . . . 71.34 113.785 -169.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.432 ' HG2' ' CE2' ' C' ' 276' ' ' TYR . 86.1 Cg_exo -55.02 -46.64 31.72 Favored 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 121.548 1.499 . . . . 63.54 113.426 176.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.438 HD11 ' HB3' ' C' ' 276' ' ' TYR . 40.5 mt -71.75 -24.03 22.83 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.28 0 C-N-CA 122.375 0.27 . . . . 64.32 110.492 -177.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -74.7 -47.03 33.81 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.121 0.569 . . . . 71.51 111.706 175.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 201' ' ' ALA . 90.3 t -70.91 -38.43 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 C-N-CA 123.736 0.814 . . . . 63.23 111.075 -176.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 55.3 t -89.76 -41.21 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 124.173 0.989 . . . . 74.41 111.782 -175.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 95.45 148.6 24.46 Favored Glycine 0 C--N 1.339 0.739 0 CA-C-N 115.581 -0.736 . . . . 72.35 111.339 -168.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 177.44 -142.67 5.82 Favored Glycine 0 C--N 1.333 0.399 0 N-CA-C 111.235 -0.746 . . . . 55.24 111.235 -177.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -125.76 123.41 38.76 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 117.277 0.538 . . . . 45.21 110.666 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.491 HG11 HG23 ' A' ' 199' ' ' VAL . 22.5 m -124.02 -171.47 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 125.425 1.49 . . . . 63.11 109.207 174.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -126.6 131.9 51.4 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.336 0.654 . . . . 71.41 111.525 178.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -114.02 166.31 11.74 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.395 1.078 . . . . 62.04 109.043 167.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 27.9 ttt -111.49 145.01 39.79 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 122.757 0.423 . . . . 71.23 110.486 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 17.4 p -114.05 -171.07 1.84 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.139 0.976 . . . . 74.1 108.868 171.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 83.5 mt -80.3 -5.24 55.97 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.93 0.715 . . . . 63.31 112.93 -175.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -139.91 9.74 2.38 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 112.848 0.685 . . . . 64.44 112.848 -177.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 154.07 175.83 25.75 Favored Glycine 0 N--CA 1.472 1.046 0 CA-C-O 119.382 -0.677 . . . . 33.0 112.413 177.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -81.65 175.79 9.12 Favored 'Trans proline' 0 C--N 1.362 1.288 0 C-N-CA 122.29 1.993 . . . . 70.23 112.559 178.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 3.2 m -148.77 132.78 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.096 1.358 . . . . 73.4 108.425 178.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -86.72 104.45 16.13 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.418 -0.956 . . . . 75.04 108.418 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 41.1 t -99.78 134.47 39.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 123.968 0.907 . . . . 74.13 110.721 -169.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -83.08 105.24 13.9 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 122.847 0.459 . . . . 60.25 109.815 174.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.433 HG11 HG22 ' A' ' 203' ' ' ILE . 11.5 p -79.23 139.97 56.56 Favored Pre-proline 0 CA--C 1.563 1.469 0 C-N-CA 124.35 1.06 . . . . 63.14 109.811 -178.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -82.04 178.68 6.18 Favored 'Trans proline' 0 C--N 1.384 2.426 0 C-N-CA 123.094 2.529 . . . . 75.51 111.806 -175.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -80.8 150.99 18.8 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 121.6 1.533 . . . . 72.53 112.387 171.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . 0.52 HH21 ' HB2' ' C' ' 261' ' ' LEU . 79.1 mtt85 67.01 25.15 9.34 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 125.159 1.383 . . . . 74.04 112.45 175.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.458 HG23 HD21 ' A' ' 233' ' ' LEU . 37.7 m -61.52 117.11 5.3 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 124.7 1.2 . . . . 64.32 110.466 175.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -110.33 139.7 45.27 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.978 0.911 . . . . 75.32 112.161 -167.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -64.57 133.79 53.05 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.459 1.104 . . . . 62.31 111.772 -177.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . 0.521 ' HA3' HH12 ' C' ' 254' ' ' ARG . . . 93.19 -24.63 24.13 Favored Glycine 0 C--N 1.341 0.836 0 CA-C-N 115.85 -0.614 . . . . 73.32 112.803 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 67.6 mtt180 -72.32 147.28 46.49 Favored 'General case' 0 C--N 1.347 0.478 0 CA-C-O 121.41 0.624 . . . . 74.0 109.744 171.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.766 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 2.9 mptp? -106.29 119.34 39.0 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.254 -1.387 . . . . 72.22 107.254 174.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.5 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 70.6 mt -74.38 100.21 3.73 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.32 -0.993 . . . . 71.4 108.32 -177.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 66.1 ttt180 -76.6 104.61 7.19 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 124.07 0.856 . . . . 64.14 110.564 -172.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.623 ' HB3' ' HG3' ' A' ' 238' ' ' LYS . 49.2 mt -103.11 96.56 6.87 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.542 0.737 . . . . 61.12 110.694 -178.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 23.8 mtpp -74.52 138.26 43.01 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 122.707 0.403 . . . . 64.43 111.231 -177.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 82.81 16.73 69.55 Favored Glycine 0 C--N 1.346 1.086 0 CA-C-N 115.603 -0.726 . . . . 74.2 112.876 -174.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.623 ' HG3' ' HB3' ' A' ' 235' ' ' LEU . 0.0 OUTLIER -121.05 -17.73 7.7 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.276 0.63 . . . . 73.01 112.572 -174.256 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -78.69 -167.42 32.2 Favored Glycine 0 C--N 1.339 0.722 0 N-CA-C 111.904 -0.478 . . . . 74.43 111.904 171.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -86.01 151.4 54.54 Favored Pre-proline 0 CA--C 1.557 1.239 0 CA-C-O 118.895 -0.574 . . . . 73.13 109.509 -172.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.42 ' HD2' ' HA3' ' A' ' 152' ' ' GLY . 29.7 Cg_exo -38.91 107.92 0.07 OUTLIER 'Trans proline' 0 C--N 1.389 2.673 0 C-N-CA 124.675 3.583 . . . . 73.33 115.52 -179.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -133.92 -158.15 8.5 Favored Glycine 0 C--N 1.35 1.354 0 CA-C-O 119.255 -0.747 . . . . 73.52 112.33 -176.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -59.8 -39.65 70.69 Favored 'Trans proline' 0 C--N 1.383 2.357 0 C-N-CA 123.695 2.93 . . . . 70.45 113.595 -174.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -89.25 21.62 3.19 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.417 0.687 . . . . 70.11 111.567 -176.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 97.29 -74.44 0.67 Allowed Glycine 0 C--N 1.346 1.121 0 N-CA-C 109.794 -1.322 . . . . 62.24 109.794 -173.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 17.1 mtp180 -122.55 157.91 31.04 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.124 0.97 . . . . 75.41 108.675 168.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -79.43 -158.54 14.52 Favored Glycine 0 C--N 1.344 0.995 0 O-C-N 123.315 0.384 . . . . 42.24 113.486 176.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . 0.431 ' H ' ' HB3' ' A' ' 192' ' ' ASP . 7.4 m-20 -104.44 172.32 6.86 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.142 0.577 . . . . 75.44 110.019 -177.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.577 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 32.5 tp -136.65 97.5 3.56 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 107.831 -1.174 . . . . 70.31 107.831 175.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.766 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 62.2 m-85 -79.45 108.57 13.07 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.266 1.026 . . . . 52.51 110.091 178.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.5 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 88.6 mt -93.42 108.31 20.0 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 122.91 0.484 . . . . 72.24 110.061 176.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . 0.538 ' HG2' ' HG3' ' A' ' 232' ' ' LYS . 35.5 mt-10 -77.67 102.64 7.17 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.531 1.132 . . . . 75.41 109.708 -172.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.417 HG12 HG13 ' A' ' 255' ' ' ILE . 42.9 t -67.93 126.07 26.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 115.008 -0.997 . . . . 24.43 111.619 -172.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -124.2 92.25 3.63 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 107.275 -1.38 . . . . 73.14 107.275 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.479 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 63.5 mt -82.79 127.69 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 122.815 0.446 . . . . 74.34 111.41 -173.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 69.1 p -111.07 154.68 23.89 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.291 1.036 . . . . 73.43 109.675 175.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.488 HD12 ' H ' ' A' ' 259' ' ' GLU . 2.5 pp -103.06 150.08 37.5 Favored Pre-proline 0 CA--C 1.558 1.263 0 C-N-CA 123.069 0.548 . . . . 73.4 109.653 175.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -51.7 -21.98 12.33 Favored 'Trans proline' 0 N--CA 1.509 2.394 0 C-N-CA 124.519 3.48 . . . . 74.45 115.133 -170.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . 0.785 ' HG2' HE21 ' C' ' 228' ' ' GLN . 29.3 mt-10 52.17 -78.46 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.991 1.317 . . . . 63.24 111.548 -167.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.9 132.19 46.88 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.566 0.746 . . . . 75.12 111.332 176.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.588 HD22 ' HB2' ' A' ' 265' ' ' GLU . 96.2 mt -143.44 150.54 39.17 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.312 1.045 . . . . 55.32 109.723 176.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 20.9 p -118.64 156.69 51.23 Favored Pre-proline 0 CA--C 1.555 1.167 0 CA-C-O 117.774 -1.108 . . . . 44.34 109.204 170.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -21.12 -50.2 0.03 OUTLIER 'Trans proline' 0 C--N 1.401 3.322 1 C-N-CA 126.871 5.047 . . . . 74.33 117.433 -172.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -56.56 -69.44 0.15 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.314 0.646 . . . . 71.44 111.289 178.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . 0.588 ' HB2' HD22 ' A' ' 261' ' ' LEU . 2.1 mp0 -71.32 -28.75 64.32 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.601 0.36 . . . . 64.2 110.062 -172.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' GLU . . . . . 0.403 ' HA ' HD13 ' A' ' 261' ' ' LEU . 18.8 tp10 -55.86 -60.97 2.7 Favored 'General case' 0 C--O 1.255 1.345 0 C-N-CA 124.22 1.008 . . . . 73.45 110.467 175.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -60.58 -38.01 83.22 Favored 'General case' 0 C--O 1.22 -0.472 0 CA-C-N 114.38 -1.282 . . . . 64.12 110.675 178.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . 0.483 HD21 ' HB2' ' C' ' 271' ' ' LYS . 11.8 tp -65.26 -40.1 93.52 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.106 0.962 . . . . 73.14 111.026 -174.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 44.4 m95 -69.41 -37.84 77.65 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.582 -0.736 . . . . 75.0 110.609 176.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . 0.666 ' HE2' ' HA ' ' C' ' 206' ' ' VAL . 1.1 mptm? -67.02 -39.47 87.05 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 123.473 0.483 . . . . 62.43 111.632 176.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -62.33 -48.83 78.07 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.089 0.556 . . . . 70.22 109.884 177.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 18.5 mt -54.36 -51.46 64.72 Favored 'General case' 0 C--O 1.203 -1.371 0 O-C-N 124.55 1.156 . . . . 63.4 110.446 173.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . 0.618 ' HA ' ' HB2' ' C' ' 202' ' ' PRO . . . -67.33 -39.95 85.89 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.697 0.999 . . . . 64.51 113.697 -168.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -86.86 -33.15 19.9 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.589 0.756 . . . . 74.35 110.996 -173.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -71.22 -33.21 69.69 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 109.916 -0.401 . . . . 71.44 109.916 169.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -67.35 -41.54 85.0 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.946 0.898 . . . . 75.02 109.453 174.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' TYR . . . . . 0.459 ' HE1' ' H ' ' C' ' 209' ' ' LYS . 25.2 t80 -62.62 -43.39 98.94 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 124.105 0.878 . . . . 70.12 108.783 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -66.55 -7.88 23.04 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-N 115.199 -0.909 . . . . 75.41 112.647 175.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 73.7 mmt-85 -127.79 13.95 6.91 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 123.885 0.874 . . . . 74.13 111.127 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.658 0 C-N-CA 122.847 0.459 . . . . 72.21 111.309 -173.864 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.0 ttt . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 109.577 -0.527 . . . . 71.44 109.577 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -101.06 -178.05 3.63 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.533 0.733 . . . . 54.1 111.038 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -59.85 103.17 0.19 Allowed 'General case' 0 C--N 1.354 0.777 0 C-N-CA 123.379 0.672 . . . . 74.04 109.375 176.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . 0.576 ' HB3' ' HG2' ' A' ' 129' ' ' GLU . 50.5 m -83.5 27.25 0.61 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.443 1.097 . . . . 52.14 112.163 -173.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 6.4 m -123.06 145.95 48.1 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 109.011 -0.737 . . . . 70.11 109.011 177.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 29.4 pt -140.18 177.76 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 C-N-CA 123.356 0.662 . . . . 64.44 111.75 -158.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -147.03 127.28 13.86 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.847 0.859 . . . . 72.01 110.053 178.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . 0.611 ' HB3' ' HB ' ' A' ' 140' ' ' VAL . 19.3 tp -65.48 148.85 51.02 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.797 1.239 . . . . 75.22 112.196 -171.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.35 -49.56 33.27 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.522 0.729 . . . . 62.4 111.886 177.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 4.2 tt 60.48 102.6 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 124.594 1.158 . . . . 74.1 110.151 -173.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.413 ' HB2' ' O ' ' A' ' 120' ' ' ARG . 74.8 mt . . . . . 0 N--CA 1.481 1.086 0 CA-C-O 118.24 -0.886 . . . . 45.35 109.738 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.237 0 N-CA-C 109.263 -0.643 . . . . 61.34 109.263 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . 63.48 -74.98 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.909 1.284 . . . . 74.4 110.67 -164.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 16.8 tp -161.43 13.69 0.09 Allowed 'General case' 0 CA--C 1.56 1.365 0 N-CA-C 111.919 0.341 . . . . 62.04 111.919 -168.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 182' ' ' VAL . . . . . 0.664 ' HA ' ' HB2' ' C' ' 139' ' ' GLU . 12.4 p -117.7 150.09 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 CA-C-O 118.533 -0.746 . . . . 71.31 110.008 178.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -169.05 6.57 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 115.21 1.559 . . . . 65.24 115.21 -177.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 79.7 m80 76.4 161.49 0.23 Allowed 'General case' 0 N--CA 1.507 2.399 0 C-N-CA 124.548 1.139 . . . . 74.15 111.437 177.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 185' ' ' VAL . . . . . 0.584 HG23 ' HA ' ' C' ' 141' ' ' ALA . 92.7 t . . . . . 0 N--CA 1.479 0.995 0 C-N-CA 122.901 0.48 . . . . 71.33 111.407 -173.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 238' ' ' THR . . . . . 0.514 HG22 HG23 ' C' ' 219' ' ' VAL . 21.9 m . . . . . 0 N--CA 1.471 0.616 0 N-CA-C 110.132 -0.322 . . . . 71.31 110.132 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 239' ' ' ALA . . . . . 0.425 ' HA ' HG22 ' C' ' 219' ' ' VAL . . . -159.71 -82.8 0.04 OUTLIER 'General case' 0 C--O 1.24 0.593 0 O-C-N 123.837 0.711 . . . . 74.42 109.561 -178.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 240' ' ' GLY . . . . . 0.417 ' HA3' ' HA ' ' C' ' 235' ' ' LEU . . . 161.91 -108.67 0.36 Allowed Glycine 0 C--N 1.333 0.367 0 N-CA-C 109.678 -1.369 . . . . 71.23 109.678 -170.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -159.92 160.45 33.53 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.35 0.66 . . . . 71.21 111.125 178.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 26.7 m95 -123.77 -83.08 0.65 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.165 0.986 . . . . 70.32 108.715 168.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -154.49 -54.87 0.1 Allowed 'General case' 0 C--N 1.362 1.152 0 C-N-CA 125.985 1.714 . . . . 74.22 106.654 -168.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -147.34 -163.28 10.49 Favored Glycine 0 C--N 1.355 1.614 0 CA-C-N 113.843 -1.526 . . . . 63.11 110.628 173.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? . . . . . 0 N--CA 1.488 1.439 0 N-CA-C 108.89 -0.781 . . . . 75.34 108.89 175.878 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.976 0 N-CA-C 109.825 -0.435 . . . . 52.01 109.825 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 4' ' ' LYS . . . . . 0.468 ' HE2' ' HE2' ' C' ' 69' ' ' TYR . 38.7 ttmt -39.42 101.15 0.02 OUTLIER 'General case' 0 C--N 1.353 0.739 0 C-N-CA 125.421 1.488 . . . . 70.52 113.766 -177.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -66.32 95.62 0.31 Allowed 'General case' 0 C--O 1.244 0.807 0 N-CA-C 108.558 -0.905 . . . . 63.2 108.558 164.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -74.7 94.71 2.74 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 106.758 -1.571 . . . . 63.22 106.758 173.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 7' ' ' TYR . . . . . 0.426 ' HB3' ' HA ' ' C' ' 53' ' ' ALA . 50.1 m-85 -56.53 -35.74 68.42 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 114.766 -1.107 . . . . 73.43 111.551 -170.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 8' ' ' TYR . . . . . 0.422 ' HD1' HG23 ' C' ' 13' ' ' VAL . 65.4 m-85 -65.9 -42.65 89.95 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.411 -1.268 . . . . 72.53 111.801 175.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.42 -39.52 94.0 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 122.643 0.377 . . . . 52.31 110.848 177.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 59.2 mt -56.88 -43.14 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.446 0.698 . . . . 63.34 109.939 175.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 11' ' ' LEU . . . . . 0.543 ' HB3' ' HB1' ' C' ' 25' ' ' ALA . 96.2 mt -76.94 -15.15 59.75 Favored 'General case' 0 CA--C 1.556 1.195 0 CA-C-N 115.268 -0.878 . . . . 45.45 113.205 177.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.67 18.86 80.04 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 113.797 0.279 . . . . 64.33 113.797 -176.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 13' ' ' VAL . . . . . 0.422 HG22 ' HB2' ' C' ' 11' ' ' LEU . 30.1 m -111.73 155.03 43.75 Favored Pre-proline 0 N--CA 1.483 1.206 0 C-N-CA 124.442 1.097 . . . . 64.04 110.015 179.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -60.59 156.53 41.67 Favored 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 123.155 2.57 . . . . 74.43 113.729 177.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 33.4 mtp-105 -69.95 7.12 1.0 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 113.804 1.038 . . . . 71.52 113.804 -174.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -127.6 9.07 6.47 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.305 1.042 . . . . 71.24 109.302 -177.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.09 130.28 45.45 Favored 'General case' 0 C--N 1.356 0.883 0 C-N-CA 123.97 0.908 . . . . 71.14 110.951 -175.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 71.5 p -68.47 166.86 15.99 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.56 0.744 . . . . 74.41 110.713 -177.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 62.4 tp60 -57.75 -33.62 68.67 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.784 0.833 . . . . 74.45 111.908 -172.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -70.1 -40.53 74.9 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.038 0.535 . . . . 64.05 111.288 177.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -65.64 -39.9 91.92 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 122.757 0.423 . . . . 73.42 110.748 179.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 22' ' ' ILE . . . . . 0.572 HD13 ' HB3' ' C' ' 57' ' ' LEU . 86.1 mt -64.75 -42.57 95.34 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 C-N-CA 124.054 0.942 . . . . 61.32 110.372 176.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -61.99 -47.13 86.17 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.367 1.067 . . . . 74.13 111.326 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 78.7 mtm180 -71.24 -35.53 71.47 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 115.987 -0.551 . . . . 73.52 110.758 -178.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . 0.543 ' HB1' ' HB3' ' C' ' 11' ' ' LEU . . . -64.11 -40.39 96.09 Favored 'General case' 0 C--O 1.249 1.031 0 C-N-CA 123.11 0.564 . . . . 75.32 110.457 176.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 26' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -57.91 -60.25 4.0 Favored 'General case' 0 C--O 1.214 -0.778 0 CA-C-N 114.77 -1.105 . . . . 72.31 109.873 175.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -60.49 -41.32 94.01 Favored 'General case' 0 N--CA 1.483 1.183 0 O-C-N 124.068 0.855 . . . . 74.1 111.653 -174.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -53.07 -58.67 6.22 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.456 1.103 . . . . 71.15 110.922 176.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 97.1 mt -80.79 -11.09 59.66 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.521 -0.763 . . . . 60.22 111.06 -176.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -80.43 -26.23 38.54 Favored 'General case' 0 C--O 1.216 -0.684 0 C-N-CA 122.906 0.482 . . . . 75.32 109.731 171.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -81.2 -39.81 24.85 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.929 0.892 . . . . 73.5 110.404 175.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -70.16 -51.15 33.53 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.171 0.588 . . . . 71.12 109.789 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 33' ' ' TYR . . . . . 0.434 ' HB3' ' O ' ' C' ' 43' ' ' ALA . 35.6 m-85 -89.73 14.65 11.27 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 115.739 -0.664 . . . . 70.15 111.798 -176.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 34' ' ' HIS . . . . . 0.493 ' HD2' ' HB3' ' C' ' 36' ' ' ASP . 6.7 t60 -62.15 103.55 0.4 Allowed Pre-proline 0 N--CA 1.487 1.397 0 C-N-CA 123.947 0.899 . . . . 72.34 110.76 -174.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 35' ' ' PRO . . . . . 0.571 ' HB3' ' HG2' ' C' ' 44' ' ' GLU . 31.7 Cg_exo -59.55 -26.88 83.48 Favored 'Trans proline' 0 C--N 1.381 2.274 0 C-N-CA 123.285 2.656 . . . . 71.32 113.12 -171.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 36' ' ' ASP . . . . . 0.493 ' HB3' ' HD2' ' C' ' 34' ' ' HIS . 25.2 t70 -64.87 -39.0 92.86 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.25 1.02 . . . . 60.34 111.833 177.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 43.5 t -94.1 -54.34 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-O 121.277 0.56 . . . . 75.33 109.677 -177.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -100.04 92.21 5.14 Favored 'General case' 0 C--O 1.243 0.732 0 C-N-CA 124.558 1.143 . . . . 54.22 109.219 178.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -79.39 76.51 5.96 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 109.346 -0.613 . . . . 62.24 109.346 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 49.5 m -129.27 118.07 19.11 Favored Pre-proline 0 CA--C 1.538 0.491 0 CA-C-O 118.091 -0.957 . . . . 74.14 108.787 177.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -45.04 -45.26 14.47 Favored 'Trans proline' 0 C--N 1.382 2.335 0 C-N-CA 123.917 3.078 . . . . 63.44 113.679 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -60.08 -39.85 87.51 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.482 -0.781 . . . . 65.44 110.94 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 43' ' ' ALA . . . . . 0.434 ' O ' ' HB3' ' C' ' 33' ' ' TYR . . . -74.42 -19.79 60.28 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.885 -0.598 . . . . 62.05 111.447 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 44' ' ' GLU . . . . . 0.571 ' HG2' ' HB3' ' C' ' 35' ' ' PRO . 39.4 mt-10 -78.35 -45.57 22.21 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 109.547 -0.538 . . . . 74.04 109.547 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -68.7 -39.68 80.37 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.258 -0.883 . . . . 42.53 109.915 177.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 46' ' ' LYS . . . . . 0.56 ' O ' HG12 ' C' ' 50' ' ' ILE . 23.1 mmtm -61.7 -42.77 99.39 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.069 -0.514 . . . . 72.32 110.836 174.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -55.93 -43.13 77.09 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.551 0.74 . . . . 62.23 110.027 175.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 48' ' ' LYS . . . . . 0.404 ' HA ' ' HB2' ' C' ' 51' ' ' ASN . 97.1 mttt -72.59 -23.32 60.94 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-N 115.641 -0.709 . . . . 72.04 112.091 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -78.05 -25.61 47.85 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 118.139 0.427 . . . . 72.33 110.342 172.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 50' ' ' ILE . . . . . 0.56 HG12 ' O ' ' C' ' 46' ' ' LYS . 18.2 mm -75.35 -36.13 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 N-CA-C 108.287 -1.005 . . . . 75.43 108.287 172.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 51' ' ' ASN . . . . . 0.404 ' HB2' ' HA ' ' C' ' 48' ' ' LYS . 0.9 OUTLIER -68.27 -36.61 79.66 Favored 'General case' 0 C--O 1.2 -1.548 0 CA-C-N 114.883 -1.053 . . . . 74.04 110.018 173.643 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -65.52 -47.05 77.26 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.902 1.281 . . . . 63.42 109.986 178.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . 0.426 ' HA ' ' HB3' ' C' ' 7' ' ' TYR . . . -57.85 -61.41 2.55 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 113.998 -1.455 . . . . 63.1 111.01 178.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 54' ' ' TYR . . . . . 0.545 ' HD1' HG22 ' C' ' 22' ' ' ILE . 76.6 t80 -71.17 -12.87 61.72 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.745 -0.661 . . . . 75.01 111.533 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.64 -57.69 7.51 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 108.95 -0.759 . . . . 60.54 108.95 171.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 48.4 t -69.04 -22.69 26.41 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 CA-C-N 114.543 -1.208 . . . . 72.43 110.814 -178.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 57' ' ' LEU . . . . . 0.572 ' HB3' HD13 ' C' ' 22' ' ' ILE . 64.7 mt -109.13 9.2 26.2 Favored 'General case' 0 CA--C 1.564 1.484 0 N-CA-C 112.772 0.656 . . . . 75.02 112.772 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 46.6 t -51.69 -45.55 63.54 Favored 'General case' 0 N--CA 1.503 2.215 0 C-N-CA 124.66 1.184 . . . . 62.42 113.292 176.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 59' ' ' ASP . . . . . 0.429 ' HB2' ' HG3' ' C' ' 62' ' ' LYS . 2.0 m-20 -114.85 148.78 41.19 Favored Pre-proline 0 C--O 1.241 0.608 0 CA-C-N 115.492 -0.776 . . . . 72.03 109.145 177.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 60' ' ' PRO . . . . . 0.503 ' O ' ' HG2' ' C' ' 64' ' ' ARG . 69.0 Cg_exo -55.75 -30.6 76.76 Favored 'Trans proline' 0 C--N 1.374 1.921 0 C-N-CA 122.636 2.224 . . . . 33.23 111.984 167.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -64.41 -49.48 71.38 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.925 0.89 . . . . 62.13 111.054 175.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 62' ' ' LYS . . . . . 0.429 ' HG3' ' HB2' ' C' ' 59' ' ' ASP . 28.1 mtpp -66.7 -30.92 71.28 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-O 121.259 0.552 . . . . 75.23 110.07 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 23.0 tpt180 -60.65 -41.68 95.44 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 115.272 -0.876 . . . . 64.42 110.145 168.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 64' ' ' ARG . . . . . 0.503 ' HG2' ' O ' ' C' ' 60' ' ' PRO . 30.5 mmm180 -65.68 -27.09 68.1 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-O 119.305 -0.379 . . . . 74.15 111.525 176.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 1.7 mp -63.46 -45.08 98.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 109.581 -0.526 . . . . 62.34 109.581 168.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -58.46 -46.39 86.69 Favored 'General case' 0 CA--C 1.562 1.429 0 N-CA-C 109.312 -0.625 . . . . 74.22 109.312 174.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -61.85 -35.68 78.99 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 124.122 0.969 . . . . 73.14 112.009 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 40.7 p -73.99 -22.55 59.56 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 119.421 -0.323 . . . . 63.2 110.775 177.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 69' ' ' TYR . . . . . 0.468 ' HE2' ' HE2' ' C' ' 4' ' ' LYS . 79.9 t80 -76.11 108.05 8.76 Favored 'General case' 0 C--N 1.355 0.84 0 N-CA-C 107.648 -1.241 . . . . 75.22 107.648 168.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 102.64 27.71 6.63 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.202 -0.759 . . . . 62.51 111.202 -167.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 25.1 m -145.95 -57.64 0.31 Allowed 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 103.494 -2.78 . . . . 72.34 103.494 173.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 5.4 m -81.2 140.18 35.09 Favored 'General case' 0 C--O 1.254 1.32 0 N-CA-C 104.618 -2.364 . . . . 73.35 104.618 157.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.23 -32.63 15.69 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.647 0.779 . . . . 73.23 110.505 -178.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -92.98 159.06 36.47 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 124.056 0.942 . . . . 53.23 109.888 177.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -59.5 150.85 73.08 Favored 'Trans proline' 0 CA--C 1.56 1.786 0 C-N-CA 122.318 2.012 . . . . 75.14 112.141 168.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -68.0 164.16 32.96 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 122.729 2.286 . . . . 63.14 112.788 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -60.64 129.73 30.53 Favored 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 122.973 2.449 . . . . 51.51 111.97 173.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 78' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -59.61 115.17 2.42 Favored 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 123.158 2.572 . . . . 74.44 113.182 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 79' ' ' PRO . . . . . 0.404 ' HA ' ' HD3' ' C' ' 80' ' ' PRO . 38.9 Cg_endo -66.16 130.6 24.55 Favored 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 122.532 2.155 . . . . 61.04 111.332 175.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 80' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' C' ' 79' ' ' PRO . 24.8 Cg_exo -62.0 88.66 0.1 Allowed 'Trans proline' 0 C--N 1.379 2.179 0 C-N-CA 122.733 2.289 . . . . 51.5 111.754 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 155.77 -33.51 0.62 Allowed Glycine 0 N--CA 1.465 0.63 0 N-CA-C 110.238 -1.145 . . . . 75.2 110.238 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 126.96 157.7 9.58 Favored Glycine 0 C--N 1.352 1.47 0 CA-C-N 114.837 -0.682 . . . . 74.45 113.462 173.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -67.69 107.89 2.72 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 107.636 -1.246 . . . . 70.14 107.636 164.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -67.21 130.19 42.31 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.396 0.617 . . . . 63.13 111.719 -169.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 85' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -132.57 52.53 2.07 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.565 1.146 . . . . 74.41 108.122 174.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 50.9 m -64.01 96.38 0.14 Allowed 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 113.295 -1.775 . . . . 45.43 111.862 -174.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 114.95 -13.95 19.56 Favored Glycine 0 C--N 1.348 1.243 0 CA-C-N 115.658 -0.701 . . . . 74.33 113.105 176.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 88' ' ' PHE . . . . . 0.409 ' HB3' ' HZ ' ' C' ' 93' ' ' PHE . 38.8 m-85 -112.3 144.01 42.44 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 117.392 0.596 . . . . 74.44 110.376 -169.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 89' ' ' ASP . . . . . 0.548 ' HA ' ' HG2' ' C' ' 171' ' ' PRO . 46.0 t0 -77.11 74.46 3.69 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.861 0.839 . . . . 72.23 110.746 -175.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 90' ' ' VAL . . . . . 0.471 HG12 ' HG3' ' C' ' 171' ' ' PRO . 5.2 p -48.85 -47.46 16.23 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.003 0 C-N-CA 126.128 1.771 . . . . 54.41 113.063 -171.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -61.78 -27.2 68.58 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 112.836 0.68 . . . . 74.21 112.836 -173.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -83.74 -11.09 57.61 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 111.796 0.295 . . . . 75.53 111.796 -173.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 93' ' ' PHE . . . . . 0.409 ' HZ ' ' HB3' ' C' ' 88' ' ' PHE . 13.5 m-30 -74.6 171.29 14.12 Favored 'General case' 0 CA--C 1.557 1.233 0 CA-C-O 120.846 0.355 . . . . 72.45 111.581 -174.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 93.6 p -76.52 174.34 10.43 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 115.105 1.52 . . . . 45.51 115.105 -164.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -51.87 -47.93 64.29 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.34 1.456 . . . . 55.43 112.644 174.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -56.94 -45.67 82.6 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.547 0.739 . . . . 65.02 110.59 -177.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 97' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.33 -47.76 80.73 Favored 'General case' 0 CA--C 1.56 1.34 0 CA-C-N 114.359 -1.291 . . . . 64.25 110.208 172.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -66.79 -14.09 62.23 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.739 0.815 . . . . 51.52 112.29 -179.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -95.73 -39.2 9.99 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.085 0.554 . . . . 74.43 112.196 177.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 43.8 tp -83.13 -51.28 7.65 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-O 121.403 0.621 . . . . 73.23 110.929 -176.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -87.75 -18.79 28.63 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.001 0.921 . . . . 73.25 110.607 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -40.33 -56.24 2.89 Favored Glycine 0 C--N 1.358 1.781 0 CA-C-O 118.137 -1.369 . . . . 54.11 115.335 177.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 0.8 OUTLIER -28.9 -37.15 0.04 OUTLIER 'Trans proline' 0 C--N 1.389 2.695 1 C-N-CA 125.831 4.354 . . . . 62.02 116.663 174.281 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -149.44 47.3 0.63 Allowed Glycine 0 C--N 1.345 1.056 0 C-N-CA 121.266 -0.492 . . . . 43.23 112.621 -179.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 105' ' ' LEU . . . . . 0.543 ' HB3' HD22 ' C' ' 169' ' ' ASN . 37.1 mt . . . . . 0 N--CA 1.48 1.042 0 CA-C-O 121.266 0.555 . . . . 73.03 111.606 170.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 CA-C-O 121.297 0.387 . . . . 45.25 113.829 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -88.5 163.54 15.87 Favored 'General case' 0 C--O 1.244 0.769 0 C-N-CA 124.733 1.213 . . . . 64.44 110.694 178.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -68.87 144.63 54.18 Favored 'General case' 0 C--O 1.245 0.849 0 N-CA-C 108.47 -0.937 . . . . 75.42 108.47 168.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 119' ' ' LEU . . . . . 0.468 HD21 HG23 ' C' ' 140' ' ' VAL . 0.0 OUTLIER -133.53 152.72 51.95 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 121.266 0.555 . . . . 75.21 110.625 175.97 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -105.49 113.52 27.15 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.046 -0.979 . . . . 72.31 108.714 -173.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 121' ' ' ALA . . . . . 0.685 ' HB1' ' HG3' ' C' ' 139' ' ' GLU . . . -111.79 116.84 31.36 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.485 -1.672 . . . . 63.21 106.485 172.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 122' ' ' GLU . . . . . 0.588 ' HB2' ' HB ' ' C' ' 177' ' ' VAL . 20.7 tt0 -114.5 138.09 51.03 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 122.638 0.375 . . . . 73.22 110.429 -171.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -142.14 133.38 13.07 Favored Pre-proline 0 CA--C 1.544 0.72 0 CA-C-N 115.403 -0.817 . . . . 73.3 111.164 -168.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.93 128.55 18.97 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.383 2.056 . . . . 72.51 110.624 164.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 125' ' ' LEU . . . . . 0.481 ' O ' ' HA ' ' C' ' 180' ' ' LEU . 14.0 tp -153.56 165.48 35.76 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 106.763 -1.569 . . . . 74.03 106.763 -174.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 126' ' ' THR . . . . . 0.422 ' H ' ' HB2' ' C' ' 129' ' ' GLU . 15.1 t -127.69 175.96 7.9 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 119.69 1.132 . . . . 61.53 110.278 173.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 127' ' ' LEU . . . . . 0.438 HD13 ' CD2' ' C' ' 186' ' ' PHE . 33.5 mt -58.89 -47.82 83.61 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.494 1.518 . . . . 62.25 110.876 -178.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 128' ' ' GLU . . . . . 0.497 ' HG3' ' HA ' ' C' ' 215' ' ' LEU . 11.4 mp0 -60.92 -36.73 80.07 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 114.904 -1.044 . . . . 75.24 110.281 177.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 129' ' ' GLU . . . . . 0.422 ' HB2' ' H ' ' C' ' 126' ' ' THR . 34.7 mm-40 -78.77 -22.67 46.04 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.548 0.739 . . . . 73.53 112.519 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 130' ' ' ALA . . . . . 0.424 ' HB2' HG22 ' C' ' 153' ' ' VAL . . . -74.39 -33.16 62.97 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 108.92 -0.77 . . . . 64.34 108.92 174.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 131' ' ' PHE . . . . . 0.42 ' HB3' ' O ' ' C' ' 128' ' ' GLU . 54.8 t80 -65.64 -48.62 71.54 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 113.922 -1.49 . . . . 75.55 110.07 169.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 132' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -73.69 -12.88 60.87 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.331 0.652 . . . . 60.22 112.013 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -37.42 -84.87 0.01 OUTLIER Glycine 0 C--N 1.365 2.176 0 O-C-N 124.649 1.218 . . . . 65.31 114.606 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 134' ' ' GLY . . . . . 0.45 ' O ' ' HA ' ' C' ' 148' ' ' ARG . . . 49.36 -135.31 23.44 Favored Glycine 0 C--N 1.356 1.666 0 O-C-N 124.278 0.634 . . . . 53.24 114.237 174.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 135' ' ' GLU . . . . . 0.522 ' HG3' ' HB2' ' C' ' 148' ' ' ARG . 1.4 mp0 -89.92 91.96 8.81 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 108.044 -1.095 . . . . 71.2 108.044 177.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 136' ' ' ARG . . . . . . . . . . . . . 66.5 mtm180 -140.82 169.29 17.9 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 121.976 0.893 . . . . 72.12 110.751 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 137' ' ' VAL . . . . . 0.623 ' HB ' ' HG2' ' C' ' 144' ' ' ARG . 15.8 m -75.14 95.41 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 CA-C-N 113.769 -1.56 . . . . 71.12 111.122 -176.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 138' ' ' VAL . . . . . 0.471 HG12 ' HB ' ' C' ' 145' ' ' VAL . 2.9 p -79.7 161.24 4.12 Favored 'Isoleucine or valine' 0 C--O 1.251 1.132 0 CA-C-N 114.176 -1.375 . . . . 72.14 112.48 -172.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 139' ' ' GLU . . . . . 0.685 ' HG3' ' HB1' ' C' ' 121' ' ' ALA . 7.7 tp10 -82.5 136.57 34.85 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 113.636 -1.62 . . . . 74.31 111.686 175.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 140' ' ' VAL . . . . . 0.468 HG23 HD21 ' C' ' 119' ' ' LEU . 5.5 p -169.76 99.52 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 124.534 1.133 . . . . 63.22 108.821 163.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 141' ' ' ALA . . . . . 0.584 ' HA ' HG23 ' B' ' 185' ' ' VAL . . . 66.32 22.64 10.83 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.247 1.019 . . . . 15.23 111.921 -178.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 86.93 -14.17 57.52 Favored Glycine 0 C--N 1.346 1.09 0 CA-C-N 116.208 -0.451 . . . . 45.25 112.726 -174.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 143' ' ' ARG . . . . . 0.62 HH11 HG22 ' C' ' 145' ' ' VAL . 0.0 OUTLIER -74.82 120.94 21.04 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 108.588 -0.893 . . . . 73.04 108.588 -178.688 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 144' ' ' ARG . . . . . 0.623 ' HG2' ' HB ' ' C' ' 137' ' ' VAL . 51.2 ttp180 -87.7 92.36 9.08 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 125.451 1.501 . . . . 71.51 109.918 -169.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 145' ' ' VAL . . . . . 0.62 HG22 HH11 ' C' ' 143' ' ' ARG . 65.5 t -98.27 121.03 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 C-N-CA 122.679 0.391 . . . . 75.03 111.067 -174.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 19.8 m -75.02 101.73 4.59 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.165 0.586 . . . . 54.21 109.819 177.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 7.5 p -152.36 158.99 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 122.337 0.255 . . . . 72.53 110.739 -174.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 148' ' ' ARG . . . . . 0.522 ' HB2' ' HG3' ' C' ' 135' ' ' GLU . 42.7 ttm180 -91.44 123.68 35.04 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 109.412 -0.588 . . . . 74.22 109.412 170.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 149' ' ' ILE . . . . . . . . . . . . . 34.2 pt -105.03 151.42 39.47 Favored Pre-proline 0 CA--C 1.548 0.904 0 N-CA-C 107.297 -1.371 . . . . 71.41 107.297 163.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -47.95 115.5 1.51 Allowed 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.852 2.368 . . . . 61.44 112.484 175.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 151' ' ' PRO . . . . . 0.537 ' HG2' ' HA2' ' C' ' 242' ' ' GLY . 28.9 Cg_endo -61.87 109.06 0.72 Allowed 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 122.613 2.209 . . . . 73.2 111.155 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 152' ' ' GLY . . . . . . . . . . . . . . . 124.5 122.96 2.7 Favored Glycine 0 C--N 1.343 0.925 0 CA-C-N 115.376 -0.829 . . . . 54.32 113.739 -173.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 153' ' ' VAL . . . . . 0.694 HG21 HG21 ' C' ' 178' ' ' VAL . 5.7 m -141.78 176.04 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 C-N-CA 123.586 0.754 . . . . 71.13 110.658 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 154' ' ' ARG . . . . . 0.718 ' HB2' ' HB2' ' C' ' 157' ' ' SER . 15.6 mtp180 -125.85 169.13 12.95 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 124.378 1.071 . . . . 75.32 109.877 -178.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 155' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -69.81 126.54 30.01 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.744 0.418 . . . . 74.51 110.814 175.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 67.9 11.7 61.14 Favored Glycine 0 C--N 1.349 1.288 0 CA-C-N 115.719 -0.673 . . . . 64.51 113.559 -178.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 157' ' ' SER . . . . . 0.718 ' HB2' ' HB2' ' C' ' 154' ' ' ARG . 33.0 t -74.07 132.8 42.67 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.131 0.572 . . . . 75.43 110.523 -174.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 158' ' ' VAL . . . . . 0.54 ' HB ' HD22 ' C' ' 175' ' ' LEU . 16.1 m -86.08 95.94 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 CA-C-N 115.527 -0.761 . . . . 64.44 109.192 171.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 159' ' ' ILE . . . . . 0.775 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 8.3 mt -68.55 90.53 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 107.468 -1.308 . . . . 52.25 107.468 171.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -83.59 100.19 10.65 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.404 -0.591 . . . . 72.21 109.404 -176.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 161' ' ' VAL . . . . . 0.519 HG13 ' HB3' ' C' ' 174' ' ' LEU . 2.6 p -102.84 103.98 36.51 Favored Pre-proline 0 CA--C 1.561 1.391 0 N-CA-C 108.477 -0.935 . . . . 75.24 108.477 175.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -62.54 142.55 90.51 Favored 'Trans proline' 0 C--N 1.386 2.534 0 C-N-CA 123.633 2.889 . . . . 63.42 113.805 -175.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 86.15 -24.98 7.32 Favored Glycine 0 C--N 1.347 1.188 0 CA-C-N 115.638 -0.71 . . . . 53.31 113.719 177.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 164' ' ' MET . . . . . . . . . . . . . 41.6 mtp -78.64 -6.47 55.77 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 113.403 0.89 . . . . 73.35 113.403 -174.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . -106.03 -151.5 19.43 Favored Glycine 0 C--N 1.334 0.465 0 N-CA-C 111.856 -0.497 . . . . 64.24 111.856 173.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . 109.27 73.36 0.77 Allowed Glycine 0 C--N 1.342 0.906 0 C-N-CA 121.562 -0.351 . . . . 75.44 112.392 -173.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 167' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -77.32 102.37 6.71 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 105.999 -1.852 . . . . 64.31 105.999 163.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . 115.51 153.1 10.21 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 108.109 -1.997 . . . . 13.44 108.109 -161.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 169' ' ' ASN . . . . . 0.543 HD22 ' HB3' ' C' ' 105' ' ' LEU . 25.0 t-20 -66.07 -66.66 1.22 Allowed Pre-proline 0 CA--C 1.583 2.245 0 CA-C-O 116.74 -1.6 . . . . 62.44 112.833 -168.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 170' ' ' PRO . . . . . 0.46 ' HD3' ' HB3' ' C' ' 169' ' ' ASN . 51.8 Cg_exo -51.08 111.94 0.67 Allowed 'Trans proline' 0 C--N 1.401 3.309 0 CA-C-N 123.076 2.134 . . . . 51.41 113.381 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 171' ' ' PRO . . . . . 0.548 ' HG2' ' HA ' ' C' ' 89' ' ' ASP . 71.6 Cg_exo -47.58 139.9 17.32 Favored 'Trans proline' 0 C--N 1.383 2.377 0 C-N-CA 124.465 3.443 . . . . 74.02 115.698 -164.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -108.69 -127.17 5.5 Favored Glycine 0 C--N 1.344 1.004 0 N-CA-C 111.329 -0.708 . . . . 74.42 111.329 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 173' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -151.88 156.47 40.19 Favored 'General case' 0 C--O 1.249 1.077 0 CA-C-O 121.606 0.717 . . . . 74.51 110.423 173.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 174' ' ' LEU . . . . . 0.519 ' HB3' HG13 ' C' ' 161' ' ' VAL . 39.4 tp -104.32 123.48 47.47 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.488 -0.778 . . . . 75.22 110.367 -177.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 175' ' ' LEU . . . . . 0.54 HD22 ' HB ' ' C' ' 158' ' ' VAL . 92.8 mt -101.95 94.87 6.01 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.619 1.167 . . . . 71.32 108.159 173.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 176' ' ' LEU . . . . . 0.775 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 44.2 mt -78.78 101.47 7.62 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.472 -0.566 . . . . 43.02 109.472 174.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 177' ' ' VAL . . . . . 0.588 ' HB ' ' HB2' ' C' ' 122' ' ' GLU . 39.5 t -84.32 94.13 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 107.172 -1.418 . . . . 74.43 107.172 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 178' ' ' VAL . . . . . 0.694 HG21 HG21 ' C' ' 153' ' ' VAL . 2.7 p -82.02 125.3 39.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.623 0.725 . . . . 74.01 110.68 -178.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 179' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -104.81 106.73 17.35 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 114.772 -1.104 . . . . 72.33 108.101 175.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 180' ' ' LEU . . . . . 0.481 ' HA ' ' O ' ' C' ' 125' ' ' LEU . 97.3 mt -70.37 148.93 47.85 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 123.677 0.611 . . . . 70.51 110.505 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 181' ' ' LEU . . . . . 0.416 HD12 ' HB ' ' C' ' 126' ' ' THR . 80.2 mt -72.62 166.58 41.12 Favored Pre-proline 0 N--CA 1.483 1.216 0 C-N-CA 123.443 0.697 . . . . 74.2 110.418 -174.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -55.57 78.74 0.03 OUTLIER 'Trans proline' 0 C--N 1.384 2.426 0 C-N-CA 122.837 2.358 . . . . 64.12 111.867 166.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 183' ' ' HIS . . . . . . . . . . . . . 76.3 t60 -173.11 57.21 0.21 Allowed Pre-proline 0 CA--C 1.559 1.297 0 CA-C-N 113.459 -1.7 . . . . 62.13 107.039 -171.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 184' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -86.16 66.73 5.12 Favored 'Trans proline' 0 C--N 1.385 2.454 0 C-N-CA 123.176 2.584 . . . . 71.54 111.323 -174.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 185' ' ' VAL . . . . . 0.514 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 21.2 t -92.66 -43.17 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 108.595 -0.891 . . . . 72.23 108.595 -173.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 186' ' ' PHE . . . . . 0.608 ' HB3' HD22 ' C' ' 193' ' ' LEU . 56.0 m-85 -119.75 119.85 34.83 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.307 0.643 . . . . 61.44 111.738 -171.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 187' ' ' ARG . . . . . 0.406 ' HB3' ' HB3' ' C' ' 194' ' ' TYR . 2.2 tmt_? -96.58 109.7 22.25 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 107.03 -1.47 . . . . 75.14 107.03 171.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 188' ' ' LEU . . . . . 0.614 HD13 ' HD2' ' C' ' 240' ' ' PHE . 67.2 tp -82.21 151.25 26.96 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.654 0.74 . . . . 74.14 112.502 -177.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -142.02 101.92 4.03 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.252 1.421 . . . . 71.33 107.298 164.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 68.28 -89.53 0.21 Allowed Glycine 0 C--N 1.35 1.354 0 O-C-N 123.205 0.316 . . . . 74.2 113.188 -177.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 191' ' ' GLN . . . . . 0.45 HE21 ' H ' ' C' ' 242' ' ' GLY . 28.4 mt-30 -119.88 -22.91 6.59 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.61 1.164 . . . . 60.21 110.789 175.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -86.45 129.0 35.01 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.574 0.749 . . . . 65.13 110.934 -173.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 193' ' ' LEU . . . . . 0.608 HD22 ' HB3' ' C' ' 186' ' ' PHE . 62.6 mt -93.72 166.71 12.08 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.913 0.485 . . . . 52.2 111.106 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 194' ' ' TYR . . . . . 0.515 ' HA ' ' O ' ' C' ' 250' ' ' TYR . 4.1 t80 -137.82 103.65 5.06 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 109.049 -0.723 . . . . 75.43 109.049 169.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 195' ' ' ALA . . . . . 0.524 ' HB3' ' HG ' ' C' ' 251' ' ' LEU . . . -101.77 -177.38 3.41 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 124.032 0.933 . . . . 65.11 110.093 176.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 56.3 m -132.56 130.17 39.96 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 108.113 -1.069 . . . . 51.32 108.113 168.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 197' ' ' LEU . . . . . . . . . . . . . 51.7 tp -106.54 135.24 48.39 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 123.769 0.828 . . . . 73.5 110.699 -171.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -78.98 101.7 7.92 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.395 0.678 . . . . 44.52 109.619 173.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 199' ' ' VAL . . . . . . . . . . . . . 40.8 t -119.11 109.94 38.54 Favored Pre-proline 0 N--CA 1.473 0.68 0 N-CA-C 108.052 -1.092 . . . . 61.21 108.052 175.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 200' ' ' PRO . . . . . 0.519 ' HG2' HD12 ' C' ' 203' ' ' ILE . 25.6 Cg_exo -60.7 147.2 95.65 Favored 'Trans proline' 0 C--N 1.363 1.325 0 C-N-CA 122.188 1.925 . . . . 71.34 111.546 175.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 201' ' ' ALA . . . . . . . . . . . . . . . -50.46 -48.39 81.6 Favored Pre-proline 0 CA--C 1.561 1.384 0 O-C-N 123.885 0.74 . . . . 74.35 112.6 176.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 202' ' ' PRO . . . . . 0.618 ' HB2' ' HA ' ' A' ' 273' ' ' ALA . 20.3 Cg_endo -58.34 -49.81 11.33 Favored 'Trans proline' 0 C--N 1.387 2.584 0 C-N-CA 121.572 1.515 . . . . 63.15 113.161 174.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 203' ' ' ILE . . . . . 0.519 HD12 ' HG2' ' C' ' 200' ' ' PRO . 37.6 mt -63.84 -29.32 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 C-N-CA 122.933 0.493 . . . . 63.4 111.22 -178.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.43 -46.02 67.76 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.166 0.986 . . . . 75.02 111.531 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 205' ' ' VAL . . . . . . . . . . . . . 72.6 t -68.52 -40.42 81.99 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 CA-C-N 115.466 -0.788 . . . . 63.41 111.617 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 206' ' ' VAL . . . . . 0.666 ' HA ' ' HE2' ' A' ' 270' ' ' LYS . 14.3 p -80.13 -38.25 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 112.787 0.662 . . . . 52.12 112.787 -173.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 85.05 71.56 1.31 Allowed Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 116.054 -0.521 . . . . 63.21 112.091 -167.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -98.62 -138.68 10.4 Favored Glycine 0 C--N 1.341 0.813 0 N-CA-C 111.294 -0.722 . . . . 51.32 111.294 176.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 209' ' ' LYS . . . . . 0.591 ' HG2' ' HA ' ' C' ' 222' ' ' ALA . 43.7 mtmt -139.7 146.3 39.45 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.451 0.7 . . . . 72.12 110.221 170.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 210' ' ' VAL . . . . . . . . . . . . . 19.9 m -138.15 137.17 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 107.923 -1.14 . . . . 62.05 107.923 173.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 211' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -75.7 127.79 33.8 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 120.685 0.278 . . . . 72.44 110.983 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -95.79 119.19 33.85 Favored 'General case' 0 C--O 1.245 0.854 0 N-CA-C 108.637 -0.875 . . . . 74.43 108.637 165.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 213' ' ' MET . . . . . . . . . . . . . 2.6 tmm? -72.08 121.69 19.66 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 107.583 -1.265 . . . . 63.12 107.583 176.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 214' ' ' THR . . . . . 0.504 ' OG1' HG12 ' C' ' 219' ' ' VAL . 0.2 OUTLIER -126.21 168.13 14.49 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 122.909 0.484 . . . . 54.24 110.568 -174.51 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 215' ' ' LEU . . . . . 0.497 ' HA ' ' HG3' ' C' ' 128' ' ' GLU . 17.0 mt -55.7 -45.27 77.9 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 125.398 1.479 . . . . 44.41 112.043 -176.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -78.64 -28.5 45.52 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 113.547 -1.66 . . . . 71.0 111.416 -176.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 154.98 -164.38 31.78 Favored Glycine 0 C--N 1.343 0.935 0 CA-C-O 119.575 -0.569 . . . . 64.11 112.018 -169.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -84.87 116.49 1.86 Allowed 'Trans proline' 0 CA--C 1.552 1.424 0 C-N-CA 122.691 2.261 . . . . 52.13 113.223 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 219' ' ' VAL . . . . . 0.514 HG23 HG22 ' B' ' 238' ' ' THR . 10.8 p -101.09 117.26 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 108.311 -0.996 . . . . 52.53 108.311 171.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 220' ' ' GLU . . . . . 0.446 ' HG2' ' HD2' ' C' ' 209' ' ' LYS . 27.4 tt0 -91.28 105.36 17.73 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 121.467 0.651 . . . . 72.32 109.986 -171.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 221' ' ' VAL . . . . . 0.413 HG11 HD21 ' C' ' 233' ' ' LEU . 64.4 t -70.23 119.92 17.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 114.846 -1.07 . . . . 74.03 112.019 -174.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 222' ' ' ALA . . . . . 0.591 ' HA ' ' HG2' ' C' ' 209' ' ' LYS . . . -76.76 99.13 5.01 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 124.149 0.906 . . . . 73.3 109.806 169.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 98.6 t -73.79 138.54 76.77 Favored Pre-proline 0 CA--C 1.555 1.161 0 C-N-CA 123.651 0.781 . . . . 73.11 109.126 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 224' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -92.35 172.86 2.32 Favored 'Trans proline' 0 C--N 1.368 1.605 0 C-N-CA 123.778 2.985 . . . . 54.33 111.787 174.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -72.85 154.24 53.52 Favored 'Trans proline' 0 C--N 1.371 1.714 0 C-N-CA 121.57 1.513 . . . . 74.0 110.837 174.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 226' ' ' ARG . . . . . 0.517 HH22 ' HB2' ' A' ' 261' ' ' LEU . 10.4 mpt_? 57.95 58.67 3.49 Favored 'General case' 0 N--CA 1.483 1.204 0 O-C-N 124.023 0.827 . . . . 70.15 111.651 177.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 227' ' ' THR . . . . . 0.615 HG22 HG11 ' C' ' 253' ' ' VAL . 90.0 m -97.28 112.23 24.13 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 122.29 -0.256 . . . . 70.3 110.625 178.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 228' ' ' GLN . . . . . 0.785 HE21 ' HG2' ' A' ' 259' ' ' GLU . 26.2 mp0 -89.03 163.41 15.53 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.941 0.897 . . . . 74.32 112.206 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -70.36 115.02 9.06 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 113.516 -1.674 . . . . 62.12 109.58 175.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 102.26 8.65 43.67 Favored Glycine 0 C--N 1.336 0.546 0 O-C-N 123.562 0.539 . . . . 62.04 113.449 -178.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 231' ' ' ARG . . . . . 0.402 ' HD3' ' HA ' ' C' ' 227' ' ' THR . 41.4 mtp180 -67.89 169.87 9.11 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 117.502 0.651 . . . . 74.12 109.435 164.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 232' ' ' LYS . . . . . 0.451 ' HA ' ' O ' ' C' ' 251' ' ' LEU . 35.4 ttmt -142.06 142.96 32.88 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.794 0.807 . . . . 71.45 112.288 -173.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 233' ' ' LEU . . . . . 0.678 HD13 ' HB2' ' C' ' 251' ' ' LEU . 3.2 mp -106.72 154.45 20.95 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.766 1.626 . . . . 74.21 108.542 178.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 10.5 ptp85 -130.89 88.08 2.57 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 122.268 1.032 . . . . 72.34 108.77 165.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 235' ' ' LEU . . . . . 0.417 ' HA ' ' HA3' ' B' ' 240' ' ' GLY . 30.5 mt -77.59 118.07 19.64 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 114.874 -1.057 . . . . 73.43 109.624 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -81.03 124.71 29.4 Favored 'General case' 0 C--O 1.241 0.605 0 CA-C-N 115.081 -0.963 . . . . 71.55 111.547 -168.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 66.78 29.64 75.0 Favored Glycine 0 C--N 1.345 1.038 0 CA-C-N 115.219 -0.901 . . . . 71.42 112.442 -177.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 34.4 mmtm -118.24 4.42 11.93 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.722 0.809 . . . . 72.03 110.722 178.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 239' ' ' GLY . . . . . 0.466 ' HA2' HD12 ' C' ' 193' ' ' LEU . . . -88.67 -135.4 5.25 Favored Glycine 0 C--N 1.347 1.164 0 N-CA-C 110.625 -0.99 . . . . 31.21 110.625 170.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 240' ' ' PHE . . . . . 0.614 ' HD2' HD13 ' C' ' 188' ' ' LEU . 44.8 m-85 -101.57 108.01 53.8 Favored Pre-proline 0 C--O 1.25 1.093 0 CA-C-N 116.968 0.384 . . . . 75.14 110.092 171.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 241' ' ' PRO . . . . . 0.705 ' HA ' ' H ' ' C' ' 246' ' ' ARG . 40.5 Cg_endo -67.51 113.28 2.87 Favored 'Trans proline' 0 C--N 1.366 1.462 0 C-N-CA 122.027 1.818 . . . . 70.21 110.281 170.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 242' ' ' GLY . . . . . 0.537 ' HA2' ' HG2' ' C' ' 151' ' ' PRO . . . -90.45 -162.45 38.27 Favored Glycine 0 N--CA 1.483 1.773 0 CA-C-N 115.347 -0.842 . . . . 70.14 113.217 -169.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -58.95 -33.38 98.69 Favored 'Trans proline' 0 C--N 1.374 1.888 0 C-N-CA 122.677 2.251 . . . . 71.42 112.11 170.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -79.01 -24.43 43.7 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.127 0.571 . . . . 71.42 110.59 169.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 74.89 98.8 0.1 Allowed Glycine 0 C--N 1.343 0.959 0 CA-C-O 119.38 -0.678 . . . . 51.32 114.149 176.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 246' ' ' ARG . . . . . 0.705 ' H ' ' HA ' ' C' ' 241' ' ' PRO . 10.5 ptt180 -162.48 -72.81 0.05 OUTLIER 'General case' 0 CA--C 1.558 1.257 0 N-CA-C 114.187 1.18 . . . . 61.31 114.187 168.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 247' ' ' GLY . . . . . 0.591 ' H ' ' HG3' ' C' ' 246' ' ' ARG . . . 45.62 128.27 0.0 OUTLIER Glycine 0 C--N 1.358 1.758 0 N-CA-C 117.449 1.74 . . . . 63.23 117.449 -159.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -125.95 119.29 27.35 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 108.308 -0.997 . . . . 73.54 108.308 175.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 249' ' ' LEU . . . . . 0.439 ' HG ' HD11 ' C' ' 251' ' ' LEU . 15.4 tp -86.78 118.49 26.22 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.039 -0.982 . . . . 74.23 109.726 -173.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 250' ' ' TYR . . . . . 0.592 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 20.4 m-85 -98.46 119.88 37.93 Favored 'General case' 0 C--O 1.211 -0.948 0 N-CA-C 108.138 -1.06 . . . . 71.43 108.138 175.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 251' ' ' LEU . . . . . 0.678 ' HB2' HD13 ' C' ' 233' ' ' LEU . 2.6 mp -111.24 139.46 46.62 Favored 'General case' 0 N--CA 1.506 2.355 0 CA-C-N 118.706 0.684 . . . . 64.53 110.029 178.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -94.2 131.14 40.08 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.984 -0.747 . . . . 73.41 108.984 171.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 253' ' ' VAL . . . . . 0.615 HG11 HG22 ' C' ' 227' ' ' THR . 83.9 t -78.65 123.93 36.28 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 C-N-CA 123.619 0.768 . . . . 73.5 111.557 -175.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 254' ' ' ARG . . . . . 0.521 HH12 ' HA3' ' A' ' 230' ' ' GLY . 9.8 mmt85 -101.36 120.92 41.0 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 109.167 -0.679 . . . . 74.13 109.167 166.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 255' ' ' ILE . . . . . . . . . . . . . 36.0 mm -83.78 94.6 3.49 Favored 'Isoleucine or valine' 0 C--O 1.241 0.636 0 O-C-N 124.265 0.978 . . . . 75.24 108.801 170.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 256' ' ' THR . . . . . 0.519 ' O ' ' HA ' ' C' ' 200' ' ' PRO . 0.0 OUTLIER -97.45 144.11 27.5 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 114.883 -1.053 . . . . 53.32 109.731 -179.799 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 2.8 pp -98.79 153.16 38.0 Favored Pre-proline 0 CA--C 1.558 1.267 0 C-N-CA 122.742 0.417 . . . . 64.54 111.227 -177.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -41.7 -24.34 0.26 Allowed 'Trans proline' 0 C--N 1.389 2.672 1 C-N-CA 125.369 4.046 . . . . 73.21 118.333 -170.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 59.88 -73.33 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 124.477 1.111 . . . . 72.3 111.08 -165.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.06 159.14 31.43 Favored 'General case' 0 C--N 1.352 0.674 0 N-CA-C 109.026 -0.731 . . . . 73.41 109.026 171.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 261' ' ' LEU . . . . . 0.52 ' HB2' HH21 ' A' ' 226' ' ' ARG . 75.7 mt -145.12 170.9 15.33 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.045 -1.095 . . . . 71.21 108.045 165.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 262' ' ' THR . . . . . 0.44 ' H ' ' HB2' ' C' ' 265' ' ' GLU . 45.1 p -122.09 159.96 49.52 Favored Pre-proline 0 CA--C 1.547 0.844 0 N-CA-C 107.587 -1.264 . . . . 61.23 107.587 164.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -38.82 -47.65 2.74 Favored 'Trans proline' 0 C--N 1.387 2.554 0 C-N-CA 123.535 2.823 . . . . 74.2 113.982 175.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -68.82 -53.26 22.54 Favored 'General case' 0 C--N 1.351 0.639 0 CA-C-N 115.886 -0.597 . . . . 71.04 111.344 -178.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 265' ' ' GLU . . . . . 0.44 ' HB2' ' H ' ' C' ' 262' ' ' THR . 47.0 mt-10 -48.24 -56.86 6.91 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 123.806 0.691 . . . . 65.11 109.474 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 266' ' ' GLU . . . . . 0.521 ' O ' ' HG2' ' C' ' 270' ' ' LYS . 33.9 tt0 -57.23 -41.53 79.71 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 114.908 -1.042 . . . . 64.21 111.364 -177.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -61.69 -41.81 98.09 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 123.424 0.69 . . . . 70.32 112.784 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 268' ' ' LEU . . . . . 0.418 ' HG ' HD11 ' A' ' 268' ' ' LEU . 10.8 mp -67.14 -40.31 86.71 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.783 0.433 . . . . 52.44 110.177 177.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -59.03 -36.51 75.11 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 116.353 -0.385 . . . . 61.11 110.761 172.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 270' ' ' LYS . . . . . 0.521 ' HG2' ' O ' ' C' ' 266' ' ' GLU . 25.3 mmtp -60.74 -50.65 72.62 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 122.859 0.464 . . . . 75.43 110.276 177.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 271' ' ' LYS . . . . . 0.483 ' HB2' HD21 ' A' ' 268' ' ' LEU . 47.2 mtpt -53.68 -41.37 66.83 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 124.112 0.883 . . . . 75.33 111.326 177.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 95.5 mt -60.96 -45.54 94.32 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 123.799 0.687 . . . . 74.33 111.135 176.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -64.13 -31.01 72.04 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.153 0.581 . . . . 34.13 111.98 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 274' ' ' GLU . . . . . 0.487 ' HG3' ' O ' ' C' ' 270' ' ' LYS . 30.7 mt-10 -77.66 -34.51 53.04 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.143 0.577 . . . . 63.21 110.402 177.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -67.06 -24.23 65.95 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 115.824 -0.625 . . . . 70.04 110.48 171.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 276' ' ' TYR . . . . . 0.444 ' HD1' HH11 ' C' ' 279' ' ' ARG . 4.1 m-85 -80.51 -35.87 34.0 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.281 -0.872 . . . . 75.52 112.077 175.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -66.98 -28.35 68.19 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 109.491 -0.559 . . . . 44.24 109.491 169.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -72.19 3.3 4.7 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 123.8 0.84 . . . . 55.2 112.878 173.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 279' ' ' ARG . . . . . 0.444 HH11 ' HD1' ' C' ' 276' ' ' TYR . 71.9 mtp180 -74.51 -18.85 60.55 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 118.15 0.432 . . . . 71.52 110.4 168.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.558 1.269 0 N-CA-C 109.602 -0.518 . . . . 75.14 109.602 175.826 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.416 ' HA ' ' CG ' ' A' ' 96' ' ' PHE . 37.1 ttpt . . . . . 0 N--CA 1.476 0.827 0 N-CA-C 115.37 1.618 . . . . 62.43 115.37 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.448 ' HD2' HD11 ' A' ' 10' ' ' ILE . 27.7 mmtp -72.26 105.2 3.95 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 108.84 -0.8 . . . . 74.32 108.84 164.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -72.99 96.06 2.09 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 105.905 -1.887 . . . . 61.41 105.905 165.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.433 ' HB2' HD11 ' A' ' 57' ' ' LEU . 67.6 m-85 -61.87 -31.18 71.43 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-N 114.96 -1.018 . . . . 73.34 111.503 -170.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -67.41 -40.23 85.57 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.408 -0.815 . . . . 73.33 109.884 176.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.85 -37.93 89.2 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 122.908 0.483 . . . . 60.32 110.921 177.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.448 HD11 ' HD2' ' A' ' 5' ' ' LYS . 65.3 mt -59.33 -41.46 84.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 123.1 0.56 . . . . 74.23 110.267 173.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.6 mt -80.49 -8.54 59.6 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 115.756 -0.656 . . . . 51.33 112.606 176.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 70.01 18.23 74.37 Favored Glycine 0 C--N 1.353 1.484 0 N-CA-C 114.239 0.455 . . . . 53.33 114.239 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.3 m -103.14 163.3 17.78 Favored Pre-proline 0 N--CA 1.486 1.347 0 C-N-CA 124.374 1.07 . . . . 71.43 110.709 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -47.54 146.75 7.24 Favored 'Trans proline' 0 C--N 1.387 2.577 0 C-N-CA 123.6 2.867 . . . . 50.12 114.043 174.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -71.36 15.78 0.12 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 114.284 1.216 . . . . 75.43 114.284 -170.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -159.8 33.56 0.18 Allowed 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 108.625 -0.88 . . . . 64.11 108.625 173.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.34 149.58 50.16 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.436 1.094 . . . . 64.31 111.834 -177.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 76.1 p -77.8 170.76 16.03 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.516 0.726 . . . . 71.11 111.88 -174.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -55.95 -41.28 74.46 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.673 1.189 . . . . 64.21 112.559 -172.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.36 -32.2 66.25 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 122.629 0.372 . . . . 72.43 110.581 -177.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.455 ' HG2' ' NH2' ' A' ' 24' ' ' ARG . 40.1 mt-10 -65.96 -40.97 91.75 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 121.101 0.476 . . . . 64.03 109.771 175.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.419 HG12 ' HB3' ' A' ' 57' ' ' LEU . 1.6 mp -65.04 -38.57 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-N 114.763 -1.108 . . . . 73.31 110.416 176.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -75.55 -33.36 60.66 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.567 0.747 . . . . 71.24 111.307 -175.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.461 ' HA ' ' NZ ' ' A' ' 27' ' ' LYS . 85.3 mtm-85 -72.78 -43.64 62.55 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 122.693 0.397 . . . . 54.12 110.566 175.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.04 -31.07 70.48 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.797 -0.638 . . . . 64.0 111.146 177.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -62.55 -58.65 6.79 Favored 'General case' 0 C--O 1.213 -0.856 0 CA-C-O 118.61 -0.709 . . . . 73.1 109.381 173.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.461 ' NZ ' ' HA ' ' A' ' 24' ' ' ARG . 35.5 mtmm -53.97 -39.43 65.98 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 123.949 0.781 . . . . 74.22 111.241 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -54.38 -58.3 7.98 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.182 0.993 . . . . 71.15 110.966 177.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.44 ' HA ' ' HB3' ' A' ' 32' ' ' GLN . 75.4 mt -86.38 -8.99 57.23 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 115.074 -0.967 . . . . 74.11 111.635 -173.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.12 -21.62 25.88 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.686 0.794 . . . . 63.3 109.95 174.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -90.87 -31.76 16.3 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.483 0.713 . . . . 72.33 110.509 170.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.44 ' HB3' ' HA ' ' A' ' 29' ' ' LEU . 35.1 tt0 -73.36 -49.06 29.3 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.999 0.52 . . . . 63.33 111.326 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -98.15 23.78 7.86 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.077 0.551 . . . . 63.25 110.796 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 51.1 t60 -63.2 101.38 0.26 Allowed Pre-proline 0 CA--C 1.554 1.101 0 C-N-CA 124.968 1.307 . . . . 63.41 112.195 -170.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -73.79 -5.44 17.05 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 123.561 2.841 . . . . 74.13 112.552 -172.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -73.73 -27.29 61.11 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 124.571 1.148 . . . . 72.45 111.479 174.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 60.5 t -123.47 -46.71 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 CA-C-O 121.561 0.696 . . . . 65.53 109.716 178.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -98.62 80.96 2.62 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.703 1.201 . . . . 61.35 109.883 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.48 69.4 10.05 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 115.806 -0.633 . . . . 73.11 109.649 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 24.2 m -108.86 134.46 20.34 Favored Pre-proline 0 N--CA 1.479 0.988 0 CA-C-O 118.518 -0.753 . . . . 54.41 109.822 -179.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -48.07 -52.24 8.6 Favored 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 123.88 3.054 . . . . 72.23 113.419 -178.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.411 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 8.2 tp10 -62.42 -32.61 73.48 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 122.85 0.46 . . . . 64.43 110.873 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -82.15 -14.75 55.21 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.928 0.491 . . . . 72.14 110.435 -179.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.425 ' O ' ' HD3' ' A' ' 48' ' ' LYS . 49.0 mm-40 -68.67 -58.9 3.57 Favored 'General case' 0 C--N 1.358 0.94 0 N-CA-C 107.21 -1.404 . . . . 62.01 107.21 170.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -53.23 -47.01 69.35 Favored 'General case' 0 C--N 1.352 0.705 0 CA-C-N 113.842 -1.527 . . . . 62.44 110.396 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.517 ' O ' HG12 ' A' ' 50' ' ' ILE . 0.1 OUTLIER -71.02 -48.9 50.39 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 114.747 -1.115 . . . . 74.03 111.193 -172.385 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -53.45 -46.54 69.91 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 123.849 0.718 . . . . 73.24 110.508 177.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.425 ' HD3' ' O ' ' A' ' 44' ' ' GLU . 2.1 mtpm? -63.3 -36.37 83.46 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 115.37 -0.832 . . . . 75.14 111.525 178.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -69.99 -30.26 67.55 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 122.62 0.368 . . . . 71.44 111.274 173.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.517 HG12 ' O ' ' A' ' 46' ' ' LYS . 18.3 mm -68.95 -36.87 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 108.843 -0.799 . . . . 70.53 108.843 175.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.416 ' O ' ' HB2' ' A' ' 55' ' ' ALA . 11.5 m-80 -80.5 -20.09 44.41 Favored 'General case' 0 C--O 1.211 -0.955 0 CA-C-N 114.435 -1.257 . . . . 73.43 111.385 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -71.98 -50.38 29.28 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.328 1.051 . . . . 63.42 109.01 171.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.16 -50.78 71.77 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 113.494 -1.684 . . . . 65.45 111.076 176.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -64.51 -37.96 89.34 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-N 115.068 -0.969 . . . . 72.32 110.525 177.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.416 ' HB2' ' O ' ' A' ' 51' ' ' ASN . . . -54.23 -46.91 72.66 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.289 0.636 . . . . 53.01 112.169 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 67.9 t -72.94 -45.86 53.9 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.116 0 CA-C-N 115.955 -0.566 . . . . 74.52 110.996 177.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.433 HD11 ' HB2' ' A' ' 7' ' ' TYR . 64.2 mt -93.57 0.84 56.77 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 114.206 1.188 . . . . 62.04 114.206 -166.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.1 t -73.58 -52.79 12.25 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.464 0.649 . . . . 74.34 109.85 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -88.89 137.21 29.95 Favored Pre-proline 0 C--O 1.241 0.657 0 CA-C-N 114.737 -1.119 . . . . 74.34 109.745 -176.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.417 ' O ' ' HG2' ' A' ' 64' ' ' ARG . 48.0 Cg_exo -56.19 -26.9 63.14 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 123.346 2.697 . . . . 72.41 112.576 178.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -64.4 -59.88 3.83 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.814 0.846 . . . . 72.3 111.451 -176.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.402 ' HA ' HD12 ' A' ' 65' ' ' ILE . 42.0 mtmt -77.36 -23.62 50.82 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 115.842 -0.617 . . . . 74.54 111.275 -176.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 44.9 tpt85 -54.77 -54.64 39.49 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 108.919 -0.771 . . . . 74.11 108.919 166.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.473 ' HA ' ' HE ' ' A' ' 64' ' ' ARG . 2.2 mmp_? -63.27 -33.37 75.36 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.582 0.753 . . . . 74.25 112.168 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.702 HG23 ' HG3' ' A' ' 76' ' ' PRO . 89.2 mt -59.46 -45.59 93.54 Favored 'Isoleucine or valine' 0 C--O 1.253 1.24 0 C-N-CA 123.105 0.562 . . . . 64.42 110.783 174.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -66.74 -42.03 86.9 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 116.237 -0.438 . . . . 75.4 109.823 178.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -53.93 -45.82 71.32 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 123.161 0.585 . . . . 64.04 110.852 175.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 50.5 p -75.36 -19.3 59.66 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.224 -0.444 . . . . 75.13 112.013 -178.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -70.5 112.33 6.7 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 109.04 -0.726 . . . . 63.45 109.04 174.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 103.36 19.99 11.68 Favored Glycine 0 N--CA 1.474 1.171 0 N-CA-C 111.711 -0.556 . . . . 52.54 111.711 -172.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 97.6 m -142.05 -58.09 0.46 Allowed 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 103.623 -2.732 . . . . 71.23 103.623 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 29.4 m -77.8 134.37 38.03 Favored 'General case' 0 C--O 1.256 1.427 0 N-CA-C 104.399 -2.445 . . . . 74.23 104.399 155.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.18 -29.27 16.55 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.328 0.651 . . . . 74.04 111.15 -177.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -94.22 168.35 11.73 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 124.085 0.954 . . . . 75.1 109.929 177.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -53.32 140.36 62.7 Favored 'Trans proline' 0 C--N 1.378 2.108 0 C-N-CA 122.164 1.909 . . . . 75.41 112.621 165.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.702 ' HG3' HG23 ' A' ' 65' ' ' ILE . 91.4 Cg_endo -72.52 175.53 10.01 Favored 'Trans proline' 0 C--N 1.375 1.925 0 C-N-CA 123.644 2.896 . . . . 74.25 112.562 -177.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.46 121.15 9.31 Favored 'Trans proline' 0 C--N 1.38 2.2 0 C-N-CA 122.002 1.801 . . . . 62.44 111.186 171.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -63.32 130.2 27.84 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.594 2.196 . . . . 43.51 112.063 176.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -59.5 141.57 97.58 Favored 'Trans proline' 0 C--N 1.381 2.269 0 C-N-CA 122.64 2.227 . . . . 71.05 111.32 172.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.29 78.28 0.45 Allowed 'Trans proline' 0 C--N 1.382 2.298 0 C-N-CA 123.156 2.571 . . . . 51.35 112.694 -177.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 159.29 -35.38 0.48 Allowed Glycine 0 N--CA 1.467 0.713 0 N-CA-C 109.669 -1.372 . . . . 62.41 109.669 -174.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.446 ' HA3' ' HA ' ' A' ' 106' ' ' PHE . . . 130.04 167.22 12.01 Favored Glycine 0 C--N 1.351 1.375 0 CA-C-N 114.899 -0.651 . . . . 53.03 112.926 170.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -69.25 100.9 1.38 Allowed 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 108.175 -1.046 . . . . 74.41 108.175 166.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.464 ' O ' ' HD1' ' A' ' 85' ' ' PHE . 12.6 t70 -63.61 152.16 39.65 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.88 0.872 . . . . 71.31 112.969 -174.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.464 ' HD1' ' O ' ' A' ' 84' ' ' ASP . 0.3 OUTLIER -148.54 72.43 1.19 Allowed 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 124.699 1.199 . . . . 70.22 107.783 169.882 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.572 ' HA ' ' HA3' ' A' ' 163' ' ' GLY . 44.8 m -55.3 87.75 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 114.562 1.319 . . . . 74.44 114.562 -174.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.608 ' HA2' ' HB3' ' A' ' 171' ' ' PRO . . . 94.56 14.48 50.21 Favored Glycine 0 N--CA 1.47 0.942 0 CA-C-N 116.237 -0.438 . . . . 70.11 113.425 176.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -123.19 111.72 16.82 Favored 'General case' 0 C--O 1.245 0.835 0 C-N-CA 122.922 0.489 . . . . 72.34 110.133 -169.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -68.69 92.97 0.49 Allowed 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.077 0.551 . . . . 71.44 110.917 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.489 HG13 ' HG2' ' A' ' 91' ' ' GLU . 2.2 p -31.82 -49.21 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 125.521 1.529 . . . . 75.21 114.311 169.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.489 ' HG2' HG13 ' A' ' 90' ' ' VAL . 7.7 mm-40 -68.27 -14.88 63.31 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.992 0.738 . . . . 75.33 112.992 -169.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -78.54 -42.3 29.75 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.504 0.722 . . . . 45.35 111.228 171.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -77.59 178.85 6.94 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 113.46 0.911 . . . . 71.01 113.46 -165.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 67.4 p -58.18 144.4 40.76 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.777 1.231 . . . . 74.5 113.711 -166.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.449 ' O ' ' HG3' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -53.65 -43.02 68.45 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 114.401 -1.272 . . . . 74.31 110.973 172.516 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.416 ' CG ' ' HA ' ' A' ' 4' ' ' LYS . 37.0 t80 -51.18 -52.88 40.01 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.368 1.067 . . . . 75.03 111.479 176.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -57.62 -46.68 83.81 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 114.786 -1.097 . . . . 63.23 110.179 178.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.452 ' HA ' HD11 ' A' ' 105' ' ' LEU . 96.3 mt-30 -70.04 -13.01 62.02 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 115.757 -0.656 . . . . 73.05 112.527 -178.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.449 ' HG3' ' O ' ' A' ' 95' ' ' GLU . 52.5 mt-10 -88.87 -52.63 5.01 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 122.982 0.513 . . . . 70.02 111.515 172.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 36.2 tp -65.14 -50.95 64.04 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.368 0.667 . . . . 55.03 111.014 -175.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -87.88 -6.0 58.3 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 115.606 -0.725 . . . . 72.11 110.74 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -42.68 -59.17 3.29 Favored Glycine 0 C--N 1.355 1.585 0 CA-C-O 118.625 -1.097 . . . . 72.43 114.859 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -39.83 -26.89 0.18 Allowed 'Trans proline' 0 C--N 1.393 2.877 0 C-N-CA 124.883 3.722 . . . . 23.1 116.365 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -152.03 37.63 0.81 Allowed Glycine 0 C--N 1.354 1.568 0 CA-C-O 118.975 -0.903 . . . . 44.4 113.427 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.452 HD11 ' HA ' ' A' ' 98' ' ' GLN . 33.9 mt -53.52 85.19 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 117.487 0.644 . . . . 74.25 112.232 174.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.446 ' HA ' ' HA3' ' A' ' 82' ' ' GLY . 0.6 OUTLIER 20.99 -110.88 0.01 OUTLIER 'General case' 0 CA--C 1.565 1.533 0 C-N-CA 127.348 2.259 . . . . 72.25 113.526 177.638 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.473 ' HA2' ' HA2' ' A' ' 168' ' ' GLY . . . 58.46 13.74 17.74 Favored Glycine 0 C--N 1.366 2.236 0 N-CA-C 114.388 0.515 . . . . 44.0 114.388 178.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.35 1.342 0 N-CA-C 110.753 -0.939 . . . . 71.34 110.753 -165.241 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.332 0 N-CA-C 113.374 0.879 . . . . 72.15 113.374 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -100.97 -164.13 27.81 Favored Glycine 0 CA--C 1.546 1.984 0 CA-C-N 115.573 -0.74 . . . . 55.22 113.304 -178.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.433 ' H ' ' HA3' ' A' ' 166' ' ' GLY . 2.6 tmt_? -108.8 137.61 46.46 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 124.121 0.968 . . . . 71.34 112.257 176.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -57.87 99.04 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 122.194 0.997 . . . . 74.23 111.685 173.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 53.5 tp -103.92 157.54 17.02 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 114.45 -1.25 . . . . 70.23 110.698 -173.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 40.5 ttp180 -109.38 142.25 40.6 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 108.817 -0.809 . . . . 74.51 108.817 170.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.547 ' HB2' HD11 ' A' ' 174' ' ' LEU . . . -128.36 159.33 35.66 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.598 0.713 . . . . 41.51 111.113 177.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.4 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 0.7 OUTLIER -116.47 109.73 17.68 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 105.944 -1.873 . . . . 61.0 105.944 -177.311 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.513 ' HB3' ' HA ' ' A' ' 178' ' ' VAL . 37.5 tp -98.86 96.58 4.11 Favored Pre-proline 0 N--CA 1.475 0.805 0 N-CA-C 108.228 -1.027 . . . . 54.05 108.228 -174.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.552 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 97.5 Cg_endo -78.75 107.72 2.31 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 121.065 1.176 . . . . 75.33 109.307 -176.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.438 ' HB3' HD23 ' A' ' 180' ' ' LEU . 43.1 tp -106.76 131.47 53.84 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 122.755 0.422 . . . . 64.01 110.238 -167.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 72.9 m -59.41 124.19 19.25 Favored 'General case' 0 CA--C 1.555 1.171 0 O-C-N 124.609 1.193 . . . . 71.34 109.037 173.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.601 ' HB3' HD22 ' A' ' 215' ' ' LEU . 61.1 mt -53.78 -40.02 65.91 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 124.16 0.984 . . . . 70.54 111.743 -171.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 16.0 mp0 -65.02 -35.42 81.14 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 114.228 -1.351 . . . . 75.32 109.683 -178.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -78.67 -22.45 46.77 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.657 0.783 . . . . 64.33 111.165 177.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -68.05 -33.73 75.13 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 109.952 -0.388 . . . . 41.43 109.952 171.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.41 ' HB2' HD12 ' A' ' 215' ' ' LEU . 82.3 t80 -74.75 -47.55 30.54 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 115.236 -0.893 . . . . 74.51 111.488 173.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 51.2 m170 -69.87 -53.82 16.28 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.416 0.686 . . . . 75.25 110.921 -173.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.91 -168.42 41.23 Favored Glycine 0 C--N 1.344 1.003 0 CA-C-N 115.78 -0.645 . . . . 71.54 112.84 -178.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 98.44 -164.62 21.17 Favored Glycine 0 C--N 1.349 1.28 0 C-N-CA 123.011 0.339 . . . . 70.42 113.512 175.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -72.06 110.59 6.64 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.535 0.734 . . . . 73.14 110.409 177.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -93.85 122.48 36.38 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 122.861 0.464 . . . . 74.4 110.604 177.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 57.4 t -78.18 113.93 18.08 Favored 'Isoleucine or valine' 0 C--O 1.243 0.728 0 N-CA-C 108.428 -0.953 . . . . 71.24 108.428 169.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.586 HG13 HG13 ' A' ' 145' ' ' VAL . 3.8 p -134.25 136.57 53.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 124.49 1.116 . . . . 73.14 108.683 178.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -123.78 133.32 53.85 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.312 0.645 . . . . 71.3 110.677 -167.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.572 HG11 HD23 ' B' ' 8' ' ' LEU . 12.4 p -166.04 135.34 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.128 0.971 . . . . 75.1 109.318 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 53.23 38.49 27.76 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.196 0.999 . . . . 74.24 112.774 173.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 86.52 -21.82 16.23 Favored Glycine 0 C--N 1.353 1.504 0 CA-C-N 116.551 -0.295 . . . . 31.1 113.323 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.584 HH12 ' HG2' ' A' ' 164' ' ' MET . 12.1 tpt180 -81.82 99.27 8.91 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.138 0.975 . . . . 72.12 111.019 -179.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 38.0 ttp180 -84.65 89.38 7.47 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 107.867 -1.16 . . . . 74.41 107.867 165.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.586 HG13 HG13 ' A' ' 138' ' ' VAL . 3.0 p -97.09 145.58 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 114.783 -1.099 . . . . 73.53 110.877 -175.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 34.2 t -106.04 85.38 2.2 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.425 -0.807 . . . . 31.45 109.1 177.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 35.7 m -84.58 121.88 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 N-CA-C 109.929 -0.397 . . . . 73.42 109.929 -177.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -74.44 97.16 3.02 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.101 0.477 . . . . 74.14 109.817 -178.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 26.9 pt -78.35 123.41 85.8 Favored Pre-proline 0 CA--C 1.557 1.219 0 CA-C-N 115.267 -0.878 . . . . 74.13 109.305 174.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -63.16 135.02 48.58 Favored 'Trans proline' 0 C--N 1.372 1.78 0 C-N-CA 122.642 2.228 . . . . 60.34 112.204 176.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -61.84 96.15 0.14 Allowed 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 122.373 2.048 . . . . 74.15 111.143 171.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.565 ' HA2' ' HD2' ' A' ' 240' ' ' PHE . . . 116.5 35.14 1.21 Allowed Glycine 0 C--N 1.342 0.896 0 CA-C-N 115.481 -0.782 . . . . 75.51 111.536 -172.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.525 HG22 HG11 ' A' ' 178' ' ' VAL . 4.7 p -89.26 135.47 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 123.39 0.676 . . . . 75.43 109.496 -178.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.797 ' HD2' ' HA ' ' A' ' 191' ' ' GLN . 7.9 mtm-85 -123.77 148.72 46.4 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 115.322 -0.854 . . . . 73.23 110.502 -162.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.445 ' HB3' ' O ' ' A' ' 188' ' ' LEU . 6.8 tp10 -52.58 118.82 3.89 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 124.357 1.063 . . . . 72.32 110.464 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 105.78 -2.54 38.86 Favored Glycine 0 C--N 1.344 1.006 0 CA-C-N 115.71 -0.677 . . . . 14.21 113.276 -176.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 26.6 t -72.34 104.31 3.69 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 108.915 -0.772 . . . . 74.23 108.915 177.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.492 HG22 HG22 ' A' ' 177' ' ' VAL . 55.6 t -86.03 95.88 4.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 123.689 0.795 . . . . 72.34 109.558 -178.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.531 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 47.7 mt -77.84 92.82 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 N-CA-C 107.809 -1.182 . . . . 75.24 107.809 169.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 65.5 ttt-85 -72.68 114.96 11.39 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 107.928 -1.138 . . . . 61.32 107.928 177.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.497 HG11 ' SD ' ' A' ' 164' ' ' MET . 7.1 p -125.46 129.51 24.4 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 123.523 0.729 . . . . 61.33 109.154 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.488 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 97.8 Cg_endo -73.93 149.3 41.89 Favored 'Trans proline' 0 CA--C 1.552 1.413 0 C-N-CA 122.069 1.846 . . . . 74.53 111.949 177.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.572 ' HA3' ' HA ' ' A' ' 86' ' ' SER . . . 83.43 -25.51 4.98 Favored Glycine 0 N--CA 1.48 1.602 0 N-CA-C 116.244 1.258 . . . . 70.43 116.244 169.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.584 ' HG2' HH12 ' A' ' 143' ' ' ARG . 66.5 mtp -75.0 -23.67 58.28 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 117.679 0.74 . . . . 64.15 111.763 -178.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.472 ' HA2' HD13 ' A' ' 174' ' ' LEU . . . -82.37 -103.21 0.44 Allowed Glycine 0 C--N 1.35 1.35 0 CA-C-O 119.747 -0.474 . . . . 73.33 113.255 -175.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.433 ' HA3' ' H ' ' A' ' 117' ' ' ARG . . . -54.99 115.61 5.8 Favored Glycine 0 C--O 1.278 2.861 0 O-C-N 124.005 0.473 . . . . 74.5 113.422 173.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -56.85 103.45 0.11 Allowed 'General case' 0 C--N 1.355 0.812 0 O-C-N 127.59 2.582 . . . . 75.42 109.088 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.473 ' HA2' ' HA2' ' A' ' 107' ' ' GLY . . . -176.85 139.12 4.29 Favored Glycine 0 N--CA 1.436 -1.32 0 CA-C-N 113.347 -1.751 . . . . 64.21 108.943 -170.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . 0.512 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . 0.1 OUTLIER -73.55 -49.46 6.49 Favored Pre-proline 0 CA--C 1.559 1.294 0 N-CA-C 109.04 -0.726 . . . . 63.11 109.04 -173.422 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.512 ' HD3' ' HB3' ' A' ' 169' ' ' ASN . 28.2 Cg_exo -68.58 146.3 67.08 Favored 'Trans proline' 0 C--N 1.379 2.132 0 N-CA-C 107.991 -1.58 . . . . 71.13 107.991 156.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.608 ' HB3' ' HA2' ' A' ' 87' ' ' GLY . 56.4 Cg_endo -64.17 120.99 8.49 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.878 2.385 . . . . 71.25 116.312 -161.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -62.93 -43.0 99.56 Favored Glycine 0 C--N 1.374 2.681 0 C-N-CA 119.169 -1.491 . . . . 72.4 111.927 161.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.488 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 14.1 m-20 95.31 147.74 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 127.396 2.279 . . . . 71.14 108.563 175.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.547 HD11 ' HB2' ' A' ' 121' ' ' ALA . 27.9 tp -140.17 143.94 36.38 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.09 0.471 . . . . 64.32 111.162 -171.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 54.0 mt -108.95 90.57 3.33 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 114.746 -1.115 . . . . 72.12 108.254 170.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.531 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 78.7 mt -69.37 87.43 0.44 Allowed 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 109.335 -0.617 . . . . 70.05 109.335 174.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.492 HG22 HG22 ' A' ' 158' ' ' VAL . 11.9 t -84.31 104.67 12.86 Favored 'Isoleucine or valine' 0 C--O 1.245 0.827 0 N-CA-C 106.182 -1.784 . . . . 61.43 106.182 174.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.525 HG11 HG22 ' A' ' 153' ' ' VAL . 9.9 p -67.51 125.67 25.55 Favored 'Isoleucine or valine' 0 C--N 1.349 0.566 0 CA-C-O 121.961 0.886 . . . . 70.33 109.381 -175.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.552 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 28.6 mmt180 -111.94 119.18 37.63 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 107.54 -1.281 . . . . 53.32 107.54 179.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.438 HD23 ' HB3' ' A' ' 125' ' ' LEU . 56.7 mt -83.38 144.02 29.92 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-N 118.348 0.522 . . . . 72.4 110.014 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 41.6 mt -54.22 153.54 9.41 Favored Pre-proline 0 N--CA 1.488 1.447 0 C-N-CA 123.898 0.879 . . . . 73.14 112.808 -169.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.93 16.79 0.41 Allowed 'Trans proline' 0 C--N 1.387 2.557 0 C-N-CA 122.97 2.447 . . . . 71.42 113.329 175.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -60.91 101.9 0.28 Allowed Pre-proline 0 CA--C 1.557 1.247 0 N-CA-C 107.213 -1.403 . . . . 73.35 107.213 164.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -78.55 25.87 0.53 Allowed 'Trans proline' 0 C--N 1.375 1.932 0 C-N-CA 124.066 3.177 . . . . 61.24 115.478 -161.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 82.3 t -96.88 -32.27 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 109.946 -0.39 . . . . 64.21 109.946 -176.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . 0.771 ' HE1' ' HA ' ' A' ' 214' ' ' THR . 35.3 m-85 -145.9 98.87 3.18 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 121.279 0.561 . . . . 72.31 111.935 178.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.625 ' HB3' ' HB2' ' A' ' 194' ' ' TYR . 52.3 ttt180 -85.93 81.63 8.45 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 107.863 -1.162 . . . . 75.51 107.863 164.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.453 ' HB2' HD23 ' A' ' 193' ' ' LEU . 35.5 tp -78.1 94.52 4.7 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-N 115.228 -0.896 . . . . 74.21 108.671 175.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -114.26 129.98 56.64 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.185 0.594 . . . . 70.31 109.753 -176.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 77.11 -73.89 1.92 Allowed Glycine 0 C--N 1.351 1.389 0 O-C-N 123.85 0.719 . . . . 65.41 111.98 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.797 ' HA ' ' HD2' ' A' ' 154' ' ' ARG . 13.6 pt20 -154.78 -7.23 0.14 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.655 0.782 . . . . 72.32 111.173 172.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -123.05 152.87 40.57 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.472 -0.785 . . . . 72.32 110.671 -167.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.453 HD23 ' HB2' ' A' ' 188' ' ' LEU . 38.8 mt -95.33 152.52 18.31 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 114.642 -1.163 . . . . 63.44 111.032 -168.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.625 ' HB2' ' HB3' ' A' ' 187' ' ' ARG . 91.8 m-85 -132.61 103.93 6.39 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 107.633 -1.247 . . . . 73.14 107.633 171.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.464 ' HB3' HD23 ' A' ' 251' ' ' LEU . . . -129.9 112.6 13.7 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.472 1.109 . . . . 74.34 110.008 -172.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 86.0 m -68.72 122.56 18.81 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-O 120.944 0.402 . . . . 70.21 111.187 -179.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.496 HD22 HD13 ' A' ' 251' ' ' LEU . 44.7 tp -108.97 119.54 39.86 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.861 0.865 . . . . 72.21 110.337 -173.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -80.02 116.96 20.44 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 108.296 -1.001 . . . . 61.43 108.296 174.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 2.8 p -144.23 127.66 8.82 Favored Pre-proline 0 N--CA 1.478 0.951 0 C-N-CA 123.335 0.654 . . . . 64.4 110.282 -175.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . 0.408 ' HA ' ' O ' ' A' ' 256' ' ' THR . 55.5 Cg_endo -72.8 150.87 50.59 Favored 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 121.868 1.712 . . . . 64.51 111.88 176.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -42.24 -60.23 2.23 Favored Pre-proline 0 N--CA 1.487 1.406 0 N-CA-C 116.485 2.032 . . . . 71.34 116.485 -173.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -75.07 -18.96 18.15 Favored 'Trans proline' 0 C--N 1.382 2.339 0 CA-C-N 121.524 1.58 . . . . 63.54 113.081 -173.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 16.4 mt -73.37 -34.73 44.21 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 N-CA-C 109.257 -0.646 . . . . 64.32 109.257 172.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.54 -42.87 81.99 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 123.094 0.558 . . . . 71.51 111.482 173.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 71.6 t -72.96 -44.45 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 123.59 0.756 . . . . 63.23 112.513 -174.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 78.7 t -88.76 -37.08 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 122.759 0.424 . . . . 74.41 110.933 -176.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 98.53 77.55 1.33 Allowed Glycine 0 C--N 1.339 0.713 0 N-CA-C 111.651 -0.58 . . . . 72.35 111.651 -176.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -103.44 -144.35 13.73 Favored Glycine 0 C--N 1.34 0.763 0 CA-C-N 115.255 -0.472 . . . . 55.24 112.042 178.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.537 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 43.1 mtmt -127.55 147.03 50.33 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 122.863 0.465 . . . . 45.21 110.614 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 24.8 m -137.14 -177.07 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.634 1.174 . . . . 63.11 108.861 170.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 26.2 ttm180 -116.62 129.24 56.04 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.609 0.763 . . . . 71.41 108.998 171.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -109.03 149.37 29.36 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.444 -0.947 . . . . 62.04 108.444 173.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -88.78 145.95 25.3 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.059 -0.719 . . . . 71.23 109.059 174.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . 0.771 ' HA ' ' HE1' ' A' ' 186' ' ' PHE . 41.0 p -127.94 174.27 9.32 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 123.914 0.886 . . . . 74.1 109.635 172.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.601 HD22 ' HB3' ' A' ' 127' ' ' LEU . 24.6 mt -59.19 -36.56 75.56 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.001 0.92 . . . . 63.31 110.889 -176.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.423 ' HA ' ' NZ ' ' B' ' 2' ' ' LYS . 15.1 mm-40 -98.87 2.07 46.32 Favored 'General case' 0 CA--C 1.554 1.127 0 CA-C-N 114.714 -1.13 . . . . 64.44 112.539 -172.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 140.8 -173.53 23.12 Favored Glycine 0 N--CA 1.483 1.77 0 CA-C-O 119.253 -0.748 . . . . 33.0 112.785 176.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -79.28 155.67 25.41 Favored 'Trans proline' 0 C--N 1.369 1.643 0 C-N-CA 122.644 2.229 . . . . 70.23 111.8 176.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 18.4 m -148.26 157.08 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 C-N-CA 123.888 0.875 . . . . 73.4 111.066 -177.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -91.24 124.93 35.82 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.951 0.9 . . . . 75.04 109.809 178.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 97.1 t -136.13 123.3 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.22 1.008 . . . . 74.13 109.163 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.537 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -89.98 133.68 34.66 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 118.163 0.438 . . . . 60.25 111.207 178.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 44.5 t -78.61 145.42 67.17 Favored Pre-proline 0 CA--C 1.561 1.384 0 C-N-CA 125.571 1.548 . . . . 63.14 110.051 -178.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -78.93 172.12 15.45 Favored 'Trans proline' 0 C--N 1.386 2.509 0 C-N-CA 122.767 2.312 . . . . 75.51 111.51 172.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.42 150.74 28.73 Favored 'Trans proline' 0 C--N 1.373 1.829 0 C-N-CA 121.87 1.713 . . . . 72.53 113.274 175.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . 0.49 HH12 ' HB2' ' C' ' 261' ' ' LEU . 85.9 mtt-85 64.16 30.04 13.81 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 125.851 1.661 . . . . 74.04 111.477 172.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.578 HG23 HD21 ' A' ' 233' ' ' LEU . 43.7 m -66.15 106.27 1.6 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.516 1.526 . . . . 64.32 111.291 178.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . 0.442 ' HB3' ' HD2' ' A' ' 231' ' ' ARG . 6.4 tp-100 -93.16 140.39 29.57 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.021 0.928 . . . . 75.32 110.657 -176.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . 0.454 ' HA ' ' HB ' ' A' ' 253' ' ' VAL . . . -66.07 157.59 30.68 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.849 0.86 . . . . 62.31 111.782 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 82.96 -40.19 2.79 Favored Glycine 0 C--N 1.347 1.179 0 CA-C-N 116.189 -0.459 . . . . 73.32 112.043 -177.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.442 ' HD2' ' HB3' ' A' ' 228' ' ' GLN . 92.6 mtt180 -66.4 157.67 31.3 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 124.147 0.979 . . . . 74.0 111.437 175.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.752 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 3.3 mptp? -109.94 125.59 53.01 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 114.856 -1.065 . . . . 72.22 108.418 177.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.578 HD21 HG23 ' A' ' 227' ' ' THR . 87.4 mt -76.14 104.82 6.85 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.883 -0.784 . . . . 71.4 108.883 177.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 18.4 ttp180 -84.95 109.6 18.27 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.27 0.628 . . . . 64.14 110.324 178.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.485 HD12 ' HG3' ' A' ' 238' ' ' LYS . 0.4 OUTLIER -120.57 117.1 26.73 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.972 0.909 . . . . 61.12 109.75 175.127 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 30.8 mmtm -60.69 151.08 30.18 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.916 1.286 . . . . 64.43 113.277 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 71.23 32.21 65.63 Favored Glycine 0 C--N 1.356 1.656 0 CA-C-N 114.682 -1.145 . . . . 74.2 113.604 172.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.485 ' HG3' HD12 ' A' ' 235' ' ' LEU . 41.8 mmtm -130.32 -30.31 1.94 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.524 0.73 . . . . 73.01 110.565 -174.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -73.04 173.87 47.64 Favored Glycine 0 C--N 1.351 1.396 0 O-C-N 123.301 0.376 . . . . 74.43 112.451 171.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . 0.565 ' HD2' ' HA2' ' A' ' 152' ' ' GLY . 5.7 m-85 -91.78 158.15 40.51 Favored Pre-proline 0 N--CA 1.48 1.044 0 C-N-CA 123.204 0.602 . . . . 73.13 110.85 -169.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -61.09 111.05 0.97 Allowed 'Trans proline' 0 C--N 1.387 2.558 0 C-N-CA 123.054 2.503 . . . . 73.33 112.158 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -125.31 -150.34 7.73 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-O 119.337 -0.702 . . . . 73.52 112.212 179.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . 0.435 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 32.6 Cg_endo -63.33 -30.77 73.48 Favored 'Trans proline' 0 C--N 1.373 1.848 0 C-N-CA 122.895 2.397 . . . . 70.45 113.07 -177.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 0.432 ' HB3' HE22 ' A' ' 191' ' ' GLN . . . -107.28 12.7 27.93 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.867 0.867 . . . . 70.11 111.4 178.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 87.66 -161.61 32.37 Favored Glycine 0 C--N 1.345 1.053 0 CA-C-N 116.327 -0.397 . . . . 62.24 112.158 -174.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 66.4 mtt85 -59.46 108.83 0.77 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.337 0.655 . . . . 75.41 110.676 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -70.5 -157.39 2.11 Favored Glycine 0 C--N 1.347 1.142 0 CA-C-N 115.605 -0.725 . . . . 42.24 113.758 -178.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -100.48 166.28 11.01 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.924 0.869 . . . . 75.44 110.641 178.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.441 ' HB3' ' HG ' ' A' ' 235' ' ' LEU . 14.5 tp -102.64 128.36 49.36 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 106.284 -1.746 . . . . 70.31 106.284 164.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.752 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 18.6 m-85 -108.77 105.1 14.54 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 107.609 -1.256 . . . . 52.51 107.609 173.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.534 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 40.1 mt -90.7 103.93 16.57 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 109.245 -0.65 . . . . 72.24 109.245 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . 0.498 ' HG2' ' HG3' ' A' ' 232' ' ' LYS . 22.3 mt-10 -76.7 101.69 5.89 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.146 0.978 . . . . 75.41 108.758 -170.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.454 ' HB ' ' HA ' ' A' ' 229' ' ' ALA . 27.0 t -64.31 122.96 16.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-N 114.849 -1.068 . . . . 24.43 112.504 -167.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 5.7 mmt180 -122.42 96.29 4.98 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.423 1.089 . . . . 73.14 108.604 169.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.447 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 73.1 mt -72.94 117.09 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 114.171 -1.377 . . . . 74.34 109.57 178.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . 0.408 ' O ' ' HA ' ' A' ' 200' ' ' PRO . 41.1 p -110.3 174.17 5.99 Favored 'General case' 0 C--O 1.255 1.348 0 C-N-CA 124.445 1.098 . . . . 73.43 110.092 178.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 26.1 pt -132.87 151.8 78.68 Favored Pre-proline 0 CA--C 1.554 1.135 0 CA-C-N 114.93 -1.032 . . . . 73.4 108.778 177.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -87.22 22.09 0.97 Allowed 'Trans proline' 0 C--N 1.365 1.429 0 C-N-CA 122.725 2.283 . . . . 74.45 112.962 -171.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 33.83 -87.89 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 125.303 1.441 . . . . 63.24 113.49 -165.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.47 132.52 47.14 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.775 0.83 . . . . 75.12 110.945 -170.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.535 HD11 HG11 ' C' ' 205' ' ' VAL . 86.0 mt -127.64 170.42 12.7 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.521 0.728 . . . . 55.32 111.094 -174.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 75.1 p -104.8 159.78 28.21 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-N 114.598 -1.183 . . . . 44.34 110.174 171.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_exo -32.7 -46.92 0.3 Allowed 'Trans proline' 0 C--N 1.383 2.346 0 C-N-CA 124.831 3.687 . . . . 74.33 116.044 172.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -57.62 -64.41 0.91 Allowed 'General case' 0 C--O 1.25 1.114 0 C-N-CA 123.987 0.915 . . . . 71.44 111.197 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -59.5 -48.3 82.17 Favored 'General case' 0 C--N 1.349 0.562 0 CA-C-N 114.54 -1.209 . . . . 64.2 110.2 -176.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' GLU . . . . . 0.536 ' O ' ' HG2' ' A' ' 270' ' ' LYS . 7.1 tp10 -53.03 -52.93 56.88 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 124.617 1.198 . . . . 73.45 111.099 -176.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -63.5 -45.19 91.84 Favored 'General case' 0 C--O 1.254 1.294 0 O-C-N 124.199 0.937 . . . . 64.12 111.94 -178.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 9.4 mp -63.38 -34.09 76.97 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-N 115.826 -0.624 . . . . 73.14 111.358 178.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' TRP . . . . . 0.44 ' O ' HG11 ' C' ' 206' ' ' VAL . 61.7 m95 -75.97 -30.51 58.63 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 118.677 -0.677 . . . . 75.0 111.349 177.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . 0.536 ' HG2' ' O ' ' A' ' 266' ' ' GLU . 0.0 OUTLIER -57.37 -60.73 3.2 Favored 'General case' 0 C--O 1.267 2.005 0 N-CA-C 108.214 -1.032 . . . . 62.43 108.214 175.103 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? -55.67 -50.24 70.78 Favored 'General case' 0 C--N 1.357 0.928 0 CA-C-N 112.002 -2.363 . . . . 70.22 110.66 -178.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' LEU . . . . . 0.407 HD12 HD12 ' C' ' 272' ' ' LEU . 2.1 tt -58.1 -58.93 6.28 Favored 'General case' 0 C--O 1.191 -2.026 0 O-C-N 124.298 0.999 . . . . 63.4 108.992 -177.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . 0.472 ' O ' ' HB3' ' A' ' 276' ' ' TYR . . . -56.21 -48.77 75.77 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 114.236 1.199 . . . . 64.51 114.236 -170.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -89.21 -21.85 23.06 Favored 'General case' 0 C--O 1.252 1.189 0 N-CA-C 112.68 0.622 . . . . 74.35 112.68 -172.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -80.47 -26.24 38.4 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.988 -0.445 . . . . 71.44 110.697 168.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . 0.472 ' HB3' ' O ' ' A' ' 273' ' ' ALA . 2.2 t80 -58.92 -55.81 30.28 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 125.79 1.636 . . . . 75.02 107.797 170.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -44.91 -66.1 0.44 Allowed 'General case' 0 C--O 1.249 1.077 0 O-C-N 125.538 1.774 . . . . 70.12 109.431 173.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -62.82 -14.24 43.11 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 114.76 -1.109 . . . . 75.41 113.841 -175.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 86.7 mtm180 -132.17 34.16 3.82 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 122.927 0.491 . . . . 74.13 110.228 -175.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.568 1.673 0 O-C-N 124.261 0.976 . . . . 72.21 113.134 175.712 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.443 ' SD ' ' N ' ' B' ' 1' ' ' MET . 1.6 mpt? . . . . . 0 N--CA 1.48 1.073 0 N-CA-C 110.338 -0.245 . . . . 71.44 110.338 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . 0.423 ' NZ ' ' HA ' ' A' ' 216' ' ' GLU . 13.3 mptt -75.16 116.93 16.43 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.668 0.787 . . . . 54.1 110.788 178.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -168.58 -38.15 0.02 OUTLIER 'General case' 0 C--O 1.242 0.701 0 C-N-CA 124.361 1.064 . . . . 74.04 109.358 174.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 23.3 t 65.39 -177.59 0.18 Allowed 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.567 1.147 . . . . 52.14 111.027 -179.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 94.6 m 68.69 131.76 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.561 1.144 . . . . 70.11 112.182 177.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 138' ' ' VAL . 42.8 pt -140.5 173.44 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.584 0.754 . . . . 64.44 110.565 -175.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -132.82 129.83 39.03 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.544 0.738 . . . . 72.01 110.269 177.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . 0.572 HD23 HG11 ' A' ' 140' ' ' VAL . 50.1 tp -78.51 155.56 29.72 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.036 0.934 . . . . 75.22 110.97 -174.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.31 -68.31 0.69 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 122.932 0.493 . . . . 62.4 111.437 176.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . 0.499 HD23 ' HB2' ' A' ' 121' ' ' ALA . 51.7 mt 68.32 2.98 3.51 Favored 'General case' 0 N--CA 1.501 2.094 0 C-N-CA 124.871 1.269 . . . . 74.1 111.844 -164.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 56.7 mt . . . . . 0 CA--C 1.555 1.169 0 C-N-CA 124.564 1.146 . . . . 45.35 112.137 -175.367 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.449 0 N-CA-C 107.346 -1.353 . . . . 61.34 107.346 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 180' ' ' ALA . . . . . 0.532 ' HB1' HG13 ' C' ' 137' ' ' VAL . . . -145.77 -63.0 0.33 Allowed 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 105.292 -2.114 . . . . 74.4 105.292 169.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 181' ' ' LEU . . . . . 0.583 ' HB3' HG12 ' C' ' 138' ' ' VAL . 37.0 tp -148.37 -32.44 0.25 Allowed 'General case' 0 CA--C 1.553 1.087 0 CA-C-N 114.22 -1.355 . . . . 62.04 108.837 160.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 182' ' ' VAL . . . . . 0.662 HG12 HD13 ' C' ' 123' ' ' LEU . 32.6 m -118.6 -176.88 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 C-N-CA 124.53 1.132 . . . . 71.31 111.499 177.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 183' ' ' ALA . . . . . 0.517 ' HB2' ' HD2' ' C' ' 124' ' ' PRO . . . -112.21 -95.44 0.44 Allowed 'General case' 0 C--N 1.357 0.92 0 C-N-CA 123.976 0.91 . . . . 65.24 110.163 167.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 35.9 m80 -157.58 -171.19 3.47 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 123.689 0.796 . . . . 74.15 110.881 -170.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 185' ' ' VAL . . . . . 0.574 HG22 HD21 ' C' ' 119' ' ' LEU . 25.1 t . . . . . 0 N--CA 1.499 1.98 0 C-N-CA 124.761 1.224 . . . . 71.33 112.853 -171.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 56.8 m . . . . . 0 N--CA 1.496 1.871 0 CA-C-O 118.359 -0.829 . . . . 71.31 110.495 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -173.92 -174.48 0.94 Allowed 'General case' 0 C--N 1.377 1.782 0 N-CA-C 114.028 1.121 . . . . 74.42 114.028 174.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . -116.62 -138.21 6.19 Favored Glycine 0 C--N 1.362 2.004 0 C-N-CA 125.348 1.451 . . . . 71.23 110.902 175.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 241' ' ' GLU . . . . . 0.427 ' HB3' ' HE3' ' B' ' 245' ' ' LYS . 11.6 pt-20 -156.65 177.05 11.92 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 117.452 0.626 . . . . 71.21 111.066 174.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 242' ' ' TRP . . . . . 0.474 ' CD2' ' HG ' ' C' ' 233' ' ' LEU . 0.0 OUTLIER -158.87 -39.46 0.06 Allowed 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.991 1.316 . . . . 70.32 108.944 179.483 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -126.36 -168.32 1.84 Allowed 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 107.484 -1.302 . . . . 74.22 107.484 162.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -71.87 91.42 0.51 Allowed Glycine 0 C--N 1.344 1.007 0 CA-C-N 116.611 -0.268 . . . . 63.11 112.529 171.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 245' ' ' LYS . . . . . 0.427 ' HE3' ' HB3' ' B' ' 241' ' ' GLU . 0.7 OUTLIER . . . . . 0 N--CA 1.482 1.158 0 C-N-CA 124.525 1.13 . . . . 75.34 110.592 176.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.95 0 CA-C-O 120.89 0.376 . . . . 52.01 110.576 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -38.52 110.12 0.12 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.129 1.772 . . . . 70.52 113.253 177.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 5' ' ' LYS . . . . . 0.53 ' HB3' HD11 ' C' ' 10' ' ' ILE . 37.7 mtpt -95.71 104.73 16.66 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 108.506 -0.924 . . . . 63.2 108.506 167.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -66.98 104.32 1.35 Allowed 'General case' 0 C--N 1.351 0.658 0 N-CA-C 109.08 -0.711 . . . . 63.22 109.08 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 7' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -63.92 -29.59 70.75 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 124.088 0.868 . . . . 73.43 112.443 -169.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -71.34 -40.43 70.71 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 122.516 0.326 . . . . 72.53 110.38 178.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.11 -37.82 88.69 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 122.825 0.45 . . . . 52.31 110.271 177.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 10' ' ' ILE . . . . . 0.53 HD11 ' HB3' ' C' ' 5' ' ' LYS . 69.4 mt -59.74 -40.25 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 123.186 0.594 . . . . 63.34 110.128 173.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 92.7 mt -82.08 -8.2 59.65 Favored 'General case' 0 CA--C 1.556 1.186 0 N-CA-C 112.935 0.717 . . . . 45.45 112.935 176.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 67.67 35.7 86.36 Favored Glycine 0 C--N 1.352 1.464 0 N-CA-C 113.845 0.298 . . . . 64.33 113.845 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 11.7 m -124.15 160.31 52.89 Favored Pre-proline 0 N--CA 1.486 1.372 0 C-N-CA 125.08 1.352 . . . . 64.04 110.175 178.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -56.91 152.24 44.41 Favored 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 122.933 2.422 . . . . 74.43 113.485 175.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -79.67 28.56 0.26 Allowed 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 113.746 1.017 . . . . 71.52 113.746 -171.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -154.83 27.73 0.43 Allowed 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 108.008 -1.108 . . . . 71.24 108.008 171.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.07 154.24 40.11 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.183 -0.917 . . . . 71.14 111.896 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 69.4 p -95.53 179.42 5.15 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.002 0.921 . . . . 74.41 111.912 -172.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -52.94 -45.0 67.47 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.46 1.104 . . . . 74.45 111.957 -177.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -70.41 -32.85 70.64 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 123.56 0.537 . . . . 64.05 111.746 -177.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -71.57 -43.04 67.05 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 122.907 0.483 . . . . 73.42 110.489 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 1.7 mp -64.86 -38.24 82.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 123.758 0.823 . . . . 61.32 110.221 175.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -64.43 -52.25 59.07 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.124 0.969 . . . . 74.13 111.031 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -69.8 -34.14 73.32 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.467 -0.788 . . . . 73.52 111.087 -177.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -72.38 -35.58 68.5 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.292 0.637 . . . . 75.32 110.979 178.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 26' ' ' TYR . . . . . 0.454 ' HD1' HG22 ' C' ' 50' ' ' ILE . 32.8 t80 -56.75 -61.35 2.49 Favored 'General case' 0 C--O 1.209 -1.065 0 O-C-N 124.261 0.976 . . . . 72.31 108.98 171.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -58.22 -41.67 84.57 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 124.15 0.906 . . . . 74.1 111.929 -177.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 45.7 ttt180 -50.75 -53.89 27.9 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.981 1.312 . . . . 71.15 110.699 176.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 87.1 mt -92.11 -6.2 51.32 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.228 -0.896 . . . . 60.22 111.743 -176.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.65 -4.7 47.18 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.694 0.798 . . . . 75.32 110.145 173.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 58.6 mtp180 -103.96 -35.2 8.21 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.92 0.888 . . . . 73.5 109.53 166.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.98 -55.15 15.73 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 109.506 -0.553 . . . . 71.12 109.506 178.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -89.9 7.22 38.39 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 112.046 0.387 . . . . 70.15 112.046 -177.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 34' ' ' HIS . . . . . . . . . . . . . 31.8 t60 -61.28 105.3 0.57 Allowed Pre-proline 0 N--CA 1.478 0.964 0 C-N-CA 124.241 1.016 . . . . 72.34 110.406 -176.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -53.87 -28.36 48.27 Favored 'Trans proline' 0 N--CA 1.507 2.29 0 C-N-CA 123.467 2.778 . . . . 71.32 115.393 -171.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -68.79 -31.81 71.08 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.534 0.734 . . . . 60.34 111.711 178.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 97.9 t -90.96 -50.7 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.402 0.681 . . . . 75.33 109.93 176.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -105.38 92.22 4.11 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.426 1.491 . . . . 54.22 108.605 -173.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -76.36 81.53 3.1 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 108.733 -0.839 . . . . 62.24 108.733 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 45.9 m -147.84 128.63 6.97 Favored Pre-proline 0 N--CA 1.48 1.06 0 C-N-CA 123.244 0.618 . . . . 74.14 110.342 177.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.8 -40.2 86.12 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 122.903 2.402 . . . . 63.44 111.002 174.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -53.0 -46.19 68.22 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 114.871 -1.059 . . . . 65.44 111.004 174.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.71 -16.9 56.69 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 122.616 0.367 . . . . 62.05 110.649 -175.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -73.97 -47.99 33.53 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 107.68 -1.23 . . . . 74.04 107.68 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -70.58 -38.06 74.0 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 114.055 -1.429 . . . . 42.53 111.465 178.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 46' ' ' LYS . . . . . 0.533 ' O ' HG12 ' C' ' 50' ' ' ILE . 34.0 mmtm -64.54 -37.34 87.22 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 116.224 -0.444 . . . . 72.32 110.577 175.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -62.2 -40.98 97.9 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.486 0.715 . . . . 62.23 109.665 175.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -60.3 -38.37 83.42 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 123.391 0.432 . . . . 72.04 111.554 173.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -68.48 -33.91 74.99 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 122.744 0.418 . . . . 72.33 111.473 177.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 50' ' ' ILE . . . . . 0.533 HG12 ' O ' ' C' ' 46' ' ' LYS . 26.6 mm -68.77 -32.82 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 N-CA-C 109.246 -0.65 . . . . 75.43 109.246 174.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 51' ' ' ASN . . . . . 0.401 ' HB3' ' HD1' ' C' ' 88' ' ' PHE . 0.9 OUTLIER -74.12 -32.1 63.04 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 114.998 -1.001 . . . . 74.04 111.05 177.761 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -66.35 -57.28 7.81 Favored 'General case' 0 C--O 1.248 0.992 0 C-N-CA 123.966 0.906 . . . . 63.42 109.903 175.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -52.15 -54.98 24.03 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 113.632 -1.622 . . . . 63.1 111.194 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -61.19 -46.11 91.84 Favored 'General case' 0 C--O 1.21 -1.024 0 CA-C-N 115.278 -0.874 . . . . 75.01 111.405 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.42 -47.55 72.66 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 122.841 0.456 . . . . 60.54 112.007 -176.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 90.5 t -63.93 -44.08 97.87 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 O-C-N 123.93 0.769 . . . . 72.43 110.331 177.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 57' ' ' LEU . . . . . . . . . . . . . 52.4 mt -88.17 0.17 56.37 Favored 'General case' 0 CA--C 1.564 1.482 0 N-CA-C 113.283 0.846 . . . . 75.02 113.283 -174.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 33.5 t -87.1 -51.31 6.07 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.142 0.977 . . . . 62.42 109.801 -178.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.44 123.06 84.56 Favored Pre-proline 0 C--O 1.217 -0.631 0 N-CA-C 107.845 -1.169 . . . . 72.03 107.845 172.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 60' ' ' PRO . . . . . 0.555 ' HD2' ' HA ' ' C' ' 145' ' ' VAL . 15.0 Cg_endo -55.95 -29.21 72.38 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 122.696 2.264 . . . . 33.23 111.216 170.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -65.39 -64.38 0.88 Allowed 'General case' 0 C--N 1.35 0.595 0 CA-C-N 115.626 -0.715 . . . . 62.13 110.825 176.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 62' ' ' LYS . . . . . 0.501 ' HD3' ' HB3' ' C' ' 83' ' ' TYR . 27.0 mtmm -64.69 -26.62 68.45 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.826 0.45 . . . . 75.23 111.414 -177.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 47.3 tpt85 -57.83 -58.49 8.13 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.642 1.177 . . . . 64.42 109.0 173.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -74.74 -16.79 60.72 Favored 'General case' 0 C--N 1.348 0.518 0 CA-C-N 115.182 -0.917 . . . . 74.15 112.215 -176.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 65' ' ' ILE . . . . . 0.635 HG23 ' HD2' ' C' ' 76' ' ' PRO . 65.2 mt -65.97 -48.26 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 N-CA-C 108.791 -0.818 . . . . 62.34 108.791 169.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -58.61 -51.77 68.49 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.311 -0.859 . . . . 74.22 110.181 176.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -54.44 -51.26 65.53 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.47 0.708 . . . . 73.14 111.643 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 68.0 p -76.0 -13.65 60.23 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 118.958 -0.544 . . . . 63.2 112.376 -177.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -67.52 107.09 2.36 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 109.004 -0.739 . . . . 75.22 109.004 176.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 114.29 17.78 7.01 Favored Glycine 0 C--N 1.343 0.945 0 CA-C-N 115.514 -0.766 . . . . 62.51 111.743 -167.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 98.8 m -148.89 -59.78 0.23 Allowed 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 104.064 -2.569 . . . . 72.34 104.064 176.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 12.4 m -77.9 138.95 39.18 Favored 'General case' 0 C--O 1.256 1.431 0 N-CA-C 104.571 -2.381 . . . . 73.35 104.571 158.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -100.05 -54.82 2.79 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 108.75 -0.833 . . . . 73.23 108.75 -173.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -72.12 151.63 92.54 Favored Pre-proline 0 CA--C 1.546 0.824 0 CA-C-N 114.688 -1.142 . . . . 53.23 109.765 173.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -56.29 123.51 14.01 Favored 'Trans proline' 0 C--N 1.369 1.63 0 C-N-CA 122.338 2.025 . . . . 75.14 110.921 169.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 76' ' ' PRO . . . . . 0.635 ' HD2' HG23 ' C' ' 65' ' ' ILE . 84.3 Cg_exo -50.98 145.79 23.71 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 123.004 2.469 . . . . 63.14 112.817 172.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 77' ' ' PRO . . . . . 0.441 ' HA ' ' HD3' ' C' ' 78' ' ' PRO . 10.8 Cg_endo -51.57 125.79 17.77 Favored 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 123.642 2.894 . . . . 51.51 112.587 -177.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 78' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' C' ' 77' ' ' PRO . 14.0 Cg_exo -69.21 141.3 47.05 Favored 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 122.89 2.393 . . . . 74.44 111.95 -177.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 79' ' ' PRO . . . . . 0.417 ' HB2' ' O ' ' C' ' 142' ' ' GLY . 30.9 Cg_endo -61.83 152.68 73.08 Favored 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 122.522 2.148 . . . . 61.04 111.218 174.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -50.73 82.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.392 2.859 0 C-N-CA 124.242 3.295 . . . . 51.5 114.494 -169.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 153.36 -53.05 0.46 Allowed Glycine 0 C--N 1.335 0.481 0 N-CA-C 109.811 -1.315 . . . . 75.2 109.811 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 141.13 -150.76 22.05 Favored Glycine 0 C--N 1.353 1.528 0 CA-C-N 115.615 -0.292 . . . . 74.45 113.662 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 83' ' ' TYR . . . . . 0.501 ' HB3' ' HD3' ' C' ' 62' ' ' LYS . 29.4 m-85 -104.01 122.24 44.83 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.274 1.43 . . . . 70.14 108.855 -177.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 84' ' ' ASP . . . . . 0.491 ' HB2' ' NE ' ' C' ' 143' ' ' ARG . 5.5 t70 -80.82 128.38 33.59 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 112.367 0.506 . . . . 63.13 112.367 -169.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 85' ' ' PHE . . . . . 0.535 ' HA ' ' HD2' ' C' ' 88' ' ' PHE . 77.0 m-85 -139.46 29.99 2.15 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.263 1.025 . . . . 74.41 109.776 176.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 13.7 m -78.6 84.94 4.68 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 114.89 -1.05 . . . . 45.43 111.39 -173.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 87' ' ' GLY . . . . . 0.591 ' N ' ' HA ' ' C' ' 171' ' ' PRO . . . 130.59 -19.73 5.0 Favored Glycine 0 N--CA 1.47 0.959 0 N-CA-C 110.24 -1.144 . . . . 74.33 110.24 -174.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 88' ' ' PHE . . . . . 0.535 ' HD2' ' HA ' ' C' ' 85' ' ' PHE . 32.5 m-85 -100.0 129.89 46.1 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 107.921 -1.14 . . . . 74.44 107.921 178.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -75.75 78.88 2.69 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.548 0.689 . . . . 72.23 110.804 -175.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 90' ' ' VAL . . . . . 0.451 HG21 ' ND2' ' C' ' 169' ' ' ASN . 5.6 p -50.06 -35.93 11.79 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 C-N-CA 125.981 1.713 . . . . 54.41 113.482 -174.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -65.94 -26.05 67.41 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 123.499 0.72 . . . . 74.21 112.124 -175.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -78.17 -26.56 47.72 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 122.674 0.389 . . . . 75.53 111.88 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 9.3 m-30 -70.13 164.33 24.38 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 123.345 0.403 . . . . 72.45 111.343 -167.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 52.1 p -59.43 149.85 28.25 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 113.969 1.1 . . . . 45.51 113.969 -166.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.71 -35.71 75.07 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 114.738 -1.119 . . . . 55.43 110.525 171.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -53.73 -50.91 64.92 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.542 1.137 . . . . 65.02 110.858 172.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 97' ' ' PHE . . . . . 0.414 ' HZ ' HG23 ' C' ' 90' ' ' VAL . 1.1 t80 -58.96 -43.04 91.23 Favored 'General case' 0 CA--C 1.552 1.043 0 CA-C-N 114.511 -1.222 . . . . 64.25 110.767 175.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -69.31 -21.4 63.85 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.077 0.551 . . . . 51.52 112.026 -177.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -82.69 -50.0 9.19 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.293 0.637 . . . . 74.43 110.621 173.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 38.6 tp -67.45 -63.73 1.0 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.775 0.83 . . . . 73.23 110.553 -175.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -80.26 -0.71 37.63 Favored 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 123.091 0.556 . . . . 73.25 112.413 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -45.57 -58.84 5.1 Favored Glycine 0 CA--C 1.544 1.85 0 CA-C-O 118.933 -0.926 . . . . 54.11 115.411 178.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -62.65 -3.38 4.36 Favored 'Trans proline' 0 C--N 1.385 2.466 0 C-N-CA 123.535 2.824 . . . . 62.02 114.528 -176.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -141.71 38.28 1.52 Allowed Glycine 0 C--N 1.354 1.535 0 CA-C-O 119.118 -0.823 . . . . 43.23 112.62 174.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 43.0 mt . . . . . 0 N--CA 1.505 2.285 0 CA-C-N 118.58 1.19 . . . . 73.03 113.922 175.71 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 116' ' ' GLY . . . . . 0.432 ' HA2' ' HA3' ' C' ' 168' ' ' GLY . . . . . . . . 0 N--CA 1.47 0.948 0 N-CA-C 113.981 0.352 . . . . 45.25 113.981 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 117' ' ' ARG . . . . . 0.546 ' HB2' ' HB2' ' C' ' 167' ' ' GLN . 2.4 mmp_? -116.29 147.51 41.46 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 124.492 1.117 . . . . 64.44 111.498 177.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -68.9 113.66 6.52 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 108.322 -0.992 . . . . 75.42 108.322 174.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 119' ' ' LEU . . . . . 0.574 HD21 HG22 ' B' ' 185' ' ' VAL . 5.7 tt -92.12 119.34 31.69 Favored 'General case' 0 C--O 1.219 -0.512 0 N-CA-C 105.953 -1.869 . . . . 75.21 105.953 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.418 ' HG2' HD12 ' C' ' 175' ' ' LEU . 98.3 mtt180 -97.48 132.95 42.69 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 107.399 -1.334 . . . . 72.31 107.399 176.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 121' ' ' ALA . . . . . . . . . . . . . . . -143.02 117.37 9.63 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.294 -0.632 . . . . 63.21 109.294 -178.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 122' ' ' GLU . . . . . 0.473 ' HA ' ' O ' ' C' ' 177' ' ' VAL . 12.7 pt-20 -99.17 130.0 45.46 Favored 'General case' 0 C--N 1.348 0.529 0 CA-C-O 120.959 0.409 . . . . 73.22 109.913 177.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 123' ' ' LEU . . . . . 0.662 HD13 HG12 ' B' ' 182' ' ' VAL . 0.4 OUTLIER -122.96 120.9 27.41 Favored Pre-proline 0 N--CA 1.473 0.7 0 C-N-CA 123.447 0.699 . . . . 73.3 111.92 -166.132 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . 0.517 ' HD2' ' HB2' ' B' ' 183' ' ' ALA . 80.4 Cg_exo -51.19 116.96 3.0 Favored 'Trans proline' 0 C--N 1.37 1.68 0 C-N-CA 122.82 2.347 . . . . 72.51 111.298 162.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 125' ' ' LEU . . . . . . . . . . . . . 26.3 tp -138.64 140.26 38.83 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.373 1.069 . . . . 74.03 108.6 -175.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.4 156.24 21.91 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.069 0.461 . . . . 61.53 111.192 -177.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 127' ' ' LEU . . . . . 0.619 ' HB3' HD22 ' C' ' 215' ' ' LEU . 95.9 mt -63.72 -44.99 91.94 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.124 0.97 . . . . 62.25 110.776 177.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -52.84 -46.39 67.77 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 114.885 -1.052 . . . . 75.24 110.513 172.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -67.01 -33.84 76.42 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.092 0.957 . . . . 73.53 111.553 -176.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -72.44 -33.1 66.84 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 123.866 0.729 . . . . 64.34 110.344 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 131' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -68.09 -41.38 81.94 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.2 0.6 . . . . 75.55 110.361 172.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 132' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -66.72 -68.91 0.34 Allowed 'General case' 0 N--CA 1.481 1.118 0 O-C-N 123.653 0.595 . . . . 60.22 111.284 -175.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 62.93 93.25 0.02 OUTLIER Glycine 0 CA--C 1.541 1.678 0 O-C-N 123.735 0.647 . . . . 65.31 113.239 -176.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . -135.89 161.38 24.82 Favored Glycine 0 N--CA 1.479 1.516 0 CA-C-O 119.473 -0.626 . . . . 53.24 111.802 177.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -71.88 95.53 1.56 Allowed 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 108.727 -0.842 . . . . 71.2 108.727 176.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 136' ' ' ARG . . . . . 0.47 ' HB2' HD22 ' B' ' 181' ' ' LEU . 90.0 mtt180 -123.93 163.52 21.16 Favored 'General case' 0 C--O 1.248 1.006 0 C-N-CA 123.563 0.745 . . . . 72.12 109.733 -173.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 137' ' ' VAL . . . . . 0.532 HG13 ' HB1' ' B' ' 180' ' ' ALA . 7.8 p -79.84 125.34 38.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 121.553 0.692 . . . . 71.12 110.621 -169.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 138' ' ' VAL . . . . . 0.583 HG12 ' HB3' ' B' ' 181' ' ' LEU . 8.1 m -112.46 141.84 26.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 124.068 0.947 . . . . 72.14 108.554 173.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 139' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -124.76 100.61 6.7 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 107.742 -1.207 . . . . 74.31 107.742 170.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 140' ' ' VAL . . . . . 0.487 HG21 HD21 ' C' ' 174' ' ' LEU . 61.3 t -116.59 100.33 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 109.376 -0.601 . . . . 63.22 109.376 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 63.41 30.69 15.4 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.444 0.698 . . . . 15.23 111.151 177.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 142' ' ' GLY . . . . . 0.417 ' O ' ' HB2' ' C' ' 79' ' ' PRO . . . 101.86 -11.6 57.59 Favored Glycine 0 C--N 1.343 0.917 0 CA-C-N 115.713 -0.676 . . . . 45.25 112.409 -179.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 143' ' ' ARG . . . . . 0.491 ' NE ' ' HB2' ' C' ' 84' ' ' ASP . 6.0 tpp180 -76.63 92.87 3.54 Favored 'General case' 0 C--N 1.352 0.699 0 N-CA-C 109.573 -0.529 . . . . 73.04 109.573 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 144' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' C' ' 138' ' ' VAL . 39.3 ttp85 -96.66 94.62 7.42 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 115.083 -0.962 . . . . 71.51 108.778 178.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 145' ' ' VAL . . . . . 0.555 ' HA ' ' HD2' ' C' ' 60' ' ' PRO . 28.6 m -131.5 176.16 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-N 114.978 -1.01 . . . . 75.03 109.879 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 49.0 m -125.12 118.83 26.97 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 109.05 -0.722 . . . . 54.21 109.05 178.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 14.1 p -142.0 150.99 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.103 0.561 . . . . 72.53 110.101 -173.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 45.2 ttp180 -103.34 110.58 22.62 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 108.346 -0.983 . . . . 74.22 108.346 169.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 149' ' ' ILE . . . . . 0.547 ' HB ' HD13 ' C' ' 159' ' ' ILE . 38.0 pt -76.46 148.29 80.04 Favored Pre-proline 0 CA--C 1.557 1.245 0 N-CA-C 109.267 -0.642 . . . . 71.41 109.267 170.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -47.88 119.64 4.03 Favored 'Trans proline' 0 C--N 1.381 2.268 0 C-N-CA 124.033 3.156 . . . . 61.44 113.723 -174.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -63.26 132.72 37.36 Favored 'Trans proline' 0 C--N 1.383 2.364 0 C-N-CA 122.903 2.402 . . . . 73.2 110.969 174.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 152' ' ' GLY . . . . . 0.578 ' HA2' ' HB3' ' C' ' 240' ' ' PHE . . . 86.92 53.92 2.74 Favored Glycine 0 C--N 1.334 0.435 0 N-CA-C 111.338 -0.705 . . . . 54.32 111.338 -173.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 153' ' ' VAL . . . . . 0.588 HG21 HD11 ' C' ' 159' ' ' ILE . 12.5 p -101.99 143.84 14.17 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.245 0 C-N-CA 123.539 0.736 . . . . 71.13 110.531 -172.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 154' ' ' ARG . . . . . 0.626 ' HA ' ' HB3' ' C' ' 188' ' ' LEU . 49.9 mtp180 -96.82 155.2 16.88 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.698 0.799 . . . . 75.32 112.329 -167.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 155' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -53.42 108.82 0.37 Allowed 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 123.267 0.627 . . . . 74.51 110.064 162.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 89.25 18.13 53.92 Favored Glycine 0 C--N 1.343 0.959 0 CA-C-O 119.803 -0.443 . . . . 64.51 113.454 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 157' ' ' SER . . . . . . . . . . . . . 3.5 m -73.35 107.1 5.47 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 117.148 0.474 . . . . 75.43 110.314 172.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 158' ' ' VAL . . . . . 0.488 HG12 HD22 ' C' ' 175' ' ' LEU . 42.1 t -85.02 90.25 2.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-N 114.438 -1.255 . . . . 64.44 108.378 176.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 159' ' ' ILE . . . . . 0.588 HD11 HG21 ' C' ' 153' ' ' VAL . 53.0 mt -75.88 118.96 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 114.972 -1.013 . . . . 52.25 110.179 -178.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 53.1 ttt180 -78.06 119.71 21.87 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 109.918 -0.401 . . . . 72.21 109.918 173.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 161' ' ' VAL . . . . . 0.607 HG11 ' SD ' ' C' ' 164' ' ' MET . 21.2 t -125.97 95.47 39.48 Favored Pre-proline 0 CA--C 1.551 1.017 0 N-CA-C 109.062 -0.718 . . . . 75.24 109.062 176.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.43 119.63 5.85 Favored 'Trans proline' 0 C--N 1.368 1.59 0 C-N-CA 122.388 2.058 . . . . 63.42 111.253 172.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 113.24 23.32 5.23 Favored Glycine 0 C--N 1.341 0.815 0 CA-C-N 115.899 -0.591 . . . . 53.31 112.843 178.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 164' ' ' MET . . . . . 0.607 ' SD ' HG11 ' C' ' 161' ' ' VAL . 28.6 mtp -148.95 3.96 0.63 Allowed 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 112.884 0.698 . . . . 73.35 112.884 -178.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 165' ' ' GLY . . . . . 0.414 ' HA3' ' O ' ' C' ' 173' ' ' ASP . . . -126.37 -123.04 2.63 Favored Glycine 0 N--CA 1.48 1.603 0 CA-C-O 118.346 -1.252 . . . . 64.24 111.067 -177.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . 68.57 73.62 0.68 Allowed Glycine 0 C--N 1.363 2.041 0 CA-C-N 118.516 1.158 . . . . 75.44 113.501 165.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 167' ' ' GLN . . . . . 0.546 ' HB2' ' HB2' ' C' ' 117' ' ' ARG . 23.4 mm-40 -67.14 98.06 0.57 Allowed 'General case' 0 C--N 1.348 0.502 0 N-CA-C 107.033 -1.469 . . . . 64.31 107.033 170.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 168' ' ' GLY . . . . . 0.432 ' HA3' ' HA2' ' C' ' 116' ' ' GLY . . . 136.57 -140.55 11.58 Favored Glycine 0 C--O 1.217 -0.939 0 CA-C-N 112.745 -2.025 . . . . 13.44 108.881 -161.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 169' ' ' ASN . . . . . 0.451 ' ND2' HG21 ' C' ' 90' ' ' VAL . 62.6 t30 -153.3 -51.6 0.02 OUTLIER Pre-proline 0 N--CA 1.497 1.894 0 CA-C-N 119.918 1.859 . . . . 62.44 111.952 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 170' ' ' PRO . . . . . 0.431 ' HD3' ' HB3' ' C' ' 169' ' ' ASN . 86.3 Cg_exo -53.81 161.99 4.13 Favored 'Trans proline' 0 C--N 1.393 2.912 0 C-N-CA 122.559 2.173 . . . . 51.41 113.504 164.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 171' ' ' PRO . . . . . 0.591 ' HA ' ' N ' ' C' ' 87' ' ' GLY . 1.5 Cg_exo -28.63 104.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.39 2.759 1 C-N-CA 125.494 4.13 . . . . 74.02 117.854 -174.438 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -121.66 -146.61 7.42 Favored Glycine 0 C--N 1.341 0.819 0 N-CA-C 109.387 -1.485 . . . . 74.42 109.387 170.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 173' ' ' ASP . . . . . 0.414 ' O ' ' HA3' ' C' ' 165' ' ' GLY . 27.2 t70 -171.16 159.5 5.94 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 117.607 0.703 . . . . 74.51 111.053 -176.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 174' ' ' LEU . . . . . 0.487 HD21 HG21 ' C' ' 140' ' ' VAL . 17.5 tp -124.89 115.4 20.56 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.727 0.811 . . . . 75.22 110.166 170.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 175' ' ' LEU . . . . . 0.488 HD22 HG12 ' C' ' 158' ' ' VAL . 76.7 mt -92.05 89.99 7.19 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.172 0.989 . . . . 71.32 110.291 174.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 176' ' ' LEU . . . . . . . . . . . . . 58.1 mt -76.66 93.78 3.69 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.48 0.712 . . . . 43.02 111.002 176.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 177' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' C' ' 122' ' ' GLU . 8.2 t -86.64 100.71 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 123.371 0.668 . . . . 74.43 109.69 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 178' ' ' VAL . . . . . 0.465 HG12 HD11 ' C' ' 123' ' ' LEU . 14.8 m -73.64 112.43 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.199 0 CA-C-O 122.336 1.065 . . . . 74.01 111.154 -174.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 179' ' ' ARG . . . . . 0.403 ' O ' ' HA ' ' C' ' 124' ' ' PRO . 7.0 mmm180 -91.4 115.39 27.99 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 114.291 -1.322 . . . . 72.33 107.687 170.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 180' ' ' LEU . . . . . . . . . . . . . 77.4 mt -69.07 135.39 50.71 Favored 'General case' 0 CA--C 1.561 1.398 0 CA-C-N 118.3 0.5 . . . . 70.51 111.436 178.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 181' ' ' LEU . . . . . 0.435 HD23 ' HB3' ' C' ' 124' ' ' PRO . 16.4 mt -53.43 169.65 0.31 Allowed Pre-proline 0 N--CA 1.501 2.102 0 C-N-CA 126.896 2.078 . . . . 74.2 113.965 -175.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -60.86 62.22 0.09 OUTLIER 'Trans proline' 0 C--N 1.397 3.112 0 C-N-CA 123.936 3.09 . . . . 64.12 112.442 161.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 183' ' ' HIS . . . . . 0.513 ' N ' ' HD3' ' C' ' 184' ' ' PRO . 85.7 t60 -162.06 28.17 0.03 OUTLIER Pre-proline 0 CA--C 1.572 1.803 0 C-N-CA 127.82 2.448 . . . . 62.13 107.203 -179.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 184' ' ' PRO . . . . . 0.513 ' HD3' ' N ' ' C' ' 183' ' ' HIS . 44.2 Cg_endo -91.81 67.57 1.0 Allowed 'Trans proline' 0 C--N 1.396 3.061 0 C-N-CA 123.719 2.946 . . . . 71.54 111.731 -162.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 185' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 2.9 t -87.81 -23.28 6.56 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.788 0 N-CA-C 107.751 -1.203 . . . . 72.23 107.751 -176.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 186' ' ' PHE . . . . . 0.532 ' HD2' HD13 ' C' ' 127' ' ' LEU . 56.7 m-85 -125.57 100.55 6.5 Favored 'General case' 0 C--N 1.346 0.439 0 N-CA-C 108.931 -0.766 . . . . 61.44 108.931 -178.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 187' ' ' ARG . . . . . 0.427 ' NH2' ' HB2' ' C' ' 184' ' ' PRO . 32.1 ttm105 -99.89 107.82 19.91 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 107.477 -1.305 . . . . 75.14 107.477 -177.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 188' ' ' LEU . . . . . 0.626 ' HB3' ' HA ' ' C' ' 154' ' ' ARG . 53.3 tp -76.52 127.89 33.71 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.199 0.814 . . . . 74.14 113.199 -163.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -112.97 104.46 12.43 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.9 1.28 . . . . 71.33 108.082 169.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 190' ' ' GLY . . . . . 0.405 ' H ' ' NE ' ' C' ' 154' ' ' ARG . . . 68.2 -103.29 0.98 Allowed Glycine 0 CA--C 1.534 1.247 0 CA-C-N 116.437 -0.347 . . . . 74.2 112.533 -176.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 191' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -113.85 -16.4 12.24 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 124.226 1.01 . . . . 60.21 110.469 175.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -99.52 130.7 45.79 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.409 1.084 . . . . 65.13 110.126 -173.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 193' ' ' LEU . . . . . 0.461 HD22 ' HB3' ' C' ' 186' ' ' PHE . 71.1 mt -74.41 152.55 39.49 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.743 0.817 . . . . 52.2 111.501 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 194' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -120.09 106.66 12.19 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 107.531 -1.285 . . . . 75.43 107.531 167.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 195' ' ' ALA . . . . . 0.48 ' HA ' ' O ' ' C' ' 185' ' ' VAL . . . -109.38 -177.73 3.37 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.264 1.026 . . . . 65.11 110.315 -177.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 95.8 m -137.83 118.42 13.95 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.598 -0.89 . . . . 51.32 108.598 165.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 197' ' ' LEU . . . . . . . . . . . . . 62.3 tp -97.09 139.48 33.03 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.182 -0.917 . . . . 73.5 110.482 -175.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -93.53 100.87 13.07 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 109.015 -0.735 . . . . 44.52 109.015 -178.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 199' ' ' VAL . . . . . 0.552 HG22 HG21 ' C' ' 210' ' ' VAL . 94.7 t -114.41 119.35 40.22 Favored Pre-proline 0 N--CA 1.484 1.232 0 C-N-CA 124.068 0.947 . . . . 61.21 109.226 -178.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 200' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -72.68 145.78 42.1 Favored 'Trans proline' 0 C--N 1.366 1.469 0 C-N-CA 121.664 1.576 . . . . 71.34 110.75 174.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 201' ' ' ALA . . . . . 0.435 ' N ' ' HD2' ' C' ' 202' ' ' PRO . . . -58.26 -38.82 70.27 Favored Pre-proline 0 CA--C 1.552 1.037 0 N-CA-C 115.348 1.61 . . . . 74.35 115.348 -173.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 202' ' ' PRO . . . . . 0.552 ' O ' HG13 ' C' ' 206' ' ' VAL . 19.4 Cg_endo -58.45 -52.43 5.54 Favored 'Trans proline' 0 C--N 1.382 2.337 0 CA-C-N 121.547 1.588 . . . . 63.15 111.417 174.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 203' ' ' ILE . . . . . . . . . . . . . 41.7 mt -63.34 -27.6 43.37 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 123.887 0.875 . . . . 63.4 110.793 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.21 -41.59 76.87 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.567 -0.742 . . . . 75.02 112.229 175.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 205' ' ' VAL . . . . . 0.535 HG11 HD11 ' A' ' 261' ' ' LEU . 90.7 t -72.14 -43.65 66.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 122.578 0.351 . . . . 63.41 111.175 -178.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 206' ' ' VAL . . . . . 0.552 HG13 ' O ' ' C' ' 202' ' ' PRO . 0.6 OUTLIER -98.25 -38.08 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 N-CA-C 111.656 0.243 . . . . 52.12 111.656 -168.265 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 106.01 123.62 5.18 Favored Glycine 0 CA--C 1.529 0.914 0 O-C-N 123.122 0.264 . . . . 63.21 112.787 -173.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -158.38 -130.92 1.22 Allowed Glycine 0 C--N 1.34 0.797 0 N-CA-C 110.197 -1.161 . . . . 51.32 110.197 176.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 209' ' ' LYS . . . . . 0.555 ' HG2' ' HA ' ' C' ' 222' ' ' ALA . 8.6 mtmp? -147.65 146.86 29.48 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 117.673 0.737 . . . . 72.12 111.558 176.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 210' ' ' VAL . . . . . 0.552 HG21 HG22 ' C' ' 199' ' ' VAL . 31.1 m -141.84 142.59 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 124.417 1.087 . . . . 62.05 109.354 173.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 211' ' ' ARG . . . . . 0.402 HH11 ' HB2' ' C' ' 218' ' ' PRO . 45.2 ttm-85 -81.45 127.81 33.2 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.656 0.782 . . . . 72.44 111.801 -172.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -105.98 112.19 25.14 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 107.574 -1.269 . . . . 74.43 107.574 169.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 213' ' ' MET . . . . . 0.578 ' HA ' ' HA ' ' C' ' 218' ' ' PRO . 4.0 ttp -77.97 100.62 6.52 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.812 -0.81 . . . . 63.12 108.812 -176.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.68 177.63 8.8 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 118.02 0.373 . . . . 54.24 110.154 -174.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 215' ' ' LEU . . . . . 0.619 HD22 ' HB3' ' C' ' 127' ' ' LEU . 12.3 mt -51.26 -61.25 2.35 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.295 1.038 . . . . 44.41 111.109 -173.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -92.86 13.36 20.65 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.239 -0.891 . . . . 71.0 111.933 -173.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 144.35 154.86 6.25 Favored Glycine 0 C--N 1.346 1.112 0 CA-C-O 119.831 -0.427 . . . . 64.11 113.128 177.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 218' ' ' PRO . . . . . 0.578 ' HA ' ' HA ' ' C' ' 213' ' ' MET . 52.8 Cg_endo -69.1 125.76 12.89 Favored 'Trans proline' 0 C--N 1.365 1.403 0 C-N-CA 122.896 2.398 . . . . 52.13 114.878 179.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 219' ' ' VAL . . . . . . . . . . . . . 9.6 p -100.71 173.21 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.809 0 N-CA-C 106.103 -1.814 . . . . 52.53 106.103 168.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 220' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -118.36 158.18 25.74 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.703 -0.48 . . . . 72.32 109.703 174.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 221' ' ' VAL . . . . . . . . . . . . . 38.0 t -115.31 127.95 72.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 124.801 1.24 . . . . 74.03 109.592 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 222' ' ' ALA . . . . . 0.555 ' HA ' ' HG2' ' C' ' 209' ' ' LYS . . . -80.14 102.32 9.31 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 108.69 -0.856 . . . . 73.3 108.69 170.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 48.5 t -76.67 126.58 85.8 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-N 115.294 -0.866 . . . . 73.11 109.344 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 224' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' B' ' 245' ' ' LYS . 6.1 Cg_exo -79.87 163.9 23.12 Favored 'Trans proline' 0 C--N 1.366 1.479 0 C-N-CA 123.715 2.943 . . . . 54.33 112.848 171.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -56.73 146.7 75.89 Favored 'Trans proline' 0 C--N 1.37 1.668 0 C-N-CA 122.128 1.885 . . . . 74.0 112.003 164.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 226' ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? 65.51 71.25 0.44 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.533 1.133 . . . . 70.15 110.929 171.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 227' ' ' THR . . . . . 0.528 HG22 HD11 ' C' ' 255' ' ' ILE . 8.0 m -116.95 125.85 52.05 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 124.287 1.035 . . . . 70.3 111.419 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 228' ' ' GLN . . . . . . . . . . . . . 24.9 mp0 -108.23 157.21 18.53 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.404 1.081 . . . . 74.32 111.017 -177.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -77.03 110.59 11.8 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 114.842 -1.072 . . . . 62.12 110.416 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 108.69 8.95 27.59 Favored Glycine 0 N--CA 1.475 1.25 0 CA-C-O 119.871 -0.405 . . . . 62.04 113.0 -169.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 231' ' ' ARG . . . . . . . . . . . . . 49.9 mtp85 -76.07 168.34 20.22 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 109.223 -0.658 . . . . 74.12 109.223 164.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 232' ' ' LYS . . . . . 0.521 ' HD3' ' HB3' ' C' ' 250' ' ' TYR . 2.4 ttmp? -134.29 146.96 50.51 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-O 121.493 0.663 . . . . 71.45 112.452 178.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 233' ' ' LEU . . . . . 0.728 HD13 ' HB2' ' C' ' 251' ' ' LEU . 5.1 mp -111.27 155.61 22.75 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.323 1.449 . . . . 74.21 111.22 -173.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 29.5 ptt-85 -125.93 91.72 3.44 Favored 'General case' 0 CA--C 1.571 1.769 0 O-C-N 125.477 1.736 . . . . 72.34 110.87 175.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 235' ' ' LEU . . . . . 0.477 ' HB2' ' HB3' ' C' ' 249' ' ' LEU . 79.5 mt -90.96 103.72 16.4 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.876 -0.787 . . . . 73.43 108.876 170.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -69.71 129.63 40.13 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.525 0.73 . . . . 71.55 111.863 -175.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 75.13 25.9 67.7 Favored Glycine 0 C--N 1.353 1.507 0 O-C-N 123.882 0.739 . . . . 71.42 114.196 175.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 31.1 mmtm -115.14 13.34 16.79 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.172 0.589 . . . . 72.03 110.621 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 239' ' ' GLY . . . . . 0.433 ' HA2' ' HG ' ' C' ' 193' ' ' LEU . . . -91.3 -163.16 38.47 Favored Glycine 0 C--N 1.353 1.51 0 O-C-N 123.511 0.507 . . . . 31.21 113.323 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 240' ' ' PHE . . . . . 0.578 ' HB3' ' HA2' ' C' ' 152' ' ' GLY . 4.6 m-85 -87.05 154.09 54.78 Favored Pre-proline 0 CA--C 1.552 1.05 0 N-CA-C 110.005 -0.368 . . . . 75.14 110.005 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 241' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.33 113.59 1.67 Allowed 'Trans proline' 0 C--N 1.386 2.513 0 C-N-CA 122.915 2.41 . . . . 70.21 111.382 175.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -111.11 164.54 12.14 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-O 118.945 -0.92 . . . . 70.14 111.714 177.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -68.65 -20.7 40.22 Favored 'Trans proline' 0 C--N 1.37 1.692 0 C-N-CA 122.902 2.401 . . . . 71.42 112.536 -178.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -98.18 20.87 11.69 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.1 0.96 . . . . 71.42 110.489 176.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 97.01 177.94 34.79 Favored Glycine 0 C--N 1.348 1.197 0 N-CA-C 111.263 -0.735 . . . . 51.32 111.263 -171.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 246' ' ' ARG . . . . . . . . . . . . . 69.4 mtm180 -71.89 142.6 49.52 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 117.465 0.632 . . . . 61.31 110.593 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -79.42 -158.18 13.79 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 123.846 0.716 . . . . 63.23 112.723 177.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -116.89 -179.86 3.81 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.725 0.81 . . . . 73.54 108.896 -174.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 249' ' ' LEU . . . . . 0.477 ' HB3' ' HB2' ' C' ' 235' ' ' LEU . 10.3 tp -122.41 109.43 14.38 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.48 -0.933 . . . . 74.23 108.48 176.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 250' ' ' TYR . . . . . 0.638 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 23.5 m-85 -101.14 105.71 16.89 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.601 -0.727 . . . . 71.43 109.736 178.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 251' ' ' LEU . . . . . 0.728 ' HB2' HD13 ' C' ' 233' ' ' LEU . 2.0 mp -98.79 149.89 22.41 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 109.536 -0.542 . . . . 64.53 109.536 -173.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -104.61 128.93 52.76 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 108.16 -1.052 . . . . 73.41 108.16 175.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 253' ' ' VAL . . . . . . . . . . . . . 67.7 t -74.99 134.66 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 112.247 0.462 . . . . 73.5 112.247 -172.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 254' ' ' ARG . . . . . 0.402 ' CZ ' ' HB ' ' C' ' 256' ' ' THR . 1.5 tmm_? -121.69 93.94 4.16 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 107.293 -1.373 . . . . 74.13 107.293 177.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 255' ' ' ILE . . . . . 0.528 HD11 HG22 ' C' ' 227' ' ' THR . 46.1 mm -68.49 124.52 24.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 O-C-N 123.264 0.353 . . . . 75.24 110.077 176.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 256' ' ' THR . . . . . 0.402 ' HB ' ' CZ ' ' C' ' 254' ' ' ARG . 0.0 OUTLIER -133.27 170.33 15.6 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.855 1.262 . . . . 53.32 110.772 -174.596 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 257' ' ' ILE . . . . . 0.45 ' HB ' ' HD2' ' C' ' 258' ' ' PRO . 2.9 pp -130.19 157.6 76.67 Favored Pre-proline 0 CA--C 1.556 1.204 0 C-N-CA 124.025 0.93 . . . . 64.54 109.44 178.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 258' ' ' PRO . . . . . 0.45 ' HD2' ' HB ' ' C' ' 257' ' ' ILE . 74.3 Cg_endo -67.14 -8.56 22.24 Favored 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 122.817 2.345 . . . . 73.21 114.031 -166.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 56.94 -71.88 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 125.024 1.329 . . . . 72.3 111.246 -164.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -73.88 152.33 40.21 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.831 0.852 . . . . 73.41 111.483 177.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 261' ' ' LEU . . . . . 0.588 HD13 ' HA ' ' C' ' 266' ' ' GLU . 31.2 mt -146.41 141.04 26.77 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.07 0.548 . . . . 71.21 112.043 179.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 53.7 p -87.72 145.33 36.73 Favored Pre-proline 0 CA--C 1.551 0.983 0 CA-C-O 117.914 -1.041 . . . . 61.23 108.369 167.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -45.02 -31.3 5.4 Favored 'Trans proline' 0 C--N 1.382 2.34 0 C-N-CA 124.471 3.448 . . . . 74.2 114.906 -176.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -56.83 -72.45 0.08 Allowed 'General case' 0 C--O 1.257 1.465 0 C-N-CA 124.599 1.159 . . . . 71.04 111.482 174.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -68.36 -24.87 64.85 Favored 'General case' 0 C--O 1.212 -0.888 0 CA-C-N 115.068 -0.969 . . . . 65.11 110.339 -176.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 266' ' ' GLU . . . . . 0.588 ' HA ' HD13 ' C' ' 261' ' ' LEU . 11.3 tp10 -59.09 -48.31 82.08 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.689 0.795 . . . . 64.21 109.95 173.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -63.74 -35.58 81.05 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.18 0.592 . . . . 70.32 111.386 177.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 268' ' ' LEU . . . . . . . . . . . . . 11.2 mp -64.52 -50.88 65.64 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 112.279 0.474 . . . . 52.44 112.279 174.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 269' ' ' TRP . . . . . 0.501 ' HH2' ' HD3' ' C' ' 202' ' ' PRO . 89.6 m95 -60.95 -32.74 72.25 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.46 0.704 . . . . 61.11 110.774 178.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 270' ' ' LYS . . . . . 0.433 ' NZ ' ' HB3' ' C' ' 270' ' ' LYS . 3.7 mmmp? -62.42 -57.75 10.13 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.092 0.957 . . . . 75.43 111.241 175.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 31.1 mmtm -66.39 -24.8 66.54 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.476 0.711 . . . . 75.33 112.475 -177.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 272' ' ' LEU . . . . . 0.407 HD12 HD12 ' A' ' 272' ' ' LEU . 55.4 mt -81.67 -32.46 31.77 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 122.981 0.512 . . . . 74.33 110.744 174.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -63.61 -40.19 96.29 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 109.613 -0.514 . . . . 34.13 109.613 172.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -64.23 -42.48 96.53 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.431 1.092 . . . . 63.21 110.355 175.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -62.17 -28.27 69.55 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.1 0.56 . . . . 70.04 111.316 173.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 276' ' ' TYR . . . . . 0.471 ' HA ' ' HD3' ' C' ' 279' ' ' ARG . 3.0 m-85 -85.05 -25.21 27.76 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.254 0.464 . . . . 75.52 112.254 178.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -68.73 -33.74 74.44 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 108.361 -0.977 . . . . 44.24 108.361 171.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -64.87 -15.63 62.17 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 115.127 -0.942 . . . . 55.2 112.491 172.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 279' ' ' ARG . . . . . 0.471 ' HD3' ' HA ' ' C' ' 276' ' ' TYR . 27.0 mtp-105 -82.15 -33.79 29.42 Favored 'General case' 0 C--N 1.357 0.906 0 N-CA-C 109.27 -0.641 . . . . 71.52 109.27 172.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.869 0 CA-C-O 118.329 -0.843 . . . . 75.14 109.502 -170.238 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt . . . . . 0 CA--C 1.54 0.588 0 N-CA-C 112.991 0.737 . . . . 62.43 112.991 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.618 ' HD2' HD11 ' A' ' 10' ' ' ILE . 29.0 mmtp -79.28 93.02 5.2 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 108.273 -1.01 . . . . 74.32 108.273 164.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -73.93 96.62 2.66 Favored 'General case' 0 C--N 1.352 0.686 0 N-CA-C 107.573 -1.269 . . . . 61.41 107.573 172.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.464 ' CD1' ' HA ' ' A' ' 53' ' ' ALA . 56.2 m-85 -64.39 -22.25 66.9 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 114.954 -1.021 . . . . 73.34 111.726 -171.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -63.48 -50.6 69.03 Favored 'General case' 0 C--N 1.353 0.72 0 O-C-N 123.484 0.49 . . . . 73.33 109.891 171.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.31 -40.25 96.82 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.392 0.677 . . . . 60.32 111.072 -178.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.618 HD11 ' HD2' ' A' ' 5' ' ' LYS . 68.5 mt -58.37 -43.66 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 123.284 0.633 . . . . 74.23 110.261 174.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 92.4 mt -83.26 -2.18 55.0 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 115.845 -0.616 . . . . 51.33 112.586 177.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 67.86 19.41 71.51 Favored Glycine 0 C--N 1.349 1.28 0 N-CA-C 114.639 0.616 . . . . 53.33 114.639 177.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.9 m -102.85 158.49 31.66 Favored Pre-proline 0 N--CA 1.481 1.1 0 C-N-CA 124.06 0.944 . . . . 71.43 110.874 178.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -60.81 158.26 34.1 Favored 'Trans proline' 0 C--N 1.387 2.553 0 C-N-CA 122.77 2.313 . . . . 50.12 112.156 177.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 27.8 mtp180 -74.88 10.85 1.25 Allowed 'General case' 0 CA--C 1.558 1.272 0 O-C-N 121.95 -0.469 . . . . 75.43 112.031 -178.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -119.19 5.63 11.25 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.777 1.631 . . . . 64.11 109.012 -178.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.33 138.53 55.5 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.717 0.807 . . . . 64.31 111.332 -176.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 33.9 p -90.26 -179.71 5.7 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.389 0.676 . . . . 71.11 110.1 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -52.43 -31.95 36.99 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.901 0.88 . . . . 64.21 112.683 179.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 19.3 tp10 -87.34 -28.51 22.19 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 112.055 0.391 . . . . 72.43 112.055 -173.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -66.12 -42.94 88.48 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 109.118 -0.697 . . . . 64.03 109.118 168.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.34 -39.85 84.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 O-C-N 124.332 1.02 . . . . 73.31 111.051 174.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -59.89 -56.0 27.2 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.935 0.894 . . . . 71.24 110.521 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 -69.56 -26.77 64.65 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 114.688 -1.142 . . . . 54.12 110.998 -176.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -75.3 -37.26 60.92 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.359 0.663 . . . . 64.0 111.079 178.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -60.06 -54.27 47.91 Favored 'General case' 0 C--O 1.216 -0.66 0 N-CA-C 108.947 -0.76 . . . . 73.1 108.947 173.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.9 mtpt -62.87 -38.02 89.2 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 124.287 0.992 . . . . 74.22 111.526 -178.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.9 ttt180 -53.14 -55.9 20.48 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.615 1.166 . . . . 71.15 110.119 174.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.7 ' HB3' HD13 ' A' ' 50' ' ' ILE . 96.5 mt -79.63 -16.22 56.2 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 115.035 -0.984 . . . . 74.11 111.613 -177.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -81.9 -19.92 39.85 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.717 0.807 . . . . 63.3 110.554 175.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 -89.7 -37.17 14.77 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.186 0.594 . . . . 72.33 110.323 171.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -69.47 -60.45 2.32 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.103 0.478 . . . . 63.33 110.391 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -93.42 34.24 1.18 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.552 0.741 . . . . 63.25 110.286 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.9 t-160 -61.58 102.5 0.31 Allowed Pre-proline 0 C--N 1.356 0.849 0 C-N-CA 124.051 0.94 . . . . 63.41 109.581 178.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -67.89 -19.66 46.16 Favored 'Trans proline' 0 C--N 1.371 1.751 0 C-N-CA 122.879 2.386 . . . . 74.13 112.279 -168.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -59.34 -39.08 82.03 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.453 1.101 . . . . 72.45 111.129 173.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.3 t -101.63 -46.63 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 123.494 0.717 . . . . 65.53 110.466 -176.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -100.51 85.63 2.99 Favored 'General case' 0 C--O 1.245 0.826 0 C-N-CA 124.482 1.113 . . . . 61.35 109.933 -177.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.72 69.94 9.6 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.316 0.646 . . . . 73.11 109.525 178.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.0 m -121.21 110.03 34.74 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-O 118.191 -0.909 . . . . 54.41 108.794 177.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -35.88 -61.9 0.26 Allowed 'Trans proline' 0 C--N 1.389 2.658 0 C-N-CA 125.157 3.904 . . . . 72.23 115.051 -171.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -67.49 -27.01 66.65 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 122.891 0.476 . . . . 64.43 111.957 -175.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.44 -30.46 67.3 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-O 121.001 0.429 . . . . 72.14 109.919 175.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.424 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 35.3 mt-10 -83.29 -28.6 28.98 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.166 -0.925 . . . . 62.01 109.337 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.478 ' HA ' ' HZ2' ' A' ' 48' ' ' LYS . 50.7 mt-10 -66.81 -43.46 83.76 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.325 0.65 . . . . 62.44 109.977 173.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 35.0 mmtm -61.61 -42.25 98.61 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 115.057 -0.974 . . . . 74.03 109.939 173.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.597 ' HA ' HD12 ' A' ' 50' ' ' ILE . 91.1 t80 -57.41 -37.16 72.28 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 123.737 0.648 . . . . 73.24 111.112 176.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.478 ' HZ2' ' HA ' ' A' ' 45' ' ' GLU . 10.4 mtmp? -70.85 -33.59 70.79 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.947 0.499 . . . . 75.14 111.472 176.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -71.14 -23.64 62.11 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 122.741 0.416 . . . . 71.44 111.082 173.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.7 HD13 ' HB3' ' A' ' 29' ' ' LEU . 59.9 mt -79.53 -35.68 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.718 1.207 . . . . 70.53 109.331 174.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -65.38 -35.86 82.25 Favored 'General case' 0 C--O 1.209 -1.05 0 CA-C-N 115.628 -0.715 . . . . 73.43 109.827 171.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -65.61 -48.9 70.71 Favored 'General case' 0 C--O 1.247 0.946 0 C-N-CA 125.344 1.458 . . . . 63.42 110.542 177.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.464 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . . . -57.87 -48.28 80.27 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 114.265 -1.334 . . . . 65.45 111.243 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -79.19 -19.87 49.78 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 115.044 -0.98 . . . . 72.32 110.891 177.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.31 -45.72 87.49 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 118.404 0.547 . . . . 53.01 109.865 174.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.594 HG13 ' HZ ' ' A' ' 101' ' ' PHE . 22.7 t -71.43 -56.37 10.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 114.138 -1.392 . . . . 74.52 110.042 175.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.676 HD22 ' HD2' ' A' ' 63' ' ' ARG . 43.5 mt -91.93 15.73 12.53 Favored 'General case' 0 CA--C 1.56 1.346 0 N-CA-C 113.644 0.979 . . . . 62.04 113.644 -164.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.2 t -71.63 -71.54 0.26 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 122.813 0.445 . . . . 74.34 110.798 171.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -79.97 143.18 57.02 Favored Pre-proline 0 N--CA 1.471 0.619 0 CA-C-N 115.439 -0.801 . . . . 74.34 110.113 -176.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -58.47 -27.06 80.73 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 123.155 2.57 . . . . 72.41 112.932 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -67.31 -59.12 3.67 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.711 0.805 . . . . 72.3 111.002 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.504 ' HA ' HD12 ' A' ' 65' ' ' ILE . 27.9 mtpt -70.07 -28.92 65.83 Favored 'General case' 0 C--O 1.248 0.987 0 CA-C-N 114.893 -1.048 . . . . 74.54 110.829 -177.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.676 ' HD2' HD22 ' A' ' 57' ' ' LEU . 31.6 tpt85 -54.21 -55.61 26.28 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 114.635 -1.166 . . . . 74.11 109.401 168.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.43 ' HA ' ' HE ' ' A' ' 64' ' ' ARG . 2.8 mmp_? -65.2 -25.68 67.81 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 115.761 -0.654 . . . . 74.25 112.113 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.504 HD12 ' HA ' ' A' ' 62' ' ' LYS . 78.6 mt -59.38 -47.15 91.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 CA-C-N 118.231 0.469 . . . . 64.42 110.138 171.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -58.35 -52.97 63.35 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 116.033 -0.53 . . . . 75.4 110.255 173.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -56.67 -41.85 77.99 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.477 0.711 . . . . 64.04 112.599 -176.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.8 p -74.13 -23.02 59.23 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 122.844 0.458 . . . . 75.13 110.95 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -71.0 126.58 29.96 Favored 'General case' 0 C--N 1.357 0.909 0 N-CA-C 107.42 -1.326 . . . . 63.45 107.42 170.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.82 13.93 41.88 Favored Glycine 0 N--CA 1.471 1.027 0 N-CA-C 112.108 -0.397 . . . . 52.54 112.108 -169.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 42.6 m -140.79 -57.56 0.51 Allowed 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 103.786 -2.672 . . . . 71.23 103.786 173.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 46.7 m -83.82 140.55 31.96 Favored 'General case' 0 C--O 1.247 0.951 0 N-CA-C 104.832 -2.284 . . . . 74.23 104.832 155.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.41 -26.29 17.3 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.027 0.531 . . . . 74.04 110.889 178.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -88.82 163.16 36.19 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 123.911 0.884 . . . . 75.1 110.516 176.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -58.23 143.88 96.43 Favored 'Trans proline' 0 C--N 1.371 1.716 0 C-N-CA 122.268 1.979 . . . . 75.41 111.657 163.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.92 159.61 47.73 Favored 'Trans proline' 0 CA--C 1.557 1.665 0 C-N-CA 122.397 2.065 . . . . 74.25 111.341 174.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -51.41 114.57 1.62 Allowed 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 122.927 2.418 . . . . 62.44 112.911 173.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -61.04 140.31 89.13 Favored 'Trans proline' 0 C--N 1.384 2.4 0 C-N-CA 123.311 2.674 . . . . 43.51 112.556 177.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.52 163.86 37.37 Favored 'Trans proline' 0 C--N 1.374 1.896 0 C-N-CA 122.766 2.311 . . . . 71.05 112.445 177.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -58.18 87.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.38 2.186 0 C-N-CA 123.122 2.548 . . . . 51.35 112.648 174.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 150.96 -34.1 0.94 Allowed Glycine 0 C--N 1.338 0.645 0 CA-C-N 114.281 -1.327 . . . . 62.41 110.006 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 106.5 -160.39 14.49 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-N 114.754 -0.723 . . . . 53.03 111.722 178.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -90.89 103.5 16.2 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 123.478 0.711 . . . . 74.41 109.3 178.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -61.63 152.51 30.53 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.728 0.811 . . . . 71.31 111.658 171.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.564 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 70.8 m-85 -142.09 75.04 1.47 Allowed 'General case' 0 C--N 1.353 0.745 0 C-N-CA 124.582 1.153 . . . . 70.22 109.411 172.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.518 ' HA ' ' O ' ' A' ' 162' ' ' PRO . 74.0 m -53.84 84.38 0.0 OUTLIER 'General case' 0 CA--C 1.562 1.405 0 C-N-CA 124.392 1.077 . . . . 74.44 113.316 -178.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 88.32 19.31 53.12 Favored Glycine 0 C--N 1.351 1.369 0 CA-C-N 115.691 -0.686 . . . . 70.11 113.992 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.564 ' HB2' ' HB3' ' A' ' 85' ' ' PHE . 37.4 m-85 -125.95 113.53 17.29 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 118.102 0.951 . . . . 72.34 110.402 -174.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -78.0 86.71 4.18 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.655 0.74 . . . . 71.44 111.008 -176.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.691 HG21 HD22 ' A' ' 105' ' ' LEU . 2.3 p -46.49 -36.31 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 124.926 1.291 . . . . 75.21 113.402 172.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.477 ' HB2' ' HG3' ' A' ' 170' ' ' PRO . 16.9 tp10 -54.32 -28.25 41.28 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.197 0.999 . . . . 75.33 111.563 -178.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -84.59 -39.53 18.61 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.654 0.781 . . . . 45.35 112.061 178.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 15.3 m-30 -66.15 162.58 19.46 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 113.404 0.89 . . . . 71.01 113.404 -162.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 92.2 p -65.03 164.55 12.63 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 114.025 1.12 . . . . 74.5 114.025 -165.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.88 -39.33 71.37 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 114.392 -1.276 . . . . 74.31 112.948 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -58.81 -45.59 89.59 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 121.654 0.74 . . . . 75.03 110.302 178.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -64.65 -41.0 96.42 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 113.995 -1.457 . . . . 63.23 110.109 178.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -73.35 -10.67 59.99 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 115.313 -0.858 . . . . 73.05 111.922 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -90.41 -54.48 3.99 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 118.267 0.485 . . . . 70.02 110.507 169.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 29.0 tp -60.47 -28.02 68.0 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.597 1.159 . . . . 55.03 111.786 -174.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.594 ' HZ ' HG13 ' A' ' 56' ' ' VAL . 95.4 m-85 -117.28 -3.97 11.42 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 123.072 0.549 . . . . 72.11 111.72 177.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -47.61 -60.63 5.21 Favored Glycine 0 CA--C 1.537 1.438 0 N-CA-C 116.035 1.174 . . . . 72.43 116.035 -175.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -66.1 5.53 0.65 Allowed 'Trans proline' 0 C--N 1.375 1.935 0 C-N-CA 123.303 2.669 . . . . 23.1 114.789 -175.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -150.58 30.92 1.03 Allowed Glycine 0 C--N 1.356 1.639 0 CA-C-O 118.79 -1.006 . . . . 44.4 112.755 170.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.691 HD22 HG21 ' A' ' 90' ' ' VAL . 17.2 mt -60.8 78.64 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 117.421 0.61 . . . . 74.25 112.502 176.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.413 ' HD1' ' H ' ' A' ' 108' ' ' GLY . 0.4 OUTLIER 38.48 -109.05 0.07 Allowed 'General case' 0 CA--C 1.563 1.464 0 C-N-CA 126.628 1.971 . . . . 72.25 113.069 -176.009 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 70.78 15.45 73.68 Favored Glycine 0 C--N 1.366 2.237 0 CA-C-O 119.165 -0.797 . . . . 44.0 114.323 -177.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.738 ' HA3' ' HB3' ' A' ' 167' ' ' GLN . . . . . . . . 0 C--N 1.366 2.202 0 C-N-CA 125.895 1.712 . . . . 71.34 115.63 166.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.603 ' HD2' ' HB2' ' A' ' 170' ' ' PRO . 24.3 tptp . . . . . 0 N--CA 1.493 1.696 0 N-CA-C 114.533 1.308 . . . . 72.15 114.533 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -83.64 175.79 52.22 Favored Glycine 0 CA--C 1.54 1.637 0 CA-C-N 115.844 -0.616 . . . . 55.22 112.592 175.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.768 ' H ' ' HA3' ' A' ' 166' ' ' GLY . 0.0 OUTLIER -116.72 174.0 6.32 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 124.118 0.967 . . . . 71.34 111.697 -178.359 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -78.46 101.66 7.43 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-O 122.02 0.914 . . . . 74.23 110.089 175.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 10.4 tt -112.2 139.84 47.4 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.938 0.895 . . . . 70.23 108.825 -174.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.4 ' HA ' ' HB2' ' A' ' 175' ' ' LEU . 58.3 ttt180 -94.42 139.02 31.66 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.33 0.652 . . . . 74.51 111.207 -178.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.4 ' HB2' HD23 ' B' ' 10' ' ' LEU . . . -134.77 169.43 17.37 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 123.981 0.912 . . . . 41.51 109.368 170.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.408 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 0.3 OUTLIER -117.64 115.74 25.68 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 107.0 -1.482 . . . . 61.0 107.0 -174.082 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 50.5 tp -100.52 100.23 11.74 Favored Pre-proline 0 N--CA 1.476 0.846 0 N-CA-C 108.912 -0.773 . . . . 54.05 108.912 -175.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.559 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 77.4 Cg_endo -84.16 111.73 1.64 Allowed 'Trans proline' 0 C--N 1.374 1.909 0 C-N-CA 121.323 1.348 . . . . 75.33 110.049 176.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.597 ' HA ' HG21 ' B' ' 6' ' ' ILE . 52.3 tp -104.99 137.09 43.28 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.706 0.402 . . . . 64.01 110.338 -176.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 90.0 m -68.06 126.69 30.3 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.035 0.934 . . . . 71.34 109.638 177.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 53.9 mt -53.6 -51.88 61.61 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.625 1.17 . . . . 70.54 112.47 -171.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -58.77 -37.39 76.16 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 115.115 -0.948 . . . . 75.32 110.007 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.464 ' HB3' ' NH2' ' A' ' 136' ' ' ARG . 44.6 mm-40 -80.48 -14.81 57.95 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.048 -0.978 . . . . 64.33 112.34 -178.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -70.51 -52.18 23.62 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 107.823 -1.177 . . . . 41.43 107.823 167.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -53.98 -40.1 66.59 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 116.028 -0.533 . . . . 74.51 110.913 175.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 35.9 m170 -78.41 -29.57 47.23 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 122.838 0.455 . . . . 75.25 112.099 -178.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 64.04 -138.05 41.42 Favored Glycine 0 N--CA 1.479 1.531 0 O-C-N 123.271 0.357 . . . . 71.54 113.844 176.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.36 -161.09 46.5 Favored Glycine 0 C--N 1.357 1.696 0 O-C-N 123.781 0.342 . . . . 70.42 113.002 175.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -76.23 119.09 19.65 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 109.255 -0.646 . . . . 73.14 109.255 170.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.464 ' NH2' ' HB3' ' A' ' 129' ' ' GLU . 10.0 tpp180 -93.52 123.35 36.77 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 109.336 -0.616 . . . . 74.4 109.336 175.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.411 HG11 ' HE ' ' A' ' 144' ' ' ARG . 98.2 t -88.37 104.07 14.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 109.018 -0.734 . . . . 71.24 109.018 175.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.401 HG22 HD11 ' B' ' 6' ' ' ILE . 15.3 t -102.64 125.36 56.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 CA-C-N 115.041 -0.981 . . . . 73.14 108.598 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -102.98 134.03 47.1 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.554 0.741 . . . . 71.3 109.968 -178.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.416 ' HB ' ' HB3' ' B' ' 8' ' ' LEU . 7.2 p -168.3 113.91 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 122.782 0.433 . . . . 75.1 111.547 178.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 61.26 24.78 14.84 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.396 1.078 . . . . 74.24 113.047 170.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 99.38 -11.25 61.59 Favored Glycine 0 C--N 1.349 1.286 0 CA-C-N 116.766 -0.197 . . . . 31.1 112.871 -178.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.417 ' NH2' HG23 ' A' ' 145' ' ' VAL . 16.4 tpt180 -87.9 108.42 19.17 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.872 0.869 . . . . 72.12 109.959 175.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.411 ' HE ' HG11 ' A' ' 137' ' ' VAL . 75.4 ttt180 -105.4 94.87 5.45 Favored 'General case' 0 C--O 1.244 0.794 0 C-N-CA 123.916 0.887 . . . . 74.41 108.864 175.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.418 HG22 HG13 ' A' ' 147' ' ' VAL . 11.5 p -95.58 143.67 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 123.205 0.602 . . . . 73.53 110.959 -176.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 33.3 t -118.16 85.6 2.38 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.82 0.848 . . . . 31.45 109.277 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.418 HG13 HG22 ' A' ' 145' ' ' VAL . 11.1 m -92.88 114.04 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 C-N-CA 123.364 0.666 . . . . 73.42 111.745 -173.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -71.32 105.56 3.54 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.449 -0.574 . . . . 74.14 109.449 173.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 21.2 pt -102.14 153.9 37.73 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 124.644 1.178 . . . . 74.13 109.772 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -57.6 -166.34 0.02 OUTLIER 'Trans proline' 0 N--CA 1.519 3.007 0 C-N-CA 124.305 3.337 . . . . 60.34 112.591 170.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -46.13 90.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.399 3.217 0 C-N-CA 121.621 1.547 . . . . 74.15 110.864 162.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 36.52 -94.58 0.01 OUTLIER Glycine 0 C--N 1.346 1.131 0 CA-C-N 113.011 -1.904 . . . . 75.51 114.521 -162.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.73 HG11 HG21 ' A' ' 178' ' ' VAL . 5.5 p 172.71 166.34 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 113.364 -1.418 . . . . 75.43 107.986 -162.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.93 146.64 50.57 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 108.59 -0.892 . . . . 73.23 108.59 177.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.56 ' HG2' ' NH1' ' A' ' 187' ' ' ARG . 14.9 tp10 -48.95 129.81 17.67 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.447 1.099 . . . . 72.32 112.263 -177.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 91.08 -4.9 81.58 Favored Glycine 0 C--N 1.346 1.114 0 CA-C-N 115.438 -0.801 . . . . 14.21 113.774 179.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 57.8 m -66.23 113.82 4.85 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 117.499 0.649 . . . . 74.23 110.409 179.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.415 HG22 HG22 ' A' ' 177' ' ' VAL . 61.1 t -90.13 94.93 5.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 C-N-CA 123.892 0.877 . . . . 72.34 108.949 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.595 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 60.1 mt -77.76 108.8 11.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 108.604 -0.887 . . . . 75.24 108.604 175.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 30.1 ttt180 -76.64 107.09 8.68 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.474 -0.565 . . . . 61.32 109.474 178.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.439 HG13 ' HB3' ' A' ' 174' ' ' LEU . 3.8 p -125.93 95.86 38.74 Favored Pre-proline 0 CA--C 1.55 0.958 0 N-CA-C 109.304 -0.628 . . . . 61.33 109.304 174.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.518 ' O ' ' HA ' ' A' ' 86' ' ' SER . 30.0 Cg_exo -62.25 142.04 90.04 Favored 'Trans proline' 0 C--N 1.369 1.636 0 C-N-CA 122.524 2.149 . . . . 74.53 111.597 174.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.424 ' N ' ' HB3' ' A' ' 171' ' ' PRO . . . 121.04 -26.36 6.79 Favored Glycine 0 N--CA 1.475 1.299 0 CA-C-N 117.855 0.298 . . . . 70.43 112.759 175.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 68.4 mtm -116.36 2.74 13.24 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 122.761 0.424 . . . . 64.15 110.858 -178.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.406 ' HA2' HD13 ' A' ' 174' ' ' LEU . . . -83.39 -108.99 0.52 Allowed Glycine 0 C--N 1.353 1.505 0 N-CA-C 110.875 -0.89 . . . . 73.33 110.875 175.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.768 ' HA3' ' H ' ' A' ' 117' ' ' ARG . . . -57.69 108.62 1.44 Allowed Glycine 0 C--O 1.263 1.932 0 N-CA-C 110.902 -0.879 . . . . 74.5 110.902 164.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.738 ' HB3' ' HA3' ' A' ' 108' ' ' GLY . 27.1 mm-40 -67.47 105.2 1.75 Allowed 'General case' 0 N--CA 1.446 -0.63 0 O-C-N 125.453 1.325 . . . . 75.42 109.204 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -178.26 169.08 40.67 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 110.871 -0.891 . . . . 64.21 110.871 -176.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . 0.53 ' ND2' ' HB3' ' A' ' 105' ' ' LEU . 4.6 t-20 -63.03 -67.98 0.94 Allowed Pre-proline 0 CA--C 1.57 1.722 0 CA-C-O 117.026 -1.464 . . . . 63.11 111.639 -170.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.603 ' HB2' ' HD2' ' A' ' 115' ' ' LYS . 17.0 Cg_exo -66.23 116.01 3.8 Favored 'Trans proline' 0 C--N 1.396 3.066 0 CA-C-N 122.878 2.063 . . . . 71.13 109.922 167.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.424 ' HB3' ' N ' ' A' ' 163' ' ' GLY . 18.8 Cg_exo -40.5 127.27 2.32 Favored 'Trans proline' 0 C--N 1.368 1.592 0 C-N-CA 125.214 3.943 . . . . 71.25 117.131 -171.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -83.11 132.14 10.87 Favored Glycine 0 C--N 1.367 2.289 0 CA-C-O 119.159 -0.801 . . . . 72.4 111.987 164.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.445 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 22.8 m-20 -64.48 108.35 1.63 Allowed 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.166 0.586 . . . . 71.14 110.82 -175.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.452 HD21 HD21 ' B' ' 8' ' ' LEU . 38.3 tp -83.64 129.31 34.96 Favored 'General case' 0 C--N 1.349 0.545 0 N-CA-C 109.623 -0.51 . . . . 64.32 109.623 175.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.4 ' HB2' ' HA ' ' A' ' 120' ' ' ARG . 55.6 mt -99.1 88.45 3.95 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 107.999 -1.112 . . . . 72.12 107.999 178.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.595 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 75.1 mt -70.62 87.32 0.67 Allowed 'General case' 0 C--N 1.35 0.609 0 N-CA-C 109.06 -0.719 . . . . 70.05 109.06 174.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.415 HG22 HG22 ' A' ' 158' ' ' VAL . 19.7 t -82.62 102.15 8.22 Favored 'Isoleucine or valine' 0 C--O 1.248 1.017 0 N-CA-C 105.749 -1.945 . . . . 61.43 105.749 175.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.73 HG21 HG11 ' A' ' 153' ' ' VAL . 5.4 p -73.42 131.89 34.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 115.034 -0.985 . . . . 70.33 110.865 -169.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.559 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 28.9 mmt180 -112.72 127.27 56.09 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 106.261 -1.755 . . . . 53.32 106.261 167.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.426 HD23 ' HB3' ' A' ' 125' ' ' LEU . 27.7 mt -80.12 147.7 31.28 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.477 -0.935 . . . . 72.4 108.477 169.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 20.2 mt -53.28 152.49 8.17 Favored Pre-proline 0 N--CA 1.482 1.145 0 O-C-N 124.174 0.921 . . . . 73.14 113.021 -167.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -65.16 5.23 0.53 Allowed 'Trans proline' 0 C--N 1.383 2.354 0 C-N-CA 123.566 2.844 . . . . 71.42 113.425 175.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 61.2 t-80 -59.56 104.0 0.41 Allowed Pre-proline 0 CA--C 1.56 1.341 0 C-N-CA 124.894 1.278 . . . . 73.35 107.985 168.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -80.81 26.36 0.6 Allowed 'Trans proline' 0 C--N 1.372 1.773 0 C-N-CA 123.792 2.995 . . . . 61.24 115.537 -162.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.424 HG12 ' HD1' ' A' ' 186' ' ' PHE . 75.5 t -95.22 -61.03 2.28 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.901 0 CA-C-O 118.715 -0.659 . . . . 64.21 110.848 -175.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . 0.424 ' HD1' HG12 ' A' ' 185' ' ' VAL . 3.9 m-85 -138.11 92.57 2.67 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 119.064 0.847 . . . . 72.31 110.34 -176.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.56 ' NH1' ' HG2' ' A' ' 155' ' ' GLU . 62.1 ttp85 -98.09 98.24 9.58 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.867 0.867 . . . . 75.51 109.391 176.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 193' ' ' LEU . 61.9 tp -68.78 142.15 55.0 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.163 0.985 . . . . 74.21 110.864 178.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -152.7 129.03 10.56 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.792 1.237 . . . . 70.31 109.973 -174.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 68.51 -80.5 0.22 Allowed Glycine 0 C--N 1.351 1.412 0 N-CA-C 111.916 -0.474 . . . . 65.41 111.916 -177.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.573 ' HG3' ' HB3' ' A' ' 244' ' ' ALA . 14.6 mm100 -147.47 -11.18 0.41 Allowed 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 125.069 1.347 . . . . 72.32 110.533 166.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -103.7 148.81 25.61 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.492 1.117 . . . . 72.32 110.944 -174.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 188' ' ' LEU . 11.6 mt -90.36 162.67 15.03 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.245 1.018 . . . . 63.44 111.02 -175.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -131.16 114.51 15.19 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.303 1.041 . . . . 73.14 109.142 173.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.524 ' HB3' HD23 ' A' ' 251' ' ' LEU . . . -135.68 174.92 10.08 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.64 1.176 . . . . 74.34 110.458 -176.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 27.9 m -120.72 144.87 48.02 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.818 0.847 . . . . 70.21 108.878 173.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.503 HD21 HG21 ' A' ' 210' ' ' VAL . 44.7 tp -129.4 115.92 18.26 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.621 0.768 . . . . 72.21 109.457 -175.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -90.24 121.05 31.92 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 108.092 -1.077 . . . . 61.43 108.092 173.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.5 p -139.5 131.02 14.85 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 124.054 0.942 . . . . 64.4 109.136 -173.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -72.35 148.58 49.23 Favored 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 121.602 1.535 . . . . 64.51 110.77 174.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -49.54 -47.4 78.17 Favored Pre-proline 0 CA--C 1.561 1.374 0 N-CA-C 114.131 1.16 . . . . 71.34 114.131 -174.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -51.66 -48.09 23.11 Favored 'Trans proline' 0 C--N 1.384 2.442 0 C-N-CA 122.022 1.815 . . . . 63.54 113.725 176.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 22.9 mt -73.12 -29.36 28.31 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 CA-C-N 115.74 -0.664 . . . . 64.32 110.514 -176.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.4 -41.71 76.06 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.979 0.512 . . . . 71.51 111.493 176.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 54.6 t -74.26 -46.88 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 123.867 0.867 . . . . 63.23 111.875 -175.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 91.5 t -90.56 -31.35 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 122.884 0.473 . . . . 74.41 111.569 -175.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 82.49 111.22 0.45 Allowed Glycine 0 C--N 1.343 0.928 0 N-CA-C 112.37 -0.292 . . . . 72.35 112.37 178.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.465 ' HA3' ' CE1' ' C' ' 277' ' ' TYR . . . -145.47 -132.61 2.47 Favored Glycine 0 C--O 1.217 -0.957 0 CA-C-O 119.178 -0.79 . . . . 55.24 111.719 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -112.05 134.83 53.36 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 118.008 0.904 . . . . 45.21 110.377 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.503 HG21 HD21 ' A' ' 197' ' ' LEU . 12.2 m -132.88 162.34 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 124.796 1.238 . . . . 63.11 108.633 171.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 5.8 tpp180 -86.1 126.96 34.58 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 109.314 -0.624 . . . . 71.41 109.314 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.44 109.93 21.84 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.409 -0.96 . . . . 62.04 108.409 170.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 16.9 tpt -83.0 111.82 19.2 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 108.45 -0.944 . . . . 71.23 108.45 177.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 26.5 p -107.55 -174.47 2.54 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 109.502 -0.555 . . . . 74.1 109.502 -174.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 80.7 mt -63.94 -33.9 76.77 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.019 0.927 . . . . 63.31 111.942 -176.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -97.24 -6.63 34.14 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.421 0.688 . . . . 64.44 112.118 -177.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 135.06 -179.03 18.08 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-O 120.054 -0.303 . . . . 33.0 112.61 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -79.6 147.35 19.72 Favored 'Trans proline' 0 CA--C 1.549 1.238 0 C-N-CA 122.94 2.426 . . . . 70.23 113.455 -176.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 31.7 m -136.04 -177.91 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.624 1.569 . . . . 73.4 107.556 172.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -109.77 127.77 54.85 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 118.499 0.59 . . . . 75.04 109.745 169.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 7.0 m -107.52 132.25 55.54 Favored 'Isoleucine or valine' 0 C--O 1.242 0.683 0 C-N-CA 124.178 0.991 . . . . 74.13 108.512 168.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -80.24 97.3 6.89 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.572 -0.899 . . . . 60.25 108.572 178.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 14.9 p -65.62 137.39 96.36 Favored Pre-proline 0 N--CA 1.479 1.007 0 C-N-CA 124.186 0.994 . . . . 63.14 109.732 -175.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -72.04 165.93 31.12 Favored 'Trans proline' 0 C--N 1.374 1.9 0 C-N-CA 122.158 1.906 . . . . 75.51 111.931 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -73.58 164.11 35.75 Favored 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 122.214 1.942 . . . . 72.53 112.916 172.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 64.2 mtt-85 61.44 26.94 16.61 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 125.377 1.471 . . . . 74.04 111.812 169.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.525 HG23 HD21 ' A' ' 233' ' ' LEU . 94.6 m -72.06 103.87 3.4 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.19 1.396 . . . . 64.32 110.873 -176.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -87.08 138.11 31.77 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.636 1.174 . . . . 75.32 110.313 -175.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . 0.482 ' HA ' ' HB ' ' A' ' 253' ' ' VAL . . . -67.2 156.64 35.76 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.561 0.744 . . . . 62.31 111.973 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 83.51 -14.87 38.48 Favored Glycine 0 N--CA 1.471 0.99 0 CA-C-N 116.024 -0.535 . . . . 73.32 112.892 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -92.42 160.78 14.93 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 123.691 0.796 . . . . 74.0 110.4 177.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -113.49 113.5 25.22 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.783 0.833 . . . . 72.22 108.79 178.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.525 HD21 HG23 ' A' ' 227' ' ' THR . 64.7 mt -76.24 117.21 17.69 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.793 0.837 . . . . 71.4 109.683 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 27.8 ttm-85 -85.97 102.69 14.0 Favored 'General case' 0 CA--C 1.551 1.001 0 N-CA-C 108.679 -0.859 . . . . 64.14 108.679 172.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.532 HD12 HD23 ' A' ' 249' ' ' LEU . 3.1 mt -87.76 110.9 20.81 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 108.581 -0.896 . . . . 61.12 108.581 -178.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -59.38 127.84 34.1 Favored 'General case' 0 CA--C 1.555 1.135 0 O-C-N 124.098 0.874 . . . . 64.43 113.254 -177.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 82.59 6.37 88.63 Favored Glycine 0 C--N 1.353 1.5 0 N-CA-C 114.847 0.699 . . . . 74.2 114.847 170.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -95.31 -20.51 19.1 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 117.515 0.657 . . . . 73.01 112.714 -172.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -82.21 -173.01 48.42 Favored Glycine 0 N--CA 1.478 1.451 0 N-CA-C 113.717 0.247 . . . . 74.43 113.717 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -84.87 146.95 47.21 Favored Pre-proline 0 N--CA 1.483 1.213 0 C-N-CA 122.898 0.479 . . . . 73.13 111.811 -167.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -68.98 157.16 62.96 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 123.323 2.682 . . . . 73.33 113.326 173.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 169.84 -156.51 27.38 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 119.305 -0.719 . . . . 73.52 112.07 -178.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -61.99 -28.27 80.43 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 123.786 2.991 . . . . 70.45 113.286 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 0.573 ' HB3' ' HG3' ' A' ' 191' ' ' GLN . . . -87.38 22.32 2.2 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.252 0.621 . . . . 70.11 111.416 176.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 75.01 -97.32 1.01 Allowed Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.47 -1.052 . . . . 62.24 110.47 -175.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 39.2 mtp180 -128.05 152.4 48.01 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.718 0.807 . . . . 75.41 110.167 166.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -91.57 -175.65 43.07 Favored Glycine 0 C--N 1.342 0.876 0 CA-C-N 116.082 -0.508 . . . . 42.24 112.031 171.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -112.62 -173.25 2.21 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.601 0.76 . . . . 75.44 110.588 178.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.532 HD23 HD12 ' A' ' 235' ' ' LEU . 19.1 tp -125.55 115.6 20.44 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 122.102 -0.374 . . . . 70.31 110.17 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -80.44 123.08 27.74 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.545 -0.539 . . . . 52.51 109.545 172.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.524 HD23 ' HB3' ' A' ' 195' ' ' ALA . 57.8 mt -114.67 119.21 35.93 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.414 0.685 . . . . 72.24 109.415 171.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -77.46 116.94 18.45 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 106.579 -1.637 . . . . 75.41 106.579 176.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.482 ' HB ' ' HA ' ' A' ' 229' ' ' ALA . 24.3 t -75.71 109.68 9.6 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 CA-C-O 121.234 0.54 . . . . 24.43 110.569 -173.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.78 93.36 4.42 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.054 1.341 . . . . 73.14 107.625 177.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.4 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 58.6 mt -83.57 132.41 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-O 120.758 0.313 . . . . 74.34 110.308 -177.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 28.0 p -121.48 172.11 8.3 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.619 1.167 . . . . 73.43 109.889 174.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.511 HD12 ' H ' ' A' ' 259' ' ' GLU . 2.1 pp -126.48 154.86 75.15 Favored Pre-proline 0 CA--C 1.562 1.429 0 N-CA-C 107.966 -1.124 . . . . 73.4 107.966 175.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' PRO . . . . . 0.461 ' HG3' ' OH ' ' C' ' 276' ' ' TYR . 61.2 Cg_endo -75.96 14.42 1.08 Allowed 'Trans proline' 0 N--CA 1.511 2.549 0 C-N-CA 123.36 2.707 . . . . 74.45 115.713 -164.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . 0.511 ' H ' HD12 ' A' ' 257' ' ' ILE . 5.6 mm-40 54.1 -125.12 2.28 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 124.142 0.977 . . . . 63.24 111.682 -170.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' ARG . . . . . 0.48 ' H ' ' HD3' ' A' ' 260' ' ' ARG . 0.0 OUTLIER -63.61 140.61 58.89 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 118.449 0.568 . . . . 75.12 110.904 -170.443 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.417 HD11 ' CG1' ' C' ' 205' ' ' VAL . 84.9 mt -110.34 160.6 16.42 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.248 0.619 . . . . 55.32 111.584 -171.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 21.3 p -103.92 146.85 33.32 Favored Pre-proline 0 CA--C 1.554 1.118 0 C-N-CA 124.652 1.181 . . . . 44.34 108.94 174.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' PRO . . . . . 0.469 ' O ' ' HB3' ' A' ' 266' ' ' GLU . 21.7 Cg_exo -29.46 -58.74 0.14 Allowed 'Trans proline' 0 C--N 1.389 2.692 1 C-N-CA 126.089 4.526 . . . . 74.33 117.948 -163.209 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -72.28 -45.41 60.22 Favored 'General case' 0 C--O 1.211 -0.949 0 CA-C-O 119.217 -0.42 . . . . 71.44 110.711 -176.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -60.17 -31.49 70.16 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 123.955 0.784 . . . . 64.2 109.819 178.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' GLU . . . . . 0.471 ' O ' ' HD3' ' A' ' 270' ' ' LYS . 8.3 tp10 -59.47 -60.58 3.62 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.925 0.89 . . . . 73.45 109.045 171.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -63.99 -21.58 66.56 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 115.235 -0.893 . . . . 64.12 112.198 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . 0.418 ' HA ' ' HE2' ' A' ' 271' ' ' LYS . 26.3 tp -79.7 -48.7 13.24 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.548 1.139 . . . . 73.14 110.24 -173.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 70.6 m95 -61.03 -39.07 88.37 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.336 -0.847 . . . . 75.0 110.401 172.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . 0.609 ' HG3' HG23 ' C' ' 206' ' ' VAL . 1.0 OUTLIER -63.08 -45.7 90.92 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 123.689 0.618 . . . . 62.43 111.676 176.09 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . 0.418 ' HE2' ' HA ' ' A' ' 268' ' ' LEU . 30.3 mtmm -56.63 -50.01 73.28 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 123.082 0.553 . . . . 70.22 110.813 176.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' LEU . . . . . 0.418 ' O ' ' HB2' ' A' ' 276' ' ' TYR . 57.8 mt -51.32 -50.97 58.36 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 124.444 1.09 . . . . 63.4 110.4 175.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -72.73 -34.1 66.84 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 114.158 1.17 . . . . 64.51 114.158 -168.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -78.06 -41.68 34.66 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 122.75 0.42 . . . . 74.35 110.105 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -67.39 -30.8 70.67 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 115.98 -0.555 . . . . 71.44 110.52 174.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . 0.418 ' HB2' ' O ' ' A' ' 272' ' ' LEU . 35.1 t80 -66.15 -62.76 1.31 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.326 1.051 . . . . 75.02 109.596 176.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -60.43 -44.04 96.19 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.525 1.13 . . . . 70.12 111.168 -172.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -63.13 -17.82 62.75 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 112.467 0.543 . . . . 75.41 112.467 -179.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 -128.27 19.62 6.37 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.668 0.787 . . . . 74.13 111.016 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.08 0 CA-C-O 118.786 -0.626 . . . . 72.21 110.552 -174.956 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.482 1.167 0 N-CA-C 108.866 -0.79 . . . . 71.44 108.866 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . 0.6 ' HA ' ' HE3' ' B' ' 2' ' ' LYS . 0.5 OUTLIER -69.31 129.34 39.52 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 123.656 0.597 . . . . 54.1 110.046 -177.22 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 22.7 tm0? -144.71 145.01 31.5 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 108.462 -0.94 . . . . 74.04 108.462 -173.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 72.5 p 54.86 -85.21 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 125.859 1.663 . . . . 52.14 113.041 -178.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 11.3 m -75.01 157.63 34.58 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.018 0.527 . . . . 70.11 110.218 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.597 HG21 ' HA ' ' A' ' 125' ' ' LEU . 36.3 pt -131.43 170.26 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 123.158 0.583 . . . . 64.44 111.071 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -142.04 132.98 25.88 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.583 0.753 . . . . 72.01 109.955 -177.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . 0.452 HD21 HD21 ' A' ' 174' ' ' LEU . 48.5 tp -79.05 154.42 29.46 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.775 0.83 . . . . 75.22 111.338 -173.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -79.17 -63.56 1.39 Allowed 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.349 0.66 . . . . 62.4 112.153 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . 0.4 HD23 ' HB2' ' A' ' 121' ' ' ALA . 86.5 mt 62.91 117.43 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 124.865 1.266 . . . . 74.1 110.566 -163.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 28.2 mt . . . . . 0 CA--C 1.584 2.278 0 N-CA-C 116.298 1.962 . . . . 45.35 116.298 -176.756 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.594 0 N-CA-C 109.441 -0.577 . . . . 61.34 109.441 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . -70.81 -36.91 73.19 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.182 0.593 . . . . 74.4 110.547 175.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 13.1 tp -159.72 18.77 0.16 Allowed 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 114.629 -1.169 . . . . 62.04 109.179 176.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 182' ' ' VAL . . . . . 0.602 HG22 ' HA ' ' C' ' 138' ' ' VAL . 55.9 t -76.86 107.0 7.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 116.089 -0.505 . . . . 71.31 111.119 -169.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 183' ' ' ALA . . . . . 0.426 ' HB2' ' HB3' ' C' ' 123' ' ' LEU . . . -86.62 -36.4 18.84 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.13 -0.941 . . . . 65.24 110.214 170.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 184' ' ' HIS . . . . . 0.525 ' HB2' HG12 ' B' ' 182' ' ' VAL . 6.3 t-80 58.42 28.88 17.46 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 125.259 1.424 . . . . 74.15 112.382 171.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 185' ' ' VAL . . . . . . . . . . . . . 53.5 t . . . . . 0 N--CA 1.481 1.123 0 C-N-CA 124.226 1.01 . . . . 71.33 109.443 -168.408 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 41.0 m . . . . . 0 N--CA 1.485 1.298 0 CA-C-O 122.986 1.374 . . . . 71.31 107.752 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 239' ' ' ALA . . . . . 0.733 ' HB2' ' H ' ' C' ' 222' ' ' ALA . . . -97.32 -173.67 2.73 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 114.329 -1.305 . . . . 74.42 111.945 -173.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . -117.1 -151.9 9.49 Favored Glycine 0 C--N 1.341 0.848 0 CA-C-N 114.799 -1.091 . . . . 71.23 111.06 178.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -110.39 141.68 43.12 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.941 0.896 . . . . 71.21 112.026 -165.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 242' ' ' TRP . . . . . 0.428 ' HB3' ' HA ' ' C' ' 233' ' ' LEU . 0.4 OUTLIER -171.09 -39.55 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.584 1.154 . . . . 70.32 109.577 174.231 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 243' ' ' GLN . . . . . 0.725 ' HG3' ' HG2' ' C' ' 224' ' ' PRO . 12.6 pt20 -157.36 162.93 39.08 Favored 'General case' 0 C--O 1.244 0.791 0 C-N-CA 124.47 1.108 . . . . 74.22 108.881 169.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -69.07 116.78 7.46 Favored Glycine 0 C--N 1.351 1.384 0 N-CA-C 111.896 -0.482 . . . . 63.11 111.896 -175.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 245' ' ' LYS . . . . . 0.565 ' HE2' ' HB1' ' C' ' 222' ' ' ALA . 9.2 tmtm? . . . . . 0 N--CA 1.476 0.839 0 CA-C-N 117.245 0.522 . . . . 75.34 110.474 -175.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.812 0 CA-C-O 120.668 0.27 . . . . 52.01 110.34 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -37.92 100.97 0.02 OUTLIER 'General case' 0 C--N 1.356 0.872 0 C-N-CA 125.778 1.631 . . . . 70.52 113.442 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 5' ' ' LYS . . . . . 0.635 ' HD2' HD11 ' C' ' 10' ' ' ILE . 25.0 mmtp -74.47 101.14 4.04 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 108.943 -0.762 . . . . 63.2 108.943 167.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 6' ' ' ASP . . . . . 0.408 ' HA ' ' OH ' ' C' ' 66' ' ' TYR . 13.5 t70 -73.73 93.12 2.06 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 106.261 -1.755 . . . . 63.22 106.261 168.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 7' ' ' TYR . . . . . 0.453 ' CD1' ' HA ' ' C' ' 53' ' ' ALA . 63.5 m-85 -61.13 -29.37 69.73 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.074 -0.966 . . . . 73.43 111.744 -171.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 8' ' ' TYR . . . . . 0.496 ' HD1' HG23 ' C' ' 13' ' ' VAL . 32.1 m-85 -64.05 -46.08 85.97 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.316 -0.856 . . . . 72.53 111.171 173.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.9 -39.39 94.08 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.103 0.561 . . . . 52.31 111.231 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 10' ' ' ILE . . . . . 0.635 HD11 ' HD2' ' C' ' 5' ' ' LYS . 62.2 mt -57.67 -43.81 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 C-N-CA 123.173 0.589 . . . . 63.34 110.042 174.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 11' ' ' LEU . . . . . 0.49 ' HB3' ' HB1' ' C' ' 25' ' ' ALA . 92.0 mt -82.72 -3.05 55.91 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 115.44 -0.8 . . . . 45.45 112.834 178.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 63.03 34.53 90.22 Favored Glycine 0 C--N 1.355 1.592 0 N-CA-C 114.088 0.395 . . . . 64.33 114.088 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 13' ' ' VAL . . . . . 0.496 HG23 ' HD1' ' C' ' 8' ' ' TYR . 8.3 m -129.38 154.33 80.68 Favored Pre-proline 0 N--CA 1.486 1.362 0 C-N-CA 124.776 1.23 . . . . 64.04 109.456 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -77.24 171.18 18.23 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 122.356 2.037 . . . . 74.43 112.778 -179.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 62.6 mtt180 -80.4 29.05 0.3 Allowed 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.518 0.727 . . . . 71.52 111.682 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -117.17 -15.94 10.43 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 125.659 1.583 . . . . 71.24 108.341 175.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.07 110.21 1.52 Allowed 'General case' 0 C--N 1.354 0.77 0 CA-C-N 114.918 -1.037 . . . . 71.14 110.655 -178.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 41.3 p -74.15 174.9 8.06 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 122.936 0.494 . . . . 74.41 109.857 172.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.93 -44.31 29.82 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 124.772 1.229 . . . . 74.45 111.745 -173.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 20' ' ' GLU . . . . . 0.668 ' HA ' ' HE3' ' C' ' 23' ' ' LYS . 2.3 tm-20 -65.08 -40.43 94.62 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.241 1.016 . . . . 64.05 110.851 -175.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . 0.49 ' HG2' ' NH2' ' C' ' 24' ' ' ARG . 33.6 mt-10 -70.57 -39.39 73.93 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.733 0.813 . . . . 73.42 110.837 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 22' ' ' ILE . . . . . 0.869 HD13 ' HB3' ' C' ' 57' ' ' LEU . 97.0 mt -64.07 -38.18 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.175 1.39 . . . . 61.32 110.368 175.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 23' ' ' LYS . . . . . 0.668 ' HE3' ' HA ' ' C' ' 20' ' ' GLU . 22.1 ttpp -67.76 -35.41 78.67 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.144 1.377 . . . . 74.13 110.438 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 24' ' ' ARG . . . . . 0.49 ' NH2' ' HG2' ' C' ' 21' ' ' GLU . 39.7 mtm180 -73.88 -33.04 63.89 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 115.848 -0.615 . . . . 73.52 112.361 172.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . 0.49 ' HB1' ' HB3' ' C' ' 11' ' ' LEU . . . -63.18 -38.4 91.04 Favored 'General case' 0 C--O 1.251 1.162 0 CA-C-O 121.465 0.65 . . . . 75.32 110.045 174.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 26' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -60.74 -58.46 8.38 Favored 'General case' 0 C--O 1.208 -1.1 0 CA-C-N 113.92 -1.491 . . . . 72.31 109.342 173.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . 0.412 ' HD3' ' HA ' ' C' ' 24' ' ' ARG . 27.5 mtpp -42.92 -52.3 5.2 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 124.042 0.839 . . . . 74.1 111.574 178.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -53.95 -62.65 1.52 Allowed 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.375 -1.284 . . . . 71.15 111.423 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 93.4 mt -84.65 -6.48 59.36 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 112.499 0.555 . . . . 60.22 112.499 -171.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.58 -17.07 20.68 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.134 0.574 . . . . 75.32 110.859 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 65.3 mtm180 -94.61 -33.08 13.14 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 123.324 0.39 . . . . 73.5 110.219 167.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -69.91 -52.77 21.83 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.042 0.537 . . . . 71.12 109.766 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 33' ' ' TYR . . . . . 0.417 ' HD1' ' HB1' ' C' ' 43' ' ' ALA . 51.2 m-85 -88.37 10.38 20.11 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 119.504 -0.284 . . . . 70.15 111.013 178.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 34' ' ' HIS . . . . . . . . . . . . . 14.5 t60 -61.11 116.76 20.68 Favored Pre-proline 0 C--N 1.363 1.173 0 CA-C-O 118.325 -0.845 . . . . 72.34 109.788 -178.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -45.46 -53.43 5.5 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 123.901 3.067 . . . . 71.32 114.272 -172.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -56.14 -40.86 74.47 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.332 0.653 . . . . 60.34 112.63 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 62.1 t -80.13 -31.37 13.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 CA-C-N 115.542 -0.754 . . . . 75.33 110.442 -173.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -143.57 74.85 1.45 Allowed 'General case' 0 C--O 1.243 0.752 0 N-CA-C 108.245 -1.02 . . . . 54.22 108.245 -174.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -69.83 79.54 0.46 Allowed 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 114.919 -1.037 . . . . 62.24 109.975 178.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 16.1 m -136.17 102.17 10.03 Favored Pre-proline 0 CA--C 1.537 0.467 0 N-CA-C 107.486 -1.301 . . . . 74.14 107.486 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -32.83 -55.25 0.36 Allowed 'Trans proline' 0 C--N 1.389 2.703 0 C-N-CA 124.796 3.664 . . . . 63.44 115.256 -175.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.4 -40.57 91.43 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.299 0.64 . . . . 65.44 111.079 -178.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 43' ' ' ALA . . . . . 0.417 ' HB1' ' HD1' ' C' ' 33' ' ' TYR . . . -71.54 -24.0 61.86 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.368 0.667 . . . . 62.05 111.205 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -85.81 -28.71 24.31 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.4 -0.592 . . . . 74.04 109.4 -178.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -71.56 -40.87 69.68 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.728 0.811 . . . . 42.53 109.627 170.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 46' ' ' LYS . . . . . 0.529 ' O ' HG12 ' C' ' 50' ' ' ILE . 38.0 mmtm -67.05 -33.18 74.97 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 115.155 -0.93 . . . . 72.32 110.342 173.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -58.58 -46.96 85.84 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.608 0.763 . . . . 62.23 109.376 172.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 48' ' ' LYS . . . . . 0.639 ' HB3' ' HE1' ' C' ' 93' ' ' PHE . 55.4 mtpt -56.58 -42.61 78.95 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 123.894 0.746 . . . . 72.04 110.947 175.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -69.68 -24.58 63.62 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 122.936 0.494 . . . . 72.33 112.187 177.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 50' ' ' ILE . . . . . 0.529 HG12 ' O ' ' C' ' 46' ' ' LYS . 27.6 mm -69.71 -41.58 80.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.793 -0.818 . . . . 75.43 108.793 172.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 51' ' ' ASN . . . . . 0.492 ' HB3' ' CD1' ' C' ' 88' ' ' PHE . 58.7 m-80 -68.37 -32.75 73.05 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-N 114.79 -1.096 . . . . 74.04 111.18 177.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -65.84 -54.07 31.57 Favored 'General case' 0 C--O 1.248 0.988 0 C-N-CA 124.677 1.191 . . . . 63.42 110.317 176.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . 0.453 ' HA ' ' CD1' ' C' ' 7' ' ' TYR . . . -56.6 -51.04 70.17 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-N 113.627 -1.624 . . . . 63.1 111.297 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -64.35 -35.73 81.83 Favored 'General case' 0 C--O 1.197 -1.664 0 CA-C-N 114.874 -1.057 . . . . 75.01 110.528 177.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 55' ' ' ALA . . . . . 0.441 ' HB2' ' CD2' ' C' ' 88' ' ' PHE . . . -58.97 -44.64 91.55 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 118.378 0.535 . . . . 60.54 111.706 -178.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 86.2 t -68.06 -42.5 85.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 CA-C-O 121.367 0.603 . . . . 72.43 110.432 174.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 57' ' ' LEU . . . . . 0.869 ' HB3' HD13 ' C' ' 22' ' ' ILE . 80.7 mt -93.35 5.13 52.6 Favored 'General case' 0 CA--C 1.563 1.467 0 N-CA-C 113.483 0.92 . . . . 75.02 113.483 -171.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 30.4 t -81.42 -44.24 17.78 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.419 0.688 . . . . 62.42 110.262 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -80.06 128.78 72.47 Favored Pre-proline 0 CA--C 1.515 -0.401 0 CA-C-O 118.246 -0.883 . . . . 72.03 109.08 175.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 60' ' ' PRO . . . . . 0.568 ' O ' ' HG2' ' C' ' 64' ' ' ARG . 87.7 Cg_exo -51.41 -33.11 45.26 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.026 1.817 . . . . 33.23 110.978 162.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . 0.47 ' HB2' ' HB3' ' C' ' 144' ' ' ARG . 8.6 tp10 -61.36 -63.97 1.1 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.424 0.689 . . . . 62.13 111.365 176.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -64.81 -23.92 67.39 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 122.886 0.474 . . . . 75.23 111.336 -177.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 63' ' ' ARG . . . . . 0.497 HH21 ' HB3' ' C' ' 66' ' ' TYR . 2.6 tpm_? -63.98 -50.57 68.04 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.827 0.851 . . . . 64.42 110.115 172.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 64' ' ' ARG . . . . . 0.568 ' HG2' ' O ' ' C' ' 60' ' ' PRO . 28.5 mmm180 -69.62 -25.02 63.74 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 122.369 0.268 . . . . 74.15 110.894 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 66.6 mt -62.97 -46.52 96.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 N-CA-C 109.46 -0.57 . . . . 62.34 109.46 169.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 66' ' ' TYR . . . . . 0.497 ' HB3' HH21 ' C' ' 63' ' ' ARG . 6.5 t80 -58.78 -46.94 86.36 Favored 'General case' 0 CA--C 1.555 1.142 0 CA-C-N 115.33 -0.85 . . . . 74.22 109.809 176.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -56.23 -46.99 79.34 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.869 0.868 . . . . 73.14 111.265 177.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 27.5 p -78.03 -11.85 59.94 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.144 -0.48 . . . . 63.2 111.809 -177.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -73.82 101.63 3.79 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 107.922 -1.14 . . . . 75.22 107.922 173.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 107.77 22.23 7.42 Favored Glycine 0 C--N 1.347 1.172 0 CA-C-N 116.054 -0.521 . . . . 62.51 111.989 -172.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 92.4 m -144.33 -56.72 0.36 Allowed 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 104.233 -2.506 . . . . 72.34 104.233 175.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 21.9 m -78.74 140.35 38.3 Favored 'General case' 0 C--O 1.256 1.437 0 N-CA-C 104.619 -2.363 . . . . 73.35 104.619 156.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.5 -22.95 15.75 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.63 0.772 . . . . 73.23 111.273 -176.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.64 154.69 38.38 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 123.423 0.689 . . . . 53.23 109.594 174.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -58.82 119.98 7.57 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.194 1.93 . . . . 75.14 110.774 168.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.43 121.25 9.7 Favored 'Trans proline' 0 C--N 1.383 2.376 0 C-N-CA 122.732 2.288 . . . . 63.14 110.918 177.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -41.28 127.54 3.02 Favored 'Trans proline' 0 C--N 1.393 2.887 0 C-N-CA 124.119 3.213 . . . . 51.51 114.091 -169.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 78' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -52.22 142.36 46.21 Favored 'Trans proline' 0 C--N 1.391 2.764 0 C-N-CA 123.8 3.0 . . . . 74.44 113.633 -175.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 79' ' ' PRO . . . . . 0.411 ' HB2' ' HA2' ' C' ' 142' ' ' GLY . 70.8 Cg_exo -54.67 162.87 4.36 Favored 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 123.551 2.834 . . . . 61.04 113.67 176.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -53.97 87.38 0.03 OUTLIER 'Trans proline' 0 C--N 1.387 2.567 0 C-N-CA 123.641 2.894 . . . . 51.5 113.007 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 144.58 -49.51 0.68 Allowed Glycine 0 CA--C 1.524 0.627 0 CA-C-N 113.54 -1.664 . . . . 75.2 109.332 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 142.69 -164.1 27.13 Favored Glycine 0 C--N 1.348 1.237 0 CA-C-N 114.807 -0.697 . . . . 74.45 111.669 -177.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -92.52 111.51 23.13 Favored 'General case' 0 C--O 1.245 0.866 0 C-N-CA 123.907 0.883 . . . . 70.14 108.896 171.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -89.38 -174.4 4.36 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 109.409 -0.589 . . . . 63.13 109.409 170.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 85' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -162.56 71.27 0.3 Allowed 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 107.644 -1.243 . . . . 74.41 107.644 176.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 86' ' ' SER . . . . . 0.412 ' OG ' ' HD3' ' C' ' 143' ' ' ARG . 50.5 m -33.73 96.71 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 118.042 2.608 . . . . 45.43 118.042 -166.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 68.16 12.71 63.5 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-N 116.093 -0.503 . . . . 74.33 113.695 173.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 88' ' ' PHE . . . . . 0.492 ' CD1' ' HB3' ' C' ' 51' ' ' ASN . 16.8 m-85 -103.74 150.85 23.67 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 124.271 1.028 . . . . 74.44 108.385 -178.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -83.54 69.31 10.06 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.061 0.458 . . . . 72.23 110.995 -173.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 90' ' ' VAL . . . . . 0.435 HG23 ' CE2' ' C' ' 97' ' ' PHE . 0.8 OUTLIER -43.55 -43.35 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 125.719 1.608 . . . . 54.41 111.945 173.007 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -60.8 -30.77 70.26 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 114.787 -1.097 . . . . 74.21 111.641 -172.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -110.85 4.86 20.16 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.107 0.563 . . . . 75.53 111.289 -176.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 93' ' ' PHE . . . . . 0.639 ' HE1' ' HB3' ' C' ' 48' ' ' LYS . 10.5 m-30 -79.84 -177.14 5.79 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.841 -0.537 . . . . 72.45 112.302 -178.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 96.6 p -67.15 161.18 25.23 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.631 0.975 . . . . 45.51 113.631 -165.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -57.81 -56.08 26.53 Favored 'General case' 0 C--O 1.217 -0.641 0 CA-C-N 113.902 -1.499 . . . . 55.43 110.356 176.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -50.88 -45.27 60.03 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.868 0.867 . . . . 65.02 112.226 -176.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 97' ' ' PHE . . . . . 0.435 ' CE2' HG23 ' C' ' 90' ' ' VAL . 7.5 t80 -58.17 -53.18 61.21 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 115.23 -0.895 . . . . 64.25 110.214 174.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -77.49 4.38 11.23 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 122.707 0.403 . . . . 51.52 112.047 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -98.47 -45.54 6.08 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.534 0.733 . . . . 74.43 110.663 170.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 22.9 tp -78.65 -56.34 4.5 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.169 0.588 . . . . 73.23 110.281 -178.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 101' ' ' PHE . . . . . 0.484 ' O ' ' HG ' ' C' ' 105' ' ' LEU . 90.4 m-85 -85.26 -15.52 43.19 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.346 -0.843 . . . . 73.25 111.257 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -46.49 -54.78 8.47 Favored Glycine 0 CA--C 1.545 1.932 0 CA-C-O 118.941 -0.922 . . . . 54.11 114.951 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_exo -45.01 -24.5 1.32 Allowed 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 124.681 3.587 . . . . 62.02 116.434 175.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -128.58 14.56 6.09 Favored Glycine 0 C--N 1.355 1.633 0 CA-C-O 118.605 -1.108 . . . . 43.23 114.237 -178.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 105' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' C' ' 101' ' ' PHE . 49.3 mt . . . . . 0 N--CA 1.492 1.671 0 CA-C-N 118.247 1.024 . . . . 73.03 112.246 177.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.478 0 CA-C-O 120.153 -0.248 . . . . 45.25 113.269 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 117' ' ' ARG . . . . . 0.456 ' HG2' ' H ' ' C' ' 118' ' ' ASP . 46.3 ttt-85 -82.98 174.67 10.69 Favored 'General case' 0 C--O 1.25 1.08 0 C-N-CA 123.459 0.704 . . . . 64.44 109.523 175.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 118' ' ' ASP . . . . . 0.456 ' H ' ' HG2' ' C' ' 117' ' ' ARG . 5.0 p-10 -64.52 151.76 43.62 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 121.59 0.709 . . . . 75.42 110.985 173.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 119' ' ' LEU . . . . . . . . . . . . . 61.1 tp -108.17 164.04 12.65 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 106.828 -1.545 . . . . 75.21 106.828 172.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 74.0 ttt-85 -138.69 120.94 15.85 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 118.665 0.666 . . . . 72.31 109.654 177.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 121' ' ' ALA . . . . . 0.467 ' HB3' HD11 ' C' ' 174' ' ' LEU . . . -140.84 118.81 11.85 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.28 1.032 . . . . 63.21 108.827 -178.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -102.05 147.6 26.39 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 110.317 -0.253 . . . . 73.22 110.317 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 123' ' ' LEU . . . . . 0.426 ' HB3' ' HB2' ' B' ' 183' ' ' ALA . 1.9 pt? -134.98 144.94 52.46 Favored Pre-proline 0 N--CA 1.478 0.954 0 C-N-CA 122.998 0.519 . . . . 73.3 111.237 -173.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.4 116.39 4.1 Favored 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 123.011 2.474 . . . . 72.51 110.076 165.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 125' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' C' ' 180' ' ' LEU . 38.4 tp -133.1 149.55 52.12 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.928 0.891 . . . . 74.03 108.687 -176.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 126' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.26 157.12 16.03 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 122.635 0.374 . . . . 61.53 110.775 -176.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 127' ' ' LEU . . . . . 0.557 HD13 ' HD2' ' C' ' 186' ' ' PHE . 17.9 mt -58.31 -47.02 85.03 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.809 1.244 . . . . 62.25 110.201 173.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 128' ' ' GLU . . . . . 0.463 ' HG3' ' HA ' ' C' ' 215' ' ' LEU . 1.8 mp0 -63.0 -38.08 89.77 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 114.267 -1.333 . . . . 75.24 110.903 178.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -79.54 -17.47 53.94 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 122.749 0.42 . . . . 73.53 111.707 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -75.37 -40.76 57.72 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 109.193 -0.669 . . . . 64.34 109.193 171.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 131' ' ' PHE . . . . . 0.603 ' HB2' HD13 ' C' ' 215' ' ' LEU . 69.2 t80 -62.38 -35.77 80.2 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.61 1.564 . . . . 75.55 111.91 172.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 132' ' ' HIS . . . . . . . . . . . . . 43.7 m170 -77.07 -51.31 11.27 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 110.318 -0.253 . . . . 60.22 110.318 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 50.55 -129.29 29.37 Favored Glycine 0 C--N 1.351 1.411 0 O-C-N 124.306 1.004 . . . . 65.31 113.894 177.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.29 -147.51 33.08 Favored Glycine 0 C--N 1.348 1.233 0 C-N-CA 123.128 0.394 . . . . 53.24 113.483 174.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -92.79 110.26 21.7 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.866 0.867 . . . . 71.2 109.898 -177.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 136' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -117.52 135.51 53.89 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.184 0.994 . . . . 72.12 110.152 -174.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 137' ' ' VAL . . . . . . . . . . . . . 35.8 m -76.86 143.98 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 122.644 0.378 . . . . 71.12 111.574 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 138' ' ' VAL . . . . . 0.602 ' HA ' HG22 ' B' ' 182' ' ' VAL . 7.4 p -158.93 139.7 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.28 1.032 . . . . 72.14 108.981 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 139' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' C' ' 143' ' ' ARG . 0.0 OUTLIER -123.8 94.84 4.35 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.559 0.743 . . . . 74.31 110.621 176.112 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 140' ' ' VAL . . . . . . . . . . . . . 11.5 p -147.77 139.85 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 122.977 0.511 . . . . 63.22 111.154 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 61.36 15.58 6.68 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 125.001 1.32 . . . . 15.23 113.72 173.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 142' ' ' GLY . . . . . 0.411 ' HA2' ' HB2' ' C' ' 79' ' ' PRO . . . 114.4 -26.64 9.5 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-N 116.489 -0.323 . . . . 45.25 112.602 -178.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 143' ' ' ARG . . . . . 0.457 ' O ' ' HA ' ' C' ' 139' ' ' GLU . 7.7 mmm180 -80.34 101.16 8.79 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.182 0.593 . . . . 73.04 111.593 178.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 144' ' ' ARG . . . . . 0.47 ' HB3' ' HB2' ' C' ' 61' ' ' GLU . 75.2 ttt180 -109.87 89.79 3.12 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 107.402 -1.333 . . . . 71.51 107.402 169.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 145' ' ' VAL . . . . . 0.433 HG11 HH21 ' C' ' 143' ' ' ARG . 12.6 p -161.05 163.8 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.904 0 C-N-CA 123.369 0.668 . . . . 75.03 111.26 -166.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 20.3 m -85.99 113.26 21.94 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 123.898 0.879 . . . . 54.21 109.972 168.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 3.9 p -89.18 129.45 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.477 0.711 . . . . 72.53 110.192 175.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 42.9 ttt180 -86.59 95.07 9.63 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.152 0.581 . . . . 74.22 109.846 178.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 149' ' ' ILE . . . . . . . . . . . . . 40.7 pt -116.53 107.02 47.53 Favored Pre-proline 0 CA--C 1.546 0.827 0 N-CA-C 108.209 -1.034 . . . . 71.41 108.209 165.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -54.2 167.4 1.25 Allowed 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 123.075 2.516 . . . . 61.44 114.005 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -47.69 115.06 1.27 Allowed 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 123.062 2.508 . . . . 73.2 113.063 171.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 152' ' ' GLY . . . . . . . . . . . . . . . 150.43 88.45 0.07 OUTLIER Glycine 0 C--N 1.344 1.021 0 C-N-CA 120.441 -0.885 . . . . 54.32 114.527 -178.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 153' ' ' VAL . . . . . 0.594 HG22 HG11 ' C' ' 178' ' ' VAL . 14.0 p -165.26 151.83 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.201 0 C-N-CA 122.885 0.474 . . . . 71.13 110.001 173.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 154' ' ' ARG . . . . . 0.575 ' HD2' ' HG2' ' C' ' 187' ' ' ARG . 37.4 ttp180 -150.55 149.18 29.59 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.182 0.993 . . . . 75.32 109.819 -170.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 155' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -42.3 129.8 3.81 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 125.288 1.435 . . . . 74.51 112.849 -177.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.87 -13.72 58.42 Favored Glycine 0 C--N 1.348 1.219 0 CA-C-N 115.753 -0.658 . . . . 64.51 113.238 177.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 157' ' ' SER . . . . . 0.521 ' O ' HG12 ' C' ' 178' ' ' VAL . 43.8 t -74.8 140.43 43.97 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 108.832 -0.803 . . . . 75.43 108.832 174.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 58.6 t -119.73 105.84 18.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.629 -0.714 . . . . 64.44 109.266 -173.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 159' ' ' ILE . . . . . 0.689 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 15.3 mt -72.06 97.16 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.66 0 CA-C-N 114.805 -1.089 . . . . 52.25 108.954 -177.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 7.2 ttt180 -78.96 97.61 6.11 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 107.673 -1.232 . . . . 72.21 107.673 175.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 161' ' ' VAL . . . . . . . . . . . . . 2.2 p -101.53 103.99 31.22 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 124.457 1.103 . . . . 75.24 108.734 -178.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -55.36 123.98 15.16 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 123.407 2.738 . . . . 63.42 114.207 -173.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 163' ' ' GLY . . . . . 0.725 ' H ' ' HA ' ' C' ' 173' ' ' ASP . . . 89.79 -10.13 74.8 Favored Glycine 0 N--CA 1.441 -1.003 0 N-CA-C 117.236 1.654 . . . . 53.31 117.236 169.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 164' ' ' MET . . . . . 0.495 ' SD ' HD23 ' C' ' 174' ' ' LEU . 46.9 ttm -75.12 -13.23 60.46 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 119.954 1.877 . . . . 73.35 111.028 -177.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . -102.75 -117.12 4.27 Favored Glycine 0 C--N 1.347 1.156 0 CA-C-O 119.368 -0.685 . . . . 64.24 111.691 173.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 166' ' ' GLY . . . . . 0.475 ' HA3' ' HA ' ' C' ' 171' ' ' PRO . . . 87.44 68.86 1.31 Allowed Glycine 0 C--N 1.358 1.766 0 CA-C-N 117.781 0.791 . . . . 75.44 113.7 176.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 167' ' ' GLN . . . . . . . . . . . . . 19.9 mm-40 -80.14 100.21 8.13 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 106.97 -1.493 . . . . 64.31 106.97 173.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . 150.51 -89.23 0.14 Allowed Glycine 0 C--O 1.213 -1.167 0 CA-C-O 118.295 -1.281 . . . . 13.44 110.014 -168.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 169' ' ' ASN . . . . . 0.55 ' HB3' ' HD3' ' C' ' 170' ' ' PRO . 2.9 t-20 -176.36 -59.95 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.706 0 CA-C-O 117.165 -1.398 . . . . 62.44 112.216 164.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 170' ' ' PRO . . . . . 0.55 ' HD3' ' HB3' ' C' ' 169' ' ' ASN . 32.4 Cg_exo -61.52 98.91 0.16 Allowed 'Trans proline' 0 C--N 1.402 3.345 0 CA-C-N 122.446 1.909 . . . . 51.41 110.418 165.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 171' ' ' PRO . . . . . 0.543 ' HB2' ' HA2' ' C' ' 163' ' ' GLY . 7.5 Cg_exo -72.33 120.55 6.83 Favored 'Trans proline' 0 C--N 1.362 1.289 0 C-N-CA 122.34 2.027 . . . . 74.02 113.118 -163.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -63.78 -73.3 0.56 Allowed Glycine 0 C--N 1.347 1.164 0 O-C-N 124.029 0.831 . . . . 74.42 111.701 175.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 173' ' ' ASP . . . . . 0.725 ' HA ' ' H ' ' C' ' 163' ' ' GLY . 5.4 p-10 -170.46 175.99 4.56 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.245 0.545 . . . . 74.51 111.828 -179.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 174' ' ' LEU . . . . . 0.495 HD23 ' SD ' ' C' ' 164' ' ' MET . 11.2 tp -120.87 136.16 55.0 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 114.633 -1.167 . . . . 75.22 108.254 168.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 175' ' ' LEU . . . . . 0.404 ' N ' HD12 ' C' ' 174' ' ' LEU . 81.7 mt -98.88 88.92 4.14 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.659 1.184 . . . . 71.32 109.449 176.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 176' ' ' LEU . . . . . 0.689 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 78.8 mt -75.3 94.73 3.06 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.303 0.641 . . . . 43.02 110.012 174.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 177' ' ' VAL . . . . . . . . . . . . . 23.5 t -84.62 114.72 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 108.597 -0.89 . . . . 74.43 108.597 -178.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 178' ' ' VAL . . . . . 0.594 HG11 HG22 ' C' ' 153' ' ' VAL . 8.4 p -82.12 126.04 39.88 Favored 'Isoleucine or valine' 0 C--O 1.251 1.15 0 CA-C-O 121.941 0.877 . . . . 74.01 110.822 -176.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 179' ' ' ARG . . . . . . . . . . . . . 24.3 mmt180 -113.82 111.09 21.18 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.188 -1.412 . . . . 72.33 107.188 170.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 180' ' ' LEU . . . . . 0.413 ' HA ' ' O ' ' C' ' 125' ' ' LEU . 93.1 mt -73.29 148.52 43.5 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.86 0.362 . . . . 70.51 110.906 -177.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 181' ' ' LEU . . . . . 0.41 ' HB3' ' HD2' ' C' ' 182' ' ' PRO . 24.9 mt -62.12 166.29 6.84 Favored Pre-proline 0 CA--C 1.564 1.483 0 C-N-CA 124.405 1.082 . . . . 74.2 111.899 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 182' ' ' PRO . . . . . 0.41 ' HD2' ' HB3' ' C' ' 181' ' ' LEU . 12.1 Cg_exo -33.95 -20.84 0.02 OUTLIER 'Trans proline' 0 C--N 1.396 3.068 1 C-N-CA 125.413 4.075 . . . . 64.12 118.26 179.329 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 183' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -104.85 96.8 11.34 Favored Pre-proline 0 CA--C 1.568 1.644 0 CA-C-N 119.14 0.882 . . . . 62.13 110.147 165.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 184' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -98.14 65.91 0.09 OUTLIER 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 123.658 2.905 . . . . 71.54 110.575 171.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 185' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 36.9 t -94.02 -43.44 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 CA-C-N 115.952 -0.567 . . . . 72.23 110.611 -164.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 186' ' ' PHE . . . . . 0.557 ' HD2' HD13 ' C' ' 127' ' ' LEU . 68.1 m-85 -99.9 116.55 32.23 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-O 121.205 0.526 . . . . 61.44 111.345 -167.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 187' ' ' ARG . . . . . 0.688 ' HB3' ' HB3' ' C' ' 194' ' ' TYR . 3.2 tmt_? -96.12 107.91 20.28 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.997 1.319 . . . . 75.14 108.919 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 188' ' ' LEU . . . . . . . . . . . . . 45.8 tp -84.16 140.92 31.42 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.445 0.535 . . . . 74.14 112.445 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -144.97 106.28 4.21 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 107.069 -1.456 . . . . 71.33 107.069 162.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 74.96 -96.43 0.96 Allowed Glycine 0 C--N 1.355 1.633 0 N-CA-C 112.022 -0.431 . . . . 74.2 112.022 -177.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 191' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -115.19 -31.28 6.06 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.108 0.963 . . . . 60.21 110.154 173.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -76.97 152.66 35.15 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 116.072 -0.513 . . . . 65.13 111.551 -170.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 193' ' ' LEU . . . . . 0.47 HD21 ' CD1' ' C' ' 240' ' ' PHE . 88.1 mt -119.82 165.59 14.38 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.735 0.814 . . . . 52.2 111.257 -176.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 194' ' ' TYR . . . . . 0.688 ' HB3' ' HB3' ' C' ' 187' ' ' ARG . 27.5 t80 -139.47 107.3 5.66 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.097 -0.956 . . . . 75.43 109.585 170.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 195' ' ' ALA . . . . . 0.479 ' HA ' ' O ' ' C' ' 185' ' ' VAL . . . -104.67 -174.99 2.67 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.22 1.008 . . . . 65.11 110.907 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 65.9 m -132.11 121.09 23.24 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 108.088 -1.079 . . . . 51.32 108.088 164.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 197' ' ' LEU . . . . . . . . . . . . . 41.0 tp -97.53 125.86 42.48 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.292 0.637 . . . . 73.5 111.183 -172.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -73.84 101.85 3.88 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.005 0.922 . . . . 44.52 108.87 176.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 199' ' ' VAL . . . . . 0.572 ' HA ' HG11 ' C' ' 210' ' ' VAL . 26.9 t -121.72 109.28 34.37 Favored Pre-proline 0 N--CA 1.475 0.812 0 N-CA-C 108.62 -0.881 . . . . 61.21 108.62 178.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 200' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -68.45 147.13 70.49 Favored 'Trans proline' 0 C--N 1.37 1.702 0 C-N-CA 121.588 1.526 . . . . 71.34 111.317 175.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 201' ' ' ALA . . . . . 0.505 ' O ' HG23 ' C' ' 205' ' ' VAL . . . -52.44 -49.24 86.65 Favored Pre-proline 0 CA--C 1.553 1.07 0 CA-C-O 118.02 -0.99 . . . . 74.35 112.958 -173.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 202' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -51.12 -47.27 26.58 Favored 'Trans proline' 0 C--N 1.387 2.6 0 C-N-CA 121.649 1.566 . . . . 63.15 112.891 176.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 203' ' ' ILE . . . . . 0.518 ' HA ' HG12 ' C' ' 206' ' ' VAL . 47.0 mt -68.56 -34.18 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 123.044 0.538 . . . . 63.4 111.139 -178.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -70.24 -28.45 65.26 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.659 0.783 . . . . 75.02 112.208 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 205' ' ' VAL . . . . . 0.505 HG23 ' O ' ' C' ' 201' ' ' ALA . 55.0 t -86.39 -40.1 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 116.084 -0.507 . . . . 63.41 111.374 178.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 206' ' ' VAL . . . . . 0.609 HG23 ' HG3' ' A' ' 270' ' ' LYS . 14.0 p -80.16 -37.83 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 O-C-N 123.375 0.422 . . . . 52.12 111.355 -171.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 88.08 61.6 1.48 Allowed Glycine 0 N--CA 1.438 -1.177 0 CA-C-N 115.741 -0.663 . . . . 63.21 112.257 -168.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -101.38 -136.65 9.39 Favored Glycine 0 C--O 1.246 0.882 0 N-CA-C 111.431 -0.668 . . . . 51.32 111.431 176.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 209' ' ' LYS . . . . . 0.564 ' HG2' ' HA ' ' C' ' 222' ' ' ALA . 8.3 mtmp? -140.28 136.3 33.15 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.395 0.617 . . . . 72.12 110.92 178.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 210' ' ' VAL . . . . . 0.572 HG11 ' HA ' ' C' ' 199' ' ' VAL . 34.3 m -119.24 -179.86 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.539 1.535 . . . . 62.05 107.272 169.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 211' ' ' ARG . . . . . 0.62 ' HD3' ' HB2' ' C' ' 218' ' ' PRO . 23.1 ttm105 -132.76 130.6 40.15 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 118.976 0.807 . . . . 72.44 112.095 -178.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -97.0 115.05 26.74 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.32 1.048 . . . . 74.43 108.492 168.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 213' ' ' MET . . . . . . . . . . . . . 4.2 tmm? -71.56 101.91 2.6 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 107.418 -1.327 . . . . 63.12 107.418 171.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 214' ' ' THR . . . . . 0.408 ' OG1' HG12 ' C' ' 219' ' ' VAL . 0.2 OUTLIER -98.88 174.25 6.46 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.348 0.594 . . . . 54.24 110.234 -173.78 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 215' ' ' LEU . . . . . 0.603 HD13 ' HB2' ' C' ' 131' ' ' PHE . 30.7 mt -65.48 -33.89 77.0 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.309 1.444 . . . . 44.41 112.712 -169.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.23 10.71 23.7 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 114.94 -1.027 . . . . 71.0 111.472 -178.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 143.65 149.37 5.08 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-O 119.86 -0.411 . . . . 64.11 112.453 176.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 218' ' ' PRO . . . . . 0.62 ' HB2' ' HD3' ' C' ' 211' ' ' ARG . 73.3 Cg_endo -77.24 106.42 2.23 Favored 'Trans proline' 0 CA--C 1.557 1.634 0 C-N-CA 122.606 2.204 . . . . 52.13 113.081 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 219' ' ' VAL . . . . . 0.408 HG12 ' OG1' ' C' ' 214' ' ' THR . 7.2 p -88.32 138.26 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 123.558 0.743 . . . . 52.53 109.903 -178.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 220' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -89.01 111.21 21.88 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 108.734 -0.839 . . . . 72.32 108.734 174.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 221' ' ' VAL . . . . . . . . . . . . . 58.7 t -78.97 128.09 38.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 114.539 -1.209 . . . . 74.03 110.627 -178.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 222' ' ' ALA . . . . . 0.733 ' H ' ' HB2' ' B' ' 239' ' ' ALA . . . -85.42 105.48 16.08 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 124.424 1.09 . . . . 73.3 109.678 176.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 59.1 t -85.71 126.73 65.33 Favored Pre-proline 0 C--O 1.213 -0.858 0 N-CA-C 108.105 -1.072 . . . . 73.11 108.105 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 224' ' ' PRO . . . . . 0.725 ' HG2' ' HG3' ' B' ' 243' ' ' GLN . 10.4 Cg_exo -79.09 156.77 26.48 Favored 'Trans proline' 0 CA--C 1.555 1.546 0 C-N-CA 123.847 3.031 . . . . 54.33 112.221 166.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.43 148.17 64.02 Favored 'Trans proline' 0 C--N 1.387 2.587 0 C-N-CA 123.208 2.605 . . . . 74.0 113.635 -178.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 226' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.5 91.64 0.08 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.229 1.011 . . . . 70.15 112.215 178.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 227' ' ' THR . . . . . 0.511 HG22 HG11 ' C' ' 253' ' ' VAL . 34.0 m -140.9 124.46 16.85 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 115.37 -0.832 . . . . 70.3 111.869 176.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 228' ' ' GLN . . . . . . . . . . . . . 27.1 mp0 -98.11 161.39 13.74 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-O 122.483 1.135 . . . . 74.32 111.024 170.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 229' ' ' ALA . . . . . 0.437 ' HB2' ' H ' ' C' ' 255' ' ' ILE . . . -67.85 150.04 49.08 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-N 113.729 -1.578 . . . . 62.12 109.375 173.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 86.46 -4.17 86.38 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.304 -0.474 . . . . 62.04 113.03 -174.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 231' ' ' ARG . . . . . 0.491 ' NH1' HE22 ' B' ' 243' ' ' GLN . 45.5 mtt180 -76.65 170.34 16.61 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 117.789 0.794 . . . . 74.12 109.334 163.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 232' ' ' LYS . . . . . 0.568 ' HD3' ' HB3' ' C' ' 250' ' ' TYR . 3.9 ttmp? -146.55 139.68 25.58 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.205 0.457 . . . . 71.45 111.921 -173.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 233' ' ' LEU . . . . . 0.584 ' O ' ' HA ' ' C' ' 250' ' ' TYR . 2.4 mp -107.77 151.79 25.23 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.625 1.17 . . . . 74.21 109.89 -177.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -118.83 90.18 3.28 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.638 0.775 . . . . 72.34 109.255 171.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 235' ' ' LEU . . . . . 0.558 HD12 HD23 ' C' ' 249' ' ' LEU . 49.1 mt -74.25 108.39 7.01 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 109.13 -0.693 . . . . 73.43 109.13 172.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -71.08 125.57 27.25 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.879 0.872 . . . . 71.55 111.125 -175.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 71.44 37.14 62.66 Favored Glycine 0 C--N 1.349 1.251 0 O-C-N 123.532 0.52 . . . . 71.42 112.968 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 20.4 mmtm -126.07 14.95 7.9 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.913 0.885 . . . . 72.03 111.065 176.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -93.0 -167.48 38.91 Favored Glycine 0 C--N 1.352 1.449 0 N-CA-C 112.002 -0.439 . . . . 31.21 112.002 171.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 240' ' ' PHE . . . . . 0.47 ' CD1' HD21 ' C' ' 193' ' ' LEU . 3.6 m-85 -69.06 153.45 96.06 Favored Pre-proline 0 N--CA 1.478 0.96 0 C-N-CA 123.74 0.816 . . . . 75.14 111.529 176.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 241' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -65.91 118.86 5.85 Favored 'Trans proline' 0 C--N 1.377 2.054 0 C-N-CA 123.75 2.967 . . . . 70.21 112.411 -175.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -126.84 -169.52 12.74 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-N 115.719 -0.673 . . . . 70.14 112.548 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -72.14 -31.61 11.84 Favored 'Trans proline' 0 C--N 1.383 2.344 0 C-N-CA 123.049 2.5 . . . . 71.42 111.006 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -80.35 6.35 12.34 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.82 0.848 . . . . 71.42 111.807 176.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 111.04 -76.56 0.22 Allowed Glycine 0 C--N 1.349 1.285 0 N-CA-C 109.907 -1.277 . . . . 51.32 109.907 -178.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 246' ' ' ARG . . . . . . . . . . . . . 29.4 mtm180 -146.09 166.44 26.12 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.847 1.259 . . . . 61.31 109.468 174.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -80.57 -158.89 19.53 Favored Glycine 0 C--N 1.347 1.172 0 CA-C-N 116.345 -0.388 . . . . 63.23 112.241 172.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -123.82 135.24 53.65 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 117.085 0.443 . . . . 73.54 109.836 -177.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 249' ' ' LEU . . . . . 0.558 HD23 HD12 ' C' ' 235' ' ' LEU . 21.0 tp -88.33 116.15 26.35 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 114.97 -1.014 . . . . 74.23 110.133 -178.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 250' ' ' TYR . . . . . 0.584 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 16.0 m-85 -102.05 99.87 10.07 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 109.838 -0.431 . . . . 71.43 109.838 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 251' ' ' LEU . . . . . 0.564 ' HB2' HD13 ' C' ' 233' ' ' LEU . 1.6 mp -97.15 136.2 38.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.8 -0.563 . . . . 64.53 110.152 -174.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -88.14 118.71 27.91 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 108.047 -1.094 . . . . 73.41 108.047 174.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 253' ' ' VAL . . . . . 0.511 HG11 HG22 ' C' ' 227' ' ' THR . 94.0 t -60.14 131.14 24.66 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 123.348 0.659 . . . . 73.5 111.066 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 254' ' ' ARG . . . . . 0.47 ' CZ ' ' HB ' ' C' ' 256' ' ' THR . 2.1 tmm_? -124.02 98.32 5.74 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 107.507 -1.294 . . . . 74.13 107.507 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 255' ' ' ILE . . . . . 0.437 ' H ' ' HB2' ' C' ' 229' ' ' ALA . 52.0 mm -72.45 120.4 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 123.356 0.41 . . . . 75.24 109.903 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 256' ' ' THR . . . . . 0.47 ' HB ' ' CZ ' ' C' ' 254' ' ' ARG . 0.0 OUTLIER -125.39 164.46 20.38 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.012 0.925 . . . . 53.32 111.1 -176.131 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 2.8 pp -137.61 149.07 63.76 Favored Pre-proline 0 CA--C 1.554 1.099 0 C-N-CA 124.224 1.01 . . . . 64.54 108.328 175.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -80.11 16.52 1.49 Allowed 'Trans proline' 0 C--N 1.375 1.936 0 C-N-CA 122.599 2.2 . . . . 73.21 113.243 -171.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 57.83 -79.87 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.237 1.415 . . . . 72.3 111.635 -173.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -78.53 148.13 33.52 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.97 0.908 . . . . 73.41 109.901 -178.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 261' ' ' LEU . . . . . . . . . . . . . 82.1 mt -132.88 165.59 24.27 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 121.524 0.678 . . . . 71.21 111.329 -178.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 1.6 p -83.61 147.4 52.27 Favored Pre-proline 0 CA--C 1.552 1.035 0 CA-C-N 114.635 -1.166 . . . . 61.23 108.894 164.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -47.73 -31.63 15.1 Favored 'Trans proline' 0 C--N 1.387 2.558 0 C-N-CA 124.476 3.451 . . . . 74.2 114.988 -173.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -60.43 -65.76 0.63 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.88 0.872 . . . . 71.04 109.73 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -57.67 -42.56 83.82 Favored 'General case' 0 C--O 1.216 -0.697 0 CA-C-N 114.466 -1.243 . . . . 65.11 109.767 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 266' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -51.82 -46.12 64.19 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 123.992 0.917 . . . . 64.21 110.718 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -67.81 -43.67 79.08 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.5 0.72 . . . . 70.32 112.05 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 268' ' ' LEU . . . . . . . . . . . . . 10.6 mp -64.72 -37.35 87.29 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 120.765 0.317 . . . . 52.44 111.295 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 84.5 m95 -70.03 -32.26 70.31 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.536 0.735 . . . . 61.11 110.377 175.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 3.9 mmmp? -57.91 -50.65 72.61 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 122.852 0.461 . . . . 75.43 109.823 171.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 9.7 mmpt? -56.33 -52.53 64.2 Favored 'General case' 0 C--O 1.252 1.223 0 O-C-N 124.183 0.927 . . . . 75.33 111.191 -178.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 57.6 mt -51.99 -60.65 2.94 Favored 'General case' 0 C--N 1.355 0.845 0 CA-C-N 115.323 -0.853 . . . . 74.33 110.216 174.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -51.9 -44.77 63.94 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.927 0.891 . . . . 34.13 112.338 -173.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -62.21 -45.49 93.14 Favored 'General case' 0 C--O 1.252 1.235 0 C-N-CA 123.579 0.752 . . . . 63.21 110.818 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -58.54 -32.03 68.49 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 116.096 -0.502 . . . . 70.04 111.399 175.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 276' ' ' TYR . . . . . 0.703 ' HA ' ' HD3' ' C' ' 279' ' ' ARG . 1.4 m-85 -85.56 -23.09 27.8 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.09 0.556 . . . . 75.52 111.801 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 277' ' ' TYR . . . . . 0.465 ' CE1' ' HA3' ' A' ' 208' ' ' GLY . 20.4 m-30 -70.43 -30.74 67.67 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 109.424 -0.584 . . . . 44.24 109.424 174.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -59.72 -18.74 45.09 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-N 115.361 -0.836 . . . . 55.2 112.384 171.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 279' ' ' ARG . . . . . 0.703 ' HD3' ' HA ' ' C' ' 276' ' ' TYR . 17.5 mtp-105 -87.76 -26.91 22.65 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.784 0.834 . . . . 71.52 110.844 175.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.025 0 C-N-CA 123.243 0.617 . . . . 75.14 110.277 -172.654 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt . . . . . 0 N--CA 1.479 0.988 0 N-CA-C 114.165 1.172 . . . . 62.43 114.165 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -65.85 109.1 2.36 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 109.278 -0.638 . . . . 74.32 109.278 169.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -73.83 89.35 1.84 Allowed 'General case' 0 C--O 1.246 0.917 0 N-CA-C 107.165 -1.42 . . . . 61.41 107.165 170.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.445 ' HB2' HD11 ' A' ' 57' ' ' LEU . 67.1 m-85 -61.29 -27.94 68.83 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 113.9 -1.5 . . . . 73.34 111.565 -172.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -68.13 -41.7 81.27 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 122.962 0.505 . . . . 73.33 110.255 177.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.13 -41.77 97.07 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.045 0.538 . . . . 60.32 110.497 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 65.2 mt -58.93 -36.73 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 O-C-N 123.804 0.69 . . . . 74.23 110.29 174.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 91.2 mt -84.71 -10.49 57.21 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 113.303 0.853 . . . . 51.33 113.303 177.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 68.74 32.52 74.33 Favored Glycine 0 CA--C 1.537 1.427 0 N-CA-C 114.03 0.372 . . . . 53.33 114.03 -178.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.3 m -118.35 162.67 29.04 Favored Pre-proline 0 N--CA 1.484 1.226 0 C-N-CA 124.609 1.164 . . . . 71.43 109.554 174.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.401 ' HG2' ' HB2' ' A' ' 17' ' ' ALA . 11.9 Cg_endo -54.79 152.35 28.83 Favored 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 122.772 2.315 . . . . 50.12 112.586 175.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 76.1 mtt-85 -74.84 19.43 0.14 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 113.648 0.981 . . . . 75.43 113.648 -172.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -148.79 12.68 0.89 Allowed 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 124.605 1.162 . . . . 64.11 109.128 -177.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.401 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . . . -66.06 145.49 55.79 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.789 1.235 . . . . 64.31 113.457 -171.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.1 p -70.45 162.71 28.22 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.363 1.065 . . . . 71.11 111.658 -178.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -57.82 -30.18 65.53 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.145 0.978 . . . . 64.21 111.262 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.499 ' HA ' ' HE2' ' A' ' 23' ' ' LYS . 0.8 OUTLIER -69.07 -40.92 78.17 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.746 0.818 . . . . 72.43 109.899 178.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.507 ' HG2' ' NH2' ' A' ' 24' ' ' ARG . 42.7 mt-10 -67.98 -35.96 79.23 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.415 0.686 . . . . 64.03 110.833 176.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.81 -33.76 65.54 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 C-N-CA 124.592 1.157 . . . . 73.31 110.326 175.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.499 ' HE2' ' HA ' ' A' ' 20' ' ' GLU . 37.6 ttpt -76.19 -33.26 59.29 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.74 1.216 . . . . 71.24 110.483 179.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.507 ' NH2' ' HG2' ' A' ' 21' ' ' GLU . 50.2 mtm-85 -70.82 -40.97 72.14 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.156 0.583 . . . . 54.12 110.235 173.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.97 -33.88 75.5 Favored 'General case' 0 C--O 1.237 0.402 0 O-C-N 124.163 0.914 . . . . 64.0 110.719 176.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -60.33 -56.97 15.0 Favored 'General case' 0 C--O 1.215 -0.724 0 O-C-N 123.913 0.758 . . . . 73.1 109.9 176.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.496 ' NZ ' ' HA ' ' A' ' 24' ' ' ARG . 35.1 mtmm -60.32 -44.81 95.12 Favored 'General case' 0 N--CA 1.482 1.164 0 O-C-N 123.869 0.73 . . . . 74.22 111.132 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 46.1 ttt180 -47.25 -52.61 15.55 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 125.087 1.355 . . . . 71.15 111.945 176.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.539 HD13 HD12 ' A' ' 50' ' ' ILE . 62.7 mt -91.74 -13.94 30.78 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.559 -0.746 . . . . 74.11 111.656 -173.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -80.51 -18.51 48.3 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.259 0.624 . . . . 63.3 109.991 172.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 51.1 mtp180 -94.55 -39.11 10.56 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.04 0.936 . . . . 72.33 110.331 172.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -71.22 -40.24 71.24 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 122.537 0.335 . . . . 63.33 111.671 -177.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -106.97 24.62 12.5 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.879 0.472 . . . . 63.25 110.319 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 75.8 t60 -57.18 94.79 0.05 OUTLIER Pre-proline 0 N--CA 1.484 1.259 0 C-N-CA 124.73 1.212 . . . . 63.41 112.105 -171.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -72.02 -22.2 23.22 Favored 'Trans proline' 0 C--N 1.368 1.575 0 C-N-CA 122.652 2.235 . . . . 74.13 111.883 -164.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -53.57 -35.82 61.21 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.473 1.509 . . . . 72.45 111.615 176.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 89.4 t -115.42 -40.32 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 CA-C-O 120.905 0.383 . . . . 65.53 110.113 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -100.5 82.46 2.47 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.23 1.012 . . . . 61.35 110.045 -177.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.99 60.87 6.51 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.043 0.537 . . . . 73.11 110.189 -178.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 63.2 m -105.14 123.85 38.42 Favored Pre-proline 0 N--CA 1.481 1.096 0 CA-C-O 117.81 -1.09 . . . . 54.41 109.706 -177.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -40.88 -51.91 3.51 Favored 'Trans proline' 0 C--N 1.391 2.778 0 C-N-CA 124.767 3.645 . . . . 72.23 114.322 -175.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -51.94 -51.17 58.9 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.067 0.947 . . . . 64.43 110.849 175.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.04 -15.46 60.64 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.403 0.681 . . . . 72.14 111.81 -178.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.6 mm-40 -74.93 -60.77 2.14 Favored 'General case' 0 C--N 1.36 1.024 0 N-CA-C 108.236 -1.024 . . . . 62.01 108.236 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -56.59 -44.45 81.07 Favored 'General case' 0 C--N 1.354 0.793 0 CA-C-N 114.214 -1.357 . . . . 62.44 109.826 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.492 ' O ' HG12 ' A' ' 50' ' ' ILE . 9.6 tppt? -66.89 -43.77 82.61 Favored 'General case' 0 C--N 1.357 0.897 0 O-C-N 124.249 0.968 . . . . 74.03 111.078 -175.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -55.66 -44.39 77.21 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 123.765 0.665 . . . . 73.24 110.523 175.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.7 mtpm? -65.37 -35.64 81.58 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 115.54 -0.754 . . . . 75.14 111.578 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -67.96 -31.24 70.83 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 122.921 0.488 . . . . 71.44 110.747 173.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.539 HD12 HD13 ' A' ' 29' ' ' LEU . 12.0 mm -67.01 -37.54 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 N-CA-C 109.099 -0.704 . . . . 70.53 109.099 173.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.43 ' O ' ' HB2' ' A' ' 55' ' ' ALA . 53.2 m-80 -69.43 -31.54 69.94 Favored 'General case' 0 C--O 1.207 -1.137 0 CA-C-N 115.283 -0.871 . . . . 73.43 111.388 177.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -64.22 -53.77 43.92 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.788 0.804 . . . . 63.42 109.874 174.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.418 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . . . -56.8 -53.27 59.8 Favored 'General case' 0 C--O 1.25 1.096 0 CA-C-N 113.569 -1.651 . . . . 65.45 111.915 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -61.51 -40.35 94.3 Favored 'General case' 0 C--O 1.209 -1.054 0 CA-C-N 115.023 -0.989 . . . . 72.32 110.517 176.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.43 ' HB2' ' O ' ' A' ' 51' ' ' ASN . . . -54.8 -47.51 73.93 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.297 0.639 . . . . 53.01 112.123 -176.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 78.7 t -69.71 -45.36 77.79 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 O-C-N 123.738 0.649 . . . . 74.52 110.671 177.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.445 HD11 ' HB2' ' A' ' 7' ' ' TYR . 58.4 mt -90.84 6.47 44.24 Favored 'General case' 0 CA--C 1.563 1.455 0 N-CA-C 113.603 0.964 . . . . 62.04 113.603 -172.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 44.4 t -71.95 -51.87 19.95 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 124.409 1.084 . . . . 74.34 111.339 -178.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -102.29 140.05 20.8 Favored Pre-proline 0 C--O 1.243 0.763 0 CA-C-N 115.209 -0.905 . . . . 74.34 109.172 -176.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.402 ' O ' ' HG2' ' A' ' 64' ' ' ARG . 75.5 Cg_exo -53.25 -26.21 33.25 Favored 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 123.705 2.937 . . . . 72.41 113.142 177.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -61.69 -62.07 2.07 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 124.485 1.114 . . . . 72.3 111.054 -179.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.458 ' HA ' HD12 ' A' ' 65' ' ' ILE . 41.2 mtmt -76.04 -24.0 55.16 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 115.688 -0.687 . . . . 74.54 111.303 -176.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 42.1 tpt85 -55.76 -53.33 57.92 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 124.099 0.875 . . . . 74.11 109.005 168.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' A' ' 60' ' ' PRO . 1.8 mmp_? -64.19 -34.91 79.17 Favored 'General case' 0 C--N 1.36 1.05 0 C-N-CA 123.459 0.704 . . . . 74.25 112.172 178.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.458 HD12 ' HA ' ' A' ' 62' ' ' LYS . 94.7 mt -57.09 -44.93 83.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 CA-C-O 121.15 0.5 . . . . 64.42 110.811 174.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -63.97 -44.88 91.41 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 115.77 -0.65 . . . . 75.4 110.09 177.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -60.61 -32.58 71.71 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 123.075 0.55 . . . . 64.04 112.019 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 48.6 p -84.4 -15.33 46.67 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.576 0.35 . . . . 75.13 111.571 178.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -72.71 106.4 4.69 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 108.636 -0.876 . . . . 63.45 108.636 170.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 105.54 18.08 12.42 Favored Glycine 0 N--CA 1.472 1.091 0 N-CA-C 111.535 -0.626 . . . . 52.54 111.535 -171.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 85.0 m -137.55 -56.64 0.69 Allowed 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 103.733 -2.691 . . . . 71.23 103.733 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.7 m -82.54 141.32 32.71 Favored 'General case' 0 C--O 1.251 1.156 0 N-CA-C 104.385 -2.45 . . . . 74.23 104.385 155.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.54 -23.13 20.99 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.364 0.665 . . . . 74.04 111.736 -176.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -111.46 169.17 6.6 Favored Pre-proline 0 N--CA 1.478 0.936 0 C-N-CA 124.181 0.993 . . . . 75.1 110.029 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -52.11 135.79 52.66 Favored 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 122.253 1.969 . . . . 75.41 112.386 167.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.455 ' HG3' HG23 ' A' ' 65' ' ' ILE . 73.0 Cg_endo -70.17 173.0 11.98 Favored 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 123.127 2.551 . . . . 74.25 112.259 -178.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -62.58 119.82 7.07 Favored 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 121.759 1.639 . . . . 62.44 111.185 170.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -64.16 145.78 89.63 Favored 'Trans proline' 0 C--N 1.382 2.331 0 C-N-CA 122.848 2.366 . . . . 43.51 112.829 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -63.66 149.62 90.43 Favored 'Trans proline' 0 C--N 1.38 2.205 0 C-N-CA 122.946 2.43 . . . . 71.05 111.954 171.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -67.87 76.35 0.61 Allowed 'Trans proline' 0 C--N 1.382 2.322 0 C-N-CA 123.601 2.867 . . . . 51.35 112.711 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 159.33 -35.47 0.48 Allowed Glycine 0 N--CA 1.462 0.384 0 N-CA-C 109.288 -1.525 . . . . 62.41 109.288 -174.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 128.13 171.36 12.99 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-N 114.804 -0.698 . . . . 53.03 112.331 171.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -67.31 107.36 2.36 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 107.977 -1.119 . . . . 74.41 107.977 166.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.451 ' O ' ' HD1' ' A' ' 85' ' ' PHE . 23.6 t70 -61.86 153.22 29.54 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.802 0.841 . . . . 71.31 112.615 -175.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.451 ' HD1' ' O ' ' A' ' 84' ' ' ASP . 0.1 OUTLIER -153.52 70.77 0.86 Allowed 'General case' 0 CA--C 1.553 1.059 0 N-CA-C 107.761 -1.2 . . . . 70.22 107.761 170.428 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.593 ' HA ' ' HA3' ' A' ' 163' ' ' GLY . 41.5 m -57.9 86.76 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 125.006 1.322 . . . . 74.44 114.367 -174.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.572 ' HA2' ' HB3' ' A' ' 171' ' ' PRO . . . 98.16 12.22 46.48 Favored Glycine 0 N--CA 1.47 0.936 0 CA-C-N 116.368 -0.378 . . . . 70.11 113.721 176.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.409 ' CD1' ' HB3' ' A' ' 51' ' ' ASN . 30.2 m-85 -123.58 110.32 14.88 Favored 'General case' 0 C--O 1.245 0.846 0 C-N-CA 122.831 0.453 . . . . 72.34 110.16 -170.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -70.23 94.8 0.94 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 122.803 0.441 . . . . 71.44 110.066 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.561 HG13 ' HG2' ' A' ' 91' ' ' GLU . 2.3 p -27.41 -50.39 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 126.203 1.801 . . . . 75.21 114.961 166.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.561 ' HG2' HG13 ' A' ' 90' ' ' VAL . 9.7 mm-40 -67.86 -12.89 61.56 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.994 0.918 . . . . 75.33 112.854 -168.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -80.97 -39.17 26.45 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.127 0.971 . . . . 45.35 111.438 175.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.421 ' CD2' ' HE2' ' A' ' 85' ' ' PHE . 22.3 m-85 -83.28 179.73 7.62 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 115.429 -0.805 . . . . 71.01 112.357 -166.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 80.1 p -59.14 142.42 51.6 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.446 1.098 . . . . 74.5 112.598 -170.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.4 -28.53 69.85 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.024 -0.989 . . . . 74.31 111.343 174.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -52.32 -55.27 22.58 Favored 'General case' 0 C--N 1.367 1.333 0 C-N-CA 123.026 0.53 . . . . 75.03 110.607 169.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -56.77 -43.53 80.92 Favored 'General case' 0 CA--C 1.548 0.887 0 O-C-N 124.065 0.853 . . . . 63.23 109.586 178.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.578 ' HA ' HD11 ' A' ' 105' ' ' LEU . 92.7 mt-30 -70.87 -12.33 61.48 Favored 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 115.458 -0.792 . . . . 73.05 112.307 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -88.07 -57.71 2.83 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.83 0.852 . . . . 70.02 111.766 171.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 51.0 tp -64.39 -42.51 96.08 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.69 0.796 . . . . 55.03 111.506 -174.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -94.62 -4.75 47.19 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-N 115.811 -0.632 . . . . 72.11 110.331 178.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -43.48 -59.24 3.69 Favored Glycine 0 C--N 1.356 1.663 0 CA-C-O 118.49 -1.172 . . . . 72.43 114.882 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -43.42 -24.15 0.58 Allowed 'Trans proline' 0 C--N 1.392 2.834 0 C-N-CA 124.717 3.612 . . . . 23.1 116.143 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -150.79 36.8 0.9 Allowed Glycine 0 C--N 1.352 1.457 0 CA-C-O 119.241 -0.755 . . . . 44.4 113.016 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.578 HD11 ' HA ' ' A' ' 98' ' ' GLN . 18.1 mt -54.33 84.62 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.147 0.579 . . . . 74.25 111.997 173.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.414 ' CD2' ' HA ' ' A' ' 84' ' ' ASP . 0.4 OUTLIER 19.19 -110.18 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 127.938 2.495 . . . . 72.25 113.831 176.192 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 58.46 16.86 30.43 Favored Glycine 0 C--N 1.361 1.931 0 CA-C-O 119.771 -0.461 . . . . 44.0 113.869 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.356 1.664 0 N-CA-C 111.396 -0.682 . . . . 71.34 111.396 -167.702 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.543 0.697 0 N-CA-C 112.188 0.44 . . . . 72.15 112.188 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -77.86 -163.57 21.41 Favored Glycine 0 CA--C 1.543 1.803 0 CA-C-N 115.476 -0.784 . . . . 55.22 114.6 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.455 ' H ' ' HA3' ' A' ' 166' ' ' GLY . 0.9 OUTLIER -112.74 130.33 56.1 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 124.587 1.155 . . . . 71.34 111.751 178.69 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -52.23 120.56 5.61 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.622 0.725 . . . . 74.23 111.487 176.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 67.2 tp -129.1 157.33 42.06 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 115.138 -0.937 . . . . 70.23 110.287 -171.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 34.3 ttp180 -111.18 146.67 36.47 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 108.793 -0.817 . . . . 74.51 108.793 171.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.556 ' HB2' HD11 ' A' ' 174' ' ' LEU . . . -128.35 158.19 38.91 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.604 0.716 . . . . 41.51 110.762 177.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.407 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 0.4 OUTLIER -112.76 108.1 16.99 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 105.262 -2.125 . . . . 61.0 105.262 -179.443 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.557 ' HB3' ' HA ' ' A' ' 178' ' ' VAL . 41.9 tp -98.44 97.44 4.68 Favored Pre-proline 0 N--CA 1.476 0.841 0 N-CA-C 108.042 -1.096 . . . . 54.05 108.042 -175.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.584 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 98.5 Cg_endo -79.22 107.62 2.23 Favored 'Trans proline' 0 C--N 1.381 2.237 0 C-N-CA 121.005 1.137 . . . . 75.33 109.309 -177.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.517 ' HB3' HD23 ' A' ' 180' ' ' LEU . 54.2 tp -109.63 132.05 54.5 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 122.362 0.265 . . . . 64.01 110.637 -166.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 97.4 m -62.59 124.87 22.11 Favored 'General case' 0 CA--C 1.551 0.986 0 O-C-N 124.496 1.122 . . . . 71.34 109.165 176.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.412 ' HB3' HD22 ' A' ' 215' ' ' LEU . 73.7 mt -52.77 -43.39 65.8 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 124.266 1.027 . . . . 70.54 112.195 -170.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -60.12 -35.84 76.14 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 114.36 -1.291 . . . . 75.32 110.241 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -83.01 -20.54 34.86 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.998 0.919 . . . . 64.33 111.314 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -66.64 -35.58 80.52 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 109.86 -0.422 . . . . 41.43 109.86 168.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -74.51 -48.05 29.46 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 115.298 -0.864 . . . . 74.51 111.831 173.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 33.3 m170 -74.03 -40.17 63.05 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 123.221 0.608 . . . . 75.25 111.886 -171.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 74.11 -151.33 43.73 Favored Glycine 0 CA--C 1.531 1.084 0 O-C-N 123.618 0.574 . . . . 71.54 113.092 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 86.34 -167.63 39.51 Favored Glycine 0 N--CA 1.473 1.166 0 C-N-CA 123.117 0.389 . . . . 70.42 112.435 -178.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.424 ' HB3' ' OG ' ' A' ' 146' ' ' SER . 2.6 mp0 -76.65 118.84 19.7 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.908 0.483 . . . . 73.14 110.289 175.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -94.47 119.88 33.85 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.658 0.783 . . . . 74.4 110.083 177.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 77.2 t -75.83 111.56 12.42 Favored 'Isoleucine or valine' 0 C--O 1.244 0.788 0 N-CA-C 108.704 -0.85 . . . . 71.24 108.704 168.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.557 HG13 HG13 ' A' ' 145' ' ' VAL . 3.5 p -135.69 138.09 48.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 124.452 1.101 . . . . 73.14 108.444 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -124.27 141.98 51.63 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.185 0.594 . . . . 71.3 110.974 -170.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.55 HG11 HD23 ' B' ' 8' ' ' LEU . 12.3 p -169.11 137.07 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 124.571 1.149 . . . . 75.1 109.07 176.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 55.49 33.21 20.55 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.129 0.972 . . . . 74.24 112.394 174.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 87.25 -23.6 11.32 Favored Glycine 0 C--N 1.352 1.443 0 CA-C-N 116.092 -0.504 . . . . 31.1 113.255 -178.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.548 ' NH1' ' HG2' ' A' ' 164' ' ' MET . 11.5 tpt180 -74.41 100.09 3.71 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.211 1.005 . . . . 72.12 110.543 179.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 19.7 ttp180 -84.47 92.53 8.1 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 107.912 -1.144 . . . . 74.41 107.912 165.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.557 HG13 HG13 ' A' ' 138' ' ' VAL . 3.7 p -98.53 143.02 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 115.041 -0.981 . . . . 73.53 110.796 -175.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.424 ' OG ' ' HB3' ' A' ' 135' ' ' GLU . 17.3 t -105.53 84.96 2.16 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 108.46 -0.941 . . . . 31.45 108.46 177.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 34.8 m -83.17 115.4 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 CA-C-O 121.244 0.545 . . . . 73.42 110.192 -177.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 48.5 ttt180 -74.18 103.36 4.58 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 109.426 -0.583 . . . . 74.14 109.426 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.447 ' HB ' HG11 ' A' ' 153' ' ' VAL . 36.3 pt -94.05 139.22 22.51 Favored Pre-proline 0 CA--C 1.557 1.243 0 C-N-CA 123.818 0.847 . . . . 74.13 109.508 176.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -73.26 140.7 31.09 Favored 'Trans proline' 0 C--N 1.372 1.784 0 C-N-CA 122.345 2.03 . . . . 60.34 111.846 176.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -57.85 93.18 0.06 OUTLIER 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 122.653 2.235 . . . . 74.15 111.494 167.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.605 ' HA2' ' HD2' ' A' ' 240' ' ' PHE . . . 124.62 31.48 0.89 Allowed Glycine 0 C--N 1.341 0.847 0 CA-C-N 115.558 -0.746 . . . . 75.51 112.474 -176.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.447 HG11 ' HB ' ' A' ' 149' ' ' ILE . 3.4 p -86.36 137.23 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 123.391 0.676 . . . . 75.43 110.323 -178.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.849 ' HD2' ' HA ' ' A' ' 191' ' ' GLN . 2.7 mtm-85 -127.46 151.29 49.03 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.815 0.846 . . . . 73.23 110.908 -163.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -53.24 116.9 2.65 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 124.694 1.246 . . . . 72.32 110.477 178.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 107.16 2.26 35.89 Favored Glycine 0 C--N 1.345 1.081 0 CA-C-N 115.76 -0.654 . . . . 14.21 113.54 -175.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 28.1 t -78.03 104.32 8.53 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 108.091 -1.078 . . . . 74.23 108.091 172.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.442 HG22 HG22 ' A' ' 177' ' ' VAL . 41.8 t -87.06 91.89 3.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 C-N-CA 124.74 1.216 . . . . 72.34 109.585 -178.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.551 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 58.9 mt -76.02 97.04 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 N-CA-C 108.576 -0.898 . . . . 75.24 108.576 173.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 74.0 ttt-85 -75.28 103.91 5.63 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.563 -0.532 . . . . 61.32 109.563 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.483 HG11 ' SD ' ' A' ' 164' ' ' MET . 7.5 p -116.46 123.15 30.95 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 123.505 0.722 . . . . 61.33 109.431 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -65.28 148.68 88.74 Favored 'Trans proline' 0 C--N 1.364 1.359 0 C-N-CA 122.707 2.271 . . . . 74.53 113.113 174.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.593 ' HA3' ' HA ' ' A' ' 86' ' ' SER . . . 83.5 -25.74 4.92 Favored Glycine 0 N--CA 1.479 1.516 0 N-CA-C 116.482 1.353 . . . . 70.43 116.482 166.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.548 ' HG2' ' NH1' ' A' ' 143' ' ' ARG . 66.7 mtp -75.11 -21.68 58.73 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 117.502 0.651 . . . . 64.15 111.691 -179.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.531 ' HA2' HD13 ' A' ' 174' ' ' LEU . . . -80.2 -106.62 0.28 Allowed Glycine 0 C--N 1.348 1.236 0 CA-C-O 119.346 -0.697 . . . . 73.33 113.107 -175.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.455 ' HA3' ' H ' ' A' ' 117' ' ' ARG . . . -53.13 109.02 0.86 Allowed Glycine 0 C--O 1.275 2.658 0 O-C-N 123.85 0.382 . . . . 74.5 112.849 168.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -54.29 104.07 0.1 Allowed 'General case' 0 C--N 1.351 0.673 0 O-C-N 127.854 2.737 . . . . 75.42 108.676 177.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -173.26 143.98 7.51 Favored Glycine 0 N--CA 1.44 -1.066 0 N-CA-C 108.556 -1.818 . . . . 64.21 108.556 -171.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . 0.54 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . 0.2 OUTLIER -73.16 -49.58 7.04 Favored Pre-proline 0 CA--C 1.558 1.27 0 N-CA-C 109.396 -0.594 . . . . 63.11 109.396 -171.688 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.54 ' HD3' ' HB3' ' A' ' 169' ' ' ASN . 18.8 Cg_exo -71.76 149.76 54.92 Favored 'Trans proline' 0 C--N 1.375 1.965 0 N-CA-C 108.19 -1.504 . . . . 71.13 108.19 156.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.572 ' HB3' ' HA2' ' A' ' 87' ' ' GLY . 74.1 Cg_endo -69.61 124.12 10.82 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 122.716 2.278 . . . . 71.25 116.247 -162.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -62.26 -46.73 93.33 Favored Glycine 0 C--N 1.374 2.641 0 C-N-CA 119.41 -1.376 . . . . 72.4 111.117 161.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 101.8 147.71 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 128.49 2.716 . . . . 71.14 108.438 177.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.556 HD11 ' HB2' ' A' ' 121' ' ' ALA . 28.3 tp -137.14 138.51 40.35 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.115 0.483 . . . . 64.32 110.768 -175.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 48.0 mt -105.34 89.8 3.23 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 114.731 -1.122 . . . . 72.12 108.166 171.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.551 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 64.6 mt -68.39 88.27 0.32 Allowed 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 109.684 -0.487 . . . . 70.05 109.684 175.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.442 HG22 HG22 ' A' ' 158' ' ' VAL . 18.2 t -85.36 104.01 12.89 Favored 'Isoleucine or valine' 0 C--O 1.25 1.1 0 N-CA-C 106.384 -1.71 . . . . 61.43 106.384 174.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.557 ' HA ' ' HB3' ' A' ' 123' ' ' LEU . 8.2 p -67.49 119.55 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 CA-C-N 115.216 -0.902 . . . . 70.33 109.688 -175.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.584 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 36.7 mmt180 -103.07 109.08 20.51 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-N 114.18 -1.373 . . . . 53.32 107.868 176.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.517 HD23 ' HB3' ' A' ' 125' ' ' LEU . 59.6 mt -74.79 143.05 44.17 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.683 -0.636 . . . . 72.4 109.496 177.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 86.2 mt -52.86 154.72 4.72 Favored Pre-proline 0 N--CA 1.486 1.325 0 C-N-CA 123.94 0.896 . . . . 73.14 112.82 -168.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.25 21.43 0.39 Allowed 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 122.695 2.263 . . . . 71.42 112.783 171.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 184' ' ' PRO . 36.7 t-80 -61.64 106.7 0.87 Allowed Pre-proline 0 CA--C 1.557 1.215 0 C-N-CA 125.817 1.647 . . . . 73.35 108.114 168.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 183' ' ' HIS . 8.0 Cg_exo -73.95 25.04 0.34 Allowed 'Trans proline' 0 C--N 1.373 1.86 0 C-N-CA 124.137 3.225 . . . . 61.24 116.428 -162.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 69.1 t -97.25 -39.08 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 118.569 0.622 . . . . 64.21 109.672 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . 0.683 ' HE1' ' HA ' ' A' ' 214' ' ' THR . 35.4 m-85 -146.29 111.59 5.44 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.114 0.483 . . . . 72.31 112.069 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.677 ' HB3' ' HB2' ' A' ' 194' ' ' TYR . 59.4 ttt180 -91.93 82.39 5.14 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 106.889 -1.523 . . . . 75.51 106.889 162.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.499 ' HB2' HD23 ' A' ' 193' ' ' LEU . 40.8 tp -79.5 95.39 5.8 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.438 -0.801 . . . . 74.21 108.872 177.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -118.74 131.12 56.12 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.609 0.764 . . . . 70.31 109.951 -174.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 77.62 -77.51 1.59 Allowed Glycine 0 C--N 1.353 1.48 0 N-CA-C 111.497 -0.641 . . . . 65.41 111.497 -178.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.849 ' HA ' ' HD2' ' A' ' 154' ' ' ARG . 13.2 pt20 -153.34 -6.03 0.18 Allowed 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.041 0.936 . . . . 72.32 111.061 173.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -122.18 150.43 42.25 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.459 0.704 . . . . 72.32 110.975 -167.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.499 HD23 ' HB2' ' A' ' 188' ' ' LEU . 38.5 mt -92.17 152.31 19.95 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.935 1.294 . . . . 63.44 111.089 -170.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.677 ' HB2' ' HB3' ' A' ' 187' ' ' ARG . 89.0 m-85 -131.34 103.09 6.25 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 107.964 -1.124 . . . . 73.14 107.964 169.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.483 ' HB3' HD23 ' A' ' 251' ' ' LEU . . . -122.93 115.95 22.78 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.464 1.106 . . . . 74.34 110.648 -173.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . 0.458 ' HA ' ' HB2' ' A' ' 252' ' ' GLU . 93.6 m -71.43 111.63 6.9 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 121.082 0.468 . . . . 70.21 110.686 -177.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.493 HD22 HD13 ' A' ' 251' ' ' LEU . 37.5 tp -99.04 119.85 38.49 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.772 0.829 . . . . 72.21 110.809 -173.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -82.38 115.86 21.6 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 108.363 -0.977 . . . . 61.43 108.363 172.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.1 p -143.62 126.35 8.75 Favored Pre-proline 0 N--CA 1.479 1.022 0 C-N-CA 123.375 0.67 . . . . 64.4 110.138 -175.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 256' ' ' THR . 54.1 Cg_endo -72.11 152.1 56.18 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 121.942 1.762 . . . . 64.51 112.095 176.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -44.22 -59.31 3.89 Favored Pre-proline 0 N--CA 1.484 1.268 0 N-CA-C 116.267 1.951 . . . . 71.34 116.267 -172.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -74.07 -19.82 19.88 Favored 'Trans proline' 0 C--N 1.384 2.411 0 CA-C-N 121.84 1.693 . . . . 63.54 112.76 -174.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 17.7 mt -75.11 -30.27 22.97 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 N-CA-C 109.521 -0.548 . . . . 64.32 109.521 172.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -72.22 -43.03 65.04 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-O 121.129 0.49 . . . . 71.51 111.23 173.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 54.5 t -71.94 -41.77 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 123.803 0.841 . . . . 63.23 112.375 -174.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 97.2 t -93.06 -32.61 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 122.546 0.338 . . . . 74.41 110.747 -178.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 89.83 77.19 1.32 Allowed Glycine 0 C--N 1.343 0.923 0 CA-C-N 116.312 -0.404 . . . . 72.35 112.137 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -96.03 -136.55 8.84 Favored Glycine 0 C--N 1.342 0.867 0 N-CA-C 112.056 -0.418 . . . . 55.24 112.056 178.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 46.0 mtmt -130.47 144.27 51.29 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.12 0.568 . . . . 45.21 110.013 178.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 16.8 m -136.32 176.71 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.533 1.133 . . . . 63.11 109.526 174.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 20.5 ttm180 -109.75 112.2 24.12 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.578 0.751 . . . . 71.41 109.529 175.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -104.6 126.62 51.86 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.721 -0.844 . . . . 62.04 108.721 176.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . 0.638 ' HA ' ' HA ' ' A' ' 218' ' ' PRO . 3.5 mpp? -74.52 138.92 43.45 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.916 0.486 . . . . 71.23 110.245 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . 0.683 ' HA ' ' HE1' ' A' ' 186' ' ' PHE . 69.0 p -117.95 179.29 4.13 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 122.999 0.52 . . . . 74.1 110.34 171.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.412 HD22 ' HB3' ' A' ' 127' ' ' LEU . 55.5 mt -67.33 -20.13 65.55 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 115.231 -0.895 . . . . 63.31 111.592 -178.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -109.24 19.71 19.12 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.619 0.767 . . . . 64.44 111.404 179.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 110.47 174.29 20.41 Favored Glycine 0 N--CA 1.474 1.224 0 CA-C-O 119.426 -0.652 . . . . 33.0 113.23 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . 0.638 ' HA ' ' HA ' ' A' ' 213' ' ' MET . 83.9 Cg_endo -76.43 145.98 27.26 Favored 'Trans proline' 0 C--N 1.368 1.581 0 C-N-CA 122.744 2.296 . . . . 70.23 112.622 -175.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 24.3 m -139.89 163.9 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 C-N-CA 123.777 0.831 . . . . 73.4 111.371 -176.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -91.28 117.54 29.73 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.154 0.982 . . . . 75.04 110.157 -178.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 57.9 t -128.81 126.59 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 124.269 1.027 . . . . 74.13 109.037 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -88.04 131.5 34.63 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.495 0.318 . . . . 60.25 111.372 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 38.4 t -73.5 146.81 86.65 Favored Pre-proline 0 CA--C 1.57 1.744 0 C-N-CA 125.749 1.62 . . . . 63.14 110.602 -178.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -78.91 171.69 16.12 Favored 'Trans proline' 0 C--N 1.388 2.613 0 C-N-CA 122.924 2.416 . . . . 75.51 111.308 169.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -81.06 150.48 17.94 Favored 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 121.92 1.746 . . . . 72.53 113.133 176.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 84.8 mtt-85 63.22 31.16 15.72 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 126.007 1.723 . . . . 74.04 111.527 174.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.595 HG23 HD21 ' A' ' 233' ' ' LEU . 50.2 m -63.26 105.75 0.78 Allowed 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 113.796 -1.547 . . . . 64.32 111.081 177.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -90.18 140.03 30.06 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.291 1.036 . . . . 75.32 110.197 -176.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -66.04 160.19 24.31 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.838 0.855 . . . . 62.31 111.461 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 81.02 -41.38 2.6 Favored Glycine 0 C--N 1.347 1.162 0 CA-C-N 116.382 -0.372 . . . . 73.32 112.405 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -67.19 156.19 36.88 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 124.339 1.056 . . . . 74.0 110.907 177.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.766 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 3.5 mptp? -106.93 124.59 49.84 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-N 114.686 -1.143 . . . . 72.22 108.492 176.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.595 HD21 HG23 ' A' ' 227' ' ' THR . 86.0 mt -74.72 106.43 6.27 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.417 -0.957 . . . . 71.4 108.417 176.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 20.6 ttp180 -87.93 110.92 20.93 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.043 0.537 . . . . 64.14 110.687 178.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.483 ' HG ' ' HB3' ' A' ' 249' ' ' LEU . 0.3 OUTLIER -120.26 117.94 29.15 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.101 0.96 . . . . 61.12 109.982 176.154 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 36.0 mmtm -59.68 151.16 25.62 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 125.155 1.382 . . . . 64.43 112.752 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 71.39 34.88 63.54 Favored Glycine 0 C--N 1.354 1.583 0 CA-C-N 114.985 -1.007 . . . . 74.2 113.757 171.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.443 ' HG3' HD12 ' A' ' 235' ' ' LEU . 41.2 mmtm -130.08 -38.87 1.4 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.16 0.584 . . . . 73.01 110.895 -176.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -71.38 168.9 50.43 Favored Glycine 0 C--N 1.35 1.318 0 CA-C-N 116.219 -0.446 . . . . 74.43 112.17 175.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . 0.605 ' HD2' ' HA2' ' A' ' 152' ' ' GLY . 4.4 m-85 -87.44 158.15 52.07 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 123.533 0.733 . . . . 73.13 111.067 -165.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -62.6 109.3 0.85 Allowed 'Trans proline' 0 C--N 1.385 2.452 0 C-N-CA 123.051 2.5 . . . . 73.33 111.994 177.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.435 ' HA3' ' HB3' ' A' ' 191' ' ' GLN . . . -122.38 -149.63 7.99 Favored Glycine 0 C--N 1.338 0.644 0 CA-C-O 119.174 -0.792 . . . . 73.52 112.696 -179.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . 0.455 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 26.1 Cg_endo -60.14 -45.71 22.17 Favored 'Trans proline' 0 C--N 1.375 1.932 0 C-N-CA 123.179 2.586 . . . . 70.45 112.845 -176.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -88.43 -19.51 26.45 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.256 0.622 . . . . 70.11 111.073 177.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 126.72 -158.46 20.76 Favored Glycine 0 C--N 1.347 1.166 0 N-CA-C 111.192 -0.763 . . . . 62.24 111.192 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 61.5 mtt180 -57.68 108.41 0.56 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.336 0.654 . . . . 75.41 110.612 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -72.21 -161.82 5.62 Favored Glycine 0 C--O 1.248 1.03 0 CA-C-O 121.977 0.765 . . . . 42.24 113.708 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -102.3 168.31 9.42 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.411 0.684 . . . . 75.44 110.549 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.483 ' HB3' ' HG ' ' A' ' 235' ' ' LEU . 16.0 tp -101.54 128.61 47.71 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 106.794 -1.558 . . . . 70.31 106.794 164.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.766 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 7.0 m-85 -108.93 104.83 14.14 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 107.763 -1.199 . . . . 52.51 107.763 174.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.551 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 46.3 mt -90.08 103.94 16.56 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 109.098 -0.705 . . . . 72.24 109.098 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . 0.504 ' HG2' ' HG3' ' A' ' 232' ' ' LYS . 23.2 mt-10 -75.91 100.09 4.72 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.229 1.012 . . . . 75.41 108.866 -171.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 38.4 t -64.97 120.43 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 CA-C-N 114.564 -1.198 . . . . 24.43 112.241 -168.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.8 mmt180 -118.33 94.72 4.59 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.489 1.115 . . . . 73.14 108.065 169.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.439 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 73.5 mt -70.76 115.67 10.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 114.706 -1.133 . . . . 74.34 109.234 176.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 200' ' ' PRO . 40.0 p -111.41 173.12 6.5 Favored 'General case' 0 C--O 1.255 1.346 0 C-N-CA 124.248 1.019 . . . . 73.43 109.994 178.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 23.0 pt -134.25 151.72 76.89 Favored Pre-proline 0 CA--C 1.556 1.195 0 CA-C-N 114.918 -1.037 . . . . 73.4 108.523 176.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' PRO . . . . . 0.427 ' O ' ' HD2' ' A' ' 260' ' ' ARG . 11.1 Cg_endo -87.56 20.12 1.25 Allowed 'Trans proline' 0 C--N 1.37 1.667 0 C-N-CA 122.699 2.266 . . . . 74.45 113.426 -166.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . 0.419 ' HA ' ' HG3' ' C' ' 226' ' ' ARG . 3.4 mp0 40.52 -89.27 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.806 1.242 . . . . 63.24 112.18 -162.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' ARG . . . . . 0.427 ' HD2' ' O ' ' A' ' 258' ' ' PRO . 0.4 OUTLIER -69.62 138.77 53.37 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.072 0.949 . . . . 75.12 111.425 -168.012 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.538 HD11 HG11 ' C' ' 205' ' ' VAL . 98.2 mt -129.28 173.14 10.78 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.016 0.926 . . . . 55.32 110.108 -178.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 40.7 p -114.16 156.7 43.83 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 124.252 1.021 . . . . 44.34 109.644 171.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -33.07 -45.22 0.27 Allowed 'Trans proline' 0 C--N 1.396 3.034 1 C-N-CA 125.351 4.034 . . . . 74.33 116.505 -176.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -59.31 -61.27 2.75 Favored 'General case' 0 C--O 1.249 1.045 0 C-N-CA 123.926 0.89 . . . . 71.44 110.778 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -57.71 -47.57 82.02 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-N 114.901 -1.045 . . . . 64.2 110.581 -178.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' GLU . . . . . 0.534 ' O ' ' HG2' ' A' ' 270' ' ' LYS . 7.2 tp10 -55.05 -50.68 68.52 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 124.543 1.152 . . . . 73.45 110.866 -176.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -62.45 -46.68 87.4 Favored 'General case' 0 C--O 1.254 1.34 0 O-C-N 124.229 0.956 . . . . 64.12 112.151 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 10.0 mp -63.22 -34.81 78.46 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 116.053 -0.522 . . . . 73.14 111.472 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' TRP . . . . . 0.451 ' O ' HG11 ' C' ' 206' ' ' VAL . 68.6 m95 -74.59 -29.74 61.44 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 118.709 -0.662 . . . . 75.0 111.345 177.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . 0.534 ' HG2' ' O ' ' A' ' 266' ' ' GLU . 0.0 OUTLIER -58.53 -61.05 2.88 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.442 -0.947 . . . . 62.43 108.442 174.478 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? -54.61 -48.97 71.56 Favored 'General case' 0 C--N 1.364 1.203 0 CA-C-N 112.636 -2.075 . . . . 70.22 110.562 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' LEU . . . . . 0.436 HD12 HD12 ' C' ' 272' ' ' LEU . 1.8 tt -58.01 -66.03 0.54 Allowed 'General case' 0 C--O 1.186 -2.268 0 O-C-N 124.244 0.965 . . . . 63.4 108.846 -179.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . 0.468 ' HA ' ' HB2' ' C' ' 202' ' ' PRO . . . -50.24 -50.67 49.17 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 114.849 1.426 . . . . 64.51 114.849 -170.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -88.66 -24.52 22.75 Favored 'General case' 0 C--O 1.255 1.379 0 N-CA-C 112.727 0.64 . . . . 74.35 112.727 -170.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -77.7 -36.21 51.34 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 121.846 -0.534 . . . . 71.44 110.631 170.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . 0.406 ' HB3' ' O ' ' A' ' 273' ' ' ALA . 2.7 t80 -47.2 -57.47 5.12 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 126.567 1.947 . . . . 75.02 109.66 167.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -44.81 -66.1 0.44 Allowed 'General case' 0 C--O 1.248 1.019 0 O-C-N 125.515 1.759 . . . . 70.12 109.426 174.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -65.14 -9.54 23.78 Favored 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 114.598 -1.183 . . . . 75.41 114.087 -176.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . 0.479 ' NH2' ' HG2' ' C' ' 264' ' ' GLU . 77.7 mtm180 -132.92 31.95 3.84 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.308 0.643 . . . . 74.13 110.08 -176.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.566 1.587 0 C-N-CA 124.07 0.948 . . . . 72.21 113.177 177.332 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.48 1.04 0 N-CA-C 109.814 -0.439 . . . . 71.44 109.814 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -72.5 101.04 2.86 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.548 0.739 . . . . 54.1 109.791 174.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -164.39 -40.98 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.312 1.045 . . . . 74.04 109.434 175.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 16.6 t 68.64 -173.45 0.19 Allowed 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.331 1.052 . . . . 52.14 111.225 176.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 17.9 m 70.46 135.62 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.992 1.317 . . . . 70.11 112.346 -178.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 38.7 pt -143.27 176.79 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.392 1.077 . . . . 64.44 109.629 -176.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -137.38 132.64 33.8 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.329 0.652 . . . . 72.01 110.307 177.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . 0.55 HD23 HG11 ' A' ' 140' ' ' VAL . 39.0 tp -81.07 157.02 25.54 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.319 1.048 . . . . 75.22 111.086 -171.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.62 -72.34 0.42 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 122.856 0.462 . . . . 62.4 111.287 176.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . 0.455 HD23 ' HB2' ' A' ' 121' ' ' ALA . 33.6 mt 72.35 -7.54 1.35 Allowed 'General case' 0 N--CA 1.503 2.193 0 C-N-CA 125.588 1.555 . . . . 74.1 112.46 -165.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 28.6 mt . . . . . 0 CA--C 1.563 1.473 0 C-N-CA 124.727 1.211 . . . . 45.35 112.257 -176.333 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.622 0 N-CA-C 107.436 -1.32 . . . . 61.34 107.436 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 180' ' ' ALA . . . . . 0.498 ' HB1' HG13 ' C' ' 137' ' ' VAL . . . -135.1 -63.14 0.7 Allowed 'General case' 0 C--O 1.238 0.473 0 N-CA-C 104.791 -2.299 . . . . 74.4 104.791 166.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 181' ' ' LEU . . . . . 0.532 HD22 ' HB2' ' C' ' 136' ' ' ARG . 21.8 tp -152.85 -6.72 0.19 Allowed 'General case' 0 CA--C 1.567 1.611 0 CA-C-N 114.613 -1.176 . . . . 62.04 110.689 158.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 182' ' ' VAL . . . . . 0.643 ' HA ' ' HB2' ' C' ' 123' ' ' LEU . 14.7 m -136.75 178.3 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 C-N-CA 124.583 1.153 . . . . 71.31 112.555 -175.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 183' ' ' ALA . . . . . 0.717 ' HB3' ' HD2' ' C' ' 124' ' ' PRO . . . -143.69 55.37 1.33 Allowed 'General case' 0 CA--C 1.552 1.049 0 CA-C-N 115.118 -0.946 . . . . 65.24 110.401 164.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 32.6 m170 70.3 -168.77 0.16 Allowed 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 114.959 1.466 . . . . 74.15 114.959 162.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 185' ' ' VAL . . . . . 0.558 HG22 HD21 ' C' ' 119' ' ' LEU . 45.9 t . . . . . 0 N--CA 1.496 1.866 0 C-N-CA 125.615 1.566 . . . . 71.33 113.263 -164.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 95.2 m . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 118.674 -0.679 . . . . 71.31 110.79 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -170.24 -179.35 3.06 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 113.44 0.904 . . . . 74.42 113.44 176.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . -114.89 -142.85 7.95 Favored Glycine 0 C--N 1.36 1.887 0 CA-C-N 114.678 -1.146 . . . . 71.23 111.757 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -167.31 156.92 10.56 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.753 0.821 . . . . 71.21 110.18 177.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 242' ' ' TRP . . . . . 0.472 ' CE2' ' HG ' ' C' ' 233' ' ' LEU . 0.0 OUTLIER -137.53 -35.19 0.67 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.176 1.391 . . . . 70.32 108.75 -172.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -123.72 -173.49 2.76 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 106.212 -1.773 . . . . 74.22 106.212 157.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -74.36 103.92 1.58 Allowed Glycine 0 C--N 1.335 0.483 0 C-N-CA 121.417 -0.421 . . . . 63.11 112.556 174.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 1.6 pptp? . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 122.039 0.923 . . . . 75.34 110.532 174.723 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.694 0 CA-C-O 121.33 0.586 . . . . 52.01 109.647 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 4' ' ' LYS . . . . . 0.4 ' HE2' ' HB3' ' C' ' 4' ' ' LYS . 31.0 ttpt -38.53 105.73 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.11 1.764 . . . . 70.52 113.589 177.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 5' ' ' LYS . . . . . 0.499 ' HB3' HD11 ' C' ' 10' ' ' ILE . 49.7 mtpt -88.47 104.15 16.53 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 107.425 -1.324 . . . . 63.2 107.425 164.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -67.8 108.35 2.94 Favored 'General case' 0 C--N 1.35 0.595 0 N-CA-C 108.401 -0.962 . . . . 63.22 108.401 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 7' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -64.96 -33.61 76.45 Favored 'General case' 0 C--O 1.244 0.81 0 O-C-N 124.162 0.914 . . . . 73.43 111.814 -169.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -68.11 -41.36 81.87 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.76 -0.654 . . . . 72.53 110.219 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.53 -39.73 94.31 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.274 0.629 . . . . 52.31 110.883 179.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 10' ' ' ILE . . . . . 0.499 HD11 ' HB3' ' C' ' 5' ' ' LYS . 81.7 mt -56.98 -43.17 80.39 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 123.686 0.795 . . . . 63.34 110.027 173.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 96.2 mt -76.59 -15.81 59.75 Favored 'General case' 0 CA--C 1.556 1.174 0 N-CA-C 112.952 0.723 . . . . 45.45 112.952 176.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.88 21.29 71.69 Favored Glycine 0 C--N 1.351 1.413 0 N-CA-C 114.021 0.368 . . . . 64.33 114.021 -177.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 23.8 m -112.52 160.26 31.07 Favored Pre-proline 0 N--CA 1.486 1.353 0 C-N-CA 124.463 1.105 . . . . 64.04 110.479 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -55.04 157.58 13.15 Favored 'Trans proline' 0 C--N 1.385 2.46 0 C-N-CA 123.582 2.855 . . . . 74.43 114.509 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 65.1 mtt85 -78.98 28.62 0.22 Allowed 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 124.113 0.965 . . . . 71.52 113.58 -176.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -158.59 15.35 0.19 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.508 1.123 . . . . 71.24 108.631 174.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.28 148.15 33.15 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.371 1.068 . . . . 71.14 112.605 -171.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 74.6 p -87.66 -175.79 5.31 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.831 0.853 . . . . 74.41 112.245 -171.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -53.11 -55.2 25.83 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.155 0.982 . . . . 74.45 111.741 -174.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -63.99 -31.37 72.53 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 123.833 0.708 . . . . 64.05 111.673 -176.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -67.59 -49.77 61.54 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 122.237 0.215 . . . . 73.42 110.516 179.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 1.7 mp -64.0 -42.51 95.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 C-N-CA 123.548 0.739 . . . . 61.32 110.932 177.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -64.41 -52.54 57.64 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.233 1.013 . . . . 74.13 111.008 -176.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -75.29 -26.84 59.04 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.662 -0.699 . . . . 73.52 111.433 -174.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -73.34 -36.49 66.17 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 122.583 0.353 . . . . 75.32 110.893 173.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 26' ' ' TYR . . . . . 0.557 ' HD1' HG22 ' C' ' 50' ' ' ILE . 51.3 t80 -58.63 -56.21 25.13 Favored 'General case' 0 C--O 1.211 -0.973 0 N-CA-C 109.031 -0.729 . . . . 72.31 109.031 173.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -56.23 -45.69 79.84 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 124.614 1.196 . . . . 74.1 111.593 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 44.7 ttt180 -50.47 -55.1 17.4 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.479 1.112 . . . . 71.15 111.245 177.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 84.4 mt -85.26 -12.01 53.47 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 114.929 -1.032 . . . . 60.22 111.558 -175.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -91.75 -4.89 54.47 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.637 0.775 . . . . 75.32 110.155 173.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 36.7 mtp-105 -95.95 -43.47 7.8 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.887 0.875 . . . . 73.5 109.741 166.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.52 -54.29 25.4 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 109.212 -0.662 . . . . 71.12 109.212 -178.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -90.5 13.5 15.59 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 116.222 -0.445 . . . . 70.15 111.722 -178.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 34' ' ' HIS . . . . . 0.408 ' HD2' HG23 ' C' ' 37' ' ' VAL . 40.3 t60 -60.61 106.69 0.82 Allowed Pre-proline 0 N--CA 1.479 1.023 0 CA-C-O 118.386 -0.816 . . . . 72.34 109.248 -179.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.28 -36.58 47.48 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 123.687 2.925 . . . . 71.32 114.855 -171.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -66.07 -34.63 78.5 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.45 1.1 . . . . 60.34 111.894 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . 0.408 HG23 ' HD2' ' C' ' 34' ' ' HIS . 80.0 t -89.15 -50.69 13.06 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 122.916 0.486 . . . . 75.33 110.429 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -102.63 104.0 14.33 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.746 1.219 . . . . 54.22 109.507 -173.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -83.86 35.16 0.51 Allowed 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 123.498 0.719 . . . . 62.24 111.973 -174.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 59.6 m -97.38 132.57 25.13 Favored Pre-proline 0 N--CA 1.488 1.434 0 CA-C-O 119.047 -0.501 . . . . 74.14 110.548 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -49.22 -42.49 39.82 Favored 'Trans proline' 0 C--N 1.384 2.413 0 C-N-CA 123.199 2.599 . . . . 63.44 112.15 168.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -58.32 -37.23 74.68 Favored 'General case' 0 C--N 1.353 0.75 0 CA-C-N 115.542 -0.754 . . . . 65.44 111.025 177.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.56 -21.79 59.33 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 119.431 -0.319 . . . . 62.05 110.768 -178.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -69.59 -51.01 39.13 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 108.987 -0.746 . . . . 74.04 108.987 174.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 45' ' ' GLU . . . . . 0.437 ' O ' ' HG3' ' C' ' 49' ' ' GLU . 42.1 mt-10 -67.88 -47.35 69.09 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 114.103 -1.408 . . . . 42.53 110.793 -175.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 46' ' ' LYS . . . . . 0.554 ' O ' HG12 ' C' ' 50' ' ' ILE . 35.8 mmtm -60.35 -43.11 96.81 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-N 115.329 -0.851 . . . . 72.32 111.097 175.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -58.22 -40.96 83.03 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 123.656 0.597 . . . . 62.23 110.546 178.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -64.68 -34.26 77.88 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 123.747 0.654 . . . . 72.04 111.601 175.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 49' ' ' GLU . . . . . 0.437 ' HG3' ' O ' ' C' ' 45' ' ' GLU . 41.6 mt-10 -69.42 -33.0 72.33 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 122.653 0.381 . . . . 72.33 111.139 174.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 50' ' ' ILE . . . . . 0.557 HG22 ' HD1' ' C' ' 26' ' ' TYR . 14.7 mm -71.66 -34.41 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 N-CA-C 108.903 -0.777 . . . . 75.43 108.903 176.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 51' ' ' ASN . . . . . 0.449 ' HB3' ' HD1' ' C' ' 88' ' ' PHE . 11.7 m120 -69.18 -36.71 77.62 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-N 114.642 -1.163 . . . . 74.04 110.662 176.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 62.2 tt0 -62.68 -54.34 40.89 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.9 0.88 . . . . 63.42 110.128 177.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -52.64 -60.88 2.71 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-N 113.467 -1.697 . . . . 63.1 111.224 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -61.19 -38.66 87.32 Favored 'General case' 0 C--O 1.21 -1.019 0 CA-C-N 115.072 -0.967 . . . . 75.01 111.895 -178.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.61 -51.26 70.58 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 122.827 0.451 . . . . 60.54 111.463 -177.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 56' ' ' VAL . . . . . 0.511 ' HA ' ' HE3' ' C' ' 62' ' ' LYS . 75.0 t -60.49 -40.63 84.92 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 O-C-N 124.307 1.004 . . . . 72.43 110.394 176.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 57' ' ' LEU . . . . . . . . . . . . . 46.9 mt -89.15 -0.8 57.74 Favored 'General case' 0 CA--C 1.565 1.544 0 N-CA-C 113.025 0.75 . . . . 75.02 113.025 -176.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 32.8 t -77.25 -57.39 3.86 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 124.339 1.056 . . . . 62.42 111.066 -178.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 59' ' ' ASP . . . . . 0.419 ' HA ' HG12 ' C' ' 145' ' ' VAL . 0.9 OUTLIER -65.83 122.83 82.81 Favored Pre-proline 0 C--N 1.354 0.796 0 N-CA-C 107.955 -1.128 . . . . 72.03 107.955 173.231 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 60' ' ' PRO . . . . . 0.54 ' HD2' ' HA ' ' C' ' 145' ' ' VAL . 19.1 Cg_endo -56.17 -27.78 67.34 Favored 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 123.066 2.51 . . . . 33.23 111.177 173.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . 0.67 ' HG2' ' HD3' ' C' ' 79' ' ' PRO . 3.2 tp10 -58.08 -66.06 0.54 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.249 1.02 . . . . 62.13 110.416 172.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 62' ' ' LYS . . . . . 0.511 ' HE3' ' HA ' ' C' ' 56' ' ' VAL . 17.7 mtmt -70.1 -22.99 62.97 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.426 0.69 . . . . 75.23 111.565 -173.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 48.8 tpt85 -61.18 -55.84 27.61 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.759 1.224 . . . . 64.42 109.233 172.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 -75.24 -19.15 59.9 Favored 'General case' 0 C--N 1.351 0.668 0 CA-C-N 115.26 -0.882 . . . . 74.15 111.523 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 65' ' ' ILE . . . . . 0.493 HG12 ' HB2' ' C' ' 76' ' ' PRO . 36.0 mt -66.03 -46.87 86.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.28 0.632 . . . . 62.34 109.55 171.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -61.46 -46.95 87.93 Favored 'General case' 0 C--N 1.353 0.727 0 O-C-N 123.803 0.689 . . . . 74.22 109.667 177.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -55.05 -48.6 73.22 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 123.675 0.609 . . . . 73.14 111.649 177.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 76.7 p -79.73 -9.15 59.61 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 112.568 0.581 . . . . 63.2 112.568 -178.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -72.38 100.37 2.65 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 108.229 -1.026 . . . . 75.22 108.229 174.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 125.05 10.83 4.54 Favored Glycine 0 N--CA 1.47 0.918 0 CA-C-N 115.348 -0.842 . . . . 62.51 111.704 -165.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 29.5 m -142.61 -55.53 0.43 Allowed 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 104.526 -2.398 . . . . 72.34 104.526 175.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 70.6 m -84.12 135.48 34.38 Favored 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 103.613 -2.736 . . . . 73.35 103.613 154.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.42 -31.09 8.31 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 118.987 0.812 . . . . 73.23 111.147 178.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -72.69 153.18 91.5 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 123.425 0.69 . . . . 53.23 109.254 171.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -54.3 113.55 1.41 Allowed 'Trans proline' 0 C--N 1.373 1.822 0 C-N-CA 122.56 2.173 . . . . 75.14 112.06 171.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 76' ' ' PRO . . . . . 0.493 ' HB2' HG12 ' C' ' 65' ' ' ILE . 45.8 Cg_exo -59.01 148.3 85.91 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 122.979 2.453 . . . . 63.14 111.525 175.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -57.82 124.43 16.0 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.985 2.457 . . . . 51.51 112.963 -169.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 78' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -63.33 153.25 75.61 Favored 'Trans proline' 0 C--N 1.38 2.221 0 C-N-CA 122.541 2.16 . . . . 74.44 111.904 175.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 79' ' ' PRO . . . . . 0.67 ' HD3' ' HG2' ' C' ' 61' ' ' GLU . 37.7 Cg_endo -66.36 147.44 82.94 Favored 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 122.128 1.885 . . . . 61.04 109.531 170.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 80' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' C' ' 79' ' ' PRO . 53.6 Cg_exo -55.22 78.77 0.03 OUTLIER 'Trans proline' 0 C--N 1.384 2.436 0 C-N-CA 124.139 3.226 . . . . 51.5 114.646 -176.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 163.7 -51.89 0.3 Allowed Glycine 0 CA--C 1.519 0.283 0 N-CA-C 108.326 -1.909 . . . . 75.2 108.326 -174.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 134.14 -157.63 22.96 Favored Glycine 0 C--N 1.351 1.383 0 C-N-CA 123.09 0.376 . . . . 74.45 113.102 173.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -97.25 121.1 38.76 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.181 0.992 . . . . 70.14 109.007 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 84' ' ' ASP . . . . . 0.499 ' HB2' ' NE ' ' C' ' 143' ' ' ARG . 7.8 t70 -79.5 126.12 30.45 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 112.516 0.562 . . . . 63.13 112.516 -171.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 85' ' ' PHE . . . . . 0.402 ' HA ' ' HD2' ' C' ' 88' ' ' PHE . 87.0 m-85 -137.61 31.7 2.54 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.184 0.994 . . . . 74.41 109.288 173.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 15.5 m -81.07 85.24 6.33 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 114.657 -1.156 . . . . 45.43 110.869 -172.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 87' ' ' GLY . . . . . 0.454 ' N ' ' HA ' ' C' ' 171' ' ' PRO . . . 129.31 -15.85 5.76 Favored Glycine 0 N--CA 1.471 0.971 0 N-CA-C 110.626 -0.99 . . . . 74.33 110.626 -172.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 88' ' ' PHE . . . . . 0.449 ' HD1' ' HB3' ' C' ' 51' ' ' ASN . 33.2 m-85 -108.57 135.87 49.11 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 108.023 -1.102 . . . . 74.44 108.023 178.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -77.18 79.26 3.7 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.014 0.525 . . . . 72.23 110.271 -175.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 90' ' ' VAL . . . . . 0.544 HG23 ' HZ ' ' C' ' 97' ' ' PHE . 3.4 p -48.48 -40.85 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 C-N-CA 124.96 1.304 . . . . 54.41 112.574 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -62.92 -29.89 71.13 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.715 0.806 . . . . 74.21 111.42 -177.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -72.32 -33.42 67.34 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.057 0.543 . . . . 75.53 112.023 178.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 93' ' ' PHE . . . . . 0.403 ' HZ ' ' HB3' ' C' ' 88' ' ' PHE . 10.6 m-30 -70.38 166.22 20.76 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 122.72 0.408 . . . . 72.45 111.208 -166.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 75.5 p -57.32 149.65 19.84 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 113.306 0.854 . . . . 45.51 113.306 -168.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.4 -32.94 70.63 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 115.299 -0.864 . . . . 55.43 111.118 170.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -52.97 -52.06 59.43 Favored 'General case' 0 C--N 1.357 0.915 0 C-N-CA 125.016 1.327 . . . . 65.02 109.934 174.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 97' ' ' PHE . . . . . 0.544 ' HZ ' HG23 ' C' ' 90' ' ' VAL . 1.8 t80 -60.35 -44.12 95.86 Favored 'General case' 0 CA--C 1.557 1.22 0 CA-C-N 113.256 -1.793 . . . . 64.25 110.677 174.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -70.79 -12.82 61.78 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 112.568 0.581 . . . . 51.52 112.568 -177.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -93.25 -40.61 10.34 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.298 0.639 . . . . 74.43 110.818 173.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 23.7 tp -75.03 -63.57 1.24 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.021 0.528 . . . . 73.23 110.795 -178.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -80.65 -11.43 59.64 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 122.851 0.46 . . . . 73.25 111.841 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -41.03 -60.91 2.11 Favored Glycine 0 CA--C 1.541 1.715 0 CA-C-O 118.726 -1.041 . . . . 54.11 115.137 178.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -50.14 -28.13 18.91 Favored 'Trans proline' 0 C--N 1.386 2.551 0 C-N-CA 124.113 3.209 . . . . 62.02 114.693 -177.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -126.77 30.55 4.16 Favored Glycine 0 C--N 1.358 1.757 0 CA-C-O 118.516 -1.158 . . . . 43.23 113.145 -175.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 34.5 mt . . . . . 0 N--CA 1.496 1.839 0 CA-C-N 118.373 1.086 . . . . 73.03 112.688 177.628 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.667 0 N-CA-C 113.618 0.207 . . . . 45.25 113.618 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 117' ' ' ARG . . . . . 0.446 ' NE ' ' HA ' ' C' ' 117' ' ' ARG . 2.2 mmp_? -116.71 155.51 28.75 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.21 1.004 . . . . 64.44 112.156 178.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -66.89 108.61 2.62 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-O 121.756 0.789 . . . . 75.42 109.428 175.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 119' ' ' LEU . . . . . 0.558 HD21 HG22 ' B' ' 185' ' ' VAL . 3.9 tt -89.22 112.74 23.84 Favored 'General case' 0 C--O 1.224 -0.28 0 N-CA-C 105.814 -1.921 . . . . 75.21 105.814 -174.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -93.66 132.68 37.77 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.516 -1.29 . . . . 72.31 107.516 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 121' ' ' ALA . . . . . . . . . . . . . . . -143.52 117.0 9.12 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.161 -0.681 . . . . 63.21 109.161 -177.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 122' ' ' GLU . . . . . 0.539 ' HA ' ' O ' ' C' ' 177' ' ' VAL . 13.1 pt-20 -92.91 125.47 37.52 Favored 'General case' 0 C--N 1.353 0.754 0 N-CA-C 109.036 -0.727 . . . . 73.22 109.036 176.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 123' ' ' LEU . . . . . 0.643 ' HB2' ' HA ' ' B' ' 182' ' ' VAL . 0.8 OUTLIER -121.51 105.72 38.49 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 115.873 -0.603 . . . . 73.3 111.63 -170.048 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . 0.717 ' HD2' ' HB3' ' B' ' 183' ' ' ALA . 28.2 Cg_exo -42.33 113.77 0.34 Allowed 'Trans proline' 0 C--N 1.374 1.9 0 C-N-CA 123.314 2.676 . . . . 72.51 112.02 161.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 125' ' ' LEU . . . . . . . . . . . . . 42.9 tp -140.09 140.78 36.16 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.829 1.252 . . . . 74.03 108.401 -170.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.43 154.11 22.98 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 121.006 0.431 . . . . 61.53 111.156 -176.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 127' ' ' LEU . . . . . 0.665 ' HB3' HD22 ' C' ' 215' ' ' LEU . 96.2 mt -63.22 -44.28 95.72 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.519 1.128 . . . . 62.25 111.067 177.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -53.55 -49.03 68.55 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 114.964 -1.016 . . . . 75.24 110.302 172.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -66.19 -32.31 73.67 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.889 0.876 . . . . 73.53 111.484 -176.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -73.05 -31.54 64.48 Favored 'General case' 0 CA--C 1.541 0.596 0 O-C-N 124.087 0.867 . . . . 64.34 110.475 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 131' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -69.45 -43.16 73.85 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.448 0.699 . . . . 75.55 110.395 171.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 132' ' ' HIS . . . . . . . . . . . . . 38.2 m170 -67.11 -67.65 0.44 Allowed 'General case' 0 N--CA 1.485 1.28 0 O-C-N 124.007 0.817 . . . . 60.22 111.924 -172.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 67.52 99.28 0.03 OUTLIER Glycine 0 CA--C 1.542 1.734 0 O-C-N 123.423 0.452 . . . . 65.31 113.607 -178.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . -142.52 162.12 27.33 Favored Glycine 0 N--CA 1.476 1.311 0 CA-C-O 119.244 -0.753 . . . . 53.24 111.272 178.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 53.6 mp0 -71.45 92.81 1.12 Allowed 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 108.565 -0.902 . . . . 71.2 108.565 177.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 136' ' ' ARG . . . . . 0.532 ' HB2' HD22 ' B' ' 181' ' ' LEU . 99.0 mtt180 -124.75 154.71 40.47 Favored 'General case' 0 C--O 1.247 0.941 0 C-N-CA 124.084 0.954 . . . . 72.12 109.302 -173.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 137' ' ' VAL . . . . . 0.498 HG13 ' HB1' ' B' ' 180' ' ' ALA . 7.6 p -81.12 108.8 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-O 121.919 0.866 . . . . 71.12 111.828 -165.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 138' ' ' VAL . . . . . 0.415 HG12 HG13 ' B' ' 182' ' ' VAL . 20.8 m -87.78 133.98 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 108.012 -1.107 . . . . 72.14 108.012 165.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 139' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' C' ' 143' ' ' ARG . 1.2 tm-20 -124.7 105.34 9.23 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 108.03 -1.1 . . . . 74.31 108.03 169.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 140' ' ' VAL . . . . . . . . . . . . . 67.1 t -127.81 110.41 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 123.796 0.838 . . . . 63.22 109.181 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 63.86 29.32 14.64 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.149 0.979 . . . . 15.23 110.976 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 97.76 -12.96 64.26 Favored Glycine 0 C--N 1.349 1.257 0 CA-C-N 115.003 -0.999 . . . . 45.25 112.738 -178.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 143' ' ' ARG . . . . . 0.499 ' NE ' ' HB2' ' C' ' 84' ' ' ASP . 5.9 tpp180 -75.26 93.92 2.93 Favored 'General case' 0 C--N 1.353 0.717 0 CA-C-N 117.253 0.527 . . . . 73.04 109.84 -177.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 28.8 ttp85 -104.73 96.68 6.74 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 124.373 1.069 . . . . 71.51 109.511 -176.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 145' ' ' VAL . . . . . 0.54 ' HA ' ' HD2' ' C' ' 60' ' ' PRO . 25.7 m -133.02 146.38 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.64 0.776 . . . . 75.03 110.615 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 46.4 m -89.79 92.48 9.06 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.949 -0.76 . . . . 54.21 108.949 174.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 147' ' ' VAL . . . . . 0.599 HG11 ' HE1' ' C' ' 164' ' ' MET . 10.8 p -113.16 145.37 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 122.942 0.497 . . . . 72.53 109.977 -174.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -101.16 101.81 12.61 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 108.499 -0.926 . . . . 74.22 108.499 170.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 149' ' ' ILE . . . . . . . . . . . . . 36.0 pt -73.57 137.1 77.49 Favored Pre-proline 0 CA--C 1.551 1.006 0 N-CA-C 107.734 -1.21 . . . . 71.41 107.734 165.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 150' ' ' PRO . . . . . 0.444 ' HA ' ' HD3' ' C' ' 151' ' ' PRO . 51.5 Cg_endo -63.76 142.66 83.9 Favored 'Trans proline' 0 C--N 1.37 1.702 0 C-N-CA 122.417 2.078 . . . . 61.44 113.136 -167.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 151' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' C' ' 150' ' ' PRO . 26.1 Cg_exo -62.92 149.95 89.94 Favored 'Trans proline' 0 C--N 1.379 2.148 0 C-N-CA 122.843 2.362 . . . . 73.2 111.719 176.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 152' ' ' GLY . . . . . 0.71 ' HA2' ' HB3' ' C' ' 240' ' ' PHE . . . 80.59 52.79 4.29 Favored Glycine 0 C--N 1.336 0.557 0 CA-C-N 116.216 -0.447 . . . . 54.32 112.435 -176.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 153' ' ' VAL . . . . . 0.527 HG21 HD11 ' C' ' 159' ' ' ILE . 8.3 p -104.14 142.83 16.87 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.312 0 C-N-CA 123.009 0.524 . . . . 71.13 110.26 -177.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 154' ' ' ARG . . . . . 0.593 ' HA ' ' HB3' ' C' ' 188' ' ' LEU . 57.5 mtp180 -97.51 161.35 13.82 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.762 0.825 . . . . 75.32 112.094 -168.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 155' ' ' GLU . . . . . 0.473 ' HG2' ' HE ' ' C' ' 187' ' ' ARG . 8.3 tp10 -54.22 115.7 2.21 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.682 0.793 . . . . 74.51 110.102 162.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 78.1 19.67 74.34 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-O 119.536 -0.591 . . . . 64.51 113.862 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 157' ' ' SER . . . . . . . . . . . . . 3.4 m -70.62 108.53 4.41 Favored 'General case' 0 C--N 1.355 0.842 0 CA-C-N 117.365 0.583 . . . . 75.43 110.105 172.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 158' ' ' VAL . . . . . 0.507 HG13 HG22 ' C' ' 177' ' ' VAL . 22.0 t -84.43 88.46 2.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 114.698 -1.137 . . . . 64.44 108.437 176.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 159' ' ' ILE . . . . . 0.527 HD11 HG21 ' C' ' 153' ' ' VAL . 37.5 mt -72.14 118.02 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 115.184 -0.916 . . . . 52.25 109.587 -178.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -75.95 118.61 18.91 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 109.091 -0.707 . . . . 72.21 109.091 173.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 161' ' ' VAL . . . . . 0.462 HG11 ' SD ' ' C' ' 164' ' ' MET . 20.6 t -125.85 95.55 39.61 Favored Pre-proline 0 CA--C 1.55 0.96 0 N-CA-C 109.556 -0.535 . . . . 75.24 109.556 174.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.38 128.11 12.5 Favored 'Trans proline' 0 C--N 1.369 1.609 0 C-N-CA 122.264 1.976 . . . . 63.42 111.342 173.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 101.92 23.92 8.93 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-N 115.793 -0.64 . . . . 53.31 113.466 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 164' ' ' MET . . . . . 0.599 ' HE1' HG11 ' C' ' 147' ' ' VAL . 28.2 mtp -151.81 6.9 0.47 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 112.619 0.6 . . . . 73.35 112.619 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 165' ' ' GLY . . . . . 0.415 ' HA3' ' O ' ' C' ' 173' ' ' ASP . . . -121.92 -122.89 2.88 Favored Glycine 0 N--CA 1.478 1.458 0 CA-C-O 118.348 -1.251 . . . . 64.24 111.515 -177.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . 69.4 81.93 0.21 Allowed Glycine 0 C--N 1.359 1.816 0 CA-C-N 118.149 0.974 . . . . 75.44 113.823 165.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 167' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -69.23 99.41 1.16 Allowed 'General case' 0 C--N 1.348 0.512 0 N-CA-C 107.035 -1.469 . . . . 64.31 107.035 166.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . 131.51 -142.51 13.91 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 108.395 -1.882 . . . . 13.44 108.395 -161.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 169' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -145.74 -62.2 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.774 0 CA-C-N 120.226 2.013 . . . . 62.44 111.784 175.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 170' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -61.88 162.79 20.97 Favored 'Trans proline' 0 C--N 1.399 3.191 0 C-N-CA 122.174 1.916 . . . . 51.41 112.345 173.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 171' ' ' PRO . . . . . 0.454 ' HA ' ' N ' ' C' ' 87' ' ' GLY . 5.8 Cg_exo -10.38 108.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.396 3.078 1 C-N-CA 127.079 5.186 . . . . 74.02 118.497 -165.189 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -140.32 -156.41 6.87 Favored Glycine 0 C--N 1.342 0.912 0 N-CA-C 109.311 -1.516 . . . . 74.42 109.311 170.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 173' ' ' ASP . . . . . 0.415 ' O ' ' HA3' ' C' ' 165' ' ' GLY . 14.5 t70 -166.3 158.29 13.85 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 117.843 0.822 . . . . 74.51 110.087 -177.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 174' ' ' LEU . . . . . 0.434 HD12 ' O ' ' C' ' 119' ' ' LEU . 45.2 tp -118.82 107.53 13.73 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.674 0.79 . . . . 75.22 109.758 175.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 175' ' ' LEU . . . . . 0.451 HD22 HG12 ' C' ' 158' ' ' VAL . 73.8 mt -86.44 85.85 7.33 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.962 0.905 . . . . 71.32 110.273 175.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 176' ' ' LEU . . . . . 0.43 ' HG ' ' HG ' ' C' ' 174' ' ' LEU . 47.9 mt -75.3 92.7 2.79 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.594 0.758 . . . . 43.02 110.543 177.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 177' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' C' ' 122' ' ' GLU . 6.5 t -84.92 94.13 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 C-N-CA 123.423 0.689 . . . . 74.43 109.921 179.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 178' ' ' VAL . . . . . . . . . . . . . 23.0 m -68.78 119.53 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 O-C-N 121.344 -0.848 . . . . 74.01 110.781 -176.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 179' ' ' ARG . . . . . 0.474 ' O ' ' HA ' ' C' ' 124' ' ' PRO . 7.0 mmm180 -100.93 119.7 39.09 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 107.023 -1.473 . . . . 72.33 107.023 171.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 180' ' ' LEU . . . . . 0.454 HD13 HD21 ' C' ' 127' ' ' LEU . 75.5 mt -68.6 134.99 50.78 Favored 'General case' 0 CA--C 1.559 1.29 0 CA-C-N 118.171 0.441 . . . . 70.51 111.397 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 181' ' ' LEU . . . . . 0.436 HD23 ' HB3' ' C' ' 124' ' ' PRO . 18.5 mt -53.12 169.64 0.29 Allowed Pre-proline 0 N--CA 1.502 2.148 0 C-N-CA 126.521 1.928 . . . . 74.2 113.538 -176.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -59.99 64.5 0.07 OUTLIER 'Trans proline' 0 C--N 1.405 3.543 0 C-N-CA 123.486 2.791 . . . . 64.12 112.268 161.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 183' ' ' HIS . . . . . 0.527 ' N ' ' HD3' ' C' ' 184' ' ' PRO . 76.4 t60 -162.37 26.15 0.02 OUTLIER Pre-proline 0 CA--C 1.576 1.957 0 C-N-CA 127.77 2.428 . . . . 62.13 107.705 -176.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 184' ' ' PRO . . . . . 0.527 ' HD3' ' N ' ' C' ' 183' ' ' HIS . 11.0 Cg_endo -88.49 67.67 3.0 Favored 'Trans proline' 0 C--N 1.401 3.341 0 C-N-CA 123.588 2.859 . . . . 71.54 111.377 -163.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 185' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 9.0 t -89.48 -23.93 6.05 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.492 0 N-CA-C 108.146 -1.057 . . . . 72.23 108.146 -177.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 186' ' ' PHE . . . . . 0.484 ' HD2' HD13 ' C' ' 127' ' ' LEU . 48.4 m-85 -127.85 101.82 6.51 Favored 'General case' 0 C--N 1.352 0.704 0 C-N-CA 123.737 0.815 . . . . 61.44 109.266 -178.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 187' ' ' ARG . . . . . 0.473 ' HE ' ' HG2' ' C' ' 155' ' ' GLU . 27.9 ttm105 -97.72 110.65 23.17 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 124.557 1.143 . . . . 75.14 108.182 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 188' ' ' LEU . . . . . 0.593 ' HB3' ' HA ' ' C' ' 154' ' ' ARG . 59.5 tp -76.77 131.94 38.99 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.387 0.613 . . . . 74.14 112.6 -166.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -116.08 106.3 13.59 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.147 1.379 . . . . 71.33 108.377 167.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 66.85 -99.8 0.51 Allowed Glycine 0 C--N 1.348 1.239 0 CA-C-N 116.053 -0.521 . . . . 74.2 112.454 -178.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 191' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -117.53 -14.21 10.28 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 124.262 1.025 . . . . 60.21 110.183 175.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -101.32 128.71 47.36 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.678 1.191 . . . . 65.13 110.401 -173.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 193' ' ' LEU . . . . . 0.432 ' HG ' ' HA2' ' C' ' 239' ' ' GLY . 77.8 mt -73.74 153.75 39.89 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.828 0.851 . . . . 52.2 111.883 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 194' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -123.83 106.72 10.7 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 107.266 -1.383 . . . . 75.43 107.266 169.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 195' ' ' ALA . . . . . 0.461 ' HA ' ' O ' ' C' ' 185' ' ' VAL . . . -110.76 -177.91 3.34 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.286 1.034 . . . . 65.11 110.38 -174.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 90.2 m -137.75 121.12 17.05 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 108.638 -0.875 . . . . 51.32 108.638 164.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 197' ' ' LEU . . . . . . . . . . . . . 63.2 tp -100.48 143.5 30.59 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.586 1.155 . . . . 73.5 110.232 -175.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -100.61 101.59 12.53 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 123.656 0.782 . . . . 44.52 109.004 -178.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 199' ' ' VAL . . . . . 0.406 HG22 HG21 ' C' ' 210' ' ' VAL . 94.9 t -114.51 125.58 29.0 Favored Pre-proline 0 N--CA 1.486 1.354 0 C-N-CA 124.404 1.081 . . . . 61.21 109.864 -176.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 200' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -74.06 145.05 34.83 Favored 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 121.675 1.583 . . . . 71.34 111.125 174.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 201' ' ' ALA . . . . . 0.461 ' O ' HG23 ' C' ' 205' ' ' VAL . . . -58.66 -38.89 70.25 Favored Pre-proline 0 CA--C 1.552 1.024 0 N-CA-C 115.263 1.579 . . . . 74.35 115.263 -173.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 202' ' ' PRO . . . . . 0.542 ' O ' HG13 ' C' ' 206' ' ' VAL . 21.2 Cg_endo -59.13 -52.33 5.16 Favored 'Trans proline' 0 C--N 1.388 2.613 0 CA-C-N 121.711 1.647 . . . . 63.15 111.205 175.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 203' ' ' ILE . . . . . . . . . . . . . 43.4 mt -62.49 -28.25 44.36 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 C-N-CA 124.228 1.011 . . . . 63.4 110.737 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.62 -43.4 76.44 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.5 -0.773 . . . . 75.02 112.305 175.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 205' ' ' VAL . . . . . 0.538 HG11 HD11 ' A' ' 261' ' ' LEU . 65.2 t -69.39 -45.42 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 122.373 0.269 . . . . 63.41 110.964 -178.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 206' ' ' VAL . . . . . 0.542 HG13 ' O ' ' C' ' 202' ' ' PRO . 0.7 OUTLIER -96.58 -38.09 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 111.514 0.19 . . . . 52.12 111.514 -167.717 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 106.07 119.49 4.55 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 112.455 -0.258 . . . . 63.21 112.455 -173.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -156.44 -137.64 2.37 Favored Glycine 0 C--N 1.336 0.56 0 N-CA-C 109.79 -1.324 . . . . 51.32 109.79 176.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 209' ' ' LYS . . . . . 0.682 ' HG2' ' HA ' ' C' ' 222' ' ' ALA . 10.2 mtmp? -142.37 151.94 42.38 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 118.08 0.94 . . . . 72.12 111.712 177.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 210' ' ' VAL . . . . . 0.406 HG21 HG22 ' C' ' 199' ' ' VAL . 30.2 m -139.42 174.0 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 125.644 1.577 . . . . 62.05 108.516 174.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 211' ' ' ARG . . . . . 0.682 HH11 ' HB2' ' C' ' 218' ' ' PRO . 40.5 ttm-85 -109.66 127.64 54.7 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 118.431 0.56 . . . . 72.44 110.778 -176.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -107.97 113.14 26.11 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 107.335 -1.358 . . . . 74.43 107.335 169.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 213' ' ' MET . . . . . 0.677 ' HA ' ' HA ' ' C' ' 218' ' ' PRO . 4.2 ttp -80.28 98.95 7.63 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 108.954 -0.758 . . . . 63.12 108.954 -176.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.11 177.74 8.58 Favored 'General case' 0 C--O 1.244 0.798 0 O-C-N 123.342 0.401 . . . . 54.24 109.936 -174.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 215' ' ' LEU . . . . . 0.665 HD22 ' HB3' ' C' ' 127' ' ' LEU . 11.9 mt -52.68 -60.81 2.8 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.055 0.942 . . . . 44.41 110.506 -175.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -86.76 8.61 21.94 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.211 -0.904 . . . . 71.0 112.185 -174.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 142.07 157.03 7.0 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-O 119.925 -0.375 . . . . 64.11 113.307 177.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 218' ' ' PRO . . . . . 0.682 ' HB2' HH11 ' C' ' 211' ' ' ARG . 31.8 Cg_endo -63.22 121.99 10.03 Favored 'Trans proline' 0 C--N 1.364 1.389 0 C-N-CA 122.95 2.433 . . . . 52.13 115.322 177.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 219' ' ' VAL . . . . . . . . . . . . . 8.0 p -98.77 167.84 1.8 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.928 0 N-CA-C 107.05 -1.463 . . . . 52.53 107.05 170.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 220' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -101.04 158.45 16.0 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 109.338 -0.616 . . . . 72.32 109.338 173.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 221' ' ' VAL . . . . . . . . . . . . . 33.3 t -121.97 123.22 68.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 125.2 1.4 . . . . 74.03 108.309 173.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 222' ' ' ALA . . . . . 0.682 ' HA ' ' HG2' ' C' ' 209' ' ' LYS . . . -84.15 101.92 12.19 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 123.118 0.567 . . . . 73.3 109.565 169.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 61.0 t -75.53 123.39 88.49 Favored Pre-proline 0 CA--C 1.549 0.91 0 CA-C-N 114.409 -1.269 . . . . 73.11 109.222 178.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 224' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -76.37 164.44 30.85 Favored 'Trans proline' 0 C--N 1.369 1.651 0 C-N-CA 123.552 2.835 . . . . 54.33 112.917 172.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -55.96 146.52 68.2 Favored 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 122.361 2.041 . . . . 74.0 112.684 165.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 226' ' ' ARG . . . . . 0.419 ' HG3' ' HA ' ' A' ' 259' ' ' GLU . 8.0 mpt_? 66.65 66.5 0.45 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.764 1.225 . . . . 70.15 110.814 171.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 227' ' ' THR . . . . . 0.533 ' HA ' ' HD3' ' C' ' 231' ' ' ARG . 16.7 m -114.89 121.79 44.29 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 114.697 -1.138 . . . . 70.3 110.779 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 228' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -111.27 163.01 14.4 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.922 0.889 . . . . 74.32 110.809 -178.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -77.18 111.43 12.79 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 114.403 -1.271 . . . . 62.12 109.965 -178.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 110.61 6.2 27.12 Favored Glycine 0 N--CA 1.476 1.311 0 CA-C-O 119.896 -0.391 . . . . 62.04 113.115 -169.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 231' ' ' ARG . . . . . 0.533 ' HD3' ' HA ' ' C' ' 227' ' ' THR . 39.4 mtp85 -77.84 169.78 17.71 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 109.623 -0.51 . . . . 74.12 109.623 164.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 232' ' ' LYS . . . . . 0.446 ' HB2' ' NZ ' ' C' ' 232' ' ' LYS . 2.1 ttmp? -135.08 151.02 50.36 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.424 0.63 . . . . 71.45 112.461 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 233' ' ' LEU . . . . . 0.715 HD13 ' HB2' ' C' ' 251' ' ' LEU . 5.6 mp -113.96 157.21 22.75 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.672 1.589 . . . . 74.21 110.874 -176.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 28.5 ptt-85 -134.57 97.12 3.71 Favored 'General case' 0 CA--C 1.559 1.324 0 O-C-N 125.327 1.642 . . . . 72.34 110.65 173.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 235' ' ' LEU . . . . . 0.478 ' HB2' ' HB3' ' C' ' 249' ' ' LEU . 87.5 mt -93.29 104.44 16.61 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.9 0.88 . . . . 73.43 108.819 171.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -68.89 132.28 46.48 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.756 0.822 . . . . 71.55 112.184 -174.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 74.37 22.58 77.32 Favored Glycine 0 C--N 1.357 1.711 0 O-C-N 123.925 0.766 . . . . 71.42 113.965 177.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 27.9 mmtm -115.79 17.96 15.88 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.462 0.705 . . . . 72.03 111.382 -178.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 239' ' ' GLY . . . . . 0.432 ' HA2' ' HG ' ' C' ' 193' ' ' LEU . . . -91.61 -159.04 35.13 Favored Glycine 0 C--N 1.349 1.252 0 O-C-N 123.421 0.45 . . . . 31.21 112.851 177.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 240' ' ' PHE . . . . . 0.71 ' HB3' ' HA2' ' C' ' 152' ' ' GLY . 4.4 m-85 -88.65 154.84 50.82 Favored Pre-proline 0 CA--C 1.551 0.997 0 CA-C-O 119.102 -0.475 . . . . 75.14 109.776 179.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 241' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -67.93 101.62 0.7 Allowed 'Trans proline' 0 C--N 1.387 2.596 0 C-N-CA 122.83 2.353 . . . . 70.21 110.66 177.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -94.12 167.86 28.14 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-N 115.623 -0.717 . . . . 70.14 112.152 177.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.02 -23.52 29.53 Favored 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 123.023 2.482 . . . . 71.42 111.412 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -99.0 27.34 5.09 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.318 1.047 . . . . 71.42 110.064 175.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 92.07 177.98 41.94 Favored Glycine 0 C--N 1.351 1.377 0 CA-C-N 115.918 -0.583 . . . . 51.32 112.186 -177.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 246' ' ' ARG . . . . . . . . . . . . . 80.1 mtm180 -72.48 138.21 46.87 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 122.699 0.399 . . . . 61.31 110.267 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -79.01 -155.54 9.07 Favored Glycine 0 C--N 1.344 1.025 0 O-C-N 123.857 0.723 . . . . 63.23 112.374 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -120.25 177.6 4.96 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 108.562 -0.903 . . . . 73.54 108.562 -175.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 249' ' ' LEU . . . . . 0.478 ' HB3' ' HB2' ' C' ' 235' ' ' LEU . 12.8 tp -119.7 109.28 15.45 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.877 -0.786 . . . . 74.23 108.877 177.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 250' ' ' TYR . . . . . 0.609 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 19.9 m-85 -101.5 105.57 16.58 Favored 'General case' 0 C--N 1.343 0.325 0 CA-C-N 115.901 -0.59 . . . . 71.43 109.605 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 251' ' ' LEU . . . . . 0.715 ' HB2' HD13 ' C' ' 233' ' ' LEU . 2.1 mp -99.71 149.47 23.29 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 109.595 -0.52 . . . . 64.53 109.595 -173.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -103.44 128.17 50.65 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.388 -0.967 . . . . 73.41 108.388 175.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 253' ' ' VAL . . . . . . . . . . . . . 95.1 t -74.15 133.28 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.172 0.589 . . . . 73.5 111.896 -172.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 254' ' ' ARG . . . . . 0.511 ' NH2' ' HB ' ' C' ' 256' ' ' THR . 1.3 tmm_? -122.27 94.98 4.47 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 107.321 -1.363 . . . . 74.13 107.321 176.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 255' ' ' ILE . . . . . 0.482 HD11 HG22 ' C' ' 227' ' ' THR . 46.6 mm -69.17 131.35 34.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 122.634 0.374 . . . . 75.24 110.459 177.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 256' ' ' THR . . . . . 0.511 ' HB ' ' NH2' ' C' ' 254' ' ' ARG . 0.0 OUTLIER -140.8 172.0 13.3 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.538 1.135 . . . . 53.32 111.153 -174.514 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 2.9 pp -130.96 154.18 81.94 Favored Pre-proline 0 CA--C 1.556 1.181 0 C-N-CA 124.351 1.06 . . . . 64.54 109.29 177.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -72.38 -2.62 11.99 Favored 'Trans proline' 0 C--N 1.377 2.065 0 C-N-CA 122.451 2.101 . . . . 73.21 113.631 -166.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 57.14 -72.12 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 125.229 1.412 . . . . 72.3 111.74 -166.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 -69.75 148.03 49.72 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.597 0.759 . . . . 73.41 111.103 177.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 261' ' ' LEU . . . . . 0.472 HD13 ' HA ' ' C' ' 266' ' ' GLU . 72.7 mt -138.35 141.47 39.69 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.243 0.617 . . . . 71.21 111.416 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 46.7 p -82.09 150.8 65.58 Favored Pre-proline 0 CA--C 1.545 0.771 0 N-CA-C 107.995 -1.113 . . . . 61.23 107.995 170.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -47.04 -39.46 25.43 Favored 'Trans proline' 0 N--CA 1.509 2.394 0 C-N-CA 123.77 2.98 . . . . 74.2 113.759 -177.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 264' ' ' GLU . . . . . 0.479 ' HG2' ' NH2' ' A' ' 279' ' ' ARG . 2.8 tp10 -55.89 -67.62 0.27 Allowed 'General case' 0 C--O 1.246 0.877 0 C-N-CA 124.578 1.151 . . . . 71.04 111.093 175.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -66.04 -28.63 69.0 Favored 'General case' 0 C--O 1.212 -0.885 0 CA-C-N 115.176 -0.92 . . . . 65.11 110.847 -173.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 266' ' ' GLU . . . . . 0.472 ' HA ' HD13 ' C' ' 261' ' ' LEU . 11.6 tp10 -57.88 -50.15 74.3 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.025 0.93 . . . . 64.21 109.575 174.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -60.4 -38.53 84.27 Favored 'General case' 0 CA--C 1.548 0.887 0 O-C-N 123.853 0.72 . . . . 70.32 111.592 176.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 268' ' ' LEU . . . . . . . . . . . . . 11.0 mp -65.06 -47.68 76.45 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 112.445 0.535 . . . . 52.44 112.445 177.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 269' ' ' TRP . . . . . 0.444 ' HH2' ' HD3' ' C' ' 202' ' ' PRO . 90.5 m95 -64.74 -33.42 75.92 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.302 0.641 . . . . 61.11 110.603 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 270' ' ' LYS . . . . . 0.4 ' NZ ' ' HB3' ' C' ' 270' ' ' LYS . 4.6 mmmp? -64.9 -48.64 73.47 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.739 0.816 . . . . 75.43 111.547 177.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 13.0 mmtm -65.74 -37.96 87.83 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.059 0.543 . . . . 75.33 111.917 179.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 272' ' ' LEU . . . . . 0.436 HD12 HD12 ' A' ' 272' ' ' LEU . 64.3 mt -76.53 -22.46 54.35 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.761 -0.654 . . . . 74.33 111.226 177.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -67.28 -47.04 71.82 Favored 'General case' 0 C--O 1.218 -0.572 0 N-CA-C 109.226 -0.657 . . . . 34.13 109.226 171.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -60.69 -37.36 81.38 Favored 'General case' 0 N--CA 1.483 1.215 0 O-C-N 124.291 0.994 . . . . 63.21 111.099 176.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -63.58 -37.2 86.43 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.625 0.77 . . . . 70.04 111.287 175.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 276' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -83.25 -22.33 33.09 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 116.311 -0.404 . . . . 75.52 112.077 178.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 20.8 m-30 -68.16 -35.93 78.84 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 108.408 -0.96 . . . . 44.24 108.408 172.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -59.39 -27.26 65.83 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 114.898 -1.047 . . . . 55.2 111.439 171.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 279' ' ' ARG . . . . . . . . . . . . . 25.3 mtp-105 -74.95 -31.54 61.52 Favored 'General case' 0 C--N 1.364 1.236 0 N-CA-C 109.648 -0.501 . . . . 71.52 109.648 175.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 N-CA-C 109.185 -0.672 . . . . 75.14 109.185 -175.233 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp . . . . . 0 CA--C 1.548 0.88 0 N-CA-C 112.955 0.724 . . . . 62.43 112.955 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -89.42 129.12 35.98 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.663 0.785 . . . . 74.32 110.269 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -84.07 86.55 7.19 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 107.007 -1.479 . . . . 61.41 107.007 170.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.435 ' CD1' ' HA ' ' A' ' 53' ' ' ALA . 69.9 m-85 -61.0 -25.96 67.26 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 114.988 -1.005 . . . . 73.34 112.024 -174.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.506 ' HE1' ' HE2' ' A' ' 66' ' ' TYR . 49.3 m-85 -66.69 -52.54 43.58 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.602 -0.726 . . . . 73.33 109.581 175.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.61 -36.54 76.51 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.592 0.757 . . . . 60.32 110.885 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 69.8 mt -59.43 -44.16 92.07 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.097 0 C-N-CA 123.91 0.884 . . . . 74.23 110.943 174.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.5 mt -77.18 -6.95 54.91 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 112.515 0.561 . . . . 51.33 112.515 175.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.92 17.83 76.29 Favored Glycine 0 C--N 1.352 1.434 0 C-N-CA 122.961 0.315 . . . . 53.33 113.561 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.6 m -108.83 152.24 42.22 Favored Pre-proline 0 CA--C 1.554 1.125 0 C-N-CA 124.055 0.942 . . . . 71.43 110.008 176.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -86.41 172.72 6.88 Favored 'Trans proline' 0 C--N 1.368 1.599 0 C-N-CA 122.366 2.044 . . . . 50.12 112.928 178.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 11.9 mmt85 -68.85 78.48 0.31 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.127 -0.942 . . . . 75.43 109.345 172.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -174.37 -31.82 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 114.335 -1.302 . . . . 64.11 108.431 -172.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.43 120.92 15.29 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.624 -0.716 . . . . 64.31 111.304 -178.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 76.2 p -82.62 175.25 10.31 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.989 0.916 . . . . 71.11 110.027 174.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -47.96 -39.81 20.43 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 124.728 1.211 . . . . 64.21 113.033 -176.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.449 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 0.5 OUTLIER -69.35 -44.82 70.83 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.521 0.729 . . . . 72.43 109.796 -175.689 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -67.39 -34.69 77.78 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 124.036 0.935 . . . . 64.03 111.455 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.555 HD13 HD13 ' A' ' 57' ' ' LEU . 77.9 mt -67.23 -36.6 77.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.98 1.312 . . . . 73.31 110.461 175.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -69.84 -38.64 76.56 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.233 -0.894 . . . . 71.24 109.672 178.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 20' ' ' GLU . 94.9 mtt180 -60.25 -48.56 81.22 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.509 0.723 . . . . 54.12 109.896 175.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.81 -43.71 98.31 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 124.541 1.151 . . . . 64.0 111.668 -177.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -61.55 -54.81 38.17 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.55 -0.75 . . . . 73.1 110.638 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.434 ' HA ' ' HB3' ' A' ' 30' ' ' ALA . 57.3 mtpt -62.66 -32.73 73.84 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 124.119 0.887 . . . . 74.22 111.7 -177.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.405 ' HA ' ' NH2' ' A' ' 31' ' ' ARG . 14.9 ttt180 -57.99 -55.38 35.63 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.341 1.056 . . . . 71.15 110.058 174.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.635 ' HB3' HD13 ' A' ' 50' ' ' ILE . 78.8 mt -74.94 -15.13 60.7 Favored 'General case' 0 CA--C 1.552 1.026 0 CA-C-N 114.865 -1.061 . . . . 74.11 110.925 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.477 ' HA ' ' HE1' ' A' ' 47' ' ' PHE . . . -89.75 -12.0 40.6 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.032 0.933 . . . . 63.3 111.723 176.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.405 ' NH2' ' HA ' ' A' ' 28' ' ' ARG . 47.1 mtm105 -90.68 -42.93 10.45 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 109.714 -0.476 . . . . 72.33 109.714 167.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -68.68 -61.4 1.83 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.491 0.717 . . . . 63.33 111.345 -177.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -92.11 17.5 9.41 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.227 0.611 . . . . 63.25 112.211 -172.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 7.2 t-160 -57.38 101.85 0.28 Allowed Pre-proline 0 CA--C 1.555 1.156 0 C-N-CA 124.645 1.178 . . . . 63.41 111.654 -172.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.87 -32.03 75.78 Favored 'Trans proline' 0 C--N 1.388 2.65 0 C-N-CA 123.883 3.055 . . . . 74.13 113.71 -171.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -47.0 -43.68 19.61 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.609 1.164 . . . . 72.45 112.331 176.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 60.3 t -104.65 -24.77 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.665 0.786 . . . . 65.53 110.069 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -127.48 73.96 1.48 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.259 0.624 . . . . 61.35 110.474 -170.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -79.16 69.19 5.3 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 109.066 -0.716 . . . . 73.11 109.066 171.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.4 m -112.06 105.05 56.43 Favored Pre-proline 0 CA--C 1.535 0.38 0 N-CA-C 107.28 -1.378 . . . . 54.41 107.28 177.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -37.3 -49.38 1.72 Allowed 'Trans proline' 0 C--N 1.389 2.698 0 C-N-CA 124.689 3.593 . . . . 72.23 114.647 -173.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -51.95 -54.32 30.99 Favored 'General case' 0 N--CA 1.48 1.042 0 O-C-N 124.314 1.009 . . . . 64.43 111.086 177.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.09 -21.54 63.12 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 114.798 -1.092 . . . . 72.14 111.385 -177.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.475 ' O ' ' HD3' ' A' ' 48' ' ' LYS . 51.8 mt-10 -83.25 -38.69 21.88 Favored 'General case' 0 C--N 1.355 0.818 0 C-N-CA 122.824 0.45 . . . . 62.01 109.891 -176.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -65.73 -43.98 87.4 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.485 0.714 . . . . 62.44 109.445 175.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -58.62 -41.01 84.94 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 114.696 -1.138 . . . . 74.03 110.265 171.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.477 ' HE1' ' HA ' ' A' ' 30' ' ' ALA . 40.9 t80 -69.51 -25.32 63.99 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 123.407 0.442 . . . . 73.24 111.886 179.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.475 ' HD3' ' O ' ' A' ' 44' ' ' GLU . 2.0 mptm? -70.32 -39.13 74.95 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 109.944 -0.391 . . . . 75.14 109.944 174.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -63.43 -41.36 98.69 Favored 'General case' 0 CA--C 1.55 0.962 0 O-C-N 123.907 0.754 . . . . 71.44 110.568 174.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.635 HD13 ' HB3' ' A' ' 29' ' ' LEU . 69.4 mt -67.91 -40.53 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 124.621 1.168 . . . . 70.53 110.994 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -63.76 -41.03 98.05 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.261 -0.881 . . . . 73.43 110.379 174.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.426 ' O ' HG23 ' A' ' 56' ' ' VAL . 33.4 tt0 -61.27 -48.85 79.52 Favored 'General case' 0 C--O 1.246 0.906 0 C-N-CA 124.62 1.168 . . . . 63.42 110.591 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.435 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . . . -58.01 -48.07 81.15 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 114.163 -1.38 . . . . 65.45 111.564 -178.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -82.8 -14.52 54.26 Favored 'General case' 0 C--O 1.212 -0.915 0 CA-C-N 115.774 -0.648 . . . . 72.32 111.649 178.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.11 -35.62 81.7 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.777 0.799 . . . . 53.01 109.661 173.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.426 HG22 ' CE1' ' A' ' 101' ' ' PHE . 34.4 t -73.05 -58.7 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 CA-C-N 113.748 -1.569 . . . . 74.52 110.264 170.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.555 HD13 HD13 ' A' ' 22' ' ' ILE . 51.8 mt -90.11 15.09 10.83 Favored 'General case' 0 CA--C 1.558 1.256 0 CA-C-N 115.215 -0.902 . . . . 62.04 113.109 -166.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 44.2 t -67.01 -68.07 0.4 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.283 0.633 . . . . 74.34 109.806 173.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -80.95 135.82 51.29 Favored Pre-proline 0 C--O 1.238 0.456 0 CA-C-N 114.799 -1.091 . . . . 74.34 108.792 176.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.465 ' O ' ' HG2' ' A' ' 64' ' ' ARG . 51.3 Cg_exo -56.43 -28.32 72.54 Favored 'Trans proline' 0 C--N 1.369 1.627 0 C-N-CA 123.016 2.477 . . . . 72.41 112.082 170.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -71.29 -48.31 51.52 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.438 0.695 . . . . 72.3 111.285 -178.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.52 ' HA ' HD12 ' A' ' 65' ' ' ILE . 37.6 mtpt -70.87 -27.25 63.68 Favored 'General case' 0 C--O 1.257 1.493 0 CA-C-O 121.36 0.6 . . . . 74.54 110.934 178.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.425 HH21 ' CD1' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -65.58 -41.76 92.5 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 115.382 -0.827 . . . . 74.11 109.436 171.159 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.465 ' HG2' ' O ' ' A' ' 60' ' ' PRO . 4.5 mmp_? -59.22 -41.68 89.22 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.572 0.749 . . . . 74.25 110.734 176.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.612 ' HA ' ' HG2' ' A' ' 76' ' ' PRO . 91.0 mt -53.34 -51.12 43.78 Favored 'Isoleucine or valine' 0 C--O 1.251 1.15 0 C-N-CA 124.037 0.935 . . . . 64.42 110.57 175.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.506 ' HE2' ' HE1' ' A' ' 8' ' ' TYR . 37.9 t80 -58.2 -52.16 66.73 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 115.826 -0.624 . . . . 75.4 111.653 173.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -56.91 -33.74 67.23 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.144 0.978 . . . . 64.04 112.041 -173.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 40.5 p -91.42 -14.91 29.76 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.133 0.573 . . . . 75.13 112.214 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -72.1 125.41 27.19 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 107.513 -1.291 . . . . 63.45 107.513 166.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.84 23.91 29.11 Favored Glycine 0 N--CA 1.47 0.918 0 N-CA-C 111.281 -0.728 . . . . 52.54 111.281 -171.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 60.0 m -144.88 -57.67 0.35 Allowed 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 103.321 -2.844 . . . . 71.23 103.321 175.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 34.2 m -78.91 134.48 36.88 Favored 'General case' 0 C--O 1.25 1.099 0 N-CA-C 104.348 -2.464 . . . . 74.23 104.348 155.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.27 -31.78 67.9 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.396 0.678 . . . . 74.04 110.733 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -92.17 161.33 33.35 Favored Pre-proline 0 C--O 1.244 0.769 0 C-N-CA 124.177 0.991 . . . . 75.1 110.561 177.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -63.85 138.65 64.35 Favored 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 121.822 1.681 . . . . 75.41 110.172 164.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.612 ' HG2' ' HA ' ' A' ' 65' ' ' ILE . 82.6 Cg_exo -52.99 156.98 8.81 Favored 'Trans proline' 0 N--CA 1.501 1.917 0 C-N-CA 124.062 3.175 . . . . 74.25 114.77 178.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -58.27 124.87 16.86 Favored 'Trans proline' 0 C--N 1.385 2.483 0 C-N-CA 123.065 2.51 . . . . 62.44 112.382 -178.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -70.1 130.67 19.3 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 123.086 2.524 . . . . 43.51 112.245 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -60.91 142.64 98.2 Favored 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 122.827 2.351 . . . . 71.05 111.436 171.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.78 84.47 0.31 Allowed 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 122.83 2.353 . . . . 51.35 111.937 -177.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 165.85 -38.19 0.27 Allowed Glycine 0 C--N 1.333 0.383 0 CA-C-N 114.18 -1.373 . . . . 62.41 109.722 -177.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 113.29 -165.21 12.02 Favored Glycine 0 C--N 1.35 1.346 0 CA-C-N 115.212 -0.494 . . . . 53.03 112.921 176.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -109.58 108.43 18.87 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.125 0.97 . . . . 74.41 109.882 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -66.54 156.09 35.89 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.965 0.906 . . . . 71.31 111.369 173.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.555 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 59.9 m-85 -144.8 77.66 1.54 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.015 0.926 . . . . 70.22 110.491 -175.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.493 ' HB3' ' HG2' ' A' ' 162' ' ' PRO . 7.0 m -48.43 85.61 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.356 0 C-N-CA 125.596 1.558 . . . . 74.44 113.597 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.03 10.95 81.47 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-N 116.013 -0.539 . . . . 70.11 113.628 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.555 ' HB2' ' HB3' ' A' ' 85' ' ' PHE . 25.2 m-85 -104.25 103.57 13.35 Favored 'General case' 0 C--N 1.351 0.652 0 C-N-CA 123.211 0.604 . . . . 72.34 109.492 -175.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -82.55 83.29 7.63 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 121.469 0.652 . . . . 71.44 110.034 -174.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.3 p -44.56 -33.27 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 C-N-CA 126.058 1.743 . . . . 75.21 114.36 176.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -55.99 -30.91 62.51 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.369 1.068 . . . . 75.33 111.647 -177.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -100.04 -6.65 26.09 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 123.787 0.835 . . . . 45.35 111.334 -175.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 12.8 m-30 -86.41 176.83 7.67 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 123.632 0.773 . . . . 71.01 110.929 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 91.9 p -67.56 161.39 25.7 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 113.161 0.8 . . . . 74.5 113.161 -169.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.85 -39.09 90.64 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 114.788 -1.096 . . . . 74.31 111.437 174.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -61.64 -40.39 94.71 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 122.655 0.382 . . . . 75.03 110.343 177.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.418 ' CD1' ' HG3' ' A' ' 52' ' ' GLU . 61.0 t80 -62.0 -41.46 98.08 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-O 121.493 0.663 . . . . 63.23 109.624 176.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -80.54 -1.22 41.01 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 114.693 -1.139 . . . . 73.05 112.531 177.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -100.15 -44.35 6.01 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 123.682 0.793 . . . . 70.02 111.872 170.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 24.7 tp -64.58 -47.68 77.81 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.454 1.101 . . . . 55.03 109.803 178.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.426 ' CE1' HG22 ' A' ' 56' ' ' VAL . 98.5 m-85 -92.65 -7.04 48.03 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.375 -0.83 . . . . 72.11 111.272 177.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -45.7 -58.89 5.16 Favored Glycine 0 CA--C 1.538 1.492 0 C-N-CA 124.458 1.028 . . . . 72.43 115.668 -177.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -61.9 -8.7 12.22 Favored 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 123.042 2.495 . . . . 23.1 114.046 -176.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -139.85 32.77 2.18 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-O 119.658 -0.523 . . . . 44.4 112.74 175.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.1 mt -68.34 22.47 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 115.007 1.484 . . . . 74.25 115.007 -177.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.511 ' HB3' ' ND2' ' A' ' 169' ' ' ASN . 0.2 OUTLIER 55.83 -107.34 0.38 Allowed 'General case' 0 CA--C 1.566 1.56 0 C-N-CA 124.06 0.944 . . . . 72.25 110.779 164.583 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 67.26 16.68 67.29 Favored Glycine 0 C--N 1.361 1.925 0 CA-C-O 120.043 -0.309 . . . . 44.0 113.479 -179.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.469 ' H ' ' HD1' ' A' ' 106' ' ' PHE . . . . . . . . 0 C--N 1.352 1.438 0 N-CA-C 111.414 -0.674 . . . . 71.34 111.414 -171.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.432 ' HA ' ' O ' ' A' ' 170' ' ' PRO . 34.8 ttmt . . . . . 0 N--CA 1.477 0.905 0 N-CA-C 113.142 0.793 . . . . 72.15 113.142 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -97.77 -170.98 32.82 Favored Glycine 0 CA--C 1.544 1.867 0 CA-C-N 115.316 -0.856 . . . . 55.22 113.716 176.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -110.21 140.28 44.5 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.327 1.051 . . . . 71.34 111.049 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -44.09 104.11 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 125.393 1.477 . . . . 74.23 112.953 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.44 ' O ' HD12 ' A' ' 174' ' ' LEU . 5.3 tt -100.39 144.53 29.28 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.209 -0.905 . . . . 70.23 108.788 -171.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.57 ' HD2' ' HB2' ' A' ' 175' ' ' LEU . 16.4 tpt180 -96.67 142.64 28.47 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 108.58 -0.896 . . . . 74.51 108.58 -178.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.559 ' HB2' HD11 ' A' ' 174' ' ' LEU . . . -139.62 166.98 23.15 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 118.737 0.698 . . . . 41.51 111.279 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.448 ' HB2' ' HB3' ' B' ' 9' ' ' ALA . 8.1 mm-40 -120.45 101.31 7.69 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 106.193 -1.78 . . . . 61.0 106.193 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.534 HD22 HD13 ' A' ' 176' ' ' LEU . 15.3 tp -99.1 101.87 13.85 Favored Pre-proline 0 C--O 1.215 -0.732 0 N-CA-C 107.918 -1.142 . . . . 54.05 107.918 -177.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.494 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 41.8 Cg_endo -64.63 150.3 88.42 Favored 'Trans proline' 0 C--N 1.368 1.592 0 N-CA-C 108.972 -1.203 . . . . 75.33 108.972 171.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.619 ' HA ' HG21 ' B' ' 6' ' ' ILE . 16.7 tp -152.12 145.99 25.16 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 119.294 0.952 . . . . 64.01 112.152 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 49.2 m -77.47 126.76 31.42 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 114.669 -1.151 . . . . 71.34 109.307 175.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.666 ' HB3' HD22 ' A' ' 215' ' ' LEU . 3.1 mm? -43.86 -55.88 4.24 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 125.955 1.702 . . . . 70.54 112.973 -176.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 -59.52 -45.47 91.64 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 114.42 -1.264 . . . . 75.32 109.917 -176.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -77.19 -11.81 59.87 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.376 -0.829 . . . . 64.33 111.976 -177.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.602 ' HB1' ' O ' ' A' ' 153' ' ' VAL . . . -79.24 -41.81 27.39 Favored 'General case' 0 C--O 1.251 1.181 0 CA-C-O 122.0 0.905 . . . . 41.43 109.433 175.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -67.99 -40.04 83.14 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 114.204 -1.362 . . . . 74.51 110.813 172.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 38.9 m170 -77.86 -43.74 29.34 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.386 0.674 . . . . 75.25 111.92 -173.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.474 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 74.7 -163.61 54.38 Favored Glycine 0 CA--C 1.533 1.209 0 N-CA-C 114.386 0.514 . . . . 71.54 114.386 178.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 102.42 -168.01 18.31 Favored Glycine 0 N--CA 1.477 1.42 0 C-N-CA 123.612 0.625 . . . . 70.42 112.743 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 11.1 mp0 -68.56 102.82 1.54 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.368 0.667 . . . . 73.14 109.442 176.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 4.2 tpp180 -94.05 122.71 36.84 Favored 'General case' 0 C--O 1.245 0.819 0 C-N-CA 123.413 0.685 . . . . 74.4 109.616 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 59.4 t -78.35 109.45 13.0 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 N-CA-C 108.99 -0.744 . . . . 71.24 108.99 176.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.484 HG13 HG13 ' A' ' 145' ' ' VAL . 3.0 p -133.19 122.43 45.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 124.3 1.04 . . . . 73.14 108.673 178.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -107.56 136.93 46.5 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.262 0.625 . . . . 71.3 109.403 -175.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.589 ' HB ' ' HB3' ' B' ' 8' ' ' LEU . 7.6 p -152.29 132.34 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.445 0.698 . . . . 75.1 109.995 178.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 62.31 22.95 13.55 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.389 1.076 . . . . 74.24 112.091 176.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 87.42 10.78 70.16 Favored Glycine 0 C--N 1.346 1.115 0 CA-C-O 119.872 -0.404 . . . . 31.1 113.181 -178.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.13 99.17 6.44 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 108.359 -0.978 . . . . 72.12 108.359 -176.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 19.2 ttt180 -71.55 92.58 1.14 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.51 1.124 . . . . 74.41 109.969 176.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.484 HG13 HG13 ' A' ' 138' ' ' VAL . 7.7 p -92.94 133.74 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-O 121.065 0.459 . . . . 73.53 110.406 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 32.8 t -98.52 85.45 3.37 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 108.57 -0.9 . . . . 31.45 108.57 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 96.3 t -81.62 113.08 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 109.166 -0.679 . . . . 73.42 109.166 -176.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 60.5 ttt85 -68.41 93.7 0.5 Allowed 'General case' 0 C--O 1.241 0.655 0 N-CA-C 108.894 -0.78 . . . . 74.14 108.894 172.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.474 HG13 ' HA2' ' A' ' 133' ' ' GLY . 47.5 pt -78.68 135.72 59.81 Favored Pre-proline 0 CA--C 1.551 0.99 0 CA-C-N 115.035 -0.984 . . . . 74.13 108.933 178.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -58.92 128.7 28.88 Favored 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 122.445 2.097 . . . . 60.34 111.539 174.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.84 92.48 0.05 OUTLIER 'Trans proline' 0 C--N 1.382 2.294 0 C-N-CA 122.655 2.236 . . . . 74.15 110.979 170.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 125.92 66.84 0.17 Allowed Glycine 0 C--N 1.336 0.529 0 C-N-CA 121.127 -0.559 . . . . 75.51 111.851 -167.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.602 ' O ' ' HB1' ' A' ' 130' ' ' ALA . 7.5 p -140.78 139.88 33.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 N-CA-C 107.351 -1.352 . . . . 75.43 107.351 171.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.594 ' HG3' ' HE2' ' A' ' 240' ' ' PHE . 52.0 mtt85 -153.02 173.59 15.23 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.072 0.949 . . . . 73.23 109.194 174.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.57 ' HB3' ' H ' ' A' ' 188' ' ' LEU . 16.7 tp10 -35.38 122.31 0.61 Allowed 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 126.505 1.922 . . . . 72.32 114.975 -168.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 93.15 -13.38 67.78 Favored Glycine 0 C--N 1.342 0.871 0 CA-C-O 119.655 -0.525 . . . . 14.21 114.174 176.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.464 ' O ' HG12 ' A' ' 178' ' ' VAL . 17.9 t -71.39 139.29 49.72 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 109.274 -0.639 . . . . 74.23 109.274 175.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 71.2 t -105.55 119.53 54.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 123.565 0.746 . . . . 72.34 109.131 -178.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.545 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 60.4 mt -98.49 115.19 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 N-CA-C 108.394 -0.965 . . . . 75.24 108.394 174.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -78.3 106.0 9.93 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 109.068 -0.716 . . . . 61.32 109.068 173.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 13.3 p -113.6 113.01 48.09 Favored Pre-proline 0 CA--C 1.556 1.205 0 N-CA-C 109.417 -0.586 . . . . 61.33 109.417 173.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.493 ' HG2' ' HB3' ' A' ' 86' ' ' SER . 43.2 Cg_endo -68.88 139.73 44.15 Favored 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 122.672 2.248 . . . . 74.53 113.042 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.457 ' N ' ' HB3' ' A' ' 171' ' ' PRO . . . 109.67 -26.68 13.75 Favored Glycine 0 N--CA 1.476 1.335 0 C-N-CA 123.442 0.544 . . . . 70.43 113.689 167.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.472 ' N ' ' SD ' ' A' ' 164' ' ' MET . 1.3 mpt? -95.67 -31.06 13.43 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.232 0.613 . . . . 64.15 109.9 -177.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.494 ' N ' ' HB2' ' A' ' 174' ' ' LEU . . . -94.32 153.39 21.03 Favored Glycine 0 CA--C 1.492 -1.4 0 N-CA-C 108.742 -1.743 . . . . 73.33 108.742 168.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.826 ' HA3' ' HA3' ' A' ' 172' ' ' GLY . . . 53.44 80.54 0.07 OUTLIER Glycine 0 CA--C 1.475 -2.407 0 CA-C-O 118.872 -0.96 . . . . 74.5 112.968 -162.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.568 ' HA ' HE21 ' A' ' 167' ' ' GLN . 0.0 OUTLIER -56.52 105.11 0.18 Allowed 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 128.149 2.911 . . . . 75.42 109.059 -178.574 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -176.89 -140.61 3.66 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.096 -1.602 . . . . 64.21 109.096 -172.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . 0.511 ' ND2' ' HB3' ' A' ' 106' ' ' PHE . 0.7 OUTLIER -133.04 -54.28 0.02 OUTLIER Pre-proline 0 N--CA 1.484 1.232 0 CA-C-N 117.613 0.707 . . . . 63.11 109.608 176.421 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.432 ' O ' ' HA ' ' A' ' 115' ' ' LYS . 19.1 Cg_exo -67.74 123.44 10.73 Favored 'Trans proline' 0 C--N 1.388 2.625 0 N-CA-C 106.44 -2.177 . . . . 71.13 106.44 159.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.457 ' HB3' ' N ' ' A' ' 163' ' ' GLY . 41.1 Cg_endo -63.43 141.24 80.19 Favored 'Trans proline' 0 N--CA 1.483 0.874 0 C-N-CA 122.508 2.139 . . . . 71.25 114.858 -164.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.826 ' HA3' ' HA3' ' A' ' 166' ' ' GLY . . . -79.52 -26.41 56.92 Favored Glycine 0 C--N 1.348 1.217 0 C-N-CA 119.553 -1.308 . . . . 72.4 111.924 159.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 89.24 137.37 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 127.385 2.274 . . . . 71.14 110.116 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.559 HD11 ' HB2' ' A' ' 121' ' ' ALA . 24.5 tp -111.21 136.89 49.62 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.26 0.624 . . . . 64.32 110.16 -174.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.57 ' HB2' ' HD2' ' A' ' 120' ' ' ARG . 59.2 mt -105.75 84.79 2.12 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.239 1.015 . . . . 72.12 109.102 -178.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.545 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 95.4 mt -69.03 100.38 1.22 Allowed 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 115.204 -0.907 . . . . 70.05 110.812 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 57.7 t -84.52 102.5 10.56 Favored 'Isoleucine or valine' 0 C--O 1.242 0.69 0 N-CA-C 107.726 -1.213 . . . . 61.43 107.726 173.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 9.1 p -69.37 122.53 21.03 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.211 0 CA-C-N 115.48 -0.782 . . . . 70.33 111.254 -173.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.494 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 23.6 mmt180 -112.44 93.58 4.51 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.449 1.5 . . . . 53.32 108.217 -178.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.561 HD13 HD13 ' A' ' 127' ' ' LEU . 22.4 mt -70.19 149.39 47.56 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.428 0.529 . . . . 72.4 112.428 -175.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 77.9 mt -59.44 159.68 15.95 Favored Pre-proline 0 CA--C 1.554 1.127 0 C-N-CA 124.49 1.116 . . . . 73.14 111.71 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -70.8 32.98 0.23 Allowed 'Trans proline' 0 C--N 1.384 2.439 0 C-N-CA 123.365 2.71 . . . . 71.42 114.7 175.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . 0.493 ' HB3' ' HG ' ' A' ' 127' ' ' LEU . 56.2 t-80 -67.39 106.53 1.26 Allowed Pre-proline 0 CA--C 1.553 1.091 0 C-N-CA 125.165 1.386 . . . . 73.35 107.533 165.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -75.39 24.51 0.4 Allowed 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 123.877 3.051 . . . . 61.24 115.683 -163.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 97.5 t -97.94 -61.76 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 122.595 0.358 . . . . 64.21 111.165 -173.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 14.6 m-30 -124.31 140.52 52.88 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 121.604 0.716 . . . . 72.31 111.937 -171.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -139.02 141.8 38.29 Favored 'General case' 0 C--O 1.215 -0.734 0 C-N-CA 125.883 1.673 . . . . 75.51 106.557 171.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.624 HD12 ' HA ' ' A' ' 193' ' ' LEU . 5.4 tp -106.36 176.3 5.21 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 107.211 -1.404 . . . . 74.21 107.211 178.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -163.16 128.08 3.05 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 109.019 -0.734 . . . . 70.31 109.019 168.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 69.0 -74.19 0.36 Allowed Glycine 0 C--N 1.349 1.256 0 N-CA-C 111.005 -0.838 . . . . 65.41 111.005 -169.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -163.81 -2.42 0.03 OUTLIER 'General case' 0 CA--C 1.564 1.495 0 C-N-CA 124.115 0.966 . . . . 72.32 110.996 173.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -98.62 150.88 21.29 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 122.818 0.447 . . . . 72.32 110.599 -178.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.624 ' HA ' HD12 ' A' ' 188' ' ' LEU . 0.4 OUTLIER -88.81 155.93 19.26 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.347 1.059 . . . . 63.44 110.796 -167.112 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -142.57 151.31 41.43 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.642 1.577 . . . . 73.14 108.134 173.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.437 ' HB3' HD23 ' A' ' 251' ' ' LEU . . . -152.72 136.68 16.33 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.168 0.987 . . . . 74.34 108.662 177.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 32.2 m -77.79 133.69 38.18 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 118.008 0.367 . . . . 70.21 110.026 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 32.3 tp -134.01 97.59 3.92 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.047 0.539 . . . . 72.21 110.262 -176.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -85.71 121.42 28.35 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 108.723 -0.843 . . . . 61.43 108.723 170.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 7.7 p -138.25 137.37 20.66 Favored Pre-proline 0 N--CA 1.482 1.164 0 C-N-CA 123.754 0.822 . . . . 64.4 109.179 -171.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -72.32 153.97 56.19 Favored 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 121.607 1.538 . . . . 64.51 111.386 177.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.4 ' HB3' ' HH2' ' A' ' 269' ' ' TRP . . . -50.98 -50.91 72.08 Favored Pre-proline 0 CA--C 1.553 1.076 0 N-CA-C 114.696 1.369 . . . . 71.34 114.696 -171.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.563 ' HG2' ' HE1' ' C' ' 276' ' ' TYR . 47.6 Cg_exo -61.2 -37.78 71.53 Favored 'Trans proline' 0 C--N 1.386 2.552 0 C-N-CA 121.851 1.7 . . . . 63.54 113.969 -179.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.531 HD11 ' HB3' ' C' ' 276' ' ' TYR . 34.9 mt -67.2 -37.64 79.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 N-CA-C 109.754 -0.462 . . . . 64.32 109.754 176.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.06 -42.83 88.94 Favored 'General case' 0 CA--C 1.554 1.127 0 CA-C-N 115.571 -0.741 . . . . 71.51 111.688 177.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 54.3 t -70.21 -48.49 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 124.081 0.952 . . . . 63.23 111.435 -176.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 57.7 t -85.14 -39.24 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-N 115.137 -0.938 . . . . 74.41 111.781 -170.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 97.67 90.08 1.9 Allowed Glycine 0 C--O 1.242 0.638 0 N-CA-C 110.873 -0.891 . . . . 72.35 110.873 -171.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.524 ' HA3' HG23 ' A' ' 203' ' ' ILE . . . -115.49 -151.48 9.91 Favored Glycine 0 C--N 1.339 0.735 0 CA-C-N 115.468 -0.366 . . . . 55.24 113.54 -175.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 27.1 mtmt -137.55 132.41 33.12 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.311 -0.625 . . . . 45.21 109.311 -176.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 30.9 m -134.39 149.84 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 108.512 -0.922 . . . . 63.11 108.512 173.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -87.12 113.3 22.75 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 109.019 -0.734 . . . . 71.41 109.019 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.55 165.57 11.17 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.02 0.928 . . . . 62.04 110.052 -176.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . 0.464 ' N ' ' SD ' ' A' ' 213' ' ' MET . 0.0 OUTLIER -98.21 151.9 19.95 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 115.658 -0.701 . . . . 71.23 109.455 -175.712 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 63.8 p -133.13 -173.82 3.31 Favored 'General case' 0 C--O 1.242 0.697 0 C-N-CA 124.814 1.246 . . . . 74.1 107.721 167.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.666 HD22 ' HB3' ' A' ' 127' ' ' LEU . 28.4 mt -81.12 -26.6 36.04 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.133 0.573 . . . . 63.31 109.901 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -87.64 -17.44 31.86 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 114.977 -1.01 . . . . 64.44 111.723 -176.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 149.34 -156.83 26.98 Favored Glycine 0 C--N 1.344 1.016 0 CA-C-O 119.35 -0.694 . . . . 33.0 111.687 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -87.61 139.92 5.03 Favored 'Trans proline' 0 C--N 1.365 1.395 0 C-N-CA 122.641 2.227 . . . . 70.23 112.055 173.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 35.1 m -132.14 169.66 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.791 1.236 . . . . 73.4 107.796 171.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -111.92 134.46 53.46 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 121.726 -0.609 . . . . 75.04 111.372 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 7.5 p -119.51 140.22 44.23 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 124.745 1.218 . . . . 74.13 109.352 -176.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -103.62 103.2 13.11 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.971 0.508 . . . . 60.25 110.05 -178.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 70.5 t -58.8 140.78 85.83 Favored Pre-proline 0 CA--C 1.567 1.614 0 C-N-CA 125.432 1.493 . . . . 63.14 110.7 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -84.72 170.47 10.12 Favored 'Trans proline' 0 C--N 1.387 2.604 0 C-N-CA 123.25 2.634 . . . . 75.51 111.549 177.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.16 148.08 30.51 Favored 'Trans proline' 0 C--N 1.368 1.558 0 C-N-CA 121.748 1.632 . . . . 72.53 113.155 174.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 63.3 mtt85 63.62 32.34 14.0 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 125.329 1.451 . . . . 74.04 111.978 175.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.48 HG23 HD21 ' A' ' 233' ' ' LEU . 90.8 m -62.31 106.68 0.78 Allowed 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 113.689 -1.596 . . . . 64.32 110.498 172.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -95.53 151.37 19.37 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.389 0.675 . . . . 75.32 110.888 -170.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -62.27 117.84 6.63 Favored 'General case' 0 C--N 1.351 0.669 0 C-N-CA 123.981 0.912 . . . . 62.31 110.774 177.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 105.51 -23.64 29.46 Favored Glycine 0 C--N 1.34 0.805 0 CA-C-N 115.903 -0.589 . . . . 73.32 112.885 178.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 231' ' ' ARG . 46.5 mtt180 -72.79 136.25 45.4 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-O 121.552 0.691 . . . . 74.0 110.944 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.727 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 39.3 mttm -101.14 112.0 24.36 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 114.09 -1.413 . . . . 72.22 109.299 -179.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.536 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 45.9 mt -75.86 100.94 4.95 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.068 0.947 . . . . 71.4 110.175 -172.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 57.1 ttt180 -73.26 125.22 27.28 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.529 1.132 . . . . 64.14 110.895 -172.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.505 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 76.7 mt -118.74 107.25 13.43 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.19 0.996 . . . . 61.12 109.614 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 3.5 mmmp? -60.93 126.06 25.99 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 113.127 0.788 . . . . 64.43 113.127 -172.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 73.6 33.64 57.96 Favored Glycine 0 C--N 1.354 1.543 0 O-C-N 123.852 0.72 . . . . 74.2 114.05 173.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -114.58 -18.31 11.47 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.242 0.617 . . . . 73.01 111.387 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -81.9 -170.14 44.03 Favored Glycine 0 C--N 1.346 1.128 0 N-CA-C 112.004 -0.438 . . . . 74.43 112.004 170.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . 0.594 ' HE2' ' HG3' ' A' ' 154' ' ' ARG . 9.9 m-85 -94.69 154.92 39.9 Favored Pre-proline 0 N--CA 1.478 0.965 0 C-N-CA 122.844 0.457 . . . . 73.13 112.149 -170.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -66.65 123.06 10.58 Favored 'Trans proline' 0 C--N 1.387 2.595 0 C-N-CA 123.216 2.611 . . . . 73.33 112.831 -178.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -151.42 -150.03 5.22 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-O 119.368 -0.685 . . . . 73.52 112.426 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -65.06 -29.84 56.56 Favored 'Trans proline' 0 C--N 1.378 2.108 0 C-N-CA 123.249 2.633 . . . . 70.45 113.179 -175.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -87.59 20.77 2.79 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.8 0.84 . . . . 70.11 111.57 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 85.55 -89.76 1.63 Allowed Glycine 0 C--N 1.35 1.332 0 N-CA-C 109.736 -1.346 . . . . 62.24 109.736 -173.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 59.1 mtm180 -127.12 157.56 39.36 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.045 0.938 . . . . 75.41 109.109 165.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -81.38 179.78 53.35 Favored Glycine 0 C--O 1.241 0.561 0 CA-C-N 115.736 -0.665 . . . . 42.24 112.179 178.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -125.27 154.26 41.96 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.725 0.81 . . . . 75.44 109.085 -179.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.562 HD13 HD13 ' A' ' 193' ' ' LEU . 40.1 tp -96.64 112.22 24.05 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 109.466 -0.568 . . . . 70.31 109.466 -179.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.727 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 22.0 m-85 -97.79 105.84 18.05 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.577 1.151 . . . . 52.51 109.307 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.536 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 16.4 mt -79.6 98.8 7.04 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 109.67 -0.493 . . . . 72.24 109.67 175.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -77.34 103.52 7.32 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 108.465 -0.939 . . . . 75.41 108.465 -175.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.456 HG11 HG22 ' A' ' 227' ' ' THR . 56.6 t -87.73 144.07 9.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 N-CA-C 114.259 1.207 . . . . 24.43 114.259 -166.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 6.7 mmm180 -128.32 113.61 15.83 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.475 1.51 . . . . 73.14 107.619 165.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 62.1 mt -75.96 138.88 19.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 122.986 0.515 . . . . 74.34 109.747 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 46.7 p -124.11 175.82 6.76 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 124.709 1.204 . . . . 73.43 109.304 177.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.48 ' HB ' ' HD2' ' A' ' 258' ' ' PRO . 28.6 pt -121.82 164.72 23.41 Favored Pre-proline 0 CA--C 1.556 1.189 0 C-N-CA 123.762 0.825 . . . . 73.4 109.286 175.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' PRO . . . . . 0.48 ' HD2' ' HB ' ' A' ' 257' ' ' ILE . 60.8 Cg_endo -69.65 6.53 1.24 Allowed 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 122.687 2.258 . . . . 74.45 114.851 177.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . 0.478 ' HG3' ' NE2' ' C' ' 228' ' ' GLN . 0.8 OUTLIER 49.35 -96.79 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.615 0.766 . . . . 63.24 109.494 -161.012 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.93 158.56 19.88 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.086 0.954 . . . . 75.12 110.778 -173.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.456 HD13 ' HA ' ' A' ' 266' ' ' GLU . 67.9 mt -135.64 -178.04 4.94 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.732 0.813 . . . . 55.32 110.719 -175.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 5.2 p -133.52 146.44 60.6 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 124.697 1.199 . . . . 44.34 109.033 176.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -17.69 -60.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.393 2.918 1 C-N-CA 127.402 5.401 . . . . 74.33 118.037 -168.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -65.03 -59.36 4.23 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.036 0.534 . . . . 71.44 111.197 -175.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -62.91 -29.69 70.97 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.712 0.805 . . . . 64.2 110.659 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' GLU . . . . . 0.456 ' HA ' HD13 ' A' ' 261' ' ' LEU . 8.6 tp10 -57.71 -54.74 43.48 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 124.236 1.015 . . . . 73.45 109.433 175.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -64.34 -33.41 75.77 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 114.681 -1.145 . . . . 64.12 111.691 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 8.8 mp -61.42 -52.22 65.46 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.0 0.52 . . . . 73.14 111.429 177.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' TRP . . . . . 0.4 ' HH2' ' HB3' ' A' ' 201' ' ' ALA . 61.2 m95 -61.7 -38.82 89.27 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.344 0.658 . . . . 75.0 111.805 178.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . 0.465 ' HE2' HG23 ' C' ' 206' ' ' VAL . 1.0 OUTLIER -67.55 -40.22 84.99 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.758 -0.655 . . . . 62.43 111.368 179.278 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -64.3 -41.93 96.61 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.071 0.548 . . . . 70.22 110.521 175.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' LEU . . . . . 0.499 ' O ' ' HB2' ' A' ' 276' ' ' TYR . 51.8 mt -55.5 -45.96 77.02 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 124.012 0.82 . . . . 63.4 110.574 175.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -77.13 -32.92 56.76 Favored 'General case' 0 C--O 1.246 0.874 0 O-C-N 124.389 1.055 . . . . 64.51 113.005 -173.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -72.47 -48.09 43.61 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.318 0.647 . . . . 74.35 110.061 177.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . 0.448 ' HB1' ' NH2' ' A' ' 279' ' ' ARG . . . -71.97 -20.77 61.68 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.51 0.724 . . . . 71.44 111.225 177.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . 0.499 ' HB2' ' O ' ' A' ' 272' ' ' LEU . 21.7 t80 -63.14 -64.96 0.76 Allowed 'General case' 0 C--N 1.356 0.884 0 C-N-CA 123.803 0.841 . . . . 75.02 108.847 171.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -63.32 -40.6 97.76 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.316 -0.856 . . . . 70.12 110.432 -172.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -59.35 -30.72 68.59 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.659 0.784 . . . . 75.41 111.834 176.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . 0.448 ' NH2' ' HB1' ' A' ' 275' ' ' ALA . 23.6 mtm180 -118.22 34.74 5.04 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.347 0.659 . . . . 74.13 109.855 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.386 0 N-CA-C 109.235 -0.654 . . . . 72.21 109.235 174.439 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.478 0.974 0 N-CA-C 109.283 -0.636 . . . . 71.44 109.283 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 59.5 tttp 71.34 115.57 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.772 1.229 . . . . 54.1 112.052 -176.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 66.4 48.34 1.58 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.575 1.55 . . . . 74.04 111.533 170.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 25.5 m -67.5 -22.74 65.44 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 114.816 -1.084 . . . . 52.14 110.574 172.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 2.5 m 71.29 150.37 0.09 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.793 1.637 . . . . 70.11 111.469 176.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.619 HG21 ' HA ' ' A' ' 125' ' ' LEU . 36.5 pt -136.97 167.67 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 113.146 0.795 . . . . 64.44 113.146 -162.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -145.57 124.33 12.61 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.274 1.03 . . . . 72.01 109.647 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . 0.589 ' HB3' ' HB ' ' A' ' 140' ' ' VAL . 44.2 tp -74.26 150.47 40.23 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.168 0.987 . . . . 75.22 111.264 -172.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . 0.448 ' HB3' ' HB2' ' A' ' 122' ' ' GLU . . . -90.74 -50.32 5.97 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.192 0.597 . . . . 62.4 112.117 -178.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 84.8 mt 66.65 115.61 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 124.677 1.191 . . . . 74.1 111.678 -170.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 56.2 mt . . . . . 0 CA--C 1.553 1.062 0 N-CA-C 108.007 -1.108 . . . . 45.35 108.007 171.888 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.972 0 CA-C-O 121.242 0.544 . . . . 61.34 110.111 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . 70.94 -34.77 0.31 Allowed 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 126.438 1.895 . . . . 74.4 113.304 -173.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 181' ' ' LEU . . . . . 0.519 HD22 ' HB2' ' C' ' 136' ' ' ARG . 60.5 tp -161.29 -71.75 0.06 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.139 0.976 . . . . 62.04 108.928 170.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 182' ' ' VAL . . . . . . . . . . . . . 49.2 t -86.71 131.08 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 109.263 -0.643 . . . . 71.31 109.263 177.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -66.19 -56.83 9.39 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 123.908 0.755 . . . . 65.24 111.263 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -169.52 178.73 4.08 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-O 121.64 0.733 . . . . 74.15 111.173 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 185' ' ' VAL . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.469 0.487 0 N-CA-C 107.564 -1.273 . . . . 71.33 107.564 160.364 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 31.4 m . . . . . 0 N--CA 1.488 1.456 0 N-CA-C 110.07 -0.345 . . . . 71.31 110.07 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -172.47 -179.19 2.16 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.054 0.942 . . . . 74.42 109.815 173.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . -106.0 -125.38 5.49 Favored Glycine 0 C--N 1.346 1.123 0 N-CA-C 112.178 -0.369 . . . . 71.23 112.178 -178.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -104.69 -168.68 1.51 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.895 0.878 . . . . 71.21 110.844 -176.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 242' ' ' TRP . . . . . 0.564 ' HZ3' ' HD3' ' C' ' 231' ' ' ARG . 0.0 OUTLIER 92.43 -13.66 0.18 Allowed 'General case' 0 N--CA 1.508 2.452 0 C-N-CA 128.035 2.534 . . . . 70.32 111.867 176.968 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -124.89 119.34 28.52 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.434 0.635 . . . . 74.22 111.989 -164.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -69.54 -33.83 72.66 Favored Glycine 0 C--N 1.345 1.056 0 N-CA-C 110.16 -1.176 . . . . 63.11 110.16 162.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 8.2 ttpp . . . . . 0 CA--C 1.558 1.285 0 C-N-CA 124.597 1.159 . . . . 75.34 113.443 161.482 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.127 0 CA-C-O 119.464 -0.303 . . . . 52.01 111.814 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -37.38 94.95 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.489 1.516 . . . . 70.52 113.862 -175.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -66.49 104.36 1.24 Allowed 'General case' 0 C--O 1.239 0.514 0 N-CA-C 107.915 -1.142 . . . . 63.2 107.915 166.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -74.63 90.98 2.3 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 107.531 -1.285 . . . . 63.22 107.531 172.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 7' ' ' TYR . . . . . 0.423 ' CD1' ' HA ' ' C' ' 53' ' ' ALA . 72.4 m-85 -62.21 -26.01 68.12 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 114.387 -1.279 . . . . 73.43 111.99 -171.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -63.13 -47.86 80.96 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.54 0.736 . . . . 72.53 110.543 173.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.75 -39.58 93.87 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.06 0.544 . . . . 52.31 110.972 178.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 65.9 mt -59.26 -39.93 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 C-N-CA 123.374 0.669 . . . . 63.34 110.737 176.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 11' ' ' LEU . . . . . 0.415 ' O ' ' HB1' ' C' ' 25' ' ' ALA . 95.5 mt -90.14 -0.17 57.47 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 112.497 0.555 . . . . 45.45 112.497 177.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 59.59 37.92 92.93 Favored Glycine 0 C--N 1.352 1.459 0 N-CA-C 114.107 0.403 . . . . 64.33 114.107 178.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 7.2 m -126.03 139.41 34.28 Favored Pre-proline 0 N--CA 1.482 1.141 0 C-N-CA 124.775 1.23 . . . . 64.04 109.209 177.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -76.87 159.83 34.31 Favored 'Trans proline' 0 C--N 1.368 1.605 0 C-N-CA 122.192 1.928 . . . . 74.43 111.976 176.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 53.6 mtt180 -74.08 76.34 1.74 Allowed 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.329 -0.989 . . . . 71.52 108.329 171.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 176.39 -27.59 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.17 1.388 . . . . 71.24 108.487 -172.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.45 135.93 57.85 Favored 'General case' 0 C--N 1.351 0.664 0 CA-C-N 115.653 -0.703 . . . . 71.14 110.172 172.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 72.0 p -65.99 160.87 22.69 Favored 'General case' 0 C--O 1.246 0.899 0 O-C-N 123.668 0.605 . . . . 74.41 109.671 177.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 19' ' ' GLN . . . . . 0.558 ' HG2' ' HD3' ' C' ' 60' ' ' PRO . 24.8 tp60 -56.57 -33.67 66.38 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.233 0.613 . . . . 74.45 111.808 -176.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -75.0 -28.78 60.67 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 119.121 -0.466 . . . . 64.05 111.698 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . 0.527 ' HG2' HH21 ' C' ' 24' ' ' ARG . 46.3 mt-10 -69.36 -41.13 76.97 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 121.109 0.481 . . . . 73.42 110.161 174.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 22' ' ' ILE . . . . . 0.432 HG21 ' HB3' ' C' ' 57' ' ' LEU . 57.2 mt -66.44 -38.3 81.45 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 CA-C-N 114.735 -1.12 . . . . 61.32 110.12 176.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 23' ' ' LYS . . . . . 0.441 ' O ' ' HD3' ' C' ' 27' ' ' LYS . 4.5 ttpt -70.11 -40.49 74.86 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 114.69 -1.141 . . . . 74.13 109.617 179.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 24' ' ' ARG . . . . . 0.527 HH21 ' HG2' ' C' ' 21' ' ' GLU . 46.6 mtm105 -72.57 -22.39 61.0 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.276 0.63 . . . . 73.52 111.283 176.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . 0.415 ' HB1' ' O ' ' C' ' 11' ' ' LEU . . . -66.96 -45.2 78.46 Favored 'General case' 0 C--O 1.242 0.661 0 O-C-N 123.537 0.523 . . . . 75.32 109.603 171.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 26' ' ' TYR . . . . . 0.553 ' HD1' HG22 ' C' ' 50' ' ' ILE . 83.4 t80 -57.76 -52.95 63.35 Favored 'General case' 0 C--N 1.355 0.82 0 CA-C-N 115.5 -0.773 . . . . 72.31 110.698 171.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . 0.459 ' HE2' ' HA ' ' C' ' 24' ' ' ARG . 6.0 mppt? -60.69 -32.63 71.84 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.433 0.693 . . . . 74.1 111.62 -176.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -61.98 -48.81 78.7 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.974 0.91 . . . . 71.15 109.494 174.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . 0.59 HD13 HD12 ' C' ' 50' ' ' ILE . 76.6 mt -77.39 -13.4 59.94 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 114.781 -1.1 . . . . 60.22 111.664 178.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -86.93 -19.68 28.45 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.488 0.715 . . . . 75.32 110.02 176.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 60.4 mtm180 -91.92 -27.23 18.03 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.309 0.644 . . . . 73.5 110.364 169.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -72.84 -59.93 2.48 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.415 0.686 . . . . 71.12 109.218 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -90.25 22.31 3.39 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.92 0.888 . . . . 70.15 110.901 -178.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 34' ' ' HIS . . . . . 0.407 ' NE2' ' HB3' ' C' ' 36' ' ' ASP . 75.8 t60 -53.18 93.97 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.586 0 C-N-CA 125.565 1.546 . . . . 72.34 113.043 -166.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 35' ' ' PRO . . . . . 0.423 ' O ' ' HG2' ' C' ' 39' ' ' LYS . 53.3 Cg_endo -76.55 -6.05 16.64 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.901 2.401 . . . . 71.32 111.806 -168.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 36' ' ' ASP . . . . . 0.407 ' HB3' ' NE2' ' C' ' 34' ' ' HIS . 24.0 t70 -63.73 -35.91 82.15 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.442 1.097 . . . . 60.34 111.46 172.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 41.1 t -122.92 -46.9 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 CA-C-O 121.191 0.519 . . . . 75.33 109.753 -177.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -98.33 81.85 2.82 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.005 0.922 . . . . 54.22 109.678 -178.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 39' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' C' ' 35' ' ' PRO . 9.7 mtmp? -84.74 70.03 10.76 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 115.641 -0.709 . . . . 62.24 109.919 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . 0.4 ' HB2' ' HB3' ' C' ' 43' ' ' ALA . 49.4 m -95.22 108.59 39.8 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-O 118.254 -0.879 . . . . 74.14 108.74 175.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -41.35 -53.01 3.33 Favored 'Trans proline' 0 C--N 1.386 2.542 0 C-N-CA 124.457 3.438 . . . . 63.44 115.157 -174.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -65.72 -31.6 72.69 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.302 0.641 . . . . 65.44 111.335 -178.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 43' ' ' ALA . . . . . 0.4 ' HB3' ' HB2' ' C' ' 40' ' ' SER . . . -77.46 -18.93 56.71 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.036 0.534 . . . . 62.05 110.546 176.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 44' ' ' GLU . . . . . 0.452 ' HA ' ' HB3' ' C' ' 47' ' ' PHE . 51.0 mt-10 -89.91 -19.39 24.61 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.797 0.839 . . . . 74.04 109.634 177.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -77.07 -39.82 48.42 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.069 0.947 . . . . 42.53 109.53 168.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 46' ' ' LYS . . . . . 0.531 ' O ' HG12 ' C' ' 50' ' ' ILE . 63.3 mttp -61.35 -48.04 83.11 Favored 'General case' 0 C--N 1.35 0.606 0 CA-C-N 115.094 -0.957 . . . . 72.32 108.847 169.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 47' ' ' PHE . . . . . 0.452 ' HB3' ' HA ' ' C' ' 44' ' ' GLU . 59.5 t80 -64.22 -27.97 69.42 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.179 0.991 . . . . 62.23 110.856 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 48' ' ' LYS . . . . . 0.518 ' HE2' ' HB3' ' C' ' 89' ' ' ASP . 2.9 tptm -62.82 -48.78 77.62 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 108.698 -0.853 . . . . 72.04 108.698 172.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -70.79 -19.68 62.67 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 112.557 0.577 . . . . 72.33 112.557 176.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 50' ' ' ILE . . . . . 0.59 HD12 HD13 ' C' ' 29' ' ' LEU . 23.6 mm -78.75 -34.43 17.39 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 N-CA-C 108.787 -0.82 . . . . 75.43 108.787 174.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 51' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -79.1 -18.23 53.66 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 124.069 0.947 . . . . 74.04 111.276 175.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 52' ' ' GLU . . . . . 0.429 ' O ' HG23 ' C' ' 56' ' ' VAL . 32.6 tt0 -76.18 -50.23 15.09 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.569 -0.9 . . . . 63.42 108.569 170.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . 0.423 ' HA ' ' CD1' ' C' ' 7' ' ' TYR . . . -60.57 -33.38 72.62 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 114.593 -1.185 . . . . 63.1 111.247 176.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 54' ' ' TYR . . . . . 0.458 ' O ' ' HB2' ' C' ' 58' ' ' SER . 20.8 t80 -81.92 -32.9 30.66 Favored 'General case' 0 C--O 1.214 -0.783 0 C-N-CA 123.788 0.835 . . . . 75.01 110.207 176.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.81 -34.37 67.63 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 120.915 0.388 . . . . 60.54 110.247 174.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 56' ' ' VAL . . . . . 0.429 HG23 ' O ' ' C' ' 52' ' ' GLU . 14.8 t -97.61 -24.62 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.26 0 CA-C-N 115.065 -0.97 . . . . 72.43 112.308 -178.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 57' ' ' LEU . . . . . 0.432 ' HB3' HG21 ' C' ' 22' ' ' ILE . 61.9 mt -125.46 29.77 5.94 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 119.242 0.928 . . . . 75.02 112.746 -177.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 58' ' ' SER . . . . . 0.458 ' HB2' ' O ' ' C' ' 54' ' ' TYR . 23.1 t -69.8 -56.44 7.13 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.238 0.542 . . . . 62.42 111.8 175.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -130.05 157.19 77.74 Favored Pre-proline 0 N--CA 1.479 0.981 0 C-N-CA 124.313 1.045 . . . . 72.03 109.303 -171.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 60' ' ' PRO . . . . . 0.558 ' HD3' ' HG2' ' C' ' 19' ' ' GLN . 18.2 Cg_endo -54.26 -21.05 21.42 Favored 'Trans proline' 0 C--N 1.391 2.797 0 C-N-CA 122.921 2.414 . . . . 33.23 112.992 -179.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -51.35 -75.62 0.03 OUTLIER 'General case' 0 CA--C 1.565 1.537 0 C-N-CA 124.554 1.142 . . . . 62.13 110.832 170.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.39 -28.68 67.32 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.592 0.757 . . . . 75.23 111.338 -176.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 10.1 ttp180 -66.14 -44.74 83.31 Favored 'General case' 0 C--N 1.351 0.644 0 N-CA-C 109.496 -0.557 . . . . 64.42 109.496 -177.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -71.0 -29.98 66.1 Favored 'General case' 0 C--N 1.359 1.003 0 O-C-N 123.876 0.735 . . . . 74.15 111.015 178.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 47.5 mm -57.19 -48.55 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 CA-C-O 121.196 0.522 . . . . 62.34 110.049 170.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -67.23 -40.72 86.39 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.773 -0.649 . . . . 74.22 111.012 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -59.42 -45.8 90.52 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 122.95 0.5 . . . . 73.14 110.565 178.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 74.2 p -73.14 -15.72 61.47 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.522 -0.763 . . . . 63.2 111.271 178.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -73.05 116.91 14.14 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 106.948 -1.501 . . . . 75.22 106.948 167.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 111.2 9.5 21.95 Favored Glycine 0 N--CA 1.472 1.073 0 N-CA-C 111.475 -0.65 . . . . 62.51 111.475 -165.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 88.3 m -141.57 -59.01 0.48 Allowed 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 103.755 -2.683 . . . . 72.34 103.755 176.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 34.4 m -73.96 134.16 43.09 Favored 'General case' 0 C--O 1.251 1.164 0 N-CA-C 103.88 -2.637 . . . . 73.35 103.88 155.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.03 -37.45 5.36 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.329 0.652 . . . . 73.23 110.8 -170.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -88.86 150.7 46.17 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 123.992 0.917 . . . . 53.23 109.098 174.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -52.37 117.66 3.85 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 122.838 2.359 . . . . 75.14 111.629 172.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.89 156.75 18.41 Favored 'Trans proline' 0 C--N 1.382 2.325 0 C-N-CA 123.494 2.796 . . . . 63.14 113.745 -176.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -66.53 121.38 8.62 Favored 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 122.209 1.939 . . . . 51.51 111.044 172.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 78' ' ' PRO . . . . . 0.449 ' HB3' ' HA3' ' C' ' 104' ' ' GLY . 32.0 Cg_endo -61.82 135.38 55.58 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 122.886 2.391 . . . . 74.44 113.414 -174.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.22 159.06 54.84 Favored 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 123.001 2.467 . . . . 61.04 112.455 176.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.49 85.9 0.04 OUTLIER 'Trans proline' 0 C--N 1.391 2.815 0 C-N-CA 123.553 2.835 . . . . 51.5 112.873 177.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 159.01 -45.33 0.45 Allowed Glycine 0 C--N 1.341 0.856 0 CA-C-N 114.967 -1.015 . . . . 75.2 111.358 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 111.55 175.23 20.02 Favored Glycine 0 C--N 1.351 1.37 0 C-N-CA 123.514 0.578 . . . . 74.45 112.053 -174.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -83.94 113.24 20.84 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.996 -0.742 . . . . 70.14 108.996 177.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -63.08 144.87 56.52 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 123.928 0.767 . . . . 63.13 112.639 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 85' ' ' PHE . . . . . 0.529 ' O ' ' HG3' ' C' ' 171' ' ' PRO . 78.3 m-85 -137.31 72.24 1.42 Allowed 'General case' 0 C--O 1.212 -0.88 0 C-N-CA 124.567 1.147 . . . . 74.41 109.348 171.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 50.7 m -47.49 86.61 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 124.31 1.044 . . . . 45.43 112.924 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 67.64 13.13 62.89 Favored Glycine 0 C--N 1.349 1.275 0 CA-C-N 115.513 -0.767 . . . . 74.33 114.611 -178.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 88' ' ' PHE . . . . . 0.493 ' HB2' ' HB3' ' C' ' 85' ' ' PHE . 18.6 m-85 -92.22 128.97 38.26 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 109.081 -0.711 . . . . 74.44 109.081 -177.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 89' ' ' ASP . . . . . 0.518 ' HB3' ' HE2' ' C' ' 48' ' ' LYS . 27.9 t70 -83.69 78.59 9.67 Favored 'General case' 0 C--O 1.246 0.898 0 CA-C-O 121.665 0.745 . . . . 72.23 110.509 -172.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 90' ' ' VAL . . . . . 0.752 HG21 HD21 ' C' ' 169' ' ' ASN . 1.3 p -43.44 -36.43 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.22 0 C-N-CA 125.934 1.694 . . . . 54.41 112.415 172.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -50.21 -36.53 31.16 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.648 1.579 . . . . 74.21 112.891 -178.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -119.26 21.41 12.26 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.524 0.729 . . . . 75.53 111.234 -170.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 21.5 m-30 -94.17 175.49 6.68 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.805 -0.559 . . . . 72.45 111.123 175.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 94' ' ' SER . . . . . 0.408 ' O ' ' HB3' ' C' ' 97' ' ' PHE . 84.5 p -74.4 173.45 10.27 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 113.754 1.02 . . . . 45.51 113.754 -164.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 95' ' ' GLU . . . . . 0.455 ' O ' ' HG3' ' C' ' 99' ' ' GLU . 4.0 mp0 -73.21 -36.52 66.52 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 114.71 -1.132 . . . . 55.43 110.617 178.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -60.57 -42.56 96.88 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-O 121.535 0.683 . . . . 65.02 110.289 173.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 97' ' ' PHE . . . . . 0.72 ' HE2' HG23 ' C' ' 90' ' ' VAL . 48.9 t80 -58.46 -43.4 88.85 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 114.282 -1.326 . . . . 64.25 109.933 174.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -66.56 -29.21 69.24 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 122.664 0.386 . . . . 51.52 111.814 176.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 99' ' ' GLU . . . . . 0.455 ' HG3' ' O ' ' C' ' 95' ' ' GLU . 45.0 mt-10 -67.21 -56.15 11.09 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 122.752 0.421 . . . . 74.43 110.24 178.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 26.7 tp -75.33 -50.18 16.81 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.392 -0.822 . . . . 73.23 111.802 -172.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -91.66 -20.3 21.75 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.299 0.64 . . . . 73.25 112.555 -173.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -46.46 -58.18 6.07 Favored Glycine 0 CA--C 1.541 1.68 0 CA-C-O 118.933 -0.926 . . . . 54.11 115.107 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -63.43 -3.29 5.04 Favored 'Trans proline' 0 C--N 1.385 2.462 0 C-N-CA 123.186 2.591 . . . . 62.02 114.464 -177.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 104' ' ' GLY . . . . . 0.449 ' HA3' ' HB3' ' C' ' 78' ' ' PRO . . . -137.91 32.53 2.35 Favored Glycine 0 C--N 1.349 1.284 0 CA-C-O 119.953 -0.359 . . . . 43.23 113.14 176.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 105' ' ' LEU . . . . . 0.403 ' HB3' ' ND2' ' C' ' 169' ' ' ASN . 48.3 mt . . . . . 0 N--CA 1.486 1.337 0 C-N-CA 123.019 0.528 . . . . 73.03 111.733 173.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 116' ' ' GLY . . . . . 0.41 ' HA2' ' HA3' ' C' ' 168' ' ' GLY . . . . . . . . 0 CA--C 1.499 -0.921 0 CA-C-O 120.926 0.181 . . . . 45.25 113.182 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 17.1 mtm180 -116.4 171.88 7.56 Favored 'General case' 0 C--O 1.263 1.81 0 CA-C-O 122.369 1.081 . . . . 64.44 111.397 -173.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 118' ' ' ASP . . . . . 0.459 ' HA ' ' O ' ' C' ' 173' ' ' ASP . 3.4 m-20 -61.3 117.95 6.28 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 112.37 -2.195 . . . . 75.42 109.138 170.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 119' ' ' LEU . . . . . 0.637 ' HG ' ' HG2' ' C' ' 167' ' ' GLN . 3.0 tt -92.89 120.72 33.52 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 105.818 -1.919 . . . . 75.21 105.818 -178.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.581 ' HE ' HG21 ' C' ' 177' ' ' VAL . 57.0 ttt180 -117.56 114.19 23.07 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.625 -0.509 . . . . 72.31 109.625 -164.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 121' ' ' ALA . . . . . . . . . . . . . . . -108.66 169.95 8.33 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 122.812 0.445 . . . . 63.21 111.805 -171.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -131.86 114.49 14.74 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 123.88 0.872 . . . . 73.22 109.636 -176.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -140.03 115.43 7.88 Favored Pre-proline 0 N--CA 1.483 1.221 0 CA-C-N 117.992 0.36 . . . . 73.3 111.858 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . 0.412 ' HA ' ' O ' ' C' ' 179' ' ' ARG . 24.6 Cg_exo -66.88 116.03 3.91 Favored 'Trans proline' 0 C--N 1.378 2.098 0 C-N-CA 122.229 1.952 . . . . 72.51 109.486 162.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 125' ' ' LEU . . . . . 0.462 ' O ' ' HA ' ' C' ' 180' ' ' LEU . 14.8 tp -139.58 166.87 23.43 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 107.392 -1.336 . . . . 74.03 107.392 -170.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 126' ' ' THR . . . . . 0.418 ' HB ' HD12 ' C' ' 181' ' ' LEU . 14.2 t -127.01 175.32 8.18 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 119.1 0.864 . . . . 61.53 110.976 175.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 127' ' ' LEU . . . . . 0.458 HD11 ' H ' ' C' ' 185' ' ' VAL . 6.5 mt -59.86 -44.55 94.09 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 126.092 1.757 . . . . 62.25 110.011 -177.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -58.16 -45.25 87.77 Favored 'General case' 0 C--O 1.213 -0.848 0 CA-C-N 113.694 -1.593 . . . . 75.24 109.586 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 129' ' ' GLU . . . . . 0.536 ' HA ' ' HB2' ' C' ' 132' ' ' HIS . 20.0 mm-40 -77.74 -18.0 56.98 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 124.446 1.091 . . . . 73.53 111.659 -178.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 130' ' ' ALA . . . . . 0.486 ' HB1' ' HA2' ' C' ' 152' ' ' GLY . . . -71.86 -36.67 70.18 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.066 -0.716 . . . . 64.34 109.066 174.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 131' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -73.07 -46.71 49.98 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 114.753 -1.112 . . . . 75.55 111.176 167.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 132' ' ' HIS . . . . . 0.536 ' HB2' ' HA ' ' C' ' 129' ' ' GLU . 32.7 m170 -74.79 -7.57 53.81 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 118.998 -0.525 . . . . 60.22 111.24 -172.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -70.28 66.96 0.72 Allowed Glycine 0 C--N 1.354 1.537 0 O-C-N 123.712 0.632 . . . . 65.31 113.482 172.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . -88.45 -139.8 6.88 Favored Glycine 0 C--N 1.348 1.206 0 N-CA-C 109.657 -1.377 . . . . 53.24 109.657 169.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -72.73 93.62 1.67 Allowed 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 108.727 -0.842 . . . . 71.2 108.727 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 136' ' ' ARG . . . . . 0.519 ' HB2' HD22 ' B' ' 181' ' ' LEU . 57.2 mtp180 -141.91 163.11 33.77 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.722 0.809 . . . . 72.12 110.756 -171.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 137' ' ' VAL . . . . . . . . . . . . . 54.2 t -71.33 95.48 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 CA-C-N 115.019 -0.991 . . . . 71.12 110.9 -171.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 138' ' ' VAL . . . . . 0.404 ' HB ' HG13 ' C' ' 145' ' ' VAL . 97.9 t -79.01 112.22 16.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 107.055 -1.461 . . . . 72.14 107.055 165.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 139' ' ' GLU . . . . . . . . . . . . . 53.7 tt0 -121.48 78.44 1.43 Allowed 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 107.567 -1.272 . . . . 74.31 107.567 -167.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 140' ' ' VAL . . . . . 0.481 HG11 HD11 ' C' ' 174' ' ' LEU . 89.3 t -128.1 104.56 12.04 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 CA-C-N 114.31 -1.313 . . . . 63.22 110.755 -166.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 68.14 24.31 7.7 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.979 1.312 . . . . 15.23 113.045 168.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 107.5 -29.48 10.43 Favored Glycine 0 C--N 1.338 0.689 0 N-CA-C 111.273 -0.731 . . . . 45.25 111.273 -176.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 143' ' ' ARG . . . . . 0.443 ' CZ ' ' HB ' ' C' ' 145' ' ' VAL . 14.0 tpt180 -70.37 106.94 3.57 Favored 'General case' 0 C--N 1.363 1.192 0 N-CA-C 108.8 -0.815 . . . . 73.04 108.8 177.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 11.4 ttt-85 -113.83 96.74 6.0 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-N 114.864 -1.062 . . . . 71.51 108.773 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 145' ' ' VAL . . . . . 0.537 HG22 ' HB ' ' C' ' 147' ' ' VAL . 3.1 p -127.71 130.28 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 124.273 1.029 . . . . 75.03 110.085 -175.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 55.5 m -90.76 86.53 6.36 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 108.803 -0.814 . . . . 54.21 108.803 174.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 147' ' ' VAL . . . . . 0.537 ' HB ' HG22 ' C' ' 145' ' ' VAL . 9.7 p -131.51 159.34 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-N 114.981 -1.008 . . . . 72.53 110.473 -170.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 23.1 ttm180 -88.56 104.52 16.91 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 108.392 -0.966 . . . . 74.22 108.392 170.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 149' ' ' ILE . . . . . 0.415 HD12 HD13 ' C' ' 159' ' ' ILE . 30.5 pt -69.74 151.52 96.4 Favored Pre-proline 0 CA--C 1.548 0.88 0 CA-C-O 118.045 -0.979 . . . . 71.41 108.861 166.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 150' ' ' PRO . . . . . 0.498 ' HD2' HG22 ' C' ' 161' ' ' VAL . 34.8 Cg_exo -39.27 108.66 0.08 OUTLIER 'Trans proline' 0 C--N 1.39 2.74 0 C-N-CA 123.547 2.831 . . . . 61.44 112.864 176.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -66.6 122.09 9.45 Favored 'Trans proline' 0 C--N 1.382 2.302 0 C-N-CA 122.537 2.158 . . . . 73.2 111.447 -171.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 152' ' ' GLY . . . . . 0.599 ' HA3' HD23 ' C' ' 188' ' ' LEU . . . 99.47 122.72 4.84 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-N 115.52 -0.764 . . . . 54.32 113.386 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 153' ' ' VAL . . . . . 0.684 HG21 HG21 ' C' ' 178' ' ' VAL . 3.5 m -129.99 176.13 9.23 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 C-N-CA 123.745 0.818 . . . . 71.13 109.487 -174.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 154' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -133.66 160.05 38.68 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.375 0.67 . . . . 75.32 110.322 177.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 155' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -67.25 103.75 1.32 Allowed 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 124.786 1.234 . . . . 74.51 112.125 -176.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 97.89 -0.79 59.29 Favored Glycine 0 C--N 1.354 1.542 0 CA-C-N 115.583 -0.735 . . . . 64.51 113.163 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 157' ' ' SER . . . . . . . . . . . . . 55.6 m -90.39 170.34 10.32 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.082 0.553 . . . . 75.43 111.966 -172.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 158' ' ' VAL . . . . . 0.528 HG12 HG22 ' C' ' 177' ' ' VAL . 28.2 m -104.99 125.77 59.97 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 CA-C-N 115.488 -0.778 . . . . 64.44 111.086 178.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 159' ' ' ILE . . . . . 0.586 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 17.3 mt -76.04 98.66 1.7 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.6 0 N-CA-C 108.082 -1.081 . . . . 52.25 108.082 166.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 21.6 ttp180 -81.97 101.25 10.18 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.993 0.917 . . . . 72.21 110.012 -178.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 161' ' ' VAL . . . . . 0.549 ' HB ' ' HB3' ' C' ' 174' ' ' LEU . 16.1 t -100.19 112.87 64.92 Favored Pre-proline 0 CA--C 1.551 1.004 0 N-CA-C 107.83 -1.174 . . . . 75.24 107.83 175.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -50.48 99.11 0.04 OUTLIER 'Trans proline' 0 C--N 1.384 2.418 0 C-N-CA 124.034 3.156 . . . . 63.42 114.745 -172.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 67.29 23.6 73.32 Favored Glycine 0 C--N 1.347 1.143 0 N-CA-C 115.73 1.052 . . . . 53.31 115.73 169.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 164' ' ' MET . . . . . . . . . . . . . 43.6 ttp -98.0 18.67 15.47 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 117.582 0.691 . . . . 73.35 109.795 174.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . -74.94 -120.95 0.1 Allowed Glycine 0 C--N 1.357 1.727 0 CA-C-N 115.81 -0.632 . . . . 64.24 112.248 174.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . 153.03 -82.87 0.17 Allowed Glycine 0 C--N 1.35 1.354 0 C-N-CA 119.057 -1.544 . . . . 75.44 114.669 172.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 167' ' ' GLN . . . . . 0.637 ' HG2' ' HG ' ' C' ' 119' ' ' LEU . 26.2 mm-40 -14.99 102.49 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.479 0 C-N-CA 126.294 1.837 . . . . 64.31 113.933 -160.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 168' ' ' GLY . . . . . 0.41 ' HA3' ' HA2' ' C' ' 116' ' ' GLY . . . 108.88 145.3 11.22 Favored Glycine 0 CA--C 1.535 1.301 0 N-CA-C 108.996 -1.642 . . . . 13.44 108.996 -161.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 169' ' ' ASN . . . . . 0.752 HD21 HG21 ' C' ' 90' ' ' VAL . 3.1 t-20 -61.42 -59.61 13.02 Favored Pre-proline 0 CA--C 1.576 1.954 0 N-CA-C 114.687 1.365 . . . . 62.44 114.687 -164.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 170' ' ' PRO . . . . . 0.539 ' HD3' ' HB3' ' C' ' 169' ' ' ASN . 7.9 Cg_exo -71.41 104.55 1.59 Allowed 'Trans proline' 0 C--N 1.398 3.142 0 C-N-CA 122.303 2.002 . . . . 51.41 110.693 175.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 171' ' ' PRO . . . . . 0.529 ' HG3' ' O ' ' C' ' 85' ' ' PHE . 58.1 Cg_endo -61.35 126.83 20.25 Favored 'Trans proline' 0 N--CA 1.502 1.972 0 C-N-CA 123.736 2.957 . . . . 74.02 114.688 -161.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -80.49 -167.18 36.09 Favored Glycine 0 C--N 1.354 1.538 0 O-C-N 123.48 0.488 . . . . 74.42 112.269 172.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 173' ' ' ASP . . . . . 0.459 ' O ' ' HA ' ' C' ' 118' ' ' ASP . 13.0 t70 -86.62 155.62 20.35 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 123.54 0.736 . . . . 74.51 110.556 -174.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 174' ' ' LEU . . . . . 0.549 ' HB3' ' HB ' ' C' ' 161' ' ' VAL . 27.7 tp -98.24 114.86 27.26 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 121.496 -0.752 . . . . 75.22 110.198 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 175' ' ' LEU . . . . . 0.445 ' O ' ' HA ' ' C' ' 120' ' ' ARG . 79.6 mt -110.97 91.03 3.5 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.316 0.646 . . . . 71.32 109.867 176.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 176' ' ' LEU . . . . . 0.586 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 62.0 mt -81.02 105.88 12.58 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 109.178 -0.675 . . . . 43.02 109.178 178.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 177' ' ' VAL . . . . . 0.581 HG21 ' HE ' ' C' ' 120' ' ' ARG . 60.3 t -81.51 107.68 13.93 Favored 'Isoleucine or valine' 0 C--O 1.249 1.045 0 CA-C-O 121.901 0.857 . . . . 74.43 108.832 -178.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 178' ' ' VAL . . . . . 0.684 HG21 HG21 ' C' ' 153' ' ' VAL . 4.0 p -93.86 140.41 16.58 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 CA-C-N 114.113 -1.403 . . . . 74.01 110.464 -178.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 179' ' ' ARG . . . . . 0.412 ' O ' ' HA ' ' C' ' 124' ' ' PRO . 50.9 mmm-85 -121.92 111.56 17.22 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 107.402 -1.333 . . . . 72.33 107.402 172.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 180' ' ' LEU . . . . . 0.462 ' HA ' ' O ' ' C' ' 125' ' ' LEU . 84.5 mt -70.52 145.88 50.57 Favored 'General case' 0 C--O 1.237 0.432 0 O-C-N 123.543 0.527 . . . . 70.51 111.299 -175.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 181' ' ' LEU . . . . . 0.418 HD12 ' HB ' ' C' ' 126' ' ' THR . 31.1 mt -60.01 168.53 2.06 Favored Pre-proline 0 CA--C 1.555 1.171 0 C-N-CA 124.914 1.286 . . . . 74.2 111.886 -178.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -42.0 -3.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.395 3.023 0 C-N-CA 124.834 3.69 . . . . 64.12 118.14 174.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 183' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -125.3 83.39 61.16 Favored Pre-proline 0 CA--C 1.569 1.69 0 CA-C-N 118.865 0.757 . . . . 62.13 110.499 166.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 184' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -85.57 69.57 5.18 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 123.671 2.914 . . . . 71.54 110.311 173.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 185' ' ' VAL . . . . . 0.458 ' H ' HD11 ' C' ' 127' ' ' LEU . 4.3 t -90.83 -43.77 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 N-CA-C 109.993 -0.373 . . . . 72.23 109.993 -166.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 186' ' ' PHE . . . . . 0.662 ' HB3' HD22 ' C' ' 193' ' ' LEU . 21.7 m-85 -99.75 113.0 25.21 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.708 0.766 . . . . 61.44 112.151 -170.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 187' ' ' ARG . . . . . 0.493 ' HB3' ' HB3' ' C' ' 194' ' ' TYR . 36.0 ttm180 -96.98 101.23 12.76 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 107.257 -1.386 . . . . 75.14 107.257 171.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 188' ' ' LEU . . . . . 0.599 HD23 ' HA3' ' C' ' 152' ' ' GLY . 41.1 tp -93.88 144.73 25.18 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 112.856 0.687 . . . . 74.14 112.856 -171.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -131.42 111.02 11.45 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 107.242 -1.392 . . . . 71.33 107.242 159.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 70.32 -86.37 0.33 Allowed Glycine 0 C--N 1.351 1.362 0 O-C-N 123.704 0.627 . . . . 74.2 113.141 177.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 191' ' ' GLN . . . . . 0.578 ' HA ' ' HB2' ' C' ' 240' ' ' PHE . 20.7 mt-30 -132.51 -10.76 3.18 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.289 0.636 . . . . 60.21 112.028 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -104.66 121.58 43.85 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 121.303 0.573 . . . . 65.13 110.839 -177.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 193' ' ' LEU . . . . . 0.662 HD22 ' HB3' ' C' ' 186' ' ' PHE . 56.7 mt -90.87 153.15 20.42 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.353 1.461 . . . . 52.2 111.034 -177.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 194' ' ' TYR . . . . . 0.493 ' HB3' ' HB3' ' C' ' 187' ' ' ARG . 46.7 t80 -112.05 148.79 33.13 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 106.983 -1.488 . . . . 75.43 106.983 162.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 195' ' ' ALA . . . . . 0.4 ' HA ' ' O ' ' C' ' 185' ' ' VAL . . . -154.66 -175.24 5.32 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.253 0.621 . . . . 65.11 110.946 -177.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 58.3 m -130.74 145.9 52.07 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.072 0.949 . . . . 51.32 108.813 168.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 197' ' ' LEU . . . . . . . . . . . . . 36.3 tp -127.4 113.64 16.48 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.359 1.064 . . . . 73.5 108.861 -176.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 198' ' ' ASP . . . . . 0.47 ' HB3' HG21 ' C' ' 256' ' ' THR . 19.9 m-20 -86.11 101.76 13.26 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 109.778 -0.453 . . . . 44.52 109.778 -178.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 199' ' ' VAL . . . . . 0.553 ' HA ' HG11 ' C' ' 210' ' ' VAL . 88.8 t -105.58 123.22 40.13 Favored Pre-proline 0 N--CA 1.474 0.747 0 C-N-CA 123.775 0.83 . . . . 61.21 109.13 177.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 200' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.88 148.03 56.91 Favored 'Trans proline' 0 C--N 1.369 1.655 0 C-N-CA 121.896 1.731 . . . . 71.34 110.929 176.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 201' ' ' ALA . . . . . . . . . . . . . . . -55.0 -43.59 99.14 Favored Pre-proline 0 CA--C 1.553 1.069 0 N-CA-C 114.174 1.176 . . . . 74.35 114.174 -175.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 202' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -54.38 -52.78 7.44 Favored 'Trans proline' 0 C--N 1.394 2.971 0 C-N-CA 121.733 1.622 . . . . 63.15 112.666 175.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 203' ' ' ILE . . . . . . . . . . . . . 44.6 mt -65.18 -31.04 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 124.089 0.956 . . . . 63.4 111.269 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.34 -43.26 81.99 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.736 0.814 . . . . 75.02 111.817 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 205' ' ' VAL . . . . . . . . . . . . . 87.4 t -72.62 -47.81 49.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 115.866 -0.606 . . . . 63.41 111.22 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 206' ' ' VAL . . . . . 0.465 HG23 ' HE2' ' A' ' 270' ' ' LYS . 11.5 p -80.96 -34.12 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 112.842 0.682 . . . . 52.12 112.842 -171.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 89.86 111.77 1.4 Allowed Glycine 0 CA--C 1.531 1.04 0 N-CA-C 111.623 -0.591 . . . . 63.21 111.623 -169.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -153.24 -121.46 0.85 Allowed Glycine 0 C--N 1.348 1.217 0 CA-C-O 119.606 -0.552 . . . . 51.32 111.76 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 209' ' ' LYS . . . . . . . . . . . . . 31.7 mtmt -151.81 153.09 33.57 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.672 0.789 . . . . 72.12 111.6 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 210' ' ' VAL . . . . . 0.553 HG11 ' HA ' ' C' ' 199' ' ' VAL . 29.3 m -139.97 178.06 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 126.764 2.026 . . . . 62.05 108.393 174.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 211' ' ' ARG . . . . . 0.429 ' NE ' ' HB2' ' C' ' 218' ' ' PRO . 0.0 OUTLIER -111.84 147.93 34.7 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.018 0.527 . . . . 72.44 111.296 177.213 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -127.18 121.29 30.91 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 107.369 -1.345 . . . . 74.43 107.369 164.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 213' ' ' MET . . . . . . . . . . . . . 1.4 tmm? -76.02 112.99 13.03 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 108.281 -1.007 . . . . 63.12 108.281 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 214' ' ' THR . . . . . 0.423 HG22 ' H ' ' C' ' 215' ' ' LEU . 0.2 OUTLIER -117.99 175.39 5.69 Favored 'General case' 0 N--CA 1.485 1.325 0 CA-C-N 118.86 0.755 . . . . 54.24 111.962 -173.373 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 215' ' ' LEU . . . . . 0.423 ' H ' HG22 ' C' ' 214' ' ' THR . 35.7 mt -73.82 -33.49 64.18 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.247 1.419 . . . . 44.41 112.384 -171.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -83.41 -4.65 58.69 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 115.262 -0.881 . . . . 71.0 110.647 175.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 132.09 173.22 13.26 Favored Glycine 0 C--N 1.342 0.878 0 N-CA-C 110.898 -0.881 . . . . 64.11 110.898 -175.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 218' ' ' PRO . . . . . 0.429 ' HB2' ' NE ' ' C' ' 211' ' ' ARG . 93.5 Cg_endo -75.56 113.22 3.7 Favored 'Trans proline' 0 CA--C 1.55 1.316 0 C-N-CA 122.253 1.969 . . . . 52.13 112.0 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 219' ' ' VAL . . . . . . . . . . . . . 14.6 p -89.03 152.3 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 108.034 -1.099 . . . . 52.53 108.034 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 220' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -111.57 107.69 16.93 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.194 -1.039 . . . . 72.32 108.194 176.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 221' ' ' VAL . . . . . 0.429 HG22 HD11 ' C' ' 235' ' ' LEU . 53.9 t -75.86 129.08 37.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 114.281 -1.327 . . . . 74.03 111.415 -174.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -77.95 138.07 38.66 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.016 0.436 . . . . 73.3 110.507 169.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 57.5 t -118.25 124.17 28.82 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 124.066 0.946 . . . . 73.11 108.916 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 224' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -76.47 162.41 33.37 Favored 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 123.065 2.51 . . . . 54.33 111.067 169.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -60.71 156.14 44.52 Favored 'Trans proline' 0 C--N 1.369 1.632 0 C-N-CA 122.526 2.151 . . . . 74.0 113.333 176.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 226' ' ' ARG . . . . . 0.468 ' HD2' ' O ' ' A' ' 259' ' ' GLU . 11.8 mmt180 59.59 63.52 1.5 Allowed 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 125.269 1.428 . . . . 70.15 111.764 176.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 227' ' ' THR . . . . . . . . . . . . . 57.8 m -100.33 132.28 45.79 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.644 0.777 . . . . 70.3 111.51 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 228' ' ' GLN . . . . . 0.478 ' NE2' ' HG3' ' A' ' 259' ' ' GLU . 26.7 mp0 -111.17 150.6 29.27 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 124.562 1.145 . . . . 74.32 112.376 -179.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 229' ' ' ALA . . . . . 0.457 ' HB2' ' H ' ' C' ' 255' ' ' ILE . . . -75.1 118.85 18.49 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 114.551 -1.204 . . . . 62.12 109.606 177.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 116.58 -1.35 20.24 Favored Glycine 0 C--N 1.339 0.747 0 O-C-N 123.688 0.617 . . . . 62.04 112.287 -176.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 231' ' ' ARG . . . . . 0.564 ' HD3' ' HZ3' ' B' ' 242' ' ' TRP . 32.4 mtt180 -66.42 172.99 3.55 Favored 'General case' 0 C--N 1.355 0.819 0 CA-C-O 120.843 0.354 . . . . 74.12 110.691 167.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 232' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' C' ' 251' ' ' LEU . 3.6 ttmp? -142.88 146.29 33.94 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 109.582 -0.525 . . . . 71.45 109.582 175.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 233' ' ' LEU . . . . . 0.425 ' O ' ' HA ' ' C' ' 250' ' ' TYR . 3.5 tt -132.91 125.36 29.72 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.726 0.811 . . . . 74.21 108.838 -168.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 35.5 ttp180 -92.31 104.25 16.62 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.776 0.322 . . . . 72.34 110.397 170.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 235' ' ' LEU . . . . . 0.483 HD12 HD23 ' C' ' 249' ' ' LEU . 72.2 mt -81.56 116.41 21.31 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 107.903 -1.147 . . . . 73.43 107.903 164.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -80.27 134.08 36.05 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 123.328 0.651 . . . . 71.55 110.963 -176.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 70.9 26.97 73.02 Favored Glycine 0 C--N 1.349 1.269 0 O-C-N 123.933 0.77 . . . . 71.42 113.235 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 21.7 mmtm -120.62 12.15 11.42 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.958 0.903 . . . . 72.03 111.515 -177.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -90.44 -133.1 5.29 Favored Glycine 0 C--N 1.343 0.966 0 N-CA-C 111.316 -0.714 . . . . 31.21 111.316 172.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 240' ' ' PHE . . . . . 0.578 ' HB2' ' HA ' ' C' ' 191' ' ' GLN . 3.5 m-85 -97.35 118.49 64.42 Favored Pre-proline 0 C--O 1.237 0.436 0 C-N-CA 123.068 0.547 . . . . 75.14 109.907 174.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 241' ' ' PRO . . . . . 0.515 ' HA ' ' HA ' ' C' ' 246' ' ' ARG . 87.4 Cg_exo -50.94 103.88 0.07 OUTLIER 'Trans proline' 0 C--N 1.365 1.432 0 C-N-CA 123.557 2.838 . . . . 70.21 113.069 166.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -77.42 174.0 54.79 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-N 114.707 -1.133 . . . . 70.14 112.974 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -66.82 -11.08 30.61 Favored 'Trans proline' 0 C--N 1.368 1.559 0 C-N-CA 123.123 2.549 . . . . 71.42 114.038 -171.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -137.29 1.72 2.44 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.687 0.795 . . . . 71.42 111.735 179.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . -171.75 -138.38 2.54 Favored Glycine 0 C--N 1.348 1.238 0 CA-C-O 119.706 -0.497 . . . . 51.32 112.949 -177.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 246' ' ' ARG . . . . . 0.515 ' HA ' ' HA ' ' C' ' 241' ' ' PRO . 85.5 mtm180 -148.44 160.87 42.62 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.845 0.858 . . . . 61.31 111.004 -178.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -96.46 -169.3 34.32 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 114.879 -1.055 . . . . 63.23 112.173 173.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -126.33 169.94 12.41 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.104 0.562 . . . . 73.54 110.495 -173.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 249' ' ' LEU . . . . . 0.483 HD23 HD12 ' C' ' 235' ' ' LEU . 17.6 tp -129.25 127.14 40.63 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.945 0.898 . . . . 74.23 109.38 -176.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 250' ' ' TYR . . . . . 0.425 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 89.5 m-85 -117.06 101.17 8.26 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.695 0.798 . . . . 71.43 110.141 -178.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 251' ' ' LEU . . . . . 0.447 ' O ' ' HA ' ' C' ' 232' ' ' LYS . 0.9 OUTLIER -99.23 129.76 45.48 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 119.286 -0.388 . . . . 64.53 110.113 -176.039 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -73.11 108.45 6.0 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.076 -1.083 . . . . 73.41 108.076 166.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 253' ' ' VAL . . . . . 0.43 HG11 ' HH2' ' B' ' 242' ' ' TRP . 46.7 t -78.79 110.69 14.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.732 -0.667 . . . . 73.5 109.977 -176.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 254' ' ' ARG . . . . . . . . . . . . . 41.0 mtm180 -94.06 159.01 15.35 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.498 0.719 . . . . 74.13 111.321 175.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 255' ' ' ILE . . . . . 0.457 ' H ' ' HB2' ' C' ' 229' ' ' ALA . 35.4 mm -105.82 127.23 60.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 114.235 -1.348 . . . . 75.24 107.983 169.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 256' ' ' THR . . . . . 0.47 HG21 ' HB3' ' C' ' 198' ' ' ASP . 0.3 OUTLIER -133.49 172.82 12.21 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.917 1.287 . . . . 53.32 108.775 -177.685 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 35.1 pt -127.02 145.55 54.4 Favored Pre-proline 0 N--CA 1.481 1.099 0 C-N-CA 123.434 0.694 . . . . 64.54 110.109 -178.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -63.33 -11.83 27.52 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.698 2.266 . . . . 73.21 113.72 -173.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 53.32 -67.25 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.961 1.704 . . . . 72.3 112.64 -165.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 8.1 ppt_? -59.77 133.65 56.29 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.33 0.652 . . . . 73.41 110.351 174.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 261' ' ' LEU . . . . . 0.556 HD22 ' HB3' ' C' ' 265' ' ' GLU . 91.2 mt -143.34 161.75 37.52 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.73 0.812 . . . . 71.21 110.488 -173.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 63.4 p -91.18 165.56 21.17 Favored Pre-proline 0 CA--C 1.55 0.954 0 N-CA-C 108.62 -0.882 . . . . 61.23 108.62 167.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -48.92 -42.13 38.37 Favored 'Trans proline' 0 C--N 1.381 2.281 0 C-N-CA 122.293 1.996 . . . . 74.2 111.988 169.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -64.18 -58.13 7.5 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 114.202 -1.363 . . . . 71.04 111.244 -178.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 265' ' ' GLU . . . . . 0.556 ' HB3' HD22 ' C' ' 261' ' ' LEU . 0.5 OUTLIER -48.85 -58.37 4.93 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.877 0.871 . . . . 65.11 110.924 177.793 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 266' ' ' GLU . . . . . 0.544 ' O ' ' HG2' ' C' ' 270' ' ' LYS . 33.6 tt0 -58.36 -39.49 79.67 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 124.17 0.919 . . . . 64.21 110.939 -175.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -60.2 -44.13 95.36 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.712 0.805 . . . . 70.32 112.408 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 268' ' ' LEU . . . . . . . . . . . . . 11.1 mp -65.65 -40.71 92.78 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 116.709 -0.223 . . . . 52.44 110.745 176.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -59.81 -36.37 76.62 Favored 'General case' 0 N--CA 1.483 1.177 0 O-C-N 123.558 0.536 . . . . 61.11 110.946 174.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 270' ' ' LYS . . . . . 0.544 ' HG2' ' O ' ' C' ' 266' ' ' GLU . 30.5 mmtp -63.9 -46.92 82.68 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.684 0.794 . . . . 75.43 110.368 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -61.68 -45.06 95.6 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.55 0.74 . . . . 75.33 111.708 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 92.7 mt -62.0 -43.75 98.18 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.236 -0.893 . . . . 74.33 110.315 177.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -59.39 -41.21 88.87 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.558 -0.746 . . . . 34.13 110.695 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -69.31 -31.91 70.69 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.185 0.594 . . . . 63.21 111.595 177.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -62.44 -31.95 72.74 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 122.531 0.332 . . . . 70.04 110.473 171.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 276' ' ' TYR . . . . . 0.563 ' HE1' ' HG2' ' A' ' 202' ' ' PRO . 79.2 m-85 -77.35 -34.56 55.15 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 122.887 0.475 . . . . 75.52 112.207 171.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 15.2 m-30 -66.27 -27.48 67.97 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.797 -0.446 . . . . 44.24 109.797 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -65.53 -1.96 3.01 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 124.413 1.085 . . . . 55.2 113.244 175.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 279' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -72.84 -22.89 60.72 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 122.697 0.399 . . . . 71.52 110.917 171.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.077 0 C-N-CA 123.581 0.752 . . . . 75.14 110.154 178.829 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt . . . . . 0 N--CA 1.472 0.668 0 N-CA-C 113.474 0.916 . . . . 62.43 113.474 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -70.74 88.92 0.73 Allowed 'General case' 0 C--O 1.241 0.62 0 N-CA-C 107.584 -1.265 . . . . 74.32 107.584 162.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.466 ' HA ' ' OH ' ' A' ' 66' ' ' TYR . 34.7 t70 -75.45 93.81 3.02 Favored 'General case' 0 C--N 1.354 0.782 0 N-CA-C 107.511 -1.292 . . . . 61.41 107.511 173.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.615 ' HB2' HD11 ' A' ' 57' ' ' LEU . 50.7 m-85 -60.17 -28.61 68.07 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 113.783 -1.553 . . . . 73.34 111.836 -169.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.429 ' CD1' HD11 ' A' ' 22' ' ' ILE . 50.3 m-85 -65.47 -47.63 75.45 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.035 0.534 . . . . 73.33 110.454 177.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.5 -38.69 91.9 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.871 -0.604 . . . . 60.32 111.427 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 69.6 mt -60.45 -38.98 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 123.733 0.646 . . . . 74.23 110.107 174.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.467 ' HB3' ' HB1' ' A' ' 25' ' ' ALA . 93.7 mt -86.31 2.81 45.98 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 115.36 -0.836 . . . . 51.33 112.505 178.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 63.83 18.23 61.65 Favored Glycine 0 C--N 1.356 1.64 0 N-CA-C 114.771 0.668 . . . . 53.33 114.771 177.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.6 m -107.48 155.35 39.75 Favored Pre-proline 0 N--CA 1.482 1.167 0 C-N-CA 124.389 1.075 . . . . 71.43 110.076 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.88 154.88 30.1 Favored 'Trans proline' 0 C--N 1.383 2.356 0 C-N-CA 123.0 2.466 . . . . 50.12 113.106 177.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 55.7 mtp180 -76.39 13.75 0.89 Allowed 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 112.763 0.653 . . . . 75.43 112.763 -173.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -119.96 -5.41 10.07 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 125.141 1.376 . . . . 64.11 109.402 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.465 ' HB1' ' HB2' ' A' ' 21' ' ' GLU . . . -58.34 127.28 31.35 Favored 'General case' 0 C--N 1.347 0.477 0 C-N-CA 124.75 1.22 . . . . 64.31 111.51 -175.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.563 ' HA ' HH21 ' A' ' 63' ' ' ARG . 79.8 p -84.17 177.05 8.37 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 122.881 0.473 . . . . 71.11 110.658 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -46.71 -32.65 3.72 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 124.982 1.313 . . . . 64.21 113.292 -175.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -81.59 -30.06 33.11 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 112.264 0.468 . . . . 72.43 112.264 -173.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.465 ' HB2' ' HB1' ' A' ' 17' ' ' ALA . 2.5 mp0 -72.92 -33.67 66.12 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 109.601 -0.518 . . . . 64.03 109.601 170.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.499 HG21 ' HB2' ' A' ' 57' ' ' LEU . 1.7 mp -67.29 -33.72 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.738 0.815 . . . . 73.31 110.265 173.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.416 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 4.6 tppp? -64.28 -53.5 47.96 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.824 0.85 . . . . 71.24 109.717 176.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -59.12 -44.43 92.01 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 124.166 0.916 . . . . 54.12 110.935 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.467 ' HB1' ' HB3' ' A' ' 11' ' ' LEU . . . -66.7 -35.54 80.37 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.792 0.837 . . . . 64.0 111.849 -177.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -64.12 -50.49 68.04 Favored 'General case' 0 C--O 1.215 -0.711 0 CA-C-N 115.403 -0.817 . . . . 73.1 109.784 175.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.416 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 54.8 mtpt -59.07 -42.82 91.27 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 123.947 0.779 . . . . 74.22 110.737 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.0 ttt180 -53.25 -55.55 23.6 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.283 1.433 . . . . 71.15 110.728 176.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.752 ' HB3' HD13 ' A' ' 50' ' ' ILE . 95.5 mt -79.28 -15.63 57.68 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.603 -0.726 . . . . 74.11 111.793 -176.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.21 -18.78 38.06 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.55 0.74 . . . . 63.3 110.595 175.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -86.07 -45.86 11.02 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 122.977 0.511 . . . . 72.33 110.37 169.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -63.86 -57.65 9.2 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.006 0.522 . . . . 63.33 110.434 -177.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -97.35 38.56 1.25 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.556 0.742 . . . . 63.25 110.025 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 7.7 t-160 -63.94 103.58 0.43 Allowed Pre-proline 0 C--N 1.354 0.782 0 C-N-CA 123.769 0.828 . . . . 63.41 109.478 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -68.38 -14.46 40.15 Favored 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 122.534 2.156 . . . . 74.13 112.86 -167.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -67.85 -39.93 83.75 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.502 1.121 . . . . 72.45 111.305 173.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 96.5 t -96.58 -51.18 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 123.291 0.636 . . . . 65.53 110.08 -177.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -102.16 89.86 3.74 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.174 0.989 . . . . 61.35 110.898 -176.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.22 44.83 1.17 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.426 0.69 . . . . 73.11 110.58 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 74.0 m -89.72 130.48 42.93 Favored Pre-proline 0 N--CA 1.474 0.766 0 CA-C-O 117.918 -1.039 . . . . 54.41 108.447 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -38.61 -70.35 0.07 OUTLIER 'Trans proline' 0 C--N 1.392 2.836 0 C-N-CA 124.76 3.64 . . . . 72.23 114.334 -172.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.483 ' HA ' ' HB2' ' A' ' 45' ' ' GLU . 30.9 tt0 -75.81 -7.21 53.89 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 116.61 -0.268 . . . . 64.43 111.642 -174.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.37 -35.62 68.53 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 108.929 -0.767 . . . . 72.14 108.929 172.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -86.56 -30.51 21.83 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-N 115.874 -0.603 . . . . 62.01 109.95 -178.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.514 ' HA ' ' HZ2' ' A' ' 48' ' ' LYS . 41.2 mt-10 -67.17 -46.49 73.83 Favored 'General case' 0 C--O 1.244 0.792 0 C-N-CA 123.339 0.656 . . . . 62.44 110.285 174.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 32.3 mmtm -61.19 -39.38 89.97 Favored 'General case' 0 C--O 1.214 -0.785 0 CA-C-N 115.633 -0.712 . . . . 74.03 110.383 171.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.457 ' HA ' HD12 ' A' ' 50' ' ' ILE . 85.2 t80 -58.46 -36.69 74.09 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 123.376 0.423 . . . . 73.24 111.179 176.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.514 ' HZ2' ' HA ' ' A' ' 45' ' ' GLU . 10.5 mtmp? -69.68 -32.81 71.65 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.009 0.523 . . . . 75.14 111.607 175.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -77.59 -22.65 50.55 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 122.603 0.361 . . . . 71.44 111.873 175.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.752 HD13 ' HB3' ' A' ' 29' ' ' LEU . 60.3 mt -77.82 -34.02 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 124.321 1.048 . . . . 70.53 108.737 172.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -64.89 -39.65 93.87 Favored 'General case' 0 C--O 1.218 -0.582 0 CA-C-N 114.817 -1.083 . . . . 73.43 109.641 171.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -61.04 -51.27 69.9 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.349 1.06 . . . . 63.42 110.603 176.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.18 -55.81 27.03 Favored 'General case' 0 C--O 1.255 1.395 0 CA-C-N 114.465 -1.243 . . . . 65.45 112.105 -178.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -65.01 -38.48 91.05 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.069 -0.968 . . . . 72.32 110.978 178.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.549 ' HB1' ' HD2' ' A' ' 85' ' ' PHE . . . -54.0 -50.07 67.44 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.334 0.654 . . . . 53.01 111.399 -178.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 70.9 t -62.71 -53.15 50.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 CA-C-N 114.706 -1.134 . . . . 74.52 110.74 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.615 HD11 ' HB2' ' A' ' 7' ' ' TYR . 55.1 mt -90.76 6.77 42.8 Favored 'General case' 0 CA--C 1.559 1.318 0 N-CA-C 113.796 1.036 . . . . 62.04 113.796 -168.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.6 t -78.4 -54.15 6.5 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.202 0.601 . . . . 74.34 110.539 176.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -75.89 131.23 76.66 Favored Pre-proline 0 C--O 1.236 0.373 0 CA-C-N 115.322 -0.853 . . . . 74.34 109.393 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.427 ' O ' ' HG2' ' A' ' 64' ' ' ARG . 22.9 Cg_endo -58.35 -32.62 96.51 Favored 'Trans proline' 0 C--N 1.385 2.491 0 C-N-CA 123.201 2.601 . . . . 72.41 112.344 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -66.45 -51.56 55.56 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.557 0.743 . . . . 72.3 110.878 -178.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 36.5 mtpt -73.74 -26.67 60.79 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.042 0.937 . . . . 74.54 111.669 -177.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.563 HH21 ' HA ' ' A' ' 18' ' ' THR . 42.6 tpt85 -59.28 -53.64 55.99 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.959 0.904 . . . . 74.11 108.925 168.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.482 ' HA ' ' HE ' ' A' ' 64' ' ' ARG . 2.4 mmp_? -61.92 -31.89 72.25 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 124.163 0.914 . . . . 74.25 111.611 178.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 64.2 mt -60.16 -47.77 90.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.16 0.584 . . . . 64.42 110.373 174.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.466 ' OH ' ' HA ' ' A' ' 6' ' ' ASP . 21.3 t80 -60.26 -48.14 83.02 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 116.037 -0.529 . . . . 75.4 110.14 177.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -54.06 -47.89 71.18 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.044 0.537 . . . . 64.04 111.546 178.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 72.2 p -72.54 -17.78 61.69 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.799 -0.637 . . . . 75.13 111.824 -177.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -74.84 107.34 6.86 Favored 'General case' 0 C--N 1.361 1.079 0 N-CA-C 107.808 -1.182 . . . . 63.45 107.808 170.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 119.71 10.76 7.53 Favored Glycine 0 N--CA 1.469 0.874 0 N-CA-C 111.744 -0.543 . . . . 52.54 111.744 -167.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 90.6 m -145.13 -56.62 0.33 Allowed 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 105.11 -2.181 . . . . 71.23 105.11 177.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 22.0 m -88.0 143.73 26.93 Favored 'General case' 0 C--O 1.251 1.157 0 N-CA-C 104.421 -2.437 . . . . 74.23 104.421 156.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.22 -31.06 9.29 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.288 0.635 . . . . 74.04 110.728 -178.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -83.85 150.63 59.37 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 123.371 0.669 . . . . 75.1 109.483 173.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.442 ' HG2' ' HG2' ' A' ' 103' ' ' PRO . 55.7 Cg_exo -56.87 135.94 73.63 Favored 'Trans proline' 0 C--N 1.371 1.733 0 C-N-CA 122.864 2.376 . . . . 75.41 112.946 175.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.01 162.98 39.46 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 123.612 2.875 . . . . 74.25 112.801 178.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -50.42 115.62 2.03 Favored 'Trans proline' 0 C--N 1.385 2.449 0 C-N-CA 123.444 2.762 . . . . 62.44 113.678 176.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -68.97 134.17 28.95 Favored 'Trans proline' 0 C--N 1.381 2.251 0 C-N-CA 122.568 2.179 . . . . 43.51 111.895 177.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -61.41 154.46 58.73 Favored 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 122.883 2.388 . . . . 71.05 112.656 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.57 87.8 0.05 OUTLIER 'Trans proline' 0 C--N 1.382 2.326 0 C-N-CA 123.375 2.716 . . . . 51.35 112.943 178.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 148.28 -39.89 0.96 Allowed Glycine 0 N--CA 1.463 0.443 0 N-CA-C 109.492 -1.443 . . . . 62.41 109.492 179.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 117.28 -165.62 12.48 Favored Glycine 0 C--N 1.345 1.068 0 CA-C-N 114.607 -0.796 . . . . 53.03 111.991 178.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -90.99 106.09 18.28 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.629 0.772 . . . . 74.41 108.942 178.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -78.14 149.05 33.86 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.454 0.702 . . . . 71.31 111.725 177.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.549 ' HD2' ' HB1' ' A' ' 55' ' ' ALA . 75.9 m-85 -134.61 75.04 1.56 Allowed 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.311 1.044 . . . . 70.22 110.006 -176.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.9 m -49.72 85.59 0.0 OUTLIER 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 125.688 1.595 . . . . 74.44 113.479 -179.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 86.18 12.04 71.46 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-O 119.573 -0.57 . . . . 70.11 114.172 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.616 ' HB3' ' HZ ' ' A' ' 93' ' ' PHE . 45.9 m-85 -119.75 117.45 28.27 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 117.883 0.841 . . . . 72.34 110.334 -174.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -73.77 87.48 1.73 Allowed 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 121.528 0.68 . . . . 71.44 110.391 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.63 HG12 ' HD3' ' A' ' 171' ' ' PRO . 6.0 p -49.45 -32.16 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 125.51 1.524 . . . . 75.21 113.378 173.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -56.2 -24.22 40.5 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.45 1.1 . . . . 75.33 111.847 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -86.1 -30.63 22.41 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.932 0.893 . . . . 45.35 112.483 -178.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.616 ' HZ ' ' HB3' ' A' ' 88' ' ' PHE . 10.3 m-30 -65.75 153.27 42.25 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 112.903 0.705 . . . . 71.01 112.903 -165.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 84.8 p -64.74 171.1 3.59 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 115.667 1.729 . . . . 74.5 115.667 -165.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.56 -42.4 82.97 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 114.46 -1.246 . . . . 74.31 112.725 177.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -57.14 -46.02 83.06 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.984 0.914 . . . . 75.03 109.592 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.429 ' CE2' HG23 ' A' ' 90' ' ' VAL . 48.9 t80 -62.46 -43.52 98.61 Favored 'General case' 0 CA--C 1.553 1.084 0 CA-C-N 113.631 -1.622 . . . . 63.23 110.468 177.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -69.26 -13.21 62.27 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.064 0.546 . . . . 73.05 111.64 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -92.59 -30.8 15.44 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.238 0.615 . . . . 70.02 111.408 170.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 25.1 tp -82.25 -63.38 1.39 Allowed 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.491 0.716 . . . . 55.03 111.412 -177.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -93.77 -6.89 45.0 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.7 0.8 . . . . 72.11 112.727 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -43.74 -56.04 5.19 Favored Glycine 0 CA--C 1.545 1.964 0 N-CA-C 116.315 1.286 . . . . 72.43 116.315 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.442 ' HG2' ' HG2' ' A' ' 75' ' ' PRO . 33.4 Cg_exo -63.14 -3.67 5.25 Favored 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 123.625 2.884 . . . . 23.1 115.367 -176.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -139.42 26.96 2.65 Favored Glycine 0 C--N 1.352 1.468 0 CA-C-O 119.159 -0.801 . . . . 44.4 112.968 175.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.583 ' HB3' ' ND2' ' A' ' 169' ' ' ASN . 23.2 mt -65.38 81.07 0.05 Allowed 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 117.583 0.692 . . . . 74.25 111.708 176.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 43.62 -108.73 0.13 Allowed 'General case' 0 CA--C 1.56 1.327 0 C-N-CA 126.274 1.83 . . . . 72.25 113.072 -178.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.1 5.63 71.57 Favored Glycine 0 C--N 1.368 2.314 0 CA-C-O 118.979 -0.9 . . . . 44.0 114.271 -174.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.689 ' HA3' ' HB3' ' A' ' 167' ' ' GLN . . . . . . . . 0 C--N 1.37 2.422 0 C-N-CA 125.781 1.658 . . . . 71.34 115.905 168.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 25.1 tptp . . . . . 0 N--CA 1.486 1.327 0 N-CA-C 113.32 0.859 . . . . 72.15 113.32 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -89.63 176.48 43.0 Favored Glycine 0 CA--C 1.541 1.712 0 O-C-N 123.691 0.619 . . . . 55.22 113.013 175.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.739 ' H ' ' HA3' ' A' ' 166' ' ' GLY . 0.0 OUTLIER -116.24 175.79 5.39 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.451 1.1 . . . . 71.34 111.211 179.537 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -86.84 95.93 10.03 Favored 'General case' 0 CA--C 1.565 1.521 0 CA-C-O 122.035 0.921 . . . . 74.23 111.025 178.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 9.2 tt -100.89 150.62 22.65 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.671 1.189 . . . . 70.23 109.3 -178.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -98.37 138.75 35.15 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.54 0.736 . . . . 74.51 111.376 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.552 ' HB2' HD11 ' A' ' 174' ' ' LEU . . . -128.74 170.5 13.23 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.939 0.895 . . . . 41.51 109.85 170.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -122.21 114.72 21.23 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 106.402 -1.703 . . . . 61.0 106.402 -178.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 53.4 tp -99.25 101.46 12.89 Favored Pre-proline 0 N--CA 1.475 0.796 0 N-CA-C 108.208 -1.034 . . . . 54.05 108.208 -175.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.57 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 7.1 Cg_endo -86.07 111.05 1.09 Allowed 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 121.403 1.402 . . . . 75.33 109.488 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.564 ' HA ' HG21 ' B' ' 6' ' ' ILE . 47.7 tp -106.48 136.95 45.35 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 110.058 -0.349 . . . . 64.01 110.058 -176.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.463 HG21 ' H ' ' B' ' 4' ' ' SER . 99.9 m -65.54 131.09 45.52 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.985 0.914 . . . . 71.34 110.049 175.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 69.3 mt -57.26 -50.81 71.71 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.908 0.883 . . . . 70.54 111.385 -175.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -59.94 -37.55 79.86 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 114.824 -1.08 . . . . 75.32 110.606 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.421 ' HB2' ' HB ' ' A' ' 126' ' ' THR . 45.1 mm-40 -82.06 -12.71 58.11 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 115.425 -0.807 . . . . 64.33 112.056 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -71.29 -54.04 12.21 Favored 'General case' 0 C--N 1.347 0.471 0 N-CA-C 107.719 -1.215 . . . . 41.43 107.719 167.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -51.98 -44.41 64.02 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 116.138 -0.483 . . . . 74.51 110.984 174.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 50.8 m170 -73.51 -30.13 62.91 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 116.468 -0.333 . . . . 75.25 111.786 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 67.9 -129.05 26.72 Favored Glycine 0 C--N 1.349 1.26 0 O-C-N 123.216 0.323 . . . . 71.54 113.257 177.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.445 ' O ' HG12 ' A' ' 149' ' ' ILE . . . 83.24 -175.59 52.74 Favored Glycine 0 C--N 1.35 1.31 0 C-N-CA 123.007 0.337 . . . . 70.42 113.856 175.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.9 111.36 13.66 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 107.783 -1.191 . . . . 73.14 107.783 169.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.407 ' NH2' ' HB3' ' A' ' 129' ' ' GLU . 13.8 tpp180 -90.16 121.35 32.12 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 109.186 -0.672 . . . . 74.4 109.186 -175.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.494 HG11 ' HE ' ' A' ' 144' ' ' ARG . 97.6 t -86.68 108.33 17.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 CA-C-N 115.204 -0.907 . . . . 71.24 108.904 177.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.453 HG22 HD11 ' B' ' 6' ' ' ILE . 14.6 t -107.37 113.03 42.52 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 115.005 -0.998 . . . . 73.14 108.417 -178.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -99.05 133.21 43.65 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.586 0.754 . . . . 71.3 109.535 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.447 HG11 HD23 ' B' ' 8' ' ' LEU . 7.3 p -166.14 119.24 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.904 0 C-N-CA 123.595 0.758 . . . . 75.1 110.776 -179.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 61.51 19.29 10.2 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.052 1.341 . . . . 74.24 113.741 172.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 102.01 -2.73 51.66 Favored Glycine 0 C--N 1.351 1.376 0 CA-C-N 117.555 0.161 . . . . 31.1 112.993 -177.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 20.7 tpt180 -99.94 112.83 25.09 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.07 0.948 . . . . 72.12 109.589 175.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.494 ' HE ' HG11 ' A' ' 137' ' ' VAL . 74.9 ttt180 -108.02 93.89 4.78 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.122 0.969 . . . . 74.41 108.642 175.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 15.0 p -94.59 149.99 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 123.318 0.647 . . . . 73.53 110.031 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 32.4 t -120.85 98.55 6.06 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.734 0.814 . . . . 31.45 108.872 176.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 19.0 m -103.48 116.63 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.375 0.67 . . . . 73.42 110.951 -176.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -67.41 112.37 4.58 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 109.608 -0.516 . . . . 74.14 109.608 172.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.445 HG12 ' O ' ' A' ' 134' ' ' GLY . 23.7 pt -101.62 152.29 38.04 Favored Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 123.727 0.811 . . . . 74.13 110.283 178.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -58.85 -165.57 0.03 OUTLIER 'Trans proline' 0 N--CA 1.517 2.872 0 C-N-CA 124.568 3.512 . . . . 60.34 112.451 168.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_exo -48.9 89.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.398 3.148 0 CA-C-N 121.025 1.402 . . . . 74.15 109.867 159.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 40.17 -98.01 0.01 OUTLIER Glycine 0 CA--C 1.494 -1.267 0 CA-C-N 112.727 -2.033 . . . . 75.51 114.647 -162.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.708 HG11 HG21 ' A' ' 178' ' ' VAL . 5.5 p 173.43 161.67 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 113.116 -1.542 . . . . 75.43 107.938 -162.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.04 152.86 43.72 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.452 -0.944 . . . . 73.23 108.452 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.453 ' HG2' ' NH1' ' A' ' 187' ' ' ARG . 11.3 tp10 -50.76 130.81 25.42 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 124.008 0.923 . . . . 72.32 112.662 -174.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.83 9.35 85.07 Favored Glycine 0 C--N 1.346 1.1 0 CA-C-N 115.412 -0.813 . . . . 14.21 114.072 178.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 42.0 m -66.18 109.84 2.78 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-N 118.016 0.908 . . . . 74.23 109.087 173.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 46.7 t -88.65 90.47 3.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 123.801 0.84 . . . . 72.34 109.024 -178.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.545 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 59.6 mt -74.24 104.96 3.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 108.656 -0.868 . . . . 75.24 108.656 175.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 46.7 ttt180 -74.86 108.85 7.87 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 109.32 -0.622 . . . . 61.32 109.32 177.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.482 HG13 ' HB3' ' A' ' 174' ' ' LEU . 3.8 p -119.48 95.58 49.33 Favored Pre-proline 0 CA--C 1.554 1.114 0 C-N-CA 123.898 0.879 . . . . 61.33 108.825 174.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.702 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 51.4 Cg_exo -59.74 126.41 20.44 Favored 'Trans proline' 0 C--N 1.372 1.77 0 C-N-CA 122.495 2.13 . . . . 74.53 114.014 175.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 128.05 -30.4 3.92 Favored Glycine 0 N--CA 1.47 0.93 0 CA-C-N 114.852 -1.067 . . . . 70.43 113.774 169.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 69.8 mtm -95.27 3.52 54.44 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 117.191 0.495 . . . . 64.15 111.699 -178.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.518 ' HA2' HD13 ' A' ' 174' ' ' LEU . . . -90.11 -98.32 1.13 Allowed Glycine 0 C--N 1.348 1.227 0 N-CA-C 110.856 -0.898 . . . . 73.33 110.856 175.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.739 ' HA3' ' H ' ' A' ' 117' ' ' ARG . . . -61.01 101.4 0.31 Allowed Glycine 0 C--O 1.265 2.089 0 N-CA-C 111.277 -0.729 . . . . 74.5 111.277 164.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.689 ' HB3' ' HA3' ' A' ' 108' ' ' GLY . 23.4 mm-40 -64.93 105.87 1.12 Allowed 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 113.151 -1.525 . . . . 75.42 109.066 177.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 174.21 164.9 29.96 Favored Glycine 0 C--O 1.238 0.344 0 N-CA-C 110.393 -1.083 . . . . 64.21 110.393 -175.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . 0.583 ' ND2' ' HB3' ' A' ' 105' ' ' LEU . 2.4 t-20 -60.8 -72.01 0.3 Allowed Pre-proline 0 CA--C 1.563 1.457 0 CA-C-O 116.657 -1.639 . . . . 63.11 112.116 -164.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.529 ' HD3' ' HB3' ' A' ' 169' ' ' ASN . 22.4 Cg_exo -65.65 115.75 3.56 Favored 'Trans proline' 0 C--N 1.389 2.71 0 CA-C-N 123.569 2.31 . . . . 71.13 109.854 171.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.63 ' HD3' HG12 ' A' ' 90' ' ' VAL . 8.7 Cg_exo -38.45 123.0 0.66 Allowed 'Trans proline' 0 C--N 1.375 1.965 1 C-N-CA 125.671 4.247 . . . . 71.25 117.42 -166.48 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -88.0 127.25 8.45 Favored Glycine 0 C--N 1.366 2.225 0 N-CA-C 111.112 -0.795 . . . . 72.4 111.112 164.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.702 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 4.9 m-20 -61.3 136.85 58.19 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.994 0.917 . . . . 71.14 111.792 -169.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.552 HD11 ' HB2' ' A' ' 121' ' ' ALA . 32.3 tp -113.7 126.93 55.79 Favored 'General case' 0 C--N 1.343 0.292 0 N-CA-C 109.786 -0.449 . . . . 64.32 109.786 173.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 83.7 mt -95.36 90.06 5.67 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.296 -0.865 . . . . 72.12 108.879 178.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.545 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 81.9 mt -70.07 88.51 0.6 Allowed 'General case' 0 C--N 1.354 0.799 0 N-CA-C 109.282 -0.636 . . . . 70.05 109.282 174.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 17.1 t -82.22 101.32 6.86 Favored 'Isoleucine or valine' 0 C--O 1.246 0.895 0 N-CA-C 105.54 -2.022 . . . . 61.43 105.54 175.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.708 HG21 HG11 ' A' ' 153' ' ' VAL . 6.0 p -71.2 136.38 25.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 115.217 -0.901 . . . . 70.33 111.01 -171.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.57 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 30.7 mmt180 -119.7 120.78 37.6 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.745 -1.576 . . . . 53.32 106.745 169.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 32.7 mt -74.82 147.2 41.39 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 109.062 -0.718 . . . . 72.4 109.062 171.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.421 ' HA ' ' HD3' ' A' ' 182' ' ' PRO . 18.5 mt -53.73 150.46 13.65 Favored Pre-proline 0 N--CA 1.484 1.241 0 C-N-CA 123.662 0.785 . . . . 73.14 112.936 -167.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 181' ' ' LEU . 24.2 Cg_exo -66.95 8.8 0.31 Allowed 'Trans proline' 0 C--N 1.387 2.558 0 C-N-CA 124.312 3.342 . . . . 71.42 113.921 176.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -60.65 103.11 0.34 Allowed Pre-proline 0 CA--C 1.562 1.423 0 C-N-CA 125.377 1.471 . . . . 73.35 107.938 165.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -80.86 26.17 0.61 Allowed 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 123.636 2.89 . . . . 61.24 115.471 -162.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.413 HG12 ' HD1' ' A' ' 186' ' ' PHE . 77.3 t -96.08 -58.94 3.44 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.908 0 CA-C-O 118.644 -0.693 . . . . 64.21 111.15 -173.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . 0.413 ' HD1' HG12 ' A' ' 185' ' ' VAL . 4.0 m-85 -139.41 91.77 2.52 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 119.191 0.905 . . . . 72.31 110.575 -177.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.453 ' NH1' ' HG2' ' A' ' 155' ' ' GLU . 44.8 ttp85 -101.26 103.8 14.82 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.073 0.949 . . . . 75.51 109.526 178.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.433 HD23 ' O ' ' A' ' 153' ' ' VAL . 51.2 tp -71.02 141.47 50.95 Favored 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 124.103 0.961 . . . . 74.21 111.218 179.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . 0.417 ' HG3' ' HB3' ' A' ' 155' ' ' GLU . 34.2 tt0 -151.8 126.1 9.33 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.822 1.249 . . . . 70.31 109.825 -175.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 70.15 -81.93 0.35 Allowed Glycine 0 C--N 1.352 1.424 0 N-CA-C 111.625 -0.59 . . . . 65.41 111.625 -176.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -147.88 -10.08 0.4 Allowed 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 125.349 1.46 . . . . 72.32 109.882 166.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -101.06 148.31 25.2 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.325 1.05 . . . . 72.32 111.205 -176.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 14.4 mt -90.92 159.89 15.96 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.26 1.024 . . . . 63.44 110.782 -176.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.505 ' HA ' ' HB2' ' A' ' 250' ' ' TYR . 41.8 m-85 -126.95 110.46 13.02 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.375 1.07 . . . . 73.14 108.919 173.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.527 ' HB3' HD23 ' A' ' 251' ' ' LEU . . . -125.88 166.95 15.95 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.217 1.007 . . . . 74.34 110.796 -178.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 24.5 m -112.9 147.42 37.08 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 108.493 -0.928 . . . . 70.21 108.493 171.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.559 HD22 HD13 ' A' ' 251' ' ' LEU . 50.8 tp -139.55 113.37 8.64 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.423 0.689 . . . . 72.21 109.51 -173.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -89.03 124.76 34.59 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 108.402 -0.962 . . . . 61.43 108.402 174.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.9 p -140.47 131.3 13.85 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 124.276 1.031 . . . . 64.4 108.966 -174.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -72.74 150.24 49.85 Favored 'Trans proline' 0 C--N 1.379 2.139 0 C-N-CA 121.554 1.503 . . . . 64.51 110.973 173.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -50.94 -46.93 87.73 Favored Pre-proline 0 CA--C 1.558 1.278 0 N-CA-C 114.654 1.353 . . . . 71.34 114.654 -173.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -52.85 -46.58 32.7 Favored 'Trans proline' 0 C--N 1.383 2.394 0 C-N-CA 121.895 1.73 . . . . 63.54 113.754 176.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.41 HG23 ' HE1' ' C' ' 277' ' ' TYR . 20.3 mt -72.54 -30.28 33.65 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 CA-C-N 115.68 -0.691 . . . . 64.32 110.403 -176.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.3 -42.66 75.13 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.205 0.602 . . . . 71.51 111.909 175.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 50.1 t -71.47 -48.62 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 123.903 0.881 . . . . 63.23 111.847 -176.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 53.2 t -87.49 -34.38 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-N 115.731 -0.668 . . . . 74.41 111.472 -173.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 85.21 113.88 0.74 Allowed Glycine 0 C--N 1.337 0.637 0 N-CA-C 111.989 -0.445 . . . . 72.35 111.989 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.44 ' HA3' ' CE1' ' C' ' 277' ' ' TYR . . . -149.7 -136.52 2.62 Favored Glycine 0 C--O 1.219 -0.805 0 CA-C-O 119.386 -0.675 . . . . 55.24 111.747 -178.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? -114.92 129.98 56.82 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 117.684 0.742 . . . . 45.21 110.444 -177.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.461 HG21 HD21 ' A' ' 197' ' ' LEU . 7.1 m -128.31 157.72 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.711 1.205 . . . . 63.11 108.489 171.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . 0.506 HH11 ' HG2' ' A' ' 220' ' ' GLU . 7.6 tpp180 -87.98 122.09 31.17 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 109.307 -0.627 . . . . 71.41 109.307 -175.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -99.69 110.98 23.36 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.943 -0.762 . . . . 62.04 108.943 176.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 17.0 tpt -82.37 116.48 21.88 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.701 -0.852 . . . . 71.23 108.701 177.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 19.7 p -108.23 -172.29 2.03 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.024 0.53 . . . . 74.1 109.583 -176.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 81.3 mt -67.15 -26.14 66.51 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.861 0.864 . . . . 63.31 112.372 -176.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -105.26 -19.19 13.88 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.15 0.58 . . . . 64.44 111.989 -175.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 152.68 -178.83 29.61 Favored Glycine 0 C--N 1.343 0.933 0 CA-C-O 119.92 -0.378 . . . . 33.0 112.426 -177.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -82.85 149.86 14.12 Favored 'Trans proline' 0 CA--C 1.552 1.423 0 C-N-CA 122.749 2.3 . . . . 70.23 113.545 -176.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 27.9 m -136.22 -178.81 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 125.657 1.583 . . . . 73.4 108.008 172.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.506 ' HG2' HH11 ' A' ' 211' ' ' ARG . 50.2 mt-10 -107.2 131.2 54.43 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 109.483 -0.562 . . . . 75.04 109.483 168.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 7.0 m -111.65 128.82 67.95 Favored 'Isoleucine or valine' 0 C--O 1.243 0.738 0 N-CA-C 108.242 -1.022 . . . . 74.13 108.242 167.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -78.23 99.2 6.16 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 109.001 -0.74 . . . . 60.25 109.001 177.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 14.8 p -67.64 137.53 93.09 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 124.066 0.947 . . . . 63.14 109.276 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -76.3 170.86 19.18 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 122.242 1.961 . . . . 75.51 110.958 -177.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.75 161.17 45.96 Favored 'Trans proline' 0 C--N 1.371 1.728 0 C-N-CA 121.378 1.385 . . . . 72.53 112.226 172.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 57.7 mtt-85 64.4 24.19 13.15 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 125.188 1.395 . . . . 74.04 112.02 168.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.537 HG23 HD21 ' A' ' 233' ' ' LEU . 98.6 m -68.27 102.38 1.37 Allowed 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 125.238 1.415 . . . . 64.32 111.162 -178.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -87.72 139.16 30.81 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.981 1.312 . . . . 75.32 110.88 -176.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . 0.458 ' HA ' ' HB ' ' A' ' 253' ' ' VAL . . . -68.13 156.98 36.33 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.405 0.682 . . . . 62.31 112.197 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 84.42 -19.08 20.66 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-N 115.886 -0.597 . . . . 73.32 112.929 -179.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -90.92 160.96 15.4 Favored 'General case' 0 C--N 1.351 0.672 0 C-N-CA 123.762 0.825 . . . . 74.0 110.654 178.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -115.95 114.44 24.63 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.193 0.997 . . . . 72.22 108.615 -177.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.537 HD21 HG23 ' A' ' 227' ' ' THR . 84.9 mt -75.71 118.67 18.78 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.817 0.847 . . . . 71.4 110.64 -177.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 27.2 ttm-85 -90.48 103.13 15.85 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 109.492 -0.559 . . . . 64.14 109.492 172.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.602 HD12 ' HG3' ' A' ' 238' ' ' LYS . 0.1 OUTLIER -97.17 123.54 40.97 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.477 0.711 . . . . 61.12 109.174 173.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -69.98 132.09 45.4 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 114.592 -1.185 . . . . 64.43 113.48 -169.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 79.44 3.3 88.67 Favored Glycine 0 C--N 1.354 1.575 0 CA-C-N 115.774 -0.648 . . . . 74.2 114.433 171.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.602 ' HG3' HD12 ' A' ' 235' ' ' LEU . 0.0 OUTLIER -90.38 -7.26 53.66 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 112.536 0.569 . . . . 73.01 112.536 -172.406 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -85.91 -166.07 41.6 Favored Glycine 0 C--N 1.351 1.399 0 C-N-CA 123.101 0.382 . . . . 74.43 113.791 175.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -89.64 147.95 38.96 Favored Pre-proline 0 N--CA 1.485 1.308 0 C-N-CA 123.375 0.67 . . . . 73.13 111.429 -171.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -66.3 146.75 81.87 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 123.576 2.851 . . . . 73.33 113.28 174.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -177.87 -155.3 13.79 Favored Glycine 0 CA--C 1.534 1.278 0 CA-C-O 118.969 -0.906 . . . . 73.52 112.138 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -64.49 -33.52 56.8 Favored 'Trans proline' 0 C--N 1.385 2.472 0 C-N-CA 123.746 2.964 . . . . 70.45 113.522 -176.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -89.96 21.03 3.84 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.136 0.574 . . . . 70.11 111.165 176.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 72.38 -152.14 47.69 Favored Glycine 0 C--N 1.35 1.346 0 N-CA-C 110.803 -0.919 . . . . 62.24 110.803 -169.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 27.4 mtp180 -76.29 137.43 39.89 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 109.608 -0.516 . . . . 75.41 109.608 170.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -80.39 -161.5 24.8 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 112.155 -0.378 . . . . 42.24 112.155 173.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -110.92 -174.38 2.46 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 123.734 0.814 . . . . 75.44 110.138 -178.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.526 ' HB3' ' HG ' ' A' ' 235' ' ' LEU . 18.6 tp -127.68 133.22 49.6 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.381 -0.97 . . . . 70.31 108.381 175.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.505 ' HB2' ' HA ' ' A' ' 194' ' ' TYR . 3.1 m-85 -96.55 126.34 41.67 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 108.611 -0.885 . . . . 52.51 108.611 173.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.559 HD13 HD22 ' A' ' 197' ' ' LEU . 88.7 mt -115.52 108.66 16.74 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.691 -0.855 . . . . 72.24 108.691 172.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -76.65 115.87 16.8 Favored 'General case' 0 C--N 1.348 0.529 0 N-CA-C 106.817 -1.549 . . . . 75.41 106.817 -176.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.458 ' HB ' ' HA ' ' A' ' 229' ' ' ALA . 22.7 t -76.25 116.06 18.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 CA-C-N 115.548 -0.751 . . . . 24.43 110.68 -169.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -119.15 91.68 3.61 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 107.091 -1.448 . . . . 73.14 107.091 178.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.406 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 62.5 mt -81.23 129.89 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 116.469 -0.332 . . . . 74.34 110.292 -176.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 32.3 p -120.28 173.22 7.26 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.645 1.178 . . . . 73.43 109.618 173.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.449 HD12 ' H ' ' A' ' 259' ' ' GLU . 2.1 pp -125.14 155.03 71.64 Favored Pre-proline 0 CA--C 1.562 1.433 0 N-CA-C 107.888 -1.152 . . . . 73.4 107.888 173.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' PRO . . . . . 0.499 ' HG3' ' OH ' ' C' ' 276' ' ' TYR . 37.9 Cg_endo -78.51 18.6 0.94 Allowed 'Trans proline' 0 N--CA 1.512 2.568 0 C-N-CA 123.382 2.721 . . . . 74.45 115.64 -164.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . 0.449 ' H ' HD12 ' A' ' 257' ' ' ILE . 5.9 mm-40 51.67 -122.91 2.06 Favored 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 124.015 0.926 . . . . 63.24 111.959 -169.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' ARG . . . . . 0.515 ' H ' ' HD3' ' A' ' 260' ' ' ARG . 0.0 OUTLIER -67.34 149.54 50.19 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 118.679 0.672 . . . . 75.12 111.743 -169.162 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 69.8 mt -120.77 160.67 22.89 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.596 0.758 . . . . 55.32 111.657 -171.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 27.5 p -90.56 148.34 38.47 Favored Pre-proline 0 CA--C 1.556 1.183 0 CA-C-O 117.782 -1.104 . . . . 44.34 108.92 170.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' PRO . . . . . 0.514 ' O ' ' HB3' ' A' ' 266' ' ' GLU . 31.5 Cg_exo -35.23 -54.0 0.7 Allowed 'Trans proline' 0 C--N 1.394 2.932 1 C-N-CA 125.418 4.079 . . . . 74.33 117.298 -167.453 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -77.87 -38.29 46.31 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 121.962 -0.461 . . . . 71.44 111.439 -176.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -64.91 -26.54 68.36 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 122.912 0.485 . . . . 64.2 110.623 173.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' GLU . . . . . 0.514 ' HB3' ' O ' ' A' ' 263' ' ' PRO . 7.9 tp10 -63.14 -58.35 7.51 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 108.353 -0.98 . . . . 73.45 108.353 172.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -66.31 -18.31 65.28 Favored 'General case' 0 CA--C 1.553 1.086 0 CA-C-N 115.321 -0.854 . . . . 64.12 112.871 177.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 41.5 tp -78.27 -47.0 18.83 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.691 0.797 . . . . 73.14 110.412 -177.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 68.6 m95 -63.08 -38.13 89.95 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.478 -0.783 . . . . 75.0 110.495 173.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . 0.5 ' HG3' HG23 ' C' ' 206' ' ' VAL . 0.9 OUTLIER -63.45 -44.07 95.57 Favored 'General case' 0 CA--C 1.557 1.216 0 O-C-N 123.672 0.607 . . . . 62.43 111.778 175.311 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 29.8 mtmm -57.18 -49.89 74.56 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 123.124 0.57 . . . . 70.22 110.664 175.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 24.7 mt -51.73 -51.0 59.49 Favored 'General case' 0 C--O 1.216 -0.7 0 O-C-N 124.596 1.185 . . . . 63.4 110.862 175.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -68.19 -38.42 81.96 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 113.935 1.087 . . . . 64.51 113.935 -169.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -76.96 -42.79 37.68 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 123.467 0.48 . . . . 74.35 110.154 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . 0.414 ' HB1' ' NH2' ' A' ' 279' ' ' ARG . . . -66.02 -30.1 70.58 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.82 -0.627 . . . . 71.44 110.899 175.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -67.71 -60.17 2.74 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.377 1.071 . . . . 75.02 109.636 177.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -60.35 -41.72 94.23 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.345 1.058 . . . . 70.12 111.017 -172.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -60.89 -20.59 62.21 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.337 0.655 . . . . 75.41 112.705 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . 0.414 ' NH2' ' HB1' ' A' ' 275' ' ' ALA . 87.6 mtm180 -128.99 18.37 6.09 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.8 0.84 . . . . 74.13 111.005 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.022 0 CA-C-O 118.412 -0.804 . . . . 72.21 110.754 -175.734 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.404 ' SD ' ' N ' ' B' ' 1' ' ' MET . 1.0 OUTLIER . . . . . 0 N--CA 1.482 1.171 0 N-CA-C 108.775 -0.824 . . . . 71.44 108.775 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . 0.577 ' HA ' ' HE3' ' B' ' 2' ' ' LYS . 0.4 OUTLIER -70.77 90.03 0.77 Allowed 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 109.425 -0.583 . . . . 54.1 109.425 179.238 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 23.9 tm0? -113.11 160.36 18.27 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.253 1.021 . . . . 74.04 108.95 -173.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . 0.463 ' H ' HG21 ' A' ' 126' ' ' THR . 80.7 p 59.25 -80.45 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 126.785 2.034 . . . . 52.14 111.655 -177.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 6.4 m -76.65 153.88 34.81 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 109.01 -0.737 . . . . 70.11 109.01 172.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.564 HG21 ' HA ' ' A' ' 125' ' ' LEU . 31.7 pt -128.74 173.76 13.14 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 CA-C-O 121.033 0.444 . . . . 64.44 111.207 -174.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -146.54 127.66 14.69 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.395 -0.821 . . . . 72.01 109.458 -177.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . 0.549 HD21 HD21 ' A' ' 174' ' ' LEU . 38.3 tp -73.1 150.73 42.02 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.419 0.688 . . . . 75.22 111.049 -176.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.68 -60.37 2.38 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 122.873 0.469 . . . . 62.4 111.027 176.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 67.3 mt 62.17 127.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 124.584 1.153 . . . . 74.1 110.114 -163.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 24.6 mt . . . . . 0 CA--C 1.561 1.383 0 O-C-N 121.706 -0.621 . . . . 45.35 110.318 178.389 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.638 0 N-CA-C 110.41 -0.218 . . . . 61.34 110.41 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.89 -39.57 93.74 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.449 0.699 . . . . 74.4 110.676 176.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 181' ' ' LEU . . . . . 0.459 HD21 HD11 ' C' ' 149' ' ' ILE . 14.8 tp -163.08 27.85 0.09 Allowed 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 114.769 -1.105 . . . . 62.04 108.341 176.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 182' ' ' VAL . . . . . 0.7 HG22 ' HA ' ' C' ' 138' ' ' VAL . 53.9 t -80.58 113.78 20.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 115.768 -0.651 . . . . 71.31 110.892 -171.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -90.21 -40.58 12.1 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.507 -0.769 . . . . 65.24 110.231 170.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 52.65 35.86 19.36 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 124.813 1.245 . . . . 74.15 111.599 175.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 185' ' ' VAL . . . . . . . . . . . . . 48.9 t . . . . . 0 N--CA 1.483 1.178 0 C-N-CA 124.755 1.222 . . . . 71.33 110.326 -170.436 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 94.0 m . . . . . 0 N--CA 1.485 1.31 0 CA-C-O 123.722 1.725 . . . . 71.31 106.642 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 239' ' ' ALA . . . . . 0.611 ' HB2' ' H ' ' C' ' 222' ' ' ALA . . . -100.31 -178.73 3.91 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.171 -1.377 . . . . 74.42 112.592 -167.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 240' ' ' GLY . . . . . 0.414 ' HA3' ' HA ' ' C' ' 235' ' ' LEU . . . -107.34 -140.08 9.43 Favored Glycine 0 C--N 1.343 0.938 0 CA-C-N 114.589 -1.187 . . . . 71.23 110.629 176.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -133.95 147.93 51.11 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.403 0.681 . . . . 71.21 111.571 -170.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -167.95 -44.21 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.018 1.327 . . . . 70.32 109.193 176.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 243' ' ' GLN . . . . . 0.812 ' HG3' ' HG2' ' C' ' 224' ' ' PRO . 6.7 pt20 -159.45 164.1 34.82 Favored 'General case' 0 C--O 1.245 0.82 0 C-N-CA 123.969 0.908 . . . . 74.22 111.17 177.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -67.1 98.15 0.42 Allowed Glycine 0 C--N 1.355 1.633 0 O-C-N 124.179 0.924 . . . . 63.11 113.567 -169.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 245' ' ' LYS . . . . . 0.519 ' HE2' ' HB1' ' C' ' 222' ' ' ALA . 9.2 tmtm? . . . . . 0 N--CA 1.47 0.545 0 C-N-CA 123.589 0.756 . . . . 75.34 110.009 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.97 0 N-CA-C 110.542 -0.17 . . . . 52.01 110.542 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -38.3 110.38 0.13 Allowed 'General case' 0 C--N 1.363 1.183 0 C-N-CA 125.362 1.465 . . . . 70.52 114.698 -172.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 5' ' ' LYS . . . . . 0.722 ' HD2' HD11 ' C' ' 10' ' ' ILE . 23.2 mmtp -82.57 99.81 9.75 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 115.479 -0.782 . . . . 63.2 109.822 170.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -75.04 89.58 2.44 Favored 'General case' 0 C--O 1.246 0.875 0 N-CA-C 107.092 -1.447 . . . . 63.22 107.092 169.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 7' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -61.1 -28.36 69.03 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 114.917 -1.038 . . . . 73.43 112.145 -170.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 8' ' ' TYR . . . . . 0.421 ' HD1' HG23 ' C' ' 13' ' ' VAL . 64.1 m-85 -72.62 -41.44 65.54 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.356 0.662 . . . . 72.53 111.548 177.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.84 -43.05 99.62 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 123.386 0.429 . . . . 52.31 110.497 175.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 10' ' ' ILE . . . . . 0.722 HD11 ' HD2' ' C' ' 5' ' ' LYS . 73.1 mt -59.06 -44.55 91.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 O-C-N 123.956 0.785 . . . . 63.34 110.619 176.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 85.1 mt -78.69 -3.33 43.58 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 112.896 0.702 . . . . 45.45 112.896 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 61.29 39.79 97.71 Favored Glycine 0 C--N 1.356 1.655 0 O-C-N 123.302 0.376 . . . . 64.33 113.438 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 13' ' ' VAL . . . . . 0.421 HG23 ' HD1' ' C' ' 8' ' ' TYR . 11.8 m -135.69 158.49 74.09 Favored Pre-proline 0 N--CA 1.48 1.057 0 C-N-CA 125.084 1.354 . . . . 64.04 109.075 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.29 163.66 38.38 Favored 'Trans proline' 0 C--N 1.377 2.071 0 C-N-CA 122.125 1.884 . . . . 74.43 112.49 178.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 58.1 mtt180 -77.81 21.96 0.29 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.004 0.921 . . . . 71.52 111.876 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -117.33 -14.16 10.41 Favored 'General case' 0 C--O 1.243 0.749 0 C-N-CA 125.951 1.7 . . . . 71.24 108.37 178.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.15 114.97 1.34 Allowed 'General case' 0 C--N 1.356 0.879 0 C-N-CA 124.214 1.006 . . . . 71.14 110.538 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 54.4 p -74.21 167.02 22.43 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.596 0.758 . . . . 74.41 109.092 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.91 -40.68 57.44 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 124.014 0.926 . . . . 74.45 111.187 -173.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 20' ' ' GLU . . . . . 0.677 ' HA ' ' HE3' ' C' ' 23' ' ' LYS . 3.7 tm-20 -66.04 -40.79 91.27 Favored 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 124.467 1.107 . . . . 64.05 110.685 -178.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . 0.515 ' HG2' ' NH2' ' C' ' 24' ' ' ARG . 32.7 mt-10 -72.26 -34.44 68.24 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 115.651 -0.704 . . . . 73.42 111.258 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 22' ' ' ILE . . . . . 0.903 HD13 ' HB3' ' C' ' 57' ' ' LEU . 96.1 mt -68.61 -38.98 79.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 124.785 1.234 . . . . 61.32 110.16 176.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 23' ' ' LYS . . . . . 0.677 ' HE3' ' HA ' ' C' ' 20' ' ' GLU . 22.2 ttpp -62.98 -35.88 81.64 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 113.896 -1.502 . . . . 74.13 110.063 177.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 24' ' ' ARG . . . . . 0.515 ' NH2' ' HG2' ' C' ' 21' ' ' GLU . 45.6 mtm180 -77.35 -30.07 53.68 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 113.235 0.828 . . . . 73.52 113.235 173.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.03 -37.38 86.97 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 121.617 0.723 . . . . 75.32 109.918 171.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 26' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -68.52 -41.93 79.24 Favored 'General case' 0 C--O 1.209 -1.051 0 CA-C-N 113.869 -1.514 . . . . 72.31 110.474 175.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . 0.451 ' HD3' ' HG2' ' C' ' 24' ' ' ARG . 27.5 mtpp -50.89 -56.23 13.29 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 118.369 0.531 . . . . 74.1 110.385 173.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -55.61 -58.88 5.95 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 114.944 -1.026 . . . . 71.15 112.138 -177.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 87.1 mt -83.21 -21.28 33.48 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 112.894 0.702 . . . . 60.22 112.894 -169.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . 0.478 ' O ' ' HB2' ' C' ' 34' ' ' HIS . . . -78.97 -30.54 44.5 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 118.809 0.732 . . . . 75.32 110.406 176.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 65.1 mtm180 -73.59 -45.54 52.6 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 109.997 -0.371 . . . . 73.5 109.997 170.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.63 -46.61 84.89 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.617 0.767 . . . . 71.12 111.023 -174.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 33' ' ' TYR . . . . . 0.5 ' HD1' ' HB1' ' C' ' 43' ' ' ALA . 52.7 m-85 -90.76 4.72 50.84 Favored 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 123.466 0.706 . . . . 70.15 112.071 -178.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 34' ' ' HIS . . . . . 0.478 ' HB2' ' O ' ' C' ' 30' ' ' ALA . 41.8 t60 -60.64 113.35 7.4 Favored Pre-proline 0 N--CA 1.49 1.551 0 CA-C-O 118.206 -0.902 . . . . 72.34 110.959 -177.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -48.47 -36.65 31.61 Favored 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 124.283 3.322 . . . . 71.32 115.287 -171.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -69.99 -41.35 74.52 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 122.688 0.395 . . . . 60.34 111.324 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 45.3 t -85.03 -28.71 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-O 121.036 0.446 . . . . 75.33 110.123 -175.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -139.0 80.22 1.77 Allowed 'General case' 0 C--O 1.248 0.981 0 C-N-CA 124.204 1.002 . . . . 54.22 108.83 -174.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -70.31 84.8 0.57 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 114.778 -1.101 . . . . 62.24 109.402 176.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . 0.576 ' HB2' ' HB3' ' C' ' 43' ' ' ALA . 16.4 m -138.68 103.75 7.65 Favored Pre-proline 0 CA--C 1.542 0.655 0 CA-C-O 117.836 -1.078 . . . . 74.14 108.117 175.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' C' ' 40' ' ' SER . 5.3 Cg_exo -37.33 -54.23 1.19 Allowed 'Trans proline' 0 C--N 1.393 2.874 0 C-N-CA 124.702 3.601 . . . . 63.44 114.183 -176.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.56 -36.49 83.96 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.973 0.509 . . . . 65.44 110.698 -177.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 43' ' ' ALA . . . . . 0.576 ' HB3' ' HB2' ' C' ' 40' ' ' SER . . . -75.17 -17.51 60.37 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.168 0.587 . . . . 62.05 111.313 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -86.2 -31.93 21.48 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.333 0.653 . . . . 74.04 109.491 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -70.1 -41.74 73.63 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.57 -0.741 . . . . 42.53 109.502 170.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 46' ' ' LYS . . . . . 0.538 ' O ' HG12 ' C' ' 50' ' ' ILE . 33.6 mmtm -63.32 -36.3 83.24 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-N 115.201 -0.908 . . . . 72.32 110.468 173.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -57.2 -49.0 77.38 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.604 0.762 . . . . 62.23 109.337 174.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 48' ' ' LYS . . . . . 0.551 ' HB3' ' HE1' ' C' ' 93' ' ' PHE . 52.0 mtpt -57.87 -38.23 75.36 Favored 'General case' 0 CA--C 1.551 1.009 0 O-C-N 123.762 0.663 . . . . 72.04 111.631 175.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -76.31 -19.39 58.29 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.203 0.601 . . . . 72.33 112.267 178.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 50' ' ' ILE . . . . . 0.538 HG12 ' O ' ' C' ' 46' ' ' LYS . 28.4 mm -76.0 -38.96 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 108.474 -0.936 . . . . 75.43 108.474 171.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 51' ' ' ASN . . . . . 0.467 ' HB3' ' CD1' ' C' ' 88' ' ' PHE . 55.7 m-80 -68.42 -30.76 69.73 Favored 'General case' 0 C--O 1.217 -0.645 0 CA-C-N 114.474 -1.239 . . . . 74.04 110.736 176.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -68.51 -55.15 12.69 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.845 1.258 . . . . 63.42 110.528 175.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.26 -50.41 69.55 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 114.035 -1.438 . . . . 63.1 111.162 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -63.56 -39.41 94.33 Favored 'General case' 0 C--O 1.198 -1.638 0 CA-C-N 115.023 -0.99 . . . . 75.01 110.775 176.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 55' ' ' ALA . . . . . 0.484 ' HB2' ' CD2' ' C' ' 88' ' ' PHE . . . -56.31 -45.04 80.43 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 118.531 0.605 . . . . 60.54 112.255 -178.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 56' ' ' VAL . . . . . 0.443 ' O ' ' HB2' ' C' ' 62' ' ' LYS . 96.1 t -65.7 -46.42 89.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 CA-C-O 121.752 0.786 . . . . 72.43 109.826 173.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 57' ' ' LEU . . . . . 0.903 ' HB3' HD13 ' C' ' 22' ' ' ILE . 81.6 mt -92.37 9.54 33.7 Favored 'General case' 0 CA--C 1.56 1.344 0 N-CA-C 113.365 0.876 . . . . 75.02 113.365 -169.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 21.9 t -86.16 -24.15 26.27 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.54 0.736 . . . . 62.42 110.491 179.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -101.61 131.54 22.82 Favored Pre-proline 0 C--O 1.241 0.633 0 N-CA-C 108.336 -0.987 . . . . 72.03 108.336 174.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 60' ' ' PRO . . . . . 0.494 ' O ' ' HG2' ' C' ' 64' ' ' ARG . 73.7 Cg_exo -53.48 -32.51 63.39 Favored 'Trans proline' 0 C--N 1.375 1.934 0 C-N-CA 122.833 2.356 . . . . 33.23 111.444 164.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -68.09 -49.44 61.26 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.078 0.951 . . . . 62.13 111.561 -177.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 62' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' C' ' 56' ' ' VAL . 62.1 mttp -73.27 -23.98 60.38 Favored 'General case' 0 CA--C 1.559 1.302 0 C-N-CA 122.386 0.274 . . . . 75.23 110.751 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 -61.38 -43.3 99.1 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 109.39 -0.596 . . . . 64.42 109.39 167.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 64' ' ' ARG . . . . . 0.494 ' HG2' ' O ' ' C' ' 60' ' ' PRO . 28.5 mmm180 -68.72 -32.07 71.6 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 119.272 -0.394 . . . . 74.15 111.56 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 65' ' ' ILE . . . . . 0.442 HG23 ' HD2' ' C' ' 76' ' ' PRO . 80.1 mt -62.29 -42.19 94.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 N-CA-C 109.716 -0.475 . . . . 62.34 109.716 171.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -63.25 -44.86 93.99 Favored 'General case' 0 CA--C 1.553 1.079 0 CA-C-N 115.573 -0.739 . . . . 74.22 109.756 176.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -58.11 -42.13 85.06 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.184 0.994 . . . . 73.14 111.064 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 68' ' ' THR . . . . . 0.425 ' OG1' ' HG2' ' C' ' 76' ' ' PRO . 39.9 p -83.93 -10.31 58.05 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.602 -0.726 . . . . 63.2 112.013 -178.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -71.81 96.7 1.68 Allowed 'General case' 0 C--N 1.36 1.037 0 N-CA-C 108.197 -1.038 . . . . 75.22 108.197 171.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 104.34 30.98 4.81 Favored Glycine 0 C--N 1.346 1.104 0 CA-C-N 116.075 -0.511 . . . . 62.51 111.94 -173.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 84.9 m -146.78 -54.16 0.24 Allowed 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 103.877 -2.638 . . . . 72.34 103.877 174.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 24.7 m -86.24 141.71 29.09 Favored 'General case' 0 C--O 1.256 1.406 0 N-CA-C 104.811 -2.292 . . . . 73.35 104.811 157.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.15 -27.62 20.58 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 123.752 0.821 . . . . 73.23 111.612 -177.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -97.24 155.77 37.03 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 123.911 0.884 . . . . 53.23 109.806 176.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_exo -60.12 114.74 2.23 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 122.65 2.234 . . . . 75.14 111.079 168.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 76' ' ' PRO . . . . . 0.442 ' HD2' HG23 ' C' ' 65' ' ' ILE . 50.0 Cg_exo -55.97 122.74 12.3 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 123.091 2.527 . . . . 63.14 111.596 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -43.63 139.85 4.74 Favored 'Trans proline' 0 C--N 1.39 2.725 0 C-N-CA 124.31 3.34 . . . . 51.51 114.849 -166.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 78' ' ' PRO . . . . . 0.494 ' HB2' ' HA2' ' C' ' 82' ' ' GLY . 25.9 Cg_endo -58.86 145.25 97.42 Favored 'Trans proline' 0 C--N 1.387 2.564 0 C-N-CA 123.483 2.788 . . . . 74.44 113.743 -172.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 79' ' ' PRO . . . . . 0.595 ' HB2' ' HA2' ' C' ' 142' ' ' GLY . 51.0 Cg_exo -55.93 163.24 6.03 Favored 'Trans proline' 0 C--N 1.385 2.458 0 C-N-CA 123.559 2.84 . . . . 61.04 112.923 176.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -55.12 87.07 0.04 OUTLIER 'Trans proline' 0 C--N 1.392 2.832 0 C-N-CA 123.569 2.846 . . . . 51.5 112.855 -177.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 145.65 -52.19 0.58 Allowed Glycine 0 C--N 1.339 0.742 0 CA-C-N 113.829 -1.532 . . . . 75.2 109.443 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.494 ' HA2' ' HB2' ' C' ' 78' ' ' PRO . . . 144.34 -170.84 25.95 Favored Glycine 0 C--N 1.344 0.998 0 C-N-CA 123.526 0.584 . . . . 74.45 111.653 -177.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -86.93 104.18 16.01 Favored 'General case' 0 C--O 1.244 0.806 0 C-N-CA 123.653 0.781 . . . . 70.14 109.273 171.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -86.55 -176.21 5.75 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.384 -0.598 . . . . 63.13 109.384 170.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 85' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -161.1 70.98 0.39 Allowed 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 107.507 -1.294 . . . . 74.41 107.507 177.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 55.0 m -36.78 95.18 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 117.875 2.546 . . . . 45.43 117.875 -164.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 75.55 6.68 81.65 Favored Glycine 0 C--N 1.355 1.608 0 C-N-CA 123.044 0.354 . . . . 74.33 113.292 174.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 88' ' ' PHE . . . . . 0.484 ' CD2' ' HB2' ' C' ' 55' ' ' ALA . 11.9 m-85 -105.59 131.13 53.35 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 107.489 -1.3 . . . . 74.44 107.489 -177.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -80.99 81.97 7.09 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 120.966 0.412 . . . . 72.23 111.337 -170.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 90' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -43.58 -36.14 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 C-N-CA 125.405 1.482 . . . . 54.41 112.74 171.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -62.66 -20.09 64.47 Favored 'General case' 0 CA--C 1.561 1.394 0 C-N-CA 124.352 1.061 . . . . 74.21 112.884 -175.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -119.82 7.37 10.97 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 122.865 0.466 . . . . 75.53 111.008 178.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 93' ' ' PHE . . . . . 0.551 ' HE1' ' HB3' ' C' ' 48' ' ' LYS . 13.9 m-30 -83.9 -174.28 5.19 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.129 -0.982 . . . . 72.45 112.114 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 97.6 p -71.3 161.8 30.48 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.839 1.052 . . . . 45.51 113.839 -167.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -59.44 -56.34 23.25 Favored 'General case' 0 C--O 1.215 -0.745 0 CA-C-N 114.249 -1.342 . . . . 55.43 110.837 174.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -51.03 -46.56 61.63 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 124.169 0.918 . . . . 65.02 111.867 -174.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 97' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -58.98 -53.44 58.39 Favored 'General case' 0 CA--C 1.554 1.13 0 CA-C-N 115.406 -0.816 . . . . 64.25 110.158 174.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -74.18 0.84 12.75 Favored 'General case' 0 CA--C 1.56 1.339 0 N-CA-C 112.611 0.597 . . . . 51.52 112.611 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -98.27 -50.74 4.23 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.984 0.914 . . . . 74.43 110.393 172.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 31.3 tp -71.07 -52.83 17.17 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.892 0.877 . . . . 73.23 110.463 -177.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 101' ' ' PHE . . . . . 0.477 ' O ' ' HG ' ' C' ' 105' ' ' LEU . 87.4 m-85 -86.22 -10.02 55.43 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.435 -0.802 . . . . 73.25 110.781 179.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -43.04 -55.73 4.79 Favored Glycine 0 CA--C 1.545 1.924 0 CA-C-O 118.479 -1.178 . . . . 54.11 115.026 176.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -37.6 -35.61 0.33 Allowed 'Trans proline' 0 C--N 1.392 2.837 0 C-N-CA 125.136 3.891 . . . . 62.02 116.279 175.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -130.9 24.59 4.27 Favored Glycine 0 C--N 1.349 1.276 0 CA-C-O 118.798 -1.001 . . . . 43.23 113.837 -174.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 105' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' C' ' 101' ' ' PHE . 38.1 mt . . . . . 0 N--CA 1.489 1.521 0 CA-C-N 118.038 0.919 . . . . 73.03 111.72 173.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 116' ' ' GLY . . . . . 0.436 ' HA2' ' HA3' ' C' ' 168' ' ' GLY . . . . . . . . 0 CA--C 1.524 0.611 0 N-CA-C 113.963 0.345 . . . . 45.25 113.963 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 117' ' ' ARG . . . . . 0.44 ' HG2' ' H ' ' C' ' 118' ' ' ASP . 56.1 ttt-85 -80.3 175.06 10.99 Favored 'General case' 0 C--O 1.252 1.214 0 C-N-CA 123.615 0.766 . . . . 64.44 109.684 174.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 118' ' ' ASP . . . . . 0.44 ' H ' ' HG2' ' C' ' 117' ' ' ARG . 3.6 p30 -65.38 155.81 34.2 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 121.687 0.756 . . . . 75.42 111.201 172.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 119' ' ' LEU . . . . . . . . . . . . . 61.9 tp -109.01 161.67 14.95 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 107.189 -1.411 . . . . 75.21 107.189 172.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 38.8 ttt-85 -131.31 119.84 22.31 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 118.77 0.714 . . . . 72.31 109.322 175.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 121' ' ' ALA . . . . . 0.469 ' HB3' HD11 ' C' ' 174' ' ' LEU . . . -138.09 118.16 13.46 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 124.129 0.972 . . . . 63.21 108.68 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 122' ' ' GLU . . . . . 0.445 ' HB3' ' HB ' ' C' ' 177' ' ' VAL . 13.0 pt-20 -108.03 148.3 29.94 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 122.339 0.255 . . . . 73.22 110.457 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -140.71 145.89 42.08 Favored Pre-proline 0 N--CA 1.481 1.109 0 C-N-CA 122.833 0.453 . . . . 73.3 111.607 -170.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -75.88 130.11 12.13 Favored 'Trans proline' 0 C--N 1.377 2.038 0 C-N-CA 122.509 2.139 . . . . 72.51 110.559 166.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 125' ' ' LEU . . . . . . . . . . . . . 30.2 tp -145.14 148.58 33.76 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 108.668 -0.864 . . . . 74.03 108.668 -175.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 126' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -94.53 158.5 15.51 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 120.911 0.386 . . . . 61.53 110.488 -178.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 127' ' ' LEU . . . . . 0.61 HD13 ' HD2' ' C' ' 186' ' ' PHE . 56.9 mt -62.33 -42.56 99.48 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.656 1.182 . . . . 62.25 110.643 173.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 128' ' ' GLU . . . . . 0.405 ' HG3' ' HA ' ' C' ' 215' ' ' LEU . 2.7 mp0 -62.2 -38.05 87.66 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 114.495 -1.229 . . . . 75.24 110.725 173.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -79.01 -17.93 54.5 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 122.968 0.507 . . . . 73.53 111.592 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -76.63 -40.29 49.71 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-O 121.719 0.771 . . . . 64.34 109.428 172.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 131' ' ' PHE . . . . . 0.622 ' HB2' HD13 ' C' ' 215' ' ' LEU . 76.8 t80 -63.09 -34.89 78.56 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 126.065 1.746 . . . . 75.55 111.873 171.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 132' ' ' HIS . . . . . . . . . . . . . 36.6 m170 -78.35 -59.26 2.85 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 122.381 0.272 . . . . 60.22 110.345 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 53.03 -127.39 35.48 Favored Glycine 0 CA--C 1.537 1.426 0 O-C-N 124.077 0.86 . . . . 65.31 113.955 177.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.51 -146.33 38.72 Favored Glycine 0 C--N 1.349 1.303 0 C-N-CA 123.24 0.448 . . . . 53.24 113.646 177.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -92.01 112.79 24.86 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.337 1.055 . . . . 71.2 109.618 -177.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 136' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -126.64 133.36 51.01 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.389 0.675 . . . . 72.12 110.432 -175.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 137' ' ' VAL . . . . . . . . . . . . . 34.0 m -73.11 138.95 20.32 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 CA-C-O 120.976 0.417 . . . . 71.12 111.479 -176.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 138' ' ' VAL . . . . . 0.7 ' HA ' HG22 ' B' ' 182' ' ' VAL . 7.3 p -152.05 135.53 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.325 1.05 . . . . 72.14 108.986 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 139' ' ' GLU . . . . . 0.5 ' HA ' ' O ' ' C' ' 143' ' ' ARG . 0.0 OUTLIER -117.69 116.25 26.67 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.19 0.596 . . . . 74.31 109.927 170.742 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 140' ' ' VAL . . . . . . . . . . . . . 13.8 p -164.39 138.33 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.823 0.849 . . . . 63.22 110.12 174.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 62.58 13.94 6.68 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 124.869 1.268 . . . . 15.23 113.72 170.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 142' ' ' GLY . . . . . 0.595 ' HA2' ' HB2' ' C' ' 79' ' ' PRO . . . 120.18 -31.63 5.21 Favored Glycine 0 C--N 1.348 1.248 0 CA-C-O 120.103 -0.276 . . . . 45.25 112.814 -178.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 143' ' ' ARG . . . . . 0.5 ' O ' ' HA ' ' C' ' 139' ' ' GLU . 9.8 mmm180 -80.33 108.37 13.89 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.034 0.534 . . . . 73.04 111.954 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 48.6 ttt180 -113.62 91.31 3.6 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 107.635 -1.246 . . . . 71.51 107.635 166.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 145' ' ' VAL . . . . . . . . . . . . . 13.0 p -157.34 159.24 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.142 0.577 . . . . 75.03 111.174 -168.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 20.3 m -78.19 106.89 10.39 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.76 0.824 . . . . 54.21 110.146 168.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 2.6 p -80.52 119.8 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 CA-C-O 121.044 0.45 . . . . 72.53 110.137 174.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 48.0 ttt180 -83.82 95.15 8.37 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.595 -0.729 . . . . 74.22 110.068 177.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 149' ' ' ILE . . . . . 0.459 HD11 HD21 ' B' ' 181' ' ' LEU . 38.3 pt -118.71 105.19 46.06 Favored Pre-proline 0 CA--C 1.547 0.861 0 N-CA-C 107.647 -1.242 . . . . 71.41 107.647 164.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -53.88 166.78 1.31 Allowed 'Trans proline' 0 C--N 1.384 2.428 0 C-N-CA 123.459 2.772 . . . . 61.44 113.903 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -44.12 108.85 0.13 Allowed 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 123.305 2.67 . . . . 73.2 113.425 171.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 152' ' ' GLY . . . . . . . . . . . . . . . 154.21 87.98 0.06 OUTLIER Glycine 0 C--N 1.349 1.292 0 N-CA-C 114.8 0.68 . . . . 54.32 114.8 -176.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 153' ' ' VAL . . . . . 0.549 HG21 HD11 ' C' ' 159' ' ' ILE . 12.4 p -165.53 155.54 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.617 0 C-N-CA 123.249 0.62 . . . . 71.13 110.656 172.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 154' ' ' ARG . . . . . 0.503 ' HD2' ' HG2' ' C' ' 187' ' ' ARG . 30.3 ttp180 -155.64 150.86 26.8 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 124.071 0.948 . . . . 75.32 110.419 -172.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 155' ' ' GLU . . . . . 0.411 ' N ' ' HG2' ' C' ' 154' ' ' ARG . 10.3 tp10 -42.93 130.66 4.3 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 125.589 1.556 . . . . 74.51 113.263 -177.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 84.53 -5.79 79.85 Favored Glycine 0 C--N 1.348 1.199 0 CA-C-N 115.827 -0.624 . . . . 64.51 113.252 178.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 157' ' ' SER . . . . . 0.499 ' O ' HG12 ' C' ' 178' ' ' VAL . 37.6 t -78.58 129.5 34.87 Favored 'General case' 0 C--O 1.245 0.82 0 N-CA-C 108.622 -0.881 . . . . 75.43 108.622 173.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 97.9 t -105.99 100.44 10.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 N-CA-C 108.261 -1.015 . . . . 64.44 108.261 -177.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 159' ' ' ILE . . . . . 0.665 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 26.1 mt -71.25 96.67 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.672 0 CA-C-N 115.046 -0.979 . . . . 52.25 108.85 -175.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 4.6 ttt180 -79.75 96.58 6.31 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 107.551 -1.277 . . . . 72.21 107.551 175.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 161' ' ' VAL . . . . . . . . . . . . . 2.2 p -97.99 108.44 46.46 Favored Pre-proline 0 C--O 1.247 0.938 0 CA-C-N 114.804 -1.089 . . . . 75.24 108.588 -178.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -52.05 115.97 2.49 Favored 'Trans proline' 0 C--N 1.387 2.572 0 C-N-CA 123.483 2.788 . . . . 63.42 114.55 -173.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 163' ' ' GLY . . . . . 0.671 ' H ' ' HA ' ' C' ' 173' ' ' ASP . . . 91.49 -13.82 65.53 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 117.513 1.765 . . . . 53.31 117.513 168.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 164' ' ' MET . . . . . 0.498 ' HB3' ' HB3' ' C' ' 174' ' ' LEU . 47.7 ttm -68.13 -19.07 64.79 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-N 120.45 2.125 . . . . 73.35 112.659 -170.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . -94.77 -112.54 2.51 Favored Glycine 0 C--N 1.347 1.181 0 CA-C-O 119.332 -0.704 . . . . 64.24 111.886 175.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 166' ' ' GLY . . . . . 0.405 ' HA3' ' HB3' ' C' ' 171' ' ' PRO . . . 86.65 67.23 1.36 Allowed Glycine 0 C--N 1.362 2.007 0 CA-C-N 118.057 0.929 . . . . 75.44 113.866 176.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 167' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -79.65 99.88 7.58 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 107.124 -1.436 . . . . 64.31 107.124 172.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 168' ' ' GLY . . . . . 0.436 ' HA3' ' HA2' ' C' ' 116' ' ' GLY . . . 153.31 -85.61 0.14 Allowed Glycine 0 C--O 1.213 -1.164 0 CA-C-O 118.432 -1.205 . . . . 13.44 110.397 -169.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 169' ' ' ASN . . . . . 0.544 ' HB3' ' HD3' ' C' ' 170' ' ' PRO . 2.9 t-20 179.95 -59.78 0.0 OUTLIER Pre-proline 0 N--CA 1.499 1.985 0 CA-C-O 117.387 -1.292 . . . . 62.44 112.189 163.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 170' ' ' PRO . . . . . 0.544 ' HD3' ' HB3' ' C' ' 169' ' ' ASN . 19.4 Cg_exo -67.77 100.24 0.59 Allowed 'Trans proline' 0 C--N 1.399 3.208 0 CA-C-N 122.623 1.972 . . . . 51.41 109.688 165.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 171' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' C' ' 170' ' ' PRO . 14.2 Cg_exo -71.05 132.06 20.58 Favored 'Trans proline' 0 C--N 1.362 1.267 0 C-N-CA 122.901 2.401 . . . . 74.02 114.469 -162.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -71.44 -72.87 0.86 Allowed Glycine 0 C--N 1.347 1.178 0 O-C-N 124.176 0.922 . . . . 74.42 111.331 173.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 173' ' ' ASP . . . . . 0.671 ' HA ' ' H ' ' C' ' 163' ' ' GLY . 4.9 p-10 -172.67 178.32 2.7 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.201 0.6 . . . . 74.51 111.897 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 174' ' ' LEU . . . . . 0.498 ' HB3' ' HB3' ' C' ' 164' ' ' MET . 12.6 tp -122.09 139.17 54.04 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.169 0.988 . . . . 75.22 109.002 170.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 175' ' ' LEU . . . . . 0.4 ' N ' HD12 ' C' ' 174' ' ' LEU . 85.9 mt -101.39 87.11 3.12 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.67 1.188 . . . . 71.32 109.594 177.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 176' ' ' LEU . . . . . 0.665 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 83.9 mt -74.22 92.93 2.28 Favored 'General case' 0 C--N 1.351 0.671 0 C-N-CA 123.09 0.556 . . . . 43.02 109.557 173.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 177' ' ' VAL . . . . . 0.445 ' HB ' ' HB3' ' C' ' 122' ' ' GLU . 22.2 t -84.51 113.52 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 108.619 -0.882 . . . . 74.43 108.619 -177.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 178' ' ' VAL . . . . . 0.549 HG11 HG22 ' C' ' 153' ' ' VAL . 7.5 p -80.76 125.17 39.26 Favored 'Isoleucine or valine' 0 C--O 1.246 0.908 0 CA-C-O 121.798 0.809 . . . . 74.01 111.036 -176.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 179' ' ' ARG . . . . . . . . . . . . . 24.3 mmt180 -110.54 122.9 48.88 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 114.028 -1.442 . . . . 72.33 107.224 169.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 180' ' ' LEU . . . . . 0.556 HD13 HD21 ' C' ' 127' ' ' LEU . 92.5 mt -85.69 149.57 25.21 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 122.774 0.43 . . . . 70.51 111.431 -177.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 181' ' ' LEU . . . . . 0.401 ' HB3' ' HD2' ' C' ' 182' ' ' PRO . 26.4 mt -65.4 165.36 18.52 Favored Pre-proline 0 CA--C 1.565 1.551 0 C-N-CA 124.624 1.17 . . . . 74.2 111.711 -178.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 182' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' C' ' 181' ' ' LEU . 12.7 Cg_exo -36.04 -20.88 0.04 OUTLIER 'Trans proline' 0 C--N 1.403 3.423 1 C-N-CA 125.642 4.228 . . . . 64.12 118.701 -177.357 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 183' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -104.94 99.54 19.66 Favored Pre-proline 0 CA--C 1.562 1.44 0 CA-C-N 119.495 1.043 . . . . 62.13 109.123 167.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 184' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -99.26 66.39 0.06 OUTLIER 'Trans proline' 0 C--N 1.38 2.221 0 C-N-CA 123.961 3.107 . . . . 71.54 110.713 174.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 185' ' ' VAL . . . . . 0.549 ' H ' HD11 ' C' ' 127' ' ' LEU . 21.6 t -92.63 -45.06 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-N 115.487 -0.779 . . . . 72.23 110.144 -165.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 186' ' ' PHE . . . . . 0.61 ' HD2' HD13 ' C' ' 127' ' ' LEU . 71.1 m-85 -100.16 114.57 28.05 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.506 0.67 . . . . 61.44 111.354 -167.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 187' ' ' ARG . . . . . 0.675 ' HB3' ' HB3' ' C' ' 194' ' ' TYR . 3.2 tmt_? -95.77 107.4 19.63 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.878 1.271 . . . . 75.14 108.72 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 188' ' ' LEU . . . . . . . . . . . . . 41.1 tp -82.32 141.78 32.59 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.835 0.68 . . . . 74.14 112.835 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -145.16 108.68 4.65 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 107.103 -1.443 . . . . 71.33 107.103 161.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 71.36 -92.5 0.5 Allowed Glycine 0 C--N 1.356 1.649 0 O-C-N 123.225 0.328 . . . . 74.2 112.534 -178.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 191' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -117.92 -26.53 6.43 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.874 0.87 . . . . 60.21 110.114 174.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -86.54 153.25 21.97 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.557 -0.747 . . . . 65.13 110.731 -166.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 193' ' ' LEU . . . . . 0.42 HD21 ' CD1' ' C' ' 240' ' ' PHE . 84.1 mt -120.3 163.7 17.42 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.6 -0.727 . . . . 52.2 111.172 -175.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 194' ' ' TYR . . . . . 0.675 ' HB3' ' HB3' ' C' ' 187' ' ' ARG . 33.8 t80 -136.64 107.56 6.67 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 114.723 -1.126 . . . . 75.43 108.884 169.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 195' ' ' ALA . . . . . 0.501 ' HB2' HD11 ' C' ' 249' ' ' LEU . . . -105.01 -175.33 2.76 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.725 0.81 . . . . 65.11 110.822 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 59.1 m -128.31 124.05 35.54 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 107.912 -1.144 . . . . 51.32 107.912 164.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 197' ' ' LEU . . . . . 0.425 HD13 ' HB2' ' C' ' 212' ' ' ALA . 35.4 tp -98.99 126.74 44.75 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 122.889 0.476 . . . . 73.5 110.743 -176.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -79.15 101.54 7.98 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.038 0.935 . . . . 44.52 108.858 177.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 199' ' ' VAL . . . . . 0.557 ' HA ' HG11 ' C' ' 210' ' ' VAL . 40.3 t -119.38 106.99 41.8 Favored Pre-proline 0 N--CA 1.478 0.936 0 C-N-CA 123.667 0.787 . . . . 61.21 109.307 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 200' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.23 147.94 67.43 Favored 'Trans proline' 0 C--N 1.373 1.836 0 C-N-CA 121.683 1.589 . . . . 71.34 111.45 175.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 201' ' ' ALA . . . . . 0.446 ' O ' HG23 ' C' ' 205' ' ' VAL . . . -55.44 -45.66 99.83 Favored Pre-proline 0 CA--C 1.551 1.016 0 N-CA-C 113.998 1.11 . . . . 74.35 113.998 -171.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 202' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -52.35 -47.32 27.57 Favored 'Trans proline' 0 C--N 1.385 2.468 0 C-N-CA 121.411 1.407 . . . . 63.15 112.569 174.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 203' ' ' ILE . . . . . 0.531 ' HA ' HG12 ' C' ' 206' ' ' VAL . 51.3 mt -69.02 -32.59 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 123.15 0.58 . . . . 63.4 111.195 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.85 -33.84 75.54 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.688 0.795 . . . . 75.02 112.145 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 205' ' ' VAL . . . . . 0.446 HG23 ' O ' ' C' ' 201' ' ' ALA . 43.1 t -85.75 -38.35 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-N 116.072 -0.513 . . . . 63.41 111.693 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 206' ' ' VAL . . . . . 0.531 HG12 ' HA ' ' C' ' 203' ' ' ILE . 14.4 p -79.09 -35.67 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 CA-C-O 120.952 0.406 . . . . 52.12 111.175 -174.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 79.8 66.8 1.63 Allowed Glycine 0 N--CA 1.435 -1.406 0 CA-C-N 115.185 -0.916 . . . . 63.21 111.948 -167.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -98.08 -137.22 9.58 Favored Glycine 0 C--O 1.244 0.766 0 N-CA-C 111.176 -0.769 . . . . 51.32 111.176 174.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 209' ' ' LYS . . . . . 0.419 ' HG2' ' HA ' ' C' ' 222' ' ' ALA . 7.2 mtmp? -134.22 133.15 40.56 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.337 0.655 . . . . 72.12 110.25 174.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 210' ' ' VAL . . . . . 0.557 HG11 ' HA ' ' C' ' 199' ' ' VAL . 35.8 m -114.84 178.49 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.012 1.325 . . . . 62.05 107.936 169.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 211' ' ' ARG . . . . . 0.604 ' HD3' ' HB2' ' C' ' 218' ' ' PRO . 24.8 ttm105 -131.56 130.24 42.01 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 118.454 0.57 . . . . 72.44 112.204 -177.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 212' ' ' ALA . . . . . 0.425 ' HB2' HD13 ' C' ' 197' ' ' LEU . . . -98.59 115.35 28.45 Favored 'General case' 0 C--N 1.348 0.519 0 C-N-CA 124.356 1.062 . . . . 74.43 108.248 169.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 213' ' ' MET . . . . . 0.423 ' HA ' ' HA ' ' C' ' 218' ' ' PRO . 2.3 tmm? -71.68 101.59 2.58 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 107.185 -1.413 . . . . 63.12 107.185 172.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 214' ' ' THR . . . . . 0.48 HG22 ' H ' ' C' ' 215' ' ' LEU . 0.6 OUTLIER -101.74 174.63 5.87 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 120.991 0.424 . . . . 54.24 110.348 -171.037 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 215' ' ' LEU . . . . . 0.622 HD13 ' HB2' ' C' ' 131' ' ' PHE . 26.5 mt -61.49 -43.42 98.9 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.793 1.637 . . . . 44.41 112.755 -173.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.86 17.5 19.36 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 115.189 -0.914 . . . . 71.0 110.927 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 127.86 159.73 10.18 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-N 115.492 -0.776 . . . . 64.11 112.567 173.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 218' ' ' PRO . . . . . 0.604 ' HB2' ' HD3' ' C' ' 211' ' ' ARG . 70.3 Cg_endo -75.31 102.88 1.65 Allowed 'Trans proline' 0 CA--C 1.561 1.845 0 C-N-CA 122.764 2.309 . . . . 52.13 114.292 -178.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 219' ' ' VAL . . . . . 0.405 HG12 ' OG1' ' C' ' 214' ' ' THR . 12.6 p -83.87 144.28 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 123.729 0.812 . . . . 52.53 110.097 -178.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 220' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -97.36 109.83 22.5 Favored 'General case' 0 C--O 1.246 0.872 0 CA-C-O 121.66 0.743 . . . . 72.32 109.636 174.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 221' ' ' VAL . . . . . 0.435 HG11 HD22 ' C' ' 233' ' ' LEU . 49.2 t -80.12 138.19 20.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 125.114 1.366 . . . . 74.03 111.136 -178.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 222' ' ' ALA . . . . . 0.611 ' H ' ' HB2' ' B' ' 239' ' ' ALA . . . -89.53 118.01 28.85 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.149 0.979 . . . . 73.3 110.309 173.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 49.0 t -92.72 130.72 35.84 Favored Pre-proline 0 CA--C 1.553 1.092 0 N-CA-C 108.18 -1.044 . . . . 73.11 108.18 174.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 224' ' ' PRO . . . . . 0.812 ' HG2' ' HG3' ' B' ' 243' ' ' GLN . 21.1 Cg_exo -72.48 157.66 52.52 Favored 'Trans proline' 0 C--N 1.37 1.697 0 C-N-CA 123.561 2.84 . . . . 54.33 111.894 164.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -58.67 142.88 98.91 Favored 'Trans proline' 0 C--N 1.382 2.337 0 C-N-CA 122.368 2.045 . . . . 74.0 111.209 174.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 226' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 67.57 95.57 0.06 Allowed 'General case' 0 N--CA 1.484 1.247 0 O-C-N 124.488 1.118 . . . . 70.15 111.331 -179.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 227' ' ' THR . . . . . 0.501 HG22 HG11 ' C' ' 253' ' ' VAL . 52.9 m -140.41 123.04 16.24 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 123.222 0.609 . . . . 70.3 112.14 175.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 228' ' ' GLN . . . . . . . . . . . . . 27.7 mp0 -97.74 158.55 15.45 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-O 122.392 1.091 . . . . 74.32 111.172 171.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 229' ' ' ALA . . . . . 0.459 ' HB2' ' H ' ' C' ' 255' ' ' ILE . . . -67.45 148.87 50.98 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-N 113.874 -1.512 . . . . 62.12 109.357 171.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 88.71 -5.44 84.62 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-O 119.689 -0.506 . . . . 62.04 112.93 -174.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 231' ' ' ARG . . . . . 0.424 ' NH1' HE22 ' B' ' 243' ' ' GLN . 57.1 mtt180 -76.85 168.97 19.18 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 109.053 -0.721 . . . . 74.12 109.053 163.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 232' ' ' LYS . . . . . 0.562 ' HD3' ' HB3' ' C' ' 250' ' ' TYR . 3.9 ttmp? -143.47 139.82 30.05 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.96 0.41 . . . . 71.45 112.087 -175.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 233' ' ' LEU . . . . . 0.576 HD13 ' HB2' ' C' ' 251' ' ' LEU . 2.4 mp -105.7 155.75 18.95 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.808 1.243 . . . . 74.21 109.724 -179.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 41.1 ttp85 -128.01 89.93 3.01 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 109.095 -0.706 . . . . 72.34 109.095 172.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 235' ' ' LEU . . . . . 0.578 HD12 HD23 ' C' ' 249' ' ' LEU . 72.3 mt -73.43 114.14 11.32 Favored 'General case' 0 C--N 1.359 0.995 0 N-CA-C 109.497 -0.557 . . . . 73.43 109.497 174.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 24.7 mmmt -72.55 124.17 24.68 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.956 0.902 . . . . 71.55 111.236 -177.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 72.27 37.52 59.24 Favored Glycine 0 C--N 1.35 1.307 0 O-C-N 123.832 0.708 . . . . 71.42 113.118 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 29.8 mmtm -125.32 14.77 8.32 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.836 0.854 . . . . 72.03 111.322 177.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -96.32 -162.96 33.08 Favored Glycine 0 C--N 1.348 1.245 0 N-CA-C 111.972 -0.451 . . . . 31.21 111.972 172.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 240' ' ' PHE . . . . . 0.42 ' CD1' HD21 ' C' ' 193' ' ' LEU . 3.3 m-85 -72.51 149.59 91.08 Favored Pre-proline 0 N--CA 1.477 0.899 0 C-N-CA 123.588 0.755 . . . . 75.14 111.489 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 241' ' ' PRO . . . . . 0.435 ' HD3' ' CD2' ' C' ' 131' ' ' PHE . 31.6 Cg_exo -59.49 119.25 6.36 Favored 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 124.101 3.201 . . . . 70.21 112.572 -176.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -131.34 -172.76 13.17 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-N 115.488 -0.778 . . . . 70.14 112.822 -174.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.56 -40.48 30.18 Favored 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 123.781 2.988 . . . . 71.42 112.652 -178.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -84.56 10.81 10.05 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.097 0.559 . . . . 71.42 111.854 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 120.11 -75.45 0.32 Allowed Glycine 0 C--N 1.348 1.207 0 N-CA-C 110.601 -1.0 . . . . 51.32 110.601 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 246' ' ' ARG . . . . . . . . . . . . . 30.5 mtm180 -142.46 -179.97 6.6 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.845 1.258 . . . . 61.31 109.655 175.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -89.02 -161.86 37.93 Favored Glycine 0 C--N 1.346 1.137 0 N-CA-C 112.105 -0.398 . . . . 63.23 112.105 173.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -122.71 137.96 54.75 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 117.358 0.579 . . . . 73.54 109.736 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 249' ' ' LEU . . . . . 0.578 HD23 HD12 ' C' ' 235' ' ' LEU . 21.1 tp -95.04 115.11 27.01 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.198 0.999 . . . . 74.23 110.177 -175.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 250' ' ' TYR . . . . . 0.562 ' HB3' ' HD3' ' C' ' 232' ' ' LYS . 8.6 m-85 -100.91 100.13 10.72 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.253 -0.647 . . . . 71.43 109.253 -179.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 251' ' ' LEU . . . . . 0.576 ' HB2' HD13 ' C' ' 233' ' ' LEU . 1.8 mp -96.98 138.65 34.18 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.651 -0.656 . . . . 64.53 109.923 -174.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -89.89 118.83 29.76 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.358 -0.978 . . . . 73.41 108.358 173.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 253' ' ' VAL . . . . . 0.501 HG11 HG22 ' C' ' 227' ' ' THR . 91.7 t -60.27 130.61 24.26 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 123.45 0.7 . . . . 73.5 110.842 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 254' ' ' ARG . . . . . 0.468 ' CZ ' ' HB ' ' C' ' 256' ' ' THR . 2.1 tmm_? -126.27 101.0 6.54 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 107.122 -1.436 . . . . 74.13 107.122 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 255' ' ' ILE . . . . . 0.459 ' H ' ' HB2' ' C' ' 229' ' ' ALA . 46.2 mm -73.45 125.92 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 109.577 -0.527 . . . . 75.24 109.577 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 256' ' ' THR . . . . . 0.468 ' HB ' ' CZ ' ' C' ' 254' ' ' ARG . 0.1 OUTLIER -128.09 163.47 24.55 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.102 0.961 . . . . 53.32 111.003 -175.418 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 2.8 pp -137.08 147.97 60.8 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 124.751 1.221 . . . . 64.54 107.827 173.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -79.17 15.48 1.53 Allowed 'Trans proline' 0 N--CA 1.501 1.943 0 C-N-CA 122.566 2.178 . . . . 73.21 113.089 -170.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 57.59 -84.3 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.406 1.483 . . . . 72.3 111.017 -171.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -73.09 137.83 45.48 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.215 1.006 . . . . 73.41 110.138 -177.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 261' ' ' LEU . . . . . . . . . . . . . 77.3 mt -130.16 165.03 23.17 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.756 0.822 . . . . 71.21 111.361 -178.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 14.9 p -84.09 146.4 48.41 Favored Pre-proline 0 CA--C 1.549 0.918 0 CA-C-N 114.245 -1.343 . . . . 61.23 108.854 167.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -51.38 -26.0 19.95 Favored 'Trans proline' 0 C--N 1.39 2.732 0 C-N-CA 124.256 3.304 . . . . 74.2 114.649 -172.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -66.36 -65.4 0.68 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.753 0.821 . . . . 71.04 109.754 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -56.13 -44.02 78.76 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 114.647 -1.16 . . . . 65.11 109.85 177.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 266' ' ' GLU . . . . . 0.409 ' O ' ' HG2' ' C' ' 270' ' ' LYS . 5.2 tp10 -50.44 -48.42 56.41 Favored 'General case' 0 CA--C 1.548 0.891 0 O-C-N 124.549 1.156 . . . . 64.21 110.529 179.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 267' ' ' ALA . . . . . 0.475 ' O ' ' HG2' ' C' ' 271' ' ' LYS . . . -66.57 -41.0 89.27 Favored 'General case' 0 C--N 1.355 0.835 0 CA-C-N 115.481 -0.781 . . . . 70.32 112.22 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 268' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.98 -38.42 91.0 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 120.797 0.332 . . . . 52.44 111.112 176.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -68.01 -32.56 73.03 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.39 0.676 . . . . 61.11 110.43 175.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 270' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' C' ' 266' ' ' GLU . 4.0 mmmp? -58.99 -49.39 78.05 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.048 0.539 . . . . 75.43 109.721 173.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 271' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' C' ' 267' ' ' ALA . 10.8 mmpt? -59.54 -48.76 80.41 Favored 'General case' 0 C--O 1.249 1.033 0 O-C-N 124.252 0.97 . . . . 75.33 111.106 -177.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 80.4 mt -54.14 -57.84 9.6 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 124.049 0.843 . . . . 74.33 110.193 173.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -52.95 -45.92 67.93 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.938 0.895 . . . . 34.13 112.339 -173.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -63.56 -43.54 96.76 Favored 'General case' 0 C--O 1.25 1.097 0 C-N-CA 123.789 0.835 . . . . 63.21 110.8 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -56.4 -34.37 66.66 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-O 121.001 0.429 . . . . 70.04 111.444 174.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 276' ' ' TYR . . . . . 0.716 ' HA ' ' HD3' ' C' ' 279' ' ' ARG . 1.0 OUTLIER -85.26 -25.65 27.14 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 115.743 -0.662 . . . . 75.52 111.596 -179.404 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 277' ' ' TYR . . . . . 0.44 ' CE1' ' HA3' ' A' ' 208' ' ' GLY . 22.1 m-30 -68.85 -32.36 71.99 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.938 -0.393 . . . . 44.24 109.938 176.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -55.57 -18.62 7.93 Favored 'General case' 0 CA--C 1.561 1.393 0 O-C-N 123.756 0.66 . . . . 55.2 112.515 173.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 279' ' ' ARG . . . . . 0.716 ' HD3' ' HA ' ' C' ' 276' ' ' TYR . 12.6 mtp-105 -89.87 -28.88 18.94 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.061 0.944 . . . . 71.52 111.833 176.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.963 0 C-N-CA 123.292 0.637 . . . . 75.14 110.671 -174.062 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt . . . . . 0 N--CA 1.476 0.864 0 N-CA-C 113.24 0.83 . . . . 62.43 113.24 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -72.13 112.02 7.86 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.587 -0.894 . . . . 74.32 108.587 166.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -75.98 84.3 2.88 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 107.242 -1.392 . . . . 61.41 107.242 178.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.485 ' HA ' HD12 ' A' ' 10' ' ' ILE . 41.7 m-85 -60.67 -29.98 69.63 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-N 114.59 -1.186 . . . . 73.34 111.996 -173.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -66.38 -42.34 88.09 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.833 -0.621 . . . . 73.33 110.432 176.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.09 -40.31 95.95 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.933 0.493 . . . . 60.32 111.19 176.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.485 HD12 ' HA ' ' A' ' 7' ' ' TYR . 62.9 mt -60.79 -39.17 80.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-N 115.807 -0.633 . . . . 74.23 110.727 178.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 92.1 mt -86.03 -7.59 58.52 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 112.287 0.477 . . . . 51.33 112.287 176.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.49 18.29 76.93 Favored Glycine 0 C--N 1.351 1.391 0 N-CA-C 114.501 0.56 . . . . 53.33 114.501 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.4 m -103.83 153.88 38.43 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 124.444 1.098 . . . . 71.43 110.041 177.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.23 165.11 20.52 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 122.785 2.323 . . . . 50.12 114.142 -176.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -81.63 61.05 4.86 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.4 1.08 . . . . 75.43 109.658 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -177.42 -26.83 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 114.073 -1.421 . . . . 64.11 108.286 -166.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -47.16 123.58 5.58 Favored 'General case' 0 C--N 1.349 0.579 0 C-N-CA 125.714 1.606 . . . . 64.31 113.137 -174.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 43.7 p -74.42 173.01 10.9 Favored 'General case' 0 C--O 1.243 0.733 0 O-C-N 124.226 0.954 . . . . 71.11 110.901 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.2 tm0? -55.81 -29.19 59.37 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.04 0.936 . . . . 64.21 110.178 179.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -57.22 -58.67 7.19 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.416 1.086 . . . . 72.43 110.845 173.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -66.03 -35.02 79.43 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.135 0.574 . . . . 64.03 111.484 -173.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.51 HG12 ' HB3' ' A' ' 57' ' ' LEU . 1.7 mp -61.76 -45.0 99.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 123.044 0.537 . . . . 73.31 110.296 173.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -61.69 -40.02 93.5 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.575 1.15 . . . . 71.24 111.035 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.613 ' HA ' ' HD3' ' A' ' 27' ' ' LYS . 18.5 mtp180 -77.15 -37.47 53.88 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.997 0.919 . . . . 54.12 111.41 -175.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.92 -37.99 89.43 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.652 -0.704 . . . . 64.0 110.161 173.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -74.97 -28.05 60.42 Favored 'General case' 0 C--O 1.215 -0.732 0 CA-C-N 115.006 -0.997 . . . . 73.1 110.964 176.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.613 ' HD3' ' HA ' ' A' ' 24' ' ' ARG . 22.6 mtpp -55.29 -53.54 54.76 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.414 -0.958 . . . . 74.22 108.414 171.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 -54.2 -67.06 0.29 Allowed 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 114.576 -1.193 . . . . 71.15 111.34 176.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 79.4 mt -70.21 -22.98 62.87 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.04 0.936 . . . . 74.11 112.952 -166.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.81 -54.79 6.66 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 109.252 -0.647 . . . . 63.3 109.252 173.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -64.11 -21.59 66.6 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 120.878 0.37 . . . . 72.33 111.509 -178.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -84.96 -44.33 13.2 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 124.721 1.209 . . . . 63.33 111.113 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -113.78 21.53 14.88 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 112.749 0.648 . . . . 63.25 112.749 -174.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -63.85 113.37 9.81 Favored Pre-proline 0 N--CA 1.484 1.263 0 CA-C-O 118.074 -0.965 . . . . 63.41 108.465 176.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.709 ' HB3' ' HG2' ' A' ' 44' ' ' GLU . 19.5 Cg_endo -57.87 -28.08 81.15 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 123.227 2.618 . . . . 74.13 113.647 -174.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -73.38 -30.55 63.36 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.881 0.873 . . . . 72.45 111.997 176.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 75.4 t -85.16 -39.23 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.017 0.527 . . . . 65.53 109.889 176.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -132.33 94.5 3.45 Favored 'General case' 0 C--O 1.244 0.793 0 C-N-CA 124.491 1.116 . . . . 61.35 109.088 -175.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.606 ' HE3' ' H ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -76.04 82.91 2.9 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 108.764 -0.828 . . . . 73.11 108.764 -179.581 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.5 m -140.08 116.22 7.99 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-O 117.998 -1.001 . . . . 54.41 108.666 177.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_exo -46.93 -42.22 25.33 Favored 'Trans proline' 0 C--N 1.387 2.579 0 C-N-CA 123.119 2.546 . . . . 72.23 112.419 175.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 34.3 tp10 -48.56 -51.29 28.47 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.05 1.34 . . . . 64.43 111.116 173.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.3 -25.6 65.22 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 115.113 -0.949 . . . . 72.14 111.031 -177.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.709 ' HG2' ' HB3' ' A' ' 35' ' ' PRO . 41.7 mt-10 -84.17 -33.94 24.11 Favored 'General case' 0 C--N 1.354 0.785 0 C-N-CA 123.324 0.65 . . . . 62.01 110.948 -174.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -76.47 -38.68 54.98 Favored 'General case' 0 C--O 1.246 0.905 0 CA-C-O 121.372 0.606 . . . . 62.44 109.459 178.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -66.35 -34.21 77.47 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.411 -0.813 . . . . 74.03 110.083 170.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -62.15 -39.74 93.63 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.361 0.665 . . . . 73.24 109.246 172.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.412 ' HG3' ' O ' ' A' ' 44' ' ' GLU . 67.1 mttm -58.14 -50.93 71.78 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 122.975 0.51 . . . . 75.14 110.688 176.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -60.29 -44.76 95.09 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.474 0.654 . . . . 71.44 111.579 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 96.6 mt -70.82 -26.91 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 124.422 1.089 . . . . 70.53 111.39 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.531 ' HA ' ' HB3' ' A' ' 54' ' ' TYR . 9.7 m-80 -94.82 -6.12 43.57 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.732 0.813 . . . . 73.43 111.474 178.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -75.94 -49.04 18.88 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 106.329 -1.73 . . . . 63.42 106.329 164.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.476 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . . . -57.27 -48.66 78.32 Favored 'General case' 0 C--N 1.349 0.573 0 CA-C-N 113.505 -1.679 . . . . 65.45 111.452 174.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.531 ' HB3' ' HA ' ' A' ' 51' ' ' ASN . 67.2 t80 -67.95 -41.31 82.66 Favored 'General case' 0 C--O 1.209 -1.07 0 CA-C-N 115.689 -0.687 . . . . 72.32 110.602 179.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.45 -51.19 60.54 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 118.42 0.554 . . . . 53.01 111.368 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.505 HG13 ' HZ ' ' A' ' 101' ' ' PHE . 47.5 t -73.65 -31.97 33.94 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 CA-C-N 115.122 -0.945 . . . . 74.52 111.204 -177.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.51 ' HB3' HG12 ' A' ' 22' ' ' ILE . 76.4 mt -103.75 3.66 34.36 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 113.961 1.097 . . . . 62.04 113.961 -175.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.3 t -63.06 -51.26 67.35 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 123.855 0.862 . . . . 74.34 111.804 -176.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -109.66 144.25 29.5 Favored Pre-proline 0 C--O 1.239 0.513 0 CA-C-N 114.439 -1.255 . . . . 74.34 108.924 -169.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.414 ' O ' ' HG2' ' A' ' 64' ' ' ARG . 48.3 Cg_exo -41.61 -51.09 4.49 Favored 'Trans proline' 0 C--N 1.383 2.379 0 C-N-CA 123.943 3.095 . . . . 72.41 114.983 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.467 ' HB2' ' HB3' ' A' ' 144' ' ' ARG . 18.9 tp10 -79.8 -31.31 40.71 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 112.531 0.567 . . . . 72.3 112.531 -172.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -62.7 -42.2 99.52 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-O 122.084 0.945 . . . . 74.54 108.884 174.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.441 ' HG2' HD22 ' A' ' 57' ' ' LEU . 4.0 tmt_? -61.98 -42.65 99.37 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 113.72 -1.582 . . . . 74.11 108.443 175.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.414 ' HG2' ' O ' ' A' ' 60' ' ' PRO . 2.8 mmp_? -62.04 -34.51 76.37 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.615 0.766 . . . . 74.25 111.364 174.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 61' ' ' GLU . 62.4 mt -62.98 -44.24 99.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 109.217 -0.66 . . . . 64.42 109.217 178.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -57.79 -54.22 49.31 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.558 -0.747 . . . . 75.4 110.181 173.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -57.62 -42.52 83.47 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.703 0.801 . . . . 64.04 111.606 -175.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 40.4 p -69.68 -31.22 69.14 Favored 'General case' 0 C--N 1.348 0.535 0 CA-C-N 115.948 -0.569 . . . . 75.13 110.311 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -80.26 137.19 36.59 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 118.212 0.46 . . . . 63.45 110.335 -177.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.15 6.93 77.95 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-N 115.764 -0.653 . . . . 52.54 111.547 -174.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 95.0 m -130.37 -61.28 0.97 Allowed 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 103.671 -2.714 . . . . 71.23 103.671 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 92.0 m -87.72 150.09 23.82 Favored 'General case' 0 C--O 1.255 1.364 0 N-CA-C 105.274 -2.121 . . . . 74.23 105.274 156.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.57 -15.34 11.44 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.768 0.827 . . . . 74.04 111.136 178.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.1 123.99 87.71 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 123.695 0.798 . . . . 75.1 110.919 177.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.455 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 61.2 Cg_endo -71.37 146.26 50.06 Favored 'Trans proline' 0 C--N 1.376 1.995 0 C-N-CA 122.413 2.075 . . . . 75.41 110.77 175.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 75' ' ' PRO . 7.1 Cg_exo -70.76 152.14 63.9 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 122.46 2.107 . . . . 74.25 110.982 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -58.63 148.5 81.77 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 122.809 2.34 . . . . 62.44 112.947 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -50.36 114.15 1.32 Allowed 'Trans proline' 0 C--N 1.391 2.812 0 C-N-CA 123.542 2.828 . . . . 43.51 112.782 177.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.467 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 85.8 Cg_endo -81.73 127.6 5.66 Favored 'Trans proline' 0 CA--C 1.557 1.648 0 C-N-CA 122.467 2.111 . . . . 71.05 112.192 -176.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 79' ' ' PRO . 34.0 Cg_exo -60.33 84.16 0.07 OUTLIER 'Trans proline' 0 C--N 1.384 2.434 0 C-N-CA 123.176 2.584 . . . . 51.35 112.854 -177.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 146.99 -44.32 0.82 Allowed Glycine 0 C--N 1.341 0.834 0 CA-C-N 114.656 -1.156 . . . . 62.41 110.549 -177.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 115.13 144.75 8.45 Favored Glycine 0 C--N 1.359 1.809 0 C-N-CA 123.282 0.468 . . . . 53.03 112.707 178.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -58.24 117.75 4.75 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.693 0.797 . . . . 74.41 109.646 174.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -54.65 108.54 0.4 Allowed 'General case' 0 N--CA 1.476 0.852 0 O-C-N 124.339 1.024 . . . . 71.31 112.967 -171.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.58 ' HA ' ' HD2' ' A' ' 88' ' ' PHE . 14.1 m-85 -134.81 38.7 3.02 Favored 'General case' 0 C--O 1.245 0.862 0 C-N-CA 125.95 1.7 . . . . 70.22 108.068 173.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.3 m -67.18 117.75 9.64 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 113.256 -1.793 . . . . 74.44 110.732 177.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 85.24 -12.07 59.25 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-N 116.116 -0.493 . . . . 70.11 113.535 -176.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.58 ' HD2' ' HA ' ' A' ' 85' ' ' PHE . 12.2 m-85 -101.59 135.53 42.96 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 109.426 -0.583 . . . . 72.34 109.426 -172.016 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -79.45 80.41 5.82 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-O 120.909 0.385 . . . . 71.44 110.237 -174.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.422 HG23 ' HZ ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -42.14 -53.64 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 125.692 1.597 . . . . 75.21 112.996 176.841 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -73.85 -5.65 42.31 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 113.374 0.879 . . . . 75.33 113.374 -173.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -95.83 -18.71 20.17 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.209 0.604 . . . . 45.35 110.986 175.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.407 ' HE1' ' HB3' ' A' ' 48' ' ' LYS . 23.2 m-30 -83.62 179.12 7.7 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 113.068 0.766 . . . . 71.01 113.068 -171.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 68.2 p -68.14 151.95 46.23 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.892 1.277 . . . . 74.5 113.236 -170.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.6 -35.23 73.91 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 115.309 -0.86 . . . . 74.31 110.727 172.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -50.08 -51.36 43.33 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.132 1.373 . . . . 75.03 110.297 176.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.422 ' HZ ' HG23 ' A' ' 90' ' ' VAL . 0.3 OUTLIER -64.37 -46.08 84.94 Favored 'General case' 0 CA--C 1.556 1.205 0 CA-C-N 114.257 -1.338 . . . . 63.23 110.831 173.859 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.452 ' HA ' HD21 ' A' ' 105' ' ' LEU . 60.7 mt-30 -70.19 -9.9 57.18 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 112.98 0.733 . . . . 73.05 112.98 -173.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -101.96 -44.46 5.48 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.952 0.901 . . . . 70.02 110.929 173.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 17.8 tp -63.66 -56.9 12.21 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.646 0.778 . . . . 55.03 111.042 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.505 ' HZ ' HG13 ' A' ' 56' ' ' VAL . 86.5 m-85 -85.77 6.97 25.53 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 115.392 -0.822 . . . . 72.11 111.073 176.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.437 ' HA2' ' HG ' ' A' ' 105' ' ' LEU . . . -41.4 -63.16 1.67 Allowed Glycine 0 C--N 1.358 1.792 0 C-N-CA 124.867 1.223 . . . . 72.43 114.659 178.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -43.55 -23.12 0.47 Allowed 'Trans proline' 0 C--N 1.389 2.689 0 C-N-CA 124.793 3.662 . . . . 23.1 115.849 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.417 ' HA3' ' HD2' ' A' ' 79' ' ' PRO . . . -152.74 51.6 0.49 Allowed Glycine 0 C--N 1.346 1.138 0 O-C-N 121.888 -0.507 . . . . 44.4 112.035 177.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.452 HD21 ' HA ' ' A' ' 98' ' ' GLN . 25.9 mt -57.48 14.05 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.241 0 N-CA-C 116.067 1.877 . . . . 74.25 116.067 177.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER 61.76 -164.66 0.24 Allowed 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.855 0.862 . . . . 72.25 110.417 166.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 61.68 45.63 95.88 Favored Glycine 0 N--CA 1.442 -0.925 0 N-CA-C 115.678 1.031 . . . . 44.0 115.678 164.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.956 0 N-CA-C 118.692 2.237 . . . . 71.34 118.692 162.069 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.404 ' HA ' ' HD2' ' A' ' 170' ' ' PRO . 7.4 tmtt? . . . . . 0 N--CA 1.51 2.543 0 N-CA-C 114.093 1.146 . . . . 72.15 114.093 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.82 129.13 41.36 Favored Glycine 0 CA--C 1.543 1.835 0 CA-C-N 115.549 -0.751 . . . . 55.22 114.7 -175.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.542 ' N ' ' HA3' ' A' ' 166' ' ' GLY . 65.0 mtt180 -77.37 160.4 28.8 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 125.214 1.406 . . . . 71.34 111.576 172.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -85.14 84.86 7.55 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 107.321 -1.362 . . . . 74.23 107.321 163.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 9.5 tt -95.9 144.54 26.14 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.365 1.066 . . . . 70.23 109.45 -171.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.432 ' HA ' ' HB2' ' A' ' 175' ' ' LEU . 53.6 ttt-85 -102.98 143.37 32.64 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.045 0.938 . . . . 74.51 109.924 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.468 ' HB3' HD11 ' A' ' 174' ' ' LEU . . . -147.4 167.46 24.32 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.308 0.575 . . . . 41.51 112.123 -178.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.438 ' O ' HD12 ' B' ' 8' ' ' LEU . 5.7 mm-40 -103.38 107.93 18.96 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 114.49 -1.232 . . . . 61.0 107.741 -175.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 24.0 tp -99.24 100.25 9.88 Favored Pre-proline 0 N--CA 1.48 1.05 0 N-CA-C 107.888 -1.153 . . . . 54.05 107.888 177.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.579 ' HG2' ' HB ' ' B' ' 6' ' ' ILE . 43.9 Cg_endo -68.29 139.03 44.63 Favored 'Trans proline' 0 C--N 1.37 1.663 0 C-N-CA 121.323 1.348 . . . . 75.33 109.269 176.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.507 HD21 HD12 ' A' ' 149' ' ' ILE . 28.5 tp -142.56 138.7 31.02 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.151 0.887 . . . . 64.01 112.027 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 98.8 m -73.18 131.05 41.55 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 114.233 -1.349 . . . . 71.34 109.189 174.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.57 HD22 HD13 ' A' ' 180' ' ' LEU . 5.4 mt -53.48 -56.74 14.41 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 124.113 0.883 . . . . 70.54 111.085 -172.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.628 ' HG2' ' HD3' ' B' ' 2' ' ' LYS . 28.8 mp0 -41.41 -53.06 3.45 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 113.148 -1.842 . . . . 75.32 111.615 176.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -65.43 -37.42 86.84 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.454 0.702 . . . . 64.33 111.219 -178.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.585 ' HB1' ' O ' ' A' ' 153' ' ' VAL . . . -60.3 -34.66 74.08 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 124.421 1.075 . . . . 41.43 111.46 178.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -82.68 -37.69 24.46 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.563 0.745 . . . . 74.51 111.527 176.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 41.4 m170 -64.59 -40.12 94.96 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.254 0.622 . . . . 75.25 110.903 -175.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 67.34 77.84 0.3 Allowed Glycine 0 C--N 1.343 0.938 0 CA-C-N 115.452 -0.795 . . . . 71.54 112.804 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.412 ' O ' HG12 ' A' ' 149' ' ' ILE . . . -155.33 -158.99 9.05 Favored Glycine 0 C--N 1.334 0.427 0 N-CA-C 112.141 -0.384 . . . . 70.42 112.141 -179.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -68.87 123.89 22.2 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 125.001 1.32 . . . . 73.14 110.401 -175.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.58 HH11 HG23 ' B' ' 5' ' ' THR . 10.1 tpp180 -126.87 120.31 28.9 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.274 -1.01 . . . . 74.4 108.274 169.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.4 t -80.66 128.0 39.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 115.18 -0.918 . . . . 71.24 109.499 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.6 p -142.58 124.03 12.12 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 C-N-CA 124.327 1.051 . . . . 73.14 108.25 -178.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -116.56 123.73 48.09 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.925 0.49 . . . . 71.3 111.695 -171.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.515 HG21 HD23 ' B' ' 8' ' ' LEU . 1.0 OUTLIER -153.69 149.4 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 125.406 1.483 . . . . 75.1 109.598 170.491 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 61.41 20.38 11.1 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.09 0.956 . . . . 74.24 112.33 176.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 85.89 -14.11 53.96 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-N 116.21 -0.45 . . . . 31.1 112.78 -175.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.586 ' HD3' ' SD ' ' A' ' 164' ' ' MET . 59.4 ttt180 -87.82 102.5 14.75 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 123.225 0.61 . . . . 72.12 109.579 177.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.467 ' HB3' ' HB2' ' A' ' 61' ' ' GLU . 41.9 ttt85 -92.41 89.79 6.94 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 107.926 -1.138 . . . . 74.41 107.926 171.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.3 p -96.86 142.95 13.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 115.34 -0.846 . . . . 73.53 109.508 -173.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 23.2 t -108.97 95.81 5.9 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 109.029 -0.73 . . . . 31.45 109.029 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 3.4 p -81.14 116.39 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.005 0.522 . . . . 73.42 110.041 -177.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 38.8 ttt85 -77.61 94.33 4.36 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 107.884 -1.154 . . . . 74.14 107.884 171.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.507 HD12 HD21 ' A' ' 125' ' ' LEU . 9.3 pt -70.45 150.69 95.69 Favored Pre-proline 0 CA--C 1.553 1.064 0 CA-C-N 114.494 -1.23 . . . . 74.13 110.805 -178.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.613 ' HB2' ' HZ ' ' A' ' 240' ' ' PHE . 92.9 Cg_endo -75.69 137.73 20.57 Favored 'Trans proline' 0 CA--C 1.566 2.098 0 C-N-CA 122.231 1.954 . . . . 60.34 111.997 178.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.24 101.64 0.36 Allowed 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 123.086 2.524 . . . . 74.15 114.119 -175.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 121.24 5.62 9.42 Favored Glycine 0 C--N 1.345 1.036 0 CA-C-N 115.006 -0.997 . . . . 75.51 112.914 178.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.585 ' O ' ' HB1' ' A' ' 130' ' ' ALA . 7.4 p -62.38 134.71 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 N-CA-C 109.314 -0.624 . . . . 75.43 109.314 175.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.712 ' HD3' ' HB3' ' A' ' 186' ' ' PHE . 70.0 mtt85 -139.17 174.68 10.26 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 122.761 0.424 . . . . 73.23 110.413 -173.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.599 ' HG3' ' HE ' ' A' ' 187' ' ' ARG . 4.2 tp10 -43.62 136.35 3.39 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 126.792 2.037 . . . . 72.32 113.297 -172.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.38 -15.33 46.03 Favored Glycine 0 CA--C 1.534 1.267 0 CA-C-O 118.885 -0.953 . . . . 14.21 114.627 177.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 22.8 t -63.23 151.76 39.53 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-N 118.648 1.224 . . . . 74.23 110.172 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.426 HG22 HG22 ' A' ' 177' ' ' VAL . 57.3 t -123.5 102.08 10.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 123.566 0.747 . . . . 72.34 109.431 -175.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.554 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 60.2 mt -83.43 108.57 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 108.282 -1.007 . . . . 75.24 108.282 172.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.433 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 78.1 ttt180 -82.39 110.07 17.2 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 109.381 -0.6 . . . . 61.32 109.381 177.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.402 HG13 ' HB3' ' A' ' 174' ' ' LEU . 3.5 p -121.66 106.52 37.22 Favored Pre-proline 0 CA--C 1.558 1.269 0 C-N-CA 123.164 0.586 . . . . 61.33 110.133 178.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.528 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 24.5 Cg_exo -64.98 129.9 24.41 Favored 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 122.938 2.425 . . . . 74.53 111.89 174.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 102.5 24.97 7.97 Favored Glycine 0 C--N 1.342 0.862 0 CA-C-O 119.713 -0.493 . . . . 70.43 114.055 177.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.586 ' SD ' ' HD3' ' A' ' 143' ' ' ARG . 18.6 tpp -138.77 -40.32 0.49 Allowed 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 117.489 0.645 . . . . 64.15 111.19 -175.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.46 ' N ' ' HB2' ' A' ' 174' ' ' LEU . . . -76.98 -85.54 0.43 Allowed Glycine 0 C--N 1.351 1.398 0 O-C-N 123.61 0.569 . . . . 73.33 112.493 -174.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.542 ' HA3' ' N ' ' A' ' 117' ' ' ARG . . . -62.33 105.04 0.86 Allowed Glycine 0 C--O 1.257 1.581 0 N-CA-C 111.697 -0.561 . . . . 74.5 111.697 171.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -60.01 124.46 20.28 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.257 -1.016 . . . . 75.42 108.257 169.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 176.47 152.92 10.09 Favored Glycine 0 CA--C 1.499 -0.967 0 O-C-N 123.758 0.661 . . . . 64.21 112.103 -176.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . 0.469 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . 3.6 t-20 -55.19 -45.45 99.85 Favored Pre-proline 0 CA--C 1.569 1.705 0 CA-C-O 118.702 -0.666 . . . . 63.11 110.903 169.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.469 ' HD3' ' HB3' ' A' ' 169' ' ' ASN . 15.1 Cg_exo -75.33 140.1 24.18 Favored 'Trans proline' 0 C--N 1.387 2.595 0 C-N-CA 121.911 1.74 . . . . 71.13 110.449 161.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.34 112.5 3.54 Favored 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 123.047 2.498 . . . . 71.25 113.159 -170.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -80.57 130.54 9.82 Favored Glycine 0 C--N 1.36 1.87 0 C-N-CA 121.004 -0.617 . . . . 72.4 113.369 177.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.528 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 22.5 m-20 -61.28 137.97 58.24 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.781 0.832 . . . . 71.14 110.392 178.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.468 HD11 ' HB3' ' A' ' 121' ' ' ALA . 43.3 tp -113.3 138.51 49.92 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.766 -0.457 . . . . 64.32 109.766 175.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.432 ' HB2' ' HA ' ' A' ' 120' ' ' ARG . 60.3 mt -103.08 86.12 2.64 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 107.947 -1.131 . . . . 72.12 107.947 172.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.554 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 68.3 mt -66.77 89.75 0.16 Allowed 'General case' 0 C--N 1.354 0.792 0 CA-C-N 115.419 -0.81 . . . . 70.05 109.298 174.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.426 HG22 HG22 ' A' ' 158' ' ' VAL . 97.3 t -84.15 99.33 6.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 107.23 -1.396 . . . . 61.43 107.23 175.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.4 p -66.06 102.38 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 CA-C-O 122.294 1.045 . . . . 70.33 111.013 -174.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.548 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 8.1 mmm180 -85.28 96.23 9.45 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 114.137 -1.392 . . . . 53.32 107.797 174.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.57 HD13 HD22 ' A' ' 127' ' ' LEU . 19.1 mt -67.91 150.48 48.48 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 109.925 -0.398 . . . . 72.4 109.925 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 74.3 mt -52.75 144.77 24.22 Favored Pre-proline 0 N--CA 1.48 1.026 0 CA-C-O 118.067 -0.968 . . . . 73.14 110.531 178.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -56.2 81.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.388 2.615 0 C-N-CA 124.149 3.232 . . . . 71.42 112.932 -174.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . 0.412 ' CG ' HD11 ' A' ' 127' ' ' LEU . 12.1 t-80 -143.84 96.91 5.46 Favored Pre-proline 0 CA--C 1.547 0.829 0 N-CA-C 105.346 -2.094 . . . . 73.35 105.346 -177.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -72.67 27.83 0.28 Allowed 'Trans proline' 0 N--CA 1.498 1.779 0 C-N-CA 124.738 3.625 . . . . 61.24 116.733 -162.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.547 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 61.3 t -93.91 -61.17 2.18 Favored 'Isoleucine or valine' 0 C--N 1.352 0.709 0 CA-C-N 119.648 1.113 . . . . 64.21 110.283 -172.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . 0.712 ' HB3' ' HD3' ' A' ' 154' ' ' ARG . 11.7 m-85 -114.52 148.27 38.17 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 114.792 1.404 . . . . 72.31 114.792 -166.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.599 ' HE ' ' HG3' ' A' ' 155' ' ' GLU . 28.5 ttm180 -148.0 134.0 19.21 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.661 1.584 . . . . 75.51 109.192 177.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.48 ' HB2' ' HB2' ' A' ' 154' ' ' ARG . 47.0 tp -97.26 110.27 22.85 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 109.334 -0.617 . . . . 74.21 109.334 174.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.42 92.57 4.75 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 106.983 -1.488 . . . . 70.31 106.983 174.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 68.82 -98.71 0.56 Allowed Glycine 0 C--N 1.346 1.095 0 CA-C-N 115.546 -0.752 . . . . 65.41 111.349 -174.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.432 ' NE2' ' H ' ' A' ' 191' ' ' GLN . 0.7 OUTLIER -115.66 -15.42 11.38 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.118 0.567 . . . . 72.32 110.702 172.141 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.403 ' O ' HD12 ' A' ' 188' ' ' LEU . 15.3 m-20 -79.2 163.58 24.89 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.226 0.61 . . . . 72.32 110.061 177.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.507 HD22 ' HD2' ' A' ' 154' ' ' ARG . 80.1 mt -125.44 141.12 52.23 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.027 0.931 . . . . 63.44 110.699 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.408 ' HB2' ' HB3' ' A' ' 187' ' ' ARG . 55.3 m-85 -102.26 140.67 36.24 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.862 -1.162 . . . . 73.14 107.862 163.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.547 ' HA ' ' O ' ' A' ' 185' ' ' VAL . . . -143.92 155.97 44.26 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.557 1.143 . . . . 74.34 109.314 -173.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 25.4 m -121.27 126.31 49.24 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 108.986 -0.746 . . . . 70.21 108.986 176.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.478 ' HB2' HD22 ' A' ' 251' ' ' LEU . 49.3 tp -117.73 117.89 30.58 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.301 0.641 . . . . 72.21 110.54 -174.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -92.68 113.91 26.31 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.683 -0.858 . . . . 61.43 108.683 169.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 7.4 p -130.46 133.33 24.75 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 124.118 0.967 . . . . 64.4 108.578 -179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -79.8 157.29 24.36 Favored 'Trans proline' 0 C--N 1.366 1.478 0 C-N-CA 121.94 1.76 . . . . 64.51 112.076 171.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -59.3 -48.55 95.89 Favored Pre-proline 0 CA--C 1.558 1.252 0 N-CA-C 114.274 1.213 . . . . 71.34 114.274 -170.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -57.42 -42.64 59.58 Favored 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 121.897 1.731 . . . . 63.54 113.652 178.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 45.3 mt -75.21 -28.24 20.37 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 CA-C-N 116.442 -0.344 . . . . 64.32 110.485 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.44 -42.4 78.92 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.46 0.704 . . . . 71.51 111.101 176.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 42.3 t -71.72 -52.12 27.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 115.184 -0.916 . . . . 63.23 111.583 -178.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 72.5 t -77.29 -31.34 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 122.867 0.467 . . . . 74.41 111.455 -176.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 77.66 71.47 1.21 Allowed Glycine 0 C--N 1.338 0.686 0 CA-C-N 116.242 -0.436 . . . . 72.35 112.015 -177.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -101.19 -123.35 5.17 Favored Glycine 0 C--N 1.346 1.102 0 N-CA-C 111.52 -0.632 . . . . 55.24 111.52 177.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -133.92 139.95 46.48 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.686 0.795 . . . . 45.21 109.395 173.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.427 HG11 HG23 ' A' ' 199' ' ' VAL . 25.1 m -120.96 162.02 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-O 121.33 0.586 . . . . 63.11 110.32 169.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 6.8 ttp180 -85.11 114.42 22.23 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.645 -1.161 . . . . 71.41 108.738 171.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -106.26 164.55 11.92 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 109.226 -0.657 . . . . 62.04 109.226 169.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . 0.414 ' HB2' HG21 ' A' ' 185' ' ' VAL . 71.6 mtp -103.94 139.42 39.11 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 108.729 -0.841 . . . . 71.23 108.729 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 77.8 p -111.42 -165.41 0.99 Allowed 'General case' 0 C--O 1.243 0.755 0 N-CA-C 108.929 -0.767 . . . . 74.1 108.929 174.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.438 HD11 ' HG2' ' A' ' 154' ' ' ARG . 69.9 mt -76.23 -14.69 60.13 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.7 -0.682 . . . . 63.31 112.112 176.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -120.56 -16.61 8.27 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 118.718 0.69 . . . . 64.44 112.071 -175.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 156.82 -165.3 33.06 Favored Glycine 0 N--CA 1.475 1.293 0 CA-C-O 119.776 -0.458 . . . . 33.0 113.694 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -83.67 141.58 9.86 Favored 'Trans proline' 0 C--N 1.367 1.504 0 C-N-CA 122.926 2.417 . . . . 70.23 113.717 -174.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 34.9 m -134.29 169.57 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 124.353 1.061 . . . . 73.4 110.073 176.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -93.53 142.38 27.4 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.361 0.664 . . . . 75.04 110.416 174.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 59.3 t -130.67 119.2 45.02 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 C-N-CA 124.075 0.95 . . . . 74.13 108.452 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -73.02 102.31 3.47 Favored 'General case' 0 C--N 1.348 0.508 0 N-CA-C 109.181 -0.674 . . . . 60.25 109.181 177.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 48.2 t -67.36 141.2 95.64 Favored Pre-proline 0 CA--C 1.555 1.152 0 C-N-CA 124.689 1.196 . . . . 63.14 110.24 -176.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.8 150.86 39.81 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 122.168 1.912 . . . . 75.51 110.448 171.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . 0.403 ' O ' ' HG2' ' A' ' 226' ' ' ARG . 21.1 Cg_exo -66.6 138.47 49.76 Favored 'Trans proline' 0 CA--C 1.55 1.291 0 C-N-CA 121.332 1.354 . . . . 72.53 112.021 170.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . 0.403 ' HG2' ' O ' ' A' ' 225' ' ' PRO 0.252 7.7 ptp180 52.43 58.77 5.05 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 127.054 2.142 . . . . 74.04 112.544 -177.391 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.498 ' O ' HD11 ' A' ' 255' ' ' ILE . 1.3 m -73.45 105.51 4.85 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 113.989 -1.46 . . . . 64.32 109.146 176.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . 0.412 ' HB3' ' HD2' ' A' ' 231' ' ' ARG . 5.9 tp-100 -84.41 132.34 34.59 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.275 0.63 . . . . 75.32 111.03 -174.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . 0.537 ' HB3' HG22 ' C' ' 256' ' ' THR . . . -66.81 142.04 57.49 Favored 'General case' 0 C--N 1.358 0.97 0 C-N-CA 123.815 0.846 . . . . 62.31 111.916 -177.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 88.3 -10.87 69.58 Favored Glycine 0 C--N 1.342 0.906 0 CA-C-N 115.323 -0.853 . . . . 73.32 113.192 -179.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.412 ' HD2' ' HB3' ' A' ' 228' ' ' GLN . 86.8 mtt180 -87.15 167.07 14.48 Favored 'General case' 0 C--O 1.249 1.062 0 N-CA-C 109.417 -0.586 . . . . 74.0 109.417 172.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.407 ' HD3' ' HA ' ' A' ' 252' ' ' GLU . 0.2 OUTLIER -120.92 126.24 49.5 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.106 -0.952 . . . . 72.22 109.218 -178.168 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 16.7 mt -83.28 99.16 9.82 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 107.363 -1.347 . . . . 71.4 107.363 177.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 69.6 ttp85 -82.38 100.8 10.21 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.442 -0.947 . . . . 64.14 108.442 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.52 HD12 HD23 ' A' ' 249' ' ' LEU . 21.6 mt -98.41 92.24 5.58 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 108.975 -0.75 . . . . 61.12 108.975 -175.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? -60.99 128.51 36.8 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.243 0.617 . . . . 64.43 110.69 -175.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 83.16 6.11 88.39 Favored Glycine 0 C--N 1.346 1.103 0 CA-C-N 115.228 -0.896 . . . . 74.2 114.012 175.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.14 6.73 47.21 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 117.715 0.757 . . . . 73.01 111.066 178.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -93.92 -162.04 35.58 Favored Glycine 0 C--N 1.34 0.79 0 CA-C-N 115.662 -0.699 . . . . 74.43 112.095 174.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . 0.613 ' HZ ' ' HB2' ' A' ' 150' ' ' PRO . 18.3 t80 -78.07 137.1 61.27 Favored Pre-proline 0 CA--C 1.551 1.016 0 CA-C-O 118.904 -0.569 . . . . 73.13 109.967 -177.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -61.16 106.65 0.4 Allowed 'Trans proline' 0 C--N 1.382 2.336 0 C-N-CA 122.152 1.902 . . . . 73.33 112.1 171.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -137.06 -153.11 6.33 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-O 119.027 -0.874 . . . . 73.52 112.776 -175.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -54.32 -42.01 71.37 Favored 'Trans proline' 0 C--N 1.384 2.416 0 C-N-CA 123.455 2.77 . . . . 70.45 113.383 176.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -82.24 23.96 0.7 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.965 0.906 . . . . 70.11 112.452 -178.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 83.14 -93.07 1.68 Allowed Glycine 0 C--N 1.35 1.308 0 N-CA-C 109.612 -1.395 . . . . 62.24 109.612 -174.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 20.1 mtm180 -128.12 141.86 51.36 Favored 'General case' 0 C--O 1.247 0.936 0 N-CA-C 107.951 -1.129 . . . . 75.41 107.951 164.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -72.99 -173.51 24.88 Favored Glycine 0 C--N 1.349 1.26 0 O-C-N 123.352 0.408 . . . . 42.24 113.884 -177.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -112.85 135.7 53.31 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.505 0.722 . . . . 75.44 110.498 -174.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.52 HD23 HD12 ' A' ' 235' ' ' LEU . 64.6 tp -97.32 104.96 17.03 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.749 -0.834 . . . . 70.31 108.749 -178.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -90.12 105.98 18.18 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.515 0.726 . . . . 52.51 110.05 -177.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.478 HD22 ' HB2' ' A' ' 197' ' ' LEU . 41.5 mt -90.14 119.21 30.28 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 122.874 0.47 . . . . 72.24 109.942 177.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 232' ' ' LYS . 0.4 OUTLIER -79.11 116.44 19.4 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 107.973 -1.121 . . . . 75.41 107.973 178.639 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 21.8 t -78.21 102.4 4.46 Favored 'Isoleucine or valine' 0 C--O 1.245 0.841 0 CA-C-O 120.969 0.414 . . . . 24.43 111.402 -174.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -101.85 95.39 6.36 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.642 1.177 . . . . 73.14 109.066 168.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.502 ' HB ' ' O ' ' C' ' 255' ' ' ILE . 63.0 mt -77.18 141.06 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 109.879 -0.415 . . . . 74.34 109.879 175.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 21.6 p -130.03 176.68 7.87 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.777 1.231 . . . . 73.43 109.161 177.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.6 pp -137.71 158.41 71.75 Favored Pre-proline 0 CA--C 1.571 1.779 0 C-N-CA 123.625 0.77 . . . . 73.4 111.208 -175.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -55.96 -14.8 11.98 Favored 'Trans proline' 0 C--N 1.39 2.724 0 C-N-CA 123.843 3.028 . . . . 74.45 116.11 -167.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . 0.757 ' HG2' HE21 ' C' ' 228' ' ' GLN . 39.9 mt-10 56.52 -69.98 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 125.53 1.532 . . . . 63.24 113.396 -173.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.36 146.19 36.83 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 108.939 -0.763 . . . . 75.12 108.939 169.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.627 HD22 ' HB2' ' A' ' 265' ' ' GLU . 66.6 mt -138.12 167.97 20.71 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.495 0.718 . . . . 55.32 109.23 172.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 71.6 p -129.75 154.13 80.95 Favored Pre-proline 0 CA--C 1.555 1.149 0 N-CA-C 107.596 -1.261 . . . . 44.34 107.596 169.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -33.65 -37.2 0.1 OUTLIER 'Trans proline' 0 C--N 1.397 3.128 0 C-N-CA 125.041 3.828 . . . . 74.33 117.221 -169.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -62.51 -68.17 0.35 Allowed 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.377 0.671 . . . . 71.44 111.798 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . 0.627 ' HB2' HD22 ' A' ' 261' ' ' LEU . 2.5 mp0 -65.25 -30.29 71.15 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 109.478 -0.564 . . . . 64.2 109.478 -176.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' GLU . . . . . 0.474 ' HA ' HD13 ' A' ' 261' ' ' LEU . 5.8 tp10 -53.21 -52.52 58.63 Favored 'General case' 0 CA--C 1.551 0.998 0 O-C-N 124.043 0.839 . . . . 73.45 109.401 174.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -61.83 -49.52 75.97 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 115.28 -0.873 . . . . 64.12 111.714 177.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 9.3 mp -56.78 -54.32 47.7 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.804 0.842 . . . . 73.14 112.145 -176.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 72.5 m95 -56.7 -49.1 76.13 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.949 0.899 . . . . 75.0 111.404 177.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . 0.659 ' HG3' HG23 ' C' ' 206' ' ' VAL . 1.1 mptm? -60.48 -34.89 74.69 Favored 'General case' 0 CA--C 1.552 1.039 0 O-C-N 123.678 0.611 . . . . 62.43 111.359 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 7.4 mmpt? -69.91 -46.87 64.45 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 117.993 0.361 . . . . 70.22 111.213 178.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' LEU . . . . . 0.443 HD21 ' HB2' ' C' ' 268' ' ' LEU . 80.9 mt -54.24 -39.83 67.16 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.827 0.851 . . . . 63.4 110.7 174.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -80.38 -41.52 24.51 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.786 1.234 . . . . 64.51 113.974 -170.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -64.93 -43.98 90.99 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 108.937 -0.764 . . . . 74.35 108.937 175.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -63.81 -38.57 91.6 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 114.909 -1.041 . . . . 71.44 110.934 173.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -59.91 -56.24 24.22 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.462 0.705 . . . . 75.02 110.109 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -63.67 -37.62 88.03 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.019 0.928 . . . . 70.12 109.967 -175.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -60.12 -26.13 66.0 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 115.463 -0.79 . . . . 75.41 111.89 173.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 49.7 mtm180 -107.38 -1.17 21.83 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.832 0.853 . . . . 74.13 111.72 178.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.248 0 N-CA-C 109.001 -0.74 . . . . 72.21 109.001 -179.231 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 111.437 0.162 . . . . 71.44 111.437 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . 0.628 ' HD3' ' HG2' ' A' ' 128' ' ' GLU . 0.4 OUTLIER -123.25 -1.85 8.64 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.377 0.671 . . . . 54.1 111.934 -178.734 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -93.2 0.62 57.18 Favored 'General case' 0 CA--C 1.559 1.307 0 N-CA-C 109.032 -0.729 . . . . 74.04 109.032 168.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 63.4 m -51.56 138.36 22.66 Favored 'General case' 0 C--N 1.357 0.903 0 C-N-CA 125.993 1.717 . . . . 52.14 113.165 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 5' ' ' THR . . . . . 0.58 HG23 HH11 ' A' ' 136' ' ' ARG . 0.3 OUTLIER -110.99 170.04 8.37 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.149 0.98 . . . . 70.11 110.108 -175.583 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.579 ' HB ' ' HG2' ' A' ' 124' ' ' PRO . 45.5 pt -132.64 173.49 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 N-CA-C 113.031 0.752 . . . . 64.44 113.031 -161.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -145.1 133.77 22.17 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.571 1.148 . . . . 72.01 108.875 171.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . 0.515 HD23 HG21 ' A' ' 140' ' ' VAL . 34.2 tp -72.83 150.77 42.42 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.868 0.867 . . . . 75.22 110.249 -176.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -79.35 -50.48 10.79 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 119.654 -0.212 . . . . 62.4 111.254 177.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 74.7 mt 62.93 109.2 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 124.338 1.055 . . . . 74.1 110.4 -167.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 85.5 mt . . . . . 0 N--CA 1.478 0.936 0 N-CA-C 109.201 -0.666 . . . . 45.35 109.201 177.986 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.993 0 CA-C-O 120.184 0.04 . . . . 61.34 110.97 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . -67.91 -46.38 71.74 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-O 121.347 0.594 . . . . 74.4 109.431 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 181' ' ' LEU . . . . . 0.582 ' HB2' ' HB3' ' C' ' 136' ' ' ARG . 33.3 tp -116.61 -96.57 0.46 Allowed 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 105.856 -1.905 . . . . 62.04 105.856 154.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 182' ' ' VAL . . . . . 0.585 HG13 ' HB2' ' C' ' 123' ' ' LEU . 7.4 p 156.74 138.6 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.245 0.857 0 C-N-CA 126.777 2.031 . . . . 71.31 105.688 -178.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 183' ' ' ALA . . . . . 0.712 ' HA ' ' HB3' ' C' ' 123' ' ' LEU . . . -160.76 -103.28 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 118.907 -0.568 . . . . 65.24 111.168 176.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 59.54 142.86 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 124.142 0.977 . . . . 74.15 111.372 -164.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 185' ' ' VAL . . . . . 0.527 ' HA ' ' HA ' ' C' ' 121' ' ' ALA . 50.8 t . . . . . 0 CA--C 1.57 1.733 0 C-N-CA 123.581 0.752 . . . . 71.33 112.707 -170.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 238' ' ' THR . . . . . 0.456 HG22 HG23 ' C' ' 219' ' ' VAL . 13.3 m . . . . . 0 N--CA 1.479 1.003 0 CA-C-O 121.488 0.661 . . . . 71.31 109.797 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -83.64 173.23 11.56 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 114.518 -1.219 . . . . 74.42 111.15 177.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 240' ' ' GLY . . . . . 0.412 ' H ' HD22 ' C' ' 235' ' ' LEU . . . -83.17 -130.7 1.65 Allowed Glycine 0 C--N 1.346 1.126 0 CA-C-N 115.369 -0.832 . . . . 71.23 112.651 178.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -151.69 156.1 39.68 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.695 0.798 . . . . 71.21 108.96 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 242' ' ' TRP . . . . . 0.471 ' CD2' ' HG ' ' C' ' 233' ' ' LEU . 1.2 p-90 -168.04 115.85 0.73 Allowed 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 113.251 0.834 . . . . 70.32 113.251 -175.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 24.83 74.23 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 128.072 2.549 . . . . 74.22 115.307 166.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 126.58 -142.62 13.72 Favored Glycine 0 C--N 1.341 0.822 0 CA-C-N 115.49 -0.777 . . . . 63.11 112.396 178.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? . . . . . 0 N--CA 1.482 1.16 0 C-N-CA 127.159 2.183 . . . . 75.34 110.145 -175.066 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.772 0 N-CA-C 110.188 -0.301 . . . . 52.01 110.188 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -34.17 93.71 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 127.041 2.137 . . . . 70.52 112.894 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 5' ' ' LYS . . . . . 0.495 ' HE2' HD11 ' C' ' 10' ' ' ILE . 14.5 mmmm -92.84 93.29 8.33 Favored 'General case' 0 C--O 1.243 0.72 0 N-CA-C 107.812 -1.181 . . . . 63.2 107.812 169.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -73.67 97.36 2.66 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 107.193 -1.41 . . . . 63.22 107.193 175.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 7' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -61.54 -37.86 85.32 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.182 -0.917 . . . . 73.43 111.598 -171.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -60.97 -45.02 96.45 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 116.181 -0.463 . . . . 72.53 110.481 175.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.96 -40.95 99.25 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.051 0.54 . . . . 52.31 111.207 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 10' ' ' ILE . . . . . 0.495 HD11 ' HE2' ' C' ' 5' ' ' LYS . 64.6 mt -61.92 -36.07 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.213 0.605 . . . . 63.34 110.576 177.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 11' ' ' LEU . . . . . 0.583 HD13 HG23 ' C' ' 22' ' ' ILE . 68.7 mt -80.61 -13.85 58.69 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 112.46 0.541 . . . . 45.45 112.46 176.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.11 35.92 42.27 Favored Glycine 0 C--N 1.351 1.364 0 N-CA-C 113.689 0.235 . . . . 64.33 113.689 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 6.1 m -131.56 153.44 81.55 Favored Pre-proline 0 N--CA 1.482 1.151 0 C-N-CA 124.691 1.196 . . . . 64.04 109.184 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -76.51 161.08 34.7 Favored 'Trans proline' 0 C--N 1.373 1.83 0 C-N-CA 122.432 2.088 . . . . 74.43 112.293 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -67.85 80.53 0.2 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.339 0.655 . . . . 71.52 109.898 176.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -179.19 -30.03 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.673 1.189 . . . . 71.24 109.038 -174.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -47.58 119.72 2.9 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 124.744 1.277 . . . . 71.14 111.688 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 72.3 p -86.25 178.35 7.21 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.802 0.841 . . . . 74.41 110.14 177.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.45 -38.28 19.46 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 124.515 1.126 . . . . 74.45 112.195 -177.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 20' ' ' GLU . . . . . 0.402 ' O ' ' HG3' ' C' ' 24' ' ' ARG . 13.9 tp10 -66.72 -52.63 42.25 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.387 0.675 . . . . 64.05 110.953 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . 0.662 ' HA ' ' HE ' ' C' ' 24' ' ' ARG . 33.7 mt-10 -65.0 -34.37 78.27 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.636 0.775 . . . . 73.42 111.285 -176.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 22' ' ' ILE . . . . . 0.896 HD13 ' HB3' ' C' ' 57' ' ' LEU . 82.1 mt -75.56 -36.08 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.214 1.405 . . . . 61.32 111.268 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -62.87 -44.21 96.74 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.758 0.823 . . . . 74.13 109.77 175.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 24' ' ' ARG . . . . . 0.662 ' HE ' ' HA ' ' C' ' 21' ' ' GLU . 42.8 mtm180 -64.63 -46.05 84.19 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 115.332 -0.849 . . . . 73.52 110.829 178.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . 0.42 ' O ' ' HB3' ' C' ' 28' ' ' ARG . . . -61.5 -37.68 84.58 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.461 0.705 . . . . 75.32 111.682 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 26' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -62.97 -52.1 64.33 Favored 'General case' 0 C--O 1.212 -0.882 0 CA-C-N 115.121 -0.945 . . . . 72.31 109.998 176.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -58.02 -37.14 73.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 123.882 0.739 . . . . 74.1 111.369 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 28' ' ' ARG . . . . . 0.42 ' HB3' ' O ' ' C' ' 25' ' ' ALA . 20.8 ttt180 -53.15 -56.03 19.54 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.294 1.037 . . . . 71.15 110.45 172.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . 0.671 ' HB3' HD13 ' C' ' 50' ' ' ILE . 91.2 mt -80.9 -11.15 59.63 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 115.769 -0.65 . . . . 60.22 111.879 -177.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -91.31 -10.7 40.39 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.126 0.97 . . . . 75.32 110.535 177.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -93.89 -48.6 6.2 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.216 0.606 . . . . 73.5 110.342 165.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 20.6 tp60 -62.44 -48.52 79.31 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.452 0.701 . . . . 71.12 111.297 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 33' ' ' TYR . . . . . 0.417 ' HE2' HD22 ' C' ' 29' ' ' LEU . 29.4 m-85 -109.01 37.11 2.65 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.218 0.607 . . . . 70.15 109.969 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 34' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -67.89 111.48 7.81 Favored Pre-proline 0 N--CA 1.473 0.719 0 CA-C-O 118.373 -0.823 . . . . 72.34 109.378 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.74 -29.21 76.94 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 122.417 2.078 . . . . 71.32 111.318 -176.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -62.07 -33.03 73.65 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.364 1.466 . . . . 60.34 112.153 176.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 98.6 t -96.71 -62.62 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 N-CA-C 108.988 -0.745 . . . . 75.33 108.988 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -98.72 96.46 7.93 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.263 1.025 . . . . 54.22 110.604 -177.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -80.03 74.66 6.8 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 108.644 -0.873 . . . . 62.24 108.644 173.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 71.1 m -126.8 97.85 32.17 Favored Pre-proline 0 CA--C 1.538 0.506 0 N-CA-C 108.591 -0.892 . . . . 74.14 108.591 175.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -39.16 -44.19 2.64 Favored 'Trans proline' 0 C--N 1.388 2.655 0 C-N-CA 124.76 3.64 . . . . 63.44 114.545 -176.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -48.6 -55.51 10.98 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 124.811 1.244 . . . . 65.44 111.023 174.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.42 -21.21 63.77 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 115.476 -0.784 . . . . 62.05 111.272 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 44' ' ' GLU . . . . . 0.437 ' O ' ' HG3' ' C' ' 48' ' ' LYS . 43.0 mt-10 -88.76 -24.57 22.61 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.529 0.731 . . . . 74.04 110.748 -175.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -81.31 -36.54 29.65 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.615 0.766 . . . . 42.53 109.248 174.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 46' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -65.21 -36.64 84.81 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.05 -0.977 . . . . 72.32 109.167 169.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 47' ' ' PHE . . . . . 0.572 ' HA ' HD12 ' C' ' 50' ' ' ILE . 41.9 t80 -66.68 -32.62 74.06 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.449 0.7 . . . . 62.23 110.408 173.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 48' ' ' LYS . . . . . 0.442 ' HB3' ' CE1' ' C' ' 93' ' ' PHE . 95.7 mttt -64.14 -39.79 94.79 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 122.889 0.476 . . . . 72.04 110.808 172.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -69.15 -28.94 66.87 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.65 0.38 . . . . 72.33 110.774 176.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 50' ' ' ILE . . . . . 0.671 HD13 ' HB3' ' C' ' 29' ' ' LEU . 71.2 mt -73.07 -32.79 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 123.856 0.863 . . . . 75.43 110.381 173.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 51' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -77.38 -24.73 50.54 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.257 0.623 . . . . 74.04 110.62 175.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -71.09 -52.85 17.02 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 108.369 -0.974 . . . . 63.42 108.369 172.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.22 -44.41 79.53 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 113.533 -1.667 . . . . 63.1 111.467 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -74.18 -38.33 63.68 Favored 'General case' 0 C--O 1.208 -1.112 0 CA-C-N 115.425 -0.807 . . . . 75.01 110.384 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.89 -35.77 75.54 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-O 120.81 0.338 . . . . 60.54 111.469 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 47.5 t -77.84 -44.71 28.55 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 CA-C-N 115.906 -0.588 . . . . 72.43 109.875 175.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 57' ' ' LEU . . . . . 0.896 ' HB3' HD13 ' C' ' 22' ' ' ILE . 52.4 mt -98.74 0.65 44.93 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 115.428 1.64 . . . . 75.02 115.428 -166.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 30.9 t -75.56 -66.12 0.81 Allowed 'General case' 0 N--CA 1.484 1.233 0 CA-C-O 121.733 0.777 . . . . 62.42 109.686 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -86.83 132.36 42.39 Favored Pre-proline 0 C--O 1.255 1.376 0 CA-C-N 114.438 -1.255 . . . . 72.03 108.885 -169.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 60' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_exo -46.6 -30.5 8.9 Favored 'Trans proline' 0 C--N 1.388 2.626 0 C-N-CA 124.218 3.279 . . . . 33.23 114.796 -175.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -57.25 -69.74 0.15 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.572 0.749 . . . . 62.13 111.413 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.28 -25.54 63.39 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 122.773 0.429 . . . . 75.23 110.619 -173.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -61.93 -47.86 83.0 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 108.147 -1.057 . . . . 64.42 108.147 175.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -70.14 -29.34 66.23 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.156 0.582 . . . . 74.15 111.618 177.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 82.0 mt -62.08 -43.8 98.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 C-N-CA 122.72 0.408 . . . . 62.34 110.384 174.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -67.08 -46.55 73.93 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.771 -0.649 . . . . 74.22 109.797 177.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -55.1 -47.58 74.75 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.228 0.611 . . . . 73.14 110.758 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 70.4 p -70.39 -26.81 63.87 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.94 -0.573 . . . . 63.2 111.518 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -69.51 136.17 51.08 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 108.81 -0.811 . . . . 75.22 108.81 178.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.05 15.28 54.5 Favored Glycine 0 N--CA 1.473 1.107 0 N-CA-C 111.632 -0.587 . . . . 62.51 111.632 -169.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 58.2 m -148.4 -60.24 0.24 Allowed 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 103.698 -2.704 . . . . 72.34 103.698 175.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 56.8 m -75.04 140.53 43.61 Favored 'General case' 0 C--O 1.252 1.218 0 N-CA-C 105.147 -2.168 . . . . 73.35 105.147 156.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.87 -36.25 6.7 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.88 0.872 . . . . 73.23 110.873 -176.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -93.32 139.17 22.88 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 123.986 0.915 . . . . 53.23 110.096 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -61.7 144.48 97.29 Favored 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 122.691 2.261 . . . . 75.14 112.096 175.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -49.84 144.34 21.07 Favored 'Trans proline' 0 C--N 1.384 2.406 0 C-N-CA 123.826 3.017 . . . . 63.14 113.805 175.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 77' ' ' PRO . . . . . 0.42 ' HA ' ' HD3' ' C' ' 78' ' ' PRO . 18.2 Cg_endo -57.82 131.87 46.52 Favored 'Trans proline' 0 C--N 1.381 2.251 0 C-N-CA 122.697 2.265 . . . . 51.51 111.65 177.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 78' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' C' ' 77' ' ' PRO . 32.2 Cg_exo -57.92 113.61 1.6 Allowed 'Trans proline' 0 C--N 1.388 2.657 0 C-N-CA 122.89 2.393 . . . . 74.44 112.221 -174.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -80.93 178.41 6.94 Favored 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 122.882 2.388 . . . . 61.04 111.902 -178.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -54.51 90.54 0.04 OUTLIER 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 122.279 1.986 . . . . 51.5 112.271 167.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 134.26 -1.64 4.14 Favored Glycine 0 N--CA 1.466 0.662 0 CA-C-N 114.937 -1.029 . . . . 75.2 112.399 175.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 67.01 -149.8 51.51 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 112.39 -0.284 . . . . 74.45 112.39 178.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -99.46 113.63 26.1 Favored 'General case' 0 C--O 1.244 0.803 0 N-CA-C 108.208 -1.034 . . . . 70.14 108.208 168.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 84' ' ' ASP . . . . . 0.404 ' HB3' ' HG3' ' C' ' 143' ' ' ARG . 4.8 p-10 -71.74 134.3 46.14 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-O 121.394 0.616 . . . . 63.13 110.009 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 85' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -159.25 22.24 0.19 Allowed 'General case' 0 C--O 1.248 0.999 0 CA-C-N 114.603 -1.181 . . . . 74.41 107.969 -177.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 86' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' C' ' 169' ' ' ASN . 19.0 m -62.79 128.27 35.14 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 113.141 -1.845 . . . . 45.43 111.273 -170.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 87' ' ' GLY . . . . . 0.572 ' HA2' ' HA ' ' C' ' 171' ' ' PRO . . . 99.25 -20.95 47.93 Favored Glycine 0 C--N 1.336 0.569 0 O-C-N 123.775 0.672 . . . . 74.33 112.938 178.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 88' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -93.79 150.64 20.22 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 117.457 0.628 . . . . 74.44 110.224 -178.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -82.56 73.69 9.58 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.113 0.565 . . . . 72.23 110.442 -174.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 90' ' ' VAL . . . . . . . . . . . . . 3.2 p -43.41 -41.72 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 C-N-CA 125.456 1.503 . . . . 54.41 112.486 177.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -56.76 -36.09 69.41 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.902 1.281 . . . . 74.21 111.945 -175.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -88.87 -21.02 23.88 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.02 0.528 . . . . 75.53 111.997 -175.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 93' ' ' PHE . . . . . 0.442 ' CE1' ' HB3' ' C' ' 48' ' ' LYS . 4.5 m-30 -81.75 164.74 21.51 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 122.326 0.251 . . . . 72.45 111.295 -168.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 94.5 p -60.19 152.08 25.51 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.586 1.154 . . . . 45.51 113.598 -165.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.55 -31.79 70.88 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 114.964 -1.016 . . . . 55.43 111.062 170.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -59.88 -44.51 94.14 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.175 0.99 . . . . 65.02 110.426 175.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 97' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -62.1 -43.33 99.07 Favored 'General case' 0 CA--C 1.558 1.28 0 CA-C-N 114.978 -1.01 . . . . 64.25 110.362 170.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -73.68 -1.46 19.13 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.184 0.593 . . . . 51.52 111.758 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -98.95 -41.32 7.64 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.559 0.743 . . . . 74.43 112.092 168.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 23.9 tp -82.02 -35.55 28.73 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.284 0.634 . . . . 73.23 111.83 -174.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -114.14 -17.76 11.82 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.673 0.789 . . . . 73.25 110.956 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -42.72 -58.73 3.47 Favored Glycine 0 CA--C 1.541 1.67 0 CA-C-O 118.689 -1.062 . . . . 54.11 115.466 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.0 -21.19 20.53 Favored 'Trans proline' 0 C--N 1.389 2.658 0 C-N-CA 123.645 2.896 . . . . 62.02 114.224 -176.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -127.68 8.72 6.88 Favored Glycine 0 C--N 1.357 1.7 0 CA-C-O 117.051 -1.972 . . . . 43.23 114.631 -175.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 28.5 mt . . . . . 0 N--CA 1.513 2.709 0 N-CA-C 114.623 1.342 . . . . 73.03 114.623 -175.677 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.413 0 N-CA-C 111.601 -0.6 . . . . 45.25 111.601 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 117' ' ' ARG . . . . . 0.693 ' HB2' ' HB2' ' C' ' 167' ' ' GLN . 50.3 mtm180 -115.46 180.0 3.8 Favored 'General case' 0 C--O 1.254 1.313 0 CA-C-O 122.056 0.931 . . . . 64.44 110.662 -174.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 118' ' ' ASP . . . . . 0.484 ' HA ' ' O ' ' C' ' 173' ' ' ASP . 0.8 OUTLIER -57.07 107.24 0.39 Allowed 'General case' 0 C--O 1.243 0.73 0 CA-C-N 112.278 -2.237 . . . . 75.42 110.193 172.124 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 119' ' ' LEU . . . . . 0.576 HD12 ' HA3' ' C' ' 166' ' ' GLY . 0.3 OUTLIER -94.91 113.89 25.67 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 107.647 -1.242 . . . . 75.21 107.647 174.619 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.463 ' HA ' ' O ' ' C' ' 175' ' ' LEU . 0.0 OUTLIER -104.4 124.8 49.88 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 110.125 -0.324 . . . . 72.31 110.125 -173.797 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 121' ' ' ALA . . . . . 0.527 ' HA ' ' HA ' ' B' ' 185' ' ' VAL . . . -111.43 137.15 49.59 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.388 0.675 . . . . 63.21 111.231 -177.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -92.66 90.15 6.97 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 107.665 -1.235 . . . . 73.22 107.665 170.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 123' ' ' LEU . . . . . 0.712 ' HB3' ' HA ' ' B' ' 183' ' ' ALA . 1.1 pt? -105.36 114.28 63.49 Favored Pre-proline 0 N--CA 1.49 1.539 0 CA-C-N 118.474 0.579 . . . . 73.3 112.116 -174.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . 0.544 ' HA ' ' O ' ' C' ' 179' ' ' ARG . 36.2 Cg_exo -64.64 112.35 1.94 Allowed 'Trans proline' 0 C--N 1.386 2.528 0 C-N-CA 122.606 2.204 . . . . 72.51 110.489 164.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 125' ' ' LEU . . . . . 0.408 HD23 HG21 ' C' ' 153' ' ' VAL . 51.3 tp -131.79 147.3 52.48 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 122.552 0.341 . . . . 74.03 110.828 -169.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 126' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -92.08 151.47 20.42 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.302 0.641 . . . . 61.53 109.946 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 127' ' ' LEU . . . . . 0.42 ' CD2' HD13 ' C' ' 180' ' ' LEU . 25.2 mt -65.82 -50.99 62.66 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.425 1.09 . . . . 62.25 110.311 -177.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -53.69 -42.87 68.44 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 113.165 -1.834 . . . . 75.24 109.896 176.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 129' ' ' GLU . . . . . 0.508 ' HA ' ' HB2' ' C' ' 132' ' ' HIS . 15.1 mm-40 -82.33 -16.93 47.5 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.737 0.815 . . . . 73.53 111.821 -175.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -71.93 -31.53 66.44 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 109.014 -0.735 . . . . 64.34 109.014 172.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 131' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -73.11 -51.12 19.16 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 115.471 -0.786 . . . . 75.55 110.659 164.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 132' ' ' HIS . . . . . 0.508 ' HB2' ' HA ' ' C' ' 129' ' ' GLU . 38.3 m80 -76.32 3.82 10.16 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.005 0.522 . . . . 60.22 112.234 -171.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -58.83 88.26 0.02 OUTLIER Glycine 0 CA--C 1.539 1.544 0 N-CA-C 114.578 0.591 . . . . 65.31 114.578 171.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . -88.03 -143.9 9.12 Favored Glycine 0 C--N 1.355 1.631 0 N-CA-C 111.34 -0.704 . . . . 53.24 111.34 170.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 26.1 mp0 -70.48 93.83 0.92 Allowed 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 107.971 -1.122 . . . . 71.2 107.971 171.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 136' ' ' ARG . . . . . 0.582 ' HB3' ' HB2' ' B' ' 181' ' ' LEU . 78.7 mtt180 -115.58 138.19 51.31 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.024 0.529 . . . . 72.12 110.081 -173.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 137' ' ' VAL . . . . . 0.507 ' HA ' ' HA ' ' C' ' 146' ' ' SER . 21.5 t -76.7 103.57 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-N 116.099 -0.501 . . . . 71.12 109.877 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 138' ' ' VAL . . . . . 0.508 ' HB ' HD23 ' B' ' 181' ' ' LEU . 4.6 p -80.43 123.69 37.45 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 123.659 0.784 . . . . 72.14 109.22 174.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 139' ' ' GLU . . . . . 0.642 ' HG2' ' HG3' ' C' ' 144' ' ' ARG . 28.3 mt-10 -118.97 92.01 3.7 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.77 0.828 . . . . 74.31 109.175 -165.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 140' ' ' VAL . . . . . 0.438 ' HB ' ' HB1' ' B' ' 183' ' ' ALA . 7.1 p -143.53 147.39 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 C-N-CA 123.282 0.633 . . . . 63.22 111.435 -168.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 64.53 17.29 10.78 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 125.045 1.338 . . . . 15.23 111.908 -174.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 87.37 -8.64 76.29 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-N 115.568 -0.742 . . . . 45.25 112.947 -175.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 143' ' ' ARG . . . . . 0.432 ' HD3' ' HA ' ' C' ' 143' ' ' ARG . 6.7 mmt180 -101.47 139.94 36.45 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.446 0.641 . . . . 73.04 111.474 -177.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 144' ' ' ARG . . . . . 0.642 ' HG3' ' HG2' ' C' ' 139' ' ' GLU . 59.7 ttt180 -115.45 93.22 4.19 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-N 114.652 -1.158 . . . . 71.51 110.178 -165.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 145' ' ' VAL . . . . . . . . . . . . . 30.3 m -118.79 142.5 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 123.179 0.591 . . . . 75.03 112.001 -172.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 146' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' C' ' 137' ' ' VAL . 20.3 m -95.0 128.97 42.23 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.266 1.026 . . . . 54.21 111.054 -177.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 14.4 p -162.75 148.1 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 123.042 0.537 . . . . 72.53 110.663 175.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 29.8 ttm-85 -84.28 117.22 23.41 Favored 'General case' 0 C--N 1.349 0.571 0 N-CA-C 108.994 -0.743 . . . . 74.22 108.994 166.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 149' ' ' ILE . . . . . 0.452 HD13 HD21 ' B' ' 181' ' ' LEU . 42.2 pt -88.36 150.12 46.12 Favored Pre-proline 0 CA--C 1.548 0.878 0 N-CA-C 108.642 -0.873 . . . . 71.41 108.642 172.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -50.02 112.29 0.69 Allowed 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 123.183 2.589 . . . . 61.44 113.236 179.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -61.5 106.35 0.41 Allowed 'Trans proline' 0 C--N 1.383 2.376 0 C-N-CA 122.958 2.439 . . . . 73.2 112.117 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 152' ' ' GLY . . . . . . . . . . . . . . . 129.19 101.53 1.0 Allowed Glycine 0 C--N 1.343 0.922 0 CA-C-N 115.214 -0.903 . . . . 54.32 111.37 -171.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 153' ' ' VAL . . . . . 0.408 HG21 HD23 ' C' ' 125' ' ' LEU . 1.0 OUTLIER -122.77 159.84 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 CA-C-N 117.145 0.472 . . . . 71.13 110.398 -179.042 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 154' ' ' ARG . . . . . 0.624 ' HB2' ' HB2' ' C' ' 157' ' ' SER . 38.6 mtp180 -119.05 121.77 40.61 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.245 1.018 . . . . 75.32 109.105 -171.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 155' ' ' GLU . . . . . 0.712 ' HB3' ' HG2' ' C' ' 187' ' ' ARG . 9.4 tp10 -45.3 122.94 3.73 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.909 0.883 . . . . 74.51 112.45 174.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 87.52 -21.25 22.86 Favored Glycine 0 C--N 1.351 1.403 0 O-C-N 124.425 1.078 . . . . 64.51 113.276 176.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 157' ' ' SER . . . . . 0.624 ' HB2' ' HB2' ' C' ' 154' ' ' ARG . 33.8 m -88.97 -177.92 5.59 Favored 'General case' 0 C--O 1.247 0.962 0 CA-C-O 121.445 0.641 . . . . 75.43 110.733 -172.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 7.2 p -128.11 127.53 67.78 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 CA-C-N 115.48 -0.782 . . . . 64.44 111.587 -173.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 159' ' ' ILE . . . . . 0.597 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 47.9 mt -73.63 139.04 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.673 1.189 . . . . 52.25 109.194 168.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 30.1 ttt85 -117.38 111.02 18.76 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 109.098 -0.705 . . . . 72.21 109.098 175.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 161' ' ' VAL . . . . . 0.619 HG13 ' HB3' ' C' ' 174' ' ' LEU . 1.6 p -106.03 98.93 20.31 Favored Pre-proline 0 CA--C 1.555 1.166 0 N-CA-C 108.295 -1.002 . . . . 75.24 108.295 168.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -76.54 140.17 21.14 Favored 'Trans proline' 0 C--N 1.384 2.433 0 C-N-CA 123.07 2.513 . . . . 63.42 112.141 178.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 110.14 -7.84 30.99 Favored Glycine 0 C--N 1.347 1.157 0 CA-C-O 119.817 -0.435 . . . . 53.31 112.455 178.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 164' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -158.13 124.17 4.65 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.959 0.904 . . . . 73.35 109.383 172.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . -125.68 -116.33 2.1 Favored Glycine 0 C--N 1.346 1.123 0 C-N-CA 123.854 0.74 . . . . 64.24 112.474 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 166' ' ' GLY . . . . . 0.576 ' HA3' HD12 ' C' ' 119' ' ' LEU . . . -169.87 -61.52 0.04 OUTLIER Glycine 0 C--N 1.346 1.103 0 C-N-CA 120.21 -0.995 . . . . 75.44 114.653 175.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 167' ' ' GLN . . . . . 0.693 ' HB2' ' HB2' ' C' ' 117' ' ' ARG . 14.1 mm100 -66.69 98.58 0.53 Allowed 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 117.09 0.445 . . . . 64.31 110.692 -165.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . 110.34 -144.25 17.01 Favored Glycine 0 C--O 1.213 -1.173 0 CA-C-O 118.352 -1.249 . . . . 13.44 111.72 -165.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 169' ' ' ASN . . . . . 0.444 ' HB3' ' HD3' ' C' ' 170' ' ' PRO . 17.9 t-20 -150.21 -51.39 0.02 OUTLIER Pre-proline 0 CA--C 1.594 2.659 0 CA-C-N 119.723 1.762 . . . . 62.44 113.291 -177.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 170' ' ' PRO . . . . . 0.444 ' HD3' ' HB3' ' C' ' 169' ' ' ASN . 49.5 Cg_exo -48.59 177.03 0.02 OUTLIER 'Trans proline' 0 N--CA 1.522 3.188 0 C-N-CA 124.359 3.373 . . . . 51.41 116.765 168.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 171' ' ' PRO . . . . . 0.572 ' HA ' ' HA2' ' C' ' 87' ' ' GLY . 1.1 Cg_exo -31.55 119.25 0.08 OUTLIER 'Trans proline' 0 C--N 1.404 3.483 1 C-N-CA 125.417 4.078 . . . . 74.02 117.272 172.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -160.56 -172.24 27.56 Favored Glycine 0 C--N 1.356 1.668 0 C-N-CA 124.276 0.941 . . . . 74.42 111.333 177.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 173' ' ' ASP . . . . . 0.484 ' O ' ' HA ' ' C' ' 118' ' ' ASP . 5.8 p-10 -140.79 147.68 39.44 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.718 0.771 . . . . 74.51 111.209 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 174' ' ' LEU . . . . . 0.619 ' HB3' HG13 ' C' ' 161' ' ' VAL . 43.9 tp -97.83 112.63 24.47 Favored 'General case' 0 C--O 1.245 0.849 0 N-CA-C 109.147 -0.686 . . . . 75.22 109.147 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 175' ' ' LEU . . . . . 0.463 ' O ' ' HA ' ' C' ' 120' ' ' ARG . 55.7 mt -87.18 112.25 21.78 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.245 -1.343 . . . . 71.32 109.664 174.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 176' ' ' LEU . . . . . 0.597 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 57.7 mt -100.41 97.26 8.02 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 109.355 -0.609 . . . . 43.02 109.355 174.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 177' ' ' VAL . . . . . . . . . . . . . 17.1 t -83.61 103.36 10.78 Favored 'Isoleucine or valine' 0 C--O 1.253 1.238 0 N-CA-C 107.904 -1.147 . . . . 74.43 107.904 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 178' ' ' VAL . . . . . . . . . . . . . 6.1 m -84.95 117.43 30.19 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 CA-C-N 114.397 -1.274 . . . . 74.01 112.086 -172.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 179' ' ' ARG . . . . . 0.544 ' O ' ' HA ' ' C' ' 124' ' ' PRO . 6.2 mmm180 -105.36 107.77 18.94 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 106.142 -1.799 . . . . 72.33 106.142 166.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 180' ' ' LEU . . . . . 0.618 HD12 ' HB2' ' C' ' 155' ' ' GLU . 58.4 mt -70.12 148.23 48.99 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 122.35 -0.219 . . . . 70.51 110.583 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 181' ' ' LEU . . . . . . . . . . . . . 67.5 mt -54.28 167.03 0.6 Allowed Pre-proline 0 N--CA 1.494 1.75 0 C-N-CA 125.261 1.425 . . . . 74.2 112.434 -176.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -56.64 71.43 0.04 OUTLIER 'Trans proline' 0 C--N 1.387 2.554 0 C-N-CA 123.029 2.486 . . . . 64.12 111.217 163.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 183' ' ' HIS . . . . . 0.41 ' N ' ' HD3' ' C' ' 184' ' ' PRO . 81.2 t60 -179.2 51.91 0.05 OUTLIER Pre-proline 0 CA--C 1.557 1.249 0 C-N-CA 126.768 2.027 . . . . 62.13 106.237 -164.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 184' ' ' PRO . . . . . 0.41 ' HD3' ' N ' ' C' ' 183' ' ' HIS . 61.5 Cg_endo -92.18 65.19 0.87 Allowed 'Trans proline' 0 C--N 1.386 2.537 0 C-N-CA 123.046 2.498 . . . . 71.54 110.662 -170.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 185' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 12.4 t -93.37 -33.86 5.52 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.41 0 CA-C-N 115.284 -0.871 . . . . 72.23 109.035 -171.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 186' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -127.79 106.0 8.83 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 118.809 0.732 . . . . 61.44 111.93 -175.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 187' ' ' ARG . . . . . 0.712 ' HG2' ' HB3' ' C' ' 155' ' ' GLU . 1.6 tmt_? -95.26 116.59 28.95 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 107.352 -1.351 . . . . 75.14 107.352 169.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 188' ' ' LEU . . . . . 0.482 HD13 ' HD2' ' C' ' 240' ' ' PHE . 65.3 tp -80.74 138.89 36.32 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 122.917 0.487 . . . . 74.14 111.762 -178.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -142.6 113.09 7.28 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 106.548 -1.649 . . . . 71.33 106.548 169.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 73.92 -109.44 2.8 Favored Glycine 0 N--CA 1.474 1.177 0 N-CA-C 111.413 -0.675 . . . . 74.2 111.413 -170.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 191' ' ' GLN . . . . . 0.455 ' HA ' HD11 ' C' ' 188' ' ' LEU . 28.1 mt-30 -123.85 7.0 8.7 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 123.564 0.745 . . . . 60.21 109.085 167.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 192' ' ' ASP . . . . . 0.481 ' HB3' ' HE1' ' C' ' 250' ' ' TYR . 3.8 m-20 -95.63 142.74 27.59 Favored 'General case' 0 C--N 1.344 0.351 0 C-N-CA 125.176 1.391 . . . . 65.13 109.188 -172.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 193' ' ' LEU . . . . . 0.472 HD21 ' CD2' ' C' ' 240' ' ' PHE . 86.7 mt -112.45 142.34 45.11 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.587 0.355 . . . . 52.2 110.777 -178.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 194' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -108.97 128.05 54.6 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 108.17 -1.048 . . . . 75.43 108.17 165.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 195' ' ' ALA . . . . . 0.584 ' HB3' ' HG ' ' C' ' 251' ' ' LEU . . . -127.03 -178.19 4.32 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.404 0.682 . . . . 65.11 110.768 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 33.0 m -135.54 111.03 9.14 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 107.675 -1.231 . . . . 51.32 107.675 169.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 197' ' ' LEU . . . . . 0.462 HD13 ' HB2' ' C' ' 212' ' ' ALA . 42.2 tp -88.92 136.89 32.77 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 123.436 0.694 . . . . 73.5 110.055 176.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -92.4 117.32 29.8 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 108.616 -0.883 . . . . 44.52 108.616 173.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 199' ' ' VAL . . . . . 0.581 ' HA ' HG11 ' C' ' 210' ' ' VAL . 21.4 t -125.6 106.57 26.7 Favored Pre-proline 0 CA--C 1.544 0.728 0 N-CA-C 108.09 -1.078 . . . . 61.21 108.09 176.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 200' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -67.76 141.69 55.29 Favored 'Trans proline' 0 C--N 1.369 1.613 0 C-N-CA 121.737 1.625 . . . . 71.34 111.33 176.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 201' ' ' ALA . . . . . . . . . . . . . . . -42.65 -49.16 13.3 Favored Pre-proline 0 CA--C 1.559 1.313 0 C-N-CA 125.498 1.519 . . . . 74.35 114.507 -176.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 202' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -55.34 -52.04 8.65 Favored 'Trans proline' 0 C--N 1.388 2.611 0 C-N-CA 121.558 1.505 . . . . 63.15 112.95 175.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 203' ' ' ILE . . . . . 0.483 ' HA ' HG12 ' C' ' 206' ' ' VAL . 53.0 mt -63.45 -34.57 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 122.885 0.474 . . . . 63.4 111.022 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -62.7 -43.27 99.24 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.79 0.836 . . . . 75.02 111.522 178.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 205' ' ' VAL . . . . . 0.48 ' HA ' ' H ' ' C' ' 226' ' ' ARG . 88.5 t -79.29 -34.12 16.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 115.842 -0.617 . . . . 63.41 112.097 -176.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 206' ' ' VAL . . . . . 0.659 HG23 ' HG3' ' A' ' 270' ' ' LYS . 9.9 p -80.24 -32.05 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 122.183 0.193 . . . . 52.12 111.04 -177.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 79.48 56.32 3.42 Favored Glycine 0 C--N 1.336 0.582 0 N-CA-C 111.366 -0.694 . . . . 63.21 111.366 -171.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -92.84 -124.21 3.53 Favored Glycine 0 C--N 1.34 0.786 0 N-CA-C 111.104 -0.798 . . . . 51.32 111.104 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 209' ' ' LYS . . . . . 0.554 ' HB3' ' HG2' ' C' ' 220' ' ' GLU . 40.5 mtmt -148.0 149.35 31.99 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.399 0.679 . . . . 72.12 111.074 176.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 210' ' ' VAL . . . . . 0.581 HG11 ' HA ' ' C' ' 199' ' ' VAL . 15.8 m -137.76 141.68 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-N 114.546 -1.206 . . . . 62.05 108.753 174.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 211' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.73 110.54 19.4 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.264 0.626 . . . . 72.44 111.013 -176.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 212' ' ' ALA . . . . . 0.462 ' HB2' HD13 ' C' ' 197' ' ' LEU . . . -90.46 113.56 25.54 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 107.742 -1.207 . . . . 74.43 107.742 165.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 213' ' ' MET . . . . . . . . . . . . . 6.8 tmm? -71.62 132.45 44.64 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 107.79 -1.189 . . . . 63.12 107.79 176.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 214' ' ' THR . . . . . 0.444 ' OG1' HG12 ' C' ' 219' ' ' VAL . 0.2 OUTLIER -127.19 175.18 8.34 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.008 0.523 . . . . 54.24 110.68 -176.93 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 215' ' ' LEU . . . . . . . . . . . . . 20.3 mt -68.17 -23.31 64.85 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.12 0.968 . . . . 44.41 112.074 -172.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -87.36 -26.83 23.16 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 114.684 -1.144 . . . . 71.0 109.735 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 141.47 179.44 18.64 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 109.403 -1.479 . . . . 64.11 109.403 -168.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -75.15 119.11 5.47 Favored 'Trans proline' 0 CA--C 1.559 1.735 0 C-N-CA 122.561 2.174 . . . . 52.13 113.481 -175.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 219' ' ' VAL . . . . . 0.456 HG23 HG22 ' B' ' 238' ' ' THR . 8.6 p -91.66 125.32 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 N-CA-C 108.253 -1.018 . . . . 52.53 108.253 169.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 220' ' ' GLU . . . . . 0.554 ' HG2' ' HB3' ' C' ' 209' ' ' LYS . 15.6 tt0 -90.53 106.33 18.43 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.874 0.845 . . . . 72.32 108.757 177.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 221' ' ' VAL . . . . . . . . . . . . . 71.0 t -72.64 126.39 33.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 113.807 -1.542 . . . . 74.03 111.972 -174.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -72.6 117.33 14.15 Favored 'General case' 0 CA--C 1.549 0.919 0 O-C-N 124.314 1.009 . . . . 73.3 110.306 169.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 90.9 t -91.35 140.93 25.68 Favored Pre-proline 0 CA--C 1.555 1.157 0 C-N-CA 124.514 1.125 . . . . 73.11 109.794 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 224' ' ' PRO . . . . . 0.543 ' HG3' HH22 ' C' ' 231' ' ' ARG . 87.3 Cg_endo -81.03 147.54 16.66 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 123.172 2.581 . . . . 54.33 112.089 167.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -52.45 132.45 44.95 Favored 'Trans proline' 0 C--N 1.372 1.793 0 C-N-CA 122.417 2.078 . . . . 74.0 112.793 169.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 226' ' ' ARG . . . . . 0.48 ' H ' ' HA ' ' C' ' 205' ' ' VAL . 0.0 OUTLIER 51.31 85.6 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 126.279 1.832 . . . . 70.15 112.583 -171.703 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 227' ' ' THR . . . . . 0.531 HG22 HG11 ' C' ' 253' ' ' VAL . 90.4 m -101.11 130.79 47.21 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 114.406 -1.27 . . . . 70.3 109.854 174.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 228' ' ' GLN . . . . . 0.757 HE21 ' HG2' ' A' ' 259' ' ' GLU . 25.2 mp0 -95.4 147.39 23.57 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.499 1.12 . . . . 74.32 111.978 -176.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -72.76 124.25 24.96 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 114.989 -1.005 . . . . 62.12 109.209 173.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 108.32 -9.76 36.03 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-O 119.641 -0.533 . . . . 62.04 112.526 -172.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 231' ' ' ARG . . . . . 0.543 HH22 ' HG3' ' C' ' 224' ' ' PRO . 34.3 mtp180 -64.35 169.92 4.27 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 117.616 0.708 . . . . 74.12 110.465 169.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 232' ' ' LYS . . . . . 0.45 ' HA ' ' O ' ' C' ' 251' ' ' LEU . 33.6 ttmt -142.92 136.96 29.11 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.226 0.536 . . . . 71.45 110.552 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 233' ' ' LEU . . . . . 0.739 HD13 ' HB2' ' C' ' 251' ' ' LEU . 4.0 mp -98.01 145.92 26.02 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 114.478 -1.237 . . . . 74.21 109.759 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 11.5 ptp85 -110.02 90.9 3.45 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 124.628 1.205 . . . . 72.34 108.183 163.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 235' ' ' LEU . . . . . 0.438 HD12 HD23 ' C' ' 249' ' ' LEU . 24.8 mt -78.25 95.95 5.12 Favored 'General case' 0 C--N 1.352 0.686 0 N-CA-C 107.407 -1.331 . . . . 73.43 107.407 169.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -70.75 125.71 27.57 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 114.516 -1.22 . . . . 71.55 111.594 -171.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 75.72 29.23 59.73 Favored Glycine 0 C--N 1.348 1.22 0 O-C-N 123.867 0.73 . . . . 71.42 112.423 -176.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -124.34 17.02 9.04 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.279 0.631 . . . . 72.03 110.535 176.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -77.53 -165.44 24.88 Favored Glycine 0 C--N 1.359 1.811 0 N-CA-C 110.893 -0.883 . . . . 31.21 110.893 167.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 240' ' ' PHE . . . . . 0.482 ' HD2' HD13 ' C' ' 188' ' ' LEU . 1.2 m-85 -70.67 127.29 92.05 Favored Pre-proline 0 C--O 1.257 1.472 0 CA-C-N 118.061 0.93 . . . . 75.14 108.959 176.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 241' ' ' PRO . . . . . 0.444 ' HA ' ' HB3' ' C' ' 246' ' ' ARG . 32.0 Cg_exo -61.47 94.94 0.12 Allowed 'Trans proline' 0 C--N 1.385 2.459 0 C-N-CA 123.553 2.836 . . . . 70.21 113.171 177.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 242' ' ' GLY . . . . . 0.517 ' H ' ' HA ' ' C' ' 246' ' ' ARG . . . -77.56 137.94 20.96 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-N 113.838 -1.528 . . . . 70.14 112.126 -179.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.47 -9.32 25.66 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 123.152 2.568 . . . . 71.42 113.804 -176.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -120.78 23.09 10.91 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.393 0.677 . . . . 71.42 110.576 176.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 115.31 143.85 8.14 Favored Glycine 0 C--N 1.341 0.83 0 N-CA-C 109.951 -1.26 . . . . 51.32 109.951 -171.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 246' ' ' ARG . . . . . 0.517 ' HA ' ' H ' ' C' ' 242' ' ' GLY . 15.3 ptp180 -99.42 170.84 8.34 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 118.01 0.905 . . . . 61.31 112.395 -171.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -92.38 -164.92 38.51 Favored Glycine 0 C--N 1.35 1.356 0 CA-C-N 114.932 -1.031 . . . . 63.23 113.581 177.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -130.35 148.11 52.14 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.08 0.952 . . . . 73.54 109.055 -172.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 249' ' ' LEU . . . . . 0.438 HD23 HD12 ' C' ' 235' ' ' LEU . 22.8 tp -101.24 137.16 39.95 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.903 0.881 . . . . 74.23 110.611 -175.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 250' ' ' TYR . . . . . 0.589 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 59.3 m-85 -127.46 101.56 6.49 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.443 1.097 . . . . 71.43 109.265 -176.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 251' ' ' LEU . . . . . 0.739 ' HB2' HD13 ' C' ' 233' ' ' LEU . 1.2 mp -101.33 139.13 37.42 Favored 'General case' 0 N--CA 1.508 2.442 0 CA-C-N 118.138 0.426 . . . . 64.53 110.923 -175.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -80.09 138.99 37.06 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 108.953 -0.758 . . . . 73.41 108.953 168.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 253' ' ' VAL . . . . . 0.531 HG11 HG22 ' C' ' 227' ' ' THR . 99.0 t -87.29 128.14 40.12 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 CA-C-O 121.079 0.466 . . . . 73.5 111.214 176.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 254' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 -110.18 111.67 23.16 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.465 1.106 . . . . 74.13 108.828 167.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 255' ' ' ILE . . . . . 0.502 ' O ' ' HB ' ' A' ' 255' ' ' ILE . 33.8 mm -80.84 120.51 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 N-CA-C 108.294 -1.002 . . . . 75.24 108.294 171.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 256' ' ' THR . . . . . 0.537 HG22 ' HB3' ' A' ' 229' ' ' ALA . 46.4 p -120.34 -172.78 2.43 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.672 0.789 . . . . 53.32 111.257 -173.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 2.7 pp -141.45 148.79 52.02 Favored Pre-proline 0 N--CA 1.489 1.477 0 C-N-CA 123.39 0.676 . . . . 64.54 110.196 178.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -61.26 -7.69 8.86 Favored 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 123.372 2.715 . . . . 73.21 114.684 -174.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 57.12 -78.35 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.908 1.283 . . . . 72.3 110.846 -166.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 22.5 ptt-85 -60.35 136.58 58.08 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 124.23 1.012 . . . . 73.41 110.26 177.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 261' ' ' LEU . . . . . 0.494 HD22 ' HB3' ' C' ' 265' ' ' GLU . 94.8 mt -143.34 148.21 35.91 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.58 0.752 . . . . 71.21 109.65 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 262' ' ' THR . . . . . 0.467 ' OG1' ' HG2' ' C' ' 265' ' ' GLU . 36.4 p -84.31 162.42 51.39 Favored Pre-proline 0 CA--C 1.548 0.898 0 N-CA-C 108.417 -0.957 . . . . 61.23 108.417 167.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -53.4 -35.84 76.94 Favored 'Trans proline' 0 C--N 1.374 1.881 0 C-N-CA 122.267 1.978 . . . . 74.2 114.202 175.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -66.43 -48.11 71.07 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 122.381 0.272 . . . . 71.04 110.514 178.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 265' ' ' GLU . . . . . 0.494 ' HB3' HD22 ' C' ' 261' ' ' LEU . 33.2 mm-40 -52.57 -51.33 60.27 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 123.612 0.57 . . . . 65.11 109.633 175.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 266' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -54.43 -41.57 69.54 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 114.354 -1.294 . . . . 64.21 110.627 -177.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 267' ' ' ALA . . . . . 0.447 ' O ' ' HG3' ' C' ' 271' ' ' LYS . . . -62.13 -46.0 90.95 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.731 -0.668 . . . . 70.32 111.573 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 268' ' ' LEU . . . . . 0.443 ' HB2' HD21 ' A' ' 272' ' ' LEU . 10.4 mp -66.33 -41.94 88.91 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 111.591 0.219 . . . . 52.44 111.591 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -63.48 -33.11 74.86 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 122.988 0.515 . . . . 61.11 111.141 176.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 270' ' ' LYS . . . . . 0.456 ' O ' ' HG2' ' C' ' 274' ' ' GLU . 4.2 mmmp? -61.04 -48.92 79.52 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.631 0.772 . . . . 75.43 110.076 173.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 271' ' ' LYS . . . . . 0.447 ' HG3' ' O ' ' C' ' 267' ' ' ALA . 63.2 mttm -58.55 -43.76 89.41 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.72 0.808 . . . . 75.33 111.568 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 91.2 mt -61.63 -40.36 94.59 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.368 -0.833 . . . . 74.33 110.404 176.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -64.38 -34.69 78.75 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 115.522 -0.763 . . . . 34.13 110.822 177.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 274' ' ' GLU . . . . . 0.456 ' HG2' ' O ' ' C' ' 270' ' ' LYS . 13.5 mm-40 -67.58 -40.3 84.85 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.127 0.571 . . . . 63.21 109.702 177.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -61.71 -30.84 71.02 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.457 0.703 . . . . 70.04 110.662 174.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 276' ' ' TYR . . . . . 0.551 ' HA ' ' HD3' ' C' ' 279' ' ' ARG . 9.6 m-85 -77.27 -31.6 55.0 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.069 -0.968 . . . . 75.52 112.733 172.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -76.3 -19.13 58.56 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 118.526 0.603 . . . . 44.24 110.198 175.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -69.13 -16.58 63.69 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.331 0.652 . . . . 55.2 110.538 169.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 279' ' ' ARG . . . . . 0.551 ' HD3' ' HA ' ' C' ' 276' ' ' TYR . 16.3 mtp-105 -83.52 -14.81 51.46 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.155 0.582 . . . . 71.52 110.978 173.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.085 -0.96 . . . . 75.14 110.338 -179.233 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.9 ttmp? . . . . . 0 N--CA 1.483 1.219 0 N-CA-C 114.472 1.286 . . . . 62.43 114.472 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -100.26 114.49 27.98 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 123.546 0.739 . . . . 74.32 109.071 164.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.502 ' HA ' ' OH ' ' A' ' 66' ' ' TYR . 23.9 t70 -82.46 102.94 11.65 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 107.729 -1.211 . . . . 61.41 107.729 168.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.434 ' HD1' HD12 ' A' ' 10' ' ' ILE . 32.4 m-85 -64.08 -30.44 71.51 Favored 'General case' 0 C--O 1.244 0.811 0 CA-C-N 115.576 -0.738 . . . . 73.34 112.131 -171.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.428 ' CD1' HD11 ' A' ' 22' ' ' ILE . 64.9 m-85 -62.04 -44.34 96.89 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 122.851 0.46 . . . . 73.33 110.394 174.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.94 -41.84 97.49 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.285 0.634 . . . . 60.32 111.229 178.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.434 HD12 ' HD1' ' A' ' 7' ' ' TYR . 65.1 mt -55.77 -43.28 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 123.469 0.707 . . . . 74.23 110.976 176.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.6 mt -79.62 -14.12 59.03 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 112.936 0.717 . . . . 51.33 112.936 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.39 36.65 59.25 Favored Glycine 0 C--N 1.351 1.378 0 O-C-N 123.026 0.204 . . . . 53.33 113.485 -176.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.3 m -119.93 157.33 52.96 Favored Pre-proline 0 N--CA 1.482 1.175 0 C-N-CA 124.764 1.226 . . . . 71.43 109.164 175.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.502 ' HG2' ' HB2' ' A' ' 17' ' ' ALA . 12.2 Cg_endo -55.93 153.1 33.05 Favored 'Trans proline' 0 C--N 1.388 2.645 0 C-N-CA 122.771 2.314 . . . . 50.12 112.508 177.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 72.3 mtp180 -81.63 59.53 4.19 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.113 0.965 . . . . 75.43 111.411 -170.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 176.37 -27.96 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.643 1.177 . . . . 64.11 109.273 -168.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.502 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . . . -37.64 138.01 0.4 Allowed 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 126.864 2.065 . . . . 64.31 114.897 -171.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.9 p -61.67 162.26 8.76 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 124.6 1.16 . . . . 71.11 112.455 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -56.05 -35.93 67.47 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.118 0.967 . . . . 64.21 112.279 -175.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.51 -29.49 61.43 Favored 'General case' 0 C--O 1.209 -1.058 0 CA-C-O 118.939 -0.553 . . . . 72.43 110.654 -177.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -69.67 -39.0 77.27 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 118.516 0.598 . . . . 64.03 110.005 173.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.428 HD11 ' CD1' ' A' ' 8' ' ' TYR . 1.6 mp -61.86 -40.91 88.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 C-N-CA 124.199 1.0 . . . . 73.31 110.345 172.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.8 ttpm? -80.32 -25.76 39.15 Favored 'General case' 0 C--O 1.213 -0.844 0 CA-C-N 114.491 -1.231 . . . . 71.24 110.197 -174.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.454 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 73.5 mtp180 -78.07 -34.85 50.1 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.484 0.714 . . . . 54.12 109.918 173.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.78 -34.36 73.65 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 123.893 0.746 . . . . 64.0 109.982 173.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -63.96 -60.23 3.51 Favored 'General case' 0 C--O 1.209 -1.068 0 CA-C-N 115.672 -0.695 . . . . 73.1 109.533 172.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.454 ' HE3' ' HA ' ' A' ' 24' ' ' ARG . 51.6 mtmt -53.87 -38.2 64.48 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 124.31 1.044 . . . . 74.22 110.686 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.2 ttt180 -59.37 -57.91 10.93 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.521 1.128 . . . . 71.15 110.956 176.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.602 ' HB3' HD13 ' A' ' 50' ' ' ILE . 84.7 mt -76.81 -11.69 59.87 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.702 0.801 . . . . 74.11 111.18 -177.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.06 -20.44 24.36 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.909 0.884 . . . . 63.3 110.535 178.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 75.4 mtm180 -95.68 -31.9 13.02 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.052 0.541 . . . . 72.33 110.673 171.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -77.03 -55.0 5.83 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 108.981 -0.748 . . . . 63.33 108.981 -178.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.629 ' HA ' HD22 ' A' ' 38' ' ' ASN . 39.2 m-85 -93.47 33.55 1.24 Allowed 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 115.879 -0.601 . . . . 63.25 110.531 173.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 7.9 t-80 -61.28 107.75 1.23 Allowed Pre-proline 0 C--N 1.357 0.912 0 N-CA-C 108.564 -0.902 . . . . 63.41 108.564 177.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -57.87 -19.32 38.84 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 122.976 2.451 . . . . 74.13 113.086 -169.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -63.42 -42.69 98.73 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.685 1.194 . . . . 72.45 112.704 178.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.5 t -105.09 -37.46 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 123.173 0.589 . . . . 65.53 109.984 -177.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.629 HD22 ' HA ' ' A' ' 33' ' ' TYR . 63.1 t30 -98.09 68.13 1.95 Allowed 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 122.634 1.207 . . . . 61.35 108.51 178.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt -79.6 75.88 6.24 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 113.827 -1.533 . . . . 73.11 109.282 -178.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.8 m -135.55 108.29 10.12 Favored Pre-proline 0 N--CA 1.467 0.422 0 CA-C-O 118.124 -0.941 . . . . 54.41 108.622 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -39.31 -45.31 3.03 Favored 'Trans proline' 0 C--N 1.387 2.569 0 C-N-CA 124.23 3.287 . . . . 72.23 114.248 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -56.22 -46.93 79.33 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.408 0.683 . . . . 64.43 111.343 178.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.5 -16.96 61.78 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.527 0.731 . . . . 72.14 111.623 -178.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -92.07 -30.72 15.87 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.532 0.733 . . . . 62.01 110.428 -176.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -72.23 -36.62 69.16 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 109.417 -0.586 . . . . 62.44 109.417 168.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -62.84 -41.28 99.27 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 116.058 -0.519 . . . . 74.03 109.834 170.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.625 ' HA ' HD12 ' A' ' 50' ' ' ILE . 52.1 t80 -63.64 -31.56 72.77 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.583 0.753 . . . . 73.24 110.716 176.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -63.64 -45.14 91.56 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 122.567 0.347 . . . . 75.14 110.975 171.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -65.63 -25.87 67.57 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 111.821 0.304 . . . . 71.44 111.821 178.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.625 HD12 ' HA ' ' A' ' 47' ' ' PHE . 66.1 mt -74.78 -39.28 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 123.847 0.859 . . . . 70.53 110.103 172.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.438 ' HB3' ' HD1' ' A' ' 88' ' ' PHE . 94.4 m-20 -71.07 -23.56 62.16 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.684 0.793 . . . . 73.43 110.911 176.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -76.05 -53.35 8.49 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.593 1.557 . . . . 63.42 109.626 177.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.06 -47.19 78.4 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 113.928 -1.487 . . . . 65.45 110.417 176.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -68.87 -37.05 78.82 Favored 'General case' 0 C--O 1.207 -1.14 0 CA-C-N 114.64 -1.164 . . . . 72.32 110.928 176.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -51.93 -53.81 36.78 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 118.658 0.663 . . . . 53.01 110.462 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.477 HG13 ' HZ ' ' A' ' 101' ' ' PHE . 47.0 t -64.1 -55.93 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 113.866 -1.515 . . . . 74.52 110.273 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 78.1 mt -81.61 2.03 31.2 Favored 'General case' 0 CA--C 1.556 1.183 0 N-CA-C 113.745 1.017 . . . . 62.04 113.745 -169.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.0 t -80.19 -75.14 0.27 Allowed 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 109.215 -0.661 . . . . 74.34 109.215 174.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -68.86 116.95 46.5 Favored Pre-proline 0 C--O 1.239 0.549 0 CA-C-O 118.651 -0.69 . . . . 74.34 109.392 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -49.88 -28.0 17.27 Favored 'Trans proline' 0 C--N 1.388 2.621 0 C-N-CA 124.069 3.179 . . . . 72.41 114.294 -175.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -60.34 -62.73 1.65 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.704 0.802 . . . . 72.3 110.735 175.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.448 ' HA ' HD12 ' A' ' 65' ' ' ILE . 29.6 mtmm -64.28 -33.12 75.09 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.176 0.591 . . . . 74.54 110.737 -177.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 22.3 ttt85 -61.83 -45.76 92.45 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.065 -0.971 . . . . 74.11 110.703 176.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -70.65 -28.25 64.65 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 119.279 -0.391 . . . . 74.25 111.262 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.448 HD12 ' HA ' ' A' ' 62' ' ' LYS . 73.2 mt -53.24 -52.8 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 N-CA-C 108.86 -0.793 . . . . 64.42 108.86 168.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.502 ' OH ' ' HA ' ' A' ' 6' ' ' ASP . 55.9 t80 -61.97 -52.01 65.76 Favored 'General case' 0 CA--C 1.556 1.179 0 CA-C-N 114.561 -1.2 . . . . 75.4 112.004 178.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -56.37 -40.54 74.73 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.135 0.974 . . . . 64.04 111.848 -175.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 58.6 p -80.35 -22.55 41.31 Favored 'General case' 0 C--O 1.215 -0.728 0 CA-C-N 115.498 -0.774 . . . . 75.13 111.07 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -66.45 109.23 2.66 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 118.909 0.777 . . . . 63.45 108.934 176.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 113.18 13.29 10.98 Favored Glycine 0 CA--C 1.537 1.429 0 CA-C-N 115.337 -0.847 . . . . 52.54 111.565 -166.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 50.7 m -148.4 -61.08 0.25 Allowed 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 103.986 -2.598 . . . . 71.23 103.986 176.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 61.8 m -75.83 139.87 41.97 Favored 'General case' 0 C--O 1.248 1.005 0 N-CA-C 104.549 -2.389 . . . . 74.23 104.549 155.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.14 -25.8 7.94 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 122.792 0.437 . . . . 74.04 111.179 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.08 132.51 90.18 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 123.851 0.86 . . . . 75.1 110.597 176.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -55.51 141.95 81.88 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 122.74 2.294 . . . . 75.41 111.252 168.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -57.72 149.93 65.27 Favored 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 123.501 2.801 . . . . 74.25 113.009 -173.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -66.2 170.81 11.25 Favored 'Trans proline' 0 C--N 1.383 2.393 0 C-N-CA 124.095 3.197 . . . . 62.44 113.742 -173.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -33.71 127.58 0.16 Allowed 'Trans proline' 0 C--N 1.401 3.304 0 C-N-CA 124.818 3.679 . . . . 43.51 114.404 174.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.569 ' HG3' ' HA3' ' A' ' 104' ' ' GLY . 42.2 Cg_endo -77.92 119.8 4.84 Favored 'Trans proline' 0 CA--C 1.559 1.73 0 C-N-CA 123.277 2.651 . . . . 71.05 113.049 -165.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.09 76.23 2.63 Favored 'Trans proline' 0 CA--C 1.554 1.511 0 C-N-CA 122.592 2.195 . . . . 51.35 112.746 -178.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 115.22 0.96 22.25 Favored Glycine 0 C--N 1.347 1.152 0 CA-C-N 115.075 -0.966 . . . . 62.41 112.002 -176.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.74 147.14 12.31 Favored Glycine 0 C--N 1.352 1.436 0 N-CA-C 110.713 -0.955 . . . . 53.03 110.713 -167.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -65.53 100.62 0.52 Allowed 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 118.349 1.074 . . . . 74.41 109.029 172.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -54.1 139.75 34.14 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.496 1.118 . . . . 71.31 112.519 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.486 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 65.2 m-85 -143.48 72.85 1.37 Allowed 'General case' 0 N--CA 1.47 0.55 0 O-C-N 124.136 0.897 . . . . 70.22 109.682 171.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 18.2 m -52.7 86.7 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 125.509 1.524 . . . . 74.44 112.68 -179.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.781 ' H ' ' HA3' ' A' ' 163' ' ' GLY . . . 80.7 1.39 89.2 Favored Glycine 0 C--N 1.34 0.767 0 CA-C-N 115.858 -0.61 . . . . 70.11 112.853 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.486 ' HB2' ' HB3' ' A' ' 85' ' ' PHE . 17.4 m-85 -97.24 114.29 26.01 Favored 'General case' 0 C--N 1.344 0.365 0 N-CA-C 107.727 -1.212 . . . . 72.34 107.727 -176.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -80.22 80.92 6.58 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.245 0.545 . . . . 71.44 110.191 -174.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.63 HG21 HD22 ' A' ' 105' ' ' LEU . 1.6 p -42.31 -39.42 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 125.413 1.485 . . . . 75.21 112.936 174.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -57.23 -33.36 67.47 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.008 0.923 . . . . 75.33 112.714 -176.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -105.32 11.6 32.66 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.236 0.541 . . . . 45.35 111.69 -178.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 17.2 m-30 -90.33 173.84 7.9 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 121.967 -0.458 . . . . 71.01 109.881 174.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 86.0 p -65.72 157.89 28.96 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 113.631 0.974 . . . . 74.5 113.631 -167.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.45 -42.77 96.82 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.345 1.058 . . . . 74.31 111.633 176.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -55.63 -49.93 71.52 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.092 0.957 . . . . 75.03 111.2 177.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.526 ' HE2' HG23 ' A' ' 90' ' ' VAL . 37.7 t80 -60.01 -42.84 95.17 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.443 -1.253 . . . . 63.23 110.584 176.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -78.27 -4.35 47.42 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.325 -0.852 . . . . 73.05 112.415 -178.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -102.34 -34.05 9.34 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.038 0.535 . . . . 70.02 111.286 169.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 41.6 tp -65.81 -52.13 53.25 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.223 0.609 . . . . 55.03 109.56 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.477 ' HZ ' HG13 ' A' ' 56' ' ' VAL . 88.8 m-85 -92.86 -0.49 57.23 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.529 -0.76 . . . . 72.11 110.745 174.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.402 ' N ' ' HD2' ' A' ' 103' ' ' PRO . . . -42.78 -56.65 4.27 Favored Glycine 0 C--N 1.353 1.509 0 CA-C-O 118.213 -1.326 . . . . 72.43 115.188 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.402 ' HD2' ' N ' ' A' ' 102' ' ' GLY . 4.8 Cg_exo -34.76 -32.49 0.07 OUTLIER 'Trans proline' 0 C--N 1.395 3.024 1 C-N-CA 125.697 4.264 . . . . 23.1 115.263 177.17 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.569 ' HA3' ' HG3' ' A' ' 79' ' ' PRO . . . -152.94 49.21 0.52 Allowed Glycine 0 C--N 1.351 1.4 0 C-N-CA 120.547 -0.835 . . . . 44.4 113.786 179.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.63 HD22 HG21 ' A' ' 90' ' ' VAL . 29.7 mt -58.22 79.61 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 112.444 0.535 . . . . 74.25 112.444 171.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.51 ' HD1' ' H ' ' A' ' 108' ' ' GLY . 0.1 OUTLIER 42.27 -110.29 0.14 Allowed 'General case' 0 CA--C 1.559 1.326 0 C-N-CA 126.514 1.925 . . . . 72.25 112.819 -179.751 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 70.24 -0.66 23.01 Favored Glycine 0 C--N 1.362 2.011 0 CA-C-N 118.27 0.486 . . . . 44.0 113.663 -172.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.51 ' H ' ' HD1' ' A' ' 106' ' ' PHE . . . . . . . . 0 C--N 1.352 1.417 0 N-CA-C 112.26 -0.336 . . . . 71.34 112.26 -172.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.524 ' HA ' ' HD2' ' A' ' 170' ' ' PRO . 8.0 tmtm? . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 107.226 -1.398 . . . . 72.15 107.226 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -73.71 148.71 40.51 Favored Glycine 0 CA--C 1.531 1.086 0 O-C-N 123.373 0.421 . . . . 55.22 113.335 -175.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.417 ' H ' ' HA3' ' A' ' 166' ' ' GLY . 8.0 tmm_? -114.79 155.6 26.43 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 124.081 0.952 . . . . 71.34 110.349 -175.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -58.37 131.42 50.64 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 123.731 0.813 . . . . 74.23 111.694 -178.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.2 tt -145.63 164.77 30.69 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 108.566 -0.901 . . . . 70.23 108.566 -172.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.483 ' NH2' HH21 ' A' ' 179' ' ' ARG . 60.1 ttt180 -129.54 139.22 51.59 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.62 -0.881 . . . . 74.51 108.62 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -135.61 151.51 50.33 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.642 0.777 . . . . 41.51 108.994 177.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.525 ' H ' ' HB3' ' B' ' 9' ' ' ALA . 13.0 mm-40 -102.18 133.78 46.5 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 107.119 -1.437 . . . . 61.0 107.119 -177.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.456 ' HA ' HD12 ' B' ' 8' ' ' LEU . 39.7 tp -102.54 95.15 5.74 Favored Pre-proline 0 CA--C 1.544 0.743 0 N-CA-C 107.991 -1.114 . . . . 54.05 107.991 179.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.536 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 52.6 Cg_endo -72.39 112.73 3.52 Favored 'Trans proline' 0 C--N 1.384 2.42 0 C-N-CA 121.532 1.488 . . . . 75.33 109.085 174.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.669 ' HA ' HG21 ' B' ' 6' ' ' ILE . 42.0 tp -123.79 137.49 54.67 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.243 0.544 . . . . 64.01 110.862 -166.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 17.3 m -75.78 133.85 40.58 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 114.984 -1.007 . . . . 71.34 109.72 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 49.5 mt -49.69 -44.01 47.76 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 124.656 1.183 . . . . 70.54 112.103 -169.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -57.58 -54.07 50.97 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.009 -0.996 . . . . 75.32 110.518 -176.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -57.8 -40.29 79.55 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 115.719 -0.673 . . . . 64.33 110.788 177.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -58.76 -48.85 79.79 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 124.291 0.994 . . . . 41.43 112.246 -176.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -74.15 -41.02 62.19 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 123.274 0.359 . . . . 74.51 111.717 -177.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -68.53 -43.54 76.51 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 120.79 0.328 . . . . 75.25 110.87 -178.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.423 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 76.21 177.57 43.44 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-N 115.418 -0.81 . . . . 71.54 113.802 178.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 109.48 -152.41 17.14 Favored Glycine 0 C--N 1.34 0.783 0 C-N-CA 123.48 0.562 . . . . 70.42 112.178 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -77.31 111.52 13.05 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.653 0.781 . . . . 73.14 111.115 -178.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 4.4 tpm_? -101.09 124.12 46.31 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 123.919 0.888 . . . . 74.4 109.81 176.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.0 t -84.33 109.5 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 123.959 0.904 . . . . 71.24 109.308 177.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.9 p -129.56 131.07 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.335 1.054 . . . . 73.14 108.881 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 144' ' ' ARG . 39.3 tt0 -113.93 142.45 46.11 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.035 0.445 . . . . 71.3 110.911 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.7 p -155.31 127.83 1.06 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.59 0 C-N-CA 124.4 1.08 . . . . 75.1 108.622 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 58.81 18.38 6.01 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.025 0.93 . . . . 74.24 112.536 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 103.12 -32.36 7.68 Favored Glycine 0 C--N 1.352 1.453 0 C-N-CA 122.903 0.287 . . . . 31.1 112.463 -176.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.35 105.26 4.02 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 108.898 -0.778 . . . . 72.12 108.898 178.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.469 ' HA ' ' HA ' ' A' ' 139' ' ' GLU . 16.1 ttm180 -94.9 98.81 10.98 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.755 0.822 . . . . 74.41 109.51 173.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 6.8 p -95.8 140.75 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.777 0.831 . . . . 73.53 111.303 -177.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 28.7 t -92.62 84.36 5.04 Favored 'General case' 0 C--O 1.243 0.742 0 N-CA-C 108.67 -0.863 . . . . 31.45 108.67 174.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 31.5 m -82.64 122.99 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 N-CA-C 110.257 -0.275 . . . . 73.42 110.257 -177.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -73.73 103.27 4.23 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.565 0.698 . . . . 74.14 109.525 174.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.423 HG13 ' HA2' ' A' ' 133' ' ' GLY . 18.1 pt -82.43 133.7 49.63 Favored Pre-proline 0 CA--C 1.554 1.112 0 CA-C-N 114.565 -1.198 . . . . 74.13 108.206 167.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -62.78 143.17 91.44 Favored 'Trans proline' 0 C--N 1.371 1.742 0 C-N-CA 121.939 1.759 . . . . 60.34 112.163 175.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -57.47 92.14 0.05 OUTLIER 'Trans proline' 0 C--N 1.389 2.695 0 C-N-CA 123.22 2.614 . . . . 74.15 112.563 176.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.687 ' HA3' ' HD2' ' A' ' 241' ' ' PRO . . . 98.65 56.87 1.01 Allowed Glycine 0 C--N 1.335 0.474 0 CA-C-N 114.812 -1.085 . . . . 75.51 111.214 -169.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.449 HG22 HG11 ' A' ' 178' ' ' VAL . 5.4 p -78.38 131.29 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-O 121.73 0.776 . . . . 75.43 109.288 178.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.676 ' HA ' HD21 ' A' ' 188' ' ' LEU . 21.8 mtt85 -100.75 149.67 23.58 Favored 'General case' 0 C--O 1.21 -0.98 0 CA-C-N 114.587 -1.188 . . . . 73.23 110.873 -163.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -58.77 118.65 5.95 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.795 0.838 . . . . 72.32 110.916 -178.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 91.66 12.33 59.56 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-N 115.214 -0.903 . . . . 14.21 113.414 -176.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 24.0 t -70.94 113.97 8.53 Favored 'General case' 0 C--N 1.356 0.874 0 N-CA-C 108.319 -0.993 . . . . 74.23 108.319 173.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.488 HG22 HG22 ' A' ' 177' ' ' VAL . 47.2 t -85.57 90.33 2.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 C-N-CA 123.565 0.746 . . . . 72.34 109.09 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 61.6 mt -71.86 93.0 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 107.779 -1.193 . . . . 75.24 107.779 171.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -81.19 109.02 15.33 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.795 -0.639 . . . . 61.32 110.416 -174.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 3.7 p -114.63 108.17 49.73 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 123.606 0.763 . . . . 61.33 109.506 177.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.612 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 52.6 Cg_endo -68.33 155.37 69.49 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 121.95 1.766 . . . . 74.53 110.894 172.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.781 ' HA3' ' H ' ' A' ' 87' ' ' GLY . . . 75.81 27.64 62.39 Favored Glycine 0 C--N 1.345 1.063 0 C-N-CA 121.44 -0.409 . . . . 70.43 114.022 176.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 36.6 tpp -134.65 -22.78 1.65 Allowed 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.031 0.532 . . . . 64.15 111.385 -178.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.6 ' HA2' HD13 ' A' ' 174' ' ' LEU . . . -68.65 -99.93 0.03 OUTLIER Glycine 0 C--N 1.354 1.54 0 N-CA-C 114.993 0.757 . . . . 73.33 114.993 -172.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.417 ' HA3' ' H ' ' A' ' 117' ' ' ARG . . . -63.69 121.51 23.88 Favored Glycine 0 C--N 1.347 1.182 0 N-CA-C 111.888 -0.485 . . . . 74.5 111.888 178.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.573 ' HA ' HE21 ' A' ' 167' ' ' GLN . 0.0 OUTLIER -67.96 104.84 1.83 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.506 0.722 . . . . 75.42 110.596 -174.726 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -165.32 170.52 40.29 Favored Glycine 0 C--N 1.339 0.733 0 CA-C-O 118.785 -1.008 . . . . 64.21 111.242 -178.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . 0.51 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . 24.4 t-20 -49.52 -65.88 0.74 Allowed Pre-proline 0 CA--C 1.561 1.399 0 CA-C-O 117.247 -1.359 . . . . 63.11 110.858 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.524 ' HD2' ' HA ' ' A' ' 115' ' ' LYS . 71.1 Cg_endo -93.83 94.06 0.13 Allowed 'Trans proline' 0 C--N 1.393 2.869 0 CA-C-N 122.645 1.98 . . . . 71.13 108.881 165.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -69.73 158.26 57.62 Favored 'Trans proline' 0 C--N 1.373 1.848 0 C-N-CA 122.475 2.117 . . . . 71.25 111.765 -164.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -70.1 171.74 42.04 Favored Glycine 0 C--N 1.34 0.802 0 CA-C-N 116.143 -0.48 . . . . 72.4 113.598 -174.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.612 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 31.0 t70 -67.63 142.75 56.31 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 109.329 -0.619 . . . . 71.14 109.329 172.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.6 HD13 ' HA2' ' A' ' 165' ' ' GLY . 23.4 tp -124.57 131.85 53.46 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 120.859 0.362 . . . . 64.32 110.291 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 47.1 mt -102.53 98.37 8.45 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.676 0.791 . . . . 72.12 109.271 176.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.642 HD22 HD11 ' B' ' 8' ' ' LEU . 80.2 mt -83.09 93.98 7.72 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 118.051 0.387 . . . . 70.05 110.577 178.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.488 HG22 HG22 ' A' ' 158' ' ' VAL . 24.2 t -85.47 107.43 16.18 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 N-CA-C 107.965 -1.124 . . . . 61.43 107.965 177.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.449 HG11 HG22 ' A' ' 153' ' ' VAL . 7.5 p -69.4 127.7 31.68 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 CA-C-O 121.386 0.613 . . . . 70.33 111.233 -174.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.536 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 37.0 mmt180 -116.77 101.7 8.78 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 125.193 1.397 . . . . 53.32 108.278 176.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 4.9 mt -69.92 143.14 52.81 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 118.559 0.618 . . . . 72.4 110.246 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 83.4 mt -61.32 155.47 57.21 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 123.995 0.918 . . . . 73.14 111.755 -175.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -76.95 53.59 4.23 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 122.892 2.395 . . . . 71.42 109.858 163.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 27.8 t-80 -79.19 131.3 66.49 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 125.014 1.326 . . . . 73.35 108.572 -171.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -9.06 -53.6 0.0 OUTLIER 'Trans proline' 0 C--N 1.383 2.379 1 C-N-CA 127.692 5.595 . . . . 61.24 119.748 -163.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 44.2 t -99.76 -59.32 3.35 Favored 'Isoleucine or valine' 0 C--N 1.356 0.855 0 CA-C-N 119.322 0.965 . . . . 64.21 109.993 -168.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . 0.631 ' HB3' HD22 ' A' ' 193' ' ' LEU . 51.8 m-85 -101.4 138.78 37.96 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 112.863 0.69 . . . . 72.31 112.863 -165.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 27.2 ttp-105 -116.58 98.51 6.58 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 106.02 -1.844 . . . . 75.51 106.02 164.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.676 HD21 ' HA ' ' A' ' 154' ' ' ARG . 56.0 tp -68.98 144.16 54.2 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.616 -0.513 . . . . 74.21 109.616 176.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -149.15 115.67 5.87 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 107.788 -1.19 . . . . 70.31 107.788 -176.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . 0.432 ' O ' ' HB3' ' A' ' 154' ' ' ARG . . . 73.29 -75.9 0.95 Allowed Glycine 0 C--N 1.349 1.29 0 CA-C-O 119.889 -0.395 . . . . 65.41 113.587 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -153.15 -2.98 0.22 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.976 0.911 . . . . 72.32 110.959 176.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -125.21 148.15 48.75 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.961 0.904 . . . . 72.32 110.446 -172.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.631 HD22 ' HB3' ' A' ' 186' ' ' PHE . 81.7 mt -90.83 149.88 21.78 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.856 0.862 . . . . 63.44 111.162 -171.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -128.58 99.59 5.43 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.312 1.045 . . . . 73.14 108.456 171.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.564 ' HB3' HD23 ' A' ' 251' ' ' LEU . . . -110.78 110.86 21.67 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.537 1.135 . . . . 74.34 111.055 -171.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 77.4 m -64.59 121.84 15.4 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 109.299 -0.63 . . . . 70.21 109.299 178.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 54.0 tp -122.62 105.73 10.36 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 123.722 0.809 . . . . 72.21 108.978 -166.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -70.35 126.2 28.96 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.144 0.497 . . . . 61.43 109.917 173.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 7.1 p -142.79 136.96 14.7 Favored Pre-proline 0 CA--C 1.548 0.894 0 N-CA-C 107.179 -1.415 . . . . 64.4 107.179 179.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.64 154.56 34.99 Favored 'Trans proline' 0 C--N 1.361 1.19 0 C-N-CA 121.55 1.5 . . . . 64.51 111.718 172.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -53.72 -47.25 97.28 Favored Pre-proline 0 CA--C 1.565 1.52 0 N-CA-C 114.718 1.377 . . . . 71.34 114.718 -174.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -59.11 -39.74 76.69 Favored 'Trans proline' 0 C--N 1.383 2.376 0 C-N-CA 122.088 1.859 . . . . 63.54 114.325 176.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 45.7 mt -75.43 -26.79 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 122.517 0.327 . . . . 64.32 110.609 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.09 -43.68 74.03 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.196 0.598 . . . . 71.51 111.158 173.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 11.1 t -69.23 -52.64 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 123.957 0.903 . . . . 63.23 112.017 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 85.3 t -85.28 -31.7 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 123.231 0.612 . . . . 74.41 111.262 -171.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 83.4 94.66 0.61 Allowed Glycine 0 CA--C 1.53 0.989 0 CA-C-N 116.308 -0.405 . . . . 72.35 113.035 -178.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -123.54 -178.15 15.34 Favored Glycine 0 N--CA 1.476 1.33 0 N-CA-C 111.487 -0.645 . . . . 55.24 111.487 174.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -81.28 134.15 35.55 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 117.963 0.882 . . . . 45.21 110.409 177.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 33.2 m -123.54 143.8 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 106.537 -1.653 . . . . 63.11 106.537 164.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . 0.428 ' HE ' ' HG2' ' A' ' 220' ' ' GLU . 29.8 ttm180 -92.87 113.65 25.98 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 121.622 -0.674 . . . . 71.41 109.809 -176.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.03 128.8 46.07 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.265 1.026 . . . . 62.04 109.22 -177.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . 0.409 ' HA ' ' HA ' ' A' ' 218' ' ' PRO . 1.6 mpt? -82.65 124.06 29.84 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.118 -0.697 . . . . 71.23 109.118 -177.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 77.2 p -109.3 -179.61 3.89 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 123.228 0.611 . . . . 74.1 109.784 178.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 49.3 mt -75.83 1.0 16.12 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.388 1.075 . . . . 63.31 111.987 -171.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -133.75 5.17 3.64 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 124.317 1.047 . . . . 64.44 111.592 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 137.49 170.6 11.93 Favored Glycine 0 N--CA 1.482 1.709 0 CA-C-O 119.802 -0.443 . . . . 33.0 113.545 176.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . 0.409 ' HA ' ' HA ' ' A' ' 213' ' ' MET . 85.2 Cg_endo -80.49 115.86 3.2 Favored 'Trans proline' 0 C--N 1.372 1.778 0 C-N-CA 122.955 2.437 . . . . 70.23 112.609 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 35.8 m -114.35 147.54 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.637 0.775 . . . . 73.4 109.834 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.428 ' HG2' ' HE ' ' A' ' 211' ' ' ARG . 42.0 mt-10 -73.85 147.18 43.54 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 109.566 -0.531 . . . . 75.04 109.566 175.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 10.1 p -137.24 116.52 15.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-O 121.544 0.688 . . . . 74.13 109.574 175.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -77.39 101.09 6.2 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 123.954 0.902 . . . . 60.25 109.522 -177.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 91.3 t -66.98 131.92 93.83 Favored Pre-proline 0 CA--C 1.556 1.205 0 CA-C-N 114.989 -1.005 . . . . 63.14 109.46 178.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.58 165.99 30.96 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.688 2.258 . . . . 75.51 110.922 175.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -69.47 158.62 56.66 Favored 'Trans proline' 0 C--N 1.37 1.695 0 C-N-CA 121.766 1.644 . . . . 72.53 111.857 175.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 15.3 mmt180 69.26 15.62 8.53 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 125.277 1.431 . . . . 74.04 112.046 175.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.429 HG23 HD21 ' A' ' 233' ' ' LEU . 4.0 m -59.89 104.65 0.31 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.188 0.995 . . . . 64.32 111.065 -179.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -92.11 139.55 30.52 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 114.418 -1.264 . . . . 75.32 111.671 -173.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -54.11 153.19 5.27 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.496 1.518 . . . . 62.31 112.337 174.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 79.36 -49.15 3.53 Favored Glycine 0 C--N 1.345 1.069 0 N-CA-C 112.269 -0.332 . . . . 73.32 112.269 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -63.73 163.44 11.55 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 124.276 1.03 . . . . 74.0 111.363 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.534 ' HG3' ' HG2' ' A' ' 252' ' ' GLU . 2.9 mppt? -112.12 129.5 56.21 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 114.838 -1.074 . . . . 72.22 110.355 -175.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.58 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 79.6 mt -77.59 104.3 8.04 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 108.323 -0.992 . . . . 71.4 108.323 170.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 42.1 ttm105 -82.25 109.3 16.4 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 122.643 0.377 . . . . 64.14 110.247 177.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.426 ' HG ' ' HB3' ' A' ' 249' ' ' LEU . 0.4 OUTLIER -120.83 106.31 11.54 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 108.055 -1.091 . . . . 61.12 108.055 169.866 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -74.56 159.87 31.62 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.069 0.948 . . . . 64.43 112.666 -169.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 73.35 9.51 77.51 Favored Glycine 0 C--N 1.349 1.294 0 CA-C-N 115.496 -0.774 . . . . 74.2 113.369 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.38 -11.63 15.15 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.295 0.638 . . . . 73.01 111.187 -176.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -79.53 -154.34 8.72 Favored Glycine 0 C--N 1.348 1.218 0 N-CA-C 112.515 -0.234 . . . . 74.43 112.515 177.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -92.41 137.69 24.47 Favored Pre-proline 0 N--CA 1.48 1.063 0 CA-C-O 118.918 -0.563 . . . . 73.13 110.132 -175.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.687 ' HD2' ' HA3' ' A' ' 152' ' ' GLY . 89.7 Cg_exo -46.78 107.99 0.14 Allowed 'Trans proline' 0 C--N 1.388 2.61 0 C-N-CA 123.973 3.115 . . . . 73.33 113.83 -178.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -134.56 -145.35 5.21 Favored Glycine 0 C--N 1.35 1.317 0 CA-C-O 119.073 -0.848 . . . . 73.52 112.585 -171.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -72.78 -26.93 15.37 Favored 'Trans proline' 0 C--N 1.385 2.475 0 C-N-CA 123.052 2.501 . . . . 70.45 112.655 -173.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -94.2 22.89 5.47 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.19 0.996 . . . . 70.11 111.066 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 90.13 -68.97 2.42 Favored Glycine 0 C--N 1.345 1.077 0 N-CA-C 109.579 -1.408 . . . . 62.24 109.579 -171.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.604 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 75.8 mtp180 -127.23 168.39 14.79 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.53 1.132 . . . . 75.41 109.306 166.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -84.95 -166.2 41.29 Favored Glycine 0 C--N 1.346 1.094 0 CA-C-N 116.171 -0.468 . . . . 42.24 111.973 172.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . 0.438 ' HB2' ' CE1' ' A' ' 250' ' ' TYR . 26.6 m-20 -104.39 158.99 16.09 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.371 0.669 . . . . 75.44 109.831 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.426 ' HB3' ' HG ' ' A' ' 235' ' ' LEU . 40.6 tp -106.57 122.74 46.91 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 107.619 -1.252 . . . . 70.31 107.619 167.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.438 ' CE1' ' HB2' ' A' ' 248' ' ' ASP . 42.4 m-85 -108.27 105.69 15.52 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.096 -1.076 . . . . 52.51 108.096 176.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.58 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 69.1 mt -84.41 102.83 13.06 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 108.75 -0.833 . . . . 72.24 108.75 176.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . 0.534 ' HG2' ' HG3' ' A' ' 232' ' ' LYS . 27.7 mt-10 -74.96 96.34 3.15 Favored 'General case' 0 C--N 1.356 0.855 0 C-N-CA 123.57 0.748 . . . . 75.41 109.091 -176.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 46.3 t -55.73 133.74 19.55 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 125.571 1.548 . . . . 24.43 112.222 -172.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -133.93 94.42 3.26 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 107.733 -1.21 . . . . 73.14 107.733 -179.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.451 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 77.6 mt -79.59 133.9 28.81 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-N 115.961 -0.563 . . . . 74.34 111.144 -176.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 31.1 p -129.87 176.22 8.22 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.548 1.139 . . . . 73.43 109.519 172.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.7 pp -133.23 153.03 80.51 Favored Pre-proline 0 CA--C 1.569 1.703 0 C-N-CA 123.803 0.841 . . . . 73.4 111.116 -174.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' PRO . . . . . 0.422 ' HG2' HD21 ' A' ' 261' ' ' LEU . 23.5 Cg_endo -59.18 -9.68 8.77 Favored 'Trans proline' 0 C--N 1.387 2.597 0 C-N-CA 123.999 3.133 . . . . 74.45 116.278 -166.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . 0.499 ' HA ' ' HB3' ' C' ' 226' ' ' ARG . 36.3 mt-10 56.67 -67.52 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.075 0 C-N-CA 125.415 1.486 . . . . 63.24 113.89 -174.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.03 132.59 39.02 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.55 -0.718 . . . . 75.12 109.66 172.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.613 HD22 ' HB2' ' A' ' 265' ' ' GLU . 56.2 mt -123.73 148.92 46.15 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.414 0.686 . . . . 55.32 110.453 173.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 21.7 p -127.9 155.09 78.12 Favored Pre-proline 0 CA--C 1.558 1.259 0 C-N-CA 125.06 1.344 . . . . 44.34 108.054 172.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -17.96 -52.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.403 3.44 1 C-N-CA 126.867 5.045 . . . . 74.33 117.989 -170.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . 0.442 ' O ' HD13 ' A' ' 268' ' ' LEU . 63.3 mm-40 -55.71 -74.68 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.012 0.525 . . . . 71.44 111.285 177.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . 0.613 ' HB2' HD22 ' A' ' 261' ' ' LEU . 1.5 mp0 -64.07 -30.31 71.39 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 122.858 0.463 . . . . 64.2 109.964 -172.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' GLU . . . . . 0.529 ' HA ' HD13 ' A' ' 261' ' ' LEU . 7.6 tp10 -55.51 -62.73 1.49 Allowed 'General case' 0 C--O 1.248 1.01 0 O-C-N 123.79 0.681 . . . . 73.45 109.69 176.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -60.63 -38.86 86.16 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 115.238 -0.892 . . . . 64.12 111.354 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . 0.442 HD13 ' O ' ' A' ' 264' ' ' GLU . 2.2 mp -63.46 -48.09 79.13 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.007 0.923 . . . . 73.14 111.921 -176.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 77.9 m95 -68.79 -33.44 73.87 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.315 0.646 . . . . 75.0 111.398 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . 0.433 ' HG2' ' O ' ' A' ' 266' ' ' GLU . 29.8 mmtp -70.43 -39.95 74.07 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 122.405 0.282 . . . . 62.43 111.504 175.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -73.44 -30.24 63.08 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.016 0.526 . . . . 70.22 110.574 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 24.0 mt -59.67 -54.4 46.84 Favored 'General case' 0 C--O 1.205 -1.252 0 N-CA-C 108.541 -0.911 . . . . 63.4 108.541 167.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -51.28 -48.57 62.22 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 124.107 0.879 . . . . 64.51 111.948 -177.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.41 ' HG3' ' O ' ' A' ' 270' ' ' LYS . 25.8 mt-10 -62.72 -56.96 12.87 Favored 'General case' 0 CA--C 1.551 0.989 0 O-C-N 123.371 0.419 . . . . 74.35 110.389 178.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -57.71 -65.85 0.57 Allowed 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.726 0.81 . . . . 71.44 111.761 -177.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . 0.516 ' HE2' ' HG3' ' C' ' 258' ' ' PRO . 81.9 t80 -45.61 -59.09 2.94 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.703 1.601 . . . . 75.02 112.826 178.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' TYR . . . . . 0.572 ' HA ' ' HB2' ' A' ' 280' ' ' ALA . 2.3 t80 -66.86 -35.01 79.07 Favored 'General case' 0 N--CA 1.482 1.132 0 O-C-N 123.59 0.556 . . . . 70.12 110.691 -170.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -61.38 -20.1 62.64 Favored 'General case' 0 CA--C 1.554 1.102 0 N-CA-C 112.761 0.652 . . . . 75.41 112.761 176.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.4 16.29 7.69 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-O 118.437 -0.792 . . . . 74.13 111.479 176.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . 0.572 ' HB2' ' HA ' ' A' ' 277' ' ' TYR . . . . . . . . 0 N--CA 1.495 1.802 0 N-CA-C 113.135 0.791 . . . . 72.21 113.135 -166.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.479 1.002 0 N-CA-C 109.167 -0.679 . . . . 71.44 109.167 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . 0.4 ' HE3' ' O ' ' B' ' 4' ' ' SER . 58.0 tptt -63.43 108.25 1.3 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.491 0.716 . . . . 54.1 109.645 175.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 61.3 tp60 -82.7 73.92 9.7 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 109.126 -0.694 . . . . 74.04 109.126 177.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . 0.4 ' O ' ' HE3' ' B' ' 2' ' ' LYS . 61.4 p 45.65 -88.06 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 126.012 1.725 . . . . 52.14 114.062 172.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 59.4 m 56.95 133.5 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 126.18 1.792 . . . . 70.11 114.044 -178.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.669 HG21 ' HA ' ' A' ' 125' ' ' LEU . 37.5 pt -137.54 172.43 14.6 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 C-N-CA 122.991 0.517 . . . . 64.44 111.971 -175.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -124.97 -167.6 1.7 Allowed 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.616 1.167 . . . . 72.01 108.991 175.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . 0.642 HD11 HD22 ' A' ' 176' ' ' LEU . 11.0 tp -130.69 167.1 19.35 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 109.428 -0.582 . . . . 75.22 109.428 177.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . 0.525 ' HB3' ' H ' ' A' ' 122' ' ' GLU . . . -87.68 -67.11 0.85 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 122.804 0.441 . . . . 62.4 110.864 173.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 3.8 tt 64.05 94.27 0.05 Allowed 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.556 1.142 . . . . 74.1 108.834 -169.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 57.2 mt . . . . . 0 CA--C 1.553 1.08 0 CA-C-O 118.751 -0.642 . . . . 45.35 109.434 -176.515 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.475 0 N-CA-C 108.276 -1.009 . . . . 61.34 108.276 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . 60.79 -74.69 0.03 OUTLIER 'General case' 0 C--N 1.358 0.963 0 O-C-N 125.111 1.507 . . . . 74.4 113.407 169.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 181' ' ' LEU . . . . . 0.439 ' HG ' ' HB ' ' C' ' 138' ' ' VAL . 30.3 tp -63.06 -30.14 71.36 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.146 1.378 . . . . 62.04 112.176 -177.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 182' ' ' VAL . . . . . 0.58 HG21 ' HB3' ' C' ' 139' ' ' GLU . 2.8 p -99.11 133.93 39.97 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 CA-C-N 116.189 -0.459 . . . . 71.31 110.982 174.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 183' ' ' ALA . . . . . 0.433 ' HB3' ' HA ' ' C' ' 123' ' ' LEU . . . -159.11 39.47 0.21 Allowed 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 114.806 -1.088 . . . . 65.24 108.453 163.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 42.5 p-80 54.49 171.44 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 127.216 2.207 . . . . 74.15 114.731 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 185' ' ' VAL . . . . . 0.478 HG21 HD11 ' C' ' 119' ' ' LEU . 6.9 p . . . . . 0 N--CA 1.479 1.007 0 CA-C-N 115.638 -0.71 . . . . 71.33 110.469 177.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 4.4 m . . . . . 0 CA--C 1.557 1.214 0 CA-C-O 121.792 0.806 . . . . 71.31 110.753 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 239' ' ' ALA . . . . . 0.426 ' HA ' HD22 ' C' ' 235' ' ' LEU . . . -83.29 153.29 24.72 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.678 0.791 . . . . 74.42 111.345 -176.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 240' ' ' GLY . . . . . 0.424 ' O ' ' HE3' ' B' ' 245' ' ' LYS . . . -86.86 -60.62 1.67 Allowed Glycine 0 C--N 1.349 1.288 0 CA-C-N 116.008 -0.542 . . . . 71.23 113.708 -164.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 241' ' ' GLU . . . . . 0.422 ' HG2' ' H ' ' C' ' 234' ' ' ARG . 15.4 pt-20 -112.18 -167.41 1.18 Allowed 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 117.49 0.645 . . . . 71.21 110.685 178.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 242' ' ' TRP . . . . . 0.416 ' CH2' HG21 ' C' ' 253' ' ' VAL 0.259 0.0 OUTLIER 59.53 166.33 0.06 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 127.647 2.379 . . . . 70.32 114.567 177.496 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' B' B ' 243' ' ' GLN . . . . . 0.466 ' HG3' ' H ' ' B' ' 245' ' ' LYS . 1.9 pt20 51.99 -166.95 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 126.519 1.928 . . . . 74.22 114.584 170.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -78.98 -43.81 10.58 Favored Glycine 0 C--N 1.362 2.007 0 CA-C-N 115.773 -0.649 . . . . 63.11 112.246 173.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 245' ' ' LYS . . . . . 0.466 ' H ' ' HG3' ' B' ' 243' ' ' GLN . 22.9 pttm . . . . . 0 N--CA 1.497 1.888 0 C-N-CA 126.324 1.85 . . . . 75.34 112.734 -178.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 114.673 1.36 . . . . 52.01 114.673 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 4.4 ttmp? 46.36 78.46 0.07 Allowed 'General case' 0 C--O 1.244 0.773 0 C-N-CA 125.93 1.692 . . . . 70.52 113.385 178.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -78.42 111.1 14.08 Favored 'General case' 0 C--O 1.246 0.882 0 N-CA-C 107.614 -1.254 . . . . 63.2 107.614 165.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 6' ' ' ASP . . . . . 0.49 ' HA ' ' OH ' ' C' ' 66' ' ' TYR . 13.9 t70 -64.73 113.35 3.72 Favored 'General case' 0 C--N 1.345 0.41 0 O-C-N 123.679 0.612 . . . . 63.22 109.837 177.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 7' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -63.83 -31.6 72.84 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 114.893 -1.049 . . . . 73.43 111.535 -176.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -64.76 -39.71 94.08 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 116.322 -0.399 . . . . 72.53 110.462 174.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.93 -41.5 86.94 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.25 0.62 . . . . 52.31 111.166 176.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 61.3 mt -58.57 -40.15 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 122.988 0.515 . . . . 63.34 110.433 178.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 94.0 mt -83.8 -12.62 55.39 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 112.606 0.595 . . . . 45.45 112.606 177.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.36 22.67 78.8 Favored Glycine 0 CA--C 1.535 1.33 0 N-CA-C 114.196 0.438 . . . . 64.33 114.196 -178.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 14.1 m -104.47 152.76 39.39 Favored Pre-proline 0 N--CA 1.482 1.136 0 C-N-CA 123.916 0.886 . . . . 64.04 110.337 177.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -64.0 157.95 50.24 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.542 2.162 . . . . 74.43 112.436 173.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 71.0 mtt180 -77.47 22.3 0.24 Allowed 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 123.508 0.723 . . . . 71.52 112.262 -179.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -120.9 8.79 10.53 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.965 1.306 . . . . 71.24 108.333 173.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.41 133.92 50.47 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 123.671 0.788 . . . . 71.14 111.328 -178.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 53.0 p -104.24 -176.11 2.99 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.564 1.146 . . . . 74.41 109.993 -178.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -48.41 -52.3 22.64 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 124.623 1.169 . . . . 74.45 112.184 -171.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.79 -48.4 63.73 Favored 'General case' 0 C--O 1.212 -0.912 0 O-C-N 123.746 0.654 . . . . 64.05 109.943 -172.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -63.93 -38.98 93.07 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.003 0.921 . . . . 73.42 111.562 -174.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 22' ' ' ILE . . . . . 0.816 HD13 ' HB3' ' C' ' 57' ' ' LEU . 78.3 mt -67.9 -50.3 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 123.977 0.911 . . . . 61.32 110.325 175.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -66.3 -22.31 66.29 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.195 -0.912 . . . . 74.13 110.017 -178.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 -74.05 -48.4 30.19 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.088 1.355 . . . . 73.52 110.035 176.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.39 -38.35 80.28 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 123.925 0.765 . . . . 75.32 110.678 175.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 26' ' ' TYR . . . . . 0.479 ' HE1' ' ND2' ' C' ' 51' ' ' ASN . 54.4 t80 -58.96 -62.52 1.82 Allowed 'General case' 0 C--O 1.208 -1.098 0 CA-C-N 115.097 -0.956 . . . . 72.31 109.857 173.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -50.33 -38.59 42.74 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 124.089 0.868 . . . . 74.1 111.582 -177.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 28' ' ' ARG . . . . . 0.405 ' HA ' ' NH2' ' C' ' 31' ' ' ARG . 59.5 ttt180 -57.95 -59.84 4.64 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.138 0.975 . . . . 71.15 110.957 176.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . 0.57 HD22 ' HE2' ' C' ' 33' ' ' TYR . 75.9 mt -76.98 -11.9 59.87 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 114.982 -1.008 . . . . 60.22 110.933 -176.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -88.83 -24.56 22.55 Favored 'General case' 0 C--O 1.213 -0.858 0 C-N-CA 124.131 0.973 . . . . 75.32 110.219 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . 0.405 ' NH2' ' HA ' ' C' ' 28' ' ' ARG . 45.3 mtm105 -85.12 -39.07 18.34 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.208 0.603 . . . . 73.5 110.204 171.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.72 -56.62 5.45 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 122.871 0.468 . . . . 71.12 110.196 -177.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 33' ' ' TYR . . . . . 0.57 ' HE2' HD22 ' C' ' 29' ' ' LEU . 50.1 m-85 -90.48 23.22 3.07 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 122.986 0.514 . . . . 70.15 111.438 -176.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 34' ' ' HIS . . . . . 0.404 ' HD2' ' HB3' ' C' ' 36' ' ' ASP . 20.6 t60 -68.99 109.1 3.72 Favored Pre-proline 0 N--CA 1.477 0.915 0 CA-C-O 118.265 -0.874 . . . . 72.34 110.114 -178.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 35' ' ' PRO . . . . . 0.505 ' HG3' ' HG2' ' C' ' 44' ' ' GLU . 76.9 Cg_exo -53.12 -25.38 29.04 Favored 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 123.663 2.909 . . . . 71.32 114.932 -173.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 36' ' ' ASP . . . . . 0.404 ' HB3' ' HD2' ' C' ' 34' ' ' HIS . 30.4 t70 -74.49 -35.74 63.25 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.508 0.723 . . . . 60.34 111.687 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 58.0 t -92.29 -56.01 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 109.336 -0.616 . . . . 75.33 109.336 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -100.62 92.17 4.99 Favored 'General case' 0 C--O 1.244 0.795 0 C-N-CA 125.098 1.359 . . . . 54.22 109.616 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.84 76.13 6.53 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.109 0.564 . . . . 62.24 109.722 -178.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . 0.463 ' O ' ' HG3' ' C' ' 44' ' ' GLU . 69.8 m -131.23 111.42 15.45 Favored Pre-proline 0 N--CA 1.475 0.777 0 CA-C-O 118.256 -0.878 . . . . 74.14 110.221 179.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -45.1 -40.88 16.1 Favored 'Trans proline' 0 C--N 1.383 2.388 0 C-N-CA 123.718 2.946 . . . . 63.44 113.397 174.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -53.41 -48.83 68.37 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.996 0.919 . . . . 65.44 110.229 175.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 43' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' C' ' 47' ' ' PHE . . . -72.01 -18.72 61.95 Favored 'General case' 0 C--O 1.212 -0.913 0 CA-C-N 113.655 -1.611 . . . . 62.05 111.393 -177.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 44' ' ' GLU . . . . . 0.505 ' HG2' ' HG3' ' C' ' 35' ' ' PRO . 44.1 mt-10 -88.43 -40.61 13.36 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.805 0.842 . . . . 74.04 111.139 -174.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -69.93 -40.85 75.27 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 109.974 -0.38 . . . . 42.53 109.974 173.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 46' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -66.43 -35.12 79.51 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.916 -0.584 . . . . 72.32 110.774 173.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 47' ' ' PHE . . . . . 0.468 ' HB2' ' O ' ' C' ' 43' ' ' ALA . 77.3 t80 -57.73 -44.63 86.13 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.364 0.666 . . . . 62.23 109.271 173.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -58.87 -46.46 87.76 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 122.878 0.471 . . . . 72.04 111.311 176.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -64.37 -32.27 73.81 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 120.719 0.295 . . . . 72.33 111.756 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 50' ' ' ILE . . . . . 0.536 HD13 ' HB3' ' C' ' 29' ' ' LEU . 80.5 mt -74.03 -31.81 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 124.148 0.979 . . . . 75.43 110.136 175.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 51' ' ' ASN . . . . . 0.479 ' ND2' ' HE1' ' C' ' 26' ' ' TYR . 0.9 OUTLIER -82.81 -14.65 54.0 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.04 0.936 . . . . 74.04 110.811 176.805 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -81.48 -50.32 9.55 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.288 1.435 . . . . 63.42 108.429 173.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.95 -40.35 76.26 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 113.276 -1.783 . . . . 63.1 110.567 174.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 54' ' ' TYR . . . . . 0.408 ' O ' ' HB2' ' C' ' 58' ' ' SER . 78.7 t80 -77.61 -33.97 53.57 Favored 'General case' 0 C--O 1.215 -0.72 0 CA-C-N 115.544 -0.753 . . . . 75.01 111.356 174.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 55' ' ' ALA . . . . . 0.713 ' HB1' ' HB3' ' C' ' 85' ' ' PHE . . . -51.01 -46.49 61.54 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.916 0.865 . . . . 60.54 110.266 178.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 47.2 t -76.71 -58.6 4.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-N 113.453 -1.703 . . . . 72.43 110.605 177.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 57' ' ' LEU . . . . . 0.816 ' HB3' HD13 ' C' ' 22' ' ' ILE . 69.6 mt -82.03 1.95 33.28 Favored 'General case' 0 CA--C 1.563 1.45 0 N-CA-C 114.465 1.283 . . . . 75.02 114.465 -166.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 58' ' ' SER . . . . . 0.408 ' HB2' ' O ' ' C' ' 54' ' ' TYR . 48.4 t -50.79 -56.45 12.05 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 124.262 1.025 . . . . 62.42 113.393 -173.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -123.79 150.42 62.05 Favored Pre-proline 0 C--O 1.252 1.207 0 CA-C-N 114.359 -1.291 . . . . 72.03 108.387 -171.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 60' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -47.19 -45.7 21.22 Favored 'Trans proline' 0 C--N 1.384 2.41 0 C-N-CA 123.761 2.974 . . . . 33.23 114.389 -169.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -58.15 -53.38 58.87 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.154 0.582 . . . . 62.13 112.365 -174.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -69.96 -37.24 75.76 Favored 'General case' 0 C--O 1.247 0.948 0 CA-C-N 115.602 -0.726 . . . . 75.23 110.821 -176.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 1.1 ppt_? -64.76 -35.85 82.4 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 115.847 -0.615 . . . . 64.42 109.601 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -73.82 -29.71 62.3 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.107 0.963 . . . . 74.15 111.198 177.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 82.6 mt -62.11 -43.68 98.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 109.57 -0.53 . . . . 62.34 109.57 172.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 66' ' ' TYR . . . . . 0.49 ' OH ' ' HA ' ' C' ' 6' ' ' ASP . 22.2 t80 -57.71 -50.82 71.93 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 116.145 -0.479 . . . . 74.22 110.094 173.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -58.45 -40.89 83.86 Favored 'General case' 0 N--CA 1.48 1.074 0 O-C-N 123.813 0.696 . . . . 73.14 112.182 -178.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 40.3 p -69.13 -22.27 63.96 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 119.604 -0.236 . . . . 63.2 110.722 178.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -81.69 142.17 32.94 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 108.678 -0.86 . . . . 75.22 108.678 166.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.72 22.05 62.62 Favored Glycine 0 C--N 1.345 1.071 0 N-CA-C 110.817 -0.913 . . . . 62.51 110.817 -174.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 61.5 m -145.54 -54.72 0.29 Allowed 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 103.045 -2.946 . . . . 72.34 103.045 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 47.3 m -83.41 142.26 31.12 Favored 'General case' 0 C--O 1.26 1.646 0 N-CA-C 105.214 -2.143 . . . . 73.35 105.214 157.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.32 -33.59 28.9 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.72 0.808 . . . . 73.23 111.022 177.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.16 152.89 71.63 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 123.741 0.817 . . . . 53.23 110.521 177.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -58.95 125.77 19.17 Favored 'Trans proline' 0 C--N 1.38 2.211 0 C-N-CA 122.638 2.226 . . . . 75.14 111.162 171.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -58.03 151.02 60.91 Favored 'Trans proline' 0 C--N 1.384 2.429 0 C-N-CA 123.323 2.682 . . . . 63.14 112.215 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -49.28 111.35 0.47 Allowed 'Trans proline' 0 C--N 1.387 2.556 0 C-N-CA 123.492 2.795 . . . . 51.51 113.347 -177.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 78' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.0 133.1 45.37 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.769 2.312 . . . . 74.44 112.493 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 79' ' ' PRO . . . . . 0.413 ' HA ' ' HD3' ' C' ' 80' ' ' PRO . 81.2 Cg_exo -50.16 124.45 12.88 Favored 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 122.399 2.066 . . . . 61.04 110.244 167.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 80' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' C' ' 79' ' ' PRO . 32.0 Cg_exo -65.68 37.81 0.13 Allowed 'Trans proline' 0 C--N 1.383 2.385 0 C-N-CA 124.741 3.627 . . . . 51.5 116.746 -172.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -163.24 -10.46 0.03 OUTLIER Glycine 0 CA--C 1.524 0.619 0 C-N-CA 123.51 0.576 . . . . 75.2 112.265 168.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 144.99 168.93 13.11 Favored Glycine 0 C--N 1.35 1.345 0 N-CA-C 114.384 0.513 . . . . 74.45 114.384 173.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -98.5 135.03 40.64 Favored 'General case' 0 C--O 1.219 -0.545 0 N-CA-C 106.744 -1.576 . . . . 70.14 106.744 171.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 84' ' ' ASP . . . . . 0.442 ' HB2' ' NE ' ' C' ' 143' ' ' ARG . 14.2 t70 -72.49 137.18 46.19 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 118.8 0.727 . . . . 63.13 112.333 -178.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 85' ' ' PHE . . . . . 0.713 ' HB3' ' HB1' ' C' ' 55' ' ' ALA . 6.8 p90 -164.49 48.46 0.11 Allowed 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.413 1.485 . . . . 74.41 109.09 170.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 86' ' ' SER . . . . . 0.67 ' HA ' ' HG2' ' C' ' 171' ' ' PRO . 68.2 m -63.38 122.89 17.32 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 115.223 -0.898 . . . . 45.43 112.056 -176.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.01 4.52 88.42 Favored Glycine 0 C--N 1.351 1.385 0 CA-C-N 115.29 -0.868 . . . . 74.33 113.401 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 88' ' ' PHE . . . . . 0.496 ' HB3' ' HZ ' ' C' ' 93' ' ' PHE . 11.7 m-85 -108.17 137.67 45.75 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 117.481 0.641 . . . . 74.44 109.579 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -79.92 78.75 6.52 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.52 0.676 . . . . 72.23 111.376 -173.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 90' ' ' VAL . . . . . . . . . . . . . 3.4 p -49.21 -34.83 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 125.478 1.511 . . . . 54.41 113.952 176.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.21 -19.99 64.8 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 123.152 0.581 . . . . 74.21 110.529 -174.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -110.91 16.05 21.46 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-O 121.01 0.433 . . . . 75.53 111.469 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 93' ' ' PHE . . . . . 0.496 ' HZ ' ' HB3' ' C' ' 88' ' ' PHE . 16.7 m-30 -89.13 166.29 13.94 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 109.797 -0.445 . . . . 72.45 109.797 172.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 80.6 p -65.53 164.62 13.71 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.683 0.793 . . . . 45.51 112.91 -170.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.14 -36.81 78.34 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 114.951 -1.022 . . . . 55.43 110.831 170.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -58.71 -45.67 89.01 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.189 0.996 . . . . 65.02 110.466 177.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 97' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -62.2 -45.63 92.5 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.936 -0.575 . . . . 64.25 109.661 176.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -81.05 -0.3 39.19 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 115.747 -0.66 . . . . 51.52 112.716 -175.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -101.55 -63.85 1.11 Allowed 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.357 0.663 . . . . 74.43 110.786 168.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 51.3 tp -55.1 -45.08 75.43 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.551 0.74 . . . . 73.23 111.265 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -98.5 -6.1 30.95 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.572 -0.74 . . . . 73.25 111.271 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -45.28 -61.42 3.6 Favored Glycine 0 C--N 1.356 1.647 0 N-CA-C 115.793 1.077 . . . . 54.11 115.793 -176.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -55.37 -27.68 59.37 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 123.097 2.531 . . . . 62.02 112.826 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -115.45 28.2 8.0 Favored Glycine 0 C--N 1.359 1.843 0 CA-C-O 118.937 -0.924 . . . . 43.23 112.815 -177.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 72.2 mt . . . . . 0 N--CA 1.495 1.776 0 CA-C-N 119.594 1.697 . . . . 73.03 110.528 170.981 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.878 0 N-CA-C 115.233 0.853 . . . . 45.25 115.233 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.04 -175.38 2.78 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.147 1.379 . . . . 64.44 110.18 -177.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -72.44 131.84 43.11 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 109.281 -0.637 . . . . 75.42 109.281 167.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 119' ' ' LEU . . . . . 0.478 HD11 HG21 ' B' ' 185' ' ' VAL . 36.1 tp -110.73 142.21 42.99 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.246 1.018 . . . . 75.21 108.617 -175.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -117.73 104.45 11.0 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 108.719 -0.845 . . . . 72.31 108.719 -169.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 121' ' ' ALA . . . . . 0.446 ' HB3' HD23 ' C' ' 176' ' ' LEU . . . -113.41 116.2 29.26 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.077 -0.712 . . . . 63.21 109.077 176.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 122' ' ' GLU . . . . . 0.493 ' HA ' ' O ' ' C' ' 177' ' ' VAL . 44.5 mt-10 -89.03 110.95 21.58 Favored 'General case' 0 C--N 1.347 0.462 0 N-CA-C 108.26 -1.015 . . . . 73.22 108.26 172.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 123' ' ' LEU . . . . . 0.6 ' H ' HD23 ' C' ' 123' ' ' LEU . 1.1 pt? -106.31 113.71 63.03 Favored Pre-proline 0 C--O 1.248 0.976 0 O-C-N 123.781 0.676 . . . . 73.3 109.39 -177.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -58.33 114.45 1.98 Allowed 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 122.205 1.937 . . . . 72.51 110.2 162.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 125' ' ' LEU . . . . . 0.547 ' O ' ' HA ' ' C' ' 180' ' ' LEU . 53.7 tp -142.94 154.94 44.57 Favored 'General case' 0 C--O 1.219 -0.547 0 N-CA-C 106.967 -1.494 . . . . 74.03 106.967 -171.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 126' ' ' THR . . . . . 0.452 ' HB ' HD12 ' C' ' 181' ' ' LEU . 11.1 t -119.3 171.62 8.18 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 119.735 1.152 . . . . 61.53 110.795 177.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 127' ' ' LEU . . . . . 0.505 HD11 ' H ' ' C' ' 185' ' ' VAL . 10.0 mt -62.86 -47.48 83.19 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 113.724 -1.58 . . . . 62.25 110.72 -171.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -58.32 -44.58 88.69 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 114.219 -1.355 . . . . 75.24 109.896 -177.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -75.25 -24.37 57.64 Favored 'General case' 0 C--O 1.216 -0.703 0 CA-C-N 114.975 -1.011 . . . . 73.53 111.445 178.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 130' ' ' ALA . . . . . 0.422 ' HB1' ' H ' ' C' ' 153' ' ' VAL . . . -71.76 -31.58 66.79 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 109.611 -0.514 . . . . 64.34 109.611 175.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 131' ' ' PHE . . . . . 0.551 ' HB2' HD13 ' C' ' 215' ' ' LEU . 75.5 t80 -70.35 -41.88 72.59 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.207 1.003 . . . . 75.55 109.855 172.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 132' ' ' HIS . . . . . . . . . . . . . 24.9 m170 -76.62 -8.23 56.83 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 115.19 -0.914 . . . . 60.22 110.99 176.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -54.02 134.1 44.52 Favored Glycine 0 C--N 1.356 1.661 0 O-C-N 123.973 0.796 . . . . 65.31 113.233 176.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . 173.17 -128.37 1.51 Allowed Glycine 0 C--O 1.24 0.526 0 N-CA-C 108.969 -1.652 . . . . 53.24 108.969 -177.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -72.0 95.54 1.61 Allowed 'General case' 0 C--N 1.35 0.587 0 N-CA-C 108.357 -0.979 . . . . 71.2 108.357 175.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 136' ' ' ARG . . . . . . . . . . . . . 19.5 mmt180 -126.1 162.48 25.24 Favored 'General case' 0 C--O 1.243 0.724 0 C-N-CA 123.522 0.729 . . . . 72.12 109.837 -178.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 137' ' ' VAL . . . . . . . . . . . . . 8.6 p -78.85 123.81 36.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 CA-C-N 115.374 -0.83 . . . . 71.12 110.119 177.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 138' ' ' VAL . . . . . 0.439 ' HB ' ' HG ' ' B' ' 181' ' ' LEU . 8.8 p -115.87 131.28 68.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 108.247 -1.02 . . . . 72.14 108.247 169.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 139' ' ' GLU . . . . . 0.58 ' HB3' HG21 ' B' ' 182' ' ' VAL . 9.9 tp10 -124.32 83.31 2.13 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 107.075 -1.454 . . . . 74.31 107.075 174.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 140' ' ' VAL . . . . . . . . . . . . . 54.6 t -140.9 148.67 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 107.214 -1.402 . . . . 63.22 107.214 178.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 68.67 23.39 7.13 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 124.14 0.976 . . . . 15.23 111.524 -177.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 67.14 40.62 92.74 Favored Glycine 0 C--N 1.347 1.167 0 O-C-N 123.931 0.769 . . . . 45.25 112.94 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 143' ' ' ARG . . . . . 0.587 ' NH2' ' HA ' ' C' ' 164' ' ' MET . 25.3 ttp-105 -153.07 124.18 7.49 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-O 120.82 0.343 . . . . 73.04 110.883 179.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 62.9 ttt-85 -88.34 124.0 33.48 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.239 -0.891 . . . . 71.51 109.269 167.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 145' ' ' VAL . . . . . . . . . . . . . 8.0 p -151.52 142.38 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.083 0.553 . . . . 75.03 109.587 173.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 52.9 p -84.33 105.36 15.1 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 109.196 -0.668 . . . . 54.21 109.196 174.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 14.5 p -123.2 146.73 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 N-CA-C 109.663 -0.495 . . . . 72.53 109.663 -178.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -91.16 114.93 27.59 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 122.933 0.493 . . . . 74.22 110.465 174.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 149' ' ' ILE . . . . . . . . . . . . . 31.5 pt -93.24 153.63 41.57 Favored Pre-proline 0 CA--C 1.55 0.953 0 N-CA-C 107.955 -1.128 . . . . 71.41 107.955 164.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -47.52 122.02 6.25 Favored 'Trans proline' 0 C--N 1.384 2.404 0 C-N-CA 123.029 2.486 . . . . 61.44 112.018 177.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -61.25 109.35 0.71 Allowed 'Trans proline' 0 C--N 1.385 2.498 0 C-N-CA 123.043 2.495 . . . . 73.2 111.536 -178.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 152' ' ' GLY . . . . . . . . . . . . . . . 110.58 109.78 3.19 Favored Glycine 0 C--N 1.338 0.673 0 CA-C-N 115.456 -0.793 . . . . 54.32 111.973 -170.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 153' ' ' VAL . . . . . 0.522 ' HB ' HG21 ' C' ' 178' ' ' VAL . 2.1 m -105.27 168.75 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 123.063 0.545 . . . . 71.13 109.647 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 154' ' ' ARG . . . . . 0.44 ' O ' HG23 ' C' ' 178' ' ' VAL . 18.2 mtp180 -115.78 116.26 27.73 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 122.905 0.482 . . . . 75.32 111.258 -174.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 155' ' ' GLU . . . . . 0.547 ' HG2' ' HE ' ' C' ' 187' ' ' ARG . 2.9 tp10 -22.7 115.95 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 126.733 2.013 . . . . 74.51 114.234 168.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 57.76 10.29 6.23 Favored Glycine 0 C--N 1.351 1.406 0 O-C-N 123.827 0.704 . . . . 64.51 114.752 171.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 157' ' ' SER . . . . . 0.425 ' HB2' ' HB2' ' C' ' 154' ' ' ARG . 49.5 m -106.74 167.28 9.98 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 121.572 0.701 . . . . 75.43 110.466 -173.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 18.4 t -103.31 104.75 17.13 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 CA-C-N 114.774 -1.103 . . . . 64.44 110.439 -169.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 159' ' ' ILE . . . . . 0.44 HD11 ' HB ' ' C' ' 153' ' ' VAL . 19.1 mt -72.23 145.87 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 109.287 -0.634 . . . . 52.25 109.287 167.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -109.82 108.4 18.71 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 109.148 -0.686 . . . . 72.21 109.148 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 161' ' ' VAL . . . . . 0.576 HG21 HD12 ' C' ' 176' ' ' LEU . 49.4 t -125.87 95.23 40.27 Favored Pre-proline 0 N--CA 1.485 1.283 0 C-N-CA 123.734 0.814 . . . . 75.24 110.967 -171.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -64.53 146.57 89.48 Favored 'Trans proline' 0 C--N 1.363 1.327 0 C-N-CA 121.805 1.67 . . . . 63.42 109.736 165.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 129.78 -16.87 5.54 Favored Glycine 0 N--CA 1.475 1.296 0 C-N-CA 121.715 -0.279 . . . . 53.31 113.569 -176.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 164' ' ' MET . . . . . 0.587 ' HA ' ' NH2' ' C' ' 143' ' ' ARG . 2.9 mpp? -121.58 -79.5 0.61 Allowed 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 109.434 -0.58 . . . . 73.35 109.434 170.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 165' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' C' ' 173' ' ' ASP . . . 68.9 174.18 9.37 Favored Glycine 0 C--N 1.349 1.28 0 N-CA-C 114.436 0.535 . . . . 64.24 114.436 -178.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . -71.11 165.14 53.43 Favored Glycine 0 C--N 1.343 0.934 0 N-CA-C 111.988 -0.445 . . . . 75.44 111.988 172.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 167' ' ' GLN . . . . . 0.514 ' HA ' HE21 ' C' ' 167' ' ' GLN . 0.0 OUTLIER -67.27 144.28 56.01 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 109.828 -0.434 . . . . 64.31 109.828 -179.655 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . 144.68 130.85 2.33 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-O 119.084 -0.842 . . . . 13.44 111.37 -174.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 169' ' ' ASN . . . . . 0.569 ' HB3' ' HD3' ' C' ' 170' ' ' PRO . 8.5 t30 -49.88 -49.82 71.74 Favored Pre-proline 0 CA--C 1.557 1.224 0 C-N-CA 124.468 1.107 . . . . 62.44 112.46 -172.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 170' ' ' PRO . . . . . 0.569 ' HD3' ' HB3' ' C' ' 169' ' ' ASN . 1.5 Cg_endo -86.87 104.71 0.64 Allowed 'Trans proline' 0 C--N 1.383 2.345 0 CA-C-N 121.522 1.579 . . . . 51.41 110.061 162.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 171' ' ' PRO . . . . . 0.67 ' HG2' ' HA ' ' C' ' 86' ' ' SER . 72.4 Cg_endo -72.83 173.09 14.05 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.906 2.404 . . . . 74.02 112.648 -175.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -117.21 -94.76 1.79 Allowed Glycine 0 C--N 1.346 1.09 0 CA-C-N 115.772 -0.649 . . . . 74.42 112.895 -177.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 173' ' ' ASP . . . . . 0.44 ' O ' ' HA2' ' C' ' 165' ' ' GLY . 6.8 t70 -166.26 151.32 8.21 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.906 0.882 . . . . 74.51 109.626 -164.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 174' ' ' LEU . . . . . . . . . . . . . 30.1 tp -117.84 105.15 11.64 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.554 0.741 . . . . 75.22 109.207 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 77.2 mt -74.81 96.18 3.04 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-N 114.523 -1.217 . . . . 71.32 109.744 172.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 176' ' ' LEU . . . . . 0.576 HD12 HG21 ' C' ' 161' ' ' VAL . 41.7 mt -85.77 96.87 9.88 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-N 115.313 -0.858 . . . . 43.02 109.945 178.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 177' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' C' ' 122' ' ' GLU . 22.0 t -84.57 101.24 8.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 107.906 -1.146 . . . . 74.43 107.906 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 178' ' ' VAL . . . . . 0.522 HG21 ' HB ' ' C' ' 153' ' ' VAL . 0.8 OUTLIER -84.74 102.66 11.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.059 -0.973 . . . . 74.01 110.632 -171.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 179' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -87.95 104.08 16.28 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.291 -1.374 . . . . 72.33 107.291 175.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 180' ' ' LEU . . . . . 0.547 ' HA ' ' O ' ' C' ' 125' ' ' LEU . 96.5 mt -68.83 138.29 54.63 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 109.99 -0.374 . . . . 70.51 109.99 177.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 181' ' ' LEU . . . . . 0.452 HD12 ' HB ' ' C' ' 126' ' ' THR . 51.8 mt -56.87 167.6 1.02 Allowed Pre-proline 0 N--CA 1.493 1.679 0 C-N-CA 125.539 1.536 . . . . 74.2 112.045 -173.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -54.62 68.38 0.03 OUTLIER 'Trans proline' 0 C--N 1.388 2.654 0 C-N-CA 123.842 3.028 . . . . 64.12 112.58 164.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 183' ' ' HIS . . . . . 0.508 ' N ' ' HD3' ' C' ' 184' ' ' PRO . 84.3 t60 177.39 48.16 0.03 OUTLIER Pre-proline 0 CA--C 1.567 1.615 0 C-N-CA 128.466 2.707 . . . . 62.13 106.444 -169.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 184' ' ' PRO . . . . . 0.508 ' HD3' ' N ' ' C' ' 183' ' ' HIS . 4.3 Cg_endo -87.95 65.66 3.57 Favored 'Trans proline' 0 C--N 1.398 3.141 0 C-N-CA 123.318 2.679 . . . . 71.54 110.236 -175.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 185' ' ' VAL . . . . . 0.505 ' H ' HD11 ' C' ' 127' ' ' LEU . 11.1 t -94.63 -24.77 4.79 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.076 0 CA-C-N 115.0 -1.0 . . . . 72.23 109.938 -170.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 186' ' ' PHE . . . . . 0.426 ' CD1' HD13 ' C' ' 127' ' ' LEU . 32.4 m-85 -124.58 105.51 9.42 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.398 0.618 . . . . 61.44 110.759 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 187' ' ' ARG . . . . . 0.547 ' HE ' ' HG2' ' C' ' 155' ' ' GLU . 35.4 ttm105 -108.3 104.41 13.79 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.708 1.203 . . . . 75.14 108.9 -174.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 188' ' ' LEU . . . . . . . . . . . . . 58.7 tp -77.91 134.89 37.82 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.202 0.815 . . . . 74.14 113.202 -167.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -132.55 119.07 20.03 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 126.008 1.723 . . . . 71.33 107.277 164.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 64.44 -99.21 0.32 Allowed Glycine 0 C--N 1.343 0.954 0 CA-C-N 116.07 -0.514 . . . . 74.2 112.614 -175.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 191' ' ' GLN . . . . . 0.462 HE21 ' HA3' ' C' ' 242' ' ' GLY . 50.4 mt-30 -127.3 -12.94 5.63 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.106 0.962 . . . . 60.21 109.336 173.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -86.74 148.49 25.4 Favored 'General case' 0 C--N 1.362 1.111 0 C-N-CA 123.509 0.724 . . . . 65.13 109.516 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 193' ' ' LEU . . . . . 0.458 HD21 ' CD2' ' C' ' 240' ' ' PHE . 90.1 mt -103.48 161.84 13.53 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.325 0.65 . . . . 52.2 110.681 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 194' ' ' TYR . . . . . 0.413 ' HB3' ' HB3' ' C' ' 187' ' ' ARG . 10.5 t80 -125.29 106.73 10.07 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.707 -1.22 . . . . 75.43 107.707 170.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 195' ' ' ALA . . . . . 0.496 ' HB2' HD11 ' C' ' 249' ' ' LEU . . . -105.76 -176.81 3.18 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.211 1.004 . . . . 65.11 110.268 177.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 87.0 m -139.07 120.95 15.48 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 114.953 -1.021 . . . . 51.32 108.836 166.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 197' ' ' LEU . . . . . 0.424 HD13 HD22 ' C' ' 251' ' ' LEU . 27.3 tp -90.69 115.48 27.82 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.886 0.874 . . . . 73.5 110.628 -175.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -78.15 104.06 8.49 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.826 0.85 . . . . 44.52 109.76 -178.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 199' ' ' VAL . . . . . 0.535 HG22 HG21 ' C' ' 210' ' ' VAL . 39.4 t -120.35 115.64 32.63 Favored Pre-proline 0 N--CA 1.482 1.145 0 C-N-CA 124.388 1.075 . . . . 61.21 109.481 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 200' ' ' PRO . . . . . 0.4 ' HG2' HD12 ' C' ' 203' ' ' ILE . 38.1 Cg_endo -69.28 149.75 70.33 Favored 'Trans proline' 0 C--N 1.367 1.529 0 C-N-CA 121.71 1.606 . . . . 71.34 111.988 175.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 201' ' ' ALA . . . . . 0.427 ' O ' HG23 ' C' ' 205' ' ' VAL . . . -54.73 -47.6 97.68 Favored Pre-proline 0 CA--C 1.562 1.42 0 N-CA-C 114.263 1.209 . . . . 74.35 114.263 -170.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 202' ' ' PRO . . . . . 0.436 ' O ' HG12 ' C' ' 206' ' ' VAL . 78.2 Cg_exo -53.3 -45.74 38.85 Favored 'Trans proline' 0 C--N 1.388 2.646 0 C-N-CA 121.763 1.642 . . . . 63.15 112.728 175.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 203' ' ' ILE . . . . . 0.4 HD12 ' HG2' ' C' ' 200' ' ' PRO . 38.7 mt -67.88 -33.86 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 124.048 0.939 . . . . 63.4 111.167 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 204' ' ' ALA . . . . . 0.411 ' HA ' HG11 ' C' ' 223' ' ' VAL . . . -68.73 -34.07 74.98 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.485 0.714 . . . . 75.02 111.654 178.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 205' ' ' VAL . . . . . 0.55 HG13 ' HG3' ' C' ' 226' ' ' ARG . 95.1 t -85.26 -40.42 14.82 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 N-CA-C 112.775 0.658 . . . . 63.41 112.775 -175.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 206' ' ' VAL . . . . . 0.436 HG12 ' O ' ' C' ' 202' ' ' PRO . 6.4 p -81.36 -39.35 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-N 118.959 0.799 . . . . 52.12 110.472 176.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 97.27 92.49 1.89 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.387 -0.685 . . . . 63.21 111.387 -166.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -113.98 -141.36 7.76 Favored Glycine 0 C--N 1.338 0.694 0 N-CA-C 111.734 -0.546 . . . . 51.32 111.734 176.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 209' ' ' LYS . . . . . 0.595 ' HG2' ' HA ' ' C' ' 222' ' ' ALA . 8.7 mtmp? -140.21 141.28 35.94 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.126 0.571 . . . . 72.12 110.557 171.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 210' ' ' VAL . . . . . 0.535 HG21 HG22 ' C' ' 199' ' ' VAL . 15.1 m -133.59 135.34 55.84 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 C-N-CA 124.912 1.285 . . . . 62.05 107.597 169.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 211' ' ' ARG . . . . . 0.498 ' HA ' ' HA ' ' C' ' 220' ' ' GLU . 0.5 OUTLIER -89.43 122.11 32.32 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 122.279 0.232 . . . . 72.44 110.761 -174.371 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 212' ' ' ALA . . . . . 0.477 ' HB3' HG13 ' C' ' 219' ' ' VAL . . . -81.16 116.35 21.02 Favored 'General case' 0 C--O 1.248 1.023 0 N-CA-C 107.678 -1.23 . . . . 74.43 107.678 173.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 213' ' ' MET . . . . . . . . . . . . . 4.8 tmm? -70.36 117.25 11.67 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 108.002 -1.11 . . . . 63.12 108.002 174.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 214' ' ' THR . . . . . 0.526 HG21 ' HD2' ' C' ' 238' ' ' LYS . 1.0 OUTLIER -115.57 168.12 10.3 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 122.043 0.925 . . . . 54.24 112.406 -176.954 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 215' ' ' LEU . . . . . 0.551 HD13 ' HB2' ' C' ' 131' ' ' PHE . 81.4 mt -65.98 -37.17 85.29 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 114.438 -1.256 . . . . 44.41 113.003 -169.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 216' ' ' GLU . . . . . 0.46 ' HG2' HH11 ' C' ' 246' ' ' ARG . 0.0 OUTLIER -105.23 9.84 33.89 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 114.492 -1.231 . . . . 71.0 110.951 -174.936 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 148.41 -144.81 12.74 Favored Glycine 0 C--N 1.353 1.484 0 CA-C-O 119.925 -0.375 . . . . 64.11 112.4 178.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -105.6 165.14 0.15 Allowed 'Trans proline' 0 CA--C 1.548 1.221 0 C-N-CA 123.61 2.873 . . . . 52.13 113.716 168.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 219' ' ' VAL . . . . . 0.477 HG13 ' HB3' ' C' ' 212' ' ' ALA . 4.5 p -145.7 116.54 1.83 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 107.154 -1.424 . . . . 52.53 107.154 163.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 220' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' C' ' 211' ' ' ARG . 28.2 tt0 -82.78 110.74 18.07 Favored 'General case' 0 C--O 1.247 0.971 0 N-CA-C 108.893 -0.78 . . . . 72.32 108.893 -179.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 221' ' ' VAL . . . . . . . . . . . . . 62.1 t -88.38 126.12 41.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 CA-C-N 115.16 -0.927 . . . . 74.03 109.515 -176.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 222' ' ' ALA . . . . . 0.595 ' HA ' ' HG2' ' C' ' 209' ' ' LYS . . . -87.24 143.72 27.15 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.666 -0.697 . . . . 73.3 110.378 176.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 223' ' ' VAL . . . . . 0.411 HG11 ' HA ' ' C' ' 204' ' ' ALA . 56.0 t -112.22 139.41 22.46 Favored Pre-proline 0 CA--C 1.558 1.254 0 C-N-CA 125.155 1.382 . . . . 73.11 108.537 -174.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 224' ' ' PRO . . . . . 0.415 ' HD3' ' CZ2' ' B' ' 242' ' ' TRP . 55.1 Cg_endo -87.76 168.34 6.98 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 123.213 2.609 . . . . 54.33 112.627 175.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -65.77 119.4 6.42 Favored 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 122.197 1.931 . . . . 74.0 112.358 174.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 226' ' ' ARG . . . . . 0.55 ' HG3' HG13 ' C' ' 205' ' ' VAL . 0.0 OUTLIER 66.48 89.81 0.1 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.211 1.804 . . . . 70.15 111.679 179.763 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 227' ' ' THR . . . . . . . . . . . . . 40.6 m -112.95 124.91 53.7 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 113.56 -1.654 . . . . 70.3 110.612 -174.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 228' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -90.52 152.02 21.1 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.946 0.898 . . . . 74.32 111.63 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 229' ' ' ALA . . . . . 0.442 ' HA ' ' O ' ' C' ' 253' ' ' VAL . . . -76.16 135.59 39.77 Favored 'General case' 0 C--O 1.243 0.745 0 CA-C-N 115.31 -0.859 . . . . 62.12 109.673 175.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 98.06 -2.38 59.75 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 115.774 -0.648 . . . . 62.04 113.339 -169.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 231' ' ' ARG . . . . . . . . . . . . . 68.8 mtt180 -66.35 172.06 4.31 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 117.75 0.775 . . . . 74.12 110.736 167.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 232' ' ' LYS . . . . . 0.559 ' HA ' ' O ' ' C' ' 251' ' ' LEU . 37.7 ttmt -154.32 143.89 21.53 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.243 0.831 . . . . 71.45 113.243 -173.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 233' ' ' LEU . . . . . 0.558 ' O ' ' HA ' ' C' ' 250' ' ' TYR . 3.4 mp -123.88 144.23 49.88 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 115.03 -0.987 . . . . 74.21 109.936 170.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 234' ' ' ARG . . . . . 0.422 ' H ' ' HG2' ' B' ' 241' ' ' GLU . 16.1 ptp180 -101.66 115.85 31.45 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 108.366 -0.976 . . . . 72.34 108.366 162.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 235' ' ' LEU . . . . . 0.426 HD22 ' HA ' ' B' ' 239' ' ' ALA . 33.7 mt -98.2 119.37 36.74 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 107.913 -1.143 . . . . 73.43 107.913 176.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -67.93 128.78 37.76 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.739 0.815 . . . . 71.55 112.087 -172.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 78.8 3.69 87.63 Favored Glycine 0 C--N 1.352 1.448 0 CA-C-N 115.731 -0.668 . . . . 71.42 113.342 176.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 238' ' ' LYS . . . . . 0.526 ' HD2' HG21 ' C' ' 214' ' ' THR . 67.0 mmtt -96.17 8.34 44.07 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.161 0.584 . . . . 72.03 111.518 -177.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -87.42 -170.09 46.17 Favored Glycine 0 C--N 1.352 1.464 0 O-C-N 123.373 0.421 . . . . 31.21 112.802 174.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 240' ' ' PHE . . . . . 0.458 ' CD2' HD21 ' C' ' 193' ' ' LEU . 2.0 m-85 -81.47 150.47 67.09 Favored Pre-proline 0 N--CA 1.48 1.073 0 N-CA-C 110.001 -0.37 . . . . 75.14 110.001 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 241' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -62.08 139.79 80.54 Favored 'Trans proline' 0 C--N 1.385 2.494 0 C-N-CA 123.26 2.64 . . . . 70.21 113.92 -174.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 242' ' ' GLY . . . . . 0.462 ' HA3' HE21 ' C' ' 191' ' ' GLN . . . -132.07 177.28 18.81 Favored Glycine 0 CA--C 1.522 0.485 0 CA-C-N 114.852 -1.067 . . . . 70.14 111.501 177.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.97 -11.25 27.21 Favored 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 122.792 2.328 . . . . 71.42 112.716 -175.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -110.34 -4.83 15.43 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.655 0.782 . . . . 71.42 111.858 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 147.65 -104.86 0.3 Allowed Glycine 0 C--N 1.35 1.342 0 N-CA-C 111.814 -0.514 . . . . 51.32 111.814 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 246' ' ' ARG . . . . . 0.46 HH11 ' HG2' ' C' ' 216' ' ' GLU . 85.0 mtm180 -146.05 167.71 22.71 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 124.78 1.232 . . . . 61.31 109.248 176.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -87.67 -156.8 30.64 Favored Glycine 0 C--N 1.346 1.136 0 N-CA-C 112.21 -0.356 . . . . 63.23 112.21 172.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -115.51 170.01 8.74 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.177 0.591 . . . . 73.54 109.585 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 249' ' ' LEU . . . . . 0.496 HD11 ' HB2' ' C' ' 195' ' ' ALA . 28.4 tp -116.02 115.06 25.46 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.406 0.682 . . . . 74.23 110.857 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 250' ' ' TYR . . . . . 0.558 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 2.1 m-30 -100.83 98.15 8.69 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.231 0.612 . . . . 71.43 109.696 -178.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 251' ' ' LEU . . . . . 0.559 ' O ' ' HA ' ' C' ' 232' ' ' LYS . 1.8 mp -94.53 126.29 39.73 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 119.448 -0.31 . . . . 64.53 110.222 -177.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -80.29 113.16 18.26 Favored 'General case' 0 C--O 1.217 -0.619 0 O-C-N 124.887 1.367 . . . . 73.41 108.579 170.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 253' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' C' ' 229' ' ' ALA . 40.5 t -72.36 133.12 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 123.15 0.58 . . . . 73.5 110.335 -174.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 254' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -122.84 114.82 21.01 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.545 1.138 . . . . 74.13 108.918 -165.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 255' ' ' ILE . . . . . 0.429 HG12 ' HB2' ' C' ' 229' ' ' ALA . 20.8 mm -88.61 115.67 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 109.19 -0.67 . . . . 75.24 109.19 -179.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 256' ' ' THR . . . . . . . . . . . . . 1.4 t -124.09 151.43 43.88 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.973 0.909 . . . . 53.32 111.394 -174.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 2.4 pp -121.55 120.49 28.78 Favored Pre-proline 0 N--CA 1.482 1.173 0 N-CA-C 107.55 -1.278 . . . . 64.54 107.55 170.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 258' ' ' PRO . . . . . 0.516 ' HG3' ' HE2' ' A' ' 276' ' ' TYR . 26.6 Cg_endo -78.98 11.68 2.5 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 C-N-CA 122.845 2.364 . . . . 73.21 113.946 -161.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 69.21 -62.24 0.41 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.592 1.557 . . . . 72.3 111.025 -173.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.51 130.43 31.75 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.24 1.016 . . . . 73.41 111.098 176.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 261' ' ' LEU . . . . . . . . . . . . . 88.0 mt -156.68 143.78 18.8 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.188 1.395 . . . . 71.21 107.702 177.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 71.8 p -83.41 152.01 63.41 Favored Pre-proline 0 CA--C 1.549 0.936 0 CA-C-O 118.105 -0.95 . . . . 61.23 108.457 172.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_exo -45.6 -33.36 9.66 Favored 'Trans proline' 0 C--N 1.384 2.432 0 C-N-CA 123.486 2.79 . . . . 74.2 114.647 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -63.07 -62.01 2.0 Allowed 'General case' 0 C--O 1.251 1.148 0 C-N-CA 124.258 1.023 . . . . 71.04 110.695 175.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -50.55 -52.0 42.83 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 115.196 -0.911 . . . . 65.11 109.798 178.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 266' ' ' GLU . . . . . 0.467 ' O ' ' HG2' ' C' ' 270' ' ' LYS . 30.6 tt0 -57.75 -38.44 75.37 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.103 1.361 . . . . 64.21 111.249 -178.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -59.65 -42.92 93.89 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.386 0.674 . . . . 70.32 110.958 177.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 268' ' ' LEU . . . . . . . . . . . . . 8.2 mp -65.02 -39.13 92.95 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 115.744 -0.662 . . . . 52.44 110.791 175.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -64.19 -29.81 70.9 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 122.582 0.353 . . . . 61.11 111.822 174.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 270' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' C' ' 266' ' ' GLU . 33.9 mmtp -68.91 -44.12 73.82 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 122.967 0.507 . . . . 75.43 109.927 176.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 11.0 mmmm -57.27 -45.98 83.52 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 123.92 0.762 . . . . 75.33 111.077 176.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 85.0 mt -62.52 -42.7 99.69 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 114.791 -1.095 . . . . 74.33 110.577 176.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -62.44 -39.16 92.44 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.491 0.716 . . . . 34.13 110.998 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -62.5 -47.82 82.28 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.542 0.737 . . . . 63.21 110.038 176.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -58.91 -30.85 68.13 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 115.319 -0.855 . . . . 70.04 111.368 176.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 276' ' ' TYR . . . . . 0.459 ' HD1' HH11 ' C' ' 279' ' ' ARG . 9.2 m-85 -80.55 -33.32 36.32 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.517 0.727 . . . . 75.52 112.662 178.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -73.36 -23.45 60.21 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 118.392 0.542 . . . . 44.24 109.822 177.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -66.79 -11.97 57.13 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 123.754 0.821 . . . . 55.2 112.289 171.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 279' ' ' ARG . . . . . 0.459 HH11 ' HD1' ' C' ' 276' ' ' TYR . 50.8 mtp180 -79.56 -12.8 59.84 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 122.845 0.458 . . . . 71.52 111.055 174.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.904 -0.57 . . . . 75.14 109.971 178.107 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 88.0 tttt . . . . . 0 N--CA 1.477 0.891 0 N-CA-C 113.76 1.022 . . . . 62.43 113.76 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.427 ' HG2' ' HB3' ' A' ' 96' ' ' PHE . 14.5 mmmm -79.7 94.58 5.75 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 107.544 -1.28 . . . . 74.32 107.544 168.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.428 ' O ' HG13 ' A' ' 10' ' ' ILE . 11.8 t70 -70.55 92.71 0.86 Allowed 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.154 -1.054 . . . . 61.41 108.154 177.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -58.84 -35.35 72.77 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.765 0.826 . . . . 73.34 112.89 -167.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.407 ' CE1' HD11 ' A' ' 22' ' ' ILE . 88.7 m-85 -63.78 -45.22 90.73 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 116.501 -0.318 . . . . 73.33 110.515 176.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.34 -39.42 90.52 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 123.597 0.561 . . . . 60.32 110.964 178.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 6' ' ' ASP . 37.7 mt -65.46 -37.06 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 123.01 0.524 . . . . 74.23 110.55 179.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.509 ' HB2' HG22 ' A' ' 13' ' ' VAL . 81.5 mt -73.25 -16.17 61.4 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.114 0.566 . . . . 51.33 111.737 174.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.71 18.0 79.36 Favored Glycine 0 C--N 1.351 1.365 0 O-C-N 123.412 0.445 . . . . 53.33 112.782 -176.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.509 HG22 ' HB2' ' A' ' 11' ' ' LEU . 27.5 m -107.58 158.18 33.95 Favored Pre-proline 0 N--CA 1.479 0.991 0 C-N-CA 124.399 1.08 . . . . 71.43 109.57 179.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -64.09 158.15 49.54 Favored 'Trans proline' 0 C--N 1.378 2.117 0 C-N-CA 122.23 1.954 . . . . 50.12 111.998 178.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -72.61 11.78 0.58 Allowed 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 113.418 0.896 . . . . 75.43 113.418 -176.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -135.75 23.34 3.36 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.768 1.227 . . . . 64.11 108.017 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.55 134.22 49.7 Favored 'General case' 0 C--N 1.348 0.518 0 CA-C-N 115.233 -0.894 . . . . 64.31 110.03 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.6 p -68.84 155.93 39.32 Favored 'General case' 0 C--O 1.241 0.646 0 O-C-N 124.053 0.846 . . . . 71.11 109.362 173.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.439 ' HA ' ' HB ' ' A' ' 22' ' ' ILE . 52.1 tt0 -62.68 -19.34 63.77 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 123.026 0.53 . . . . 64.21 110.769 177.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -62.14 -53.55 53.7 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 125.019 1.328 . . . . 72.43 109.773 171.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -64.65 -32.97 74.88 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.846 0.858 . . . . 64.03 111.58 177.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.449 HD13 ' HB3' ' A' ' 57' ' ' LEU . 78.6 mt -69.68 -33.03 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.555 1.142 . . . . 73.31 110.846 177.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -72.99 -35.43 66.85 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.494 0.718 . . . . 71.24 110.263 175.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 52.8 mtp180 -66.55 -40.78 89.21 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.383 0.673 . . . . 54.12 110.649 173.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.81 -36.33 82.12 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.508 0.723 . . . . 64.0 110.47 178.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -59.98 -63.18 1.39 Allowed 'General case' 0 C--O 1.21 -0.985 0 CA-C-N 114.847 -1.07 . . . . 73.1 109.918 173.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -52.03 -48.37 64.56 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.066 0.547 . . . . 74.22 111.404 -177.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 50.5 ttt180 -56.38 -68.05 0.25 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.083 0.553 . . . . 71.15 111.784 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.44 ' HB3' HD13 ' A' ' 50' ' ' ILE . 93.8 mt -78.73 -43.38 25.89 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-N 115.74 -0.664 . . . . 74.11 111.753 -168.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.73 -25.35 63.8 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 118.015 -0.993 . . . . 63.3 112.814 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.56 ' HA ' ' HB2' ' A' ' 34' ' ' HIS . 81.7 mtp180 -85.02 -31.57 23.39 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 120.3 1.409 . . . . 72.33 110.969 171.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 48.0 tp60 -66.84 -32.57 73.93 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.607 0.363 . . . . 63.33 111.282 174.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.428 ' HB3' ' HB2' ' A' ' 47' ' ' PHE . 23.8 m-85 -111.24 16.53 20.92 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.553 0.741 . . . . 63.25 110.493 -178.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.56 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 2.7 t-80 -67.86 116.65 40.49 Favored Pre-proline 0 C--N 1.354 0.781 0 CA-C-O 118.181 -0.914 . . . . 63.41 109.743 -175.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_exo -47.57 -31.94 14.94 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 123.317 2.678 . . . . 74.13 113.534 -178.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -59.91 -53.05 62.41 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.885 0.874 . . . . 72.45 111.493 176.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.6 t -90.44 -56.87 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 122.969 0.508 . . . . 65.53 109.737 -173.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -97.7 84.81 3.44 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 121.808 0.813 . . . . 61.35 108.816 -178.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -79.54 69.23 5.78 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 114.45 -1.25 . . . . 73.11 109.475 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.9 m -134.53 107.68 10.99 Favored Pre-proline 0 N--CA 1.473 0.703 0 CA-C-O 118.386 -0.816 . . . . 54.41 109.475 -177.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.443 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 24.5 Cg_exo -36.81 -56.11 0.78 Allowed 'Trans proline' 0 C--N 1.388 2.62 0 C-N-CA 124.713 3.609 . . . . 72.23 114.597 -177.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.476 ' HG2' ' HE3' ' A' ' 46' ' ' LYS . 28.3 tt0 -54.39 -43.48 71.47 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.088 0.955 . . . . 64.43 111.348 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.99 -31.48 69.19 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.023 -0.99 . . . . 72.14 110.375 -178.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.444 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 51.5 mt-10 -78.9 -23.13 44.98 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.224 0.61 . . . . 62.01 109.674 -178.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 41' ' ' PRO . 23.6 mm-40 -71.5 -47.9 52.43 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.366 0.666 . . . . 62.44 109.527 172.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.476 ' HE3' ' HG2' ' A' ' 42' ' ' GLU . 97.0 mttt -60.32 -37.02 79.3 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 115.0 -1.0 . . . . 74.03 110.251 175.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.428 ' HB2' ' HB3' ' A' ' 33' ' ' TYR . 85.1 t80 -57.72 -53.88 53.21 Favored 'General case' 0 C--O 1.215 -0.713 0 C-N-CA 124.115 0.966 . . . . 73.24 109.307 173.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 44' ' ' GLU . 91.2 mttt -52.41 -45.86 66.09 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.468 0.707 . . . . 75.14 111.582 -179.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -62.47 -51.76 66.17 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 123.575 0.547 . . . . 71.44 111.885 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.44 HD13 ' HB3' ' A' ' 29' ' ' LEU . 86.5 mt -64.13 -31.4 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 124.216 1.006 . . . . 70.53 110.712 -178.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -95.67 -7.78 36.54 Favored 'General case' 0 C--O 1.215 -0.735 0 C-N-CA 123.679 0.792 . . . . 73.43 111.731 -176.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -72.35 -50.25 28.12 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 106.616 -1.624 . . . . 63.42 106.616 163.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.13 -49.8 68.38 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 112.756 -2.02 . . . . 65.45 111.477 175.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -67.31 -43.93 80.44 Favored 'General case' 0 C--O 1.212 -0.883 0 CA-C-N 115.357 -0.838 . . . . 72.32 110.795 177.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.451 ' HB2' ' CD2' ' A' ' 88' ' ' PHE . . . -56.54 -33.1 65.78 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 112.446 0.536 . . . . 53.01 112.446 -176.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 95.4 t -74.06 -53.92 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 CA-C-N 115.809 -0.632 . . . . 74.52 109.894 171.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.449 ' HB3' HD13 ' A' ' 22' ' ' ILE . 82.4 mt -83.99 7.12 19.46 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 113.912 1.079 . . . . 62.04 113.912 -169.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.0 t -87.83 -41.25 13.38 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.104 0.961 . . . . 74.34 110.517 178.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -104.27 107.57 57.83 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 108.593 -0.892 . . . . 74.34 108.593 -174.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -33.75 -32.86 0.06 OUTLIER 'Trans proline' 0 C--N 1.388 2.655 1 C-N-CA 125.613 4.208 . . . . 72.41 116.953 -179.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.458 ' HB2' ' HB2' ' A' ' 144' ' ' ARG . 16.3 tp10 -63.61 -65.01 0.74 Allowed 'General case' 0 N--CA 1.485 1.316 0 CA-C-O 121.197 0.522 . . . . 72.3 110.596 179.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -65.67 -31.99 73.3 Favored 'General case' 0 C--O 1.247 0.929 0 CA-C-N 114.805 -1.089 . . . . 74.54 110.955 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.496 HH11 ' HG2' ' A' ' 63' ' ' ARG . 26.4 ttt-85 -58.27 -54.59 45.27 Favored 'General case' 0 C--N 1.344 0.345 0 CA-C-N 115.316 -0.856 . . . . 74.11 109.917 176.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -71.07 -21.26 62.26 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.527 -0.76 . . . . 74.25 111.787 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.461 HG23 ' HG2' ' A' ' 76' ' ' PRO . 50.9 mt -58.88 -50.13 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 N-CA-C 109.327 -0.62 . . . . 64.42 109.327 168.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.422 ' OH ' ' HA ' ' A' ' 6' ' ' ASP . 34.1 t80 -59.68 -49.98 75.63 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 123.68 0.613 . . . . 75.4 110.534 175.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -57.72 -34.93 69.99 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.457 0.703 . . . . 64.04 112.062 -178.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 69.7 p -89.81 -16.31 30.44 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 119.203 -0.427 . . . . 75.13 111.457 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -74.4 131.34 41.01 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 109.268 -0.642 . . . . 63.45 109.268 178.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 98.34 14.66 37.78 Favored Glycine 0 CA--C 1.53 0.982 0 N-CA-C 110.884 -0.886 . . . . 52.54 110.884 -164.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 37.6 m -146.97 -53.25 0.22 Allowed 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 103.622 -2.733 . . . . 71.23 103.622 177.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.5 m -75.45 135.58 40.71 Favored 'General case' 0 C--O 1.253 1.258 0 N-CA-C 104.408 -2.442 . . . . 74.23 104.408 155.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.23 -34.19 5.99 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.775 0.83 . . . . 74.04 110.917 -173.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -84.71 150.65 56.77 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 123.662 0.785 . . . . 75.1 109.625 176.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.419 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 34.6 Cg_exo -60.28 133.12 47.62 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 122.393 2.062 . . . . 75.41 111.259 175.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.461 ' HG2' HG23 ' A' ' 65' ' ' ILE . 39.3 Cg_exo -60.43 153.86 57.48 Favored 'Trans proline' 0 C--N 1.375 1.934 0 C-N-CA 123.27 2.646 . . . . 74.25 113.174 -173.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.29 128.16 15.16 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.498 2.132 . . . . 62.44 111.415 175.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -62.92 116.02 3.3 Favored 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 123.043 2.495 . . . . 43.51 112.214 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -65.33 169.33 12.59 Favored 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 123.087 2.524 . . . . 71.05 111.979 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.83 86.23 0.03 OUTLIER 'Trans proline' 0 C--N 1.386 2.543 0 C-N-CA 123.394 2.729 . . . . 51.35 112.905 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.429 ' HA3' ' HA ' ' A' ' 141' ' ' ALA . . . 141.99 -37.44 1.58 Allowed Glycine 0 C--N 1.347 1.184 0 CA-C-N 115.021 -0.99 . . . . 62.41 111.411 178.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 114.14 -149.6 18.71 Favored Glycine 0 C--N 1.352 1.436 0 N-CA-C 112.274 -0.33 . . . . 53.03 112.274 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -110.98 73.62 0.83 Allowed 'General case' 0 C--O 1.242 0.66 0 C-N-CA 124.25 1.02 . . . . 74.41 108.283 175.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -57.38 125.11 21.34 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 115.511 -0.768 . . . . 71.31 110.914 177.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -121.92 24.28 9.67 Favored 'General case' 0 C--O 1.248 0.975 0 C-N-CA 123.737 0.815 . . . . 70.22 110.703 -175.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.412 ' OG ' ' HA2' ' A' ' 166' ' ' GLY . 74.0 m -50.61 124.9 11.75 Favored 'General case' 0 C--N 1.355 0.815 0 O-C-N 124.116 0.885 . . . . 74.44 111.814 176.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 129.0 -40.95 1.62 Allowed Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 109.012 -1.635 . . . . 70.11 109.012 -174.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.451 ' CD2' ' HB2' ' A' ' 55' ' ' ALA . 28.5 m-85 -137.18 143.31 42.32 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.78 0.432 . . . . 72.34 110.041 -170.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -75.37 89.37 2.62 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-O 121.515 0.674 . . . . 71.44 110.445 -177.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.557 HG21 ' ND2' ' A' ' 169' ' ' ASN . 2.8 p -38.01 -44.58 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 126.303 1.841 . . . . 75.21 114.068 172.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -70.28 -19.53 63.1 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.477 0.711 . . . . 75.33 111.789 -168.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -80.27 -24.8 39.83 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.102 0.561 . . . . 45.35 110.709 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -73.79 173.2 10.2 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 113.572 0.953 . . . . 71.01 113.572 -166.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.401 ' OG ' ' HG3' ' A' ' 5' ' ' LYS . 81.2 p -81.88 178.12 8.48 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 114.564 1.32 . . . . 74.5 114.564 -164.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -62.67 -52.52 62.99 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 113.181 -1.827 . . . . 74.31 112.307 -170.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.427 ' HB3' ' HG2' ' A' ' 5' ' ' LYS . 78.0 t80 -54.28 -41.97 69.47 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 123.501 0.72 . . . . 75.03 111.533 -178.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.511 ' CE2' HG23 ' A' ' 90' ' ' VAL . 36.9 t80 -64.9 -46.2 82.72 Favored 'General case' 0 CA--C 1.555 1.157 0 CA-C-N 114.763 -1.108 . . . . 63.23 110.513 176.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -67.05 -12.89 61.18 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.323 0.649 . . . . 73.05 112.371 178.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -89.82 -53.43 4.5 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.289 0.636 . . . . 70.02 111.36 173.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.2 tp -66.66 -52.78 41.02 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.059 0.944 . . . . 55.03 111.269 -171.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -96.21 -3.04 44.99 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.161 0.584 . . . . 72.11 111.174 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.419 ' N ' ' HD2' ' A' ' 103' ' ' PRO . . . -44.34 -55.83 5.72 Favored Glycine 0 C--N 1.354 1.551 0 CA-C-O 118.724 -1.042 . . . . 72.43 115.366 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.419 ' HD2' ' N ' ' A' ' 102' ' ' GLY . 9.5 Cg_endo -47.69 -28.11 8.93 Favored 'Trans proline' 0 C--N 1.388 2.655 0 C-N-CA 124.211 3.274 . . . . 23.1 114.941 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -134.69 35.08 2.25 Favored Glycine 0 C--N 1.346 1.134 0 CA-C-O 119.487 -0.618 . . . . 44.4 112.888 -176.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 17.6 mt -67.53 26.2 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 114.683 1.364 . . . . 74.25 114.683 176.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER 58.6 -107.39 0.35 Allowed 'General case' 0 CA--C 1.562 1.437 0 C-N-CA 124.46 1.104 . . . . 72.25 110.884 163.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.661 ' H ' ' HB2' ' A' ' 169' ' ' ASN . . . 74.92 8.64 82.92 Favored Glycine 0 C--N 1.354 1.539 0 C-N-CA 123.18 0.419 . . . . 44.0 112.709 -177.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.353 1.481 0 N-CA-C 111.854 -0.499 . . . . 71.34 111.854 -170.486 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 27.9 tptp . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 115.557 1.688 . . . . 72.15 115.557 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.453 ' HA2' ' HA3' ' A' ' 168' ' ' GLY . . . -84.4 167.88 43.57 Favored Glycine 0 C--N 1.343 0.935 0 N-CA-C 115.587 0.995 . . . . 55.22 115.587 -176.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.519 ' HB3' ' HB2' ' A' ' 167' ' ' GLN . 12.5 ttm180 -115.65 144.32 44.09 Favored 'General case' 0 C--O 1.26 1.628 0 C-N-CA 124.17 0.988 . . . . 71.34 111.31 -174.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.467 ' HA ' ' H ' ' A' ' 173' ' ' ASP . 9.3 p-10 -64.6 134.9 55.29 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 114.719 -1.128 . . . . 74.23 109.978 169.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.505 HD11 ' HB2' ' B' ' 11' ' ' LEU . 7.9 tp -144.12 143.67 31.23 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.08 -0.341 . . . . 70.23 110.08 -174.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 45.8 ttm180 -97.53 111.13 23.52 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.715 -0.846 . . . . 74.51 108.715 166.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -112.56 167.13 10.71 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 107.957 -1.127 . . . . 41.51 107.957 172.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.497 ' HG2' ' HB ' ' A' ' 177' ' ' VAL . 38.2 mt-10 -127.82 118.55 23.91 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 118.786 0.721 . . . . 61.0 109.648 -172.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.442 HD22 HD13 ' A' ' 176' ' ' LEU . 57.1 tp -100.13 104.62 30.5 Favored Pre-proline 0 N--CA 1.478 0.974 0 C-N-CA 123.985 0.914 . . . . 54.05 111.372 -164.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.653 ' HA ' ' HB2' ' A' ' 179' ' ' ARG . 24.6 Cg_exo -61.68 141.04 89.47 Favored 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 122.428 2.085 . . . . 75.33 110.511 176.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 13.4 tp -148.41 149.34 31.57 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.268 0.556 . . . . 64.01 111.975 177.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 97.8 m -85.5 140.26 30.82 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.708 1.203 . . . . 71.34 109.393 175.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.576 ' HB3' HD22 ' A' ' 215' ' ' LEU . 34.0 mt -54.79 -59.88 4.12 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 124.364 1.066 . . . . 70.54 113.359 -171.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -58.82 -39.1 80.18 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 114.961 -1.018 . . . . 75.32 110.644 -178.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -72.6 -21.83 61.06 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.06 0.944 . . . . 64.33 111.591 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.593 ' HB1' ' O ' ' A' ' 153' ' ' VAL . . . -74.87 -43.5 54.07 Favored 'General case' 0 C--O 1.247 0.947 0 C-N-CA 123.795 0.838 . . . . 41.43 110.915 178.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -72.05 -32.12 66.8 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 116.128 -0.487 . . . . 74.51 110.479 173.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 52.0 m170 -59.69 -48.13 82.88 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 123.4 0.438 . . . . 75.25 110.671 175.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.42 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 81.07 -136.08 15.65 Favored Glycine 0 CA--C 1.526 0.755 0 O-C-N 123.822 0.701 . . . . 71.54 111.583 -176.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 85.34 -172.04 46.6 Favored Glycine 0 C--N 1.344 0.983 0 O-C-N 123.632 0.254 . . . . 70.42 112.75 178.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.487 ' HB3' ' HB3' ' A' ' 146' ' ' SER . 1.8 mp0 -87.96 108.42 19.19 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 108.15 -1.056 . . . . 73.14 108.15 173.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 13.8 tpp180 -93.53 122.3 35.82 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 122.85 0.46 . . . . 74.4 110.003 -173.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 95.9 t -78.68 124.36 36.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 123.582 0.753 . . . . 71.24 109.782 -178.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.3 p -151.03 133.04 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 C-N-CA 123.82 0.848 . . . . 73.14 109.873 -174.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -84.93 135.25 34.13 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.196 0.998 . . . . 71.3 110.927 -176.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.66 HG23 ' HB2' ' B' ' 10' ' ' LEU . 2.6 p -166.4 111.56 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.201 0 C-N-CA 123.544 0.738 . . . . 75.1 111.168 -178.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.429 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . 60.25 37.71 20.33 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 113.796 1.035 . . . . 74.24 113.796 168.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 77.34 11.87 85.1 Favored Glycine 0 N--CA 1.475 1.298 0 CA-C-N 116.208 -0.451 . . . . 31.1 113.125 -178.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 26.6 ttm-85 -116.78 119.86 36.75 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.775 1.23 . . . . 72.12 108.197 174.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.458 ' HB2' ' HB2' ' A' ' 61' ' ' GLU . 14.1 tpp180 -93.34 89.62 6.44 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 106.707 -1.59 . . . . 74.41 106.707 170.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 11.6 p -89.53 140.16 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-O 121.368 0.604 . . . . 73.53 110.569 -170.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.487 ' HB3' ' HB3' ' A' ' 135' ' ' GLU . 25.2 m -106.01 90.14 3.28 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 107.768 -1.197 . . . . 31.45 107.768 174.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 3.3 p -77.35 112.56 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-O 121.335 0.588 . . . . 73.42 109.44 -174.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 5.8 tpm_? -67.06 92.12 0.24 Allowed 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 108.454 -0.943 . . . . 74.14 108.454 175.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.56 HG22 HD13 ' A' ' 159' ' ' ILE . 33.3 pt -93.44 131.74 31.88 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-N 115.203 -0.908 . . . . 74.13 109.089 -179.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -63.25 139.4 71.79 Favored 'Trans proline' 0 C--N 1.37 1.667 0 C-N-CA 122.414 2.076 . . . . 60.34 111.502 175.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -59.23 114.13 1.89 Allowed 'Trans proline' 0 C--N 1.383 2.393 0 C-N-CA 123.068 2.512 . . . . 74.15 111.855 -178.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 98.87 76.43 1.26 Allowed Glycine 0 C--N 1.345 1.066 0 N-CA-C 110.068 -1.213 . . . . 75.51 110.068 -175.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.593 ' O ' ' HB1' ' A' ' 130' ' ' ALA . 4.7 p -126.23 132.02 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 124.315 1.046 . . . . 75.43 108.453 172.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.65 ' HD2' HD12 ' A' ' 215' ' ' LEU . 0.0 OUTLIER -134.71 156.86 48.06 Favored 'General case' 0 N--CA 1.483 1.176 0 O-C-N 121.715 -0.616 . . . . 73.23 110.915 -169.92 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -51.66 117.09 2.45 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 125.222 1.409 . . . . 72.32 112.223 -172.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 114.55 -9.63 21.9 Favored Glycine 0 C--N 1.339 0.748 0 CA-C-N 115.596 -0.729 . . . . 14.21 112.708 -176.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 27.5 t -76.01 144.01 41.14 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.459 -0.941 . . . . 74.23 108.459 171.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 18.6 t -113.75 102.44 13.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 N-CA-C 108.357 -0.979 . . . . 72.34 108.357 174.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.632 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 50.9 mt -70.65 84.48 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.831 0 N-CA-C 107.45 -1.315 . . . . 75.24 107.45 172.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 70.9 ttt-85 -75.56 100.63 4.63 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.076 -1.083 . . . . 61.32 108.076 176.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.516 HG13 ' HB3' ' A' ' 174' ' ' LEU . 2.4 p -105.9 102.78 40.99 Favored Pre-proline 0 CA--C 1.546 0.825 0 N-CA-C 108.175 -1.046 . . . . 61.33 108.175 175.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -61.97 140.84 86.92 Favored 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 122.613 2.208 . . . . 74.53 110.582 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.409 ' HA2' ' HB2' ' A' ' 171' ' ' PRO . . . 83.33 26.11 44.96 Favored Glycine 0 CA--C 1.523 0.544 0 CA-C-O 118.984 -0.898 . . . . 70.43 114.557 178.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.435 ' C ' ' HB2' ' A' ' 174' ' ' LEU . 44.0 ttm -139.06 -6.06 1.44 Allowed 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 118.768 1.284 . . . . 64.15 113.423 -177.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.477 ' HA2' HD13 ' A' ' 174' ' ' LEU . . . -49.25 -59.58 6.9 Favored Glycine 0 N--CA 1.499 2.87 0 CA-C-O 122.406 1.003 . . . . 73.33 111.111 -177.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.509 ' H ' ' HA3' ' A' ' 172' ' ' GLY . . . 132.74 -86.66 0.28 Allowed Glycine 0 CA--C 1.48 -2.1 0 CA-C-N 112.227 -1.987 . . . . 74.5 109.554 158.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.519 ' HB2' ' HB3' ' A' ' 117' ' ' ARG . 19.0 mm-40 -23.36 105.32 0.02 OUTLIER 'General case' 0 C--N 1.364 1.207 0 O-C-N 129.193 3.525 . . . . 75.42 115.947 -160.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.453 ' HA3' ' HA2' ' A' ' 116' ' ' GLY . . . 137.86 -118.74 1.71 Allowed Glycine 0 N--CA 1.44 -1.071 0 N-CA-C 105.668 -2.973 . . . . 64.21 105.668 -164.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . 0.661 ' HB2' ' H ' ' A' ' 107' ' ' GLY . 57.7 t30 -165.37 -43.12 0.0 OUTLIER Pre-proline 0 N--CA 1.481 1.101 0 CA-C-N 117.769 0.784 . . . . 63.11 110.912 165.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -61.21 165.32 12.89 Favored 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 121.872 1.715 . . . . 71.13 109.647 160.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.409 ' HB2' ' HA2' ' A' ' 163' ' ' GLY . 18.6 Cg_endo -56.28 113.75 1.59 Allowed 'Trans proline' 0 CA--C 1.548 1.186 0 C-N-CA 122.811 2.34 . . . . 71.25 116.58 -168.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.509 ' HA3' ' H ' ' A' ' 166' ' ' GLY . . . -67.46 -142.06 0.07 OUTLIER Glycine 0 C--N 1.371 2.479 0 C-N-CA 118.593 -1.765 . . . . 72.4 113.534 153.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.467 ' H ' ' HA ' ' A' ' 118' ' ' ASP . 45.1 m-20 -152.27 108.53 3.41 Favored 'General case' 0 N--CA 1.51 2.569 0 CA-C-N 118.49 1.145 . . . . 71.14 108.916 176.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.516 ' HB3' HG13 ' A' ' 161' ' ' VAL . 7.8 tp -91.55 135.13 34.08 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 118.478 0.581 . . . . 64.32 112.019 -167.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 6.2 mt -115.99 93.94 4.46 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 106.029 -1.841 . . . . 72.12 106.029 177.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.632 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 82.2 mt -88.36 101.89 14.33 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.171 0.588 . . . . 70.05 111.519 -175.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.497 ' HB ' ' HG2' ' A' ' 122' ' ' GLU . 61.4 t -82.53 97.85 4.41 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 N-CA-C 107.378 -1.341 . . . . 61.43 107.378 174.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.507 HG11 HG22 ' A' ' 153' ' ' VAL . 10.5 p -64.84 124.01 18.84 Favored 'Isoleucine or valine' 0 C--O 1.251 1.158 0 CA-C-N 115.469 -0.787 . . . . 70.33 110.585 -174.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.653 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 8.4 mmt85 -87.94 148.17 24.71 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.03 -1.441 . . . . 53.32 108.526 167.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.488 HD11 ' HA ' ' A' ' 154' ' ' ARG . 29.2 mt -118.54 152.39 36.07 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.878 -0.786 . . . . 72.4 108.878 165.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 85.9 mt -53.09 153.87 5.97 Favored Pre-proline 0 CA--C 1.558 1.264 0 O-C-N 124.389 1.056 . . . . 73.14 111.111 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.28 11.66 0.1 Allowed 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 123.456 2.771 . . . . 71.42 115.372 -174.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . 0.57 ' HB3' HD11 ' A' ' 127' ' ' LEU . 4.0 t-80 -61.35 104.54 0.47 Allowed Pre-proline 0 CA--C 1.565 1.529 0 C-N-CA 125.166 1.386 . . . . 73.35 108.17 169.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -80.11 29.28 0.51 Allowed 'Trans proline' 0 C--N 1.368 1.571 0 C-N-CA 124.53 3.486 . . . . 61.24 117.229 -159.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.582 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 23.8 t -89.41 -51.39 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 120.379 1.445 . . . . 64.21 108.703 -172.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . 0.428 ' CZ ' ' HA ' ' A' ' 214' ' ' THR . 65.1 m-85 -114.2 129.38 56.63 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 112.267 0.469 . . . . 72.31 112.267 -169.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.571 HH22 ' HB2' ' A' ' 189' ' ' GLU . 28.4 ttp85 -127.86 123.91 36.22 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.048 -1.093 . . . . 75.51 108.048 164.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 9.1 tp -93.0 148.05 22.32 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 123.15 0.58 . . . . 74.21 110.475 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . 0.571 ' HB2' HH22 ' A' ' 187' ' ' ARG . 10.0 tp10 -123.5 90.58 3.31 Favored 'General case' 0 C--O 1.246 0.911 0 N-CA-C 107.583 -1.266 . . . . 70.31 107.583 163.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 64.83 -82.2 0.06 OUTLIER Glycine 0 C--N 1.353 1.506 0 CA-C-N 114.373 -1.285 . . . . 65.41 113.494 176.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 5.3 pm0 -93.18 -45.4 7.89 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.447 0.699 . . . . 72.32 111.362 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -111.09 144.85 39.56 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.38 -0.825 . . . . 72.32 113.009 -163.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.428 ' HB2' ' HA ' ' A' ' 249' ' ' LEU . 86.7 mt -91.46 157.41 17.07 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.491 1.116 . . . . 63.44 110.971 -177.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -131.1 105.22 7.56 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 107.777 -1.194 . . . . 73.14 107.777 170.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.582 ' HA ' ' O ' ' A' ' 185' ' ' VAL . . . -104.7 -175.77 2.89 Favored 'General case' 0 C--O 1.218 -0.567 0 C-N-CA 124.393 1.077 . . . . 74.34 110.67 178.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 34.7 m -125.18 128.66 48.71 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.672 -0.862 . . . . 70.21 108.672 173.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.423 HD22 HD13 ' A' ' 251' ' ' LEU . 48.3 tp -129.55 121.17 26.62 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 109.835 -0.432 . . . . 72.21 109.835 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -85.92 122.12 29.52 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 108.886 -0.783 . . . . 61.43 108.886 169.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 7.1 p -133.19 133.24 22.77 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 107.866 -1.161 . . . . 64.4 107.866 178.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.5 152.19 59.78 Favored 'Trans proline' 0 C--N 1.364 1.372 0 C-N-CA 121.378 1.385 . . . . 64.51 111.192 175.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.64 ' HB3' ' HH2' ' A' ' 269' ' ' TRP . . . -53.92 -44.5 98.29 Favored Pre-proline 0 CA--C 1.557 1.223 0 N-CA-C 114.782 1.401 . . . . 71.34 114.782 -175.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -64.2 -37.28 42.13 Favored 'Trans proline' 0 C--N 1.381 2.266 0 CA-C-N 121.677 1.635 . . . . 63.54 112.994 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 38.0 mt -73.59 -31.52 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.021 0.529 . . . . 64.32 110.21 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.15 -44.71 79.1 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.495 0.718 . . . . 71.51 110.999 177.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 69.5 t -68.32 -63.62 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 123.208 0.603 . . . . 63.23 110.273 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 96.4 t -72.56 -40.12 62.43 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 CA-C-N 115.466 -0.788 . . . . 74.41 111.899 -168.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 96.89 108.32 2.53 Favored Glycine 0 C--N 1.339 0.726 0 N-CA-C 111.1 -0.8 . . . . 72.35 111.1 -173.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -144.33 -157.44 7.2 Favored Glycine 0 C--N 1.342 0.871 0 CA-C-O 120.137 -0.257 . . . . 55.24 112.551 -177.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -117.18 130.41 56.58 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 117.17 0.485 . . . . 45.21 110.897 -176.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 29.8 m -132.94 -172.39 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 N-CA-C 107.591 -1.263 . . . . 63.11 107.591 167.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . 0.497 ' HD3' ' HB2' ' A' ' 218' ' ' PRO . 25.7 ttm180 -113.55 126.49 55.35 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 121.897 -0.502 . . . . 71.41 110.663 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -104.57 116.74 32.59 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.868 0.867 . . . . 62.04 109.009 175.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . 0.421 ' N ' ' SD ' ' A' ' 213' ' ' MET . 3.3 mpp? -82.75 104.72 13.21 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.836 -0.802 . . . . 71.23 108.836 178.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . 0.428 ' HA ' ' CZ ' ' A' ' 186' ' ' PHE . 82.1 p -116.49 174.09 6.26 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 123.314 0.646 . . . . 74.1 110.364 -178.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.65 HD12 ' HD2' ' A' ' 154' ' ' ARG . 14.6 mt -75.76 -17.64 59.82 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.131 0.573 . . . . 63.31 110.053 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.406 ' HG2' ' OG1' ' A' ' 214' ' ' THR . 1.5 pm0 -88.41 -5.21 58.41 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.772 1.229 . . . . 64.44 110.755 174.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 125.21 162.46 11.35 Favored Glycine 0 C--N 1.35 1.323 0 C-N-CA 123.579 0.609 . . . . 33.0 113.274 172.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . 0.497 ' HB2' ' HD3' ' A' ' 211' ' ' ARG . 60.5 Cg_endo -72.06 99.61 1.01 Allowed 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 122.463 2.109 . . . . 70.23 110.143 174.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 35.2 m -102.39 161.26 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.666 0.786 . . . . 73.4 111.466 -172.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -83.04 107.4 15.6 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 108.95 -0.759 . . . . 75.04 108.95 171.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 7.6 p -96.5 116.41 38.45 Favored 'Isoleucine or valine' 0 C--O 1.246 0.907 0 N-CA-C 109.161 -0.681 . . . . 74.13 109.161 178.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -81.97 97.32 8.04 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.646 -0.872 . . . . 60.25 108.646 175.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 97.5 t -58.22 121.82 54.44 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 124.454 1.101 . . . . 63.14 109.308 176.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.67 159.83 51.99 Favored 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 122.416 2.077 . . . . 75.51 111.453 176.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -65.04 156.35 63.19 Favored 'Trans proline' 0 C--N 1.365 1.417 0 C-N-CA 121.91 1.74 . . . . 72.53 111.711 171.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . 0.775 HH11 ' HA ' ' C' ' 260' ' ' ARG . 3.2 mmp_? 73.97 11.15 4.47 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.638 1.575 . . . . 74.04 111.89 176.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 13.2 m -59.69 120.78 10.14 Favored 'General case' 0 C--N 1.356 0.861 0 C-N-CA 124.002 0.921 . . . . 64.32 110.588 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . 0.523 ' HA ' HD11 ' A' ' 255' ' ' ILE . 48.0 tt0 -128.17 142.49 51.17 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.316 -0.402 . . . . 75.32 111.033 -166.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -60.95 133.85 56.51 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 124.1 0.875 . . . . 62.31 111.079 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 98.89 -38.67 3.01 Favored Glycine 0 C--N 1.34 0.792 0 O-C-N 123.553 0.533 . . . . 73.32 111.92 -177.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 28.5 mtm-85 -70.38 170.04 12.69 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-O 121.214 0.531 . . . . 74.0 111.053 173.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.667 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 2.9 mptp? -124.39 129.52 50.83 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.45 -0.795 . . . . 72.22 109.553 -176.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.452 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 54.7 mt -79.63 99.72 7.49 Favored 'General case' 0 C--N 1.346 0.455 0 N-CA-C 109.012 -0.736 . . . . 71.4 109.012 173.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 32.8 ttp180 -72.09 100.51 2.54 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.042 0.937 . . . . 64.14 110.014 178.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.495 HD11 HD11 ' A' ' 251' ' ' LEU . 5.0 mt -87.75 102.2 14.43 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 107.64 -1.245 . . . . 61.12 107.64 176.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -51.69 126.51 17.92 Favored 'General case' 0 CA--C 1.549 0.932 0 O-C-N 124.148 0.905 . . . . 64.43 113.219 -173.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 75.3 10.22 84.37 Favored Glycine 0 C--N 1.347 1.194 0 CA-C-N 115.051 -0.977 . . . . 74.2 115.47 168.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? -84.37 -11.17 56.78 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 117.615 0.707 . . . . 73.01 110.865 175.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -98.91 -164.94 30.17 Favored Glycine 0 C--N 1.348 1.215 0 N-CA-C 111.206 -0.758 . . . . 74.43 111.206 168.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . 0.403 ' N ' ' CD1' ' A' ' 240' ' ' PHE . 2.4 m-30 -96.06 131.6 28.58 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 123.895 0.878 . . . . 73.13 110.326 -168.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.13 153.91 62.35 Favored 'Trans proline' 0 CA--C 1.547 1.139 0 C-N-CA 122.742 2.295 . . . . 73.33 112.564 177.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -148.78 -178.14 23.6 Favored Glycine 0 C--N 1.347 1.149 0 CA-C-O 119.396 -0.669 . . . . 73.52 112.876 177.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -52.75 -53.36 6.96 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 123.63 2.886 . . . . 70.45 113.315 175.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -120.46 -28.26 5.01 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 122.963 0.505 . . . . 70.11 111.575 178.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -97.67 99.64 2.27 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 111.837 -0.505 . . . . 62.24 111.837 -176.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -86.03 121.83 29.2 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 108.959 -0.756 . . . . 75.41 108.959 173.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.63 130.1 10.03 Favored Glycine 0 C--O 1.246 0.852 0 N-CA-C 114.851 0.7 . . . . 42.24 114.851 -173.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -123.12 165.38 16.94 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.933 0.893 . . . . 75.44 108.961 176.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.464 HD23 HD12 ' A' ' 235' ' ' LEU . 38.0 tp -99.33 101.68 13.04 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 109.086 -0.709 . . . . 70.31 109.086 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.667 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 14.0 m-85 -87.04 103.58 15.51 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 109.155 -0.683 . . . . 52.51 109.155 -177.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.576 HD23 ' HB3' ' A' ' 195' ' ' ALA . 87.4 mt -83.22 108.63 16.59 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 108.777 -0.823 . . . . 72.24 108.777 177.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . 0.516 ' HG2' ' HG3' ' A' ' 232' ' ' LYS . 40.6 mt-10 -75.11 110.9 9.81 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 108.394 -0.965 . . . . 75.41 108.394 -175.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 59.5 t -67.16 125.57 24.91 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 CA-C-N 114.0 -1.454 . . . . 24.43 111.832 -170.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 3.3 mmm-85 -118.13 94.2 4.41 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 125.066 1.346 . . . . 73.14 107.626 170.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.523 HD11 ' HA ' ' A' ' 228' ' ' GLN . 57.5 mt -70.35 128.81 34.15 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 N-CA-C 109.02 -0.733 . . . . 74.34 109.02 174.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 51.9 p -122.59 146.66 47.23 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 124.434 1.094 . . . . 73.43 108.904 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.556 HD11 HE21 ' C' ' 228' ' ' GLN . 2.7 pp -109.75 147.37 36.0 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 123.32 0.648 . . . . 73.4 109.458 175.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -50.49 -18.8 4.08 Favored 'Trans proline' 0 N--CA 1.505 2.16 0 C-N-CA 124.658 3.572 . . . . 74.45 115.906 -168.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 58.51 -80.33 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.761 1.225 . . . . 63.24 110.644 -168.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 12.1 ptm85 -73.93 139.43 44.91 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 109.227 -0.657 . . . . 75.12 109.227 173.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.641 ' HB3' ' HB2' ' A' ' 266' ' ' GLU . 9.3 mt -145.04 138.13 26.51 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.228 0.611 . . . . 55.32 111.403 -169.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 27.0 p -83.04 153.41 66.7 Favored Pre-proline 0 CA--C 1.555 1.15 0 C-N-CA 124.647 1.179 . . . . 44.34 109.572 175.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -39.14 -65.3 0.17 Allowed 'Trans proline' 0 C--N 1.384 2.396 0 C-N-CA 124.878 3.719 . . . . 74.33 116.798 -171.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -68.79 -40.69 79.51 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.016 0.526 . . . . 71.44 111.816 -172.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -68.13 -37.73 81.41 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.063 0.545 . . . . 64.2 110.974 -178.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' GLU . . . . . 0.641 ' HB2' ' HB3' ' A' ' 261' ' ' LEU . 41.3 tt0 -64.2 -48.07 77.29 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 121.487 0.661 . . . . 73.45 109.306 176.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . 0.427 ' HB1' ' HE3' ' A' ' 271' ' ' LYS . . . -54.66 -41.94 70.73 Favored 'General case' 0 C--O 1.208 -1.123 0 CA-C-N 113.8 -1.545 . . . . 64.12 109.81 175.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 12.4 tp -64.81 -46.47 81.87 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.234 1.014 . . . . 73.14 110.885 -175.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' TRP . . . . . 0.64 ' HH2' ' HB3' ' A' ' 201' ' ' ALA . 73.5 m95 -55.59 -44.94 77.4 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 115.232 -0.894 . . . . 75.0 111.331 173.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . 0.615 ' HE3' ' HA ' ' C' ' 206' ' ' VAL . 53.6 mtpt -90.27 -9.31 48.42 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 115.359 -0.837 . . . . 62.43 112.267 -171.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . 0.427 ' HE3' ' HB1' ' A' ' 267' ' ' ALA . 90.1 mttt -76.05 -45.09 36.0 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.55 -1.278 . . . . 70.22 107.55 166.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' LEU . . . . . 0.622 HD21 ' HB2' ' C' ' 268' ' ' LEU . 46.1 mt -55.57 -47.23 76.73 Favored 'General case' 0 C--O 1.213 -0.831 0 CA-C-N 114.4 -1.273 . . . . 63.4 110.185 169.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . 0.532 ' HB3' ' HA ' ' A' ' 270' ' ' LYS . . . -63.75 -47.27 81.7 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 124.258 0.974 . . . . 64.51 112.758 -174.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -65.8 -44.2 86.38 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 123.226 0.329 . . . . 74.35 110.909 177.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -67.27 -27.52 67.26 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 122.885 0.474 . . . . 71.44 111.598 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . 0.514 ' HE2' ' HG3' ' C' ' 258' ' ' PRO . 24.0 t80 -75.1 -74.95 0.18 Allowed 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 107.974 -1.121 . . . . 75.02 107.974 177.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -49.69 -60.5 2.83 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.307 1.843 . . . . 70.12 112.315 -175.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -70.23 -8.24 48.49 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 112.926 0.713 . . . . 75.41 112.926 -172.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . 0.467 ' HA ' ' HE ' ' A' ' 279' ' ' ARG . 1.0 OUTLIER -121.64 1.65 10.04 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-O 118.906 -0.569 . . . . 74.13 111.391 -178.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.416 0 O-C-N 124.392 1.058 . . . . 72.21 111.185 -172.514 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mpp? . . . . . 0 N--CA 1.482 1.154 0 N-CA-C 109.302 -0.629 . . . . 71.44 109.302 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -67.33 116.88 8.59 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 108.999 -0.741 . . . . 54.1 108.999 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -86.15 68.9 10.42 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 122.344 1.068 . . . . 74.04 108.91 175.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 18.7 m -104.97 113.28 26.78 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-N 113.881 -1.509 . . . . 52.14 108.415 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.95 174.67 7.79 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 121.094 0.473 . . . . 70.11 110.524 -178.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 25.0 pt -138.93 160.13 29.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 123.357 0.663 . . . . 64.44 111.665 -163.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -136.17 143.43 44.44 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 107.09 -1.448 . . . . 72.01 107.09 166.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 35.4 tp -71.41 -89.01 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.579 0.752 . . . . 75.22 110.656 -170.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . 159.16 -61.36 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 126.188 1.795 . . . . 62.4 106.761 -175.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . 0.66 ' HB2' HG23 ' A' ' 140' ' ' VAL . 3.1 tt 53.49 115.65 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 113.561 -1.654 . . . . 74.1 110.024 -162.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.505 ' HB2' HD11 ' A' ' 119' ' ' LEU . 51.9 mt . . . . . 0 CA--C 1.546 0.819 0 N-CA-C 108.874 -0.787 . . . . 45.35 108.874 179.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.186 0 CA-C-O 121.671 0.748 . . . . 61.34 110.822 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 180' ' ' ALA . . . . . 0.401 ' HB1' HG23 ' C' ' 137' ' ' VAL . . . -174.38 -43.15 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.561 1.544 . . . . 74.4 107.385 -177.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 181' ' ' LEU . . . . . 0.738 HD23 ' HB ' ' C' ' 138' ' ' VAL . 41.8 tp -177.25 -63.87 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 126.48 1.912 . . . . 62.04 106.878 169.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 182' ' ' VAL . . . . . . . . . . . . . 15.0 p -107.2 149.18 10.83 Favored 'Isoleucine or valine' 0 C--O 1.244 0.787 0 CA-C-N 114.461 -1.245 . . . . 71.31 108.556 175.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -76.33 -62.72 1.52 Allowed 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 109.088 -0.708 . . . . 65.24 109.088 172.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 26.1 t-80 -171.42 -95.06 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.72 0 O-C-N 124.335 1.022 . . . . 74.15 108.437 173.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 185' ' ' VAL . . . . . 0.575 ' HA ' ' HB1' ' C' ' 121' ' ' ALA . 58.5 t . . . . . 0 N--CA 1.489 1.489 0 CA-C-N 118.844 0.747 . . . . 71.33 110.305 -179.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 30.7 m . . . . . 0 C--O 1.237 0.412 0 N-CA-C 108.16 -1.052 . . . . 71.31 108.16 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -168.05 -89.65 0.01 OUTLIER 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.059 0.944 . . . . 74.42 109.899 164.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . 159.11 -169.73 35.37 Favored Glycine 0 C--N 1.338 0.692 0 N-CA-C 111.404 -0.678 . . . . 71.23 111.404 -167.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 241' ' ' GLU . . . . . 0.473 ' HG3' ' HG3' ' C' ' 234' ' ' ARG . 9.7 pt-20 -93.04 -13.86 28.09 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 113.376 0.88 . . . . 71.21 113.376 -166.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 11.3 m95 55.9 -88.12 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 124.242 1.017 . . . . 70.32 111.706 -177.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 243' ' ' GLN . . . . . 0.509 ' HA ' ' NH2' ' C' ' 234' ' ' ARG . 9.9 pt20 173.67 -37.77 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 126.438 1.895 . . . . 74.22 108.059 -166.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -175.94 128.0 1.32 Allowed Glycine 0 C--N 1.348 1.247 0 N-CA-C 110.033 -1.227 . . . . 63.11 110.033 177.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 245' ' ' LYS . . . . . 0.649 ' HA ' ' HB3' ' C' ' 224' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.817 0 C-N-CA 123.582 0.753 . . . . 75.34 110.128 -172.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.542 0 N-CA-C 108.885 -0.783 . . . . 52.01 108.885 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -36.55 94.54 0.01 OUTLIER 'General case' 0 C--N 1.365 1.241 0 C-N-CA 125.232 1.413 . . . . 70.52 113.371 -175.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 5' ' ' LYS . . . . . 0.433 ' HB3' HD11 ' C' ' 10' ' ' ILE . 29.7 mmtp -65.76 95.84 0.26 Allowed 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.485 -1.234 . . . . 63.2 108.625 169.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 6' ' ' ASP . . . . . 0.478 ' HA ' ' OH ' ' C' ' 66' ' ' TYR . 16.2 t70 -73.14 97.25 2.35 Favored 'General case' 0 C--N 1.343 0.321 0 N-CA-C 106.975 -1.491 . . . . 63.22 106.975 169.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 7' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -63.6 -30.23 71.37 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 114.811 -1.086 . . . . 73.43 112.389 -169.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -61.56 -44.47 96.97 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.593 0.357 . . . . 72.53 110.16 172.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.47 -42.95 98.59 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.177 0.591 . . . . 52.31 110.934 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 10' ' ' ILE . . . . . 0.433 HD11 ' HB3' ' C' ' 5' ' ' LYS . 56.2 mt -59.98 -39.09 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 C-N-CA 123.407 0.683 . . . . 63.34 110.762 178.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 93.0 mt -76.98 -20.84 55.58 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 116.081 -0.509 . . . . 45.45 112.272 175.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.55 39.48 56.18 Favored Glycine 0 C--N 1.346 1.128 0 O-C-N 123.189 0.306 . . . . 64.33 112.549 -176.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 27.2 m -120.32 157.28 53.96 Favored Pre-proline 0 N--CA 1.479 0.976 0 C-N-CA 124.915 1.286 . . . . 64.04 109.097 176.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -51.16 145.76 25.19 Favored 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 122.849 2.366 . . . . 74.43 113.105 177.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 79.2 mtt180 -74.21 18.13 0.16 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 114.105 1.15 . . . . 71.52 114.105 -175.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -148.76 21.1 1.02 Allowed 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 124.985 1.314 . . . . 71.24 108.176 177.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.47 156.41 32.53 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.314 1.046 . . . . 71.14 112.883 -170.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 70.3 p -65.18 148.39 51.77 Favored 'General case' 0 C--N 1.348 0.534 0 CA-C-N 115.365 -0.834 . . . . 74.41 108.75 170.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 19' ' ' GLN . . . . . 0.447 ' OE1' ' HD2' ' C' ' 63' ' ' ARG . 1.2 mp0 -63.29 -20.01 65.09 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 122.954 0.502 . . . . 74.45 110.477 175.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -65.4 -44.7 86.64 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.261 -0.881 . . . . 64.05 111.408 168.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -63.71 -35.3 80.12 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.114 0.565 . . . . 73.42 110.657 176.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 22' ' ' ILE . . . . . 0.652 HG12 ' HB3' ' C' ' 57' ' ' LEU . 1.7 mp -59.72 -41.33 85.01 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 CA-C-N 115.664 -0.698 . . . . 61.32 109.833 170.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 23' ' ' LYS . . . . . 0.468 ' HA ' ' HB3' ' C' ' 26' ' ' TYR . 36.0 mtmm -77.94 -14.96 59.35 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.217 0.607 . . . . 74.13 112.631 175.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -75.18 -37.39 61.24 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 108.622 -0.881 . . . . 73.52 108.622 170.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -76.94 -25.21 52.6 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.246 -0.888 . . . . 75.32 110.936 175.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 26' ' ' TYR . . . . . 0.528 ' O ' ' HB3' ' C' ' 30' ' ' ALA . 87.5 t80 -66.73 -47.43 72.32 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 109.315 -0.624 . . . . 72.31 109.315 169.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' C' ' 23' ' ' LYS . 45.0 mtmt -59.04 -53.69 55.52 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 109.29 -0.633 . . . . 74.1 109.29 173.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 18.5 ttm180 -50.5 -69.34 0.12 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.9 1.28 . . . . 71.15 110.589 -175.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . 0.406 ' HB3' ' CD1' ' C' ' 50' ' ' ILE . 94.3 mt -82.17 -35.59 28.23 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 114.799 -1.092 . . . . 60.22 112.862 -169.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' C' ' 26' ' ' TYR . . . -87.21 -5.78 58.84 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 118.345 0.521 . . . . 75.32 112.222 -176.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . 0.506 ' HA ' ' HB2' ' C' ' 34' ' ' HIS . 99.4 mtt180 -96.68 -37.37 10.35 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 118.323 0.51 . . . . 73.5 109.902 163.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -62.02 -43.17 99.4 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.344 0.658 . . . . 71.12 111.148 177.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 33' ' ' TYR . . . . . 0.523 ' HD2' HD11 ' C' ' 50' ' ' ILE . 19.3 m-85 -109.42 26.05 11.09 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.36 1.064 . . . . 70.15 110.044 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 34' ' ' HIS . . . . . 0.506 ' HB2' ' HA ' ' C' ' 31' ' ' ARG . 37.8 t60 -63.68 112.76 7.9 Favored Pre-proline 0 N--CA 1.475 0.79 0 CA-C-O 118.505 -0.76 . . . . 72.34 109.189 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.41 -18.81 15.62 Favored 'Trans proline' 0 N--CA 1.501 1.966 0 C-N-CA 123.392 2.728 . . . . 71.32 114.834 -170.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 36' ' ' ASP . . . . . 0.417 ' HB3' ' HD2' ' C' ' 34' ' ' HIS . 13.0 t70 -80.04 -46.72 16.07 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.041 0.936 . . . . 60.34 110.804 176.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 71.0 t -84.15 -54.49 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 123.361 0.664 . . . . 75.33 109.818 -175.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -98.45 83.83 3.09 Favored 'General case' 0 C--O 1.244 0.787 0 N-CA-C 107.991 -1.115 . . . . 54.22 107.991 176.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -79.03 78.09 5.48 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.011 -0.995 . . . . 62.24 109.895 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 71.0 m -139.37 118.55 9.09 Favored Pre-proline 0 CA--C 1.542 0.673 0 C-N-CA 123.882 0.873 . . . . 74.14 108.743 174.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_exo -47.05 -38.74 24.82 Favored 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 123.606 2.871 . . . . 63.44 113.207 176.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -58.05 -44.23 87.3 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.839 0.856 . . . . 65.44 110.211 177.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.47 -21.29 61.96 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.23 -0.896 . . . . 62.05 110.603 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 44' ' ' GLU . . . . . 0.407 ' O ' ' HG2' ' C' ' 48' ' ' LYS . 0.4 OUTLIER -81.54 -33.2 31.9 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.14 0.976 . . . . 74.04 109.2 -178.776 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -68.21 -45.39 73.49 Favored 'General case' 0 C--O 1.261 1.695 0 C-N-CA 124.013 0.925 . . . . 42.53 109.475 174.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 46' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -61.05 -38.61 86.78 Favored 'General case' 0 C--N 1.348 0.518 0 CA-C-N 114.588 -1.187 . . . . 72.32 110.33 172.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 47' ' ' PHE . . . . . 0.676 ' HA ' HD12 ' C' ' 50' ' ' ILE . 65.3 t80 -57.77 -41.13 81.35 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.177 0.991 . . . . 62.23 110.299 176.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 48' ' ' LYS . . . . . 0.407 ' HG2' ' O ' ' C' ' 44' ' ' GLU . 72.3 mmtt -59.01 -49.94 75.97 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 122.383 0.273 . . . . 72.04 110.59 175.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -58.93 -39.43 81.55 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 124.23 0.956 . . . . 72.33 112.097 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 50' ' ' ILE . . . . . 0.676 HD12 ' HA ' ' C' ' 47' ' ' PHE . 55.2 mt -62.76 -47.89 90.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 124.254 1.022 . . . . 75.43 109.628 177.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 51' ' ' ASN . . . . . 0.561 ' HA ' ' HB3' ' C' ' 54' ' ' TYR . 64.2 m-80 -79.85 -5.91 56.36 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 115.522 -0.763 . . . . 74.04 112.176 -178.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 52' ' ' GLU . . . . . 0.444 ' HA ' ' CE2' ' C' ' 93' ' ' PHE . 32.0 tt0 -75.3 -56.23 4.92 Favored 'General case' 0 C--O 1.249 1.027 0 CA-C-O 122.166 0.984 . . . . 63.42 108.844 167.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.86 -37.31 73.7 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 113.485 -1.689 . . . . 63.1 111.442 174.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 54' ' ' TYR . . . . . 0.561 ' HB3' ' HA ' ' C' ' 51' ' ' ASN . 70.0 t80 -75.84 -34.32 60.07 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.263 -0.88 . . . . 75.01 110.5 178.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.57 -40.71 75.68 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.099 0.476 . . . . 60.54 110.508 175.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 44.4 t -79.95 -37.23 17.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 114.737 -1.12 . . . . 72.43 112.578 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 57' ' ' LEU . . . . . 0.652 ' HB3' HG12 ' C' ' 22' ' ' ILE . 94.6 mt -111.14 12.38 21.89 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 114.033 1.123 . . . . 75.02 114.033 -170.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 47.4 t -57.94 -58.97 6.05 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.239 0.616 . . . . 62.42 111.073 178.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -99.73 150.93 37.26 Favored Pre-proline 0 N--CA 1.47 0.558 0 CA-C-N 114.786 -1.097 . . . . 72.03 110.236 -178.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 60' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -54.31 -34.63 80.94 Favored 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 123.659 2.906 . . . . 33.23 112.513 171.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -66.19 -47.17 74.79 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.912 0.885 . . . . 62.13 110.645 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -66.05 -33.59 76.15 Favored 'General case' 0 C--O 1.249 1.042 0 CA-C-N 115.093 -0.958 . . . . 75.23 111.049 178.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 63' ' ' ARG . . . . . 0.447 ' HD2' ' OE1' ' C' ' 19' ' ' GLN . 13.6 ttt180 -60.94 -47.27 87.21 Favored 'General case' 0 C--O 1.218 -0.585 0 CA-C-N 115.718 -0.674 . . . . 64.42 109.901 173.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -61.83 -34.42 75.92 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 123.603 0.564 . . . . 74.15 111.285 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 72.6 mt -54.2 -57.55 5.73 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.95 0 N-CA-C 108.522 -0.918 . . . . 62.34 108.522 169.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 66' ' ' TYR . . . . . 0.478 ' OH ' ' HA ' ' C' ' 6' ' ' ASP . 10.0 t80 -52.37 -51.52 58.47 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.253 0.621 . . . . 74.22 112.025 176.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -55.22 -36.33 65.87 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.899 0.88 . . . . 73.14 111.257 -174.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 68' ' ' THR . . . . . 0.402 ' O ' ' HB ' ' C' ' 72' ' ' THR . 54.8 p -102.37 -14.29 16.96 Favored 'General case' 0 CA--C 1.556 1.189 0 N-CA-C 112.782 0.66 . . . . 63.2 112.782 -178.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -122.05 125.02 45.32 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.023 0.529 . . . . 75.22 109.663 -173.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 74.61 18.93 80.02 Favored Glycine 0 N--CA 1.473 1.155 0 CA-C-O 121.539 0.522 . . . . 62.51 111.937 -175.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 47.8 m -141.31 -50.33 0.42 Allowed 'General case' 0 C--O 1.239 0.505 0 N-CA-C 103.898 -2.63 . . . . 72.34 103.898 178.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . 0.402 ' HB ' ' O ' ' C' ' 68' ' ' THR . 19.2 m -106.62 163.61 12.76 Favored 'General case' 0 C--O 1.253 1.244 0 N-CA-C 105.192 -2.151 . . . . 73.35 105.192 156.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.09 13.06 27.84 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.511 1.124 . . . . 73.23 111.115 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.42 -152.25 0.0 OUTLIER Pre-proline 0 CA--C 1.607 3.15 0 CA-C-O 115.936 -1.983 . . . . 53.23 113.066 -175.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 75' ' ' PRO . . . . . 0.481 ' HA ' ' HD2' ' C' ' 76' ' ' PRO . 0.8 OUTLIER 0.75 118.32 0.0 OUTLIER 'Trans proline' 1 C--N 1.427 4.684 1 C-N-CA 125.92 4.413 . . . . 75.14 119.796 -158.671 . . . . . . . . 5 4 . 1 . 010 nuclear nobuild core ' C' C ' 76' ' ' PRO . . . . . 0.481 ' HD2' ' HA ' ' C' ' 75' ' ' PRO . 55.7 Cg_endo -63.39 178.22 1.3 Allowed 'Trans proline' 0 N--CA 1.51 2.472 0 C-N-CA 123.864 3.043 . . . . 63.14 112.745 176.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 77' ' ' PRO . . . . . 0.523 ' HA ' ' HD3' ' C' ' 78' ' ' PRO . 0.7 OUTLIER -26.41 116.96 0.03 OUTLIER 'Trans proline' 0 C--N 1.401 3.318 0 C-N-CA 124.929 3.753 . . . . 51.51 115.437 173.631 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 78' ' ' PRO . . . . . 0.523 ' HD3' ' HA ' ' C' ' 77' ' ' PRO . 25.3 Cg_exo -65.68 167.92 16.19 Favored 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 124.111 3.207 . . . . 74.44 114.17 -171.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -54.16 132.91 52.88 Favored 'Trans proline' 0 C--N 1.39 2.712 0 C-N-CA 123.104 2.536 . . . . 61.04 113.227 175.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -58.47 83.76 0.05 OUTLIER 'Trans proline' 0 C--N 1.39 2.726 0 C-N-CA 123.65 2.9 . . . . 51.5 111.879 176.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.41 -34.08 0.04 OUTLIER Glycine 0 C--O 1.225 -0.442 0 N-CA-C 109.329 -1.508 . . . . 75.2 109.329 -176.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.438 ' HA2' ' O ' ' C' ' 104' ' ' GLY . . . 95.09 165.15 35.29 Favored Glycine 0 C--N 1.35 1.339 0 N-CA-C 116.607 1.403 . . . . 74.45 116.607 166.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -69.58 135.84 50.51 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 124.258 1.023 . . . . 70.14 108.318 168.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 84' ' ' ASP . . . . . 0.402 ' HB2' ' HB2' ' C' ' 143' ' ' ARG . 35.6 t70 -66.94 129.22 39.18 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 118.273 0.488 . . . . 63.13 109.728 175.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 85' ' ' PHE . . . . . 0.524 ' HB3' ' HG3' ' C' ' 171' ' ' PRO . 23.5 t80 -116.68 34.77 4.89 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.688 0.795 . . . . 74.41 109.857 -165.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 52.8 m -5.74 78.99 0.0 OUTLIER 'General case' 0 CA--C 1.569 1.691 0 N-CA-C 116.836 2.161 . . . . 45.43 116.836 -170.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 53.06 31.71 41.04 Favored Glycine 0 CA--C 1.545 1.959 0 N-CA-C 116.399 1.32 . . . . 74.33 116.399 175.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 88' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -101.67 155.34 18.16 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 119.134 1.467 . . . . 74.44 113.643 -173.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -85.13 79.04 9.72 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.337 0.655 . . . . 72.23 111.128 -178.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 90' ' ' VAL . . . . . . . . . . . . . 2.0 p -42.17 -37.45 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 114.4 1.259 . . . . 54.41 114.4 177.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.11 -14.64 7.21 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 114.19 1.182 . . . . 74.21 114.19 -176.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -113.32 -3.49 13.81 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 112.757 0.651 . . . . 75.53 112.757 -175.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 93' ' ' PHE . . . . . 0.444 ' CE2' ' HA ' ' C' ' 52' ' ' GLU . 2.3 m-85 -77.13 153.33 34.33 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 122.741 0.417 . . . . 72.45 110.937 -176.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 97.0 p -82.94 -178.81 7.25 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.768 0.827 . . . . 45.51 113.013 -166.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.38 -61.81 2.33 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 114.552 -1.204 . . . . 55.43 112.911 -175.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 96' ' ' PHE . . . . . 0.413 ' HB3' ' HG2' ' C' ' 5' ' ' LYS . 84.4 t80 -58.07 -38.98 77.38 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 118.753 0.706 . . . . 65.02 110.743 -171.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 97' ' ' PHE . . . . . 0.446 ' CE2' ' HE2' ' C' ' 85' ' ' PHE . 83.4 t80 -60.31 -54.75 41.94 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 114.43 -1.259 . . . . 64.25 110.009 175.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -81.69 5.18 19.19 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 112.478 0.547 . . . . 51.52 112.478 -177.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -100.05 -39.11 8.28 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.836 0.855 . . . . 74.43 109.942 170.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 45.6 tp -78.5 -52.51 8.41 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.892 0.853 . . . . 73.23 109.502 -178.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 101' ' ' PHE . . . . . 0.446 ' HB3' HD13 ' C' ' 105' ' ' LEU . 96.5 m-85 -86.31 -20.72 27.96 Favored 'General case' 0 C--O 1.214 -0.77 0 CA-C-N 113.952 -1.477 . . . . 73.25 111.347 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -49.26 -50.81 27.96 Favored Glycine 0 CA--C 1.549 2.217 0 CA-C-O 118.558 -1.135 . . . . 54.11 115.754 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -49.34 -25.33 9.89 Favored 'Trans proline' 0 C--N 1.387 2.596 0 C-N-CA 124.139 3.226 . . . . 62.02 115.09 175.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 104' ' ' GLY . . . . . 0.438 ' O ' ' HA2' ' C' ' 82' ' ' GLY . . . -137.72 31.68 2.46 Favored Glycine 0 C--N 1.353 1.485 0 CA-C-O 119.401 -0.666 . . . . 43.23 112.188 174.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 105' ' ' LEU . . . . . 0.446 HD13 ' HB3' ' C' ' 101' ' ' PHE . 13.1 tp . . . . . 0 N--CA 1.476 0.843 0 CA-C-N 118.103 0.951 . . . . 73.03 109.128 179.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 116' ' ' GLY . . . . . 0.551 ' HA3' ' HA ' ' C' ' 171' ' ' PRO . . . . . . . . 0 CA--C 1.486 -1.734 0 N-CA-C 109.768 -1.333 . . . . 45.25 109.768 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -90.5 161.42 15.51 Favored 'General case' 0 C--O 1.264 1.835 0 N-CA-C 108.076 -1.083 . . . . 64.44 108.076 172.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -62.6 155.35 26.3 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 115.031 -0.986 . . . . 75.42 109.416 168.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 119' ' ' LEU . . . . . 0.478 HD13 ' HA ' ' C' ' 174' ' ' LEU . 0.0 OUTLIER -119.64 144.57 47.08 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 108.247 -1.02 . . . . 75.21 108.247 171.562 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.439 ' HA ' ' O ' ' C' ' 175' ' ' LEU . 19.6 ttt180 -138.9 106.77 5.66 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 109.612 -0.514 . . . . 72.31 109.612 -162.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 121' ' ' ALA . . . . . 0.575 ' HB1' ' HA ' ' B' ' 185' ' ' VAL . . . -134.83 127.67 31.24 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 115.492 -0.776 . . . . 63.21 109.835 -172.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 122' ' ' GLU . . . . . 0.474 ' HA ' ' O ' ' C' ' 177' ' ' VAL . 13.2 pt-20 -85.54 141.16 30.07 Favored 'General case' 0 C--O 1.244 0.77 0 N-CA-C 110.13 -0.322 . . . . 73.22 110.13 176.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -142.71 144.28 29.31 Favored Pre-proline 0 N--CA 1.481 1.102 0 CA-C-N 116.182 -0.463 . . . . 73.3 110.937 -170.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -75.44 121.69 6.56 Favored 'Trans proline' 0 C--N 1.368 1.603 0 C-N-CA 123.147 2.565 . . . . 72.51 111.278 173.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 125' ' ' LEU . . . . . 0.521 ' HB3' HG23 ' C' ' 178' ' ' VAL . 55.7 tp -137.37 147.11 45.25 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.279 0.631 . . . . 74.03 110.058 -177.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.73 155.21 18.44 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 123.449 0.7 . . . . 61.53 110.308 -178.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 127' ' ' LEU . . . . . 0.508 HD13 ' HD2' ' C' ' 186' ' ' PHE . 96.2 mt -66.3 -44.74 82.62 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.373 1.069 . . . . 62.25 111.234 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 18.4 mp0 -65.09 -33.33 75.77 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.729 1.212 . . . . 75.24 109.733 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 53.3 mm-40 -77.83 -25.38 48.75 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.712 0.805 . . . . 73.53 112.116 177.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -74.3 -32.75 62.99 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 109.142 -0.688 . . . . 64.34 109.142 173.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 131' ' ' PHE . . . . . 0.423 ' HB2' HD13 ' C' ' 215' ' ' LEU . 70.7 t80 -67.46 -44.89 77.51 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.407 1.083 . . . . 75.55 111.088 173.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 132' ' ' HIS . . . . . . . . . . . . . 54.2 m170 -70.72 -49.46 46.7 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 116.261 -0.427 . . . . 60.22 110.685 -176.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 68.39 -90.65 0.23 Allowed Glycine 0 C--N 1.345 1.069 0 N-CA-C 110.664 -0.974 . . . . 65.31 110.664 -170.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.28 161.83 5.7 Favored Glycine 0 C--N 1.353 1.509 0 O-C-N 123.876 0.398 . . . . 53.24 114.008 174.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -71.44 94.69 1.28 Allowed 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 109.105 -0.702 . . . . 71.2 109.105 174.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 136' ' ' ARG . . . . . 0.641 ' HB3' ' HB2' ' B' ' 181' ' ' LEU . 2.7 mpt_? -105.15 158.77 16.35 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.669 1.187 . . . . 72.12 109.051 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 137' ' ' VAL . . . . . 0.401 HG23 ' HB1' ' B' ' 180' ' ' ALA . 23.0 m -104.62 127.77 58.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 109.798 -0.445 . . . . 71.12 109.798 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 138' ' ' VAL . . . . . 0.738 ' HB ' HD23 ' B' ' 181' ' ' LEU . 6.1 p -113.12 114.61 47.44 Favored 'Isoleucine or valine' 0 C--O 1.248 0.986 0 C-N-CA 123.531 0.733 . . . . 72.14 110.052 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 139' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -120.68 93.15 3.94 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 124.829 1.252 . . . . 74.31 108.067 178.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 140' ' ' VAL . . . . . . . . . . . . . 12.7 p -147.61 149.04 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 108.877 -0.786 . . . . 63.22 108.877 -177.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 141' ' ' ALA . . . . . 0.425 ' HB1' ' NE2' ' C' ' 167' ' ' GLN . . . 65.2 19.47 11.74 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 124.75 1.22 . . . . 15.23 112.1 177.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 84.39 -4.03 84.92 Favored Glycine 0 C--N 1.344 0.991 0 CA-C-N 115.675 -0.693 . . . . 45.25 113.553 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 143' ' ' ARG . . . . . 0.526 ' NH2' ' HB3' ' C' ' 164' ' ' MET . 0.0 OUTLIER -111.41 124.37 52.12 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.41 0.684 . . . . 73.04 109.658 -176.722 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 12.9 ttt180 -114.3 121.61 44.18 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.656 1.182 . . . . 71.51 110.859 -171.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 145' ' ' VAL . . . . . 0.549 HG21 ' SD ' ' C' ' 164' ' ' MET . 21.9 m -143.25 177.1 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 C-N-CA 123.922 0.889 . . . . 75.03 110.581 172.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 23.0 t -119.36 129.79 55.01 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.761 0.825 . . . . 54.21 108.78 171.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 11.4 p -149.01 154.47 9.6 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 C-N-CA 123.489 0.716 . . . . 72.53 111.003 -178.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 22.0 ttm180 -96.06 116.19 28.58 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 108.082 -1.081 . . . . 74.22 108.082 164.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 149' ' ' ILE . . . . . 0.457 HD13 HD11 ' B' ' 181' ' ' LEU . 31.9 pt -73.22 147.41 87.86 Favored Pre-proline 0 CA--C 1.551 1.001 0 CA-C-O 118.597 -0.716 . . . . 71.41 109.302 172.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -43.07 115.07 0.51 Allowed 'Trans proline' 0 C--N 1.385 2.45 0 C-N-CA 123.698 2.932 . . . . 61.44 113.594 178.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -62.18 95.96 0.15 Allowed 'Trans proline' 0 C--N 1.386 2.533 0 C-N-CA 123.046 2.497 . . . . 73.2 111.636 178.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 152' ' ' GLY . . . . . . . . . . . . . . . 131.28 108.23 1.19 Allowed Glycine 0 C--N 1.343 0.943 0 CA-C-N 114.98 -1.009 . . . . 54.32 112.44 -174.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 153' ' ' VAL . . . . . 0.705 HG21 HG21 ' C' ' 178' ' ' VAL . 1.8 m -131.1 163.53 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 CA-C-N 117.121 0.46 . . . . 71.13 111.067 -179.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 154' ' ' ARG . . . . . 0.416 ' HE ' ' HA ' ' C' ' 189' ' ' GLU . 29.6 mtt85 -118.49 144.27 46.14 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.823 0.849 . . . . 75.32 109.443 -178.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 155' ' ' GLU . . . . . 0.497 ' HB2' HD12 ' C' ' 180' ' ' LEU . 4.6 tp10 -56.22 128.32 35.09 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.267 0.627 . . . . 74.51 111.974 173.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 68.29 14.66 66.79 Favored Glycine 0 C--N 1.344 1.024 0 O-C-N 123.882 0.739 . . . . 64.51 113.68 176.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 157' ' ' SER . . . . . . . . . . . . . 34.0 t -104.05 164.53 11.64 Favored 'General case' 0 C--N 1.349 0.566 0 C-N-CA 123.201 0.6 . . . . 75.43 109.534 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 8.8 p -112.48 108.01 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.136 0 CA-C-O 121.738 0.78 . . . . 64.44 111.007 -170.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 159' ' ' ILE . . . . . . . . . . . . . 14.6 mt -71.38 117.2 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.588 1.155 . . . . 52.25 108.91 172.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 48.1 ttt-85 -95.44 119.73 34.45 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 118.532 0.605 . . . . 72.21 109.676 171.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 161' ' ' VAL . . . . . 0.611 ' HB ' ' HB3' ' C' ' 174' ' ' LEU . 92.9 t -99.0 99.02 7.1 Favored Pre-proline 0 C--O 1.246 0.892 0 N-CA-C 107.9 -1.148 . . . . 75.24 107.9 171.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -80.83 153.19 19.58 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.638 2.225 . . . . 63.42 112.002 -178.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 89.92 28.7 17.52 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-O 119.42 -0.656 . . . . 53.31 113.647 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 164' ' ' MET . . . . . 0.549 ' SD ' HG21 ' C' ' 145' ' ' VAL . 20.7 mtm -130.67 -88.14 0.49 Allowed 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 117.888 0.844 . . . . 73.35 111.717 178.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 165' ' ' GLY . . . . . 0.421 ' HA3' ' HB3' ' C' ' 171' ' ' PRO . . . 131.91 147.93 6.02 Favored Glycine 0 N--CA 1.482 1.737 0 CA-C-N 118.686 0.676 . . . . 64.24 114.501 -172.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . -108.16 -105.95 3.04 Favored Glycine 0 C--N 1.371 2.494 0 N-CA-C 112.279 -0.328 . . . . 75.44 112.279 172.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 167' ' ' GLN . . . . . 0.425 ' NE2' ' HB1' ' C' ' 141' ' ' ALA . 22.7 mm-40 -105.38 107.0 17.76 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.515 0.726 . . . . 64.31 111.642 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . 129.9 159.54 9.81 Favored Glycine 0 C--N 1.357 1.702 0 CA-C-N 117.762 0.256 . . . . 13.44 113.108 171.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 169' ' ' ASN . . . . . 0.471 ' HB2' ' HD3' ' C' ' 170' ' ' PRO . 1.3 m-20 -61.72 -63.18 4.57 Favored Pre-proline 0 CA--C 1.572 1.795 0 C-N-CA 125.008 1.323 . . . . 62.44 114.01 -168.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 170' ' ' PRO . . . . . 0.471 ' HD3' ' HB2' ' C' ' 169' ' ' ASN . 73.2 Cg_endo -79.03 98.7 1.2 Allowed 'Trans proline' 0 C--N 1.406 3.569 0 CA-C-N 122.309 1.86 . . . . 51.41 110.335 173.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 171' ' ' PRO . . . . . 0.551 ' HA ' ' HA3' ' C' ' 116' ' ' GLY . 10.2 Cg_exo -69.74 142.47 48.13 Favored 'Trans proline' 0 C--N 1.369 1.658 0 C-N-CA 123.704 2.936 . . . . 74.02 116.557 -159.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 172' ' ' GLY . . . . . 0.4 ' O ' ' HA2' ' C' ' 165' ' ' GLY . . . -109.01 141.51 15.95 Favored Glycine 0 C--O 1.213 -1.208 0 N-CA-C 106.549 -2.62 . . . . 74.42 106.549 163.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 173' ' ' ASP . . . . . 0.444 ' HB3' ' O ' ' C' ' 161' ' ' VAL . 64.8 m-20 -81.12 -161.51 0.41 Allowed 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 115.349 1.611 . . . . 74.51 115.349 -159.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 174' ' ' LEU . . . . . 0.611 ' HB3' ' HB ' ' C' ' 161' ' ' VAL . 40.7 tp -94.34 141.95 27.98 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 121.504 -0.747 . . . . 75.22 110.896 -176.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 175' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' C' ' 120' ' ' ARG . 76.2 mt -130.06 84.78 2.23 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.416 1.486 . . . . 71.32 109.435 176.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 176' ' ' LEU . . . . . . . . . . . . . 69.5 mt -80.2 107.45 13.0 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.424 0.69 . . . . 43.02 109.644 175.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 177' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' C' ' 122' ' ' GLU . 58.2 t -83.06 95.48 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 107.553 -1.277 . . . . 74.43 107.553 175.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 178' ' ' VAL . . . . . 0.705 HG21 HG21 ' C' ' 153' ' ' VAL . 3.0 p -71.25 122.65 23.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.875 0.845 . . . . 74.01 111.334 -174.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 179' ' ' ARG . . . . . . . . . . . . . 17.1 mmm-85 -105.62 111.74 24.55 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 107.277 -1.379 . . . . 72.33 107.277 169.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 180' ' ' LEU . . . . . 0.502 HD13 HD21 ' C' ' 127' ' ' LEU . 97.3 mt -72.12 136.85 46.67 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.35 0.595 . . . . 70.51 111.101 -177.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 181' ' ' LEU . . . . . . . . . . . . . 60.3 mt -62.98 167.14 6.51 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 126.016 1.726 . . . . 74.2 113.857 -173.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -52.04 71.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.396 3.068 0 C-N-CA 124.208 3.272 . . . . 64.12 113.165 167.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 183' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -178.15 49.0 0.05 OUTLIER Pre-proline 0 CA--C 1.549 0.933 0 N-CA-C 105.153 -2.165 . . . . 62.13 105.153 -171.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 184' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -90.2 65.29 1.88 Allowed 'Trans proline' 0 C--N 1.387 2.586 0 C-N-CA 123.229 2.619 . . . . 71.54 111.655 -163.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 185' ' ' VAL . . . . . 0.566 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 21.2 t -95.73 -59.68 3.02 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.443 0 N-CA-C 108.223 -1.029 . . . . 72.23 108.223 -174.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 186' ' ' PHE . . . . . 0.508 ' HD2' HD13 ' C' ' 127' ' ' LEU . 53.8 m-85 -100.11 125.32 46.2 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.725 0.81 . . . . 61.44 110.787 -168.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 187' ' ' ARG . . . . . 0.414 ' HG2' ' HB3' ' C' ' 155' ' ' GLU . 0.0 OUTLIER -126.23 109.35 12.21 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 107.256 -1.387 . . . . 75.14 107.256 178.906 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 188' ' ' LEU . . . . . 0.468 HD13 ' HD2' ' C' ' 240' ' ' PHE . 52.3 tp -77.48 154.13 32.83 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.617 0.969 . . . . 74.14 113.617 -169.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 189' ' ' GLU . . . . . 0.416 ' HA ' ' HE ' ' C' ' 154' ' ' ARG . 7.9 tp10 -142.25 103.47 4.29 Favored 'General case' 0 C--O 1.248 1.01 0 N-CA-C 107.06 -1.459 . . . . 71.33 107.06 158.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 75.13 -88.39 0.79 Allowed Glycine 0 C--N 1.349 1.253 0 CA-C-N 115.471 -0.786 . . . . 74.2 112.526 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 191' ' ' GLN . . . . . 0.517 ' HB3' ' HA3' ' C' ' 247' ' ' GLY . 48.3 mt-30 -123.83 -23.05 4.75 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.659 1.184 . . . . 60.21 110.303 176.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -93.23 127.26 38.74 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 123.756 0.822 . . . . 65.13 110.79 -171.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 193' ' ' LEU . . . . . . . . . . . . . 84.3 mt -86.64 165.72 15.92 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.849 0.86 . . . . 52.2 111.316 -177.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 194' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -126.96 103.69 7.61 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.56 -1.274 . . . . 75.43 107.56 165.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 195' ' ' ALA . . . . . 0.566 ' HA ' ' O ' ' C' ' 185' ' ' VAL . . . -98.41 -177.08 3.58 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 124.024 0.93 . . . . 65.11 109.843 172.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 88.6 m -132.41 106.67 8.02 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 107.9 -1.148 . . . . 51.32 107.9 168.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 197' ' ' LEU . . . . . . . . . . . . . 43.3 tp -78.12 122.22 25.34 Favored 'General case' 0 C--N 1.35 0.596 0 N-CA-C 109.327 -0.62 . . . . 73.5 109.327 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -96.18 100.44 12.08 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 108.396 -0.965 . . . . 44.52 108.396 -177.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 199' ' ' VAL . . . . . . . . . . . . . 25.6 t -108.25 124.58 34.18 Favored Pre-proline 0 N--CA 1.481 1.11 0 C-N-CA 123.285 0.634 . . . . 61.21 109.649 -176.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 200' ' ' PRO . . . . . 0.556 ' HG2' HD12 ' C' ' 203' ' ' ILE . 4.5 Cg_exo -63.31 145.92 93.26 Favored 'Trans proline' 0 C--N 1.37 1.673 0 C-N-CA 121.961 1.774 . . . . 71.34 110.834 170.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 201' ' ' ALA . . . . . . . . . . . . . . . -53.37 -47.4 96.33 Favored Pre-proline 0 CA--C 1.558 1.262 0 N-CA-C 113.834 1.05 . . . . 74.35 113.834 -179.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 202' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -63.77 -41.88 22.44 Favored 'Trans proline' 0 C--N 1.384 2.444 0 C-N-CA 121.509 1.473 . . . . 63.15 112.523 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 203' ' ' ILE . . . . . 0.556 HD12 ' HG2' ' C' ' 200' ' ' PRO . 39.5 mt -65.73 -36.04 76.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.009 0.524 . . . . 63.4 110.324 179.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 204' ' ' ALA . . . . . 0.454 ' HA ' HG11 ' C' ' 223' ' ' VAL . . . -62.05 -43.01 99.75 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.33 0.652 . . . . 75.02 110.897 176.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 205' ' ' VAL . . . . . . . . . . . . . 70.0 t -67.97 -45.35 83.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.659 0.784 . . . . 63.41 112.529 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 206' ' ' VAL . . . . . 0.615 ' HA ' ' HE3' ' A' ' 270' ' ' LYS . 14.8 p -78.9 -31.15 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 CA-C-O 121.021 0.438 . . . . 52.12 110.98 -176.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 82.12 52.06 4.2 Favored Glycine 0 C--N 1.336 0.546 0 CA-C-N 115.345 -0.843 . . . . 63.21 111.701 -172.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -84.22 -135.83 3.08 Favored Glycine 0 C--N 1.346 1.099 0 N-CA-C 111.868 -0.493 . . . . 51.32 111.868 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 209' ' ' LYS . . . . . 0.519 ' HG2' ' HA ' ' C' ' 222' ' ' ALA . 9.7 mtmp? -137.01 139.84 41.69 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 117.509 0.654 . . . . 72.12 111.397 175.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 210' ' ' VAL . . . . . 0.486 HG13 HG21 ' C' ' 203' ' ' ILE . 22.3 m -128.33 135.59 62.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.399 1.08 . . . . 62.05 109.216 175.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 211' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -84.62 112.51 20.51 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 120.852 0.358 . . . . 72.44 110.833 -176.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -81.69 114.58 20.46 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.07 0.948 . . . . 74.43 108.607 170.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 213' ' ' MET . . . . . . . . . . . . . 4.1 tmm? -74.87 116.08 15.19 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 107.311 -1.366 . . . . 63.12 107.311 178.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 214' ' ' THR . . . . . 0.443 ' OG1' HG12 ' C' ' 219' ' ' VAL . 0.2 OUTLIER -116.96 174.4 6.11 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.286 0.565 . . . . 54.24 110.478 -174.167 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 215' ' ' LEU . . . . . 0.423 HD13 ' HB2' ' C' ' 131' ' ' PHE . 27.1 mt -64.47 -29.89 70.93 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.107 1.363 . . . . 44.41 112.067 -177.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -91.65 1.4 57.18 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 114.78 -1.1 . . . . 71.0 110.826 -177.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 110.77 -170.06 13.72 Favored Glycine 0 C--N 1.341 0.843 0 N-CA-C 110.693 -0.963 . . . . 64.11 110.693 -169.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -80.5 119.12 3.67 Favored 'Trans proline' 0 CA--C 1.554 1.524 0 C-N-CA 122.566 2.178 . . . . 52.13 113.506 -173.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 219' ' ' VAL . . . . . 0.443 HG12 ' OG1' ' C' ' 214' ' ' THR . 14.8 p -97.82 148.05 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 N-CA-C 107.728 -1.212 . . . . 52.53 107.728 165.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 220' ' ' GLU . . . . . 0.484 ' HG2' ' HB3' ' C' ' 209' ' ' LYS . 13.3 tt0 -96.93 155.94 16.56 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 108.574 -0.899 . . . . 72.32 108.574 175.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 221' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' C' ' 209' ' ' LYS . 41.9 t -122.5 116.88 50.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 124.094 0.958 . . . . 74.03 110.154 -178.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 222' ' ' ALA . . . . . 0.519 ' HA ' ' HG2' ' C' ' 209' ' ' LYS . . . -78.74 102.64 8.2 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 108.965 -0.754 . . . . 73.3 108.965 171.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 223' ' ' VAL . . . . . 0.454 HG11 ' HA ' ' C' ' 204' ' ' ALA . 58.2 t -76.43 142.81 71.57 Favored Pre-proline 0 CA--C 1.566 1.574 0 C-N-CA 124.643 1.177 . . . . 73.11 110.372 -177.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 224' ' ' PRO . . . . . 0.649 ' HB3' ' HA ' ' B' ' 245' ' ' LYS . 71.7 Cg_endo -78.69 154.49 26.93 Favored 'Trans proline' 0 C--N 1.38 2.186 0 C-N-CA 122.957 2.438 . . . . 54.33 113.073 168.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -58.89 119.59 6.94 Favored 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 123.496 2.797 . . . . 74.0 112.674 175.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 226' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.0 82.92 0.13 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.275 1.43 . . . . 70.15 110.795 -175.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 227' ' ' THR . . . . . 0.414 HG22 HG11 ' C' ' 253' ' ' VAL . 97.8 m -93.31 133.08 36.92 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 114.295 -1.32 . . . . 70.3 109.482 174.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 228' ' ' GLN . . . . . 0.556 HE21 HD11 ' A' ' 257' ' ' ILE . 1.6 mp0 -100.09 147.75 25.32 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 121.24 0.543 . . . . 74.32 110.65 176.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 229' ' ' ALA . . . . . 0.41 ' HB2' ' H ' ' C' ' 255' ' ' ILE . . . -67.83 140.44 56.59 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 114.967 -1.015 . . . . 62.12 109.521 173.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 105.83 -18.37 40.45 Favored Glycine 0 C--N 1.333 0.37 0 N-CA-C 111.471 -0.652 . . . . 62.04 111.471 -171.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 231' ' ' ARG . . . . . . . . . . . . . 36.1 mtt85 -62.69 168.35 3.84 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 117.105 0.452 . . . . 74.12 111.697 169.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 232' ' ' LYS . . . . . 0.644 ' HD3' ' HB3' ' C' ' 250' ' ' TYR . 3.9 ttmp? -150.18 131.76 14.86 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.33 0.586 . . . . 71.45 111.117 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 233' ' ' LEU . . . . . 0.595 HD13 ' HB2' ' C' ' 251' ' ' LEU . 4.7 mp -88.03 158.44 18.61 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.65 1.18 . . . . 74.21 110.214 178.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 234' ' ' ARG . . . . . 0.509 ' NH2' ' HA ' ' B' ' 243' ' ' GLN . 3.1 ptt85 -128.17 87.89 2.67 Favored 'General case' 0 CA--C 1.55 0.96 0 O-C-N 125.171 1.544 . . . . 72.34 108.19 164.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 54.4 mt -77.29 120.46 22.36 Favored 'General case' 0 C--N 1.361 1.071 0 CA-C-N 115.468 -0.787 . . . . 73.43 109.008 174.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -80.94 127.28 32.39 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.686 0.795 . . . . 71.55 111.48 -172.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 72.95 36.17 57.49 Favored Glycine 0 C--N 1.347 1.154 0 O-C-N 123.853 0.721 . . . . 71.42 113.028 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 24.0 mmtm -129.01 21.52 5.8 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.561 0.745 . . . . 72.03 110.987 176.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -92.78 -164.08 37.74 Favored Glycine 0 C--N 1.353 1.505 0 O-C-N 123.559 0.537 . . . . 31.21 112.975 175.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 240' ' ' PHE . . . . . 0.468 ' HD2' HD13 ' C' ' 188' ' ' LEU . 2.5 m-85 -80.89 157.58 71.43 Favored Pre-proline 0 CA--C 1.557 1.244 0 CA-C-O 119.352 -0.356 . . . . 75.14 110.065 177.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 241' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -59.26 114.52 2.06 Favored 'Trans proline' 0 C--N 1.387 2.565 0 C-N-CA 123.415 2.744 . . . . 70.21 112.786 -177.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 242' ' ' GLY . . . . . 0.458 ' HA3' ' NE2' ' C' ' 191' ' ' GLN . . . -99.53 168.3 21.65 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-N 115.217 -0.901 . . . . 70.14 112.812 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -67.46 -23.0 44.32 Favored 'Trans proline' 0 C--N 1.374 1.89 0 C-N-CA 123.116 2.544 . . . . 71.42 112.302 176.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -95.33 -4.18 45.93 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.837 0.855 . . . . 71.42 111.3 177.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 141.55 -85.55 0.2 Allowed Glycine 0 C--N 1.349 1.274 0 N-CA-C 111.311 -0.716 . . . . 51.32 111.311 -178.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 246' ' ' ARG . . . . . . . . . . . . . 85.6 mtm180 -138.61 175.26 9.71 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.657 1.183 . . . . 61.31 110.119 178.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 247' ' ' GLY . . . . . 0.517 ' HA3' ' HB3' ' C' ' 191' ' ' GLN . . . -104.08 -158.46 24.25 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 115.201 -0.909 . . . . 63.23 111.926 165.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -118.79 174.66 6.15 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.295 0.638 . . . . 73.54 109.492 -178.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 249' ' ' LEU . . . . . 0.463 ' HG ' HD11 ' C' ' 251' ' ' LEU . 20.6 tp -126.93 118.03 23.71 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.576 0.751 . . . . 74.23 110.841 -173.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 250' ' ' TYR . . . . . 0.644 ' HB3' ' HD3' ' C' ' 232' ' ' LYS . 22.3 m-30 -100.89 106.47 17.83 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.47 0.708 . . . . 71.43 110.715 178.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 251' ' ' LEU . . . . . 0.595 ' HB2' HD13 ' C' ' 233' ' ' LEU . 2.9 mp -105.3 124.32 49.34 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-N 118.836 0.744 . . . . 64.53 111.2 -174.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -76.7 120.2 21.55 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 109.068 -0.716 . . . . 73.41 109.068 174.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 253' ' ' VAL . . . . . 0.414 HG11 HG22 ' C' ' 227' ' ' THR . 72.1 t -77.16 128.16 38.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 C-N-CA 123.235 0.614 . . . . 73.5 111.289 -176.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 254' ' ' ARG . . . . . . . . . . . . . 28.2 mtm180 -107.04 137.22 45.52 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.391 -0.966 . . . . 74.13 108.391 164.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 255' ' ' ILE . . . . . 0.485 ' O ' ' HB ' ' A' ' 255' ' ' ILE . 30.2 mm -98.64 109.61 24.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 105.843 -1.91 . . . . 75.24 105.843 165.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 256' ' ' THR . . . . . . . . . . . . . 7.5 t -131.15 176.87 7.9 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 124.09 0.956 . . . . 53.32 109.793 -170.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 49.6 pt -126.81 155.65 75.01 Favored Pre-proline 0 CA--C 1.557 1.226 0 C-N-CA 123.356 0.662 . . . . 64.54 110.254 -177.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 258' ' ' PRO . . . . . 0.514 ' HG3' ' HE2' ' A' ' 276' ' ' TYR . 49.6 Cg_endo -80.86 41.4 1.14 Allowed 'Trans proline' 0 C--N 1.377 2.051 0 C-N-CA 123.625 2.883 . . . . 73.21 113.945 -175.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 259' ' ' GLU . . . . . 0.404 ' O ' ' HD3' ' A' ' 226' ' ' ARG . 60.8 mm-40 60.51 -93.63 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.882 1.273 . . . . 72.3 110.015 -171.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 260' ' ' ARG . . . . . 0.775 ' HA ' HH11 ' A' ' 226' ' ' ARG . 0.0 OUTLIER -115.03 164.1 14.66 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.514 1.126 . . . . 73.41 110.197 -178.16 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 261' ' ' LEU . . . . . . . . . . . . . 45.6 mt -126.96 173.15 9.85 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.023 0.929 . . . . 71.21 111.398 -171.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 73.4 p -84.27 148.6 53.32 Favored Pre-proline 0 CA--C 1.552 1.051 0 CA-C-N 114.942 -1.026 . . . . 61.23 108.801 168.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -43.34 -36.78 6.75 Favored 'Trans proline' 0 C--N 1.382 2.324 0 C-N-CA 124.478 3.452 . . . . 74.2 115.114 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -64.23 -60.94 2.6 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.251 0.62 . . . . 71.04 110.905 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -53.32 -51.1 63.44 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.448 -0.796 . . . . 65.11 109.874 178.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 266' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -55.99 -36.17 67.6 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 114.547 -1.206 . . . . 64.21 111.706 -178.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -63.76 -48.89 75.13 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.2 0.6 . . . . 70.32 111.259 176.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 268' ' ' LEU . . . . . 0.622 ' HB2' HD21 ' A' ' 272' ' ' LEU . 8.0 mp -63.94 -38.17 90.09 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 123.033 0.208 . . . . 52.44 111.379 178.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 77.1 m95 -64.78 -33.36 75.79 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.054 0.542 . . . . 61.11 111.017 175.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -70.87 -31.78 68.56 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.109 0.564 . . . . 75.43 111.74 175.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -69.76 -38.79 76.88 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 120.567 0.223 . . . . 75.33 110.903 175.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 92.9 mt -60.63 -44.91 95.81 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 115.723 -0.671 . . . . 74.33 109.581 170.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -62.12 -41.69 98.48 Favored 'General case' 0 C--O 1.216 -0.709 0 CA-C-N 115.42 -0.809 . . . . 34.13 111.401 -178.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -69.54 -33.71 73.19 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.386 0.675 . . . . 63.21 111.021 178.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -60.55 -33.77 73.16 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 121.243 0.544 . . . . 70.04 110.398 171.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 276' ' ' TYR . . . . . 0.706 ' HA ' ' HD3' ' C' ' 279' ' ' ARG . 16.4 m-85 -80.91 -31.39 35.13 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.251 -0.886 . . . . 75.52 112.839 174.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 18.6 m-30 -73.17 -22.2 60.53 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 118.391 0.541 . . . . 44.24 109.886 178.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -64.94 -23.43 67.22 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.474 0.71 . . . . 55.2 111.109 171.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 279' ' ' ARG . . . . . 0.706 ' HD3' ' HA ' ' C' ' 276' ' ' TYR . 17.2 mtp-105 -78.63 -21.37 48.51 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.498 0.719 . . . . 71.52 110.515 174.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.137 0 C-N-CA 123.507 0.723 . . . . 75.14 109.231 -178.857 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.8 ttpp . . . . . 0 N--CA 1.486 1.328 0 N-CA-C 114.103 1.149 . . . . 62.43 114.103 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -77.57 131.18 37.71 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.205 1.002 . . . . 74.32 110.427 177.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -83.76 86.84 7.08 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 107.022 -1.474 . . . . 61.41 107.022 166.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.453 ' CD1' ' HA ' ' A' ' 53' ' ' ALA . 66.6 m-85 -61.2 -31.11 70.87 Favored 'General case' 0 C--O 1.249 1.063 0 CA-C-N 115.094 -0.957 . . . . 73.34 112.144 -174.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -57.37 -55.38 35.51 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.241 0.617 . . . . 73.33 109.494 172.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.73 -33.66 74.43 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.816 0.847 . . . . 60.32 111.764 -177.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 78.1 mt -62.89 -40.14 87.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.287 0.635 . . . . 74.23 110.477 175.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 93.3 mt -80.03 -2.81 45.82 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 112.49 0.552 . . . . 51.33 112.49 173.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.26 18.03 72.63 Favored Glycine 0 C--N 1.351 1.394 0 O-C-N 123.3 0.375 . . . . 53.33 113.67 177.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.607 HG21 HG12 ' A' ' 22' ' ' ILE . 22.8 m -111.55 142.06 25.79 Favored Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 123.209 0.604 . . . . 71.43 110.185 177.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -82.94 169.78 12.89 Favored 'Trans proline' 0 C--N 1.366 1.453 0 C-N-CA 122.255 1.97 . . . . 50.12 112.048 174.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.6 mmt85 -67.92 80.43 0.21 Allowed 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 114.969 -1.014 . . . . 75.43 110.422 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -174.96 -32.75 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.166 1.387 . . . . 64.11 108.399 -177.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.28 122.07 17.08 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.831 -0.622 . . . . 64.31 110.56 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 72.8 p -76.58 175.13 9.57 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.14 0.976 . . . . 71.11 110.236 178.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -50.41 -38.63 43.99 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 124.424 1.09 . . . . 64.21 112.484 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.455 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 1.8 tm-20 -74.05 -41.76 61.26 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.397 1.079 . . . . 72.43 110.265 -175.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -67.86 -37.51 81.92 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 123.871 0.869 . . . . 64.03 110.623 177.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.666 HD13 HD13 ' A' ' 57' ' ' LEU . 45.0 mt -68.06 -33.06 58.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 C-N-CA 125.342 1.457 . . . . 73.31 110.612 175.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.2 ttmm -69.76 -38.99 76.98 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.733 0.813 . . . . 71.24 109.63 177.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.455 ' HG3' ' O ' ' A' ' 20' ' ' GLU . 48.9 mtt180 -61.36 -45.67 93.41 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 123.582 0.551 . . . . 54.12 109.97 174.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.72 -46.02 84.98 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 124.262 0.976 . . . . 64.0 111.302 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -60.6 -49.81 76.02 Favored 'General case' 0 C--N 1.348 0.534 0 O-C-N 123.693 0.621 . . . . 73.1 111.02 177.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -61.43 -35.95 78.99 Favored 'General case' 0 N--CA 1.484 1.229 0 O-C-N 124.078 0.861 . . . . 74.22 111.601 -178.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.8 ttt180 -58.52 -51.11 71.27 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.642 1.177 . . . . 71.15 110.355 174.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.704 ' HB3' HD13 ' A' ' 50' ' ' ILE . 54.2 mt -73.94 -21.07 60.17 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 114.843 -1.071 . . . . 74.11 110.708 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -88.4 -9.57 52.17 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.361 1.064 . . . . 63.3 111.392 179.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 48.4 mtm105 -93.5 -46.68 7.2 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.08 0.552 . . . . 72.33 109.967 166.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -69.75 -60.12 2.51 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.451 0.7 . . . . 63.33 111.423 -174.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.428 ' HE2' HD22 ' A' ' 29' ' ' LEU . 26.4 m-85 -92.97 19.52 7.68 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.371 0.668 . . . . 63.25 111.541 -174.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 -57.52 102.91 0.33 Allowed Pre-proline 0 N--CA 1.48 1.025 0 C-N-CA 125.147 1.379 . . . . 63.41 111.323 -172.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -62.17 -25.08 76.81 Favored 'Trans proline' 0 C--N 1.375 1.935 0 C-N-CA 123.164 2.576 . . . . 74.13 113.367 -177.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -59.66 -31.11 69.25 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.446 0.698 . . . . 72.45 111.416 175.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.9 t -102.2 -63.18 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 N-CA-C 109.254 -0.647 . . . . 65.53 109.254 176.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -97.95 86.07 3.65 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.397 1.079 . . . . 61.35 109.869 -174.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -77.13 71.46 3.63 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 115.382 -0.826 . . . . 73.11 109.707 174.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 43.7 m -118.19 117.57 34.9 Favored Pre-proline 0 N--CA 1.471 0.606 0 N-CA-C 108.287 -1.005 . . . . 54.41 108.287 178.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -41.22 -50.47 4.37 Favored 'Trans proline' 0 C--N 1.388 2.637 0 C-N-CA 124.291 3.327 . . . . 72.23 113.955 -171.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -53.98 -48.51 70.29 Favored 'General case' 0 CA--C 1.549 0.922 0 O-C-N 124.583 1.177 . . . . 64.43 111.323 -179.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.3 -28.74 67.44 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.384 -0.826 . . . . 72.14 111.237 -178.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.458 ' O ' ' HD3' ' A' ' 48' ' ' LYS . 49.2 mt-10 -84.84 -36.74 21.39 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.334 0.654 . . . . 62.01 110.321 -172.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -70.29 -42.68 71.73 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.842 0.857 . . . . 62.44 109.336 177.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -57.73 -41.48 81.91 Favored 'General case' 0 C--N 1.35 0.593 0 CA-C-N 114.857 -1.065 . . . . 74.03 109.689 169.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.426 ' HA ' HD12 ' A' ' 50' ' ' ILE . 35.1 t80 -70.47 -23.2 62.65 Favored 'General case' 0 CA--C 1.547 0.845 0 O-C-N 123.468 0.48 . . . . 73.24 111.836 179.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.458 ' HD3' ' O ' ' A' ' 44' ' ' GLU . 1.9 mptm? -68.98 -41.22 78.16 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 109.702 -0.481 . . . . 75.14 109.702 171.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -65.25 -37.37 87.01 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 123.629 0.58 . . . . 71.44 110.537 176.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.704 HD13 ' HB3' ' A' ' 29' ' ' LEU . 79.9 mt -69.14 -39.43 79.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.783 1.233 . . . . 70.53 110.565 177.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -67.95 -36.14 79.61 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.606 -0.724 . . . . 73.43 110.396 175.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.443 ' O ' HG23 ' A' ' 56' ' ' VAL . 32.4 tt0 -63.78 -53.39 51.57 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.551 1.141 . . . . 63.42 110.138 179.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.453 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . . . -60.41 -44.15 96.02 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 113.372 -1.74 . . . . 65.45 112.063 -177.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -82.54 -18.28 42.02 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 115.994 -0.548 . . . . 72.32 111.629 177.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.431 ' HB1' ' CD2' ' A' ' 85' ' ' PHE . . . -61.55 -36.62 81.1 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.8 0.809 . . . . 53.01 109.663 172.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.474 HG22 ' CE1' ' A' ' 101' ' ' PHE . 38.0 t -69.77 -61.73 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 CA-C-N 113.439 -1.709 . . . . 74.52 110.433 170.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.666 HD13 HD13 ' A' ' 22' ' ' ILE . 52.8 mt -86.45 12.78 9.52 Favored 'General case' 0 CA--C 1.559 1.322 0 CA-C-N 114.864 -1.062 . . . . 62.04 113.166 -165.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.6 t -67.88 -56.24 9.86 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.774 0.83 . . . . 74.34 110.664 174.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -95.04 148.05 34.04 Favored Pre-proline 0 N--CA 1.47 0.547 0 CA-C-N 115.095 -0.957 . . . . 74.34 110.286 -177.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.75 -41.15 57.65 Favored 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 123.266 2.644 . . . . 72.41 111.207 169.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -60.57 -54.69 42.35 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 123.97 0.908 . . . . 72.3 111.527 -178.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.436 ' HA ' HD12 ' A' ' 65' ' ' ILE . 37.6 mtpt -73.39 -32.04 64.24 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.625 0.77 . . . . 74.54 112.386 -174.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.462 HH21 HD12 ' A' ' 22' ' ' ILE . 7.6 ptm180 -67.31 -38.94 85.78 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.636 -0.505 . . . . 74.11 109.636 175.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -65.05 -35.91 82.68 Favored 'General case' 0 C--N 1.362 1.134 0 O-C-N 123.593 0.558 . . . . 74.25 110.904 174.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.436 HD12 ' HA ' ' A' ' 62' ' ' LYS . 83.4 mt -55.58 -47.14 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 C-N-CA 123.366 0.666 . . . . 64.42 110.469 174.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -58.04 -55.61 32.68 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 115.578 -0.737 . . . . 75.4 111.274 170.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -58.75 -31.8 68.67 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.467 0.707 . . . . 64.04 112.135 -173.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 67.8 p -86.98 -18.3 31.02 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.301 0.64 . . . . 75.13 111.338 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -72.47 134.64 45.42 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 106.839 -1.541 . . . . 63.45 106.839 164.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.63 26.77 49.52 Favored Glycine 0 N--CA 1.471 1.0 0 N-CA-C 111.201 -0.76 . . . . 52.54 111.201 -171.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 52.8 m -144.42 -56.45 0.36 Allowed 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 102.587 -3.116 . . . . 71.23 102.587 172.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.5 m -84.2 140.95 31.37 Favored 'General case' 0 C--O 1.25 1.098 0 N-CA-C 104.782 -2.303 . . . . 74.23 104.782 157.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.23 -41.84 63.27 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.08 0.552 . . . . 74.04 110.539 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.78 151.8 53.04 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 123.731 0.812 . . . . 75.1 110.134 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -63.0 133.8 43.11 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.214 1.943 . . . . 75.41 110.58 172.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.404 ' HG2' ' HA ' ' A' ' 65' ' ' ILE . 67.8 Cg_exo -47.26 150.44 3.3 Favored 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 124.373 3.382 . . . . 74.25 115.207 -178.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -55.82 113.35 1.39 Allowed 'Trans proline' 0 C--N 1.389 2.662 0 C-N-CA 123.302 2.668 . . . . 62.44 112.46 -178.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -62.58 146.45 95.39 Favored 'Trans proline' 0 C--N 1.382 2.297 0 C-N-CA 123.397 2.731 . . . . 43.51 113.283 -178.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -66.21 150.24 84.98 Favored 'Trans proline' 0 C--N 1.373 1.844 0 C-N-CA 122.819 2.346 . . . . 71.05 111.566 174.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.478 ' HD2' ' HA3' ' A' ' 142' ' ' GLY . 74.1 Cg_endo -72.75 64.89 3.94 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 123.576 2.851 . . . . 51.35 112.124 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -178.51 -31.98 0.05 OUTLIER Glycine 0 CA--C 1.522 0.484 0 CA-C-N 114.502 -1.227 . . . . 62.41 110.047 -170.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.77 -169.03 18.8 Favored Glycine 0 C--N 1.356 1.674 0 C-N-CA 122.993 0.33 . . . . 53.03 113.115 176.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -108.0 111.76 24.0 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.326 1.05 . . . . 74.41 110.165 -178.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -67.76 155.5 39.14 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.76 1.224 . . . . 71.31 110.944 172.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.523 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 64.8 m-85 -144.39 77.64 1.55 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.894 0.878 . . . . 70.22 110.517 -177.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.462 ' HB3' ' HG2' ' A' ' 162' ' ' PRO . 6.0 m -49.42 85.06 0.0 OUTLIER 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 125.446 1.499 . . . . 74.44 113.667 -179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.33 20.71 79.96 Favored Glycine 0 CA--C 1.535 1.299 0 CA-C-N 116.118 -0.492 . . . . 70.11 113.772 -179.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.523 ' HB2' ' HB3' ' A' ' 85' ' ' PHE . 24.2 m-85 -114.09 106.86 14.89 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 117.41 0.605 . . . . 72.34 109.502 -176.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -83.73 80.52 9.11 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 121.686 0.755 . . . . 71.44 109.907 -177.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.439 ' HA ' ' CD2' ' A' ' 93' ' ' PHE . 3.4 p -39.94 -32.94 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 C-N-CA 126.635 1.974 . . . . 75.21 114.688 174.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -53.47 -38.55 63.73 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.557 1.143 . . . . 75.33 111.783 -176.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -97.18 0.68 48.74 Favored 'General case' 0 CA--C 1.554 1.126 0 CA-C-N 115.332 -0.849 . . . . 45.35 111.495 -173.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.439 ' CD2' ' HA ' ' A' ' 90' ' ' VAL . 10.3 m-30 -88.68 -178.12 5.72 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.588 0.755 . . . . 71.01 110.555 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 89.6 p -77.47 163.74 26.07 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 113.595 0.961 . . . . 74.5 113.595 -168.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.413 ' O ' ' HG3' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -61.57 -40.34 94.38 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 114.312 -1.313 . . . . 74.31 112.123 175.889 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -63.33 -39.31 94.2 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 110.085 -0.339 . . . . 75.03 110.085 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -62.14 -40.33 95.61 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.529 -0.759 . . . . 63.23 109.654 176.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -81.16 -1.61 45.24 Favored 'General case' 0 CA--C 1.558 1.272 0 CA-C-N 114.801 -1.091 . . . . 73.05 112.288 177.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 95' ' ' GLU . 51.8 mt-10 -96.6 -46.46 6.31 Favored 'General case' 0 N--CA 1.503 2.224 0 C-N-CA 123.278 0.631 . . . . 70.02 111.62 167.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 33.5 tp -65.41 -45.55 83.5 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.678 1.191 . . . . 55.03 110.215 -177.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.474 ' CE1' HG22 ' A' ' 56' ' ' VAL . 97.5 m-85 -95.71 -7.97 35.89 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.544 -0.753 . . . . 72.11 111.033 176.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -45.16 -58.58 4.98 Favored Glycine 0 CA--C 1.541 1.67 0 CA-C-O 118.656 -1.08 . . . . 72.43 115.625 -177.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -62.3 -8.21 12.01 Favored 'Trans proline' 0 C--N 1.386 2.512 0 C-N-CA 123.169 2.58 . . . . 23.1 113.86 -175.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -142.01 33.49 1.93 Allowed Glycine 0 C--N 1.357 1.731 0 CA-C-O 119.551 -0.583 . . . . 44.4 112.771 175.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.5 mt -66.79 20.92 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.305 0 N-CA-C 114.864 1.431 . . . . 74.25 114.864 -178.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.571 ' HD1' ' H ' ' A' ' 108' ' ' GLY . 0.2 OUTLIER 57.06 -107.26 0.37 Allowed 'General case' 0 CA--C 1.564 1.486 0 C-N-CA 124.182 0.993 . . . . 72.25 110.541 165.123 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 66.22 15.36 63.11 Favored Glycine 0 C--N 1.362 1.975 0 CA-C-N 118.044 0.384 . . . . 44.0 113.414 -176.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.571 ' H ' ' HD1' ' A' ' 106' ' ' PHE . . . . . . . . 0 C--N 1.353 1.5 0 N-CA-C 111.482 -0.647 . . . . 71.34 111.482 -170.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 170' ' ' PRO . 39.2 ttmt . . . . . 0 N--CA 1.476 0.855 0 N-CA-C 112.365 0.506 . . . . 72.15 112.365 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -97.18 -168.21 33.07 Favored Glycine 0 CA--C 1.549 2.196 0 CA-C-N 115.643 -0.708 . . . . 55.22 113.29 179.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -112.95 139.06 48.92 Favored 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 124.374 1.07 . . . . 71.34 109.766 177.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -50.61 113.92 1.02 Allowed 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.962 0.887 . . . . 74.23 112.724 -176.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.431 ' O ' HD12 ' A' ' 174' ' ' LEU . 5.4 tt -105.81 148.65 27.28 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 114.652 -1.158 . . . . 70.23 108.795 -168.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.447 ' HD2' ' HB2' ' A' ' 175' ' ' LEU . 14.8 tpt180 -98.21 143.13 29.04 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 108.586 -0.894 . . . . 74.51 108.586 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.557 ' HB2' HD11 ' A' ' 174' ' ' LEU . . . -138.93 166.19 25.12 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 118.768 0.713 . . . . 41.51 111.45 -178.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.544 ' HB2' ' HB3' ' B' ' 9' ' ' ALA . 18.0 mm-40 -116.61 98.4 6.52 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 106.874 -1.528 . . . . 61.0 106.874 179.024 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.496 ' HB2' HD22 ' A' ' 176' ' ' LEU . 11.7 tp -98.25 103.57 18.65 Favored Pre-proline 0 C--O 1.213 -0.86 0 N-CA-C 107.392 -1.336 . . . . 54.05 107.392 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.489 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 55.2 Cg_endo -66.81 151.22 82.83 Favored 'Trans proline' 0 C--N 1.362 1.276 0 C-N-CA 121.253 1.302 . . . . 75.33 108.847 169.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.649 ' HA ' HG21 ' B' ' 6' ' ' ILE . 17.9 tp -150.91 148.2 28.14 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 119.283 0.947 . . . . 64.01 112.016 177.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 33.8 m -76.21 127.05 32.13 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 114.436 -1.256 . . . . 71.34 109.341 175.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.578 ' HB3' HD22 ' A' ' 215' ' ' LEU . 3.5 mm? -44.61 -57.73 3.46 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 125.516 1.526 . . . . 70.54 112.452 -178.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 17.5 mp0 -59.13 -44.56 92.05 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 114.33 -1.304 . . . . 75.32 109.632 -176.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -76.63 -12.28 59.99 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 115.185 -0.916 . . . . 64.33 111.856 -178.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.603 ' HB1' ' O ' ' A' ' 153' ' ' VAL . . . -79.45 -38.5 34.48 Favored 'General case' 0 C--O 1.252 1.223 0 CA-C-O 121.772 0.796 . . . . 41.43 109.206 176.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.461 ' HB2' HH21 ' A' ' 154' ' ' ARG . 89.2 t80 -70.57 -41.87 71.85 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 114.564 -1.198 . . . . 74.51 110.762 171.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 33.6 m170 -77.22 -36.46 54.68 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.149 0.579 . . . . 75.25 112.065 -172.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.513 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 70.21 -150.35 48.58 Favored Glycine 0 CA--C 1.531 1.087 0 O-C-N 123.411 0.444 . . . . 71.54 114.009 -179.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 91.57 -174.29 37.87 Favored Glycine 0 C--N 1.352 1.461 0 C-N-CA 123.483 0.563 . . . . 70.42 112.571 178.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 21.5 mp0 -67.95 113.16 5.42 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.823 0.849 . . . . 73.14 109.231 179.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 13.1 tpp180 -108.67 122.77 47.81 Favored 'General case' 0 C--O 1.244 0.806 0 C-N-CA 123.626 0.771 . . . . 74.4 109.626 -175.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 48.7 t -73.45 114.86 13.57 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 O-C-N 124.01 0.819 . . . . 71.24 109.156 175.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.466 HG13 HG13 ' A' ' 145' ' ' VAL . 5.5 p -142.39 134.64 26.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 124.65 1.18 . . . . 73.14 107.889 177.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -123.43 144.38 49.54 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 121.973 -0.454 . . . . 71.3 110.732 -175.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.518 ' HB ' ' HB3' ' B' ' 8' ' ' LEU . 11.9 p -159.32 141.09 4.69 Favored 'Isoleucine or valine' 0 C--O 1.243 0.715 0 C-N-CA 124.646 1.178 . . . . 75.1 108.111 173.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 58.92 31.71 21.57 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.911 0.885 . . . . 74.24 110.795 -177.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.478 ' HA3' ' HD2' ' A' ' 80' ' ' PRO . . . 73.05 0.15 50.09 Favored Glycine 0 C--N 1.355 1.598 0 CA-C-N 115.399 -0.818 . . . . 31.1 114.282 -178.378 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.75 99.08 10.41 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.317 1.047 . . . . 72.12 108.311 -174.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 27.1 ttt-85 -74.82 92.38 2.51 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.464 1.106 . . . . 74.41 109.702 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.466 HG13 HG13 ' A' ' 138' ' ' VAL . 7.5 p -95.62 136.76 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 123.217 0.607 . . . . 73.53 110.899 -177.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 40.3 t -102.02 85.2 2.64 Favored 'General case' 0 C--O 1.243 0.718 0 N-CA-C 108.523 -0.917 . . . . 31.45 108.523 177.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 89.0 t -81.16 113.17 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 108.598 -0.89 . . . . 73.42 108.598 -176.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 40.4 ttt85 -68.79 93.04 0.51 Allowed 'General case' 0 C--O 1.242 0.692 0 N-CA-C 108.552 -0.907 . . . . 74.14 108.552 173.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.513 HG13 ' HA2' ' A' ' 133' ' ' GLY . 41.2 pt -72.91 133.16 82.24 Favored Pre-proline 0 CA--C 1.553 1.084 0 CA-C-N 114.481 -1.236 . . . . 74.13 108.832 177.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -59.87 128.52 27.03 Favored 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 122.527 2.152 . . . . 60.34 111.701 177.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.09 92.78 0.09 OUTLIER 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 122.5 2.134 . . . . 74.15 110.519 172.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 126.29 60.59 0.15 Allowed Glycine 0 C--N 1.339 0.698 0 CA-C-O 121.721 0.623 . . . . 75.51 111.709 -168.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.603 ' O ' ' HB1' ' A' ' 130' ' ' ALA . 7.5 p -137.46 138.02 45.26 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.754 0 N-CA-C 107.068 -1.456 . . . . 75.43 107.068 169.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.622 HH21 HD12 ' A' ' 215' ' ' LEU . 57.6 mtt180 -151.13 175.12 12.44 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.627 0.771 . . . . 73.23 109.102 173.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.561 ' HB3' ' H ' ' A' ' 188' ' ' LEU . 17.3 tp10 -34.7 128.16 0.47 Allowed 'General case' 0 N--CA 1.502 2.162 0 C-N-CA 126.442 1.897 . . . . 72.32 114.852 -166.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.72 -9.98 66.51 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 114.823 0.689 . . . . 14.21 114.823 175.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 15.3 t -73.18 153.56 40.65 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 117.329 0.564 . . . . 74.23 109.562 174.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 85.6 t -119.94 108.16 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.749 0.82 . . . . 72.34 109.846 -175.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.568 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 59.5 mt -86.7 113.85 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 N-CA-C 108.718 -0.845 . . . . 75.24 108.718 174.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -76.27 107.08 8.27 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 108.691 -0.855 . . . . 61.32 108.691 171.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 15.0 p -117.14 114.9 38.62 Favored Pre-proline 0 CA--C 1.554 1.106 0 N-CA-C 109.281 -0.637 . . . . 61.33 109.281 174.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.462 ' HG2' ' HB3' ' A' ' 86' ' ' SER . 50.4 Cg_endo -69.22 140.83 45.72 Favored 'Trans proline' 0 C--N 1.369 1.633 0 C-N-CA 122.368 2.045 . . . . 74.53 112.62 178.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.533 ' N ' ' HB3' ' A' ' 171' ' ' PRO . . . 116.2 -26.52 8.66 Favored Glycine 0 N--CA 1.477 1.409 0 C-N-CA 123.519 0.58 . . . . 70.43 113.355 166.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.538 ' HB2' HD22 ' A' ' 174' ' ' LEU . 1.0 OUTLIER -102.37 -33.25 9.63 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.213 0.605 . . . . 64.15 110.245 -174.798 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.471 ' N ' ' HB2' ' A' ' 174' ' ' LEU . . . -89.86 151.97 22.06 Favored Glycine 0 CA--C 1.493 -1.343 0 N-CA-C 108.801 -1.72 . . . . 73.33 108.801 170.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.701 ' HA3' ' HA3' ' A' ' 172' ' ' GLY . . . 53.13 79.16 0.09 OUTLIER Glycine 0 CA--C 1.48 -2.129 0 CA-C-O 118.67 -1.072 . . . . 74.5 112.335 -161.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.544 ' HA ' HE21 ' A' ' 167' ' ' GLN . 0.0 OUTLIER -55.59 104.09 0.12 Allowed 'General case' 0 C--N 1.353 0.725 0 O-C-N 128.275 2.986 . . . . 75.42 109.27 -177.4 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -174.46 -135.95 2.15 Favored Glycine 0 N--CA 1.435 -1.414 0 N-CA-C 109.32 -1.512 . . . . 64.21 109.32 -172.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . 0.547 ' ND2' ' HB3' ' A' ' 106' ' ' PHE . 0.5 OUTLIER -134.31 -57.01 0.02 OUTLIER Pre-proline 0 CA--C 1.552 1.039 0 CA-C-O 118.518 -0.753 . . . . 63.11 109.204 176.344 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.462 ' O ' ' HA ' ' A' ' 115' ' ' LYS . 17.2 Cg_exo -67.98 124.1 11.43 Favored 'Trans proline' 0 C--N 1.39 2.751 0 N-CA-C 106.461 -2.169 . . . . 71.13 106.461 160.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.533 ' HB3' ' N ' ' A' ' 163' ' ' GLY . 57.2 Cg_endo -67.46 143.08 61.85 Favored 'Trans proline' 0 C--O 1.244 0.777 0 C-N-CA 122.067 1.845 . . . . 71.25 114.612 -164.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.701 ' HA3' ' HA3' ' A' ' 166' ' ' GLY . . . -74.68 -29.54 61.24 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 119.597 -1.287 . . . . 72.4 110.872 158.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 92.58 138.79 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 127.975 2.51 . . . . 71.14 109.635 -177.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.557 HD11 ' HB2' ' A' ' 121' ' ' ALA . 26.4 tp -109.05 141.02 41.8 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 122.678 0.391 . . . . 64.32 110.343 -173.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.447 ' HB2' ' HD2' ' A' ' 120' ' ' ARG . 65.8 mt -107.98 83.2 1.75 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.332 1.053 . . . . 72.12 108.686 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.568 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 92.1 mt -66.62 101.33 0.77 Allowed 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.174 -0.921 . . . . 70.05 110.283 179.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 64.0 t -84.29 102.81 10.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 N-CA-C 107.677 -1.231 . . . . 61.43 107.677 173.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 7.3 p -66.88 128.43 30.05 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 CA-C-N 115.358 -0.837 . . . . 70.33 110.592 -177.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.489 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 33.3 mmt180 -124.09 91.82 3.54 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.255 1.422 . . . . 53.32 107.272 -174.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.569 HD13 HD13 ' A' ' 127' ' ' LEU . 27.9 mt -70.17 147.52 49.77 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.597 -0.729 . . . . 72.4 112.181 -171.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 61.9 mt -58.95 149.14 67.33 Favored Pre-proline 0 N--CA 1.479 1.024 0 C-N-CA 124.362 1.065 . . . . 73.14 110.814 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -58.86 79.42 0.05 OUTLIER 'Trans proline' 0 C--N 1.383 2.381 0 C-N-CA 123.413 2.742 . . . . 71.42 112.703 176.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 66.5 t-80 -129.39 103.5 18.01 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 105.917 -1.882 . . . . 73.35 105.917 -175.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -73.58 25.39 0.32 Allowed 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 123.638 2.892 . . . . 61.24 116.227 -163.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 71.5 t -97.57 -61.21 2.32 Favored 'Isoleucine or valine' 0 C--N 1.351 0.669 0 CA-C-N 118.425 0.557 . . . . 64.21 110.465 -177.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 15.5 m-30 -124.34 147.92 47.85 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-O 121.829 0.823 . . . . 72.31 112.714 -171.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -144.8 150.28 36.89 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.328 1.851 . . . . 75.51 106.665 172.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.632 HD12 ' HA ' ' A' ' 193' ' ' LEU . 6.3 tp -121.17 173.43 7.31 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 107.177 -1.416 . . . . 74.21 107.177 178.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -159.56 128.98 5.34 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 109.076 -0.713 . . . . 70.31 109.076 165.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 68.6 -74.55 0.31 Allowed Glycine 0 C--N 1.347 1.169 0 N-CA-C 110.979 -0.848 . . . . 65.41 110.979 -170.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -164.17 -0.68 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 123.758 0.823 . . . . 72.32 111.547 172.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -95.89 146.49 24.54 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.914 -0.491 . . . . 72.32 109.685 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.632 ' HA ' HD12 ' A' ' 188' ' ' LEU . 0.8 OUTLIER -89.69 157.2 18.1 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.473 1.109 . . . . 63.44 111.486 -165.765 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -142.96 154.9 44.51 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.648 1.579 . . . . 73.14 107.631 175.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.439 ' HB3' HD23 ' A' ' 251' ' ' LEU . . . -158.84 127.16 5.21 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.902 0.881 . . . . 74.34 109.122 -176.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 31.1 m -75.66 127.23 32.62 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 118.163 0.438 . . . . 70.21 110.128 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 38.5 tp -130.7 104.32 7.12 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.522 0.729 . . . . 72.21 110.032 -175.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -89.85 124.59 34.82 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 109.261 -0.644 . . . . 61.43 109.261 171.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 8.9 p -138.06 137.62 21.53 Favored Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 123.874 0.869 . . . . 64.4 109.16 -174.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.85 155.16 53.69 Favored 'Trans proline' 0 C--N 1.378 2.086 0 C-N-CA 121.765 1.643 . . . . 64.51 111.327 174.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -52.2 -49.66 83.5 Favored Pre-proline 0 CA--C 1.552 1.043 0 N-CA-C 114.633 1.346 . . . . 71.34 114.633 -172.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.443 ' HG2' ' HE1' ' C' ' 276' ' ' TYR . 54.3 Cg_exo -58.75 -41.28 64.83 Favored 'Trans proline' 0 C--N 1.386 2.541 0 C-N-CA 121.912 1.741 . . . . 63.54 113.997 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.485 HD11 ' HB3' ' C' ' 276' ' ' TYR . 44.0 mt -68.29 -35.57 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 109.907 -0.405 . . . . 64.32 109.907 178.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.16 -45.82 79.59 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.46 0.704 . . . . 71.51 111.751 176.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 53.0 t -68.26 -48.75 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 124.194 0.998 . . . . 63.23 111.522 -176.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 54.7 t -83.13 -37.59 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.042 0.937 . . . . 74.41 111.613 -172.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 92.22 70.61 1.17 Allowed Glycine 0 C--O 1.24 0.48 0 CA-C-N 115.765 -0.652 . . . . 72.35 111.493 -174.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -92.18 -154.23 30.7 Favored Glycine 0 C--N 1.34 0.793 0 CA-C-N 115.055 -0.572 . . . . 55.24 113.312 -177.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 36.3 mtmt -130.02 132.84 46.39 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.327 -0.62 . . . . 45.21 109.327 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 29.0 m -132.52 160.37 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 N-CA-C 108.678 -0.86 . . . . 63.11 108.678 172.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -97.68 115.36 27.8 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.358 -0.979 . . . . 71.41 108.358 177.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.89 165.65 11.24 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.936 0.894 . . . . 62.04 110.326 -174.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . 0.456 ' N ' ' SD ' ' A' ' 213' ' ' MET . 0.0 OUTLIER -98.98 137.04 38.08 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.241 -0.89 . . . . 71.23 109.211 -174.941 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 67.6 p -124.53 177.51 5.89 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 107.934 -1.135 . . . . 74.1 107.934 163.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.622 HD12 HH21 ' A' ' 154' ' ' ARG . 33.0 mt -78.26 -23.14 47.42 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.81 -0.632 . . . . 63.31 110.395 -177.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -83.62 -12.84 55.49 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.148 0.979 . . . . 64.44 111.175 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 138.28 -164.62 25.6 Favored Glycine 0 C--N 1.346 1.137 0 N-CA-C 111.564 -0.614 . . . . 33.0 111.564 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -79.09 134.8 11.87 Favored 'Trans proline' 0 C--N 1.363 1.303 0 C-N-CA 122.262 1.974 . . . . 70.23 111.693 175.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 34.8 m -130.89 168.14 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 107.681 -1.229 . . . . 73.4 107.681 171.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -106.54 152.84 23.17 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 121.856 -0.528 . . . . 75.04 111.894 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 10.2 p -142.63 141.65 27.41 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 CA-C-N 114.868 -1.06 . . . . 74.13 109.319 -173.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -106.83 104.77 14.53 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 109.608 -0.515 . . . . 60.25 109.608 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 66.7 t -58.53 142.78 82.27 Favored Pre-proline 0 CA--C 1.569 1.68 0 C-N-CA 125.262 1.425 . . . . 63.14 110.472 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -84.31 167.36 12.13 Favored 'Trans proline' 0 C--N 1.386 2.515 0 C-N-CA 122.863 2.375 . . . . 75.51 111.195 175.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.12 145.91 28.26 Favored 'Trans proline' 0 C--N 1.367 1.546 0 C-N-CA 121.495 1.463 . . . . 72.53 112.681 174.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 71.9 mtt85 65.76 34.18 7.66 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 125.341 1.456 . . . . 74.04 111.642 175.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.503 HG22 HG11 ' A' ' 253' ' ' VAL . 89.3 m -63.15 108.67 1.31 Allowed 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 113.657 -1.611 . . . . 64.32 110.705 174.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -98.71 150.89 21.34 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.597 0.759 . . . . 75.32 110.824 -169.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -63.86 128.04 34.05 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.896 0.879 . . . . 62.31 110.742 177.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 97.0 -26.18 23.71 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-N 116.377 -0.374 . . . . 73.32 112.53 -178.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 55.8 mtt180 -74.36 135.3 42.47 Favored 'General case' 0 C--N 1.36 1.057 0 CA-C-O 121.623 0.725 . . . . 74.0 111.094 -178.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.634 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 33.6 mttm -102.71 112.37 25.12 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 114.219 -1.355 . . . . 72.22 109.03 -178.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.548 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 45.6 mt -75.33 99.5 4.12 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.031 0.932 . . . . 71.4 109.755 -172.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 58.9 ttt180 -73.64 123.89 24.91 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.59 1.156 . . . . 64.14 110.958 -173.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.491 HD12 HD23 ' A' ' 249' ' ' LEU . 67.3 mt -116.64 109.41 17.16 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.964 0.905 . . . . 61.12 109.889 -179.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -62.5 125.31 23.5 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 123.668 0.787 . . . . 64.43 112.767 -173.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 73.08 30.65 62.79 Favored Glycine 0 C--N 1.352 1.43 0 O-C-N 124.036 0.835 . . . . 74.2 113.881 174.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -115.77 -12.38 11.49 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.333 0.653 . . . . 73.01 111.65 -178.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -87.17 -168.77 45.14 Favored Glycine 0 C--N 1.348 1.205 0 O-C-N 123.311 0.382 . . . . 74.43 112.323 171.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . 0.494 ' HE2' ' HG3' ' A' ' 154' ' ' ARG . 13.2 m-30 -95.0 154.29 39.69 Favored Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 123.039 0.536 . . . . 73.13 111.903 -169.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.521 ' HA ' ' HA ' ' A' ' 246' ' ' ARG . 59.5 Cg_endo -70.16 120.54 7.25 Favored 'Trans proline' 0 C--N 1.386 2.544 0 C-N-CA 123.339 2.692 . . . . 73.33 113.62 -176.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -157.05 -138.78 2.58 Favored Glycine 0 C--N 1.35 1.327 0 CA-C-O 119.208 -0.773 . . . . 73.52 112.645 -178.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -70.57 -16.31 34.12 Favored 'Trans proline' 0 C--N 1.385 2.493 0 C-N-CA 123.24 2.627 . . . . 70.45 113.549 -173.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -100.18 20.43 14.62 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.737 0.815 . . . . 70.11 110.643 177.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 79.09 -80.19 1.53 Allowed Glycine 0 C--N 1.351 1.398 0 N-CA-C 109.503 -1.439 . . . . 62.24 109.503 -171.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.521 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 44.8 mtm180 -125.6 159.36 32.33 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.476 1.11 . . . . 75.41 108.514 164.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -87.64 -176.81 48.3 Favored Glycine 0 C--N 1.339 0.696 0 CA-C-N 116.14 -0.482 . . . . 42.24 112.285 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -123.2 151.6 42.07 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.027 0.931 . . . . 75.44 109.648 178.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.491 HD23 HD12 ' A' ' 235' ' ' LEU . 53.8 tp -96.84 111.31 23.55 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 109.434 -0.58 . . . . 70.31 109.434 -178.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.634 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 18.7 m-85 -96.82 105.91 18.12 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.323 1.049 . . . . 52.51 109.539 -179.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.548 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 12.1 mt -81.63 97.4 7.86 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.949 0.5 . . . . 72.24 109.739 176.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -77.47 105.74 8.79 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.988 0.915 . . . . 75.41 108.726 -174.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.503 HG11 HG22 ' A' ' 227' ' ' THR . 55.0 t -88.79 144.35 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 N-CA-C 114.192 1.182 . . . . 24.43 114.192 -165.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -128.65 111.47 13.23 Favored 'General case' 0 C--N 1.351 0.666 0 C-N-CA 125.838 1.655 . . . . 73.14 108.01 168.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 58.2 mt -76.8 138.6 20.28 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 122.955 0.502 . . . . 74.34 109.769 178.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 48.2 p -122.87 173.48 7.75 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.588 1.155 . . . . 73.43 109.307 176.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.455 HG13 ' H ' ' A' ' 259' ' ' GLU . 27.3 pt -117.82 162.18 30.42 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 123.301 0.64 . . . . 73.4 109.68 175.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -66.65 5.98 0.65 Allowed 'Trans proline' 0 N--CA 1.502 1.979 0 C-N-CA 123.263 2.642 . . . . 74.45 115.609 176.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . 0.477 ' HG3' ' NE2' ' C' ' 228' ' ' GLN . 2.4 mp0 48.52 -97.68 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.692 0.797 . . . . 63.24 109.659 -161.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.7 160.95 17.9 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.062 0.945 . . . . 75.12 111.003 -172.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 79.7 mt -138.51 157.38 46.29 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.673 0.789 . . . . 55.32 110.446 -175.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 78.4 p -102.67 151.19 38.24 Favored Pre-proline 0 CA--C 1.554 1.133 0 N-CA-C 108.394 -0.965 . . . . 44.34 108.394 169.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -25.79 -46.29 0.06 OUTLIER 'Trans proline' 0 C--N 1.394 2.958 1 C-N-CA 126.58 4.854 . . . . 74.33 117.932 -170.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -66.64 -62.73 1.3 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 122.935 0.494 . . . . 71.44 111.445 -176.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -66.12 -25.81 67.16 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 122.509 0.324 . . . . 64.2 110.5 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 266' ' ' GLU . . . . . 0.404 ' O ' ' HD3' ' A' ' 270' ' ' LYS . 7.8 tp10 -56.75 -52.12 66.22 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 124.179 0.924 . . . . 73.45 109.455 173.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -62.39 -42.42 99.41 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.698 -1.137 . . . . 64.12 111.653 176.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 10.4 mp -58.04 -55.46 34.63 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 122.971 0.508 . . . . 73.14 111.955 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 66.4 m95 -60.12 -39.79 87.46 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.487 0.715 . . . . 75.0 111.647 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . 0.569 ' HE2' HG23 ' C' ' 206' ' ' VAL . 1.1 mptm? -64.34 -44.03 92.78 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 123.62 0.575 . . . . 62.43 111.585 177.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -63.72 -43.02 97.78 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 122.993 0.517 . . . . 70.22 110.608 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 272' ' ' LEU . . . . . 0.492 ' O ' ' HB2' ' A' ' 276' ' ' TYR . 75.6 mt -56.53 -46.01 80.83 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 124.422 1.076 . . . . 63.4 110.57 174.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -74.69 -37.99 62.49 Favored 'General case' 0 C--O 1.244 0.797 0 O-C-N 124.468 1.105 . . . . 64.51 113.63 -171.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -77.3 -39.11 49.1 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.072 0.549 . . . . 74.35 109.566 -179.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . 0.445 ' HB1' ' NH2' ' A' ' 279' ' ' ARG . . . -74.19 -20.49 60.18 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.162 0.585 . . . . 71.44 111.034 174.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . 0.492 ' HB2' ' O ' ' A' ' 272' ' ' LEU . 14.7 t80 -65.16 -63.63 1.06 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.079 0.951 . . . . 75.02 108.762 172.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -64.94 -38.64 91.64 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 114.987 -1.006 . . . . 70.12 110.406 -173.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -62.85 -26.15 68.62 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.236 0.614 . . . . 75.41 112.093 176.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . 0.445 ' NH2' ' HB1' ' A' ' 275' ' ' ALA . 27.5 mtm180 -117.4 31.2 6.86 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.477 0.711 . . . . 74.13 109.938 179.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.393 0 N-CA-C 109.087 -0.708 . . . . 72.21 109.087 171.984 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.481 1.081 0 N-CA-C 109.872 -0.418 . . . . 71.44 109.872 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 57.6 tttp 70.97 135.11 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.931 1.292 . . . . 54.1 113.594 176.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 63.08 30.14 16.21 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 125.62 1.568 . . . . 74.04 112.168 171.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 11.9 m -66.63 -34.96 79.04 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.769 0.428 . . . . 52.14 110.448 175.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 1.8 m 69.14 152.03 0.09 Allowed 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 125.593 1.557 . . . . 70.11 112.167 177.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.649 HG21 ' HA ' ' A' ' 125' ' ' LEU . 31.4 pt -136.83 171.2 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 N-CA-C 113.044 0.757 . . . . 64.44 113.044 -158.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -146.05 123.58 11.75 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.169 0.988 . . . . 72.01 110.187 -178.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . 0.538 HD11 ' HB1' ' A' ' 121' ' ' ALA . 36.3 tp -77.75 145.37 36.53 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.119 0.968 . . . . 75.22 110.908 -173.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . 0.544 ' HB3' ' HB2' ' A' ' 122' ' ' GLU . . . -88.79 -50.39 6.26 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.052 0.541 . . . . 62.4 111.828 178.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 86.9 mt 68.0 122.57 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 124.872 1.269 . . . . 74.1 111.283 -166.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 N--CA 1.481 1.078 0 N-CA-C 108.046 -1.094 . . . . 45.35 108.046 171.664 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.879 0 N-CA-C 108.97 -0.752 . . . . 61.34 108.97 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . -162.14 -28.84 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 115.127 -0.942 . . . . 74.4 110.292 175.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 181' ' ' LEU . . . . . 0.573 HD22 ' HB2' ' C' ' 136' ' ' ARG . 29.3 tp -153.45 -68.7 0.15 Allowed 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 107.636 -1.246 . . . . 62.04 107.636 168.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 182' ' ' VAL . . . . . . . . . . . . . 62.6 t -76.43 131.81 34.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 108.123 -1.066 . . . . 71.31 108.123 168.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.1 -48.79 74.77 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 123.726 0.641 . . . . 65.24 110.695 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 179.9 -170.44 0.14 Allowed 'General case' 0 N--CA 1.485 1.301 0 O-C-N 124.2 0.938 . . . . 74.15 110.738 173.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 185' ' ' VAL . . . . . 0.507 HG23 ' HA ' ' C' ' 121' ' ' ALA . 1.8 p . . . . . 0 N--CA 1.47 0.548 0 N-CA-C 106.557 -1.645 . . . . 71.33 106.557 160.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 238' ' ' THR . . . . . 0.475 HG22 HG23 ' C' ' 219' ' ' VAL . 6.2 m . . . . . 0 CA--C 1.545 0.753 0 N-CA-C 109.946 -0.391 . . . . 71.31 109.946 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -165.63 -98.84 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 123.337 0.655 . . . . 74.42 110.44 171.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . 173.32 -148.52 10.36 Favored Glycine 0 C--N 1.35 1.334 0 N-CA-C 111.615 -0.594 . . . . 71.23 111.615 -176.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -86.38 -167.96 2.06 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.516 0.726 . . . . 71.21 111.144 -176.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 242' ' ' TRP . . . . . 0.59 ' HZ3' ' HD3' ' C' ' 231' ' ' ARG . 0.0 OUTLIER 86.59 -26.82 0.08 Allowed 'General case' 0 N--CA 1.504 2.231 0 C-N-CA 127.191 2.197 . . . . 70.32 111.66 175.872 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 243' ' ' GLN . . . . . 0.409 ' H ' ' HG2' ' B' ' 243' ' ' GLN . 0.6 OUTLIER -102.24 120.69 40.89 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 124.054 0.942 . . . . 74.22 110.676 -168.461 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -60.35 -40.73 97.91 Favored Glycine 0 C--N 1.353 1.49 0 N-CA-C 110.458 -1.057 . . . . 63.11 110.458 165.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 5.5 ttpp . . . . . 0 N--CA 1.478 0.934 0 C-N-CA 125.148 1.379 . . . . 75.34 112.755 162.928 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.809 0 CA-C-O 120.267 0.079 . . . . 52.01 111.055 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -37.47 95.1 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 125.693 1.597 . . . . 70.52 114.197 -176.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -67.19 107.73 2.44 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 108.288 -1.004 . . . . 63.2 108.288 166.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -77.74 92.73 4.2 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 106.739 -1.578 . . . . 63.22 106.739 171.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 7' ' ' TYR . . . . . 0.438 ' CD1' ' HA ' ' C' ' 53' ' ' ALA . 75.8 m-85 -62.73 -25.9 68.42 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 114.51 -1.223 . . . . 73.43 112.128 -172.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -64.91 -46.49 81.46 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.382 0.673 . . . . 72.53 110.408 174.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.64 -39.44 94.36 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.266 0.626 . . . . 52.31 111.011 178.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 66.7 mt -59.75 -41.1 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 123.797 0.686 . . . . 63.34 110.475 175.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 98.0 mt -85.57 -3.55 58.9 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 112.265 0.469 . . . . 45.45 112.265 176.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 61.27 44.6 97.89 Favored Glycine 0 C--N 1.354 1.54 0 N-CA-C 114.063 0.385 . . . . 64.33 114.063 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 11.0 m -133.13 148.56 69.71 Favored Pre-proline 0 N--CA 1.487 1.423 0 C-N-CA 124.795 1.238 . . . . 64.04 109.823 177.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -75.29 161.36 38.03 Favored 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 122.721 2.281 . . . . 74.43 111.844 170.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 -77.07 20.17 0.27 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.806 0.842 . . . . 71.52 112.518 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -119.0 -15.39 9.29 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.243 1.017 . . . . 71.24 109.079 177.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.08 131.98 51.36 Favored 'General case' 0 C--N 1.355 0.828 0 C-N-CA 123.246 0.618 . . . . 71.14 109.595 175.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 59.8 p -65.59 161.8 19.57 Favored 'General case' 0 C--O 1.246 0.872 0 C-N-CA 123.047 0.539 . . . . 74.41 109.866 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 19' ' ' GLN . . . . . 0.525 ' HG2' ' HD3' ' C' ' 60' ' ' PRO . 25.1 tp60 -54.26 -38.82 66.25 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.586 0.754 . . . . 74.45 111.978 -173.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 20' ' ' GLU . . . . . 0.443 ' O ' ' HG3' ' C' ' 24' ' ' ARG . 0.4 OUTLIER -68.72 -35.6 77.35 Favored 'General case' 0 C--O 1.211 -0.933 0 CA-C-O 119.182 -0.437 . . . . 64.05 111.128 -179.058 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . 0.747 ' HG2' HH21 ' C' ' 24' ' ' ARG . 37.4 mt-10 -68.92 -38.11 79.32 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-O 121.006 0.431 . . . . 73.42 110.76 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 66.6 mt -66.15 -38.58 82.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 124.188 0.995 . . . . 61.32 109.889 174.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 23' ' ' LYS . . . . . 0.438 ' O ' ' HD3' ' C' ' 27' ' ' LYS . 6.6 ttpt -71.4 -33.85 69.85 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 114.68 -1.145 . . . . 74.13 109.972 178.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 24' ' ' ARG . . . . . 0.747 HH21 ' HG2' ' C' ' 21' ' ' GLU . 40.8 mtm180 -75.84 -24.21 55.8 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.305 0.642 . . . . 73.52 110.478 176.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.67 -43.96 87.73 Favored 'General case' 0 C--N 1.345 0.41 0 O-C-N 123.711 0.632 . . . . 75.32 109.636 170.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 26' ' ' TYR . . . . . 0.466 ' HD1' HG22 ' C' ' 50' ' ' ILE . 81.6 t80 -58.01 -52.42 65.58 Favored 'General case' 0 C--N 1.36 1.04 0 O-C-N 123.624 0.578 . . . . 72.31 110.865 171.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . 0.441 ' HE2' ' HA ' ' C' ' 24' ' ' ARG . 4.8 mppt? -61.0 -31.8 71.41 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 122.878 0.471 . . . . 74.1 111.487 -177.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 28' ' ' ARG . . . . . 0.493 HH21 HD21 ' C' ' 29' ' ' LEU . 38.9 ttp180 -62.28 -48.19 81.01 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.908 0.883 . . . . 71.15 109.602 174.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . 0.721 HD13 HD12 ' C' ' 50' ' ' ILE . 49.9 mt -74.55 -19.09 60.47 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 114.738 -1.119 . . . . 60.22 111.487 178.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.11 -22.49 33.37 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.409 0.684 . . . . 75.32 110.197 178.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' C' ' 27' ' ' LYS . 58.6 mtm180 -86.85 -31.78 20.61 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.252 0.621 . . . . 73.5 110.318 170.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -70.27 -60.58 2.19 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.827 0.851 . . . . 71.12 109.493 -178.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -90.61 24.52 2.63 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.028 0.931 . . . . 70.15 110.934 -177.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 34' ' ' HIS . . . . . 0.474 ' NE2' ' HB3' ' C' ' 36' ' ' ASP . 55.0 t60 -55.12 96.42 0.09 OUTLIER Pre-proline 0 N--CA 1.486 1.345 0 C-N-CA 124.963 1.305 . . . . 72.34 112.84 -164.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 35' ' ' PRO . . . . . 0.518 ' O ' ' HG2' ' C' ' 39' ' ' LYS . 57.9 Cg_endo -76.55 -2.24 12.42 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 123.429 2.753 . . . . 71.32 112.758 -167.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 36' ' ' ASP . . . . . 0.474 ' HB3' ' NE2' ' C' ' 34' ' ' HIS . 32.7 t70 -75.88 -38.03 58.28 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.949 0.899 . . . . 60.34 110.81 173.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 59.6 t -117.32 -52.69 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 122.89 0.476 . . . . 75.33 109.835 -174.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -97.51 79.29 2.73 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.701 0.762 . . . . 54.22 108.945 178.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 39' ' ' LYS . . . . . 0.518 ' HG2' ' O ' ' C' ' 35' ' ' PRO . 9.8 mtmp? -81.14 69.37 7.73 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 115.189 -0.914 . . . . 62.24 109.815 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . 0.551 ' HB2' ' HB3' ' C' ' 43' ' ' ALA . 49.6 m -92.5 111.66 51.77 Favored Pre-proline 0 CA--C 1.546 0.81 0 CA-C-O 118.317 -0.849 . . . . 74.14 108.99 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -38.93 -61.09 0.42 Allowed 'Trans proline' 0 C--N 1.387 2.596 0 C-N-CA 124.571 3.514 . . . . 63.44 114.905 -174.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -61.18 -33.94 74.27 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.857 0.863 . . . . 65.44 111.397 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 43' ' ' ALA . . . . . 0.551 ' HB3' ' HB2' ' C' ' 40' ' ' SER . . . -77.35 -20.52 54.7 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.248 0.619 . . . . 62.05 110.659 -178.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -84.06 -28.44 27.6 Favored 'General case' 0 C--N 1.351 0.659 0 N-CA-C 109.127 -0.694 . . . . 74.04 109.127 176.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -70.62 -42.19 71.24 Favored 'General case' 0 C--O 1.25 1.125 0 C-N-CA 123.676 0.79 . . . . 42.53 109.602 173.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 46' ' ' LYS . . . . . 0.523 ' O ' HG12 ' C' ' 50' ' ' ILE . 63.5 mttp -58.12 -45.65 86.96 Favored 'General case' 0 C--N 1.355 0.832 0 CA-C-N 114.789 -1.096 . . . . 72.32 109.429 168.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -62.66 -30.31 71.29 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.926 0.89 . . . . 62.23 110.963 -178.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 2.7 mptm? -63.54 -50.37 69.82 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 109.07 -0.715 . . . . 72.04 109.07 171.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -67.57 -17.34 64.6 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 112.791 0.663 . . . . 72.33 112.791 176.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 50' ' ' ILE . . . . . 0.721 HD12 HD13 ' C' ' 29' ' ' LEU . 28.2 mm -78.36 -38.03 22.51 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 N-CA-C 108.832 -0.803 . . . . 75.43 108.832 173.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 51' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -78.85 -11.87 60.01 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.799 0.84 . . . . 74.04 111.399 174.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 52' ' ' GLU . . . . . 0.448 ' O ' HG23 ' C' ' 56' ' ' VAL . 30.0 tt0 -77.83 -53.07 7.92 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 108.064 -1.088 . . . . 63.42 108.064 169.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . 0.438 ' HA ' ' CD1' ' C' ' 7' ' ' TYR . . . -57.8 -34.14 69.31 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 114.432 -1.258 . . . . 63.1 111.399 175.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 54' ' ' TYR . . . . . 0.467 ' O ' ' HB2' ' C' ' 58' ' ' SER . 22.9 t80 -82.9 -32.45 27.28 Favored 'General case' 0 C--O 1.216 -0.68 0 C-N-CA 123.79 0.836 . . . . 75.01 110.378 177.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.39 -31.66 66.03 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 118.277 0.489 . . . . 60.54 110.537 173.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 56' ' ' VAL . . . . . 0.465 HG12 ' HB2' ' C' ' 66' ' ' TYR . 10.1 t -100.06 -21.3 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.245 0 CA-C-N 115.129 -0.941 . . . . 72.43 112.598 -179.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 57' ' ' LEU . . . . . 0.547 HD22 ' HG3' ' C' ' 63' ' ' ARG . 71.0 mt -127.4 29.3 5.56 Favored 'General case' 0 N--CA 1.501 2.122 0 CA-C-N 119.424 1.011 . . . . 75.02 112.655 -179.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 58' ' ' SER . . . . . 0.467 ' HB2' ' O ' ' C' ' 54' ' ' TYR . 21.4 t -68.62 -60.81 2.15 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.297 0.57 . . . . 62.42 112.221 177.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -125.9 158.98 63.8 Favored Pre-proline 0 N--CA 1.481 1.097 0 C-N-CA 124.393 1.077 . . . . 72.03 109.117 -171.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 60' ' ' PRO . . . . . 0.525 ' HD3' ' HG2' ' C' ' 19' ' ' GLN . 10.3 Cg_endo -48.89 -30.46 17.53 Favored 'Trans proline' 0 C--N 1.388 2.631 0 C-N-CA 123.162 2.574 . . . . 33.23 113.299 178.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . 0.441 ' O ' HG12 ' C' ' 65' ' ' ILE . 18.4 tt0 -50.79 -69.34 0.11 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.306 1.042 . . . . 62.13 110.625 170.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -60.22 -44.81 94.86 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-N 114.724 -1.125 . . . . 75.23 111.357 -174.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 63' ' ' ARG . . . . . 0.547 ' HG3' HD22 ' C' ' 57' ' ' LEU . 31.7 ttp-105 -62.77 -46.14 89.41 Favored 'General case' 0 C--N 1.349 0.544 0 CA-C-N 114.865 -1.062 . . . . 64.42 110.595 -174.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -72.57 -25.95 61.54 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 123.744 0.652 . . . . 74.15 111.552 -178.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 65' ' ' ILE . . . . . 0.441 HG12 ' O ' ' C' ' 61' ' ' GLU . 46.1 mm -60.13 -46.61 94.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 109.351 -0.611 . . . . 62.34 109.351 168.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 66' ' ' TYR . . . . . 0.465 ' HB2' HG12 ' C' ' 56' ' ' VAL . 18.3 t80 -63.63 -46.26 86.51 Favored 'General case' 0 C--N 1.353 0.723 0 CA-C-N 115.664 -0.698 . . . . 74.22 110.677 176.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -62.44 -33.67 75.28 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.219 0.607 . . . . 73.14 111.461 -176.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 44.5 p -78.14 -20.27 52.41 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.362 -0.381 . . . . 63.2 111.001 175.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -75.02 133.65 41.6 Favored 'General case' 0 CA--C 1.556 1.181 0 N-CA-C 108.415 -0.957 . . . . 75.22 108.415 165.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 91.28 15.6 55.25 Favored Glycine 0 N--CA 1.476 1.345 0 N-CA-C 111.225 -0.75 . . . . 62.51 111.225 -167.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 99.9 m -141.27 -60.34 0.49 Allowed 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 103.601 -2.74 . . . . 72.34 103.601 175.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 91.0 m -78.15 139.09 39.0 Favored 'General case' 0 C--O 1.251 1.155 0 N-CA-C 104.268 -2.493 . . . . 73.35 104.268 155.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.38 -45.93 4.34 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.62 0.768 . . . . 73.23 109.659 -172.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -73.87 144.32 82.5 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 123.435 0.694 . . . . 53.23 109.979 178.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.82 120.78 8.69 Favored 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 122.738 2.292 . . . . 75.14 110.989 173.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -54.27 159.59 7.79 Favored 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 123.685 2.924 . . . . 63.14 114.444 -176.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.57 127.75 14.37 Favored 'Trans proline' 0 C--N 1.381 2.242 0 C-N-CA 122.249 1.966 . . . . 51.51 110.839 172.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 78' ' ' PRO . . . . . 0.46 ' HB3' ' HA3' ' C' ' 104' ' ' GLY . 18.1 Cg_endo -59.02 129.91 34.06 Favored 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 122.609 2.206 . . . . 74.44 112.75 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.07 156.02 66.43 Favored 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 122.749 2.299 . . . . 61.04 111.45 174.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_exo -53.78 87.47 0.03 OUTLIER 'Trans proline' 0 C--N 1.385 2.494 0 C-N-CA 123.314 2.676 . . . . 51.5 112.707 176.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 159.55 -45.45 0.43 Allowed Glycine 0 C--N 1.342 0.894 0 CA-C-N 114.673 -1.149 . . . . 75.2 111.179 178.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 109.45 167.87 20.27 Favored Glycine 0 C--N 1.352 1.433 0 C-N-CA 123.669 0.652 . . . . 74.45 111.987 -175.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -78.03 112.15 14.65 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 109.293 -0.632 . . . . 70.14 109.293 176.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -63.56 146.22 54.13 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.808 0.843 . . . . 63.13 112.801 -178.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 85' ' ' PHE . . . . . 0.47 ' O ' ' HB3' ' C' ' 171' ' ' PRO . 75.9 m-85 -138.62 71.33 1.39 Allowed 'General case' 0 C--N 1.356 0.878 0 C-N-CA 124.299 1.039 . . . . 74.41 110.207 171.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 37.0 m -51.0 86.75 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 125.05 1.34 . . . . 45.43 112.744 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 75.68 -5.54 37.66 Favored Glycine 0 CA--C 1.535 1.294 0 CA-C-N 116.067 -0.515 . . . . 74.33 113.493 -176.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 88' ' ' PHE . . . . . 0.451 ' HB2' ' HB3' ' C' ' 85' ' ' PHE . 12.8 m-85 -81.19 118.52 22.64 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.829 -0.804 . . . . 74.44 108.829 -171.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -76.86 81.4 3.44 Favored 'General case' 0 C--O 1.243 0.745 0 CA-C-O 121.204 0.526 . . . . 72.23 110.483 -173.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 90' ' ' VAL . . . . . 0.746 HG21 HD21 ' C' ' 169' ' ' ASN . 1.5 p -44.41 -40.96 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 125.46 1.504 . . . . 54.41 111.852 175.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -48.12 -40.0 22.2 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.716 1.606 . . . . 74.21 112.961 -178.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -85.1 -29.37 24.91 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.583 0.753 . . . . 75.53 112.165 -173.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 17.1 m-30 -68.98 170.39 9.9 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 113.143 0.794 . . . . 72.45 113.143 -164.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 81.0 p -71.95 172.77 9.37 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 124.77 1.228 . . . . 45.51 113.779 -164.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 95' ' ' GLU . . . . . 0.49 ' O ' ' HG3' ' C' ' 99' ' ' GLU . 4.7 mp0 -71.6 -34.0 69.5 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 115.275 -0.875 . . . . 55.43 110.953 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -61.19 -44.2 97.67 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-O 121.494 0.664 . . . . 65.02 110.33 174.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 97' ' ' PHE . . . . . 0.652 ' HE2' HG23 ' C' ' 90' ' ' VAL . 47.9 t80 -56.93 -43.77 81.8 Favored 'General case' 0 CA--C 1.554 1.103 0 CA-C-N 114.148 -1.387 . . . . 64.25 109.884 172.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -70.6 -18.97 62.88 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.055 0.542 . . . . 51.52 112.459 177.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 99' ' ' GLU . . . . . 0.49 ' HG3' ' O ' ' C' ' 95' ' ' GLU . 43.2 mt-10 -74.27 -55.35 6.13 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.127 0.489 . . . . 74.43 110.015 173.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 27.3 tp -74.91 -45.22 44.17 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.819 -1.082 . . . . 73.23 111.643 -170.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -97.24 -19.1 18.82 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.599 0.76 . . . . 73.25 112.257 -175.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -47.42 -57.96 6.93 Favored Glycine 0 CA--C 1.545 1.913 0 CA-C-O 118.947 -0.918 . . . . 54.11 115.119 -178.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -59.07 -9.41 7.97 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 123.788 2.992 . . . . 62.02 114.621 -179.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 104' ' ' GLY . . . . . 0.46 ' HA3' ' HB3' ' C' ' 78' ' ' PRO . . . -136.8 34.29 2.23 Favored Glycine 0 C--N 1.351 1.414 0 CA-C-O 119.985 -0.342 . . . . 43.23 113.116 178.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 105' ' ' LEU . . . . . 0.555 ' HB3' ' ND2' ' C' ' 169' ' ' ASN . 43.1 mt . . . . . 0 N--CA 1.485 1.282 0 C-N-CA 123.314 0.645 . . . . 73.03 111.474 172.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 116' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' C' ' 170' ' ' PRO . . . . . . . . 0 C--O 1.239 0.42 0 CA-C-O 120.399 -0.112 . . . . 45.25 113.102 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 117' ' ' ARG . . . . . 0.557 HH21 ' HB3' ' C' ' 167' ' ' GLN . 69.4 mtm180 -110.41 163.86 13.26 Favored 'General case' 0 C--O 1.265 1.891 0 CA-C-O 122.154 0.978 . . . . 64.44 110.534 -177.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.09 117.74 5.06 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 112.589 -2.096 . . . . 75.42 108.353 165.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 119' ' ' LEU . . . . . 0.505 ' HG ' ' HG2' ' C' ' 167' ' ' GLN . 3.3 tt -92.23 116.18 28.73 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 104.59 -2.374 . . . . 75.21 104.59 178.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.423 ' HA ' ' O ' ' C' ' 175' ' ' LEU . 63.0 ttt180 -117.98 118.84 33.04 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.35 -0.982 . . . . 72.31 108.35 -164.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 121' ' ' ALA . . . . . 0.507 ' HA ' HG23 ' B' ' 185' ' ' VAL . . . -108.58 170.03 8.28 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 113.847 1.055 . . . . 63.21 113.847 -164.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -127.79 108.14 10.47 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 114.16 -1.382 . . . . 73.22 110.288 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -139.12 111.68 7.94 Favored Pre-proline 0 N--CA 1.487 1.42 0 CA-C-N 118.535 0.607 . . . . 73.3 112.431 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -65.74 121.59 9.0 Favored 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 122.037 1.824 . . . . 72.51 109.692 162.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 125' ' ' LEU . . . . . 0.484 ' O ' ' HA ' ' C' ' 180' ' ' LEU . 12.7 tp -145.56 167.93 21.85 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 107.585 -1.265 . . . . 74.03 107.585 -169.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 126' ' ' THR . . . . . . . . . . . . . 14.5 t -128.26 176.99 7.25 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 119.366 0.985 . . . . 61.53 110.911 173.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 127' ' ' LEU . . . . . 0.469 HD11 ' H ' ' C' ' 185' ' ' VAL . 6.3 mt -60.73 -43.54 97.76 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.485 1.514 . . . . 62.25 109.696 -177.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -60.96 -39.67 90.43 Favored 'General case' 0 C--O 1.213 -0.836 0 CA-C-N 114.133 -1.394 . . . . 75.24 110.031 179.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 129' ' ' GLU . . . . . 0.532 ' HA ' ' HB2' ' C' ' 132' ' ' HIS . 50.3 mm-40 -77.2 -22.85 51.74 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.783 0.833 . . . . 73.53 111.225 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 130' ' ' ALA . . . . . 0.487 ' HB1' ' HA2' ' C' ' 152' ' ' GLY . . . -72.26 -35.26 68.73 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 109.297 -0.631 . . . . 64.34 109.297 175.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 131' ' ' PHE . . . . . 0.546 ' HB2' HD13 ' C' ' 215' ' ' LEU . 10.5 t80 -71.09 -43.56 67.47 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 114.131 -1.395 . . . . 75.55 110.855 168.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 132' ' ' HIS . . . . . 0.532 ' HB2' ' HA ' ' C' ' 129' ' ' GLU . 32.4 m170 -75.32 -6.82 51.88 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.854 0.461 . . . . 60.22 110.378 -178.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -59.57 77.81 0.01 OUTLIER Glycine 0 C--N 1.356 1.648 0 C-N-CA 123.815 0.721 . . . . 65.31 112.904 168.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . -113.94 -152.61 10.78 Favored Glycine 0 C--N 1.342 0.884 0 N-CA-C 109.417 -1.473 . . . . 53.24 109.417 174.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -71.55 92.99 1.17 Allowed 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 108.409 -0.96 . . . . 71.2 108.409 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 136' ' ' ARG . . . . . 0.573 ' HB2' HD22 ' B' ' 181' ' ' LEU . 78.3 mtp180 -139.55 159.48 42.06 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.116 0.966 . . . . 72.12 109.589 -173.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 137' ' ' VAL . . . . . . . . . . . . . 93.5 t -70.78 98.87 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.887 0 CA-C-O 121.978 0.894 . . . . 71.12 110.664 -175.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 138' ' ' VAL . . . . . . . . . . . . . 72.9 t -79.17 112.16 16.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 CA-C-N 113.853 -1.521 . . . . 72.14 107.831 169.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 139' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -115.69 82.22 1.72 Allowed 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 108.092 -1.077 . . . . 74.31 108.092 -170.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 140' ' ' VAL . . . . . 0.503 HG11 HD11 ' C' ' 174' ' ' LEU . 67.4 t -122.86 104.65 14.82 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 C-N-CA 124.292 1.037 . . . . 63.22 110.833 -169.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 69.21 15.01 8.64 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 125.145 1.378 . . . . 15.23 113.388 168.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 116.8 -30.15 6.51 Favored Glycine 0 C--N 1.339 0.746 0 N-CA-C 110.987 -0.845 . . . . 45.25 110.987 -175.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 143' ' ' ARG . . . . . 0.489 ' CZ ' ' HB ' ' C' ' 145' ' ' VAL . 13.0 tpt180 -70.73 114.32 8.7 Favored 'General case' 0 C--N 1.361 1.092 0 N-CA-C 109.055 -0.72 . . . . 73.04 109.055 177.005 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 7.5 ttt-85 -114.27 99.26 7.47 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 115.339 -0.846 . . . . 71.51 108.95 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 145' ' ' VAL . . . . . 0.551 HG22 ' HB ' ' C' ' 147' ' ' VAL . 3.1 p -124.85 124.41 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.473 1.109 . . . . 75.03 110.028 -178.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 29.2 m -87.13 86.41 7.29 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 108.906 -0.775 . . . . 54.21 108.906 177.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 147' ' ' VAL . . . . . 0.551 ' HB ' HG22 ' C' ' 145' ' ' VAL . 7.3 p -134.81 160.56 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 124.114 0.966 . . . . 72.53 110.59 -169.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 28.5 ttm-85 -90.18 104.89 17.41 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 108.11 -1.071 . . . . 74.22 108.11 168.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 149' ' ' ILE . . . . . . . . . . . . . 29.6 pt -69.34 150.73 97.09 Favored Pre-proline 0 CA--C 1.548 0.872 0 CA-C-O 117.755 -1.117 . . . . 71.41 108.438 165.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 150' ' ' PRO . . . . . 0.564 ' HD2' HG22 ' C' ' 161' ' ' VAL . 28.4 Cg_exo -38.68 107.97 0.07 OUTLIER 'Trans proline' 0 C--N 1.393 2.88 0 C-N-CA 123.415 2.743 . . . . 61.44 113.124 178.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -69.71 130.66 19.79 Favored 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 122.671 2.247 . . . . 73.2 111.541 -171.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 152' ' ' GLY . . . . . 0.538 ' HA3' HD23 ' C' ' 188' ' ' LEU . . . 91.71 112.01 1.8 Allowed Glycine 0 C--N 1.342 0.905 0 CA-C-N 115.645 -0.707 . . . . 54.32 113.091 -177.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 153' ' ' VAL . . . . . 0.71 HG21 HG21 ' C' ' 178' ' ' VAL . 3.0 m -123.64 177.66 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 C-N-CA 123.745 0.818 . . . . 71.13 109.595 -173.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 154' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -135.03 155.48 50.69 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 123.429 0.692 . . . . 75.32 110.775 -178.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 155' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -67.88 102.53 1.27 Allowed 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.911 1.284 . . . . 74.51 112.036 -176.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 97.36 3.5 58.66 Favored Glycine 0 C--N 1.348 1.236 0 CA-C-N 115.354 -0.839 . . . . 64.51 113.009 179.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 157' ' ' SER . . . . . . . . . . . . . 52.0 m -95.75 169.82 9.74 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 117.205 0.502 . . . . 75.43 111.394 -175.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 158' ' ' VAL . . . . . 0.435 HG12 HG22 ' C' ' 177' ' ' VAL . 27.6 m -105.68 127.87 60.27 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 CA-C-O 121.604 0.716 . . . . 64.44 111.038 178.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 159' ' ' ILE . . . . . 0.594 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 15.2 mt -78.07 98.21 2.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 107.995 -1.113 . . . . 52.25 107.995 168.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 36.5 ttp180 -78.74 99.64 6.74 Favored 'General case' 0 C--O 1.239 0.51 0 O-C-N 123.794 0.684 . . . . 72.21 109.683 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 161' ' ' VAL . . . . . 0.613 ' HB ' ' HB3' ' C' ' 174' ' ' LEU . 19.3 t -95.99 113.11 61.52 Favored Pre-proline 0 C--O 1.251 1.15 0 N-CA-C 108.223 -1.028 . . . . 75.24 108.223 175.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -53.31 106.95 0.17 Allowed 'Trans proline' 0 C--N 1.381 2.277 0 C-N-CA 123.848 3.032 . . . . 63.42 114.476 -174.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 71.44 16.4 75.61 Favored Glycine 0 C--N 1.347 1.189 0 N-CA-C 115.694 1.038 . . . . 53.31 115.694 168.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 164' ' ' MET . . . . . 0.435 ' SD ' HG11 ' C' ' 145' ' ' VAL . 37.5 ttp -105.28 21.76 16.58 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 118.143 0.972 . . . . 73.35 110.939 -178.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . -78.12 -121.81 0.26 Allowed Glycine 0 C--N 1.35 1.345 0 CA-C-O 119.42 -0.656 . . . . 64.24 112.311 174.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . 150.98 -80.1 0.2 Allowed Glycine 0 C--N 1.356 1.639 0 C-N-CA 118.909 -1.615 . . . . 75.44 114.442 170.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 167' ' ' GLN . . . . . 0.557 ' HB3' HH21 ' C' ' 117' ' ' ARG . 31.6 mm-40 -14.91 101.18 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.491 0 C-N-CA 126.244 1.818 . . . . 64.31 114.043 -161.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . 115.1 143.57 8.11 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 109.078 -1.609 . . . . 13.44 109.078 -162.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 169' ' ' ASN . . . . . 0.746 HD21 HG21 ' C' ' 90' ' ' VAL . 2.7 t-20 -54.76 -57.61 18.36 Favored Pre-proline 0 CA--C 1.572 1.812 0 N-CA-C 114.597 1.332 . . . . 62.44 114.597 -164.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 170' ' ' PRO . . . . . 0.455 ' HD3' ' HB3' ' C' ' 169' ' ' ASN . 33.1 Cg_exo -62.18 154.16 64.72 Favored 'Trans proline' 0 C--N 1.393 2.905 0 CA-C-N 121.93 1.725 . . . . 51.41 112.208 172.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 171' ' ' PRO . . . . . 0.47 ' HB3' ' O ' ' C' ' 85' ' ' PHE . 22.7 Cg_endo -62.08 129.88 28.75 Favored 'Trans proline' 0 C--N 1.368 1.553 0 C-N-CA 122.234 1.956 . . . . 74.02 112.828 175.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -99.39 -175.23 31.37 Favored Glycine 0 N--CA 1.474 1.174 0 N-CA-C 110.51 -1.036 . . . . 74.42 110.51 166.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 173' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -98.91 152.97 19.19 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 117.993 0.896 . . . . 74.51 109.302 178.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 174' ' ' LEU . . . . . 0.613 ' HB3' ' HB ' ' C' ' 161' ' ' VAL . 26.5 tp -99.25 121.74 41.47 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 121.946 -0.472 . . . . 75.22 110.585 -176.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 175' ' ' LEU . . . . . 0.423 ' O ' ' HA ' ' C' ' 120' ' ' ARG . 81.3 mt -117.74 87.71 2.77 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.281 0.632 . . . . 71.32 109.9 176.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 176' ' ' LEU . . . . . 0.594 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 48.6 mt -76.22 108.46 9.17 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 116.232 -0.44 . . . . 43.02 109.949 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 177' ' ' VAL . . . . . 0.435 HG22 HG12 ' C' ' 158' ' ' VAL . 61.5 t -81.82 106.46 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 N-CA-C 108.256 -1.016 . . . . 74.43 108.256 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 178' ' ' VAL . . . . . 0.71 HG21 HG21 ' C' ' 153' ' ' VAL . 4.0 p -95.64 138.83 20.24 Favored 'Isoleucine or valine' 0 C--O 1.242 0.69 0 CA-C-N 114.344 -1.298 . . . . 74.01 110.344 -177.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 179' ' ' ARG . . . . . . . . . . . . . 52.4 mmm-85 -121.68 109.9 15.31 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 107.73 -1.211 . . . . 72.33 107.73 175.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 180' ' ' LEU . . . . . 0.484 ' HA ' ' O ' ' C' ' 125' ' ' LEU . 87.6 mt -71.11 147.87 48.02 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.199 0.6 . . . . 70.51 111.843 -176.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 181' ' ' LEU . . . . . . . . . . . . . 30.5 mt -62.01 167.83 4.42 Favored Pre-proline 0 CA--C 1.559 1.316 0 C-N-CA 124.892 1.277 . . . . 74.2 112.106 -179.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -42.43 -1.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.398 3.157 1 C-N-CA 125.364 4.043 . . . . 64.12 118.557 175.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 183' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -127.2 81.2 70.42 Favored Pre-proline 0 CA--C 1.562 1.438 0 CA-C-N 118.971 0.805 . . . . 62.13 109.792 166.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 184' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -85.51 69.6 5.23 Favored 'Trans proline' 0 C--N 1.371 1.713 0 C-N-CA 123.628 2.886 . . . . 71.54 110.485 174.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 185' ' ' VAL . . . . . 0.469 ' H ' HD11 ' C' ' 127' ' ' LEU . 3.9 t -89.89 -42.37 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 109.843 -0.429 . . . . 72.23 109.843 -165.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 186' ' ' PHE . . . . . 0.598 ' HB3' HD22 ' C' ' 193' ' ' LEU . 20.9 m-85 -99.38 116.05 30.65 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.369 0.604 . . . . 61.44 112.425 -170.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 187' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -102.51 101.77 11.99 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.312 1.445 . . . . 75.14 107.339 171.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 188' ' ' LEU . . . . . 0.538 HD23 ' HA3' ' C' ' 152' ' ' GLY . 57.8 tp -92.55 141.16 28.8 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 113.301 0.852 . . . . 74.14 113.301 -169.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -125.23 101.25 6.9 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 107.857 -1.164 . . . . 71.33 107.857 160.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 72.2 -81.12 0.59 Allowed Glycine 0 C--N 1.353 1.504 0 CA-C-N 115.18 -0.918 . . . . 74.2 113.51 176.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 191' ' ' GLN . . . . . 0.584 ' HA ' ' HB2' ' C' ' 240' ' ' PHE . 19.4 mt-30 -132.64 -9.94 3.16 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.318 0.647 . . . . 60.21 111.746 178.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -105.49 115.38 30.16 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 121.23 0.538 . . . . 65.13 110.587 -176.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 193' ' ' LEU . . . . . 0.598 HD22 ' HB3' ' C' ' 186' ' ' PHE . 72.2 mt -86.0 152.27 23.06 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.932 1.293 . . . . 52.2 111.132 -178.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 194' ' ' TYR . . . . . 0.47 ' O ' ' HA ' ' C' ' 186' ' ' PHE . 49.7 t80 -111.98 148.96 32.68 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 107.25 -1.389 . . . . 75.43 107.25 162.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 195' ' ' ALA . . . . . 0.42 ' HA ' ' O ' ' C' ' 185' ' ' VAL . . . -154.42 -176.95 6.14 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.078 0.551 . . . . 65.11 111.177 -177.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 40.2 m -128.36 139.05 52.59 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.049 -0.978 . . . . 51.32 108.893 168.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 197' ' ' LEU . . . . . 0.431 HD13 HD22 ' C' ' 251' ' ' LEU . 35.9 tp -115.53 143.46 45.28 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.522 1.129 . . . . 73.5 108.473 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -113.04 102.1 10.09 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.388 -0.597 . . . . 44.52 109.388 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 199' ' ' VAL . . . . . 0.605 ' HA ' HG11 ' C' ' 210' ' ' VAL . 95.2 t -108.08 119.36 50.17 Favored Pre-proline 0 N--CA 1.473 0.698 0 C-N-CA 123.901 0.88 . . . . 61.21 109.005 176.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 200' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.94 149.54 65.91 Favored 'Trans proline' 0 C--N 1.371 1.751 0 C-N-CA 121.858 1.705 . . . . 71.34 110.934 175.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 201' ' ' ALA . . . . . . . . . . . . . . . -56.02 -43.44 99.23 Favored Pre-proline 0 CA--C 1.553 1.093 0 N-CA-C 114.093 1.145 . . . . 74.35 114.093 -174.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 202' ' ' PRO . . . . . 0.427 ' O ' HG12 ' C' ' 206' ' ' VAL . 77.0 Cg_exo -54.18 -53.44 6.31 Favored 'Trans proline' 0 C--N 1.398 3.156 0 C-N-CA 121.752 1.635 . . . . 63.15 112.286 175.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 203' ' ' ILE . . . . . . . . . . . . . 41.0 mt -62.73 -32.99 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 124.554 1.142 . . . . 63.4 111.209 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.96 -43.9 81.92 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.756 0.822 . . . . 75.02 112.013 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 205' ' ' VAL . . . . . . . . . . . . . 87.9 t -71.7 -47.95 54.38 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 123.256 0.622 . . . . 63.41 111.199 -179.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 206' ' ' VAL . . . . . 0.569 HG23 ' HE2' ' A' ' 270' ' ' LYS . 14.7 p -80.1 -34.74 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 112.761 0.652 . . . . 52.12 112.761 -171.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 90.57 104.5 1.25 Allowed Glycine 0 C--N 1.343 0.92 0 N-CA-C 111.069 -0.812 . . . . 63.21 111.069 -167.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -143.44 -126.71 2.03 Favored Glycine 0 C--N 1.343 0.927 0 N-CA-C 111.679 -0.568 . . . . 51.32 111.679 -176.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 209' ' ' LYS . . . . . 0.478 ' HG2' ' HG2' ' C' ' 220' ' ' GLU . 34.1 ttmt -157.21 137.18 12.53 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 117.633 0.717 . . . . 72.12 110.85 -176.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 210' ' ' VAL . . . . . 0.605 HG11 ' HA ' ' C' ' 199' ' ' VAL . 23.4 m -129.95 177.03 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 125.501 1.52 . . . . 62.05 109.526 174.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 211' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.46 149.99 28.76 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 118.436 0.562 . . . . 72.44 111.204 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -129.5 118.55 22.26 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 107.45 -1.315 . . . . 74.43 107.45 166.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 213' ' ' MET . . . . . . . . . . . . . 1.4 tmm? -73.82 117.79 16.02 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.344 -0.984 . . . . 63.12 108.344 -179.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 214' ' ' THR . . . . . 0.429 ' OG1' HG12 ' C' ' 219' ' ' VAL . 0.2 OUTLIER -122.8 175.76 6.36 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 119.014 0.824 . . . . 54.24 112.095 -173.521 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 215' ' ' LEU . . . . . 0.546 HD13 ' HB2' ' C' ' 131' ' ' PHE . 41.7 mt -75.82 -29.8 58.78 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.459 1.503 . . . . 44.41 112.012 -171.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -87.11 3.28 46.86 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 114.803 -1.09 . . . . 71.0 110.272 176.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 118.26 -178.22 16.75 Favored Glycine 0 C--N 1.348 1.208 0 N-CA-C 110.433 -1.067 . . . . 64.11 110.433 -172.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -75.26 125.2 9.0 Favored 'Trans proline' 0 CA--C 1.554 1.477 0 C-N-CA 121.954 1.769 . . . . 52.13 111.97 178.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 219' ' ' VAL . . . . . 0.475 HG23 HG22 ' B' ' 238' ' ' THR . 14.0 p -100.56 157.51 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 N-CA-C 106.865 -1.531 . . . . 52.53 106.865 171.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 220' ' ' GLU . . . . . 0.478 ' HG2' ' HG2' ' C' ' 209' ' ' LYS . 16.5 tt0 -126.63 108.33 11.01 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.859 -0.793 . . . . 72.32 108.859 -177.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 221' ' ' VAL . . . . . 0.423 HG22 HD21 ' C' ' 235' ' ' LEU . 32.1 t -68.9 123.99 23.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 125.858 1.663 . . . . 74.03 111.2 -174.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -84.67 108.49 17.42 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 109.413 -0.588 . . . . 73.3 109.413 172.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 61.1 t -84.25 127.64 65.54 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 123.744 0.818 . . . . 73.11 110.508 -176.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 224' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -79.76 161.83 24.33 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 123.233 2.622 . . . . 54.33 111.082 168.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -63.12 159.05 40.7 Favored 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 122.427 2.084 . . . . 74.0 113.483 177.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 226' ' ' ARG . . . . . 0.444 ' HD2' ' O ' ' A' ' 259' ' ' GLU . 9.5 mmt180 55.3 63.0 2.24 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.514 1.526 . . . . 70.15 111.894 177.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 227' ' ' THR . . . . . . . . . . . . . 52.4 m -96.92 128.93 44.36 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 123.815 0.846 . . . . 70.3 110.97 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 228' ' ' GLN . . . . . 0.477 ' NE2' ' HG3' ' A' ' 259' ' ' GLU . 27.8 mp0 -105.23 147.67 27.8 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 124.545 1.138 . . . . 74.32 111.893 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -73.28 123.4 23.65 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 115.43 -0.805 . . . . 62.12 109.264 177.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 116.12 -7.41 18.99 Favored Glycine 0 C--N 1.337 0.599 0 O-C-N 123.522 0.514 . . . . 62.04 112.064 -176.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 231' ' ' ARG . . . . . 0.59 ' HD3' ' HZ3' ' B' ' 242' ' ' TRP . 36.0 mtt180 -63.02 169.57 3.27 Favored 'General case' 0 C--N 1.354 0.79 0 CA-C-N 116.846 0.323 . . . . 74.12 110.925 171.072 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 232' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' C' ' 251' ' ' LEU . 3.7 ttmp? -139.29 147.06 41.13 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.567 -0.531 . . . . 71.45 109.567 176.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 233' ' ' LEU . . . . . 0.468 ' O ' ' HA ' ' C' ' 250' ' ' TYR . 1.7 tt -133.01 125.01 28.77 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.693 0.797 . . . . 74.21 109.308 -166.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -93.19 104.22 16.43 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-O 121.065 0.459 . . . . 72.34 110.614 170.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 235' ' ' LEU . . . . . 0.423 HD21 HG22 ' C' ' 221' ' ' VAL . 75.8 mt -85.11 123.88 31.14 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.391 -0.966 . . . . 73.43 108.391 166.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -85.32 131.75 34.36 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 123.349 0.66 . . . . 71.55 111.541 -171.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 80.83 -1.28 84.45 Favored Glycine 0 C--N 1.351 1.402 0 O-C-N 124.033 0.833 . . . . 71.42 113.687 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 238' ' ' LYS . . . . . 0.405 ' HG3' ' HB3' ' C' ' 235' ' ' LEU . 14.0 mmtm -95.11 9.05 41.03 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.19 0.996 . . . . 72.03 112.019 -172.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -86.29 -133.01 3.27 Favored Glycine 0 C--N 1.346 1.085 0 N-CA-C 111.723 -0.551 . . . . 31.21 111.723 172.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 240' ' ' PHE . . . . . 0.584 ' HB2' ' HA ' ' C' ' 191' ' ' GLN . 1.9 m-85 -103.37 128.45 27.48 Favored Pre-proline 0 N--CA 1.47 0.558 0 C-N-CA 123.105 0.562 . . . . 75.14 110.132 177.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 241' ' ' PRO . . . . . 0.454 ' HA ' ' HG2' ' C' ' 246' ' ' ARG . 31.4 Cg_exo -61.98 105.21 0.37 Allowed 'Trans proline' 0 C--N 1.37 1.688 0 C-N-CA 123.405 2.736 . . . . 70.21 112.916 173.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -75.67 173.16 53.58 Favored Glycine 0 CA--C 1.531 1.081 0 CA-C-N 115.195 -0.911 . . . . 70.14 112.798 174.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -64.86 -17.17 58.69 Favored 'Trans proline' 0 C--N 1.367 1.545 0 C-N-CA 123.184 2.589 . . . . 71.42 113.955 -170.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -130.84 1.07 4.34 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.631 0.773 . . . . 71.42 111.907 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . -173.19 -136.66 2.22 Favored Glycine 0 C--N 1.35 1.349 0 CA-C-O 119.648 -0.529 . . . . 51.32 113.09 -178.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 246' ' ' ARG . . . . . 0.454 ' HG2' ' HA ' ' C' ' 241' ' ' PRO . 77.8 mtm180 -150.04 165.06 33.89 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.826 0.851 . . . . 61.31 110.891 -176.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -102.35 -166.66 26.63 Favored Glycine 0 C--N 1.35 1.322 0 CA-C-N 114.801 -1.091 . . . . 63.23 111.951 174.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -129.44 164.12 24.36 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 121.114 0.483 . . . . 73.54 110.359 -171.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 249' ' ' LEU . . . . . 0.413 HD23 HD12 ' C' ' 235' ' ' LEU . 17.7 tp -120.18 127.62 52.63 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.167 0.987 . . . . 74.23 109.401 -174.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 250' ' ' TYR . . . . . 0.468 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 79.0 m-85 -117.24 100.78 7.93 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.704 0.802 . . . . 71.43 110.323 -177.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 251' ' ' LEU . . . . . 0.447 ' O ' ' HA ' ' C' ' 232' ' ' LYS . 0.6 OUTLIER -100.97 134.29 44.19 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 109.932 -0.395 . . . . 64.53 109.932 -176.133 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -76.68 107.73 9.19 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.145 -1.057 . . . . 73.41 108.145 168.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 253' ' ' VAL . . . . . . . . . . . . . 46.2 t -75.07 113.78 14.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 115.199 -0.91 . . . . 73.5 110.2 -176.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 254' ' ' ARG . . . . . . . . . . . . . 39.1 mtm180 -97.13 155.46 16.81 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.297 0.639 . . . . 74.13 110.882 177.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 255' ' ' ILE . . . . . . . . . . . . . 36.9 mm -101.56 124.88 55.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 114.764 -1.107 . . . . 75.24 108.052 166.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 256' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.07 175.97 8.46 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.138 1.375 . . . . 53.32 108.536 -178.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 35.4 pt -131.16 147.88 67.99 Favored Pre-proline 0 N--CA 1.484 1.243 0 C-N-CA 123.491 0.716 . . . . 64.54 110.047 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -62.56 -12.89 30.3 Favored 'Trans proline' 0 C--N 1.377 2.07 0 C-N-CA 122.862 2.375 . . . . 73.21 113.858 -172.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 54.24 -67.58 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 125.481 1.512 . . . . 72.3 112.194 -164.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 8.0 ppt_? -60.07 132.7 54.76 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.264 0.626 . . . . 73.41 110.433 174.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 261' ' ' LEU . . . . . . . . . . . . . 92.4 mt -139.9 147.86 41.2 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.728 0.811 . . . . 71.21 109.978 -174.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 74.4 p -81.89 160.45 63.56 Favored Pre-proline 0 CA--C 1.553 1.084 0 N-CA-C 107.97 -1.122 . . . . 61.23 107.97 168.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -45.84 -44.08 18.67 Favored 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 122.782 2.322 . . . . 74.2 112.538 172.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -60.97 -54.18 48.14 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-N 114.18 -1.373 . . . . 71.04 111.514 176.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -50.02 -58.45 5.46 Favored 'General case' 0 C--N 1.359 0.994 0 O-C-N 124.284 0.99 . . . . 65.11 109.992 -177.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 266' ' ' GLU . . . . . 0.468 ' O ' ' HG2' ' C' ' 270' ' ' LYS . 26.8 tt0 -61.34 -38.21 86.09 Favored 'General case' 0 C--N 1.349 0.574 0 CA-C-N 114.719 -1.128 . . . . 64.21 111.336 -175.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -57.28 -46.43 83.11 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.201 0.6 . . . . 70.32 112.351 177.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 268' ' ' LEU . . . . . 0.477 ' HB2' HD21 ' A' ' 272' ' ' LEU . 10.4 mp -66.15 -39.97 90.21 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 116.407 -0.36 . . . . 52.44 110.89 177.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -60.44 -36.0 77.17 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 123.266 0.354 . . . . 61.11 111.277 174.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 270' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' C' ' 266' ' ' GLU . 34.2 mmtp -64.08 -45.94 86.49 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.397 0.679 . . . . 75.43 110.439 178.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -56.29 -47.42 78.69 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 124.036 0.835 . . . . 75.33 111.577 176.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 91.3 mt -61.42 -42.09 98.19 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 114.834 -1.075 . . . . 74.33 110.803 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -61.47 -40.4 94.39 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.373 0.669 . . . . 34.13 111.046 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -68.16 -34.06 75.62 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.715 0.806 . . . . 63.21 111.634 177.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -62.67 -31.43 72.32 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 115.838 -0.619 . . . . 70.04 110.331 172.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 276' ' ' TYR . . . . . 0.485 ' HB3' HD11 ' A' ' 203' ' ' ILE . 53.6 m-85 -79.82 -30.99 40.61 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.084 0.554 . . . . 75.52 112.437 171.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 19.0 m-30 -68.11 -24.23 65.0 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 118.517 0.599 . . . . 44.24 110.205 178.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -61.32 -8.3 3.74 Favored 'General case' 0 CA--C 1.559 1.326 0 C-N-CA 124.193 0.997 . . . . 55.2 113.425 172.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 279' ' ' ARG . . . . . . . . . . . . . 81.3 mtt180 -73.59 -24.07 60.01 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 122.739 0.416 . . . . 71.52 112.005 174.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.556 1.186 0 O-C-N 124.417 1.073 . . . . 75.14 112.781 -167.514 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp . . . . . 0 CA--C 1.553 1.07 0 N-CA-C 113.789 1.033 . . . . 62.43 113.789 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.417 ' HB3' HD11 ' A' ' 10' ' ' ILE . 51.3 mtmt -87.96 128.18 35.38 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 108.565 -0.902 . . . . 74.32 108.565 169.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.492 ' HA ' ' OH ' ' A' ' 66' ' ' TYR . 10.7 t70 -76.48 105.81 7.75 Favored 'General case' 0 C--N 1.347 0.491 0 N-CA-C 109.187 -0.672 . . . . 61.41 109.187 -177.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -68.44 -33.31 73.98 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.692 0.797 . . . . 73.34 112.531 -170.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -64.12 -45.62 87.77 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 109.634 -0.506 . . . . 73.33 109.634 174.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.48 -42.1 95.59 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.632 -0.713 . . . . 60.32 111.375 178.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.417 HD11 ' HB3' ' A' ' 5' ' ' LYS . 81.4 mt -58.79 -42.22 84.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 123.676 0.79 . . . . 74.23 110.231 176.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.2 mt -76.14 -11.81 60.0 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 112.912 0.708 . . . . 51.33 112.912 178.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.56 35.09 56.12 Favored Glycine 0 C--N 1.351 1.385 0 O-C-N 122.972 0.17 . . . . 53.33 112.709 -178.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.5 m -127.1 154.5 76.67 Favored Pre-proline 0 CA--C 1.552 1.028 0 C-N-CA 124.916 1.286 . . . . 71.43 109.608 178.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -74.57 168.56 24.52 Favored 'Trans proline' 0 C--N 1.374 1.914 0 C-N-CA 122.282 1.988 . . . . 50.12 112.25 177.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 83.7 mtt180 -75.12 17.36 0.24 Allowed 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 113.142 0.793 . . . . 75.43 113.142 -178.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -124.78 15.42 8.67 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.101 0.96 . . . . 64.11 108.974 173.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.11 112.08 2.84 Favored 'General case' 0 C--N 1.349 0.566 0 CA-C-N 115.069 -0.969 . . . . 64.31 110.437 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 62.1 p -72.31 169.76 15.57 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.59 0.756 . . . . 71.11 109.708 176.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -54.03 -41.06 67.62 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.954 0.902 . . . . 64.21 112.07 -177.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -65.69 -41.28 92.6 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.187 0.595 . . . . 72.43 110.598 -177.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -69.29 -40.81 77.51 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.36 0.664 . . . . 64.03 111.014 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.554 HD13 ' HB3' ' A' ' 57' ' ' LEU . 60.9 mt -68.68 -32.86 56.74 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 C-N-CA 124.271 1.028 . . . . 73.31 110.721 178.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp -73.49 -37.88 65.57 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.177 0.991 . . . . 71.24 110.341 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -75.72 -29.25 58.86 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.044 0.538 . . . . 54.12 110.909 175.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.87 -33.85 71.01 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.351 0.66 . . . . 64.0 110.073 174.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -64.96 -53.05 52.36 Favored 'General case' 0 C--O 1.201 -1.466 0 CA-C-N 114.916 -1.038 . . . . 73.1 109.369 173.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -54.08 -40.14 66.96 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.643 0.777 . . . . 74.22 111.703 178.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.419 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 61.0 ttt180 -55.08 -68.19 0.21 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.174 1.39 . . . . 71.15 110.79 177.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.745 ' HB3' HD13 ' A' ' 50' ' ' ILE . 96.2 mt -74.43 -16.71 60.86 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.411 -0.813 . . . . 74.11 111.745 -174.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.21 -56.71 8.75 Favored 'General case' 0 C--O 1.204 -1.306 0 N-CA-C 108.177 -1.046 . . . . 63.3 108.177 174.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 69.2 mtp180 -55.22 -51.88 65.17 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 124.127 0.892 . . . . 72.33 110.768 177.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.419 ' HG2' ' O ' ' A' ' 28' ' ' ARG . 14.5 mm100 -54.28 -47.13 72.68 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 124.303 1.002 . . . . 63.33 111.728 -178.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.404 ' HE2' HD22 ' A' ' 29' ' ' LEU . 27.7 m-85 -117.82 29.54 7.77 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.36 0.664 . . . . 63.25 111.775 -168.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -75.84 111.79 16.56 Favored Pre-proline 0 N--CA 1.485 1.281 0 CA-C-O 117.795 -1.098 . . . . 63.41 109.705 -179.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.4 -26.86 83.71 Favored 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 122.516 2.144 . . . . 74.13 111.759 176.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -59.81 -37.39 79.04 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.126 1.37 . . . . 72.45 111.572 175.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 73.5 t -101.97 -58.66 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 CA-C-O 121.478 0.656 . . . . 65.53 109.74 -178.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -97.0 98.96 10.51 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.122 1.369 . . . . 61.35 109.739 -177.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -74.36 82.76 1.91 Allowed 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.953 -0.758 . . . . 73.11 108.953 177.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.412 ' O ' ' HG3' ' A' ' 44' ' ' GLU . 53.7 m -139.64 113.52 7.87 Favored Pre-proline 0 N--CA 1.474 0.753 0 CA-C-O 118.492 -0.765 . . . . 54.41 109.281 177.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -48.19 -40.95 34.97 Favored 'Trans proline' 0 C--N 1.385 2.48 0 C-N-CA 123.606 2.87 . . . . 72.23 113.437 178.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -55.15 -47.03 75.68 Favored 'General case' 0 C--O 1.248 0.999 0 C-N-CA 124.578 1.151 . . . . 64.43 110.696 175.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.64 -23.04 63.43 Favored 'General case' 0 C--N 1.354 0.787 0 CA-C-N 115.077 -0.965 . . . . 72.14 110.782 -178.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.526 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 33.5 mt-10 -76.31 -49.11 17.8 Favored 'General case' 0 C--N 1.358 0.957 0 O-C-N 123.511 0.507 . . . . 62.01 109.781 -176.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -67.95 -39.68 83.38 Favored 'General case' 0 C--O 1.251 1.166 0 O-C-N 123.801 0.688 . . . . 62.44 110.927 -179.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 42.8 mttp -56.94 -48.95 77.1 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 116.168 -0.469 . . . . 74.03 110.177 170.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -59.71 -32.91 70.97 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.101 0.96 . . . . 73.24 110.84 179.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.526 ' HG2' ' O ' ' A' ' 44' ' ' GLU . 33.5 mmtp -66.66 -43.41 84.63 Favored 'General case' 0 C--N 1.349 0.548 0 CA-C-O 119.245 -0.407 . . . . 75.14 110.662 177.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -68.17 -26.56 65.81 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 123.706 0.629 . . . . 71.44 112.278 176.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.745 HD13 ' HB3' ' A' ' 29' ' ' LEU . 59.5 mt -76.76 -35.2 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 124.106 0.962 . . . . 70.53 110.242 175.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -79.3 -21.61 45.73 Favored 'General case' 0 C--O 1.212 -0.891 0 C-N-CA 123.889 0.875 . . . . 73.43 110.621 175.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -77.27 -45.64 25.71 Favored 'General case' 0 C--O 1.247 0.924 0 C-N-CA 124.977 1.311 . . . . 63.42 108.726 176.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.78 -47.45 82.51 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-N 113.672 -1.604 . . . . 65.45 110.184 174.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.488 ' HD2' ' HZ ' ' A' ' 88' ' ' PHE . 16.6 t80 -76.48 -23.27 53.8 Favored 'General case' 0 C--O 1.207 -1.166 0 CA-C-N 115.435 -0.802 . . . . 72.32 110.713 177.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.408 ' HB1' ' HD2' ' A' ' 85' ' ' PHE . . . -60.97 -36.16 78.69 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 118.833 0.742 . . . . 53.01 110.875 175.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.532 HG11 ' HB2' ' A' ' 66' ' ' TYR . 19.2 t -76.04 -57.66 5.79 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 CA-C-N 115.363 -0.835 . . . . 74.52 110.099 171.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.554 ' HB3' HD13 ' A' ' 22' ' ' ILE . 49.2 mt -87.31 12.0 12.99 Favored 'General case' 0 CA--C 1.561 1.397 0 CA-C-N 115.003 -0.999 . . . . 62.04 112.964 -164.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.463 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 26.0 t -69.06 -38.61 79.17 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 123.933 0.893 . . . . 74.34 111.228 176.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.481 ' HB2' ' HD3' ' A' ' 62' ' ' LYS . 8.8 m-20 -124.6 142.07 39.57 Favored Pre-proline 0 N--CA 1.475 0.813 0 N-CA-C 108.96 -0.755 . . . . 74.34 108.96 -177.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.423 ' O ' ' HG2' ' A' ' 64' ' ' ARG . 40.0 Cg_exo -58.04 -27.45 79.57 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 122.972 2.448 . . . . 72.41 113.115 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -59.43 -58.72 7.39 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.012 0.925 . . . . 72.3 110.817 176.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.481 ' HD3' ' HB2' ' A' ' 59' ' ' ASP . 20.8 mtpt -73.07 -29.56 63.04 Favored 'General case' 0 C--O 1.249 1.078 0 CA-C-N 114.53 -1.214 . . . . 74.54 111.029 -175.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.432 ' HG3' HD22 ' A' ' 57' ' ' LEU . 61.6 ttt-85 -60.05 -43.92 95.05 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.204 -0.907 . . . . 74.11 109.462 172.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.423 ' HG2' ' O ' ' A' ' 60' ' ' PRO . 22.8 mmt180 -68.93 -31.34 70.17 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 123.736 0.648 . . . . 74.25 112.029 177.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.448 HD12 ' HA ' ' A' ' 62' ' ' LYS . 87.3 mt -54.38 -46.5 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 CA-C-O 121.255 0.55 . . . . 64.42 109.653 169.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.532 ' HB2' HG11 ' A' ' 56' ' ' VAL . 7.7 t80 -63.82 -49.99 70.7 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 115.532 -0.758 . . . . 75.4 111.377 175.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -57.68 -36.07 71.43 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.997 0.919 . . . . 64.04 111.323 -176.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 60.8 p -79.31 -28.08 42.18 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 119.054 -0.498 . . . . 75.13 110.922 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -67.88 102.78 1.32 Allowed 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 109.455 -0.572 . . . . 63.45 109.455 176.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 119.68 17.63 4.64 Favored Glycine 0 N--CA 1.473 1.124 0 C-N-CA 124.053 0.835 . . . . 52.54 111.346 -170.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 67.8 m -150.61 -55.75 0.16 Allowed 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 104.208 -2.516 . . . . 71.23 104.208 177.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 34.0 m -78.98 138.45 38.06 Favored 'General case' 0 C--O 1.251 1.146 0 N-CA-C 104.466 -2.42 . . . . 74.23 104.466 156.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.75 -31.58 12.17 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.015 0.526 . . . . 74.04 110.122 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.72 152.15 87.04 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 123.923 0.889 . . . . 75.1 110.314 175.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -62.32 116.58 3.59 Favored 'Trans proline' 0 C--N 1.375 1.934 0 C-N-CA 122.262 1.975 . . . . 75.41 109.952 168.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -51.02 144.99 26.33 Favored 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 123.653 2.902 . . . . 74.25 114.07 -177.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.438 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 11.0 Cg_endo -50.54 124.46 13.36 Favored 'Trans proline' 0 C--N 1.389 2.705 0 C-N-CA 123.828 3.019 . . . . 62.44 113.279 -174.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 77' ' ' PRO . 25.4 Cg_exo -63.87 135.33 47.59 Favored 'Trans proline' 0 C--N 1.379 2.152 0 C-N-CA 122.627 2.218 . . . . 43.51 112.227 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.402 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 85.3 Cg_exo -51.16 149.91 15.07 Favored 'Trans proline' 0 C--N 1.378 2.091 0 C-N-CA 122.932 2.422 . . . . 71.05 112.281 168.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 79' ' ' PRO . 38.9 Cg_exo -61.3 85.23 0.09 OUTLIER 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 123.183 2.589 . . . . 51.35 113.266 -175.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 150.03 -34.29 1.02 Allowed Glycine 0 N--CA 1.466 0.674 0 N-CA-C 109.963 -1.255 . . . . 62.41 109.963 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 140.76 -152.73 23.27 Favored Glycine 0 C--N 1.35 1.32 0 C-N-CA 124.151 0.882 . . . . 53.03 110.955 175.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -99.01 113.22 25.29 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.152 0.981 . . . . 74.41 108.897 175.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -55.1 141.76 33.32 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.638 1.175 . . . . 71.31 111.47 174.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.429 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 55.8 m-85 -140.58 77.99 1.63 Allowed 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 124.429 1.092 . . . . 70.22 110.215 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.592 ' HA ' ' HA3' ' A' ' 163' ' ' GLY . 1.7 m -45.62 82.86 0.0 OUTLIER 'General case' 0 CA--C 1.561 1.392 0 C-N-CA 125.892 1.677 . . . . 74.44 113.225 -177.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 62.4 28.48 71.15 Favored Glycine 0 C--N 1.349 1.282 0 CA-C-N 116.044 -0.525 . . . . 70.11 114.306 -176.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.488 ' HZ ' ' HD2' ' A' ' 54' ' ' TYR . 30.1 m-85 -112.23 117.66 33.16 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.034 0.534 . . . . 72.34 110.031 -176.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.494 ' HA ' ' HB3' ' A' ' 170' ' ' PRO . 5.7 m-20 -82.89 74.75 9.83 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 122.405 1.097 . . . . 71.44 110.225 178.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.512 HG21 HD22 ' A' ' 105' ' ' LEU . 1.6 p -50.13 -30.0 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 126.613 1.965 . . . . 75.21 113.11 171.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -63.59 -4.99 3.33 Favored 'General case' 0 CA--C 1.566 1.595 0 C-N-CA 124.651 1.18 . . . . 75.33 111.989 177.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -119.03 -15.49 9.27 Favored 'General case' 0 CA--C 1.562 1.433 0 C-N-CA 124.652 1.181 . . . . 45.35 111.559 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 18.7 m-30 -74.94 -170.06 1.03 Allowed 'General case' 0 N--CA 1.503 2.212 0 C-N-CA 123.75 0.82 . . . . 71.01 112.625 -173.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 82.5 p -77.76 167.3 21.77 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 113.693 0.997 . . . . 74.5 113.693 -169.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.02 -49.02 77.72 Favored 'General case' 0 C--N 1.365 1.276 0 CA-C-N 115.455 -0.793 . . . . 74.31 111.665 179.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -56.35 -40.87 75.2 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.592 0.757 . . . . 75.03 110.258 -177.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -65.27 -45.88 82.74 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 114.606 -1.179 . . . . 63.23 110.228 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.503 ' HA ' HD11 ' A' ' 105' ' ' LEU . 41.1 mt-30 -80.82 1.73 29.35 Favored 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 114.994 -1.003 . . . . 73.05 111.868 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -99.64 -51.09 3.85 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 124.074 0.95 . . . . 70.02 111.748 170.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 43.0 tp -66.61 -46.92 74.31 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.548 0.739 . . . . 55.03 110.382 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -90.76 -5.05 56.19 Favored 'General case' 0 CA--C 1.55 0.981 0 CA-C-N 115.766 -0.652 . . . . 72.11 110.694 176.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -44.99 -59.39 4.47 Favored Glycine 0 CA--C 1.541 1.681 0 CA-C-O 118.651 -1.083 . . . . 72.43 114.975 178.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -59.6 -1.72 1.18 Allowed 'Trans proline' 0 C--N 1.387 2.564 0 C-N-CA 123.711 2.941 . . . . 23.1 115.126 -177.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -149.49 36.32 1.01 Allowed Glycine 0 C--N 1.354 1.574 0 CA-C-N 118.549 0.613 . . . . 44.4 112.82 173.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.512 HD22 HG21 ' A' ' 90' ' ' VAL . 18.3 mt -71.94 62.51 0.45 Allowed 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 117.705 0.753 . . . . 74.25 112.348 172.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 35.47 -112.07 0.07 Allowed 'General case' 0 CA--C 1.561 1.378 0 C-N-CA 126.403 1.881 . . . . 72.25 114.214 173.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 56.86 18.88 27.24 Favored Glycine 0 C--N 1.369 2.397 0 N-CA-C 111.77 -0.532 . . . . 44.0 111.77 -163.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.361 1.972 0 O-C-N 124.604 0.826 . . . . 71.34 111.96 -166.583 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.532 ' HA ' ' HD2' ' A' ' 170' ' ' PRO . 37.4 tttp . . . . . 0 N--CA 1.482 1.169 0 N-CA-C 112.637 0.606 . . . . 72.15 112.637 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -80.47 165.75 48.64 Favored Glycine 0 C--N 1.348 1.239 0 O-C-N 124.108 0.88 . . . . 55.22 115.094 -168.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.436 ' O ' ' HA3' ' A' ' 172' ' ' GLY . 24.3 ttt180 -59.99 143.93 50.54 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.819 1.248 . . . . 71.34 111.495 176.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -78.68 126.92 31.38 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 108.733 -0.84 . . . . 74.23 108.733 166.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 53.9 tp -119.25 132.56 55.94 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 109.386 -0.598 . . . . 70.23 109.386 -176.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 67.9 ttp85 -90.8 110.97 22.17 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 108.36 -0.978 . . . . 74.51 108.36 171.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -114.72 150.97 34.47 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.637 0.775 . . . . 41.51 109.131 178.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -106.95 118.63 37.21 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 107.134 -1.432 . . . . 61.0 107.134 -170.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.41 HD11 ' HE ' ' A' ' 136' ' ' ARG . 13.2 tp -99.79 100.14 10.48 Favored Pre-proline 0 N--CA 1.472 0.67 0 N-CA-C 108.892 -0.781 . . . . 54.05 108.892 -176.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.643 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 50.8 Cg_endo -71.75 111.05 3.05 Favored 'Trans proline' 0 C--N 1.374 1.891 0 N-CA-C 108.544 -1.368 . . . . 75.33 108.544 172.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.474 ' HB3' HD23 ' A' ' 180' ' ' LEU . 60.6 tp -115.78 140.22 49.43 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.438 0.637 . . . . 64.01 110.263 -171.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 93.3 m -74.87 134.4 41.66 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 114.068 -1.423 . . . . 71.34 111.078 179.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.429 HD13 ' HB2' ' A' ' 186' ' ' PHE . 91.0 mt -57.96 -38.36 75.87 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.939 0.895 . . . . 70.54 111.134 -177.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -56.2 -42.6 77.44 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 114.492 -1.231 . . . . 75.32 110.045 176.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -73.26 -34.61 65.91 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.583 0.753 . . . . 64.33 111.412 178.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -67.23 -25.94 66.35 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 121.128 0.49 . . . . 41.43 110.326 178.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -78.49 -42.75 28.78 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 114.657 -1.156 . . . . 74.51 110.538 173.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 36.6 m170 -68.32 -66.69 0.54 Allowed 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.14 0.576 . . . . 75.25 111.055 -177.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.588 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 81.97 56.48 2.89 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-N 116.068 -0.515 . . . . 71.54 112.789 177.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -126.42 -170.11 12.89 Favored Glycine 0 N--CA 1.471 1.017 0 N-CA-C 111.584 -0.606 . . . . 70.42 111.584 178.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 30.1 mp0 -71.37 104.71 3.27 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.447 0.699 . . . . 73.14 109.69 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.738 HH22 HD12 ' A' ' 159' ' ' ILE . 0.0 OUTLIER -90.93 147.08 23.37 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.298 -1.001 . . . . 74.4 108.298 174.843 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 62.3 t -102.68 132.44 48.78 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 N-CA-C 107.923 -1.139 . . . . 71.24 107.923 171.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.492 HG13 HG13 ' A' ' 145' ' ' VAL . 2.2 p -139.08 113.0 6.98 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 124.362 1.065 . . . . 73.14 108.389 -177.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -95.97 142.6 28.0 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 115.599 -0.728 . . . . 71.3 109.76 -176.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.2 p -168.97 138.59 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 123.617 0.767 . . . . 75.1 109.939 173.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 57.2 32.07 21.11 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 124.404 1.082 . . . . 74.24 112.548 175.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 78.41 0.37 78.27 Favored Glycine 0 C--N 1.35 1.349 0 CA-C-N 116.538 -0.301 . . . . 31.1 113.333 -178.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.92 104.39 14.36 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 124.266 1.026 . . . . 72.12 108.233 178.153 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 27.9 ttp-105 -92.67 104.4 16.68 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 125.135 1.374 . . . . 74.41 108.775 175.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.492 HG13 HG13 ' A' ' 138' ' ' VAL . 3.4 p -107.23 131.69 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 CA-C-O 120.935 0.398 . . . . 73.53 112.045 -175.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 37.6 t -100.4 110.55 22.76 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 108.249 -1.019 . . . . 31.45 108.249 170.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -136.37 140.53 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.8 1.24 . . . . 73.42 108.593 -178.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.488 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 52.7 ttt85 -83.41 144.55 29.54 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.354 0.662 . . . . 74.14 110.9 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.588 HG13 ' HA2' ' A' ' 133' ' ' GLY . 6.3 pt -106.56 145.62 31.41 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 124.609 1.164 . . . . 74.13 108.359 167.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -70.95 143.12 44.27 Favored 'Trans proline' 0 C--N 1.369 1.647 0 C-N-CA 122.272 1.981 . . . . 60.34 111.428 170.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.4 97.5 0.12 Allowed 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 122.606 2.204 . . . . 74.15 110.485 170.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 106.03 66.21 0.66 Allowed Glycine 0 C--N 1.339 0.74 0 CA-C-N 115.675 -0.693 . . . . 75.51 111.837 -168.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.432 HG22 HG11 ' A' ' 178' ' ' VAL . 2.1 p -111.89 110.91 33.94 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 N-CA-C 107.999 -1.112 . . . . 75.43 107.999 175.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.51 ' HG3' ' HG ' ' A' ' 188' ' ' LEU . 0.0 OUTLIER -93.87 159.5 15.16 Favored 'General case' 0 C--O 1.205 -1.278 0 C-N-CA 124.09 0.956 . . . . 73.23 110.704 -165.633 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -50.89 119.01 3.52 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.934 1.294 . . . . 72.32 110.357 175.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 93.46 1.19 66.56 Favored Glycine 0 CA--C 1.534 1.252 0 CA-C-O 119.296 -0.725 . . . . 14.21 113.875 -179.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 12.7 t -72.19 126.53 30.02 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 108.458 -0.941 . . . . 74.23 108.458 178.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.572 HG22 HG22 ' A' ' 177' ' ' VAL . 48.4 t -102.38 105.46 18.14 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 C-N-CA 123.552 0.741 . . . . 72.34 110.416 -172.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.738 HD12 HH22 ' A' ' 136' ' ' ARG . 57.2 mt -76.3 102.23 3.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 107.777 -1.194 . . . . 75.24 107.777 166.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 58.1 ttt180 -74.42 101.06 3.99 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 107.798 -1.186 . . . . 61.32 107.798 172.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 6.2 p -124.41 95.57 42.98 Favored Pre-proline 0 CA--C 1.547 0.856 0 N-CA-C 109.448 -0.575 . . . . 61.33 109.448 177.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.507 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 28.9 Cg_endo -63.91 152.55 80.27 Favored 'Trans proline' 0 C--N 1.369 1.616 0 C-N-CA 121.963 1.776 . . . . 74.53 111.667 172.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.592 ' HA3' ' HA ' ' A' ' 86' ' ' SER . . . 105.12 -25.9 23.73 Favored Glycine 0 C--N 1.335 0.514 0 CA-C-N 116.043 -0.526 . . . . 70.43 113.628 176.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -103.61 0.05 30.28 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 117.331 0.566 . . . . 64.15 110.949 178.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.576 ' HA2' HD13 ' A' ' 174' ' ' LEU . . . -82.71 -129.65 1.36 Allowed Glycine 0 C--N 1.35 1.315 0 O-C-N 123.286 0.366 . . . . 73.33 113.904 -174.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -73.95 158.27 52.0 Favored Glycine 0 C--N 1.338 0.683 0 CA-C-N 115.507 -0.346 . . . . 74.5 113.089 -176.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -71.7 111.53 7.06 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.955 1.302 . . . . 75.42 112.09 -169.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -174.7 159.56 28.34 Favored Glycine 0 C--O 1.221 -0.661 0 CA-C-O 118.327 -1.263 . . . . 64.21 110.723 176.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . 0.597 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . 55.3 t30 -55.35 -56.64 26.69 Favored Pre-proline 0 N--CA 1.496 1.872 0 CA-C-N 118.262 1.031 . . . . 63.11 111.36 -169.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.597 ' HD3' ' HB3' ' A' ' 169' ' ' ASN . 3.3 Cg_endo -88.55 94.4 0.38 Allowed 'Trans proline' 0 C--N 1.386 2.545 0 N-CA-C 107.403 -1.807 . . . . 71.13 107.403 157.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -65.45 154.5 73.39 Favored 'Trans proline' 0 C--N 1.378 2.086 0 C-N-CA 122.111 1.874 . . . . 71.25 111.805 -167.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.436 ' HA3' ' O ' ' A' ' 117' ' ' ARG . . . -74.28 -179.55 41.08 Favored Glycine 0 C--O 1.241 0.559 0 N-CA-C 115.372 0.909 . . . . 72.4 115.372 -164.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.507 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 7.0 m-20 -74.59 108.58 7.44 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.105 0.962 . . . . 71.14 110.425 -173.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.576 HD13 ' HA2' ' A' ' 165' ' ' GLY . 21.9 tp -82.9 99.84 10.01 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 108.759 -0.83 . . . . 64.32 108.759 176.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 77.0 mt -74.77 89.15 2.28 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.206 -0.906 . . . . 72.12 109.188 174.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.473 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 65.9 mt -75.46 90.17 2.7 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.474 -0.784 . . . . 70.05 110.025 177.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.572 HG22 HG22 ' A' ' 158' ' ' VAL . 46.3 t -84.33 103.71 11.83 Favored 'Isoleucine or valine' 0 C--O 1.244 0.809 0 N-CA-C 107.234 -1.395 . . . . 61.43 107.234 175.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.432 HG11 HG22 ' A' ' 153' ' ' VAL . 11.6 p -70.27 118.63 15.06 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 CA-C-N 115.136 -0.938 . . . . 70.33 111.396 -173.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.643 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 35.4 mmt180 -98.94 104.52 16.57 Favored 'General case' 0 C--O 1.216 -0.706 0 N-CA-C 108.263 -1.014 . . . . 53.32 108.263 170.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.474 HD23 ' HB3' ' A' ' 125' ' ' LEU . 77.1 mt -69.23 142.48 54.19 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 118.7 0.682 . . . . 72.4 109.534 178.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 82.9 mt -54.17 161.56 1.86 Allowed Pre-proline 0 N--CA 1.486 1.348 0 C-N-CA 124.19 0.996 . . . . 73.14 112.939 -170.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -76.34 30.72 0.4 Allowed 'Trans proline' 0 C--N 1.383 2.382 0 C-N-CA 122.791 2.327 . . . . 71.42 111.982 164.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -64.59 115.49 20.73 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 125.976 1.71 . . . . 73.35 107.283 175.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -76.5 24.73 0.45 Allowed 'Trans proline' 0 N--CA 1.497 1.709 0 C-N-CA 123.474 2.783 . . . . 61.24 115.832 -161.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.419 HG12 ' CD1' ' A' ' 186' ' ' PHE . 51.0 t -106.99 -61.01 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 122.841 0.457 . . . . 64.21 110.446 -176.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . 0.552 ' HE2' HD13 ' A' ' 193' ' ' LEU . 2.9 m-30 -131.42 165.78 22.75 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.939 0.895 . . . . 72.31 110.792 -172.051 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 22.8 ttp85 -150.4 87.73 1.46 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 114.362 -1.29 . . . . 75.51 108.338 169.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.51 ' HG ' ' HG3' ' A' ' 154' ' ' ARG . 51.5 tp -62.23 104.81 0.52 Allowed 'General case' 0 C--O 1.207 -1.157 0 CA-C-N 115.141 -0.936 . . . . 74.21 108.776 174.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -136.44 132.93 36.08 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.068 1.347 . . . . 70.31 109.02 -171.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 82.72 -84.81 1.52 Allowed Glycine 0 C--N 1.35 1.32 0 N-CA-C 110.757 -0.937 . . . . 65.41 110.757 -177.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.61 ' HG2' ' HD2' ' A' ' 243' ' ' PRO . 0.9 OUTLIER -153.89 3.73 0.27 Allowed 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 125.158 1.383 . . . . 72.32 109.962 165.917 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.413 ' HB3' ' H ' ' A' ' 248' ' ' ASP . 2.5 p-10 -118.74 175.29 5.81 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.246 1.419 . . . . 72.32 109.809 -169.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.552 HD13 ' HE2' ' A' ' 186' ' ' PHE . 41.3 mt -114.75 126.16 54.53 Favored 'General case' 0 C--O 1.215 -0.762 0 C-N-CA 123.276 0.63 . . . . 63.44 110.544 -171.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -105.21 102.23 11.73 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.469 0.707 . . . . 73.14 109.437 174.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.58 ' HB3' HD23 ' A' ' 251' ' ' LEU . . . -108.28 156.46 19.35 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.946 -0.761 . . . . 74.34 108.946 172.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 57.0 m -93.6 123.57 37.01 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 109.036 -0.727 . . . . 70.21 109.036 178.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.514 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 32.5 tp -113.09 94.62 4.98 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 108.662 -0.866 . . . . 72.21 108.662 178.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -79.5 122.09 26.02 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 107.026 -1.472 . . . . 61.43 107.026 169.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 9.2 p -133.48 137.47 29.06 Favored Pre-proline 0 CA--C 1.545 0.765 0 N-CA-C 108.156 -1.053 . . . . 64.4 108.156 -177.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.75 159.51 48.34 Favored 'Trans proline' 0 C--N 1.36 1.183 0 C-N-CA 121.796 1.664 . . . . 64.51 111.5 173.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -56.32 -52.94 69.08 Favored Pre-proline 0 CA--C 1.555 1.146 0 CA-C-O 117.715 -1.136 . . . . 71.34 113.242 -172.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -59.3 -40.97 63.34 Favored 'Trans proline' 0 C--N 1.391 2.804 0 C-N-CA 122.03 1.82 . . . . 63.54 113.417 -179.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.534 HD11 ' HB3' ' C' ' 276' ' ' TYR . 36.0 mt -71.93 -31.42 40.65 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.962 0 C-N-CA 122.782 0.433 . . . . 64.32 110.368 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.71 -40.73 84.26 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-O 121.155 0.502 . . . . 71.51 110.606 174.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.521 HG13 HD11 ' C' ' 261' ' ' LEU . 48.4 t -71.21 -46.92 63.45 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 C-N-CA 124.189 0.995 . . . . 63.23 112.167 -176.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.503 HG21 ' HA ' ' C' ' 270' ' ' LYS . 94.6 t -98.92 -26.38 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 123.698 0.799 . . . . 74.41 111.574 -170.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 99.03 160.29 29.46 Favored Glycine 0 C--O 1.241 0.554 0 N-CA-C 110.941 -0.864 . . . . 72.35 110.941 -170.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.469 ' O ' HG12 ' A' ' 223' ' ' VAL . . . 162.18 168.37 23.99 Favored Glycine 0 N--CA 1.467 0.73 0 N-CA-C 111.84 -0.504 . . . . 55.24 111.84 177.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -99.62 117.65 34.46 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 117.068 0.434 . . . . 45.21 110.519 -175.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 35.9 m -121.71 162.46 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 124.136 0.974 . . . . 63.11 109.055 177.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -70.39 115.29 9.41 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 120.635 0.255 . . . . 71.41 110.96 -177.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -103.12 112.54 25.44 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 108.176 -1.046 . . . . 62.04 108.176 168.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -76.48 116.57 17.29 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 107.382 -1.34 . . . . 71.23 107.382 173.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . 0.408 ' HA ' ' CE1' ' A' ' 186' ' ' PHE . 72.8 p -118.79 167.92 11.24 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.804 0.442 . . . . 74.1 110.354 178.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 72.1 mt -66.2 -20.77 66.23 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.278 0.631 . . . . 63.31 111.595 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -91.29 -18.31 24.55 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 123.555 0.742 . . . . 64.44 111.562 177.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 147.34 170.63 15.73 Favored Glycine 0 C--N 1.36 1.909 0 CA-C-O 119.97 -0.35 . . . . 33.0 113.594 174.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.79 103.98 1.67 Allowed 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 122.482 2.122 . . . . 70.23 111.404 176.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 33.6 m -106.9 179.83 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 124.25 1.02 . . . . 73.4 110.444 -177.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -110.99 119.54 39.4 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.357 0.663 . . . . 75.04 109.248 173.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 7.2 p -96.85 121.0 46.91 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 N-CA-C 108.979 -0.749 . . . . 74.13 108.979 175.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -80.09 96.68 6.57 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.662 -0.866 . . . . 60.25 108.662 172.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.469 HG12 ' O ' ' A' ' 208' ' ' GLY . 10.7 p -68.35 132.72 91.4 Favored Pre-proline 0 CA--C 1.554 1.102 0 N-CA-C 108.916 -0.772 . . . . 63.14 108.916 178.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.39 163.55 26.3 Favored 'Trans proline' 0 C--N 1.374 1.875 0 C-N-CA 122.483 2.122 . . . . 75.51 112.455 174.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -64.77 163.9 26.21 Favored 'Trans proline' 0 C--N 1.37 1.664 0 C-N-CA 121.993 1.795 . . . . 72.53 112.95 169.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . 0.423 ' HE ' ' N ' ' A' ' 226' ' ' ARG . 0.0 OUTLIER 41.25 67.78 0.5 Allowed 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 126.057 1.743 . . . . 74.04 112.824 -173.207 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.532 HG23 HD21 ' A' ' 233' ' ' LEU . 95.0 m -101.68 103.01 13.77 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 114.407 -1.27 . . . . 64.32 109.224 177.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . 0.813 ' HB3' ' HD3' ' A' ' 231' ' ' ARG . 5.5 tp-100 -87.18 145.96 26.2 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.166 0.986 . . . . 75.32 111.784 -172.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -73.15 143.42 47.29 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.975 0.91 . . . . 62.31 111.267 179.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 85.26 -0.59 88.73 Favored Glycine 0 C--N 1.348 1.233 0 CA-C-N 115.787 -0.642 . . . . 73.32 113.103 -178.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.813 ' HD3' ' HB3' ' A' ' 228' ' ' GLN . 78.7 mtp180 -112.03 162.49 15.33 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.536 1.134 . . . . 74.0 108.949 176.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.414 ' HB3' ' HG2' ' A' ' 252' ' ' GLU . 49.6 pttt -129.63 136.31 49.6 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 122.902 0.481 . . . . 72.22 110.389 -171.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.532 HD21 HG23 ' A' ' 227' ' ' THR . 26.3 mt -86.72 110.97 20.26 Favored 'General case' 0 C--O 1.212 -0.882 0 CA-C-N 115.281 -0.872 . . . . 71.4 110.133 -172.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -77.22 106.94 9.26 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.01 0.524 . . . . 64.14 110.25 175.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.497 HD12 HD23 ' A' ' 249' ' ' LEU . 8.5 mt -101.68 93.54 5.39 Favored 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 108.454 -0.943 . . . . 61.12 108.454 172.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 4.5 tmtm? -73.67 117.97 16.06 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.437 0.695 . . . . 64.43 111.939 -164.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 101.45 32.16 5.27 Favored Glycine 0 C--N 1.347 1.157 0 CA-C-N 115.813 -0.63 . . . . 74.2 112.614 175.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 2.8 mmmt -117.26 -28.19 6.23 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.941 0.896 . . . . 73.01 111.229 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -79.0 -166.87 32.04 Favored Glycine 0 C--N 1.342 0.915 0 O-C-N 123.663 0.602 . . . . 74.43 113.256 174.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -97.59 158.97 32.15 Favored Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 123.565 0.746 . . . . 73.13 110.333 -173.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -58.64 151.92 59.57 Favored 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 122.656 2.237 . . . . 73.33 113.322 -173.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -173.88 -163.42 27.32 Favored Glycine 0 C--N 1.341 0.816 0 CA-C-N 115.65 -0.705 . . . . 73.52 113.761 177.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . 0.61 ' HD2' ' HG2' ' A' ' 191' ' ' GLN . 73.4 Cg_endo -70.8 -5.86 17.81 Favored 'Trans proline' 0 C--N 1.373 1.862 0 C-N-CA 123.708 2.939 . . . . 70.45 113.613 -179.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -103.94 23.12 13.38 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.74 0.816 . . . . 70.11 109.954 171.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 82.37 -84.44 1.51 Allowed Glycine 0 C--N 1.351 1.4 0 N-CA-C 110.78 -0.928 . . . . 62.24 110.78 -177.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 50.2 mtm180 -125.68 144.64 50.51 Favored 'General case' 0 C--O 1.246 0.871 0 N-CA-C 108.348 -0.982 . . . . 75.41 108.348 171.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -65.79 166.82 35.11 Favored Glycine 0 N--CA 1.448 -0.552 0 O-C-N 123.979 0.799 . . . . 42.24 113.457 176.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . 0.413 ' H ' ' HB3' ' A' ' 192' ' ' ASP . 4.1 m-20 -110.91 -178.31 3.44 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 123.776 0.831 . . . . 75.44 108.89 -179.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.497 HD23 HD12 ' A' ' 235' ' ' LEU . 31.1 tp -118.63 96.53 5.32 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 107.875 -1.157 . . . . 70.31 107.875 169.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -79.69 109.52 14.17 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.285 1.034 . . . . 52.51 109.79 175.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.58 HD23 ' HB3' ' A' ' 195' ' ' ALA . 89.7 mt -97.88 97.86 9.31 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.5 -0.773 . . . . 72.24 109.483 177.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . 0.414 ' HG2' ' HB3' ' A' ' 232' ' ' LYS . 28.7 mt-10 -75.61 115.97 15.84 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.374 0.67 . . . . 75.41 109.611 -176.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 91.7 t -86.43 132.89 31.11 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 C-N-CA 125.468 1.507 . . . . 24.43 113.06 -163.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -130.07 107.04 9.03 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.19 1.396 . . . . 73.14 108.565 173.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.538 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 73.4 mt -84.01 130.74 35.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 123.257 0.623 . . . . 74.34 111.016 -176.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 20.3 p -119.1 174.15 6.49 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.497 1.119 . . . . 73.43 109.844 173.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.418 ' HB ' ' HD2' ' A' ' 258' ' ' PRO . 2.9 pp -136.13 154.91 77.72 Favored Pre-proline 0 CA--C 1.566 1.576 0 C-N-CA 123.696 0.798 . . . . 73.4 109.938 -179.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 258' ' ' PRO . . . . . 0.418 ' HD2' ' HB ' ' A' ' 257' ' ' ILE . 49.1 Cg_endo -64.67 -5.56 10.53 Favored 'Trans proline' 0 C--N 1.385 2.493 0 C-N-CA 123.457 2.771 . . . . 74.45 116.1 -163.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . 0.503 ' HG2' ' NE2' ' C' ' 228' ' ' GLN . 31.4 mt-10 52.42 -87.37 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.422 0 C-N-CA 124.122 0.969 . . . . 63.24 112.728 -170.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.27 132.84 47.83 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 109.935 -0.394 . . . . 75.12 109.935 -177.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.401 HD21 ' HG2' ' A' ' 258' ' ' PRO . 97.5 mt -130.93 134.62 46.91 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.702 0.801 . . . . 55.32 110.575 -177.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 19.1 p -84.16 146.26 47.87 Favored Pre-proline 0 CA--C 1.545 0.788 0 CA-C-O 117.874 -1.06 . . . . 44.34 108.841 169.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -30.94 -42.98 0.11 Allowed 'Trans proline' 0 C--N 1.39 2.731 1 C-N-CA 126.062 4.508 . . . . 74.33 116.569 -172.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -64.59 -64.3 0.91 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.25 0.62 . . . . 71.44 110.99 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -61.48 -32.49 72.5 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.086 0.954 . . . . 64.2 110.866 -178.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -53.48 -52.95 57.89 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.779 1.231 . . . . 73.45 109.847 174.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . 0.406 ' O ' ' HG3' ' A' ' 271' ' ' LYS . . . -65.69 -41.72 92.07 Favored 'General case' 0 C--O 1.214 -0.795 0 CA-C-N 114.923 -1.035 . . . . 64.12 111.585 178.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 10.9 mp -57.24 -47.0 82.47 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 123.071 0.548 . . . . 73.14 111.544 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -64.89 -40.76 95.6 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 123.755 0.659 . . . . 75.0 111.091 178.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . 0.469 ' HE2' ' HA ' ' C' ' 206' ' ' VAL . 1.5 mptm? -71.68 -25.33 62.06 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.093 0.557 . . . . 62.43 111.98 178.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . 0.406 ' HG3' ' O ' ' A' ' 267' ' ' ALA . 97.1 mttt -73.75 -48.82 28.99 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.873 -0.788 . . . . 70.22 108.873 176.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 72.6 mt -55.28 -40.96 71.62 Favored 'General case' 0 C--O 1.198 -1.641 0 O-C-N 124.774 1.296 . . . . 63.4 109.992 172.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -65.79 -55.51 16.8 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.056 0.942 . . . . 64.51 113.105 -174.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -66.57 -43.75 84.16 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 123.787 0.679 . . . . 74.35 110.76 -176.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -62.59 -47.95 81.59 Favored 'General case' 0 C--N 1.355 0.82 0 O-C-N 123.944 0.778 . . . . 71.44 110.285 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -62.75 -45.77 91.14 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.729 0.812 . . . . 75.02 110.945 -177.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -66.82 -40.04 87.89 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 123.519 0.512 . . . . 70.12 110.103 -176.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -66.62 -17.86 65.06 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 115.824 -0.625 . . . . 75.41 111.579 174.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 82.6 mtt180 -117.76 20.05 13.56 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.134 0.974 . . . . 74.13 109.733 178.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.845 0 N-CA-C 109.173 -0.677 . . . . 72.21 109.173 179.193 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 63.7 mtt . . . . . 0 N--CA 1.483 1.182 0 N-CA-C 109.104 -0.702 . . . . 71.44 109.104 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -82.06 126.65 32.25 Favored 'General case' 0 C--N 1.353 0.733 0 N-CA-C 108.649 -0.871 . . . . 54.1 108.649 172.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -106.34 37.49 2.28 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.137 0.575 . . . . 74.04 110.095 -176.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 55.2 m -53.89 -3.51 0.04 OUTLIER 'General case' 0 CA--C 1.565 1.535 0 N-CA-C 117.31 2.337 . . . . 52.14 117.31 -162.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 16.9 m -132.27 147.6 52.41 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 119.316 0.962 . . . . 70.11 110.291 171.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 15.1 pt -138.23 169.59 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 123.85 0.86 . . . . 64.44 112.384 -164.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -131.51 147.68 52.56 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 124.21 1.004 . . . . 72.01 109.672 176.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 15.2 tp -85.51 157.0 20.54 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.863 0.865 . . . . 75.22 110.918 -172.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.44 -59.52 2.67 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.322 0.649 . . . . 62.4 111.81 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 66.1 mt 61.12 18.1 8.72 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.863 1.265 . . . . 74.1 111.911 -165.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 64.5 mt . . . . . 0 N--CA 1.485 1.309 0 C-N-CA 124.771 1.228 . . . . 45.35 112.116 179.477 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.776 0 N-CA-C 108.843 -0.799 . . . . 61.34 108.843 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . -66.11 -35.22 79.91 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 109.368 -0.604 . . . . 74.4 109.368 166.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 181' ' ' LEU . . . . . 0.527 ' HB2' ' HB3' ' C' ' 136' ' ' ARG . 58.0 tp -159.79 -69.95 0.08 Allowed 'General case' 0 C--N 1.353 0.726 0 CA-C-N 115.816 -0.629 . . . . 62.04 111.186 -176.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 182' ' ' VAL . . . . . 0.523 HG11 ' H ' ' C' ' 139' ' ' GLU . 8.2 p -79.93 150.43 4.96 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 CA-C-N 115.355 -0.839 . . . . 71.31 112.711 -163.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -119.67 38.17 3.98 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.909 0.883 . . . . 65.24 109.278 171.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 184' ' ' HIS . . . . . 0.401 ' H ' HG22 ' B' ' 182' ' ' VAL . 35.7 m80 56.85 -87.11 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.723 1.209 . . . . 74.15 110.589 -171.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 185' ' ' VAL . . . . . 0.559 HG23 ' HA ' ' C' ' 121' ' ' ALA . 1.5 p . . . . . 0 N--CA 1.469 0.489 0 C-N-CA 124.382 1.073 . . . . 71.33 108.71 173.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 238' ' ' THR . . . . . 0.479 HG21 ' H ' ' C' ' 220' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 113.599 0.962 . . . . 71.31 113.599 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -163.81 174.38 11.64 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.803 0.729 . . . . 74.42 111.113 -165.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . -79.51 -106.29 0.24 Allowed Glycine 0 C--N 1.345 1.051 0 CA-C-N 115.409 -0.814 . . . . 71.23 111.804 174.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.29 -179.52 5.62 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.41 0.684 . . . . 71.21 111.132 -178.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 242' ' ' TRP . . . . . 0.485 ' CZ3' HG21 ' C' ' 253' ' ' VAL . 7.8 m0 -94.18 -60.54 1.71 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.198 0.999 . . . . 70.32 109.375 -175.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -172.25 -33.16 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 113.472 -1.694 . . . . 74.22 109.097 -167.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -162.15 101.7 0.2 Allowed Glycine 0 C--N 1.347 1.185 0 N-CA-C 111.375 -0.69 . . . . 63.11 111.375 174.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 39.1 tptt . . . . . 0 N--CA 1.476 0.867 0 C-N-CA 124.13 0.972 . . . . 75.34 109.976 179.301 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.835 0 CA-C-O 120.632 0.253 . . . . 52.01 110.534 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -36.89 117.52 0.52 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.891 1.676 . . . . 70.52 114.288 -176.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 5' ' ' LYS . . . . . 0.462 ' HB3' HD11 ' C' ' 10' ' ' ILE . 14.1 mmmm -93.93 108.59 20.37 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 108.355 -0.98 . . . . 63.2 108.355 167.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -71.94 93.97 1.41 Allowed 'General case' 0 C--O 1.238 0.487 0 N-CA-C 107.583 -1.265 . . . . 63.22 107.583 175.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 7' ' ' TYR . . . . . 0.483 ' HA ' HD12 ' C' ' 10' ' ' ILE . 30.9 m-85 -60.41 -30.36 69.56 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 115.004 -0.998 . . . . 73.43 112.158 -171.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -66.76 -45.04 79.78 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.572 -0.74 . . . . 72.53 110.521 177.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.9 -42.58 99.25 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.088 0.555 . . . . 52.31 110.685 177.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 10' ' ' ILE . . . . . 0.483 HD12 ' HA ' ' C' ' 7' ' ' TYR . 69.5 mt -55.3 -50.95 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 123.72 0.808 . . . . 63.34 111.144 178.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 83.4 mt -74.48 -12.0 60.37 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.528 -0.76 . . . . 45.45 112.371 -179.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 69.99 33.82 70.35 Favored Glycine 0 C--N 1.351 1.384 0 O-C-N 123.045 0.216 . . . . 64.33 112.754 -176.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 13' ' ' VAL . . . . . 0.447 ' HB ' ' HD2' ' C' ' 14' ' ' PRO . 11.6 m -108.46 164.39 14.86 Favored Pre-proline 0 N--CA 1.479 1.021 0 C-N-CA 124.46 1.104 . . . . 64.04 109.615 174.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 14' ' ' PRO . . . . . 0.447 ' HD2' ' HB ' ' C' ' 13' ' ' VAL . 35.5 Cg_endo -60.12 162.79 15.76 Favored 'Trans proline' 0 C--N 1.384 2.4 0 C-N-CA 122.095 1.863 . . . . 74.43 112.596 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 8.8 mmm180 -77.18 14.31 0.94 Allowed 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.042 0.937 . . . . 71.52 112.413 -170.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -148.99 14.75 0.92 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.692 1.197 . . . . 71.24 108.716 -176.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.04 137.5 56.81 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 123.923 0.889 . . . . 71.14 112.914 -170.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 78.8 p -70.77 161.87 30.13 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.798 0.839 . . . . 74.41 110.649 178.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -57.52 -29.34 64.26 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.519 0.728 . . . . 74.45 111.541 -177.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -65.68 -47.92 73.84 Favored 'General case' 0 C--O 1.215 -0.733 0 CA-C-O 119.33 -0.367 . . . . 64.05 110.486 176.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -61.24 -35.62 77.73 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 123.711 0.632 . . . . 73.42 110.821 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.46 -44.04 97.85 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.928 0 C-N-CA 123.671 0.788 . . . . 61.32 110.756 173.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 6.5 ttpm? -73.02 -31.43 64.46 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.539 0.736 . . . . 74.13 111.304 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 40.0 mtt180 -69.08 -45.47 70.21 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.124 0.97 . . . . 73.52 110.083 178.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -71.77 -31.81 67.01 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 124.522 1.139 . . . . 75.32 111.183 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 26' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -58.0 -60.3 3.94 Favored 'General case' 0 C--O 1.21 -0.995 0 O-C-N 124.191 0.932 . . . . 72.31 109.323 171.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . 0.423 ' O ' ' HG3' ' C' ' 31' ' ' ARG . 53.4 mtmt -63.07 -35.08 79.04 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 124.366 1.041 . . . . 74.1 111.336 -178.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 28' ' ' ARG . . . . . 0.613 ' HA ' HH21 ' C' ' 31' ' ' ARG . 63.7 ttt180 -58.11 -51.88 67.86 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.071 0.948 . . . . 71.15 110.244 177.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . 0.517 ' HA ' ' HB3' ' C' ' 32' ' ' GLN . 83.2 mt -90.62 -0.02 57.54 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 113.983 -1.462 . . . . 60.22 111.195 -177.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.15 -10.96 29.05 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.778 0.831 . . . . 75.32 110.003 169.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . 0.613 HH21 ' HA ' ' C' ' 28' ' ' ARG . 32.7 mtm105 -93.66 -35.81 12.66 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.261 0.624 . . . . 73.5 109.454 165.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 32' ' ' GLN . . . . . 0.517 ' HB3' ' HA ' ' C' ' 29' ' ' LEU . 8.3 tt0 -67.69 -60.55 2.45 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 122.489 0.316 . . . . 71.12 110.386 176.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -92.38 31.71 1.28 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.287 0.635 . . . . 70.15 109.781 178.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 34' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -58.91 106.46 0.72 Allowed Pre-proline 0 N--CA 1.481 1.078 0 C-N-CA 124.184 0.993 . . . . 72.34 109.059 -179.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -58.37 -29.45 88.25 Favored 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 123.041 2.494 . . . . 71.32 113.146 -165.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -72.28 -33.15 67.22 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.042 0.937 . . . . 60.34 112.442 178.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 61.8 t -97.73 -23.15 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 123.457 0.703 . . . . 75.33 110.689 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -128.86 83.61 2.17 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.74 0.816 . . . . 54.22 109.504 -168.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -81.85 36.05 0.44 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.134 0.973 . . . . 62.24 111.374 178.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . 0.47 ' HB2' ' HB3' ' C' ' 43' ' ' ALA . 20.0 m -93.02 107.71 26.97 Favored Pre-proline 0 CA--C 1.544 0.742 0 N-CA-C 108.63 -0.878 . . . . 74.14 108.63 -178.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -43.39 -54.67 3.4 Favored 'Trans proline' 0 C--N 1.386 2.507 0 C-N-CA 124.437 3.425 . . . . 63.44 114.439 -171.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -67.29 -31.14 71.25 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.974 0.91 . . . . 65.44 110.777 -176.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 43' ' ' ALA . . . . . 0.47 ' HB3' ' HB2' ' C' ' 40' ' ' SER . . . -77.31 -19.13 56.84 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.021 0.528 . . . . 62.05 110.68 177.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -82.9 -28.06 30.23 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.11 0.564 . . . . 74.04 109.504 176.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -75.63 -32.74 60.36 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.542 0.737 . . . . 42.53 109.832 173.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 46' ' ' LYS . . . . . . . . . . . . . 41.1 mmtm -65.17 -44.02 89.87 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.73 -0.668 . . . . 72.32 109.992 168.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -56.71 -37.01 70.32 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.529 0.732 . . . . 62.23 110.171 174.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -62.41 -44.33 96.71 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 123.745 0.653 . . . . 72.04 111.72 174.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -66.35 -33.87 76.69 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 122.334 0.253 . . . . 72.33 111.628 176.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 50' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.56 -39.44 85.05 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 C-N-CA 123.77 0.828 . . . . 75.43 109.751 173.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 51' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -72.08 -29.29 63.97 Favored 'General case' 0 C--O 1.212 -0.88 0 C-N-CA 124.034 0.934 . . . . 74.04 110.785 177.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -67.51 -57.53 6.33 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.566 1.146 . . . . 63.42 109.966 177.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.57 -47.12 85.32 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-N 113.158 -1.837 . . . . 63.1 111.629 -176.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -60.22 -57.76 11.4 Favored 'General case' 0 C--O 1.203 -1.362 0 CA-C-N 115.051 -0.977 . . . . 75.01 110.567 174.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.97 -30.77 64.38 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 113.174 0.805 . . . . 60.54 113.174 -170.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 94.3 t -73.78 -60.06 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 N-CA-C 109.843 -0.429 . . . . 72.43 109.843 170.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 57' ' ' LEU . . . . . 0.432 HD11 ' HB2' ' C' ' 7' ' ' TYR . 79.7 mt -81.64 4.6 21.06 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 113.454 0.909 . . . . 75.02 113.454 -169.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 41.8 t -74.62 -36.53 62.92 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.447 1.099 . . . . 62.42 109.717 177.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -82.96 127.78 68.16 Favored Pre-proline 0 C--N 1.331 -0.206 0 N-CA-C 108.399 -0.963 . . . . 72.03 108.399 174.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 60' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -54.71 -32.91 78.05 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.571 2.181 . . . . 33.23 111.073 165.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -55.4 -64.64 0.78 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.957 1.303 . . . . 62.13 110.864 174.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 36.8 mtpt -76.45 -16.0 59.78 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.13 0.972 . . . . 75.23 112.197 -173.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -71.37 -45.15 63.57 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 107.816 -1.179 . . . . 64.42 107.816 171.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -72.13 -24.06 61.41 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.199 0.599 . . . . 74.15 111.861 175.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 90.3 mt -66.06 -42.93 92.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 N-CA-C 109.204 -0.665 . . . . 62.34 109.204 171.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -60.58 -48.89 79.77 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 115.486 -0.779 . . . . 74.22 109.5 174.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -57.39 -42.73 82.76 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.801 0.84 . . . . 73.14 112.112 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 35.8 p -74.13 -23.18 59.25 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.659 0.384 . . . . 63.2 111.431 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -74.11 142.93 45.56 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 109.133 -0.692 . . . . 75.22 109.133 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.64 11.99 65.18 Favored Glycine 0 N--CA 1.476 1.351 0 N-CA-C 112.072 -0.411 . . . . 62.51 112.072 -171.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 36.2 m -144.75 -54.26 0.32 Allowed 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 104.259 -2.497 . . . . 72.34 104.259 175.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 55.0 m -88.73 151.98 22.08 Favored 'General case' 0 C--O 1.246 0.88 0 N-CA-C 104.949 -2.241 . . . . 73.35 104.949 156.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.56 -17.33 2.27 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.872 0.869 . . . . 73.23 110.29 -176.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.88 132.55 77.28 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 123.572 0.749 . . . . 53.23 110.466 174.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -61.46 156.87 44.17 Favored 'Trans proline' 0 C--N 1.377 2.071 0 C-N-CA 123.413 2.742 . . . . 75.14 112.48 175.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -63.21 169.08 9.87 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 123.421 2.748 . . . . 63.14 112.81 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.85 122.58 5.92 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 121.86 1.707 . . . . 51.51 111.305 171.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 78' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.81 122.8 7.53 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 122.51 2.14 . . . . 74.44 112.043 175.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -82.72 159.55 16.4 Favored 'Trans proline' 0 CA--C 1.557 1.672 0 C-N-CA 122.72 2.28 . . . . 61.04 112.109 173.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.27 84.77 0.04 OUTLIER 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 123.123 2.549 . . . . 51.5 112.18 169.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . 0.564 ' HA3' ' HB1' ' C' ' 141' ' ' ALA . . . 160.21 -30.18 0.37 Allowed Glycine 0 C--O 1.239 0.43 0 CA-C-N 114.559 -1.2 . . . . 75.2 110.316 -178.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 92.14 178.86 41.58 Favored Glycine 0 C--N 1.35 1.311 0 CA-C-N 115.196 -0.502 . . . . 74.45 112.314 173.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -80.68 102.16 9.71 Favored 'General case' 0 C--O 1.243 0.761 0 N-CA-C 106.927 -1.508 . . . . 70.14 106.927 168.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -53.73 132.69 41.56 Favored 'General case' 0 C--O 1.248 0.978 0 O-C-N 124.769 1.293 . . . . 63.13 111.42 -174.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 85' ' ' PHE . . . . . 0.495 ' CD1' ' HB ' ' C' ' 90' ' ' VAL . 2.1 t80 -156.18 24.02 0.36 Allowed 'General case' 0 C--O 1.243 0.761 0 CA-C-N 114.624 -1.171 . . . . 74.41 110.697 -173.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 52.3 m -58.45 128.38 36.85 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.274 -0.876 . . . . 45.43 111.01 -176.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 91.47 -30.31 6.55 Favored Glycine 0 C--N 1.342 0.906 0 CA-C-O 119.591 -0.561 . . . . 74.33 113.175 -179.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 88' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -94.44 137.74 33.22 Favored 'General case' 0 C--N 1.355 0.823 0 N-CA-C 108.443 -0.947 . . . . 74.44 108.443 -177.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -86.64 70.45 10.41 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.244 0.618 . . . . 72.23 111.142 -169.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 90' ' ' VAL . . . . . 0.495 ' HB ' ' CD1' ' C' ' 85' ' ' PHE . 1.3 p -39.59 -47.13 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 C-N-CA 125.138 1.375 . . . . 54.41 113.446 178.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -69.93 -23.38 63.2 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 114.695 -1.139 . . . . 74.21 111.753 -167.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -100.77 -7.18 23.96 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.293 0.637 . . . . 75.53 111.1 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 8.1 m-30 -78.73 -172.12 2.85 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 109.869 -0.419 . . . . 72.45 109.869 176.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 88.0 p -68.27 148.81 50.26 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 112.332 0.493 . . . . 45.51 112.332 -170.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.63 -38.26 89.55 Favored 'General case' 0 CA--C 1.551 1.009 0 CA-C-N 114.871 -1.059 . . . . 55.43 110.869 175.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -49.05 -52.45 25.38 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.658 1.183 . . . . 65.02 111.375 171.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 97' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -62.37 -43.68 98.25 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 114.409 -1.268 . . . . 64.25 110.626 178.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -73.3 -5.06 37.15 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.428 0.691 . . . . 51.52 112.341 -178.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -100.08 -41.96 6.93 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.267 0.627 . . . . 74.43 111.712 167.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 26.6 tp -67.24 -42.86 83.28 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.329 0.652 . . . . 73.23 111.573 -173.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -109.91 5.13 22.18 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-O 121.062 0.458 . . . . 73.25 109.875 173.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -44.96 -52.56 7.87 Favored Glycine 0 CA--C 1.538 1.514 0 CA-C-O 118.416 -1.213 . . . . 54.11 115.153 -177.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -35.03 -29.05 0.05 OUTLIER 'Trans proline' 0 C--N 1.389 2.658 0 C-N-CA 125.045 3.83 . . . . 62.02 117.142 175.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -145.73 21.79 1.82 Allowed Glycine 0 C--N 1.36 1.91 0 CA-C-N 118.552 0.615 . . . . 43.23 113.891 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 6.9 mt . . . . . 0 N--CA 1.48 1.039 0 N-CA-C 113.284 0.846 . . . . 73.03 113.284 -179.859 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.401 0 CA-C-O 120.084 -0.287 . . . . 45.25 113.573 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 16.2 mtm180 -58.21 124.53 19.73 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.43 0.692 . . . . 64.44 109.25 174.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -57.92 135.22 56.87 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 123.836 0.71 . . . . 75.42 109.249 176.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 119' ' ' LEU . . . . . . . . . . . . . 4.9 tt -95.28 121.34 36.83 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 107.57 -1.27 . . . . 75.21 107.57 -172.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.76 94.78 5.26 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 107.668 -1.234 . . . . 72.31 107.668 -168.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 121' ' ' ALA . . . . . 0.559 ' HA ' HG23 ' B' ' 185' ' ' VAL . . . -108.58 113.0 25.65 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 108.308 -0.997 . . . . 63.21 108.308 -176.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 122' ' ' GLU . . . . . 0.456 ' HA ' ' O ' ' C' ' 177' ' ' VAL . 0.0 OUTLIER -94.15 110.52 22.23 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 106.959 -1.497 . . . . 73.22 106.959 -178.649 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 123' ' ' LEU . . . . . 0.432 ' H ' HD23 ' C' ' 123' ' ' LEU . 2.4 pt? -129.82 133.32 24.89 Favored Pre-proline 0 N--CA 1.48 1.031 0 C-N-CA 122.481 0.313 . . . . 73.3 111.801 -165.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . 0.434 ' HA ' ' O ' ' C' ' 179' ' ' ARG . 10.7 Cg_exo -73.53 119.57 6.01 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 123.077 2.518 . . . . 72.51 111.172 170.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 125' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' C' ' 180' ' ' LEU . 47.1 tp -128.97 165.32 21.34 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.187 0.995 . . . . 74.03 108.631 -177.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.61 170.9 7.62 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 121.541 0.686 . . . . 61.53 111.686 179.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 127' ' ' LEU . . . . . 0.478 HD22 ' CD2' ' C' ' 183' ' ' HIS . 2.4 mt -81.46 -56.69 3.87 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 114.583 -1.189 . . . . 62.25 109.698 -162.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -49.07 -47.13 45.27 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 112.756 -2.02 . . . . 75.24 110.33 170.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -67.88 -33.0 73.88 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 115.707 -0.679 . . . . 73.53 111.456 -177.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 130' ' ' ALA . . . . . 0.477 ' HB1' HG22 ' C' ' 153' ' ' VAL . . . -68.17 -31.95 71.87 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 123.698 0.623 . . . . 64.34 110.721 173.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 131' ' ' PHE . . . . . 0.405 ' HB2' HD13 ' C' ' 215' ' ' LEU . 74.0 t80 -75.28 -31.85 60.85 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 124.029 0.932 . . . . 75.55 111.37 174.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 132' ' ' HIS . . . . . . . . . . . . . 34.6 m170 -79.62 -55.64 4.88 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 112.335 0.495 . . . . 60.22 112.335 -173.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.07 -111.41 3.34 Favored Glycine 0 C--N 1.345 1.068 0 N-CA-C 110.253 -1.139 . . . . 65.31 110.253 -167.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.41 168.2 35.53 Favored Glycine 0 C--N 1.356 1.645 0 CA-C-N 117.426 0.613 . . . . 53.24 113.511 177.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -71.05 93.65 1.04 Allowed 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 108.932 -0.766 . . . . 71.2 108.932 175.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 136' ' ' ARG . . . . . 0.527 ' HB3' ' HB2' ' B' ' 181' ' ' LEU . 9.6 mpt_? -117.47 133.5 55.9 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.452 1.101 . . . . 72.12 109.493 -174.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 137' ' ' VAL . . . . . . . . . . . . . 27.8 m -71.91 131.12 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-O 121.346 0.593 . . . . 71.12 111.616 -176.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 138' ' ' VAL . . . . . 0.523 HG11 ' SD ' ' C' ' 164' ' ' MET . 13.2 p -115.3 130.12 70.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 C-N-CA 124.684 1.194 . . . . 72.14 107.808 170.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 139' ' ' GLU . . . . . 0.523 ' H ' HG11 ' B' ' 182' ' ' VAL . 42.4 mt-10 -126.61 86.52 2.52 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 108.117 -1.068 . . . . 74.31 108.117 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 140' ' ' VAL . . . . . . . . . . . . . 11.0 m -125.39 107.59 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 123.25 0.62 . . . . 63.22 111.319 -175.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 141' ' ' ALA . . . . . 0.564 ' HB1' ' HA3' ' C' ' 81' ' ' GLY . . . 56.31 28.74 13.84 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.812 1.245 . . . . 15.23 113.27 173.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 119.49 -24.3 8.13 Favored Glycine 0 C--N 1.353 1.475 0 CA-C-N 116.5 -0.318 . . . . 45.25 113.663 177.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 143' ' ' ARG . . . . . 0.563 ' HG2' ' HG3' ' C' ' 164' ' ' MET . 0.3 OUTLIER -76.44 97.63 4.35 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.511 0.724 . . . . 73.04 109.059 178.838 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 40.9 ttp180 -113.42 95.45 5.37 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 109.17 -0.678 . . . . 71.51 109.17 176.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 145' ' ' VAL . . . . . . . . . . . . . 7.6 p -142.31 141.62 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 123.438 0.695 . . . . 75.03 111.254 -176.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 28.0 t -80.4 101.4 8.99 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 108.754 -0.832 . . . . 54.21 108.754 170.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 12.4 p -122.79 152.58 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.102 0.961 . . . . 72.53 110.014 -176.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -99.98 98.86 9.57 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 107.488 -1.301 . . . . 74.22 107.488 171.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 149' ' ' ILE . . . . . 0.653 HD12 HG21 ' C' ' 159' ' ' ILE . 45.9 pt -68.72 151.39 97.27 Favored Pre-proline 0 CA--C 1.55 0.961 0 N-CA-C 108.873 -0.788 . . . . 71.41 108.873 173.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -43.09 110.53 0.17 Allowed 'Trans proline' 0 C--N 1.387 2.604 0 C-N-CA 123.451 2.767 . . . . 61.44 113.543 -178.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -62.3 131.3 33.61 Favored 'Trans proline' 0 C--N 1.386 2.53 0 C-N-CA 122.786 2.324 . . . . 73.2 110.992 178.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 152' ' ' GLY . . . . . . . . . . . . . . . 102.13 61.57 0.74 Allowed Glycine 0 C--N 1.334 0.422 0 N-CA-C 110.396 -1.082 . . . . 54.32 110.396 -171.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 153' ' ' VAL . . . . . 0.501 ' HB ' HG12 ' C' ' 159' ' ' ILE . 0.9 OUTLIER -77.98 158.64 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 108.679 -0.86 . . . . 71.13 108.679 -179.691 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 154' ' ' ARG . . . . . 0.752 ' HG2' HD23 ' C' ' 188' ' ' LEU . 33.8 mtp180 -110.52 111.69 23.1 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 118.757 -0.639 . . . . 75.32 110.179 -170.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 155' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -43.29 120.29 1.84 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.735 1.214 . . . . 74.51 112.853 173.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.12 -7.8 20.47 Favored Glycine 0 C--N 1.354 1.551 0 C-N-CA 124.395 0.997 . . . . 64.51 114.182 177.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 157' ' ' SER . . . . . 0.522 ' HB2' ' HB2' ' C' ' 154' ' ' ARG . 69.4 m -109.91 -172.78 2.11 Favored 'General case' 0 C--O 1.246 0.905 0 C-N-CA 124.461 1.105 . . . . 75.43 110.735 -175.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 158' ' ' VAL . . . . . 0.448 HG21 HD22 ' C' ' 175' ' ' LEU . 12.1 p -88.25 138.99 18.07 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 CA-C-N 114.346 -1.297 . . . . 64.44 112.894 -170.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 159' ' ' ILE . . . . . 0.678 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 8.7 mt -108.31 93.25 2.41 Favored 'Isoleucine or valine' 0 C--O 1.245 0.819 0 N-CA-C 105.428 -2.064 . . . . 52.25 105.428 161.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -82.27 123.65 29.24 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 108.951 -0.759 . . . . 72.21 108.951 178.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 161' ' ' VAL . . . . . 0.653 HG13 ' HB3' ' C' ' 174' ' ' LEU . 2.0 p -126.47 95.9 37.22 Favored Pre-proline 0 C--O 1.247 0.966 0 N-CA-C 107.694 -1.225 . . . . 75.24 107.694 170.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.26 147.75 88.12 Favored 'Trans proline' 0 C--N 1.381 2.268 0 C-N-CA 122.499 2.133 . . . . 63.42 110.836 175.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 87.64 25.73 31.88 Favored Glycine 0 C--N 1.338 0.686 0 CA-C-O 119.372 -0.682 . . . . 53.31 112.039 -171.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 164' ' ' MET . . . . . 0.563 ' HG3' ' HG2' ' C' ' 143' ' ' ARG . 34.4 ttm -156.44 23.26 0.35 Allowed 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 117.373 0.586 . . . . 73.35 112.144 -177.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . -86.77 -160.94 35.46 Favored Glycine 0 N--CA 1.48 1.604 0 N-CA-C 114.36 0.504 . . . . 64.24 114.36 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . -96.63 -175.46 35.45 Favored Glycine 0 C--N 1.357 1.733 0 C-N-CA 123.02 0.343 . . . . 75.44 113.514 -177.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 167' ' ' GLN . . . . . 0.429 ' HA ' HE21 ' C' ' 167' ' ' GLN . 0.0 OUTLIER -43.42 122.01 2.46 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 126.036 1.734 . . . . 64.31 113.334 -176.941 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . 177.07 -126.46 1.11 Allowed Glycine 0 C--N 1.349 1.288 0 CA-C-O 118.889 -0.951 . . . . 13.44 112.003 -175.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 169' ' ' ASN . . . . . 0.55 ' HB3' ' HD3' ' C' ' 170' ' ' PRO . 2.2 t-20 -174.53 -66.57 0.0 OUTLIER Pre-proline 0 CA--C 1.565 1.532 0 CA-C-O 117.759 -1.115 . . . . 62.44 110.731 163.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 170' ' ' PRO . . . . . 0.55 ' HD3' ' HB3' ' C' ' 169' ' ' ASN . 6.9 Cg_exo -69.31 -70.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.403 3.439 0 CA-C-N 122.015 1.755 . . . . 51.41 113.685 -177.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 171' ' ' PRO . . . . . 0.51 ' HD3' ' HB2' ' C' ' 170' ' ' PRO . 85.0 Cg_endo -93.85 126.08 0.53 Allowed 'Trans proline' 0 C--N 1.405 3.542 0 CA-C-N 123.901 2.429 . . . . 74.02 111.521 178.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -154.43 107.79 0.34 Allowed Glycine 0 C--N 1.331 0.25 0 N-CA-C 109.293 -1.523 . . . . 74.42 109.293 176.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 173' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -126.06 121.99 34.53 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 123.447 0.699 . . . . 74.51 109.473 -166.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 174' ' ' LEU . . . . . 0.653 ' HB3' HG13 ' C' ' 161' ' ' VAL . 61.8 tp -81.96 107.3 14.57 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 109.467 -0.568 . . . . 75.22 109.467 177.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 175' ' ' LEU . . . . . 0.448 HD22 HG21 ' C' ' 158' ' ' VAL . 11.4 mt -89.76 87.91 7.16 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 115.632 -0.713 . . . . 71.32 109.641 174.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 176' ' ' LEU . . . . . 0.678 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 98.5 mt -73.8 98.12 2.89 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 108.431 -0.951 . . . . 43.02 108.431 171.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 177' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' C' ' 122' ' ' GLU . 23.7 t -81.24 97.96 3.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 106.585 -1.635 . . . . 74.43 106.585 178.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 178' ' ' VAL . . . . . 0.432 HG21 HG21 ' C' ' 153' ' ' VAL . 3.5 p -87.86 129.95 38.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.012 -0.994 . . . . 74.01 110.756 -169.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 179' ' ' ARG . . . . . 0.434 ' O ' ' HA ' ' C' ' 124' ' ' PRO . 7.4 mmm180 -115.26 107.05 14.76 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 106.216 -1.772 . . . . 72.33 106.216 169.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 180' ' ' LEU . . . . . 0.413 ' HA ' ' O ' ' C' ' 125' ' ' LEU . 80.8 mt -68.38 138.51 55.42 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 109.147 -0.686 . . . . 70.51 109.147 175.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 181' ' ' LEU . . . . . . . . . . . . . 86.7 mt -50.55 129.76 26.36 Favored Pre-proline 0 N--CA 1.495 1.817 0 CA-C-O 117.848 -1.072 . . . . 74.2 108.672 -173.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER 11.42 -67.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.39 2.723 1 C-N-CA 126.135 4.557 . . . . 64.12 116.329 -153.024 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 183' ' ' HIS . . . . . 0.478 ' CD2' HD22 ' C' ' 127' ' ' LEU . 37.7 t-80 57.29 73.33 0.79 Allowed Pre-proline 0 N--CA 1.479 0.992 0 C-N-CA 124.18 0.992 . . . . 62.13 111.964 168.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 184' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -93.22 59.22 0.44 Allowed 'Trans proline' 0 C--N 1.358 1.042 0 N-CA-C 107.678 -1.701 . . . . 71.54 107.678 163.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 185' ' ' VAL . . . . . 0.626 HG11 ' SD ' ' C' ' 213' ' ' MET . 2.2 t -119.5 -59.01 2.95 Favored 'Isoleucine or valine' 0 C--N 1.362 1.133 0 N-CA-C 108.652 -0.87 . . . . 72.23 108.652 178.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 186' ' ' PHE . . . . . 0.495 ' HZ ' ' HA ' ' C' ' 214' ' ' THR . 40.8 m-85 -128.82 173.02 10.73 Favored 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 113.564 0.95 . . . . 61.44 113.564 -172.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 187' ' ' ARG . . . . . 0.442 ' NH1' ' HB2' ' C' ' 189' ' ' GLU . 2.1 tmt_? -152.61 120.92 6.3 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.983 1.313 . . . . 75.14 108.138 167.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 188' ' ' LEU . . . . . 0.752 HD23 ' HG2' ' C' ' 154' ' ' ARG . 48.7 tp -85.59 129.9 34.7 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 118.765 0.711 . . . . 74.14 112.797 -175.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 189' ' ' GLU . . . . . 0.442 ' HB2' ' NH1' ' C' ' 187' ' ' ARG . 14.6 tp10 -133.8 122.41 23.24 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 107.618 -1.253 . . . . 71.33 107.618 165.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 67.27 -107.98 2.25 Favored Glycine 0 C--N 1.344 1.025 0 N-CA-C 111.473 -0.651 . . . . 74.2 111.473 -172.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 191' ' ' GLN . . . . . 0.442 ' NE2' ' HA3' ' C' ' 242' ' ' GLY . 24.7 mt-30 -122.93 -16.93 6.92 Favored 'General case' 0 C--O 1.258 1.513 0 C-N-CA 124.506 1.123 . . . . 60.21 109.446 174.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -81.37 135.8 35.69 Favored 'General case' 0 C--N 1.355 0.816 0 C-N-CA 124.76 1.224 . . . . 65.13 110.295 -178.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 193' ' ' LEU . . . . . 0.523 HD21 ' CD2' ' C' ' 240' ' ' PHE . 95.4 mt -92.9 154.04 18.44 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.771 0.428 . . . . 52.2 110.67 177.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 194' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -116.64 105.75 12.77 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.076 -1.453 . . . . 75.43 107.076 167.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 195' ' ' ALA . . . . . 0.527 ' HB3' ' HG ' ' C' ' 251' ' ' LEU . . . -103.07 -177.5 3.39 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 124.017 0.927 . . . . 65.11 110.536 177.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 46.7 m -134.64 110.83 9.55 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 108.702 -0.851 . . . . 51.32 108.702 168.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 197' ' ' LEU . . . . . 0.446 HD22 HD12 ' C' ' 233' ' ' LEU . 47.9 tp -85.22 146.13 27.23 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 109.139 -0.689 . . . . 73.5 109.139 174.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 198' ' ' ASP . . . . . 0.508 ' HA ' ' HB2' ' C' ' 254' ' ' ARG . 28.4 t70 -117.89 105.88 12.39 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 108.661 -0.866 . . . . 44.52 108.661 -179.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 199' ' ' VAL . . . . . 0.428 HG22 HG21 ' C' ' 210' ' ' VAL . 44.7 t -115.05 122.12 33.99 Favored Pre-proline 0 N--CA 1.48 1.046 0 C-N-CA 124.095 0.958 . . . . 61.21 109.435 -176.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 200' ' ' PRO . . . . . 0.451 ' HA ' ' O ' ' C' ' 256' ' ' THR . 55.3 Cg_endo -70.36 148.91 62.24 Favored 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 122.021 1.814 . . . . 71.34 111.341 175.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 201' ' ' ALA . . . . . . . . . . . . . . . -53.9 -45.41 98.92 Favored Pre-proline 0 CA--C 1.559 1.318 0 C-N-CA 124.844 1.258 . . . . 74.35 113.763 -172.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 202' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -55.49 -49.27 16.63 Favored 'Trans proline' 0 C--N 1.396 3.064 0 C-N-CA 121.879 1.719 . . . . 63.15 112.847 175.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 203' ' ' ILE . . . . . . . . . . . . . 58.0 mt -68.12 -33.14 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.721 0.808 . . . . 63.4 110.869 -178.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 204' ' ' ALA . . . . . 0.401 ' HA ' HG11 ' C' ' 223' ' ' VAL . . . -64.25 -44.07 92.93 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.653 0.781 . . . . 75.02 110.856 178.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 205' ' ' VAL . . . . . 0.503 ' HA ' ' HA ' ' C' ' 226' ' ' ARG . 87.0 t -75.4 -39.16 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 115.508 -0.769 . . . . 63.41 112.131 -176.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 206' ' ' VAL . . . . . 0.469 ' HA ' ' HE2' ' A' ' 270' ' ' LYS . 14.6 p -77.34 -37.04 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 CA-C-N 118.078 0.399 . . . . 52.12 110.635 -178.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 86.57 57.68 2.05 Favored Glycine 0 C--N 1.337 0.631 0 N-CA-C 111.384 -0.687 . . . . 63.21 111.384 -168.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -89.49 -131.61 4.36 Favored Glycine 0 C--N 1.345 1.075 0 N-CA-C 110.915 -0.874 . . . . 51.32 110.915 177.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 209' ' ' LYS . . . . . 0.513 ' HG2' ' HG2' ' C' ' 220' ' ' GLU . 4.6 ttmp? -150.44 143.35 24.72 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.345 0.658 . . . . 72.12 110.123 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 210' ' ' VAL . . . . . 0.428 HG21 HG22 ' C' ' 199' ' ' VAL . 30.4 m -134.34 167.98 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 C-N-CA 124.824 1.25 . . . . 62.05 109.486 177.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 211' ' ' ARG . . . . . 0.452 ' HA ' ' HA ' ' C' ' 220' ' ' GLU . 36.2 ttm180 -92.24 127.77 37.85 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 122.608 0.363 . . . . 72.44 111.027 179.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -102.47 122.99 45.41 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 107.817 -1.179 . . . . 74.43 107.817 164.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 213' ' ' MET . . . . . 0.626 ' SD ' HG11 ' C' ' 185' ' ' VAL . 1.3 tmt? -77.63 136.63 38.26 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.757 -0.831 . . . . 63.12 108.757 175.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 214' ' ' THR . . . . . 0.495 ' HA ' ' HZ ' ' C' ' 186' ' ' PHE . 0.1 OUTLIER -134.32 166.8 21.98 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.014 0.526 . . . . 54.24 110.932 178.15 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 215' ' ' LEU . . . . . 0.405 HD13 ' HB2' ' C' ' 131' ' ' PHE . 52.1 mt -60.12 -38.77 84.03 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.752 1.221 . . . . 44.41 112.851 -171.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.41 14.64 22.55 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.044 0.938 . . . . 71.0 111.844 -174.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 148.77 169.2 15.28 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-O 119.645 -0.531 . . . . 64.11 112.735 176.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -91.73 118.3 0.49 Allowed 'Trans proline' 0 CA--C 1.56 1.815 0 C-N-CA 122.829 2.353 . . . . 52.13 113.004 176.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 219' ' ' VAL . . . . . 0.491 HG12 ' OG1' ' C' ' 214' ' ' THR . 2.9 p -100.01 115.26 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.13 0.572 . . . . 52.53 110.174 178.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 220' ' ' GLU . . . . . 0.513 ' HG2' ' HG2' ' C' ' 209' ' ' LYS . 24.8 tt0 -82.93 103.79 12.66 Favored 'General case' 0 CA--C 1.556 1.173 0 N-CA-C 108.015 -1.106 . . . . 72.32 108.015 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 221' ' ' VAL . . . . . 0.469 HG21 HD11 ' C' ' 233' ' ' LEU . 7.6 p -101.79 138.87 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.648 0.779 . . . . 74.03 112.513 -168.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -81.45 117.58 21.99 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.839 1.256 . . . . 73.3 112.424 -173.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 223' ' ' VAL . . . . . 0.401 HG11 ' HA ' ' C' ' 204' ' ' ALA . 59.7 t -77.7 142.09 65.39 Favored Pre-proline 0 CA--C 1.564 1.491 0 C-N-CA 125.801 1.64 . . . . 73.11 110.423 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 224' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -84.47 155.26 12.26 Favored 'Trans proline' 0 C--N 1.384 2.444 0 C-N-CA 123.408 2.739 . . . . 54.33 113.188 174.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.88 117.67 4.33 Favored 'Trans proline' 0 C--N 1.382 2.306 0 C-N-CA 123.49 2.793 . . . . 74.0 113.3 176.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 226' ' ' ARG . . . . . 0.503 ' HA ' ' HA ' ' C' ' 205' ' ' VAL . 0.0 OUTLIER 65.35 88.69 0.1 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.652 1.581 . . . . 70.15 112.224 -177.917 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 227' ' ' THR . . . . . . . . . . . . . 58.4 m -106.5 131.57 53.53 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 114.337 -1.301 . . . . 70.3 110.345 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 228' ' ' GLN . . . . . 0.503 ' NE2' ' HG2' ' A' ' 259' ' ' GLU . 22.8 mp0 -103.81 152.68 21.61 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.833 0.853 . . . . 74.32 110.816 177.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -69.27 140.71 54.46 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.032 -0.985 . . . . 62.12 109.523 177.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 93.28 -3.88 73.14 Favored Glycine 0 C--N 1.338 0.654 0 CA-C-O 119.639 -0.534 . . . . 62.04 112.942 -174.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 231' ' ' ARG . . . . . 0.439 ' HD2' ' H ' ' C' ' 228' ' ' GLN . 54.3 mtt180 -64.81 174.51 1.82 Allowed 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 117.564 0.682 . . . . 74.12 111.376 168.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 232' ' ' LYS . . . . . 0.467 ' HA ' ' O ' ' C' ' 251' ' ' LEU . 2.6 ttmp? -143.29 151.43 40.51 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.641 0.734 . . . . 71.45 111.064 179.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 233' ' ' LEU . . . . . 0.553 HD13 HD13 ' C' ' 251' ' ' LEU . 1.9 tt -127.97 142.35 51.27 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.049 1.74 . . . . 74.21 107.873 -169.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 234' ' ' ARG . . . . . 0.424 ' HA ' ' O ' ' C' ' 249' ' ' LEU . 36.3 ptt180 -115.22 116.78 28.91 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 121.577 0.703 . . . . 72.34 111.379 173.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 235' ' ' LEU . . . . . 0.456 ' HB2' ' HB3' ' C' ' 249' ' ' LEU . 67.9 mt -109.63 99.42 8.61 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 108.839 -0.8 . . . . 73.43 108.839 171.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -69.4 126.19 28.99 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 114.335 -1.302 . . . . 71.55 110.949 -172.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 87.56 7.06 76.2 Favored Glycine 0 C--N 1.349 1.269 0 O-C-N 123.749 0.656 . . . . 71.42 113.956 -177.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 238' ' ' LYS . . . . . 0.43 ' HD2' HG21 ' C' ' 214' ' ' THR . 74.5 mmtt -109.91 17.16 21.43 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.469 0.708 . . . . 72.03 111.412 -178.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 239' ' ' GLY . . . . . 0.423 ' HA2' ' HG ' ' C' ' 193' ' ' LEU . . . -86.78 -166.11 42.06 Favored Glycine 0 C--N 1.348 1.239 0 N-CA-C 112.081 -0.408 . . . . 31.21 112.081 174.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 240' ' ' PHE . . . . . 0.523 ' CD2' HD21 ' C' ' 193' ' ' LEU . 2.2 m-85 -86.79 152.61 54.23 Favored Pre-proline 0 CA--C 1.558 1.261 0 N-CA-C 108.845 -0.798 . . . . 75.14 108.845 175.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 241' ' ' PRO . . . . . 0.43 ' HA ' ' HG2' ' C' ' 246' ' ' ARG . 31.5 Cg_exo -43.34 141.07 3.49 Favored 'Trans proline' 0 C--N 1.382 2.309 0 C-N-CA 124.622 3.548 . . . . 70.21 115.674 178.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 242' ' ' GLY . . . . . 0.442 ' HA3' ' NE2' ' C' ' 191' ' ' GLN . . . -133.88 148.95 19.61 Favored Glycine 0 C--N 1.348 1.217 0 CA-C-O 119.097 -0.835 . . . . 70.14 112.422 -176.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -60.09 -40.36 61.48 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 123.729 2.953 . . . . 71.42 113.462 -169.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -118.45 19.46 13.34 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.865 0.866 . . . . 71.42 110.787 -175.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 142.16 136.3 3.21 Favored Glycine 0 C--N 1.344 1.022 0 N-CA-C 110.063 -1.215 . . . . 51.32 110.063 -175.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 246' ' ' ARG . . . . . 0.43 ' HG2' ' HA ' ' C' ' 241' ' ' PRO . 90.5 mtt180 -78.25 150.72 33.37 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 117.349 0.575 . . . . 61.31 110.918 -172.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -72.76 -170.47 17.03 Favored Glycine 0 C--N 1.35 1.311 0 O-C-N 124.29 0.993 . . . . 63.23 114.831 -171.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -129.9 155.1 46.59 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.761 0.824 . . . . 73.54 109.017 -170.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 249' ' ' LEU . . . . . 0.486 HD11 ' HB2' ' C' ' 195' ' ' ALA . 24.0 tp -100.27 133.37 44.77 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.934 0.894 . . . . 74.23 110.89 -171.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 250' ' ' TYR . . . . . 0.488 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 1.0 OUTLIER -122.7 100.56 6.98 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.236 1.014 . . . . 71.43 111.084 178.662 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 251' ' ' LEU . . . . . 0.553 HD13 HD13 ' C' ' 233' ' ' LEU . 1.6 mp -97.0 125.69 41.6 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 118.9 -0.572 . . . . 64.53 110.586 -176.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -82.6 136.22 34.86 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 108.852 -0.795 . . . . 73.41 108.852 167.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 253' ' ' VAL . . . . . 0.485 HG21 ' CZ3' ' B' ' 242' ' ' TRP . 47.0 t -92.71 138.03 20.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 123.887 0.875 . . . . 73.5 112.82 -168.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 254' ' ' ARG . . . . . 0.508 ' HB2' ' HA ' ' C' ' 198' ' ' ASP . 20.6 mmt85 -102.65 136.07 43.15 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.2 1.4 . . . . 74.13 108.49 168.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 255' ' ' ILE . . . . . . . . . . . . . 32.7 mm -102.14 104.45 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 107.188 -1.412 . . . . 75.24 107.188 163.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 256' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' C' ' 200' ' ' PRO . 1.7 t -107.82 148.25 29.79 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.365 1.066 . . . . 53.32 109.902 -175.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 2.9 pp -111.9 145.73 33.31 Favored Pre-proline 0 N--CA 1.476 0.853 0 N-CA-C 109.393 -0.595 . . . . 64.54 109.393 176.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -60.4 -8.41 8.66 Favored 'Trans proline' 0 N--CA 1.507 2.268 0 C-N-CA 123.036 2.49 . . . . 73.21 115.36 -169.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 58.61 -68.5 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.572 1.549 . . . . 72.3 112.38 -168.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.17 149.68 44.75 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.771 0.829 . . . . 73.41 109.377 170.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 261' ' ' LEU . . . . . 0.521 HD11 HG13 ' A' ' 205' ' ' VAL . 77.6 mt -141.41 148.39 39.52 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.077 0.465 . . . . 71.21 111.089 -178.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 69.2 p -94.28 154.66 40.38 Favored Pre-proline 0 CA--C 1.554 1.129 0 N-CA-C 108.544 -0.91 . . . . 61.23 108.544 168.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -45.27 -45.06 15.52 Favored 'Trans proline' 0 C--N 1.391 2.798 0 C-N-CA 123.553 2.836 . . . . 74.2 114.188 -176.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -61.37 -52.59 64.01 Favored 'General case' 0 C--O 1.249 1.045 0 CA-C-N 115.1 -0.955 . . . . 71.04 110.856 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -52.06 -60.32 3.33 Favored 'General case' 0 C--N 1.362 1.129 0 O-C-N 124.537 1.148 . . . . 65.11 110.373 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 266' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -61.43 -33.82 74.35 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 124.179 0.924 . . . . 64.21 111.732 -172.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -59.63 -51.52 69.44 Favored 'General case' 0 CA--C 1.552 1.042 0 O-C-N 123.273 0.358 . . . . 70.32 111.359 173.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 268' ' ' LEU . . . . . . . . . . . . . 11.1 mp -66.61 -41.74 87.92 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 119.327 -0.368 . . . . 52.44 111.766 179.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -58.76 -38.57 78.74 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.654 0.782 . . . . 61.11 110.716 177.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 270' ' ' LYS . . . . . 0.503 ' HA ' HG21 ' A' ' 206' ' ' VAL . 9.6 mtpm? -66.51 -46.38 76.4 Favored 'General case' 0 C--N 1.361 1.091 0 C-N-CA 122.997 0.519 . . . . 75.43 111.139 176.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.83 -37.59 74.11 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 123.66 0.6 . . . . 75.33 111.405 178.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 82.5 mt -68.35 -42.48 79.16 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.537 -0.756 . . . . 74.33 110.356 174.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -67.58 -25.6 65.86 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.408 0.683 . . . . 34.13 111.369 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -81.31 -36.34 29.91 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.252 1.021 . . . . 63.21 109.879 176.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -61.02 -28.36 68.99 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.522 -0.763 . . . . 70.04 110.327 168.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 276' ' ' TYR . . . . . 0.534 ' HB3' HD11 ' A' ' 203' ' ' ILE . 7.9 m-85 -82.08 -32.4 30.32 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.419 1.088 . . . . 75.52 111.863 175.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 23.0 m-30 -64.68 -30.16 71.17 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 109.483 -0.562 . . . . 44.24 109.483 172.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -66.38 -15.48 63.32 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 123.784 0.834 . . . . 55.2 112.41 175.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 279' ' ' ARG . . . . . . . . . . . . . 26.3 mtp-105 -82.47 -15.67 51.66 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.1 0.56 . . . . 71.52 111.091 175.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.065 0 C-N-CA 122.938 0.495 . . . . 75.14 109.718 178.317 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 76.6 tttt . . . . . 0 N--CA 1.485 1.293 0 N-CA-C 114.312 1.227 . . . . 62.43 114.312 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -87.9 102.77 15.04 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 107.479 -1.304 . . . . 74.32 107.479 163.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.485 ' HA ' ' OH ' ' A' ' 66' ' ' TYR . 7.3 t0 -71.37 92.7 1.08 Allowed 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 108.455 -0.943 . . . . 61.41 108.455 178.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -62.93 -36.28 82.89 Favored 'General case' 0 C--O 1.244 0.796 0 C-N-CA 123.613 0.765 . . . . 73.34 111.979 -171.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.419 ' CE1' HD11 ' A' ' 22' ' ' ILE . 77.7 m-85 -62.98 -44.49 95.9 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.595 -0.73 . . . . 73.33 110.674 175.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.91 -36.91 83.33 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.965 0.506 . . . . 60.32 111.431 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 6' ' ' ASP . 76.3 mt -61.61 -41.69 91.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.134 0.574 . . . . 74.23 110.086 176.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.1 mt -75.28 -14.12 60.48 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-N 116.145 -0.48 . . . . 51.33 111.955 175.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.49 24.13 76.77 Favored Glycine 0 C--N 1.353 1.476 0 CA-C-N 116.745 -0.207 . . . . 53.33 113.256 -177.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.5 m -108.48 152.38 42.04 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 124.128 0.971 . . . . 71.43 110.008 178.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -58.87 152.51 57.08 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.904 2.402 . . . . 50.12 112.602 174.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -69.49 7.34 0.84 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 112.664 0.616 . . . . 75.43 112.664 178.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -128.44 28.5 5.44 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.025 1.33 . . . . 64.11 107.786 177.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.6 168.7 2.75 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.96 0.904 . . . . 64.31 111.436 176.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 67.2 p -114.08 172.91 6.71 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.275 0.63 . . . . 71.11 109.642 175.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -58.02 -36.53 72.82 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.327 0.651 . . . . 64.21 110.393 176.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -66.59 -43.96 83.48 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.474 0.709 . . . . 72.43 111.433 177.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -67.42 -40.2 85.54 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.204 0.602 . . . . 64.03 111.743 -178.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.601 HD13 ' HB3' ' A' ' 57' ' ' LEU . 69.0 mt -71.59 -38.78 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.135 0.974 . . . . 73.31 110.748 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -65.25 -50.94 63.85 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.198 -0.91 . . . . 71.24 110.295 177.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 31.9 mtm180 -67.52 -33.12 74.42 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.352 0.661 . . . . 54.12 111.565 -178.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.32 -49.91 73.74 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 123.902 0.751 . . . . 64.0 109.588 174.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -60.58 -44.02 96.68 Favored 'General case' 0 C--O 1.206 -1.19 0 O-C-N 124.088 0.868 . . . . 73.1 110.589 178.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -58.69 -46.74 86.58 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.846 0.859 . . . . 74.22 110.833 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 47.4 ttt180 -57.14 -53.85 53.42 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.134 0.974 . . . . 71.15 110.671 177.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.643 ' HB3' HD13 ' A' ' 50' ' ' ILE . 73.6 mt -77.35 -21.66 53.01 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 115.274 -0.875 . . . . 74.11 111.368 -172.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -80.29 -32.09 38.17 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.443 0.697 . . . . 63.3 110.785 178.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 78.3 mtp180 -81.08 -39.99 24.83 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 122.938 0.495 . . . . 72.33 110.245 174.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.558 HE21 ' HA ' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -70.12 -50.13 43.75 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.297 0.639 . . . . 63.33 111.34 -175.288 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.51 ' HE2' HD22 ' A' ' 29' ' ' LEU . 15.6 m-85 -100.21 30.19 3.94 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.153 0.581 . . . . 63.25 109.628 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -65.71 111.44 6.32 Favored Pre-proline 0 C--N 1.354 0.763 0 N-CA-C 108.59 -0.893 . . . . 63.41 108.59 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -53.87 -38.37 85.79 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 123.186 2.591 . . . . 74.13 113.778 -168.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -70.24 -28.94 65.65 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.055 0.942 . . . . 72.45 112.3 -179.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 46.9 t -88.51 -61.58 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 N-CA-C 109.122 -0.696 . . . . 65.53 109.122 177.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -100.13 90.26 4.31 Favored 'General case' 0 C--O 1.243 0.759 0 C-N-CA 124.384 1.074 . . . . 61.35 108.881 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -81.04 69.93 7.75 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 108.67 -0.863 . . . . 73.11 108.67 178.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.2 m -125.03 106.04 28.8 Favored Pre-proline 0 C--O 1.237 0.4 0 N-CA-C 107.883 -1.154 . . . . 54.41 107.883 178.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_exo -43.89 -44.7 11.78 Favored 'Trans proline' 0 C--N 1.388 2.626 0 C-N-CA 123.749 2.966 . . . . 72.23 112.979 -177.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -50.81 -52.43 41.24 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.395 1.078 . . . . 64.43 111.31 176.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.7 -28.45 69.08 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 114.434 -1.257 . . . . 72.14 110.426 -177.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -82.19 -33.6 29.37 Favored 'General case' 0 C--O 1.219 -0.55 0 O-C-N 123.936 0.772 . . . . 62.01 110.293 -175.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.651 ' HA ' ' HD3' ' A' ' 48' ' ' LYS . 44.0 mt-10 -66.89 -46.35 75.19 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.961 0.905 . . . . 62.44 109.983 176.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -62.22 -42.64 99.49 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 114.224 -1.353 . . . . 74.03 109.875 174.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -56.99 -40.53 76.73 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.302 1.041 . . . . 73.24 110.725 176.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.651 ' HD3' ' HA ' ' A' ' 45' ' ' GLU . 24.0 mtpp -60.68 -48.75 80.38 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.703 0.801 . . . . 75.14 109.982 177.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -65.57 -26.5 67.89 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 123.38 0.425 . . . . 71.44 111.848 177.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.643 HD13 ' HB3' ' A' ' 29' ' ' LEU . 72.7 mt -74.5 -29.49 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 124.241 1.016 . . . . 70.53 110.058 175.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -73.27 -35.08 66.12 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.126 0.57 . . . . 73.43 110.444 172.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -67.86 -45.31 74.93 Favored 'General case' 0 C--O 1.256 1.443 0 C-N-CA 124.76 1.224 . . . . 63.42 110.302 175.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.13 -51.31 70.15 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 113.762 -1.563 . . . . 65.45 110.186 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 92.5 t80 -63.26 -35.26 79.75 Favored 'General case' 0 C--O 1.205 -1.267 0 CA-C-N 114.7 -1.136 . . . . 72.32 110.691 174.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.04 -51.34 66.61 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.298 0.639 . . . . 53.01 111.838 -177.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 94.4 t -75.39 -38.78 40.7 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 CA-C-N 115.121 -0.945 . . . . 74.52 110.893 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.601 ' HB3' HD13 ' A' ' 22' ' ' ILE . 73.1 mt -89.02 3.97 49.88 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 113.43 0.9 . . . . 62.04 113.43 -174.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.2 t -68.18 -73.12 0.15 Allowed 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.751 0.821 . . . . 74.34 110.497 -179.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -83.41 120.54 75.75 Favored Pre-proline 0 C--O 1.25 1.095 0 N-CA-C 108.346 -0.983 . . . . 74.34 108.346 178.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.553 ' O ' ' HG3' ' A' ' 64' ' ' ARG . 9.5 Cg_endo -53.82 -19.76 15.76 Favored 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 123.582 2.855 . . . . 72.41 115.187 -172.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -72.63 -53.14 12.63 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 119.397 0.999 . . . . 72.3 111.183 178.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -56.25 -41.16 75.32 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 122.417 1.103 . . . . 74.54 110.112 173.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.477 ' HB3' ' HA ' ' A' ' 60' ' ' PRO . 32.6 ttt180 -60.12 -43.09 95.91 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 113.273 -1.785 . . . . 74.11 111.142 175.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.553 ' HG3' ' O ' ' A' ' 60' ' ' PRO . 42.1 mtm180 -62.04 -37.23 84.16 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-O 118.974 -0.536 . . . . 74.25 110.314 177.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 84.9 mt -57.65 -44.55 85.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 O-C-N 123.982 0.801 . . . . 64.42 109.655 176.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.485 ' OH ' ' HA ' ' A' ' 6' ' ' ASP . 35.1 t80 -61.13 -50.51 72.89 Favored 'General case' 0 CA--C 1.558 1.25 0 CA-C-N 115.912 -0.585 . . . . 75.4 111.163 175.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -65.26 -23.85 67.16 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.857 0.863 . . . . 64.04 112.425 -179.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 81.5 p -97.0 -7.3 33.32 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 122.855 0.462 . . . . 75.13 110.601 176.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -73.28 103.76 4.09 Favored 'General case' 0 C--N 1.353 0.737 0 N-CA-C 106.997 -1.483 . . . . 63.45 106.997 168.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 110.15 23.95 5.9 Favored Glycine 0 CA--C 1.531 1.055 0 N-CA-C 110.947 -0.861 . . . . 52.54 110.947 -164.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 94.3 m -145.69 -56.33 0.3 Allowed 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 104.633 -2.358 . . . . 71.23 104.633 172.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 85.8 m -89.85 148.22 23.31 Favored 'General case' 0 C--O 1.252 1.235 0 N-CA-C 105.23 -2.137 . . . . 74.23 105.23 157.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.78 -42.32 4.53 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 123.405 0.682 . . . . 74.04 110.895 -178.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.25 134.98 51.13 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 123.346 0.658 . . . . 75.1 109.315 177.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.414 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 75.0 Cg_exo -52.28 126.16 19.7 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.718 2.279 . . . . 75.41 111.749 175.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 75' ' ' PRO . 43.4 Cg_exo -57.51 160.99 12.76 Favored 'Trans proline' 0 C--N 1.375 1.974 0 C-N-CA 123.305 2.67 . . . . 74.25 113.562 -177.088 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -64.48 121.25 8.78 Favored 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 122.195 1.93 . . . . 62.44 111.523 173.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.479 ' HG3' ' HA3' ' A' ' 104' ' ' GLY . 35.9 Cg_endo -63.25 136.43 55.63 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 122.871 2.38 . . . . 43.51 111.702 177.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -57.89 157.07 25.61 Favored 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 123.183 2.589 . . . . 71.05 112.626 175.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -60.37 84.46 0.07 OUTLIER 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 122.801 2.334 . . . . 51.35 111.411 172.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.21 -32.3 0.32 Allowed Glycine 0 CA--C 1.525 0.672 0 CA-C-N 114.312 -1.313 . . . . 62.41 109.824 -176.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.92 156.32 31.37 Favored Glycine 0 C--N 1.351 1.366 0 C-N-CA 123.413 0.53 . . . . 53.03 113.072 171.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -63.06 94.47 0.07 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.809 0.843 . . . . 74.41 110.169 170.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -76.78 157.89 31.28 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 109.002 -0.74 . . . . 71.31 109.002 169.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.521 ' HE2' ' HD2' ' A' ' 93' ' ' PHE . 16.1 t80 -127.49 50.46 2.01 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.567 0.699 . . . . 70.22 109.563 -178.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 57.8 m -0.41 83.69 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.484 0 C-N-CA 127.288 2.235 . . . . 74.44 116.475 -174.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.86 -13.94 2.94 Favored Glycine 0 N--CA 1.482 1.748 0 N-CA-C 116.655 1.422 . . . . 70.11 116.655 168.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.502 ' HB3' ' HE2' ' A' ' 93' ' ' PHE . 63.5 m-85 -90.34 136.98 32.72 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 118.158 0.979 . . . . 72.34 110.179 -174.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -66.17 92.51 0.18 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.091 0.556 . . . . 71.44 110.695 -170.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.568 HG13 ' HG3' ' A' ' 91' ' ' GLU . 2.3 p -40.9 -51.49 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 125.12 1.368 . . . . 75.21 113.0 171.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.568 ' HG3' HG13 ' A' ' 90' ' ' VAL . 40.3 mt-10 -71.87 -12.1 61.11 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.614 0.766 . . . . 75.33 111.528 -173.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -87.09 -34.35 19.17 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.518 0.727 . . . . 45.35 110.632 174.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.521 ' HD2' ' HE2' ' A' ' 85' ' ' PHE . 26.5 m-85 -91.49 174.14 7.53 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.158 0.799 . . . . 71.01 113.158 -168.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 88.5 p -58.76 151.39 21.32 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 115.395 1.628 . . . . 74.5 115.395 -162.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.91 -42.87 80.72 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.028 -1.442 . . . . 74.31 110.877 170.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -50.61 -50.99 52.76 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.185 0.994 . . . . 75.03 111.042 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.478 ' HE2' HG23 ' A' ' 90' ' ' VAL . 1.4 t80 -59.69 -50.56 73.35 Favored 'General case' 0 CA--C 1.555 1.172 0 O-C-N 124.226 0.954 . . . . 63.23 109.829 174.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -66.56 -6.6 15.71 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.207 0.603 . . . . 73.05 112.249 -176.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -103.0 -30.95 10.47 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.168 0.987 . . . . 70.02 111.831 170.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 26.3 tp -73.59 -56.19 5.33 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.341 0.657 . . . . 55.03 110.842 -177.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -93.51 -6.55 46.54 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.115 0.566 . . . . 72.11 110.662 174.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -47.48 -55.75 8.93 Favored Glycine 0 C--N 1.351 1.394 0 CA-C-O 118.767 -1.018 . . . . 72.43 115.579 -177.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -46.4 -13.83 0.11 Allowed 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 124.792 3.661 . . . . 23.1 116.746 176.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.479 ' HA3' ' HG3' ' A' ' 78' ' ' PRO . . . -149.93 29.03 1.14 Allowed Glycine 0 C--N 1.355 1.585 0 CA-C-O 118.599 -1.112 . . . . 44.4 114.215 174.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.526 HD13 HD21 ' A' ' 169' ' ' ASN . 15.1 mt -60.99 79.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 113.005 0.743 . . . . 74.25 113.005 177.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.77 ' HB3' ' HA ' ' A' ' 169' ' ' ASN . 0.5 OUTLIER 24.72 -100.9 0.01 OUTLIER 'General case' 0 CA--C 1.569 1.7 0 C-N-CA 127.249 2.219 . . . . 72.25 113.956 170.175 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 80.06 6.28 89.23 Favored Glycine 0 C--N 1.363 2.046 0 CA-C-N 117.896 0.317 . . . . 44.0 113.431 -176.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.348 1.231 0 N-CA-C 111.317 -0.713 . . . . 71.34 111.317 -172.436 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 88.3 tttt . . . . . 0 CA--C 1.554 1.102 0 N-CA-C 111.756 0.28 . . . . 72.15 111.756 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -88.65 169.98 37.87 Favored Glycine 0 C--N 1.353 1.478 0 CA-C-N 116.337 -0.392 . . . . 55.22 112.961 178.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.418 ' H ' ' HD3' ' A' ' 117' ' ' ARG . 0.0 OUTLIER -113.95 -178.25 3.33 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.523 0.729 . . . . 71.34 110.353 -179.839 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -77.07 142.54 39.77 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 109.04 -0.726 . . . . 74.23 109.04 170.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.472 HD11 ' HB3' ' B' ' 10' ' ' LEU . 7.7 tt -144.18 125.75 14.98 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 107.658 -1.238 . . . . 70.23 107.658 -175.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.5 ' NH2' ' HB ' ' A' ' 177' ' ' VAL . 0.0 OUTLIER -97.58 126.44 42.88 Favored 'General case' 0 C--O 1.217 -0.625 0 N-CA-C 107.293 -1.373 . . . . 74.51 107.293 175.903 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.475 ' HB3' HD23 ' A' ' 176' ' ' LEU . . . -120.42 155.7 32.93 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-N 118.39 0.541 . . . . 41.51 111.534 -177.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.549 ' HB2' ' HB3' ' B' ' 9' ' ' ALA . 1.2 mm-40 -92.8 111.7 23.41 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 106.244 -1.761 . . . . 61.0 106.244 175.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.487 ' HB3' ' HA ' ' A' ' 178' ' ' VAL . 61.1 tp -101.35 96.17 5.79 Favored Pre-proline 0 N--CA 1.476 0.854 0 N-CA-C 108.29 -1.004 . . . . 54.05 108.29 177.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.645 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 58.5 Cg_endo -73.23 112.37 3.51 Favored 'Trans proline' 0 C--N 1.376 2.016 0 C-N-CA 121.406 1.404 . . . . 75.33 110.001 178.198 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.5 ' HB3' HD23 ' A' ' 180' ' ' LEU . 52.8 tp -116.73 138.9 51.13 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.413 0.625 . . . . 64.01 111.536 -168.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.633 ' HB ' ' HG2' ' A' ' 129' ' ' GLU . 93.3 m -72.3 125.73 28.06 Favored 'General case' 0 CA--C 1.553 1.072 0 CA-C-N 113.856 -1.52 . . . . 71.34 109.369 174.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.449 ' HB3' HD22 ' A' ' 215' ' ' LEU . 48.9 mt -53.4 -39.7 64.48 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 124.032 0.933 . . . . 70.54 112.249 -171.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -69.03 -33.85 74.28 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 115.465 -0.789 . . . . 75.32 110.628 -177.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.633 ' HG2' ' HB ' ' A' ' 126' ' ' THR . 12.2 mm-40 -72.99 -26.42 61.33 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 109.949 -0.389 . . . . 64.33 109.949 175.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.433 ' HB1' ' O ' ' A' ' 153' ' ' VAL . . . -66.7 -37.62 85.08 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 123.393 0.433 . . . . 41.43 110.54 174.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -65.38 -50.52 65.22 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 115.025 -0.989 . . . . 74.51 111.287 173.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 30.9 m170 -70.74 -45.19 65.29 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.183 0.593 . . . . 75.25 111.624 -171.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.07 -163.27 54.11 Favored Glycine 0 C--N 1.339 0.742 0 O-C-N 123.465 0.478 . . . . 71.54 112.834 -175.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 96.93 -173.84 29.64 Favored Glycine 0 C--N 1.345 1.051 0 N-CA-C 112.554 -0.219 . . . . 70.42 112.554 179.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 2.0 mp0 -78.88 109.53 13.24 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 122.655 -0.321 . . . . 73.14 110.357 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -90.97 126.46 36.08 Favored 'General case' 0 C--O 1.248 1.022 0 N-CA-C 109.317 -0.623 . . . . 74.4 109.317 173.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.412 HG13 ' HG3' ' A' ' 144' ' ' ARG . 76.3 t -80.31 116.31 24.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 114.742 -1.117 . . . . 71.24 108.483 168.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.638 ' HB ' HG13 ' A' ' 145' ' ' VAL . 62.2 t -124.75 129.21 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.08 0.952 . . . . 73.14 109.042 -175.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -98.03 142.92 29.15 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 122.996 0.518 . . . . 71.3 110.941 -177.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.549 ' HB ' ' HB3' ' B' ' 8' ' ' LEU . 8.1 p -160.67 121.86 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 C-N-CA 123.515 0.726 . . . . 75.1 111.023 174.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 65.51 14.3 9.4 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.471 1.108 . . . . 74.24 113.911 169.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 84.6 28.04 33.69 Favored Glycine 0 N--CA 1.479 1.518 0 N-CA-C 111.9 -0.48 . . . . 31.1 111.9 -174.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 17.9 tpt85 -152.62 97.31 2.23 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 107.737 -1.208 . . . . 72.12 107.737 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.549 ' NH1' ' HB2' ' A' ' 146' ' ' SER . 0.0 OUTLIER -64.54 129.96 41.86 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 114.908 -1.042 . . . . 74.41 111.424 179.375 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.638 HG13 ' HB ' ' A' ' 138' ' ' VAL . 1.4 p -91.79 130.09 41.46 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 C-N-CA 124.346 1.058 . . . . 73.53 109.223 165.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.549 ' HB2' ' NH1' ' A' ' 144' ' ' ARG . 47.5 t -92.96 132.03 37.43 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 108.317 -0.994 . . . . 31.45 108.317 167.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 2.1 p -139.81 118.01 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 O-C-N 123.65 0.594 . . . . 73.42 109.919 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.443 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 47.8 ttt85 -74.37 93.41 2.41 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 107.864 -1.162 . . . . 74.14 107.864 167.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.554 ' HB ' HG11 ' A' ' 153' ' ' VAL . 34.2 pt -71.75 125.23 91.7 Favored Pre-proline 0 CA--C 1.55 0.956 0 N-CA-C 108.408 -0.96 . . . . 74.13 108.408 175.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -59.39 138.28 83.3 Favored 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 122.371 2.048 . . . . 60.34 111.951 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -62.84 93.02 0.14 Allowed 'Trans proline' 0 C--N 1.374 1.877 0 C-N-CA 121.996 1.797 . . . . 74.15 110.116 171.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.503 ' HA2' ' CD2' ' A' ' 240' ' ' PHE . . . 125.02 24.21 1.69 Allowed Glycine 0 C--N 1.345 1.046 0 CA-C-N 115.1 -0.954 . . . . 75.51 113.084 -173.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.581 HG21 HD11 ' A' ' 159' ' ' ILE . 2.6 p -75.38 149.67 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 123.626 0.77 . . . . 75.43 110.366 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.467 ' O ' HG13 ' A' ' 178' ' ' VAL . 0.1 OUTLIER -119.24 -165.35 1.14 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.507 0.723 . . . . 73.23 112.099 -161.043 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.549 ' HB3' ' O ' ' A' ' 188' ' ' LEU . 3.0 tp10 -86.6 141.36 29.06 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 105.481 -2.044 . . . . 72.32 105.481 160.252 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 65.71 9.03 43.46 Favored Glycine 0 CA--C 1.535 1.311 0 N-CA-C 115.322 0.889 . . . . 14.21 115.322 177.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.501 ' O ' HG12 ' A' ' 178' ' ' VAL . 23.2 t -74.64 117.89 16.98 Favored 'General case' 0 C--N 1.355 0.833 0 N-CA-C 107.949 -1.13 . . . . 74.23 107.949 175.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.521 HG22 HG22 ' A' ' 177' ' ' VAL . 41.7 t -84.84 88.63 2.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.577 -0.898 . . . . 72.34 108.577 -178.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.581 HD11 HG21 ' A' ' 153' ' ' VAL . 30.0 mt -72.3 98.82 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 107.704 -1.221 . . . . 75.24 107.704 174.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -79.61 98.19 6.81 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 114.581 -1.19 . . . . 61.32 108.687 -176.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 3.4 p -123.51 94.92 45.81 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 123.649 0.78 . . . . 61.33 109.473 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.613 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 10.8 Cg_endo -56.65 143.67 88.47 Favored 'Trans proline' 0 C--N 1.363 1.336 0 C-N-CA 123.025 2.483 . . . . 74.53 112.874 167.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 95.51 20.37 27.27 Favored Glycine 0 N--CA 1.445 -0.764 0 CA-C-N 114.658 -1.155 . . . . 70.43 115.056 172.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.458 ' HG3' HG23 ' A' ' 145' ' ' VAL . 24.9 mmt -143.99 7.96 1.43 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.16 0.584 . . . . 64.15 110.433 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.563 ' HA2' HD13 ' A' ' 174' ' ' LEU . . . -90.55 -121.13 2.31 Favored Glycine 0 C--N 1.346 1.115 0 CA-C-N 115.672 -0.694 . . . . 73.33 114.436 -168.129 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.492 ' O ' ' HA ' ' A' ' 171' ' ' PRO . . . -60.94 115.71 8.25 Favored Glycine 0 C--N 1.362 2.007 0 CA-C-O 119.493 -0.615 . . . . 74.5 113.494 -169.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -59.59 146.25 41.5 Favored 'General case' 0 C--N 1.35 0.615 0 O-C-N 125.087 1.11 . . . . 75.42 111.034 -175.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 169.18 -125.25 1.24 Allowed Glycine 0 CA--C 1.495 -1.197 0 N-CA-C 106.816 -2.514 . . . . 64.21 106.816 -174.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . 0.77 ' HA ' ' HB3' ' A' ' 106' ' ' PHE . 43.4 t-20 -98.31 -57.09 0.17 Allowed Pre-proline 0 CA--C 1.55 0.981 0 N-CA-C 107.415 -1.328 . . . . 63.11 107.415 170.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.668 ' HD3' ' HB3' ' A' ' 169' ' ' ASN . 59.5 Cg_endo -95.03 109.18 0.13 Allowed 'Trans proline' 0 C--N 1.382 2.341 0 C-N-CA 122.033 1.822 . . . . 71.13 110.937 165.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.492 ' HA ' ' O ' ' A' ' 166' ' ' GLY . 29.6 Cg_endo -61.59 113.58 1.87 Allowed 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 121.74 1.627 . . . . 71.25 108.936 174.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -63.94 -142.06 0.02 OUTLIER Glycine 0 N--CA 1.484 1.841 0 N-CA-C 116.096 1.198 . . . . 72.4 116.096 -166.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.613 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 38.9 t70 -80.85 124.71 29.32 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 122.177 -0.602 . . . . 71.14 109.427 -177.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.563 HD13 ' HA2' ' A' ' 165' ' ' GLY . 26.9 tp -106.88 118.36 36.48 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.148 0.499 . . . . 64.32 110.5 -174.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.479 ' HB2' ' HA ' ' A' ' 120' ' ' ARG . 47.5 mt -94.58 85.53 4.54 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 124.061 0.944 . . . . 72.12 108.764 176.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.538 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 43.1 mt -72.73 84.37 1.19 Allowed 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.025 -0.534 . . . . 70.05 109.852 178.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.521 HG22 HG22 ' A' ' 158' ' ' VAL . 46.6 t -82.9 98.71 5.13 Favored 'Isoleucine or valine' 0 C--O 1.248 1.026 0 N-CA-C 104.917 -2.253 . . . . 61.43 104.917 176.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.501 HG12 ' O ' ' A' ' 157' ' ' SER . 10.0 p -76.27 113.29 15.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 112.108 -2.315 . . . . 70.33 111.001 -166.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.645 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 30.8 mmm-85 -90.16 106.45 18.49 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-N 115.499 -0.773 . . . . 53.32 108.989 178.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.5 HD23 ' HB3' ' A' ' 125' ' ' LEU . 23.3 mt -68.66 147.36 51.98 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 118.76 0.709 . . . . 72.4 110.29 177.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 125' ' ' LEU . 83.9 mt -55.37 159.1 4.8 Favored Pre-proline 0 N--CA 1.484 1.261 0 C-N-CA 124.17 0.988 . . . . 73.14 112.289 -176.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -74.87 24.01 0.39 Allowed 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 122.991 2.46 . . . . 71.42 112.689 170.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . 0.418 ' ND1' HD12 ' A' ' 127' ' ' LEU . 65.5 t-80 -61.62 116.09 18.67 Favored Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 125.231 1.412 . . . . 73.35 108.327 174.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -75.51 24.89 0.4 Allowed 'Trans proline' 0 C--N 1.371 1.727 0 C-N-CA 124.146 3.23 . . . . 61.24 116.902 -160.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 97.0 t -97.24 -57.82 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 119.168 0.895 . . . . 64.21 109.695 -179.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . 0.501 ' CE1' ' HB2' ' A' ' 195' ' ' ALA . 19.1 m-85 -132.87 143.61 49.63 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 112.551 0.574 . . . . 72.31 112.551 -171.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . 0.686 ' HB3' ' HB2' ' A' ' 194' ' ' TYR . 0.0 OUTLIER -114.12 83.33 1.85 Allowed 'General case' 0 C--O 1.239 0.508 0 N-CA-C 106.735 -1.58 . . . . 75.51 106.735 163.389 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.549 ' O ' ' HB3' ' A' ' 155' ' ' GLU . 48.1 tp -75.07 131.1 40.32 Favored 'General case' 0 C--O 1.202 -1.395 0 CA-C-N 114.465 -1.243 . . . . 74.21 109.367 177.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -147.2 129.89 16.05 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.089 -1.078 . . . . 70.31 108.089 171.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 66.26 -81.86 0.1 Allowed Glycine 0 C--N 1.344 0.98 0 O-C-N 124.352 1.032 . . . . 65.41 112.564 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.5 ' HB2' ' HA2' ' A' ' 247' ' ' GLY . 0.7 OUTLIER -129.97 -32.63 1.83 Allowed 'General case' 0 C--O 1.249 1.071 0 C-N-CA 123.834 0.853 . . . . 72.32 109.867 179.268 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -88.26 149.38 23.85 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.625 -0.716 . . . . 72.32 111.776 -166.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.478 HD23 ' HB2' ' A' ' 188' ' ' LEU . 88.6 mt -103.25 158.99 15.94 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.532 1.133 . . . . 63.44 108.97 173.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.686 ' HB2' ' HB3' ' A' ' 187' ' ' ARG . 28.5 m-85 -131.35 101.33 5.5 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 108.707 -0.849 . . . . 73.14 108.707 168.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.501 ' HB2' ' CE1' ' A' ' 186' ' ' PHE . . . -105.4 131.48 52.78 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 109.145 -0.687 . . . . 74.34 109.145 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . 0.586 ' HA ' ' HB2' ' A' ' 252' ' ' GLU . 30.4 m -71.72 110.75 6.47 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 109.308 -0.627 . . . . 70.21 109.308 177.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.568 HD22 HD13 ' A' ' 251' ' ' LEU . 50.1 tp -103.15 101.14 11.09 Favored 'General case' 0 C--N 1.347 0.487 0 N-CA-C 110.111 -0.329 . . . . 72.21 110.111 -178.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -73.6 127.7 33.47 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.562 -1.273 . . . . 61.43 107.562 164.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.581 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 7.1 p -142.18 135.35 14.14 Favored Pre-proline 0 CA--C 1.539 0.545 0 N-CA-C 107.889 -1.152 . . . . 64.4 107.889 178.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.3 158.72 37.0 Favored 'Trans proline' 0 C--N 1.361 1.222 0 C-N-CA 121.475 1.45 . . . . 64.51 112.196 172.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.411 ' HB3' ' HD3' ' A' ' 202' ' ' PRO . . . -56.83 -49.66 92.57 Favored Pre-proline 0 N--CA 1.481 1.109 0 N-CA-C 113.233 0.827 . . . . 71.34 113.233 -178.08 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.411 ' HD3' ' HB3' ' A' ' 201' ' ' ALA . 57.1 Cg_exo -57.28 -45.42 35.14 Favored 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 121.953 1.768 . . . . 63.54 113.802 178.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 55.4 mt -71.39 -29.69 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 122.953 0.501 . . . . 64.32 110.86 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.89 -42.2 85.92 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.715 0.406 . . . . 71.51 110.391 175.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 46.0 t -68.85 -55.66 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.593 0.757 . . . . 63.23 111.292 -178.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.653 HG21 ' HA ' ' C' ' 270' ' ' LYS . 61.4 t -83.06 -41.69 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-O 120.872 0.367 . . . . 74.41 111.173 -172.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 88.96 168.89 44.27 Favored Glycine 0 C--N 1.338 0.692 0 CA-C-N 115.968 -0.56 . . . . 72.35 111.973 -174.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 161.32 -125.34 1.43 Allowed Glycine 0 C--O 1.224 -0.495 0 N-CA-C 110.149 -1.18 . . . . 55.24 110.149 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -137.97 135.74 36.29 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 118.099 0.95 . . . . 45.21 110.882 175.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 28.4 m -129.34 -176.71 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 124.181 0.993 . . . . 63.11 109.276 170.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -80.86 133.24 35.55 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.32 0.648 . . . . 71.41 110.765 176.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -119.92 111.94 18.57 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.542 -1.281 . . . . 62.04 107.542 165.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -71.81 129.16 37.96 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.055 -0.72 . . . . 71.23 109.055 177.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 43.4 p -109.27 179.82 4.05 Favored 'General case' 0 C--O 1.243 0.763 0 N-CA-C 107.744 -1.206 . . . . 74.1 107.744 171.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.449 HD22 ' HB3' ' A' ' 127' ' ' LEU . 72.2 mt -61.21 -22.11 64.46 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 114.021 1.119 . . . . 63.31 114.021 -170.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -142.64 28.7 1.6 Allowed 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 112.705 0.632 . . . . 64.44 112.705 -177.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 155.89 159.67 9.51 Favored Glycine 0 N--CA 1.477 1.419 0 N-CA-C 114.28 0.472 . . . . 33.0 114.28 173.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -87.69 130.39 2.7 Favored 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 123.199 2.599 . . . . 70.23 113.305 178.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 30.9 m -110.99 175.59 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 123.749 0.82 . . . . 73.4 110.262 175.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -101.82 111.22 23.4 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.803 0.841 . . . . 75.04 109.355 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 14.7 p -100.15 133.81 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 123.156 0.582 . . . . 74.13 109.584 177.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -86.64 104.47 16.08 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 122.955 0.502 . . . . 60.25 110.49 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 60.2 t -71.24 128.74 89.95 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 123.914 0.886 . . . . 63.14 109.857 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -74.62 167.02 28.07 Favored 'Trans proline' 0 C--N 1.373 1.835 0 C-N-CA 122.743 2.295 . . . . 75.51 111.636 172.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . 0.466 ' HB2' ' HE ' ' A' ' 226' ' ' ARG . 58.8 Cg_endo -70.35 159.99 51.07 Favored 'Trans proline' 0 C--N 1.365 1.418 0 C-N-CA 122.712 2.274 . . . . 72.53 113.441 171.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . 0.466 ' HE ' ' HB2' ' A' ' 225' ' ' PRO 0.266 0.0 OUTLIER 38.03 55.96 1.64 Allowed 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 126.428 1.891 . . . . 74.04 113.378 -175.913 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.522 HG23 HD21 ' A' ' 233' ' ' LEU . 64.2 m -84.2 90.44 7.51 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 113.06 -1.882 . . . . 64.32 108.953 173.198 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -86.15 146.45 26.58 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.766 0.826 . . . . 75.32 111.545 -171.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -64.8 148.45 51.23 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.846 0.858 . . . . 62.31 112.333 -176.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . 0.405 ' HA3' ' NH2' ' C' ' 254' ' ' ARG . . . 90.78 -21.16 34.71 Favored Glycine 0 C--N 1.345 1.041 0 CA-C-N 115.434 -0.803 . . . . 73.32 113.311 -178.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -81.2 170.81 15.64 Favored 'General case' 0 C--O 1.245 0.821 0 C-N-CA 123.757 0.823 . . . . 74.0 110.993 -179.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.444 ' HG3' ' HB3' ' A' ' 250' ' ' TYR . 0.3 OUTLIER -129.02 117.28 20.65 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 114.601 -1.181 . . . . 72.22 109.03 -178.892 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.522 HD21 HG23 ' A' ' 227' ' ' THR . 58.2 mt -78.33 110.86 13.73 Favored 'General case' 0 C--O 1.218 -0.558 0 N-CA-C 108.034 -1.098 . . . . 71.4 108.034 175.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -80.99 106.51 13.05 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.974 0.909 . . . . 64.14 109.974 175.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.598 HD12 ' HG3' ' A' ' 238' ' ' LYS . 0.2 OUTLIER -118.68 107.22 13.43 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.229 0.537 . . . . 61.12 109.757 171.912 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 248' ' ' ASP . 25.6 mtpp -76.52 159.75 30.08 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.36 1.064 . . . . 64.43 111.079 -177.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 66.37 18.56 67.63 Favored Glycine 0 C--N 1.348 1.207 0 CA-C-N 115.688 -0.687 . . . . 74.2 113.279 -176.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.598 ' HG3' HD12 ' A' ' 235' ' ' LEU . 45.5 mmtm -114.32 -29.93 6.76 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.229 1.011 . . . . 73.01 109.805 -179.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -79.04 -154.98 8.56 Favored Glycine 0 C--N 1.343 0.95 0 CA-C-N 115.001 -1.0 . . . . 74.43 111.107 169.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . 0.503 ' CD2' ' HA2' ' A' ' 152' ' ' GLY . 35.3 m-85 -95.35 123.44 56.72 Favored Pre-proline 0 C--O 1.239 0.504 0 N-CA-C 109.519 -0.548 . . . . 73.13 109.519 -173.383 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.728 ' HA ' ' HA ' ' A' ' 246' ' ' ARG . 73.8 Cg_endo -73.24 132.16 17.52 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 122.721 2.281 . . . . 73.33 113.116 -170.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -101.65 -167.48 27.44 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 110.757 -0.937 . . . . 73.52 110.757 167.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -60.07 -62.54 0.15 Allowed 'Trans proline' 0 C--N 1.377 2.037 0 C-N-CA 122.915 2.41 . . . . 70.45 111.649 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -106.34 -25.31 11.98 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.449 0.7 . . . . 70.11 110.104 170.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -89.84 67.42 2.7 Favored Glycine 0 C--N 1.352 1.447 0 CA-C-N 115.759 -0.655 . . . . 62.24 112.457 -175.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.728 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 52.3 mtm-85 -69.92 118.24 12.51 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 123.529 0.732 . . . . 75.41 109.853 175.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . 0.5 ' HA2' ' HB2' ' A' ' 191' ' ' GLN . . . -52.85 149.86 10.4 Favored Glycine 0 C--N 1.351 1.376 0 N-CA-C 117.346 1.698 . . . . 42.24 117.346 -167.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . 0.488 ' HA ' ' HA ' ' A' ' 236' ' ' LYS . 0.8 OUTLIER -98.46 172.87 7.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 113.858 -1.171 . . . . 75.44 109.173 -179.228 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.503 ' HB3' ' HG ' ' A' ' 235' ' ' LEU . 17.5 tp -137.06 101.78 4.65 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 106.21 -1.774 . . . . 70.31 106.21 170.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.444 ' HB3' ' HG3' ' A' ' 232' ' ' LYS . 84.6 m-85 -85.98 112.14 20.93 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 123.553 0.741 . . . . 52.51 109.219 174.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.568 HD13 HD22 ' A' ' 197' ' ' LEU . 94.0 mt -88.92 121.12 30.96 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.152 -0.931 . . . . 72.24 110.065 178.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . 0.586 ' HB2' ' HA ' ' A' ' 196' ' ' THR . 45.9 mm-40 -75.15 91.49 2.6 Favored 'General case' 0 C--N 1.352 0.711 0 N-CA-C 108.132 -1.062 . . . . 75.41 108.132 177.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 42.0 t -65.41 115.59 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 O-C-N 123.705 0.628 . . . . 24.43 110.239 -178.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . 0.478 ' HD3' ' HA ' ' A' ' 254' ' ' ARG . 7.2 mmt180 -129.23 102.22 6.36 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.703 0.801 . . . . 73.14 108.921 172.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.581 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 60.9 mt -77.38 134.04 29.4 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-N 114.174 -1.375 . . . . 74.34 110.706 -179.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 28.4 p -127.7 174.5 9.05 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.638 1.175 . . . . 73.43 109.503 173.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.9 pp -134.98 152.89 78.08 Favored Pre-proline 0 CA--C 1.567 1.625 0 C-N-CA 123.583 0.753 . . . . 73.4 110.768 -177.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -65.95 -6.77 15.06 Favored 'Trans proline' 0 N--CA 1.51 2.448 0 C-N-CA 123.854 3.036 . . . . 74.45 115.58 -166.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . 0.446 ' O ' ' HG2' ' C' ' 226' ' ' ARG . 39.1 mt-10 48.16 -83.62 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.751 1.221 . . . . 63.24 112.368 -164.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 7.1 ppt_? -61.02 137.86 58.21 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.388 0.675 . . . . 75.12 110.115 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.473 HD13 ' HA ' ' A' ' 266' ' ' GLU . 74.1 mt -137.86 140.92 40.68 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.321 0.581 . . . . 55.32 111.1 -172.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 37.0 p -83.4 138.74 41.57 Favored Pre-proline 0 CA--C 1.554 1.097 0 CA-C-O 117.683 -1.151 . . . . 44.34 108.745 175.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 263' ' ' PRO . . . . . 0.403 ' O ' ' HB3' ' A' ' 266' ' ' GLU . 24.6 Cg_exo -24.79 -56.02 0.07 OUTLIER 'Trans proline' 0 C--N 1.386 2.55 1 C-N-CA 126.309 4.673 . . . . 74.33 117.382 -169.481 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -80.94 -33.22 34.14 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 112.481 0.548 . . . . 71.44 112.481 -173.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -69.95 -35.61 74.64 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 122.833 0.453 . . . . 64.2 110.066 174.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 266' ' ' GLU . . . . . 0.473 ' HA ' HD13 ' A' ' 261' ' ' LEU . 8.1 tp10 -54.36 -52.98 59.9 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 124.119 0.968 . . . . 73.45 109.091 169.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . 0.538 ' O ' ' HG3' ' A' ' 271' ' ' LYS . . . -57.42 -43.96 84.24 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 114.291 -1.322 . . . . 64.12 111.486 177.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 4.7 mp -59.55 -53.23 60.53 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 123.983 0.913 . . . . 73.14 111.286 -176.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -53.88 -48.15 70.35 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 124.198 0.937 . . . . 75.0 110.608 175.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . 0.533 ' HG3' HG23 ' C' ' 206' ' ' VAL . 1.0 OUTLIER -62.76 -34.82 78.03 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 123.875 0.735 . . . . 62.43 112.715 -179.327 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . 0.538 ' HG3' ' O ' ' A' ' 267' ' ' ALA . 64.2 mttm -62.33 -59.03 5.58 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.814 -0.81 . . . . 70.22 108.814 177.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 272' ' ' LEU . . . . . 0.534 ' O ' ' HB2' ' A' ' 276' ' ' TYR . 82.2 mt -49.2 -46.19 45.35 Favored 'General case' 0 C--N 1.358 0.963 0 O-C-N 125.564 1.79 . . . . 63.4 110.366 178.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . 0.488 ' HA ' ' HB2' ' C' ' 202' ' ' PRO . . . -79.12 -47.73 15.57 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 114.556 1.317 . . . . 64.51 114.556 -165.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -74.48 -31.4 62.2 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 110.123 -0.325 . . . . 74.35 110.123 -178.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . 0.449 ' O ' ' HG3' ' A' ' 279' ' ' ARG . . . -68.19 -42.04 80.51 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 109.756 -0.461 . . . . 71.44 109.756 169.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . 0.534 ' HB2' ' O ' ' A' ' 272' ' ' LEU . 32.7 t80 -56.26 -49.99 72.64 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 124.906 1.283 . . . . 75.02 110.683 178.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -64.18 -41.57 97.05 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 114.556 -1.202 . . . . 70.12 109.54 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -68.99 -10.42 57.39 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 123.432 0.693 . . . . 75.41 112.599 176.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 275' ' ' ALA . 74.4 mtt180 -89.51 -11.28 43.34 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.377 0.671 . . . . 74.13 111.23 175.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.302 0 N-CA-C 109.206 -0.664 . . . . 72.21 109.206 177.851 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.41 ' HB2' ' HB2' ' B' ' 4' ' ' SER . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.407 0 N-CA-C 108.683 -0.858 . . . . 71.44 108.683 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -81.16 -46.96 14.11 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 108.352 -0.981 . . . . 54.1 108.352 170.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 20.6 mm-40 -138.43 91.38 2.54 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.395 1.478 . . . . 74.04 108.531 173.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . 0.41 ' HB2' ' HB2' ' B' ' 1' ' ' MET . 47.6 t -108.35 151.69 25.66 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 123.991 0.916 . . . . 52.14 108.774 174.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 4.5 m -123.87 156.19 36.68 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 123.121 0.568 . . . . 70.11 110.813 -172.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.444 HG21 ' HA ' ' A' ' 125' ' ' LEU . 25.8 pt -139.32 174.21 9.81 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 C-N-CA 124.325 1.05 . . . . 64.44 111.449 -165.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -115.15 -163.31 0.87 Allowed 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.113 0.965 . . . . 72.01 110.295 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . 0.57 HD22 HG11 ' A' ' 145' ' ' VAL . 14.9 tp -148.09 178.89 8.16 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.129 0.571 . . . . 75.22 110.66 -178.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . 0.549 ' HB3' ' HB2' ' A' ' 122' ' ' GLU . . . -156.91 105.51 2.18 Favored 'General case' 0 C--N 1.358 0.937 0 C-N-CA 124.576 1.15 . . . . 62.4 108.389 178.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . 0.472 ' HB3' HD11 ' A' ' 119' ' ' LEU . 93.6 mt -79.59 121.27 25.05 Favored 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 123.997 0.919 . . . . 74.1 111.522 -173.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.459 ' O ' ' HG ' ' A' ' 119' ' ' LEU . 2.9 mt . . . . . 0 N--CA 1.506 2.357 0 C-N-CA 124.679 1.191 . . . . 45.35 109.195 -178.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.823 0 N-CA-C 109.618 -0.512 . . . . 61.34 109.618 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 180' ' ' ALA . . . . . 0.514 ' HB1' ' HB ' ' C' ' 137' ' ' VAL . . . 61.5 -79.19 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 124.461 1.104 . . . . 74.4 109.881 -165.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 181' ' ' LEU . . . . . 0.578 HD22 ' HB2' ' C' ' 136' ' ' ARG . 15.4 tp -168.29 21.48 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.315 0 C-N-CA 123.587 0.755 . . . . 62.04 110.364 172.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 182' ' ' VAL . . . . . . . . . . . . . 26.2 t -136.16 148.98 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.403 -0.81 . . . . 71.31 110.701 -173.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -149.07 -72.38 0.19 Allowed 'General case' 0 C--N 1.359 0.999 0 C-N-CA 123.376 0.67 . . . . 65.24 110.933 169.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 56.0 p-80 -150.52 161.37 42.67 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 122.402 0.281 . . . . 74.15 111.548 -174.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 185' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 CA--C 1.561 1.379 0 C-N-CA 124.389 1.076 . . . . 71.33 109.065 175.844 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 20.8 m . . . . . 0 CA--C 1.553 1.081 0 CA-C-O 120.974 0.416 . . . . 71.31 111.206 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -75.86 145.57 40.46 Favored 'General case' 0 C--N 1.348 0.532 0 C-N-CA 123.833 0.853 . . . . 74.42 112.262 -177.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 240' ' ' GLY . . . . . 0.508 ' H ' HD22 ' C' ' 235' ' ' LEU . . . -74.93 -138.78 0.59 Allowed Glycine 0 CA--C 1.533 1.158 0 CA-C-N 114.656 -1.157 . . . . 71.23 111.984 168.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -158.93 172.65 17.82 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.068 0.547 . . . . 71.21 111.221 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 242' ' ' TRP . . . . . 0.543 ' HH2' HG21 ' C' ' 227' ' ' THR . 0.0 OUTLIER -157.2 -46.65 0.07 Allowed 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.247 1.419 . . . . 70.32 108.514 -172.147 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 243' ' ' GLN . . . . . 0.593 ' HB2' ' HG2' ' C' ' 224' ' ' PRO . 35.8 mt-30 -117.76 -170.06 1.8 Allowed 'General case' 0 C--O 1.247 0.928 0 N-CA-C 107.71 -1.218 . . . . 74.22 107.71 166.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -78.37 89.4 1.11 Allowed Glycine 0 C--N 1.345 1.036 0 N-CA-C 111.147 -0.781 . . . . 63.11 111.147 171.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 1.7 pptp? . . . . . 0 N--CA 1.478 0.971 0 C-N-CA 123.05 0.54 . . . . 75.34 111.513 -177.802 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.916 0 N-CA-C 110.257 -0.275 . . . . 52.01 110.257 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 5.0 ttmp? -38.33 99.43 0.02 OUTLIER 'General case' 0 C--N 1.364 1.2 0 C-N-CA 124.691 1.196 . . . . 70.52 113.536 -176.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 5' ' ' LYS . . . . . 0.453 ' HG3' ' OG ' ' C' ' 94' ' ' SER . 1.3 mmmp? -67.64 96.87 0.57 Allowed 'General case' 0 C--O 1.241 0.651 0 N-CA-C 107.319 -1.363 . . . . 63.2 107.319 165.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 6' ' ' ASP . . . . . 0.481 ' HA ' ' OH ' ' C' ' 66' ' ' TYR . 38.4 t70 -70.42 96.56 1.16 Allowed 'General case' 0 C--N 1.348 0.539 0 N-CA-C 108.453 -0.943 . . . . 63.22 108.453 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 7' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -58.36 -34.32 70.54 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 113.835 -1.53 . . . . 73.43 111.737 -173.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -62.0 -47.22 85.76 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 115.777 -0.647 . . . . 72.53 110.42 175.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.99 -40.32 93.0 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.252 0.621 . . . . 52.31 111.288 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 10' ' ' ILE . . . . . 0.411 HG22 HD13 ' C' ' 50' ' ' ILE . 58.6 mt -60.93 -39.59 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.079 0.552 . . . . 63.34 110.227 176.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 11' ' ' LEU . . . . . 0.417 ' HB2' HG22 ' C' ' 13' ' ' VAL . 87.0 mt -80.26 -6.97 58.77 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 112.785 0.661 . . . . 45.45 112.785 177.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 69.2 31.39 71.85 Favored Glycine 0 C--N 1.353 1.5 0 O-C-N 123.055 0.222 . . . . 64.33 113.189 -178.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 13' ' ' VAL . . . . . 0.417 HG22 ' HB2' ' C' ' 11' ' ' LEU . 26.9 m -126.34 154.67 74.78 Favored Pre-proline 0 N--CA 1.481 1.107 0 C-N-CA 124.932 1.293 . . . . 64.04 109.268 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -80.36 167.56 19.23 Favored 'Trans proline' 0 C--N 1.371 1.743 0 C-N-CA 122.401 2.067 . . . . 74.43 112.754 178.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -72.85 74.29 1.14 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.12 0.968 . . . . 71.52 109.652 173.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -178.3 -19.3 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.164 1.386 . . . . 71.24 108.538 -176.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -49.42 112.04 0.58 Allowed 'General case' 0 C--N 1.354 0.782 0 C-N-CA 125.176 1.391 . . . . 71.14 112.345 175.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 77.9 p -73.62 -177.94 2.91 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.011 0.925 . . . . 74.41 111.429 -178.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -51.74 -52.25 50.06 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.307 0.643 . . . . 74.45 111.846 -176.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -67.18 -32.01 72.81 Favored 'General case' 0 C--O 1.206 -1.227 0 CA-C-O 118.679 -0.677 . . . . 64.05 112.107 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -68.92 -40.77 78.87 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 119.014 0.824 . . . . 73.42 110.767 -179.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 22' ' ' ILE . . . . . 0.884 HD13 ' HB3' ' C' ' 57' ' ' LEU . 96.6 mt -69.62 -37.77 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.553 1.141 . . . . 61.32 110.199 174.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 23' ' ' LYS . . . . . 0.475 ' O ' ' HG3' ' C' ' 27' ' ' LYS . 10.4 tppt? -65.41 -42.86 92.08 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 114.942 -1.026 . . . . 74.13 109.636 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 24' ' ' ARG . . . . . 0.438 ' HA ' ' HD2' ' C' ' 27' ' ' LYS . 97.3 mtt180 -77.71 -28.23 50.84 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 124.607 1.163 . . . . 73.52 110.669 -177.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.72 -43.65 95.9 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 123.895 0.747 . . . . 75.32 109.065 172.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 26' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -65.08 -45.36 85.55 Favored 'General case' 0 C--O 1.213 -0.818 0 CA-C-N 114.939 -1.028 . . . . 72.31 110.886 176.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' C' ' 23' ' ' LYS . 83.9 mttt -55.57 -46.19 77.22 Favored 'General case' 0 N--CA 1.502 2.14 0 C-N-CA 123.824 0.85 . . . . 74.1 110.143 178.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 25.0 ttm180 -56.07 -56.58 19.1 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 114.338 -1.301 . . . . 71.15 110.203 178.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . 0.622 HD13 HD12 ' C' ' 50' ' ' ILE . 66.1 mt -80.46 -9.61 59.76 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 114.543 -1.208 . . . . 60.22 111.636 -172.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.77 -27.52 26.83 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.702 0.801 . . . . 75.32 110.248 173.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 81.9 mtm180 -90.9 -21.71 21.26 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 123.56 0.537 . . . . 73.5 111.107 171.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -82.55 -55.67 4.33 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.363 0.665 . . . . 71.12 110.187 -178.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -89.63 17.08 6.8 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.221 0.609 . . . . 70.15 110.984 178.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 34' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -47.14 94.8 0.08 OUTLIER Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 125.151 1.38 . . . . 72.34 112.365 -169.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -75.35 -8.87 20.02 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 123.313 2.675 . . . . 71.32 112.817 -164.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -65.05 -41.32 95.26 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.62 1.168 . . . . 60.34 110.107 171.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 88.5 t -97.06 -48.11 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 115.683 -0.69 . . . . 75.33 109.868 -178.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -97.0 75.02 2.62 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 108.152 -1.055 . . . . 54.22 108.152 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 10.5 mtmp? -75.8 75.83 2.75 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 114.377 -1.283 . . . . 62.24 109.247 177.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 49.7 m -139.42 132.72 15.59 Favored Pre-proline 0 C--O 1.245 0.831 0 CA-C-N 115.027 -0.988 . . . . 74.14 109.847 -176.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . 0.548 ' HA ' ' HB2' ' C' ' 44' ' ' GLU . 81.7 Cg_exo -47.37 -33.16 16.22 Favored 'Trans proline' 0 C--N 1.389 2.709 0 C-N-CA 124.049 3.166 . . . . 63.44 113.059 174.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -45.17 -59.62 2.54 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.418 1.087 . . . . 65.44 110.494 171.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.6 -7.93 59.65 Favored 'General case' 0 C--O 1.211 -0.923 0 CA-C-N 114.339 -1.301 . . . . 62.05 110.646 -177.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 44' ' ' GLU . . . . . 0.548 ' HB2' ' HA ' ' C' ' 41' ' ' PRO . 22.0 mm-40 -78.26 -60.57 2.32 Favored 'General case' 0 C--O 1.213 -0.825 0 N-CA-C 108.422 -0.955 . . . . 74.04 108.422 175.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -53.28 -47.89 68.79 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.147 0.979 . . . . 42.53 110.925 176.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 46' ' ' LYS . . . . . 0.509 ' O ' HG12 ' C' ' 50' ' ' ILE . 49.4 mttp -65.48 -52.28 53.99 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.301 -0.863 . . . . 72.32 112.32 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -68.98 -23.1 64.08 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 118.511 0.596 . . . . 62.23 111.624 -178.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 48' ' ' LYS . . . . . 0.436 ' HD3' ' O ' ' C' ' 44' ' ' GLU . 13.1 mptt -75.85 -35.89 59.78 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 122.59 0.356 . . . . 72.04 110.27 177.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -67.28 -33.23 74.87 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 117.763 0.256 . . . . 72.33 110.351 170.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 50' ' ' ILE . . . . . 0.622 HD12 HD13 ' C' ' 29' ' ' LEU . 22.8 mm -66.34 -38.88 82.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 N-CA-C 109.538 -0.542 . . . . 75.43 109.538 173.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 51' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -65.3 -42.29 93.2 Favored 'General case' 0 C--O 1.204 -1.335 0 C-N-CA 123.637 0.775 . . . . 74.04 110.08 178.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -61.82 -52.73 62.97 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.329 1.052 . . . . 63.42 110.097 177.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.13 -56.56 19.41 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-N 113.582 -1.644 . . . . 63.1 111.571 -176.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -64.51 -35.82 82.2 Favored 'General case' 0 C--O 1.204 -1.318 0 CA-C-N 114.19 -1.368 . . . . 75.01 111.226 177.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.78 -39.72 92.66 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 118.779 0.718 . . . . 60.54 111.747 -176.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 78.8 t -72.94 -50.34 33.27 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 O-C-N 123.597 0.56 . . . . 72.43 109.715 174.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 57' ' ' LEU . . . . . 0.884 ' HB3' HD13 ' C' ' 22' ' ' ILE . 60.9 mt -88.12 1.43 54.36 Favored 'General case' 0 CA--C 1.56 1.362 0 N-CA-C 114.582 1.327 . . . . 75.02 114.582 -168.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 41.5 t -55.8 -38.08 69.47 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 124.599 1.16 . . . . 62.42 112.719 -173.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -121.41 137.91 27.54 Favored Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 107.409 -1.33 . . . . 72.03 107.409 -168.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 60' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -48.9 -36.64 34.75 Favored 'Trans proline' 0 C--N 1.381 2.261 0 C-N-CA 123.839 3.026 . . . . 33.23 113.441 -177.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -58.12 -66.76 0.43 Allowed 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 114.261 -1.336 . . . . 62.13 111.398 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 1.8 mtpm? -72.4 -23.31 61.08 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.54 0.736 . . . . 75.23 111.7 -174.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 -57.24 -50.13 73.85 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.276 -0.874 . . . . 64.42 109.153 169.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 64' ' ' ARG . . . . . 0.514 ' HA ' ' HB2' ' C' ' 67' ' ' ASP . 27.4 mmt180 -72.7 -21.81 60.99 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.636 -0.711 . . . . 74.15 112.117 178.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 1.6 mp -58.86 -46.92 90.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-N 118.556 0.616 . . . . 62.34 109.417 167.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 66' ' ' TYR . . . . . 0.481 ' OH ' ' HA ' ' C' ' 6' ' ' ASP . 37.0 t80 -62.41 -51.41 67.65 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 115.78 -0.646 . . . . 74.22 110.52 174.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 67' ' ' ASP . . . . . 0.514 ' HB2' ' HA ' ' C' ' 64' ' ' ARG . 27.4 m-20 -59.83 -31.14 69.46 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.704 0.802 . . . . 73.14 112.021 -176.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 39.9 p -81.31 -26.93 35.26 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 119.269 -0.396 . . . . 63.2 110.986 176.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 69' ' ' TYR . . . . . 0.402 ' HE2' ' HE1' ' C' ' 96' ' ' PHE . 71.2 t80 -72.6 133.52 44.73 Favored 'General case' 0 C--N 1.359 1.019 0 N-CA-C 108.518 -0.919 . . . . 75.22 108.518 173.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.46 16.94 41.11 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.286 -0.726 . . . . 62.51 111.286 -164.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 63.1 m -146.76 -61.42 0.3 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 103.497 -2.779 . . . . 72.34 103.497 172.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 28.3 m -76.5 142.08 41.04 Favored 'General case' 0 C--O 1.25 1.099 0 N-CA-C 104.997 -2.223 . . . . 73.35 104.997 157.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.46 -10.74 8.39 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.342 0.657 . . . . 73.23 110.82 177.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -77.5 138.61 63.26 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 123.242 0.617 . . . . 53.23 109.529 171.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -63.16 136.66 57.2 Favored 'Trans proline' 0 C--N 1.373 1.836 0 C-N-CA 122.602 2.201 . . . . 75.14 111.808 174.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.04 159.37 53.31 Favored 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 123.323 2.682 . . . . 63.14 112.229 -178.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -59.51 116.38 3.25 Favored 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 122.693 2.262 . . . . 51.51 112.637 174.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 78' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -68.48 136.5 36.8 Favored 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 122.675 2.25 . . . . 74.44 111.82 175.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 79' ' ' PRO . . . . . 0.621 ' HB3' ' HA3' ' C' ' 142' ' ' GLY . 38.5 Cg_exo -45.77 159.46 0.21 Allowed 'Trans proline' 0 CA--C 1.567 2.134 0 C-N-CA 123.955 3.103 . . . . 61.04 114.303 166.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -66.02 84.21 0.25 Allowed 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 123.075 2.516 . . . . 51.5 111.892 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 146.67 -28.19 1.62 Allowed Glycine 0 C--N 1.336 0.567 0 CA-C-N 114.668 -1.151 . . . . 75.2 110.799 -178.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 146.93 173.77 18.43 Favored Glycine 0 C--N 1.344 1.026 0 C-N-CA 123.857 0.741 . . . . 74.45 112.004 172.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 83' ' ' TYR . . . . . 0.478 ' HA ' ' HD2' ' C' ' 79' ' ' PRO . 76.5 m-85 -52.05 120.34 5.29 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.009 0.924 . . . . 70.14 110.591 176.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 84' ' ' ASP . . . . . 0.604 ' HB2' ' HG2' ' C' ' 79' ' ' PRO . 44.3 t0 -60.65 124.83 21.55 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 124.502 1.126 . . . . 63.13 110.385 -176.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 85' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -169.34 17.94 0.02 OUTLIER 'General case' 0 C--O 1.257 1.492 0 CA-C-N 114.185 -1.37 . . . . 74.41 107.493 -167.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 19.6 m -59.08 116.44 3.84 Favored 'General case' 0 C--N 1.361 1.09 0 CA-C-N 113.755 -1.566 . . . . 45.43 110.781 -166.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 87' ' ' GLY . . . . . 0.504 ' HA2' ' HA ' ' C' ' 171' ' ' PRO . . . 124.1 -20.57 7.1 Favored Glycine 0 C--N 1.342 0.867 0 O-C-N 123.732 0.645 . . . . 74.33 112.936 179.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 88' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -123.32 131.96 53.84 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 117.599 0.7 . . . . 74.44 111.804 -169.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -75.42 86.16 2.56 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.553 0.741 . . . . 72.23 111.154 -171.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 90' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -39.8 -43.72 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 C-N-CA 125.901 1.68 . . . . 54.41 114.74 174.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -65.07 -18.52 65.37 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.327 0.651 . . . . 74.21 112.149 -174.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -79.3 -30.44 42.89 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 122.848 0.459 . . . . 75.53 110.693 177.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -85.47 174.64 9.36 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.484 0.714 . . . . 72.45 112.908 -164.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 94' ' ' SER . . . . . 0.453 ' OG ' ' HG3' ' C' ' 5' ' ' LYS . 93.7 p -78.88 178.24 8.11 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 114.363 1.246 . . . . 45.51 114.363 -163.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -62.61 -54.02 45.91 Favored 'General case' 0 C--N 1.355 0.818 0 CA-C-N 113.888 -1.505 . . . . 55.43 111.2 -176.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 96' ' ' PHE . . . . . 0.402 ' HE1' ' HE2' ' C' ' 69' ' ' TYR . 48.6 t80 -48.44 -50.19 32.28 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 123.629 0.772 . . . . 65.02 111.626 -176.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 97' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -60.14 -52.01 67.14 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 114.592 -1.186 . . . . 64.25 110.116 175.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 98' ' ' GLN . . . . . 0.632 ' HA ' HD11 ' C' ' 105' ' ' LEU . 22.2 mt-30 -73.13 3.78 5.18 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 112.753 0.649 . . . . 51.52 112.753 -178.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -100.47 -54.5 2.83 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.879 0.872 . . . . 74.43 111.796 168.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 28.9 tp -63.84 -44.76 92.19 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.215 0.606 . . . . 73.23 110.809 -176.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 101' ' ' PHE . . . . . 0.458 ' O ' ' HG ' ' C' ' 105' ' ' LEU . 42.3 m-85 -94.78 -5.76 44.53 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.387 -0.824 . . . . 73.25 110.152 177.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -42.61 -60.97 2.67 Favored Glycine 0 CA--C 1.541 1.669 0 CA-C-O 118.553 -1.137 . . . . 54.11 115.076 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -41.42 -24.49 0.23 Allowed 'Trans proline' 0 C--N 1.391 2.785 0 C-N-CA 125.05 3.833 . . . . 62.02 116.584 -179.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -149.29 38.92 0.94 Allowed Glycine 0 C--N 1.35 1.352 0 CA-C-O 119.226 -0.763 . . . . 43.23 112.706 -176.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 105' ' ' LEU . . . . . 0.632 HD11 ' HA ' ' C' ' 98' ' ' GLN . 38.5 mt . . . . . 0 N--CA 1.496 1.863 0 N-CA-C 114.647 1.351 . . . . 73.03 114.647 176.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 116' ' ' GLY . . . . . 0.412 ' HA2' ' HA3' ' C' ' 168' ' ' GLY . . . . . . . . 0 C--O 1.241 0.585 0 CA-C-O 118.822 -0.988 . . . . 45.25 110.653 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 37.8 ttp180 -57.24 101.99 0.08 Allowed 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.401 -0.963 . . . . 64.44 108.401 -177.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -47.05 100.55 0.02 OUTLIER 'General case' 0 C--N 1.351 0.653 0 O-C-N 124.739 1.274 . . . . 75.42 107.734 172.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 119' ' ' LEU . . . . . . . . . . . . . 23.3 tp -91.15 119.21 31.07 Favored 'General case' 0 C--N 1.338 0.095 0 CA-C-N 114.466 -1.243 . . . . 75.21 109.441 -161.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 10.6 mtt180 -112.22 88.56 2.84 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 114.312 -1.313 . . . . 72.31 107.734 -169.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 121' ' ' ALA . . . . . 0.484 ' HB3' HD23 ' C' ' 176' ' ' LEU . . . -109.46 142.38 40.55 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 109.363 -0.606 . . . . 63.21 109.363 -174.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -126.97 127.81 45.4 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 107.152 -1.425 . . . . 73.22 107.152 178.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -138.51 147.32 54.6 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 123.249 0.62 . . . . 73.3 110.992 -167.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' C' ' 179' ' ' ARG . 6.1 Cg_exo -80.78 122.73 4.47 Favored 'Trans proline' 0 C--N 1.368 1.576 0 C-N-CA 123.184 2.59 . . . . 72.51 110.445 166.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 125' ' ' LEU . . . . . 0.463 ' HB3' HG13 ' C' ' 178' ' ' VAL . 18.1 tp -132.23 151.97 51.56 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 108.995 -0.743 . . . . 74.03 108.995 -177.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 126' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -95.04 152.61 18.18 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-O 120.734 0.302 . . . . 61.53 110.47 -178.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 127' ' ' LEU . . . . . 0.548 HD13 ' HD2' ' C' ' 186' ' ' PHE . 89.4 mt -60.51 -49.16 78.67 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.272 1.029 . . . . 62.25 111.029 177.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 22.1 mp0 -66.32 -33.45 75.76 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 115.564 -0.743 . . . . 75.24 110.564 179.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -68.83 -29.09 67.35 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.423 0.689 . . . . 73.53 111.363 176.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -75.18 -40.95 59.01 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 109.256 -0.646 . . . . 64.34 109.256 176.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 131' ' ' PHE . . . . . 0.596 ' HB2' HD13 ' C' ' 215' ' ' LEU . 84.6 t80 -55.06 -40.12 69.95 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.044 0.937 . . . . 75.55 110.744 174.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 132' ' ' HIS . . . . . . . . . . . . . 35.4 m170 -64.75 -59.52 4.14 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 115.545 -0.752 . . . . 60.22 109.676 174.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 62.77 -132.59 43.82 Favored Glycine 0 C--N 1.352 1.434 0 CA-C-N 115.719 -0.673 . . . . 65.31 111.925 -176.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 134' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' C' ' 148' ' ' ARG . . . 63.52 -151.65 48.52 Favored Glycine 0 C--N 1.351 1.41 0 O-C-N 123.956 0.445 . . . . 53.24 112.905 175.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -70.82 107.96 4.25 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.268 0.627 . . . . 71.2 109.784 178.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 136' ' ' ARG . . . . . 0.578 ' HB2' HD22 ' B' ' 181' ' ' LEU . 5.6 mmp_? -106.48 145.51 31.72 Favored 'General case' 0 C--O 1.249 1.029 0 C-N-CA 123.942 0.897 . . . . 72.12 109.185 171.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 137' ' ' VAL . . . . . 0.514 ' HB ' ' HB1' ' B' ' 180' ' ' ALA . 82.9 t -72.07 106.57 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.175 0.99 . . . . 71.12 110.412 -178.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 138' ' ' VAL . . . . . 0.56 ' HB ' HD23 ' B' ' 181' ' ' LEU . 12.1 p -119.54 111.73 34.26 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 CA-C-O 121.534 0.683 . . . . 72.14 110.173 176.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 139' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' C' ' 143' ' ' ARG . 1.4 tm-20 -119.32 99.85 6.95 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 106.882 -1.525 . . . . 74.31 106.882 169.289 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 140' ' ' VAL . . . . . . . . . . . . . 7.3 p -139.03 134.83 42.15 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 109.128 -0.693 . . . . 63.22 109.128 -179.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 141' ' ' ALA . . . . . 0.589 ' HB1' ' HG2' ' C' ' 167' ' ' GLN . . . 68.7 6.81 5.72 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.759 1.223 . . . . 15.23 112.713 -179.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 142' ' ' GLY . . . . . 0.621 ' HA3' ' HB3' ' C' ' 79' ' ' PRO . . . 105.49 -8.1 43.64 Favored Glycine 0 C--N 1.349 1.304 0 N-CA-C 112.611 -0.196 . . . . 45.25 112.611 -176.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 143' ' ' ARG . . . . . 0.459 ' O ' ' HA ' ' C' ' 139' ' ' GLU . 23.9 ttt85 -86.42 104.21 15.7 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.403 0.681 . . . . 73.04 110.615 179.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 39.8 ttt180 -98.18 107.76 20.31 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.684 0.794 . . . . 71.51 109.9 177.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 145' ' ' VAL . . . . . . . . . . . . . 7.2 p -150.94 157.14 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 123.914 0.886 . . . . 75.03 109.787 177.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 41.3 m -100.83 105.1 16.37 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.106 -1.072 . . . . 54.21 108.106 168.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 147' ' ' VAL . . . . . 0.477 HG21 HG13 ' C' ' 161' ' ' VAL . 7.6 p -104.67 146.26 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 N-CA-C 110.311 -0.255 . . . . 72.53 110.311 -173.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 148' ' ' ARG . . . . . 0.408 ' HA ' ' O ' ' C' ' 134' ' ' GLY . 12.6 ttm180 -85.78 109.73 18.86 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 116.224 -0.444 . . . . 74.22 110.318 177.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 149' ' ' ILE . . . . . . . . . . . . . 31.3 pt -91.99 150.08 39.94 Favored Pre-proline 0 C--O 1.245 0.846 0 CA-C-N 114.971 -1.013 . . . . 71.41 108.334 169.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 150' ' ' PRO . . . . . 0.513 ' HD2' HG23 ' C' ' 159' ' ' ILE . 19.3 Cg_endo -56.04 125.76 20.13 Favored 'Trans proline' 0 C--N 1.383 2.359 0 C-N-CA 122.744 2.296 . . . . 61.44 110.974 178.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 151' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' C' ' 150' ' ' PRO . 46.8 Cg_exo -57.07 93.77 0.05 OUTLIER 'Trans proline' 0 C--N 1.383 2.346 0 C-N-CA 123.187 2.592 . . . . 73.2 111.971 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 152' ' ' GLY . . . . . . . . . . . . . . . 114.25 131.44 5.21 Favored Glycine 0 C--N 1.342 0.9 0 CA-C-N 115.259 -0.882 . . . . 54.32 112.633 -174.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 p -145.66 158.95 12.5 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.11 0 C-N-CA 123.694 0.797 . . . . 71.13 110.664 -177.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 154' ' ' ARG . . . . . . . . . . . . . 16.7 mtt85 -101.98 153.19 20.11 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 124.399 1.08 . . . . 75.32 110.335 -173.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 155' ' ' GLU . . . . . 0.432 ' HB2' HD12 ' C' ' 180' ' ' LEU . 12.7 tp10 -65.59 127.25 31.14 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.891 0.877 . . . . 74.51 110.372 169.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 76.18 6.08 82.4 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-N 115.576 -0.738 . . . . 64.51 114.566 178.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 157' ' ' SER . . . . . . . . . . . . . 26.7 t -107.38 156.41 18.96 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 117.337 0.569 . . . . 75.43 111.229 -175.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 158' ' ' VAL . . . . . 0.406 ' HB ' ' HB3' ' C' ' 175' ' ' LEU . 18.4 m -93.31 134.25 31.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-N 114.83 -1.077 . . . . 64.44 111.772 -176.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 159' ' ' ILE . . . . . 0.564 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 80.9 mt -86.88 132.04 33.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 C-N-CA 124.187 0.995 . . . . 52.25 108.53 166.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 21.3 ttm180 -82.49 99.97 9.8 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 109.084 -0.71 . . . . 72.21 109.084 171.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 161' ' ' VAL . . . . . 0.477 HG13 HG21 ' C' ' 147' ' ' VAL . 63.5 t -96.24 95.37 1.96 Allowed Pre-proline 0 CA--C 1.548 0.866 0 N-CA-C 106.432 -1.692 . . . . 75.24 106.432 169.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -94.86 165.68 1.7 Allowed 'Trans proline' 0 C--N 1.361 1.232 0 C-N-CA 123.05 2.5 . . . . 63.42 115.226 -162.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 65.83 13.41 59.18 Favored Glycine 0 C--N 1.345 1.044 0 CA-C-N 114.114 -1.403 . . . . 53.31 114.829 172.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 164' ' ' MET . . . . . 0.432 ' SD ' ' NH2' ' C' ' 143' ' ' ARG . 35.1 mtm -136.81 -88.68 0.29 Allowed 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 117.468 0.634 . . . . 73.35 110.067 -175.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . 79.85 -152.56 35.24 Favored Glycine 0 C--N 1.351 1.412 0 CA-C-N 116.762 -0.199 . . . . 64.24 113.369 -172.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . -98.77 -159.64 29.68 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-N 115.307 -0.447 . . . . 75.44 112.819 -178.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 167' ' ' GLN . . . . . 0.589 ' HG2' ' HB1' ' C' ' 141' ' ' ALA . 27.4 mm-40 -70.66 118.91 14.05 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.899 0.88 . . . . 64.31 111.533 -174.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 168' ' ' GLY . . . . . 0.412 ' HA3' ' HA2' ' C' ' 116' ' ' GLY . . . 161.77 162.48 13.13 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 109.929 -1.269 . . . . 13.44 109.929 178.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 169' ' ' ASN . . . . . 0.723 ' HB2' ' HD3' ' C' ' 170' ' ' PRO . 1.7 m-20 -73.57 -68.41 0.36 Allowed Pre-proline 0 CA--C 1.578 2.051 0 CA-C-O 117.846 -1.073 . . . . 62.44 112.97 -166.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 170' ' ' PRO . . . . . 0.723 ' HD3' ' HB2' ' C' ' 169' ' ' ASN . 34.1 Cg_exo -63.73 176.17 2.48 Favored 'Trans proline' 0 C--N 1.401 3.298 0 C-N-CA 122.475 2.117 . . . . 51.41 113.281 172.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 171' ' ' PRO . . . . . 0.504 ' HA ' ' HA2' ' C' ' 87' ' ' GLY . 29.7 Cg_endo -62.28 139.23 76.35 Favored 'Trans proline' 0 C--N 1.389 2.666 0 C-N-CA 122.551 2.167 . . . . 74.02 111.76 172.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -116.18 -34.03 1.41 Allowed Glycine 0 C--N 1.336 0.574 0 CA-C-N 116.089 -0.505 . . . . 74.42 112.56 177.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 173' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 71.04 147.97 0.08 Allowed 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 125.089 1.355 . . . . 74.51 111.273 -179.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 174' ' ' LEU . . . . . . . . . . . . . 11.0 tp -121.97 128.55 51.61 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.904 0.882 . . . . 75.22 108.853 -174.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 175' ' ' LEU . . . . . 0.439 ' HA ' ' O ' ' C' ' 159' ' ' ILE . 71.8 mt -110.49 130.58 55.53 Favored 'General case' 0 C--O 1.243 0.721 0 C-N-CA 123.597 0.759 . . . . 71.32 109.23 172.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 176' ' ' LEU . . . . . 0.564 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 95.7 mt -108.33 107.97 18.77 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.373 0.669 . . . . 43.02 110.884 178.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 177' ' ' VAL . . . . . . . . . . . . . 56.0 t -81.53 101.12 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 107.147 -1.427 . . . . 74.43 107.147 173.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 178' ' ' VAL . . . . . 0.463 HG13 ' HB3' ' C' ' 125' ' ' LEU . 39.7 t -76.65 128.87 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 114.599 -1.182 . . . . 74.01 110.755 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 179' ' ' ARG . . . . . 0.466 ' O ' ' HA ' ' C' ' 124' ' ' PRO . 36.6 mmt180 -111.94 101.03 9.36 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 105.325 -2.102 . . . . 72.33 105.325 171.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 180' ' ' LEU . . . . . 0.454 ' HA ' ' O ' ' C' ' 125' ' ' LEU . 28.9 mt -68.93 133.03 47.65 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 108.922 -0.77 . . . . 70.51 108.922 -176.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 181' ' ' LEU . . . . . . . . . . . . . 85.0 mt -54.05 163.01 1.29 Allowed Pre-proline 0 N--CA 1.493 1.717 0 C-N-CA 125.31 1.444 . . . . 74.2 113.317 -167.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -51.52 77.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.391 2.813 0 C-N-CA 123.744 2.963 . . . . 64.12 111.982 164.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 183' ' ' HIS . . . . . . . . . . . . . 75.3 t60 -174.08 53.92 0.15 Allowed Pre-proline 0 CA--C 1.553 1.059 0 N-CA-C 104.112 -2.551 . . . . 62.13 104.112 -170.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 184' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -86.67 65.79 4.68 Favored 'Trans proline' 0 C--N 1.388 2.65 0 C-N-CA 123.535 2.823 . . . . 71.54 112.079 -164.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 185' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 11.7 t -95.89 -50.24 11.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 108.047 -1.094 . . . . 72.23 108.047 -178.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 186' ' ' PHE . . . . . 0.548 ' HD2' HD13 ' C' ' 127' ' ' LEU . 34.0 m-85 -117.67 156.39 28.28 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.488 0.715 . . . . 61.44 111.956 -174.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 187' ' ' ARG . . . . . 0.49 ' O ' ' HB3' ' C' ' 194' ' ' TYR . 33.8 ttp180 -153.64 112.11 3.64 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.476 1.51 . . . . 75.14 107.742 177.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 188' ' ' LEU . . . . . 0.431 HD21 ' O ' ' C' ' 190' ' ' GLY . 47.9 tp -80.73 153.1 28.02 Favored 'General case' 0 CA--C 1.558 1.263 0 N-CA-C 115.392 1.627 . . . . 74.14 115.392 -163.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -126.92 99.59 5.8 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.889 1.675 . . . . 71.33 107.182 159.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 190' ' ' GLY . . . . . 0.431 ' O ' HD21 ' C' ' 188' ' ' LEU . . . 63.61 -80.09 0.04 OUTLIER Glycine 0 CA--C 1.539 1.575 0 N-CA-C 114.194 0.438 . . . . 74.2 114.194 175.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 191' ' ' GLN . . . . . 0.456 HE21 ' HA3' ' C' ' 242' ' ' GLY . 42.8 mt-30 -122.42 -34.86 3.2 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.877 1.271 . . . . 60.21 109.635 177.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -83.63 125.12 31.5 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.189 0.995 . . . . 65.13 110.983 -174.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 193' ' ' LEU . . . . . 0.439 ' HG ' ' HA2' ' C' ' 239' ' ' GLY . 91.7 mt -80.65 159.09 25.44 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.253 0.621 . . . . 52.2 112.017 -179.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 194' ' ' TYR . . . . . 0.49 ' HB3' ' O ' ' C' ' 187' ' ' ARG . 43.7 t80 -119.12 106.94 12.88 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 108.112 -1.07 . . . . 75.43 108.112 165.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 195' ' ' ALA . . . . . 0.549 ' HB2' HD11 ' C' ' 249' ' ' LEU . . . -108.2 -174.9 2.63 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.553 0.741 . . . . 65.11 110.099 175.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 29.3 m -138.47 119.06 13.93 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.586 -0.733 . . . . 51.32 109.604 174.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 197' ' ' LEU . . . . . 0.491 HD13 ' HB2' ' C' ' 212' ' ' ALA . 53.5 tp -98.78 118.21 35.01 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.292 0.637 . . . . 73.5 109.375 -179.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 198' ' ' ASP . . . . . 0.584 ' HA ' ' HB2' ' C' ' 254' ' ' ARG . 26.4 t70 -85.69 99.97 11.67 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.501 0.721 . . . . 44.52 109.087 -178.102 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 199' ' ' VAL . . . . . 0.482 HG22 HG21 ' C' ' 210' ' ' VAL . 21.4 t -110.59 123.6 35.26 Favored Pre-proline 0 N--CA 1.479 0.989 0 N-CA-C 108.661 -0.866 . . . . 61.21 108.661 -178.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 200' ' ' PRO . . . . . 0.439 ' HD2' HG11 ' C' ' 210' ' ' VAL . 46.2 Cg_endo -69.09 147.22 66.72 Favored 'Trans proline' 0 C--N 1.367 1.546 0 C-N-CA 121.565 1.51 . . . . 71.34 110.553 173.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 201' ' ' ALA . . . . . 0.476 ' HB3' ' HH2' ' C' ' 269' ' ' TRP . . . -52.59 -45.46 96.06 Favored Pre-proline 0 CA--C 1.555 1.158 0 C-N-CA 124.638 1.175 . . . . 74.35 113.467 -176.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 202' ' ' PRO . . . . . 0.488 ' HB2' ' HA ' ' A' ' 273' ' ' ALA . 23.7 Cg_endo -57.99 -49.71 12.09 Favored 'Trans proline' 0 C--N 1.391 2.774 0 C-N-CA 121.384 1.389 . . . . 63.15 112.304 177.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 203' ' ' ILE . . . . . . . . . . . . . 29.2 mt -64.42 -32.34 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 123.218 0.607 . . . . 63.4 111.145 178.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.8 -37.6 84.87 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.134 0.574 . . . . 75.02 111.512 179.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 205' ' ' VAL . . . . . 0.425 ' HA ' ' HA ' ' C' ' 226' ' ' ARG . 91.2 t -82.09 -37.24 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 123.233 0.613 . . . . 63.41 111.972 -178.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 206' ' ' VAL . . . . . 0.533 HG23 ' HG3' ' A' ' 270' ' ' LYS . 8.3 p -87.61 -33.58 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 N-CA-C 111.975 0.361 . . . . 52.12 111.975 -175.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 90.33 126.44 3.22 Favored Glycine 0 C--N 1.344 0.98 0 N-CA-C 111.076 -0.81 . . . . 63.21 111.076 -167.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -159.93 -137.3 2.2 Favored Glycine 0 C--N 1.336 0.57 0 CA-C-N 117.81 0.805 . . . . 51.32 111.466 179.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 209' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' C' ' 221' ' ' VAL . 7.6 mtmp? -139.26 134.75 33.06 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 123.43 0.692 . . . . 72.12 110.603 171.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 210' ' ' VAL . . . . . 0.482 HG21 HG22 ' C' ' 199' ' ' VAL . 27.7 m -134.3 140.57 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 107.754 -1.202 . . . . 62.05 107.754 169.021 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 211' ' ' ARG . . . . . 0.53 ' HA ' ' HA ' ' C' ' 220' ' ' GLU . 32.4 ttm105 -80.5 133.12 35.78 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 122.975 0.51 . . . . 72.44 111.66 -175.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 212' ' ' ALA . . . . . 0.491 ' HB2' HD13 ' C' ' 197' ' ' LEU . . . -104.18 130.36 51.94 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.785 1.234 . . . . 74.43 107.704 164.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 213' ' ' MET . . . . . 0.407 ' HG2' ' N ' ' C' ' 214' ' ' THR . 6.6 ttt -70.39 149.49 47.24 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 109.264 -0.643 . . . . 63.12 109.264 168.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 214' ' ' THR . . . . . 0.528 HG21 ' HD2' ' C' ' 238' ' ' LYS . 0.1 OUTLIER -139.92 169.14 18.26 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.173 0.511 . . . . 54.24 110.415 168.101 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 215' ' ' LEU . . . . . 0.596 HD13 ' HB2' ' C' ' 131' ' ' PHE . 54.4 mt -61.82 -36.05 80.02 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.144 1.378 . . . . 44.41 112.667 -172.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.78 -2.67 27.63 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.396 0.679 . . . . 71.0 112.11 -177.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 155.69 171.41 22.14 Favored Glycine 0 C--O 1.212 -1.274 0 CA-C-O 119.556 -0.58 . . . . 64.11 112.492 -178.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -88.26 126.01 1.91 Allowed 'Trans proline' 0 CA--C 1.556 1.618 0 C-N-CA 122.998 2.465 . . . . 52.13 112.748 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 219' ' ' VAL . . . . . 0.44 HG13 ' HB3' ' C' ' 212' ' ' ALA . 3.3 p -103.2 115.12 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 123.925 0.89 . . . . 52.53 109.696 177.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 220' ' ' GLU . . . . . 0.53 ' HA ' ' HA ' ' C' ' 211' ' ' ARG . 23.6 tt0 -84.43 109.38 17.83 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 109.491 -0.559 . . . . 72.32 109.491 -179.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 221' ' ' VAL . . . . . 0.458 HG11 HD21 ' C' ' 233' ' ' LEU . 47.7 t -74.13 127.88 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 124.491 1.116 . . . . 74.03 111.957 -174.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 222' ' ' ALA . . . . . 0.421 ' HA ' ' HG2' ' C' ' 209' ' ' LYS . . . -80.97 103.52 10.85 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 124.199 0.937 . . . . 73.3 109.05 167.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 62.1 t -79.04 129.47 72.91 Favored Pre-proline 0 CA--C 1.553 1.079 0 C-N-CA 123.744 0.818 . . . . 73.11 109.721 176.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 224' ' ' PRO . . . . . 0.593 ' HG2' ' HB2' ' B' ' 243' ' ' GLN . 3.1 Cg_exo -78.68 160.64 28.01 Favored 'Trans proline' 0 C--N 1.371 1.722 0 C-N-CA 123.925 3.084 . . . . 54.33 112.103 169.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.51 143.49 98.02 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 122.944 2.429 . . . . 74.0 112.93 176.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 226' ' ' ARG . . . . . 0.446 ' HG2' ' O ' ' A' ' 259' ' ' GLU . 0.6 OUTLIER 55.18 86.02 0.06 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.468 1.907 . . . . 70.15 113.79 173.748 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 227' ' ' THR . . . . . 0.543 HG21 ' HH2' ' B' ' 242' ' ' TRP . 82.1 m -123.93 133.36 53.74 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 114.828 -1.078 . . . . 70.3 111.143 -178.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 228' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -104.77 155.71 18.65 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.712 0.768 . . . . 74.32 110.702 176.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -72.23 145.59 47.86 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.328 -0.851 . . . . 62.12 109.936 176.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 95.42 -9.34 69.36 Favored Glycine 0 N--CA 1.464 0.561 0 CA-C-N 115.746 -0.661 . . . . 62.04 112.118 -171.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 231' ' ' ARG . . . . . 0.404 ' NH1' ' HA ' ' C' ' 227' ' ' THR . 81.8 mtt180 -69.55 178.34 2.54 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 117.339 0.569 . . . . 74.12 110.761 167.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 232' ' ' LYS . . . . . 0.571 ' HD3' ' HB3' ' C' ' 250' ' ' TYR . 1.9 ttmp? -153.93 126.86 8.29 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 112.258 0.466 . . . . 71.45 112.258 -174.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 233' ' ' LEU . . . . . 0.615 ' O ' ' HA ' ' C' ' 250' ' ' TYR . 5.1 mp -86.39 158.66 19.57 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.488 1.115 . . . . 74.21 110.437 175.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 19.1 ptt-85 -128.92 88.46 2.72 Favored 'General case' 0 CA--C 1.556 1.204 0 O-C-N 124.712 1.257 . . . . 72.34 109.513 170.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 235' ' ' LEU . . . . . 0.508 HD22 ' H ' ' B' ' 240' ' ' GLY . 56.9 mt -86.55 105.99 17.22 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 108.213 -1.032 . . . . 73.43 108.213 174.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -67.71 132.75 48.05 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.36 0.664 . . . . 71.55 111.639 -168.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 80.95 1.38 89.79 Favored Glycine 0 C--N 1.349 1.254 0 N-CA-C 115.018 0.767 . . . . 71.42 115.018 174.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 238' ' ' LYS . . . . . 0.528 ' HD2' HG21 ' C' ' 214' ' ' THR . 73.8 mmtt -92.8 13.18 21.09 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 123.588 0.755 . . . . 72.03 111.116 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 239' ' ' GLY . . . . . 0.439 ' HA2' ' HG ' ' C' ' 193' ' ' LEU . . . -95.17 -169.6 36.3 Favored Glycine 0 C--N 1.358 1.772 0 C-N-CA 122.977 0.322 . . . . 31.21 113.205 177.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 240' ' ' PHE . . . . . 0.41 ' HD2' HD13 ' C' ' 188' ' ' LEU . 3.8 m-85 -78.73 148.28 72.49 Favored Pre-proline 0 N--CA 1.481 1.102 0 C-N-CA 123.027 0.531 . . . . 75.14 110.397 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 241' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -63.64 137.31 58.5 Favored 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 123.43 2.753 . . . . 70.21 112.103 -178.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 242' ' ' GLY . . . . . 0.456 ' HA3' HE21 ' C' ' 191' ' ' GLN . . . -131.71 168.6 22.26 Favored Glycine 0 C--N 1.342 0.911 0 CA-C-O 120.169 -0.24 . . . . 70.14 113.678 -175.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -73.91 -2.38 12.17 Favored 'Trans proline' 0 C--N 1.38 2.206 0 C-N-CA 123.642 2.894 . . . . 71.42 114.553 -173.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -137.62 11.8 2.95 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.655 0.782 . . . . 71.42 111.118 178.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 137.43 167.79 11.17 Favored Glycine 0 C--N 1.348 1.214 0 N-CA-C 111.111 -0.795 . . . . 51.32 111.111 -176.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 246' ' ' ARG . . . . . . . . . . . . . 26.8 mtm-85 -81.85 151.32 27.38 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-N 117.275 0.537 . . . . 61.31 109.914 176.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -78.13 -169.93 35.31 Favored Glycine 0 C--N 1.34 0.798 0 O-C-N 123.872 0.733 . . . . 63.23 113.48 -178.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -123.79 142.66 50.89 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.122 -1.066 . . . . 73.54 108.122 -173.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 249' ' ' LEU . . . . . 0.549 HD11 ' HB2' ' C' ' 195' ' ' ALA . 25.6 tp -83.89 109.52 17.65 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.95 -0.568 . . . . 74.23 109.797 -179.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 250' ' ' TYR . . . . . 0.615 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 22.0 m-30 -101.02 100.53 11.15 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 109.498 -0.556 . . . . 71.43 109.498 179.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 251' ' ' LEU . . . . . 0.578 ' HB2' HD13 ' C' ' 233' ' ' LEU . 2.2 mp -100.39 121.91 42.29 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 119.166 -0.445 . . . . 64.53 110.338 -172.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 252' ' ' GLU . . . . . 0.454 ' HB2' ' HE1' ' C' ' 194' ' ' TYR . 25.3 tt0 -75.07 129.7 38.04 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-O 121.129 0.49 . . . . 73.41 109.681 170.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 253' ' ' VAL . . . . . 0.52 HG11 HG22 ' C' ' 227' ' ' THR . 60.4 t -76.23 135.19 27.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 115.166 -0.925 . . . . 73.5 111.012 -175.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 254' ' ' ARG . . . . . 0.584 ' HB2' ' HA ' ' C' ' 198' ' ' ASP . 11.4 mmt85 -103.8 135.19 45.8 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.321 1.448 . . . . 74.13 108.32 165.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 255' ' ' ILE . . . . . . . . . . . . . 33.0 mm -106.94 105.34 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 107.028 -1.471 . . . . 75.24 107.028 165.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 256' ' ' THR . . . . . . . . . . . . . 3.5 t -115.76 171.72 7.58 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.037 0.935 . . . . 53.32 110.067 -173.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 10.7 pt -134.95 152.93 78.18 Favored Pre-proline 0 CA--C 1.552 1.037 0 C-N-CA 123.987 0.915 . . . . 64.54 109.876 -173.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -80.79 20.98 0.91 Allowed 'Trans proline' 0 C--N 1.381 2.274 0 C-N-CA 123.372 2.715 . . . . 73.21 113.737 -168.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 57.3 -89.81 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.778 1.231 . . . . 72.3 111.18 -174.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 260' ' ' ARG . . . . . 0.594 ' H ' ' HD2' ' C' ' 260' ' ' ARG . 0.0 OUTLIER -80.39 145.86 31.78 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 123.214 0.606 . . . . 73.41 109.473 -179.317 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 261' ' ' LEU . . . . . . . . . . . . . 96.4 mt -128.73 154.69 46.1 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.89 0.876 . . . . 71.21 109.566 176.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 45.1 p -84.92 155.72 61.11 Favored Pre-proline 0 CA--C 1.555 1.142 0 N-CA-C 109.252 -0.647 . . . . 61.23 109.252 170.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -34.35 -51.81 0.62 Allowed 'Trans proline' 0 C--N 1.382 2.302 1 C-N-CA 125.684 4.256 . . . . 74.2 115.836 -178.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -62.94 -55.05 29.33 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.954 0.501 . . . . 71.04 110.259 -177.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -49.31 -55.14 13.77 Favored 'General case' 0 C--N 1.356 0.866 0 O-C-N 124.451 1.094 . . . . 65.11 109.675 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 266' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' C' ' 270' ' ' LYS . 15.4 tp10 -54.62 -43.27 72.09 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 124.655 1.222 . . . . 64.21 110.997 -177.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -60.6 -45.42 94.07 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.508 0.723 . . . . 70.32 112.217 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 268' ' ' LEU . . . . . 0.511 ' HB2' HD21 ' A' ' 272' ' ' LEU . 10.3 mp -66.35 -50.99 61.69 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 116.729 -0.214 . . . . 52.44 110.93 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 269' ' ' TRP . . . . . 0.476 ' HH2' ' HB3' ' C' ' 201' ' ' ALA . 92.5 m95 -56.95 -32.41 65.99 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.292 0.637 . . . . 61.11 111.039 177.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 270' ' ' LYS . . . . . 0.653 ' HA ' HG21 ' A' ' 206' ' ' VAL . 10.2 tmtt? -67.76 -46.46 72.02 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.987 0.915 . . . . 75.43 110.336 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -63.2 -37.21 86.32 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 122.73 0.412 . . . . 75.33 111.486 177.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 272' ' ' LEU . . . . . 0.416 HD12 ' HA ' ' C' ' 269' ' ' TRP . 75.1 mt -64.9 -37.11 86.54 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.295 0.638 . . . . 74.33 110.125 176.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -63.43 -45.39 91.16 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.438 0.695 . . . . 34.13 111.055 177.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -65.72 -36.71 84.38 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.289 0.636 . . . . 63.21 111.036 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -62.7 -33.07 74.33 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 115.596 -0.729 . . . . 70.04 110.584 174.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 276' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -73.46 -42.34 62.06 Favored 'General case' 0 CA--C 1.554 1.114 0 CA-C-N 115.36 -0.836 . . . . 75.52 111.939 174.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -68.05 -22.61 64.94 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.949 -0.469 . . . . 44.24 111.403 178.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -59.77 -22.53 62.26 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.504 0.722 . . . . 55.2 112.131 174.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 279' ' ' ARG . . . . . . . . . . . . . 39.0 mtm180 -72.66 -29.84 63.77 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 122.743 0.417 . . . . 71.52 110.738 178.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.044 0 C-N-CA 123.7 0.8 . . . . 75.14 109.378 -173.402 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.484 1.245 0 N-CA-C 113.039 0.755 . . . . 62.43 113.039 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -77.68 109.34 11.57 Favored 'General case' 0 C--O 1.245 0.863 0 C-N-CA 124.031 0.932 . . . . 74.32 109.413 171.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -82.34 94.53 7.39 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 108.459 -0.941 . . . . 61.41 108.459 177.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -60.54 -37.46 81.3 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.191 0.997 . . . . 73.34 111.672 -174.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.497 ' HB3' ' O ' ' A' ' 13' ' ' VAL . 95.1 m-85 -67.28 -35.74 80.12 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 114.609 -1.178 . . . . 73.33 111.324 178.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.86 -40.13 72.51 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 122.897 0.479 . . . . 60.32 111.014 177.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 77.0 mt -56.0 -42.75 72.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 123.613 0.765 . . . . 74.23 109.455 174.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 87.7 mt -81.06 -17.47 50.0 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 115.212 -0.903 . . . . 51.33 112.392 176.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.09 18.74 78.06 Favored Glycine 0 CA--C 1.536 1.398 0 N-CA-C 114.71 0.644 . . . . 53.33 114.71 -178.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.497 ' O ' ' HB3' ' A' ' 8' ' ' TYR . 19.6 m -103.89 144.07 27.94 Favored Pre-proline 0 N--CA 1.484 1.228 0 C-N-CA 123.666 0.787 . . . . 71.43 109.252 173.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -54.58 151.01 32.81 Favored 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 122.889 2.393 . . . . 50.12 113.282 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.33 69.48 1.61 Allowed 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.692 0.797 . . . . 75.43 110.561 179.253 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 170.92 -24.36 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.805 1.242 . . . . 64.11 109.422 -173.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.09 138.85 19.12 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.283 1.033 . . . . 64.31 111.761 -177.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 67.2 p -63.49 166.08 7.1 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.17 0.988 . . . . 71.11 111.033 -175.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -56.64 -33.37 66.25 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.985 0.914 . . . . 64.21 111.384 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -69.72 -36.1 75.6 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 122.89 0.476 . . . . 72.43 111.062 -178.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -72.02 -42.06 66.83 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.629 0.772 . . . . 64.03 110.664 177.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 73.7 mt -58.59 -39.53 76.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 124.558 1.143 . . . . 73.31 110.241 173.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.734 ' HG2' ' HE3' ' A' ' 27' ' ' LYS . 33.9 ttmt -71.67 -37.94 70.71 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 114.555 -1.202 . . . . 71.24 110.259 -177.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 49.1 mtp180 -57.36 -52.46 65.25 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.503 0.721 . . . . 54.12 110.319 173.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.33 -38.47 91.14 Favored 'General case' 0 C--O 1.246 0.899 0 CA-C-N 114.435 -1.257 . . . . 64.0 111.653 -177.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -61.87 -60.75 3.18 Favored 'General case' 0 C--O 1.209 -1.067 0 CA-C-N 115.433 -0.803 . . . . 73.1 109.487 177.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.734 ' HE3' ' HG2' ' A' ' 23' ' ' LYS . 10.1 mtmp? -58.71 -33.58 70.36 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 124.266 0.979 . . . . 74.22 111.913 -177.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 14.6 ttt180 -52.74 -58.72 5.94 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.299 1.04 . . . . 71.15 109.856 171.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.662 ' HB3' HD13 ' A' ' 50' ' ' ILE . 88.1 mt -81.21 -10.28 59.64 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 115.172 -0.922 . . . . 74.11 111.991 -178.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.489 ' HB3' ' HA ' ' A' ' 27' ' ' LYS . . . -94.53 -14.59 24.92 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.772 0.829 . . . . 63.3 111.34 -178.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.4 mtm105 -97.96 -38.09 9.53 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.957 -0.757 . . . . 72.33 108.957 168.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -65.43 -47.36 76.48 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.26 0.624 . . . . 63.33 111.092 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -107.4 29.21 7.37 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.515 0.726 . . . . 63.25 110.734 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -68.23 101.51 0.31 Allowed Pre-proline 0 N--CA 1.483 1.204 0 C-N-CA 123.979 0.911 . . . . 63.41 110.547 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.528 ' O ' ' HG3' ' A' ' 39' ' ' LYS . 46.6 Cg_exo -55.07 -39.82 89.0 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 123.073 2.516 . . . . 74.13 113.306 -169.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -46.89 -36.94 8.11 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.799 1.239 . . . . 72.45 112.786 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 48.7 t -101.79 -49.25 10.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 C-N-CA 123.657 0.783 . . . . 65.53 109.28 178.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -107.27 75.26 1.01 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 125.121 1.368 . . . . 61.35 110.665 -176.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.528 ' HG3' ' O ' ' A' ' 35' ' ' PRO . 9.0 mtmp? -78.02 72.47 4.56 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 109.636 -0.505 . . . . 73.11 109.636 172.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 70.4 m -116.9 113.31 39.85 Favored Pre-proline 0 N--CA 1.471 0.621 0 N-CA-C 107.906 -1.146 . . . . 54.41 107.906 176.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -42.8 -53.29 4.01 Favored 'Trans proline' 0 C--N 1.387 2.591 0 C-N-CA 124.58 3.52 . . . . 72.23 114.191 -170.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -52.12 -46.82 65.49 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.221 1.009 . . . . 64.43 111.817 176.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.82 -29.16 69.01 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.597 0.759 . . . . 72.14 110.982 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.503 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 46.1 mt-10 -84.47 -29.7 25.83 Favored 'General case' 0 C--N 1.352 0.707 0 C-N-CA 123.423 0.689 . . . . 62.01 110.461 -175.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -72.31 -43.45 64.16 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.929 0.892 . . . . 62.44 109.791 176.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.422 ' HD3' ' HA ' ' A' ' 46' ' ' LYS . 40.2 mmtm -62.65 -39.7 94.72 Favored 'General case' 0 C--N 1.345 0.405 0 CA-C-N 115.038 -0.983 . . . . 74.03 109.631 171.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.485 ' HE1' ' HA ' ' A' ' 30' ' ' ALA . 60.0 t80 -63.08 -30.14 71.36 Favored 'General case' 0 C--N 1.356 0.866 0 O-C-N 123.867 0.729 . . . . 73.24 110.656 176.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.503 ' HG2' ' O ' ' A' ' 44' ' ' GLU . 34.3 mmtp -62.98 -47.36 83.49 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 109.893 -0.41 . . . . 75.14 109.893 171.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -67.95 -25.88 65.67 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 112.384 0.513 . . . . 71.44 112.384 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.662 HD13 ' HB3' ' A' ' 29' ' ' LEU . 63.0 mt -79.47 -33.46 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 C-N-CA 124.515 1.126 . . . . 70.53 110.102 176.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -70.22 -39.14 75.29 Favored 'General case' 0 C--O 1.208 -1.08 0 CA-C-N 115.265 -0.879 . . . . 73.43 109.81 173.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -61.01 -48.75 80.37 Favored 'General case' 0 C--O 1.247 0.952 0 C-N-CA 124.986 1.314 . . . . 63.42 109.541 176.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.32 -60.42 3.36 Favored 'General case' 0 C--N 1.352 0.69 0 CA-C-N 113.52 -1.673 . . . . 65.45 111.188 177.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -63.92 -35.73 81.62 Favored 'General case' 0 C--O 1.214 -0.771 0 CA-C-N 115.686 -0.688 . . . . 72.32 111.412 -179.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.14 -53.34 58.29 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.579 0.752 . . . . 53.01 110.831 -177.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 66.4 t -62.84 -50.86 78.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 114.533 -1.212 . . . . 74.52 110.352 177.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 67.2 mt -76.07 -8.3 56.67 Favored 'General case' 0 CA--C 1.557 1.242 0 N-CA-C 113.152 0.797 . . . . 62.04 113.152 -172.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.2 t -65.42 -58.46 5.8 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.405 1.082 . . . . 74.34 111.853 -176.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.491 ' HB2' ' HD3' ' A' ' 62' ' ' LYS . 13.4 m-20 -99.31 142.33 24.41 Favored Pre-proline 0 C--O 1.244 0.778 0 C-N-CA 123.419 0.688 . . . . 74.34 109.432 -174.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.515 ' O ' ' HG2' ' A' ' 64' ' ' ARG . 48.7 Cg_exo -54.55 -47.23 27.92 Favored 'Trans proline' 0 C--N 1.385 2.447 0 C-N-CA 123.167 2.578 . . . . 72.41 112.941 -172.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.485 ' O ' HG12 ' A' ' 65' ' ' ILE . 3.1 mp0 -58.78 -58.2 9.64 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.505 0.722 . . . . 72.3 111.213 -174.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.491 ' HD3' ' HB2' ' A' ' 59' ' ' ASP . 37.9 mtpt -58.28 -43.52 88.05 Favored 'General case' 0 C--O 1.257 1.492 0 C-N-CA 124.29 1.036 . . . . 74.54 111.135 -178.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -59.04 -46.81 87.3 Favored 'General case' 0 C--N 1.349 0.581 0 CA-C-N 114.667 -1.152 . . . . 74.11 110.793 178.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.515 ' HG2' ' O ' ' A' ' 60' ' ' PRO . 30.2 mmm180 -77.6 -18.66 56.61 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 123.677 0.61 . . . . 74.25 111.305 -175.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.485 HG12 ' O ' ' A' ' 61' ' ' GLU . 28.3 mm -62.29 -50.93 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 N-CA-C 108.081 -1.081 . . . . 64.42 108.081 168.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -60.35 -52.25 66.07 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 114.908 -1.042 . . . . 75.4 111.001 175.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -63.31 -31.22 72.31 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.457 0.703 . . . . 64.04 112.059 -172.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.3 p -76.65 -31.55 57.41 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 119.166 -0.445 . . . . 75.13 110.773 173.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -64.06 115.12 4.63 Favored 'General case' 0 CA--C 1.556 1.2 0 N-CA-C 109.492 -0.559 . . . . 63.45 109.492 178.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 115.38 5.66 18.82 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 123.562 0.601 . . . . 52.54 111.969 -169.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 86.2 m -147.59 -56.62 0.24 Allowed 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 104.823 -2.288 . . . . 71.23 104.823 178.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.4 m -82.79 141.92 31.95 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 104.446 -2.427 . . . . 74.23 104.446 156.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.79 -35.08 10.25 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 118.617 0.644 . . . . 74.04 111.145 -179.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -93.24 134.18 27.41 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 123.393 0.677 . . . . 75.1 109.412 179.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.92 116.93 3.61 Favored 'Trans proline' 0 C--N 1.373 1.833 0 C-N-CA 122.299 1.999 . . . . 75.41 110.532 171.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -52.14 142.32 45.58 Favored 'Trans proline' 0 C--N 1.38 2.19 0 C-N-CA 123.035 2.49 . . . . 74.25 112.611 177.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -43.4 129.86 6.58 Favored 'Trans proline' 0 C--N 1.388 2.642 0 C-N-CA 123.969 3.113 . . . . 62.44 113.424 -174.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.421 ' HG3' ' HA3' ' A' ' 104' ' ' GLY . 28.2 Cg_endo -58.41 144.02 96.98 Favored 'Trans proline' 0 C--N 1.387 2.579 0 C-N-CA 122.84 2.36 . . . . 43.51 112.705 -171.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.404 ' HB2' HH21 ' A' ' 143' ' ' ARG . 58.9 Cg_endo -65.89 167.49 17.59 Favored 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 122.876 2.384 . . . . 71.05 112.59 -177.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.84 88.45 0.07 OUTLIER 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 122.665 2.244 . . . . 51.35 111.694 176.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 149.91 -40.88 0.84 Allowed Glycine 0 CA--C 1.524 0.611 0 CA-C-N 113.728 -1.578 . . . . 62.41 109.525 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 110.63 -169.51 13.46 Favored Glycine 0 C--N 1.351 1.383 0 C-N-CA 123.594 0.616 . . . . 53.03 111.686 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -84.72 88.36 7.37 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 123.431 0.692 . . . . 74.41 109.867 176.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -58.11 157.96 7.49 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 114.407 -1.269 . . . . 71.31 111.828 175.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -154.56 72.44 0.86 Allowed 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 108.597 -0.89 . . . . 70.22 108.597 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.4 m -43.58 84.99 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 126.134 1.774 . . . . 74.44 115.218 -165.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.451 ' N ' ' HA3' ' A' ' 163' ' ' GLY . . . 67.78 10.81 59.23 Favored Glycine 0 C--N 1.352 1.449 0 CA-C-N 115.815 -0.629 . . . . 70.11 114.008 175.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -93.23 122.95 36.15 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.231 -1.396 . . . . 72.34 107.231 178.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -69.74 90.39 0.59 Allowed 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 110.177 -0.305 . . . . 71.44 110.177 -173.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.491 HG23 ' HE2' ' A' ' 97' ' ' PHE . 2.4 p -34.81 -50.31 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 125.578 1.551 . . . . 75.21 114.084 175.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -59.84 -34.22 72.81 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.255 1.022 . . . . 75.33 111.297 -173.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -78.08 -30.84 49.87 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.218 1.007 . . . . 45.35 111.753 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -82.14 172.19 13.48 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 122.746 0.419 . . . . 71.01 110.161 -173.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 83.8 p -57.56 150.06 19.94 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 114.093 1.145 . . . . 74.5 114.093 -164.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.96 -41.8 71.58 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 114.568 -1.196 . . . . 74.31 110.881 170.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -59.76 -43.06 94.5 Favored 'General case' 0 C--N 1.354 0.769 0 C-N-CA 123.226 0.61 . . . . 75.03 110.755 -177.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.491 ' HE2' HG23 ' A' ' 90' ' ' VAL . 26.5 t80 -58.58 -49.99 75.42 Favored 'General case' 0 CA--C 1.548 0.895 0 O-C-N 123.761 0.663 . . . . 63.23 109.242 173.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.524 ' HA ' HD11 ' A' ' 105' ' ' LEU . 46.4 mt-30 -71.97 -5.6 36.04 Favored 'General case' 0 CA--C 1.557 1.237 0 CA-C-N 115.347 -0.842 . . . . 73.05 112.291 -178.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -97.65 -47.61 5.55 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 124.239 1.015 . . . . 70.02 111.903 173.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 37.2 tp -70.86 -52.75 18.34 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.655 0.782 . . . . 55.03 109.739 -176.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -86.16 -11.64 52.01 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 115.718 -0.674 . . . . 72.11 110.745 178.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -39.27 -58.82 1.94 Allowed Glycine 0 CA--C 1.543 1.792 0 CA-C-O 118.623 -1.098 . . . . 72.43 114.742 177.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -35.02 -36.92 0.13 Allowed 'Trans proline' 0 C--N 1.394 2.937 0 C-N-CA 125.289 3.993 . . . . 23.1 116.362 176.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.421 ' HA3' ' HG3' ' A' ' 78' ' ' PRO . . . -145.77 42.38 0.97 Allowed Glycine 0 C--N 1.354 1.53 0 CA-C-O 119.224 -0.764 . . . . 44.4 112.117 -178.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.524 HD11 ' HA ' ' A' ' 98' ' ' GLN . 8.1 mt -63.2 71.73 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.071 0.948 . . . . 74.25 112.867 177.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.72 ' HB3' ' HA ' ' A' ' 169' ' ' ASN . 1.5 t80 32.4 -105.13 0.02 OUTLIER 'General case' 0 CA--C 1.562 1.413 0 C-N-CA 126.3 1.84 . . . . 72.25 111.738 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 80.48 -40.03 2.38 Favored Glycine 0 C--N 1.359 1.844 0 CA-C-O 119.213 -0.77 . . . . 44.0 113.204 179.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.686 ' HA3' ' HB3' ' A' ' 167' ' ' GLN . . . . . . . . 0 C--N 1.359 1.839 0 C-N-CA 123.514 0.578 . . . . 71.34 113.519 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.586 ' HA ' ' HD2' ' A' ' 170' ' ' PRO . 21.9 ttmm . . . . . 0 CA--C 1.548 0.886 0 N-CA-C 109.842 -0.429 . . . . 72.15 109.842 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -89.36 161.18 29.86 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-N 116.65 -0.25 . . . . 55.22 113.7 -177.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -100.97 145.59 28.47 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.797 1.239 . . . . 71.34 108.174 175.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -58.6 144.95 41.25 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 118.717 0.69 . . . . 74.23 112.014 -175.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.416 ' O ' HD12 ' A' ' 174' ' ' LEU . 7.8 tt -144.5 137.13 26.68 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 109.049 -0.723 . . . . 70.23 109.049 -173.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -93.19 130.56 38.83 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.306 0.642 . . . . 74.51 109.364 174.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.619 ' HB1' HD11 ' B' ' 8' ' ' LEU . . . -141.31 140.86 33.9 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.415 -0.957 . . . . 41.51 108.415 176.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.461 ' HG3' HD11 ' B' ' 11' ' ' LEU . 42.6 mt-10 -123.11 109.27 13.83 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 108.704 -0.85 . . . . 61.0 108.704 -166.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.797 HD23 HD22 ' A' ' 176' ' ' LEU . 3.8 pp -101.27 114.84 65.71 Favored Pre-proline 0 N--CA 1.484 1.252 0 N-CA-C 110.293 -0.262 . . . . 54.05 110.293 -169.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.659 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 40.4 Cg_endo -67.24 109.56 1.79 Allowed 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 120.7 0.933 . . . . 75.33 110.309 173.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.722 ' HA ' HG21 ' B' ' 6' ' ' ILE . 57.7 tp -110.25 144.25 39.21 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 123.555 0.742 . . . . 64.01 110.829 -171.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 40.5 m -71.43 136.71 47.8 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 114.908 -1.042 . . . . 71.34 110.892 178.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.875 ' HB3' HD22 ' A' ' 215' ' ' LEU . 59.4 mt -54.37 -49.5 69.68 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.109 0.963 . . . . 70.54 111.688 -177.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -54.99 -46.51 75.14 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 114.646 -1.161 . . . . 75.32 111.452 175.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -65.66 -29.43 69.99 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 122.743 0.417 . . . . 64.33 111.451 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -66.75 -47.54 71.91 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.878 0.471 . . . . 41.43 110.503 178.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -63.96 -44.51 92.55 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 114.762 -1.108 . . . . 74.51 111.518 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 30.8 m170 -76.64 -45.58 29.39 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 115.709 -0.678 . . . . 75.25 111.404 -174.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.487 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 74.49 -153.25 45.85 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 123.54 0.525 . . . . 71.54 112.689 -177.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 81.72 -153.12 32.66 Favored Glycine 0 C--N 1.348 1.245 0 C-N-CA 123.223 0.439 . . . . 70.42 112.935 178.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -72.22 97.4 1.97 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.286 0.635 . . . . 73.14 110.09 -177.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.668 HH11 HD13 ' A' ' 125' ' ' LEU . 5.2 tmm_? -96.05 120.4 36.28 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 107.365 -1.346 . . . . 74.4 107.365 173.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 59.6 t -85.75 134.61 26.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 108.945 -0.761 . . . . 71.24 108.945 178.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.504 ' HB ' HG13 ' A' ' 145' ' ' VAL . 85.9 t -116.41 133.44 62.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 C-N-CA 124.007 0.923 . . . . 73.14 108.627 176.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -106.81 114.16 28.09 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 107.719 -1.215 . . . . 71.3 107.719 171.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.554 ' HB ' ' HB3' ' B' ' 8' ' ' LEU . 3.1 p -147.09 108.44 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 122.81 0.444 . . . . 75.1 111.845 -170.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 62.5 20.67 12.1 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.31 1.044 . . . . 74.24 112.198 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 92.64 4.87 65.31 Favored Glycine 0 C--N 1.352 1.428 0 CA-C-N 116.257 -0.429 . . . . 31.1 112.782 -175.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.468 ' HA ' ' NE ' ' A' ' 143' ' ' ARG . 3.7 tpm_? -98.59 106.67 18.97 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.567 0.747 . . . . 72.12 109.998 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 49.5 ttp180 -85.32 98.75 10.71 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.716 0.806 . . . . 74.41 109.252 174.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.504 HG13 ' HB ' ' A' ' 138' ' ' VAL . 2.5 p -110.8 131.93 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 123.458 0.703 . . . . 73.53 110.906 -177.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 48.3 t -89.35 93.28 9.48 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.705 0.802 . . . . 31.45 109.501 177.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 43.4 t -93.95 111.17 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 109.353 -0.61 . . . . 73.42 109.353 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 58.9 ttt85 -77.84 105.18 8.86 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 109.432 -0.581 . . . . 74.14 109.432 175.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.487 HG13 ' HA2' ' A' ' 133' ' ' GLY . 33.2 pt -90.71 149.17 40.04 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 123.766 0.826 . . . . 74.13 110.409 177.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -63.73 132.14 33.97 Favored 'Trans proline' 0 C--N 1.379 2.158 0 C-N-CA 122.843 2.362 . . . . 60.34 111.794 175.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.24 95.54 0.06 OUTLIER 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 123.155 2.57 . . . . 74.15 112.184 171.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 107.81 47.32 0.97 Allowed Glycine 0 C--N 1.341 0.828 0 N-CA-C 111.255 -0.738 . . . . 75.51 111.255 -172.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 5.2 p -86.25 141.39 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 108.219 -1.03 . . . . 75.43 108.219 175.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.529 ' HG2' ' HA ' ' A' ' 191' ' ' GLN . 0.0 OUTLIER -118.97 135.76 54.44 Favored 'General case' 0 C--O 1.198 -1.62 0 CA-C-O 117.116 -1.421 . . . . 73.23 110.146 -160.839 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.469 ' HB3' ' HB3' ' A' ' 188' ' ' LEU . 5.0 tp10 -43.62 129.94 5.35 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 119.386 0.994 . . . . 72.32 111.381 174.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 88.3 -7.47 81.49 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-O 119.062 -0.855 . . . . 14.21 113.594 -175.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.423 ' O ' HG12 ' A' ' 178' ' ' VAL . 8.2 t -66.26 113.53 4.65 Favored 'General case' 0 C--N 1.362 1.129 0 N-CA-C 107.247 -1.39 . . . . 74.23 107.247 176.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 58.9 t -85.12 91.27 3.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 107.696 -1.224 . . . . 72.34 107.696 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.599 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 32.8 mt -70.71 82.82 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 107.3 -1.37 . . . . 75.24 107.3 174.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 63.2 ttt-85 -74.57 97.93 3.26 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 107.804 -1.184 . . . . 61.32 107.804 179.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.401 ' HA ' ' HD2' ' A' ' 162' ' ' PRO . 2.5 p -106.82 104.71 52.67 Favored Pre-proline 0 C--O 1.242 0.707 0 N-CA-C 108.834 -0.802 . . . . 61.33 108.834 -178.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 161' ' ' VAL . 29.0 Cg_endo -62.03 104.16 0.32 Allowed 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 122.055 1.836 . . . . 74.53 109.956 173.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.451 ' HA3' ' N ' ' A' ' 87' ' ' GLY . . . 124.56 26.82 1.38 Allowed Glycine 0 C--N 1.341 0.843 0 N-CA-C 115.759 1.063 . . . . 70.43 115.759 174.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 22.5 mmt -138.63 1.75 2.15 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 117.999 0.899 . . . . 64.15 111.33 172.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.639 ' HA2' HD13 ' A' ' 174' ' ' LEU . . . -84.01 -123.09 0.98 Allowed Glycine 0 C--N 1.351 1.38 0 N-CA-C 114.252 0.461 . . . . 73.33 114.252 -171.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -58.54 143.95 43.96 Favored Glycine 0 C--N 1.351 1.37 0 O-C-N 124.122 0.542 . . . . 74.5 111.864 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.686 ' HB3' ' HA3' ' A' ' 108' ' ' GLY . 27.1 mm-40 -68.47 103.98 1.8 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.956 0.902 . . . . 75.42 111.937 -164.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -156.05 168.62 33.52 Favored Glycine 0 C--N 1.338 0.69 0 N-CA-C 109.759 -1.337 . . . . 64.21 109.759 177.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . 0.72 ' HA ' ' HB3' ' A' ' 106' ' ' PHE . 0.3 OUTLIER -62.14 -53.62 57.32 Favored Pre-proline 0 N--CA 1.485 1.289 0 CA-C-N 118.401 1.1 . . . . 63.11 110.032 -179.198 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.659 ' HD3' ' HB3' ' A' ' 169' ' ' ASN . 24.4 Cg_endo -95.99 90.79 0.09 OUTLIER 'Trans proline' 0 C--N 1.387 2.558 0 C-N-CA 122.089 1.86 . . . . 71.13 108.079 159.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.428 ' HD3' ' O ' ' A' ' 169' ' ' ASN . 25.3 Cg_exo -60.58 174.82 1.42 Allowed 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 122.786 2.324 . . . . 71.25 113.857 -171.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -66.35 175.15 21.01 Favored Glycine 0 N--CA 1.472 1.052 0 N-CA-C 115.397 0.919 . . . . 72.4 115.397 -175.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -69.79 97.43 1.09 Allowed 'General case' 0 C--O 1.242 0.693 0 N-CA-C 108.225 -1.028 . . . . 71.14 108.225 172.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.639 HD13 ' HA2' ' A' ' 165' ' ' GLY . 21.4 tp -78.47 104.0 8.78 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 109.518 -0.549 . . . . 64.32 109.518 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 68.4 mt -71.67 81.58 0.85 Allowed 'General case' 0 C--O 1.242 0.67 0 C-N-CA 124.1 0.96 . . . . 72.12 109.07 173.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.797 HD22 HD23 ' A' ' 123' ' ' LEU . 34.8 mt -76.02 90.06 3.01 Favored 'General case' 0 C--N 1.35 0.627 0 CA-C-N 115.978 -0.556 . . . . 70.05 110.133 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.446 ' HB ' ' HG2' ' A' ' 122' ' ' GLU . 17.4 t -82.22 105.04 11.65 Favored 'Isoleucine or valine' 0 C--O 1.246 0.886 0 N-CA-C 106.954 -1.498 . . . . 61.43 106.954 179.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.423 HG12 ' O ' ' A' ' 157' ' ' SER . 7.1 p -71.21 106.42 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.037 0 CA-C-N 114.924 -1.034 . . . . 70.33 110.963 -174.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.659 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 33.7 mmt180 -91.89 94.46 9.32 Favored 'General case' 0 C--O 1.208 -1.089 0 C-N-CA 123.233 0.613 . . . . 53.32 110.215 179.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.536 HD23 ' HB3' ' A' ' 125' ' ' LEU . 17.6 mt -67.12 143.73 56.48 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 121.379 -0.826 . . . . 72.4 110.564 -177.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.41 ' HA ' ' HD3' ' A' ' 182' ' ' PRO . 82.5 mt -54.37 144.62 41.01 Favored Pre-proline 0 N--CA 1.476 0.835 0 O-C-N 124.367 1.042 . . . . 73.14 111.329 -172.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 181' ' ' LEU . 8.0 Cg_exo -75.17 36.52 0.45 Allowed 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 123.041 2.494 . . . . 71.42 113.073 176.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . 0.488 ' HB3' HD11 ' A' ' 127' ' ' LEU . 24.1 t-80 -61.45 126.26 86.16 Favored Pre-proline 0 CA--C 1.549 0.929 0 N-CA-C 107.636 -1.246 . . . . 73.35 107.636 171.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 183' ' ' HIS . 21.2 Cg_exo -66.16 24.06 0.1 OUTLIER 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 124.078 3.185 . . . . 61.24 118.689 -160.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 16.2 t -102.93 -59.99 3.1 Favored 'Isoleucine or valine' 0 C--N 1.367 1.366 0 CA-C-N 121.23 1.832 . . . . 64.21 109.362 175.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . 0.543 ' CD1' ' HB2' ' A' ' 195' ' ' ALA . 49.0 m-85 -120.09 140.6 50.8 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.006 0.743 . . . . 72.31 113.006 -168.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -117.49 92.18 3.78 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 104.604 -2.369 . . . . 75.51 104.604 162.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.579 ' HA ' ' HA ' ' A' ' 193' ' ' LEU . 13.9 tp -73.33 162.14 29.68 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.468 1.107 . . . . 74.21 109.897 -177.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . 0.466 ' H ' HD12 ' A' ' 188' ' ' LEU . 11.4 tp10 -163.99 129.53 2.95 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.766 0.827 . . . . 70.31 109.464 171.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 75.25 -77.99 1.15 Allowed Glycine 0 C--N 1.348 1.237 0 O-C-N 123.388 0.43 . . . . 65.41 112.986 175.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.529 ' HA ' ' HG2' ' A' ' 154' ' ' ARG . 0.5 OUTLIER -153.26 -0.8 0.24 Allowed 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 124.708 1.203 . . . . 72.32 110.364 170.28 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.47 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 6.4 p-10 -117.95 133.19 56.16 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.998 1.319 . . . . 72.32 111.566 -172.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.579 ' HA ' ' HA ' ' A' ' 188' ' ' LEU . 18.2 mt -88.43 155.11 19.86 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.611 1.165 . . . . 63.44 110.126 -171.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -126.2 99.13 5.75 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 108.489 -0.93 . . . . 73.14 108.489 167.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.544 ' HB3' HD23 ' A' ' 251' ' ' LEU . . . -103.02 173.19 6.42 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.021 0.929 . . . . 74.34 109.325 175.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 30.7 m -110.88 149.06 31.15 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 108.457 -0.942 . . . . 70.21 108.457 171.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.424 HD22 HD13 ' A' ' 251' ' ' LEU . 49.5 tp -142.44 109.53 5.55 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 109.248 -0.649 . . . . 72.21 109.248 -176.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -86.35 121.93 29.61 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 108.296 -1.002 . . . . 61.43 108.296 173.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 7.5 p -140.36 133.25 14.8 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 123.987 0.915 . . . . 64.4 108.588 -176.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.69 156.55 48.93 Favored 'Trans proline' 0 C--N 1.369 1.645 0 C-N-CA 121.858 1.705 . . . . 64.51 111.911 175.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -57.51 -46.64 99.77 Favored Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 124.725 1.21 . . . . 71.34 114.038 -170.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -57.86 -45.04 35.28 Favored 'Trans proline' 0 C--N 1.39 2.75 0 C-N-CA 121.643 1.562 . . . . 63.54 113.082 175.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.471 HD11 ' HB3' ' C' ' 276' ' ' TYR . 33.8 mt -71.33 -27.19 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.087 0.555 . . . . 64.32 110.273 -179.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -71.52 -47.33 55.93 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.359 0.663 . . . . 71.51 111.08 177.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 53.0 t -65.71 -49.94 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 123.629 0.772 . . . . 63.23 111.309 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 59.0 t -88.74 -43.47 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.588 0.755 . . . . 74.41 111.509 -170.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 96.19 121.75 3.98 Favored Glycine 0 C--N 1.338 0.666 0 CA-C-N 115.947 -0.569 . . . . 72.35 112.683 -174.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.451 ' H ' ' HB ' ' A' ' 223' ' ' VAL . . . -141.98 -137.2 3.34 Favored Glycine 0 C--N 1.341 0.827 0 N-CA-C 111.095 -0.802 . . . . 55.24 111.095 178.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -136.24 137.71 41.07 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 118.006 0.903 . . . . 45.21 109.739 174.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 26.9 m -133.74 149.47 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 N-CA-C 108.59 -0.893 . . . . 63.11 108.59 172.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 21.3 ttm105 -75.36 107.58 7.57 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 121.101 0.477 . . . . 71.41 110.12 177.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -105.78 144.81 31.99 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.348 1.059 . . . . 62.04 109.181 175.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . 0.514 ' N ' ' SD ' ' A' ' 213' ' ' MET . 0.5 OUTLIER -87.02 151.82 22.92 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 123.07 0.548 . . . . 71.23 109.898 -177.998 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 81.3 p -122.05 -162.67 1.01 Allowed 'General case' 0 C--O 1.243 0.732 0 N-CA-C 108.36 -0.978 . . . . 74.1 108.36 170.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.875 HD22 ' HB3' ' A' ' 127' ' ' LEU . 34.1 mt -65.36 -42.63 92.57 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.159 0.584 . . . . 63.31 110.781 177.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -129.3 30.35 5.0 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 115.331 -0.85 . . . . 64.44 112.351 -165.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 155.45 158.2 8.65 Favored Glycine 0 C--N 1.352 1.457 0 CA-C-O 119.75 -0.472 . . . . 33.0 113.888 173.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -94.25 101.67 0.13 Allowed 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 123.277 2.651 . . . . 70.23 112.716 178.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 29.7 m -90.63 173.67 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 123.822 0.849 . . . . 73.4 109.771 -176.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 25.9 pt-20 -100.74 124.01 45.76 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 108.47 -0.937 . . . . 75.04 108.47 169.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 14.4 p -100.22 129.21 51.29 Favored 'Isoleucine or valine' 0 C--O 1.245 0.867 0 N-CA-C 108.493 -0.928 . . . . 74.13 108.493 173.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -84.43 101.24 11.87 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 109.379 -0.6 . . . . 60.25 109.379 178.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.451 ' HB ' ' H ' ' A' ' 208' ' ' GLY . 62.4 t -58.33 136.49 85.16 Favored Pre-proline 0 CA--C 1.553 1.067 0 CA-C-N 113.677 -1.601 . . . . 63.14 110.064 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -81.8 176.32 8.5 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 122.987 2.458 . . . . 75.51 110.716 177.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -71.53 159.09 52.27 Favored 'Trans proline' 0 C--N 1.359 1.131 0 C-N-CA 120.607 0.871 . . . . 72.53 110.844 165.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . 0.572 ' HD2' ' O ' ' C' ' 259' ' ' GLU . 11.1 mmt180 65.81 26.95 11.16 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 124.56 1.144 . . . . 74.04 113.195 168.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.529 HG23 HD21 ' A' ' 233' ' ' LEU . 31.4 m -65.1 84.43 0.05 OUTLIER 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 124.969 1.308 . . . . 64.32 109.568 175.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -86.39 138.89 31.44 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.291 1.036 . . . . 75.32 110.713 -171.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -50.11 127.26 16.42 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.39 1.476 . . . . 62.31 112.112 -176.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 88.29 -25.06 9.6 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-N 115.543 -0.753 . . . . 73.32 114.462 172.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.432 ' O ' HG23 ' A' ' 253' ' ' VAL . 70.8 mtt180 -67.5 156.01 37.69 Favored 'General case' 0 C--N 1.345 0.408 0 N-CA-C 109.323 -0.621 . . . . 74.0 109.323 172.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? -110.46 123.29 49.63 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.558 -0.904 . . . . 72.22 108.558 -176.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.529 HD21 HG23 ' A' ' 227' ' ' THR . 80.7 mt -72.42 111.53 7.69 Favored 'General case' 0 C--O 1.217 -0.645 0 N-CA-C 107.525 -1.287 . . . . 71.4 107.525 179.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -95.21 100.28 12.11 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 123.462 0.476 . . . . 64.14 110.185 -178.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.568 HD12 ' HG3' ' A' ' 238' ' ' LYS . 0.2 OUTLIER -107.31 107.02 17.74 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.547 0.739 . . . . 61.12 109.455 -179.659 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.609 ' HA ' ' HB3' ' A' ' 248' ' ' ASP . 14.2 mmmm -67.54 148.91 50.84 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.702 0.801 . . . . 64.43 111.73 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.475 ' HA2' ' HB2' ' A' ' 246' ' ' ARG . . . 73.55 23.79 76.2 Favored Glycine 0 C--N 1.352 1.45 0 CA-C-N 116.164 -0.471 . . . . 74.2 113.566 177.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.568 ' HG3' HD12 ' A' ' 235' ' ' LEU . 46.6 mmtm -123.05 -26.23 4.4 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.873 0.869 . . . . 73.01 110.985 -174.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -80.19 -155.19 10.58 Favored Glycine 0 C--N 1.345 1.079 0 CA-C-N 115.948 -0.569 . . . . 74.43 113.009 171.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . 0.5 ' HZ ' HD11 ' A' ' 215' ' ' LEU . 3.9 m-85 -94.92 139.03 21.98 Favored Pre-proline 0 N--CA 1.478 0.95 0 CA-C-O 118.893 -0.575 . . . . 73.13 111.175 -168.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.597 ' HA ' ' HA ' ' A' ' 246' ' ' ARG . 59.6 Cg_exo -42.4 129.04 4.75 Favored 'Trans proline' 0 C--N 1.391 2.79 0 C-N-CA 124.437 3.425 . . . . 73.33 114.585 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -165.23 -147.15 5.04 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-O 119.334 -0.703 . . . . 73.52 112.586 -176.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . 0.465 ' HD2' ' HG2' ' A' ' 191' ' ' GLN . 28.1 Cg_exo -62.71 -28.42 76.51 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 123.761 2.974 . . . . 70.45 113.138 -177.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -90.82 21.28 4.2 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.964 0.906 . . . . 70.11 111.524 -179.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 78.28 -70.11 2.65 Favored Glycine 0 C--N 1.35 1.346 0 N-CA-C 109.762 -1.335 . . . . 62.24 109.762 -170.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.597 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 64.0 mtm180 -122.65 144.82 48.88 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 107.154 -1.425 . . . . 75.41 107.154 164.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -69.55 -165.81 4.81 Favored Glycine 0 C--N 1.335 0.514 0 CA-C-O 121.435 0.464 . . . . 42.24 113.919 172.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . 0.609 ' HB3' ' HA ' ' A' ' 236' ' ' LYS . 0.9 OUTLIER -121.0 173.53 7.2 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.589 0.755 . . . . 75.44 111.492 -174.049 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.467 HD23 HD11 ' A' ' 235' ' ' LEU . 16.2 tp -126.56 136.25 52.32 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.297 -1.001 . . . . 70.31 108.297 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.443 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 56.5 m-85 -111.78 113.94 26.61 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.352 1.061 . . . . 52.51 109.112 176.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.544 HD23 ' HB3' ' A' ' 195' ' ' ALA . 78.2 mt -102.39 106.85 17.67 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 109.262 -0.644 . . . . 72.24 109.262 178.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -76.79 117.94 18.9 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 109.435 -0.58 . . . . 75.41 109.435 -178.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 231' ' ' ARG . 49.2 t -71.61 134.19 30.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-N 114.477 -1.238 . . . . 24.43 111.31 -171.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -130.94 91.23 3.02 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 106.82 -1.548 . . . . 73.14 106.82 177.113 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.492 HD13 HG23 ' C' ' 257' ' ' ILE . 62.0 mt -77.52 127.88 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 122.767 0.427 . . . . 74.34 111.243 -173.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 25.6 p -116.11 165.16 13.46 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.738 1.215 . . . . 73.43 110.263 175.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.486 ' HB ' ' HD2' ' A' ' 258' ' ' PRO . 2.9 pp -134.17 154.54 80.13 Favored Pre-proline 0 N--CA 1.486 1.363 0 C-N-CA 123.519 0.728 . . . . 73.4 109.079 174.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 258' ' ' PRO . . . . . 0.486 ' HD2' ' HB ' ' A' ' 257' ' ' ILE . 18.4 Cg_endo -54.28 -17.84 12.89 Favored 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 123.705 2.937 . . . . 74.45 116.336 -164.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . 0.413 ' H ' HD12 ' A' ' 257' ' ' ILE . 7.7 mm-40 59.18 -64.49 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 125.234 1.414 . . . . 63.24 113.119 -167.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -79.24 129.68 34.7 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.792 -0.568 . . . . 75.12 111.013 178.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.413 HD12 ' HD2' ' C' ' 226' ' ' ARG . 67.4 mt -143.29 154.59 43.94 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.412 1.085 . . . . 55.32 109.852 177.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . 0.445 ' HB ' ' HD2' ' A' ' 263' ' ' PRO . 18.0 p -132.33 159.3 72.84 Favored Pre-proline 0 CA--C 1.564 1.515 0 C-N-CA 124.791 1.236 . . . . 44.34 108.787 174.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 263' ' ' PRO . . . . . 0.445 ' HD2' ' HB ' ' A' ' 262' ' ' THR . 39.2 Cg_exo -17.21 -58.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.398 3.155 1 C-N-CA 127.317 5.344 . . . . 74.33 119.167 -170.921 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -70.9 -47.51 58.76 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 118.056 0.389 . . . . 71.44 111.861 -173.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . 0.4 ' HB3' HD22 ' A' ' 261' ' ' LEU . 5.5 mp0 -66.05 -36.97 84.67 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 109.506 -0.553 . . . . 64.2 109.506 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 266' ' ' GLU . . . . . 0.461 ' O ' ' HG3' ' A' ' 270' ' ' LYS . 4.2 tp10 -52.55 -48.97 65.81 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 124.509 1.131 . . . . 73.45 109.238 172.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -58.65 -51.16 71.11 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.697 1.199 . . . . 64.12 112.835 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 11.0 mp -59.94 -46.62 88.81 Favored 'General case' 0 N--CA 1.483 1.223 0 O-C-N 123.717 0.636 . . . . 73.14 110.689 -178.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -65.61 -34.93 79.37 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 123.58 0.752 . . . . 75.0 112.385 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' A' ' 266' ' ' GLU . 9.1 mtpm? -63.06 -55.31 26.6 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 122.961 0.504 . . . . 62.43 110.793 176.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 30.7 mmtm -62.98 -27.99 69.78 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 124.085 0.865 . . . . 70.22 111.634 -178.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 272' ' ' LEU . . . . . 0.434 ' O ' ' HB2' ' A' ' 276' ' ' TYR . 40.9 mt -60.12 -55.42 34.05 Favored 'General case' 0 C--O 1.207 -1.158 0 O-C-N 123.836 0.71 . . . . 63.4 109.887 167.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -63.34 -33.42 75.48 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.874 0.87 . . . . 64.51 113.184 -176.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -69.57 -55.34 10.39 Favored 'General case' 0 C--O 1.252 1.203 0 C-N-CA 123.957 0.903 . . . . 74.35 109.736 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -77.26 -2.86 36.86 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-N 115.032 -0.985 . . . . 71.44 111.668 178.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . 0.434 ' HB2' ' O ' ' A' ' 272' ' ' LEU . 33.4 t80 -79.53 -61.79 1.89 Allowed 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.236 -1.024 . . . . 75.02 108.236 171.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 277' ' ' TYR . . . . . 0.472 ' HA ' ' HB2' ' A' ' 280' ' ' ALA . 2.6 t80 -58.03 -38.76 76.84 Favored 'General case' 0 C--N 1.356 0.877 0 O-C-N 124.988 1.43 . . . . 70.12 109.53 -175.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -48.03 -38.05 16.31 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.67 1.188 . . . . 75.41 113.7 175.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.55 37.85 3.47 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 109.319 -0.623 . . . . 74.13 109.319 179.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . 0.472 ' HB2' ' HA ' ' A' ' 277' ' ' TYR . . . . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 118.89 -0.576 . . . . 72.21 112.102 -175.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 61.1 mtm . . . . . 0 N--CA 1.483 1.18 0 N-CA-C 109.488 -0.56 . . . . 71.44 109.488 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt 67.09 -77.42 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 125.335 1.454 . . . . 54.1 111.552 177.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 36.6 tp60 -154.51 128.01 8.57 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 107.258 -1.386 . . . . 74.04 107.258 -177.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 39.4 m -141.75 100.65 3.8 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 108.763 -0.828 . . . . 52.14 108.763 -178.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 8.6 m -64.09 153.34 37.86 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.353 0.661 . . . . 70.11 112.428 -168.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.722 HG21 ' HA ' ' A' ' 125' ' ' LEU . 19.1 pt -117.55 -177.64 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 N-CA-C 113.12 0.785 . . . . 64.44 113.12 -167.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -135.76 143.66 45.39 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 114.572 -1.194 . . . . 72.01 110.322 177.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . 0.619 HD11 ' HB1' ' A' ' 121' ' ' ALA . 36.9 tp -115.76 157.72 23.91 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.842 1.257 . . . . 75.22 108.494 173.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -103.73 -35.66 8.14 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.016 0.526 . . . . 62.4 111.926 178.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . 0.424 ' HG ' HG21 ' A' ' 140' ' ' VAL . 88.4 mt 76.68 2.58 3.4 Favored 'General case' 0 N--CA 1.502 2.145 0 C-N-CA 125.556 1.543 . . . . 74.1 110.726 -162.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.461 HD11 ' HG3' ' A' ' 122' ' ' GLU . 65.0 mt . . . . . 0 CA--C 1.578 2.043 0 N-CA-C 116.383 1.994 . . . . 45.35 116.383 177.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.214 0 N-CA-C 109.042 -0.725 . . . . 61.34 109.042 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 180' ' ' ALA . . . . . 0.635 ' HB1' HG23 ' C' ' 137' ' ' VAL . . . -161.77 -69.81 0.06 Allowed 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 108.505 -0.924 . . . . 74.4 108.505 172.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 20.1 tp -88.35 -68.72 0.75 Allowed 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 107.171 -1.418 . . . . 62.04 107.171 160.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 182' ' ' VAL . . . . . . . . . . . . . 78.4 t -135.64 -70.95 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.705 0.802 . . . . 71.31 109.644 175.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -171.64 -89.44 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.257 0.623 . . . . 65.24 110.537 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 26.7 p-80 -168.01 -167.58 0.85 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.481 0.712 . . . . 74.15 110.869 -173.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 185' ' ' VAL . . . . . . . . . . . . . 89.6 t . . . . . 0 N--CA 1.482 1.165 0 C-N-CA 124.1 0.96 . . . . 71.33 111.011 -179.267 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 33.0 m . . . . . 0 CA--C 1.544 0.713 0 CA-C-O 121.48 0.657 . . . . 71.31 110.016 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 239' ' ' ALA . . . . . 0.417 ' HA ' HD22 ' C' ' 235' ' ' LEU . . . -68.96 137.96 54.18 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 114.671 -1.15 . . . . 74.42 111.16 172.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . -70.34 -101.57 0.04 OUTLIER Glycine 0 C--N 1.355 1.586 0 N-CA-C 110.923 -0.871 . . . . 71.23 110.923 172.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 241' ' ' GLU . . . . . 0.496 ' HB3' ' HG3' ' B' ' 245' ' ' LYS . 24.0 pt-20 -175.31 171.58 2.87 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.847 0.859 . . . . 71.21 111.462 169.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 242' ' ' TRP . . . . . 0.424 ' CZ3' HG21 ' C' ' 253' ' ' VAL . 0.7 OUTLIER -98.27 -66.11 0.92 Allowed 'General case' 0 C--O 1.237 0.408 0 N-CA-C 107.094 -1.447 . . . . 70.32 107.094 -175.773 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -141.72 19.49 2.17 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 112.586 -2.097 . . . . 74.22 106.974 -175.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 114.41 164.88 15.09 Favored Glycine 0 CA--C 1.535 1.341 0 N-CA-C 109.75 -1.34 . . . . 63.11 109.75 -156.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 245' ' ' LYS . . . . . 0.496 ' HG3' ' HB3' ' B' ' 241' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.374 0 C-N-CA 123.727 0.811 . . . . 75.34 111.019 177.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.838 0 N-CA-C 110.308 -0.256 . . . . 52.01 110.308 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? -37.64 96.2 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 125.616 1.566 . . . . 70.52 113.179 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 5' ' ' LYS . . . . . 0.484 ' HB3' HD11 ' C' ' 10' ' ' ILE . 97.4 mttt -96.86 106.93 19.34 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.72 0.808 . . . . 63.2 109.561 174.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -73.83 97.62 2.79 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 107.076 -1.453 . . . . 63.22 107.076 166.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 7' ' ' TYR . . . . . 0.41 ' HA ' HD12 ' C' ' 10' ' ' ILE . 61.1 m-85 -61.16 -26.04 67.42 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 114.451 -1.249 . . . . 73.43 112.257 -172.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -68.67 -46.77 68.22 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.851 0.461 . . . . 72.53 109.792 176.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.3 -42.88 92.35 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.366 0.666 . . . . 52.31 110.678 178.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 10' ' ' ILE . . . . . 0.484 HD11 ' HB3' ' C' ' 5' ' ' LYS . 83.3 mt -54.17 -47.39 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 C-N-CA 124.023 0.929 . . . . 63.34 110.615 174.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 11' ' ' LEU . . . . . 0.4 ' HB2' HG22 ' C' ' 13' ' ' VAL . 85.8 mt -75.79 -13.6 60.29 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 115.397 -0.82 . . . . 45.45 112.787 179.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.66 21.29 75.06 Favored Glycine 0 C--N 1.351 1.393 0 CA-C-N 117.903 0.32 . . . . 64.33 113.655 -177.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 13' ' ' VAL . . . . . 0.4 HG22 ' HB2' ' C' ' 11' ' ' LEU . 12.5 m -106.19 160.58 25.7 Favored Pre-proline 0 N--CA 1.483 1.187 0 C-N-CA 124.291 1.036 . . . . 64.04 110.271 176.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -56.82 153.37 37.47 Favored 'Trans proline' 0 C--N 1.388 2.65 0 C-N-CA 122.714 2.276 . . . . 74.43 112.152 177.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 63.6 mtp180 -70.67 7.21 1.16 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 113.661 0.985 . . . . 71.52 113.661 -174.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -135.93 21.94 3.29 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.276 1.031 . . . . 71.24 108.594 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.04 128.07 34.99 Favored 'General case' 0 C--N 1.35 0.608 0 CA-C-N 114.684 -1.144 . . . . 71.14 111.089 -176.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 70.8 p -71.44 169.22 15.84 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 123.662 0.785 . . . . 74.41 110.252 177.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -50.98 -38.59 51.89 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.052 0.941 . . . . 74.45 111.615 -178.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 20' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' C' ' 24' ' ' ARG . 0.3 OUTLIER -69.68 -45.56 68.04 Favored 'General case' 0 CA--C 1.553 1.061 0 O-C-N 123.952 0.783 . . . . 64.05 110.539 -176.14 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -63.47 -43.41 97.42 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.724 0.773 . . . . 73.42 110.741 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 22' ' ' ILE . . . . . 0.755 HD13 ' HB3' ' C' ' 57' ' ' LEU . 89.8 mt -63.13 -34.3 65.88 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 CA-C-N 114.044 -1.435 . . . . 61.32 110.75 175.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -72.67 -29.95 63.86 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.928 0.891 . . . . 74.13 111.223 176.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 24' ' ' ARG . . . . . 0.431 ' HG3' ' O ' ' C' ' 20' ' ' GLU . 94.6 mtt180 -64.81 -53.05 52.94 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.142 0.577 . . . . 73.52 109.541 175.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.93 -40.96 97.32 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 114.704 -1.135 . . . . 75.32 111.24 178.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 26' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -52.48 -64.43 0.82 Allowed 'General case' 0 C--O 1.212 -0.877 0 O-C-N 124.789 1.306 . . . . 72.31 110.309 176.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -59.01 -38.73 79.9 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 124.339 1.025 . . . . 74.1 111.45 -174.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 -55.03 -53.68 52.67 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 123.715 0.634 . . . . 71.15 110.588 177.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . 0.526 ' HB3' HD13 ' C' ' 50' ' ' ILE . 72.4 mt -82.65 -17.14 45.66 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 115.009 -0.996 . . . . 60.22 111.941 -176.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -85.84 -16.6 38.17 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.738 0.815 . . . . 75.32 110.472 179.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -95.19 -37.7 10.92 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.525 0.73 . . . . 73.5 109.954 170.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 25.8 tp60 -65.07 -47.76 76.17 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.393 0.677 . . . . 71.12 111.187 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -108.69 22.7 15.57 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.333 0.653 . . . . 70.15 111.069 -175.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 34' ' ' HIS . . . . . 0.527 ' CD2' ' HB3' ' C' ' 36' ' ' ASP . 54.3 t60 -60.51 99.39 0.18 Allowed Pre-proline 0 N--CA 1.487 1.412 0 C-N-CA 124.913 1.285 . . . . 72.34 111.547 -174.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -61.97 -22.37 74.15 Favored 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 123.51 2.806 . . . . 71.32 113.916 -167.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 36' ' ' ASP . . . . . 0.527 ' HB3' ' CD2' ' C' ' 34' ' ' HIS . 9.4 t70 -56.44 -43.88 79.91 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.38 1.072 . . . . 60.34 111.603 174.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . 0.432 HG23 ' HD2' ' C' ' 34' ' ' HIS . 51.7 t -99.94 -46.24 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-O 121.762 0.791 . . . . 75.33 109.754 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -100.93 84.5 2.7 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.391 1.476 . . . . 54.22 109.921 -175.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -83.37 54.88 2.96 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.402 0.681 . . . . 62.24 110.663 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 44.3 m -104.37 108.33 60.14 Favored Pre-proline 0 N--CA 1.475 0.791 0 CA-C-O 118.572 -0.728 . . . . 74.14 109.136 -178.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -40.75 -52.12 3.34 Favored 'Trans proline' 0 C--N 1.387 2.6 0 C-N-CA 124.655 3.57 . . . . 63.44 114.707 -174.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 42' ' ' GLU . . . . . 0.404 ' O ' ' HD3' ' C' ' 46' ' ' LYS . 41.8 tt0 -56.81 -47.39 80.35 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 124.043 0.839 . . . . 65.44 110.813 178.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.05 -20.87 66.32 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 115.966 -0.561 . . . . 62.05 110.901 -178.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 44' ' ' GLU . . . . . 0.406 ' O ' ' HD3' ' C' ' 48' ' ' LYS . 45.7 mt-10 -86.29 -28.87 23.47 Favored 'General case' 0 C--N 1.355 0.814 0 C-N-CA 123.21 0.604 . . . . 74.04 109.995 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -60.85 -50.26 74.17 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.753 -0.832 . . . . 42.53 108.753 171.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 46' ' ' LYS . . . . . 0.404 ' HD3' ' O ' ' C' ' 42' ' ' GLU . 12.3 mptt -62.5 -48.79 78.04 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 113.811 -1.541 . . . . 72.32 110.07 179.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -56.25 -39.19 72.18 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.809 0.844 . . . . 62.23 110.79 178.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 48' ' ' LYS . . . . . 0.406 ' HD3' ' O ' ' C' ' 44' ' ' GLU . 1.2 mptm? -62.02 -49.19 77.01 Favored 'General case' 0 C--O 1.214 -0.794 0 O-C-N 123.841 0.713 . . . . 72.04 109.97 179.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -70.68 -22.02 62.53 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 112.557 0.577 . . . . 72.33 112.557 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 50' ' ' ILE . . . . . 0.526 HD13 ' HB3' ' C' ' 29' ' ' LEU . 73.2 mt -80.11 -36.78 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 124.423 1.089 . . . . 75.43 110.69 176.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 51' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -89.63 -8.64 52.07 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.031 0.932 . . . . 74.04 110.521 177.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 52' ' ' GLU . . . . . 0.413 ' O ' HG23 ' C' ' 56' ' ' VAL . 29.4 tt0 -79.0 -47.19 16.71 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.93 1.292 . . . . 63.42 107.928 166.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.42 -44.34 80.29 Favored 'General case' 0 C--N 1.346 0.431 0 CA-C-N 114.243 -1.344 . . . . 63.1 110.684 173.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -80.93 -22.84 39.31 Favored 'General case' 0 CA--C 1.553 1.06 0 CA-C-N 115.501 -0.772 . . . . 75.01 111.125 178.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.85 -38.24 78.28 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 118.839 0.745 . . . . 60.54 110.22 171.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 56' ' ' VAL . . . . . 0.413 HG23 ' O ' ' C' ' 52' ' ' GLU . 26.1 t -77.34 -47.69 26.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-N 114.891 -1.049 . . . . 72.43 110.501 174.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 57' ' ' LEU . . . . . 0.755 ' HB3' HD13 ' C' ' 22' ' ' ILE . 85.1 mt -103.72 20.8 17.36 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 113.569 0.952 . . . . 75.02 113.569 -166.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 33.6 t -55.89 -43.1 76.92 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 124.161 0.984 . . . . 62.42 113.275 177.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -140.71 156.91 68.82 Favored Pre-proline 0 N--CA 1.472 0.664 0 C-N-CA 124.379 1.072 . . . . 72.03 109.559 -170.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 60' ' ' PRO . . . . . 0.472 ' O ' ' HG2' ' C' ' 64' ' ' ARG . 19.6 Cg_endo -54.62 -29.21 59.8 Favored 'Trans proline' 0 C--N 1.394 2.959 0 C-N-CA 123.408 2.739 . . . . 33.23 112.454 179.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -54.04 -63.16 1.24 Allowed 'General case' 0 C--O 1.252 1.199 0 C-N-CA 124.823 1.249 . . . . 62.13 111.801 177.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 44.0 mtpt -81.55 -24.64 36.45 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 113.94 -1.482 . . . . 75.23 110.152 -171.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -54.3 -50.13 68.05 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.763 1.225 . . . . 64.42 109.595 166.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 64' ' ' ARG . . . . . 0.472 ' HG2' ' O ' ' C' ' 60' ' ' PRO . 20.9 mmt180 -71.11 -29.02 64.74 Favored 'General case' 0 C--N 1.358 0.967 0 CA-C-O 119.13 -0.462 . . . . 74.15 111.801 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 65' ' ' ILE . . . . . 0.401 HG23 ' HG2' ' C' ' 76' ' ' PRO . 69.4 mt -56.86 -44.92 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-O 121.296 0.57 . . . . 62.34 110.317 168.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -63.19 -48.15 79.6 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.994 -0.548 . . . . 74.22 110.969 176.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -58.84 -41.4 86.86 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 123.581 0.551 . . . . 73.14 111.725 -177.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 64.9 p -67.8 -28.99 68.06 Favored 'General case' 0 C--N 1.349 0.574 0 O-C-N 123.341 0.4 . . . . 63.2 110.671 176.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -77.26 142.71 39.36 Favored 'General case' 0 C--N 1.359 0.989 0 N-CA-C 109.052 -0.721 . . . . 75.22 109.052 171.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.69 13.3 82.6 Favored Glycine 0 C--N 1.346 1.102 0 N-CA-C 112.009 -0.436 . . . . 62.51 112.009 -177.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 28.8 m -136.93 -54.5 0.71 Allowed 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 103.749 -2.686 . . . . 72.34 103.749 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 82.2 m -97.51 150.17 21.37 Favored 'General case' 0 C--O 1.255 1.354 0 N-CA-C 104.532 -2.395 . . . . 73.35 104.532 156.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.12 -34.16 11.8 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.844 0.858 . . . . 73.23 110.258 -178.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -70.64 128.1 91.31 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 123.742 0.817 . . . . 53.23 110.732 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -67.13 150.38 82.12 Favored 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 122.647 2.231 . . . . 75.14 111.176 172.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 76' ' ' PRO . . . . . 0.401 ' HG2' HG23 ' C' ' 65' ' ' ILE . 48.1 Cg_exo -58.75 147.39 88.44 Favored 'Trans proline' 0 C--N 1.373 1.856 0 C-N-CA 122.645 2.23 . . . . 63.14 112.123 173.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 77' ' ' PRO . . . . . 0.401 ' HA ' ' HD3' ' C' ' 78' ' ' PRO . 50.5 Cg_exo -56.43 147.42 68.55 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 122.388 2.059 . . . . 51.51 112.113 171.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 78' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' C' ' 77' ' ' PRO . 43.3 Cg_exo -59.05 123.05 12.63 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.975 2.45 . . . . 74.44 112.618 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -71.91 170.68 18.25 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 122.872 2.382 . . . . 61.04 112.178 178.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 80' ' ' PRO . . . . . 0.49 ' HB2' ' HB1' ' C' ' 141' ' ' ALA . 82.4 Cg_exo -48.8 89.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.393 2.911 0 C-N-CA 123.468 2.779 . . . . 51.5 113.607 178.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 118.29 -40.1 2.4 Favored Glycine 0 C--O 1.225 -0.464 0 CA-C-N 114.651 -1.158 . . . . 75.2 110.255 177.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 126.5 -176.04 17.68 Favored Glycine 0 C--N 1.347 1.18 0 N-CA-C 111.249 -0.741 . . . . 74.45 111.249 -172.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -73.98 124.13 25.63 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.839 0.856 . . . . 70.14 111.152 -176.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 84' ' ' ASP . . . . . 0.662 ' HB3' HH21 ' C' ' 143' ' ' ARG . 6.9 p-10 -70.77 149.15 47.18 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.616 0.766 . . . . 63.13 110.506 177.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 85' ' ' PHE . . . . . 0.543 ' HB3' ' HB2' ' C' ' 88' ' ' PHE . 53.6 m-85 -148.37 74.86 1.3 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.641 0.777 . . . . 74.41 110.056 -179.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 16.5 m -54.98 86.57 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 125.131 1.373 . . . . 45.43 113.645 -175.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 85.49 13.45 70.45 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-N 115.686 -0.688 . . . . 74.33 112.829 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 88' ' ' PHE . . . . . 0.543 ' HB2' ' HB3' ' C' ' 85' ' ' PHE . 18.5 m-85 -115.34 108.15 16.16 Favored 'General case' 0 C--N 1.355 0.815 0 C-N-CA 123.135 0.574 . . . . 74.44 109.641 -174.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -74.46 88.13 2.1 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 108.042 -1.095 . . . . 72.23 108.042 177.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 90' ' ' VAL . . . . . 0.715 HG21 HD22 ' C' ' 105' ' ' LEU . 2.1 p -47.35 -40.65 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 CA-C-N 114.317 -1.311 . . . . 54.41 113.151 176.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 91' ' ' GLU . . . . . 0.443 ' HB2' ' ND2' ' C' ' 169' ' ' ASN . 33.7 tt0 -65.99 -21.3 66.4 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.863 0.865 . . . . 74.21 111.43 -175.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -86.42 -21.59 27.03 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 123.728 0.811 . . . . 75.53 111.239 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -77.24 -177.72 4.72 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.339 0.656 . . . . 72.45 112.338 -175.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 94' ' ' SER . . . . . 0.404 ' CB ' ' HZ2' ' C' ' 5' ' ' LYS . 92.4 p -78.14 173.31 12.38 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 113.307 0.854 . . . . 45.51 113.307 -168.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.21 -51.07 71.59 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 114.333 -1.303 . . . . 55.43 111.557 178.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -56.17 -40.51 74.0 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.984 0.914 . . . . 65.02 111.087 -175.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 97' ' ' PHE . . . . . 0.427 ' HE2' HG23 ' C' ' 90' ' ' VAL . 60.1 t80 -64.72 -50.36 67.22 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 114.519 -1.219 . . . . 64.25 110.04 177.113 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -80.06 2.69 22.89 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 115.213 -0.903 . . . . 51.52 112.56 -177.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -100.07 -45.12 5.77 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.568 0.747 . . . . 74.43 110.507 170.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 13.2 tp -62.74 -58.29 7.96 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.242 0.617 . . . . 73.23 110.127 176.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -81.87 -11.36 58.97 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 115.71 -0.677 . . . . 73.25 111.408 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -37.38 -63.18 0.84 Allowed Glycine 0 C--N 1.358 1.767 0 C-N-CA 124.807 1.194 . . . . 54.11 115.679 -177.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_exo -46.21 -34.13 13.08 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 123.841 3.028 . . . . 62.02 115.282 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -119.05 27.88 6.87 Favored Glycine 0 C--N 1.356 1.647 0 CA-C-O 119.318 -0.712 . . . . 43.23 113.823 -175.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 105' ' ' LEU . . . . . 0.715 HD22 HG21 ' C' ' 90' ' ' VAL . 29.0 mt . . . . . 0 N--CA 1.482 1.17 0 CA-C-N 117.761 0.78 . . . . 73.03 112.706 176.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 116' ' ' GLY . . . . . 0.514 ' HA2' ' HA3' ' C' ' 168' ' ' GLY . . . . . . . . 0 CA--C 1.516 0.121 0 N-CA-C 113.902 0.321 . . . . 45.25 113.902 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.09 -176.82 2.99 Favored 'General case' 0 C--O 1.26 1.621 0 C-N-CA 124.301 1.041 . . . . 64.44 108.907 168.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 118' ' ' ASP . . . . . 0.471 ' HA ' ' O ' ' C' ' 173' ' ' ASP . 4.8 p-10 -60.62 152.99 24.9 Favored 'General case' 0 C--O 1.244 0.764 0 CA-C-N 115.127 -0.942 . . . . 75.42 112.828 -171.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 119' ' ' LEU . . . . . 0.469 ' O ' HD12 ' C' ' 174' ' ' LEU . 20.0 tp -110.85 118.28 35.71 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 106.57 -1.641 . . . . 75.21 106.57 173.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 21.8 ttm180 -112.37 106.03 14.45 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 121.207 0.527 . . . . 72.31 110.761 -167.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 121' ' ' ALA . . . . . . . . . . . . . . . -124.13 117.28 24.3 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.445 -0.798 . . . . 63.21 109.314 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -82.14 125.44 30.89 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 108.478 -0.934 . . . . 73.22 108.478 170.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 123' ' ' LEU . . . . . 0.434 HD13 HD22 ' C' ' 176' ' ' LEU . 2.2 pt? -130.33 115.3 17.34 Favored Pre-proline 0 CA--C 1.554 1.134 0 C-N-CA 123.03 0.532 . . . . 73.3 110.461 -171.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . 0.461 ' HA ' ' O ' ' C' ' 179' ' ' ARG . 53.6 Cg_exo -62.78 115.69 3.08 Favored 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 123.301 2.667 . . . . 72.51 113.707 170.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 125' ' ' LEU . . . . . 0.592 HD23 HG11 ' C' ' 153' ' ' VAL . 19.0 tp -131.32 166.52 21.05 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 106.308 -1.738 . . . . 74.03 106.308 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 126' ' ' THR . . . . . 0.443 ' H ' ' HB2' ' C' ' 129' ' ' GLU . 11.7 t -129.54 176.03 8.31 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 120.833 1.651 . . . . 61.53 112.1 175.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 127' ' ' LEU . . . . . 0.483 HD23 HD13 ' C' ' 180' ' ' LEU . 7.4 mt -60.79 -41.67 96.07 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.003 1.721 . . . . 62.25 110.069 -177.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -65.02 -43.63 91.83 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 113.867 -1.515 . . . . 75.24 110.716 176.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 129' ' ' GLU . . . . . 0.443 ' HB2' ' H ' ' C' ' 126' ' ' THR . 38.8 mm-40 -72.59 -21.17 61.17 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-N 115.47 -0.786 . . . . 73.53 111.224 -179.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 130' ' ' ALA . . . . . 0.555 ' HB2' HG12 ' C' ' 153' ' ' VAL . . . -78.57 -46.25 19.84 Favored 'General case' 0 C--O 1.22 -0.456 0 O-C-N 124.139 0.899 . . . . 64.34 109.194 174.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 131' ' ' PHE . . . . . 0.623 ' HB2' HD13 ' C' ' 215' ' ' LEU . 88.1 t80 -50.68 -42.99 57.42 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.709 1.204 . . . . 75.55 110.796 173.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 132' ' ' HIS . . . . . . . . . . . . . 28.0 m170 -67.44 -67.43 0.46 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.187 -0.915 . . . . 60.22 108.754 175.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 50.51 -139.28 22.04 Favored Glycine 0 C--N 1.358 1.791 0 O-C-N 124.198 0.936 . . . . 65.31 113.662 175.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.86 -152.97 37.58 Favored Glycine 0 C--N 1.342 0.913 0 O-C-N 123.958 0.446 . . . . 53.24 113.27 177.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -79.15 94.4 5.37 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 108.554 -0.906 . . . . 71.2 108.554 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 136' ' ' ARG . . . . . . . . . . . . . 28.1 mmm-85 -103.39 125.35 49.95 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.778 0.831 . . . . 72.12 109.382 -177.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 137' ' ' VAL . . . . . 0.635 HG23 ' HB1' ' B' ' 180' ' ' ALA . 31.6 m -77.43 135.96 25.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 N-CA-C 109.361 -0.607 . . . . 71.12 109.361 174.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 138' ' ' VAL . . . . . . . . . . . . . 7.3 p -136.28 126.42 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.607 0.763 . . . . 72.14 109.35 -176.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 139' ' ' GLU . . . . . 0.496 ' HG3' ' HB2' ' C' ' 144' ' ' ARG . 1.6 mp0 -86.72 75.81 9.6 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.543 -0.539 . . . . 74.31 109.543 -176.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 140' ' ' VAL . . . . . . . . . . . . . 87.0 t -86.04 113.02 23.41 Favored 'Isoleucine or valine' 0 C--O 1.246 0.891 0 N-CA-C 108.396 -0.964 . . . . 63.22 108.396 -178.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 141' ' ' ALA . . . . . 0.49 ' HB1' ' HB2' ' C' ' 80' ' ' PRO . . . 62.78 37.01 12.75 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 124.565 1.165 . . . . 15.23 110.914 176.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 101.55 -34.81 5.36 Favored Glycine 0 C--N 1.351 1.363 0 CA-C-N 114.856 -1.065 . . . . 45.25 112.803 177.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 143' ' ' ARG . . . . . 0.662 HH21 ' HB3' ' C' ' 84' ' ' ASP . 0.2 OUTLIER -92.4 118.96 31.47 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 117.179 0.489 . . . . 73.04 111.324 -171.508 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 144' ' ' ARG . . . . . 0.523 ' HG3' ' HB ' ' C' ' 137' ' ' VAL . 35.4 ttm180 -73.92 115.95 13.97 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.194 -0.912 . . . . 71.51 109.638 171.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 145' ' ' VAL . . . . . . . . . . . . . 4.2 p -131.51 128.87 61.46 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 C-N-CA 124.049 0.94 . . . . 75.03 109.775 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 36.1 t -75.45 93.02 2.9 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 123.977 0.911 . . . . 54.21 110.582 -177.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 8.8 p -88.15 119.12 35.04 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 N-CA-C 109.241 -0.652 . . . . 72.53 109.241 175.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -75.53 104.33 6.04 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 109.513 -0.551 . . . . 74.22 109.513 174.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 149' ' ' ILE . . . . . 0.422 HG21 HG21 ' C' ' 159' ' ' ILE . 36.0 pt -120.29 95.46 49.07 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 107.133 -1.432 . . . . 71.41 107.133 165.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -49.78 161.14 0.96 Allowed 'Trans proline' 0 C--N 1.395 2.994 0 C-N-CA 124.271 3.314 . . . . 61.44 114.205 -174.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -43.56 94.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.389 2.7 0 C-N-CA 123.345 2.697 . . . . 73.2 112.247 174.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 152' ' ' GLY . . . . . 0.449 ' HA2' ' CD2' ' C' ' 240' ' ' PHE . . . 151.44 132.76 1.93 Allowed Glycine 0 C--N 1.348 1.222 0 CA-C-N 115.073 -0.967 . . . . 54.32 113.637 -174.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 153' ' ' VAL . . . . . 0.612 HG22 HG11 ' C' ' 178' ' ' VAL . 0.6 OUTLIER -153.59 160.23 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.028 0 CA-C-N 116.745 0.273 . . . . 71.13 110.948 169.696 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 154' ' ' ARG . . . . . 0.457 ' HG2' ' HB3' ' C' ' 188' ' ' LEU . 22.1 mtp180 -121.36 123.49 42.26 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.206 1.002 . . . . 75.32 110.447 -170.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 155' ' ' GLU . . . . . 0.47 ' HB2' HD12 ' C' ' 180' ' ' LEU . 13.3 tp10 -51.18 124.74 12.26 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.439 0.696 . . . . 74.51 112.241 171.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 76.28 12.39 84.23 Favored Glycine 0 C--N 1.348 1.241 0 O-C-N 124.394 1.059 . . . . 64.51 114.008 170.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 157' ' ' SER . . . . . . . . . . . . . 55.4 m -101.94 156.1 17.74 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.202 0.525 . . . . 75.43 110.829 -178.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 158' ' ' VAL . . . . . 0.643 HG12 HG22 ' C' ' 177' ' ' VAL . 27.1 m -96.56 111.71 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 CA-C-N 115.103 -0.953 . . . . 64.44 109.161 175.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 159' ' ' ILE . . . . . 0.714 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 57.1 mt -71.39 94.95 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 107.903 -1.147 . . . . 52.25 107.903 170.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 12.1 ttp180 -86.87 100.75 12.78 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 109.336 -0.616 . . . . 72.21 109.336 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 161' ' ' VAL . . . . . 0.601 HG13 ' HB3' ' C' ' 174' ' ' LEU . 2.1 p -101.03 102.46 20.19 Favored Pre-proline 0 CA--C 1.553 1.076 0 N-CA-C 108.866 -0.79 . . . . 75.24 108.866 172.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -63.76 136.34 53.07 Favored 'Trans proline' 0 C--N 1.386 2.52 0 C-N-CA 122.921 2.414 . . . . 63.42 112.855 -175.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 163' ' ' GLY . . . . . 0.418 ' O ' ' HB2' ' C' ' 171' ' ' PRO . . . 98.29 -6.82 61.69 Favored Glycine 0 C--N 1.341 0.847 0 CA-C-N 115.317 -0.856 . . . . 53.31 113.512 177.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 164' ' ' MET . . . . . . . . . . . . . 82.7 mtp -103.26 30.68 4.74 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 118.016 0.908 . . . . 73.35 110.883 178.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 165' ' ' GLY . . . . . 0.499 ' HA2' ' O ' ' C' ' 173' ' ' ASP . . . -57.34 162.8 7.73 Favored Glycine 0 C--N 1.351 1.393 0 CA-C-N 114.932 -1.031 . . . . 64.24 114.82 177.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . -117.85 -59.55 0.29 Allowed Glycine 0 C--N 1.346 1.101 0 C-N-CA 121.532 -0.366 . . . . 75.44 112.764 -170.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 167' ' ' GLN . . . . . 0.41 ' O ' ' HA2' ' C' ' 116' ' ' GLY . 29.9 mm-40 -88.46 99.07 12.0 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 110.164 -0.31 . . . . 64.31 110.164 -173.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 168' ' ' GLY . . . . . 0.514 ' HA3' ' HA2' ' C' ' 116' ' ' GLY . . . 123.04 147.96 7.5 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-O 119.564 -0.575 . . . . 13.44 112.9 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 169' ' ' ASN . . . . . 0.465 ' OD1' ' HB3' ' C' ' 105' ' ' LEU . 7.3 t30 -61.04 -59.41 13.91 Favored Pre-proline 0 N--CA 1.491 1.607 0 CA-C-O 117.621 -1.18 . . . . 62.44 113.781 -169.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 170' ' ' PRO . . . . . 0.453 ' HD3' ' HB3' ' C' ' 169' ' ' ASN . 6.6 Cg_exo -75.12 106.08 2.21 Favored 'Trans proline' 0 C--N 1.39 2.76 0 C-N-CA 122.01 1.807 . . . . 51.41 109.792 170.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 171' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' C' ' 170' ' ' PRO . 17.0 Cg_exo -66.58 126.02 14.79 Favored 'Trans proline' 0 C--N 1.372 1.798 0 C-N-CA 122.75 2.3 . . . . 74.02 113.229 -167.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -71.37 -74.94 0.68 Allowed Glycine 0 C--N 1.355 1.619 0 O-C-N 123.797 0.686 . . . . 74.42 113.464 -177.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 173' ' ' ASP . . . . . 0.499 ' O ' ' HA2' ' C' ' 165' ' ' GLY . 4.6 p-10 -164.05 166.64 21.21 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.04 0.936 . . . . 74.51 109.746 175.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 174' ' ' LEU . . . . . 0.601 ' HB3' HG13 ' C' ' 161' ' ' VAL . 31.6 tp -113.48 113.76 25.6 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.901 -0.778 . . . . 75.22 108.901 176.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 175' ' ' LEU . . . . . 0.469 HD22 ' HB ' ' C' ' 158' ' ' VAL . 70.4 mt -87.72 93.54 9.47 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 123.882 0.873 . . . . 71.32 109.879 170.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 176' ' ' LEU . . . . . 0.714 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 82.3 mt -82.92 100.44 10.4 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 108.989 -0.745 . . . . 43.02 108.989 170.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 177' ' ' VAL . . . . . 0.643 HG22 HG12 ' C' ' 158' ' ' VAL . 41.4 t -81.49 93.35 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 108.49 -0.93 . . . . 74.43 108.49 -178.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 178' ' ' VAL . . . . . 0.612 HG11 HG22 ' C' ' 153' ' ' VAL . 2.1 p -76.77 125.29 36.43 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 CA-C-N 115.329 -0.85 . . . . 74.01 110.996 -172.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 179' ' ' ARG . . . . . 0.461 ' O ' ' HA ' ' C' ' 124' ' ' PRO . 34.8 mmt180 -120.29 112.9 19.62 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 114.355 -1.293 . . . . 72.33 108.308 178.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 180' ' ' LEU . . . . . 0.545 ' HA ' ' O ' ' C' ' 125' ' ' LEU . 80.5 mt -69.48 143.32 53.54 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 116.561 -0.291 . . . . 70.51 111.579 -178.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 181' ' ' LEU . . . . . . . . . . . . . 36.6 mt -60.94 156.49 47.07 Favored Pre-proline 0 N--CA 1.482 1.17 0 CA-C-O 117.731 -1.128 . . . . 74.2 109.92 -179.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -49.02 79.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.395 2.987 0 C-N-CA 124.205 3.27 . . . . 64.12 115.516 -174.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 183' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 171.87 76.78 0.04 OUTLIER Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 128.456 2.702 . . . . 62.13 106.82 172.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 184' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.22 68.86 4.99 Favored 'Trans proline' 0 C--N 1.38 2.19 0 C-N-CA 123.686 2.924 . . . . 71.54 111.533 178.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 185' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 13.1 t -90.48 -41.16 13.32 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.702 0 N-CA-C 109.326 -0.62 . . . . 72.23 109.326 -168.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 186' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -122.25 111.03 16.44 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 120.9 0.381 . . . . 61.44 111.718 -172.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 187' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -95.98 112.9 24.51 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 106.562 -1.644 . . . . 75.14 106.562 170.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 188' ' ' LEU . . . . . 0.457 ' HB3' ' HG2' ' C' ' 154' ' ' ARG . 62.0 tp -80.75 144.8 31.88 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-O 121.272 0.558 . . . . 74.14 112.465 -175.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -136.9 101.52 4.6 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.634 1.574 . . . . 71.33 107.124 169.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 72.41 -97.27 0.77 Allowed Glycine 0 C--N 1.349 1.263 0 N-CA-C 112.084 -0.406 . . . . 74.2 112.084 -175.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 191' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -119.86 -18.57 8.21 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 124.323 1.049 . . . . 60.21 110.321 175.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -94.53 140.94 29.18 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.168 0.987 . . . . 65.13 110.467 -172.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 193' ' ' LEU . . . . . 0.55 HD21 ' CE2' ' C' ' 240' ' ' PHE . 88.5 mt -100.25 170.18 8.62 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 113.119 0.785 . . . . 52.2 113.119 -169.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 194' ' ' TYR . . . . . 0.423 ' HA ' ' O ' ' C' ' 250' ' ' TYR . 52.1 t80 -127.97 108.42 10.66 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.787 0.835 . . . . 75.43 110.197 167.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 195' ' ' ALA . . . . . 0.522 ' HA ' ' O ' ' C' ' 185' ' ' VAL . . . -110.68 -175.85 2.82 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.823 0.849 . . . . 65.11 109.125 168.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 17.9 m -121.8 132.15 54.44 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 108.432 -0.951 . . . . 51.32 108.432 167.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 197' ' ' LEU . . . . . 0.476 HD22 HD12 ' C' ' 233' ' ' LEU . 53.7 tp -102.1 145.68 29.01 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.459 0.704 . . . . 73.5 110.444 -177.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -116.61 101.61 8.75 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.274 -1.01 . . . . 44.52 108.274 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 199' ' ' VAL . . . . . . . . . . . . . 39.5 t -115.13 126.29 27.98 Favored Pre-proline 0 N--CA 1.476 0.872 0 N-CA-C 108.826 -0.805 . . . . 61.21 108.826 177.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 200' ' ' PRO . . . . . 0.635 ' HG2' HD12 ' C' ' 203' ' ' ILE . 24.0 Cg_exo -60.73 150.01 84.81 Favored 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 122.588 2.192 . . . . 71.34 112.204 168.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 201' ' ' ALA . . . . . 0.454 ' O ' HG23 ' C' ' 205' ' ' VAL . . . -51.84 -57.92 13.02 Favored Pre-proline 0 CA--C 1.56 1.358 0 C-N-CA 124.756 1.222 . . . . 74.35 113.409 177.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 202' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -71.46 -30.68 14.9 Favored 'Trans proline' 0 C--N 1.389 2.71 0 CA-C-N 121.585 1.602 . . . . 63.15 112.544 -174.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 203' ' ' ILE . . . . . 0.635 HD12 ' HG2' ' C' ' 200' ' ' PRO . 20.4 mt -64.43 -40.48 89.21 Favored 'Isoleucine or valine' 0 C--N 1.361 1.085 0 N-CA-C 109.307 -0.627 . . . . 63.4 109.307 172.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 204' ' ' ALA . . . . . 0.534 ' HB1' ' HB ' ' C' ' 227' ' ' THR . . . -62.06 -39.06 91.1 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.24 -0.891 . . . . 75.02 110.816 176.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 205' ' ' VAL . . . . . 0.454 HG23 ' O ' ' C' ' 201' ' ' ALA . 53.4 t -74.06 -48.86 36.27 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 N-CA-C 114.027 1.121 . . . . 63.41 114.027 -173.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 206' ' ' VAL . . . . . . . . . . . . . 9.0 p -92.73 -33.55 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 CA-C-N 119.551 1.069 . . . . 52.12 111.453 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 105.58 121.69 4.9 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.399 -0.68 . . . . 63.21 111.399 -173.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 208' ' ' GLY . . . . . 0.405 ' H ' ' HB ' ' C' ' 223' ' ' VAL . . . -145.41 -136.22 2.95 Favored Glycine 0 C--N 1.339 0.709 0 N-CA-C 110.833 -0.907 . . . . 51.32 110.833 178.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 209' ' ' LYS . . . . . 0.425 ' HA ' ' O ' ' C' ' 221' ' ' VAL . 20.2 ttpp -151.7 118.48 5.78 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 117.523 0.661 . . . . 72.12 109.903 175.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 210' ' ' VAL . . . . . . . . . . . . . 19.1 m -111.35 170.0 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 124.829 1.252 . . . . 62.05 109.671 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 211' ' ' ARG . . . . . . . . . . . . . 8.1 tmm_? -103.25 125.35 49.87 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 120.922 0.391 . . . . 72.44 110.909 -179.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 212' ' ' ALA . . . . . 0.463 ' HB3' HG13 ' C' ' 219' ' ' VAL . . . -105.72 152.36 23.27 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.849 1.26 . . . . 74.43 109.728 168.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 213' ' ' MET . . . . . . . . . . . . . 17.8 mmm -85.15 142.06 29.74 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.439 0.695 . . . . 63.12 110.017 174.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 214' ' ' THR . . . . . 0.523 HG21 ' HD3' ' C' ' 238' ' ' LYS . 0.2 OUTLIER -141.23 175.05 9.96 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.114 0.566 . . . . 54.24 111.204 172.619 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 215' ' ' LEU . . . . . 0.623 HD13 ' HB2' ' C' ' 131' ' ' PHE . 23.9 mt -61.92 -48.46 80.33 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.246 1.018 . . . . 44.41 111.394 -173.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -91.21 13.62 16.61 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 114.399 -1.273 . . . . 71.0 111.416 -176.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 124.39 -171.21 16.56 Favored Glycine 0 C--N 1.351 1.392 0 N-CA-C 111.824 -0.51 . . . . 64.11 111.824 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -81.7 129.55 6.44 Favored 'Trans proline' 0 CA--C 1.558 1.719 0 C-N-CA 122.675 2.25 . . . . 52.13 113.848 -178.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 219' ' ' VAL . . . . . 0.463 HG13 ' HB3' ' C' ' 212' ' ' ALA . 5.1 p -97.5 140.32 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 N-CA-C 108.361 -0.978 . . . . 52.53 108.361 172.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 220' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -98.44 107.98 20.56 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 118.583 0.629 . . . . 72.32 109.651 179.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 221' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' C' ' 209' ' ' LYS . 37.9 t -69.8 116.04 10.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 126.058 1.743 . . . . 74.03 112.708 -179.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -76.01 113.67 13.78 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.493 0.717 . . . . 73.3 109.146 168.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 223' ' ' VAL . . . . . 0.405 ' HB ' ' H ' ' C' ' 208' ' ' GLY . 47.0 t -92.17 138.08 24.61 Favored Pre-proline 0 CA--C 1.561 1.371 0 C-N-CA 124.136 0.975 . . . . 73.11 110.646 -174.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 224' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -86.22 164.19 9.86 Favored 'Trans proline' 0 C--N 1.387 2.6 0 C-N-CA 123.377 2.718 . . . . 54.33 112.103 173.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.07 128.48 21.87 Favored 'Trans proline' 0 C--N 1.377 2.079 0 C-N-CA 122.751 2.3 . . . . 74.0 113.705 177.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 226' ' ' ARG . . . . . 0.452 ' HA ' ' HA ' ' C' ' 205' ' ' VAL . 0.0 OUTLIER 59.43 89.09 0.07 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.814 2.045 . . . . 70.15 110.988 179.886 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 227' ' ' THR . . . . . 0.534 ' HB ' ' HB1' ' C' ' 204' ' ' ALA . 24.7 m -106.63 135.68 47.73 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 113.789 -1.551 . . . . 70.3 110.221 178.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 228' ' ' GLN . . . . . 0.44 ' H ' ' NE ' ' C' ' 231' ' ' ARG . 3.9 tp-100 -110.35 142.83 41.47 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 124.291 1.036 . . . . 74.32 110.479 -175.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -71.23 137.46 48.67 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.677 -0.86 . . . . 62.12 108.677 174.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 100.99 0.68 54.97 Favored Glycine 0 CA--C 1.521 0.411 0 CA-C-N 116.08 -0.509 . . . . 62.04 112.286 -170.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 231' ' ' ARG . . . . . 0.509 ' HD2' HG23 ' C' ' 227' ' ' THR . 86.2 mtt180 -76.08 172.4 12.85 Favored 'General case' 0 C--N 1.359 1.018 0 CA-C-N 117.115 0.458 . . . . 74.12 110.142 164.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 232' ' ' LYS . . . . . 0.65 ' HD3' ' HB3' ' C' ' 250' ' ' TYR . 4.0 ttmp? -148.07 109.4 4.35 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.394 0.616 . . . . 71.45 110.164 175.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 233' ' ' LEU . . . . . 0.607 ' O ' ' HA ' ' C' ' 250' ' ' TYR . 0.5 OUTLIER -72.14 144.75 48.5 Favored 'General case' 0 C--O 1.209 -1.075 0 C-N-CA 125.781 1.632 . . . . 74.21 109.429 -178.02 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 10.1 ptt180 -118.37 90.48 3.34 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 124.912 1.285 . . . . 72.34 110.108 173.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 235' ' ' LEU . . . . . 0.55 ' HB2' ' HB3' ' C' ' 249' ' ' LEU . 66.4 mt -77.79 116.41 18.29 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.509 0.723 . . . . 73.43 111.057 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -63.02 117.03 5.88 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.089 0.956 . . . . 71.55 112.65 -176.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 77.78 11.79 85.08 Favored Glycine 0 C--N 1.351 1.399 0 CA-C-N 115.223 -0.899 . . . . 71.42 114.688 175.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 238' ' ' LYS . . . . . 0.527 ' NZ ' ' HA ' ' C' ' 238' ' ' LYS . 0.1 OUTLIER -99.96 8.53 43.99 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.008 0.523 . . . . 72.03 111.053 178.447 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -86.44 -151.25 18.26 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 110.852 -0.899 . . . . 31.21 110.852 164.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 240' ' ' PHE . . . . . 0.55 ' CE2' HD21 ' C' ' 193' ' ' LEU . 48.3 m-85 -90.57 137.02 27.46 Favored Pre-proline 0 N--CA 1.476 0.856 0 CA-C-N 117.036 0.418 . . . . 75.14 110.65 175.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 241' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -57.39 120.98 9.25 Favored 'Trans proline' 0 C--N 1.383 2.382 0 C-N-CA 123.254 2.636 . . . . 70.21 111.353 175.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 242' ' ' GLY . . . . . 0.407 ' H ' ' HA ' ' C' ' 246' ' ' ARG . . . -100.28 157.77 19.48 Favored Glycine 0 C--N 1.348 1.246 0 CA-C-O 119.612 -0.549 . . . . 70.14 113.096 -173.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -65.62 -21.98 58.61 Favored 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 123.036 2.491 . . . . 71.42 113.61 -176.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -132.06 25.56 4.58 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.778 0.831 . . . . 71.42 110.57 178.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 164.25 -137.78 4.92 Favored Glycine 0 C--N 1.346 1.124 0 N-CA-C 111.549 -0.62 . . . . 51.32 111.549 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 246' ' ' ARG . . . . . 0.407 ' HA ' ' H ' ' C' ' 242' ' ' GLY . 0.0 OUTLIER -157.12 163.07 39.33 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.037 0.935 . . . . 61.31 109.664 173.546 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -86.87 170.53 41.84 Favored Glycine 0 C--O 1.242 0.613 0 CA-C-N 116.088 -0.506 . . . . 63.23 111.986 178.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -124.32 136.42 54.09 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 107.763 -1.199 . . . . 73.54 107.763 -178.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 249' ' ' LEU . . . . . 0.55 ' HB3' ' HB2' ' C' ' 235' ' ' LEU . 19.4 tp -81.57 117.86 22.3 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.18 0.592 . . . . 74.23 109.877 -176.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 250' ' ' TYR . . . . . 0.65 ' HB3' ' HD3' ' C' ' 232' ' ' LYS . 19.4 m-30 -99.68 101.76 13.05 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 122.799 0.439 . . . . 71.43 109.915 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 251' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' C' ' 232' ' ' LYS . 2.0 mp -101.44 124.4 47.05 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 119.375 -0.345 . . . . 64.53 110.303 -175.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -70.97 109.31 5.0 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.544 -0.91 . . . . 73.41 108.544 173.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 253' ' ' VAL . . . . . 0.424 HG21 ' CZ3' ' B' ' 242' ' ' TRP . 57.0 t -77.52 128.96 37.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 123.427 0.691 . . . . 73.5 111.655 -169.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 254' ' ' ARG . . . . . . . . . . . . . 20.9 mtm180 -108.64 147.26 32.13 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.125 0.97 . . . . 74.13 109.568 170.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 255' ' ' ILE . . . . . 0.471 HD11 HG22 ' C' ' 227' ' ' THR . 36.5 mm -107.05 125.56 63.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 C-N-CA 124.452 1.101 . . . . 75.24 108.065 171.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 256' ' ' THR . . . . . . . . . . . . . 60.2 p -122.94 -175.59 3.21 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.855 0.862 . . . . 53.32 111.69 -171.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 257' ' ' ILE . . . . . 0.544 ' HB ' ' HD2' ' C' ' 258' ' ' PRO . 44.9 pt -135.48 161.58 62.32 Favored Pre-proline 0 CA--C 1.571 1.756 0 C-N-CA 123.53 0.732 . . . . 64.54 111.233 -179.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 258' ' ' PRO . . . . . 0.544 ' HD2' ' HB ' ' C' ' 257' ' ' ILE . 61.3 Cg_endo -69.43 11.26 0.37 Allowed 'Trans proline' 0 C--N 1.395 3.021 0 C-N-CA 123.733 2.956 . . . . 73.21 116.696 -170.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 259' ' ' GLU . . . . . 0.572 ' O ' ' HD2' ' A' ' 226' ' ' ARG . 5.5 mm-40 60.85 -84.29 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.607 0.763 . . . . 72.3 109.775 -170.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.47 172.02 8.66 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.45 0.7 . . . . 73.41 110.771 175.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 261' ' ' LEU . . . . . 0.47 ' HB2' HH12 ' A' ' 226' ' ' ARG . 11.3 mt -149.47 163.33 38.08 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 121.604 0.716 . . . . 71.21 111.919 176.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 1.2 p -104.36 147.62 34.66 Favored Pre-proline 0 CA--C 1.562 1.404 0 CA-C-N 113.494 -1.685 . . . . 61.23 108.997 171.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -45.51 -48.8 11.37 Favored 'Trans proline' 0 C--N 1.39 2.758 0 C-N-CA 125.038 3.825 . . . . 74.2 115.868 -166.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -64.62 -51.2 63.91 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-O 121.303 0.573 . . . . 71.04 111.242 -173.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 11.4 mp0 -60.98 -45.53 94.4 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 114.502 -1.226 . . . . 65.11 109.44 -177.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 266' ' ' GLU . . . . . 0.433 ' HG2' ' HE3' ' C' ' 270' ' ' LYS . 42.4 tt0 -61.42 -37.44 83.5 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 114.934 -1.03 . . . . 64.21 111.076 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -63.71 -38.55 91.54 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.591 0.756 . . . . 70.32 111.52 177.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 268' ' ' LEU . . . . . . . . . . . . . 11.1 mp -62.23 -43.38 98.96 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 123.242 0.339 . . . . 52.44 110.72 172.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 92.9 m95 -58.34 -36.11 72.94 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 122.904 0.482 . . . . 61.11 111.104 174.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 270' ' ' LYS . . . . . 0.433 ' HE3' ' HG2' ' C' ' 266' ' ' GLU . 99.5 mttt -70.75 -39.35 73.32 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.543 0.737 . . . . 75.43 111.442 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.64 -38.35 89.11 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.954 0.502 . . . . 75.33 110.611 178.009 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 88.8 mt -73.49 -31.31 63.68 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.618 0.767 . . . . 74.33 110.891 176.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -66.24 -40.93 90.57 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.295 0.638 . . . . 34.13 110.021 175.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -69.3 -37.84 77.99 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.13 0.972 . . . . 63.21 110.97 178.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -62.85 -30.76 71.75 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.298 0.639 . . . . 70.04 110.43 172.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 276' ' ' TYR . . . . . 0.471 ' HB3' HD11 ' A' ' 203' ' ' ILE . 1.6 m-85 -75.25 -38.04 60.73 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.705 0.802 . . . . 75.52 111.492 173.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -69.56 -24.26 63.68 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 122.456 0.302 . . . . 44.24 110.254 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -63.45 -20.1 65.28 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.922 0.889 . . . . 55.2 112.176 173.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 279' ' ' ARG . . . . . 0.459 ' HD3' ' HA ' ' C' ' 276' ' ' TYR . 14.9 mtp-105 -75.22 -9.64 58.74 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.251 0.62 . . . . 71.52 111.8 176.098 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.151 0 CA-C-O 118.252 -0.88 . . . . 75.14 108.673 174.149 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt . . . . . 0 N--CA 1.472 0.672 0 N-CA-C 113.357 0.873 . . . . 62.43 113.357 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.527 ' HB3' HD11 ' A' ' 10' ' ' ILE . 14.3 mmmm -63.4 110.86 2.07 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.29 -1.004 . . . . 74.32 108.29 170.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -73.39 93.64 1.97 Allowed 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 107.638 -1.245 . . . . 61.41 107.638 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.42 ' CD1' ' HA ' ' A' ' 53' ' ' ALA . 62.4 m-85 -63.82 -30.13 71.26 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 114.88 -1.055 . . . . 73.34 112.291 -168.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -66.4 -44.47 82.92 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 116.215 -0.448 . . . . 73.33 109.961 173.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.47 -37.58 87.85 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.943 0.497 . . . . 60.32 111.421 178.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.527 HD11 ' HB3' ' A' ' 5' ' ' LYS . 72.9 mt -64.13 -36.22 76.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 123.452 0.701 . . . . 74.23 110.462 176.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.0 mt -81.05 -10.36 59.7 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 112.331 0.493 . . . . 51.33 112.331 173.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.02 32.4 60.71 Favored Glycine 0 C--N 1.35 1.352 0 N-CA-C 113.888 0.315 . . . . 53.33 113.888 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.4 m -126.07 155.21 73.77 Favored Pre-proline 0 N--CA 1.482 1.148 0 C-N-CA 124.346 1.058 . . . . 71.43 110.377 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.2 158.98 55.16 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 122.491 2.128 . . . . 50.12 112.335 173.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 35.3 mtm180 -82.02 64.37 6.67 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.068 0.947 . . . . 75.43 110.347 -177.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -179.7 -14.81 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.257 1.423 . . . . 64.11 109.032 -175.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.52 131.15 29.1 Favored 'General case' 0 C--N 1.36 1.061 0 C-N-CA 123.604 0.762 . . . . 64.31 111.325 176.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 58.1 p -63.37 164.6 8.85 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 123.867 0.729 . . . . 71.11 111.148 -175.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 47.6 tp60 -61.32 -27.39 68.45 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.376 0.671 . . . . 64.21 111.538 -176.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -67.97 -46.29 71.78 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.47 -0.786 . . . . 72.43 109.771 175.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -67.24 -35.96 80.65 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.209 0.604 . . . . 64.03 111.012 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.449 HG21 ' HB3' ' A' ' 57' ' ' LEU . 70.9 mt -66.06 -47.13 86.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.361 1.064 . . . . 73.31 110.586 178.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 51.4 tttt -55.65 -48.43 75.02 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.597 1.159 . . . . 71.24 110.533 173.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 63.9 mtt180 -75.94 -15.97 60.08 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 115.805 -0.634 . . . . 54.12 111.763 -177.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -77.26 -40.13 45.8 Favored 'General case' 0 C--O 1.251 1.17 0 C-N-CA 123.356 0.663 . . . . 64.0 110.262 173.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.546 ' HD1' HG22 ' A' ' 50' ' ' ILE . 64.6 t80 -55.45 -56.79 16.09 Favored 'General case' 0 C--N 1.352 0.702 0 CA-C-N 114.83 -1.077 . . . . 73.1 108.984 169.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.425 ' O ' ' HG3' ' A' ' 31' ' ' ARG . 55.5 mtpt -60.7 -38.98 86.84 Favored 'General case' 0 N--CA 1.483 1.208 0 O-C-N 124.248 0.967 . . . . 74.22 111.701 -177.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 45.6 ttt180 -52.04 -60.23 3.44 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 125.122 1.369 . . . . 71.15 110.913 175.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 95.9 mt -79.22 -13.5 59.65 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 114.876 -1.056 . . . . 74.11 111.314 -178.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.89 -14.72 46.93 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.309 0.643 . . . . 63.3 110.934 175.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.425 ' HG3' ' O ' ' A' ' 27' ' ' LYS . 82.7 mtm180 -89.63 -39.55 13.16 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.248 0.619 . . . . 72.33 109.734 168.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -67.28 -59.73 3.18 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.272 0.558 . . . . 63.33 111.447 178.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.689 ' HD2' HD11 ' A' ' 50' ' ' ILE . 21.3 m-85 -91.0 25.83 2.31 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.958 0.903 . . . . 63.25 110.718 -178.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 40.1 t60 -62.61 108.57 1.73 Allowed Pre-proline 0 C--N 1.358 0.955 0 CA-C-O 118.439 -0.791 . . . . 63.41 110.215 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.466 ' HB3' ' HG2' ' A' ' 44' ' ' GLU . 16.5 Cg_endo -53.64 -40.17 80.41 Favored 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 123.281 2.654 . . . . 74.13 113.447 -167.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -60.65 -40.7 93.01 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.553 0.741 . . . . 72.45 112.551 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 64.8 t -89.8 -30.08 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 CA-C-O 121.184 0.516 . . . . 65.53 110.28 -175.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 53.6 t-20 -108.44 97.29 6.98 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 124.397 1.079 . . . . 61.35 108.845 -172.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -81.1 71.11 8.07 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.618 0.767 . . . . 73.11 109.795 -177.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 62.2 m -152.07 112.55 2.88 Favored Pre-proline 0 N--CA 1.476 0.86 0 C-N-CA 123.88 0.872 . . . . 54.41 109.156 178.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -51.31 -36.02 55.76 Favored 'Trans proline' 0 C--N 1.388 2.633 0 C-N-CA 123.347 2.698 . . . . 72.23 111.662 176.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -47.34 -51.15 20.3 Favored 'General case' 0 C--N 1.35 0.596 0 C-N-CA 124.993 1.317 . . . . 64.43 111.339 174.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.79 -20.05 61.23 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.004 -0.998 . . . . 72.14 111.307 -175.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.466 ' HG2' ' HB3' ' A' ' 35' ' ' PRO . 40.4 mt-10 -86.03 -33.34 21.05 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.594 0.758 . . . . 62.01 110.777 -177.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -70.62 -42.7 70.57 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.831 -0.803 . . . . 62.44 108.831 174.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.528 ' O ' HG13 ' A' ' 50' ' ' ILE . 13.2 mptt -65.55 -32.87 74.7 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 114.76 -1.109 . . . . 74.03 110.685 171.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.686 ' HA ' HD12 ' A' ' 50' ' ' ILE . 86.9 t80 -62.86 -40.3 97.06 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.402 0.681 . . . . 73.24 110.453 175.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.473 ' HB3' ' HE1' ' A' ' 93' ' ' PHE . 48.2 mtmt -69.11 -33.43 73.48 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.929 -0.578 . . . . 75.14 110.799 176.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -65.37 -30.79 71.66 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-N 117.734 0.243 . . . . 71.44 111.577 172.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.689 HD11 ' HD2' ' A' ' 33' ' ' TYR . 31.1 mt -65.18 -43.48 95.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 109.012 -0.736 . . . . 70.53 109.012 172.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.429 ' HB3' ' HD1' ' A' ' 88' ' ' PHE . 43.7 m-80 -69.11 -21.53 64.03 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 115.282 -0.872 . . . . 73.43 111.716 175.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -73.37 -51.79 16.11 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-O 122.244 1.021 . . . . 63.42 108.974 175.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.42 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . . . -57.24 -41.75 80.15 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 113.35 -1.75 . . . . 65.45 111.032 175.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.441 ' O ' ' HB2' ' A' ' 58' ' ' SER . 13.0 t80 -79.15 -22.93 44.38 Favored 'General case' 0 C--O 1.212 -0.887 0 CA-C-N 114.887 -1.051 . . . . 72.32 110.279 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.93 -26.54 65.13 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.815 -0.553 . . . . 53.01 110.789 173.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.57 HG22 ' HE1' ' A' ' 101' ' ' PHE . 20.6 t -95.68 -23.12 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 115.8 -0.636 . . . . 74.52 111.778 173.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.498 HD22 ' HG2' ' A' ' 63' ' ' ARG . 62.3 mt -123.72 26.07 7.86 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.575 -0.703 . . . . 62.04 112.292 -174.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.441 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 16.5 t -66.24 -48.24 71.17 Favored 'General case' 0 N--CA 1.502 2.16 0 CA-C-O 121.45 0.643 . . . . 74.34 111.801 176.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -110.28 154.32 42.94 Favored Pre-proline 0 N--CA 1.475 0.798 0 CA-C-N 114.697 -1.138 . . . . 74.34 109.109 -176.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.12 -28.26 83.07 Favored 'Trans proline' 0 C--N 1.382 2.333 0 C-N-CA 122.637 2.225 . . . . 72.41 111.818 173.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -70.68 -53.73 14.59 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.269 1.028 . . . . 72.3 111.534 -179.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -58.48 -40.15 81.93 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 121.692 0.758 . . . . 74.54 110.475 175.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.498 ' HG2' HD22 ' A' ' 57' ' ' LEU . 4.5 tmt_? -58.39 -42.19 86.55 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 113.92 -1.491 . . . . 74.11 109.762 178.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -72.19 -27.28 62.46 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 118.601 -0.714 . . . . 74.25 112.721 175.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 78.9 mt -62.66 -45.97 97.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 CA-C-N 118.754 0.706 . . . . 64.42 109.456 174.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -64.87 -45.39 86.22 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 115.688 -0.687 . . . . 75.4 110.503 176.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -54.61 -42.8 71.58 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 122.892 0.477 . . . . 64.04 111.194 176.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 80.8 p -82.28 -12.68 57.88 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 118.889 -0.577 . . . . 75.13 111.58 -178.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -65.72 120.46 13.03 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 108.305 -0.998 . . . . 63.45 108.305 172.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 109.14 8.3 27.58 Favored Glycine 0 C--N 1.344 1.021 0 CA-C-N 115.948 -0.569 . . . . 52.54 111.929 -164.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 85.9 m -147.27 -57.94 0.26 Allowed 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 103.862 -2.644 . . . . 71.23 103.862 176.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 27.1 m -71.37 123.83 23.2 Favored 'General case' 0 C--O 1.246 0.874 0 N-CA-C 103.402 -2.814 . . . . 74.23 103.402 154.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.32 -35.0 6.19 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 117.934 0.334 . . . . 74.04 110.628 -178.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.35 138.91 74.88 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 123.232 0.613 . . . . 75.1 109.832 173.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -57.0 149.9 59.27 Favored 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 122.769 2.312 . . . . 75.41 110.994 171.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.46 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 22.7 Cg_endo -57.3 136.18 74.7 Favored 'Trans proline' 0 CA--C 1.564 1.984 0 C-N-CA 122.695 2.263 . . . . 74.25 112.249 -176.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 76' ' ' PRO . 50.0 Cg_exo -55.43 123.24 13.32 Favored 'Trans proline' 0 C--N 1.386 2.538 0 C-N-CA 123.668 2.912 . . . . 62.44 113.916 -173.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -67.39 120.15 7.19 Favored 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 122.766 2.311 . . . . 43.51 112.842 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -78.97 167.12 22.46 Favored 'Trans proline' 0 C--N 1.378 2.108 0 C-N-CA 122.826 2.351 . . . . 71.05 111.621 173.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.24 82.89 0.05 OUTLIER 'Trans proline' 0 C--N 1.388 2.605 0 C-N-CA 123.415 2.743 . . . . 51.35 112.131 175.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 147.37 -44.8 0.79 Allowed Glycine 0 C--N 1.337 0.637 0 CA-C-N 114.74 -1.118 . . . . 62.41 110.331 -176.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 104.39 -160.52 15.73 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 116.478 0.139 . . . . 53.03 113.134 -176.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -106.77 128.68 54.44 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.993 0.917 . . . . 74.41 111.486 -175.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.412 ' HA ' ' HD2' ' A' ' 106' ' ' PHE . 13.2 t70 -70.14 144.58 51.98 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.017 1.327 . . . . 71.31 112.811 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.594 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 54.0 m-85 -136.54 72.18 1.43 Allowed 'General case' 0 C--N 1.358 0.977 0 CA-C-O 121.998 0.904 . . . . 70.22 111.453 -178.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 51.3 m -52.93 105.59 0.13 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 113.398 -1.728 . . . . 74.44 113.314 177.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.667 ' H ' ' HA3' ' A' ' 163' ' ' GLY . . . 67.9 2.3 23.02 Favored Glycine 0 C--N 1.343 0.938 0 C-N-CA 123.187 0.423 . . . . 70.11 113.976 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.594 ' HB2' ' HB3' ' A' ' 85' ' ' PHE . 19.0 m-85 -95.78 121.77 37.86 Favored 'General case' 0 C--N 1.349 0.569 0 N-CA-C 108.948 -0.76 . . . . 72.34 108.948 -174.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -82.85 60.06 5.16 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 122.119 0.962 . . . . 71.44 109.899 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.499 ' HA ' ' CD2' ' A' ' 93' ' ' PHE . 1.3 p -47.97 -38.69 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 126.532 1.933 . . . . 75.21 113.531 -179.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -55.61 -31.66 62.45 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 124.048 0.939 . . . . 75.33 112.236 -178.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -108.7 0.64 20.66 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.39 0.676 . . . . 45.35 112.111 -176.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.499 ' CD2' ' HA ' ' A' ' 90' ' ' VAL . 20.9 m-30 -72.05 178.97 3.48 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.907 -0.495 . . . . 71.01 110.697 177.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 77.5 p -58.94 155.72 12.84 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.637 0.775 . . . . 74.5 113.007 -173.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.464 ' O ' ' HG3' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -58.85 -41.67 87.52 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.165 -0.925 . . . . 74.31 110.631 173.381 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -57.92 -44.18 86.68 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.79 0.436 . . . . 75.03 111.286 175.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.43 ' HE2' HG23 ' A' ' 90' ' ' VAL . 47.2 t80 -59.92 -44.39 94.34 Favored 'General case' 0 C--O 1.244 0.805 0 CA-C-O 121.424 0.631 . . . . 63.23 109.814 177.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -75.44 -2.6 29.45 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 114.314 -1.312 . . . . 73.05 111.753 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.464 ' HG3' ' O ' ' A' ' 95' ' ' GLU . 48.8 mt-10 -93.88 -47.61 6.66 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 123.011 0.525 . . . . 70.02 110.949 163.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 48.8 tp -63.45 -32.16 73.52 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.54 1.136 . . . . 55.03 111.679 -171.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.57 ' HE1' HG22 ' A' ' 56' ' ' VAL . 93.7 m-85 -120.13 9.24 11.08 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.979 0.512 . . . . 72.11 110.477 173.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.41 ' HA2' ' HG ' ' A' ' 105' ' ' LEU . . . -48.47 -62.2 4.56 Favored Glycine 0 C--N 1.352 1.458 0 C-N-CA 124.702 1.144 . . . . 72.43 115.894 -172.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -56.63 -17.34 22.14 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 123.366 2.711 . . . . 23.1 113.474 178.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -129.57 43.22 1.33 Allowed Glycine 0 C--N 1.35 1.329 0 CA-C-O 119.679 -0.512 . . . . 44.4 112.287 178.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.496 HD22 HG21 ' A' ' 90' ' ' VAL . 33.7 mt -78.95 56.98 2.06 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 117.855 0.827 . . . . 74.25 111.065 170.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.686 ' HD1' ' H ' ' A' ' 108' ' ' GLY . 0.2 OUTLIER 35.05 -108.55 0.04 OUTLIER 'General case' 0 CA--C 1.568 1.651 0 C-N-CA 126.29 1.836 . . . . 72.25 112.565 178.215 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 72.06 12.2 75.34 Favored Glycine 0 C--N 1.357 1.701 0 CA-C-N 118.485 0.584 . . . . 44.0 112.722 -173.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.686 ' H ' ' HD1' ' A' ' 106' ' ' PHE . . . . . . . . 0 C--N 1.342 0.865 0 C-N-CA 124.058 0.837 . . . . 71.34 113.446 -178.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.451 ' HG3' ' O ' ' A' ' 170' ' ' PRO . 87.1 tttt . . . . . 0 N--CA 1.493 1.676 0 N-CA-C 112.789 0.663 . . . . 72.15 112.789 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -81.31 171.94 53.55 Favored Glycine 0 C--N 1.345 1.05 0 CA-C-N 115.438 -0.801 . . . . 55.22 113.371 174.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.8 tmm_? -87.19 140.43 29.55 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 108.568 -0.901 . . . . 71.34 108.568 176.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -53.68 116.9 2.74 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.949 0.9 . . . . 74.23 111.383 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.0 tt -109.86 140.99 43.18 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 121.833 -0.542 . . . . 70.23 109.953 -167.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 29.6 ttt-85 -99.01 107.52 19.97 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.992 0.917 . . . . 74.51 108.755 -178.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.441 ' HB2' HD11 ' A' ' 174' ' ' LEU . . . -111.14 165.14 12.15 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.275 0.63 . . . . 41.51 109.425 178.065 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.455 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 19.4 mm-40 -123.78 111.41 16.1 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 107.49 -1.3 . . . . 61.0 107.49 -174.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.406 ' O ' ' HA ' ' A' ' 178' ' ' VAL . 60.0 tp -99.71 96.66 4.85 Favored Pre-proline 0 N--CA 1.487 1.398 0 CA-C-N 118.869 0.759 . . . . 54.05 109.55 -172.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.46 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 39.3 Cg_endo -74.92 112.19 3.5 Favored 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 121.189 1.259 . . . . 75.33 110.067 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.616 ' HA ' HG21 ' B' ' 6' ' ' ILE . 38.2 tp -117.26 141.71 47.96 Favored 'General case' 0 C--N 1.338 0.08 0 C-N-CA 123.856 0.863 . . . . 64.01 110.113 -169.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.415 ' HB ' ' HG2' ' A' ' 129' ' ' GLU . 27.0 m -74.78 130.17 38.98 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.177 0.991 . . . . 71.34 110.199 178.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.4 HD23 HD22 ' A' ' 180' ' ' LEU . 64.9 mt -53.84 -52.87 58.99 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.225 1.01 . . . . 70.54 111.852 -177.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.448 ' HA ' ' HB3' ' A' ' 215' ' ' LEU . 5.7 mp0 -58.83 -38.17 78.06 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.938 0.895 . . . . 75.32 110.377 -176.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.415 ' HB3' ' CZ ' ' A' ' 136' ' ' ARG . 16.0 mm-40 -74.95 -28.4 60.56 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 114.925 -1.034 . . . . 64.33 110.837 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -68.79 -35.64 77.29 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.969 0.508 . . . . 41.43 111.182 176.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.431 ' HB2' HD12 ' A' ' 215' ' ' LEU . 77.6 t80 -67.19 -49.56 64.18 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 123.481 0.488 . . . . 74.51 110.815 173.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 34.6 m170 -70.35 -36.49 74.23 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 123.526 0.516 . . . . 75.25 111.789 -175.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.437 ' HA3' ' HG3' ' A' ' 151' ' ' PRO . . . 72.7 -171.37 50.13 Favored Glycine 0 CA--C 1.528 0.889 0 O-C-N 123.451 0.469 . . . . 71.54 113.574 -176.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.15 172.95 25.25 Favored Glycine 0 N--CA 1.476 1.347 0 C-N-CA 122.704 0.193 . . . . 70.42 112.788 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.422 ' HG3' ' HB2' ' A' ' 148' ' ' ARG . 1.8 mp0 -71.68 108.82 5.21 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.362 0.665 . . . . 73.14 111.112 -174.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.415 ' CZ ' ' HB3' ' A' ' 129' ' ' GLU . 6.5 tpp180 -92.84 122.11 34.89 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 108.628 -0.878 . . . . 74.4 108.628 -177.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 94.6 t -78.39 96.71 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 109.237 -0.653 . . . . 71.24 109.237 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.579 ' HB ' HG13 ' B' ' 6' ' ' ILE . 0.2 OUTLIER -112.27 118.37 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 108.294 -1.002 . . . . 73.14 108.294 176.388 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 144' ' ' ARG . 30.5 mt-10 -101.29 133.99 45.04 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.092 0.557 . . . . 71.3 111.152 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.585 HG11 HD23 ' B' ' 8' ' ' LEU . 15.0 p -170.64 139.08 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.039 0 O-C-N 123.628 0.58 . . . . 75.1 111.613 -178.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 55.43 26.28 8.67 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 115.696 1.739 . . . . 74.24 115.696 163.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 98.22 10.15 52.08 Favored Glycine 0 N--CA 1.476 1.301 0 C-N-CA 121.694 -0.289 . . . . 31.1 113.02 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 34.0 ttm105 -144.07 106.58 4.42 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 123.343 0.657 . . . . 72.12 110.958 -171.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.438 ' HA ' ' HA ' ' A' ' 139' ' ' GLU . 32.4 ttm180 -78.48 93.57 4.79 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 107.173 -1.418 . . . . 74.41 107.173 162.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.452 ' O ' HG13 ' A' ' 138' ' ' VAL . 1.5 p -84.83 107.82 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 108.306 -0.998 . . . . 73.53 108.306 175.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 26.9 t -84.53 83.03 8.15 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 107.586 -1.265 . . . . 31.45 107.586 172.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.6 p -87.86 109.65 19.87 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 CA-C-O 121.422 0.629 . . . . 73.42 110.343 -173.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.422 ' HB2' ' HG3' ' A' ' 135' ' ' GLU . 20.3 ttm180 -57.47 93.42 0.01 OUTLIER 'General case' 0 C--O 1.24 0.565 0 CA-C-N 115.232 -0.895 . . . . 74.14 108.924 166.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.623 ' HB ' HG11 ' A' ' 153' ' ' VAL . 28.8 pt -72.88 118.64 70.01 Favored Pre-proline 0 CA--C 1.547 0.85 0 CA-C-N 114.068 -1.424 . . . . 74.13 108.192 173.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -63.52 128.69 23.02 Favored 'Trans proline' 0 C--N 1.368 1.578 0 C-N-CA 122.248 1.965 . . . . 60.34 110.723 177.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.437 ' HG3' ' HA3' ' A' ' 133' ' ' GLY . 52.1 Cg_exo -53.36 100.37 0.06 OUTLIER 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 122.579 2.186 . . . . 74.15 111.272 177.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.444 ' HA2' ' CD2' ' A' ' 240' ' ' PHE . . . 116.75 36.44 1.06 Allowed Glycine 0 C--N 1.342 0.914 0 CA-C-N 115.532 -0.758 . . . . 75.51 112.647 -173.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.623 HG11 ' HB ' ' A' ' 149' ' ' ILE . 2.1 p -91.66 132.8 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 123.843 0.857 . . . . 75.43 108.737 176.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.401 ' HB3' ' HA ' ' A' ' 189' ' ' GLU . 0.1 OUTLIER -101.97 168.1 9.62 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.983 0.913 . . . . 73.23 113.047 -161.09 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.579 ' HB3' ' O ' ' A' ' 188' ' ' LEU . 9.0 tp10 -68.37 127.1 31.75 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 108.747 -0.835 . . . . 72.32 108.747 167.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 73.07 14.59 78.81 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-N 115.378 -0.828 . . . . 14.21 113.362 -174.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 46.5 t -66.34 109.76 2.82 Favored 'General case' 0 C--N 1.359 0.999 0 N-CA-C 107.721 -1.214 . . . . 74.23 107.721 171.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.45 HG13 ' HB3' ' A' ' 175' ' ' LEU . 58.6 t -84.86 87.13 2.37 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 N-CA-C 108.59 -0.893 . . . . 72.34 108.59 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.66 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 54.6 mt -74.01 91.89 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.642 0 N-CA-C 107.763 -1.199 . . . . 75.24 107.763 174.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -74.87 105.25 5.82 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 115.566 -0.743 . . . . 61.32 109.528 179.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 4.3 p -115.05 110.36 45.97 Favored Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 123.68 0.792 . . . . 61.33 108.94 173.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.467 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 46.5 Cg_endo -66.61 153.8 76.69 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 122.698 2.265 . . . . 74.53 111.684 177.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.667 ' HA3' ' H ' ' A' ' 87' ' ' GLY . . . 76.93 15.9 81.25 Favored Glycine 0 C--N 1.34 0.756 0 CA-C-N 115.827 -0.624 . . . . 70.43 113.892 178.241 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 49.2 mtt -125.46 -3.13 7.37 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 117.954 0.877 . . . . 64.15 111.465 177.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.488 ' HA2' HD13 ' A' ' 174' ' ' LEU . . . -85.15 -124.12 1.29 Allowed Glycine 0 C--N 1.343 0.956 0 N-CA-C 113.739 0.256 . . . . 73.33 113.739 -168.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -65.13 164.54 36.36 Favored Glycine 0 C--N 1.348 1.225 0 O-C-N 123.97 0.453 . . . . 74.5 113.422 -176.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.417 ' HB3' ' HA3' ' A' ' 108' ' ' GLY . 29.3 mm-40 -65.47 105.65 1.23 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.47 1.108 . . . . 75.42 111.581 -171.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -169.96 167.21 40.34 Favored Glycine 0 C--N 1.354 1.563 0 CA-C-O 118.96 -0.911 . . . . 64.21 112.124 -178.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . 0.639 ' HA ' ' HB3' ' A' ' 106' ' ' PHE . 48.3 t30 -63.74 -59.04 12.57 Favored Pre-proline 0 N--CA 1.493 1.694 0 CA-C-N 118.077 0.938 . . . . 63.11 110.752 -173.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.556 ' HD3' ' HB3' ' A' ' 169' ' ' ASN . 27.1 Cg_endo -94.64 95.13 0.11 Allowed 'Trans proline' 0 C--N 1.381 2.247 0 N-CA-C 106.181 -2.276 . . . . 71.13 106.181 156.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_exo -51.9 175.73 0.06 OUTLIER 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 123.391 2.727 . . . . 71.25 115.205 -170.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -62.72 -178.6 4.01 Favored Glycine 0 N--CA 1.474 1.229 0 CA-C-O 121.844 0.691 . . . . 72.4 114.499 -176.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.467 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 3.5 m-20 -79.9 104.76 10.7 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.441 -0.948 . . . . 71.14 108.441 171.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.488 HD13 ' HA2' ' A' ' 165' ' ' GLY . 18.2 tp -78.95 124.64 28.44 Favored 'General case' 0 C--N 1.346 0.421 0 N-CA-C 109.29 -0.633 . . . . 64.32 109.29 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.45 ' HB3' HG13 ' A' ' 158' ' ' VAL . 42.8 mt -101.28 88.88 3.59 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 106.661 -1.607 . . . . 72.12 106.661 -177.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.66 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 91.2 mt -72.66 83.18 1.15 Allowed 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 109.357 -0.608 . . . . 70.05 109.357 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.442 HG22 HG22 ' A' ' 158' ' ' VAL . 23.3 t -84.36 98.89 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 107.97 -1.122 . . . . 61.43 107.97 -176.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 98.6 t -56.58 140.46 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 N-CA-C 113.046 0.758 . . . . 70.33 113.046 -172.318 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.46 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 62.5 mmt-85 -114.52 89.92 3.21 Favored 'General case' 0 C--N 1.343 0.296 0 N-CA-C 107.463 -1.31 . . . . 53.32 107.463 163.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.4 HD22 HD23 ' A' ' 127' ' ' LEU . 10.7 mt -66.63 125.01 24.43 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 107.675 -1.232 . . . . 72.4 107.675 178.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 44.4 mt -51.85 152.9 4.82 Favored Pre-proline 0 N--CA 1.485 1.279 0 O-C-N 124.639 1.212 . . . . 73.14 113.628 -162.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -72.36 23.41 0.27 Allowed 'Trans proline' 0 C--N 1.382 2.321 0 C-N-CA 123.311 2.674 . . . . 71.42 113.366 178.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . 0.467 ' HA ' ' HD3' ' A' ' 184' ' ' PRO . 59.7 t-80 -59.84 105.49 0.57 Allowed Pre-proline 0 CA--C 1.556 1.179 0 N-CA-C 106.399 -1.704 . . . . 73.35 106.399 164.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 183' ' ' HIS . 13.7 Cg_exo -69.2 25.31 0.16 Allowed 'Trans proline' 0 C--N 1.375 1.921 0 C-N-CA 124.049 3.166 . . . . 61.24 117.534 -161.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 87.5 t -97.02 -58.92 3.49 Favored 'Isoleucine or valine' 0 C--N 1.35 0.623 0 CA-C-N 119.524 1.056 . . . . 64.21 110.422 -175.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -121.51 121.4 37.41 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 118.373 0.533 . . . . 72.31 112.22 -174.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.57 92.15 4.99 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 107.215 -1.402 . . . . 75.51 107.215 165.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.579 ' O ' ' HB3' ' A' ' 155' ' ' GLU . 53.7 tp -87.91 139.97 29.97 Favored 'General case' 0 C--O 1.207 -1.157 0 C-N-CA 123.769 0.828 . . . . 74.21 109.855 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . 0.401 ' HA ' ' HB3' ' A' ' 154' ' ' ARG . 40.0 tt0 -162.22 125.47 3.0 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 118.482 0.583 . . . . 70.31 110.003 177.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 73.59 -65.37 1.74 Allowed Glycine 0 C--N 1.356 1.691 0 O-C-N 123.586 0.554 . . . . 65.41 112.223 -173.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.428 ' HB3' ' HA3' ' A' ' 242' ' ' GLY . 4.3 pm0 -164.45 -19.42 0.03 OUTLIER 'General case' 0 C--O 1.249 1.037 0 C-N-CA 125.694 1.598 . . . . 72.32 109.104 177.073 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.422 ' H ' ' H ' ' A' ' 191' ' ' GLN . 2.0 p30 -94.65 134.81 36.83 Favored 'General case' 0 C--N 1.358 0.968 0 C-N-CA 123.908 0.883 . . . . 72.32 112.005 -169.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.555 ' HB2' ' HA ' ' A' ' 249' ' ' LEU . 66.8 mt -95.91 150.12 20.79 Favored 'General case' 0 C--O 1.22 -0.463 0 C-N-CA 125.788 1.635 . . . . 63.44 110.368 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -133.74 105.27 6.72 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 106.944 -1.502 . . . . 73.14 106.944 169.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.502 ' HB3' HD23 ' A' ' 251' ' ' LEU . . . -118.6 119.33 34.16 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.658 1.183 . . . . 74.34 109.906 -172.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 31.8 m -69.83 129.41 39.47 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 123.358 0.411 . . . . 70.21 109.912 -175.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 54.6 tp -128.79 99.99 5.53 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 109.001 -0.74 . . . . 72.21 109.001 -170.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -80.21 121.43 25.6 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.955 -0.757 . . . . 61.43 108.955 176.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 6.3 p -138.68 135.58 18.02 Favored Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 124.714 1.206 . . . . 64.4 108.374 -175.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -74.12 152.73 45.86 Favored 'Trans proline' 0 C--N 1.368 1.553 0 C-N-CA 121.923 1.748 . . . . 64.51 111.081 173.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -53.35 -50.57 82.0 Favored Pre-proline 0 CA--C 1.553 1.07 0 N-CA-C 113.93 1.085 . . . . 71.34 113.93 -173.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -55.52 -46.25 33.58 Favored 'Trans proline' 0 C--N 1.38 2.19 0 C-N-CA 121.902 1.735 . . . . 63.54 113.581 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 19.6 mt -70.32 -32.32 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 CA-C-N 116.141 -0.481 . . . . 64.32 110.927 -176.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.89 -42.4 85.58 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.004 0.522 . . . . 71.51 111.301 175.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.419 ' CG1' HD11 ' C' ' 261' ' ' LEU . 53.9 t -73.17 -40.85 58.43 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.037 0 C-N-CA 124.082 0.953 . . . . 63.23 112.577 -174.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 65.0 t -95.58 -34.77 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 122.614 0.366 . . . . 74.41 111.694 -175.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 93.42 108.84 1.94 Allowed Glycine 0 C--N 1.335 0.508 0 CA-C-N 116.354 -0.384 . . . . 72.35 112.166 -178.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -141.45 -161.94 8.93 Favored Glycine 0 N--CA 1.469 0.841 0 N-CA-C 110.741 -0.943 . . . . 55.24 110.741 177.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 44.5 mtmt -100.43 124.11 45.52 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 118.426 1.113 . . . . 45.21 110.814 176.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 31.4 m -108.89 166.07 4.75 Favored 'Isoleucine or valine' 0 C--O 1.247 0.924 0 C-N-CA 125.014 1.326 . . . . 63.11 108.973 170.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . 0.651 HH21 ' HA ' ' A' ' 220' ' ' GLU . 0.0 OUTLIER -95.16 117.41 30.18 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.022 -0.733 . . . . 71.41 109.022 174.501 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -119.71 130.97 55.27 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 107.481 -1.303 . . . . 62.04 107.481 172.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . 0.546 ' HA ' ' HA ' ' A' ' 218' ' ' PRO . 0.8 OUTLIER -80.27 148.62 30.69 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 122.46 0.304 . . . . 71.23 110.505 -176.497 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 71.5 p -117.67 -177.81 3.33 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 108.808 -0.812 . . . . 74.1 108.808 168.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.448 ' HB3' ' HA ' ' A' ' 128' ' ' GLU . 86.0 mt -76.89 -1.98 31.23 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.642 -0.708 . . . . 63.31 112.098 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -126.89 -2.17 6.56 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.145 0.578 . . . . 64.44 111.805 177.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 149.17 167.31 13.82 Favored Glycine 0 N--CA 1.481 1.635 0 N-CA-C 114.626 0.61 . . . . 33.0 114.626 173.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . 0.546 ' HA ' ' HA ' ' A' ' 213' ' ' MET . 2.7 Cg_exo -76.19 116.59 4.4 Favored 'Trans proline' 0 C--N 1.374 1.888 0 C-N-CA 123.662 2.908 . . . . 70.23 111.968 -177.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.412 HG23 HG23 ' A' ' 221' ' ' VAL . 34.7 m -106.42 162.29 5.32 Favored 'Isoleucine or valine' 0 C--O 1.254 1.317 0 C-N-CA 123.98 0.912 . . . . 73.4 112.03 -172.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.651 ' HA ' HH21 ' A' ' 211' ' ' ARG . 29.4 mt-10 -86.49 103.12 14.72 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 114.213 -1.358 . . . . 75.04 109.889 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.412 HG23 HG23 ' A' ' 219' ' ' VAL . 39.7 t -106.93 116.9 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.172 0.589 . . . . 74.13 109.48 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -77.88 99.36 5.95 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 109.255 -0.646 . . . . 60.25 109.255 174.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 14.3 p -64.9 134.0 95.93 Favored Pre-proline 0 CA--C 1.559 1.326 0 N-CA-C 109.491 -0.559 . . . . 63.14 109.491 177.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -61.44 168.71 7.64 Favored 'Trans proline' 0 C--N 1.38 2.227 0 C-N-CA 122.735 2.29 . . . . 75.51 112.654 176.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.77 150.96 31.34 Favored 'Trans proline' 0 C--N 1.374 1.904 0 C-N-CA 121.624 1.549 . . . . 72.53 112.474 172.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 45.3 mtt-85 66.29 27.34 10.17 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 125.692 1.597 . . . . 74.04 110.963 169.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.651 HG23 HD21 ' A' ' 233' ' ' LEU . 80.6 m -63.59 104.87 0.7 Allowed 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 113.06 -1.882 . . . . 64.32 110.843 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -85.14 139.83 31.4 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 123.945 0.898 . . . . 75.32 110.647 -176.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -62.24 157.4 19.59 Favored 'General case' 0 C--N 1.356 0.863 0 C-N-CA 124.152 0.981 . . . . 62.31 111.082 177.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 81.1 -38.74 2.41 Favored Glycine 0 C--N 1.346 1.088 0 CA-C-N 116.637 -0.256 . . . . 73.32 112.606 177.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -69.07 166.94 17.06 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 123.686 0.794 . . . . 74.0 110.26 173.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.705 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 2.7 mptp? -124.85 131.87 53.39 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 115.13 -0.941 . . . . 72.22 108.772 -178.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.651 HD21 HG23 ' A' ' 227' ' ' THR . 59.4 mt -76.62 97.54 4.44 Favored 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 107.903 -1.147 . . . . 71.4 107.903 176.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . 0.419 ' HG3' ' HB3' ' A' ' 248' ' ' ASP . 40.7 ttp180 -78.73 103.52 8.73 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 123.599 0.562 . . . . 64.14 109.737 -176.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.46 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 10.7 mt -100.04 89.33 4.0 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.217 -1.031 . . . . 61.12 108.217 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -71.0 139.08 50.42 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.751 0.42 . . . . 64.43 110.977 -173.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 79.32 2.6 87.76 Favored Glycine 0 CA--C 1.536 1.346 0 O-C-N 123.533 0.521 . . . . 74.2 113.271 -174.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.493 ' HA ' ' HE3' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -105.83 -16.45 14.66 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 117.47 0.635 . . . . 73.01 111.73 -179.395 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -72.32 -163.29 6.63 Favored Glycine 0 CA--C 1.534 1.238 0 O-C-N 123.412 0.445 . . . . 74.43 112.87 173.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . 0.444 ' CD2' ' HA2' ' A' ' 152' ' ' GLY . 58.6 m-85 -95.01 166.26 15.29 Favored Pre-proline 0 N--CA 1.485 1.284 0 CA-C-O 118.282 -0.866 . . . . 73.13 109.869 -177.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -49.69 146.26 15.86 Favored 'Trans proline' 0 C--N 1.392 2.868 0 C-N-CA 123.399 2.733 . . . . 73.33 113.943 -177.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.428 ' HA3' ' HB3' ' A' ' 191' ' ' GLN . . . -168.65 -158.68 12.91 Favored Glycine 0 C--N 1.338 0.657 0 CA-C-N 114.928 -1.033 . . . . 73.52 112.002 -178.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -78.46 -5.52 14.95 Favored 'Trans proline' 0 C--N 1.369 1.626 0 C-N-CA 123.284 2.656 . . . . 70.45 112.749 -173.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -113.51 22.0 14.57 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.003 0.921 . . . . 70.11 110.309 177.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 90.84 -75.28 1.63 Allowed Glycine 0 C--N 1.345 1.031 0 N-CA-C 109.996 -1.241 . . . . 62.24 109.996 -174.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 73.9 mtp180 -119.94 175.29 5.98 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.994 0.918 . . . . 75.41 109.279 168.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -105.58 -161.03 23.14 Favored Glycine 0 C--N 1.341 0.85 0 CA-C-N 115.988 -0.551 . . . . 42.24 114.306 -177.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . 0.419 ' HB3' ' HG3' ' A' ' 234' ' ' ARG . 19.3 m-20 -110.7 134.75 52.18 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 124.032 0.933 . . . . 75.44 108.813 -174.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.555 ' HA ' ' HB2' ' A' ' 193' ' ' LEU . 12.3 tp -98.95 95.51 7.21 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.0 -1.111 . . . . 70.31 108.0 176.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.705 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 84.4 m-85 -82.27 108.28 15.6 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 109.523 -0.547 . . . . 52.51 109.523 178.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.512 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 86.7 mt -86.8 105.7 17.19 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 109.298 -0.63 . . . . 72.24 109.298 172.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -76.54 106.99 8.5 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.358 0.663 . . . . 75.41 109.504 -174.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.454 HG11 HG22 ' A' ' 227' ' ' THR . 23.9 t -69.27 127.93 31.91 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 124.252 1.021 . . . . 24.43 112.089 -170.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -127.5 93.93 3.85 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 107.365 -1.346 . . . . 73.14 107.365 178.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.409 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 69.6 mt -83.25 136.11 23.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 C-N-CA 122.641 0.377 . . . . 74.34 110.762 -177.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 22.5 p -124.93 169.57 11.95 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.594 1.157 . . . . 73.43 109.497 172.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.554 HD12 ' H ' ' A' ' 259' ' ' GLU . 2.3 pp -109.58 141.18 23.07 Favored Pre-proline 0 N--CA 1.484 1.25 0 C-N-CA 122.928 0.491 . . . . 73.4 109.92 178.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 258' ' ' PRO . . . . . 0.539 ' HB3' ' HE1' ' C' ' 276' ' ' TYR . 12.7 Cg_endo -52.53 -20.95 13.03 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 124.598 3.532 . . . . 74.45 115.615 -170.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . 0.554 ' H ' HD12 ' A' ' 257' ' ' ILE . 23.2 mt-10 50.85 -78.93 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.561 1.144 . . . . 63.24 110.576 -160.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.59 129.34 16.26 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.271 1.029 . . . . 75.12 111.713 176.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.43 HD22 ' HB3' ' A' ' 265' ' ' GLU . 89.1 mt -154.99 144.85 21.6 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.555 1.142 . . . . 55.32 109.096 -179.073 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 64.2 p -93.86 156.72 39.06 Favored Pre-proline 0 CA--C 1.555 1.151 0 CA-C-O 118.06 -0.971 . . . . 44.34 109.101 171.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -34.98 -48.07 0.69 Allowed 'Trans proline' 0 C--N 1.388 2.639 0 C-N-CA 124.843 3.695 . . . . 74.33 116.532 -177.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -68.46 -49.47 59.6 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.05 0.54 . . . . 71.44 111.406 -178.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . 0.43 ' HB3' HD22 ' A' ' 261' ' ' LEU . 49.9 mt-10 -56.95 -43.77 81.91 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.077 0.551 . . . . 64.2 110.344 178.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -57.12 -45.81 83.18 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 114.483 -1.235 . . . . 73.45 110.513 177.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -60.93 -41.67 96.65 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.162 -0.926 . . . . 64.12 111.685 178.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . 0.406 ' HG ' ' HG ' ' C' ' 268' ' ' LEU . 9.7 mp -64.78 -48.53 74.17 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.296 0.638 . . . . 73.14 111.193 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 68.5 m95 -57.86 -45.58 86.08 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.142 0.577 . . . . 75.0 111.583 178.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . 0.619 ' HE3' HG23 ' C' ' 206' ' ' VAL . 44.9 mttp -65.16 -42.95 93.22 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-N 115.536 -0.756 . . . . 62.43 111.547 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 34.4 mmtm -63.31 -42.94 99.05 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 122.88 0.472 . . . . 70.22 111.789 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 272' ' ' LEU . . . . . 0.44 ' O ' ' HB2' ' A' ' 276' ' ' TYR . 67.5 mt -54.93 -49.28 71.69 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 124.251 0.97 . . . . 63.4 109.435 172.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -70.06 -33.22 71.66 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.076 1.139 . . . . 64.51 114.076 -175.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.428 ' HG3' ' O ' ' A' ' 270' ' ' LYS . 40.6 mt-10 -65.08 -53.94 37.81 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.373 -0.973 . . . . 74.35 108.373 176.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -69.87 -20.83 63.38 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 113.567 -1.651 . . . . 71.44 112.161 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . 0.554 ' HE2' ' HB3' ' C' ' 258' ' ' PRO . 23.8 t80 -75.49 -64.07 1.15 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.188 0.995 . . . . 75.02 109.4 178.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -72.09 -23.06 61.28 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 114.799 -1.091 . . . . 70.12 111.848 -170.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -59.24 -26.99 65.37 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 112.762 0.653 . . . . 75.41 112.762 172.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -77.58 -15.14 59.42 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 116.429 -0.351 . . . . 74.13 110.497 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.131 0 C-N-CA 123.857 0.863 . . . . 72.21 109.042 175.507 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 14.6 tpt . . . . . 0 N--CA 1.479 0.979 0 N-CA-C 109.391 -0.596 . . . . 71.44 109.391 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt 59.86 33.94 21.69 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 124.568 1.147 . . . . 54.1 112.126 175.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 59.22 72.94 0.5 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.736 1.214 . . . . 74.04 109.814 -173.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 11.1 p -82.87 -17.51 43.57 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 115.029 -0.987 . . . . 52.14 111.864 -176.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 4.5 m 68.94 158.72 0.16 Allowed 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 125.234 1.413 . . . . 70.11 113.252 174.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.616 HG21 ' HA ' ' A' ' 125' ' ' LEU . 14.5 pt -138.57 175.08 8.93 Favored 'Isoleucine or valine' 0 C--N 1.364 1.199 0 C-N-CA 123.316 0.646 . . . . 64.44 111.117 -172.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -150.38 141.81 23.39 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.074 0.95 . . . . 72.01 109.017 172.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . 0.585 HD23 HG11 ' A' ' 140' ' ' VAL . 52.7 tp -75.76 143.03 42.22 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.263 1.025 . . . . 75.22 109.91 -174.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.93 -68.1 0.35 Allowed 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 109.513 -0.551 . . . . 62.4 109.513 172.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 6.6 tt 53.39 101.23 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 125.365 1.466 . . . . 74.1 110.527 -176.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 31.0 mt . . . . . 0 CA--C 1.556 1.209 0 C-N-CA 124.732 1.213 . . . . 45.35 110.769 -179.6 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.023 0 N-CA-C 109.57 -0.53 . . . . 61.34 109.57 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . 58.37 -79.24 0.02 OUTLIER 'General case' 0 C--N 1.359 1.0 0 C-N-CA 124.953 1.301 . . . . 74.4 110.472 -164.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 181' ' ' LEU . . . . . 0.503 HD22 ' HB3' ' C' ' 136' ' ' ARG . 12.8 tp -162.94 26.61 0.09 Allowed 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.699 0.762 . . . . 62.04 109.505 174.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 182' ' ' VAL . . . . . 0.464 HG13 ' HB3' ' C' ' 139' ' ' GLU . 76.7 t -83.44 147.45 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.505 1.122 . . . . 71.31 110.761 -174.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 183' ' ' ALA . . . . . 0.457 ' HB2' HD13 ' C' ' 123' ' ' LEU . . . -134.05 -13.69 2.43 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.54 0.736 . . . . 65.24 112.222 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 55.53 -138.77 1.02 Allowed 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.995 0.918 . . . . 74.15 108.836 -174.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 185' ' ' VAL . . . . . . . . . . . . . 61.0 t . . . . . 0 N--CA 1.47 0.554 0 N-CA-C 106.997 -1.483 . . . . 71.33 106.997 158.528 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 238' ' ' THR . . . . . 0.461 HG22 HG23 ' C' ' 219' ' ' VAL . 6.9 m . . . . . 0 CA--C 1.553 1.081 0 CA-C-O 121.046 0.45 . . . . 71.31 110.197 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 239' ' ' ALA . . . . . 0.658 ' HB2' ' HA ' ' C' ' 221' ' ' VAL . . . -60.79 -177.09 0.07 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.032 1.333 . . . . 74.42 114.117 -178.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . -103.21 -95.48 2.33 Favored Glycine 0 C--N 1.341 0.837 0 N-CA-C 110.32 -1.112 . . . . 71.23 110.32 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -166.07 157.12 13.29 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.506 0.723 . . . . 71.21 110.789 -179.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -170.58 -69.37 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.17 0.988 . . . . 70.32 109.971 174.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -136.74 -6.97 1.91 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.389 1.076 . . . . 74.22 110.505 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 142.74 -163.79 27.21 Favored Glycine 0 C--N 1.352 1.468 0 N-CA-C 113.472 0.149 . . . . 63.11 113.472 174.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.544 0.748 0 C-N-CA 124.322 1.049 . . . . 75.34 109.526 -174.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.783 0 N-CA-C 109.693 -0.484 . . . . 52.01 109.693 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -37.72 101.63 0.02 OUTLIER 'General case' 0 C--N 1.354 0.773 0 C-N-CA 125.765 1.626 . . . . 70.52 113.756 -176.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 5' ' ' LYS . . . . . 0.477 ' HE2' HD11 ' C' ' 10' ' ' ILE . 14.6 mmmm -73.32 98.94 2.78 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.46 -1.311 . . . . 63.2 107.46 164.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -71.15 92.78 1.01 Allowed 'General case' 0 C--O 1.234 0.258 0 N-CA-C 107.759 -1.2 . . . . 63.22 107.759 177.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 7' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -58.64 -29.96 66.94 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 114.668 -1.151 . . . . 73.43 112.17 -170.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -67.33 -48.75 66.63 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.112 -0.949 . . . . 72.53 110.002 176.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.12 -38.52 86.66 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.978 0.511 . . . . 52.31 110.941 178.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 10' ' ' ILE . . . . . 0.477 HD11 ' HE2' ' C' ' 5' ' ' LYS . 59.5 mt -61.79 -39.36 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.335 0.654 . . . . 63.34 110.185 176.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 96.0 mt -80.44 -7.47 59.16 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 112.586 0.587 . . . . 45.45 112.586 176.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.37 35.84 51.41 Favored Glycine 0 C--N 1.352 1.454 0 CA-C-N 117.917 0.326 . . . . 64.33 113.636 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 6.3 m -133.55 155.89 80.15 Favored Pre-proline 0 N--CA 1.483 1.206 0 C-N-CA 125.109 1.364 . . . . 64.04 109.576 177.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -81.98 155.42 17.49 Favored 'Trans proline' 0 C--N 1.371 1.714 0 C-N-CA 122.195 1.93 . . . . 74.43 112.306 174.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 90.1 mtm-85 -67.35 75.98 0.16 Allowed 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.747 0.819 . . . . 71.52 110.311 174.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -177.48 -31.63 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.572 1.149 . . . . 71.24 108.779 -175.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.68 134.22 56.52 Favored 'General case' 0 C--N 1.353 0.748 0 CA-C-N 115.578 -0.737 . . . . 71.14 110.401 177.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 75.0 p -71.36 173.46 7.8 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.319 0.648 . . . . 74.41 111.671 -175.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 19' ' ' GLN . . . . . 0.464 HE22 ' HE2' ' C' ' 23' ' ' LYS . 0.1 OUTLIER -60.24 -39.55 87.09 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.347 1.059 . . . . 74.45 110.376 -176.005 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 20' ' ' GLU . . . . . 0.42 ' O ' ' HG3' ' C' ' 24' ' ' ARG . 7.8 tm-20 -66.64 -34.94 78.98 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 123.148 0.579 . . . . 64.05 110.015 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -70.97 -36.95 72.73 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 122.734 0.414 . . . . 73.42 110.773 176.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 1.4 mp -63.87 -34.52 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.333 1.053 . . . . 61.32 110.078 173.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 23' ' ' LYS . . . . . 0.534 ' O ' ' HG3' ' C' ' 27' ' ' LYS . 13.7 tppt? -66.55 -45.18 80.22 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.295 0.638 . . . . 74.13 109.305 178.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 24' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' C' ' 20' ' ' GLU . 63.1 mtm-85 -63.49 -41.99 98.55 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 123.459 0.475 . . . . 73.52 110.839 178.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.95 -38.45 86.14 Favored 'General case' 0 C--O 1.253 1.251 0 CA-C-N 115.257 -0.883 . . . . 75.32 110.987 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 26' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -57.14 -55.78 30.25 Favored 'General case' 0 C--O 1.216 -0.685 0 CA-C-N 114.541 -1.208 . . . . 72.31 109.13 173.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . 0.534 ' HG3' ' O ' ' C' ' 23' ' ' LYS . 33.2 mtmt -57.39 -41.56 80.47 Favored 'General case' 0 N--CA 1.483 1.186 0 O-C-N 124.424 1.078 . . . . 74.1 110.824 -177.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -55.32 -51.45 66.69 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.004 0.921 . . . . 71.15 110.961 178.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 82.3 mt -86.07 -6.02 59.1 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.724 -0.671 . . . . 60.22 111.498 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.41 -0.09 49.75 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.934 0.893 . . . . 75.32 110.011 171.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . 0.402 ' HG3' ' O ' ' C' ' 27' ' ' LYS . 95.7 mtt180 -100.94 -41.89 6.64 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.26 1.024 . . . . 73.5 109.208 165.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.33 -50.16 49.07 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 115.637 -0.71 . . . . 71.12 109.629 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 33' ' ' TYR . . . . . 0.422 ' HB3' ' O ' ' C' ' 43' ' ' ALA . 37.2 m-85 -95.4 14.94 20.9 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.924 0.49 . . . . 70.15 111.52 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 34' ' ' HIS . . . . . 0.422 ' CD2' HG23 ' C' ' 37' ' ' VAL . 12.4 t60 -61.4 107.82 1.27 Allowed Pre-proline 0 N--CA 1.489 1.48 0 C-N-CA 124.36 1.064 . . . . 72.34 110.792 -177.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -61.74 -21.31 71.87 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 123.018 2.479 . . . . 71.32 114.16 -172.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.05 -26.31 36.44 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.951 0.9 . . . . 60.34 111.668 178.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . 0.422 HG23 ' CD2' ' C' ' 34' ' ' HIS . 90.2 t -97.39 -58.33 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 109.046 -0.724 . . . . 75.33 109.046 176.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -98.12 84.21 3.24 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 114.801 -1.09 . . . . 54.22 108.907 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.26 79.21 0.99 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 114.866 -1.061 . . . . 62.24 108.635 175.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 67.1 m -140.38 114.9 7.53 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-O 118.301 -0.857 . . . . 74.14 109.387 -178.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -52.12 -41.85 62.61 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 123.326 2.684 . . . . 63.44 112.774 -176.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -48.62 -50.62 31.94 Favored 'General case' 0 N--CA 1.483 1.18 0 O-C-N 124.078 0.861 . . . . 65.44 110.85 173.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 43' ' ' ALA . . . . . 0.422 ' O ' ' HB3' ' C' ' 33' ' ' TYR . . . -71.55 -23.55 61.78 Favored 'General case' 0 C--O 1.216 -0.679 0 CA-C-N 114.768 -1.105 . . . . 62.05 110.931 -176.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 44' ' ' GLU . . . . . 0.469 ' O ' ' HG3' ' C' ' 48' ' ' LYS . 47.9 mt-10 -80.72 -33.48 35.22 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 122.992 0.517 . . . . 74.04 110.672 -176.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 45' ' ' GLU . . . . . 0.418 ' HA ' ' HD2' ' C' ' 48' ' ' LYS . 40.3 mt-10 -76.36 -39.4 53.95 Favored 'General case' 0 C--O 1.244 0.763 0 C-N-CA 123.316 0.647 . . . . 42.53 109.643 178.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 46' ' ' LYS . . . . . 0.535 ' O ' HG12 ' C' ' 50' ' ' ILE . 99.6 mttt -64.26 -34.7 78.71 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.008 -0.997 . . . . 72.32 110.131 170.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -66.34 -35.87 81.45 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.919 0.888 . . . . 62.23 110.297 175.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 48' ' ' LYS . . . . . 0.469 ' HG3' ' O ' ' C' ' 44' ' ' GLU . 95.1 mttt -60.67 -42.32 96.83 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 109.773 -0.454 . . . . 72.04 109.773 173.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -66.67 -33.8 76.45 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 123.653 0.596 . . . . 72.33 111.578 174.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 50' ' ' ILE . . . . . 0.535 HG12 ' O ' ' C' ' 46' ' ' LYS . 32.8 mm -65.72 -33.93 66.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 109.005 -0.739 . . . . 75.43 109.005 175.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 51' ' ' ASN . . . . . 0.555 ' HA ' ' HB3' ' C' ' 54' ' ' TYR . 36.3 m-80 -93.0 -3.98 53.46 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.123 0.969 . . . . 74.04 112.333 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -81.53 -51.45 8.25 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 107.243 -1.391 . . . . 63.42 107.243 165.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.14 -37.29 71.82 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 112.503 -2.135 . . . . 63.1 111.304 173.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 54' ' ' TYR . . . . . 0.555 ' HB3' ' HA ' ' C' ' 51' ' ' ASN . 58.1 t80 -78.18 -39.21 41.51 Favored 'General case' 0 C--O 1.215 -0.724 0 CA-C-N 115.5 -0.773 . . . . 75.01 110.411 174.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.52 -28.32 44.46 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 118.751 0.705 . . . . 60.54 111.56 177.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 56' ' ' VAL . . . . . 0.462 ' O ' ' HB2' ' C' ' 62' ' ' LYS . 47.3 t -83.28 -67.09 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 CA-C-O 121.288 0.566 . . . . 72.43 110.443 169.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 57' ' ' LEU . . . . . . . . . . . . . 52.1 mt -84.47 15.5 3.67 Favored 'General case' 0 CA--C 1.565 1.538 0 N-CA-C 113.066 0.765 . . . . 75.02 113.066 -164.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 45.5 t -61.2 -45.8 93.09 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 124.188 0.995 . . . . 62.42 112.291 -178.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -123.31 149.83 58.82 Favored Pre-proline 0 C--O 1.242 0.69 0 CA-C-N 114.897 -1.047 . . . . 72.03 108.639 -173.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 60' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -51.43 -26.97 22.9 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 123.299 2.666 . . . . 33.23 113.088 174.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -62.56 -70.28 0.21 Allowed 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.439 -0.8 . . . . 62.13 111.272 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 62' ' ' LYS . . . . . 0.486 ' HD3' ' H ' ' C' ' 62' ' ' LYS . 0.0 OUTLIER -70.64 -20.66 62.71 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 122.117 0.167 . . . . 75.23 110.857 -175.568 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -53.59 -62.11 1.87 Allowed 'General case' 0 C--N 1.354 0.776 0 O-C-N 124.002 0.814 . . . . 64.42 109.864 168.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -70.1 -27.56 64.69 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 112.249 0.463 . . . . 74.15 112.249 -176.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 88.5 mt -57.71 -50.27 78.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 109.68 -0.489 . . . . 62.34 109.68 172.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -61.74 -47.61 84.45 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.112 0.565 . . . . 74.22 111.691 174.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -53.94 -32.16 52.75 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.119 0.568 . . . . 73.14 111.979 -178.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 68' ' ' THR . . . . . 0.446 ' O ' ' HB ' ' C' ' 72' ' ' THR . 40.1 p -97.02 -24.09 15.96 Favored 'General case' 0 CA--C 1.553 1.069 0 N-CA-C 112.512 0.56 . . . . 63.2 112.512 176.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 69' ' ' TYR . . . . . 0.444 ' HE2' ' HD3' ' C' ' 78' ' ' PRO . 3.4 t80 -118.25 120.29 37.22 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.31 -0.869 . . . . 75.22 110.763 -172.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.94 23.58 66.25 Favored Glycine 0 C--N 1.346 1.136 0 N-CA-C 111.616 -0.594 . . . . 62.51 111.616 -173.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 54.8 m -142.18 -53.58 0.42 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 103.745 -2.687 . . . . 72.34 103.745 175.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . 0.446 ' HB ' ' O ' ' C' ' 68' ' ' THR . 21.1 m -105.25 173.3 6.36 Favored 'General case' 0 CA--C 1.564 1.498 0 N-CA-C 104.969 -2.234 . . . . 73.35 104.969 158.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -90.85 11.41 22.67 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 118.999 0.818 . . . . 73.23 111.081 173.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 74' ' ' ALA . . . . . 0.45 ' HB1' ' HD2' ' C' ' 75' ' ' PRO . . . -62.12 -163.35 0.0 OUTLIER Pre-proline 0 CA--C 1.594 2.646 0 C-N-CA 125.728 1.611 . . . . 53.23 112.305 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 75' ' ' PRO . . . . . 0.523 ' HA ' ' HD2' ' C' ' 76' ' ' PRO . 0.2 OUTLIER 8.2 109.24 0.0 OUTLIER 'Trans proline' 1 C--N 1.419 4.25 0 C-N-CA 125.153 3.902 . . . . 75.14 118.512 -156.134 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' C' C ' 76' ' ' PRO . . . . . 0.523 ' HD2' ' HA ' ' C' ' 75' ' ' PRO . 42.5 Cg_endo -62.12 165.96 13.59 Favored 'Trans proline' 0 C--N 1.387 2.556 0 C-N-CA 123.52 2.813 . . . . 63.14 113.321 -179.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -21.39 106.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.405 3.517 1 C-N-CA 126.157 4.572 . . . . 51.51 116.029 178.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 78' ' ' PRO . . . . . 0.624 ' HG2' ' HA ' ' C' ' 101' ' ' PHE . 1.3 Cg_exo -37.59 146.45 0.11 Allowed 'Trans proline' 0 C--N 1.379 2.133 1 C-N-CA 126.277 4.651 . . . . 74.44 117.639 -171.781 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -58.87 119.43 6.68 Favored 'Trans proline' 0 C--N 1.391 2.813 0 C-N-CA 123.555 2.837 . . . . 61.04 113.411 -178.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -62.12 75.49 0.1 OUTLIER 'Trans proline' 0 C--N 1.391 2.811 0 C-N-CA 123.56 2.84 . . . . 51.5 110.321 169.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -167.48 -24.89 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 113.704 -1.589 . . . . 75.2 110.281 -166.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.41 ' HA2' ' O ' ' C' ' 104' ' ' GLY . . . 118.21 141.73 6.81 Favored Glycine 0 C--N 1.361 1.969 0 N-CA-C 116.377 1.311 . . . . 74.45 116.377 163.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 83' ' ' TYR . . . . . 0.505 ' CE1' ' HB3' ' C' ' 78' ' ' PRO . 22.7 m-85 -110.03 92.93 4.24 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 107.311 -1.366 . . . . 70.14 107.311 165.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -27.67 135.29 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 127.471 2.308 . . . . 63.13 116.157 -175.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 85' ' ' PHE . . . . . 0.564 ' HZ ' HD22 ' C' ' 105' ' ' LEU . 16.0 m-85 -135.49 74.21 1.5 Allowed 'General case' 0 C--N 1.346 0.451 0 CA-C-N 115.167 -0.924 . . . . 74.41 110.999 -177.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 86' ' ' SER . . . . . 0.521 ' OG ' ' HA2' ' C' ' 163' ' ' GLY . 1.4 m -55.82 83.21 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 123.715 0.806 . . . . 45.43 110.523 177.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 62.65 16.0 54.92 Favored Glycine 0 CA--C 1.54 1.637 0 CA-C-O 119.007 -0.885 . . . . 74.33 114.624 -170.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 88' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -86.46 120.81 28.19 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 118.536 1.168 . . . . 74.44 109.772 -174.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -76.56 88.67 3.28 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 120.856 0.36 . . . . 72.23 110.604 -174.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 90' ' ' VAL . . . . . . . . . . . . . 6.0 p -45.43 -43.96 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 124.333 1.053 . . . . 54.41 113.06 175.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -61.48 -31.2 71.17 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.745 0.818 . . . . 74.21 111.381 -176.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -79.08 -24.89 43.18 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.275 -0.875 . . . . 75.53 111.083 -176.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 19.1 m-30 -73.83 165.51 24.98 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 122.637 0.375 . . . . 72.45 110.787 -175.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 86.3 p -67.62 163.45 21.33 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 113.509 0.929 . . . . 45.51 113.509 -167.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.11 -42.91 95.72 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.027 -0.988 . . . . 55.43 110.645 172.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -58.44 -43.53 88.82 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.161 0.584 . . . . 65.02 110.653 178.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 97' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -61.51 -43.67 98.45 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.203 -0.908 . . . . 64.25 109.691 177.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 98' ' ' GLN . . . . . 0.541 ' HA ' HD12 ' C' ' 105' ' ' LEU . 48.6 mt-30 -82.58 -5.21 58.65 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 115.091 -0.958 . . . . 51.52 113.306 -177.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -101.4 -35.95 9.03 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.412 0.685 . . . . 74.43 110.947 172.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 46.3 tp -74.2 -61.4 1.87 Allowed 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 109.067 -0.716 . . . . 73.23 109.067 -178.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 101' ' ' PHE . . . . . 0.624 ' HA ' ' HG2' ' C' ' 78' ' ' PRO . 65.6 m-85 -92.08 8.72 36.54 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 115.389 -0.823 . . . . 73.25 111.55 -177.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -46.52 -58.28 6.05 Favored Glycine 0 CA--C 1.544 1.895 0 N-CA-C 117.629 1.811 . . . . 54.11 117.629 -169.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . 0.433 ' HD2' ' HD2' ' C' ' 78' ' ' PRO . 52.9 Cg_exo -58.49 -18.55 39.84 Favored 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 123.359 2.706 . . . . 62.02 114.41 179.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 104' ' ' GLY . . . . . 0.41 ' O ' ' HA2' ' C' ' 82' ' ' GLY . . . -105.35 -1.71 41.05 Favored Glycine 0 C--N 1.348 1.197 0 CA-C-O 119.501 -0.61 . . . . 43.23 113.814 179.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 105' ' ' LEU . . . . . 0.564 HD22 ' HZ ' ' C' ' 85' ' ' PHE . 15.3 mt . . . . . 0 N--CA 1.494 1.761 0 CA-C-N 119.284 1.542 . . . . 73.03 113.595 -175.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 116' ' ' GLY . . . . . 0.431 ' HA3' ' HB3' ' C' ' 171' ' ' PRO . . . . . . . . 0 C--O 1.24 0.518 0 N-CA-C 111.965 -0.454 . . . . 45.25 111.965 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 60.4 mtt180 -80.26 174.91 11.13 Favored 'General case' 0 C--O 1.247 0.947 0 N-CA-C 108.963 -0.755 . . . . 64.44 108.963 175.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.39 130.91 43.19 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-O 120.865 0.364 . . . . 75.42 110.293 174.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 119' ' ' LEU . . . . . . . . . . . . . 5.1 tt -90.47 137.35 32.43 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 105.15 -2.167 . . . . 75.21 105.15 -179.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.443 ' H ' ' HD2' ' C' ' 120' ' ' ARG . 0.0 OUTLIER -127.48 148.88 50.31 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 110.14 -0.318 . . . . 72.31 110.14 -172.765 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.27 118.56 6.84 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.525 -0.761 . . . . 63.21 109.45 177.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 122' ' ' GLU . . . . . 0.417 ' HA ' ' O ' ' C' ' 177' ' ' VAL . 38.5 tt0 -83.93 132.54 34.76 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 109.772 -0.455 . . . . 73.22 109.772 178.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 123' ' ' LEU . . . . . 0.457 HD13 ' HB2' ' B' ' 183' ' ' ALA . 2.6 pt? -144.69 129.88 9.38 Favored Pre-proline 0 N--CA 1.481 1.1 0 C-N-CA 122.646 0.378 . . . . 73.3 110.185 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . 0.478 ' HA ' ' O ' ' C' ' 179' ' ' ARG . 17.3 Cg_exo -72.14 124.83 10.33 Favored 'Trans proline' 0 C--N 1.366 1.452 0 C-N-CA 122.218 1.945 . . . . 72.51 111.281 165.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 125' ' ' LEU . . . . . . . . . . . . . 38.0 tp -142.64 155.05 44.89 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.199 1.0 . . . . 74.03 109.015 -170.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 126' ' ' THR . . . . . 0.587 ' HB ' ' HG2' ' C' ' 129' ' ' GLU . 1.8 m -101.45 158.04 16.36 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 122.965 0.506 . . . . 61.53 110.289 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 127' ' ' LEU . . . . . 0.565 HD21 HD13 ' C' ' 180' ' ' LEU . 56.1 mt -64.45 -44.69 90.33 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.581 1.153 . . . . 62.25 110.92 178.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -59.93 -36.98 78.19 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 114.954 -1.021 . . . . 75.24 110.505 175.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 129' ' ' GLU . . . . . 0.587 ' HG2' ' HB ' ' C' ' 126' ' ' THR . 6.8 mm-40 -78.54 -22.08 47.81 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.105 0.562 . . . . 73.53 111.401 -179.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -73.79 -31.68 63.39 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 121.118 0.485 . . . . 64.34 109.935 174.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 131' ' ' PHE . . . . . 0.421 ' CZ ' ' HB3' ' C' ' 216' ' ' GLU . 49.4 t80 -69.19 -46.84 66.5 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 114.575 -1.193 . . . . 75.55 110.186 167.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 132' ' ' HIS . . . . . . . . . . . . . 28.1 m170 -78.03 -6.32 54.17 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.152 0.581 . . . . 60.22 111.608 -176.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -55.45 -94.29 0.01 OUTLIER Glycine 0 C--N 1.355 1.631 0 O-C-N 123.977 0.798 . . . . 65.31 113.259 175.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . 55.06 -137.0 45.1 Favored Glycine 0 C--N 1.355 1.636 0 CA-C-N 117.306 0.553 . . . . 53.24 112.799 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 135' ' ' GLU . . . . . 0.499 ' HG3' ' HB2' ' C' ' 148' ' ' ARG . 2.5 mp0 -76.29 96.4 3.96 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 108.839 -0.8 . . . . 71.2 108.839 172.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 136' ' ' ARG . . . . . 0.515 ' HA ' ' HE ' ' C' ' 136' ' ' ARG . 2.4 tpm_? -140.43 160.2 40.52 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-O 120.842 0.353 . . . . 72.12 110.296 -175.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 137' ' ' VAL . . . . . . . . . . . . . 19.9 m -74.73 96.19 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.191 0 CA-C-O 122.249 1.023 . . . . 71.12 111.741 -177.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 138' ' ' VAL . . . . . . . . . . . . . 42.8 t -90.36 136.54 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 114.621 -1.172 . . . . 72.14 108.758 172.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 139' ' ' GLU . . . . . 0.487 ' HA ' ' O ' ' C' ' 143' ' ' ARG . 1.4 tm-20 -124.09 115.89 21.89 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 108.165 -1.05 . . . . 74.31 108.165 174.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 140' ' ' VAL . . . . . . . . . . . . . 66.8 t -137.64 109.13 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 124.187 0.995 . . . . 63.22 109.148 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 63.59 25.75 14.45 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.265 1.026 . . . . 15.23 113.186 173.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 108.68 -8.24 34.29 Favored Glycine 0 N--CA 1.473 1.153 0 CA-C-N 116.666 -0.243 . . . . 45.25 113.006 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 143' ' ' ARG . . . . . 0.705 HH12 ' HA ' ' C' ' 164' ' ' MET . 27.4 mmm-85 -87.85 95.98 10.3 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.135 0.574 . . . . 73.04 110.718 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 47.1 ttp180 -96.9 98.84 10.44 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 108.631 -0.878 . . . . 71.51 108.631 175.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 145' ' ' VAL . . . . . 0.536 HG21 ' NH2' ' C' ' 143' ' ' ARG . 69.8 t -132.38 133.09 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.061 0.944 . . . . 75.03 110.525 -169.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 15.7 m -85.59 85.03 7.44 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 108.455 -0.943 . . . . 54.21 108.455 170.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 147' ' ' VAL . . . . . 0.404 ' HB ' HG12 ' C' ' 145' ' ' VAL . 10.4 p -118.54 145.35 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 123.232 0.613 . . . . 72.53 110.428 -171.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 148' ' ' ARG . . . . . 0.499 ' HB2' ' HG3' ' C' ' 135' ' ' GLU . 42.3 ttm180 -78.25 105.76 9.7 Favored 'General case' 0 C--N 1.348 0.518 0 N-CA-C 108.468 -0.938 . . . . 74.22 108.468 169.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 149' ' ' ILE . . . . . 0.633 HD12 HG21 ' C' ' 159' ' ' ILE . 6.9 pt -80.82 152.71 72.33 Favored Pre-proline 0 C--O 1.246 0.869 0 N-CA-C 107.299 -1.371 . . . . 71.41 107.299 165.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -39.79 108.91 0.08 OUTLIER 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 122.828 2.352 . . . . 61.44 112.12 168.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -63.98 107.91 0.85 Allowed 'Trans proline' 0 C--N 1.382 2.32 0 C-N-CA 122.928 2.419 . . . . 73.2 110.662 -176.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 152' ' ' GLY . . . . . . . . . . . . . . . 105.11 137.61 9.11 Favored Glycine 0 C--N 1.34 0.803 0 CA-C-N 115.837 -0.62 . . . . 54.32 113.955 -170.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 153' ' ' VAL . . . . . 0.704 HG21 HG21 ' C' ' 178' ' ' VAL . 1.9 m -134.57 171.84 17.13 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.192 0 C-N-CA 123.029 0.532 . . . . 71.13 110.922 -175.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 154' ' ' ARG . . . . . . . . . . . . . 8.7 mtp180 -135.34 145.06 47.03 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.176 0.99 . . . . 75.32 108.906 -174.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 155' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -56.17 126.07 24.51 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 118.601 0.637 . . . . 74.51 111.766 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 60.84 24.04 62.01 Favored Glycine 0 C--N 1.351 1.364 0 CA-C-N 115.305 -0.861 . . . . 64.51 114.01 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 157' ' ' SER . . . . . . . . . . . . . 37.7 m -107.91 163.59 13.0 Favored 'General case' 0 C--O 1.246 0.87 0 CA-C-O 121.209 0.528 . . . . 75.43 110.275 178.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 20.7 m -102.67 110.42 29.3 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 CA-C-N 114.997 -1.001 . . . . 64.44 110.528 -174.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 159' ' ' ILE . . . . . 0.633 HG21 HD12 ' C' ' 149' ' ' ILE . 7.4 mt -71.51 97.9 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.791 0 N-CA-C 108.251 -1.018 . . . . 52.25 108.251 172.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 160' ' ' ARG . . . . . 0.456 ' HA ' ' O ' ' C' ' 174' ' ' LEU . 15.3 ttp180 -79.62 102.63 9.02 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.591 -0.732 . . . . 72.21 110.572 -177.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 161' ' ' VAL . . . . . 0.645 HG22 ' HB3' ' C' ' 174' ' ' LEU . 0.7 OUTLIER -109.2 130.34 22.86 Favored Pre-proline 0 CA--C 1.548 0.892 0 N-CA-C 108.221 -1.029 . . . . 75.24 108.221 178.05 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -76.67 147.35 27.81 Favored 'Trans proline' 0 C--N 1.369 1.617 0 C-N-CA 122.528 2.152 . . . . 63.42 111.014 169.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 163' ' ' GLY . . . . . 0.521 ' HA2' ' OG ' ' C' ' 86' ' ' SER . . . 112.53 24.88 4.84 Favored Glycine 0 N--CA 1.47 0.917 0 CA-C-O 119.38 -0.678 . . . . 53.31 114.015 174.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 164' ' ' MET . . . . . 0.705 ' HA ' HH12 ' C' ' 143' ' ' ARG . 26.4 mmt -130.2 -79.75 0.54 Allowed 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 118.002 0.901 . . . . 73.35 110.769 -179.005 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 165' ' ' GLY . . . . . 0.611 ' H ' ' HA ' ' C' ' 173' ' ' ASP . . . 84.13 139.36 4.12 Favored Glycine 0 C--N 1.349 1.3 0 N-CA-C 114.033 0.373 . . . . 64.24 114.033 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . -76.37 -170.93 31.9 Favored Glycine 0 C--N 1.363 2.045 0 CA-C-N 117.213 0.507 . . . . 75.44 112.5 167.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 167' ' ' GLN . . . . . 0.607 ' HA ' HE21 ' C' ' 167' ' ' GLN . 0.0 OUTLIER -77.08 105.78 8.38 Favored 'General case' 0 N--CA 1.479 0.982 0 O-C-N 122.18 -0.6 . . . . 64.31 111.841 -174.192 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . 149.85 171.38 18.25 Favored Glycine 0 C--N 1.346 1.138 0 CA-C-O 121.492 0.496 . . . . 13.44 113.713 177.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 169' ' ' ASN . . . . . 0.503 ' HB3' ' HD2' ' C' ' 170' ' ' PRO . 1.0 OUTLIER -60.2 158.98 24.33 Favored Pre-proline 0 CA--C 1.559 1.317 0 C-N-CA 126.642 1.977 . . . . 62.44 109.498 175.537 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 170' ' ' PRO . . . . . 0.503 ' HD2' ' HB3' ' C' ' 169' ' ' ASN . 6.5 Cg_exo -0.05 75.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.403 3.415 1 C-N-CA 126.326 4.684 . . . . 51.41 115.511 -162.054 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 171' ' ' PRO . . . . . 0.522 ' HD2' ' O ' ' C' ' 85' ' ' PHE . 93.9 Cg_endo -81.97 176.54 8.18 Favored 'Trans proline' 0 C--N 1.37 1.708 0 C-N-CA 123.065 2.51 . . . . 74.02 114.965 -165.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 172' ' ' GLY . . . . . 0.436 ' O ' ' HA2' ' C' ' 165' ' ' GLY . . . -95.49 127.82 9.29 Favored Glycine 0 C--N 1.342 0.882 0 CA-C-N 114.247 -1.342 . . . . 74.42 110.118 -178.038 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 173' ' ' ASP . . . . . 0.611 ' HA ' ' H ' ' C' ' 165' ' ' GLY . 50.0 m-20 -72.85 -162.05 0.1 Allowed 'General case' 0 CA--C 1.555 1.15 0 N-CA-C 114.038 1.125 . . . . 74.51 114.038 -169.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 174' ' ' LEU . . . . . 0.645 ' HB3' HG22 ' C' ' 161' ' ' VAL . 38.2 tp -87.99 142.29 27.91 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 112.621 0.6 . . . . 75.22 112.621 -164.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 49.8 mt -129.21 95.23 3.99 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.681 1.592 . . . . 71.32 107.95 177.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 176' ' ' LEU . . . . . 0.582 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 95.4 mt -82.24 109.04 16.16 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 110.037 -0.357 . . . . 43.02 110.037 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 177' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' C' ' 122' ' ' GLU . 57.8 t -83.52 95.63 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 107.657 -1.238 . . . . 74.43 107.657 -179.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 178' ' ' VAL . . . . . 0.704 HG21 HG21 ' C' ' 153' ' ' VAL . 3.3 p -87.26 140.19 16.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 121.342 0.591 . . . . 74.01 112.117 -172.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 179' ' ' ARG . . . . . 0.478 ' O ' ' HA ' ' C' ' 124' ' ' PRO . 36.7 mmt180 -117.65 105.5 12.1 Favored 'General case' 0 C--N 1.342 0.276 0 C-N-CA 124.939 1.296 . . . . 72.33 107.872 177.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 180' ' ' LEU . . . . . 0.565 HD13 HD21 ' C' ' 127' ' ' LEU . 96.2 mt -73.45 143.02 46.84 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 122.547 0.339 . . . . 70.51 111.47 -175.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 181' ' ' LEU . . . . . . . . . . . . . 16.8 mt -61.19 166.86 4.47 Favored Pre-proline 0 CA--C 1.56 1.359 0 C-N-CA 124.66 1.184 . . . . 74.2 112.27 -178.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 99.4 Cg_exo -52.71 12.59 0.02 OUTLIER 'Trans proline' 0 C--N 1.39 2.755 0 C-N-CA 124.305 3.337 . . . . 64.12 118.361 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 183' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -129.38 74.24 81.08 Favored Pre-proline 0 CA--C 1.564 1.51 0 CA-C-N 119.069 0.85 . . . . 62.13 108.779 163.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 184' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -86.43 66.08 4.9 Favored 'Trans proline' 0 C--N 1.378 2.091 0 C-N-CA 123.099 2.532 . . . . 71.54 110.484 178.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 185' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 26.2 t -91.47 -45.25 14.53 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.552 0 CA-C-N 115.623 -0.717 . . . . 72.23 109.331 -166.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 186' ' ' PHE . . . . . 0.491 ' HB3' HD13 ' C' ' 193' ' ' LEU . 42.8 m-85 -103.95 101.45 11.23 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.534 0.734 . . . . 61.44 110.058 -173.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 187' ' ' ARG . . . . . . . . . . . . . 18.1 ttt180 -103.61 129.51 50.89 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.403 0.681 . . . . 75.14 109.298 -177.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 188' ' ' LEU . . . . . 0.557 HD13 ' HD2' ' C' ' 240' ' ' PHE . 53.7 tp -79.93 144.73 33.1 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 112.421 0.526 . . . . 74.14 112.421 -173.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -143.75 116.75 8.86 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 107.176 -1.416 . . . . 71.33 107.176 163.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 63.1 -97.08 0.18 Allowed Glycine 0 C--N 1.345 1.075 0 N-CA-C 111.436 -0.666 . . . . 74.2 111.436 -172.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 191' ' ' GLN . . . . . 0.421 ' HA ' HD11 ' C' ' 188' ' ' LEU . 45.8 mt-30 -129.01 -10.34 4.82 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.992 0.917 . . . . 60.21 110.675 171.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 192' ' ' ASP . . . . . 0.413 ' O ' HD12 ' C' ' 188' ' ' LEU . 22.2 m-20 -82.86 161.91 21.77 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.706 0.802 . . . . 65.13 110.448 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 193' ' ' LEU . . . . . 0.619 HD21 ' CD2' ' C' ' 240' ' ' PHE . 79.6 mt -123.03 161.33 24.5 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 122.885 0.474 . . . . 52.2 111.901 -176.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 194' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -124.27 128.99 49.98 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 107.824 -1.176 . . . . 75.43 107.824 168.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 195' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' C' ' 185' ' ' VAL . . . -136.33 -176.65 4.4 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.576 1.15 . . . . 65.11 109.305 -177.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 87.9 m -137.98 119.93 15.42 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 108.594 -0.891 . . . . 51.32 108.594 171.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 197' ' ' LEU . . . . . . . . . . . . . 55.8 tp -96.66 124.1 40.55 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.066 0.546 . . . . 73.5 110.606 -175.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -77.75 104.59 8.39 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.42 1.088 . . . . 44.52 109.64 179.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 199' ' ' VAL . . . . . 0.577 HG22 HG21 ' C' ' 210' ' ' VAL . 41.1 t -121.53 120.4 28.84 Favored Pre-proline 0 N--CA 1.481 1.105 0 C-N-CA 124.413 1.085 . . . . 61.21 109.196 -178.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 200' ' ' PRO . . . . . 0.504 ' HG2' HD12 ' C' ' 203' ' ' ILE . 12.9 Cg_exo -66.3 150.53 84.6 Favored 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 122.534 2.156 . . . . 71.34 112.12 173.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 201' ' ' ALA . . . . . . . . . . . . . . . -57.09 -48.42 97.44 Favored Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 123.746 0.819 . . . . 74.35 113.068 178.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 202' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -57.13 -49.34 14.42 Favored 'Trans proline' 0 C--N 1.383 2.369 0 C-N-CA 121.631 1.554 . . . . 63.15 112.856 175.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 203' ' ' ILE . . . . . 0.504 HD12 ' HG2' ' C' ' 200' ' ' PRO . 27.2 mt -63.11 -29.53 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 123.276 0.631 . . . . 63.4 111.055 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -74.45 -36.59 63.36 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.612 0.765 . . . . 75.02 112.217 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 205' ' ' VAL . . . . . . . . . . . . . 69.1 t -76.73 -41.15 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 122.909 0.483 . . . . 63.41 111.984 -179.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 206' ' ' VAL . . . . . 0.619 HG23 ' HE3' ' A' ' 270' ' ' LYS . 12.4 p -90.88 -34.61 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 112.218 0.451 . . . . 52.12 112.218 -176.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 94.03 127.65 4.86 Favored Glycine 0 C--N 1.344 0.999 0 N-CA-C 111.644 -0.582 . . . . 63.21 111.644 -167.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -156.81 -131.18 1.32 Allowed Glycine 0 C--N 1.346 1.108 0 N-CA-C 111.042 -0.823 . . . . 51.32 111.042 177.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 209' ' ' LYS . . . . . 0.492 ' HG2' ' HA ' ' C' ' 222' ' ' ALA . 8.2 mtmp? -147.07 140.77 25.71 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.486 0.714 . . . . 72.12 111.072 173.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 210' ' ' VAL . . . . . 0.577 HG21 HG22 ' C' ' 199' ' ' VAL . 17.8 m -136.6 138.92 45.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 125.216 1.406 . . . . 62.05 108.32 172.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 211' ' ' ARG . . . . . . . . . . . . . 36.0 ttm180 -86.82 126.82 34.88 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.376 0.51 . . . . 72.44 112.376 -173.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 212' ' ' ALA . . . . . 0.503 ' HB3' HG13 ' C' ' 219' ' ' VAL . . . -92.56 114.84 27.5 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 123.97 0.908 . . . . 74.43 108.568 164.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 213' ' ' MET . . . . . . . . . . . . . 5.4 tmm? -77.31 105.8 8.65 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 107.895 -1.15 . . . . 63.12 107.895 175.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 214' ' ' THR . . . . . 0.526 ' OG1' HG12 ' C' ' 219' ' ' VAL . 0.2 OUTLIER -100.75 173.09 6.68 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.49 0.662 . . . . 54.24 110.594 -176.269 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 215' ' ' LEU . . . . . 0.408 HD13 ' CE1' ' C' ' 240' ' ' PHE . 25.9 mt -69.91 -26.72 64.29 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 114.488 -1.233 . . . . 44.41 112.836 -169.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 216' ' ' GLU . . . . . 0.421 ' HB3' ' CZ ' ' C' ' 131' ' ' PHE . 0.0 OUTLIER -111.52 8.69 21.13 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.206 1.002 . . . . 71.0 111.614 -178.985 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 137.92 172.67 12.63 Favored Glycine 0 C--N 1.341 0.833 0 CA-C-O 119.803 -0.443 . . . . 64.11 112.607 179.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -87.62 119.48 1.36 Allowed 'Trans proline' 0 CA--C 1.555 1.562 0 C-N-CA 123.178 2.586 . . . . 52.13 113.099 -174.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 219' ' ' VAL . . . . . 0.526 HG12 ' OG1' ' C' ' 214' ' ' THR . 3.8 p -98.71 115.4 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 108.961 -0.755 . . . . 52.53 108.961 173.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 220' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -80.99 106.6 13.12 Favored 'General case' 0 C--O 1.244 0.77 0 N-CA-C 108.716 -0.846 . . . . 72.32 108.716 178.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 221' ' ' VAL . . . . . 0.658 ' HA ' ' HB2' ' B' ' 239' ' ' ALA . 88.3 t -77.85 127.34 38.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 114.786 -1.097 . . . . 74.03 110.589 -176.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 222' ' ' ALA . . . . . 0.492 ' HA ' ' HG2' ' C' ' 209' ' ' LYS . . . -95.58 130.51 42.41 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.585 0.754 . . . . 73.3 111.099 177.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 94.8 t -108.35 140.31 21.62 Favored Pre-proline 0 CA--C 1.558 1.28 0 C-N-CA 125.328 1.451 . . . . 73.11 110.065 -173.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 224' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -89.47 168.59 5.0 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 123.556 2.838 . . . . 54.33 111.958 169.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -58.35 142.66 97.82 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.386 2.057 . . . . 74.0 112.428 170.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 226' ' ' ARG . . . . . . . . . . . . . 30.8 mmt-85 66.44 95.12 0.06 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.531 1.533 . . . . 70.15 111.073 -176.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 227' ' ' THR . . . . . 0.435 HG22 HG11 ' C' ' 253' ' ' VAL . 25.7 m -137.29 116.78 12.84 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.637 0.775 . . . . 70.3 111.32 173.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 228' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -101.8 155.88 17.86 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.842 0.857 . . . . 74.32 111.17 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 229' ' ' ALA . . . . . 0.484 ' HB2' ' H ' ' C' ' 255' ' ' ILE . . . -70.37 144.0 51.75 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 115.197 -0.91 . . . . 62.12 109.986 175.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 97.02 -11.85 65.75 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-O 119.2 -0.778 . . . . 62.04 113.024 -172.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 231' ' ' ARG . . . . . . . . . . . . . 54.9 mtt180 -69.37 174.34 4.93 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 118.348 1.074 . . . . 74.12 111.04 170.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 232' ' ' LYS . . . . . 0.425 ' HD3' ' HB3' ' C' ' 250' ' ' TYR . 28.0 ttmt -147.75 141.95 26.15 Favored 'General case' 0 C--N 1.355 0.819 0 CA-C-O 121.371 0.605 . . . . 71.45 112.222 -176.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 233' ' ' LEU . . . . . 0.539 ' O ' ' HA ' ' C' ' 250' ' ' TYR . 3.3 mp -114.63 154.53 28.21 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.945 1.298 . . . . 74.21 109.519 -179.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -122.95 120.72 34.23 Favored 'General case' 0 C--O 1.243 0.744 0 N-CA-C 109.19 -0.67 . . . . 72.34 109.19 167.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 44.5 mt -107.54 125.35 51.19 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.418 -0.956 . . . . 73.43 108.418 177.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -74.3 130.11 39.08 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.848 0.859 . . . . 71.55 112.192 -171.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 77.87 -0.69 71.03 Favored Glycine 0 C--N 1.35 1.336 0 CA-C-N 115.16 -0.927 . . . . 71.42 114.013 178.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -92.11 8.6 37.11 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.361 0.664 . . . . 72.03 112.06 -173.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -81.63 -168.29 40.5 Favored Glycine 0 C--N 1.349 1.303 0 N-CA-C 111.367 -0.693 . . . . 31.21 111.367 167.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 240' ' ' PHE . . . . . 0.619 ' CD2' HD21 ' C' ' 193' ' ' LEU . 18.4 m-85 -78.86 149.59 74.16 Favored Pre-proline 0 CA--C 1.558 1.287 0 CA-C-N 117.105 0.452 . . . . 75.14 110.249 178.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 241' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -82.65 142.18 11.38 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 123.492 2.794 . . . . 70.21 112.501 -173.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -132.63 165.06 23.91 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-O 119.422 -0.654 . . . . 70.14 112.69 -178.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -67.79 -1.81 7.48 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 123.527 2.818 . . . . 71.42 113.768 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -121.82 -15.45 7.88 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.657 0.783 . . . . 71.42 111.299 174.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 154.7 174.7 24.99 Favored Glycine 0 C--N 1.357 1.703 0 CA-C-O 120.16 -0.244 . . . . 51.32 113.474 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 246' ' ' ARG . . . . . . . . . . . . . 59.3 mtm180 -91.94 157.32 16.89 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 123.983 0.913 . . . . 61.31 111.049 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -85.38 -161.19 34.14 Favored Glycine 0 C--N 1.353 1.493 0 CA-C-O 120.137 -0.257 . . . . 63.23 113.705 176.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -127.41 136.47 51.89 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 117.458 0.629 . . . . 73.54 109.906 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 249' ' ' LEU . . . . . 0.447 HD11 ' HB2' ' C' ' 195' ' ' ALA . 31.0 tp -86.22 119.87 26.97 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.6 0.76 . . . . 74.23 110.59 -177.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 250' ' ' TYR . . . . . 0.539 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 14.3 m-85 -100.84 102.79 13.93 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 109.372 -0.603 . . . . 71.43 109.372 176.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 251' ' ' LEU . . . . . 0.435 ' HB2' HD13 ' C' ' 233' ' ' LEU . 1.3 mp -97.52 135.93 38.66 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.58 -0.896 . . . . 64.53 108.58 -178.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -98.17 121.07 39.64 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 108.906 -0.776 . . . . 73.41 108.906 175.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 253' ' ' VAL . . . . . 0.435 HG11 HG22 ' C' ' 227' ' ' THR . 92.0 t -58.48 138.32 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 124.403 1.081 . . . . 73.5 111.897 -176.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 254' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -131.72 109.06 9.9 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.22 1.008 . . . . 74.13 108.295 -178.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 255' ' ' ILE . . . . . 0.484 ' H ' ' HB2' ' C' ' 229' ' ' ALA . 41.4 mm -81.34 123.05 37.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 122.759 0.423 . . . . 75.24 110.186 179.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 256' ' ' THR . . . . . 0.431 ' O ' ' HA ' ' C' ' 200' ' ' PRO . 0.0 OUTLIER -125.79 151.78 46.29 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.157 1.383 . . . . 53.32 109.177 -179.565 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 2.8 pp -114.77 153.14 46.9 Favored Pre-proline 0 N--CA 1.49 1.532 0 C-N-CA 122.883 0.473 . . . . 64.54 111.137 -176.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 258' ' ' PRO . . . . . 0.554 ' HB3' ' HE2' ' A' ' 276' ' ' TYR . 37.7 Cg_endo -62.01 -2.9 3.28 Favored 'Trans proline' 0 C--N 1.385 2.46 0 C-N-CA 123.451 2.767 . . . . 73.21 115.119 -173.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 58.38 -83.33 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.111 1.364 . . . . 72.3 111.567 -173.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 260' ' ' ARG . . . . . 0.475 HH21 ' HB2' ' C' ' 258' ' ' PRO . 0.0 OUTLIER -66.41 158.09 30.24 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 122.878 0.471 . . . . 73.41 110.631 -177.178 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 261' ' ' LEU . . . . . 0.653 HD13 ' HA ' ' C' ' 266' ' ' GLU . 95.7 mt -145.96 130.86 18.15 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.542 -0.54 . . . . 71.21 109.542 175.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 58.3 p -82.84 154.69 67.97 Favored Pre-proline 0 N--CA 1.479 0.988 0 CA-C-O 117.264 -1.351 . . . . 61.23 107.729 170.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -34.66 -40.59 0.23 Allowed 'Trans proline' 0 N--CA 1.508 2.353 0 C-N-CA 124.314 3.343 . . . . 74.2 116.52 -175.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -76.58 -54.95 5.99 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.83 0.452 . . . . 71.04 110.963 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 265' ' ' GLU . . . . . 0.469 ' HB3' HD22 ' C' ' 261' ' ' LEU . 16.0 mm-40 -44.56 -51.88 8.55 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 124.1 0.875 . . . . 65.11 109.84 173.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 266' ' ' GLU . . . . . 0.653 ' HA ' HD13 ' C' ' 261' ' ' LEU . 7.9 tp10 -48.82 -60.29 2.86 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 112.856 -1.974 . . . . 64.21 111.007 176.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -53.23 -43.43 67.29 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 124.131 0.894 . . . . 70.32 112.92 -175.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 268' ' ' LEU . . . . . 0.418 ' O ' ' HG ' ' C' ' 272' ' ' LEU . 10.5 mp -65.13 -54.12 34.63 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 116.564 -0.289 . . . . 52.44 111.123 179.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 93.3 m95 -60.36 -31.51 70.41 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 111.76 0.281 . . . . 61.11 111.76 178.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 270' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' C' ' 266' ' ' GLU . 4.5 mmmp? -61.4 -52.63 63.81 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.483 0.713 . . . . 75.43 109.801 176.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 42.3 mtpt -59.8 -38.9 83.25 Favored 'General case' 0 N--CA 1.481 1.102 0 O-C-N 123.858 0.724 . . . . 75.33 111.848 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 272' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' C' ' 268' ' ' LEU . 78.1 mt -63.0 -41.88 99.7 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 123.823 0.702 . . . . 74.33 111.174 178.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -71.81 -41.13 68.61 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 115.599 -0.728 . . . . 34.13 112.257 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -67.84 -34.07 76.0 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.263 0.625 . . . . 63.21 110.084 179.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -62.87 -37.53 87.24 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 114.974 -1.012 . . . . 70.04 110.451 172.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 276' ' ' TYR . . . . . 0.539 ' HE1' ' HB3' ' A' ' 258' ' ' PRO . 0.2 OUTLIER -66.72 -44.84 80.54 Favored 'General case' 0 CA--C 1.554 1.107 0 CA-C-N 115.184 -0.916 . . . . 75.52 111.612 173.903 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -69.04 -22.61 64.04 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 122.707 0.403 . . . . 44.24 110.15 -178.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -69.49 0.34 5.4 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.982 0.913 . . . . 55.2 113.012 175.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 279' ' ' ARG . . . . . . . . . . . . . 73.3 mtm180 -82.24 -31.25 30.31 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 117.945 0.339 . . . . 71.52 110.335 168.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.98 0 C-N-CA 123.763 0.825 . . . . 75.14 109.246 -177.252 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.416 ' HE2' ' HD2' ' A' ' 69' ' ' TYR . 40.9 ttmt . . . . . 0 N--CA 1.483 1.224 0 N-CA-C 113.255 0.835 . . . . 62.43 113.255 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.411 ' HE2' HD11 ' A' ' 10' ' ' ILE . 49.5 mtpt -80.93 120.17 24.4 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 108.061 -1.088 . . . . 74.32 108.061 168.089 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -71.22 94.92 1.21 Allowed 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 108.23 -1.026 . . . . 61.41 108.23 178.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -63.39 -28.7 70.17 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 114.513 -1.221 . . . . 73.34 112.016 -172.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -67.01 -43.48 82.79 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 122.888 0.475 . . . . 73.33 110.14 176.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.05 -43.66 98.0 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 123.65 0.594 . . . . 60.32 110.467 177.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.411 HD11 ' HE2' ' A' ' 5' ' ' LYS . 65.8 mt -57.4 -40.62 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 123.917 0.761 . . . . 74.23 110.662 176.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 87.2 mt -79.4 -21.09 46.11 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 112.448 0.536 . . . . 51.33 112.448 177.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.62 49.59 8.91 Favored Glycine 0 CA--C 1.539 1.56 0 CA-C-N 117.688 0.222 . . . . 53.33 113.35 -175.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.547 HG13 ' HB2' ' A' ' 25' ' ' ALA . 3.4 m -134.25 161.45 63.64 Favored Pre-proline 0 N--CA 1.491 1.602 0 C-N-CA 125.226 1.41 . . . . 71.43 109.581 175.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -46.73 147.76 4.31 Favored 'Trans proline' 0 C--N 1.392 2.862 0 C-N-CA 123.104 2.536 . . . . 50.12 113.032 173.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 61.7 mtp180 -80.88 27.32 0.39 Allowed 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 113.359 0.874 . . . . 75.43 113.359 -166.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -161.08 20.74 0.13 Allowed 'General case' 0 CA--C 1.559 1.319 0 C-N-CA 124.894 1.278 . . . . 64.11 108.646 172.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.58 147.25 51.95 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.762 1.225 . . . . 64.31 112.731 -171.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.2 p -79.89 176.95 9.27 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.806 0.843 . . . . 71.11 112.658 -175.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -52.2 -47.09 65.79 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.492 1.517 . . . . 64.21 113.09 -172.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.453 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 17.2 tp10 -75.42 -28.16 59.27 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 111.656 0.243 . . . . 72.43 111.656 -174.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -65.81 -46.78 77.36 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 121.031 0.443 . . . . 64.03 109.973 174.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.628 HG12 ' HB3' ' A' ' 57' ' ' LEU . 1.7 mp -61.33 -36.39 72.57 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 CA-C-N 114.632 -1.167 . . . . 73.31 110.912 174.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.494 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 1.6 tppp? -63.12 -47.98 80.48 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.937 0.895 . . . . 71.24 109.639 179.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 20' ' ' GLU . 52.8 mtm180 -67.76 -38.22 83.16 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.166 0.987 . . . . 54.12 111.424 -177.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.547 ' HB2' HG13 ' A' ' 13' ' ' VAL . . . -61.72 -43.88 98.01 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.725 0.81 . . . . 64.0 110.49 176.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -59.07 -49.24 78.65 Favored 'General case' 0 C--O 1.202 -1.404 0 CA-C-N 114.335 -1.302 . . . . 73.1 110.238 174.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 88.2 mttt -52.63 -50.33 63.35 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.732 0.813 . . . . 74.22 110.854 -178.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 54.1 ttp180 -55.8 -55.88 27.11 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 114.501 -1.227 . . . . 71.15 111.571 178.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.614 ' HB3' HD13 ' A' ' 50' ' ' ILE . 96.8 mt -76.64 -18.97 58.28 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.476 0.711 . . . . 74.11 112.527 -174.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -86.33 -29.16 23.21 Favored 'General case' 0 C--O 1.211 -0.93 0 C-N-CA 123.134 0.574 . . . . 63.3 110.153 -178.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 45.7 mtp180 -83.94 -35.01 24.33 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 122.446 0.298 . . . . 72.33 110.397 173.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -71.79 -45.49 61.42 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.332 0.653 . . . . 63.33 110.72 -179.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.482 ' HA ' HD22 ' A' ' 38' ' ' ASN . 22.4 m-85 -107.56 35.98 2.89 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.516 0.726 . . . . 63.25 109.829 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -66.11 114.72 17.88 Favored Pre-proline 0 N--CA 1.476 0.866 0 N-CA-C 108.63 -0.878 . . . . 63.41 108.63 178.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.404 ' O ' ' HG2' ' A' ' 39' ' ' LYS . 32.1 Cg_exo -58.04 -15.2 21.64 Favored 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 123.249 2.633 . . . . 74.13 114.564 -168.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -94.66 -32.1 13.54 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.814 0.846 . . . . 72.45 111.882 177.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 99.3 t -85.46 -59.97 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 CA-C-O 121.679 0.752 . . . . 65.53 109.084 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.482 HD22 ' HA ' ' A' ' 33' ' ' TYR . 37.4 t30 -98.7 75.64 2.15 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 114.507 -1.224 . . . . 61.35 108.745 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.404 ' HG2' ' O ' ' A' ' 35' ' ' PRO . 45.4 mtmt -78.04 79.6 4.49 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 114.538 -1.21 . . . . 73.11 108.891 177.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.2 m -131.59 125.62 20.66 Favored Pre-proline 0 N--CA 1.471 0.623 0 N-CA-C 108.812 -0.811 . . . . 54.41 108.812 176.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -43.09 -45.73 9.33 Favored 'Trans proline' 0 C--N 1.383 2.392 0 C-N-CA 123.498 2.798 . . . . 72.23 113.281 171.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -51.27 -47.53 62.47 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.893 1.277 . . . . 64.43 111.194 174.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.23 -23.67 62.05 Favored 'General case' 0 C--N 1.35 0.623 0 CA-C-N 114.498 -1.228 . . . . 72.14 111.13 -177.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.457 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 46.9 mt-10 -78.82 -41.27 30.64 Favored 'General case' 0 C--N 1.359 0.989 0 O-C-N 123.623 0.577 . . . . 62.01 109.651 -178.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -64.58 -46.89 80.79 Favored 'General case' 0 C--O 1.251 1.174 0 C-N-CA 124.25 1.02 . . . . 62.44 110.622 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -61.9 -44.0 97.69 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 114.951 -1.022 . . . . 74.03 110.087 173.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -61.56 -31.36 71.39 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.717 0.807 . . . . 73.24 110.867 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' A' ' 44' ' ' GLU . 33.0 mmtp -65.16 -50.64 65.18 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.072 0.549 . . . . 75.14 109.993 175.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -64.51 -29.88 70.91 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 123.247 0.342 . . . . 71.44 111.56 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.614 HD13 ' HB3' ' A' ' 29' ' ' LEU . 84.6 mt -74.1 -31.89 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.577 1.151 . . . . 70.53 110.208 175.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -72.59 -36.64 68.19 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.579 0.752 . . . . 73.43 110.522 175.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -66.88 -49.46 65.58 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.286 1.034 . . . . 63.42 109.976 176.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.1 -52.06 66.98 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 114.558 -1.201 . . . . 65.45 111.138 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -63.52 -33.65 76.04 Favored 'General case' 0 C--O 1.209 -1.026 0 CA-C-N 115.166 -0.924 . . . . 72.32 110.615 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.54 -56.46 20.99 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.798 0.439 . . . . 53.01 110.861 177.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.415 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 48.5 t -66.28 -33.42 63.43 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 CA-C-N 114.595 -1.184 . . . . 74.52 111.303 -176.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.628 ' HB3' HG12 ' A' ' 22' ' ' ILE . 75.4 mt -102.38 -5.02 24.63 Favored 'General case' 0 CA--C 1.555 1.163 0 N-CA-C 114.416 1.265 . . . . 62.04 114.416 -172.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 34.8 t -75.03 -56.82 4.36 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 118.497 0.59 . . . . 74.34 109.916 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.5 ' HB2' ' HE3' ' A' ' 62' ' ' LYS . 12.9 m-20 -80.62 127.38 75.67 Favored Pre-proline 0 C--O 1.255 1.35 0 CA-C-N 115.372 -0.831 . . . . 74.34 110.041 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.464 ' O ' ' HG2' ' A' ' 64' ' ' ARG . 64.6 Cg_exo -53.11 -26.43 32.93 Favored 'Trans proline' 0 C--N 1.387 2.575 0 C-N-CA 123.57 2.847 . . . . 72.41 113.02 177.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -54.13 -65.72 0.52 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.006 1.322 . . . . 72.3 111.688 174.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.58 ' HE2' ' HB3' ' A' ' 84' ' ' ASP . 21.9 mttt -72.08 -26.14 62.04 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 115.667 -0.697 . . . . 74.54 110.117 -173.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.6 tpt180 -55.34 -51.34 67.1 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 124.015 0.822 . . . . 74.11 109.802 168.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.464 ' HG2' ' O ' ' A' ' 60' ' ' PRO . 1.7 mmp_? -63.67 -36.56 84.24 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.889 0.476 . . . . 74.25 111.392 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.622 HD11 ' HG3' ' A' ' 79' ' ' PRO . 79.5 mt -60.73 -40.19 84.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 123.753 0.658 . . . . 64.42 110.535 175.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -69.18 -41.83 76.66 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.827 -0.624 . . . . 75.4 109.462 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -61.36 -43.09 99.46 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.222 0.609 . . . . 64.04 110.899 177.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 50.9 p -72.07 -20.44 61.66 Favored 'General case' 0 C--N 1.348 0.537 0 CA-C-N 115.701 -0.682 . . . . 75.13 110.653 177.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.416 ' HD2' ' HE2' ' A' ' 4' ' ' LYS . 46.2 t80 -86.01 101.18 12.69 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 108.243 -1.021 . . . . 63.45 108.243 173.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 115.2 17.63 6.63 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.894 -0.882 . . . . 52.54 110.894 -166.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 90.6 m -142.17 -61.39 0.45 Allowed 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 103.822 -2.659 . . . . 71.23 103.822 173.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 50.9 m -79.92 146.35 32.17 Favored 'General case' 0 C--O 1.251 1.178 0 N-CA-C 105.032 -2.211 . . . . 74.23 105.032 157.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.36 -39.85 10.26 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.025 0.53 . . . . 74.04 111.375 -177.163 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.47 155.9 56.65 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 123.633 0.773 . . . . 75.1 110.528 -176.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -57.08 119.71 7.14 Favored 'Trans proline' 0 C--N 1.384 2.4 0 C-N-CA 122.673 2.249 . . . . 75.41 111.266 175.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.45 155.99 23.53 Favored 'Trans proline' 0 C--N 1.384 2.431 0 C-N-CA 122.909 2.406 . . . . 74.25 112.841 178.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -56.12 135.45 69.93 Favored 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 122.512 2.141 . . . . 62.44 111.123 174.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -42.61 118.69 1.2 Allowed 'Trans proline' 0 C--N 1.383 2.36 0 C-N-CA 123.687 2.925 . . . . 43.51 113.821 177.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.622 ' HG3' HD11 ' A' ' 65' ' ' ILE . 52.2 Cg_endo -62.31 166.58 12.7 Favored 'Trans proline' 0 C--N 1.383 2.391 0 C-N-CA 123.723 2.949 . . . . 71.05 112.342 -176.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -49.45 83.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.398 3.155 0 C-N-CA 124.095 3.197 . . . . 51.35 114.007 -175.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 136.26 -61.81 0.61 Allowed Glycine 0 N--CA 1.445 -0.701 0 CA-C-N 113.905 -1.498 . . . . 62.41 109.551 -176.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.407 ' O ' ' HG2' ' A' ' 79' ' ' PRO . . . 144.86 -157.75 27.39 Favored Glycine 0 N--CA 1.468 0.812 0 N-CA-C 110.579 -1.008 . . . . 53.03 110.579 -169.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.407 ' HE1' HD13 ' A' ' 65' ' ' ILE . 96.3 m-85 -105.1 106.54 17.08 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.489 0.716 . . . . 74.41 109.884 -177.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.58 ' HB3' ' HE2' ' A' ' 62' ' ' LYS . 5.0 t70 -78.98 138.59 38.12 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.298 1.039 . . . . 71.31 112.313 -177.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -136.59 68.98 1.42 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.802 0.841 . . . . 70.22 109.812 170.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 59.0 m -53.32 94.71 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 125.104 1.362 . . . . 74.44 113.766 -176.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.34 9.14 63.76 Favored Glycine 0 C--N 1.352 1.436 0 CA-C-N 115.901 -0.591 . . . . 70.11 114.144 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -96.23 130.59 43.27 Favored 'General case' 0 C--O 1.241 0.63 0 N-CA-C 107.71 -1.218 . . . . 72.34 107.71 -179.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -75.32 81.56 2.42 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 121.668 0.747 . . . . 71.44 111.134 -171.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.568 HG23 ' HZ ' ' A' ' 97' ' ' PHE . 0.9 OUTLIER -40.02 -41.19 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 126.633 1.973 . . . . 75.21 112.4 171.66 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -69.51 -5.85 26.84 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.328 1.051 . . . . 75.33 113.167 -172.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -115.45 -12.08 11.74 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.997 0.519 . . . . 45.35 111.753 -177.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 20.8 m-30 -85.53 168.57 14.39 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 112.919 0.711 . . . . 71.01 112.919 -167.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 98.7 p -65.69 168.51 7.59 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 124.919 1.288 . . . . 74.5 114.233 -164.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.24 -35.9 82.34 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 115.308 -0.86 . . . . 74.31 111.148 174.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -58.29 -47.08 84.79 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.96 0.904 . . . . 75.03 109.901 177.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.568 ' HZ ' HG23 ' A' ' 90' ' ' VAL . 5.3 t80 -56.94 -52.28 65.83 Favored 'General case' 0 CA--C 1.554 1.126 0 O-C-N 124.348 1.03 . . . . 63.23 110.114 172.226 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -65.59 -17.23 64.43 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 112.81 0.67 . . . . 73.05 112.81 -173.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -99.9 -36.5 9.38 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 112.93 0.715 . . . . 70.02 112.93 178.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 50.6 tp -78.23 -41.91 32.82 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-O 121.392 0.615 . . . . 55.03 110.355 -179.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -97.18 -24.88 15.51 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.213 1.005 . . . . 72.11 111.278 -175.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -44.17 -56.13 5.47 Favored Glycine 0 CA--C 1.545 1.958 0 CA-C-O 118.807 -0.996 . . . . 72.43 115.193 -178.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_exo -47.32 -25.8 5.13 Favored 'Trans proline' 0 C--N 1.391 2.769 0 C-N-CA 124.039 3.16 . . . . 23.1 115.53 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -133.11 28.96 3.27 Favored Glycine 0 C--N 1.354 1.581 0 CA-C-O 119.53 -0.594 . . . . 44.4 113.427 -177.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 44.6 mt -72.19 72.25 0.9 Allowed 'General case' 0 CA--C 1.563 1.477 0 CA-C-N 117.316 0.558 . . . . 74.25 112.151 170.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 11.8 p90 32.4 -130.76 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 127.27 2.228 . . . . 72.25 116.199 163.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.443 ' HA2' ' H ' ' A' ' 169' ' ' ASN . . . 92.2 36.36 6.32 Favored Glycine 0 C--N 1.354 1.541 0 N-CA-C 111.49 -0.644 . . . . 44.0 111.49 -165.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.359 1.838 0 CA-C-O 121.434 0.463 . . . . 71.34 112.847 167.84 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 48.6 tptt . . . . . 0 N--CA 1.505 2.284 0 N-CA-C 115.85 1.796 . . . . 72.15 115.85 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.714 ' H ' ' HA3' ' A' ' 172' ' ' GLY . . . -121.29 -155.56 9.53 Favored Glycine 0 CA--C 1.548 2.152 0 C-N-CA 127.317 2.389 . . . . 55.22 112.76 162.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.437 ' H ' ' HA ' ' A' ' 171' ' ' PRO . 0.0 OUTLIER -67.06 143.46 56.7 Favored 'General case' 0 C--O 1.285 2.97 0 N-CA-C 116.361 1.985 . . . . 71.34 116.361 178.926 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.598 ' HA ' ' O ' ' A' ' 173' ' ' ASP . 14.8 p-10 -76.16 104.57 6.75 Favored 'General case' 0 CA--C 1.552 1.052 0 CA-C-N 112.175 -2.284 . . . . 74.23 113.151 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.462 ' O ' HD12 ' A' ' 174' ' ' LEU . 6.4 tt -93.37 165.36 12.82 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.1 1.36 . . . . 70.23 107.556 174.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 30.4 ttp85 -112.66 130.82 55.91 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 118.503 0.592 . . . . 74.51 110.127 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.641 ' HB3' HD11 ' A' ' 174' ' ' LEU . . . -146.33 176.54 9.69 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.998 0.919 . . . . 41.51 110.886 -175.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -107.89 139.88 41.83 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-N 114.533 -1.212 . . . . 61.0 109.197 -171.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.587 ' HB2' HD13 ' A' ' 176' ' ' LEU . 45.7 tp -100.18 96.97 5.55 Favored Pre-proline 0 N--CA 1.473 0.71 0 N-CA-C 107.368 -1.345 . . . . 54.05 107.368 170.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.512 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 53.0 Cg_endo -75.54 107.31 2.44 Favored 'Trans proline' 0 C--N 1.37 1.704 0 N-CA-C 106.923 -1.991 . . . . 75.33 106.923 171.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.524 ' HB3' HD23 ' A' ' 180' ' ' LEU . 59.5 tp -116.54 127.47 54.55 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 109.241 -0.651 . . . . 64.01 109.241 -167.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.634 HG21 ' HB2' ' B' ' 4' ' ' SER . 50.6 m -57.03 130.55 46.58 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 124.66 1.225 . . . . 71.34 110.965 -178.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 35.4 mt -47.62 -47.22 29.01 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.358 1.063 . . . . 70.54 111.232 -178.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -56.23 -49.53 73.87 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 114.391 -1.277 . . . . 75.32 110.695 178.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -64.26 -33.71 76.45 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.298 0.639 . . . . 64.33 111.7 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.474 ' HB2' HD22 ' A' ' 180' ' ' LEU . . . -62.46 -38.68 90.76 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.459 0.704 . . . . 41.43 110.825 177.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -66.33 -46.02 78.26 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 114.874 -1.057 . . . . 74.51 111.071 173.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.499 ' HE1' ' HA ' ' B' ' 2' ' ' LYS . 24.0 m170 -66.55 -65.52 0.67 Allowed 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.282 0.633 . . . . 75.25 111.378 -173.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.509 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 90.82 179.76 43.15 Favored Glycine 0 C--N 1.346 1.117 0 CA-C-N 116.14 -0.482 . . . . 71.54 112.421 -177.029 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.59 -157.45 27.67 Favored Glycine 0 C--N 1.345 1.038 0 C-N-CA 123.298 0.475 . . . . 70.42 112.313 179.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 13.7 mp0 -70.98 98.77 1.67 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.929 0.892 . . . . 73.14 111.091 -176.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 7.1 tpp180 -94.01 119.95 33.59 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.872 0.869 . . . . 74.4 109.295 172.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.489 ' O ' HG23 ' B' ' 5' ' ' THR . 76.2 t -79.44 106.01 9.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 114.749 -1.114 . . . . 71.24 109.218 172.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.441 HG23 HG13 ' B' ' 6' ' ' ILE . 3.6 p -111.32 125.1 68.63 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 N-CA-C 108.86 -0.793 . . . . 73.14 108.86 172.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.553 ' HB3' ' HG3' ' A' ' 144' ' ' ARG . 6.4 pt-20 -124.97 116.46 22.19 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.547 0.739 . . . . 71.3 111.426 -166.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.476 HG11 ' HB2' ' B' ' 8' ' ' LEU . 9.2 p -159.92 155.19 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.166 0.986 . . . . 75.1 108.963 177.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 61.63 22.68 13.13 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 124.274 1.03 . . . . 74.24 112.757 174.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 87.42 -13.05 61.15 Favored Glycine 0 C--N 1.353 1.486 0 CA-C-N 116.369 -0.378 . . . . 31.1 113.285 -177.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 22.7 tpt180 -95.81 115.09 26.92 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.395 0.678 . . . . 72.12 110.251 178.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.553 ' HG3' ' HB3' ' A' ' 139' ' ' GLU . 13.1 ttt180 -100.55 88.22 3.57 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.081 0.952 . . . . 74.41 108.726 173.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 11.2 p -94.88 144.99 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 123.083 0.553 . . . . 73.53 110.909 -173.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 22.9 t -107.64 86.97 2.39 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 109.226 -0.657 . . . . 31.45 109.226 176.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.7 p -85.02 124.17 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 123.305 0.642 . . . . 73.42 110.003 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 61.6 ttt85 -75.88 95.74 3.58 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.311 0.577 . . . . 74.14 109.652 177.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.509 HG13 ' HA2' ' A' ' 133' ' ' GLY . 33.6 pt -77.37 140.2 64.76 Favored Pre-proline 0 CA--C 1.557 1.225 0 CA-C-N 115.255 -0.884 . . . . 74.13 109.977 175.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -61.86 130.83 32.54 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.547 2.164 . . . . 60.34 112.301 174.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -61.96 112.11 1.42 Allowed 'Trans proline' 0 C--N 1.377 2.065 0 C-N-CA 122.389 2.059 . . . . 74.15 111.45 170.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 84.37 46.3 5.87 Favored Glycine 0 C--N 1.343 0.951 0 N-CA-C 111.128 -0.789 . . . . 75.51 111.128 -171.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -80.36 153.1 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 N-CA-C 109.525 -0.546 . . . . 75.43 109.525 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.542 ' HG2' ' HA ' ' A' ' 191' ' ' GLN . 0.0 OUTLIER -124.91 159.46 31.09 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 123.448 0.699 . . . . 73.23 110.926 -174.629 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.437 ' HB2' ' HB3' ' A' ' 188' ' ' LEU . 10.4 tp10 -57.73 126.29 26.71 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.222 1.409 . . . . 72.32 110.998 -179.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 103.52 -10.32 53.46 Favored Glycine 0 C--N 1.347 1.148 0 CA-C-O 119.175 -0.792 . . . . 14.21 113.993 178.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 33.6 t -63.63 112.18 2.71 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 117.693 0.746 . . . . 74.23 109.962 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.471 HG22 HG22 ' A' ' 177' ' ' VAL . 41.8 t -89.51 115.96 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.156 0.582 . . . . 72.34 110.672 -176.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 55.2 mt -108.22 108.14 24.54 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 123.967 0.907 . . . . 75.24 108.684 175.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -75.39 101.17 4.67 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 108.68 -0.859 . . . . 61.32 108.68 174.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.438 HG11 HD12 ' A' ' 176' ' ' LEU . 7.6 p -124.15 113.58 27.99 Favored Pre-proline 0 CA--C 1.541 0.62 0 N-CA-C 108.26 -1.015 . . . . 61.33 108.26 -173.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.414 ' HA ' ' H ' ' A' ' 174' ' ' LEU . 10.1 Cg_exo -71.66 146.43 48.94 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 121.106 1.204 . . . . 74.53 111.839 178.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.538 ' H ' ' HA ' ' A' ' 173' ' ' ASP . . . 131.36 -23.91 4.24 Favored Glycine 0 C--N 1.344 0.977 0 N-CA-C 116.646 1.418 . . . . 70.43 116.646 170.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -124.47 -3.8 7.84 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 113.498 0.925 . . . . 64.15 113.498 -165.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.691 ' HA2' HD13 ' A' ' 174' ' ' LEU . . . -74.7 -100.23 0.1 OUTLIER Glycine 0 N--CA 1.474 1.202 0 CA-C-O 118.653 -1.082 . . . . 73.33 113.836 -174.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.659 ' HA3' ' HB2' ' A' ' 171' ' ' PRO . . . -70.04 167.17 49.19 Favored Glycine 0 C--N 1.377 2.808 0 C-N-CA 118.079 -2.01 . . . . 74.5 111.333 172.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.526 ' HA ' HE21 ' A' ' 167' ' ' GLN . 0.0 OUTLIER -104.32 102.85 12.52 Favored 'General case' 0 CA--C 1.56 1.359 0 CA-C-N 118.675 1.238 . . . . 75.42 114.095 -177.434 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 122.1 -161.64 16.17 Favored Glycine 0 C--N 1.369 2.392 0 N-CA-C 115.653 1.021 . . . . 64.21 115.653 164.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . 0.443 ' H ' ' HA2' ' A' ' 107' ' ' GLY . 20.4 m120 -63.88 -45.91 81.27 Favored Pre-proline 0 CA--C 1.576 1.953 0 CA-C-O 118.494 -0.765 . . . . 63.11 111.023 174.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.472 ' HB2' ' HD3' ' A' ' 171' ' ' PRO . 12.6 Cg_exo -72.67 -56.7 0.09 OUTLIER 'Trans proline' 0 CA--C 1.593 3.451 0 CA-C-N 121.973 1.74 . . . . 71.13 116.001 175.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.659 ' HB2' ' HA3' ' A' ' 166' ' ' GLY . 18.8 Cg_endo -98.75 155.27 0.7 Allowed 'Trans proline' 0 C--N 1.399 3.189 0 C-N-CA 122.647 2.231 . . . . 71.25 111.24 167.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.714 ' HA3' ' H ' ' A' ' 116' ' ' GLY . . . -170.13 -80.04 0.05 OUTLIER Glycine 0 C--N 1.379 2.951 0 N-CA-C 120.489 2.956 . . . . 72.4 120.489 -164.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.598 ' O ' ' HA ' ' A' ' 118' ' ' ASP . 59.0 m-20 -63.08 162.96 10.71 Favored 'General case' 0 N--CA 1.509 2.476 0 CA-C-N 118.054 0.927 . . . . 71.14 112.179 -168.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.691 HD13 ' HA2' ' A' ' 165' ' ' GLY . 20.1 tp -128.42 147.85 50.68 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 120.132 1.333 . . . . 64.32 113.608 -177.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 8.4 mt -111.09 92.75 4.17 Favored 'General case' 0 CA--C 1.555 1.145 0 N-CA-C 106.774 -1.565 . . . . 72.12 106.774 168.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.587 HD13 ' HB2' ' A' ' 123' ' ' LEU . 15.0 mt -76.19 138.51 40.71 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 118.132 0.424 . . . . 70.05 111.607 178.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.471 HG22 HG22 ' A' ' 158' ' ' VAL . 47.4 t -119.71 116.0 49.25 Favored 'Isoleucine or valine' 0 C--O 1.242 0.677 0 N-CA-C 106.017 -1.846 . . . . 61.43 106.017 164.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.449 ' HA ' ' HB3' ' A' ' 123' ' ' LEU . 10.1 p -72.12 120.32 20.3 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 CA-C-O 121.848 0.832 . . . . 70.33 111.314 -171.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.512 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 32.3 mmt180 -106.82 99.53 9.09 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 107.849 -1.167 . . . . 53.32 107.849 172.109 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.794 HD12 ' HG ' ' A' ' 188' ' ' LEU . 80.4 mt -70.12 131.22 43.96 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 109.162 -0.681 . . . . 72.4 109.162 179.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.486 HD12 ' HA ' ' A' ' 126' ' ' THR . 54.7 mt -53.38 150.5 11.92 Favored Pre-proline 0 N--CA 1.481 1.084 0 O-C-N 124.606 1.191 . . . . 73.14 113.666 -163.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -83.21 49.1 2.9 Favored 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 122.796 2.331 . . . . 71.42 108.488 160.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 26.6 t-80 -69.97 131.5 89.08 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 107.254 -1.387 . . . . 73.35 107.254 178.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_exo -16.84 -34.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.386 2.522 1 C-N-CA 127.977 5.784 . . . . 61.24 120.623 -164.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 4.8 t -95.06 -59.57 3.05 Favored 'Isoleucine or valine' 0 C--N 1.353 0.744 0 CA-C-N 120.011 1.278 . . . . 64.21 108.728 -172.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . 0.487 ' CD1' ' HB2' ' A' ' 195' ' ' ALA . 49.2 m-85 -115.76 154.62 29.28 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 121.177 0.513 . . . . 72.31 111.333 -169.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 26.6 ttp180 -138.6 129.57 26.77 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 107.032 -1.47 . . . . 75.51 107.032 165.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.794 ' HG ' HD12 ' A' ' 180' ' ' LEU . 4.5 mm? -79.51 166.16 22.24 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.96 0.886 . . . . 74.21 112.3 -176.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -163.83 96.86 0.83 Allowed 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 105.663 -1.976 . . . . 70.31 105.663 174.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 62.02 -122.6 29.11 Favored Glycine 0 CA--C 1.531 1.075 0 N-CA-C 111.413 -0.675 . . . . 65.41 111.413 -168.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.542 ' HA ' ' HG2' ' A' ' 154' ' ' ARG . 2.2 mp0 -86.39 -13.89 45.0 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.793 0.837 . . . . 72.32 111.512 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -107.98 156.57 19.08 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 121.718 0.771 . . . . 72.32 112.684 -168.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.536 HD21 ' HE1' ' A' ' 240' ' ' PHE . 59.5 mt -103.61 155.7 18.35 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.781 1.633 . . . . 63.44 111.06 -170.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -132.04 100.13 4.95 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 107.845 -1.168 . . . . 73.14 107.845 169.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.571 ' HB3' HD23 ' A' ' 251' ' ' LEU . . . -105.32 116.0 31.2 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.429 1.091 . . . . 74.34 110.656 -176.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 38.3 m -71.4 102.62 2.68 Favored 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 109.409 -0.589 . . . . 70.21 109.409 176.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.582 HD22 HD13 ' A' ' 251' ' ' LEU . 33.2 tp -101.26 104.42 15.45 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 108.727 -0.842 . . . . 72.21 108.727 -174.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -84.4 108.68 17.35 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.891 -0.781 . . . . 61.43 108.891 175.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.53 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 6.2 p -120.76 137.27 26.2 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 124.71 1.204 . . . . 64.4 108.316 -177.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.29 156.84 33.28 Favored 'Trans proline' 0 C--N 1.363 1.327 0 C-N-CA 121.485 1.457 . . . . 64.51 111.605 173.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.411 ' HB3' ' HH2' ' A' ' 269' ' ' TRP . . . -56.46 -48.82 96.35 Favored Pre-proline 0 CA--C 1.557 1.227 0 N-CA-C 114.701 1.371 . . . . 71.34 114.701 -168.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -57.5 -42.71 58.25 Favored 'Trans proline' 0 C--N 1.395 2.995 0 CA-C-N 121.526 1.581 . . . . 63.54 112.079 178.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.438 HG12 ' HE1' ' C' ' 277' ' ' TYR . 20.2 mt -73.21 -28.74 26.51 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 CA-C-N 115.262 -0.881 . . . . 64.32 110.634 -176.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -72.05 -48.64 42.89 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.348 0.659 . . . . 71.51 111.371 178.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.479 HG11 HD11 ' C' ' 261' ' ' LEU . 95.6 t -72.03 -41.54 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.469 0.708 . . . . 63.23 111.747 -175.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 70.3 t -87.32 -41.9 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 116.07 -0.513 . . . . 74.41 111.384 -176.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 91.73 83.81 1.46 Allowed Glycine 0 CA--C 1.525 0.711 0 CA-C-N 116.097 -0.501 . . . . 72.35 112.83 -177.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -126.22 -172.42 13.35 Favored Glycine 0 N--CA 1.473 1.149 0 N-CA-C 111.363 -0.695 . . . . 55.24 111.363 173.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 221' ' ' VAL . 50.2 mtmt -85.06 133.16 34.24 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 117.75 0.775 . . . . 45.21 112.522 -174.281 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 34.8 m -121.55 170.55 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 124.253 1.021 . . . . 63.11 108.726 166.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 22.2 ttm180 -82.43 109.36 16.6 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 109.473 -0.566 . . . . 71.41 109.473 172.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -103.18 132.32 49.52 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 108.426 -0.953 . . . . 62.04 108.426 173.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . 0.444 ' N ' ' SD ' ' A' ' 213' ' ' MET . 1.5 mpt? -92.38 135.75 33.77 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.494 -0.558 . . . . 71.23 109.494 -175.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 55.8 p -111.79 -176.45 2.94 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.379 0.672 . . . . 74.1 109.517 174.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 58.5 mt -80.41 -4.17 52.59 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.658 0.783 . . . . 63.31 111.949 -177.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.428 ' HA ' ' HE2' ' B' ' 2' ' ' LYS . 56.3 mm-40 -115.65 -17.93 10.99 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.356 0.662 . . . . 64.44 111.507 176.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 156.16 175.35 27.04 Favored Glycine 0 C--N 1.354 1.536 0 C-N-CA 121.465 -0.398 . . . . 33.0 114.012 176.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -77.93 124.41 6.76 Favored 'Trans proline' 0 C--N 1.372 1.795 0 C-N-CA 122.934 2.423 . . . . 70.23 112.349 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 30.9 m -121.11 179.92 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 124.451 1.1 . . . . 73.4 109.429 177.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -102.58 150.27 23.58 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.356 0.662 . . . . 75.04 109.584 172.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 209' ' ' LYS . 2.8 p -145.98 141.36 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 N-CA-C 108.972 -0.751 . . . . 74.13 108.972 176.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -86.45 100.81 12.62 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.045 0.538 . . . . 60.25 110.47 -178.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 91.8 t -53.9 143.29 41.88 Favored Pre-proline 0 N--CA 1.494 1.734 0 C-N-CA 125.204 1.402 . . . . 63.14 111.136 -179.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -62.11 162.83 21.59 Favored 'Trans proline' 0 C--N 1.386 2.534 0 C-N-CA 122.627 2.218 . . . . 75.51 112.406 172.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.54 155.47 35.92 Favored 'Trans proline' 0 C--N 1.367 1.521 0 C-N-CA 121.408 1.405 . . . . 72.53 111.134 166.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . 0.404 ' HD2' ' O ' ' C' ' 259' ' ' GLU . 21.1 mmt180 65.33 20.59 11.87 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 125.305 1.442 . . . . 74.04 112.244 173.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.437 HG23 HD21 ' A' ' 233' ' ' LEU . 96.5 m -59.19 104.52 0.25 Allowed 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 124.715 1.206 . . . . 64.32 111.202 -176.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 5.3 tp60 -98.11 133.97 41.83 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.689 1.196 . . . . 75.32 111.994 -168.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -62.48 140.32 58.6 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.833 1.253 . . . . 62.31 112.892 -173.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 92.37 -35.69 3.94 Favored Glycine 0 C--N 1.349 1.291 0 O-C-N 123.877 0.736 . . . . 73.32 112.005 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -74.04 161.76 29.71 Favored 'General case' 0 C--N 1.349 0.555 0 C-N-CA 123.867 0.867 . . . . 74.0 111.352 -177.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.723 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 3.4 mptp? -113.34 118.46 34.65 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.909 0.884 . . . . 72.22 109.065 -175.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.486 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 39.0 mt -76.79 100.25 5.41 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.764 -0.828 . . . . 71.4 108.764 178.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 54.3 ttm-85 -71.86 105.86 3.97 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 110.245 -0.279 . . . . 64.14 110.245 179.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.531 HD12 HD23 ' A' ' 249' ' ' LEU . 9.1 mt -95.31 104.06 15.94 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 107.508 -1.293 . . . . 61.12 107.508 173.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 18.0 tptp -71.47 118.82 14.76 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.353 0.661 . . . . 64.43 111.181 -172.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 85.47 32.21 19.92 Favored Glycine 0 C--N 1.35 1.347 0 O-C-N 123.418 0.449 . . . . 74.2 113.251 177.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -125.62 5.69 7.52 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.68 0.792 . . . . 73.01 112.443 -175.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -93.86 -157.5 33.15 Favored Glycine 0 N--CA 1.469 0.868 0 C-N-CA 123.378 0.513 . . . . 74.43 112.451 171.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . 0.536 ' HE1' HD21 ' A' ' 193' ' ' LEU . 27.2 m-85 -83.38 140.44 41.9 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 122.954 0.502 . . . . 73.13 111.136 -175.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 240' ' ' PHE . 3.6 Cg_exo -77.41 138.09 17.26 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 123.558 2.839 . . . . 73.33 112.587 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 178.19 -138.52 3.75 Favored Glycine 0 CA--C 1.534 1.275 0 CA-C-O 119.056 -0.858 . . . . 73.52 112.449 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -67.69 -12.52 35.8 Favored 'Trans proline' 0 C--N 1.382 2.337 0 C-N-CA 123.844 3.03 . . . . 70.45 114.086 -177.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -103.96 21.77 15.78 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.744 0.418 . . . . 70.11 110.37 175.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 71.88 -93.74 0.58 Allowed Glycine 0 C--N 1.353 1.483 0 N-CA-C 110.329 -1.108 . . . . 62.24 110.329 -173.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 -126.18 131.46 52.0 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 107.626 -1.25 . . . . 75.41 107.626 167.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -70.35 -168.0 7.0 Favored Glycine 0 C--N 1.352 1.419 0 O-C-N 123.266 0.354 . . . . 42.24 112.871 178.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -111.55 173.34 6.4 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 117.513 0.656 . . . . 75.44 111.112 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.531 HD23 HD12 ' A' ' 235' ' ' LEU . 23.5 tp -128.9 104.07 7.39 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.556 -0.905 . . . . 70.31 108.556 176.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.723 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 0.4 OUTLIER -89.81 105.65 17.94 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.701 -0.852 . . . . 52.51 108.701 -178.881 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.582 HD13 HD22 ' A' ' 197' ' ' LEU . 66.3 mt -84.93 101.95 12.75 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.906 -0.775 . . . . 72.24 108.906 177.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . 0.588 ' HG2' ' HG3' ' A' ' 232' ' ' LYS . 26.0 mt-10 -76.36 104.47 6.89 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.025 0.93 . . . . 75.41 108.743 -177.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 40.6 t -67.11 127.68 29.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 114.316 -1.311 . . . . 24.43 112.145 -167.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.49 91.93 3.4 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 107.516 -1.291 . . . . 73.14 107.516 175.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.53 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 66.7 mt -79.4 133.55 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 109.777 -0.453 . . . . 74.34 109.777 -178.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 19.6 p -130.52 175.26 9.13 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.144 0.978 . . . . 73.43 110.481 174.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.513 HD12 ' H ' ' A' ' 259' ' ' GLU . 2.7 pp -132.38 152.45 80.09 Favored Pre-proline 0 CA--C 1.558 1.26 0 C-N-CA 123.843 0.857 . . . . 73.4 109.557 -178.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -76.55 8.63 2.91 Favored 'Trans proline' 0 N--CA 1.507 2.301 0 C-N-CA 123.157 2.571 . . . . 74.45 115.03 -165.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . 0.579 ' HG2' ' NE2' ' C' ' 228' ' ' GLN . 33.3 mt-10 53.11 -85.53 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.616 1.166 . . . . 63.24 111.219 -163.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.83 158.93 5.86 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.163 0.985 . . . . 75.12 111.878 179.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.619 HD22 ' HB3' ' A' ' 265' ' ' GLU . 74.7 mt -143.39 151.22 40.15 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.416 0.686 . . . . 55.32 110.558 178.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 58.3 p -83.67 161.57 55.74 Favored Pre-proline 0 CA--C 1.559 1.303 0 N-CA-C 108.689 -0.856 . . . . 44.34 108.689 166.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -42.06 -47.03 6.95 Favored 'Trans proline' 0 C--N 1.385 2.45 0 C-N-CA 123.779 2.986 . . . . 74.33 115.217 177.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -67.14 -47.42 71.15 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.017 0.527 . . . . 71.44 109.856 -179.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . 0.619 ' HB3' HD22 ' A' ' 261' ' ' LEU . 43.6 mt-10 -56.83 -42.46 79.67 Favored 'General case' 0 C--N 1.352 0.693 0 O-C-N 123.873 0.733 . . . . 64.2 110.866 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -62.58 -50.13 72.53 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 123.195 0.31 . . . . 73.45 110.292 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -54.97 -51.61 65.65 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 124.158 0.912 . . . . 64.12 111.569 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . 0.478 ' HB2' HD21 ' C' ' 272' ' ' LEU . 10.1 mp -73.67 -43.62 58.89 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.291 0.637 . . . . 73.14 111.935 -173.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 269' ' ' TRP . . . . . 0.411 ' HH2' ' HB3' ' A' ' 201' ' ' ALA . 62.5 m95 -58.68 -45.79 88.66 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 123.358 0.663 . . . . 75.0 111.086 177.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . 0.417 ' NZ ' ' HB3' ' A' ' 270' ' ' LYS . 8.7 mtpm? -63.34 -50.06 71.48 Favored 'General case' 0 C--N 1.352 0.693 0 CA-C-N 115.842 -0.617 . . . . 62.43 111.012 178.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -64.38 -29.66 70.72 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.045 0.538 . . . . 70.22 111.979 -179.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 272' ' ' LEU . . . . . 0.424 ' O ' ' HB2' ' A' ' 276' ' ' TYR . 31.5 mt -61.62 -52.41 64.48 Favored 'General case' 0 C--O 1.211 -0.943 0 N-CA-C 109.377 -0.601 . . . . 63.4 109.377 172.238 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -64.68 -37.04 86.23 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 123.904 0.752 . . . . 64.51 112.824 -178.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -67.18 -47.65 70.3 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.823 0.849 . . . . 74.35 110.485 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . 0.514 ' O ' ' HG2' ' A' ' 279' ' ' ARG . . . -59.68 -60.13 4.34 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.546 0.738 . . . . 71.44 109.767 175.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . 0.424 ' HB2' ' O ' ' A' ' 272' ' ' LEU . 24.5 t80 -39.24 -58.96 1.1 Allowed 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 127.45 2.3 . . . . 75.02 111.939 178.072 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -62.45 -46.02 90.44 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 114.572 -1.195 . . . . 70.12 109.963 -176.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -69.81 -8.9 52.24 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.005 0.742 . . . . 75.41 113.005 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . 0.514 ' HG2' ' O ' ' A' ' 275' ' ' ALA . 8.7 mmm180 -93.26 -7.45 45.02 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 117.902 0.319 . . . . 74.13 111.63 177.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 1.163 0 CA-C-O 118.309 -0.853 . . . . 72.21 109.811 179.676 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.2 mmt . . . . . 0 N--CA 1.475 0.796 0 N-CA-C 110.135 -0.321 . . . . 71.44 110.135 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . 0.499 ' HA ' ' HE1' ' A' ' 132' ' ' HIS . 0.2 OUTLIER -78.68 1.45 22.86 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.934 0.894 . . . . 54.1 113.286 -165.996 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.62 10.04 4.71 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.811 0.845 . . . . 74.04 111.118 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . 0.634 ' HB2' HG21 ' A' ' 126' ' ' THR . 60.8 m -70.81 101.11 2.04 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-O 121.599 0.714 . . . . 52.14 110.703 -176.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 5' ' ' THR . . . . . 0.489 HG23 ' O ' ' A' ' 137' ' ' VAL . 92.9 m -85.85 154.78 21.3 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 114.337 -1.301 . . . . 70.11 110.986 -179.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.493 HD13 ' HA ' ' A' ' 125' ' ' LEU . 21.9 pt -126.61 178.44 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 C-N-CA 124.509 1.124 . . . . 64.44 111.487 -167.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -147.19 134.5 20.66 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.805 1.242 . . . . 72.01 108.448 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . 0.502 HD12 ' HA ' ' A' ' 123' ' ' LEU . 1.5 mm? -63.59 150.9 43.04 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 118.575 0.625 . . . . 75.22 111.569 -178.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.04 -43.17 79.33 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 114.787 -1.097 . . . . 62.4 110.054 173.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 29.9 mt 74.34 -40.76 0.46 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 126.477 1.911 . . . . 74.1 113.525 -179.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 53.1 mt . . . . . 0 CA--C 1.565 1.533 0 C-N-CA 124.566 1.146 . . . . 45.35 110.714 -173.121 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.849 0 CA-C-O 120.787 0.327 . . . . 61.34 110.726 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 180' ' ' ALA . . . . . 0.495 ' HB1' HG23 ' C' ' 137' ' ' VAL . . . -63.71 -63.68 1.1 Allowed 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 109.16 -0.681 . . . . 74.4 109.16 170.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 181' ' ' LEU . . . . . 0.574 HD13 ' HB2' ' C' ' 136' ' ' ARG . 45.1 tp -143.85 -67.28 0.34 Allowed 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 106.727 -1.582 . . . . 62.04 106.727 167.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 182' ' ' VAL . . . . . 0.559 HG23 ' HB2' ' C' ' 125' ' ' LEU . 14.7 p -151.4 153.78 9.34 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 N-CA-C 107.185 -1.413 . . . . 71.31 107.185 -177.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -83.08 63.97 7.41 Favored 'General case' 0 CA--C 1.562 1.438 0 N-CA-C 115.266 1.58 . . . . 65.24 115.266 -158.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 12.3 m170 60.79 -176.16 0.11 Allowed 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 114.379 1.252 . . . . 74.15 114.379 161.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 185' ' ' VAL . . . . . . . . . . . . . 2.6 p . . . . . 0 N--CA 1.476 0.869 0 C-N-CA 122.816 0.446 . . . . 71.33 110.509 173.238 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 238' ' ' THR . . . . . 0.571 HG22 HG23 ' C' ' 219' ' ' VAL . 3.0 m . . . . . 0 N--CA 1.474 0.736 0 N-CA-C 107.527 -1.286 . . . . 71.31 107.527 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -84.09 169.13 15.21 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.746 -0.661 . . . . 74.42 110.204 175.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 240' ' ' GLY . . . . . 0.515 ' H ' HD22 ' C' ' 235' ' ' LEU . . . -109.91 -93.08 2.22 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 110.778 -0.929 . . . . 71.23 110.778 -173.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 241' ' ' GLU . . . . . 0.413 ' HG3' ' HG3' ' C' ' 234' ' ' ARG . 8.5 pt-20 -165.34 161.2 18.89 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.7 0.8 . . . . 71.21 110.097 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 13.8 m95 -108.19 -82.08 0.56 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.655 0.782 . . . . 70.32 108.944 177.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -153.12 -162.21 1.44 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.765 1.626 . . . . 74.22 107.772 -171.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -73.7 79.53 0.83 Allowed Glycine 0 C--N 1.349 1.274 0 N-CA-C 111.199 -0.76 . . . . 63.11 111.199 170.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 2.1 pptp? . . . . . 0 N--CA 1.479 0.993 0 C-N-CA 123.946 0.898 . . . . 75.34 111.55 -174.685 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.903 0 CA-C-O 121.006 0.431 . . . . 52.01 111.304 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -36.86 117.51 0.51 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.974 1.71 . . . . 70.52 114.133 173.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -76.07 102.58 5.75 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.849 -0.796 . . . . 63.2 108.849 165.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 6' ' ' ASP . . . . . 0.432 ' HA ' ' OH ' ' C' ' 66' ' ' TYR . 8.6 t70 -75.01 94.24 2.83 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.184 -1.043 . . . . 63.22 108.184 176.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 7' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -61.44 -35.51 77.78 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-N 115.264 -0.88 . . . . 73.43 112.361 -171.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -60.12 -50.24 74.49 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 116.121 -0.49 . . . . 72.53 110.179 175.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.7 -39.16 93.62 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.899 -0.591 . . . . 52.31 111.506 -178.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 81.5 mt -58.14 -42.13 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 C-N-CA 123.665 0.786 . . . . 63.34 110.163 176.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 95.9 mt -74.35 -24.01 59.11 Favored 'General case' 0 N--CA 1.48 1.075 0 CA-C-N 116.19 -0.459 . . . . 45.45 112.025 175.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.99 38.31 10.44 Favored Glycine 0 C--N 1.345 1.079 0 CA-C-N 116.93 -0.123 . . . . 64.33 113.187 -176.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 6.0 m -125.78 157.14 69.87 Favored Pre-proline 0 N--CA 1.481 1.116 0 C-N-CA 124.786 1.235 . . . . 64.04 110.226 176.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -67.77 165.38 27.95 Favored 'Trans proline' 0 C--N 1.383 2.386 0 C-N-CA 122.782 2.321 . . . . 74.43 112.423 177.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -77.54 16.38 0.66 Allowed 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 123.18 0.592 . . . . 71.52 111.982 -179.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -119.18 -0.15 11.1 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.786 1.635 . . . . 71.24 108.406 178.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.46 133.01 47.99 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.406 0.682 . . . . 71.14 111.94 -171.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 68.4 p -87.69 175.47 7.86 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.452 1.101 . . . . 74.41 110.862 -178.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -51.5 -39.14 57.01 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.183 0.993 . . . . 74.45 111.527 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -62.59 -47.46 83.72 Favored 'General case' 0 C--N 1.349 0.584 0 O-C-N 123.811 0.694 . . . . 64.05 111.258 178.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -66.77 -37.99 85.69 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.659 0.784 . . . . 73.42 111.322 -177.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 22' ' ' ILE . . . . . 0.629 HG12 ' HB3' ' C' ' 57' ' ' LEU . 1.7 mp -62.28 -42.56 95.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.323 1.049 . . . . 61.32 110.439 175.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -69.24 -39.65 78.37 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 114.853 -1.067 . . . . 74.13 110.891 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -70.27 -33.63 71.81 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.737 0.815 . . . . 73.52 110.572 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -74.65 -36.26 62.85 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.777 0.831 . . . . 75.32 110.624 177.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 26' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -60.03 -48.28 82.35 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 115.447 -0.797 . . . . 72.31 108.988 172.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -60.1 -44.76 94.6 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.317 1.047 . . . . 74.1 111.203 178.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 22.6 ttt180 -51.25 -52.16 47.38 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.744 1.217 . . . . 71.15 110.963 177.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . 0.454 ' HB3' HD13 ' C' ' 50' ' ' ILE . 83.3 mt -83.6 -12.47 56.02 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 114.585 -1.189 . . . . 60.22 111.506 -178.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.19 -2.65 55.01 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.684 0.793 . . . . 75.32 110.41 173.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 76.6 mtp180 -95.89 -45.35 6.99 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.6 0.76 . . . . 73.5 109.045 166.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -68.31 -52.84 29.08 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 115.343 -0.844 . . . . 71.12 111.188 -178.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 33' ' ' TYR . . . . . 0.448 ' HE2' HD22 ' C' ' 29' ' ' LEU . 37.3 m-85 -100.97 26.26 7.16 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.577 0.751 . . . . 70.15 110.464 -178.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 34' ' ' HIS . . . . . . . . . . . . . 13.0 t60 -55.12 99.16 0.19 Allowed Pre-proline 0 N--CA 1.488 1.46 0 C-N-CA 124.765 1.226 . . . . 72.34 110.738 -177.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -59.58 -27.88 86.05 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 123.088 2.525 . . . . 71.32 113.97 -167.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -72.1 -25.86 61.92 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.357 0.663 . . . . 60.34 111.929 -177.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 67.2 t -113.22 -25.59 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 CA-C-O 121.352 0.596 . . . . 75.33 110.783 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -105.43 83.98 2.03 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 106.807 -1.553 . . . . 54.22 106.807 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.96 76.5 7.9 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.89 -0.782 . . . . 62.24 108.89 -178.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 67.4 m -143.08 108.43 5.37 Favored Pre-proline 0 C--O 1.235 0.329 0 N-CA-C 107.004 -1.48 . . . . 74.14 107.004 172.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . 0.44 ' O ' ' HG2' ' C' ' 45' ' ' GLU . 76.9 Cg_exo -46.79 -30.59 9.53 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 123.548 2.832 . . . . 63.44 114.161 175.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -57.14 -45.53 83.48 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.752 0.821 . . . . 65.44 111.216 175.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.54 -19.19 62.91 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.508 -0.769 . . . . 62.05 110.84 178.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 44' ' ' GLU . . . . . 0.411 ' O ' ' HG3' ' C' ' 48' ' ' LYS . 36.5 mt-10 -87.6 -30.36 20.54 Favored 'General case' 0 C--N 1.358 0.95 0 C-N-CA 123.184 0.594 . . . . 74.04 110.409 -178.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 45' ' ' GLU . . . . . 0.44 ' HG2' ' O ' ' C' ' 41' ' ' PRO . 11.8 mm-40 -72.39 -40.09 67.51 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 108.895 -0.78 . . . . 42.53 108.895 174.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 46' ' ' LYS . . . . . 0.41 ' O ' HG13 ' C' ' 50' ' ' ILE . 48.4 mttp -63.25 -38.11 89.88 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-N 114.587 -1.188 . . . . 72.32 110.413 170.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 47' ' ' PHE . . . . . 0.813 ' HA ' HD12 ' C' ' 50' ' ' ILE . 26.8 t80 -62.45 -35.28 78.81 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 123.526 0.516 . . . . 62.23 110.387 175.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 48' ' ' LYS . . . . . 0.428 ' HB3' ' CE1' ' C' ' 93' ' ' PHE . 98.3 mttt -63.16 -44.74 94.64 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.099 0.56 . . . . 72.04 111.009 174.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -61.13 -36.38 79.6 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 120.997 0.427 . . . . 72.33 111.407 177.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 50' ' ' ILE . . . . . 0.813 HD12 ' HA ' ' C' ' 47' ' ' PHE . 52.5 mt -65.89 -40.28 87.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 124.051 0.94 . . . . 75.43 109.887 174.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 51' ' ' ASN . . . . . 0.413 ' HB3' ' CD1' ' C' ' 88' ' ' PHE . 28.5 m-80 -75.93 -16.68 59.98 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.067 0.947 . . . . 74.04 111.757 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -73.18 -53.39 11.08 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 108.939 -0.763 . . . . 63.42 108.939 170.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.29 -42.88 82.57 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 113.852 -1.522 . . . . 63.1 111.051 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -68.44 -40.67 81.06 Favored 'General case' 0 C--O 1.204 -1.307 0 CA-C-N 114.655 -1.157 . . . . 75.01 110.129 175.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.55 -35.04 73.46 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 112.373 0.508 . . . . 60.54 112.373 -179.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 56' ' ' VAL . . . . . 0.414 HG13 ' HZ ' ' C' ' 101' ' ' PHE . 15.6 t -96.39 -16.48 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 O-C-N 123.47 0.482 . . . . 72.43 111.882 -177.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 57' ' ' LEU . . . . . 0.629 ' HB3' HG12 ' C' ' 22' ' ' ILE . 92.9 mt -118.81 11.01 12.52 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.086 -1.009 . . . . 75.02 113.153 177.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 58' ' ' SER . . . . . 0.474 ' HB3' ' HD2' ' C' ' 62' ' ' LYS . 43.1 t -52.7 -34.21 51.2 Favored 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 124.749 1.219 . . . . 62.42 113.315 -176.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -134.28 155.93 79.45 Favored Pre-proline 0 N--CA 1.474 0.763 0 C-N-CA 124.803 1.241 . . . . 72.03 108.891 -174.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 60' ' ' PRO . . . . . 0.407 ' O ' ' HG2' ' C' ' 64' ' ' ARG . 50.3 Cg_exo -55.5 -29.73 70.61 Favored 'Trans proline' 0 C--N 1.383 2.347 0 C-N-CA 122.79 2.327 . . . . 33.23 112.354 169.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -56.8 -61.84 2.15 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.738 0.815 . . . . 62.13 110.278 174.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 62' ' ' LYS . . . . . 0.474 ' HD2' ' HB3' ' C' ' 58' ' ' SER . 56.1 mttp -64.31 -37.79 88.75 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 114.527 -1.215 . . . . 75.23 110.785 -176.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -56.28 -49.61 73.75 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 114.072 -1.422 . . . . 64.42 110.389 178.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 64' ' ' ARG . . . . . 0.407 ' HG2' ' O ' ' C' ' 60' ' ' PRO . 29.9 mmt180 -73.1 -27.54 61.77 Favored 'General case' 0 C--N 1.35 0.595 0 CA-C-O 118.591 -0.718 . . . . 74.15 111.755 -177.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 81.3 mt -58.73 -47.29 89.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-O 121.215 0.531 . . . . 62.34 109.585 170.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 66' ' ' TYR . . . . . 0.432 ' OH ' ' HA ' ' C' ' 6' ' ' ASP . 25.2 t80 -60.17 -52.75 63.98 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.028 -0.987 . . . . 74.22 110.323 175.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -62.05 -34.38 76.15 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.356 0.662 . . . . 73.14 111.831 -175.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 72.0 p -77.24 -24.97 51.12 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 119.223 -0.418 . . . . 63.2 110.634 176.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -66.7 128.95 38.23 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 108.816 -0.809 . . . . 75.22 108.816 173.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 93.79 15.55 48.91 Favored Glycine 0 C--N 1.344 1.021 0 N-CA-C 111.498 -0.641 . . . . 62.51 111.498 -168.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 86.3 m -143.95 -62.46 0.39 Allowed 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 102.959 -2.978 . . . . 72.34 102.959 174.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 27.1 m -70.41 132.93 46.35 Favored 'General case' 0 C--O 1.25 1.115 0 N-CA-C 104.615 -2.365 . . . . 73.35 104.615 155.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.16 -43.83 6.18 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 122.853 0.461 . . . . 73.23 111.316 -173.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -90.89 136.95 27.05 Favored Pre-proline 0 N--CA 1.477 0.886 0 C-N-CA 123.653 0.781 . . . . 53.23 109.834 -179.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.33 138.43 86.19 Favored 'Trans proline' 0 C--N 1.376 2.02 0 C-N-CA 122.761 2.308 . . . . 75.14 111.856 171.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -59.73 152.63 61.78 Favored 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 122.604 2.202 . . . . 63.14 112.417 176.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -51.67 136.77 50.3 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 122.98 2.454 . . . . 51.51 111.848 178.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 78' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.87 124.03 15.28 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 123.052 2.501 . . . . 74.44 112.565 -176.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.87 173.91 2.02 Favored 'Trans proline' 0 N--CA 1.51 2.46 0 C-N-CA 123.727 2.951 . . . . 61.04 114.447 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -57.11 88.62 0.04 OUTLIER 'Trans proline' 0 C--N 1.392 2.856 0 C-N-CA 122.857 2.372 . . . . 51.5 112.628 171.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 130.34 -23.93 4.51 Favored Glycine 0 N--CA 1.467 0.738 0 CA-C-N 114.442 -1.254 . . . . 75.2 110.729 178.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 107.75 -171.1 15.92 Favored Glycine 0 C--N 1.349 1.289 0 C-N-CA 124.852 1.215 . . . . 74.45 111.006 176.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -65.0 90.18 0.08 Allowed 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.59 -0.893 . . . . 70.14 108.59 165.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 84' ' ' ASP . . . . . 0.602 ' HB3' ' HG3' ' C' ' 143' ' ' ARG . 18.4 t0 -62.36 139.79 58.54 Favored 'General case' 0 C--O 1.241 0.652 0 O-C-N 124.1 0.875 . . . . 63.13 109.624 178.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 85' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -153.74 6.49 0.33 Allowed 'General case' 0 C--O 1.243 0.73 0 CA-C-N 115.447 -0.797 . . . . 74.41 110.273 -175.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 86' ' ' SER . . . . . 0.488 ' HB3' ' O ' ' C' ' 163' ' ' GLY . 74.8 m -64.41 146.75 53.99 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.315 -0.857 . . . . 45.43 110.859 -177.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 97.9 -28.03 16.35 Favored Glycine 0 C--N 1.339 0.719 0 N-CA-C 110.765 -0.934 . . . . 74.33 110.765 -165.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 88' ' ' PHE . . . . . 0.413 ' CD1' ' HB3' ' C' ' 51' ' ' ASN . 23.2 m-85 -116.07 138.03 51.59 Favored 'General case' 0 C--N 1.356 0.882 0 N-CA-C 108.684 -0.858 . . . . 74.44 108.684 -178.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -74.73 81.85 2.08 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.638 0.775 . . . . 72.23 110.589 -174.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 90' ' ' VAL . . . . . 0.438 HG13 ' HG2' ' C' ' 91' ' ' GLU . 6.5 p -41.54 -43.69 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 C-N-CA 125.119 1.368 . . . . 54.41 112.845 177.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 91' ' ' GLU . . . . . 0.438 ' HG2' HG13 ' C' ' 90' ' ' VAL . 51.5 mm-40 -74.97 8.09 2.76 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.653 1.181 . . . . 74.21 113.288 -172.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -120.38 -27.35 5.23 Favored 'General case' 0 C--O 1.243 0.753 0 C-N-CA 123.811 0.844 . . . . 75.53 110.929 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 93' ' ' PHE . . . . . 0.428 ' CE1' ' HB3' ' C' ' 48' ' ' LYS . 2.3 m-30 -77.73 170.95 15.7 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 120.864 0.364 . . . . 72.45 111.726 -165.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 87.1 p -63.02 164.21 8.65 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 114.964 1.468 . . . . 45.51 114.964 -162.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 95' ' ' GLU . . . . . 0.458 ' O ' ' HG3' ' C' ' 99' ' ' GLU . 0.0 OUTLIER -66.59 -33.02 74.74 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 113.749 -1.568 . . . . 55.43 111.401 173.767 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -66.61 -40.08 88.67 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 120.938 0.399 . . . . 65.02 110.469 176.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 97' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -58.85 -44.13 90.92 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 115.415 -0.811 . . . . 64.25 109.73 170.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 98' ' ' GLN . . . . . 0.426 ' O ' ' HA3' ' C' ' 102' ' ' GLY . 69.4 mt-30 -66.78 -18.62 65.46 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 123.463 0.705 . . . . 51.52 112.05 177.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 99' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' C' ' 95' ' ' GLU . 47.5 mt-10 -81.14 -48.15 12.52 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.156 0.583 . . . . 74.43 112.123 171.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 19.3 tp -82.14 -49.42 10.17 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 116.149 -0.478 . . . . 73.23 111.517 -168.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 101' ' ' PHE . . . . . 0.414 ' HZ ' HG13 ' C' ' 56' ' ' VAL . 93.2 m-85 -100.12 -25.11 14.4 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.117 0.567 . . . . 73.25 111.474 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 102' ' ' GLY . . . . . 0.426 ' HA3' ' O ' ' C' ' 98' ' ' GLN . . . -43.08 -58.27 3.83 Favored Glycine 0 CA--C 1.546 2.02 0 CA-C-O 118.961 -0.911 . . . . 54.11 115.325 -178.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -54.68 -22.35 28.5 Favored 'Trans proline' 0 C--N 1.387 2.583 0 C-N-CA 123.843 3.029 . . . . 62.02 113.957 -177.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -126.29 16.17 6.74 Favored Glycine 0 C--N 1.356 1.658 0 CA-C-O 118.756 -1.024 . . . . 43.23 113.95 -177.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 34.4 mt . . . . . 0 N--CA 1.487 1.402 0 CA-C-N 117.829 0.814 . . . . 73.03 111.607 176.849 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.625 0 CA-C-O 120.034 -0.315 . . . . 45.25 112.473 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 74.9 mtt85 -89.86 173.17 8.39 Favored 'General case' 0 C--O 1.253 1.261 0 C-N-CA 123.422 0.689 . . . . 64.44 111.51 -178.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -66.93 133.93 50.99 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 107.69 -1.226 . . . . 75.42 107.69 169.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 119' ' ' LEU . . . . . 0.435 HD11 ' HB2' ' C' ' 141' ' ' ALA . 3.9 tt -93.61 137.49 32.82 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 106.607 -1.627 . . . . 75.21 106.607 -177.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.405 ' N ' HD23 ' C' ' 119' ' ' LEU . 6.0 mmm-85 -128.0 104.02 7.56 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.194 0.521 . . . . 72.31 109.682 -172.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 121' ' ' ALA . . . . . 0.468 ' HB3' HD23 ' C' ' 176' ' ' LEU . . . -109.29 115.52 30.15 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.206 -1.405 . . . . 63.21 107.206 172.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -104.42 88.93 3.08 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 105.174 -2.158 . . . . 73.22 105.174 174.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 123' ' ' LEU . . . . . 0.438 ' H ' HD23 ' C' ' 123' ' ' LEU . 1.7 pt? -125.52 136.21 27.98 Favored Pre-proline 0 N--CA 1.485 1.294 0 N-CA-C 114.252 1.204 . . . . 73.3 114.252 -158.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . 0.527 ' HA ' ' O ' ' C' ' 179' ' ' ARG . 53.2 Cg_exo -57.42 140.41 93.06 Favored 'Trans proline' 0 C--N 1.39 2.753 0 C-N-CA 123.816 3.01 . . . . 72.51 114.519 175.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 125' ' ' LEU . . . . . 0.559 ' HB2' HG23 ' B' ' 182' ' ' VAL . 54.3 tp -158.38 155.56 28.9 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.071 0.948 . . . . 74.03 109.791 176.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 126' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -102.49 153.7 19.8 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.122 0.569 . . . . 61.53 110.427 178.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 127' ' ' LEU . . . . . 0.67 HD13 ' HD2' ' C' ' 186' ' ' PHE . 98.0 mt -63.15 -44.46 95.46 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.237 1.015 . . . . 62.25 111.353 176.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 12.2 mp0 -62.04 -37.27 84.29 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 114.729 -1.123 . . . . 75.24 110.553 177.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -67.95 -37.82 82.06 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.68 0.792 . . . . 73.53 111.283 177.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -68.27 -33.58 74.62 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 123.748 0.655 . . . . 64.34 109.972 178.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 131' ' ' PHE . . . . . 0.442 ' HB2' HD13 ' C' ' 215' ' ' LEU . 83.0 t80 -67.21 -42.46 84.05 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.412 1.085 . . . . 75.55 111.007 174.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 132' ' ' HIS . . . . . . . . . . . . . 35.3 m170 -61.89 -40.96 97.23 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 123.585 0.553 . . . . 60.22 110.076 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 64.09 -108.37 2.22 Favored Glycine 0 C--N 1.355 1.588 0 N-CA-C 111.04 -0.824 . . . . 65.31 111.04 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . 70.49 147.09 0.37 Allowed Glycine 0 C--N 1.354 1.568 0 O-C-N 124.23 0.606 . . . . 53.24 114.535 173.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -80.19 92.94 5.76 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 107.359 -1.349 . . . . 71.2 107.359 176.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 136' ' ' ARG . . . . . 0.574 ' HB2' HD13 ' B' ' 181' ' ' LEU . 72.7 mtp180 -123.82 155.89 37.16 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 124.08 0.952 . . . . 72.12 109.501 -168.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 137' ' ' VAL . . . . . 0.495 HG23 ' HB1' ' B' ' 180' ' ' ALA . 31.3 m -78.97 122.52 34.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 CA-C-O 121.242 0.544 . . . . 71.12 111.893 -172.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 138' ' ' VAL . . . . . 0.533 ' HB ' HD23 ' B' ' 181' ' ' LEU . 12.9 p -111.56 140.8 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 107.681 -1.229 . . . . 72.14 107.681 169.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 139' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -109.83 100.77 9.7 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 108.131 -1.063 . . . . 74.31 108.131 179.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 140' ' ' VAL . . . . . . . . . . . . . 11.7 p -143.62 134.88 22.65 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.111 0 C-N-CA 123.484 0.714 . . . . 63.22 109.579 -173.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 141' ' ' ALA . . . . . 0.435 ' HB2' HD11 ' C' ' 119' ' ' LEU . . . 67.26 -1.67 1.43 Allowed 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 125.301 1.44 . . . . 15.23 114.173 178.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 119.55 -2.13 13.86 Favored Glycine 0 C--N 1.348 1.238 0 CA-C-O 119.23 -0.761 . . . . 45.25 114.231 179.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 143' ' ' ARG . . . . . 0.602 ' HG3' ' HB3' ' C' ' 84' ' ' ASP . 64.2 mtm180 -119.41 130.7 55.42 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 118.367 1.083 . . . . 73.04 111.744 175.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -83.76 103.61 13.19 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 107.709 -1.219 . . . . 71.51 107.709 164.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 145' ' ' VAL . . . . . . . . . . . . . 7.3 p -125.18 130.41 73.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.162 0.585 . . . . 75.03 111.733 -174.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 46.2 m -74.5 95.94 2.84 Favored 'General case' 0 C--N 1.353 0.736 0 C-N-CA 123.602 0.761 . . . . 54.21 110.369 176.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 35.1 m -123.42 152.29 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.538 0.735 . . . . 72.53 109.564 177.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 45.5 ttp180 -107.1 105.7 15.84 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 107.594 -1.262 . . . . 74.22 107.594 170.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 149' ' ' ILE . . . . . . . . . . . . . 31.6 pt -69.52 147.43 96.76 Favored Pre-proline 0 CA--C 1.55 0.946 0 CA-C-O 118.235 -0.888 . . . . 71.41 108.647 170.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -35.9 115.75 0.12 Allowed 'Trans proline' 0 C--N 1.394 2.925 0 C-N-CA 124.185 3.256 . . . . 61.44 113.578 -178.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -57.21 95.58 0.06 OUTLIER 'Trans proline' 0 C--N 1.39 2.715 0 C-N-CA 123.052 2.501 . . . . 73.2 111.886 -176.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 152' ' ' GLY . . . . . . . . . . . . . . . 109.64 136.11 7.4 Favored Glycine 0 C--N 1.345 1.08 0 CA-C-N 114.785 -1.098 . . . . 54.32 114.873 -174.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 153' ' ' VAL . . . . . 0.442 HG11 HD11 ' C' ' 159' ' ' ILE . 7.0 m -146.61 174.47 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 124.613 1.165 . . . . 71.13 111.077 172.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 154' ' ' ARG . . . . . 0.543 ' HB3' ' H ' ' C' ' 188' ' ' LEU . 11.7 ptt180 -124.72 168.74 12.77 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.495 1.118 . . . . 75.32 109.11 174.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 155' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -60.03 119.88 8.62 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.319 0.648 . . . . 74.51 111.104 176.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 82.27 15.05 75.26 Favored Glycine 0 C--N 1.351 1.368 0 CA-C-N 115.649 -0.705 . . . . 64.51 113.476 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 157' ' ' SER . . . . . . . . . . . . . 34.1 t -75.63 125.59 29.34 Favored 'General case' 0 C--N 1.353 0.736 0 N-CA-C 109.162 -0.681 . . . . 75.43 109.162 176.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 6.0 p -98.5 97.06 5.62 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 CA-C-O 121.844 0.83 . . . . 64.44 109.714 -177.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 159' ' ' ILE . . . . . 0.666 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 58.0 mt -70.71 113.17 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-N 115.179 -0.919 . . . . 52.25 109.678 175.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 160' ' ' ARG . . . . . 0.417 ' HA ' ' O ' ' C' ' 174' ' ' LEU . 61.8 ttt180 -99.22 101.25 12.51 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 109.696 -0.483 . . . . 72.21 109.696 179.006 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 161' ' ' VAL . . . . . 0.682 ' HB ' ' HB3' ' C' ' 174' ' ' LEU . 97.7 t -82.95 119.7 74.79 Favored Pre-proline 0 C--O 1.25 1.116 0 N-CA-C 108.455 -0.943 . . . . 75.24 108.455 174.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -60.64 106.04 0.34 Allowed 'Trans proline' 0 C--N 1.384 2.42 0 C-N-CA 123.335 2.69 . . . . 63.42 113.163 -173.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 163' ' ' GLY . . . . . 0.488 ' O ' ' HB3' ' C' ' 86' ' ' SER . . . 91.06 -25.34 14.5 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 118.581 -1.122 . . . . 53.31 114.927 169.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 164' ' ' MET . . . . . 0.433 ' O ' ' HB2' ' C' ' 174' ' ' LEU . 39.6 ttp -87.39 50.66 2.05 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 118.536 1.168 . . . . 73.35 112.783 -165.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . -125.69 -96.11 1.03 Allowed Glycine 0 N--CA 1.472 1.041 0 N-CA-C 110.665 -0.974 . . . . 64.24 110.665 171.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . 61.98 40.29 98.69 Favored Glycine 0 C--N 1.353 1.475 0 N-CA-C 115.61 1.004 . . . . 75.44 115.61 162.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 167' ' ' GLN . . . . . 0.675 ' HA ' HE21 ' C' ' 167' ' ' GLN . 0.0 OUTLIER -64.96 105.26 0.99 Allowed 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 117.155 0.477 . . . . 64.31 110.126 177.689 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . 159.0 -67.91 0.27 Allowed Glycine 0 C--O 1.219 -0.827 0 N-CA-C 110.867 -0.893 . . . . 13.44 110.867 -178.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 169' ' ' ASN . . . . . 0.604 ' HB3' ' HD3' ' C' ' 170' ' ' PRO . 26.6 t-20 -173.7 -62.21 0.0 OUTLIER Pre-proline 0 CA--C 1.575 1.916 0 C-N-CA 124.172 0.989 . . . . 62.44 111.569 172.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 170' ' ' PRO . . . . . 0.604 ' HD3' ' HB3' ' C' ' 169' ' ' ASN . 13.4 Cg_exo -72.63 160.34 46.7 Favored 'Trans proline' 0 C--N 1.4 3.259 0 C-N-CA 121.802 1.668 . . . . 51.41 111.618 172.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 171' ' ' PRO . . . . . 0.403 ' HB3' ' HA ' ' C' ' 86' ' ' SER . 30.7 Cg_endo -62.79 152.47 78.4 Favored 'Trans proline' 0 C--N 1.374 1.875 0 C-N-CA 122.163 1.909 . . . . 74.02 113.073 177.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -130.96 -103.48 0.97 Allowed Glycine 0 C--N 1.341 0.855 0 N-CA-C 109.29 -1.524 . . . . 74.42 109.29 174.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 173' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -170.68 162.91 7.98 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 124.72 1.208 . . . . 74.51 109.474 165.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 174' ' ' LEU . . . . . 0.682 ' HB3' ' HB ' ' C' ' 161' ' ' VAL . 28.3 tp -104.86 137.47 42.58 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.425 0.69 . . . . 75.22 110.523 -175.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 96.8 mt -124.08 92.02 3.58 Favored 'General case' 0 C--O 1.246 0.88 0 C-N-CA 124.62 1.168 . . . . 71.32 109.538 177.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 176' ' ' LEU . . . . . 0.666 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 74.3 mt -83.21 92.38 7.45 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 108.817 -0.808 . . . . 43.02 108.817 173.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 177' ' ' VAL . . . . . . . . . . . . . 96.0 t -83.45 102.24 9.16 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 N-CA-C 107.642 -1.244 . . . . 74.43 107.642 174.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 178' ' ' VAL . . . . . . . . . . . . . 5.9 p -74.83 132.14 33.84 Favored 'Isoleucine or valine' 0 C--O 1.249 1.039 0 CA-C-N 114.433 -1.258 . . . . 74.01 111.693 -173.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 179' ' ' ARG . . . . . 0.527 ' O ' ' HA ' ' C' ' 124' ' ' PRO . 23.0 mmt180 -110.74 103.27 11.79 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 106.844 -1.539 . . . . 72.33 106.844 170.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 180' ' ' LEU . . . . . 0.609 HD13 HD21 ' C' ' 127' ' ' LEU . 83.9 mt -69.92 148.33 49.11 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 116.006 -0.543 . . . . 70.51 111.059 -179.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 181' ' ' LEU . . . . . . . . . . . . . 63.5 mt -66.83 166.91 15.77 Favored Pre-proline 0 CA--C 1.552 1.045 0 CA-C-N 115.083 -0.962 . . . . 74.2 111.299 -175.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -57.33 78.1 0.04 OUTLIER 'Trans proline' 0 C--N 1.394 2.936 0 C-N-CA 122.99 2.46 . . . . 64.12 111.815 170.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 183' ' ' HIS . . . . . 0.413 ' N ' ' HD3' ' C' ' 184' ' ' PRO . 62.6 t60 176.68 51.65 0.03 OUTLIER Pre-proline 0 CA--C 1.556 1.202 0 C-N-CA 127.772 2.429 . . . . 62.13 105.591 -173.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 184' ' ' PRO . . . . . 0.413 ' HD3' ' N ' ' C' ' 183' ' ' HIS . 79.8 Cg_endo -94.47 65.12 0.31 Allowed 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 122.919 2.413 . . . . 71.54 110.903 -169.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 185' ' ' VAL . . . . . 0.605 HG12 ' HB1' ' C' ' 195' ' ' ALA . 6.7 t -94.09 -52.64 9.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 108.951 -0.759 . . . . 72.23 108.951 -167.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 186' ' ' PHE . . . . . 0.67 ' HD2' HD13 ' C' ' 127' ' ' LEU . 67.1 m-85 -99.79 121.35 41.15 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.437 0.695 . . . . 61.44 110.288 -169.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 187' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -114.99 107.59 15.58 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.066 0.946 . . . . 75.14 108.699 179.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 188' ' ' LEU . . . . . 0.543 ' H ' ' HB3' ' C' ' 154' ' ' ARG . 58.8 tp -77.12 140.69 40.31 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.479 1.112 . . . . 74.14 112.964 -171.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -142.0 123.58 15.02 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 106.925 -1.509 . . . . 71.33 106.925 163.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 68.02 -111.54 4.1 Favored Glycine 0 CA--C 1.536 1.377 0 N-CA-C 111.526 -0.629 . . . . 74.2 111.526 -172.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 191' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -113.89 -10.95 12.89 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 124.086 0.954 . . . . 60.21 110.057 172.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -95.96 147.45 23.68 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.029 0.932 . . . . 65.13 109.98 -168.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 193' ' ' LEU . . . . . 0.504 HD21 ' CD2' ' C' ' 240' ' ' PHE . 84.6 mt -104.21 158.25 16.57 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.018 0.527 . . . . 52.2 111.115 -176.15 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 194' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -131.46 106.67 8.38 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 108.119 -1.067 . . . . 75.43 108.119 165.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 195' ' ' ALA . . . . . 0.605 ' HB1' HG12 ' C' ' 185' ' ' VAL . . . -116.15 -177.75 3.24 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.159 0.984 . . . . 65.11 109.549 176.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 25.2 m -128.73 111.42 13.13 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 109.32 -0.622 . . . . 51.32 109.32 178.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 197' ' ' LEU . . . . . 0.504 HD13 ' HB2' ' C' ' 212' ' ' ALA . 55.2 tp -85.18 130.88 34.52 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.289 1.036 . . . . 73.5 110.497 -179.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -89.8 112.14 23.37 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.359 0.663 . . . . 44.52 109.386 174.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 199' ' ' VAL . . . . . 0.55 ' HA ' HG11 ' C' ' 210' ' ' VAL . 59.3 t -117.77 113.55 38.04 Favored Pre-proline 0 N--CA 1.471 0.612 0 C-N-CA 124.347 1.059 . . . . 61.21 108.621 177.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 200' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' C' ' 256' ' ' THR . 39.7 Cg_endo -68.3 146.25 68.57 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 121.788 1.659 . . . . 71.34 110.907 176.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 201' ' ' ALA . . . . . . . . . . . . . . . -53.23 -46.18 97.98 Favored Pre-proline 0 CA--C 1.56 1.357 0 C-N-CA 124.917 1.287 . . . . 74.35 114.271 -172.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 202' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -59.3 -45.51 26.63 Favored 'Trans proline' 0 C--N 1.397 3.09 0 CA-C-N 121.212 1.469 . . . . 63.15 111.977 178.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 203' ' ' ILE . . . . . . . . . . . . . 42.4 mt -66.1 -30.54 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 123.84 0.856 . . . . 63.4 110.675 178.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.32 -42.69 79.01 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.332 0.653 . . . . 75.02 111.799 178.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 205' ' ' VAL . . . . . 0.515 HG11 HD11 ' A' ' 261' ' ' LEU . 57.5 t -75.71 -46.84 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 116.016 -0.538 . . . . 63.41 111.942 -176.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 206' ' ' VAL . . . . . . . . . . . . . 14.1 p -81.14 -28.9 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 CA-C-O 120.743 0.306 . . . . 52.12 111.118 -179.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 80.12 83.13 0.71 Allowed Glycine 0 C--N 1.337 0.624 0 N-CA-C 111.431 -0.668 . . . . 63.21 111.431 -174.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -105.92 -127.83 5.98 Favored Glycine 0 C--N 1.34 0.78 0 N-CA-C 110.365 -1.094 . . . . 51.32 110.365 176.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 209' ' ' LYS . . . . . 0.493 ' HG2' ' HA ' ' C' ' 222' ' ' ALA . 8.2 mtmp? -139.19 145.32 39.17 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.494 0.664 . . . . 72.12 110.545 172.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 210' ' ' VAL . . . . . 0.55 HG11 ' HA ' ' C' ' 199' ' ' VAL . 34.1 m -126.87 178.6 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.299 1.44 . . . . 62.05 107.671 173.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 211' ' ' ARG . . . . . 0.497 ' HD3' ' HB2' ' C' ' 218' ' ' PRO . 33.6 ttm-85 -128.65 124.01 34.65 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 118.522 0.601 . . . . 72.44 112.167 -178.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 212' ' ' ALA . . . . . 0.504 ' HB2' HD13 ' C' ' 197' ' ' LEU . . . -97.81 114.24 26.23 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 107.756 -1.202 . . . . 74.43 107.756 166.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 213' ' ' MET . . . . . . . . . . . . . 2.3 tmm? -77.06 98.53 5.03 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 107.112 -1.44 . . . . 63.12 107.112 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 214' ' ' THR . . . . . 0.485 ' OG1' HG12 ' C' ' 219' ' ' VAL . 1.0 OUTLIER -100.98 170.67 8.13 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.359 0.599 . . . . 54.24 109.746 -172.991 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 215' ' ' LEU . . . . . 0.442 HD13 ' HB2' ' C' ' 131' ' ' PHE . 8.4 mt -61.94 -43.55 98.61 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.24 1.416 . . . . 44.41 110.956 -173.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -93.35 17.83 10.65 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 113.824 -1.535 . . . . 71.0 111.627 -177.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 125.44 152.86 8.32 Favored Glycine 0 C--N 1.344 0.982 0 CA-C-N 116.006 -0.543 . . . . 64.11 111.744 178.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 218' ' ' PRO . . . . . 0.497 ' HB2' ' HD3' ' C' ' 211' ' ' ARG . 68.8 Cg_endo -74.98 103.29 1.7 Allowed 'Trans proline' 0 CA--C 1.554 1.507 0 C-N-CA 122.377 2.051 . . . . 52.13 112.517 175.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 219' ' ' VAL . . . . . 0.571 HG23 HG22 ' B' ' 238' ' ' THR . 1.5 p -75.43 127.4 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 122.938 0.495 . . . . 52.53 109.667 178.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 220' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -87.0 104.62 16.48 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 107.383 -1.339 . . . . 72.32 107.383 171.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 221' ' ' VAL . . . . . . . . . . . . . 47.6 t -71.22 125.96 30.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 125.733 1.613 . . . . 74.03 111.631 -177.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 222' ' ' ALA . . . . . 0.493 ' HA ' ' HG2' ' C' ' 209' ' ' LYS . . . -78.55 106.94 10.85 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.174 0.59 . . . . 73.3 109.821 171.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 223' ' ' VAL . . . . . 0.407 ' HA ' ' HD3' ' C' ' 224' ' ' PRO . 60.4 t -83.05 132.69 49.95 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 123.906 0.882 . . . . 73.11 109.179 178.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 224' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' C' ' 223' ' ' VAL . 2.2 Cg_endo -83.13 156.76 15.0 Favored 'Trans proline' 0 C--N 1.379 2.179 0 C-N-CA 123.271 2.647 . . . . 54.33 110.979 172.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -57.64 134.52 63.63 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 122.309 2.006 . . . . 74.0 112.012 174.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 226' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? 70.97 82.16 0.15 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.617 1.167 . . . . 70.15 110.374 177.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 227' ' ' THR . . . . . . . . . . . . . 53.2 m -115.91 123.23 47.58 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.775 0.83 . . . . 70.3 110.612 179.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 228' ' ' GLN . . . . . 0.579 ' NE2' ' HG2' ' A' ' 259' ' ' GLU . 24.7 mp0 -102.33 150.8 22.96 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.307 1.043 . . . . 74.32 111.197 -179.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -72.47 134.11 45.16 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 114.559 -1.2 . . . . 62.12 109.563 176.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 102.88 -6.45 51.75 Favored Glycine 0 C--N 1.339 0.712 0 O-C-N 123.681 0.613 . . . . 62.04 112.375 -173.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 231' ' ' ARG . . . . . 0.411 ' HD2' ' H ' ' C' ' 228' ' ' GLN . 59.6 mtt180 -65.38 171.97 3.54 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 117.266 0.533 . . . . 74.12 110.85 167.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 232' ' ' LYS . . . . . 0.45 ' HA ' ' O ' ' C' ' 251' ' ' LEU . 37.1 ttmt -148.51 124.74 10.83 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.2 -0.455 . . . . 71.45 110.849 -177.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 233' ' ' LEU . . . . . 0.582 ' O ' ' HA ' ' C' ' 250' ' ' TYR . 6.3 mp -84.66 156.9 21.3 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.444 1.098 . . . . 74.21 110.254 174.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 234' ' ' ARG . . . . . 0.413 ' HG3' ' HG3' ' B' ' 241' ' ' GLU . 18.2 ptt-85 -128.0 85.2 2.32 Favored 'General case' 0 CA--C 1.553 1.08 0 O-C-N 124.966 1.416 . . . . 72.34 108.527 166.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 235' ' ' LEU . . . . . 0.515 HD22 ' H ' ' B' ' 240' ' ' GLY . 49.8 mt -79.0 116.02 19.04 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.434 -0.803 . . . . 73.43 108.849 176.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -77.28 129.62 36.12 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 123.219 0.607 . . . . 71.55 111.835 -169.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 76.18 14.74 82.0 Favored Glycine 0 C--N 1.346 1.088 0 O-C-N 124.451 1.095 . . . . 71.42 114.731 177.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 14.2 mmtm -98.87 9.65 43.0 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.386 0.674 . . . . 72.03 111.493 -179.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 239' ' ' GLY . . . . . 0.417 ' HA2' ' HG ' ' C' ' 193' ' ' LEU . . . -86.88 -169.55 46.0 Favored Glycine 0 C--N 1.346 1.113 0 O-C-N 123.447 0.467 . . . . 31.21 112.763 177.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 240' ' ' PHE . . . . . 0.504 ' CD2' HD21 ' C' ' 193' ' ' LEU . 12.8 m-85 -81.35 150.7 67.99 Favored Pre-proline 0 C--O 1.247 0.968 0 CA-C-O 119.167 -0.444 . . . . 75.14 110.005 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 241' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_exo -71.44 96.14 0.72 Allowed 'Trans proline' 0 C--N 1.388 2.647 0 C-N-CA 123.418 2.745 . . . . 70.21 112.341 -175.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -83.03 177.52 53.2 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 115.255 -0.884 . . . . 70.14 113.278 178.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -69.82 -18.93 36.46 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 123.134 2.556 . . . . 71.42 112.602 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -111.21 15.51 21.46 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.052 0.941 . . . . 71.42 110.563 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 109.42 177.26 21.33 Favored Glycine 0 C--N 1.354 1.534 0 N-CA-C 111.712 -0.555 . . . . 51.32 111.712 -175.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 246' ' ' ARG . . . . . . . . . . . . . 34.2 mtm180 -71.72 147.81 47.02 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.124 0.569 . . . . 61.31 111.393 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -78.64 -159.0 12.97 Favored Glycine 0 N--CA 1.48 1.59 0 O-C-N 123.43 0.456 . . . . 63.23 113.329 176.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -124.47 135.96 53.64 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 108.944 -0.761 . . . . 73.54 108.944 -175.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 249' ' ' LEU . . . . . 0.5 HD23 HD12 ' C' ' 235' ' ' LEU . 18.7 tp -83.89 121.9 27.98 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.0 0.92 . . . . 74.23 110.397 -179.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 250' ' ' TYR . . . . . 0.582 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 23.1 m-85 -101.64 109.94 21.83 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.221 -0.659 . . . . 71.43 109.221 175.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 251' ' ' LEU . . . . . 0.558 HD23 ' HB3' ' C' ' 195' ' ' ALA . 68.5 mt -102.64 112.85 25.8 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 116.402 -0.363 . . . . 64.53 110.917 -175.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -70.4 128.46 36.27 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 108.537 -0.912 . . . . 73.41 108.537 168.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 253' ' ' VAL . . . . . . . . . . . . . 84.6 t -82.01 122.53 36.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.014 -0.539 . . . . 73.5 110.944 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 254' ' ' ARG . . . . . . . . . . . . . 13.8 mmt180 -102.1 114.42 28.54 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 107.853 -1.166 . . . . 74.13 107.853 164.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 255' ' ' ILE . . . . . 0.513 ' O ' ' HB ' ' A' ' 255' ' ' ILE . 34.2 mm -76.7 119.16 24.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 106.455 -1.683 . . . . 75.24 106.455 164.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 256' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' C' ' 200' ' ' PRO . 2.3 t -134.4 172.32 13.06 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.594 1.158 . . . . 53.32 109.416 -171.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 257' ' ' ILE . . . . . 0.434 HD12 ' H ' ' C' ' 259' ' ' GLU . 2.9 pp -135.2 156.11 78.38 Favored Pre-proline 0 N--CA 1.482 1.137 0 C-N-CA 123.273 0.629 . . . . 64.54 109.793 -176.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -77.43 22.31 0.59 Allowed 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 122.835 2.357 . . . . 73.21 114.952 -170.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 259' ' ' GLU . . . . . 0.434 ' H ' HD12 ' C' ' 257' ' ' ILE . 43.5 mt-10 61.55 -78.49 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.98 1.312 . . . . 72.3 111.098 -174.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.11 178.23 8.2 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.389 0.675 . . . . 73.41 110.026 179.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 261' ' ' LEU . . . . . 0.552 HD22 ' HB3' ' C' ' 265' ' ' GLU . 85.6 mt -142.57 151.36 41.48 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.888 0.875 . . . . 71.21 109.504 169.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 66.2 p -82.76 155.36 68.21 Favored Pre-proline 0 N--CA 1.479 0.981 0 N-CA-C 107.689 -1.226 . . . . 61.23 107.689 166.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -39.21 -44.27 2.71 Favored 'Trans proline' 0 C--N 1.381 2.285 0 C-N-CA 123.814 3.009 . . . . 74.2 115.592 178.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -67.43 -50.4 59.55 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.298 0.639 . . . . 71.04 110.826 -178.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 265' ' ' GLU . . . . . 0.552 ' HB3' HD22 ' C' ' 261' ' ' LEU . 47.8 mt-10 -55.31 -52.08 64.64 Favored 'General case' 0 C--N 1.358 0.968 0 O-C-N 123.927 0.767 . . . . 65.11 109.943 176.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 266' ' ' GLU . . . . . 0.444 ' O ' ' HG2' ' C' ' 270' ' ' LYS . 3.7 tp10 -43.98 -56.08 4.2 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.596 1.558 . . . . 64.21 111.209 176.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -59.97 -48.85 80.01 Favored 'General case' 0 CA--C 1.549 0.93 0 O-C-N 124.217 0.948 . . . . 70.32 112.503 -176.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 268' ' ' LEU . . . . . . . . . . . . . 11.1 mp -65.37 -44.19 88.41 Favored 'General case' 0 N--CA 1.481 1.12 0 O-C-N 123.392 0.433 . . . . 52.44 111.319 -178.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 78.3 m95 -61.26 -37.68 83.99 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.558 0.743 . . . . 61.11 111.221 177.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 270' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' C' ' 266' ' ' GLU . 31.1 mmtp -64.73 -47.23 79.03 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.142 0.577 . . . . 75.43 110.695 178.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -64.15 -41.46 97.16 Favored 'General case' 0 N--CA 1.484 1.234 0 O-C-N 123.534 0.521 . . . . 75.33 111.486 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 272' ' ' LEU . . . . . 0.478 HD21 ' HB2' ' A' ' 268' ' ' LEU . 69.2 mt -57.92 -45.85 85.88 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 123.92 0.763 . . . . 74.33 110.146 174.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -60.67 -44.2 96.74 Favored 'General case' 0 C--O 1.209 -1.063 0 O-C-N 124.4 1.062 . . . . 34.13 111.718 -176.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -63.13 -49.92 72.48 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-O 121.437 0.637 . . . . 63.21 110.428 178.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -61.17 -23.25 65.43 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 114.493 -1.231 . . . . 70.04 111.342 176.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 276' ' ' TYR . . . . . 0.457 ' HB2' ' O ' ' C' ' 272' ' ' LEU . 6.7 t80 -89.46 -31.69 17.57 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.416 1.086 . . . . 75.52 110.665 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 277' ' ' TYR . . . . . 0.438 ' HE1' HG12 ' A' ' 203' ' ' ILE . 22.7 m-85 -68.24 -25.61 65.27 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 109.176 -0.676 . . . . 44.24 109.176 176.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -53.48 -26.61 21.25 Favored 'General case' 0 CA--C 1.554 1.13 0 O-C-N 124.331 1.019 . . . . 55.2 112.954 171.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 279' ' ' ARG . . . . . . . . . . . . . 26.4 mtm180 -73.5 -16.45 61.28 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 117.898 0.317 . . . . 71.52 111.726 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.087 0 C-N-CA 123.289 0.636 . . . . 75.14 109.764 -177.231 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 114.869 1.433 . . . . 62.43 114.869 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.54 ' HB3' HD11 ' A' ' 10' ' ' ILE . 99.5 mttt -81.21 123.23 28.29 Favored 'General case' 0 C--O 1.245 0.85 0 N-CA-C 108.924 -0.769 . . . . 74.32 108.924 167.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.459 ' HA ' ' OH ' ' A' ' 66' ' ' TYR . 37.2 t70 -75.53 103.97 5.89 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 107.58 -1.267 . . . . 61.41 107.58 167.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.404 ' HB2' HD11 ' A' ' 57' ' ' LEU . 38.4 m-85 -61.83 -27.57 68.86 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 114.876 -1.056 . . . . 73.34 111.873 -173.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.548 ' HE1' HD11 ' A' ' 22' ' ' ILE . 30.7 m-85 -68.12 -42.26 80.5 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 116.355 -0.384 . . . . 73.33 110.038 175.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.21 -45.58 92.69 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.13 0.572 . . . . 60.32 110.403 177.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.54 HD11 ' HB3' ' A' ' 5' ' ' LYS . 64.0 mt -52.91 -47.78 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 123.236 0.614 . . . . 74.23 110.41 175.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.465 ' HB3' ' HB1' ' A' ' 25' ' ' ALA . 88.6 mt -81.16 -9.47 59.79 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 115.159 -0.928 . . . . 51.33 113.16 -178.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.71 27.7 68.66 Favored Glycine 0 CA--C 1.543 1.824 0 N-CA-C 114.412 0.525 . . . . 53.33 114.412 179.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.407 HG13 ' HB2' ' A' ' 25' ' ' ALA . 5.9 m -114.49 162.08 25.28 Favored Pre-proline 0 N--CA 1.486 1.345 0 C-N-CA 124.507 1.123 . . . . 71.43 110.087 176.359 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -64.3 163.72 25.43 Favored 'Trans proline' 0 C--N 1.389 2.688 0 C-N-CA 122.38 2.053 . . . . 50.12 112.769 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 41.1 mtp180 -83.23 41.43 0.76 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.065 0.946 . . . . 75.43 112.135 -170.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.44 ' H ' ' H ' ' A' ' 17' ' ' ALA . 24.7 t-20 -172.86 -5.24 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.053 1.341 . . . . 64.11 109.355 -171.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.44 ' H ' ' H ' ' A' ' 16' ' ' ASN . . . -40.8 131.43 2.42 Favored 'General case' 0 C--N 1.364 1.229 0 C-N-CA 125.879 1.672 . . . . 64.31 112.674 178.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 63.2 p -78.29 -178.94 5.96 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.2 0.6 . . . . 71.11 112.249 -174.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -46.44 -58.72 3.49 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 124.915 1.286 . . . . 64.21 112.778 -177.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -71.1 -33.36 70.1 Favored 'General case' 0 C--O 1.211 -0.966 0 CA-C-O 119.111 -0.471 . . . . 72.43 111.114 -174.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -62.12 -49.29 76.48 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.137 0.494 . . . . 64.03 110.959 179.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.548 HD11 ' HE1' ' A' ' 8' ' ' TYR . 71.9 mt -61.76 -42.41 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.123 0.969 . . . . 73.31 110.518 177.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -70.85 -28.17 64.38 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.121 -0.945 . . . . 71.24 111.624 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -73.06 -36.94 66.97 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.331 0.653 . . . . 54.12 110.12 175.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.465 ' HB1' ' HB3' ' A' ' 11' ' ' LEU . . . -66.95 -39.95 87.42 Favored 'General case' 0 C--O 1.246 0.909 0 O-C-N 124.028 0.83 . . . . 64.0 110.874 175.006 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.472 ' HD1' HG22 ' A' ' 50' ' ' ILE . 48.8 t80 -57.03 -66.87 0.38 Allowed 'General case' 0 C--O 1.203 -1.391 0 CA-C-N 114.398 -1.273 . . . . 73.1 109.08 172.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -50.74 -40.93 55.88 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.567 1.147 . . . . 74.22 111.888 -178.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.8 ttt180 -57.5 -67.54 0.32 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.247 0.619 . . . . 71.15 110.59 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 83.9 mt -71.72 -22.79 61.58 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.499 -0.773 . . . . 74.11 111.577 -173.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.9 -26.14 29.62 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.466 0.707 . . . . 63.3 110.782 -178.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 85.0 mtt180 -83.82 -26.48 29.5 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 122.951 0.501 . . . . 72.33 110.551 172.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -70.58 -52.18 23.32 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 121.004 0.431 . . . . 63.33 110.393 173.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.465 ' HD2' HD11 ' A' ' 50' ' ' ILE . 14.4 m-85 -97.97 35.51 1.71 Allowed 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.988 0.915 . . . . 63.25 109.843 -177.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.488 ' CD2' ' HB3' ' A' ' 36' ' ' ASP . 18.3 t60 -76.63 109.91 10.07 Favored Pre-proline 0 N--CA 1.473 0.695 0 C-N-CA 124.763 1.225 . . . . 63.41 110.156 -172.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -52.21 -37.22 69.73 Favored 'Trans proline' 0 C--N 1.379 2.148 0 C-N-CA 123.584 2.856 . . . . 74.13 113.274 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.488 ' HB3' ' CD2' ' A' ' 34' ' ' HIS . 15.9 t70 -64.28 -31.49 72.71 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.93 0.892 . . . . 72.45 111.778 178.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 85.3 t -84.79 -54.25 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 122.868 0.467 . . . . 65.53 109.876 176.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -133.9 110.05 9.46 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.319 1.048 . . . . 61.35 109.762 -174.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -85.97 63.7 8.18 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.376 0.671 . . . . 73.11 109.983 -178.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 66.9 m -99.8 112.56 64.0 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-O 117.654 -1.165 . . . . 54.41 108.459 174.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -38.61 -53.54 1.79 Allowed 'Trans proline' 0 C--N 1.39 2.732 0 C-N-CA 124.411 3.408 . . . . 72.23 114.044 -177.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -63.12 -35.04 78.96 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.671 0.788 . . . . 64.43 111.816 -178.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.451 ' O ' ' HB3' ' A' ' 33' ' ' TYR . . . -71.2 -29.78 65.58 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 122.829 0.452 . . . . 72.14 110.157 176.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -82.54 -26.74 32.16 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 109.422 -0.585 . . . . 62.01 109.422 -178.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -69.01 -41.83 77.25 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.913 0.885 . . . . 62.44 109.653 172.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 9.7 mptt -64.66 -41.02 96.39 Favored 'General case' 0 C--O 1.212 -0.903 0 CA-C-N 115.315 -0.857 . . . . 74.03 110.271 174.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.491 ' HA ' HD12 ' A' ' 50' ' ' ILE . 90.7 t80 -55.78 -45.42 78.18 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.794 0.838 . . . . 73.24 109.684 174.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.466 ' HB3' ' HE1' ' A' ' 93' ' ' PHE . 52.4 mtpt -60.25 -41.26 92.84 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.866 0.866 . . . . 75.14 111.435 176.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -67.61 -34.47 77.07 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.479 0.712 . . . . 71.44 111.717 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.491 HD12 ' HA ' ' A' ' 47' ' ' PHE . 53.8 mt -69.33 -35.93 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.496 1.118 . . . . 70.53 109.499 174.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -83.43 -13.55 54.54 Favored 'General case' 0 C--O 1.206 -1.222 0 C-N-CA 124.224 1.01 . . . . 73.43 111.401 178.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -74.27 -56.8 4.47 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 107.646 -1.242 . . . . 63.42 107.646 169.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -52.94 -50.64 63.6 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-N 113.152 -1.84 . . . . 65.45 110.515 177.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -66.35 -41.91 88.86 Favored 'General case' 0 C--O 1.205 -1.247 0 CA-C-N 115.296 -0.865 . . . . 72.32 110.857 178.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.62 -39.65 65.11 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 118.76 0.709 . . . . 53.01 111.986 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 61.1 t -70.8 -51.06 39.31 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 CA-C-N 115.794 -0.639 . . . . 74.52 110.748 174.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.454 HD13 HD13 ' A' ' 22' ' ' ILE . 48.6 mt -89.81 -0.1 57.34 Favored 'General case' 0 CA--C 1.568 1.657 0 N-CA-C 113.806 1.039 . . . . 62.04 113.806 -167.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 48.0 t -71.07 -51.15 26.89 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 124.091 0.956 . . . . 74.34 111.411 -173.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -86.59 125.19 68.07 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 114.613 -1.176 . . . . 74.34 107.87 177.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -53.21 -26.01 32.21 Favored 'Trans proline' 0 C--N 1.374 1.921 0 C-N-CA 123.322 2.681 . . . . 72.41 113.335 178.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -70.93 -56.26 6.61 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.957 0.903 . . . . 72.3 110.911 177.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.496 ' HA ' HD12 ' A' ' 65' ' ' ILE . 46.4 mtpt -66.96 -27.7 67.67 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 123.829 0.852 . . . . 74.54 111.477 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -60.92 -55.5 32.17 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 114.48 -1.236 . . . . 74.11 109.713 171.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -54.21 -40.61 67.78 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 124.165 0.916 . . . . 74.25 111.159 177.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.665 HD13 ' HE1' ' A' ' 83' ' ' TYR . 77.3 mt -51.92 -63.78 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.025 0 O-C-N 124.404 1.065 . . . . 64.42 109.265 174.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.459 ' OH ' ' HA ' ' A' ' 6' ' ' ASP . 32.6 t80 -50.19 -54.66 19.41 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 119.024 -0.512 . . . . 75.4 112.071 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -43.27 -55.22 4.13 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 124.433 1.083 . . . . 64.04 110.585 -178.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.425 ' HB ' ' HB3' ' A' ' 74' ' ' ALA . 69.1 p -98.47 -2.53 38.73 Favored 'General case' 0 CA--C 1.551 1.019 0 CA-C-N 115.071 -0.968 . . . . 75.13 113.258 -171.271 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -117.78 118.72 32.82 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 118.754 0.706 . . . . 63.45 109.428 -178.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.08 21.81 72.81 Favored Glycine 0 C--N 1.344 0.991 0 CA-C-O 121.6 0.556 . . . . 52.54 112.781 177.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 90.6 m -146.67 -51.81 0.22 Allowed 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 103.969 -2.604 . . . . 71.23 103.969 178.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 60.6 m -102.2 161.43 13.7 Favored 'General case' 0 C--O 1.258 1.533 0 CA-C-N 112.198 -2.273 . . . . 74.23 105.165 158.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.89 12.3 17.77 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.409 0.683 . . . . 74.04 112.203 179.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.425 ' HB3' ' HB ' ' A' ' 68' ' ' THR . . . -70.3 -152.05 0.0 OUTLIER Pre-proline 0 CA--C 1.589 2.456 0 CA-C-O 116.775 -1.583 . . . . 75.1 111.333 176.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.427 ' HA ' ' HD2' ' A' ' 76' ' ' PRO . 6.2 Cg_exo 7.76 107.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.412 3.909 0 C-N-CA 124.384 3.39 . . . . 75.41 117.835 -153.026 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 75' ' ' PRO . 28.9 Cg_endo -57.98 -177.44 0.09 OUTLIER 'Trans proline' 0 N--CA 1.518 2.961 0 C-N-CA 124.519 3.48 . . . . 74.25 113.217 174.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -39.11 131.49 1.36 Allowed 'Trans proline' 0 C--N 1.402 3.351 0 C-N-CA 123.111 2.54 . . . . 62.44 114.056 173.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.473 ' HG3' ' HE2' ' A' ' 83' ' ' TYR . 0.5 OUTLIER -29.03 123.31 0.05 OUTLIER 'Trans proline' 0 C--N 1.382 2.324 1 C-N-CA 126.105 4.537 . . . . 43.51 117.314 -172.433 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -78.39 156.45 28.96 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 123.137 2.558 . . . . 71.05 114.07 -176.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -56.35 80.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.393 2.915 0 C-N-CA 124.384 3.389 . . . . 51.35 113.191 175.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -178.15 -34.85 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 N-CA-C 109.903 -1.279 . . . . 62.41 109.903 -177.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 75.63 168.82 25.41 Favored Glycine 0 C--N 1.353 1.52 0 N-CA-C 115.194 0.838 . . . . 53.03 115.194 171.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.665 ' HE1' HD13 ' A' ' 65' ' ' ILE . 27.0 m-85 -111.06 102.25 10.72 Favored 'General case' 0 C--O 1.243 0.731 0 C-N-CA 124.789 1.236 . . . . 74.41 109.406 178.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -89.49 152.79 21.26 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.148 0.579 . . . . 71.31 110.819 175.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -127.65 77.89 1.78 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.386 1.074 . . . . 70.22 108.367 175.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 9.0 m -38.37 86.67 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 126.982 2.113 . . . . 74.44 115.505 -172.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 76.03 -7.27 29.8 Favored Glycine 0 C--N 1.35 1.32 0 CA-C-N 116.041 -0.527 . . . . 70.11 113.789 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -89.71 125.29 35.22 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.609 1.164 . . . . 72.34 108.208 -178.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -71.71 88.68 0.99 Allowed 'General case' 0 N--CA 1.482 1.139 0 CA-C-O 121.52 0.676 . . . . 71.44 110.082 -175.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -47.13 -43.05 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 126.112 1.765 . . . . 75.21 111.949 177.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -73.88 -6.5 47.55 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 115.214 -0.903 . . . . 75.33 111.889 -173.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -91.64 -27.93 17.81 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.976 0.911 . . . . 45.35 110.787 172.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.466 ' HE1' ' HB3' ' A' ' 48' ' ' LYS . 23.8 m-85 -76.78 -176.2 3.76 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 112.802 0.667 . . . . 71.01 112.802 -170.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 67.8 p -56.86 145.28 30.22 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.194 0.998 . . . . 74.5 112.944 -167.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.63 -41.26 85.55 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.0 -1.0 . . . . 74.31 111.428 177.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -58.91 -44.3 91.25 Favored 'General case' 0 C--N 1.355 0.812 0 C-N-CA 123.038 0.535 . . . . 75.03 110.145 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -58.08 -49.64 76.21 Favored 'General case' 0 CA--C 1.555 1.16 0 CA-C-N 116.077 -0.51 . . . . 63.23 109.963 174.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -73.98 -3.92 32.08 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 112.428 0.529 . . . . 73.05 112.428 -178.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -95.73 -60.15 1.71 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.427 0.691 . . . . 70.02 110.398 171.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.4 HD23 ' CE2' ' A' ' 101' ' ' PHE . 24.2 tp -58.5 -56.77 17.9 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.916 1.286 . . . . 55.03 110.785 -177.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.4 ' CE2' HD23 ' A' ' 100' ' ' LEU . 92.2 m-85 -84.25 -8.13 59.13 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 114.251 -1.341 . . . . 72.11 111.043 178.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -40.65 -66.28 0.88 Allowed Glycine 0 C--N 1.351 1.376 0 N-CA-C 116.114 1.206 . . . . 72.43 116.114 -174.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.452 ' HB2' ' HG2' ' A' ' 78' ' ' PRO . 23.7 Cg_exo -62.6 -14.86 42.43 Favored 'Trans proline' 0 C--N 1.373 1.864 0 C-N-CA 122.749 2.299 . . . . 23.1 114.06 -175.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -103.36 -2.23 47.58 Favored Glycine 0 C--N 1.358 1.773 0 CA-C-O 118.91 -0.939 . . . . 44.4 113.825 -177.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.43 ' HB3' ' OD1' ' A' ' 169' ' ' ASN . 86.6 mt -63.32 77.11 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 124.065 0.946 . . . . 74.25 113.007 -177.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 19.65 -105.14 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.256 0 C-N-CA 127.9 2.48 . . . . 72.25 116.36 174.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 71.85 2.88 53.59 Favored Glycine 0 C--N 1.35 1.353 0 CA-C-O 119.576 -0.569 . . . . 44.0 112.664 -164.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.355 1.584 0 O-C-N 123.923 0.425 . . . . 71.34 112.763 -172.631 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 51.7 tttm . . . . . 0 N--CA 1.484 1.228 0 N-CA-C 112.906 0.706 . . . . 72.15 112.906 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -85.99 -178.3 50.0 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 115.7 -0.682 . . . . 55.22 113.646 177.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.437 ' O ' ' HA3' ' A' ' 172' ' ' GLY . 13.4 ptt180 -96.05 173.43 7.43 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.796 0.838 . . . . 71.34 111.061 179.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -78.82 138.76 38.33 Favored 'General case' 0 CA--C 1.549 0.941 0 N-CA-C 109.267 -0.642 . . . . 74.23 109.267 166.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 9.3 tt -144.95 139.33 27.48 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 107.966 -1.124 . . . . 70.23 107.966 -173.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.543 ' HA ' ' HB2' ' A' ' 175' ' ' LEU . 2.8 tmm_? -100.26 119.04 37.78 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 108.891 -0.781 . . . . 74.51 108.891 175.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.488 ' HB2' HD11 ' A' ' 174' ' ' LEU . . . -111.73 169.87 8.53 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-O 121.7 0.762 . . . . 41.51 110.41 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.413 ' HB2' ' HB3' ' B' ' 9' ' ' ALA . 7.4 mm-40 -120.26 113.42 20.39 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 106.497 -1.668 . . . . 61.0 106.497 -176.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 51.1 tp -98.64 98.02 5.53 Favored Pre-proline 0 N--CA 1.473 0.682 0 N-CA-C 108.194 -1.039 . . . . 54.05 108.194 -178.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.647 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 73.4 Cg_endo -77.05 114.24 3.77 Favored 'Trans proline' 0 C--N 1.372 1.789 0 C-N-CA 121.32 1.347 . . . . 75.33 108.958 177.194 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.524 ' HA ' HG21 ' B' ' 6' ' ' ILE . 61.6 tp -123.06 139.56 53.95 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.075 0.55 . . . . 64.01 110.687 -169.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 27.2 m -68.56 128.86 38.14 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.861 0.864 . . . . 71.34 109.99 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.526 HD23 ' HB3' ' A' ' 180' ' ' LEU . 75.7 mt -50.93 -49.88 58.8 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 124.187 0.995 . . . . 70.54 111.21 -174.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -55.93 -49.4 73.59 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.239 -1.346 . . . . 75.32 109.911 -178.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -75.06 -19.84 59.82 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 114.631 -1.168 . . . . 64.33 111.677 -176.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -68.86 -43.69 74.88 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.334 0.653 . . . . 41.43 109.723 174.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -70.8 -35.51 72.57 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 115.126 -0.943 . . . . 74.51 111.364 176.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -73.65 -39.95 64.09 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 116.202 -0.453 . . . . 75.25 111.885 -178.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.581 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 77.29 -166.44 53.67 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-N 116.513 -0.312 . . . . 71.54 113.42 -176.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 100.08 179.04 30.32 Favored Glycine 0 C--N 1.35 1.311 0 C-N-CA 122.828 0.251 . . . . 70.42 113.161 176.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.432 ' HB3' ' OG ' ' A' ' 146' ' ' SER . 2.1 mp0 -74.75 100.63 4.07 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 122.96 0.504 . . . . 73.14 110.2 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -90.57 123.99 34.67 Favored 'General case' 0 C--O 1.244 0.8 0 N-CA-C 109.307 -0.627 . . . . 74.4 109.307 -177.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 98.3 t -72.39 108.41 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 N-CA-C 109.043 -0.725 . . . . 71.24 109.043 173.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.557 HG13 HG13 ' A' ' 145' ' ' VAL . 3.1 p -121.57 133.16 68.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 124.752 1.221 . . . . 73.14 108.312 175.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -122.42 146.59 47.22 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.037 0.535 . . . . 71.3 110.243 -170.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 10.7 p -163.89 135.03 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 123.26 0.624 . . . . 75.1 110.06 175.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 61.9 19.89 11.05 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.727 1.211 . . . . 74.24 112.871 176.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 96.87 -19.91 52.84 Favored Glycine 0 C--N 1.348 1.226 0 CA-C-N 116.386 -0.37 . . . . 31.1 112.844 -176.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -80.31 115.8 20.04 Favored 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 108.58 -0.896 . . . . 72.12 108.58 -179.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 42.2 ttt180 -98.38 99.53 10.73 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.187 0.995 . . . . 74.41 109.781 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.557 HG13 HG13 ' A' ' 138' ' ' VAL . 6.7 p -104.37 153.01 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 C-N-CA 123.231 0.612 . . . . 73.53 110.446 -177.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.432 ' OG ' ' HB3' ' A' ' 135' ' ' GLU . 32.0 t -124.61 103.99 8.44 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.599 0.759 . . . . 31.45 109.6 -179.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 4.8 p -101.38 121.99 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 123.169 0.588 . . . . 73.42 110.646 -175.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -73.84 99.36 3.19 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.422 0.629 . . . . 74.14 109.969 173.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.581 HG13 ' HA2' ' A' ' 133' ' ' GLY . 24.1 pt -80.96 142.89 52.48 Favored Pre-proline 0 CA--C 1.558 1.25 0 CA-C-N 114.608 -1.178 . . . . 74.13 109.622 173.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -66.43 136.28 42.63 Favored 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 122.538 2.159 . . . . 60.34 113.24 174.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -56.36 96.9 0.06 OUTLIER 'Trans proline' 0 C--N 1.385 2.45 0 C-N-CA 123.084 2.523 . . . . 74.15 112.409 168.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 104.57 39.63 2.35 Favored Glycine 0 C--N 1.339 0.713 0 CA-C-N 115.298 -0.865 . . . . 75.51 111.675 -174.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 11.6 p -78.56 140.94 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 N-CA-C 109.158 -0.682 . . . . 75.43 109.158 177.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.414 ' NH1' ' HD3' ' A' ' 243' ' ' PRO . 9.5 mtm105 -115.23 147.15 40.7 Favored 'General case' 0 C--O 1.205 -1.264 0 CA-C-N 115.937 -0.574 . . . . 73.23 111.77 -164.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -53.77 120.01 5.7 Favored 'General case' 0 CA--C 1.551 0.984 0 O-C-N 124.266 0.979 . . . . 72.32 110.355 175.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 105.09 -8.34 45.23 Favored Glycine 0 C--N 1.347 1.14 0 CA-C-N 115.536 -0.757 . . . . 14.21 113.425 -176.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 44.1 m -68.32 105.09 2.03 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 117.447 0.623 . . . . 74.23 110.253 177.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.444 HG22 HG22 ' A' ' 177' ' ' VAL . 41.5 t -85.17 90.81 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-N 115.117 -0.947 . . . . 72.34 109.31 -178.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.599 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 56.9 mt -70.44 91.64 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 108.404 -0.961 . . . . 75.24 108.404 175.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 67.9 ttt-85 -78.38 100.05 6.62 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.778 -0.647 . . . . 61.32 109.273 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.6 p -106.6 105.39 54.56 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 123.662 0.785 . . . . 61.33 109.266 177.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.478 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 23.8 Cg_exo -65.25 104.18 0.59 Allowed 'Trans proline' 0 C--N 1.377 2.058 0 C-N-CA 122.551 2.168 . . . . 74.53 111.283 175.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' A' ' 171' ' ' PRO . . . 126.99 25.77 1.18 Allowed Glycine 0 C--N 1.342 0.873 0 N-CA-C 115.801 1.081 . . . . 70.43 115.801 175.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 24.7 mmt -137.57 0.44 2.26 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 119.013 1.406 . . . . 64.15 112.057 177.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.695 ' HA2' HD13 ' A' ' 174' ' ' LEU . . . -75.85 -108.22 0.12 Allowed Glycine 0 N--CA 1.477 1.404 0 C-N-CA 123.685 0.66 . . . . 73.33 114.274 -170.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -58.22 119.05 15.25 Favored Glycine 0 C--N 1.344 0.992 0 N-CA-C 110.051 -1.22 . . . . 74.5 110.051 168.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -64.45 109.09 1.83 Allowed 'General case' 0 CA--C 1.538 0.503 0 O-C-N 124.67 0.865 . . . . 75.42 110.056 -175.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -146.77 174.14 26.71 Favored Glycine 0 C--N 1.339 0.739 0 N-CA-C 110.1 -1.2 . . . . 64.21 110.1 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . 0.447 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . 50.4 t30 -59.61 -61.05 8.66 Favored Pre-proline 0 CA--C 1.565 1.525 0 CA-C-O 118.629 -0.7 . . . . 63.11 109.742 -176.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.447 ' HD3' ' HB3' ' A' ' 169' ' ' ASN . 19.6 Cg_endo -94.81 96.16 0.11 Allowed 'Trans proline' 0 C--N 1.382 2.314 0 CA-C-N 121.44 1.55 . . . . 71.13 108.16 154.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.44 ' O ' ' HA2' ' A' ' 163' ' ' GLY . 18.1 Cg_exo -61.59 167.41 9.95 Favored 'Trans proline' 0 C--N 1.385 2.473 0 C-N-CA 122.361 2.041 . . . . 71.25 112.638 -169.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.437 ' HA3' ' O ' ' A' ' 117' ' ' ARG . . . -85.81 -168.83 45.25 Favored Glycine 0 C--O 1.216 -0.989 0 C-N-CA 121.172 -0.537 . . . . 72.4 113.247 -177.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.478 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 13.6 m-20 -72.59 138.69 46.99 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 122.94 0.496 . . . . 71.14 110.467 -176.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.695 HD13 ' HA2' ' A' ' 165' ' ' GLY . 25.6 tp -119.21 132.05 55.9 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 110.0 -0.37 . . . . 64.32 110.0 177.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.543 ' HB2' ' HA ' ' A' ' 120' ' ' ARG . 44.6 mt -102.09 85.74 2.73 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 107.999 -1.112 . . . . 72.12 107.999 176.083 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.599 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 79.8 mt -71.72 85.83 0.92 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 109.543 -0.539 . . . . 70.05 109.543 176.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.444 HG22 HG22 ' A' ' 158' ' ' VAL . 18.9 t -82.64 102.22 8.33 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 N-CA-C 106.787 -1.56 . . . . 61.43 106.787 178.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 8.2 p -67.92 107.7 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.961 0 CA-C-O 122.516 1.151 . . . . 70.33 110.705 -171.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.647 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 36.0 mmt180 -95.18 100.08 11.95 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.116 -1.402 . . . . 53.32 108.953 175.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.526 ' HB3' HD23 ' A' ' 127' ' ' LEU . 26.3 mt -68.98 142.91 54.53 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 109.753 -0.462 . . . . 72.4 109.753 -179.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 55.2 mt -53.97 159.06 3.02 Favored Pre-proline 0 N--CA 1.486 1.336 0 C-N-CA 124.281 1.032 . . . . 73.14 113.142 -168.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -74.8 28.72 0.35 Allowed 'Trans proline' 0 C--N 1.38 2.215 0 C-N-CA 123.488 2.792 . . . . 71.42 112.485 167.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 64.8 t-80 -60.1 104.83 0.48 Allowed Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 125.722 1.609 . . . . 73.35 106.881 169.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -70.03 24.53 0.18 Allowed 'Trans proline' 0 C--N 1.382 2.34 0 C-N-CA 124.513 3.475 . . . . 61.24 116.801 -160.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 49.1 t -98.92 -50.94 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 118.721 0.691 . . . . 64.21 109.349 178.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . 0.485 ' HB3' HD22 ' A' ' 193' ' ' LEU . 82.9 m-85 -127.74 124.8 38.65 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.045 0.538 . . . . 72.31 110.864 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 52.1 ttp85 -103.5 87.96 2.98 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 107.007 -1.479 . . . . 75.51 107.007 164.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.459 ' HA ' ' HA ' ' A' ' 193' ' ' LEU . 16.3 tp -66.9 155.84 37.37 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.29 0.636 . . . . 74.21 109.601 177.089 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . 0.404 ' H ' HD12 ' A' ' 188' ' ' LEU . 44.7 tt0 -163.92 121.07 1.73 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.236 0.614 . . . . 70.31 109.384 178.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 74.62 -79.23 0.97 Allowed Glycine 0 C--N 1.348 1.238 0 N-CA-C 112.239 -0.344 . . . . 65.41 112.239 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.538 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 3.8 pm0 -146.25 -13.3 0.46 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.567 1.147 . . . . 72.32 110.251 173.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -112.03 140.31 46.81 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.285 1.034 . . . . 72.32 111.503 -169.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.485 HD22 ' HB3' ' A' ' 186' ' ' PHE . 35.5 mt -90.2 153.88 20.17 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.312 1.445 . . . . 63.44 111.027 -172.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -128.2 98.89 5.24 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 107.738 -1.208 . . . . 73.14 107.738 170.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.459 ' HB3' HD23 ' A' ' 251' ' ' LEU . . . -113.08 130.1 56.28 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.755 0.822 . . . . 74.34 109.932 -176.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 41.2 m -77.25 131.43 38.18 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 109.579 -0.526 . . . . 70.21 109.579 -176.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.422 HD22 HD13 ' A' ' 251' ' ' LEU . 57.1 tp -124.91 108.03 11.47 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 123.216 0.606 . . . . 72.21 109.704 -170.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -80.72 107.74 13.79 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 108.513 -0.921 . . . . 61.43 108.513 173.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 6.7 p -126.51 130.59 23.85 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 124.055 0.942 . . . . 64.4 108.58 -179.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . 0.401 ' HB2' ' HE1' ' C' ' 276' ' ' TYR . 72.9 Cg_endo -75.45 157.44 40.88 Favored 'Trans proline' 0 C--N 1.365 1.409 0 C-N-CA 121.627 1.551 . . . . 64.51 111.96 173.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.425 ' HB3' ' HD3' ' A' ' 202' ' ' PRO . . . -54.09 -53.29 60.21 Favored Pre-proline 0 CA--C 1.559 1.295 0 N-CA-C 114.177 1.177 . . . . 71.34 114.177 -169.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.425 ' HD3' ' HB3' ' A' ' 201' ' ' ALA . 50.4 Cg_exo -58.5 -35.63 98.43 Favored 'Trans proline' 0 C--N 1.382 2.292 0 C-N-CA 122.02 1.813 . . . . 63.54 113.682 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 46.2 mt -74.51 -33.89 34.03 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 N-CA-C 109.966 -0.383 . . . . 64.32 109.966 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . 0.508 ' HA ' HG11 ' A' ' 223' ' ' VAL . . . -67.92 -41.32 82.78 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.303 0.641 . . . . 71.51 111.275 175.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.534 HG13 HD11 ' C' ' 261' ' ' LEU . 55.1 t -78.94 -42.16 24.02 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 C-N-CA 123.865 0.866 . . . . 63.23 112.466 -172.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 84.6 t -84.17 -33.0 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 122.793 0.437 . . . . 74.41 110.288 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 88.04 48.5 4.08 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-N 115.551 -0.749 . . . . 72.35 111.796 -177.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -76.93 173.86 54.62 Favored Glycine 0 C--N 1.341 0.853 0 N-CA-C 111.334 -0.706 . . . . 55.24 111.334 173.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.528 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 46.8 mtmt -84.76 129.92 34.76 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 117.694 0.747 . . . . 45.21 111.915 -178.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.42 HG21 HD11 ' A' ' 197' ' ' LEU . 30.2 m -111.56 -172.12 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.961 0 N-CA-C 106.237 -1.764 . . . . 63.11 106.237 161.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . 0.508 ' HD3' ' HB2' ' A' ' 218' ' ' PRO . 15.5 ttm180 -127.39 132.16 50.2 Favored 'General case' 0 C--O 1.237 0.432 0 O-C-N 121.954 -0.466 . . . . 71.41 110.353 177.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -99.51 111.75 24.05 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 108.29 -1.004 . . . . 62.04 108.29 174.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . 0.5 ' HA ' ' HA ' ' A' ' 218' ' ' PRO . 3.5 mpp? -71.93 123.78 23.46 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 108.602 -0.888 . . . . 71.23 108.602 173.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . 0.453 ' HA ' ' HE1' ' A' ' 186' ' ' PHE . 24.5 p -108.81 -177.74 3.4 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 109.405 -0.591 . . . . 74.1 109.405 179.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.437 HD11 ' HZ ' ' A' ' 240' ' ' PHE . 61.5 mt -58.82 -27.21 64.88 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.661 1.184 . . . . 63.31 113.141 -171.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -142.34 28.84 1.64 Allowed 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 116.323 -0.399 . . . . 64.44 111.222 -175.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 155.72 146.59 4.48 Favored Glycine 0 C--N 1.35 1.346 0 O-C-N 121.513 -0.742 . . . . 33.0 114.612 171.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . 0.508 ' HB2' ' HD3' ' A' ' 211' ' ' ARG . 72.9 Cg_endo -85.94 108.82 0.98 Allowed 'Trans proline' 0 C--N 1.369 1.613 0 C-N-CA 122.962 2.441 . . . . 70.23 112.567 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 30.1 m -103.05 150.28 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 123.592 0.757 . . . . 73.4 109.648 -178.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -79.36 142.32 36.14 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 117.802 0.273 . . . . 75.04 110.613 -177.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 3.9 m -134.1 110.87 14.34 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 C-N-CA 124.163 0.985 . . . . 74.13 108.578 174.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.528 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -72.61 114.53 10.85 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 109.145 -0.687 . . . . 60.25 109.145 174.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.508 HG11 ' HA ' ' A' ' 204' ' ' ALA . 50.5 t -59.53 146.63 79.46 Favored Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 124.357 1.063 . . . . 63.14 109.425 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -70.75 158.9 54.36 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 121.592 1.528 . . . . 75.51 109.316 169.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -72.34 151.46 54.14 Favored 'Trans proline' 0 CA--C 1.549 1.25 0 CA-C-N 119.925 1.009 . . . . 72.53 111.969 171.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 46.1 mtt180 64.82 39.26 6.22 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 125.331 1.452 . . . . 74.04 110.894 169.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.604 HG23 HD21 ' A' ' 233' ' ' LEU . 53.2 m -74.42 109.58 8.01 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 112.989 -1.914 . . . . 64.32 111.716 -177.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . 0.401 ' HB3' ' HD2' ' A' ' 231' ' ' ARG . 5.8 tp60 -84.86 140.96 30.78 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.618 1.167 . . . . 75.32 111.521 -177.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -63.31 145.56 55.29 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.061 0.944 . . . . 62.31 112.184 -179.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 86.29 -24.89 7.58 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-N 116.334 -0.394 . . . . 73.32 113.355 178.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.401 ' HD2' ' HB3' ' A' ' 228' ' ' GLN . 93.7 mtt180 -69.15 160.83 30.37 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-O 121.46 0.648 . . . . 74.0 110.905 176.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.623 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 2.8 mppt? -115.16 114.87 25.85 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.112 -1.07 . . . . 72.22 108.112 178.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.604 HD21 HG23 ' A' ' 227' ' ' THR . 87.9 mt -76.16 103.44 6.2 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 115.46 -0.791 . . . . 71.4 109.905 -175.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -76.14 105.09 6.99 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 123.712 0.632 . . . . 64.14 109.982 177.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.5 ' HG ' ' HB3' ' A' ' 249' ' ' LEU . 0.4 OUTLIER -108.45 115.45 30.13 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.006 -1.109 . . . . 61.12 108.006 167.772 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -69.73 141.44 53.46 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 114.651 -1.159 . . . . 64.43 111.978 -167.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 69.98 17.42 73.58 Favored Glycine 0 C--N 1.348 1.221 0 O-C-N 123.936 0.773 . . . . 74.2 113.922 174.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.451 ' HG3' HD12 ' A' ' 235' ' ' LEU . 33.7 mmtp -107.62 5.15 26.65 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.225 0.61 . . . . 73.01 111.086 -176.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -101.74 -156.3 26.42 Favored Glycine 0 C--N 1.347 1.19 0 C-N-CA 123.194 0.426 . . . . 74.43 112.659 173.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . 0.437 ' HZ ' HD11 ' A' ' 215' ' ' LEU . 3.4 m-85 -94.23 145.18 29.28 Favored Pre-proline 0 N--CA 1.481 1.079 0 C-N-CA 123.136 0.575 . . . . 73.13 111.065 -172.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' A' ' 246' ' ' ARG . 37.4 Cg_exo -60.56 119.09 6.07 Favored 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 123.52 2.813 . . . . 73.33 112.85 178.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -156.42 -148.19 4.99 Favored Glycine 0 C--N 1.35 1.323 0 CA-C-O 118.548 -1.14 . . . . 73.52 113.746 -173.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . 0.538 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 74.2 Cg_exo -51.92 -38.52 68.82 Favored 'Trans proline' 0 C--N 1.39 2.747 0 C-N-CA 124.138 3.225 . . . . 70.45 113.84 -176.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -82.98 15.33 2.8 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.821 0.848 . . . . 70.11 112.207 -178.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 81.16 -71.57 2.89 Favored Glycine 0 C--N 1.345 1.048 0 N-CA-C 109.814 -1.314 . . . . 62.24 109.814 -169.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.41 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 23.1 mtp180 -122.12 147.49 46.08 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.491 1.117 . . . . 75.41 108.723 168.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -86.14 -177.44 49.89 Favored Glycine 0 C--N 1.339 0.706 0 CA-C-N 116.303 -0.408 . . . . 42.24 112.346 175.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -111.45 170.93 7.79 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.29 0.636 . . . . 75.44 110.072 -179.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.5 ' HB3' ' HG ' ' A' ' 235' ' ' LEU . 34.0 tp -114.91 134.39 55.19 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.361 -1.348 . . . . 70.31 107.361 170.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.623 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 62.0 m-85 -116.38 106.28 13.45 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 107.945 -1.131 . . . . 52.51 107.945 175.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.459 HD23 ' HB3' ' A' ' 195' ' ' ALA . 49.5 mt -90.23 108.2 19.61 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 109.51 -0.552 . . . . 72.24 109.51 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . 0.516 ' HG2' ' HG3' ' A' ' 232' ' ' LYS . 30.6 mt-10 -76.33 111.5 11.84 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.663 1.185 . . . . 75.41 109.068 -172.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 27.5 t -69.81 119.24 15.49 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 C-N-CA 123.827 0.851 . . . . 24.43 111.902 -168.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.28 91.67 3.59 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 107.433 -1.321 . . . . 73.14 107.433 174.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.475 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 62.4 mt -78.61 129.68 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 O-C-N 123.204 0.315 . . . . 74.34 110.305 -177.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 51.9 p -113.94 166.46 11.57 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.939 0.895 . . . . 73.43 109.703 173.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.632 HG23 HG21 ' C' ' 255' ' ' ILE . 2.6 pp -118.17 157.52 48.67 Favored Pre-proline 0 CA--C 1.56 1.329 0 C-N-CA 123.735 0.814 . . . . 73.4 110.378 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 258' ' ' PRO . . . . . 0.503 ' HD2' ' HB ' ' A' ' 257' ' ' ILE . 25.7 Cg_endo -56.23 -17.2 19.65 Favored 'Trans proline' 0 N--CA 1.513 2.631 0 C-N-CA 124.42 3.413 . . . . 74.45 115.165 -168.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . 0.727 ' HG2' HE21 ' C' ' 228' ' ' GLN . 40.5 mt-10 50.01 -81.61 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 124.859 1.264 . . . . 63.24 111.659 -166.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.6 161.49 29.52 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 120.114 1.325 . . . . 75.12 109.806 173.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.697 HD22 ' HB3' ' A' ' 265' ' ' GLU . 54.6 mt -147.47 146.5 29.55 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.37 0.668 . . . . 55.32 109.936 173.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 72.5 p -83.97 161.35 55.67 Favored Pre-proline 0 CA--C 1.551 1.011 0 N-CA-C 107.958 -1.127 . . . . 44.34 107.958 165.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -50.24 -40.25 52.08 Favored 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 123.279 2.653 . . . . 74.33 113.562 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -63.1 -56.99 12.16 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.745 -0.661 . . . . 71.44 110.53 177.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . 0.697 ' HB3' HD22 ' A' ' 261' ' ' LEU . 53.0 mt-10 -57.38 -35.97 70.66 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 123.626 0.579 . . . . 64.2 111.102 -179.032 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 266' ' ' GLU . . . . . 0.54 ' HA ' HD13 ' A' ' 261' ' ' LEU . 7.3 tp10 -59.69 -50.41 73.96 Favored 'General case' 0 C--O 1.248 0.984 0 C-N-CA 123.985 0.914 . . . . 73.45 109.519 178.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -60.71 -41.54 95.45 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 114.627 -1.169 . . . . 64.12 111.814 177.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 10.1 mp -69.85 -45.28 68.11 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.42 0.688 . . . . 73.14 111.786 -176.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 63.1 m95 -66.68 -35.38 80.02 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.563 0.745 . . . . 75.0 111.62 -179.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . 0.455 ' HE2' HG23 ' C' ' 206' ' ' VAL . 96.2 mttt -85.22 -16.79 39.09 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 116.216 -0.447 . . . . 62.43 112.142 177.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 4.0 mmmp? -74.47 -32.79 62.69 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 110.029 -0.36 . . . . 70.22 110.029 166.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 91.6 mt -61.87 -58.24 8.7 Favored 'General case' 0 C--O 1.212 -0.892 0 N-CA-C 108.338 -0.986 . . . . 63.4 108.338 170.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -57.5 -32.59 67.16 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.52 1.128 . . . . 64.51 112.793 -177.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -65.17 -62.68 1.4 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.443 0.697 . . . . 74.35 109.35 172.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -70.6 -6.35 36.02 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.276 0.631 . . . . 71.44 112.564 -175.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -93.64 -80.51 0.39 Allowed 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 107.612 -1.255 . . . . 75.02 107.612 174.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -73.27 -38.1 66.06 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.33 -0.85 . . . . 70.12 112.005 -166.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -73.37 -4.54 34.05 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 122.345 -0.222 . . . . 75.41 111.1 178.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -120.96 10.74 10.88 Favored 'General case' 0 C--N 1.358 0.961 0 C-N-CA 123.451 0.7 . . . . 74.13 110.059 176.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.142 0 C-N-CA 123.603 0.761 . . . . 72.21 111.314 -178.502 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.435 ' HB3' ' HB3' ' B' ' 4' ' ' SER . 1.5 mpt? . . . . . 0 N--CA 1.477 0.898 0 N-CA-C 110.238 -0.282 . . . . 71.44 110.238 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -79.77 -49.43 12.04 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.189 0.596 . . . . 54.1 110.608 176.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -93.88 19.89 8.37 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.312 0.645 . . . . 74.04 112.3 -171.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . 0.435 ' HB3' ' HB3' ' B' ' 1' ' ' MET . 13.9 p -65.97 -56.31 12.33 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-O 120.945 0.403 . . . . 52.14 110.156 178.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 4.1 m 67.78 151.8 0.08 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.501 1.52 . . . . 70.11 112.328 174.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.524 HG21 ' HA ' ' A' ' 125' ' ' LEU . 46.2 pt -130.93 159.99 42.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 123.019 0.527 . . . . 64.44 111.645 -162.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -131.93 134.74 45.99 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.828 0.851 . . . . 72.01 110.104 178.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 32.7 tp -73.15 144.69 46.81 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.429 0.691 . . . . 75.22 110.378 -176.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . 0.413 ' HB3' ' HB2' ' A' ' 122' ' ' GLU . . . -80.39 -50.03 10.67 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 122.477 0.311 . . . . 62.4 111.345 178.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 31.4 mt 71.22 -25.09 0.17 Allowed 'General case' 0 N--CA 1.504 2.251 0 C-N-CA 125.295 1.438 . . . . 74.1 113.282 -172.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 61.0 mt . . . . . 0 CA--C 1.558 1.278 0 C-N-CA 124.468 1.107 . . . . 45.35 109.649 -168.391 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.13 0 CA-C-O 121.378 0.608 . . . . 61.34 109.979 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . -176.92 -57.57 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 105.869 -1.9 . . . . 74.4 105.869 170.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 46.1 tp -142.75 123.18 13.95 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 106.35 -1.722 . . . . 62.04 106.35 163.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 182' ' ' VAL . . . . . 0.7 ' HB ' ' HB2' ' C' ' 123' ' ' LEU . 69.5 t -68.67 131.94 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.064 0.546 . . . . 71.31 110.817 -172.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -119.54 16.78 12.91 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.767 0.827 . . . . 65.24 112.264 -172.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 28.5 m-70 -62.18 100.39 0.17 Allowed 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 122.789 0.436 . . . . 74.15 111.138 -178.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 185' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' C' ' 121' ' ' ALA . 60.6 t . . . . . 0 N--CA 1.48 1.048 0 C-N-CA 123.826 0.851 . . . . 71.33 110.102 177.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 90.8 m . . . . . 0 CA--C 1.56 1.348 0 N-CA-C 110.148 -0.316 . . . . 71.31 110.148 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -88.95 168.1 12.66 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 113.88 1.067 . . . . 74.42 113.88 -176.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 240' ' ' GLY . . . . . 0.567 ' H ' HD22 ' C' ' 235' ' ' LEU . . . -102.44 -118.79 4.48 Favored Glycine 0 C--N 1.34 0.766 0 CA-C-N 112.94 -1.936 . . . . 71.23 110.543 176.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -161.11 -179.49 7.53 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-O 121.705 0.764 . . . . 71.21 110.334 174.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 242' ' ' TRP . . . . . 0.438 ' CZ3' HG21 ' C' ' 253' ' ' VAL . 2.6 m0 -106.17 -52.57 2.78 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 106.468 -1.678 . . . . 70.32 106.468 174.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 243' ' ' GLN . . . . . 0.403 ' CD ' HH21 ' C' ' 231' ' ' ARG . 5.1 pt20 179.76 -152.13 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.139 0 CA-C-N 112.987 -1.915 . . . . 74.22 107.802 -167.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -62.02 116.31 9.18 Favored Glycine 0 CA--C 1.542 1.751 0 CA-C-N 117.785 0.266 . . . . 63.11 113.629 175.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? . . . . . 0 CA--C 1.55 0.98 0 C-N-CA 124.052 0.941 . . . . 75.34 108.886 179.181 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.808 0 CA-C-O 121.185 0.517 . . . . 52.01 109.798 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -37.91 123.8 1.1 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.237 1.815 . . . . 70.52 114.951 -174.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 22.3 mmtp -93.53 122.68 36.22 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.6 -0.727 . . . . 63.2 109.591 166.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -82.65 86.18 6.89 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 107.48 -1.304 . . . . 63.22 107.48 170.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 7' ' ' TYR . . . . . 0.437 ' HB3' ' HA ' ' C' ' 53' ' ' ALA . 73.9 m-85 -61.61 -35.12 76.95 Favored 'General case' 0 C--O 1.244 0.764 0 CA-C-N 114.341 -1.299 . . . . 73.43 111.198 -176.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -60.26 -46.86 88.34 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.584 -0.735 . . . . 72.53 110.113 175.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.55 -39.19 92.83 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.888 0.475 . . . . 52.31 111.27 179.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 69.0 mt -57.86 -39.79 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 122.984 0.513 . . . . 63.34 110.704 174.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 11' ' ' LEU . . . . . 0.509 HD13 HG23 ' C' ' 22' ' ' ILE . 67.9 mt -79.92 -17.13 53.85 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 122.898 0.479 . . . . 45.45 112.068 176.059 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.66 26.7 45.22 Favored Glycine 0 CA--C 1.537 1.445 0 N-CA-C 113.887 0.315 . . . . 64.33 113.887 -178.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 12.3 m -120.0 156.83 54.11 Favored Pre-proline 0 CA--C 1.555 1.167 0 C-N-CA 124.76 1.224 . . . . 64.04 110.069 178.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.62 164.03 36.79 Favored 'Trans proline' 0 C--N 1.383 2.357 0 C-N-CA 122.85 2.366 . . . . 74.43 112.283 177.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -70.03 8.06 0.82 Allowed 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 114.068 1.136 . . . . 71.52 114.068 -174.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -128.01 16.13 6.79 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.508 0.723 . . . . 71.24 109.432 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.5 123.44 19.23 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.354 1.062 . . . . 71.14 110.788 178.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 76.0 p -74.0 177.18 5.83 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.303 0.641 . . . . 74.41 111.003 -177.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.46 -55.44 21.92 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 124.269 1.028 . . . . 74.45 111.191 -171.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -67.9 -29.11 68.12 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.393 0.677 . . . . 64.05 112.008 -174.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -71.16 -47.37 58.14 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-O 121.12 0.486 . . . . 73.42 110.682 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 22' ' ' ILE . . . . . 0.767 HD13 ' HB3' ' C' ' 57' ' ' LEU . 82.3 mt -57.89 -44.01 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 124.447 1.099 . . . . 61.32 110.27 172.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 23' ' ' LYS . . . . . 0.446 ' HG2' ' HE2' ' C' ' 27' ' ' LYS . 79.1 tttt -66.35 -35.86 81.43 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 113.723 -1.58 . . . . 74.13 111.257 -176.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 27.2 mtm180 -78.95 -33.84 44.96 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 123.323 0.649 . . . . 73.52 111.463 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.98 -44.61 95.56 Favored 'General case' 0 C--O 1.257 1.482 0 CA-C-O 121.812 0.815 . . . . 75.32 110.032 173.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 26' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -60.95 -57.89 10.72 Favored 'General case' 0 C--O 1.201 -1.48 0 CA-C-N 113.797 -1.547 . . . . 72.31 110.125 175.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . 0.446 ' HE2' ' HG2' ' C' ' 23' ' ' LYS . 49.9 mtmt -54.8 -35.55 64.0 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 123.698 0.799 . . . . 74.1 111.142 -176.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 39.7 ttp180 -57.13 -57.77 11.14 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.026 0.531 . . . . 71.15 109.75 172.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . 0.623 ' HB3' HD13 ' C' ' 50' ' ' ILE . 95.5 mt -74.71 -14.84 60.78 Favored 'General case' 0 CA--C 1.557 1.229 0 CA-C-N 115.686 -0.688 . . . . 60.22 112.586 -177.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.32 -23.46 19.26 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.376 1.07 . . . . 75.32 111.129 -176.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -88.86 -35.98 16.25 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 109.041 -0.726 . . . . 73.5 109.041 171.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.45 -50.1 55.01 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 122.996 0.518 . . . . 71.12 109.759 -178.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -97.43 25.8 5.39 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.886 0.474 . . . . 70.15 111.178 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 34' ' ' HIS . . . . . . . . . . . . . 13.2 t-160 -59.92 106.87 0.83 Allowed Pre-proline 0 N--CA 1.487 1.406 0 CA-C-O 118.708 -0.663 . . . . 72.34 111.324 -173.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.06 -22.49 69.7 Favored 'Trans proline' 0 C--N 1.383 2.355 0 C-N-CA 123.351 2.701 . . . . 71.32 113.233 -172.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -70.08 -36.48 74.95 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.782 0.833 . . . . 60.34 111.094 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 62.1 t -98.81 -57.54 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 CA-C-O 121.676 0.75 . . . . 75.33 109.266 -179.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -94.0 79.49 4.1 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 124.836 1.254 . . . . 54.22 107.979 -178.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -75.59 78.85 2.59 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-N 113.738 -1.574 . . . . 62.24 109.196 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 26.7 m -132.54 107.09 13.1 Favored Pre-proline 0 C--O 1.236 0.352 0 N-CA-C 108.35 -0.981 . . . . 74.14 108.35 178.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . 0.431 ' O ' ' HG2' ' C' ' 45' ' ' GLU . 48.0 Cg_exo -42.02 -45.7 7.13 Favored 'Trans proline' 0 C--N 1.386 2.512 0 C-N-CA 123.814 3.009 . . . . 63.44 113.308 178.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -59.92 -41.16 91.14 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.672 0.789 . . . . 65.44 111.481 -179.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.89 -27.34 65.7 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 115.678 -0.692 . . . . 62.05 109.956 178.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 44' ' ' GLU . . . . . 0.473 ' O ' ' HG3' ' C' ' 48' ' ' LYS . 38.5 mt-10 -79.2 -27.72 42.58 Favored 'General case' 0 C--O 1.215 -0.759 0 O-C-N 123.827 0.704 . . . . 74.04 109.508 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 45' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' C' ' 41' ' ' PRO . 29.6 mm-40 -70.78 -48.08 56.16 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.636 0.774 . . . . 42.53 110.344 177.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 46' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -57.89 -42.77 85.32 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 114.8 -1.091 . . . . 72.32 109.484 172.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -65.62 -30.15 70.82 Favored 'General case' 0 C--O 1.213 -0.834 0 CA-C-N 115.04 -0.982 . . . . 62.23 111.202 178.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 48' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' C' ' 44' ' ' GLU . 92.8 mttt -64.89 -43.42 92.94 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.057 0.543 . . . . 72.04 110.384 174.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -61.9 -39.69 92.86 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.595 0.712 . . . . 72.33 111.221 177.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 50' ' ' ILE . . . . . 0.623 HD13 ' HB3' ' C' ' 29' ' ' LEU . 79.0 mt -67.35 -34.1 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 CA-C-N 115.018 -0.992 . . . . 75.43 110.468 173.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 51' ' ' ASN . . . . . 0.515 ' HB3' ' CD1' ' C' ' 88' ' ' PHE . 70.8 m-20 -76.92 -17.06 59.17 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.586 1.154 . . . . 74.04 111.408 177.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -75.48 -51.27 13.39 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 108.103 -1.073 . . . . 63.42 108.103 171.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . 0.437 ' HA ' ' HB3' ' C' ' 7' ' ' TYR . . . -55.3 -38.15 68.29 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 113.752 -1.567 . . . . 63.1 111.518 174.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -80.9 -29.87 35.55 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.132 0.973 . . . . 75.01 110.454 178.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.56 -28.21 66.93 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 123.17 0.588 . . . . 60.54 110.559 174.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 21.1 t -92.02 -45.31 14.34 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.166 0 CA-C-N 115.285 -0.871 . . . . 72.43 112.023 175.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 57' ' ' LEU . . . . . 0.767 ' HB3' HD13 ' C' ' 22' ' ' ILE . 87.3 mt -104.52 4.58 33.19 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 115.584 1.698 . . . . 75.02 115.584 -163.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 38.6 t -66.71 -74.55 0.11 Allowed 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 118.56 0.618 . . . . 62.42 112.414 -177.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -66.6 140.97 96.72 Favored Pre-proline 0 C--N 1.349 0.571 0 N-CA-C 108.7 -0.852 . . . . 72.03 108.7 176.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 60' ' ' PRO . . . . . 0.46 ' O ' ' HG2' ' C' ' 64' ' ' ARG . 18.1 Cg_endo -58.29 -27.75 82.05 Favored 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 122.067 1.845 . . . . 33.23 111.013 174.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -65.01 -52.23 57.24 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.541 0.736 . . . . 62.13 111.418 175.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 62' ' ' LYS . . . . . 0.557 ' HD3' ' HB3' ' C' ' 84' ' ' ASP . 46.4 mtmt -66.06 -36.49 83.35 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 121.163 0.506 . . . . 75.23 110.72 -178.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 45.0 ttt-85 -57.44 -46.06 84.0 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.14 -0.936 . . . . 64.42 108.74 175.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 64' ' ' ARG . . . . . 0.46 ' HG2' ' O ' ' C' ' 60' ' ' PRO . 24.0 mmt180 -68.75 -24.65 64.47 Favored 'General case' 0 C--O 1.213 -0.823 0 CA-C-N 115.442 -0.799 . . . . 74.15 111.999 177.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 65' ' ' ILE . . . . . 0.543 HG12 ' HG2' ' C' ' 76' ' ' PRO . 78.4 mt -60.89 -45.28 98.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 108.906 -0.776 . . . . 62.34 108.906 171.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -60.86 -51.38 69.57 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 115.146 -0.933 . . . . 74.22 109.95 174.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -58.01 -40.0 79.69 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.605 0.762 . . . . 73.14 111.862 -177.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 63.5 p -74.64 -24.83 58.89 Favored 'General case' 0 C--O 1.217 -0.615 0 CA-C-O 119.288 -0.387 . . . . 63.2 110.339 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -75.28 120.12 20.32 Favored 'General case' 0 C--N 1.356 0.868 0 N-CA-C 108.653 -0.869 . . . . 75.22 108.653 174.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.55 24.87 22.59 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.293 -0.723 . . . . 62.51 111.293 -169.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 56.8 m -145.62 -62.49 0.33 Allowed 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 103.269 -2.863 . . . . 72.34 103.269 171.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 23.6 m -85.1 148.67 26.02 Favored 'General case' 0 C--O 1.254 1.29 0 N-CA-C 105.458 -2.052 . . . . 73.35 105.458 157.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.94 -28.56 15.11 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.273 0.629 . . . . 73.23 110.703 176.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -87.56 136.97 32.43 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 123.594 0.757 . . . . 53.23 110.253 178.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -68.51 127.59 15.85 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.435 2.09 . . . . 75.14 110.495 175.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 76' ' ' PRO . . . . . 0.543 ' HG2' HG12 ' C' ' 65' ' ' ILE . 9.8 Cg_endo -51.87 132.87 43.8 Favored 'Trans proline' 0 C--N 1.387 2.602 0 C-N-CA 123.058 2.505 . . . . 63.14 111.741 177.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -48.08 128.54 16.94 Favored 'Trans proline' 0 C--N 1.387 2.585 0 C-N-CA 123.877 3.051 . . . . 51.51 114.101 -169.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 78' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -67.95 154.72 72.08 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 122.383 2.055 . . . . 74.44 111.574 178.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.97 156.39 39.14 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.398 2.065 . . . . 61.04 111.439 170.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -54.75 85.56 0.03 OUTLIER 'Trans proline' 0 C--N 1.388 2.645 0 C-N-CA 123.367 2.712 . . . . 51.5 113.13 177.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 153.17 -42.11 0.66 Allowed Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 114.032 -1.44 . . . . 75.2 110.492 -179.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 137.54 169.44 11.63 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-N 115.151 -0.525 . . . . 74.45 112.1 178.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -57.93 148.81 24.52 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.008 0.923 . . . . 70.14 110.36 172.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 84' ' ' ASP . . . . . 0.557 ' HB3' ' HD3' ' C' ' 62' ' ' LYS . 18.0 t0 -57.32 130.82 47.95 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 123.739 0.649 . . . . 63.13 111.88 -179.114 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 85' ' ' PHE . . . . . 0.497 ' CD1' ' HB2' ' C' ' 88' ' ' PHE . 0.3 OUTLIER -148.91 32.97 0.76 Allowed 'General case' 0 C--O 1.241 0.624 0 O-C-N 123.625 0.578 . . . . 74.41 111.543 -170.808 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 86' ' ' SER . . . . . 0.592 ' HA ' ' O ' ' C' ' 169' ' ' ASN . 18.3 m -70.89 93.75 1.0 Allowed 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.286 -0.87 . . . . 45.43 112.721 -169.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 86.62 10.02 74.01 Favored Glycine 0 C--N 1.346 1.112 0 CA-C-N 114.796 -1.093 . . . . 74.33 113.306 177.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 88' ' ' PHE . . . . . 0.525 ' HB3' ' HE2' ' C' ' 93' ' ' PHE . 10.2 m-85 -92.62 138.18 31.72 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 108.384 -0.969 . . . . 74.44 108.384 -176.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -84.32 76.63 10.1 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 122.029 -0.42 . . . . 72.23 110.799 -168.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 90' ' ' VAL . . . . . 0.414 HG23 HD22 ' C' ' 105' ' ' LEU . 4.2 p -43.46 -55.53 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 C-N-CA 125.177 1.391 . . . . 54.41 114.594 -176.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -70.76 -19.71 62.69 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.52 0.328 . . . . 74.21 111.813 -173.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -87.64 -23.0 24.38 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 110.221 -0.289 . . . . 75.53 110.221 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 93' ' ' PHE . . . . . 0.525 ' HE2' ' HB3' ' C' ' 88' ' ' PHE . 11.9 m-30 -72.35 171.86 11.42 Favored 'General case' 0 C--N 1.352 0.683 0 N-CA-C 113.314 0.857 . . . . 72.45 113.314 -168.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 49.7 m -60.24 150.51 29.93 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 114.288 -1.324 . . . . 45.51 112.463 -172.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 95' ' ' GLU . . . . . 0.425 ' O ' ' HG3' ' C' ' 99' ' ' GLU . 0.0 OUTLIER -66.38 -45.05 81.37 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.448 0.699 . . . . 55.43 110.854 -178.542 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -52.09 -44.41 64.38 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.556 1.142 . . . . 65.02 110.946 172.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 97' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -66.56 -39.7 88.65 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 114.118 -1.401 . . . . 64.25 110.605 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -76.66 -9.7 58.85 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.644 0.778 . . . . 51.52 112.037 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 99' ' ' GLU . . . . . 0.425 ' HG3' ' O ' ' C' ' 95' ' ' GLU . 51.1 mt-10 -90.28 -47.02 8.03 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.916 0.486 . . . . 74.43 111.102 169.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 25.6 tp -66.6 -50.0 64.48 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.844 0.858 . . . . 73.23 110.808 -176.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -92.54 -1.23 57.09 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.664 -0.698 . . . . 73.25 111.257 177.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -45.47 -61.42 3.69 Favored Glycine 0 C--N 1.356 1.68 0 CA-C-O 118.769 -1.017 . . . . 54.11 114.704 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -46.66 -18.8 0.57 Allowed 'Trans proline' 0 C--N 1.391 2.808 0 C-N-CA 124.511 3.474 . . . . 62.02 114.735 179.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -150.62 53.32 0.5 Allowed Glycine 0 C--N 1.347 1.163 0 CA-C-O 119.894 -0.392 . . . . 43.23 112.728 177.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 105' ' ' LEU . . . . . 0.414 HD22 HG23 ' C' ' 90' ' ' VAL . 32.6 mt . . . . . 0 N--CA 1.504 2.268 0 N-CA-C 113.94 1.089 . . . . 73.03 113.94 172.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.887 0 N-CA-C 110.197 -1.161 . . . . 45.25 110.197 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' C' C ' 117' ' ' ARG . . . . . 0.438 ' O ' ' HA2' ' C' ' 166' ' ' GLY . 49.8 ttp180 -88.19 116.62 26.52 Favored 'General case' 0 C--O 1.253 1.246 0 N-CA-C 108.96 -0.755 . . . . 64.44 108.96 177.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -40.8 120.58 1.32 Allowed 'General case' 0 N--CA 1.483 1.189 0 O-C-N 124.465 1.103 . . . . 75.42 109.908 175.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 119' ' ' LEU . . . . . . . . . . . . . 13.5 tp -94.81 154.36 17.3 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 118.687 -1.205 . . . . 75.21 108.289 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.49 112.71 6.77 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 105.823 -1.917 . . . . 72.31 105.823 -175.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 121' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' B' ' 185' ' ' VAL . . . -132.38 116.52 16.95 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 109.002 -0.74 . . . . 63.21 109.002 -177.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 122' ' ' GLU . . . . . 0.504 ' HA ' ' O ' ' C' ' 177' ' ' VAL . 13.8 pt-20 -88.91 131.44 35.13 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 109.357 -0.609 . . . . 73.22 109.357 178.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 123' ' ' LEU . . . . . 0.7 ' HB2' ' HB ' ' B' ' 182' ' ' VAL . 2.6 pt? -134.86 124.37 16.63 Favored Pre-proline 0 N--CA 1.478 0.964 0 N-CA-C 111.89 0.33 . . . . 73.3 111.89 -170.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . 0.451 ' HD2' HG11 ' B' ' 182' ' ' VAL . 16.2 Cg_exo -68.95 117.84 5.29 Favored 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 122.924 2.416 . . . . 72.51 110.314 170.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 125' ' ' LEU . . . . . 0.487 HD23 HG11 ' C' ' 153' ' ' VAL . 42.9 tp -143.68 146.77 33.46 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 122.896 0.479 . . . . 74.03 109.785 -169.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 126' ' ' THR . . . . . 0.486 HG23 HD12 ' C' ' 181' ' ' LEU . 34.0 p -93.93 166.75 12.02 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.753 0.787 . . . . 61.53 110.379 171.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 127' ' ' LEU . . . . . 0.549 HD21 HD13 ' C' ' 180' ' ' LEU . 15.2 mt -71.25 -37.7 71.94 Favored 'General case' 0 C--O 1.249 1.065 0 CA-C-N 114.04 -1.436 . . . . 62.25 109.358 178.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 11.2 mp0 -61.36 -49.87 75.19 Favored 'General case' 0 C--O 1.216 -0.696 0 CA-C-N 113.085 -1.871 . . . . 75.24 109.134 178.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 129' ' ' GLU . . . . . 0.691 ' HA ' ' HB2' ' C' ' 132' ' ' HIS . 28.7 mm-40 -81.52 -7.48 59.59 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 123.848 0.717 . . . . 73.53 111.562 178.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -68.6 -46.34 69.58 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 109.478 -0.564 . . . . 64.34 109.478 166.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 131' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -67.11 -51.27 56.31 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 115.719 -0.673 . . . . 75.55 110.426 169.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 132' ' ' HIS . . . . . 0.691 ' HB2' ' HA ' ' C' ' 129' ' ' GLU . 30.6 m170 -74.06 -1.17 18.95 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.694 0.798 . . . . 60.22 111.604 -174.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -63.3 -101.37 0.01 OUTLIER Glycine 0 C--N 1.352 1.453 0 N-CA-C 111.365 -0.694 . . . . 65.31 111.365 165.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 134' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' C' ' 148' ' ' ARG . . . 53.74 -108.49 0.83 Allowed Glycine 0 C--N 1.349 1.253 0 N-CA-C 111.61 -0.596 . . . . 53.24 111.61 -177.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -77.13 95.99 4.38 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.173 -1.047 . . . . 71.2 108.173 174.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 136' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.29 138.53 47.88 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 123.755 0.822 . . . . 72.12 109.291 -174.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 137' ' ' VAL . . . . . . . . . . . . . 34.0 m -86.61 131.54 34.51 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 N-CA-C 109.181 -0.674 . . . . 71.12 109.181 174.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 138' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' C' ' 144' ' ' ARG . 7.6 p -133.96 143.74 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.22 1.008 . . . . 72.14 108.464 -176.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 139' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -123.47 82.99 2.07 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.237 0.541 . . . . 74.31 109.813 176.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 140' ' ' VAL . . . . . 0.563 HG11 ' HG2' ' C' ' 164' ' ' MET . 6.9 p -96.34 137.21 24.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 115.299 -0.864 . . . . 63.22 109.226 176.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 55.93 28.27 12.37 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 123.978 0.911 . . . . 15.23 111.701 -177.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 72.2 31.19 64.12 Favored Glycine 0 C--N 1.35 1.338 0 CA-C-N 116.343 -0.39 . . . . 45.25 113.394 -179.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 143' ' ' ARG . . . . . . . . . . . . . 55.5 ttt180 -128.03 104.3 7.71 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.561 0.744 . . . . 73.04 109.632 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 144' ' ' ARG . . . . . 0.419 ' HA ' ' O ' ' C' ' 138' ' ' VAL . 49.1 ttt180 -85.35 107.42 17.34 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.618 0.767 . . . . 71.51 110.845 -178.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 145' ' ' VAL . . . . . . . . . . . . . 22.7 t -123.05 140.98 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.534 0.734 . . . . 75.03 110.187 178.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 20.0 m -83.13 96.0 8.26 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 108.88 -0.785 . . . . 54.21 108.88 168.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 29.4 m -98.73 157.93 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 123.528 0.731 . . . . 72.53 109.839 -178.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 148' ' ' ARG . . . . . 0.461 HH22 ' HB3' ' C' ' 243' ' ' PRO . 62.8 ttt180 -116.73 94.5 4.63 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 108.638 -0.875 . . . . 74.22 108.638 167.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 149' ' ' ILE . . . . . . . . . . . . . 19.4 pt -79.03 150.94 75.54 Favored Pre-proline 0 N--CA 1.476 0.863 0 N-CA-C 107.818 -1.179 . . . . 71.41 107.818 170.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -53.82 120.85 8.56 Favored 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 122.092 1.861 . . . . 61.44 110.875 176.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -60.04 98.39 0.12 Allowed 'Trans proline' 0 C--N 1.386 2.515 0 C-N-CA 122.509 2.139 . . . . 73.2 110.204 177.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 152' ' ' GLY . . . . . 0.433 ' HA2' ' CZ ' ' C' ' 240' ' ' PHE . . . 147.63 145.34 4.16 Favored Glycine 0 C--N 1.347 1.18 0 CA-C-N 115.943 -0.572 . . . . 54.32 113.35 -172.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 153' ' ' VAL . . . . . 0.487 HG11 HD23 ' C' ' 125' ' ' LEU . 2.9 p -159.99 155.07 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.314 0 N-CA-C 112.708 0.633 . . . . 71.13 112.708 172.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 154' ' ' ARG . . . . . . . . . . . . . 16.7 ttm180 -120.72 132.07 54.87 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.626 1.57 . . . . 75.32 109.089 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 155' ' ' GLU . . . . . 0.579 ' HB2' HD12 ' C' ' 180' ' ' LEU . 8.3 tp10 -41.61 127.65 3.14 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 124.779 1.232 . . . . 74.51 112.887 175.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 74.04 0.76 57.6 Favored Glycine 0 C--N 1.352 1.429 0 N-CA-C 114.44 0.536 . . . . 64.51 114.44 173.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 157' ' ' SER . . . . . . . . . . . . . 36.1 t -92.71 155.52 17.65 Favored 'General case' 0 C--O 1.255 1.365 0 CA-C-O 121.519 0.676 . . . . 75.43 109.877 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 158' ' ' VAL . . . . . 0.578 HG12 HG22 ' C' ' 177' ' ' VAL . 29.7 m -99.54 122.0 50.84 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 CA-C-N 114.209 -1.36 . . . . 64.44 110.086 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 159' ' ' ILE . . . . . 0.664 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 31.7 mt -80.22 105.14 9.46 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 N-CA-C 107.198 -1.408 . . . . 52.25 107.198 170.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 62.0 ttm-85 -74.33 99.25 3.43 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 107.658 -1.238 . . . . 72.21 107.658 173.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 161' ' ' VAL . . . . . . . . . . . . . 2.4 p -117.48 101.97 52.28 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 124.301 1.041 . . . . 75.24 109.736 -178.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.69 145.46 81.41 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.106 1.87 . . . . 63.42 110.144 168.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 99.36 4.05 56.34 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-O 119.468 -0.629 . . . . 53.31 113.857 -176.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 164' ' ' MET . . . . . 0.588 ' SD ' HD23 ' C' ' 174' ' ' LEU . 19.1 ttm -144.42 5.75 1.25 Allowed 'General case' 0 CA--C 1.559 1.293 0 CA-C-N 117.668 0.734 . . . . 73.35 112.698 -174.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . -129.43 177.56 17.93 Favored Glycine 0 N--CA 1.488 2.143 0 CA-C-O 118.421 -1.211 . . . . 64.24 113.203 177.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 166' ' ' GLY . . . . . 0.438 ' HA2' ' O ' ' C' ' 117' ' ' ARG . . . 98.28 106.11 2.54 Favored Glycine 0 C--N 1.364 2.087 0 CA-C-N 119.636 1.718 . . . . 75.44 116.366 176.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 167' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -99.98 100.18 11.04 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 105.87 -1.9 . . . . 64.31 105.87 160.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . 163.12 -139.11 5.7 Favored Glycine 0 C--O 1.208 -1.521 0 CA-C-O 119.188 -0.784 . . . . 13.44 112.521 -169.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 169' ' ' ASN . . . . . 0.623 ' HB3' ' HD3' ' C' ' 170' ' ' PRO . 2.1 t30 -145.3 -66.05 0.02 OUTLIER Pre-proline 0 CA--C 1.574 1.87 0 CA-C-O 116.846 -1.55 . . . . 62.44 111.254 -176.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 170' ' ' PRO . . . . . 0.623 ' HD3' ' HB3' ' C' ' 169' ' ' ASN . 73.9 Cg_exo -54.12 142.45 66.43 Favored 'Trans proline' 0 C--N 1.405 3.528 0 CA-C-N 124.046 2.481 . . . . 51.41 112.897 174.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 171' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -85.18 150.55 10.7 Favored 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 123.424 2.749 . . . . 74.02 115.22 -161.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -160.96 -109.3 0.24 Allowed Glycine 0 C--N 1.357 1.71 0 CA-C-O 118.629 -1.095 . . . . 74.42 113.495 177.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 173' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -173.56 171.94 3.76 Favored 'General case' 0 C--O 1.263 1.785 0 CA-C-O 123.782 1.753 . . . . 74.51 115.19 -168.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 174' ' ' LEU . . . . . 0.588 HD23 ' SD ' ' C' ' 164' ' ' MET . 9.9 tp -110.89 143.25 41.81 Favored 'General case' 0 C--N 1.353 0.723 0 CA-C-N 112.008 -2.36 . . . . 75.22 108.934 170.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 175' ' ' LEU . . . . . 0.439 ' HB3' ' HB ' ' C' ' 158' ' ' VAL . 72.1 mt -106.97 95.68 5.89 Favored 'General case' 0 C--O 1.249 1.036 0 N-CA-C 108.054 -1.091 . . . . 71.32 108.054 171.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 176' ' ' LEU . . . . . 0.664 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 67.5 mt -72.61 101.14 2.95 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.767 -0.651 . . . . 43.02 109.913 175.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 177' ' ' VAL . . . . . 0.578 HG22 HG12 ' C' ' 158' ' ' VAL . 25.3 t -82.67 96.94 3.95 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 N-CA-C 107.701 -1.222 . . . . 74.43 107.701 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 178' ' ' VAL . . . . . 0.475 HG21 HG11 ' C' ' 153' ' ' VAL . 8.5 p -72.99 135.45 27.68 Favored 'Isoleucine or valine' 0 C--O 1.248 1.003 0 CA-C-O 121.938 0.875 . . . . 74.01 111.62 -172.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 179' ' ' ARG . . . . . 0.416 ' O ' ' HA ' ' C' ' 124' ' ' PRO . 35.3 mmt180 -110.57 94.55 5.06 Favored 'General case' 0 C--O 1.243 0.717 0 N-CA-C 106.596 -1.631 . . . . 72.33 106.596 171.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 180' ' ' LEU . . . . . 0.579 HD12 ' HB2' ' C' ' 155' ' ' GLU . 80.0 mt -69.17 136.5 52.2 Favored 'General case' 0 C--N 1.351 0.631 0 CA-C-O 120.981 0.419 . . . . 70.51 110.462 178.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 181' ' ' LEU . . . . . 0.486 HD12 HG23 ' C' ' 126' ' ' THR . 98.7 mt -72.88 165.21 54.51 Favored Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 123.806 0.842 . . . . 74.2 111.234 -173.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -53.84 80.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.391 2.78 0 C-N-CA 123.154 2.569 . . . . 64.12 112.478 169.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 183' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -172.93 60.72 0.26 Allowed Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 126.165 1.786 . . . . 62.13 106.373 -175.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 184' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -82.51 65.38 8.21 Favored 'Trans proline' 0 C--N 1.384 2.397 0 C-N-CA 123.066 2.511 . . . . 71.54 111.293 -176.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 185' ' ' VAL . . . . . . . . . . . . . 17.8 t -95.45 -36.75 6.94 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.593 0 CA-C-N 115.705 -0.68 . . . . 72.23 109.248 -177.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 186' ' ' PHE . . . . . 0.408 ' HD1' ' HB2' ' C' ' 195' ' ' ALA . 38.0 m-85 -133.38 157.39 45.66 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.287 1.035 . . . . 61.44 110.825 -178.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 187' ' ' ARG . . . . . 0.434 ' HE ' ' HB3' ' C' ' 155' ' ' GLU . 35.8 ttt180 -150.73 131.82 14.37 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 108.967 -0.753 . . . . 75.14 108.967 168.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 188' ' ' LEU . . . . . 0.594 HD13 ' HD2' ' C' ' 240' ' ' PHE . 39.5 tp -79.93 146.83 31.9 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 114.266 1.21 . . . . 74.14 114.266 -168.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -139.79 100.6 3.99 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 126.157 1.783 . . . . 71.33 106.907 165.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 70.88 -95.9 0.57 Allowed Glycine 0 N--CA 1.477 1.375 0 CA-C-N 116.495 -0.32 . . . . 74.2 112.597 -176.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 191' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -124.4 -14.08 6.99 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.423 1.089 . . . . 60.21 109.805 169.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -84.38 153.53 23.39 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.397 0.679 . . . . 65.13 109.456 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 193' ' ' LEU . . . . . 0.524 HD21 ' CE2' ' C' ' 240' ' ' PHE . 89.1 mt -117.32 156.27 28.11 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.26 0.553 . . . . 52.2 111.636 -173.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 194' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -121.44 109.45 14.87 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 107.199 -1.408 . . . . 75.43 107.199 168.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 195' ' ' ALA . . . . . 0.633 ' HB3' ' HG ' ' C' ' 251' ' ' LEU . . . -111.42 -177.56 3.23 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 123.576 0.75 . . . . 65.11 111.578 -175.142 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 38.8 m -136.05 118.48 15.77 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.293 -0.867 . . . . 51.32 109.572 170.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 197' ' ' LEU . . . . . 0.431 HD13 ' HB2' ' C' ' 212' ' ' ALA . 51.4 tp -98.25 136.38 38.53 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.428 0.691 . . . . 73.5 109.758 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 198' ' ' ASP . . . . . 0.463 ' HB3' HG21 ' C' ' 256' ' ' THR . 66.9 m-20 -101.83 102.0 12.54 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 109.122 -0.696 . . . . 44.52 109.122 179.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 199' ' ' VAL . . . . . 0.401 HG22 HG21 ' C' ' 210' ' ' VAL . 21.4 t -107.05 117.15 57.17 Favored Pre-proline 0 N--CA 1.473 0.72 0 N-CA-C 108.41 -0.959 . . . . 61.21 108.41 178.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 200' ' ' PRO . . . . . 0.495 ' HD2' HG11 ' C' ' 210' ' ' VAL . 45.4 Cg_endo -69.49 151.76 70.66 Favored 'Trans proline' 0 C--N 1.371 1.718 0 C-N-CA 122.001 1.801 . . . . 71.34 111.81 175.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 201' ' ' ALA . . . . . . . . . . . . . . . -54.65 -47.16 98.74 Favored Pre-proline 0 CA--C 1.564 1.489 0 N-CA-C 114.425 1.268 . . . . 74.35 114.425 -171.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 202' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -54.49 -51.37 10.65 Favored 'Trans proline' 0 C--N 1.384 2.41 0 C-N-CA 121.813 1.675 . . . . 63.15 112.916 175.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 203' ' ' ILE . . . . . 0.459 HG21 HG13 ' C' ' 210' ' ' VAL . 53.9 mt -64.92 -32.86 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.303 0.641 . . . . 63.4 111.032 -178.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -63.72 -48.07 78.55 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.737 0.815 . . . . 75.02 111.187 178.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 205' ' ' VAL . . . . . . . . . . . . . 79.5 t -69.35 -43.26 81.19 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 CA-C-N 115.125 -0.943 . . . . 63.41 112.315 -176.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 206' ' ' VAL . . . . . 0.455 HG23 ' HE2' ' A' ' 270' ' ' LYS . 9.1 p -79.26 -36.19 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 123.248 0.343 . . . . 52.12 111.715 -176.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 82.21 71.77 1.29 Allowed Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.773 -0.649 . . . . 63.21 111.912 -168.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -100.81 -128.32 6.33 Favored Glycine 0 C--N 1.342 0.907 0 N-CA-C 111.249 -0.74 . . . . 51.32 111.249 176.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 209' ' ' LYS . . . . . 0.484 ' HG2' ' HA ' ' C' ' 222' ' ' ALA . 8.5 mtmp? -140.7 143.62 35.15 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.207 0.603 . . . . 72.12 110.424 174.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 210' ' ' VAL . . . . . 0.495 HG11 ' HD2' ' C' ' 200' ' ' PRO . 30.4 m -135.18 149.93 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 124.453 1.101 . . . . 62.05 108.207 172.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 211' ' ' ARG . . . . . 0.406 HH11 ' HB2' ' C' ' 218' ' ' PRO . 8.1 tmm_? -94.94 126.63 40.41 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 122.74 0.416 . . . . 72.44 111.033 -175.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 212' ' ' ALA . . . . . 0.431 ' HB2' HD13 ' C' ' 197' ' ' LEU . . . -96.92 118.73 33.98 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 107.201 -1.407 . . . . 74.43 107.201 167.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 213' ' ' MET . . . . . . . . . . . . . 4.3 tmm? -76.68 104.96 7.46 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 108.445 -0.946 . . . . 63.12 108.445 -178.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.49 168.74 10.0 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.857 0.837 . . . . 54.24 110.561 -176.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 215' ' ' LEU . . . . . . . . . . . . . 14.6 mt -71.53 -32.34 68.05 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 113.636 -1.62 . . . . 44.41 111.66 -168.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.28 17.75 19.93 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 114.813 -1.085 . . . . 71.0 111.366 -177.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 144.92 164.51 10.65 Favored Glycine 0 C--N 1.355 1.587 0 CA-C-O 119.685 -0.509 . . . . 64.11 112.521 176.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 218' ' ' PRO . . . . . 0.406 ' HB2' HH11 ' C' ' 211' ' ' ARG . 94.6 Cg_endo -84.12 113.37 1.8 Allowed 'Trans proline' 0 CA--C 1.552 1.397 0 C-N-CA 122.633 2.222 . . . . 52.13 112.027 177.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 219' ' ' VAL . . . . . . . . . . . . . 12.1 p -93.62 130.65 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 109.941 -0.392 . . . . 52.53 109.941 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 220' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -98.33 105.74 17.93 Favored 'General case' 0 C--N 1.349 0.559 0 N-CA-C 109.184 -0.673 . . . . 72.32 109.184 176.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 221' ' ' VAL . . . . . 0.511 HG11 HD21 ' C' ' 233' ' ' LEU . 70.7 t -73.14 131.74 34.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 125.236 1.414 . . . . 74.03 112.35 -177.033 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 222' ' ' ALA . . . . . 0.484 ' HA ' ' HG2' ' C' ' 209' ' ' LYS . . . -81.19 108.1 14.55 Favored 'General case' 0 CA--C 1.548 0.887 0 O-C-N 123.91 0.756 . . . . 73.3 110.247 169.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 83.7 t -81.85 136.19 48.0 Favored Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 124.87 1.268 . . . . 73.11 109.697 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 224' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -83.81 160.2 14.09 Favored 'Trans proline' 0 C--N 1.383 2.366 0 C-N-CA 123.019 2.479 . . . . 54.33 111.8 172.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -62.09 140.3 83.29 Favored 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 122.292 1.995 . . . . 74.0 111.4 174.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 226' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? 63.31 68.14 0.62 Allowed 'General case' 0 N--CA 1.477 0.883 0 O-C-N 124.243 0.964 . . . . 70.15 110.635 -178.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 227' ' ' THR . . . . . 0.442 ' O ' HG12 ' A' ' 257' ' ' ILE . 16.8 m -93.44 115.17 27.7 Favored 'General case' 0 C--O 1.219 -0.521 0 C-N-CA 123.051 0.54 . . . . 70.3 109.729 176.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 228' ' ' GLN . . . . . 0.727 HE21 ' HG2' ' A' ' 259' ' ' GLU . 27.4 mp0 -89.57 151.36 21.97 Favored 'General case' 0 C--O 1.246 0.895 0 C-N-CA 124.521 1.128 . . . . 74.32 111.94 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -72.17 108.42 5.34 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 113.914 -1.494 . . . . 62.12 109.016 174.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 121.0 1.22 11.53 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 119.215 -0.77 . . . . 62.04 113.569 -176.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 231' ' ' ARG . . . . . 0.546 ' HD2' ' H ' ' C' ' 228' ' ' GLN . 19.3 mtp180 -71.53 -179.78 2.68 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 118.107 0.953 . . . . 74.12 110.872 172.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 232' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' C' ' 251' ' ' LEU . 31.7 ttmt -143.27 144.88 32.31 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.38 0.609 . . . . 71.45 111.76 -176.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 233' ' ' LEU . . . . . 0.683 HD13 ' HB2' ' C' ' 251' ' ' LEU . 5.3 mp -114.05 156.98 23.14 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.198 1.399 . . . . 74.21 109.986 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 20.9 ptt180 -129.92 86.11 2.37 Favored 'General case' 0 CA--C 1.553 1.081 0 O-C-N 124.948 1.405 . . . . 72.34 109.19 170.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 235' ' ' LEU . . . . . 0.567 HD22 ' H ' ' B' ' 240' ' ' GLY . 59.6 mt -83.36 98.62 9.56 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 108.464 -0.939 . . . . 73.43 108.464 173.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -65.71 133.38 50.94 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.805 0.842 . . . . 71.55 111.273 -175.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 237' ' ' GLY . . . . . 0.405 ' O ' ' HD3' ' C' ' 246' ' ' ARG . . . 77.24 7.29 86.85 Favored Glycine 0 C--N 1.348 1.207 0 O-C-N 123.444 0.465 . . . . 71.42 114.058 179.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -105.95 16.3 25.31 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.279 0.632 . . . . 72.03 111.603 -177.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -78.6 -135.06 0.95 Allowed Glycine 0 C--N 1.348 1.214 0 N-CA-C 111.285 -0.726 . . . . 31.21 111.285 170.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 240' ' ' PHE . . . . . 0.594 ' HD2' HD13 ' C' ' 188' ' ' LEU . 48.2 m-85 -97.59 116.53 65.82 Favored Pre-proline 0 C--O 1.247 0.964 0 N-CA-C 109.201 -0.666 . . . . 75.14 109.201 168.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 241' ' ' PRO . . . . . 0.432 ' HA ' ' HG2' ' C' ' 246' ' ' ARG . 48.9 Cg_exo -59.13 99.99 0.12 Allowed 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 123.446 2.764 . . . . 70.21 113.071 169.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -82.82 159.32 37.87 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-N 114.428 -1.26 . . . . 70.14 111.927 175.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 243' ' ' PRO . . . . . 0.461 ' HB3' HH22 ' C' ' 148' ' ' ARG . 59.4 Cg_endo -70.16 -1.71 9.25 Favored 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 122.89 2.394 . . . . 71.42 113.688 -179.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -119.47 -10.98 9.56 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.549 0.74 . . . . 71.42 111.425 176.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 158.22 157.86 8.69 Favored Glycine 0 C--N 1.346 1.116 0 N-CA-C 112.147 -0.381 . . . . 51.32 112.147 -178.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 246' ' ' ARG . . . . . 0.432 ' HG2' ' HA ' ' C' ' 241' ' ' PRO . 41.8 mtt180 -85.89 146.47 26.7 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.733 0.813 . . . . 61.31 111.576 -179.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -82.78 -172.23 48.1 Favored Glycine 0 C--N 1.35 1.349 0 N-CA-C 111.573 -0.611 . . . . 63.23 111.573 165.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -115.7 164.54 14.21 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 117.567 0.683 . . . . 73.54 109.886 -176.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 249' ' ' LEU . . . . . 0.551 HD23 HD12 ' C' ' 235' ' ' LEU . 34.2 tp -113.12 109.19 18.39 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 123.734 0.814 . . . . 74.23 109.08 177.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 250' ' ' TYR . . . . . 0.548 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 39.1 m-85 -102.0 103.14 13.74 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 108.97 -0.752 . . . . 71.43 108.97 177.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 251' ' ' LEU . . . . . 0.683 ' HB2' HD13 ' C' ' 233' ' ' LEU . 2.8 mp -96.78 147.56 23.8 Favored 'General case' 0 N--CA 1.505 2.275 0 N-CA-C 109.903 -0.406 . . . . 64.53 109.903 -173.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -107.53 137.67 45.14 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 108.883 -0.784 . . . . 73.41 108.883 169.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 253' ' ' VAL . . . . . 0.438 HG21 ' CZ3' ' B' ' 242' ' ' TRP . 45.8 t -89.68 142.59 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 113.377 0.88 . . . . 73.5 113.377 -169.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 254' ' ' ARG . . . . . . . . . . . . . 42.8 mtm180 -119.78 145.27 46.75 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.405 1.082 . . . . 74.13 108.255 163.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 255' ' ' ILE . . . . . 0.632 HG21 HG23 ' A' ' 257' ' ' ILE . 29.6 mm -98.32 123.46 50.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 107.958 -1.127 . . . . 75.24 107.958 169.199 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 256' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' C' ' 200' ' ' PRO . 0.5 OUTLIER -127.3 172.71 10.37 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.524 1.13 . . . . 53.32 109.215 -173.569 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 257' ' ' ILE . . . . . 0.448 HD12 ' H ' ' C' ' 259' ' ' GLU . 2.8 pp -136.91 157.53 74.6 Favored Pre-proline 0 CA--C 1.567 1.621 0 C-N-CA 124.124 0.969 . . . . 64.54 109.529 177.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -80.98 17.01 1.51 Allowed 'Trans proline' 0 C--N 1.384 2.404 0 C-N-CA 122.775 2.317 . . . . 73.21 114.209 -167.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 259' ' ' GLU . . . . . 0.448 ' H ' HD12 ' C' ' 257' ' ' ILE . 31.8 mt-10 55.32 -83.45 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.507 1.123 . . . . 72.3 110.547 -164.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 260' ' ' ARG . . . . . 0.416 ' H ' ' HG2' ' C' ' 260' ' ' ARG . 2.4 ptp85 -78.68 134.75 37.09 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 124.312 1.045 . . . . 73.41 110.812 -174.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 261' ' ' LEU . . . . . 0.534 HD11 HG13 ' A' ' 205' ' ' VAL . 65.3 mt -113.54 154.17 27.56 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 115.065 -0.971 . . . . 71.21 111.347 -170.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 52.7 p -83.74 164.05 46.38 Favored Pre-proline 0 CA--C 1.555 1.14 0 N-CA-C 108.31 -0.996 . . . . 61.23 108.31 169.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -51.05 -42.31 53.36 Favored 'Trans proline' 0 C--N 1.382 2.298 0 C-N-CA 122.417 2.078 . . . . 74.2 112.933 173.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -57.82 -58.14 9.68 Favored 'General case' 0 C--O 1.252 1.213 0 C-N-CA 124.058 0.943 . . . . 71.04 110.316 178.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -48.01 -67.22 0.29 Allowed 'General case' 0 C--N 1.357 0.91 0 O-C-N 125.056 1.473 . . . . 65.11 109.999 177.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 266' ' ' GLU . . . . . 0.524 ' HG3' ' HE2' ' C' ' 270' ' ' LYS . 8.3 tp10 -49.18 -51.33 33.29 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.2 1.4 . . . . 64.21 111.838 -171.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -60.7 -49.11 78.84 Favored 'General case' 0 C--O 1.257 1.479 0 CA-C-N 115.582 -0.736 . . . . 70.32 112.012 -177.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 268' ' ' LEU . . . . . 0.412 ' O ' ' HG ' ' C' ' 272' ' ' LEU . 7.6 mp -65.39 -38.3 89.58 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.428 -0.806 . . . . 52.44 110.906 -178.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 73.1 m95 -58.41 -41.72 85.58 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.103 0.561 . . . . 61.11 110.693 175.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 270' ' ' LYS . . . . . 0.524 ' HE2' ' HG3' ' C' ' 266' ' ' GLU . 68.3 mmtt -56.08 -51.53 67.53 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 123.327 0.392 . . . . 75.43 110.134 176.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -56.45 -43.63 79.69 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 114.872 -1.058 . . . . 75.33 111.541 -178.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 272' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' C' ' 268' ' ' LEU . 82.8 mt -65.83 -41.1 92.2 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.14 -0.937 . . . . 74.33 110.656 -179.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -59.17 -42.68 91.37 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.758 0.423 . . . . 34.13 110.431 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -63.26 -38.99 93.32 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.23 0.612 . . . . 63.21 111.28 176.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -61.69 -30.04 70.49 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.037 0.535 . . . . 70.04 111.366 174.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 276' ' ' TYR . . . . . 0.401 ' HE1' ' HB2' ' A' ' 200' ' ' PRO . 2.6 m-85 -78.68 -33.86 46.63 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.04 0.536 . . . . 75.52 112.042 176.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -63.14 -32.53 73.94 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 120.993 0.425 . . . . 44.24 109.955 170.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -68.48 -14.21 62.85 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 123.587 0.755 . . . . 55.2 112.066 175.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 279' ' ' ARG . . . . . . . . . . . . . 42.4 mtm180 -83.86 -16.26 45.11 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 122.749 0.419 . . . . 71.52 110.394 174.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.628 0 N-CA-C 108.268 -1.012 . . . . 75.14 108.268 173.582 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? . . . . . 0 N--CA 1.486 1.371 0 N-CA-C 114.135 1.161 . . . . 62.43 114.135 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.472 ' HG2' ' HB3' ' A' ' 96' ' ' PHE . 70.5 mmtt -93.44 94.32 8.63 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 107.907 -1.145 . . . . 74.32 107.907 171.158 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.41 ' O ' HG13 ' A' ' 10' ' ' ILE . 49.3 t0 -69.37 95.71 0.82 Allowed 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 107.305 -1.368 . . . . 61.41 107.305 173.09 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -61.82 -35.32 77.89 Favored 'General case' 0 C--O 1.244 0.803 0 O-C-N 124.121 0.888 . . . . 73.34 112.252 -171.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -65.04 -45.91 83.47 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.079 -0.51 . . . . 73.33 110.045 177.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.01 -37.86 84.02 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 123.435 0.459 . . . . 60.32 111.119 179.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.41 HG13 ' O ' ' A' ' 6' ' ' ASP . 68.3 mt -61.7 -39.58 83.73 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 C-N-CA 123.367 0.667 . . . . 74.23 110.318 175.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 92.9 mt -80.3 -5.52 56.42 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 112.543 0.572 . . . . 51.33 112.543 176.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.23 34.24 58.23 Favored Glycine 0 C--N 1.354 1.577 0 O-C-N 123.146 0.279 . . . . 53.33 113.396 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 23.8 m -133.23 158.77 74.91 Favored Pre-proline 0 CA--C 1.559 1.295 0 C-N-CA 124.853 1.261 . . . . 71.43 109.622 -177.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -75.3 166.55 28.63 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 122.417 2.078 . . . . 50.12 112.145 176.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -70.49 9.84 0.57 Allowed 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 113.706 1.002 . . . . 75.43 113.706 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -116.86 -1.19 12.07 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.493 1.117 . . . . 64.11 108.897 -177.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.63 121.73 14.62 Favored 'General case' 0 C--N 1.347 0.492 0 C-N-CA 124.477 1.111 . . . . 64.31 110.133 176.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.7 p -75.07 173.0 11.35 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.543 0.737 . . . . 71.11 110.931 -176.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -58.02 -33.11 68.61 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.796 0.839 . . . . 64.21 110.801 178.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.448 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 16.9 tp10 -58.0 -49.57 76.37 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.149 0.98 . . . . 72.43 110.567 171.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -70.68 -30.01 66.47 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.477 0.711 . . . . 64.03 111.85 -176.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.4 mp -69.25 -39.93 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 123.718 0.807 . . . . 73.31 109.213 174.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -64.0 -42.52 97.13 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 124.122 0.889 . . . . 71.24 110.357 178.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.52 ' HA ' ' HD3' ' A' ' 27' ' ' LYS . 66.2 mtm180 -68.69 -44.72 73.38 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.087 0.555 . . . . 54.12 110.849 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.2 -40.31 89.6 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.434 -0.803 . . . . 64.0 110.243 177.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -64.92 -47.73 76.67 Favored 'General case' 0 C--O 1.201 -1.486 0 CA-C-N 115.164 -0.926 . . . . 73.1 110.6 177.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.52 ' HD3' ' HA ' ' A' ' 24' ' ' ARG . 25.4 mtpp -50.07 -47.74 53.47 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 123.674 0.789 . . . . 74.22 110.428 178.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.436 ' HA ' ' NH2' ' A' ' 31' ' ' ARG . 8.1 tpt180 -56.52 -56.19 24.39 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 114.326 -1.306 . . . . 71.15 111.285 176.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.621 HD22 ' HE2' ' A' ' 33' ' ' TYR . 64.5 mt -82.62 -12.06 57.94 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.594 0.758 . . . . 74.11 112.297 -171.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 34' ' ' HIS . . . -93.37 -18.79 21.99 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.733 0.813 . . . . 63.3 110.015 179.106 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.436 ' NH2' ' HA ' ' A' ' 28' ' ' ARG . 48.8 mtm180 -84.96 -44.98 12.62 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 123.311 0.382 . . . . 72.33 110.204 165.088 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -67.5 -48.29 67.51 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.43 0.692 . . . . 63.33 111.03 -174.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.621 ' HE2' HD22 ' A' ' 29' ' ' LEU . 60.6 m-85 -102.9 24.82 10.11 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.169 0.588 . . . . 63.25 111.308 -176.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.486 ' CD2' ' HB3' ' A' ' 36' ' ' ASP . 48.8 t60 -71.09 102.05 0.44 Allowed Pre-proline 0 N--CA 1.482 1.141 0 C-N-CA 124.362 1.065 . . . . 63.41 110.726 -177.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.507 ' HB3' ' HG2' ' A' ' 44' ' ' GLU . 23.6 Cg_exo -62.06 -25.8 77.78 Favored 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 123.066 2.511 . . . . 74.13 113.29 -168.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.486 ' HB3' ' CD2' ' A' ' 34' ' ' HIS . 8.0 t70 -62.92 -40.18 96.83 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.117 1.367 . . . . 72.45 112.208 179.109 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 98.5 t -103.83 -44.7 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-O 121.431 0.634 . . . . 65.53 109.684 -177.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -98.44 83.1 2.97 Favored 'General case' 0 C--O 1.243 0.721 0 C-N-CA 124.344 1.057 . . . . 61.35 108.333 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -78.26 79.22 4.71 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.146 -0.934 . . . . 73.11 108.616 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 74.3 m -138.71 115.62 8.9 Favored Pre-proline 0 CA--C 1.542 0.671 0 CA-C-N 115.297 -0.865 . . . . 54.41 108.985 178.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_exo -46.15 -42.83 21.34 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 124.213 3.275 . . . . 72.23 114.353 -178.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -51.33 -49.82 60.64 Favored 'General case' 0 N--CA 1.482 1.161 0 O-C-N 124.245 0.966 . . . . 64.43 110.49 175.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.26 -26.85 67.54 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-N 114.676 -1.147 . . . . 72.14 111.602 -177.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.507 ' HG2' ' HB3' ' A' ' 35' ' ' PRO . 39.8 mt-10 -81.68 -34.48 30.67 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 122.86 0.464 . . . . 62.01 110.964 -173.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -82.3 -32.44 29.48 Favored 'General case' 0 C--O 1.246 0.897 0 N-CA-C 110.305 -0.257 . . . . 62.44 110.305 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 36.5 mmtm -62.54 -40.63 97.4 Favored 'General case' 0 C--N 1.348 0.502 0 CA-C-N 115.715 -0.675 . . . . 74.03 109.369 167.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -60.16 -38.63 83.74 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.555 0.742 . . . . 73.24 110.489 175.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -56.74 -57.49 12.2 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 120.793 0.33 . . . . 75.14 110.341 174.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -58.61 -41.43 85.85 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 115.151 -0.931 . . . . 71.44 111.786 -176.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.457 HD13 ' HB3' ' A' ' 29' ' ' LEU . 77.3 mt -74.33 -33.1 32.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.777 1.231 . . . . 70.53 111.217 -176.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -88.31 -10.58 49.04 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 119.237 -0.411 . . . . 73.43 111.28 179.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -75.89 -49.19 18.59 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 108.06 -1.089 . . . . 63.42 108.06 166.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -53.5 -46.9 70.21 Favored 'General case' 0 C--N 1.35 0.623 0 CA-C-N 113.625 -1.625 . . . . 65.45 111.307 174.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -69.05 -44.66 72.21 Favored 'General case' 0 C--O 1.216 -0.662 0 CA-C-N 115.026 -0.988 . . . . 72.32 110.618 177.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.409 ' HB2' ' CD2' ' A' ' 88' ' ' PHE . . . -50.1 -37.74 35.32 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.41 0.684 . . . . 53.01 112.224 -179.003 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 88.3 t -76.86 -57.74 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.971 0 CA-C-N 115.267 -0.878 . . . . 74.52 110.943 175.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 65.9 mt -87.22 6.04 35.12 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 113.619 0.97 . . . . 62.04 113.619 -166.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 37.2 t -73.03 -42.15 63.46 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 124.154 0.981 . . . . 74.34 111.349 -178.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -116.25 138.22 24.09 Favored Pre-proline 0 N--CA 1.471 0.579 0 CA-C-N 115.112 -0.949 . . . . 74.34 108.483 -171.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -58.61 -20.95 52.81 Favored 'Trans proline' 0 C--N 1.383 2.375 0 C-N-CA 123.844 3.029 . . . . 72.41 113.416 -172.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -66.6 -70.01 0.27 Allowed 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.622 0.769 . . . . 72.3 110.867 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt -67.22 -25.28 66.03 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.698 0.799 . . . . 74.54 110.894 -178.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -54.97 -56.92 14.34 Favored 'General case' 0 C--N 1.35 0.614 0 CA-C-N 114.791 -1.095 . . . . 74.11 109.702 169.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -58.13 -37.91 75.5 Favored 'General case' 0 C--N 1.364 1.236 0 O-C-N 123.784 0.677 . . . . 74.25 111.362 178.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.564 HG23 ' HG2' ' A' ' 76' ' ' PRO . 1.7 mp -54.31 -48.64 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 123.521 0.513 . . . . 64.42 110.997 175.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -69.72 -43.13 73.0 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 119.43 -0.319 . . . . 75.4 110.88 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -57.68 -39.95 78.3 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.156 0.582 . . . . 64.04 111.344 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 63.1 p -74.17 -25.5 59.76 Favored 'General case' 0 C--N 1.347 0.495 0 CA-C-N 115.617 -0.72 . . . . 75.13 110.6 177.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -72.86 136.41 45.32 Favored 'General case' 0 CA--C 1.551 0.983 0 N-CA-C 108.752 -0.833 . . . . 63.45 108.752 169.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.95 18.0 56.88 Favored Glycine 0 N--CA 1.471 1.007 0 N-CA-C 111.513 -0.635 . . . . 52.54 111.513 -171.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 34.9 m -144.33 -58.81 0.38 Allowed 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 103.415 -2.809 . . . . 71.23 103.415 176.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 51.3 m -80.93 142.82 33.14 Favored 'General case' 0 C--O 1.25 1.127 0 N-CA-C 105.411 -2.07 . . . . 74.23 105.411 156.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.67 -25.22 13.23 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.66 0.784 . . . . 74.04 110.637 178.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.98 143.19 77.29 Favored Pre-proline 0 C--O 1.245 0.843 0 C-N-CA 123.71 0.804 . . . . 75.1 110.094 175.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.416 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 34.0 Cg_endo -62.55 143.56 93.06 Favored 'Trans proline' 0 C--N 1.371 1.761 0 C-N-CA 122.224 1.95 . . . . 75.41 109.921 170.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.564 ' HG2' HG23 ' A' ' 65' ' ' ILE . 31.6 Cg_exo -59.98 144.37 99.47 Favored 'Trans proline' 0 C--N 1.371 1.741 0 C-N-CA 122.831 2.354 . . . . 74.25 112.293 -179.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.53 119.21 6.27 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 122.647 2.231 . . . . 62.44 111.421 176.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -65.74 134.35 37.45 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 122.76 2.307 . . . . 43.51 112.78 -173.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -72.92 145.49 40.34 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.387 2.058 . . . . 71.05 111.201 174.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -59.88 87.01 0.07 OUTLIER 'Trans proline' 0 C--N 1.384 2.402 0 C-N-CA 122.924 2.416 . . . . 51.35 111.605 178.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 155.26 -46.67 0.52 Allowed Glycine 0 C--N 1.332 0.308 0 N-CA-C 109.141 -1.584 . . . . 62.41 109.141 -176.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.489 ' HA3' ' HA ' ' A' ' 106' ' ' PHE . . . 117.01 -174.01 14.99 Favored Glycine 0 C--N 1.346 1.102 0 CA-C-N 115.575 -0.313 . . . . 53.03 113.55 174.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -92.78 130.45 38.39 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.825 0.85 . . . . 74.41 110.655 -178.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.65 158.19 30.63 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 124.464 1.103 . . . . 71.31 110.432 174.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -153.35 75.33 1.06 Allowed 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 107.93 -1.137 . . . . 70.22 107.93 177.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.511 ' HA ' ' HE3' ' A' ' 164' ' ' MET . 12.9 m -38.4 84.87 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 127.229 2.212 . . . . 74.44 116.536 -164.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 71.69 20.17 78.42 Favored Glycine 0 C--N 1.342 0.88 0 N-CA-C 114.791 0.676 . . . . 70.11 114.791 174.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.421 ' HB3' ' CE2' ' A' ' 93' ' ' PHE . 35.0 m-85 -122.04 135.87 54.87 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 123.62 0.768 . . . . 72.34 109.454 -174.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -74.9 88.47 2.32 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 115.842 -0.617 . . . . 71.44 111.22 -171.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.6 p -33.11 -47.9 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.562 1.426 0 C-N-CA 126.34 1.856 . . . . 75.21 113.529 169.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -64.76 -22.85 67.07 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.048 0.939 . . . . 75.33 111.984 -170.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -89.38 -27.74 20.24 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.216 0.606 . . . . 45.35 112.437 -178.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.421 ' CE2' ' HB3' ' A' ' 88' ' ' PHE . 40.1 m-85 -75.7 173.93 10.45 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 113.288 0.847 . . . . 71.01 113.288 -166.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 53.2 p -71.56 175.43 5.58 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 114.655 1.354 . . . . 74.5 114.655 -161.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -67.23 -50.64 59.95 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 113.562 -1.654 . . . . 74.31 110.374 -174.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.472 ' HB3' ' HG2' ' A' ' 5' ' ' LYS . 72.5 t80 -54.01 -41.06 67.55 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 124.48 1.113 . . . . 75.03 111.729 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -60.46 -51.97 67.2 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 115.384 -0.825 . . . . 63.23 110.121 172.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.527 ' HA ' HD11 ' A' ' 105' ' ' LEU . 46.8 mt-30 -70.04 -3.14 14.99 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.609 0.763 . . . . 73.05 112.281 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -98.29 -47.98 5.24 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.191 0.996 . . . . 70.02 111.684 170.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 52.8 tp -73.4 -50.77 20.05 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.394 0.678 . . . . 55.03 110.531 -172.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -90.11 -7.44 53.75 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.363 -0.835 . . . . 72.11 110.067 175.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.418 ' HA2' ' HG ' ' A' ' 105' ' ' LEU . . . -44.64 -59.1 4.42 Favored Glycine 0 C--N 1.364 2.096 0 CA-C-O 118.058 -1.412 . . . . 72.43 115.078 -178.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -40.56 -25.8 0.2 Allowed 'Trans proline' 0 C--N 1.391 2.809 0 C-N-CA 124.687 3.591 . . . . 23.1 115.739 178.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -149.11 54.79 0.5 Allowed Glycine 0 C--N 1.348 1.216 0 N-CA-C 111.461 -0.656 . . . . 44.4 111.461 177.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.527 HD11 ' HA ' ' A' ' 98' ' ' GLN . 13.4 mt -69.0 73.3 0.27 Allowed 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 117.468 0.634 . . . . 74.25 110.998 171.142 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.613 ' CG ' ' HA3' ' A' ' 168' ' ' GLY . 0.1 OUTLIER 43.97 -115.02 0.39 Allowed 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 125.639 1.576 . . . . 72.25 113.152 177.769 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.459 ' H ' ' HB3' ' A' ' 106' ' ' PHE . . . 60.8 20.86 57.65 Favored Glycine 0 C--N 1.36 1.863 0 CA-C-O 119.712 -0.493 . . . . 44.0 112.965 -168.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.36 1.903 0 N-CA-C 111.577 -0.609 . . . . 71.34 111.577 -171.89 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 22.5 tptm . . . . . 0 N--CA 1.479 1.011 0 CA-C-O 120.498 0.189 . . . . 72.15 110.953 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.602 ' HA2' ' HA ' ' A' ' 170' ' ' PRO . . . -106.37 177.42 22.19 Favored Glycine 0 CA--C 1.5 -0.886 0 N-CA-C 122.751 3.86 . . . . 55.22 122.751 -162.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -120.97 150.18 41.51 Favored 'General case' 0 C--O 1.266 1.926 0 CA-C-N 111.197 -2.501 . . . . 71.34 110.034 175.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -66.21 149.95 49.54 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.837 1.255 . . . . 74.23 112.466 -174.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 10.0 tt -149.32 147.05 27.87 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.881 -0.785 . . . . 70.23 108.881 178.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.497 HH21 HG21 ' A' ' 177' ' ' VAL . 33.8 mtp-105 -94.26 122.76 37.13 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.011 0.524 . . . . 74.51 109.961 176.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.466 ' HB2' HD11 ' A' ' 174' ' ' LEU . . . -113.57 166.63 11.33 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.549 -0.908 . . . . 41.51 108.549 171.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -127.59 118.9 24.79 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.666 -1.235 . . . . 61.0 107.666 -174.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 25.4 tp -99.92 99.76 9.84 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 108.611 -0.885 . . . . 54.05 108.611 -169.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.493 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 56.3 Cg_endo -73.61 113.55 3.81 Favored 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 121.69 1.594 . . . . 75.33 108.637 176.04 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.553 ' HA ' HG21 ' B' ' 6' ' ' ILE . 28.0 tp -120.82 138.43 54.05 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 123.44 0.696 . . . . 64.01 109.848 -169.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.437 HG21 ' H ' ' B' ' 4' ' ' SER . 96.6 m -67.79 128.85 38.01 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 114.408 -1.269 . . . . 71.34 110.062 176.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.898 ' HB3' HD22 ' A' ' 215' ' ' LEU . 8.2 mt -54.8 -47.63 73.78 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 122.264 1.031 . . . . 70.54 111.914 -173.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 16.7 mp0 -62.28 -44.04 97.45 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 113.292 -1.776 . . . . 75.32 109.997 -177.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -76.57 -20.09 57.2 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 115.577 -0.738 . . . . 64.33 111.798 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.515 ' HB1' ' O ' ' A' ' 153' ' ' VAL . . . -69.26 -39.98 78.1 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.523 0.729 . . . . 41.43 109.636 175.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -75.78 -38.91 57.86 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 115.06 -0.973 . . . . 74.51 111.564 176.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 54.4 m170 -71.25 -35.51 71.45 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 122.565 0.346 . . . . 75.25 111.188 -178.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.94 -141.15 26.83 Favored Glycine 0 C--N 1.344 1.012 0 CA-C-N 116.069 -0.514 . . . . 71.54 113.039 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 84.09 -175.48 51.5 Favored Glycine 0 C--N 1.348 1.249 0 C-N-CA 123.254 0.454 . . . . 70.42 113.036 178.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.445 ' HB3' ' OG ' ' A' ' 146' ' ' SER . 1.2 mp0 -72.29 111.87 7.87 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.249 0.62 . . . . 73.14 109.588 174.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 8.3 tpp180 -93.65 119.32 32.52 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.246 0.618 . . . . 74.4 109.611 -178.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 74.9 t -81.65 105.37 11.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 108.326 -0.99 . . . . 71.24 108.326 175.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.0 p -124.99 123.33 65.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 C-N-CA 124.396 1.078 . . . . 73.14 108.44 176.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -121.2 146.63 46.58 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.119 0.568 . . . . 71.3 109.971 -177.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 11.0 p -160.4 131.66 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-N 115.5 -0.773 . . . . 75.1 109.509 -177.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 59.93 24.64 13.75 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 124.319 1.048 . . . . 74.24 112.007 -177.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 92.85 -24.65 23.17 Favored Glycine 0 C--N 1.355 1.627 0 CA-C-N 116.13 -0.486 . . . . 31.1 112.387 -176.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 66.1 ttp85 -74.52 99.81 3.7 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.772 0.829 . . . . 72.12 110.489 -177.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -89.97 116.13 27.79 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 123.674 0.79 . . . . 74.41 109.977 178.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.3 p -121.5 148.39 24.93 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 C-N-CA 123.993 0.917 . . . . 73.53 109.506 177.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.445 ' OG ' ' HB3' ' A' ' 135' ' ' GLU . 34.6 t -113.48 87.56 2.64 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.109 0.963 . . . . 31.45 109.035 179.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 29.6 m -83.83 112.51 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-N 116.093 -0.503 . . . . 73.42 109.729 -176.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.442 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 57.4 ttt85 -68.46 95.01 0.59 Allowed 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.329 0.585 . . . . 74.14 109.461 177.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.607 ' HB ' HG11 ' A' ' 153' ' ' VAL . 44.6 pt -81.45 138.13 48.16 Favored Pre-proline 0 CA--C 1.554 1.108 0 CA-C-N 114.896 -1.047 . . . . 74.13 109.506 178.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.401 ' HA ' ' HD3' ' A' ' 151' ' ' PRO . 56.2 Cg_endo -69.48 140.38 43.59 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 122.282 1.988 . . . . 60.34 111.525 177.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 150' ' ' PRO . 31.7 Cg_exo -61.07 93.53 0.11 Allowed 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 123.076 2.518 . . . . 74.15 111.913 174.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 138.59 -5.74 3.19 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-O 118.946 -0.919 . . . . 75.51 113.22 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.607 HG11 ' HB ' ' A' ' 149' ' ' ILE . 7.5 p -58.8 123.22 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 C-N-CA 123.767 0.827 . . . . 75.43 110.969 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.775 ' HD3' HD21 ' A' ' 193' ' ' LEU . 95.4 mtt180 -140.67 167.97 20.91 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 121.704 -0.622 . . . . 73.23 111.271 -173.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.514 ' HB3' ' H ' ' A' ' 188' ' ' LEU . 10.3 tp10 -35.62 118.46 0.48 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 126.977 2.111 . . . . 72.32 114.119 -172.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 107.95 -27.25 15.0 Favored Glycine 0 C--N 1.342 0.867 0 CA-C-O 119.398 -0.668 . . . . 14.21 112.92 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 30.7 t -59.6 112.51 1.82 Allowed 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.533 0.733 . . . . 74.23 110.133 -178.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 48.4 t -86.67 96.88 5.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 115.633 -0.712 . . . . 72.34 109.266 -179.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.593 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 65.8 mt -72.91 102.5 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 N-CA-C 108.409 -0.96 . . . . 75.24 108.409 171.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 51.9 ttt-85 -85.53 103.36 14.32 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.929 -0.578 . . . . 61.32 109.991 -175.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.473 HG13 ' HB3' ' A' ' 174' ' ' LEU . 4.4 p -120.64 116.81 31.64 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 122.895 0.478 . . . . 61.33 109.999 178.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.576 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 48.3 Cg_endo -68.86 175.77 6.92 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.573 2.182 . . . . 74.53 112.809 178.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 65.05 6.37 25.03 Favored Glycine 0 C--N 1.351 1.404 0 N-CA-C 115.787 1.075 . . . . 70.43 115.787 173.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.511 ' HE3' ' HA ' ' A' ' 86' ' ' SER . 64.1 mtt -131.44 -1.7 3.91 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 117.776 0.788 . . . . 64.15 112.796 -173.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -54.63 -89.11 0.01 OUTLIER Glycine 0 N--CA 1.487 2.091 0 N-CA-C 110.54 -1.024 . . . . 73.33 110.54 -176.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.588 ' O ' ' HA ' ' A' ' 171' ' ' PRO . . . -74.89 161.49 53.43 Favored Glycine 0 CA--C 1.541 1.689 0 N-CA-C 106.185 -2.766 . . . . 74.5 106.185 155.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.498 ' HA ' HE21 ' A' ' 167' ' ' GLN . 0.0 OUTLIER -102.7 99.67 9.67 Favored 'General case' 0 CA--C 1.56 1.339 0 CA-C-N 120.153 1.977 . . . . 75.42 113.61 -174.162 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.613 ' HA3' ' CG ' ' A' ' 106' ' ' PHE . . . 75.06 -19.68 2.13 Favored Glycine 0 C--N 1.363 2.076 0 N-CA-C 119.471 2.548 . . . . 64.21 119.471 158.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . 0.552 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . 10.8 t30 -107.8 -43.88 0.12 Allowed Pre-proline 0 C--N 1.319 -0.757 0 N-CA-C 105.111 -2.181 . . . . 63.11 105.111 164.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.602 ' HA ' ' HA2' ' A' ' 116' ' ' GLY . 97.2 Cg_endo -106.64 52.28 0.02 OUTLIER 'Trans proline' 0 CA--C 1.587 3.126 0 C-N-CA 122.361 2.041 . . . . 71.13 114.687 158.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.588 ' HA ' ' O ' ' A' ' 166' ' ' GLY . 59.0 Cg_endo -63.89 102.61 0.37 Allowed 'Trans proline' 1 C--N 1.43 4.855 0 C-N-CA 122.746 2.297 . . . . 71.25 110.997 -177.771 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -116.75 -169.63 15.24 Favored Glycine 0 N--CA 1.482 1.761 0 C-N-CA 120.665 -0.779 . . . . 72.4 114.677 -169.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.576 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 33.5 m-20 -79.33 105.84 10.93 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 108.725 -0.842 . . . . 71.14 108.725 169.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.473 ' HB3' HG13 ' A' ' 161' ' ' VAL . 20.8 tp -82.73 108.67 16.26 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.416 -0.811 . . . . 64.32 110.004 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 82.4 mt -85.93 93.68 9.0 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.764 -0.828 . . . . 72.12 108.764 175.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.593 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 92.2 mt -78.02 93.88 4.55 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-N 115.794 -0.639 . . . . 70.05 109.958 178.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.497 HG21 HH21 ' A' ' 120' ' ' ARG . 41.9 t -81.99 98.21 4.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 106.137 -1.801 . . . . 61.43 106.137 174.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 12.8 p -65.39 110.77 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-O 121.797 0.808 . . . . 70.33 110.101 -174.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.493 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 11.9 mmm-85 -91.32 127.45 36.75 Favored 'General case' 0 C--O 1.219 -0.509 0 N-CA-C 107.636 -1.246 . . . . 53.32 107.636 173.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.408 HD13 HD22 ' A' ' 127' ' ' LEU . 15.5 mt -91.16 147.33 23.13 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.806 -0.442 . . . . 72.4 109.806 176.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 89.3 mt -55.88 162.77 2.49 Favored Pre-proline 0 N--CA 1.487 1.395 0 C-N-CA 124.979 1.312 . . . . 73.14 113.841 -169.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.23 14.55 0.29 Allowed 'Trans proline' 0 C--N 1.395 2.987 0 C-N-CA 123.052 2.501 . . . . 71.42 113.696 173.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . 0.414 ' HA ' ' HD3' ' A' ' 184' ' ' PRO . 66.2 t-80 -60.85 105.36 0.57 Allowed Pre-proline 0 CA--C 1.563 1.47 0 N-CA-C 106.317 -1.734 . . . . 73.35 106.317 165.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 183' ' ' HIS . 6.6 Cg_exo -72.13 28.24 0.26 Allowed 'Trans proline' 0 N--CA 1.506 2.222 0 C-N-CA 124.764 3.643 . . . . 61.24 118.161 -158.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 21.6 t -93.97 -57.95 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-N 119.583 1.083 . . . . 64.21 110.303 -172.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . 0.538 ' HB3' HD22 ' A' ' 193' ' ' LEU . 26.8 m-85 -124.81 155.82 38.79 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 112.815 0.672 . . . . 72.31 112.815 -169.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -147.39 99.18 3.1 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 106.076 -1.824 . . . . 75.51 106.076 171.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.514 ' H ' ' HB3' ' A' ' 155' ' ' GLU . 0.7 OUTLIER -78.83 158.03 28.25 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 122.736 0.415 . . . . 74.21 111.429 -175.356 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -148.61 128.64 13.58 Favored 'General case' 0 C--O 1.247 0.937 0 N-CA-C 107.439 -1.319 . . . . 70.31 107.439 166.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 70.85 -82.38 0.41 Allowed Glycine 0 C--N 1.349 1.267 0 O-C-N 123.653 0.596 . . . . 65.41 112.716 -178.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.403 ' OE1' ' HD2' ' A' ' 243' ' ' PRO . 0.1 OUTLIER -147.63 -5.8 0.47 Allowed 'General case' 0 C--O 1.252 1.222 0 C-N-CA 123.19 0.596 . . . . 72.32 111.776 179.856 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -111.23 147.84 34.13 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 122.886 0.474 . . . . 72.32 111.262 -175.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.775 HD21 ' HD3' ' A' ' 154' ' ' ARG . 83.8 mt -93.54 137.25 33.01 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.191 0.996 . . . . 63.44 111.035 -177.149 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -105.74 103.37 12.86 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 108.063 -1.088 . . . . 73.14 108.063 165.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.495 ' HB3' HD23 ' A' ' 251' ' ' LEU . . . -103.15 172.55 6.75 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.285 1.034 . . . . 74.34 110.759 179.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 91.1 m -119.81 131.84 55.43 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.625 0.77 . . . . 70.21 108.956 171.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.436 ' HB2' HD22 ' A' ' 251' ' ' LEU . 38.2 tp -113.86 129.05 56.63 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.358 0.663 . . . . 72.21 110.793 -176.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -88.15 120.64 29.69 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 107.411 -1.329 . . . . 61.43 107.411 167.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.2 p -142.88 120.65 7.11 Favored Pre-proline 0 CA--C 1.544 0.747 0 N-CA-C 109.404 -0.591 . . . . 64.4 109.404 179.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.72 151.22 74.69 Favored 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 121.763 1.642 . . . . 64.51 111.038 174.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -51.05 -45.54 88.34 Favored Pre-proline 0 CA--C 1.552 1.021 0 N-CA-C 114.756 1.391 . . . . 71.34 114.756 -173.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -55.96 -45.79 35.99 Favored 'Trans proline' 0 C--N 1.388 2.616 0 C-N-CA 122.013 1.809 . . . . 63.54 113.584 175.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.566 HD11 ' HB3' ' C' ' 276' ' ' TYR . 27.8 mt -71.4 -28.27 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 123.082 0.553 . . . . 64.32 110.645 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.95 -41.86 77.47 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.043 0.537 . . . . 71.51 110.761 177.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 34.1 t -71.18 -48.19 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.602 0.761 . . . . 63.23 111.828 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 86.8 t -94.26 -35.5 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.059 0.544 . . . . 74.41 112.1 -169.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 88.68 111.7 1.17 Allowed Glycine 0 CA--C 1.53 0.977 0 CA-C-N 116.366 -0.379 . . . . 72.35 113.569 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -173.62 -158.7 18.54 Favored Glycine 0 C--N 1.351 1.402 0 CA-C-O 120.174 -0.237 . . . . 55.24 112.763 177.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -80.31 119.2 22.73 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.343 0.868 . . . . 45.21 113.343 -167.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.426 HG21 HD11 ' A' ' 197' ' ' LEU . 29.2 m -110.84 -172.74 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 114.158 -1.383 . . . . 63.11 107.665 162.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . 0.457 ' HD2' ' HB2' ' A' ' 218' ' ' PRO . 60.2 ttp180 -126.4 115.93 20.38 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 109.823 -0.436 . . . . 71.41 109.823 172.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -105.68 160.06 15.5 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.94 -0.763 . . . . 62.04 108.94 172.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 54.1 ttm -97.09 147.86 23.62 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 109.164 -0.68 . . . . 71.23 109.164 176.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 81.4 p -124.86 -173.3 2.77 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 108.455 -0.943 . . . . 74.1 108.455 169.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.898 HD22 ' HB3' ' A' ' 127' ' ' LEU . 22.5 mt -72.64 -19.78 61.38 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.044 0.538 . . . . 63.31 110.699 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -110.6 25.95 11.22 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.978 0.911 . . . . 64.44 110.506 178.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 98.94 -175.26 28.53 Favored Glycine 0 C--N 1.351 1.373 0 N-CA-C 114.839 0.696 . . . . 33.0 114.839 173.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . 0.457 ' HB2' ' HD2' ' A' ' 211' ' ' ARG . 83.8 Cg_endo -76.58 132.07 13.05 Favored 'Trans proline' 0 CA--C 1.557 1.671 0 C-N-CA 123.399 2.733 . . . . 70.23 113.719 -174.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 27.2 m -125.7 153.93 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 124.891 1.276 . . . . 73.4 110.257 177.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -79.79 130.08 35.02 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.947 -0.39 . . . . 75.04 109.947 173.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 88.9 t -119.96 121.73 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 123.6 0.76 . . . . 74.13 110.269 -176.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -81.33 103.5 11.14 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.184 0.593 . . . . 60.25 109.812 177.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 92.9 t -67.64 146.58 98.58 Favored Pre-proline 0 CA--C 1.56 1.328 0 C-N-CA 125.497 1.519 . . . . 63.14 110.609 177.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -83.04 161.82 15.66 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 122.434 2.09 . . . . 75.51 111.268 172.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -70.47 148.4 60.37 Favored 'Trans proline' 0 C--N 1.365 1.44 0 C-N-CA 122.23 1.953 . . . . 72.53 112.647 176.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 57.6 mtt-85 69.32 28.41 4.82 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.578 1.551 . . . . 74.04 111.575 171.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.459 HG23 HD21 ' A' ' 233' ' ' LEU . 19.6 m -69.27 104.45 2.23 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.665 1.586 . . . . 64.32 110.512 174.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . 0.476 HE21 ' HG3' ' C' ' 259' ' ' GLU . 6.0 tt0 -101.21 151.61 21.65 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.712 0.805 . . . . 75.32 110.475 -177.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . 0.45 ' HA ' ' HB ' ' A' ' 253' ' ' VAL . . . -75.01 152.01 38.74 Favored 'General case' 0 C--N 1.355 0.847 0 N-CA-C 113.19 0.811 . . . . 62.31 113.19 -169.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 85.73 -3.34 87.28 Favored Glycine 0 C--N 1.348 1.209 0 CA-C-N 114.719 -1.128 . . . . 73.32 112.988 -176.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -98.02 156.74 16.5 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.671 0.788 . . . . 74.0 110.563 -178.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -104.82 112.39 25.48 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.936 0.895 . . . . 72.22 108.683 176.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.459 HD21 HG23 ' A' ' 227' ' ' THR . 65.9 mt -75.8 99.83 4.56 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 107.906 -1.146 . . . . 71.4 107.906 174.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -83.58 100.46 10.82 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 109.578 -0.527 . . . . 64.14 109.578 176.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.511 ' H ' HD23 ' A' ' 235' ' ' LEU . 0.3 OUTLIER -95.94 115.48 27.49 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 107.838 -1.171 . . . . 61.12 107.838 172.118 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -68.09 136.66 54.1 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 114.577 -1.192 . . . . 64.43 112.203 -171.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 84.99 35.82 12.08 Favored Glycine 0 C--N 1.349 1.282 0 O-C-N 123.807 0.692 . . . . 74.2 114.375 169.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.407 ' HE3' HD12 ' A' ' 235' ' ' LEU . 74.5 mmtt -116.04 -23.2 8.62 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.787 0.435 . . . . 73.01 111.68 -177.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -89.06 -173.64 46.47 Favored Glycine 0 C--N 1.348 1.211 0 N-CA-C 111.063 -0.815 . . . . 74.43 111.063 171.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -96.27 164.24 18.89 Favored Pre-proline 0 N--CA 1.49 1.563 0 CA-C-N 117.794 0.797 . . . . 73.13 111.398 -173.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.516 ' HA ' ' HA ' ' A' ' 246' ' ' ARG . 96.4 Cg_exo -48.75 135.57 28.03 Favored 'Trans proline' 0 C--N 1.388 2.655 0 C-N-CA 123.356 2.704 . . . . 73.33 114.949 175.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -161.42 -162.42 12.87 Favored Glycine 0 C--N 1.347 1.144 0 CA-C-O 119.253 -0.749 . . . . 73.52 112.601 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . 0.403 ' HD2' ' OE1' ' A' ' 191' ' ' GLN . 32.0 Cg_exo -58.15 -23.65 62.6 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 123.399 2.733 . . . . 70.45 113.164 177.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -88.09 19.06 3.84 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.777 0.831 . . . . 70.11 111.716 176.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 81.44 -82.41 1.57 Allowed Glycine 0 C--N 1.349 1.26 0 N-CA-C 110.269 -1.132 . . . . 62.24 110.269 -174.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.516 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 70.2 mtm180 -126.51 151.86 47.27 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.709 1.203 . . . . 75.41 108.032 169.149 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -83.74 175.96 52.13 Favored Glycine 0 C--N 1.347 1.185 0 N-CA-C 114.192 0.437 . . . . 42.24 114.192 -174.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -122.83 -175.68 3.22 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.113 0.965 . . . . 75.44 110.906 -174.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.487 ' HB3' ' HG ' ' A' ' 235' ' ' LEU . 50.9 tp -127.58 130.44 49.07 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.048 -1.093 . . . . 70.31 108.048 169.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -113.24 105.33 13.29 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 107.429 -1.323 . . . . 52.51 107.429 178.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.495 HD23 ' HB3' ' A' ' 195' ' ' ALA . 36.8 mt -93.6 110.92 22.5 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.129 0.571 . . . . 72.24 110.016 -176.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -77.69 109.72 11.92 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.256 0.623 . . . . 75.41 109.491 -177.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.45 ' HB ' ' HA ' ' A' ' 229' ' ' ALA . 31.9 t -68.99 111.25 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 CA-C-N 114.669 -1.151 . . . . 24.43 111.691 -170.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -110.8 99.93 8.76 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 107.803 -1.184 . . . . 73.14 107.803 167.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.559 HD12 ' HA ' ' C' ' 256' ' ' THR . 72.4 mt -76.9 122.18 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 114.853 -1.067 . . . . 74.34 109.985 179.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 61.8 p -107.46 165.36 11.46 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 124.164 0.986 . . . . 73.43 109.667 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.773 HD11 HE21 ' C' ' 228' ' ' GLN . 2.8 pp -130.86 152.24 80.26 Favored Pre-proline 0 CA--C 1.557 1.231 0 C-N-CA 123.517 0.727 . . . . 73.4 110.285 -176.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_exo -53.44 -16.4 7.43 Favored 'Trans proline' 0 C--N 1.383 2.344 0 C-N-CA 123.891 3.061 . . . . 74.45 116.744 -169.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . 0.437 ' HA ' ' HB3' ' C' ' 226' ' ' ARG . 64.8 mt-10 50.54 -74.22 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 124.581 1.152 . . . . 63.24 112.947 -167.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.51 139.71 42.35 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 109.814 -0.439 . . . . 75.12 109.814 174.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.633 HD22 ' HB2' ' A' ' 265' ' ' GLU . 83.4 mt -134.99 152.25 51.56 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.436 0.694 . . . . 55.32 109.949 174.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.0 155.6 39.74 Favored Pre-proline 0 CA--C 1.552 1.039 0 N-CA-C 106.513 -1.662 . . . . 44.34 106.513 164.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -42.95 -27.92 1.06 Allowed 'Trans proline' 0 C--N 1.39 2.74 0 C-N-CA 124.325 3.35 . . . . 74.33 115.515 -174.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -60.51 -71.49 0.13 Allowed 'General case' 0 C--O 1.252 1.194 0 C-N-CA 124.28 1.032 . . . . 71.44 111.842 178.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . 0.633 ' HB2' HD22 ' A' ' 261' ' ' LEU . 2.1 mp0 -65.83 -30.92 71.62 Favored 'General case' 0 C--N 1.356 0.871 0 N-CA-C 109.265 -0.643 . . . . 64.2 109.265 -177.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 266' ' ' GLU . . . . . 0.568 ' HA ' HD13 ' A' ' 261' ' ' LEU . 4.7 tp10 -51.58 -54.77 24.08 Favored 'General case' 0 C--N 1.355 0.815 0 O-C-N 124.294 0.996 . . . . 73.45 109.678 174.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -65.71 -37.41 86.36 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.214 0.606 . . . . 64.12 112.108 -177.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . 0.445 HD21 ' HE3' ' C' ' 271' ' ' LYS . 9.3 mp -59.47 -60.33 4.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 123.452 0.47 . . . . 73.14 110.982 175.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -55.65 -38.43 69.54 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.359 1.064 . . . . 75.0 112.465 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . 0.676 ' HG3' HG23 ' C' ' 206' ' ' VAL . 0.0 OUTLIER -65.47 -50.17 66.33 Favored 'General case' 0 N--CA 1.478 0.969 0 O-C-N 123.52 0.512 . . . . 62.43 110.181 -179.784 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 3.2 tmpt? -57.64 -48.9 78.18 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 123.68 0.612 . . . . 70.22 109.89 179.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 272' ' ' LEU . . . . . 0.502 ' O ' ' HB2' ' A' ' 276' ' ' TYR . 83.9 mt -52.43 -50.5 62.43 Favored 'General case' 0 C--N 1.357 0.916 0 O-C-N 124.413 1.07 . . . . 63.4 110.586 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -72.33 -43.49 64.05 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.019 1.118 . . . . 64.51 114.019 -171.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -75.39 -36.16 60.92 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.038 0.535 . . . . 74.35 110.13 -175.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -72.33 -32.91 66.92 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 116.293 -0.412 . . . . 71.44 110.414 171.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . 0.518 ' HE2' ' HG3' ' C' ' 258' ' ' PRO . 51.4 t80 -55.93 -53.01 62.08 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.344 1.058 . . . . 75.02 109.37 176.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 277' ' ' TYR . . . . . 0.413 ' HA ' ' HB3' ' A' ' 280' ' ' ALA . 0.2 OUTLIER -69.37 -34.75 75.02 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 115.401 -0.818 . . . . 70.12 110.391 -179.236 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -63.0 -10.54 14.23 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 112.757 0.651 . . . . 75.41 112.757 173.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . 0.46 HH22 ' CD ' ' C' ' 265' ' ' GLU . 49.7 mtm180 -122.95 3.65 9.39 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.777 0.831 . . . . 74.13 111.033 174.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . 0.413 ' HB3' ' HA ' ' A' ' 277' ' ' TYR . . . . . . . . 0 C--O 1.257 1.465 0 C-N-CA 123.576 0.75 . . . . 72.21 109.775 176.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.297 0 N-CA-C 111.394 0.146 . . . . 71.44 111.394 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -89.62 120.22 30.72 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.727 0.811 . . . . 54.1 110.056 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -82.05 -10.94 59.05 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.743 -0.598 . . . . 74.04 112.154 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . 0.437 ' H ' HG21 ' A' ' 126' ' ' THR . 19.5 m 58.97 -84.11 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 125.384 1.474 . . . . 52.14 112.838 177.015 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 11.8 m -95.49 150.8 19.92 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.277 0.631 . . . . 70.11 110.139 -175.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.553 HG21 ' HA ' ' A' ' 125' ' ' LEU . 38.2 pt -134.13 169.92 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 123.388 0.675 . . . . 64.44 112.329 -163.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -139.44 134.38 32.27 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.314 1.046 . . . . 72.01 109.582 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 52.9 tp -74.32 147.87 41.88 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.213 1.005 . . . . 75.22 111.705 -171.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.35 -57.73 3.96 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.075 0.55 . . . . 62.4 111.559 178.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 21.8 mt 67.43 -13.31 0.23 Allowed 'General case' 0 N--CA 1.506 2.367 0 C-N-CA 124.961 1.304 . . . . 74.1 113.449 -169.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 83.9 mt . . . . . 0 CA--C 1.551 1.015 0 C-N-CA 125.155 1.382 . . . . 45.35 112.305 -176.315 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.805 0 N-CA-C 112.669 0.618 . . . . 61.34 112.669 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . 68.3 -67.26 0.2 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.329 1.452 . . . . 74.4 110.541 -169.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 35.1 tp -154.63 114.86 3.86 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 109.109 -0.7 . . . . 62.04 109.109 -178.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 182' ' ' VAL . . . . . . . . . . . . . 14.4 p 44.53 111.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 C-N-CA 127.033 2.133 . . . . 71.31 116.196 178.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -103.61 84.61 2.31 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 107.579 -1.267 . . . . 65.24 107.579 167.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 23.7 p-80 64.85 165.3 0.16 Allowed 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 126.871 2.068 . . . . 74.15 113.841 174.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 185' ' ' VAL . . . . . 0.619 HG23 ' HA ' ' C' ' 121' ' ' ALA . 7.7 p . . . . . 0 CA--C 1.55 0.969 0 CA-C-N 115.02 -0.991 . . . . 71.33 111.875 -170.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 238' ' ' THR . . . . . 0.604 HG22 HG23 ' C' ' 219' ' ' VAL . 59.3 m . . . . . 0 N--CA 1.465 0.314 0 N-CA-C 107.072 -1.455 . . . . 71.31 107.072 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -162.78 -88.56 0.02 OUTLIER 'General case' 0 C--O 1.236 0.387 0 N-CA-C 109.42 -0.585 . . . . 74.42 109.42 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 240' ' ' GLY . . . . . 0.577 ' HA3' ' HA ' ' C' ' 235' ' ' LEU . . . 162.55 -128.9 1.95 Allowed Glycine 0 C--N 1.339 0.705 0 N-CA-C 110.628 -0.989 . . . . 71.23 110.628 -169.04 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 241' ' ' GLU . . . . . 0.676 ' HG3' ' HG3' ' C' ' 234' ' ' ARG . 6.4 pt-20 -150.24 138.08 20.05 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.412 0.685 . . . . 71.21 109.784 -175.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 242' ' ' TRP . . . . . 0.408 ' CD2' ' HG ' ' C' ' 233' ' ' LEU . 1.0 OUTLIER -173.16 117.24 0.29 Allowed 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 107.155 -1.424 . . . . 70.32 107.155 170.628 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 59.69 -82.56 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 124.104 0.962 . . . . 74.22 109.081 -168.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 179.83 88.22 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 107.362 -2.295 . . . . 63.11 107.362 177.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 245' ' ' LYS . . . . . 0.427 ' HD3' ' HB3' ' C' ' 222' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.931 0 N-CA-C 112.337 0.495 . . . . 75.34 112.337 -172.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.101 0 CA-C-O 120.808 0.337 . . . . 52.01 110.588 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -39.42 100.76 0.02 OUTLIER 'General case' 0 C--N 1.351 0.674 0 C-N-CA 125.301 1.44 . . . . 70.52 112.996 171.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -76.42 123.18 25.6 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 106.445 -1.687 . . . . 63.2 106.445 166.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -72.4 96.0 1.83 Allowed 'General case' 0 C--O 1.245 0.818 0 N-CA-C 108.705 -0.85 . . . . 63.22 108.705 -176.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 7' ' ' TYR . . . . . 0.432 ' CE2' HG21 ' C' ' 56' ' ' VAL . 50.2 m-85 -66.89 -24.2 66.08 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 113.893 -1.503 . . . . 73.43 112.083 -169.099 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -66.36 -49.11 68.0 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.803 -0.443 . . . . 72.53 109.803 174.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.09 -41.87 97.47 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 123.635 0.584 . . . . 52.31 110.986 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 58.3 mt -59.05 -41.83 84.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 123.645 0.591 . . . . 63.34 110.715 176.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 11' ' ' LEU . . . . . 0.429 ' HB2' HG22 ' C' ' 13' ' ' VAL . 78.4 mt -69.97 -26.24 64.0 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 115.994 -0.548 . . . . 45.45 111.869 174.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.95 22.31 55.52 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-N 116.694 -0.23 . . . . 64.33 112.953 -173.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 13' ' ' VAL . . . . . 0.429 HG22 ' HB2' ' C' ' 11' ' ' LEU . 19.0 m -107.23 150.5 40.02 Favored Pre-proline 0 N--CA 1.481 1.077 0 C-N-CA 124.184 0.994 . . . . 64.04 109.588 174.156 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -66.38 163.15 33.33 Favored 'Trans proline' 0 C--N 1.371 1.738 0 C-N-CA 122.455 2.103 . . . . 74.43 111.809 178.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -77.27 21.59 0.24 Allowed 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 123.175 0.59 . . . . 71.52 112.326 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -131.49 18.3 4.81 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.1 1.36 . . . . 71.24 107.691 173.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.23 123.72 18.07 Favored 'General case' 0 C--N 1.353 0.74 0 C-N-CA 124.166 0.986 . . . . 71.14 111.322 -178.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 44.0 p -66.72 170.29 6.65 Favored 'General case' 0 C--O 1.251 1.168 0 N-CA-C 109.059 -0.719 . . . . 74.41 109.059 170.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 59.4 tp60 -61.43 -36.42 80.31 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.538 -0.301 . . . . 74.45 111.081 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 20' ' ' GLU . . . . . 0.448 ' HB3' ' NH1' ' C' ' 24' ' ' ARG . 0.1 OUTLIER -73.27 -36.59 66.38 Favored 'General case' 0 C--O 1.212 -0.91 0 CA-C-O 118.869 -0.586 . . . . 64.05 110.171 179.773 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -55.93 -48.79 75.07 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.383 0.611 . . . . 73.42 111.188 174.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 22' ' ' ILE . . . . . 0.544 HD13 ' HB3' ' C' ' 57' ' ' LEU . 71.7 mt -61.6 -43.05 96.36 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-N 114.743 -1.117 . . . . 61.32 110.964 176.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 23' ' ' LYS . . . . . 0.542 ' O ' ' HG3' ' C' ' 27' ' ' LYS . 13.1 tppt? -68.76 -25.45 64.73 Favored 'General case' 0 CA--C 1.558 1.287 0 CA-C-N 115.34 -0.845 . . . . 74.13 110.158 179.214 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 24' ' ' ARG . . . . . 0.448 ' NH1' ' HB3' ' C' ' 20' ' ' GLU . 68.5 mtt85 -71.94 -50.95 24.66 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.775 0.83 . . . . 73.52 110.283 178.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.87 -37.73 74.45 Favored 'General case' 0 C--O 1.246 0.917 0 O-C-N 124.296 0.997 . . . . 75.32 110.293 177.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 26' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -56.31 -71.37 0.09 Allowed 'General case' 0 C--N 1.358 0.968 0 CA-C-O 117.642 -1.171 . . . . 72.31 110.487 172.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . 0.542 ' HG3' ' O ' ' C' ' 23' ' ' LYS . 39.0 mttp -50.24 -39.59 45.17 Favored 'General case' 0 N--CA 1.504 2.237 0 C-N-CA 123.633 0.773 . . . . 74.1 112.259 -173.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -54.75 -62.7 1.49 Allowed 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.691 1.197 . . . . 71.15 110.852 176.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . 0.514 HD13 HD13 ' C' ' 50' ' ' ILE . 42.3 mt -81.66 -8.81 59.75 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 115.25 -0.886 . . . . 60.22 111.256 -175.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . 0.463 ' HA ' ' HE1' ' C' ' 47' ' ' PHE . . . -93.36 -14.51 26.79 Favored 'General case' 0 C--O 1.215 -0.763 0 C-N-CA 124.23 1.012 . . . . 75.32 110.579 179.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 54.1 mtm180 -92.4 -41.67 10.19 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 109.245 -0.65 . . . . 73.5 109.245 164.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 23.9 tp60 -63.78 -50.61 68.35 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.764 0.826 . . . . 71.12 111.564 -175.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 33' ' ' TYR . . . . . 0.428 ' HE2' HD22 ' C' ' 29' ' ' LEU . 32.6 m-85 -104.26 20.16 18.87 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.235 0.614 . . . . 70.15 110.846 -177.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 34' ' ' HIS . . . . . 0.429 ' CD2' ' HB3' ' C' ' 36' ' ' ASP . 5.8 t60 -62.57 114.48 12.17 Favored Pre-proline 0 N--CA 1.475 0.819 0 CA-C-O 118.405 -0.807 . . . . 72.34 109.461 -179.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -51.15 -33.47 44.09 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 123.345 2.696 . . . . 71.32 114.414 -173.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 36' ' ' ASP . . . . . 0.429 ' HB3' ' CD2' ' C' ' 34' ' ' HIS . 15.7 t70 -68.51 -44.13 75.32 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.745 0.818 . . . . 60.34 111.639 177.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 61.5 t -80.51 -51.14 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 CA-C-O 121.495 0.664 . . . . 75.33 110.05 -173.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -112.67 96.79 6.17 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 114.809 -1.087 . . . . 54.22 108.939 177.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -84.08 67.03 9.53 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.899 0.479 . . . . 62.24 109.961 178.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 49.4 m -124.41 109.77 28.73 Favored Pre-proline 0 N--CA 1.477 0.878 0 C-N-CA 123.645 0.778 . . . . 74.14 108.933 177.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -43.82 -47.21 10.09 Favored 'Trans proline' 0 C--N 1.386 2.547 0 C-N-CA 124.197 3.265 . . . . 63.44 113.775 -177.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -55.25 -42.36 73.4 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.913 0.885 . . . . 65.44 111.299 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.68 -27.37 61.19 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 114.972 -1.013 . . . . 62.05 110.754 -178.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -81.51 -24.69 36.51 Favored 'General case' 0 C--N 1.352 0.689 0 O-C-N 123.774 0.671 . . . . 74.04 109.955 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -73.32 -45.07 57.5 Favored 'General case' 0 C--O 1.244 0.774 0 C-N-CA 123.709 0.804 . . . . 42.53 109.688 173.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 46' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -60.83 -41.03 94.99 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 115.605 -0.725 . . . . 72.32 110.36 171.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 47' ' ' PHE . . . . . 0.463 ' HE1' ' HA ' ' C' ' 30' ' ' ALA . 84.6 t80 -57.09 -45.99 82.92 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 124.149 0.906 . . . . 62.23 109.933 176.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 48' ' ' LYS . . . . . 0.484 ' HE3' ' HB3' ' C' ' 89' ' ' ASP . 48.5 mtpt -58.98 -46.26 88.54 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 123.965 0.791 . . . . 72.04 111.555 178.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -60.56 -43.15 97.56 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.303 0.573 . . . . 72.33 112.099 178.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 50' ' ' ILE . . . . . 0.514 HD13 HD13 ' C' ' 29' ' ' LEU . 82.8 mt -70.56 -29.35 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 124.187 0.995 . . . . 75.43 110.526 178.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 51' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -90.21 -5.58 56.23 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.802 0.841 . . . . 74.04 111.212 178.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -78.0 -48.49 16.06 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 107.319 -1.363 . . . . 63.42 107.319 164.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . 0.428 ' HA ' ' CD1' ' C' ' 7' ' ' TYR . . . -53.87 -43.6 69.7 Favored 'General case' 0 C--N 1.344 0.331 0 CA-C-N 113.236 -1.802 . . . . 63.1 111.29 174.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -79.32 -30.37 42.75 Favored 'General case' 0 C--O 1.214 -0.8 0 CA-C-N 114.934 -1.03 . . . . 75.01 111.111 176.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.82 -36.92 68.01 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 119.01 0.823 . . . . 60.54 111.172 176.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 56' ' ' VAL . . . . . 0.436 HG13 ' HZ ' ' C' ' 101' ' ' PHE . 35.3 t -78.78 -55.02 10.82 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 CA-C-N 114.894 -1.048 . . . . 72.43 110.445 174.024 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 57' ' ' LEU . . . . . 0.544 ' HB3' HD13 ' C' ' 22' ' ' ILE . 79.4 mt -92.56 19.18 7.59 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 113.021 0.749 . . . . 75.02 113.021 -168.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 29.9 t -51.31 -61.48 2.21 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.852 1.261 . . . . 62.42 113.657 -177.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -133.03 151.59 78.2 Favored Pre-proline 0 N--CA 1.476 0.846 0 N-CA-C 108.422 -0.955 . . . . 72.03 108.422 -172.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 60' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -41.01 -31.53 0.77 Allowed 'Trans proline' 0 C--N 1.386 2.528 0 C-N-CA 124.997 3.798 . . . . 33.23 116.417 -175.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -70.13 -58.97 3.2 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 118.078 0.399 . . . . 62.13 111.242 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -65.23 -28.63 69.5 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.028 0.442 . . . . 75.23 111.544 179.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 45.0 tpt85 -54.71 -53.46 54.68 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.371 1.069 . . . . 64.42 110.001 168.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -73.11 -19.16 61.2 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 115.806 -0.634 . . . . 74.15 112.386 -179.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 68.0 mt -65.34 -44.46 94.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 N-CA-C 108.869 -0.789 . . . . 62.34 108.869 170.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -60.54 -47.76 84.77 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.725 -0.67 . . . . 74.22 110.334 173.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -56.62 -45.79 81.3 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.312 0.645 . . . . 73.14 111.814 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 67.2 p -71.62 -25.48 62.18 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.197 -0.456 . . . . 63.2 110.829 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 69' ' ' TYR . . . . . 0.425 ' CD1' HD13 ' C' ' 100' ' ' LEU . 5.6 t80 -79.68 137.07 36.95 Favored 'General case' 0 C--N 1.358 0.953 0 N-CA-C 109.728 -0.471 . . . . 75.22 109.728 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.48 17.89 53.82 Favored Glycine 0 N--CA 1.473 1.144 0 N-CA-C 111.339 -0.704 . . . . 62.51 111.339 -170.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 87.7 m -147.32 -58.98 0.27 Allowed 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 103.615 -2.735 . . . . 72.34 103.615 176.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 34.7 m -84.48 148.96 26.26 Favored 'General case' 0 C--O 1.249 1.048 0 N-CA-C 105.403 -2.073 . . . . 73.35 105.403 156.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.96 -16.13 7.65 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.929 0.892 . . . . 73.23 110.202 -176.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.92 125.88 87.64 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 123.086 0.554 . . . . 53.23 109.781 174.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -61.57 148.49 92.89 Favored 'Trans proline' 0 C--N 1.372 1.804 0 C-N-CA 122.684 2.256 . . . . 75.14 111.373 169.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -65.83 165.24 24.13 Favored 'Trans proline' 0 CA--C 1.56 1.806 0 C-N-CA 122.735 2.29 . . . . 63.14 112.725 -179.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -67.37 158.54 56.56 Favored 'Trans proline' 0 C--N 1.374 1.918 0 C-N-CA 122.868 2.379 . . . . 51.51 111.427 167.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 78' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.27 116.83 3.5 Favored 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 122.498 2.132 . . . . 74.44 111.758 175.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -66.7 155.67 69.37 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 122.469 2.112 . . . . 61.04 110.087 177.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_exo -46.52 76.27 0.01 OUTLIER 'Trans proline' 0 N--CA 1.509 2.428 0 C-N-CA 124.819 3.68 . . . . 51.5 116.309 -172.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 137.51 -47.06 0.97 Allowed Glycine 0 CA--C 1.53 1.01 0 CA-C-N 115.879 -0.6 . . . . 75.2 112.266 -178.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 141.25 164.61 10.03 Favored Glycine 0 N--CA 1.473 1.151 0 N-CA-C 109.799 -1.32 . . . . 74.45 109.799 -174.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -70.18 115.15 9.05 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 122.945 0.498 . . . . 70.14 110.028 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -52.09 121.99 7.74 Favored 'General case' 0 C--O 1.242 0.662 0 O-C-N 124.698 1.249 . . . . 63.13 111.661 176.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 85' ' ' PHE . . . . . 0.518 ' HA ' ' HD2' ' C' ' 88' ' ' PHE . 56.3 m-85 -135.39 59.23 1.73 Allowed 'General case' 0 N--CA 1.475 0.789 0 O-C-N 124.074 0.859 . . . . 74.41 110.444 169.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 25.0 m -61.0 89.59 0.02 OUTLIER 'General case' 0 C--N 1.354 0.783 0 CA-C-N 114.311 -1.313 . . . . 45.43 113.326 179.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 79.74 13.45 82.35 Favored Glycine 0 C--N 1.35 1.36 0 CA-C-N 115.271 -0.877 . . . . 74.33 112.967 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 88' ' ' PHE . . . . . 0.518 ' HD2' ' HA ' ' C' ' 85' ' ' PHE . 5.7 m-85 -100.8 119.77 39.13 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 107.657 -1.238 . . . . 74.44 107.657 -178.05 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 89' ' ' ASP . . . . . 0.484 ' HB3' ' HE3' ' C' ' 48' ' ' LYS . 62.7 t0 -80.19 72.21 6.99 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-O 121.647 0.737 . . . . 72.23 110.622 -176.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 90' ' ' VAL . . . . . 0.579 HG23 ' HE2' ' C' ' 97' ' ' PHE . 5.3 p -49.91 -42.53 18.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 125.416 1.486 . . . . 54.41 113.261 -176.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -66.39 -23.07 66.26 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.512 0.725 . . . . 74.21 111.575 -173.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -90.38 -19.54 23.86 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.429 0.691 . . . . 75.53 111.112 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 20.1 m-30 -77.81 178.02 7.72 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.138 0.575 . . . . 72.45 111.778 -174.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 94' ' ' SER . . . . . 0.419 ' O ' ' HB3' ' C' ' 97' ' ' PHE . 78.4 p -62.16 153.87 28.94 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.607 0.763 . . . . 45.51 112.323 -171.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 95' ' ' GLU . . . . . 0.455 ' O ' ' HG3' ' C' ' 99' ' ' GLU . 0.0 OUTLIER -68.49 -32.14 71.9 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.723 -0.671 . . . . 55.43 111.199 178.582 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -51.38 -53.1 39.84 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.131 0.972 . . . . 65.02 110.556 169.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 97' ' ' PHE . . . . . 0.579 ' HE2' HG23 ' C' ' 90' ' ' VAL . 48.6 t80 -56.6 -47.51 79.46 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-N 113.775 -1.557 . . . . 64.25 110.327 178.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -76.58 -9.21 58.49 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 114.753 -1.112 . . . . 51.52 112.988 -176.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 99' ' ' GLU . . . . . 0.455 ' HG3' ' O ' ' C' ' 95' ' ' GLU . 61.7 mt-10 -82.61 -51.31 7.87 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.211 0.604 . . . . 74.43 109.563 166.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 100' ' ' LEU . . . . . 0.425 HD13 ' CD1' ' C' ' 69' ' ' TYR . 18.7 tp -59.35 -44.84 92.62 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 114.438 -1.256 . . . . 73.23 111.911 -171.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 101' ' ' PHE . . . . . 0.436 ' HZ ' HG13 ' C' ' 56' ' ' VAL . 48.2 m-85 -105.38 11.47 32.69 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.375 0.27 . . . . 73.25 111.03 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -42.23 -64.63 1.48 Allowed Glycine 0 C--N 1.357 1.745 0 C-N-CA 124.823 1.201 . . . . 54.11 114.538 -171.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -29.93 -31.44 0.02 OUTLIER 'Trans proline' 0 C--N 1.389 2.69 1 C-N-CA 126.299 4.666 . . . . 62.02 117.266 176.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -156.83 52.67 0.41 Allowed Glycine 0 C--N 1.354 1.538 0 C-N-CA 120.934 -0.651 . . . . 43.23 113.024 179.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 105' ' ' LEU . . . . . 0.532 ' HB3' HG21 ' C' ' 90' ' ' VAL . 92.7 mt . . . . . 0 CA--C 1.579 2.065 0 N-CA-C 117.218 2.303 . . . . 73.03 117.218 177.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.637 0 N-CA-C 109.813 -1.315 . . . . 45.25 109.813 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 67.0 mtt180 -97.49 113.13 24.76 Favored 'General case' 0 C--O 1.257 1.463 0 CA-C-O 122.304 1.049 . . . . 64.44 110.903 -172.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -74.36 109.28 7.72 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 111.612 -2.54 . . . . 75.42 105.647 162.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 119' ' ' LEU . . . . . 0.629 HD12 ' HA2' ' C' ' 165' ' ' GLY . 70.0 mt -91.01 106.84 18.8 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.341 -0.391 . . . . 75.21 110.445 -162.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -90.01 94.45 9.8 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 106.604 -1.628 . . . . 72.31 106.604 -178.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 121' ' ' ALA . . . . . 0.619 ' HA ' HG23 ' B' ' 185' ' ' VAL . . . -105.44 113.8 27.6 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 109.104 -0.702 . . . . 63.21 109.104 -171.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -73.31 107.74 5.79 Favored 'General case' 0 C--O 1.244 0.775 0 N-CA-C 106.981 -1.489 . . . . 73.22 106.981 171.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -116.13 137.27 23.31 Favored Pre-proline 0 N--CA 1.474 0.756 0 CA-C-O 120.48 0.181 . . . . 73.3 111.465 -179.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.13 116.84 4.54 Favored 'Trans proline' 0 C--N 1.371 1.734 0 C-N-CA 122.984 2.456 . . . . 72.51 110.802 168.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 125' ' ' LEU . . . . . 0.484 ' HB3' HG13 ' C' ' 178' ' ' VAL . 13.6 tp -152.63 161.28 42.78 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 109.479 -0.563 . . . . 74.03 109.479 -178.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 126' ' ' THR . . . . . 0.462 ' HB ' ' HG ' ' C' ' 181' ' ' LEU . 6.2 t -125.98 175.25 7.84 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.56 0.695 . . . . 61.53 109.96 171.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 127' ' ' LEU . . . . . 0.516 HD21 HD13 ' C' ' 180' ' ' LEU . 13.6 mt -60.4 -48.52 81.41 Favored 'General case' 0 C--O 1.245 0.821 0 C-N-CA 125.55 1.54 . . . . 62.25 110.303 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 128' ' ' GLU . . . . . 0.521 ' HG3' ' HA ' ' C' ' 215' ' ' LEU . 8.5 mp0 -63.55 -33.06 74.75 Favored 'General case' 0 C--O 1.215 -0.723 0 CA-C-N 114.009 -1.45 . . . . 75.24 110.748 178.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 129' ' ' GLU . . . . . 0.413 ' HA ' ' HB2' ' C' ' 132' ' ' HIS . 19.4 mm-40 -84.65 -13.65 50.89 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.779 0.832 . . . . 73.53 111.771 178.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 130' ' ' ALA . . . . . 0.516 ' HB2' HG12 ' C' ' 153' ' ' VAL . . . -76.33 -34.61 59.0 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.876 -0.787 . . . . 64.34 108.876 170.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 131' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -70.54 -46.28 63.89 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 113.993 -1.458 . . . . 75.55 111.512 168.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 132' ' ' HIS . . . . . 0.413 ' HB2' ' HA ' ' C' ' 129' ' ' GLU . 35.8 m170 -80.65 -9.71 59.77 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 123.365 0.666 . . . . 60.22 111.02 -178.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -66.44 -120.16 0.01 OUTLIER Glycine 0 C--N 1.354 1.528 0 O-C-N 123.921 0.763 . . . . 65.31 113.371 177.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . 64.85 -103.69 0.81 Allowed Glycine 0 C--N 1.342 0.91 0 N-CA-C 110.852 -0.899 . . . . 53.24 110.852 -173.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 135' ' ' GLU . . . . . 0.71 ' HG3' ' HB2' ' C' ' 148' ' ' ARG . 2.7 mp0 -87.94 94.06 9.66 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.03 0.932 . . . . 71.2 109.277 -177.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 136' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -142.41 166.95 23.28 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.502 0.721 . . . . 72.12 110.263 -177.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 137' ' ' VAL . . . . . . . . . . . . . 17.7 m -73.89 88.66 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.1 0 CA-C-N 115.251 -0.886 . . . . 71.12 111.202 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 138' ' ' VAL . . . . . 0.53 ' O ' ' HA ' ' C' ' 144' ' ' ARG . 37.4 t -80.21 129.76 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.912 0.885 . . . . 72.14 109.819 175.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 139' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -124.95 113.73 18.21 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 108.3 -1.0 . . . . 74.31 108.3 169.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 140' ' ' VAL . . . . . 0.617 HG13 ' HB ' ' B' ' 185' ' ' VAL . 30.7 t -150.02 126.88 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.215 1.006 . . . . 63.22 108.341 167.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 65.04 32.4 10.43 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.172 0.989 . . . . 15.23 112.895 172.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 73.03 26.94 69.64 Favored Glycine 0 C--N 1.344 0.991 0 N-CA-C 111.722 -0.551 . . . . 45.25 111.722 -178.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 143' ' ' ARG . . . . . . . . . . . . . 45.2 mtp180 -115.74 96.27 5.53 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 107.539 -1.282 . . . . 73.04 107.539 171.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 144' ' ' ARG . . . . . 0.53 ' HA ' ' O ' ' C' ' 138' ' ' VAL . 29.2 ttp-105 -114.25 104.22 11.87 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 123.491 0.716 . . . . 71.51 109.539 -178.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 145' ' ' VAL . . . . . . . . . . . . . 7.7 p -150.47 146.21 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.34 0.656 . . . . 75.03 110.639 -175.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 24.7 m -77.62 88.29 3.92 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 108.601 -0.889 . . . . 54.21 108.601 171.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 11.2 p -117.18 154.44 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.656 0.782 . . . . 72.53 109.91 -173.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 148' ' ' ARG . . . . . 0.71 ' HB2' ' HG3' ' C' ' 135' ' ' GLU . 31.5 ttt85 -92.54 114.27 26.77 Favored 'General case' 0 C--O 1.242 0.669 0 O-C-N 123.801 0.688 . . . . 74.22 111.02 177.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 149' ' ' ILE . . . . . 0.449 HD12 HD13 ' C' ' 159' ' ' ILE . 26.2 pt -94.47 154.26 40.24 Favored Pre-proline 0 CA--C 1.552 1.028 0 N-CA-C 107.493 -1.299 . . . . 71.41 107.493 163.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -51.15 115.6 2.15 Favored 'Trans proline' 0 CA--C 1.565 2.038 0 C-N-CA 122.311 2.007 . . . . 61.44 111.378 174.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -61.36 113.45 1.78 Allowed 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 123.359 2.706 . . . . 73.2 111.169 -178.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 152' ' ' GLY . . . . . . . . . . . . . . . 129.28 142.15 5.24 Favored Glycine 0 C--N 1.34 0.779 0 O-C-N 123.449 0.468 . . . . 54.32 114.13 -172.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 153' ' ' VAL . . . . . 0.516 HG12 ' HB2' ' C' ' 130' ' ' ALA . 3.0 p -164.69 168.36 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.39 0 N-CA-C 112.524 0.564 . . . . 71.13 112.524 174.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 154' ' ' ARG . . . . . 0.471 ' HB3' ' HB2' ' C' ' 157' ' ' SER . 0.8 OUTLIER -125.81 169.48 12.57 Favored 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 125.806 1.642 . . . . 75.32 108.563 176.96 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 155' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -65.06 128.45 35.83 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.158 0.583 . . . . 74.51 110.289 169.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 71.82 12.0 74.19 Favored Glycine 0 C--N 1.348 1.215 0 O-C-N 123.891 0.744 . . . . 64.51 113.478 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 157' ' ' SER . . . . . 0.471 ' HB2' ' HB3' ' C' ' 154' ' ' ARG . 43.6 t -78.82 140.98 38.1 Favored 'General case' 0 C--O 1.252 1.206 0 C-N-CA 123.117 0.567 . . . . 75.43 109.903 -179.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 158' ' ' VAL . . . . . 0.477 HG23 ' HB3' ' C' ' 175' ' ' LEU . 5.4 p -108.78 96.94 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 O-C-N 125.077 1.485 . . . . 64.44 108.956 -174.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 159' ' ' ILE . . . . . 0.616 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 56.4 mt -78.41 111.45 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 108.687 -0.857 . . . . 52.25 108.687 178.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 26.4 ttt180 -85.58 107.94 17.73 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 108.826 -0.805 . . . . 72.21 108.826 173.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 161' ' ' VAL . . . . . . . . . . . . . 2.2 t -98.17 105.66 30.0 Favored Pre-proline 0 CA--C 1.557 1.228 0 N-CA-C 106.219 -1.771 . . . . 75.24 106.219 171.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -64.68 132.02 31.43 Favored 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 123.512 2.808 . . . . 63.42 113.042 -171.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 64.83 19.57 65.52 Favored Glycine 0 C--N 1.347 1.194 0 O-C-N 124.01 0.819 . . . . 53.31 113.348 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 164' ' ' MET . . . . . . . . . . . . . 31.8 mmm -110.08 -2.48 16.96 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.583 0.753 . . . . 73.35 111.753 -178.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 165' ' ' GLY . . . . . 0.629 ' HA2' HD12 ' C' ' 119' ' ' LEU . . . -89.5 -111.87 1.33 Allowed Glycine 0 C--N 1.347 1.162 0 N-CA-C 108.293 -1.923 . . . . 64.24 108.293 164.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . -156.78 118.11 0.82 Allowed Glycine 0 C--N 1.335 0.498 0 C-N-CA 120.692 -0.766 . . . . 75.44 111.831 161.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 167' ' ' GLN . . . . . 0.556 ' HA ' ' HA ' ' C' ' 171' ' ' PRO . 15.0 mm-40 -71.23 101.9 2.42 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 107.792 -1.188 . . . . 64.31 107.792 175.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . -115.77 -125.5 3.88 Favored Glycine 0 N--CA 1.467 0.758 0 N-CA-C 110.275 -1.13 . . . . 13.44 110.275 178.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 169' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -61.41 -67.19 1.15 Allowed Pre-proline 0 CA--C 1.574 1.865 0 CA-C-N 117.956 0.878 . . . . 62.44 110.562 175.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 170' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -93.94 113.82 0.22 Allowed 'Trans proline' 0 C--N 1.393 2.878 0 CA-C-N 122.107 1.788 . . . . 51.41 109.143 163.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 171' ' ' PRO . . . . . 0.556 ' HA ' ' HA ' ' C' ' 167' ' ' GLN . 6.5 Cg_exo -33.87 131.78 0.15 Allowed 'Trans proline' 0 C--N 1.372 1.763 0 C-N-CA 124.609 3.54 . . . . 74.02 115.514 -178.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 172' ' ' GLY . . . . . 0.549 ' H ' ' HA ' ' C' ' 167' ' ' GLN . . . -120.85 115.93 3.04 Favored Glycine 0 C--N 1.341 0.828 0 N-CA-C 110.968 -0.853 . . . . 74.42 110.968 -171.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 173' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -107.75 158.9 16.91 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 108.512 -0.921 . . . . 74.51 108.512 175.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 174' ' ' LEU . . . . . 0.442 HD11 HG21 ' C' ' 140' ' ' VAL . 9.8 tp -81.41 107.56 14.29 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 109.739 -0.467 . . . . 75.22 109.739 -177.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 175' ' ' LEU . . . . . 0.477 ' HB3' HG23 ' C' ' 158' ' ' VAL . 78.6 mt -95.12 82.22 3.75 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.43 1.092 . . . . 71.32 110.084 179.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 176' ' ' LEU . . . . . 0.616 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 75.7 mt -68.4 100.76 1.12 Allowed 'General case' 0 CA--C 1.546 0.804 0 CA-C-O 121.022 0.439 . . . . 43.02 110.86 178.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 177' ' ' VAL . . . . . . . . . . . . . 61.0 t -85.53 101.57 10.11 Favored 'Isoleucine or valine' 0 C--O 1.244 0.784 0 C-N-CA 124.147 0.979 . . . . 74.43 108.398 176.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 178' ' ' VAL . . . . . 0.484 HG13 ' HB3' ' C' ' 125' ' ' LEU . 52.1 t -84.93 135.82 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 N-CA-C 112.538 0.57 . . . . 74.01 112.538 -174.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 179' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -110.76 113.27 25.73 Favored 'General case' 0 C--O 1.254 1.33 0 C-N-CA 124.981 1.312 . . . . 72.33 108.436 169.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 180' ' ' LEU . . . . . 0.516 HD13 HD21 ' C' ' 127' ' ' LEU . 91.8 mt -76.53 153.76 35.15 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 124.572 1.149 . . . . 70.51 111.445 178.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 181' ' ' LEU . . . . . 0.462 ' HG ' ' HB ' ' C' ' 126' ' ' THR . 8.2 mt -65.73 168.4 8.75 Favored Pre-proline 0 N--CA 1.49 1.553 0 C-N-CA 123.105 0.562 . . . . 74.2 110.892 -179.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -60.45 70.07 0.07 OUTLIER 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 122.482 2.121 . . . . 64.12 110.793 160.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 183' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -160.44 62.39 1.73 Allowed Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 106.753 -1.573 . . . . 62.13 106.753 -167.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 184' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -85.34 64.53 5.97 Favored 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 123.03 2.486 . . . . 71.54 111.217 -170.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 185' ' ' VAL . . . . . 0.618 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 18.1 t -95.55 -56.42 5.22 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.905 0 N-CA-C 107.826 -1.176 . . . . 72.23 107.826 -173.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 186' ' ' PHE . . . . . 0.478 ' HD1' ' HB2' ' C' ' 195' ' ' ALA . 33.9 m-85 -114.8 153.66 29.99 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.56 0.744 . . . . 61.44 110.832 -174.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 187' ' ' ARG . . . . . . . . . . . . . 7.5 mtm180 -143.42 115.74 8.5 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.569 1.148 . . . . 75.14 108.772 175.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 188' ' ' LEU . . . . . 0.536 HD13 ' HD2' ' C' ' 240' ' ' PHE . 55.6 tp -77.48 143.27 38.63 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.973 0.731 . . . . 74.14 112.973 -171.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -141.76 105.22 4.67 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 107.14 -1.429 . . . . 71.33 107.14 166.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 74.32 -101.06 1.21 Allowed Glycine 0 CA--C 1.536 1.37 0 N-CA-C 111.885 -0.486 . . . . 74.2 111.885 -175.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 191' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -123.14 -5.13 8.41 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 124.246 1.018 . . . . 60.21 110.744 172.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -101.92 140.14 36.61 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.299 0.64 . . . . 65.13 110.088 -174.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 193' ' ' LEU . . . . . 0.434 HD21 ' CE2' ' C' ' 240' ' ' PHE . 82.0 mt -99.39 153.24 19.14 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.558 0.743 . . . . 52.2 111.273 -174.134 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 194' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -113.73 107.27 15.52 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 107.418 -1.327 . . . . 75.43 107.418 168.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 195' ' ' ALA . . . . . 0.618 ' HA ' ' O ' ' C' ' 185' ' ' VAL . . . -105.09 -178.59 3.7 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.164 0.586 . . . . 65.11 110.119 175.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 26.0 m -142.35 99.33 3.48 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 107.457 -1.312 . . . . 51.32 107.457 171.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 197' ' ' LEU . . . . . 0.446 HD13 ' HB2' ' C' ' 212' ' ' ALA . 25.7 tp -80.44 121.31 25.58 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.773 -0.649 . . . . 73.5 111.013 -171.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -74.51 100.1 3.78 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 108.166 -1.05 . . . . 44.52 108.166 175.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 199' ' ' VAL . . . . . . . . . . . . . 58.5 t -111.32 117.69 48.97 Favored Pre-proline 0 N--CA 1.474 0.731 0 N-CA-C 108.23 -1.026 . . . . 61.21 108.23 178.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 200' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -72.17 143.96 40.95 Favored 'Trans proline' 0 C--N 1.369 1.625 0 C-N-CA 121.727 1.618 . . . . 71.34 109.81 174.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 201' ' ' ALA . . . . . 0.43 ' N ' ' HD2' ' C' ' 202' ' ' PRO . . . -55.0 -44.28 99.52 Favored Pre-proline 0 CA--C 1.552 1.058 0 N-CA-C 114.119 1.155 . . . . 74.35 114.119 -173.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 202' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' C' ' 201' ' ' ALA . 17.3 Cg_endo -55.29 -46.99 28.51 Favored 'Trans proline' 0 C--N 1.393 2.906 0 C-N-CA 121.883 1.722 . . . . 63.15 112.67 176.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 203' ' ' ILE . . . . . 0.471 ' HA ' HG12 ' C' ' 206' ' ' VAL . 48.0 mt -68.18 -37.52 78.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.14 0.576 . . . . 63.4 110.871 -178.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 204' ' ' ALA . . . . . 0.434 ' HA ' HG11 ' C' ' 223' ' ' VAL . . . -58.53 -44.13 89.44 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.477 0.711 . . . . 75.02 111.338 176.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 205' ' ' VAL . . . . . 0.503 ' HA ' ' HA ' ' C' ' 226' ' ' ARG . 81.7 t -72.74 -42.65 61.87 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 115.156 -0.929 . . . . 63.41 111.786 -177.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 206' ' ' VAL . . . . . 0.676 HG23 ' HG3' ' A' ' 270' ' ' LYS . 11.3 p -77.05 -29.38 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 CA-C-O 120.676 0.274 . . . . 52.12 110.74 -174.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 77.18 51.91 5.93 Favored Glycine 0 C--N 1.341 0.826 0 N-CA-C 110.634 -0.987 . . . . 63.21 110.634 -171.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -91.78 -120.37 2.55 Favored Glycine 0 C--N 1.344 1.026 0 N-CA-C 111.246 -0.741 . . . . 51.32 111.246 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 209' ' ' LYS . . . . . 0.58 ' HG2' ' HG2' ' C' ' 220' ' ' GLU . 34.6 ttmt -151.72 133.17 14.64 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.619 0.723 . . . . 72.12 111.208 -178.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 210' ' ' VAL . . . . . . . . . . . . . 26.8 m -115.16 -175.28 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 126.596 1.958 . . . . 62.05 108.091 174.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 211' ' ' ARG . . . . . 0.473 ' HD3' ' HB2' ' C' ' 218' ' ' PRO . 36.9 ttm105 -142.85 127.99 18.61 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 118.236 0.471 . . . . 72.44 111.908 -178.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 212' ' ' ALA . . . . . 0.446 ' HB2' HD13 ' C' ' 197' ' ' LEU . . . -101.68 113.49 26.7 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 108.039 -1.097 . . . . 74.43 108.039 168.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 213' ' ' MET . . . . . 0.468 ' HA ' ' HA ' ' C' ' 218' ' ' PRO . 2.9 ttp -69.73 105.87 2.89 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 107.86 -1.163 . . . . 63.12 107.86 174.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 214' ' ' THR . . . . . 0.549 ' OG1' HG12 ' C' ' 219' ' ' VAL . 0.2 OUTLIER -101.02 175.63 5.53 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.506 0.669 . . . . 54.24 110.243 -173.144 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 215' ' ' LEU . . . . . 0.521 ' HA ' ' HG3' ' C' ' 128' ' ' GLU . 9.2 mt -63.0 -41.14 99.5 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.711 1.604 . . . . 44.41 111.326 -175.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -92.77 0.33 57.4 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 114.32 -1.309 . . . . 71.0 111.15 -177.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 134.36 162.65 9.98 Favored Glycine 0 C--N 1.343 0.931 0 N-CA-C 111.669 -0.572 . . . . 64.11 111.669 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 218' ' ' PRO . . . . . 0.473 ' HB2' ' HD3' ' C' ' 211' ' ' ARG . 59.9 Cg_endo -70.04 107.88 2.01 Favored 'Trans proline' 0 CA--C 1.555 1.575 0 C-N-CA 122.708 2.272 . . . . 52.13 112.952 -178.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 219' ' ' VAL . . . . . 0.604 HG23 HG22 ' B' ' 238' ' ' THR . 7.3 p -80.71 120.85 33.12 Favored 'Isoleucine or valine' 0 C--N 1.355 0.832 0 N-CA-C 107.664 -1.236 . . . . 52.53 107.664 174.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 220' ' ' GLU . . . . . 0.58 ' HG2' ' HG2' ' C' ' 209' ' ' LYS . 16.3 tt0 -92.75 103.79 16.12 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 107.583 -1.266 . . . . 72.32 107.583 -179.059 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 221' ' ' VAL . . . . . . . . . . . . . 60.8 t -85.88 123.29 39.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 113.534 -1.666 . . . . 74.03 112.319 -165.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 222' ' ' ALA . . . . . 0.427 ' HB3' ' HD3' ' B' ' 245' ' ' LYS . . . -74.84 143.56 43.85 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.311 0.644 . . . . 73.3 110.508 173.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 223' ' ' VAL . . . . . 0.434 HG11 ' HA ' ' C' ' 204' ' ' ALA . 98.0 t -116.62 138.11 24.22 Favored Pre-proline 0 N--CA 1.485 1.299 0 C-N-CA 124.316 1.047 . . . . 73.11 109.512 -174.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 224' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -78.74 156.02 27.43 Favored 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 123.279 2.653 . . . . 54.33 111.488 170.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.48 124.46 16.31 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 123.346 2.697 . . . . 74.0 113.137 -175.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 226' ' ' ARG . . . . . 0.503 ' HA ' ' HA ' ' C' ' 205' ' ' VAL . 0.0 OUTLIER 58.53 90.87 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.62 1.568 . . . . 70.15 112.378 -179.495 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 227' ' ' THR . . . . . 0.548 HG22 HG11 ' C' ' 253' ' ' VAL . 21.6 m -110.03 127.96 55.13 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 114.817 -1.083 . . . . 70.3 111.378 179.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 228' ' ' GLN . . . . . 0.773 HE21 HD11 ' A' ' 257' ' ' ILE . 0.8 OUTLIER -96.54 153.52 17.8 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.11 0.964 . . . . 74.32 111.859 -179.596 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 229' ' ' ALA . . . . . 0.49 ' HB2' ' H ' ' C' ' 255' ' ' ILE . . . -70.45 134.01 47.38 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 114.681 -1.145 . . . . 62.12 109.69 173.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 110.45 -19.28 26.77 Favored Glycine 0 C--N 1.339 0.702 0 O-C-N 123.613 0.571 . . . . 62.04 112.088 -173.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 231' ' ' ARG . . . . . 0.543 ' NH1' ' HA ' ' C' ' 227' ' ' THR . 71.3 mtt180 -65.78 174.9 2.13 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 117.138 0.469 . . . . 74.12 111.46 173.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 232' ' ' LYS . . . . . 0.444 ' HA ' ' O ' ' C' ' 251' ' ' LEU . 30.2 ttmt -142.85 145.71 33.42 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 121.206 0.527 . . . . 71.45 111.525 -178.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 233' ' ' LEU . . . . . 0.728 HD13 ' HB2' ' C' ' 251' ' ' LEU . 1.7 mp -113.26 145.33 41.2 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.815 1.246 . . . . 74.21 108.412 178.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 234' ' ' ARG . . . . . 0.676 ' HG3' ' HG3' ' B' ' 241' ' ' GLU . 9.2 ptp85 -120.29 95.06 4.59 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 121.957 0.884 . . . . 72.34 109.432 169.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 235' ' ' LEU . . . . . 0.577 ' HA ' ' HA3' ' B' ' 240' ' ' GLY . 26.0 mt -84.67 107.66 16.99 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.611 -0.722 . . . . 73.43 109.324 178.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -69.07 122.99 19.85 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 123.627 0.771 . . . . 71.55 111.483 -174.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 76.54 32.56 50.6 Favored Glycine 0 C--N 1.344 0.994 0 O-C-N 124.199 0.937 . . . . 71.42 113.192 178.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 33.5 mmtm -123.83 14.99 9.34 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.821 0.848 . . . . 72.03 111.209 175.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -91.62 -147.39 20.02 Favored Glycine 0 C--N 1.353 1.477 0 N-CA-C 111.178 -0.769 . . . . 31.21 111.178 170.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 240' ' ' PHE . . . . . 0.536 ' HD2' HD13 ' C' ' 188' ' ' LEU . 39.9 m-85 -94.56 142.12 24.36 Favored Pre-proline 0 N--CA 1.482 1.141 0 CA-C-N 117.572 0.686 . . . . 75.14 111.302 178.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 241' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' C' ' 240' ' ' PHE . 3.3 Cg_exo -76.65 113.99 3.76 Favored 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 123.837 3.025 . . . . 70.21 113.69 -172.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -96.78 159.96 21.65 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-O 119.015 -0.88 . . . . 70.14 111.396 170.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.58 -13.43 37.27 Favored 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 122.781 2.32 . . . . 71.42 112.857 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -103.25 -16.71 15.6 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.515 0.726 . . . . 71.42 110.935 174.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 157.88 158.41 8.96 Favored Glycine 0 C--N 1.356 1.641 0 O-C-N 123.119 0.262 . . . . 51.32 113.702 177.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 246' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -73.65 152.62 40.44 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.804 0.842 . . . . 61.31 110.22 174.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.44 -164.69 22.9 Favored Glycine 0 C--N 1.346 1.112 0 O-C-N 123.702 0.626 . . . . 63.23 112.004 173.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -119.72 154.48 34.06 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 108.877 -0.786 . . . . 73.54 108.877 -178.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 249' ' ' LEU . . . . . 0.561 HD23 HD12 ' C' ' 235' ' ' LEU . 19.0 tp -99.61 109.24 21.76 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.637 -0.71 . . . . 74.23 109.284 175.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 250' ' ' TYR . . . . . 0.593 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 20.2 m-85 -99.44 100.36 11.39 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 109.236 -0.653 . . . . 71.43 109.236 178.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 251' ' ' LEU . . . . . 0.728 ' HB2' HD13 ' C' ' 233' ' ' LEU . 0.8 OUTLIER -100.4 140.37 34.74 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.232 -0.655 . . . . 64.53 109.232 -176.716 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -89.54 128.43 36.01 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 108.225 -1.028 . . . . 73.41 108.225 168.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 253' ' ' VAL . . . . . 0.548 HG11 HG22 ' C' ' 227' ' ' THR . 80.0 t -67.97 131.97 32.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 123.641 0.776 . . . . 73.5 110.25 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 254' ' ' ARG . . . . . 0.416 HH11 ' HB3' ' C' ' 254' ' ' ARG . 0.0 OUTLIER -126.72 93.06 3.67 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.354 -1.351 . . . . 74.13 107.354 179.226 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 255' ' ' ILE . . . . . 0.49 ' H ' ' HB2' ' C' ' 229' ' ' ALA . 49.8 mm -73.11 127.49 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 O-C-N 123.853 0.721 . . . . 75.24 109.788 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 256' ' ' THR . . . . . 0.559 ' HA ' HD12 ' A' ' 255' ' ' ILE . 1.7 t -144.73 171.04 14.97 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 124.412 1.07 . . . . 53.32 110.396 -171.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 257' ' ' ILE . . . . . 0.467 HD12 ' H ' ' C' ' 259' ' ' GLU . 2.7 pp -132.59 148.31 69.06 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 123.735 0.814 . . . . 64.54 109.398 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 258' ' ' PRO . . . . . 0.518 ' HG3' ' HE2' ' A' ' 276' ' ' TYR . 98.5 Cg_endo -74.53 11.14 1.37 Allowed 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 123.323 2.682 . . . . 73.21 114.277 -172.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 259' ' ' GLU . . . . . 0.476 ' HG3' HE21 ' A' ' 228' ' ' GLN . 18.0 mt-10 62.1 -80.64 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 125.194 1.398 . . . . 72.3 111.101 -171.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 2.8 ptp85 -77.87 143.89 37.41 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.518 1.527 . . . . 73.41 110.928 -173.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 261' ' ' LEU . . . . . . . . . . . . . 75.3 mt -141.7 169.98 16.58 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.046 0.938 . . . . 71.21 110.107 -177.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 23.9 p -84.04 152.02 61.37 Favored Pre-proline 0 CA--C 1.552 1.024 0 N-CA-C 107.765 -1.198 . . . . 61.23 107.765 169.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -48.12 -34.64 24.24 Favored 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 123.173 2.582 . . . . 74.2 113.9 176.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.52 -56.14 9.36 Favored 'General case' 0 C--O 1.268 2.037 0 C-N-CA 124.249 1.019 . . . . 71.04 110.624 -178.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 265' ' ' GLU . . . . . 0.46 ' CD ' HH22 ' A' ' 279' ' ' ARG . 40.7 mm-40 -51.16 -55.09 19.66 Favored 'General case' 0 C--N 1.359 1.002 0 CA-C-N 114.953 -1.021 . . . . 65.11 110.359 175.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 266' ' ' GLU . . . . . 0.483 ' O ' ' HG2' ' C' ' 270' ' ' LYS . 30.8 tt0 -61.15 -31.46 71.18 Favored 'General case' 0 C--O 1.217 -0.652 0 CA-C-N 114.186 -1.37 . . . . 64.21 111.39 -175.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -60.76 -45.15 95.46 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 123.461 0.475 . . . . 70.32 110.866 174.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 268' ' ' LEU . . . . . 0.536 ' HA ' ' HE2' ' C' ' 271' ' ' LYS . 11.2 mp -64.18 -42.32 96.74 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 116.202 -0.454 . . . . 52.44 111.465 174.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -65.12 -25.36 67.73 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 122.797 0.439 . . . . 61.11 111.296 175.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 270' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' C' ' 266' ' ' GLU . 13.2 mmmm -67.93 -49.66 60.53 Favored 'General case' 0 C--N 1.363 1.175 0 C-N-CA 122.837 0.455 . . . . 75.43 109.867 175.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 271' ' ' LYS . . . . . 0.536 ' HE2' ' HA ' ' C' ' 268' ' ' LEU . 52.7 mtmt -57.62 -44.72 85.72 Favored 'General case' 0 N--CA 1.484 1.243 0 O-C-N 123.688 0.618 . . . . 75.33 111.294 178.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 88.3 mt -62.08 -41.41 98.16 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.237 0.615 . . . . 74.33 111.189 175.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -64.83 -45.35 86.56 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 115.573 -0.74 . . . . 34.13 111.545 -177.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -70.26 -32.42 70.24 Favored 'General case' 0 C--O 1.242 0.667 0 O-C-N 124.142 0.901 . . . . 63.21 110.62 -178.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -61.82 -34.13 75.39 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.684 -0.689 . . . . 70.04 110.678 170.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 276' ' ' TYR . . . . . 0.566 ' HB3' HD11 ' A' ' 203' ' ' ILE . 10.0 m-85 -83.49 -25.48 31.07 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 113.047 0.758 . . . . 75.52 113.047 174.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 20.3 m-30 -72.81 -21.23 61.01 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 118.524 0.602 . . . . 44.24 109.933 176.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -61.81 -3.6 1.2 Allowed 'General case' 0 CA--C 1.558 1.266 0 CA-C-N 115.02 -0.991 . . . . 55.2 112.821 169.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 279' ' ' ARG . . . . . . . . . . . . . 81.7 mtt180 -72.7 -14.12 61.5 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.255 0.622 . . . . 71.52 112.441 171.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.257 0 C-N-CA 124.452 1.101 . . . . 75.14 112.683 -175.924 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt . . . . . 0 N--CA 1.472 0.627 0 N-CA-C 113.072 0.768 . . . . 62.43 113.072 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.48 ' HE3' ' HB3' ' A' ' 94' ' ' SER . 94.6 mttt -70.84 133.08 46.19 Favored 'General case' 0 C--O 1.244 0.766 0 N-CA-C 108.917 -0.772 . . . . 74.32 108.917 166.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -75.44 86.74 2.58 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 106.388 -1.708 . . . . 61.41 106.388 168.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -60.62 -34.67 74.59 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-N 115.002 -0.999 . . . . 73.34 111.231 -173.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.418 ' HE1' HD11 ' A' ' 22' ' ' ILE . 88.9 m-85 -62.56 -45.02 94.87 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.517 -0.765 . . . . 73.33 110.713 175.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.81 -42.84 99.52 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.871 0.468 . . . . 60.32 111.254 178.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.407 HD11 ' HB3' ' A' ' 5' ' ' LYS . 71.3 mt -55.88 -45.13 79.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 C-N-CA 123.508 0.723 . . . . 74.23 110.311 177.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.662 HD13 HG23 ' A' ' 22' ' ' ILE . 83.1 mt -69.43 -29.87 67.68 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 115.898 -0.592 . . . . 51.33 111.674 175.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.3 46.54 5.24 Favored Glycine 0 C--N 1.344 0.995 0 CA-C-O 120.946 0.192 . . . . 53.33 112.737 -173.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.528 HG13 ' HB2' ' A' ' 25' ' ' ALA . 3.1 m -141.5 154.76 67.06 Favored Pre-proline 0 N--CA 1.483 1.204 0 C-N-CA 125.166 1.387 . . . . 71.43 109.615 178.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -69.07 165.7 29.26 Favored 'Trans proline' 0 N--CA 1.502 1.994 0 C-N-CA 123.239 2.626 . . . . 50.12 113.328 178.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -73.68 14.23 0.39 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 113.855 1.057 . . . . 75.43 113.855 -172.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -135.74 19.97 3.3 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 108.954 -0.758 . . . . 64.11 108.954 175.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.36 121.96 15.56 Favored 'General case' 0 C--N 1.343 0.291 0 CA-C-N 115.095 -0.957 . . . . 64.31 110.137 178.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 39.9 p -76.88 171.13 15.25 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.554 -0.748 . . . . 71.11 110.166 175.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 15.9 mp0 -53.54 -28.98 34.57 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 124.399 1.08 . . . . 64.21 112.359 -177.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -71.95 -48.0 48.37 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.017 0.927 . . . . 72.43 110.869 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -63.88 -41.97 97.6 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 121.742 0.782 . . . . 64.03 110.493 178.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.662 HG23 HD13 ' A' ' 11' ' ' LEU . 74.9 mt -68.07 -32.07 54.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 114.093 -1.412 . . . . 73.31 111.174 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -70.53 -35.97 73.46 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.463 0.705 . . . . 71.24 110.907 175.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 45.9 mtm105 -61.94 -50.85 70.48 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 109.68 -0.489 . . . . 54.12 109.68 173.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.528 ' HB2' HG13 ' A' ' 13' ' ' VAL . . . -62.08 -37.66 85.88 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 114.891 -1.05 . . . . 64.0 111.764 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -60.26 -64.21 1.03 Allowed 'General case' 0 C--O 1.207 -1.142 0 CA-C-N 114.831 -1.077 . . . . 73.1 109.362 176.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -55.15 -30.5 59.97 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 124.167 0.917 . . . . 74.22 112.021 -177.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.47 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 50.2 ttp180 -59.46 -67.98 0.32 Allowed 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.567 -0.531 . . . . 71.15 109.567 172.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.633 ' HB3' HD13 ' A' ' 50' ' ' ILE . 91.8 mt -70.9 -14.34 62.35 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.171 0.588 . . . . 74.11 112.171 -175.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.638 ' HA ' ' HE1' ' A' ' 47' ' ' PHE . . . -82.96 -38.66 22.43 Favored 'General case' 0 C--O 1.206 -1.229 0 C-N-CA 123.695 0.798 . . . . 63.3 109.864 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.0 mtm180 -78.98 -33.41 45.11 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 122.497 0.319 . . . . 72.33 110.692 176.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.47 ' HG2' ' O ' ' A' ' 28' ' ' ARG . 15.1 mm100 -67.46 -62.44 1.42 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 122.962 0.505 . . . . 63.33 110.44 177.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.452 ' HE2' HD22 ' A' ' 29' ' ' LEU . 21.7 m-85 -94.83 31.39 1.84 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.288 0.635 . . . . 63.25 110.941 -176.027 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -61.5 105.65 0.65 Allowed Pre-proline 0 N--CA 1.482 1.16 0 C-N-CA 123.877 0.871 . . . . 63.41 109.983 -178.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.65 -14.53 36.56 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.423 2.082 . . . . 74.13 111.444 -172.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -62.65 -37.48 86.53 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.399 1.08 . . . . 72.45 111.065 173.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 46.7 t -104.58 -51.64 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 CA-C-O 121.356 0.598 . . . . 65.53 109.862 -178.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -99.12 86.13 3.38 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.552 1.141 . . . . 61.35 110.72 -177.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.4 mtmp? -85.78 61.06 6.61 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.352 0.596 . . . . 73.11 110.402 176.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 66.4 m -107.13 110.58 63.46 Favored Pre-proline 0 N--CA 1.476 0.845 0 CA-C-O 118.176 -0.916 . . . . 54.41 109.202 176.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.421 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 2.8 Cg_endo -38.07 -53.62 1.57 Allowed 'Trans proline' 0 C--N 1.393 2.911 0 C-N-CA 124.941 3.761 . . . . 72.23 114.151 -172.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -47.43 -52.9 15.54 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 124.657 1.183 . . . . 64.43 112.005 177.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.58 -24.89 63.75 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 114.599 -1.182 . . . . 72.14 111.244 -176.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -85.03 -36.46 21.24 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.753 0.821 . . . . 62.01 110.84 -175.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 41' ' ' PRO . 28.0 mm-40 -68.74 -47.73 65.53 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 108.854 -0.795 . . . . 62.44 108.854 177.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 49.4 mttp -65.87 -33.15 75.18 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 114.856 -1.065 . . . . 74.03 111.38 175.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.638 ' HE1' ' HA ' ' A' ' 30' ' ' ALA . 88.2 t80 -58.6 -44.64 89.94 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.051 0.54 . . . . 73.24 110.292 173.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.534 ' HB3' ' HE1' ' A' ' 93' ' ' PHE . 48.5 mtmt -62.45 -39.54 93.7 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.258 -0.428 . . . . 75.14 111.055 177.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -65.4 -28.7 69.44 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.044 0.45 . . . . 71.44 111.926 176.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.633 HD13 ' HB3' ' A' ' 29' ' ' LEU . 68.2 mt -73.86 -32.9 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.516 0.726 . . . . 70.53 109.834 173.088 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.413 ' O ' ' HB2' ' A' ' 55' ' ' ALA . 25.9 m-80 -81.19 -14.7 57.3 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.541 0.736 . . . . 73.43 111.3 174.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -73.68 -55.56 6.11 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.82 1.248 . . . . 63.42 108.484 170.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.76 -51.47 65.6 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 113.448 -1.705 . . . . 65.45 110.707 175.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -60.82 -45.91 92.59 Favored 'General case' 0 C--O 1.21 -0.984 0 CA-C-N 114.936 -1.029 . . . . 72.32 110.649 177.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 51' ' ' ASN . . . -52.64 -52.58 54.93 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.355 0.662 . . . . 53.01 112.246 -177.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 97.3 t -61.11 -49.44 84.64 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 O-C-N 124.201 0.938 . . . . 74.52 109.782 178.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.538 ' HB3' HD13 ' A' ' 22' ' ' ILE . 69.5 mt -87.75 -6.82 58.0 Favored 'General case' 0 CA--C 1.56 1.335 0 N-CA-C 114.6 1.333 . . . . 62.04 114.6 -168.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.2 t -79.83 -32.63 40.65 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 123.268 0.627 . . . . 74.34 110.694 -177.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -100.55 129.43 27.78 Favored Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 108.296 -1.002 . . . . 74.34 108.296 -176.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.82 -40.18 86.33 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 123.297 2.665 . . . . 72.41 113.499 -172.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.422 ' O ' HG13 ' A' ' 65' ' ' ILE . 13.0 mp0 -64.77 -56.09 15.71 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.055 0.942 . . . . 72.3 110.067 -178.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.463 ' HA ' HD12 ' A' ' 65' ' ' ILE . 44.3 mtpt -65.11 -36.49 84.44 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.838 0.855 . . . . 74.54 111.65 -176.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 54.2 ttt180 -56.91 -49.98 73.93 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 124.051 0.844 . . . . 74.11 108.967 174.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -69.73 -25.27 63.76 Favored 'General case' 0 C--O 1.214 -0.814 0 CA-C-N 115.091 -0.959 . . . . 74.25 112.354 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.555 HG12 ' HG2' ' A' ' 76' ' ' PRO . 85.1 mt -61.14 -48.08 90.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 108.763 -0.828 . . . . 64.42 108.763 172.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -58.03 -58.26 9.22 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 115.414 -0.812 . . . . 75.4 110.774 173.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -58.13 -38.47 76.6 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.415 1.086 . . . . 64.04 112.381 -172.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 73.1 p -76.14 -33.1 59.4 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 118.935 -0.555 . . . . 75.13 110.459 178.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -63.46 120.71 12.2 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-N 118.535 0.607 . . . . 63.45 109.915 -176.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 107.61 5.61 33.79 Favored Glycine 0 CA--C 1.54 1.597 0 C-N-CA 123.443 0.544 . . . . 52.54 112.034 -166.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 91.4 m -146.53 -57.7 0.28 Allowed 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 104.583 -2.377 . . . . 71.23 104.583 175.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 96.4 m -79.14 149.14 32.11 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 105.277 -2.12 . . . . 74.23 105.277 155.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.58 -17.77 3.23 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 122.863 0.465 . . . . 74.04 111.942 -171.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -101.98 140.96 21.63 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 123.42 0.688 . . . . 75.1 109.666 177.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.13 126.85 13.53 Favored 'Trans proline' 0 C--N 1.374 1.884 0 C-N-CA 122.803 2.335 . . . . 75.41 112.322 177.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.555 ' HG2' HG12 ' A' ' 65' ' ' ILE . 71.4 Cg_exo -53.7 149.28 32.92 Favored 'Trans proline' 0 C--N 1.385 2.495 0 C-N-CA 123.751 2.967 . . . . 74.25 113.419 177.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -55.36 136.83 75.42 Favored 'Trans proline' 0 C--N 1.383 2.39 0 C-N-CA 122.941 2.427 . . . . 62.44 112.181 -176.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -61.27 126.02 18.34 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.907 2.404 . . . . 43.51 112.796 -178.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -58.09 157.95 23.41 Favored 'Trans proline' 0 C--N 1.382 2.328 0 C-N-CA 123.415 2.743 . . . . 71.05 113.038 173.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.548 ' HD2' ' HA3' ' A' ' 142' ' ' GLY . 79.8 Cg_exo -48.78 82.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.388 2.64 0 C-N-CA 124.648 3.565 . . . . 51.35 115.42 178.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 136.84 -39.55 1.62 Allowed Glycine 0 N--CA 1.467 0.766 0 N-CA-C 109.881 -1.287 . . . . 62.41 109.881 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 144.61 -176.89 23.5 Favored Glycine 0 C--N 1.344 0.982 0 C-N-CA 124.237 0.922 . . . . 53.03 110.969 176.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -58.79 98.47 0.04 OUTLIER 'General case' 0 C--O 1.243 0.738 0 N-CA-C 107.604 -1.258 . . . . 74.41 107.604 164.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -64.8 110.68 2.49 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.51 0.671 . . . . 71.31 109.307 -173.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.417 ' H ' ' HE2' ' A' ' 106' ' ' PHE . 23.0 t80 -133.05 23.9 4.2 Favored 'General case' 0 C--O 1.259 1.567 0 C-N-CA 124.862 1.265 . . . . 70.22 108.664 -168.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.457 ' HA ' ' CG ' ' A' ' 171' ' ' PRO . 73.4 m -58.5 146.28 36.0 Favored 'General case' 0 C--N 1.349 0.559 0 CA-C-N 113.986 -1.461 . . . . 74.44 112.279 -171.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.456 ' H ' ' HG2' ' A' ' 171' ' ' PRO . . . 79.73 -9.08 45.97 Favored Glycine 0 CA--C 1.536 1.382 0 CA-C-O 118.803 -0.998 . . . . 70.11 114.629 -176.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.429 ' HB3' ' HE2' ' A' ' 93' ' ' PHE . 51.8 m-85 -112.74 142.63 45.13 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 119.383 1.591 . . . . 72.34 112.575 -176.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -82.42 75.89 9.31 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 124.149 0.98 . . . . 71.44 111.126 -172.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.601 HG23 ' HE2' ' A' ' 97' ' ' PHE . 2.5 p -39.4 -48.55 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.62 0 C-N-CA 125.787 1.635 . . . . 75.21 113.904 176.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.17 -36.52 70.88 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 124.157 0.983 . . . . 75.33 112.195 -176.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -72.69 -31.7 65.23 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.949 -0.568 . . . . 45.35 110.902 -175.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.534 ' HE1' ' HB3' ' A' ' 48' ' ' LYS . 15.4 m-30 -80.05 174.71 11.32 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.905 -0.589 . . . . 71.01 111.939 -164.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.48 ' HB3' ' HE3' ' A' ' 5' ' ' LYS . 78.7 p -57.1 149.41 19.47 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.808 0.843 . . . . 74.5 113.129 -168.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.16 -39.61 72.59 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 114.839 -1.073 . . . . 74.31 110.084 168.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -54.49 -47.25 73.26 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.384 1.074 . . . . 75.03 110.896 176.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.601 ' HE2' HG23 ' A' ' 90' ' ' VAL . 44.3 t80 -59.42 -50.07 75.35 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 115.338 -0.847 . . . . 63.23 110.092 175.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -76.31 -2.18 30.36 Favored 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 112.403 0.52 . . . . 73.05 112.403 -175.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -93.94 -59.3 2.01 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.652 0.781 . . . . 70.02 110.191 169.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 33.4 tp -62.46 -46.18 89.68 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.979 0.912 . . . . 55.03 111.24 -176.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.407 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 82.4 m-85 -92.75 -3.65 54.44 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.104 0.562 . . . . 72.11 111.477 177.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -46.35 -57.73 6.28 Favored Glycine 0 CA--C 1.544 1.87 0 CA-C-O 118.988 -0.895 . . . . 72.43 115.195 177.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -68.21 11.51 0.26 Allowed 'Trans proline' 0 C--N 1.382 2.317 0 C-N-CA 123.637 2.891 . . . . 23.1 114.635 -178.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -147.05 16.5 1.54 Allowed Glycine 0 C--N 1.348 1.228 0 CA-C-O 119.078 -0.845 . . . . 44.4 113.077 171.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 101' ' ' PHE . 35.5 mt -66.65 79.81 0.11 Allowed 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 118.01 0.905 . . . . 74.25 111.61 174.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.417 ' HE2' ' H ' ' A' ' 85' ' ' PHE . 2.7 m-85 38.55 -113.27 0.12 Allowed 'General case' 0 CA--C 1.56 1.34 0 C-N-CA 126.632 1.973 . . . . 72.25 115.813 172.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 70.31 0.49 29.96 Favored Glycine 0 C--N 1.368 2.311 0 N-CA-C 112.29 -0.324 . . . . 44.0 112.29 -162.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.355 1.604 0 C-N-CA 123.198 0.428 . . . . 71.34 113.284 -171.805 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? . . . . . 0 CA--C 1.55 0.974 0 N-CA-C 109.181 -0.674 . . . . 72.15 109.181 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.429 ' HA2' HH11 ' A' ' 117' ' ' ARG . . . -64.53 160.52 40.4 Favored Glycine 0 C--N 1.343 0.954 0 CA-C-O 121.664 0.591 . . . . 55.22 113.471 178.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.527 ' H ' ' HA3' ' A' ' 166' ' ' GLY . 2.7 mpt_? -102.87 165.43 11.05 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.424 1.09 . . . . 71.34 110.923 -168.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -76.44 115.75 16.48 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 106.698 -1.593 . . . . 74.23 106.698 163.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.524 HD12 ' HA2' ' A' ' 166' ' ' GLY . 3.6 tt -114.99 136.85 52.67 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 107.756 -1.201 . . . . 70.23 107.756 -174.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 29.8 ttt-85 -117.02 135.94 53.33 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 108.554 -0.906 . . . . 74.51 108.554 174.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.97 168.7 23.06 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 121.192 0.52 . . . . 41.51 111.407 -177.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -111.66 112.77 24.7 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.324 1.05 . . . . 61.0 109.439 -169.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 37.5 tp -100.92 96.2 5.39 Favored Pre-proline 0 CA--C 1.549 0.909 0 N-CA-C 108.796 -0.816 . . . . 54.05 108.796 -178.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.426 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 1.1 Cg_endo -83.53 114.27 2.07 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 122.695 2.263 . . . . 75.33 110.61 -173.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.521 ' HB3' HD23 ' A' ' 180' ' ' LEU . 46.3 tp -117.41 141.55 48.19 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.152 0.501 . . . . 64.01 111.134 -169.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 24.0 m -69.41 142.05 53.96 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 114.908 -1.042 . . . . 71.34 110.277 173.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.586 HD13 ' HB2' ' A' ' 186' ' ' PHE . 84.5 mt -57.65 -46.53 84.1 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.245 0.618 . . . . 70.54 110.389 179.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -62.67 -37.51 86.7 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 115.071 -0.968 . . . . 75.32 110.519 -177.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -76.6 -21.4 55.63 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.256 0.622 . . . . 64.33 111.574 178.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -71.71 -40.9 69.18 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.023 0.529 . . . . 41.43 110.166 171.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -65.02 -42.43 94.38 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.477 1.111 . . . . 74.51 110.547 177.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 41.7 m170 -69.16 -48.3 62.66 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.384 -0.826 . . . . 75.25 111.273 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.46 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 71.3 -141.96 33.36 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 115.941 -0.572 . . . . 71.54 112.496 -175.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 71.97 -161.2 54.25 Favored Glycine 0 C--N 1.349 1.297 0 C-N-CA 122.987 0.327 . . . . 70.42 113.141 178.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.671 ' HB3' ' HB2' ' A' ' 146' ' ' SER . 26.2 mp0 -69.54 118.46 12.44 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 122.949 0.5 . . . . 73.14 110.146 178.354 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 11.1 tpp180 -101.21 118.91 37.92 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.794 -0.817 . . . . 74.4 108.794 176.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.581 ' HB ' HG21 ' B' ' 5' ' ' THR . 97.2 t -81.74 96.0 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 121.413 0.625 . . . . 71.24 109.465 -178.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.1 p -115.47 124.11 71.65 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-N 114.985 -1.007 . . . . 73.14 108.435 173.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -85.13 115.11 22.73 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 114.792 -1.095 . . . . 71.3 110.246 178.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 33.9 m -122.58 127.65 75.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 124.226 1.011 . . . . 75.1 110.684 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 63.17 21.26 12.76 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.105 0.962 . . . . 74.24 112.575 177.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.548 ' HA3' ' HD2' ' A' ' 80' ' ' PRO . . . 90.2 -17.95 51.04 Favored Glycine 0 C--N 1.35 1.33 0 C-N-CA 122.689 0.185 . . . . 31.1 113.075 -175.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -87.83 118.64 27.49 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.201 1.001 . . . . 72.12 108.831 176.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 45.4 ttm105 -82.4 115.46 21.44 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.592 0.757 . . . . 74.41 109.05 178.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 14.7 p -125.47 149.54 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-O 121.4 0.619 . . . . 73.53 110.607 -177.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.671 ' HB2' ' HB3' ' A' ' 135' ' ' GLU . 35.9 p -107.55 93.27 4.45 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 124.382 1.073 . . . . 31.45 110.45 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 3.4 p -80.57 112.68 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 123.108 0.563 . . . . 73.42 109.564 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -67.02 95.28 0.38 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.658 0.742 . . . . 74.14 110.378 176.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.46 HG13 ' HA2' ' A' ' 133' ' ' GLY . 44.5 pt -78.15 140.58 61.63 Favored Pre-proline 0 CA--C 1.556 1.186 0 CA-C-N 114.42 -1.264 . . . . 74.13 108.713 170.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -66.31 138.48 51.19 Favored 'Trans proline' 0 C--N 1.373 1.833 0 C-N-CA 121.995 1.797 . . . . 60.34 112.187 176.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -63.82 92.63 0.17 Allowed 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 122.424 2.083 . . . . 74.15 110.749 171.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 123.4 27.35 1.49 Allowed Glycine 0 CA--C 1.526 0.736 0 CA-C-N 114.756 -1.111 . . . . 75.51 110.993 -171.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 5.7 p -73.67 137.45 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 123.294 0.637 . . . . 75.43 109.552 179.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.56 HH21 ' HG2' ' A' ' 241' ' ' PRO . 0.0 OUTLIER -112.36 154.61 25.47 Favored 'General case' 0 C--O 1.211 -0.941 0 CA-C-N 116.372 -0.376 . . . . 73.23 111.816 -163.704 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -54.0 124.26 15.02 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 124.049 0.843 . . . . 72.32 110.248 171.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.46 4.88 70.13 Favored Glycine 0 C--N 1.342 0.9 0 CA-C-O 119.159 -0.8 . . . . 14.21 113.747 -178.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 58.3 m -67.78 102.09 1.17 Allowed 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 118.157 0.979 . . . . 74.23 108.857 170.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 53.9 t -83.94 91.4 2.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 107.34 -1.356 . . . . 72.34 107.34 177.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.653 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 53.0 mt -71.99 85.12 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.801 0 N-CA-C 107.618 -1.253 . . . . 75.24 107.618 174.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -74.17 99.52 3.42 Favored 'General case' 0 C--N 1.353 0.76 0 N-CA-C 107.378 -1.342 . . . . 61.32 107.378 175.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.0 p -110.13 118.75 48.87 Favored Pre-proline 0 CA--C 1.548 0.903 0 CA-C-N 115.076 -0.966 . . . . 61.33 110.872 -169.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -79.06 125.3 6.45 Favored 'Trans proline' 0 C--N 1.369 1.626 0 C-N-CA 122.386 2.057 . . . . 74.53 106.841 160.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.421 ' HA2' ' O ' ' A' ' 86' ' ' SER . . . 130.0 -23.75 4.63 Favored Glycine 0 N--CA 1.469 0.9 0 N-CA-C 111.303 -0.719 . . . . 70.43 111.303 -165.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -134.22 144.55 48.5 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 106.152 -1.795 . . . . 64.15 106.152 163.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -175.85 -160.95 24.27 Favored Glycine 0 CA--C 1.498 -0.993 0 N-CA-C 114.596 0.598 . . . . 73.33 114.596 171.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.527 ' HA3' ' H ' ' A' ' 117' ' ' ARG . . . -57.79 135.64 51.56 Favored Glycine 0 C--N 1.356 1.691 0 O-C-N 124.476 0.75 . . . . 74.5 112.322 175.059 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -70.38 105.11 2.91 Favored 'General case' 0 CA--C 1.548 0.899 0 O-C-N 125.686 1.462 . . . . 75.42 110.105 -172.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -170.39 155.7 25.51 Favored Glycine 0 C--N 1.339 0.727 0 CA-C-O 118.887 -0.952 . . . . 64.21 111.253 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . 0.495 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . 7.3 t30 -64.74 -56.26 22.99 Favored Pre-proline 0 N--CA 1.488 1.438 0 CA-C-O 117.826 -1.083 . . . . 63.11 111.41 -170.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.495 ' HD3' ' HB3' ' A' ' 169' ' ' ASN . 1.7 Cg_endo -82.68 91.74 0.96 Allowed 'Trans proline' 0 C--N 1.388 2.649 0 N-CA-C 106.965 -1.975 . . . . 71.13 106.965 162.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.457 ' CG ' ' HA ' ' A' ' 86' ' ' SER . 56.0 Cg_endo -76.6 174.58 12.61 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 123.479 2.786 . . . . 71.25 117.232 -156.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -95.48 -158.86 32.73 Favored Glycine 0 C--N 1.363 2.05 0 CA-C-N 114.724 -1.125 . . . . 72.4 114.736 -177.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -133.52 146.08 50.73 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 125.386 1.474 . . . . 71.14 108.147 -177.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 41.8 tp -118.26 141.63 48.31 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 120.966 0.412 . . . . 64.32 112.015 -172.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 68.9 mt -97.2 91.67 5.65 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 124.268 1.027 . . . . 72.12 108.284 171.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.653 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 85.4 mt -74.28 85.61 1.93 Allowed 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.392 -0.966 . . . . 70.05 108.392 170.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 46.5 t -83.34 97.82 4.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 107.037 -1.468 . . . . 61.43 107.037 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 8.9 p -68.41 125.88 27.1 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 CA-C-N 115.558 -0.746 . . . . 70.33 110.144 -173.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.426 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 40.4 mmm-85 -116.94 97.61 6.04 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.497 1.119 . . . . 53.32 108.215 -176.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.521 HD23 ' HB3' ' A' ' 125' ' ' LEU . 45.3 mt -69.34 141.11 54.31 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 110.067 -0.346 . . . . 72.4 110.067 -179.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 79.6 mt -57.52 148.2 56.51 Favored Pre-proline 0 CA--C 1.549 0.929 0 O-C-N 124.066 0.854 . . . . 73.14 111.202 -177.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -77.43 48.19 2.49 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 123.084 2.523 . . . . 71.42 110.441 167.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . 0.431 ' HA ' ' HD3' ' A' ' 184' ' ' PRO . 53.2 t-80 -70.28 136.94 86.54 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 125.27 1.428 . . . . 73.35 109.051 -172.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 183' ' ' HIS . 53.1 Cg_exo -58.32 12.09 0.04 OUTLIER 'Trans proline' 0 C--N 1.381 2.253 0 C-N-CA 124.202 3.268 . . . . 61.24 118.127 -168.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 40.2 t -106.63 -55.2 5.61 Favored 'Isoleucine or valine' 0 C--N 1.352 0.702 0 CA-C-N 119.43 1.014 . . . . 64.21 109.181 172.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . 0.586 ' HB2' HD13 ' A' ' 127' ' ' LEU . 23.1 m-85 -134.49 147.11 50.3 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 115.061 -0.972 . . . . 72.31 111.681 -168.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -133.79 90.96 2.77 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 106.177 -1.786 . . . . 75.51 106.177 165.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.49 HD13 ' HG ' ' A' ' 193' ' ' LEU . 60.0 tp -71.47 161.33 31.21 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 124.48 1.112 . . . . 74.21 111.652 -177.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -154.28 107.54 2.89 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 122.905 0.482 . . . . 70.31 110.59 174.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 82.22 -53.37 4.76 Favored Glycine 0 C--N 1.36 1.861 0 C-N-CA 123.375 0.512 . . . . 65.41 114.216 174.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -178.97 -21.43 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 126.917 2.087 . . . . 72.32 107.789 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -85.31 120.37 26.72 Favored 'General case' 0 C--N 1.357 0.923 0 CA-C-N 114.405 -1.271 . . . . 72.32 109.509 -178.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.566 HD13 HD13 ' A' ' 249' ' ' LEU . 0.6 OUTLIER -89.97 142.7 27.46 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.06 0.944 . . . . 63.44 110.112 -170.23 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -119.3 145.18 46.35 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 107.878 -1.156 . . . . 73.14 107.878 166.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.441 ' HB3' HD23 ' A' ' 251' ' ' LEU . . . -144.63 175.84 9.85 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.609 1.164 . . . . 74.34 109.485 -171.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 2.9 m -118.41 139.84 50.77 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.643 -0.873 . . . . 70.21 108.643 172.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.628 HD22 HD13 ' A' ' 251' ' ' LEU . 34.5 tp -145.61 105.87 4.05 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 110.127 -0.323 . . . . 72.21 110.127 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -73.62 133.38 43.46 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 109.285 -0.635 . . . . 61.43 109.285 167.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 7.3 p -143.59 133.03 11.63 Favored Pre-proline 0 CA--C 1.548 0.879 0 N-CA-C 107.781 -1.192 . . . . 64.4 107.781 178.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.28 146.15 35.46 Favored 'Trans proline' 0 C--N 1.368 1.586 0 C-N-CA 121.313 1.342 . . . . 64.51 110.404 169.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.477 ' HB3' ' HH2' ' A' ' 269' ' ' TRP . . . -44.13 -52.0 17.16 Favored Pre-proline 0 CA--C 1.568 1.669 0 N-CA-C 115.644 1.72 . . . . 71.34 115.644 -173.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.408 ' HD3' ' HB3' ' A' ' 201' ' ' ALA . 50.5 Cg_exo -60.07 -38.55 76.86 Favored 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 121.809 1.673 . . . . 63.54 113.845 -179.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 46.3 mt -70.17 -29.4 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 110.016 -0.364 . . . . 64.32 110.016 179.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.18 -48.83 61.1 Favored 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 123.069 0.548 . . . . 71.51 111.941 172.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 201' ' ' ALA . 93.4 t -65.54 -43.04 94.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 C-N-CA 123.837 0.855 . . . . 63.23 111.859 -175.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.472 HG21 ' HB2' ' C' ' 273' ' ' ALA . 70.4 t -92.55 -34.68 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.594 0.757 . . . . 74.41 111.458 -173.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 88.09 89.21 1.12 Allowed Glycine 0 C--N 1.341 0.845 0 N-CA-C 111.319 -0.712 . . . . 72.35 111.319 -175.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -107.4 -139.28 9.1 Favored Glycine 0 C--N 1.34 0.798 0 CA-C-O 120.277 -0.18 . . . . 55.24 112.67 -177.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -130.85 128.21 40.16 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.175 0.99 . . . . 45.21 108.917 177.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 29.3 m -129.83 159.24 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 109.038 -0.727 . . . . 63.11 109.038 175.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 55.2 ttm-85 -93.93 107.24 19.16 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 109.494 -0.558 . . . . 71.41 109.494 178.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -102.25 124.35 47.69 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 124.111 0.964 . . . . 62.04 109.436 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . 0.413 ' N ' ' SD ' ' A' ' 213' ' ' MET . 1.0 OUTLIER -75.08 126.08 30.27 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.202 0.601 . . . . 71.23 109.747 175.922 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 72.7 p -116.1 -178.01 3.3 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 123.876 0.87 . . . . 74.1 108.726 173.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.424 ' HG ' ' HE2' ' A' ' 186' ' ' PHE . 63.8 mt -77.01 -7.6 55.93 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 122.778 0.431 . . . . 63.31 110.727 174.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -99.98 -19.66 16.46 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.225 1.01 . . . . 64.44 110.553 176.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 139.53 172.84 12.86 Favored Glycine 0 C--N 1.353 1.504 0 CA-C-O 119.858 -0.412 . . . . 33.0 113.451 175.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -75.9 99.32 1.27 Allowed 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 122.93 2.42 . . . . 70.23 111.285 178.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 32.5 m -103.2 159.34 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.208 1.003 . . . . 73.4 110.619 -174.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -93.8 105.07 17.12 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.152 -0.684 . . . . 75.04 109.152 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 8.7 p -101.64 137.52 29.09 Favored 'Isoleucine or valine' 0 C--O 1.253 1.273 0 C-N-CA 123.832 0.853 . . . . 74.13 110.021 -174.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -86.42 102.75 14.34 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.784 0.834 . . . . 60.25 110.744 -178.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 48.8 t -63.48 137.76 97.17 Favored Pre-proline 0 CA--C 1.56 1.353 0 C-N-CA 124.458 1.103 . . . . 63.14 110.304 179.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -79.98 164.01 22.76 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 122.673 2.249 . . . . 75.51 110.612 174.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.99 152.4 46.11 Favored 'Trans proline' 0 C--N 1.369 1.63 0 C-N-CA 121.786 1.657 . . . . 72.53 112.814 178.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . 0.571 HH12 ' HG ' ' C' ' 261' ' ' LEU . 63.5 mtt-85 67.54 26.06 8.22 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 125.533 1.533 . . . . 74.04 111.873 172.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.504 HG23 HD21 ' A' ' 233' ' ' LEU . 10.5 m -61.17 104.01 0.34 Allowed 'General case' 0 CA--C 1.559 1.323 0 C-N-CA 125.699 1.6 . . . . 64.32 111.026 175.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . 0.562 ' HB3' ' HD2' ' A' ' 231' ' ' ARG . 4.8 tp-100 -97.38 143.89 27.67 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.085 0.954 . . . . 75.32 111.263 -173.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -63.57 150.91 42.94 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.588 0.755 . . . . 62.31 112.462 -177.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 83.71 -28.27 4.03 Favored Glycine 0 C--N 1.349 1.271 0 O-C-N 123.684 0.615 . . . . 73.32 112.523 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.562 ' HD2' ' HB3' ' A' ' 228' ' ' GLN . 76.6 mtt180 -77.63 167.11 22.12 Favored 'General case' 0 C--N 1.347 0.492 0 C-N-CA 123.971 0.908 . . . . 74.0 110.469 178.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.443 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 12.5 mptt -121.82 120.55 34.89 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 115.067 -0.97 . . . . 72.22 108.571 -178.078 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.504 HD21 HG23 ' A' ' 227' ' ' THR . 81.8 mt -74.59 110.3 8.77 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 108.595 -0.891 . . . . 71.4 108.595 177.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . 0.563 ' HG3' ' HB3' ' A' ' 248' ' ' ASP . 39.9 ttp180 -87.63 100.77 13.05 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 122.622 0.369 . . . . 64.14 110.121 178.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.503 ' H ' HD23 ' A' ' 235' ' ' LEU . 0.2 OUTLIER -100.84 106.84 18.25 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 106.466 -1.679 . . . . 61.12 106.466 170.662 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -76.18 143.95 40.81 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 115.045 -0.979 . . . . 64.43 111.708 -169.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 71.35 32.62 64.97 Favored Glycine 0 C--N 1.348 1.2 0 O-C-N 123.704 0.627 . . . . 74.2 112.536 -178.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.491 ' HG3' HD12 ' A' ' 235' ' ' LEU . 43.9 mmtm -125.32 -17.18 5.71 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.985 0.914 . . . . 73.01 110.453 178.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . 0.515 ' HA2' HD12 ' A' ' 193' ' ' LEU . . . -79.6 -151.86 6.85 Favored Glycine 0 C--N 1.353 1.474 0 CA-C-N 116.298 -0.41 . . . . 74.43 112.655 176.354 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -96.72 146.06 30.65 Favored Pre-proline 0 N--CA 1.482 1.169 0 C-N-CA 122.882 0.473 . . . . 73.13 109.857 -179.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.728 ' HA ' ' HA ' ' A' ' 246' ' ' ARG . 33.1 Cg_endo -61.27 167.26 9.66 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 123.203 2.602 . . . . 73.33 114.195 -175.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -175.2 -176.35 43.4 Favored Glycine 0 CA--C 1.535 1.335 0 CA-C-N 115.213 -0.903 . . . . 73.52 112.18 177.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -62.44 -19.31 67.05 Favored 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 123.68 2.92 . . . . 70.45 113.961 -175.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -102.53 22.52 13.4 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 124.027 0.931 . . . . 70.11 110.855 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 90.18 -164.38 30.9 Favored Glycine 0 C--N 1.35 1.338 0 N-CA-C 111.471 -0.651 . . . . 62.24 111.471 -174.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.728 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 25.1 ttm180 -73.08 139.37 46.45 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 117.664 0.732 . . . . 75.41 110.383 177.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -70.06 179.11 28.58 Favored Glycine 0 C--N 1.34 0.775 0 CA-C-N 115.709 -0.678 . . . . 42.24 113.379 -176.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . 0.563 ' HB3' ' HG3' ' A' ' 234' ' ' ARG . 55.7 m-20 -106.12 140.57 38.89 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.52 0.728 . . . . 75.44 109.493 -173.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.566 HD13 HD13 ' A' ' 193' ' ' LEU . 34.4 tp -97.61 120.0 37.19 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.349 -0.982 . . . . 70.31 108.349 178.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.443 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 2.9 m-85 -100.93 106.18 17.49 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.363 1.065 . . . . 52.51 108.66 177.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.628 HD13 HD22 ' A' ' 197' ' ' LEU . 47.1 mt -87.03 121.45 29.51 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.392 0.677 . . . . 72.24 109.659 177.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . 0.427 ' HB2' ' O ' ' A' ' 195' ' ' ALA . 2.8 tm-20 -74.38 107.3 6.45 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 107.45 -1.315 . . . . 75.41 107.45 -178.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.497 HG12 HG13 ' A' ' 255' ' ' ILE . 42.6 t -67.36 99.67 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.687 0 O-C-N 124.117 0.886 . . . . 24.43 110.223 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.25 92.16 4.39 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 107.181 -1.414 . . . . 73.14 107.181 177.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.497 HG13 HG12 ' A' ' 253' ' ' VAL . 70.2 mt -83.8 130.95 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-O 120.779 0.323 . . . . 74.34 110.583 -177.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 51.8 p -128.99 169.38 14.75 Favored 'General case' 0 C--O 1.253 1.265 0 C-N-CA 123.942 0.897 . . . . 73.43 109.585 172.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.551 HD13 HG22 ' C' ' 205' ' ' VAL . 2.1 pp -119.14 155.95 52.91 Favored Pre-proline 0 CA--C 1.564 1.513 0 N-CA-C 108.121 -1.066 . . . . 73.4 108.121 173.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -76.27 9.21 2.56 Favored 'Trans proline' 0 N--CA 1.512 2.564 0 C-N-CA 123.027 2.485 . . . . 74.45 115.328 -162.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . 0.48 ' H ' HD12 ' A' ' 257' ' ' ILE . 5.6 mm-40 56.72 -90.72 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 123.858 0.863 . . . . 63.24 109.925 -164.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 260' ' ' ARG . . . . . 0.464 HH22 HG23 ' A' ' 262' ' ' THR . 0.0 OUTLIER -74.33 144.32 44.53 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.589 0.756 . . . . 75.12 111.521 -175.029 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.435 HD11 HG11 ' C' ' 205' ' ' VAL . 49.5 mt -123.41 178.67 5.05 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.046 0.938 . . . . 55.32 111.165 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . 0.464 HG23 HH22 ' A' ' 260' ' ' ARG . 1.2 p -128.16 143.88 49.61 Favored Pre-proline 0 CA--C 1.556 1.181 0 CA-C-N 114.007 -1.451 . . . . 44.34 108.43 176.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -28.26 -53.91 0.14 Allowed 'Trans proline' 0 C--N 1.39 2.757 1 C-N-CA 126.166 4.577 . . . . 74.33 117.734 -167.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . 0.406 ' O ' HD13 ' A' ' 268' ' ' LEU . 16.9 tp10 -70.25 -47.52 60.98 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 122.589 0.356 . . . . 71.44 110.68 -174.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -64.51 -29.22 70.26 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.284 1.034 . . . . 64.2 110.319 178.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -62.76 -50.53 70.69 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.736 0.814 . . . . 73.45 109.047 175.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -62.76 -37.13 85.4 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 114.991 -1.004 . . . . 64.12 112.097 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . 0.5 HD21 ' HB3' ' C' ' 271' ' ' LYS . 6.7 mp -64.73 -56.05 16.08 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.704 0.802 . . . . 73.14 111.396 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 269' ' ' TRP . . . . . 0.477 ' HH2' ' HB3' ' A' ' 201' ' ' ALA . 68.1 m95 -58.62 -41.73 86.57 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.431 0.693 . . . . 75.0 111.279 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -60.25 -58.54 8.07 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 123.828 0.705 . . . . 62.43 111.516 178.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 30.8 mmtm -66.34 -33.64 76.18 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 112.418 0.525 . . . . 70.22 112.418 -175.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 13.7 mt -54.25 -53.54 52.3 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 109.224 -0.658 . . . . 63.4 109.224 169.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . 0.443 ' HA ' ' HB2' ' C' ' 202' ' ' PRO . . . -67.41 -37.84 83.68 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.671 1.188 . . . . 64.51 113.664 -172.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -67.81 -53.81 24.08 Favored 'General case' 0 C--O 1.243 0.733 0 C-N-CA 123.956 0.902 . . . . 74.35 109.398 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -66.29 -30.41 70.82 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 115.538 -0.755 . . . . 71.44 111.145 178.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -68.57 -44.65 74.0 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.474 0.71 . . . . 75.02 109.945 178.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 277' ' ' TYR . . . . . 0.465 ' HA ' ' HB3' ' A' ' 280' ' ' ALA . 70.3 t80 -65.12 -37.53 87.75 Favored 'General case' 0 C--O 1.242 0.674 0 O-C-N 124.06 0.85 . . . . 70.12 110.245 -178.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -57.79 -23.83 54.3 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 115.571 -0.74 . . . . 75.41 111.683 173.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 67.7 mtm-85 -102.89 -15.76 16.08 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 124.026 0.93 . . . . 74.13 111.398 176.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . 0.465 ' HB3' ' HA ' ' A' ' 277' ' ' TYR . . . . . . . . 0 C--O 1.259 1.561 0 C-N-CA 123.851 0.86 . . . . 72.21 110.275 -176.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 62.9 mtm . . . . . 0 N--CA 1.482 1.148 0 N-CA-C 109.25 -0.648 . . . . 71.44 109.25 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 61.93 -158.23 0.33 Allowed 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.766 0.826 . . . . 54.1 109.777 -177.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -90.47 67.5 6.58 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 108.108 -1.071 . . . . 74.04 108.108 169.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 21.8 p -69.94 97.57 1.15 Allowed 'General case' 0 C--O 1.244 0.776 0 CA-C-N 115.53 -0.759 . . . . 52.14 110.543 -177.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 5' ' ' THR . . . . . 0.581 HG21 ' HB ' ' A' ' 137' ' ' VAL . 0.0 OUTLIER -97.07 166.17 11.72 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.475 -0.784 . . . . 70.11 111.71 -174.59 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 19.7 pt -133.78 166.57 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 115.248 -0.887 . . . . 64.44 112.385 -157.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -128.59 155.31 45.15 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.878 1.271 . . . . 72.01 108.625 173.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 45.7 tp -89.36 -98.55 0.1 Allowed 'General case' 0 CA--C 1.55 0.961 0 CA-C-O 119.131 -0.461 . . . . 75.22 110.574 -173.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . 166.31 -55.0 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 125.126 1.371 . . . . 62.4 109.065 -173.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 93.0 mt 57.95 91.29 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.983 1.313 . . . . 74.1 110.459 -168.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 78.7 mt . . . . . 0 CA--C 1.546 0.792 0 C-N-CA 123.526 0.73 . . . . 45.35 109.434 -177.069 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.89 0 N-CA-C 108.46 -0.941 . . . . 61.34 108.46 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 180' ' ' ALA . . . . . 0.565 ' HB1' HG23 ' C' ' 137' ' ' VAL . . . -170.03 -76.97 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.197 1.399 . . . . 74.4 107.553 177.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 181' ' ' LEU . . . . . 0.672 HD22 ' HB2' ' C' ' 136' ' ' ARG . 33.9 tp -132.46 -58.01 0.94 Allowed 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 107.518 -1.289 . . . . 62.04 107.518 163.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 182' ' ' VAL . . . . . 0.494 HG13 ' H ' ' B' ' 184' ' ' HIS . 11.5 p -74.04 160.51 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-N 114.883 -1.053 . . . . 71.31 110.812 178.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -90.33 22.75 3.21 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.888 0.875 . . . . 65.24 111.305 173.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 184' ' ' HIS . . . . . 0.494 ' H ' HG13 ' B' ' 182' ' ' VAL . 77.1 t60 64.98 -83.65 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.138 1.375 . . . . 74.15 107.885 -166.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 185' ' ' VAL . . . . . 0.439 HG23 ' HA ' ' C' ' 121' ' ' ALA . 1.7 p . . . . . 0 N--CA 1.475 0.813 0 C-N-CA 123.921 0.888 . . . . 71.33 109.002 168.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 238' ' ' THR . . . . . 0.455 ' HB ' ' HA ' ' C' ' 219' ' ' VAL . 6.3 m . . . . . 0 CA--C 1.555 1.159 0 CA-C-O 120.599 0.238 . . . . 71.31 110.826 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 239' ' ' ALA . . . . . 0.511 ' HB2' ' HA ' ' C' ' 221' ' ' VAL . . . -77.14 172.95 12.42 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.867 1.062 . . . . 74.42 113.867 -167.125 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 240' ' ' GLY . . . . . 0.439 ' H ' HD22 ' C' ' 235' ' ' LEU . . . -113.05 -101.3 2.5 Favored Glycine 0 C--N 1.339 0.723 0 CA-C-N 114.015 -1.448 . . . . 71.23 109.634 177.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -157.51 162.16 38.84 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.588 0.709 . . . . 71.21 111.562 -175.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 242' ' ' TRP . . . . . 0.592 ' HH2' HG21 ' C' ' 199' ' ' VAL . 5.4 m95 -107.04 -47.36 3.71 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 114.106 -1.406 . . . . 70.32 107.478 172.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 177.69 -35.78 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 111.532 -2.576 . . . . 74.22 105.504 -166.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -156.5 -176.0 28.1 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 113.487 -1.688 . . . . 63.11 109.459 166.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.476 0.874 0 C-N-CA 123.661 0.784 . . . . 75.34 110.303 175.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.701 0 N-CA-C 109.56 -0.533 . . . . 52.01 109.56 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -40.5 95.67 0.01 OUTLIER 'General case' 0 C--N 1.359 0.99 0 C-N-CA 125.564 1.546 . . . . 70.52 114.045 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 5' ' ' LYS . . . . . 0.416 ' HB3' HD11 ' C' ' 10' ' ' ILE . 48.6 mtmt -87.72 124.52 33.67 Favored 'General case' 0 C--O 1.247 0.942 0 N-CA-C 108.899 -0.778 . . . . 63.2 108.899 170.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -75.84 112.88 12.7 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.629 -0.878 . . . . 63.22 108.629 175.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 7' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -64.47 -26.16 68.32 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.713 0.805 . . . . 73.43 112.711 -171.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -70.89 -45.07 65.0 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 109.319 -0.623 . . . . 72.53 109.319 178.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.57 -36.91 84.16 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.973 -1.012 . . . . 52.31 110.762 176.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 10' ' ' ILE . . . . . 0.416 HD11 ' HB3' ' C' ' 5' ' ' LYS . 56.6 mt -59.46 -46.57 92.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 122.908 0.483 . . . . 63.34 110.06 174.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 11' ' ' LEU . . . . . 0.622 ' HB3' ' HB1' ' C' ' 25' ' ' ALA . 56.6 mt -71.39 -6.73 42.36 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 112.639 0.607 . . . . 45.45 112.639 176.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.84 21.09 79.66 Favored Glycine 0 C--N 1.355 1.629 0 C-N-CA 122.812 0.244 . . . . 64.33 113.62 178.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 13' ' ' VAL . . . . . 0.421 HG11 ' HB2' ' C' ' 25' ' ' ALA . 31.3 m -113.98 161.51 27.57 Favored Pre-proline 0 N--CA 1.477 0.885 0 C-N-CA 124.111 0.964 . . . . 64.04 110.259 -177.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -54.89 148.52 46.32 Favored 'Trans proline' 0 C--N 1.382 2.294 0 C-N-CA 122.617 2.211 . . . . 74.43 113.05 174.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 68.4 mtm180 -76.94 19.9 0.28 Allowed 'General case' 0 CA--C 1.559 1.296 0 C-N-CA 123.757 0.823 . . . . 71.52 112.969 -172.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -136.97 8.17 2.97 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 125.076 1.35 . . . . 71.24 109.344 179.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.07 141.13 58.84 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.851 0.86 . . . . 71.14 112.242 -174.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 47.7 p -93.24 176.44 6.4 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.276 1.03 . . . . 74.41 112.335 -174.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -53.41 -36.34 61.39 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 125.288 1.435 . . . . 74.45 112.585 -175.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -57.95 -47.98 81.31 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.55 1.14 . . . . 64.05 111.405 175.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -76.89 -29.98 56.0 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.042 -1.436 . . . . 73.42 111.194 -174.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 22' ' ' ILE . . . . . 0.452 HG12 ' HB3' ' C' ' 57' ' ' LEU . 1.7 mp -72.28 -34.11 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 C-N-CA 124.119 0.968 . . . . 61.32 110.058 175.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 23' ' ' LYS . . . . . 0.534 ' HD3' ' NH2' ' C' ' 148' ' ' ARG . 34.1 ttpt -61.5 -50.64 71.9 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.694 0.798 . . . . 74.13 109.973 173.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 50.1 mtm180 -75.5 -20.23 58.89 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 115.582 -0.736 . . . . 73.52 112.423 -178.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . 0.622 ' HB1' ' HB3' ' C' ' 11' ' ' LEU . . . -74.23 -38.75 63.45 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.098 0.559 . . . . 75.32 110.238 172.364 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 26' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -63.8 -43.69 95.57 Favored 'General case' 0 C--O 1.216 -0.7 0 CA-C-N 114.846 -1.07 . . . . 72.31 109.524 174.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -55.48 -55.14 35.21 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.886 0.474 . . . . 74.1 109.994 175.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -46.5 -62.39 1.39 Allowed 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.047 1.339 . . . . 71.15 111.956 -179.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 62.7 mt -74.46 -38.83 62.85 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.385 -0.825 . . . . 60.22 112.168 -173.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.01 2.96 32.25 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 122.573 0.349 . . . . 75.32 111.742 -178.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -95.94 -44.99 7.12 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 108.944 -0.761 . . . . 73.5 108.944 163.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 21.3 tp60 -67.65 -55.86 11.63 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 123.501 0.5 . . . . 71.12 112.216 -176.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 33' ' ' TYR . . . . . 0.472 ' HD2' HD11 ' C' ' 50' ' ' ILE . 11.1 m-85 -95.66 25.5 4.54 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.699 0.8 . . . . 70.15 110.942 -178.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 34' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 -64.9 114.86 16.44 Favored Pre-proline 0 CA--C 1.546 0.813 0 CA-C-O 118.251 -0.881 . . . . 72.34 109.691 -177.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -55.62 -16.14 14.02 Favored 'Trans proline' 0 C--N 1.38 2.211 0 C-N-CA 123.216 2.611 . . . . 71.32 114.314 -177.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -67.75 -53.26 28.79 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.486 0.714 . . . . 60.34 110.391 169.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 77.1 t -77.07 -50.67 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.801 0.84 . . . . 75.33 110.508 -173.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -114.26 86.58 2.45 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.775 1.23 . . . . 54.22 109.011 -178.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -75.96 77.21 2.84 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 116.056 -0.52 . . . . 62.24 109.786 178.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 22.5 m -135.37 121.06 14.01 Favored Pre-proline 0 N--CA 1.471 0.608 0 CA-C-O 118.284 -0.865 . . . . 74.14 109.278 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -47.99 -37.16 29.22 Favored 'Trans proline' 0 C--N 1.384 2.443 0 C-N-CA 123.346 2.697 . . . . 63.44 112.694 174.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -59.94 -41.84 92.69 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.16 0.984 . . . . 65.44 110.246 177.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.7 -17.98 61.06 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 116.2 -0.455 . . . . 62.05 110.521 177.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 44' ' ' GLU . . . . . 0.526 ' HA ' ' HB3' ' C' ' 47' ' ' PHE . 50.1 mt-10 -86.22 -14.88 42.6 Favored 'General case' 0 C--N 1.358 0.953 0 C-N-CA 123.045 0.538 . . . . 74.04 110.371 177.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 45' ' ' GLU . . . . . 0.425 ' O ' ' HB2' ' C' ' 48' ' ' LYS . 32.6 mt-10 -82.72 -38.29 23.52 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.924 -0.769 . . . . 42.53 108.924 169.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 46' ' ' LYS . . . . . 0.502 ' O ' HG13 ' C' ' 50' ' ' ILE . 59.0 mttp -64.13 -32.04 73.46 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.597 -0.729 . . . . 72.32 110.115 166.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 47' ' ' PHE . . . . . 0.526 ' HB3' ' HA ' ' C' ' 44' ' ' GLU . 46.3 t80 -78.29 -21.98 48.91 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.582 0.753 . . . . 62.23 110.533 177.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 48' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' C' ' 45' ' ' GLU . 50.6 mttp -60.35 -53.13 61.29 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 107.961 -1.125 . . . . 72.04 107.961 164.033 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -56.81 -40.19 75.53 Favored 'General case' 0 CA--C 1.55 0.954 0 O-C-N 124.447 1.092 . . . . 72.33 112.132 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 50' ' ' ILE . . . . . 0.502 HG13 ' O ' ' C' ' 46' ' ' LYS . 69.9 mt -62.75 -55.13 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 C-N-CA 123.312 0.645 . . . . 75.43 110.082 176.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 51' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -71.67 -20.91 61.87 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 114.823 -1.08 . . . . 74.04 112.174 -173.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -79.52 -54.29 6.05 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.279 1.032 . . . . 63.42 108.548 178.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.71 -33.74 72.0 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 114.125 -1.398 . . . . 63.1 111.732 176.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -81.66 -33.74 31.13 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 119.138 -0.458 . . . . 75.01 110.452 177.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 55' ' ' ALA . . . . . 0.417 ' HB1' ' HD2' ' C' ' 85' ' ' PHE . . . -56.6 -35.33 68.12 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 118.023 0.374 . . . . 60.54 110.535 174.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 56' ' ' VAL . . . . . 0.459 ' O ' ' HB2' ' C' ' 62' ' ' LYS . 46.2 t -81.02 -62.2 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 CA-C-N 115.559 -0.746 . . . . 72.43 110.986 176.087 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 57' ' ' LEU . . . . . 0.452 ' HB3' HG12 ' C' ' 22' ' ' ILE . 39.4 mt -79.84 -7.88 58.96 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 114.169 1.174 . . . . 75.02 114.169 -164.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 32.6 t -59.92 -51.9 67.69 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.335 0.588 . . . . 62.42 110.433 178.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.86 126.39 80.14 Favored Pre-proline 0 C--O 1.246 0.891 0 CA-C-N 114.787 -1.097 . . . . 72.03 108.805 172.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 60' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -59.12 -23.77 70.61 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.095 1.863 . . . . 33.23 111.231 168.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -64.8 -54.74 26.49 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 124.568 1.147 . . . . 62.13 110.905 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 62' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' C' ' 56' ' ' VAL . 70.3 mttt -69.77 -30.85 68.51 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 115.873 -0.603 . . . . 75.23 110.804 178.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 1.3 ttp180 -57.91 -43.6 86.3 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.62 -0.882 . . . . 64.42 108.62 175.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -72.13 -28.4 63.24 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 115.053 -0.976 . . . . 74.15 112.32 177.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 65' ' ' ILE . . . . . 0.475 HD13 ' HE1' ' C' ' 83' ' ' TYR . 78.6 mt -59.82 -44.54 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 109.878 -0.416 . . . . 62.34 109.878 170.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -67.58 -42.65 82.2 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 116.169 -0.469 . . . . 74.22 110.207 176.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -58.91 -39.96 83.06 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.329 0.652 . . . . 73.14 111.423 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 71.6 p -77.1 -19.33 57.13 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 122.948 0.499 . . . . 63.2 110.983 177.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -74.08 114.29 12.23 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 108.517 -0.92 . . . . 75.22 108.517 170.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 112.26 11.92 14.69 Favored Glycine 0 N--CA 1.472 1.084 0 N-CA-C 111.699 -0.561 . . . . 62.51 111.699 -166.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 95.2 m -144.38 -50.39 0.29 Allowed 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 105.05 -2.204 . . . . 72.34 105.05 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 33.1 m -93.8 137.3 33.19 Favored 'General case' 0 C--O 1.249 1.078 0 N-CA-C 103.527 -2.768 . . . . 73.35 103.527 156.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.06 -31.75 13.44 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 118.384 0.538 . . . . 73.23 110.687 177.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.94 140.91 74.39 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 123.582 0.753 . . . . 53.23 109.968 176.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 75' ' ' PRO . . . . . 0.41 ' HB3' ' O ' ' C' ' 100' ' ' LEU . 10.2 Cg_endo -53.03 115.87 2.56 Favored 'Trans proline' 0 C--N 1.376 2.016 0 C-N-CA 123.173 2.582 . . . . 75.14 112.306 176.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -53.44 148.9 32.18 Favored 'Trans proline' 0 C--N 1.391 2.772 0 C-N-CA 123.911 3.074 . . . . 63.14 113.276 -178.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -50.87 118.62 4.37 Favored 'Trans proline' 0 C--N 1.389 2.663 0 C-N-CA 123.24 2.627 . . . . 51.51 113.521 -178.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 78' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.11 139.48 80.31 Favored 'Trans proline' 0 C--N 1.386 2.511 0 C-N-CA 123.343 2.695 . . . . 74.44 112.943 -178.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.58 158.02 17.31 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 123.078 2.519 . . . . 61.04 112.591 177.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -74.91 42.48 0.84 Allowed 'Trans proline' 0 C--N 1.382 2.312 0 C-N-CA 123.678 2.918 . . . . 51.5 112.735 174.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -159.46 16.86 0.23 Allowed Glycine 0 CA--C 1.529 0.951 0 N-CA-C 108.585 -1.806 . . . . 75.2 108.585 177.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 67.6 -171.93 32.86 Favored Glycine 0 C--N 1.365 2.179 0 C-N-CA 124.439 1.019 . . . . 74.45 111.959 -175.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 83' ' ' TYR . . . . . 0.475 ' HE1' HD13 ' C' ' 65' ' ' ILE . 58.8 m-85 -83.58 98.15 9.44 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 105.991 -1.855 . . . . 70.14 105.991 162.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 84' ' ' ASP . . . . . 0.492 ' OD1' ' HA3' ' C' ' 163' ' ' GLY . 0.3 OUTLIER -56.32 137.18 52.88 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 112.015 0.376 . . . . 63.13 112.015 -175.114 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' C' C ' 85' ' ' PHE . . . . . 0.459 ' HB3' ' HB2' ' C' ' 88' ' ' PHE . 30.7 m-85 -133.06 73.1 1.5 Allowed 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.523 1.129 . . . . 74.41 108.325 177.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 86' ' ' SER . . . . . 0.411 ' HA ' ' HB2' ' C' ' 162' ' ' PRO . 50.4 m -51.64 85.72 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 124.308 1.043 . . . . 45.43 112.345 178.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 65.61 19.11 66.7 Favored Glycine 0 CA--C 1.534 1.273 0 CA-C-N 115.566 -0.743 . . . . 74.33 113.672 -175.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 88' ' ' PHE . . . . . 0.459 ' HB2' ' HB3' ' C' ' 85' ' ' PHE . 23.0 m-85 -101.81 118.55 37.16 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 109.411 -0.588 . . . . 74.44 109.411 -176.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -75.74 90.23 2.86 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.216 0.531 . . . . 72.23 109.686 -178.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 90' ' ' VAL . . . . . 0.432 HG23 HD22 ' C' ' 105' ' ' LEU . 1.6 p -41.12 -47.99 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 CA-C-N 113.96 -1.473 . . . . 54.41 113.326 171.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -68.78 -19.32 64.31 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.275 0.63 . . . . 74.21 111.635 -175.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -93.06 -2.89 55.16 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.354 0.662 . . . . 75.53 111.583 -178.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -95.21 174.77 6.89 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 122.714 0.405 . . . . 72.45 111.803 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 90.0 p -66.23 167.15 10.71 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 114.643 1.349 . . . . 45.51 114.643 -168.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 95' ' ' GLU . . . . . 0.403 ' O ' ' HG3' ' C' ' 99' ' ' GLU . 0.0 OUTLIER -59.49 -50.89 72.19 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 114.962 -1.017 . . . . 55.43 112.026 178.744 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -57.13 -46.44 82.66 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.608 0.763 . . . . 65.02 110.502 -176.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 97' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -54.64 -52.29 62.77 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 114.756 -1.111 . . . . 64.25 110.634 175.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 98' ' ' GLN . . . . . 0.576 ' HA ' HD21 ' C' ' 105' ' ' LEU . 98.0 mt-30 -69.0 -18.29 64.03 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.617 -0.719 . . . . 51.52 112.558 -175.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 99' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' C' ' 95' ' ' GLU . 44.3 mt-10 -86.65 -52.42 5.55 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.729 0.411 . . . . 74.43 111.087 176.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 100' ' ' LEU . . . . . 0.41 ' O ' ' HB3' ' C' ' 75' ' ' PRO . 54.5 tp -62.09 -39.58 92.94 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.528 0.731 . . . . 73.23 111.012 -178.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -96.57 7.49 46.41 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.987 -0.551 . . . . 73.25 110.839 178.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 102' ' ' GLY . . . . . 0.481 ' HA2' ' HG ' ' C' ' 105' ' ' LEU . . . -43.38 -62.34 2.49 Favored Glycine 0 C--N 1.356 1.672 0 C-N-CA 124.906 1.241 . . . . 54.11 114.916 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -49.6 -21.22 5.07 Favored 'Trans proline' 0 C--N 1.384 2.431 0 C-N-CA 123.985 3.123 . . . . 62.02 115.105 -177.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -146.97 41.26 0.97 Allowed Glycine 0 C--N 1.36 1.909 0 CA-C-O 119.576 -0.569 . . . . 43.23 112.823 178.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 105' ' ' LEU . . . . . 0.576 HD21 ' HA ' ' C' ' 98' ' ' GLN . 13.2 mt . . . . . 0 N--CA 1.511 2.59 0 N-CA-C 115.717 1.747 . . . . 73.03 115.717 177.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.732 0 CA-C-O 120.09 -0.283 . . . . 45.25 112.901 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 4.6 ppt_? -116.51 137.25 52.32 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.714 -0.847 . . . . 64.44 108.714 167.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 118' ' ' ASP . . . . . 0.894 ' HA ' ' HA2' ' C' ' 166' ' ' GLY . 8.7 p-10 -61.3 134.85 57.41 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 123.851 0.861 . . . . 75.42 111.517 -172.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 119' ' ' LEU . . . . . 0.563 ' HB2' ' O ' ' C' ' 165' ' ' GLY . 0.2 OUTLIER -92.81 143.62 26.1 Favored 'General case' 0 N--CA 1.504 2.252 0 C-N-CA 119.293 -0.963 . . . . 75.21 109.697 -176.979 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -128.87 95.44 4.09 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 107.947 -1.131 . . . . 72.31 107.947 175.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 121' ' ' ALA . . . . . 0.453 ' HB3' HD23 ' C' ' 176' ' ' LEU . . . -108.33 114.1 27.7 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 108.542 -0.911 . . . . 63.21 108.542 -177.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 122' ' ' GLU . . . . . 0.484 ' HA ' ' O ' ' C' ' 177' ' ' VAL . 37.4 mt-10 -95.27 101.44 13.17 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 107.114 -1.439 . . . . 73.22 107.114 172.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 123' ' ' LEU . . . . . 0.63 ' H ' HD23 ' C' ' 123' ' ' LEU . 1.7 pt? -105.57 115.52 61.63 Favored Pre-proline 0 N--CA 1.478 0.942 0 CA-C-N 115.702 -0.681 . . . . 73.3 110.896 -168.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . 0.535 ' HA ' ' O ' ' C' ' 179' ' ' ARG . 85.8 Cg_exo -52.76 113.46 1.26 Allowed 'Trans proline' 0 C--N 1.384 2.426 0 C-N-CA 122.506 2.138 . . . . 72.51 111.121 164.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 125' ' ' LEU . . . . . 0.566 HD23 HG11 ' C' ' 153' ' ' VAL . 37.8 tp -129.99 143.84 51.01 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.648 0.379 . . . . 74.03 110.106 -175.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 126' ' ' THR . . . . . . . . . . . . . 2.5 m -85.37 149.49 25.4 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 116.033 -0.531 . . . . 61.53 110.917 -177.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 127' ' ' LEU . . . . . 0.476 HD11 ' H ' ' C' ' 185' ' ' VAL . 9.8 mt -70.61 -52.14 23.47 Favored 'General case' 0 C--O 1.247 0.962 0 C-N-CA 124.198 0.999 . . . . 62.25 109.038 -178.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 128' ' ' GLU . . . . . 0.551 ' HG3' ' HA ' ' C' ' 215' ' ' LEU . 1.7 mp0 -59.49 -34.72 72.93 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 113.88 -1.509 . . . . 75.24 111.227 178.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 129' ' ' GLU . . . . . 0.518 ' HA ' ' HB2' ' C' ' 132' ' ' HIS . 17.7 mm-40 -84.47 -19.55 33.18 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.616 0.366 . . . . 73.53 111.544 -179.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -70.5 -33.68 71.49 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 108.882 -0.785 . . . . 64.34 108.882 171.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 131' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -65.46 -49.06 70.53 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 115.482 -0.781 . . . . 75.55 109.91 167.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 132' ' ' HIS . . . . . 0.518 ' HB2' ' HA ' ' C' ' 129' ' ' GLU . 32.8 m170 -72.18 -3.82 25.62 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 112.704 0.631 . . . . 60.22 112.704 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -54.41 165.13 2.83 Favored Glycine 0 CA--C 1.547 2.047 0 N-CA-C 115.715 1.046 . . . . 65.31 115.715 174.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . 158.52 -130.44 2.53 Favored Glycine 0 C--N 1.348 1.218 0 N-CA-C 110.269 -1.133 . . . . 53.24 110.269 -174.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 17.0 mp0 -81.2 95.53 6.95 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 108.263 -1.014 . . . . 71.2 108.263 169.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 136' ' ' ARG . . . . . 0.672 ' HB2' HD22 ' B' ' 181' ' ' LEU . 26.9 mmt180 -121.83 147.04 46.48 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 122.897 0.479 . . . . 72.12 110.662 -172.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 137' ' ' VAL . . . . . 0.565 HG23 ' HB1' ' B' ' 180' ' ' ALA . 8.0 m -74.42 132.55 33.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 121.69 0.757 . . . . 71.12 110.72 -175.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 138' ' ' VAL . . . . . 0.412 HG13 HG11 ' B' ' 182' ' ' VAL . 2.3 t -139.02 133.31 40.64 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 C-N-CA 124.656 1.183 . . . . 72.14 109.269 -175.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 139' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -125.28 109.17 12.49 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 107.898 -1.149 . . . . 74.31 107.898 171.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 140' ' ' VAL . . . . . . . . . . . . . 3.2 p -143.32 134.03 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.022 0.929 . . . . 63.22 109.174 178.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 64.42 8.17 4.1 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.613 1.165 . . . . 15.23 113.329 177.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 105.29 1.46 41.17 Favored Glycine 0 C--N 1.351 1.37 0 CA-C-O 119.63 -0.539 . . . . 45.25 113.817 -178.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 143' ' ' ARG . . . . . 0.425 HH11 ' HG2' ' C' ' 164' ' ' MET . 77.2 ttt180 -100.14 124.98 46.17 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 118.037 0.918 . . . . 73.04 110.708 -179.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 49.2 ttt-85 -96.22 116.57 29.22 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.163 0.985 . . . . 71.51 108.944 170.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 145' ' ' VAL . . . . . 0.437 HG11 ' SD ' ' C' ' 164' ' ' MET . 7.7 p -151.74 147.4 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 122.714 0.405 . . . . 75.03 111.104 -177.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 50.8 m -85.39 93.47 8.74 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 108.044 -1.095 . . . . 54.21 108.044 166.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 6.2 p -81.33 154.41 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-O 120.853 0.359 . . . . 72.53 110.414 -175.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 148' ' ' ARG . . . . . 0.534 ' NH2' ' HD3' ' C' ' 23' ' ' LYS . 53.5 ttm-85 -113.77 95.79 5.51 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 108.275 -1.009 . . . . 74.22 108.275 172.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 149' ' ' ILE . . . . . . . . . . . . . 34.8 pt -106.91 150.99 40.45 Favored Pre-proline 0 CA--C 1.548 0.898 0 N-CA-C 108.49 -0.93 . . . . 71.41 108.49 171.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -40.24 111.73 0.15 Allowed 'Trans proline' 0 C--N 1.384 2.409 0 C-N-CA 124.311 3.341 . . . . 61.44 115.042 -179.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -64.09 93.78 0.19 Allowed 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.996 2.464 . . . . 73.2 109.856 166.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 152' ' ' GLY . . . . . . . . . . . . . . . 113.17 90.6 1.87 Allowed Glycine 0 C--N 1.341 0.816 0 N-CA-C 110.004 -1.238 . . . . 54.32 110.004 -165.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 153' ' ' VAL . . . . . 0.566 HG11 HD23 ' C' ' 125' ' ' LEU . 2.0 p -115.51 156.74 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 C-N-CA 123.051 0.54 . . . . 71.13 110.152 -174.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 154' ' ' ARG . . . . . 0.517 ' HB2' ' HB3' ' C' ' 157' ' ' SER . 56.7 mtp180 -107.54 135.26 49.3 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.68 0.792 . . . . 75.32 110.675 -174.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 155' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -47.04 120.91 3.33 Favored 'General case' 0 CA--C 1.553 1.059 0 CA-C-N 118.663 0.665 . . . . 74.51 111.588 166.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.59 -0.49 88.23 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-O 119.263 -0.743 . . . . 64.51 114.496 176.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 157' ' ' SER . . . . . 0.517 ' HB3' ' HB2' ' C' ' 154' ' ' ARG . 91.5 p -77.83 147.96 34.93 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 118.183 0.991 . . . . 75.43 109.93 177.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 6.1 p -119.63 109.58 26.69 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 CA-C-O 121.668 0.746 . . . . 64.44 109.902 -173.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 159' ' ' ILE . . . . . 0.586 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 17.3 mt -88.24 116.01 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.613 1.165 . . . . 52.25 109.078 -178.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -91.01 111.84 23.48 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.521 -0.548 . . . . 72.21 109.521 177.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 161' ' ' VAL . . . . . 0.454 HG11 ' HE2' ' C' ' 164' ' ' MET . 1.9 p -122.21 96.4 46.39 Favored Pre-proline 0 CA--C 1.558 1.286 0 C-N-CA 124.254 1.022 . . . . 75.24 108.964 177.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 162' ' ' PRO . . . . . 0.83 ' HA ' ' HA ' ' C' ' 173' ' ' ASP . 10.6 Cg_endo -57.05 128.03 28.18 Favored 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 122.847 2.364 . . . . 63.42 113.329 176.023 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 163' ' ' GLY . . . . . 0.492 ' HA3' ' OD1' ' C' ' 84' ' ' ASP . . . 107.31 13.03 22.12 Favored Glycine 0 C--N 1.348 1.209 0 N-CA-C 115.179 0.832 . . . . 53.31 115.179 172.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 164' ' ' MET . . . . . 0.454 ' HE2' HG11 ' C' ' 161' ' ' VAL . 5.7 mtm -126.67 32.0 5.23 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 117.991 0.896 . . . . 73.35 112.216 -176.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 165' ' ' GLY . . . . . 0.673 ' H ' ' HA2' ' C' ' 172' ' ' GLY . . . 112.35 122.49 4.07 Favored Glycine 0 C--O 1.192 -2.483 0 CA-C-O 115.526 -2.819 . . . . 64.24 107.48 -176.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 166' ' ' GLY . . . . . 0.894 ' HA2' ' HA ' ' C' ' 118' ' ' ASP . . . 144.5 -143.57 12.23 Favored Glycine 0 C--O 1.199 -2.035 0 CA-C-N 122.379 3.089 . . . . 75.44 113.239 -161.18 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 167' ' ' GLN . . . . . 0.52 ' H ' ' HB3' ' C' ' 173' ' ' ASP . 22.2 mm-40 -90.07 114.33 26.21 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 118.968 1.384 . . . . 64.31 110.539 177.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . -167.59 -150.97 6.74 Favored Glycine 0 N--CA 1.479 1.502 0 CA-C-O 119.654 -0.526 . . . . 13.44 113.118 -175.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 169' ' ' ASN . . . . . 0.598 ' HB3' ' HD3' ' C' ' 170' ' ' PRO . 25.1 t-20 -72.33 -56.23 4.31 Favored Pre-proline 0 C--N 1.358 0.973 0 N-CA-C 108.354 -0.98 . . . . 62.44 108.354 168.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 170' ' ' PRO . . . . . 0.598 ' HD3' ' HB3' ' C' ' 169' ' ' ASN . 57.7 Cg_endo -98.83 -160.11 0.05 OUTLIER 'Trans proline' 0 C--N 1.365 1.409 0 N-CA-C 105.292 -2.619 . . . . 51.41 105.292 159.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 171' ' ' PRO . . . . . 0.508 ' HA ' ' O ' ' C' ' 166' ' ' GLY . 22.3 Cg_exo -47.17 119.47 3.52 Favored 'Trans proline' 0 CA--C 1.587 3.13 0 CA-C-N 121.543 1.587 . . . . 74.02 114.733 160.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 172' ' ' GLY . . . . . 0.673 ' HA2' ' H ' ' C' ' 165' ' ' GLY . . . -150.96 84.45 0.16 Allowed Glycine 1 CA--C 1.587 4.575 0 N-CA-C 117.169 1.628 . . . . 74.42 117.169 168.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' C' C ' 173' ' ' ASP . . . . . 0.83 ' HA ' ' HA ' ' C' ' 162' ' ' PRO . 29.0 t70 163.05 93.21 0.0 OUTLIER 'General case' 0 N--CA 1.535 3.817 0 C-N-CA 127.58 2.352 . . . . 74.51 108.231 -178.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 174' ' ' LEU . . . . . . . . . . . . . 15.1 tp -104.45 139.79 38.87 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 114.724 -1.125 . . . . 75.22 113.035 -162.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 66.9 mt -110.26 92.26 3.98 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.462 1.105 . . . . 71.32 109.398 172.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 176' ' ' LEU . . . . . 0.586 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 68.1 mt -75.29 93.6 2.89 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-N 114.796 -1.093 . . . . 43.02 110.953 175.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 177' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' C' ' 122' ' ' GLU . 59.4 t -84.53 101.33 8.91 Favored 'Isoleucine or valine' 0 C--O 1.244 0.777 0 N-CA-C 107.28 -1.378 . . . . 74.43 107.28 172.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 178' ' ' VAL . . . . . . . . . . . . . 28.9 m -76.92 122.05 30.58 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 CA-C-O 121.927 0.87 . . . . 74.01 110.18 -176.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 179' ' ' ARG . . . . . 0.535 ' O ' ' HA ' ' C' ' 124' ' ' PRO . 9.9 mmm180 -113.71 111.87 22.52 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 106.376 -1.713 . . . . 72.33 106.376 174.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 180' ' ' LEU . . . . . . . . . . . . . 53.2 mt -67.8 148.19 51.56 Favored 'General case' 0 CA--C 1.558 1.253 0 CA-C-N 117.619 0.191 . . . . 70.51 111.026 -176.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 181' ' ' LEU . . . . . . . . . . . . . 41.1 mt -53.23 167.75 0.41 Allowed Pre-proline 0 N--CA 1.5 2.068 0 C-N-CA 125.671 1.588 . . . . 74.2 113.827 -171.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -61.66 68.7 0.1 Allowed 'Trans proline' 0 C--N 1.393 2.9 0 C-N-CA 122.861 2.374 . . . . 64.12 110.252 161.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 183' ' ' HIS . . . . . 0.407 ' N ' ' HD3' ' C' ' 184' ' ' PRO . 81.6 t60 172.85 47.52 0.01 OUTLIER Pre-proline 0 CA--C 1.562 1.404 0 C-N-CA 129.031 2.932 . . . . 62.13 104.503 -167.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 184' ' ' PRO . . . . . 0.407 ' HD3' ' N ' ' C' ' 183' ' ' HIS . 85.8 Cg_endo -95.05 63.89 0.23 Allowed 'Trans proline' 0 C--N 1.387 2.573 0 C-N-CA 122.395 2.064 . . . . 71.54 109.713 -167.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 185' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 9.8 t -92.85 -23.02 5.66 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.476 0 CA-C-N 114.748 -1.114 . . . . 72.23 109.271 -168.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 186' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -130.68 101.03 5.51 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 118.746 0.703 . . . . 61.44 110.945 -175.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 187' ' ' ARG . . . . . . . . . . . . . 40.7 ttt85 -94.57 117.27 29.86 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 114.494 -1.23 . . . . 75.14 108.066 171.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 188' ' ' LEU . . . . . 0.515 HD13 ' HD2' ' C' ' 240' ' ' PHE . 61.5 tp -82.03 145.95 29.95 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 121.489 0.661 . . . . 74.14 111.824 -179.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 189' ' ' GLU . . . . . 0.427 ' HA ' ' NE ' ' C' ' 154' ' ' ARG . 31.2 tt0 -143.71 111.98 6.32 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 107.064 -1.458 . . . . 71.33 107.064 164.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 67.49 -100.51 0.61 Allowed Glycine 0 C--N 1.35 1.316 0 N-CA-C 111.271 -0.732 . . . . 74.2 111.271 -171.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 191' ' ' GLN . . . . . 0.482 ' HA ' HD11 ' C' ' 188' ' ' LEU . 48.9 mt-30 -125.61 -6.27 6.93 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.531 0.732 . . . . 60.21 111.136 171.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -84.8 138.99 32.26 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 122.892 0.477 . . . . 65.13 110.475 179.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 193' ' ' LEU . . . . . 0.494 HD21 ' CD2' ' C' ' 240' ' ' PHE . 90.4 mt -101.49 163.61 12.18 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.408 0.623 . . . . 52.2 111.142 178.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 194' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -129.82 115.4 17.19 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 114.59 -1.186 . . . . 75.43 108.915 172.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 195' ' ' ALA . . . . . 0.531 ' HA ' ' O ' ' C' ' 185' ' ' VAL . . . -114.59 -178.32 3.34 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.73 0.812 . . . . 65.11 111.242 176.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 196' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' C' ' 252' ' ' GLU . 78.1 m -136.32 114.53 11.57 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 108.27 -1.011 . . . . 51.32 108.27 164.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 197' ' ' LEU . . . . . . . . . . . . . 45.7 tp -88.85 132.57 34.6 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 123.814 0.846 . . . . 73.5 110.542 -176.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -88.22 105.32 17.46 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 108.551 -0.907 . . . . 44.52 108.551 175.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 199' ' ' VAL . . . . . 0.592 HG21 ' HH2' ' B' ' 242' ' ' TRP . 51.2 t -115.22 118.5 39.92 Favored Pre-proline 0 N--CA 1.469 0.504 0 N-CA-C 108.019 -1.104 . . . . 61.21 108.019 177.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 200' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.69 138.36 31.8 Favored 'Trans proline' 0 C--N 1.372 1.785 0 C-N-CA 121.76 1.64 . . . . 71.34 110.612 175.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 201' ' ' ALA . . . . . 0.404 ' O ' HG23 ' C' ' 205' ' ' VAL . . . -41.47 -48.14 9.19 Favored Pre-proline 0 CA--C 1.562 1.411 0 N-CA-C 115.363 1.616 . . . . 74.35 115.363 178.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 202' ' ' PRO . . . . . 0.443 ' HB2' ' HA ' ' A' ' 273' ' ' ALA . 11.9 Cg_endo -53.36 -54.46 4.92 Favored 'Trans proline' 0 C--N 1.386 2.548 0 CA-C-N 121.281 1.493 . . . . 63.15 112.638 176.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 203' ' ' ILE . . . . . . . . . . . . . 63.9 mt -63.74 -29.88 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 123.197 0.599 . . . . 63.4 110.703 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.96 -35.79 78.98 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.995 0.918 . . . . 75.02 112.377 179.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 205' ' ' VAL . . . . . 0.551 HG22 HD13 ' A' ' 257' ' ' ILE . 46.3 t -80.04 -42.8 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 CA-C-O 119.355 -0.355 . . . . 63.41 111.675 179.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 206' ' ' VAL . . . . . . . . . . . . . 10.9 p -80.18 -36.84 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 112.558 0.577 . . . . 52.12 112.558 -172.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 83.31 89.45 0.73 Allowed Glycine 0 C--N 1.344 1.024 0 N-CA-C 111.755 -0.538 . . . . 63.21 111.755 -166.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -127.8 -129.55 3.23 Favored Glycine 0 C--N 1.344 1.006 0 N-CA-C 111.03 -0.828 . . . . 51.32 111.03 177.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 209' ' ' LYS . . . . . 0.581 ' HG2' ' HA ' ' C' ' 222' ' ' ALA . 5.9 mtmp? -136.3 146.95 47.19 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 117.711 0.756 . . . . 72.12 111.71 170.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 210' ' ' VAL . . . . . 0.429 HG21 HG22 ' C' ' 199' ' ' VAL . 33.4 m -128.67 168.22 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 125.225 1.41 . . . . 62.05 107.678 169.075 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 211' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -106.19 136.43 45.91 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 118.117 0.417 . . . . 72.44 111.391 -177.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 212' ' ' ALA . . . . . 0.532 ' HB3' HG13 ' C' ' 219' ' ' VAL . . . -120.56 120.72 36.64 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 107.6 -1.259 . . . . 74.43 107.6 171.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 213' ' ' MET . . . . . 0.426 ' SD ' ' N ' ' C' ' 214' ' ' THR . 8.7 tmm? -71.98 146.38 47.77 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.431 -0.951 . . . . 63.12 108.431 173.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 214' ' ' THR . . . . . 0.561 HG21 ' HD2' ' C' ' 238' ' ' LYS . 0.1 OUTLIER -141.79 168.85 18.78 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 119.035 0.834 . . . . 54.24 112.333 178.165 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' C' C ' 215' ' ' LEU . . . . . 0.551 ' HA ' ' HG3' ' C' ' 128' ' ' GLU . 30.8 mt -62.8 -35.78 80.99 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 124.566 1.146 . . . . 44.41 113.444 -166.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.48 -2.21 15.61 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 114.546 -1.207 . . . . 71.0 111.495 -171.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 164.37 -168.16 38.61 Favored Glycine 0 C--O 1.21 -1.363 0 CA-C-O 119.6 -0.556 . . . . 64.11 111.786 -174.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -94.41 165.42 1.91 Allowed 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 122.302 2.001 . . . . 52.13 112.554 171.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 219' ' ' VAL . . . . . 0.631 ' HB ' ' HE3' ' C' ' 238' ' ' LYS . 2.2 p -142.96 112.9 2.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 108.073 -1.084 . . . . 52.53 108.073 168.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 220' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -90.78 108.12 19.62 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 108.277 -1.009 . . . . 72.32 108.277 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 221' ' ' VAL . . . . . 0.511 ' HA ' ' HB2' ' B' ' 239' ' ' ALA . 39.4 t -71.33 127.15 32.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 114.012 -1.449 . . . . 74.03 112.767 -171.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 222' ' ' ALA . . . . . 0.581 ' HA ' ' HG2' ' C' ' 209' ' ' LYS . . . -81.41 109.09 15.57 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 123.713 0.633 . . . . 73.3 109.346 169.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 58.1 t -82.02 139.6 46.13 Favored Pre-proline 0 CA--C 1.558 1.263 0 C-N-CA 124.282 1.033 . . . . 73.11 110.116 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 224' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -84.93 160.81 11.86 Favored 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 122.929 2.419 . . . . 54.33 111.938 170.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -63.36 140.57 77.33 Favored 'Trans proline' 0 C--N 1.372 1.779 0 C-N-CA 122.247 1.965 . . . . 74.0 110.828 169.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 226' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? 70.0 83.62 0.15 Allowed 'General case' 0 N--CA 1.483 1.189 0 O-C-N 124.403 1.065 . . . . 70.15 111.174 177.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 227' ' ' THR . . . . . 0.604 HG22 HD11 ' C' ' 255' ' ' ILE . 52.7 m -128.1 122.05 31.11 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.874 -0.603 . . . . 70.3 112.404 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 228' ' ' GLN . . . . . 0.452 HE21 HG13 ' A' ' 257' ' ' ILE . 26.1 mp0 -108.89 162.28 14.35 Favored 'General case' 0 C--O 1.253 1.259 0 CA-C-O 122.615 1.197 . . . . 74.32 111.152 168.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 229' ' ' ALA . . . . . 0.432 ' HB2' ' H ' ' C' ' 255' ' ' ILE . . . -65.64 138.29 57.91 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 112.934 -1.939 . . . . 62.12 109.32 175.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 101.56 -4.79 54.21 Favored Glycine 0 CA--C 1.523 0.574 0 CA-C-O 119.616 -0.547 . . . . 62.04 113.012 -174.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 231' ' ' ARG . . . . . . . . . . . . . 43.1 mtt85 -70.19 171.3 9.97 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 108.567 -0.901 . . . . 74.12 108.567 162.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 232' ' ' LYS . . . . . 0.505 ' HA ' ' O ' ' C' ' 251' ' ' LEU . 32.6 ttmt -155.48 126.18 6.92 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.274 0.559 . . . . 71.45 111.744 -178.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 233' ' ' LEU . . . . . 0.631 HD13 ' HB2' ' C' ' 251' ' ' LEU . 4.5 mp -84.92 155.03 21.84 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 114.762 -1.108 . . . . 74.21 110.712 -178.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -122.78 100.62 7.0 Favored 'General case' 0 CA--C 1.55 0.953 0 O-C-N 125.099 1.5 . . . . 72.34 108.941 165.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 235' ' ' LEU . . . . . 0.448 HD13 HG21 ' C' ' 219' ' ' VAL . 61.3 mt -95.22 114.88 26.72 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.495 0.718 . . . . 73.43 109.165 176.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -71.83 130.82 42.0 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.795 0.838 . . . . 71.55 111.899 -174.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 85.01 -12.81 57.0 Favored Glycine 0 C--N 1.352 1.426 0 CA-C-N 116.029 -0.532 . . . . 71.42 113.123 178.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 238' ' ' LYS . . . . . 0.631 ' HE3' ' HB ' ' C' ' 219' ' ' VAL . 68.5 mmtt -92.25 13.13 20.1 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.743 0.817 . . . . 72.03 112.279 -172.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -80.16 -163.25 27.77 Favored Glycine 0 C--N 1.352 1.462 0 N-CA-C 110.992 -0.843 . . . . 31.21 110.992 164.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 240' ' ' PHE . . . . . 0.515 ' HD2' HD13 ' C' ' 188' ' ' LEU . 1.9 m-85 -73.21 124.23 90.36 Favored Pre-proline 0 C--O 1.249 1.036 0 CA-C-N 118.167 0.983 . . . . 75.14 109.141 175.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 241' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' C' ' 240' ' ' PHE . 39.4 Cg_exo -63.51 107.28 0.69 Allowed 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 123.353 2.702 . . . . 70.21 114.381 178.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -79.41 158.3 43.44 Favored Glycine 0 C--N 1.341 0.834 0 CA-C-O 118.904 -0.942 . . . . 70.14 111.371 168.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -57.31 -30.1 86.43 Favored 'Trans proline' 0 C--N 1.374 1.89 0 C-N-CA 123.53 2.82 . . . . 71.42 113.826 -170.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -134.27 17.55 3.72 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.023 0.529 . . . . 71.42 111.439 -177.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 175.77 115.29 0.41 Allowed Glycine 0 C--N 1.346 1.116 0 N-CA-C 111.761 -0.535 . . . . 51.32 111.761 -178.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 246' ' ' ARG . . . . . . . . . . . . . 52.4 mtm180 -82.21 156.33 24.46 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.508 0.723 . . . . 61.31 110.264 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -82.24 -160.93 28.17 Favored Glycine 0 N--CA 1.479 1.509 0 N-CA-C 113.825 0.29 . . . . 63.23 113.825 178.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -133.41 133.31 42.2 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 121.539 0.685 . . . . 73.54 110.647 -175.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 249' ' ' LEU . . . . . 0.439 HD23 HD12 ' C' ' 235' ' ' LEU . 19.2 tp -88.96 129.5 35.62 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.108 0.963 . . . . 74.23 110.85 -175.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 250' ' ' TYR . . . . . 0.588 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 26.8 m-85 -112.38 101.62 9.81 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.856 0.863 . . . . 71.43 110.092 177.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 251' ' ' LEU . . . . . 0.631 ' HB2' HD13 ' C' ' 233' ' ' LEU . 3.3 mp -96.94 117.1 30.4 Favored 'General case' 0 N--CA 1.504 2.249 0 C-N-CA 120.845 -0.342 . . . . 64.53 110.59 -175.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 252' ' ' GLU . . . . . 0.424 ' O ' ' HA ' ' C' ' 196' ' ' THR . 6.3 tp10 -70.55 128.94 37.86 Favored 'General case' 0 C--O 1.218 -0.578 0 N-CA-C 108.522 -0.918 . . . . 73.41 108.522 170.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 253' ' ' VAL . . . . . . . . . . . . . 78.1 t -85.41 140.27 16.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 O-C-N 121.815 -0.553 . . . . 73.5 111.306 -174.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 254' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 -128.81 121.57 28.59 Favored 'General case' 0 C--N 1.346 0.456 0 C-N-CA 124.337 1.055 . . . . 74.13 108.899 169.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 255' ' ' ILE . . . . . 0.604 HD11 HG22 ' C' ' 227' ' ' THR . 38.7 mm -87.7 125.97 41.28 Favored 'Isoleucine or valine' 0 C--N 1.344 0.328 0 CA-C-N 115.854 -0.612 . . . . 75.24 109.775 178.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 256' ' ' THR . . . . . . . . . . . . . 43.9 p -121.61 -174.8 2.94 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.024 0.93 . . . . 53.32 111.027 -173.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 257' ' ' ILE . . . . . 0.466 HD12 ' H ' ' C' ' 259' ' ' GLU . 2.8 pp -140.0 156.45 70.43 Favored Pre-proline 0 CA--C 1.561 1.381 0 C-N-CA 123.408 0.683 . . . . 64.54 110.815 -176.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -56.5 -10.86 5.56 Favored 'Trans proline' 0 C--N 1.387 2.576 0 C-N-CA 124.046 3.164 . . . . 73.21 115.795 -174.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 259' ' ' GLU . . . . . 0.466 ' H ' HD12 ' C' ' 257' ' ' ILE . 50.6 mt-10 53.87 -84.62 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 124.772 1.229 . . . . 72.3 110.006 -163.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 260' ' ' ARG . . . . . 0.406 ' H ' ' HG3' ' C' ' 260' ' ' ARG . 0.0 OUTLIER -73.28 155.68 39.24 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.012 0.925 . . . . 73.41 110.827 176.765 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' C' C ' 261' ' ' LEU . . . . . 0.571 ' HG ' HH12 ' A' ' 226' ' ' ARG . 85.2 mt -130.97 141.36 50.25 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.297 0.639 . . . . 71.21 110.161 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 80.6 p -84.65 164.66 41.57 Favored Pre-proline 0 CA--C 1.558 1.279 0 N-CA-C 107.812 -1.181 . . . . 61.23 107.812 166.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -45.61 -41.87 18.82 Favored 'Trans proline' 0 C--N 1.387 2.574 0 C-N-CA 122.783 2.322 . . . . 74.2 113.776 176.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -55.25 -63.37 1.18 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.037 1.335 . . . . 71.04 111.056 175.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -58.4 -41.46 84.95 Favored 'General case' 0 C--N 1.348 0.525 0 CA-C-N 114.442 -1.253 . . . . 65.11 110.719 -176.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 266' ' ' GLU . . . . . 0.568 ' HA ' HD13 ' C' ' 261' ' ' LEU . 11.0 tp10 -56.31 -51.64 67.47 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.908 0.883 . . . . 64.21 110.43 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -59.44 -49.99 75.68 Favored 'General case' 0 CA--C 1.553 1.085 0 CA-C-N 115.747 -0.66 . . . . 70.32 112.114 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 268' ' ' LEU . . . . . . . . . . . . . 10.3 mp -71.4 -38.31 71.47 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 112.536 0.569 . . . . 52.44 112.536 -174.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -70.98 -30.21 66.41 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 122.629 0.371 . . . . 61.11 111.09 177.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 26.8 mmtp -68.14 -40.45 82.44 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 122.913 0.485 . . . . 75.43 111.172 173.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 271' ' ' LYS . . . . . 0.5 ' HB3' HD21 ' A' ' 268' ' ' LEU . 3.4 mmtm -64.14 -41.3 97.25 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 121.048 0.451 . . . . 75.33 111.256 175.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 72.7 mt -61.41 -42.31 98.54 Favored 'General case' 0 C--O 1.217 -0.649 0 CA-C-N 115.728 -0.669 . . . . 74.33 110.177 172.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 273' ' ' ALA . . . . . 0.472 ' HB2' HG21 ' A' ' 206' ' ' VAL . . . -56.51 -43.09 79.41 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.07 0.548 . . . . 34.13 110.899 -179.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -58.66 -52.15 66.9 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.177 0.991 . . . . 63.21 110.845 174.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -57.88 -28.92 64.62 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 115.05 -0.977 . . . . 70.04 112.09 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 276' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -95.87 -17.23 21.27 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.532 0.733 . . . . 75.52 111.943 -179.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 19.5 m-30 -67.41 -33.88 76.1 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.544 -0.91 . . . . 44.24 108.544 168.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -71.66 -1.05 12.37 Favored 'General case' 0 CA--C 1.557 1.228 0 CA-C-N 114.671 -1.15 . . . . 55.2 112.737 173.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 279' ' ' ARG . . . . . . . . . . . . . 30.2 mtp-105 -99.63 -1.71 37.37 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.403 0.681 . . . . 71.52 110.973 171.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.051 0 CA-C-O 118.551 -0.738 . . . . 75.14 109.722 175.671 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 88.0 tttt . . . . . 0 N--CA 1.479 1.011 0 N-CA-C 114.288 1.218 . . . . 62.43 114.288 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.442 ' HZ2' ' HB3' ' A' ' 94' ' ' SER . 29.3 mmtp -73.18 97.66 2.46 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 107.766 -1.198 . . . . 74.32 107.766 164.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.515 ' HA ' ' OH ' ' A' ' 66' ' ' TYR . 14.3 t70 -74.06 90.55 2.01 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.562 -1.273 . . . . 61.41 107.562 174.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.416 ' HB2' HD11 ' A' ' 57' ' ' LEU . 48.9 m-85 -58.16 -31.69 67.49 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 113.919 -1.491 . . . . 73.34 112.264 -170.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -66.22 -44.56 83.48 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 122.822 0.449 . . . . 73.33 110.736 177.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.73 -41.83 99.36 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 122.992 0.517 . . . . 60.32 110.828 178.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.423 HD11 ' HD2' ' A' ' 5' ' ' LYS . 65.6 mt -58.73 -41.19 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 O-C-N 124.071 0.857 . . . . 74.23 110.683 177.096 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 87.6 mt -80.11 -12.21 59.69 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 112.681 0.622 . . . . 51.33 112.681 177.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.86 17.85 78.61 Favored Glycine 0 C--N 1.349 1.267 0 O-C-N 122.958 0.161 . . . . 53.33 113.403 -176.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.9 m -101.34 154.4 37.24 Favored Pre-proline 0 N--CA 1.482 1.144 0 C-N-CA 124.075 0.95 . . . . 71.43 109.623 174.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -58.5 154.56 41.21 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 122.695 2.263 . . . . 50.12 113.534 176.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 79.0 mtt180 -77.02 66.7 2.89 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.184 0.994 . . . . 75.43 109.797 177.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -178.86 -25.24 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 114.629 -1.169 . . . . 64.11 109.088 -168.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.21 133.32 39.48 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 125.098 1.359 . . . . 64.31 113.338 -174.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.439 ' O ' HD13 ' A' ' 22' ' ' ILE . 51.1 p -78.44 172.98 12.85 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.768 0.827 . . . . 71.11 111.16 179.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 22.7 tm0? -50.4 -37.26 36.69 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.814 1.246 . . . . 64.21 111.016 176.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.446 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 0.3 OUTLIER -61.47 -47.56 85.09 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 124.502 1.121 . . . . 72.43 110.217 -179.522 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -70.32 -34.52 72.78 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.308 1.043 . . . . 64.03 111.211 -178.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.439 HD13 ' O ' ' A' ' 18' ' ' THR . 1.5 mp -64.6 -36.96 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.375 1.07 . . . . 73.31 110.04 174.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -73.42 -30.47 63.26 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.766 0.826 . . . . 71.24 110.42 179.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.446 ' HG3' ' O ' ' A' ' 20' ' ' GLU . 95.3 mtt180 -62.02 -54.67 38.24 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.296 0.57 . . . . 54.12 110.031 172.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.8 -34.29 72.84 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 114.541 -1.208 . . . . 64.0 111.61 178.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -62.82 -49.95 72.92 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.957 0.903 . . . . 73.1 111.12 176.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.438 ' HE2' ' HA ' ' A' ' 24' ' ' ARG . 49.5 mtmt -57.57 -55.15 38.55 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 109.799 -0.445 . . . . 74.22 109.799 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.7 ttp-105 -52.57 -65.89 0.48 Allowed 'General case' 0 N--CA 1.479 1.022 0 O-C-N 123.825 0.703 . . . . 71.15 111.523 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.732 ' HB3' HD13 ' A' ' 50' ' ' ILE . 95.4 mt -72.23 -48.7 40.85 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.186 -0.915 . . . . 74.11 112.434 -170.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.75 -15.54 59.73 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 112.872 0.693 . . . . 63.3 112.872 -173.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -81.3 -40.24 23.96 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 119.187 0.903 . . . . 72.33 109.57 165.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -63.43 -33.94 76.65 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 115.46 -0.791 . . . . 63.33 111.84 -179.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.439 ' HB3' ' O ' ' A' ' 43' ' ' ALA . 21.7 m-85 -111.6 15.97 20.85 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.89 0.876 . . . . 63.25 110.474 -175.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -69.8 119.35 70.72 Favored Pre-proline 0 C--N 1.352 0.685 0 C-N-CA 123.492 0.717 . . . . 63.41 109.332 -176.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.453 ' HG3' ' HG2' ' A' ' 44' ' ' GLU . 32.6 Cg_exo -60.51 -8.66 9.34 Favored 'Trans proline' 0 C--N 1.373 1.829 0 C-N-CA 123.12 2.547 . . . . 74.13 114.369 -178.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -73.56 -43.74 59.1 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.965 0.506 . . . . 72.45 110.601 170.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 52.3 t -95.75 -63.66 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 123.286 0.634 . . . . 65.53 110.168 -177.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -98.28 80.58 2.67 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 122.303 1.049 . . . . 61.35 109.223 -173.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -76.43 81.45 3.15 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 114.205 -1.361 . . . . 73.11 109.638 178.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 69.8 m -140.43 113.94 7.38 Favored Pre-proline 0 N--CA 1.475 0.78 0 C-N-CA 124.152 0.981 . . . . 54.41 108.439 174.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -40.82 -46.17 4.86 Favored 'Trans proline' 0 C--N 1.387 2.568 0 C-N-CA 124.31 3.34 . . . . 72.23 114.05 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.401 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 6.4 tm-20 -54.37 -50.43 67.52 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.679 1.192 . . . . 64.43 109.924 177.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.439 ' O ' ' HB3' ' A' ' 33' ' ' TYR . . . -62.55 -31.86 72.73 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 115.121 -0.945 . . . . 72.14 110.691 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.639 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 47.9 mt-10 -77.4 -34.4 54.82 Favored 'General case' 0 C--O 1.217 -0.626 0 O-C-N 123.75 0.656 . . . . 62.01 109.945 -173.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -65.59 -44.22 87.32 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.533 0.733 . . . . 62.44 109.932 174.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 42' ' ' GLU . 13.3 mmmm -58.13 -44.94 88.07 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 123.772 0.67 . . . . 74.03 109.869 174.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -58.96 -38.97 80.29 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.085 1.354 . . . . 73.24 110.968 178.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.639 ' HG2' ' O ' ' A' ' 44' ' ' GLU . 32.9 mmtp -66.55 -43.45 85.04 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 122.688 0.395 . . . . 75.14 110.925 179.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -58.59 -42.54 88.3 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 123.855 0.722 . . . . 71.44 111.184 175.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.732 HD13 ' HB3' ' A' ' 29' ' ' LEU . 62.3 mt -76.1 -28.68 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 124.935 1.294 . . . . 70.53 111.321 -176.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.422 ' HA ' ' HB3' ' A' ' 54' ' ' TYR . 13.7 m-80 -93.61 -5.65 48.31 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.587 0.755 . . . . 73.43 111.421 175.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -77.01 -53.47 7.77 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 107.49 -1.3 . . . . 63.42 107.49 164.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.18 -37.09 76.53 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 112.962 -1.927 . . . . 65.45 111.133 176.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.422 ' HB3' ' HA ' ' A' ' 51' ' ' ASN . 61.4 t80 -73.43 -47.27 43.04 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-O 118.811 -0.614 . . . . 72.32 110.537 173.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -50.27 -36.18 30.31 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 123.231 0.613 . . . . 53.01 112.368 -178.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.527 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 61.3 t -78.74 -67.48 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 CA-C-N 114.697 -1.138 . . . . 74.52 110.025 175.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.466 HD22 ' HG2' ' A' ' 63' ' ' ARG . 46.3 mt -80.09 4.59 16.74 Favored 'General case' 0 CA--C 1.564 1.483 0 N-CA-C 113.484 0.92 . . . . 62.04 113.484 -165.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.5 t -76.24 -25.0 54.57 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 123.875 0.87 . . . . 74.34 110.275 174.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -109.99 117.47 51.87 Favored Pre-proline 0 N--CA 1.449 -0.524 0 N-CA-C 107.142 -1.429 . . . . 74.34 107.142 176.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.447 ' O ' ' HG2' ' A' ' 64' ' ' ARG . 84.0 Cg_exo -46.96 -26.47 4.89 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 123.147 2.565 . . . . 72.41 113.318 171.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -63.62 -61.21 2.47 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 122.962 0.505 . . . . 72.3 111.274 175.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.527 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 34.8 mttp -66.79 -26.72 67.09 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 122.375 0.27 . . . . 74.54 111.029 -178.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.466 ' HG2' HD22 ' A' ' 57' ' ' LEU . 4.2 tmt_? -61.58 -48.17 82.2 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.845 1.258 . . . . 74.11 108.826 176.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.447 ' HG2' ' O ' ' A' ' 60' ' ' PRO . 19.7 mmm180 -67.1 -33.84 76.33 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.516 -0.765 . . . . 74.25 111.717 176.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.436 HD12 ' HA ' ' A' ' 62' ' ' LYS . 84.5 mt -60.49 -42.87 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 C-N-CA 123.077 0.551 . . . . 64.42 110.169 176.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.515 ' OH ' ' HA ' ' A' ' 6' ' ' ASP . 32.5 t80 -62.76 -51.92 65.23 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.623 -0.717 . . . . 75.4 110.068 175.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -54.17 -41.48 68.57 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 123.826 0.704 . . . . 64.04 111.271 -178.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 68.7 p -79.07 -22.39 45.37 Favored 'General case' 0 C--N 1.348 0.506 0 CA-C-N 115.637 -0.711 . . . . 75.13 111.931 -178.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -70.9 112.46 7.1 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 109.186 -0.672 . . . . 63.45 109.186 177.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 111.34 9.34 21.95 Favored Glycine 0 N--CA 1.473 1.109 0 CA-C-N 115.832 -0.622 . . . . 52.54 111.638 -170.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.8 m -141.44 -59.4 0.48 Allowed 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 104.177 -2.527 . . . . 71.23 104.177 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.5 m -76.64 141.81 40.87 Favored 'General case' 0 C--O 1.252 1.232 0 N-CA-C 104.472 -2.418 . . . . 74.23 104.472 155.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.66 -49.38 6.32 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.243 0.617 . . . . 74.04 111.219 -178.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -97.08 142.49 24.61 Favored Pre-proline 0 N--CA 1.477 0.893 0 C-N-CA 123.037 0.535 . . . . 75.1 110.441 -174.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.421 ' HB2' ' HG3' ' A' ' 103' ' ' PRO . 37.2 Cg_exo -59.34 151.85 65.03 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 123.114 2.543 . . . . 75.41 112.697 174.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.05 158.86 45.52 Favored 'Trans proline' 0 C--N 1.377 2.053 0 C-N-CA 123.216 2.611 . . . . 74.25 114.36 -175.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.96 120.26 7.96 Favored 'Trans proline' 0 C--N 1.386 2.54 0 C-N-CA 123.221 2.614 . . . . 62.44 112.198 171.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.45 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 60.3 Cg_endo -69.18 118.31 5.6 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 122.859 2.372 . . . . 43.51 112.087 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.588 ' HB2' ' HA3' ' A' ' 142' ' ' GLY . 6.5 Cg_exo -74.16 165.62 31.52 Favored 'Trans proline' 0 CA--C 1.566 2.115 0 C-N-CA 122.868 2.378 . . . . 71.05 111.726 178.151 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_exo -51.91 85.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.393 2.913 0 C-N-CA 123.921 3.081 . . . . 51.35 114.428 -176.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 141.29 -44.89 0.99 Allowed Glycine 0 C--N 1.338 0.69 0 N-CA-C 109.767 -1.333 . . . . 62.41 109.767 178.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.42 -168.19 33.27 Favored Glycine 0 C--N 1.351 1.399 0 C-N-CA 123.38 0.514 . . . . 53.03 113.535 176.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -70.14 100.48 1.66 Allowed 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.476 1.11 . . . . 74.41 110.215 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.472 ' HB3' ' NE ' ' A' ' 143' ' ' ARG . 32.6 t0 -60.84 115.82 3.97 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.84 0.856 . . . . 71.31 109.783 173.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -112.9 70.24 0.71 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.458 1.103 . . . . 70.22 108.374 -174.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 16.1 m -44.57 86.56 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 126.232 1.813 . . . . 74.44 115.479 -164.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 65.44 23.39 70.21 Favored Glycine 0 C--N 1.353 1.489 0 CA-C-N 115.496 -0.774 . . . . 70.11 114.741 173.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -102.4 136.25 42.56 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 109.617 -0.512 . . . . 72.34 109.617 -178.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -77.37 91.16 3.83 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 122.111 -0.368 . . . . 71.44 110.033 -175.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.4 p -34.69 -56.65 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 115.019 1.488 . . . . 75.21 115.019 175.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -64.4 -26.32 68.41 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 118.363 0.529 . . . . 75.33 112.369 -178.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -79.85 -21.04 44.6 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.614 0.765 . . . . 45.35 111.006 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -94.82 170.33 9.51 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 107.974 -1.121 . . . . 71.01 107.974 177.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.442 ' HB3' ' HZ2' ' A' ' 5' ' ' LYS . 80.4 p -60.3 149.65 32.84 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 113.826 1.047 . . . . 74.5 113.826 -165.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.42 ' O ' ' HG3' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -61.06 -30.16 70.16 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 114.893 -1.049 . . . . 74.31 110.486 168.127 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -57.83 -45.07 86.7 Favored 'General case' 0 C--N 1.355 0.812 0 C-N-CA 124.002 0.921 . . . . 75.03 110.838 172.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -63.5 -44.54 94.02 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 115.311 -0.859 . . . . 63.23 109.729 175.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.414 ' HA ' HD11 ' A' ' 105' ' ' LEU . 51.1 mt-30 -68.47 -9.8 51.26 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 115.963 -0.562 . . . . 73.05 111.917 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.42 ' HG3' ' O ' ' A' ' 95' ' ' GLU . 38.7 mt-10 -88.78 -59.29 2.27 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 124.119 0.968 . . . . 70.02 111.208 165.099 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 33.8 tp -60.83 -35.67 77.13 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.943 1.297 . . . . 55.03 112.474 -167.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -116.14 6.43 13.95 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.117 0.567 . . . . 72.11 110.67 176.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -42.84 -57.99 3.81 Favored Glycine 0 C--N 1.357 1.721 0 C-N-CA 124.629 1.109 . . . . 72.43 115.131 177.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.421 ' HG3' ' HB2' ' A' ' 75' ' ' PRO . 28.3 Cg_endo -56.88 -19.08 30.17 Favored 'Trans proline' 0 C--N 1.39 2.752 0 C-N-CA 123.264 2.643 . . . . 23.1 113.377 -173.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -142.1 39.89 1.34 Allowed Glycine 0 C--N 1.354 1.563 0 CA-C-O 119.718 -0.49 . . . . 44.4 112.426 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.466 ' HB3' ' ND2' ' A' ' 169' ' ' ASN . 48.6 mt -61.72 72.61 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 123.026 0.53 . . . . 74.25 111.487 169.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.612 ' HB3' ' HA ' ' A' ' 169' ' ' ASN . 2.2 t80 21.09 -106.12 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.432 0 C-N-CA 127.109 2.163 . . . . 72.25 112.774 -170.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 58.99 41.41 96.37 Favored Glycine 0 C--N 1.364 2.11 0 CA-C-O 119.744 -0.475 . . . . 44.0 112.644 178.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.846 ' HA3' ' HB3' ' A' ' 167' ' ' GLN . . . . . . . . 0 C--N 1.367 2.269 0 C-N-CA 124.896 1.236 . . . . 71.34 114.887 165.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 82.4 tttt . . . . . 0 N--CA 1.479 1.008 0 N-CA-C 114.907 1.447 . . . . 72.15 114.907 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -90.22 -173.47 44.89 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-N 115.129 -0.941 . . . . 55.22 113.601 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -93.86 164.07 13.26 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 124.926 1.29 . . . . 71.34 109.572 -177.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -74.25 99.67 3.51 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 121.216 -0.927 . . . . 74.23 109.887 174.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 38.3 tp -95.5 141.19 29.32 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 121.039 0.447 . . . . 70.23 111.484 -167.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -93.0 122.18 35.09 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 107.184 -1.413 . . . . 74.51 107.184 169.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -129.9 168.99 15.77 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.399 -0.593 . . . . 41.51 109.399 176.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -128.91 115.4 17.8 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.482 -0.933 . . . . 61.0 108.482 -175.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 65.3 tp -99.59 100.39 10.71 Favored Pre-proline 0 N--CA 1.472 0.659 0 N-CA-C 108.432 -0.951 . . . . 54.05 108.432 -173.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.555 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 46.4 Cg_endo -67.41 135.86 37.96 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 121.587 1.525 . . . . 75.33 109.535 178.047 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.627 ' HA ' HG21 ' B' ' 6' ' ' ILE . 57.1 tp -146.66 154.93 42.03 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 118.467 0.576 . . . . 64.01 110.311 -176.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 48.5 m -84.67 145.24 28.07 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 124.536 1.134 . . . . 71.34 110.337 178.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.736 ' HB3' HD22 ' A' ' 215' ' ' LEU . 18.7 mt -55.83 -60.55 3.3 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.927 0.891 . . . . 70.54 112.233 -175.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -51.33 -46.37 62.6 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 114.447 -1.252 . . . . 75.32 110.836 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -70.48 -23.94 62.77 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.138 0.975 . . . . 64.33 111.997 -177.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -67.91 -48.01 67.17 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 123.198 0.599 . . . . 41.43 109.596 176.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.419 ' HA ' ' HA2' ' A' ' 152' ' ' GLY . 61.0 t80 -71.85 -28.92 63.88 Favored 'General case' 0 CA--C 1.556 1.199 0 O-C-N 124.015 0.822 . . . . 74.51 111.702 178.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 49.6 m170 -69.61 -53.43 18.85 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 122.663 0.385 . . . . 75.25 111.039 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.563 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 81.19 -167.7 49.65 Favored Glycine 0 CA--C 1.538 1.474 0 CA-C-N 116.266 -0.425 . . . . 71.54 113.199 -178.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.82 -175.75 23.46 Favored Glycine 0 N--CA 1.477 1.41 0 C-N-CA 123.563 0.601 . . . . 70.42 112.205 -179.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.467 ' HB3' ' HB3' ' A' ' 146' ' ' SER . 2.5 mp0 -72.16 108.8 5.53 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.696 -0.853 . . . . 73.14 108.696 176.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 17.8 tpt180 -91.47 127.05 36.76 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.625 -0.88 . . . . 74.4 108.625 -177.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.44 ' HB ' HG21 ' B' ' 5' ' ' THR . 61.6 t -72.7 118.04 17.2 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 N-CA-C 108.779 -0.822 . . . . 71.24 108.779 176.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.512 ' HB ' HG13 ' A' ' 145' ' ' VAL . 59.2 t -132.23 115.8 27.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 124.056 0.942 . . . . 73.14 109.236 -175.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -79.62 124.73 28.8 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 109.04 -0.726 . . . . 71.3 109.04 170.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.532 HG21 HD23 ' B' ' 8' ' ' LEU . 12.2 p -167.68 138.13 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 122.899 0.48 . . . . 75.1 110.57 172.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 64.66 12.3 7.45 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.933 1.293 . . . . 74.24 112.205 -178.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.588 ' HA3' ' HB2' ' A' ' 79' ' ' PRO . . . 76.05 20.41 77.6 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-N 116.562 -0.29 . . . . 31.1 113.132 -172.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.472 ' NE ' ' HB3' ' A' ' 84' ' ' ASP . 1.0 OUTLIER -123.85 114.32 19.71 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 107.926 -1.138 . . . . 72.12 107.926 175.866 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 55.0 ttt-85 -73.16 87.57 1.43 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.3 1.04 . . . . 74.41 109.357 176.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.512 HG13 ' HB ' ' A' ' 138' ' ' VAL . 5.7 p -86.06 134.48 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 123.572 0.749 . . . . 73.53 111.136 -176.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.467 ' HB3' ' HB3' ' A' ' 135' ' ' GLU . 15.2 m -94.41 84.86 4.43 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 114.879 -1.055 . . . . 31.45 108.515 174.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 90.0 t -79.92 108.84 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 N-CA-C 108.207 -1.034 . . . . 73.42 108.207 -177.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 50.5 ttt180 -76.23 92.87 3.32 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 109.116 -0.698 . . . . 74.14 109.116 -177.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.633 ' HB ' HG11 ' A' ' 153' ' ' VAL . 42.2 pt -80.1 137.96 53.04 Favored Pre-proline 0 CA--C 1.555 1.163 0 CA-C-N 114.481 -1.236 . . . . 74.13 109.266 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -62.56 141.58 86.74 Favored 'Trans proline' 0 C--N 1.374 1.888 0 C-N-CA 122.519 2.146 . . . . 60.34 112.245 176.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -58.88 93.79 0.08 OUTLIER 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 122.659 2.24 . . . . 74.15 111.045 170.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . 104.85 77.19 1.13 Allowed Glycine 0 C--N 1.335 0.524 0 CA-C-N 115.032 -0.986 . . . . 75.51 110.85 -172.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.633 HG11 ' HB ' ' A' ' 149' ' ' ILE . 5.8 p -135.01 103.37 4.3 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.239 0 C-N-CA 123.899 0.88 . . . . 75.43 109.248 174.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.618 ' HD2' HD11 ' A' ' 193' ' ' LEU . 60.5 mtt180 -113.32 173.74 6.25 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 113.3 0.852 . . . . 73.23 113.3 -166.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.53 ' HB2' ' HB2' ' A' ' 180' ' ' LEU . 8.6 tp10 -47.65 94.06 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 127.222 2.209 . . . . 72.32 113.965 -167.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 121.49 8.57 7.59 Favored Glycine 0 N--CA 1.478 1.471 0 CA-C-O 119.82 -0.433 . . . . 14.21 114.065 178.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 21.8 t -80.9 147.76 30.18 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 109.048 -0.723 . . . . 74.23 109.048 171.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 61.2 t -114.49 94.15 2.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 C-N-CA 123.584 0.754 . . . . 72.34 109.072 -178.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.594 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 51.7 mt -74.95 95.13 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 N-CA-C 108.212 -1.033 . . . . 75.24 108.212 173.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -79.94 118.01 21.3 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.395 -0.366 . . . . 61.32 110.127 179.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.5 p -118.08 108.89 41.6 Favored Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 123.653 0.781 . . . . 61.33 109.594 175.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -76.37 115.3 4.07 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 123.103 2.536 . . . . 74.53 111.141 175.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 125.56 -28.07 5.08 Favored Glycine 0 CA--C 1.507 -0.458 0 N-CA-C 111.205 -0.758 . . . . 70.43 111.205 176.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 87.9 mtp -94.77 144.21 25.82 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 105.229 -2.137 . . . . 64.15 105.229 162.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 171.4 -124.79 1.14 Allowed Glycine 0 CA--C 1.498 -0.995 0 C-N-CA 121.724 -0.274 . . . . 73.33 112.434 175.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -68.93 160.98 52.11 Favored Glycine 0 C--O 1.245 0.787 0 O-C-N 124.508 0.769 . . . . 74.5 111.967 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.846 ' HB3' ' HA3' ' A' ' 108' ' ' GLY . 31.9 mm-40 -68.87 104.58 2.09 Favored 'General case' 0 CA--C 1.55 0.972 0 O-C-N 125.142 1.143 . . . . 75.42 111.706 -169.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -171.33 162.57 35.24 Favored Glycine 0 C--N 1.344 1.016 0 CA-C-O 118.762 -1.021 . . . . 64.21 112.182 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . 0.622 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . 49.5 t-20 -56.54 -58.69 15.43 Favored Pre-proline 0 N--CA 1.503 2.214 0 CA-C-O 118.288 -0.863 . . . . 63.11 110.571 -171.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.622 ' HD3' ' HB3' ' A' ' 169' ' ' ASN . 12.8 Cg_endo -91.6 97.21 0.21 Allowed 'Trans proline' 0 C--N 1.383 2.376 0 N-CA-C 107.779 -1.662 . . . . 71.13 107.779 157.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.43 165.3 3.32 Favored 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 122.502 2.134 . . . . 71.25 113.861 -170.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -69.0 -118.34 0.03 OUTLIER Glycine 0 N--CA 1.484 1.881 0 N-CA-C 115.401 0.92 . . . . 72.4 115.401 -170.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -135.7 118.89 16.56 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 107.667 -1.234 . . . . 71.14 107.667 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 11.2 tp -105.58 132.46 51.71 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.082 0.467 . . . . 64.32 111.303 -166.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 58.9 mt -108.37 94.69 5.2 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 114.915 -1.039 . . . . 72.12 108.445 176.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.594 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 72.2 mt -78.5 93.84 4.85 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.564 -0.744 . . . . 70.05 109.732 -179.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.0 t -83.4 96.76 4.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 107.498 -1.297 . . . . 61.43 107.498 176.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 12.8 p -65.76 110.37 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.083 0 CA-C-N 115.009 -0.996 . . . . 70.33 111.032 -172.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.555 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 38.8 mmm-85 -96.88 96.14 8.33 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 114.817 -1.083 . . . . 53.32 109.677 179.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.53 ' HB2' ' HB2' ' A' ' 155' ' ' GLU . 29.3 mt -69.59 151.21 46.23 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 122.423 -0.173 . . . . 72.4 110.895 178.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 99.3 mt -51.63 143.08 21.64 Favored Pre-proline 0 N--CA 1.481 1.076 0 C-N-CA 124.173 0.989 . . . . 73.14 111.489 -175.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.2 86.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.387 2.582 0 C-N-CA 123.475 2.784 . . . . 71.42 112.407 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . 0.506 ' HA ' ' HD3' ' A' ' 184' ' ' PRO . 16.3 t-80 -136.96 112.69 9.64 Favored Pre-proline 0 CA--C 1.546 0.823 0 N-CA-C 107.0 -1.482 . . . . 73.35 107.0 -178.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.506 ' HD3' ' HA ' ' A' ' 183' ' ' HIS . 14.2 Cg_exo -70.35 27.05 0.19 Allowed 'Trans proline' 0 CA--C 1.556 1.611 0 C-N-CA 124.42 3.413 . . . . 61.24 117.916 -162.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 14.5 t -94.66 -60.08 2.76 Favored 'Isoleucine or valine' 0 C--N 1.364 1.225 0 CA-C-N 121.102 1.774 . . . . 64.21 109.13 177.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . 0.434 ' HB3' HD21 ' A' ' 193' ' ' LEU . 48.7 m-85 -109.29 140.92 42.33 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 114.765 1.394 . . . . 72.31 114.765 -164.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 7.9 tpp180 -145.13 94.38 2.52 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 126.592 1.957 . . . . 75.51 106.839 172.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.519 ' HA ' ' HA ' ' A' ' 193' ' ' LEU . 22.5 tp -75.0 150.24 39.03 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.056 0.942 . . . . 74.21 110.556 173.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -131.25 100.15 5.09 Favored 'General case' 0 C--O 1.244 0.805 0 N-CA-C 107.879 -1.156 . . . . 70.31 107.879 167.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 65.92 -87.51 0.11 Allowed Glycine 0 C--N 1.352 1.448 0 CA-C-N 115.522 -0.763 . . . . 65.41 113.412 176.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.588 HE21 ' HA3' ' A' ' 242' ' ' GLY . 33.3 tt0 -107.04 -35.13 6.96 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.078 0.951 . . . . 72.32 110.931 -175.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.448 ' HB2' ' HE1' ' A' ' 250' ' ' TYR . 10.6 p-10 -108.02 125.13 51.19 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-O 121.699 0.762 . . . . 72.32 110.598 -168.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.618 HD11 ' HD2' ' A' ' 154' ' ' ARG . 0.4 OUTLIER -91.9 125.7 36.7 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.12 -0.946 . . . . 63.44 108.628 -169.985 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.452 ' HA ' ' HB2' ' A' ' 250' ' ' TYR . 39.3 m-85 -95.97 158.25 15.53 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.837 -0.801 . . . . 73.14 108.837 170.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.466 ' HB2' HD11 ' A' ' 249' ' ' LEU . . . -156.05 176.17 13.01 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 123.155 0.582 . . . . 74.34 109.581 -173.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 35.6 m -130.51 142.08 50.48 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.824 0.849 . . . . 70.21 108.792 172.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 47.6 tp -135.47 125.21 25.41 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 123.796 0.838 . . . . 72.21 109.526 -174.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -82.99 126.2 32.26 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 109.186 -0.672 . . . . 61.43 109.186 170.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 7.5 p -141.19 134.08 14.34 Favored Pre-proline 0 CA--C 1.542 0.662 0 N-CA-C 107.508 -1.293 . . . . 64.4 107.508 175.031 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -78.65 161.22 27.91 Favored 'Trans proline' 0 CA--C 1.545 1.047 0 C-N-CA 121.537 1.491 . . . . 64.51 111.377 169.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.524 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -55.55 -53.89 57.35 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 124.621 1.169 . . . . 71.34 113.899 -171.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -67.53 -28.98 37.78 Favored 'Trans proline' 0 C--N 1.384 2.421 0 CA-C-N 120.769 1.31 . . . . 63.54 112.032 -173.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 17.8 mt -73.74 -34.06 39.75 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 C-N-CA 123.632 0.773 . . . . 64.32 110.318 176.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.79 -38.61 80.12 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 122.858 0.463 . . . . 71.51 111.389 176.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 201' ' ' ALA . 39.9 t -78.43 -42.93 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 123.096 0.558 . . . . 63.23 111.941 -175.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.421 HG11 ' HD2' ' C' ' 270' ' ' LYS . 56.0 t -89.38 -37.81 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 122.507 0.323 . . . . 74.41 111.45 -177.006 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 101.0 105.45 2.8 Favored Glycine 0 C--N 1.337 0.604 0 CA-C-N 116.413 -0.358 . . . . 72.35 112.421 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.434 ' HA3' ' CE1' ' C' ' 277' ' ' TYR . . . -158.69 178.46 34.88 Favored Glycine 0 C--N 1.347 1.152 0 CA-C-N 116.631 0.215 . . . . 55.24 113.163 -178.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.428 ' HE3' ' HB2' ' A' ' 209' ' ' LYS . 38.1 mtmt -79.98 137.38 36.83 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.945 0.498 . . . . 45.21 111.63 -172.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.462 HG11 ' HA ' ' A' ' 199' ' ' VAL . 27.5 m -130.45 151.74 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.83 1.252 . . . . 63.11 108.0 167.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 43.3 ttp180 -84.18 115.13 22.26 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 110.054 -0.35 . . . . 71.41 110.054 -179.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.29 132.09 47.0 Favored 'General case' 0 C--O 1.245 0.832 0 C-N-CA 123.502 0.721 . . . . 62.04 109.415 174.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . 0.509 ' N ' ' SD ' ' A' ' 213' ' ' MET . 1.0 OUTLIER -86.37 101.79 13.43 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 107.64 -1.244 . . . . 71.23 107.64 178.931 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 60.2 p -111.23 168.99 9.09 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 108.896 -0.779 . . . . 74.1 108.896 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.736 HD22 ' HB3' ' A' ' 127' ' ' LEU . 7.2 mt -79.14 -6.76 57.28 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 120.865 0.364 . . . . 63.31 111.183 -172.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -100.31 -4.36 29.39 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.697 1.199 . . . . 64.44 110.92 173.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 132.67 -175.36 20.02 Favored Glycine 0 C--N 1.351 1.37 0 CA-C-O 120.038 -0.312 . . . . 33.0 113.312 174.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -83.68 101.36 0.92 Allowed 'Trans proline' 0 C--N 1.369 1.628 0 C-N-CA 122.754 2.302 . . . . 70.23 111.155 175.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 34.9 m -101.37 162.2 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 123.151 0.58 . . . . 73.4 109.836 -177.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -100.82 112.63 25.09 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 109.397 -0.594 . . . . 75.04 109.397 176.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 76.6 t -93.84 106.3 17.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 107.985 -1.117 . . . . 74.13 107.985 177.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -71.91 99.65 2.27 Favored 'General case' 0 C--N 1.347 0.495 0 N-CA-C 107.923 -1.14 . . . . 60.25 107.923 172.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 90.6 t -62.77 133.33 95.04 Favored Pre-proline 0 CA--C 1.543 0.705 0 CA-C-N 114.015 -1.448 . . . . 63.14 109.569 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -58.03 155.63 32.89 Favored 'Trans proline' 0 C--N 1.376 1.986 0 C-N-CA 122.493 2.129 . . . . 75.51 112.614 171.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.33 156.77 64.81 Favored 'Trans proline' 0 C--N 1.372 1.771 0 C-N-CA 121.798 1.665 . . . . 72.53 112.33 172.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . 0.435 HH21 ' HG ' ' C' ' 261' ' ' LEU . 1.5 ptp85 43.53 48.45 6.3 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 126.484 1.914 . . . . 74.04 113.047 -178.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 20.1 m -86.63 115.68 24.25 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 113.053 -1.885 . . . . 64.32 109.815 175.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -87.13 147.3 25.7 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.652 0.781 . . . . 75.32 111.291 -175.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -63.65 132.92 52.61 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.884 0.874 . . . . 62.31 110.9 175.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 99.29 -19.82 52.39 Favored Glycine 0 C--N 1.343 0.924 0 CA-C-O 119.612 -0.549 . . . . 73.32 112.902 177.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 30.1 mtm-85 -77.35 158.93 29.87 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 117.289 0.544 . . . . 74.0 110.424 175.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -108.97 123.46 49.15 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.122 0.969 . . . . 72.22 109.883 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.45 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 57.5 mt -77.9 108.3 11.05 Favored 'General case' 0 C--N 1.348 0.542 0 N-CA-C 108.489 -0.93 . . . . 71.4 108.489 173.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -88.07 109.37 19.8 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 122.96 0.504 . . . . 64.14 110.927 -178.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.525 ' HG ' ' HB3' ' A' ' 249' ' ' LEU . 0.6 OUTLIER -121.85 111.79 17.55 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.15 0.58 . . . . 61.12 111.577 -179.194 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.456 ' HE3' ' HB3' ' A' ' 248' ' ' ASP . 4.2 mmpt? -52.87 147.92 8.36 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.862 1.265 . . . . 64.43 113.096 174.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 101.56 -17.32 55.36 Favored Glycine 0 C--N 1.351 1.377 0 CA-C-N 115.562 -0.745 . . . . 74.2 114.315 173.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.407 ' HB2' ' HB2' ' A' ' 249' ' ' LEU . 73.0 mmtt -104.91 5.75 33.12 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 112.567 0.58 . . . . 73.01 112.567 -175.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -100.23 174.81 26.59 Favored Glycine 0 C--N 1.349 1.27 0 N-CA-C 112.383 -0.287 . . . . 74.43 112.383 166.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -100.53 163.92 17.24 Favored Pre-proline 0 N--CA 1.48 1.074 0 C-N-CA 125.155 1.382 . . . . 73.13 112.584 -163.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -46.94 140.63 13.07 Favored 'Trans proline' 0 C--N 1.394 2.952 0 C-N-CA 124.23 3.286 . . . . 73.33 114.563 174.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.588 ' HA3' HE21 ' A' ' 191' ' ' GLN . . . 175.75 -167.48 39.33 Favored Glycine 0 CA--C 1.534 1.271 0 CA-C-N 115.422 -0.808 . . . . 73.52 112.122 179.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -56.32 -28.81 73.96 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 123.733 2.956 . . . . 70.45 114.439 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -92.83 22.43 4.85 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.562 0.745 . . . . 70.11 111.843 -178.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 78.18 -93.1 1.19 Allowed Glycine 0 C--N 1.348 1.233 0 N-CA-C 109.762 -1.335 . . . . 62.24 109.762 -172.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 30.3 mtp180 -127.19 148.09 50.19 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.88 0.872 . . . . 75.41 108.904 166.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -78.32 -157.03 9.64 Favored Glycine 0 CA--C 1.535 1.33 0 CA-C-O 121.637 0.576 . . . . 42.24 113.902 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . 0.456 ' HB3' ' HE3' ' A' ' 236' ' ' LYS . 0.4 OUTLIER -134.49 165.0 26.2 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.404 1.081 . . . . 75.44 111.223 -174.96 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.55 HD13 HD13 ' A' ' 193' ' ' LEU . 61.6 tp -100.39 153.31 19.44 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.493 1.117 . . . . 70.31 109.756 178.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.452 ' HB2' ' HA ' ' A' ' 194' ' ' TYR . 62.9 m-85 -128.65 103.6 7.18 Favored 'General case' 0 C--O 1.219 -0.536 0 N-CA-C 108.873 -0.788 . . . . 52.51 108.873 177.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.45 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 32.8 mt -90.09 104.16 16.76 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.122 -0.696 . . . . 72.24 109.122 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -77.36 125.27 29.07 Favored 'General case' 0 C--N 1.362 1.141 0 CA-C-O 121.64 0.734 . . . . 75.41 109.933 -176.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 61.1 t -78.76 117.61 24.6 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-N 114.271 -1.331 . . . . 24.43 111.701 -169.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 15.8 mmm-85 -114.49 96.17 5.63 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.126 -1.064 . . . . 73.14 108.126 170.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.501 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 69.8 mt -75.44 133.95 30.27 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 CA-C-N 114.86 -1.064 . . . . 74.34 110.12 178.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 22.6 p -126.09 -177.95 4.13 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.865 1.266 . . . . 73.43 110.144 178.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . 0.538 HG23 HG21 ' C' ' 255' ' ' ILE . 2.4 pp -139.01 159.66 65.93 Favored Pre-proline 0 N--CA 1.491 1.589 0 C-N-CA 123.803 0.841 . . . . 73.4 110.655 -177.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -60.96 -9.44 12.06 Favored 'Trans proline' 0 C--N 1.393 2.903 0 C-N-CA 123.112 2.541 . . . . 74.45 115.519 -167.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . 0.826 ' HG2' HE21 ' C' ' 228' ' ' GLN . 42.4 mt-10 57.0 -64.92 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 125.824 1.649 . . . . 63.24 114.288 -174.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.15 157.16 16.87 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 109.326 -0.62 . . . . 75.12 109.326 168.157 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.594 HD13 ' HA ' ' A' ' 266' ' ' GLU . 64.2 mt -141.9 131.47 23.95 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 118.287 0.494 . . . . 55.32 111.237 -178.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.46 148.35 52.1 Favored Pre-proline 0 CA--C 1.555 1.143 0 N-CA-C 107.702 -1.222 . . . . 44.34 107.702 167.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -40.8 -31.82 0.76 Allowed 'Trans proline' 0 C--N 1.392 2.838 0 C-N-CA 124.939 3.76 . . . . 74.33 116.58 -167.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -61.38 -68.08 0.35 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.448 0.699 . . . . 71.44 110.758 176.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . 0.543 ' HB2' HD22 ' A' ' 261' ' ' LEU . 1.7 mp0 -67.17 -28.28 67.98 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 123.487 0.492 . . . . 64.2 110.28 -175.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 266' ' ' GLU . . . . . 0.594 ' HA ' HD13 ' A' ' 261' ' ' LEU . 8.3 tp10 -50.38 -58.46 5.65 Favored 'General case' 0 C--O 1.253 1.249 0 C-N-CA 124.258 1.023 . . . . 73.45 109.459 171.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . 0.447 ' O ' ' HG2' ' A' ' 271' ' ' LYS . . . -59.13 -58.43 8.67 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 114.702 -1.135 . . . . 64.12 111.15 177.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 10.2 mp -57.6 -45.92 84.69 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 123.852 0.861 . . . . 73.14 112.854 -170.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 63.3 m95 -60.23 -46.92 88.1 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 123.749 0.655 . . . . 75.0 110.805 175.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . 0.625 ' HE2' ' HA ' ' C' ' 206' ' ' VAL . 2.2 mptm? -63.05 -34.33 77.35 Favored 'General case' 0 CA--C 1.548 0.874 0 O-C-N 123.727 0.642 . . . . 62.43 112.03 178.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' A' ' 267' ' ' ALA . 26.4 mmmt -73.96 -40.31 63.12 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 118.084 0.402 . . . . 70.22 110.366 -177.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 39.5 mt -57.72 -39.38 77.11 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 123.467 0.707 . . . . 63.4 110.204 170.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -65.97 -45.1 82.92 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 124.129 0.893 . . . . 64.51 112.644 -177.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -67.35 -42.85 82.83 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.811 0.844 . . . . 74.35 110.763 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -62.53 -44.13 97.1 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.38 -0.827 . . . . 71.44 110.231 177.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -63.69 -44.25 94.25 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.415 1.086 . . . . 75.02 109.909 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -62.71 -43.6 98.4 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.82 1.248 . . . . 70.12 109.492 -177.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -75.02 -5.03 41.83 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 115.236 -0.893 . . . . 75.41 112.563 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 43.7 mtm180 -115.38 -0.88 13.01 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.808 0.843 . . . . 74.13 110.08 173.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.1 0 N-CA-C 108.546 -0.909 . . . . 72.21 108.546 178.975 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.476 0.874 0 N-CA-C 109.627 -0.509 . . . . 71.44 109.627 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 2' ' ' LYS . . . . . 0.408 ' HG2' ' HG3' ' B' ' 3' ' ' GLN . 85.1 tttt 65.43 143.89 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 125.483 1.513 . . . . 54.1 111.906 -176.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 3' ' ' GLN . . . . . 0.408 ' HG3' ' HG2' ' B' ' 2' ' ' LYS . 25.1 mt-30 64.64 1.66 1.43 Allowed 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 125.164 1.386 . . . . 74.04 113.479 -178.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 43.3 m -72.57 95.28 1.8 Allowed 'General case' 0 C--N 1.354 0.797 0 C-N-CA 123.468 0.707 . . . . 52.14 109.111 -179.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 5' ' ' THR . . . . . 0.44 HG21 ' HB ' ' A' ' 137' ' ' VAL . 0.1 OUTLIER -83.39 160.85 21.53 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.418 -0.81 . . . . 70.11 111.102 -171.879 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.627 HG21 ' HA ' ' A' ' 125' ' ' LEU . 38.5 pt -130.34 168.89 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 112.943 0.72 . . . . 64.44 112.943 -154.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -145.25 124.78 13.17 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.82 0.848 . . . . 72.01 108.975 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . 0.532 HD23 HG21 ' A' ' 140' ' ' VAL . 60.7 tp -63.53 138.3 58.46 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.066 0.946 . . . . 75.22 110.894 -174.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.52 -48.63 80.9 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 124.183 0.927 . . . . 62.4 111.074 177.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 6.1 tt 53.67 89.79 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.155 0 O-C-N 124.53 1.144 . . . . 74.1 108.957 -172.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 91.7 mt . . . . . 0 CA--C 1.547 0.833 0 N-CA-C 110.045 -0.354 . . . . 45.35 110.045 -176.05 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.319 0 N-CA-C 114.308 1.225 . . . . 61.34 114.308 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . 54.54 48.45 20.41 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.838 0.828 . . . . 74.4 109.088 -168.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 31.2 tp 62.25 -77.56 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.28 0 CA-C-N 113.277 -1.783 . . . . 62.04 111.584 -166.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 182' ' ' VAL . . . . . 0.667 ' HA ' ' HB3' ' C' ' 123' ' ' LEU . 91.3 t -96.5 141.3 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 123.839 0.856 . . . . 71.31 111.364 -175.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -134.8 8.05 3.52 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.5 0.72 . . . . 65.24 112.708 -176.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 184' ' ' HIS . . . . . 0.438 ' HD2' ' HB3' ' C' ' 122' ' ' GLU . 80.0 t60 -145.44 152.33 39.64 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 118.104 0.411 . . . . 74.15 110.371 179.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 185' ' ' VAL . . . . . . . . . . . . . 71.4 t . . . . . 0 N--CA 1.501 2.087 0 C-N-CA 126.124 1.77 . . . . 71.33 110.439 -170.83 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 8.9 m . . . . . 0 CA--C 1.555 1.149 0 N-CA-C 109.562 -0.533 . . . . 71.31 109.562 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 239' ' ' ALA . . . . . 0.518 ' HB2' ' HA ' ' C' ' 221' ' ' VAL . . . -67.91 -179.36 1.17 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.345 1.058 . . . . 74.42 111.964 176.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 240' ' ' GLY . . . . . 0.469 ' HA3' ' O ' ' C' ' 234' ' ' ARG . . . -103.38 -114.09 3.89 Favored Glycine 0 C--N 1.343 0.956 0 CA-C-O 119.718 -0.49 . . . . 71.23 111.903 -176.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -149.99 142.55 24.47 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.217 0.607 . . . . 71.21 111.087 -178.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -179.63 117.25 0.06 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 125.279 1.432 . . . . 70.32 108.971 173.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 243' ' ' GLN . . . . . 0.618 HE21 ' HG2' ' C' ' 224' ' ' PRO . 26.2 mt-30 65.36 -79.48 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 125.068 1.347 . . . . 74.22 113.004 176.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 152.63 100.13 0.19 Allowed Glycine 0 C--N 1.347 1.177 0 N-CA-C 111.699 -0.561 . . . . 63.11 111.699 -177.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.552 1.058 0 C-N-CA 123.835 0.854 . . . . 75.34 111.48 -178.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.656 0 N-CA-C 110.008 -0.367 . . . . 52.01 110.008 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -38.72 104.96 0.04 OUTLIER 'General case' 0 C--N 1.358 0.939 0 C-N-CA 125.504 1.522 . . . . 70.52 112.779 178.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 5' ' ' LYS . . . . . 0.47 ' HE2' HD11 ' C' ' 10' ' ' ILE . 47.6 mtpt -97.34 112.37 24.22 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.625 -0.88 . . . . 63.2 108.625 173.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -71.07 105.01 3.19 Favored 'General case' 0 C--O 1.244 0.788 0 N-CA-C 108.806 -0.813 . . . . 63.22 108.806 174.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 7' ' ' TYR . . . . . 0.421 ' HA ' HD12 ' C' ' 10' ' ' ILE . 75.5 m-85 -63.42 -26.54 68.78 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 114.544 -1.207 . . . . 73.43 112.074 -173.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -63.58 -48.23 78.25 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 109.578 -0.527 . . . . 72.53 109.578 173.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.95 -37.84 83.77 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.102 0.561 . . . . 52.31 111.544 179.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 10' ' ' ILE . . . . . 0.47 HD11 ' HE2' ' C' ' 5' ' ' LYS . 63.8 mt -58.78 -43.9 89.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 C-N-CA 123.225 0.61 . . . . 63.34 110.465 174.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 73.4 mt -76.32 -11.83 59.97 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 115.77 -0.65 . . . . 45.45 112.698 177.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.32 40.22 55.7 Favored Glycine 0 C--N 1.35 1.353 0 N-CA-C 112.821 -0.112 . . . . 64.33 112.821 -176.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 14.6 m -131.78 156.66 79.83 Favored Pre-proline 0 N--CA 1.485 1.295 0 C-N-CA 124.927 1.291 . . . . 64.04 109.826 178.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -80.97 177.16 8.23 Favored 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 122.452 2.101 . . . . 74.43 112.421 176.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 90.5 mtt180 -83.78 36.99 0.57 Allowed 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 122.485 1.136 . . . . 71.52 111.297 176.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -117.34 -15.59 10.35 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.702 2.001 . . . . 71.24 107.417 172.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.79 104.69 0.56 Allowed 'General case' 0 C--N 1.35 0.621 0 CA-C-N 114.383 -1.28 . . . . 71.14 112.834 -169.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 76.7 p -71.28 -170.13 0.46 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.894 1.278 . . . . 74.41 110.841 174.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.83 -42.89 90.34 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 124.276 1.03 . . . . 74.45 110.152 177.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 20' ' ' GLU . . . . . 0.493 ' O ' ' HG3' ' C' ' 24' ' ' ARG . 0.9 OUTLIER -75.58 -35.74 60.52 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 116.235 -0.438 . . . . 64.05 110.326 -175.582 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -68.52 -38.85 81.26 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-O 121.223 0.535 . . . . 73.42 110.55 178.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 1.1 mp -60.14 -39.53 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.397 1.079 . . . . 61.32 109.796 169.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -70.01 -31.39 69.04 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.297 -0.865 . . . . 74.13 110.812 178.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 24' ' ' ARG . . . . . 0.493 ' HG3' ' O ' ' C' ' 20' ' ' GLU . 89.0 mtt180 -65.81 -44.87 84.35 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 109.398 -0.593 . . . . 73.52 109.398 177.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.09 -34.9 79.11 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 114.57 -1.196 . . . . 75.32 111.562 176.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 26' ' ' TYR . . . . . 0.418 ' O ' ' HB3' ' C' ' 30' ' ' ALA . 86.6 t80 -67.9 -48.15 66.8 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 123.816 0.698 . . . . 72.31 110.631 177.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -59.37 -56.11 26.18 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.381 -0.6 . . . . 74.1 109.381 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 32.3 ttt180 -50.49 -70.76 0.08 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.947 0.899 . . . . 71.15 111.489 177.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 86.7 mt -75.0 -50.31 16.98 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.42 -0.809 . . . . 60.22 112.04 -168.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' C' ' 26' ' ' TYR . . . -67.57 -28.52 67.85 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-O 117.714 -1.136 . . . . 75.32 112.239 -176.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . 0.462 ' HA ' ' HB2' ' C' ' 34' ' ' HIS . 74.5 mtm180 -80.9 -28.24 35.95 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 120.051 1.296 . . . . 73.5 110.842 173.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -65.34 -31.33 72.4 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.212 0.605 . . . . 71.12 110.367 171.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 33' ' ' TYR . . . . . 0.453 ' HB3' ' O ' ' C' ' 43' ' ' ALA . 21.7 m-85 -111.02 8.13 21.8 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.884 0.873 . . . . 70.15 112.056 -174.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 34' ' ' HIS . . . . . 0.462 ' HB2' ' HA ' ' C' ' 31' ' ' ARG . 9.4 t-160 -75.43 114.33 34.79 Favored Pre-proline 0 N--CA 1.479 1.003 0 CA-C-O 118.26 -0.876 . . . . 72.34 110.152 -174.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.52 -20.53 49.9 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 122.423 2.082 . . . . 71.32 112.882 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -53.5 -43.69 68.45 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.773 1.229 . . . . 60.34 112.181 173.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 86.5 t -107.53 -52.49 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 123.109 0.564 . . . . 75.33 109.955 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -98.37 90.68 4.88 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.128 0.971 . . . . 54.22 109.898 -176.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -74.84 81.4 2.12 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 109.113 -0.699 . . . . 62.24 109.113 176.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 70.8 m -137.37 117.02 10.31 Favored Pre-proline 0 N--CA 1.48 1.037 0 C-N-CA 123.459 0.704 . . . . 74.14 109.756 176.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -50.52 -43.33 45.52 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 123.882 3.055 . . . . 63.44 114.005 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -58.06 -40.3 80.66 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.406 0.682 . . . . 65.44 110.549 175.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 43' ' ' ALA . . . . . 0.453 ' O ' ' HB3' ' C' ' 33' ' ' TYR . . . -73.41 -17.93 61.21 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 115.661 -0.7 . . . . 62.05 110.259 -178.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 44' ' ' GLU . . . . . 0.457 ' O ' ' HD3' ' C' ' 48' ' ' LYS . 44.1 mt-10 -74.87 -43.9 51.9 Favored 'General case' 0 C--N 1.358 0.947 0 N-CA-C 109.217 -0.66 . . . . 74.04 109.217 175.01 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -57.69 -46.03 84.87 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 121.672 0.748 . . . . 42.53 110.048 175.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 46' ' ' LYS . . . . . 0.557 ' O ' HG12 ' C' ' 50' ' ' ILE . 99.9 mttt -63.6 -39.56 94.67 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 114.237 -1.347 . . . . 72.32 110.802 176.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -62.94 -32.53 73.86 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.869 0.868 . . . . 62.23 110.476 177.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 48' ' ' LYS . . . . . 0.457 ' HD3' ' O ' ' C' ' 44' ' ' GLU . 2.5 mptm? -65.81 -47.32 75.48 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 122.959 0.504 . . . . 72.04 109.702 173.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -58.57 -44.59 89.81 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.13 0.572 . . . . 72.33 111.304 178.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 50' ' ' ILE . . . . . 0.557 HG12 ' O ' ' C' ' 46' ' ' LYS . 20.3 mm -63.21 -49.31 83.7 Favored 'Isoleucine or valine' 0 C--N 1.361 1.078 0 CA-C-N 115.686 -0.688 . . . . 75.43 109.733 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 51' ' ' ASN . . . . . 0.51 ' HA ' ' HB3' ' C' ' 54' ' ' TYR . 22.0 m-80 -79.9 -9.18 59.65 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.703 0.801 . . . . 74.04 112.169 -176.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -71.26 -61.37 1.79 Allowed 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 107.842 -1.17 . . . . 63.42 107.842 167.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.65 -41.72 86.71 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 113.626 -1.624 . . . . 63.1 112.216 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 54' ' ' TYR . . . . . 0.51 ' HB3' ' HA ' ' C' ' 51' ' ' ASN . 67.2 t80 -65.1 -52.68 54.04 Favored 'General case' 0 C--O 1.213 -0.837 0 CA-C-N 115.148 -0.933 . . . . 75.01 109.884 177.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.68 -38.2 63.95 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 112.199 0.444 . . . . 60.54 112.199 -177.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 98.2 t -64.61 -55.61 20.39 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 O-C-N 123.99 0.807 . . . . 72.43 110.887 173.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 57' ' ' LEU . . . . . . . . . . . . . 68.0 mt -94.27 7.58 44.86 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 113.616 0.969 . . . . 75.02 113.616 -168.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 43.8 t -69.65 -81.03 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.719 0.807 . . . . 62.42 110.919 -175.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -83.8 145.4 47.0 Favored Pre-proline 0 C--O 1.248 1.021 0 N-CA-C 109.37 -0.604 . . . . 72.03 109.37 -174.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 60' ' ' PRO . . . . . 0.402 ' O ' ' HG2' ' C' ' 64' ' ' ARG . 9.8 Cg_endo -47.13 -33.92 16.4 Favored 'Trans proline' 0 C--N 1.387 2.588 0 C-N-CA 124.546 3.497 . . . . 33.23 113.634 -176.02 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -56.11 -71.03 0.1 Allowed 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 124.492 1.117 . . . . 62.13 111.62 178.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 33.8 mtmt -66.01 -29.08 69.39 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.74 0.816 . . . . 75.23 111.185 -174.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 23.8 tpt85 -54.19 -52.47 61.1 Favored 'General case' 0 C--N 1.356 0.876 0 O-C-N 124.277 0.986 . . . . 64.42 109.583 170.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 64' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' C' ' 60' ' ' PRO . 1.7 mmp_? -63.33 -35.99 82.21 Favored 'General case' 0 C--N 1.357 0.896 0 CA-C-O 118.613 -0.708 . . . . 74.15 111.915 178.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 1.5 mp -55.98 -45.31 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-N 118.281 0.492 . . . . 62.34 110.363 175.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -61.59 -55.17 33.7 Favored 'General case' 0 C--N 1.358 0.957 0 N-CA-C 109.937 -0.394 . . . . 74.22 109.937 176.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -56.48 -36.48 69.15 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.646 0.778 . . . . 73.14 112.586 -176.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 45.5 p -77.35 -30.65 54.0 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 119.085 -0.484 . . . . 63.2 110.92 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -66.82 128.39 36.13 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 118.425 0.557 . . . . 75.22 110.471 -179.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.19 14.85 55.4 Favored Glycine 0 C--N 1.345 1.059 0 N-CA-C 111.582 -0.607 . . . . 62.51 111.582 -176.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 29.8 m -142.48 -57.44 0.44 Allowed 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 103.942 -2.614 . . . . 72.34 103.942 177.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 49.5 m -79.73 141.15 36.61 Favored 'General case' 0 C--O 1.257 1.494 0 N-CA-C 104.871 -2.27 . . . . 73.35 104.871 154.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.4 -40.07 10.12 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.486 0.714 . . . . 73.23 109.833 178.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -77.88 128.28 79.56 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 123.886 0.874 . . . . 53.23 110.619 -175.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -62.48 121.28 9.18 Favored 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 122.642 2.228 . . . . 75.14 110.746 174.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -52.23 131.19 38.67 Favored 'Trans proline' 0 C--N 1.38 2.193 0 C-N-CA 123.328 2.685 . . . . 63.14 113.001 -179.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 77' ' ' PRO . . . . . 0.503 ' HA ' ' HD3' ' C' ' 78' ' ' PRO . 12.2 Cg_endo -53.03 126.79 22.62 Favored 'Trans proline' 0 C--N 1.39 2.743 0 C-N-CA 123.392 2.728 . . . . 51.51 112.232 -175.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 78' ' ' PRO . . . . . 0.503 ' HD3' ' HA ' ' C' ' 77' ' ' PRO . 19.7 Cg_exo -64.09 148.53 91.39 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 122.738 2.292 . . . . 74.44 112.317 -172.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -57.34 158.1 19.81 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 122.512 2.141 . . . . 61.04 111.251 171.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -53.42 80.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.386 2.52 0 C-N-CA 124.069 3.179 . . . . 51.5 115.259 -171.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 149.75 -41.91 0.81 Allowed Glycine 0 C--N 1.341 0.826 0 N-CA-C 110.773 -0.931 . . . . 75.2 110.773 -178.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 145.86 174.86 18.42 Favored Glycine 0 C--N 1.343 0.921 0 C-N-CA 123.472 0.558 . . . . 74.45 111.881 177.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -53.56 124.32 14.64 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.209 1.004 . . . . 70.14 109.799 169.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -58.1 110.85 1.01 Allowed 'General case' 0 N--CA 1.479 0.984 0 O-C-N 123.88 0.737 . . . . 63.13 111.179 175.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 85' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -142.86 31.62 1.42 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.371 1.469 . . . . 74.41 108.736 170.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 86' ' ' SER . . . . . 0.462 ' OG ' ' HD2' ' C' ' 143' ' ' ARG . 7.4 m -71.04 106.88 3.86 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 114.216 -1.356 . . . . 45.43 110.191 -173.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 100.84 -21.8 42.21 Favored Glycine 0 C--N 1.337 0.626 0 CA-C-N 116.107 -0.497 . . . . 74.33 112.811 -176.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 88' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -88.0 130.65 34.9 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 108.203 -1.036 . . . . 74.44 108.203 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -75.68 69.55 2.39 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.964 0.905 . . . . 72.23 110.664 -170.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 90' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -48.34 -43.27 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 125.679 1.592 . . . . 54.41 112.114 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -62.76 -30.78 71.7 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.267 0.627 . . . . 74.21 111.91 -176.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -81.53 -26.02 35.43 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.511 0.324 . . . . 75.53 110.607 177.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 15.1 m-30 -68.95 166.75 17.24 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.499 0.319 . . . . 72.45 110.855 -174.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 65.1 p -63.68 162.2 13.6 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 114.3 1.222 . . . . 45.51 114.3 -165.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 95' ' ' GLU . . . . . 0.421 ' O ' ' HG3' ' C' ' 99' ' ' GLU . 0.0 OUTLIER -63.39 -44.17 95.47 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 114.988 -1.006 . . . . 55.43 111.931 178.245 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -55.79 -46.95 77.85 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.313 0.645 . . . . 65.02 110.545 177.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 97' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -56.58 -46.85 80.59 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 113.77 -1.559 . . . . 64.25 110.271 175.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 98' ' ' GLN . . . . . 0.489 ' HA ' ' CD1' ' C' ' 105' ' ' LEU . 93.1 mt-30 -73.89 -12.71 60.75 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.183 0.808 . . . . 51.52 113.183 -176.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 99' ' ' GLU . . . . . 0.421 ' HG3' ' O ' ' C' ' 95' ' ' GLU . 46.8 mt-10 -87.1 -48.43 8.08 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.19 0.596 . . . . 74.43 111.211 172.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 13.3 tp -66.6 -60.1 3.01 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.588 0.755 . . . . 73.23 111.313 -175.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 101' ' ' PHE . . . . . 0.402 ' C ' ' HG ' ' C' ' 105' ' ' LEU . 64.4 m-85 -85.23 -8.98 58.29 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 116.205 -0.452 . . . . 73.25 110.994 -177.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -39.0 -55.24 2.34 Favored Glycine 0 C--N 1.365 2.157 0 CA-C-O 118.407 -1.218 . . . . 54.11 114.943 -176.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -29.24 -37.47 0.04 OUTLIER 'Trans proline' 0 C--N 1.391 2.782 1 C-N-CA 125.731 4.287 . . . . 62.02 116.888 173.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -147.52 36.45 1.17 Allowed Glycine 0 C--N 1.352 1.454 0 C-N-CA 121.559 -0.353 . . . . 43.23 112.982 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 105' ' ' LEU . . . . . 0.489 ' CD1' ' HA ' ' C' ' 98' ' ' GLN . 4.1 mt . . . . . 0 N--CA 1.488 1.436 0 N-CA-C 115.629 1.714 . . . . 73.03 115.629 -174.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.969 0 N-CA-C 111.252 -0.739 . . . . 45.25 111.252 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 67.7 mtp180 -93.91 163.55 13.45 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.545 0.738 . . . . 64.44 109.977 177.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 118' ' ' ASP . . . . . 0.403 ' HA ' ' O ' ' C' ' 173' ' ' ASP . 9.6 p-10 -73.33 93.52 1.92 Allowed 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 108.57 -0.9 . . . . 75.42 108.57 174.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 119' ' ' LEU . . . . . 0.462 HD13 ' HA ' ' C' ' 174' ' ' LEU . 0.0 OUTLIER -95.33 157.08 16.05 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 108.233 -1.025 . . . . 75.21 108.233 -178.544 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.64 126.41 48.97 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.94 -0.392 . . . . 72.31 109.94 -174.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 121' ' ' ALA . . . . . . . . . . . . . . . -125.19 118.71 26.65 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 108.747 -0.834 . . . . 63.21 108.747 -178.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 122' ' ' GLU . . . . . 0.438 ' HB3' ' HD2' ' B' ' 184' ' ' HIS . 37.2 tt0 -94.88 148.16 22.6 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 122.676 0.39 . . . . 73.22 110.839 -171.116 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 123' ' ' LEU . . . . . 0.667 ' HB3' ' HA ' ' B' ' 182' ' ' VAL . 1.0 OUTLIER -144.61 114.82 5.19 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 122.862 0.465 . . . . 73.3 111.137 -177.318 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' C' ' 179' ' ' ARG . 33.1 Cg_endo -66.18 114.45 3.03 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 121.862 1.708 . . . . 72.51 108.964 162.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 125' ' ' LEU . . . . . 0.583 HD23 HG11 ' C' ' 153' ' ' VAL . 18.4 tp -138.15 155.52 48.64 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.579 0.351 . . . . 74.03 110.846 -164.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 126' ' ' THR . . . . . . . . . . . . . 15.0 p -100.09 160.6 14.19 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-O 121.871 0.843 . . . . 61.53 111.218 173.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 127' ' ' LEU . . . . . 0.486 HD21 HD13 ' C' ' 180' ' ' LEU . 8.4 mt -67.13 -35.46 79.77 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 113.46 -1.7 . . . . 62.25 108.479 174.127 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -62.88 -47.23 84.2 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 113.145 -1.843 . . . . 75.24 109.605 176.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -66.46 -28.82 68.89 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 122.854 0.462 . . . . 73.53 111.732 176.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 130' ' ' ALA . . . . . 0.416 ' HB2' HG12 ' C' ' 153' ' ' VAL . . . -63.85 -41.23 97.85 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 123.463 0.477 . . . . 64.34 110.51 175.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 131' ' ' PHE . . . . . 0.439 ' HB2' HD13 ' C' ' 215' ' ' LEU . 52.3 t80 -65.31 -43.0 92.46 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.965 0.906 . . . . 75.55 110.292 172.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 132' ' ' HIS . . . . . 0.472 ' O ' ' HD3' ' C' ' 136' ' ' ARG . 23.5 m170 -80.01 -1.8 41.35 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.206 -0.906 . . . . 60.22 110.781 -176.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -69.15 65.47 0.52 Allowed Glycine 0 C--N 1.358 1.8 0 C-N-CA 123.977 0.799 . . . . 65.31 114.447 174.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . -93.47 -126.23 4.25 Favored Glycine 0 C--N 1.343 0.936 0 N-CA-C 109.442 -1.463 . . . . 53.24 109.442 165.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 13.8 mp0 -71.97 94.79 1.5 Allowed 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 117.667 0.734 . . . . 71.2 109.119 175.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 136' ' ' ARG . . . . . 0.472 ' HD3' ' O ' ' C' ' 132' ' ' HIS . 17.9 mmm180 -110.82 147.64 34.07 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.45 0.7 . . . . 72.12 110.313 -175.081 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 137' ' ' VAL . . . . . . . . . . . . . 35.8 m -91.73 144.19 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 108.823 -0.806 . . . . 71.12 108.823 178.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 138' ' ' VAL . . . . . 0.432 HG22 HG23 ' C' ' 140' ' ' VAL . 14.7 p -160.64 151.0 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 O-C-N 123.211 0.32 . . . . 72.14 110.936 -177.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 139' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -120.1 113.27 20.22 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 107.561 -1.274 . . . . 74.31 107.561 171.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 140' ' ' VAL . . . . . 0.512 HG11 HD13 ' C' ' 174' ' ' LEU . 90.0 t -130.14 101.61 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 123.759 0.824 . . . . 63.22 110.794 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 141' ' ' ALA . . . . . 0.652 ' HB3' HH21 ' C' ' 143' ' ' ARG . . . 55.45 44.65 26.69 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.576 1.551 . . . . 15.23 112.562 168.04 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 103.08 6.26 45.72 Favored Glycine 0 C--N 1.347 1.175 0 CA-C-N 115.46 -0.791 . . . . 45.25 113.183 178.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 143' ' ' ARG . . . . . 0.652 HH21 ' HB3' ' C' ' 141' ' ' ALA . 0.0 OUTLIER -120.82 95.39 4.69 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 117.452 0.626 . . . . 73.04 110.19 -176.95 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 52.9 ttt180 -90.49 87.25 6.69 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 107.767 -1.197 . . . . 71.51 107.767 168.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 145' ' ' VAL . . . . . . . . . . . . . 27.4 m -119.66 148.77 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 115.4 -0.818 . . . . 75.03 111.574 -176.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 16.0 p -99.11 96.9 8.1 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 124.492 1.117 . . . . 54.21 108.433 168.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 14.8 p -124.83 151.52 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.753 0.821 . . . . 72.53 110.471 -173.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 24.2 ttm180 -98.24 110.15 22.78 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 109.952 -0.388 . . . . 74.22 109.952 169.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 149' ' ' ILE . . . . . 0.429 HD12 HD13 ' C' ' 159' ' ' ILE . 39.8 pt -78.82 153.88 78.04 Favored Pre-proline 0 CA--C 1.552 1.038 0 N-CA-C 108.085 -1.08 . . . . 71.41 108.085 164.297 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -43.03 111.73 0.24 Allowed 'Trans proline' 0 C--N 1.385 2.45 0 C-N-CA 122.989 2.459 . . . . 61.44 112.879 175.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.95 102.6 0.13 Allowed 'Trans proline' 0 C--N 1.389 2.708 0 C-N-CA 123.507 2.805 . . . . 73.2 111.257 -178.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 152' ' ' GLY . . . . . 0.48 ' HA3' HD22 ' C' ' 188' ' ' LEU . . . 132.06 140.33 4.49 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 116.025 -0.534 . . . . 54.32 112.635 -171.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 153' ' ' VAL . . . . . 0.657 HG22 HG11 ' C' ' 178' ' ' VAL . 0.3 OUTLIER -152.59 167.26 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 N-CA-C 112.267 0.469 . . . . 71.13 112.267 -174.899 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 154' ' ' ARG . . . . . 0.459 ' HB2' ' OG ' ' C' ' 157' ' ' SER . 19.2 mtt180 -138.61 162.89 33.47 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.529 1.131 . . . . 75.32 109.28 -173.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 155' ' ' GLU . . . . . 0.43 ' HB2' HD12 ' C' ' 180' ' ' LEU . 10.2 tp10 -72.76 132.65 43.89 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 123.98 0.912 . . . . 74.51 111.953 178.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 65.17 19.73 66.41 Favored Glycine 0 C--N 1.359 1.839 0 O-C-N 123.745 0.653 . . . . 64.51 113.601 173.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 157' ' ' SER . . . . . 0.459 ' OG ' ' HB2' ' C' ' 154' ' ' ARG . 53.4 m -98.18 172.19 7.75 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.241 0.616 . . . . 75.43 111.018 -172.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 7.7 p -127.13 118.55 50.46 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.987 0 CA-C-N 115.173 -0.921 . . . . 64.44 110.062 -173.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 159' ' ' ILE . . . . . 0.69 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 25.4 mt -94.58 103.56 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 108.281 -1.007 . . . . 52.25 108.281 178.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 160' ' ' ARG . . . . . 0.479 HH12 ' HB3' ' C' ' 162' ' ' PRO . 64.4 ttp85 -83.55 100.92 11.09 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 109.819 -0.437 . . . . 72.21 109.819 -179.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 161' ' ' VAL . . . . . 0.609 ' HB ' ' HB3' ' C' ' 174' ' ' LEU . 58.2 t -94.59 103.37 11.02 Favored Pre-proline 0 CA--C 1.554 1.13 0 N-CA-C 108.404 -0.961 . . . . 75.24 108.404 175.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 162' ' ' PRO . . . . . 0.479 ' HB3' HH12 ' C' ' 160' ' ' ARG . 90.9 Cg_endo -73.87 164.19 35.2 Favored 'Trans proline' 0 C--N 1.373 1.843 0 C-N-CA 122.924 2.416 . . . . 63.42 113.879 -172.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.46 -25.14 6.58 Favored Glycine 0 C--N 1.345 1.055 0 CA-C-N 114.886 -1.052 . . . . 53.31 114.294 172.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 164' ' ' MET . . . . . 0.413 ' SD ' ' HG2' ' C' ' 143' ' ' ARG . 23.9 ttp -83.5 -77.7 0.24 Allowed 'General case' 0 C--N 1.356 0.853 0 CA-C-N 117.779 0.789 . . . . 73.35 110.071 -172.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . 87.21 -173.27 44.32 Favored Glycine 0 C--N 1.342 0.887 0 CA-C-O 120.116 -0.269 . . . . 64.24 113.664 179.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . -83.2 -125.53 1.03 Allowed Glycine 0 C--N 1.345 1.048 0 CA-C-O 119.98 -0.344 . . . . 75.44 112.826 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 167' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -79.64 146.64 32.39 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 117.037 0.419 . . . . 64.31 110.851 -177.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . 78.11 -166.48 52.8 Favored Glycine 0 C--N 1.348 1.216 0 O-C-N 123.876 0.735 . . . . 13.44 112.934 -175.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 169' ' ' ASN . . . . . 0.402 ' HB3' ' HD3' ' C' ' 170' ' ' PRO . 23.0 t30 -104.6 -64.35 0.04 OUTLIER Pre-proline 0 CA--C 1.558 1.275 0 CA-C-O 117.214 -1.374 . . . . 62.44 114.421 -164.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 170' ' ' PRO . . . . . 0.402 ' HD3' ' HB3' ' C' ' 169' ' ' ASN . 95.6 Cg_exo -42.67 117.4 0.86 Allowed 'Trans proline' 0 C--N 1.408 3.679 0 C-N-CA 123.3 2.667 . . . . 51.41 114.216 -162.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 171' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -36.27 115.72 0.13 Allowed 'Trans proline' 0 C--N 1.397 3.099 1 C-N-CA 125.614 4.21 . . . . 74.02 115.876 -163.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -118.87 -150.51 8.8 Favored Glycine 0 C--N 1.345 1.03 0 CA-C-N 115.863 -0.608 . . . . 74.42 112.358 178.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 173' ' ' ASP . . . . . 0.403 ' O ' ' HA ' ' C' ' 118' ' ' ASP . 11.6 m-20 -136.43 147.12 47.09 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-O 121.794 0.807 . . . . 74.51 111.189 -178.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 174' ' ' LEU . . . . . 0.609 ' HB3' ' HB ' ' C' ' 161' ' ' VAL . 19.0 tp -103.06 136.72 42.34 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 114.194 -1.366 . . . . 75.22 107.71 168.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 66.5 mt -123.44 85.87 2.49 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.321 1.049 . . . . 71.32 108.97 -178.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 176' ' ' LEU . . . . . 0.69 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 82.0 mt -71.43 108.15 4.71 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.156 -0.475 . . . . 43.02 110.352 179.384 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 177' ' ' VAL . . . . . . . . . . . . . 25.1 t -84.96 93.46 3.57 Favored 'Isoleucine or valine' 0 C--N 1.347 0.472 0 N-CA-C 108.253 -1.017 . . . . 74.43 108.253 178.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 178' ' ' VAL . . . . . 0.657 HG11 HG22 ' C' ' 153' ' ' VAL . 2.4 p -84.11 117.15 29.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.292 -0.867 . . . . 74.01 110.525 -175.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 179' ' ' ARG . . . . . 0.404 ' O ' ' HA ' ' C' ' 124' ' ' PRO . 6.1 mmm180 -108.2 116.0 31.16 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 107.8 -1.185 . . . . 72.33 107.8 172.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 180' ' ' LEU . . . . . 0.486 HD13 HD21 ' C' ' 127' ' ' LEU . 92.9 mt -74.59 148.33 40.89 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 120.854 0.359 . . . . 70.51 110.499 178.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 181' ' ' LEU . . . . . . . . . . . . . 80.9 mt -70.14 166.09 37.12 Favored Pre-proline 0 CA--C 1.552 1.049 0 CA-C-O 118.236 -0.888 . . . . 74.2 109.348 177.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -54.2 76.15 0.03 OUTLIER 'Trans proline' 0 C--N 1.393 2.869 0 C-N-CA 123.224 2.616 . . . . 64.12 112.58 170.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 183' ' ' HIS . . . . . 0.432 ' N ' ' HD3' ' C' ' 184' ' ' PRO . 74.5 t60 174.88 54.48 0.03 OUTLIER Pre-proline 0 CA--C 1.561 1.384 0 C-N-CA 126.895 2.078 . . . . 62.13 106.384 -167.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 184' ' ' PRO . . . . . 0.432 ' HD3' ' N ' ' C' ' 183' ' ' HIS . 66.3 Cg_endo -93.83 65.1 0.41 Allowed 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.409 2.739 . . . . 71.54 110.628 -174.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 185' ' ' VAL . . . . . 0.527 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 16.4 t -93.28 -58.04 3.93 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.559 0 N-CA-C 108.946 -0.761 . . . . 72.23 108.946 -167.249 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 186' ' ' PHE . . . . . 0.405 ' H ' HD13 ' C' ' 127' ' ' LEU . 48.2 m-85 -101.23 104.31 15.35 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 121.201 0.524 . . . . 61.44 111.052 -169.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 187' ' ' ARG . . . . . 0.428 ' NH1' ' HB2' ' C' ' 189' ' ' GLU . 4.0 tmt_? -95.63 122.37 38.32 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 107.79 -1.189 . . . . 75.14 107.79 174.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 188' ' ' LEU . . . . . 0.577 HD13 ' HD2' ' C' ' 240' ' ' PHE . 59.2 tp -80.34 147.94 30.87 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.689 0.396 . . . . 74.14 111.861 -177.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 189' ' ' GLU . . . . . 0.428 ' HB2' ' NH1' ' C' ' 187' ' ' ARG . 8.8 tp10 -144.93 110.54 5.33 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 107.756 -1.202 . . . . 71.33 107.756 161.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 67.88 -93.12 0.26 Allowed Glycine 0 C--N 1.35 1.345 0 N-CA-C 111.58 -0.608 . . . . 74.2 111.58 -172.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 191' ' ' GLN . . . . . 0.517 ' NE2' ' HA3' ' C' ' 242' ' ' GLY . 51.0 mt-30 -128.37 -16.39 4.42 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.383 1.073 . . . . 60.21 110.553 173.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -91.63 134.86 34.33 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.09 0.956 . . . . 65.13 110.249 -173.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 193' ' ' LEU . . . . . 0.63 ' HG ' ' HA2' ' C' ' 239' ' ' GLY . 17.4 mt -98.27 173.13 7.15 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 122.878 0.471 . . . . 52.2 112.043 -171.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 194' ' ' TYR . . . . . 0.512 ' HA ' ' O ' ' C' ' 250' ' ' TYR . 35.4 t80 -139.05 107.04 5.69 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 114.824 -1.08 . . . . 75.43 108.843 171.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 195' ' ' ALA . . . . . 0.527 ' HA ' ' O ' ' C' ' 185' ' ' VAL . . . -106.72 -176.16 3.0 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.322 1.049 . . . . 65.11 109.871 175.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 41.0 m -132.31 110.66 10.75 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 108.909 -0.774 . . . . 51.32 108.909 167.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 197' ' ' LEU . . . . . 0.473 ' HB2' HD22 ' C' ' 251' ' ' LEU . 35.6 tp -97.7 109.38 22.14 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.835 0.854 . . . . 73.5 109.169 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -88.94 104.5 17.01 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-O 121.917 0.865 . . . . 44.52 110.071 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 199' ' ' VAL . . . . . 0.405 ' HA ' HG11 ' C' ' 210' ' ' VAL . 42.3 t -92.35 123.22 62.92 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 124.958 1.303 . . . . 61.21 109.148 179.215 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 200' ' ' PRO . . . . . 0.431 ' HA ' ' O ' ' C' ' 256' ' ' THR . 55.6 Cg_endo -69.48 149.44 68.66 Favored 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 121.95 1.767 . . . . 71.34 110.826 176.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 201' ' ' ALA . . . . . 0.41 ' HB3' ' HH2' ' C' ' 269' ' ' TRP . . . -54.89 -46.84 99.47 Favored Pre-proline 0 CA--C 1.553 1.061 0 CA-C-O 117.579 -1.2 . . . . 74.35 113.909 -169.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 202' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -54.08 -47.16 28.57 Favored 'Trans proline' 0 C--N 1.395 3.006 0 C-N-CA 121.926 1.751 . . . . 63.15 112.625 176.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 203' ' ' ILE . . . . . . . . . . . . . 48.6 mt -69.77 -37.75 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.152 0.981 . . . . 63.4 111.156 -177.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -61.71 -43.95 97.87 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.507 0.723 . . . . 75.02 110.87 178.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 205' ' ' VAL . . . . . . . . . . . . . 78.7 t -74.16 -40.99 51.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 115.024 -0.989 . . . . 63.41 112.378 -176.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 206' ' ' VAL . . . . . 0.625 ' HA ' ' HE2' ' A' ' 270' ' ' LYS . 11.1 p -78.15 -33.99 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 CA-C-N 118.047 0.385 . . . . 52.12 110.839 -177.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 85.13 52.64 3.37 Favored Glycine 0 C--N 1.338 0.652 0 CA-C-N 115.779 -0.646 . . . . 63.21 111.518 -170.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -90.13 -123.49 2.56 Favored Glycine 0 C--N 1.345 1.055 0 CA-C-N 115.104 -0.548 . . . . 51.32 111.778 -177.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 209' ' ' LYS . . . . . 0.516 ' HG2' ' HA ' ' C' ' 222' ' ' ALA . 6.5 mtmp? -147.2 144.13 28.7 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.53 0.681 . . . . 72.12 111.103 175.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 210' ' ' VAL . . . . . 0.405 HG11 ' HA ' ' C' ' 199' ' ' VAL . 16.2 m -122.67 178.66 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 113.6 -1.637 . . . . 62.05 107.468 167.073 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 211' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -132.3 130.29 40.64 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.922 0.392 . . . . 72.44 110.542 -178.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 212' ' ' ALA . . . . . 0.566 ' HB3' HG13 ' C' ' 219' ' ' VAL . . . -104.85 113.98 27.91 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 107.171 -1.418 . . . . 74.43 107.171 173.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 213' ' ' MET . . . . . . . . . . . . . 5.4 tmm? -67.38 135.51 53.31 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 107.84 -1.17 . . . . 63.12 107.84 171.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 214' ' ' THR . . . . . 0.536 HG21 ' HD2' ' C' ' 238' ' ' LYS . 0.1 OUTLIER -134.46 171.42 14.33 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-O 122.088 0.947 . . . . 54.24 111.962 -174.896 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 215' ' ' LEU . . . . . 0.439 HD13 ' HB2' ' C' ' 131' ' ' PHE . 27.4 mt -73.24 -31.16 63.96 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 114.151 -1.386 . . . . 44.41 113.08 -163.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.92 8.04 21.97 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.956 -1.02 . . . . 71.0 111.362 -178.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 149.37 -163.11 29.18 Favored Glycine 0 C--N 1.351 1.381 0 CA-C-O 119.479 -0.623 . . . . 64.11 111.938 -177.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -96.44 163.89 1.19 Allowed 'Trans proline' 0 C--N 1.362 1.269 0 C-N-CA 122.984 2.456 . . . . 52.13 113.415 173.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 219' ' ' VAL . . . . . 0.744 ' HB ' ' HE3' ' C' ' 238' ' ' LYS . 1.7 p -142.44 114.64 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.099 0 N-CA-C 108.154 -1.054 . . . . 52.53 108.154 166.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 220' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -90.84 107.74 19.38 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.081 -1.081 . . . . 72.32 108.081 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 221' ' ' VAL . . . . . 0.518 ' HA ' ' HB2' ' B' ' 239' ' ' ALA . 56.0 t -76.07 129.77 36.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 125.124 1.37 . . . . 74.03 111.798 -172.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 222' ' ' ALA . . . . . 0.516 ' HA ' ' HG2' ' C' ' 209' ' ' LYS . . . -90.99 123.77 34.72 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.59 0.756 . . . . 73.3 109.848 173.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 58.4 t -99.17 142.0 23.84 Favored Pre-proline 0 CA--C 1.561 1.389 0 C-N-CA 125.149 1.38 . . . . 73.11 110.168 -172.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 224' ' ' PRO . . . . . 0.618 ' HG2' HE21 ' B' ' 243' ' ' GLN . 5.1 Cg_exo -85.6 158.9 10.73 Favored 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 123.958 3.105 . . . . 54.33 112.923 168.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -55.95 128.52 30.59 Favored 'Trans proline' 0 C--N 1.385 2.497 0 C-N-CA 123.462 2.775 . . . . 74.0 113.448 178.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 226' ' ' ARG . . . . . 0.554 HH11 HD12 ' A' ' 261' ' ' LEU . 0.0 OUTLIER 52.45 81.14 0.09 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.756 1.622 . . . . 70.15 112.141 -178.82 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 227' ' ' THR . . . . . 0.561 HG22 HG11 ' C' ' 253' ' ' VAL . 54.7 m -93.64 142.27 27.54 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 114.869 -1.06 . . . . 70.3 110.204 176.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 228' ' ' GLN . . . . . 0.826 HE21 ' HG2' ' A' ' 259' ' ' GLU . 27.3 mp0 -101.94 146.56 27.69 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.733 0.813 . . . . 74.32 112.271 -173.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -69.56 118.14 12.05 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 114.647 -1.16 . . . . 62.12 108.519 169.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 113.12 -2.3 25.47 Favored Glycine 0 C--N 1.339 0.717 0 CA-C-O 119.6 -0.556 . . . . 62.04 112.205 -175.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 231' ' ' ARG . . . . . . . . . . . . . 60.0 mtp85 -73.79 -179.49 3.68 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 117.126 0.463 . . . . 74.12 111.273 171.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 232' ' ' LYS . . . . . 0.575 ' HD3' ' HB3' ' C' ' 250' ' ' TYR . 34.4 ttmt -148.61 146.43 28.22 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.891 -0.595 . . . . 71.45 111.225 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 233' ' ' LEU . . . . . 0.649 HD13 ' HB2' ' C' ' 251' ' ' LEU . 0.9 OUTLIER -117.26 155.61 29.17 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.998 1.319 . . . . 74.21 108.495 177.349 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 234' ' ' ARG . . . . . 0.469 ' O ' ' HA3' ' B' ' 240' ' ' GLY . 16.8 ptt180 -127.07 109.6 12.05 Favored 'General case' 0 N--CA 1.475 0.775 0 O-C-N 123.702 0.626 . . . . 72.34 109.583 166.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 235' ' ' LEU . . . . . 0.481 HD12 HD23 ' C' ' 249' ' ' LEU . 26.8 mt -95.82 128.08 42.39 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.614 0.765 . . . . 73.43 109.185 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -79.87 125.76 30.13 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.25 0.62 . . . . 71.55 112.284 -168.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 77.77 13.71 83.16 Favored Glycine 0 C--N 1.353 1.481 0 O-C-N 124.124 0.89 . . . . 71.42 113.458 178.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 238' ' ' LYS . . . . . 0.744 ' HE3' ' HB ' ' C' ' 219' ' ' VAL . 69.6 mmtt -105.05 19.85 19.88 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.592 0.757 . . . . 72.03 111.446 -178.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 239' ' ' GLY . . . . . 0.63 ' HA2' ' HG ' ' C' ' 193' ' ' LEU . . . -92.53 -171.08 40.86 Favored Glycine 0 C--N 1.345 1.071 0 CA-C-N 116.217 -0.447 . . . . 31.21 112.749 171.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 240' ' ' PHE . . . . . 0.577 ' HD2' HD13 ' C' ' 188' ' ' LEU . 11.9 m-85 -79.04 154.68 77.61 Favored Pre-proline 0 CA--C 1.563 1.447 0 C-N-CA 122.965 0.506 . . . . 75.14 110.221 177.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 241' ' ' PRO . . . . . 0.584 ' HA ' ' HG2' ' C' ' 246' ' ' ARG . 18.6 Cg_exo -67.55 136.73 40.4 Favored 'Trans proline' 0 C--N 1.396 3.05 0 C-N-CA 124.183 3.255 . . . . 70.21 114.355 -172.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 242' ' ' GLY . . . . . 0.517 ' HA3' ' NE2' ' C' ' 191' ' ' GLN . . . -134.2 171.96 21.97 Favored Glycine 0 C--N 1.35 1.344 0 CA-C-N 115.514 -0.767 . . . . 70.14 113.041 178.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.01 -25.06 38.53 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 123.764 2.976 . . . . 71.42 113.321 -177.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -112.7 14.52 20.02 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.894 0.878 . . . . 71.42 111.008 178.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 119.45 177.09 16.3 Favored Glycine 0 C--N 1.349 1.299 0 N-CA-C 112.078 -0.409 . . . . 51.32 112.078 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 246' ' ' ARG . . . . . 0.584 ' HG2' ' HA ' ' C' ' 241' ' ' PRO . 72.4 mtm-85 -85.09 158.77 20.33 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.856 0.862 . . . . 61.31 111.005 -177.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.82 -155.03 6.18 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 114.045 0.378 . . . . 63.23 114.045 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -124.96 139.11 54.12 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.363 0.665 . . . . 73.54 109.578 -179.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 249' ' ' LEU . . . . . 0.481 HD23 HD12 ' C' ' 235' ' ' LEU . 28.8 tp -85.2 115.27 22.88 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.927 0.891 . . . . 74.23 110.836 -177.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 250' ' ' TYR . . . . . 0.587 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 16.0 m-30 -99.91 101.7 12.89 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 110.022 -0.362 . . . . 71.43 110.022 179.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 251' ' ' LEU . . . . . 0.649 ' HB2' HD13 ' C' ' 233' ' ' LEU . 0.8 OUTLIER -100.62 138.41 37.72 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.632 -0.668 . . . . 64.53 109.802 -175.716 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -87.57 125.44 34.35 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.895 -0.78 . . . . 73.41 108.895 171.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 253' ' ' VAL . . . . . 0.561 HG11 HG22 ' C' ' 227' ' ' THR . 59.3 t -74.5 136.84 24.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 123.213 0.605 . . . . 73.5 110.899 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 254' ' ' ARG . . . . . . . . . . . . . 40.8 mtm180 -116.12 147.11 41.67 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 107.63 -1.248 . . . . 74.13 107.63 163.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 255' ' ' ILE . . . . . 0.538 HG21 HG23 ' A' ' 257' ' ' ILE . 33.4 mm -97.89 119.07 45.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 106.757 -1.571 . . . . 75.24 106.757 164.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 256' ' ' THR . . . . . 0.431 ' O ' ' HA ' ' C' ' 200' ' ' PRO . 0.0 OUTLIER -123.4 173.59 7.89 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.031 1.333 . . . . 53.32 108.461 -178.947 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 2.3 pp -144.12 153.27 56.36 Favored Pre-proline 0 N--CA 1.477 0.888 0 C-N-CA 123.181 0.592 . . . . 64.54 110.569 -174.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.51 6.1 1.35 Allowed 'Trans proline' 0 C--N 1.385 2.495 0 C-N-CA 122.812 2.341 . . . . 73.21 114.278 -175.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 52.43 -84.29 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.858 1.663 . . . . 72.3 112.825 -174.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.14 140.1 58.83 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.908 0.883 . . . . 73.41 110.718 -177.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 261' ' ' LEU . . . . . 0.508 HD22 ' HB3' ' C' ' 265' ' ' GLU . 65.1 mt -124.7 152.97 43.04 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.363 0.665 . . . . 71.21 111.101 -176.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 67.6 p -85.05 168.35 21.15 Favored Pre-proline 0 CA--C 1.556 1.202 0 N-CA-C 107.572 -1.27 . . . . 61.23 107.572 164.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -51.16 -37.44 58.61 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 122.799 2.333 . . . . 74.2 112.863 171.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -58.71 -64.08 1.06 Allowed 'General case' 0 C--O 1.251 1.138 0 C-N-CA 124.762 1.225 . . . . 71.04 110.845 175.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 265' ' ' GLU . . . . . 0.508 ' HB3' HD22 ' C' ' 261' ' ' LEU . 32.1 mm-40 -53.21 -44.06 67.72 Favored 'General case' 0 C--N 1.352 0.704 0 O-C-N 124.375 1.047 . . . . 65.11 110.493 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 266' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -58.72 -43.02 90.01 Favored 'General case' 0 C--O 1.214 -0.791 0 C-N-CA 123.462 0.705 . . . . 64.21 110.374 -178.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -62.22 -51.84 66.17 Favored 'General case' 0 CA--C 1.555 1.157 0 O-C-N 123.726 0.641 . . . . 70.32 111.764 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 268' ' ' LEU . . . . . . . . . . . . . 8.7 mp -66.75 -48.69 68.33 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 116.498 -0.319 . . . . 52.44 111.238 -176.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 269' ' ' TRP . . . . . 0.41 ' HH2' ' HB3' ' C' ' 201' ' ' ALA . 94.6 m95 -61.22 -32.53 72.31 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.511 0.724 . . . . 61.11 111.281 176.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 270' ' ' LYS . . . . . 0.421 ' HD2' HG11 ' A' ' 206' ' ' VAL . 1.2 mmmm -61.35 -52.34 65.07 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 123.433 0.693 . . . . 75.43 110.872 176.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -63.48 -37.57 87.82 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 123.686 0.616 . . . . 75.33 111.233 -178.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 95.5 mt -67.14 -35.1 79.0 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 122.744 0.418 . . . . 74.33 111.586 173.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -64.3 -45.53 87.55 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.35 0.66 . . . . 34.13 110.479 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -69.27 -38.72 78.53 Favored 'General case' 0 C--O 1.245 0.845 0 O-C-N 124.38 1.05 . . . . 63.21 110.931 -179.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -60.91 -30.7 70.34 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.768 -0.651 . . . . 70.04 110.554 172.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 276' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -94.05 -13.73 26.58 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 122.984 0.514 . . . . 75.52 112.304 177.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 277' ' ' TYR . . . . . 0.434 ' CE1' ' HA3' ' A' ' 208' ' ' GLY . 22.6 m-30 -70.3 -30.65 67.7 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.001 -1.111 . . . . 44.24 108.001 169.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -63.79 2.61 0.46 Allowed 'General case' 0 CA--C 1.557 1.249 0 CA-C-N 114.177 -1.374 . . . . 55.2 113.07 169.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 279' ' ' ARG . . . . . . . . . . . . . 51.9 ttt180 -73.91 -33.54 64.01 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.043 0.537 . . . . 71.52 110.882 171.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 1.168 0 O-C-N 123.333 0.396 . . . . 75.14 110.725 -169.499 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.405 ' H3 ' ' CD ' ' A' ' 95' ' ' GLU . 52.6 mtm . . . . . 0 CA--C 1.545 0.778 0 N-CA-C 109.648 -0.501 . . . . 64.12 109.648 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 66.0 43.29 3.02 Favored 'General case' 0 C--N 1.364 1.197 0 C-N-CA 124.907 1.283 . . . . 51.4 112.55 177.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -66.78 78.55 0.12 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.628 0.771 . . . . 74.04 111.368 175.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -35.99 92.89 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 125.703 1.601 . . . . 62.43 113.409 -178.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.8 mmtp -68.07 107.27 2.66 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-N 115.239 -0.891 . . . . 74.32 108.725 168.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -72.83 88.77 1.34 Allowed 'General case' 0 C--O 1.241 0.637 0 N-CA-C 107.415 -1.328 . . . . 61.41 107.415 174.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -60.26 -30.64 69.57 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 114.827 -1.079 . . . . 73.34 111.678 -175.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -64.9 -53.53 45.13 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.958 -0.565 . . . . 73.33 110.357 176.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.16 -34.63 76.78 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 122.72 0.408 . . . . 60.32 111.3 -178.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 76.5 mt -59.96 -43.35 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 N-CA-C 109.865 -0.42 . . . . 74.23 109.865 172.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.445 HD23 HG23 ' A' ' 50' ' ' ILE . 97.0 mt -75.71 -12.24 60.15 Favored 'General case' 0 CA--C 1.555 1.172 0 CA-C-N 116.042 -0.527 . . . . 51.33 112.3 175.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.52 36.56 33.41 Favored Glycine 0 C--N 1.349 1.302 0 CA-C-N 117.75 0.25 . . . . 53.33 113.686 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.8 m -131.34 159.8 70.07 Favored Pre-proline 0 N--CA 1.484 1.25 0 C-N-CA 124.935 1.294 . . . . 71.43 109.14 177.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -75.96 166.35 28.19 Favored 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 122.524 2.149 . . . . 50.12 112.846 177.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 43.3 mtm-85 -74.73 21.02 0.11 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 113.309 0.855 . . . . 75.43 113.309 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -122.15 6.67 9.72 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.184 0.993 . . . . 64.11 108.982 174.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.47 136.26 47.54 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.508 0.723 . . . . 64.31 111.936 -175.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.5 p -85.6 176.44 8.19 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.284 1.034 . . . . 71.11 110.691 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.3 tm0? -57.15 -37.65 72.38 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.384 0.674 . . . . 64.21 109.978 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.44 ' HB3' ' NH1' ' A' ' 24' ' ' ARG . 43.3 mm-40 -56.69 -54.33 47.34 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 123.772 0.67 . . . . 72.43 111.054 174.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -63.25 -38.82 92.66 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.994 0.518 . . . . 64.03 111.016 -177.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.6 mp -59.55 -39.52 79.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 124.52 1.128 . . . . 73.31 110.6 173.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -68.25 -56.07 9.96 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.414 -0.812 . . . . 71.24 111.056 -175.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.44 ' NH1' ' HB3' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -66.85 -28.84 68.67 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 122.976 0.172 . . . . 54.12 111.203 -179.204 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.434 ' HB1' ' O ' ' A' ' 11' ' ' LEU . . . -62.66 -51.09 68.63 Favored 'General case' 0 C--O 1.245 0.866 0 O-C-N 123.609 0.568 . . . . 64.0 110.754 173.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -58.75 -45.77 88.93 Favored 'General case' 0 C--O 1.215 -0.711 0 CA-C-N 114.73 -1.123 . . . . 73.1 110.469 178.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.427 ' O ' ' HG3' ' A' ' 31' ' ' ARG . 57.3 mtpt -63.14 -44.01 96.75 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 123.888 0.743 . . . . 74.22 111.128 -177.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.1 ttp85 -54.86 -48.25 73.17 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.609 0.763 . . . . 71.15 110.6 175.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.679 ' HB3' HD13 ' A' ' 50' ' ' ILE . 81.6 mt -77.39 -20.65 54.39 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 115.619 -0.719 . . . . 74.11 111.671 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.535 ' HA ' ' HE1' ' A' ' 47' ' ' PHE . . . -81.21 -22.32 38.92 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.615 0.766 . . . . 63.3 111.118 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.427 ' HG3' ' O ' ' A' ' 27' ' ' LYS . 58.1 mtm180 -91.75 -41.85 10.46 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 122.981 0.512 . . . . 72.33 110.047 174.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -69.45 -55.36 10.5 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.319 0.648 . . . . 63.33 111.191 -176.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -96.85 31.25 2.41 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 122.849 0.46 . . . . 63.25 110.27 179.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.492 ' HD2' HG23 ' A' ' 37' ' ' VAL . 44.2 t60 -60.26 101.6 0.26 Allowed Pre-proline 0 N--CA 1.477 0.904 0 C-N-CA 123.99 0.916 . . . . 63.41 110.234 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -70.11 -13.9 34.35 Favored 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 123.061 2.507 . . . . 74.13 113.216 -164.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.409 ' HB3' ' CD2' ' A' ' 34' ' ' HIS . 28.5 t70 -71.53 -35.12 70.58 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.477 0.711 . . . . 72.45 110.526 175.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.492 HG23 ' HD2' ' A' ' 34' ' ' HIS . 99.0 t -94.52 -48.97 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-O 121.309 0.576 . . . . 65.53 109.46 178.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -100.54 71.91 1.54 Allowed 'General case' 0 C--O 1.249 1.035 0 C-N-CA 124.104 0.961 . . . . 61.35 109.486 -177.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -74.36 81.34 1.88 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.049 -0.978 . . . . 73.11 108.873 176.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 67.4 m -138.83 108.67 7.71 Favored Pre-proline 0 C--O 1.24 0.571 0 CA-C-O 118.168 -0.92 . . . . 54.41 108.724 177.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -30.93 -52.43 0.25 Allowed 'Trans proline' 0 C--N 1.392 2.846 0 C-N-CA 125.284 3.989 . . . . 72.23 115.784 -175.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -51.3 -51.39 54.71 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.492 0.717 . . . . 64.43 111.743 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.24 -22.26 62.91 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 115.381 -0.827 . . . . 72.14 111.752 -177.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -88.91 -37.56 15.19 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.372 0.669 . . . . 62.01 110.514 -173.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.515 ' HA ' ' HE2' ' A' ' 48' ' ' LYS . 35.8 mm-40 -70.22 -41.48 73.56 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 108.807 -0.812 . . . . 62.44 108.807 175.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 15.4 tppt? -59.35 -45.54 91.1 Favored 'General case' 0 C--N 1.348 0.541 0 CA-C-N 114.641 -1.163 . . . . 74.03 110.011 173.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.59 ' HA ' HD12 ' A' ' 50' ' ' ILE . 71.3 t80 -58.09 -40.69 81.76 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 123.954 0.784 . . . . 73.24 110.984 176.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.524 ' HB3' ' CE1' ' A' ' 93' ' ' PHE . 43.4 mtmt -66.78 -32.83 74.38 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 119.414 -0.327 . . . . 75.14 111.858 178.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.85 -34.58 76.98 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 120.831 0.348 . . . . 71.44 110.439 172.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.679 HD13 ' HB3' ' A' ' 29' ' ' LEU . 73.3 mt -66.97 -30.27 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.049 0.939 . . . . 70.53 109.721 174.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.414 ' O ' ' HB2' ' A' ' 55' ' ' ALA . 11.7 m-80 -83.29 -19.89 35.46 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.815 0.846 . . . . 73.43 112.125 174.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -70.98 -52.11 21.69 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 122.509 1.147 . . . . 63.42 108.389 171.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.66 -54.3 45.95 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 112.801 -1.999 . . . . 65.45 111.088 176.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -63.18 -37.84 88.81 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-N 115.262 -0.881 . . . . 72.32 111.176 177.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.414 ' HB2' ' O ' ' A' ' 51' ' ' ASN . . . -51.2 -53.53 34.17 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 122.98 0.512 . . . . 53.01 111.407 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 68.0 t -68.02 -44.11 85.0 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 CA-C-N 114.377 -1.283 . . . . 74.52 110.449 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.492 HD22 ' HD2' ' A' ' 63' ' ' ARG . 41.9 mt -91.48 5.8 48.02 Favored 'General case' 0 CA--C 1.563 1.457 0 N-CA-C 113.875 1.065 . . . . 62.04 113.875 -170.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.8 t -80.68 -47.89 13.37 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 123.218 0.607 . . . . 74.34 110.926 177.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -93.35 134.36 26.98 Favored Pre-proline 0 N--CA 1.474 0.768 0 CA-C-O 117.72 -1.133 . . . . 74.34 109.906 -173.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.521 ' O ' ' HG2' ' A' ' 64' ' ' ARG . 9.1 Cg_endo -49.7 -43.98 37.81 Favored 'Trans proline' 0 C--N 1.385 2.492 0 C-N-CA 124.014 3.142 . . . . 72.41 114.027 -177.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.404 ' O ' HG13 ' A' ' 65' ' ' ILE . 3.8 mp0 -67.88 -54.14 21.15 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 122.939 0.496 . . . . 72.3 111.635 -177.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.529 ' HA ' HD12 ' A' ' 65' ' ' ILE . 47.4 mtpt -61.52 -35.17 76.96 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.536 0.734 . . . . 74.54 110.787 -178.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.492 ' HD2' HD22 ' A' ' 57' ' ' LEU . 46.4 tpt85 -54.52 -58.27 8.13 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 114.311 -1.313 . . . . 74.11 108.891 171.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.521 ' HG2' ' O ' ' A' ' 60' ' ' PRO . 1.2 mmp_? -61.58 -28.7 69.53 Favored 'General case' 0 C--O 1.214 -0.801 0 CA-C-N 115.354 -0.839 . . . . 74.25 111.783 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.583 HG23 ' HD2' ' A' ' 76' ' ' PRO . 89.6 mt -61.69 -47.7 92.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 122.931 0.492 . . . . 64.42 109.677 176.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -60.79 -53.77 53.33 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 115.961 -0.563 . . . . 75.4 110.28 175.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -54.13 -44.73 71.61 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.533 0.733 . . . . 64.04 111.801 -176.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 53.7 p -73.77 -27.33 61.1 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.73 0.412 . . . . 75.13 111.332 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -73.37 119.49 17.67 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 109.105 -0.702 . . . . 63.45 109.105 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 101.19 16.22 25.88 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-N 115.964 -0.562 . . . . 52.54 111.964 -168.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 62.9 m -143.29 -59.27 0.42 Allowed 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 104.021 -2.585 . . . . 71.23 104.021 174.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.4 m -83.56 148.85 26.95 Favored 'General case' 0 C--O 1.249 1.061 0 N-CA-C 105.225 -2.139 . . . . 74.23 105.225 157.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.56 -30.15 9.21 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.273 1.029 . . . . 74.04 110.734 -176.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.17 139.9 61.03 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 123.321 0.648 . . . . 75.1 110.005 175.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -62.34 119.02 5.94 Favored 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 122.33 2.02 . . . . 75.41 111.111 175.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.583 ' HD2' HG23 ' A' ' 65' ' ' ILE . 78.6 Cg_exo -51.55 122.14 9.75 Favored 'Trans proline' 0 C--N 1.384 2.42 0 C-N-CA 123.357 2.705 . . . . 74.25 113.183 178.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -44.11 134.51 8.52 Favored 'Trans proline' 0 C--N 1.389 2.703 0 C-N-CA 124.504 3.469 . . . . 62.44 115.176 -168.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -63.15 135.03 48.64 Favored 'Trans proline' 0 C--N 1.386 2.545 0 C-N-CA 122.965 2.444 . . . . 43.51 112.456 -177.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.15 157.66 16.85 Favored 'Trans proline' 0 C--N 1.381 2.268 0 C-N-CA 122.953 2.436 . . . . 71.05 112.1 175.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -60.39 84.45 0.07 OUTLIER 'Trans proline' 0 C--N 1.38 2.222 0 C-N-CA 122.718 2.279 . . . . 51.35 112.185 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 155.01 -42.32 0.59 Allowed Glycine 0 CA--C 1.527 0.785 0 N-CA-C 109.873 -1.291 . . . . 62.41 109.873 -176.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 128.44 -160.5 22.13 Favored Glycine 0 C--N 1.351 1.414 0 CA-C-N 115.103 -0.548 . . . . 53.03 111.79 176.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -97.65 107.55 20.07 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 123.402 0.681 . . . . 74.41 109.166 176.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -54.91 155.09 4.65 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 115.632 -0.713 . . . . 71.31 111.849 170.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -155.98 60.16 0.59 Allowed 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 108.448 -0.945 . . . . 70.22 108.448 174.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 20.4 m -31.93 86.05 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 126.692 1.997 . . . . 74.44 116.39 -169.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 57.13 24.87 52.68 Favored Glycine 0 CA--C 1.536 1.347 0 N-CA-C 114.953 0.741 . . . . 70.11 114.953 176.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -96.58 154.38 17.31 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.412 0.685 . . . . 72.34 110.063 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -82.03 72.05 9.07 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 123.864 0.866 . . . . 71.44 111.476 -168.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.449 HG23 ' HE2' ' A' ' 97' ' ' PHE . 2.1 p -46.31 -50.37 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 C-N-CA 125.171 1.388 . . . . 75.21 113.537 -175.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.41 ' HG2' HG13 ' A' ' 90' ' ' VAL . 11.7 mm-40 -71.64 -4.04 24.99 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 113.55 0.944 . . . . 75.33 113.55 -171.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -107.42 -17.97 13.98 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.157 0.583 . . . . 45.35 111.27 178.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.524 ' CE1' ' HB3' ' A' ' 48' ' ' LYS . 7.6 m-30 -85.64 176.13 8.36 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 122.497 0.319 . . . . 71.01 111.134 -171.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 89.5 p -59.46 151.09 24.86 Favored 'General case' 0 C--O 1.247 0.926 0 N-CA-C 114.163 1.172 . . . . 74.5 114.163 -166.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.405 ' CD ' ' H3 ' ' A' ' 1' ' ' MET . 3.4 pt-20 -53.34 -44.65 68.65 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 114.54 -1.209 . . . . 74.31 110.007 167.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.403 ' H ' ' HG3' ' A' ' 95' ' ' GLU . 73.8 t80 -49.79 -51.04 42.44 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.614 1.166 . . . . 75.03 111.331 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.449 ' HE2' HG23 ' A' ' 90' ' ' VAL . 3.5 t80 -58.78 -54.89 42.02 Favored 'General case' 0 CA--C 1.55 0.97 0 O-C-N 123.981 0.801 . . . . 63.23 110.28 174.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -70.8 -6.66 39.45 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 113.371 0.878 . . . . 73.05 113.371 -172.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -101.83 -38.8 7.68 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.275 0.63 . . . . 70.02 111.834 174.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 30.3 tp -69.01 -49.32 58.78 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 121.305 0.574 . . . . 55.03 109.798 177.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -92.04 -8.72 45.16 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 115.231 -0.895 . . . . 72.11 111.42 178.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -45.5 -59.07 4.94 Favored Glycine 0 N--CA 1.482 1.765 0 N-CA-C 115.579 0.991 . . . . 72.43 115.579 178.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -45.37 -23.1 1.12 Allowed 'Trans proline' 0 C--N 1.388 2.635 0 C-N-CA 124.45 3.433 . . . . 23.1 115.441 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.529 ' HA2' ' NH2' ' A' ' 111' ' ' ARG . . . -144.28 39.69 1.22 Allowed Glycine 0 C--N 1.354 1.53 0 CA-C-O 118.989 -0.895 . . . . 44.4 113.399 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 13.1 mt -66.02 38.03 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 114.79 1.404 . . . . 74.25 114.79 178.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.647 ' HB3' ' HA ' ' A' ' 169' ' ' ASN . 0.3 OUTLIER 55.78 -102.81 0.16 Allowed 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 123.888 0.875 . . . . 72.25 110.639 162.433 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 70.2 13.3 70.07 Favored Glycine 0 C--N 1.362 2.003 0 C-N-CA 122.776 0.227 . . . . 44.0 112.811 176.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.569 ' H ' ' HD1' ' A' ' 106' ' ' PHE . . . 61.22 -110.19 2.93 Favored Glycine 0 C--N 1.346 1.104 0 C-N-CA 123.522 0.582 . . . . 71.34 112.568 -173.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -107.64 -5.72 17.31 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.651 0.781 . . . . 64.11 110.351 176.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -81.26 -39.2 13.05 Favored Glycine 0 C--N 1.346 1.121 0 CA-C-N 115.901 -0.59 . . . . 55.25 111.912 174.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.529 ' NH2' ' HA2' ' A' ' 104' ' ' GLY . 11.9 tpt180 75.8 -31.46 0.2 Allowed 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 126.18 1.792 . . . . 71.44 113.415 176.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 17.2 ttt180 -84.71 51.56 2.17 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.08 0.952 . . . . 73.25 110.834 -177.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 70.8 m 58.39 33.0 22.75 Favored 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 114.383 1.253 . . . . 74.21 114.383 169.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -71.44 155.76 40.24 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.305 0.242 . . . . 74.52 110.617 176.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.476 ' HA ' ' HD2' ' A' ' 170' ' ' PRO . 27.1 tptp -80.57 146.7 31.13 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.665 1.186 . . . . 72.15 111.331 -175.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -87.46 144.39 19.06 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-N 115.603 -0.726 . . . . 55.22 112.364 172.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -86.92 160.59 18.64 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.156 0.583 . . . . 71.34 111.821 -177.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -60.26 139.22 57.72 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.147 0.579 . . . . 74.23 111.305 176.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.445 HD23 ' N ' ' A' ' 120' ' ' ARG . 4.8 tt -145.89 160.78 41.33 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 107.994 -1.113 . . . . 70.23 107.994 -179.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.445 ' N ' HD23 ' A' ' 119' ' ' LEU . 0.3 OUTLIER -124.77 123.89 40.96 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 109.501 -0.555 . . . . 74.51 109.501 176.794 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.406 ' HB3' HD21 ' A' ' 174' ' ' LEU . . . -129.89 164.95 23.05 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.479 0.712 . . . . 41.51 110.477 -177.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.439 ' O ' HD12 ' B' ' 8' ' ' LEU . 4.2 mm-40 -106.73 120.34 41.73 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 106.976 -1.49 . . . . 61.0 106.976 -172.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.413 HD22 HD13 ' A' ' 176' ' ' LEU . 47.4 tp -97.92 99.84 7.55 Favored Pre-proline 0 CA--C 1.54 0.594 0 N-CA-C 108.191 -1.04 . . . . 54.05 108.191 -176.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.599 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 93.3 Cg_endo -77.74 110.99 3.04 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 121.374 1.383 . . . . 75.33 109.407 177.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.63 ' HA ' HG21 ' B' ' 6' ' ' ILE . 44.2 tp -119.57 136.22 54.46 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.87 0.468 . . . . 64.01 110.862 -168.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 67.9 m -67.92 129.41 39.84 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.927 0.891 . . . . 71.34 110.221 -179.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.475 HD23 ' HB3' ' A' ' 180' ' ' LEU . 51.5 mt -55.11 -43.37 74.0 Favored 'General case' 0 N--CA 1.481 1.123 0 O-C-N 124.376 1.048 . . . . 70.54 111.163 -174.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -57.34 -46.44 83.28 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 114.76 -1.109 . . . . 75.32 110.442 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -72.39 -29.0 63.35 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 115.339 -0.846 . . . . 64.33 110.719 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -67.12 -33.25 75.04 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.199 0.6 . . . . 41.43 110.564 175.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -66.62 -56.22 11.7 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 123.754 0.659 . . . . 74.51 109.744 172.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -61.27 -50.25 73.77 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 114.895 -1.048 . . . . 75.25 112.162 -169.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.04 131.9 0.28 Allowed Glycine 0 C--N 1.344 0.988 0 O-C-N 123.595 0.559 . . . . 71.54 112.937 -178.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 153.93 -161.34 29.9 Favored Glycine 0 C--N 1.338 0.643 0 N-CA-C 111.693 -0.563 . . . . 70.42 111.693 -177.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -71.23 134.7 47.06 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 109.813 -0.44 . . . . 73.14 109.813 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.556 ' NE ' ' HA ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -120.45 124.68 46.05 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 120.759 0.314 . . . . 74.4 110.634 179.701 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.44 ' HB ' HG23 ' B' ' 5' ' ' THR . 92.6 t -77.9 103.63 5.15 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-N 115.118 -0.947 . . . . 71.24 109.452 175.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 57.4 t -115.98 112.51 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.679 1.191 . . . . 73.14 107.792 177.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -111.97 129.54 56.15 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 120.98 0.419 . . . . 71.3 110.675 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.415 HG11 HD23 ' B' ' 8' ' ' LEU . 7.9 p -169.65 149.94 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.99 0 C-N-CA 124.906 1.282 . . . . 75.1 108.388 -177.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 60.68 19.56 9.58 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 113.237 0.828 . . . . 74.24 113.237 174.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 98.68 -31.03 8.59 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 116.402 -0.363 . . . . 31.1 112.607 -178.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.566 ' NH1' ' SD ' ' A' ' 164' ' ' MET . 66.3 ttt180 -86.7 137.62 32.3 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 122.804 0.441 . . . . 72.12 110.811 -178.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 43.1 ttm105 -112.34 97.15 6.43 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 108.189 -1.041 . . . . 74.41 108.189 169.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.6 p -87.21 145.73 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 CA-C-N 115.457 -0.792 . . . . 73.53 111.405 -177.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 39.8 t -103.59 89.05 3.23 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 108.475 -0.935 . . . . 31.45 108.475 170.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 4.9 p -94.45 118.44 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 109.702 -0.481 . . . . 73.42 109.702 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 58.1 ttt85 -72.95 104.16 3.99 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.022 0.439 . . . . 74.14 110.142 177.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 23.6 pt -74.18 143.14 79.81 Favored Pre-proline 0 CA--C 1.554 1.123 0 CA-C-N 115.184 -0.916 . . . . 74.13 110.164 175.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -63.32 138.46 66.27 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.782 2.321 . . . . 60.34 112.315 175.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -62.78 106.38 0.51 Allowed 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.801 2.334 . . . . 74.15 111.837 174.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 90.71 46.68 3.9 Favored Glycine 0 C--N 1.342 0.904 0 CA-C-N 115.508 -0.769 . . . . 75.51 112.184 -176.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.488 HG22 HG11 ' A' ' 178' ' ' VAL . 4.6 p -81.04 126.85 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.314 0.646 . . . . 75.43 110.784 -174.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.707 ' HD2' ' HA ' ' A' ' 191' ' ' GLN . 12.9 mtm180 -108.71 156.98 18.97 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.422 1.089 . . . . 73.23 110.225 -166.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.547 ' HB3' ' HA ' ' A' ' 189' ' ' GLU . 12.9 tp10 -49.62 130.36 20.57 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.011 0.925 . . . . 72.32 112.376 -177.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 89.78 0.18 78.85 Favored Glycine 0 C--N 1.347 1.152 0 CA-C-N 115.483 -0.78 . . . . 14.21 114.008 177.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 58.2 m -67.39 115.31 6.89 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 117.717 0.758 . . . . 74.23 109.784 174.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.505 HG22 HG22 ' A' ' 177' ' ' VAL . 90.3 t -95.98 106.02 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 124.164 0.986 . . . . 72.34 110.209 -174.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.515 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 54.1 mt -87.73 100.67 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 108.243 -1.021 . . . . 75.24 108.243 172.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 65.2 ttt-85 -75.15 100.45 4.27 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 109.247 -0.649 . . . . 61.32 109.247 176.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 4.5 p -125.28 117.36 25.28 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 123.927 0.891 . . . . 61.33 109.348 -178.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.19 147.54 79.09 Favored 'Trans proline' 0 C--N 1.371 1.759 0 C-N-CA 121.451 1.434 . . . . 74.53 110.435 169.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.578 ' HA2' ' HD2' ' A' ' 171' ' ' PRO . . . 124.28 -19.72 7.16 Favored Glycine 0 C--N 1.341 0.838 0 N-CA-C 115.213 0.845 . . . . 70.43 115.213 174.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.566 ' SD ' ' NH1' ' A' ' 143' ' ' ARG . 3.6 mpp? -124.12 8.93 8.61 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 117.687 0.744 . . . . 64.15 111.675 -178.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -87.92 -126.14 2.37 Favored Glycine 0 N--CA 1.477 1.382 0 CA-C-N 117.926 0.33 . . . . 73.33 113.32 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -62.71 153.65 43.93 Favored Glycine 0 C--N 1.357 1.72 0 O-C-N 123.481 0.165 . . . . 74.5 112.698 175.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -70.29 123.02 20.67 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.14 0.576 . . . . 75.42 110.903 -173.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -174.48 167.27 39.53 Favored Glycine 0 C--N 1.345 1.066 0 CA-C-O 119.365 -0.686 . . . . 64.21 111.571 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . 0.647 ' HA ' ' HB3' ' A' ' 106' ' ' PHE . 2.9 t-20 -69.98 -50.78 15.96 Favored Pre-proline 0 N--CA 1.479 0.982 0 CA-C-N 118.281 1.04 . . . . 63.11 110.279 174.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.559 ' HD3' ' HB3' ' A' ' 169' ' ' ASN . 8.3 Cg_endo -90.45 84.69 0.4 Allowed 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 121.703 1.602 . . . . 71.13 108.237 160.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.578 ' HD2' ' HA2' ' A' ' 163' ' ' GLY . 2.7 Cg_exo -71.26 178.99 4.87 Favored 'Trans proline' 0 C--N 1.369 1.657 0 C-N-CA 122.525 2.15 . . . . 71.25 113.007 -163.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -62.85 146.46 50.22 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 117.494 1.758 . . . . 72.4 117.494 -162.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -69.5 89.04 0.5 Allowed 'General case' 0 C--O 1.241 0.658 0 C-N-CA 124.872 1.269 . . . . 71.14 108.547 175.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.406 HD21 ' HB3' ' A' ' 121' ' ' ALA . 22.6 tp -83.14 149.18 27.03 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 114.994 -1.003 . . . . 64.32 111.332 -173.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 80.3 mt -110.56 95.93 5.87 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.037 0.935 . . . . 72.12 108.618 174.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.515 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 93.0 mt -71.21 92.25 1.0 Allowed 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 109.835 -0.431 . . . . 70.05 109.835 175.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.505 HG22 HG22 ' A' ' 158' ' ' VAL . 57.5 t -82.7 100.4 6.38 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 N-CA-C 106.923 -1.51 . . . . 61.43 106.923 173.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.488 HG11 HG22 ' A' ' 153' ' ' VAL . 9.9 p -65.87 113.45 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 CA-C-O 122.036 0.922 . . . . 70.33 110.922 -171.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.599 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 37.6 mmt180 -102.51 106.46 17.18 Favored 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 106.705 -1.591 . . . . 53.32 106.705 171.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.719 HD12 ' HB3' ' A' ' 188' ' ' LEU . 33.0 mt -70.09 143.29 52.46 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 118.921 0.782 . . . . 72.4 109.884 178.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 44.0 mt -54.08 158.07 3.91 Favored Pre-proline 0 N--CA 1.49 1.551 0 C-N-CA 124.314 1.046 . . . . 73.14 112.82 -167.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -75.92 44.01 1.22 Allowed 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 123.298 2.665 . . . . 71.42 111.022 163.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 62.0 t-80 -70.73 131.94 87.43 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 125.371 1.469 . . . . 73.35 107.178 177.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -64.34 12.3 0.1 OUTLIER 'Trans proline' 0 C--N 1.37 1.68 0 C-N-CA 123.557 2.838 . . . . 61.24 117.427 -162.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 4.1 t -112.03 -64.54 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.89 0 CA-C-N 120.455 1.479 . . . . 64.21 110.1 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . 0.552 ' CD1' ' HB2' ' A' ' 195' ' ' ALA . 39.2 m-85 -126.41 163.57 23.01 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 121.614 0.721 . . . . 72.31 111.869 -168.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 31.5 ttp-105 -141.35 96.07 2.93 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 107.102 -1.444 . . . . 75.51 107.102 161.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.719 ' HB3' HD12 ' A' ' 180' ' ' LEU . 54.5 tp -66.24 117.25 8.25 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.784 0.834 . . . . 74.21 110.465 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.551 ' HB3' ' HE1' ' A' ' 194' ' ' TYR . 35.8 tt0 -138.36 132.76 32.02 Favored 'General case' 0 C--O 1.247 0.925 0 C-N-CA 124.164 0.986 . . . . 70.31 109.084 -177.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 78.0 -82.78 1.2 Allowed Glycine 0 C--N 1.343 0.924 0 CA-C-N 115.687 -0.688 . . . . 65.41 111.56 -177.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.707 ' HA ' ' HD2' ' A' ' 154' ' ' ARG . 4.7 pm0 -147.68 -4.79 0.49 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.978 0.911 . . . . 72.32 110.647 174.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -130.73 156.18 45.37 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 122.997 0.519 . . . . 72.32 112.087 -165.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.495 HD21 ' HE1' ' A' ' 240' ' ' PHE . 68.9 mt -90.4 144.49 25.76 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.999 0.92 . . . . 63.44 110.334 -174.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.551 ' HE1' ' HB3' ' A' ' 189' ' ' GLU . 63.7 m-85 -117.24 110.45 18.13 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 109.049 -0.723 . . . . 73.14 109.049 171.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.604 ' HB3' HD23 ' A' ' 251' ' ' LEU . . . -121.52 -175.02 2.99 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.827 0.851 . . . . 74.34 110.999 178.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 22.8 m -125.08 145.63 49.83 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.715 0.806 . . . . 70.21 109.184 175.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.577 HD22 HD13 ' A' ' 251' ' ' LEU . 21.9 tp -133.77 101.16 4.99 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.931 -0.396 . . . . 72.21 109.931 176.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -80.67 113.49 18.9 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.321 -0.992 . . . . 61.43 108.321 166.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 6.4 p -133.26 133.21 22.65 Favored Pre-proline 0 N--CA 1.481 1.089 0 C-N-CA 123.652 0.781 . . . . 64.4 109.097 -171.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.37 151.89 60.25 Favored 'Trans proline' 0 C--N 1.375 1.941 0 C-N-CA 121.386 1.391 . . . . 64.51 112.146 177.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -55.52 -45.81 99.81 Favored Pre-proline 0 CA--C 1.553 1.083 0 N-CA-C 114.507 1.299 . . . . 71.34 114.507 -171.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -57.73 -45.4 33.46 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 121.442 1.428 . . . . 63.54 112.734 175.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 41.9 mt -71.11 -27.67 30.44 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 CA-C-N 116.117 -0.492 . . . . 64.32 111.12 -178.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -72.38 -45.0 61.74 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.268 0.627 . . . . 71.51 111.428 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 73.7 t -71.5 -49.86 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 123.356 0.662 . . . . 63.23 111.52 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.504 HG21 ' HA ' ' C' ' 270' ' ' LYS . 47.8 t -83.67 -35.18 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.196 0.598 . . . . 74.41 110.907 -172.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 91.87 73.96 1.26 Allowed Glycine 0 C--N 1.348 1.202 0 CA-C-N 116.084 -0.507 . . . . 72.35 113.35 176.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -110.42 170.33 13.99 Favored Glycine 0 N--CA 1.473 1.134 0 C-N-CA 122.853 0.263 . . . . 55.24 112.646 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -81.22 128.23 33.56 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.016 0.527 . . . . 45.21 111.921 -175.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.561 HG21 HD11 ' A' ' 197' ' ' LEU . 34.4 m -116.02 168.38 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.124 0.97 . . . . 63.11 108.705 169.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 37.9 ttp-105 -88.51 105.69 17.79 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.643 -0.873 . . . . 71.41 108.643 174.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -103.31 123.48 46.86 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.791 -0.818 . . . . 62.04 108.791 176.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 57.6 mtm -68.06 143.8 55.36 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 122.904 0.482 . . . . 71.23 110.72 -177.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 8.5 m -136.71 166.01 24.56 Favored 'General case' 0 CA--C 1.554 1.106 0 N-CA-C 108.762 -0.829 . . . . 74.1 108.762 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.457 HD21 ' HD2' ' A' ' 186' ' ' PHE . 52.6 mt -65.72 -12.85 57.21 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 114.495 1.294 . . . . 63.31 114.495 -170.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -128.2 31.3 5.08 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 109.355 -0.609 . . . . 64.44 109.355 178.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 112.9 160.71 14.61 Favored Glycine 0 C--N 1.351 1.408 0 CA-C-N 114.883 -1.053 . . . . 33.0 112.887 176.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -74.44 142.56 29.93 Favored 'Trans proline' 0 C--N 1.372 1.783 0 C-N-CA 123.141 2.56 . . . . 70.23 111.917 -178.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 34.7 m -128.88 152.0 36.44 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 C-N-CA 124.026 0.93 . . . . 73.4 109.898 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -78.62 117.97 20.28 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-O 121.248 0.547 . . . . 75.04 110.476 176.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 66.2 t -118.11 114.52 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 123.774 0.83 . . . . 74.13 109.063 -177.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -67.78 101.97 1.15 Allowed 'General case' 0 C--N 1.349 0.556 0 N-CA-C 109.525 -0.546 . . . . 60.25 109.525 172.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 96.3 t -53.9 137.58 55.29 Favored Pre-proline 0 CA--C 1.554 1.105 0 C-N-CA 124.354 1.062 . . . . 63.14 109.823 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . 0.419 ' HD3' HD13 ' B' ' 441' ' ' ILE . 16.1 Cg_endo -56.22 156.31 21.34 Favored 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 122.522 2.148 . . . . 75.51 111.864 174.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -77.97 151.82 27.76 Favored 'Trans proline' 0 C--N 1.366 1.449 0 C-N-CA 121.616 1.544 . . . . 72.53 111.553 177.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 67.4 mtt-85 67.1 26.68 8.82 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 125.056 1.342 . . . . 74.04 111.498 174.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.444 HG23 HD21 ' A' ' 233' ' ' LEU . 28.8 m -64.16 109.01 1.71 Allowed 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 124.581 1.153 . . . . 64.32 111.468 177.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -101.53 146.56 27.5 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.324 1.05 . . . . 75.32 110.572 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -71.01 145.45 49.98 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.225 0.61 . . . . 62.31 112.367 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 95.19 -1.32 64.68 Favored Glycine 0 C--N 1.342 0.901 0 CA-C-N 115.241 -0.89 . . . . 73.32 112.368 -176.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -109.56 167.97 9.75 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.69 0.796 . . . . 74.0 111.449 -176.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -118.59 115.71 25.12 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.079 0.952 . . . . 72.22 109.919 -177.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.516 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 73.9 mt -80.51 110.19 15.74 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 122.76 0.424 . . . . 71.4 110.279 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . 0.486 ' HA ' ' O ' ' A' ' 249' ' ' LEU . 42.4 ttm180 -74.18 106.65 5.93 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 124.309 1.006 . . . . 64.14 110.392 175.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.52 HD22 HG12 ' B' ' 441' ' ' ILE . 5.0 mt -112.14 101.57 9.82 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 108.331 -0.988 . . . . 61.12 108.331 173.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -67.43 156.18 37.21 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.399 0.68 . . . . 64.43 111.89 -177.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 81.18 -6.81 62.1 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 116.512 -0.313 . . . . 74.2 113.627 177.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.19 -39.83 20.47 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.651 0.781 . . . . 73.01 109.968 176.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -78.98 173.84 55.34 Favored Glycine 0 C--N 1.347 1.153 0 O-C-N 123.676 0.61 . . . . 74.43 111.944 178.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . 0.495 ' HE1' HD21 ' A' ' 193' ' ' LEU . 63.2 m-85 -96.45 160.4 29.7 Favored Pre-proline 0 N--CA 1.473 0.703 0 C-N-CA 123.875 0.87 . . . . 73.13 111.472 -167.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' A' ' 245' ' ' GLY . 11.7 Cg_endo -52.7 140.35 56.46 Favored 'Trans proline' 0 C--N 1.387 2.568 0 C-N-CA 122.79 2.327 . . . . 73.33 112.348 175.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 179.94 -153.04 11.45 Favored Glycine 0 C--N 1.341 0.821 0 CA-C-O 118.738 -1.035 . . . . 73.52 111.597 -176.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . 0.493 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 85.0 Cg_exo -50.0 -43.52 41.48 Favored 'Trans proline' 0 C--N 1.382 2.342 0 C-N-CA 123.955 3.103 . . . . 70.45 114.482 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -85.29 21.45 1.71 Allowed 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.544 0.738 . . . . 70.11 112.372 -175.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 241' ' ' PRO . . . 81.1 -77.1 2.07 Favored Glycine 0 C--N 1.347 1.192 0 N-CA-C 109.253 -1.539 . . . . 62.24 109.253 -170.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 73.1 mtp180 -126.19 160.64 29.69 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.243 1.017 . . . . 75.41 108.537 163.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -92.18 172.03 34.57 Favored Glycine 0 C--O 1.25 1.124 0 CA-C-O 122.134 0.852 . . . . 42.24 113.589 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -101.2 -170.95 1.91 Allowed 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 114.105 -1.048 . . . . 75.44 110.238 -177.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.486 ' O ' ' HA ' ' A' ' 234' ' ' ARG . 22.3 tp -121.54 144.61 48.62 Favored 'General case' 0 C--O 1.216 -0.704 0 N-CA-C 107.041 -1.466 . . . . 70.31 107.041 164.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -124.84 106.24 9.87 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 108.471 -0.937 . . . . 52.51 108.471 173.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.604 HD23 ' HB3' ' A' ' 195' ' ' ALA . 83.1 mt -90.35 119.3 30.53 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 115.386 -0.825 . . . . 72.24 110.712 -179.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -77.21 104.0 7.47 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.011 -0.737 . . . . 75.41 109.011 177.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 38.8 t -73.15 123.53 28.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 115.254 -0.885 . . . . 24.43 111.582 -173.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -125.02 100.96 6.82 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 107.379 -1.341 . . . . 73.14 107.379 166.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.535 ' HB ' ' O ' ' C' ' 255' ' ' ILE . 64.0 mt -75.23 137.15 23.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 115.909 -0.587 . . . . 74.34 109.946 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 39.9 p -119.44 169.49 9.98 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.081 0.952 . . . . 73.43 108.667 173.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.517 ' HB ' ' HD2' ' A' ' 258' ' ' PRO . 2.9 pp -134.38 157.0 78.43 Favored Pre-proline 0 CA--C 1.561 1.392 0 N-CA-C 108.547 -0.909 . . . . 73.4 108.547 175.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . 0.517 ' HD2' ' HB ' ' A' ' 257' ' ' ILE . 37.3 Cg_endo -58.81 -12.34 14.53 Favored 'Trans proline' 0 C--N 1.385 2.481 0 C-N-CA 123.617 2.878 . . . . 74.45 116.147 -162.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.58 ' HA ' ' HB3' ' C' ' 226' ' ' ARG . 29.9 tt0 58.25 -70.26 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 125.352 1.461 . . . . 63.24 112.646 -172.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -74.01 131.01 40.96 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 109.285 -0.635 . . . . 75.12 109.285 172.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 19.6 mt -138.58 144.24 39.73 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.78 0.8 . . . . 55.32 111.587 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 24.5 p -96.92 148.9 35.07 Favored Pre-proline 0 CA--C 1.559 1.32 0 CA-C-N 114.167 -1.378 . . . . 44.34 108.954 173.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -39.87 -47.55 3.76 Favored 'Trans proline' 0 C--N 1.387 2.566 0 C-N-CA 125.114 3.876 . . . . 74.33 116.937 -168.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -67.92 -49.16 63.48 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 122.747 0.419 . . . . 71.44 111.417 -175.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -58.48 -44.57 89.39 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 109.91 -0.404 . . . . 64.2 109.91 177.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' GLU . . . . . 0.407 ' OE1' ' HD2' ' C' ' 226' ' ' ARG . 11.8 tp10 -62.65 -33.65 75.47 Favored 'General case' 0 CA--C 1.549 0.92 0 O-C-N 123.754 0.659 . . . . 73.45 111.278 178.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -66.63 -41.71 87.9 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 122.843 0.457 . . . . 64.12 110.782 176.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 10.9 mp -65.54 -47.73 74.87 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.13 0.572 . . . . 73.14 110.7 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 65.9 m95 -58.63 -43.97 89.87 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.925 0.89 . . . . 75.0 111.752 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . 0.485 ' O ' ' HG3' ' A' ' 274' ' ' GLU . 42.9 mttp -67.53 -42.78 82.17 Favored 'General case' 0 C--O 1.215 -0.736 0 CA-C-O 119.215 -0.422 . . . . 62.43 111.44 178.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . 0.417 ' HA ' ' HD3' ' A' ' 271' ' ' LYS . 32.2 mmtm -62.87 -35.62 80.59 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 117.884 0.311 . . . . 70.22 111.706 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' LEU . . . . . 0.652 HD21 ' HB2' ' C' ' 268' ' ' LEU . 86.7 mt -60.31 -50.81 72.14 Favored 'General case' 0 C--O 1.214 -0.768 0 O-C-N 123.909 0.755 . . . . 63.4 109.5 169.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . 0.445 ' HA ' ' HB2' ' C' ' 202' ' ' PRO . . . -65.41 -29.93 70.68 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.492 1.117 . . . . 64.51 113.721 -174.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.773 ' HG2' ' HA ' ' B' ' 251' ' ' ALA . 41.1 mt-10 -81.3 -49.09 11.15 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 123.27 0.628 . . . . 74.35 109.311 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -67.7 -18.81 65.05 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 115.605 -0.725 . . . . 71.44 111.156 177.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . 0.404 ' HE2' ' HG3' ' C' ' 258' ' ' PRO . 21.0 t80 -77.9 -76.66 0.18 Allowed 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 108.349 -0.982 . . . . 75.02 108.349 171.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -50.05 -60.63 2.76 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.673 1.189 . . . . 70.12 111.543 -171.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' B' ' 277' ' ' LEU . . . -61.63 -28.65 69.52 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 123.7 0.625 . . . . 75.41 111.795 -174.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . 0.487 ' HE ' ' HA ' ' A' ' 279' ' ' ARG . 4.6 mmp_? -117.84 32.48 6.13 Favored 'General case' 0 C--N 1.349 0.548 0 N-CA-C 109.507 -0.553 . . . . 74.13 109.507 -174.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.198 0 N-CA-C 108.709 -0.848 . . . . 72.21 108.709 171.524 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 68.4 mtm . . . . . 0 N--CA 1.483 1.185 0 N-CA-C 109.936 -0.394 . . . . 71.44 109.936 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -104.06 84.96 2.31 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.473 0.709 . . . . 54.1 109.354 -173.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -67.78 -72.34 0.18 Allowed 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 109.44 -0.578 . . . . 74.04 109.44 178.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 22.4 m 64.88 -65.87 0.14 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 125.132 1.373 . . . . 52.14 112.716 176.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 0.44 HG23 ' HB ' ' A' ' 137' ' ' VAL . 4.3 m -74.44 153.44 39.18 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 123.635 0.774 . . . . 70.11 111.254 177.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.63 HG21 ' HA ' ' A' ' 125' ' ' LEU . 41.6 pt -135.6 -179.84 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 123.173 0.589 . . . . 64.44 112.282 -169.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -130.35 -158.24 0.88 Allowed 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 124.258 1.023 . . . . 72.01 109.612 178.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.439 HD12 ' O ' ' A' ' 122' ' ' GLU . 45.3 tp -141.4 149.75 41.47 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.735 0.814 . . . . 75.22 109.802 179.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.84 -51.25 8.81 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 122.747 0.419 . . . . 62.4 111.764 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 27.0 mt 74.71 -22.46 0.26 Allowed 'General case' 0 N--CA 1.499 2.013 0 C-N-CA 125.381 1.472 . . . . 74.1 113.788 -174.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.423 ' N ' ' HD3' ' B' ' 12' ' ' PRO . 79.9 mt 53.38 58.12 13.74 Favored Pre-proline 0 CA--C 1.565 1.549 0 C-N-CA 124.385 1.074 . . . . 45.35 111.877 -172.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.423 ' HD3' ' N ' ' B' ' 11' ' ' LEU . 4.6 Cg_exo -81.51 -26.08 3.41 Favored 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 122.791 2.327 . . . . 61.33 111.868 176.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -159.97 171.34 19.54 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 124.558 1.143 . . . . 75.01 108.251 -174.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 52.3 tp -104.3 117.99 35.55 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.316 -0.994 . . . . 64.54 108.316 172.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -64.89 115.26 5.17 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.257 0.623 . . . . 60.01 109.871 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 47.1 p -82.49 143.38 47.63 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 123.564 0.746 . . . . 51.11 110.133 176.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -76.81 169.01 22.53 Favored 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 122.816 2.344 . . . . 62.42 113.213 178.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 7.3 p -105.93 135.86 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 123.914 0.886 . . . . 61.41 110.347 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 29.3 p -67.29 144.35 55.95 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.137 0.975 . . . . 71.22 112.035 -178.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -123.24 176.51 6.06 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.463 1.105 . . . . 62.34 109.967 -179.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.97 109.99 2.74 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 122.996 0.518 . . . . 75.34 110.036 175.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . 0.437 ' NH2' ' HA ' ' B' ' 377' ' ' PHE . 41.1 ttt180 -159.06 153.82 24.66 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.808 0.843 . . . . 73.31 110.027 -171.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' THR . . . . . 0.681 ' HA ' ' HG3' ' B' ' 376' ' ' GLU . 85.1 m 70.69 83.65 0.15 Allowed Pre-proline 0 N--CA 1.478 0.967 0 C-N-CA 124.748 1.219 . . . . 72.45 112.185 174.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -91.08 33.47 0.31 Allowed 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 123.418 2.745 . . . . 74.55 111.373 166.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -84.07 75.22 10.18 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 123.976 0.91 . . . . 74.53 110.079 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . 0.538 ' HB3' ' HD3' ' B' ' 27' ' ' PRO . 1.4 tpt -164.33 -48.24 0.0 OUTLIER Pre-proline 0 CA--C 1.554 1.103 0 CA-C-N 114.808 -1.087 . . . . 75.13 108.931 175.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' PRO . . . . . 0.538 ' HD3' ' HB3' ' B' ' 26' ' ' MET . 2.7 Cg_endo -85.92 96.22 0.57 Allowed 'Trans proline' 0 C--N 1.388 2.618 0 C-N-CA 121.687 1.591 . . . . 71.1 108.776 159.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.472 HG21 ' HB2' ' B' ' 139' ' ' ASN . 7.2 p -58.93 122.75 9.67 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 CA-C-N 116.147 -0.478 . . . . 73.51 110.784 -178.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.432 HD13 ' H ' ' B' ' 31' ' ' ASN . 1.9 tm? -104.54 115.82 31.02 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 106.401 -1.703 . . . . 62.2 106.401 172.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -64.34 -32.83 74.59 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.026 0.931 . . . . 70.24 112.226 -172.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' ASN . . . . . 0.432 ' H ' HD13 ' B' ' 29' ' ' LEU . 65.5 t30 70.38 13.89 7.49 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 124.873 1.269 . . . . 74.34 111.983 175.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' ARG . . . . . 0.444 ' HB3' ' HB1' ' C' ' 244' ' ' ALA . 4.3 ppt_? -85.99 -1.28 57.19 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.559 0.744 . . . . 72.22 112.603 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.1 118.48 11.32 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 122.975 0.51 . . . . 73.31 110.066 174.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . 59.09 29.7 19.32 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 124.468 1.107 . . . . 53.33 112.182 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . 0.663 ' HA ' ' HB3' ' C' ' 236' ' ' LYS . 28.1 tt0 -78.27 -30.9 48.76 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.02 0.928 . . . . 73.13 112.305 -173.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.02 -83.33 0.23 Allowed Glycine 0 CA--C 1.531 1.07 0 N-CA-C 111.647 -0.581 . . . . 74.33 111.647 -173.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . 0.491 ' HB2' ' HG2' ' B' ' 35' ' ' GLN . 31.5 t70 60.51 -83.26 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 125.564 1.546 . . . . 61.44 111.995 170.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 7.5 tt -96.78 85.04 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 CA-C-O 122.375 1.083 . . . . 75.44 108.47 173.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 43.7 m -110.51 -43.08 3.93 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 114.856 -1.066 . . . . 64.25 109.108 177.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.08 119.01 72.14 Favored Pre-proline 0 CA--C 1.549 0.911 0 CA-C-N 115.655 -0.702 . . . . 64.0 109.372 172.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -65.97 89.1 0.24 Allowed 'Trans proline' 0 C--N 1.381 2.277 0 C-N-CA 123.107 2.538 . . . . 72.44 112.457 -177.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.78 -80.17 1.08 Allowed Glycine 0 C--N 1.345 1.055 0 CA-C-N 115.529 -0.76 . . . . 45.24 111.642 -176.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.88 -66.62 3.87 Favored Glycine 0 C--N 1.346 1.119 0 N-CA-C 112.044 -0.423 . . . . 42.15 112.044 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . 58.26 -168.99 0.13 Allowed 'General case' 0 C--N 1.36 1.056 0 C-N-CA 124.696 1.198 . . . . 63.2 111.216 -176.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.543 ' HB2' ' HB3' ' B' ' 127' ' ' SER . 0.0 OUTLIER -92.21 128.96 38.25 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 107.467 -1.309 . . . . 74.21 107.467 169.531 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -86.15 81.07 8.57 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 107.637 -1.246 . . . . 75.02 107.637 178.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.429 HD23 ' HA3' ' B' ' 229' ' ' GLY . 2.8 tm? -124.16 101.41 7.19 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 108.021 -1.103 . . . . 53.22 108.021 175.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 10.3 t -179.69 171.76 1.17 Allowed 'General case' 0 C--O 1.245 0.853 0 O-C-N 124.816 1.323 . . . . 51.22 108.104 169.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 145.53 157.96 7.49 Favored Glycine 0 C--N 1.345 1.08 0 N-CA-C 111.841 -0.503 . . . . 74.15 111.841 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -82.73 54.55 2.72 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.997 0.919 . . . . 64.2 110.429 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' GLN . . . . . 0.615 ' HG2' HD22 ' B' ' 55' ' ' LEU . 9.5 tp-100 66.8 128.85 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 125.723 1.609 . . . . 75.3 111.48 -173.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 95.1 m -147.31 103.02 3.53 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 123.298 0.639 . . . . 73.31 109.294 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . 63.65 169.31 0.16 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.932 1.293 . . . . 73.24 113.049 177.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . 72.76 -16.82 0.43 Allowed 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.168 1.387 . . . . 75.51 113.795 176.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.615 HD22 ' HG2' ' B' ' 51' ' ' GLN . 40.5 tp -62.82 128.69 37.08 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 118.772 0.715 . . . . 72.35 109.713 176.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 26.5 mmm180 78.1 -45.49 0.42 Allowed 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 125.76 1.624 . . . . 73.2 112.072 -174.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -69.38 -72.21 0.2 Allowed 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.42 0.688 . . . . 75.31 109.974 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 20.0 m 66.18 4.98 3.36 Favored 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 125.007 1.323 . . . . 62.01 114.028 169.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 60.8 tp 57.94 95.17 0.03 OUTLIER 'General case' 0 C--N 1.36 1.03 0 C-N-CA 124.647 1.179 . . . . 72.44 110.401 -170.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 41.3 m -78.26 90.88 4.35 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 122.869 0.467 . . . . 63.51 109.831 177.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -114.75 148.81 37.84 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.196 0.598 . . . . 71.45 109.79 172.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' LYS . . . . . 0.599 ' HE2' ' HA ' ' B' ' 62' ' ' LYS . 10.8 mmpt? 75.11 141.38 0.08 OUTLIER Pre-proline 0 N--CA 1.484 1.241 0 C-N-CA 125.747 1.619 . . . . 72.3 111.737 -177.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -69.09 90.76 0.45 Allowed 'Trans proline' 0 C--N 1.383 2.344 0 C-N-CA 123.262 2.641 . . . . 72.24 111.641 -177.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 76.32 -48.19 0.56 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 125.647 1.579 . . . . 72.04 111.559 -171.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.402 ' HB2' ' HB2' ' B' ' 62' ' ' LYS . 37.4 ttmt 71.89 -73.28 0.1 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.417 1.487 . . . . 65.32 109.258 -174.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 45.4 t30 54.05 -102.03 0.13 Allowed 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 124.301 1.041 . . . . 72.41 110.589 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 17.3 mm -90.71 95.2 5.34 Favored 'Isoleucine or valine' 0 C--N 1.355 0.843 0 N-CA-C 107.794 -1.188 . . . . 72.03 107.794 177.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 6.4 tp -60.1 117.02 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.23 0 C-N-CA 124.094 0.958 . . . . 73.4 111.94 -175.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 58.6 tp 72.3 -62.89 0.45 Allowed 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 125.868 1.667 . . . . 73.12 112.136 176.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.19 47.86 1.4 Allowed 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 123.915 0.886 . . . . 44.44 111.018 -174.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 9.2 tt -61.41 -43.77 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 123.047 0.539 . . . . 74.32 109.872 172.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.53 -67.61 2.54 Favored Glycine 0 C--N 1.35 1.345 0 CA-C-N 115.798 -0.637 . . . . 62.21 112.157 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 11.5 t70 79.0 -62.5 0.31 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 126.765 2.026 . . . . 63.44 110.789 176.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . 0.467 ' H ' ' HB2' ' B' ' 77' ' ' ASP . . . 107.8 -63.94 0.27 Allowed Glycine 0 C--N 1.343 0.961 0 N-CA-C 112.362 -0.295 . . . . 64.42 112.362 176.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 21.2 ptp -87.15 -24.61 24.43 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 122.866 0.466 . . . . 74.01 111.23 -176.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . -111.54 14.04 27.57 Favored Glycine 0 C--N 1.346 1.117 0 N-CA-C 111.54 -0.624 . . . . 71.13 111.54 174.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . 0.467 ' HB2' ' H ' ' B' ' 74' ' ' GLY . 15.2 t70 -62.68 135.4 57.35 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.686 1.194 . . . . 73.03 111.927 -178.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 22.8 t -166.29 158.39 13.95 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.369 0.668 . . . . 51.1 110.309 178.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 68.55 -71.05 0.12 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 125.678 1.591 . . . . 74.44 112.181 176.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 12.3 tt -53.38 -23.65 7.32 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.295 0 C-N-CA 124.764 1.226 . . . . 72.52 112.936 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -56.71 -47.42 79.99 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.006 0.922 . . . . 71.34 110.958 177.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . 0.427 ' HA ' ' HB2' ' B' ' 86' ' ' TYR . . . -66.59 -23.47 66.2 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 114.975 -1.011 . . . . 61.11 112.498 -175.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.9 -41.56 86.92 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.378 0.671 . . . . 71.35 111.229 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 18.4 tpp180 -160.64 140.37 10.97 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.214 0.606 . . . . 73.0 110.363 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 67.46 30.35 6.86 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.493 1.117 . . . . 72.23 112.001 177.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 86' ' ' TYR . . . . . 0.427 ' HB2' ' HA ' ' B' ' 82' ' ' ALA . 50.7 t80 -77.38 77.54 3.91 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 109.198 -0.667 . . . . 63.12 109.198 172.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . 164.03 -34.93 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 126.851 2.061 . . . . 52.24 108.877 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 66.26 -78.04 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 124.806 1.242 . . . . 74.14 108.194 -167.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . 0.641 ' HA3' ' HG2' ' B' ' 95' ' ' LYS . . . 151.7 -58.7 0.42 Allowed Glycine 0 C--N 1.343 0.928 0 N-CA-C 110.878 -0.889 . . . . 54.33 110.878 176.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . 0.472 ' HB3' ' HB3' ' B' ' 95' ' ' LYS . . . -176.73 113.18 0.1 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.522 1.129 . . . . 62.33 108.836 177.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -66.92 86.87 0.13 Allowed Glycine 0 C--N 1.35 1.352 0 N-CA-C 110.96 -0.856 . . . . 70.11 110.96 174.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . 0.563 ' H ' ' HA3' ' B' ' 96' ' ' GLY . . . 92.04 -138.99 14.49 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.961 -0.856 . . . . 23.53 110.961 -167.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 62.73 -75.95 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.911 1.285 . . . . 74.22 111.501 177.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -143.66 -48.78 0.3 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.519 1.128 . . . . 71.21 109.427 176.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . 0.641 ' HG2' ' HA3' ' B' ' 89' ' ' GLY . 28.0 tptp -61.95 -47.67 83.82 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.682 0.793 . . . . 74.14 111.31 -177.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 96' ' ' GLY . . . . . 0.563 ' HA3' ' H ' ' B' ' 92' ' ' GLY . . . -65.75 82.44 0.09 OUTLIER Glycine 0 C--N 1.345 1.054 0 O-C-N 123.954 0.784 . . . . 72.31 112.638 178.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 31.8 pt -84.96 -20.78 8.21 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 124.035 0.934 . . . . 72.22 109.586 176.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -139.67 172.56 12.62 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 125.087 1.355 . . . . 75.21 108.497 168.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -142.84 -40.4 0.33 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.612 0.365 . . . . 61.12 110.629 -177.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 93.5 mt -124.94 81.11 62.71 Favored Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 123.375 0.67 . . . . 74.2 110.767 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -85.09 -8.33 8.96 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 122.345 2.03 . . . . 72.21 112.936 170.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . 0.499 ' HB3' ' HA ' ' B' ' 105' ' ' GLN . 3.5 mm? -77.56 -45.03 26.58 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.597 0.759 . . . . 73.12 109.811 177.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 14.5 m 65.35 78.47 0.28 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.621 1.169 . . . . 75.52 110.537 178.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 66.96 22.43 72.23 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-N 114.606 -1.179 . . . . 51.35 112.732 -176.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 105' ' ' GLN . . . . . 0.499 ' HA ' ' HB3' ' B' ' 102' ' ' LEU . 8.9 tp-100 57.37 76.36 0.32 Allowed 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 124.462 1.105 . . . . 75.22 109.699 -169.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 64.37 107.62 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 125.682 1.593 . . . . 74.44 113.804 175.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 50.2 p -78.18 -173.63 3.3 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 123.529 0.732 . . . . 63.32 110.497 171.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -79.7 80.34 6.09 Favored 'General case' 0 CA--C 1.558 1.272 0 CA-C-O 122.042 0.925 . . . . 71.44 109.895 177.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -74.28 -41.92 60.43 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 121.785 -0.572 . . . . 53.33 109.86 176.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -169.53 -46.69 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.702 1.201 . . . . 71.24 108.396 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 5.7 tt -170.97 -51.72 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 106.311 -1.737 . . . . 64.15 106.311 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 65.36 -133.73 0.23 Allowed 'General case' 0 CA--C 1.555 1.155 0 CA-C-N 114.149 -1.387 . . . . 73.2 109.474 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 113' ' ' LYS . . . . . 0.542 ' HA ' ' HE2' ' B' ' 113' ' ' LYS . 11.5 mmpt? 69.74 -3.31 1.72 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.115 1.366 . . . . 75.13 113.621 175.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 13.3 mptt 51.2 -92.18 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.525 1.13 . . . . 74.01 110.888 -173.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . 0.536 HG22 ' HD3' ' B' ' 117' ' ' LYS . 12.1 m 58.13 -74.56 0.02 OUTLIER 'General case' 0 CA--C 1.562 1.408 0 C-N-CA 125.33 1.452 . . . . 73.23 112.755 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.16 47.42 4.7 Favored Glycine 0 C--N 1.354 1.572 0 N-CA-C 111.625 -0.59 . . . . 55.33 111.625 -178.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . 0.536 ' HD3' HG22 ' B' ' 115' ' ' THR . 5.1 mptp? -119.68 -52.08 0.04 OUTLIER Pre-proline 0 CA--C 1.569 1.681 0 CA-C-O 117.786 -1.102 . . . . 70.25 112.861 -173.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 118' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -61.72 106.09 0.41 Allowed 'Trans proline' 0 C--N 1.39 2.76 0 C-N-CA 121.985 1.79 . . . . 60.53 113.162 -176.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 119' ' ' ASP . . . . . . . . . . . . . 31.0 t70 76.24 161.6 0.23 Allowed 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 125.207 1.403 . . . . 75.33 112.924 173.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 120' ' ' TYR . . . . . 0.505 ' HA ' ' HB2' ' B' ' 221' ' ' ARG . 0.8 OUTLIER -152.57 -2.77 0.25 Allowed 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 124.36 1.064 . . . . 70.1 111.483 176.1 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 15.9 m -126.94 -31.14 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 113.419 0.896 . . . . 74.32 113.419 -170.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 45.1 m -77.26 91.13 3.75 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.126 0.571 . . . . 75.24 110.284 -174.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -154.5 162.03 41.36 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.146 0.578 . . . . 64.3 109.886 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 46.1 m -101.44 12.93 36.48 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.395 0.678 . . . . 43.31 111.987 -176.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.67 130.35 42.99 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.503 0.721 . . . . 73.02 110.641 177.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.96 -22.73 67.05 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.825 -0.625 . . . . 74.13 110.697 176.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 127' ' ' SER . . . . . 0.543 ' HB3' ' HB2' ' B' ' 45' ' ' ARG . 53.6 m 67.78 26.06 7.83 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.811 1.245 . . . . 70.01 111.906 171.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -104.66 -25.79 12.57 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.55 0.74 . . . . 72.01 110.768 176.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 41.1 p -76.99 89.35 3.54 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 121.105 0.479 . . . . 54.34 110.675 178.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . -85.75 69.58 10.61 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 109.481 -0.562 . . . . 44.22 109.481 175.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 131' ' ' TRP . . . . . 0.436 ' CD1' ' HB3' ' C' ' 132' ' ' HIS . 66.8 t-105 66.23 -76.17 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 125.193 1.397 . . . . 73.51 110.801 -177.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 36.4 t -162.88 162.01 26.14 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.102 0.961 . . . . 51.4 109.303 176.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 63.6 m -153.81 141.18 19.67 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 108.993 -0.743 . . . . 62.25 108.993 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . -148.13 135.69 5.63 Favored Glycine 0 C--N 1.343 0.96 0 N-CA-C 111.465 -0.654 . . . . 55.15 111.465 177.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 135' ' ' VAL . . . . . . . . . . . . . 18.9 m -90.76 178.27 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 123.451 0.7 . . . . 73.24 109.857 175.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 136' ' ' LYS . . . . . 0.418 ' O ' ' HA ' ' B' ' 371' ' ' VAL . 18.8 pttp -88.86 47.72 1.54 Allowed 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 121.079 0.466 . . . . 52.43 109.839 173.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 45.3 m 56.69 -83.68 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.237 0 C-N-CA 125.381 1.472 . . . . 75.31 113.07 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -134.82 174.43 10.59 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.166 0.987 . . . . 75.52 108.995 -169.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . 0.472 ' HB2' HG21 ' B' ' 28' ' ' VAL . 30.0 p-10 -78.5 -41.66 31.79 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 121.747 -0.596 . . . . 73.24 110.638 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 140' ' ' GLY . . . . . 0.835 ' HA3' HG21 ' B' ' 371' ' ' VAL . . . 58.07 -136.41 50.92 Favored Glycine 0 C--N 1.35 1.359 0 N-CA-C 115.068 0.787 . . . . 65.04 115.068 171.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -110.17 -38.38 5.3 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.821 0.849 . . . . 75.34 111.354 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 23.4 mt 73.97 171.57 0.29 Allowed 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 126.103 1.761 . . . . 70.15 111.598 -176.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.63 -172.08 53.18 Favored Glycine 0 C--N 1.346 1.113 0 CA-C-N 115.542 -0.754 . . . . 61.25 113.615 178.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 43.3 t 75.5 -33.98 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 C-N-CA 125.738 1.615 . . . . 75.31 112.183 -178.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -60.96 106.15 0.55 Allowed 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 123.87 0.868 . . . . 64.3 111.215 178.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 82.4 mt -128.05 -74.0 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 107.85 -1.167 . . . . 72.52 107.85 172.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 147' ' ' HIS . . . . . 0.618 ' HA ' HG21 ' B' ' 306' ' ' VAL . 34.1 t-80 72.44 -56.32 0.65 Allowed 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 125.444 1.498 . . . . 72.43 114.678 173.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . 0.427 ' HG3' ' O ' ' B' ' 197' ' ' SER . 6.7 mm-40 -46.17 138.88 4.99 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 115.64 1.719 . . . . 73.05 115.64 -155.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 149' ' ' LYS . . . . . 0.461 ' HA ' ' O ' ' B' ' 302' ' ' ASP . 33.2 mtmt -123.48 -93.34 0.51 Allowed 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 114.279 -1.328 . . . . 72.23 109.599 -173.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 38.7 t70 178.45 -123.85 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 125.175 1.39 . . . . 74.11 107.592 172.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 151' ' ' HIS . . . . . 0.41 ' HA ' ' HB2' ' C' ' 118' ' ' ASP . 10.4 p-80 -176.43 113.96 0.26 Allowed Pre-proline 0 C--N 1.356 0.886 0 C-N-CA 124.629 1.171 . . . . 74.43 109.122 -176.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -77.58 -17.9 14.03 Favored 'Trans proline' 0 C--N 1.366 1.499 0 C-N-CA 122.186 1.924 . . . . 42.51 110.862 169.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 21.9 m -111.11 131.55 55.0 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.457 1.103 . . . . 74.2 109.29 -176.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 15.8 tt -142.57 160.77 19.01 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 C-N-CA 124.478 1.111 . . . . 74.25 108.108 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 155' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' B' ' 187' ' ' SER . 58.7 mt 70.47 172.8 0.31 Allowed 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 124.872 1.269 . . . . 72.1 112.628 177.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -172.69 -154.22 0.08 Allowed 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 124.698 1.199 . . . . 72.23 108.639 172.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 157' ' ' MET . . . . . . . . . . . . . 60.2 mtt -52.55 -74.83 0.03 OUTLIER 'General case' 0 C--N 1.365 1.27 0 C-N-CA 123.823 0.849 . . . . 53.54 110.994 173.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 158' ' ' ALA . . . . . . . . . . . . . . . 172.17 -71.0 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.561 1.144 . . . . 34.04 108.996 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 32.5 mtmm 46.27 69.07 0.51 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.548 1.539 . . . . 55.45 112.668 -175.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -86.61 59.28 5.54 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.103 0.561 . . . . 70.22 109.578 174.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -69.87 121.66 17.75 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.794 0.837 . . . . 71.1 111.26 -173.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 83.68 -73.64 2.64 Favored Glycine 0 C--N 1.347 1.175 0 N-CA-C 111.718 -0.553 . . . . 73.4 111.718 -177.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 25.4 tp 62.7 8.38 2.98 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 125.173 1.389 . . . . 65.02 112.393 175.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 164' ' ' ALA . . . . . . . . . . . . . . . -170.4 -46.37 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.843 1.257 . . . . 75.34 107.715 -174.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 48.4 p -103.5 -174.55 2.57 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 114.304 -1.316 . . . . 64.15 109.211 169.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . 113.34 -136.02 13.07 Favored Glycine 0 C--N 1.344 0.983 0 N-CA-C 111.111 -0.796 . . . . 71.15 111.111 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 167' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -83.01 68.45 9.51 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 108.742 -0.836 . . . . 72.31 108.742 176.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . 0.509 HG23 ' H ' ' B' ' 169' ' ' SER . 17.4 m -108.0 -62.8 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 CA-C-N 115.216 -0.902 . . . . 74.13 110.503 -176.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 169' ' ' SER . . . . . 0.754 ' HA ' ' HB2' ' B' ' 174' ' ' GLN . 20.1 m 49.62 -176.96 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.412 0 N-CA-C 115.427 1.64 . . . . 54.35 115.427 177.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 48.0 m -150.25 98.87 2.73 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.692 -0.855 . . . . 63.1 108.692 176.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . 0.527 ' H ' ' HG2' ' C' ' 128' ' ' GLU . . . 72.46 -64.8 0.38 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 125.28 1.432 . . . . 53.32 111.209 -178.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 172' ' ' GLU . . . . . . . . . . . . . 15.6 mp0 -105.3 170.89 7.62 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.151 0.981 . . . . 73.22 109.055 168.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 173' ' ' LEU . . . . . 0.553 ' H ' HD13 ' B' ' 173' ' ' LEU . 0.0 OUTLIER -57.25 131.1 49.0 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 123.511 0.724 . . . . 74.23 111.721 178.658 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 174' ' ' GLN . . . . . 0.754 ' HB2' ' HA ' ' B' ' 169' ' ' SER . 8.2 mm100 -131.63 -26.68 2.0 Allowed 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.129 0.972 . . . . 74.45 110.731 -178.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 175' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -153.99 149.51 27.3 Favored 'General case' 0 C--O 1.245 0.831 0 O-C-N 123.477 0.485 . . . . 74.1 110.241 174.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -148.27 81.02 1.47 Allowed 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.124 0.97 . . . . 74.11 108.823 172.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 177' ' ' THR . . . . . 0.465 ' N ' ' HD3' ' B' ' 178' ' ' PRO . 2.8 m -130.25 47.5 2.93 Favored Pre-proline 0 CA--C 1.582 2.178 0 CA-C-N 115.951 -0.568 . . . . 64.31 112.248 175.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 178' ' ' PRO . . . . . 0.465 ' HD3' ' N ' ' B' ' 177' ' ' THR . 91.4 Cg_endo -99.1 -152.39 0.03 OUTLIER 'Trans proline' 0 C--N 1.393 2.915 0 C-N-CA 122.319 2.012 . . . . 74.53 110.338 168.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -64.41 -47.21 80.01 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 109.506 -0.553 . . . . 61.34 109.506 167.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . -172.73 -56.06 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 114.527 -1.215 . . . . 74.4 108.482 170.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 181' ' ' LEU . . . . . 0.628 ' HB2' ' HB3' ' C' ' 136' ' ' ARG . 59.3 tp -105.9 -89.38 0.43 Allowed 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 107.602 -1.259 . . . . 62.04 107.602 169.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 182' ' ' VAL . . . . . 0.505 HG11 ' HB2' ' C' ' 123' ' ' LEU . 30.5 m -129.04 -173.04 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.932 0 C-N-CA 124.716 1.206 . . . . 71.31 108.477 170.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -171.94 95.99 0.16 Allowed 'General case' 0 CA--C 1.547 0.865 0 CA-C-O 118.414 -0.803 . . . . 65.24 112.394 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 11.1 p-80 164.56 159.19 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.724 0 C-N-CA 125.551 1.54 . . . . 74.15 112.396 160.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 185' ' ' VAL . . . . . . . . . . . . . 34.8 t -77.45 171.77 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 C-N-CA 124.901 1.28 . . . . 71.33 109.33 169.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 186' ' ' THR . . . . . 0.444 HG22 ' HB3' ' C' ' 122' ' ' GLU . 17.9 p -56.07 86.88 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.461 0.704 . . . . 51.31 110.625 170.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 187' ' ' SER . . . . . 0.445 ' HA ' HD23 ' B' ' 155' ' ' LEU . 10.3 t -111.63 12.65 21.21 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.948 0.899 . . . . 62.14 111.377 -170.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 2.4 tpm_? -131.96 -54.8 0.99 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.527 0.731 . . . . 71.52 109.395 177.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -170.55 174.1 5.23 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.788 0.835 . . . . 72.52 111.402 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 190' ' ' CYS . . . . . . . . . . . . . 42.4 t -161.27 124.05 3.15 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.751 0.82 . . . . 70.33 109.511 175.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -64.16 -67.95 0.39 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.238 0.615 . . . . 74.04 111.213 -176.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 179.75 157.5 20.11 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-O 119.142 -0.81 . . . . 64.22 111.215 -177.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 193' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.43 -72.96 0.02 OUTLIER 'Trans proline' 0 C--N 1.366 1.496 0 C-N-CA 122.534 2.156 . . . . 64.32 112.397 -177.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 194' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' B' ' 197' ' ' SER . 19.8 m -81.0 -4.76 56.25 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.037 0.935 . . . . 24.51 111.68 -179.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 195' ' ' ALA . . . . . . . . . . . . . . . -67.45 -53.41 29.2 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 122.901 0.48 . . . . 74.32 110.254 174.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 68.9 p -93.27 -23.57 18.46 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.331 -0.85 . . . . 73.32 111.59 -177.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 197' ' ' SER . . . . . 0.444 ' O ' ' HA ' ' B' ' 194' ' ' SER . 22.0 m -146.75 96.32 2.73 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.201 0.6 . . . . 75.11 110.377 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 198' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -70.61 -16.4 62.84 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-O 121.176 0.512 . . . . 51.12 110.718 171.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.93 91.85 1.76 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.672 1.189 . . . . 74.4 109.334 -173.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 200' ' ' CYS . . . . . 0.41 ' SG ' ' HG2' ' B' ' 148' ' ' GLU . 23.8 p -94.24 112.88 59.21 Favored Pre-proline 0 N--CA 1.476 0.826 0 N-CA-C 109.568 -0.53 . . . . 73.31 109.568 177.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 201' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -78.02 162.64 28.93 Favored 'Trans proline' 0 C--N 1.37 1.658 0 C-N-CA 122.385 2.056 . . . . 71.34 111.808 174.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . -165.2 -37.65 0.02 OUTLIER Glycine 0 C--N 1.339 0.72 0 CA-C-N 116.275 -0.42 . . . . 63.04 112.574 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -79.14 78.19 5.61 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.605 -0.887 . . . . 71.33 108.605 174.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -168.86 82.39 0.14 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.854 0.862 . . . . 74.01 109.096 178.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 205' ' ' LEU . . . . . 0.553 HD23 ' H ' ' B' ' 205' ' ' LEU . 1.4 pt? -115.27 21.6 14.0 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.213 0.605 . . . . 51.03 110.585 -178.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 206' ' ' GLU . . . . . 0.488 ' HB3' ' NH1' ' C' ' 148' ' ' ARG . 16.6 tt0 56.01 -94.42 0.04 OUTLIER 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 125.415 1.486 . . . . 62.32 112.752 172.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 48.3 tttm -179.66 -64.27 0.01 OUTLIER 'General case' 0 C--N 1.354 0.776 0 C-N-CA 123.553 0.741 . . . . 74.32 109.5 -169.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 75.92 165.01 17.45 Favored Glycine 0 C--N 1.35 1.311 0 CA-C-N 115.704 -0.68 . . . . 71.52 111.911 -169.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 158.17 174.36 27.78 Favored Glycine 0 N--CA 1.468 0.796 0 O-C-N 122.217 -0.578 . . . . 42.21 112.777 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 210' ' ' LYS . . . . . 0.474 ' HG3' ' HB2' ' B' ' 326' ' ' ASP . 53.9 mtpt 65.37 6.25 3.57 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 125.047 1.339 . . . . 74.51 112.238 -178.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . -84.49 -100.25 0.62 Allowed Glycine 0 C--N 1.348 1.206 0 N-CA-C 110.859 -0.896 . . . . 74.43 110.859 -177.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 212' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' B' ' 354' ' ' ALA . 19.7 m 61.21 10.3 2.92 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.039 0.936 . . . . 74.04 112.294 -175.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 9.7 tp -160.96 131.08 0.79 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.855 0 N-CA-C 107.404 -1.332 . . . . 64.4 107.404 -175.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 15.0 t -159.76 12.63 0.13 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 122.911 0.484 . . . . 75.43 110.698 -174.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 215' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -70.49 -29.23 65.71 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 122.909 0.483 . . . . 73.31 110.514 -171.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -80.77 84.23 6.35 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 109.412 -0.588 . . . . 61.42 109.412 175.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -78.53 -33.45 47.93 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 108.622 -0.881 . . . . 75.4 108.622 173.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 6.1 mp -68.22 97.31 0.71 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.627 0.771 . . . . 71.43 110.178 -178.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -75.26 -43.85 49.16 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 109.928 -0.397 . . . . 71.24 109.928 174.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -113.27 -72.31 0.71 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.158 0.583 . . . . 61.1 111.496 -178.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 221' ' ' ARG . . . . . 0.505 ' HB2' ' HA ' ' B' ' 120' ' ' TYR . 1.0 OUTLIER -155.72 -81.62 0.07 Allowed 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 119.53 -0.271 . . . . 73.55 111.205 -179.644 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . 0.407 ' HA ' HD13 ' B' ' 226' ' ' LEU . . . -169.51 138.99 2.01 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.688 0.395 . . . . 42.52 111.559 -173.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 31.2 t70 50.89 -81.88 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 125.982 1.713 . . . . 61.02 114.352 168.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 7.1 p -61.22 -39.65 83.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.605 0.762 . . . . 74.2 110.885 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 18.5 m -145.05 84.63 1.72 Allowed 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 107.99 -1.115 . . . . 54.34 107.99 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . 0.549 ' HB3' ' HA ' ' B' ' 174' ' ' GLN . 58.1 tp -103.81 -14.17 16.15 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.614 0.766 . . . . 74.43 110.212 178.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . -151.74 178.79 28.83 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-N 116.32 -0.4 . . . . 51.31 112.539 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 78.11 -72.77 2.25 Favored Glycine 0 C--N 1.346 1.135 0 C-N-CA 122.871 0.272 . . . . 72.41 112.662 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 229' ' ' GLY . . . . . 0.429 ' HA3' HD23 ' B' ' 47' ' ' LEU . . . 77.16 -76.68 1.61 Allowed Glycine 0 C--N 1.344 1.027 0 CA-C-N 115.684 -0.258 . . . . 70.24 112.742 177.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -152.31 113.43 4.23 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.641 0.776 . . . . 70.23 109.944 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 231' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -135.99 84.55 2.09 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.697 0.799 . . . . 73.24 109.269 176.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 41.5 p -76.14 155.77 34.34 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 122.95 0.5 . . . . 74.24 111.11 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -134.88 124.77 25.53 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.659 0.783 . . . . 70.41 109.513 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -171.39 98.6 0.19 Allowed 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 108.138 -1.06 . . . . 72.31 108.138 176.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -154.24 148.9 26.41 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 109.161 -0.681 . . . . 54.41 109.161 -172.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 236' ' ' THR . . . . . . . . . . . . . 5.5 m -50.73 -54.36 23.89 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.638 1.575 . . . . 73.34 113.016 -176.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -161.5 83.45 0.62 Allowed 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.724 -0.671 . . . . 71.12 110.273 -175.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 23.0 m -88.61 -5.76 57.96 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 123.253 0.621 . . . . 71.31 110.639 174.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 239' ' ' ALA . . . . . 0.555 ' HB2' ' HA ' ' C' ' 221' ' ' VAL . . . -55.27 -78.63 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.184 0.994 . . . . 74.42 112.951 -175.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . 152.82 -114.32 0.62 Allowed Glycine 0 C--N 1.339 0.699 0 N-CA-C 110.623 -0.991 . . . . 71.23 110.623 -172.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -151.61 136.07 16.91 Favored 'General case' 0 C--O 1.245 0.855 0 C-N-CA 123.455 0.702 . . . . 71.21 110.012 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 242' ' ' TRP . . . . . 0.528 ' CD2' ' HG ' ' C' ' 233' ' ' LEU . 4.7 p-90 -172.21 138.24 0.96 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.809 0.843 . . . . 70.32 112.106 173.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 71.8 mm-40 62.99 -75.0 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.819 1.648 . . . . 74.22 111.765 175.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 178.96 58.9 0.07 OUTLIER Glycine 0 C--N 1.342 0.9 0 N-CA-C 112.226 -0.35 . . . . 63.11 112.226 177.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 245' ' ' LYS . . . . . 0.771 ' HE2' ' HB1' ' C' ' 222' ' ' ALA . 52.8 tptt -69.23 96.28 0.83 Allowed 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 120.883 0.373 . . . . 75.34 110.767 177.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 4.8 t -68.51 131.88 46.01 Favored 'General case' 0 C--O 1.244 0.815 0 N-CA-C 108.399 -0.963 . . . . 71.02 108.399 164.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 247' ' ' LEU . . . . . . . . . . . . . 46.9 tp -62.45 88.29 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.752 0.821 . . . . 72.51 110.478 -174.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 248' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -141.61 121.55 13.64 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.611 1.165 . . . . 75.15 108.574 -178.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.65 -55.17 5.75 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 122.608 0.363 . . . . 71.33 110.414 -178.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 250' ' ' GLN . . . . . 0.536 ' N ' HE21 ' B' ' 250' ' ' GLN . 0.0 OUTLIER 53.17 -171.62 0.04 OUTLIER 'General case' 0 CA--C 1.561 1.374 0 C-N-CA 125.264 1.426 . . . . 65.4 112.933 -177.444 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 251' ' ' ALA . . . . . 0.773 ' HA ' ' HG2' ' A' ' 274' ' ' GLU . . . 61.03 74.38 0.45 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.548 1.139 . . . . 61.03 112.438 173.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -119.46 -41.19 2.72 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-N 115.791 -0.64 . . . . 72.3 110.934 -177.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . 80.02 -36.31 0.15 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 125.679 1.592 . . . . 51.41 113.144 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -52.58 98.59 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.238 1.015 . . . . 72.51 112.509 -171.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -142.44 -38.97 0.07 OUTLIER Glycine 0 C--N 1.34 0.77 0 CA-C-N 114.579 -1.191 . . . . 54.22 110.877 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 256' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -161.03 -56.73 0.05 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.157 0.583 . . . . 52.52 110.586 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 14.7 mp0 54.44 36.38 25.44 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.531 1.132 . . . . 74.31 112.416 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 258' ' ' LEU . . . . . . . . . . . . . 8.0 mp 67.73 -73.48 0.08 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.856 1.263 . . . . 75.13 110.896 178.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 57.4 t -109.3 -53.91 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 123.204 0.601 . . . . 63.02 110.298 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 260' ' ' SER . . . . . . . . . . . . . 58.4 p -157.12 164.96 37.29 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.07 0.548 . . . . 73.11 110.577 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -87.29 -39.14 15.64 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.376 0.67 . . . . 52.21 111.846 -172.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 262' ' ' ALA . . . . . . . . . . . . . . . -73.68 88.27 1.71 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.286 0.634 . . . . 43.43 110.373 -177.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . 67.34 -74.26 0.07 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 125.225 1.41 . . . . 70.44 111.929 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 31.3 t 69.56 -73.26 0.09 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.569 1.548 . . . . 51.14 111.963 175.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 265' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -66.13 -21.83 66.36 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.939 0.896 . . . . 64.12 111.15 -177.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 266' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -121.91 144.65 48.73 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.749 0.82 . . . . 71.52 109.559 173.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 30.7 t -96.15 -53.28 3.7 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.608 0.763 . . . . 73.13 109.675 177.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 11.9 p -164.3 146.36 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 115.956 -0.566 . . . . 74.44 110.132 -176.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 269' ' ' THR . . . . . . . . . . . . . 33.6 m -142.1 96.07 2.9 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 107.986 -1.116 . . . . 74.31 107.986 173.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 270' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 56.64 -85.81 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 125.423 1.489 . . . . 72.41 112.054 177.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 271' ' ' ALA . . . . . . . . . . . . . . . -141.65 -65.61 0.42 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 106.681 -1.6 . . . . 75.3 106.681 171.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 272' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 60.2 -70.1 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 125.948 1.699 . . . . 54.14 113.559 172.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 65.37 50.99 1.63 Allowed 'General case' 0 C--N 1.355 0.828 0 C-N-CA 125.013 1.325 . . . . 61.32 109.789 -175.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -106.63 157.5 17.65 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 114.04 -1.436 . . . . 71.44 108.923 173.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 275' ' ' LYS . . . . . 0.559 ' N ' ' HD3' ' B' ' 276' ' ' PRO . 3.4 mptp? 60.65 42.58 0.61 Allowed Pre-proline 0 CA--C 1.58 2.099 0 C-N-CA 124.799 1.24 . . . . 71.33 112.412 -168.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 276' ' ' PRO . . . . . 0.559 ' HD3' ' N ' ' B' ' 275' ' ' LYS . 43.7 Cg_endo -109.41 42.35 0.02 OUTLIER 'Trans proline' 0 C--N 1.392 2.866 0 C-N-CA 124.459 3.439 . . . . 62.35 112.112 -177.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 277' ' ' LEU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 278' ' ' ALA . 91.4 mt 81.4 -23.87 0.21 Allowed 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 126.351 1.861 . . . . 63.32 112.5 -174.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -173.22 132.63 0.5 Allowed 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 124.549 1.14 . . . . 62.0 108.725 168.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . 174.52 -103.89 0.19 Allowed Glycine 0 C--N 1.345 1.032 0 CA-C-O 119.875 -0.403 . . . . 75.43 113.04 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 1.5 tm? 56.69 -90.81 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 125.12 1.368 . . . . 53.23 108.912 -170.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -149.11 -63.49 0.23 Allowed 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 106.356 -1.72 . . . . 75.31 106.356 171.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . 54.84 -165.85 0.1 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.684 1.193 . . . . 65.41 112.838 172.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 34.3 t70 61.08 87.99 0.09 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.841 1.256 . . . . 72.33 112.103 174.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . -74.93 -163.32 10.63 Favored Glycine 0 CA--C 1.533 1.187 0 CA-C-N 115.581 -0.736 . . . . 61.45 112.49 171.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 70.06 -75.37 0.07 Allowed 'General case' 0 CA--C 1.558 1.288 0 C-N-CA 124.829 1.251 . . . . 72.41 110.552 -176.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 286' ' ' MET . . . . . . . . . . . . 0.285 58.2 mtt 41.42 -90.04 0.0 OUTLIER Pre-proline 0 CA--C 1.585 2.296 0 C-N-CA 127.328 2.251 . . . . 64.1 114.562 -177.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 287' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -75.91 -26.98 8.99 Favored 'Trans proline' 1 C--N 1.423 4.472 0 CA-C-N 124.905 2.788 . . . . 73.33 112.827 178.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 288' ' ' VAL . . . . . . . . . . . . . 41.4 t 50.91 -91.47 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.564 1.486 0 C-N-CA 124.817 1.247 . . . . 74.32 110.759 -173.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 289' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? 51.55 95.78 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 126.27 1.828 . . . . 72.14 112.715 176.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 290' ' ' TRP . . . . . . . . . . . . . 45.1 p90 -77.64 137.61 38.64 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.132 0.573 . . . . 75.34 110.451 173.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 291' ' ' LEU . . . . . . . . . . . . . 2.8 pp -88.79 -17.9 28.83 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.98 0.512 . . . . 64.34 110.747 175.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . -93.77 103.46 3.04 Favored Glycine 0 C--N 1.35 1.327 0 CA-C-N 115.619 -0.719 . . . . 62.12 111.414 -179.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -85.65 17.6 1.73 Allowed 'Trans proline' 0 C--N 1.374 1.891 0 C-N-CA 123.411 2.741 . . . . 51.12 113.593 -172.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 11.0 mmpt? 63.25 -83.25 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.494 1.518 . . . . 41.23 110.135 -174.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -147.17 157.66 43.68 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.621 0.768 . . . . 34.32 110.128 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 24.9 p -88.86 -59.11 2.32 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.2 0.6 . . . . 65.42 109.638 176.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 73.6 t80 60.27 93.88 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 125.05 1.34 . . . . 64.12 111.596 176.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 41.0 m80 -99.2 71.27 1.8 Allowed 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.696 0.76 . . . . 71.5 109.15 177.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . -139.48 175.32 21.78 Favored Glycine 0 C--N 1.342 0.88 0 CA-C-N 114.466 -1.243 . . . . 63.41 111.898 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 300' ' ' ASN . . . . . 0.436 ' HB3' ' HB2' ' B' ' 194' ' ' SER . 10.9 t-20 62.43 32.95 16.53 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.619 1.168 . . . . 72.23 109.011 -174.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 301' ' ' ILE . . . . . . . . . . . . . 2.0 pp -67.26 160.17 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 CA-C-N 113.26 -1.791 . . . . 72.24 112.807 -173.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 302' ' ' ASP . . . . . 0.461 ' O ' ' HA ' ' B' ' 149' ' ' LYS 0.275 6.1 p-10 34.25 -88.91 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 126.128 1.771 . . . . 63.41 113.148 -168.663 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 303' ' ' LYS . . . . . 0.633 ' HZ3' ' HB3' ' B' ' 303' ' ' LYS . 4.7 ttpm? 54.99 70.98 1.41 Allowed Pre-proline 0 CA--C 1.565 1.526 0 CA-C-N 118.332 0.514 . . . . 74.11 109.803 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 304' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -83.77 35.68 0.57 Allowed 'Trans proline' 0 C--N 1.374 1.887 0 C-N-CA 123.162 2.575 . . . . 75.12 111.851 -178.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -74.54 -11.85 60.32 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.66 1.184 . . . . 42.33 112.07 -178.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . 0.618 HG21 ' HA ' ' B' ' 147' ' ' HIS . 40.4 t -71.99 95.26 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 C-N-CA 123.342 0.657 . . . . 72.33 109.32 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 23.7 p -69.68 -59.58 2.86 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 114.871 -1.059 . . . . 74.23 110.688 -178.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 308' ' ' CYS . . . . . . . . . . . . . 52.4 t -81.42 119.72 24.08 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 122.925 0.49 . . . . 74.22 110.123 177.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . 0.418 ' HA ' HD22 ' B' ' 367' ' ' LEU . 13.5 t 177.06 -36.64 0.0 OUTLIER Pre-proline 0 CA--C 1.568 1.645 0 C-N-CA 125.689 1.596 . . . . 72.2 112.366 177.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -95.13 20.98 0.53 Allowed 'Trans proline' 0 C--N 1.408 3.699 0 CA-C-N 122.728 2.01 . . . . 63.14 112.949 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 311' ' ' ASN . . . . . 0.41 HD21 ' HB2' ' B' ' 314' ' ' ARG . 4.6 t30 -97.27 109.86 51.73 Favored Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 123.73 0.812 . . . . 73.13 109.674 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 312' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -87.04 80.63 1.46 Allowed 'Trans proline' 0 C--N 1.372 1.772 0 C-N-CA 122.898 2.399 . . . . 70.14 111.935 176.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 313' ' ' GLN . . . . . 0.455 HE21 ' HB2' ' B' ' 316' ' ' ASP . 22.7 tm0? 70.3 138.42 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 125.232 1.413 . . . . 75.13 111.472 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 314' ' ' ARG . . . . . 0.41 ' HB2' HD21 ' B' ' 311' ' ' ASN . 44.4 ttp180 -153.41 -79.09 0.1 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.47 0.708 . . . . 72.01 110.354 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 315' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -112.21 75.41 0.92 Allowed 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 122.13 0.967 . . . . 72.12 109.302 -175.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 316' ' ' ASP . . . . . 0.455 ' HB2' HE21 ' B' ' 313' ' ' GLN . 2.5 m-20 -111.45 -178.15 3.38 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 114.528 -1.214 . . . . 74.4 111.08 -173.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 3.8 m -83.4 -67.41 0.79 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.528 -0.76 . . . . 75.41 108.973 -179.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 318' ' ' VAL . . . . . 0.419 ' O ' ' HG3' ' B' ' 363' ' ' GLU . 12.7 p 177.1 137.86 0.22 Allowed Pre-proline 0 CA--C 1.556 1.18 0 C-N-CA 124.861 1.265 . . . . 73.13 109.049 -179.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 319' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -73.96 45.06 1.06 Allowed 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 122.581 2.187 . . . . 65.1 113.557 173.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 320' ' ' THR . . . . . . . . . . . . . 11.1 m -144.48 28.79 1.3 Allowed 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 124.764 1.226 . . . . 53.31 108.128 176.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 321' ' ' LEU . . . . . . . . . . . . . 66.3 tp -83.32 -59.64 2.39 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 121.876 -0.515 . . . . 65.14 110.233 176.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 322' ' ' ALA . . . . . . . . . . . . . . . -63.65 100.4 0.28 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.701 0.801 . . . . 64.54 110.726 -177.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 323' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 71.77 -12.49 0.65 Allowed 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 124.934 1.294 . . . . 74.02 112.789 177.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 324' ' ' MET . . . . . . . . . . . . . 91.9 mtp 62.87 -76.04 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 125.065 1.346 . . . . 71.32 110.743 -170.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 325' ' ' THR . . . . . . . . . . . . . 52.5 m -137.09 124.26 21.71 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.444 -0.947 . . . . 72.33 108.444 174.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 326' ' ' ASP . . . . . 0.474 ' HB2' ' HG3' ' B' ' 210' ' ' LYS . 4.8 p-10 -75.75 -37.8 58.99 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.906 0.482 . . . . 72.01 110.8 -178.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -161.13 -69.9 0.06 Allowed 'General case' 0 C--N 1.345 0.402 0 C-N-CA 124.235 1.014 . . . . 54.34 109.306 178.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 328' ' ' ALA . . . . . . . . . . . . . . . -171.0 -70.06 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 108.625 -0.88 . . . . 72.03 108.625 -176.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 329' ' ' ILE . . . . . . . . . . . . . 29.9 mm 65.08 -64.42 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.429 0 C-N-CA 126.003 1.721 . . . . 73.5 112.532 174.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 330' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -55.09 -53.06 60.63 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.176 0.99 . . . . 63.42 111.154 175.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 331' ' ' LEU . . . . . . . . . . . . . 85.2 mt -110.76 90.06 3.22 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.251 -1.018 . . . . 63.34 108.251 172.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 44.5 tp -85.6 -21.96 28.23 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.082 0.553 . . . . 74.41 111.366 -174.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 333' ' ' SER . . . . . . . . . . . . . 36.7 m 52.04 41.3 29.74 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.081 0.952 . . . . 65.04 111.714 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 6.9 tmtm? -73.42 -50.35 22.22 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.405 -0.816 . . . . 63.11 109.935 -174.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 335' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -139.0 149.38 44.62 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.507 0.723 . . . . 73.25 109.745 -176.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -64.92 -27.33 68.78 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.98 0.912 . . . . 61.02 111.64 -176.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 337' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.1 168.19 13.73 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 124.005 0.922 . . . . 62.43 109.737 -177.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 338' ' ' GLY . . . . . . . . . . . . . . . -80.26 62.36 4.28 Favored Glycine 0 C--N 1.349 1.29 0 N-CA-C 111.971 -0.452 . . . . 72.34 111.971 177.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 339' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 61.9 -173.19 0.14 Allowed 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 125.254 1.422 . . . . 74.33 112.243 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 340' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -86.75 -49.2 7.62 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 109.792 -0.448 . . . . 75.24 109.792 174.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 341' ' ' LEU . . . . . 0.499 HD12 ' HG2' ' B' ' 344' ' ' GLU . 54.6 tp 35.66 86.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 126.326 1.85 . . . . 75.34 113.379 178.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 342' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -94.8 -68.82 0.78 Allowed 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 109.06 -0.718 . . . . 64.25 109.06 177.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 343' ' ' VAL . . . . . . . . . . . . . 4.4 p -160.43 87.68 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 107.688 -1.227 . . . . 64.24 107.688 178.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 344' ' ' GLU . . . . . 0.499 ' HG2' HD12 ' B' ' 341' ' ' LEU . 11.8 mm-40 -97.33 32.57 2.19 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-N 115.571 -0.74 . . . . 73.03 109.147 -176.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 345' ' ' GLY . . . . . . . . . . . . . . . 84.43 -65.91 3.99 Favored Glycine 0 C--N 1.345 1.066 0 N-CA-C 109.674 -1.37 . . . . 62.31 109.674 -165.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 346' ' ' ALA . . . . . . . . . . . . . . . -134.33 -171.06 2.66 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.552 1.141 . . . . 72.22 108.756 172.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 80.1 p -74.15 165.75 24.62 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 109.49 -0.559 . . . . 72.21 109.49 166.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 8.8 tt -82.1 57.18 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.551 0 CA-C-O 121.945 0.879 . . . . 73.42 109.849 178.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 349' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -62.29 -60.84 2.99 Favored 'General case' 0 C--N 1.359 1.001 0 N-CA-C 108.987 -0.746 . . . . 71.13 108.987 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 350' ' ' LYS . . . . . 0.401 ' O ' ' HB2' ' B' ' 351' ' ' GLN . 71.1 tttt 67.14 -12.25 0.25 Allowed 'General case' 0 CA--C 1.56 1.348 0 C-N-CA 124.747 1.219 . . . . 74.52 114.286 164.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 351' ' ' GLN . . . . . 0.401 ' HB2' ' O ' ' B' ' 350' ' ' LYS . 1.5 mp0 72.03 5.68 5.39 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 124.856 1.262 . . . . 71.32 110.951 -160.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -156.21 155.01 31.67 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.501 0.72 . . . . 74.35 110.585 -174.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 353' ' ' HIS . . . . . 0.517 ' HB3' ' HB3' ' C' ' 20' ' ' GLU . 19.5 t-80 -150.17 -41.48 0.13 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.805 1.242 . . . . 74.33 108.338 179.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 354' ' ' ALA . . . . . 0.573 ' HB3' HH21 ' C' ' 24' ' ' ARG . . . -161.19 16.04 0.11 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.43 0.692 . . . . 70.11 111.499 176.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 355' ' ' ALA . . . . . . . . . . . . . . . 64.59 -78.2 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 125.222 1.409 . . . . 75.44 110.989 -174.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 356' ' ' ASN . . . . . 0.531 HD22 ' HG2' ' C' ' 24' ' ' ARG . 61.8 t30 62.46 106.96 0.03 OUTLIER Pre-proline 0 CA--C 1.556 1.209 0 C-N-CA 125.566 1.546 . . . . 74.32 112.875 172.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 357' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.19 139.83 86.43 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 123.679 2.919 . . . . 55.22 113.84 -173.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 358' ' ' CYS . . . . . 0.569 ' HA ' ' HD3' ' C' ' 27' ' ' LYS . 74.9 m -67.1 165.3 16.15 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.119 0.968 . . . . 73.32 112.271 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 359' ' ' GLY . . . . . . . . . . . . . . . -68.79 113.67 5.4 Favored Glycine 0 C--N 1.35 1.343 0 CA-C-O 119.422 -0.654 . . . . 62.01 112.07 177.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 360' ' ' GLN . . . . . . . . . . . . . 25.3 tp60 65.59 35.54 7.05 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 124.723 1.209 . . . . 53.34 110.018 -177.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 361' ' ' ILE . . . . . 0.443 HD12 ' H ' ' B' ' 358' ' ' CYS . 19.3 tt -57.91 -32.64 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 C-N-CA 124.337 1.055 . . . . 61.31 112.222 -176.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 362' ' ' GLY . . . . . . . . . . . . . . . -159.82 98.11 0.17 Allowed Glycine 0 C--O 1.243 0.686 0 N-CA-C 110.704 -0.958 . . . . 72.35 110.704 176.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 363' ' ' GLU . . . . . 0.419 ' HG3' ' O ' ' B' ' 318' ' ' VAL . 1.9 tm-20 -175.52 86.82 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 107.443 -1.317 . . . . 73.13 107.443 175.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 364' ' ' THR . . . . . . . . . . . . . 89.7 m 65.09 -69.48 0.1 Allowed 'General case' 0 CA--C 1.57 1.741 0 C-N-CA 124.314 1.045 . . . . 74.04 112.537 177.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 22.0 t 64.39 42.52 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 126.195 1.798 . . . . 74.01 109.198 -178.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 34.0 t70 69.62 -60.17 0.48 Allowed 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 126.495 1.918 . . . . 50.12 112.043 179.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 367' ' ' LEU . . . . . 0.418 HD22 ' HA ' ' B' ' 309' ' ' THR . 49.8 tp -54.13 -26.59 28.4 Favored 'General case' 0 CA--C 1.564 1.485 0 C-N-CA 125.4 1.48 . . . . 75.05 113.161 176.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 368' ' ' ASP . . . . . 0.578 ' O ' HG22 ' B' ' 371' ' ' VAL . 19.4 t70 80.21 -14.79 0.81 Allowed 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 126.25 1.82 . . . . 71.23 112.154 -178.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 369' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -62.39 -16.04 52.41 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.665 0.786 . . . . 70.1 112.96 -175.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 370' ' ' ALA . . . . . . . . . . . . . . . -58.33 -23.76 57.61 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 122.687 0.395 . . . . 74.25 111.806 175.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 371' ' ' VAL . . . . . 0.835 HG21 ' HA3' ' B' ' 140' ' ' GLY . 11.2 m -107.98 11.97 8.82 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.226 0 C-N-CA 123.83 0.852 . . . . 74.11 111.568 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 372' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -135.13 151.03 50.33 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.993 0.917 . . . . 63.2 110.933 -176.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 373' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -146.91 49.02 1.14 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.264 0.626 . . . . 72.05 109.967 174.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . 66.17 179.21 0.21 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 124.89 1.276 . . . . 71.45 111.872 -173.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 375' ' ' LEU . . . . . 0.443 ' HA ' ' HA3' ' C' ' 190' ' ' GLY . 47.0 tp -163.5 -37.41 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.844 0.458 . . . . 62.01 110.768 175.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 376' ' ' GLU . . . . . 0.681 ' HG3' ' HA ' ' B' ' 23' ' ' THR . 12.9 mm-40 -114.89 153.75 29.93 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.496 0.718 . . . . 73.13 112.442 -176.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 377' ' ' PHE . . . . . 0.437 ' HA ' ' NH2' ' B' ' 22' ' ' ARG . 74.6 t80 -168.73 -63.2 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.023 -0.989 . . . . 73.31 108.412 178.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 378' ' ' ALA . . . . . . . . . . . . . . . -174.07 84.89 0.04 OUTLIER 'General case' 0 C--O 1.245 0.819 0 C-N-CA 124.942 1.297 . . . . 61.1 109.003 -178.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm -61.43 -20.51 63.17 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.084 0.553 . . . . 72.01 111.44 176.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 380' ' ' LYS . . . . . . . . . . . . . 65.1 mttm 80.47 -52.13 0.34 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 126.223 1.809 . . . . 53.14 111.474 176.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 381' ' ' GLU . . . . . 0.481 ' HG2' ' H ' ' B' ' 383' ' ' ASN . 25.8 tt0 66.03 -76.59 0.04 OUTLIER 'General case' 0 C--N 1.359 1.0 0 C-N-CA 124.348 1.059 . . . . 74.34 110.243 -176.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . 100.92 -18.72 54.39 Favored Glycine 0 C--N 1.349 1.266 0 CA-C-N 116.043 -0.526 . . . . 73.1 113.567 176.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 383' ' ' ASN . . . . . 0.481 ' H ' ' HG2' ' B' ' 381' ' ' GLU . 2.8 t-20 -67.71 -11.73 58.98 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 123.51 0.724 . . . . 73.1 111.94 -176.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 384' ' ' THR . . . . . . . . . . . . . 40.1 p -63.58 -15.51 58.28 Favored 'General case' 0 CA--C 1.56 1.348 0 C-N-CA 123.71 0.804 . . . . 63.41 112.317 172.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 82.6 mt -75.67 -176.11 3.17 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.615 0.766 . . . . 75.12 111.815 174.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 386' ' ' VAL . . . . . . . . . . . . . 94.2 t 77.91 -41.14 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 C-N-CA 125.595 1.558 . . . . 62.42 112.091 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 387' ' ' ILE . . . . . . . . . . . . . 33.5 mm -76.51 75.38 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 C-N-CA 123.686 0.794 . . . . 74.12 110.766 -174.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 388' ' ' VAL . . . . . 0.516 HG12 ' H ' ' B' ' 391' ' ' ASP . 21.7 t 43.6 91.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 126.444 1.898 . . . . 54.33 112.674 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 389' ' ' THR . . . . . . . . . . . . . 34.6 p -75.87 3.56 9.83 Favored 'General case' 0 CA--C 1.559 1.326 0 N-CA-C 112.328 0.492 . . . . 71.25 112.328 -175.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . -94.8 -69.52 0.75 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.564 0.746 . . . . 70.34 110.677 171.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 391' ' ' ASP . . . . . 0.516 ' H ' HG12 ' B' ' 388' ' ' VAL . 13.2 m-20 -92.11 -12.76 32.11 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.026 0.931 . . . . 64.12 111.566 -169.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 392' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 64.94 18.57 11.55 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 125.114 1.365 . . . . 72.42 111.474 -174.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 393' ' ' ALA . . . . . 0.44 ' HA ' ' OE1' ' B' ' 397' ' ' GLN . . . 66.19 -73.65 0.07 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 125.387 1.475 . . . . 61.53 112.203 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 19.4 t60 56.67 66.56 1.15 Allowed 'General case' 0 C--N 1.359 0.997 0 C-N-CA 124.31 1.044 . . . . 73.31 108.91 -175.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . 60.95 -158.64 0.33 Allowed 'General case' 0 CA--C 1.559 1.32 0 CA-C-N 115.106 -0.952 . . . . 71.44 110.734 -172.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 33.3 t 63.31 -80.43 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.357 1.063 . . . . 75.55 112.497 173.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 397' ' ' GLN . . . . . 0.44 ' OE1' ' HA ' ' B' ' 393' ' ' ALA . 92.2 mt-30 -60.95 -40.3 92.82 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.356 1.062 . . . . 71.41 110.498 178.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 12.6 tt -156.52 116.2 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 N-CA-C 108.216 -1.031 . . . . 75.44 108.216 173.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 399' ' ' VAL . . . . . . . . . . . . . 3.3 p -113.67 -46.47 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 123.354 0.662 . . . . 73.32 112.65 -169.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 400' ' ' ALA . . . . . 0.525 ' HB3' ' HD3' ' B' ' 401' ' ' PRO . . . -69.12 -54.57 11.68 Favored Pre-proline 0 CA--C 1.56 1.338 0 CA-C-O 118.8 -0.619 . . . . 51.41 112.521 -173.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 401' ' ' PRO . . . . . 0.525 ' HD3' ' HB3' ' B' ' 400' ' ' ALA . 59.7 Cg_endo -98.16 112.5 0.09 OUTLIER 'Trans proline' 0 C--N 1.383 2.37 0 C-N-CA 122.03 1.82 . . . . 71.04 112.698 173.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -72.9 -39.77 66.1 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 109.052 -0.721 . . . . 74.34 109.052 172.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 403' ' ' THR . . . . . . . . . . . . . 7.7 t 173.44 172.65 0.15 Allowed 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 126.019 1.728 . . . . 51.3 108.248 170.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 404' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm 74.89 -47.24 0.62 Allowed 'General case' 0 N--CA 1.507 2.404 0 C-N-CA 125.465 1.506 . . . . 70.03 112.514 -176.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 405' ' ' ALA . . . . . . . . . . . . . . . -58.54 -38.62 67.5 Favored Pre-proline 0 CA--C 1.566 1.559 0 N-CA-C 115.008 1.484 . . . . 71.24 115.008 177.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 406' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -44.12 91.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.396 3.048 0 C-N-CA 122.922 2.414 . . . . 44.44 114.85 174.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . -133.77 -40.8 0.18 Allowed Glycine 0 C--N 1.338 0.642 0 CA-C-N 114.762 -1.108 . . . . 55.33 110.715 -178.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 408' ' ' LEU . . . . . . . . . . . . . 61.7 tp -63.75 -39.75 95.05 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.385 0.674 . . . . 72.03 109.616 170.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 70.8 p -72.8 -16.77 61.61 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.04 -0.982 . . . . 73.52 111.057 174.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 410' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 67.37 -144.97 0.14 Allowed 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 125.315 1.446 . . . . 51.32 108.944 -176.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . 79.37 -28.71 0.15 Allowed 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 124.978 1.311 . . . . 63.14 113.091 177.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 1.5 tt 50.9 78.49 0.11 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 125.864 1.665 . . . . 60.41 111.83 172.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 77.43 -54.59 0.54 Allowed 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 125.496 1.518 . . . . 71.14 112.119 177.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 414' ' ' THR . . . . . . . . . . . . . 13.0 m 72.87 -69.02 0.2 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 126.077 1.751 . . . . 73.24 112.089 176.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 415' ' ' LYS . . . . . . . . . . . . 0.269 12.8 ptmm? 59.36 -57.4 0.06 Allowed 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 127.653 2.381 . . . . 73.42 114.145 -175.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -79.15 94.38 5.37 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 121.498 -0.751 . . . . 75.33 110.391 175.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 417' ' ' GLY . . . . . . . . . . . . . . . -160.12 67.25 0.26 Allowed Glycine 0 C--N 1.347 1.173 0 CA-C-N 114.323 -1.308 . . . . 43.15 109.853 177.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 418' ' ' ALA . . . . . . . . . . . . . . . -70.65 -31.9 69.0 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.856 0.862 . . . . 70.25 110.647 -177.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 419' ' ' VAL . . . . . . . . . . . . . 46.2 t -101.41 -91.4 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 N-CA-C 107.29 -1.374 . . . . 62.03 107.29 170.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 420' ' ' MET . . . . . . . . . . . . . 26.8 ttt 48.81 -82.49 0.01 OUTLIER 'General case' 0 C--N 1.37 1.477 0 C-N-CA 123.929 0.892 . . . . 73.12 110.385 -167.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 421' ' ' VAL . . . . . . . . . . . . . 69.0 t -110.25 -78.73 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.209 0 N-CA-C 107.035 -1.468 . . . . 72.42 107.035 167.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 422' ' ' MET . . . . . . . . . . . . . 49.1 tpp 55.88 -73.82 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 126.327 1.851 . . . . 74.1 113.215 177.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 423' ' ' SER . . . . . . . . . . . . . 21.2 p -53.4 150.9 6.0 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.112 0.965 . . . . 62.22 112.67 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 424' ' ' TYR . . . . . . . . . . . . . 44.9 t80 74.58 -65.78 0.33 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 125.747 1.619 . . . . 72.42 110.474 -174.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . 58.33 43.3 95.71 Favored Glycine 0 C--N 1.351 1.373 0 N-CA-C 114.181 0.432 . . . . 75.12 114.181 173.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 426' ' ' ASN . . . . . . . . . . . . . 18.8 m120 58.59 23.84 11.34 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 124.064 0.946 . . . . 75.43 112.086 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 427' ' ' SER . . . . . . . . . . . . . 28.5 t -132.46 168.15 18.69 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.84 0.856 . . . . 75.14 109.458 -178.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -77.98 87.95 4.15 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-O 121.338 0.589 . . . . 73.23 110.617 -176.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 429' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -93.57 101.07 13.23 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 106.219 -1.771 . . . . 63.42 106.219 166.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 430' ' ' ASP . . . . . 0.412 ' HB3' HE22 ' B' ' 432' ' ' GLN . 9.7 m-20 -58.11 -53.91 52.89 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.252 1.021 . . . . 55.41 111.104 -172.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 17.7 m 65.67 -96.29 0.04 OUTLIER 'General case' 0 CA--C 1.561 1.389 0 O-C-N 124.941 1.401 . . . . 73.31 111.867 -177.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 432' ' ' GLN . . . . . 0.412 HE22 ' HB3' ' B' ' 430' ' ' ASP . 2.1 mp0 58.16 176.03 0.06 Allowed 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 124.897 1.279 . . . . 71.1 113.001 -170.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 433' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -81.46 103.06 10.94 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.49 1.116 . . . . 73.43 108.562 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 434' ' ' HIS . . . . . . . . . . . . . 10.5 m170 -126.87 170.07 12.6 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.68 0.792 . . . . 65.13 111.277 -172.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 435' ' ' THR . . . . . . . . . . . . . 15.8 m -71.31 -20.86 62.14 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.109 0.964 . . . . 73.42 112.115 -175.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . -59.18 -20.87 51.82 Favored Glycine 0 N--CA 1.475 1.267 0 N-CA-C 114.599 0.599 . . . . 43.54 114.599 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 72.3 p -55.22 -40.96 71.43 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.978 1.311 . . . . 54.14 112.957 -178.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 438' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -34.13 114.37 0.2 Allowed 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 125.94 1.696 . . . . 71.55 113.976 -172.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 439' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -149.86 152.45 35.13 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.128 0.571 . . . . 74.24 110.793 -176.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 440' ' ' ARG . . . . . . . . . . . . . 7.1 tpp180 -156.81 98.34 1.77 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.518 1.127 . . . . 70.1 108.225 177.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 441' ' ' ILE . . . . . 0.52 HG12 HD22 ' A' ' 235' ' ' LEU . 22.2 mt -69.52 118.83 14.49 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 CA-C-N 115.586 -0.734 . . . . 74.15 111.358 -173.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 442' ' ' ALA . . . . . . . . . . . . . . . -130.75 38.08 3.74 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 114.951 -1.022 . . . . 71.41 109.593 178.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . -80.94 170.18 16.58 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.455 -0.793 . . . . 74.21 110.024 173.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -55.02 142.02 31.83 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.843 0.857 . . . . 65.34 112.123 -178.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . 120.34 -78.69 0.32 Allowed Glycine 0 C--N 1.345 1.079 0 N-CA-C 110.744 -0.943 . . . . 74.34 110.744 -176.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 446' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -77.19 71.62 6.24 Favored 'Trans proline' 0 C--N 1.379 2.15 0 C-N-CA 122.8 2.334 . . . . 63.02 112.144 175.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 447' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -138.75 128.17 24.45 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 124.49 1.116 . . . . 60.0 109.503 175.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . 61.83 -176.07 0.13 Allowed 'General case' 0 CA--C 1.549 0.939 0 O-C-N 124.346 1.029 . . . . 74.31 112.986 175.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 449' ' ' ALA . . . . . 0.617 ' HB1' ' SD ' ' B' ' 464' ' ' MET . . . 62.57 -82.63 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 124.834 1.254 . . . . 61.52 112.753 171.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 450' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -79.98 -34.35 38.69 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.067 0.947 . . . . 61.12 111.382 -176.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 61.6 t -62.8 -76.73 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 123.964 0.906 . . . . 63.1 111.746 -170.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 452' ' ' VAL . . . . . . . . . . . . . 4.7 m -137.69 42.74 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 124.193 0.997 . . . . 60.45 108.823 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 72.22 -161.59 54.35 Favored Glycine 0 C--N 1.34 0.768 0 CA-C-N 114.736 -1.12 . . . . 73.44 110.449 -166.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 454' ' ' LEU . . . . . 0.463 ' HG ' ' H ' ' B' ' 461' ' ' PHE . 3.5 mm? -73.31 -64.29 1.01 Allowed 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 117.3 0.55 . . . . 72.5 110.629 -178.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 14.0 t -169.06 176.28 5.39 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 122.806 0.442 . . . . 61.41 110.81 174.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -84.87 63.32 7.98 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-O 122.029 0.919 . . . . 74.3 109.713 178.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 457' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -169.55 166.74 10.0 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 114.948 -1.024 . . . . 42.14 108.46 -177.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 34.1 p -70.25 -5.31 26.76 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.064 0.546 . . . . 72.13 111.578 172.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 459' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -67.86 89.19 0.27 Allowed 'General case' 0 C--N 1.353 0.728 0 N-CA-C 109.054 -0.721 . . . . 73.31 109.054 169.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 2.6 pp -145.47 144.5 30.63 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.05 -0.977 . . . . 65.42 108.864 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 461' ' ' PHE . . . . . 0.463 ' H ' ' HG ' ' B' ' 454' ' ' LEU . 96.6 m-85 -137.92 149.62 46.36 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.612 0.765 . . . . 62.31 109.521 -178.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 24.8 p90 -89.2 12.62 15.39 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.178 0.591 . . . . 72.53 111.207 177.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 41.1 p -74.72 85.05 2.13 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.204 1.002 . . . . 61.35 111.772 -172.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 464' ' ' MET . . . . . 0.617 ' SD ' ' HB1' ' B' ' 449' ' ' ALA . 83.5 mtp -147.98 101.15 3.27 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.3 1.04 . . . . 75.31 108.839 176.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -88.17 134.76 33.7 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 109.261 -0.644 . . . . 72.15 109.261 174.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -100.82 -48.87 4.33 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.25 0.62 . . . . 62.32 112.031 -174.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . -71.14 -30.39 66.42 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.894 0.878 . . . . 75.3 112.009 -175.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 90.7 mt -129.41 142.09 50.88 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 107.678 -1.23 . . . . 45.51 107.678 175.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 469' ' ' GLY . . . . . 0.522 ' HA3' ' HB2' ' C' ' 260' ' ' ARG . . . -72.98 99.41 0.94 Allowed Glycine 0 CA--C 1.527 0.843 0 N-CA-C 111.022 -0.831 . . . . 50.44 111.022 172.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 470' ' ' LEU . . . . . 0.414 HD13 ' N ' ' B' ' 471' ' ' LYS . 0.5 OUTLIER -150.05 147.82 28.28 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 108.113 -1.069 . . . . 73.2 108.113 -179.563 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 471' ' ' LYS . . . . . 0.414 ' N ' HD13 ' B' ' 470' ' ' LEU . 1.2 tmtp? . . . . . 0 C--O 1.247 0.97 0 N-CA-C 108.703 -0.851 . . . . 74.2 108.703 177.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.482 1.146 0 N-CA-C 109.883 -0.414 . . . . 55.23 109.883 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 60.08 19.32 8.54 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 125.357 1.463 . . . . 65.31 114.776 170.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -88.83 49.01 1.71 Allowed 'General case' 0 N--CA 1.485 1.287 0 O-C-N 121.662 -0.649 . . . . 52.01 110.881 178.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -39.11 102.75 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.607 1.563 . . . . 70.52 113.548 177.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 5' ' ' LYS . . . . . 0.484 ' HE2' HD11 ' C' ' 10' ' ' ILE . 48.0 mtpt -84.47 125.44 32.37 Favored 'General case' 0 C--O 1.245 0.832 0 N-CA-C 109.402 -0.592 . . . . 63.2 109.402 173.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -77.16 100.98 5.96 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.627 -0.879 . . . . 63.22 108.627 177.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 7' ' ' TYR . . . . . 0.54 ' HD1' HD12 ' C' ' 10' ' ' ILE . 23.4 m-85 -63.27 -31.17 72.25 Favored 'General case' 0 C--O 1.252 1.185 0 C-N-CA 123.741 0.817 . . . . 73.43 112.158 -172.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 8' ' ' TYR . . . . . 0.422 ' HE1' HD11 ' C' ' 22' ' ' ILE . 89.7 m-85 -60.51 -47.77 84.71 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.828 -0.624 . . . . 72.53 109.846 174.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.7 -38.02 88.05 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.546 0.738 . . . . 52.31 111.102 -177.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 10' ' ' ILE . . . . . 0.54 HD12 ' HD1' ' C' ' 7' ' ' TYR . 72.0 mt -58.28 -39.93 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 123.225 0.61 . . . . 63.34 110.41 175.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 11' ' ' LEU . . . . . 0.528 ' O ' ' HB1' ' C' ' 25' ' ' ALA . 86.0 mt -86.3 -11.67 51.57 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 112.654 0.613 . . . . 45.45 112.654 175.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.69 24.15 65.58 Favored Glycine 0 CA--C 1.535 1.328 0 N-CA-C 114.347 0.499 . . . . 64.33 114.347 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 5.8 m -105.84 156.19 37.02 Favored Pre-proline 0 N--CA 1.486 1.374 0 C-N-CA 124.056 0.942 . . . . 64.04 109.955 171.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -78.4 168.29 21.71 Favored 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 122.825 2.35 . . . . 74.43 114.427 -178.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 80.2 mtt180 -75.01 72.2 2.13 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.766 0.827 . . . . 71.52 109.87 173.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 175.11 -19.94 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.99 1.316 . . . . 71.24 108.896 -175.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -46.49 133.47 9.98 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 125.484 1.513 . . . . 71.14 113.447 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 18.2 p -74.19 148.2 41.85 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 123.946 0.779 . . . . 74.41 109.074 175.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 19' ' ' GLN . . . . . 0.402 ' HA ' HD12 ' C' ' 22' ' ' ILE . 25.9 tt0 -51.51 -34.11 34.58 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 124.069 0.948 . . . . 74.45 112.131 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 20' ' ' GLU . . . . . 0.517 ' HB3' ' HB3' ' B' ' 353' ' ' HIS . 0.9 OUTLIER -70.11 -44.98 67.86 Favored 'General case' 0 CA--C 1.556 1.201 0 CA-C-N 114.838 -1.074 . . . . 64.05 110.331 -179.461 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -73.38 -27.27 61.39 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 123.023 0.529 . . . . 73.42 111.659 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 22' ' ' ILE . . . . . 0.514 HD13 HD13 ' C' ' 57' ' ' LEU . 76.5 mt -61.97 -44.29 98.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 123.94 0.896 . . . . 61.32 109.073 169.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 23' ' ' LYS . . . . . 0.439 ' O ' ' HG3' ' C' ' 27' ' ' LYS . 5.1 ttpm? -65.02 -32.64 74.46 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 114.922 -1.036 . . . . 74.13 111.388 175.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 24' ' ' ARG . . . . . 0.636 ' HA ' ' HE3' ' C' ' 27' ' ' LYS . 56.1 mtt180 -62.67 -46.91 85.98 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 120.961 0.41 . . . . 73.52 111.118 175.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . 0.528 ' HB1' ' O ' ' C' ' 11' ' ' LEU . . . -62.13 -39.17 91.69 Favored 'General case' 0 C--O 1.251 1.14 0 CA-C-N 114.814 -1.084 . . . . 75.32 111.389 177.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 26' ' ' TYR . . . . . 0.477 ' HD1' HG22 ' C' ' 50' ' ' ILE . 38.9 t80 -54.3 -54.7 36.66 Favored 'General case' 0 C--O 1.207 -1.147 0 CA-C-N 115.115 -0.948 . . . . 72.31 109.975 170.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . 0.636 ' HE3' ' HA ' ' C' ' 24' ' ' ARG . 10.3 mtmp? -56.85 -40.13 75.54 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 123.319 0.647 . . . . 74.1 111.452 -176.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 28' ' ' ARG . . . . . 0.466 ' HA ' ' NH2' ' C' ' 31' ' ' ARG . 34.8 ttp180 -57.9 -52.25 66.26 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 123.936 0.773 . . . . 71.15 110.606 177.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . 0.425 ' HA ' ' HB3' ' C' ' 32' ' ' GLN . 80.6 mt -84.28 -9.72 58.25 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-N 114.905 -1.043 . . . . 60.22 111.756 -176.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -86.85 -23.5 25.26 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.991 0.917 . . . . 75.32 110.214 175.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . 0.466 ' NH2' ' HA ' ' C' ' 28' ' ' ARG . 54.7 mtm180 -80.4 -45.88 16.94 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.518 0.727 . . . . 73.5 109.108 167.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 32' ' ' GLN . . . . . 0.425 ' HB3' ' HA ' ' C' ' 29' ' ' LEU . 59.4 tp60 -60.94 -50.97 71.26 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.245 1.018 . . . . 71.12 112.263 -175.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 33' ' ' TYR . . . . . 0.514 ' HB3' ' O ' ' C' ' 43' ' ' ALA . 31.2 m-85 -103.94 20.03 18.92 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.066 0.547 . . . . 70.15 111.843 -172.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 34' ' ' HIS . . . . . 0.478 ' HB3' ' HB ' ' C' ' 37' ' ' VAL . 5.7 t60 -63.87 114.34 13.22 Favored Pre-proline 0 N--CA 1.482 1.16 0 CA-C-O 118.526 -0.75 . . . . 72.34 111.023 -172.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 35' ' ' PRO . . . . . 0.431 ' HA ' ' HG2' ' C' ' 44' ' ' GLU . 34.7 Cg_exo -40.25 -50.43 3.58 Favored 'Trans proline' 0 C--N 1.385 2.488 0 C-N-CA 124.868 3.712 . . . . 71.32 116.111 -166.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -91.39 -23.7 19.97 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 111.797 0.295 . . . . 60.34 111.797 -173.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . 0.478 ' HB ' ' HB3' ' C' ' 34' ' ' HIS . 69.0 t -74.67 -41.94 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 108.658 -0.867 . . . . 75.33 108.658 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -112.8 96.12 5.79 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.399 -1.334 . . . . 54.22 107.399 175.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -70.61 76.44 0.59 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.801 0.841 . . . . 62.24 110.138 -175.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 62.5 m -152.04 104.62 2.81 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 123.659 0.784 . . . . 74.14 109.306 -176.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -44.64 -38.4 12.33 Favored 'Trans proline' 0 C--N 1.382 2.305 0 C-N-CA 123.882 3.054 . . . . 63.44 113.554 173.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -52.02 -49.94 62.38 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.647 0.779 . . . . 65.44 110.588 174.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 43' ' ' ALA . . . . . 0.514 ' O ' ' HB3' ' C' ' 33' ' ' TYR . . . -71.11 -21.72 62.18 Favored 'General case' 0 C--O 1.213 -0.831 0 CA-C-N 115.143 -0.935 . . . . 62.05 110.805 -178.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 44' ' ' GLU . . . . . 0.471 ' O ' ' HG3' ' C' ' 48' ' ' LYS . 38.0 mt-10 -76.37 -36.06 58.34 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.481 -0.563 . . . . 74.04 109.481 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -73.27 -38.73 65.84 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.756 0.822 . . . . 42.53 110.382 176.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 46' ' ' LYS . . . . . 0.5 ' O ' HG12 ' C' ' 50' ' ' ILE . 0.4 OUTLIER -63.91 -39.16 93.53 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.751 -0.659 . . . . 72.32 109.355 172.711 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -63.52 -34.53 78.0 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.08 0.952 . . . . 62.23 110.317 176.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 48' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' C' ' 44' ' ' GLU . 94.6 mttt -63.28 -43.47 97.83 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.487 -0.324 . . . . 72.04 110.28 174.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -64.11 -33.88 76.77 Favored 'General case' 0 CA--C 1.555 1.148 0 O-C-N 122.928 0.142 . . . . 72.33 110.741 176.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 50' ' ' ILE . . . . . 0.5 HG12 ' O ' ' C' ' 46' ' ' LYS . 13.2 mm -65.11 -42.48 94.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 CA-C-O 121.571 0.701 . . . . 75.43 109.441 175.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 51' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -76.31 -18.18 59.07 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 114.454 -1.248 . . . . 74.04 111.972 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 52' ' ' GLU . . . . . 0.454 ' O ' HG23 ' C' ' 56' ' ' VAL . 33.6 tt0 -74.86 -56.52 4.68 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.323 1.049 . . . . 63.42 108.611 176.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.95 -44.37 78.37 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 113.823 -1.535 . . . . 63.1 110.781 177.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -67.45 -38.6 84.73 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.33 -0.85 . . . . 75.01 111.152 176.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.32 -36.57 68.87 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 117.891 0.314 . . . . 60.54 111.197 177.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 56' ' ' VAL . . . . . 0.464 HG13 ' HZ ' ' C' ' 101' ' ' PHE . 3.0 t -94.98 -11.82 8.73 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 CA-C-N 115.902 -0.59 . . . . 72.43 111.871 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 57' ' ' LEU . . . . . 0.514 HD13 HD13 ' C' ' 22' ' ' ILE . 86.5 mt -126.37 19.86 7.44 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.98 -1.075 . . . . 75.02 113.654 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 45.9 t -80.74 -56.52 4.09 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 123.22 0.608 . . . . 62.42 112.456 178.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . 0.624 ' HB2' ' HD3' ' C' ' 62' ' ' LYS . 3.6 m-20 -108.68 153.6 42.16 Favored Pre-proline 0 N--CA 1.487 1.414 0 CA-C-O 118.086 -0.959 . . . . 72.03 109.904 -168.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 60' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -44.09 -43.47 12.75 Favored 'Trans proline' 0 C--N 1.397 3.106 0 C-N-CA 124.453 3.436 . . . . 33.23 114.192 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -61.89 -60.4 3.7 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.637 -0.71 . . . . 62.13 111.491 -178.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 62' ' ' LYS . . . . . 0.624 ' HD3' ' HB2' ' C' ' 59' ' ' ASP . 0.1 OUTLIER -62.67 -40.12 96.08 Favored 'General case' 0 C--O 1.248 1.01 0 O-C-N 124.244 0.965 . . . . 75.23 109.419 -173.164 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 47.2 tpt85 -51.84 -55.79 17.84 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 114.06 -1.427 . . . . 64.42 109.993 176.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -74.93 -18.07 60.46 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.333 -0.849 . . . . 74.15 112.499 -177.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 69.2 mt -62.94 -48.85 86.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 108.645 -0.872 . . . . 62.34 108.645 170.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -65.7 -43.86 87.88 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.799 -0.637 . . . . 74.22 110.681 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -61.59 -36.13 79.8 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 122.765 0.426 . . . . 73.14 111.578 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 74.4 p -83.9 -15.49 47.84 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 119.144 -0.455 . . . . 63.2 111.165 175.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -71.33 136.25 47.75 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.42 -0.956 . . . . 75.22 108.42 175.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.64 19.21 55.0 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 111.296 -0.721 . . . . 62.51 111.296 -167.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 58.6 m -145.84 -59.07 0.32 Allowed 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 103.274 -2.862 . . . . 72.34 103.274 174.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 13.3 m -79.88 137.47 36.92 Favored 'General case' 0 C--O 1.251 1.168 0 N-CA-C 104.63 -2.359 . . . . 73.35 104.63 156.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.09 -30.9 5.53 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.957 0.903 . . . . 73.23 110.15 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.45 124.86 91.4 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 115.614 -0.721 . . . . 53.23 109.219 174.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -53.31 146.1 41.97 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 122.871 2.381 . . . . 75.14 112.293 173.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -51.89 139.59 50.1 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 123.01 2.473 . . . . 63.14 112.849 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.66 138.9 86.81 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 122.743 2.295 . . . . 51.51 111.705 172.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 78' ' ' PRO . . . . . 0.512 ' HB3' ' HB2' ' C' ' 103' ' ' PRO . 18.0 Cg_endo -59.22 116.45 3.28 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 122.85 2.366 . . . . 74.44 112.581 -176.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -64.21 124.05 12.82 Favored 'Trans proline' 0 C--N 1.376 2.023 0 C-N-CA 122.324 2.016 . . . . 61.04 109.729 171.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -55.32 83.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.392 2.824 0 C-N-CA 123.751 2.967 . . . . 51.5 112.697 -175.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 161.91 -59.99 0.29 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 109.245 -1.542 . . . . 75.2 109.245 -174.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.437 ' HA3' ' HG3' ' C' ' 167' ' ' GLN . . . 143.61 172.69 14.61 Favored Glycine 0 C--N 1.358 1.795 0 C-N-CA 123.069 0.366 . . . . 74.45 112.761 -177.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -90.37 119.02 30.31 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.684 -0.858 . . . . 70.14 108.684 171.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 84' ' ' ASP . . . . . 0.612 ' HB2' ' HA ' ' C' ' 164' ' ' MET . 6.6 p-10 -70.29 133.21 46.76 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.509 0.724 . . . . 63.13 111.156 -178.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 85' ' ' PHE . . . . . 0.597 ' HB3' ' HB2' ' C' ' 88' ' ' PHE . 54.8 m-85 -139.43 69.81 1.37 Allowed 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.813 0.816 . . . . 74.41 110.796 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 16.7 m -61.5 96.07 0.06 Allowed 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 114.276 -1.329 . . . . 45.43 111.442 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.11 5.11 90.34 Favored Glycine 0 C--N 1.347 1.14 0 CA-C-N 115.807 -0.633 . . . . 74.33 113.317 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 88' ' ' PHE . . . . . 0.597 ' HB2' ' HB3' ' C' ' 85' ' ' PHE . 6.3 m-85 -103.78 118.07 35.83 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 108.154 -1.054 . . . . 74.44 108.154 -179.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -83.7 73.32 10.28 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 122.2 1.0 . . . . 72.23 110.766 -176.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 90' ' ' VAL . . . . . 0.666 HG11 ' HB3' ' C' ' 106' ' ' PHE . 2.4 p -41.32 -43.28 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 C-N-CA 126.551 1.94 . . . . 54.41 113.961 175.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -61.78 -32.01 72.26 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.831 0.852 . . . . 74.21 112.049 -175.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -101.26 4.18 41.55 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.482 0.313 . . . . 75.53 111.471 -176.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 93' ' ' PHE . . . . . 0.454 ' CD2' ' HA ' ' C' ' 90' ' ' VAL . 19.4 m-30 -78.04 177.5 8.26 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 110.23 -0.285 . . . . 72.45 110.23 174.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 77.4 p -62.18 158.63 16.49 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.829 0.852 . . . . 45.51 113.269 -173.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 95' ' ' GLU . . . . . 0.465 ' O ' ' HG3' ' C' ' 99' ' ' GLU . 0.0 OUTLIER -64.25 -25.69 68.17 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 123.51 0.507 . . . . 55.43 111.008 170.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -62.44 -45.41 93.19 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.694 0.798 . . . . 65.02 110.413 172.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 97' ' ' PHE . . . . . 0.535 ' HE2' HG23 ' C' ' 90' ' ' VAL . 32.5 t80 -64.93 -37.17 86.74 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 115.02 -0.991 . . . . 64.25 109.432 175.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 98' ' ' GLN . . . . . 0.409 ' HB2' ' HA ' ' C' ' 95' ' ' GLU . 70.3 mt-30 -71.12 -17.27 62.57 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.021 -0.99 . . . . 51.52 112.003 178.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . 0.465 ' HG3' ' O ' ' C' ' 95' ' ' GLU . 40.2 mt-10 -78.22 -57.9 3.54 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 109.602 -0.518 . . . . 74.43 109.602 167.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 26.6 tp -65.94 -31.26 72.08 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 114.369 -1.287 . . . . 73.23 112.336 -166.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 101' ' ' PHE . . . . . 0.464 ' HZ ' HG13 ' C' ' 56' ' ' VAL . 76.6 m-85 -120.34 13.37 11.88 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.377 0.671 . . . . 73.25 110.885 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -43.55 -63.8 2.05 Favored Glycine 0 C--N 1.352 1.437 0 N-CA-C 116.241 1.256 . . . . 54.11 116.241 -173.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . 0.512 ' HB2' ' HB3' ' C' ' 78' ' ' PRO . 38.8 Cg_exo -58.81 -6.3 3.31 Favored 'Trans proline' 0 C--N 1.373 1.837 0 C-N-CA 123.545 2.83 . . . . 62.02 115.225 -174.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -147.28 41.02 0.97 Allowed Glycine 0 C--N 1.351 1.407 0 CA-C-O 119.634 -0.537 . . . . 43.23 112.712 176.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 105' ' ' LEU . . . . . 0.408 HD11 ' HA ' ' C' ' 98' ' ' GLN . 38.0 mt -62.88 21.59 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 116.445 2.017 . . . . 73.03 116.445 -177.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 106' ' ' PHE . . . . . 0.666 ' HB3' HG11 ' C' ' 90' ' ' VAL . 17.2 t80 57.9 -94.34 0.05 OUTLIER 'General case' 0 CA--C 1.568 1.658 0 CA-C-N 120.252 1.387 . . . . 64.24 111.583 164.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 107' ' ' GLY . . . . . 0.694 ' HA3' ' HB2' ' C' ' 113' ' ' SER . . . 113.97 17.81 7.16 Favored Glycine 0 C--N 1.344 1.026 0 C-N-CA 125.393 1.473 . . . . 51.05 113.861 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . -9.49 -70.7 0.01 OUTLIER Glycine 0 N--CA 1.479 1.538 0 C-N-CA 127.035 2.255 . . . . 74.41 118.262 172.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 109' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -123.78 25.15 8.17 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.028 0.531 . . . . 74.45 110.274 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 110' ' ' GLY . . . . . . . . . . . . . . . -76.27 -1.78 70.87 Favored Glycine 0 C--N 1.35 1.317 0 CA-C-N 115.593 -0.731 . . . . 54.22 113.11 173.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 9.2 tpp180 81.9 -41.17 0.13 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 127.074 2.15 . . . . 75.25 112.481 171.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 112' ' ' ARG . . . . . 0.468 ' O ' ' N ' ' C' ' 114' ' ' ARG . 9.8 tpp180 -126.88 -39.62 1.95 Allowed 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 117.273 -1.346 . . . . 74.1 113.308 170.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 113' ' ' SER . . . . . 0.694 ' HB2' ' HA3' ' C' ' 107' ' ' GLY . 12.7 m -5.63 -33.75 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.469 0 N-CA-C 120.206 3.41 . . . . 72.53 120.206 -168.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 114' ' ' ARG . . . . . 0.518 ' HB3' ' HA2' ' C' ' 168' ' ' GLY . 1.5 tpp180 -159.9 161.96 34.43 Favored 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 107.683 -1.229 . . . . 74.05 107.683 164.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 115' ' ' LYS . . . . . . . . . . . . . 23.4 tptp -85.07 130.12 34.67 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 108.155 -1.054 . . . . 54.14 108.155 165.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 116' ' ' GLY . . . . . 0.592 ' HA2' ' HA3' ' C' ' 168' ' ' GLY . . . -51.92 111.54 1.52 Allowed Glycine 0 C--N 1.358 1.754 0 O-C-N 124.68 1.237 . . . . 45.25 113.302 -178.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 117' ' ' ARG . . . . . 0.452 ' HB2' ' HA3' ' C' ' 166' ' ' GLY . 52.1 mmm-85 -70.03 97.9 1.23 Allowed 'General case' 0 C--O 1.249 1.027 0 N-CA-C 107.314 -1.365 . . . . 64.44 107.314 174.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 118' ' ' ASP . . . . . 0.41 ' HB2' ' HA ' ' B' ' 151' ' ' HIS . 4.5 m-20 -67.09 98.12 0.56 Allowed 'General case' 0 C--O 1.242 0.659 0 CA-C-N 114.767 -1.106 . . . . 75.42 108.166 -178.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 119' ' ' LEU . . . . . 0.41 ' O ' HD12 ' C' ' 174' ' ' LEU . 56.0 tp -93.05 98.67 11.49 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 108.134 -1.061 . . . . 75.21 108.134 -168.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.444 HH12 HG21 ' C' ' 158' ' ' VAL . 40.8 ttm-85 -100.48 114.83 28.76 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.58 -0.896 . . . . 72.31 108.58 -177.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 121' ' ' ALA . . . . . 0.505 ' HB3' HD23 ' C' ' 176' ' ' LEU . . . -115.46 130.25 56.82 Favored 'General case' 0 C--O 1.219 -0.534 0 C-N-CA 123.644 0.777 . . . . 63.21 110.366 -174.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 122' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' C' ' 177' ' ' VAL . 11.5 pt-20 -90.06 147.63 23.53 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 109.413 -0.588 . . . . 73.22 109.413 174.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 123' ' ' LEU . . . . . 0.505 ' HB2' HG11 ' B' ' 182' ' ' VAL . 2.6 pt? -143.81 123.12 7.34 Favored Pre-proline 0 N--CA 1.482 1.173 0 N-CA-C 112.68 0.622 . . . . 73.3 112.68 -176.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . 0.445 ' HA ' ' O ' ' C' ' 179' ' ' ARG . 24.3 Cg_exo -65.7 117.67 4.83 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 122.739 2.293 . . . . 72.51 110.905 170.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 125' ' ' LEU . . . . . 0.458 HD23 HG11 ' C' ' 153' ' ' VAL . 44.7 tp -145.32 153.72 41.56 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.92 0.488 . . . . 74.03 110.311 -172.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 126' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.31 166.01 10.68 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.766 0.827 . . . . 61.53 109.873 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 127' ' ' LEU . . . . . 0.5 HD21 HD13 ' C' ' 180' ' ' LEU . 94.4 mt -78.13 -36.79 47.42 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.854 0.862 . . . . 62.25 111.333 -178.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 128' ' ' GLU . . . . . 0.527 ' HG2' ' H ' ' B' ' 171' ' ' ALA . 18.0 mp0 -70.52 -32.18 69.54 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.987 -1.006 . . . . 75.24 109.542 173.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -87.4 -8.71 56.25 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.095 0.558 . . . . 73.53 111.416 176.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -76.56 -43.19 40.04 Favored 'General case' 0 C--O 1.22 -0.461 0 N-CA-C 108.191 -1.04 . . . . 64.34 108.191 164.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 131' ' ' PHE . . . . . 0.461 ' HB2' HD13 ' C' ' 215' ' ' LEU . 77.5 t80 -60.2 -37.99 81.94 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.781 1.233 . . . . 75.55 111.234 174.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 132' ' ' HIS . . . . . 0.436 ' HB3' ' CD1' ' B' ' 131' ' ' TRP . 65.7 m170 -78.68 -69.96 0.53 Allowed 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.831 -0.622 . . . . 60.22 110.669 177.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 49.46 -103.81 0.09 OUTLIER Glycine 0 C--N 1.353 1.52 0 O-C-N 124.047 0.842 . . . . 65.31 112.986 -178.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.98 -153.8 34.67 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 114.525 0.57 . . . . 53.24 114.525 170.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -93.42 93.86 8.39 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.152 -1.055 . . . . 71.2 108.152 -167.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 136' ' ' ARG . . . . . 0.628 ' HB3' ' HB2' ' B' ' 181' ' ' LEU . 0.9 OUTLIER -142.19 147.45 36.61 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 122.229 -0.295 . . . . 72.12 110.979 -167.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 137' ' ' VAL . . . . . 0.583 ' HA ' ' HA ' ' C' ' 146' ' ' SER . 7.7 p -95.07 129.99 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-O 121.493 0.664 . . . . 71.12 111.364 -177.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 138' ' ' VAL . . . . . . . . . . . . . 3.0 p -114.84 140.72 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.612 1.165 . . . . 72.14 108.953 178.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 139' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -108.0 111.59 23.74 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 107.8 -1.185 . . . . 74.31 107.8 172.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 140' ' ' VAL . . . . . 0.415 HG21 ' HB2' ' C' ' 121' ' ' ALA . 2.7 p -130.63 128.15 62.94 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 C-N-CA 123.896 0.878 . . . . 63.22 109.215 -179.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 65.37 33.36 9.03 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.803 0.841 . . . . 15.23 112.388 174.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 78.7 12.5 84.15 Favored Glycine 0 C--N 1.345 1.044 0 CA-C-N 116.399 -0.364 . . . . 45.25 112.302 -176.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 143' ' ' ARG . . . . . . . . . . . . . 29.1 tpt180 -126.32 100.83 6.45 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.445 0.698 . . . . 73.04 109.991 -168.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -83.99 129.33 34.92 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.181 -0.918 . . . . 71.51 109.225 176.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 145' ' ' VAL . . . . . . . . . . . . . 3.7 p -166.34 140.26 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 123.822 0.849 . . . . 75.03 109.854 -174.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 146' ' ' SER . . . . . 0.583 ' HA ' ' HA ' ' C' ' 137' ' ' VAL . 56.8 p -100.7 146.05 27.69 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.075 0.55 . . . . 54.21 111.998 -174.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 8.9 p -151.67 150.33 13.22 Favored 'Isoleucine or valine' 0 C--O 1.242 0.711 0 CA-C-N 115.716 -0.674 . . . . 72.53 109.838 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 148' ' ' ARG . . . . . 0.488 ' NH1' ' HB3' ' B' ' 206' ' ' GLU . 20.3 ttt180 -105.36 94.67 5.34 Favored 'General case' 0 C--N 1.347 0.482 0 N-CA-C 107.971 -1.122 . . . . 74.22 107.971 168.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 149' ' ' ILE . . . . . 0.418 HD12 HD13 ' C' ' 159' ' ' ILE . 37.8 pt -75.97 146.68 79.44 Favored Pre-proline 0 CA--C 1.55 0.956 0 CA-C-O 118.603 -0.713 . . . . 71.41 109.513 176.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.37 115.75 2.8 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 122.408 2.072 . . . . 61.44 111.619 177.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -51.72 111.69 0.65 Allowed 'Trans proline' 0 C--N 1.384 2.424 0 C-N-CA 123.633 2.889 . . . . 73.2 114.081 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 152' ' ' GLY . . . . . . . . . . . . . . . 139.77 136.28 3.35 Favored Glycine 0 C--N 1.35 1.324 0 CA-C-N 115.373 -0.83 . . . . 54.32 113.175 -174.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 153' ' ' VAL . . . . . 0.458 HG11 HD23 ' C' ' 125' ' ' LEU . 1.7 p -160.38 160.72 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.777 0 CA-C-N 117.192 0.496 . . . . 71.13 112.2 177.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 154' ' ' ARG . . . . . 0.475 ' HD3' ' O ' ' C' ' 188' ' ' LEU . 43.9 ttp180 -128.2 139.68 52.33 Favored 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 125.052 1.341 . . . . 75.32 109.225 177.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 155' ' ' GLU . . . . . 0.609 ' HB2' HD12 ' C' ' 180' ' ' LEU . 21.8 tp10 -40.51 123.53 1.83 Allowed 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 125.464 1.506 . . . . 74.51 113.9 176.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 81.09 -13.46 32.02 Favored Glycine 0 C--N 1.353 1.486 0 CA-C-N 115.054 -0.976 . . . . 64.51 113.951 176.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 157' ' ' SER . . . . . . . . . . . . . 17.1 m -83.56 166.28 18.36 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.226 0.61 . . . . 75.43 111.203 -174.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 158' ' ' VAL . . . . . 0.547 HG22 HG22 ' C' ' 177' ' ' VAL . 21.5 t -111.66 136.44 47.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 CA-C-N 115.245 -0.889 . . . . 64.44 110.884 -163.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 159' ' ' ILE . . . . . 0.687 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 27.2 mt -105.99 122.13 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 107.136 -1.431 . . . . 52.25 107.136 172.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 16.8 ttm180 -83.8 141.22 31.54 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 117.947 0.339 . . . . 72.21 110.151 178.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 161' ' ' VAL . . . . . 0.505 ' HB ' ' HB3' ' C' ' 174' ' ' LEU . 39.8 t -128.74 97.65 26.74 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 107.24 -1.393 . . . . 75.24 107.24 164.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -62.92 127.67 21.05 Favored 'Trans proline' 0 C--N 1.377 2.038 0 C-N-CA 122.92 2.413 . . . . 63.42 113.489 -172.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 163' ' ' GLY . . . . . 0.676 ' H ' ' HB3' ' C' ' 173' ' ' ASP . . . 84.67 -18.39 25.61 Favored Glycine 0 CA--C 1.541 1.665 0 N-CA-C 115.135 0.814 . . . . 53.31 115.135 177.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 164' ' ' MET . . . . . 0.612 ' HA ' ' HB2' ' C' ' 84' ' ' ASP . 31.3 ttp -94.77 38.71 1.11 Allowed 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 117.94 0.87 . . . . 73.35 112.317 -167.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . -109.02 -147.01 11.96 Favored Glycine 0 N--CA 1.473 1.132 0 CA-C-N 115.718 -0.674 . . . . 64.24 112.649 174.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 166' ' ' GLY . . . . . 0.452 ' HA3' ' HB2' ' C' ' 117' ' ' ARG . . . -88.88 -177.22 46.53 Favored Glycine 0 C--N 1.351 1.405 0 CA-C-O 119.868 -0.407 . . . . 75.44 112.992 -179.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 167' ' ' GLN . . . . . 0.662 ' HA ' ' HA ' ' C' ' 106' ' ' PHE . 28.4 mt-30 -49.97 129.21 20.16 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.168 1.387 . . . . 64.31 112.894 -173.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 168' ' ' GLY . . . . . 0.592 ' HA3' ' HA2' ' C' ' 116' ' ' GLY . . . 165.71 158.07 10.47 Favored Glycine 0 C--N 1.351 1.412 0 N-CA-C 114.984 0.754 . . . . 13.44 114.984 173.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 169' ' ' ASN . . . . . 0.548 ' HB3' ' HD3' ' C' ' 170' ' ' PRO . 5.0 t30 -90.37 -55.43 0.28 Allowed Pre-proline 0 CA--C 1.557 1.213 0 CA-C-N 114.166 -1.017 . . . . 62.44 110.298 165.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 170' ' ' PRO . . . . . 0.548 ' HD3' ' HB3' ' C' ' 169' ' ' ASN . 20.9 Cg_exo -64.44 118.52 5.48 Favored 'Trans proline' 0 C--N 1.399 3.221 0 CA-C-N 120.883 1.351 . . . . 51.41 109.029 175.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 171' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -46.17 107.0 0.1 Allowed 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 123.335 2.69 . . . . 74.02 114.073 -167.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -82.62 -48.15 5.67 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-N 115.154 -0.93 . . . . 74.42 111.154 175.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 173' ' ' ASP . . . . . 0.676 ' HB3' ' H ' ' C' ' 163' ' ' GLY . 2.4 p30 50.84 173.11 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 115.709 1.744 . . . . 74.51 115.709 172.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 174' ' ' LEU . . . . . 0.505 ' HB3' ' HB ' ' C' ' 161' ' ' VAL . 49.5 tp -100.73 132.87 45.91 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 115.488 -0.778 . . . . 75.22 109.759 -177.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 175' ' ' LEU . . . . . 0.506 HD21 ' HE1' ' B' ' 147' ' ' HIS . 90.0 mt -127.54 89.31 2.93 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.924 0.869 . . . . 71.32 110.316 -173.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 176' ' ' LEU . . . . . 0.687 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 96.0 mt -76.36 97.26 4.2 Favored 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 114.262 -1.336 . . . . 43.02 111.945 -175.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 177' ' ' VAL . . . . . 0.547 HG22 HG22 ' C' ' 158' ' ' VAL . 71.5 t -83.56 109.94 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 108.334 -0.987 . . . . 74.43 108.334 174.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 178' ' ' VAL . . . . . 0.433 ' HA ' HD23 ' C' ' 123' ' ' LEU . 8.2 p -75.14 136.03 25.96 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 CA-C-O 121.919 0.866 . . . . 74.01 111.707 -173.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 179' ' ' ARG . . . . . 0.445 ' O ' ' HA ' ' C' ' 124' ' ' PRO . 8.5 mmm180 -109.76 96.1 6.03 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 105.563 -2.014 . . . . 72.33 105.563 171.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 180' ' ' LEU . . . . . 0.609 HD12 ' HB2' ' C' ' 155' ' ' GLU . 77.0 mt -68.97 148.52 50.02 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-O 121.26 0.552 . . . . 70.51 111.046 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 181' ' ' LEU . . . . . . . . . . . . . 56.8 mt -68.97 171.49 6.37 Favored Pre-proline 0 N--CA 1.484 1.235 0 CA-C-N 114.217 -1.356 . . . . 74.2 110.494 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -60.98 67.37 0.09 OUTLIER 'Trans proline' 0 C--N 1.384 2.423 0 C-N-CA 122.543 2.162 . . . . 64.12 111.855 166.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 183' ' ' HIS . . . . . 0.595 ' H ' ' HD3' ' C' ' 184' ' ' PRO . 71.1 t60 -170.25 27.39 0.01 OUTLIER Pre-proline 0 CA--C 1.582 2.195 0 C-N-CA 126.726 2.01 . . . . 62.13 109.894 -177.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 184' ' ' PRO . . . . . 0.595 ' HD3' ' H ' ' C' ' 183' ' ' HIS . 12.2 Cg_endo -84.74 68.22 6.2 Favored 'Trans proline' 0 C--N 1.405 3.522 0 C-N-CA 122.542 2.161 . . . . 71.54 110.513 -173.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 185' ' ' VAL . . . . . 0.596 HG12 ' HB1' ' C' ' 195' ' ' ALA . 5.9 t -90.4 -40.95 13.21 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.573 0 N-CA-C 107.658 -1.238 . . . . 72.23 107.658 -172.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 186' ' ' PHE . . . . . 0.415 ' HB2' HD13 ' C' ' 127' ' ' LEU . 74.5 m-85 -99.24 104.56 16.5 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.687 0.795 . . . . 61.44 109.825 -172.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 187' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -94.41 113.3 25.15 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.292 1.437 . . . . 75.14 108.465 -177.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 188' ' ' LEU . . . . . 0.588 HD13 ' HD2' ' C' ' 240' ' ' PHE . 64.7 tp -81.93 146.99 29.5 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 113.233 0.827 . . . . 74.14 113.233 -171.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 189' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' B' ' 375' ' ' LEU . 32.8 tt0 -145.59 101.88 3.62 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.033 1.333 . . . . 71.33 107.55 164.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 190' ' ' GLY . . . . . 0.443 ' HA3' ' HA ' ' B' ' 375' ' ' LEU . . . 74.73 -102.25 1.39 Allowed Glycine 0 C--N 1.346 1.115 0 N-CA-C 112.159 -0.376 . . . . 74.2 112.159 -175.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 191' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -112.24 -13.68 13.45 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.493 0.717 . . . . 60.21 110.363 170.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -87.72 141.06 28.89 Favored 'General case' 0 C--O 1.213 -0.835 0 C-N-CA 123.689 0.796 . . . . 65.13 110.685 -170.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 193' ' ' LEU . . . . . . . . . . . . . 85.6 mt -106.58 167.56 9.77 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 122.899 0.48 . . . . 52.2 110.871 -176.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 194' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -143.2 105.3 4.4 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.567 -0.531 . . . . 75.43 109.567 171.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 195' ' ' ALA . . . . . 0.596 ' HB1' HG12 ' C' ' 185' ' ' VAL . . . -119.52 -176.35 3.14 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.607 1.163 . . . . 65.11 109.324 177.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 30.1 m -123.78 133.58 53.8 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 109.306 -0.628 . . . . 51.32 109.306 176.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 197' ' ' LEU . . . . . 0.458 HD13 ' HB2' ' C' ' 212' ' ' ALA . 32.0 tp -107.2 122.73 47.11 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.403 0.681 . . . . 73.5 109.567 -178.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -82.56 98.16 8.83 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 108.566 -0.901 . . . . 44.52 108.566 176.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 199' ' ' VAL . . . . . . . . . . . . . 60.3 t -107.77 121.42 44.11 Favored Pre-proline 0 N--CA 1.478 0.964 0 C-N-CA 123.296 0.639 . . . . 61.21 109.335 -175.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 200' ' ' PRO . . . . . 0.612 ' HG2' HD12 ' C' ' 203' ' ' ILE . 15.9 Cg_exo -63.23 140.69 78.92 Favored 'Trans proline' 0 C--N 1.367 1.541 0 C-N-CA 121.839 1.693 . . . . 71.34 111.181 172.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 201' ' ' ALA . . . . . 0.404 ' N ' ' HD2' ' C' ' 202' ' ' PRO . . . -53.5 -46.43 98.13 Favored Pre-proline 0 CA--C 1.554 1.107 0 N-CA-C 113.49 0.922 . . . . 74.35 113.49 178.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 202' ' ' PRO . . . . . 0.445 ' HB2' ' HA ' ' A' ' 273' ' ' ALA . 39.2 Cg_endo -62.06 -42.64 28.76 Favored 'Trans proline' 0 C--N 1.384 2.407 0 CA-C-N 120.722 1.294 . . . . 63.15 111.946 178.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 203' ' ' ILE . . . . . 0.612 HD12 ' HG2' ' C' ' 200' ' ' PRO . 24.8 mt -64.48 -34.68 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 122.839 0.456 . . . . 63.4 110.958 177.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 204' ' ' ALA . . . . . 0.496 ' HA ' HG11 ' C' ' 223' ' ' VAL . . . -68.13 -35.29 77.87 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.687 0.795 . . . . 75.02 111.913 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 205' ' ' VAL . . . . . 0.535 ' HA ' ' HA ' ' C' ' 226' ' ' ARG . 95.6 t -77.96 -42.09 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-N 115.836 -0.62 . . . . 63.41 112.498 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 206' ' ' VAL . . . . . 0.466 HG23 ' HG2' ' A' ' 270' ' ' LYS . 11.7 p -76.6 -32.73 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 CA-C-O 121.028 0.442 . . . . 52.12 110.009 -177.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 84.3 49.95 4.48 Favored Glycine 0 N--CA 1.44 -1.062 0 CA-C-N 115.095 -0.957 . . . . 63.21 111.846 -172.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -84.37 -136.92 3.44 Favored Glycine 0 C--N 1.347 1.187 0 CA-C-O 119.62 -0.545 . . . . 51.32 112.03 177.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 209' ' ' LYS . . . . . 0.493 ' HB3' ' HG2' ' C' ' 220' ' ' GLU . 9.2 mtmp? -139.02 140.89 38.27 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 117.649 0.724 . . . . 72.12 112.83 -178.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 210' ' ' VAL . . . . . . . . . . . . . 57.5 t -132.78 129.48 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 124.953 1.301 . . . . 62.05 108.614 178.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 211' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -80.28 125.57 30.04 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 118.16 0.436 . . . . 72.44 111.505 -177.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 212' ' ' ALA . . . . . 0.458 ' HB2' HD13 ' C' ' 197' ' ' LEU . . . -103.12 120.08 40.04 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 108.038 -1.097 . . . . 74.43 108.038 165.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 213' ' ' MET . . . . . . . . . . . . . 5.4 tmm? -79.12 108.53 12.68 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 108.331 -0.989 . . . . 63.12 108.331 -177.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.93 171.85 7.1 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 118.128 0.422 . . . . 54.24 110.772 -173.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 215' ' ' LEU . . . . . 0.461 HD13 ' HB2' ' C' ' 131' ' ' PHE . 25.2 mt -58.41 -37.84 76.15 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 125.302 1.441 . . . . 44.41 113.49 -165.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 216' ' ' GLU . . . . . 0.47 ' HG2' HH11 ' C' ' 246' ' ' ARG . 0.0 OUTLIER -110.1 -6.32 15.14 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.057 0.943 . . . . 71.0 111.483 -174.579 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 169.42 156.23 10.62 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-O 119.761 -0.466 . . . . 64.11 113.303 -177.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.74 111.17 3.08 Favored 'Trans proline' 0 CA--C 1.557 1.656 0 C-N-CA 122.933 2.422 . . . . 52.13 112.403 178.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 219' ' ' VAL . . . . . 0.503 ' HB ' ' HE3' ' C' ' 238' ' ' LYS . 9.0 p -84.21 140.16 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 O-C-N 122.07 -0.394 . . . . 52.53 110.019 176.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 220' ' ' GLU . . . . . 0.493 ' HG2' ' HB3' ' C' ' 209' ' ' LYS . 25.5 tt0 -101.23 108.02 19.56 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 107.657 -1.238 . . . . 72.32 107.657 176.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 221' ' ' VAL . . . . . 0.555 ' HA ' ' HB2' ' B' ' 239' ' ' ALA . 42.5 t -77.07 119.48 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 124.055 0.942 . . . . 74.03 111.897 -174.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 222' ' ' ALA . . . . . 0.771 ' HB1' ' HE2' ' B' ' 245' ' ' LYS . . . -80.69 112.71 18.31 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.537 0.735 . . . . 73.3 110.277 169.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . 0.496 HG11 ' HA ' ' C' ' 204' ' ' ALA . 63.8 t -89.19 138.89 28.65 Favored Pre-proline 0 CA--C 1.559 1.306 0 C-N-CA 124.719 1.208 . . . . 73.11 110.028 -178.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 224' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.62 154.38 64.36 Favored 'Trans proline' 0 C--N 1.389 2.705 0 C-N-CA 122.501 2.134 . . . . 54.33 112.147 172.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.31 114.21 1.83 Allowed 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 122.768 2.312 . . . . 74.0 111.906 174.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 226' ' ' ARG . . . . . 0.58 ' HB3' ' HA ' ' A' ' 259' ' ' GLU . 0.0 OUTLIER 70.69 97.91 0.07 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.879 1.672 . . . . 70.15 112.406 -178.186 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 227' ' ' THR . . . . . 0.48 HG22 HG11 ' C' ' 253' ' ' VAL . 50.5 m -120.29 129.28 53.95 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 124.726 1.21 . . . . 70.3 111.562 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 228' ' ' GLN . . . . . 0.424 ' H ' ' HD2' ' C' ' 231' ' ' ARG . 27.0 mp0 -95.14 156.43 16.32 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 124.247 1.019 . . . . 74.32 111.635 175.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 229' ' ' ALA . . . . . 0.457 ' HB2' ' H ' ' C' ' 255' ' ' ILE . . . -75.72 131.32 39.77 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 114.84 -1.073 . . . . 62.12 109.742 177.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 110.95 -18.96 25.9 Favored Glycine 0 C--N 1.339 0.697 0 CA-C-N 115.711 -0.677 . . . . 62.04 112.085 -170.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 231' ' ' ARG . . . . . 0.424 ' HD2' ' H ' ' C' ' 228' ' ' GLN . 56.4 mtt180 -62.35 161.86 10.9 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 116.754 0.277 . . . . 74.12 110.318 169.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 232' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -137.65 138.91 39.93 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.042 0.449 . . . . 71.45 110.76 -174.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 233' ' ' LEU . . . . . 0.64 ' O ' ' HA ' ' C' ' 250' ' ' TYR . 6.1 mp -97.11 153.01 18.22 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 114.366 -1.288 . . . . 74.21 109.431 176.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 17.3 ptt180 -130.78 91.33 3.05 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 107.855 -1.165 . . . . 72.34 107.855 162.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 235' ' ' LEU . . . . . 0.575 HD12 HD23 ' C' ' 249' ' ' LEU . 17.1 mt -71.4 106.41 3.9 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 114.29 -1.323 . . . . 73.43 109.061 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 236' ' ' LYS . . . . . 0.663 ' HB3' ' HA ' ' B' ' 35' ' ' GLN . 26.2 mmmt -69.82 115.25 8.83 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 113.997 -1.456 . . . . 71.55 110.872 -171.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 81.39 33.15 29.18 Favored Glycine 0 C--N 1.346 1.1 0 CA-C-N 115.799 -0.637 . . . . 71.42 112.955 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 238' ' ' LYS . . . . . 0.503 ' HE3' ' HB ' ' C' ' 219' ' ' VAL . 64.6 mmtt -125.77 24.41 7.11 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.723 0.809 . . . . 72.03 111.364 177.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -102.32 -156.1 25.77 Favored Glycine 0 C--N 1.344 1.007 0 N-CA-C 111.652 -0.579 . . . . 31.21 111.652 171.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 240' ' ' PHE . . . . . 0.588 ' HD2' HD13 ' C' ' 188' ' ' LEU . 56.8 m-85 -81.67 153.38 70.49 Favored Pre-proline 0 CA--C 1.553 1.086 0 C-N-CA 122.868 0.467 . . . . 75.14 109.915 175.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 241' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -66.95 136.05 39.93 Favored 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 123.746 2.964 . . . . 70.21 114.806 -168.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -134.9 173.11 21.71 Favored Glycine 0 C--N 1.351 1.416 0 CA-C-N 115.487 -0.779 . . . . 70.14 112.869 175.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -60.91 -42.8 34.76 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 123.899 3.066 . . . . 71.42 112.796 -174.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 244' ' ' ALA . . . . . 0.444 ' HB1' ' HB3' ' B' ' 32' ' ' ARG . . . -83.53 -17.36 42.1 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.725 0.81 . . . . 71.42 110.698 178.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 143.92 -179.19 21.46 Favored Glycine 0 C--N 1.346 1.108 0 CA-C-N 115.621 -0.718 . . . . 51.32 111.423 -176.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 246' ' ' ARG . . . . . 0.47 HH11 ' HG2' ' C' ' 216' ' ' GLU . 80.8 mtm180 -71.34 159.52 34.42 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.298 0.639 . . . . 61.31 111.192 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -70.42 -164.29 4.99 Favored Glycine 0 C--N 1.353 1.504 0 CA-C-N 116.074 -0.512 . . . . 63.23 113.463 178.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -117.17 124.46 49.18 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 108.803 -0.814 . . . . 73.54 108.803 -173.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 249' ' ' LEU . . . . . 0.575 HD23 HD12 ' C' ' 235' ' ' LEU . 11.0 tp -79.58 119.99 23.31 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.902 -0.777 . . . . 74.23 108.902 177.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 250' ' ' TYR . . . . . 0.64 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 20.0 m-85 -96.24 111.93 23.83 Favored 'General case' 0 C--O 1.221 -0.419 0 N-CA-C 108.205 -1.035 . . . . 71.43 108.205 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 251' ' ' LEU . . . . . 0.588 HD12 HD22 ' C' ' 233' ' ' LEU . 77.1 mt -105.32 123.02 47.16 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 109.218 -0.66 . . . . 64.53 109.218 -177.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -81.32 120.27 24.72 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.273 -1.01 . . . . 73.41 108.273 173.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 253' ' ' VAL . . . . . 0.48 HG11 HG22 ' C' ' 227' ' ' THR . 60.3 t -72.29 128.93 35.66 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 C-N-CA 123.018 0.527 . . . . 73.5 110.954 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 254' ' ' ARG . . . . . . . . . . . . . 39.4 mtm105 -112.38 129.77 56.2 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 107.462 -1.31 . . . . 74.13 107.462 162.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 255' ' ' ILE . . . . . 0.535 ' O ' ' HB ' ' A' ' 255' ' ' ILE . 37.9 mm -94.65 114.21 30.75 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.775 0 N-CA-C 106.14 -1.8 . . . . 75.24 106.14 173.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 256' ' ' THR . . . . . 0.486 ' O ' ' HA ' ' C' ' 200' ' ' PRO . 0.1 OUTLIER -132.56 155.28 48.94 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 123.991 0.916 . . . . 53.32 108.93 -170.642 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 2.7 pp -124.0 151.07 64.58 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 109.086 -0.709 . . . . 64.54 109.086 -175.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 258' ' ' PRO . . . . . 0.404 ' HG3' ' HE2' ' A' ' 276' ' ' TYR . 68.9 Cg_endo -75.04 8.88 2.23 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.45 2.1 . . . . 73.21 113.025 -171.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 61.37 -79.25 0.02 OUTLIER 'General case' 0 C--N 1.359 0.987 0 C-N-CA 125.718 1.607 . . . . 72.3 110.268 -170.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 260' ' ' ARG . . . . . 0.522 ' HB2' ' HA3' ' B' ' 469' ' ' GLY . 2.6 ptp85 -72.95 142.63 47.82 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.396 1.478 . . . . 73.41 110.671 -178.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 261' ' ' LEU . . . . . 0.473 HD22 ' HB3' ' C' ' 265' ' ' GLU . 85.6 mt -139.04 168.25 20.25 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.771 0.829 . . . . 71.21 110.579 -174.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 49.4 p -86.53 162.94 43.78 Favored Pre-proline 0 CA--C 1.553 1.063 0 N-CA-C 108.401 -0.963 . . . . 61.23 108.401 168.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -50.49 -40.99 53.85 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 122.738 2.292 . . . . 74.2 113.107 173.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -60.44 -59.21 5.77 Favored 'General case' 0 C--O 1.262 1.73 0 C-N-CA 124.011 0.924 . . . . 71.04 110.846 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 265' ' ' GLU . . . . . 0.473 ' HB3' HD22 ' C' ' 261' ' ' LEU . 49.3 mm-40 -51.04 -63.5 1.11 Allowed 'General case' 0 C--N 1.353 0.724 0 CA-C-N 114.416 -1.265 . . . . 65.11 110.538 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 266' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -55.58 -38.68 69.7 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.365 1.066 . . . . 64.21 111.58 -173.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -58.01 -51.31 70.18 Favored 'General case' 0 C--O 1.248 1.008 0 O-C-N 123.606 0.566 . . . . 70.32 111.427 177.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 268' ' ' LEU . . . . . 0.652 ' HB2' HD21 ' A' ' 272' ' ' LEU . 10.6 mp -64.68 -39.8 94.29 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 119.288 -0.387 . . . . 52.44 111.332 178.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -58.88 -36.64 74.98 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 122.854 0.462 . . . . 61.11 111.683 176.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 270' ' ' LYS . . . . . 0.504 ' HA ' HG21 ' A' ' 206' ' ' VAL . 9.5 mtpm? -72.71 -34.96 67.47 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.244 0.618 . . . . 75.43 111.352 178.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 271' ' ' LYS . . . . . 0.403 ' HA ' ' HD3' ' C' ' 271' ' ' LYS . 69.3 mmtt -68.17 -32.83 73.36 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 123.108 0.255 . . . . 75.33 111.627 175.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 272' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' C' ' 268' ' ' LEU . 68.6 mt -67.89 -41.56 82.57 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.202 0.601 . . . . 74.33 109.622 173.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -62.68 -38.61 91.03 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 115.732 -0.667 . . . . 34.13 111.227 176.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -66.22 -37.51 85.71 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.781 0.832 . . . . 63.21 110.756 176.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -62.9 -35.25 79.43 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.891 0.476 . . . . 70.04 111.046 173.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 276' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -69.97 -45.76 66.7 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.559 -0.746 . . . . 75.52 112.179 175.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -63.84 -33.98 76.89 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-O 121.066 0.46 . . . . 44.24 109.801 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -63.29 -17.21 62.28 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 114.882 -1.054 . . . . 55.2 112.659 178.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 279' ' ' ARG . . . . . . . . . . . . . 70.3 mtm180 -73.21 -24.46 60.52 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 122.486 0.314 . . . . 71.52 111.298 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.558 1.255 0 CA-C-O 118.459 -0.781 . . . . 75.14 109.771 -176.481 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.575 ' SD ' ' HG2' ' A' ' 95' ' ' GLU . 1.3 mpt? . . . . . 0 N--CA 1.488 1.451 0 N-CA-C 111.108 0.04 . . . . 64.12 111.108 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 54.23 29.12 10.07 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.318 1.447 . . . . 51.4 112.938 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.32 77.49 4.81 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.13 0.572 . . . . 74.04 110.105 -176.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.5 tmmm? -38.14 105.35 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.93 1.692 . . . . 62.43 112.63 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.638 ' HB3' HD11 ' A' ' 10' ' ' ILE . 48.8 mtpt -97.92 109.32 22.1 Favored 'General case' 0 C--O 1.244 0.782 0 N-CA-C 107.882 -1.155 . . . . 74.32 107.882 172.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.516 ' HA ' ' OH ' ' A' ' 66' ' ' TYR . 24.9 t70 -70.98 109.33 5.03 Favored 'General case' 0 C--N 1.351 0.657 0 N-CA-C 108.101 -1.074 . . . . 61.41 108.101 173.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -65.65 -32.23 73.68 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-N 115.114 -0.948 . . . . 73.34 111.998 -170.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -63.25 -43.49 97.87 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 109.846 -0.427 . . . . 73.33 109.846 173.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.4 -45.86 90.31 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.52 0.728 . . . . 60.32 111.337 178.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.638 HD11 ' HB3' ' A' ' 5' ' ' LYS . 66.1 mt -56.09 -45.02 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 O-C-N 123.903 0.752 . . . . 74.23 110.613 177.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.514 HD13 HG23 ' A' ' 22' ' ' ILE . 69.1 mt -69.74 -23.19 63.35 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 115.644 -0.707 . . . . 51.33 112.207 176.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.78 44.4 7.24 Favored Glycine 0 C--N 1.349 1.253 0 O-C-N 123.182 0.301 . . . . 53.33 112.976 -176.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.0 m -138.17 152.62 72.07 Favored Pre-proline 0 N--CA 1.486 1.326 0 C-N-CA 124.658 1.183 . . . . 71.43 109.839 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -59.26 157.3 30.99 Favored 'Trans proline' 0 C--N 1.384 2.397 0 C-N-CA 122.799 2.333 . . . . 50.12 112.366 177.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 10.9 mtm105 -72.68 8.71 1.35 Allowed 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 113.676 0.991 . . . . 75.43 113.676 -167.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -129.45 14.66 6.06 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.073 0.949 . . . . 64.11 109.474 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.76 131.78 51.79 Favored 'General case' 0 C--N 1.35 0.61 0 C-N-CA 124.273 1.029 . . . . 64.31 111.361 -176.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.1 p -71.98 162.63 29.17 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.568 0.747 . . . . 71.11 110.594 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 8.6 tm0? -55.23 -31.57 61.6 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.096 0.958 . . . . 64.21 110.301 178.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -62.93 -51.11 68.21 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 125.033 1.333 . . . . 72.43 110.481 177.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -71.97 -32.36 67.18 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.613 0.765 . . . . 64.03 111.361 -178.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.599 HD13 ' HB3' ' A' ' 57' ' ' LEU . 61.4 mt -70.66 -30.71 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.269 1.427 . . . . 73.31 110.116 176.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.428 ' HG2' ' HE2' ' A' ' 27' ' ' LYS . 13.7 ttmm -69.74 -44.82 69.46 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.745 0.818 . . . . 71.24 109.114 174.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 71.4 mtp180 -59.62 -42.06 91.81 Favored 'General case' 0 N--CA 1.485 1.275 0 O-C-N 123.981 0.801 . . . . 54.12 111.008 176.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.25 -39.22 75.13 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.783 0.833 . . . . 64.0 111.297 -178.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -60.44 -54.78 41.46 Favored 'General case' 0 C--O 1.216 -0.662 0 CA-C-N 114.917 -1.038 . . . . 73.1 109.361 176.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.428 ' HE2' ' HG2' ' A' ' 23' ' ' LYS . 68.4 mttm -56.75 -42.17 78.86 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.892 0.877 . . . . 74.22 110.964 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -55.7 -55.96 26.03 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.672 0.789 . . . . 71.15 110.855 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.593 ' HB3' HD13 ' A' ' 50' ' ' ILE . 95.3 mt -79.25 -15.17 58.41 Favored 'General case' 0 CA--C 1.555 1.137 0 CA-C-N 115.471 -0.786 . . . . 74.11 111.579 -176.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.66 -20.5 33.46 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.983 0.913 . . . . 63.3 110.985 175.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 28.3 mtm180 -96.55 -25.36 15.65 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.591 0.757 . . . . 72.33 110.164 172.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -69.07 -65.75 0.67 Allowed 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 107.964 -1.124 . . . . 63.33 107.964 176.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -92.89 29.91 1.71 Allowed 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.061 0.544 . . . . 63.25 110.896 -177.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.406 ' CE1' ' HB3' ' A' ' 36' ' ' ASP . 9.4 t-160 -52.71 99.91 0.22 Allowed Pre-proline 0 N--CA 1.486 1.366 0 C-N-CA 125.52 1.528 . . . . 63.41 112.365 -170.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -60.95 -17.88 54.05 Favored 'Trans proline' 0 C--N 1.384 2.415 0 C-N-CA 123.336 2.691 . . . . 74.13 113.914 -171.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.406 ' HB3' ' CE1' ' A' ' 34' ' ' HIS . 32.1 t70 -66.98 -39.17 87.12 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.447 0.699 . . . . 72.45 111.862 176.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 82.2 t -102.28 -52.09 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 123.174 0.589 . . . . 65.53 109.624 -178.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -96.71 87.51 4.36 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 124.166 0.986 . . . . 61.35 109.568 -178.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -84.39 49.19 1.63 Allowed 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 115.439 -0.8 . . . . 73.11 110.653 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 74.0 m -91.94 115.62 64.96 Favored Pre-proline 0 N--CA 1.471 0.59 0 CA-C-O 118.054 -0.974 . . . . 54.41 108.548 176.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.403 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 85.2 Cg_exo -44.77 -49.6 9.34 Favored 'Trans proline' 0 C--N 1.384 2.439 0 C-N-CA 123.756 2.971 . . . . 72.23 113.295 -176.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -54.8 -43.32 72.78 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.963 0.905 . . . . 64.43 111.312 178.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.94 -27.68 64.95 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.513 -0.767 . . . . 72.14 110.926 -177.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.441 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 50.1 mt-10 -84.0 -29.98 26.54 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.173 0.589 . . . . 62.01 110.47 -175.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 41' ' ' PRO . 44.6 mt-10 -77.54 -38.45 48.67 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.186 0.595 . . . . 62.44 109.991 177.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -66.14 -34.24 77.59 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.855 -0.611 . . . . 74.03 109.766 170.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.805 ' HA ' HD12 ' A' ' 50' ' ' ILE . 88.0 t80 -62.04 -37.22 84.11 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 122.879 0.472 . . . . 73.24 110.475 172.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 44' ' ' GLU . 97.7 mttt -64.89 -35.12 80.13 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.723 0.409 . . . . 75.14 111.327 174.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -69.88 -29.9 67.22 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 122.421 0.288 . . . . 71.44 111.753 175.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.805 HD12 ' HA ' ' A' ' 47' ' ' PHE . 47.3 mt -70.43 -40.91 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 123.405 0.682 . . . . 70.53 109.794 173.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.413 ' HB3' ' HD1' ' A' ' 88' ' ' PHE . 3.2 m-20 -74.25 -20.15 60.26 Favored 'General case' 0 C--O 1.21 -0.99 0 C-N-CA 123.747 0.819 . . . . 73.43 110.934 176.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -74.92 -48.59 23.82 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.682 1.193 . . . . 63.42 109.564 174.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.25 -47.18 87.22 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 113.674 -1.603 . . . . 65.45 110.691 177.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 45.4 t80 -73.92 -23.6 59.56 Favored 'General case' 0 C--O 1.216 -0.661 0 CA-C-N 114.9 -1.045 . . . . 72.32 110.249 176.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.437 ' HA ' ' CD2' ' A' ' 88' ' ' PHE . . . -56.35 -50.82 70.4 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 118.357 0.526 . . . . 53.01 110.272 172.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.405 HG13 ' HZ ' ' A' ' 101' ' ' PHE . 38.3 t -64.46 -51.77 63.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 O-C-N 124.588 1.18 . . . . 74.52 110.409 177.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.599 ' HB3' HD13 ' A' ' 22' ' ' ILE . 45.1 mt -94.05 13.07 24.15 Favored 'General case' 0 CA--C 1.565 1.555 0 N-CA-C 113.095 0.776 . . . . 62.04 113.095 -166.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.1 t -66.77 -63.05 1.15 Allowed 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 123.668 0.787 . . . . 74.34 112.135 175.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.607 ' HB2' ' HD3' ' A' ' 62' ' ' LYS . 9.0 m-20 -100.64 145.53 30.49 Favored Pre-proline 0 N--CA 1.475 0.816 0 CA-C-O 118.478 -0.773 . . . . 74.34 110.046 -173.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.421 ' O ' ' HG2' ' A' ' 64' ' ' ARG . 19.8 Cg_endo -56.65 -32.25 89.96 Favored 'Trans proline' 0 C--N 1.384 2.404 0 C-N-CA 123.427 2.751 . . . . 72.41 113.294 -175.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -66.12 -47.67 73.37 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.707 0.803 . . . . 72.3 111.855 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.607 ' HD3' ' HB2' ' A' ' 59' ' ' ASP . 32.1 mtpt -74.59 -33.49 62.65 Favored 'General case' 0 C--O 1.252 1.209 0 C-N-CA 123.958 0.903 . . . . 74.54 110.641 -176.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 22.2 tpt85 -52.9 -51.39 61.35 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 113.922 -1.49 . . . . 74.11 108.827 167.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.421 ' HG2' ' O ' ' A' ' 60' ' ' PRO . 4.7 mmp_? -59.7 -38.97 83.07 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 123.802 0.689 . . . . 74.25 111.644 176.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.577 HG23 ' HD2' ' A' ' 76' ' ' PRO . 87.2 mt -54.96 -45.34 76.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 C-N-CA 122.681 0.392 . . . . 64.42 110.512 178.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.516 ' OH ' ' HA ' ' A' ' 6' ' ' ASP . 5.2 t80 -65.44 -49.22 69.96 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 120.77 -0.372 . . . . 75.4 110.813 175.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -57.8 -35.52 70.94 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.347 0.659 . . . . 64.04 112.062 -176.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 61.0 p -75.82 -32.27 59.76 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.044 0.538 . . . . 75.13 110.213 177.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -69.31 110.15 4.5 Favored 'General case' 0 C--N 1.359 0.992 0 N-CA-C 108.865 -0.791 . . . . 63.45 108.865 176.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 108.39 15.4 14.0 Favored Glycine 0 C--N 1.342 0.908 0 CA-C-N 115.905 -0.589 . . . . 52.54 112.151 -171.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 43.7 m -142.83 -57.17 0.43 Allowed 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 104.95 -2.241 . . . . 71.23 104.95 176.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.9 m -89.79 146.72 24.27 Favored 'General case' 0 C--O 1.25 1.121 0 N-CA-C 104.438 -2.43 . . . . 74.23 104.438 156.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.54 -35.56 19.45 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 109.981 -0.377 . . . . 74.04 109.981 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -84.02 131.05 52.47 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 123.85 0.86 . . . . 75.1 110.373 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -64.99 133.48 36.0 Favored 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 122.465 2.11 . . . . 75.41 110.717 173.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.577 ' HD2' HG23 ' A' ' 65' ' ' ILE . 58.7 Cg_exo -44.97 143.89 4.15 Favored 'Trans proline' 0 C--N 1.382 2.298 0 C-N-CA 124.211 3.274 . . . . 74.25 114.404 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -42.97 130.35 5.76 Favored 'Trans proline' 0 C--N 1.387 2.554 0 C-N-CA 124.115 3.21 . . . . 62.44 113.383 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -49.06 119.75 4.76 Favored 'Trans proline' 0 C--N 1.386 2.512 0 C-N-CA 123.378 2.719 . . . . 43.51 112.559 -177.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -51.91 164.15 1.17 Allowed 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 123.648 2.899 . . . . 71.05 113.785 177.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -53.18 88.29 0.03 OUTLIER 'Trans proline' 0 C--N 1.384 2.397 0 C-N-CA 123.379 2.719 . . . . 51.35 113.498 178.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 133.92 -33.53 2.52 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-N 114.541 -1.209 . . . . 62.41 110.33 177.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 139.67 -171.41 23.8 Favored Glycine 0 C--N 1.34 0.752 0 N-CA-C 109.835 -1.306 . . . . 53.03 109.835 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -67.48 105.4 1.82 Allowed 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.274 -1.01 . . . . 74.41 108.274 167.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.465 ' HB3' ' HD2' ' A' ' 62' ' ' LYS . 9.4 t70 -63.87 144.69 56.87 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 122.951 0.5 . . . . 71.31 112.186 -176.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.444 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 67.7 m-85 -139.37 71.11 1.37 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.917 0.887 . . . . 70.22 109.886 174.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.526 ' HA ' ' O ' ' A' ' 162' ' ' PRO . 51.0 m -59.99 85.36 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.244 0 CA-C-N 114.787 -1.097 . . . . 74.44 112.863 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 95.73 11.63 54.84 Favored Glycine 0 C--N 1.35 1.349 0 CA-C-N 115.646 -0.706 . . . . 70.11 113.972 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.444 ' HB2' ' HB3' ' A' ' 85' ' ' PHE . 26.7 m-85 -123.65 114.05 19.47 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 117.951 0.876 . . . . 72.34 110.575 -170.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -80.37 83.25 6.24 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-O 121.401 0.619 . . . . 71.44 110.504 -174.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.825 HG21 HD22 ' A' ' 105' ' ' LEU . 1.6 p -49.21 -42.21 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 N-CA-C 114.543 1.312 . . . . 75.21 114.543 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -66.07 -18.63 65.47 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 120.897 0.379 . . . . 75.33 111.01 -176.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -95.38 -7.24 39.05 Favored 'General case' 0 CA--C 1.559 1.298 0 C-N-CA 123.659 0.783 . . . . 45.35 111.167 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 21.6 m-30 -87.77 -172.46 3.87 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 123.491 0.716 . . . . 71.01 111.87 -177.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 86.1 p -74.78 166.68 23.22 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 113.349 0.87 . . . . 74.5 113.349 -169.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.575 ' HG2' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -61.03 -49.42 77.46 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 114.96 -1.018 . . . . 74.31 111.789 178.097 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -58.94 -40.0 83.3 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.597 0.759 . . . . 75.03 110.718 -175.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -62.63 -49.5 74.94 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.423 -1.262 . . . . 63.23 110.195 176.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.538 ' HA ' HD11 ' A' ' 105' ' ' LEU . 46.3 mt-30 -77.86 -4.37 46.34 Favored 'General case' 0 CA--C 1.552 1.038 0 CA-C-N 115.482 -0.781 . . . . 73.05 112.735 -178.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -92.54 -50.24 5.71 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.628 0.771 . . . . 70.02 109.918 172.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 26.0 tp -58.94 -54.85 42.47 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.1 0.96 . . . . 55.03 110.581 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.405 ' HZ ' HG13 ' A' ' 56' ' ' VAL . 88.5 m-85 -87.48 -1.54 58.0 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 115.801 -0.636 . . . . 72.11 111.098 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -41.28 -58.37 2.87 Favored Glycine 0 N--CA 1.482 1.74 0 N-CA-C 115.879 1.112 . . . . 72.43 115.879 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -50.35 -20.15 5.49 Favored 'Trans proline' 0 C--N 1.385 2.467 0 C-N-CA 124.318 3.346 . . . . 23.1 115.216 -177.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -141.59 31.89 2.09 Favored Glycine 0 C--N 1.355 1.632 0 CA-C-O 119.239 -0.756 . . . . 44.4 113.901 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.825 HD22 HG21 ' A' ' 90' ' ' VAL . 39.8 mt -66.68 78.19 0.11 Allowed 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 117.746 0.773 . . . . 74.25 112.028 171.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.438 ' HB2' ' HA ' ' A' ' 169' ' ' ASN . 24.5 m-85 36.5 -108.68 0.05 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.202 1.401 . . . . 72.25 114.78 177.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 59.77 16.12 37.06 Favored Glycine 0 C--N 1.36 1.916 0 N-CA-C 111.256 -0.738 . . . . 44.0 111.256 -160.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 52.61 -123.27 22.55 Favored Glycine 0 C--N 1.36 1.887 0 O-C-N 124.321 0.66 . . . . 71.34 112.612 -164.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -98.69 -1.84 39.71 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.95 0.9 . . . . 64.11 110.599 176.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -85.12 -30.14 26.36 Favored Glycine 0 C--N 1.346 1.127 0 CA-C-N 116.376 -0.374 . . . . 55.25 112.317 177.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 65.3 -4.0 0.58 Allowed 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 114.704 1.372 . . . . 71.44 114.704 173.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.33 -30.11 68.13 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.946 0.899 . . . . 73.25 110.918 172.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 70.1 m 78.83 68.9 0.04 OUTLIER 'General case' 0 C--N 1.354 0.763 0 C-N-CA 125.102 1.361 . . . . 74.21 111.657 177.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -133.18 161.73 33.65 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 115.464 -0.789 . . . . 74.52 109.887 177.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 43.4 tttp -63.66 145.19 56.19 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 123.902 0.881 . . . . 72.15 113.01 -165.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -85.34 -177.76 50.65 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-N 115.566 -0.743 . . . . 55.22 113.725 178.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.56 ' H ' ' HA3' ' A' ' 166' ' ' GLY . 22.1 ttm180 -94.19 164.52 13.02 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.186 1.394 . . . . 71.34 110.362 176.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.421 ' N ' ' HG2' ' A' ' 117' ' ' ARG . 7.9 p-10 -82.95 124.8 30.72 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 108.221 -1.029 . . . . 74.23 108.221 164.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 10.5 tt -122.75 121.31 36.02 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.42 -1.326 . . . . 70.23 107.42 -172.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.543 ' HA ' ' HB2' ' A' ' 175' ' ' LEU . 3.7 tmt_? -92.21 110.62 22.01 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 109.001 -0.74 . . . . 74.51 109.001 -177.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -111.21 171.93 7.18 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.265 1.026 . . . . 41.51 109.564 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.463 ' HA ' ' O ' ' A' ' 177' ' ' VAL . 68.0 mt-10 -121.75 125.84 47.51 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 109.0 -0.741 . . . . 61.0 109.0 -177.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 46.2 tp -98.79 100.91 10.58 Favored Pre-proline 0 N--CA 1.471 0.614 0 N-CA-C 107.307 -1.368 . . . . 54.05 107.307 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.598 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 55.4 Cg_endo -71.37 113.45 3.62 Favored 'Trans proline' 0 C--N 1.373 1.839 0 N-CA-C 108.587 -1.351 . . . . 75.33 108.587 176.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.494 ' HB3' HD23 ' A' ' 180' ' ' LEU . 47.1 tp -122.85 134.57 54.39 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 119.021 0.828 . . . . 64.01 111.067 -171.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.542 ' HA ' HD12 ' A' ' 181' ' ' LEU . 22.8 m -64.81 134.67 54.59 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 114.275 -1.329 . . . . 71.34 110.333 176.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 47.3 mt -59.55 -38.46 81.13 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 122.927 0.491 . . . . 70.54 111.524 -174.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -59.17 -42.56 91.05 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.385 0.674 . . . . 75.32 109.558 177.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.576 ' HG2' ' HB3' ' B' ' 4' ' ' SER . 50.0 mm-40 -65.78 -37.36 86.1 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.926 0.89 . . . . 64.33 111.768 173.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -66.07 -30.22 70.7 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 121.088 0.47 . . . . 41.43 110.838 -177.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -78.58 -59.78 2.64 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 115.016 -0.993 . . . . 74.51 110.551 177.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 44.7 m80 -75.87 -44.55 40.12 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.33 0.652 . . . . 75.25 112.323 -167.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.423 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 85.7 -170.05 43.55 Favored Glycine 0 N--CA 1.477 1.377 0 N-CA-C 114.117 0.407 . . . . 71.54 114.117 176.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 108.16 -166.68 13.06 Favored Glycine 0 C--N 1.353 1.51 0 C-N-CA 123.077 0.37 . . . . 70.42 113.019 177.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -70.7 105.83 3.32 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 122.957 0.503 . . . . 73.14 110.598 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 3.1 tpp180 -94.26 120.12 34.04 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 109.124 -0.695 . . . . 74.4 109.124 171.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 58.1 t -84.07 115.02 25.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 N-CA-C 107.889 -1.152 . . . . 71.24 107.889 173.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.443 HG13 HG13 ' A' ' 145' ' ' VAL . 2.7 p -129.44 129.92 67.19 Favored 'Isoleucine or valine' 0 C--O 1.246 0.916 0 C-N-CA 123.593 0.757 . . . . 73.14 109.754 -177.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -92.86 144.5 25.22 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.223 1.009 . . . . 71.3 110.189 -177.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.611 ' HB ' ' HB3' ' B' ' 8' ' ' LEU . 6.6 p -162.68 105.79 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 120.933 0.397 . . . . 75.1 111.07 174.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 57.84 34.23 24.13 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.092 0.957 . . . . 74.24 111.473 178.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 95.41 -19.68 53.1 Favored Glycine 0 C--N 1.35 1.311 0 CA-C-N 115.796 -0.638 . . . . 31.1 113.29 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 18.3 tpt85 -76.26 103.26 6.2 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.878 0.871 . . . . 72.12 110.503 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -87.87 97.22 10.81 Favored 'General case' 0 C--O 1.243 0.732 0 C-N-CA 123.873 0.869 . . . . 74.41 109.386 173.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.443 HG13 HG13 ' A' ' 138' ' ' VAL . 3.6 p -102.47 125.3 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-O 121.209 0.528 . . . . 73.53 110.14 177.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 34.6 t -91.48 83.97 5.48 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 108.189 -1.041 . . . . 31.45 108.189 174.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.7 p -92.5 123.56 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 115.703 -0.681 . . . . 73.42 109.705 -176.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 24.2 ttm180 -71.52 107.31 4.35 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.158 0.504 . . . . 74.14 110.037 174.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.423 HG13 ' HA2' ' A' ' 133' ' ' GLY . 20.2 pt -76.96 126.03 86.13 Favored Pre-proline 0 CA--C 1.555 1.172 0 CA-C-N 114.9 -1.045 . . . . 74.13 109.073 170.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -64.12 132.11 32.99 Favored 'Trans proline' 0 C--N 1.37 1.706 0 C-N-CA 122.493 2.128 . . . . 60.34 112.169 176.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -56.91 109.78 0.5 Allowed 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 122.888 2.392 . . . . 74.15 111.499 172.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.42 ' HA3' ' HD2' ' A' ' 241' ' ' PRO . . . 97.2 48.78 1.98 Allowed Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.844 -0.503 . . . . 75.51 111.844 -174.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 4.5 p -96.61 137.85 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.564 0.745 . . . . 75.43 109.507 177.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.414 ' HG2' ' HA ' ' A' ' 191' ' ' GLN . 0.0 OUTLIER -116.48 168.18 10.39 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.613 0.765 . . . . 73.23 111.519 -169.528 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.52 ' HB3' ' HA ' ' A' ' 189' ' ' GLU . 15.9 tp10 -56.61 129.91 42.98 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.594 0.758 . . . . 72.32 111.165 177.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 78.08 10.96 85.83 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-N 115.548 -0.751 . . . . 14.21 114.235 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 10.7 t -75.18 129.85 38.2 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 118.015 0.908 . . . . 74.23 108.665 175.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 21.7 t -108.61 114.78 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 123.199 0.6 . . . . 72.34 110.7 -167.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.553 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 48.4 mt -93.93 92.35 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 107.212 -1.403 . . . . 75.24 107.212 169.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 31.5 ttt180 -74.2 100.39 3.67 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 109.422 -0.584 . . . . 61.32 109.422 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.2 p -126.35 99.35 30.82 Favored Pre-proline 0 CA--C 1.557 1.239 0 C-N-CA 124.129 0.972 . . . . 61.33 110.427 -176.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.526 ' O ' ' HA ' ' A' ' 86' ' ' SER . 65.1 Cg_exo -50.56 158.02 3.04 Favored 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 123.062 2.508 . . . . 74.53 114.186 172.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 108.96 -26.82 14.26 Favored Glycine 0 N--CA 1.48 1.571 0 N-CA-C 113.872 0.309 . . . . 70.43 113.872 169.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.425 ' HB2' HD22 ' A' ' 174' ' ' LEU . 63.7 mtm -118.67 -0.04 11.39 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 122.608 0.363 . . . . 64.15 110.891 -177.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -88.17 -106.9 0.99 Allowed Glycine 0 C--N 1.351 1.379 0 N-CA-C 111.025 -0.83 . . . . 73.33 111.025 175.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.56 ' HA3' ' H ' ' A' ' 117' ' ' ARG . . . -69.1 117.73 8.18 Favored Glycine 0 C--O 1.251 1.196 0 N-CA-C 111.589 -0.604 . . . . 74.5 111.589 171.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -75.17 104.78 5.88 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 109.218 -0.66 . . . . 75.42 109.218 -175.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -169.92 158.21 30.18 Favored Glycine 0 C--N 1.339 0.725 0 N-CA-C 110.826 -0.91 . . . . 64.21 110.826 -176.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . 0.527 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . 54.0 t30 -61.59 -62.82 5.15 Favored Pre-proline 0 N--CA 1.488 1.43 0 CA-C-O 117.438 -1.268 . . . . 63.11 110.619 -169.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.527 ' HD3' ' HB3' ' A' ' 169' ' ' ASN . 21.2 Cg_exo -63.1 109.32 0.92 Allowed 'Trans proline' 0 C--N 1.391 2.779 0 CA-C-N 122.487 1.924 . . . . 71.13 107.789 162.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -60.3 128.46 26.31 Favored 'Trans proline' 0 CA--C 1.55 1.301 0 C-N-CA 123.379 2.719 . . . . 71.25 113.622 -163.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -77.34 136.85 19.43 Favored Glycine 0 C--N 1.358 1.752 0 N-CA-C 111.377 -0.689 . . . . 72.4 111.377 175.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.497 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 15.1 m-20 -61.98 128.81 37.94 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.935 0.894 . . . . 71.14 112.034 -172.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.425 HD22 ' HB2' ' A' ' 164' ' ' MET . 49.6 tp -102.69 107.84 18.88 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.887 -0.783 . . . . 64.32 108.887 169.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.543 ' HB2' ' HA ' ' A' ' 120' ' ' ARG . 42.7 mt -79.3 94.21 5.43 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 108.663 -0.866 . . . . 72.12 108.663 176.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.553 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 91.8 mt -74.22 82.13 1.83 Allowed 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 109.468 -0.567 . . . . 70.05 109.468 175.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 122' ' ' GLU . 11.8 t -87.87 103.7 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 N-CA-C 107.261 -1.385 . . . . 61.43 107.261 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 8.1 p -73.91 119.15 20.57 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.219 0 N-CA-C 113.39 0.885 . . . . 70.33 113.39 -165.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.598 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 20.8 mmt180 -92.71 102.23 14.64 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.195 0.998 . . . . 53.32 109.437 170.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.494 HD23 ' HB3' ' A' ' 125' ' ' LEU . 96.0 mt -72.91 136.12 45.18 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 122.052 -0.405 . . . . 72.4 110.757 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.542 HD12 ' HA ' ' A' ' 126' ' ' THR . 85.5 mt -55.71 156.25 9.57 Favored Pre-proline 0 N--CA 1.484 1.247 0 C-N-CA 124.649 1.18 . . . . 73.14 112.507 -174.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -82.47 40.72 1.0 Allowed 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 122.943 2.429 . . . . 71.42 111.515 171.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.427 ' HA ' ' HD3' ' A' ' 184' ' ' PRO . 51.9 t-80 -62.24 125.44 85.57 Favored Pre-proline 0 CA--C 1.551 0.997 0 N-CA-C 107.615 -1.254 . . . . 73.35 107.615 172.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 183' ' ' HIS . 23.5 Cg_exo -66.17 23.85 0.09 OUTLIER 'Trans proline' 0 N--CA 1.502 2.014 0 C-N-CA 124.239 3.292 . . . . 61.24 118.289 -162.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 58.9 t -106.3 -59.32 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 120.294 1.406 . . . . 64.21 109.809 177.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . 0.506 ' CE1' ' HB2' ' A' ' 195' ' ' ALA . 21.6 m-85 -127.14 125.6 41.47 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.92 -0.582 . . . . 72.31 111.061 -172.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.427 HH22 ' HG2' ' A' ' 155' ' ' GLU . 0.0 OUTLIER -102.31 71.56 1.24 Allowed 'General case' 0 C--O 1.237 0.399 0 N-CA-C 106.452 -1.684 . . . . 75.51 106.452 171.316 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.438 ' HB2' HD23 ' A' ' 193' ' ' LEU . 7.4 tp -64.27 132.95 51.75 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 113.348 -1.751 . . . . 74.21 110.516 -176.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.52 ' HA ' ' HB3' ' A' ' 155' ' ' GLU . 11.9 tp10 -138.75 123.6 18.78 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.691 1.196 . . . . 70.31 109.643 -178.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 70.73 -75.04 0.58 Allowed Glycine 0 C--N 1.354 1.545 0 O-C-N 123.491 0.495 . . . . 65.41 113.694 175.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.414 ' HA ' ' HG2' ' A' ' 154' ' ' ARG . 2.9 pm0 -145.02 -14.29 0.53 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.669 1.188 . . . . 72.32 110.792 175.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.431 ' HB3' ' H ' ' A' ' 248' ' ' ASP . 2.6 p-10 -112.57 137.23 51.1 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.274 1.43 . . . . 72.32 112.708 -165.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.504 HD22 ' HB3' ' A' ' 186' ' ' PHE . 77.3 mt -88.84 159.85 17.51 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.836 1.254 . . . . 63.44 111.003 -173.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -130.78 101.59 5.72 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 108.256 -1.016 . . . . 73.14 108.256 169.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.506 ' HB2' ' CE1' ' A' ' 186' ' ' PHE . . . -104.75 148.14 26.93 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 108.806 -0.812 . . . . 74.34 108.806 175.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 26.1 m -86.87 141.45 28.77 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 109.601 -0.518 . . . . 70.21 109.601 175.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 56.4 tp -138.88 102.33 4.53 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.15 0.58 . . . . 72.21 109.548 -173.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -79.95 125.75 30.15 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 108.968 -0.753 . . . . 61.43 108.968 173.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.491 HG23 HG11 ' A' ' 210' ' ' VAL . 5.5 p -139.81 136.78 17.68 Favored Pre-proline 0 CA--C 1.55 0.956 0 C-N-CA 124.462 1.105 . . . . 64.4 108.626 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -77.58 155.32 31.57 Favored 'Trans proline' 0 C--N 1.368 1.595 0 C-N-CA 121.714 1.609 . . . . 64.51 112.483 173.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.417 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -58.1 -50.24 89.18 Favored Pre-proline 0 CA--C 1.552 1.038 0 N-CA-C 113.785 1.032 . . . . 71.34 113.785 -169.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.432 ' HG2' ' CE2' ' C' ' 276' ' ' TYR . 86.1 Cg_exo -55.02 -46.64 31.72 Favored 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 121.548 1.499 . . . . 63.54 113.426 176.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.438 HD11 ' HB3' ' C' ' 276' ' ' TYR . 40.5 mt -71.75 -24.03 22.83 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.28 0 C-N-CA 122.375 0.27 . . . . 64.32 110.492 -177.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -74.7 -47.03 33.81 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.121 0.569 . . . . 71.51 111.706 175.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 201' ' ' ALA . 90.3 t -70.91 -38.43 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 C-N-CA 123.736 0.814 . . . . 63.23 111.075 -176.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 55.3 t -89.76 -41.21 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 124.173 0.989 . . . . 74.41 111.782 -175.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 95.45 148.6 24.46 Favored Glycine 0 C--N 1.339 0.739 0 CA-C-N 115.581 -0.736 . . . . 72.35 111.339 -168.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 177.44 -142.67 5.82 Favored Glycine 0 C--N 1.333 0.399 0 N-CA-C 111.235 -0.746 . . . . 55.24 111.235 -177.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -125.76 123.41 38.76 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 117.277 0.538 . . . . 45.21 110.666 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.491 HG11 HG23 ' A' ' 199' ' ' VAL . 22.5 m -124.02 -171.47 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 125.425 1.49 . . . . 63.11 109.207 174.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -126.6 131.9 51.4 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.336 0.654 . . . . 71.41 111.525 178.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -114.02 166.31 11.74 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.395 1.078 . . . . 62.04 109.043 167.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 27.9 ttt -111.49 145.01 39.79 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 122.757 0.423 . . . . 71.23 110.486 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 17.4 p -114.05 -171.07 1.84 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.139 0.976 . . . . 74.1 108.868 171.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 83.5 mt -80.3 -5.24 55.97 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.93 0.715 . . . . 63.31 112.93 -175.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -139.91 9.74 2.38 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 112.848 0.685 . . . . 64.44 112.848 -177.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 154.07 175.83 25.75 Favored Glycine 0 N--CA 1.472 1.046 0 CA-C-O 119.382 -0.677 . . . . 33.0 112.413 177.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -81.65 175.79 9.12 Favored 'Trans proline' 0 C--N 1.362 1.288 0 C-N-CA 122.29 1.993 . . . . 70.23 112.559 178.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 3.2 m -148.77 132.78 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.096 1.358 . . . . 73.4 108.425 178.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.49 ' HB2' ' HA2' ' B' ' 436' ' ' GLY . 6.4 mm-40 -86.72 104.45 16.13 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.418 -0.956 . . . . 75.04 108.418 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 41.1 t -99.78 134.47 39.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 123.968 0.907 . . . . 74.13 110.721 -169.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -83.08 105.24 13.9 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 122.847 0.459 . . . . 60.25 109.815 174.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.558 ' HA ' HD12 ' B' ' 441' ' ' ILE . 11.5 p -79.23 139.97 56.56 Favored Pre-proline 0 CA--C 1.563 1.469 0 C-N-CA 124.35 1.06 . . . . 63.14 109.811 -178.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -82.04 178.68 6.18 Favored 'Trans proline' 0 C--N 1.384 2.426 0 C-N-CA 123.094 2.529 . . . . 75.51 111.806 -175.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -80.8 150.99 18.8 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 121.6 1.533 . . . . 72.53 112.387 171.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . 0.525 ' HB3' HE22 ' B' ' 35' ' ' GLN . 79.1 mtt85 67.01 25.15 9.34 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 125.159 1.383 . . . . 74.04 112.45 175.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.458 HG23 HD21 ' A' ' 233' ' ' LEU . 37.7 m -61.52 117.11 5.3 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 124.7 1.2 . . . . 64.32 110.466 175.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . 0.586 ' HG2' HH12 ' B' ' 221' ' ' ARG . 6.3 tp-100 -110.33 139.7 45.27 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.978 0.911 . . . . 75.32 112.161 -167.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -64.57 133.79 53.05 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.459 1.104 . . . . 62.31 111.772 -177.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . 0.521 ' HA3' HH12 ' C' ' 254' ' ' ARG . . . 93.19 -24.63 24.13 Favored Glycine 0 C--N 1.341 0.836 0 CA-C-N 115.85 -0.614 . . . . 73.32 112.803 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 67.6 mtt180 -72.32 147.28 46.49 Favored 'General case' 0 C--N 1.347 0.478 0 CA-C-O 121.41 0.624 . . . . 74.0 109.744 171.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.766 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 2.9 mptp? -106.29 119.34 39.0 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.254 -1.387 . . . . 72.22 107.254 174.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.555 HD13 HD13 ' B' ' 441' ' ' ILE . 70.6 mt -74.38 100.21 3.73 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.32 -0.993 . . . . 71.4 108.32 -177.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 66.1 ttt180 -76.6 104.61 7.19 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 124.07 0.856 . . . . 64.14 110.564 -172.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.675 HD21 HG23 ' B' ' 441' ' ' ILE . 49.2 mt -103.11 96.56 6.87 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.542 0.737 . . . . 61.12 110.694 -178.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 23.8 mtpp -74.52 138.26 43.01 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 122.707 0.403 . . . . 64.43 111.231 -177.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 82.81 16.73 69.55 Favored Glycine 0 C--N 1.346 1.086 0 CA-C-N 115.603 -0.726 . . . . 74.2 112.876 -174.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.623 ' HG3' ' HB3' ' A' ' 235' ' ' LEU . 0.0 OUTLIER -121.05 -17.73 7.7 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.276 0.63 . . . . 73.01 112.572 -174.256 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -78.69 -167.42 32.2 Favored Glycine 0 C--N 1.339 0.722 0 N-CA-C 111.904 -0.478 . . . . 74.43 111.904 171.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -86.01 151.4 54.54 Favored Pre-proline 0 CA--C 1.557 1.239 0 CA-C-O 118.895 -0.574 . . . . 73.13 109.509 -172.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.42 ' HD2' ' HA3' ' A' ' 152' ' ' GLY . 29.7 Cg_exo -38.91 107.92 0.07 OUTLIER 'Trans proline' 0 C--N 1.389 2.673 0 C-N-CA 124.675 3.583 . . . . 73.33 115.52 -179.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -133.92 -158.15 8.5 Favored Glycine 0 C--N 1.35 1.354 0 CA-C-O 119.255 -0.747 . . . . 73.52 112.33 -176.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -59.8 -39.65 70.69 Favored 'Trans proline' 0 C--N 1.383 2.357 0 C-N-CA 123.695 2.93 . . . . 70.45 113.595 -174.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -89.25 21.62 3.19 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.417 0.687 . . . . 70.11 111.567 -176.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 97.29 -74.44 0.67 Allowed Glycine 0 C--N 1.346 1.121 0 N-CA-C 109.794 -1.322 . . . . 62.24 109.794 -173.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 17.1 mtp180 -122.55 157.91 31.04 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.124 0.97 . . . . 75.41 108.675 168.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -79.43 -158.54 14.52 Favored Glycine 0 C--N 1.344 0.995 0 O-C-N 123.315 0.384 . . . . 42.24 113.486 176.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . 0.431 ' H ' ' HB3' ' A' ' 192' ' ' ASP . 7.4 m-20 -104.44 172.32 6.86 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.142 0.577 . . . . 75.44 110.019 -177.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.577 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 32.5 tp -136.65 97.5 3.56 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 107.831 -1.174 . . . . 70.31 107.831 175.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.766 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 62.2 m-85 -79.45 108.57 13.07 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.266 1.026 . . . . 52.51 110.091 178.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.5 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 88.6 mt -93.42 108.31 20.0 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 122.91 0.484 . . . . 72.24 110.061 176.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.538 ' HG2' ' HG3' ' A' ' 232' ' ' LYS . 35.5 mt-10 -77.67 102.64 7.17 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.531 1.132 . . . . 75.41 109.708 -172.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.417 HG12 HG13 ' A' ' 255' ' ' ILE . 42.9 t -67.93 126.07 26.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 115.008 -0.997 . . . . 24.43 111.619 -172.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -124.2 92.25 3.63 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 107.275 -1.38 . . . . 73.14 107.275 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.479 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 63.5 mt -82.79 127.69 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 122.815 0.446 . . . . 74.34 111.41 -173.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 69.1 p -111.07 154.68 23.89 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.291 1.036 . . . . 73.43 109.675 175.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.488 HD12 ' H ' ' A' ' 259' ' ' GLU . 2.5 pp -103.06 150.08 37.5 Favored Pre-proline 0 CA--C 1.558 1.263 0 C-N-CA 123.069 0.548 . . . . 73.4 109.653 175.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -51.7 -21.98 12.33 Favored 'Trans proline' 0 N--CA 1.509 2.394 0 C-N-CA 124.519 3.48 . . . . 74.45 115.133 -170.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.785 ' HG2' HE21 ' C' ' 228' ' ' GLN . 29.3 mt-10 52.17 -78.46 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.991 1.317 . . . . 63.24 111.548 -167.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.9 132.19 46.88 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.566 0.746 . . . . 75.12 111.332 176.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.588 HD22 ' HB2' ' A' ' 265' ' ' GLU . 96.2 mt -143.44 150.54 39.17 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.312 1.045 . . . . 55.32 109.723 176.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 20.9 p -118.64 156.69 51.23 Favored Pre-proline 0 CA--C 1.555 1.167 0 CA-C-O 117.774 -1.108 . . . . 44.34 109.204 170.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -21.12 -50.2 0.03 OUTLIER 'Trans proline' 0 C--N 1.401 3.322 1 C-N-CA 126.871 5.047 . . . . 74.33 117.433 -172.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -56.56 -69.44 0.15 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.314 0.646 . . . . 71.44 111.289 178.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . 0.588 ' HB2' HD22 ' A' ' 261' ' ' LEU . 2.1 mp0 -71.32 -28.75 64.32 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.601 0.36 . . . . 64.2 110.062 -172.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' GLU . . . . . 0.403 ' HA ' HD13 ' A' ' 261' ' ' LEU . 18.8 tp10 -55.86 -60.97 2.7 Favored 'General case' 0 C--O 1.255 1.345 0 C-N-CA 124.22 1.008 . . . . 73.45 110.467 175.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . 0.412 ' HB2' HH22 ' B' ' 373' ' ' ARG . . . -60.58 -38.01 83.22 Favored 'General case' 0 C--O 1.22 -0.472 0 CA-C-N 114.38 -1.282 . . . . 64.12 110.675 178.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . 0.483 HD21 ' HB2' ' C' ' 271' ' ' LYS . 11.8 tp -65.26 -40.1 93.52 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.106 0.962 . . . . 73.14 111.026 -174.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 44.4 m95 -69.41 -37.84 77.65 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.582 -0.736 . . . . 75.0 110.609 176.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . 0.666 ' HE2' ' HA ' ' C' ' 206' ' ' VAL . 1.1 mptm? -67.02 -39.47 87.05 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 123.473 0.483 . . . . 62.43 111.632 176.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -62.33 -48.83 78.07 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.089 0.556 . . . . 70.22 109.884 177.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 18.5 mt -54.36 -51.46 64.72 Favored 'General case' 0 C--O 1.203 -1.371 0 O-C-N 124.55 1.156 . . . . 63.4 110.446 173.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . 0.618 ' HA ' ' HB2' ' C' ' 202' ' ' PRO . . . -67.33 -39.95 85.89 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.697 0.999 . . . . 64.51 113.697 -168.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.508 ' HB3' HE21 ' B' ' 250' ' ' GLN . 41.6 mt-10 -86.86 -33.15 19.9 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.589 0.756 . . . . 74.35 110.996 -173.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -71.22 -33.21 69.69 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 109.916 -0.401 . . . . 71.44 109.916 169.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -67.35 -41.54 85.0 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.946 0.898 . . . . 75.02 109.453 174.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' TYR . . . . . 0.459 ' HE1' ' H ' ' C' ' 209' ' ' LYS . 25.2 t80 -62.62 -43.39 98.94 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 124.105 0.878 . . . . 70.12 108.783 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -66.55 -7.88 23.04 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-N 115.199 -0.909 . . . . 75.41 112.647 175.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 73.7 mmt-85 -127.79 13.95 6.91 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 123.885 0.874 . . . . 74.13 111.127 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.658 0 C-N-CA 122.847 0.459 . . . . 72.21 111.309 -173.864 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.0 ttt . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 109.577 -0.527 . . . . 71.44 109.577 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -101.06 -178.05 3.63 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.533 0.733 . . . . 54.1 111.038 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -59.85 103.17 0.19 Allowed 'General case' 0 C--N 1.354 0.777 0 C-N-CA 123.379 0.672 . . . . 74.04 109.375 176.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . 0.576 ' HB3' ' HG2' ' A' ' 129' ' ' GLU . 50.5 m -83.5 27.25 0.61 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.443 1.097 . . . . 52.14 112.163 -173.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 6.4 m -123.06 145.95 48.1 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 109.011 -0.737 . . . . 70.11 109.011 177.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 29.4 pt -140.18 177.76 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 C-N-CA 123.356 0.662 . . . . 64.44 111.75 -158.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -147.03 127.28 13.86 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.847 0.859 . . . . 72.01 110.053 178.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.611 ' HB3' ' HB ' ' A' ' 140' ' ' VAL . 19.3 tp -65.48 148.85 51.02 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.797 1.239 . . . . 75.22 112.196 -171.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.35 -49.56 33.27 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.522 0.729 . . . . 62.4 111.886 177.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 4.2 tt 60.48 102.6 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 124.594 1.158 . . . . 74.1 110.151 -173.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.413 ' HB2' ' O ' ' A' ' 120' ' ' ARG . 74.8 mt -121.93 122.32 27.75 Favored Pre-proline 0 N--CA 1.481 1.086 0 CA-C-O 118.24 -0.886 . . . . 45.35 109.738 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -37.53 -58.8 0.57 Allowed 'Trans proline' 0 C--N 1.387 2.56 0 C-N-CA 125.268 3.979 . . . . 61.33 114.728 -173.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . 0.55 HD13 ' HD3' ' A' ' 117' ' ' ARG . 2.2 pt? -177.44 121.34 0.12 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.853 0.861 . . . . 75.01 109.464 172.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -160.69 137.41 8.83 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.122 0.969 . . . . 64.54 109.905 177.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 34.0 p90 30.91 86.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 126.843 2.057 . . . . 60.01 114.623 -176.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 81.3 m -70.07 123.06 88.04 Favored Pre-proline 0 CA--C 1.554 1.105 0 CA-C-N 115.272 -0.876 . . . . 51.11 110.629 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -60.15 137.72 77.07 Favored 'Trans proline' 0 C--N 1.372 1.79 0 C-N-CA 123.201 2.601 . . . . 62.42 112.689 177.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 48.2 t -120.74 -44.66 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 123.422 0.689 . . . . 61.41 110.91 -175.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 46.3 p -70.79 116.0 10.59 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-O 121.004 0.431 . . . . 71.22 111.196 -176.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -79.53 -14.13 59.08 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.799 0.839 . . . . 62.34 110.758 177.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 63.44 68.72 0.59 Allowed 'General case' 0 C--N 1.358 0.968 0 C-N-CA 125.114 1.366 . . . . 75.34 110.967 176.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -91.91 165.53 13.18 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.15 -0.932 . . . . 73.31 109.438 176.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' THR . . . . . . . . . . . . . 48.4 m -66.6 116.8 38.14 Favored Pre-proline 0 CA--C 1.554 1.128 0 C-N-CA 123.036 0.534 . . . . 72.45 111.024 -178.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -90.12 -170.28 0.4 Allowed 'Trans proline' 0 C--N 1.373 1.818 0 C-N-CA 122.772 2.315 . . . . 74.55 111.935 176.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -78.3 154.52 30.83 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 109.395 -0.594 . . . . 74.53 109.395 175.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 61.3 mtt -111.77 98.07 39.97 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 123.229 0.612 . . . . 75.13 109.382 178.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -64.11 154.16 72.13 Favored 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 123.172 2.582 . . . . 71.1 112.796 176.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 14.0 p -65.7 -36.78 78.39 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 C-N-CA 122.756 0.422 . . . . 73.51 109.868 174.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.413 HD21 ' HB2' ' B' ' 32' ' ' ARG . 2.8 tt 59.53 -77.75 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 126.413 1.885 . . . . 62.2 111.726 170.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.462 ' HG2' ' HD2' ' B' ' 337' ' ' LYS . 42.3 mt-10 68.24 78.82 0.22 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.824 1.65 . . . . 70.24 112.39 178.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' ASN . . . . . 0.684 ' HB3' ' HA ' ' B' ' 34' ' ' ALA . 6.1 m120 55.88 97.66 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 125.656 1.582 . . . . 74.34 113.35 176.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' ARG . . . . . 0.418 ' NH2' ' HB3' ' B' ' 215' ' ' GLU . 33.6 ttt180 -64.98 99.14 0.33 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.466 1.106 . . . . 72.22 110.355 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . 0.579 ' HA ' ' HA2' ' B' ' 211' ' ' GLY . . . 64.25 13.11 7.69 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 125.073 1.349 . . . . 73.31 111.995 -175.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . 0.684 ' HA ' ' HB3' ' B' ' 31' ' ' ASN . . . 58.68 -77.18 0.02 OUTLIER 'General case' 0 C--N 1.36 1.043 0 C-N-CA 125.576 1.55 . . . . 53.33 111.698 -168.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . 0.525 HE22 ' HB3' ' A' ' 226' ' ' ARG . 18.0 pt20 -164.44 -46.5 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.152 0.981 . . . . 73.13 109.082 -178.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 138.04 -179.81 17.89 Favored Glycine 0 C--N 1.346 1.121 0 N-CA-C 110.977 -0.849 . . . . 74.33 110.977 -171.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -164.81 157.83 16.82 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.081 0.553 . . . . 61.44 110.668 -175.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . 0.551 HG12 ' HB2' ' C' ' 259' ' ' GLU . 36.6 mm -118.81 15.4 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 C-N-CA 123.803 0.841 . . . . 75.44 110.814 -175.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 29.8 p -120.55 -77.55 0.58 Allowed 'General case' 0 N--CA 1.484 1.254 0 O-C-N 120.719 -1.238 . . . . 64.25 109.9 171.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.423 ' HB3' ' HD3' ' B' ' 41' ' ' PRO . . . -176.97 -57.75 0.0 OUTLIER Pre-proline 0 CA--C 1.555 1.147 0 C-N-CA 124.725 1.21 . . . . 64.0 110.762 177.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . 0.423 ' HD3' ' HB3' ' B' ' 40' ' ' ALA . 25.4 Cg_endo -89.25 -17.64 1.87 Allowed 'Trans proline' 0 C--N 1.391 2.776 0 C-N-CA 121.714 1.609 . . . . 72.44 113.852 -172.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 130.89 -38.8 1.88 Allowed Glycine 0 C--N 1.342 0.917 0 N-CA-C 110.491 -1.044 . . . . 45.24 110.491 -167.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . 0.41 ' H ' ' HG2' ' B' ' 41' ' ' PRO . . . 82.42 -175.54 53.57 Favored Glycine 0 C--N 1.342 0.866 0 N-CA-C 112.174 -0.37 . . . . 42.15 112.174 -177.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . 0.412 ' HB3' ' HA ' ' C' ' 262' ' ' THR . . . -83.52 65.17 8.28 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.11 0.564 . . . . 63.2 110.953 -173.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -73.73 -4.99 37.86 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.357 0.663 . . . . 74.21 112.726 -172.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' ARG . . . . . 0.494 ' HB3' ' H ' ' B' ' 266' ' ' ASN . 0.0 OUTLIER -130.18 -179.1 5.04 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.086 0.954 . . . . 75.02 108.605 174.319 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.4 HD21 ' HB2' ' B' ' 449' ' ' ALA . 1.5 pt? -131.9 175.69 9.0 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.844 0.458 . . . . 53.22 111.199 -177.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 4.4 m -74.37 -28.99 61.36 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.106 -0.952 . . . . 51.22 111.033 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . 0.437 ' HA3' ' HB3' ' B' ' 267' ' ' SER . . . 65.76 -103.48 0.84 Allowed Glycine 0 C--N 1.349 1.295 0 CA-C-N 115.537 -0.756 . . . . 74.15 111.861 -176.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -167.98 -78.05 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.77 0.428 . . . . 64.2 110.317 173.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 8.3 tp60 -121.16 -49.69 2.17 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.224 0.61 . . . . 75.3 110.844 -174.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . 0.434 ' HA ' ' HB3' ' B' ' 287' ' ' PRO . 14.3 t -143.51 170.08 16.5 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.068 0.461 . . . . 73.31 111.591 -176.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -101.28 110.22 22.2 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.973 0.909 . . . . 73.24 109.527 178.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.2 158.02 32.07 Favored 'General case' 0 C--O 1.245 0.847 0 C-N-CA 123.452 0.701 . . . . 75.51 111.161 177.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.578 HD21 ' H ' ' B' ' 113' ' ' LYS . 24.7 tp -102.88 31.61 4.1 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.813 1.245 . . . . 72.35 108.381 -179.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . 0.724 HH21 ' HA ' ' B' ' 464' ' ' MET . 25.7 ttm180 67.6 164.1 0.21 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.724 1.21 . . . . 73.2 108.561 -155.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . 0.496 ' N ' ' HG2' ' B' ' 56' ' ' ARG . 3.9 m-20 -65.1 89.58 0.08 Allowed 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 124.061 0.945 . . . . 75.31 111.542 -177.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . 0.655 ' HA ' ' HB2' ' B' ' 313' ' ' GLN . 19.3 m -82.57 -52.7 6.58 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.971 0.908 . . . . 62.01 111.311 -174.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . 0.432 ' HB3' HG21 ' B' ' 306' ' ' VAL . 62.2 tp -75.42 -33.58 60.95 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.988 -0.551 . . . . 72.44 109.987 176.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 22.0 m 58.6 -152.17 0.41 Allowed 'General case' 0 CA--C 1.557 1.25 0 C-N-CA 124.199 1.0 . . . . 63.51 111.201 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . 0.405 ' HA ' ' HA ' ' B' ' 308' ' ' CYS . 20.1 t70 -84.19 -68.67 0.7 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.534 0.734 . . . . 71.45 109.134 168.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' LYS . . . . . . . . . . . . . 8.1 mtmp? -124.8 105.4 29.77 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 124.247 1.019 . . . . 72.3 108.314 174.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.25 159.12 54.15 Favored 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 122.742 2.295 . . . . 72.24 111.25 177.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.11 -154.27 0.37 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.537 0.735 . . . . 72.04 110.437 -174.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 42.4 mttp 63.99 92.05 0.07 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 124.132 0.973 . . . . 65.32 110.731 172.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 50.3 t30 72.9 -55.84 0.67 Allowed 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 124.906 1.282 . . . . 72.41 109.583 -170.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . 0.501 HG22 HD12 ' B' ' 68' ' ' ILE . 23.6 mm -58.81 141.13 16.19 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.105 0 C-N-CA 124.558 1.143 . . . . 72.03 109.067 168.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . 0.501 HD12 HG22 ' B' ' 67' ' ' ILE . 2.2 mp 69.51 132.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 C-N-CA 124.513 1.125 . . . . 73.4 108.587 -163.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.436 ' HB3' ' O ' ' B' ' 96' ' ' GLY . 68.3 mt 66.37 9.75 6.69 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 125.284 1.434 . . . . 73.12 111.86 -169.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 7.1 tt -83.15 -44.34 15.18 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 109.482 -0.562 . . . . 44.44 109.482 -176.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 47.1 mm 65.14 -77.12 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.067 0 C-N-CA 124.824 1.25 . . . . 74.32 109.893 -174.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 64.46 31.92 82.49 Favored Glycine 0 C--N 1.355 1.613 0 C-N-CA 122.949 0.309 . . . . 62.21 113.65 177.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -96.32 161.2 14.04 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.532 0.733 . . . . 63.44 110.127 -176.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -70.73 -12.83 71.14 Favored Glycine 0 C--N 1.347 1.174 0 CA-C-N 116.086 -0.506 . . . . 64.42 113.039 176.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 45.0 mtm 65.41 16.82 10.72 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 125.232 1.413 . . . . 74.01 112.126 173.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 66.7 62.74 4.33 Favored Glycine 0 C--N 1.343 0.961 0 CA-C-N 115.961 -0.563 . . . . 71.13 112.89 -178.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 9.3 t70 68.81 -82.04 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.352 1.061 . . . . 73.03 110.811 175.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . 0.484 ' H ' ' HE1' ' B' ' 424' ' ' TYR . 12.0 t 56.29 50.45 13.3 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 125.089 1.356 . . . . 51.1 112.241 176.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.34 -3.55 8.46 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 123.693 0.797 . . . . 74.44 113.122 178.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 38.8 mm -44.21 -42.66 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 125.509 1.524 . . . . 72.52 111.581 177.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 35.6 m -131.68 94.17 3.47 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-N 115.377 -0.829 . . . . 71.34 109.032 172.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.43 84.16 2.53 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 115.493 -0.776 . . . . 61.11 108.996 172.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.54 84.9 0.61 Allowed 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.254 -0.885 . . . . 71.35 109.556 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 65.0 -75.25 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.531 1.532 . . . . 73.0 109.967 -168.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -133.36 -55.43 0.91 Allowed 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 106.806 -1.553 . . . . 72.23 106.806 170.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -159.44 108.25 1.83 Allowed 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.438 1.495 . . . . 63.12 107.285 174.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -131.98 -75.27 0.51 Allowed 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 108.594 -0.891 . . . . 52.24 108.594 178.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -73.95 141.47 45.93 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 108.719 -0.845 . . . . 74.14 108.719 172.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . 0.547 ' HA3' ' HB2' ' B' ' 93' ' ' PHE . . . -89.72 45.91 3.1 Favored Glycine 0 C--N 1.342 0.905 0 CA-C-O 119.4 -0.666 . . . . 54.33 114.005 -171.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . 47.24 -87.13 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 125.69 1.596 . . . . 62.33 113.088 172.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -133.22 -31.96 0.41 Allowed Glycine 0 C--N 1.348 1.211 0 N-CA-C 111.337 -0.705 . . . . 70.11 111.337 175.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -63.45 -29.16 73.75 Favored Glycine 0 C--N 1.35 1.343 0 N-CA-C 114.421 0.528 . . . . 23.53 114.421 -174.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . 0.547 ' HB2' ' HA3' ' B' ' 89' ' ' GLY . 93.5 t80 -61.97 -37.66 85.61 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.543 0.737 . . . . 74.22 111.351 177.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -70.84 -13.42 62.03 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.373 -0.831 . . . . 71.21 112.169 -174.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . 0.497 ' HG3' HD11 ' B' ' 100' ' ' LEU . 0.8 OUTLIER -75.12 -29.88 60.67 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.77 0.828 . . . . 74.14 110.13 174.539 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 96' ' ' GLY . . . . . 0.436 ' O ' ' HB3' ' B' ' 69' ' ' LEU . . . -75.82 -7.81 84.01 Favored Glycine 0 C--N 1.35 1.314 0 CA-C-N 115.507 -0.769 . . . . 72.31 113.848 177.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 71.1 mt -64.77 -56.27 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 117.302 0.551 . . . . 72.22 110.31 176.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -87.9 -84.96 0.19 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.012 0.525 . . . . 75.21 110.511 -178.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . 168.07 -37.07 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.701 1.2 . . . . 61.12 110.106 -172.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . 0.497 HD11 ' HG3' ' B' ' 95' ' ' LYS . 83.2 mt 54.6 59.22 11.35 Favored Pre-proline 0 N--CA 1.483 1.198 0 C-N-CA 124.825 1.25 . . . . 74.2 109.911 -167.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 101' ' ' PRO . . . . . 0.547 ' HA ' ' HB2' ' B' ' 105' ' ' GLN . 77.6 Cg_endo -85.24 139.14 6.91 Favored 'Trans proline' 0 C--N 1.369 1.632 0 C-N-CA 122.01 1.807 . . . . 72.21 114.138 -164.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 6.6 tt -68.04 -69.06 0.34 Allowed 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 106.809 -1.552 . . . . 73.12 106.809 167.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 88.2 m -159.46 99.35 1.45 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.598 1.159 . . . . 75.52 107.937 173.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 60.65 59.03 10.94 Favored Glycine 0 C--N 1.353 1.486 0 N-CA-C 111.521 -0.631 . . . . 51.35 111.521 -173.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 105' ' ' GLN . . . . . 0.547 ' HB2' ' HA ' ' B' ' 101' ' ' PRO . 55.0 tp60 -58.19 -27.01 63.47 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.776 0.831 . . . . 75.22 112.776 -170.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -56.97 -31.2 64.79 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 125.04 1.336 . . . . 74.44 112.471 -176.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 7.3 m -129.18 4.03 5.24 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.579 0.752 . . . . 63.32 110.857 -179.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 27.9 t60 -74.02 81.93 1.73 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.219 0.608 . . . . 71.44 111.146 -173.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 72.56 -43.54 0.57 Allowed 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 126.213 1.805 . . . . 53.33 112.692 -177.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . 0.583 ' HB1' ' HB3' ' B' ' 317' ' ' SER . . . -76.53 75.51 3.25 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.536 1.135 . . . . 71.24 111.398 -178.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 46.4 tp -173.4 -81.71 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 107.229 -1.397 . . . . 64.15 107.229 174.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -81.75 130.61 35.12 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 109.139 -0.689 . . . . 73.2 109.139 176.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 113' ' ' LYS . . . . . 0.578 ' H ' HD21 ' B' ' 55' ' ' LEU . 44.3 mttm -93.97 85.02 4.63 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 122.917 0.487 . . . . 75.13 111.011 -170.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 4.5 tmtt? 69.76 -76.98 0.06 Allowed 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 125.85 1.66 . . . . 74.01 112.026 171.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . 0.7 HG23 ' HB3' ' B' ' 300' ' ' ASN . 54.0 m 71.51 92.19 0.09 Allowed 'General case' 0 C--N 1.361 1.085 0 C-N-CA 125.329 1.452 . . . . 73.23 111.459 -176.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 163.57 -174.92 39.83 Favored Glycine 0 C--N 1.353 1.509 0 N-CA-C 114.375 0.51 . . . . 55.33 114.375 174.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp 57.3 81.5 0.25 Allowed Pre-proline 0 N--CA 1.488 1.439 0 C-N-CA 125.775 1.63 . . . . 70.25 111.949 -178.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 118' ' ' PRO . . . . . 0.465 ' HG3' ' HG3' ' B' ' 294' ' ' LYS . 55.6 Cg_endo -86.16 83.2 1.29 Allowed 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 123.399 2.733 . . . . 60.53 111.927 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 119' ' ' ASP . . . . . 0.472 ' HB2' ' NH2' ' B' ' 289' ' ' ARG . 5.6 m-20 -67.3 127.23 31.88 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.636 -0.711 . . . . 75.33 110.65 -174.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 120' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -68.11 150.38 48.46 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.971 0.908 . . . . 70.1 112.363 178.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 121' ' ' VAL . . . . . 0.477 HG11 HD11 ' B' ' 265' ' ' LEU . 30.2 m -110.85 15.38 8.28 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 CA-C-N 114.714 -1.13 . . . . 74.32 110.782 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 11.1 p -105.85 5.86 31.08 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.389 1.076 . . . . 75.24 112.123 -173.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -91.49 -178.78 5.2 Favored 'General case' 0 CA--C 1.561 1.374 0 C-N-CA 123.955 0.902 . . . . 64.3 110.316 -178.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 124' ' ' SER . . . . . 0.662 ' HB2' ' HB3' ' B' ' 207' ' ' LYS . 23.0 t -58.81 124.98 21.63 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.132 0.973 . . . . 43.31 112.538 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . 0.437 ' HA ' ' HG2' ' B' ' 342' ' ' GLN . . . -62.64 137.69 58.32 Favored 'General case' 0 C--N 1.352 0.692 0 C-N-CA 123.512 0.725 . . . . 73.02 110.208 172.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . 0.606 ' HA ' ' HA3' ' B' ' 211' ' ' GLY . . . -75.37 -67.8 0.62 Allowed 'General case' 0 N--CA 1.471 0.615 0 O-C-N 123.051 0.219 . . . . 74.13 111.091 -176.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 19.8 m 61.68 -167.64 0.2 Allowed 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 124.223 1.009 . . . . 70.01 112.489 176.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -146.85 138.09 24.13 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.41 0.684 . . . . 72.01 109.794 169.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 27.7 p -134.37 145.8 49.31 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.402 1.081 . . . . 54.34 108.961 178.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 130' ' ' ALA . . . . . 0.529 ' HA ' ' HA ' ' B' ' 163' ' ' LEU . . . 63.19 82.95 0.17 Allowed 'General case' 0 C--O 1.243 0.76 0 C-N-CA 124.48 1.112 . . . . 44.22 113.578 171.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 24.1 m-90 -75.38 141.24 43.3 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 115.147 -0.933 . . . . 73.51 109.061 172.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 22.7 m -90.8 31.62 1.05 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.669 0.788 . . . . 51.4 111.741 -173.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 81.4 m -58.55 -49.33 77.8 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.64 1.176 . . . . 62.25 111.981 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . -138.77 72.22 0.43 Allowed Glycine 0 C--N 1.34 0.783 0 CA-C-N 115.434 -0.803 . . . . 55.15 112.266 -174.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 135' ' ' VAL . . . . . . . . . . . . . 10.0 m 51.02 -168.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 C-N-CA 125.867 1.667 . . . . 73.24 113.358 176.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 136' ' ' LYS . . . . . 0.512 ' HD2' ' HB3' ' B' ' 164' ' ' ALA . 75.0 mmtt -127.47 -155.92 0.72 Allowed 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 108.77 -0.826 . . . . 52.43 108.77 176.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 23.3 m 82.61 -40.65 0.11 Allowed 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 125.421 1.488 . . . . 75.31 113.447 173.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -84.93 43.76 1.02 Allowed 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.549 0.74 . . . . 75.52 112.688 -171.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . 0.524 ' HB3' ' HA ' ' B' ' 164' ' ' ALA . 37.9 p30 -75.68 -5.67 46.73 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.266 0.626 . . . . 73.24 112.319 178.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -83.64 2.15 87.74 Favored Glycine 0 C--N 1.345 1.063 0 CA-C-O 120.172 -0.238 . . . . 65.04 113.202 173.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -85.41 133.87 34.1 Favored 'General case' 0 C--N 1.349 0.567 0 C-N-CA 123.156 0.582 . . . . 75.34 110.432 176.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 6.4 mp -72.96 147.89 44.78 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 108.722 -0.844 . . . . 70.15 108.722 172.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 128.4 -140.56 11.86 Favored Glycine 0 C--N 1.34 0.788 0 N-CA-C 111.151 -0.78 . . . . 61.25 111.151 -177.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 84.6 t 76.32 -39.0 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 C-N-CA 124.985 1.314 . . . . 75.31 112.55 177.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 22.0 t70 66.09 -83.48 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.389 1.476 . . . . 64.3 109.865 -171.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 8.0 tp 45.25 23.61 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 C-N-CA 126.452 1.901 . . . . 72.52 112.959 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 26.8 t-80 -75.28 -30.96 60.57 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.65 -0.704 . . . . 72.43 110.301 -175.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 70.56 -72.82 0.1 Allowed 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 125.477 1.511 . . . . 73.05 109.87 169.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 149' ' ' LYS . . . . . 0.642 ' HE2' ' HA ' ' B' ' 260' ' ' SER . 63.7 mttp -132.82 -63.19 0.79 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.528 0.731 . . . . 72.23 110.428 172.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -159.71 -66.73 0.08 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.812 0.445 . . . . 74.11 110.43 -170.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 -71.69 -37.88 5.73 Favored Pre-proline 0 CA--C 1.561 1.375 0 CA-C-O 117.767 -1.111 . . . . 74.43 113.886 -174.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -53.79 111.44 0.69 Allowed 'Trans proline' 0 C--N 1.385 2.462 0 C-N-CA 121.814 1.676 . . . . 42.51 112.788 172.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 46.2 m -101.8 151.7 21.75 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.603 1.161 . . . . 74.2 110.295 -175.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 14.6 tt -82.94 115.29 25.17 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 CA-C-O 121.028 0.442 . . . . 74.25 110.106 176.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 155' ' ' LEU . . . . . 0.685 ' HB2' ' HB2' ' B' ' 158' ' ' ALA . 5.4 mp -116.43 138.92 50.98 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 108.627 -0.879 . . . . 72.1 108.627 173.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -71.85 -19.86 61.9 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.467 0.707 . . . . 72.23 112.785 -172.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 157' ' ' MET . . . . . 0.513 ' HA ' ' HA ' ' B' ' 161' ' ' ALA . 95.0 mmm -118.72 11.75 12.83 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-O 119.09 -0.481 . . . . 53.54 111.61 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 158' ' ' ALA . . . . . 0.685 ' HB2' ' HB2' ' B' ' 155' ' ' LEU . . . -53.94 95.53 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.829 0.852 . . . . 34.04 112.551 -174.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . 0.418 ' H ' ' HB2' ' B' ' 198' ' ' GLU . 94.5 mttt 65.54 -76.13 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 125.635 1.574 . . . . 55.45 112.059 175.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -105.95 23.33 14.14 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.633 0.773 . . . . 70.22 110.532 177.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' B' ' 157' ' ' MET . . . 82.74 24.07 0.17 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 126.023 1.729 . . . . 71.1 112.806 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 76.95 -68.15 2.61 Favored Glycine 0 C--N 1.353 1.522 0 CA-C-N 116.224 -0.444 . . . . 73.4 113.061 170.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . 0.529 ' HA ' ' HA ' ' B' ' 130' ' ' ALA . 0.2 OUTLIER -141.98 -40.18 0.36 Allowed 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 107.35 -1.352 . . . . 65.02 107.35 171.537 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 164' ' ' ALA . . . . . 0.524 ' HA ' ' HB3' ' B' ' 139' ' ' ASN . . . 71.24 0.84 3.59 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.453 1.501 . . . . 75.34 112.997 175.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 15.3 t -152.87 169.0 23.91 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 123.406 0.683 . . . . 64.15 109.985 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . -178.08 -49.94 0.07 OUTLIER Glycine 0 C--N 1.339 0.747 0 N-CA-C 109.846 -1.302 . . . . 71.15 109.846 -178.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 167' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -75.58 150.48 38.05 Favored 'General case' 0 C--O 1.245 0.816 0 N-CA-C 108.424 -0.954 . . . . 72.31 108.424 170.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . 0.512 HG22 ' HB2' ' B' ' 175' ' ' ASP . 97.0 t 64.23 -87.24 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 C-N-CA 123.809 0.844 . . . . 74.13 108.82 -170.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 58.3 p 44.13 -90.51 0.01 OUTLIER 'General case' 0 CA--C 1.565 1.525 0 C-N-CA 125.311 1.445 . . . . 54.35 114.046 -177.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 28.6 m -82.9 87.33 6.84 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 109.189 -0.671 . . . . 63.1 109.189 -177.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' C' ' 214' ' ' THR . . . 60.91 -160.88 0.3 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.615 1.166 . . . . 53.32 109.762 -168.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 172' ' ' GLU . . . . . 0.442 ' HB3' HG13 ' B' ' 168' ' ' VAL . 0.1 OUTLIER -132.29 150.75 52.09 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.953 -0.758 . . . . 73.22 108.953 169.585 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 173' ' ' LEU . . . . . . . . . . . . . 27.2 tp -88.88 -53.71 4.48 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 108.533 -0.914 . . . . 74.23 108.533 178.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 174' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -165.2 41.82 0.07 Allowed 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 107.724 -1.213 . . . . 74.45 107.724 173.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 175' ' ' ASP . . . . . 0.512 ' HB2' HG22 ' B' ' 168' ' ' VAL . 6.3 m-20 -113.34 -37.29 4.73 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 114.959 -1.019 . . . . 74.1 112.585 -164.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -113.89 114.81 26.75 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 112.932 0.716 . . . . 74.11 112.932 -166.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 8.0 t -156.36 127.94 3.81 Favored Pre-proline 0 CA--C 1.556 1.202 0 C-N-CA 124.21 1.004 . . . . 64.31 109.287 168.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 178' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.88 -61.96 0.04 OUTLIER 'Trans proline' 0 C--N 1.383 2.345 0 C-N-CA 122.475 2.117 . . . . 74.53 112.845 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -152.76 33.03 0.49 Allowed 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.021 0.928 . . . . 61.34 109.263 -178.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . 63.48 -74.98 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.909 1.284 . . . . 74.4 110.67 -164.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 16.8 tp -161.43 13.69 0.09 Allowed 'General case' 0 CA--C 1.56 1.365 0 N-CA-C 111.919 0.341 . . . . 62.04 111.919 -168.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 182' ' ' VAL . . . . . 0.664 ' HA ' ' HB2' ' C' ' 139' ' ' GLU . 12.4 p -117.7 150.09 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 CA-C-O 118.533 -0.746 . . . . 71.31 110.008 178.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -169.05 6.57 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 115.21 1.559 . . . . 65.24 115.21 -177.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 79.7 m80 76.4 161.49 0.23 Allowed 'General case' 0 N--CA 1.507 2.399 0 C-N-CA 124.548 1.139 . . . . 74.15 111.437 177.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 185' ' ' VAL . . . . . 0.584 HG23 ' HA ' ' C' ' 141' ' ' ALA . 92.7 t -64.41 106.82 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 122.901 0.48 . . . . 71.33 111.407 -173.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 186' ' ' THR . . . . . 0.798 ' HA ' ' HB3' ' C' ' 122' ' ' GLU . 65.2 p 66.43 105.48 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.872 1.669 . . . . 51.31 114.392 163.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 187' ' ' SER . . . . . . . . . . . . . 51.5 p -171.82 97.58 0.17 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.658 1.183 . . . . 62.14 109.573 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 188' ' ' ARG . . . . . 0.438 ' HG2' ' HB3' ' C' ' 179' ' ' ARG . 0.0 OUTLIER -73.83 113.22 10.73 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 107.346 -1.353 . . . . 71.52 107.346 173.171 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 189' ' ' LYS . . . . . 0.404 ' HB2' ' HB3' ' C' ' 124' ' ' PRO . 1.2 tmtm? -69.74 98.27 1.18 Allowed 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 109.19 -0.67 . . . . 72.52 109.19 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 190' ' ' CYS . . . . . . . . . . . . . 6.4 p -76.98 112.64 13.83 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-N 115.302 -0.863 . . . . 70.33 109.909 176.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -79.84 124.81 28.97 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.08 0.552 . . . . 74.04 110.621 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -89.83 112.36 4.02 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-O 118.458 -1.19 . . . . 64.22 110.74 168.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 193' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.14 -41.05 82.42 Favored 'Trans proline' 0 C--N 1.385 2.449 0 C-N-CA 122.917 2.412 . . . . 64.32 112.82 177.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 194' ' ' SER . . . . . . . . . . . . . 21.4 t 62.85 20.26 12.07 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 124.839 1.256 . . . . 24.51 111.652 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 195' ' ' ALA . . . . . . . . . . . . . . . -83.7 77.64 9.83 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.538 0.735 . . . . 74.32 111.377 -173.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 72.1 m -70.65 130.3 41.42 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.272 -0.876 . . . . 73.32 108.763 169.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 45.5 m -69.47 83.12 0.4 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.612 0.765 . . . . 75.11 112.765 -169.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 198' ' ' GLU . . . . . 0.418 ' HB2' ' H ' ' B' ' 159' ' ' LYS . 1.0 OUTLIER 55.05 -91.1 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 126.072 1.749 . . . . 51.12 110.728 178.294 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? -155.96 61.23 0.58 Allowed 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 105.762 -1.94 . . . . 74.4 105.762 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 200' ' ' CYS . . . . . . . . . . . . . 54.0 t -59.12 -39.4 73.23 Favored Pre-proline 0 CA--C 1.559 1.293 0 CA-C-N 113.314 -1.766 . . . . 73.31 112.818 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 201' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -63.94 -10.11 21.64 Favored 'Trans proline' 0 C--N 1.39 2.754 0 C-N-CA 121.509 1.472 . . . . 71.34 114.113 171.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . -125.89 67.91 0.53 Allowed Glycine 0 C--N 1.353 1.497 0 C-N-CA 123.002 0.334 . . . . 63.04 112.509 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -120.84 16.23 11.8 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.916 0.886 . . . . 71.33 110.036 177.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . 64.78 17.4 10.95 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.796 1.238 . . . . 74.01 112.163 -174.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 205' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 54.61 78.04 0.18 Allowed 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 125.664 1.586 . . . . 51.03 110.946 175.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -171.92 -54.87 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.608 0.763 . . . . 62.32 109.893 -174.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 207' ' ' LYS . . . . . 0.662 ' HB3' ' HB2' ' B' ' 124' ' ' SER . 13.2 mptt -65.6 -36.0 82.47 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 114.992 -1.003 . . . . 74.32 110.821 -178.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 79.27 -78.79 1.69 Allowed Glycine 0 C--N 1.345 1.034 0 CA-C-N 115.788 -0.642 . . . . 71.52 111.96 -178.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 171.42 -65.77 0.14 Allowed Glycine 0 C--N 1.345 1.043 0 N-CA-C 110.296 -1.122 . . . . 42.21 110.296 -177.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 63.92 -78.34 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 125.318 1.447 . . . . 74.51 111.835 169.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 211' ' ' GLY . . . . . 0.606 ' HA3' ' HA ' ' B' ' 126' ' ' ALA . . . -83.88 52.76 4.77 Favored Glycine 0 C--N 1.35 1.346 0 N-CA-C 111.72 -0.552 . . . . 74.43 111.72 173.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 70.9 m -149.85 177.27 9.97 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.657 1.183 . . . . 74.04 109.79 -174.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 72.1 mt 71.77 -69.29 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 C-N-CA 125.516 1.526 . . . . 64.4 111.592 178.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 40.7 m 70.51 -67.88 0.23 Allowed 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 125.705 1.602 . . . . 75.43 110.685 -175.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 215' ' ' GLU . . . . . 0.418 ' HB3' ' NH2' ' B' ' 32' ' ' ARG . 33.5 tt0 64.31 107.02 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.183 1.393 . . . . 73.31 112.747 173.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 59.7 81.99 0.16 Allowed 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.0 1.32 . . . . 61.42 112.688 171.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.34 117.18 5.48 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 107.801 -1.185 . . . . 75.4 107.801 173.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -72.52 113.66 9.8 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 108.431 -0.951 . . . . 71.43 108.431 178.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 61.8 t30 75.89 -69.65 0.16 Allowed 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 125.526 1.53 . . . . 71.24 112.615 175.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . 70.71 -73.11 0.1 Allowed 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 125.351 1.461 . . . . 61.1 111.87 -175.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 221' ' ' ARG . . . . . 0.586 HH12 ' HG2' ' A' ' 228' ' ' GLN . 0.8 OUTLIER -134.38 131.18 37.94 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.472 1.109 . . . . 73.55 108.486 -178.22 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -157.81 26.19 0.27 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.415 0.686 . . . . 42.52 110.451 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -64.17 100.78 0.35 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.175 0.99 . . . . 61.02 110.26 -171.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . 0.427 ' O ' ' HB3' ' C' ' 211' ' ' ARG . 11.3 p -109.74 41.05 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 C-N-CA 124.827 1.251 . . . . 74.2 108.817 -173.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 73.6 p -51.56 -46.92 63.57 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 113.818 -1.537 . . . . 54.34 111.719 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 2.4 tm? 60.85 95.37 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.08 1.352 . . . . 74.43 109.601 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . -107.73 150.0 16.82 Favored Glycine 0 C--N 1.334 0.464 0 CA-C-N 115.819 -0.628 . . . . 51.31 112.859 -177.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . -79.9 101.2 1.92 Allowed Glycine 0 C--N 1.343 0.92 0 N-CA-C 111.207 -0.757 . . . . 72.41 111.207 175.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -62.87 -7.21 15.01 Favored Glycine 0 C--N 1.351 1.411 0 N-CA-C 115.034 0.774 . . . . 70.24 115.034 -178.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . 0.451 ' HA ' HE21 ' B' ' 252' ' ' GLN . . . -130.53 147.75 52.26 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 124.775 1.23 . . . . 70.23 108.892 171.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 231' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -61.84 120.92 11.67 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.6 0.36 . . . . 73.24 110.521 177.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 8.6 t -158.04 162.43 38.12 Favored 'General case' 0 C--O 1.246 0.884 0 C-N-CA 124.101 0.961 . . . . 74.24 108.423 174.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -72.71 113.35 9.65 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.939 -1.134 . . . . 70.41 107.939 171.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -74.94 82.23 2.19 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 121.186 0.517 . . . . 72.31 109.946 178.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -76.97 172.29 13.42 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 124.067 0.947 . . . . 54.41 110.148 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 236' ' ' THR . . . . . . . . . . . . . 43.2 m 74.54 86.32 0.1 Allowed 'General case' 0 C--N 1.354 0.768 0 C-N-CA 124.865 1.266 . . . . 73.34 109.524 -176.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -94.37 25.59 3.8 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 114.697 -1.138 . . . . 71.12 110.775 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 238' ' ' THR . . . . . 0.514 HG22 HG23 ' C' ' 219' ' ' VAL . 21.9 m -55.75 105.72 0.2 Allowed 'General case' 0 C--N 1.361 1.108 0 C-N-CA 123.624 0.77 . . . . 71.31 110.132 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 239' ' ' ALA . . . . . 0.425 ' HA ' HG22 ' C' ' 219' ' ' VAL . . . -159.71 -82.8 0.04 OUTLIER 'General case' 0 C--O 1.24 0.593 0 O-C-N 123.837 0.711 . . . . 74.42 109.561 -178.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 240' ' ' GLY . . . . . 0.417 ' HA3' ' HA ' ' C' ' 235' ' ' LEU . . . 161.91 -108.67 0.36 Allowed Glycine 0 C--N 1.333 0.367 0 N-CA-C 109.678 -1.369 . . . . 71.23 109.678 -170.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -159.92 160.45 33.53 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.35 0.66 . . . . 71.21 111.125 178.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 26.7 m95 -123.77 -83.08 0.65 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.165 0.986 . . . . 70.32 108.715 168.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -154.49 -54.87 0.1 Allowed 'General case' 0 C--N 1.362 1.152 0 C-N-CA 125.985 1.714 . . . . 74.22 106.654 -168.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -147.34 -163.28 10.49 Favored Glycine 0 C--N 1.355 1.614 0 CA-C-N 113.843 -1.526 . . . . 63.11 110.628 173.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? -171.69 133.41 0.77 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.89 -0.781 . . . . 75.34 108.89 175.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . 0.601 HG21 HG12 ' B' ' 371' ' ' VAL . 91.6 m -133.53 151.46 51.75 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.572 1.149 . . . . 71.02 108.759 176.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 247' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -132.44 -178.83 5.1 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.458 0.703 . . . . 72.51 110.017 176.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 248' ' ' ARG . . . . . 0.686 ' HD2' ' HA ' ' B' ' 370' ' ' ALA . 2.4 tpm_? -161.68 157.34 24.32 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.975 0.91 . . . . 75.15 109.422 -178.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 249' ' ' GLU . . . . . 0.443 ' HG2' ' NH2' ' B' ' 248' ' ' ARG . 13.4 pt-20 -114.88 160.68 19.21 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.589 0.756 . . . . 71.33 109.274 170.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 250' ' ' GLN . . . . . 0.508 HE21 ' HB3' ' A' ' 274' ' ' GLU . 0.0 OUTLIER -146.41 177.22 9.19 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.454 0.702 . . . . 65.4 109.692 -173.563 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 251' ' ' ALA . . . . . . . . . . . . . . . -88.37 -7.15 57.12 Favored 'General case' 0 N--CA 1.483 1.223 0 O-C-N 122.292 -0.255 . . . . 61.03 111.507 174.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . 0.499 ' H ' ' HG2' ' B' ' 250' ' ' GLN . 1.4 tm0? 70.0 -68.73 0.19 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.954 1.701 . . . . 72.3 111.563 172.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -76.44 74.21 3.19 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.012 0.925 . . . . 51.41 110.608 176.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -86.32 -77.84 0.3 Allowed 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 114.667 -1.151 . . . . 72.51 108.106 175.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -84.62 -28.66 31.81 Favored Glycine 0 N--CA 1.47 0.931 0 CA-C-N 117.998 0.363 . . . . 54.22 112.244 169.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 256' ' ' TYR . . . . . . . . . . . . . 78.0 t80 67.4 -76.45 0.05 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.254 1.421 . . . . 52.52 109.616 -171.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 257' ' ' GLN . . . . . 0.619 ' HA ' ' HB1' ' B' ' 355' ' ' ALA . 78.2 mt-30 38.45 88.49 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 126.189 1.796 . . . . 74.31 114.309 171.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 258' ' ' LEU . . . . . . . . . . . . . 2.6 tt -86.0 64.89 8.83 Favored 'General case' 0 CA--C 1.556 1.208 0 N-CA-C 109.243 -0.651 . . . . 75.13 109.243 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 33.4 m 38.2 31.69 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 C-N-CA 127.248 2.219 . . . . 63.02 115.899 172.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 260' ' ' SER . . . . . 0.642 ' HA ' ' HE2' ' B' ' 149' ' ' LYS . 32.4 m -76.96 -29.64 55.65 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 112.425 0.528 . . . . 73.11 112.425 -175.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 28.3 t0 69.31 176.01 0.28 Allowed 'General case' 0 N--CA 1.483 1.193 0 O-C-N 124.36 1.038 . . . . 52.21 111.733 169.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 262' ' ' ALA . . . . . . . . . . . . . . . -137.97 134.97 35.55 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 123.581 0.752 . . . . 43.43 110.062 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 263' ' ' ALA . . . . . 0.449 ' HB2' ' HB ' ' B' ' 348' ' ' ILE . . . -80.65 62.46 4.72 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.566 0.746 . . . . 70.44 111.076 176.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 50.7 m -123.12 -9.45 8.18 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.942 0.897 . . . . 51.14 110.564 176.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 265' ' ' LEU . . . . . 0.477 HD11 HG11 ' B' ' 121' ' ' VAL . 68.9 mt 54.04 58.73 4.77 Favored 'General case' 0 C--N 1.363 1.166 0 C-N-CA 124.446 1.099 . . . . 64.12 110.439 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 266' ' ' ASN . . . . . 0.494 ' H ' ' HB3' ' B' ' 46' ' ' ARG . 29.3 m120 78.13 -63.94 0.3 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 126.574 1.95 . . . . 71.52 111.13 -172.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 267' ' ' SER . . . . . 0.437 ' HB3' ' HA3' ' B' ' 49' ' ' GLY . 32.6 t 56.63 55.82 6.07 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.49 0.716 . . . . 73.13 109.074 -171.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 39.0 t -63.88 102.54 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 115.362 -0.835 . . . . 74.44 110.828 -172.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 269' ' ' THR . . . . . 0.403 ' OG1' ' HB2' ' B' ' 470' ' ' LEU . 14.2 t -159.83 -40.52 0.05 Allowed 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 111.932 0.345 . . . . 74.31 111.932 -175.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 270' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -123.04 132.54 54.16 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 123.414 0.686 . . . . 72.41 110.4 -167.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 271' ' ' ALA . . . . . 0.44 ' HB3' ' HB1' ' B' ' 467' ' ' ALA . . . -174.45 -28.9 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 O-C-N 123.913 0.758 . . . . 75.3 111.937 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 272' ' ' ASN . . . . . 0.604 HD22 HD12 ' B' ' 468' ' ' LEU . 65.5 t30 -90.9 61.83 4.79 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-O 121.367 0.603 . . . . 54.14 111.803 -170.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 63.47 -0.51 0.69 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 116.061 1.874 . . . . 61.32 116.061 165.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -68.51 -44.85 73.78 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 118.725 0.693 . . . . 71.44 109.279 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 275' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -105.34 99.04 18.4 Favored Pre-proline 0 N--CA 1.478 0.944 0 N-CA-C 107.24 -1.392 . . . . 71.33 107.24 169.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -61.76 85.94 0.1 OUTLIER 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 123.101 2.534 . . . . 62.35 114.257 -169.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 277' ' ' LEU . . . . . . . . . . . . . 9.7 mp 60.17 -72.47 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 126.977 2.111 . . . . 63.32 114.482 169.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 278' ' ' LEU . . . . . 0.674 HD13 ' H ' ' B' ' 278' ' ' LEU . 0.0 OUTLIER -103.82 0.76 30.73 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.761 0.825 . . . . 62.0 111.78 -175.271 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . -72.28 -78.06 0.52 Allowed Glycine 0 C--N 1.352 1.46 0 O-C-N 123.416 0.448 . . . . 75.43 112.722 179.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 69.51 152.91 0.1 Allowed 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 125.188 1.395 . . . . 53.23 113.728 178.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -114.4 37.45 3.38 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 106.294 -1.743 . . . . 75.31 106.294 165.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -64.59 87.68 0.06 Allowed 'General case' 0 C--N 1.357 0.926 0 CA-C-N 114.561 -1.199 . . . . 65.41 111.856 -171.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -107.34 -13.95 14.99 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.862 1.265 . . . . 72.33 109.442 175.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . -61.94 97.71 0.16 Allowed Glycine 0 C--N 1.345 1.052 0 CA-C-N 115.672 -0.695 . . . . 61.45 113.505 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -67.23 -48.13 68.73 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.021 0.928 . . . . 72.41 110.09 177.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 286' ' ' MET . . . . . . . . . . . . . 44.4 tpp -163.21 108.9 1.0 Allowed Pre-proline 0 CA--C 1.543 0.705 0 N-CA-C 108.729 -0.841 . . . . 64.1 108.729 178.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 287' ' ' PRO . . . . . 0.434 ' HB3' ' HA ' ' B' ' 52' ' ' THR . 28.2 Cg_exo -65.1 78.81 0.21 Allowed 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 123.53 2.82 . . . . 73.33 112.585 178.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 288' ' ' VAL . . . . . 0.551 HG23 ' H ' ' B' ' 289' ' ' ARG 0.269 6.2 m 35.69 -96.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 C-N-CA 125.504 1.521 . . . . 74.32 112.448 -170.071 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 289' ' ' ARG . . . . . 0.551 ' H ' HG23 ' B' ' 288' ' ' VAL . 24.6 tpt180 62.25 -82.5 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.638 1.175 . . . . 72.14 111.152 176.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 290' ' ' TRP . . . . . . . . . . . . . 31.9 t90 -107.01 -31.42 8.3 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.303 1.041 . . . . 75.34 109.221 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 291' ' ' LEU . . . . . . . . . . . . . 47.9 tp -67.66 126.36 29.12 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.469 1.107 . . . . 64.34 110.617 177.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . 90.86 -161.29 28.08 Favored Glycine 0 C--N 1.348 1.213 0 O-C-N 123.633 0.583 . . . . 62.12 112.581 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.84 162.58 41.53 Favored 'Trans proline' 0 C--N 1.371 1.743 0 C-N-CA 122.761 2.308 . . . . 51.12 112.647 176.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 294' ' ' LYS . . . . . 0.465 ' HG3' ' HG3' ' B' ' 118' ' ' PRO . 5.6 ttpm? -57.56 91.28 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.885 1.274 . . . . 41.23 111.384 -177.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . 59.09 13.36 2.88 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.863 1.265 . . . . 34.32 112.334 -178.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 296' ' ' THR . . . . . 0.428 ' HB ' ' HA3' ' B' ' 299' ' ' GLY . 6.9 m 51.14 47.69 24.4 Favored 'General case' 0 C--N 1.364 1.221 0 C-N-CA 124.687 1.195 . . . . 65.42 110.103 -169.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 62.68 -78.49 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.431 1.493 . . . . 64.12 110.325 -171.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 298' ' ' HIS . . . . . 0.474 ' HA ' HG21 ' B' ' 115' ' ' THR . 54.6 t-80 -136.7 38.21 2.63 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 108.418 -0.956 . . . . 71.5 108.418 177.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 299' ' ' GLY . . . . . 0.428 ' HA3' ' HB ' ' B' ' 296' ' ' THR . . . -67.04 -29.25 74.31 Favored Glycine 0 C--N 1.349 1.283 0 CA-C-N 115.107 -0.951 . . . . 63.41 112.603 177.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 300' ' ' ASN . . . . . 0.7 ' HB3' HG23 ' B' ' 115' ' ' THR . 7.1 t30 -71.92 91.77 1.22 Allowed 'General case' 0 CA--C 1.549 0.911 0 CA-C-O 121.682 0.753 . . . . 72.23 109.132 171.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 301' ' ' ILE . . . . . . . . . . . . . 12.7 tt -133.7 -21.26 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 CA-C-N 114.703 -1.135 . . . . 72.24 109.561 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 10.5 t70 71.16 108.1 0.06 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 125.252 1.421 . . . . 63.41 111.688 -178.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 303' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -147.75 -53.78 0.02 OUTLIER Pre-proline 0 CA--C 1.56 1.36 0 C-N-CA 125.155 1.382 . . . . 74.11 110.409 176.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 304' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -72.42 -3.32 13.19 Favored 'Trans proline' 0 C--N 1.401 3.307 0 C-N-CA 122.345 2.03 . . . . 75.12 113.61 -176.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 305' ' ' ALA . . . . . 0.407 ' HB1' ' HB3' ' B' ' 470' ' ' LEU . . . -85.56 -78.03 0.28 Allowed 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 109.703 -0.48 . . . . 42.33 109.703 175.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . 0.432 HG21 ' HB3' ' B' ' 59' ' ' LEU . 17.3 m -43.56 -51.0 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 114.918 1.451 . . . . 72.33 114.918 -168.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 21.4 m 62.72 -70.02 0.06 Allowed 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 124.784 1.234 . . . . 74.23 111.057 -170.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 308' ' ' CYS . . . . . 0.405 ' HA ' ' HA ' ' B' ' 61' ' ' ASP . 18.8 p -156.13 96.55 1.71 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.035 0.934 . . . . 74.22 109.901 177.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 30.0 p -131.04 135.27 27.03 Favored Pre-proline 0 N--CA 1.484 1.275 0 C-N-CA 123.684 0.794 . . . . 72.2 111.67 -174.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -80.35 -0.98 11.04 Favored 'Trans proline' 0 C--N 1.379 2.157 0 C-N-CA 122.831 2.354 . . . . 63.14 114.454 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 311' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -80.58 122.33 82.27 Favored Pre-proline 0 N--CA 1.481 1.12 0 N-CA-C 109.387 -0.598 . . . . 73.13 109.387 177.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 312' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -83.59 144.18 11.17 Favored 'Trans proline' 0 C--N 1.37 1.692 0 C-N-CA 121.996 1.797 . . . . 70.14 113.503 176.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 313' ' ' GLN . . . . . 0.655 ' HB2' ' HA ' ' B' ' 58' ' ' SER . 6.8 tp60 -62.51 -37.02 84.41 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 115.202 -0.908 . . . . 75.13 110.207 167.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 314' ' ' ARG . . . . . 0.433 HH22 ' HG3' ' B' ' 105' ' ' GLN . 32.6 ttt180 -144.77 118.48 9.22 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 113.839 -1.528 . . . . 72.01 109.047 -173.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 315' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -76.62 -50.85 12.77 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 107.36 -1.348 . . . . 72.12 107.36 170.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 316' ' ' ASP . . . . . . . . . . . . . 32.5 t70 176.13 108.19 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.648 1.579 . . . . 74.4 108.817 158.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 317' ' ' SER . . . . . 0.583 ' HB3' ' HB1' ' B' ' 110' ' ' ALA . 35.1 t -92.73 91.29 7.43 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 121.513 0.673 . . . . 75.41 109.754 175.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 318' ' ' VAL . . . . . . . . . . . . . 14.0 p -91.12 -24.43 0.27 Allowed Pre-proline 0 CA--C 1.583 2.229 0 N-CA-C 114.117 1.154 . . . . 73.13 114.117 173.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 319' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -76.92 25.05 0.46 Allowed 'Trans proline' 0 C--N 1.414 3.986 0 CA-C-N 123.343 2.229 . . . . 65.1 114.883 -170.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 320' ' ' THR . . . . . . . . . . . . . 72.6 m -60.03 -51.71 68.48 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.789 0.836 . . . . 53.31 109.758 170.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 321' ' ' LEU . . . . . 0.586 ' HB3' ' HB3' ' B' ' 434' ' ' HIS . 2.4 tm? 61.19 -78.8 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 125.601 1.561 . . . . 65.14 110.884 176.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 322' ' ' ALA . . . . . . . . . . . . . . . -139.64 108.24 5.9 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.857 0.863 . . . . 64.54 109.461 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 323' ' ' GLN . . . . . . . . . . . . . 5.4 pp0? -82.63 7.47 14.64 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.414 0.686 . . . . 74.02 111.731 -178.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 324' ' ' MET . . . . . . . . . . . . . 9.5 ptt? -56.07 -26.16 48.26 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 124.15 0.98 . . . . 71.32 112.057 -177.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 325' ' ' THR . . . . . . . . . . . . . 19.8 m -56.94 154.21 9.89 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 124.438 1.095 . . . . 72.33 110.708 174.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 326' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -57.69 159.22 5.37 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.932 0.893 . . . . 72.01 111.696 -179.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . 0.52 ' H ' ' HG ' ' B' ' 331' ' ' LEU . 3.2 mptp? -102.41 3.84 38.23 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.316 0.647 . . . . 54.34 110.426 -179.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 328' ' ' ALA . . . . . . . . . . . . . . . 58.81 -85.0 0.02 OUTLIER 'General case' 0 C--N 1.363 1.195 0 C-N-CA 125.293 1.437 . . . . 72.03 109.987 -172.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 329' ' ' ILE . . . . . . . . . . . . . 2.7 pp -61.25 141.96 16.76 Favored 'Isoleucine or valine' 0 C--O 1.244 0.793 0 C-N-CA 123.587 0.755 . . . . 73.5 111.326 176.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 330' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 65.34 4.27 2.62 Favored 'General case' 0 CA--C 1.566 1.592 0 C-N-CA 124.054 0.942 . . . . 63.42 112.166 177.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 331' ' ' LEU . . . . . 0.52 ' HG ' ' H ' ' B' ' 327' ' ' LYS . 2.2 tm? -112.55 89.17 3.0 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 108.966 -0.753 . . . . 63.34 108.966 -174.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 51.44 -85.82 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 125.868 1.667 . . . . 74.41 113.493 171.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 333' ' ' SER . . . . . . . . . . . . . 15.3 m -61.1 -58.08 9.84 Favored 'General case' 0 C--N 1.354 0.773 0 C-N-CA 124.253 1.021 . . . . 65.04 109.512 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 23.2 pttm 41.28 -169.92 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 126.618 1.967 . . . . 63.11 115.415 176.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 335' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -124.53 172.15 9.44 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 123.621 0.768 . . . . 73.25 109.203 171.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.75 -47.19 80.62 Favored 'General case' 0 CA--C 1.556 1.194 0 C-N-CA 124.041 0.936 . . . . 61.02 113.264 -173.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 337' ' ' LYS . . . . . 0.462 ' HD2' ' HG2' ' B' ' 30' ' ' GLU . 20.0 ptmt -173.77 -27.07 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.935 0.894 . . . . 62.43 110.26 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 338' ' ' GLY . . . . . . . . . . . . . . . 90.62 -55.39 3.45 Favored Glycine 0 C--N 1.354 1.572 0 O-C-N 123.558 0.537 . . . . 72.34 111.798 177.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 339' ' ' PHE . . . . . 0.533 ' HB2' ' HA ' ' B' ' 446' ' ' PRO . 22.6 p90 -120.12 115.98 24.75 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.624 0.77 . . . . 74.33 109.284 177.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 340' ' ' PHE . . . . . 0.457 ' HD1' ' H ' ' B' ' 340' ' ' PHE . 1.9 p90 -66.77 -51.11 59.58 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.451 0.7 . . . . 75.24 110.968 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 341' ' ' LEU . . . . . 0.505 HD23 HH21 ' B' ' 289' ' ' ARG . 29.4 tp 51.04 77.85 0.12 Allowed 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.906 1.282 . . . . 75.34 110.679 178.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 342' ' ' GLN . . . . . 0.437 ' HG2' ' HA ' ' B' ' 125' ' ' ALA . 3.3 tp-100 -109.53 -69.95 0.83 Allowed 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 115.714 -0.675 . . . . 64.25 111.049 -166.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 343' ' ' VAL . . . . . . . . . . . . . 12.0 p -160.21 -35.66 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.827 0 C-N-CA 123.317 0.647 . . . . 64.24 109.792 -173.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 54.07 -78.41 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 125.56 1.544 . . . . 73.03 113.277 174.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 345' ' ' GLY . . . . . . . . . . . . . . . -70.39 -8.5 62.68 Favored Glycine 0 N--CA 1.484 1.881 0 CA-C-N 118.614 0.643 . . . . 62.31 114.626 -178.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 346' ' ' ALA . . . . . . . . . . . . . . . 77.42 -61.54 0.41 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.69 1.596 . . . . 72.22 112.562 172.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 48.4 p -70.18 -28.75 65.57 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.348 0.659 . . . . 72.21 111.747 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 348' ' ' ILE . . . . . 0.449 ' HB ' ' HB2' ' B' ' 263' ' ' ALA . 2.6 pp 42.02 28.29 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 C-N-CA 126.714 2.005 . . . . 73.42 115.055 177.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 349' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -85.8 122.38 29.8 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.786 -0.643 . . . . 71.13 110.437 -171.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 350' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -121.18 26.25 9.07 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.213 1.005 . . . . 74.52 109.764 178.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -143.73 90.25 2.13 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.407 1.083 . . . . 71.32 109.91 -170.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 26.9 t70 83.59 -47.21 0.12 Allowed 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 125.384 1.474 . . . . 74.35 112.828 178.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 353' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -99.24 29.47 3.92 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 123.213 0.605 . . . . 74.33 109.542 -177.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 354' ' ' ALA . . . . . . . . . . . . . . . -82.82 63.7 7.06 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.131 0.972 . . . . 70.11 112.723 -168.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 355' ' ' ALA . . . . . 0.619 ' HB1' ' HA ' ' B' ' 257' ' ' GLN . . . 60.52 11.51 3.06 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.994 1.318 . . . . 75.44 113.445 175.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 356' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 66.7 146.0 0.1 Allowed Pre-proline 0 N--CA 1.487 1.383 0 C-N-CA 125.672 1.589 . . . . 74.32 111.271 -168.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 357' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -62.36 133.72 44.7 Favored 'Trans proline' 0 C--N 1.382 2.32 0 C-N-CA 122.051 1.834 . . . . 55.22 110.698 175.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 358' ' ' CYS . . . . . . . . . . . . . 56.2 m -53.97 127.83 27.92 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 124.075 0.859 . . . . 73.32 111.35 -176.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 359' ' ' GLY . . . . . . . . . . . . . . . -60.14 -27.95 65.84 Favored Glycine 0 C--N 1.353 1.505 0 O-C-N 123.45 0.469 . . . . 62.01 113.004 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 360' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 59.03 -79.14 0.02 OUTLIER 'General case' 0 C--N 1.356 0.857 0 C-N-CA 125.961 1.704 . . . . 53.34 113.023 176.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 361' ' ' ILE . . . . . . . . . . . . . 51.7 mt -59.32 96.97 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 C-N-CA 124.152 0.981 . . . . 61.31 110.076 -174.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 362' ' ' GLY . . . . . . . . . . . . . . . -162.56 22.27 0.19 Allowed Glycine 0 C--N 1.342 0.898 0 CA-C-N 115.216 -0.902 . . . . 72.35 112.656 -173.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 363' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -115.39 131.02 57.06 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.121 0.969 . . . . 73.13 108.633 176.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 364' ' ' THR . . . . . . . . . . . . . 13.7 m -74.2 -29.53 61.78 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 122.925 0.49 . . . . 74.04 111.092 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 21.9 t 65.74 117.93 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 125.402 1.481 . . . . 74.01 110.067 -177.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 73.28 -64.95 0.38 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 125.702 1.601 . . . . 50.12 111.133 -176.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 367' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -67.87 -4.17 11.96 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.564 1.146 . . . . 75.05 112.566 -175.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 368' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -83.08 38.76 0.61 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.698 0.799 . . . . 71.23 109.636 171.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 369' ' ' GLU . . . . . 0.418 ' HB3' ' HA ' ' B' ' 372' ' ' GLN . 35.4 mt-10 -54.0 -28.09 35.85 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 126.023 1.729 . . . . 70.1 112.969 -163.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 370' ' ' ALA . . . . . 0.686 ' HA ' ' HD2' ' B' ' 248' ' ' ARG . . . 77.43 -68.29 0.17 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.603 1.561 . . . . 74.25 111.78 171.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 371' ' ' VAL . . . . . 0.601 HG12 HG21 ' B' ' 246' ' ' THR . 29.1 m -130.36 15.84 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 C-N-CA 123.662 0.785 . . . . 74.11 110.078 171.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 372' ' ' GLN . . . . . 0.418 ' HA ' ' HB3' ' B' ' 369' ' ' GLU . 8.9 tp-100 79.99 147.57 0.09 Allowed 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 125.809 1.644 . . . . 63.2 109.71 -166.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 373' ' ' ARG . . . . . 0.412 HH22 ' HB2' ' A' ' 267' ' ' ALA . 8.4 ptp180 -145.94 171.92 14.12 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.052 0.941 . . . . 72.05 109.627 -173.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . 74.43 -48.55 0.65 Allowed 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 125.248 1.419 . . . . 71.45 112.63 177.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 375' ' ' LEU . . . . . . . . . . . . . 67.8 mt -81.88 55.41 2.74 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.652 1.181 . . . . 62.01 110.036 176.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 53.08 -122.88 2.11 Favored 'General case' 0 CA--C 1.566 1.584 0 C-N-CA 124.603 1.161 . . . . 73.13 110.028 -172.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 377' ' ' PHE . . . . . . . . . . . . . 5.7 t80 56.24 -178.1 0.05 OUTLIER 'General case' 0 CA--C 1.566 1.564 0 C-N-CA 125.165 1.386 . . . . 73.31 111.969 -178.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 378' ' ' ALA . . . . . . . . . . . . . . . 64.84 24.46 12.78 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.077 0.951 . . . . 61.1 111.389 173.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -150.26 155.52 39.85 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.478 -0.783 . . . . 72.01 110.067 -167.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 380' ' ' LYS . . . . . 0.477 ' HD3' ' H ' ' B' ' 380' ' ' LYS . 0.0 OUTLIER -119.29 -177.57 3.38 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.819 0.848 . . . . 53.14 108.955 170.664 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 381' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -82.68 111.71 18.88 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 109.027 -0.731 . . . . 74.34 109.027 175.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . 131.86 151.7 6.94 Favored Glycine 0 N--CA 1.473 1.128 0 N-CA-C 111.949 -0.46 . . . . 73.1 111.949 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 383' ' ' ASN . . . . . 0.404 HD21 ' HB3' ' B' ' 392' ' ' HIS . 32.4 p-10 -165.29 -161.4 0.53 Allowed 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 123.607 0.763 . . . . 73.1 109.88 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 384' ' ' THR . . . . . . . . . . . . . 24.4 m -65.76 153.55 41.49 Favored 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 123.74 0.816 . . . . 63.41 111.998 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 385' ' ' LEU . . . . . 0.469 HD12 ' H ' ' B' ' 392' ' ' HIS . 97.4 mt 79.27 163.52 0.2 Allowed 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 126.16 1.784 . . . . 75.12 111.951 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 386' ' ' VAL . . . . . . . . . . . . . 26.8 m -104.72 -170.2 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 123.678 0.791 . . . . 62.42 111.618 -169.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 387' ' ' ILE . . . . . 0.607 HG21 ' HA ' ' B' ' 405' ' ' ALA . 3.1 mp -70.91 -49.75 47.93 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.962 0 C-N-CA 122.902 0.481 . . . . 74.12 110.137 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 388' ' ' VAL . . . . . . . . . . . . . 96.5 t -68.05 -60.72 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 122.95 0.5 . . . . 54.33 110.687 -177.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 389' ' ' THR . . . . . . . . . . . . . 36.4 m -75.35 90.29 2.64 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.07 -1.085 . . . . 71.25 108.07 169.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . -72.42 -112.84 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.025 0 CA-C-N 114.99 -1.005 . . . . 70.34 111.679 -172.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 391' ' ' ASP . . . . . . . . . . . . . 34.5 t70 58.9 -74.62 0.02 OUTLIER 'General case' 0 CA--C 1.565 1.521 0 C-N-CA 124.624 1.17 . . . . 64.12 111.923 -178.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 392' ' ' HIS . . . . . 0.469 ' H ' HD12 ' B' ' 385' ' ' LEU . 89.5 m-70 67.59 78.3 0.24 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.356 1.462 . . . . 72.42 111.386 175.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . 57.12 40.8 28.08 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.187 0.995 . . . . 61.53 110.682 178.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 25.8 m170 74.03 121.15 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.984 1.713 . . . . 73.31 110.299 -174.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . -51.14 103.87 0.07 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.725 1.21 . . . . 71.44 113.149 -172.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 38.5 m -143.5 -164.19 1.81 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.631 1.172 . . . . 75.55 109.505 -179.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 397' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -93.82 32.74 1.39 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.93 0.892 . . . . 71.41 109.872 175.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 398' ' ' ILE . . . . . 0.413 HG23 HG23 ' B' ' 399' ' ' VAL . 7.3 tp -64.23 -33.64 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 124.552 1.141 . . . . 75.44 112.316 -173.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 399' ' ' VAL . . . . . 0.413 HG23 HG23 ' B' ' 398' ' ' ILE . 36.9 t -122.45 4.95 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 N-CA-C 108.75 -0.833 . . . . 73.32 108.75 174.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 400' ' ' ALA . . . . . 0.475 ' HB1' ' HD2' ' B' ' 401' ' ' PRO . . . 66.63 170.52 0.1 Allowed Pre-proline 0 CA--C 1.567 1.626 0 C-N-CA 124.412 1.085 . . . . 51.41 110.164 -169.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 401' ' ' PRO . . . . . 0.475 ' HD2' ' HB1' ' B' ' 400' ' ' ALA . 36.4 Cg_endo -64.87 -1.78 4.63 Favored 'Trans proline' 0 C--N 1.384 2.443 0 C-N-CA 121.507 1.471 . . . . 71.04 114.681 176.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -72.37 90.5 1.29 Allowed 'General case' 0 N--CA 1.481 1.124 0 CA-C-O 121.253 0.549 . . . . 74.34 109.935 174.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 403' ' ' THR . . . . . . . . . . . . . 4.9 t -156.02 122.56 5.18 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.36 1.064 . . . . 51.3 108.563 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 404' ' ' LYS . . . . . . . . . . . . . 7.6 mtmt -137.74 155.33 49.19 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.66 0.784 . . . . 70.03 110.941 -172.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 405' ' ' ALA . . . . . 0.607 ' HA ' HG21 ' B' ' 387' ' ' ILE . . . -70.64 -54.94 7.72 Favored Pre-proline 0 CA--C 1.555 1.15 0 C-N-CA 123.539 0.736 . . . . 71.24 112.552 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 406' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -79.73 8.85 3.76 Favored 'Trans proline' 0 C--N 1.388 2.607 0 C-N-CA 121.438 1.425 . . . . 44.44 113.252 -176.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . 172.28 97.16 0.11 Allowed Glycine 0 C--N 1.34 0.756 0 N-CA-C 110.419 -1.072 . . . . 55.33 110.419 178.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 408' ' ' LEU . . . . . . . . . . . . . 62.3 tp -48.49 -68.1 0.21 Allowed 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 124.775 1.23 . . . . 72.03 111.832 -169.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 50.8 m -113.17 74.76 0.88 Allowed 'General case' 0 C--O 1.237 0.405 0 N-CA-C 107.45 -1.315 . . . . 73.52 107.45 169.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 410' ' ' GLN . . . . . . . . . . . . . 10.4 mm-40 67.85 -70.2 0.13 Allowed 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 125.558 1.543 . . . . 51.32 110.232 -176.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . -72.07 178.86 3.56 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 124.284 1.034 . . . . 63.14 111.278 170.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 1.7 tm? 66.72 83.02 0.17 Allowed 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.765 1.226 . . . . 60.41 109.136 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -77.61 74.57 4.17 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.658 0.783 . . . . 71.14 110.8 -176.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 414' ' ' THR . . . . . . . . . . . . . 15.8 m 76.12 -53.97 0.61 Allowed 'General case' 0 CA--C 1.56 1.341 0 C-N-CA 125.978 1.711 . . . . 73.24 113.28 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 415' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm 74.75 150.65 0.11 Allowed 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 125.177 1.391 . . . . 73.42 110.712 -171.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -57.74 119.88 7.42 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.891 0.476 . . . . 75.33 109.74 171.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 417' ' ' GLY . . . . . . . . . . . . . . . -82.31 62.76 4.53 Favored Glycine 0 C--N 1.342 0.872 0 O-C-N 123.477 0.485 . . . . 43.15 112.653 -178.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 418' ' ' ALA . . . . . . . . . . . . . . . -70.77 -31.56 68.39 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.481 0.712 . . . . 70.25 110.034 173.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 419' ' ' VAL . . . . . . . . . . . . . 27.8 m -87.69 -10.71 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 CA-C-N 115.118 -0.946 . . . . 62.03 111.341 175.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 420' ' ' MET . . . . . . . . . . . . . 22.1 ttt -82.9 -51.92 7.18 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.445 0.698 . . . . 73.12 109.613 175.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 421' ' ' VAL . . . . . . . . . . . . . 11.4 p -64.41 140.36 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 123.047 0.539 . . . . 72.42 111.132 -177.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 422' ' ' MET . . . . . 0.536 ' HG3' HG21 ' B' ' 435' ' ' THR . 6.0 tmm? 63.46 80.99 0.22 Allowed 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 125.123 1.369 . . . . 74.1 109.526 -172.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 423' ' ' SER . . . . . . . . . . . . . 28.3 p 177.39 -72.27 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.636 1.174 . . . . 62.22 110.395 173.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 424' ' ' TYR . . . . . 0.484 ' HE1' ' H ' ' B' ' 78' ' ' SER . 15.5 t80 -78.92 -36.24 42.17 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.342 0.657 . . . . 72.42 111.24 -168.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . -90.04 12.46 67.59 Favored Glycine 0 N--CA 1.472 1.081 0 CA-C-O 119.513 -0.604 . . . . 75.12 113.569 178.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 426' ' ' ASN . . . . . . . . . . . . . 15.0 m120 65.45 97.3 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.826 1.251 . . . . 75.43 112.115 173.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 427' ' ' SER . . . . . 0.512 ' O ' ' HG2' ' B' ' 422' ' ' MET . 21.0 t 72.92 -62.09 0.48 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 125.661 1.584 . . . . 75.14 112.65 175.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 56.27 -90.93 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 124.008 0.923 . . . . 73.23 112.856 173.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 429' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -111.17 84.31 1.91 Allowed 'General case' 0 C--N 1.356 0.861 0 C-N-CA 124.162 0.985 . . . . 63.42 108.631 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -94.1 109.66 21.42 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 109.19 -0.67 . . . . 55.41 109.19 -178.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 21.1 m -64.16 108.8 1.65 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.674 0.79 . . . . 73.31 111.357 -176.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 432' ' ' GLN . . . . . 0.409 ' HB2' ' NE2' ' B' ' 438' ' ' GLN . 1.4 mp0 57.92 -87.54 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.429 1.492 . . . . 71.1 111.033 -175.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 433' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -144.67 126.02 14.82 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.751 1.221 . . . . 73.43 108.355 -178.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 434' ' ' HIS . . . . . 0.586 ' HB3' ' HB3' ' B' ' 321' ' ' LEU . 13.5 p-80 51.92 100.85 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 126.501 1.92 . . . . 65.13 113.22 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 435' ' ' THR . . . . . 0.536 HG21 ' HG3' ' B' ' 422' ' ' MET . 15.9 p -64.25 -43.07 96.02 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.211 0.604 . . . . 73.42 111.088 174.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 436' ' ' GLY . . . . . 0.49 ' HA2' ' HB2' ' A' ' 220' ' ' GLU . . . -61.68 103.12 0.52 Allowed Glycine 0 C--N 1.35 1.32 0 CA-C-N 115.391 -0.822 . . . . 43.54 112.409 178.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 83.5 p 61.84 43.5 9.36 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.798 1.639 . . . . 54.14 111.679 -174.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 438' ' ' GLN . . . . . 0.41 ' HB2' ' O ' ' B' ' 434' ' ' HIS . 5.6 tp60 -63.59 -42.5 98.25 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 115.468 -0.787 . . . . 71.55 110.448 171.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 439' ' ' LEU . . . . . 0.418 ' HB2' ' HD3' ' A' ' 238' ' ' LYS . 3.8 pp -134.02 133.61 41.45 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 109.039 -0.726 . . . . 74.24 109.039 176.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 440' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.37 152.13 34.54 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.823 0.849 . . . . 70.1 109.651 -177.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 441' ' ' ILE . . . . . 0.675 HG23 HD21 ' A' ' 235' ' ' LEU . 62.6 mt -105.06 134.69 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.314 0.646 . . . . 74.15 111.348 -175.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 442' ' ' ALA . . . . . . . . . . . . . . . -107.2 -78.83 0.58 Allowed 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 108.522 -0.918 . . . . 71.41 108.522 166.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . 56.83 -83.26 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 125.166 1.386 . . . . 74.21 113.11 176.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -152.25 -177.48 6.21 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.932 0.893 . . . . 65.34 110.207 -178.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . 99.07 103.73 2.45 Favored Glycine 0 C--N 1.349 1.277 0 CA-C-O 118.566 -1.13 . . . . 74.34 110.394 -174.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 446' ' ' PRO . . . . . 0.533 ' HA ' ' HB2' ' B' ' 339' ' ' PHE . 95.4 Cg_endo -74.06 71.35 4.32 Favored 'Trans proline' 0 C--N 1.382 2.327 0 C-N-CA 123.174 2.583 . . . . 63.02 113.593 -173.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 447' ' ' HIS . . . . . . . . . . . . . 13.2 t60 67.38 -67.84 0.17 Allowed 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 125.965 1.706 . . . . 60.0 112.812 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . 68.6 164.69 0.24 Allowed 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 125.154 1.382 . . . . 74.31 111.077 -173.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 449' ' ' ALA . . . . . 0.4 ' HB2' HD21 ' B' ' 47' ' ' LEU . . . -82.1 63.46 6.32 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 120.841 0.353 . . . . 61.52 110.705 178.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 450' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -168.79 -75.68 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.824 0.85 . . . . 61.12 109.934 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 61.2 t -71.65 92.57 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 123.531 0.732 . . . . 63.1 111.296 -166.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 452' ' ' VAL . . . . . . . . . . . . . 14.9 p -102.1 -9.78 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.15 0 CA-C-N 114.655 -1.157 . . . . 60.45 109.873 175.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 113.99 -81.3 0.29 Allowed Glycine 0 C--N 1.355 1.62 0 CA-C-N 116.296 -0.411 . . . . 73.44 113.611 169.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 454' ' ' LEU . . . . . 0.545 HD11 ' HA ' ' B' ' 110' ' ' ALA . 3.4 tm? -64.71 106.27 1.15 Allowed 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.539 0.736 . . . . 72.5 109.731 -174.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 30.2 m -94.43 152.74 18.37 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 114.716 -1.129 . . . . 61.41 109.411 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -83.21 -86.37 0.11 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 122.493 0.317 . . . . 74.3 110.401 177.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 457' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 178.62 -68.49 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 108.372 -0.973 . . . . 42.14 108.372 -168.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 35.4 p -101.76 75.74 1.59 Allowed 'General case' 0 C--N 1.35 0.599 0 CA-C-O 122.631 1.205 . . . . 72.13 108.995 178.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 459' ' ' ASP . . . . . 0.454 ' HB3' ' O ' ' B' ' 463' ' ' THR . 9.1 m-20 -87.35 23.62 1.83 Allowed 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 114.195 -1.366 . . . . 73.31 111.144 -173.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 460' ' ' LEU . . . . . 0.443 ' H ' ' HG ' ' B' ' 460' ' ' LEU . 1.8 pp -67.4 -12.67 60.81 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 124.306 1.042 . . . . 65.42 112.863 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -75.32 -56.95 4.21 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 122.679 0.392 . . . . 62.31 110.756 -177.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -148.24 29.04 0.89 Allowed 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 123.109 0.563 . . . . 72.53 112.307 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 463' ' ' THR . . . . . 0.454 ' O ' ' HB3' ' B' ' 459' ' ' ASP . 6.1 p 54.16 -71.24 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 126.015 1.726 . . . . 61.35 114.144 -177.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 464' ' ' MET . . . . . 0.724 ' HA ' HH21 ' B' ' 56' ' ' ARG . 41.9 ttm -155.22 -44.58 0.08 Allowed 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.734 -0.604 . . . . 75.31 110.414 178.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 465' ' ' LYS . . . . . 0.44 ' HD3' ' H ' ' B' ' 465' ' ' LYS . 0.0 OUTLIER -70.33 138.9 51.83 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 123.529 0.518 . . . . 72.15 110.4 175.702 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -64.81 -67.84 0.41 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.168 0.587 . . . . 62.32 110.492 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 467' ' ' ALA . . . . . 0.44 ' HB1' ' HB3' ' B' ' 271' ' ' ALA . . . 69.52 -11.56 0.5 Allowed 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 115.027 1.492 . . . . 75.3 115.027 168.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 468' ' ' LEU . . . . . 0.604 HD12 HD22 ' B' ' 272' ' ' ASN . 53.2 tp -65.66 -30.52 71.23 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.913 0.885 . . . . 45.51 112.07 -172.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 469' ' ' GLY . . . . . . . . . . . . . . . 119.89 56.36 0.25 Allowed Glycine 0 C--N 1.343 0.97 0 N-CA-C 111.232 -0.747 . . . . 50.44 111.232 -178.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 470' ' ' LEU . . . . . 0.407 ' HB3' ' HB1' ' B' ' 305' ' ' ALA . 6.8 mp -79.33 -27.98 42.08 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.172 0.589 . . . . 73.2 110.947 -173.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 471' ' ' LYS . . . . . 0.436 ' NZ ' ' HB3' ' B' ' 471' ' ' LYS . 0.2 OUTLIER . . . . . 0 CA--C 1.56 1.346 0 C-N-CA 124.287 1.035 . . . . 74.2 109.219 -172.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 110.085 -0.339 . . . . 55.23 110.085 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.42 36.44 17.3 Favored 'General case' 0 C--N 1.351 0.671 0 C-N-CA 125.389 1.476 . . . . 65.31 112.473 176.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.8 73.11 4.37 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 109.825 -0.435 . . . . 52.01 109.825 175.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 4' ' ' LYS . . . . . 0.468 ' HE2' ' HE2' ' C' ' 69' ' ' TYR . 38.7 ttmt -39.42 101.15 0.02 OUTLIER 'General case' 0 C--N 1.353 0.739 0 C-N-CA 125.421 1.488 . . . . 70.52 113.766 -177.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -66.32 95.62 0.31 Allowed 'General case' 0 C--O 1.244 0.807 0 N-CA-C 108.558 -0.905 . . . . 63.2 108.558 164.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -74.7 94.71 2.74 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 106.758 -1.571 . . . . 63.22 106.758 173.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 7' ' ' TYR . . . . . 0.426 ' HB3' ' HA ' ' C' ' 53' ' ' ALA . 50.1 m-85 -56.53 -35.74 68.42 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 114.766 -1.107 . . . . 73.43 111.551 -170.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 8' ' ' TYR . . . . . 0.422 ' HD1' HG23 ' C' ' 13' ' ' VAL . 65.4 m-85 -65.9 -42.65 89.95 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.411 -1.268 . . . . 72.53 111.801 175.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.42 -39.52 94.0 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 122.643 0.377 . . . . 52.31 110.848 177.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 59.2 mt -56.88 -43.14 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.446 0.698 . . . . 63.34 109.939 175.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 11' ' ' LEU . . . . . 0.543 ' HB3' ' HB1' ' C' ' 25' ' ' ALA . 96.2 mt -76.94 -15.15 59.75 Favored 'General case' 0 CA--C 1.556 1.195 0 CA-C-N 115.268 -0.878 . . . . 45.45 113.205 177.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.67 18.86 80.04 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 113.797 0.279 . . . . 64.33 113.797 -176.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 13' ' ' VAL . . . . . 0.422 HG23 ' HD1' ' C' ' 8' ' ' TYR . 30.1 m -111.73 155.03 43.75 Favored Pre-proline 0 N--CA 1.483 1.206 0 C-N-CA 124.442 1.097 . . . . 64.04 110.015 179.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -60.59 156.53 41.67 Favored 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 123.155 2.57 . . . . 74.43 113.729 177.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 33.4 mtp-105 -69.95 7.12 1.0 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 113.804 1.038 . . . . 71.52 113.804 -174.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -127.6 9.07 6.47 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.305 1.042 . . . . 71.24 109.302 -177.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.09 130.28 45.45 Favored 'General case' 0 C--N 1.356 0.883 0 C-N-CA 123.97 0.908 . . . . 71.14 110.951 -175.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 71.5 p -68.47 166.86 15.99 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.56 0.744 . . . . 74.41 110.713 -177.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 62.4 tp60 -57.75 -33.62 68.67 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.784 0.833 . . . . 74.45 111.908 -172.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -70.1 -40.53 74.9 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.038 0.535 . . . . 64.05 111.288 177.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -65.64 -39.9 91.92 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 122.757 0.423 . . . . 73.42 110.748 179.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 22' ' ' ILE . . . . . 0.572 HD13 ' HB3' ' C' ' 57' ' ' LEU . 86.1 mt -64.75 -42.57 95.34 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 C-N-CA 124.054 0.942 . . . . 61.32 110.372 176.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -61.99 -47.13 86.17 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.367 1.067 . . . . 74.13 111.326 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 78.7 mtm180 -71.24 -35.53 71.47 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 115.987 -0.551 . . . . 73.52 110.758 -178.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . 0.543 ' HB1' ' HB3' ' C' ' 11' ' ' LEU . . . -64.11 -40.39 96.09 Favored 'General case' 0 C--O 1.249 1.031 0 C-N-CA 123.11 0.564 . . . . 75.32 110.457 176.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 26' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -57.91 -60.25 4.0 Favored 'General case' 0 C--O 1.214 -0.778 0 CA-C-N 114.77 -1.105 . . . . 72.31 109.873 175.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -60.49 -41.32 94.01 Favored 'General case' 0 N--CA 1.483 1.183 0 O-C-N 124.068 0.855 . . . . 74.1 111.653 -174.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -53.07 -58.67 6.22 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.456 1.103 . . . . 71.15 110.922 176.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 97.1 mt -80.79 -11.09 59.66 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.521 -0.763 . . . . 60.22 111.06 -176.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -80.43 -26.23 38.54 Favored 'General case' 0 C--O 1.216 -0.684 0 C-N-CA 122.906 0.482 . . . . 75.32 109.731 171.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -81.2 -39.81 24.85 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.929 0.892 . . . . 73.5 110.404 175.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -70.16 -51.15 33.53 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.171 0.588 . . . . 71.12 109.789 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 33' ' ' TYR . . . . . 0.434 ' HB3' ' O ' ' C' ' 43' ' ' ALA . 35.6 m-85 -89.73 14.65 11.27 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 115.739 -0.664 . . . . 70.15 111.798 -176.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 34' ' ' HIS . . . . . 0.493 ' HD2' ' HB3' ' C' ' 36' ' ' ASP . 6.7 t60 -62.15 103.55 0.4 Allowed Pre-proline 0 N--CA 1.487 1.397 0 C-N-CA 123.947 0.899 . . . . 72.34 110.76 -174.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 35' ' ' PRO . . . . . 0.571 ' HB3' ' HG2' ' C' ' 44' ' ' GLU . 31.7 Cg_exo -59.55 -26.88 83.48 Favored 'Trans proline' 0 C--N 1.381 2.274 0 C-N-CA 123.285 2.656 . . . . 71.32 113.12 -171.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 36' ' ' ASP . . . . . 0.493 ' HB3' ' HD2' ' C' ' 34' ' ' HIS . 25.2 t70 -64.87 -39.0 92.86 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.25 1.02 . . . . 60.34 111.833 177.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 43.5 t -94.1 -54.34 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-O 121.277 0.56 . . . . 75.33 109.677 -177.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -100.04 92.21 5.14 Favored 'General case' 0 C--O 1.243 0.732 0 C-N-CA 124.558 1.143 . . . . 54.22 109.219 178.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -79.39 76.51 5.96 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 109.346 -0.613 . . . . 62.24 109.346 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 49.5 m -129.27 118.07 19.11 Favored Pre-proline 0 CA--C 1.538 0.491 0 CA-C-O 118.091 -0.957 . . . . 74.14 108.787 177.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -45.04 -45.26 14.47 Favored 'Trans proline' 0 C--N 1.382 2.335 0 C-N-CA 123.917 3.078 . . . . 63.44 113.679 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -60.08 -39.85 87.51 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.482 -0.781 . . . . 65.44 110.94 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 43' ' ' ALA . . . . . 0.434 ' O ' ' HB3' ' C' ' 33' ' ' TYR . . . -74.42 -19.79 60.28 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.885 -0.598 . . . . 62.05 111.447 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 44' ' ' GLU . . . . . 0.571 ' HG2' ' HB3' ' C' ' 35' ' ' PRO . 39.4 mt-10 -78.35 -45.57 22.21 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 109.547 -0.538 . . . . 74.04 109.547 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -68.7 -39.68 80.37 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.258 -0.883 . . . . 42.53 109.915 177.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 46' ' ' LYS . . . . . 0.56 ' O ' HG12 ' C' ' 50' ' ' ILE . 23.1 mmtm -61.7 -42.77 99.39 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.069 -0.514 . . . . 72.32 110.836 174.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -55.93 -43.13 77.09 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.551 0.74 . . . . 62.23 110.027 175.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 48' ' ' LYS . . . . . 0.404 ' HA ' ' HB2' ' C' ' 51' ' ' ASN . 97.1 mttt -72.59 -23.32 60.94 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-N 115.641 -0.709 . . . . 72.04 112.091 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -78.05 -25.61 47.85 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 118.139 0.427 . . . . 72.33 110.342 172.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 50' ' ' ILE . . . . . 0.56 HG12 ' O ' ' C' ' 46' ' ' LYS . 18.2 mm -75.35 -36.13 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 N-CA-C 108.287 -1.005 . . . . 75.43 108.287 172.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 51' ' ' ASN . . . . . 0.404 ' HB2' ' HA ' ' C' ' 48' ' ' LYS . 0.9 OUTLIER -68.27 -36.61 79.66 Favored 'General case' 0 C--O 1.2 -1.548 0 CA-C-N 114.883 -1.053 . . . . 74.04 110.018 173.643 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -65.52 -47.05 77.26 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.902 1.281 . . . . 63.42 109.986 178.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . 0.426 ' HA ' ' HB3' ' C' ' 7' ' ' TYR . . . -57.85 -61.41 2.55 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 113.998 -1.455 . . . . 63.1 111.01 178.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 54' ' ' TYR . . . . . 0.545 ' HD1' HG22 ' C' ' 22' ' ' ILE . 76.6 t80 -71.17 -12.87 61.72 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.745 -0.661 . . . . 75.01 111.533 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.64 -57.69 7.51 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 108.95 -0.759 . . . . 60.54 108.95 171.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 48.4 t -69.04 -22.69 26.41 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 CA-C-N 114.543 -1.208 . . . . 72.43 110.814 -178.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 57' ' ' LEU . . . . . 0.572 ' HB3' HD13 ' C' ' 22' ' ' ILE . 64.7 mt -109.13 9.2 26.2 Favored 'General case' 0 CA--C 1.564 1.484 0 N-CA-C 112.772 0.656 . . . . 75.02 112.772 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 46.6 t -51.69 -45.55 63.54 Favored 'General case' 0 N--CA 1.503 2.215 0 C-N-CA 124.66 1.184 . . . . 62.42 113.292 176.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . 0.429 ' HB2' ' HG3' ' C' ' 62' ' ' LYS . 2.0 m-20 -114.85 148.78 41.19 Favored Pre-proline 0 C--O 1.241 0.608 0 CA-C-N 115.492 -0.776 . . . . 72.03 109.145 177.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 60' ' ' PRO . . . . . 0.503 ' O ' ' HG2' ' C' ' 64' ' ' ARG . 69.0 Cg_exo -55.75 -30.6 76.76 Favored 'Trans proline' 0 C--N 1.374 1.921 0 C-N-CA 122.636 2.224 . . . . 33.23 111.984 167.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -64.41 -49.48 71.38 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.925 0.89 . . . . 62.13 111.054 175.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 62' ' ' LYS . . . . . 0.429 ' HG3' ' HB2' ' C' ' 59' ' ' ASP . 28.1 mtpp -66.7 -30.92 71.28 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-O 121.259 0.552 . . . . 75.23 110.07 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 23.0 tpt180 -60.65 -41.68 95.44 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 115.272 -0.876 . . . . 64.42 110.145 168.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 64' ' ' ARG . . . . . 0.503 ' HG2' ' O ' ' C' ' 60' ' ' PRO . 30.5 mmm180 -65.68 -27.09 68.1 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-O 119.305 -0.379 . . . . 74.15 111.525 176.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 1.7 mp -63.46 -45.08 98.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 109.581 -0.526 . . . . 62.34 109.581 168.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -58.46 -46.39 86.69 Favored 'General case' 0 CA--C 1.562 1.429 0 N-CA-C 109.312 -0.625 . . . . 74.22 109.312 174.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -61.85 -35.68 78.99 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 124.122 0.969 . . . . 73.14 112.009 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 40.7 p -73.99 -22.55 59.56 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 119.421 -0.323 . . . . 63.2 110.775 177.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 69' ' ' TYR . . . . . 0.468 ' HE2' ' HE2' ' C' ' 4' ' ' LYS . 79.9 t80 -76.11 108.05 8.76 Favored 'General case' 0 C--N 1.355 0.84 0 N-CA-C 107.648 -1.241 . . . . 75.22 107.648 168.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 102.64 27.71 6.63 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.202 -0.759 . . . . 62.51 111.202 -167.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 25.1 m -145.95 -57.64 0.31 Allowed 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 103.494 -2.78 . . . . 72.34 103.494 173.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 5.4 m -81.2 140.18 35.09 Favored 'General case' 0 C--O 1.254 1.32 0 N-CA-C 104.618 -2.364 . . . . 73.35 104.618 157.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.23 -32.63 15.69 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.647 0.779 . . . . 73.23 110.505 -178.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -92.98 159.06 36.47 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 124.056 0.942 . . . . 53.23 109.888 177.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -59.5 150.85 73.08 Favored 'Trans proline' 0 CA--C 1.56 1.786 0 C-N-CA 122.318 2.012 . . . . 75.14 112.141 168.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -68.0 164.16 32.96 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 122.729 2.286 . . . . 63.14 112.788 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -60.64 129.73 30.53 Favored 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 122.973 2.449 . . . . 51.51 111.97 173.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 78' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -59.61 115.17 2.42 Favored 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 123.158 2.572 . . . . 74.44 113.182 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 79' ' ' PRO . . . . . 0.404 ' HA ' ' HD3' ' C' ' 80' ' ' PRO . 38.9 Cg_endo -66.16 130.6 24.55 Favored 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 122.532 2.155 . . . . 61.04 111.332 175.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 80' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' C' ' 79' ' ' PRO . 24.8 Cg_exo -62.0 88.66 0.1 Allowed 'Trans proline' 0 C--N 1.379 2.179 0 C-N-CA 122.733 2.289 . . . . 51.5 111.754 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 155.77 -33.51 0.62 Allowed Glycine 0 N--CA 1.465 0.63 0 N-CA-C 110.238 -1.145 . . . . 75.2 110.238 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 126.96 157.7 9.58 Favored Glycine 0 C--N 1.352 1.47 0 CA-C-N 114.837 -0.682 . . . . 74.45 113.462 173.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -67.69 107.89 2.72 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 107.636 -1.246 . . . . 70.14 107.636 164.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -67.21 130.19 42.31 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.396 0.617 . . . . 63.13 111.719 -169.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 85' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -132.57 52.53 2.07 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.565 1.146 . . . . 74.41 108.122 174.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 50.9 m -64.01 96.38 0.14 Allowed 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 113.295 -1.775 . . . . 45.43 111.862 -174.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 114.95 -13.95 19.56 Favored Glycine 0 C--N 1.348 1.243 0 CA-C-N 115.658 -0.701 . . . . 74.33 113.105 176.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 88' ' ' PHE . . . . . 0.409 ' HB3' ' HZ ' ' C' ' 93' ' ' PHE . 38.8 m-85 -112.3 144.01 42.44 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 117.392 0.596 . . . . 74.44 110.376 -169.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 89' ' ' ASP . . . . . 0.548 ' HA ' ' HG2' ' C' ' 171' ' ' PRO . 46.0 t0 -77.11 74.46 3.69 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.861 0.839 . . . . 72.23 110.746 -175.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 90' ' ' VAL . . . . . 0.471 HG12 ' HG3' ' C' ' 171' ' ' PRO . 5.2 p -48.85 -47.46 16.23 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.003 0 C-N-CA 126.128 1.771 . . . . 54.41 113.063 -171.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -61.78 -27.2 68.58 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 112.836 0.68 . . . . 74.21 112.836 -173.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -83.74 -11.09 57.61 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 111.796 0.295 . . . . 75.53 111.796 -173.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 93' ' ' PHE . . . . . 0.409 ' HZ ' ' HB3' ' C' ' 88' ' ' PHE . 13.5 m-30 -74.6 171.29 14.12 Favored 'General case' 0 CA--C 1.557 1.233 0 CA-C-O 120.846 0.355 . . . . 72.45 111.581 -174.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 93.6 p -76.52 174.34 10.43 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 115.105 1.52 . . . . 45.51 115.105 -164.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -51.87 -47.93 64.29 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.34 1.456 . . . . 55.43 112.644 174.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -56.94 -45.67 82.6 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.547 0.739 . . . . 65.02 110.59 -177.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 97' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.33 -47.76 80.73 Favored 'General case' 0 CA--C 1.56 1.34 0 CA-C-N 114.359 -1.291 . . . . 64.25 110.208 172.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -66.79 -14.09 62.23 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.739 0.815 . . . . 51.52 112.29 -179.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -95.73 -39.2 9.99 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.085 0.554 . . . . 74.43 112.196 177.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 43.8 tp -83.13 -51.28 7.65 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-O 121.403 0.621 . . . . 73.23 110.929 -176.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -87.75 -18.79 28.63 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.001 0.921 . . . . 73.25 110.607 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -40.33 -56.24 2.89 Favored Glycine 0 C--N 1.358 1.781 0 CA-C-O 118.137 -1.369 . . . . 54.11 115.335 177.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 0.8 OUTLIER -28.9 -37.15 0.04 OUTLIER 'Trans proline' 0 C--N 1.389 2.695 1 C-N-CA 125.831 4.354 . . . . 62.02 116.663 174.281 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -149.44 47.3 0.63 Allowed Glycine 0 C--N 1.345 1.056 0 C-N-CA 121.266 -0.492 . . . . 43.23 112.621 -179.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 105' ' ' LEU . . . . . 0.543 ' HB3' HD22 ' C' ' 169' ' ' ASN . 37.1 mt -61.19 80.55 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 121.266 0.555 . . . . 73.03 111.606 170.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 106' ' ' PHE . . . . . 0.524 ' HB3' ' H ' ' C' ' 168' ' ' GLY . 87.0 m-85 45.22 -110.25 0.21 Allowed 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 125.796 1.638 . . . . 64.24 114.159 -178.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 107' ' ' GLY . . . . . 0.4 ' CA ' ' H ' ' C' ' 113' ' ' SER . . . 66.17 15.0 62.48 Favored Glycine 0 C--N 1.362 1.981 0 C-N-CA 121.016 -0.611 . . . . 51.05 112.723 -162.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 59.48 -122.02 28.68 Favored Glycine 0 C--N 1.349 1.294 0 N-CA-C 111.072 -0.811 . . . . 74.41 111.072 -167.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 109' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -100.46 -7.77 23.9 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 122.919 0.488 . . . . 74.45 109.961 173.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 110' ' ' GLY . . . . . . . . . . . . . . . -93.11 -6.32 63.26 Favored Glycine 0 C--N 1.353 1.49 0 CA-C-O 119.293 -0.726 . . . . 54.22 114.322 -173.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 51.55 16.78 0.48 Allowed 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 125.016 1.327 . . . . 75.25 112.371 178.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 112' ' ' ARG . . . . . 0.446 ' HD2' ' HB2' ' C' ' 114' ' ' ARG . 1.5 tmt_? -58.27 -33.52 69.49 Favored 'General case' 0 CA--C 1.56 1.346 0 C-N-CA 124.165 0.986 . . . . 74.1 110.045 172.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 113' ' ' SER . . . . . 0.4 ' H ' ' CA ' ' C' ' 107' ' ' GLY . 55.4 m 60.5 34.53 20.4 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.824 1.65 . . . . 72.53 112.382 176.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 114' ' ' ARG . . . . . 0.565 ' NE ' ' HA ' ' C' ' 114' ' ' ARG . 1.1 tpm_? -105.9 -159.32 0.7 Allowed 'General case' 0 C--O 1.209 -1.027 0 CA-C-O 117.847 -1.073 . . . . 74.05 111.023 176.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 115' ' ' LYS . . . . . 0.492 ' H ' ' HG3' ' C' ' 114' ' ' ARG . 5.5 tmtt? -58.24 125.37 22.94 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 120.146 1.339 . . . . 54.14 112.172 -163.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 116' ' ' GLY . . . . . 0.435 ' N ' ' HD3' ' C' ' 115' ' ' LYS . . . -63.48 118.96 14.92 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-N 114.667 -1.151 . . . . 45.25 113.829 177.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -88.5 163.54 15.87 Favored 'General case' 0 C--O 1.244 0.769 0 C-N-CA 124.733 1.213 . . . . 64.44 110.694 178.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -68.87 144.63 54.18 Favored 'General case' 0 C--O 1.245 0.849 0 N-CA-C 108.47 -0.937 . . . . 75.42 108.47 168.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 119' ' ' LEU . . . . . 0.468 HD21 HG23 ' C' ' 140' ' ' VAL . 0.0 OUTLIER -133.53 152.72 51.95 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 121.266 0.555 . . . . 75.21 110.625 175.97 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -105.49 113.52 27.15 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.046 -0.979 . . . . 72.31 108.714 -173.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 121' ' ' ALA . . . . . 0.685 ' HB1' ' HG3' ' C' ' 139' ' ' GLU . . . -111.79 116.84 31.36 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.485 -1.672 . . . . 63.21 106.485 172.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 122' ' ' GLU . . . . . 0.798 ' HB3' ' HA ' ' B' ' 186' ' ' THR . 20.7 tt0 -114.5 138.09 51.03 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 122.638 0.375 . . . . 73.22 110.429 -171.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -142.14 133.38 13.07 Favored Pre-proline 0 CA--C 1.544 0.72 0 CA-C-N 115.403 -0.817 . . . . 73.3 111.164 -168.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . 0.404 ' HB3' ' HB2' ' B' ' 189' ' ' LYS . 36.4 Cg_endo -66.93 128.55 18.97 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.383 2.056 . . . . 72.51 110.624 164.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 125' ' ' LEU . . . . . 0.481 ' O ' ' HA ' ' C' ' 180' ' ' LEU . 14.0 tp -153.56 165.48 35.76 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 106.763 -1.569 . . . . 74.03 106.763 -174.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 126' ' ' THR . . . . . 0.422 ' H ' ' HB2' ' C' ' 129' ' ' GLU . 15.1 t -127.69 175.96 7.9 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 119.69 1.132 . . . . 61.53 110.278 173.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 127' ' ' LEU . . . . . 0.438 HD13 ' CD2' ' C' ' 186' ' ' PHE . 33.5 mt -58.89 -47.82 83.61 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.494 1.518 . . . . 62.25 110.876 -178.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 128' ' ' GLU . . . . . 0.497 ' HG3' ' HA ' ' C' ' 215' ' ' LEU . 11.4 mp0 -60.92 -36.73 80.07 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 114.904 -1.044 . . . . 75.24 110.281 177.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 129' ' ' GLU . . . . . 0.422 ' HB2' ' H ' ' C' ' 126' ' ' THR . 34.7 mm-40 -78.77 -22.67 46.04 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.548 0.739 . . . . 73.53 112.519 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 130' ' ' ALA . . . . . 0.424 ' HB2' HG22 ' C' ' 153' ' ' VAL . . . -74.39 -33.16 62.97 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 108.92 -0.77 . . . . 64.34 108.92 174.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 131' ' ' PHE . . . . . 0.42 ' HB3' ' O ' ' C' ' 128' ' ' GLU . 54.8 t80 -65.64 -48.62 71.54 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 113.922 -1.49 . . . . 75.55 110.07 169.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 132' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -73.69 -12.88 60.87 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.331 0.652 . . . . 60.22 112.013 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -37.42 -84.87 0.01 OUTLIER Glycine 0 C--N 1.365 2.176 0 O-C-N 124.649 1.218 . . . . 65.31 114.606 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 134' ' ' GLY . . . . . 0.45 ' O ' ' HA ' ' C' ' 148' ' ' ARG . . . 49.36 -135.31 23.44 Favored Glycine 0 C--N 1.356 1.666 0 O-C-N 124.278 0.634 . . . . 53.24 114.237 174.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 135' ' ' GLU . . . . . 0.522 ' HG3' ' HB2' ' C' ' 148' ' ' ARG . 1.4 mp0 -89.92 91.96 8.81 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 108.044 -1.095 . . . . 71.2 108.044 177.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 136' ' ' ARG . . . . . . . . . . . . . 66.5 mtm180 -140.82 169.29 17.9 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 121.976 0.893 . . . . 72.12 110.751 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 137' ' ' VAL . . . . . 0.623 ' HB ' ' HG2' ' C' ' 144' ' ' ARG . 15.8 m -75.14 95.41 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 CA-C-N 113.769 -1.56 . . . . 71.12 111.122 -176.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 138' ' ' VAL . . . . . 0.471 HG12 ' HB ' ' C' ' 145' ' ' VAL . 2.9 p -79.7 161.24 4.12 Favored 'Isoleucine or valine' 0 C--O 1.251 1.132 0 CA-C-N 114.176 -1.375 . . . . 72.14 112.48 -172.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 139' ' ' GLU . . . . . 0.685 ' HG3' ' HB1' ' C' ' 121' ' ' ALA . 7.7 tp10 -82.5 136.57 34.85 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 113.636 -1.62 . . . . 74.31 111.686 175.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 140' ' ' VAL . . . . . 0.468 HG23 HD21 ' C' ' 119' ' ' LEU . 5.5 p -169.76 99.52 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 124.534 1.133 . . . . 63.22 108.821 163.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 141' ' ' ALA . . . . . 0.584 ' HA ' HG23 ' B' ' 185' ' ' VAL . . . 66.32 22.64 10.83 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.247 1.019 . . . . 15.23 111.921 -178.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 86.93 -14.17 57.52 Favored Glycine 0 C--N 1.346 1.09 0 CA-C-N 116.208 -0.451 . . . . 45.25 112.726 -174.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 143' ' ' ARG . . . . . 0.62 HH11 HG22 ' C' ' 145' ' ' VAL . 0.0 OUTLIER -74.82 120.94 21.04 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 108.588 -0.893 . . . . 73.04 108.588 -178.688 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 144' ' ' ARG . . . . . 0.623 ' HG2' ' HB ' ' C' ' 137' ' ' VAL . 51.2 ttp180 -87.7 92.36 9.08 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 125.451 1.501 . . . . 71.51 109.918 -169.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 145' ' ' VAL . . . . . 0.62 HG22 HH11 ' C' ' 143' ' ' ARG . 65.5 t -98.27 121.03 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 C-N-CA 122.679 0.391 . . . . 75.03 111.067 -174.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 19.8 m -75.02 101.73 4.59 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.165 0.586 . . . . 54.21 109.819 177.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 7.5 p -152.36 158.99 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 122.337 0.255 . . . . 72.53 110.739 -174.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 148' ' ' ARG . . . . . 0.522 ' HB2' ' HG3' ' C' ' 135' ' ' GLU . 42.7 ttm180 -91.44 123.68 35.04 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 109.412 -0.588 . . . . 74.22 109.412 170.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 149' ' ' ILE . . . . . . . . . . . . . 34.2 pt -105.03 151.42 39.47 Favored Pre-proline 0 CA--C 1.548 0.904 0 N-CA-C 107.297 -1.371 . . . . 71.41 107.297 163.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -47.95 115.5 1.51 Allowed 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.852 2.368 . . . . 61.44 112.484 175.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 151' ' ' PRO . . . . . 0.537 ' HG2' ' HA2' ' C' ' 242' ' ' GLY . 28.9 Cg_endo -61.87 109.06 0.72 Allowed 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 122.613 2.209 . . . . 73.2 111.155 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 152' ' ' GLY . . . . . . . . . . . . . . . 124.5 122.96 2.7 Favored Glycine 0 C--N 1.343 0.925 0 CA-C-N 115.376 -0.829 . . . . 54.32 113.739 -173.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 153' ' ' VAL . . . . . 0.694 HG21 HG21 ' C' ' 178' ' ' VAL . 5.7 m -141.78 176.04 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 C-N-CA 123.586 0.754 . . . . 71.13 110.658 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 154' ' ' ARG . . . . . 0.718 ' HB2' ' HB2' ' C' ' 157' ' ' SER . 15.6 mtp180 -125.85 169.13 12.95 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 124.378 1.071 . . . . 75.32 109.877 -178.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 155' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -69.81 126.54 30.01 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.744 0.418 . . . . 74.51 110.814 175.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 67.9 11.7 61.14 Favored Glycine 0 C--N 1.349 1.288 0 CA-C-N 115.719 -0.673 . . . . 64.51 113.559 -178.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 157' ' ' SER . . . . . 0.718 ' HB2' ' HB2' ' C' ' 154' ' ' ARG . 33.0 t -74.07 132.8 42.67 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.131 0.572 . . . . 75.43 110.523 -174.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 158' ' ' VAL . . . . . 0.54 ' HB ' HD22 ' C' ' 175' ' ' LEU . 16.1 m -86.08 95.94 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 CA-C-N 115.527 -0.761 . . . . 64.44 109.192 171.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 159' ' ' ILE . . . . . 0.775 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 8.3 mt -68.55 90.53 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 107.468 -1.308 . . . . 52.25 107.468 171.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -83.59 100.19 10.65 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.404 -0.591 . . . . 72.21 109.404 -176.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 161' ' ' VAL . . . . . 0.519 HG13 ' HB3' ' C' ' 174' ' ' LEU . 2.6 p -102.84 103.98 36.51 Favored Pre-proline 0 CA--C 1.561 1.391 0 N-CA-C 108.477 -0.935 . . . . 75.24 108.477 175.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -62.54 142.55 90.51 Favored 'Trans proline' 0 C--N 1.386 2.534 0 C-N-CA 123.633 2.889 . . . . 63.42 113.805 -175.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 86.15 -24.98 7.32 Favored Glycine 0 C--N 1.347 1.188 0 CA-C-N 115.638 -0.71 . . . . 53.31 113.719 177.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 164' ' ' MET . . . . . . . . . . . . . 41.6 mtp -78.64 -6.47 55.77 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 113.403 0.89 . . . . 73.35 113.403 -174.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . -106.03 -151.5 19.43 Favored Glycine 0 C--N 1.334 0.465 0 N-CA-C 111.856 -0.497 . . . . 64.24 111.856 173.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . 109.27 73.36 0.77 Allowed Glycine 0 C--N 1.342 0.906 0 C-N-CA 121.562 -0.351 . . . . 75.44 112.392 -173.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 167' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -77.32 102.37 6.71 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 105.999 -1.852 . . . . 64.31 105.999 163.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 168' ' ' GLY . . . . . 0.524 ' H ' ' HB3' ' C' ' 106' ' ' PHE . . . 115.51 153.1 10.21 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 108.109 -1.997 . . . . 13.44 108.109 -161.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 169' ' ' ASN . . . . . 0.543 HD22 ' HB3' ' C' ' 105' ' ' LEU . 25.0 t-20 -66.07 -66.66 1.22 Allowed Pre-proline 0 CA--C 1.583 2.245 0 CA-C-O 116.74 -1.6 . . . . 62.44 112.833 -168.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 170' ' ' PRO . . . . . 0.46 ' HD3' ' HB3' ' C' ' 169' ' ' ASN . 51.8 Cg_exo -51.08 111.94 0.67 Allowed 'Trans proline' 0 C--N 1.401 3.309 0 CA-C-N 123.076 2.134 . . . . 51.41 113.381 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 171' ' ' PRO . . . . . 0.548 ' HG2' ' HA ' ' C' ' 89' ' ' ASP . 71.6 Cg_exo -47.58 139.9 17.32 Favored 'Trans proline' 0 C--N 1.383 2.377 0 C-N-CA 124.465 3.443 . . . . 74.02 115.698 -164.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -108.69 -127.17 5.5 Favored Glycine 0 C--N 1.344 1.004 0 N-CA-C 111.329 -0.708 . . . . 74.42 111.329 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 173' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -151.88 156.47 40.19 Favored 'General case' 0 C--O 1.249 1.077 0 CA-C-O 121.606 0.717 . . . . 74.51 110.423 173.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 174' ' ' LEU . . . . . 0.519 ' HB3' HG13 ' C' ' 161' ' ' VAL . 39.4 tp -104.32 123.48 47.47 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.488 -0.778 . . . . 75.22 110.367 -177.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 175' ' ' LEU . . . . . 0.54 HD22 ' HB ' ' C' ' 158' ' ' VAL . 92.8 mt -101.95 94.87 6.01 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.619 1.167 . . . . 71.32 108.159 173.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 176' ' ' LEU . . . . . 0.775 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 44.2 mt -78.78 101.47 7.62 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.472 -0.566 . . . . 43.02 109.472 174.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 177' ' ' VAL . . . . . 0.588 ' HB ' ' HB2' ' C' ' 122' ' ' GLU . 39.5 t -84.32 94.13 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 107.172 -1.418 . . . . 74.43 107.172 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 178' ' ' VAL . . . . . 0.694 HG21 HG21 ' C' ' 153' ' ' VAL . 2.7 p -82.02 125.3 39.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.623 0.725 . . . . 74.01 110.68 -178.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 179' ' ' ARG . . . . . 0.438 ' HB3' ' HG2' ' B' ' 188' ' ' ARG . 39.6 mmt180 -104.81 106.73 17.35 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 114.772 -1.104 . . . . 72.33 108.101 175.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 180' ' ' LEU . . . . . 0.481 ' HA ' ' O ' ' C' ' 125' ' ' LEU . 97.3 mt -70.37 148.93 47.85 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 123.677 0.611 . . . . 70.51 110.505 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 181' ' ' LEU . . . . . 0.416 HD12 ' HB ' ' C' ' 126' ' ' THR . 80.2 mt -72.62 166.58 41.12 Favored Pre-proline 0 N--CA 1.483 1.216 0 C-N-CA 123.443 0.697 . . . . 74.2 110.418 -174.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -55.57 78.74 0.03 OUTLIER 'Trans proline' 0 C--N 1.384 2.426 0 C-N-CA 122.837 2.358 . . . . 64.12 111.867 166.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 183' ' ' HIS . . . . . . . . . . . . . 76.3 t60 -173.11 57.21 0.21 Allowed Pre-proline 0 CA--C 1.559 1.297 0 CA-C-N 113.459 -1.7 . . . . 62.13 107.039 -171.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 184' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -86.16 66.73 5.12 Favored 'Trans proline' 0 C--N 1.385 2.454 0 C-N-CA 123.176 2.584 . . . . 71.54 111.323 -174.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 185' ' ' VAL . . . . . 0.514 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 21.2 t -92.66 -43.17 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 108.595 -0.891 . . . . 72.23 108.595 -173.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 186' ' ' PHE . . . . . 0.608 ' HB3' HD22 ' C' ' 193' ' ' LEU . 56.0 m-85 -119.75 119.85 34.83 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.307 0.643 . . . . 61.44 111.738 -171.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 187' ' ' ARG . . . . . 0.406 ' HB3' ' HB3' ' C' ' 194' ' ' TYR . 2.2 tmt_? -96.58 109.7 22.25 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 107.03 -1.47 . . . . 75.14 107.03 171.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 188' ' ' LEU . . . . . 0.614 HD13 ' HD2' ' C' ' 240' ' ' PHE . 67.2 tp -82.21 151.25 26.96 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.654 0.74 . . . . 74.14 112.502 -177.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -142.02 101.92 4.03 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.252 1.421 . . . . 71.33 107.298 164.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 68.28 -89.53 0.21 Allowed Glycine 0 C--N 1.35 1.354 0 O-C-N 123.205 0.316 . . . . 74.2 113.188 -177.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 191' ' ' GLN . . . . . 0.45 HE21 ' H ' ' C' ' 242' ' ' GLY . 28.4 mt-30 -119.88 -22.91 6.59 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.61 1.164 . . . . 60.21 110.789 175.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -86.45 129.0 35.01 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.574 0.749 . . . . 65.13 110.934 -173.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 193' ' ' LEU . . . . . 0.608 HD22 ' HB3' ' C' ' 186' ' ' PHE . 62.6 mt -93.72 166.71 12.08 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.913 0.485 . . . . 52.2 111.106 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 194' ' ' TYR . . . . . 0.515 ' HA ' ' O ' ' C' ' 250' ' ' TYR . 4.1 t80 -137.82 103.65 5.06 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 109.049 -0.723 . . . . 75.43 109.049 169.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 195' ' ' ALA . . . . . 0.524 ' HB3' ' HG ' ' C' ' 251' ' ' LEU . . . -101.77 -177.38 3.41 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 124.032 0.933 . . . . 65.11 110.093 176.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 56.3 m -132.56 130.17 39.96 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 108.113 -1.069 . . . . 51.32 108.113 168.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 197' ' ' LEU . . . . . . . . . . . . . 51.7 tp -106.54 135.24 48.39 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 123.769 0.828 . . . . 73.5 110.699 -171.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -78.98 101.7 7.92 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.395 0.678 . . . . 44.52 109.619 173.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 199' ' ' VAL . . . . . . . . . . . . . 40.8 t -119.11 109.94 38.54 Favored Pre-proline 0 N--CA 1.473 0.68 0 N-CA-C 108.052 -1.092 . . . . 61.21 108.052 175.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 200' ' ' PRO . . . . . 0.519 ' HA ' ' O ' ' C' ' 256' ' ' THR . 25.6 Cg_exo -60.7 147.2 95.65 Favored 'Trans proline' 0 C--N 1.363 1.325 0 C-N-CA 122.188 1.925 . . . . 71.34 111.546 175.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 201' ' ' ALA . . . . . . . . . . . . . . . -50.46 -48.39 81.6 Favored Pre-proline 0 CA--C 1.561 1.384 0 O-C-N 123.885 0.74 . . . . 74.35 112.6 176.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 202' ' ' PRO . . . . . 0.618 ' HB2' ' HA ' ' A' ' 273' ' ' ALA . 20.3 Cg_endo -58.34 -49.81 11.33 Favored 'Trans proline' 0 C--N 1.387 2.584 0 C-N-CA 121.572 1.515 . . . . 63.15 113.161 174.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 203' ' ' ILE . . . . . 0.519 HD12 ' HG2' ' C' ' 200' ' ' PRO . 37.6 mt -63.84 -29.32 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 C-N-CA 122.933 0.493 . . . . 63.4 111.22 -178.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.43 -46.02 67.76 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.166 0.986 . . . . 75.02 111.531 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 205' ' ' VAL . . . . . . . . . . . . . 72.6 t -68.52 -40.42 81.99 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 CA-C-N 115.466 -0.788 . . . . 63.41 111.617 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 206' ' ' VAL . . . . . 0.666 ' HA ' ' HE2' ' A' ' 270' ' ' LYS . 14.3 p -80.13 -38.25 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 112.787 0.662 . . . . 52.12 112.787 -173.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 85.05 71.56 1.31 Allowed Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 116.054 -0.521 . . . . 63.21 112.091 -167.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -98.62 -138.68 10.4 Favored Glycine 0 C--N 1.341 0.813 0 N-CA-C 111.294 -0.722 . . . . 51.32 111.294 176.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 209' ' ' LYS . . . . . 0.591 ' HG2' ' HA ' ' C' ' 222' ' ' ALA . 43.7 mtmt -139.7 146.3 39.45 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.451 0.7 . . . . 72.12 110.221 170.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 210' ' ' VAL . . . . . . . . . . . . . 19.9 m -138.15 137.17 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 107.923 -1.14 . . . . 62.05 107.923 173.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 211' ' ' ARG . . . . . 0.427 ' HB3' ' O ' ' B' ' 224' ' ' VAL . 37.2 ttm180 -75.7 127.79 33.8 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 120.685 0.278 . . . . 72.44 110.983 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -95.79 119.19 33.85 Favored 'General case' 0 C--O 1.245 0.854 0 N-CA-C 108.637 -0.875 . . . . 74.43 108.637 165.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 213' ' ' MET . . . . . . . . . . . . . 2.6 tmm? -72.08 121.69 19.66 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 107.583 -1.265 . . . . 63.12 107.583 176.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 214' ' ' THR . . . . . 0.504 ' OG1' HG12 ' C' ' 219' ' ' VAL . 0.2 OUTLIER -126.21 168.13 14.49 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 122.909 0.484 . . . . 54.24 110.568 -174.51 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 215' ' ' LEU . . . . . 0.497 ' HA ' ' HG3' ' C' ' 128' ' ' GLU . 17.0 mt -55.7 -45.27 77.9 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 125.398 1.479 . . . . 44.41 112.043 -176.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -78.64 -28.5 45.52 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 113.547 -1.66 . . . . 71.0 111.416 -176.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 154.98 -164.38 31.78 Favored Glycine 0 C--N 1.343 0.935 0 CA-C-O 119.575 -0.569 . . . . 64.11 112.018 -169.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -84.87 116.49 1.86 Allowed 'Trans proline' 0 CA--C 1.552 1.424 0 C-N-CA 122.691 2.261 . . . . 52.13 113.223 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 219' ' ' VAL . . . . . 0.514 HG23 HG22 ' B' ' 238' ' ' THR . 10.8 p -101.09 117.26 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 108.311 -0.996 . . . . 52.53 108.311 171.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 220' ' ' GLU . . . . . 0.446 ' HG2' ' HD2' ' C' ' 209' ' ' LYS . 27.4 tt0 -91.28 105.36 17.73 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 121.467 0.651 . . . . 72.32 109.986 -171.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 221' ' ' VAL . . . . . 0.413 HG11 HD21 ' C' ' 233' ' ' LEU . 64.4 t -70.23 119.92 17.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 114.846 -1.07 . . . . 74.03 112.019 -174.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 222' ' ' ALA . . . . . 0.591 ' HA ' ' HG2' ' C' ' 209' ' ' LYS . . . -76.76 99.13 5.01 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 124.149 0.906 . . . . 73.3 109.806 169.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 98.6 t -73.79 138.54 76.77 Favored Pre-proline 0 CA--C 1.555 1.161 0 C-N-CA 123.651 0.781 . . . . 73.11 109.126 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 224' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -92.35 172.86 2.32 Favored 'Trans proline' 0 C--N 1.368 1.605 0 C-N-CA 123.778 2.985 . . . . 54.33 111.787 174.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -72.85 154.24 53.52 Favored 'Trans proline' 0 C--N 1.371 1.714 0 C-N-CA 121.57 1.513 . . . . 74.0 110.837 174.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 226' ' ' ARG . . . . . 0.517 HH22 ' HB2' ' A' ' 261' ' ' LEU . 10.4 mpt_? 57.95 58.67 3.49 Favored 'General case' 0 N--CA 1.483 1.204 0 O-C-N 124.023 0.827 . . . . 70.15 111.651 177.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 227' ' ' THR . . . . . 0.615 HG22 HG11 ' C' ' 253' ' ' VAL . 90.0 m -97.28 112.23 24.13 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 122.29 -0.256 . . . . 70.3 110.625 178.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 228' ' ' GLN . . . . . 0.785 HE21 ' HG2' ' A' ' 259' ' ' GLU . 26.2 mp0 -89.03 163.41 15.53 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.941 0.897 . . . . 74.32 112.206 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -70.36 115.02 9.06 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 113.516 -1.674 . . . . 62.12 109.58 175.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 102.26 8.65 43.67 Favored Glycine 0 C--N 1.336 0.546 0 O-C-N 123.562 0.539 . . . . 62.04 113.449 -178.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 231' ' ' ARG . . . . . 0.402 ' HD3' ' HA ' ' C' ' 227' ' ' THR . 41.4 mtp180 -67.89 169.87 9.11 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 117.502 0.651 . . . . 74.12 109.435 164.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 232' ' ' LYS . . . . . 0.451 ' HA ' ' O ' ' C' ' 251' ' ' LEU . 35.4 ttmt -142.06 142.96 32.88 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.794 0.807 . . . . 71.45 112.288 -173.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 233' ' ' LEU . . . . . 0.678 HD13 ' HB2' ' C' ' 251' ' ' LEU . 3.2 mp -106.72 154.45 20.95 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.766 1.626 . . . . 74.21 108.542 178.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 10.5 ptp85 -130.89 88.08 2.57 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 122.268 1.032 . . . . 72.34 108.77 165.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 235' ' ' LEU . . . . . 0.417 ' HA ' ' HA3' ' B' ' 240' ' ' GLY . 30.5 mt -77.59 118.07 19.64 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 114.874 -1.057 . . . . 73.43 109.624 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -81.03 124.71 29.4 Favored 'General case' 0 C--O 1.241 0.605 0 CA-C-N 115.081 -0.963 . . . . 71.55 111.547 -168.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 66.78 29.64 75.0 Favored Glycine 0 C--N 1.345 1.038 0 CA-C-N 115.219 -0.901 . . . . 71.42 112.442 -177.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 34.4 mmtm -118.24 4.42 11.93 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.722 0.809 . . . . 72.03 110.722 178.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 239' ' ' GLY . . . . . 0.466 ' HA2' HD12 ' C' ' 193' ' ' LEU . . . -88.67 -135.4 5.25 Favored Glycine 0 C--N 1.347 1.164 0 N-CA-C 110.625 -0.99 . . . . 31.21 110.625 170.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 240' ' ' PHE . . . . . 0.614 ' HD2' HD13 ' C' ' 188' ' ' LEU . 44.8 m-85 -101.57 108.01 53.8 Favored Pre-proline 0 C--O 1.25 1.093 0 CA-C-N 116.968 0.384 . . . . 75.14 110.092 171.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 241' ' ' PRO . . . . . 0.705 ' HA ' ' H ' ' C' ' 246' ' ' ARG . 40.5 Cg_endo -67.51 113.28 2.87 Favored 'Trans proline' 0 C--N 1.366 1.462 0 C-N-CA 122.027 1.818 . . . . 70.21 110.281 170.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 242' ' ' GLY . . . . . 0.537 ' HA2' ' HG2' ' C' ' 151' ' ' PRO . . . -90.45 -162.45 38.27 Favored Glycine 0 N--CA 1.483 1.773 0 CA-C-N 115.347 -0.842 . . . . 70.14 113.217 -169.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -58.95 -33.38 98.69 Favored 'Trans proline' 0 C--N 1.374 1.888 0 C-N-CA 122.677 2.251 . . . . 71.42 112.11 170.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -79.01 -24.43 43.7 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.127 0.571 . . . . 71.42 110.59 169.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 74.89 98.8 0.1 Allowed Glycine 0 C--N 1.343 0.959 0 CA-C-O 119.38 -0.678 . . . . 51.32 114.149 176.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 246' ' ' ARG . . . . . 0.705 ' H ' ' HA ' ' C' ' 241' ' ' PRO . 10.5 ptt180 -162.48 -72.81 0.05 OUTLIER 'General case' 0 CA--C 1.558 1.257 0 N-CA-C 114.187 1.18 . . . . 61.31 114.187 168.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 247' ' ' GLY . . . . . 0.591 ' H ' ' HG3' ' C' ' 246' ' ' ARG . . . 45.62 128.27 0.0 OUTLIER Glycine 0 C--N 1.358 1.758 0 N-CA-C 117.449 1.74 . . . . 63.23 117.449 -159.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -125.95 119.29 27.35 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 108.308 -0.997 . . . . 73.54 108.308 175.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 249' ' ' LEU . . . . . 0.439 ' HG ' HD11 ' C' ' 251' ' ' LEU . 15.4 tp -86.78 118.49 26.22 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.039 -0.982 . . . . 74.23 109.726 -173.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 250' ' ' TYR . . . . . 0.592 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 20.4 m-85 -98.46 119.88 37.93 Favored 'General case' 0 C--O 1.211 -0.948 0 N-CA-C 108.138 -1.06 . . . . 71.43 108.138 175.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 251' ' ' LEU . . . . . 0.678 ' HB2' HD13 ' C' ' 233' ' ' LEU . 2.6 mp -111.24 139.46 46.62 Favored 'General case' 0 N--CA 1.506 2.355 0 CA-C-N 118.706 0.684 . . . . 64.53 110.029 178.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -94.2 131.14 40.08 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.984 -0.747 . . . . 73.41 108.984 171.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 253' ' ' VAL . . . . . 0.615 HG11 HG22 ' C' ' 227' ' ' THR . 83.9 t -78.65 123.93 36.28 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 C-N-CA 123.619 0.768 . . . . 73.5 111.557 -175.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 254' ' ' ARG . . . . . 0.521 HH12 ' HA3' ' A' ' 230' ' ' GLY . 9.8 mmt85 -101.36 120.92 41.0 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 109.167 -0.679 . . . . 74.13 109.167 166.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 255' ' ' ILE . . . . . . . . . . . . . 36.0 mm -83.78 94.6 3.49 Favored 'Isoleucine or valine' 0 C--O 1.241 0.636 0 O-C-N 124.265 0.978 . . . . 75.24 108.801 170.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 256' ' ' THR . . . . . 0.519 ' O ' ' HA ' ' C' ' 200' ' ' PRO . 0.0 OUTLIER -97.45 144.11 27.5 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 114.883 -1.053 . . . . 53.32 109.731 -179.799 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 2.8 pp -98.79 153.16 38.0 Favored Pre-proline 0 CA--C 1.558 1.267 0 C-N-CA 122.742 0.417 . . . . 64.54 111.227 -177.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -41.7 -24.34 0.26 Allowed 'Trans proline' 0 C--N 1.389 2.672 1 C-N-CA 125.369 4.046 . . . . 73.21 118.333 -170.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 259' ' ' GLU . . . . . 0.551 ' HB2' HG12 ' B' ' 38' ' ' ILE . 58.1 mm-40 59.88 -73.33 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 124.477 1.111 . . . . 72.3 111.08 -165.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.06 159.14 31.43 Favored 'General case' 0 C--N 1.352 0.674 0 N-CA-C 109.026 -0.731 . . . . 73.41 109.026 171.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 261' ' ' LEU . . . . . 0.52 ' HB2' HH21 ' A' ' 226' ' ' ARG . 75.7 mt -145.12 170.9 15.33 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.045 -1.095 . . . . 71.21 108.045 165.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 262' ' ' THR . . . . . 0.44 ' H ' ' HB2' ' C' ' 265' ' ' GLU . 45.1 p -122.09 159.96 49.52 Favored Pre-proline 0 CA--C 1.547 0.844 0 N-CA-C 107.587 -1.264 . . . . 61.23 107.587 164.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -38.82 -47.65 2.74 Favored 'Trans proline' 0 C--N 1.387 2.554 0 C-N-CA 123.535 2.823 . . . . 74.2 113.982 175.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -68.82 -53.26 22.54 Favored 'General case' 0 C--N 1.351 0.639 0 CA-C-N 115.886 -0.597 . . . . 71.04 111.344 -178.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 265' ' ' GLU . . . . . 0.44 ' HB2' ' H ' ' C' ' 262' ' ' THR . 47.0 mt-10 -48.24 -56.86 6.91 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 123.806 0.691 . . . . 65.11 109.474 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 266' ' ' GLU . . . . . 0.521 ' O ' ' HG2' ' C' ' 270' ' ' LYS . 33.9 tt0 -57.23 -41.53 79.71 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 114.908 -1.042 . . . . 64.21 111.364 -177.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -61.69 -41.81 98.09 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 123.424 0.69 . . . . 70.32 112.784 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 268' ' ' LEU . . . . . 0.418 ' HG ' HD11 ' A' ' 268' ' ' LEU . 10.8 mp -67.14 -40.31 86.71 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.783 0.433 . . . . 52.44 110.177 177.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -59.03 -36.51 75.11 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 116.353 -0.385 . . . . 61.11 110.761 172.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 270' ' ' LYS . . . . . 0.521 ' HG2' ' O ' ' C' ' 266' ' ' GLU . 25.3 mmtp -60.74 -50.65 72.62 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 122.859 0.464 . . . . 75.43 110.276 177.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 271' ' ' LYS . . . . . 0.483 ' HB2' HD21 ' A' ' 268' ' ' LEU . 47.2 mtpt -53.68 -41.37 66.83 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 124.112 0.883 . . . . 75.33 111.326 177.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 95.5 mt -60.96 -45.54 94.32 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 123.799 0.687 . . . . 74.33 111.135 176.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -64.13 -31.01 72.04 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.153 0.581 . . . . 34.13 111.98 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 274' ' ' GLU . . . . . 0.487 ' HG3' ' O ' ' C' ' 270' ' ' LYS . 30.7 mt-10 -77.66 -34.51 53.04 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.143 0.577 . . . . 63.21 110.402 177.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -67.06 -24.23 65.95 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 115.824 -0.625 . . . . 70.04 110.48 171.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 276' ' ' TYR . . . . . 0.444 ' HD1' HH11 ' C' ' 279' ' ' ARG . 4.1 m-85 -80.51 -35.87 34.0 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.281 -0.872 . . . . 75.52 112.077 175.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -66.98 -28.35 68.19 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 109.491 -0.559 . . . . 44.24 109.491 169.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -72.19 3.3 4.7 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 123.8 0.84 . . . . 55.2 112.878 173.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 279' ' ' ARG . . . . . 0.444 HH11 ' HD1' ' C' ' 276' ' ' TYR . 71.9 mtp180 -74.51 -18.85 60.55 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 118.15 0.432 . . . . 71.52 110.4 168.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.558 1.269 0 N-CA-C 109.602 -0.518 . . . . 75.14 109.602 175.826 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.4 mtp . . . . . 0 N--CA 1.472 0.631 0 N-CA-C 110.222 -0.288 . . . . 64.12 110.222 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.4 33.55 22.41 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 113.979 1.103 . . . . 51.4 113.979 164.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -85.27 48.36 1.56 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 122.789 0.435 . . . . 74.04 110.193 176.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.416 ' HA ' ' CG ' ' A' ' 96' ' ' PHE . 37.1 ttpt -38.09 108.85 0.09 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.021 1.728 . . . . 62.43 115.37 -172.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.448 ' HD2' HD11 ' A' ' 10' ' ' ILE . 27.7 mmtp -72.26 105.2 3.95 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 108.84 -0.8 . . . . 74.32 108.84 164.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -72.99 96.06 2.09 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 105.905 -1.887 . . . . 61.41 105.905 165.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.433 ' HB2' HD11 ' A' ' 57' ' ' LEU . 67.6 m-85 -61.87 -31.18 71.43 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-N 114.96 -1.018 . . . . 73.34 111.503 -170.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -67.41 -40.23 85.57 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.408 -0.815 . . . . 73.33 109.884 176.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.85 -37.93 89.2 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 122.908 0.483 . . . . 60.32 110.921 177.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.448 HD11 ' HD2' ' A' ' 5' ' ' LYS . 65.3 mt -59.33 -41.46 84.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 123.1 0.56 . . . . 74.23 110.267 173.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.6 mt -80.49 -8.54 59.6 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 115.756 -0.656 . . . . 51.33 112.606 176.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 70.01 18.23 74.37 Favored Glycine 0 C--N 1.353 1.484 0 N-CA-C 114.239 0.455 . . . . 53.33 114.239 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.3 m -103.14 163.3 17.78 Favored Pre-proline 0 N--CA 1.486 1.347 0 C-N-CA 124.374 1.07 . . . . 71.43 110.709 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -47.54 146.75 7.24 Favored 'Trans proline' 0 C--N 1.387 2.577 0 C-N-CA 123.6 2.867 . . . . 50.12 114.043 174.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -71.36 15.78 0.12 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 114.284 1.216 . . . . 75.43 114.284 -170.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -159.8 33.56 0.18 Allowed 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 108.625 -0.88 . . . . 64.11 108.625 173.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.34 149.58 50.16 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.436 1.094 . . . . 64.31 111.834 -177.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 76.1 p -77.8 170.76 16.03 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.516 0.726 . . . . 71.11 111.88 -174.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -55.95 -41.28 74.46 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.673 1.189 . . . . 64.21 112.559 -172.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.36 -32.2 66.25 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 122.629 0.372 . . . . 72.43 110.581 -177.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.455 ' HG2' ' NH2' ' A' ' 24' ' ' ARG . 40.1 mt-10 -65.96 -40.97 91.75 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 121.101 0.476 . . . . 64.03 109.771 175.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.419 HG12 ' HB3' ' A' ' 57' ' ' LEU . 1.6 mp -65.04 -38.57 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-N 114.763 -1.108 . . . . 73.31 110.416 176.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -75.55 -33.36 60.66 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.567 0.747 . . . . 71.24 111.307 -175.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.461 ' HA ' ' NZ ' ' A' ' 27' ' ' LYS . 85.3 mtm-85 -72.78 -43.64 62.55 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 122.693 0.397 . . . . 54.12 110.566 175.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.04 -31.07 70.48 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.797 -0.638 . . . . 64.0 111.146 177.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -62.55 -58.65 6.79 Favored 'General case' 0 C--O 1.213 -0.856 0 CA-C-O 118.61 -0.709 . . . . 73.1 109.381 173.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.461 ' NZ ' ' HA ' ' A' ' 24' ' ' ARG . 35.5 mtmm -53.97 -39.43 65.98 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 123.949 0.781 . . . . 74.22 111.241 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -54.38 -58.3 7.98 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.182 0.993 . . . . 71.15 110.966 177.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.44 ' HA ' ' HB3' ' A' ' 32' ' ' GLN . 75.4 mt -86.38 -8.99 57.23 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 115.074 -0.967 . . . . 74.11 111.635 -173.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.12 -21.62 25.88 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.686 0.794 . . . . 63.3 109.95 174.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -90.87 -31.76 16.3 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.483 0.713 . . . . 72.33 110.509 170.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.44 ' HB3' ' HA ' ' A' ' 29' ' ' LEU . 35.1 tt0 -73.36 -49.06 29.3 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.999 0.52 . . . . 63.33 111.326 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -98.15 23.78 7.86 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.077 0.551 . . . . 63.25 110.796 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 51.1 t60 -63.2 101.38 0.26 Allowed Pre-proline 0 CA--C 1.554 1.101 0 C-N-CA 124.968 1.307 . . . . 63.41 112.195 -170.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -73.79 -5.44 17.05 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 123.561 2.841 . . . . 74.13 112.552 -172.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -73.73 -27.29 61.11 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 124.571 1.148 . . . . 72.45 111.479 174.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 60.5 t -123.47 -46.71 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 CA-C-O 121.561 0.696 . . . . 65.53 109.716 178.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -98.62 80.96 2.62 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.703 1.201 . . . . 61.35 109.883 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.48 69.4 10.05 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 115.806 -0.633 . . . . 73.11 109.649 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 24.2 m -108.86 134.46 20.34 Favored Pre-proline 0 N--CA 1.479 0.988 0 CA-C-O 118.518 -0.753 . . . . 54.41 109.822 -179.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -48.07 -52.24 8.6 Favored 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 123.88 3.054 . . . . 72.23 113.419 -178.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.411 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 8.2 tp10 -62.42 -32.61 73.48 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 122.85 0.46 . . . . 64.43 110.873 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -82.15 -14.75 55.21 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.928 0.491 . . . . 72.14 110.435 -179.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.425 ' O ' ' HD3' ' A' ' 48' ' ' LYS . 49.0 mm-40 -68.67 -58.9 3.57 Favored 'General case' 0 C--N 1.358 0.94 0 N-CA-C 107.21 -1.404 . . . . 62.01 107.21 170.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -53.23 -47.01 69.35 Favored 'General case' 0 C--N 1.352 0.705 0 CA-C-N 113.842 -1.527 . . . . 62.44 110.396 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.517 ' O ' HG12 ' A' ' 50' ' ' ILE . 0.1 OUTLIER -71.02 -48.9 50.39 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 114.747 -1.115 . . . . 74.03 111.193 -172.385 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -53.45 -46.54 69.91 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 123.849 0.718 . . . . 73.24 110.508 177.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.425 ' HD3' ' O ' ' A' ' 44' ' ' GLU . 2.1 mtpm? -63.3 -36.37 83.46 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 115.37 -0.832 . . . . 75.14 111.525 178.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -69.99 -30.26 67.55 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 122.62 0.368 . . . . 71.44 111.274 173.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.517 HG12 ' O ' ' A' ' 46' ' ' LYS . 18.3 mm -68.95 -36.87 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 108.843 -0.799 . . . . 70.53 108.843 175.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.416 ' O ' ' HB2' ' A' ' 55' ' ' ALA . 11.5 m-80 -80.5 -20.09 44.41 Favored 'General case' 0 C--O 1.211 -0.955 0 CA-C-N 114.435 -1.257 . . . . 73.43 111.385 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -71.98 -50.38 29.28 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.328 1.051 . . . . 63.42 109.01 171.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.16 -50.78 71.77 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 113.494 -1.684 . . . . 65.45 111.076 176.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -64.51 -37.96 89.34 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-N 115.068 -0.969 . . . . 72.32 110.525 177.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.416 ' HB2' ' O ' ' A' ' 51' ' ' ASN . . . -54.23 -46.91 72.66 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.289 0.636 . . . . 53.01 112.169 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 67.9 t -72.94 -45.86 53.9 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.116 0 CA-C-N 115.955 -0.566 . . . . 74.52 110.996 177.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.433 HD11 ' HB2' ' A' ' 7' ' ' TYR . 64.2 mt -93.57 0.84 56.77 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 114.206 1.188 . . . . 62.04 114.206 -166.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.1 t -73.58 -52.79 12.25 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.464 0.649 . . . . 74.34 109.85 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -88.89 137.21 29.95 Favored Pre-proline 0 C--O 1.241 0.657 0 CA-C-N 114.737 -1.119 . . . . 74.34 109.745 -176.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.417 ' O ' ' HG2' ' A' ' 64' ' ' ARG . 48.0 Cg_exo -56.19 -26.9 63.14 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 123.346 2.697 . . . . 72.41 112.576 178.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -64.4 -59.88 3.83 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.814 0.846 . . . . 72.3 111.451 -176.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.402 ' HA ' HD12 ' A' ' 65' ' ' ILE . 42.0 mtmt -77.36 -23.62 50.82 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 115.842 -0.617 . . . . 74.54 111.275 -176.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 44.9 tpt85 -54.77 -54.64 39.49 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 108.919 -0.771 . . . . 74.11 108.919 166.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.473 ' HE ' ' HA ' ' A' ' 64' ' ' ARG . 2.2 mmp_? -63.27 -33.37 75.36 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.582 0.753 . . . . 74.25 112.168 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.702 HG23 ' HG3' ' A' ' 76' ' ' PRO . 89.2 mt -59.46 -45.59 93.54 Favored 'Isoleucine or valine' 0 C--O 1.253 1.24 0 C-N-CA 123.105 0.562 . . . . 64.42 110.783 174.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -66.74 -42.03 86.9 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 116.237 -0.438 . . . . 75.4 109.823 178.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -53.93 -45.82 71.32 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 123.161 0.585 . . . . 64.04 110.852 175.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 50.5 p -75.36 -19.3 59.66 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.224 -0.444 . . . . 75.13 112.013 -178.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -70.5 112.33 6.7 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 109.04 -0.726 . . . . 63.45 109.04 174.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 103.36 19.99 11.68 Favored Glycine 0 N--CA 1.474 1.171 0 N-CA-C 111.711 -0.556 . . . . 52.54 111.711 -172.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 97.6 m -142.05 -58.09 0.46 Allowed 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 103.623 -2.732 . . . . 71.23 103.623 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 29.4 m -77.8 134.37 38.03 Favored 'General case' 0 C--O 1.256 1.427 0 N-CA-C 104.399 -2.445 . . . . 74.23 104.399 155.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.18 -29.27 16.55 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.328 0.651 . . . . 74.04 111.15 -177.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -94.22 168.35 11.73 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 124.085 0.954 . . . . 75.1 109.929 177.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -53.32 140.36 62.7 Favored 'Trans proline' 0 C--N 1.378 2.108 0 C-N-CA 122.164 1.909 . . . . 75.41 112.621 165.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.702 ' HG3' HG23 ' A' ' 65' ' ' ILE . 91.4 Cg_endo -72.52 175.53 10.01 Favored 'Trans proline' 0 C--N 1.375 1.925 0 C-N-CA 123.644 2.896 . . . . 74.25 112.562 -177.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.46 121.15 9.31 Favored 'Trans proline' 0 C--N 1.38 2.2 0 C-N-CA 122.002 1.801 . . . . 62.44 111.186 171.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -63.32 130.2 27.84 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.594 2.196 . . . . 43.51 112.063 176.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -59.5 141.57 97.58 Favored 'Trans proline' 0 C--N 1.381 2.269 0 C-N-CA 122.64 2.227 . . . . 71.05 111.32 172.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.29 78.28 0.45 Allowed 'Trans proline' 0 C--N 1.382 2.298 0 C-N-CA 123.156 2.571 . . . . 51.35 112.694 -177.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 159.29 -35.38 0.48 Allowed Glycine 0 N--CA 1.467 0.713 0 N-CA-C 109.669 -1.372 . . . . 62.41 109.669 -174.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.446 ' HA3' ' HA ' ' A' ' 106' ' ' PHE . . . 130.04 167.22 12.01 Favored Glycine 0 C--N 1.351 1.375 0 CA-C-N 114.899 -0.651 . . . . 53.03 112.926 170.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -69.25 100.9 1.38 Allowed 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 108.175 -1.046 . . . . 74.41 108.175 166.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.464 ' O ' ' HD1' ' A' ' 85' ' ' PHE . 12.6 t70 -63.61 152.16 39.65 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.88 0.872 . . . . 71.31 112.969 -174.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.464 ' HD1' ' O ' ' A' ' 84' ' ' ASP . 0.3 OUTLIER -148.54 72.43 1.19 Allowed 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 124.699 1.199 . . . . 70.22 107.783 169.882 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.572 ' HA ' ' HA3' ' A' ' 163' ' ' GLY . 44.8 m -55.3 87.75 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 114.562 1.319 . . . . 74.44 114.562 -174.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.608 ' HA2' ' HB3' ' A' ' 171' ' ' PRO . . . 94.56 14.48 50.21 Favored Glycine 0 N--CA 1.47 0.942 0 CA-C-N 116.237 -0.438 . . . . 70.11 113.425 176.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -123.19 111.72 16.82 Favored 'General case' 0 C--O 1.245 0.835 0 C-N-CA 122.922 0.489 . . . . 72.34 110.133 -169.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -68.69 92.97 0.49 Allowed 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.077 0.551 . . . . 71.44 110.917 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.489 HG13 ' HG2' ' A' ' 91' ' ' GLU . 2.2 p -31.82 -49.21 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 125.521 1.529 . . . . 75.21 114.311 169.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.489 ' HG2' HG13 ' A' ' 90' ' ' VAL . 7.7 mm-40 -68.27 -14.88 63.31 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.992 0.738 . . . . 75.33 112.992 -169.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -78.54 -42.3 29.75 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.504 0.722 . . . . 45.35 111.228 171.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -77.59 178.85 6.94 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 113.46 0.911 . . . . 71.01 113.46 -165.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 67.4 p -58.18 144.4 40.76 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.777 1.231 . . . . 74.5 113.711 -166.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.449 ' O ' ' HG3' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -53.65 -43.02 68.45 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 114.401 -1.272 . . . . 74.31 110.973 172.516 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.416 ' CG ' ' HA ' ' A' ' 4' ' ' LYS . 37.0 t80 -51.18 -52.88 40.01 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.368 1.067 . . . . 75.03 111.479 176.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -57.62 -46.68 83.81 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 114.786 -1.097 . . . . 63.23 110.179 178.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.452 ' HA ' HD11 ' A' ' 105' ' ' LEU . 96.3 mt-30 -70.04 -13.01 62.02 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 115.757 -0.656 . . . . 73.05 112.527 -178.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.449 ' HG3' ' O ' ' A' ' 95' ' ' GLU . 52.5 mt-10 -88.87 -52.63 5.01 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 122.982 0.513 . . . . 70.02 111.515 172.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 36.2 tp -65.14 -50.95 64.04 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.368 0.667 . . . . 55.03 111.014 -175.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -87.88 -6.0 58.3 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 115.606 -0.725 . . . . 72.11 110.74 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -42.68 -59.17 3.29 Favored Glycine 0 C--N 1.355 1.585 0 CA-C-O 118.625 -1.097 . . . . 72.43 114.859 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -39.83 -26.89 0.18 Allowed 'Trans proline' 0 C--N 1.393 2.877 0 C-N-CA 124.883 3.722 . . . . 23.1 116.365 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -152.03 37.63 0.81 Allowed Glycine 0 C--N 1.354 1.568 0 CA-C-O 118.975 -0.903 . . . . 44.4 113.427 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.452 HD11 ' HA ' ' A' ' 98' ' ' GLN . 33.9 mt -53.52 85.19 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 117.487 0.644 . . . . 74.25 112.232 174.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.446 ' HA ' ' HA3' ' A' ' 82' ' ' GLY . 0.6 OUTLIER 20.99 -110.88 0.01 OUTLIER 'General case' 0 CA--C 1.565 1.533 0 C-N-CA 127.348 2.259 . . . . 72.25 113.526 177.638 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.473 ' HA2' ' HA2' ' A' ' 168' ' ' GLY . . . 58.46 13.74 17.74 Favored Glycine 0 C--N 1.366 2.236 0 N-CA-C 114.388 0.515 . . . . 44.0 114.388 178.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 70.62 -94.22 0.49 Allowed Glycine 0 C--N 1.35 1.342 0 N-CA-C 110.753 -0.939 . . . . 71.34 110.753 -165.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -140.02 17.57 2.46 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.716 1.207 . . . . 64.11 108.853 170.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -62.63 -23.61 65.25 Favored Glycine 0 C--N 1.356 1.667 0 CA-C-N 115.78 -0.645 . . . . 55.25 114.324 -175.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 77.22 -39.19 0.31 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 125.313 1.445 . . . . 71.44 112.982 174.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.32 -15.06 59.1 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.176 0.591 . . . . 73.25 110.463 174.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 2.5 m 73.46 68.6 0.11 Allowed 'General case' 0 C--N 1.36 1.038 0 C-N-CA 124.668 1.187 . . . . 74.21 110.776 172.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.461 ' HD2' ' HA ' ' A' ' 114' ' ' ARG . 0.2 OUTLIER -124.62 170.46 10.92 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 112.379 0.511 . . . . 74.52 112.379 -172.178 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.95 149.39 23.1 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 125.981 1.712 . . . . 72.15 113.374 -164.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -100.97 -164.13 27.81 Favored Glycine 0 CA--C 1.546 1.984 0 CA-C-N 115.573 -0.74 . . . . 55.22 113.304 -178.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.433 ' H ' ' HA3' ' A' ' 166' ' ' GLY . 2.6 tmt_? -108.8 137.61 46.46 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 124.121 0.968 . . . . 71.34 112.257 176.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -57.87 99.04 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 122.194 0.997 . . . . 74.23 111.685 173.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 53.5 tp -103.92 157.54 17.02 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 114.45 -1.25 . . . . 70.23 110.698 -173.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 40.5 ttp180 -109.38 142.25 40.6 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 108.817 -0.809 . . . . 74.51 108.817 170.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.547 ' HB2' HD11 ' A' ' 174' ' ' LEU . . . -128.36 159.33 35.66 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.598 0.713 . . . . 41.51 111.113 177.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.4 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 0.7 OUTLIER -116.47 109.73 17.68 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 105.944 -1.873 . . . . 61.0 105.944 -177.311 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.513 ' HB3' ' HA ' ' A' ' 178' ' ' VAL . 37.5 tp -98.86 96.58 4.11 Favored Pre-proline 0 N--CA 1.475 0.805 0 N-CA-C 108.228 -1.027 . . . . 54.05 108.228 -174.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.552 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 97.5 Cg_endo -78.75 107.72 2.31 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 121.065 1.176 . . . . 75.33 109.307 -176.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.438 ' HB3' HD23 ' A' ' 180' ' ' LEU . 43.1 tp -106.76 131.47 53.84 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 122.755 0.422 . . . . 64.01 110.238 -167.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 72.9 m -59.41 124.19 19.25 Favored 'General case' 0 CA--C 1.555 1.171 0 O-C-N 124.609 1.193 . . . . 71.34 109.037 173.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.601 ' HB3' HD22 ' A' ' 215' ' ' LEU . 61.1 mt -53.78 -40.02 65.91 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 124.16 0.984 . . . . 70.54 111.743 -171.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 16.0 mp0 -65.02 -35.42 81.14 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 114.228 -1.351 . . . . 75.32 109.683 -178.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -78.67 -22.45 46.77 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.657 0.783 . . . . 64.33 111.165 177.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -68.05 -33.73 75.13 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 109.952 -0.388 . . . . 41.43 109.952 171.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.41 ' HB2' HD12 ' A' ' 215' ' ' LEU . 82.3 t80 -74.75 -47.55 30.54 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 115.236 -0.893 . . . . 74.51 111.488 173.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 51.2 m170 -69.87 -53.82 16.28 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.416 0.686 . . . . 75.25 110.921 -173.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.91 -168.42 41.23 Favored Glycine 0 C--N 1.344 1.003 0 CA-C-N 115.78 -0.645 . . . . 71.54 112.84 -178.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 98.44 -164.62 21.17 Favored Glycine 0 C--N 1.349 1.28 0 C-N-CA 123.011 0.339 . . . . 70.42 113.512 175.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -72.06 110.59 6.64 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.535 0.734 . . . . 73.14 110.409 177.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -93.85 122.48 36.38 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 122.861 0.464 . . . . 74.4 110.604 177.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 57.4 t -78.18 113.93 18.08 Favored 'Isoleucine or valine' 0 C--O 1.243 0.728 0 N-CA-C 108.428 -0.953 . . . . 71.24 108.428 169.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.586 HG13 HG13 ' A' ' 145' ' ' VAL . 3.8 p -134.25 136.57 53.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 124.49 1.116 . . . . 73.14 108.683 178.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -123.78 133.32 53.85 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.312 0.645 . . . . 71.3 110.677 -167.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.572 HG11 HD23 ' B' ' 8' ' ' LEU . 12.4 p -166.04 135.34 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.128 0.971 . . . . 75.1 109.318 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 53.23 38.49 27.76 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.196 0.999 . . . . 74.24 112.774 173.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 86.52 -21.82 16.23 Favored Glycine 0 C--N 1.353 1.504 0 CA-C-N 116.551 -0.295 . . . . 31.1 113.323 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.584 HH12 ' HG2' ' A' ' 164' ' ' MET . 12.1 tpt180 -81.82 99.27 8.91 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.138 0.975 . . . . 72.12 111.019 -179.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 38.0 ttp180 -84.65 89.38 7.47 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 107.867 -1.16 . . . . 74.41 107.867 165.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.586 HG13 HG13 ' A' ' 138' ' ' VAL . 3.0 p -97.09 145.58 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 114.783 -1.099 . . . . 73.53 110.877 -175.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 34.2 t -106.04 85.38 2.2 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.425 -0.807 . . . . 31.45 109.1 177.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 35.7 m -84.58 121.88 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 N-CA-C 109.929 -0.397 . . . . 73.42 109.929 -177.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -74.44 97.16 3.02 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.101 0.477 . . . . 74.14 109.817 -178.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 26.9 pt -78.35 123.41 85.8 Favored Pre-proline 0 CA--C 1.557 1.219 0 CA-C-N 115.267 -0.878 . . . . 74.13 109.305 174.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -63.16 135.02 48.58 Favored 'Trans proline' 0 C--N 1.372 1.78 0 C-N-CA 122.642 2.228 . . . . 60.34 112.204 176.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -61.84 96.15 0.14 Allowed 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 122.373 2.048 . . . . 74.15 111.143 171.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.565 ' HA2' ' HD2' ' A' ' 240' ' ' PHE . . . 116.5 35.14 1.21 Allowed Glycine 0 C--N 1.342 0.896 0 CA-C-N 115.481 -0.782 . . . . 75.51 111.536 -172.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.525 HG22 HG11 ' A' ' 178' ' ' VAL . 4.7 p -89.26 135.47 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 123.39 0.676 . . . . 75.43 109.496 -178.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.797 ' HD2' ' HA ' ' A' ' 191' ' ' GLN . 7.9 mtm-85 -123.77 148.72 46.4 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 115.322 -0.854 . . . . 73.23 110.502 -162.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.445 ' HB3' ' O ' ' A' ' 188' ' ' LEU . 6.8 tp10 -52.58 118.82 3.89 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 124.357 1.063 . . . . 72.32 110.464 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 105.78 -2.54 38.86 Favored Glycine 0 C--N 1.344 1.006 0 CA-C-N 115.71 -0.677 . . . . 14.21 113.276 -176.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 26.6 t -72.34 104.31 3.69 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 108.915 -0.772 . . . . 74.23 108.915 177.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.492 HG22 HG22 ' A' ' 177' ' ' VAL . 55.6 t -86.03 95.88 4.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 123.689 0.795 . . . . 72.34 109.558 -178.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.531 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 47.7 mt -77.84 92.82 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 N-CA-C 107.809 -1.182 . . . . 75.24 107.809 169.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 65.5 ttt-85 -72.68 114.96 11.39 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 107.928 -1.138 . . . . 61.32 107.928 177.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.497 HG11 ' SD ' ' A' ' 164' ' ' MET . 7.1 p -125.46 129.51 24.4 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 123.523 0.729 . . . . 61.33 109.154 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.488 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 97.8 Cg_endo -73.93 149.3 41.89 Favored 'Trans proline' 0 CA--C 1.552 1.413 0 C-N-CA 122.069 1.846 . . . . 74.53 111.949 177.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.572 ' HA3' ' HA ' ' A' ' 86' ' ' SER . . . 83.43 -25.51 4.98 Favored Glycine 0 N--CA 1.48 1.602 0 N-CA-C 116.244 1.258 . . . . 70.43 116.244 169.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.584 ' HG2' HH12 ' A' ' 143' ' ' ARG . 66.5 mtp -75.0 -23.67 58.28 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 117.679 0.74 . . . . 64.15 111.763 -178.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.472 ' HA2' HD13 ' A' ' 174' ' ' LEU . . . -82.37 -103.21 0.44 Allowed Glycine 0 C--N 1.35 1.35 0 CA-C-O 119.747 -0.474 . . . . 73.33 113.255 -175.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.433 ' HA3' ' H ' ' A' ' 117' ' ' ARG . . . -54.99 115.61 5.8 Favored Glycine 0 C--O 1.278 2.861 0 O-C-N 124.005 0.473 . . . . 74.5 113.422 173.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -56.85 103.45 0.11 Allowed 'General case' 0 C--N 1.355 0.812 0 O-C-N 127.59 2.582 . . . . 75.42 109.088 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.473 ' HA2' ' HA2' ' A' ' 107' ' ' GLY . . . -176.85 139.12 4.29 Favored Glycine 0 N--CA 1.436 -1.32 0 CA-C-N 113.347 -1.751 . . . . 64.21 108.943 -170.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . 0.512 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . 0.1 OUTLIER -73.55 -49.46 6.49 Favored Pre-proline 0 CA--C 1.559 1.294 0 N-CA-C 109.04 -0.726 . . . . 63.11 109.04 -173.422 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.512 ' HD3' ' HB3' ' A' ' 169' ' ' ASN . 28.2 Cg_exo -68.58 146.3 67.08 Favored 'Trans proline' 0 C--N 1.379 2.132 0 N-CA-C 107.991 -1.58 . . . . 71.13 107.991 156.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.608 ' HB3' ' HA2' ' A' ' 87' ' ' GLY . 56.4 Cg_endo -64.17 120.99 8.49 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.878 2.385 . . . . 71.25 116.312 -161.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -62.93 -43.0 99.56 Favored Glycine 0 C--N 1.374 2.681 0 C-N-CA 119.169 -1.491 . . . . 72.4 111.927 161.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.488 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 14.1 m-20 95.31 147.74 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 127.396 2.279 . . . . 71.14 108.563 175.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.547 HD11 ' HB2' ' A' ' 121' ' ' ALA . 27.9 tp -140.17 143.94 36.38 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.09 0.471 . . . . 64.32 111.162 -171.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 54.0 mt -108.95 90.57 3.33 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 114.746 -1.115 . . . . 72.12 108.254 170.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.531 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 78.7 mt -69.37 87.43 0.44 Allowed 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 109.335 -0.617 . . . . 70.05 109.335 174.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.492 HG22 HG22 ' A' ' 158' ' ' VAL . 11.9 t -84.31 104.67 12.86 Favored 'Isoleucine or valine' 0 C--O 1.245 0.827 0 N-CA-C 106.182 -1.784 . . . . 61.43 106.182 174.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.525 HG11 HG22 ' A' ' 153' ' ' VAL . 9.9 p -67.51 125.67 25.55 Favored 'Isoleucine or valine' 0 C--N 1.349 0.566 0 CA-C-O 121.961 0.886 . . . . 70.33 109.381 -175.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.552 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 28.6 mmt180 -111.94 119.18 37.63 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 107.54 -1.281 . . . . 53.32 107.54 179.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.438 HD23 ' HB3' ' A' ' 125' ' ' LEU . 56.7 mt -83.38 144.02 29.92 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-N 118.348 0.522 . . . . 72.4 110.014 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 41.6 mt -54.22 153.54 9.41 Favored Pre-proline 0 N--CA 1.488 1.447 0 C-N-CA 123.898 0.879 . . . . 73.14 112.808 -169.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.93 16.79 0.41 Allowed 'Trans proline' 0 C--N 1.387 2.557 0 C-N-CA 122.97 2.447 . . . . 71.42 113.329 175.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -60.91 101.9 0.28 Allowed Pre-proline 0 CA--C 1.557 1.247 0 N-CA-C 107.213 -1.403 . . . . 73.35 107.213 164.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -78.55 25.87 0.53 Allowed 'Trans proline' 0 C--N 1.375 1.932 0 C-N-CA 124.066 3.177 . . . . 61.24 115.478 -161.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 82.3 t -96.88 -32.27 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 109.946 -0.39 . . . . 64.21 109.946 -176.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . 0.771 ' HE1' ' HA ' ' A' ' 214' ' ' THR . 35.3 m-85 -145.9 98.87 3.18 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 121.279 0.561 . . . . 72.31 111.935 178.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.625 ' HB3' ' HB2' ' A' ' 194' ' ' TYR . 52.3 ttt180 -85.93 81.63 8.45 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 107.863 -1.162 . . . . 75.51 107.863 164.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.453 ' HB2' HD23 ' A' ' 193' ' ' LEU . 35.5 tp -78.1 94.52 4.7 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-N 115.228 -0.896 . . . . 74.21 108.671 175.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -114.26 129.98 56.64 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.185 0.594 . . . . 70.31 109.753 -176.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 77.11 -73.89 1.92 Allowed Glycine 0 C--N 1.351 1.389 0 O-C-N 123.85 0.719 . . . . 65.41 111.98 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.797 ' HA ' ' HD2' ' A' ' 154' ' ' ARG . 13.6 pt20 -154.78 -7.23 0.14 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.655 0.782 . . . . 72.32 111.173 172.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -123.05 152.87 40.57 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.472 -0.785 . . . . 72.32 110.671 -167.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.453 HD23 ' HB2' ' A' ' 188' ' ' LEU . 38.8 mt -95.33 152.52 18.31 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 114.642 -1.163 . . . . 63.44 111.032 -168.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.625 ' HB2' ' HB3' ' A' ' 187' ' ' ARG . 91.8 m-85 -132.61 103.93 6.39 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 107.633 -1.247 . . . . 73.14 107.633 171.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.464 ' HB3' HD23 ' A' ' 251' ' ' LEU . . . -129.9 112.6 13.7 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.472 1.109 . . . . 74.34 110.008 -172.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 86.0 m -68.72 122.56 18.81 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-O 120.944 0.402 . . . . 70.21 111.187 -179.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.496 HD22 HD13 ' A' ' 251' ' ' LEU . 44.7 tp -108.97 119.54 39.86 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.861 0.865 . . . . 72.21 110.337 -173.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -80.02 116.96 20.44 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 108.296 -1.001 . . . . 61.43 108.296 174.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 2.8 p -144.23 127.66 8.82 Favored Pre-proline 0 N--CA 1.478 0.951 0 C-N-CA 123.335 0.654 . . . . 64.4 110.282 -175.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.408 ' HA ' ' O ' ' A' ' 256' ' ' THR . 55.5 Cg_endo -72.8 150.87 50.59 Favored 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 121.868 1.712 . . . . 64.51 111.88 176.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -42.24 -60.23 2.23 Favored Pre-proline 0 N--CA 1.487 1.406 0 N-CA-C 116.485 2.032 . . . . 71.34 116.485 -173.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -75.07 -18.96 18.15 Favored 'Trans proline' 0 C--N 1.382 2.339 0 CA-C-N 121.524 1.58 . . . . 63.54 113.081 -173.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 16.4 mt -73.37 -34.73 44.21 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 N-CA-C 109.257 -0.646 . . . . 64.32 109.257 172.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.54 -42.87 81.99 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 123.094 0.558 . . . . 71.51 111.482 173.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 71.6 t -72.96 -44.45 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 123.59 0.756 . . . . 63.23 112.513 -174.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 78.7 t -88.76 -37.08 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 122.759 0.424 . . . . 74.41 110.933 -176.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 98.53 77.55 1.33 Allowed Glycine 0 C--N 1.339 0.713 0 N-CA-C 111.651 -0.58 . . . . 72.35 111.651 -176.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -103.44 -144.35 13.73 Favored Glycine 0 C--N 1.34 0.763 0 CA-C-N 115.255 -0.472 . . . . 55.24 112.042 178.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.537 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 43.1 mtmt -127.55 147.03 50.33 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 122.863 0.465 . . . . 45.21 110.614 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 24.8 m -137.14 -177.07 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.634 1.174 . . . . 63.11 108.861 170.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 26.2 ttm180 -116.62 129.24 56.04 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.609 0.763 . . . . 71.41 108.998 171.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -109.03 149.37 29.36 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.444 -0.947 . . . . 62.04 108.444 173.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -88.78 145.95 25.3 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.059 -0.719 . . . . 71.23 109.059 174.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . 0.771 ' HA ' ' HE1' ' A' ' 186' ' ' PHE . 41.0 p -127.94 174.27 9.32 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 123.914 0.886 . . . . 74.1 109.635 172.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.601 HD22 ' HB3' ' A' ' 127' ' ' LEU . 24.6 mt -59.19 -36.56 75.56 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.001 0.92 . . . . 63.31 110.889 -176.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.423 ' HA ' ' NZ ' ' B' ' 2' ' ' LYS . 15.1 mm-40 -98.87 2.07 46.32 Favored 'General case' 0 CA--C 1.554 1.127 0 CA-C-N 114.714 -1.13 . . . . 64.44 112.539 -172.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 140.8 -173.53 23.12 Favored Glycine 0 N--CA 1.483 1.77 0 CA-C-O 119.253 -0.748 . . . . 33.0 112.785 176.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -79.28 155.67 25.41 Favored 'Trans proline' 0 C--N 1.369 1.643 0 C-N-CA 122.644 2.229 . . . . 70.23 111.8 176.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 18.4 m -148.26 157.08 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 C-N-CA 123.888 0.875 . . . . 73.4 111.066 -177.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -91.24 124.93 35.82 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.951 0.9 . . . . 75.04 109.809 178.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 97.1 t -136.13 123.3 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.22 1.008 . . . . 74.13 109.163 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.537 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -89.98 133.68 34.66 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 118.163 0.438 . . . . 60.25 111.207 178.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.562 ' HA ' HD12 ' B' ' 441' ' ' ILE . 44.5 t -78.61 145.42 67.17 Favored Pre-proline 0 CA--C 1.561 1.384 0 C-N-CA 125.571 1.548 . . . . 63.14 110.051 -178.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -78.93 172.12 15.45 Favored 'Trans proline' 0 C--N 1.386 2.509 0 C-N-CA 122.767 2.312 . . . . 75.51 111.51 172.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.42 150.74 28.73 Favored 'Trans proline' 0 C--N 1.373 1.829 0 C-N-CA 121.87 1.713 . . . . 72.53 113.274 175.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . 0.49 HH12 ' HB2' ' C' ' 261' ' ' LEU . 85.9 mtt-85 64.16 30.04 13.81 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 125.851 1.661 . . . . 74.04 111.477 172.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.578 HG23 HD21 ' A' ' 233' ' ' LEU . 43.7 m -66.15 106.27 1.6 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.516 1.526 . . . . 64.32 111.291 178.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . 0.442 ' HB3' ' HD2' ' A' ' 231' ' ' ARG . 6.4 tp-100 -93.16 140.39 29.57 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.021 0.928 . . . . 75.32 110.657 -176.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . 0.454 ' HA ' ' HB ' ' A' ' 253' ' ' VAL . . . -66.07 157.59 30.68 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.849 0.86 . . . . 62.31 111.782 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 82.96 -40.19 2.79 Favored Glycine 0 C--N 1.347 1.179 0 CA-C-N 116.189 -0.459 . . . . 73.32 112.043 -177.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.442 ' HD2' ' HB3' ' A' ' 228' ' ' GLN . 92.6 mtt180 -66.4 157.67 31.3 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 124.147 0.979 . . . . 74.0 111.437 175.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.752 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 3.3 mptp? -109.94 125.59 53.01 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 114.856 -1.065 . . . . 72.22 108.418 177.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.578 HD21 HG23 ' A' ' 227' ' ' THR . 87.4 mt -76.14 104.82 6.85 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.883 -0.784 . . . . 71.4 108.883 177.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 18.4 ttp180 -84.95 109.6 18.27 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.27 0.628 . . . . 64.14 110.324 178.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.59 HD22 HG23 ' B' ' 441' ' ' ILE . 0.4 OUTLIER -120.57 117.1 26.73 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.972 0.909 . . . . 61.12 109.75 175.127 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 30.8 mmtm -60.69 151.08 30.18 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.916 1.286 . . . . 64.43 113.277 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 71.23 32.21 65.63 Favored Glycine 0 C--N 1.356 1.656 0 CA-C-N 114.682 -1.145 . . . . 74.2 113.604 172.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.485 ' HG3' HD12 ' A' ' 235' ' ' LEU . 41.8 mmtm -130.32 -30.31 1.94 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.524 0.73 . . . . 73.01 110.565 -174.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -73.04 173.87 47.64 Favored Glycine 0 C--N 1.351 1.396 0 O-C-N 123.301 0.376 . . . . 74.43 112.451 171.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . 0.565 ' HD2' ' HA2' ' A' ' 152' ' ' GLY . 5.7 m-85 -91.78 158.15 40.51 Favored Pre-proline 0 N--CA 1.48 1.044 0 C-N-CA 123.204 0.602 . . . . 73.13 110.85 -169.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -61.09 111.05 0.97 Allowed 'Trans proline' 0 C--N 1.387 2.558 0 C-N-CA 123.054 2.503 . . . . 73.33 112.158 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -125.31 -150.34 7.73 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-O 119.337 -0.702 . . . . 73.52 112.212 179.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . 0.435 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 32.6 Cg_endo -63.33 -30.77 73.48 Favored 'Trans proline' 0 C--N 1.373 1.848 0 C-N-CA 122.895 2.397 . . . . 70.45 113.07 -177.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.432 ' HB3' HE22 ' A' ' 191' ' ' GLN . . . -107.28 12.7 27.93 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.867 0.867 . . . . 70.11 111.4 178.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 87.66 -161.61 32.37 Favored Glycine 0 C--N 1.345 1.053 0 CA-C-N 116.327 -0.397 . . . . 62.24 112.158 -174.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 66.4 mtt85 -59.46 108.83 0.77 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.337 0.655 . . . . 75.41 110.676 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -70.5 -157.39 2.11 Favored Glycine 0 C--N 1.347 1.142 0 CA-C-N 115.605 -0.725 . . . . 42.24 113.758 -178.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -100.48 166.28 11.01 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.924 0.869 . . . . 75.44 110.641 178.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.441 ' HB3' ' HG ' ' A' ' 235' ' ' LEU . 14.5 tp -102.64 128.36 49.36 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 106.284 -1.746 . . . . 70.31 106.284 164.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.752 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 18.6 m-85 -108.77 105.1 14.54 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 107.609 -1.256 . . . . 52.51 107.609 173.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.534 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 40.1 mt -90.7 103.93 16.57 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 109.245 -0.65 . . . . 72.24 109.245 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.498 ' HG2' ' HG3' ' A' ' 232' ' ' LYS . 22.3 mt-10 -76.7 101.69 5.89 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.146 0.978 . . . . 75.41 108.758 -170.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.454 ' HB ' ' HA ' ' A' ' 229' ' ' ALA . 27.0 t -64.31 122.96 16.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-N 114.849 -1.068 . . . . 24.43 112.504 -167.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . 0.515 ' HD2' ' SD ' ' B' ' 26' ' ' MET . 5.7 mmt180 -122.42 96.29 4.98 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.423 1.089 . . . . 73.14 108.604 169.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.447 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 73.1 mt -72.94 117.09 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 114.171 -1.377 . . . . 74.34 109.57 178.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . 0.408 ' O ' ' HA ' ' A' ' 200' ' ' PRO . 41.1 p -110.3 174.17 5.99 Favored 'General case' 0 C--O 1.255 1.348 0 C-N-CA 124.445 1.098 . . . . 73.43 110.092 178.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 26.1 pt -132.87 151.8 78.68 Favored Pre-proline 0 CA--C 1.554 1.135 0 CA-C-N 114.93 -1.032 . . . . 73.4 108.778 177.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -87.22 22.09 0.97 Allowed 'Trans proline' 0 C--N 1.365 1.429 0 C-N-CA 122.725 2.283 . . . . 74.45 112.962 -171.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 33.83 -87.89 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 125.303 1.441 . . . . 63.24 113.49 -165.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.47 132.52 47.14 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.775 0.83 . . . . 75.12 110.945 -170.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.535 HD11 HG11 ' C' ' 205' ' ' VAL . 86.0 mt -127.64 170.42 12.7 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.521 0.728 . . . . 55.32 111.094 -174.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 75.1 p -104.8 159.78 28.21 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-N 114.598 -1.183 . . . . 44.34 110.174 171.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_exo -32.7 -46.92 0.3 Allowed 'Trans proline' 0 C--N 1.383 2.346 0 C-N-CA 124.831 3.687 . . . . 74.33 116.044 172.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -57.62 -64.41 0.91 Allowed 'General case' 0 C--O 1.25 1.114 0 C-N-CA 123.987 0.915 . . . . 71.44 111.197 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -59.5 -48.3 82.17 Favored 'General case' 0 C--N 1.349 0.562 0 CA-C-N 114.54 -1.209 . . . . 64.2 110.2 -176.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' GLU . . . . . 0.536 ' O ' ' HG2' ' A' ' 270' ' ' LYS . 7.1 tp10 -53.03 -52.93 56.88 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 124.617 1.198 . . . . 73.45 111.099 -176.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -63.5 -45.19 91.84 Favored 'General case' 0 C--O 1.254 1.294 0 O-C-N 124.199 0.937 . . . . 64.12 111.94 -178.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 9.4 mp -63.38 -34.09 76.97 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-N 115.826 -0.624 . . . . 73.14 111.358 178.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' TRP . . . . . 0.44 ' O ' HG11 ' C' ' 206' ' ' VAL . 61.7 m95 -75.97 -30.51 58.63 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 118.677 -0.677 . . . . 75.0 111.349 177.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . 0.536 ' HG2' ' O ' ' A' ' 266' ' ' GLU . 0.0 OUTLIER -57.37 -60.73 3.2 Favored 'General case' 0 C--O 1.267 2.005 0 N-CA-C 108.214 -1.032 . . . . 62.43 108.214 175.103 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? -55.67 -50.24 70.78 Favored 'General case' 0 C--N 1.357 0.928 0 CA-C-N 112.002 -2.363 . . . . 70.22 110.66 -178.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' LEU . . . . . 0.407 HD12 HD12 ' C' ' 272' ' ' LEU . 2.1 tt -58.1 -58.93 6.28 Favored 'General case' 0 C--O 1.191 -2.026 0 O-C-N 124.298 0.999 . . . . 63.4 108.992 -177.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . 0.472 ' O ' ' HB3' ' A' ' 276' ' ' TYR . . . -56.21 -48.77 75.77 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 114.236 1.199 . . . . 64.51 114.236 -170.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -89.21 -21.85 23.06 Favored 'General case' 0 C--O 1.252 1.189 0 N-CA-C 112.68 0.622 . . . . 74.35 112.68 -172.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -80.47 -26.24 38.4 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.988 -0.445 . . . . 71.44 110.697 168.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . 0.472 ' HB3' ' O ' ' A' ' 273' ' ' ALA . 2.2 t80 -58.92 -55.81 30.28 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 125.79 1.636 . . . . 75.02 107.797 170.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -44.91 -66.1 0.44 Allowed 'General case' 0 C--O 1.249 1.077 0 O-C-N 125.538 1.774 . . . . 70.12 109.431 173.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -62.82 -14.24 43.11 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 114.76 -1.109 . . . . 75.41 113.841 -175.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 86.7 mtm180 -132.17 34.16 3.82 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 122.927 0.491 . . . . 74.13 110.228 -175.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.568 1.673 0 O-C-N 124.261 0.976 . . . . 72.21 113.134 175.712 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.443 ' SD ' ' N ' ' B' ' 1' ' ' MET . 1.6 mpt? . . . . . 0 N--CA 1.48 1.073 0 N-CA-C 110.338 -0.245 . . . . 71.44 110.338 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.423 ' NZ ' ' HA ' ' A' ' 216' ' ' GLU . 13.3 mptt -75.16 116.93 16.43 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.668 0.787 . . . . 54.1 110.788 178.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -168.58 -38.15 0.02 OUTLIER 'General case' 0 C--O 1.242 0.701 0 C-N-CA 124.361 1.064 . . . . 74.04 109.358 174.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 23.3 t 65.39 -177.59 0.18 Allowed 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.567 1.147 . . . . 52.14 111.027 -179.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 94.6 m 68.69 131.76 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.561 1.144 . . . . 70.11 112.182 177.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 138' ' ' VAL . 42.8 pt -140.5 173.44 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.584 0.754 . . . . 64.44 110.565 -175.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -132.82 129.83 39.03 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.544 0.738 . . . . 72.01 110.269 177.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.572 HD23 HG11 ' A' ' 140' ' ' VAL . 50.1 tp -78.51 155.56 29.72 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.036 0.934 . . . . 75.22 110.97 -174.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.31 -68.31 0.69 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 122.932 0.493 . . . . 62.4 111.437 176.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . 0.499 HD23 ' HB2' ' A' ' 121' ' ' ALA . 51.7 mt 68.32 2.98 3.51 Favored 'General case' 0 N--CA 1.501 2.094 0 C-N-CA 124.871 1.269 . . . . 74.1 111.844 -164.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 56.7 mt 55.36 71.07 1.35 Allowed Pre-proline 0 CA--C 1.555 1.169 0 C-N-CA 124.564 1.146 . . . . 45.35 112.137 -175.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -98.66 -145.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 123.922 3.082 . . . . 61.33 111.053 173.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 76.1 mt -59.84 -38.85 83.25 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.444 0.698 . . . . 75.01 111.478 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 3.2 pp -139.55 151.6 46.21 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.561 0.744 . . . . 64.54 110.349 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -144.78 176.51 9.39 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.263 0.625 . . . . 60.01 110.566 -178.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 6.2 t -71.55 135.22 83.91 Favored Pre-proline 0 CA--C 1.556 1.199 0 C-N-CA 123.934 0.894 . . . . 51.11 110.841 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.63 85.55 1.29 Allowed 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 122.167 1.911 . . . . 62.42 112.141 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.533 HG11 ' HD2' ' A' ' 179' ' ' ARG . 35.7 t -80.0 86.13 1.34 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.605 0 N-CA-C 108.607 -0.886 . . . . 61.41 108.607 177.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . 0.452 HG22 ' HD3' ' B' ' 117' ' ' LYS . 1.1 m -85.0 -27.16 26.62 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.405 -0.816 . . . . 71.22 110.587 -175.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 59.5 mttm 67.08 -79.51 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.665 1.186 . . . . 62.34 111.334 -174.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -101.65 75.2 1.56 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.516 0.727 . . . . 75.34 111.683 -169.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 -137.29 118.24 14.26 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 107.786 -1.19 . . . . 73.31 107.786 161.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' THR . . . . . . . . . . . . . 19.7 p -135.2 61.87 48.02 Favored Pre-proline 0 CA--C 1.555 1.139 0 C-N-CA 123.689 0.796 . . . . 72.45 110.12 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -89.92 24.82 0.61 Allowed 'Trans proline' 0 C--N 1.382 2.303 0 C-N-CA 122.809 2.339 . . . . 74.55 112.329 -177.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -84.19 71.83 10.57 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.992 0.917 . . . . 74.53 109.287 -175.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . 0.515 ' SD ' ' HD2' ' A' ' 254' ' ' ARG . 59.1 mtm -128.41 157.56 74.31 Favored Pre-proline 0 CA--C 1.549 0.93 0 CA-C-N 114.792 -1.094 . . . . 75.13 108.511 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -74.69 65.31 5.77 Favored 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 122.739 2.292 . . . . 71.1 115.418 -173.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.414 HG11 ' HB2' ' B' ' 31' ' ' ASN . 54.4 t 70.43 -49.52 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 C-N-CA 126.504 1.922 . . . . 73.51 114.599 169.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.561 HD12 ' HB3' ' C' ' 228' ' ' GLN . 1.9 mm? 74.31 -64.42 0.39 Allowed 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 125.816 1.646 . . . . 62.2 112.213 170.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -56.59 -65.38 0.62 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.238 0.615 . . . . 70.24 110.383 176.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' ASN . . . . . 0.414 ' HB2' HG11 ' B' ' 28' ' ' VAL . 12.3 m120 -80.95 8.49 8.27 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 112.032 0.382 . . . . 74.34 112.032 -179.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 15.9 ttt85 -77.28 -26.07 52.04 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 109.466 -0.568 . . . . 72.22 109.466 170.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -125.7 -86.2 0.62 Allowed 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 123.606 0.763 . . . . 73.31 109.381 168.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . 61.67 11.28 3.84 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 124.562 1.145 . . . . 53.33 113.848 176.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -142.71 144.13 32.57 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 122.825 0.45 . . . . 73.13 110.475 -168.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.78 98.19 0.12 Allowed Glycine 0 C--N 1.341 0.814 0 N-CA-C 109.669 -1.372 . . . . 74.33 109.669 176.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 12.7 t70 62.67 -175.26 0.14 Allowed 'General case' 0 CA--C 1.565 1.551 0 C-N-CA 124.431 1.092 . . . . 61.44 111.21 176.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 36.8 pt -92.72 -12.49 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.575 -0.703 . . . . 75.44 110.692 170.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . 0.463 ' O ' ' HB2' ' B' ' 155' ' ' LEU . 76.1 p 56.38 -71.09 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 126.795 2.038 . . . . 64.25 113.216 -172.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . 69.05 160.29 0.15 Allowed Pre-proline 0 N--CA 1.491 1.593 0 C-N-CA 124.271 1.028 . . . . 64.0 112.234 177.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.66 138.69 35.48 Favored 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 122.188 1.925 . . . . 72.44 112.484 173.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.1 -80.68 0.06 OUTLIER Glycine 0 C--N 1.347 1.14 0 N-CA-C 111.931 -0.468 . . . . 45.24 111.931 177.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . 0.637 ' HA2' ' HB2' ' B' ' 159' ' ' LYS . . . -170.88 -170.61 35.29 Favored Glycine 0 C--N 1.343 0.97 0 O-C-N 123.372 0.101 . . . . 42.15 113.075 -176.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . 0.614 ' HA ' HG12 ' B' ' 154' ' ' ILE . . . -141.54 -171.0 3.22 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.59 0.756 . . . . 63.2 110.773 -176.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -68.86 85.49 0.33 Allowed 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 108.958 -0.756 . . . . 74.21 108.958 173.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' ARG . . . . . 0.433 ' O ' ' HA ' ' B' ' 149' ' ' LYS . 30.6 ttm-85 -57.6 100.5 0.05 Allowed 'General case' 0 C--N 1.359 1.005 0 C-N-CA 124.235 1.014 . . . . 75.02 110.512 -176.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.57 HD12 ' HG3' ' B' ' 148' ' ' GLU . 86.6 mt 52.64 32.23 11.49 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.004 0.922 . . . . 53.22 111.702 177.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 42.5 m -118.24 86.43 2.53 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 115.08 -0.963 . . . . 51.22 108.596 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -62.51 -54.18 36.05 Favored Glycine 0 C--N 1.349 1.294 0 N-CA-C 110.274 -1.13 . . . . 74.15 110.274 172.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -165.97 104.12 0.67 Allowed 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 106.752 -1.573 . . . . 64.2 106.752 162.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 73.03 -67.22 0.28 Allowed 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 125.748 1.619 . . . . 75.3 110.211 -163.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 49.1 p -106.32 163.25 12.98 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.854 0.862 . . . . 73.31 110.272 177.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.07 113.3 2.76 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 108.775 -0.824 . . . . 73.24 108.775 169.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.412 ' HB3' ' HE2' ' B' ' 138' ' ' TYR . . . 58.75 -156.94 0.32 Allowed 'General case' 0 N--CA 1.485 1.309 0 O-C-N 124.123 0.889 . . . . 75.51 110.612 -171.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.424 ' HB3' ' HG2' ' B' ' 235' ' ' GLU . 63.0 tp -156.4 -76.64 0.09 Allowed 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.134 -0.691 . . . . 72.35 109.134 173.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . 0.524 ' NH1' ' HA ' ' B' ' 290' ' ' TRP . 48.4 ttp85 -168.2 106.58 0.5 Allowed 'General case' 0 C--O 1.24 0.565 0 C-N-CA 124.122 0.969 . . . . 73.2 108.729 -173.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -49.08 -73.4 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 125.302 1.441 . . . . 75.31 112.288 -171.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 9.8 m 75.14 -36.59 0.32 Allowed 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 125.334 1.454 . . . . 62.01 114.2 169.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 51.4 tp -65.71 -34.36 78.02 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.474 1.109 . . . . 72.44 110.819 -176.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . 0.507 ' HB3' ' HB3' ' B' ' 297' ' ' TYR . 8.0 m 73.57 -67.49 0.26 Allowed 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 125.644 1.578 . . . . 63.51 112.175 171.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . 0.442 ' HB2' ' H ' ' B' ' 298' ' ' HIS . 21.3 t70 -108.03 130.84 55.05 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.979 0.912 . . . . 71.45 110.077 -177.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' LYS . . . . . . . . . . . . . 8.8 mptt -126.64 77.29 73.87 Favored Pre-proline 0 N--CA 1.493 1.725 0 C-N-CA 123.623 0.769 . . . . 72.3 109.691 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -98.49 -0.09 1.18 Allowed 'Trans proline' 0 C--N 1.37 1.683 0 C-N-CA 123.103 2.536 . . . . 72.24 114.221 178.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 63.04 88.26 0.1 Allowed 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.506 1.122 . . . . 72.04 109.852 -166.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -85.4 22.95 1.41 Allowed 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.541 0.736 . . . . 65.32 111.888 -174.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -85.48 6.17 28.05 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.763 0.825 . . . . 72.41 111.214 -178.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 50.8 mm 74.42 -72.5 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 C-N-CA 125.885 1.674 . . . . 72.03 111.186 177.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 3.9 pt -122.25 125.92 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 123.61 0.764 . . . . 73.4 110.178 -176.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.45 ' HG ' ' HB3' ' B' ' 230' ' ' ALA . 2.8 mm? -112.68 -168.4 1.31 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.494 1.118 . . . . 73.12 109.431 -177.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . 0.441 ' HB2' ' O ' ' B' ' 121' ' ' VAL . 3.5 mm? 56.31 -146.67 0.55 Allowed 'General case' 0 CA--C 1.562 1.438 0 C-N-CA 124.115 0.966 . . . . 44.44 111.42 178.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . 0.653 HG21 ' HZ1' ' A' ' 232' ' ' LYS . 11.3 tp 58.03 111.2 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 C-N-CA 127.082 2.153 . . . . 74.32 113.192 176.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 115.9 -24.34 10.22 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-N 115.43 -0.805 . . . . 62.21 111.801 -175.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -57.07 142.96 40.39 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 124.247 1.019 . . . . 63.44 112.139 -175.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 129.14 -156.38 21.2 Favored Glycine 0 C--N 1.341 0.842 0 N-CA-C 110.781 -0.928 . . . . 64.42 110.781 -177.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 75' ' ' MET . . . . . 0.415 ' HE2' ' O ' ' B' ' 110' ' ' ALA . 19.7 ptm -154.37 132.94 12.08 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 122.967 0.507 . . . . 74.01 109.919 -177.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . -129.42 -92.69 0.68 Allowed Glycine 0 C--N 1.342 0.862 0 N-CA-C 110.582 -1.007 . . . . 71.13 110.582 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . 0.49 ' HB2' ' HB ' ' B' ' 80' ' ' ILE . 6.5 p-10 -71.05 169.63 14.56 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.301 0.64 . . . . 73.03 112.083 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . 0.455 ' O ' ' HA2' ' B' ' 104' ' ' GLY . 21.4 m -118.88 93.74 4.2 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 108.095 -1.076 . . . . 51.1 108.095 172.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 66.53 3.47 2.9 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 125.343 1.457 . . . . 74.44 113.249 178.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.49 ' HB ' ' HB2' ' B' ' 77' ' ' ASP . 40.0 mm -75.58 -18.42 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 123.605 0.762 . . . . 72.52 111.058 -172.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 62.1 m -88.37 -64.24 1.18 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 122.854 0.462 . . . . 71.34 110.61 173.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -80.45 -67.04 0.81 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.484 0.714 . . . . 61.11 112.372 -167.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . 0.469 ' HB1' HD23 ' B' ' 102' ' ' LEU . . . -92.6 31.32 1.37 Allowed 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.966 0.906 . . . . 71.35 112.523 -165.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -86.87 13.85 8.26 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 113.739 1.014 . . . . 73.0 113.739 -168.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . 0.488 ' HA ' HD12 ' B' ' 385' ' ' LEU . 28.7 t-20 -162.46 -58.33 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 119.045 0.838 . . . . 72.23 111.359 -177.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -89.18 164.88 14.8 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.943 0.497 . . . . 63.12 111.312 -173.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . 0.719 ' HB2' ' H ' ' B' ' 100' ' ' LEU . . . -91.17 128.73 37.11 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 115.969 -0.56 . . . . 52.24 109.72 174.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -82.35 80.44 8.53 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 121.542 0.687 . . . . 74.14 110.447 -178.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . 0.511 ' H ' ' HG2' ' C' ' 279' ' ' ARG . . . 171.96 136.28 2.11 Favored Glycine 0 C--N 1.342 0.906 0 N-CA-C 109.83 -1.308 . . . . 54.33 109.83 175.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -53.58 -44.84 69.7 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.011 0.924 . . . . 62.33 111.401 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -118.36 31.19 5.71 Favored Glycine 0 C--N 1.342 0.908 0 CA-C-N 114.746 -1.116 . . . . 70.11 111.279 172.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -79.04 2.0 71.94 Favored Glycine 0 C--N 1.352 1.457 0 C-N-CA 123.127 0.394 . . . . 23.53 113.168 -175.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -92.65 155.22 17.88 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.179 1.392 . . . . 74.22 108.568 179.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 94' ' ' PHE . . . . . 0.823 ' HB2' ' HB2' ' B' ' 98' ' ' ASP . 25.1 m-85 -68.41 136.06 52.71 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 108.696 -0.853 . . . . 71.21 108.696 169.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . 0.427 ' N ' ' HD2' ' B' ' 95' ' ' LYS . 10.4 mptt -71.06 84.67 0.71 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.556 1.143 . . . . 74.14 112.0 -164.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 178.25 -59.34 0.09 OUTLIER Glycine 0 C--N 1.341 0.825 0 CA-C-N 114.181 -1.372 . . . . 72.31 109.953 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 16.2 tt -172.54 -26.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 C-N-CA 124.23 1.012 . . . . 72.22 110.103 175.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . 0.823 ' HB2' ' HB2' ' B' ' 94' ' ' PHE . 4.3 m-20 -56.61 112.58 1.32 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.017 1.327 . . . . 75.21 111.792 -169.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.92 159.99 31.15 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.041 0.448 . . . . 61.12 111.024 177.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . 0.719 ' H ' ' HB2' ' B' ' 87' ' ' ALA . 4.4 mm? -112.17 77.83 2.25 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 124.217 1.007 . . . . 74.2 108.69 169.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 101' ' ' PRO . . . . . 0.526 ' HB2' HD11 ' B' ' 385' ' ' LEU . 83.7 Cg_endo -81.3 107.78 1.9 Allowed 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 122.072 1.848 . . . . 72.21 110.699 -179.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . 0.469 HD23 ' HB1' ' B' ' 83' ' ' ALA . 3.0 mm? -56.05 -41.16 74.6 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 122.959 0.504 . . . . 73.12 110.158 -177.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 34.3 m 65.6 -70.09 0.1 Allowed 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 125.706 1.602 . . . . 75.52 112.089 173.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 104' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' B' ' 78' ' ' SER . . . -144.41 -29.54 0.1 Allowed Glycine 0 C--N 1.338 0.674 0 CA-C-N 114.904 -1.043 . . . . 51.35 111.719 174.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 40.09 -74.51 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 126.966 2.106 . . . . 75.22 114.312 -174.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 27.0 p90 -94.29 32.64 1.5 Allowed 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 124.167 0.987 . . . . 74.44 111.625 -178.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 63.1 m -66.97 116.72 8.11 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 122.129 -0.357 . . . . 63.32 110.89 178.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 42.3 p-80 -165.81 87.25 0.38 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.763 1.225 . . . . 71.44 108.052 170.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 67.1 t80 65.74 -84.54 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.622 1.169 . . . . 53.33 110.203 -175.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . 0.415 ' O ' ' HE2' ' B' ' 75' ' ' MET . . . 75.16 -54.74 0.65 Allowed 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 125.55 1.54 . . . . 71.24 114.179 171.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 1.7 pp -52.21 123.43 10.66 Favored 'General case' 0 CA--C 1.555 1.149 0 N-CA-C 114.042 1.127 . . . . 64.15 114.042 -172.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -129.11 89.42 2.86 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 107.577 -1.268 . . . . 73.2 107.577 172.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 113' ' ' LYS . . . . . 0.554 ' HA ' HG21 ' B' ' 224' ' ' VAL . 56.0 pttt -144.63 30.32 1.22 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 114.166 -1.379 . . . . 75.13 108.925 -176.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -54.8 -69.27 0.13 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 125.16 1.384 . . . . 74.01 110.876 -171.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 7.8 p -147.2 128.06 14.43 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 125.048 1.339 . . . . 73.23 107.451 173.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 177.39 153.91 11.54 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 110.974 -0.851 . . . . 55.33 110.974 -177.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . 0.452 ' HD3' HG22 ' B' ' 19' ' ' THR . 27.1 ttpp -162.45 127.45 2.1 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 123.021 0.528 . . . . 70.25 109.893 -178.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 118' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.57 -35.17 17.85 Favored 'Trans proline' 0 C--N 1.381 2.268 0 C-N-CA 122.658 2.239 . . . . 60.53 111.283 167.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 119' ' ' ASP . . . . . . . . . . . . . 27.3 t70 66.23 -81.07 0.03 OUTLIER 'General case' 0 C--N 1.361 1.089 0 C-N-CA 125.589 1.556 . . . . 75.33 111.676 177.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 120' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -59.27 -26.11 64.66 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.73 1.212 . . . . 70.1 112.746 -175.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 121' ' ' VAL . . . . . 0.441 ' O ' ' HB2' ' B' ' 70' ' ' LEU . 51.9 t 67.85 -72.7 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.365 1.269 0 C-N-CA 125.164 1.386 . . . . 74.32 110.881 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 16.5 m -45.9 -60.49 2.22 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.582 1.553 . . . . 75.24 113.067 -177.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 14.9 t0 57.64 -85.13 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 125.19 1.396 . . . . 64.3 110.043 -174.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 30.9 m 60.73 -177.46 0.11 Allowed 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 124.901 1.28 . . . . 43.31 113.4 172.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -170.31 110.29 0.39 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.699 0.8 . . . . 73.02 109.751 172.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -71.28 154.35 41.7 Favored 'General case' 0 C--O 1.246 0.895 0 O-C-N 123.879 0.737 . . . . 74.13 110.826 177.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 17.0 t 67.65 -174.22 0.19 Allowed 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 124.775 1.23 . . . . 70.01 111.586 177.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . 0.535 ' HA ' ' SD ' ' C' ' 213' ' ' MET . . . -147.32 152.61 38.52 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.806 0.842 . . . . 72.01 109.695 177.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 129' ' ' THR . . . . . 0.412 HG21 ' O ' ' C' ' 215' ' ' LEU . 33.9 m -76.77 85.34 3.38 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 122.915 0.486 . . . . 54.34 110.351 178.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . 54.92 -149.21 0.45 Allowed 'General case' 0 CA--C 1.561 1.37 0 C-N-CA 124.521 1.128 . . . . 44.22 112.483 171.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 23.5 m95 58.71 -114.86 0.77 Allowed 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 124.572 1.149 . . . . 73.51 110.841 176.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 49.9 m 51.18 19.45 0.72 Allowed 'General case' 0 C--N 1.372 1.549 0 C-N-CA 124.69 1.196 . . . . 51.4 112.509 -171.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 133' ' ' THR . . . . . 0.435 HG21 HG23 ' B' ' 137' ' ' THR . 68.0 p 48.98 18.45 0.21 Allowed 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 126.197 1.799 . . . . 62.25 113.836 -172.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 61.36 22.88 61.67 Favored Glycine 0 C--N 1.359 1.859 0 CA-C-O 119.342 -0.699 . . . . 55.15 114.022 -176.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 135' ' ' VAL . . . . . . . . . . . . . 89.2 t 74.92 -48.52 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 C-N-CA 125.687 1.595 . . . . 73.24 111.198 -174.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -76.37 91.2 3.25 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.43 1.092 . . . . 52.43 109.557 173.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 137' ' ' THR . . . . . 0.435 HG23 HG21 ' B' ' 133' ' ' THR . 16.6 m -83.04 117.27 22.71 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 123.926 0.89 . . . . 75.31 111.294 -169.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 138' ' ' TYR . . . . . 0.412 ' HE2' ' HB3' ' B' ' 54' ' ' ALA . 74.2 m-85 74.58 -47.76 0.64 Allowed 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 125.888 1.675 . . . . 75.52 112.92 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 7.0 t30 74.03 -56.19 0.65 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 125.267 1.427 . . . . 73.24 111.195 -177.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -60.25 -64.55 4.05 Favored Glycine 0 C--N 1.348 1.22 0 CA-C-O 119.678 -0.512 . . . . 65.04 112.14 172.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . 64.79 -64.91 0.15 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 125.735 1.614 . . . . 75.34 111.102 -175.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 7.3 mp -52.91 113.11 0.99 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.378 1.471 . . . . 70.15 110.862 173.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 149.31 132.84 2.13 Favored Glycine 0 C--N 1.336 0.542 0 N-CA-C 111.245 -0.742 . . . . 61.25 111.245 178.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 25.8 t 61.08 32.41 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.564 1.494 0 CA-C-O 122.515 1.15 . . . . 75.31 110.112 -178.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -63.48 -43.62 96.76 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 115.011 -0.995 . . . . 64.3 110.58 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 39.8 mm -73.81 118.93 20.05 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-N 115.247 -0.888 . . . . 72.52 108.785 175.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 60.48 -167.99 0.17 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.301 1.04 . . . . 72.43 113.796 176.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . 0.57 ' HG3' HD12 ' B' ' 47' ' ' LEU . 8.9 tp10 67.16 29.95 7.52 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 125.737 1.615 . . . . 73.05 110.404 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 149' ' ' LYS . . . . . 0.433 ' HA ' ' O ' ' B' ' 46' ' ' ARG . 8.3 pttm -158.08 -63.74 0.09 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 114.03 -1.441 . . . . 72.23 107.898 171.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 69.99 0.71 3.19 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 114.226 1.195 . . . . 74.11 114.226 164.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 54.6 p-80 43.21 66.33 4.63 Favored Pre-proline 0 N--CA 1.492 1.644 0 C-N-CA 124.794 1.237 . . . . 74.43 111.438 -168.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -90.36 29.0 0.4 Allowed 'Trans proline' 0 C--N 1.369 1.636 0 C-N-CA 122.86 2.373 . . . . 42.51 111.913 -164.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 1.6 m 54.23 -144.07 0.69 Allowed 'General case' 0 CA--C 1.569 1.678 0 C-N-CA 124.912 1.285 . . . . 74.2 109.236 -167.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 154' ' ' ILE . . . . . 0.614 HG12 ' HA ' ' B' ' 44' ' ' ALA . 0.0 OUTLIER -173.0 139.3 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 N-CA-C 107.746 -1.205 . . . . 74.25 107.746 -177.098 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 155' ' ' LEU . . . . . 0.463 ' HB2' ' O ' ' B' ' 39' ' ' THR . 1.4 pt? -145.28 -59.69 0.34 Allowed 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 122.646 0.378 . . . . 72.1 111.228 176.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 61.6 tt0 -81.24 168.15 18.79 Favored 'General case' 0 CA--C 1.561 1.379 0 C-N-CA 123.705 0.802 . . . . 72.23 111.238 -176.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 157' ' ' MET . . . . . 0.6 ' HG3' ' HG2' ' B' ' 241' ' ' GLU . 4.5 mpp? -45.02 -68.45 0.2 Allowed 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 125.524 1.529 . . . . 53.54 111.932 177.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 158' ' ' ALA . . . . . . . . . . . . . . . -156.29 14.96 0.32 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.969 0.908 . . . . 34.04 110.48 -178.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . 0.637 ' HB2' ' HA2' ' B' ' 43' ' ' GLY . 34.0 ttpt 64.52 -77.41 0.04 OUTLIER 'General case' 0 C--N 1.358 0.974 0 C-N-CA 125.074 1.349 . . . . 55.45 111.575 -173.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -163.43 35.39 0.09 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.536 1.134 . . . . 70.22 108.705 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -112.21 152.98 27.77 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.786 0.834 . . . . 71.1 110.097 178.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 84.04 -80.7 1.8 Allowed Glycine 0 C--N 1.347 1.177 0 CA-C-N 116.166 -0.47 . . . . 73.4 111.942 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 8.2 mp 60.75 -80.82 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 125.126 1.371 . . . . 65.02 111.793 -175.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 164' ' ' ALA . . . . . . . . . . . . . . . -69.84 -68.39 0.42 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.264 0.626 . . . . 75.34 111.214 -175.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 26.4 p -138.95 -70.18 0.42 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.417 0.687 . . . . 64.15 110.304 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . -178.86 71.29 0.07 OUTLIER Glycine 0 C--N 1.342 0.868 0 N-CA-C 110.459 -1.057 . . . . 71.15 110.459 -174.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 167' ' ' ASN . . . . . . . . . . . . . 61.7 t30 72.98 -61.92 0.49 Allowed 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 126.302 1.841 . . . . 72.31 111.221 -175.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 7.2 p -138.82 139.29 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.668 0.787 . . . . 74.13 110.304 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 14.3 m -85.33 71.4 10.83 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.868 0.867 . . . . 54.35 109.517 -177.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 35.9 m -70.81 86.08 0.68 Allowed 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 124.282 1.033 . . . . 63.1 110.846 -173.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -133.21 -31.78 1.23 Allowed 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.058 0.543 . . . . 53.32 112.134 -172.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 172' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -83.1 62.7 6.74 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-O 122.381 1.086 . . . . 73.22 110.608 -176.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 173' ' ' LEU . . . . . . . . . . . . . 5.4 mp -109.91 -25.46 10.28 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.569 1.148 . . . . 74.23 108.117 169.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 174' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -132.54 175.65 9.12 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 124.923 1.289 . . . . 74.45 109.189 -178.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 175' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -116.49 160.37 20.7 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.649 0.78 . . . . 74.1 109.972 173.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -118.45 144.2 46.15 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.926 -0.768 . . . . 74.11 108.926 173.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 57.7 m -138.87 103.32 7.53 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 123.689 0.795 . . . . 64.31 109.301 -178.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 178' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.93 -38.73 12.47 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.715 2.277 . . . . 74.53 111.447 175.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -166.98 -63.39 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 107.346 -1.353 . . . . 61.34 107.346 178.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 180' ' ' ALA . . . . . 0.532 ' HB1' HG13 ' C' ' 137' ' ' VAL . . . -145.77 -63.0 0.33 Allowed 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 105.292 -2.114 . . . . 74.4 105.292 169.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 181' ' ' LEU . . . . . 0.583 ' HB3' HG12 ' C' ' 138' ' ' VAL . 37.0 tp -148.37 -32.44 0.25 Allowed 'General case' 0 CA--C 1.553 1.087 0 CA-C-N 114.22 -1.355 . . . . 62.04 108.837 160.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 182' ' ' VAL . . . . . 0.662 HG12 HD13 ' C' ' 123' ' ' LEU . 32.6 m -118.6 -176.88 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 C-N-CA 124.53 1.132 . . . . 71.31 111.499 177.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 183' ' ' ALA . . . . . 0.517 ' HB2' ' HD2' ' C' ' 124' ' ' PRO . . . -112.21 -95.44 0.44 Allowed 'General case' 0 C--N 1.357 0.92 0 C-N-CA 123.976 0.91 . . . . 65.24 110.163 167.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 35.9 m80 -157.58 -171.19 3.47 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 123.689 0.796 . . . . 74.15 110.881 -170.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 185' ' ' VAL . . . . . 0.574 HG22 HD21 ' C' ' 119' ' ' LEU . 25.1 t -68.82 159.78 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 C-N-CA 124.761 1.224 . . . . 71.33 112.853 -171.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 6.7 t -149.6 -171.35 3.87 Favored 'General case' 0 CA--C 1.56 1.364 0 C-N-CA 125.776 1.63 . . . . 51.31 108.583 171.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 187' ' ' SER . . . . . 0.446 ' H ' ' HD2' ' B' ' 188' ' ' ARG . 55.6 m -137.41 12.82 3.01 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.271 0.628 . . . . 62.14 111.521 177.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 188' ' ' ARG . . . . . 0.446 ' HD2' ' H ' ' B' ' 187' ' ' SER . 1.8 mpt_? -117.9 153.58 33.32 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 122.688 0.395 . . . . 71.52 110.803 -172.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 189' ' ' LYS . . . . . 0.463 ' HE2' HG11 ' C' ' 177' ' ' VAL . 33.5 mtmm 70.47 125.64 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.487 1.515 . . . . 72.52 113.392 171.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 190' ' ' CYS . . . . . 0.525 ' HA ' HG11 ' C' ' 158' ' ' VAL . 26.0 p -147.98 103.74 3.51 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.301 1.04 . . . . 70.33 109.218 178.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -143.86 -172.29 3.72 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.643 1.577 . . . . 74.04 108.025 -176.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -152.4 65.18 0.35 Allowed Glycine 0 CA--C 1.536 1.386 0 CA-C-O 119.467 -0.63 . . . . 64.22 113.164 173.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 193' ' ' PRO . . . . . 0.572 ' HG2' ' HA ' ' C' ' 157' ' ' SER . 27.7 Cg_endo -98.42 83.84 0.06 OUTLIER 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 123.674 2.916 . . . . 64.32 111.943 175.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 194' ' ' SER . . . . . . . . . . . . . 45.8 t -102.97 146.97 27.53 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.735 0.814 . . . . 24.51 109.844 178.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 195' ' ' ALA . . . . . 0.411 ' HB1' ' HD3' ' C' ' 243' ' ' PRO . . . -150.42 136.64 18.67 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.417 0.687 . . . . 74.32 110.967 -177.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 8.4 m 71.14 160.82 0.22 Allowed 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 124.922 1.289 . . . . 73.32 112.254 175.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 18.7 m -116.47 -62.0 1.65 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.561 0.744 . . . . 75.11 109.74 176.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 198' ' ' GLU . . . . . 0.458 ' HG3' ' H ' ' B' ' 199' ' ' LYS . 6.7 pt-20 -166.23 -59.01 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.886 0.875 . . . . 51.12 110.116 -178.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 199' ' ' LYS . . . . . 0.458 ' H ' ' HG3' ' B' ' 198' ' ' GLU . 75.0 mmtt -90.27 87.68 6.92 Favored 'General case' 0 C--N 1.345 0.374 0 C-N-CA 123.646 0.778 . . . . 74.4 109.105 -173.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 200' ' ' CYS . . . . . . . . . . . . . 46.2 t -159.93 79.4 2.59 Favored Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 114.824 -1.08 . . . . 73.31 108.49 175.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 201' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -64.01 -45.84 9.52 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 122.807 2.338 . . . . 71.34 112.576 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 78.65 52.48 5.05 Favored Glycine 0 C--N 1.346 1.131 0 N-CA-C 111.624 -0.591 . . . . 63.04 111.624 -174.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -70.23 -47.8 59.82 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.033 0.933 . . . . 71.33 110.934 -176.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -70.52 89.28 0.7 Allowed 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.868 -0.605 . . . . 74.01 109.635 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 205' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -102.27 118.41 36.81 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-N 115.703 -0.681 . . . . 51.03 109.609 -174.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -76.77 132.65 39.38 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.658 -0.701 . . . . 62.32 109.604 173.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -92.4 -23.94 19.03 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.892 0.877 . . . . 74.32 110.824 177.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 103.67 120.24 4.74 Favored Glycine 0 C--N 1.347 1.172 0 CA-C-N 115.816 -0.629 . . . . 71.52 112.352 175.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . -76.75 -5.53 83.82 Favored Glycine 0 C--N 1.351 1.385 0 CA-C-O 119.874 -0.404 . . . . 42.21 113.148 174.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt 57.53 -67.38 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 127.582 2.353 . . . . 74.51 114.935 171.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . -68.48 99.32 0.58 Allowed Glycine 0 C--N 1.348 1.237 0 CA-C-O 119.557 -0.58 . . . . 74.43 112.528 -178.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 25.9 t 83.02 -10.81 1.0 Allowed 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 126.228 1.811 . . . . 74.04 111.69 -175.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 2.8 mp -92.69 88.49 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 N-CA-C 107.444 -1.317 . . . . 64.4 107.444 176.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 34.2 p -139.24 80.51 1.78 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.74 0.816 . . . . 75.43 109.682 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 215' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -118.77 159.17 24.18 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 109.059 -0.719 . . . . 73.31 109.059 172.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 67.69 116.57 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.09 1.356 . . . . 61.42 111.713 -175.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . 0.804 HD12 ' HG2' ' B' ' 221' ' ' ARG . 2.6 mm? 58.78 44.03 17.59 Favored 'General case' 0 C--N 1.36 1.048 0 C-N-CA 124.801 1.241 . . . . 75.4 109.874 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 10.2 tt -61.41 139.51 58.19 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 113.806 -1.543 . . . . 71.43 111.309 -174.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 60.7 26.01 15.78 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 124.836 1.254 . . . . 71.24 112.309 -173.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . 0.414 ' O ' ' HG3' ' B' ' 221' ' ' ARG . . . 74.5 -1.98 2.94 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 125.295 1.438 . . . . 61.1 113.177 175.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 221' ' ' ARG . . . . . 0.804 ' HG2' HD12 ' B' ' 217' ' ' LEU 0.251 0.0 OUTLIER 61.61 -21.59 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.337 0 C-N-CA 127.603 2.361 . . . . 73.55 116.734 175.973 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . 71.6 104.86 0.07 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 125.37 1.468 . . . . 42.52 112.521 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -103.14 158.23 16.45 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.036 0.935 . . . . 61.02 110.325 177.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . 0.554 HG21 ' HA ' ' B' ' 113' ' ' LYS . 10.7 p -167.15 9.67 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.54 0 C-N-CA 123.848 0.859 . . . . 74.2 110.539 178.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 37.1 p -122.63 146.48 47.41 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.273 0.629 . . . . 54.34 111.922 -169.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 63.64 -88.94 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.655 1.182 . . . . 74.43 113.19 169.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . 121.35 -155.57 16.43 Favored Glycine 0 N--CA 1.475 1.289 0 N-CA-C 110.875 -0.89 . . . . 51.31 110.875 -167.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . -172.61 51.51 0.17 Allowed Glycine 0 C--N 1.345 1.08 0 CA-C-N 117.569 0.685 . . . . 72.41 112.872 178.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . 65.45 -143.14 45.3 Favored Glycine 0 C--N 1.344 1.016 0 CA-C-O 119.901 -0.388 . . . . 70.24 113.818 172.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . 0.45 ' HB3' ' HG ' ' B' ' 69' ' ' LEU . . . 178.54 161.54 0.66 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.361 1.465 . . . . 70.23 109.406 172.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 231' ' ' LYS . . . . . 0.476 ' HE3' ' SD ' ' C' ' 213' ' ' MET . 4.0 mptp? -135.02 -153.86 0.54 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.135 0.974 . . . . 73.24 108.575 178.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 6.1 m -144.1 152.68 41.28 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 109.575 -0.528 . . . . 74.24 109.575 176.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 233' ' ' PHE . . . . . 0.44 ' HA ' ' H ' ' C' ' 211' ' ' ARG . 48.2 p90 -83.46 170.32 14.59 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 113.748 1.018 . . . . 70.41 113.748 -169.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . 0.591 ' HB3' ' HE ' ' C' ' 211' ' ' ARG . . . -166.07 -148.0 0.09 Allowed 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 125.353 1.461 . . . . 72.31 108.093 173.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . 0.424 ' HG2' ' HB3' ' B' ' 55' ' ' LEU . 0.0 OUTLIER -126.43 134.27 51.03 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.797 0.839 . . . . 54.41 111.136 -179.891 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 236' ' ' THR . . . . . 0.492 HG22 ' H ' ' B' ' 237' ' ' ALA . 3.5 m -156.18 177.73 11.1 Favored 'General case' 0 CA--C 1.564 1.489 0 C-N-CA 126.545 1.938 . . . . 73.34 107.188 176.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . 0.492 ' H ' HG22 ' B' ' 236' ' ' THR . . . -130.31 42.42 3.26 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 119.07 0.85 . . . . 71.12 111.873 -179.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 56.8 m -140.98 134.32 29.72 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 118.359 -0.829 . . . . 71.31 110.495 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -173.92 -174.48 0.94 Allowed 'General case' 0 C--N 1.377 1.782 0 N-CA-C 114.028 1.121 . . . . 74.42 114.028 174.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . -116.62 -138.21 6.19 Favored Glycine 0 C--N 1.362 2.004 0 C-N-CA 125.348 1.451 . . . . 71.23 110.902 175.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 241' ' ' GLU . . . . . 0.6 ' HG2' ' HG3' ' B' ' 157' ' ' MET . 11.6 pt-20 -156.65 177.05 11.92 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 117.452 0.626 . . . . 71.21 111.066 174.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 242' ' ' TRP . . . . . 0.474 ' CD2' ' HG ' ' C' ' 233' ' ' LEU . 0.0 OUTLIER -158.87 -39.46 0.06 Allowed 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.991 1.316 . . . . 70.32 108.944 179.483 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -126.36 -168.32 1.84 Allowed 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 107.484 -1.302 . . . . 74.22 107.484 162.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -71.87 91.42 0.51 Allowed Glycine 0 C--N 1.344 1.007 0 CA-C-N 116.611 -0.268 . . . . 63.11 112.529 171.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 245' ' ' LYS . . . . . 0.427 ' HE3' ' HB3' ' B' ' 241' ' ' GLU . 0.7 OUTLIER -80.55 51.08 1.4 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.525 1.13 . . . . 75.34 110.592 176.122 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . 0.579 ' HA ' HG23 ' B' ' 154' ' ' ILE . 55.9 p -112.92 67.25 0.66 Allowed 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.053 -1.43 . . . . 71.02 110.062 -168.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 247' ' ' LEU . . . . . 0.434 HD13 ' N ' ' B' ' 248' ' ' ARG . 2.1 tm? -156.12 140.13 16.35 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.123 -0.695 . . . . 72.51 109.123 -176.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 248' ' ' ARG . . . . . 0.457 ' HD3' ' N ' ' B' ' 249' ' ' GLU . 1.1 tmt_? -159.94 143.34 14.07 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 107.767 -1.197 . . . . 75.15 107.767 169.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 249' ' ' GLU . . . . . 0.457 ' N ' ' HD3' ' B' ' 248' ' ' ARG . 0.3 OUTLIER -144.41 149.5 36.17 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 123.993 0.917 . . . . 71.33 109.437 -179.179 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -142.3 -38.55 0.37 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.947 0.899 . . . . 65.4 111.821 178.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 251' ' ' ALA . . . . . 0.438 ' HB3' ' HB3' ' B' ' 358' ' ' CYS . . . -160.83 54.9 0.31 Allowed 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 112.56 0.578 . . . . 61.03 112.56 -166.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . 0.527 ' HA ' ' HA ' ' B' ' 363' ' ' GLU . 33.0 tt0 -73.21 -50.54 21.89 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.705 0.802 . . . . 72.3 109.566 174.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -76.17 71.84 2.93 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 114.687 -1.142 . . . . 51.41 108.26 170.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 23.3 tpt180 -82.02 -5.97 58.78 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 114.49 -1.232 . . . . 72.51 110.649 -172.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -59.32 -60.89 7.99 Favored Glycine 0 C--N 1.356 1.646 0 O-C-N 123.511 0.507 . . . . 54.22 111.89 175.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 256' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 72.52 -44.73 0.6 Allowed 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 125.813 1.645 . . . . 52.52 113.115 177.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -63.42 95.44 0.1 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.493 0.717 . . . . 74.31 110.312 177.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 258' ' ' LEU . . . . . . . . . . . . . 31.5 tp -96.62 4.13 52.13 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.129 0.972 . . . . 75.13 109.96 176.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 81.12 -26.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 C-N-CA 126.684 1.994 . . . . 63.02 111.474 -176.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 260' ' ' SER . . . . . . . . . . . . . 14.1 m -68.73 120.61 14.97 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.261 1.024 . . . . 73.11 109.947 173.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 10.0 t70 71.14 -72.06 0.12 Allowed 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 125.068 1.347 . . . . 52.21 112.812 175.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 262' ' ' ALA . . . . . . . . . . . . . . . -60.39 -10.96 5.49 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 114.696 1.369 . . . . 43.43 114.696 -170.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -77.77 -21.29 51.96 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 112.54 0.571 . . . . 70.44 112.54 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 34.0 t -153.78 -51.0 0.1 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 122.665 0.386 . . . . 51.14 110.944 -173.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 265' ' ' LEU . . . . . . . . . . . . . 38.6 tp -72.82 -57.82 3.8 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.383 0.673 . . . . 64.12 111.048 -175.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 266' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 71.87 106.36 0.07 Allowed 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 124.948 1.299 . . . . 71.52 112.273 173.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 94.4 p 56.35 17.4 2.86 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 126.378 1.871 . . . . 73.13 113.774 177.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 46.6 t 56.56 -73.11 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 126.136 1.775 . . . . 74.44 113.425 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 269' ' ' THR . . . . . . . . . . . . . 10.7 m 58.4 52.39 7.25 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.381 1.072 . . . . 74.31 110.238 174.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 270' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -81.13 73.26 8.17 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 114.994 -1.003 . . . . 72.41 109.501 -175.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 271' ' ' ALA . . . . . . . . . . . . . . . 64.65 -70.62 0.08 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 125.38 1.472 . . . . 75.3 111.937 -175.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 272' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -127.28 -34.24 2.31 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.598 1.159 . . . . 54.14 109.864 173.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -66.53 112.97 4.38 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.216 1.006 . . . . 61.32 111.434 -175.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 62.16 104.58 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.75 1.22 . . . . 71.44 112.592 173.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 275' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -155.85 90.9 2.76 Favored Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 123.751 0.821 . . . . 71.33 109.66 175.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -49.47 -61.71 0.53 Allowed 'Trans proline' 0 C--N 1.387 2.589 0 C-N-CA 123.767 2.978 . . . . 62.35 112.714 176.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 277' ' ' LEU . . . . . . . . . . . . . 82.2 mt 50.6 93.1 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 125.192 1.397 . . . . 63.32 113.268 173.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 1.1 pp -80.96 2.91 24.8 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 113.331 0.863 . . . . 62.0 113.331 -171.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . -92.98 48.31 2.47 Favored Glycine 0 C--N 1.348 1.229 0 CA-C-O 120.024 -0.32 . . . . 75.43 113.29 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 4.8 tt 64.48 -88.94 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.083 1.353 . . . . 53.23 110.374 -177.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 63.57 -75.48 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.996 1.318 . . . . 75.31 112.718 -176.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . 63.33 -114.48 0.44 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.987 1.315 . . . . 65.41 111.303 -175.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -61.93 106.58 0.72 Allowed 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.64 0.776 . . . . 72.33 112.503 -169.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . 129.34 -48.43 0.97 Allowed Glycine 0 N--CA 1.47 0.959 0 N-CA-C 110.815 -0.914 . . . . 61.45 110.815 -175.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -100.63 12.29 37.71 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.549 0.74 . . . . 72.41 110.501 173.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 286' ' ' MET . . . . . 0.543 ' HB2' ' HE2' ' B' ' 350' ' ' LYS . 17.0 tpt -161.27 142.13 8.45 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 126.76 2.024 . . . . 64.1 105.795 178.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 287' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -42.98 -52.1 4.99 Favored 'Trans proline' 0 C--N 1.384 2.426 0 C-N-CA 123.532 2.821 . . . . 73.33 113.248 175.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 288' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -145.35 -100.33 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.215 0 C-N-CA 124.489 1.116 . . . . 74.32 108.415 170.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 289' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.58 -30.56 0.76 Allowed 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 106.762 -1.57 . . . . 72.14 106.762 169.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 290' ' ' TRP . . . . . 0.524 ' HA ' ' NH1' ' B' ' 56' ' ' ARG . 30.9 m-90 -67.03 167.74 11.3 Favored 'General case' 0 C--N 1.357 0.911 0 CA-C-N 115.289 -0.869 . . . . 75.34 110.889 164.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 291' ' ' LEU . . . . . 0.407 HD23 ' HB3' ' B' ' 290' ' ' TRP . 1.7 pt? -44.51 -32.33 1.38 Allowed 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 125.288 1.435 . . . . 64.34 113.354 172.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . 174.03 -156.0 22.76 Favored Glycine 0 C--N 1.344 0.991 0 N-CA-C 111.322 -0.711 . . . . 62.12 111.322 177.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.9 3.73 2.21 Favored 'Trans proline' 0 CA--C 1.557 1.626 0 C-N-CA 123.294 2.663 . . . . 51.12 113.913 172.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 294' ' ' LYS . . . . . 0.542 ' HA ' ' HE3' ' B' ' 334' ' ' LYS . 13.7 tmtt? -63.23 113.4 3.16 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.0 0.92 . . . . 41.23 110.721 176.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -126.44 18.59 7.52 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 124.161 0.985 . . . . 34.32 109.734 170.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 32.1 m -67.43 101.88 1.03 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.007 0.923 . . . . 65.42 112.339 -172.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 297' ' ' TYR . . . . . 0.507 ' HB3' ' HB3' ' B' ' 60' ' ' SER . 38.4 p90 -100.82 154.7 18.42 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.685 0.794 . . . . 64.12 108.988 165.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 298' ' ' HIS . . . . . 0.442 ' H ' ' HB2' ' B' ' 61' ' ' ASP . 67.2 t60 66.4 111.77 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.581 1.152 . . . . 71.5 109.768 -171.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . -58.88 110.96 2.93 Favored Glycine 0 C--N 1.347 1.15 0 CA-C-N 115.824 -0.626 . . . . 63.41 113.624 -178.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 24.5 p30 -70.49 -33.48 71.27 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.933 0.893 . . . . 72.23 111.975 -177.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 301' ' ' ILE . . . . . . . . . . . . . 15.2 tt -90.69 -19.77 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 C-N-CA 123.539 0.735 . . . . 72.24 110.67 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -71.64 -30.69 66.03 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.946 0.899 . . . . 63.41 110.408 177.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 303' ' ' LYS . . . . . 0.512 ' HA ' ' HE2' ' B' ' 303' ' ' LYS . 0.6 OUTLIER -64.24 -54.3 40.12 Favored Pre-proline 0 CA--C 1.562 1.437 0 CA-C-O 118.534 -0.746 . . . . 74.11 111.453 -177.892 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 304' ' ' PRO . . . . . 0.48 ' HA ' ' SG ' ' B' ' 308' ' ' CYS . 91.6 Cg_endo -79.77 165.94 21.91 Favored 'Trans proline' 0 C--N 1.38 2.2 0 CA-C-N 121.443 1.551 . . . . 75.12 111.304 166.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . 66.17 -75.52 0.05 Allowed 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.923 1.289 . . . . 42.33 112.993 177.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 41.3 t -57.88 -55.68 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.864 1.265 . . . . 72.33 111.711 -171.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 80.9 p -89.56 -4.42 57.88 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.58 0.352 . . . . 74.23 111.884 -179.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 308' ' ' CYS . . . . . 0.48 ' SG ' ' HA ' ' B' ' 304' ' ' PRO . 75.3 m -72.82 -31.86 65.11 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.252 0.548 . . . . 74.22 110.322 173.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 39.3 p -90.21 146.95 35.83 Favored Pre-proline 0 CA--C 1.554 1.104 0 CA-C-N 115.202 -0.908 . . . . 72.2 109.285 171.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.34 161.43 40.75 Favored 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 122.764 2.309 . . . . 63.14 112.865 -178.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 311' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -59.96 -39.14 67.23 Favored Pre-proline 0 N--CA 1.491 1.611 0 C-N-CA 123.596 0.758 . . . . 73.13 112.801 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 312' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -74.54 72.33 4.38 Favored 'Trans proline' 0 C--N 1.385 2.474 0 CA-C-N 121.079 1.421 . . . . 70.14 112.056 164.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 313' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -72.03 -45.07 62.24 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 108.426 -0.953 . . . . 75.13 108.426 170.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 314' ' ' ARG . . . . . . . . . . . . . 59.5 mtt85 65.29 -79.0 0.03 OUTLIER 'General case' 0 C--N 1.359 1.0 0 C-N-CA 125.717 1.607 . . . . 72.01 111.29 -178.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 315' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -161.75 -162.61 0.88 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.92 1.288 . . . . 72.12 108.343 -172.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 316' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 70.76 146.09 0.07 Allowed 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 124.434 1.094 . . . . 74.4 112.541 -178.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 61.2 m -142.35 144.98 33.43 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.488 -0.778 . . . . 75.41 109.609 177.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 318' ' ' VAL . . . . . . . . . . . . . 17.0 m -124.82 149.53 63.0 Favored Pre-proline 0 N--CA 1.478 0.945 0 C-N-CA 124.151 0.98 . . . . 73.13 109.168 176.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 319' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -65.67 153.39 78.37 Favored 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 122.209 1.939 . . . . 65.1 111.027 172.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 320' ' ' THR . . . . . 0.437 HG23 ' NE2' ' B' ' 323' ' ' GLN . 6.8 m 68.92 11.44 8.34 Favored 'General case' 0 CA--C 1.561 1.381 0 C-N-CA 123.941 0.897 . . . . 53.31 111.415 177.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 321' ' ' LEU . . . . . . . . . . . . . 52.4 tp -62.33 114.19 3.34 Favored 'General case' 0 C--N 1.359 0.998 0 N-CA-C 109.509 -0.552 . . . . 65.14 109.509 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 322' ' ' ALA . . . . . . . . . . . . . . . 75.39 -66.41 0.29 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.403 1.481 . . . . 64.54 111.34 -175.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 323' ' ' GLN . . . . . 0.437 ' NE2' HG23 ' B' ' 320' ' ' THR . 32.1 tt0 57.59 56.25 5.06 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 124.432 1.093 . . . . 74.02 109.689 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 324' ' ' MET . . . . . . . . . . . . . 55.7 ttp 77.12 -38.68 0.3 Allowed 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 125.513 1.525 . . . . 71.32 112.189 -176.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 325' ' ' THR . . . . . . . . . . . . . 3.0 m 63.37 20.13 12.08 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 125.03 1.332 . . . . 72.33 110.902 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 326' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 62.21 -174.54 0.14 Allowed 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.386 1.074 . . . . 72.01 111.718 -172.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? 68.34 156.68 0.13 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 124.931 1.293 . . . . 54.34 112.414 -178.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 328' ' ' ALA . . . . . 0.532 ' HB1' ' HA ' ' B' ' 332' ' ' LEU . . . 68.2 -73.08 0.09 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.461 1.505 . . . . 72.03 111.07 -171.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 329' ' ' ILE . . . . . . . . . . . . . 2.0 mp 66.86 125.19 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 C-N-CA 125.218 1.407 . . . . 73.5 111.575 -178.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 330' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 64.51 -74.0 0.05 Allowed 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 125.366 1.466 . . . . 63.42 112.598 168.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 331' ' ' LEU . . . . . 0.407 HD22 ' HA ' ' B' ' 335' ' ' ASN . 61.3 mt -57.36 -45.27 84.58 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.032 1.333 . . . . 63.34 111.285 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 332' ' ' LEU . . . . . 0.532 ' HA ' ' HB1' ' B' ' 328' ' ' ALA . 95.7 mt 59.97 -82.55 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.981 1.312 . . . . 74.41 111.853 179.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 333' ' ' SER . . . . . . . . . . . . . 37.9 t -92.31 58.38 3.22 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.86 0.864 . . . . 65.04 109.354 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 334' ' ' LYS . . . . . 0.542 ' HE3' ' HA ' ' B' ' 294' ' ' LYS . 23.9 ttmm 68.42 165.32 0.24 Allowed 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 124.647 1.179 . . . . 63.11 110.949 -175.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 335' ' ' ASN . . . . . 0.407 ' HA ' HD22 ' B' ' 331' ' ' LEU . 2.8 t-20 -67.44 96.15 0.49 Allowed 'General case' 0 C--N 1.355 0.819 0 N-CA-C 109.213 -0.662 . . . . 73.25 109.213 169.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -77.92 -58.15 3.42 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 114.642 -1.163 . . . . 61.02 109.447 176.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 337' ' ' LYS . . . . . . . . . . . . . 28.7 tptp 63.13 -72.87 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 125.378 1.471 . . . . 62.43 109.929 -171.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 338' ' ' GLY . . . . . . . . . . . . . . . -110.68 156.05 15.77 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 111.401 -0.68 . . . . 72.34 111.401 172.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 339' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 67.58 112.53 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 125.109 1.364 . . . . 74.33 112.369 177.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 340' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -56.02 97.39 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.921 1.289 . . . . 75.24 112.049 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 341' ' ' LEU . . . . . . . . . . . . . 7.1 mp 61.76 8.7 2.51 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 125.043 1.337 . . . . 75.34 112.721 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 342' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 61.42 146.87 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 125.889 1.675 . . . . 64.25 112.203 -174.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 343' ' ' VAL . . . . . 0.661 HG22 ' H ' ' B' ' 345' ' ' GLY . 9.9 p -137.86 147.63 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 O-C-N 121.771 -0.581 . . . . 64.24 110.222 -171.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -70.19 -14.62 62.71 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.197 0.599 . . . . 73.03 111.603 178.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 345' ' ' GLY . . . . . 0.661 ' H ' HG22 ' B' ' 343' ' ' VAL . . . -84.19 44.49 3.34 Favored Glycine 0 C--N 1.347 1.139 0 CA-C-N 116.472 -0.331 . . . . 62.31 113.618 174.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 346' ' ' ALA . . . . . . . . . . . . . . . -90.96 -13.36 33.57 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.747 0.819 . . . . 72.22 110.799 176.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 74.8 m -147.01 152.37 38.49 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.477 1.111 . . . . 72.21 109.185 173.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 35.0 mm -86.09 91.8 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 109.36 -0.608 . . . . 73.42 109.36 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 349' ' ' ASP . . . . . . . . . . . . . 15.2 t70 71.59 -66.32 0.3 Allowed 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 125.805 1.642 . . . . 71.13 111.042 178.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 350' ' ' LYS . . . . . 0.543 ' HE2' ' HB2' ' B' ' 286' ' ' MET . 25.0 tttp 76.98 -70.33 0.13 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 126.311 1.844 . . . . 74.52 110.562 171.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -174.02 -30.36 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.91 0.884 . . . . 71.32 109.499 177.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -78.83 66.56 4.33 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.917 0.887 . . . . 74.35 109.18 177.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 353' ' ' HIS . . . . . . . . . . . . . 10.2 t-80 164.85 -46.79 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 126.924 2.09 . . . . 74.33 108.176 176.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 354' ' ' ALA . . . . . . . . . . . . . . . 64.71 30.84 12.31 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.835 1.254 . . . . 70.11 112.94 170.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 355' ' ' ALA . . . . . . . . . . . . . . . -91.02 -1.28 57.83 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.37 0.668 . . . . 75.44 111.4 176.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 356' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -58.17 -42.73 96.52 Favored Pre-proline 0 CA--C 1.565 1.549 0 C-N-CA 123.826 0.85 . . . . 74.32 111.915 175.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 357' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -72.83 118.57 5.63 Favored 'Trans proline' 0 C--N 1.39 2.73 0 C-N-CA 121.987 1.791 . . . . 55.22 111.884 166.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 358' ' ' CYS . . . . . 0.438 ' HB3' ' HB3' ' B' ' 251' ' ' ALA . 26.4 p -78.26 138.4 38.6 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.58 0.752 . . . . 73.32 110.014 176.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 359' ' ' GLY . . . . . . . . . . . . . . . -138.54 67.18 0.52 Allowed Glycine 0 C--N 1.339 0.701 0 CA-C-O 119.8 -0.444 . . . . 62.01 112.294 -177.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 360' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 74.15 -61.77 0.48 Allowed 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 125.157 1.383 . . . . 53.34 113.15 170.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 361' ' ' ILE . . . . . . . . . . . . . 45.1 mm -59.45 129.04 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.588 1.155 . . . . 61.31 111.471 -175.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 362' ' ' GLY . . . . . 0.41 ' HA3' ' HA ' ' B' ' 249' ' ' GLU . . . 84.81 -55.18 4.98 Favored Glycine 0 C--N 1.343 0.93 0 CA-C-N 115.384 -0.826 . . . . 72.35 113.371 -173.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 363' ' ' GLU . . . . . 0.527 ' HA ' ' HA ' ' B' ' 252' ' ' GLN . 35.4 tt0 -59.05 -70.21 0.16 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 125.064 1.346 . . . . 73.13 112.893 -174.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 364' ' ' THR . . . . . 0.453 HG23 ' HG2' ' B' ' 363' ' ' GLU . 2.0 p -105.27 0.01 26.74 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.874 0.869 . . . . 74.04 112.815 -167.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 4.8 p -92.95 88.49 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 CA-C-O 121.7 0.762 . . . . 74.01 109.9 177.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 73.74 -19.05 0.36 Allowed 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 125.67 1.588 . . . . 50.12 114.229 175.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 367' ' ' LEU . . . . . . . . . . . . . 5.7 mp 58.08 -83.62 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.979 1.312 . . . . 75.05 110.277 -175.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 368' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -142.31 -64.48 0.42 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.41 1.084 . . . . 71.23 109.026 178.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 369' ' ' GLU . . . . . . . . . . . . . 55.7 tt0 47.39 -85.53 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 125.723 1.609 . . . . 70.1 112.315 -173.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 370' ' ' ALA . . . . . . . . . . . . . . . -167.77 124.11 1.09 Allowed 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.648 1.179 . . . . 74.25 107.964 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 371' ' ' VAL . . . . . . . . . . . . . 58.5 t -68.95 109.08 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 109.064 -0.717 . . . . 74.11 109.064 177.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 372' ' ' GLN . . . . . 0.439 ' HB3' HD21 ' B' ' 375' ' ' LEU . 21.6 tm0? 85.77 -28.55 0.07 Allowed 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 125.897 1.679 . . . . 63.2 111.709 177.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 373' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? 78.63 -55.03 0.47 Allowed 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 125.75 1.62 . . . . 72.05 113.277 176.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -88.68 74.51 8.38 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.021 0.528 . . . . 71.45 111.625 -172.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 375' ' ' LEU . . . . . 0.439 HD21 ' HB3' ' B' ' 372' ' ' GLN . 2.9 mm? -117.99 89.4 3.11 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.243 0.617 . . . . 62.01 110.083 179.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -119.27 86.85 2.62 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.664 0.745 . . . . 73.13 108.994 173.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 377' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -125.15 176.16 6.9 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 108.049 -1.093 . . . . 73.31 108.049 177.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 378' ' ' ALA . . . . . . . . . . . . . . . 64.48 14.76 9.12 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 113.199 0.814 . . . . 61.1 113.199 173.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -84.01 86.54 7.18 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.102 0.961 . . . . 72.01 109.423 -171.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 380' ' ' LYS . . . . . . . . . . . . . 47.4 mttp 58.52 22.29 9.51 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 124.903 1.281 . . . . 53.14 112.117 -168.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 381' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -92.38 16.88 10.78 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.656 0.782 . . . . 74.34 111.015 -178.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -79.05 -75.3 1.01 Allowed Glycine 0 C--N 1.35 1.358 0 CA-C-N 115.968 -0.56 . . . . 73.1 112.006 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 383' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 62.7 14.48 7.26 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 124.937 1.295 . . . . 73.1 113.566 174.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 384' ' ' THR . . . . . . . . . . . . . 9.9 p -149.38 -75.86 0.16 Allowed 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.348 1.059 . . . . 63.41 108.981 178.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 385' ' ' LEU . . . . . 0.526 HD11 ' HB2' ' B' ' 101' ' ' PRO . 2.8 mm? 50.58 -84.86 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 125.922 1.689 . . . . 75.12 112.746 -175.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 386' ' ' VAL . . . . . . . . . . . . . 9.2 p -160.21 134.32 1.39 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.666 0 N-CA-C 106.808 -1.553 . . . . 62.42 106.808 177.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 387' ' ' ILE . . . . . 0.591 HG22 HG22 ' B' ' 389' ' ' THR . 31.4 mm 62.81 86.11 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 123.937 0.895 . . . . 74.12 108.664 -170.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 388' ' ' VAL . . . . . . . . . . . . . 18.9 m -73.58 72.22 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.291 0 C-N-CA 124.221 1.009 . . . . 54.33 112.662 -169.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 389' ' ' THR . . . . . 0.591 HG22 HG22 ' B' ' 387' ' ' ILE . 10.1 t -156.77 144.76 19.41 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 123.794 0.838 . . . . 71.25 109.175 -178.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . 68.18 -73.64 0.08 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.234 1.413 . . . . 70.34 112.353 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 391' ' ' ASP . . . . . . . . . . . . . 38.0 t70 58.85 45.16 15.74 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.524 1.13 . . . . 64.12 109.9 -174.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 392' ' ' HIS . . . . . . . . . . . . . 20.3 t-160 71.4 143.07 0.06 Allowed 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 114.576 -1.193 . . . . 72.42 110.116 -175.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -56.49 93.57 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.856 0.862 . . . . 61.53 111.005 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 27.4 m170 -72.6 -59.08 2.89 Favored 'General case' 0 C--N 1.351 0.655 0 N-CA-C 108.361 -0.977 . . . . 73.31 108.361 177.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . 57.34 45.61 19.8 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 124.604 1.19 . . . . 71.44 110.394 -175.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 18.8 m 65.74 11.78 7.82 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.101 1.361 . . . . 75.55 112.303 -176.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 397' ' ' GLN . . . . . . . . . . . . . 21.1 tp60 57.01 99.79 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.378 1.471 . . . . 71.41 111.637 -176.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 2.2 mp -70.81 91.58 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 N-CA-C 108.372 -0.973 . . . . 75.44 108.372 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 399' ' ' VAL . . . . . . . . . . . . . 44.6 t 55.45 -88.0 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.158 0 C-N-CA 125.205 1.402 . . . . 73.32 110.657 -173.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 400' ' ' ALA . . . . . . . . . . . . . . . -176.85 88.81 0.26 Allowed Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 124.602 1.161 . . . . 51.41 109.088 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 401' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -66.74 -15.81 48.47 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.704 2.269 . . . . 71.04 111.795 168.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -60.48 -46.58 89.57 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.919 1.288 . . . . 74.34 110.074 172.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 403' ' ' THR . . . . . . . . . . . . . 30.4 p 48.49 -88.05 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.035 1.734 . . . . 51.3 112.574 -173.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 404' ' ' LYS . . . . . 0.588 ' H ' ' HD2' ' B' ' 404' ' ' LYS . 7.0 mptt -74.7 -48.75 24.22 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.545 -0.909 . . . . 70.03 108.545 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 405' ' ' ALA . . . . . . . . . . . . . . . -171.67 -55.51 0.0 OUTLIER Pre-proline 0 CA--C 1.561 1.38 0 CA-C-N 114.644 -1.162 . . . . 71.24 112.374 -169.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 406' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -70.85 105.51 1.68 Allowed 'Trans proline' 0 C--N 1.396 3.032 0 C-N-CA 122.329 2.019 . . . . 44.44 112.917 -171.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . -163.99 -2.53 0.04 OUTLIER Glycine 0 N--CA 1.468 0.803 0 CA-C-N 115.715 -0.675 . . . . 55.33 112.511 178.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 408' ' ' LEU . . . . . . . . . . . . . 5.3 mp -85.99 3.9 40.15 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 124.901 1.281 . . . . 72.03 110.536 176.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 76.4 p -62.53 -164.65 0.01 OUTLIER 'General case' 0 CA--C 1.566 1.567 0 C-N-CA 125.875 1.67 . . . . 73.52 113.684 -178.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 410' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 74.88 -75.38 0.07 Allowed 'General case' 0 C--N 1.367 1.34 0 C-N-CA 125.661 1.584 . . . . 51.32 110.694 175.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . -167.51 134.66 2.29 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.639 0.775 . . . . 63.14 109.21 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 412' ' ' LEU . . . . . 0.456 ' H ' ' HB2' ' B' ' 416' ' ' ASP . 8.1 mp 72.61 168.84 0.32 Allowed 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 125.245 1.418 . . . . 60.41 111.485 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 13.6 m120 70.77 -55.23 0.64 Allowed 'General case' 0 N--CA 1.501 2.089 0 C-N-CA 125.462 1.505 . . . . 71.14 109.633 -164.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 414' ' ' THR . . . . . 0.461 HG22 ' HA ' ' B' ' 98' ' ' ASP . 55.0 p -65.14 170.43 4.55 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.415 1.086 . . . . 73.24 111.079 164.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 415' ' ' LYS . . . . . 0.706 ' HE3' HG23 ' B' ' 419' ' ' VAL . 84.4 tttt -74.7 77.64 2.05 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 108.663 -0.866 . . . . 73.42 108.663 171.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 416' ' ' ASP . . . . . 0.456 ' HB2' ' H ' ' B' ' 412' ' ' LEU . 21.9 t70 -88.79 -61.22 1.76 Allowed 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 107.927 -1.138 . . . . 75.33 107.927 176.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 417' ' ' GLY . . . . . . . . . . . . . . . -69.63 88.05 0.28 Allowed Glycine 0 C--N 1.35 1.35 0 N-CA-C 109.897 -1.281 . . . . 43.15 109.897 165.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 418' ' ' ALA . . . . . 0.454 ' HB1' ' HE2' ' B' ' 415' ' ' LYS . . . -77.32 89.07 3.73 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.662 0.785 . . . . 70.25 112.166 -168.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 419' ' ' VAL . . . . . 0.706 HG23 ' HE3' ' B' ' 415' ' ' LYS . 72.8 t 47.62 -80.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 126.155 1.782 . . . . 62.03 113.176 178.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 420' ' ' MET . . . . . . . . . . . . . 25.6 ttt -27.89 105.62 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 126.627 1.971 . . . . 73.12 113.86 -171.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 421' ' ' VAL . . . . . . . . . . . . . 7.5 p -60.61 -36.1 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.594 0.757 . . . . 72.42 111.176 -175.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 422' ' ' MET . . . . . . . . . . . . . 5.0 tpt -73.19 89.88 1.55 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.831 0.852 . . . . 74.1 110.458 -175.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 423' ' ' SER . . . . . . . . . . . . . 22.7 t 67.15 -3.23 1.02 Allowed 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 125.006 1.322 . . . . 62.22 113.338 174.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 424' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 54.66 79.58 0.14 Allowed 'General case' 0 C--N 1.365 1.259 0 C-N-CA 124.367 1.067 . . . . 72.42 110.457 -170.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . -65.85 90.09 0.13 Allowed Glycine 0 C--N 1.348 1.232 0 CA-C-N 114.64 -1.164 . . . . 75.12 113.892 -171.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 426' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 61.72 -83.65 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 125.217 1.407 . . . . 75.43 111.378 177.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 427' ' ' SER . . . . . . . . . . . . . 26.9 t -141.46 63.86 1.42 Allowed 'General case' 0 C--O 1.239 0.53 0 N-CA-C 106.877 -1.527 . . . . 75.14 106.877 174.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 71.82 -67.45 0.26 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.761 1.624 . . . . 73.23 110.661 -176.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 429' ' ' GLU . . . . . 0.442 ' HB2' ' CE1' ' B' ' 434' ' ' HIS . 34.4 mm-40 60.74 20.49 10.55 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.379 1.472 . . . . 63.42 112.129 177.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -102.46 145.75 29.1 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.513 0.725 . . . . 55.41 109.984 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 30.2 t -142.36 -50.43 0.38 Allowed 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.696 -0.853 . . . . 73.31 108.696 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 432' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -139.63 -25.15 0.83 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.27 0.628 . . . . 71.1 110.708 176.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 433' ' ' GLU . . . . . 0.606 ' HG2' ' HB2' ' B' ' 438' ' ' GLN . 0.3 OUTLIER -165.3 125.5 1.86 Allowed 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 108.904 -0.776 . . . . 73.43 108.904 176.051 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 434' ' ' HIS . . . . . 0.442 ' CE1' ' HB2' ' B' ' 429' ' ' GLU . 11.8 t-160 -148.76 91.74 1.91 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.361 0.664 . . . . 65.13 109.254 172.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 435' ' ' THR . . . . . . . . . . . . . 5.2 m 61.69 69.55 0.64 Allowed 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 124.541 1.136 . . . . 73.42 111.169 172.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . 70.88 22.8 78.36 Favored Glycine 0 C--N 1.348 1.223 0 CA-C-N 115.61 -0.723 . . . . 43.54 114.18 175.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 98.8 p -107.97 29.26 7.44 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.294 0.638 . . . . 54.14 110.183 177.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 438' ' ' GLN . . . . . 0.606 ' HB2' ' HG2' ' B' ' 433' ' ' GLU . 29.5 tt0 -70.12 -95.38 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 122.802 0.441 . . . . 71.55 110.036 175.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 439' ' ' LEU . . . . . . . . . . . . . 80.6 mt 47.94 31.0 2.17 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 124.36 1.064 . . . . 74.24 112.688 -175.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 440' ' ' ARG . . . . . . . . . . . . . 6.9 mmt180 -72.98 127.9 33.9 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.836 0.854 . . . . 70.1 109.867 -172.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 441' ' ' ILE . . . . . 0.59 HG23 HD22 ' A' ' 235' ' ' LEU . 76.7 mt -69.44 110.63 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 O-C-N 123.924 0.765 . . . . 74.15 111.513 -173.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 442' ' ' ALA . . . . . . . . . . . . . . . -91.06 76.84 6.12 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 109.077 -0.712 . . . . 71.41 109.077 171.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . -122.03 -160.2 0.86 Allowed 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.179 0.991 . . . . 74.21 109.313 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -59.89 103.03 0.18 Allowed 'General case' 0 CA--C 1.555 1.157 0 CA-C-O 121.678 0.751 . . . . 65.34 111.521 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . -167.9 84.79 0.1 OUTLIER Glycine 0 C--N 1.344 0.992 0 N-CA-C 109.38 -1.488 . . . . 74.34 109.38 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 446' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.63 90.38 0.06 OUTLIER 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 123.671 2.914 . . . . 63.02 114.189 -171.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 447' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 58.73 -90.1 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.285 0 C-N-CA 125.662 1.585 . . . . 60.0 111.755 174.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . 51.78 -84.65 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 125.547 1.539 . . . . 74.31 114.792 173.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 449' ' ' ALA . . . . . . . . . . . . . . . -69.51 88.78 0.5 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.045 0.938 . . . . 61.52 112.506 -167.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 450' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -142.18 -72.06 0.32 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.49 1.116 . . . . 61.12 108.396 172.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 7.3 m -128.71 -43.32 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 123.654 0.782 . . . . 63.1 110.359 177.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 452' ' ' VAL . . . . . . . . . . . . . 4.8 t 56.71 30.59 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.412 0 C-N-CA 124.658 1.183 . . . . 60.45 110.37 -176.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 164.32 171.43 30.56 Favored Glycine 0 C--N 1.351 1.399 0 CA-C-N 115.87 -0.605 . . . . 73.44 112.693 -178.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 454' ' ' LEU . . . . . 0.58 ' HA ' ' HB2' ' B' ' 461' ' ' PHE . 3.5 pp -92.79 153.77 18.68 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.377 0.671 . . . . 72.5 111.126 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 30.2 m -112.21 75.87 0.94 Allowed 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 107.221 -1.4 . . . . 61.41 107.221 175.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 456' ' ' ASP . . . . . 0.471 ' HB2' HD13 ' B' ' 454' ' ' LEU . 26.5 t70 -63.22 85.54 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.87 0.868 . . . . 74.3 111.722 -170.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 457' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -136.07 43.16 2.55 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 106.993 -1.484 . . . . 42.14 106.993 177.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 17.3 m 71.85 74.49 0.17 Allowed 'General case' 0 C--N 1.355 0.839 0 C-N-CA 125.225 1.41 . . . . 72.13 107.267 -159.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 459' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -170.08 149.75 3.63 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 114.322 -1.308 . . . . 73.31 109.255 -170.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 37.7 tp -150.46 66.91 0.95 Allowed 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 109.23 -0.656 . . . . 65.42 109.23 178.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 461' ' ' PHE . . . . . 0.58 ' HB2' ' HA ' ' B' ' 454' ' ' LEU . 22.9 m-85 -66.11 102.51 0.83 Allowed 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 108.846 -0.798 . . . . 62.31 108.846 168.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -59.59 -51.85 68.06 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.186 0.594 . . . . 72.53 109.856 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 10.4 m 70.16 -8.87 0.79 Allowed 'General case' 0 CA--C 1.568 1.643 0 C-N-CA 125.341 1.457 . . . . 61.35 112.43 175.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 464' ' ' MET . . . . . . . . . . . . . 3.8 mpp? 50.52 48.34 22.69 Favored 'General case' 0 C--N 1.363 1.172 0 C-N-CA 125.505 1.522 . . . . 75.31 111.797 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -72.98 159.13 34.17 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.704 -1.135 . . . . 72.15 110.871 177.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -154.23 175.4 13.53 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 124.347 1.059 . . . . 62.32 108.897 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . -85.62 44.63 1.12 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.42 0.688 . . . . 75.3 110.757 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 47.5 tp -165.96 -40.47 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.281 1.033 . . . . 45.51 109.597 -176.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 469' ' ' GLY . . . . . . . . . . . . . . . -175.84 -153.51 10.5 Favored Glycine 0 C--N 1.351 1.375 0 CA-C-N 116.412 -0.358 . . . . 50.44 112.454 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 470' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -148.17 161.84 40.65 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.034 0.933 . . . . 73.2 109.298 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 471' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? . . . . . 0 CA--C 1.551 0.987 0 N-CA-C 106.985 -1.487 . . . . 74.2 106.985 174.255 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 67.3 mtm . . . . . 0 N--CA 1.476 0.86 0 N-CA-C 110.485 -0.191 . . . . 55.23 110.485 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . 0.4 ' HA ' ' HD1' ' C' ' 96' ' ' PHE . . . 68.11 44.07 1.5 Allowed 'General case' 0 C--N 1.36 1.041 0 C-N-CA 124.306 1.043 . . . . 65.31 111.519 172.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.5 61.66 2.32 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 115.45 -0.795 . . . . 52.01 110.576 176.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -38.52 110.12 0.12 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.129 1.772 . . . . 70.52 113.253 177.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 5' ' ' LYS . . . . . 0.53 ' HB3' HD11 ' C' ' 10' ' ' ILE . 37.7 mtpt -95.71 104.73 16.66 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 108.506 -0.924 . . . . 63.2 108.506 167.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -66.98 104.32 1.35 Allowed 'General case' 0 C--N 1.351 0.658 0 N-CA-C 109.08 -0.711 . . . . 63.22 109.08 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 7' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -63.92 -29.59 70.75 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 124.088 0.868 . . . . 73.43 112.443 -169.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -71.34 -40.43 70.71 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 122.516 0.326 . . . . 72.53 110.38 178.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.11 -37.82 88.69 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 122.825 0.45 . . . . 52.31 110.271 177.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 10' ' ' ILE . . . . . 0.53 HD11 ' HB3' ' C' ' 5' ' ' LYS . 69.4 mt -59.74 -40.25 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 123.186 0.594 . . . . 63.34 110.128 173.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 92.7 mt -82.08 -8.2 59.65 Favored 'General case' 0 CA--C 1.556 1.186 0 N-CA-C 112.935 0.717 . . . . 45.45 112.935 176.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 67.67 35.7 86.36 Favored Glycine 0 C--N 1.352 1.464 0 N-CA-C 113.845 0.298 . . . . 64.33 113.845 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 11.7 m -124.15 160.31 52.89 Favored Pre-proline 0 N--CA 1.486 1.372 0 C-N-CA 125.08 1.352 . . . . 64.04 110.175 178.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -56.91 152.24 44.41 Favored 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 122.933 2.422 . . . . 74.43 113.485 175.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -79.67 28.56 0.26 Allowed 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 113.746 1.017 . . . . 71.52 113.746 -171.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -154.83 27.73 0.43 Allowed 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 108.008 -1.108 . . . . 71.24 108.008 171.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.07 154.24 40.11 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.183 -0.917 . . . . 71.14 111.896 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 69.4 p -95.53 179.42 5.15 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.002 0.921 . . . . 74.41 111.912 -172.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -52.94 -45.0 67.47 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.46 1.104 . . . . 74.45 111.957 -177.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -70.41 -32.85 70.64 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 123.56 0.537 . . . . 64.05 111.746 -177.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -71.57 -43.04 67.05 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 122.907 0.483 . . . . 73.42 110.489 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 1.7 mp -64.86 -38.24 82.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 123.758 0.823 . . . . 61.32 110.221 175.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -64.43 -52.25 59.07 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.124 0.969 . . . . 74.13 111.031 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -69.8 -34.14 73.32 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.467 -0.788 . . . . 73.52 111.087 -177.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -72.38 -35.58 68.5 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.292 0.637 . . . . 75.32 110.979 178.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 26' ' ' TYR . . . . . 0.454 ' HD1' HG22 ' C' ' 50' ' ' ILE . 32.8 t80 -56.75 -61.35 2.49 Favored 'General case' 0 C--O 1.209 -1.065 0 O-C-N 124.261 0.976 . . . . 72.31 108.98 171.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -58.22 -41.67 84.57 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 124.15 0.906 . . . . 74.1 111.929 -177.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 45.7 ttt180 -50.75 -53.89 27.9 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.981 1.312 . . . . 71.15 110.699 176.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 87.1 mt -92.11 -6.2 51.32 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.228 -0.896 . . . . 60.22 111.743 -176.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.65 -4.7 47.18 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.694 0.798 . . . . 75.32 110.145 173.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 58.6 mtp180 -103.96 -35.2 8.21 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.92 0.888 . . . . 73.5 109.53 166.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.98 -55.15 15.73 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 109.506 -0.553 . . . . 71.12 109.506 178.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -89.9 7.22 38.39 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 112.046 0.387 . . . . 70.15 112.046 -177.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 34' ' ' HIS . . . . . . . . . . . . . 31.8 t60 -61.28 105.3 0.57 Allowed Pre-proline 0 N--CA 1.478 0.964 0 C-N-CA 124.241 1.016 . . . . 72.34 110.406 -176.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -53.87 -28.36 48.27 Favored 'Trans proline' 0 N--CA 1.507 2.29 0 C-N-CA 123.467 2.778 . . . . 71.32 115.393 -171.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -68.79 -31.81 71.08 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.534 0.734 . . . . 60.34 111.711 178.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 97.9 t -90.96 -50.7 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.402 0.681 . . . . 75.33 109.93 176.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -105.38 92.22 4.11 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.426 1.491 . . . . 54.22 108.605 -173.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -76.36 81.53 3.1 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 108.733 -0.839 . . . . 62.24 108.733 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 45.9 m -147.84 128.63 6.97 Favored Pre-proline 0 N--CA 1.48 1.06 0 C-N-CA 123.244 0.618 . . . . 74.14 110.342 177.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.8 -40.2 86.12 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 122.903 2.402 . . . . 63.44 111.002 174.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -53.0 -46.19 68.22 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 114.871 -1.059 . . . . 65.44 111.004 174.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.71 -16.9 56.69 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 122.616 0.367 . . . . 62.05 110.649 -175.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -73.97 -47.99 33.53 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 107.68 -1.23 . . . . 74.04 107.68 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -70.58 -38.06 74.0 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 114.055 -1.429 . . . . 42.53 111.465 178.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 46' ' ' LYS . . . . . 0.533 ' O ' HG12 ' C' ' 50' ' ' ILE . 34.0 mmtm -64.54 -37.34 87.22 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 116.224 -0.444 . . . . 72.32 110.577 175.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -62.2 -40.98 97.9 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.486 0.715 . . . . 62.23 109.665 175.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -60.3 -38.37 83.42 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 123.391 0.432 . . . . 72.04 111.554 173.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -68.48 -33.91 74.99 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 122.744 0.418 . . . . 72.33 111.473 177.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 50' ' ' ILE . . . . . 0.533 HG12 ' O ' ' C' ' 46' ' ' LYS . 26.6 mm -68.77 -32.82 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 N-CA-C 109.246 -0.65 . . . . 75.43 109.246 174.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 51' ' ' ASN . . . . . 0.401 ' HB3' ' HD1' ' C' ' 88' ' ' PHE . 0.9 OUTLIER -74.12 -32.1 63.04 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 114.998 -1.001 . . . . 74.04 111.05 177.761 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -66.35 -57.28 7.81 Favored 'General case' 0 C--O 1.248 0.992 0 C-N-CA 123.966 0.906 . . . . 63.42 109.903 175.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -52.15 -54.98 24.03 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 113.632 -1.622 . . . . 63.1 111.194 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -61.19 -46.11 91.84 Favored 'General case' 0 C--O 1.21 -1.024 0 CA-C-N 115.278 -0.874 . . . . 75.01 111.405 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.42 -47.55 72.66 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 122.841 0.456 . . . . 60.54 112.007 -176.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 90.5 t -63.93 -44.08 97.87 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 O-C-N 123.93 0.769 . . . . 72.43 110.331 177.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 57' ' ' LEU . . . . . . . . . . . . . 52.4 mt -88.17 0.17 56.37 Favored 'General case' 0 CA--C 1.564 1.482 0 N-CA-C 113.283 0.846 . . . . 75.02 113.283 -174.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 33.5 t -87.1 -51.31 6.07 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.142 0.977 . . . . 62.42 109.801 -178.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.44 123.06 84.56 Favored Pre-proline 0 C--O 1.217 -0.631 0 N-CA-C 107.845 -1.169 . . . . 72.03 107.845 172.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 60' ' ' PRO . . . . . 0.555 ' HD2' ' HA ' ' C' ' 145' ' ' VAL . 15.0 Cg_endo -55.95 -29.21 72.38 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 122.696 2.264 . . . . 33.23 111.216 170.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -65.39 -64.38 0.88 Allowed 'General case' 0 C--N 1.35 0.595 0 CA-C-N 115.626 -0.715 . . . . 62.13 110.825 176.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 62' ' ' LYS . . . . . 0.501 ' HD3' ' HB3' ' C' ' 83' ' ' TYR . 27.0 mtmm -64.69 -26.62 68.45 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.826 0.45 . . . . 75.23 111.414 -177.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 47.3 tpt85 -57.83 -58.49 8.13 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.642 1.177 . . . . 64.42 109.0 173.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -74.74 -16.79 60.72 Favored 'General case' 0 C--N 1.348 0.518 0 CA-C-N 115.182 -0.917 . . . . 74.15 112.215 -176.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 65' ' ' ILE . . . . . 0.635 HG23 ' HD2' ' C' ' 76' ' ' PRO . 65.2 mt -65.97 -48.26 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 N-CA-C 108.791 -0.818 . . . . 62.34 108.791 169.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -58.61 -51.77 68.49 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.311 -0.859 . . . . 74.22 110.181 176.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -54.44 -51.26 65.53 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.47 0.708 . . . . 73.14 111.643 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 68.0 p -76.0 -13.65 60.23 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 118.958 -0.544 . . . . 63.2 112.376 -177.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -67.52 107.09 2.36 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 109.004 -0.739 . . . . 75.22 109.004 176.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 114.29 17.78 7.01 Favored Glycine 0 C--N 1.343 0.945 0 CA-C-N 115.514 -0.766 . . . . 62.51 111.743 -167.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 98.8 m -148.89 -59.78 0.23 Allowed 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 104.064 -2.569 . . . . 72.34 104.064 176.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 12.4 m -77.9 138.95 39.18 Favored 'General case' 0 C--O 1.256 1.431 0 N-CA-C 104.571 -2.381 . . . . 73.35 104.571 158.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -100.05 -54.82 2.79 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 108.75 -0.833 . . . . 73.23 108.75 -173.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -72.12 151.63 92.54 Favored Pre-proline 0 CA--C 1.546 0.824 0 CA-C-N 114.688 -1.142 . . . . 53.23 109.765 173.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -56.29 123.51 14.01 Favored 'Trans proline' 0 C--N 1.369 1.63 0 C-N-CA 122.338 2.025 . . . . 75.14 110.921 169.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 76' ' ' PRO . . . . . 0.635 ' HD2' HG23 ' C' ' 65' ' ' ILE . 84.3 Cg_exo -50.98 145.79 23.71 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 123.004 2.469 . . . . 63.14 112.817 172.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 77' ' ' PRO . . . . . 0.441 ' HA ' ' HD3' ' C' ' 78' ' ' PRO . 10.8 Cg_endo -51.57 125.79 17.77 Favored 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 123.642 2.894 . . . . 51.51 112.587 -177.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 78' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' C' ' 77' ' ' PRO . 14.0 Cg_exo -69.21 141.3 47.05 Favored 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 122.89 2.393 . . . . 74.44 111.95 -177.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 79' ' ' PRO . . . . . 0.417 ' HB2' ' O ' ' C' ' 142' ' ' GLY . 30.9 Cg_endo -61.83 152.68 73.08 Favored 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 122.522 2.148 . . . . 61.04 111.218 174.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -50.73 82.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.392 2.859 0 C-N-CA 124.242 3.295 . . . . 51.5 114.494 -169.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 153.36 -53.05 0.46 Allowed Glycine 0 C--N 1.335 0.481 0 N-CA-C 109.811 -1.315 . . . . 75.2 109.811 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 141.13 -150.76 22.05 Favored Glycine 0 C--N 1.353 1.528 0 CA-C-N 115.615 -0.292 . . . . 74.45 113.662 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 83' ' ' TYR . . . . . 0.501 ' HB3' ' HD3' ' C' ' 62' ' ' LYS . 29.4 m-85 -104.01 122.24 44.83 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.274 1.43 . . . . 70.14 108.855 -177.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 84' ' ' ASP . . . . . 0.491 ' HB2' ' NE ' ' C' ' 143' ' ' ARG . 5.5 t70 -80.82 128.38 33.59 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 112.367 0.506 . . . . 63.13 112.367 -169.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 85' ' ' PHE . . . . . 0.535 ' HA ' ' HD2' ' C' ' 88' ' ' PHE . 77.0 m-85 -139.46 29.99 2.15 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.263 1.025 . . . . 74.41 109.776 176.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 13.7 m -78.6 84.94 4.68 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 114.89 -1.05 . . . . 45.43 111.39 -173.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 87' ' ' GLY . . . . . 0.591 ' N ' ' HA ' ' C' ' 171' ' ' PRO . . . 130.59 -19.73 5.0 Favored Glycine 0 N--CA 1.47 0.959 0 N-CA-C 110.24 -1.144 . . . . 74.33 110.24 -174.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 88' ' ' PHE . . . . . 0.535 ' HD2' ' HA ' ' C' ' 85' ' ' PHE . 32.5 m-85 -100.0 129.89 46.1 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 107.921 -1.14 . . . . 74.44 107.921 178.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -75.75 78.88 2.69 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.548 0.689 . . . . 72.23 110.804 -175.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 90' ' ' VAL . . . . . 0.451 HG21 ' ND2' ' C' ' 169' ' ' ASN . 5.6 p -50.06 -35.93 11.79 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 C-N-CA 125.981 1.713 . . . . 54.41 113.482 -174.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -65.94 -26.05 67.41 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 123.499 0.72 . . . . 74.21 112.124 -175.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -78.17 -26.56 47.72 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 122.674 0.389 . . . . 75.53 111.88 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 9.3 m-30 -70.13 164.33 24.38 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 123.345 0.403 . . . . 72.45 111.343 -167.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 52.1 p -59.43 149.85 28.25 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 113.969 1.1 . . . . 45.51 113.969 -166.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.71 -35.71 75.07 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 114.738 -1.119 . . . . 55.43 110.525 171.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 96' ' ' PHE . . . . . 0.4 ' HD1' ' HA ' ' C' ' 2' ' ' ALA . 47.1 t80 -53.73 -50.91 64.92 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.542 1.137 . . . . 65.02 110.858 172.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 97' ' ' PHE . . . . . 0.414 ' HZ ' HG23 ' C' ' 90' ' ' VAL . 1.1 t80 -58.96 -43.04 91.23 Favored 'General case' 0 CA--C 1.552 1.043 0 CA-C-N 114.511 -1.222 . . . . 64.25 110.767 175.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -69.31 -21.4 63.85 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.077 0.551 . . . . 51.52 112.026 -177.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -82.69 -50.0 9.19 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.293 0.637 . . . . 74.43 110.621 173.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 38.6 tp -67.45 -63.73 1.0 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.775 0.83 . . . . 73.23 110.553 -175.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -80.26 -0.71 37.63 Favored 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 123.091 0.556 . . . . 73.25 112.413 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -45.57 -58.84 5.1 Favored Glycine 0 CA--C 1.544 1.85 0 CA-C-O 118.933 -0.926 . . . . 54.11 115.411 178.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -62.65 -3.38 4.36 Favored 'Trans proline' 0 C--N 1.385 2.466 0 C-N-CA 123.535 2.824 . . . . 62.02 114.528 -176.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -141.71 38.28 1.52 Allowed Glycine 0 C--N 1.354 1.535 0 CA-C-O 119.118 -0.823 . . . . 43.23 112.62 174.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 43.0 mt -70.86 41.24 0.06 Allowed 'General case' 0 N--CA 1.505 2.285 0 CA-C-N 118.58 1.19 . . . . 73.03 113.922 175.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 106' ' ' PHE . . . . . 0.518 ' O ' ' HA ' ' C' ' 111' ' ' ARG . 0.3 OUTLIER 68.59 -108.39 0.09 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.44 1.496 . . . . 64.24 111.926 163.09 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 107' ' ' GLY . . . . . 0.581 ' HA3' ' H ' ' C' ' 113' ' ' SER . . . 65.09 29.75 76.15 Favored Glycine 0 C--N 1.353 1.511 0 CA-C-N 118.534 0.606 . . . . 51.05 113.086 -168.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 60.86 -123.27 32.25 Favored Glycine 0 C--N 1.351 1.375 0 N-CA-C 111.505 -0.638 . . . . 74.41 111.505 -173.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 109' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -99.95 -7.14 25.54 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.443 0.697 . . . . 74.45 110.686 171.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.83 -12.41 66.41 Favored Glycine 0 C--N 1.348 1.224 0 O-C-N 123.603 0.564 . . . . 54.22 112.749 -178.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . 0.518 ' HA ' ' O ' ' C' ' 106' ' ' PHE . 77.6 mtm180 56.89 11.79 1.03 Allowed 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 124.539 1.135 . . . . 75.25 113.887 176.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 112' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -48.72 -29.53 4.56 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 126.649 1.98 . . . . 74.1 112.891 173.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 113' ' ' SER . . . . . 0.581 ' H ' ' HA3' ' C' ' 107' ' ' GLY . 38.0 m 63.6 15.54 8.96 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.244 1.418 . . . . 72.53 112.383 -177.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 114' ' ' ARG . . . . . 0.521 ' HG3' ' H ' ' C' ' 115' ' ' LYS . 12.9 tpt180 -117.88 -169.19 1.64 Allowed 'General case' 0 C--O 1.21 -1.01 0 CA-C-O 118.314 -0.851 . . . . 74.05 110.777 -174.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 115' ' ' LYS . . . . . 0.521 ' H ' ' HG3' ' C' ' 114' ' ' ARG . 57.7 tttp -35.82 126.27 0.7 Allowed 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 126.53 1.932 . . . . 54.14 116.123 -161.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 116' ' ' GLY . . . . . 0.432 ' HA2' ' HA3' ' C' ' 168' ' ' GLY . . . -79.94 153.96 36.86 Favored Glycine 0 C--N 1.36 1.9 0 CA-C-N 115.634 -0.712 . . . . 45.25 113.981 -177.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 117' ' ' ARG . . . . . 0.546 ' HB2' ' HB2' ' C' ' 167' ' ' GLN . 2.4 mmp_? -116.29 147.51 41.46 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 124.492 1.117 . . . . 64.44 111.498 177.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -68.9 113.66 6.52 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 108.322 -0.992 . . . . 75.42 108.322 174.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 119' ' ' LEU . . . . . 0.574 HD21 HG22 ' B' ' 185' ' ' VAL . 5.7 tt -92.12 119.34 31.69 Favored 'General case' 0 C--O 1.219 -0.512 0 N-CA-C 105.953 -1.869 . . . . 75.21 105.953 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.418 ' HG2' HD12 ' C' ' 175' ' ' LEU . 98.3 mtt180 -97.48 132.95 42.69 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 107.399 -1.334 . . . . 72.31 107.399 176.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 121' ' ' ALA . . . . . . . . . . . . . . . -143.02 117.37 9.63 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.294 -0.632 . . . . 63.21 109.294 -178.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 122' ' ' GLU . . . . . 0.473 ' HA ' ' O ' ' C' ' 177' ' ' VAL . 12.7 pt-20 -99.17 130.0 45.46 Favored 'General case' 0 C--N 1.348 0.529 0 CA-C-O 120.959 0.409 . . . . 73.22 109.913 177.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 123' ' ' LEU . . . . . 0.662 HD13 HG12 ' B' ' 182' ' ' VAL . 0.4 OUTLIER -122.96 120.9 27.41 Favored Pre-proline 0 N--CA 1.473 0.7 0 C-N-CA 123.447 0.699 . . . . 73.3 111.92 -166.132 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . 0.517 ' HD2' ' HB2' ' B' ' 183' ' ' ALA . 80.4 Cg_exo -51.19 116.96 3.0 Favored 'Trans proline' 0 C--N 1.37 1.68 0 C-N-CA 122.82 2.347 . . . . 72.51 111.298 162.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 125' ' ' LEU . . . . . . . . . . . . . 26.3 tp -138.64 140.26 38.83 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.373 1.069 . . . . 74.03 108.6 -175.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.4 156.24 21.91 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.069 0.461 . . . . 61.53 111.192 -177.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 127' ' ' LEU . . . . . 0.619 ' HB3' HD22 ' C' ' 215' ' ' LEU . 95.9 mt -63.72 -44.99 91.94 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.124 0.97 . . . . 62.25 110.776 177.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -52.84 -46.39 67.77 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 114.885 -1.052 . . . . 75.24 110.513 172.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -67.01 -33.84 76.42 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.092 0.957 . . . . 73.53 111.553 -176.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -72.44 -33.1 66.84 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 123.866 0.729 . . . . 64.34 110.344 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 131' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -68.09 -41.38 81.94 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.2 0.6 . . . . 75.55 110.361 172.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 132' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -66.72 -68.91 0.34 Allowed 'General case' 0 N--CA 1.481 1.118 0 O-C-N 123.653 0.595 . . . . 60.22 111.284 -175.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 62.93 93.25 0.02 OUTLIER Glycine 0 CA--C 1.541 1.678 0 O-C-N 123.735 0.647 . . . . 65.31 113.239 -176.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . -135.89 161.38 24.82 Favored Glycine 0 N--CA 1.479 1.516 0 CA-C-O 119.473 -0.626 . . . . 53.24 111.802 177.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -71.88 95.53 1.56 Allowed 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 108.727 -0.842 . . . . 71.2 108.727 176.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 136' ' ' ARG . . . . . 0.47 ' HB2' HD22 ' B' ' 181' ' ' LEU . 90.0 mtt180 -123.93 163.52 21.16 Favored 'General case' 0 C--O 1.248 1.006 0 C-N-CA 123.563 0.745 . . . . 72.12 109.733 -173.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 137' ' ' VAL . . . . . 0.532 HG13 ' HB1' ' B' ' 180' ' ' ALA . 7.8 p -79.84 125.34 38.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 121.553 0.692 . . . . 71.12 110.621 -169.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 138' ' ' VAL . . . . . 0.583 HG12 ' HB3' ' B' ' 181' ' ' LEU . 8.1 m -112.46 141.84 26.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 124.068 0.947 . . . . 72.14 108.554 173.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 139' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -124.76 100.61 6.7 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 107.742 -1.207 . . . . 74.31 107.742 170.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 140' ' ' VAL . . . . . 0.487 HG21 HD21 ' C' ' 174' ' ' LEU . 61.3 t -116.59 100.33 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 109.376 -0.601 . . . . 63.22 109.376 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 63.41 30.69 15.4 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.444 0.698 . . . . 15.23 111.151 177.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 142' ' ' GLY . . . . . 0.417 ' O ' ' HB2' ' C' ' 79' ' ' PRO . . . 101.86 -11.6 57.59 Favored Glycine 0 C--N 1.343 0.917 0 CA-C-N 115.713 -0.676 . . . . 45.25 112.409 -179.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 143' ' ' ARG . . . . . 0.491 ' NE ' ' HB2' ' C' ' 84' ' ' ASP . 6.0 tpp180 -76.63 92.87 3.54 Favored 'General case' 0 C--N 1.352 0.699 0 N-CA-C 109.573 -0.529 . . . . 73.04 109.573 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 144' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' C' ' 138' ' ' VAL . 39.3 ttp85 -96.66 94.62 7.42 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 115.083 -0.962 . . . . 71.51 108.778 178.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 145' ' ' VAL . . . . . 0.555 ' HA ' ' HD2' ' C' ' 60' ' ' PRO . 28.6 m -131.5 176.16 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-N 114.978 -1.01 . . . . 75.03 109.879 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 49.0 m -125.12 118.83 26.97 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 109.05 -0.722 . . . . 54.21 109.05 178.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 14.1 p -142.0 150.99 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.103 0.561 . . . . 72.53 110.101 -173.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 45.2 ttp180 -103.34 110.58 22.62 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 108.346 -0.983 . . . . 74.22 108.346 169.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 149' ' ' ILE . . . . . 0.547 ' HB ' HD13 ' C' ' 159' ' ' ILE . 38.0 pt -76.46 148.29 80.04 Favored Pre-proline 0 CA--C 1.557 1.245 0 N-CA-C 109.267 -0.642 . . . . 71.41 109.267 170.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -47.88 119.64 4.03 Favored 'Trans proline' 0 C--N 1.381 2.268 0 C-N-CA 124.033 3.156 . . . . 61.44 113.723 -174.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -63.26 132.72 37.36 Favored 'Trans proline' 0 C--N 1.383 2.364 0 C-N-CA 122.903 2.402 . . . . 73.2 110.969 174.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 152' ' ' GLY . . . . . 0.578 ' HA2' ' HB3' ' C' ' 240' ' ' PHE . . . 86.92 53.92 2.74 Favored Glycine 0 C--N 1.334 0.435 0 N-CA-C 111.338 -0.705 . . . . 54.32 111.338 -173.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 153' ' ' VAL . . . . . 0.588 HG21 HD11 ' C' ' 159' ' ' ILE . 12.5 p -101.99 143.84 14.17 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.245 0 C-N-CA 123.539 0.736 . . . . 71.13 110.531 -172.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 154' ' ' ARG . . . . . 0.626 ' HA ' ' HB3' ' C' ' 188' ' ' LEU . 49.9 mtp180 -96.82 155.2 16.88 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.698 0.799 . . . . 75.32 112.329 -167.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 155' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -53.42 108.82 0.37 Allowed 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 123.267 0.627 . . . . 74.51 110.064 162.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 89.25 18.13 53.92 Favored Glycine 0 C--N 1.343 0.959 0 CA-C-O 119.803 -0.443 . . . . 64.51 113.454 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 157' ' ' SER . . . . . 0.572 ' HA ' ' HG2' ' B' ' 193' ' ' PRO . 3.5 m -73.35 107.1 5.47 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 117.148 0.474 . . . . 75.43 110.314 172.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 158' ' ' VAL . . . . . 0.525 HG11 ' HA ' ' B' ' 190' ' ' CYS . 42.1 t -85.02 90.25 2.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-N 114.438 -1.255 . . . . 64.44 108.378 176.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 159' ' ' ILE . . . . . 0.588 HD11 HG21 ' C' ' 153' ' ' VAL . 53.0 mt -75.88 118.96 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 114.972 -1.013 . . . . 52.25 110.179 -178.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 53.1 ttt180 -78.06 119.71 21.87 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 109.918 -0.401 . . . . 72.21 109.918 173.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 161' ' ' VAL . . . . . 0.607 HG11 ' SD ' ' C' ' 164' ' ' MET . 21.2 t -125.97 95.47 39.48 Favored Pre-proline 0 CA--C 1.551 1.017 0 N-CA-C 109.062 -0.718 . . . . 75.24 109.062 176.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.43 119.63 5.85 Favored 'Trans proline' 0 C--N 1.368 1.59 0 C-N-CA 122.388 2.058 . . . . 63.42 111.253 172.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 113.24 23.32 5.23 Favored Glycine 0 C--N 1.341 0.815 0 CA-C-N 115.899 -0.591 . . . . 53.31 112.843 178.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 164' ' ' MET . . . . . 0.607 ' SD ' HG11 ' C' ' 161' ' ' VAL . 28.6 mtp -148.95 3.96 0.63 Allowed 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 112.884 0.698 . . . . 73.35 112.884 -178.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 165' ' ' GLY . . . . . 0.414 ' HA3' ' O ' ' C' ' 173' ' ' ASP . . . -126.37 -123.04 2.63 Favored Glycine 0 N--CA 1.48 1.603 0 CA-C-O 118.346 -1.252 . . . . 64.24 111.067 -177.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . 68.57 73.62 0.68 Allowed Glycine 0 C--N 1.363 2.041 0 CA-C-N 118.516 1.158 . . . . 75.44 113.501 165.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 167' ' ' GLN . . . . . 0.546 ' HB2' ' HB2' ' C' ' 117' ' ' ARG . 23.4 mm-40 -67.14 98.06 0.57 Allowed 'General case' 0 C--N 1.348 0.502 0 N-CA-C 107.033 -1.469 . . . . 64.31 107.033 170.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 168' ' ' GLY . . . . . 0.432 ' HA3' ' HA2' ' C' ' 116' ' ' GLY . . . 136.57 -140.55 11.58 Favored Glycine 0 C--O 1.217 -0.939 0 CA-C-N 112.745 -2.025 . . . . 13.44 108.881 -161.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 169' ' ' ASN . . . . . 0.451 ' ND2' HG21 ' C' ' 90' ' ' VAL . 62.6 t30 -153.3 -51.6 0.02 OUTLIER Pre-proline 0 N--CA 1.497 1.894 0 CA-C-N 119.918 1.859 . . . . 62.44 111.952 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 170' ' ' PRO . . . . . 0.431 ' HD3' ' HB3' ' C' ' 169' ' ' ASN . 86.3 Cg_exo -53.81 161.99 4.13 Favored 'Trans proline' 0 C--N 1.393 2.912 0 C-N-CA 122.559 2.173 . . . . 51.41 113.504 164.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 171' ' ' PRO . . . . . 0.591 ' HA ' ' N ' ' C' ' 87' ' ' GLY . 1.5 Cg_exo -28.63 104.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.39 2.759 1 C-N-CA 125.494 4.13 . . . . 74.02 117.854 -174.438 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -121.66 -146.61 7.42 Favored Glycine 0 C--N 1.341 0.819 0 N-CA-C 109.387 -1.485 . . . . 74.42 109.387 170.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 173' ' ' ASP . . . . . 0.414 ' O ' ' HA3' ' C' ' 165' ' ' GLY . 27.2 t70 -171.16 159.5 5.94 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 117.607 0.703 . . . . 74.51 111.053 -176.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 174' ' ' LEU . . . . . 0.487 HD21 HG21 ' C' ' 140' ' ' VAL . 17.5 tp -124.89 115.4 20.56 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.727 0.811 . . . . 75.22 110.166 170.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 175' ' ' LEU . . . . . 0.488 HD22 HG12 ' C' ' 158' ' ' VAL . 76.7 mt -92.05 89.99 7.19 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.172 0.989 . . . . 71.32 110.291 174.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 176' ' ' LEU . . . . . . . . . . . . . 58.1 mt -76.66 93.78 3.69 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.48 0.712 . . . . 43.02 111.002 176.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 177' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' C' ' 122' ' ' GLU . 8.2 t -86.64 100.71 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 123.371 0.668 . . . . 74.43 109.69 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 178' ' ' VAL . . . . . 0.465 HG12 HD11 ' C' ' 123' ' ' LEU . 14.8 m -73.64 112.43 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.199 0 CA-C-O 122.336 1.065 . . . . 74.01 111.154 -174.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 179' ' ' ARG . . . . . 0.403 ' O ' ' HA ' ' C' ' 124' ' ' PRO . 7.0 mmm180 -91.4 115.39 27.99 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 114.291 -1.322 . . . . 72.33 107.687 170.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 180' ' ' LEU . . . . . . . . . . . . . 77.4 mt -69.07 135.39 50.71 Favored 'General case' 0 CA--C 1.561 1.398 0 CA-C-N 118.3 0.5 . . . . 70.51 111.436 178.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 181' ' ' LEU . . . . . 0.435 HD23 ' HB3' ' C' ' 124' ' ' PRO . 16.4 mt -53.43 169.65 0.31 Allowed Pre-proline 0 N--CA 1.501 2.102 0 C-N-CA 126.896 2.078 . . . . 74.2 113.965 -175.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -60.86 62.22 0.09 OUTLIER 'Trans proline' 0 C--N 1.397 3.112 0 C-N-CA 123.936 3.09 . . . . 64.12 112.442 161.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 183' ' ' HIS . . . . . 0.513 ' N ' ' HD3' ' C' ' 184' ' ' PRO . 85.7 t60 -162.06 28.17 0.03 OUTLIER Pre-proline 0 CA--C 1.572 1.803 0 C-N-CA 127.82 2.448 . . . . 62.13 107.203 -179.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 184' ' ' PRO . . . . . 0.513 ' HD3' ' N ' ' C' ' 183' ' ' HIS . 44.2 Cg_endo -91.81 67.57 1.0 Allowed 'Trans proline' 0 C--N 1.396 3.061 0 C-N-CA 123.719 2.946 . . . . 71.54 111.731 -162.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 185' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 2.9 t -87.81 -23.28 6.56 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.788 0 N-CA-C 107.751 -1.203 . . . . 72.23 107.751 -176.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 186' ' ' PHE . . . . . 0.532 ' HD2' HD13 ' C' ' 127' ' ' LEU . 56.7 m-85 -125.57 100.55 6.5 Favored 'General case' 0 C--N 1.346 0.439 0 N-CA-C 108.931 -0.766 . . . . 61.44 108.931 -178.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 187' ' ' ARG . . . . . 0.427 ' NH2' ' HB2' ' C' ' 184' ' ' PRO . 32.1 ttm105 -99.89 107.82 19.91 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 107.477 -1.305 . . . . 75.14 107.477 -177.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 188' ' ' LEU . . . . . 0.626 ' HB3' ' HA ' ' C' ' 154' ' ' ARG . 53.3 tp -76.52 127.89 33.71 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.199 0.814 . . . . 74.14 113.199 -163.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -112.97 104.46 12.43 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.9 1.28 . . . . 71.33 108.082 169.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 190' ' ' GLY . . . . . 0.405 ' H ' ' NE ' ' C' ' 154' ' ' ARG . . . 68.2 -103.29 0.98 Allowed Glycine 0 CA--C 1.534 1.247 0 CA-C-N 116.437 -0.347 . . . . 74.2 112.533 -176.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 191' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -113.85 -16.4 12.24 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 124.226 1.01 . . . . 60.21 110.469 175.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -99.52 130.7 45.79 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.409 1.084 . . . . 65.13 110.126 -173.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 193' ' ' LEU . . . . . 0.461 HD22 ' HB3' ' C' ' 186' ' ' PHE . 71.1 mt -74.41 152.55 39.49 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.743 0.817 . . . . 52.2 111.501 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 194' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -120.09 106.66 12.19 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 107.531 -1.285 . . . . 75.43 107.531 167.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 195' ' ' ALA . . . . . 0.48 ' HA ' ' O ' ' C' ' 185' ' ' VAL . . . -109.38 -177.73 3.37 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.264 1.026 . . . . 65.11 110.315 -177.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 95.8 m -137.83 118.42 13.95 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.598 -0.89 . . . . 51.32 108.598 165.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 197' ' ' LEU . . . . . . . . . . . . . 62.3 tp -97.09 139.48 33.03 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.182 -0.917 . . . . 73.5 110.482 -175.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -93.53 100.87 13.07 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 109.015 -0.735 . . . . 44.52 109.015 -178.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 199' ' ' VAL . . . . . 0.552 HG22 HG21 ' C' ' 210' ' ' VAL . 94.7 t -114.41 119.35 40.22 Favored Pre-proline 0 N--CA 1.484 1.232 0 C-N-CA 124.068 0.947 . . . . 61.21 109.226 -178.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 200' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -72.68 145.78 42.1 Favored 'Trans proline' 0 C--N 1.366 1.469 0 C-N-CA 121.664 1.576 . . . . 71.34 110.75 174.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 201' ' ' ALA . . . . . 0.435 ' N ' ' HD2' ' C' ' 202' ' ' PRO . . . -58.26 -38.82 70.27 Favored Pre-proline 0 CA--C 1.552 1.037 0 N-CA-C 115.348 1.61 . . . . 74.35 115.348 -173.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 202' ' ' PRO . . . . . 0.552 ' O ' HG13 ' C' ' 206' ' ' VAL . 19.4 Cg_endo -58.45 -52.43 5.54 Favored 'Trans proline' 0 C--N 1.382 2.337 0 CA-C-N 121.547 1.588 . . . . 63.15 111.417 174.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 203' ' ' ILE . . . . . . . . . . . . . 41.7 mt -63.34 -27.6 43.37 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 123.887 0.875 . . . . 63.4 110.793 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.21 -41.59 76.87 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.567 -0.742 . . . . 75.02 112.229 175.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 205' ' ' VAL . . . . . 0.535 HG11 HD11 ' A' ' 261' ' ' LEU . 90.7 t -72.14 -43.65 66.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 122.578 0.351 . . . . 63.41 111.175 -178.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 206' ' ' VAL . . . . . 0.552 HG13 ' O ' ' C' ' 202' ' ' PRO . 0.6 OUTLIER -98.25 -38.08 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 N-CA-C 111.656 0.243 . . . . 52.12 111.656 -168.265 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 106.01 123.62 5.18 Favored Glycine 0 CA--C 1.529 0.914 0 O-C-N 123.122 0.264 . . . . 63.21 112.787 -173.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -158.38 -130.92 1.22 Allowed Glycine 0 C--N 1.34 0.797 0 N-CA-C 110.197 -1.161 . . . . 51.32 110.197 176.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 209' ' ' LYS . . . . . 0.555 ' HG2' ' HA ' ' C' ' 222' ' ' ALA . 8.6 mtmp? -147.65 146.86 29.48 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 117.673 0.737 . . . . 72.12 111.558 176.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 210' ' ' VAL . . . . . 0.552 HG21 HG22 ' C' ' 199' ' ' VAL . 31.1 m -141.84 142.59 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 124.417 1.087 . . . . 62.05 109.354 173.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 211' ' ' ARG . . . . . 0.591 ' HE ' ' HB3' ' B' ' 234' ' ' ALA . 45.2 ttm-85 -81.45 127.81 33.2 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.656 0.782 . . . . 72.44 111.801 -172.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -105.98 112.19 25.14 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 107.574 -1.269 . . . . 74.43 107.574 169.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 213' ' ' MET . . . . . 0.578 ' HA ' ' HA ' ' C' ' 218' ' ' PRO . 4.0 ttp -77.97 100.62 6.52 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.812 -0.81 . . . . 63.12 108.812 -176.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.68 177.63 8.8 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 118.02 0.373 . . . . 54.24 110.154 -174.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 215' ' ' LEU . . . . . 0.619 HD22 ' HB3' ' C' ' 127' ' ' LEU . 12.3 mt -51.26 -61.25 2.35 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.295 1.038 . . . . 44.41 111.109 -173.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -92.86 13.36 20.65 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.239 -0.891 . . . . 71.0 111.933 -173.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 144.35 154.86 6.25 Favored Glycine 0 C--N 1.346 1.112 0 CA-C-O 119.831 -0.427 . . . . 64.11 113.128 177.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 218' ' ' PRO . . . . . 0.578 ' HA ' ' HA ' ' C' ' 213' ' ' MET . 52.8 Cg_endo -69.1 125.76 12.89 Favored 'Trans proline' 0 C--N 1.365 1.403 0 C-N-CA 122.896 2.398 . . . . 52.13 114.878 179.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 219' ' ' VAL . . . . . . . . . . . . . 9.6 p -100.71 173.21 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.809 0 N-CA-C 106.103 -1.814 . . . . 52.53 106.103 168.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 220' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -118.36 158.18 25.74 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.703 -0.48 . . . . 72.32 109.703 174.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 221' ' ' VAL . . . . . . . . . . . . . 38.0 t -115.31 127.95 72.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 124.801 1.24 . . . . 74.03 109.592 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 222' ' ' ALA . . . . . 0.555 ' HA ' ' HG2' ' C' ' 209' ' ' LYS . . . -80.14 102.32 9.31 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 108.69 -0.856 . . . . 73.3 108.69 170.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 48.5 t -76.67 126.58 85.8 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-N 115.294 -0.866 . . . . 73.11 109.344 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 224' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' B' ' 245' ' ' LYS . 6.1 Cg_exo -79.87 163.9 23.12 Favored 'Trans proline' 0 C--N 1.366 1.479 0 C-N-CA 123.715 2.943 . . . . 54.33 112.848 171.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -56.73 146.7 75.89 Favored 'Trans proline' 0 C--N 1.37 1.668 0 C-N-CA 122.128 1.885 . . . . 74.0 112.003 164.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 226' ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? 65.51 71.25 0.44 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.533 1.133 . . . . 70.15 110.929 171.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 227' ' ' THR . . . . . 0.528 HG22 HD11 ' C' ' 255' ' ' ILE . 8.0 m -116.95 125.85 52.05 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 124.287 1.035 . . . . 70.3 111.419 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 228' ' ' GLN . . . . . 0.561 ' HB3' HD12 ' B' ' 29' ' ' LEU . 24.9 mp0 -108.23 157.21 18.53 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.404 1.081 . . . . 74.32 111.017 -177.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 229' ' ' ALA . . . . . 0.533 ' O ' ' HG ' ' B' ' 29' ' ' LEU . . . -77.03 110.59 11.8 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 114.842 -1.072 . . . . 62.12 110.416 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 108.69 8.95 27.59 Favored Glycine 0 N--CA 1.475 1.25 0 CA-C-O 119.871 -0.405 . . . . 62.04 113.0 -169.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 231' ' ' ARG . . . . . . . . . . . . . 49.9 mtp85 -76.07 168.34 20.22 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 109.223 -0.658 . . . . 74.12 109.223 164.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 232' ' ' LYS . . . . . 0.521 ' HD3' ' HB3' ' C' ' 250' ' ' TYR . 2.4 ttmp? -134.29 146.96 50.51 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-O 121.493 0.663 . . . . 71.45 112.452 178.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 233' ' ' LEU . . . . . 0.728 HD13 ' HB2' ' C' ' 251' ' ' LEU . 5.1 mp -111.27 155.61 22.75 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.323 1.449 . . . . 74.21 111.22 -173.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 29.5 ptt-85 -125.93 91.72 3.44 Favored 'General case' 0 CA--C 1.571 1.769 0 O-C-N 125.477 1.736 . . . . 72.34 110.87 175.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 235' ' ' LEU . . . . . 0.477 ' HB2' ' HB3' ' C' ' 249' ' ' LEU . 79.5 mt -90.96 103.72 16.4 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.876 -0.787 . . . . 73.43 108.876 170.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -69.71 129.63 40.13 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.525 0.73 . . . . 71.55 111.863 -175.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 75.13 25.9 67.7 Favored Glycine 0 C--N 1.353 1.507 0 O-C-N 123.882 0.739 . . . . 71.42 114.196 175.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 31.1 mmtm -115.14 13.34 16.79 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.172 0.589 . . . . 72.03 110.621 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 239' ' ' GLY . . . . . 0.433 ' HA2' ' HG ' ' C' ' 193' ' ' LEU . . . -91.3 -163.16 38.47 Favored Glycine 0 C--N 1.353 1.51 0 O-C-N 123.511 0.507 . . . . 31.21 113.323 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 240' ' ' PHE . . . . . 0.578 ' HB3' ' HA2' ' C' ' 152' ' ' GLY . 4.6 m-85 -87.05 154.09 54.78 Favored Pre-proline 0 CA--C 1.552 1.05 0 N-CA-C 110.005 -0.368 . . . . 75.14 110.005 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 241' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.33 113.59 1.67 Allowed 'Trans proline' 0 C--N 1.386 2.513 0 C-N-CA 122.915 2.41 . . . . 70.21 111.382 175.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -111.11 164.54 12.14 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-O 118.945 -0.92 . . . . 70.14 111.714 177.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 243' ' ' PRO . . . . . 0.411 ' HD3' ' HB1' ' B' ' 195' ' ' ALA . 59.8 Cg_endo -68.65 -20.7 40.22 Favored 'Trans proline' 0 C--N 1.37 1.692 0 C-N-CA 122.902 2.401 . . . . 71.42 112.536 -178.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -98.18 20.87 11.69 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.1 0.96 . . . . 71.42 110.489 176.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 97.01 177.94 34.79 Favored Glycine 0 C--N 1.348 1.197 0 N-CA-C 111.263 -0.735 . . . . 51.32 111.263 -171.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 246' ' ' ARG . . . . . . . . . . . . . 69.4 mtm180 -71.89 142.6 49.52 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 117.465 0.632 . . . . 61.31 110.593 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -79.42 -158.18 13.79 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 123.846 0.716 . . . . 63.23 112.723 177.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -116.89 -179.86 3.81 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.725 0.81 . . . . 73.54 108.896 -174.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 249' ' ' LEU . . . . . 0.477 ' HB3' ' HB2' ' C' ' 235' ' ' LEU . 10.3 tp -122.41 109.43 14.38 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.48 -0.933 . . . . 74.23 108.48 176.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 250' ' ' TYR . . . . . 0.638 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 23.5 m-85 -101.14 105.71 16.89 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.601 -0.727 . . . . 71.43 109.736 178.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 251' ' ' LEU . . . . . 0.728 ' HB2' HD13 ' C' ' 233' ' ' LEU . 2.0 mp -98.79 149.89 22.41 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 109.536 -0.542 . . . . 64.53 109.536 -173.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -104.61 128.93 52.76 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 108.16 -1.052 . . . . 73.41 108.16 175.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 253' ' ' VAL . . . . . . . . . . . . . 67.7 t -74.99 134.66 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 112.247 0.462 . . . . 73.5 112.247 -172.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 254' ' ' ARG . . . . . 0.402 ' CZ ' ' HB ' ' C' ' 256' ' ' THR . 1.5 tmm_? -121.69 93.94 4.16 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 107.293 -1.373 . . . . 74.13 107.293 177.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 255' ' ' ILE . . . . . 0.528 HD11 HG22 ' C' ' 227' ' ' THR . 46.1 mm -68.49 124.52 24.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 O-C-N 123.264 0.353 . . . . 75.24 110.077 176.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 256' ' ' THR . . . . . 0.402 ' HB ' ' CZ ' ' C' ' 254' ' ' ARG . 0.0 OUTLIER -133.27 170.33 15.6 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.855 1.262 . . . . 53.32 110.772 -174.596 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 257' ' ' ILE . . . . . 0.45 ' HB ' ' HD2' ' C' ' 258' ' ' PRO . 2.9 pp -130.19 157.6 76.67 Favored Pre-proline 0 CA--C 1.556 1.204 0 C-N-CA 124.025 0.93 . . . . 64.54 109.44 178.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 258' ' ' PRO . . . . . 0.45 ' HD2' ' HB ' ' C' ' 257' ' ' ILE . 74.3 Cg_endo -67.14 -8.56 22.24 Favored 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 122.817 2.345 . . . . 73.21 114.031 -166.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 56.94 -71.88 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 125.024 1.329 . . . . 72.3 111.246 -164.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -73.88 152.33 40.21 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.831 0.852 . . . . 73.41 111.483 177.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 261' ' ' LEU . . . . . 0.588 HD13 ' HA ' ' C' ' 266' ' ' GLU . 31.2 mt -146.41 141.04 26.77 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.07 0.548 . . . . 71.21 112.043 179.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 53.7 p -87.72 145.33 36.73 Favored Pre-proline 0 CA--C 1.551 0.983 0 CA-C-O 117.914 -1.041 . . . . 61.23 108.369 167.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -45.02 -31.3 5.4 Favored 'Trans proline' 0 C--N 1.382 2.34 0 C-N-CA 124.471 3.448 . . . . 74.2 114.906 -176.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -56.83 -72.45 0.08 Allowed 'General case' 0 C--O 1.257 1.465 0 C-N-CA 124.599 1.159 . . . . 71.04 111.482 174.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -68.36 -24.87 64.85 Favored 'General case' 0 C--O 1.212 -0.888 0 CA-C-N 115.068 -0.969 . . . . 65.11 110.339 -176.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 266' ' ' GLU . . . . . 0.588 ' HA ' HD13 ' C' ' 261' ' ' LEU . 11.3 tp10 -59.09 -48.31 82.08 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.689 0.795 . . . . 64.21 109.95 173.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -63.74 -35.58 81.05 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.18 0.592 . . . . 70.32 111.386 177.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 268' ' ' LEU . . . . . . . . . . . . . 11.2 mp -64.52 -50.88 65.64 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 112.279 0.474 . . . . 52.44 112.279 174.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 269' ' ' TRP . . . . . 0.501 ' HH2' ' HD3' ' C' ' 202' ' ' PRO . 89.6 m95 -60.95 -32.74 72.25 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.46 0.704 . . . . 61.11 110.774 178.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 270' ' ' LYS . . . . . 0.433 ' HB3' ' NZ ' ' C' ' 270' ' ' LYS . 3.7 mmmp? -62.42 -57.75 10.13 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.092 0.957 . . . . 75.43 111.241 175.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 31.1 mmtm -66.39 -24.8 66.54 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.476 0.711 . . . . 75.33 112.475 -177.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 272' ' ' LEU . . . . . 0.407 HD12 HD12 ' A' ' 272' ' ' LEU . 55.4 mt -81.67 -32.46 31.77 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 122.981 0.512 . . . . 74.33 110.744 174.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -63.61 -40.19 96.29 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 109.613 -0.514 . . . . 34.13 109.613 172.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -64.23 -42.48 96.53 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.431 1.092 . . . . 63.21 110.355 175.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -62.17 -28.27 69.55 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.1 0.56 . . . . 70.04 111.316 173.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 276' ' ' TYR . . . . . 0.471 ' HA ' ' HD3' ' C' ' 279' ' ' ARG . 3.0 m-85 -85.05 -25.21 27.76 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.254 0.464 . . . . 75.52 112.254 178.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -68.73 -33.74 74.44 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 108.361 -0.977 . . . . 44.24 108.361 171.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -64.87 -15.63 62.17 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 115.127 -0.942 . . . . 55.2 112.491 172.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 279' ' ' ARG . . . . . 0.511 ' HG2' ' H ' ' B' ' 89' ' ' GLY . 27.0 mtp-105 -82.15 -33.79 29.42 Favored 'General case' 0 C--N 1.357 0.906 0 N-CA-C 109.27 -0.641 . . . . 71.52 109.27 172.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.869 0 CA-C-O 118.329 -0.843 . . . . 75.14 109.502 -170.238 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.0 mtt . . . . . 0 N--CA 1.474 0.735 0 N-CA-C 107.716 -1.216 . . . . 64.12 107.716 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 78.54 -39.97 0.26 Allowed 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 125.809 1.644 . . . . 51.4 112.036 -178.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.02 76.28 4.54 Favored 'General case' 0 C--N 1.353 0.74 0 C-N-CA 123.948 0.899 . . . . 74.04 110.641 176.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -40.51 121.11 1.36 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.389 1.076 . . . . 62.43 112.991 166.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.618 ' HD2' HD11 ' A' ' 10' ' ' ILE . 29.0 mmtp -79.28 93.02 5.2 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 108.273 -1.01 . . . . 74.32 108.273 164.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -73.93 96.62 2.66 Favored 'General case' 0 C--N 1.352 0.686 0 N-CA-C 107.573 -1.269 . . . . 61.41 107.573 172.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.464 ' CD1' ' HA ' ' A' ' 53' ' ' ALA . 56.2 m-85 -64.39 -22.25 66.9 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 114.954 -1.021 . . . . 73.34 111.726 -171.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -63.48 -50.6 69.03 Favored 'General case' 0 C--N 1.353 0.72 0 O-C-N 123.484 0.49 . . . . 73.33 109.891 171.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.31 -40.25 96.82 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.392 0.677 . . . . 60.32 111.072 -178.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.618 HD11 ' HD2' ' A' ' 5' ' ' LYS . 68.5 mt -58.37 -43.66 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 123.284 0.633 . . . . 74.23 110.261 174.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 92.4 mt -83.26 -2.18 55.0 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 115.845 -0.616 . . . . 51.33 112.586 177.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 67.86 19.41 71.51 Favored Glycine 0 C--N 1.349 1.28 0 N-CA-C 114.639 0.616 . . . . 53.33 114.639 177.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.9 m -102.85 158.49 31.66 Favored Pre-proline 0 N--CA 1.481 1.1 0 C-N-CA 124.06 0.944 . . . . 71.43 110.874 178.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -60.81 158.26 34.1 Favored 'Trans proline' 0 C--N 1.387 2.553 0 C-N-CA 122.77 2.313 . . . . 50.12 112.156 177.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 27.8 mtp180 -74.88 10.85 1.25 Allowed 'General case' 0 CA--C 1.558 1.272 0 O-C-N 121.95 -0.469 . . . . 75.43 112.031 -178.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -119.19 5.63 11.25 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.777 1.631 . . . . 64.11 109.012 -178.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.33 138.53 55.5 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.717 0.807 . . . . 64.31 111.332 -176.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 33.9 p -90.26 -179.71 5.7 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.389 0.676 . . . . 71.11 110.1 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -52.43 -31.95 36.99 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.901 0.88 . . . . 64.21 112.683 179.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 19.3 tp10 -87.34 -28.51 22.19 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 112.055 0.391 . . . . 72.43 112.055 -173.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -66.12 -42.94 88.48 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 109.118 -0.697 . . . . 64.03 109.118 168.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.34 -39.85 84.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 O-C-N 124.332 1.02 . . . . 73.31 111.051 174.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -59.89 -56.0 27.2 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.935 0.894 . . . . 71.24 110.521 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 -69.56 -26.77 64.65 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 114.688 -1.142 . . . . 54.12 110.998 -176.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -75.3 -37.26 60.92 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.359 0.663 . . . . 64.0 111.079 178.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -60.06 -54.27 47.91 Favored 'General case' 0 C--O 1.216 -0.66 0 N-CA-C 108.947 -0.76 . . . . 73.1 108.947 173.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.9 mtpt -62.87 -38.02 89.2 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 124.287 0.992 . . . . 74.22 111.526 -178.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.9 ttt180 -53.14 -55.9 20.48 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.615 1.166 . . . . 71.15 110.119 174.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.7 ' HB3' HD13 ' A' ' 50' ' ' ILE . 96.5 mt -79.63 -16.22 56.2 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 115.035 -0.984 . . . . 74.11 111.613 -177.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -81.9 -19.92 39.85 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.717 0.807 . . . . 63.3 110.554 175.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 -89.7 -37.17 14.77 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.186 0.594 . . . . 72.33 110.323 171.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -69.47 -60.45 2.32 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.103 0.478 . . . . 63.33 110.391 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -93.42 34.24 1.18 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.552 0.741 . . . . 63.25 110.286 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.9 t-160 -61.58 102.5 0.31 Allowed Pre-proline 0 C--N 1.356 0.849 0 C-N-CA 124.051 0.94 . . . . 63.41 109.581 178.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -67.89 -19.66 46.16 Favored 'Trans proline' 0 C--N 1.371 1.751 0 C-N-CA 122.879 2.386 . . . . 74.13 112.279 -168.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -59.34 -39.08 82.03 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.453 1.101 . . . . 72.45 111.129 173.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.3 t -101.63 -46.63 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 123.494 0.717 . . . . 65.53 110.466 -176.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -100.51 85.63 2.99 Favored 'General case' 0 C--O 1.245 0.826 0 C-N-CA 124.482 1.113 . . . . 61.35 109.933 -177.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.72 69.94 9.6 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.316 0.646 . . . . 73.11 109.525 178.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.0 m -121.21 110.03 34.74 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-O 118.191 -0.909 . . . . 54.41 108.794 177.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -35.88 -61.9 0.26 Allowed 'Trans proline' 0 C--N 1.389 2.658 0 C-N-CA 125.157 3.904 . . . . 72.23 115.051 -171.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -67.49 -27.01 66.65 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 122.891 0.476 . . . . 64.43 111.957 -175.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.44 -30.46 67.3 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-O 121.001 0.429 . . . . 72.14 109.919 175.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.424 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 35.3 mt-10 -83.29 -28.6 28.98 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.166 -0.925 . . . . 62.01 109.337 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.478 ' HA ' ' HZ2' ' A' ' 48' ' ' LYS . 50.7 mt-10 -66.81 -43.46 83.76 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.325 0.65 . . . . 62.44 109.977 173.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 35.0 mmtm -61.61 -42.25 98.61 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 115.057 -0.974 . . . . 74.03 109.939 173.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.597 ' HA ' HD12 ' A' ' 50' ' ' ILE . 91.1 t80 -57.41 -37.16 72.28 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 123.737 0.648 . . . . 73.24 111.112 176.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.478 ' HZ2' ' HA ' ' A' ' 45' ' ' GLU . 10.4 mtmp? -70.85 -33.59 70.79 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.947 0.499 . . . . 75.14 111.472 176.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -71.14 -23.64 62.11 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 122.741 0.416 . . . . 71.44 111.082 173.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.7 HD13 ' HB3' ' A' ' 29' ' ' LEU . 59.9 mt -79.53 -35.68 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.718 1.207 . . . . 70.53 109.331 174.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -65.38 -35.86 82.25 Favored 'General case' 0 C--O 1.209 -1.05 0 CA-C-N 115.628 -0.715 . . . . 73.43 109.827 171.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -65.61 -48.9 70.71 Favored 'General case' 0 C--O 1.247 0.946 0 C-N-CA 125.344 1.458 . . . . 63.42 110.542 177.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.464 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . . . -57.87 -48.28 80.27 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 114.265 -1.334 . . . . 65.45 111.243 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -79.19 -19.87 49.78 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 115.044 -0.98 . . . . 72.32 110.891 177.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.31 -45.72 87.49 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 118.404 0.547 . . . . 53.01 109.865 174.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.594 HG13 ' HZ ' ' A' ' 101' ' ' PHE . 22.7 t -71.43 -56.37 10.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 114.138 -1.392 . . . . 74.52 110.042 175.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.676 HD22 ' HD2' ' A' ' 63' ' ' ARG . 43.5 mt -91.93 15.73 12.53 Favored 'General case' 0 CA--C 1.56 1.346 0 N-CA-C 113.644 0.979 . . . . 62.04 113.644 -164.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.2 t -71.63 -71.54 0.26 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 122.813 0.445 . . . . 74.34 110.798 171.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -79.97 143.18 57.02 Favored Pre-proline 0 N--CA 1.471 0.619 0 CA-C-N 115.439 -0.801 . . . . 74.34 110.113 -176.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -58.47 -27.06 80.73 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 123.155 2.57 . . . . 72.41 112.932 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -67.31 -59.12 3.67 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.711 0.805 . . . . 72.3 111.002 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.504 ' HA ' HD12 ' A' ' 65' ' ' ILE . 27.9 mtpt -70.07 -28.92 65.83 Favored 'General case' 0 C--O 1.248 0.987 0 CA-C-N 114.893 -1.048 . . . . 74.54 110.829 -177.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.676 ' HD2' HD22 ' A' ' 57' ' ' LEU . 31.6 tpt85 -54.21 -55.61 26.28 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 114.635 -1.166 . . . . 74.11 109.401 168.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.43 ' HE ' ' HA ' ' A' ' 64' ' ' ARG . 2.8 mmp_? -65.2 -25.68 67.81 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 115.761 -0.654 . . . . 74.25 112.113 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.504 HD12 ' HA ' ' A' ' 62' ' ' LYS . 78.6 mt -59.38 -47.15 91.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 CA-C-N 118.231 0.469 . . . . 64.42 110.138 171.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -58.35 -52.97 63.35 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 116.033 -0.53 . . . . 75.4 110.255 173.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -56.67 -41.85 77.99 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.477 0.711 . . . . 64.04 112.599 -176.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.8 p -74.13 -23.02 59.23 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 122.844 0.458 . . . . 75.13 110.95 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -71.0 126.58 29.96 Favored 'General case' 0 C--N 1.357 0.909 0 N-CA-C 107.42 -1.326 . . . . 63.45 107.42 170.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.82 13.93 41.88 Favored Glycine 0 N--CA 1.471 1.027 0 N-CA-C 112.108 -0.397 . . . . 52.54 112.108 -169.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 42.6 m -140.79 -57.56 0.51 Allowed 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 103.786 -2.672 . . . . 71.23 103.786 173.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 46.7 m -83.82 140.55 31.96 Favored 'General case' 0 C--O 1.247 0.951 0 N-CA-C 104.832 -2.284 . . . . 74.23 104.832 155.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.41 -26.29 17.3 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.027 0.531 . . . . 74.04 110.889 178.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -88.82 163.16 36.19 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 123.911 0.884 . . . . 75.1 110.516 176.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -58.23 143.88 96.43 Favored 'Trans proline' 0 C--N 1.371 1.716 0 C-N-CA 122.268 1.979 . . . . 75.41 111.657 163.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.92 159.61 47.73 Favored 'Trans proline' 0 CA--C 1.557 1.665 0 C-N-CA 122.397 2.065 . . . . 74.25 111.341 174.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -51.41 114.57 1.62 Allowed 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 122.927 2.418 . . . . 62.44 112.911 173.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -61.04 140.31 89.13 Favored 'Trans proline' 0 C--N 1.384 2.4 0 C-N-CA 123.311 2.674 . . . . 43.51 112.556 177.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.52 163.86 37.37 Favored 'Trans proline' 0 C--N 1.374 1.896 0 C-N-CA 122.766 2.311 . . . . 71.05 112.445 177.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -58.18 87.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.38 2.186 0 C-N-CA 123.122 2.548 . . . . 51.35 112.648 174.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 150.96 -34.1 0.94 Allowed Glycine 0 C--N 1.338 0.645 0 CA-C-N 114.281 -1.327 . . . . 62.41 110.006 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 106.5 -160.39 14.49 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-N 114.754 -0.723 . . . . 53.03 111.722 178.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -90.89 103.5 16.2 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 123.478 0.711 . . . . 74.41 109.3 178.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -61.63 152.51 30.53 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.728 0.811 . . . . 71.31 111.658 171.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.564 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 70.8 m-85 -142.09 75.04 1.47 Allowed 'General case' 0 C--N 1.353 0.745 0 C-N-CA 124.582 1.153 . . . . 70.22 109.411 172.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.518 ' HA ' ' O ' ' A' ' 162' ' ' PRO . 74.0 m -53.84 84.38 0.0 OUTLIER 'General case' 0 CA--C 1.562 1.405 0 C-N-CA 124.392 1.077 . . . . 74.44 113.316 -178.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 88.32 19.31 53.12 Favored Glycine 0 C--N 1.351 1.369 0 CA-C-N 115.691 -0.686 . . . . 70.11 113.992 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.564 ' HB2' ' HB3' ' A' ' 85' ' ' PHE . 37.4 m-85 -125.95 113.53 17.29 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 118.102 0.951 . . . . 72.34 110.402 -174.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -78.0 86.71 4.18 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.655 0.74 . . . . 71.44 111.008 -176.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.691 HG21 HD22 ' A' ' 105' ' ' LEU . 2.3 p -46.49 -36.31 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 124.926 1.291 . . . . 75.21 113.402 172.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.477 ' HB2' ' HG3' ' A' ' 170' ' ' PRO . 16.9 tp10 -54.32 -28.25 41.28 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.197 0.999 . . . . 75.33 111.563 -178.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -84.59 -39.53 18.61 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.654 0.781 . . . . 45.35 112.061 178.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 15.3 m-30 -66.15 162.58 19.46 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 113.404 0.89 . . . . 71.01 113.404 -162.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 92.2 p -65.03 164.55 12.63 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 114.025 1.12 . . . . 74.5 114.025 -165.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.88 -39.33 71.37 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 114.392 -1.276 . . . . 74.31 112.948 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -58.81 -45.59 89.59 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 121.654 0.74 . . . . 75.03 110.302 178.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -64.65 -41.0 96.42 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 113.995 -1.457 . . . . 63.23 110.109 178.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -73.35 -10.67 59.99 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 115.313 -0.858 . . . . 73.05 111.922 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -90.41 -54.48 3.99 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 118.267 0.485 . . . . 70.02 110.507 169.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 29.0 tp -60.47 -28.02 68.0 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.597 1.159 . . . . 55.03 111.786 -174.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.594 ' HZ ' HG13 ' A' ' 56' ' ' VAL . 95.4 m-85 -117.28 -3.97 11.42 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 123.072 0.549 . . . . 72.11 111.72 177.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -47.61 -60.63 5.21 Favored Glycine 0 CA--C 1.537 1.438 0 N-CA-C 116.035 1.174 . . . . 72.43 116.035 -175.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -66.1 5.53 0.65 Allowed 'Trans proline' 0 C--N 1.375 1.935 0 C-N-CA 123.303 2.669 . . . . 23.1 114.789 -175.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -150.58 30.92 1.03 Allowed Glycine 0 C--N 1.356 1.639 0 CA-C-O 118.79 -1.006 . . . . 44.4 112.755 170.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.691 HD22 HG21 ' A' ' 90' ' ' VAL . 17.2 mt -60.8 78.64 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 117.421 0.61 . . . . 74.25 112.502 176.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.413 ' HD1' ' H ' ' A' ' 108' ' ' GLY . 0.4 OUTLIER 38.48 -109.05 0.07 Allowed 'General case' 0 CA--C 1.563 1.464 0 C-N-CA 126.628 1.971 . . . . 72.25 113.069 -176.009 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 70.78 15.45 73.68 Favored Glycine 0 C--N 1.366 2.237 0 CA-C-O 119.165 -0.797 . . . . 44.0 114.323 -177.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.738 ' HA3' ' HB3' ' A' ' 167' ' ' GLN . . . -12.76 -69.55 0.01 OUTLIER Glycine 0 C--N 1.366 2.202 0 C-N-CA 125.895 1.712 . . . . 71.34 115.63 166.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -86.04 70.08 10.57 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 109.418 -0.586 . . . . 64.11 109.418 171.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -10.43 -74.28 0.01 OUTLIER Glycine 0 C--N 1.361 1.938 0 C-N-CA 126.534 2.016 . . . . 55.25 116.09 167.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 20.3 ttp180 -5.83 -42.16 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.481 0 C-N-CA 127.379 2.272 . . . . 71.44 116.852 166.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 -122.57 -35.41 3.08 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.194 0.998 . . . . 73.25 110.195 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 49.9 m 64.21 2.29 1.44 Allowed 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 124.775 1.23 . . . . 74.21 113.233 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 39.4 ttt180 -131.43 -148.94 0.37 Allowed 'General case' 0 CA--C 1.555 1.155 0 CA-C-O 118.219 -0.895 . . . . 74.52 109.168 -169.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.603 ' HD2' ' HB2' ' A' ' 170' ' ' PRO . 24.3 tptp -41.23 122.33 1.81 Allowed 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 125.724 1.61 . . . . 72.15 114.533 -163.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -83.64 175.79 52.22 Favored Glycine 0 CA--C 1.54 1.637 0 CA-C-N 115.844 -0.616 . . . . 55.22 112.592 175.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.768 ' H ' ' HA3' ' A' ' 166' ' ' GLY . 0.0 OUTLIER -116.72 174.0 6.32 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 124.118 0.967 . . . . 71.34 111.697 -178.359 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -78.46 101.66 7.43 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-O 122.02 0.914 . . . . 74.23 110.089 175.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.524 HD21 ' HD3' ' B' ' 12' ' ' PRO . 10.4 tt -112.2 139.84 47.4 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.938 0.895 . . . . 70.23 108.825 -174.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.4 ' HA ' ' HB2' ' A' ' 175' ' ' LEU . 58.3 ttt180 -94.42 139.02 31.66 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.33 0.652 . . . . 74.51 111.207 -178.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.4 ' HB2' HD23 ' B' ' 10' ' ' LEU . . . -134.77 169.43 17.37 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 123.981 0.912 . . . . 41.51 109.368 170.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.408 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 0.3 OUTLIER -117.64 115.74 25.68 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 107.0 -1.482 . . . . 61.0 107.0 -174.082 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 50.5 tp -100.52 100.23 11.74 Favored Pre-proline 0 N--CA 1.476 0.846 0 N-CA-C 108.912 -0.773 . . . . 54.05 108.912 -175.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.559 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 77.4 Cg_endo -84.16 111.73 1.64 Allowed 'Trans proline' 0 C--N 1.374 1.909 0 C-N-CA 121.323 1.348 . . . . 75.33 110.049 176.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.597 ' HA ' HG21 ' B' ' 6' ' ' ILE . 52.3 tp -104.99 137.09 43.28 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.706 0.402 . . . . 64.01 110.338 -176.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 90.0 m -68.06 126.69 30.3 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.035 0.934 . . . . 71.34 109.638 177.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 53.9 mt -53.6 -51.88 61.61 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.625 1.17 . . . . 70.54 112.47 -171.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -58.77 -37.39 76.16 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 115.115 -0.948 . . . . 75.32 110.007 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.464 ' HB3' ' NH2' ' A' ' 136' ' ' ARG . 44.6 mm-40 -80.48 -14.81 57.95 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.048 -0.978 . . . . 64.33 112.34 -178.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -70.51 -52.18 23.62 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 107.823 -1.177 . . . . 41.43 107.823 167.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -53.98 -40.1 66.59 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 116.028 -0.533 . . . . 74.51 110.913 175.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 35.9 m170 -78.41 -29.57 47.23 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 122.838 0.455 . . . . 75.25 112.099 -178.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 64.04 -138.05 41.42 Favored Glycine 0 N--CA 1.479 1.531 0 O-C-N 123.271 0.357 . . . . 71.54 113.844 176.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.36 -161.09 46.5 Favored Glycine 0 C--N 1.357 1.696 0 O-C-N 123.781 0.342 . . . . 70.42 113.002 175.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -76.23 119.09 19.65 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 109.255 -0.646 . . . . 73.14 109.255 170.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.464 ' NH2' ' HB3' ' A' ' 129' ' ' GLU . 10.0 tpp180 -93.52 123.35 36.77 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 109.336 -0.616 . . . . 74.4 109.336 175.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.411 HG11 ' HE ' ' A' ' 144' ' ' ARG . 98.2 t -88.37 104.07 14.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 109.018 -0.734 . . . . 71.24 109.018 175.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.401 HG22 HD11 ' B' ' 6' ' ' ILE . 15.3 t -102.64 125.36 56.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 CA-C-N 115.041 -0.981 . . . . 73.14 108.598 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -102.98 134.03 47.1 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.554 0.741 . . . . 71.3 109.968 -178.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.416 ' HB ' ' HB3' ' B' ' 8' ' ' LEU . 7.2 p -168.3 113.91 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 122.782 0.433 . . . . 75.1 111.547 178.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 61.26 24.78 14.84 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.396 1.078 . . . . 74.24 113.047 170.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 99.38 -11.25 61.59 Favored Glycine 0 C--N 1.349 1.286 0 CA-C-N 116.766 -0.197 . . . . 31.1 112.871 -178.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.417 ' NH2' HG23 ' A' ' 145' ' ' VAL . 16.4 tpt180 -87.9 108.42 19.17 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.872 0.869 . . . . 72.12 109.959 175.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.411 ' HE ' HG11 ' A' ' 137' ' ' VAL . 75.4 ttt180 -105.4 94.87 5.45 Favored 'General case' 0 C--O 1.244 0.794 0 C-N-CA 123.916 0.887 . . . . 74.41 108.864 175.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.418 HG22 HG13 ' A' ' 147' ' ' VAL . 11.5 p -95.58 143.67 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 123.205 0.602 . . . . 73.53 110.959 -176.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 33.3 t -118.16 85.6 2.38 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.82 0.848 . . . . 31.45 109.277 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.418 HG13 HG22 ' A' ' 145' ' ' VAL . 11.1 m -92.88 114.04 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 C-N-CA 123.364 0.666 . . . . 73.42 111.745 -173.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -71.32 105.56 3.54 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.449 -0.574 . . . . 74.14 109.449 173.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 21.2 pt -102.14 153.9 37.73 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 124.644 1.178 . . . . 74.13 109.772 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -57.6 -166.34 0.02 OUTLIER 'Trans proline' 0 N--CA 1.519 3.007 0 C-N-CA 124.305 3.337 . . . . 60.34 112.591 170.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -46.13 90.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.399 3.217 0 C-N-CA 121.621 1.547 . . . . 74.15 110.864 162.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 36.52 -94.58 0.01 OUTLIER Glycine 0 C--N 1.346 1.131 0 CA-C-N 113.011 -1.904 . . . . 75.51 114.521 -162.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.73 HG11 HG21 ' A' ' 178' ' ' VAL . 5.5 p 172.71 166.34 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 113.364 -1.418 . . . . 75.43 107.986 -162.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.93 146.64 50.57 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 108.59 -0.892 . . . . 73.23 108.59 177.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.56 ' HG2' ' NH1' ' A' ' 187' ' ' ARG . 14.9 tp10 -48.95 129.81 17.67 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.447 1.099 . . . . 72.32 112.263 -177.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 91.08 -4.9 81.58 Favored Glycine 0 C--N 1.346 1.114 0 CA-C-N 115.438 -0.801 . . . . 14.21 113.774 179.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 57.8 m -66.23 113.82 4.85 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 117.499 0.649 . . . . 74.23 110.409 179.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.415 HG22 HG22 ' A' ' 177' ' ' VAL . 61.1 t -90.13 94.93 5.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 C-N-CA 123.892 0.877 . . . . 72.34 108.949 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.595 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 60.1 mt -77.76 108.8 11.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 108.604 -0.887 . . . . 75.24 108.604 175.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 30.1 ttt180 -76.64 107.09 8.68 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.474 -0.565 . . . . 61.32 109.474 178.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.439 HG13 ' HB3' ' A' ' 174' ' ' LEU . 3.8 p -125.93 95.86 38.74 Favored Pre-proline 0 CA--C 1.55 0.958 0 N-CA-C 109.304 -0.628 . . . . 61.33 109.304 174.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.518 ' O ' ' HA ' ' A' ' 86' ' ' SER . 30.0 Cg_exo -62.25 142.04 90.04 Favored 'Trans proline' 0 C--N 1.369 1.636 0 C-N-CA 122.524 2.149 . . . . 74.53 111.597 174.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.424 ' N ' ' HB3' ' A' ' 171' ' ' PRO . . . 121.04 -26.36 6.79 Favored Glycine 0 N--CA 1.475 1.299 0 CA-C-N 117.855 0.298 . . . . 70.43 112.759 175.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 68.4 mtm -116.36 2.74 13.24 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 122.761 0.424 . . . . 64.15 110.858 -178.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.406 ' HA2' HD13 ' A' ' 174' ' ' LEU . . . -83.39 -108.99 0.52 Allowed Glycine 0 C--N 1.353 1.505 0 N-CA-C 110.875 -0.89 . . . . 73.33 110.875 175.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.768 ' HA3' ' H ' ' A' ' 117' ' ' ARG . . . -57.69 108.62 1.44 Allowed Glycine 0 C--O 1.263 1.932 0 N-CA-C 110.902 -0.879 . . . . 74.5 110.902 164.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.738 ' HB3' ' HA3' ' A' ' 108' ' ' GLY . 27.1 mm-40 -67.47 105.2 1.75 Allowed 'General case' 0 N--CA 1.446 -0.63 0 O-C-N 125.453 1.325 . . . . 75.42 109.204 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -178.26 169.08 40.67 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 110.871 -0.891 . . . . 64.21 110.871 -176.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . 0.53 ' ND2' ' HB3' ' A' ' 105' ' ' LEU . 4.6 t-20 -63.03 -67.98 0.94 Allowed Pre-proline 0 CA--C 1.57 1.722 0 CA-C-O 117.026 -1.464 . . . . 63.11 111.639 -170.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.603 ' HB2' ' HD2' ' A' ' 115' ' ' LYS . 17.0 Cg_exo -66.23 116.01 3.8 Favored 'Trans proline' 0 C--N 1.396 3.066 0 CA-C-N 122.878 2.063 . . . . 71.13 109.922 167.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.424 ' HB3' ' N ' ' A' ' 163' ' ' GLY . 18.8 Cg_exo -40.5 127.27 2.32 Favored 'Trans proline' 0 C--N 1.368 1.592 0 C-N-CA 125.214 3.943 . . . . 71.25 117.131 -171.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -83.11 132.14 10.87 Favored Glycine 0 C--N 1.367 2.289 0 CA-C-O 119.159 -0.801 . . . . 72.4 111.987 164.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.445 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 22.8 m-20 -64.48 108.35 1.63 Allowed 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.166 0.586 . . . . 71.14 110.82 -175.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.452 HD21 HD21 ' B' ' 8' ' ' LEU . 38.3 tp -83.64 129.31 34.96 Favored 'General case' 0 C--N 1.349 0.545 0 N-CA-C 109.623 -0.51 . . . . 64.32 109.623 175.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.4 ' HB2' ' HA ' ' A' ' 120' ' ' ARG . 55.6 mt -99.1 88.45 3.95 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 107.999 -1.112 . . . . 72.12 107.999 178.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.595 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 75.1 mt -70.62 87.32 0.67 Allowed 'General case' 0 C--N 1.35 0.609 0 N-CA-C 109.06 -0.719 . . . . 70.05 109.06 174.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.415 HG22 HG22 ' A' ' 158' ' ' VAL . 19.7 t -82.62 102.15 8.22 Favored 'Isoleucine or valine' 0 C--O 1.248 1.017 0 N-CA-C 105.749 -1.945 . . . . 61.43 105.749 175.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.73 HG21 HG11 ' A' ' 153' ' ' VAL . 5.4 p -73.42 131.89 34.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 115.034 -0.985 . . . . 70.33 110.865 -169.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.559 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 28.9 mmt180 -112.72 127.27 56.09 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 106.261 -1.755 . . . . 53.32 106.261 167.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.426 HD23 ' HB3' ' A' ' 125' ' ' LEU . 27.7 mt -80.12 147.7 31.28 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.477 -0.935 . . . . 72.4 108.477 169.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 20.2 mt -53.28 152.49 8.17 Favored Pre-proline 0 N--CA 1.482 1.145 0 O-C-N 124.174 0.921 . . . . 73.14 113.021 -167.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . 0.446 ' HB3' ' HG2' ' B' ' 149' ' ' LYS . 24.6 Cg_exo -65.16 5.23 0.53 Allowed 'Trans proline' 0 C--N 1.383 2.354 0 C-N-CA 123.566 2.844 . . . . 71.42 113.425 175.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 61.2 t-80 -59.56 104.0 0.41 Allowed Pre-proline 0 CA--C 1.56 1.341 0 C-N-CA 124.894 1.278 . . . . 73.35 107.985 168.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -80.81 26.36 0.6 Allowed 'Trans proline' 0 C--N 1.372 1.773 0 C-N-CA 123.792 2.995 . . . . 61.24 115.537 -162.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.424 HG12 ' HD1' ' A' ' 186' ' ' PHE . 75.5 t -95.22 -61.03 2.28 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.901 0 CA-C-O 118.715 -0.659 . . . . 64.21 110.848 -175.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . 0.424 ' HD1' HG12 ' A' ' 185' ' ' VAL . 3.9 m-85 -138.11 92.57 2.67 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 119.064 0.847 . . . . 72.31 110.34 -176.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.56 ' NH1' ' HG2' ' A' ' 155' ' ' GLU . 62.1 ttp85 -98.09 98.24 9.58 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.867 0.867 . . . . 75.51 109.391 176.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 193' ' ' LEU . 61.9 tp -68.78 142.15 55.0 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.163 0.985 . . . . 74.21 110.864 178.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -152.7 129.03 10.56 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.792 1.237 . . . . 70.31 109.973 -174.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 68.51 -80.5 0.22 Allowed Glycine 0 C--N 1.351 1.412 0 N-CA-C 111.916 -0.474 . . . . 65.41 111.916 -177.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.573 ' HG3' ' HB3' ' A' ' 244' ' ' ALA . 14.6 mm100 -147.47 -11.18 0.41 Allowed 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 125.069 1.347 . . . . 72.32 110.533 166.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -103.7 148.81 25.61 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.492 1.117 . . . . 72.32 110.944 -174.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 188' ' ' LEU . 11.6 mt -90.36 162.67 15.03 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.245 1.018 . . . . 63.44 111.02 -175.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -131.16 114.51 15.19 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.303 1.041 . . . . 73.14 109.142 173.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.524 ' HB3' HD23 ' A' ' 251' ' ' LEU . . . -135.68 174.92 10.08 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.64 1.176 . . . . 74.34 110.458 -176.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 27.9 m -120.72 144.87 48.02 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.818 0.847 . . . . 70.21 108.878 173.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.503 HD21 HG21 ' A' ' 210' ' ' VAL . 44.7 tp -129.4 115.92 18.26 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.621 0.768 . . . . 72.21 109.457 -175.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -90.24 121.05 31.92 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 108.092 -1.077 . . . . 61.43 108.092 173.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.5 p -139.5 131.02 14.85 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 124.054 0.942 . . . . 64.4 109.136 -173.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -72.35 148.58 49.23 Favored 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 121.602 1.535 . . . . 64.51 110.77 174.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -49.54 -47.4 78.17 Favored Pre-proline 0 CA--C 1.561 1.374 0 N-CA-C 114.131 1.16 . . . . 71.34 114.131 -174.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -51.66 -48.09 23.11 Favored 'Trans proline' 0 C--N 1.384 2.442 0 C-N-CA 122.022 1.815 . . . . 63.54 113.725 176.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 22.9 mt -73.12 -29.36 28.31 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 CA-C-N 115.74 -0.664 . . . . 64.32 110.514 -176.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.4 -41.71 76.06 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.979 0.512 . . . . 71.51 111.493 176.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 54.6 t -74.26 -46.88 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 123.867 0.867 . . . . 63.23 111.875 -175.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 91.5 t -90.56 -31.35 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 122.884 0.473 . . . . 74.41 111.569 -175.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 82.49 111.22 0.45 Allowed Glycine 0 C--N 1.343 0.928 0 N-CA-C 112.37 -0.292 . . . . 72.35 112.37 178.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.465 ' HA3' ' CE1' ' C' ' 277' ' ' TYR . . . -145.47 -132.61 2.47 Favored Glycine 0 C--O 1.217 -0.957 0 CA-C-O 119.178 -0.79 . . . . 55.24 111.719 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -112.05 134.83 53.36 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 118.008 0.904 . . . . 45.21 110.377 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.503 HG21 HD21 ' A' ' 197' ' ' LEU . 12.2 m -132.88 162.34 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 124.796 1.238 . . . . 63.11 108.633 171.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . 0.468 ' HG2' HG13 ' B' ' 421' ' ' VAL . 5.8 tpp180 -86.1 126.96 34.58 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 109.314 -0.624 . . . . 71.41 109.314 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.44 109.93 21.84 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.409 -0.96 . . . . 62.04 108.409 170.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 16.9 tpt -83.0 111.82 19.2 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 108.45 -0.944 . . . . 71.23 108.45 177.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 26.5 p -107.55 -174.47 2.54 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 109.502 -0.555 . . . . 74.1 109.502 -174.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 80.7 mt -63.94 -33.9 76.77 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.019 0.927 . . . . 63.31 111.942 -176.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -97.24 -6.63 34.14 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.421 0.688 . . . . 64.44 112.118 -177.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 135.06 -179.03 18.08 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-O 120.054 -0.303 . . . . 33.0 112.61 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -79.6 147.35 19.72 Favored 'Trans proline' 0 CA--C 1.549 1.238 0 C-N-CA 122.94 2.426 . . . . 70.23 113.455 -176.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 31.7 m -136.04 -177.91 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.624 1.569 . . . . 73.4 107.556 172.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.565 ' HB2' ' H ' ' B' ' 437' ' ' SER . 55.5 mt-10 -109.77 127.77 54.85 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 118.499 0.59 . . . . 75.04 109.745 169.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.452 ' HB ' HD11 ' B' ' 441' ' ' ILE . 7.0 m -107.52 132.25 55.54 Favored 'Isoleucine or valine' 0 C--O 1.242 0.683 0 C-N-CA 124.178 0.991 . . . . 74.13 108.512 168.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -80.24 97.3 6.89 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.572 -0.899 . . . . 60.25 108.572 178.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 14.9 p -65.62 137.39 96.36 Favored Pre-proline 0 N--CA 1.479 1.007 0 C-N-CA 124.186 0.994 . . . . 63.14 109.732 -175.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -72.04 165.93 31.12 Favored 'Trans proline' 0 C--N 1.374 1.9 0 C-N-CA 122.158 1.906 . . . . 75.51 111.931 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -73.58 164.11 35.75 Favored 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 122.214 1.942 . . . . 72.53 112.916 172.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 64.2 mtt-85 61.44 26.94 16.61 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 125.377 1.471 . . . . 74.04 111.812 169.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.525 HG23 HD21 ' A' ' 233' ' ' LEU . 94.6 m -72.06 103.87 3.4 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.19 1.396 . . . . 64.32 110.873 -176.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -87.08 138.11 31.77 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.636 1.174 . . . . 75.32 110.313 -175.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . 0.482 ' HA ' ' HB ' ' A' ' 253' ' ' VAL . . . -67.2 156.64 35.76 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.561 0.744 . . . . 62.31 111.973 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 83.51 -14.87 38.48 Favored Glycine 0 N--CA 1.471 0.99 0 CA-C-N 116.024 -0.535 . . . . 73.32 112.892 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -92.42 160.78 14.93 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 123.691 0.796 . . . . 74.0 110.4 177.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -113.49 113.5 25.22 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.783 0.833 . . . . 72.22 108.79 178.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.525 HD21 HG23 ' A' ' 227' ' ' THR . 64.7 mt -76.24 117.21 17.69 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.793 0.837 . . . . 71.4 109.683 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 27.8 ttm-85 -85.97 102.69 14.0 Favored 'General case' 0 CA--C 1.551 1.001 0 N-CA-C 108.679 -0.859 . . . . 64.14 108.679 172.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.532 HD12 HD23 ' A' ' 249' ' ' LEU . 3.1 mt -87.76 110.9 20.81 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 108.581 -0.896 . . . . 61.12 108.581 -178.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -59.38 127.84 34.1 Favored 'General case' 0 CA--C 1.555 1.135 0 O-C-N 124.098 0.874 . . . . 64.43 113.254 -177.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 82.59 6.37 88.63 Favored Glycine 0 C--N 1.353 1.5 0 N-CA-C 114.847 0.699 . . . . 74.2 114.847 170.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -95.31 -20.51 19.1 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 117.515 0.657 . . . . 73.01 112.714 -172.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -82.21 -173.01 48.42 Favored Glycine 0 N--CA 1.478 1.451 0 N-CA-C 113.717 0.247 . . . . 74.43 113.717 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -84.87 146.95 47.21 Favored Pre-proline 0 N--CA 1.483 1.213 0 C-N-CA 122.898 0.479 . . . . 73.13 111.811 -167.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -68.98 157.16 62.96 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 123.323 2.682 . . . . 73.33 113.326 173.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 169.84 -156.51 27.38 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 119.305 -0.719 . . . . 73.52 112.07 -178.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -61.99 -28.27 80.43 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 123.786 2.991 . . . . 70.45 113.286 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.573 ' HB3' ' HG3' ' A' ' 191' ' ' GLN . . . -87.38 22.32 2.2 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.252 0.621 . . . . 70.11 111.416 176.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 75.01 -97.32 1.01 Allowed Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.47 -1.052 . . . . 62.24 110.47 -175.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 39.2 mtp180 -128.05 152.4 48.01 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.718 0.807 . . . . 75.41 110.167 166.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -91.57 -175.65 43.07 Favored Glycine 0 C--N 1.342 0.876 0 CA-C-N 116.082 -0.508 . . . . 42.24 112.031 171.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -112.62 -173.25 2.21 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.601 0.76 . . . . 75.44 110.588 178.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.532 HD23 HD12 ' A' ' 235' ' ' LEU . 19.1 tp -125.55 115.6 20.44 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 122.102 -0.374 . . . . 70.31 110.17 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -80.44 123.08 27.74 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.545 -0.539 . . . . 52.51 109.545 172.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.524 HD23 ' HB3' ' A' ' 195' ' ' ALA . 57.8 mt -114.67 119.21 35.93 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.414 0.685 . . . . 72.24 109.415 171.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -77.46 116.94 18.45 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 106.579 -1.637 . . . . 75.41 106.579 176.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.482 ' HB ' ' HA ' ' A' ' 229' ' ' ALA . 24.3 t -75.71 109.68 9.6 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 CA-C-O 121.234 0.54 . . . . 24.43 110.569 -173.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.78 93.36 4.42 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.054 1.341 . . . . 73.14 107.625 177.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.4 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 58.6 mt -83.57 132.41 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-O 120.758 0.313 . . . . 74.34 110.308 -177.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 28.0 p -121.48 172.11 8.3 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.619 1.167 . . . . 73.43 109.889 174.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.511 HD12 ' H ' ' A' ' 259' ' ' GLU . 2.1 pp -126.48 154.86 75.15 Favored Pre-proline 0 CA--C 1.562 1.429 0 N-CA-C 107.966 -1.124 . . . . 73.4 107.966 175.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . 0.461 ' HG3' ' OH ' ' C' ' 276' ' ' TYR . 61.2 Cg_endo -75.96 14.42 1.08 Allowed 'Trans proline' 0 N--CA 1.511 2.549 0 C-N-CA 123.36 2.707 . . . . 74.45 115.713 -164.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.511 ' H ' HD12 ' A' ' 257' ' ' ILE . 5.6 mm-40 54.1 -125.12 2.28 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 124.142 0.977 . . . . 63.24 111.682 -170.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' ARG . . . . . 0.48 ' HD3' ' H ' ' A' ' 260' ' ' ARG . 0.0 OUTLIER -63.61 140.61 58.89 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 118.449 0.568 . . . . 75.12 110.904 -170.443 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.417 HD11 ' CG1' ' C' ' 205' ' ' VAL . 84.9 mt -110.34 160.6 16.42 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.248 0.619 . . . . 55.32 111.584 -171.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 21.3 p -103.92 146.85 33.32 Favored Pre-proline 0 CA--C 1.554 1.118 0 C-N-CA 124.652 1.181 . . . . 44.34 108.94 174.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' PRO . . . . . 0.469 ' O ' ' HB3' ' A' ' 266' ' ' GLU . 21.7 Cg_exo -29.46 -58.74 0.14 Allowed 'Trans proline' 0 C--N 1.389 2.692 1 C-N-CA 126.089 4.526 . . . . 74.33 117.948 -163.209 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -72.28 -45.41 60.22 Favored 'General case' 0 C--O 1.211 -0.949 0 CA-C-O 119.217 -0.42 . . . . 71.44 110.711 -176.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -60.17 -31.49 70.16 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 123.955 0.784 . . . . 64.2 109.819 178.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' GLU . . . . . 0.471 ' O ' ' HD3' ' A' ' 270' ' ' LYS . 8.3 tp10 -59.47 -60.58 3.62 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.925 0.89 . . . . 73.45 109.045 171.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -63.99 -21.58 66.56 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 115.235 -0.893 . . . . 64.12 112.198 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . 0.418 ' HA ' ' HE2' ' A' ' 271' ' ' LYS . 26.3 tp -79.7 -48.7 13.24 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.548 1.139 . . . . 73.14 110.24 -173.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 70.6 m95 -61.03 -39.07 88.37 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.336 -0.847 . . . . 75.0 110.401 172.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . 0.609 ' HG3' HG23 ' C' ' 206' ' ' VAL . 1.0 OUTLIER -63.08 -45.7 90.92 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 123.689 0.618 . . . . 62.43 111.676 176.09 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . 0.418 ' HE2' ' HA ' ' A' ' 268' ' ' LEU . 30.3 mtmm -56.63 -50.01 73.28 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 123.082 0.553 . . . . 70.22 110.813 176.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' LEU . . . . . 0.418 ' O ' ' HB2' ' A' ' 276' ' ' TYR . 57.8 mt -51.32 -50.97 58.36 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 124.444 1.09 . . . . 63.4 110.4 175.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -72.73 -34.1 66.84 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 114.158 1.17 . . . . 64.51 114.158 -168.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -78.06 -41.68 34.66 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 122.75 0.42 . . . . 74.35 110.105 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -67.39 -30.8 70.67 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 115.98 -0.555 . . . . 71.44 110.52 174.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . 0.418 ' HB2' ' O ' ' A' ' 272' ' ' LEU . 35.1 t80 -66.15 -62.76 1.31 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.326 1.051 . . . . 75.02 109.596 176.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -60.43 -44.04 96.19 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.525 1.13 . . . . 70.12 111.168 -172.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -63.13 -17.82 62.75 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 112.467 0.543 . . . . 75.41 112.467 -179.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 -128.27 19.62 6.37 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.668 0.787 . . . . 74.13 111.016 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.08 0 CA-C-O 118.786 -0.626 . . . . 72.21 110.552 -174.956 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.482 1.167 0 N-CA-C 108.866 -0.79 . . . . 71.44 108.866 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.6 ' HE3' ' HA ' ' B' ' 2' ' ' LYS . 0.5 OUTLIER -69.31 129.34 39.52 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 123.656 0.597 . . . . 54.1 110.046 -177.22 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 22.7 tm0? -144.71 145.01 31.5 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 108.462 -0.94 . . . . 74.04 108.462 -173.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 72.5 p 54.86 -85.21 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 125.859 1.663 . . . . 52.14 113.041 -178.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 11.3 m -75.01 157.63 34.58 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.018 0.527 . . . . 70.11 110.218 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.597 HG21 ' HA ' ' A' ' 125' ' ' LEU . 36.3 pt -131.43 170.26 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 123.158 0.583 . . . . 64.44 111.071 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -142.04 132.98 25.88 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.583 0.753 . . . . 72.01 109.955 -177.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.452 HD21 HD21 ' A' ' 174' ' ' LEU . 48.5 tp -79.05 154.42 29.46 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.775 0.83 . . . . 75.22 111.338 -173.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -79.17 -63.56 1.39 Allowed 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.349 0.66 . . . . 62.4 112.153 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . 0.4 HD23 ' HB2' ' A' ' 121' ' ' ALA . 86.5 mt 62.91 117.43 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 124.865 1.266 . . . . 74.1 110.566 -163.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 28.2 mt -89.63 -15.89 0.21 Allowed Pre-proline 0 CA--C 1.584 2.278 0 N-CA-C 116.298 1.962 . . . . 45.35 116.298 -176.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.524 ' HD3' HD21 ' A' ' 119' ' ' LEU . 63.8 Cg_endo -67.11 -4.13 11.02 Favored 'Trans proline' 0 C--N 1.406 3.563 0 CA-C-N 124.068 2.489 . . . . 61.33 114.653 -175.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . 0.524 HD23 ' H ' ' B' ' 13' ' ' LEU . 2.1 pt? -128.94 6.54 5.48 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.986 0.915 . . . . 75.01 110.644 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 18.2 tp -102.64 167.49 9.87 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 108.582 -0.896 . . . . 64.54 108.582 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -64.26 115.17 4.78 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 122.677 0.391 . . . . 60.01 110.516 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . 0.402 ' HB ' ' HD2' ' B' ' 17' ' ' PRO . 63.2 p -128.39 176.94 2.37 Favored Pre-proline 0 CA--C 1.559 1.326 0 C-N-CA 124.746 1.218 . . . . 51.11 108.46 176.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' PRO . . . . . 0.402 ' HD2' ' HB ' ' B' ' 16' ' ' THR . 54.7 Cg_exo -47.07 149.01 3.79 Favored 'Trans proline' 0 C--N 1.384 2.437 0 C-N-CA 122.604 2.202 . . . . 62.42 113.563 166.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 15.4 m -76.28 78.63 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 CA-C-O 122.473 1.13 . . . . 61.41 111.522 -174.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 27.3 p -76.64 91.98 3.47 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 114.663 -1.153 . . . . 71.22 110.403 -177.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp 75.21 -51.21 0.66 Allowed 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 126.075 1.75 . . . . 62.34 112.345 177.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.28 100.47 1.05 Allowed 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.954 -0.758 . . . . 75.34 108.954 167.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 -153.25 9.28 0.42 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.241 0.616 . . . . 73.31 112.036 -172.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' THR . . . . . 0.429 ' HB ' ' HD2' ' B' ' 24' ' ' PRO . 26.9 p 59.58 -176.33 0.03 OUTLIER Pre-proline 0 CA--C 1.576 1.946 0 C-N-CA 124.736 1.215 . . . . 72.45 111.279 177.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . 0.429 ' HD2' ' HB ' ' B' ' 23' ' ' THR . 81.4 Cg_exo -54.19 -10.64 2.17 Favored 'Trans proline' 0 C--N 1.392 2.844 0 C-N-CA 122.19 1.927 . . . . 74.55 114.822 165.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 78.83 -32.35 0.15 Allowed 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 126.299 1.84 . . . . 74.53 112.218 174.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -124.04 50.45 3.57 Favored Pre-proline 0 CA--C 1.573 1.834 0 C-N-CA 123.547 0.739 . . . . 75.13 112.097 169.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -85.12 -2.23 9.46 Favored 'Trans proline' 0 C--N 1.397 3.087 0 C-N-CA 121.653 1.569 . . . . 71.1 111.215 169.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 16.8 m -125.15 -152.9 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 C-N-CA 125.749 1.62 . . . . 73.51 108.511 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.466 ' O ' ' HG3' ' B' ' 337' ' ' LYS . 83.5 mt 81.72 -49.8 0.24 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 125.938 1.695 . . . . 62.2 111.325 177.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.468 ' HG3' ' H ' ' B' ' 32' ' ' ARG . 8.7 tp10 68.83 141.65 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.562 1.145 . . . . 70.24 111.841 177.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -87.81 25.1 1.59 Allowed 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.671 0.788 . . . . 74.34 111.704 -179.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' ARG . . . . . 0.468 ' H ' ' HG3' ' B' ' 30' ' ' GLU . 11.1 ptm180 -65.76 -14.14 60.76 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.799 0.84 . . . . 72.22 111.958 174.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . 0.407 ' HB3' ' HG2' ' C' ' 162' ' ' PRO . . . -79.71 18.88 0.71 Allowed 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 124.254 1.021 . . . . 73.31 113.476 -174.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -155.24 92.1 1.4 Allowed 'General case' 0 C--O 1.242 0.683 0 C-N-CA 123.666 0.786 . . . . 53.33 109.679 173.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -76.99 -41.8 41.4 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 116.35 -0.386 . . . . 73.13 109.992 173.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 141.97 -31.68 2.07 Favored Glycine 0 C--N 1.342 0.889 0 CA-C-N 115.515 -0.766 . . . . 74.33 112.212 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . 0.498 ' HA ' ' HG2' ' C' ' 27' ' ' LYS . 24.2 m-20 -70.71 103.58 2.6 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.417 0.687 . . . . 61.44 111.819 -176.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . 0.496 HG22 ' HD2' ' C' ' 23' ' ' LYS . 31.6 mt -129.52 80.44 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 N-CA-C 107.61 -1.256 . . . . 75.44 107.61 172.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 59.3 p 56.13 129.89 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 126.93 2.092 . . . . 64.25 114.95 178.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -87.49 -177.35 0.86 Allowed Pre-proline 0 CA--C 1.573 1.841 0 CA-C-O 117.456 -1.259 . . . . 64.0 108.581 175.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -77.72 -168.18 0.57 Allowed 'Trans proline' 0 C--N 1.4 3.279 0 CA-C-N 122.965 2.095 . . . . 72.44 112.986 -168.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 178.79 -139.98 4.26 Favored Glycine 0 C--N 1.339 0.744 0 N-CA-C 110.501 -1.039 . . . . 45.24 110.501 177.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -81.38 72.56 2.74 Favored Glycine 0 C--N 1.342 0.874 0 N-CA-C 111.893 -0.483 . . . . 42.15 111.893 176.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -83.78 59.23 5.07 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.713 0.805 . . . . 63.2 109.462 177.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.656 ' HG2' ' HA ' ' B' ' 48' ' ' THR . 75.8 ttt180 -73.12 84.06 1.32 Allowed 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.304 1.041 . . . . 74.21 110.46 -169.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 29.1 ttm180 -65.46 129.11 38.56 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.731 1.212 . . . . 75.02 110.042 -178.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 10.4 tt 74.52 -14.81 0.68 Allowed 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 124.991 1.317 . . . . 53.22 111.738 -177.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.656 ' HA ' ' HG2' ' B' ' 45' ' ' ARG . 41.2 m 62.44 -78.25 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.247 1.419 . . . . 51.22 111.988 -171.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.37 69.96 1.12 Allowed Glycine 0 C--N 1.343 0.956 0 N-CA-C 111.395 -0.682 . . . . 74.15 111.395 -173.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 68.78 -79.24 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 125.273 1.429 . . . . 64.2 113.181 173.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 15.9 tp60 57.49 -88.83 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 124.696 1.198 . . . . 75.3 111.842 -172.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 5.6 m -109.04 49.21 0.83 Allowed 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 122.517 1.151 . . . . 73.31 109.244 -175.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -94.43 37.04 1.12 Allowed 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 114.988 -1.006 . . . . 73.24 110.197 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . 66.11 29.9 9.68 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.669 1.188 . . . . 75.51 111.697 175.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 59.4 tp -67.24 -65.47 0.68 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.581 0.753 . . . . 72.35 110.005 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -132.11 14.43 4.69 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.34 1.056 . . . . 73.2 109.725 177.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -83.18 81.27 8.77 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 124.235 1.014 . . . . 75.31 110.094 -170.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 22.6 m -83.31 77.64 9.76 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.252 -0.885 . . . . 62.01 110.179 -177.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . 0.671 ' HG ' ' HA ' ' B' ' 63' ' ' PRO . 2.9 tt 62.74 72.24 0.5 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.804 1.242 . . . . 72.44 109.924 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 18.5 m -73.9 -35.47 64.65 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-N 115.418 -0.81 . . . . 63.51 109.965 174.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -166.86 -56.57 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.88 1.672 . . . . 71.45 106.5 175.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -55.79 120.63 34.3 Favored Pre-proline 0 CA--C 1.547 0.862 0 CA-C-N 113.767 -1.56 . . . . 72.3 109.947 168.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . 0.671 ' HA ' ' HG ' ' B' ' 59' ' ' LEU . 26.5 Cg_endo -61.02 -46.53 15.51 Favored 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 122.765 2.31 . . . . 72.24 111.86 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 67.46 -8.15 0.5 Allowed 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 125.114 1.365 . . . . 72.04 113.574 177.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm 66.44 5.89 4.03 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 125.326 1.45 . . . . 65.32 111.936 -176.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -85.13 108.28 17.61 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 123.864 0.866 . . . . 72.41 110.847 -171.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 4.3 tt -157.94 100.85 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 124.364 1.065 . . . . 72.03 108.706 176.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 57.8 mt 65.84 -76.47 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 125.716 1.607 . . . . 73.4 111.232 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -145.85 -169.23 3.19 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.042 0.937 . . . . 73.12 108.875 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . 0.549 HD23 ' H ' ' B' ' 70' ' ' LEU . 1.5 pt? -55.33 92.04 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.128 0 CA-C-O 121.995 0.902 . . . . 44.44 109.685 167.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 8.3 tp -79.9 -39.09 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 115.115 -0.948 . . . . 74.32 111.087 -172.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.36 106.75 0.43 Allowed Glycine 0 C--O 1.241 0.579 0 N-CA-C 111.309 -0.717 . . . . 62.21 111.309 -169.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -66.98 96.25 0.42 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.761 0.824 . . . . 63.44 109.439 -178.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.85 44.77 60.86 Favored Glycine 0 C--N 1.349 1.301 0 N-CA-C 111.533 -0.627 . . . . 64.42 111.533 -172.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 50.6 mtt 71.01 -63.78 0.41 Allowed 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 125.688 1.595 . . . . 74.01 111.29 -168.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 59.06 38.61 93.25 Favored Glycine 0 C--N 1.355 1.633 0 N-CA-C 112.136 -0.386 . . . . 71.13 112.136 177.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -58.12 -27.64 63.92 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.106 1.363 . . . . 73.03 113.118 -169.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 23.1 t 69.25 59.84 0.32 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.711 1.204 . . . . 51.1 109.263 -175.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -96.6 144.45 26.65 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 114.614 -1.176 . . . . 74.44 111.166 -172.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.478 HG23 ' H ' ' B' ' 81' ' ' THR 0.283 0.0 OUTLIER 49.22 -75.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 C-N-CA 127.242 2.217 . . . . 72.52 114.027 178.634 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . 0.478 ' H ' HG23 ' B' ' 80' ' ' ILE . 8.7 t -80.63 -21.13 41.78 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.79 0.836 . . . . 71.34 110.23 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 73.15 153.86 0.14 Allowed 'General case' 0 C--N 1.354 0.786 0 C-N-CA 125.611 1.564 . . . . 61.11 111.965 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -87.07 67.36 9.7 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.543 0.737 . . . . 71.35 109.749 -176.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 83.2 mtm180 -79.53 95.82 5.94 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 114.935 -1.029 . . . . 73.0 110.39 -178.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -95.34 130.16 42.21 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 123.839 0.856 . . . . 72.23 109.696 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -73.56 118.6 16.71 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.919 -0.771 . . . . 63.12 108.919 174.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.84 87.54 0.53 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.037 0.935 . . . . 52.24 111.911 -171.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -107.27 -41.86 5.0 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.068 0.947 . . . . 74.14 109.414 176.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -146.94 65.67 0.42 Allowed Glycine 0 C--N 1.341 0.858 0 CA-C-N 115.017 -0.992 . . . . 54.33 110.754 -177.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.21 -172.91 2.6 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 123.69 0.796 . . . . 62.33 110.968 178.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -70.53 6.37 6.11 Favored Glycine 0 C--N 1.351 1.384 0 N-CA-C 115.453 0.941 . . . . 70.11 115.453 -172.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -81.92 31.11 2.84 Favored Glycine 0 C--N 1.356 1.642 0 CA-C-N 117.542 0.671 . . . . 23.53 113.804 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -71.94 100.47 2.46 Favored 'General case' 0 C--N 1.351 0.665 0 N-CA-C 109.59 -0.522 . . . . 74.22 109.59 174.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -153.59 94.29 1.77 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.171 -0.677 . . . . 71.21 109.171 173.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . 0.701 ' HG2' ' HB3' ' B' ' 98' ' ' ASP . 24.4 tptm -84.77 -58.41 2.73 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.88 -0.785 . . . . 74.14 108.88 173.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.44 15.91 77.34 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-N 115.707 -0.679 . . . . 72.31 114.076 173.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 10.2 tp -156.1 11.62 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.559 1.311 0 CA-C-O 122.046 0.927 . . . . 72.22 109.535 -178.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . 0.701 ' HB3' ' HG2' ' B' ' 95' ' ' LYS . 6.8 p-10 -80.85 114.38 19.7 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 123.465 0.706 . . . . 75.21 110.134 -178.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' B' ' 323' ' ' GLN . . . -91.44 65.9 5.36 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.528 -0.76 . . . . 61.12 109.098 174.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . 0.479 ' HG ' ' HB2' ' B' ' 98' ' ' ASP . 95.7 mt -98.85 123.84 47.98 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 115.619 -0.719 . . . . 74.2 110.135 -176.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 101' ' ' PRO . . . . . 0.497 ' HA ' ' HG2' ' B' ' 324' ' ' MET . 89.1 Cg_endo -78.42 133.08 11.6 Favored 'Trans proline' 0 C--N 1.375 1.945 0 C-N-CA 122.98 2.453 . . . . 72.21 112.488 178.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . 0.584 HD21 ' HB1' ' B' ' 322' ' ' ALA . 2.5 mm? -90.45 -38.41 13.29 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.341 0.656 . . . . 73.12 109.748 176.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 15.3 t -151.76 -172.36 4.2 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 115.206 -0.906 . . . . 75.52 109.582 -175.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . -71.34 86.26 0.41 Allowed Glycine 0 C--N 1.351 1.401 0 N-CA-C 112.345 -0.302 . . . . 51.35 112.345 177.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 105' ' ' GLN . . . . . 0.533 ' NE2' ' HA ' ' B' ' 326' ' ' ASP . 24.2 tm0? -68.46 113.72 6.25 Favored 'General case' 0 C--N 1.35 0.625 0 N-CA-C 108.828 -0.804 . . . . 75.22 108.828 176.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 14.5 m-30 60.06 -179.73 0.09 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.678 1.191 . . . . 74.44 113.247 -178.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 71.0 p -96.3 34.02 1.67 Allowed 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.696 0.799 . . . . 63.32 112.063 -174.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 26.5 p80 -90.21 38.13 0.92 Allowed 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.584 0.706 . . . . 71.44 110.552 175.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -120.76 -60.9 1.62 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.71 1.204 . . . . 53.33 107.958 -176.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.75 164.92 20.33 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-N 115.198 -0.91 . . . . 71.24 108.731 166.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . 0.743 ' HA ' ' HA ' ' C' ' 243' ' ' PRO . 84.1 mt 64.87 21.58 12.37 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.755 0.822 . . . . 64.15 110.97 -175.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 33.9 t-20 -78.7 135.35 37.15 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.46 0.704 . . . . 73.2 110.258 -170.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 113' ' ' LYS . . . . . 0.517 ' HG2' ' H ' ' B' ' 114' ' ' LYS 0.279 0.0 OUTLIER 32.44 -76.02 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 127.493 2.317 . . . . 75.13 114.129 -166.712 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' B' B ' 114' ' ' LYS . . . . . 0.517 ' H ' ' HG2' ' B' ' 113' ' ' LYS . 1.5 tpmt? -179.45 -162.18 0.04 OUTLIER 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 125.332 1.453 . . . . 74.01 107.232 -174.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 32.0 p -58.82 -63.73 1.19 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.098 0.959 . . . . 73.23 110.496 171.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -94.82 -136.85 8.61 Favored Glycine 0 C--N 1.347 1.141 0 CA-C-N 115.801 -0.636 . . . . 55.33 111.562 175.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . 0.577 ' H ' ' HD2' ' B' ' 118' ' ' PRO . 9.5 mtpm? -147.03 -54.14 0.02 OUTLIER Pre-proline 0 CA--C 1.562 1.436 0 C-N-CA 124.85 1.26 . . . . 70.25 110.771 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 118' ' ' PRO . . . . . 0.577 ' HD2' ' H ' ' B' ' 117' ' ' LYS . 73.3 Cg_endo -73.95 -51.71 0.14 Allowed 'Trans proline' 0 C--N 1.396 3.058 0 C-N-CA 121.37 1.38 . . . . 60.53 114.036 -174.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 119' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -154.47 156.01 35.95 Favored 'General case' 0 C--O 1.243 0.751 0 C-N-CA 124.5 1.12 . . . . 75.33 108.202 -173.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 120' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -131.86 3.81 4.13 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 122.907 0.483 . . . . 70.1 111.215 -169.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 121' ' ' VAL . . . . . 0.42 HG23 ' H ' ' B' ' 122' ' ' THR . 3.7 m -137.49 -63.77 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 C-N-CA 123.287 0.635 . . . . 74.32 112.571 -173.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . 0.42 ' H ' HG23 ' B' ' 121' ' ' VAL . 67.4 m -80.92 -66.35 0.9 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.646 0.778 . . . . 75.24 111.539 -171.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -87.66 -52.01 5.56 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 124.155 0.982 . . . . 64.3 110.676 -174.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 28.8 m 62.01 -107.94 0.27 Allowed 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 125.237 1.415 . . . . 43.31 112.2 177.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . 175.91 138.57 0.06 Allowed 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.196 0.998 . . . . 73.02 109.987 -174.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -155.52 143.14 19.64 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.916 0.886 . . . . 74.13 109.471 177.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 127' ' ' SER . . . . . 0.423 ' HB2' HH22 ' C' ' 154' ' ' ARG . 73.7 p -156.35 179.49 9.2 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 112.485 0.55 . . . . 70.01 112.485 -176.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -76.9 145.94 37.94 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.917 0.887 . . . . 72.01 110.552 172.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 129' ' ' THR . . . . . 0.444 ' HB ' HD21 ' B' ' 155' ' ' LEU . 15.5 m -70.5 -16.5 62.91 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 123.345 0.658 . . . . 54.34 111.958 -179.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . -66.83 153.49 43.28 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.039 0.535 . . . . 44.22 111.297 176.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 131' ' ' TRP . . . . . 0.483 ' HA ' ' HB2' ' C' ' 187' ' ' ARG . 15.8 p90 -57.31 -29.56 64.03 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.527 1.131 . . . . 73.51 112.812 -172.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 132' ' ' SER . . . . . 0.67 ' HB3' HG23 ' B' ' 135' ' ' VAL . 35.6 t -118.56 150.21 40.04 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 123.423 0.689 . . . . 51.4 110.646 178.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 7.3 m -68.92 -29.66 67.97 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 115.623 -0.717 . . . . 62.25 109.315 168.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . -72.38 -5.45 63.12 Favored Glycine 0 C--N 1.355 1.634 0 CA-C-N 114.919 -1.037 . . . . 55.15 114.652 -178.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 135' ' ' VAL . . . . . 0.67 HG23 ' HB3' ' B' ' 132' ' ' SER . 47.6 t -74.44 -37.39 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 CA-C-N 117.554 0.677 . . . . 73.24 109.628 174.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt 68.87 10.37 7.88 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 124.76 1.224 . . . . 52.43 113.108 168.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 10.4 p -68.57 106.23 2.51 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 121.783 -0.573 . . . . 75.31 111.095 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 138' ' ' TYR . . . . . 0.602 ' HB2' ' HG3' ' B' ' 148' ' ' GLU . 49.6 t80 65.11 -75.95 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 125.901 1.681 . . . . 75.52 111.177 -176.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . 0.614 HD21 HD11 ' B' ' 341' ' ' LEU . 63.3 t30 71.94 155.61 0.15 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 125.367 1.467 . . . . 73.24 112.369 176.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . 90.58 50.45 2.93 Favored Glycine 0 C--N 1.348 1.213 0 CA-C-N 116.289 -0.414 . . . . 65.04 113.307 175.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . 75.44 -27.89 0.19 Allowed 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 125.338 1.455 . . . . 75.34 114.781 169.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . 0.261 0.3 OUTLIER 44.56 -81.57 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 125.897 1.679 . . . . 70.15 114.241 -172.369 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 96.23 -44.61 1.99 Allowed Glycine 0 C--N 1.352 1.47 0 N-CA-C 111.87 -0.492 . . . . 61.25 111.87 -175.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 26.1 t -101.18 153.38 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 108.295 -1.002 . . . . 75.31 108.295 173.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 145' ' ' ASP . . . . . 0.476 ' HB3' HE22 ' B' ' 397' ' ' GLN . 3.5 p-10 -63.43 -49.05 75.26 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 109.683 -0.488 . . . . 64.3 109.683 176.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 68.0 mt 66.28 -12.32 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.56 1.345 0 C-N-CA 125.696 1.599 . . . . 72.52 112.366 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 19.0 p-80 32.88 74.62 0.05 Allowed 'General case' 0 C--N 1.372 1.586 0 C-N-CA 125.482 1.513 . . . . 72.43 111.169 -163.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . 0.602 ' HG3' ' HB2' ' B' ' 138' ' ' TYR . 4.4 tm-20 -54.31 132.97 44.89 Favored 'General case' 0 C--N 1.358 0.953 0 CA-C-N 113.875 -1.511 . . . . 73.05 109.56 -172.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 149' ' ' LYS . . . . . 0.446 ' HG2' ' HB3' ' A' ' 182' ' ' PRO . 36.0 mtmm 73.54 -77.47 0.05 Allowed 'General case' 0 N--CA 1.478 0.935 0 O-C-N 125.188 1.555 . . . . 72.23 109.388 -163.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 25.4 t0 171.84 163.9 0.1 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 125.857 1.663 . . . . 74.11 108.509 174.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 151' ' ' HIS . . . . . 0.439 ' HB3' ' HD2' ' B' ' 152' ' ' PRO . 98.6 m-70 69.92 171.82 0.1 Allowed Pre-proline 0 CA--C 1.565 1.544 0 C-N-CA 124.366 1.066 . . . . 74.43 111.981 173.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 152' ' ' PRO . . . . . 0.439 ' HD2' ' HB3' ' B' ' 151' ' ' HIS . 25.0 Cg_endo -62.47 -177.18 0.28 Allowed 'Trans proline' 0 C--N 1.389 2.692 0 C-N-CA 122.509 2.14 . . . . 42.51 113.47 169.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 62.2 m 77.98 -52.37 0.51 Allowed 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 125.668 1.587 . . . . 74.2 110.552 -174.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 60.6 mt 61.58 -83.6 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 125.005 1.322 . . . . 74.25 111.946 170.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 155' ' ' LEU . . . . . 0.444 HD21 ' HB ' ' B' ' 129' ' ' THR . 1.0 OUTLIER -114.68 38.57 3.08 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.807 0.843 . . . . 72.1 110.851 -175.257 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 78.06 -27.32 0.17 Allowed 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 125.701 1.6 . . . . 72.23 112.127 -177.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 157' ' ' MET . . . . . 0.597 ' HB3' ' HG2' ' C' ' 252' ' ' GLU . 53.0 mtt 65.26 23.92 12.2 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.094 0.957 . . . . 53.54 111.394 -174.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 158' ' ' ALA . . . . . . . . . . . . . . . 70.34 -65.34 0.33 Allowed 'General case' 0 C--N 1.362 1.145 0 C-N-CA 125.788 1.635 . . . . 34.04 111.582 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . 0.405 ' HA ' HG21 ' C' ' 196' ' ' THR . 87.7 mttt 61.46 61.4 1.51 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.023 1.329 . . . . 55.45 111.179 177.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -72.17 153.24 41.74 Favored 'General case' 0 C--O 1.247 0.97 0 CA-C-N 114.338 -1.301 . . . . 70.22 108.9 167.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . 75.6 145.15 0.08 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.87 1.268 . . . . 71.1 112.619 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 162' ' ' GLY . . . . . 0.482 ' H ' ' HB2' ' B' ' 356' ' ' ASN . . . 159.39 -45.59 0.44 Allowed Glycine 0 C--N 1.352 1.449 0 CA-C-N 115.918 -0.583 . . . . 73.4 111.908 -176.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 1.6 pp -130.01 141.24 50.77 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.111 0.964 . . . . 65.02 109.739 175.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 164' ' ' ALA . . . . . . . . . . . . . . . -70.97 102.69 2.47 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.468 0.707 . . . . 75.34 111.183 -172.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 11.8 p -88.0 96.25 10.43 Favored 'General case' 0 C--O 1.244 0.769 0 C-N-CA 123.288 0.635 . . . . 64.15 109.857 174.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . -81.44 54.62 4.79 Favored Glycine 0 C--N 1.349 1.303 0 CA-C-N 115.703 -0.68 . . . . 71.15 112.666 178.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 167' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -148.44 2.04 0.63 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.601 1.16 . . . . 72.31 108.765 178.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 10.3 p -166.63 40.12 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.114 0 CA-C-O 122.596 1.189 . . . . 74.13 108.592 -173.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 13.3 m -56.91 -26.46 59.28 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 114.076 -1.42 . . . . 54.35 112.84 -173.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 3.8 m -144.8 -72.31 0.26 Allowed 'General case' 0 C--O 1.24 0.601 0 N-CA-C 107.704 -1.221 . . . . 63.1 107.704 176.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . 174.72 58.19 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.788 1.635 . . . . 53.32 107.193 -174.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 172' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -61.61 97.47 0.07 Allowed 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.636 -0.711 . . . . 73.22 111.002 -175.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 173' ' ' LEU . . . . . . . . . . . . . 1.7 pp -83.24 6.5 19.31 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.957 0.903 . . . . 74.23 111.75 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 174' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -73.12 77.34 1.25 Allowed 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.821 0.848 . . . . 74.45 108.801 173.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 175' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -153.86 158.66 41.12 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-N 114.581 -1.19 . . . . 74.1 108.888 -171.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -151.74 35.06 0.55 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.782 0.833 . . . . 74.11 110.673 -176.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 97.4 m -64.42 126.28 90.22 Favored Pre-proline 0 CA--C 1.555 1.155 0 CA-C-N 115.701 -0.681 . . . . 64.31 109.621 172.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 178' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -81.79 51.38 3.82 Favored 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 123.308 2.672 . . . . 74.53 112.989 -176.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -135.38 96.95 3.57 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.623 0.769 . . . . 61.34 109.441 177.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . -70.81 -36.91 73.19 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.182 0.593 . . . . 74.4 110.547 175.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 13.1 tp -159.72 18.77 0.16 Allowed 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 114.629 -1.169 . . . . 62.04 109.179 176.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 182' ' ' VAL . . . . . 0.602 HG22 ' HA ' ' C' ' 138' ' ' VAL . 55.9 t -76.86 107.0 7.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 116.089 -0.505 . . . . 71.31 111.119 -169.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 183' ' ' ALA . . . . . 0.426 ' HB2' ' HB3' ' C' ' 123' ' ' LEU . . . -86.62 -36.4 18.84 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.13 -0.941 . . . . 65.24 110.214 170.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 184' ' ' HIS . . . . . 0.525 ' HB2' HG12 ' B' ' 182' ' ' VAL . 6.3 t-80 58.42 28.88 17.46 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 125.259 1.424 . . . . 74.15 112.382 171.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 185' ' ' VAL . . . . . . . . . . . . . 53.5 t 59.92 76.83 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 124.226 1.01 . . . . 71.33 109.443 -168.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 186' ' ' THR . . . . . 0.682 HG22 ' HG2' ' C' ' 122' ' ' GLU . 59.6 p 52.64 76.74 0.18 Allowed 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 125.452 1.501 . . . . 51.31 112.422 176.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 187' ' ' SER . . . . . 0.496 ' HB3' ' HB3' ' B' ' 184' ' ' HIS . 32.6 t -148.58 133.46 18.04 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 123.465 0.706 . . . . 62.14 109.4 -177.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -133.14 124.65 27.91 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.659 0.784 . . . . 71.52 110.363 -177.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -109.47 161.05 15.69 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 108.67 -0.863 . . . . 72.52 108.67 164.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 190' ' ' CYS . . . . . . . . . . . . . 77.8 m -148.05 132.83 17.95 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.529 0.732 . . . . 70.33 109.85 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -87.14 130.83 34.36 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 109.376 -0.602 . . . . 74.04 109.376 175.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . 0.617 ' H ' ' HG2' ' B' ' 312' ' ' PRO . . . -71.2 127.62 14.91 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-O 117.778 -1.568 . . . . 64.22 110.463 174.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 193' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -47.18 -30.11 10.13 Favored 'Trans proline' 0 C--N 1.388 2.656 0 C-N-CA 124.235 3.29 . . . . 64.32 114.993 -169.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 194' ' ' SER . . . . . . . . . . . . . 37.1 m 72.27 -66.48 0.3 Allowed 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.729 1.612 . . . . 24.51 111.547 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 195' ' ' ALA . . . . . . . . . . . . . . . -86.21 154.52 21.24 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 123.256 0.623 . . . . 74.32 109.694 173.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 59.3 m -73.36 -66.04 0.74 Allowed 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.701 0.8 . . . . 73.32 110.2 178.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 42.4 t -170.25 99.74 0.27 Allowed 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 109.045 -0.724 . . . . 75.11 109.045 177.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 198' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -92.47 6.49 46.91 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.324 0.649 . . . . 51.12 111.373 178.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 63.6 mttm 74.11 -63.13 0.44 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 125.9 1.68 . . . . 74.4 109.937 -173.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 200' ' ' CYS . . . . . . . . . . . . . 70.9 m 72.66 108.08 0.03 OUTLIER Pre-proline 0 N--CA 1.481 1.118 0 C-N-CA 125.595 1.558 . . . . 73.31 111.213 178.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 201' ' ' PRO . . . . . 0.539 ' HA ' ' HG2' ' B' ' 363' ' ' GLU . 31.7 Cg_exo -59.86 99.32 0.13 Allowed 'Trans proline' 0 C--N 1.38 2.205 0 C-N-CA 122.769 2.312 . . . . 71.34 112.804 175.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 153.07 26.17 0.04 OUTLIER Glycine 0 C--N 1.351 1.41 0 CA-C-N 115.91 -0.586 . . . . 63.04 113.525 178.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -79.82 -31.78 40.65 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 117.343 0.571 . . . . 71.33 110.663 175.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -146.17 132.04 19.09 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 123.129 0.572 . . . . 74.01 110.212 178.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 205' ' ' LEU . . . . . . . . . . . . . 47.2 tp -71.0 -48.58 52.37 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.766 0.827 . . . . 51.03 109.166 173.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.1 -127.22 0.14 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.468 1.107 . . . . 62.32 109.042 175.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 12.7 mptt 64.5 -75.99 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 124.473 1.109 . . . . 74.32 110.336 -167.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 111.08 147.44 10.99 Favored Glycine 0 C--N 1.349 1.283 0 N-CA-C 111.484 -0.646 . . . . 71.52 111.484 -177.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . -78.6 -31.23 46.0 Favored Glycine 0 N--CA 1.466 0.675 0 N-CA-C 111.774 -0.53 . . . . 42.21 111.774 175.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 210' ' ' LYS . . . . . 0.655 ' HB3' ' HG2' ' B' ' 235' ' ' GLU . 60.5 mttm 60.04 -85.81 0.02 OUTLIER 'General case' 0 C--N 1.365 1.259 0 C-N-CA 124.891 1.277 . . . . 74.51 112.134 168.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . -80.17 73.06 2.53 Favored Glycine 0 C--N 1.353 1.519 0 N-CA-C 108.975 -1.65 . . . . 74.43 108.975 167.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 23.1 t -78.12 71.87 4.61 Favored 'General case' 0 C--N 1.357 0.902 0 C-N-CA 124.278 1.031 . . . . 74.04 110.559 -173.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 18.9 pt -112.14 33.02 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.625 1.57 . . . . 64.4 107.976 177.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 76.4 p -70.34 -27.0 64.01 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.905 1.282 . . . . 75.43 112.346 -169.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 215' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -77.79 -24.85 48.73 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 115.799 -0.637 . . . . 73.31 110.176 174.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 19.5 tm0? 77.24 -63.62 0.35 Allowed 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 125.814 1.645 . . . . 61.42 112.667 168.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . 0.439 HD23 HD13 ' B' ' 218' ' ' LEU . 3.6 tt -72.19 82.42 1.0 Allowed 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.327 1.051 . . . . 75.4 110.914 -169.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . 0.439 HD13 HD23 ' B' ' 217' ' ' LEU . 9.2 mp 63.65 -70.98 0.06 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.833 1.653 . . . . 71.43 113.932 167.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 77.24 -35.06 0.21 Allowed 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 126.053 1.741 . . . . 71.24 111.488 -178.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . 0.61 ' HA ' HD22 ' B' ' 226' ' ' LEU . . . -68.68 -7.87 37.32 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.366 0.666 . . . . 61.1 111.382 164.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 221' ' ' ARG . . . . . . . . . . . . . 44.7 mtp180 70.99 -80.07 0.04 OUTLIER 'General case' 0 C--N 1.364 1.216 0 C-N-CA 125.814 1.646 . . . . 73.55 110.973 172.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -150.45 0.32 0.43 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.699 0.799 . . . . 42.52 110.487 175.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -73.84 -19.31 60.77 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.827 1.251 . . . . 61.02 111.445 -177.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 58.8 t 66.55 -73.07 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 125.441 1.496 . . . . 74.2 111.253 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 4.3 t -69.8 -43.17 72.64 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.931 0.892 . . . . 54.34 110.947 175.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . 0.61 HD22 ' HA ' ' B' ' 220' ' ' ALA . 22.3 tp 58.86 -75.32 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.506 1.522 . . . . 74.43 111.91 -175.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . -170.63 30.57 0.13 Allowed Glycine 0 C--N 1.338 0.659 0 N-CA-C 111.446 -0.662 . . . . 51.31 111.446 176.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 84.62 -46.43 3.67 Favored Glycine 0 C--N 1.348 1.217 0 N-CA-C 112.139 -0.384 . . . . 72.41 112.139 -172.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . 70.21 -91.2 0.37 Allowed Glycine 0 C--N 1.356 1.66 0 C-N-CA 123.175 0.417 . . . . 70.24 112.634 174.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -69.34 -43.63 73.29 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.065 0.546 . . . . 70.23 110.132 174.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 231' ' ' LYS . . . . . . . . . . . . . 45.3 mttp 62.44 -75.87 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 125.893 1.677 . . . . 73.24 111.638 178.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 33.2 m -65.1 98.12 0.28 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.322 1.049 . . . . 74.24 110.789 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -72.66 112.98 9.2 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 115.327 -0.851 . . . . 70.41 108.853 172.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -139.81 -169.95 2.83 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.415 0.686 . . . . 72.31 110.679 -174.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . 0.681 ' HG3' ' HE2' ' C' ' 209' ' ' LYS . 17.5 tp10 78.79 134.13 0.06 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.847 1.659 . . . . 54.41 111.517 178.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 236' ' ' THR . . . . . 0.673 HG23 HD21 ' B' ' 247' ' ' LEU . 88.9 m -118.27 -62.78 1.5 Allowed 'General case' 0 C--O 1.241 0.64 0 CA-C-N 115.13 -0.941 . . . . 73.34 110.527 -174.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -170.32 155.08 5.08 Favored 'General case' 0 C--N 1.351 0.652 0 O-C-N 123.538 0.524 . . . . 71.12 111.389 -171.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 41.0 m -146.31 27.72 1.13 Allowed 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 122.986 1.374 . . . . 71.31 107.752 166.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 239' ' ' ALA . . . . . 0.733 ' HB2' ' H ' ' C' ' 222' ' ' ALA . . . -97.32 -173.67 2.73 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 114.329 -1.305 . . . . 74.42 111.945 -173.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . -117.1 -151.9 9.49 Favored Glycine 0 C--N 1.341 0.848 0 CA-C-N 114.799 -1.091 . . . . 71.23 111.06 178.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -110.39 141.68 43.12 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.941 0.896 . . . . 71.21 112.026 -165.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 242' ' ' TRP . . . . . 0.428 ' HB3' ' HA ' ' C' ' 233' ' ' LEU . 0.4 OUTLIER -171.09 -39.55 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.584 1.154 . . . . 70.32 109.577 174.231 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 243' ' ' GLN . . . . . 0.766 ' HA ' ' HA ' ' B' ' 378' ' ' ALA . 12.6 pt20 -157.36 162.93 39.08 Favored 'General case' 0 C--O 1.244 0.791 0 C-N-CA 124.47 1.108 . . . . 74.22 108.881 169.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -69.07 116.78 7.46 Favored Glycine 0 C--N 1.351 1.384 0 N-CA-C 111.896 -0.482 . . . . 63.11 111.896 -175.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 245' ' ' LYS . . . . . 0.565 ' HE2' ' HB1' ' C' ' 222' ' ' ALA . 9.2 tmtm? -85.1 112.28 20.52 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 117.245 0.522 . . . . 75.34 110.474 -175.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 60.7 p -95.78 149.95 20.94 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.556 0.742 . . . . 71.02 109.005 167.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 247' ' ' LEU . . . . . 0.673 HD21 HG23 ' B' ' 236' ' ' THR . 97.8 mt -83.46 -177.06 6.6 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.845 0.858 . . . . 72.51 112.574 -172.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 248' ' ' ARG . . . . . 0.479 ' HA ' ' HE ' ' B' ' 248' ' ' ARG . 1.5 tpm_? -105.92 148.97 27.03 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.37 1.068 . . . . 75.15 109.035 173.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -130.05 137.32 50.17 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 107.495 -1.298 . . . . 71.33 107.495 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -88.95 40.28 0.97 Allowed 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 124.248 1.019 . . . . 65.4 111.488 -171.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 251' ' ' ALA . . . . . . . . . . . . . . . -59.56 -53.54 56.92 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.047 0.939 . . . . 61.03 111.876 -178.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -101.49 -15.64 17.07 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 124.271 1.028 . . . . 72.3 111.359 -178.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -68.87 -32.99 73.04 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.872 0.469 . . . . 51.41 111.066 174.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -72.09 92.48 1.33 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 122.953 0.501 . . . . 72.51 109.85 175.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . 59.24 -96.45 0.08 OUTLIER Glycine 0 C--N 1.353 1.495 0 O-C-N 123.745 0.653 . . . . 54.22 112.474 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 256' ' ' TYR . . . . . . . . . . . . . 22.9 t80 61.5 -74.7 0.03 OUTLIER 'General case' 0 C--N 1.363 1.156 0 C-N-CA 126.247 1.819 . . . . 52.52 111.16 178.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 257' ' ' GLN . . . . . 0.424 ' NE2' ' H ' ' B' ' 257' ' ' GLN . 2.2 mp0 -64.06 -62.11 1.84 Allowed 'General case' 0 C--N 1.35 0.605 0 C-N-CA 124.163 0.985 . . . . 74.31 108.537 176.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 258' ' ' LEU . . . . . . . . . . . . . 1.5 tt 56.11 -84.75 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 125.603 1.561 . . . . 75.13 110.708 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . 0.516 ' HA ' ' HB3' ' B' ' 262' ' ' ALA . 62.2 t -85.21 97.23 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 123.199 0.6 . . . . 63.02 109.491 178.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 260' ' ' SER . . . . . . . . . . . . . 22.2 m -134.4 96.16 3.53 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 107.159 -1.422 . . . . 73.11 107.159 173.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 61.33 32.28 19.2 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.118 0.967 . . . . 52.21 110.333 -168.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 262' ' ' ALA . . . . . 0.516 ' HB3' ' HA ' ' B' ' 259' ' ' VAL . . . -128.47 39.96 3.73 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.213 1.005 . . . . 43.43 110.536 -174.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -63.22 -38.93 93.11 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 116.047 -0.524 . . . . 70.44 110.214 173.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 33.4 t -88.23 168.45 12.72 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 114.8 -1.091 . . . . 51.14 110.168 175.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 265' ' ' LEU . . . . . . . . . . . . . 90.9 mt -90.13 32.03 0.95 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.788 0.835 . . . . 64.12 111.337 -177.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 266' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 69.82 -65.91 0.29 Allowed 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 125.962 1.705 . . . . 71.52 111.25 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 33.5 m -139.8 -63.82 0.5 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.216 1.006 . . . . 73.13 108.4 173.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 11.4 p -174.12 -32.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 124.209 1.003 . . . . 74.44 110.038 -178.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 269' ' ' THR . . . . . . . . . . . . . 35.0 m -68.51 91.24 0.4 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.777 0.831 . . . . 74.31 111.515 -173.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 270' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.48 -175.78 4.98 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.004 1.322 . . . . 72.41 108.436 175.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 271' ' ' ALA . . . . . 0.533 ' HB3' ' HB3' ' B' ' 275' ' ' LYS . . . -120.8 53.49 1.12 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 122.893 0.477 . . . . 75.3 110.786 -175.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 272' ' ' ASN . . . . . 0.536 ' O ' ' HG3' ' B' ' 275' ' ' LYS . 42.7 m-80 61.14 -157.91 0.33 Allowed 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.25 1.02 . . . . 54.14 111.303 176.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -70.14 -7.42 41.54 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.774 -0.579 . . . . 61.32 111.433 170.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -85.09 4.93 31.85 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.094 0.958 . . . . 71.44 112.278 -176.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 275' ' ' LYS . . . . . 0.536 ' HG3' ' O ' ' B' ' 272' ' ' ASN . 2.2 pptp? -94.82 109.42 43.81 Favored Pre-proline 0 CA--C 1.555 1.137 0 CA-C-N 118.31 0.505 . . . . 71.33 111.134 177.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -89.12 151.44 5.67 Favored 'Trans proline' 0 C--N 1.377 2.028 0 C-N-CA 122.683 2.256 . . . . 62.35 111.564 170.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 277' ' ' LEU . . . . . . . . . . . . . 4.2 tt -90.78 99.94 12.88 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 107.222 -1.399 . . . . 63.32 107.222 176.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -64.75 -36.09 83.19 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.657 0.783 . . . . 62.0 111.725 -175.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . 92.3 36.03 6.4 Favored Glycine 0 C--N 1.346 1.118 0 CA-C-N 116.263 -0.426 . . . . 75.43 114.05 174.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -155.93 178.49 10.21 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.284 0.634 . . . . 53.23 110.029 172.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -65.47 107.98 1.85 Allowed 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 108.9 -0.778 . . . . 75.31 108.9 176.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -84.41 35.7 0.56 Allowed 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.433 0.901 . . . . 65.41 113.433 -167.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -160.71 -97.08 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 122.785 0.434 . . . . 72.33 110.501 175.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . 144.8 -90.29 0.16 Allowed Glycine 0 C--N 1.355 1.594 0 N-CA-C 111.374 -0.691 . . . . 61.45 111.374 -172.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -146.28 5.92 0.97 Allowed 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 124.15 0.98 . . . . 72.41 111.221 -175.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 286' ' ' MET . . . . . . . . . . . . . 14.8 tpt -60.14 -56.93 30.62 Favored Pre-proline 0 CA--C 1.566 1.576 0 N-CA-C 114.787 1.403 . . . . 64.1 114.787 -165.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 287' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -90.58 35.39 0.32 Allowed 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 122.28 1.987 . . . . 73.33 111.622 -173.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 288' ' ' VAL . . . . . 0.616 HG13 ' H ' ' B' ' 289' ' ' ARG 0.288 7.2 p 41.07 -86.3 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.282 0 C-N-CA 125.941 1.697 . . . . 74.32 111.936 -163.887 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 289' ' ' ARG . . . . . 0.616 ' H ' HG13 ' B' ' 288' ' ' VAL . 7.0 tpm_? 53.41 37.7 26.16 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 122.451 1.119 . . . . 72.14 111.321 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 290' ' ' TRP . . . . . . . . . . . . . 64.7 t90 -63.25 114.72 3.96 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 114.451 -1.25 . . . . 75.34 111.395 -175.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 291' ' ' LEU . . . . . . . . . . . . . 53.9 mt 56.02 -78.25 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 126.799 2.04 . . . . 64.34 113.804 175.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . -176.83 -98.92 0.11 Allowed Glycine 0 CA--C 1.525 0.689 0 CA-C-O 118.741 -1.033 . . . . 62.12 110.777 -178.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.08 87.75 0.24 Allowed 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 122.843 2.362 . . . . 51.12 111.419 172.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 8.2 mtpm? -65.42 -32.33 73.89 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 114.799 -1.091 . . . . 41.23 111.287 -177.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -125.29 113.08 17.13 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 123.869 0.867 . . . . 34.32 109.015 171.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 6.4 t -72.57 150.94 42.68 Favored 'General case' 0 C--O 1.244 0.815 0 N-CA-C 109.336 -0.616 . . . . 65.42 109.336 171.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -73.11 -85.26 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 108.805 -0.813 . . . . 64.12 108.805 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 164.53 -158.15 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 126.786 2.034 . . . . 71.5 107.054 -179.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . 98.42 -73.29 0.58 Allowed Glycine 0 C--N 1.337 0.633 0 N-CA-C 111.705 -0.558 . . . . 63.41 111.705 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -98.48 11.37 38.46 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.303 0.641 . . . . 72.23 111.667 -172.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 301' ' ' ILE . . . . . . . . . . . . . 42.8 pt -119.68 12.3 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 C-N-CA 123.131 0.572 . . . . 72.24 111.058 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -91.95 27.2 2.19 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.737 0.815 . . . . 63.41 111.82 -174.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 303' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -66.2 142.81 98.06 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 124.164 0.985 . . . . 74.11 110.364 177.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 304' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -49.04 -23.89 6.84 Favored 'Trans proline' 0 C--N 1.388 2.606 0 C-N-CA 124.787 3.658 . . . . 75.12 116.032 -171.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -59.55 -43.02 93.66 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.612 0.765 . . . . 42.33 112.0 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 28.1 m -111.97 -33.38 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 123.271 0.628 . . . . 72.33 111.24 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 9.8 m 66.74 -74.3 0.07 Allowed 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 126.325 1.85 . . . . 74.23 110.727 -174.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 308' ' ' CYS . . . . . . . . . . . . . 40.9 m -122.34 -20.39 6.15 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.439 0.695 . . . . 74.22 110.281 175.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . . . . . . . . 0.25 73.5 m 112.9 -59.43 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.14 0 C-N-CA 128.558 2.743 . . . . 72.2 112.021 177.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -90.92 35.77 0.3 Allowed 'Trans proline' 0 C--N 1.394 2.923 0 C-N-CA 122.614 2.21 . . . . 63.14 113.378 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 311' ' ' ASN . . . . . 0.429 ' HB2' ' HD3' ' B' ' 312' ' ' PRO . 11.7 m120 -76.82 -53.79 1.78 Allowed Pre-proline 0 CA--C 1.561 1.37 0 C-N-CA 123.437 0.695 . . . . 73.13 112.014 -178.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 312' ' ' PRO . . . . . 0.617 ' HG2' ' H ' ' B' ' 192' ' ' GLY . 69.6 Cg_endo -95.47 59.06 0.19 Allowed 'Trans proline' 0 C--N 1.385 2.462 0 C-N-CA 122.204 1.936 . . . . 70.14 112.341 -178.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 313' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -71.58 84.4 0.86 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.182 0.593 . . . . 75.13 111.223 178.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 314' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -111.66 75.32 0.91 Allowed 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 107.592 -1.262 . . . . 72.01 107.592 168.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 315' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -155.06 102.55 2.33 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.066 -0.97 . . . . 72.12 108.603 -176.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 316' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -87.49 -49.89 6.9 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.518 -0.919 . . . . 74.4 108.518 172.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 85.0 p 54.64 -74.29 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 126.146 1.778 . . . . 75.41 111.551 -173.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 318' ' ' VAL . . . . . 0.418 HG23 ' HB2' ' B' ' 95' ' ' LYS . 26.5 m 39.79 55.76 6.43 Favored Pre-proline 0 N--CA 1.488 1.448 0 C-N-CA 126.58 1.952 . . . . 73.13 113.724 177.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 319' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -62.81 138.69 70.33 Favored 'Trans proline' 0 C--N 1.387 2.574 0 C-N-CA 122.76 2.307 . . . . 65.1 111.972 -168.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 320' ' ' THR . . . . . . . . . . . . . 52.9 m -149.06 -60.78 0.22 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.411 0.684 . . . . 53.31 110.215 -172.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 321' ' ' LEU . . . . . 0.79 HD12 ' HB2' ' B' ' 323' ' ' GLN . 0.1 OUTLIER -70.26 -56.69 6.14 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.923 0.889 . . . . 65.14 110.305 -171.568 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 322' ' ' ALA . . . . . 0.584 ' HB1' HD21 ' B' ' 102' ' ' LEU . . . 60.16 36.28 21.06 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 124.274 1.03 . . . . 64.54 111.639 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 323' ' ' GLN . . . . . 0.79 ' HB2' HD12 ' B' ' 321' ' ' LEU . 24.2 tp60 -73.91 110.88 8.55 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 108.553 -0.906 . . . . 74.02 108.553 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 324' ' ' MET . . . . . 0.497 ' HG2' ' HA ' ' B' ' 101' ' ' PRO . 76.0 mtm -85.55 41.65 0.91 Allowed 'General case' 0 CA--C 1.556 1.174 0 N-CA-C 113.278 0.844 . . . . 71.32 113.278 -164.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 325' ' ' THR . . . . . . . . . . . . . 57.7 m 70.67 -59.17 0.54 Allowed 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 126.24 1.816 . . . . 72.33 111.654 177.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 326' ' ' ASP . . . . . 0.533 ' HA ' ' NE2' ' B' ' 105' ' ' GLN . 19.7 m-20 75.0 17.33 2.73 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.118 1.367 . . . . 72.01 112.461 171.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -105.1 126.56 52.21 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 108.483 -0.932 . . . . 54.34 108.483 173.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 328' ' ' ALA . . . . . 0.432 ' H ' HD12 ' B' ' 329' ' ' ILE . . . -142.0 0.15 1.36 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.373 0.669 . . . . 72.03 111.517 -179.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 329' ' ' ILE . . . . . 0.432 HD12 ' H ' ' B' ' 328' ' ' ALA . 3.0 mp -85.17 106.89 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 N-CA-C 108.96 -0.756 . . . . 73.5 108.96 -170.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 330' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 69.94 130.94 0.03 OUTLIER 'General case' 0 CA--C 1.561 1.387 0 C-N-CA 126.896 2.078 . . . . 63.42 111.826 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 331' ' ' LEU . . . . . 0.4 HD12 HD22 ' B' ' 332' ' ' LEU . 0.4 OUTLIER -140.85 18.38 2.32 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.345 1.058 . . . . 63.34 110.861 -172.216 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 332' ' ' LEU . . . . . 0.4 HD22 HD12 ' B' ' 331' ' ' LEU . 2.4 pt? -146.12 -163.82 1.82 Allowed 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.324 0.649 . . . . 74.41 111.267 -170.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 333' ' ' SER . . . . . . . . . . . . . 16.0 t 68.1 5.66 4.76 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.291 1.036 . . . . 65.04 113.323 164.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 12.6 ptmt -70.16 -40.55 74.65 Favored 'General case' 0 C--N 1.354 0.796 0 C-N-CA 122.691 0.396 . . . . 63.11 110.448 177.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 335' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 68.32 139.28 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 125.56 1.544 . . . . 73.25 111.686 -177.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 336' ' ' GLU . . . . . 0.403 ' HB2' ' HA ' ' B' ' 118' ' ' PRO . 46.7 mt-10 -135.75 -164.37 1.53 Allowed 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.477 1.111 . . . . 61.02 108.542 176.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 337' ' ' LYS . . . . . 0.466 ' HG3' ' O ' ' B' ' 29' ' ' LEU . 7.8 tmtt? -130.32 132.6 45.94 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 107.201 -1.407 . . . . 62.43 107.201 169.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 338' ' ' GLY . . . . . . . . . . . . . . . -82.36 48.15 3.89 Favored Glycine 0 C--N 1.35 1.308 0 O-C-N 123.302 0.376 . . . . 72.34 113.722 -175.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 339' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -89.68 20.81 3.8 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.897 0.879 . . . . 74.33 109.147 173.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 340' ' ' PHE . . . . . 0.406 ' HA ' ' O ' ' C' ' 158' ' ' VAL . 21.9 m-85 -72.0 -2.11 17.03 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.53 1.132 . . . . 75.24 112.06 -177.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 341' ' ' LEU . . . . . 0.614 HD11 HD21 ' B' ' 139' ' ' ASN . 1.8 tm? -73.52 -51.33 17.41 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.824 0.85 . . . . 75.34 109.08 175.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 342' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 60.35 -130.78 0.9 Allowed 'General case' 0 CA--C 1.565 1.548 0 C-N-CA 124.381 1.072 . . . . 64.25 109.44 -178.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 343' ' ' VAL . . . . . . . . . . . . . 11.6 p -158.78 41.1 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.243 0 CA-C-O 122.425 1.107 . . . . 64.24 108.895 178.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -63.84 143.58 57.73 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 115.042 -0.981 . . . . 73.03 110.96 177.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 345' ' ' GLY . . . . . . . . . . . . . . . -157.68 47.2 0.46 Allowed Glycine 0 C--N 1.345 1.069 0 CA-C-N 115.821 -0.627 . . . . 62.31 111.77 -178.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 346' ' ' ALA . . . . . . . . . . . . . . . -152.04 -81.66 0.1 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.389 0.676 . . . . 72.22 109.52 176.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 62.1 m 59.06 -80.76 0.02 OUTLIER 'General case' 0 C--N 1.365 1.277 0 C-N-CA 124.795 1.238 . . . . 72.21 112.362 -177.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 348' ' ' ILE . . . . . 0.425 ' O ' ' HG2' ' B' ' 351' ' ' GLN . 2.0 pp -102.56 -3.99 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 123.994 0.917 . . . . 73.42 111.847 -176.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 349' ' ' ASP . . . . . . . . . . . . . 31.7 t70 69.54 -78.44 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.698 1.199 . . . . 71.13 109.642 -175.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 350' ' ' LYS . . . . . . . . . . . . . 9.3 mptt -134.17 -67.68 0.58 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.652 -0.869 . . . . 74.52 108.652 167.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 351' ' ' GLN . . . . . 0.425 ' HG2' ' O ' ' B' ' 348' ' ' ILE . 86.7 mm-40 63.4 167.98 0.14 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 125.041 1.336 . . . . 71.32 111.985 -174.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -87.47 -23.32 24.49 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.138 -0.69 . . . . 74.35 109.138 174.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 353' ' ' HIS . . . . . . . . . . . . . 14.5 p80 52.54 18.35 0.95 Allowed 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 126.984 2.114 . . . . 74.33 114.017 173.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 354' ' ' ALA . . . . . 0.453 ' HB1' ' HA3' ' B' ' 162' ' ' GLY . . . -101.32 49.43 0.87 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.796 0.838 . . . . 70.11 110.364 -177.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 355' ' ' ALA . . . . . . . . . . . . . . . -71.6 107.45 4.47 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.135 0.574 . . . . 75.44 110.214 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 356' ' ' ASN . . . . . 0.482 ' HB2' ' H ' ' B' ' 162' ' ' GLY . 0.2 OUTLIER -101.16 120.54 54.8 Favored Pre-proline 0 N--CA 1.48 1.068 0 C-N-CA 123.192 0.597 . . . . 74.32 109.474 -173.571 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 357' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -67.07 150.54 82.43 Favored 'Trans proline' 0 C--N 1.372 1.813 0 C-N-CA 122.817 2.344 . . . . 55.22 111.588 171.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 358' ' ' CYS . . . . . . . . . . . . . 66.0 m -136.05 11.51 3.33 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.561 0.744 . . . . 73.32 111.54 -177.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 359' ' ' GLY . . . . . . . . . . . . . . . -139.43 156.82 24.82 Favored Glycine 0 C--N 1.347 1.186 0 N-CA-C 111.749 -0.54 . . . . 62.01 111.749 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 360' ' ' GLN . . . . . 0.478 ' HB2' ' HD2' ' C' ' 211' ' ' ARG . 23.5 pt20 -164.68 79.79 0.36 Allowed 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 122.791 0.436 . . . . 53.34 111.705 -175.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 361' ' ' ILE . . . . . . . . . . . . . 66.0 mt 69.07 148.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 C-N-CA 124.659 1.183 . . . . 61.31 111.208 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 362' ' ' GLY . . . . . . . . . . . . . . . -119.3 -20.7 3.91 Favored Glycine 0 N--CA 1.472 1.067 0 O-C-N 122.066 -0.396 . . . . 72.35 113.083 172.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 363' ' ' GLU . . . . . 0.539 ' HG2' ' HA ' ' B' ' 201' ' ' PRO . 1.6 mp0 -84.77 -4.2 58.95 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.072 0.949 . . . . 73.13 111.899 -173.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 364' ' ' THR . . . . . . . . . . . . . 61.6 m 73.59 -63.86 0.42 Allowed 'General case' 0 C--N 1.358 0.956 0 C-N-CA 125.602 1.561 . . . . 74.04 109.93 -169.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 76.7 t 70.18 142.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 C-N-CA 124.865 1.266 . . . . 74.01 110.932 -177.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -58.52 141.69 51.18 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.109 0.964 . . . . 50.12 111.459 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 367' ' ' LEU . . . . . . . . . . . . . 7.7 mp -59.95 -27.0 66.43 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.418 1.087 . . . . 75.05 111.455 -177.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 368' ' ' ASP . . . . . . . . . . . . . 31.8 t70 68.3 -75.92 0.06 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.503 1.521 . . . . 71.23 111.312 176.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 369' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 70.42 143.11 0.05 Allowed 'General case' 0 CA--C 1.56 1.346 0 C-N-CA 125.133 1.373 . . . . 70.1 112.06 174.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 370' ' ' ALA . . . . . 0.429 ' H ' HE21 ' B' ' 372' ' ' GLN . . . -136.06 -174.5 3.69 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.019 0.928 . . . . 74.25 110.02 -177.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 371' ' ' VAL . . . . . . . . . . . . . 47.7 t -64.21 -37.68 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 C-N-CA 123.687 0.795 . . . . 74.11 110.909 -177.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 372' ' ' GLN . . . . . 0.429 HE21 ' H ' ' B' ' 370' ' ' ALA . 59.9 mm-40 65.97 89.07 0.1 Allowed 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 125.277 1.431 . . . . 63.2 111.115 179.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 373' ' ' ARG . . . . . 0.653 ' HG3' ' HE2' ' B' ' 377' ' ' PHE . 0.2 OUTLIER -96.06 76.61 3.09 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.591 -0.732 . . . . 72.05 109.605 -177.087 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -160.45 11.18 0.1 Allowed 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.488 -0.778 . . . . 71.45 112.106 -175.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 375' ' ' LEU . . . . . . . . . . . . . 81.9 mt -91.76 9.35 32.99 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.233 0.613 . . . . 62.01 111.341 -174.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -143.86 -22.78 0.57 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.29 1.036 . . . . 73.13 110.362 -178.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 377' ' ' PHE . . . . . 0.653 ' HE2' ' HG3' ' B' ' 373' ' ' ARG . 97.6 m-85 -76.1 91.79 3.15 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 109.274 -0.639 . . . . 73.31 109.274 172.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 378' ' ' ALA . . . . . 0.766 ' HA ' ' HA ' ' B' ' 243' ' ' GLN . . . -129.29 -88.97 0.51 Allowed 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 116.174 -0.466 . . . . 61.1 111.845 -177.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt 60.21 93.46 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.126 0.97 . . . . 72.01 109.194 -168.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 380' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 70.83 171.96 0.31 Allowed 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.774 1.23 . . . . 53.14 110.853 -173.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 381' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -161.07 -53.7 0.05 OUTLIER 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.846 -0.615 . . . . 74.34 111.124 -175.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -166.47 86.89 0.1 OUTLIER Glycine 0 C--N 1.355 1.593 0 C-N-CA 121.596 -0.335 . . . . 73.1 113.872 -175.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 383' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -159.89 -12.27 0.06 Allowed 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 113.615 0.968 . . . . 73.1 113.615 -175.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 384' ' ' THR . . . . . . . . . . . . . 7.0 t -89.53 114.96 26.57 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 118.815 0.734 . . . . 63.41 112.064 -173.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 56.3 mt -93.17 47.51 1.27 Allowed 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.548 0.739 . . . . 75.12 110.093 173.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 386' ' ' VAL . . . . . . . . . . . . . 87.6 t 72.76 -62.64 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 125.44 1.496 . . . . 62.42 111.305 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 387' ' ' ILE . . . . . 0.439 HD13 ' H ' ' B' ' 415' ' ' LYS . 8.0 tp -55.62 -30.13 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 125.128 1.371 . . . . 74.12 112.613 -177.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 388' ' ' VAL . . . . . . . . . . . . . 57.6 t -62.92 -43.89 99.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.421 0.688 . . . . 54.33 110.922 -177.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 389' ' ' THR . . . . . 0.466 ' HB ' ' HB2' ' B' ' 395' ' ' ALA . 35.4 p -97.38 -11.56 23.83 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.476 0.71 . . . . 71.25 111.677 177.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . 55.13 32.1 17.68 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 125.258 1.423 . . . . 70.34 112.471 178.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 391' ' ' ASP . . . . . . . . . . . . . 20.1 t70 65.87 -78.62 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 125.113 1.365 . . . . 64.12 110.725 -171.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 392' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -139.05 179.52 6.45 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 123.892 0.877 . . . . 72.42 109.883 -177.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . 61.32 23.0 13.29 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 124.211 1.004 . . . . 61.53 111.641 -178.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -166.23 -43.18 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.428 1.091 . . . . 73.31 108.792 -170.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 395' ' ' ALA . . . . . 0.466 ' HB2' ' HB ' ' B' ' 389' ' ' THR . . . -66.17 173.97 2.84 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.934 0.893 . . . . 71.44 112.093 178.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 49.7 m -65.94 -32.39 73.86 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.068 0.547 . . . . 75.55 111.399 176.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 397' ' ' GLN . . . . . 0.476 HE22 ' HB3' ' B' ' 145' ' ' ASP . 0.3 OUTLIER -93.35 107.36 19.2 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 108.26 -1.015 . . . . 71.41 108.26 176.71 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 398' ' ' ILE . . . . . 0.404 HG22 HG13 ' B' ' 399' ' ' VAL . 62.3 mt -134.67 -75.23 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 N-CA-C 107.585 -1.265 . . . . 75.44 107.585 172.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 399' ' ' VAL . . . . . 0.404 HG13 HG22 ' B' ' 398' ' ' ILE . 29.2 m -105.39 176.93 0.99 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.699 0 C-N-CA 124.062 0.945 . . . . 73.32 110.046 -177.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 400' ' ' ALA . . . . . . . . . . . . . . . -62.76 -46.27 88.16 Favored Pre-proline 0 CA--C 1.562 1.41 0 CA-C-O 118.285 -0.864 . . . . 51.41 111.327 178.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 401' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.57 53.07 3.86 Favored 'Trans proline' 0 C--N 1.387 2.579 0 C-N-CA 121.939 1.759 . . . . 71.04 112.935 165.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 62.1 -82.06 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 125.644 1.578 . . . . 74.34 112.807 177.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 403' ' ' THR . . . . . . . . . . . . . 18.8 p -129.38 168.44 16.28 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.944 0.898 . . . . 51.3 111.284 -169.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 404' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.32 143.49 42.04 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 114.614 -1.176 . . . . 70.03 108.62 167.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 405' ' ' ALA . . . . . . . . . . . . . . . -69.44 -54.68 10.74 Favored Pre-proline 0 CA--C 1.564 1.508 0 CA-C-O 118.532 -0.747 . . . . 71.24 112.241 -177.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 406' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -83.82 113.91 1.94 Allowed 'Trans proline' 0 C--N 1.393 2.896 0 C-N-CA 122.237 1.958 . . . . 44.44 111.081 -176.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . -54.61 -81.75 0.06 OUTLIER Glycine 0 N--CA 1.478 1.462 0 O-C-N 123.628 0.58 . . . . 55.33 113.825 -174.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 408' ' ' LEU . . . . . . . . . . . . . 29.8 tp -176.06 153.69 1.34 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.082 0.953 . . . . 72.03 108.461 176.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 18.6 p -57.96 -38.03 75.28 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.643 0.777 . . . . 73.52 111.297 178.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 410' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 -132.72 101.96 5.49 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 109.156 -0.683 . . . . 51.32 109.156 169.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . -79.78 -59.85 2.57 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.441 -0.578 . . . . 63.14 109.441 177.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 99.2 mt 58.01 -87.68 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.236 1.414 . . . . 60.41 111.38 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 49.35 80.3 0.07 Allowed 'General case' 0 C--N 1.358 0.943 0 C-N-CA 124.769 1.228 . . . . 71.14 111.396 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 414' ' ' THR . . . . . . . . . . . . . 46.7 m -77.82 79.92 4.29 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 109.018 -0.734 . . . . 73.24 109.018 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 415' ' ' LYS . . . . . 0.439 ' H ' HD13 ' B' ' 387' ' ' ILE . 57.2 mttp 52.46 46.66 26.26 Favored 'General case' 0 C--N 1.362 1.128 0 CA-C-N 114.389 -1.278 . . . . 73.42 110.816 -177.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 18.0 t70 75.03 -58.08 0.59 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 125.587 1.555 . . . . 75.33 111.266 -173.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 417' ' ' GLY . . . . . . . . . . . . . . . 144.94 -38.66 1.25 Allowed Glycine 0 C--O 1.246 0.889 0 N-CA-C 110.619 -0.992 . . . . 43.15 110.619 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 418' ' ' ALA . . . . . . . . . . . . . . . -72.67 127.44 32.56 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 123.212 0.605 . . . . 70.25 109.723 175.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 419' ' ' VAL . . . . . . . . . . . . . 14.1 m 48.99 35.36 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 C-N-CA 126.013 1.725 . . . . 62.03 112.768 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 420' ' ' MET . . . . . 0.406 ' O ' ' HD2' ' B' ' 415' ' ' LYS . 0.0 OUTLIER -57.42 -35.64 70.31 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.035 0.934 . . . . 73.12 112.496 -175.005 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 421' ' ' VAL . . . . . 0.468 HG13 ' HG2' ' A' ' 211' ' ' ARG . 3.4 p -83.65 82.33 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 CA-C-O 122.533 1.159 . . . . 72.42 108.319 170.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 422' ' ' MET . . . . . . . . . . . . . 15.3 ptp -86.61 -14.4 42.85 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 114.436 -1.256 . . . . 74.1 110.75 177.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 423' ' ' SER . . . . . . . . . . . . . 50.0 m 70.29 -71.33 0.13 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 126.081 1.752 . . . . 62.22 112.393 173.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 424' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 56.41 40.21 29.77 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.012 0.925 . . . . 72.42 109.45 -171.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . 87.91 -79.72 1.71 Allowed Glycine 0 C--N 1.346 1.101 0 CA-C-N 114.577 -1.192 . . . . 75.12 110.95 -171.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 426' ' ' ASN . . . . . . . . . . . . . 6.3 t30 64.34 -69.29 0.09 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 125.299 1.44 . . . . 75.43 110.583 -172.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 427' ' ' SER . . . . . 0.495 ' HB2' ' HB3' ' B' ' 432' ' ' GLN . 19.8 m -90.69 150.3 21.71 Favored 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 108.66 -0.867 . . . . 75.14 108.66 170.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -79.72 -52.05 8.44 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 113.729 1.011 . . . . 73.23 113.729 -162.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 429' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -61.15 83.82 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 123.539 0.736 . . . . 63.42 112.52 -169.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 36.9 t70 47.03 58.33 4.89 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 124.953 1.301 . . . . 55.41 110.819 -177.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 40.5 t 76.77 -46.1 0.5 Allowed 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 125.497 1.519 . . . . 73.31 111.324 -173.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 432' ' ' GLN . . . . . 0.495 ' HB3' ' HB2' ' B' ' 427' ' ' SER . 49.5 tp60 76.08 -49.75 0.6 Allowed 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 126.323 1.849 . . . . 71.1 112.112 178.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 433' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -84.1 61.32 6.42 Favored 'General case' 0 C--O 1.243 0.759 0 C-N-CA 123.922 0.889 . . . . 73.43 110.676 -179.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 434' ' ' HIS . . . . . . . . . . . . . 19.9 m170 -74.61 108.18 7.2 Favored 'General case' 0 C--N 1.34 0.193 0 N-CA-C 108.57 -0.9 . . . . 65.13 108.57 175.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 435' ' ' THR . . . . . . . . . . . . . 1.3 m -82.85 1.43 39.3 Favored 'General case' 0 CA--C 1.556 1.182 0 CA-C-N 115.037 -0.983 . . . . 73.42 111.67 -168.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . -176.36 -96.95 0.1 Allowed Glycine 0 C--N 1.352 1.435 0 CA-C-O 119.525 -0.597 . . . . 43.54 111.684 175.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 437' ' ' SER . . . . . 0.565 ' H ' ' HB2' ' A' ' 220' ' ' GLU . 31.1 t 76.48 -9.11 1.54 Allowed 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 125.541 1.536 . . . . 54.14 112.478 178.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 438' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -83.06 -27.9 29.95 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.763 0.825 . . . . 71.55 109.955 178.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 439' ' ' LEU . . . . . . . . . . . . . 5.1 mp -76.85 87.68 3.43 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.516 -0.765 . . . . 74.24 109.457 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 440' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -86.5 162.33 18.13 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.205 0.526 . . . . 70.1 110.632 178.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 441' ' ' ILE . . . . . 0.452 HD11 ' HB ' ' A' ' 221' ' ' VAL . 82.3 mt -133.64 149.38 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 124.276 1.031 . . . . 74.15 110.001 -172.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 442' ' ' ALA . . . . . . . . . . . . . . . -104.94 -77.35 0.58 Allowed 'General case' 0 CA--C 1.553 1.07 0 N-CA-C 109.251 -0.648 . . . . 71.41 109.251 168.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . 56.14 -88.01 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 125.179 1.392 . . . . 74.21 112.221 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -164.14 170.9 15.8 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.187 1.395 . . . . 65.34 108.375 173.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . 134.82 -61.05 0.64 Allowed Glycine 0 N--CA 1.469 0.881 0 N-CA-C 111.759 -0.537 . . . . 74.34 111.759 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 446' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -58.33 105.8 0.23 Allowed 'Trans proline' 0 C--N 1.382 2.311 0 C-N-CA 122.091 1.86 . . . . 63.02 108.886 164.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 447' ' ' HIS . . . . . . . . . . . . . 11.5 t60 -87.31 -29.03 21.91 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 116.229 -0.442 . . . . 60.0 110.258 -173.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . -153.72 25.17 0.51 Allowed 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.247 1.019 . . . . 74.31 109.555 169.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 449' ' ' ALA . . . . . 0.4 ' HB2' ' HB2' ' B' ' 468' ' ' LEU . . . -107.91 19.02 20.59 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.69 0.796 . . . . 61.52 110.253 178.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 450' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -80.31 89.43 5.52 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.338 -0.846 . . . . 61.12 109.716 -170.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 30.0 m 39.15 70.28 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 C-N-CA 125.807 1.643 . . . . 63.1 113.06 -177.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 452' ' ' VAL . . . . . . . . . . . . . 34.1 m -68.47 -17.73 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 CA-C-N 115.317 -0.856 . . . . 60.45 111.694 -176.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 81.26 60.94 2.16 Favored Glycine 0 C--N 1.348 1.194 0 N-CA-C 110.483 -1.047 . . . . 73.44 110.483 -178.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 454' ' ' LEU . . . . . . . . . . . . . 20.8 tp -94.13 12.27 27.09 Favored 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 123.679 0.792 . . . . 72.5 110.642 -175.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 3.2 m 60.02 21.27 10.39 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 124.592 1.157 . . . . 61.41 110.118 -175.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -78.39 149.27 33.38 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 114.674 -1.148 . . . . 74.3 110.813 -173.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 457' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -143.91 -74.82 0.25 Allowed 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.483 -0.781 . . . . 42.14 109.201 -172.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 17.9 p -147.37 -76.68 0.18 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.523 0.729 . . . . 72.13 111.473 -177.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 459' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -51.5 -93.2 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 125.616 1.566 . . . . 73.31 115.065 -160.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 8.0 mp -89.27 27.14 1.47 Allowed 'General case' 0 N--CA 1.481 1.114 0 O-C-N 121.423 -0.798 . . . . 65.42 109.976 -177.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -101.17 13.07 36.3 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.737 0.815 . . . . 62.31 110.773 -177.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -76.51 87.0 3.22 Favored 'General case' 0 C--N 1.355 0.835 0 N-CA-C 107.958 -1.127 . . . . 72.53 107.958 170.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 34.3 p -106.82 109.58 21.52 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 123.545 0.738 . . . . 61.35 109.835 -178.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 464' ' ' MET . . . . . . . . . . . . . 56.3 ttp -83.82 -59.14 2.52 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 108.717 -0.846 . . . . 75.31 108.717 175.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt 55.31 -83.74 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 125.279 1.432 . . . . 72.15 112.317 178.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -150.17 176.75 10.56 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.657 1.183 . . . . 62.32 109.523 -178.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . -81.31 95.07 6.87 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 109.22 -0.659 . . . . 75.3 109.22 174.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 468' ' ' LEU . . . . . 0.4 ' HB2' ' HB2' ' B' ' 449' ' ' ALA . 3.6 mm? -65.63 92.62 0.15 Allowed 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.072 0.549 . . . . 45.51 109.702 175.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 469' ' ' GLY . . . . . . . . . . . . . . . -155.87 64.76 0.32 Allowed Glycine 0 C--N 1.342 0.897 0 N-CA-C 110.232 -1.147 . . . . 50.44 110.232 -178.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 470' ' ' LEU . . . . . . . . . . . . . 5.6 mp -83.88 63.28 7.45 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.111 0.964 . . . . 73.2 110.5 -175.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 471' ' ' LYS . . . . . . . . . . . . . 88.1 tttt . . . . . 0 CA--C 1.547 0.855 0 N-CA-C 107.97 -1.122 . . . . 74.2 107.97 -178.871 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtm . . . . . 0 N--CA 1.469 0.52 0 N-CA-C 109.029 -0.73 . . . . 55.23 109.029 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 58.02 26.73 13.87 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.482 1.113 . . . . 65.31 112.143 -177.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -89.04 56.25 3.64 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.883 0.873 . . . . 52.01 110.34 -174.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -37.92 100.97 0.02 OUTLIER 'General case' 0 C--N 1.356 0.872 0 C-N-CA 125.778 1.631 . . . . 70.52 113.442 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 5' ' ' LYS . . . . . 0.635 ' HD2' HD11 ' C' ' 10' ' ' ILE . 25.0 mmtp -74.47 101.14 4.04 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 108.943 -0.762 . . . . 63.2 108.943 167.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 6' ' ' ASP . . . . . 0.408 ' HA ' ' OH ' ' C' ' 66' ' ' TYR . 13.5 t70 -73.73 93.12 2.06 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 106.261 -1.755 . . . . 63.22 106.261 168.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 7' ' ' TYR . . . . . 0.453 ' CD1' ' HA ' ' C' ' 53' ' ' ALA . 63.5 m-85 -61.13 -29.37 69.73 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.074 -0.966 . . . . 73.43 111.744 -171.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 8' ' ' TYR . . . . . 0.496 ' HD1' HG23 ' C' ' 13' ' ' VAL . 32.1 m-85 -64.05 -46.08 85.97 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.316 -0.856 . . . . 72.53 111.171 173.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.9 -39.39 94.08 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.103 0.561 . . . . 52.31 111.231 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 10' ' ' ILE . . . . . 0.635 HD11 ' HD2' ' C' ' 5' ' ' LYS . 62.2 mt -57.67 -43.81 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 C-N-CA 123.173 0.589 . . . . 63.34 110.042 174.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 11' ' ' LEU . . . . . 0.49 ' HB3' ' HB1' ' C' ' 25' ' ' ALA . 92.0 mt -82.72 -3.05 55.91 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 115.44 -0.8 . . . . 45.45 112.834 178.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 63.03 34.53 90.22 Favored Glycine 0 C--N 1.355 1.592 0 N-CA-C 114.088 0.395 . . . . 64.33 114.088 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 13' ' ' VAL . . . . . 0.496 HG23 ' HD1' ' C' ' 8' ' ' TYR . 8.3 m -129.38 154.33 80.68 Favored Pre-proline 0 N--CA 1.486 1.362 0 C-N-CA 124.776 1.23 . . . . 64.04 109.456 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -77.24 171.18 18.23 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 122.356 2.037 . . . . 74.43 112.778 -179.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 62.6 mtt180 -80.4 29.05 0.3 Allowed 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.518 0.727 . . . . 71.52 111.682 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -117.17 -15.94 10.43 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 125.659 1.583 . . . . 71.24 108.341 175.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.07 110.21 1.52 Allowed 'General case' 0 C--N 1.354 0.77 0 CA-C-N 114.918 -1.037 . . . . 71.14 110.655 -178.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 41.3 p -74.15 174.9 8.06 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 122.936 0.494 . . . . 74.41 109.857 172.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.93 -44.31 29.82 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 124.772 1.229 . . . . 74.45 111.745 -173.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 20' ' ' GLU . . . . . 0.668 ' HA ' ' HE3' ' C' ' 23' ' ' LYS . 2.3 tm-20 -65.08 -40.43 94.62 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.241 1.016 . . . . 64.05 110.851 -175.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . 0.49 ' HG2' ' NH2' ' C' ' 24' ' ' ARG . 33.6 mt-10 -70.57 -39.39 73.93 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.733 0.813 . . . . 73.42 110.837 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 22' ' ' ILE . . . . . 0.869 HD13 ' HB3' ' C' ' 57' ' ' LEU . 97.0 mt -64.07 -38.18 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.175 1.39 . . . . 61.32 110.368 175.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 23' ' ' LYS . . . . . 0.668 ' HE3' ' HA ' ' C' ' 20' ' ' GLU . 22.1 ttpp -67.76 -35.41 78.67 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.144 1.377 . . . . 74.13 110.438 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 24' ' ' ARG . . . . . 0.49 ' NH2' ' HG2' ' C' ' 21' ' ' GLU . 39.7 mtm180 -73.88 -33.04 63.89 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 115.848 -0.615 . . . . 73.52 112.361 172.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . 0.49 ' HB1' ' HB3' ' C' ' 11' ' ' LEU . . . -63.18 -38.4 91.04 Favored 'General case' 0 C--O 1.251 1.162 0 CA-C-O 121.465 0.65 . . . . 75.32 110.045 174.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 26' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -60.74 -58.46 8.38 Favored 'General case' 0 C--O 1.208 -1.1 0 CA-C-N 113.92 -1.491 . . . . 72.31 109.342 173.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . 0.498 ' HG2' ' HA ' ' B' ' 37' ' ' ASP . 27.5 mtpp -42.92 -52.3 5.2 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 124.042 0.839 . . . . 74.1 111.574 178.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -53.95 -62.65 1.52 Allowed 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.375 -1.284 . . . . 71.15 111.423 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 93.4 mt -84.65 -6.48 59.36 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 112.499 0.555 . . . . 60.22 112.499 -171.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.58 -17.07 20.68 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.134 0.574 . . . . 75.32 110.859 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 65.3 mtm180 -94.61 -33.08 13.14 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 123.324 0.39 . . . . 73.5 110.219 167.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -69.91 -52.77 21.83 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.042 0.537 . . . . 71.12 109.766 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 33' ' ' TYR . . . . . 0.417 ' HD1' ' HB1' ' C' ' 43' ' ' ALA . 51.2 m-85 -88.37 10.38 20.11 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 119.504 -0.284 . . . . 70.15 111.013 178.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 34' ' ' HIS . . . . . . . . . . . . . 14.5 t60 -61.11 116.76 20.68 Favored Pre-proline 0 C--N 1.363 1.173 0 CA-C-O 118.325 -0.845 . . . . 72.34 109.788 -178.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -45.46 -53.43 5.5 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 123.901 3.067 . . . . 71.32 114.272 -172.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -56.14 -40.86 74.47 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.332 0.653 . . . . 60.34 112.63 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 62.1 t -80.13 -31.37 13.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 CA-C-N 115.542 -0.754 . . . . 75.33 110.442 -173.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -143.57 74.85 1.45 Allowed 'General case' 0 C--O 1.243 0.752 0 N-CA-C 108.245 -1.02 . . . . 54.22 108.245 -174.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -69.83 79.54 0.46 Allowed 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 114.919 -1.037 . . . . 62.24 109.975 178.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 16.1 m -136.17 102.17 10.03 Favored Pre-proline 0 CA--C 1.537 0.467 0 N-CA-C 107.486 -1.301 . . . . 74.14 107.486 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -32.83 -55.25 0.36 Allowed 'Trans proline' 0 C--N 1.389 2.703 0 C-N-CA 124.796 3.664 . . . . 63.44 115.256 -175.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.4 -40.57 91.43 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.299 0.64 . . . . 65.44 111.079 -178.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 43' ' ' ALA . . . . . 0.417 ' HB1' ' HD1' ' C' ' 33' ' ' TYR . . . -71.54 -24.0 61.86 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.368 0.667 . . . . 62.05 111.205 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -85.81 -28.71 24.31 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.4 -0.592 . . . . 74.04 109.4 -178.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -71.56 -40.87 69.68 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.728 0.811 . . . . 42.53 109.627 170.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 46' ' ' LYS . . . . . 0.529 ' O ' HG12 ' C' ' 50' ' ' ILE . 38.0 mmtm -67.05 -33.18 74.97 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 115.155 -0.93 . . . . 72.32 110.342 173.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -58.58 -46.96 85.84 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.608 0.763 . . . . 62.23 109.376 172.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 48' ' ' LYS . . . . . 0.639 ' HB3' ' HE1' ' C' ' 93' ' ' PHE . 55.4 mtpt -56.58 -42.61 78.95 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 123.894 0.746 . . . . 72.04 110.947 175.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -69.68 -24.58 63.62 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 122.936 0.494 . . . . 72.33 112.187 177.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 50' ' ' ILE . . . . . 0.529 HG12 ' O ' ' C' ' 46' ' ' LYS . 27.6 mm -69.71 -41.58 80.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.793 -0.818 . . . . 75.43 108.793 172.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 51' ' ' ASN . . . . . 0.492 ' HB3' ' CD1' ' C' ' 88' ' ' PHE . 58.7 m-80 -68.37 -32.75 73.05 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-N 114.79 -1.096 . . . . 74.04 111.18 177.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -65.84 -54.07 31.57 Favored 'General case' 0 C--O 1.248 0.988 0 C-N-CA 124.677 1.191 . . . . 63.42 110.317 176.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . 0.453 ' HA ' ' CD1' ' C' ' 7' ' ' TYR . . . -56.6 -51.04 70.17 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-N 113.627 -1.624 . . . . 63.1 111.297 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -64.35 -35.73 81.83 Favored 'General case' 0 C--O 1.197 -1.664 0 CA-C-N 114.874 -1.057 . . . . 75.01 110.528 177.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 55' ' ' ALA . . . . . 0.441 ' HB2' ' CD2' ' C' ' 88' ' ' PHE . . . -58.97 -44.64 91.55 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 118.378 0.535 . . . . 60.54 111.706 -178.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 86.2 t -68.06 -42.5 85.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 CA-C-O 121.367 0.603 . . . . 72.43 110.432 174.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 57' ' ' LEU . . . . . 0.869 ' HB3' HD13 ' C' ' 22' ' ' ILE . 80.7 mt -93.35 5.13 52.6 Favored 'General case' 0 CA--C 1.563 1.467 0 N-CA-C 113.483 0.92 . . . . 75.02 113.483 -171.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 30.4 t -81.42 -44.24 17.78 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.419 0.688 . . . . 62.42 110.262 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -80.06 128.78 72.47 Favored Pre-proline 0 CA--C 1.515 -0.401 0 CA-C-O 118.246 -0.883 . . . . 72.03 109.08 175.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 60' ' ' PRO . . . . . 0.568 ' O ' ' HG2' ' C' ' 64' ' ' ARG . 87.7 Cg_exo -51.41 -33.11 45.26 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.026 1.817 . . . . 33.23 110.978 162.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . 0.47 ' HB2' ' HB3' ' C' ' 144' ' ' ARG . 8.6 tp10 -61.36 -63.97 1.1 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.424 0.689 . . . . 62.13 111.365 176.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -64.81 -23.92 67.39 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 122.886 0.474 . . . . 75.23 111.336 -177.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 63' ' ' ARG . . . . . 0.497 HH21 ' HB3' ' C' ' 66' ' ' TYR . 2.6 tpm_? -63.98 -50.57 68.04 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.827 0.851 . . . . 64.42 110.115 172.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 64' ' ' ARG . . . . . 0.568 ' HG2' ' O ' ' C' ' 60' ' ' PRO . 28.5 mmm180 -69.62 -25.02 63.74 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 122.369 0.268 . . . . 74.15 110.894 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 66.6 mt -62.97 -46.52 96.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 N-CA-C 109.46 -0.57 . . . . 62.34 109.46 169.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 66' ' ' TYR . . . . . 0.497 ' HB3' HH21 ' C' ' 63' ' ' ARG . 6.5 t80 -58.78 -46.94 86.36 Favored 'General case' 0 CA--C 1.555 1.142 0 CA-C-N 115.33 -0.85 . . . . 74.22 109.809 176.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -56.23 -46.99 79.34 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.869 0.868 . . . . 73.14 111.265 177.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 27.5 p -78.03 -11.85 59.94 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.144 -0.48 . . . . 63.2 111.809 -177.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -73.82 101.63 3.79 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 107.922 -1.14 . . . . 75.22 107.922 173.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 107.77 22.23 7.42 Favored Glycine 0 C--N 1.347 1.172 0 CA-C-N 116.054 -0.521 . . . . 62.51 111.989 -172.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 92.4 m -144.33 -56.72 0.36 Allowed 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 104.233 -2.506 . . . . 72.34 104.233 175.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 21.9 m -78.74 140.35 38.3 Favored 'General case' 0 C--O 1.256 1.437 0 N-CA-C 104.619 -2.363 . . . . 73.35 104.619 156.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.5 -22.95 15.75 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.63 0.772 . . . . 73.23 111.273 -176.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.64 154.69 38.38 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 123.423 0.689 . . . . 53.23 109.594 174.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -58.82 119.98 7.57 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.194 1.93 . . . . 75.14 110.774 168.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.43 121.25 9.7 Favored 'Trans proline' 0 C--N 1.383 2.376 0 C-N-CA 122.732 2.288 . . . . 63.14 110.918 177.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -41.28 127.54 3.02 Favored 'Trans proline' 0 C--N 1.393 2.887 0 C-N-CA 124.119 3.213 . . . . 51.51 114.091 -169.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 78' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -52.22 142.36 46.21 Favored 'Trans proline' 0 C--N 1.391 2.764 0 C-N-CA 123.8 3.0 . . . . 74.44 113.633 -175.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 79' ' ' PRO . . . . . 0.411 ' HB2' ' HA2' ' C' ' 142' ' ' GLY . 70.8 Cg_exo -54.67 162.87 4.36 Favored 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 123.551 2.834 . . . . 61.04 113.67 176.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -53.97 87.38 0.03 OUTLIER 'Trans proline' 0 C--N 1.387 2.567 0 C-N-CA 123.641 2.894 . . . . 51.5 113.007 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 144.58 -49.51 0.68 Allowed Glycine 0 CA--C 1.524 0.627 0 CA-C-N 113.54 -1.664 . . . . 75.2 109.332 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 142.69 -164.1 27.13 Favored Glycine 0 C--N 1.348 1.237 0 CA-C-N 114.807 -0.697 . . . . 74.45 111.669 -177.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -92.52 111.51 23.13 Favored 'General case' 0 C--O 1.245 0.866 0 C-N-CA 123.907 0.883 . . . . 70.14 108.896 171.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -89.38 -174.4 4.36 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 109.409 -0.589 . . . . 63.13 109.409 170.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 85' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -162.56 71.27 0.3 Allowed 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 107.644 -1.243 . . . . 74.41 107.644 176.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 86' ' ' SER . . . . . 0.412 ' OG ' ' HD3' ' C' ' 143' ' ' ARG . 50.5 m -33.73 96.71 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 118.042 2.608 . . . . 45.43 118.042 -166.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 68.16 12.71 63.5 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-N 116.093 -0.503 . . . . 74.33 113.695 173.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 88' ' ' PHE . . . . . 0.492 ' CD1' ' HB3' ' C' ' 51' ' ' ASN . 16.8 m-85 -103.74 150.85 23.67 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 124.271 1.028 . . . . 74.44 108.385 -178.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -83.54 69.31 10.06 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.061 0.458 . . . . 72.23 110.995 -173.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 90' ' ' VAL . . . . . 0.435 HG23 ' CE2' ' C' ' 97' ' ' PHE . 0.8 OUTLIER -43.55 -43.35 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 125.719 1.608 . . . . 54.41 111.945 173.007 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -60.8 -30.77 70.26 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 114.787 -1.097 . . . . 74.21 111.641 -172.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -110.85 4.86 20.16 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.107 0.563 . . . . 75.53 111.289 -176.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 93' ' ' PHE . . . . . 0.639 ' HE1' ' HB3' ' C' ' 48' ' ' LYS . 10.5 m-30 -79.84 -177.14 5.79 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.841 -0.537 . . . . 72.45 112.302 -178.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 96.6 p -67.15 161.18 25.23 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.631 0.975 . . . . 45.51 113.631 -165.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -57.81 -56.08 26.53 Favored 'General case' 0 C--O 1.217 -0.641 0 CA-C-N 113.902 -1.499 . . . . 55.43 110.356 176.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -50.88 -45.27 60.03 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.868 0.867 . . . . 65.02 112.226 -176.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 97' ' ' PHE . . . . . 0.435 ' CE2' HG23 ' C' ' 90' ' ' VAL . 7.5 t80 -58.17 -53.18 61.21 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 115.23 -0.895 . . . . 64.25 110.214 174.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -77.49 4.38 11.23 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 122.707 0.403 . . . . 51.52 112.047 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -98.47 -45.54 6.08 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.534 0.733 . . . . 74.43 110.663 170.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 22.9 tp -78.65 -56.34 4.5 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.169 0.588 . . . . 73.23 110.281 -178.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 101' ' ' PHE . . . . . 0.484 ' O ' ' HG ' ' C' ' 105' ' ' LEU . 90.4 m-85 -85.26 -15.52 43.19 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.346 -0.843 . . . . 73.25 111.257 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -46.49 -54.78 8.47 Favored Glycine 0 CA--C 1.545 1.932 0 CA-C-O 118.941 -0.922 . . . . 54.11 114.951 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_exo -45.01 -24.5 1.32 Allowed 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 124.681 3.587 . . . . 62.02 116.434 175.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -128.58 14.56 6.09 Favored Glycine 0 C--N 1.355 1.633 0 CA-C-O 118.605 -1.108 . . . . 43.23 114.237 -178.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 105' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' C' ' 101' ' ' PHE . 49.3 mt -70.54 74.03 0.54 Allowed 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 118.247 1.024 . . . . 73.03 112.246 177.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 106' ' ' PHE . . . . . 0.435 ' HD2' HD22 ' C' ' 169' ' ' ASN . 32.1 m-85 35.41 -103.93 0.03 OUTLIER 'General case' 0 CA--C 1.563 1.473 0 C-N-CA 125.496 1.519 . . . . 64.24 114.788 174.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 107' ' ' GLY . . . . . 0.412 ' H ' ' HB2' ' C' ' 169' ' ' ASN . . . 61.16 28.74 69.56 Favored Glycine 0 C--N 1.363 2.056 0 N-CA-C 111.266 -0.734 . . . . 51.05 111.266 -163.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 68.44 -94.34 0.33 Allowed Glycine 0 C--N 1.348 1.247 0 N-CA-C 108.842 -1.703 . . . . 74.41 108.842 -163.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 109' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -136.47 5.21 2.93 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 124.165 0.986 . . . . 74.45 110.056 168.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 110' ' ' GLY . . . . . . . . . . . . . . . -92.91 -6.3 63.62 Favored Glycine 0 C--N 1.347 1.159 0 CA-C-N 115.857 -0.611 . . . . 54.22 113.449 175.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 52.77 18.47 1.04 Allowed 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 124.962 1.305 . . . . 75.25 113.441 174.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.84 -35.86 71.49 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.534 0.734 . . . . 74.1 110.378 167.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 113' ' ' SER . . . . . . . . . . . . . 50.7 m 75.69 48.85 0.08 Allowed 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 125.976 1.711 . . . . 72.53 110.993 -170.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 114' ' ' ARG . . . . . 0.429 ' HG2' ' N ' ' C' ' 115' ' ' LYS . 64.5 ttt-85 -69.86 159.56 33.42 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 115.565 -0.743 . . . . 74.05 109.733 176.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 115' ' ' LYS . . . . . 0.558 ' HA ' ' HD2' ' C' ' 170' ' ' PRO . 3.9 ttmt -61.15 135.87 57.89 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 118.971 0.805 . . . . 54.14 111.836 -177.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -84.18 128.18 8.49 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-N 114.962 -1.017 . . . . 45.25 113.269 -176.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 117' ' ' ARG . . . . . 0.456 ' HG2' ' H ' ' C' ' 118' ' ' ASP . 46.3 ttt-85 -82.98 174.67 10.69 Favored 'General case' 0 C--O 1.25 1.08 0 C-N-CA 123.459 0.704 . . . . 64.44 109.523 175.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 118' ' ' ASP . . . . . 0.456 ' H ' ' HG2' ' C' ' 117' ' ' ARG . 5.0 p-10 -64.52 151.76 43.62 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 121.59 0.709 . . . . 75.42 110.985 173.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 119' ' ' LEU . . . . . . . . . . . . . 61.1 tp -108.17 164.04 12.65 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 106.828 -1.545 . . . . 75.21 106.828 172.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 74.0 ttt-85 -138.69 120.94 15.85 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 118.665 0.666 . . . . 72.31 109.654 177.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 121' ' ' ALA . . . . . 0.467 ' HB3' HD11 ' C' ' 174' ' ' LEU . . . -140.84 118.81 11.85 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.28 1.032 . . . . 63.21 108.827 -178.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 122' ' ' GLU . . . . . 0.682 ' HG2' HG22 ' B' ' 186' ' ' THR . 13.6 pt-20 -102.05 147.6 26.39 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 110.317 -0.253 . . . . 73.22 110.317 178.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 123' ' ' LEU . . . . . 0.426 ' HB3' ' HB2' ' B' ' 183' ' ' ALA . 1.9 pt? -134.98 144.94 52.46 Favored Pre-proline 0 N--CA 1.478 0.954 0 C-N-CA 122.998 0.519 . . . . 73.3 111.237 -173.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.4 116.39 4.1 Favored 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 123.011 2.474 . . . . 72.51 110.076 165.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 125' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' C' ' 180' ' ' LEU . 38.4 tp -133.1 149.55 52.12 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.928 0.891 . . . . 74.03 108.687 -176.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 126' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.26 157.12 16.03 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 122.635 0.374 . . . . 61.53 110.775 -176.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 127' ' ' LEU . . . . . 0.557 HD13 ' HD2' ' C' ' 186' ' ' PHE . 17.9 mt -58.31 -47.02 85.03 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.809 1.244 . . . . 62.25 110.201 173.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 128' ' ' GLU . . . . . 0.463 ' HG3' ' HA ' ' C' ' 215' ' ' LEU . 1.8 mp0 -63.0 -38.08 89.77 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 114.267 -1.333 . . . . 75.24 110.903 178.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -79.54 -17.47 53.94 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 122.749 0.42 . . . . 73.53 111.707 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -75.37 -40.76 57.72 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 109.193 -0.669 . . . . 64.34 109.193 171.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 131' ' ' PHE . . . . . 0.603 ' HB2' HD13 ' C' ' 215' ' ' LEU . 69.2 t80 -62.38 -35.77 80.2 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.61 1.564 . . . . 75.55 111.91 172.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 132' ' ' HIS . . . . . . . . . . . . . 43.7 m170 -77.07 -51.31 11.27 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 110.318 -0.253 . . . . 60.22 110.318 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 50.55 -129.29 29.37 Favored Glycine 0 C--N 1.351 1.411 0 O-C-N 124.306 1.004 . . . . 65.31 113.894 177.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.29 -147.51 33.08 Favored Glycine 0 C--N 1.348 1.233 0 C-N-CA 123.128 0.394 . . . . 53.24 113.483 174.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -92.79 110.26 21.7 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.866 0.867 . . . . 71.2 109.898 -177.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 136' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -117.52 135.51 53.89 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.184 0.994 . . . . 72.12 110.152 -174.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 137' ' ' VAL . . . . . . . . . . . . . 35.8 m -76.86 143.98 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 122.644 0.378 . . . . 71.12 111.574 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 138' ' ' VAL . . . . . 0.602 ' HA ' HG22 ' B' ' 182' ' ' VAL . 7.4 p -158.93 139.7 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.28 1.032 . . . . 72.14 108.981 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 139' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' C' ' 143' ' ' ARG . 0.0 OUTLIER -123.8 94.84 4.35 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.559 0.743 . . . . 74.31 110.621 176.112 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 140' ' ' VAL . . . . . . . . . . . . . 11.5 p -147.77 139.85 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 122.977 0.511 . . . . 63.22 111.154 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 61.36 15.58 6.68 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 125.001 1.32 . . . . 15.23 113.72 173.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 142' ' ' GLY . . . . . 0.411 ' HA2' ' HB2' ' C' ' 79' ' ' PRO . . . 114.4 -26.64 9.5 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-N 116.489 -0.323 . . . . 45.25 112.602 -178.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 143' ' ' ARG . . . . . 0.457 ' O ' ' HA ' ' C' ' 139' ' ' GLU . 7.7 mmm180 -80.34 101.16 8.79 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.182 0.593 . . . . 73.04 111.593 178.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 144' ' ' ARG . . . . . 0.47 ' HB3' ' HB2' ' C' ' 61' ' ' GLU . 75.2 ttt180 -109.87 89.79 3.12 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 107.402 -1.333 . . . . 71.51 107.402 169.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 145' ' ' VAL . . . . . 0.433 HG11 HH21 ' C' ' 143' ' ' ARG . 12.6 p -161.05 163.8 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.904 0 C-N-CA 123.369 0.668 . . . . 75.03 111.26 -166.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 20.3 m -85.99 113.26 21.94 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 123.898 0.879 . . . . 54.21 109.972 168.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 3.9 p -89.18 129.45 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.477 0.711 . . . . 72.53 110.192 175.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 148' ' ' ARG . . . . . 0.426 ' HD2' HG23 ' B' ' 38' ' ' ILE . 42.9 ttt180 -86.59 95.07 9.63 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.152 0.581 . . . . 74.22 109.846 178.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 149' ' ' ILE . . . . . . . . . . . . . 40.7 pt -116.53 107.02 47.53 Favored Pre-proline 0 CA--C 1.546 0.827 0 N-CA-C 108.209 -1.034 . . . . 71.41 108.209 165.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -54.2 167.4 1.25 Allowed 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 123.075 2.516 . . . . 61.44 114.005 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -47.69 115.06 1.27 Allowed 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 123.062 2.508 . . . . 73.2 113.063 171.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 152' ' ' GLY . . . . . 0.411 ' HA3' ' HD2' ' B' ' 117' ' ' LYS . . . 150.43 88.45 0.07 OUTLIER Glycine 0 C--N 1.344 1.021 0 C-N-CA 120.441 -0.885 . . . . 54.32 114.527 -178.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 153' ' ' VAL . . . . . 0.594 HG22 HG11 ' C' ' 178' ' ' VAL . 14.0 p -165.26 151.83 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.201 0 C-N-CA 122.885 0.474 . . . . 71.13 110.001 173.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 154' ' ' ARG . . . . . 0.575 ' HD2' ' HG2' ' C' ' 187' ' ' ARG . 37.4 ttp180 -150.55 149.18 29.59 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.182 0.993 . . . . 75.32 109.819 -170.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 155' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -42.3 129.8 3.81 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 125.288 1.435 . . . . 74.51 112.849 -177.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.87 -13.72 58.42 Favored Glycine 0 C--N 1.348 1.219 0 CA-C-N 115.753 -0.658 . . . . 64.51 113.238 177.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 157' ' ' SER . . . . . 0.521 ' O ' HG12 ' C' ' 178' ' ' VAL . 43.8 t -74.8 140.43 43.97 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 108.832 -0.803 . . . . 75.43 108.832 174.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 158' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' B' ' 340' ' ' PHE . 58.6 t -119.73 105.84 18.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.629 -0.714 . . . . 64.44 109.266 -173.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 159' ' ' ILE . . . . . 0.689 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 15.3 mt -72.06 97.16 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.66 0 CA-C-N 114.805 -1.089 . . . . 52.25 108.954 -177.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 7.2 ttt180 -78.96 97.61 6.11 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 107.673 -1.232 . . . . 72.21 107.673 175.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 161' ' ' VAL . . . . . . . . . . . . . 2.2 p -101.53 103.99 31.22 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 124.457 1.103 . . . . 75.24 108.734 -178.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 162' ' ' PRO . . . . . 0.407 ' HG2' ' HB3' ' B' ' 33' ' ' ALA . 54.1 Cg_exo -55.36 123.98 15.16 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 123.407 2.738 . . . . 63.42 114.207 -173.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 163' ' ' GLY . . . . . 0.725 ' H ' ' HA ' ' C' ' 173' ' ' ASP . . . 89.79 -10.13 74.8 Favored Glycine 0 N--CA 1.441 -1.003 0 N-CA-C 117.236 1.654 . . . . 53.31 117.236 169.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 164' ' ' MET . . . . . 0.495 ' SD ' HD23 ' C' ' 174' ' ' LEU . 46.9 ttm -75.12 -13.23 60.46 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 119.954 1.877 . . . . 73.35 111.028 -177.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . -102.75 -117.12 4.27 Favored Glycine 0 C--N 1.347 1.156 0 CA-C-O 119.368 -0.685 . . . . 64.24 111.691 173.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 166' ' ' GLY . . . . . 0.475 ' HA3' ' HA ' ' C' ' 171' ' ' PRO . . . 87.44 68.86 1.31 Allowed Glycine 0 C--N 1.358 1.766 0 CA-C-N 117.781 0.791 . . . . 75.44 113.7 176.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 167' ' ' GLN . . . . . . . . . . . . . 19.9 mm-40 -80.14 100.21 8.13 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 106.97 -1.493 . . . . 64.31 106.97 173.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . 150.51 -89.23 0.14 Allowed Glycine 0 C--O 1.213 -1.167 0 CA-C-O 118.295 -1.281 . . . . 13.44 110.014 -168.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 169' ' ' ASN . . . . . 0.55 ' HB3' ' HD3' ' C' ' 170' ' ' PRO . 2.9 t-20 -176.36 -59.95 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.706 0 CA-C-O 117.165 -1.398 . . . . 62.44 112.216 164.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 170' ' ' PRO . . . . . 0.558 ' HD2' ' HA ' ' C' ' 115' ' ' LYS . 32.4 Cg_exo -61.52 98.91 0.16 Allowed 'Trans proline' 0 C--N 1.402 3.345 0 CA-C-N 122.446 1.909 . . . . 51.41 110.418 165.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 171' ' ' PRO . . . . . 0.543 ' HB2' ' HA2' ' C' ' 163' ' ' GLY . 7.5 Cg_exo -72.33 120.55 6.83 Favored 'Trans proline' 0 C--N 1.362 1.289 0 C-N-CA 122.34 2.027 . . . . 74.02 113.118 -163.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -63.78 -73.3 0.56 Allowed Glycine 0 C--N 1.347 1.164 0 O-C-N 124.029 0.831 . . . . 74.42 111.701 175.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 173' ' ' ASP . . . . . 0.725 ' HA ' ' H ' ' C' ' 163' ' ' GLY . 5.4 p-10 -170.46 175.99 4.56 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.245 0.545 . . . . 74.51 111.828 -179.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 174' ' ' LEU . . . . . 0.495 HD23 ' SD ' ' C' ' 164' ' ' MET . 11.2 tp -120.87 136.16 55.0 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 114.633 -1.167 . . . . 75.22 108.254 168.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 175' ' ' LEU . . . . . 0.404 ' N ' HD12 ' C' ' 174' ' ' LEU . 81.7 mt -98.88 88.92 4.14 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.659 1.184 . . . . 71.32 109.449 176.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 176' ' ' LEU . . . . . 0.689 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 78.8 mt -75.3 94.73 3.06 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.303 0.641 . . . . 43.02 110.012 174.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 177' ' ' VAL . . . . . . . . . . . . . 23.5 t -84.62 114.72 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 108.597 -0.89 . . . . 74.43 108.597 -178.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 178' ' ' VAL . . . . . 0.594 HG11 HG22 ' C' ' 153' ' ' VAL . 8.4 p -82.12 126.04 39.88 Favored 'Isoleucine or valine' 0 C--O 1.251 1.15 0 CA-C-O 121.941 0.877 . . . . 74.01 110.822 -176.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 179' ' ' ARG . . . . . . . . . . . . . 24.3 mmt180 -113.82 111.09 21.18 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.188 -1.412 . . . . 72.33 107.188 170.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 180' ' ' LEU . . . . . 0.413 ' HA ' ' O ' ' C' ' 125' ' ' LEU . 93.1 mt -73.29 148.52 43.5 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.86 0.362 . . . . 70.51 110.906 -177.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 181' ' ' LEU . . . . . 0.41 ' HB3' ' HD2' ' C' ' 182' ' ' PRO . 24.9 mt -62.12 166.29 6.84 Favored Pre-proline 0 CA--C 1.564 1.483 0 C-N-CA 124.405 1.082 . . . . 74.2 111.899 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 182' ' ' PRO . . . . . 0.41 ' HD2' ' HB3' ' C' ' 181' ' ' LEU . 12.1 Cg_exo -33.95 -20.84 0.02 OUTLIER 'Trans proline' 0 C--N 1.396 3.068 1 C-N-CA 125.413 4.075 . . . . 64.12 118.26 179.329 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 183' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -104.85 96.8 11.34 Favored Pre-proline 0 CA--C 1.568 1.644 0 CA-C-N 119.14 0.882 . . . . 62.13 110.147 165.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 184' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -98.14 65.91 0.09 OUTLIER 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 123.658 2.905 . . . . 71.54 110.575 171.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 185' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 36.9 t -94.02 -43.44 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 CA-C-N 115.952 -0.567 . . . . 72.23 110.611 -164.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 186' ' ' PHE . . . . . 0.557 ' HD2' HD13 ' C' ' 127' ' ' LEU . 68.1 m-85 -99.9 116.55 32.23 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-O 121.205 0.526 . . . . 61.44 111.345 -167.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 187' ' ' ARG . . . . . 0.688 ' HB3' ' HB3' ' C' ' 194' ' ' TYR . 3.2 tmt_? -96.12 107.91 20.28 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.997 1.319 . . . . 75.14 108.919 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 188' ' ' LEU . . . . . . . . . . . . . 45.8 tp -84.16 140.92 31.42 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.445 0.535 . . . . 74.14 112.445 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -144.97 106.28 4.21 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 107.069 -1.456 . . . . 71.33 107.069 162.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 74.96 -96.43 0.96 Allowed Glycine 0 C--N 1.355 1.633 0 N-CA-C 112.022 -0.431 . . . . 74.2 112.022 -177.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 191' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -115.19 -31.28 6.06 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.108 0.963 . . . . 60.21 110.154 173.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -76.97 152.66 35.15 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 116.072 -0.513 . . . . 65.13 111.551 -170.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 193' ' ' LEU . . . . . 0.47 HD21 ' CD1' ' C' ' 240' ' ' PHE . 88.1 mt -119.82 165.59 14.38 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.735 0.814 . . . . 52.2 111.257 -176.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 194' ' ' TYR . . . . . 0.688 ' HB3' ' HB3' ' C' ' 187' ' ' ARG . 27.5 t80 -139.47 107.3 5.66 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.097 -0.956 . . . . 75.43 109.585 170.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 195' ' ' ALA . . . . . 0.479 ' HA ' ' O ' ' C' ' 185' ' ' VAL . . . -104.67 -174.99 2.67 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.22 1.008 . . . . 65.11 110.907 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 196' ' ' THR . . . . . 0.405 HG21 ' HA ' ' B' ' 159' ' ' LYS . 65.9 m -132.11 121.09 23.24 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 108.088 -1.079 . . . . 51.32 108.088 164.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 197' ' ' LEU . . . . . . . . . . . . . 41.0 tp -97.53 125.86 42.48 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.292 0.637 . . . . 73.5 111.183 -172.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -73.84 101.85 3.88 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.005 0.922 . . . . 44.52 108.87 176.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 199' ' ' VAL . . . . . 0.572 ' HA ' HG11 ' C' ' 210' ' ' VAL . 26.9 t -121.72 109.28 34.37 Favored Pre-proline 0 N--CA 1.475 0.812 0 N-CA-C 108.62 -0.881 . . . . 61.21 108.62 178.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 200' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -68.45 147.13 70.49 Favored 'Trans proline' 0 C--N 1.37 1.702 0 C-N-CA 121.588 1.526 . . . . 71.34 111.317 175.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 201' ' ' ALA . . . . . 0.505 ' O ' HG23 ' C' ' 205' ' ' VAL . . . -52.44 -49.24 86.65 Favored Pre-proline 0 CA--C 1.553 1.07 0 CA-C-O 118.02 -0.99 . . . . 74.35 112.958 -173.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 202' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -51.12 -47.27 26.58 Favored 'Trans proline' 0 C--N 1.387 2.6 0 C-N-CA 121.649 1.566 . . . . 63.15 112.891 176.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 203' ' ' ILE . . . . . 0.518 ' HA ' HG12 ' C' ' 206' ' ' VAL . 47.0 mt -68.56 -34.18 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 123.044 0.538 . . . . 63.4 111.139 -178.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -70.24 -28.45 65.26 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.659 0.783 . . . . 75.02 112.208 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 205' ' ' VAL . . . . . 0.505 HG23 ' O ' ' C' ' 201' ' ' ALA . 55.0 t -86.39 -40.1 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 116.084 -0.507 . . . . 63.41 111.374 178.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 206' ' ' VAL . . . . . 0.609 HG23 ' HG3' ' A' ' 270' ' ' LYS . 14.0 p -80.16 -37.83 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 O-C-N 123.375 0.422 . . . . 52.12 111.355 -171.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 88.08 61.6 1.48 Allowed Glycine 0 N--CA 1.438 -1.177 0 CA-C-N 115.741 -0.663 . . . . 63.21 112.257 -168.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -101.38 -136.65 9.39 Favored Glycine 0 C--O 1.246 0.882 0 N-CA-C 111.431 -0.668 . . . . 51.32 111.431 176.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 209' ' ' LYS . . . . . 0.681 ' HE2' ' HG3' ' B' ' 235' ' ' GLU . 8.3 mtmp? -140.28 136.3 33.15 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.395 0.617 . . . . 72.12 110.92 178.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 210' ' ' VAL . . . . . 0.572 HG11 ' HA ' ' C' ' 199' ' ' VAL . 34.3 m -119.24 -179.86 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.539 1.535 . . . . 62.05 107.272 169.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 211' ' ' ARG . . . . . 0.62 ' HD3' ' HB2' ' C' ' 218' ' ' PRO . 23.1 ttm105 -132.76 130.6 40.15 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 118.976 0.807 . . . . 72.44 112.095 -178.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -97.0 115.05 26.74 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.32 1.048 . . . . 74.43 108.492 168.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 213' ' ' MET . . . . . . . . . . . . . 4.2 tmm? -71.56 101.91 2.6 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 107.418 -1.327 . . . . 63.12 107.418 171.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 214' ' ' THR . . . . . 0.408 ' OG1' HG12 ' C' ' 219' ' ' VAL . 0.2 OUTLIER -98.88 174.25 6.46 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.348 0.594 . . . . 54.24 110.234 -173.78 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 215' ' ' LEU . . . . . 0.603 HD13 ' HB2' ' C' ' 131' ' ' PHE . 30.7 mt -65.48 -33.89 77.0 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.309 1.444 . . . . 44.41 112.712 -169.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.23 10.71 23.7 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 114.94 -1.027 . . . . 71.0 111.472 -178.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 143.65 149.37 5.08 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-O 119.86 -0.411 . . . . 64.11 112.453 176.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 218' ' ' PRO . . . . . 0.62 ' HB2' ' HD3' ' C' ' 211' ' ' ARG . 73.3 Cg_endo -77.24 106.42 2.23 Favored 'Trans proline' 0 CA--C 1.557 1.634 0 C-N-CA 122.606 2.204 . . . . 52.13 113.081 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 219' ' ' VAL . . . . . 0.408 HG12 ' OG1' ' C' ' 214' ' ' THR . 7.2 p -88.32 138.26 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 123.558 0.743 . . . . 52.53 109.903 -178.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 220' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -89.01 111.21 21.88 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 108.734 -0.839 . . . . 72.32 108.734 174.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 221' ' ' VAL . . . . . . . . . . . . . 58.7 t -78.97 128.09 38.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 114.539 -1.209 . . . . 74.03 110.627 -178.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 222' ' ' ALA . . . . . 0.733 ' H ' ' HB2' ' B' ' 239' ' ' ALA . . . -85.42 105.48 16.08 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 124.424 1.09 . . . . 73.3 109.678 176.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 59.1 t -85.71 126.73 65.33 Favored Pre-proline 0 C--O 1.213 -0.858 0 N-CA-C 108.105 -1.072 . . . . 73.11 108.105 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 224' ' ' PRO . . . . . 0.725 ' HG2' ' HG3' ' B' ' 243' ' ' GLN . 10.4 Cg_exo -79.09 156.77 26.48 Favored 'Trans proline' 0 CA--C 1.555 1.546 0 C-N-CA 123.847 3.031 . . . . 54.33 112.221 166.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.43 148.17 64.02 Favored 'Trans proline' 0 C--N 1.387 2.587 0 C-N-CA 123.208 2.605 . . . . 74.0 113.635 -178.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 226' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.5 91.64 0.08 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.229 1.011 . . . . 70.15 112.215 178.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 227' ' ' THR . . . . . 0.511 HG22 HG11 ' C' ' 253' ' ' VAL . 34.0 m -140.9 124.46 16.85 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 115.37 -0.832 . . . . 70.3 111.869 176.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 228' ' ' GLN . . . . . . . . . . . . . 27.1 mp0 -98.11 161.39 13.74 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-O 122.483 1.135 . . . . 74.32 111.024 170.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 229' ' ' ALA . . . . . 0.437 ' HB2' ' H ' ' C' ' 255' ' ' ILE . . . -67.85 150.04 49.08 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-N 113.729 -1.578 . . . . 62.12 109.375 173.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 86.46 -4.17 86.38 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.304 -0.474 . . . . 62.04 113.03 -174.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 231' ' ' ARG . . . . . 0.491 ' NH1' HE22 ' B' ' 243' ' ' GLN . 45.5 mtt180 -76.65 170.34 16.61 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 117.789 0.794 . . . . 74.12 109.334 163.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 232' ' ' LYS . . . . . 0.568 ' HD3' ' HB3' ' C' ' 250' ' ' TYR . 3.9 ttmp? -146.55 139.68 25.58 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.205 0.457 . . . . 71.45 111.921 -173.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 233' ' ' LEU . . . . . 0.584 ' O ' ' HA ' ' C' ' 250' ' ' TYR . 2.4 mp -107.77 151.79 25.23 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.625 1.17 . . . . 74.21 109.89 -177.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -118.83 90.18 3.28 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.638 0.775 . . . . 72.34 109.255 171.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 235' ' ' LEU . . . . . 0.558 HD12 HD23 ' C' ' 249' ' ' LEU . 49.1 mt -74.25 108.39 7.01 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 109.13 -0.693 . . . . 73.43 109.13 172.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -71.08 125.57 27.25 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.879 0.872 . . . . 71.55 111.125 -175.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 71.44 37.14 62.66 Favored Glycine 0 C--N 1.349 1.251 0 O-C-N 123.532 0.52 . . . . 71.42 112.968 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 20.4 mmtm -126.07 14.95 7.9 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.913 0.885 . . . . 72.03 111.065 176.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -93.0 -167.48 38.91 Favored Glycine 0 C--N 1.352 1.449 0 N-CA-C 112.002 -0.439 . . . . 31.21 112.002 171.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 240' ' ' PHE . . . . . 0.47 ' CD1' HD21 ' C' ' 193' ' ' LEU . 3.6 m-85 -69.06 153.45 96.06 Favored Pre-proline 0 N--CA 1.478 0.96 0 C-N-CA 123.74 0.816 . . . . 75.14 111.529 176.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 241' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -65.91 118.86 5.85 Favored 'Trans proline' 0 C--N 1.377 2.054 0 C-N-CA 123.75 2.967 . . . . 70.21 112.411 -175.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -126.84 -169.52 12.74 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-N 115.719 -0.673 . . . . 70.14 112.548 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 243' ' ' PRO . . . . . 0.743 ' HA ' ' HA ' ' B' ' 111' ' ' LEU . 2.0 Cg_endo -72.14 -31.61 11.84 Favored 'Trans proline' 0 C--N 1.383 2.344 0 C-N-CA 123.049 2.5 . . . . 71.42 111.006 -178.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -80.35 6.35 12.34 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.82 0.848 . . . . 71.42 111.807 176.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 111.04 -76.56 0.22 Allowed Glycine 0 C--N 1.349 1.285 0 N-CA-C 109.907 -1.277 . . . . 51.32 109.907 -178.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 246' ' ' ARG . . . . . . . . . . . . . 29.4 mtm180 -146.09 166.44 26.12 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.847 1.259 . . . . 61.31 109.468 174.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -80.57 -158.89 19.53 Favored Glycine 0 C--N 1.347 1.172 0 CA-C-N 116.345 -0.388 . . . . 63.23 112.241 172.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -123.82 135.24 53.65 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 117.085 0.443 . . . . 73.54 109.836 -177.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 249' ' ' LEU . . . . . 0.558 HD23 HD12 ' C' ' 235' ' ' LEU . 21.0 tp -88.33 116.15 26.35 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 114.97 -1.014 . . . . 74.23 110.133 -178.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 250' ' ' TYR . . . . . 0.584 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 16.0 m-85 -102.05 99.87 10.07 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 109.838 -0.431 . . . . 71.43 109.838 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 251' ' ' LEU . . . . . 0.564 ' HB2' HD13 ' C' ' 233' ' ' LEU . 1.6 mp -97.15 136.2 38.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.8 -0.563 . . . . 64.53 110.152 -174.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 252' ' ' GLU . . . . . 0.597 ' HG2' ' HB3' ' B' ' 157' ' ' MET . 4.9 tp10 -88.14 118.71 27.91 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 108.047 -1.094 . . . . 73.41 108.047 174.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 253' ' ' VAL . . . . . 0.511 HG11 HG22 ' C' ' 227' ' ' THR . 94.0 t -60.14 131.14 24.66 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 123.348 0.659 . . . . 73.5 111.066 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 254' ' ' ARG . . . . . 0.47 ' CZ ' ' HB ' ' C' ' 256' ' ' THR . 2.1 tmm_? -124.02 98.32 5.74 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 107.507 -1.294 . . . . 74.13 107.507 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 255' ' ' ILE . . . . . 0.437 ' H ' ' HB2' ' C' ' 229' ' ' ALA . 52.0 mm -72.45 120.4 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 123.356 0.41 . . . . 75.24 109.903 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 256' ' ' THR . . . . . 0.47 ' HB ' ' CZ ' ' C' ' 254' ' ' ARG . 0.0 OUTLIER -125.39 164.46 20.38 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.012 0.925 . . . . 53.32 111.1 -176.131 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 2.8 pp -137.61 149.07 63.76 Favored Pre-proline 0 CA--C 1.554 1.099 0 C-N-CA 124.224 1.01 . . . . 64.54 108.328 175.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -80.11 16.52 1.49 Allowed 'Trans proline' 0 C--N 1.375 1.936 0 C-N-CA 122.599 2.2 . . . . 73.21 113.243 -171.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 57.83 -79.87 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.237 1.415 . . . . 72.3 111.635 -173.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -78.53 148.13 33.52 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.97 0.908 . . . . 73.41 109.901 -178.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 261' ' ' LEU . . . . . . . . . . . . . 82.1 mt -132.88 165.59 24.27 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 121.524 0.678 . . . . 71.21 111.329 -178.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 1.6 p -83.61 147.4 52.27 Favored Pre-proline 0 CA--C 1.552 1.035 0 CA-C-N 114.635 -1.166 . . . . 61.23 108.894 164.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -47.73 -31.63 15.1 Favored 'Trans proline' 0 C--N 1.387 2.558 0 C-N-CA 124.476 3.451 . . . . 74.2 114.988 -173.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -60.43 -65.76 0.63 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.88 0.872 . . . . 71.04 109.73 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -57.67 -42.56 83.82 Favored 'General case' 0 C--O 1.216 -0.697 0 CA-C-N 114.466 -1.243 . . . . 65.11 109.767 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 266' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -51.82 -46.12 64.19 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 123.992 0.917 . . . . 64.21 110.718 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -67.81 -43.67 79.08 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.5 0.72 . . . . 70.32 112.05 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 268' ' ' LEU . . . . . . . . . . . . . 10.6 mp -64.72 -37.35 87.29 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 120.765 0.317 . . . . 52.44 111.295 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 84.5 m95 -70.03 -32.26 70.31 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.536 0.735 . . . . 61.11 110.377 175.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 3.9 mmmp? -57.91 -50.65 72.61 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 122.852 0.461 . . . . 75.43 109.823 171.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 9.7 mmpt? -56.33 -52.53 64.2 Favored 'General case' 0 C--O 1.252 1.223 0 O-C-N 124.183 0.927 . . . . 75.33 111.191 -178.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 57.6 mt -51.99 -60.65 2.94 Favored 'General case' 0 C--N 1.355 0.845 0 CA-C-N 115.323 -0.853 . . . . 74.33 110.216 174.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -51.9 -44.77 63.94 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.927 0.891 . . . . 34.13 112.338 -173.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -62.21 -45.49 93.14 Favored 'General case' 0 C--O 1.252 1.235 0 C-N-CA 123.579 0.752 . . . . 63.21 110.818 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -58.54 -32.03 68.49 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 116.096 -0.502 . . . . 70.04 111.399 175.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 276' ' ' TYR . . . . . 0.703 ' HA ' ' HD3' ' C' ' 279' ' ' ARG . 1.4 m-85 -85.56 -23.09 27.8 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.09 0.556 . . . . 75.52 111.801 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 277' ' ' TYR . . . . . 0.465 ' CE1' ' HA3' ' A' ' 208' ' ' GLY . 20.4 m-30 -70.43 -30.74 67.67 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 109.424 -0.584 . . . . 44.24 109.424 174.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -59.72 -18.74 45.09 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-N 115.361 -0.836 . . . . 55.2 112.384 171.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 279' ' ' ARG . . . . . 0.703 ' HD3' ' HA ' ' C' ' 276' ' ' TYR . 17.5 mtp-105 -87.76 -26.91 22.65 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.784 0.834 . . . . 71.52 110.844 175.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.025 0 C-N-CA 123.243 0.617 . . . . 75.14 110.277 -172.654 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.2 mtp . . . . . 0 N--CA 1.47 0.555 0 N-CA-C 108.463 -0.94 . . . . 64.12 108.463 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.67 30.99 19.73 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.29 1.036 . . . . 51.4 111.999 -179.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.0 64.75 6.83 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.828 0.851 . . . . 74.04 110.458 -175.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -39.3 100.74 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.499 1.52 . . . . 62.43 114.165 -175.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -65.85 109.1 2.36 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 109.278 -0.638 . . . . 74.32 109.278 169.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -73.83 89.35 1.84 Allowed 'General case' 0 C--O 1.246 0.917 0 N-CA-C 107.165 -1.42 . . . . 61.41 107.165 170.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.445 ' HB2' HD11 ' A' ' 57' ' ' LEU . 67.1 m-85 -61.29 -27.94 68.83 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 113.9 -1.5 . . . . 73.34 111.565 -172.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -68.13 -41.7 81.27 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 122.962 0.505 . . . . 73.33 110.255 177.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.13 -41.77 97.07 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.045 0.538 . . . . 60.32 110.497 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 65.2 mt -58.93 -36.73 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 O-C-N 123.804 0.69 . . . . 74.23 110.29 174.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 91.2 mt -84.71 -10.49 57.21 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 113.303 0.853 . . . . 51.33 113.303 177.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 68.74 32.52 74.33 Favored Glycine 0 CA--C 1.537 1.427 0 N-CA-C 114.03 0.372 . . . . 53.33 114.03 -178.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.3 m -118.35 162.67 29.04 Favored Pre-proline 0 N--CA 1.484 1.226 0 C-N-CA 124.609 1.164 . . . . 71.43 109.554 174.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.401 ' HG2' ' HB2' ' A' ' 17' ' ' ALA . 11.9 Cg_endo -54.79 152.35 28.83 Favored 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 122.772 2.315 . . . . 50.12 112.586 175.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 76.1 mtt-85 -74.84 19.43 0.14 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 113.648 0.981 . . . . 75.43 113.648 -172.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -148.79 12.68 0.89 Allowed 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 124.605 1.162 . . . . 64.11 109.128 -177.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.401 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . . . -66.06 145.49 55.79 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.789 1.235 . . . . 64.31 113.457 -171.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.1 p -70.45 162.71 28.22 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.363 1.065 . . . . 71.11 111.658 -178.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -57.82 -30.18 65.53 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.145 0.978 . . . . 64.21 111.262 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.499 ' HA ' ' HE2' ' A' ' 23' ' ' LYS . 0.8 OUTLIER -69.07 -40.92 78.17 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.746 0.818 . . . . 72.43 109.899 178.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.507 ' HG2' ' NH2' ' A' ' 24' ' ' ARG . 42.7 mt-10 -67.98 -35.96 79.23 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.415 0.686 . . . . 64.03 110.833 176.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.81 -33.76 65.54 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 C-N-CA 124.592 1.157 . . . . 73.31 110.326 175.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.499 ' HE2' ' HA ' ' A' ' 20' ' ' GLU . 37.6 ttpt -76.19 -33.26 59.29 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.74 1.216 . . . . 71.24 110.483 179.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.507 ' NH2' ' HG2' ' A' ' 21' ' ' GLU . 50.2 mtm-85 -70.82 -40.97 72.14 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.156 0.583 . . . . 54.12 110.235 173.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.97 -33.88 75.5 Favored 'General case' 0 C--O 1.237 0.402 0 O-C-N 124.163 0.914 . . . . 64.0 110.719 176.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -60.33 -56.97 15.0 Favored 'General case' 0 C--O 1.215 -0.724 0 O-C-N 123.913 0.758 . . . . 73.1 109.9 176.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.496 ' NZ ' ' HA ' ' A' ' 24' ' ' ARG . 35.1 mtmm -60.32 -44.81 95.12 Favored 'General case' 0 N--CA 1.482 1.164 0 O-C-N 123.869 0.73 . . . . 74.22 111.132 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 46.1 ttt180 -47.25 -52.61 15.55 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 125.087 1.355 . . . . 71.15 111.945 176.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.539 HD13 HD12 ' A' ' 50' ' ' ILE . 62.7 mt -91.74 -13.94 30.78 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.559 -0.746 . . . . 74.11 111.656 -173.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -80.51 -18.51 48.3 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.259 0.624 . . . . 63.3 109.991 172.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 51.1 mtp180 -94.55 -39.11 10.56 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.04 0.936 . . . . 72.33 110.331 172.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -71.22 -40.24 71.24 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 122.537 0.335 . . . . 63.33 111.671 -177.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -106.97 24.62 12.5 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.879 0.472 . . . . 63.25 110.319 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 75.8 t60 -57.18 94.79 0.05 OUTLIER Pre-proline 0 N--CA 1.484 1.259 0 C-N-CA 124.73 1.212 . . . . 63.41 112.105 -171.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -72.02 -22.2 23.22 Favored 'Trans proline' 0 C--N 1.368 1.575 0 C-N-CA 122.652 2.235 . . . . 74.13 111.883 -164.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -53.57 -35.82 61.21 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.473 1.509 . . . . 72.45 111.615 176.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 89.4 t -115.42 -40.32 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 CA-C-O 120.905 0.383 . . . . 65.53 110.113 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -100.5 82.46 2.47 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.23 1.012 . . . . 61.35 110.045 -177.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.99 60.87 6.51 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.043 0.537 . . . . 73.11 110.189 -178.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 63.2 m -105.14 123.85 38.42 Favored Pre-proline 0 N--CA 1.481 1.096 0 CA-C-O 117.81 -1.09 . . . . 54.41 109.706 -177.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -40.88 -51.91 3.51 Favored 'Trans proline' 0 C--N 1.391 2.778 0 C-N-CA 124.767 3.645 . . . . 72.23 114.322 -175.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -51.94 -51.17 58.9 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.067 0.947 . . . . 64.43 110.849 175.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.04 -15.46 60.64 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.403 0.681 . . . . 72.14 111.81 -178.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.6 mm-40 -74.93 -60.77 2.14 Favored 'General case' 0 C--N 1.36 1.024 0 N-CA-C 108.236 -1.024 . . . . 62.01 108.236 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -56.59 -44.45 81.07 Favored 'General case' 0 C--N 1.354 0.793 0 CA-C-N 114.214 -1.357 . . . . 62.44 109.826 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.492 ' O ' HG12 ' A' ' 50' ' ' ILE . 9.6 tppt? -66.89 -43.77 82.61 Favored 'General case' 0 C--N 1.357 0.897 0 O-C-N 124.249 0.968 . . . . 74.03 111.078 -175.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -55.66 -44.39 77.21 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 123.765 0.665 . . . . 73.24 110.523 175.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.7 mtpm? -65.37 -35.64 81.58 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 115.54 -0.754 . . . . 75.14 111.578 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -67.96 -31.24 70.83 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 122.921 0.488 . . . . 71.44 110.747 173.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.539 HD12 HD13 ' A' ' 29' ' ' LEU . 12.0 mm -67.01 -37.54 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 N-CA-C 109.099 -0.704 . . . . 70.53 109.099 173.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.43 ' O ' ' HB2' ' A' ' 55' ' ' ALA . 53.2 m-80 -69.43 -31.54 69.94 Favored 'General case' 0 C--O 1.207 -1.137 0 CA-C-N 115.283 -0.871 . . . . 73.43 111.388 177.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -64.22 -53.77 43.92 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.788 0.804 . . . . 63.42 109.874 174.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.418 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . . . -56.8 -53.27 59.8 Favored 'General case' 0 C--O 1.25 1.096 0 CA-C-N 113.569 -1.651 . . . . 65.45 111.915 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -61.51 -40.35 94.3 Favored 'General case' 0 C--O 1.209 -1.054 0 CA-C-N 115.023 -0.989 . . . . 72.32 110.517 176.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.43 ' HB2' ' O ' ' A' ' 51' ' ' ASN . . . -54.8 -47.51 73.93 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.297 0.639 . . . . 53.01 112.123 -176.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 78.7 t -69.71 -45.36 77.79 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 O-C-N 123.738 0.649 . . . . 74.52 110.671 177.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.445 HD11 ' HB2' ' A' ' 7' ' ' TYR . 58.4 mt -90.84 6.47 44.24 Favored 'General case' 0 CA--C 1.563 1.455 0 N-CA-C 113.603 0.964 . . . . 62.04 113.603 -172.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 44.4 t -71.95 -51.87 19.95 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 124.409 1.084 . . . . 74.34 111.339 -178.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -102.29 140.05 20.8 Favored Pre-proline 0 C--O 1.243 0.763 0 CA-C-N 115.209 -0.905 . . . . 74.34 109.172 -176.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.402 ' O ' ' HG2' ' A' ' 64' ' ' ARG . 75.5 Cg_exo -53.25 -26.21 33.25 Favored 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 123.705 2.937 . . . . 72.41 113.142 177.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -61.69 -62.07 2.07 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 124.485 1.114 . . . . 72.3 111.054 -179.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.458 ' HA ' HD12 ' A' ' 65' ' ' ILE . 41.2 mtmt -76.04 -24.0 55.16 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 115.688 -0.687 . . . . 74.54 111.303 -176.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 42.1 tpt85 -55.76 -53.33 57.92 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 124.099 0.875 . . . . 74.11 109.005 168.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' A' ' 60' ' ' PRO . 1.8 mmp_? -64.19 -34.91 79.17 Favored 'General case' 0 C--N 1.36 1.05 0 C-N-CA 123.459 0.704 . . . . 74.25 112.172 178.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.458 HD12 ' HA ' ' A' ' 62' ' ' LYS . 94.7 mt -57.09 -44.93 83.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 CA-C-O 121.15 0.5 . . . . 64.42 110.811 174.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -63.97 -44.88 91.41 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 115.77 -0.65 . . . . 75.4 110.09 177.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -60.61 -32.58 71.71 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 123.075 0.55 . . . . 64.04 112.019 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 48.6 p -84.4 -15.33 46.67 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.576 0.35 . . . . 75.13 111.571 178.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -72.71 106.4 4.69 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 108.636 -0.876 . . . . 63.45 108.636 170.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 105.54 18.08 12.42 Favored Glycine 0 N--CA 1.472 1.091 0 N-CA-C 111.535 -0.626 . . . . 52.54 111.535 -171.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 85.0 m -137.55 -56.64 0.69 Allowed 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 103.733 -2.691 . . . . 71.23 103.733 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.7 m -82.54 141.32 32.71 Favored 'General case' 0 C--O 1.251 1.156 0 N-CA-C 104.385 -2.45 . . . . 74.23 104.385 155.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.54 -23.13 20.99 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.364 0.665 . . . . 74.04 111.736 -176.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -111.46 169.17 6.6 Favored Pre-proline 0 N--CA 1.478 0.936 0 C-N-CA 124.181 0.993 . . . . 75.1 110.029 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -52.11 135.79 52.66 Favored 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 122.253 1.969 . . . . 75.41 112.386 167.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.455 ' HG3' HG23 ' A' ' 65' ' ' ILE . 73.0 Cg_endo -70.17 173.0 11.98 Favored 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 123.127 2.551 . . . . 74.25 112.259 -178.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -62.58 119.82 7.07 Favored 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 121.759 1.639 . . . . 62.44 111.185 170.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -64.16 145.78 89.63 Favored 'Trans proline' 0 C--N 1.382 2.331 0 C-N-CA 122.848 2.366 . . . . 43.51 112.829 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -63.66 149.62 90.43 Favored 'Trans proline' 0 C--N 1.38 2.205 0 C-N-CA 122.946 2.43 . . . . 71.05 111.954 171.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -67.87 76.35 0.61 Allowed 'Trans proline' 0 C--N 1.382 2.322 0 C-N-CA 123.601 2.867 . . . . 51.35 112.711 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 159.33 -35.47 0.48 Allowed Glycine 0 N--CA 1.462 0.384 0 N-CA-C 109.288 -1.525 . . . . 62.41 109.288 -174.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 128.13 171.36 12.99 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-N 114.804 -0.698 . . . . 53.03 112.331 171.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -67.31 107.36 2.36 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 107.977 -1.119 . . . . 74.41 107.977 166.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.451 ' O ' ' HD1' ' A' ' 85' ' ' PHE . 23.6 t70 -61.86 153.22 29.54 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.802 0.841 . . . . 71.31 112.615 -175.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.451 ' HD1' ' O ' ' A' ' 84' ' ' ASP . 0.1 OUTLIER -153.52 70.77 0.86 Allowed 'General case' 0 CA--C 1.553 1.059 0 N-CA-C 107.761 -1.2 . . . . 70.22 107.761 170.428 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.593 ' HA ' ' HA3' ' A' ' 163' ' ' GLY . 41.5 m -57.9 86.76 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 125.006 1.322 . . . . 74.44 114.367 -174.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.572 ' HA2' ' HB3' ' A' ' 171' ' ' PRO . . . 98.16 12.22 46.48 Favored Glycine 0 N--CA 1.47 0.936 0 CA-C-N 116.368 -0.378 . . . . 70.11 113.721 176.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.409 ' CD1' ' HB3' ' A' ' 51' ' ' ASN . 30.2 m-85 -123.58 110.32 14.88 Favored 'General case' 0 C--O 1.245 0.846 0 C-N-CA 122.831 0.453 . . . . 72.34 110.16 -170.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -70.23 94.8 0.94 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 122.803 0.441 . . . . 71.44 110.066 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.561 HG13 ' HG2' ' A' ' 91' ' ' GLU . 2.3 p -27.41 -50.39 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 126.203 1.801 . . . . 75.21 114.961 166.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.561 ' HG2' HG13 ' A' ' 90' ' ' VAL . 9.7 mm-40 -67.86 -12.89 61.56 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.994 0.918 . . . . 75.33 112.854 -168.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -80.97 -39.17 26.45 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.127 0.971 . . . . 45.35 111.438 175.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.421 ' CD2' ' HE2' ' A' ' 85' ' ' PHE . 22.3 m-85 -83.28 179.73 7.62 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 115.429 -0.805 . . . . 71.01 112.357 -166.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 80.1 p -59.14 142.42 51.6 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.446 1.098 . . . . 74.5 112.598 -170.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.4 -28.53 69.85 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.024 -0.989 . . . . 74.31 111.343 174.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -52.32 -55.27 22.58 Favored 'General case' 0 C--N 1.367 1.333 0 C-N-CA 123.026 0.53 . . . . 75.03 110.607 169.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -56.77 -43.53 80.92 Favored 'General case' 0 CA--C 1.548 0.887 0 O-C-N 124.065 0.853 . . . . 63.23 109.586 178.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.578 ' HA ' HD11 ' A' ' 105' ' ' LEU . 92.7 mt-30 -70.87 -12.33 61.48 Favored 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 115.458 -0.792 . . . . 73.05 112.307 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -88.07 -57.71 2.83 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.83 0.852 . . . . 70.02 111.766 171.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 51.0 tp -64.39 -42.51 96.08 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.69 0.796 . . . . 55.03 111.506 -174.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -94.62 -4.75 47.19 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-N 115.811 -0.632 . . . . 72.11 110.331 178.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -43.48 -59.24 3.69 Favored Glycine 0 C--N 1.356 1.663 0 CA-C-O 118.49 -1.172 . . . . 72.43 114.882 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -43.42 -24.15 0.58 Allowed 'Trans proline' 0 C--N 1.392 2.834 0 C-N-CA 124.717 3.612 . . . . 23.1 116.143 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -150.79 36.8 0.9 Allowed Glycine 0 C--N 1.352 1.457 0 CA-C-O 119.241 -0.755 . . . . 44.4 113.016 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.578 HD11 ' HA ' ' A' ' 98' ' ' GLN . 18.1 mt -54.33 84.62 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.147 0.579 . . . . 74.25 111.997 173.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.414 ' CD2' ' HA ' ' A' ' 84' ' ' ASP . 0.4 OUTLIER 19.19 -110.18 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 127.938 2.495 . . . . 72.25 113.831 176.192 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 58.46 16.86 30.43 Favored Glycine 0 C--N 1.361 1.931 0 CA-C-O 119.771 -0.461 . . . . 44.0 113.869 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 64.86 -100.04 0.41 Allowed Glycine 0 C--N 1.356 1.664 0 N-CA-C 111.396 -0.682 . . . . 71.34 111.396 -167.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -132.69 7.84 4.13 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.356 1.062 . . . . 64.11 109.842 177.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -69.07 -30.3 72.08 Favored Glycine 0 C--N 1.355 1.633 0 CA-C-N 115.509 -0.769 . . . . 55.25 113.037 178.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 74.52 -30.79 0.21 Allowed 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 124.758 1.223 . . . . 71.44 113.773 176.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.72 -11.7 58.93 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.483 0.713 . . . . 73.25 110.443 175.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 2.9 m 69.69 58.29 0.31 Allowed 'General case' 0 C--N 1.357 0.897 0 C-N-CA 124.218 1.007 . . . . 74.21 109.285 174.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -119.62 169.01 10.46 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.832 -0.622 . . . . 74.52 111.924 -174.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.09 132.0 47.5 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.337 1.455 . . . . 72.15 112.188 -164.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -77.86 -163.57 21.41 Favored Glycine 0 CA--C 1.543 1.803 0 CA-C-N 115.476 -0.784 . . . . 55.22 114.6 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.455 ' H ' ' HA3' ' A' ' 166' ' ' GLY . 0.9 OUTLIER -112.74 130.33 56.1 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 124.587 1.155 . . . . 71.34 111.751 178.69 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -52.23 120.56 5.61 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.622 0.725 . . . . 74.23 111.487 176.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 67.2 tp -129.1 157.33 42.06 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 115.138 -0.937 . . . . 70.23 110.287 -171.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 34.3 ttp180 -111.18 146.67 36.47 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 108.793 -0.817 . . . . 74.51 108.793 171.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.556 ' HB2' HD11 ' A' ' 174' ' ' LEU . . . -128.35 158.19 38.91 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.604 0.716 . . . . 41.51 110.762 177.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.407 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 0.4 OUTLIER -112.76 108.1 16.99 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 105.262 -2.125 . . . . 61.0 105.262 -179.443 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.557 ' HB3' ' HA ' ' A' ' 178' ' ' VAL . 41.9 tp -98.44 97.44 4.68 Favored Pre-proline 0 N--CA 1.476 0.841 0 N-CA-C 108.042 -1.096 . . . . 54.05 108.042 -175.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.584 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 98.5 Cg_endo -79.22 107.62 2.23 Favored 'Trans proline' 0 C--N 1.381 2.237 0 C-N-CA 121.005 1.137 . . . . 75.33 109.309 -177.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.517 ' HB3' HD23 ' A' ' 180' ' ' LEU . 54.2 tp -109.63 132.05 54.5 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 122.362 0.265 . . . . 64.01 110.637 -166.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 97.4 m -62.59 124.87 22.11 Favored 'General case' 0 CA--C 1.551 0.986 0 O-C-N 124.496 1.122 . . . . 71.34 109.165 176.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.412 ' HB3' HD22 ' A' ' 215' ' ' LEU . 73.7 mt -52.77 -43.39 65.8 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 124.266 1.027 . . . . 70.54 112.195 -170.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -60.12 -35.84 76.14 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 114.36 -1.291 . . . . 75.32 110.241 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -83.01 -20.54 34.86 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.998 0.919 . . . . 64.33 111.314 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -66.64 -35.58 80.52 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 109.86 -0.422 . . . . 41.43 109.86 168.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -74.51 -48.05 29.46 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 115.298 -0.864 . . . . 74.51 111.831 173.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 33.3 m170 -74.03 -40.17 63.05 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 123.221 0.608 . . . . 75.25 111.886 -171.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 74.11 -151.33 43.73 Favored Glycine 0 CA--C 1.531 1.084 0 O-C-N 123.618 0.574 . . . . 71.54 113.092 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 86.34 -167.63 39.51 Favored Glycine 0 N--CA 1.473 1.166 0 C-N-CA 123.117 0.389 . . . . 70.42 112.435 -178.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.424 ' HB3' ' OG ' ' A' ' 146' ' ' SER . 2.6 mp0 -76.65 118.84 19.7 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.908 0.483 . . . . 73.14 110.289 175.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -94.47 119.88 33.85 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.658 0.783 . . . . 74.4 110.083 177.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 77.2 t -75.83 111.56 12.42 Favored 'Isoleucine or valine' 0 C--O 1.244 0.788 0 N-CA-C 108.704 -0.85 . . . . 71.24 108.704 168.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.557 HG13 HG13 ' A' ' 145' ' ' VAL . 3.5 p -135.69 138.09 48.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 124.452 1.101 . . . . 73.14 108.444 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -124.27 141.98 51.63 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.185 0.594 . . . . 71.3 110.974 -170.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.55 HG11 HD23 ' B' ' 8' ' ' LEU . 12.3 p -169.11 137.07 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 124.571 1.149 . . . . 75.1 109.07 176.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 55.49 33.21 20.55 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.129 0.972 . . . . 74.24 112.394 174.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 87.25 -23.6 11.32 Favored Glycine 0 C--N 1.352 1.443 0 CA-C-N 116.092 -0.504 . . . . 31.1 113.255 -178.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.548 ' NH1' ' HG2' ' A' ' 164' ' ' MET . 11.5 tpt180 -74.41 100.09 3.71 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.211 1.005 . . . . 72.12 110.543 179.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 19.7 ttp180 -84.47 92.53 8.1 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 107.912 -1.144 . . . . 74.41 107.912 165.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.557 HG13 HG13 ' A' ' 138' ' ' VAL . 3.7 p -98.53 143.02 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 115.041 -0.981 . . . . 73.53 110.796 -175.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.424 ' OG ' ' HB3' ' A' ' 135' ' ' GLU . 17.3 t -105.53 84.96 2.16 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 108.46 -0.941 . . . . 31.45 108.46 177.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 34.8 m -83.17 115.4 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 CA-C-O 121.244 0.545 . . . . 73.42 110.192 -177.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 48.5 ttt180 -74.18 103.36 4.58 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 109.426 -0.583 . . . . 74.14 109.426 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.447 ' HB ' HG11 ' A' ' 153' ' ' VAL . 36.3 pt -94.05 139.22 22.51 Favored Pre-proline 0 CA--C 1.557 1.243 0 C-N-CA 123.818 0.847 . . . . 74.13 109.508 176.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -73.26 140.7 31.09 Favored 'Trans proline' 0 C--N 1.372 1.784 0 C-N-CA 122.345 2.03 . . . . 60.34 111.846 176.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -57.85 93.18 0.06 OUTLIER 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 122.653 2.235 . . . . 74.15 111.494 167.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.605 ' HA2' ' HD2' ' A' ' 240' ' ' PHE . . . 124.62 31.48 0.89 Allowed Glycine 0 C--N 1.341 0.847 0 CA-C-N 115.558 -0.746 . . . . 75.51 112.474 -176.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.447 HG11 ' HB ' ' A' ' 149' ' ' ILE . 3.4 p -86.36 137.23 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 123.391 0.676 . . . . 75.43 110.323 -178.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.849 ' HD2' ' HA ' ' A' ' 191' ' ' GLN . 2.7 mtm-85 -127.46 151.29 49.03 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.815 0.846 . . . . 73.23 110.908 -163.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -53.24 116.9 2.65 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 124.694 1.246 . . . . 72.32 110.477 178.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 107.16 2.26 35.89 Favored Glycine 0 C--N 1.345 1.081 0 CA-C-N 115.76 -0.654 . . . . 14.21 113.54 -175.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 28.1 t -78.03 104.32 8.53 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 108.091 -1.078 . . . . 74.23 108.091 172.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.442 HG22 HG22 ' A' ' 177' ' ' VAL . 41.8 t -87.06 91.89 3.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 C-N-CA 124.74 1.216 . . . . 72.34 109.585 -178.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.551 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 58.9 mt -76.02 97.04 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 N-CA-C 108.576 -0.898 . . . . 75.24 108.576 173.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 74.0 ttt-85 -75.28 103.91 5.63 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.563 -0.532 . . . . 61.32 109.563 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.483 HG11 ' SD ' ' A' ' 164' ' ' MET . 7.5 p -116.46 123.15 30.95 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 123.505 0.722 . . . . 61.33 109.431 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -65.28 148.68 88.74 Favored 'Trans proline' 0 C--N 1.364 1.359 0 C-N-CA 122.707 2.271 . . . . 74.53 113.113 174.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.593 ' HA3' ' HA ' ' A' ' 86' ' ' SER . . . 83.5 -25.74 4.92 Favored Glycine 0 N--CA 1.479 1.516 0 N-CA-C 116.482 1.353 . . . . 70.43 116.482 166.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.548 ' HG2' ' NH1' ' A' ' 143' ' ' ARG . 66.7 mtp -75.11 -21.68 58.73 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 117.502 0.651 . . . . 64.15 111.691 -179.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.531 ' HA2' HD13 ' A' ' 174' ' ' LEU . . . -80.2 -106.62 0.28 Allowed Glycine 0 C--N 1.348 1.236 0 CA-C-O 119.346 -0.697 . . . . 73.33 113.107 -175.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.455 ' HA3' ' H ' ' A' ' 117' ' ' ARG . . . -53.13 109.02 0.86 Allowed Glycine 0 C--O 1.275 2.658 0 O-C-N 123.85 0.382 . . . . 74.5 112.849 168.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -54.29 104.07 0.1 Allowed 'General case' 0 C--N 1.351 0.673 0 O-C-N 127.854 2.737 . . . . 75.42 108.676 177.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -173.26 143.98 7.51 Favored Glycine 0 N--CA 1.44 -1.066 0 N-CA-C 108.556 -1.818 . . . . 64.21 108.556 -171.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . 0.54 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . 0.2 OUTLIER -73.16 -49.58 7.04 Favored Pre-proline 0 CA--C 1.558 1.27 0 N-CA-C 109.396 -0.594 . . . . 63.11 109.396 -171.688 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.54 ' HD3' ' HB3' ' A' ' 169' ' ' ASN . 18.8 Cg_exo -71.76 149.76 54.92 Favored 'Trans proline' 0 C--N 1.375 1.965 0 N-CA-C 108.19 -1.504 . . . . 71.13 108.19 156.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.572 ' HB3' ' HA2' ' A' ' 87' ' ' GLY . 74.1 Cg_endo -69.61 124.12 10.82 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 122.716 2.278 . . . . 71.25 116.247 -162.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -62.26 -46.73 93.33 Favored Glycine 0 C--N 1.374 2.641 0 C-N-CA 119.41 -1.376 . . . . 72.4 111.117 161.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 101.8 147.71 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 128.49 2.716 . . . . 71.14 108.438 177.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.556 HD11 ' HB2' ' A' ' 121' ' ' ALA . 28.3 tp -137.14 138.51 40.35 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.115 0.483 . . . . 64.32 110.768 -175.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 48.0 mt -105.34 89.8 3.23 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 114.731 -1.122 . . . . 72.12 108.166 171.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.551 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 64.6 mt -68.39 88.27 0.32 Allowed 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 109.684 -0.487 . . . . 70.05 109.684 175.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.442 HG22 HG22 ' A' ' 158' ' ' VAL . 18.2 t -85.36 104.01 12.89 Favored 'Isoleucine or valine' 0 C--O 1.25 1.1 0 N-CA-C 106.384 -1.71 . . . . 61.43 106.384 174.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.557 ' HA ' ' HB3' ' A' ' 123' ' ' LEU . 8.2 p -67.49 119.55 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 CA-C-N 115.216 -0.902 . . . . 70.33 109.688 -175.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.584 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 36.7 mmt180 -103.07 109.08 20.51 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-N 114.18 -1.373 . . . . 53.32 107.868 176.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.517 HD23 ' HB3' ' A' ' 125' ' ' LEU . 59.6 mt -74.79 143.05 44.17 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.683 -0.636 . . . . 72.4 109.496 177.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 86.2 mt -52.86 154.72 4.72 Favored Pre-proline 0 N--CA 1.486 1.325 0 C-N-CA 123.94 0.896 . . . . 73.14 112.82 -168.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . 0.436 ' HD3' HG22 ' B' ' 18' ' ' VAL . 72.2 Cg_endo -74.25 21.43 0.39 Allowed 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 122.695 2.263 . . . . 71.42 112.783 171.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 184' ' ' PRO . 36.7 t-80 -61.64 106.7 0.87 Allowed Pre-proline 0 CA--C 1.557 1.215 0 C-N-CA 125.817 1.647 . . . . 73.35 108.114 168.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.453 ' HB3' ' HA ' ' B' ' 23' ' ' THR . 8.0 Cg_exo -73.95 25.04 0.34 Allowed 'Trans proline' 0 C--N 1.373 1.86 0 C-N-CA 124.137 3.225 . . . . 61.24 116.428 -162.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 69.1 t -97.25 -39.08 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 118.569 0.622 . . . . 64.21 109.672 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . 0.683 ' HE1' ' HA ' ' A' ' 214' ' ' THR . 35.4 m-85 -146.29 111.59 5.44 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.114 0.483 . . . . 72.31 112.069 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.677 ' HB3' ' HB2' ' A' ' 194' ' ' TYR . 59.4 ttt180 -91.93 82.39 5.14 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 106.889 -1.523 . . . . 75.51 106.889 162.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.499 ' HB2' HD23 ' A' ' 193' ' ' LEU . 40.8 tp -79.5 95.39 5.8 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.438 -0.801 . . . . 74.21 108.872 177.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -118.74 131.12 56.12 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.609 0.764 . . . . 70.31 109.951 -174.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 77.62 -77.51 1.59 Allowed Glycine 0 C--N 1.353 1.48 0 N-CA-C 111.497 -0.641 . . . . 65.41 111.497 -178.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.849 ' HA ' ' HD2' ' A' ' 154' ' ' ARG . 13.2 pt20 -153.34 -6.03 0.18 Allowed 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.041 0.936 . . . . 72.32 111.061 173.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -122.18 150.43 42.25 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.459 0.704 . . . . 72.32 110.975 -167.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.499 HD23 ' HB2' ' A' ' 188' ' ' LEU . 38.5 mt -92.17 152.31 19.95 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.935 1.294 . . . . 63.44 111.089 -170.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.677 ' HB2' ' HB3' ' A' ' 187' ' ' ARG . 89.0 m-85 -131.34 103.09 6.25 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 107.964 -1.124 . . . . 73.14 107.964 169.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.483 ' HB3' HD23 ' A' ' 251' ' ' LEU . . . -122.93 115.95 22.78 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.464 1.106 . . . . 74.34 110.648 -173.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . 0.458 ' HA ' ' HB2' ' A' ' 252' ' ' GLU . 93.6 m -71.43 111.63 6.9 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 121.082 0.468 . . . . 70.21 110.686 -177.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.493 HD22 HD13 ' A' ' 251' ' ' LEU . 37.5 tp -99.04 119.85 38.49 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.772 0.829 . . . . 72.21 110.809 -173.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -82.38 115.86 21.6 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 108.363 -0.977 . . . . 61.43 108.363 172.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.1 p -143.62 126.35 8.75 Favored Pre-proline 0 N--CA 1.479 1.022 0 C-N-CA 123.375 0.67 . . . . 64.4 110.138 -175.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 256' ' ' THR . 54.1 Cg_endo -72.11 152.1 56.18 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 121.942 1.762 . . . . 64.51 112.095 176.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -44.22 -59.31 3.89 Favored Pre-proline 0 N--CA 1.484 1.268 0 N-CA-C 116.267 1.951 . . . . 71.34 116.267 -172.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -74.07 -19.82 19.88 Favored 'Trans proline' 0 C--N 1.384 2.411 0 CA-C-N 121.84 1.693 . . . . 63.54 112.76 -174.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 17.7 mt -75.11 -30.27 22.97 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 N-CA-C 109.521 -0.548 . . . . 64.32 109.521 172.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -72.22 -43.03 65.04 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-O 121.129 0.49 . . . . 71.51 111.23 173.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 54.5 t -71.94 -41.77 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 123.803 0.841 . . . . 63.23 112.375 -174.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 97.2 t -93.06 -32.61 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 122.546 0.338 . . . . 74.41 110.747 -178.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 89.83 77.19 1.32 Allowed Glycine 0 C--N 1.343 0.923 0 CA-C-N 116.312 -0.404 . . . . 72.35 112.137 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -96.03 -136.55 8.84 Favored Glycine 0 C--N 1.342 0.867 0 N-CA-C 112.056 -0.418 . . . . 55.24 112.056 178.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 46.0 mtmt -130.47 144.27 51.29 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.12 0.568 . . . . 45.21 110.013 178.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 16.8 m -136.32 176.71 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.533 1.133 . . . . 63.11 109.526 174.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 20.5 ttm180 -109.75 112.2 24.12 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.578 0.751 . . . . 71.41 109.529 175.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -104.6 126.62 51.86 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.721 -0.844 . . . . 62.04 108.721 176.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . 0.638 ' HA ' ' HA ' ' A' ' 218' ' ' PRO . 3.5 mpp? -74.52 138.92 43.45 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.916 0.486 . . . . 71.23 110.245 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . 0.683 ' HA ' ' HE1' ' A' ' 186' ' ' PHE . 69.0 p -117.95 179.29 4.13 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 122.999 0.52 . . . . 74.1 110.34 171.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.412 HD22 ' HB3' ' A' ' 127' ' ' LEU . 55.5 mt -67.33 -20.13 65.55 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 115.231 -0.895 . . . . 63.31 111.592 -178.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -109.24 19.71 19.12 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.619 0.767 . . . . 64.44 111.404 179.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 110.47 174.29 20.41 Favored Glycine 0 N--CA 1.474 1.224 0 CA-C-O 119.426 -0.652 . . . . 33.0 113.23 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . 0.638 ' HA ' ' HA ' ' A' ' 213' ' ' MET . 83.9 Cg_endo -76.43 145.98 27.26 Favored 'Trans proline' 0 C--N 1.368 1.581 0 C-N-CA 122.744 2.296 . . . . 70.23 112.622 -175.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 24.3 m -139.89 163.9 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 C-N-CA 123.777 0.831 . . . . 73.4 111.371 -176.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -91.28 117.54 29.73 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.154 0.982 . . . . 75.04 110.157 -178.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 57.9 t -128.81 126.59 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 124.269 1.027 . . . . 74.13 109.037 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -88.04 131.5 34.63 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.495 0.318 . . . . 60.25 111.372 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.477 ' HA ' HD12 ' B' ' 441' ' ' ILE . 38.4 t -73.5 146.81 86.65 Favored Pre-proline 0 CA--C 1.57 1.744 0 C-N-CA 125.749 1.62 . . . . 63.14 110.602 -178.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -78.91 171.69 16.12 Favored 'Trans proline' 0 C--N 1.388 2.613 0 C-N-CA 122.924 2.416 . . . . 75.51 111.308 169.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -81.06 150.48 17.94 Favored 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 121.92 1.746 . . . . 72.53 113.133 176.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 84.8 mtt-85 63.22 31.16 15.72 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 126.007 1.723 . . . . 74.04 111.527 174.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.595 HG23 HD21 ' A' ' 233' ' ' LEU . 50.2 m -63.26 105.75 0.78 Allowed 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 113.796 -1.547 . . . . 64.32 111.081 177.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -90.18 140.03 30.06 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.291 1.036 . . . . 75.32 110.197 -176.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -66.04 160.19 24.31 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.838 0.855 . . . . 62.31 111.461 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 81.02 -41.38 2.6 Favored Glycine 0 C--N 1.347 1.162 0 CA-C-N 116.382 -0.372 . . . . 73.32 112.405 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -67.19 156.19 36.88 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 124.339 1.056 . . . . 74.0 110.907 177.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.766 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 3.5 mptp? -106.93 124.59 49.84 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-N 114.686 -1.143 . . . . 72.22 108.492 176.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.595 HD21 HG23 ' A' ' 227' ' ' THR . 86.0 mt -74.72 106.43 6.27 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.417 -0.957 . . . . 71.4 108.417 176.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 20.6 ttp180 -87.93 110.92 20.93 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.043 0.537 . . . . 64.14 110.687 178.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.594 HD13 HG12 ' B' ' 441' ' ' ILE . 0.3 OUTLIER -120.26 117.94 29.15 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.101 0.96 . . . . 61.12 109.982 176.154 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 36.0 mmtm -59.68 151.16 25.62 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 125.155 1.382 . . . . 64.43 112.752 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 71.39 34.88 63.54 Favored Glycine 0 C--N 1.354 1.583 0 CA-C-N 114.985 -1.007 . . . . 74.2 113.757 171.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.443 ' HG3' HD12 ' A' ' 235' ' ' LEU . 41.2 mmtm -130.08 -38.87 1.4 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.16 0.584 . . . . 73.01 110.895 -176.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -71.38 168.9 50.43 Favored Glycine 0 C--N 1.35 1.318 0 CA-C-N 116.219 -0.446 . . . . 74.43 112.17 175.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . 0.605 ' HD2' ' HA2' ' A' ' 152' ' ' GLY . 4.4 m-85 -87.44 158.15 52.07 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 123.533 0.733 . . . . 73.13 111.067 -165.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -62.6 109.3 0.85 Allowed 'Trans proline' 0 C--N 1.385 2.452 0 C-N-CA 123.051 2.5 . . . . 73.33 111.994 177.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.435 ' HA3' ' HB3' ' A' ' 191' ' ' GLN . . . -122.38 -149.63 7.99 Favored Glycine 0 C--N 1.338 0.644 0 CA-C-O 119.174 -0.792 . . . . 73.52 112.696 -179.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . 0.455 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 26.1 Cg_endo -60.14 -45.71 22.17 Favored 'Trans proline' 0 C--N 1.375 1.932 0 C-N-CA 123.179 2.586 . . . . 70.45 112.845 -176.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -88.43 -19.51 26.45 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.256 0.622 . . . . 70.11 111.073 177.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 126.72 -158.46 20.76 Favored Glycine 0 C--N 1.347 1.166 0 N-CA-C 111.192 -0.763 . . . . 62.24 111.192 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 61.5 mtt180 -57.68 108.41 0.56 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.336 0.654 . . . . 75.41 110.612 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -72.21 -161.82 5.62 Favored Glycine 0 C--O 1.248 1.03 0 CA-C-O 121.977 0.765 . . . . 42.24 113.708 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -102.3 168.31 9.42 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.411 0.684 . . . . 75.44 110.549 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.483 ' HB3' ' HG ' ' A' ' 235' ' ' LEU . 16.0 tp -101.54 128.61 47.71 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 106.794 -1.558 . . . . 70.31 106.794 164.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.766 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 7.0 m-85 -108.93 104.83 14.14 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 107.763 -1.199 . . . . 52.51 107.763 174.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.551 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 46.3 mt -90.08 103.94 16.56 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 109.098 -0.705 . . . . 72.24 109.098 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.504 ' HG2' ' HG3' ' A' ' 232' ' ' LYS . 23.2 mt-10 -75.91 100.09 4.72 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.229 1.012 . . . . 75.41 108.866 -171.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 38.4 t -64.97 120.43 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 CA-C-N 114.564 -1.198 . . . . 24.43 112.241 -168.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . 0.47 ' HD2' ' SD ' ' B' ' 26' ' ' MET . 10.8 mmt180 -118.33 94.72 4.59 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.489 1.115 . . . . 73.14 108.065 169.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.439 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 73.5 mt -70.76 115.67 10.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 114.706 -1.133 . . . . 74.34 109.234 176.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 200' ' ' PRO . 40.0 p -111.41 173.12 6.5 Favored 'General case' 0 C--O 1.255 1.346 0 C-N-CA 124.248 1.019 . . . . 73.43 109.994 178.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 23.0 pt -134.25 151.72 76.89 Favored Pre-proline 0 CA--C 1.556 1.195 0 CA-C-N 114.918 -1.037 . . . . 73.4 108.523 176.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . 0.508 ' HB2' ' HB3' ' B' ' 88' ' ' GLU . 11.1 Cg_endo -87.56 20.12 1.25 Allowed 'Trans proline' 0 C--N 1.37 1.667 0 C-N-CA 122.699 2.266 . . . . 74.45 113.426 -166.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.419 ' HA ' ' HG3' ' C' ' 226' ' ' ARG . 3.4 mp0 40.52 -89.27 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.806 1.242 . . . . 63.24 112.18 -162.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' ARG . . . . . 0.427 ' HD2' ' O ' ' A' ' 258' ' ' PRO . 0.4 OUTLIER -69.62 138.77 53.37 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.072 0.949 . . . . 75.12 111.425 -168.012 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.538 HD11 HG11 ' C' ' 205' ' ' VAL . 98.2 mt -129.28 173.14 10.78 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.016 0.926 . . . . 55.32 110.108 -178.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 40.7 p -114.16 156.7 43.83 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 124.252 1.021 . . . . 44.34 109.644 171.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -33.07 -45.22 0.27 Allowed 'Trans proline' 0 C--N 1.396 3.034 1 C-N-CA 125.351 4.034 . . . . 74.33 116.505 -176.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -59.31 -61.27 2.75 Favored 'General case' 0 C--O 1.249 1.045 0 C-N-CA 123.926 0.89 . . . . 71.44 110.778 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -57.71 -47.57 82.02 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-N 114.901 -1.045 . . . . 64.2 110.581 -178.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' GLU . . . . . 0.534 ' O ' ' HG2' ' A' ' 270' ' ' LYS . 7.2 tp10 -55.05 -50.68 68.52 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 124.543 1.152 . . . . 73.45 110.866 -176.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -62.45 -46.68 87.4 Favored 'General case' 0 C--O 1.254 1.34 0 O-C-N 124.229 0.956 . . . . 64.12 112.151 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 10.0 mp -63.22 -34.81 78.46 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 116.053 -0.522 . . . . 73.14 111.472 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' TRP . . . . . 0.451 ' O ' HG11 ' C' ' 206' ' ' VAL . 68.6 m95 -74.59 -29.74 61.44 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 118.709 -0.662 . . . . 75.0 111.345 177.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . 0.534 ' HG2' ' O ' ' A' ' 266' ' ' GLU . 0.0 OUTLIER -58.53 -61.05 2.88 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.442 -0.947 . . . . 62.43 108.442 174.478 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? -54.61 -48.97 71.56 Favored 'General case' 0 C--N 1.364 1.203 0 CA-C-N 112.636 -2.075 . . . . 70.22 110.562 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' LEU . . . . . 0.436 HD12 HD12 ' C' ' 272' ' ' LEU . 1.8 tt -58.01 -66.03 0.54 Allowed 'General case' 0 C--O 1.186 -2.268 0 O-C-N 124.244 0.965 . . . . 63.4 108.846 -179.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . 0.468 ' HA ' ' HB2' ' C' ' 202' ' ' PRO . . . -50.24 -50.67 49.17 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 114.849 1.426 . . . . 64.51 114.849 -170.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -88.66 -24.52 22.75 Favored 'General case' 0 C--O 1.255 1.379 0 N-CA-C 112.727 0.64 . . . . 74.35 112.727 -170.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -77.7 -36.21 51.34 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 121.846 -0.534 . . . . 71.44 110.631 170.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . 0.406 ' HB3' ' O ' ' A' ' 273' ' ' ALA . 2.7 t80 -47.2 -57.47 5.12 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 126.567 1.947 . . . . 75.02 109.66 167.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -44.81 -66.1 0.44 Allowed 'General case' 0 C--O 1.248 1.019 0 O-C-N 125.515 1.759 . . . . 70.12 109.426 174.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -65.14 -9.54 23.78 Favored 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 114.598 -1.183 . . . . 75.41 114.087 -176.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . 0.479 ' NH2' ' HG2' ' C' ' 264' ' ' GLU . 77.7 mtm180 -132.92 31.95 3.84 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.308 0.643 . . . . 74.13 110.08 -176.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.566 1.587 0 C-N-CA 124.07 0.948 . . . . 72.21 113.177 177.332 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.48 1.04 0 N-CA-C 109.814 -0.439 . . . . 71.44 109.814 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -72.5 101.04 2.86 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.548 0.739 . . . . 54.1 109.791 174.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -164.39 -40.98 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.312 1.045 . . . . 74.04 109.434 175.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 16.6 t 68.64 -173.45 0.19 Allowed 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.331 1.052 . . . . 52.14 111.225 176.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 17.9 m 70.46 135.62 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.992 1.317 . . . . 70.11 112.346 -178.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 38.7 pt -143.27 176.79 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.392 1.077 . . . . 64.44 109.629 -176.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -137.38 132.64 33.8 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.329 0.652 . . . . 72.01 110.307 177.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.55 HD23 HG11 ' A' ' 140' ' ' VAL . 39.0 tp -81.07 157.02 25.54 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.319 1.048 . . . . 75.22 111.086 -171.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.62 -72.34 0.42 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 122.856 0.462 . . . . 62.4 111.287 176.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . 0.455 HD23 ' HB2' ' A' ' 121' ' ' ALA . 33.6 mt 72.35 -7.54 1.35 Allowed 'General case' 0 N--CA 1.503 2.193 0 C-N-CA 125.588 1.555 . . . . 74.1 112.46 -165.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.404 ' N ' ' HD3' ' B' ' 12' ' ' PRO . 28.6 mt 55.87 56.97 10.04 Favored Pre-proline 0 CA--C 1.563 1.473 0 C-N-CA 124.727 1.211 . . . . 45.35 112.257 -176.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.404 ' HD3' ' N ' ' B' ' 11' ' ' LEU . 2.8 Cg_endo -88.78 -67.1 0.01 OUTLIER 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 123.14 2.56 . . . . 61.33 111.926 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 75.7 mt -119.21 -41.83 2.71 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.05 0.94 . . . . 75.01 109.6 177.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 3.4 pp -134.92 -176.94 4.41 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.905 0.882 . . . . 64.54 110.187 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -156.77 -176.13 5.81 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.717 0.807 . . . . 60.01 110.551 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 7.6 t -86.73 141.19 33.63 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 124.02 0.928 . . . . 51.11 110.814 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -83.2 42.68 1.32 Allowed 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 122.896 2.397 . . . . 62.42 113.518 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.505 HG11 ' HB3' ' A' ' 179' ' ' ARG . 98.7 t -74.76 108.7 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 108.842 -0.799 . . . . 61.41 108.842 171.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 2.9 m -101.97 1.21 36.43 Favored 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 123.597 0.759 . . . . 71.22 111.053 -174.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 51.2 mttm 66.11 -81.68 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.803 1.241 . . . . 62.34 111.243 -174.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -100.13 75.84 1.87 Allowed 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.297 0.639 . . . . 75.34 111.883 -169.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -144.89 120.6 10.5 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.368 -0.975 . . . . 73.31 108.368 164.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' THR . . . . . 0.453 ' HA ' ' HB3' ' A' ' 184' ' ' PRO . 17.2 p -135.71 62.49 48.31 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 123.966 0.906 . . . . 72.45 109.935 -177.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -87.06 34.23 0.44 Allowed 'Trans proline' 0 C--N 1.382 2.294 0 C-N-CA 123.273 2.649 . . . . 74.55 112.186 -175.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -93.4 29.42 1.96 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 123.899 0.88 . . . . 74.53 110.504 -173.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . 0.632 ' HB3' HD21 ' B' ' 29' ' ' LEU . 51.7 mtm -80.4 155.83 73.93 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 123.757 0.823 . . . . 75.13 109.747 177.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -75.37 59.68 5.5 Favored 'Trans proline' 0 C--N 1.384 2.436 0 C-N-CA 123.041 2.494 . . . . 71.1 114.611 -177.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.518 HG11 ' HB2' ' B' ' 31' ' ' ASN . 71.9 t 68.03 -61.58 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 125.977 1.711 . . . . 73.51 113.54 172.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.632 HD21 ' HB3' ' B' ' 26' ' ' MET . 2.1 mm? 77.35 -54.83 0.54 Allowed 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 126.164 1.786 . . . . 62.2 112.543 172.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.583 ' HA ' ' HG2' ' C' ' 231' ' ' ARG . 13.3 tp10 -58.68 -68.57 0.25 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 122.777 0.431 . . . . 70.24 110.35 174.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' ASN . . . . . 0.518 ' HB2' HG11 ' B' ' 28' ' ' VAL . 10.8 m120 -71.12 -19.14 62.48 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 122.668 0.387 . . . . 74.34 111.427 -177.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 18.3 ttt85 -61.03 -31.88 71.5 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.736 0.814 . . . . 72.22 111.028 175.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -109.11 -88.7 0.48 Allowed 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 109.119 -0.697 . . . . 73.31 109.119 168.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . 58.66 15.04 3.44 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 125.014 1.326 . . . . 53.33 113.674 176.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -133.51 141.16 47.63 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 122.902 0.481 . . . . 73.13 110.752 -169.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -176.98 61.68 0.1 OUTLIER Glycine 0 C--N 1.341 0.819 0 N-CA-C 110.543 -1.023 . . . . 74.33 110.543 175.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 37.8 t70 68.97 172.82 0.3 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 124.325 1.05 . . . . 61.44 111.116 178.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 45.2 pt -70.99 -18.5 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 123.217 0.607 . . . . 75.44 111.56 173.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . 0.536 ' O ' ' HB2' ' B' ' 155' ' ' LEU . 69.9 p 62.31 -69.05 0.06 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 126.408 1.883 . . . . 64.25 112.155 -172.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . 74.2 161.78 0.15 Allowed Pre-proline 0 N--CA 1.495 1.817 0 C-N-CA 124.394 1.077 . . . . 64.0 112.397 174.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.0 145.29 35.41 Favored 'Trans proline' 0 C--N 1.385 2.457 0 C-N-CA 122.351 2.034 . . . . 72.44 113.02 178.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 178.35 -76.48 0.07 OUTLIER Glycine 0 C--N 1.352 1.459 0 CA-C-N 116.182 -0.463 . . . . 45.24 112.648 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 176.66 -166.77 37.83 Favored Glycine 0 C--N 1.347 1.165 0 N-CA-C 112.314 -0.314 . . . . 42.15 112.314 -176.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . 0.562 ' HA ' HG12 ' B' ' 154' ' ' ILE . . . -141.21 178.73 7.2 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 112.598 0.592 . . . . 63.2 112.598 -173.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.556 ' HG3' ' HB ' ' B' ' 154' ' ' ILE . 29.9 mtp180 -69.47 78.9 0.4 Allowed 'General case' 0 C--N 1.357 0.926 0 C-N-CA 123.83 0.852 . . . . 74.21 109.217 175.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -63.79 107.87 1.31 Allowed 'General case' 0 C--N 1.353 0.737 0 C-N-CA 124.227 1.011 . . . . 75.02 109.65 -177.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.459 HD12 ' HG3' ' B' ' 148' ' ' GLU . 81.4 mt 52.46 33.44 13.19 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.212 1.005 . . . . 53.22 111.896 177.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 25.8 m -128.11 76.13 1.67 Allowed 'General case' 0 C--O 1.246 0.874 0 C-N-CA 124.07 0.948 . . . . 51.22 108.831 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -67.64 -45.07 79.36 Favored Glycine 0 C--N 1.35 1.349 0 N-CA-C 110.742 -0.943 . . . . 74.15 110.742 173.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -168.96 105.82 0.42 Allowed 'General case' 0 C--O 1.24 0.58 0 N-CA-C 105.54 -2.022 . . . . 64.2 105.54 164.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 67.41 -72.07 0.09 Allowed 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 124.967 1.307 . . . . 75.3 110.381 -166.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 52.6 p -99.21 167.04 10.93 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.331 1.052 . . . . 73.31 110.465 176.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.16 120.49 13.3 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.606 -0.887 . . . . 73.24 108.606 169.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . 57.68 -160.27 0.25 Allowed 'General case' 0 N--CA 1.484 1.25 0 O-C-N 124.031 0.832 . . . . 75.51 111.241 -175.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.401 HD13 ' HA ' ' B' ' 353' ' ' HIS . 60.4 tp -148.47 -82.82 0.11 Allowed 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.842 -0.799 . . . . 72.35 108.842 169.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . 0.456 ' NH1' ' HA ' ' B' ' 290' ' ' TRP . 48.9 ttp85 -165.85 106.86 0.73 Allowed 'General case' 0 C--N 1.345 0.389 0 N-CA-C 108.969 -0.752 . . . . 73.2 108.969 -173.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -46.66 -71.28 0.07 Allowed 'General case' 0 N--CA 1.479 0.987 0 O-C-N 125.306 1.629 . . . . 75.31 111.9 -171.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 15.1 m 73.44 -35.87 0.33 Allowed 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 125.524 1.53 . . . . 62.01 114.657 169.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 56.9 tp -65.71 -31.51 72.56 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.137 0.975 . . . . 72.44 110.812 -177.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 1.8 m 71.23 -72.45 0.11 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.283 1.433 . . . . 63.51 111.666 172.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . 0.413 ' HB2' ' H ' ' B' ' 298' ' ' HIS . 30.8 t70 -101.87 126.28 48.73 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.028 1.331 . . . . 71.45 110.283 -174.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -124.55 78.41 62.73 Favored Pre-proline 0 N--CA 1.49 1.565 0 C-N-CA 123.606 0.763 . . . . 72.3 109.407 177.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' B' ' 125' ' ' ALA . 20.4 Cg_endo -93.43 -2.76 3.23 Favored 'Trans proline' 0 C--N 1.371 1.736 0 C-N-CA 122.915 2.41 . . . . 72.24 113.17 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 63.54 89.7 0.09 Allowed 'General case' 0 C--N 1.36 1.047 0 O-C-N 124.798 1.311 . . . . 72.04 109.971 -164.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -86.99 30.14 0.78 Allowed 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.742 0.817 . . . . 65.32 110.235 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' ASN . . . . . 0.483 HD22 ' NH2' ' C' ' 254' ' ' ARG . 2.0 m-20 -91.76 -3.85 55.69 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.978 1.311 . . . . 72.41 110.87 -169.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 50.4 mm 75.81 -69.14 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 126.189 1.795 . . . . 72.03 112.013 176.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 3.2 pt -135.77 131.49 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 123.545 0.738 . . . . 73.4 110.072 -177.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.499 ' HG ' ' HB2' ' B' ' 230' ' ' ALA . 3.1 mm? -121.49 -175.09 3.0 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.454 1.102 . . . . 73.12 110.097 -173.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . 0.414 ' HB3' ' H ' ' B' ' 71' ' ' ILE . 3.8 mm? 54.2 -144.28 0.68 Allowed 'General case' 0 CA--C 1.562 1.427 0 O-C-N 123.987 0.804 . . . . 44.44 111.204 178.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . 0.491 ' HA ' ' HG2' ' B' ' 118' ' ' PRO 0.279 10.4 tp 55.66 105.15 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 C-N-CA 127.076 2.15 . . . . 74.32 112.982 177.942 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 119.8 -11.78 10.97 Favored Glycine 0 C--N 1.353 1.506 0 CA-C-N 115.098 -0.956 . . . . 62.21 111.984 -174.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -64.94 149.58 49.43 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 124.218 1.007 . . . . 63.44 111.809 -173.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 123.76 -167.34 16.05 Favored Glycine 0 C--N 1.339 0.73 0 CA-C-N 115.416 -0.811 . . . . 64.42 111.65 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 17.7 ptm -137.58 130.49 30.25 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.925 -0.769 . . . . 74.01 108.925 -177.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . -147.32 -60.65 0.01 OUTLIER Glycine 0 C--N 1.34 0.755 0 N-CA-C 110.372 -1.091 . . . . 71.13 110.372 -177.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -74.0 156.2 37.8 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.401 0.68 . . . . 73.03 110.812 177.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 52.9 m -135.0 79.67 1.8 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.917 0.887 . . . . 51.1 108.714 172.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . 0.428 ' HB2' ' HA2' ' B' ' 104' ' ' GLY . 12.1 mm-40 73.54 -8.94 1.26 Allowed 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 125.922 1.689 . . . . 74.44 113.965 174.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 24.5 mm -72.41 -24.27 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 123.202 0.601 . . . . 72.52 110.463 -173.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 84.4 m -86.6 -47.06 9.53 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.808 0.443 . . . . 71.34 110.254 173.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.1 -89.87 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 115.638 -0.71 . . . . 61.11 112.09 -171.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -100.02 51.36 0.91 Allowed 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.398 0.679 . . . . 71.35 111.123 -169.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 84' ' ' ARG . . . . . 0.41 ' HA ' ' HA ' ' B' ' 103' ' ' THR . 13.8 ptm180 -78.49 9.76 3.72 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 113.798 1.036 . . . . 73.0 113.798 -171.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . 0.518 ' HA ' HD12 ' B' ' 385' ' ' LEU . 29.4 t-20 -167.95 -45.94 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 118.346 0.521 . . . . 72.23 110.889 -178.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -87.74 158.86 18.69 Favored 'General case' 0 C--O 1.244 0.816 0 CA-C-N 116.092 -0.504 . . . . 63.12 111.983 -173.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.76 131.29 34.35 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-N 115.359 -0.837 . . . . 52.24 109.503 171.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 88' ' ' GLU . . . . . 0.508 ' HB3' ' HB2' ' A' ' 258' ' ' PRO . 32.1 mt-10 -83.44 77.29 9.84 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.402 0.62 . . . . 74.14 110.049 178.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . 0.489 ' H ' ' HG2' ' C' ' 279' ' ' ARG . . . 172.19 137.07 2.26 Favored Glycine 0 C--N 1.342 0.888 0 N-CA-C 110.263 -1.135 . . . . 54.33 110.263 177.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.2 -47.2 84.2 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.239 1.015 . . . . 62.33 111.43 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -98.36 31.46 8.02 Favored Glycine 0 C--N 1.345 1.071 0 CA-C-N 115.646 -0.707 . . . . 70.11 112.24 177.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -91.54 25.95 13.85 Favored Glycine 0 C--N 1.355 1.63 0 CA-C-N 116.885 0.342 . . . . 23.53 112.769 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -126.1 116.49 21.46 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.449 1.1 . . . . 74.22 108.953 -175.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 94' ' ' PHE . . . . . 0.49 ' HB2' ' HB2' ' B' ' 98' ' ' ASP . 81.9 m-85 -72.94 171.11 13.39 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 122.612 0.365 . . . . 71.21 110.442 175.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -66.26 -6.55 14.23 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.847 0.859 . . . . 74.14 113.146 -170.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . -80.44 -88.53 0.55 Allowed Glycine 0 C--N 1.348 1.21 0 N-CA-C 110.602 -0.999 . . . . 72.31 110.602 167.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 12.9 tt -163.22 19.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 C-N-CA 124.77 1.228 . . . . 72.22 108.073 174.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . 0.548 ' HA ' HG21 ' B' ' 414' ' ' THR . 6.6 m-20 -72.29 82.66 1.03 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.814 0.845 . . . . 75.21 112.904 -160.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -81.8 107.64 14.7 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.898 -1.149 . . . . 61.12 107.898 165.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . 0.45 HD21 ' HE1' ' B' ' 94' ' ' PHE . 3.4 mm? -66.88 107.46 1.68 Allowed Pre-proline 0 CA--C 1.55 0.959 0 O-C-N 123.866 0.729 . . . . 74.2 110.321 -178.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -83.02 104.81 1.29 Allowed 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 122.449 2.099 . . . . 72.21 111.257 -178.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -56.63 -42.42 78.8 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.062 0.545 . . . . 73.12 109.743 178.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 103' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' B' ' 84' ' ' ARG . 27.0 m 62.43 -69.81 0.06 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 126.228 1.811 . . . . 75.52 113.341 169.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 104' ' ' GLY . . . . . 0.428 ' HA2' ' HB2' ' B' ' 79' ' ' GLU . . . -142.36 -35.04 0.09 OUTLIER Glycine 0 C--N 1.341 0.826 0 CA-C-O 119.737 -0.48 . . . . 51.35 112.039 175.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 105' ' ' GLN . . . . . 0.446 ' HG3' ' H ' ' B' ' 106' ' ' TYR . 20.9 pt20 41.87 -75.75 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 127.041 2.136 . . . . 75.22 114.29 -177.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 106' ' ' TYR . . . . . 0.446 ' H ' ' HG3' ' B' ' 105' ' ' GLN . 51.6 p90 -90.42 33.74 0.9 Allowed 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 123.699 0.8 . . . . 74.44 111.243 -178.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 91.5 m -69.64 107.51 3.46 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 121.155 0.503 . . . . 63.32 110.59 177.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 8.1 p-80 -154.55 63.28 0.67 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.603 1.161 . . . . 71.44 108.726 178.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 92.1 t80 68.68 -82.11 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 124.821 1.248 . . . . 53.33 110.003 -174.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . 71.06 -41.01 0.49 Allowed 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 125.569 1.548 . . . . 71.24 114.821 172.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 3.6 pp -63.69 132.76 52.07 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.624 0.77 . . . . 64.15 112.624 -168.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 13.2 t30 -142.63 91.22 2.29 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 107.431 -1.322 . . . . 73.2 107.431 173.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 113' ' ' LYS . . . . . 0.658 ' HA ' HG21 ' B' ' 224' ' ' VAL . 54.9 pttt -137.14 35.07 2.55 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.544 1.538 . . . . 75.13 108.541 -175.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -55.1 -65.06 0.65 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.45 1.5 . . . . 74.01 111.54 -169.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 2.9 p -152.08 164.86 36.38 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.258 1.423 . . . . 73.23 108.652 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 129.97 162.48 10.81 Favored Glycine 0 C--N 1.338 0.653 0 N-CA-C 111.176 -0.77 . . . . 55.33 111.176 -177.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 22.6 ttpp -166.62 121.57 0.89 Allowed Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 123.711 0.804 . . . . 70.25 109.159 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 118' ' ' PRO . . . . . 0.491 ' HG2' ' HA ' ' B' ' 71' ' ' ILE . 14.7 Cg_exo -70.18 79.14 1.1 Allowed 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 122.433 2.089 . . . . 60.53 109.324 165.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 119' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -67.69 -46.56 71.95 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 114.678 -1.146 . . . . 75.33 110.401 -174.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 120' ' ' TYR . . . . . 0.461 ' HA ' ' HB3' ' B' ' 312' ' ' PRO . 0.5 OUTLIER -70.44 -23.85 62.8 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 114.251 -1.341 . . . . 70.1 112.254 177.977 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 121' ' ' VAL . . . . . 0.481 HG21 ' HA ' ' B' ' 314' ' ' ARG . 98.9 t 62.01 -78.38 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 125.009 1.324 . . . . 74.32 112.043 177.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 32.9 m -65.18 -60.56 2.87 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.517 1.127 . . . . 75.24 112.735 -175.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 55.82 -87.86 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.483 1.113 . . . . 64.3 111.42 -166.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 28.5 m 55.77 -158.09 0.23 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.293 1.037 . . . . 43.31 111.992 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . 0.628 ' HB3' ' HE2' ' B' ' 231' ' ' LYS . . . -168.11 121.81 0.91 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.344 0.658 . . . . 73.02 109.281 170.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.51 139.58 58.78 Favored 'General case' 0 C--O 1.245 0.817 0 O-C-N 124.183 0.927 . . . . 74.13 110.423 177.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 10.3 t 64.56 -168.97 0.2 Allowed 'General case' 0 CA--C 1.558 1.269 0 C-N-CA 124.902 1.281 . . . . 70.01 111.136 -178.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . 0.497 ' HA ' ' SD ' ' C' ' 213' ' ' MET . . . -137.95 149.38 46.11 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.565 0.746 . . . . 72.01 109.495 177.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 23.8 m -75.49 82.56 2.55 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.399 0.68 . . . . 54.34 110.224 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . 55.17 -151.08 0.4 Allowed 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 125.195 1.398 . . . . 44.22 112.284 176.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 40.4 m95 58.34 -131.78 1.22 Allowed 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 124.441 1.097 . . . . 73.51 110.149 -178.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 32.2 m 60.3 14.22 4.5 Favored 'General case' 0 C--N 1.374 1.671 0 C-N-CA 124.633 1.173 . . . . 51.4 111.718 -177.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 133' ' ' THR . . . . . 0.429 HG21 HG23 ' B' ' 137' ' ' THR . 70.3 p 48.32 18.15 0.15 Allowed 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 126.128 1.771 . . . . 62.25 114.068 -173.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 53.72 34.42 50.52 Favored Glycine 0 C--N 1.357 1.725 0 CA-C-O 119.283 -0.732 . . . . 55.15 113.572 -174.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 135' ' ' VAL . . . . . . . . . . . . . 59.5 t 76.46 -47.09 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 C-N-CA 125.562 1.545 . . . . 73.24 111.639 -175.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -73.95 89.21 1.88 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.894 1.278 . . . . 52.43 109.887 177.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 137' ' ' THR . . . . . 0.429 HG23 HG21 ' B' ' 133' ' ' THR . 12.1 m -83.25 119.76 24.97 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 123.269 0.627 . . . . 75.31 111.455 -170.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 75.3 -52.31 0.66 Allowed 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 126.122 1.769 . . . . 75.52 112.744 -178.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 8.2 t30 73.99 -56.86 0.64 Allowed 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 125.447 1.499 . . . . 73.24 110.867 -176.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -64.12 -70.69 1.0 Allowed Glycine 0 C--N 1.353 1.473 0 CA-C-O 119.795 -0.447 . . . . 65.04 112.018 170.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . 71.97 -60.93 0.51 Allowed 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 125.421 1.489 . . . . 75.34 112.646 176.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 7.1 mp -64.85 110.35 2.39 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.869 0.868 . . . . 70.15 109.904 177.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 162.62 132.31 1.32 Allowed Glycine 0 C--N 1.338 0.659 0 N-CA-C 111.021 -0.832 . . . . 61.25 111.021 -178.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 5.1 t 58.48 36.24 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.425 0 C-N-CA 124.641 1.176 . . . . 75.31 109.846 -178.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -66.55 -37.36 84.82 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 114.355 -1.293 . . . . 64.3 110.291 -178.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 44.4 mm -78.16 121.77 31.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 115.03 -0.987 . . . . 72.52 109.231 176.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 58.99 -163.39 0.22 Allowed 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 124.261 1.024 . . . . 72.43 112.307 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . 0.459 ' HG3' HD12 ' B' ' 47' ' ' LEU . 11.3 tp10 70.13 23.77 5.16 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 125.131 1.372 . . . . 73.05 110.824 175.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 149' ' ' LYS . . . . . 0.408 ' HG3' ' H ' ' B' ' 150' ' ' ASP . 10.3 pttm -157.86 -71.74 0.09 Allowed 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 107.546 -1.279 . . . . 72.23 107.546 174.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 150' ' ' ASP . . . . . 0.408 ' H ' ' HG3' ' B' ' 149' ' ' LYS . 20.9 m-20 66.25 21.32 11.05 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.244 1.018 . . . . 74.11 113.617 165.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 56.4 p-80 42.32 60.75 9.38 Favored Pre-proline 0 N--CA 1.496 1.861 0 C-N-CA 125.607 1.563 . . . . 74.43 112.443 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -86.51 12.56 2.97 Favored 'Trans proline' 0 C--N 1.37 1.681 0 C-N-CA 122.711 2.274 . . . . 42.51 113.347 -162.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . 0.564 HG22 ' H ' ' B' ' 154' ' ' ILE . 1.6 m 61.62 -155.46 0.35 Allowed 'General case' 0 CA--C 1.568 1.663 0 C-N-CA 124.487 1.115 . . . . 74.2 109.013 -173.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 154' ' ' ILE . . . . . 0.564 ' H ' HG22 ' B' ' 153' ' ' THR . 0.0 OUTLIER -160.58 148.97 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 N-CA-C 107.82 -1.178 . . . . 74.25 107.82 178.316 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 155' ' ' LEU . . . . . 0.548 ' N ' HD13 ' B' ' 154' ' ' ILE . 2.0 pt? -158.41 -22.95 0.08 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.425 0.69 . . . . 72.1 111.132 173.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -122.89 94.29 4.23 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.723 0.809 . . . . 72.23 110.805 -178.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 157' ' ' MET . . . . . 0.577 ' HG3' ' HG2' ' B' ' 241' ' ' GLU . 3.8 mpp? 30.31 -87.95 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.418 0 C-N-CA 127.051 2.141 . . . . 53.54 114.412 174.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 158' ' ' ALA . . . . . 0.534 ' HB1' ' HB3' ' B' ' 161' ' ' ALA . . . -141.31 -3.07 1.21 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.539 1.536 . . . . 34.04 109.605 178.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt 55.95 -83.29 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 126.043 1.737 . . . . 55.45 112.074 -171.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -123.19 7.06 9.13 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.787 0.835 . . . . 70.22 111.699 -174.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . 0.534 ' HB3' ' HB1' ' B' ' 158' ' ' ALA . . . -89.58 119.39 29.97 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.19 0.596 . . . . 71.1 110.208 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 82.36 -90.48 1.5 Allowed Glycine 0 C--N 1.349 1.271 0 CA-C-O 119.792 -0.449 . . . . 73.4 112.561 177.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 10.6 mp 66.28 -71.99 0.08 Allowed 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 125.324 1.45 . . . . 65.02 111.525 -174.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 164' ' ' ALA . . . . . . . . . . . . . . . -65.3 -64.18 0.92 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.218 0.607 . . . . 75.34 111.215 -177.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 165' ' ' THR . . . . . 0.438 ' O ' ' HE3' ' C' ' 238' ' ' LYS . 25.9 p -136.66 -71.55 0.45 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.358 0.663 . . . . 64.15 110.774 -178.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . 163.99 74.2 0.03 OUTLIER Glycine 0 C--N 1.338 0.646 0 N-CA-C 111.343 -0.703 . . . . 71.15 111.343 -178.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 167' ' ' ASN . . . . . . . . . . . . . 48.2 t30 74.17 -65.04 0.37 Allowed 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 125.643 1.577 . . . . 72.31 111.323 -178.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 7.3 p -149.54 137.03 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 124.083 0.953 . . . . 74.13 110.101 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 19.2 m -83.08 90.04 7.0 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.642 0.777 . . . . 54.35 109.198 178.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 19.3 m -85.28 73.6 10.55 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.17 0.988 . . . . 63.1 109.448 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -120.68 -49.95 2.21 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 112.666 0.617 . . . . 53.32 112.666 -169.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 172' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -82.63 22.04 0.93 Allowed 'General case' 0 CA--C 1.559 1.296 0 CA-C-O 121.654 0.74 . . . . 73.22 112.139 -169.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 173' ' ' LEU . . . . . . . . . . . . . 7.6 mp -71.29 -23.46 61.96 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.247 0.619 . . . . 74.23 109.622 170.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 174' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -131.85 159.09 39.59 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.811 1.244 . . . . 74.45 108.605 173.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 175' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -100.26 165.8 11.3 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 109.465 -0.568 . . . . 74.1 109.465 172.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -121.56 149.5 43.03 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.781 0.833 . . . . 74.11 108.832 172.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 57.5 m -141.8 106.94 5.87 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 123.3 0.64 . . . . 64.31 109.412 -178.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 178' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -66.05 -44.38 7.48 Favored 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 122.669 2.246 . . . . 74.53 111.465 173.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -168.29 -71.56 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 107.436 -1.32 . . . . 61.34 107.436 -178.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 180' ' ' ALA . . . . . 0.498 ' HB1' HG13 ' C' ' 137' ' ' VAL . . . -135.1 -63.14 0.7 Allowed 'General case' 0 C--O 1.238 0.473 0 N-CA-C 104.791 -2.299 . . . . 74.4 104.791 166.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 181' ' ' LEU . . . . . 0.532 HD22 ' HB2' ' C' ' 136' ' ' ARG . 21.8 tp -152.85 -6.72 0.19 Allowed 'General case' 0 CA--C 1.567 1.611 0 CA-C-N 114.613 -1.176 . . . . 62.04 110.689 158.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 182' ' ' VAL . . . . . 0.643 ' HA ' ' HB2' ' C' ' 123' ' ' LEU . 14.7 m -136.75 178.3 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 C-N-CA 124.583 1.153 . . . . 71.31 112.555 -175.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 183' ' ' ALA . . . . . 0.717 ' HB3' ' HD2' ' C' ' 124' ' ' PRO . . . -143.69 55.37 1.33 Allowed 'General case' 0 CA--C 1.552 1.049 0 CA-C-N 115.118 -0.946 . . . . 65.24 110.401 164.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 32.6 m170 70.3 -168.77 0.16 Allowed 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 114.959 1.466 . . . . 74.15 114.959 162.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 185' ' ' VAL . . . . . 0.558 HG22 HD21 ' C' ' 119' ' ' LEU . 45.9 t -79.23 147.34 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 C-N-CA 125.615 1.566 . . . . 71.33 113.263 -164.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 186' ' ' THR . . . . . 0.488 ' HB ' ' HG2' ' C' ' 122' ' ' GLU . 15.2 t -126.02 174.24 8.58 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 125.325 1.45 . . . . 51.31 109.383 166.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 187' ' ' SER . . . . . . . . . . . . . 51.8 m -111.75 -16.85 13.11 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.634 0.774 . . . . 62.14 111.046 173.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -99.96 160.87 13.98 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.425 0.69 . . . . 71.52 111.388 -171.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 31.3 mtmm 70.96 120.42 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 125.48 1.512 . . . . 72.52 112.512 172.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 190' ' ' CYS . . . . . 0.537 ' HA ' HG11 ' C' ' 158' ' ' VAL . 11.6 p -151.82 108.14 3.44 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.507 0.723 . . . . 70.33 109.874 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 191' ' ' TYR . . . . . 0.404 ' H ' HG11 ' C' ' 158' ' ' VAL . 96.1 m-85 -148.48 -165.73 2.35 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 126.273 1.829 . . . . 74.04 108.073 -177.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -150.54 62.04 0.41 Allowed Glycine 0 CA--C 1.539 1.553 0 CA-C-O 119.418 -0.657 . . . . 64.22 113.122 170.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 193' ' ' PRO . . . . . 0.567 ' HG2' ' HA ' ' C' ' 157' ' ' SER . 37.4 Cg_endo -94.82 91.05 0.11 Allowed 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 123.458 2.772 . . . . 64.32 111.339 175.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 194' ' ' SER . . . . . . . . . . . . . 35.0 t -128.72 141.65 51.26 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.821 0.849 . . . . 24.51 109.319 -178.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 195' ' ' ALA . . . . . 0.465 ' HB1' ' HD3' ' C' ' 243' ' ' PRO . . . -149.54 156.66 42.33 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.645 0.778 . . . . 74.32 110.445 -176.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 4.4 m 72.6 159.93 0.22 Allowed 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 125.135 1.374 . . . . 73.32 111.772 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 18.9 m -119.52 -68.18 0.93 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.574 0.75 . . . . 75.11 109.598 177.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 198' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -168.86 -55.89 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.96 0.904 . . . . 51.12 109.605 -176.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -93.67 90.13 6.49 Favored 'General case' 0 C--N 1.349 0.544 0 C-N-CA 123.6 0.76 . . . . 74.4 109.266 -178.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 200' ' ' CYS . . . . . . . . . . . . . 53.4 t -164.62 81.84 1.27 Allowed Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 124.013 0.925 . . . . 73.31 108.955 175.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 201' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -73.92 -39.8 1.62 Allowed 'Trans proline' 0 C--N 1.374 1.871 0 C-N-CA 122.457 2.105 . . . . 71.34 113.099 -177.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 69.65 57.79 6.96 Favored Glycine 0 C--N 1.351 1.369 0 N-CA-C 111.724 -0.55 . . . . 63.04 111.724 -173.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -69.82 -49.02 56.73 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.944 0.898 . . . . 71.33 111.483 -174.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.57 124.16 23.21 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.834 -0.432 . . . . 74.01 109.834 176.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 205' ' ' LEU . . . . . 0.471 HD11 ' HB3' ' C' ' 236' ' ' LYS . 3.1 tm? -141.99 130.52 22.56 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 108.503 -0.925 . . . . 51.03 108.503 -176.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -77.67 116.76 18.47 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.601 0.76 . . . . 62.32 109.283 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -63.24 -29.83 71.09 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.76 0.824 . . . . 74.32 111.447 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 131.88 96.32 0.67 Allowed Glycine 0 C--N 1.348 1.247 0 N-CA-C 111.796 -0.521 . . . . 71.52 111.796 174.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . -66.03 -18.91 67.34 Favored Glycine 0 C--N 1.352 1.436 0 CA-C-O 119.623 -0.543 . . . . 42.21 114.045 177.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 210' ' ' LYS . . . . . 0.409 ' HG3' ' H ' ' B' ' 211' ' ' GLY . 18.1 ptpt 52.09 -75.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 126.772 2.029 . . . . 74.51 115.07 171.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 211' ' ' GLY . . . . . 0.409 ' H ' ' HG3' ' B' ' 210' ' ' LYS . . . -67.17 96.47 0.33 Allowed Glycine 0 C--N 1.355 1.6 0 CA-C-O 119.7 -0.5 . . . . 74.43 113.26 -173.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 23.0 t 80.79 -8.06 1.49 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 126.018 1.727 . . . . 74.04 112.326 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 2.6 mp -88.54 87.01 2.7 Favored 'Isoleucine or valine' 0 C--N 1.355 0.805 0 N-CA-C 107.497 -1.297 . . . . 64.4 107.497 172.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 29.5 p -131.68 84.41 2.17 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.815 0.846 . . . . 75.43 109.29 178.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 215' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -125.57 145.29 50.19 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 109.178 -0.675 . . . . 73.31 109.178 178.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 19.3 mm100 68.78 132.22 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 125.544 1.538 . . . . 61.42 111.425 -172.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 3.0 mm? 61.4 44.99 8.95 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.613 1.165 . . . . 75.4 110.092 -178.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 10.2 tt -59.8 125.81 25.12 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.965 1.306 . . . . 71.43 110.57 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 62.37 24.43 14.54 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 124.467 1.107 . . . . 71.24 112.491 -176.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . 62.47 14.11 6.7 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 124.73 1.212 . . . . 61.1 113.024 177.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 221' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 47.7 7.09 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.135 0 C-N-CA 127.195 2.198 . . . . 73.55 116.817 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . 57.23 91.79 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 124.702 1.201 . . . . 42.52 112.27 -178.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -83.77 154.07 23.77 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.648 0.779 . . . . 61.02 110.524 177.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . 0.658 HG21 ' HA ' ' B' ' 113' ' ' LYS . 7.3 p -173.81 -35.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 124.862 1.265 . . . . 74.2 110.091 -178.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 40.4 p -74.57 125.22 28.16 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 114.909 -1.041 . . . . 54.34 112.245 -172.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . 0.457 ' HB3' ' OH ' ' B' ' 120' ' ' TYR . 4.3 mm? 70.95 -74.79 0.08 Allowed 'General case' 0 CA--C 1.56 1.329 0 C-N-CA 124.812 1.245 . . . . 74.43 113.154 165.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . 86.53 -133.9 12.14 Favored Glycine 0 N--CA 1.474 1.194 0 N-CA-C 111.542 -0.623 . . . . 51.31 111.542 -174.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 228' ' ' GLY . . . . . 0.451 ' HA3' HH12 ' C' ' 187' ' ' ARG . . . 110.86 128.41 5.35 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-N 117.016 0.408 . . . . 72.41 113.898 169.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 229' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' C' ' 185' ' ' VAL . . . 126.45 161.86 11.05 Favored Glycine 0 C--N 1.348 1.233 0 CA-C-O 119.738 -0.479 . . . . 70.24 113.193 174.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . 0.499 ' HB2' ' HG ' ' B' ' 69' ' ' LEU . . . 175.3 145.8 0.07 Allowed 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.635 1.174 . . . . 70.23 110.119 174.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 231' ' ' LYS . . . . . 0.628 ' HE2' ' HB3' ' B' ' 125' ' ' ALA . 4.8 tptp -148.53 -158.09 0.88 Allowed 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.128 0.971 . . . . 73.24 108.457 177.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 3.9 m -143.91 156.09 44.31 Favored 'General case' 0 CA--C 1.56 1.34 0 N-CA-C 109.231 -0.655 . . . . 74.24 109.231 175.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 233' ' ' PHE . . . . . 0.401 ' HA ' ' HB3' ' C' ' 211' ' ' ARG . 50.4 p90 -88.04 155.26 19.9 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 114.07 1.137 . . . . 70.41 114.07 -167.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . 0.723 ' HB3' ' HE ' ' C' ' 211' ' ' ARG . . . -174.84 167.05 3.68 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 125.411 1.485 . . . . 72.31 109.839 171.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -76.79 140.91 40.88 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 114.033 1.123 . . . . 54.41 114.033 -168.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 236' ' ' THR . . . . . 0.639 ' HB ' ' HB2' ' C' ' 220' ' ' GLU . 1.7 m -149.29 -150.79 0.36 Allowed 'General case' 0 CA--C 1.577 1.992 0 C-N-CA 125.697 1.599 . . . . 73.34 107.095 174.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . 0.468 ' H ' HG22 ' B' ' 236' ' ' THR . . . -155.94 32.21 0.35 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 120.173 1.351 . . . . 71.12 112.084 178.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 95.2 m -146.92 128.33 14.93 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 118.674 -0.679 . . . . 71.31 110.79 -176.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -170.24 -179.35 3.06 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 113.44 0.904 . . . . 74.42 113.44 176.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . -114.89 -142.85 7.95 Favored Glycine 0 C--N 1.36 1.887 0 CA-C-N 114.678 -1.146 . . . . 71.23 111.757 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 241' ' ' GLU . . . . . 0.577 ' HG2' ' HG3' ' B' ' 157' ' ' MET . 11.9 pt-20 -167.31 156.92 10.56 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.753 0.821 . . . . 71.21 110.18 177.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 242' ' ' TRP . . . . . 0.472 ' CE2' ' HG ' ' C' ' 233' ' ' LEU . 0.0 OUTLIER -137.53 -35.19 0.67 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.176 1.391 . . . . 70.32 108.75 -172.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -123.72 -173.49 2.76 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 106.212 -1.773 . . . . 74.22 106.212 157.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -74.36 103.92 1.58 Allowed Glycine 0 C--N 1.335 0.483 0 C-N-CA 121.417 -0.421 . . . . 63.11 112.556 174.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 245' ' ' LYS . . . . . 0.468 ' HD2' HD12 ' B' ' 154' ' ' ILE . 1.6 pptp? -85.37 41.67 0.9 Allowed 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 122.039 0.923 . . . . 75.34 110.532 174.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . 0.405 ' HA ' HG23 ' B' ' 154' ' ' ILE . 81.9 p -94.12 55.08 2.0 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.003 1.321 . . . . 71.02 110.062 -173.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 247' ' ' LEU . . . . . 0.452 HD11 ' HE2' ' A' ' 270' ' ' LYS . 2.3 tm? -143.91 139.72 29.34 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 108.217 -1.031 . . . . 72.51 108.217 -175.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 248' ' ' ARG . . . . . 0.435 ' N ' HD13 ' B' ' 247' ' ' LEU . 1.6 tmt_? -161.29 149.33 15.49 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 107.526 -1.287 . . . . 75.15 107.526 171.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 249' ' ' GLU . . . . . 0.441 ' HA ' ' HA3' ' B' ' 362' ' ' GLY . 0.4 OUTLIER -151.62 153.42 34.43 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 123.489 0.716 . . . . 71.33 109.854 -179.253 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -149.28 -34.03 0.2 Allowed 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 123.985 0.914 . . . . 65.4 112.18 176.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 251' ' ' ALA . . . . . . . . . . . . . . . -158.24 38.4 0.25 Allowed 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 114.383 1.253 . . . . 61.03 114.383 -163.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -67.56 -47.43 69.82 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.273 0.629 . . . . 72.3 109.728 175.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -79.21 76.99 5.74 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 108.317 -0.994 . . . . 51.41 108.317 168.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 24.0 tpt180 -85.41 -5.17 59.32 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 114.967 -1.015 . . . . 72.51 111.284 -171.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -59.22 -61.01 7.8 Favored Glycine 0 C--N 1.354 1.568 0 N-CA-C 111.914 -0.474 . . . . 54.22 111.914 177.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 256' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 71.94 -50.77 0.7 Allowed 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 125.836 1.655 . . . . 52.52 113.002 178.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -61.5 99.24 0.1 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.957 0.903 . . . . 74.31 110.903 177.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 258' ' ' LEU . . . . . . . . . . . . . 30.1 tp -96.05 23.42 6.48 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 124.081 0.952 . . . . 75.13 109.301 176.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 4.3 p 50.65 21.8 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 C-N-CA 126.537 1.935 . . . . 63.02 112.71 -174.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 260' ' ' SER . . . . . . . . . . . . . 44.8 m -124.68 131.18 53.48 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 107.896 -1.15 . . . . 73.11 107.896 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 15.9 t70 67.68 -73.98 0.08 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.34 1.456 . . . . 52.21 111.704 -176.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 262' ' ' ALA . . . . . 0.465 ' HA ' ' HA ' ' B' ' 266' ' ' ASN . . . -58.05 -13.48 4.81 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.325 1.05 . . . . 43.43 113.114 -178.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -59.41 -32.12 69.89 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 124.07 0.948 . . . . 70.44 112.524 174.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 27.2 t -158.2 -41.39 0.06 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.86 0.464 . . . . 51.14 112.227 -178.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 265' ' ' LEU . . . . . . . . . . . . . 40.2 tp -72.64 -47.32 48.55 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.347 0.659 . . . . 64.12 110.823 -176.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 266' ' ' ASN . . . . . 0.465 ' HA ' ' HA ' ' B' ' 262' ' ' ALA . 51.4 m-80 64.71 111.2 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 125.306 1.442 . . . . 71.52 112.655 172.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 267' ' ' SER . . . . . 0.412 ' O ' ' HD2' ' B' ' 276' ' ' PRO . 95.5 p 55.28 25.1 7.05 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 125.266 1.426 . . . . 73.13 112.333 178.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 54.2 t 52.3 -82.32 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 C-N-CA 125.853 1.661 . . . . 74.44 112.464 -177.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 269' ' ' THR . . . . . 0.58 HG23 ' HE2' ' B' ' 275' ' ' LYS . 10.9 m 58.24 59.7 2.94 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.502 1.121 . . . . 74.31 109.97 -177.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 270' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -83.54 75.65 10.01 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 115.403 -0.817 . . . . 72.41 108.864 -177.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 271' ' ' ALA . . . . . . . . . . . . . . . 65.36 -75.01 0.05 OUTLIER 'General case' 0 CA--C 1.558 1.271 0 C-N-CA 125.072 1.349 . . . . 75.3 111.402 -175.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 272' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -124.55 -31.76 3.2 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.351 1.06 . . . . 54.14 109.689 175.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -73.19 121.88 21.0 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.209 1.003 . . . . 61.32 111.714 -174.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 58.56 102.32 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 125.329 1.452 . . . . 71.44 112.847 173.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 275' ' ' LYS . . . . . 0.58 ' HE2' HG23 ' B' ' 269' ' ' THR . 16.6 ptpt -153.41 95.17 2.94 Favored Pre-proline 0 CA--C 1.553 1.091 0 C-N-CA 123.165 0.586 . . . . 71.33 110.305 178.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 276' ' ' PRO . . . . . 0.448 ' HB3' ' HB ' ' B' ' 348' ' ' ILE . 88.7 Cg_exo -49.49 -67.9 0.1 OUTLIER 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 123.442 2.761 . . . . 62.35 112.219 168.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 277' ' ' LEU . . . . . . . . . . . . . 87.8 mt 49.98 89.97 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 125.0 1.32 . . . . 63.32 113.087 176.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 1.8 pp -75.77 6.48 4.9 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 113.665 0.987 . . . . 62.0 113.665 -174.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . -88.46 45.92 3.3 Favored Glycine 0 C--N 1.349 1.25 0 CA-C-O 119.612 -0.549 . . . . 75.43 113.339 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 4.9 tt 61.23 -87.59 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.093 1.357 . . . . 53.23 109.782 -175.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 281' ' ' PHE . . . . . 0.415 ' HB3' HD22 ' B' ' 285' ' ' ASN . 77.8 m-85 58.48 -77.52 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 125.15 1.38 . . . . 75.31 112.441 -176.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . 60.75 -98.42 0.08 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.867 1.267 . . . . 65.41 110.732 -176.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -68.44 99.58 0.97 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.229 0.612 . . . . 72.33 109.962 -175.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . 135.9 -38.74 1.74 Allowed Glycine 0 N--CA 1.475 1.28 0 CA-C-N 115.746 -0.661 . . . . 61.45 111.568 -176.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 285' ' ' ASN . . . . . 0.415 HD22 ' HB3' ' B' ' 281' ' ' PHE . 27.7 m-80 -116.03 12.73 15.72 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 124.113 0.965 . . . . 72.41 110.484 178.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 286' ' ' MET . . . . . 0.432 ' SD ' ' HD2' ' B' ' 287' ' ' PRO . 15.7 tpt -161.92 139.2 6.45 Favored Pre-proline 0 C--O 1.247 0.948 0 N-CA-C 105.582 -2.007 . . . . 64.1 105.582 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 287' ' ' PRO . . . . . 0.432 ' HD2' ' SD ' ' B' ' 286' ' ' MET . 55.3 Cg_exo -40.47 -41.82 3.67 Favored 'Trans proline' 0 C--N 1.388 2.637 0 C-N-CA 124.092 3.195 . . . . 73.33 114.152 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 288' ' ' VAL . . . . . 0.486 HG23 ' H ' ' B' ' 289' ' ' ARG . 0.0 OUTLIER -151.25 -86.11 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.233 0 C-N-CA 125.106 1.363 . . . . 74.32 107.81 169.295 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 289' ' ' ARG . . . . . 0.486 ' H ' HG23 ' B' ' 288' ' ' VAL . 0.0 OUTLIER -159.95 -26.64 0.06 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.032 1.733 . . . . 72.14 107.1 170.791 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 290' ' ' TRP . . . . . 0.456 ' HA ' ' NH1' ' B' ' 56' ' ' ARG . 31.8 m-90 -64.44 165.89 9.16 Favored 'General case' 0 C--N 1.357 0.925 0 CA-C-N 115.348 -0.842 . . . . 75.34 110.396 160.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 291' ' ' LEU . . . . . 0.403 HD23 ' HB3' ' B' ' 290' ' ' TRP . 1.8 pt? -44.92 -32.26 1.55 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 125.659 1.584 . . . . 64.34 113.471 175.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . 170.03 -152.8 20.12 Favored Glycine 0 C--N 1.348 1.219 0 CA-C-O 119.547 -0.585 . . . . 62.12 112.094 176.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.14 6.39 1.46 Allowed 'Trans proline' 0 C--N 1.369 1.63 0 C-N-CA 123.366 2.711 . . . . 51.12 113.79 172.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -68.18 106.34 2.39 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.666 0.786 . . . . 41.23 109.849 174.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -119.46 17.69 12.92 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.31 1.044 . . . . 34.32 109.589 167.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 22.5 m -69.95 109.89 4.75 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.041 0.936 . . . . 65.42 112.512 -171.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -107.19 159.03 16.64 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.518 1.127 . . . . 64.12 108.663 165.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 298' ' ' HIS . . . . . 0.413 ' H ' ' HB2' ' B' ' 61' ' ' ASP . 80.1 t60 64.85 113.79 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.496 1.118 . . . . 71.5 110.334 -173.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . -60.98 94.99 0.08 OUTLIER Glycine 0 C--N 1.347 1.191 0 CA-C-N 116.232 -0.44 . . . . 63.41 113.092 177.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -71.03 -28.94 64.76 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.106 0.962 . . . . 72.23 111.186 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 301' ' ' ILE . . . . . . . . . . . . . 12.7 tt -87.41 -21.16 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 123.903 0.881 . . . . 72.24 110.622 176.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.54 -29.45 61.38 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.843 0.857 . . . . 63.41 110.652 177.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 303' ' ' LYS . . . . . 0.462 ' HA ' ' HE2' ' B' ' 303' ' ' LYS . 0.6 OUTLIER -62.31 -47.63 89.15 Favored Pre-proline 0 CA--C 1.567 1.598 0 C-N-CA 123.722 0.809 . . . . 74.11 111.551 -178.056 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 304' ' ' PRO . . . . . 0.519 ' HA ' ' SG ' ' B' ' 308' ' ' CYS . 92.2 Cg_endo -79.21 164.12 24.67 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 121.798 1.666 . . . . 75.12 111.452 160.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . 67.55 -78.01 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 124.906 1.282 . . . . 42.33 113.05 177.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 56.2 t -61.76 -58.27 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 124.32 1.048 . . . . 72.33 111.636 -170.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 82.7 p -88.1 4.76 44.17 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.642 0.377 . . . . 74.23 111.723 -177.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 308' ' ' CYS . . . . . 0.519 ' SG ' ' HA ' ' B' ' 304' ' ' PRO . 77.8 m -77.49 -43.35 32.5 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 109.233 -0.655 . . . . 74.22 109.233 171.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 41.2 p -83.52 144.14 45.52 Favored Pre-proline 0 CA--C 1.548 0.898 0 CA-C-N 114.775 -1.102 . . . . 72.2 109.59 174.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.36 146.04 89.21 Favored 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 122.738 2.292 . . . . 63.14 111.712 178.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 311' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -57.11 -39.51 78.24 Favored Pre-proline 0 N--CA 1.486 1.375 0 C-N-CA 124.282 1.033 . . . . 73.13 112.582 -178.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 312' ' ' PRO . . . . . 0.461 ' HB3' ' HA ' ' B' ' 120' ' ' TYR . 60.2 Cg_endo -70.76 66.29 2.37 Favored 'Trans proline' 0 C--N 1.399 3.191 0 C-N-CA 122.091 1.861 . . . . 70.14 112.592 164.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 313' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -66.08 -38.99 89.66 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 109.509 -0.552 . . . . 75.13 109.509 174.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 314' ' ' ARG . . . . . 0.481 ' HA ' HG21 ' B' ' 121' ' ' VAL . 91.8 mtt180 67.88 -76.33 0.06 Allowed 'General case' 0 C--N 1.362 1.133 0 C-N-CA 125.526 1.53 . . . . 72.01 111.186 -178.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 315' ' ' ASN . . . . . 0.428 ' HB2' ' CZ ' ' A' ' 194' ' ' TYR . 7.5 p-10 -164.49 -165.47 0.95 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.477 1.111 . . . . 72.12 108.872 -172.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 316' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 68.7 158.79 0.16 Allowed 'General case' 0 N--CA 1.499 2.023 0 C-N-CA 124.345 1.058 . . . . 74.4 112.573 -176.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 67.2 m -152.73 136.73 16.35 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.031 0.932 . . . . 75.41 109.458 175.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 318' ' ' VAL . . . . . . . . . . . . . 30.9 m -113.13 148.13 38.8 Favored Pre-proline 0 N--CA 1.48 1.032 0 C-N-CA 123.978 0.911 . . . . 73.13 109.984 178.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 319' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -69.1 147.83 67.99 Favored 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 122.457 2.105 . . . . 65.1 111.108 173.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 320' ' ' THR . . . . . . . . . . . . . 8.7 m 69.77 15.12 8.04 Favored 'General case' 0 CA--C 1.562 1.405 0 C-N-CA 124.53 1.132 . . . . 53.31 111.162 -179.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 321' ' ' LEU . . . . . . . . . . . . . 56.2 tp -59.35 113.7 2.3 Favored 'General case' 0 C--N 1.358 0.939 0 C-N-CA 123.188 0.595 . . . . 65.14 109.758 177.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 322' ' ' ALA . . . . . . . . . . . . . . . 77.2 -67.06 0.22 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.314 1.446 . . . . 64.54 112.015 -177.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 323' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 60.97 40.96 14.73 Favored 'General case' 0 CA--C 1.561 1.391 0 C-N-CA 124.069 0.948 . . . . 74.02 109.43 -177.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 324' ' ' MET . . . . . . . . . . . . . 63.6 ttp 77.36 -30.98 0.17 Allowed 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 125.684 1.594 . . . . 71.32 112.093 -175.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 325' ' ' THR . . . . . . . . . . . . . 3.2 m 63.5 30.98 15.14 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 124.956 1.302 . . . . 72.33 110.799 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 326' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 66.04 -176.47 0.19 Allowed 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.941 1.297 . . . . 72.01 112.028 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? 65.85 162.2 0.15 Allowed 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 125.424 1.489 . . . . 54.34 112.65 -178.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 328' ' ' ALA . . . . . 0.437 ' HB1' ' HA ' ' B' ' 332' ' ' LEU . . . 72.28 -66.15 0.32 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.731 1.612 . . . . 72.03 111.442 -178.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 329' ' ' ILE . . . . . . . . . . . . . 2.0 mp 60.51 112.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 C-N-CA 125.009 1.324 . . . . 73.5 111.546 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 330' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 72.21 -66.8 0.29 Allowed 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.281 1.432 . . . . 63.42 112.69 174.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 331' ' ' LEU . . . . . 0.46 HD22 ' HA ' ' B' ' 335' ' ' ASN . 39.7 mt -62.78 -48.81 77.52 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.196 0.998 . . . . 63.34 111.858 -173.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 332' ' ' LEU . . . . . 0.437 ' HA ' ' HB1' ' B' ' 328' ' ' ALA . 89.4 mt 62.18 -76.05 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 125.272 1.429 . . . . 74.41 112.451 177.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 333' ' ' SER . . . . . . . . . . . . . 38.9 t -100.88 59.0 0.92 Allowed 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.942 0.897 . . . . 65.04 109.081 178.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm 69.83 162.53 0.23 Allowed 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 125.014 1.325 . . . . 63.11 111.29 -175.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 335' ' ' ASN . . . . . 0.46 ' HA ' HD22 ' B' ' 331' ' ' LEU . 27.1 t-20 -63.26 91.52 0.05 Allowed 'General case' 0 C--N 1.361 1.074 0 N-CA-C 107.948 -1.13 . . . . 73.25 107.948 167.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -71.29 -50.0 37.08 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 114.901 -1.045 . . . . 61.02 108.914 176.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 337' ' ' LYS . . . . . . . . . . . . . 26.9 tptp 63.34 -71.97 0.05 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.812 1.645 . . . . 62.43 110.19 -175.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 338' ' ' GLY . . . . . . . . . . . . . . . -125.95 167.58 18.31 Favored Glycine 0 C--N 1.338 0.678 0 N-CA-C 111.385 -0.686 . . . . 72.34 111.385 171.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 339' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 67.11 113.78 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 125.188 1.395 . . . . 74.33 111.318 -178.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 340' ' ' PHE . . . . . 0.509 ' HD1' ' HD2' ' C' ' 260' ' ' ARG . 9.8 p90 -50.9 93.95 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 125.702 1.601 . . . . 75.24 112.917 -179.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 341' ' ' LEU . . . . . . . . . . . . . 6.7 mp 61.31 8.45 2.11 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 124.886 1.274 . . . . 75.34 112.861 -178.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 342' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 61.98 137.44 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 125.893 1.677 . . . . 64.25 111.525 -174.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 343' ' ' VAL . . . . . 0.619 HG22 ' H ' ' B' ' 345' ' ' GLY . 12.7 p -134.49 147.12 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 O-C-N 121.652 -0.655 . . . . 64.24 111.147 -169.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -67.32 -20.18 65.57 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.783 0.833 . . . . 73.03 111.441 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 345' ' ' GLY . . . . . 0.619 ' H ' HG22 ' B' ' 343' ' ' VAL . . . -80.32 24.97 3.35 Favored Glycine 0 C--N 1.348 1.223 0 N-CA-C 114.845 0.698 . . . . 62.31 114.845 177.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 346' ' ' ALA . . . . . . . . . . . . . . . -79.04 -19.8 50.5 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.335 0.654 . . . . 72.22 110.792 173.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 73.4 m -128.68 130.38 47.12 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.857 0.863 . . . . 72.21 109.295 173.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 348' ' ' ILE . . . . . 0.448 ' HB ' ' HB3' ' B' ' 276' ' ' PRO . 40.3 mm -77.8 89.15 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.071 0 N-CA-C 109.011 -0.737 . . . . 73.42 109.011 175.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 349' ' ' ASP . . . . . . . . . . . . . 14.5 t70 72.59 -66.23 0.32 Allowed 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 126.002 1.721 . . . . 71.13 112.074 178.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 350' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' B' ' 276' ' ' PRO . 8.2 tttp 72.47 -75.17 0.08 Allowed 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 125.866 1.666 . . . . 74.52 110.027 177.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -175.05 -20.88 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.083 1.353 . . . . 71.32 109.627 177.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -81.79 56.22 2.98 Favored 'General case' 0 CA--C 1.558 1.287 0 C-N-CA 123.795 0.838 . . . . 74.35 109.472 178.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 353' ' ' HIS . . . . . 0.401 ' HA ' HD13 ' B' ' 55' ' ' LEU . 11.4 t-80 173.41 -49.04 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 126.091 1.756 . . . . 74.33 108.684 179.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 354' ' ' ALA . . . . . . . . . . . . . . . 62.39 37.16 13.87 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.533 1.133 . . . . 70.11 112.743 171.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 355' ' ' ALA . . . . . . . . . . . . . . . -91.84 -0.07 57.5 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.461 0.704 . . . . 75.44 111.729 173.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 356' ' ' ASN . . . . . 0.432 ' HB3' ' HD3' ' B' ' 357' ' ' PRO . 24.3 t-20 -60.98 -45.79 96.6 Favored Pre-proline 0 CA--C 1.565 1.545 0 CA-C-O 118.789 -0.624 . . . . 74.32 111.026 172.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 357' ' ' PRO . . . . . 0.432 ' HD3' ' HB3' ' B' ' 356' ' ' ASN . 24.3 Cg_exo -67.89 114.12 3.25 Favored 'Trans proline' 0 C--N 1.393 2.878 0 C-N-CA 121.972 1.781 . . . . 55.22 112.097 167.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 358' ' ' CYS . . . . . . . . . . . . . 6.8 p -78.02 144.95 36.24 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.629 0.771 . . . . 73.32 110.881 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 359' ' ' GLY . . . . . . . . . . . . . . . -139.35 53.79 0.69 Allowed Glycine 0 C--N 1.35 1.315 0 CA-C-O 119.52 -0.6 . . . . 62.01 113.515 -171.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 360' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 70.49 -63.68 0.4 Allowed 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 125.744 1.618 . . . . 53.34 113.003 176.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 361' ' ' ILE . . . . . . . . . . . . . 39.6 mm -57.46 108.27 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 124.802 1.241 . . . . 61.31 111.053 -173.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 362' ' ' GLY . . . . . 0.441 ' HA3' ' HA ' ' B' ' 249' ' ' GLU . . . 109.56 -55.15 0.52 Allowed Glycine 0 C--N 1.338 0.651 0 CA-C-N 114.649 -1.159 . . . . 72.35 112.395 -176.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 363' ' ' GLU . . . . . 0.535 ' HG2' HG23 ' B' ' 364' ' ' THR . 38.4 tt0 -68.38 -68.93 0.36 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.264 1.026 . . . . 73.13 111.486 -174.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 364' ' ' THR . . . . . 0.535 HG23 ' HG2' ' B' ' 363' ' ' GLU . 40.1 p -110.08 68.13 0.66 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.62 0.768 . . . . 74.04 110.576 -174.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 4.5 p -161.12 87.5 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.135 0 CA-C-O 121.635 0.731 . . . . 74.01 110.075 174.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 23.8 t70 76.73 -26.54 0.19 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 126.242 1.817 . . . . 50.12 113.124 177.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 367' ' ' LEU . . . . . . . . . . . . . 7.4 mp 71.0 -97.21 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.37 1.468 . . . . 75.05 111.717 174.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 368' ' ' ASP . . . . . . . . . . . . . 33.4 p-10 -153.41 -2.03 0.22 Allowed 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 113.96 1.096 . . . . 71.23 113.96 -162.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 369' ' ' GLU . . . . . 0.413 ' HB3' ' NH2' ' B' ' 373' ' ' ARG . 36.0 tt0 -53.94 -62.34 1.72 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.419 0.688 . . . . 70.1 112.832 -171.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 370' ' ' ALA . . . . . . . . . . . . . . . -169.61 169.9 8.41 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.248 0.619 . . . . 74.25 110.633 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 371' ' ' VAL . . . . . . . . . . . . . 59.7 t -110.46 122.05 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 108.099 -1.074 . . . . 74.11 108.099 173.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 372' ' ' GLN . . . . . 0.434 ' HB3' HD21 ' B' ' 375' ' ' LEU . 17.9 tm0? 81.46 -33.53 0.1 Allowed 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 125.667 1.587 . . . . 63.2 112.824 172.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 373' ' ' ARG . . . . . 0.413 ' NH2' ' HB3' ' B' ' 369' ' ' GLU . 7.0 mpt_? 80.43 -54.53 0.35 Allowed 'General case' 0 N--CA 1.507 2.391 0 C-N-CA 125.448 1.499 . . . . 72.05 113.561 173.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -83.26 69.86 10.02 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.051 0.541 . . . . 71.45 110.894 -174.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 375' ' ' LEU . . . . . 0.434 HD21 ' HB3' ' B' ' 372' ' ' GLN . 3.2 mm? -115.84 101.43 8.79 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.7 0.8 . . . . 62.01 109.365 178.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -122.74 92.76 3.78 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.591 -0.892 . . . . 73.13 108.591 172.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 377' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -132.86 162.17 32.26 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.381 1.072 . . . . 73.31 108.897 178.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 378' ' ' ALA . . . . . . . . . . . . . . . 67.87 16.87 9.68 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 124.496 1.119 . . . . 61.1 112.552 176.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -77.6 86.45 3.92 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.058 0.943 . . . . 72.01 109.586 -175.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 380' ' ' LYS . . . . . 0.426 ' H ' HD21 ' B' ' 408' ' ' LEU . 56.3 mttp 59.36 19.57 7.82 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 124.959 1.303 . . . . 53.14 112.037 -169.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 381' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -90.18 18.05 6.39 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.32 0.648 . . . . 74.34 111.265 -176.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -66.16 -69.01 1.46 Allowed Glycine 0 C--N 1.348 1.242 0 N-CA-C 110.996 -0.841 . . . . 73.1 110.996 173.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 383' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 69.31 -20.44 0.17 Allowed 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 125.707 1.603 . . . . 73.1 113.73 175.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 384' ' ' THR . . . . . . . . . . . . . 22.0 p -132.68 -64.93 0.73 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.902 0.881 . . . . 63.41 110.04 -171.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 385' ' ' LEU . . . . . 0.518 HD12 ' HA ' ' B' ' 85' ' ' ASN . 2.1 mm? 53.89 -86.29 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 125.801 1.64 . . . . 75.12 112.177 -178.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 386' ' ' VAL . . . . . . . . . . . . . 8.2 p -161.75 139.24 2.13 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 N-CA-C 106.773 -1.566 . . . . 62.42 106.773 178.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 387' ' ' ILE . . . . . . . . . . . . . 29.8 mm 58.91 75.44 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 N-CA-C 107.796 -1.187 . . . . 74.12 107.796 -166.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 388' ' ' VAL . . . . . . . . . . . . . 17.3 m -61.72 88.84 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.259 0 CA-C-N 114.537 -1.211 . . . . 54.33 112.658 -169.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 389' ' ' THR . . . . . . . . . . . . . 11.3 t -173.51 159.62 3.68 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.306 1.042 . . . . 71.25 110.049 178.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . 64.71 -76.61 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 125.572 1.549 . . . . 70.34 113.01 177.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 391' ' ' ASP . . . . . . . . . . . . . 34.3 t70 58.04 51.23 9.05 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 124.536 1.134 . . . . 64.12 109.892 -174.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 392' ' ' HIS . . . . . . . . . . . . . 10.4 t60 70.62 137.36 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 115.274 -0.875 . . . . 72.42 108.852 -172.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -60.5 92.75 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 122.878 0.471 . . . . 61.53 110.09 176.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 29.6 m170 -71.07 -58.9 3.11 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.956 0.903 . . . . 73.31 109.988 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . 60.01 43.47 14.53 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.081 0.952 . . . . 71.44 110.022 -169.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 36.4 m 68.65 4.71 4.5 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 125.782 1.633 . . . . 75.55 112.459 -174.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 397' ' ' GLN . . . . . 0.433 ' NE2' ' HD3' ' B' ' 401' ' ' PRO . 18.8 tp60 62.43 105.31 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.444 1.498 . . . . 71.41 112.26 -178.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 2.1 mp -69.82 99.46 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 N-CA-C 107.6 -1.259 . . . . 75.44 107.6 174.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 399' ' ' VAL . . . . . . . . . . . . . 39.4 t 54.08 -95.21 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 C-N-CA 125.176 1.39 . . . . 73.32 110.55 -170.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 400' ' ' ALA . . . . . . . . . . . . . . . 172.94 98.04 0.05 OUTLIER Pre-proline 0 C--N 1.364 1.226 0 C-N-CA 124.757 1.223 . . . . 51.41 109.327 178.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 401' ' ' PRO . . . . . 0.433 ' HD3' ' NE2' ' B' ' 397' ' ' GLN . 32.4 Cg_exo -61.12 -17.05 49.93 Favored 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 123.393 2.728 . . . . 71.04 112.55 174.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -51.5 -48.5 62.91 Favored 'General case' 0 C--N 1.348 0.517 0 C-N-CA 125.301 1.44 . . . . 74.34 110.071 173.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 403' ' ' THR . . . . . . . . . . . . . 55.1 p 52.09 -83.41 0.01 OUTLIER 'General case' 0 C--N 1.36 1.036 0 C-N-CA 126.107 1.763 . . . . 51.3 111.695 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 404' ' ' LYS . . . . . . . . . . . . . 10.1 mptt -75.96 -55.36 5.69 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.352 -0.981 . . . . 70.03 108.352 175.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 405' ' ' ALA . . . . . . . . . . . . . . . -172.79 -47.39 0.0 OUTLIER Pre-proline 0 CA--C 1.561 1.394 0 CA-C-N 114.643 -1.162 . . . . 71.24 111.838 -176.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 406' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -62.06 108.33 0.65 Allowed 'Trans proline' 0 C--N 1.4 3.288 0 C-N-CA 122.201 1.934 . . . . 44.44 113.118 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 407' ' ' GLY . . . . . 0.421 ' H ' ' H ' ' B' ' 408' ' ' LEU . . . -171.2 -10.18 0.02 OUTLIER Glycine 0 N--CA 1.467 0.751 0 CA-C-N 115.549 -0.751 . . . . 55.33 112.555 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 408' ' ' LEU . . . . . 0.426 HD21 ' H ' ' B' ' 380' ' ' LYS . 5.8 mp -81.02 15.12 1.96 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.741 1.217 . . . . 72.03 111.728 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 78.3 p -76.19 -165.17 0.45 Allowed 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 125.181 1.392 . . . . 73.52 112.681 -173.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 410' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 67.83 -85.0 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 125.331 1.452 . . . . 51.32 111.163 175.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . -138.27 138.23 38.24 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.184 0.593 . . . . 63.14 110.505 -174.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 7.0 mp 58.04 -165.5 0.17 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 125.411 1.485 . . . . 60.41 112.353 178.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 14.5 m120 67.2 -71.51 0.1 Allowed 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 125.033 1.333 . . . . 71.14 109.948 -169.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 414' ' ' THR . . . . . 0.548 HG21 ' HA ' ' B' ' 98' ' ' ASP . 81.4 p -84.03 -162.15 0.62 Allowed 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.573 1.549 . . . . 73.24 111.442 -178.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 415' ' ' LYS . . . . . 0.598 ' HE3' HG23 ' B' ' 419' ' ' VAL . 68.8 tttt -79.79 34.37 0.28 Allowed 'General case' 0 CA--C 1.571 1.769 0 C-N-CA 123.67 0.788 . . . . 73.42 112.238 -178.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -65.02 -46.61 80.6 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 108.651 -0.87 . . . . 75.33 108.651 168.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 417' ' ' GLY . . . . . . . . . . . . . . . -78.09 79.62 1.45 Allowed Glycine 0 C--N 1.351 1.386 0 N-CA-C 109.182 -1.567 . . . . 43.15 109.182 163.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 418' ' ' ALA . . . . . 0.517 ' HA ' ' HG2' ' B' ' 415' ' ' LYS . . . -78.18 86.57 4.3 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.352 0.871 . . . . 70.25 113.352 -163.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 419' ' ' VAL . . . . . 0.598 HG23 ' HE3' ' B' ' 415' ' ' LYS . 66.2 t 52.28 -77.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 C-N-CA 126.392 1.877 . . . . 62.03 113.983 171.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 420' ' ' MET . . . . . . . . . . . . . 23.3 ttt -44.71 122.0 2.96 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.934 1.294 . . . . 73.12 113.652 -167.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 421' ' ' VAL . . . . . . . . . . . . . 13.1 p -64.58 -30.98 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 O-C-N 124.371 1.044 . . . . 72.42 112.361 -174.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 422' ' ' MET . . . . . . . . . . . . . 3.5 tpt -68.03 85.39 0.24 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.308 0.643 . . . . 74.1 109.731 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 423' ' ' SER . . . . . . . . . . . . . 9.5 t 66.49 -5.43 0.61 Allowed 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 125.425 1.49 . . . . 62.22 114.121 173.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 424' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 55.31 30.91 15.63 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 124.493 1.117 . . . . 72.42 110.988 -173.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . -68.13 142.67 39.91 Favored Glycine 0 C--N 1.354 1.54 0 CA-C-N 114.796 -1.093 . . . . 75.12 113.817 -171.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 426' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 55.6 -91.53 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.972 1.309 . . . . 75.43 110.46 -173.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 427' ' ' SER . . . . . . . . . . . . . 36.1 t -170.03 78.26 0.09 Allowed 'General case' 0 C--N 1.353 0.749 0 C-N-CA 123.885 0.874 . . . . 75.14 109.228 176.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 73.56 -68.16 0.23 Allowed 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 125.148 1.379 . . . . 73.23 111.241 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 429' ' ' GLU . . . . . 0.467 ' HB2' ' CE1' ' B' ' 434' ' ' HIS . 15.5 mm-40 62.45 18.95 10.8 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 125.053 1.341 . . . . 63.42 112.779 174.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -108.14 138.55 44.22 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.824 0.85 . . . . 55.41 110.778 -176.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 46.3 t -125.97 -78.03 0.59 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 108.63 -0.878 . . . . 73.31 108.63 178.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 432' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -116.85 -11.39 10.88 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.44 0.696 . . . . 71.1 110.198 173.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 433' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -170.78 139.22 1.47 Allowed 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 107.993 -1.114 . . . . 73.43 107.993 178.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 434' ' ' HIS . . . . . 0.467 ' CE1' ' HB2' ' B' ' 429' ' ' GLU . 11.2 t-160 -151.35 88.18 1.42 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 122.945 0.498 . . . . 65.13 109.768 172.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 435' ' ' THR . . . . . . . . . . . . . 4.1 m 60.24 23.98 13.37 Favored 'General case' 0 CA--C 1.562 1.441 0 C-N-CA 123.957 0.903 . . . . 73.42 112.542 164.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . 144.05 -26.44 2.04 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-O 119.79 -0.45 . . . . 43.54 113.161 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 47.5 p -83.25 70.02 10.05 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-O 121.75 0.786 . . . . 54.14 110.574 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 438' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -101.78 -97.14 0.28 Allowed 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 107.592 -1.262 . . . . 71.55 107.592 175.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 439' ' ' LEU . . . . . . . . . . . . . 95.9 mt 49.89 27.56 2.42 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 124.303 1.041 . . . . 74.24 113.093 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 440' ' ' ARG . . . . . 0.41 ' NH1' ' HB2' ' A' ' 222' ' ' ALA . 8.1 mmt180 -70.34 123.49 21.84 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.699 0.8 . . . . 70.1 109.891 -172.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 441' ' ' ILE . . . . . 0.594 HG12 HD13 ' A' ' 235' ' ' LEU . 71.8 mt -66.6 134.01 30.54 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 124.18 0.992 . . . . 74.15 112.129 -168.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 442' ' ' ALA . . . . . . . . . . . . . . . -107.12 34.04 3.67 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.032 1.333 . . . . 71.41 110.867 -178.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 443' ' ' ALA . . . . . 0.592 ' H ' HG22 ' B' ' 441' ' ' ILE . . . -84.78 -167.48 1.83 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.309 0.644 . . . . 74.21 110.932 177.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -57.34 105.16 0.21 Allowed 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 123.624 0.77 . . . . 65.34 111.923 -177.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . -165.55 83.08 0.1 Allowed Glycine 0 C--N 1.342 0.911 0 N-CA-C 109.616 -1.394 . . . . 74.34 109.616 178.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 446' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -58.15 92.35 0.06 OUTLIER 'Trans proline' 0 C--N 1.383 2.343 0 C-N-CA 123.748 2.965 . . . . 63.02 114.002 -173.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 447' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 57.15 -92.93 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 125.369 1.468 . . . . 60.0 111.169 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 448' ' ' ALA . . . . . 0.67 ' HA ' HD21 ' B' ' 470' ' ' LEU . . . 49.2 -83.89 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.638 1.575 . . . . 74.31 114.394 178.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 449' ' ' ALA . . . . . . . . . . . . . . . -71.83 89.57 1.07 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.345 1.058 . . . . 61.52 112.826 -166.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 450' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -138.35 -68.33 0.45 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.13 0.972 . . . . 61.12 108.443 167.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 7.8 m -137.14 -42.86 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 123.843 0.857 . . . . 63.1 110.834 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 452' ' ' VAL . . . . . . . . . . . . . 6.4 t 57.55 33.72 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.702 0 C-N-CA 124.529 1.132 . . . . 60.45 110.505 -178.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 174.34 170.89 38.1 Favored Glycine 0 C--N 1.346 1.138 0 CA-C-N 115.447 -0.797 . . . . 73.44 112.152 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 454' ' ' LEU . . . . . 0.687 HD22 HD12 ' B' ' 460' ' ' LEU . 3.1 pp -105.38 138.45 41.56 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.164 0.586 . . . . 72.5 111.13 -178.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 13.4 m -96.19 87.46 4.52 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 107.695 -1.224 . . . . 61.41 107.695 172.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -74.2 89.8 2.04 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.376 0.608 . . . . 74.3 111.236 -175.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 457' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -124.18 45.1 2.57 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 107.382 -1.34 . . . . 42.14 107.382 170.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 21.8 m 72.26 71.47 0.15 Allowed 'General case' 0 C--N 1.352 0.684 0 C-N-CA 125.231 1.412 . . . . 72.13 107.926 -159.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 459' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -167.05 153.55 8.35 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 114.496 -1.229 . . . . 73.31 109.296 -172.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 460' ' ' LEU . . . . . 0.687 HD12 HD22 ' B' ' 454' ' ' LEU . 34.3 tp -149.0 73.61 1.22 Allowed 'General case' 0 C--O 1.24 0.576 0 N-CA-C 109.112 -0.699 . . . . 65.42 109.112 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -63.72 99.88 0.25 Allowed 'General case' 0 C--N 1.359 0.994 0 N-CA-C 107.159 -1.423 . . . . 62.31 107.159 165.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -54.96 -49.47 71.33 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 123.923 0.764 . . . . 72.53 109.697 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 21.5 m 71.9 -24.93 0.18 Allowed 'General case' 0 CA--C 1.564 1.518 0 C-N-CA 125.547 1.539 . . . . 61.35 113.192 174.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 464' ' ' MET . . . . . . . . . . . . . 3.9 mpp? 55.17 61.24 3.0 Favored 'General case' 0 C--N 1.361 1.103 0 C-N-CA 125.352 1.461 . . . . 75.31 110.722 -177.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -83.22 136.51 34.38 Favored 'General case' 0 C--N 1.35 0.597 0 CA-C-N 114.998 -1.001 . . . . 72.15 110.288 177.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -125.22 166.87 15.69 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 124.737 1.215 . . . . 62.32 108.533 173.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . -83.58 51.35 1.99 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.643 0.777 . . . . 75.3 110.813 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 52.0 tp -168.66 -44.67 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.623 1.169 . . . . 45.51 108.757 -175.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 469' ' ' GLY . . . . . . . . . . . . . . . -178.56 -144.35 5.6 Favored Glycine 0 C--N 1.347 1.194 0 CA-C-N 115.367 -0.833 . . . . 50.44 111.662 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 470' ' ' LEU . . . . . 0.67 HD21 ' HA ' ' B' ' 448' ' ' ALA . 2.6 pt? -156.62 164.35 38.27 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.821 0.849 . . . . 73.2 109.529 178.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 471' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? . . . . . 0 CA--C 1.553 1.08 0 N-CA-C 107.556 -1.276 . . . . 74.2 107.556 173.128 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 69.2 mtm . . . . . 0 N--CA 1.482 1.169 0 CA-C-O 120.261 0.077 . . . . 55.23 111.192 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 69.29 41.67 1.31 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.546 1.138 . . . . 65.31 112.206 169.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.55 69.94 9.42 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.787 -0.642 . . . . 52.01 109.647 175.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 4' ' ' LYS . . . . . 0.4 ' HE2' ' HB3' ' C' ' 4' ' ' LYS . 31.0 ttpt -38.53 105.73 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.11 1.764 . . . . 70.52 113.589 177.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 5' ' ' LYS . . . . . 0.499 ' HB3' HD11 ' C' ' 10' ' ' ILE . 49.7 mtpt -88.47 104.15 16.53 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 107.425 -1.324 . . . . 63.2 107.425 164.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -67.8 108.35 2.94 Favored 'General case' 0 C--N 1.35 0.595 0 N-CA-C 108.401 -0.962 . . . . 63.22 108.401 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 7' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -64.96 -33.61 76.45 Favored 'General case' 0 C--O 1.244 0.81 0 O-C-N 124.162 0.914 . . . . 73.43 111.814 -169.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -68.11 -41.36 81.87 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.76 -0.654 . . . . 72.53 110.219 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.53 -39.73 94.31 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.274 0.629 . . . . 52.31 110.883 179.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 10' ' ' ILE . . . . . 0.499 HD11 ' HB3' ' C' ' 5' ' ' LYS . 81.7 mt -56.98 -43.17 80.39 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 123.686 0.795 . . . . 63.34 110.027 173.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 96.2 mt -76.59 -15.81 59.75 Favored 'General case' 0 CA--C 1.556 1.174 0 N-CA-C 112.952 0.723 . . . . 45.45 112.952 176.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.88 21.29 71.69 Favored Glycine 0 C--N 1.351 1.413 0 N-CA-C 114.021 0.368 . . . . 64.33 114.021 -177.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 23.8 m -112.52 160.26 31.07 Favored Pre-proline 0 N--CA 1.486 1.353 0 C-N-CA 124.463 1.105 . . . . 64.04 110.479 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -55.04 157.58 13.15 Favored 'Trans proline' 0 C--N 1.385 2.46 0 C-N-CA 123.582 2.855 . . . . 74.43 114.509 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 65.1 mtt85 -78.98 28.62 0.22 Allowed 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 124.113 0.965 . . . . 71.52 113.58 -176.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -158.59 15.35 0.19 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.508 1.123 . . . . 71.24 108.631 174.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.28 148.15 33.15 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.371 1.068 . . . . 71.14 112.605 -171.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 74.6 p -87.66 -175.79 5.31 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.831 0.853 . . . . 74.41 112.245 -171.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -53.11 -55.2 25.83 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.155 0.982 . . . . 74.45 111.741 -174.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -63.99 -31.37 72.53 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 123.833 0.708 . . . . 64.05 111.673 -176.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -67.59 -49.77 61.54 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 122.237 0.215 . . . . 73.42 110.516 179.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 1.7 mp -64.0 -42.51 95.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 C-N-CA 123.548 0.739 . . . . 61.32 110.932 177.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -64.41 -52.54 57.64 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.233 1.013 . . . . 74.13 111.008 -176.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -75.29 -26.84 59.04 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.662 -0.699 . . . . 73.52 111.433 -174.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -73.34 -36.49 66.17 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 122.583 0.353 . . . . 75.32 110.893 173.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 26' ' ' TYR . . . . . 0.557 ' HD1' HG22 ' C' ' 50' ' ' ILE . 51.3 t80 -58.63 -56.21 25.13 Favored 'General case' 0 C--O 1.211 -0.973 0 N-CA-C 109.031 -0.729 . . . . 72.31 109.031 173.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -56.23 -45.69 79.84 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 124.614 1.196 . . . . 74.1 111.593 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 44.7 ttt180 -50.47 -55.1 17.4 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.479 1.112 . . . . 71.15 111.245 177.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 84.4 mt -85.26 -12.01 53.47 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 114.929 -1.032 . . . . 60.22 111.558 -175.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -91.75 -4.89 54.47 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.637 0.775 . . . . 75.32 110.155 173.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 36.7 mtp-105 -95.95 -43.47 7.8 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.887 0.875 . . . . 73.5 109.741 166.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.52 -54.29 25.4 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 109.212 -0.662 . . . . 71.12 109.212 -178.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -90.5 13.5 15.59 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 116.222 -0.445 . . . . 70.15 111.722 -178.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 34' ' ' HIS . . . . . 0.408 ' HD2' HG23 ' C' ' 37' ' ' VAL . 40.3 t60 -60.61 106.69 0.82 Allowed Pre-proline 0 N--CA 1.479 1.023 0 CA-C-O 118.386 -0.816 . . . . 72.34 109.248 -179.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.28 -36.58 47.48 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 123.687 2.925 . . . . 71.32 114.855 -171.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -66.07 -34.63 78.5 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.45 1.1 . . . . 60.34 111.894 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . 0.408 HG23 ' HD2' ' C' ' 34' ' ' HIS . 80.0 t -89.15 -50.69 13.06 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 122.916 0.486 . . . . 75.33 110.429 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -102.63 104.0 14.33 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.746 1.219 . . . . 54.22 109.507 -173.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -83.86 35.16 0.51 Allowed 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 123.498 0.719 . . . . 62.24 111.973 -174.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 59.6 m -97.38 132.57 25.13 Favored Pre-proline 0 N--CA 1.488 1.434 0 CA-C-O 119.047 -0.501 . . . . 74.14 110.548 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -49.22 -42.49 39.82 Favored 'Trans proline' 0 C--N 1.384 2.413 0 C-N-CA 123.199 2.599 . . . . 63.44 112.15 168.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -58.32 -37.23 74.68 Favored 'General case' 0 C--N 1.353 0.75 0 CA-C-N 115.542 -0.754 . . . . 65.44 111.025 177.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.56 -21.79 59.33 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 119.431 -0.319 . . . . 62.05 110.768 -178.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -69.59 -51.01 39.13 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 108.987 -0.746 . . . . 74.04 108.987 174.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 45' ' ' GLU . . . . . 0.437 ' O ' ' HG3' ' C' ' 49' ' ' GLU . 42.1 mt-10 -67.88 -47.35 69.09 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 114.103 -1.408 . . . . 42.53 110.793 -175.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 46' ' ' LYS . . . . . 0.554 ' O ' HG12 ' C' ' 50' ' ' ILE . 35.8 mmtm -60.35 -43.11 96.81 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-N 115.329 -0.851 . . . . 72.32 111.097 175.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -58.22 -40.96 83.03 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 123.656 0.597 . . . . 62.23 110.546 178.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -64.68 -34.26 77.88 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 123.747 0.654 . . . . 72.04 111.601 175.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 49' ' ' GLU . . . . . 0.437 ' HG3' ' O ' ' C' ' 45' ' ' GLU . 41.6 mt-10 -69.42 -33.0 72.33 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 122.653 0.381 . . . . 72.33 111.139 174.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 50' ' ' ILE . . . . . 0.557 HG22 ' HD1' ' C' ' 26' ' ' TYR . 14.7 mm -71.66 -34.41 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 N-CA-C 108.903 -0.777 . . . . 75.43 108.903 176.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 51' ' ' ASN . . . . . 0.449 ' HB3' ' HD1' ' C' ' 88' ' ' PHE . 11.7 m120 -69.18 -36.71 77.62 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-N 114.642 -1.163 . . . . 74.04 110.662 176.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 62.2 tt0 -62.68 -54.34 40.89 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.9 0.88 . . . . 63.42 110.128 177.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -52.64 -60.88 2.71 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-N 113.467 -1.697 . . . . 63.1 111.224 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -61.19 -38.66 87.32 Favored 'General case' 0 C--O 1.21 -1.019 0 CA-C-N 115.072 -0.967 . . . . 75.01 111.895 -178.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.61 -51.26 70.58 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 122.827 0.451 . . . . 60.54 111.463 -177.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 56' ' ' VAL . . . . . 0.511 ' HA ' ' HE3' ' C' ' 62' ' ' LYS . 75.0 t -60.49 -40.63 84.92 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 O-C-N 124.307 1.004 . . . . 72.43 110.394 176.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 57' ' ' LEU . . . . . . . . . . . . . 46.9 mt -89.15 -0.8 57.74 Favored 'General case' 0 CA--C 1.565 1.544 0 N-CA-C 113.025 0.75 . . . . 75.02 113.025 -176.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 32.8 t -77.25 -57.39 3.86 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 124.339 1.056 . . . . 62.42 111.066 -178.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . 0.419 ' HA ' HG12 ' C' ' 145' ' ' VAL . 0.9 OUTLIER -65.83 122.83 82.81 Favored Pre-proline 0 C--N 1.354 0.796 0 N-CA-C 107.955 -1.128 . . . . 72.03 107.955 173.231 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 60' ' ' PRO . . . . . 0.54 ' HD2' ' HA ' ' C' ' 145' ' ' VAL . 19.1 Cg_endo -56.17 -27.78 67.34 Favored 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 123.066 2.51 . . . . 33.23 111.177 173.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . 0.67 ' HG2' ' HD3' ' C' ' 79' ' ' PRO . 3.2 tp10 -58.08 -66.06 0.54 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.249 1.02 . . . . 62.13 110.416 172.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 62' ' ' LYS . . . . . 0.511 ' HE3' ' HA ' ' C' ' 56' ' ' VAL . 17.7 mtmt -70.1 -22.99 62.97 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.426 0.69 . . . . 75.23 111.565 -173.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 48.8 tpt85 -61.18 -55.84 27.61 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.759 1.224 . . . . 64.42 109.233 172.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 -75.24 -19.15 59.9 Favored 'General case' 0 C--N 1.351 0.668 0 CA-C-N 115.26 -0.882 . . . . 74.15 111.523 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 65' ' ' ILE . . . . . 0.493 HG12 ' HB2' ' C' ' 76' ' ' PRO . 36.0 mt -66.03 -46.87 86.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.28 0.632 . . . . 62.34 109.55 171.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -61.46 -46.95 87.93 Favored 'General case' 0 C--N 1.353 0.727 0 O-C-N 123.803 0.689 . . . . 74.22 109.667 177.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -55.05 -48.6 73.22 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 123.675 0.609 . . . . 73.14 111.649 177.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 76.7 p -79.73 -9.15 59.61 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 112.568 0.581 . . . . 63.2 112.568 -178.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -72.38 100.37 2.65 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 108.229 -1.026 . . . . 75.22 108.229 174.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 125.05 10.83 4.54 Favored Glycine 0 N--CA 1.47 0.918 0 CA-C-N 115.348 -0.842 . . . . 62.51 111.704 -165.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 29.5 m -142.61 -55.53 0.43 Allowed 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 104.526 -2.398 . . . . 72.34 104.526 175.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 70.6 m -84.12 135.48 34.38 Favored 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 103.613 -2.736 . . . . 73.35 103.613 154.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.42 -31.09 8.31 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 118.987 0.812 . . . . 73.23 111.147 178.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -72.69 153.18 91.5 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 123.425 0.69 . . . . 53.23 109.254 171.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -54.3 113.55 1.41 Allowed 'Trans proline' 0 C--N 1.373 1.822 0 C-N-CA 122.56 2.173 . . . . 75.14 112.06 171.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 76' ' ' PRO . . . . . 0.493 ' HB2' HG12 ' C' ' 65' ' ' ILE . 45.8 Cg_exo -59.01 148.3 85.91 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 122.979 2.453 . . . . 63.14 111.525 175.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -57.82 124.43 16.0 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.985 2.457 . . . . 51.51 112.963 -169.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 78' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -63.33 153.25 75.61 Favored 'Trans proline' 0 C--N 1.38 2.221 0 C-N-CA 122.541 2.16 . . . . 74.44 111.904 175.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 79' ' ' PRO . . . . . 0.67 ' HD3' ' HG2' ' C' ' 61' ' ' GLU . 37.7 Cg_endo -66.36 147.44 82.94 Favored 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 122.128 1.885 . . . . 61.04 109.531 170.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 80' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' C' ' 79' ' ' PRO . 53.6 Cg_exo -55.22 78.77 0.03 OUTLIER 'Trans proline' 0 C--N 1.384 2.436 0 C-N-CA 124.139 3.226 . . . . 51.5 114.646 -176.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 163.7 -51.89 0.3 Allowed Glycine 0 CA--C 1.519 0.283 0 N-CA-C 108.326 -1.909 . . . . 75.2 108.326 -174.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 134.14 -157.63 22.96 Favored Glycine 0 C--N 1.351 1.383 0 C-N-CA 123.09 0.376 . . . . 74.45 113.102 173.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -97.25 121.1 38.76 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.181 0.992 . . . . 70.14 109.007 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 84' ' ' ASP . . . . . 0.499 ' HB2' ' NE ' ' C' ' 143' ' ' ARG . 7.8 t70 -79.5 126.12 30.45 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 112.516 0.562 . . . . 63.13 112.516 -171.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 85' ' ' PHE . . . . . 0.402 ' HA ' ' HD2' ' C' ' 88' ' ' PHE . 87.0 m-85 -137.61 31.7 2.54 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.184 0.994 . . . . 74.41 109.288 173.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 15.5 m -81.07 85.24 6.33 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 114.657 -1.156 . . . . 45.43 110.869 -172.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 87' ' ' GLY . . . . . 0.454 ' N ' ' HA ' ' C' ' 171' ' ' PRO . . . 129.31 -15.85 5.76 Favored Glycine 0 N--CA 1.471 0.971 0 N-CA-C 110.626 -0.99 . . . . 74.33 110.626 -172.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 88' ' ' PHE . . . . . 0.449 ' HD1' ' HB3' ' C' ' 51' ' ' ASN . 33.2 m-85 -108.57 135.87 49.11 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 108.023 -1.102 . . . . 74.44 108.023 178.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -77.18 79.26 3.7 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.014 0.525 . . . . 72.23 110.271 -175.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 90' ' ' VAL . . . . . 0.544 HG23 ' HZ ' ' C' ' 97' ' ' PHE . 3.4 p -48.48 -40.85 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 C-N-CA 124.96 1.304 . . . . 54.41 112.574 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -62.92 -29.89 71.13 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.715 0.806 . . . . 74.21 111.42 -177.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -72.32 -33.42 67.34 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.057 0.543 . . . . 75.53 112.023 178.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 93' ' ' PHE . . . . . 0.403 ' HZ ' ' HB3' ' C' ' 88' ' ' PHE . 10.6 m-30 -70.38 166.22 20.76 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 122.72 0.408 . . . . 72.45 111.208 -166.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 75.5 p -57.32 149.65 19.84 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 113.306 0.854 . . . . 45.51 113.306 -168.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.4 -32.94 70.63 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 115.299 -0.864 . . . . 55.43 111.118 170.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -52.97 -52.06 59.43 Favored 'General case' 0 C--N 1.357 0.915 0 C-N-CA 125.016 1.327 . . . . 65.02 109.934 174.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 97' ' ' PHE . . . . . 0.544 ' HZ ' HG23 ' C' ' 90' ' ' VAL . 1.8 t80 -60.35 -44.12 95.86 Favored 'General case' 0 CA--C 1.557 1.22 0 CA-C-N 113.256 -1.793 . . . . 64.25 110.677 174.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -70.79 -12.82 61.78 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 112.568 0.581 . . . . 51.52 112.568 -177.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -93.25 -40.61 10.34 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.298 0.639 . . . . 74.43 110.818 173.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 23.7 tp -75.03 -63.57 1.24 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.021 0.528 . . . . 73.23 110.795 -178.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -80.65 -11.43 59.64 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 122.851 0.46 . . . . 73.25 111.841 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -41.03 -60.91 2.11 Favored Glycine 0 CA--C 1.541 1.715 0 CA-C-O 118.726 -1.041 . . . . 54.11 115.137 178.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -50.14 -28.13 18.91 Favored 'Trans proline' 0 C--N 1.386 2.551 0 C-N-CA 124.113 3.209 . . . . 62.02 114.693 -177.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -126.77 30.55 4.16 Favored Glycine 0 C--N 1.358 1.757 0 CA-C-O 118.516 -1.158 . . . . 43.23 113.145 -175.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 34.5 mt -68.28 72.17 0.19 Allowed 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 118.373 1.086 . . . . 73.03 112.688 177.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 106' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 43.53 -107.99 0.11 Allowed 'General case' 0 CA--C 1.562 1.441 0 C-N-CA 126.494 1.918 . . . . 64.24 113.874 170.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . 70.46 23.4 77.57 Favored Glycine 0 C--N 1.357 1.698 0 CA-C-O 120.002 -0.332 . . . . 51.05 112.943 -169.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 62.2 -104.14 0.7 Allowed Glycine 0 C--N 1.36 1.878 0 N-CA-C 111.668 -0.573 . . . . 74.41 111.668 -174.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 109' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -122.46 -7.28 8.67 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.571 1.148 . . . . 74.45 110.118 172.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 110' ' ' GLY . . . . . . . . . . . . . . . -88.83 -10.05 67.45 Favored Glycine 0 C--N 1.349 1.259 0 C-N-CA 123.48 0.562 . . . . 54.22 113.044 179.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 53.7 mtm-85 58.33 8.11 0.78 Allowed 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 124.642 1.177 . . . . 75.25 113.891 173.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 112' ' ' ARG . . . . . 0.679 ' HE ' ' HB3' ' C' ' 114' ' ' ARG . 44.3 ttp180 -55.7 -23.3 28.02 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 125.192 1.397 . . . . 74.1 112.544 176.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 113' ' ' SER . . . . . . . . . . . . . 27.4 m 65.14 17.5 11.07 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.963 1.305 . . . . 72.53 112.156 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 114' ' ' ARG . . . . . 0.679 ' HB3' ' HE ' ' C' ' 112' ' ' ARG . 14.4 tpt180 -119.57 177.59 4.88 Favored 'General case' 0 CA--C 1.555 1.142 0 CA-C-O 118.509 -0.757 . . . . 74.05 110.829 -170.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 115' ' ' LYS . . . . . 0.471 ' H ' ' HG3' ' C' ' 114' ' ' ARG . 53.9 tttp -25.16 129.24 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.362 0 C-N-CA 127.218 2.207 . . . . 54.14 116.262 -164.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -93.41 158.6 23.71 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-N 115.046 -0.979 . . . . 45.25 113.618 -173.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 117' ' ' ARG . . . . . 0.446 ' HA ' ' NE ' ' C' ' 117' ' ' ARG . 2.2 mmp_? -116.71 155.51 28.75 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.21 1.004 . . . . 64.44 112.156 178.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -66.89 108.61 2.62 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-O 121.756 0.789 . . . . 75.42 109.428 175.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 119' ' ' LEU . . . . . 0.558 HD21 HG22 ' B' ' 185' ' ' VAL . 3.9 tt -89.22 112.74 23.84 Favored 'General case' 0 C--O 1.224 -0.28 0 N-CA-C 105.814 -1.921 . . . . 75.21 105.814 -174.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -93.66 132.68 37.77 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.516 -1.29 . . . . 72.31 107.516 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 121' ' ' ALA . . . . . . . . . . . . . . . -143.52 117.0 9.12 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.161 -0.681 . . . . 63.21 109.161 -177.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 122' ' ' GLU . . . . . 0.539 ' HA ' ' O ' ' C' ' 177' ' ' VAL . 13.1 pt-20 -92.91 125.47 37.52 Favored 'General case' 0 C--N 1.353 0.754 0 N-CA-C 109.036 -0.727 . . . . 73.22 109.036 176.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 123' ' ' LEU . . . . . 0.643 ' HB2' ' HA ' ' B' ' 182' ' ' VAL . 0.8 OUTLIER -121.51 105.72 38.49 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 115.873 -0.603 . . . . 73.3 111.63 -170.048 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . 0.717 ' HD2' ' HB3' ' B' ' 183' ' ' ALA . 28.2 Cg_exo -42.33 113.77 0.34 Allowed 'Trans proline' 0 C--N 1.374 1.9 0 C-N-CA 123.314 2.676 . . . . 72.51 112.02 161.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 125' ' ' LEU . . . . . . . . . . . . . 42.9 tp -140.09 140.78 36.16 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.829 1.252 . . . . 74.03 108.401 -170.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.43 154.11 22.98 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 121.006 0.431 . . . . 61.53 111.156 -176.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 127' ' ' LEU . . . . . 0.665 ' HB3' HD22 ' C' ' 215' ' ' LEU . 96.2 mt -63.22 -44.28 95.72 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.519 1.128 . . . . 62.25 111.067 177.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -53.55 -49.03 68.55 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 114.964 -1.016 . . . . 75.24 110.302 172.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -66.19 -32.31 73.67 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.889 0.876 . . . . 73.53 111.484 -176.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -73.05 -31.54 64.48 Favored 'General case' 0 CA--C 1.541 0.596 0 O-C-N 124.087 0.867 . . . . 64.34 110.475 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 131' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -69.45 -43.16 73.85 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.448 0.699 . . . . 75.55 110.395 171.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 132' ' ' HIS . . . . . . . . . . . . . 38.2 m170 -67.11 -67.65 0.44 Allowed 'General case' 0 N--CA 1.485 1.28 0 O-C-N 124.007 0.817 . . . . 60.22 111.924 -172.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 67.52 99.28 0.03 OUTLIER Glycine 0 CA--C 1.542 1.734 0 O-C-N 123.423 0.452 . . . . 65.31 113.607 -178.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . -142.52 162.12 27.33 Favored Glycine 0 N--CA 1.476 1.311 0 CA-C-O 119.244 -0.753 . . . . 53.24 111.272 178.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 53.6 mp0 -71.45 92.81 1.12 Allowed 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 108.565 -0.902 . . . . 71.2 108.565 177.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 136' ' ' ARG . . . . . 0.532 ' HB2' HD22 ' B' ' 181' ' ' LEU . 99.0 mtt180 -124.75 154.71 40.47 Favored 'General case' 0 C--O 1.247 0.941 0 C-N-CA 124.084 0.954 . . . . 72.12 109.302 -173.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 137' ' ' VAL . . . . . 0.498 HG13 ' HB1' ' B' ' 180' ' ' ALA . 7.6 p -81.12 108.8 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-O 121.919 0.866 . . . . 71.12 111.828 -165.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 138' ' ' VAL . . . . . 0.415 HG12 HG13 ' B' ' 182' ' ' VAL . 20.8 m -87.78 133.98 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 108.012 -1.107 . . . . 72.14 108.012 165.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 139' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' C' ' 143' ' ' ARG . 1.2 tm-20 -124.7 105.34 9.23 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 108.03 -1.1 . . . . 74.31 108.03 169.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 140' ' ' VAL . . . . . . . . . . . . . 67.1 t -127.81 110.41 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 123.796 0.838 . . . . 63.22 109.181 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 63.86 29.32 14.64 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.149 0.979 . . . . 15.23 110.976 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 97.76 -12.96 64.26 Favored Glycine 0 C--N 1.349 1.257 0 CA-C-N 115.003 -0.999 . . . . 45.25 112.738 -178.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 143' ' ' ARG . . . . . 0.499 ' NE ' ' HB2' ' C' ' 84' ' ' ASP . 5.9 tpp180 -75.26 93.92 2.93 Favored 'General case' 0 C--N 1.353 0.717 0 CA-C-N 117.253 0.527 . . . . 73.04 109.84 -177.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 28.8 ttp85 -104.73 96.68 6.74 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 124.373 1.069 . . . . 71.51 109.511 -176.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 145' ' ' VAL . . . . . 0.54 ' HA ' ' HD2' ' C' ' 60' ' ' PRO . 25.7 m -133.02 146.38 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.64 0.776 . . . . 75.03 110.615 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 46.4 m -89.79 92.48 9.06 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.949 -0.76 . . . . 54.21 108.949 174.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 147' ' ' VAL . . . . . 0.599 HG11 ' HE1' ' C' ' 164' ' ' MET . 10.8 p -113.16 145.37 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 122.942 0.497 . . . . 72.53 109.977 -174.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -101.16 101.81 12.61 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 108.499 -0.926 . . . . 74.22 108.499 170.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 149' ' ' ILE . . . . . . . . . . . . . 36.0 pt -73.57 137.1 77.49 Favored Pre-proline 0 CA--C 1.551 1.006 0 N-CA-C 107.734 -1.21 . . . . 71.41 107.734 165.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 150' ' ' PRO . . . . . 0.444 ' HA ' ' HD3' ' C' ' 151' ' ' PRO . 51.5 Cg_endo -63.76 142.66 83.9 Favored 'Trans proline' 0 C--N 1.37 1.702 0 C-N-CA 122.417 2.078 . . . . 61.44 113.136 -167.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 151' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' C' ' 150' ' ' PRO . 26.1 Cg_exo -62.92 149.95 89.94 Favored 'Trans proline' 0 C--N 1.379 2.148 0 C-N-CA 122.843 2.362 . . . . 73.2 111.719 176.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 152' ' ' GLY . . . . . 0.71 ' HA2' ' HB3' ' C' ' 240' ' ' PHE . . . 80.59 52.79 4.29 Favored Glycine 0 C--N 1.336 0.557 0 CA-C-N 116.216 -0.447 . . . . 54.32 112.435 -176.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 153' ' ' VAL . . . . . 0.527 HG21 HD11 ' C' ' 159' ' ' ILE . 8.3 p -104.14 142.83 16.87 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.312 0 C-N-CA 123.009 0.524 . . . . 71.13 110.26 -177.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 154' ' ' ARG . . . . . 0.593 ' HA ' ' HB3' ' C' ' 188' ' ' LEU . 57.5 mtp180 -97.51 161.35 13.82 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.762 0.825 . . . . 75.32 112.094 -168.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 155' ' ' GLU . . . . . 0.473 ' HG2' ' HE ' ' C' ' 187' ' ' ARG . 8.3 tp10 -54.22 115.7 2.21 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.682 0.793 . . . . 74.51 110.102 162.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 78.1 19.67 74.34 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-O 119.536 -0.591 . . . . 64.51 113.862 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 157' ' ' SER . . . . . 0.567 ' HA ' ' HG2' ' B' ' 193' ' ' PRO . 3.4 m -70.62 108.53 4.41 Favored 'General case' 0 C--N 1.355 0.842 0 CA-C-N 117.365 0.583 . . . . 75.43 110.105 172.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 158' ' ' VAL . . . . . 0.537 HG11 ' HA ' ' B' ' 190' ' ' CYS . 22.0 t -84.43 88.46 2.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 114.698 -1.137 . . . . 64.44 108.437 176.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 159' ' ' ILE . . . . . 0.527 HD11 HG21 ' C' ' 153' ' ' VAL . 37.5 mt -72.14 118.02 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 115.184 -0.916 . . . . 52.25 109.587 -178.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -75.95 118.61 18.91 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 109.091 -0.707 . . . . 72.21 109.091 173.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 161' ' ' VAL . . . . . 0.462 HG11 ' SD ' ' C' ' 164' ' ' MET . 20.6 t -125.85 95.55 39.61 Favored Pre-proline 0 CA--C 1.55 0.96 0 N-CA-C 109.556 -0.535 . . . . 75.24 109.556 174.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.38 128.11 12.5 Favored 'Trans proline' 0 C--N 1.369 1.609 0 C-N-CA 122.264 1.976 . . . . 63.42 111.342 173.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 101.92 23.92 8.93 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-N 115.793 -0.64 . . . . 53.31 113.466 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 164' ' ' MET . . . . . 0.599 ' HE1' HG11 ' C' ' 147' ' ' VAL . 28.2 mtp -151.81 6.9 0.47 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 112.619 0.6 . . . . 73.35 112.619 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 165' ' ' GLY . . . . . 0.415 ' HA3' ' O ' ' C' ' 173' ' ' ASP . . . -121.92 -122.89 2.88 Favored Glycine 0 N--CA 1.478 1.458 0 CA-C-O 118.348 -1.251 . . . . 64.24 111.515 -177.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . 69.4 81.93 0.21 Allowed Glycine 0 C--N 1.359 1.816 0 CA-C-N 118.149 0.974 . . . . 75.44 113.823 165.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 167' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -69.23 99.41 1.16 Allowed 'General case' 0 C--N 1.348 0.512 0 N-CA-C 107.035 -1.469 . . . . 64.31 107.035 166.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . 131.51 -142.51 13.91 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 108.395 -1.882 . . . . 13.44 108.395 -161.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 169' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -145.74 -62.2 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.774 0 CA-C-N 120.226 2.013 . . . . 62.44 111.784 175.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 170' ' ' PRO . . . . . 0.466 ' HG2' ' HA ' ' C' ' 115' ' ' LYS . 26.6 Cg_endo -61.88 162.79 20.97 Favored 'Trans proline' 0 C--N 1.399 3.191 0 C-N-CA 122.174 1.916 . . . . 51.41 112.345 173.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 171' ' ' PRO . . . . . 0.454 ' HA ' ' N ' ' C' ' 87' ' ' GLY . 5.8 Cg_exo -10.38 108.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.396 3.078 1 C-N-CA 127.079 5.186 . . . . 74.02 118.497 -165.189 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -140.32 -156.41 6.87 Favored Glycine 0 C--N 1.342 0.912 0 N-CA-C 109.311 -1.516 . . . . 74.42 109.311 170.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 173' ' ' ASP . . . . . 0.415 ' O ' ' HA3' ' C' ' 165' ' ' GLY . 14.5 t70 -166.3 158.29 13.85 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 117.843 0.822 . . . . 74.51 110.087 -177.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 174' ' ' LEU . . . . . 0.434 HD12 ' O ' ' C' ' 119' ' ' LEU . 45.2 tp -118.82 107.53 13.73 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.674 0.79 . . . . 75.22 109.758 175.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 175' ' ' LEU . . . . . 0.451 HD22 HG12 ' C' ' 158' ' ' VAL . 73.8 mt -86.44 85.85 7.33 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.962 0.905 . . . . 71.32 110.273 175.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 176' ' ' LEU . . . . . 0.43 ' HG ' ' HG ' ' C' ' 174' ' ' LEU . 47.9 mt -75.3 92.7 2.79 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.594 0.758 . . . . 43.02 110.543 177.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 177' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' C' ' 122' ' ' GLU . 6.5 t -84.92 94.13 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 C-N-CA 123.423 0.689 . . . . 74.43 109.921 179.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 178' ' ' VAL . . . . . . . . . . . . . 23.0 m -68.78 119.53 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 O-C-N 121.344 -0.848 . . . . 74.01 110.781 -176.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 179' ' ' ARG . . . . . 0.474 ' O ' ' HA ' ' C' ' 124' ' ' PRO . 7.0 mmm180 -100.93 119.7 39.09 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 107.023 -1.473 . . . . 72.33 107.023 171.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 180' ' ' LEU . . . . . 0.454 HD13 HD21 ' C' ' 127' ' ' LEU . 75.5 mt -68.6 134.99 50.78 Favored 'General case' 0 CA--C 1.559 1.29 0 CA-C-N 118.171 0.441 . . . . 70.51 111.397 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 181' ' ' LEU . . . . . 0.436 HD23 ' HB3' ' C' ' 124' ' ' PRO . 18.5 mt -53.12 169.64 0.29 Allowed Pre-proline 0 N--CA 1.502 2.148 0 C-N-CA 126.521 1.928 . . . . 74.2 113.538 -176.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -59.99 64.5 0.07 OUTLIER 'Trans proline' 0 C--N 1.405 3.543 0 C-N-CA 123.486 2.791 . . . . 64.12 112.268 161.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 183' ' ' HIS . . . . . 0.527 ' N ' ' HD3' ' C' ' 184' ' ' PRO . 76.4 t60 -162.37 26.15 0.02 OUTLIER Pre-proline 0 CA--C 1.576 1.957 0 C-N-CA 127.77 2.428 . . . . 62.13 107.705 -176.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 184' ' ' PRO . . . . . 0.527 ' HD3' ' N ' ' C' ' 183' ' ' HIS . 11.0 Cg_endo -88.49 67.67 3.0 Favored 'Trans proline' 0 C--N 1.401 3.341 0 C-N-CA 123.588 2.859 . . . . 71.54 111.377 -163.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 185' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 9.0 t -89.48 -23.93 6.05 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.492 0 N-CA-C 108.146 -1.057 . . . . 72.23 108.146 -177.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 186' ' ' PHE . . . . . 0.484 ' HD2' HD13 ' C' ' 127' ' ' LEU . 48.4 m-85 -127.85 101.82 6.51 Favored 'General case' 0 C--N 1.352 0.704 0 C-N-CA 123.737 0.815 . . . . 61.44 109.266 -178.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 187' ' ' ARG . . . . . 0.473 ' HE ' ' HG2' ' C' ' 155' ' ' GLU . 27.9 ttm105 -97.72 110.65 23.17 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 124.557 1.143 . . . . 75.14 108.182 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 188' ' ' LEU . . . . . 0.593 ' HB3' ' HA ' ' C' ' 154' ' ' ARG . 59.5 tp -76.77 131.94 38.99 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.387 0.613 . . . . 74.14 112.6 -166.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -116.08 106.3 13.59 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.147 1.379 . . . . 71.33 108.377 167.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 66.85 -99.8 0.51 Allowed Glycine 0 C--N 1.348 1.239 0 CA-C-N 116.053 -0.521 . . . . 74.2 112.454 -178.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 191' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -117.53 -14.21 10.28 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 124.262 1.025 . . . . 60.21 110.183 175.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -101.32 128.71 47.36 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.678 1.191 . . . . 65.13 110.401 -173.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 193' ' ' LEU . . . . . 0.432 ' HG ' ' HA2' ' C' ' 239' ' ' GLY . 77.8 mt -73.74 153.75 39.89 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.828 0.851 . . . . 52.2 111.883 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 194' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -123.83 106.72 10.7 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 107.266 -1.383 . . . . 75.43 107.266 169.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 195' ' ' ALA . . . . . 0.461 ' HA ' ' O ' ' C' ' 185' ' ' VAL . . . -110.76 -177.91 3.34 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.286 1.034 . . . . 65.11 110.38 -174.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 90.2 m -137.75 121.12 17.05 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 108.638 -0.875 . . . . 51.32 108.638 164.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 197' ' ' LEU . . . . . . . . . . . . . 63.2 tp -100.48 143.5 30.59 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.586 1.155 . . . . 73.5 110.232 -175.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -100.61 101.59 12.53 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 123.656 0.782 . . . . 44.52 109.004 -178.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 199' ' ' VAL . . . . . 0.406 HG22 HG21 ' C' ' 210' ' ' VAL . 94.9 t -114.51 125.58 29.0 Favored Pre-proline 0 N--CA 1.486 1.354 0 C-N-CA 124.404 1.081 . . . . 61.21 109.864 -176.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 200' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -74.06 145.05 34.83 Favored 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 121.675 1.583 . . . . 71.34 111.125 174.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 201' ' ' ALA . . . . . 0.461 ' O ' HG23 ' C' ' 205' ' ' VAL . . . -58.66 -38.89 70.25 Favored Pre-proline 0 CA--C 1.552 1.024 0 N-CA-C 115.263 1.579 . . . . 74.35 115.263 -173.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 202' ' ' PRO . . . . . 0.542 ' O ' HG13 ' C' ' 206' ' ' VAL . 21.2 Cg_endo -59.13 -52.33 5.16 Favored 'Trans proline' 0 C--N 1.388 2.613 0 CA-C-N 121.711 1.647 . . . . 63.15 111.205 175.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 203' ' ' ILE . . . . . . . . . . . . . 43.4 mt -62.49 -28.25 44.36 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 C-N-CA 124.228 1.011 . . . . 63.4 110.737 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.62 -43.4 76.44 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.5 -0.773 . . . . 75.02 112.305 175.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 205' ' ' VAL . . . . . 0.538 HG11 HD11 ' A' ' 261' ' ' LEU . 65.2 t -69.39 -45.42 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 122.373 0.269 . . . . 63.41 110.964 -178.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 206' ' ' VAL . . . . . 0.542 HG13 ' O ' ' C' ' 202' ' ' PRO . 0.7 OUTLIER -96.58 -38.09 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 111.514 0.19 . . . . 52.12 111.514 -167.717 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 106.07 119.49 4.55 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 112.455 -0.258 . . . . 63.21 112.455 -173.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -156.44 -137.64 2.37 Favored Glycine 0 C--N 1.336 0.56 0 N-CA-C 109.79 -1.324 . . . . 51.32 109.79 176.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 209' ' ' LYS . . . . . 0.682 ' HG2' ' HA ' ' C' ' 222' ' ' ALA . 10.2 mtmp? -142.37 151.94 42.38 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 118.08 0.94 . . . . 72.12 111.712 177.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 210' ' ' VAL . . . . . 0.406 HG21 HG22 ' C' ' 199' ' ' VAL . 30.2 m -139.42 174.0 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 125.644 1.577 . . . . 62.05 108.516 174.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 211' ' ' ARG . . . . . 0.723 ' HE ' ' HB3' ' B' ' 234' ' ' ALA . 40.5 ttm-85 -109.66 127.64 54.7 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 118.431 0.56 . . . . 72.44 110.778 -176.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -107.97 113.14 26.11 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 107.335 -1.358 . . . . 74.43 107.335 169.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 213' ' ' MET . . . . . 0.677 ' HA ' ' HA ' ' C' ' 218' ' ' PRO . 4.2 ttp -80.28 98.95 7.63 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 108.954 -0.758 . . . . 63.12 108.954 -176.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.11 177.74 8.58 Favored 'General case' 0 C--O 1.244 0.798 0 O-C-N 123.342 0.401 . . . . 54.24 109.936 -174.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 215' ' ' LEU . . . . . 0.665 HD22 ' HB3' ' C' ' 127' ' ' LEU . 11.9 mt -52.68 -60.81 2.8 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.055 0.942 . . . . 44.41 110.506 -175.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -86.76 8.61 21.94 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.211 -0.904 . . . . 71.0 112.185 -174.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 142.07 157.03 7.0 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-O 119.925 -0.375 . . . . 64.11 113.307 177.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 218' ' ' PRO . . . . . 0.682 ' HB2' HH11 ' C' ' 211' ' ' ARG . 31.8 Cg_endo -63.22 121.99 10.03 Favored 'Trans proline' 0 C--N 1.364 1.389 0 C-N-CA 122.95 2.433 . . . . 52.13 115.322 177.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 219' ' ' VAL . . . . . . . . . . . . . 8.0 p -98.77 167.84 1.8 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.928 0 N-CA-C 107.05 -1.463 . . . . 52.53 107.05 170.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 220' ' ' GLU . . . . . 0.639 ' HB2' ' HB ' ' B' ' 236' ' ' THR . 3.0 tt0 -101.04 158.45 16.0 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 109.338 -0.616 . . . . 72.32 109.338 173.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 221' ' ' VAL . . . . . . . . . . . . . 33.3 t -121.97 123.22 68.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 125.2 1.4 . . . . 74.03 108.309 173.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 222' ' ' ALA . . . . . 0.682 ' HA ' ' HG2' ' C' ' 209' ' ' LYS . . . -84.15 101.92 12.19 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 123.118 0.567 . . . . 73.3 109.565 169.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 61.0 t -75.53 123.39 88.49 Favored Pre-proline 0 CA--C 1.549 0.91 0 CA-C-N 114.409 -1.269 . . . . 73.11 109.222 178.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 224' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -76.37 164.44 30.85 Favored 'Trans proline' 0 C--N 1.369 1.651 0 C-N-CA 123.552 2.835 . . . . 54.33 112.917 172.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -55.96 146.52 68.2 Favored 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 122.361 2.041 . . . . 74.0 112.684 165.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 226' ' ' ARG . . . . . 0.419 ' HG3' ' HA ' ' A' ' 259' ' ' GLU . 8.0 mpt_? 66.65 66.5 0.45 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.764 1.225 . . . . 70.15 110.814 171.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 227' ' ' THR . . . . . 0.533 ' HA ' ' HD3' ' C' ' 231' ' ' ARG . 16.7 m -114.89 121.79 44.29 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 114.697 -1.138 . . . . 70.3 110.779 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 228' ' ' GLN . . . . . 0.401 ' HB3' HD12 ' B' ' 29' ' ' LEU . 24.6 mp0 -111.27 163.01 14.4 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.922 0.889 . . . . 74.32 110.809 -178.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -77.18 111.43 12.79 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 114.403 -1.271 . . . . 62.12 109.965 -178.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 110.61 6.2 27.12 Favored Glycine 0 N--CA 1.476 1.311 0 CA-C-O 119.896 -0.391 . . . . 62.04 113.115 -169.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 231' ' ' ARG . . . . . 0.583 ' HG2' ' HA ' ' B' ' 30' ' ' GLU . 39.4 mtp85 -77.84 169.78 17.71 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 109.623 -0.51 . . . . 74.12 109.623 164.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 232' ' ' LYS . . . . . 0.466 ' HB2' ' HZ2' ' C' ' 232' ' ' LYS . 2.1 ttmp? -135.08 151.02 50.36 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.424 0.63 . . . . 71.45 112.461 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 233' ' ' LEU . . . . . 0.715 HD13 ' HB2' ' C' ' 251' ' ' LEU . 5.6 mp -113.96 157.21 22.75 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.672 1.589 . . . . 74.21 110.874 -176.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 28.5 ptt-85 -134.57 97.12 3.71 Favored 'General case' 0 CA--C 1.559 1.324 0 O-C-N 125.327 1.642 . . . . 72.34 110.65 173.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 235' ' ' LEU . . . . . 0.478 ' HB2' ' HB3' ' C' ' 249' ' ' LEU . 87.5 mt -93.29 104.44 16.61 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.9 0.88 . . . . 73.43 108.819 171.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 236' ' ' LYS . . . . . 0.471 ' HB3' HD11 ' B' ' 205' ' ' LEU . 29.3 mmmt -68.89 132.28 46.48 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.756 0.822 . . . . 71.55 112.184 -174.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 74.37 22.58 77.32 Favored Glycine 0 C--N 1.357 1.711 0 O-C-N 123.925 0.766 . . . . 71.42 113.965 177.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 238' ' ' LYS . . . . . 0.438 ' HE3' ' O ' ' B' ' 165' ' ' THR . 27.9 mmtm -115.79 17.96 15.88 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.462 0.705 . . . . 72.03 111.382 -178.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 239' ' ' GLY . . . . . 0.432 ' HA2' ' HG ' ' C' ' 193' ' ' LEU . . . -91.61 -159.04 35.13 Favored Glycine 0 C--N 1.349 1.252 0 O-C-N 123.421 0.45 . . . . 31.21 112.851 177.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 240' ' ' PHE . . . . . 0.71 ' HB3' ' HA2' ' C' ' 152' ' ' GLY . 4.4 m-85 -88.65 154.84 50.82 Favored Pre-proline 0 CA--C 1.551 0.997 0 CA-C-O 119.102 -0.475 . . . . 75.14 109.776 179.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 241' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -67.93 101.62 0.7 Allowed 'Trans proline' 0 C--N 1.387 2.596 0 C-N-CA 122.83 2.353 . . . . 70.21 110.66 177.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -94.12 167.86 28.14 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-N 115.623 -0.717 . . . . 70.14 112.152 177.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 243' ' ' PRO . . . . . 0.465 ' HD3' ' HB1' ' B' ' 195' ' ' ALA . 73.8 Cg_endo -70.02 -23.52 29.53 Favored 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 123.023 2.482 . . . . 71.42 111.412 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -99.0 27.34 5.09 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.318 1.047 . . . . 71.42 110.064 175.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 92.07 177.98 41.94 Favored Glycine 0 C--N 1.351 1.377 0 CA-C-N 115.918 -0.583 . . . . 51.32 112.186 -177.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 246' ' ' ARG . . . . . . . . . . . . . 80.1 mtm180 -72.48 138.21 46.87 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 122.699 0.399 . . . . 61.31 110.267 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -79.01 -155.54 9.07 Favored Glycine 0 C--N 1.344 1.025 0 O-C-N 123.857 0.723 . . . . 63.23 112.374 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -120.25 177.6 4.96 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 108.562 -0.903 . . . . 73.54 108.562 -175.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 249' ' ' LEU . . . . . 0.478 ' HB3' ' HB2' ' C' ' 235' ' ' LEU . 12.8 tp -119.7 109.28 15.45 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.877 -0.786 . . . . 74.23 108.877 177.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 250' ' ' TYR . . . . . 0.609 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 19.9 m-85 -101.5 105.57 16.58 Favored 'General case' 0 C--N 1.343 0.325 0 CA-C-N 115.901 -0.59 . . . . 71.43 109.605 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 251' ' ' LEU . . . . . 0.715 ' HB2' HD13 ' C' ' 233' ' ' LEU . 2.1 mp -99.71 149.47 23.29 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 109.595 -0.52 . . . . 64.53 109.595 -173.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -103.44 128.17 50.65 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.388 -0.967 . . . . 73.41 108.388 175.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 253' ' ' VAL . . . . . . . . . . . . . 95.1 t -74.15 133.28 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.172 0.589 . . . . 73.5 111.896 -172.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 254' ' ' ARG . . . . . 0.511 ' NH2' ' HB ' ' C' ' 256' ' ' THR . 1.3 tmm_? -122.27 94.98 4.47 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 107.321 -1.363 . . . . 74.13 107.321 176.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 255' ' ' ILE . . . . . 0.482 HD11 HG22 ' C' ' 227' ' ' THR . 46.6 mm -69.17 131.35 34.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 122.634 0.374 . . . . 75.24 110.459 177.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 256' ' ' THR . . . . . 0.511 ' HB ' ' NH2' ' C' ' 254' ' ' ARG . 0.0 OUTLIER -140.8 172.0 13.3 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.538 1.135 . . . . 53.32 111.153 -174.514 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 2.9 pp -130.96 154.18 81.94 Favored Pre-proline 0 CA--C 1.556 1.181 0 C-N-CA 124.351 1.06 . . . . 64.54 109.29 177.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -72.38 -2.62 11.99 Favored 'Trans proline' 0 C--N 1.377 2.065 0 C-N-CA 122.451 2.101 . . . . 73.21 113.631 -166.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 57.14 -72.12 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 125.229 1.412 . . . . 72.3 111.74 -166.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 260' ' ' ARG . . . . . 0.509 ' HD2' ' HD1' ' B' ' 340' ' ' PHE . 27.4 ptt180 -69.75 148.03 49.72 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.597 0.759 . . . . 73.41 111.103 177.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 261' ' ' LEU . . . . . 0.472 HD13 ' HA ' ' C' ' 266' ' ' GLU . 72.7 mt -138.35 141.47 39.69 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.243 0.617 . . . . 71.21 111.416 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 46.7 p -82.09 150.8 65.58 Favored Pre-proline 0 CA--C 1.545 0.771 0 N-CA-C 107.995 -1.113 . . . . 61.23 107.995 170.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -47.04 -39.46 25.43 Favored 'Trans proline' 0 N--CA 1.509 2.394 0 C-N-CA 123.77 2.98 . . . . 74.2 113.759 -177.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 264' ' ' GLU . . . . . 0.479 ' HG2' ' NH2' ' A' ' 279' ' ' ARG . 2.8 tp10 -55.89 -67.62 0.27 Allowed 'General case' 0 C--O 1.246 0.877 0 C-N-CA 124.578 1.151 . . . . 71.04 111.093 175.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -66.04 -28.63 69.0 Favored 'General case' 0 C--O 1.212 -0.885 0 CA-C-N 115.176 -0.92 . . . . 65.11 110.847 -173.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 266' ' ' GLU . . . . . 0.472 ' HA ' HD13 ' C' ' 261' ' ' LEU . 11.6 tp10 -57.88 -50.15 74.3 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.025 0.93 . . . . 64.21 109.575 174.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -60.4 -38.53 84.27 Favored 'General case' 0 CA--C 1.548 0.887 0 O-C-N 123.853 0.72 . . . . 70.32 111.592 176.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 268' ' ' LEU . . . . . . . . . . . . . 11.0 mp -65.06 -47.68 76.45 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 112.445 0.535 . . . . 52.44 112.445 177.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 269' ' ' TRP . . . . . 0.444 ' HH2' ' HD3' ' C' ' 202' ' ' PRO . 90.5 m95 -64.74 -33.42 75.92 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.302 0.641 . . . . 61.11 110.603 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 270' ' ' LYS . . . . . 0.4 ' NZ ' ' HB3' ' C' ' 270' ' ' LYS . 4.6 mmmp? -64.9 -48.64 73.47 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.739 0.816 . . . . 75.43 111.547 177.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 13.0 mmtm -65.74 -37.96 87.83 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.059 0.543 . . . . 75.33 111.917 179.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 272' ' ' LEU . . . . . 0.436 HD12 HD12 ' A' ' 272' ' ' LEU . 64.3 mt -76.53 -22.46 54.35 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.761 -0.654 . . . . 74.33 111.226 177.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -67.28 -47.04 71.82 Favored 'General case' 0 C--O 1.218 -0.572 0 N-CA-C 109.226 -0.657 . . . . 34.13 109.226 171.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -60.69 -37.36 81.38 Favored 'General case' 0 N--CA 1.483 1.215 0 O-C-N 124.291 0.994 . . . . 63.21 111.099 176.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -63.58 -37.2 86.43 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.625 0.77 . . . . 70.04 111.287 175.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 276' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -83.25 -22.33 33.09 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 116.311 -0.404 . . . . 75.52 112.077 178.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 20.8 m-30 -68.16 -35.93 78.84 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 108.408 -0.96 . . . . 44.24 108.408 172.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -59.39 -27.26 65.83 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 114.898 -1.047 . . . . 55.2 111.439 171.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 279' ' ' ARG . . . . . 0.489 ' HG2' ' H ' ' B' ' 89' ' ' GLY . 25.3 mtp-105 -74.95 -31.54 61.52 Favored 'General case' 0 C--N 1.364 1.236 0 N-CA-C 109.648 -0.501 . . . . 71.52 109.648 175.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 N-CA-C 109.185 -0.672 . . . . 75.14 109.185 -175.233 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.0 mtp . . . . . 0 N--CA 1.473 0.701 0 N-CA-C 109.711 -0.477 . . . . 64.12 109.711 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.93 40.95 28.49 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.904 1.282 . . . . 51.4 112.612 174.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.6 61.47 5.74 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 122.986 0.515 . . . . 74.04 110.146 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -38.49 113.37 0.29 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.88 1.672 . . . . 62.43 112.955 -177.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -89.42 129.12 35.98 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.663 0.785 . . . . 74.32 110.269 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -84.07 86.55 7.19 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 107.007 -1.479 . . . . 61.41 107.007 170.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.435 ' CD1' ' HA ' ' A' ' 53' ' ' ALA . 69.9 m-85 -61.0 -25.96 67.26 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 114.988 -1.005 . . . . 73.34 112.024 -174.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.506 ' HE1' ' HE2' ' A' ' 66' ' ' TYR . 49.3 m-85 -66.69 -52.54 43.58 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.602 -0.726 . . . . 73.33 109.581 175.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.61 -36.54 76.51 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.592 0.757 . . . . 60.32 110.885 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 69.8 mt -59.43 -44.16 92.07 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.097 0 C-N-CA 123.91 0.884 . . . . 74.23 110.943 174.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.5 mt -77.18 -6.95 54.91 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 112.515 0.561 . . . . 51.33 112.515 175.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.92 17.83 76.29 Favored Glycine 0 C--N 1.352 1.434 0 C-N-CA 122.961 0.315 . . . . 53.33 113.561 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.6 m -108.83 152.24 42.22 Favored Pre-proline 0 CA--C 1.554 1.125 0 C-N-CA 124.055 0.942 . . . . 71.43 110.008 176.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -86.41 172.72 6.88 Favored 'Trans proline' 0 C--N 1.368 1.599 0 C-N-CA 122.366 2.044 . . . . 50.12 112.928 178.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 11.9 mmt85 -68.85 78.48 0.31 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.127 -0.942 . . . . 75.43 109.345 172.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -174.37 -31.82 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 114.335 -1.302 . . . . 64.11 108.431 -172.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.43 120.92 15.29 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.624 -0.716 . . . . 64.31 111.304 -178.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 76.2 p -82.62 175.25 10.31 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.989 0.916 . . . . 71.11 110.027 174.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -47.96 -39.81 20.43 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 124.728 1.211 . . . . 64.21 113.033 -176.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.449 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 0.5 OUTLIER -69.35 -44.82 70.83 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.521 0.729 . . . . 72.43 109.796 -175.689 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -67.39 -34.69 77.78 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 124.036 0.935 . . . . 64.03 111.455 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.555 HD13 HD13 ' A' ' 57' ' ' LEU . 77.9 mt -67.23 -36.6 77.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.98 1.312 . . . . 73.31 110.461 175.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -69.84 -38.64 76.56 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.233 -0.894 . . . . 71.24 109.672 178.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 20' ' ' GLU . 94.9 mtt180 -60.25 -48.56 81.22 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.509 0.723 . . . . 54.12 109.896 175.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.81 -43.71 98.31 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 124.541 1.151 . . . . 64.0 111.668 -177.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -61.55 -54.81 38.17 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.55 -0.75 . . . . 73.1 110.638 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.434 ' HA ' ' HB3' ' A' ' 30' ' ' ALA . 57.3 mtpt -62.66 -32.73 73.84 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 124.119 0.887 . . . . 74.22 111.7 -177.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.405 ' HA ' ' NH2' ' A' ' 31' ' ' ARG . 14.9 ttt180 -57.99 -55.38 35.63 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.341 1.056 . . . . 71.15 110.058 174.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.635 ' HB3' HD13 ' A' ' 50' ' ' ILE . 78.8 mt -74.94 -15.13 60.7 Favored 'General case' 0 CA--C 1.552 1.026 0 CA-C-N 114.865 -1.061 . . . . 74.11 110.925 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.477 ' HA ' ' HE1' ' A' ' 47' ' ' PHE . . . -89.75 -12.0 40.6 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.032 0.933 . . . . 63.3 111.723 176.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.405 ' NH2' ' HA ' ' A' ' 28' ' ' ARG . 47.1 mtm105 -90.68 -42.93 10.45 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 109.714 -0.476 . . . . 72.33 109.714 167.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -68.68 -61.4 1.83 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.491 0.717 . . . . 63.33 111.345 -177.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -92.11 17.5 9.41 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.227 0.611 . . . . 63.25 112.211 -172.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 7.2 t-160 -57.38 101.85 0.28 Allowed Pre-proline 0 CA--C 1.555 1.156 0 C-N-CA 124.645 1.178 . . . . 63.41 111.654 -172.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.87 -32.03 75.78 Favored 'Trans proline' 0 C--N 1.388 2.65 0 C-N-CA 123.883 3.055 . . . . 74.13 113.71 -171.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -47.0 -43.68 19.61 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.609 1.164 . . . . 72.45 112.331 176.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 60.3 t -104.65 -24.77 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.665 0.786 . . . . 65.53 110.069 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -127.48 73.96 1.48 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.259 0.624 . . . . 61.35 110.474 -170.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -79.16 69.19 5.3 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 109.066 -0.716 . . . . 73.11 109.066 171.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.4 m -112.06 105.05 56.43 Favored Pre-proline 0 CA--C 1.535 0.38 0 N-CA-C 107.28 -1.378 . . . . 54.41 107.28 177.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -37.3 -49.38 1.72 Allowed 'Trans proline' 0 C--N 1.389 2.698 0 C-N-CA 124.689 3.593 . . . . 72.23 114.647 -173.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -51.95 -54.32 30.99 Favored 'General case' 0 N--CA 1.48 1.042 0 O-C-N 124.314 1.009 . . . . 64.43 111.086 177.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.09 -21.54 63.12 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 114.798 -1.092 . . . . 72.14 111.385 -177.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.475 ' O ' ' HD3' ' A' ' 48' ' ' LYS . 51.8 mt-10 -83.25 -38.69 21.88 Favored 'General case' 0 C--N 1.355 0.818 0 C-N-CA 122.824 0.45 . . . . 62.01 109.891 -176.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -65.73 -43.98 87.4 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.485 0.714 . . . . 62.44 109.445 175.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -58.62 -41.01 84.94 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 114.696 -1.138 . . . . 74.03 110.265 171.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.477 ' HE1' ' HA ' ' A' ' 30' ' ' ALA . 40.9 t80 -69.51 -25.32 63.99 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 123.407 0.442 . . . . 73.24 111.886 179.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.475 ' HD3' ' O ' ' A' ' 44' ' ' GLU . 2.0 mptm? -70.32 -39.13 74.95 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 109.944 -0.391 . . . . 75.14 109.944 174.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -63.43 -41.36 98.69 Favored 'General case' 0 CA--C 1.55 0.962 0 O-C-N 123.907 0.754 . . . . 71.44 110.568 174.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.635 HD13 ' HB3' ' A' ' 29' ' ' LEU . 69.4 mt -67.91 -40.53 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 124.621 1.168 . . . . 70.53 110.994 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -63.76 -41.03 98.05 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.261 -0.881 . . . . 73.43 110.379 174.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.426 ' O ' HG23 ' A' ' 56' ' ' VAL . 33.4 tt0 -61.27 -48.85 79.52 Favored 'General case' 0 C--O 1.246 0.906 0 C-N-CA 124.62 1.168 . . . . 63.42 110.591 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.435 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . . . -58.01 -48.07 81.15 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 114.163 -1.38 . . . . 65.45 111.564 -178.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -82.8 -14.52 54.26 Favored 'General case' 0 C--O 1.212 -0.915 0 CA-C-N 115.774 -0.648 . . . . 72.32 111.649 178.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.11 -35.62 81.7 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.777 0.799 . . . . 53.01 109.661 173.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.426 HG22 ' CE1' ' A' ' 101' ' ' PHE . 34.4 t -73.05 -58.7 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 CA-C-N 113.748 -1.569 . . . . 74.52 110.264 170.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.555 HD13 HD13 ' A' ' 22' ' ' ILE . 51.8 mt -90.11 15.09 10.83 Favored 'General case' 0 CA--C 1.558 1.256 0 CA-C-N 115.215 -0.902 . . . . 62.04 113.109 -166.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 44.2 t -67.01 -68.07 0.4 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.283 0.633 . . . . 74.34 109.806 173.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -80.95 135.82 51.29 Favored Pre-proline 0 C--O 1.238 0.456 0 CA-C-N 114.799 -1.091 . . . . 74.34 108.792 176.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.465 ' O ' ' HG2' ' A' ' 64' ' ' ARG . 51.3 Cg_exo -56.43 -28.32 72.54 Favored 'Trans proline' 0 C--N 1.369 1.627 0 C-N-CA 123.016 2.477 . . . . 72.41 112.082 170.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -71.29 -48.31 51.52 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.438 0.695 . . . . 72.3 111.285 -178.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.52 ' HA ' HD12 ' A' ' 65' ' ' ILE . 37.6 mtpt -70.87 -27.25 63.68 Favored 'General case' 0 C--O 1.257 1.493 0 CA-C-O 121.36 0.6 . . . . 74.54 110.934 178.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.425 HH21 ' CD1' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -65.58 -41.76 92.5 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 115.382 -0.827 . . . . 74.11 109.436 171.159 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.465 ' HG2' ' O ' ' A' ' 60' ' ' PRO . 4.5 mmp_? -59.22 -41.68 89.22 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.572 0.749 . . . . 74.25 110.734 176.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.612 ' HA ' ' HG2' ' A' ' 76' ' ' PRO . 91.0 mt -53.34 -51.12 43.78 Favored 'Isoleucine or valine' 0 C--O 1.251 1.15 0 C-N-CA 124.037 0.935 . . . . 64.42 110.57 175.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.506 ' HE2' ' HE1' ' A' ' 8' ' ' TYR . 37.9 t80 -58.2 -52.16 66.73 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 115.826 -0.624 . . . . 75.4 111.653 173.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -56.91 -33.74 67.23 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.144 0.978 . . . . 64.04 112.041 -173.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 40.5 p -91.42 -14.91 29.76 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.133 0.573 . . . . 75.13 112.214 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -72.1 125.41 27.19 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 107.513 -1.291 . . . . 63.45 107.513 166.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.84 23.91 29.11 Favored Glycine 0 N--CA 1.47 0.918 0 N-CA-C 111.281 -0.728 . . . . 52.54 111.281 -171.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 60.0 m -144.88 -57.67 0.35 Allowed 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 103.321 -2.844 . . . . 71.23 103.321 175.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 34.2 m -78.91 134.48 36.88 Favored 'General case' 0 C--O 1.25 1.099 0 N-CA-C 104.348 -2.464 . . . . 74.23 104.348 155.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.27 -31.78 67.9 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.396 0.678 . . . . 74.04 110.733 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -92.17 161.33 33.35 Favored Pre-proline 0 C--O 1.244 0.769 0 C-N-CA 124.177 0.991 . . . . 75.1 110.561 177.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -63.85 138.65 64.35 Favored 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 121.822 1.681 . . . . 75.41 110.172 164.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.612 ' HG2' ' HA ' ' A' ' 65' ' ' ILE . 82.6 Cg_exo -52.99 156.98 8.81 Favored 'Trans proline' 0 N--CA 1.501 1.917 0 C-N-CA 124.062 3.175 . . . . 74.25 114.77 178.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -58.27 124.87 16.86 Favored 'Trans proline' 0 C--N 1.385 2.483 0 C-N-CA 123.065 2.51 . . . . 62.44 112.382 -178.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -70.1 130.67 19.3 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 123.086 2.524 . . . . 43.51 112.245 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -60.91 142.64 98.2 Favored 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 122.827 2.351 . . . . 71.05 111.436 171.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.78 84.47 0.31 Allowed 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 122.83 2.353 . . . . 51.35 111.937 -177.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 165.85 -38.19 0.27 Allowed Glycine 0 C--N 1.333 0.383 0 CA-C-N 114.18 -1.373 . . . . 62.41 109.722 -177.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 113.29 -165.21 12.02 Favored Glycine 0 C--N 1.35 1.346 0 CA-C-N 115.212 -0.494 . . . . 53.03 112.921 176.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -109.58 108.43 18.87 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.125 0.97 . . . . 74.41 109.882 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -66.54 156.09 35.89 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.965 0.906 . . . . 71.31 111.369 173.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.555 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 59.9 m-85 -144.8 77.66 1.54 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.015 0.926 . . . . 70.22 110.491 -175.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.493 ' HB3' ' HG2' ' A' ' 162' ' ' PRO . 7.0 m -48.43 85.61 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.356 0 C-N-CA 125.596 1.558 . . . . 74.44 113.597 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.03 10.95 81.47 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-N 116.013 -0.539 . . . . 70.11 113.628 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.555 ' HB2' ' HB3' ' A' ' 85' ' ' PHE . 25.2 m-85 -104.25 103.57 13.35 Favored 'General case' 0 C--N 1.351 0.652 0 C-N-CA 123.211 0.604 . . . . 72.34 109.492 -175.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -82.55 83.29 7.63 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 121.469 0.652 . . . . 71.44 110.034 -174.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.3 p -44.56 -33.27 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 C-N-CA 126.058 1.743 . . . . 75.21 114.36 176.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.481 ' HB2' ' NH2' ' A' ' 114' ' ' ARG . 20.8 tp10 -55.99 -30.91 62.51 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.369 1.068 . . . . 75.33 111.647 -177.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -100.04 -6.65 26.09 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 123.787 0.835 . . . . 45.35 111.334 -175.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 12.8 m-30 -86.41 176.83 7.67 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 123.632 0.773 . . . . 71.01 110.929 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 91.9 p -67.56 161.39 25.7 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 113.161 0.8 . . . . 74.5 113.161 -169.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.85 -39.09 90.64 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 114.788 -1.096 . . . . 74.31 111.437 174.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -61.64 -40.39 94.71 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 122.655 0.382 . . . . 75.03 110.343 177.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.418 ' CD1' ' HG3' ' A' ' 52' ' ' GLU . 61.0 t80 -62.0 -41.46 98.08 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-O 121.493 0.663 . . . . 63.23 109.624 176.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -80.54 -1.22 41.01 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 114.693 -1.139 . . . . 73.05 112.531 177.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -100.15 -44.35 6.01 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 123.682 0.793 . . . . 70.02 111.872 170.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 24.7 tp -64.58 -47.68 77.81 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.454 1.101 . . . . 55.03 109.803 178.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.426 ' CE1' HG22 ' A' ' 56' ' ' VAL . 98.5 m-85 -92.65 -7.04 48.03 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.375 -0.83 . . . . 72.11 111.272 177.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -45.7 -58.89 5.16 Favored Glycine 0 CA--C 1.538 1.492 0 C-N-CA 124.458 1.028 . . . . 72.43 115.668 -177.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -61.9 -8.7 12.22 Favored 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 123.042 2.495 . . . . 23.1 114.046 -176.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -139.85 32.77 2.18 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-O 119.658 -0.523 . . . . 44.4 112.74 175.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.1 mt -68.34 22.47 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 115.007 1.484 . . . . 74.25 115.007 -177.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.511 ' HB3' ' ND2' ' A' ' 169' ' ' ASN . 0.2 OUTLIER 55.83 -107.34 0.38 Allowed 'General case' 0 CA--C 1.566 1.56 0 C-N-CA 124.06 0.944 . . . . 72.25 110.779 164.583 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 67.26 16.68 67.29 Favored Glycine 0 C--N 1.361 1.925 0 CA-C-O 120.043 -0.309 . . . . 44.0 113.479 -179.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.469 ' H ' ' HD1' ' A' ' 106' ' ' PHE . . . 62.35 -98.62 0.21 Allowed Glycine 0 C--N 1.352 1.438 0 N-CA-C 111.414 -0.674 . . . . 71.34 111.414 -171.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -134.34 4.83 3.46 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.973 0.909 . . . . 64.11 110.326 176.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -81.19 -13.86 80.06 Favored Glycine 0 C--N 1.352 1.466 0 CA-C-O 119.914 -0.381 . . . . 55.25 113.128 176.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 52.3 mtt180 75.02 -43.26 0.51 Allowed 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 126.666 1.986 . . . . 71.44 113.655 175.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 43.0 ttt180 -87.94 44.75 1.22 Allowed 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.223 0.609 . . . . 73.25 110.533 -172.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 36.5 m 46.9 57.03 6.0 Favored 'General case' 0 C--N 1.359 1.021 0 C-N-CA 124.648 1.179 . . . . 74.21 112.244 167.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.481 ' NH2' ' HB2' ' A' ' 91' ' ' GLU . 0.0 OUTLIER -116.76 161.83 18.64 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 111.812 0.301 . . . . 74.52 111.812 -168.443 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.432 ' HA ' ' O ' ' A' ' 170' ' ' PRO . 34.8 ttmt -68.9 138.03 54.32 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.687 0.795 . . . . 72.15 113.142 -164.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -97.77 -170.98 32.82 Favored Glycine 0 CA--C 1.544 1.867 0 CA-C-N 115.316 -0.856 . . . . 55.22 113.716 176.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.545 ' NH2' ' HB3' ' B' ' 13' ' ' LEU . 7.2 tmm_? -110.21 140.28 44.5 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.327 1.051 . . . . 71.34 111.049 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -44.09 104.11 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 125.393 1.477 . . . . 74.23 112.953 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.44 ' O ' HD12 ' A' ' 174' ' ' LEU . 5.3 tt -100.39 144.53 29.28 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.209 -0.905 . . . . 70.23 108.788 -171.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.57 ' HD2' ' HB2' ' A' ' 175' ' ' LEU . 16.4 tpt180 -96.67 142.64 28.47 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 108.58 -0.896 . . . . 74.51 108.58 -178.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.559 ' HB2' HD11 ' A' ' 174' ' ' LEU . . . -139.62 166.98 23.15 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 118.737 0.698 . . . . 41.51 111.279 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.448 ' HB2' ' HB3' ' B' ' 9' ' ' ALA . 8.1 mm-40 -120.45 101.31 7.69 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 106.193 -1.78 . . . . 61.0 106.193 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.534 HD22 HD13 ' A' ' 176' ' ' LEU . 15.3 tp -99.1 101.87 13.85 Favored Pre-proline 0 C--O 1.215 -0.732 0 N-CA-C 107.918 -1.142 . . . . 54.05 107.918 -177.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.494 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 41.8 Cg_endo -64.63 150.3 88.42 Favored 'Trans proline' 0 C--N 1.368 1.592 0 N-CA-C 108.972 -1.203 . . . . 75.33 108.972 171.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.619 ' HA ' HG21 ' B' ' 6' ' ' ILE . 16.7 tp -152.12 145.99 25.16 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 119.294 0.952 . . . . 64.01 112.152 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 49.2 m -77.47 126.76 31.42 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 114.669 -1.151 . . . . 71.34 109.307 175.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.666 ' HB3' HD22 ' A' ' 215' ' ' LEU . 3.1 mm? -43.86 -55.88 4.24 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 125.955 1.702 . . . . 70.54 112.973 -176.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 -59.52 -45.47 91.64 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 114.42 -1.264 . . . . 75.32 109.917 -176.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -77.19 -11.81 59.87 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.376 -0.829 . . . . 64.33 111.976 -177.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.602 ' HB1' ' O ' ' A' ' 153' ' ' VAL . . . -79.24 -41.81 27.39 Favored 'General case' 0 C--O 1.251 1.181 0 CA-C-O 122.0 0.905 . . . . 41.43 109.433 175.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -67.99 -40.04 83.14 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 114.204 -1.362 . . . . 74.51 110.813 172.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 38.9 m170 -77.86 -43.74 29.34 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.386 0.674 . . . . 75.25 111.92 -173.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.474 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 74.7 -163.61 54.38 Favored Glycine 0 CA--C 1.533 1.209 0 N-CA-C 114.386 0.514 . . . . 71.54 114.386 178.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 102.42 -168.01 18.31 Favored Glycine 0 N--CA 1.477 1.42 0 C-N-CA 123.612 0.625 . . . . 70.42 112.743 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 11.1 mp0 -68.56 102.82 1.54 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.368 0.667 . . . . 73.14 109.442 176.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 4.2 tpp180 -94.05 122.71 36.84 Favored 'General case' 0 C--O 1.245 0.819 0 C-N-CA 123.413 0.685 . . . . 74.4 109.616 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 59.4 t -78.35 109.45 13.0 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 N-CA-C 108.99 -0.744 . . . . 71.24 108.99 176.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.484 HG13 HG13 ' A' ' 145' ' ' VAL . 3.0 p -133.19 122.43 45.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 124.3 1.04 . . . . 73.14 108.673 178.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -107.56 136.93 46.5 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.262 0.625 . . . . 71.3 109.403 -175.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.589 ' HB ' ' HB3' ' B' ' 8' ' ' LEU . 7.6 p -152.29 132.34 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.445 0.698 . . . . 75.1 109.995 178.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 62.31 22.95 13.55 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.389 1.076 . . . . 74.24 112.091 176.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 87.42 10.78 70.16 Favored Glycine 0 C--N 1.346 1.115 0 CA-C-O 119.872 -0.404 . . . . 31.1 113.181 -178.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.13 99.17 6.44 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 108.359 -0.978 . . . . 72.12 108.359 -176.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 19.2 ttt180 -71.55 92.58 1.14 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.51 1.124 . . . . 74.41 109.969 176.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.484 HG13 HG13 ' A' ' 138' ' ' VAL . 7.7 p -92.94 133.74 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-O 121.065 0.459 . . . . 73.53 110.406 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 32.8 t -98.52 85.45 3.37 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 108.57 -0.9 . . . . 31.45 108.57 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 96.3 t -81.62 113.08 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 109.166 -0.679 . . . . 73.42 109.166 -176.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 60.5 ttt85 -68.41 93.7 0.5 Allowed 'General case' 0 C--O 1.241 0.655 0 N-CA-C 108.894 -0.78 . . . . 74.14 108.894 172.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.474 HG13 ' HA2' ' A' ' 133' ' ' GLY . 47.5 pt -78.68 135.72 59.81 Favored Pre-proline 0 CA--C 1.551 0.99 0 CA-C-N 115.035 -0.984 . . . . 74.13 108.933 178.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -58.92 128.7 28.88 Favored 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 122.445 2.097 . . . . 60.34 111.539 174.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.84 92.48 0.05 OUTLIER 'Trans proline' 0 C--N 1.382 2.294 0 C-N-CA 122.655 2.236 . . . . 74.15 110.979 170.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 125.92 66.84 0.17 Allowed Glycine 0 C--N 1.336 0.529 0 C-N-CA 121.127 -0.559 . . . . 75.51 111.851 -167.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.602 ' O ' ' HB1' ' A' ' 130' ' ' ALA . 7.5 p -140.78 139.88 33.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 N-CA-C 107.351 -1.352 . . . . 75.43 107.351 171.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.594 ' HG3' ' HE2' ' A' ' 240' ' ' PHE . 52.0 mtt85 -153.02 173.59 15.23 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.072 0.949 . . . . 73.23 109.194 174.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.57 ' HB3' ' H ' ' A' ' 188' ' ' LEU . 16.7 tp10 -35.38 122.31 0.61 Allowed 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 126.505 1.922 . . . . 72.32 114.975 -168.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 93.15 -13.38 67.78 Favored Glycine 0 C--N 1.342 0.871 0 CA-C-O 119.655 -0.525 . . . . 14.21 114.174 176.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.464 ' O ' HG12 ' A' ' 178' ' ' VAL . 17.9 t -71.39 139.29 49.72 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 109.274 -0.639 . . . . 74.23 109.274 175.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 71.2 t -105.55 119.53 54.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 123.565 0.746 . . . . 72.34 109.131 -178.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.545 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 60.4 mt -98.49 115.19 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 N-CA-C 108.394 -0.965 . . . . 75.24 108.394 174.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -78.3 106.0 9.93 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 109.068 -0.716 . . . . 61.32 109.068 173.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 13.3 p -113.6 113.01 48.09 Favored Pre-proline 0 CA--C 1.556 1.205 0 N-CA-C 109.417 -0.586 . . . . 61.33 109.417 173.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.493 ' HG2' ' HB3' ' A' ' 86' ' ' SER . 43.2 Cg_endo -68.88 139.73 44.15 Favored 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 122.672 2.248 . . . . 74.53 113.042 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.457 ' N ' ' HB3' ' A' ' 171' ' ' PRO . . . 109.67 -26.68 13.75 Favored Glycine 0 N--CA 1.476 1.335 0 C-N-CA 123.442 0.544 . . . . 70.43 113.689 167.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.472 ' SD ' ' N ' ' A' ' 164' ' ' MET . 1.3 mpt? -95.67 -31.06 13.43 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.232 0.613 . . . . 64.15 109.9 -177.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.494 ' N ' ' HB2' ' A' ' 174' ' ' LEU . . . -94.32 153.39 21.03 Favored Glycine 0 CA--C 1.492 -1.4 0 N-CA-C 108.742 -1.743 . . . . 73.33 108.742 168.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.826 ' HA3' ' HA3' ' A' ' 172' ' ' GLY . . . 53.44 80.54 0.07 OUTLIER Glycine 0 CA--C 1.475 -2.407 0 CA-C-O 118.872 -0.96 . . . . 74.5 112.968 -162.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.568 HE21 ' HA ' ' A' ' 167' ' ' GLN . 0.0 OUTLIER -56.52 105.11 0.18 Allowed 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 128.149 2.911 . . . . 75.42 109.059 -178.574 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -176.89 -140.61 3.66 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.096 -1.602 . . . . 64.21 109.096 -172.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . 0.511 ' ND2' ' HB3' ' A' ' 106' ' ' PHE . 0.7 OUTLIER -133.04 -54.28 0.02 OUTLIER Pre-proline 0 N--CA 1.484 1.232 0 CA-C-N 117.613 0.707 . . . . 63.11 109.608 176.421 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.432 ' O ' ' HA ' ' A' ' 115' ' ' LYS . 19.1 Cg_exo -67.74 123.44 10.73 Favored 'Trans proline' 0 C--N 1.388 2.625 0 N-CA-C 106.44 -2.177 . . . . 71.13 106.44 159.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.457 ' HB3' ' N ' ' A' ' 163' ' ' GLY . 41.1 Cg_endo -63.43 141.24 80.19 Favored 'Trans proline' 0 N--CA 1.483 0.874 0 C-N-CA 122.508 2.139 . . . . 71.25 114.858 -164.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.826 ' HA3' ' HA3' ' A' ' 166' ' ' GLY . . . -79.52 -26.41 56.92 Favored Glycine 0 C--N 1.348 1.217 0 C-N-CA 119.553 -1.308 . . . . 72.4 111.924 159.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 89.24 137.37 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 127.385 2.274 . . . . 71.14 110.116 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.559 HD11 ' HB2' ' A' ' 121' ' ' ALA . 24.5 tp -111.21 136.89 49.62 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.26 0.624 . . . . 64.32 110.16 -174.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.57 ' HB2' ' HD2' ' A' ' 120' ' ' ARG . 59.2 mt -105.75 84.79 2.12 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.239 1.015 . . . . 72.12 109.102 -178.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.545 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 95.4 mt -69.03 100.38 1.22 Allowed 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 115.204 -0.907 . . . . 70.05 110.812 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 57.7 t -84.52 102.5 10.56 Favored 'Isoleucine or valine' 0 C--O 1.242 0.69 0 N-CA-C 107.726 -1.213 . . . . 61.43 107.726 173.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 9.1 p -69.37 122.53 21.03 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.211 0 CA-C-N 115.48 -0.782 . . . . 70.33 111.254 -173.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.494 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 23.6 mmt180 -112.44 93.58 4.51 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.449 1.5 . . . . 53.32 108.217 -178.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.561 HD13 HD13 ' A' ' 127' ' ' LEU . 22.4 mt -70.19 149.39 47.56 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.428 0.529 . . . . 72.4 112.428 -175.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 77.9 mt -59.44 159.68 15.95 Favored Pre-proline 0 CA--C 1.554 1.127 0 C-N-CA 124.49 1.116 . . . . 73.14 111.71 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -70.8 32.98 0.23 Allowed 'Trans proline' 0 C--N 1.384 2.439 0 C-N-CA 123.365 2.71 . . . . 71.42 114.7 175.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.493 ' HB3' ' HG ' ' A' ' 127' ' ' LEU . 56.2 t-80 -67.39 106.53 1.26 Allowed Pre-proline 0 CA--C 1.553 1.091 0 C-N-CA 125.165 1.386 . . . . 73.35 107.533 165.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -75.39 24.51 0.4 Allowed 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 123.877 3.051 . . . . 61.24 115.683 -163.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 97.5 t -97.94 -61.76 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 122.595 0.358 . . . . 64.21 111.165 -173.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 14.6 m-30 -124.31 140.52 52.88 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 121.604 0.716 . . . . 72.31 111.937 -171.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -139.02 141.8 38.29 Favored 'General case' 0 C--O 1.215 -0.734 0 C-N-CA 125.883 1.673 . . . . 75.51 106.557 171.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.624 HD12 ' HA ' ' A' ' 193' ' ' LEU . 5.4 tp -106.36 176.3 5.21 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 107.211 -1.404 . . . . 74.21 107.211 178.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.598 ' HG3' ' H ' ' B' ' 302' ' ' ASP . 6.9 tp10 -163.16 128.08 3.05 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 109.019 -0.734 . . . . 70.31 109.019 168.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 69.0 -74.19 0.36 Allowed Glycine 0 C--N 1.349 1.256 0 N-CA-C 111.005 -0.838 . . . . 65.41 111.005 -169.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.506 ' H ' HD21 ' B' ' 300' ' ' ASN . 4.6 tp-100 -163.81 -2.42 0.03 OUTLIER 'General case' 0 CA--C 1.564 1.495 0 C-N-CA 124.115 0.966 . . . . 72.32 110.996 173.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -98.62 150.88 21.29 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 122.818 0.447 . . . . 72.32 110.599 -178.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.624 ' HA ' HD12 ' A' ' 188' ' ' LEU . 0.4 OUTLIER -88.81 155.93 19.26 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.347 1.059 . . . . 63.44 110.796 -167.112 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -142.57 151.31 41.43 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.642 1.577 . . . . 73.14 108.134 173.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.437 ' HB3' HD23 ' A' ' 251' ' ' LEU . . . -152.72 136.68 16.33 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.168 0.987 . . . . 74.34 108.662 177.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 32.2 m -77.79 133.69 38.18 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 118.008 0.367 . . . . 70.21 110.026 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 32.3 tp -134.01 97.59 3.92 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.047 0.539 . . . . 72.21 110.262 -176.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -85.71 121.42 28.35 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 108.723 -0.843 . . . . 61.43 108.723 170.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 7.7 p -138.25 137.37 20.66 Favored Pre-proline 0 N--CA 1.482 1.164 0 C-N-CA 123.754 0.822 . . . . 64.4 109.179 -171.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -72.32 153.97 56.19 Favored 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 121.607 1.538 . . . . 64.51 111.386 177.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.4 ' HB3' ' HH2' ' A' ' 269' ' ' TRP . . . -50.98 -50.91 72.08 Favored Pre-proline 0 CA--C 1.553 1.076 0 N-CA-C 114.696 1.369 . . . . 71.34 114.696 -171.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.563 ' HG2' ' HE1' ' C' ' 276' ' ' TYR . 47.6 Cg_exo -61.2 -37.78 71.53 Favored 'Trans proline' 0 C--N 1.386 2.552 0 C-N-CA 121.851 1.7 . . . . 63.54 113.969 -179.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.531 HD11 ' HB3' ' C' ' 276' ' ' TYR . 34.9 mt -67.2 -37.64 79.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 N-CA-C 109.754 -0.462 . . . . 64.32 109.754 176.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.06 -42.83 88.94 Favored 'General case' 0 CA--C 1.554 1.127 0 CA-C-N 115.571 -0.741 . . . . 71.51 111.688 177.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 54.3 t -70.21 -48.49 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 124.081 0.952 . . . . 63.23 111.435 -176.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 57.7 t -85.14 -39.24 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-N 115.137 -0.938 . . . . 74.41 111.781 -170.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 97.67 90.08 1.9 Allowed Glycine 0 C--O 1.242 0.638 0 N-CA-C 110.873 -0.891 . . . . 72.35 110.873 -171.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.524 ' HA3' HG23 ' A' ' 203' ' ' ILE . . . -115.49 -151.48 9.91 Favored Glycine 0 C--N 1.339 0.735 0 CA-C-N 115.468 -0.366 . . . . 55.24 113.54 -175.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.521 ' HD2' ' SD ' ' B' ' 422' ' ' MET . 27.1 mtmt -137.55 132.41 33.12 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.311 -0.625 . . . . 45.21 109.311 -176.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 30.9 m -134.39 149.84 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 108.512 -0.922 . . . . 63.11 108.512 173.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . 0.529 ' HD2' ' HA ' ' B' ' 385' ' ' LEU . 30.7 ttm180 -87.12 113.3 22.75 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 109.019 -0.734 . . . . 71.41 109.019 178.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.55 165.57 11.17 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.02 0.928 . . . . 62.04 110.052 -176.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . 0.464 ' SD ' ' N ' ' A' ' 213' ' ' MET . 0.0 OUTLIER -98.21 151.9 19.95 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 115.658 -0.701 . . . . 71.23 109.455 -175.712 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 63.8 p -133.13 -173.82 3.31 Favored 'General case' 0 C--O 1.242 0.697 0 C-N-CA 124.814 1.246 . . . . 74.1 107.721 167.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.666 HD22 ' HB3' ' A' ' 127' ' ' LEU . 28.4 mt -81.12 -26.6 36.04 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.133 0.573 . . . . 63.31 109.901 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -87.64 -17.44 31.86 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 114.977 -1.01 . . . . 64.44 111.723 -176.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 149.34 -156.83 26.98 Favored Glycine 0 C--N 1.344 1.016 0 CA-C-O 119.35 -0.694 . . . . 33.0 111.687 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -87.61 139.92 5.03 Favored 'Trans proline' 0 C--N 1.365 1.395 0 C-N-CA 122.641 2.227 . . . . 70.23 112.055 173.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 35.1 m -132.14 169.66 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.791 1.236 . . . . 73.4 107.796 171.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -111.92 134.46 53.46 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 121.726 -0.609 . . . . 75.04 111.372 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 7.5 p -119.51 140.22 44.23 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 124.745 1.218 . . . . 74.13 109.352 -176.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.525 ' HB3' ' HA ' ' B' ' 440' ' ' ARG . . . -103.62 103.2 13.11 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.971 0.508 . . . . 60.25 110.05 -178.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.592 ' HA ' HD12 ' B' ' 441' ' ' ILE . 70.5 t -58.8 140.78 85.83 Favored Pre-proline 0 CA--C 1.567 1.614 0 C-N-CA 125.432 1.493 . . . . 63.14 110.7 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -84.72 170.47 10.12 Favored 'Trans proline' 0 C--N 1.387 2.604 0 C-N-CA 123.25 2.634 . . . . 75.51 111.549 177.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.16 148.08 30.51 Favored 'Trans proline' 0 C--N 1.368 1.558 0 C-N-CA 121.748 1.632 . . . . 72.53 113.155 174.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 63.3 mtt85 63.62 32.34 14.0 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 125.329 1.451 . . . . 74.04 111.978 175.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.48 HG23 HD21 ' A' ' 233' ' ' LEU . 90.8 m -62.31 106.68 0.78 Allowed 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 113.689 -1.596 . . . . 64.32 110.498 172.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -95.53 151.37 19.37 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.389 0.675 . . . . 75.32 110.888 -170.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -62.27 117.84 6.63 Favored 'General case' 0 C--N 1.351 0.669 0 C-N-CA 123.981 0.912 . . . . 62.31 110.774 177.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 105.51 -23.64 29.46 Favored Glycine 0 C--N 1.34 0.805 0 CA-C-N 115.903 -0.589 . . . . 73.32 112.885 178.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 231' ' ' ARG . 46.5 mtt180 -72.79 136.25 45.4 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-O 121.552 0.691 . . . . 74.0 110.944 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.727 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 39.3 mttm -101.14 112.0 24.36 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 114.09 -1.413 . . . . 72.22 109.299 -179.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.536 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 45.9 mt -75.86 100.94 4.95 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.068 0.947 . . . . 71.4 110.175 -172.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 57.1 ttt180 -73.26 125.22 27.28 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.529 1.132 . . . . 64.14 110.895 -172.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.505 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 76.7 mt -118.74 107.25 13.43 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.19 0.996 . . . . 61.12 109.614 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 3.5 mmmp? -60.93 126.06 25.99 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 113.127 0.788 . . . . 64.43 113.127 -172.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 73.6 33.64 57.96 Favored Glycine 0 C--N 1.354 1.543 0 O-C-N 123.852 0.72 . . . . 74.2 114.05 173.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -114.58 -18.31 11.47 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.242 0.617 . . . . 73.01 111.387 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -81.9 -170.14 44.03 Favored Glycine 0 C--N 1.346 1.128 0 N-CA-C 112.004 -0.438 . . . . 74.43 112.004 170.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . 0.594 ' HE2' ' HG3' ' A' ' 154' ' ' ARG . 9.9 m-85 -94.69 154.92 39.9 Favored Pre-proline 0 N--CA 1.478 0.965 0 C-N-CA 122.844 0.457 . . . . 73.13 112.149 -170.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -66.65 123.06 10.58 Favored 'Trans proline' 0 C--N 1.387 2.595 0 C-N-CA 123.216 2.611 . . . . 73.33 112.831 -178.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -151.42 -150.03 5.22 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-O 119.368 -0.685 . . . . 73.52 112.426 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -65.06 -29.84 56.56 Favored 'Trans proline' 0 C--N 1.378 2.108 0 C-N-CA 123.249 2.633 . . . . 70.45 113.179 -175.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -87.59 20.77 2.79 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.8 0.84 . . . . 70.11 111.57 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 85.55 -89.76 1.63 Allowed Glycine 0 C--N 1.35 1.332 0 N-CA-C 109.736 -1.346 . . . . 62.24 109.736 -173.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 59.1 mtm180 -127.12 157.56 39.36 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.045 0.938 . . . . 75.41 109.109 165.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -81.38 179.78 53.35 Favored Glycine 0 C--O 1.241 0.561 0 CA-C-N 115.736 -0.665 . . . . 42.24 112.179 178.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -125.27 154.26 41.96 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.725 0.81 . . . . 75.44 109.085 -179.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.562 HD13 HD13 ' A' ' 193' ' ' LEU . 40.1 tp -96.64 112.22 24.05 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 109.466 -0.568 . . . . 70.31 109.466 -179.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.727 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 22.0 m-85 -97.79 105.84 18.05 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.577 1.151 . . . . 52.51 109.307 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.536 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 16.4 mt -79.6 98.8 7.04 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 109.67 -0.493 . . . . 72.24 109.67 175.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -77.34 103.52 7.32 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 108.465 -0.939 . . . . 75.41 108.465 -175.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.456 HG11 HG22 ' A' ' 227' ' ' THR . 56.6 t -87.73 144.07 9.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 N-CA-C 114.259 1.207 . . . . 24.43 114.259 -166.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 6.7 mmm180 -128.32 113.61 15.83 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.475 1.51 . . . . 73.14 107.619 165.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 62.1 mt -75.96 138.88 19.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 122.986 0.515 . . . . 74.34 109.747 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 46.7 p -124.11 175.82 6.76 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 124.709 1.204 . . . . 73.43 109.304 177.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.48 ' HB ' ' HD2' ' A' ' 258' ' ' PRO . 28.6 pt -121.82 164.72 23.41 Favored Pre-proline 0 CA--C 1.556 1.189 0 C-N-CA 123.762 0.825 . . . . 73.4 109.286 175.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . 0.48 ' HD2' ' HB ' ' A' ' 257' ' ' ILE . 60.8 Cg_endo -69.65 6.53 1.24 Allowed 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 122.687 2.258 . . . . 74.45 114.851 177.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.478 ' HG3' ' NE2' ' C' ' 228' ' ' GLN . 0.8 OUTLIER 49.35 -96.79 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.615 0.766 . . . . 63.24 109.494 -161.012 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.93 158.56 19.88 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.086 0.954 . . . . 75.12 110.778 -173.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.456 HD13 ' HA ' ' A' ' 266' ' ' GLU . 67.9 mt -135.64 -178.04 4.94 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.732 0.813 . . . . 55.32 110.719 -175.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 5.2 p -133.52 146.44 60.6 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 124.697 1.199 . . . . 44.34 109.033 176.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -17.69 -60.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.393 2.918 1 C-N-CA 127.402 5.401 . . . . 74.33 118.037 -168.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -65.03 -59.36 4.23 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.036 0.534 . . . . 71.44 111.197 -175.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -62.91 -29.69 70.97 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.712 0.805 . . . . 64.2 110.659 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' GLU . . . . . 0.456 ' HA ' HD13 ' A' ' 261' ' ' LEU . 8.6 tp10 -57.71 -54.74 43.48 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 124.236 1.015 . . . . 73.45 109.433 175.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -64.34 -33.41 75.77 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 114.681 -1.145 . . . . 64.12 111.691 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 8.8 mp -61.42 -52.22 65.46 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.0 0.52 . . . . 73.14 111.429 177.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' TRP . . . . . 0.4 ' HH2' ' HB3' ' A' ' 201' ' ' ALA . 61.2 m95 -61.7 -38.82 89.27 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.344 0.658 . . . . 75.0 111.805 178.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . 0.465 ' HE2' HG23 ' C' ' 206' ' ' VAL . 1.0 OUTLIER -67.55 -40.22 84.99 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.758 -0.655 . . . . 62.43 111.368 179.278 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -64.3 -41.93 96.61 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.071 0.548 . . . . 70.22 110.521 175.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' LEU . . . . . 0.499 ' O ' ' HB2' ' A' ' 276' ' ' TYR . 51.8 mt -55.5 -45.96 77.02 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 124.012 0.82 . . . . 63.4 110.574 175.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -77.13 -32.92 56.76 Favored 'General case' 0 C--O 1.246 0.874 0 O-C-N 124.389 1.055 . . . . 64.51 113.005 -173.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -72.47 -48.09 43.61 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.318 0.647 . . . . 74.35 110.061 177.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . 0.448 ' HB1' ' NH2' ' A' ' 279' ' ' ARG . . . -71.97 -20.77 61.68 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.51 0.724 . . . . 71.44 111.225 177.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . 0.499 ' HB2' ' O ' ' A' ' 272' ' ' LEU . 21.7 t80 -63.14 -64.96 0.76 Allowed 'General case' 0 C--N 1.356 0.884 0 C-N-CA 123.803 0.841 . . . . 75.02 108.847 171.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -63.32 -40.6 97.76 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.316 -0.856 . . . . 70.12 110.432 -172.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . 0.47 ' HB1' ' HG2' ' B' ' 275' ' ' LYS . . . -59.35 -30.72 68.59 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.659 0.784 . . . . 75.41 111.834 176.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . 0.448 ' NH2' ' HB1' ' A' ' 275' ' ' ALA . 23.6 mtm180 -118.22 34.74 5.04 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.347 0.659 . . . . 74.13 109.855 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.386 0 N-CA-C 109.235 -0.654 . . . . 72.21 109.235 174.439 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.478 0.974 0 N-CA-C 109.283 -0.636 . . . . 71.44 109.283 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 59.5 tttp 71.34 115.57 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.772 1.229 . . . . 54.1 112.052 -176.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 66.4 48.34 1.58 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.575 1.55 . . . . 74.04 111.533 170.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 25.5 m -67.5 -22.74 65.44 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 114.816 -1.084 . . . . 52.14 110.574 172.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 2.5 m 71.29 150.37 0.09 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.793 1.637 . . . . 70.11 111.469 176.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.619 HG21 ' HA ' ' A' ' 125' ' ' LEU . 36.5 pt -136.97 167.67 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 113.146 0.795 . . . . 64.44 113.146 -162.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -145.57 124.33 12.61 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.274 1.03 . . . . 72.01 109.647 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.589 ' HB3' ' HB ' ' A' ' 140' ' ' VAL . 44.2 tp -74.26 150.47 40.23 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.168 0.987 . . . . 75.22 111.264 -172.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . 0.448 ' HB3' ' HB2' ' A' ' 122' ' ' GLU . . . -90.74 -50.32 5.97 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.192 0.597 . . . . 62.4 112.117 -178.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 84.8 mt 66.65 115.61 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 124.677 1.191 . . . . 74.1 111.678 -170.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 56.2 mt -109.01 102.28 48.07 Favored Pre-proline 0 CA--C 1.553 1.062 0 N-CA-C 108.007 -1.108 . . . . 45.35 108.007 171.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -52.39 -69.21 0.06 OUTLIER 'Trans proline' 0 C--N 1.382 2.301 0 C-N-CA 123.283 2.655 . . . . 61.33 112.461 -175.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . 0.545 ' HB3' ' NH2' ' A' ' 117' ' ' ARG . 2.1 pt? -162.59 140.78 8.56 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.93 -0.766 . . . . 75.01 108.93 175.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 94.4 mt 69.96 -16.38 0.29 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.854 1.262 . . . . 64.54 113.981 175.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -80.15 87.66 5.48 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-O 121.612 0.72 . . . . 60.01 109.478 -177.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 61.4 m -134.7 125.22 17.33 Favored Pre-proline 0 CA--C 1.542 0.64 0 N-CA-C 107.549 -1.278 . . . . 51.11 107.549 178.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.12 76.44 0.12 Allowed 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 123.242 2.628 . . . . 62.42 113.986 -176.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 62.0 t -137.55 87.7 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.2 1.0 . . . . 61.41 109.351 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 5.5 m 61.68 12.76 4.81 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 124.665 1.186 . . . . 71.22 113.31 167.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -160.2 -72.0 0.07 Allowed 'General case' 0 N--CA 1.474 0.748 0 O-C-N 121.502 -0.749 . . . . 62.34 111.026 -174.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.26 77.8 3.79 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.22 0.608 . . . . 75.34 111.279 -171.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? 56.25 93.62 0.03 OUTLIER 'General case' 0 C--N 1.356 0.868 0 C-N-CA 125.328 1.451 . . . . 73.31 110.175 -172.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' THR . . . . . 0.619 HG21 HD13 ' B' ' 218' ' ' LEU . 26.8 m -95.95 114.33 63.92 Favored Pre-proline 0 CA--C 1.546 0.824 0 N-CA-C 108.938 -0.764 . . . . 72.45 108.938 176.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -61.26 -38.52 65.1 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 123.091 2.528 . . . . 74.55 112.394 178.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . 0.504 ' HG2' ' HB2' ' B' ' 219' ' ' ASN . 10.9 tp10 -72.39 116.03 12.34 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.664 -0.698 . . . . 74.53 109.726 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 27.0 ttt -172.89 -48.23 0.0 OUTLIER Pre-proline 0 CA--C 1.561 1.402 0 C-N-CA 124.461 1.105 . . . . 75.13 110.407 -174.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -70.07 163.1 39.77 Favored 'Trans proline' 0 C--N 1.395 3.026 0 C-N-CA 121.938 1.759 . . . . 71.1 111.957 173.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 61.8 t 76.98 -34.41 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 C-N-CA 125.867 1.667 . . . . 73.51 110.741 -174.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 50.8 mt -68.62 167.92 14.14 Favored 'General case' 0 C--O 1.246 0.912 0 C-N-CA 124.421 1.088 . . . . 62.2 111.517 171.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 62.51 35.23 14.75 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.324 1.049 . . . . 70.24 111.066 -176.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -66.75 108.65 2.58 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.616 0.767 . . . . 74.34 110.905 -177.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 2.9 mpp_? -87.45 -10.33 52.18 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 123.837 0.855 . . . . 72.22 111.666 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -73.14 -72.37 0.26 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.418 0.687 . . . . 73.31 111.204 -174.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -116.99 109.44 17.01 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.834 0.854 . . . . 53.33 109.163 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -165.63 71.36 0.15 Allowed 'General case' 0 C--N 1.356 0.868 0 CA-C-O 121.75 0.786 . . . . 73.13 110.251 -178.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . 0.506 ' HA2' ' HA2' ' C' ' 247' ' ' GLY . . . 64.14 -120.61 20.38 Favored Glycine 0 C--N 1.345 1.07 0 CA-C-N 114.753 -1.112 . . . . 74.33 114.195 177.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -62.17 -28.21 69.5 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.016 0.926 . . . . 61.44 113.365 -175.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 11.3 tt -65.87 -27.63 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 CA-C-O 120.74 0.305 . . . . 75.44 111.054 -175.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 12.1 t -103.41 -32.78 9.35 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.532 0.733 . . . . 64.25 110.946 178.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -166.85 105.25 0.64 Allowed Pre-proline 0 N--CA 1.476 0.842 0 C-N-CA 123.839 0.856 . . . . 64.0 109.53 -178.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -71.35 71.5 2.37 Favored 'Trans proline' 0 C--N 1.376 2.001 0 C-N-CA 123.135 2.557 . . . . 72.44 112.348 175.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 63.55 -89.61 0.07 OUTLIER Glycine 0 C--N 1.351 1.381 0 CA-C-N 115.571 -0.74 . . . . 45.24 112.835 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 178.37 21.05 0.03 OUTLIER Glycine 0 CA--C 1.527 0.813 0 C-N-CA 123.356 0.503 . . . . 42.15 112.037 177.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . 61.18 -78.78 0.02 OUTLIER 'General case' 0 C--N 1.363 1.159 0 C-N-CA 125.067 1.347 . . . . 63.2 110.351 -169.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -68.47 127.7 33.95 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.398 0.679 . . . . 74.21 109.207 170.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 5.1 tmm_? -76.78 -28.03 55.51 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 108.629 -0.878 . . . . 75.02 108.629 174.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 29.5 tp 79.63 -35.83 0.15 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 126.377 1.871 . . . . 53.22 112.956 168.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 3.8 m 68.72 9.67 7.47 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 124.329 1.052 . . . . 51.22 111.262 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.58 24.27 63.14 Favored Glycine 0 C--N 1.349 1.281 0 CA-C-N 115.94 -0.573 . . . . 74.15 112.287 -173.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -77.49 146.08 36.65 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.42 0.688 . . . . 64.2 110.764 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -135.2 4.55 3.21 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.998 0.919 . . . . 75.3 110.032 178.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 5.0 m 57.7 30.15 18.44 Favored 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 124.771 1.228 . . . . 73.31 111.514 177.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.42 107.11 2.32 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 122.904 0.481 . . . . 73.24 110.615 -177.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . 68.12 6.26 5.13 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.005 1.322 . . . . 75.51 112.02 -176.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 25.9 tp 57.08 25.18 10.49 Favored 'General case' 0 CA--C 1.564 1.49 0 C-N-CA 124.748 1.219 . . . . 72.35 110.302 -172.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 83.0 mtt85 -134.37 177.53 7.68 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.248 1.019 . . . . 73.2 110.957 -173.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -65.69 -8.63 21.79 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 125.224 1.41 . . . . 75.31 113.058 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 34.9 t -55.37 -22.54 19.99 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 124.602 1.161 . . . . 62.01 113.074 178.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -67.94 -33.78 75.33 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-O 121.02 0.438 . . . . 72.44 111.439 178.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 2.7 t -94.98 114.59 26.43 Favored 'General case' 0 C--O 1.244 0.773 0 N-CA-C 108.255 -1.017 . . . . 63.51 108.255 -171.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -72.28 147.58 46.27 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.777 0.831 . . . . 71.45 111.698 -170.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm 57.69 75.85 0.52 Allowed Pre-proline 0 CA--C 1.552 1.031 0 C-N-CA 125.476 1.51 . . . . 72.3 112.614 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -70.94 -0.38 7.8 Favored 'Trans proline' 0 C--N 1.38 2.197 0 C-N-CA 123.418 2.745 . . . . 72.24 112.904 168.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 73.33 -76.91 0.06 Allowed 'General case' 0 C--N 1.362 1.135 0 C-N-CA 126.041 1.736 . . . . 72.04 111.66 174.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -112.37 -10.74 13.75 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.546 0.738 . . . . 65.32 111.039 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 71.61 151.51 0.11 Allowed 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 124.758 1.223 . . . . 72.41 111.446 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 12.2 tt 44.59 41.73 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 C-N-CA 126.821 2.048 . . . . 72.03 112.873 176.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 20.2 pt -81.8 67.58 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.111 0 CA-C-N 114.695 -1.139 . . . . 73.4 111.175 -176.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 85.4 mt -77.68 119.88 21.83 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.225 -0.898 . . . . 73.12 109.863 -176.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mp 67.43 -74.81 0.07 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 125.586 1.554 . . . . 44.44 110.663 -178.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 12.9 tt -143.61 102.63 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 124.289 1.036 . . . . 74.32 108.615 177.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -88.32 27.08 7.19 Favored Glycine 0 C--N 1.348 1.232 0 CA-C-N 115.978 -0.555 . . . . 62.21 112.319 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -113.22 -1.73 14.26 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.95 1.3 . . . . 63.44 110.239 -175.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 105.08 169.82 24.11 Favored Glycine 0 C--N 1.352 1.46 0 N-CA-C 111.446 -0.662 . . . . 64.42 111.446 -174.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 75' ' ' MET . . . . . 0.433 ' N ' ' SD ' ' B' ' 75' ' ' MET . 0.4 OUTLIER -91.38 65.35 5.3 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 122.256 1.027 . . . . 74.01 110.459 -177.352 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . -128.99 49.9 0.91 Allowed Glycine 0 C--N 1.334 0.417 0 N-CA-C 109.014 -1.634 . . . . 71.13 109.014 171.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -50.45 -63.19 1.2 Allowed 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.488 1.515 . . . . 73.03 111.977 -170.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 38.7 p 50.98 -74.07 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 125.939 1.695 . . . . 51.1 113.42 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . 0.451 ' HG3' HG12 ' B' ' 80' ' ' ILE . 14.2 tp10 71.29 -86.54 0.03 OUTLIER 'General case' 0 C--N 1.357 0.895 0 C-N-CA 125.157 1.383 . . . . 74.44 110.131 176.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.451 HG12 ' HG3' ' B' ' 79' ' ' GLU . 35.8 pt -145.52 -162.78 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 124.708 1.203 . . . . 72.52 107.839 179.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 50.0 m -56.96 140.63 48.14 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 108.969 -0.752 . . . . 71.34 108.969 165.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -49.91 93.26 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.175 0.99 . . . . 61.11 111.817 -175.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -159.29 -62.53 0.07 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.723 1.209 . . . . 71.35 108.783 -175.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -84.9 75.78 10.33 Favored 'General case' 0 C--N 1.355 0.837 0 N-CA-C 108.657 -0.868 . . . . 73.0 108.657 172.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -113.73 -68.33 0.93 Allowed 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 107.087 -1.449 . . . . 72.23 107.087 176.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 27.6 t80 63.78 151.88 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 125.19 1.396 . . . . 63.12 112.944 173.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . 62.31 -163.85 0.26 Allowed 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.595 1.158 . . . . 52.24 110.744 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 72.82 -69.79 0.18 Allowed 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 125.156 1.382 . . . . 74.14 110.001 177.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 166.11 -38.36 0.26 Allowed Glycine 0 C--N 1.336 0.538 0 N-CA-C 110.542 -1.023 . . . . 54.33 110.542 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.15 -34.09 73.07 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.767 0.827 . . . . 62.33 111.953 178.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -131.83 77.44 0.39 Allowed Glycine 0 C--N 1.348 1.224 0 N-CA-C 111.776 -0.529 . . . . 70.11 111.776 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.26 -59.71 9.53 Favored Glycine 0 C--N 1.35 1.33 0 CA-C-N 116.761 0.281 . . . . 23.53 112.598 178.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 32.0 t80 50.63 68.74 0.72 Allowed 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.534 1.534 . . . . 74.22 111.274 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -78.12 -9.41 59.15 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 114.479 -1.237 . . . . 71.21 111.357 -178.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 46.9 mttp 75.38 -24.94 0.21 Allowed 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 126.077 1.751 . . . . 74.14 113.281 169.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 80.53 -2.41 78.34 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-O 119.431 -0.649 . . . . 72.31 112.805 -171.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 97' ' ' ILE . . . . . 0.514 ' HA ' HD12 ' B' ' 100' ' ' LEU . 14.0 tt -62.67 -24.83 36.58 Favored 'Isoleucine or valine' 0 C--N 1.362 1.137 0 C-N-CA 124.334 1.053 . . . . 72.22 111.596 -172.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -59.42 132.25 53.42 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.683 0.793 . . . . 75.21 110.357 173.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . 71.88 2.97 4.5 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 124.73 1.212 . . . . 61.12 113.393 175.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . 0.514 HD12 ' HA ' ' B' ' 97' ' ' ILE . 79.6 mt -82.41 -41.1 0.93 Allowed Pre-proline 0 CA--C 1.56 1.363 0 CA-C-O 118.079 -0.962 . . . . 74.2 112.268 173.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -59.78 108.75 0.5 Allowed 'Trans proline' 0 C--N 1.398 3.134 0 C-N-CA 121.9 1.733 . . . . 72.21 111.861 171.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 59.1 tp -63.92 138.63 58.56 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 115.56 -0.746 . . . . 73.12 109.855 176.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 40.0 m -69.63 91.84 0.62 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.198 0.599 . . . . 75.52 110.148 178.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . -73.85 127.49 10.38 Favored Glycine 0 C--N 1.343 0.953 0 CA-C-N 114.803 -1.089 . . . . 51.35 111.293 176.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 26.3 mp0 -69.06 -29.41 67.53 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.124 0.97 . . . . 75.22 110.427 178.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 85.3 t80 78.11 -36.85 0.22 Allowed 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 125.626 1.571 . . . . 74.44 112.868 171.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 58.7 p -78.91 84.19 4.96 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 124.397 1.079 . . . . 63.32 111.764 -173.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 63.2 m80 68.17 125.58 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.886 1.674 . . . . 71.44 113.298 173.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.448 ' HD2' ' HA3' ' B' ' 202' ' ' GLY . 89.2 m-85 -127.58 40.98 3.6 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.195 0.998 . . . . 53.33 108.859 173.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -73.81 90.41 1.88 Allowed 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 114.562 -1.199 . . . . 71.24 110.779 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 4.4 pp -82.54 137.64 34.53 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.112 0.565 . . . . 64.15 110.72 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 67.75 -67.94 0.17 Allowed 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 126.137 1.775 . . . . 73.2 111.792 178.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 113' ' ' LYS . . . . . 0.725 ' HG2' ' HB2' ' C' ' 36' ' ' ASP . 18.5 tppt? 80.69 -63.97 0.19 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.236 1.814 . . . . 75.13 112.542 173.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.93 94.2 2.68 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-O 121.994 0.902 . . . . 74.01 112.105 -174.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 25.5 m -150.31 89.64 1.59 Allowed 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 108.345 -0.983 . . . . 73.23 108.345 174.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 62.06 -114.88 7.22 Favored Glycine 0 C--N 1.362 2.025 0 CA-C-O 118.584 -1.12 . . . . 55.33 110.568 -173.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 107.69 -69.95 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.814 0 C-N-CA 126.766 2.026 . . . . 70.25 115.426 156.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 118' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -56.94 -64.04 0.14 Allowed 'Trans proline' 0 C--N 1.402 3.389 0 C-N-CA 122.635 2.223 . . . . 60.53 114.743 -166.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 119' ' ' ASP . . . . . . . . . . . . . 37.9 t70 64.64 -75.88 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.895 1.278 . . . . 75.33 110.73 -173.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 120' ' ' TYR . . . . . 0.405 ' OH ' ' HD2' ' C' ' 160' ' ' ARG . 33.4 m-85 56.81 79.97 0.17 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 125.176 1.39 . . . . 70.1 112.245 177.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 24.9 m -100.86 -20.43 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 CA-C-N 115.427 -0.806 . . . . 74.32 110.182 170.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 33.1 m 55.42 77.13 0.23 Allowed 'General case' 0 C--N 1.358 0.95 0 C-N-CA 125.014 1.326 . . . . 75.24 110.082 -172.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -82.48 152.74 25.95 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 114.642 -1.163 . . . . 64.3 110.997 -175.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 92.4 p 53.32 -160.11 0.13 Allowed 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 125.967 1.707 . . . . 43.31 112.73 176.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -143.98 -67.62 0.34 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.588 0.755 . . . . 73.02 110.165 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -169.57 -168.08 0.75 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.936 0.894 . . . . 74.13 109.888 -179.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 127' ' ' SER . . . . . 0.403 ' OG ' ' HA ' ' B' ' 186' ' ' THR . 66.9 m -134.33 -64.52 0.68 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.179 0.992 . . . . 70.01 109.232 178.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -140.86 65.63 1.39 Allowed 'General case' 0 C--O 1.238 0.45 0 N-CA-C 108.295 -1.002 . . . . 72.01 108.295 177.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 9.0 t -63.26 130.9 46.5 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 115.282 -0.872 . . . . 54.34 111.012 -172.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 130' ' ' ALA . . . . . 0.443 ' H ' ' HG3' ' C' ' 179' ' ' ARG . . . 74.85 124.64 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 126.032 1.733 . . . . 44.22 110.214 -165.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 23.3 t90 76.33 -60.15 0.49 Allowed 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 125.546 1.539 . . . . 73.51 111.993 177.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 36.6 m 76.58 -61.82 0.43 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 125.501 1.52 . . . . 51.4 113.996 169.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 26.5 m -68.92 89.57 0.41 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.323 1.049 . . . . 62.25 111.644 -172.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 119.29 -11.93 11.38 Favored Glycine 0 N--CA 1.476 1.334 0 CA-C-N 115.991 -0.55 . . . . 55.15 113.004 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 135' ' ' VAL . . . . . . . . . . . . . 36.2 t 69.25 -79.3 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 125.553 1.541 . . . . 73.24 112.529 174.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 136' ' ' LYS . . . . . 0.427 ' HE3' HG23 ' B' ' 153' ' ' THR . 24.3 ttmm 57.99 47.12 15.39 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.416 1.087 . . . . 52.43 110.76 178.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 68.4 p 61.62 -3.23 0.22 Allowed 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 126.274 1.83 . . . . 75.31 115.127 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 36.1 p90 39.41 -64.4 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.32 0 C-N-CA 127.932 2.493 . . . . 75.52 116.366 -177.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 13.3 m120 66.89 24.43 9.7 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 125.275 1.43 . . . . 73.24 112.093 177.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . 84.72 -63.23 4.44 Favored Glycine 0 C--N 1.341 0.833 0 CA-C-N 115.544 -0.753 . . . . 65.04 112.494 174.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . 66.62 101.51 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.969 1.307 . . . . 75.34 110.263 -174.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -143.53 -167.44 2.57 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.756 0.822 . . . . 70.15 109.23 -175.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 167.86 -47.8 0.24 Allowed Glycine 0 C--N 1.348 1.206 0 N-CA-C 111.928 -0.469 . . . . 61.25 111.928 176.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 72.0 t 76.68 -50.29 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 C-N-CA 125.705 1.602 . . . . 75.31 111.16 178.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -83.11 -34.54 26.07 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.054 0.941 . . . . 64.3 109.775 169.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 2.8 pp -128.95 -169.72 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 124.38 1.072 . . . . 72.52 109.625 175.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 35.3 p-80 -149.72 145.28 26.59 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.213 0.605 . . . . 72.43 110.409 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 63.24 -78.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 125.508 1.523 . . . . 73.05 112.903 170.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 149' ' ' LYS . . . . . . . . . . . . . 56.4 tttm 70.27 -85.29 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 125.71 1.604 . . . . 72.23 113.361 173.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -100.67 -51.92 3.46 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 113.197 0.814 . . . . 74.11 113.197 -165.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -79.36 -55.25 0.91 Allowed Pre-proline 0 CA--C 1.567 1.617 0 N-CA-C 114.605 1.335 . . . . 74.43 114.605 -165.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -57.16 89.93 0.05 OUTLIER 'Trans proline' 0 C--N 1.393 2.885 0 C-N-CA 123.042 2.495 . . . . 42.51 115.014 -166.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . 0.427 HG23 ' HE3' ' B' ' 136' ' ' LYS . 3.4 m 56.18 27.38 11.53 Favored 'General case' 0 CA--C 1.559 1.3 0 C-N-CA 125.561 1.544 . . . . 74.2 113.38 167.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 50.3 mm -71.87 -33.87 49.39 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 CA-C-N 115.543 -0.753 . . . . 74.25 109.591 176.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 1.8 tt -89.0 54.51 3.02 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 124.362 1.065 . . . . 72.1 108.964 175.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -165.63 -110.26 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.056 0 CA-C-O 119.045 -0.502 . . . . 72.23 109.689 173.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 157' ' ' MET . . . . . . . . . . . . . 24.3 ptt? -172.26 -43.14 0.02 OUTLIER 'General case' 0 C--N 1.363 1.183 0 C-N-CA 123.493 0.717 . . . . 53.54 110.508 -172.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 158' ' ' ALA . . . . . . . . . . . . . . . -83.53 75.24 10.04 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 121.517 0.675 . . . . 34.04 109.462 -176.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -121.8 -71.13 0.74 Allowed 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 106.951 -1.5 . . . . 55.45 106.951 -174.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . 176.77 97.68 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.398 1.479 . . . . 70.22 107.471 177.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -168.31 25.32 0.03 OUTLIER 'General case' 0 C--O 1.246 0.887 0 O-C-N 123.622 0.576 . . . . 71.1 111.08 -171.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . -65.18 -48.03 74.54 Favored Glycine 0 C--N 1.35 1.327 0 N-CA-C 111.409 -0.677 . . . . 73.4 111.409 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . 0.463 HD12 ' HB3' ' B' ' 173' ' ' LEU . 49.7 tp 68.21 -78.24 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 124.728 1.211 . . . . 65.02 111.963 166.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 164' ' ' ALA . . . . . . . . . . . . . . . -89.26 -12.86 39.51 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.483 0.713 . . . . 75.34 111.229 177.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 15.2 t -129.41 165.9 20.64 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.661 0.784 . . . . 64.15 110.194 -177.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . 134.17 164.35 10.6 Favored Glycine 0 C--N 1.345 1.078 0 N-CA-C 111.425 -0.67 . . . . 71.15 111.425 -177.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 167' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -80.51 119.05 22.67 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.151 0.581 . . . . 72.31 109.89 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 77.8 t 72.75 -69.76 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 125.915 1.686 . . . . 74.13 111.386 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 34.4 t 63.13 -88.74 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 125.024 1.33 . . . . 54.35 110.036 -178.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 42.7 m 71.03 -55.02 0.66 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 125.637 1.575 . . . . 63.1 113.868 174.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . 0.401 ' HB2' ' HG2' ' C' ' 128' ' ' GLU . . . -64.37 171.25 3.24 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.758 0.823 . . . . 53.32 111.615 176.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 172' ' ' GLU . . . . . 0.546 ' HB3' ' HG2' ' C' ' 213' ' ' MET . 10.8 tp10 -60.79 87.96 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.058 0.943 . . . . 73.22 111.532 -173.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 173' ' ' LEU . . . . . 0.463 ' HB3' HD12 ' B' ' 163' ' ' LEU . 84.2 mt 62.4 14.4 6.86 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.107 1.363 . . . . 74.23 112.964 177.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 174' ' ' GLN . . . . . 0.427 ' NE2' ' SD ' ' B' ' 286' ' ' MET . 27.1 mm-40 -91.97 101.33 13.89 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.367 0.667 . . . . 74.45 109.97 -175.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 175' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -93.06 159.03 15.48 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.861 0.865 . . . . 74.1 111.045 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -169.85 166.28 9.56 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.463 1.105 . . . . 74.11 109.937 175.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 33.5 p -132.54 78.34 67.57 Favored Pre-proline 0 CA--C 1.559 1.323 0 C-N-CA 123.847 0.859 . . . . 64.31 109.862 172.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 178' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -79.46 148.41 20.75 Favored 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 122.425 2.083 . . . . 74.53 111.696 174.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -83.72 65.43 8.52 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.116 0.566 . . . . 61.34 110.111 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . 70.94 -34.77 0.31 Allowed 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 126.438 1.895 . . . . 74.4 113.304 -173.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 181' ' ' LEU . . . . . 0.519 HD22 ' HB2' ' C' ' 136' ' ' ARG . 60.5 tp -161.29 -71.75 0.06 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.139 0.976 . . . . 62.04 108.928 170.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 182' ' ' VAL . . . . . . . . . . . . . 49.2 t -86.71 131.08 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 109.263 -0.643 . . . . 71.31 109.263 177.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -66.19 -56.83 9.39 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 123.908 0.755 . . . . 65.24 111.263 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -169.52 178.73 4.08 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-O 121.64 0.733 . . . . 74.15 111.173 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 185' ' ' VAL . . . . . 0.442 ' O ' ' HG2' ' B' ' 188' ' ' ARG . 1.9 p -130.19 122.03 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 107.564 -1.273 . . . . 71.33 107.564 160.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 186' ' ' THR . . . . . 0.403 ' HA ' ' OG ' ' B' ' 127' ' ' SER . 50.0 p 49.04 -96.26 0.03 OUTLIER 'General case' 0 CA--C 1.565 1.526 0 C-N-CA 124.941 1.296 . . . . 51.31 113.389 172.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 187' ' ' SER . . . . . . . . . . . . . 56.7 m -140.51 88.58 2.21 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.592 0.757 . . . . 62.14 109.793 -177.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 188' ' ' ARG . . . . . 0.442 ' HG2' ' O ' ' B' ' 185' ' ' VAL . 13.7 mmt180 -132.34 -178.39 4.89 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.126 0.97 . . . . 71.52 109.571 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -96.98 178.85 5.14 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.879 0.872 . . . . 72.52 110.202 171.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 190' ' ' CYS . . . . . 0.479 ' SG ' ' NZ ' ' B' ' 337' ' ' LYS . 45.6 t -153.52 165.0 37.25 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.899 0.88 . . . . 70.33 109.69 178.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -148.31 168.07 23.52 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.888 0.875 . . . . 74.04 109.746 -170.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -68.78 153.65 53.0 Favored Glycine 0 C--N 1.352 1.439 0 CA-C-O 118.889 -0.95 . . . . 64.22 112.429 174.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 193' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -57.24 150.61 56.9 Favored 'Trans proline' 0 N--CA 1.504 2.13 0 C-N-CA 123.817 3.011 . . . . 64.32 113.896 -169.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 194' ' ' SER . . . . . . . . . . . . . 21.8 m -151.37 118.72 5.98 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.719 0.808 . . . . 24.51 109.821 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 195' ' ' ALA . . . . . . . . . . . . . . . -162.53 164.76 26.73 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.794 0.838 . . . . 74.32 110.093 177.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 99.4 m -106.88 -67.5 0.94 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.353 0.661 . . . . 73.32 110.087 177.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 49.5 m -153.7 -48.85 0.09 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.134 0.974 . . . . 75.11 108.61 -177.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 198' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 60.19 -81.9 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 125.969 1.708 . . . . 51.12 110.237 178.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 199' ' ' LYS . . . . . 0.456 ' HE2' ' HA ' ' B' ' 199' ' ' LYS . 0.6 OUTLIER 70.88 -19.02 0.24 Allowed 'General case' 0 CA--C 1.562 1.411 0 N-CA-C 115.144 1.535 . . . . 74.4 115.144 163.211 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 200' ' ' CYS . . . . . . . . . . . . . 69.2 m -67.09 105.6 0.91 Allowed Pre-proline 0 CA--C 1.56 1.34 0 C-N-CA 124.062 0.945 . . . . 73.31 112.43 -171.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 201' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -105.01 10.3 0.24 Allowed 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 123.591 2.861 . . . . 71.34 114.053 -178.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 202' ' ' GLY . . . . . 0.448 ' HA3' ' HD2' ' B' ' 109' ' ' TYR . . . -79.23 -7.44 88.47 Favored Glycine 0 C--N 1.353 1.492 0 CA-C-O 119.14 -0.811 . . . . 63.04 114.539 -170.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 64.6 t30 66.84 173.18 0.25 Allowed 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.312 1.045 . . . . 71.33 111.766 173.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -61.4 -53.6 54.52 Favored 'General case' 0 C--N 1.351 0.65 0 C-N-CA 123.336 0.654 . . . . 74.01 109.622 167.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 205' ' ' LEU . . . . . . . . . . . . . 4.5 tt 54.5 92.47 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.936 1.294 . . . . 51.03 110.666 173.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.54 -88.41 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.332 0 CA-C-O 119.386 -0.34 . . . . 62.32 110.424 175.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 35.0 mmtm -145.48 -41.88 0.22 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.427 0.691 . . . . 74.32 110.471 177.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . -78.31 -31.1 47.87 Favored Glycine 0 C--N 1.346 1.102 0 O-C-N 123.137 0.273 . . . . 71.52 113.242 -178.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 114.96 -21.37 13.57 Favored Glycine 0 N--CA 1.474 1.184 0 N-CA-C 111.622 -0.591 . . . . 42.21 111.622 -176.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 49.9 tttm -172.12 118.6 0.4 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.306 1.442 . . . . 74.51 107.709 178.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . -156.63 147.68 16.48 Favored Glycine 0 C--N 1.344 0.992 0 CA-C-O 119.535 -0.592 . . . . 74.43 111.739 -179.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 40.6 t 55.93 94.59 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 125.331 1.453 . . . . 74.04 111.918 -176.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 10.1 tp -72.46 -28.64 28.83 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 CA-C-N 116.109 -0.496 . . . . 64.4 110.388 177.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 24.2 m 61.66 -80.79 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 125.509 1.524 . . . . 75.43 111.53 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 215' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -152.12 4.11 0.39 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.692 0.797 . . . . 73.31 111.209 -178.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -70.05 141.91 52.78 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.6 0.76 . . . . 61.42 110.008 176.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . 0.584 HD12 ' H ' ' B' ' 218' ' ' LEU 0.324 4.0 pp 51.53 -71.53 0.01 OUTLIER 'General case' 0 CA--C 1.57 1.73 0 C-N-CA 126.772 2.029 . . . . 75.4 114.421 -178.662 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . 0.619 HD13 HG21 ' B' ' 23' ' ' THR . 88.8 mt 61.13 -77.75 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 125.857 1.663 . . . . 71.43 111.824 -177.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 219' ' ' ASN . . . . . 0.504 ' HB2' ' HG2' ' B' ' 25' ' ' GLU . 21.7 t-20 -160.47 154.12 22.43 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 108.148 -1.056 . . . . 71.24 108.148 174.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -134.89 -171.27 2.75 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.975 0.91 . . . . 61.1 110.214 -175.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 221' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -68.36 -71.01 0.23 Allowed 'General case' 0 C--N 1.351 0.638 0 N-CA-C 107.416 -1.327 . . . . 73.55 107.416 171.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . 0.66 ' HB3' ' HE ' ' C' ' 187' ' ' ARG . . . 39.87 66.05 0.64 Allowed 'General case' 0 C--N 1.368 1.39 0 C-N-CA 124.952 1.301 . . . . 42.52 111.228 178.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -86.35 -166.18 1.47 Allowed 'General case' 0 C--O 1.243 0.717 0 CA-C-N 114.09 -1.414 . . . . 61.02 111.948 -163.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 33.6 m -61.73 -31.23 50.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 115.477 -0.783 . . . . 74.2 112.529 -177.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 225' ' ' THR . . . . . 0.411 HG21 HG22 ' C' ' 185' ' ' VAL . 63.1 m 76.22 -53.44 0.61 Allowed 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.896 1.678 . . . . 54.34 113.215 177.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 1.4 tm? 68.38 83.89 0.16 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.205 1.402 . . . . 74.43 107.619 -168.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . -160.65 24.52 0.27 Allowed Glycine 0 C--N 1.344 1.014 0 CA-C-N 115.784 -0.643 . . . . 51.31 112.535 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . -86.98 -106.35 0.84 Allowed Glycine 0 C--N 1.353 1.482 0 N-CA-C 111.535 -0.626 . . . . 72.41 111.535 174.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . 63.8 -130.62 39.74 Favored Glycine 0 C--N 1.355 1.59 0 CA-C-O 119.9 -0.389 . . . . 70.24 113.38 176.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -148.2 153.09 38.3 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.167 0.987 . . . . 70.23 109.106 178.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 231' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -169.45 161.59 9.83 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.13 0.572 . . . . 73.24 110.2 -172.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 232' ' ' THR . . . . . 0.515 HG22 ' HA ' ' B' ' 280' ' ' LEU . 66.0 p -49.54 102.2 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.655 1.582 . . . . 74.24 113.042 -178.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 233' ' ' PHE . . . . . 0.735 ' HB2' HH22 ' C' ' 211' ' ' ARG . 18.6 t80 -156.26 -49.88 0.08 Allowed 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.338 -0.616 . . . . 70.41 109.338 173.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . 79.01 -40.42 0.25 Allowed 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 125.638 1.575 . . . . 72.31 112.338 177.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . 0.412 ' CG ' ' HB3' ' C' ' 220' ' ' GLU . 0.3 OUTLIER 73.09 132.31 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.34 1.456 . . . . 54.41 112.386 168.071 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 236' ' ' THR . . . . . 0.457 ' HB ' ' O ' ' B' ' 348' ' ' ILE . 39.7 m -138.54 79.41 1.73 Allowed 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.149 0.98 . . . . 73.34 108.658 172.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . 0.468 ' HB1' ' H ' ' B' ' 355' ' ' ALA . . . 70.49 79.94 0.17 Allowed 'General case' 0 CA--C 1.56 1.339 0 CA-C-N 113.921 -1.49 . . . . 71.12 112.681 170.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 238' ' ' THR . . . . . 0.466 ' OG1' ' HB2' ' B' ' 351' ' ' GLN . 31.4 m -154.1 99.0 2.21 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.877 1.271 . . . . 71.31 110.07 176.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -172.47 -179.19 2.16 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.054 0.942 . . . . 74.42 109.815 173.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . -106.0 -125.38 5.49 Favored Glycine 0 C--N 1.346 1.123 0 N-CA-C 112.178 -0.369 . . . . 71.23 112.178 -178.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -104.69 -168.68 1.51 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.895 0.878 . . . . 71.21 110.844 -176.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 242' ' ' TRP . . . . . 0.564 ' HZ3' ' HD3' ' C' ' 231' ' ' ARG . 0.0 OUTLIER 92.43 -13.66 0.18 Allowed 'General case' 0 N--CA 1.508 2.452 0 C-N-CA 128.035 2.534 . . . . 70.32 111.867 176.968 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -124.89 119.34 28.52 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.434 0.635 . . . . 74.22 111.989 -164.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -69.54 -33.83 72.66 Favored Glycine 0 C--N 1.345 1.056 0 N-CA-C 110.16 -1.176 . . . . 63.11 110.16 162.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 8.2 ttpp 61.97 9.33 2.97 Favored 'General case' 0 CA--C 1.558 1.285 0 C-N-CA 124.597 1.159 . . . . 75.34 113.443 161.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 34.0 p -102.42 -8.61 20.98 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.633 0.773 . . . . 71.02 111.092 -177.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 247' ' ' LEU . . . . . 0.566 HD13 ' HG2' ' C' ' 225' ' ' PRO . 4.0 tt -84.55 101.74 12.33 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 109.446 -0.575 . . . . 72.51 109.446 -173.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 248' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 72.44 -75.34 0.08 Allowed 'General case' 0 CA--C 1.558 1.261 0 C-N-CA 125.86 1.664 . . . . 75.15 112.206 174.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 61.54 21.29 11.96 Favored 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 124.672 1.189 . . . . 71.33 111.495 -171.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 250' ' ' GLN . . . . . 0.455 ' OE1' ' HA ' ' B' ' 250' ' ' GLN . 9.2 mm-40 67.24 155.47 0.1 Allowed 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 126.069 1.748 . . . . 65.4 114.57 -178.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 251' ' ' ALA . . . . . . . . . . . . . . . -69.78 138.22 52.55 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 114.546 -1.206 . . . . 61.03 109.537 175.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 -77.36 89.23 3.76 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 109.121 -0.696 . . . . 72.3 109.121 -176.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -60.38 136.73 58.13 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-N 115.31 -0.859 . . . . 51.41 110.112 176.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 68.78 87.56 0.12 Allowed 'General case' 0 N--CA 1.476 0.868 0 O-C-N 124.716 1.26 . . . . 72.51 109.526 -173.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 255' ' ' GLY . . . . . 0.592 ' HA2' ' HA ' ' B' ' 259' ' ' VAL . . . -150.3 54.78 0.48 Allowed Glycine 0 C--N 1.346 1.1 0 CA-C-N 115.597 -0.729 . . . . 54.22 112.83 -173.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 256' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -65.18 99.82 0.41 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.636 0.774 . . . . 52.52 109.597 174.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 15.0 tm0? 58.89 -82.27 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.57 1.548 . . . . 74.31 109.553 -174.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 258' ' ' LEU . . . . . . . . . . . . . 5.1 tt -117.68 85.6 2.37 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 107.633 -1.247 . . . . 75.13 107.633 173.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . 0.592 ' HA ' ' HA2' ' B' ' 255' ' ' GLY . 73.4 t 63.77 -74.4 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 C-N-CA 125.711 1.604 . . . . 63.02 112.514 177.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 260' ' ' SER . . . . . . . . . . . . . 22.1 p -174.41 -35.38 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 125.662 1.585 . . . . 73.11 107.464 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -167.39 156.99 10.49 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.545 1.138 . . . . 52.21 109.717 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 262' ' ' ALA . . . . . . . . . . . . . . . -80.14 -62.82 1.56 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.561 0.744 . . . . 43.43 109.316 171.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -177.18 101.36 0.05 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.421 1.089 . . . . 70.44 108.685 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 10.9 m 59.42 11.42 2.23 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 125.19 1.396 . . . . 51.14 113.38 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 265' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -75.81 -40.64 54.62 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 108.889 -0.782 . . . . 64.12 108.889 -173.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 266' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -66.09 -16.0 63.56 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 123.567 0.747 . . . . 71.52 110.124 176.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 18.2 m 79.0 -54.87 0.45 Allowed 'General case' 0 C--N 1.365 1.263 0 C-N-CA 126.348 1.859 . . . . 73.13 111.933 171.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 39.7 t -58.88 -48.18 87.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 C-N-CA 124.227 1.011 . . . . 74.44 111.063 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 269' ' ' THR . . . . . . . . . . . . . 26.6 m 50.25 74.5 0.21 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.938 1.295 . . . . 74.31 110.328 -172.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 270' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -66.15 -31.69 72.68 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 113.744 -1.571 . . . . 72.41 111.933 -173.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 271' ' ' ALA . . . . . . . . . . . . . . . 58.49 39.03 25.44 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 124.311 1.007 . . . . 75.3 110.682 -175.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 272' ' ' ASN . . . . . . . . . . . . . 44.5 t-20 -60.62 132.5 54.08 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.167 -0.924 . . . . 54.14 110.922 -173.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.06 93.02 0.99 Allowed 'General case' 0 CA--C 1.54 0.563 0 O-C-N 124.141 0.901 . . . . 61.32 108.959 -177.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 -136.02 79.81 1.79 Allowed 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 107.211 -1.403 . . . . 71.44 107.211 171.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 275' ' ' LYS . . . . . 0.47 ' HG2' ' HB1' ' A' ' 278' ' ' ALA . 9.8 mptt 52.06 68.17 3.41 Favored Pre-proline 0 CA--C 1.552 1.037 0 CA-C-N 114.122 -1.399 . . . . 71.33 111.896 -178.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -83.81 17.96 1.61 Allowed 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 122.699 2.266 . . . . 62.35 111.954 174.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 277' ' ' LEU . . . . . 0.433 HD22 ' HA ' ' A' ' 279' ' ' ARG . 5.4 mp -81.41 -99.21 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 108.392 -0.966 . . . . 63.32 108.392 175.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 78.3 mt 59.5 22.51 11.08 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 118.918 0.781 . . . . 62.0 112.397 178.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . 108.05 -15.49 36.66 Favored Glycine 0 C--N 1.354 1.545 0 C-N-CA 123.086 0.374 . . . . 75.43 113.177 -176.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 280' ' ' LEU . . . . . 0.515 ' HA ' HG22 ' B' ' 232' ' ' THR . 2.2 tm? -63.77 -43.84 95.21 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.948 0.899 . . . . 53.23 109.622 177.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -78.18 -49.76 13.21 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 109.339 -0.615 . . . . 75.31 109.339 174.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . 78.31 -38.83 0.25 Allowed 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 126.063 1.745 . . . . 65.41 112.681 176.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 19.1 t70 66.92 -71.18 0.1 Allowed 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 126.326 1.85 . . . . 72.33 111.429 -176.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . -78.57 66.62 3.26 Favored Glycine 0 C--N 1.347 1.144 0 N-CA-C 111.794 -0.523 . . . . 61.45 111.794 175.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -77.77 88.84 4.0 Favored 'General case' 0 C--O 1.245 0.858 0 N-CA-C 108.08 -1.082 . . . . 72.41 108.08 177.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 286' ' ' MET . . . . . 0.558 ' HB3' ' HD2' ' B' ' 287' ' ' PRO . 65.5 mtm 70.0 176.9 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.533 0 C-N-CA 124.488 1.115 . . . . 64.1 110.611 -175.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 287' ' ' PRO . . . . . 0.558 ' HD2' ' HB3' ' B' ' 286' ' ' MET . 37.9 Cg_endo -65.73 5.37 0.61 Allowed 'Trans proline' 0 C--N 1.389 2.702 0 C-N-CA 121.897 1.731 . . . . 73.33 114.081 172.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 288' ' ' VAL . . . . . . . . . . . . . 26.1 t -74.28 80.29 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 CA-C-O 121.629 0.728 . . . . 74.32 109.206 171.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 289' ' ' ARG . . . . . . . . . . . . . 53.6 ttt180 -116.8 -7.77 11.44 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 124.478 1.111 . . . . 72.14 109.779 177.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 290' ' ' TRP . . . . . . . . . . . . . 72.2 t-105 69.22 116.41 0.04 OUTLIER 'General case' 0 C--N 1.362 1.118 0 C-N-CA 125.02 1.328 . . . . 75.34 110.157 -173.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 291' ' ' LEU . . . . . . . . . . . . . 30.8 tp 72.8 149.99 0.1 Allowed 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 125.712 1.605 . . . . 64.34 111.064 -172.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . 159.07 -65.06 0.29 Allowed Glycine 0 C--N 1.348 1.245 0 CA-C-N 116.007 -0.542 . . . . 62.12 111.907 -179.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -83.96 40.09 0.86 Allowed 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 123.394 2.729 . . . . 51.12 113.201 -178.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -71.44 120.54 17.16 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.383 1.073 . . . . 41.23 111.198 -175.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -163.59 -62.54 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.451 1.1 . . . . 34.32 108.751 169.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 24.8 m 68.79 149.9 0.07 Allowed 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 125.661 1.584 . . . . 65.42 112.417 176.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 84.5 t80 66.2 -82.38 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 124.847 1.259 . . . . 64.12 111.852 175.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 21.5 p80 39.75 85.24 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 125.966 1.707 . . . . 71.5 113.765 -176.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . -79.07 62.86 3.95 Favored Glycine 0 C--N 1.352 1.444 0 CA-C-N 115.934 -0.576 . . . . 63.41 112.841 179.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 300' ' ' ASN . . . . . 0.525 ' ND2' ' H ' ' B' ' 301' ' ' ILE . 11.0 t30 -171.45 -151.04 0.07 Allowed 'General case' 0 CA--C 1.551 0.999 0 N-CA-C 106.131 -1.803 . . . . 72.23 106.131 -175.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 301' ' ' ILE . . . . . 0.525 ' H ' ' ND2' ' B' ' 300' ' ' ASN . 29.7 mm 74.87 142.15 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.562 1.407 0 C-N-CA 124.907 1.283 . . . . 72.24 111.582 174.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 302' ' ' ASP . . . . . 0.598 ' H ' ' HG3' ' A' ' 189' ' ' GLU . 18.5 t0 78.83 161.27 0.2 Allowed 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 125.885 1.674 . . . . 63.41 112.737 171.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 303' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.51 -36.71 24.3 Favored Pre-proline 0 CA--C 1.571 1.778 0 N-CA-C 115.255 1.576 . . . . 74.11 115.255 -165.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 304' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -49.83 -33.79 34.2 Favored 'Trans proline' 0 C--N 1.394 2.944 0 C-N-CA 122.624 2.216 . . . . 75.12 114.13 169.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . 68.53 -72.74 0.1 Allowed 'General case' 0 C--N 1.362 1.142 0 C-N-CA 125.353 1.461 . . . . 42.33 110.558 -175.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . 0.427 HG22 ' H ' ' B' ' 308' ' ' CYS . 6.9 p -124.28 139.46 50.56 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 C-N-CA 123.799 0.84 . . . . 72.33 109.372 172.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 24.4 m -61.17 -27.71 68.6 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.677 1.191 . . . . 74.23 112.475 -175.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 308' ' ' CYS . . . . . 0.427 ' H ' HG22 ' B' ' 306' ' ' VAL . 20.2 p -70.1 -10.22 58.04 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.309 0.644 . . . . 74.22 111.735 -178.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 65.6 p -130.3 88.32 48.08 Favored Pre-proline 0 CA--C 1.554 1.134 0 C-N-CA 123.7 0.8 . . . . 72.2 109.36 174.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -79.68 162.75 24.25 Favored 'Trans proline' 0 C--N 1.376 2.023 0 C-N-CA 122.676 2.251 . . . . 63.14 112.266 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 311' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -83.86 -46.64 0.76 Allowed Pre-proline 0 CA--C 1.564 1.507 0 CA-C-O 119.04 -0.505 . . . . 73.13 111.317 178.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 312' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -92.63 -157.19 0.05 OUTLIER 'Trans proline' 0 C--N 1.386 2.538 0 C-N-CA 122.095 1.863 . . . . 70.14 110.543 166.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 313' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -89.3 9.69 25.07 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.563 0.345 . . . . 75.13 110.78 174.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 314' ' ' ARG . . . . . . . . . . . . . 37.9 ttp-105 72.99 -71.01 0.14 Allowed 'General case' 0 C--N 1.364 1.201 0 C-N-CA 125.922 1.689 . . . . 72.01 111.04 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 315' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 62.44 -81.02 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.921 1.289 . . . . 72.12 112.091 -179.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 316' ' ' ASP . . . . . . . . . . . . . 33.1 t70 64.35 -75.9 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.499 1.52 . . . . 74.4 112.394 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 317' ' ' SER . . . . . 0.623 ' HA ' HG22 ' B' ' 325' ' ' THR . 69.7 m -96.65 -6.95 35.4 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.787 0.835 . . . . 75.41 112.437 -177.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 318' ' ' VAL . . . . . 0.671 HG12 ' HA ' ' B' ' 322' ' ' ALA . 29.7 m -118.97 92.11 44.48 Favored Pre-proline 0 CA--C 1.557 1.242 0 C-N-CA 123.181 0.593 . . . . 73.13 110.752 -178.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 319' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -67.98 -37.63 14.73 Favored 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 122.572 2.181 . . . . 65.1 111.312 173.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 320' ' ' THR . . . . . . . . . . . . . 88.5 m -144.08 -58.0 0.38 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.482 1.113 . . . . 53.31 108.292 174.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 321' ' ' LEU . . . . . . . . . . . . . 93.9 mt -112.05 169.58 8.75 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-N 115.325 -0.852 . . . . 65.14 110.016 178.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 322' ' ' ALA . . . . . 0.671 ' HA ' HG12 ' B' ' 318' ' ' VAL . . . -79.63 72.09 6.29 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.61 0.764 . . . . 64.54 110.278 177.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 323' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -88.85 -25.15 22.33 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 115.175 -0.921 . . . . 74.02 109.497 175.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 324' ' ' MET . . . . . 0.44 ' HA ' ' HB3' ' B' ' 317' ' ' SER . 43.1 tpp 73.18 125.65 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.357 1.463 . . . . 71.32 113.441 166.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 325' ' ' THR . . . . . 0.623 HG22 ' HA ' ' B' ' 317' ' ' SER . 4.4 t -104.78 103.39 13.0 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 107.312 -1.366 . . . . 72.33 107.312 163.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 326' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -60.63 147.05 43.25 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.312 0.645 . . . . 72.01 110.019 -177.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . 0.439 ' HD2' ' N ' ' B' ' 327' ' ' LYS . 2.9 mptp? -83.45 22.9 0.98 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.685 0.794 . . . . 54.34 113.021 -170.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 328' ' ' ALA . . . . . . . . . . . . . . . 77.71 164.28 0.23 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.127 1.371 . . . . 72.03 113.193 167.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 329' ' ' ILE . . . . . . . . . . . . . 13.6 tt -144.7 173.24 4.51 Favored 'Isoleucine or valine' 0 C--O 1.251 1.144 0 CA-C-N 113.242 -1.799 . . . . 73.5 106.334 175.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 330' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -66.74 -81.33 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 108.134 -1.061 . . . . 63.42 108.134 164.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 331' ' ' LEU . . . . . . . . . . . . . 60.2 tp 48.31 -93.89 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 124.318 1.047 . . . . 63.34 110.585 -174.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 96.9 mt 30.69 -90.62 0.01 OUTLIER 'General case' 0 C--N 1.368 1.382 0 C-N-CA 126.739 2.016 . . . . 74.41 113.84 178.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 333' ' ' SER . . . . . . . . . . . . . 16.5 p -176.64 -66.44 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.491 1.516 . . . . 65.04 107.119 -178.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt 75.21 -45.08 0.55 Allowed 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 125.988 1.715 . . . . 63.11 113.047 172.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 335' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -53.41 109.37 0.43 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.982 1.313 . . . . 73.25 112.426 -176.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 55.73 32.33 19.21 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.865 1.266 . . . . 61.02 113.61 166.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 337' ' ' LYS . . . . . 0.479 ' NZ ' ' SG ' ' B' ' 190' ' ' CYS . 30.8 mtpt -75.94 79.62 2.83 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 121.391 0.615 . . . . 62.43 109.565 173.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 338' ' ' GLY . . . . . . . . . . . . . . . 110.63 157.12 15.27 Favored Glycine 0 C--N 1.342 0.874 0 CA-C-N 114.861 -1.063 . . . . 72.34 110.786 -169.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 339' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -140.4 178.81 7.05 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.623 0.769 . . . . 74.33 109.689 -178.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 340' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -65.36 163.53 15.41 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.672 0.789 . . . . 75.24 112.065 -176.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 341' ' ' LEU . . . . . . . . . . . . . 6.3 tt -146.94 117.59 7.54 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 107.751 -1.203 . . . . 75.34 107.751 176.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 342' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -91.11 127.37 36.51 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 122.944 0.498 . . . . 64.25 110.158 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 343' ' ' VAL . . . . . . . . . . . . . 7.5 p -96.11 -32.59 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.486 0.714 . . . . 64.24 109.618 173.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 63.43 -77.54 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 126.351 1.86 . . . . 73.03 111.384 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 345' ' ' GLY . . . . . . . . . . . . . . . -117.49 148.56 18.72 Favored Glycine 0 C--N 1.342 0.886 0 N-CA-C 112.332 -0.307 . . . . 62.31 112.332 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 346' ' ' ALA . . . . . . . . . . . . . . . -87.84 178.17 6.78 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.956 0.902 . . . . 72.22 110.157 173.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 46.8 t -66.63 -61.7 1.84 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.076 0.55 . . . . 72.21 109.979 177.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 348' ' ' ILE . . . . . 0.457 ' O ' ' HB ' ' B' ' 236' ' ' THR . 61.0 mt 68.02 -62.02 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 125.977 1.711 . . . . 73.42 112.247 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 349' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -52.28 92.35 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 125.41 1.484 . . . . 71.13 112.106 -178.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 350' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? 48.09 73.72 0.2 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 125.317 1.447 . . . . 74.52 111.419 173.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 351' ' ' GLN . . . . . 0.466 ' HB2' ' OG1' ' B' ' 238' ' ' THR . 23.2 mt-30 -78.7 158.08 28.42 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.215 -0.902 . . . . 71.32 112.199 -170.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 7.7 t0 62.0 -99.9 0.09 Allowed 'General case' 0 CA--C 1.563 1.445 0 C-N-CA 124.993 1.317 . . . . 74.35 111.626 169.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 353' ' ' HIS . . . . . . . . . . . . . 44.6 p-80 -135.42 13.04 3.51 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.439 0.695 . . . . 74.33 109.494 -177.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 354' ' ' ALA . . . . . . . . . . . . . . . 72.21 177.07 0.26 Allowed 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 125.522 1.529 . . . . 70.11 110.821 -162.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 355' ' ' ALA . . . . . 0.468 ' H ' ' HB1' ' B' ' 237' ' ' ALA . . . -90.79 168.55 11.65 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.168 0.587 . . . . 75.44 109.591 177.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 356' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -111.52 98.79 42.0 Favored Pre-proline 0 N--CA 1.476 0.873 0 C-N-CA 123.347 0.659 . . . . 74.32 109.538 174.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 357' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -88.12 0.21 6.87 Favored 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 122.97 2.447 . . . . 55.22 111.8 166.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 358' ' ' CYS . . . . . . . . . . . . . 8.9 p -162.96 115.58 1.58 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.435 1.094 . . . . 73.32 108.272 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 359' ' ' GLY . . . . . . . . . . . . . . . -75.73 76.09 1.4 Allowed Glycine 0 C--N 1.349 1.254 0 N-CA-C 110.484 -1.046 . . . . 62.01 110.484 176.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 360' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 69.89 -67.92 0.22 Allowed 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 125.763 1.625 . . . . 53.34 108.75 -165.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 361' ' ' ILE . . . . . 0.479 HG22 ' H ' ' B' ' 363' ' ' GLU . 45.0 mt -96.38 147.82 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 123.745 0.818 . . . . 61.31 109.208 174.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 362' ' ' GLY . . . . . . . . . . . . . . . -65.36 -37.4 93.83 Favored Glycine 0 C--N 1.352 1.45 0 O-C-N 123.323 0.39 . . . . 72.35 113.053 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 363' ' ' GLU . . . . . 0.479 ' H ' HG22 ' B' ' 361' ' ' ILE . 4.1 mp0 -71.85 -23.31 61.51 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.953 0.901 . . . . 73.13 112.181 -178.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 364' ' ' THR . . . . . . . . . . . . . 69.3 m -59.66 -37.41 78.66 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.445 0.698 . . . . 74.04 111.592 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 17.0 m -108.82 -58.29 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.245 0 CA-C-O 118.751 -0.642 . . . . 74.01 110.504 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 32.4 t70 38.43 -94.23 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 126.024 1.73 . . . . 50.12 113.141 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 367' ' ' LEU . . . . . . . . . . . . . 7.6 mp -133.89 131.35 39.02 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 106.802 -1.555 . . . . 75.05 106.802 167.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 368' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -81.43 177.98 8.64 Favored 'General case' 0 CA--C 1.553 1.069 0 N-CA-C 110.172 -0.307 . . . . 71.23 110.172 177.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 369' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 68.83 -82.38 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 124.86 1.264 . . . . 70.1 111.004 -172.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 370' ' ' ALA . . . . . . . . . . . . . . . 59.12 -83.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 125.01 1.324 . . . . 74.25 111.931 -174.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 371' ' ' VAL . . . . . . . . . . . . . 43.3 t 61.17 -84.43 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 125.807 1.643 . . . . 74.11 112.133 178.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 372' ' ' GLN . . . . . . . . . . . . . 22.0 tp60 -151.18 5.52 0.48 Allowed 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.788 0.835 . . . . 63.2 110.362 -172.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 373' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 61.85 94.1 0.04 OUTLIER 'General case' 0 C--N 1.36 1.028 0 C-N-CA 124.517 1.127 . . . . 72.05 109.66 -171.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -62.35 115.6 4.33 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.523 -0.762 . . . . 71.45 111.468 -172.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 375' ' ' LEU . . . . . . . . . . . . . 53.5 tp -73.99 117.6 15.97 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 108.732 -0.84 . . . . 62.01 108.732 174.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 376' ' ' GLU . . . . . 0.461 ' HB3' ' HA ' ' A' ' 258' ' ' PRO . 0.0 OUTLIER -61.81 -31.09 71.29 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.164 0.985 . . . . 73.13 112.717 -177.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 377' ' ' PHE . . . . . 0.488 ' HZ ' ' HB3' ' B' ' 394' ' ' HIS . 79.5 t80 -62.44 -34.88 77.66 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.119 0.968 . . . . 73.31 111.009 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 378' ' ' ALA . . . . . . . . . . . . . . . -66.07 -37.35 85.59 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.446 -0.797 . . . . 61.1 110.158 176.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? 78.42 -28.08 0.16 Allowed 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 125.743 1.617 . . . . 72.01 111.938 170.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 380' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt 72.26 -82.59 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 125.931 1.692 . . . . 53.14 111.927 169.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 381' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -84.83 101.08 11.99 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.088 0.555 . . . . 74.34 111.297 -176.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . 67.35 65.83 2.59 Favored Glycine 0 C--N 1.349 1.303 0 CA-C-N 115.209 -0.905 . . . . 73.1 113.236 175.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 383' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -89.82 -61.54 1.67 Allowed 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 109.555 -0.535 . . . . 73.1 109.555 175.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 384' ' ' THR . . . . . . . . . . . . . 26.2 m 62.88 -79.61 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 125.498 1.519 . . . . 63.41 111.028 -173.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 385' ' ' LEU . . . . . 0.529 ' HA ' ' HD2' ' A' ' 211' ' ' ARG . 96.9 mt 56.95 -89.96 0.03 OUTLIER 'General case' 0 C--N 1.355 0.813 0 C-N-CA 124.604 1.162 . . . . 75.12 109.533 -168.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 386' ' ' VAL . . . . . 0.429 ' HB ' ' HB3' ' B' ' 391' ' ' ASP . 2.9 t -124.87 45.94 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 107.66 -1.237 . . . . 62.42 107.66 174.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 387' ' ' ILE . . . . . . . . . . . . . 1.9 mp 69.96 -65.04 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 C-N-CA 125.664 1.586 . . . . 74.12 109.306 -172.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 388' ' ' VAL . . . . . 0.521 HG23 ' HB2' ' B' ' 391' ' ' ASP . 10.7 m -86.54 135.98 23.91 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 C-N-CA 123.502 0.721 . . . . 54.33 109.584 169.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 389' ' ' THR . . . . . . . . . . . . . 14.9 t -79.28 -16.26 56.69 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.364 0.665 . . . . 71.25 111.74 -175.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . -73.78 -20.76 60.39 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.324 0.649 . . . . 70.34 112.098 178.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 391' ' ' ASP . . . . . 0.521 ' HB2' HG23 ' B' ' 388' ' ' VAL . 7.1 t70 -80.79 170.61 16.07 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.298 0.639 . . . . 64.12 111.147 -175.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 392' ' ' HIS . . . . . . . . . . . . . 81.2 t60 66.12 35.81 5.98 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.849 1.26 . . . . 72.42 108.445 -169.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . 67.39 22.66 9.38 Favored 'General case' 0 C--N 1.357 0.915 0 CA-C-N 113.938 -1.483 . . . . 61.53 113.069 173.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 394' ' ' HIS . . . . . 0.488 ' HB3' ' HZ ' ' B' ' 377' ' ' PHE . 64.8 m170 -75.46 -11.03 59.95 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 112.25 0.463 . . . . 73.31 112.25 -177.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . -66.01 99.18 0.48 Allowed 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 109.134 -0.691 . . . . 71.44 109.134 166.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 32.0 p -72.59 81.5 1.1 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.975 0.91 . . . . 75.55 110.601 -177.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 397' ' ' GLN . . . . . . . . . . . . . 87.5 mm-40 -141.01 88.08 2.15 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.181 0.992 . . . . 71.41 108.875 -176.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 398' ' ' ILE . . . . . 0.652 ' HB ' HG21 ' B' ' 409' ' ' THR . 14.3 tt -111.25 89.57 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 CA-C-O 121.601 0.715 . . . . 75.44 109.508 178.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 399' ' ' VAL . . . . . . . . . . . . . 45.4 t -68.9 -75.12 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 CA-C-N 115.792 -0.64 . . . . 73.32 110.222 -174.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 400' ' ' ALA . . . . . . . . . . . . . . . -162.96 80.88 1.64 Allowed Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 123.352 0.661 . . . . 51.41 109.733 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 401' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -81.95 47.04 2.38 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 123.562 2.842 . . . . 71.04 111.712 173.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -64.16 -37.78 88.68 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.387 1.075 . . . . 74.34 111.895 -168.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 403' ' ' THR . . . . . . . . . . . . . 9.3 t -136.39 138.76 41.9 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 108.353 -0.98 . . . . 51.3 108.353 172.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 404' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? 55.8 86.0 0.06 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.364 1.066 . . . . 70.03 110.431 -173.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 405' ' ' ALA . . . . . . . . . . . . . . . -109.65 96.46 23.66 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 123.847 0.859 . . . . 71.24 110.786 -176.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 406' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -83.48 11.9 3.15 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 123.063 2.509 . . . . 44.44 112.852 173.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . 83.18 -84.14 1.57 Allowed Glycine 0 C--N 1.346 1.099 0 CA-C-O 119.693 -0.504 . . . . 55.33 112.058 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 408' ' ' LEU . . . . . . . . . . . . . 82.0 mt 61.54 5.74 1.31 Allowed 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 124.881 1.272 . . . . 72.03 112.814 -178.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 409' ' ' THR . . . . . 0.652 HG21 ' HB ' ' B' ' 398' ' ' ILE . 14.6 t -158.06 157.79 33.56 Favored 'General case' 0 C--O 1.244 0.766 0 C-N-CA 125.14 1.376 . . . . 73.52 107.582 -176.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 410' ' ' GLN . . . . . . . . . . . . . 27.0 pt20 43.69 78.75 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 125.481 1.512 . . . . 51.32 113.391 -178.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . 77.7 -53.92 0.52 Allowed 'General case' 0 N--CA 1.498 1.925 0 C-N-CA 125.55 1.54 . . . . 63.14 113.791 176.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 39.0 tp -73.81 96.35 2.55 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.736 0.814 . . . . 60.41 111.813 -171.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -164.13 -70.9 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 124.435 1.094 . . . . 71.14 108.702 170.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 414' ' ' THR . . . . . . . . . . . . . 36.9 p -112.1 159.45 18.5 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.066 0.946 . . . . 73.24 110.194 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 415' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -104.78 -18.81 14.12 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.066 0.946 . . . . 73.42 111.069 -176.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -78.08 169.37 18.38 Favored 'General case' 0 C--O 1.245 0.852 0 C-N-CA 124.438 1.095 . . . . 75.33 111.841 -171.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 417' ' ' GLY . . . . . . . . . . . . . . . 137.94 -23.42 3.06 Favored Glycine 0 C--N 1.341 0.814 0 CA-C-N 115.127 -0.942 . . . . 43.15 113.308 176.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 418' ' ' ALA . . . . . . . . . . . . . . . -150.22 147.54 27.81 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 117.49 0.645 . . . . 70.25 111.03 -177.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 419' ' ' VAL . . . . . . . . . . . . . 50.2 t -59.04 -43.75 89.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.202 1.001 . . . . 62.03 109.649 172.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 420' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -123.7 115.18 20.99 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 107.512 -1.292 . . . . 73.12 107.512 173.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 421' ' ' VAL . . . . . . . . . . . . . 6.3 p -123.65 121.83 63.41 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 C-N-CA 123.657 0.783 . . . . 72.42 110.056 -177.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 422' ' ' MET . . . . . 0.521 ' SD ' ' HD2' ' A' ' 209' ' ' LYS . 0.0 OUTLIER -122.1 10.58 10.08 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.03 0.932 . . . . 74.1 111.117 175.888 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 423' ' ' SER . . . . . . . . . . . . . 19.9 m -108.89 18.76 20.37 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.333 1.053 . . . . 62.22 109.818 169.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 424' ' ' TYR . . . . . 0.411 ' HB3' ' HG2' ' B' ' 429' ' ' GLU . 14.7 t80 -54.16 -58.45 7.31 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.06 1.344 . . . . 72.42 109.709 172.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . -105.15 51.01 0.8 Allowed Glycine 0 C--N 1.347 1.148 0 CA-C-N 114.945 -1.025 . . . . 75.12 111.0 172.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 426' ' ' ASN . . . . . . . . . . . . . 21.1 m120 71.79 -66.66 0.29 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.441 1.497 . . . . 75.43 112.534 175.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 427' ' ' SER . . . . . . . . . . . . . 72.9 m -147.53 151.94 37.16 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.49 0.716 . . . . 75.14 111.269 175.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 51.76 93.04 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 125.773 1.629 . . . . 73.23 112.013 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 429' ' ' GLU . . . . . 0.691 ' HG3' ' H ' ' B' ' 431' ' ' SER . 17.0 tp10 -110.9 152.83 26.27 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.864 -0.607 . . . . 63.42 111.589 -171.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -56.86 -35.23 68.65 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.985 1.314 . . . . 55.41 111.009 171.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 431' ' ' SER . . . . . 0.691 ' H ' ' HG3' ' B' ' 429' ' ' GLU . 18.4 m -64.39 81.84 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.092 0.957 . . . . 73.31 110.797 177.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 432' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -120.58 26.79 8.93 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.264 1.025 . . . . 71.1 108.989 175.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 433' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -64.17 112.42 3.01 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 115.206 -0.906 . . . . 73.43 109.192 177.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 434' ' ' HIS . . . . . . . . . . . . . 50.3 t60 66.01 34.94 6.67 Favored 'General case' 0 CA--C 1.566 1.558 0 O-C-N 124.409 1.068 . . . . 65.13 110.387 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 435' ' ' THR . . . . . . . . . . . . . 10.6 t -73.31 -8.79 57.36 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.395 0.678 . . . . 73.42 111.622 177.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . -56.2 -31.4 59.2 Favored Glycine 0 C--N 1.357 1.737 0 O-C-N 123.576 0.547 . . . . 43.54 112.187 170.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 68.9 m -70.08 83.08 0.51 Allowed 'General case' 0 C--N 1.354 0.782 0 N-CA-C 107.544 -1.28 . . . . 54.14 107.544 161.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 438' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -66.34 93.94 0.24 Allowed 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 114.44 -1.255 . . . . 71.55 111.762 -170.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 439' ' ' LEU . . . . . . . . . . . . . 86.0 mt -83.21 -5.53 59.16 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 114.943 -1.026 . . . . 74.24 110.604 171.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 440' ' ' ARG . . . . . 0.525 ' HA ' ' HB3' ' A' ' 222' ' ' ALA . 13.1 mtp180 -89.52 108.55 19.72 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.449 -0.945 . . . . 70.1 108.449 177.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 441' ' ' ILE . . . . . 0.592 HD12 ' HA ' ' A' ' 223' ' ' VAL . 57.0 mt -69.25 124.03 24.16 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 C-N-CA 123.353 0.661 . . . . 74.15 112.315 -167.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 442' ' ' ALA . . . . . . . . . . . . . . . -115.27 32.41 6.07 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.071 0.948 . . . . 71.41 110.15 175.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 443' ' ' ALA . . . . . 0.537 ' H ' HG22 ' B' ' 441' ' ' ILE . . . -68.77 163.64 23.61 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.351 0.66 . . . . 74.21 111.425 178.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 15.3 m-30 78.3 -24.72 0.21 Allowed 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 125.744 1.617 . . . . 65.34 111.912 -174.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . 66.89 69.52 1.34 Allowed Glycine 0 C--N 1.352 1.424 0 N-CA-C 110.403 -1.079 . . . . 74.34 110.403 -168.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 446' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -49.08 98.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 124.246 3.297 . . . . 63.02 114.237 -165.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 447' ' ' HIS . . . . . 0.57 ' HD1' HD12 ' B' ' 454' ' ' LEU . 7.8 p-80 -121.4 95.26 4.61 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.937 0.895 . . . . 60.0 109.429 177.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . -90.64 -170.72 2.81 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.658 -0.701 . . . . 74.31 109.978 176.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 449' ' ' ALA . . . . . . . . . . . . . . . 63.24 30.82 15.78 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.081 0.952 . . . . 61.52 111.619 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 450' ' ' ASN . . . . . . . . . . . . . 10.8 t30 65.33 15.66 10.13 Favored 'General case' 0 CA--C 1.56 1.355 0 C-N-CA 124.601 1.161 . . . . 61.12 112.153 174.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 40.5 t -78.93 76.91 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 CA-C-O 122.01 0.909 . . . . 63.1 108.756 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 452' ' ' VAL . . . . . . . . . . . . . 8.0 p -75.8 -29.49 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-N 114.334 -1.303 . . . . 60.45 111.68 -172.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . -80.03 67.07 3.49 Favored Glycine 0 C--N 1.349 1.304 0 CA-C-N 115.745 -0.661 . . . . 73.44 112.056 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 454' ' ' LEU . . . . . 0.57 HD12 ' HD1' ' B' ' 447' ' ' HIS . 3.1 tm? -153.55 123.52 6.89 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 106.625 -1.62 . . . . 72.5 106.625 -178.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 58.7 m -79.33 -82.71 0.1 Allowed 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 108.991 -0.744 . . . . 61.41 108.991 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -140.02 155.17 47.2 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.731 0.812 . . . . 74.3 109.057 178.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 457' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 63.26 98.28 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.711 1.204 . . . . 42.14 110.551 -173.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 3.7 m -90.49 3.76 53.01 Favored 'General case' 0 CA--C 1.56 1.344 0 C-N-CA 123.714 0.806 . . . . 72.13 110.738 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 459' ' ' ASP . . . . . . . . . . . . . 28.5 t70 66.5 113.62 0.03 OUTLIER 'General case' 0 C--N 1.362 1.114 0 C-N-CA 125.775 1.63 . . . . 73.31 110.054 -172.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 1.3 tt 66.07 99.69 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 124.845 1.258 . . . . 65.42 108.801 -177.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -73.9 70.55 1.48 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.712 0.805 . . . . 62.31 111.029 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 41.2 t80 -152.66 17.62 0.6 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.231 1.412 . . . . 72.53 107.934 177.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 24.3 p -84.66 54.56 3.08 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.227 1.411 . . . . 61.35 109.978 178.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 464' ' ' MET . . . . . . . . . . . . . 24.6 ptt? -95.03 32.74 1.62 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.959 1.303 . . . . 75.31 110.09 -176.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.15 82.17 0.71 Allowed 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.326 1.05 . . . . 72.15 110.89 -173.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -105.17 -172.05 2.03 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.386 1.074 . . . . 62.32 109.368 177.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . -81.46 12.9 3.32 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 123.376 0.67 . . . . 75.3 111.868 178.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 1.4 pp -53.17 151.76 4.84 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.713 1.205 . . . . 45.51 112.675 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 469' ' ' GLY . . . . . . . . . . . . . . . 76.22 -80.46 1.12 Allowed Glycine 0 C--N 1.341 0.825 0 N-CA-C 110.437 -1.065 . . . . 50.44 110.437 -168.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 470' ' ' LEU . . . . . . . . . . . . . 53.1 tp -170.28 -44.25 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.457 1.103 . . . . 73.2 108.813 177.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 471' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? . . . . . 0 CA--C 1.56 1.353 0 C-N-CA 125.351 1.46 . . . . 74.2 109.681 -176.461 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 63.2 mtt . . . . . 0 N--CA 1.475 0.816 0 N-CA-C 109.184 -0.673 . . . . 55.23 109.184 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 63.61 31.55 14.52 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.805 1.242 . . . . 65.31 111.411 -176.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -85.61 35.11 0.6 Allowed 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.334 0.654 . . . . 52.01 111.814 -175.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -37.38 94.95 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.489 1.516 . . . . 70.52 113.862 -175.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -66.49 104.36 1.24 Allowed 'General case' 0 C--O 1.239 0.514 0 N-CA-C 107.915 -1.142 . . . . 63.2 107.915 166.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -74.63 90.98 2.3 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 107.531 -1.285 . . . . 63.22 107.531 172.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 7' ' ' TYR . . . . . 0.423 ' CD1' ' HA ' ' C' ' 53' ' ' ALA . 72.4 m-85 -62.21 -26.01 68.12 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 114.387 -1.279 . . . . 73.43 111.99 -171.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -63.13 -47.86 80.96 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.54 0.736 . . . . 72.53 110.543 173.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.75 -39.58 93.87 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.06 0.544 . . . . 52.31 110.972 178.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 65.9 mt -59.26 -39.93 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 C-N-CA 123.374 0.669 . . . . 63.34 110.737 176.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 11' ' ' LEU . . . . . 0.415 ' O ' ' HB1' ' C' ' 25' ' ' ALA . 95.5 mt -90.14 -0.17 57.47 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 112.497 0.555 . . . . 45.45 112.497 177.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 59.59 37.92 92.93 Favored Glycine 0 C--N 1.352 1.459 0 N-CA-C 114.107 0.403 . . . . 64.33 114.107 178.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 7.2 m -126.03 139.41 34.28 Favored Pre-proline 0 N--CA 1.482 1.141 0 C-N-CA 124.775 1.23 . . . . 64.04 109.209 177.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -76.87 159.83 34.31 Favored 'Trans proline' 0 C--N 1.368 1.605 0 C-N-CA 122.192 1.928 . . . . 74.43 111.976 176.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 53.6 mtt180 -74.08 76.34 1.74 Allowed 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.329 -0.989 . . . . 71.52 108.329 171.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 176.39 -27.59 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.17 1.388 . . . . 71.24 108.487 -172.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.45 135.93 57.85 Favored 'General case' 0 C--N 1.351 0.664 0 CA-C-N 115.653 -0.703 . . . . 71.14 110.172 172.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 72.0 p -65.99 160.87 22.69 Favored 'General case' 0 C--O 1.246 0.899 0 O-C-N 123.668 0.605 . . . . 74.41 109.671 177.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 19' ' ' GLN . . . . . 0.558 ' HG2' ' HD3' ' C' ' 60' ' ' PRO . 24.8 tp60 -56.57 -33.67 66.38 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.233 0.613 . . . . 74.45 111.808 -176.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -75.0 -28.78 60.67 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 119.121 -0.466 . . . . 64.05 111.698 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . 0.527 ' HG2' HH21 ' C' ' 24' ' ' ARG . 46.3 mt-10 -69.36 -41.13 76.97 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 121.109 0.481 . . . . 73.42 110.161 174.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 22' ' ' ILE . . . . . 0.432 HG21 ' HB3' ' C' ' 57' ' ' LEU . 57.2 mt -66.44 -38.3 81.45 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 CA-C-N 114.735 -1.12 . . . . 61.32 110.12 176.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 23' ' ' LYS . . . . . 0.441 ' O ' ' HD3' ' C' ' 27' ' ' LYS . 4.5 ttpt -70.11 -40.49 74.86 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 114.69 -1.141 . . . . 74.13 109.617 179.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 24' ' ' ARG . . . . . 0.527 HH21 ' HG2' ' C' ' 21' ' ' GLU . 46.6 mtm105 -72.57 -22.39 61.0 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.276 0.63 . . . . 73.52 111.283 176.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . 0.415 ' HB1' ' O ' ' C' ' 11' ' ' LEU . . . -66.96 -45.2 78.46 Favored 'General case' 0 C--O 1.242 0.661 0 O-C-N 123.537 0.523 . . . . 75.32 109.603 171.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 26' ' ' TYR . . . . . 0.553 ' HD1' HG22 ' C' ' 50' ' ' ILE . 83.4 t80 -57.76 -52.95 63.35 Favored 'General case' 0 C--N 1.355 0.82 0 CA-C-N 115.5 -0.773 . . . . 72.31 110.698 171.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . 0.459 ' HE2' ' HA ' ' C' ' 24' ' ' ARG . 6.0 mppt? -60.69 -32.63 71.84 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.433 0.693 . . . . 74.1 111.62 -176.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -61.98 -48.81 78.7 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.974 0.91 . . . . 71.15 109.494 174.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . 0.59 HD13 HD12 ' C' ' 50' ' ' ILE . 76.6 mt -77.39 -13.4 59.94 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 114.781 -1.1 . . . . 60.22 111.664 178.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -86.93 -19.68 28.45 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.488 0.715 . . . . 75.32 110.02 176.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 60.4 mtm180 -91.92 -27.23 18.03 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.309 0.644 . . . . 73.5 110.364 169.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -72.84 -59.93 2.48 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.415 0.686 . . . . 71.12 109.218 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -90.25 22.31 3.39 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.92 0.888 . . . . 70.15 110.901 -178.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 34' ' ' HIS . . . . . 0.407 ' NE2' ' HB3' ' C' ' 36' ' ' ASP . 75.8 t60 -53.18 93.97 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.586 0 C-N-CA 125.565 1.546 . . . . 72.34 113.043 -166.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 35' ' ' PRO . . . . . 0.423 ' O ' ' HG2' ' C' ' 39' ' ' LYS . 53.3 Cg_endo -76.55 -6.05 16.64 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.901 2.401 . . . . 71.32 111.806 -168.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 36' ' ' ASP . . . . . 0.725 ' HB2' ' HG2' ' B' ' 113' ' ' LYS . 24.0 t70 -63.73 -35.91 82.15 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.442 1.097 . . . . 60.34 111.46 172.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 41.1 t -122.92 -46.9 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 CA-C-O 121.191 0.519 . . . . 75.33 109.753 -177.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -98.33 81.85 2.82 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.005 0.922 . . . . 54.22 109.678 -178.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 39' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' C' ' 35' ' ' PRO . 9.7 mtmp? -84.74 70.03 10.76 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 115.641 -0.709 . . . . 62.24 109.919 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . 0.4 ' HB2' ' HB3' ' C' ' 43' ' ' ALA . 49.4 m -95.22 108.59 39.8 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-O 118.254 -0.879 . . . . 74.14 108.74 175.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -41.35 -53.01 3.33 Favored 'Trans proline' 0 C--N 1.386 2.542 0 C-N-CA 124.457 3.438 . . . . 63.44 115.157 -174.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -65.72 -31.6 72.69 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.302 0.641 . . . . 65.44 111.335 -178.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 43' ' ' ALA . . . . . 0.4 ' HB3' ' HB2' ' C' ' 40' ' ' SER . . . -77.46 -18.93 56.71 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.036 0.534 . . . . 62.05 110.546 176.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 44' ' ' GLU . . . . . 0.452 ' HA ' ' HB3' ' C' ' 47' ' ' PHE . 51.0 mt-10 -89.91 -19.39 24.61 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.797 0.839 . . . . 74.04 109.634 177.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -77.07 -39.82 48.42 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.069 0.947 . . . . 42.53 109.53 168.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 46' ' ' LYS . . . . . 0.531 ' O ' HG12 ' C' ' 50' ' ' ILE . 63.3 mttp -61.35 -48.04 83.11 Favored 'General case' 0 C--N 1.35 0.606 0 CA-C-N 115.094 -0.957 . . . . 72.32 108.847 169.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 47' ' ' PHE . . . . . 0.452 ' HB3' ' HA ' ' C' ' 44' ' ' GLU . 59.5 t80 -64.22 -27.97 69.42 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.179 0.991 . . . . 62.23 110.856 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 48' ' ' LYS . . . . . 0.518 ' HE2' ' HB3' ' C' ' 89' ' ' ASP . 2.9 tptm -62.82 -48.78 77.62 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 108.698 -0.853 . . . . 72.04 108.698 172.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -70.79 -19.68 62.67 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 112.557 0.577 . . . . 72.33 112.557 176.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 50' ' ' ILE . . . . . 0.59 HD12 HD13 ' C' ' 29' ' ' LEU . 23.6 mm -78.75 -34.43 17.39 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 N-CA-C 108.787 -0.82 . . . . 75.43 108.787 174.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 51' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -79.1 -18.23 53.66 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 124.069 0.947 . . . . 74.04 111.276 175.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 52' ' ' GLU . . . . . 0.429 ' O ' HG23 ' C' ' 56' ' ' VAL . 32.6 tt0 -76.18 -50.23 15.09 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.569 -0.9 . . . . 63.42 108.569 170.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . 0.423 ' HA ' ' CD1' ' C' ' 7' ' ' TYR . . . -60.57 -33.38 72.62 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 114.593 -1.185 . . . . 63.1 111.247 176.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 54' ' ' TYR . . . . . 0.458 ' O ' ' HB2' ' C' ' 58' ' ' SER . 20.8 t80 -81.92 -32.9 30.66 Favored 'General case' 0 C--O 1.214 -0.783 0 C-N-CA 123.788 0.835 . . . . 75.01 110.207 176.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.81 -34.37 67.63 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 120.915 0.388 . . . . 60.54 110.247 174.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 56' ' ' VAL . . . . . 0.429 HG23 ' O ' ' C' ' 52' ' ' GLU . 14.8 t -97.61 -24.62 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.26 0 CA-C-N 115.065 -0.97 . . . . 72.43 112.308 -178.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 57' ' ' LEU . . . . . 0.432 ' HB3' HG21 ' C' ' 22' ' ' ILE . 61.9 mt -125.46 29.77 5.94 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 119.242 0.928 . . . . 75.02 112.746 -177.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 58' ' ' SER . . . . . 0.458 ' HB2' ' O ' ' C' ' 54' ' ' TYR . 23.1 t -69.8 -56.44 7.13 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.238 0.542 . . . . 62.42 111.8 175.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -130.05 157.19 77.74 Favored Pre-proline 0 N--CA 1.479 0.981 0 C-N-CA 124.313 1.045 . . . . 72.03 109.303 -171.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 60' ' ' PRO . . . . . 0.558 ' HD3' ' HG2' ' C' ' 19' ' ' GLN . 18.2 Cg_endo -54.26 -21.05 21.42 Favored 'Trans proline' 0 C--N 1.391 2.797 0 C-N-CA 122.921 2.414 . . . . 33.23 112.992 -179.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -51.35 -75.62 0.03 OUTLIER 'General case' 0 CA--C 1.565 1.537 0 C-N-CA 124.554 1.142 . . . . 62.13 110.832 170.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.39 -28.68 67.32 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.592 0.757 . . . . 75.23 111.338 -176.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 10.1 ttp180 -66.14 -44.74 83.31 Favored 'General case' 0 C--N 1.351 0.644 0 N-CA-C 109.496 -0.557 . . . . 64.42 109.496 -177.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -71.0 -29.98 66.1 Favored 'General case' 0 C--N 1.359 1.003 0 O-C-N 123.876 0.735 . . . . 74.15 111.015 178.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 47.5 mm -57.19 -48.55 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 CA-C-O 121.196 0.522 . . . . 62.34 110.049 170.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -67.23 -40.72 86.39 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.773 -0.649 . . . . 74.22 111.012 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -59.42 -45.8 90.52 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 122.95 0.5 . . . . 73.14 110.565 178.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 74.2 p -73.14 -15.72 61.47 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.522 -0.763 . . . . 63.2 111.271 178.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -73.05 116.91 14.14 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 106.948 -1.501 . . . . 75.22 106.948 167.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 111.2 9.5 21.95 Favored Glycine 0 N--CA 1.472 1.073 0 N-CA-C 111.475 -0.65 . . . . 62.51 111.475 -165.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 88.3 m -141.57 -59.01 0.48 Allowed 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 103.755 -2.683 . . . . 72.34 103.755 176.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 34.4 m -73.96 134.16 43.09 Favored 'General case' 0 C--O 1.251 1.164 0 N-CA-C 103.88 -2.637 . . . . 73.35 103.88 155.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.03 -37.45 5.36 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.329 0.652 . . . . 73.23 110.8 -170.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -88.86 150.7 46.17 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 123.992 0.917 . . . . 53.23 109.098 174.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -52.37 117.66 3.85 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 122.838 2.359 . . . . 75.14 111.629 172.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.89 156.75 18.41 Favored 'Trans proline' 0 C--N 1.382 2.325 0 C-N-CA 123.494 2.796 . . . . 63.14 113.745 -176.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -66.53 121.38 8.62 Favored 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 122.209 1.939 . . . . 51.51 111.044 172.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 78' ' ' PRO . . . . . 0.449 ' HB3' ' HA3' ' C' ' 104' ' ' GLY . 32.0 Cg_endo -61.82 135.38 55.58 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 122.886 2.391 . . . . 74.44 113.414 -174.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.22 159.06 54.84 Favored 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 123.001 2.467 . . . . 61.04 112.455 176.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.49 85.9 0.04 OUTLIER 'Trans proline' 0 C--N 1.391 2.815 0 C-N-CA 123.553 2.835 . . . . 51.5 112.873 177.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 159.01 -45.33 0.45 Allowed Glycine 0 C--N 1.341 0.856 0 CA-C-N 114.967 -1.015 . . . . 75.2 111.358 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 111.55 175.23 20.02 Favored Glycine 0 C--N 1.351 1.37 0 C-N-CA 123.514 0.578 . . . . 74.45 112.053 -174.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -83.94 113.24 20.84 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.996 -0.742 . . . . 70.14 108.996 177.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 84' ' ' ASP . . . . . 0.424 ' HA ' ' CZ ' ' C' ' 106' ' ' PHE . 2.0 t70 -63.08 144.87 56.52 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 123.928 0.767 . . . . 63.13 112.639 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 85' ' ' PHE . . . . . 0.529 ' O ' ' HG3' ' C' ' 171' ' ' PRO . 78.3 m-85 -137.31 72.24 1.42 Allowed 'General case' 0 C--O 1.212 -0.88 0 C-N-CA 124.567 1.147 . . . . 74.41 109.348 171.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 50.7 m -47.49 86.61 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 124.31 1.044 . . . . 45.43 112.924 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 67.64 13.13 62.89 Favored Glycine 0 C--N 1.349 1.275 0 CA-C-N 115.513 -0.767 . . . . 74.33 114.611 -178.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 88' ' ' PHE . . . . . 0.493 ' HB2' ' HB3' ' C' ' 85' ' ' PHE . 18.6 m-85 -92.22 128.97 38.26 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 109.081 -0.711 . . . . 74.44 109.081 -177.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 89' ' ' ASP . . . . . 0.518 ' HB3' ' HE2' ' C' ' 48' ' ' LYS . 27.9 t70 -83.69 78.59 9.67 Favored 'General case' 0 C--O 1.246 0.898 0 CA-C-O 121.665 0.745 . . . . 72.23 110.509 -172.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 90' ' ' VAL . . . . . 0.752 HG21 HD21 ' C' ' 169' ' ' ASN . 1.3 p -43.44 -36.43 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.22 0 C-N-CA 125.934 1.694 . . . . 54.41 112.415 172.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -50.21 -36.53 31.16 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.648 1.579 . . . . 74.21 112.891 -178.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -119.26 21.41 12.26 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.524 0.729 . . . . 75.53 111.234 -170.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 21.5 m-30 -94.17 175.49 6.68 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.805 -0.559 . . . . 72.45 111.123 175.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 94' ' ' SER . . . . . 0.408 ' O ' ' HB3' ' C' ' 97' ' ' PHE . 84.5 p -74.4 173.45 10.27 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 113.754 1.02 . . . . 45.51 113.754 -164.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 95' ' ' GLU . . . . . 0.455 ' O ' ' HG3' ' C' ' 99' ' ' GLU . 4.0 mp0 -73.21 -36.52 66.52 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 114.71 -1.132 . . . . 55.43 110.617 178.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -60.57 -42.56 96.88 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-O 121.535 0.683 . . . . 65.02 110.289 173.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 97' ' ' PHE . . . . . 0.72 ' HE2' HG23 ' C' ' 90' ' ' VAL . 48.9 t80 -58.46 -43.4 88.85 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 114.282 -1.326 . . . . 64.25 109.933 174.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -66.56 -29.21 69.24 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 122.664 0.386 . . . . 51.52 111.814 176.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . 0.455 ' HG3' ' O ' ' C' ' 95' ' ' GLU . 45.0 mt-10 -67.21 -56.15 11.09 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 122.752 0.421 . . . . 74.43 110.24 178.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 26.7 tp -75.33 -50.18 16.81 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.392 -0.822 . . . . 73.23 111.802 -172.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -91.66 -20.3 21.75 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.299 0.64 . . . . 73.25 112.555 -173.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -46.46 -58.18 6.07 Favored Glycine 0 CA--C 1.541 1.68 0 CA-C-O 118.933 -0.926 . . . . 54.11 115.107 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -63.43 -3.29 5.04 Favored 'Trans proline' 0 C--N 1.385 2.462 0 C-N-CA 123.186 2.591 . . . . 62.02 114.464 -177.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 104' ' ' GLY . . . . . 0.449 ' HA3' ' HB3' ' C' ' 78' ' ' PRO . . . -137.91 32.53 2.35 Favored Glycine 0 C--N 1.349 1.284 0 CA-C-O 119.953 -0.359 . . . . 43.23 113.14 176.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 105' ' ' LEU . . . . . 0.403 ' HB3' ' ND2' ' C' ' 169' ' ' ASN . 48.3 mt -73.81 71.2 1.47 Allowed 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.019 0.528 . . . . 73.03 111.733 173.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 106' ' ' PHE . . . . . 0.553 ' HB3' ' H ' ' C' ' 168' ' ' GLY . 34.3 m-85 48.41 -109.3 0.3 Allowed 'General case' 0 CA--C 1.56 1.356 0 C-N-CA 125.05 1.34 . . . . 64.24 113.688 177.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . 66.22 6.58 33.8 Favored Glycine 0 C--N 1.369 2.393 0 CA-C-O 119.757 -0.468 . . . . 51.05 114.103 -165.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 56.36 -128.71 46.84 Favored Glycine 0 C--N 1.361 1.929 0 N-CA-C 111.798 -0.521 . . . . 74.41 111.798 -171.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 109' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -107.49 5.61 27.32 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.798 0.839 . . . . 74.45 110.037 168.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 110' ' ' GLY . . . . . . . . . . . . . . . -92.57 -7.93 62.84 Favored Glycine 0 C--N 1.352 1.418 0 O-C-N 123.642 0.588 . . . . 54.22 112.943 -175.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? 57.47 9.2 0.73 Allowed 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 114.246 1.202 . . . . 75.25 114.246 176.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 112' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -55.9 -33.67 64.85 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.628 1.171 . . . . 74.1 111.066 171.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 113' ' ' SER . . . . . . . . . . . . . 20.4 m 55.85 25.67 8.79 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.73 1.212 . . . . 72.53 112.086 175.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 114' ' ' ARG . . . . . 0.422 ' HA ' ' HD2' ' C' ' 114' ' ' ARG . 4.6 tpt180 -137.77 -164.13 1.56 Allowed 'General case' 0 CA--C 1.555 1.138 0 CA-C-O 117.415 -1.279 . . . . 74.05 109.684 -173.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 115' ' ' LYS . . . . . . . . . . . . . 11.1 ttpp -22.5 117.96 0.03 OUTLIER 'General case' 0 N--CA 1.509 2.485 0 N-CA-C 115.946 1.832 . . . . 54.14 115.946 -162.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 116' ' ' GLY . . . . . 0.41 ' HA2' ' HA3' ' C' ' 168' ' ' GLY . . . -77.91 147.72 32.42 Favored Glycine 0 C--N 1.343 0.936 0 CA-C-N 115.197 -0.91 . . . . 45.25 113.182 -177.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 17.1 mtm180 -116.4 171.88 7.56 Favored 'General case' 0 C--O 1.263 1.81 0 CA-C-O 122.369 1.081 . . . . 64.44 111.397 -173.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 118' ' ' ASP . . . . . 0.459 ' HA ' ' O ' ' C' ' 173' ' ' ASP . 3.4 m-20 -61.3 117.95 6.28 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 112.37 -2.195 . . . . 75.42 109.138 170.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 119' ' ' LEU . . . . . 0.637 ' HG ' ' HG2' ' C' ' 167' ' ' GLN . 3.0 tt -92.89 120.72 33.52 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 105.818 -1.919 . . . . 75.21 105.818 -178.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.581 ' HE ' HG21 ' C' ' 177' ' ' VAL . 57.0 ttt180 -117.56 114.19 23.07 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.625 -0.509 . . . . 72.31 109.625 -164.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 121' ' ' ALA . . . . . . . . . . . . . . . -108.66 169.95 8.33 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 122.812 0.445 . . . . 63.21 111.805 -171.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -131.86 114.49 14.74 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 123.88 0.872 . . . . 73.22 109.636 -176.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -140.03 115.43 7.88 Favored Pre-proline 0 N--CA 1.483 1.221 0 CA-C-N 117.992 0.36 . . . . 73.3 111.858 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . 0.412 ' HA ' ' O ' ' C' ' 179' ' ' ARG . 24.6 Cg_exo -66.88 116.03 3.91 Favored 'Trans proline' 0 C--N 1.378 2.098 0 C-N-CA 122.229 1.952 . . . . 72.51 109.486 162.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 125' ' ' LEU . . . . . 0.462 ' O ' ' HA ' ' C' ' 180' ' ' LEU . 14.8 tp -139.58 166.87 23.43 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 107.392 -1.336 . . . . 74.03 107.392 -170.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 126' ' ' THR . . . . . 0.418 ' HB ' HD12 ' C' ' 181' ' ' LEU . 14.2 t -127.01 175.32 8.18 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 119.1 0.864 . . . . 61.53 110.976 175.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 127' ' ' LEU . . . . . 0.458 HD11 ' H ' ' C' ' 185' ' ' VAL . 6.5 mt -59.86 -44.55 94.09 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 126.092 1.757 . . . . 62.25 110.011 -177.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 128' ' ' GLU . . . . . 0.401 ' HG2' ' HB2' ' B' ' 171' ' ' ALA . 1.8 mp0 -58.16 -45.25 87.77 Favored 'General case' 0 C--O 1.213 -0.848 0 CA-C-N 113.694 -1.593 . . . . 75.24 109.586 178.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 129' ' ' GLU . . . . . 0.536 ' HA ' ' HB2' ' C' ' 132' ' ' HIS . 20.0 mm-40 -77.74 -18.0 56.98 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 124.446 1.091 . . . . 73.53 111.659 -178.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 130' ' ' ALA . . . . . 0.486 ' HB1' ' HA2' ' C' ' 152' ' ' GLY . . . -71.86 -36.67 70.18 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.066 -0.716 . . . . 64.34 109.066 174.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 131' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -73.07 -46.71 49.98 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 114.753 -1.112 . . . . 75.55 111.176 167.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 132' ' ' HIS . . . . . 0.536 ' HB2' ' HA ' ' C' ' 129' ' ' GLU . 32.7 m170 -74.79 -7.57 53.81 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 118.998 -0.525 . . . . 60.22 111.24 -172.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -70.28 66.96 0.72 Allowed Glycine 0 C--N 1.354 1.537 0 O-C-N 123.712 0.632 . . . . 65.31 113.482 172.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . -88.45 -139.8 6.88 Favored Glycine 0 C--N 1.348 1.206 0 N-CA-C 109.657 -1.377 . . . . 53.24 109.657 169.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -72.73 93.62 1.67 Allowed 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 108.727 -0.842 . . . . 71.2 108.727 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 136' ' ' ARG . . . . . 0.519 ' HB2' HD22 ' B' ' 181' ' ' LEU . 57.2 mtp180 -141.91 163.11 33.77 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.722 0.809 . . . . 72.12 110.756 -171.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 137' ' ' VAL . . . . . . . . . . . . . 54.2 t -71.33 95.48 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 CA-C-N 115.019 -0.991 . . . . 71.12 110.9 -171.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 138' ' ' VAL . . . . . 0.404 ' HB ' HG13 ' C' ' 145' ' ' VAL . 97.9 t -79.01 112.22 16.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 107.055 -1.461 . . . . 72.14 107.055 165.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 139' ' ' GLU . . . . . . . . . . . . . 53.7 tt0 -121.48 78.44 1.43 Allowed 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 107.567 -1.272 . . . . 74.31 107.567 -167.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 140' ' ' VAL . . . . . 0.481 HG11 HD11 ' C' ' 174' ' ' LEU . 89.3 t -128.1 104.56 12.04 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 CA-C-N 114.31 -1.313 . . . . 63.22 110.755 -166.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 68.14 24.31 7.7 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.979 1.312 . . . . 15.23 113.045 168.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 107.5 -29.48 10.43 Favored Glycine 0 C--N 1.338 0.689 0 N-CA-C 111.273 -0.731 . . . . 45.25 111.273 -176.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 143' ' ' ARG . . . . . 0.443 ' CZ ' ' HB ' ' C' ' 145' ' ' VAL . 14.0 tpt180 -70.37 106.94 3.57 Favored 'General case' 0 C--N 1.363 1.192 0 N-CA-C 108.8 -0.815 . . . . 73.04 108.8 177.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 11.4 ttt-85 -113.83 96.74 6.0 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-N 114.864 -1.062 . . . . 71.51 108.773 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 145' ' ' VAL . . . . . 0.537 HG22 ' HB ' ' C' ' 147' ' ' VAL . 3.1 p -127.71 130.28 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 124.273 1.029 . . . . 75.03 110.085 -175.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 55.5 m -90.76 86.53 6.36 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 108.803 -0.814 . . . . 54.21 108.803 174.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 147' ' ' VAL . . . . . 0.537 ' HB ' HG22 ' C' ' 145' ' ' VAL . 9.7 p -131.51 159.34 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-N 114.981 -1.008 . . . . 72.53 110.473 -170.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 23.1 ttm180 -88.56 104.52 16.91 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 108.392 -0.966 . . . . 74.22 108.392 170.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 149' ' ' ILE . . . . . 0.415 HD12 HD13 ' C' ' 159' ' ' ILE . 30.5 pt -69.74 151.52 96.4 Favored Pre-proline 0 CA--C 1.548 0.88 0 CA-C-O 118.045 -0.979 . . . . 71.41 108.861 166.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 150' ' ' PRO . . . . . 0.498 ' HD2' HG22 ' C' ' 161' ' ' VAL . 34.8 Cg_exo -39.27 108.66 0.08 OUTLIER 'Trans proline' 0 C--N 1.39 2.74 0 C-N-CA 123.547 2.831 . . . . 61.44 112.864 176.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -66.6 122.09 9.45 Favored 'Trans proline' 0 C--N 1.382 2.302 0 C-N-CA 122.537 2.158 . . . . 73.2 111.447 -171.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 152' ' ' GLY . . . . . 0.599 ' HA3' HD23 ' C' ' 188' ' ' LEU . . . 99.47 122.72 4.84 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-N 115.52 -0.764 . . . . 54.32 113.386 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 153' ' ' VAL . . . . . 0.684 HG21 HG21 ' C' ' 178' ' ' VAL . 3.5 m -129.99 176.13 9.23 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 C-N-CA 123.745 0.818 . . . . 71.13 109.487 -174.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 154' ' ' ARG . . . . . 0.482 ' HD2' ' HB2' ' B' ' 217' ' ' LEU . 98.3 mtt180 -133.66 160.05 38.68 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.375 0.67 . . . . 75.32 110.322 177.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 155' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -67.25 103.75 1.32 Allowed 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 124.786 1.234 . . . . 74.51 112.125 -176.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 97.89 -0.79 59.29 Favored Glycine 0 C--N 1.354 1.542 0 CA-C-N 115.583 -0.735 . . . . 64.51 113.163 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 157' ' ' SER . . . . . 0.425 ' HB3' ' HA ' ' B' ' 217' ' ' LEU . 55.6 m -90.39 170.34 10.32 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.082 0.553 . . . . 75.43 111.966 -172.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 158' ' ' VAL . . . . . 0.528 HG12 HG22 ' C' ' 177' ' ' VAL . 28.2 m -104.99 125.77 59.97 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 CA-C-N 115.488 -0.778 . . . . 64.44 111.086 178.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 159' ' ' ILE . . . . . 0.586 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 17.3 mt -76.04 98.66 1.7 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.6 0 N-CA-C 108.082 -1.081 . . . . 52.25 108.082 166.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 160' ' ' ARG . . . . . 0.405 ' HD2' ' OH ' ' B' ' 120' ' ' TYR . 21.6 ttp180 -81.97 101.25 10.18 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.993 0.917 . . . . 72.21 110.012 -178.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 161' ' ' VAL . . . . . 0.549 ' HB ' ' HB3' ' C' ' 174' ' ' LEU . 16.1 t -100.19 112.87 64.92 Favored Pre-proline 0 CA--C 1.551 1.004 0 N-CA-C 107.83 -1.174 . . . . 75.24 107.83 175.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -50.48 99.11 0.04 OUTLIER 'Trans proline' 0 C--N 1.384 2.418 0 C-N-CA 124.034 3.156 . . . . 63.42 114.745 -172.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 67.29 23.6 73.32 Favored Glycine 0 C--N 1.347 1.143 0 N-CA-C 115.73 1.052 . . . . 53.31 115.73 169.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 164' ' ' MET . . . . . . . . . . . . . 43.6 ttp -98.0 18.67 15.47 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 117.582 0.691 . . . . 73.35 109.795 174.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . -74.94 -120.95 0.1 Allowed Glycine 0 C--N 1.357 1.727 0 CA-C-N 115.81 -0.632 . . . . 64.24 112.248 174.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . 153.03 -82.87 0.17 Allowed Glycine 0 C--N 1.35 1.354 0 C-N-CA 119.057 -1.544 . . . . 75.44 114.669 172.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 167' ' ' GLN . . . . . 0.637 ' HG2' ' HG ' ' C' ' 119' ' ' LEU . 26.2 mm-40 -14.99 102.49 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.479 0 C-N-CA 126.294 1.837 . . . . 64.31 113.933 -160.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 168' ' ' GLY . . . . . 0.553 ' H ' ' HB3' ' C' ' 106' ' ' PHE . . . 108.88 145.3 11.22 Favored Glycine 0 CA--C 1.535 1.301 0 N-CA-C 108.996 -1.642 . . . . 13.44 108.996 -161.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 169' ' ' ASN . . . . . 0.752 HD21 HG21 ' C' ' 90' ' ' VAL . 3.1 t-20 -61.42 -59.61 13.02 Favored Pre-proline 0 CA--C 1.576 1.954 0 N-CA-C 114.687 1.365 . . . . 62.44 114.687 -164.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 170' ' ' PRO . . . . . 0.539 ' HD3' ' HB3' ' C' ' 169' ' ' ASN . 7.9 Cg_exo -71.41 104.55 1.59 Allowed 'Trans proline' 0 C--N 1.398 3.142 0 C-N-CA 122.303 2.002 . . . . 51.41 110.693 175.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 171' ' ' PRO . . . . . 0.529 ' HG3' ' O ' ' C' ' 85' ' ' PHE . 58.1 Cg_endo -61.35 126.83 20.25 Favored 'Trans proline' 0 N--CA 1.502 1.972 0 C-N-CA 123.736 2.957 . . . . 74.02 114.688 -161.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -80.49 -167.18 36.09 Favored Glycine 0 C--N 1.354 1.538 0 O-C-N 123.48 0.488 . . . . 74.42 112.269 172.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 173' ' ' ASP . . . . . 0.459 ' O ' ' HA ' ' C' ' 118' ' ' ASP . 13.0 t70 -86.62 155.62 20.35 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 123.54 0.736 . . . . 74.51 110.556 -174.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 174' ' ' LEU . . . . . 0.549 ' HB3' ' HB ' ' C' ' 161' ' ' VAL . 27.7 tp -98.24 114.86 27.26 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 121.496 -0.752 . . . . 75.22 110.198 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 175' ' ' LEU . . . . . 0.445 ' O ' ' HA ' ' C' ' 120' ' ' ARG . 79.6 mt -110.97 91.03 3.5 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.316 0.646 . . . . 71.32 109.867 176.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 176' ' ' LEU . . . . . 0.586 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 62.0 mt -81.02 105.88 12.58 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 109.178 -0.675 . . . . 43.02 109.178 178.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 177' ' ' VAL . . . . . 0.581 HG21 ' HE ' ' C' ' 120' ' ' ARG . 60.3 t -81.51 107.68 13.93 Favored 'Isoleucine or valine' 0 C--O 1.249 1.045 0 CA-C-O 121.901 0.857 . . . . 74.43 108.832 -178.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 178' ' ' VAL . . . . . 0.684 HG21 HG21 ' C' ' 153' ' ' VAL . 4.0 p -93.86 140.41 16.58 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 CA-C-N 114.113 -1.403 . . . . 74.01 110.464 -178.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 179' ' ' ARG . . . . . 0.443 ' HG3' ' H ' ' B' ' 130' ' ' ALA . 50.9 mmm-85 -121.92 111.56 17.22 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 107.402 -1.333 . . . . 72.33 107.402 172.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 180' ' ' LEU . . . . . 0.462 ' HA ' ' O ' ' C' ' 125' ' ' LEU . 84.5 mt -70.52 145.88 50.57 Favored 'General case' 0 C--O 1.237 0.432 0 O-C-N 123.543 0.527 . . . . 70.51 111.299 -175.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 181' ' ' LEU . . . . . 0.418 HD12 ' HB ' ' C' ' 126' ' ' THR . 31.1 mt -60.01 168.53 2.06 Favored Pre-proline 0 CA--C 1.555 1.171 0 C-N-CA 124.914 1.286 . . . . 74.2 111.886 -178.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -42.0 -3.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.395 3.023 0 C-N-CA 124.834 3.69 . . . . 64.12 118.14 174.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 183' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -125.3 83.39 61.16 Favored Pre-proline 0 CA--C 1.569 1.69 0 CA-C-N 118.865 0.757 . . . . 62.13 110.499 166.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 184' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -85.57 69.57 5.18 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 123.671 2.914 . . . . 71.54 110.311 173.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 185' ' ' VAL . . . . . 0.458 ' H ' HD11 ' C' ' 127' ' ' LEU . 4.3 t -90.83 -43.77 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 N-CA-C 109.993 -0.373 . . . . 72.23 109.993 -166.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 186' ' ' PHE . . . . . 0.662 ' HB3' HD22 ' C' ' 193' ' ' LEU . 21.7 m-85 -99.75 113.0 25.21 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.708 0.766 . . . . 61.44 112.151 -170.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 187' ' ' ARG . . . . . 0.66 ' HE ' ' HB3' ' B' ' 222' ' ' ALA . 36.0 ttm180 -96.98 101.23 12.76 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 107.257 -1.386 . . . . 75.14 107.257 171.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 188' ' ' LEU . . . . . 0.599 HD23 ' HA3' ' C' ' 152' ' ' GLY . 41.1 tp -93.88 144.73 25.18 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 112.856 0.687 . . . . 74.14 112.856 -171.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -131.42 111.02 11.45 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 107.242 -1.392 . . . . 71.33 107.242 159.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 70.32 -86.37 0.33 Allowed Glycine 0 C--N 1.351 1.362 0 O-C-N 123.704 0.627 . . . . 74.2 113.141 177.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 191' ' ' GLN . . . . . 0.578 ' HA ' ' HB2' ' C' ' 240' ' ' PHE . 20.7 mt-30 -132.51 -10.76 3.18 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.289 0.636 . . . . 60.21 112.028 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -104.66 121.58 43.85 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 121.303 0.573 . . . . 65.13 110.839 -177.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 193' ' ' LEU . . . . . 0.662 HD22 ' HB3' ' C' ' 186' ' ' PHE . 56.7 mt -90.87 153.15 20.42 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.353 1.461 . . . . 52.2 111.034 -177.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 194' ' ' TYR . . . . . 0.493 ' HB3' ' HB3' ' C' ' 187' ' ' ARG . 46.7 t80 -112.05 148.79 33.13 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 106.983 -1.488 . . . . 75.43 106.983 162.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 195' ' ' ALA . . . . . 0.4 ' HA ' ' O ' ' C' ' 185' ' ' VAL . . . -154.66 -175.24 5.32 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.253 0.621 . . . . 65.11 110.946 -177.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 58.3 m -130.74 145.9 52.07 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.072 0.949 . . . . 51.32 108.813 168.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 197' ' ' LEU . . . . . . . . . . . . . 36.3 tp -127.4 113.64 16.48 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.359 1.064 . . . . 73.5 108.861 -176.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 198' ' ' ASP . . . . . 0.47 ' HB3' HG21 ' C' ' 256' ' ' THR . 19.9 m-20 -86.11 101.76 13.26 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 109.778 -0.453 . . . . 44.52 109.778 -178.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 199' ' ' VAL . . . . . 0.553 ' HA ' HG11 ' C' ' 210' ' ' VAL . 88.8 t -105.58 123.22 40.13 Favored Pre-proline 0 N--CA 1.474 0.747 0 C-N-CA 123.775 0.83 . . . . 61.21 109.13 177.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 200' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.88 148.03 56.91 Favored 'Trans proline' 0 C--N 1.369 1.655 0 C-N-CA 121.896 1.731 . . . . 71.34 110.929 176.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 201' ' ' ALA . . . . . . . . . . . . . . . -55.0 -43.59 99.14 Favored Pre-proline 0 CA--C 1.553 1.069 0 N-CA-C 114.174 1.176 . . . . 74.35 114.174 -175.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 202' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -54.38 -52.78 7.44 Favored 'Trans proline' 0 C--N 1.394 2.971 0 C-N-CA 121.733 1.622 . . . . 63.15 112.666 175.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 203' ' ' ILE . . . . . . . . . . . . . 44.6 mt -65.18 -31.04 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 124.089 0.956 . . . . 63.4 111.269 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.34 -43.26 81.99 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.736 0.814 . . . . 75.02 111.817 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 205' ' ' VAL . . . . . . . . . . . . . 87.4 t -72.62 -47.81 49.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 115.866 -0.606 . . . . 63.41 111.22 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 206' ' ' VAL . . . . . 0.465 HG23 ' HE2' ' A' ' 270' ' ' LYS . 11.5 p -80.96 -34.12 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 112.842 0.682 . . . . 52.12 112.842 -171.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 89.86 111.77 1.4 Allowed Glycine 0 CA--C 1.531 1.04 0 N-CA-C 111.623 -0.591 . . . . 63.21 111.623 -169.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -153.24 -121.46 0.85 Allowed Glycine 0 C--N 1.348 1.217 0 CA-C-O 119.606 -0.552 . . . . 51.32 111.76 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 209' ' ' LYS . . . . . . . . . . . . . 31.7 mtmt -151.81 153.09 33.57 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.672 0.789 . . . . 72.12 111.6 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 210' ' ' VAL . . . . . 0.553 HG11 ' HA ' ' C' ' 199' ' ' VAL . 29.3 m -139.97 178.06 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 126.764 2.026 . . . . 62.05 108.393 174.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 211' ' ' ARG . . . . . 0.735 HH22 ' HB2' ' B' ' 233' ' ' PHE . 0.0 OUTLIER -111.84 147.93 34.7 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.018 0.527 . . . . 72.44 111.296 177.213 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -127.18 121.29 30.91 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 107.369 -1.345 . . . . 74.43 107.369 164.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 213' ' ' MET . . . . . 0.546 ' HG2' ' HB3' ' B' ' 172' ' ' GLU . 1.4 tmm? -76.02 112.99 13.03 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 108.281 -1.007 . . . . 63.12 108.281 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 214' ' ' THR . . . . . 0.423 HG22 ' H ' ' C' ' 215' ' ' LEU . 0.2 OUTLIER -117.99 175.39 5.69 Favored 'General case' 0 N--CA 1.485 1.325 0 CA-C-N 118.86 0.755 . . . . 54.24 111.962 -173.373 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 215' ' ' LEU . . . . . 0.423 ' H ' HG22 ' C' ' 214' ' ' THR . 35.7 mt -73.82 -33.49 64.18 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.247 1.419 . . . . 44.41 112.384 -171.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -83.41 -4.65 58.69 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 115.262 -0.881 . . . . 71.0 110.647 175.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 132.09 173.22 13.26 Favored Glycine 0 C--N 1.342 0.878 0 N-CA-C 110.898 -0.881 . . . . 64.11 110.898 -175.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 218' ' ' PRO . . . . . 0.429 ' HB2' ' NE ' ' C' ' 211' ' ' ARG . 93.5 Cg_endo -75.56 113.22 3.7 Favored 'Trans proline' 0 CA--C 1.55 1.316 0 C-N-CA 122.253 1.969 . . . . 52.13 112.0 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 219' ' ' VAL . . . . . . . . . . . . . 14.6 p -89.03 152.3 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 108.034 -1.099 . . . . 52.53 108.034 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 220' ' ' GLU . . . . . 0.412 ' HB3' ' CG ' ' B' ' 235' ' ' GLU . 18.1 tt0 -111.57 107.69 16.93 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.194 -1.039 . . . . 72.32 108.194 176.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 221' ' ' VAL . . . . . 0.429 HG22 HD11 ' C' ' 235' ' ' LEU . 53.9 t -75.86 129.08 37.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 114.281 -1.327 . . . . 74.03 111.415 -174.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -77.95 138.07 38.66 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.016 0.436 . . . . 73.3 110.507 169.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 57.5 t -118.25 124.17 28.82 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 124.066 0.946 . . . . 73.11 108.916 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 224' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -76.47 162.41 33.37 Favored 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 123.065 2.51 . . . . 54.33 111.067 169.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 225' ' ' PRO . . . . . 0.566 ' HG2' HD13 ' B' ' 247' ' ' LEU . 41.7 Cg_exo -60.71 156.14 44.52 Favored 'Trans proline' 0 C--N 1.369 1.632 0 C-N-CA 122.526 2.151 . . . . 74.0 113.333 176.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 226' ' ' ARG . . . . . 0.468 ' HD2' ' O ' ' A' ' 259' ' ' GLU . 11.8 mmt180 59.59 63.52 1.5 Allowed 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 125.269 1.428 . . . . 70.15 111.764 176.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 227' ' ' THR . . . . . . . . . . . . . 57.8 m -100.33 132.28 45.79 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.644 0.777 . . . . 70.3 111.51 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 228' ' ' GLN . . . . . 0.478 ' NE2' ' HG3' ' A' ' 259' ' ' GLU . 26.7 mp0 -111.17 150.6 29.27 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 124.562 1.145 . . . . 74.32 112.376 -179.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 229' ' ' ALA . . . . . 0.457 ' HB2' ' H ' ' C' ' 255' ' ' ILE . . . -75.1 118.85 18.49 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 114.551 -1.204 . . . . 62.12 109.606 177.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 116.58 -1.35 20.24 Favored Glycine 0 C--N 1.339 0.747 0 O-C-N 123.688 0.617 . . . . 62.04 112.287 -176.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 231' ' ' ARG . . . . . 0.564 ' HD3' ' HZ3' ' B' ' 242' ' ' TRP . 32.4 mtt180 -66.42 172.99 3.55 Favored 'General case' 0 C--N 1.355 0.819 0 CA-C-O 120.843 0.354 . . . . 74.12 110.691 167.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 232' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' C' ' 251' ' ' LEU . 3.6 ttmp? -142.88 146.29 33.94 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 109.582 -0.525 . . . . 71.45 109.582 175.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 233' ' ' LEU . . . . . 0.425 ' O ' ' HA ' ' C' ' 250' ' ' TYR . 3.5 tt -132.91 125.36 29.72 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.726 0.811 . . . . 74.21 108.838 -168.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 35.5 ttp180 -92.31 104.25 16.62 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.776 0.322 . . . . 72.34 110.397 170.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 235' ' ' LEU . . . . . 0.483 HD12 HD23 ' C' ' 249' ' ' LEU . 72.2 mt -81.56 116.41 21.31 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 107.903 -1.147 . . . . 73.43 107.903 164.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -80.27 134.08 36.05 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 123.328 0.651 . . . . 71.55 110.963 -176.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 70.9 26.97 73.02 Favored Glycine 0 C--N 1.349 1.269 0 O-C-N 123.933 0.77 . . . . 71.42 113.235 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 21.7 mmtm -120.62 12.15 11.42 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.958 0.903 . . . . 72.03 111.515 -177.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -90.44 -133.1 5.29 Favored Glycine 0 C--N 1.343 0.966 0 N-CA-C 111.316 -0.714 . . . . 31.21 111.316 172.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 240' ' ' PHE . . . . . 0.578 ' HB2' ' HA ' ' C' ' 191' ' ' GLN . 3.5 m-85 -97.35 118.49 64.42 Favored Pre-proline 0 C--O 1.237 0.436 0 C-N-CA 123.068 0.547 . . . . 75.14 109.907 174.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 241' ' ' PRO . . . . . 0.515 ' HA ' ' HA ' ' C' ' 246' ' ' ARG . 87.4 Cg_exo -50.94 103.88 0.07 OUTLIER 'Trans proline' 0 C--N 1.365 1.432 0 C-N-CA 123.557 2.838 . . . . 70.21 113.069 166.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -77.42 174.0 54.79 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-N 114.707 -1.133 . . . . 70.14 112.974 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -66.82 -11.08 30.61 Favored 'Trans proline' 0 C--N 1.368 1.559 0 C-N-CA 123.123 2.549 . . . . 71.42 114.038 -171.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -137.29 1.72 2.44 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.687 0.795 . . . . 71.42 111.735 179.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . -171.75 -138.38 2.54 Favored Glycine 0 C--N 1.348 1.238 0 CA-C-O 119.706 -0.497 . . . . 51.32 112.949 -177.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 246' ' ' ARG . . . . . 0.515 ' HA ' ' HA ' ' C' ' 241' ' ' PRO . 85.5 mtm180 -148.44 160.87 42.62 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.845 0.858 . . . . 61.31 111.004 -178.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 247' ' ' GLY . . . . . 0.506 ' HA2' ' HA2' ' B' ' 36' ' ' GLY . . . -96.46 -169.3 34.32 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 114.879 -1.055 . . . . 63.23 112.173 173.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -126.33 169.94 12.41 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.104 0.562 . . . . 73.54 110.495 -173.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 249' ' ' LEU . . . . . 0.483 HD23 HD12 ' C' ' 235' ' ' LEU . 17.6 tp -129.25 127.14 40.63 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.945 0.898 . . . . 74.23 109.38 -176.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 250' ' ' TYR . . . . . 0.425 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 89.5 m-85 -117.06 101.17 8.26 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.695 0.798 . . . . 71.43 110.141 -178.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 251' ' ' LEU . . . . . 0.447 ' O ' ' HA ' ' C' ' 232' ' ' LYS . 0.9 OUTLIER -99.23 129.76 45.48 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 119.286 -0.388 . . . . 64.53 110.113 -176.039 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -73.11 108.45 6.0 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.076 -1.083 . . . . 73.41 108.076 166.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 253' ' ' VAL . . . . . 0.43 HG11 ' HH2' ' B' ' 242' ' ' TRP . 46.7 t -78.79 110.69 14.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.732 -0.667 . . . . 73.5 109.977 -176.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 254' ' ' ARG . . . . . . . . . . . . . 41.0 mtm180 -94.06 159.01 15.35 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.498 0.719 . . . . 74.13 111.321 175.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 255' ' ' ILE . . . . . 0.457 ' H ' ' HB2' ' C' ' 229' ' ' ALA . 35.4 mm -105.82 127.23 60.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 114.235 -1.348 . . . . 75.24 107.983 169.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 256' ' ' THR . . . . . 0.47 HG21 ' HB3' ' C' ' 198' ' ' ASP . 0.3 OUTLIER -133.49 172.82 12.21 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.917 1.287 . . . . 53.32 108.775 -177.685 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 35.1 pt -127.02 145.55 54.4 Favored Pre-proline 0 N--CA 1.481 1.099 0 C-N-CA 123.434 0.694 . . . . 64.54 110.109 -178.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -63.33 -11.83 27.52 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.698 2.266 . . . . 73.21 113.72 -173.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 53.32 -67.25 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.961 1.704 . . . . 72.3 112.64 -165.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 8.1 ppt_? -59.77 133.65 56.29 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.33 0.652 . . . . 73.41 110.351 174.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 261' ' ' LEU . . . . . 0.556 HD22 ' HB3' ' C' ' 265' ' ' GLU . 91.2 mt -143.34 161.75 37.52 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.73 0.812 . . . . 71.21 110.488 -173.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 63.4 p -91.18 165.56 21.17 Favored Pre-proline 0 CA--C 1.55 0.954 0 N-CA-C 108.62 -0.882 . . . . 61.23 108.62 167.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -48.92 -42.13 38.37 Favored 'Trans proline' 0 C--N 1.381 2.281 0 C-N-CA 122.293 1.996 . . . . 74.2 111.988 169.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -64.18 -58.13 7.5 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 114.202 -1.363 . . . . 71.04 111.244 -178.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 265' ' ' GLU . . . . . 0.556 ' HB3' HD22 ' C' ' 261' ' ' LEU . 0.5 OUTLIER -48.85 -58.37 4.93 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.877 0.871 . . . . 65.11 110.924 177.793 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 266' ' ' GLU . . . . . 0.544 ' O ' ' HG2' ' C' ' 270' ' ' LYS . 33.6 tt0 -58.36 -39.49 79.67 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 124.17 0.919 . . . . 64.21 110.939 -175.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -60.2 -44.13 95.36 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.712 0.805 . . . . 70.32 112.408 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 268' ' ' LEU . . . . . . . . . . . . . 11.1 mp -65.65 -40.71 92.78 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 116.709 -0.223 . . . . 52.44 110.745 176.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -59.81 -36.37 76.62 Favored 'General case' 0 N--CA 1.483 1.177 0 O-C-N 123.558 0.536 . . . . 61.11 110.946 174.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 270' ' ' LYS . . . . . 0.544 ' HG2' ' O ' ' C' ' 266' ' ' GLU . 30.5 mmtp -63.9 -46.92 82.68 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.684 0.794 . . . . 75.43 110.368 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -61.68 -45.06 95.6 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.55 0.74 . . . . 75.33 111.708 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 92.7 mt -62.0 -43.75 98.18 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.236 -0.893 . . . . 74.33 110.315 177.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -59.39 -41.21 88.87 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.558 -0.746 . . . . 34.13 110.695 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -69.31 -31.91 70.69 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.185 0.594 . . . . 63.21 111.595 177.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -62.44 -31.95 72.74 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 122.531 0.332 . . . . 70.04 110.473 171.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 276' ' ' TYR . . . . . 0.563 ' HE1' ' HG2' ' A' ' 202' ' ' PRO . 79.2 m-85 -77.35 -34.56 55.15 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 122.887 0.475 . . . . 75.52 112.207 171.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 15.2 m-30 -66.27 -27.48 67.97 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.797 -0.446 . . . . 44.24 109.797 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -65.53 -1.96 3.01 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 124.413 1.085 . . . . 55.2 113.244 175.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 279' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -72.84 -22.89 60.72 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 122.697 0.399 . . . . 71.52 110.917 171.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.077 0 C-N-CA 123.581 0.752 . . . . 75.14 110.154 178.829 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.8 mtt . . . . . 0 N--CA 1.477 0.916 0 N-CA-C 107.625 -1.25 . . . . 64.12 107.625 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 69.12 -9.01 0.63 Allowed 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 125.092 1.357 . . . . 51.4 113.234 -176.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -90.18 64.53 6.13 Favored 'General case' 0 C--N 1.351 0.666 0 C-N-CA 123.843 0.857 . . . . 74.04 109.974 -174.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -41.46 107.67 0.08 Allowed 'General case' 0 C--N 1.352 0.7 0 N-CA-C 113.474 0.916 . . . . 62.43 113.474 172.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -70.74 88.92 0.73 Allowed 'General case' 0 C--O 1.241 0.62 0 N-CA-C 107.584 -1.265 . . . . 74.32 107.584 162.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.466 ' HA ' ' OH ' ' A' ' 66' ' ' TYR . 34.7 t70 -75.45 93.81 3.02 Favored 'General case' 0 C--N 1.354 0.782 0 N-CA-C 107.511 -1.292 . . . . 61.41 107.511 173.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.615 ' HB2' HD11 ' A' ' 57' ' ' LEU . 50.7 m-85 -60.17 -28.61 68.07 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 113.783 -1.553 . . . . 73.34 111.836 -169.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.429 ' CD1' HD11 ' A' ' 22' ' ' ILE . 50.3 m-85 -65.47 -47.63 75.45 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.035 0.534 . . . . 73.33 110.454 177.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.5 -38.69 91.9 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.871 -0.604 . . . . 60.32 111.427 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 69.6 mt -60.45 -38.98 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 123.733 0.646 . . . . 74.23 110.107 174.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.467 ' HB3' ' HB1' ' A' ' 25' ' ' ALA . 93.7 mt -86.31 2.81 45.98 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 115.36 -0.836 . . . . 51.33 112.505 178.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 63.83 18.23 61.65 Favored Glycine 0 C--N 1.356 1.64 0 N-CA-C 114.771 0.668 . . . . 53.33 114.771 177.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.6 m -107.48 155.35 39.75 Favored Pre-proline 0 N--CA 1.482 1.167 0 C-N-CA 124.389 1.075 . . . . 71.43 110.076 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.88 154.88 30.1 Favored 'Trans proline' 0 C--N 1.383 2.356 0 C-N-CA 123.0 2.466 . . . . 50.12 113.106 177.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 55.7 mtp180 -76.39 13.75 0.89 Allowed 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 112.763 0.653 . . . . 75.43 112.763 -173.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -119.96 -5.41 10.07 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 125.141 1.376 . . . . 64.11 109.402 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.465 ' HB1' ' HB2' ' A' ' 21' ' ' GLU . . . -58.34 127.28 31.35 Favored 'General case' 0 C--N 1.347 0.477 0 C-N-CA 124.75 1.22 . . . . 64.31 111.51 -175.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.563 ' HA ' HH21 ' A' ' 63' ' ' ARG . 79.8 p -84.17 177.05 8.37 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 122.881 0.473 . . . . 71.11 110.658 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -46.71 -32.65 3.72 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 124.982 1.313 . . . . 64.21 113.292 -175.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -81.59 -30.06 33.11 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 112.264 0.468 . . . . 72.43 112.264 -173.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.465 ' HB2' ' HB1' ' A' ' 17' ' ' ALA . 2.5 mp0 -72.92 -33.67 66.12 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 109.601 -0.518 . . . . 64.03 109.601 170.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.499 HG21 ' HB2' ' A' ' 57' ' ' LEU . 1.7 mp -67.29 -33.72 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.738 0.815 . . . . 73.31 110.265 173.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.416 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 4.6 tppp? -64.28 -53.5 47.96 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.824 0.85 . . . . 71.24 109.717 176.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -59.12 -44.43 92.01 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 124.166 0.916 . . . . 54.12 110.935 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.467 ' HB1' ' HB3' ' A' ' 11' ' ' LEU . . . -66.7 -35.54 80.37 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.792 0.837 . . . . 64.0 111.849 -177.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -64.12 -50.49 68.04 Favored 'General case' 0 C--O 1.215 -0.711 0 CA-C-N 115.403 -0.817 . . . . 73.1 109.784 175.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.416 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 54.8 mtpt -59.07 -42.82 91.27 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 123.947 0.779 . . . . 74.22 110.737 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.0 ttt180 -53.25 -55.55 23.6 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.283 1.433 . . . . 71.15 110.728 176.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.752 ' HB3' HD13 ' A' ' 50' ' ' ILE . 95.5 mt -79.28 -15.63 57.68 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.603 -0.726 . . . . 74.11 111.793 -176.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.21 -18.78 38.06 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.55 0.74 . . . . 63.3 110.595 175.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -86.07 -45.86 11.02 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 122.977 0.511 . . . . 72.33 110.37 169.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -63.86 -57.65 9.2 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.006 0.522 . . . . 63.33 110.434 -177.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -97.35 38.56 1.25 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.556 0.742 . . . . 63.25 110.025 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 7.7 t-160 -63.94 103.58 0.43 Allowed Pre-proline 0 C--N 1.354 0.782 0 C-N-CA 123.769 0.828 . . . . 63.41 109.478 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -68.38 -14.46 40.15 Favored 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 122.534 2.156 . . . . 74.13 112.86 -167.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -67.85 -39.93 83.75 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.502 1.121 . . . . 72.45 111.305 173.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 96.5 t -96.58 -51.18 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 123.291 0.636 . . . . 65.53 110.08 -177.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -102.16 89.86 3.74 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.174 0.989 . . . . 61.35 110.898 -176.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.22 44.83 1.17 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.426 0.69 . . . . 73.11 110.58 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 74.0 m -89.72 130.48 42.93 Favored Pre-proline 0 N--CA 1.474 0.766 0 CA-C-O 117.918 -1.039 . . . . 54.41 108.447 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -38.61 -70.35 0.07 OUTLIER 'Trans proline' 0 C--N 1.392 2.836 0 C-N-CA 124.76 3.64 . . . . 72.23 114.334 -172.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.483 ' HA ' ' HB2' ' A' ' 45' ' ' GLU . 30.9 tt0 -75.81 -7.21 53.89 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 116.61 -0.268 . . . . 64.43 111.642 -174.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.37 -35.62 68.53 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 108.929 -0.767 . . . . 72.14 108.929 172.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -86.56 -30.51 21.83 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-N 115.874 -0.603 . . . . 62.01 109.95 -178.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.514 ' HA ' ' HZ2' ' A' ' 48' ' ' LYS . 41.2 mt-10 -67.17 -46.49 73.83 Favored 'General case' 0 C--O 1.244 0.792 0 C-N-CA 123.339 0.656 . . . . 62.44 110.285 174.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 32.3 mmtm -61.19 -39.38 89.97 Favored 'General case' 0 C--O 1.214 -0.785 0 CA-C-N 115.633 -0.712 . . . . 74.03 110.383 171.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.457 ' HA ' HD12 ' A' ' 50' ' ' ILE . 85.2 t80 -58.46 -36.69 74.09 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 123.376 0.423 . . . . 73.24 111.179 176.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.514 ' HZ2' ' HA ' ' A' ' 45' ' ' GLU . 10.5 mtmp? -69.68 -32.81 71.65 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.009 0.523 . . . . 75.14 111.607 175.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -77.59 -22.65 50.55 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 122.603 0.361 . . . . 71.44 111.873 175.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.752 HD13 ' HB3' ' A' ' 29' ' ' LEU . 60.3 mt -77.82 -34.02 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 124.321 1.048 . . . . 70.53 108.737 172.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -64.89 -39.65 93.87 Favored 'General case' 0 C--O 1.218 -0.582 0 CA-C-N 114.817 -1.083 . . . . 73.43 109.641 171.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -61.04 -51.27 69.9 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.349 1.06 . . . . 63.42 110.603 176.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.18 -55.81 27.03 Favored 'General case' 0 C--O 1.255 1.395 0 CA-C-N 114.465 -1.243 . . . . 65.45 112.105 -178.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -65.01 -38.48 91.05 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.069 -0.968 . . . . 72.32 110.978 178.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.549 ' HB1' ' HD2' ' A' ' 85' ' ' PHE . . . -54.0 -50.07 67.44 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.334 0.654 . . . . 53.01 111.399 -178.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 70.9 t -62.71 -53.15 50.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 CA-C-N 114.706 -1.134 . . . . 74.52 110.74 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.615 HD11 ' HB2' ' A' ' 7' ' ' TYR . 55.1 mt -90.76 6.77 42.8 Favored 'General case' 0 CA--C 1.559 1.318 0 N-CA-C 113.796 1.036 . . . . 62.04 113.796 -168.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.6 t -78.4 -54.15 6.5 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.202 0.601 . . . . 74.34 110.539 176.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -75.89 131.23 76.66 Favored Pre-proline 0 C--O 1.236 0.373 0 CA-C-N 115.322 -0.853 . . . . 74.34 109.393 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.427 ' O ' ' HG2' ' A' ' 64' ' ' ARG . 22.9 Cg_endo -58.35 -32.62 96.51 Favored 'Trans proline' 0 C--N 1.385 2.491 0 C-N-CA 123.201 2.601 . . . . 72.41 112.344 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -66.45 -51.56 55.56 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.557 0.743 . . . . 72.3 110.878 -178.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 36.5 mtpt -73.74 -26.67 60.79 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.042 0.937 . . . . 74.54 111.669 -177.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.563 HH21 ' HA ' ' A' ' 18' ' ' THR . 42.6 tpt85 -59.28 -53.64 55.99 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.959 0.904 . . . . 74.11 108.925 168.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.482 ' HE ' ' HA ' ' A' ' 64' ' ' ARG . 2.4 mmp_? -61.92 -31.89 72.25 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 124.163 0.914 . . . . 74.25 111.611 178.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 64.2 mt -60.16 -47.77 90.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.16 0.584 . . . . 64.42 110.373 174.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.466 ' OH ' ' HA ' ' A' ' 6' ' ' ASP . 21.3 t80 -60.26 -48.14 83.02 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 116.037 -0.529 . . . . 75.4 110.14 177.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -54.06 -47.89 71.18 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.044 0.537 . . . . 64.04 111.546 178.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 72.2 p -72.54 -17.78 61.69 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.799 -0.637 . . . . 75.13 111.824 -177.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -74.84 107.34 6.86 Favored 'General case' 0 C--N 1.361 1.079 0 N-CA-C 107.808 -1.182 . . . . 63.45 107.808 170.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 119.71 10.76 7.53 Favored Glycine 0 N--CA 1.469 0.874 0 N-CA-C 111.744 -0.543 . . . . 52.54 111.744 -167.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 90.6 m -145.13 -56.62 0.33 Allowed 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 105.11 -2.181 . . . . 71.23 105.11 177.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 22.0 m -88.0 143.73 26.93 Favored 'General case' 0 C--O 1.251 1.157 0 N-CA-C 104.421 -2.437 . . . . 74.23 104.421 156.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.22 -31.06 9.29 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.288 0.635 . . . . 74.04 110.728 -178.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -83.85 150.63 59.37 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 123.371 0.669 . . . . 75.1 109.483 173.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.442 ' HG2' ' HG2' ' A' ' 103' ' ' PRO . 55.7 Cg_exo -56.87 135.94 73.63 Favored 'Trans proline' 0 C--N 1.371 1.733 0 C-N-CA 122.864 2.376 . . . . 75.41 112.946 175.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.01 162.98 39.46 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 123.612 2.875 . . . . 74.25 112.801 178.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -50.42 115.62 2.03 Favored 'Trans proline' 0 C--N 1.385 2.449 0 C-N-CA 123.444 2.762 . . . . 62.44 113.678 176.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -68.97 134.17 28.95 Favored 'Trans proline' 0 C--N 1.381 2.251 0 C-N-CA 122.568 2.179 . . . . 43.51 111.895 177.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -61.41 154.46 58.73 Favored 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 122.883 2.388 . . . . 71.05 112.656 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.57 87.8 0.05 OUTLIER 'Trans proline' 0 C--N 1.382 2.326 0 C-N-CA 123.375 2.716 . . . . 51.35 112.943 178.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 148.28 -39.89 0.96 Allowed Glycine 0 N--CA 1.463 0.443 0 N-CA-C 109.492 -1.443 . . . . 62.41 109.492 179.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 117.28 -165.62 12.48 Favored Glycine 0 C--N 1.345 1.068 0 CA-C-N 114.607 -0.796 . . . . 53.03 111.991 178.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -90.99 106.09 18.28 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.629 0.772 . . . . 74.41 108.942 178.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -78.14 149.05 33.86 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.454 0.702 . . . . 71.31 111.725 177.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.549 ' HD2' ' HB1' ' A' ' 55' ' ' ALA . 75.9 m-85 -134.61 75.04 1.56 Allowed 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.311 1.044 . . . . 70.22 110.006 -176.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.9 m -49.72 85.59 0.0 OUTLIER 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 125.688 1.595 . . . . 74.44 113.479 -179.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 86.18 12.04 71.46 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-O 119.573 -0.57 . . . . 70.11 114.172 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.616 ' HB3' ' HZ ' ' A' ' 93' ' ' PHE . 45.9 m-85 -119.75 117.45 28.27 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 117.883 0.841 . . . . 72.34 110.334 -174.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -73.77 87.48 1.73 Allowed 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 121.528 0.68 . . . . 71.44 110.391 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.63 HG12 ' HD3' ' A' ' 171' ' ' PRO . 6.0 p -49.45 -32.16 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 125.51 1.524 . . . . 75.21 113.378 173.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -56.2 -24.22 40.5 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.45 1.1 . . . . 75.33 111.847 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -86.1 -30.63 22.41 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.932 0.893 . . . . 45.35 112.483 -178.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.616 ' HZ ' ' HB3' ' A' ' 88' ' ' PHE . 10.3 m-30 -65.75 153.27 42.25 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 112.903 0.705 . . . . 71.01 112.903 -165.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 84.8 p -64.74 171.1 3.59 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 115.667 1.729 . . . . 74.5 115.667 -165.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.56 -42.4 82.97 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 114.46 -1.246 . . . . 74.31 112.725 177.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -57.14 -46.02 83.06 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.984 0.914 . . . . 75.03 109.592 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.429 ' CE2' HG23 ' A' ' 90' ' ' VAL . 48.9 t80 -62.46 -43.52 98.61 Favored 'General case' 0 CA--C 1.553 1.084 0 CA-C-N 113.631 -1.622 . . . . 63.23 110.468 177.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -69.26 -13.21 62.27 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.064 0.546 . . . . 73.05 111.64 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -92.59 -30.8 15.44 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.238 0.615 . . . . 70.02 111.408 170.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 25.1 tp -82.25 -63.38 1.39 Allowed 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.491 0.716 . . . . 55.03 111.412 -177.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -93.77 -6.89 45.0 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.7 0.8 . . . . 72.11 112.727 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -43.74 -56.04 5.19 Favored Glycine 0 CA--C 1.545 1.964 0 N-CA-C 116.315 1.286 . . . . 72.43 116.315 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.442 ' HG2' ' HG2' ' A' ' 75' ' ' PRO . 33.4 Cg_exo -63.14 -3.67 5.25 Favored 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 123.625 2.884 . . . . 23.1 115.367 -176.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -139.42 26.96 2.65 Favored Glycine 0 C--N 1.352 1.468 0 CA-C-O 119.159 -0.801 . . . . 44.4 112.968 175.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.583 ' HB3' ' ND2' ' A' ' 169' ' ' ASN . 23.2 mt -65.38 81.07 0.05 Allowed 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 117.583 0.692 . . . . 74.25 111.708 176.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 43.62 -108.73 0.13 Allowed 'General case' 0 CA--C 1.56 1.327 0 C-N-CA 126.274 1.83 . . . . 72.25 113.072 -178.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' A' ' 113' ' ' SER . . . 74.1 5.63 71.57 Favored Glycine 0 C--N 1.368 2.314 0 CA-C-O 118.979 -0.9 . . . . 44.0 114.271 -174.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.689 ' HA3' ' HB3' ' A' ' 167' ' ' GLN . . . -13.08 -70.15 0.01 OUTLIER Glycine 0 C--N 1.37 2.422 0 C-N-CA 125.781 1.658 . . . . 71.34 115.905 168.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -85.1 65.58 9.31 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.738 0.815 . . . . 64.11 109.741 172.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -10.62 -75.72 0.01 OUTLIER Glycine 0 C--N 1.369 2.37 0 C-N-CA 126.888 2.185 . . . . 55.25 116.914 169.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 24.4 ttp180 -7.05 -43.64 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.604 0 N-CA-C 116.837 2.162 . . . . 71.44 116.837 166.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 51.6 ttp180 -124.28 -36.14 2.7 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.279 1.032 . . . . 73.25 110.289 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.425 ' HA ' ' HA2' ' A' ' 107' ' ' GLY . 75.6 m 65.75 -11.42 0.19 Allowed 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 125.398 1.479 . . . . 74.21 114.81 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 59.3 ttt180 -109.35 -136.23 0.36 Allowed 'General case' 0 CA--C 1.558 1.265 0 CA-C-O 117.776 -1.107 . . . . 74.52 109.287 -171.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -49.7 128.97 19.02 Favored 'General case' 0 C--N 1.367 1.334 0 C-N-CA 124.666 1.187 . . . . 72.15 113.32 -164.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -89.63 176.48 43.0 Favored Glycine 0 CA--C 1.541 1.712 0 O-C-N 123.691 0.619 . . . . 55.22 113.013 175.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.739 ' H ' ' HA3' ' A' ' 166' ' ' GLY . 0.0 OUTLIER -116.24 175.79 5.39 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.451 1.1 . . . . 71.34 111.211 179.537 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -86.84 95.93 10.03 Favored 'General case' 0 CA--C 1.565 1.521 0 CA-C-O 122.035 0.921 . . . . 74.23 111.025 178.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 9.2 tt -100.89 150.62 22.65 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.671 1.189 . . . . 70.23 109.3 -178.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -98.37 138.75 35.15 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.54 0.736 . . . . 74.51 111.376 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.552 ' HB2' HD11 ' A' ' 174' ' ' LEU . . . -128.74 170.5 13.23 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.939 0.895 . . . . 41.51 109.85 170.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -122.21 114.72 21.23 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 106.402 -1.703 . . . . 61.0 106.402 -178.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 53.4 tp -99.25 101.46 12.89 Favored Pre-proline 0 N--CA 1.475 0.796 0 N-CA-C 108.208 -1.034 . . . . 54.05 108.208 -175.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.57 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 7.1 Cg_endo -86.07 111.05 1.09 Allowed 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 121.403 1.402 . . . . 75.33 109.488 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.564 ' HA ' HG21 ' B' ' 6' ' ' ILE . 47.7 tp -106.48 136.95 45.35 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 110.058 -0.349 . . . . 64.01 110.058 -176.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.463 HG21 ' H ' ' B' ' 4' ' ' SER . 99.9 m -65.54 131.09 45.52 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.985 0.914 . . . . 71.34 110.049 175.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 69.3 mt -57.26 -50.81 71.71 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.908 0.883 . . . . 70.54 111.385 -175.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -59.94 -37.55 79.86 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 114.824 -1.08 . . . . 75.32 110.606 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.421 ' HB2' ' HB ' ' A' ' 126' ' ' THR . 45.1 mm-40 -82.06 -12.71 58.11 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 115.425 -0.807 . . . . 64.33 112.056 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -71.29 -54.04 12.21 Favored 'General case' 0 C--N 1.347 0.471 0 N-CA-C 107.719 -1.215 . . . . 41.43 107.719 167.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -51.98 -44.41 64.02 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 116.138 -0.483 . . . . 74.51 110.984 174.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 50.8 m170 -73.51 -30.13 62.91 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 116.468 -0.333 . . . . 75.25 111.786 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 67.9 -129.05 26.72 Favored Glycine 0 C--N 1.349 1.26 0 O-C-N 123.216 0.323 . . . . 71.54 113.257 177.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.445 ' O ' HG12 ' A' ' 149' ' ' ILE . . . 83.24 -175.59 52.74 Favored Glycine 0 C--N 1.35 1.31 0 C-N-CA 123.007 0.337 . . . . 70.42 113.856 175.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.9 111.36 13.66 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 107.783 -1.191 . . . . 73.14 107.783 169.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.407 ' NH2' ' HB3' ' A' ' 129' ' ' GLU . 13.8 tpp180 -90.16 121.35 32.12 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 109.186 -0.672 . . . . 74.4 109.186 -175.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.494 HG11 ' HE ' ' A' ' 144' ' ' ARG . 97.6 t -86.68 108.33 17.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 CA-C-N 115.204 -0.907 . . . . 71.24 108.904 177.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.453 HG22 HD11 ' B' ' 6' ' ' ILE . 14.6 t -107.37 113.03 42.52 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 115.005 -0.998 . . . . 73.14 108.417 -178.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -99.05 133.21 43.65 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.586 0.754 . . . . 71.3 109.535 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.447 HG11 HD23 ' B' ' 8' ' ' LEU . 7.3 p -166.14 119.24 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.904 0 C-N-CA 123.595 0.758 . . . . 75.1 110.776 -179.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 61.51 19.29 10.2 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.052 1.341 . . . . 74.24 113.741 172.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 102.01 -2.73 51.66 Favored Glycine 0 C--N 1.351 1.376 0 CA-C-N 117.555 0.161 . . . . 31.1 112.993 -177.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 20.7 tpt180 -99.94 112.83 25.09 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.07 0.948 . . . . 72.12 109.589 175.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.494 ' HE ' HG11 ' A' ' 137' ' ' VAL . 74.9 ttt180 -108.02 93.89 4.78 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.122 0.969 . . . . 74.41 108.642 175.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 15.0 p -94.59 149.99 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 123.318 0.647 . . . . 73.53 110.031 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 32.4 t -120.85 98.55 6.06 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.734 0.814 . . . . 31.45 108.872 176.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 19.0 m -103.48 116.63 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.375 0.67 . . . . 73.42 110.951 -176.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -67.41 112.37 4.58 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 109.608 -0.516 . . . . 74.14 109.608 172.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.445 HG12 ' O ' ' A' ' 134' ' ' GLY . 23.7 pt -101.62 152.29 38.04 Favored Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 123.727 0.811 . . . . 74.13 110.283 178.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -58.85 -165.57 0.03 OUTLIER 'Trans proline' 0 N--CA 1.517 2.872 0 C-N-CA 124.568 3.512 . . . . 60.34 112.451 168.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_exo -48.9 89.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.398 3.148 0 CA-C-N 121.025 1.402 . . . . 74.15 109.867 159.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 40.17 -98.01 0.01 OUTLIER Glycine 0 CA--C 1.494 -1.267 0 CA-C-N 112.727 -2.033 . . . . 75.51 114.647 -162.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.708 HG11 HG21 ' A' ' 178' ' ' VAL . 5.5 p 173.43 161.67 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 113.116 -1.542 . . . . 75.43 107.938 -162.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.04 152.86 43.72 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.452 -0.944 . . . . 73.23 108.452 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.453 ' HG2' ' NH1' ' A' ' 187' ' ' ARG . 11.3 tp10 -50.76 130.81 25.42 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 124.008 0.923 . . . . 72.32 112.662 -174.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.83 9.35 85.07 Favored Glycine 0 C--N 1.346 1.1 0 CA-C-N 115.412 -0.813 . . . . 14.21 114.072 178.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 42.0 m -66.18 109.84 2.78 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-N 118.016 0.908 . . . . 74.23 109.087 173.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 46.7 t -88.65 90.47 3.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 123.801 0.84 . . . . 72.34 109.024 -178.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.545 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 59.6 mt -74.24 104.96 3.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 108.656 -0.868 . . . . 75.24 108.656 175.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 46.7 ttt180 -74.86 108.85 7.87 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 109.32 -0.622 . . . . 61.32 109.32 177.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.482 HG13 ' HB3' ' A' ' 174' ' ' LEU . 3.8 p -119.48 95.58 49.33 Favored Pre-proline 0 CA--C 1.554 1.114 0 C-N-CA 123.898 0.879 . . . . 61.33 108.825 174.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.702 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 51.4 Cg_exo -59.74 126.41 20.44 Favored 'Trans proline' 0 C--N 1.372 1.77 0 C-N-CA 122.495 2.13 . . . . 74.53 114.014 175.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 128.05 -30.4 3.92 Favored Glycine 0 N--CA 1.47 0.93 0 CA-C-N 114.852 -1.067 . . . . 70.43 113.774 169.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 69.8 mtm -95.27 3.52 54.44 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 117.191 0.495 . . . . 64.15 111.699 -178.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.518 ' HA2' HD13 ' A' ' 174' ' ' LEU . . . -90.11 -98.32 1.13 Allowed Glycine 0 C--N 1.348 1.227 0 N-CA-C 110.856 -0.898 . . . . 73.33 110.856 175.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.739 ' HA3' ' H ' ' A' ' 117' ' ' ARG . . . -61.01 101.4 0.31 Allowed Glycine 0 C--O 1.265 2.089 0 N-CA-C 111.277 -0.729 . . . . 74.5 111.277 164.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.689 ' HB3' ' HA3' ' A' ' 108' ' ' GLY . 23.4 mm-40 -64.93 105.87 1.12 Allowed 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 113.151 -1.525 . . . . 75.42 109.066 177.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 174.21 164.9 29.96 Favored Glycine 0 C--O 1.238 0.344 0 N-CA-C 110.393 -1.083 . . . . 64.21 110.393 -175.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . 0.583 ' ND2' ' HB3' ' A' ' 105' ' ' LEU . 2.4 t-20 -60.8 -72.01 0.3 Allowed Pre-proline 0 CA--C 1.563 1.457 0 CA-C-O 116.657 -1.639 . . . . 63.11 112.116 -164.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.529 ' HD3' ' HB3' ' A' ' 169' ' ' ASN . 22.4 Cg_exo -65.65 115.75 3.56 Favored 'Trans proline' 0 C--N 1.389 2.71 0 CA-C-N 123.569 2.31 . . . . 71.13 109.854 171.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.63 ' HD3' HG12 ' A' ' 90' ' ' VAL . 8.7 Cg_exo -38.45 123.0 0.66 Allowed 'Trans proline' 0 C--N 1.375 1.965 1 C-N-CA 125.671 4.247 . . . . 71.25 117.42 -166.48 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -88.0 127.25 8.45 Favored Glycine 0 C--N 1.366 2.225 0 N-CA-C 111.112 -0.795 . . . . 72.4 111.112 164.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.702 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 4.9 m-20 -61.3 136.85 58.19 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.994 0.917 . . . . 71.14 111.792 -169.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.552 HD11 ' HB2' ' A' ' 121' ' ' ALA . 32.3 tp -113.7 126.93 55.79 Favored 'General case' 0 C--N 1.343 0.292 0 N-CA-C 109.786 -0.449 . . . . 64.32 109.786 173.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 83.7 mt -95.36 90.06 5.67 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.296 -0.865 . . . . 72.12 108.879 178.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.545 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 81.9 mt -70.07 88.51 0.6 Allowed 'General case' 0 C--N 1.354 0.799 0 N-CA-C 109.282 -0.636 . . . . 70.05 109.282 174.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 17.1 t -82.22 101.32 6.86 Favored 'Isoleucine or valine' 0 C--O 1.246 0.895 0 N-CA-C 105.54 -2.022 . . . . 61.43 105.54 175.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.708 HG21 HG11 ' A' ' 153' ' ' VAL . 6.0 p -71.2 136.38 25.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 115.217 -0.901 . . . . 70.33 111.01 -171.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.57 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 30.7 mmt180 -119.7 120.78 37.6 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.745 -1.576 . . . . 53.32 106.745 169.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 32.7 mt -74.82 147.2 41.39 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 109.062 -0.718 . . . . 72.4 109.062 171.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.421 ' HA ' ' HD3' ' A' ' 182' ' ' PRO . 18.5 mt -53.73 150.46 13.65 Favored Pre-proline 0 N--CA 1.484 1.241 0 C-N-CA 123.662 0.785 . . . . 73.14 112.936 -167.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 181' ' ' LEU . 24.2 Cg_exo -66.95 8.8 0.31 Allowed 'Trans proline' 0 C--N 1.387 2.558 0 C-N-CA 124.312 3.342 . . . . 71.42 113.921 176.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -60.65 103.11 0.34 Allowed Pre-proline 0 CA--C 1.562 1.423 0 C-N-CA 125.377 1.471 . . . . 73.35 107.938 165.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -80.86 26.17 0.61 Allowed 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 123.636 2.89 . . . . 61.24 115.471 -162.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.413 HG12 ' HD1' ' A' ' 186' ' ' PHE . 77.3 t -96.08 -58.94 3.44 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.908 0 CA-C-O 118.644 -0.693 . . . . 64.21 111.15 -173.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . 0.413 ' HD1' HG12 ' A' ' 185' ' ' VAL . 4.0 m-85 -139.41 91.77 2.52 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 119.191 0.905 . . . . 72.31 110.575 -177.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.453 ' NH1' ' HG2' ' A' ' 155' ' ' GLU . 44.8 ttp85 -101.26 103.8 14.82 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.073 0.949 . . . . 75.51 109.526 178.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.433 HD23 ' O ' ' A' ' 153' ' ' VAL . 51.2 tp -71.02 141.47 50.95 Favored 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 124.103 0.961 . . . . 74.21 111.218 179.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.417 ' HG3' ' HB3' ' A' ' 155' ' ' GLU . 34.2 tt0 -151.8 126.1 9.33 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.822 1.249 . . . . 70.31 109.825 -175.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 70.15 -81.93 0.35 Allowed Glycine 0 C--N 1.352 1.424 0 N-CA-C 111.625 -0.59 . . . . 65.41 111.625 -176.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -147.88 -10.08 0.4 Allowed 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 125.349 1.46 . . . . 72.32 109.882 166.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -101.06 148.31 25.2 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.325 1.05 . . . . 72.32 111.205 -176.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 14.4 mt -90.92 159.89 15.96 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.26 1.024 . . . . 63.44 110.782 -176.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.505 ' HA ' ' HB2' ' A' ' 250' ' ' TYR . 41.8 m-85 -126.95 110.46 13.02 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.375 1.07 . . . . 73.14 108.919 173.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.527 ' HB3' HD23 ' A' ' 251' ' ' LEU . . . -125.88 166.95 15.95 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.217 1.007 . . . . 74.34 110.796 -178.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 24.5 m -112.9 147.42 37.08 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 108.493 -0.928 . . . . 70.21 108.493 171.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.559 HD22 HD13 ' A' ' 251' ' ' LEU . 50.8 tp -139.55 113.37 8.64 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.423 0.689 . . . . 72.21 109.51 -173.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -89.03 124.76 34.59 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 108.402 -0.962 . . . . 61.43 108.402 174.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.9 p -140.47 131.3 13.85 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 124.276 1.031 . . . . 64.4 108.966 -174.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -72.74 150.24 49.85 Favored 'Trans proline' 0 C--N 1.379 2.139 0 C-N-CA 121.554 1.503 . . . . 64.51 110.973 173.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -50.94 -46.93 87.73 Favored Pre-proline 0 CA--C 1.558 1.278 0 N-CA-C 114.654 1.353 . . . . 71.34 114.654 -173.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -52.85 -46.58 32.7 Favored 'Trans proline' 0 C--N 1.383 2.394 0 C-N-CA 121.895 1.73 . . . . 63.54 113.754 176.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.41 HG23 ' HE1' ' C' ' 277' ' ' TYR . 20.3 mt -72.54 -30.28 33.65 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 CA-C-N 115.68 -0.691 . . . . 64.32 110.403 -176.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.3 -42.66 75.13 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.205 0.602 . . . . 71.51 111.909 175.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 50.1 t -71.47 -48.62 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 123.903 0.881 . . . . 63.23 111.847 -176.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 53.2 t -87.49 -34.38 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-N 115.731 -0.668 . . . . 74.41 111.472 -173.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 85.21 113.88 0.74 Allowed Glycine 0 C--N 1.337 0.637 0 N-CA-C 111.989 -0.445 . . . . 72.35 111.989 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.44 ' HA3' ' CE1' ' C' ' 277' ' ' TYR . . . -149.7 -136.52 2.62 Favored Glycine 0 C--O 1.219 -0.805 0 CA-C-O 119.386 -0.675 . . . . 55.24 111.747 -178.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? -114.92 129.98 56.82 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 117.684 0.742 . . . . 45.21 110.444 -177.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.461 HG21 HD21 ' A' ' 197' ' ' LEU . 7.1 m -128.31 157.72 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.711 1.205 . . . . 63.11 108.489 171.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . 0.616 ' HG2' HG13 ' B' ' 421' ' ' VAL . 7.6 tpp180 -87.98 122.09 31.17 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 109.307 -0.627 . . . . 71.41 109.307 -175.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -99.69 110.98 23.36 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.943 -0.762 . . . . 62.04 108.943 176.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 17.0 tpt -82.37 116.48 21.88 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.701 -0.852 . . . . 71.23 108.701 177.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 19.7 p -108.23 -172.29 2.03 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.024 0.53 . . . . 74.1 109.583 -176.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 81.3 mt -67.15 -26.14 66.51 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.861 0.864 . . . . 63.31 112.372 -176.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -105.26 -19.19 13.88 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.15 0.58 . . . . 64.44 111.989 -175.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 152.68 -178.83 29.61 Favored Glycine 0 C--N 1.343 0.933 0 CA-C-O 119.92 -0.378 . . . . 33.0 112.426 -177.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -82.85 149.86 14.12 Favored 'Trans proline' 0 CA--C 1.552 1.423 0 C-N-CA 122.749 2.3 . . . . 70.23 113.545 -176.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 27.9 m -136.22 -178.81 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 125.657 1.583 . . . . 73.4 108.008 172.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.506 ' HG2' HH11 ' A' ' 211' ' ' ARG . 50.2 mt-10 -107.2 131.2 54.43 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 109.483 -0.562 . . . . 75.04 109.483 168.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 7.0 m -111.65 128.82 67.95 Favored 'Isoleucine or valine' 0 C--O 1.243 0.738 0 N-CA-C 108.242 -1.022 . . . . 74.13 108.242 167.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -78.23 99.2 6.16 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 109.001 -0.74 . . . . 60.25 109.001 177.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.731 ' HA ' HD12 ' B' ' 441' ' ' ILE . 14.8 p -67.64 137.53 93.09 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 124.066 0.947 . . . . 63.14 109.276 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -76.3 170.86 19.18 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 122.242 1.961 . . . . 75.51 110.958 -177.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.75 161.17 45.96 Favored 'Trans proline' 0 C--N 1.371 1.728 0 C-N-CA 121.378 1.385 . . . . 72.53 112.226 172.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 57.7 mtt-85 64.4 24.19 13.15 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 125.188 1.395 . . . . 74.04 112.02 168.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.537 HG23 HD21 ' A' ' 233' ' ' LEU . 98.6 m -68.27 102.38 1.37 Allowed 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 125.238 1.415 . . . . 64.32 111.162 -178.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -87.72 139.16 30.81 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.981 1.312 . . . . 75.32 110.88 -176.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . 0.458 ' HA ' ' HB ' ' A' ' 253' ' ' VAL . . . -68.13 156.98 36.33 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.405 0.682 . . . . 62.31 112.197 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 84.42 -19.08 20.66 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-N 115.886 -0.597 . . . . 73.32 112.929 -179.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -90.92 160.96 15.4 Favored 'General case' 0 C--N 1.351 0.672 0 C-N-CA 123.762 0.825 . . . . 74.0 110.654 178.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -115.95 114.44 24.63 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.193 0.997 . . . . 72.22 108.615 -177.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.537 HD21 HG23 ' A' ' 227' ' ' THR . 84.9 mt -75.71 118.67 18.78 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.817 0.847 . . . . 71.4 110.64 -177.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 27.2 ttm-85 -90.48 103.13 15.85 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 109.492 -0.559 . . . . 64.14 109.492 172.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.67 HD13 HG12 ' B' ' 441' ' ' ILE . 0.1 OUTLIER -97.17 123.54 40.97 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.477 0.711 . . . . 61.12 109.174 173.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -69.98 132.09 45.4 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 114.592 -1.185 . . . . 64.43 113.48 -169.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 79.44 3.3 88.67 Favored Glycine 0 C--N 1.354 1.575 0 CA-C-N 115.774 -0.648 . . . . 74.2 114.433 171.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.602 ' HG3' HD12 ' A' ' 235' ' ' LEU . 0.0 OUTLIER -90.38 -7.26 53.66 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 112.536 0.569 . . . . 73.01 112.536 -172.406 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -85.91 -166.07 41.6 Favored Glycine 0 C--N 1.351 1.399 0 C-N-CA 123.101 0.382 . . . . 74.43 113.791 175.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -89.64 147.95 38.96 Favored Pre-proline 0 N--CA 1.485 1.308 0 C-N-CA 123.375 0.67 . . . . 73.13 111.429 -171.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -66.3 146.75 81.87 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 123.576 2.851 . . . . 73.33 113.28 174.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -177.87 -155.3 13.79 Favored Glycine 0 CA--C 1.534 1.278 0 CA-C-O 118.969 -0.906 . . . . 73.52 112.138 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -64.49 -33.52 56.8 Favored 'Trans proline' 0 C--N 1.385 2.472 0 C-N-CA 123.746 2.964 . . . . 70.45 113.522 -176.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -89.96 21.03 3.84 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.136 0.574 . . . . 70.11 111.165 176.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 72.38 -152.14 47.69 Favored Glycine 0 C--N 1.35 1.346 0 N-CA-C 110.803 -0.919 . . . . 62.24 110.803 -169.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 27.4 mtp180 -76.29 137.43 39.89 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 109.608 -0.516 . . . . 75.41 109.608 170.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -80.39 -161.5 24.8 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 112.155 -0.378 . . . . 42.24 112.155 173.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -110.92 -174.38 2.46 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 123.734 0.814 . . . . 75.44 110.138 -178.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.526 ' HB3' ' HG ' ' A' ' 235' ' ' LEU . 18.6 tp -127.68 133.22 49.6 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.381 -0.97 . . . . 70.31 108.381 175.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.505 ' HB2' ' HA ' ' A' ' 194' ' ' TYR . 3.1 m-85 -96.55 126.34 41.67 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 108.611 -0.885 . . . . 52.51 108.611 173.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.559 HD13 HD22 ' A' ' 197' ' ' LEU . 88.7 mt -115.52 108.66 16.74 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.691 -0.855 . . . . 72.24 108.691 172.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -76.65 115.87 16.8 Favored 'General case' 0 C--N 1.348 0.529 0 N-CA-C 106.817 -1.549 . . . . 75.41 106.817 -176.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.458 ' HB ' ' HA ' ' A' ' 229' ' ' ALA . 22.7 t -76.25 116.06 18.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 CA-C-N 115.548 -0.751 . . . . 24.43 110.68 -169.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -119.15 91.68 3.61 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 107.091 -1.448 . . . . 73.14 107.091 178.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.406 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 62.5 mt -81.23 129.89 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 116.469 -0.332 . . . . 74.34 110.292 -176.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 32.3 p -120.28 173.22 7.26 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.645 1.178 . . . . 73.43 109.618 173.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.449 HD12 ' H ' ' A' ' 259' ' ' GLU . 2.1 pp -125.14 155.03 71.64 Favored Pre-proline 0 CA--C 1.562 1.433 0 N-CA-C 107.888 -1.152 . . . . 73.4 107.888 173.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . 0.499 ' HG3' ' OH ' ' C' ' 276' ' ' TYR . 37.9 Cg_endo -78.51 18.6 0.94 Allowed 'Trans proline' 0 N--CA 1.512 2.568 0 C-N-CA 123.382 2.721 . . . . 74.45 115.64 -164.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.449 ' H ' HD12 ' A' ' 257' ' ' ILE . 5.9 mm-40 51.67 -122.91 2.06 Favored 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 124.015 0.926 . . . . 63.24 111.959 -169.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' ARG . . . . . 0.515 ' HD3' ' H ' ' A' ' 260' ' ' ARG . 0.0 OUTLIER -67.34 149.54 50.19 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 118.679 0.672 . . . . 75.12 111.743 -169.162 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 69.8 mt -120.77 160.67 22.89 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.596 0.758 . . . . 55.32 111.657 -171.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 27.5 p -90.56 148.34 38.47 Favored Pre-proline 0 CA--C 1.556 1.183 0 CA-C-O 117.782 -1.104 . . . . 44.34 108.92 170.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' PRO . . . . . 0.514 ' O ' ' HB3' ' A' ' 266' ' ' GLU . 31.5 Cg_exo -35.23 -54.0 0.7 Allowed 'Trans proline' 0 C--N 1.394 2.932 1 C-N-CA 125.418 4.079 . . . . 74.33 117.298 -167.453 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -77.87 -38.29 46.31 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 121.962 -0.461 . . . . 71.44 111.439 -176.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -64.91 -26.54 68.36 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 122.912 0.485 . . . . 64.2 110.623 173.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' GLU . . . . . 0.514 ' HB3' ' O ' ' A' ' 263' ' ' PRO . 7.9 tp10 -63.14 -58.35 7.51 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 108.353 -0.98 . . . . 73.45 108.353 172.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -66.31 -18.31 65.28 Favored 'General case' 0 CA--C 1.553 1.086 0 CA-C-N 115.321 -0.854 . . . . 64.12 112.871 177.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 41.5 tp -78.27 -47.0 18.83 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.691 0.797 . . . . 73.14 110.412 -177.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 68.6 m95 -63.08 -38.13 89.95 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.478 -0.783 . . . . 75.0 110.495 173.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . 0.5 ' HG3' HG23 ' C' ' 206' ' ' VAL . 0.9 OUTLIER -63.45 -44.07 95.57 Favored 'General case' 0 CA--C 1.557 1.216 0 O-C-N 123.672 0.607 . . . . 62.43 111.778 175.311 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 29.8 mtmm -57.18 -49.89 74.56 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 123.124 0.57 . . . . 70.22 110.664 175.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 24.7 mt -51.73 -51.0 59.49 Favored 'General case' 0 C--O 1.216 -0.7 0 O-C-N 124.596 1.185 . . . . 63.4 110.862 175.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -68.19 -38.42 81.96 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 113.935 1.087 . . . . 64.51 113.935 -169.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -76.96 -42.79 37.68 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 123.467 0.48 . . . . 74.35 110.154 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . 0.414 ' HB1' ' NH2' ' A' ' 279' ' ' ARG . . . -66.02 -30.1 70.58 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.82 -0.627 . . . . 71.44 110.899 175.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -67.71 -60.17 2.74 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.377 1.071 . . . . 75.02 109.636 177.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -60.35 -41.72 94.23 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.345 1.058 . . . . 70.12 111.017 -172.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -60.89 -20.59 62.21 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.337 0.655 . . . . 75.41 112.705 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . 0.414 ' NH2' ' HB1' ' A' ' 275' ' ' ALA . 87.6 mtm180 -128.99 18.37 6.09 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.8 0.84 . . . . 74.13 111.005 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.022 0 CA-C-O 118.412 -0.804 . . . . 72.21 110.754 -175.734 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.404 ' SD ' ' N ' ' B' ' 1' ' ' MET . 1.0 OUTLIER . . . . . 0 N--CA 1.482 1.171 0 N-CA-C 108.775 -0.824 . . . . 71.44 108.775 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.577 ' HE3' ' HA ' ' B' ' 2' ' ' LYS . 0.4 OUTLIER -70.77 90.03 0.77 Allowed 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 109.425 -0.583 . . . . 54.1 109.425 179.238 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 23.9 tm0? -113.11 160.36 18.27 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.253 1.021 . . . . 74.04 108.95 -173.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . 0.463 ' H ' HG21 ' A' ' 126' ' ' THR . 80.7 p 59.25 -80.45 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 126.785 2.034 . . . . 52.14 111.655 -177.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 6.4 m -76.65 153.88 34.81 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 109.01 -0.737 . . . . 70.11 109.01 172.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.564 HG21 ' HA ' ' A' ' 125' ' ' LEU . 31.7 pt -128.74 173.76 13.14 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 CA-C-O 121.033 0.444 . . . . 64.44 111.207 -174.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -146.54 127.66 14.69 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.395 -0.821 . . . . 72.01 109.458 -177.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.549 HD21 HD21 ' A' ' 174' ' ' LEU . 38.3 tp -73.1 150.73 42.02 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.419 0.688 . . . . 75.22 111.049 -176.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.68 -60.37 2.38 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 122.873 0.469 . . . . 62.4 111.027 176.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 67.3 mt 62.17 127.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 124.584 1.153 . . . . 74.1 110.114 -163.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 24.6 mt -118.35 71.7 9.37 Favored Pre-proline 0 CA--C 1.561 1.383 0 O-C-N 121.706 -0.621 . . . . 45.35 110.318 178.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -91.07 -24.4 0.42 Allowed 'Trans proline' 0 C--N 1.385 2.484 0 C-N-CA 122.44 2.093 . . . . 61.33 113.041 174.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -158.27 13.86 0.2 Allowed 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 112.07 0.396 . . . . 75.01 112.07 -173.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 37.7 tp -63.81 160.5 17.23 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.81 -0.441 . . . . 64.54 109.81 175.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' PHE . . . . . 0.406 ' HE2' HG21 ' B' ' 343' ' ' VAL . 78.3 t80 -53.29 96.57 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 124.203 1.001 . . . . 60.01 111.82 -178.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 54.2 p -116.59 -177.87 0.48 Allowed Pre-proline 0 CA--C 1.556 1.176 0 C-N-CA 125.308 1.443 . . . . 51.11 108.428 176.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -49.25 143.05 20.36 Favored 'Trans proline' 0 C--N 1.383 2.354 0 C-N-CA 121.944 1.762 . . . . 62.42 112.711 162.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 10.7 m -72.21 86.24 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.348 0 CA-C-O 122.205 1.003 . . . . 61.41 112.013 -171.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 37.6 p -89.72 114.02 25.63 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.27 -0.877 . . . . 71.22 111.328 -177.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp 68.66 -68.65 0.17 Allowed 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 126.153 1.781 . . . . 62.34 111.93 174.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.57 93.08 0.48 Allowed 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 107.845 -1.169 . . . . 75.34 107.845 166.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 16.6 ptt180 -146.71 13.86 1.19 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.739 0.815 . . . . 73.31 111.131 -176.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' THR . . . . . 0.629 ' HB ' ' HD2' ' B' ' 24' ' ' PRO . 28.2 p 57.72 -173.89 0.02 OUTLIER Pre-proline 0 CA--C 1.577 2.012 0 C-N-CA 125.195 1.398 . . . . 72.45 111.391 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . 0.629 ' HD2' ' HB ' ' B' ' 23' ' ' THR . 26.5 Cg_endo -65.08 -2.01 5.12 Favored 'Trans proline' 0 C--N 1.398 3.166 0 CA-C-N 121.569 1.596 . . . . 74.55 114.075 165.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 78.72 -32.87 0.15 Allowed 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 126.004 1.722 . . . . 74.53 113.601 168.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -113.83 27.35 0.1 OUTLIER Pre-proline 0 CA--C 1.582 2.205 0 N-CA-C 114.806 1.41 . . . . 75.13 114.806 176.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -77.69 -10.57 17.07 Favored 'Trans proline' 0 C--N 1.411 3.842 0 CA-C-N 123.508 2.288 . . . . 71.1 110.848 168.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 30.0 m -100.63 -157.72 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 C-N-CA 125.191 1.397 . . . . 73.51 108.967 173.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 76.3 mt 81.98 -50.3 0.23 Allowed 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 126.054 1.742 . . . . 62.2 111.93 174.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 65.63 112.86 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 125.146 1.379 . . . . 70.24 112.152 -178.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 21.3 p-10 -93.28 35.09 1.1 Allowed 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 125.017 1.327 . . . . 74.34 111.278 -177.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' ARG . . . . . 0.609 HH22 ' HB2' ' B' ' 119' ' ' ASP . 27.8 ptt180 -63.39 -20.8 65.85 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.785 0.834 . . . . 72.22 112.221 179.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.22 80.86 0.72 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.989 0.916 . . . . 73.31 110.381 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -164.23 35.97 0.08 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.102 0.961 . . . . 53.33 110.238 -175.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -76.87 -44.82 30.58 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 116.407 -0.36 . . . . 73.13 110.187 177.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 126.26 -28.36 4.82 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-O 119.403 -0.665 . . . . 74.33 114.311 171.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . 0.546 ' HA ' ' HG2' ' C' ' 27' ' ' LYS . 18.9 m-20 -64.02 94.46 0.1 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.025 0.53 . . . . 61.44 111.839 -174.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . 0.512 HG23 ' HD2' ' C' ' 148' ' ' ARG . 39.4 mt -125.12 80.52 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.044 0 N-CA-C 107.583 -1.266 . . . . 75.44 107.583 173.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 75.5 p 56.15 131.79 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 126.931 2.092 . . . . 64.25 115.698 178.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.5 177.65 2.37 Favored Pre-proline 0 CA--C 1.569 1.705 0 CA-C-O 117.482 -1.247 . . . . 64.0 108.494 172.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -82.98 -159.14 0.1 OUTLIER 'Trans proline' 0 C--N 1.4 3.258 0 CA-C-N 122.824 2.044 . . . . 72.44 113.035 -168.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . 0.544 ' HA3' ' HA ' ' B' ' 327' ' ' LYS . . . 174.7 -112.81 0.42 Allowed Glycine 0 C--N 1.349 1.285 0 N-CA-C 111.222 -0.751 . . . . 45.24 111.222 179.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . 0.445 ' HA3' ' HB2' ' B' ' 326' ' ' ASP . . . -97.41 59.09 1.12 Allowed Glycine 0 C--N 1.344 1.02 0 N-CA-C 111.876 -0.49 . . . . 42.15 111.876 178.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.65 75.02 4.21 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.698 0.799 . . . . 63.2 109.39 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.454 ' HG2' ' HA ' ' B' ' 48' ' ' THR . 49.8 ttt180 -84.13 82.62 8.28 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 114.785 -1.098 . . . . 74.21 110.728 -168.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 17.6 ttm180 -64.88 134.46 54.08 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.712 0.805 . . . . 75.02 109.688 175.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 9.6 tt 78.83 -30.33 0.15 Allowed 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 125.657 1.583 . . . . 53.22 111.782 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.454 ' HA ' ' HG2' ' B' ' 45' ' ' ARG . 70.9 m 72.4 -63.14 0.44 Allowed 'General case' 0 C--N 1.36 1.028 0 C-N-CA 125.903 1.681 . . . . 51.22 111.362 -176.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.66 47.28 4.89 Favored Glycine 0 C--N 1.342 0.863 0 CA-C-O 120.099 -0.279 . . . . 74.15 112.536 178.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . 0.67 ' HB3' ' HB2' ' B' ' 53' ' ' ALA . 10.8 m-20 71.28 -69.51 0.18 Allowed 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 125.567 1.547 . . . . 64.2 111.801 175.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 22.8 tp60 63.27 -82.84 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.159 1.383 . . . . 75.3 111.493 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 5.2 m -93.26 52.03 1.72 Allowed 'General case' 0 CA--C 1.55 0.973 0 CA-C-O 121.808 0.813 . . . . 73.31 109.443 -175.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . 0.67 ' HB2' ' HB3' ' B' ' 50' ' ' ASP . . . -87.06 22.44 2.04 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.334 0.654 . . . . 73.24 112.697 -172.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.471 ' HA ' ' HB2' ' B' ' 57' ' ' ASP . . . 67.64 25.17 8.28 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 124.869 1.268 . . . . 75.51 110.243 -174.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 50.0 tp -68.53 -67.7 0.45 Allowed 'General case' 0 C--N 1.348 0.533 0 CA-C-N 114.756 -1.111 . . . . 72.35 108.8 -176.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -117.47 12.17 14.08 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.975 0.91 . . . . 73.2 109.709 173.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . 0.471 ' HB2' ' HA ' ' B' ' 54' ' ' ALA . 9.6 m-20 -86.07 72.0 10.49 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.588 1.155 . . . . 75.31 110.747 -170.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 47.1 m -88.54 81.95 7.03 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.269 -0.878 . . . . 62.01 108.985 178.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 2.5 tt 60.07 70.88 0.6 Allowed 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.871 1.268 . . . . 72.44 110.304 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 18.6 m -74.55 -36.68 63.11 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 121.788 0.804 . . . . 63.51 109.822 173.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -164.81 -56.0 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 105.888 -1.893 . . . . 71.45 105.888 176.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -49.79 135.97 19.71 Favored Pre-proline 0 CA--C 1.551 0.984 0 CA-C-N 113.156 -1.838 . . . . 72.3 111.067 166.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -49.53 -47.89 21.02 Favored 'Trans proline' 0 C--N 1.394 2.95 0 C-N-CA 123.882 3.054 . . . . 72.24 112.958 -176.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 71.5 -54.89 0.67 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 125.585 1.554 . . . . 72.04 112.587 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm 69.81 15.87 7.89 Favored 'General case' 0 CA--C 1.56 1.346 0 C-N-CA 124.984 1.314 . . . . 65.32 110.327 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -94.12 99.35 11.65 Favored 'General case' 0 C--N 1.351 0.666 0 C-N-CA 124.679 1.191 . . . . 72.41 108.979 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 4.9 tt -151.12 96.04 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 C-N-CA 123.574 0.75 . . . . 72.03 109.13 177.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 61.4 mt 64.4 -76.34 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 C-N-CA 125.434 1.494 . . . . 73.4 110.623 -174.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -144.84 -167.7 2.73 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.065 0.946 . . . . 73.12 109.255 178.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . 0.529 HD23 ' H ' ' B' ' 70' ' ' LEU . 2.1 pt? -64.59 83.07 0.04 OUTLIER 'General case' 0 CA--C 1.561 1.392 0 CA-C-O 122.047 0.927 . . . . 44.44 110.387 171.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 8.7 tp -67.12 -29.82 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 123.696 0.798 . . . . 74.32 111.129 -178.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.26 108.92 0.13 Allowed Glycine 0 C--N 1.345 1.074 0 CA-C-N 116.05 -0.523 . . . . 62.21 112.109 -175.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -61.0 102.71 0.22 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.735 0.814 . . . . 63.44 110.152 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.45 55.97 26.01 Favored Glycine 0 C--N 1.356 1.645 0 O-C-N 123.976 0.798 . . . . 64.42 111.934 -177.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 66.9 mtt 67.84 -69.0 0.15 Allowed 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 125.329 1.452 . . . . 74.01 110.085 -166.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 60.07 32.79 76.88 Favored Glycine 0 C--N 1.36 1.916 0 N-CA-C 111.845 -0.502 . . . . 71.13 111.845 -178.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -58.9 -32.96 70.0 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.564 1.145 . . . . 73.03 112.072 -171.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 48.2 t 68.36 47.18 0.98 Allowed 'General case' 0 CA--C 1.55 0.963 0 O-C-N 124.739 1.274 . . . . 51.1 109.335 -177.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -85.66 150.58 24.52 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.45 1.1 . . . . 74.44 111.62 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.492 HG23 ' H ' ' B' ' 81' ' ' THR 0.291 0.0 OUTLIER 50.65 -77.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 C-N-CA 127.631 2.372 . . . . 72.52 113.079 176.02 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . 0.492 ' H ' HG23 ' B' ' 80' ' ' ILE . 9.4 t -75.88 -18.22 59.49 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.829 0.852 . . . . 71.34 110.627 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 69.02 178.39 0.25 Allowed 'General case' 0 C--N 1.356 0.855 0 C-N-CA 125.052 1.341 . . . . 61.11 111.394 -172.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -100.52 54.7 0.88 Allowed 'General case' 0 C--O 1.243 0.756 0 N-CA-C 108.675 -0.861 . . . . 71.35 108.675 175.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 -69.0 85.7 0.34 Allowed 'General case' 0 C--N 1.353 0.745 0 CA-C-N 115.15 -0.932 . . . . 73.0 109.941 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -116.04 137.16 52.36 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.099 1.359 . . . . 72.23 108.745 -178.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -66.48 116.06 7.05 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 109.239 -0.652 . . . . 63.12 109.239 177.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.83 86.37 0.51 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.549 0.74 . . . . 52.24 111.122 -174.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -109.86 -56.02 2.37 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.803 1.241 . . . . 74.14 108.337 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -88.39 56.69 4.22 Favored Glycine 0 C--N 1.349 1.261 0 CA-C-N 115.154 -0.93 . . . . 54.33 111.224 171.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.88 166.25 22.48 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.591 0.757 . . . . 62.33 110.904 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.2 26.57 1.81 Allowed Glycine 0 CA--C 1.536 1.373 0 N-CA-C 114.448 0.539 . . . . 70.11 114.448 -177.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -97.09 29.89 9.96 Favored Glycine 0 C--N 1.352 1.458 0 C-N-CA 123.493 0.568 . . . . 23.53 112.619 178.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . 0.41 ' HA ' ' HB ' ' B' ' 318' ' ' VAL . 87.1 m-85 -68.51 94.82 0.59 Allowed 'General case' 0 C--N 1.352 0.677 0 N-CA-C 109.4 -0.593 . . . . 74.22 109.4 175.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 94' ' ' PHE . . . . . 0.415 ' H ' ' HB ' ' B' ' 318' ' ' VAL . 72.8 t80 -169.69 102.96 0.32 Allowed 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.551 -0.907 . . . . 71.21 108.551 174.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -95.44 -47.93 6.07 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 109.486 -0.561 . . . . 74.14 109.486 174.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.94 -39.54 3.07 Favored Glycine 0 C--N 1.348 1.236 0 CA-C-N 116.142 -0.481 . . . . 72.31 112.718 176.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 9.2 tp -102.79 20.74 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.373 0 CA-C-O 122.036 0.922 . . . . 72.22 109.47 176.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -87.14 155.29 20.18 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 121.83 -0.544 . . . . 75.21 110.925 177.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -142.15 123.86 15.1 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.099 0.96 . . . . 61.12 109.317 -178.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 94.9 mt -127.37 140.82 39.01 Favored Pre-proline 0 N--CA 1.474 0.766 0 C-N-CA 124.122 0.969 . . . . 74.2 108.773 178.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -80.39 98.44 1.09 Allowed 'Trans proline' 0 C--N 1.371 1.728 0 C-N-CA 122.189 1.926 . . . . 72.21 111.001 172.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -68.41 -45.18 73.32 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 109.407 -0.59 . . . . 73.12 109.407 175.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 13.0 t -151.57 -179.17 7.18 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-N 115.117 -0.947 . . . . 75.52 109.723 -176.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . -68.66 90.86 0.25 Allowed Glycine 0 C--N 1.349 1.279 0 N-CA-C 111.313 -0.715 . . . . 51.35 111.313 171.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 12.9 tm0? -65.18 99.24 0.36 Allowed 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 108.407 -0.96 . . . . 75.22 108.407 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 56.78 -170.45 0.09 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.345 1.058 . . . . 74.44 113.078 -177.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 70.5 p -96.82 24.77 5.8 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 112.878 0.696 . . . . 63.32 112.878 -172.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 31.5 p80 -81.16 69.22 7.72 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-O 122.492 1.139 . . . . 71.44 109.698 173.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -162.74 -62.71 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 106.928 -1.508 . . . . 53.33 106.928 -172.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -79.24 163.41 24.99 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 114.838 -1.074 . . . . 71.24 108.501 164.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . 0.588 ' HA ' ' HA ' ' C' ' 243' ' ' PRO . 38.3 mt 62.28 23.94 14.21 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 123.641 0.777 . . . . 64.15 110.874 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 37.0 t-20 -79.32 141.09 37.29 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.749 0.82 . . . . 73.2 110.657 -168.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 113' ' ' LYS . . . . . 0.504 ' HG2' ' H ' ' B' ' 114' ' ' LYS 0.292 0.0 OUTLIER 31.54 -77.64 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 127.802 2.441 . . . . 75.13 114.258 -169.853 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' B' B ' 114' ' ' LYS . . . . . 0.504 ' H ' ' HG2' ' B' ' 113' ' ' LYS . 0.6 OUTLIER -174.83 -165.08 0.18 Allowed 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 107.039 -1.467 . . . . 74.01 107.039 -175.062 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . 0.446 ' H ' ' HG3' ' B' ' 114' ' ' LYS . 17.1 p -56.1 -70.81 0.1 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.358 0.663 . . . . 73.23 110.324 172.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -90.34 -140.0 8.15 Favored Glycine 0 C--N 1.343 0.944 0 N-CA-C 111.458 -0.657 . . . . 55.33 111.458 173.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . 0.564 ' H ' ' HD2' ' B' ' 118' ' ' PRO . 10.2 mtpm? -142.0 -58.06 0.02 OUTLIER Pre-proline 0 N--CA 1.485 1.3 0 C-N-CA 124.343 1.057 . . . . 70.25 110.993 176.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 118' ' ' PRO . . . . . 0.779 ' HA ' ' HB2' ' B' ' 336' ' ' GLU . 62.7 Cg_endo -70.37 -49.57 0.46 Allowed 'Trans proline' 0 C--N 1.397 3.129 0 C-N-CA 121.217 1.278 . . . . 60.53 113.27 -172.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 119' ' ' ASP . . . . . 0.609 ' HB2' HH22 ' B' ' 32' ' ' ARG . 15.3 t70 -161.07 153.92 20.99 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 124.56 1.144 . . . . 75.33 107.958 -175.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 120' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -122.14 -15.89 7.62 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.126 0.57 . . . . 70.1 111.309 -168.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 6.0 m -134.22 -57.31 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 113.606 0.965 . . . . 74.32 113.606 -170.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 53.6 m -79.96 -67.85 0.73 Allowed 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.17 0.51 . . . . 75.24 111.515 -170.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -88.37 -60.99 1.81 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.85 1.26 . . . . 64.3 111.028 -172.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 124' ' ' SER . . . . . 0.561 ' H ' ' HB3' ' B' ' 119' ' ' ASP . 39.2 m 56.92 -159.36 0.24 Allowed 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 125.329 1.452 . . . . 43.31 112.259 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -157.29 149.41 22.67 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.303 0.641 . . . . 73.02 110.733 178.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -153.08 160.6 42.95 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.269 1.028 . . . . 74.13 109.51 177.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 59.4 p -156.02 -178.22 7.15 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 112.652 0.612 . . . . 70.01 112.652 -171.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -76.85 146.58 37.65 Favored 'General case' 0 C--N 1.354 0.785 0 C-N-CA 123.896 0.878 . . . . 72.01 109.963 171.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 129' ' ' THR . . . . . 0.518 ' HB ' HD21 ' B' ' 155' ' ' LEU . 7.5 m -71.46 -11.27 60.79 Favored 'General case' 0 CA--C 1.556 1.173 0 C-N-CA 123.097 0.559 . . . . 54.34 111.464 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.88 147.98 50.57 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.126 0.57 . . . . 44.22 111.133 172.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 131' ' ' TRP . . . . . 0.41 ' HA ' ' HB2' ' C' ' 187' ' ' ARG . 20.7 p90 -55.43 -25.55 36.72 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 125.045 1.338 . . . . 73.51 113.201 -174.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 132' ' ' SER . . . . . 0.623 ' HB3' HG23 ' B' ' 135' ' ' VAL . 39.1 t -122.73 149.12 44.51 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 123.648 0.779 . . . . 51.4 110.557 178.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 6.5 m -68.92 -28.52 66.73 Favored 'General case' 0 CA--C 1.551 0.995 0 N-CA-C 109.194 -0.669 . . . . 62.25 109.194 167.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . -68.86 -8.14 56.94 Favored Glycine 0 C--N 1.357 1.716 0 CA-C-N 114.727 -1.124 . . . . 55.15 115.173 -178.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 135' ' ' VAL . . . . . 0.623 HG23 ' HB3' ' B' ' 132' ' ' SER . 39.6 t -77.36 -32.81 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 CA-C-N 117.568 0.684 . . . . 73.24 109.722 174.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt 66.41 15.25 10.04 Favored 'General case' 0 CA--C 1.572 1.789 0 C-N-CA 125.024 1.33 . . . . 52.43 112.833 170.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 137' ' ' THR . . . . . 0.481 HG23 HG12 ' B' ' 135' ' ' VAL . 11.5 p -69.93 100.7 1.62 Allowed 'General case' 0 N--CA 1.481 1.093 0 O-C-N 121.842 -0.536 . . . . 75.31 111.257 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 55.6 t80 68.08 -80.26 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.553 1.541 . . . . 75.52 110.345 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 4.7 t30 61.56 93.7 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.984 1.314 . . . . 73.24 112.085 176.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . 170.66 42.37 0.03 OUTLIER Glycine 0 C--N 1.354 1.542 0 CA-C-O 119.625 -0.541 . . . . 65.04 114.065 176.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . 76.12 -35.2 0.25 Allowed 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 125.278 1.431 . . . . 75.34 114.114 174.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . 0.265 0.3 OUTLIER 42.85 -86.64 0.01 OUTLIER 'General case' 0 CA--C 1.567 1.622 0 C-N-CA 126.11 1.764 . . . . 70.15 114.026 -176.901 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.32 -35.03 4.83 Favored Glycine 0 C--N 1.356 1.668 0 N-CA-C 112.141 -0.384 . . . . 61.25 112.141 -176.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 42.4 t -102.59 164.12 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 107.581 -1.266 . . . . 75.31 107.581 171.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 145' ' ' ASP . . . . . 0.496 ' HB3' HE22 ' B' ' 397' ' ' GLN . 6.3 p-10 -64.28 -43.87 93.46 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 118.325 0.511 . . . . 64.3 111.66 -178.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 1.7 mp 72.05 -29.07 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.568 1.654 0 C-N-CA 125.323 1.449 . . . . 72.52 112.308 -176.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 36.6 p-80 37.73 71.86 0.14 Allowed 'General case' 0 C--N 1.373 1.613 0 C-N-CA 125.277 1.431 . . . . 72.43 110.926 -163.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -54.1 131.85 41.71 Favored 'General case' 0 C--N 1.359 0.999 0 CA-C-N 114.163 -1.381 . . . . 73.05 110.763 -168.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 149' ' ' LYS . . . . . . . . . . . . . 31.6 mtmm 71.16 -80.26 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.859 1.664 . . . . 72.23 109.152 -164.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 34.5 t0 178.65 160.48 0.62 Allowed 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.637 1.175 . . . . 74.11 109.127 177.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 69.85 171.66 0.1 Allowed Pre-proline 0 N--CA 1.491 1.598 0 C-N-CA 124.724 1.21 . . . . 74.43 112.073 177.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.86 -173.43 0.2 Allowed 'Trans proline' 0 C--N 1.389 2.677 0 C-N-CA 122.618 2.212 . . . . 42.51 113.721 167.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 47.5 m 76.96 -53.3 0.57 Allowed 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 125.772 1.629 . . . . 74.2 110.391 -172.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 65.2 mt 64.67 -80.72 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.227 0 C-N-CA 125.132 1.373 . . . . 74.25 112.186 169.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 155' ' ' LEU . . . . . 0.518 HD21 ' HB ' ' B' ' 129' ' ' THR . 0.9 OUTLIER -121.63 41.4 3.37 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.894 0.878 . . . . 72.1 111.04 -174.331 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 79.91 -31.14 0.13 Allowed 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 125.77 1.628 . . . . 72.23 112.327 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 157' ' ' MET . . . . . 0.546 ' HB3' ' HG2' ' C' ' 252' ' ' GLU . 51.6 mtt 69.09 25.03 5.93 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.731 1.212 . . . . 53.54 111.618 -173.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 158' ' ' ALA . . . . . . . . . . . . . . . 68.71 -66.7 0.23 Allowed 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 125.931 1.693 . . . . 34.04 112.528 178.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . 0.571 ' HA ' HG21 ' C' ' 196' ' ' THR . 89.0 mttt 60.83 61.43 1.66 Allowed 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.833 1.253 . . . . 55.45 110.686 178.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -84.31 54.21 2.9 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 114.878 -1.055 . . . . 70.22 109.657 174.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . 0.429 ' HA ' ' HA ' ' B' ' 356' ' ' ASN . . . -175.9 132.31 0.26 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.655 1.182 . . . . 71.1 109.495 -174.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 162' ' ' GLY . . . . . 0.511 ' H ' ' HB2' ' B' ' 356' ' ' ASN . . . 170.56 -53.59 0.19 Allowed Glycine 0 C--N 1.354 1.566 0 N-CA-C 112.139 -0.384 . . . . 73.4 112.139 178.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 1.5 pp -129.15 138.3 51.7 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.952 0.901 . . . . 65.02 110.642 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 164' ' ' ALA . . . . . . . . . . . . . . . -71.09 102.13 2.4 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.845 0.858 . . . . 75.34 111.854 -171.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 21.5 p -90.03 100.14 13.02 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.345 0.658 . . . . 64.15 110.243 174.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . -84.41 59.39 4.93 Favored Glycine 0 C--N 1.351 1.396 0 CA-C-N 115.965 -0.561 . . . . 71.15 112.596 -177.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 167' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -150.79 -0.93 0.38 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.381 1.072 . . . . 72.31 108.968 178.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 8.1 p -161.85 34.28 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.219 0 CA-C-O 122.254 1.026 . . . . 74.13 108.72 -173.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 10.3 m -55.48 -46.29 76.88 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 114.154 -1.384 . . . . 54.35 111.552 -174.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 6.5 m -112.5 -77.37 0.58 Allowed 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.061 -1.089 . . . . 63.1 108.061 174.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . 174.89 55.36 0.0 OUTLIER 'General case' 0 C--O 1.242 0.665 0 N-CA-C 106.453 -1.684 . . . . 53.32 106.453 -172.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 172' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -54.99 97.7 0.02 OUTLIER 'General case' 0 C--N 1.357 0.903 0 CA-C-N 115.306 -0.861 . . . . 73.22 111.814 -173.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 173' ' ' LEU . . . . . . . . . . . . . 1.2 pp -87.89 21.23 2.74 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.354 1.062 . . . . 74.23 111.413 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 174' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -76.99 -6.78 53.98 Favored 'General case' 0 CA--C 1.562 1.42 0 C-N-CA 124.738 1.215 . . . . 74.45 110.312 178.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 175' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -68.4 154.14 42.38 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.675 1.19 . . . . 74.1 110.015 168.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . 0.425 ' H ' ' HB3' ' B' ' 191' ' ' TYR . . . -141.41 26.56 1.96 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.293 0.637 . . . . 74.11 111.911 -174.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 92.5 m -60.52 123.66 74.94 Favored Pre-proline 0 CA--C 1.559 1.308 0 C-N-CA 123.158 0.583 . . . . 64.31 110.267 175.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 178' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.44 -3.38 12.9 Favored 'Trans proline' 0 C--N 1.387 2.575 0 C-N-CA 123.241 2.627 . . . . 74.53 113.887 -173.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -70.21 95.89 1.04 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.245 0.618 . . . . 61.34 110.41 176.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.89 -39.57 93.74 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.449 0.699 . . . . 74.4 110.676 176.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 181' ' ' LEU . . . . . 0.459 HD21 HD11 ' C' ' 149' ' ' ILE . 14.8 tp -163.08 27.85 0.09 Allowed 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 114.769 -1.105 . . . . 62.04 108.341 176.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 182' ' ' VAL . . . . . 0.7 HG22 ' HA ' ' C' ' 138' ' ' VAL . 53.9 t -80.58 113.78 20.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 115.768 -0.651 . . . . 71.31 110.892 -171.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -90.21 -40.58 12.1 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.507 -0.769 . . . . 65.24 110.231 170.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 184' ' ' HIS . . . . . 0.671 ' HB3' ' HB3' ' B' ' 187' ' ' SER . 49.7 t-80 52.65 35.86 19.36 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 124.813 1.245 . . . . 74.15 111.599 175.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 185' ' ' VAL . . . . . . . . . . . . . 48.9 t 56.71 82.37 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 124.755 1.222 . . . . 71.33 110.326 -170.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 186' ' ' THR . . . . . 0.67 HG22 ' HG2' ' C' ' 122' ' ' GLU . 38.1 p 61.79 11.88 4.34 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 125.738 1.615 . . . . 51.31 114.059 172.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 187' ' ' SER . . . . . 0.671 ' HB3' ' HB3' ' B' ' 184' ' ' HIS . 35.4 t -83.92 143.39 29.88 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.491 0.716 . . . . 62.14 110.328 178.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 188' ' ' ARG . . . . . 0.445 ' HG3' ' HG3' ' C' ' 124' ' ' PRO . 35.9 ttt180 -149.66 137.65 20.39 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.859 0.864 . . . . 71.52 110.291 -174.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -127.43 158.43 37.34 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.946 0.898 . . . . 72.52 109.114 169.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 190' ' ' CYS . . . . . . . . . . . . . 74.8 m -144.2 127.82 17.11 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.732 0.813 . . . . 70.33 109.681 178.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 191' ' ' TYR . . . . . 0.425 ' HB3' ' H ' ' B' ' 176' ' ' ALA . 94.0 t80 -85.49 132.34 34.22 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.134 0.974 . . . . 74.04 109.701 178.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . 0.442 ' H ' ' HG2' ' B' ' 312' ' ' PRO . . . -67.11 134.99 31.74 Favored Glycine 0 C--N 1.349 1.297 0 CA-C-O 118.221 -1.321 . . . . 64.22 111.664 176.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 193' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -50.15 -29.23 21.8 Favored 'Trans proline' 0 C--N 1.388 2.61 0 C-N-CA 124.154 3.236 . . . . 64.32 114.964 -169.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 194' ' ' SER . . . . . . . . . . . . . 31.7 m 71.62 -65.77 0.33 Allowed 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 125.378 1.471 . . . . 24.51 112.107 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 195' ' ' ALA . . . . . . . . . . . . . . . -89.39 166.83 13.48 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.438 0.695 . . . . 74.32 110.613 174.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 31.8 m -86.66 -67.12 0.84 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.693 0.797 . . . . 73.32 109.792 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 39.8 t -167.56 102.63 0.5 Allowed 'General case' 0 C--N 1.35 0.605 0 N-CA-C 108.63 -0.878 . . . . 75.11 108.63 178.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 198' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -106.09 17.84 22.95 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.731 -0.668 . . . . 51.12 111.189 -175.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 64.1 mttm 68.51 -69.2 0.16 Allowed 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 125.24 1.416 . . . . 74.4 110.685 -177.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 200' ' ' CYS . . . . . . . . . . . . . 59.4 m 74.68 96.0 0.04 OUTLIER Pre-proline 0 N--CA 1.482 1.144 0 C-N-CA 125.398 1.479 . . . . 73.31 111.453 173.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 201' ' ' PRO . . . . . 0.554 ' HA ' ' HG2' ' B' ' 363' ' ' GLU . 32.1 Cg_exo -58.72 89.63 0.06 OUTLIER 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 123.317 2.678 . . . . 71.34 112.895 178.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 160.63 24.06 0.02 OUTLIER Glycine 0 C--N 1.345 1.07 0 CA-C-N 115.645 -0.707 . . . . 63.04 113.678 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -84.71 -19.24 33.06 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 117.647 0.724 . . . . 71.33 110.553 172.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -147.83 139.82 24.14 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.532 0.733 . . . . 74.01 110.162 176.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 205' ' ' LEU . . . . . . . . . . . . . 59.3 tp -76.41 -54.92 6.06 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.011 -0.737 . . . . 51.03 109.011 173.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.17 -91.04 0.56 Allowed 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.317 1.047 . . . . 62.32 108.983 175.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 207' ' ' LYS . . . . . 0.533 ' HD3' ' HA3' ' C' ' 217' ' ' GLY . 0.2 OUTLIER 61.9 -82.23 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 124.415 1.086 . . . . 74.32 111.442 -178.782 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 112.09 127.0 4.82 Favored Glycine 0 C--N 1.346 1.117 0 N-CA-C 110.604 -0.998 . . . . 71.52 110.604 -172.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 209' ' ' GLY . . . . . 0.527 ' HA3' HG23 ' B' ' 364' ' ' THR . . . -66.41 -48.01 66.48 Favored Glycine 0 C--N 1.352 1.422 0 N-CA-C 111.391 -0.684 . . . . 42.21 111.391 174.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 62.1 mttm 62.59 -81.22 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.547 1.139 . . . . 74.51 111.128 170.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . -72.61 80.3 0.66 Allowed Glycine 0 C--N 1.348 1.219 0 N-CA-C 108.665 -1.774 . . . . 74.43 108.665 159.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 18.4 t -83.39 31.64 0.46 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.685 1.194 . . . . 74.04 111.078 -172.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 19.8 pt -90.16 29.95 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 C-N-CA 125.413 1.485 . . . . 64.4 110.019 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 79.5 p -63.55 -23.16 67.27 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.429 1.092 . . . . 75.43 112.323 -171.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 215' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -80.12 -26.59 39.41 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.656 0.782 . . . . 73.31 111.013 176.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 16.4 tm0? 81.09 -55.26 0.3 Allowed 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 125.936 1.694 . . . . 61.42 113.369 167.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 1.8 tt -84.21 62.97 7.45 Favored 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 123.392 0.677 . . . . 75.4 111.412 -166.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 8.3 mp 74.93 -52.76 0.67 Allowed 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 125.61 1.564 . . . . 71.43 113.755 168.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 73.66 -41.77 0.5 Allowed 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 125.866 1.666 . . . . 71.24 111.698 -174.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . 0.591 ' HA ' HD22 ' B' ' 226' ' ' LEU . . . -63.24 -17.77 62.82 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.685 0.794 . . . . 61.1 111.908 166.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 221' ' ' ARG . . . . . . . . . . . . . 38.4 mtp-105 70.1 -81.17 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 125.54 1.536 . . . . 73.55 111.275 172.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -135.98 -9.72 2.05 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.845 0.858 . . . . 42.52 111.099 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.02 -35.37 78.16 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.88 1.272 . . . . 61.02 110.326 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 86.0 t 69.0 -68.54 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 125.455 1.502 . . . . 74.2 111.051 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 8.5 t -65.2 -41.95 94.03 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 123.916 0.887 . . . . 54.34 110.94 174.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . 0.591 HD22 ' HA ' ' B' ' 220' ' ' ALA . 37.8 tp 50.88 -80.76 0.01 OUTLIER 'General case' 0 C--N 1.366 1.321 0 C-N-CA 125.949 1.7 . . . . 74.43 112.203 -176.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . -167.96 12.03 0.06 OUTLIER Glycine 0 C--N 1.341 0.85 0 CA-C-N 116.485 -0.325 . . . . 51.31 112.476 176.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 88.7 -32.61 4.46 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-O 119.875 -0.403 . . . . 72.41 112.701 -173.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 229' ' ' GLY . . . . . 0.529 ' HA3' ' HA ' ' B' ' 283' ' ' ASP . . . 69.26 -104.05 1.2 Allowed Glycine 0 C--N 1.352 1.456 0 N-CA-C 112.511 -0.236 . . . . 70.24 112.511 175.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -64.7 -37.41 87.49 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.489 0.716 . . . . 70.23 110.243 172.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 231' ' ' LYS . . . . . . . . . . . . . 49.1 mttp 63.26 10.86 4.95 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 125.511 1.524 . . . . 73.24 112.169 178.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 86.6 m -121.34 110.59 16.29 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.151 0.581 . . . . 74.24 110.951 -168.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -95.11 95.63 8.69 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 108.408 -0.96 . . . . 70.41 108.408 173.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -144.76 -162.08 1.42 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.186 0.594 . . . . 72.31 110.095 -174.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . 0.524 ' HG3' ' HE2' ' C' ' 209' ' ' LYS . 17.9 tp10 76.76 121.27 0.05 OUTLIER 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 125.069 1.348 . . . . 54.41 112.087 173.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 236' ' ' THR . . . . . 0.705 HG23 HD21 ' B' ' 247' ' ' LEU . 49.3 m -96.25 -61.82 1.38 Allowed 'General case' 0 C--O 1.24 0.557 0 C-N-CA 125.614 1.565 . . . . 73.34 110.695 -173.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . 0.501 ' HA ' ' HD3' ' C' ' 209' ' ' LYS . . . 179.54 -178.3 0.37 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.574 0.75 . . . . 71.12 111.617 -171.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 238' ' ' THR . . . . . 0.506 ' HA ' HE22 ' B' ' 372' ' ' GLN . 94.0 m -152.7 38.46 0.53 Allowed 'General case' 0 N--CA 1.485 1.31 0 CA-C-O 123.722 1.725 . . . . 71.31 106.642 162.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 239' ' ' ALA . . . . . 0.611 ' HB2' ' H ' ' C' ' 222' ' ' ALA . . . -100.31 -178.73 3.91 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.171 -1.377 . . . . 74.42 112.592 -167.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 240' ' ' GLY . . . . . 0.414 ' HA3' ' HA ' ' C' ' 235' ' ' LEU . . . -107.34 -140.08 9.43 Favored Glycine 0 C--N 1.343 0.938 0 CA-C-N 114.589 -1.187 . . . . 71.23 110.629 176.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -133.95 147.93 51.11 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.403 0.681 . . . . 71.21 111.571 -170.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -167.95 -44.21 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.018 1.327 . . . . 70.32 109.193 176.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 243' ' ' GLN . . . . . 0.812 ' HG3' ' HG2' ' C' ' 224' ' ' PRO . 6.7 pt20 -159.45 164.1 34.82 Favored 'General case' 0 C--O 1.245 0.82 0 C-N-CA 123.969 0.908 . . . . 74.22 111.17 177.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -67.1 98.15 0.42 Allowed Glycine 0 C--N 1.355 1.633 0 O-C-N 124.179 0.924 . . . . 63.11 113.567 -169.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 245' ' ' LYS . . . . . 0.519 ' HE2' ' HB1' ' C' ' 222' ' ' ALA . 9.2 tmtm? -75.92 130.55 38.66 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.589 0.756 . . . . 75.34 110.009 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 35.1 p -116.25 139.31 50.49 Favored 'General case' 0 C--O 1.244 0.777 0 C-N-CA 124.095 0.958 . . . . 71.02 109.371 174.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 247' ' ' LEU . . . . . 0.705 HD21 HG23 ' B' ' 236' ' ' THR . 89.3 mt -72.71 158.64 35.21 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.839 0.856 . . . . 72.51 112.425 -175.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 248' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -82.88 145.51 29.4 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.069 0.947 . . . . 75.15 110.268 178.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -125.11 133.97 52.65 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 107.434 -1.321 . . . . 71.33 107.434 175.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -93.91 36.48 1.11 Allowed 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.818 0.847 . . . . 65.4 111.654 -170.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.96 -33.51 70.72 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 123.96 0.904 . . . . 61.03 113.301 -177.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -113.63 -23.61 9.65 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.682 0.793 . . . . 72.3 111.173 -176.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -64.08 -36.06 82.77 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.047 0.539 . . . . 51.41 110.872 173.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -70.73 87.51 0.69 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.752 0.821 . . . . 72.51 110.085 176.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 255' ' ' GLY . . . . . 0.507 ' HA2' HD13 ' B' ' 277' ' ' LEU . . . 59.04 -97.17 0.08 OUTLIER Glycine 0 C--N 1.353 1.52 0 O-C-N 123.968 0.793 . . . . 54.22 112.568 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 256' ' ' TYR . . . . . . . . . . . . . 23.0 t80 63.03 -73.78 0.04 OUTLIER 'General case' 0 C--N 1.367 1.364 0 C-N-CA 125.667 1.587 . . . . 52.52 110.547 175.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 257' ' ' GLN . . . . . 0.43 ' NE2' ' H ' ' B' ' 257' ' ' GLN . 2.2 mp0 -62.03 -64.46 0.93 Allowed 'General case' 0 C--N 1.35 0.588 0 C-N-CA 124.436 1.095 . . . . 74.31 108.514 169.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 258' ' ' LEU . . . . . . . . . . . . . 2.0 tt 57.35 -81.75 0.02 OUTLIER 'General case' 0 C--N 1.362 1.147 0 C-N-CA 125.775 1.63 . . . . 75.13 110.51 -178.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 45.2 t -90.85 99.32 9.47 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 N-CA-C 108.91 -0.774 . . . . 63.02 108.91 175.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 260' ' ' SER . . . . . . . . . . . . . 56.7 m -138.58 104.32 5.1 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.446 1.098 . . . . 73.11 108.198 176.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 62.3 23.26 13.75 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.59 1.156 . . . . 52.21 111.049 -170.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 262' ' ' ALA . . . . . . . . . . . . . . . -113.49 59.52 0.66 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.897 0.879 . . . . 43.43 109.773 -177.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -68.75 -32.2 71.79 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 115.746 -0.661 . . . . 70.44 110.469 175.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 34.6 t -98.55 161.75 13.5 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.939 0.896 . . . . 51.14 110.03 174.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 265' ' ' LEU . . . . . . . . . . . . . 85.8 mt -93.25 40.21 1.06 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.285 1.034 . . . . 64.12 110.644 -178.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 266' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 70.03 -67.0 0.25 Allowed 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 125.411 1.485 . . . . 71.52 109.999 -173.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 59.6 m -145.63 -57.84 0.32 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.578 1.151 . . . . 73.13 108.224 170.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 12.3 p -176.17 -23.18 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 C-N-CA 124.025 0.93 . . . . 74.44 110.28 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 269' ' ' THR . . . . . . . . . . . . . 12.5 m -66.17 85.05 0.09 Allowed 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.007 0.923 . . . . 74.31 111.822 -174.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 270' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -167.04 173.59 9.09 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.463 1.505 . . . . 72.41 108.749 178.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 271' ' ' ALA . . . . . 0.539 ' HB3' ' HB3' ' B' ' 275' ' ' LYS . . . -109.92 62.36 0.6 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 122.949 0.5 . . . . 75.3 110.688 -176.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 272' ' ' ASN . . . . . 0.503 ' O ' ' HG3' ' B' ' 275' ' ' LYS . 34.3 m-80 61.21 -167.91 0.19 Allowed 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 124.536 1.134 . . . . 54.14 111.398 174.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 5.6 pm0 -66.7 -15.92 63.86 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 122.882 0.473 . . . . 61.32 111.103 170.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -62.17 -35.66 79.48 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.515 1.126 . . . . 71.44 112.728 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 275' ' ' LYS . . . . . 0.539 ' HB3' ' HB3' ' B' ' 271' ' ' ALA . 2.2 pptp? -67.1 130.31 93.79 Favored Pre-proline 0 CA--C 1.555 1.172 0 N-CA-C 112.139 0.422 . . . . 71.33 112.139 -176.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -95.12 178.03 0.79 Allowed 'Trans proline' 0 C--N 1.371 1.739 0 C-N-CA 122.831 2.354 . . . . 62.35 112.297 171.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 277' ' ' LEU . . . . . 0.507 HD13 ' HA2' ' B' ' 255' ' ' GLY . 4.8 tt -107.0 110.33 22.44 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 106.804 -1.554 . . . . 63.32 106.804 174.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -68.13 -28.43 67.31 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.975 0.91 . . . . 62.0 112.386 -172.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . 84.22 17.98 63.64 Favored Glycine 0 N--CA 1.475 1.277 0 N-CA-C 114.401 0.52 . . . . 75.43 114.401 173.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -150.07 -179.65 7.34 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.468 0.707 . . . . 53.23 109.324 174.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -64.98 109.79 2.24 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 108.772 -0.825 . . . . 75.31 108.772 176.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -83.66 31.78 0.47 Allowed 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.568 0.951 . . . . 65.41 113.568 -166.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 283' ' ' ASP . . . . . 0.529 ' HA ' ' HA3' ' B' ' 229' ' ' GLY . 24.2 t70 -157.35 -93.59 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 122.682 0.393 . . . . 72.33 111.108 176.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . 138.68 -89.82 0.2 Allowed Glycine 0 C--N 1.352 1.446 0 N-CA-C 110.999 -0.84 . . . . 61.45 110.999 -170.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -145.94 3.21 0.93 Allowed 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 123.794 0.838 . . . . 72.41 111.984 -176.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 286' ' ' MET . . . . . . . . . . . . . 17.2 tpt -56.12 -57.29 23.23 Favored Pre-proline 0 CA--C 1.572 1.817 0 N-CA-C 115.424 1.638 . . . . 64.1 115.424 -165.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 287' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -92.65 36.63 0.23 Allowed 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 122.336 2.024 . . . . 73.33 111.633 -171.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 288' ' ' VAL . . . . . 0.611 HG13 ' H ' ' B' ' 289' ' ' ARG 0.299 7.3 p 41.96 -86.99 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.56 1.329 0 C-N-CA 126.005 1.722 . . . . 74.32 111.915 -161.783 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 289' ' ' ARG . . . . . 0.611 ' H ' HG13 ' B' ' 288' ' ' VAL . 6.2 tpm_? 55.14 49.49 17.27 Favored 'General case' 0 CA--C 1.56 1.357 0 CA-C-O 122.382 1.087 . . . . 72.14 110.564 -175.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 290' ' ' TRP . . . . . . . . . . . . . 75.7 t90 -64.7 114.59 4.54 Favored 'General case' 0 CA--C 1.552 1.04 0 CA-C-N 114.273 -1.33 . . . . 75.34 111.045 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 291' ' ' LEU . . . . . . . . . . . . . 74.1 mt 50.02 -81.37 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 126.747 2.019 . . . . 64.34 114.505 172.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . -177.0 -90.56 0.08 OUTLIER Glycine 0 C--N 1.338 0.666 0 N-CA-C 110.616 -0.994 . . . . 62.12 110.616 -177.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -64.44 101.27 0.35 Allowed 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.603 2.202 . . . . 51.12 110.802 173.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -72.67 -1.96 18.31 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.03 0.932 . . . . 41.23 112.026 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -148.52 175.15 11.39 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.072 0.949 . . . . 34.32 110.744 174.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 4.6 t -129.83 133.74 47.12 Favored 'General case' 0 C--O 1.243 0.759 0 N-CA-C 107.834 -1.173 . . . . 65.42 107.834 165.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -82.68 -10.95 58.69 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 122.838 0.455 . . . . 64.12 111.762 -174.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 50.5 m-70 63.64 -156.75 0.32 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.017 0.927 . . . . 71.5 110.388 -173.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . 77.11 18.25 78.74 Favored Glycine 0 C--N 1.35 1.315 0 CA-C-O 120.146 -0.252 . . . . 63.41 112.629 -175.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -162.87 -51.33 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.635 0.774 . . . . 72.23 110.271 -175.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 301' ' ' ILE . . . . . . . . . . . . . 37.3 pt -82.54 7.2 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 N-CA-C 112.829 0.678 . . . . 72.24 112.829 -174.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -80.43 74.37 7.3 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.642 0.777 . . . . 63.41 109.377 -174.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 303' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -95.95 136.36 22.23 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 107.629 -1.249 . . . . 74.11 107.629 178.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 304' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -34.1 -37.83 0.12 Allowed 'Trans proline' 0 C--N 1.387 2.579 1 C-N-CA 125.715 4.277 . . . . 75.12 116.946 -170.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -58.52 -54.28 48.87 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.821 0.848 . . . . 42.33 111.974 178.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 23.0 m -93.16 -51.07 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 122.859 0.464 . . . . 72.33 111.129 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 52.9 m 56.75 -90.39 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 125.1 1.36 . . . . 74.23 110.98 -175.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 308' ' ' CYS . . . . . . . . . . . . . 34.3 m -92.99 -31.48 14.87 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.437 0.695 . . . . 74.22 110.23 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . . . . . . . . 0.254 60.5 m 107.84 -59.1 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.773 0 C-N-CA 128.56 2.744 . . . . 72.2 111.757 -178.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -93.19 51.11 0.4 Allowed 'Trans proline' 0 C--N 1.392 2.818 0 CA-C-N 122.018 1.756 . . . . 63.14 112.794 174.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 311' ' ' ASN . . . . . 0.431 ' HB2' ' HD3' ' B' ' 312' ' ' PRO . 13.7 m120 -74.17 -58.3 2.03 Favored Pre-proline 0 CA--C 1.561 1.387 0 CA-C-O 118.823 -0.608 . . . . 73.13 111.586 177.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 312' ' ' PRO . . . . . 0.442 ' HG2' ' H ' ' B' ' 192' ' ' GLY . 55.9 Cg_endo -97.86 63.44 0.09 OUTLIER 'Trans proline' 0 C--N 1.388 2.611 0 C-N-CA 122.398 2.065 . . . . 70.14 111.943 -172.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 313' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -70.35 78.14 0.54 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.606 0.763 . . . . 75.13 111.186 -176.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 314' ' ' ARG . . . . . . . . . . . . . 4.6 mpt_? -124.04 69.46 1.06 Allowed 'General case' 0 C--O 1.238 0.491 0 N-CA-C 106.827 -1.546 . . . . 72.01 106.827 174.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 315' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -160.27 92.44 0.99 Allowed 'General case' 0 C--O 1.242 0.662 0 CA-C-N 114.311 -1.313 . . . . 72.12 107.671 176.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 316' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -74.2 -32.22 62.97 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.23 -0.895 . . . . 74.4 109.365 175.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 85.7 p 56.38 -74.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 126.12 1.768 . . . . 75.41 111.847 -173.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 318' ' ' VAL . . . . . 0.415 ' HB ' ' H ' ' B' ' 94' ' ' PHE . 21.5 m 38.51 58.05 5.32 Favored Pre-proline 0 N--CA 1.493 1.702 0 C-N-CA 126.333 1.853 . . . . 73.13 114.066 175.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 319' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -79.77 148.01 19.77 Favored 'Trans proline' 0 C--N 1.373 1.84 0 C-N-CA 122.02 1.814 . . . . 65.1 112.363 -172.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 320' ' ' THR . . . . . . . . . . . . . 33.8 m -151.56 -62.77 0.18 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.257 1.023 . . . . 53.31 110.071 -176.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 321' ' ' LEU . . . . . 0.614 HD12 ' HB2' ' B' ' 323' ' ' GLN . 0.1 OUTLIER -61.42 -55.58 29.78 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 124.14 0.9 . . . . 65.14 110.478 -168.576 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 322' ' ' ALA . . . . . . . . . . . . . . . 63.04 28.86 16.31 Favored 'General case' 0 CA--C 1.55 0.952 0 O-C-N 124.717 1.26 . . . . 64.54 111.696 175.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 323' ' ' GLN . . . . . 0.614 ' HB2' HD12 ' B' ' 321' ' ' LEU . 28.7 tp60 -66.79 114.67 5.84 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 123.387 0.675 . . . . 74.02 109.798 -177.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 324' ' ' MET . . . . . . . . . . . . . 76.9 mtm -80.99 15.52 1.81 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.609 0.763 . . . . 71.32 113.007 -170.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 325' ' ' THR . . . . . . . . . . . . . 31.7 m 77.1 -43.96 0.45 Allowed 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 126.139 1.776 . . . . 72.33 111.4 177.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 326' ' ' ASP . . . . . 0.445 ' HB2' ' HA3' ' B' ' 43' ' ' GLY . 1.5 m-20 69.63 18.4 7.64 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.736 1.214 . . . . 72.01 112.409 166.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . 0.544 ' HA ' ' HA3' ' B' ' 42' ' ' GLY . 39.9 ttpt -89.41 116.01 27.28 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.49 -0.93 . . . . 54.34 108.49 173.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 328' ' ' ALA . . . . . . . . . . . . . . . -127.42 -9.62 5.74 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.246 0.618 . . . . 72.03 112.541 -172.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 329' ' ' ILE . . . . . . . . . . . . . 3.4 mp -89.41 112.4 24.31 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.177 0 C-N-CA 122.729 0.412 . . . . 73.5 109.985 -169.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 330' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 68.85 135.17 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 127.292 2.237 . . . . 63.42 112.202 178.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 331' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.85 20.45 1.8 Allowed 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.43 1.092 . . . . 63.34 110.918 -172.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -144.79 -164.95 2.04 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.348 0.659 . . . . 74.41 111.806 -172.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 333' ' ' SER . . . . . . . . . . . . . 16.5 t 67.18 12.36 8.9 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 124.503 1.121 . . . . 65.04 113.671 164.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 15.5 ptmt -67.87 -32.29 72.69 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 122.84 0.456 . . . . 63.11 110.985 176.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 335' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 69.1 127.85 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 125.349 1.46 . . . . 73.25 111.374 -175.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 336' ' ' GLU . . . . . 0.779 ' HB2' ' HA ' ' B' ' 118' ' ' PRO . 62.5 mt-10 -130.27 -164.4 1.42 Allowed 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.405 1.082 . . . . 61.02 109.025 172.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 337' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -147.88 131.89 17.22 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 107.756 -1.202 . . . . 62.43 107.756 174.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 338' ' ' GLY . . . . . . . . . . . . . . . -75.07 81.11 0.93 Allowed Glycine 0 C--N 1.347 1.166 0 O-C-N 123.535 0.522 . . . . 72.34 112.6 -178.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 339' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -126.55 23.12 6.88 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 107.618 -1.253 . . . . 74.33 107.618 171.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 340' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -78.32 -0.09 27.52 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.04 -0.982 . . . . 75.24 111.989 -176.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 341' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -78.31 -57.29 3.86 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.183 0.993 . . . . 75.34 109.327 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 342' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 60.14 -132.27 0.87 Allowed 'General case' 0 CA--C 1.566 1.589 0 C-N-CA 124.326 1.05 . . . . 64.25 108.536 -177.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 343' ' ' VAL . . . . . 0.406 HG21 ' HE2' ' B' ' 15' ' ' PHE . 6.7 p -163.97 74.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.677 0 N-CA-C 107.161 -1.422 . . . . 64.24 107.161 173.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -79.25 157.79 27.71 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 114.234 -1.348 . . . . 73.03 109.968 176.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 345' ' ' GLY . . . . . . . . . . . . . . . -163.4 50.67 0.3 Allowed Glycine 0 C--N 1.336 0.565 0 CA-C-N 115.472 -0.786 . . . . 62.31 112.114 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 346' ' ' ALA . . . . . . . . . . . . . . . -159.93 -88.38 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 109.164 -0.68 . . . . 72.22 109.164 175.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 70.3 m 61.01 -80.27 0.02 OUTLIER 'General case' 0 C--N 1.366 1.299 0 C-N-CA 124.541 1.136 . . . . 72.21 111.94 -178.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 348' ' ' ILE . . . . . 0.447 ' O ' ' HG2' ' B' ' 351' ' ' GLN . 2.4 pp -98.2 -6.96 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 123.959 0.904 . . . . 73.42 111.211 178.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 349' ' ' ASP . . . . . . . . . . . . . 29.3 t70 66.74 -82.36 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.632 1.573 . . . . 71.13 109.642 -174.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 350' ' ' LYS . . . . . . . . . . . . . 8.4 mptt -135.45 -76.46 0.44 Allowed 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.496 -0.927 . . . . 74.52 108.496 167.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 351' ' ' GLN . . . . . 0.447 ' HG2' ' O ' ' B' ' 348' ' ' ILE . 67.1 mm-40 59.73 176.36 0.08 Allowed 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 125.797 1.639 . . . . 71.32 112.843 -175.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -82.43 -28.23 31.46 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.676 -0.693 . . . . 74.35 109.521 175.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 353' ' ' HIS . . . . . . . . . . . . . 13.0 p80 52.54 12.67 0.26 Allowed 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 127.433 2.293 . . . . 74.33 114.706 174.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 354' ' ' ALA . . . . . 0.475 ' HB1' ' HA3' ' B' ' 162' ' ' GLY . . . -96.42 43.52 1.08 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.574 0.75 . . . . 70.11 110.594 -176.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 355' ' ' ALA . . . . . . . . . . . . . . . -66.34 99.96 0.59 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.543 0.737 . . . . 75.44 110.179 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 356' ' ' ASN . . . . . 0.511 ' HB2' ' H ' ' B' ' 162' ' ' GLY . 0.2 OUTLIER -85.14 113.38 49.88 Favored Pre-proline 0 N--CA 1.479 0.994 0 C-N-CA 124.164 0.986 . . . . 74.32 109.951 -171.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 357' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -83.73 149.55 12.67 Favored 'Trans proline' 0 C--N 1.373 1.852 0 C-N-CA 123.134 2.556 . . . . 55.22 111.107 173.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 358' ' ' CYS . . . . . . . . . . . . . 86.1 m -138.05 21.97 2.82 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.903 0.881 . . . . 73.32 109.554 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 359' ' ' GLY . . . . . . . . . . . . . . . -73.81 127.79 10.64 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 115.237 -0.892 . . . . 62.01 113.461 -174.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 360' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -143.36 52.67 1.35 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.96 0.904 . . . . 53.34 110.479 -171.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 361' ' ' ILE . . . . . 0.432 HG22 ' H ' ' B' ' 363' ' ' GLU . 51.4 mt 68.23 -79.09 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 125.24 1.416 . . . . 61.31 110.568 178.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 362' ' ' GLY . . . . . . . . . . . . . . . 118.4 -43.55 1.58 Allowed Glycine 0 C--N 1.346 1.117 0 N-CA-C 111.605 -0.598 . . . . 72.35 111.605 -176.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 363' ' ' GLU . . . . . 0.554 ' HG2' ' HA ' ' B' ' 201' ' ' PRO . 1.7 mp0 -86.84 -8.66 57.1 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.634 0.774 . . . . 73.13 111.245 179.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 364' ' ' THR . . . . . 0.527 HG23 ' HA3' ' B' ' 209' ' ' GLY . 72.9 m 74.81 -63.44 0.42 Allowed 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.754 1.622 . . . . 74.04 110.955 -173.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 39.5 t 66.02 160.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 C-N-CA 124.401 1.08 . . . . 74.01 110.804 -178.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -52.04 130.45 29.9 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.404 0.682 . . . . 50.12 111.995 178.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 367' ' ' LEU . . . . . . . . . . . . . 8.2 mp -60.73 -32.89 72.13 Favored 'General case' 0 C--N 1.352 0.693 0 O-C-N 124.404 1.065 . . . . 75.05 110.449 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 368' ' ' ASP . . . . . . . . . . . . . 32.5 t70 69.38 -66.54 0.25 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.747 1.619 . . . . 71.23 111.718 173.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 369' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 74.0 117.32 0.05 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.487 1.515 . . . . 70.1 111.861 169.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 370' ' ' ALA . . . . . 0.516 ' HB3' ' NE2' ' B' ' 372' ' ' GLN . . . -92.27 -179.31 5.2 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.755 0.822 . . . . 74.25 111.347 -176.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 371' ' ' VAL . . . . . . . . . . . . . 85.5 t -74.19 -30.46 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.029 0.932 . . . . 74.11 111.187 -178.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 372' ' ' GLN . . . . . 0.516 ' NE2' ' HB3' ' B' ' 370' ' ' ALA . 51.0 mm-40 64.24 83.45 0.16 Allowed 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 125.092 1.357 . . . . 63.2 111.122 179.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 373' ' ' ARG . . . . . 0.431 ' HA ' ' NE ' ' B' ' 373' ' ' ARG . 1.3 tpm_? -95.35 68.14 3.0 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.424 -0.807 . . . . 72.05 109.486 -176.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 374' ' ' ALA . . . . . 0.479 ' HA ' ' HD2' ' B' ' 377' ' ' PHE . . . -151.92 13.89 0.62 Allowed 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 115.068 -0.969 . . . . 71.45 111.383 -177.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 375' ' ' LEU . . . . . . . . . . . . . 76.6 mt -81.74 -12.59 58.53 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.208 0.603 . . . . 62.01 111.646 -175.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -111.93 -31.15 7.01 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.272 1.029 . . . . 73.13 110.386 178.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 377' ' ' PHE . . . . . 0.479 ' HD2' ' HA ' ' B' ' 374' ' ' ALA . 71.7 m-85 -72.18 92.29 1.35 Allowed 'General case' 0 C--N 1.352 0.687 0 C-N-CA 123.341 0.656 . . . . 73.31 109.787 -178.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 378' ' ' ALA . . . . . . . . . . . . . . . -107.12 -83.64 0.53 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.485 0.714 . . . . 61.1 110.65 -177.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 40.8 mtmt 56.25 72.92 0.47 Allowed 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.728 0.811 . . . . 72.01 109.461 -172.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 380' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 66.21 -173.02 0.19 Allowed 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 124.682 1.193 . . . . 53.14 110.655 -170.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 381' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -165.0 -46.43 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.321 0.649 . . . . 74.34 110.248 -177.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -176.97 93.35 0.09 OUTLIER Glycine 0 C--N 1.346 1.115 0 CA-C-N 116.041 -0.527 . . . . 73.1 112.09 -172.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 383' ' ' ASN . . . . . . . . . . . . . 25.5 p30 -164.88 -10.44 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 112.849 0.685 . . . . 73.1 112.849 -172.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 384' ' ' THR . . . . . . . . . . . . . 6.5 t -97.93 108.56 21.29 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.435 0.636 . . . . 63.41 112.316 -174.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 68.3 mt -88.31 59.34 5.18 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 109.411 -0.589 . . . . 75.12 109.411 171.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 386' ' ' VAL . . . . . . . . . . . . . 98.0 t 70.67 -67.1 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 125.855 1.662 . . . . 62.42 111.929 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 387' ' ' ILE . . . . . . . . . . . . . 8.7 tp -57.91 -29.42 35.8 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.165 0 C-N-CA 125.078 1.351 . . . . 74.12 113.338 -172.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 388' ' ' VAL . . . . . . . . . . . . . 58.1 t -62.9 -48.57 87.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 123.09 0.556 . . . . 54.33 110.965 -177.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 389' ' ' THR . . . . . . . . . . . . . 29.8 p -84.59 -24.37 29.22 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 122.626 0.37 . . . . 71.25 111.182 174.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . 58.99 32.17 22.03 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 124.991 1.317 . . . . 70.34 112.137 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 391' ' ' ASP . . . . . . . . . . . . . 16.9 t70 67.6 -76.69 0.05 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 125.01 1.324 . . . . 64.12 111.112 -176.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 392' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -138.22 177.14 8.1 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.774 0.83 . . . . 72.42 109.185 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . 64.15 15.86 9.62 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 124.345 1.058 . . . . 61.53 112.56 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -164.59 -34.21 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.045 0.938 . . . . 73.31 109.838 -176.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . -65.03 165.46 10.99 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.888 0.875 . . . . 71.44 112.105 176.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 28.8 m -59.94 -32.61 70.95 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.384 0.674 . . . . 75.55 111.231 174.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 397' ' ' GLN . . . . . 0.496 HE22 ' HB3' ' B' ' 145' ' ' ASP . 0.4 OUTLIER -95.28 108.96 21.14 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 108.628 -0.878 . . . . 71.41 108.628 177.179 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 59.3 mt -136.96 -75.24 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 N-CA-C 106.973 -1.491 . . . . 75.44 106.973 171.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 399' ' ' VAL . . . . . . . . . . . . . 27.5 m -102.2 -178.85 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.322 1.049 . . . . 73.32 110.28 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 400' ' ' ALA . . . . . . . . . . . . . . . -70.04 -40.82 13.45 Favored Pre-proline 0 CA--C 1.56 1.35 0 C-N-CA 123.021 0.529 . . . . 51.41 112.386 178.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 401' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -74.61 39.55 0.57 Allowed 'Trans proline' 0 C--N 1.384 2.431 0 C-N-CA 122.234 1.956 . . . . 71.04 113.713 160.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 69.25 -80.06 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 126.14 1.776 . . . . 74.34 112.585 173.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 403' ' ' THR . . . . . . . . . . . . . 40.9 p -122.2 -176.92 3.47 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.111 0.564 . . . . 51.3 111.814 -173.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 404' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.88 142.62 42.77 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.484 1.114 . . . . 70.03 109.101 173.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 405' ' ' ALA . . . . . . . . . . . . . . . -72.99 -50.62 6.68 Favored Pre-proline 0 CA--C 1.557 1.228 0 CA-C-O 118.466 -0.778 . . . . 71.24 112.481 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 406' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -75.04 100.08 1.32 Allowed 'Trans proline' 0 C--N 1.39 2.76 0 CA-C-N 120.925 1.366 . . . . 44.44 111.166 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . -55.26 -87.82 0.01 OUTLIER Glycine 0 C--N 1.352 1.444 0 O-C-N 124.036 0.835 . . . . 55.33 113.995 -172.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 408' ' ' LEU . . . . . . . . . . . . . 21.7 tp -171.81 159.31 5.18 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.352 0.661 . . . . 72.03 109.642 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 16.6 p -64.67 -53.85 41.03 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.133 0.973 . . . . 73.52 111.134 174.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 410' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -139.11 108.01 5.98 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-O 121.456 0.646 . . . . 51.32 109.685 174.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . -94.94 -54.28 3.52 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.42 0.688 . . . . 63.14 110.135 178.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 95.2 mt 63.81 -77.85 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.451 1.5 . . . . 60.41 110.989 -177.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 42.1 t-20 48.52 75.23 0.15 Allowed 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 125.42 1.488 . . . . 71.14 111.863 175.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 414' ' ' THR . . . . . . . . . . . . . 45.4 m -84.76 78.14 9.93 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 109.443 -0.577 . . . . 73.24 109.443 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 415' ' ' LYS . . . . . . . . . . . . . 58.1 mttp 58.04 46.39 16.4 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.562 1.145 . . . . 73.42 111.136 -178.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 21.7 t70 72.04 -74.72 0.08 Allowed 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 125.058 1.343 . . . . 75.33 111.664 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 417' ' ' GLY . . . . . . . . . . . . . . . 163.94 -42.07 0.32 Allowed Glycine 0 C--N 1.339 0.745 0 N-CA-C 110.666 -0.974 . . . . 43.15 110.666 -176.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 418' ' ' ALA . . . . . . . . . . . . . . . -72.02 127.37 32.34 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.428 0.691 . . . . 70.25 109.437 173.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 419' ' ' VAL . . . . . . . . . . . . . 14.1 m 48.52 34.18 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 C-N-CA 126.02 1.728 . . . . 62.03 112.951 -178.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 420' ' ' MET . . . . . 0.402 ' SD ' ' N ' ' B' ' 421' ' ' VAL . 0.0 OUTLIER -58.19 -37.76 75.4 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.725 0.81 . . . . 73.12 111.699 -179.055 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 421' ' ' VAL . . . . . 0.616 HG13 ' HG2' ' A' ' 211' ' ' ARG . 3.9 p -90.23 74.65 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 CA-C-O 122.717 1.246 . . . . 72.42 108.463 168.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 422' ' ' MET . . . . . . . . . . . . . 17.8 ptp -80.15 -18.44 49.74 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 114.469 -1.241 . . . . 74.1 110.294 174.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 423' ' ' SER . . . . . . . . . . . . . 37.3 m 74.08 -60.63 0.52 Allowed 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 126.433 1.893 . . . . 62.22 113.237 170.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 424' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 59.03 34.65 23.63 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.066 0.946 . . . . 72.42 110.14 -172.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . 99.05 -64.03 0.72 Allowed Glycine 0 C--N 1.349 1.277 0 CA-C-N 114.23 -1.35 . . . . 75.12 110.862 -172.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 426' ' ' ASN . . . . . . . . . . . . . 6.5 t30 63.81 -67.51 0.1 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 126.259 1.824 . . . . 75.43 111.251 -174.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 427' ' ' SER . . . . . 0.552 ' HB2' ' HB3' ' B' ' 432' ' ' GLN . 20.0 m -90.4 138.85 31.21 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 108.905 -0.776 . . . . 75.14 108.905 171.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -88.14 11.53 16.03 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.163 0.585 . . . . 73.23 112.064 -164.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 429' ' ' GLU . . . . . 0.556 ' HB2' ' HB2' ' B' ' 432' ' ' GLN . 11.2 mp0 -95.38 33.22 1.62 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.596 0.758 . . . . 63.42 110.173 178.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 31.9 t70 58.61 93.62 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.848 1.259 . . . . 55.41 110.763 -176.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 44.8 t 66.36 -73.28 0.07 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.963 1.305 . . . . 73.31 110.099 -172.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 432' ' ' GLN . . . . . 0.556 ' HB2' ' HB2' ' B' ' 429' ' ' GLU . 52.7 tp60 73.01 -65.29 0.36 Allowed 'General case' 0 C--N 1.361 1.088 0 C-N-CA 125.866 1.666 . . . . 71.1 111.583 175.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 433' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -73.45 72.61 1.36 Allowed 'General case' 0 C--O 1.242 0.702 0 N-CA-C 108.345 -0.983 . . . . 73.43 108.345 174.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 434' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -82.55 93.8 7.36 Favored 'General case' 0 C--N 1.345 0.382 0 CA-C-N 114.751 -1.113 . . . . 65.13 108.292 -168.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 435' ' ' THR . . . . . 0.43 ' HB ' ' HG3' ' A' ' 220' ' ' GLU . 0.6 OUTLIER -69.56 -10.63 58.96 Favored 'General case' 0 CA--C 1.557 1.244 0 CA-C-N 114.999 -1.0 . . . . 73.42 112.56 -163.595 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . 176.5 -112.18 0.38 Allowed Glycine 0 C--N 1.353 1.525 0 CA-C-O 119.5 -0.611 . . . . 43.54 112.56 175.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 437' ' ' SER . . . . . 0.489 ' N ' ' HB2' ' A' ' 220' ' ' GLU . 16.4 t 84.33 -13.02 0.74 Allowed 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 126.69 1.996 . . . . 54.14 112.141 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 438' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -65.58 -28.81 69.41 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.103 0.561 . . . . 71.55 109.766 169.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 439' ' ' LEU . . . . . . . . . . . . . 4.9 mp -76.68 96.19 4.14 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.151 0.98 . . . . 74.24 109.323 175.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 440' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -90.28 161.41 15.67 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.509 0.724 . . . . 70.1 110.614 176.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 441' ' ' ILE . . . . . 0.731 HD12 ' HA ' ' A' ' 223' ' ' VAL . 44.7 mt -120.66 135.04 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 123.542 0.737 . . . . 74.15 110.564 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 442' ' ' ALA . . . . . . . . . . . . . . . -88.33 -87.08 0.16 Allowed 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 109.542 -0.54 . . . . 71.41 109.542 173.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . 55.99 -86.33 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.239 0 C-N-CA 125.232 1.413 . . . . 74.21 112.801 177.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -170.58 167.31 8.02 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.68 1.592 . . . . 65.34 107.871 178.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . 139.53 -64.33 0.54 Allowed Glycine 0 N--CA 1.469 0.839 0 N-CA-C 111.494 -0.642 . . . . 74.34 111.494 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 446' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -63.14 101.02 0.27 Allowed 'Trans proline' 0 C--N 1.382 2.342 0 C-N-CA 122.345 2.03 . . . . 63.02 108.874 166.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 447' ' ' HIS . . . . . 0.52 ' HB3' ' HA2' ' B' ' 469' ' ' GLY . 12.4 t60 -85.04 -23.97 28.36 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 115.639 -0.71 . . . . 60.0 110.227 -173.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . -156.56 26.86 0.34 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.986 0.914 . . . . 74.31 110.224 174.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 449' ' ' ALA . . . . . 0.479 ' HB2' ' HB2' ' B' ' 468' ' ' LEU . . . -120.93 21.29 11.42 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.305 0.642 . . . . 61.52 111.497 -175.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 450' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -78.44 89.08 4.41 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.477 0.711 . . . . 61.12 110.065 -174.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 27.2 m 41.28 81.4 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 C-N-CA 126.227 1.811 . . . . 63.1 113.164 -178.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 452' ' ' VAL . . . . . . . . . . . . . 34.9 m -80.14 5.66 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 CA-C-N 115.582 -0.736 . . . . 60.45 112.454 -176.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 67.61 47.62 61.01 Favored Glycine 0 C--N 1.352 1.45 0 N-CA-C 111.289 -0.724 . . . . 73.44 111.289 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 454' ' ' LEU . . . . . . . . . . . . . 32.1 tp -69.87 -6.62 33.92 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 124.444 1.098 . . . . 72.5 112.714 -170.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 6.1 m 65.45 30.92 10.61 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 122.548 1.166 . . . . 61.41 108.782 -171.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -91.16 174.95 7.13 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 114.417 -1.265 . . . . 74.3 110.966 -175.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 457' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -157.62 -79.77 0.07 Allowed 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.83 -0.623 . . . . 42.14 110.096 179.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 9.1 p -149.85 -48.95 0.14 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.212 0.605 . . . . 72.13 111.416 -170.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 459' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -80.74 -130.22 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 124.561 1.144 . . . . 73.31 112.19 -167.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 6.7 mp -68.44 85.02 0.27 Allowed 'General case' 0 C--N 1.366 1.293 0 CA-C-N 119.044 0.838 . . . . 65.42 110.22 -177.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -147.12 22.94 1.2 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.462 1.505 . . . . 62.31 108.945 177.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 21.9 t80 -69.49 90.35 0.54 Allowed 'General case' 0 C--N 1.359 1.006 0 C-N-CA 123.836 0.854 . . . . 72.53 109.916 -175.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 37.6 p -106.97 89.13 2.91 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.749 0.82 . . . . 61.35 109.569 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 464' ' ' MET . . . . . . . . . . . . . 48.3 ttp -72.22 -60.0 2.45 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.52 -0.919 . . . . 75.31 108.52 173.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt 56.6 -83.43 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 125.955 1.702 . . . . 72.15 112.23 173.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -162.63 173.9 13.3 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.146 1.378 . . . . 62.32 109.398 -177.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . -83.03 99.25 9.73 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 109.502 -0.555 . . . . 75.3 109.502 175.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 468' ' ' LEU . . . . . 0.479 ' HB2' ' HB2' ' B' ' 449' ' ' ALA . 3.4 mm? -66.27 100.33 0.62 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.229 0.612 . . . . 45.51 109.933 177.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 469' ' ' GLY . . . . . 0.52 ' HA2' ' HB3' ' B' ' 447' ' ' HIS . . . -157.1 61.41 0.33 Allowed Glycine 0 C--N 1.34 0.796 0 N-CA-C 110.913 -0.875 . . . . 50.44 110.913 -178.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 470' ' ' LEU . . . . . . . . . . . . . 5.7 mp -80.81 69.52 7.38 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 123.779 0.832 . . . . 73.2 110.619 -174.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 471' ' ' LYS . . . . . . . . . . . . . 88.2 tttt . . . . . 0 CA--C 1.556 1.179 0 C-N-CA 125.152 1.381 . . . . 74.2 107.947 177.335 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 73.1 mtm . . . . . 0 N--CA 1.474 0.736 0 N-CA-C 109.29 -0.633 . . . . 55.23 109.29 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 60.28 33.55 20.91 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.316 1.047 . . . . 65.31 111.442 -175.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -88.5 51.44 2.18 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.055 0.942 . . . . 52.01 110.542 -175.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -38.3 110.38 0.13 Allowed 'General case' 0 C--N 1.363 1.183 0 C-N-CA 125.362 1.465 . . . . 70.52 114.698 -172.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 5' ' ' LYS . . . . . 0.722 ' HD2' HD11 ' C' ' 10' ' ' ILE . 23.2 mmtp -82.57 99.81 9.75 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 115.479 -0.782 . . . . 63.2 109.822 170.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -75.04 89.58 2.44 Favored 'General case' 0 C--O 1.246 0.875 0 N-CA-C 107.092 -1.447 . . . . 63.22 107.092 169.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 7' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -61.1 -28.36 69.03 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 114.917 -1.038 . . . . 73.43 112.145 -170.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 8' ' ' TYR . . . . . 0.421 ' HD1' HG23 ' C' ' 13' ' ' VAL . 64.1 m-85 -72.62 -41.44 65.54 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.356 0.662 . . . . 72.53 111.548 177.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.84 -43.05 99.62 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 123.386 0.429 . . . . 52.31 110.497 175.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 10' ' ' ILE . . . . . 0.722 HD11 ' HD2' ' C' ' 5' ' ' LYS . 73.1 mt -59.06 -44.55 91.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 O-C-N 123.956 0.785 . . . . 63.34 110.619 176.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 85.1 mt -78.69 -3.33 43.58 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 112.896 0.702 . . . . 45.45 112.896 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 61.29 39.79 97.71 Favored Glycine 0 C--N 1.356 1.655 0 O-C-N 123.302 0.376 . . . . 64.33 113.438 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 13' ' ' VAL . . . . . 0.421 HG23 ' HD1' ' C' ' 8' ' ' TYR . 11.8 m -135.69 158.49 74.09 Favored Pre-proline 0 N--CA 1.48 1.057 0 C-N-CA 125.084 1.354 . . . . 64.04 109.075 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.29 163.66 38.38 Favored 'Trans proline' 0 C--N 1.377 2.071 0 C-N-CA 122.125 1.884 . . . . 74.43 112.49 178.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 58.1 mtt180 -77.81 21.96 0.29 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.004 0.921 . . . . 71.52 111.876 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -117.33 -14.16 10.41 Favored 'General case' 0 C--O 1.243 0.749 0 C-N-CA 125.951 1.7 . . . . 71.24 108.37 178.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.15 114.97 1.34 Allowed 'General case' 0 C--N 1.356 0.879 0 C-N-CA 124.214 1.006 . . . . 71.14 110.538 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 54.4 p -74.21 167.02 22.43 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.596 0.758 . . . . 74.41 109.092 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.91 -40.68 57.44 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 124.014 0.926 . . . . 74.45 111.187 -173.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 20' ' ' GLU . . . . . 0.677 ' HA ' ' HE3' ' C' ' 23' ' ' LYS . 3.7 tm-20 -66.04 -40.79 91.27 Favored 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 124.467 1.107 . . . . 64.05 110.685 -178.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . 0.515 ' HG2' ' NH2' ' C' ' 24' ' ' ARG . 32.7 mt-10 -72.26 -34.44 68.24 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 115.651 -0.704 . . . . 73.42 111.258 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 22' ' ' ILE . . . . . 0.903 HD13 ' HB3' ' C' ' 57' ' ' LEU . 96.1 mt -68.61 -38.98 79.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 124.785 1.234 . . . . 61.32 110.16 176.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 23' ' ' LYS . . . . . 0.677 ' HE3' ' HA ' ' C' ' 20' ' ' GLU . 22.2 ttpp -62.98 -35.88 81.64 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 113.896 -1.502 . . . . 74.13 110.063 177.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 24' ' ' ARG . . . . . 0.515 ' NH2' ' HG2' ' C' ' 21' ' ' GLU . 45.6 mtm180 -77.35 -30.07 53.68 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 113.235 0.828 . . . . 73.52 113.235 173.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.03 -37.38 86.97 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 121.617 0.723 . . . . 75.32 109.918 171.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 26' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -68.52 -41.93 79.24 Favored 'General case' 0 C--O 1.209 -1.051 0 CA-C-N 113.869 -1.514 . . . . 72.31 110.474 175.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . 0.546 ' HG2' ' HA ' ' B' ' 37' ' ' ASP . 27.5 mtpp -50.89 -56.23 13.29 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 118.369 0.531 . . . . 74.1 110.385 173.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -55.61 -58.88 5.95 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 114.944 -1.026 . . . . 71.15 112.138 -177.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 87.1 mt -83.21 -21.28 33.48 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 112.894 0.702 . . . . 60.22 112.894 -169.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . 0.478 ' O ' ' HB2' ' C' ' 34' ' ' HIS . . . -78.97 -30.54 44.5 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 118.809 0.732 . . . . 75.32 110.406 176.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 65.1 mtm180 -73.59 -45.54 52.6 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 109.997 -0.371 . . . . 73.5 109.997 170.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.63 -46.61 84.89 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.617 0.767 . . . . 71.12 111.023 -174.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 33' ' ' TYR . . . . . 0.5 ' HD1' ' HB1' ' C' ' 43' ' ' ALA . 52.7 m-85 -90.76 4.72 50.84 Favored 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 123.466 0.706 . . . . 70.15 112.071 -178.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 34' ' ' HIS . . . . . 0.478 ' HB2' ' O ' ' C' ' 30' ' ' ALA . 41.8 t60 -60.64 113.35 7.4 Favored Pre-proline 0 N--CA 1.49 1.551 0 CA-C-O 118.206 -0.902 . . . . 72.34 110.959 -177.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -48.47 -36.65 31.61 Favored 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 124.283 3.322 . . . . 71.32 115.287 -171.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -69.99 -41.35 74.52 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 122.688 0.395 . . . . 60.34 111.324 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 45.3 t -85.03 -28.71 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-O 121.036 0.446 . . . . 75.33 110.123 -175.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -139.0 80.22 1.77 Allowed 'General case' 0 C--O 1.248 0.981 0 C-N-CA 124.204 1.002 . . . . 54.22 108.83 -174.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -70.31 84.8 0.57 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 114.778 -1.101 . . . . 62.24 109.402 176.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . 0.576 ' HB2' ' HB3' ' C' ' 43' ' ' ALA . 16.4 m -138.68 103.75 7.65 Favored Pre-proline 0 CA--C 1.542 0.655 0 CA-C-O 117.836 -1.078 . . . . 74.14 108.117 175.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' C' ' 40' ' ' SER . 5.3 Cg_exo -37.33 -54.23 1.19 Allowed 'Trans proline' 0 C--N 1.393 2.874 0 C-N-CA 124.702 3.601 . . . . 63.44 114.183 -176.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.56 -36.49 83.96 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.973 0.509 . . . . 65.44 110.698 -177.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 43' ' ' ALA . . . . . 0.576 ' HB3' ' HB2' ' C' ' 40' ' ' SER . . . -75.17 -17.51 60.37 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.168 0.587 . . . . 62.05 111.313 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -86.2 -31.93 21.48 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.333 0.653 . . . . 74.04 109.491 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -70.1 -41.74 73.63 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.57 -0.741 . . . . 42.53 109.502 170.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 46' ' ' LYS . . . . . 0.538 ' O ' HG12 ' C' ' 50' ' ' ILE . 33.6 mmtm -63.32 -36.3 83.24 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-N 115.201 -0.908 . . . . 72.32 110.468 173.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -57.2 -49.0 77.38 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.604 0.762 . . . . 62.23 109.337 174.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 48' ' ' LYS . . . . . 0.551 ' HB3' ' HE1' ' C' ' 93' ' ' PHE . 52.0 mtpt -57.87 -38.23 75.36 Favored 'General case' 0 CA--C 1.551 1.009 0 O-C-N 123.762 0.663 . . . . 72.04 111.631 175.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -76.31 -19.39 58.29 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.203 0.601 . . . . 72.33 112.267 178.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 50' ' ' ILE . . . . . 0.538 HG12 ' O ' ' C' ' 46' ' ' LYS . 28.4 mm -76.0 -38.96 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 108.474 -0.936 . . . . 75.43 108.474 171.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 51' ' ' ASN . . . . . 0.467 ' HB3' ' CD1' ' C' ' 88' ' ' PHE . 55.7 m-80 -68.42 -30.76 69.73 Favored 'General case' 0 C--O 1.217 -0.645 0 CA-C-N 114.474 -1.239 . . . . 74.04 110.736 176.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -68.51 -55.15 12.69 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.845 1.258 . . . . 63.42 110.528 175.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.26 -50.41 69.55 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 114.035 -1.438 . . . . 63.1 111.162 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -63.56 -39.41 94.33 Favored 'General case' 0 C--O 1.198 -1.638 0 CA-C-N 115.023 -0.99 . . . . 75.01 110.775 176.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 55' ' ' ALA . . . . . 0.484 ' HB2' ' CD2' ' C' ' 88' ' ' PHE . . . -56.31 -45.04 80.43 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 118.531 0.605 . . . . 60.54 112.255 -178.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 56' ' ' VAL . . . . . 0.443 ' O ' ' HB2' ' C' ' 62' ' ' LYS . 96.1 t -65.7 -46.42 89.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 CA-C-O 121.752 0.786 . . . . 72.43 109.826 173.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 57' ' ' LEU . . . . . 0.903 ' HB3' HD13 ' C' ' 22' ' ' ILE . 81.6 mt -92.37 9.54 33.7 Favored 'General case' 0 CA--C 1.56 1.344 0 N-CA-C 113.365 0.876 . . . . 75.02 113.365 -169.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 21.9 t -86.16 -24.15 26.27 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.54 0.736 . . . . 62.42 110.491 179.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -101.61 131.54 22.82 Favored Pre-proline 0 C--O 1.241 0.633 0 N-CA-C 108.336 -0.987 . . . . 72.03 108.336 174.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 60' ' ' PRO . . . . . 0.494 ' O ' ' HG2' ' C' ' 64' ' ' ARG . 73.7 Cg_exo -53.48 -32.51 63.39 Favored 'Trans proline' 0 C--N 1.375 1.934 0 C-N-CA 122.833 2.356 . . . . 33.23 111.444 164.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -68.09 -49.44 61.26 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.078 0.951 . . . . 62.13 111.561 -177.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 62' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' C' ' 56' ' ' VAL . 62.1 mttp -73.27 -23.98 60.38 Favored 'General case' 0 CA--C 1.559 1.302 0 C-N-CA 122.386 0.274 . . . . 75.23 110.751 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 -61.38 -43.3 99.1 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 109.39 -0.596 . . . . 64.42 109.39 167.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 64' ' ' ARG . . . . . 0.494 ' HG2' ' O ' ' C' ' 60' ' ' PRO . 28.5 mmm180 -68.72 -32.07 71.6 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 119.272 -0.394 . . . . 74.15 111.56 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 65' ' ' ILE . . . . . 0.442 HG23 ' HD2' ' C' ' 76' ' ' PRO . 80.1 mt -62.29 -42.19 94.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 N-CA-C 109.716 -0.475 . . . . 62.34 109.716 171.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -63.25 -44.86 93.99 Favored 'General case' 0 CA--C 1.553 1.079 0 CA-C-N 115.573 -0.739 . . . . 74.22 109.756 176.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -58.11 -42.13 85.06 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.184 0.994 . . . . 73.14 111.064 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 68' ' ' THR . . . . . 0.425 ' OG1' ' HG2' ' C' ' 76' ' ' PRO . 39.9 p -83.93 -10.31 58.05 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.602 -0.726 . . . . 63.2 112.013 -178.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -71.81 96.7 1.68 Allowed 'General case' 0 C--N 1.36 1.037 0 N-CA-C 108.197 -1.038 . . . . 75.22 108.197 171.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 104.34 30.98 4.81 Favored Glycine 0 C--N 1.346 1.104 0 CA-C-N 116.075 -0.511 . . . . 62.51 111.94 -173.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 84.9 m -146.78 -54.16 0.24 Allowed 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 103.877 -2.638 . . . . 72.34 103.877 174.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 24.7 m -86.24 141.71 29.09 Favored 'General case' 0 C--O 1.256 1.406 0 N-CA-C 104.811 -2.292 . . . . 73.35 104.811 157.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.15 -27.62 20.58 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 123.752 0.821 . . . . 73.23 111.612 -177.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -97.24 155.77 37.03 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 123.911 0.884 . . . . 53.23 109.806 176.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_exo -60.12 114.74 2.23 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 122.65 2.234 . . . . 75.14 111.079 168.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 76' ' ' PRO . . . . . 0.442 ' HD2' HG23 ' C' ' 65' ' ' ILE . 50.0 Cg_exo -55.97 122.74 12.3 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 123.091 2.527 . . . . 63.14 111.596 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -43.63 139.85 4.74 Favored 'Trans proline' 0 C--N 1.39 2.725 0 C-N-CA 124.31 3.34 . . . . 51.51 114.849 -166.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 78' ' ' PRO . . . . . 0.494 ' HB2' ' HA2' ' C' ' 82' ' ' GLY . 25.9 Cg_endo -58.86 145.25 97.42 Favored 'Trans proline' 0 C--N 1.387 2.564 0 C-N-CA 123.483 2.788 . . . . 74.44 113.743 -172.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 79' ' ' PRO . . . . . 0.595 ' HB2' ' HA2' ' C' ' 142' ' ' GLY . 51.0 Cg_exo -55.93 163.24 6.03 Favored 'Trans proline' 0 C--N 1.385 2.458 0 C-N-CA 123.559 2.84 . . . . 61.04 112.923 176.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -55.12 87.07 0.04 OUTLIER 'Trans proline' 0 C--N 1.392 2.832 0 C-N-CA 123.569 2.846 . . . . 51.5 112.855 -177.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 145.65 -52.19 0.58 Allowed Glycine 0 C--N 1.339 0.742 0 CA-C-N 113.829 -1.532 . . . . 75.2 109.443 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.494 ' HA2' ' HB2' ' C' ' 78' ' ' PRO . . . 144.34 -170.84 25.95 Favored Glycine 0 C--N 1.344 0.998 0 C-N-CA 123.526 0.584 . . . . 74.45 111.653 -177.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -86.93 104.18 16.01 Favored 'General case' 0 C--O 1.244 0.806 0 C-N-CA 123.653 0.781 . . . . 70.14 109.273 171.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -86.55 -176.21 5.75 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.384 -0.598 . . . . 63.13 109.384 170.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 85' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -161.1 70.98 0.39 Allowed 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 107.507 -1.294 . . . . 74.41 107.507 177.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 55.0 m -36.78 95.18 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 117.875 2.546 . . . . 45.43 117.875 -164.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 75.55 6.68 81.65 Favored Glycine 0 C--N 1.355 1.608 0 C-N-CA 123.044 0.354 . . . . 74.33 113.292 174.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 88' ' ' PHE . . . . . 0.484 ' CD2' ' HB2' ' C' ' 55' ' ' ALA . 11.9 m-85 -105.59 131.13 53.35 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 107.489 -1.3 . . . . 74.44 107.489 -177.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -80.99 81.97 7.09 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 120.966 0.412 . . . . 72.23 111.337 -170.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 90' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -43.58 -36.14 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 C-N-CA 125.405 1.482 . . . . 54.41 112.74 171.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -62.66 -20.09 64.47 Favored 'General case' 0 CA--C 1.561 1.394 0 C-N-CA 124.352 1.061 . . . . 74.21 112.884 -175.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -119.82 7.37 10.97 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 122.865 0.466 . . . . 75.53 111.008 178.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 93' ' ' PHE . . . . . 0.551 ' HE1' ' HB3' ' C' ' 48' ' ' LYS . 13.9 m-30 -83.9 -174.28 5.19 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.129 -0.982 . . . . 72.45 112.114 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 97.6 p -71.3 161.8 30.48 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.839 1.052 . . . . 45.51 113.839 -167.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -59.44 -56.34 23.25 Favored 'General case' 0 C--O 1.215 -0.745 0 CA-C-N 114.249 -1.342 . . . . 55.43 110.837 174.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -51.03 -46.56 61.63 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 124.169 0.918 . . . . 65.02 111.867 -174.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 97' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -58.98 -53.44 58.39 Favored 'General case' 0 CA--C 1.554 1.13 0 CA-C-N 115.406 -0.816 . . . . 64.25 110.158 174.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -74.18 0.84 12.75 Favored 'General case' 0 CA--C 1.56 1.339 0 N-CA-C 112.611 0.597 . . . . 51.52 112.611 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -98.27 -50.74 4.23 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.984 0.914 . . . . 74.43 110.393 172.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 31.3 tp -71.07 -52.83 17.17 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.892 0.877 . . . . 73.23 110.463 -177.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 101' ' ' PHE . . . . . 0.477 ' O ' ' HG ' ' C' ' 105' ' ' LEU . 87.4 m-85 -86.22 -10.02 55.43 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.435 -0.802 . . . . 73.25 110.781 179.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -43.04 -55.73 4.79 Favored Glycine 0 CA--C 1.545 1.924 0 CA-C-O 118.479 -1.178 . . . . 54.11 115.026 176.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -37.6 -35.61 0.33 Allowed 'Trans proline' 0 C--N 1.392 2.837 0 C-N-CA 125.136 3.891 . . . . 62.02 116.279 175.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -130.9 24.59 4.27 Favored Glycine 0 C--N 1.349 1.276 0 CA-C-O 118.798 -1.001 . . . . 43.23 113.837 -174.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 105' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' C' ' 101' ' ' PHE . 38.1 mt -74.52 67.04 1.46 Allowed 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 118.038 0.919 . . . . 73.03 111.72 173.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 106' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 39.31 -102.85 0.03 OUTLIER 'General case' 0 CA--C 1.562 1.441 0 C-N-CA 125.643 1.577 . . . . 64.24 114.686 172.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . 67.44 26.4 73.6 Favored Glycine 0 C--N 1.362 1.995 0 N-CA-C 111.493 -0.643 . . . . 51.05 111.493 -163.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 70.47 -83.45 0.36 Allowed Glycine 0 C--N 1.347 1.174 0 N-CA-C 109.277 -1.529 . . . . 74.41 109.277 -163.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 109' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -136.45 -8.91 1.94 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.986 0.914 . . . . 74.45 110.321 169.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 110' ' ' GLY . . . . . . . . . . . . . . . -92.09 -2.73 68.44 Favored Glycine 0 C--N 1.352 1.439 0 N-CA-C 114.597 0.599 . . . . 54.22 114.597 -175.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 40.8 ttp180 54.4 16.4 1.26 Allowed 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 124.785 1.234 . . . . 75.25 113.452 176.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.51 -31.24 67.7 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.642 1.177 . . . . 74.1 110.426 166.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 113' ' ' SER . . . . . . . . . . . . . 49.2 m 72.46 49.64 0.2 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 125.78 1.632 . . . . 72.53 111.666 -176.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 42.9 ttt180 -70.6 160.11 33.13 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 115.386 -0.825 . . . . 74.05 110.374 177.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 115' ' ' LYS . . . . . 0.633 ' HE2' ' HB2' ' C' ' 170' ' ' PRO . 3.3 tpmt? -62.15 131.91 51.05 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.279 0.631 . . . . 54.14 111.521 -178.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 116' ' ' GLY . . . . . 0.436 ' HA2' ' HA3' ' C' ' 168' ' ' GLY . . . -82.28 127.81 8.15 Favored Glycine 0 C--N 1.345 1.043 0 CA-C-N 115.373 -0.83 . . . . 45.25 113.963 -174.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 117' ' ' ARG . . . . . 0.44 ' HG2' ' H ' ' C' ' 118' ' ' ASP . 56.1 ttt-85 -80.3 175.06 10.99 Favored 'General case' 0 C--O 1.252 1.214 0 C-N-CA 123.615 0.766 . . . . 64.44 109.684 174.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 118' ' ' ASP . . . . . 0.44 ' H ' ' HG2' ' C' ' 117' ' ' ARG . 3.6 p30 -65.38 155.81 34.2 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 121.687 0.756 . . . . 75.42 111.201 172.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 119' ' ' LEU . . . . . . . . . . . . . 61.9 tp -109.01 161.67 14.95 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 107.189 -1.411 . . . . 75.21 107.189 172.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 38.8 ttt-85 -131.31 119.84 22.31 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 118.77 0.714 . . . . 72.31 109.322 175.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 121' ' ' ALA . . . . . 0.469 ' HB3' HD11 ' C' ' 174' ' ' LEU . . . -138.09 118.16 13.46 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 124.129 0.972 . . . . 63.21 108.68 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 122' ' ' GLU . . . . . 0.67 ' HG2' HG22 ' B' ' 186' ' ' THR . 13.0 pt-20 -108.03 148.3 29.94 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 122.339 0.255 . . . . 73.22 110.457 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -140.71 145.89 42.08 Favored Pre-proline 0 N--CA 1.481 1.109 0 C-N-CA 122.833 0.453 . . . . 73.3 111.607 -170.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . 0.445 ' HG3' ' HG3' ' B' ' 188' ' ' ARG . 97.8 Cg_endo -75.88 130.11 12.13 Favored 'Trans proline' 0 C--N 1.377 2.038 0 C-N-CA 122.509 2.139 . . . . 72.51 110.559 166.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 125' ' ' LEU . . . . . . . . . . . . . 30.2 tp -145.14 148.58 33.76 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 108.668 -0.864 . . . . 74.03 108.668 -175.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 126' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -94.53 158.5 15.51 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 120.911 0.386 . . . . 61.53 110.488 -178.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 127' ' ' LEU . . . . . 0.61 HD13 ' HD2' ' C' ' 186' ' ' PHE . 56.9 mt -62.33 -42.56 99.48 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.656 1.182 . . . . 62.25 110.643 173.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 128' ' ' GLU . . . . . 0.405 ' HG3' ' HA ' ' C' ' 215' ' ' LEU . 2.7 mp0 -62.2 -38.05 87.66 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 114.495 -1.229 . . . . 75.24 110.725 173.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -79.01 -17.93 54.5 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 122.968 0.507 . . . . 73.53 111.592 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -76.63 -40.29 49.71 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-O 121.719 0.771 . . . . 64.34 109.428 172.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 131' ' ' PHE . . . . . 0.622 ' HB2' HD13 ' C' ' 215' ' ' LEU . 76.8 t80 -63.09 -34.89 78.56 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 126.065 1.746 . . . . 75.55 111.873 171.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 132' ' ' HIS . . . . . . . . . . . . . 36.6 m170 -78.35 -59.26 2.85 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 122.381 0.272 . . . . 60.22 110.345 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 53.03 -127.39 35.48 Favored Glycine 0 CA--C 1.537 1.426 0 O-C-N 124.077 0.86 . . . . 65.31 113.955 177.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.51 -146.33 38.72 Favored Glycine 0 C--N 1.349 1.303 0 C-N-CA 123.24 0.448 . . . . 53.24 113.646 177.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -92.01 112.79 24.86 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.337 1.055 . . . . 71.2 109.618 -177.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 136' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -126.64 133.36 51.01 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.389 0.675 . . . . 72.12 110.432 -175.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 137' ' ' VAL . . . . . . . . . . . . . 34.0 m -73.11 138.95 20.32 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 CA-C-O 120.976 0.417 . . . . 71.12 111.479 -176.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 138' ' ' VAL . . . . . 0.7 ' HA ' HG22 ' B' ' 182' ' ' VAL . 7.3 p -152.05 135.53 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.325 1.05 . . . . 72.14 108.986 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 139' ' ' GLU . . . . . 0.5 ' HA ' ' O ' ' C' ' 143' ' ' ARG . 0.0 OUTLIER -117.69 116.25 26.67 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.19 0.596 . . . . 74.31 109.927 170.742 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 140' ' ' VAL . . . . . . . . . . . . . 13.8 p -164.39 138.33 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.823 0.849 . . . . 63.22 110.12 174.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 62.58 13.94 6.68 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 124.869 1.268 . . . . 15.23 113.72 170.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 142' ' ' GLY . . . . . 0.595 ' HA2' ' HB2' ' C' ' 79' ' ' PRO . . . 120.18 -31.63 5.21 Favored Glycine 0 C--N 1.348 1.248 0 CA-C-O 120.103 -0.276 . . . . 45.25 112.814 -178.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 143' ' ' ARG . . . . . 0.5 ' O ' ' HA ' ' C' ' 139' ' ' GLU . 9.8 mmm180 -80.33 108.37 13.89 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.034 0.534 . . . . 73.04 111.954 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 48.6 ttt180 -113.62 91.31 3.6 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 107.635 -1.246 . . . . 71.51 107.635 166.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 145' ' ' VAL . . . . . . . . . . . . . 13.0 p -157.34 159.24 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.142 0.577 . . . . 75.03 111.174 -168.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 20.3 m -78.19 106.89 10.39 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.76 0.824 . . . . 54.21 110.146 168.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 2.6 p -80.52 119.8 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 CA-C-O 121.044 0.45 . . . . 72.53 110.137 174.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 148' ' ' ARG . . . . . 0.512 ' HD2' HG23 ' B' ' 38' ' ' ILE . 48.0 ttt180 -83.82 95.15 8.37 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.595 -0.729 . . . . 74.22 110.068 177.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 149' ' ' ILE . . . . . 0.459 HD11 HD21 ' B' ' 181' ' ' LEU . 38.3 pt -118.71 105.19 46.06 Favored Pre-proline 0 CA--C 1.547 0.861 0 N-CA-C 107.647 -1.242 . . . . 71.41 107.647 164.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -53.88 166.78 1.31 Allowed 'Trans proline' 0 C--N 1.384 2.428 0 C-N-CA 123.459 2.772 . . . . 61.44 113.903 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -44.12 108.85 0.13 Allowed 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 123.305 2.67 . . . . 73.2 113.425 171.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 152' ' ' GLY . . . . . . . . . . . . . . . 154.21 87.98 0.06 OUTLIER Glycine 0 C--N 1.349 1.292 0 N-CA-C 114.8 0.68 . . . . 54.32 114.8 -176.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 153' ' ' VAL . . . . . 0.549 HG22 HG11 ' C' ' 178' ' ' VAL . 12.4 p -165.53 155.54 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.617 0 C-N-CA 123.249 0.62 . . . . 71.13 110.656 172.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 154' ' ' ARG . . . . . 0.503 ' HD2' ' HG2' ' C' ' 187' ' ' ARG . 30.3 ttp180 -155.64 150.86 26.8 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 124.071 0.948 . . . . 75.32 110.419 -172.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 155' ' ' GLU . . . . . 0.411 ' N ' ' HG2' ' C' ' 154' ' ' ARG . 10.3 tp10 -42.93 130.66 4.3 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 125.589 1.556 . . . . 74.51 113.263 -177.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 84.53 -5.79 79.85 Favored Glycine 0 C--N 1.348 1.199 0 CA-C-N 115.827 -0.624 . . . . 64.51 113.252 178.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 157' ' ' SER . . . . . 0.499 ' O ' HG12 ' C' ' 178' ' ' VAL . 37.6 t -78.58 129.5 34.87 Favored 'General case' 0 C--O 1.245 0.82 0 N-CA-C 108.622 -0.881 . . . . 75.43 108.622 173.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 97.9 t -105.99 100.44 10.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 N-CA-C 108.261 -1.015 . . . . 64.44 108.261 -177.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 159' ' ' ILE . . . . . 0.665 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 26.1 mt -71.25 96.67 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.672 0 CA-C-N 115.046 -0.979 . . . . 52.25 108.85 -175.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 4.6 ttt180 -79.75 96.58 6.31 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 107.551 -1.277 . . . . 72.21 107.551 175.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 161' ' ' VAL . . . . . . . . . . . . . 2.2 p -97.99 108.44 46.46 Favored Pre-proline 0 C--O 1.247 0.938 0 CA-C-N 114.804 -1.089 . . . . 75.24 108.588 -178.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -52.05 115.97 2.49 Favored 'Trans proline' 0 C--N 1.387 2.572 0 C-N-CA 123.483 2.788 . . . . 63.42 114.55 -173.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 163' ' ' GLY . . . . . 0.671 ' H ' ' HA ' ' C' ' 173' ' ' ASP . . . 91.49 -13.82 65.53 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 117.513 1.765 . . . . 53.31 117.513 168.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 164' ' ' MET . . . . . 0.498 ' HB3' ' HB3' ' C' ' 174' ' ' LEU . 47.7 ttm -68.13 -19.07 64.79 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-N 120.45 2.125 . . . . 73.35 112.659 -170.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . -94.77 -112.54 2.51 Favored Glycine 0 C--N 1.347 1.181 0 CA-C-O 119.332 -0.704 . . . . 64.24 111.886 175.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 166' ' ' GLY . . . . . 0.405 ' HA3' ' HB3' ' C' ' 171' ' ' PRO . . . 86.65 67.23 1.36 Allowed Glycine 0 C--N 1.362 2.007 0 CA-C-N 118.057 0.929 . . . . 75.44 113.866 176.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 167' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -79.65 99.88 7.58 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 107.124 -1.436 . . . . 64.31 107.124 172.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 168' ' ' GLY . . . . . 0.436 ' HA3' ' HA2' ' C' ' 116' ' ' GLY . . . 153.31 -85.61 0.14 Allowed Glycine 0 C--O 1.213 -1.164 0 CA-C-O 118.432 -1.205 . . . . 13.44 110.397 -169.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 169' ' ' ASN . . . . . 0.544 ' HB3' ' HD3' ' C' ' 170' ' ' PRO . 2.9 t-20 179.95 -59.78 0.0 OUTLIER Pre-proline 0 N--CA 1.499 1.985 0 CA-C-O 117.387 -1.292 . . . . 62.44 112.189 163.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 170' ' ' PRO . . . . . 0.633 ' HB2' ' HE2' ' C' ' 115' ' ' LYS . 19.4 Cg_exo -67.77 100.24 0.59 Allowed 'Trans proline' 0 C--N 1.399 3.208 0 CA-C-N 122.623 1.972 . . . . 51.41 109.688 165.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 171' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' C' ' 170' ' ' PRO . 14.2 Cg_exo -71.05 132.06 20.58 Favored 'Trans proline' 0 C--N 1.362 1.267 0 C-N-CA 122.901 2.401 . . . . 74.02 114.469 -162.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -71.44 -72.87 0.86 Allowed Glycine 0 C--N 1.347 1.178 0 O-C-N 124.176 0.922 . . . . 74.42 111.331 173.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 173' ' ' ASP . . . . . 0.671 ' HA ' ' H ' ' C' ' 163' ' ' GLY . 4.9 p-10 -172.67 178.32 2.7 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.201 0.6 . . . . 74.51 111.897 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 174' ' ' LEU . . . . . 0.498 ' HB3' ' HB3' ' C' ' 164' ' ' MET . 12.6 tp -122.09 139.17 54.04 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.169 0.988 . . . . 75.22 109.002 170.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 175' ' ' LEU . . . . . 0.4 ' N ' HD12 ' C' ' 174' ' ' LEU . 85.9 mt -101.39 87.11 3.12 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.67 1.188 . . . . 71.32 109.594 177.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 176' ' ' LEU . . . . . 0.665 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 83.9 mt -74.22 92.93 2.28 Favored 'General case' 0 C--N 1.351 0.671 0 C-N-CA 123.09 0.556 . . . . 43.02 109.557 173.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 177' ' ' VAL . . . . . 0.445 ' HB ' ' HB3' ' C' ' 122' ' ' GLU . 22.2 t -84.51 113.52 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 108.619 -0.882 . . . . 74.43 108.619 -177.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 178' ' ' VAL . . . . . 0.549 HG11 HG22 ' C' ' 153' ' ' VAL . 7.5 p -80.76 125.17 39.26 Favored 'Isoleucine or valine' 0 C--O 1.246 0.908 0 CA-C-O 121.798 0.809 . . . . 74.01 111.036 -176.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 179' ' ' ARG . . . . . . . . . . . . . 24.3 mmt180 -110.54 122.9 48.88 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 114.028 -1.442 . . . . 72.33 107.224 169.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 180' ' ' LEU . . . . . 0.556 HD13 HD21 ' C' ' 127' ' ' LEU . 92.5 mt -85.69 149.57 25.21 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 122.774 0.43 . . . . 70.51 111.431 -177.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 181' ' ' LEU . . . . . 0.401 ' HB3' ' HD2' ' C' ' 182' ' ' PRO . 26.4 mt -65.4 165.36 18.52 Favored Pre-proline 0 CA--C 1.565 1.551 0 C-N-CA 124.624 1.17 . . . . 74.2 111.711 -178.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 182' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' C' ' 181' ' ' LEU . 12.7 Cg_exo -36.04 -20.88 0.04 OUTLIER 'Trans proline' 0 C--N 1.403 3.423 1 C-N-CA 125.642 4.228 . . . . 64.12 118.701 -177.357 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 183' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -104.94 99.54 19.66 Favored Pre-proline 0 CA--C 1.562 1.44 0 CA-C-N 119.495 1.043 . . . . 62.13 109.123 167.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 184' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -99.26 66.39 0.06 OUTLIER 'Trans proline' 0 C--N 1.38 2.221 0 C-N-CA 123.961 3.107 . . . . 71.54 110.713 174.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 185' ' ' VAL . . . . . 0.549 ' H ' HD11 ' C' ' 127' ' ' LEU . 21.6 t -92.63 -45.06 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-N 115.487 -0.779 . . . . 72.23 110.144 -165.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 186' ' ' PHE . . . . . 0.61 ' HD2' HD13 ' C' ' 127' ' ' LEU . 71.1 m-85 -100.16 114.57 28.05 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.506 0.67 . . . . 61.44 111.354 -167.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 187' ' ' ARG . . . . . 0.675 ' HB3' ' HB3' ' C' ' 194' ' ' TYR . 3.2 tmt_? -95.77 107.4 19.63 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.878 1.271 . . . . 75.14 108.72 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 188' ' ' LEU . . . . . . . . . . . . . 41.1 tp -82.32 141.78 32.59 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.835 0.68 . . . . 74.14 112.835 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -145.16 108.68 4.65 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 107.103 -1.443 . . . . 71.33 107.103 161.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 71.36 -92.5 0.5 Allowed Glycine 0 C--N 1.356 1.649 0 O-C-N 123.225 0.328 . . . . 74.2 112.534 -178.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 191' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -117.92 -26.53 6.43 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.874 0.87 . . . . 60.21 110.114 174.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -86.54 153.25 21.97 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.557 -0.747 . . . . 65.13 110.731 -166.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 193' ' ' LEU . . . . . 0.42 HD21 ' CD1' ' C' ' 240' ' ' PHE . 84.1 mt -120.3 163.7 17.42 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.6 -0.727 . . . . 52.2 111.172 -175.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 194' ' ' TYR . . . . . 0.675 ' HB3' ' HB3' ' C' ' 187' ' ' ARG . 33.8 t80 -136.64 107.56 6.67 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 114.723 -1.126 . . . . 75.43 108.884 169.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 195' ' ' ALA . . . . . 0.501 ' HB2' HD11 ' C' ' 249' ' ' LEU . . . -105.01 -175.33 2.76 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.725 0.81 . . . . 65.11 110.822 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 196' ' ' THR . . . . . 0.571 HG21 ' HA ' ' B' ' 159' ' ' LYS . 59.1 m -128.31 124.05 35.54 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 107.912 -1.144 . . . . 51.32 107.912 164.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 197' ' ' LEU . . . . . 0.425 HD13 ' HB2' ' C' ' 212' ' ' ALA . 35.4 tp -98.99 126.74 44.75 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 122.889 0.476 . . . . 73.5 110.743 -176.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -79.15 101.54 7.98 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.038 0.935 . . . . 44.52 108.858 177.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 199' ' ' VAL . . . . . 0.557 ' HA ' HG11 ' C' ' 210' ' ' VAL . 40.3 t -119.38 106.99 41.8 Favored Pre-proline 0 N--CA 1.478 0.936 0 C-N-CA 123.667 0.787 . . . . 61.21 109.307 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 200' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.23 147.94 67.43 Favored 'Trans proline' 0 C--N 1.373 1.836 0 C-N-CA 121.683 1.589 . . . . 71.34 111.45 175.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 201' ' ' ALA . . . . . 0.446 ' O ' HG23 ' C' ' 205' ' ' VAL . . . -55.44 -45.66 99.83 Favored Pre-proline 0 CA--C 1.551 1.016 0 N-CA-C 113.998 1.11 . . . . 74.35 113.998 -171.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 202' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -52.35 -47.32 27.57 Favored 'Trans proline' 0 C--N 1.385 2.468 0 C-N-CA 121.411 1.407 . . . . 63.15 112.569 174.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 203' ' ' ILE . . . . . 0.531 ' HA ' HG12 ' C' ' 206' ' ' VAL . 51.3 mt -69.02 -32.59 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 123.15 0.58 . . . . 63.4 111.195 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.85 -33.84 75.54 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.688 0.795 . . . . 75.02 112.145 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 205' ' ' VAL . . . . . 0.446 HG23 ' O ' ' C' ' 201' ' ' ALA . 43.1 t -85.75 -38.35 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-N 116.072 -0.513 . . . . 63.41 111.693 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 206' ' ' VAL . . . . . 0.531 HG12 ' HA ' ' C' ' 203' ' ' ILE . 14.4 p -79.09 -35.67 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 CA-C-O 120.952 0.406 . . . . 52.12 111.175 -174.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 79.8 66.8 1.63 Allowed Glycine 0 N--CA 1.435 -1.406 0 CA-C-N 115.185 -0.916 . . . . 63.21 111.948 -167.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -98.08 -137.22 9.58 Favored Glycine 0 C--O 1.244 0.766 0 N-CA-C 111.176 -0.769 . . . . 51.32 111.176 174.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 209' ' ' LYS . . . . . 0.524 ' HE2' ' HG3' ' B' ' 235' ' ' GLU . 7.2 mtmp? -134.22 133.15 40.56 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.337 0.655 . . . . 72.12 110.25 174.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 210' ' ' VAL . . . . . 0.557 HG11 ' HA ' ' C' ' 199' ' ' VAL . 35.8 m -114.84 178.49 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.012 1.325 . . . . 62.05 107.936 169.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 211' ' ' ARG . . . . . 0.604 ' HD3' ' HB2' ' C' ' 218' ' ' PRO . 24.8 ttm105 -131.56 130.24 42.01 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 118.454 0.57 . . . . 72.44 112.204 -177.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 212' ' ' ALA . . . . . 0.425 ' HB2' HD13 ' C' ' 197' ' ' LEU . . . -98.59 115.35 28.45 Favored 'General case' 0 C--N 1.348 0.519 0 C-N-CA 124.356 1.062 . . . . 74.43 108.248 169.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 213' ' ' MET . . . . . 0.423 ' HA ' ' HA ' ' C' ' 218' ' ' PRO . 2.3 tmm? -71.68 101.59 2.58 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 107.185 -1.413 . . . . 63.12 107.185 172.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 214' ' ' THR . . . . . 0.48 HG22 ' H ' ' C' ' 215' ' ' LEU . 0.6 OUTLIER -101.74 174.63 5.87 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 120.991 0.424 . . . . 54.24 110.348 -171.037 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 215' ' ' LEU . . . . . 0.622 HD13 ' HB2' ' C' ' 131' ' ' PHE . 26.5 mt -61.49 -43.42 98.9 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.793 1.637 . . . . 44.41 112.755 -173.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.86 17.5 19.36 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 115.189 -0.914 . . . . 71.0 110.927 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 217' ' ' GLY . . . . . 0.533 ' HA3' ' HD3' ' B' ' 207' ' ' LYS . . . 127.86 159.73 10.18 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-N 115.492 -0.776 . . . . 64.11 112.567 173.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 218' ' ' PRO . . . . . 0.604 ' HB2' ' HD3' ' C' ' 211' ' ' ARG . 70.3 Cg_endo -75.31 102.88 1.65 Allowed 'Trans proline' 0 CA--C 1.561 1.845 0 C-N-CA 122.764 2.309 . . . . 52.13 114.292 -178.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 219' ' ' VAL . . . . . 0.405 HG12 ' OG1' ' C' ' 214' ' ' THR . 12.6 p -83.87 144.28 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 123.729 0.812 . . . . 52.53 110.097 -178.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 220' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -97.36 109.83 22.5 Favored 'General case' 0 C--O 1.246 0.872 0 CA-C-O 121.66 0.743 . . . . 72.32 109.636 174.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 221' ' ' VAL . . . . . 0.435 HG11 HD22 ' C' ' 233' ' ' LEU . 49.2 t -80.12 138.19 20.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 125.114 1.366 . . . . 74.03 111.136 -178.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 222' ' ' ALA . . . . . 0.611 ' H ' ' HB2' ' B' ' 239' ' ' ALA . . . -89.53 118.01 28.85 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.149 0.979 . . . . 73.3 110.309 173.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 49.0 t -92.72 130.72 35.84 Favored Pre-proline 0 CA--C 1.553 1.092 0 N-CA-C 108.18 -1.044 . . . . 73.11 108.18 174.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 224' ' ' PRO . . . . . 0.812 ' HG2' ' HG3' ' B' ' 243' ' ' GLN . 21.1 Cg_exo -72.48 157.66 52.52 Favored 'Trans proline' 0 C--N 1.37 1.697 0 C-N-CA 123.561 2.84 . . . . 54.33 111.894 164.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -58.67 142.88 98.91 Favored 'Trans proline' 0 C--N 1.382 2.337 0 C-N-CA 122.368 2.045 . . . . 74.0 111.209 174.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 226' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 67.57 95.57 0.06 Allowed 'General case' 0 N--CA 1.484 1.247 0 O-C-N 124.488 1.118 . . . . 70.15 111.331 -179.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 227' ' ' THR . . . . . 0.501 HG22 HG11 ' C' ' 253' ' ' VAL . 52.9 m -140.41 123.04 16.24 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 123.222 0.609 . . . . 70.3 112.14 175.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 228' ' ' GLN . . . . . . . . . . . . . 27.7 mp0 -97.74 158.55 15.45 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-O 122.392 1.091 . . . . 74.32 111.172 171.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 229' ' ' ALA . . . . . 0.459 ' HB2' ' H ' ' C' ' 255' ' ' ILE . . . -67.45 148.87 50.98 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-N 113.874 -1.512 . . . . 62.12 109.357 171.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 88.71 -5.44 84.62 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-O 119.689 -0.506 . . . . 62.04 112.93 -174.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 231' ' ' ARG . . . . . 0.424 ' NH1' HE22 ' B' ' 243' ' ' GLN . 57.1 mtt180 -76.85 168.97 19.18 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 109.053 -0.721 . . . . 74.12 109.053 163.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 232' ' ' LYS . . . . . 0.562 ' HD3' ' HB3' ' C' ' 250' ' ' TYR . 3.9 ttmp? -143.47 139.82 30.05 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.96 0.41 . . . . 71.45 112.087 -175.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 233' ' ' LEU . . . . . 0.576 HD13 ' HB2' ' C' ' 251' ' ' LEU . 2.4 mp -105.7 155.75 18.95 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.808 1.243 . . . . 74.21 109.724 -179.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 41.1 ttp85 -128.01 89.93 3.01 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 109.095 -0.706 . . . . 72.34 109.095 172.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 235' ' ' LEU . . . . . 0.578 HD12 HD23 ' C' ' 249' ' ' LEU . 72.3 mt -73.43 114.14 11.32 Favored 'General case' 0 C--N 1.359 0.995 0 N-CA-C 109.497 -0.557 . . . . 73.43 109.497 174.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 24.7 mmmt -72.55 124.17 24.68 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.956 0.902 . . . . 71.55 111.236 -177.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 72.27 37.52 59.24 Favored Glycine 0 C--N 1.35 1.307 0 O-C-N 123.832 0.708 . . . . 71.42 113.118 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 29.8 mmtm -125.32 14.77 8.32 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.836 0.854 . . . . 72.03 111.322 177.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -96.32 -162.96 33.08 Favored Glycine 0 C--N 1.348 1.245 0 N-CA-C 111.972 -0.451 . . . . 31.21 111.972 172.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 240' ' ' PHE . . . . . 0.42 ' CD1' HD21 ' C' ' 193' ' ' LEU . 3.3 m-85 -72.51 149.59 91.08 Favored Pre-proline 0 N--CA 1.477 0.899 0 C-N-CA 123.588 0.755 . . . . 75.14 111.489 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 241' ' ' PRO . . . . . 0.435 ' HD3' ' CD2' ' C' ' 131' ' ' PHE . 31.6 Cg_exo -59.49 119.25 6.36 Favored 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 124.101 3.201 . . . . 70.21 112.572 -176.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -131.34 -172.76 13.17 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-N 115.488 -0.778 . . . . 70.14 112.822 -174.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 243' ' ' PRO . . . . . 0.588 ' HA ' ' HA ' ' B' ' 111' ' ' LEU . 37.9 Cg_endo -63.56 -40.48 30.18 Favored 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 123.781 2.988 . . . . 71.42 112.652 -178.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -84.56 10.81 10.05 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.097 0.559 . . . . 71.42 111.854 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 120.11 -75.45 0.32 Allowed Glycine 0 C--N 1.348 1.207 0 N-CA-C 110.601 -1.0 . . . . 51.32 110.601 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 246' ' ' ARG . . . . . . . . . . . . . 30.5 mtm180 -142.46 -179.97 6.6 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.845 1.258 . . . . 61.31 109.655 175.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -89.02 -161.86 37.93 Favored Glycine 0 C--N 1.346 1.137 0 N-CA-C 112.105 -0.398 . . . . 63.23 112.105 173.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -122.71 137.96 54.75 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 117.358 0.579 . . . . 73.54 109.736 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 249' ' ' LEU . . . . . 0.578 HD23 HD12 ' C' ' 235' ' ' LEU . 21.1 tp -95.04 115.11 27.01 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.198 0.999 . . . . 74.23 110.177 -175.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 250' ' ' TYR . . . . . 0.562 ' HB3' ' HD3' ' C' ' 232' ' ' LYS . 8.6 m-85 -100.91 100.13 10.72 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.253 -0.647 . . . . 71.43 109.253 -179.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 251' ' ' LEU . . . . . 0.576 ' HB2' HD13 ' C' ' 233' ' ' LEU . 1.8 mp -96.98 138.65 34.18 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.651 -0.656 . . . . 64.53 109.923 -174.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 252' ' ' GLU . . . . . 0.546 ' HG2' ' HB3' ' B' ' 157' ' ' MET . 4.9 tp10 -89.89 118.83 29.76 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.358 -0.978 . . . . 73.41 108.358 173.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 253' ' ' VAL . . . . . 0.501 HG11 HG22 ' C' ' 227' ' ' THR . 91.7 t -60.27 130.61 24.26 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 123.45 0.7 . . . . 73.5 110.842 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 254' ' ' ARG . . . . . 0.468 ' CZ ' ' HB ' ' C' ' 256' ' ' THR . 2.1 tmm_? -126.27 101.0 6.54 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 107.122 -1.436 . . . . 74.13 107.122 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 255' ' ' ILE . . . . . 0.459 ' H ' ' HB2' ' C' ' 229' ' ' ALA . 46.2 mm -73.45 125.92 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 109.577 -0.527 . . . . 75.24 109.577 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 256' ' ' THR . . . . . 0.468 ' HB ' ' CZ ' ' C' ' 254' ' ' ARG . 0.1 OUTLIER -128.09 163.47 24.55 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.102 0.961 . . . . 53.32 111.003 -175.418 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 2.8 pp -137.08 147.97 60.8 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 124.751 1.221 . . . . 64.54 107.827 173.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -79.17 15.48 1.53 Allowed 'Trans proline' 0 N--CA 1.501 1.943 0 C-N-CA 122.566 2.178 . . . . 73.21 113.089 -170.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 57.59 -84.3 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.406 1.483 . . . . 72.3 111.017 -171.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -73.09 137.83 45.48 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.215 1.006 . . . . 73.41 110.138 -177.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 261' ' ' LEU . . . . . . . . . . . . . 77.3 mt -130.16 165.03 23.17 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.756 0.822 . . . . 71.21 111.361 -178.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 14.9 p -84.09 146.4 48.41 Favored Pre-proline 0 CA--C 1.549 0.918 0 CA-C-N 114.245 -1.343 . . . . 61.23 108.854 167.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -51.38 -26.0 19.95 Favored 'Trans proline' 0 C--N 1.39 2.732 0 C-N-CA 124.256 3.304 . . . . 74.2 114.649 -172.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -66.36 -65.4 0.68 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.753 0.821 . . . . 71.04 109.754 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -56.13 -44.02 78.76 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 114.647 -1.16 . . . . 65.11 109.85 177.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 266' ' ' GLU . . . . . 0.409 ' O ' ' HG2' ' C' ' 270' ' ' LYS . 5.2 tp10 -50.44 -48.42 56.41 Favored 'General case' 0 CA--C 1.548 0.891 0 O-C-N 124.549 1.156 . . . . 64.21 110.529 179.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 267' ' ' ALA . . . . . 0.475 ' O ' ' HG2' ' C' ' 271' ' ' LYS . . . -66.57 -41.0 89.27 Favored 'General case' 0 C--N 1.355 0.835 0 CA-C-N 115.481 -0.781 . . . . 70.32 112.22 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 268' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.98 -38.42 91.0 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 120.797 0.332 . . . . 52.44 111.112 176.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -68.01 -32.56 73.03 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.39 0.676 . . . . 61.11 110.43 175.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 270' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' C' ' 266' ' ' GLU . 4.0 mmmp? -58.99 -49.39 78.05 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.048 0.539 . . . . 75.43 109.721 173.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 271' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' C' ' 267' ' ' ALA . 10.8 mmpt? -59.54 -48.76 80.41 Favored 'General case' 0 C--O 1.249 1.033 0 O-C-N 124.252 0.97 . . . . 75.33 111.106 -177.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 80.4 mt -54.14 -57.84 9.6 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 124.049 0.843 . . . . 74.33 110.193 173.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -52.95 -45.92 67.93 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.938 0.895 . . . . 34.13 112.339 -173.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -63.56 -43.54 96.76 Favored 'General case' 0 C--O 1.25 1.097 0 C-N-CA 123.789 0.835 . . . . 63.21 110.8 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -56.4 -34.37 66.66 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-O 121.001 0.429 . . . . 70.04 111.444 174.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 276' ' ' TYR . . . . . 0.716 ' HA ' ' HD3' ' C' ' 279' ' ' ARG . 1.0 OUTLIER -85.26 -25.65 27.14 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 115.743 -0.662 . . . . 75.52 111.596 -179.404 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 277' ' ' TYR . . . . . 0.44 ' CE1' ' HA3' ' A' ' 208' ' ' GLY . 22.1 m-30 -68.85 -32.36 71.99 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.938 -0.393 . . . . 44.24 109.938 176.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -55.57 -18.62 7.93 Favored 'General case' 0 CA--C 1.561 1.393 0 O-C-N 123.756 0.66 . . . . 55.2 112.515 173.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 279' ' ' ARG . . . . . 0.716 ' HD3' ' HA ' ' C' ' 276' ' ' TYR . 12.6 mtp-105 -89.87 -28.88 18.94 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.061 0.944 . . . . 71.52 111.833 176.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.963 0 C-N-CA 123.292 0.637 . . . . 75.14 110.671 -174.062 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.485 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.0 OUTLIER . . . . . 0 N--CA 1.482 1.127 0 CA-C-O 119.713 -0.184 . . . . 64.12 110.807 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.38 40.56 27.38 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.41 1.084 . . . . 51.4 111.917 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -73.77 79.19 1.57 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.045 0.538 . . . . 74.04 109.769 177.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -36.0 104.35 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.63 1.572 . . . . 62.43 113.24 -178.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -72.13 112.02 7.86 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.587 -0.894 . . . . 74.32 108.587 166.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -75.98 84.3 2.88 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 107.242 -1.392 . . . . 61.41 107.242 178.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.485 ' HA ' HD12 ' A' ' 10' ' ' ILE . 41.7 m-85 -60.67 -29.98 69.63 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-N 114.59 -1.186 . . . . 73.34 111.996 -173.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -66.38 -42.34 88.09 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.833 -0.621 . . . . 73.33 110.432 176.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.09 -40.31 95.95 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.933 0.493 . . . . 60.32 111.19 176.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.485 HD12 ' HA ' ' A' ' 7' ' ' TYR . 62.9 mt -60.79 -39.17 80.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-N 115.807 -0.633 . . . . 74.23 110.727 178.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 92.1 mt -86.03 -7.59 58.52 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 112.287 0.477 . . . . 51.33 112.287 176.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.49 18.29 76.93 Favored Glycine 0 C--N 1.351 1.391 0 N-CA-C 114.501 0.56 . . . . 53.33 114.501 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.4 m -103.83 153.88 38.43 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 124.444 1.098 . . . . 71.43 110.041 177.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.23 165.11 20.52 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 122.785 2.323 . . . . 50.12 114.142 -176.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -81.63 61.05 4.86 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.4 1.08 . . . . 75.43 109.658 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -177.42 -26.83 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 114.073 -1.421 . . . . 64.11 108.286 -166.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -47.16 123.58 5.58 Favored 'General case' 0 C--N 1.349 0.579 0 C-N-CA 125.714 1.606 . . . . 64.31 113.137 -174.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 43.7 p -74.42 173.01 10.9 Favored 'General case' 0 C--O 1.243 0.733 0 O-C-N 124.226 0.954 . . . . 71.11 110.901 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.2 tm0? -55.81 -29.19 59.37 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.04 0.936 . . . . 64.21 110.178 179.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -57.22 -58.67 7.19 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.416 1.086 . . . . 72.43 110.845 173.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -66.03 -35.02 79.43 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.135 0.574 . . . . 64.03 111.484 -173.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.51 HG12 ' HB3' ' A' ' 57' ' ' LEU . 1.7 mp -61.76 -45.0 99.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 123.044 0.537 . . . . 73.31 110.296 173.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -61.69 -40.02 93.5 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.575 1.15 . . . . 71.24 111.035 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.613 ' HA ' ' HD3' ' A' ' 27' ' ' LYS . 18.5 mtp180 -77.15 -37.47 53.88 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.997 0.919 . . . . 54.12 111.41 -175.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.92 -37.99 89.43 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.652 -0.704 . . . . 64.0 110.161 173.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -74.97 -28.05 60.42 Favored 'General case' 0 C--O 1.215 -0.732 0 CA-C-N 115.006 -0.997 . . . . 73.1 110.964 176.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.613 ' HD3' ' HA ' ' A' ' 24' ' ' ARG . 22.6 mtpp -55.29 -53.54 54.76 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.414 -0.958 . . . . 74.22 108.414 171.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 -54.2 -67.06 0.29 Allowed 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 114.576 -1.193 . . . . 71.15 111.34 176.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 79.4 mt -70.21 -22.98 62.87 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.04 0.936 . . . . 74.11 112.952 -166.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.81 -54.79 6.66 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 109.252 -0.647 . . . . 63.3 109.252 173.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -64.11 -21.59 66.6 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 120.878 0.37 . . . . 72.33 111.509 -178.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -84.96 -44.33 13.2 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 124.721 1.209 . . . . 63.33 111.113 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -113.78 21.53 14.88 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 112.749 0.648 . . . . 63.25 112.749 -174.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -63.85 113.37 9.81 Favored Pre-proline 0 N--CA 1.484 1.263 0 CA-C-O 118.074 -0.965 . . . . 63.41 108.465 176.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.709 ' HB3' ' HG2' ' A' ' 44' ' ' GLU . 19.5 Cg_endo -57.87 -28.08 81.15 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 123.227 2.618 . . . . 74.13 113.647 -174.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -73.38 -30.55 63.36 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.881 0.873 . . . . 72.45 111.997 176.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 75.4 t -85.16 -39.23 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.017 0.527 . . . . 65.53 109.889 176.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -132.33 94.5 3.45 Favored 'General case' 0 C--O 1.244 0.793 0 C-N-CA 124.491 1.116 . . . . 61.35 109.088 -175.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.606 ' H ' ' HE3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -76.04 82.91 2.9 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 108.764 -0.828 . . . . 73.11 108.764 -179.581 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.5 m -140.08 116.22 7.99 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-O 117.998 -1.001 . . . . 54.41 108.666 177.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_exo -46.93 -42.22 25.33 Favored 'Trans proline' 0 C--N 1.387 2.579 0 C-N-CA 123.119 2.546 . . . . 72.23 112.419 175.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 34.3 tp10 -48.56 -51.29 28.47 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.05 1.34 . . . . 64.43 111.116 173.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.3 -25.6 65.22 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 115.113 -0.949 . . . . 72.14 111.031 -177.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.709 ' HG2' ' HB3' ' A' ' 35' ' ' PRO . 41.7 mt-10 -84.17 -33.94 24.11 Favored 'General case' 0 C--N 1.354 0.785 0 C-N-CA 123.324 0.65 . . . . 62.01 110.948 -174.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -76.47 -38.68 54.98 Favored 'General case' 0 C--O 1.246 0.905 0 CA-C-O 121.372 0.606 . . . . 62.44 109.459 178.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -66.35 -34.21 77.47 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.411 -0.813 . . . . 74.03 110.083 170.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -62.15 -39.74 93.63 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.361 0.665 . . . . 73.24 109.246 172.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.412 ' HG3' ' O ' ' A' ' 44' ' ' GLU . 67.1 mttm -58.14 -50.93 71.78 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 122.975 0.51 . . . . 75.14 110.688 176.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -60.29 -44.76 95.09 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.474 0.654 . . . . 71.44 111.579 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 96.6 mt -70.82 -26.91 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 124.422 1.089 . . . . 70.53 111.39 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.531 ' HA ' ' HB3' ' A' ' 54' ' ' TYR . 9.7 m-80 -94.82 -6.12 43.57 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.732 0.813 . . . . 73.43 111.474 178.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -75.94 -49.04 18.88 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 106.329 -1.73 . . . . 63.42 106.329 164.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.476 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . . . -57.27 -48.66 78.32 Favored 'General case' 0 C--N 1.349 0.573 0 CA-C-N 113.505 -1.679 . . . . 65.45 111.452 174.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.531 ' HB3' ' HA ' ' A' ' 51' ' ' ASN . 67.2 t80 -67.95 -41.31 82.66 Favored 'General case' 0 C--O 1.209 -1.07 0 CA-C-N 115.689 -0.687 . . . . 72.32 110.602 179.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.45 -51.19 60.54 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 118.42 0.554 . . . . 53.01 111.368 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.505 HG13 ' HZ ' ' A' ' 101' ' ' PHE . 47.5 t -73.65 -31.97 33.94 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 CA-C-N 115.122 -0.945 . . . . 74.52 111.204 -177.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.51 ' HB3' HG12 ' A' ' 22' ' ' ILE . 76.4 mt -103.75 3.66 34.36 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 113.961 1.097 . . . . 62.04 113.961 -175.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.3 t -63.06 -51.26 67.35 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 123.855 0.862 . . . . 74.34 111.804 -176.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -109.66 144.25 29.5 Favored Pre-proline 0 C--O 1.239 0.513 0 CA-C-N 114.439 -1.255 . . . . 74.34 108.924 -169.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.414 ' O ' ' HG2' ' A' ' 64' ' ' ARG . 48.3 Cg_exo -41.61 -51.09 4.49 Favored 'Trans proline' 0 C--N 1.383 2.379 0 C-N-CA 123.943 3.095 . . . . 72.41 114.983 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.467 ' HB2' ' HB3' ' A' ' 144' ' ' ARG . 18.9 tp10 -79.8 -31.31 40.71 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 112.531 0.567 . . . . 72.3 112.531 -172.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -62.7 -42.2 99.52 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-O 122.084 0.945 . . . . 74.54 108.884 174.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.441 ' HG2' HD22 ' A' ' 57' ' ' LEU . 4.0 tmt_? -61.98 -42.65 99.37 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 113.72 -1.582 . . . . 74.11 108.443 175.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.414 ' HG2' ' O ' ' A' ' 60' ' ' PRO . 2.8 mmp_? -62.04 -34.51 76.37 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.615 0.766 . . . . 74.25 111.364 174.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 61' ' ' GLU . 62.4 mt -62.98 -44.24 99.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 109.217 -0.66 . . . . 64.42 109.217 178.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -57.79 -54.22 49.31 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.558 -0.747 . . . . 75.4 110.181 173.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -57.62 -42.52 83.47 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.703 0.801 . . . . 64.04 111.606 -175.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 40.4 p -69.68 -31.22 69.14 Favored 'General case' 0 C--N 1.348 0.535 0 CA-C-N 115.948 -0.569 . . . . 75.13 110.311 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -80.26 137.19 36.59 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 118.212 0.46 . . . . 63.45 110.335 -177.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.15 6.93 77.95 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-N 115.764 -0.653 . . . . 52.54 111.547 -174.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 95.0 m -130.37 -61.28 0.97 Allowed 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 103.671 -2.714 . . . . 71.23 103.671 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 92.0 m -87.72 150.09 23.82 Favored 'General case' 0 C--O 1.255 1.364 0 N-CA-C 105.274 -2.121 . . . . 74.23 105.274 156.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.57 -15.34 11.44 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.768 0.827 . . . . 74.04 111.136 178.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.1 123.99 87.71 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 123.695 0.798 . . . . 75.1 110.919 177.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.455 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 61.2 Cg_endo -71.37 146.26 50.06 Favored 'Trans proline' 0 C--N 1.376 1.995 0 C-N-CA 122.413 2.075 . . . . 75.41 110.77 175.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 75' ' ' PRO . 7.1 Cg_exo -70.76 152.14 63.9 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 122.46 2.107 . . . . 74.25 110.982 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -58.63 148.5 81.77 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 122.809 2.34 . . . . 62.44 112.947 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -50.36 114.15 1.32 Allowed 'Trans proline' 0 C--N 1.391 2.812 0 C-N-CA 123.542 2.828 . . . . 43.51 112.782 177.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.467 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 85.8 Cg_endo -81.73 127.6 5.66 Favored 'Trans proline' 0 CA--C 1.557 1.648 0 C-N-CA 122.467 2.111 . . . . 71.05 112.192 -176.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 79' ' ' PRO . 34.0 Cg_exo -60.33 84.16 0.07 OUTLIER 'Trans proline' 0 C--N 1.384 2.434 0 C-N-CA 123.176 2.584 . . . . 51.35 112.854 -177.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 146.99 -44.32 0.82 Allowed Glycine 0 C--N 1.341 0.834 0 CA-C-N 114.656 -1.156 . . . . 62.41 110.549 -177.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 115.13 144.75 8.45 Favored Glycine 0 C--N 1.359 1.809 0 C-N-CA 123.282 0.468 . . . . 53.03 112.707 178.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -58.24 117.75 4.75 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.693 0.797 . . . . 74.41 109.646 174.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -54.65 108.54 0.4 Allowed 'General case' 0 N--CA 1.476 0.852 0 O-C-N 124.339 1.024 . . . . 71.31 112.967 -171.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.58 ' HA ' ' HD2' ' A' ' 88' ' ' PHE . 14.1 m-85 -134.81 38.7 3.02 Favored 'General case' 0 C--O 1.245 0.862 0 C-N-CA 125.95 1.7 . . . . 70.22 108.068 173.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.3 m -67.18 117.75 9.64 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 113.256 -1.793 . . . . 74.44 110.732 177.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 85.24 -12.07 59.25 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-N 116.116 -0.493 . . . . 70.11 113.535 -176.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.58 ' HD2' ' HA ' ' A' ' 85' ' ' PHE . 12.2 m-85 -101.59 135.53 42.96 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 109.426 -0.583 . . . . 72.34 109.426 -172.016 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -79.45 80.41 5.82 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-O 120.909 0.385 . . . . 71.44 110.237 -174.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.422 HG23 ' HZ ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -42.14 -53.64 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 125.692 1.597 . . . . 75.21 112.996 176.841 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -73.85 -5.65 42.31 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 113.374 0.879 . . . . 75.33 113.374 -173.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -95.83 -18.71 20.17 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.209 0.604 . . . . 45.35 110.986 175.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.407 ' HE1' ' HB3' ' A' ' 48' ' ' LYS . 23.2 m-30 -83.62 179.12 7.7 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 113.068 0.766 . . . . 71.01 113.068 -171.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 68.2 p -68.14 151.95 46.23 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.892 1.277 . . . . 74.5 113.236 -170.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.6 -35.23 73.91 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 115.309 -0.86 . . . . 74.31 110.727 172.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -50.08 -51.36 43.33 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.132 1.373 . . . . 75.03 110.297 176.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.422 ' HZ ' HG23 ' A' ' 90' ' ' VAL . 0.3 OUTLIER -64.37 -46.08 84.94 Favored 'General case' 0 CA--C 1.556 1.205 0 CA-C-N 114.257 -1.338 . . . . 63.23 110.831 173.859 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.452 ' HA ' HD21 ' A' ' 105' ' ' LEU . 60.7 mt-30 -70.19 -9.9 57.18 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 112.98 0.733 . . . . 73.05 112.98 -173.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -101.96 -44.46 5.48 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.952 0.901 . . . . 70.02 110.929 173.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 17.8 tp -63.66 -56.9 12.21 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.646 0.778 . . . . 55.03 111.042 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.505 ' HZ ' HG13 ' A' ' 56' ' ' VAL . 86.5 m-85 -85.77 6.97 25.53 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 115.392 -0.822 . . . . 72.11 111.073 176.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.437 ' HA2' ' HG ' ' A' ' 105' ' ' LEU . . . -41.4 -63.16 1.67 Allowed Glycine 0 C--N 1.358 1.792 0 C-N-CA 124.867 1.223 . . . . 72.43 114.659 178.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -43.55 -23.12 0.47 Allowed 'Trans proline' 0 C--N 1.389 2.689 0 C-N-CA 124.793 3.662 . . . . 23.1 115.849 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.417 ' HA3' ' HD2' ' A' ' 79' ' ' PRO . . . -152.74 51.6 0.49 Allowed Glycine 0 C--N 1.346 1.138 0 O-C-N 121.888 -0.507 . . . . 44.4 112.035 177.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.452 HD21 ' HA ' ' A' ' 98' ' ' GLN . 25.9 mt -57.48 14.05 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.241 0 N-CA-C 116.067 1.877 . . . . 74.25 116.067 177.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER 61.76 -164.66 0.24 Allowed 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.855 0.862 . . . . 72.25 110.417 166.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 61.68 45.63 95.88 Favored Glycine 0 N--CA 1.442 -0.925 0 N-CA-C 115.678 1.031 . . . . 44.0 115.678 164.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.736 ' HA3' ' HB2' ' A' ' 114' ' ' ARG . . . 63.18 -69.47 0.03 OUTLIER Glycine 0 CA--C 1.529 0.956 0 N-CA-C 118.692 2.237 . . . . 71.34 118.692 162.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.434 ' HE2' HH11 ' A' ' 114' ' ' ARG . 61.4 m-85 -72.49 -8.94 57.72 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.308 0.643 . . . . 64.11 109.656 173.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -84.59 13.51 51.8 Favored Glycine 0 CA--C 1.542 1.776 0 CA-C-N 114.874 -1.057 . . . . 55.25 111.501 161.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? 74.96 -15.29 0.67 Allowed 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 126.942 2.097 . . . . 71.44 112.596 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -97.96 52.26 1.06 Allowed 'General case' 0 CA--C 1.562 1.419 0 N-CA-C 113.443 0.905 . . . . 73.25 113.443 -175.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.531 ' O ' ' HA2' ' A' ' 168' ' ' GLY . 25.7 m 67.53 89.12 0.1 Allowed 'General case' 0 N--CA 1.504 2.258 0 N-CA-C 114.998 1.481 . . . . 74.21 114.998 161.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.736 ' HB2' ' HA3' ' A' ' 108' ' ' GLY . 27.1 ttt180 -72.69 -148.64 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.638 0 CA-C-N 121.266 1.848 . . . . 74.52 111.901 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.404 ' HA ' ' HD2' ' A' ' 170' ' ' PRO . 7.4 tmtt? -10.81 111.23 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.543 0 C-N-CA 126.469 1.908 . . . . 72.15 114.093 -160.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.82 129.13 41.36 Favored Glycine 0 CA--C 1.543 1.835 0 CA-C-N 115.549 -0.751 . . . . 55.22 114.7 -175.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.542 ' N ' ' HA3' ' A' ' 166' ' ' GLY . 65.0 mtt180 -77.37 160.4 28.8 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 125.214 1.406 . . . . 71.34 111.576 172.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -85.14 84.86 7.55 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 107.321 -1.362 . . . . 74.23 107.321 163.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 9.5 tt -95.9 144.54 26.14 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.365 1.066 . . . . 70.23 109.45 -171.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.432 ' HA ' ' HB2' ' A' ' 175' ' ' LEU . 53.6 ttt-85 -102.98 143.37 32.64 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.045 0.938 . . . . 74.51 109.924 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.468 ' HB3' HD11 ' A' ' 174' ' ' LEU . . . -147.4 167.46 24.32 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.308 0.575 . . . . 41.51 112.123 -178.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.438 ' O ' HD12 ' B' ' 8' ' ' LEU . 5.7 mm-40 -103.38 107.93 18.96 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 114.49 -1.232 . . . . 61.0 107.741 -175.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 24.0 tp -99.24 100.25 9.88 Favored Pre-proline 0 N--CA 1.48 1.05 0 N-CA-C 107.888 -1.153 . . . . 54.05 107.888 177.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.579 ' HG2' ' HB ' ' B' ' 6' ' ' ILE . 43.9 Cg_endo -68.29 139.03 44.63 Favored 'Trans proline' 0 C--N 1.37 1.663 0 C-N-CA 121.323 1.348 . . . . 75.33 109.269 176.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.507 HD21 HD12 ' A' ' 149' ' ' ILE . 28.5 tp -142.56 138.7 31.02 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.151 0.887 . . . . 64.01 112.027 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 98.8 m -73.18 131.05 41.55 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 114.233 -1.349 . . . . 71.34 109.189 174.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.57 HD22 HD13 ' A' ' 180' ' ' LEU . 5.4 mt -53.48 -56.74 14.41 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 124.113 0.883 . . . . 70.54 111.085 -172.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.628 ' HG2' ' HD3' ' B' ' 2' ' ' LYS . 28.8 mp0 -41.41 -53.06 3.45 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 113.148 -1.842 . . . . 75.32 111.615 176.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -65.43 -37.42 86.84 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.454 0.702 . . . . 64.33 111.219 -178.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.585 ' HB1' ' O ' ' A' ' 153' ' ' VAL . . . -60.3 -34.66 74.08 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 124.421 1.075 . . . . 41.43 111.46 178.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -82.68 -37.69 24.46 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.563 0.745 . . . . 74.51 111.527 176.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 41.4 m170 -64.59 -40.12 94.96 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.254 0.622 . . . . 75.25 110.903 -175.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 67.34 77.84 0.3 Allowed Glycine 0 C--N 1.343 0.938 0 CA-C-N 115.452 -0.795 . . . . 71.54 112.804 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.412 ' O ' HG12 ' A' ' 149' ' ' ILE . . . -155.33 -158.99 9.05 Favored Glycine 0 C--N 1.334 0.427 0 N-CA-C 112.141 -0.384 . . . . 70.42 112.141 -179.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -68.87 123.89 22.2 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 125.001 1.32 . . . . 73.14 110.401 -175.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.58 HH11 HG23 ' B' ' 5' ' ' THR . 10.1 tpp180 -126.87 120.31 28.9 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.274 -1.01 . . . . 74.4 108.274 169.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.4 t -80.66 128.0 39.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 115.18 -0.918 . . . . 71.24 109.499 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.6 p -142.58 124.03 12.12 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 C-N-CA 124.327 1.051 . . . . 73.14 108.25 -178.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -116.56 123.73 48.09 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.925 0.49 . . . . 71.3 111.695 -171.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.515 HG21 HD23 ' B' ' 8' ' ' LEU . 1.0 OUTLIER -153.69 149.4 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 125.406 1.483 . . . . 75.1 109.598 170.491 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 61.41 20.38 11.1 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.09 0.956 . . . . 74.24 112.33 176.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 85.89 -14.11 53.96 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-N 116.21 -0.45 . . . . 31.1 112.78 -175.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.586 ' HD3' ' SD ' ' A' ' 164' ' ' MET . 59.4 ttt180 -87.82 102.5 14.75 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 123.225 0.61 . . . . 72.12 109.579 177.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.467 ' HB3' ' HB2' ' A' ' 61' ' ' GLU . 41.9 ttt85 -92.41 89.79 6.94 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 107.926 -1.138 . . . . 74.41 107.926 171.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.3 p -96.86 142.95 13.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 115.34 -0.846 . . . . 73.53 109.508 -173.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 23.2 t -108.97 95.81 5.9 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 109.029 -0.73 . . . . 31.45 109.029 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 3.4 p -81.14 116.39 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.005 0.522 . . . . 73.42 110.041 -177.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 38.8 ttt85 -77.61 94.33 4.36 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 107.884 -1.154 . . . . 74.14 107.884 171.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.507 HD12 HD21 ' A' ' 125' ' ' LEU . 9.3 pt -70.45 150.69 95.69 Favored Pre-proline 0 CA--C 1.553 1.064 0 CA-C-N 114.494 -1.23 . . . . 74.13 110.805 -178.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.613 ' HB2' ' HZ ' ' A' ' 240' ' ' PHE . 92.9 Cg_endo -75.69 137.73 20.57 Favored 'Trans proline' 0 CA--C 1.566 2.098 0 C-N-CA 122.231 1.954 . . . . 60.34 111.997 178.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.24 101.64 0.36 Allowed 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 123.086 2.524 . . . . 74.15 114.119 -175.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 121.24 5.62 9.42 Favored Glycine 0 C--N 1.345 1.036 0 CA-C-N 115.006 -0.997 . . . . 75.51 112.914 178.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.585 ' O ' ' HB1' ' A' ' 130' ' ' ALA . 7.4 p -62.38 134.71 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 N-CA-C 109.314 -0.624 . . . . 75.43 109.314 175.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.712 ' HD3' ' HB3' ' A' ' 186' ' ' PHE . 70.0 mtt85 -139.17 174.68 10.26 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 122.761 0.424 . . . . 73.23 110.413 -173.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.599 ' HG3' ' HE ' ' A' ' 187' ' ' ARG . 4.2 tp10 -43.62 136.35 3.39 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 126.792 2.037 . . . . 72.32 113.297 -172.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.38 -15.33 46.03 Favored Glycine 0 CA--C 1.534 1.267 0 CA-C-O 118.885 -0.953 . . . . 14.21 114.627 177.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 22.8 t -63.23 151.76 39.53 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-N 118.648 1.224 . . . . 74.23 110.172 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.426 HG22 HG22 ' A' ' 177' ' ' VAL . 57.3 t -123.5 102.08 10.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 123.566 0.747 . . . . 72.34 109.431 -175.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.554 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 60.2 mt -83.43 108.57 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 108.282 -1.007 . . . . 75.24 108.282 172.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.433 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 78.1 ttt180 -82.39 110.07 17.2 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 109.381 -0.6 . . . . 61.32 109.381 177.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.402 HG13 ' HB3' ' A' ' 174' ' ' LEU . 3.5 p -121.66 106.52 37.22 Favored Pre-proline 0 CA--C 1.558 1.269 0 C-N-CA 123.164 0.586 . . . . 61.33 110.133 178.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.528 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 24.5 Cg_exo -64.98 129.9 24.41 Favored 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 122.938 2.425 . . . . 74.53 111.89 174.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 102.5 24.97 7.97 Favored Glycine 0 C--N 1.342 0.862 0 CA-C-O 119.713 -0.493 . . . . 70.43 114.055 177.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.586 ' SD ' ' HD3' ' A' ' 143' ' ' ARG . 18.6 tpp -138.77 -40.32 0.49 Allowed 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 117.489 0.645 . . . . 64.15 111.19 -175.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.46 ' N ' ' HB2' ' A' ' 174' ' ' LEU . . . -76.98 -85.54 0.43 Allowed Glycine 0 C--N 1.351 1.398 0 O-C-N 123.61 0.569 . . . . 73.33 112.493 -174.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.542 ' HA3' ' N ' ' A' ' 117' ' ' ARG . . . -62.33 105.04 0.86 Allowed Glycine 0 C--O 1.257 1.581 0 N-CA-C 111.697 -0.561 . . . . 74.5 111.697 171.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -60.01 124.46 20.28 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.257 -1.016 . . . . 75.42 108.257 169.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.531 ' HA2' ' O ' ' A' ' 113' ' ' SER . . . 176.47 152.92 10.09 Favored Glycine 0 CA--C 1.499 -0.967 0 O-C-N 123.758 0.661 . . . . 64.21 112.103 -176.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . 0.469 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . 3.6 t-20 -55.19 -45.45 99.85 Favored Pre-proline 0 CA--C 1.569 1.705 0 CA-C-O 118.702 -0.666 . . . . 63.11 110.903 169.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.469 ' HD3' ' HB3' ' A' ' 169' ' ' ASN . 15.1 Cg_exo -75.33 140.1 24.18 Favored 'Trans proline' 0 C--N 1.387 2.595 0 C-N-CA 121.911 1.74 . . . . 71.13 110.449 161.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.34 112.5 3.54 Favored 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 123.047 2.498 . . . . 71.25 113.159 -170.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -80.57 130.54 9.82 Favored Glycine 0 C--N 1.36 1.87 0 C-N-CA 121.004 -0.617 . . . . 72.4 113.369 177.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.528 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 22.5 m-20 -61.28 137.97 58.24 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.781 0.832 . . . . 71.14 110.392 178.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.468 HD11 ' HB3' ' A' ' 121' ' ' ALA . 43.3 tp -113.3 138.51 49.92 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.766 -0.457 . . . . 64.32 109.766 175.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.432 ' HB2' ' HA ' ' A' ' 120' ' ' ARG . 60.3 mt -103.08 86.12 2.64 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 107.947 -1.131 . . . . 72.12 107.947 172.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.554 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 68.3 mt -66.77 89.75 0.16 Allowed 'General case' 0 C--N 1.354 0.792 0 CA-C-N 115.419 -0.81 . . . . 70.05 109.298 174.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.426 HG22 HG22 ' A' ' 158' ' ' VAL . 97.3 t -84.15 99.33 6.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 107.23 -1.396 . . . . 61.43 107.23 175.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.4 p -66.06 102.38 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 CA-C-O 122.294 1.045 . . . . 70.33 111.013 -174.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.548 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 8.1 mmm180 -85.28 96.23 9.45 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 114.137 -1.392 . . . . 53.32 107.797 174.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.57 HD13 HD22 ' A' ' 127' ' ' LEU . 19.1 mt -67.91 150.48 48.48 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 109.925 -0.398 . . . . 72.4 109.925 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 74.3 mt -52.75 144.77 24.22 Favored Pre-proline 0 N--CA 1.48 1.026 0 CA-C-O 118.067 -0.968 . . . . 73.14 110.531 178.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -56.2 81.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.388 2.615 0 C-N-CA 124.149 3.232 . . . . 71.42 112.932 -174.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.412 ' CG ' HD11 ' A' ' 127' ' ' LEU . 12.1 t-80 -143.84 96.91 5.46 Favored Pre-proline 0 CA--C 1.547 0.829 0 N-CA-C 105.346 -2.094 . . . . 73.35 105.346 -177.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -72.67 27.83 0.28 Allowed 'Trans proline' 0 N--CA 1.498 1.779 0 C-N-CA 124.738 3.625 . . . . 61.24 116.733 -162.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.547 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 61.3 t -93.91 -61.17 2.18 Favored 'Isoleucine or valine' 0 C--N 1.352 0.709 0 CA-C-N 119.648 1.113 . . . . 64.21 110.283 -172.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . 0.712 ' HB3' ' HD3' ' A' ' 154' ' ' ARG . 11.7 m-85 -114.52 148.27 38.17 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 114.792 1.404 . . . . 72.31 114.792 -166.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.599 ' HE ' ' HG3' ' A' ' 155' ' ' GLU . 28.5 ttm180 -148.0 134.0 19.21 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.661 1.584 . . . . 75.51 109.192 177.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.48 ' HB2' ' HB2' ' A' ' 154' ' ' ARG . 47.0 tp -97.26 110.27 22.85 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 109.334 -0.617 . . . . 74.21 109.334 174.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.42 92.57 4.75 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 106.983 -1.488 . . . . 70.31 106.983 174.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.485 ' HA3' ' HB3' ' B' ' 380' ' ' LYS . . . 68.82 -98.71 0.56 Allowed Glycine 0 C--N 1.346 1.095 0 CA-C-N 115.546 -0.752 . . . . 65.41 111.349 -174.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.5 HE22 ' HG2' ' B' ' 380' ' ' LYS . 0.7 OUTLIER -115.66 -15.42 11.38 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.118 0.567 . . . . 72.32 110.702 172.141 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.403 ' O ' HD12 ' A' ' 188' ' ' LEU . 15.3 m-20 -79.2 163.58 24.89 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.226 0.61 . . . . 72.32 110.061 177.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.507 HD22 ' HD2' ' A' ' 154' ' ' ARG . 80.1 mt -125.44 141.12 52.23 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.027 0.931 . . . . 63.44 110.699 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.408 ' HB2' ' HB3' ' A' ' 187' ' ' ARG . 55.3 m-85 -102.26 140.67 36.24 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.862 -1.162 . . . . 73.14 107.862 163.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.547 ' HA ' ' O ' ' A' ' 185' ' ' VAL . . . -143.92 155.97 44.26 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.557 1.143 . . . . 74.34 109.314 -173.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 25.4 m -121.27 126.31 49.24 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 108.986 -0.746 . . . . 70.21 108.986 176.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.478 ' HB2' HD22 ' A' ' 251' ' ' LEU . 49.3 tp -117.73 117.89 30.58 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.301 0.641 . . . . 72.21 110.54 -174.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -92.68 113.91 26.31 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.683 -0.858 . . . . 61.43 108.683 169.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 7.4 p -130.46 133.33 24.75 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 124.118 0.967 . . . . 64.4 108.578 -179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -79.8 157.29 24.36 Favored 'Trans proline' 0 C--N 1.366 1.478 0 C-N-CA 121.94 1.76 . . . . 64.51 112.076 171.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -59.3 -48.55 95.89 Favored Pre-proline 0 CA--C 1.558 1.252 0 N-CA-C 114.274 1.213 . . . . 71.34 114.274 -170.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -57.42 -42.64 59.58 Favored 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 121.897 1.731 . . . . 63.54 113.652 178.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 45.3 mt -75.21 -28.24 20.37 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 CA-C-N 116.442 -0.344 . . . . 64.32 110.485 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.44 -42.4 78.92 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.46 0.704 . . . . 71.51 111.101 176.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 42.3 t -71.72 -52.12 27.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 115.184 -0.916 . . . . 63.23 111.583 -178.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 72.5 t -77.29 -31.34 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 122.867 0.467 . . . . 74.41 111.455 -176.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 77.66 71.47 1.21 Allowed Glycine 0 C--N 1.338 0.686 0 CA-C-N 116.242 -0.436 . . . . 72.35 112.015 -177.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -101.19 -123.35 5.17 Favored Glycine 0 C--N 1.346 1.102 0 N-CA-C 111.52 -0.632 . . . . 55.24 111.52 177.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -133.92 139.95 46.48 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.686 0.795 . . . . 45.21 109.395 173.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.427 HG11 HG23 ' A' ' 199' ' ' VAL . 25.1 m -120.96 162.02 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-O 121.33 0.586 . . . . 63.11 110.32 169.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 6.8 ttp180 -85.11 114.42 22.23 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.645 -1.161 . . . . 71.41 108.738 171.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -106.26 164.55 11.92 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 109.226 -0.657 . . . . 62.04 109.226 169.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . 0.414 ' HB2' HG21 ' A' ' 185' ' ' VAL . 71.6 mtp -103.94 139.42 39.11 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 108.729 -0.841 . . . . 71.23 108.729 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 77.8 p -111.42 -165.41 0.99 Allowed 'General case' 0 C--O 1.243 0.755 0 N-CA-C 108.929 -0.767 . . . . 74.1 108.929 174.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.438 HD11 ' HG2' ' A' ' 154' ' ' ARG . 69.9 mt -76.23 -14.69 60.13 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.7 -0.682 . . . . 63.31 112.112 176.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -120.56 -16.61 8.27 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 118.718 0.69 . . . . 64.44 112.071 -175.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 156.82 -165.3 33.06 Favored Glycine 0 N--CA 1.475 1.293 0 CA-C-O 119.776 -0.458 . . . . 33.0 113.694 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -83.67 141.58 9.86 Favored 'Trans proline' 0 C--N 1.367 1.504 0 C-N-CA 122.926 2.417 . . . . 70.23 113.717 -174.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 34.9 m -134.29 169.57 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 124.353 1.061 . . . . 73.4 110.073 176.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.403 ' HB2' ' HB2' ' B' ' 112' ' ' ASN . 49.7 mt-10 -93.53 142.38 27.4 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.361 0.664 . . . . 75.04 110.416 174.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 59.3 t -130.67 119.2 45.02 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 C-N-CA 124.075 0.95 . . . . 74.13 108.452 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.428 ' HB3' ' HA ' ' B' ' 440' ' ' ARG . . . -73.02 102.31 3.47 Favored 'General case' 0 C--N 1.348 0.508 0 N-CA-C 109.181 -0.674 . . . . 60.25 109.181 177.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 48.2 t -67.36 141.2 95.64 Favored Pre-proline 0 CA--C 1.555 1.152 0 C-N-CA 124.689 1.196 . . . . 63.14 110.24 -176.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.8 150.86 39.81 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 122.168 1.912 . . . . 75.51 110.448 171.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . 0.403 ' O ' ' HG2' ' A' ' 226' ' ' ARG . 21.1 Cg_exo -66.6 138.47 49.76 Favored 'Trans proline' 0 CA--C 1.55 1.291 0 C-N-CA 121.332 1.354 . . . . 72.53 112.021 170.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . 0.403 ' HG2' ' O ' ' A' ' 225' ' ' PRO 0.252 7.7 ptp180 52.43 58.77 5.05 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 127.054 2.142 . . . . 74.04 112.544 -177.391 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.498 ' O ' HD11 ' A' ' 255' ' ' ILE . 1.3 m -73.45 105.51 4.85 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 113.989 -1.46 . . . . 64.32 109.146 176.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . 0.412 ' HB3' ' HD2' ' A' ' 231' ' ' ARG . 5.9 tp-100 -84.41 132.34 34.59 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.275 0.63 . . . . 75.32 111.03 -174.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . 0.537 ' HB3' HG22 ' C' ' 256' ' ' THR . . . -66.81 142.04 57.49 Favored 'General case' 0 C--N 1.358 0.97 0 C-N-CA 123.815 0.846 . . . . 62.31 111.916 -177.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . 0.647 ' HA3' HD21 ' B' ' 219' ' ' ASN . . . 88.3 -10.87 69.58 Favored Glycine 0 C--N 1.342 0.906 0 CA-C-N 115.323 -0.853 . . . . 73.32 113.192 -179.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.6 HH11 ' HE1' ' B' ' 444' ' ' TYR . 86.8 mtt180 -87.15 167.07 14.48 Favored 'General case' 0 C--O 1.249 1.062 0 N-CA-C 109.417 -0.586 . . . . 74.0 109.417 172.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.407 ' HD3' ' HA ' ' A' ' 252' ' ' GLU . 0.2 OUTLIER -120.92 126.24 49.5 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.106 -0.952 . . . . 72.22 109.218 -178.168 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.45 HD13 HD13 ' B' ' 441' ' ' ILE . 16.7 mt -83.28 99.16 9.82 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 107.363 -1.347 . . . . 71.4 107.363 177.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 69.6 ttp85 -82.38 100.8 10.21 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.442 -0.947 . . . . 64.14 108.442 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.52 HD12 HD23 ' A' ' 249' ' ' LEU . 21.6 mt -98.41 92.24 5.58 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 108.975 -0.75 . . . . 61.12 108.975 -175.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.519 ' HB3' ' HD2' ' B' ' 434' ' ' HIS . 6.2 tmtm? -60.99 128.51 36.8 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.243 0.617 . . . . 64.43 110.69 -175.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 83.16 6.11 88.39 Favored Glycine 0 C--N 1.346 1.103 0 CA-C-N 115.228 -0.896 . . . . 74.2 114.012 175.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.14 6.73 47.21 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 117.715 0.757 . . . . 73.01 111.066 178.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -93.92 -162.04 35.58 Favored Glycine 0 C--N 1.34 0.79 0 CA-C-N 115.662 -0.699 . . . . 74.43 112.095 174.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . 0.613 ' HZ ' ' HB2' ' A' ' 150' ' ' PRO . 18.3 t80 -78.07 137.1 61.27 Favored Pre-proline 0 CA--C 1.551 1.016 0 CA-C-O 118.904 -0.569 . . . . 73.13 109.967 -177.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -61.16 106.65 0.4 Allowed 'Trans proline' 0 C--N 1.382 2.336 0 C-N-CA 122.152 1.902 . . . . 73.33 112.1 171.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -137.06 -153.11 6.33 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-O 119.027 -0.874 . . . . 73.52 112.776 -175.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . 0.454 ' HA ' HD11 ' B' ' 387' ' ' ILE . 59.2 Cg_exo -54.32 -42.01 71.37 Favored 'Trans proline' 0 C--N 1.384 2.416 0 C-N-CA 123.455 2.77 . . . . 70.45 113.383 176.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -82.24 23.96 0.7 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.965 0.906 . . . . 70.11 112.452 -178.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 83.14 -93.07 1.68 Allowed Glycine 0 C--N 1.35 1.308 0 N-CA-C 109.612 -1.395 . . . . 62.24 109.612 -174.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 20.1 mtm180 -128.12 141.86 51.36 Favored 'General case' 0 C--O 1.247 0.936 0 N-CA-C 107.951 -1.129 . . . . 75.41 107.951 164.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -72.99 -173.51 24.88 Favored Glycine 0 C--N 1.349 1.26 0 O-C-N 123.352 0.408 . . . . 42.24 113.884 -177.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -112.85 135.7 53.31 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.505 0.722 . . . . 75.44 110.498 -174.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.52 HD23 HD12 ' A' ' 235' ' ' LEU . 64.6 tp -97.32 104.96 17.03 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.749 -0.834 . . . . 70.31 108.749 -178.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.57 ' HE2' HG13 ' B' ' 154' ' ' ILE . 67.4 m-85 -90.12 105.98 18.18 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.515 0.726 . . . . 52.51 110.05 -177.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.478 HD22 ' HB2' ' A' ' 197' ' ' LEU . 41.5 mt -90.14 119.21 30.28 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 122.874 0.47 . . . . 72.24 109.942 177.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 232' ' ' LYS . 0.4 OUTLIER -79.11 116.44 19.4 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 107.973 -1.121 . . . . 75.41 107.973 178.639 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 21.8 t -78.21 102.4 4.46 Favored 'Isoleucine or valine' 0 C--O 1.245 0.841 0 CA-C-O 120.969 0.414 . . . . 24.43 111.402 -174.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -101.85 95.39 6.36 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.642 1.177 . . . . 73.14 109.066 168.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.502 ' HB ' ' O ' ' C' ' 255' ' ' ILE . 63.0 mt -77.18 141.06 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 109.879 -0.415 . . . . 74.34 109.879 175.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 21.6 p -130.03 176.68 7.87 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.777 1.231 . . . . 73.43 109.161 177.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.6 pp -137.71 158.41 71.75 Favored Pre-proline 0 CA--C 1.571 1.779 0 C-N-CA 123.625 0.77 . . . . 73.4 111.208 -175.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -55.96 -14.8 11.98 Favored 'Trans proline' 0 C--N 1.39 2.724 0 C-N-CA 123.843 3.028 . . . . 74.45 116.11 -167.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.757 ' HG2' HE21 ' C' ' 228' ' ' GLN . 39.9 mt-10 56.52 -69.98 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 125.53 1.532 . . . . 63.24 113.396 -173.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.36 146.19 36.83 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 108.939 -0.763 . . . . 75.12 108.939 169.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.627 HD22 ' HB2' ' A' ' 265' ' ' GLU . 66.6 mt -138.12 167.97 20.71 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.495 0.718 . . . . 55.32 109.23 172.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . 0.562 ' HA ' HD23 ' B' ' 258' ' ' LEU . 71.6 p -129.75 154.13 80.95 Favored Pre-proline 0 CA--C 1.555 1.149 0 N-CA-C 107.596 -1.261 . . . . 44.34 107.596 169.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -33.65 -37.2 0.1 OUTLIER 'Trans proline' 0 C--N 1.397 3.128 0 C-N-CA 125.041 3.828 . . . . 74.33 117.221 -169.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -62.51 -68.17 0.35 Allowed 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.377 0.671 . . . . 71.44 111.798 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . 0.627 ' HB2' HD22 ' A' ' 261' ' ' LEU . 2.5 mp0 -65.25 -30.29 71.15 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 109.478 -0.564 . . . . 64.2 109.478 -176.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' GLU . . . . . 0.474 ' HA ' HD13 ' A' ' 261' ' ' LEU . 5.8 tp10 -53.21 -52.52 58.63 Favored 'General case' 0 CA--C 1.551 0.998 0 O-C-N 124.043 0.839 . . . . 73.45 109.401 174.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -61.83 -49.52 75.97 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 115.28 -0.873 . . . . 64.12 111.714 177.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 9.3 mp -56.78 -54.32 47.7 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.804 0.842 . . . . 73.14 112.145 -176.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 72.5 m95 -56.7 -49.1 76.13 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.949 0.899 . . . . 75.0 111.404 177.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . 0.659 ' HG3' HG23 ' C' ' 206' ' ' VAL . 1.1 mptm? -60.48 -34.89 74.69 Favored 'General case' 0 CA--C 1.552 1.039 0 O-C-N 123.678 0.611 . . . . 62.43 111.359 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 7.4 mmpt? -69.91 -46.87 64.45 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 117.993 0.361 . . . . 70.22 111.213 178.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' LEU . . . . . 0.443 HD21 ' HB2' ' C' ' 268' ' ' LEU . 80.9 mt -54.24 -39.83 67.16 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.827 0.851 . . . . 63.4 110.7 174.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -80.38 -41.52 24.51 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.786 1.234 . . . . 64.51 113.974 -170.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -64.93 -43.98 90.99 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 108.937 -0.764 . . . . 74.35 108.937 175.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -63.81 -38.57 91.6 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 114.909 -1.041 . . . . 71.44 110.934 173.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -59.91 -56.24 24.22 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.462 0.705 . . . . 75.02 110.109 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -63.67 -37.62 88.03 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.019 0.928 . . . . 70.12 109.967 -175.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -60.12 -26.13 66.0 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 115.463 -0.79 . . . . 75.41 111.89 173.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 49.7 mtm180 -107.38 -1.17 21.83 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.832 0.853 . . . . 74.13 111.72 178.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.248 0 N-CA-C 109.001 -0.74 . . . . 72.21 109.001 -179.231 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 111.437 0.162 . . . . 71.44 111.437 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.628 ' HD3' ' HG2' ' A' ' 128' ' ' GLU . 0.4 OUTLIER -123.25 -1.85 8.64 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.377 0.671 . . . . 54.1 111.934 -178.734 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . 0.41 ' HG3' HD21 ' B' ' 413' ' ' ASN . 23.5 tt0 -93.2 0.62 57.18 Favored 'General case' 0 CA--C 1.559 1.307 0 N-CA-C 109.032 -0.729 . . . . 74.04 109.032 168.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 63.4 m -51.56 138.36 22.66 Favored 'General case' 0 C--N 1.357 0.903 0 C-N-CA 125.993 1.717 . . . . 52.14 113.165 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 0.58 HG23 HH11 ' A' ' 136' ' ' ARG . 0.3 OUTLIER -110.99 170.04 8.37 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.149 0.98 . . . . 70.11 110.108 -175.583 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.579 ' HB ' ' HG2' ' A' ' 124' ' ' PRO . 45.5 pt -132.64 173.49 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 N-CA-C 113.031 0.752 . . . . 64.44 113.031 -161.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -145.1 133.77 22.17 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.571 1.148 . . . . 72.01 108.875 171.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.515 HD23 HG21 ' A' ' 140' ' ' VAL . 34.2 tp -72.83 150.77 42.42 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.868 0.867 . . . . 75.22 110.249 -176.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -79.35 -50.48 10.79 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 119.654 -0.212 . . . . 62.4 111.254 177.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 74.7 mt 62.93 109.2 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 124.338 1.055 . . . . 74.1 110.4 -167.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 85.5 mt -111.41 94.91 24.1 Favored Pre-proline 0 N--CA 1.478 0.936 0 N-CA-C 109.201 -0.666 . . . . 45.35 109.201 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -64.82 -52.71 1.17 Allowed 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 122.863 2.376 . . . . 61.33 111.897 175.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 pp -158.93 -17.6 0.07 Allowed 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 112.912 0.708 . . . . 75.01 112.912 177.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -74.72 100.91 4.12 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 109.014 -0.735 . . . . 64.54 109.014 -177.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -77.67 118.28 19.89 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 108.211 -1.033 . . . . 60.01 108.211 173.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . 0.478 ' HB ' HG13 ' B' ' 18' ' ' VAL . 30.8 p -80.05 109.53 12.71 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 123.629 0.771 . . . . 51.11 110.899 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -85.42 46.05 1.69 Allowed 'Trans proline' 0 C--N 1.377 2.058 0 C-N-CA 122.904 2.402 . . . . 62.42 111.649 177.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.478 HG13 ' HB ' ' B' ' 16' ' ' THR . 8.1 m -57.34 89.2 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.12 0 C-N-CA 124.968 1.307 . . . . 61.41 112.36 -173.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 2.7 m 50.01 50.45 18.48 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.538 1.535 . . . . 71.22 110.217 -176.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -109.79 -10.53 14.77 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 114.825 -1.079 . . . . 62.34 110.21 176.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -172.38 98.7 0.15 Allowed 'General case' 0 C--O 1.24 0.591 0 C-N-CA 124.96 1.304 . . . . 75.34 107.985 173.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 73.9 mtm180 -77.54 -2.8 37.42 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 122.891 0.476 . . . . 73.31 111.071 175.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' THR . . . . . . . . . . . . . 98.5 m -109.13 100.92 42.86 Favored Pre-proline 0 CA--C 1.546 0.813 0 N-CA-C 107.926 -1.139 . . . . 72.45 107.926 158.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . 0.408 ' O ' ' HD2' ' B' ' 27' ' ' PRO . 98.1 Cg_endo -80.02 8.11 4.26 Favored 'Trans proline' 0 C--N 1.38 2.193 0 C-N-CA 122.604 2.203 . . . . 74.55 112.467 176.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -79.62 82.24 5.76 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.705 0.802 . . . . 74.53 109.157 175.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 25.4 ttt -172.57 -49.02 0.0 OUTLIER Pre-proline 0 CA--C 1.561 1.37 0 CA-C-O 118.05 -0.976 . . . . 75.13 110.831 173.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' PRO . . . . . 0.408 ' HD2' ' O ' ' B' ' 24' ' ' PRO . 65.7 Cg_exo -44.26 122.38 3.68 Favored 'Trans proline' 0 C--N 1.404 3.472 0 C-N-CA 122.942 2.428 . . . . 71.1 113.853 172.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 32.4 m -60.17 162.12 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 123.827 0.851 . . . . 73.51 112.091 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.493 HD23 ' H ' ' B' ' 29' ' ' LEU . 2.0 pt? -127.38 -0.83 6.3 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.911 0.884 . . . . 62.2 110.219 179.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.403 ' HG3' ' HG ' ' B' ' 29' ' ' LEU . 38.3 mt-10 -130.04 -169.44 2.13 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.449 1.099 . . . . 70.24 110.523 -172.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 26.4 p30 -147.07 -167.63 2.83 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.35 1.06 . . . . 74.34 110.188 -173.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' ARG . . . . . 0.44 ' HB2' ' HB3' ' B' ' 317' ' ' SER . 6.5 ttp180 -109.1 5.79 24.35 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 124.138 0.975 . . . . 72.22 110.14 177.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.82 132.23 47.01 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.558 0.743 . . . . 73.31 111.702 -172.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . 67.32 17.41 10.2 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 125.317 1.447 . . . . 53.33 111.951 -175.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -123.32 -87.68 0.63 Allowed 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.409 0.684 . . . . 73.13 109.398 177.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . 0.411 ' H ' ' HG2' ' B' ' 32' ' ' ARG . . . 63.45 -85.45 0.05 OUTLIER Glycine 0 C--N 1.354 1.55 0 N-CA-C 111.772 -0.531 . . . . 74.33 111.772 -171.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . 0.529 ' HA ' ' HA3' ' C' ' 110' ' ' GLY . 3.0 p30 49.97 26.29 1.96 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 126.733 2.013 . . . . 61.44 115.679 170.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . 0.485 HG13 ' HD2' ' C' ' 109' ' ' PHE . 7.8 tt -163.33 132.52 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 CA-C-N 118.36 0.527 . . . . 75.44 110.243 173.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 18.1 p -134.96 -62.54 0.72 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.593 0.757 . . . . 64.25 110.436 -173.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.411 ' HA ' ' HD3' ' B' ' 41' ' ' PRO . . . -70.96 133.7 85.97 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 123.662 0.785 . . . . 64.0 111.82 -176.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' B' ' 40' ' ' ALA . 17.4 Cg_exo -68.33 -58.37 0.12 Allowed 'Trans proline' 0 C--N 1.378 2.091 0 C-N-CA 122.728 2.285 . . . . 72.44 112.562 173.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.13 -74.14 1.46 Allowed Glycine 0 C--N 1.345 1.075 0 N-CA-C 111.865 -0.494 . . . . 45.24 111.865 -175.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . 0.652 ' HA2' ' HB2' ' B' ' 326' ' ' ASP . . . 137.41 144.94 4.84 Favored Glycine 0 C--N 1.342 0.913 0 N-CA-C 111.751 -0.539 . . . . 42.15 111.751 177.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . 0.517 ' HB2' ' H ' ' C' ' 142' ' ' GLY . . . -151.68 91.46 1.65 Allowed 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 112.609 0.596 . . . . 63.2 112.609 -171.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.445 ' NH1' ' HB2' ' B' ' 327' ' ' LYS . 0.0 OUTLIER -172.97 173.99 3.61 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 124.729 1.211 . . . . 74.21 109.431 169.07 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' ARG . . . . . 0.579 ' HB3' ' HA ' ' B' ' 179' ' ' ALA . 37.4 ttt-85 -83.53 53.27 2.46 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-O 121.735 0.779 . . . . 75.02 110.666 -178.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 3.1 tt -91.35 70.79 6.07 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 106.39 -1.708 . . . . 53.22 106.39 176.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 9.0 t -172.72 -32.34 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 113.527 -1.669 . . . . 51.22 108.49 -170.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.98 73.78 1.46 Allowed Glycine 0 C--N 1.359 1.823 0 CA-C-N 115.85 -0.614 . . . . 74.15 111.671 176.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -79.89 114.15 18.59 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.284 1.034 . . . . 64.2 110.128 -176.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' GLN . . . . . 0.453 ' HB2' HD22 ' B' ' 55' ' ' LEU . 4.0 pt20 37.45 76.61 0.05 Allowed 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 126.198 1.799 . . . . 75.3 113.747 176.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 57.0 p -106.84 104.93 14.73 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.386 0.675 . . . . 73.31 110.784 -176.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . 62.28 -78.25 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 125.193 1.397 . . . . 73.24 112.508 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.72 93.12 0.24 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.077 0.951 . . . . 75.51 110.715 -178.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.453 HD22 ' HB2' ' B' ' 51' ' ' GLN . 46.7 tp -147.05 125.43 12.32 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 107.606 -1.257 . . . . 72.35 107.606 177.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 56.2 ttt180 71.41 -77.65 0.05 Allowed 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 125.199 1.4 . . . . 73.2 111.611 175.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -54.64 -50.58 67.8 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.996 1.318 . . . . 75.31 113.811 -166.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 48.1 t 68.51 -8.56 0.6 Allowed 'General case' 0 CA--C 1.56 1.35 0 C-N-CA 124.155 0.982 . . . . 62.01 113.393 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 72.7 mt 58.28 18.36 5.39 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 124.982 1.313 . . . . 72.44 112.693 -178.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . 0.495 ' HB2' ' HB2' ' B' ' 346' ' ' ALA . 25.2 t -76.94 -42.4 39.38 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.37 -0.604 . . . . 63.51 109.37 179.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 32.7 t70 62.33 97.92 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.783 1.633 . . . . 71.45 110.922 -178.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' LYS . . . . . . . . . . . . . 65.2 mttm 64.86 92.48 0.06 OUTLIER Pre-proline 0 N--CA 1.479 1.024 0 C-N-CA 124.748 1.219 . . . . 72.3 111.409 176.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . 0.412 ' HB3' HD21 ' B' ' 173' ' ' LEU . 31.9 Cg_exo -62.48 148.68 92.94 Favored 'Trans proline' 0 C--N 1.369 1.634 0 C-N-CA 122.366 2.044 . . . . 72.24 112.629 172.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 58.91 37.04 24.8 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.121 0.968 . . . . 72.04 111.712 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -84.27 27.87 0.66 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.95 0.9 . . . . 65.32 112.991 -174.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -54.6 -49.99 69.12 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.992 1.317 . . . . 72.41 112.72 -173.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 37.3 pt -123.76 23.32 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 N-CA-C 112.506 0.558 . . . . 72.03 112.506 -173.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 34.9 pt -69.24 117.24 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 CA-C-N 118.351 0.523 . . . . 73.4 109.891 177.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 75.5 mt 63.44 10.11 4.6 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.349 1.06 . . . . 73.12 111.789 -174.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 84.0 mt -129.12 18.02 6.05 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.702 1.201 . . . . 44.44 109.944 -176.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 11.8 tt -66.8 118.2 9.6 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 N-CA-C 109.054 -0.721 . . . . 74.32 109.054 175.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 171.28 -165.73 38.8 Favored Glycine 0 C--O 1.243 0.694 0 N-CA-C 111.47 -0.652 . . . . 62.21 111.47 -176.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 61.71 -169.87 0.17 Allowed 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.292 1.037 . . . . 63.44 111.73 -178.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 83.81 -62.35 4.61 Favored Glycine 0 C--N 1.35 1.332 0 N-CA-C 112.323 -0.311 . . . . 64.42 112.323 -178.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 62.1 mtm -71.22 89.05 0.85 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.894 0.878 . . . . 74.01 109.582 178.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . 0.602 ' H ' HD21 ' B' ' 265' ' ' LEU . . . 86.6 53.34 2.93 Favored Glycine 0 C--N 1.344 0.973 0 CA-C-N 115.425 -0.807 . . . . 71.13 111.393 -174.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . 0.572 ' HB3' ' HB ' ' B' ' 80' ' ' ILE . 22.5 t70 -107.98 157.99 17.75 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.252 0.621 . . . . 73.03 110.683 -175.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 44.1 m -69.24 -37.43 77.97 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.847 0.859 . . . . 51.1 112.279 -177.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . 0.416 ' HB3' HH12 ' B' ' 84' ' ' ARG . 41.8 mt-10 -92.01 -47.52 7.24 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.69 0.796 . . . . 74.44 110.474 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.572 ' HB ' ' HB3' ' B' ' 77' ' ' ASP . 2.7 mp -74.52 86.88 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 108.053 -1.091 . . . . 72.52 108.053 175.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 11.8 t -178.09 -37.03 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.248 1.419 . . . . 71.34 108.622 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -174.4 -88.87 0.01 OUTLIER 'General case' 0 C--N 1.361 1.081 0 C-N-CA 124.399 1.079 . . . . 61.11 109.575 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . 60.64 -77.67 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 125.579 1.552 . . . . 71.35 112.956 178.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 84' ' ' ARG . . . . . 0.475 ' NH2' ' HA ' ' B' ' 236' ' ' THR . 0.2 OUTLIER -105.51 112.67 25.85 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 108.451 -0.944 . . . . 73.0 108.451 179.896 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 69.58 117.29 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.607 1.163 . . . . 72.23 111.745 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 20.8 p90 -172.6 143.98 1.39 Allowed 'General case' 0 C--O 1.241 0.641 0 C-N-CA 124.912 1.285 . . . . 63.12 109.011 -175.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . 0.585 ' H ' ' HA ' ' B' ' 262' ' ' ALA . . . 60.34 81.34 0.18 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.448 1.099 . . . . 52.24 111.796 175.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -55.46 173.31 0.12 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.223 1.409 . . . . 74.14 113.179 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -78.23 31.08 1.84 Allowed Glycine 0 CA--C 1.536 1.348 0 CA-C-N 115.866 -0.606 . . . . 54.33 114.081 178.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . 60.47 72.58 0.52 Allowed 'General case' 0 C--N 1.352 0.714 0 C-N-CA 125.392 1.477 . . . . 62.33 111.897 176.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -74.11 -54.43 6.33 Favored Glycine 0 C--N 1.339 0.705 0 N-CA-C 110.306 -1.118 . . . . 70.11 110.306 170.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.72 -129.58 9.37 Favored Glycine 0 C--N 1.348 1.21 0 CA-C-N 115.057 -0.572 . . . . 23.53 113.862 171.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 53.54 -90.48 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.175 1.39 . . . . 74.22 111.384 -174.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 94' ' ' PHE . . . . . 0.461 ' HB2' ' O ' ' B' ' 256' ' ' TYR . 18.1 p90 160.5 -30.7 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 126.783 2.033 . . . . 71.21 108.036 -176.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . 0.506 ' HE2' HG21 ' A' ' 262' ' ' THR . 56.0 tttm -137.62 26.19 2.82 Favored 'General case' 0 CA--C 1.556 1.199 0 CA-C-N 114.448 -1.251 . . . . 74.14 109.341 -173.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . -66.79 -5.91 33.96 Favored Glycine 0 N--CA 1.482 1.765 0 N-CA-C 115.476 0.95 . . . . 72.31 115.476 -173.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 97' ' ' ILE . . . . . 0.79 HD13 HH22 ' C' ' 226' ' ' ARG . 41.6 mt -76.99 -32.52 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.163 0 C-N-CA 123.346 0.659 . . . . 72.22 110.344 173.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -129.86 124.7 33.87 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.811 0.844 . . . . 75.21 110.304 -178.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.95 -59.12 2.91 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.112 0.565 . . . . 61.12 110.555 179.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -144.05 135.13 12.47 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 124.065 0.946 . . . . 74.2 108.992 177.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -51.22 137.38 46.32 Favored 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 122.996 2.464 . . . . 72.21 112.697 175.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -79.69 77.85 6.28 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.093 0.957 . . . . 73.12 110.43 -170.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 70.0 p -90.7 124.71 35.3 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.42 0.688 . . . . 75.52 110.182 -174.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . -79.17 -11.0 85.54 Favored Glycine 0 C--N 1.348 1.216 0 O-C-N 123.198 0.311 . . . . 51.35 113.063 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 19.6 tp60 73.57 13.41 4.45 Favored 'General case' 0 CA--C 1.565 1.519 0 C-N-CA 125.419 1.487 . . . . 75.22 111.479 177.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 62.99 93.98 0.05 Allowed 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.574 1.55 . . . . 74.44 112.822 176.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . 0.457 HG23 ' H ' ' B' ' 109' ' ' TYR . 2.8 t -107.87 162.84 13.64 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 107.764 -1.199 . . . . 63.32 107.764 165.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 45.0 p-80 -75.19 -19.68 59.69 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 122.371 0.268 . . . . 71.44 111.514 -177.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.457 ' H ' HG23 ' B' ' 107' ' ' THR . 85.1 m-85 62.68 -79.16 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.592 1.557 . . . . 53.33 110.505 -174.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -138.86 -81.39 0.31 Allowed 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 108.493 -0.928 . . . . 71.24 108.493 174.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 63.9 tp -175.69 -60.61 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.792 1.237 . . . . 64.15 107.874 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 112' ' ' ASN . . . . . 0.405 ' OD1' ' HB2' ' A' ' 222' ' ' ALA . 26.4 t-20 58.71 -82.78 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 124.698 1.199 . . . . 73.2 110.037 -170.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 113' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? 52.76 89.8 0.03 OUTLIER 'General case' 0 C--N 1.363 1.156 0 C-N-CA 125.078 1.351 . . . . 75.13 110.721 176.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 114' ' ' LYS . . . . . 0.476 ' HA ' ' HD3' ' B' ' 440' ' ' ARG . 24.8 pttm -71.61 -14.94 62.22 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 112.594 0.59 . . . . 74.01 112.594 -171.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 25.3 m 72.46 -55.0 0.68 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 125.938 1.695 . . . . 73.23 111.071 -176.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 114.02 34.98 1.57 Allowed Glycine 0 C--N 1.344 1.026 0 N-CA-C 111.325 -0.71 . . . . 55.33 111.325 177.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . 0.536 ' H ' ' HD2' ' B' ' 118' ' ' PRO . 59.9 tttp -162.38 -69.22 0.01 OUTLIER Pre-proline 0 CA--C 1.557 1.242 0 CA-C-O 117.793 -1.098 . . . . 70.25 111.089 -177.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 118' ' ' PRO . . . . . 0.536 ' HD2' ' H ' ' B' ' 117' ' ' LYS . 13.3 Cg_exo -11.49 49.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.404 3.497 1 C-N-CA 127.17 5.247 . . . . 60.53 118.437 -155.262 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 119' ' ' ASP . . . . . . . . . . . . . 20.6 t70 177.12 154.86 0.26 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.671 1.189 . . . . 75.33 109.265 -177.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 120' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -151.67 11.18 0.58 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.46 1.104 . . . . 70.1 110.219 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 56.3 t -132.83 -70.97 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 123.776 0.831 . . . . 74.32 110.666 -172.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 44.7 m -83.19 82.81 8.1 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.018 0.927 . . . . 75.24 111.089 -170.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -170.63 104.48 0.26 Allowed 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 107.627 -1.249 . . . . 64.3 107.627 171.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 44.1 t -90.54 -80.19 0.33 Allowed 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 123.327 0.651 . . . . 43.31 111.538 -173.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . 58.7 25.79 13.79 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 124.399 1.08 . . . . 73.02 111.527 -172.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -69.49 -54.32 14.84 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 123.502 0.721 . . . . 74.13 110.61 -174.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 12.4 p 42.53 35.88 0.72 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 126.019 1.728 . . . . 70.01 113.304 175.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . 0.464 ' N ' ' SD ' ' B' ' 157' ' ' MET . . . -67.45 -59.69 3.17 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.779 1.231 . . . . 72.01 111.016 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 33.1 m -75.57 88.99 2.72 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.306 -0.998 . . . . 54.34 108.306 170.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . -69.53 175.48 4.08 Favored 'General case' 0 C--O 1.248 1.002 0 CA-C-N 115.427 -0.806 . . . . 44.22 110.466 177.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 131' ' ' TRP . . . . . 0.451 ' HB2' HG23 ' B' ' 133' ' ' THR . 4.3 m-90 66.02 9.1 5.92 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 124.714 1.205 . . . . 73.51 111.551 -178.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 37.9 m 44.89 36.57 1.95 Allowed 'General case' 0 CA--C 1.559 1.326 0 C-N-CA 124.797 1.239 . . . . 51.4 112.151 -174.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 133' ' ' THR . . . . . 0.451 HG23 ' HB2' ' B' ' 131' ' ' TRP . 11.4 p -73.72 86.71 1.68 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.462 0.705 . . . . 62.25 111.074 -177.047 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . -137.9 -141.43 4.19 Favored Glycine 0 C--N 1.343 0.968 0 CA-C-N 115.374 -0.83 . . . . 55.15 111.029 177.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 135' ' ' VAL . . . . . 0.663 HG22 ' H ' ' B' ' 137' ' ' THR . 12.5 p -145.68 147.07 18.86 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 CA-C-N 117.683 0.742 . . . . 73.24 110.446 -177.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 136' ' ' LYS . . . . . 0.52 ' HE3' ' HA ' ' B' ' 215' ' ' GLU . 13.1 ptmm? -80.21 -13.91 58.86 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.304 0.641 . . . . 52.43 111.696 178.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 137' ' ' THR . . . . . 0.663 ' H ' HG22 ' B' ' 135' ' ' VAL . 87.0 m 72.52 102.29 0.07 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.492 1.517 . . . . 75.31 111.626 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 45.4 t80 69.04 151.03 0.08 Allowed 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 125.859 1.664 . . . . 75.52 112.49 177.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . 0.603 HD21 HG23 ' B' ' 329' ' ' ILE . 32.3 m-80 -50.38 -48.68 55.79 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.771 1.228 . . . . 73.24 111.885 176.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . 90.15 127.54 3.43 Favored Glycine 0 C--N 1.343 0.933 0 CA-C-N 115.483 -0.78 . . . . 65.04 111.306 -176.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -149.85 160.52 43.51 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.795 0.438 . . . . 75.34 111.368 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . 0.421 ' HA ' ' SG ' ' B' ' 190' ' ' CYS . 67.2 mt 71.63 -12.71 0.62 Allowed 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 125.607 1.563 . . . . 70.15 113.821 172.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.64 -2.06 64.69 Favored Glycine 0 C--N 1.35 1.319 0 CA-C-N 117.823 0.283 . . . . 61.25 113.366 -173.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 7.3 t -111.06 15.67 8.21 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.308 0 C-N-CA 123.936 0.894 . . . . 75.31 109.777 -176.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -90.76 134.93 34.06 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.156 0.582 . . . . 64.3 109.517 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 10.6 mt 62.52 28.73 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 C-N-CA 125.026 1.33 . . . . 72.52 110.067 -174.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -63.14 -38.68 92.12 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 125.087 1.355 . . . . 72.43 110.994 -178.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -83.05 130.4 35.13 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.601 -0.727 . . . . 73.05 110.895 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 149' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -140.11 88.56 2.23 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.857 0.863 . . . . 72.23 109.441 176.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -81.02 -40.96 23.44 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 108.5 -0.926 . . . . 74.11 108.5 164.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 151' ' ' HIS . . . . . 0.43 ' HA ' ' HD2' ' B' ' 152' ' ' PRO . 62.3 m-70 -111.69 105.73 56.66 Favored Pre-proline 0 C--O 1.242 0.667 0 CA-C-N 114.329 -1.305 . . . . 74.43 108.381 173.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 152' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' B' ' 151' ' ' HIS . 16.5 Cg_endo -55.45 -32.88 84.03 Favored 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 123.367 2.711 . . . . 42.51 111.912 174.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 43.8 p 54.32 -87.16 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 126.322 1.849 . . . . 74.2 112.68 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 154' ' ' ILE . . . . . 0.57 HG13 ' HE2' ' A' ' 250' ' ' TYR . 40.2 mm 48.52 74.52 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.359 1.008 0 C-N-CA 124.74 1.216 . . . . 74.25 109.434 -170.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 75.1 mt -74.73 71.69 1.96 Allowed 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 114.915 -1.038 . . . . 72.1 110.647 -174.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 23.5 -72.95 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 127.829 2.451 . . . . 72.23 115.783 170.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 157' ' ' MET . . . . . 0.464 ' SD ' ' N ' ' B' ' 128' ' ' ALA . 45.0 mtm -91.0 -48.1 7.18 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.518 1.127 . . . . 53.54 110.758 -173.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 158' ' ' ALA . . . . . . . . . . . . . . . -74.43 -25.71 59.61 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 114.825 -1.08 . . . . 34.04 112.875 -172.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . 0.56 ' HE3' ' HA ' ' B' ' 159' ' ' LYS . 1.0 OUTLIER -97.55 75.37 2.48 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.504 0.669 . . . . 55.45 109.297 -176.369 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.92 157.3 26.26 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 114.685 -1.143 . . . . 70.22 108.779 178.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.56 82.85 2.02 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 122.768 0.427 . . . . 71.1 110.423 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 162' ' ' GLY . . . . . 0.464 ' HA2' ' HA3' ' B' ' 166' ' ' GLY . . . -91.87 -73.02 1.24 Allowed Glycine 0 C--N 1.353 1.501 0 N-CA-C 111.141 -0.784 . . . . 73.4 111.141 177.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 60.29 -78.1 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 125.182 1.393 . . . . 65.02 112.47 173.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 164' ' ' ALA . . . . . . . . . . . . . . . -104.12 -55.32 2.39 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.571 0.748 . . . . 75.34 109.789 178.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 165' ' ' THR . . . . . 0.464 HG22 ' HB3' ' B' ' 174' ' ' GLN . 28.9 p -122.42 -75.2 0.6 Allowed 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 115.404 -0.816 . . . . 64.15 110.162 -176.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 166' ' ' GLY . . . . . 0.464 ' HA3' ' HA2' ' B' ' 162' ' ' GLY . . . 92.18 -135.37 12.69 Favored Glycine 0 C--N 1.346 1.123 0 N-CA-C 113.426 0.13 . . . . 71.15 113.426 177.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 167' ' ' ASN . . . . . 0.464 HD21 ' HB2' ' B' ' 221' ' ' ARG . 0.2 OUTLIER -92.21 42.01 1.09 Allowed 'General case' 0 CA--C 1.552 1.021 0 CA-C-O 121.811 0.815 . . . . 72.31 109.168 -173.61 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . 0.62 HG23 ' H ' ' B' ' 170' ' ' THR . 23.7 m -76.99 -5.43 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.252 1.021 . . . . 74.13 111.843 177.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 15.1 m 70.21 -0.86 2.65 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 125.428 1.491 . . . . 54.35 112.025 -177.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 170' ' ' THR . . . . . 0.62 ' H ' HG23 ' B' ' 168' ' ' VAL . 57.3 m 56.6 107.76 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 126.035 1.734 . . . . 63.1 112.786 -173.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -97.89 14.66 26.39 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.955 0.902 . . . . 53.32 110.861 174.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 172' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 64.24 14.53 8.74 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 125.847 1.659 . . . . 73.22 112.659 -177.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 173' ' ' LEU . . . . . 0.412 HD21 ' HB3' ' B' ' 63' ' ' PRO . 82.1 mt -116.95 13.63 14.94 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.282 0.633 . . . . 74.23 111.889 -173.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 174' ' ' GLN . . . . . 0.464 ' HB3' HG22 ' B' ' 165' ' ' THR . 78.5 mt-30 -138.65 -59.62 0.61 Allowed 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 111.993 0.368 . . . . 74.45 111.993 -168.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 175' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -66.02 119.49 11.46 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.334 1.053 . . . . 74.1 111.772 -170.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -156.2 -175.13 5.27 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.931 0.892 . . . . 74.11 110.668 -174.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 93.7 m -127.58 117.58 21.24 Favored Pre-proline 0 CA--C 1.555 1.167 0 C-N-CA 123.899 0.88 . . . . 64.31 109.923 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 178' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -76.5 -30.35 5.2 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 122.728 2.285 . . . . 74.53 113.846 -178.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 179' ' ' ALA . . . . . 0.579 ' HA ' ' HB3' ' B' ' 46' ' ' ARG . . . -88.04 171.58 10.18 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.3 0.64 . . . . 61.34 110.97 -177.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . -67.91 -46.38 71.74 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-O 121.347 0.594 . . . . 74.4 109.431 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 181' ' ' LEU . . . . . 0.582 ' HB2' ' HB3' ' C' ' 136' ' ' ARG . 33.3 tp -116.61 -96.57 0.46 Allowed 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 105.856 -1.905 . . . . 62.04 105.856 154.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 182' ' ' VAL . . . . . 0.585 HG13 ' HB2' ' C' ' 123' ' ' LEU . 7.4 p 156.74 138.6 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.245 0.857 0 C-N-CA 126.777 2.031 . . . . 71.31 105.688 -178.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 183' ' ' ALA . . . . . 0.712 ' HA ' ' HB3' ' C' ' 123' ' ' LEU . . . -160.76 -103.28 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 118.907 -0.568 . . . . 65.24 111.168 176.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 59.54 142.86 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 124.142 0.977 . . . . 74.15 111.372 -164.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 185' ' ' VAL . . . . . 0.527 ' HA ' ' HA ' ' C' ' 121' ' ' ALA . 50.8 t -69.48 157.24 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.733 0 C-N-CA 123.581 0.752 . . . . 71.33 112.707 -170.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 186' ' ' THR . . . . . 0.816 ' HA ' ' HB2' ' C' ' 122' ' ' GLU . 16.3 p -40.94 138.81 0.98 Allowed 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 126.673 1.989 . . . . 51.31 114.587 -177.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 187' ' ' SER . . . . . 0.576 ' HA ' ' HG2' ' B' ' 324' ' ' MET . 16.3 m -138.37 -67.93 0.46 Allowed 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 115.472 -0.786 . . . . 62.14 112.231 -170.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 188' ' ' ARG . . . . . 0.563 ' HB3' ' HB3' ' B' ' 139' ' ' ASN . 11.4 ptp180 -91.71 67.81 5.45 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 121.808 0.813 . . . . 71.52 111.95 -166.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -142.12 -85.89 0.17 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.063 0.945 . . . . 72.52 109.001 175.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 190' ' ' CYS . . . . . 0.472 ' SG ' ' HA2' ' B' ' 208' ' ' GLY . 84.5 m -154.68 82.43 1.1 Allowed 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 108.362 -0.977 . . . . 70.33 108.362 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 191' ' ' TYR . . . . . 0.481 ' HA ' ' HA ' ' B' ' 320' ' ' THR . 35.5 t80 -99.78 149.73 23.06 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 116.05 -0.523 . . . . 74.04 109.863 -178.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -169.75 -164.26 25.16 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 110.767 -0.933 . . . . 64.22 110.767 176.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 193' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.68 -72.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.372 1.807 0 C-N-CA 122.424 2.083 . . . . 64.32 112.753 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 194' ' ' SER . . . . . . . . . . . . . 29.8 t -156.14 37.15 0.34 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.171 0.589 . . . . 24.51 109.771 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 195' ' ' ALA . . . . . . . . . . . . . . . -63.15 -72.56 0.13 Allowed 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.549 -0.75 . . . . 74.32 112.234 -171.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 196' ' ' THR . . . . . 0.546 ' HB ' ' HB3' ' B' ' 200' ' ' CYS . 29.1 p -97.12 1.74 50.32 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.153 0.581 . . . . 73.32 112.092 -176.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 197' ' ' SER . . . . . 0.447 ' HA ' HG22 ' B' ' 318' ' ' VAL . 82.3 p -67.47 -37.92 83.63 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.202 0.601 . . . . 75.11 111.386 -177.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 198' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -84.59 -36.65 21.92 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.61 -0.723 . . . . 51.12 111.593 -178.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -152.18 123.52 7.72 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 122.882 0.473 . . . . 74.4 110.596 -176.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 200' ' ' CYS . . . . . 0.609 ' SG ' HG11 ' B' ' 318' ' ' VAL . 27.2 p -164.85 154.38 11.7 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 125.053 1.341 . . . . 73.31 108.994 179.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 201' ' ' PRO . . . . . 0.457 ' HB2' ' HB2' ' B' ' 204' ' ' ALA . 30.1 Cg_exo -64.95 149.83 88.93 Favored 'Trans proline' 0 C--N 1.37 1.664 0 C-N-CA 121.996 1.797 . . . . 71.34 110.971 164.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . -58.59 101.59 0.22 Allowed Glycine 0 C--N 1.349 1.274 0 O-C-N 123.546 0.529 . . . . 63.04 113.852 -174.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 65.61 40.83 4.31 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.828 1.251 . . . . 71.33 111.719 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 204' ' ' ALA . . . . . 0.457 ' HB2' ' HB2' ' B' ' 201' ' ' PRO . . . -73.54 114.3 11.62 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.628 -0.715 . . . . 74.01 109.882 171.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 205' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 60.61 34.35 20.18 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.549 1.14 . . . . 51.03 111.06 -177.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -55.86 -40.57 73.11 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.974 0.91 . . . . 62.32 112.601 -177.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -76.29 -24.58 54.42 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.579 0.752 . . . . 74.32 111.487 -178.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 208' ' ' GLY . . . . . 0.472 ' HA2' ' SG ' ' B' ' 190' ' ' CYS . . . 82.86 -60.72 4.85 Favored Glycine 0 C--N 1.347 1.19 0 O-C-N 123.199 0.312 . . . . 71.52 112.923 179.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . -62.46 -13.01 42.44 Favored Glycine 0 C--N 1.351 1.384 0 CA-C-O 119.802 -0.444 . . . . 42.21 113.237 172.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt 76.12 -65.77 0.3 Allowed 'General case' 0 C--N 1.364 1.234 0 C-N-CA 125.348 1.459 . . . . 74.51 111.098 168.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . -91.91 11.42 72.17 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-O 119.895 -0.392 . . . . 74.43 112.498 170.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 49.0 m 58.41 19.43 6.44 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.845 1.258 . . . . 74.04 112.308 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 2.1 pp -87.12 176.21 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 124.299 1.039 . . . . 64.4 110.502 177.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 29.5 m 77.01 -37.73 0.28 Allowed 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 125.234 1.414 . . . . 75.43 112.061 -178.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 215' ' ' GLU . . . . . 0.52 ' HA ' ' HE3' ' B' ' 136' ' ' LYS . 68.6 mm-40 -62.35 -74.41 0.09 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.12 0.968 . . . . 73.31 112.104 174.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 216' ' ' GLN . . . . . 0.448 ' NE2' HH12 ' C' ' 179' ' ' ARG . 12.6 mm-40 -100.76 94.53 6.12 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.014 0.525 . . . . 61.42 110.003 -176.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 93.7 mt -97.45 16.33 20.52 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 114.998 -1.001 . . . . 75.4 111.288 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 19.3 mt -109.25 100.41 9.54 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.559 0.743 . . . . 71.43 110.002 -170.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 219' ' ' ASN . . . . . 0.647 HD21 ' HA3' ' A' ' 230' ' ' GLY . 3.9 p-10 -97.96 53.32 1.09 Allowed 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 123.978 0.911 . . . . 71.24 109.769 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . 68.44 -88.81 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.297 1.439 . . . . 61.1 110.467 -170.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 221' ' ' ARG . . . . . 0.464 ' HB2' HD21 ' B' ' 167' ' ' ASN . 56.6 mtp180 57.67 111.5 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.773 1.229 . . . . 73.55 112.579 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -79.86 81.47 6.12 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 107.548 -1.278 . . . . 42.52 107.548 165.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -67.52 108.74 2.95 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-N 115.354 -0.839 . . . . 61.02 109.847 -170.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 21.4 t 65.07 7.86 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.577 2.01 0 C-N-CA 125.176 1.39 . . . . 74.2 110.504 -175.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 2.5 m 53.69 21.92 2.86 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 125.904 1.682 . . . . 54.34 111.21 -173.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 22.2 tp -90.92 -8.84 48.22 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.861 0.864 . . . . 74.43 110.615 -175.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . -62.73 -54.02 36.83 Favored Glycine 0 C--N 1.358 1.751 0 C-N-CA 123.033 0.349 . . . . 51.31 113.313 178.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 177.07 137.2 2.62 Favored Glycine 0 C--N 1.341 0.822 0 N-CA-C 111.56 -0.616 . . . . 72.41 111.56 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -83.09 -171.69 47.74 Favored Glycine 0 C--N 1.345 1.054 0 N-CA-C 114.015 0.366 . . . . 70.24 114.015 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -144.16 114.01 7.24 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.716 0.807 . . . . 70.23 110.296 -174.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 231' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -154.84 41.64 0.46 Allowed 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 125.04 1.336 . . . . 73.24 110.066 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 33.2 m -80.79 91.65 5.96 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-O 121.089 0.471 . . . . 74.24 110.383 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -79.62 83.36 5.61 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.654 0.781 . . . . 70.41 109.834 176.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -168.71 88.27 0.21 Allowed 'General case' 0 C--O 1.243 0.735 0 C-N-CA 125.148 1.379 . . . . 72.31 107.543 178.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -86.87 -100.64 0.07 Allowed 'General case' 0 CA--C 1.555 1.139 0 CA-C-N 115.668 -0.696 . . . . 54.41 111.416 -169.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 236' ' ' THR . . . . . 0.475 ' HA ' ' NH2' ' B' ' 84' ' ' ARG . 5.2 m 54.51 18.84 2.12 Favored 'General case' 0 CA--C 1.566 1.591 0 C-N-CA 124.815 1.246 . . . . 73.34 112.138 -175.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . 0.432 ' O ' ' HE3' ' B' ' 294' ' ' LYS . . . 52.92 78.32 0.14 Allowed 'General case' 0 C--N 1.357 0.923 0 C-N-CA 125.17 1.388 . . . . 71.12 111.33 -169.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 238' ' ' THR . . . . . 0.456 HG22 HG23 ' C' ' 219' ' ' VAL . 13.3 m -71.13 -36.28 72.04 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 121.488 0.661 . . . . 71.31 109.797 174.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -83.64 173.23 11.56 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 114.518 -1.219 . . . . 74.42 111.15 177.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 240' ' ' GLY . . . . . 0.412 ' H ' HD22 ' C' ' 235' ' ' LEU . . . -83.17 -130.7 1.65 Allowed Glycine 0 C--N 1.346 1.126 0 CA-C-N 115.369 -0.832 . . . . 71.23 112.651 178.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -151.69 156.1 39.68 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.695 0.798 . . . . 71.21 108.96 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 242' ' ' TRP . . . . . 0.471 ' CD2' ' HG ' ' C' ' 233' ' ' LEU . 1.2 p-90 -168.04 115.85 0.73 Allowed 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 113.251 0.834 . . . . 70.32 113.251 -175.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 24.83 74.23 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 128.072 2.549 . . . . 74.22 115.307 166.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 126.58 -142.62 13.72 Favored Glycine 0 C--N 1.341 0.822 0 CA-C-N 115.49 -0.777 . . . . 63.11 112.396 178.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? 89.5 83.74 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 127.159 2.183 . . . . 75.34 110.145 -175.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . 0.487 HG23 ' HG2' ' C' ' 225' ' ' PRO . 3.5 t -92.25 -168.89 2.09 Favored 'General case' 0 CA--C 1.561 1.37 0 N-CA-C 106.925 -1.509 . . . . 71.02 106.925 155.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 247' ' ' LEU . . . . . 0.52 ' HG ' ' H ' ' B' ' 248' ' ' ARG . 12.1 tp -143.84 178.19 8.0 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 119.872 1.215 . . . . 72.51 109.938 173.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 248' ' ' ARG . . . . . 0.52 ' H ' ' HG ' ' B' ' 247' ' ' LEU . 0.0 OUTLIER -132.56 148.75 52.38 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.416 0.687 . . . . 75.15 112.096 -169.136 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 249' ' ' GLU . . . . . 0.686 ' HB3' ' HB2' ' B' ' 260' ' ' SER . 7.5 tp10 -159.95 128.56 4.94 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 114.163 -1.38 . . . . 71.33 108.21 178.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -77.54 -50.02 13.47 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 122.826 0.45 . . . . 65.4 110.648 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 251' ' ' ALA . . . . . . . . . . . . . . . 39.3 -100.29 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 125.961 1.704 . . . . 61.03 113.72 -177.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -138.98 27.38 2.4 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.478 1.111 . . . . 72.3 108.64 175.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -79.18 67.16 4.83 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.446 1.098 . . . . 51.41 108.975 172.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 3.5 ptp180 -112.14 97.46 6.67 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 114.82 -1.082 . . . . 72.51 109.173 -174.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . 81.82 -24.62 4.4 Favored Glycine 0 C--N 1.342 0.894 0 CA-C-O 119.66 -0.522 . . . . 54.22 113.329 -177.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 256' ' ' TYR . . . . . 0.461 ' O ' ' HB2' ' B' ' 94' ' ' PHE . 92.8 m-85 -70.75 -95.61 0.01 OUTLIER 'General case' 0 C--N 1.355 0.837 0 C-N-CA 123.328 0.651 . . . . 52.52 109.247 176.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 16.4 pm0 -104.83 167.23 9.85 Favored 'General case' 0 C--N 1.355 0.829 0 CA-C-O 121.478 0.656 . . . . 74.31 110.492 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 258' ' ' LEU . . . . . 0.562 HD23 ' HA ' ' A' ' 262' ' ' THR . 0.3 OUTLIER -91.31 102.96 15.67 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 114.719 -1.128 . . . . 75.13 110.361 178.491 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . 0.54 ' HB ' ' H ' ' B' ' 249' ' ' GLU . 34.3 m 46.73 -163.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 C-N-CA 126.187 1.795 . . . . 63.02 113.993 -177.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 260' ' ' SER . . . . . 0.686 ' HB2' ' HB3' ' B' ' 249' ' ' GLU . 48.7 m -135.13 121.01 19.71 Favored 'General case' 0 C--N 1.36 1.037 0 O-C-N 121.869 -0.519 . . . . 73.11 111.419 178.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -64.99 -29.11 70.01 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.904 0.882 . . . . 52.21 110.923 171.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 262' ' ' ALA . . . . . 0.585 ' HA ' ' H ' ' B' ' 87' ' ' ALA . . . -57.67 -8.82 0.98 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.208 1.003 . . . . 43.43 113.116 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . 79.94 -69.91 0.1 Allowed 'General case' 0 C--N 1.356 0.851 0 C-N-CA 126.169 1.787 . . . . 70.44 109.796 173.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 45.4 t 67.13 179.27 0.22 Allowed 'General case' 0 CA--C 1.558 1.265 0 O-C-N 124.314 1.008 . . . . 51.14 111.478 173.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 265' ' ' LEU . . . . . 0.602 HD21 ' H ' ' B' ' 76' ' ' GLY . 1.0 OUTLIER -95.16 100.76 12.52 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 109.281 -0.637 . . . . 64.12 109.281 -178.143 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 266' ' ' ASN . . . . . 0.478 ' HA ' ' OG1' ' B' ' 269' ' ' THR . 17.2 t-20 -94.34 175.0 6.85 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 124.007 0.923 . . . . 71.52 111.213 -174.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 21.2 m 86.0 -47.99 0.06 Allowed 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 126.925 2.09 . . . . 73.13 112.191 172.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 7.2 p -112.42 22.11 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 123.097 0.559 . . . . 74.44 109.57 175.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 269' ' ' THR . . . . . 0.478 ' OG1' ' HA ' ' B' ' 266' ' ' ASN . 3.9 m -53.75 -48.91 69.23 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.939 0.895 . . . . 74.31 112.032 -174.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 270' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 60.95 -83.26 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.989 0 O-C-N 124.496 1.122 . . . . 72.41 111.723 -178.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 271' ' ' ALA . . . . . . . . . . . . . . . -152.8 -171.68 4.01 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 124.079 0.952 . . . . 75.3 109.956 -175.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 272' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 61.51 -86.28 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.09 1.356 . . . . 54.14 110.687 -178.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 45.9 tp60 43.53 65.37 1.01 Allowed 'General case' 0 C--N 1.353 0.734 0 C-N-CA 125.537 1.535 . . . . 61.32 111.395 -174.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -87.43 12.16 12.86 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 114.124 -1.398 . . . . 71.44 110.793 -177.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 275' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -134.98 68.31 70.54 Favored Pre-proline 0 CA--C 1.56 1.347 0 C-N-CA 123.948 0.899 . . . . 71.33 109.955 173.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -84.04 -79.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.382 2.297 0 C-N-CA 122.374 2.049 . . . . 62.35 109.081 164.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 277' ' ' LEU . . . . . 0.445 HD13 ' HB2' ' B' ' 87' ' ' ALA . 1.6 tt 178.76 -60.41 0.01 OUTLIER 'General case' 0 C--N 1.36 1.033 0 C-N-CA 125.184 1.394 . . . . 63.32 107.432 164.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 88.4 mt -112.83 -176.82 2.99 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.471 0.708 . . . . 62.0 110.015 174.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . -138.98 152.0 22.01 Favored Glycine 0 N--CA 1.474 1.204 0 N-CA-C 110.725 -0.95 . . . . 75.43 110.725 175.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 8.6 mp 61.98 101.24 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 124.41 1.084 . . . . 53.23 110.016 -171.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -110.22 148.58 31.57 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 123.65 0.78 . . . . 75.31 109.936 -175.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -174.2 -30.18 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.817 0.847 . . . . 65.41 111.787 -173.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -75.02 -67.96 0.6 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.285 0.634 . . . . 72.33 109.861 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . 70.37 152.12 0.78 Allowed Glycine 0 CA--C 1.534 1.238 0 CA-C-N 115.666 -0.697 . . . . 61.45 114.035 -177.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 76.04 -51.94 0.62 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.753 1.621 . . . . 72.41 115.241 164.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 286' ' ' MET . . . . . . . . . . . . . 23.7 mmt -48.01 -43.17 53.98 Favored Pre-proline 0 N--CA 1.493 1.678 0 N-CA-C 116.441 2.015 . . . . 64.1 116.441 -152.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 287' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -52.04 -45.28 39.9 Favored 'Trans proline' 0 C--N 1.389 2.69 0 C-N-CA 122.125 1.884 . . . . 73.33 112.738 173.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 288' ' ' VAL . . . . . . . . . . . . . 47.2 t 61.87 -78.48 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 C-N-CA 125.893 1.677 . . . . 74.32 111.08 -178.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 289' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 56.41 98.74 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.655 1.182 . . . . 72.14 110.613 -173.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 290' ' ' TRP . . . . . . . . . . . . . 15.5 m-90 -75.28 72.05 2.31 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 121.579 0.704 . . . . 75.34 109.351 177.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 291' ' ' LEU . . . . . . . . . . . . . 3.6 tt -86.84 73.84 9.89 Favored 'General case' 0 C--N 1.352 0.682 0 N-CA-C 107.568 -1.271 . . . . 64.34 107.568 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . -164.44 72.93 0.18 Allowed Glycine 0 C--O 1.244 0.762 0 CA-C-N 115.229 -0.896 . . . . 62.12 111.254 -178.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -59.04 -20.46 53.82 Favored 'Trans proline' 0 C--N 1.382 2.32 0 C-N-CA 123.255 2.637 . . . . 51.12 112.836 175.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 294' ' ' LYS . . . . . 0.432 ' HE3' ' O ' ' B' ' 237' ' ' ALA . 6.3 ptpp? 47.58 -151.24 0.11 Allowed 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 125.954 1.702 . . . . 41.23 112.345 173.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -124.17 103.48 8.28 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 109.279 -0.637 . . . . 34.32 109.279 174.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 33.0 m -92.84 -37.58 12.22 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.288 1.035 . . . . 65.42 110.862 -175.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 67.45 177.5 0.24 Allowed 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 125.525 1.53 . . . . 64.12 113.496 176.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -135.78 -79.1 0.42 Allowed 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.721 -1.127 . . . . 71.5 108.355 170.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . 60.32 -89.06 0.03 OUTLIER Glycine 0 C--N 1.354 1.561 0 CA-C-N 117.598 0.181 . . . . 63.41 113.013 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -93.95 128.38 40.24 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.312 0.645 . . . . 72.23 109.929 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 301' ' ' ILE . . . . . . . . . . . . . 6.5 tt -142.86 145.8 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.939 0.895 . . . . 72.24 109.341 177.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 25.1 t70 68.79 157.64 0.15 Allowed 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.453 1.101 . . . . 63.41 112.409 173.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 303' ' ' LYS . . . . . . . . . . . . . 62.7 tttm 63.89 66.61 1.05 Allowed Pre-proline 0 CA--C 1.565 1.529 0 C-N-CA 125.054 1.342 . . . . 74.11 111.556 175.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 304' ' ' PRO . . . . . 0.553 ' HA ' ' HG2' ' C' ' 243' ' ' PRO . 72.4 Cg_endo -82.0 140.64 11.42 Favored 'Trans proline' 0 C--N 1.38 2.231 0 C-N-CA 122.269 1.98 . . . . 75.12 113.019 178.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -127.22 85.97 2.44 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.545 0.738 . . . . 42.33 110.453 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 54.9 t -123.99 110.56 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 108.346 -0.983 . . . . 72.33 108.346 176.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 14.5 p -113.21 15.52 19.36 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.758 0.823 . . . . 74.23 110.99 177.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 308' ' ' CYS . . . . . . . . . . . . . 59.8 m -87.95 -30.49 20.01 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.587 0.755 . . . . 74.22 111.228 176.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 32.5 p -99.48 -45.52 0.22 Allowed Pre-proline 0 CA--C 1.572 1.808 0 N-CA-C 115.058 1.503 . . . . 72.2 115.058 -174.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -59.92 -63.92 0.11 Allowed 'Trans proline' 0 C--N 1.4 3.241 0 C-N-CA 122.096 1.864 . . . . 63.14 113.973 -168.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 311' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -146.14 90.98 5.61 Favored Pre-proline 0 CA--C 1.548 0.895 0 CA-C-N 117.703 0.229 . . . . 73.13 110.622 -173.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 312' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -91.54 21.86 0.74 Allowed 'Trans proline' 0 CA--C 1.559 1.772 0 C-N-CA 123.096 2.531 . . . . 70.14 113.988 171.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 313' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.74 123.01 22.45 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.583 -0.895 . . . . 75.13 108.583 174.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 314' ' ' ARG . . . . . 0.689 ' HG3' HD21 ' C' ' 175' ' ' LEU . 1.5 mmp_? -147.17 176.61 9.83 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.15 1.167 . . . . 72.01 114.15 -166.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 315' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -70.92 -57.65 4.37 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 114.702 -1.135 . . . . 72.12 109.281 173.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 316' ' ' ASP . . . . . . . . . . . . . 6.9 t70 63.66 -68.43 0.09 Allowed 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 126.067 1.747 . . . . 74.4 112.798 -177.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 317' ' ' SER . . . . . 0.44 ' HB3' ' HB2' ' B' ' 32' ' ' ARG . 50.4 m 88.72 16.66 0.06 Allowed 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 126.657 1.983 . . . . 75.41 110.61 -171.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 318' ' ' VAL . . . . . 0.609 HG11 ' SG ' ' B' ' 200' ' ' CYS 0.25 2.8 m 63.06 152.94 0.11 Allowed Pre-proline 0 N--CA 1.5 2.031 0 C-N-CA 127.815 2.446 . . . . 73.13 113.258 171.813 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 319' ' ' PRO . . . . . 0.489 ' HD2' ' HB ' ' B' ' 318' ' ' VAL . 18.1 Cg_endo -57.46 -13.72 14.29 Favored 'Trans proline' 0 C--N 1.392 2.86 0 C-N-CA 123.296 2.664 . . . . 65.1 116.484 -170.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 320' ' ' THR . . . . . 0.509 HG22 HG23 ' B' ' 318' ' ' VAL . 9.5 t -87.01 55.7 3.69 Favored 'General case' 0 N--CA 1.486 1.325 0 CA-C-O 122.149 0.976 . . . . 53.31 110.111 175.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 321' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -155.28 120.32 4.86 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.331 -0.85 . . . . 65.14 109.339 -176.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 322' ' ' ALA . . . . . 0.469 ' HB3' HG11 ' B' ' 185' ' ' VAL . . . 82.48 115.87 0.06 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.472 1.509 . . . . 64.54 114.532 163.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 323' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 65.61 -77.84 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 126.509 1.923 . . . . 74.02 114.266 164.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 324' ' ' MET . . . . . 0.576 ' HG2' ' HA ' ' B' ' 187' ' ' SER . 0.2 OUTLIER 69.2 -77.79 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 125.259 1.423 . . . . 71.32 109.958 -170.847 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 325' ' ' THR . . . . . . . . . . . . . 3.1 t -95.26 96.22 9.03 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.007 0.923 . . . . 72.33 110.197 -173.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 326' ' ' ASP . . . . . 0.652 ' HB2' ' HA2' ' B' ' 43' ' ' GLY . 3.3 p-10 -79.38 -58.0 3.42 Favored 'General case' 0 CA--C 1.556 1.196 0 CA-C-N 116.248 -0.433 . . . . 72.01 111.202 -173.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . 0.486 ' HG2' ' O ' ' B' ' 326' ' ' ASP . 0.0 OUTLIER 178.13 -37.39 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 126.985 2.114 . . . . 54.34 108.753 -176.037 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 328' ' ' ALA . . . . . . . . . . . . . . . -78.16 -51.24 10.54 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.351 0.66 . . . . 72.03 111.396 -177.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 329' ' ' ILE . . . . . 0.603 HG23 HD21 ' B' ' 139' ' ' ASN . 2.2 mp 66.63 -80.67 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.563 1.451 0 C-N-CA 124.538 1.135 . . . . 73.5 111.348 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 330' ' ' GLU . . . . . 0.556 ' HG2' ' NH2' ' B' ' 188' ' ' ARG . 44.7 mt-10 -138.53 -4.98 1.6 Allowed 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 123.556 0.743 . . . . 63.42 111.497 -176.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 331' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -139.71 174.7 10.25 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 123.418 0.687 . . . . 63.34 109.787 -173.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 332' ' ' LEU . . . . . 0.704 ' HB3' ' HB3' ' B' ' 335' ' ' ASN . 3.7 mm? -67.79 -29.91 69.21 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.61 0.764 . . . . 74.41 110.99 -178.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 333' ' ' SER . . . . . . . . . . . . . 48.9 m 58.42 -84.8 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.38 1.472 . . . . 65.04 112.897 175.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -89.63 -17.96 27.43 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.562 0.745 . . . . 63.11 112.32 -175.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 335' ' ' ASN . . . . . 0.704 ' HB3' ' HB3' ' B' ' 332' ' ' LEU . 7.0 t30 -67.41 97.75 0.59 Allowed 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 108.326 -0.99 . . . . 73.25 108.326 172.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -65.68 -51.16 61.63 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.269 1.027 . . . . 61.02 110.668 -173.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 337' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.13 108.35 4.07 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.774 0.829 . . . . 62.43 111.655 -169.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 338' ' ' GLY . . . . . . . . . . . . . . . -87.94 171.97 41.57 Favored Glycine 0 C--N 1.348 1.216 0 CA-C-N 115.495 -0.775 . . . . 72.34 111.947 170.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 339' ' ' PHE . . . . . . . . . . . . . 53.3 t80 60.19 83.35 0.14 Allowed 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.459 1.104 . . . . 74.33 109.756 -176.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 340' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -94.94 -69.25 0.76 Allowed 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 116.268 -0.424 . . . . 75.24 110.02 -174.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 341' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 61.42 78.81 0.27 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.616 1.167 . . . . 75.34 111.828 178.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 342' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -91.68 -31.4 15.84 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 115.464 -0.789 . . . . 64.25 110.743 175.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 343' ' ' VAL . . . . . . . . . . . . . 94.8 t -135.74 105.48 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.792 0.837 . . . . 64.24 109.368 -177.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -104.73 65.19 0.75 Allowed 'General case' 0 C--O 1.242 0.702 0 C-N-CA 124.01 0.924 . . . . 73.03 109.075 177.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 345' ' ' GLY . . . . . . . . . . . . . . . 73.37 13.37 79.89 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-N 115.335 -0.848 . . . . 62.31 112.762 -173.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 346' ' ' ALA . . . . . 0.495 ' HB2' ' HB2' ' B' ' 60' ' ' SER . . . -72.95 140.62 47.54 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.559 0.743 . . . . 72.22 111.433 -177.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 31.2 t -160.33 142.25 12.74 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 108.229 -1.026 . . . . 72.21 108.229 175.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 2.9 pp -75.4 142.04 15.06 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 N-CA-C 109.888 -0.412 . . . . 73.42 109.888 176.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 349' ' ' ASP . . . . . 0.418 ' HA ' ' HB3' ' B' ' 353' ' ' HIS . 24.7 t70 -89.87 -78.67 0.36 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.311 -0.996 . . . . 71.13 108.311 174.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 350' ' ' LYS . . . . . . . . . . . . . 98.1 mttt 50.81 36.11 13.76 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.461 1.104 . . . . 74.52 111.881 177.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 65.7 -70.25 0.1 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.747 1.619 . . . . 71.32 111.318 -172.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 352' ' ' ASP . . . . . 0.601 ' HB3' ' HB2' ' B' ' 355' ' ' ALA . 12.0 m-20 -79.72 75.06 6.4 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.932 0.893 . . . . 74.35 110.359 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 353' ' ' HIS . . . . . 0.418 ' HB3' ' HA ' ' B' ' 349' ' ' ASP . 2.3 p-80 -83.36 79.12 9.51 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.588 0.755 . . . . 74.33 109.085 174.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 354' ' ' ALA . . . . . . . . . . . . . . . 64.35 86.35 0.13 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 114.574 -1.193 . . . . 70.11 109.052 -164.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 355' ' ' ALA . . . . . 0.601 ' HB2' ' HB3' ' B' ' 352' ' ' ASP . . . -75.07 -97.91 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 118.826 -0.607 . . . . 75.44 110.494 -178.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 356' ' ' ASN . . . . . . . . . . . . . 12.0 m120 50.42 100.16 0.04 OUTLIER Pre-proline 0 CA--C 1.558 1.27 0 C-N-CA 125.131 1.372 . . . . 74.32 112.42 172.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 357' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.53 141.78 56.76 Favored 'Trans proline' 0 C--N 1.37 1.677 0 C-N-CA 122.541 2.16 . . . . 55.22 112.37 -168.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 358' ' ' CYS . . . . . . . . . . . . . 46.5 t -75.15 71.49 2.19 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-O 121.679 0.752 . . . . 73.32 110.044 177.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 359' ' ' GLY . . . . . . . . . . . . . . . -81.24 0.04 88.22 Favored Glycine 0 C--N 1.347 1.187 0 CA-C-N 115.042 -0.981 . . . . 62.01 113.141 -177.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 360' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 61.32 74.67 0.44 Allowed 'General case' 0 C--N 1.357 0.917 0 C-N-CA 124.767 1.227 . . . . 53.34 109.734 -177.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 361' ' ' ILE . . . . . . . . . . . . . 6.6 tt -140.47 135.21 35.33 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 CA-C-N 115.254 -0.884 . . . . 61.31 109.329 -176.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 362' ' ' GLY . . . . . . . . . . . . . . . -162.25 -132.42 1.33 Allowed Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 110.193 -1.163 . . . . 72.35 110.193 176.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 363' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -170.78 139.91 1.58 Allowed 'General case' 0 C--O 1.24 0.561 0 N-CA-C 107.419 -1.326 . . . . 73.13 107.419 175.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 364' ' ' THR . . . . . . . . . . . . . 92.7 m -56.41 -59.06 5.51 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.071 0.549 . . . . 74.04 110.195 176.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 36.9 t 53.54 -82.28 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.942 0 C-N-CA 125.404 1.482 . . . . 74.01 110.781 -171.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 22.6 t70 61.96 75.43 0.41 Allowed 'General case' 0 C--O 1.241 0.613 0 C-N-CA 124.589 1.156 . . . . 50.12 109.404 -171.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 367' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.01 -27.01 26.7 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 114.026 -1.443 . . . . 75.05 107.875 166.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 368' ' ' ASP . . . . . . . . . . . . . 26.2 t70 62.47 -77.71 0.03 OUTLIER 'General case' 0 C--N 1.364 1.231 0 C-N-CA 125.808 1.643 . . . . 71.23 110.692 -177.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 369' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 44.4 27.93 0.26 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 126.31 1.844 . . . . 70.1 113.48 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 370' ' ' ALA . . . . . . . . . . . . . . . -111.98 -35.44 5.68 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.028 0.931 . . . . 74.25 110.389 -178.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 371' ' ' VAL . . . . . . . . . . . . . 66.3 t 66.51 -70.94 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 C-N-CA 125.17 1.388 . . . . 74.11 111.921 177.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 372' ' ' GLN . . . . . 0.401 ' HG3' ' H ' ' B' ' 374' ' ' ALA . 7.1 tp-100 -160.87 138.25 9.19 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.727 0.811 . . . . 63.2 109.365 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 373' ' ' ARG . . . . . . . . . . . . . 4.4 ppt_? -58.61 -20.52 48.1 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 124.186 0.994 . . . . 72.05 113.285 -177.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 374' ' ' ALA . . . . . 0.401 ' H ' ' HG3' ' B' ' 372' ' ' GLN . . . -149.09 92.5 1.97 Allowed 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 108.034 -1.098 . . . . 71.45 108.034 172.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 375' ' ' LEU . . . . . . . . . . . . . 35.4 tp -77.96 -104.55 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.146 0 CA-C-O 118.981 -0.533 . . . . 62.01 109.821 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -140.62 22.38 2.33 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 119.11 0.868 . . . . 73.13 111.385 -171.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 377' ' ' PHE . . . . . . . . . . . . . 62.7 t80 56.84 -79.79 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.922 1.289 . . . . 73.31 112.831 174.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 378' ' ' ALA . . . . . . . . . . . . . . . -145.79 -17.3 0.46 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.529 0.732 . . . . 61.1 111.465 -176.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? 69.6 125.64 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 125.486 1.514 . . . . 72.01 112.928 178.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 380' ' ' LYS . . . . . 0.5 ' HG2' HE22 ' A' ' 191' ' ' GLN . 52.8 tptt -105.81 162.25 13.72 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 125.271 1.429 . . . . 53.14 108.605 173.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 381' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -54.39 125.86 21.07 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.102 0.961 . . . . 74.34 110.934 176.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -91.82 28.83 8.01 Favored Glycine 0 C--N 1.346 1.139 0 O-C-N 123.684 0.615 . . . . 73.1 112.702 177.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 383' ' ' ASN . . . . . . . . . . . . . 20.8 p-10 -63.51 -50.26 70.3 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 109.182 -0.673 . . . . 73.1 109.182 175.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 384' ' ' THR . . . . . . . . . . . . . 62.2 p 40.68 -155.51 0.01 OUTLIER 'General case' 0 C--N 1.361 1.088 0 C-N-CA 126.622 1.969 . . . . 63.41 114.279 174.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 17.1 tp 61.6 39.75 14.21 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.454 1.102 . . . . 75.12 110.527 173.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 386' ' ' VAL . . . . . . . . . . . . . 25.4 t 59.02 49.16 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.542 0 C-N-CA 124.286 1.034 . . . . 62.42 109.45 -176.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 387' ' ' ILE . . . . . 0.454 HD11 ' HA ' ' A' ' 243' ' ' PRO . 2.6 mp 58.3 82.36 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 125.19 1.396 . . . . 74.12 109.989 -175.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 388' ' ' VAL . . . . . . . . . . . . . 11.8 p 38.09 68.48 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.63 0 C-N-CA 126.613 1.965 . . . . 54.33 113.609 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 389' ' ' THR . . . . . . . . . . . . . 6.0 m 69.72 -1.26 2.36 Favored 'General case' 0 CA--C 1.57 1.73 0 C-N-CA 125.66 1.584 . . . . 71.25 112.476 177.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . 57.88 28.64 16.36 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 124.71 1.204 . . . . 70.34 110.959 -167.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 391' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -139.69 -77.82 0.33 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.314 1.045 . . . . 64.12 110.467 -172.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 392' ' ' HIS . . . . . . . . . . . . . 48.4 t-80 172.75 -36.53 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.027 0.931 . . . . 72.42 109.411 -164.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . 68.27 -151.12 0.16 Allowed 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.928 1.291 . . . . 61.53 110.845 -177.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 74.43 -63.02 0.44 Allowed 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 125.356 1.463 . . . . 73.31 109.776 -167.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . -167.88 103.91 0.48 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.334 1.054 . . . . 71.44 108.412 174.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 33.5 t -98.34 -90.5 0.28 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.098 0.559 . . . . 75.55 110.593 -176.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 397' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -101.8 -77.65 0.55 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.294 0.637 . . . . 71.41 110.111 -172.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 2.6 pp -101.38 117.9 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 CA-C-O 121.402 0.62 . . . . 75.44 109.987 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 399' ' ' VAL . . . . . . . . . . . . . 3.6 m -134.97 -10.77 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 124.499 1.12 . . . . 73.32 110.284 177.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 400' ' ' ALA . . . . . . . . . . . . . . . -69.23 -44.15 26.28 Favored Pre-proline 0 CA--C 1.56 1.342 0 C-N-CA 124.304 1.042 . . . . 51.41 113.736 176.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 401' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -67.8 102.18 0.73 Allowed 'Trans proline' 0 C--N 1.39 2.744 0 CA-C-N 121.08 1.422 . . . . 71.04 111.352 174.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -80.96 -172.98 4.0 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 122.847 0.459 . . . . 74.34 110.736 -179.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 403' ' ' THR . . . . . 0.603 ' HA ' ' HD2' ' B' ' 415' ' ' LYS . 5.5 m -76.14 -52.76 9.43 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 123.192 0.597 . . . . 51.3 111.802 -171.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 404' ' ' LYS . . . . . 0.666 ' HA ' ' H ' ' B' ' 413' ' ' ASN . 36.1 ttpt -83.88 -37.78 21.97 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 115.32 -0.855 . . . . 70.03 111.874 -171.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 405' ' ' ALA . . . . . 0.486 ' O ' ' HA ' ' B' ' 410' ' ' GLN . . . 63.29 81.42 0.23 Allowed Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 124.549 1.139 . . . . 71.24 110.122 -174.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 406' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -84.14 5.85 6.09 Favored 'Trans proline' 0 C--N 1.373 1.841 0 C-N-CA 123.681 2.921 . . . . 44.44 113.98 -172.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . -61.9 -69.37 1.32 Allowed Glycine 0 C--N 1.351 1.412 0 O-C-N 123.272 0.357 . . . . 55.33 112.645 -177.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 408' ' ' LEU . . . . . . . . . . . . . 43.3 tp -150.59 142.16 23.54 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 108.738 -0.838 . . . . 72.03 108.738 177.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 21.2 m 76.21 -43.8 0.48 Allowed 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 125.46 1.504 . . . . 73.52 112.547 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 410' ' ' GLN . . . . . 0.486 ' HA ' ' O ' ' B' ' 405' ' ' ALA . 76.1 mt-30 66.37 122.03 0.02 OUTLIER 'General case' 0 C--N 1.358 0.956 0 C-N-CA 125.692 1.597 . . . . 51.32 110.974 -174.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . -60.62 -26.51 67.07 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.708 0.403 . . . . 63.14 110.23 169.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 1.7 tt 64.44 56.54 1.25 Allowed 'General case' 0 C--N 1.358 0.975 0 C-N-CA 125.198 1.399 . . . . 60.41 107.892 -177.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 413' ' ' ASN . . . . . 0.666 ' H ' ' HA ' ' B' ' 404' ' ' LYS . 3.2 m-20 74.7 -11.91 0.99 Allowed 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 113.014 -1.903 . . . . 71.14 113.485 172.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 414' ' ' THR . . . . . . . . . . . . . 70.2 p -71.75 -5.17 32.11 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 112.899 0.703 . . . . 73.24 112.899 -173.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 415' ' ' LYS . . . . . 0.603 ' HD2' ' HA ' ' B' ' 403' ' ' THR . 13.5 mmmm 77.31 -55.29 0.54 Allowed 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 126.218 1.807 . . . . 73.42 111.36 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 416' ' ' ASP . . . . . 0.519 ' HB3' HG22 ' B' ' 419' ' ' VAL . 16.2 t70 -160.46 -51.62 0.05 Allowed 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.767 1.227 . . . . 75.33 108.337 -176.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 417' ' ' GLY . . . . . . . . . . . . . . . 105.41 -50.54 0.82 Allowed Glycine 0 C--N 1.351 1.384 0 CA-C-N 115.106 -0.952 . . . . 43.15 112.293 177.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 418' ' ' ALA . . . . . . . . . . . . . . . -75.59 -21.02 58.18 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.039 0.536 . . . . 70.25 111.859 -175.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 419' ' ' VAL . . . . . 0.519 HG22 ' HB3' ' B' ' 416' ' ' ASP . 24.2 m -74.32 81.79 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.247 0 CA-C-O 122.594 1.187 . . . . 62.03 111.021 176.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 420' ' ' MET . . . . . . . . . . . . . 64.7 mtm -94.54 -8.55 37.93 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 114.979 -1.009 . . . . 73.12 111.567 -178.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 421' ' ' VAL . . . . . 0.434 HG12 ' H ' ' B' ' 423' ' ' SER . 88.7 t -74.74 -83.23 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 C-N-CA 122.71 0.404 . . . . 72.42 110.037 176.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 422' ' ' MET . . . . . . . . . . . . . 94.2 mmm 54.1 13.36 0.57 Allowed 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 124.758 1.223 . . . . 74.1 113.889 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 423' ' ' SER . . . . . 0.434 ' H ' HG12 ' B' ' 421' ' ' VAL . 23.0 t -113.03 109.66 19.2 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.214 0.606 . . . . 62.22 110.739 -170.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 424' ' ' TYR . . . . . . . . . . . . . 81.4 t80 67.58 -77.88 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.32 1.448 . . . . 72.42 111.445 176.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . 166.11 145.29 4.39 Favored Glycine 0 C--N 1.339 0.709 0 CA-C-O 119.14 -0.811 . . . . 75.12 111.116 -177.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 426' ' ' ASN . . . . . . . . . . . . . 9.2 p30 45.33 35.27 1.78 Allowed 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 125.699 1.6 . . . . 75.43 112.608 -176.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 427' ' ' SER . . . . . . . . . . . . . 20.3 m 54.73 69.68 0.7 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.629 1.171 . . . . 75.14 110.639 -172.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 46.25 106.72 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 126.274 1.83 . . . . 73.23 113.583 -174.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 429' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -61.05 96.58 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.332 0.653 . . . . 63.42 111.212 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 17.8 t70 35.61 63.78 0.52 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 126.704 2.002 . . . . 55.41 113.511 173.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 29.9 p -110.43 -35.64 5.99 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.527 -0.76 . . . . 73.31 110.698 178.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 432' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 52.82 54.93 9.72 Favored 'General case' 0 CA--C 1.557 1.222 0 CA-C-O 122.349 1.071 . . . . 71.1 110.061 -173.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 433' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -69.2 156.28 39.0 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 114.552 -1.204 . . . . 73.43 108.367 178.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 434' ' ' HIS . . . . . 0.519 ' HD2' ' HB3' ' A' ' 236' ' ' LYS . 53.8 m-70 -50.51 100.55 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.32 1.048 . . . . 65.13 110.371 -176.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 435' ' ' THR . . . . . 0.473 ' HA ' ' HB3' ' B' ' 118' ' ' PRO 0.289 9.7 t 65.58 -15.65 0.11 Allowed 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 128.021 2.528 . . . . 73.42 114.821 -173.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . 71.43 -77.04 0.62 Allowed Glycine 0 C--N 1.352 1.472 0 CA-C-N 118.378 0.536 . . . . 43.54 112.2 178.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 32.8 t -129.38 171.09 12.87 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.092 0.957 . . . . 54.14 109.041 172.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 438' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 65.76 114.79 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 124.876 1.27 . . . . 71.55 111.023 -174.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 439' ' ' LEU . . . . . 0.504 HD23 ' H ' ' B' ' 439' ' ' LEU . 1.9 pt? -73.1 87.25 1.39 Allowed 'General case' 0 CA--C 1.558 1.253 0 CA-C-O 122.78 1.276 . . . . 74.24 110.686 -178.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 440' ' ' ARG . . . . . 0.476 ' HD3' ' HA ' ' B' ' 114' ' ' LYS . 57.6 mtt180 -91.9 -10.38 39.81 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 113.915 -1.493 . . . . 70.1 111.028 178.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 441' ' ' ILE . . . . . 0.452 ' HA ' HD22 ' A' ' 235' ' ' LEU . 58.9 mt 69.69 125.46 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.001 0 C-N-CA 125.817 1.647 . . . . 74.15 113.086 174.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 442' ' ' ALA . . . . . . . . . . . . . . . -145.37 105.35 4.02 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 107.201 -1.407 . . . . 71.41 107.201 172.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . -158.01 -52.08 0.07 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.506 0.722 . . . . 74.21 109.836 -172.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 444' ' ' TYR . . . . . 0.6 ' HE1' HH11 ' A' ' 231' ' ' ARG . 0.0 OUTLIER -164.71 115.84 1.2 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.595 0.758 . . . . 65.34 110.13 176.409 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . 126.73 -65.19 0.57 Allowed Glycine 0 CA--C 1.54 1.603 0 CA-C-O 118.744 -1.031 . . . . 74.34 114.011 176.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 446' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -43.86 -29.82 2.72 Favored 'Trans proline' 0 C--N 1.397 3.081 0 C-N-CA 124.501 3.467 . . . . 63.02 115.186 178.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 447' ' ' HIS . . . . . . . . . . . . . 18.5 m80 -119.23 -75.22 0.58 Allowed 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 108.343 -0.984 . . . . 60.0 108.343 174.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . 67.24 148.09 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.911 1.284 . . . . 74.31 112.096 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 449' ' ' ALA . . . . . . . . . . . . . . . -77.13 73.68 3.71 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-O 121.565 0.698 . . . . 61.52 110.363 177.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 450' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -157.86 -62.94 0.09 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.223 1.009 . . . . 61.12 109.538 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 7.2 p -77.49 -23.04 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 C-N-CA 122.86 0.464 . . . . 63.1 110.656 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 452' ' ' VAL . . . . . . . . . . . . . 34.5 m -70.31 124.95 27.55 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 C-N-CA 122.972 0.509 . . . . 60.45 110.801 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . -99.33 7.29 59.92 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-N 115.819 -0.628 . . . . 73.44 112.272 177.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 454' ' ' LEU . . . . . . . . . . . . . 63.2 tp -72.26 -81.76 0.05 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.656 0.782 . . . . 72.5 110.131 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . 0.521 HG21 ' HA ' ' B' ' 461' ' ' PHE . 19.1 m 45.8 70.54 0.36 Allowed 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 124.423 1.089 . . . . 61.41 112.077 -178.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -94.96 13.01 26.37 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 115.216 -0.902 . . . . 74.3 110.721 178.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 457' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -91.66 46.84 1.31 Allowed 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 124.103 0.961 . . . . 42.14 110.114 -178.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 13.7 m 59.35 72.98 0.5 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.39 1.476 . . . . 72.13 112.337 177.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 459' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 58.29 -152.28 0.4 Allowed 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.159 0.984 . . . . 73.31 111.21 171.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 75.2 mt 78.6 -56.7 0.46 Allowed 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 126.022 1.729 . . . . 65.42 112.309 172.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 461' ' ' PHE . . . . . 0.521 ' HA ' HG21 ' B' ' 455' ' ' THR . 76.3 t80 70.15 -73.47 0.09 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.086 1.355 . . . . 62.31 109.634 -172.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 462' ' ' TYR . . . . . 0.535 ' HA ' ' SD ' ' B' ' 464' ' ' MET . 14.9 t80 61.54 -171.23 0.15 Allowed 'General case' 0 CA--C 1.561 1.373 0 C-N-CA 124.149 0.979 . . . . 72.53 110.51 175.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 4.0 m 70.79 3.22 4.5 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 124.067 0.947 . . . . 61.35 112.316 177.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 464' ' ' MET . . . . . 0.535 ' SD ' ' HA ' ' B' ' 462' ' ' TYR . 0.0 OUTLIER -78.98 71.33 5.43 Favored 'General case' 0 CA--C 1.557 1.227 0 CA-C-O 122.708 1.242 . . . . 75.31 110.399 -178.557 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -102.38 4.89 39.4 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.668 1.187 . . . . 72.15 111.256 -174.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -61.44 139.56 58.19 Favored 'General case' 0 C--N 1.349 0.571 0 C-N-CA 123.395 0.678 . . . . 62.32 109.573 174.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . -60.54 -24.76 65.63 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 122.98 0.512 . . . . 75.3 111.168 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -82.3 118.96 23.54 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 108.013 -1.106 . . . . 45.51 108.013 167.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 469' ' ' GLY . . . . . . . . . . . . . . . -72.04 86.08 0.48 Allowed Glycine 0 C--N 1.348 1.199 0 N-CA-C 111.286 -0.726 . . . . 50.44 111.286 176.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 470' ' ' LEU . . . . . . . . . . . . . 63.9 tp -61.42 -59.06 5.83 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.147 0.979 . . . . 73.2 111.195 -177.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 471' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? . . . . . 0 C--O 1.253 1.266 0 N-CA-C 106.796 -1.557 . . . . 74.2 106.796 -175.299 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . 0.493 ' SD ' ' N ' ' C' ' 1' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.478 0.94 0 N-CA-C 110.165 -0.309 . . . . 55.23 110.165 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 60.54 37.54 19.49 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 125.207 1.403 . . . . 65.31 112.859 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -72.8 80.62 1.15 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 122.508 0.323 . . . . 52.01 110.188 175.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -34.17 93.71 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 127.041 2.137 . . . . 70.52 112.894 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 5' ' ' LYS . . . . . 0.495 ' HE2' HD11 ' C' ' 10' ' ' ILE . 14.5 mmmm -92.84 93.29 8.33 Favored 'General case' 0 C--O 1.243 0.72 0 N-CA-C 107.812 -1.181 . . . . 63.2 107.812 169.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -73.67 97.36 2.66 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 107.193 -1.41 . . . . 63.22 107.193 175.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 7' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -61.54 -37.86 85.32 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.182 -0.917 . . . . 73.43 111.598 -171.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -60.97 -45.02 96.45 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 116.181 -0.463 . . . . 72.53 110.481 175.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.96 -40.95 99.25 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.051 0.54 . . . . 52.31 111.207 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 10' ' ' ILE . . . . . 0.495 HD11 ' HE2' ' C' ' 5' ' ' LYS . 64.6 mt -61.92 -36.07 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.213 0.605 . . . . 63.34 110.576 177.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 11' ' ' LEU . . . . . 0.583 HD13 HG23 ' C' ' 22' ' ' ILE . 68.7 mt -80.61 -13.85 58.69 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 112.46 0.541 . . . . 45.45 112.46 176.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.11 35.92 42.27 Favored Glycine 0 C--N 1.351 1.364 0 N-CA-C 113.689 0.235 . . . . 64.33 113.689 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 6.1 m -131.56 153.44 81.55 Favored Pre-proline 0 N--CA 1.482 1.151 0 C-N-CA 124.691 1.196 . . . . 64.04 109.184 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -76.51 161.08 34.7 Favored 'Trans proline' 0 C--N 1.373 1.83 0 C-N-CA 122.432 2.088 . . . . 74.43 112.293 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -67.85 80.53 0.2 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.339 0.655 . . . . 71.52 109.898 176.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -179.19 -30.03 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.673 1.189 . . . . 71.24 109.038 -174.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -47.58 119.72 2.9 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 124.744 1.277 . . . . 71.14 111.688 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 72.3 p -86.25 178.35 7.21 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.802 0.841 . . . . 74.41 110.14 177.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.45 -38.28 19.46 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 124.515 1.126 . . . . 74.45 112.195 -177.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 20' ' ' GLU . . . . . 0.402 ' O ' ' HG3' ' C' ' 24' ' ' ARG . 13.9 tp10 -66.72 -52.63 42.25 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.387 0.675 . . . . 64.05 110.953 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . 0.662 ' HA ' ' HE ' ' C' ' 24' ' ' ARG . 33.7 mt-10 -65.0 -34.37 78.27 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.636 0.775 . . . . 73.42 111.285 -176.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 22' ' ' ILE . . . . . 0.896 HD13 ' HB3' ' C' ' 57' ' ' LEU . 82.1 mt -75.56 -36.08 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.214 1.405 . . . . 61.32 111.268 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -62.87 -44.21 96.74 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.758 0.823 . . . . 74.13 109.77 175.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 24' ' ' ARG . . . . . 0.662 ' HE ' ' HA ' ' C' ' 21' ' ' GLU . 42.8 mtm180 -64.63 -46.05 84.19 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 115.332 -0.849 . . . . 73.52 110.829 178.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . 0.42 ' O ' ' HB3' ' C' ' 28' ' ' ARG . . . -61.5 -37.68 84.58 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.461 0.705 . . . . 75.32 111.682 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 26' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -62.97 -52.1 64.33 Favored 'General case' 0 C--O 1.212 -0.882 0 CA-C-N 115.121 -0.945 . . . . 72.31 109.998 176.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -58.02 -37.14 73.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 123.882 0.739 . . . . 74.1 111.369 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 28' ' ' ARG . . . . . 0.42 ' HB3' ' O ' ' C' ' 25' ' ' ALA . 20.8 ttt180 -53.15 -56.03 19.54 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.294 1.037 . . . . 71.15 110.45 172.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . 0.671 ' HB3' HD13 ' C' ' 50' ' ' ILE . 91.2 mt -80.9 -11.15 59.63 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 115.769 -0.65 . . . . 60.22 111.879 -177.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -91.31 -10.7 40.39 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.126 0.97 . . . . 75.32 110.535 177.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -93.89 -48.6 6.2 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.216 0.606 . . . . 73.5 110.342 165.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 20.6 tp60 -62.44 -48.52 79.31 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.452 0.701 . . . . 71.12 111.297 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 33' ' ' TYR . . . . . 0.417 ' HE2' HD22 ' C' ' 29' ' ' LEU . 29.4 m-85 -109.01 37.11 2.65 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.218 0.607 . . . . 70.15 109.969 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 34' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -67.89 111.48 7.81 Favored Pre-proline 0 N--CA 1.473 0.719 0 CA-C-O 118.373 -0.823 . . . . 72.34 109.378 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.74 -29.21 76.94 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 122.417 2.078 . . . . 71.32 111.318 -176.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -62.07 -33.03 73.65 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.364 1.466 . . . . 60.34 112.153 176.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 98.6 t -96.71 -62.62 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 N-CA-C 108.988 -0.745 . . . . 75.33 108.988 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -98.72 96.46 7.93 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.263 1.025 . . . . 54.22 110.604 -177.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -80.03 74.66 6.8 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 108.644 -0.873 . . . . 62.24 108.644 173.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 71.1 m -126.8 97.85 32.17 Favored Pre-proline 0 CA--C 1.538 0.506 0 N-CA-C 108.591 -0.892 . . . . 74.14 108.591 175.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -39.16 -44.19 2.64 Favored 'Trans proline' 0 C--N 1.388 2.655 0 C-N-CA 124.76 3.64 . . . . 63.44 114.545 -176.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -48.6 -55.51 10.98 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 124.811 1.244 . . . . 65.44 111.023 174.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.42 -21.21 63.77 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 115.476 -0.784 . . . . 62.05 111.272 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 44' ' ' GLU . . . . . 0.437 ' O ' ' HG3' ' C' ' 48' ' ' LYS . 43.0 mt-10 -88.76 -24.57 22.61 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.529 0.731 . . . . 74.04 110.748 -175.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -81.31 -36.54 29.65 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.615 0.766 . . . . 42.53 109.248 174.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 46' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -65.21 -36.64 84.81 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.05 -0.977 . . . . 72.32 109.167 169.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 47' ' ' PHE . . . . . 0.572 ' HA ' HD12 ' C' ' 50' ' ' ILE . 41.9 t80 -66.68 -32.62 74.06 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.449 0.7 . . . . 62.23 110.408 173.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 48' ' ' LYS . . . . . 0.442 ' HB3' ' CE1' ' C' ' 93' ' ' PHE . 95.7 mttt -64.14 -39.79 94.79 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 122.889 0.476 . . . . 72.04 110.808 172.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -69.15 -28.94 66.87 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.65 0.38 . . . . 72.33 110.774 176.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 50' ' ' ILE . . . . . 0.671 HD13 ' HB3' ' C' ' 29' ' ' LEU . 71.2 mt -73.07 -32.79 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 123.856 0.863 . . . . 75.43 110.381 173.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 51' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -77.38 -24.73 50.54 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.257 0.623 . . . . 74.04 110.62 175.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -71.09 -52.85 17.02 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 108.369 -0.974 . . . . 63.42 108.369 172.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.22 -44.41 79.53 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 113.533 -1.667 . . . . 63.1 111.467 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -74.18 -38.33 63.68 Favored 'General case' 0 C--O 1.208 -1.112 0 CA-C-N 115.425 -0.807 . . . . 75.01 110.384 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.89 -35.77 75.54 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-O 120.81 0.338 . . . . 60.54 111.469 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 47.5 t -77.84 -44.71 28.55 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 CA-C-N 115.906 -0.588 . . . . 72.43 109.875 175.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 57' ' ' LEU . . . . . 0.896 ' HB3' HD13 ' C' ' 22' ' ' ILE . 52.4 mt -98.74 0.65 44.93 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 115.428 1.64 . . . . 75.02 115.428 -166.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 30.9 t -75.56 -66.12 0.81 Allowed 'General case' 0 N--CA 1.484 1.233 0 CA-C-O 121.733 0.777 . . . . 62.42 109.686 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -86.83 132.36 42.39 Favored Pre-proline 0 C--O 1.255 1.376 0 CA-C-N 114.438 -1.255 . . . . 72.03 108.885 -169.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 60' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_exo -46.6 -30.5 8.9 Favored 'Trans proline' 0 C--N 1.388 2.626 0 C-N-CA 124.218 3.279 . . . . 33.23 114.796 -175.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -57.25 -69.74 0.15 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.572 0.749 . . . . 62.13 111.413 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.28 -25.54 63.39 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 122.773 0.429 . . . . 75.23 110.619 -173.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -61.93 -47.86 83.0 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 108.147 -1.057 . . . . 64.42 108.147 175.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -70.14 -29.34 66.23 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.156 0.582 . . . . 74.15 111.618 177.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 82.0 mt -62.08 -43.8 98.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 C-N-CA 122.72 0.408 . . . . 62.34 110.384 174.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -67.08 -46.55 73.93 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.771 -0.649 . . . . 74.22 109.797 177.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -55.1 -47.58 74.75 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.228 0.611 . . . . 73.14 110.758 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 70.4 p -70.39 -26.81 63.87 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.94 -0.573 . . . . 63.2 111.518 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -69.51 136.17 51.08 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 108.81 -0.811 . . . . 75.22 108.81 178.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.05 15.28 54.5 Favored Glycine 0 N--CA 1.473 1.107 0 N-CA-C 111.632 -0.587 . . . . 62.51 111.632 -169.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 58.2 m -148.4 -60.24 0.24 Allowed 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 103.698 -2.704 . . . . 72.34 103.698 175.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 56.8 m -75.04 140.53 43.61 Favored 'General case' 0 C--O 1.252 1.218 0 N-CA-C 105.147 -2.168 . . . . 73.35 105.147 156.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.87 -36.25 6.7 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.88 0.872 . . . . 73.23 110.873 -176.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -93.32 139.17 22.88 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 123.986 0.915 . . . . 53.23 110.096 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -61.7 144.48 97.29 Favored 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 122.691 2.261 . . . . 75.14 112.096 175.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -49.84 144.34 21.07 Favored 'Trans proline' 0 C--N 1.384 2.406 0 C-N-CA 123.826 3.017 . . . . 63.14 113.805 175.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 77' ' ' PRO . . . . . 0.42 ' HA ' ' HD3' ' C' ' 78' ' ' PRO . 18.2 Cg_endo -57.82 131.87 46.52 Favored 'Trans proline' 0 C--N 1.381 2.251 0 C-N-CA 122.697 2.265 . . . . 51.51 111.65 177.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 78' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' C' ' 77' ' ' PRO . 32.2 Cg_exo -57.92 113.61 1.6 Allowed 'Trans proline' 0 C--N 1.388 2.657 0 C-N-CA 122.89 2.393 . . . . 74.44 112.221 -174.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -80.93 178.41 6.94 Favored 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 122.882 2.388 . . . . 61.04 111.902 -178.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -54.51 90.54 0.04 OUTLIER 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 122.279 1.986 . . . . 51.5 112.271 167.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 134.26 -1.64 4.14 Favored Glycine 0 N--CA 1.466 0.662 0 CA-C-N 114.937 -1.029 . . . . 75.2 112.399 175.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 67.01 -149.8 51.51 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 112.39 -0.284 . . . . 74.45 112.39 178.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -99.46 113.63 26.1 Favored 'General case' 0 C--O 1.244 0.803 0 N-CA-C 108.208 -1.034 . . . . 70.14 108.208 168.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 84' ' ' ASP . . . . . 0.554 ' HA ' ' HD2' ' C' ' 106' ' ' PHE . 4.8 p-10 -71.74 134.3 46.14 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-O 121.394 0.616 . . . . 63.13 110.009 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 85' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -159.25 22.24 0.19 Allowed 'General case' 0 C--O 1.248 0.999 0 CA-C-N 114.603 -1.181 . . . . 74.41 107.969 -177.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 86' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' C' ' 169' ' ' ASN . 19.0 m -62.79 128.27 35.14 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 113.141 -1.845 . . . . 45.43 111.273 -170.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 87' ' ' GLY . . . . . 0.572 ' HA2' ' HA ' ' C' ' 171' ' ' PRO . . . 99.25 -20.95 47.93 Favored Glycine 0 C--N 1.336 0.569 0 O-C-N 123.775 0.672 . . . . 74.33 112.938 178.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 88' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -93.79 150.64 20.22 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 117.457 0.628 . . . . 74.44 110.224 -178.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -82.56 73.69 9.58 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.113 0.565 . . . . 72.23 110.442 -174.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 90' ' ' VAL . . . . . . . . . . . . . 3.2 p -43.41 -41.72 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 C-N-CA 125.456 1.503 . . . . 54.41 112.486 177.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -56.76 -36.09 69.41 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.902 1.281 . . . . 74.21 111.945 -175.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -88.87 -21.02 23.88 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.02 0.528 . . . . 75.53 111.997 -175.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 93' ' ' PHE . . . . . 0.442 ' CE1' ' HB3' ' C' ' 48' ' ' LYS . 4.5 m-30 -81.75 164.74 21.51 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 122.326 0.251 . . . . 72.45 111.295 -168.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 94.5 p -60.19 152.08 25.51 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.586 1.154 . . . . 45.51 113.598 -165.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 95' ' ' GLU . . . . . 0.451 ' HG2' ' SD ' ' C' ' 1' ' ' MET . 0.0 OUTLIER -60.55 -31.79 70.88 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 114.964 -1.016 . . . . 55.43 111.062 170.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -59.88 -44.51 94.14 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.175 0.99 . . . . 65.02 110.426 175.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 97' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -62.1 -43.33 99.07 Favored 'General case' 0 CA--C 1.558 1.28 0 CA-C-N 114.978 -1.01 . . . . 64.25 110.362 170.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -73.68 -1.46 19.13 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.184 0.593 . . . . 51.52 111.758 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -98.95 -41.32 7.64 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.559 0.743 . . . . 74.43 112.092 168.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 23.9 tp -82.02 -35.55 28.73 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.284 0.634 . . . . 73.23 111.83 -174.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -114.14 -17.76 11.82 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.673 0.789 . . . . 73.25 110.956 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -42.72 -58.73 3.47 Favored Glycine 0 CA--C 1.541 1.67 0 CA-C-O 118.689 -1.062 . . . . 54.11 115.466 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.0 -21.19 20.53 Favored 'Trans proline' 0 C--N 1.389 2.658 0 C-N-CA 123.645 2.896 . . . . 62.02 114.224 -176.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -127.68 8.72 6.88 Favored Glycine 0 C--N 1.357 1.7 0 CA-C-O 117.051 -1.972 . . . . 43.23 114.631 -175.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 28.5 mt -46.53 83.0 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.709 0 N-CA-C 114.623 1.342 . . . . 73.03 114.623 -175.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 106' ' ' PHE . . . . . 0.554 ' HD2' ' HA ' ' C' ' 84' ' ' ASP . 0.1 OUTLIER 28.99 -107.95 0.02 OUTLIER 'General case' 0 CA--C 1.568 1.653 0 C-N-CA 127.154 2.182 . . . . 64.24 113.864 171.752 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 107' ' ' GLY . . . . . 0.548 ' HA2' ' HA2' ' C' ' 168' ' ' GLY . . . 57.92 26.49 58.12 Favored Glycine 0 C--N 1.37 2.425 0 CA-C-N 118.889 0.768 . . . . 51.05 112.826 -170.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 108' ' ' GLY . . . . . 0.448 ' HA3' ' O ' ' B' ' 37' ' ' ASP . . . 51.38 -124.35 21.95 Favored Glycine 0 C--N 1.349 1.276 0 O-C-N 124.195 0.585 . . . . 74.41 112.268 -167.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 109' ' ' PHE . . . . . 0.485 ' HD2' HG13 ' B' ' 38' ' ' ILE . 92.6 m-85 -111.19 10.61 21.83 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.124 0.97 . . . . 74.45 109.799 172.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 110' ' ' GLY . . . . . 0.529 ' HA3' ' HA ' ' B' ' 37' ' ' ASP . . . -89.41 -16.44 57.13 Favored Glycine 0 C--N 1.347 1.175 0 N-CA-C 111.029 -0.829 . . . . 54.22 111.029 172.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 58.2 13.35 2.27 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 125.028 1.331 . . . . 75.25 113.592 167.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 112' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -66.16 -20.98 66.31 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 124.864 1.265 . . . . 74.1 111.657 172.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 113' ' ' SER . . . . . 0.416 ' H ' ' HA3' ' C' ' 107' ' ' GLY . 45.4 m 63.98 9.32 4.5 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 124.711 1.204 . . . . 72.53 113.173 177.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 114' ' ' ARG . . . . . 0.453 ' HD2' ' HA ' ' C' ' 114' ' ' ARG . 7.2 tpt180 -100.49 -165.82 1.25 Allowed 'General case' 0 C--O 1.21 -1.01 0 CA-C-O 117.79 -1.1 . . . . 74.05 111.228 -171.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 115' ' ' LYS . . . . . . . . . . . . . 56.7 tttp -30.55 116.91 0.15 Allowed 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 116.185 1.92 . . . . 54.14 116.185 -161.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.18 128.3 30.78 Favored Glycine 0 C--N 1.356 1.676 0 O-C-N 124.486 1.116 . . . . 45.25 111.601 169.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 117' ' ' ARG . . . . . 0.693 ' HB2' ' HB2' ' C' ' 167' ' ' GLN . 50.3 mtm180 -115.46 180.0 3.8 Favored 'General case' 0 C--O 1.254 1.313 0 CA-C-O 122.056 0.931 . . . . 64.44 110.662 -174.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 118' ' ' ASP . . . . . 0.484 ' HA ' ' O ' ' C' ' 173' ' ' ASP . 0.8 OUTLIER -57.07 107.24 0.39 Allowed 'General case' 0 C--O 1.243 0.73 0 CA-C-N 112.278 -2.237 . . . . 75.42 110.193 172.124 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 119' ' ' LEU . . . . . 0.576 HD12 ' HA3' ' C' ' 166' ' ' GLY . 0.3 OUTLIER -94.91 113.89 25.67 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 107.647 -1.242 . . . . 75.21 107.647 174.619 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.463 ' HA ' ' O ' ' C' ' 175' ' ' LEU . 0.0 OUTLIER -104.4 124.8 49.88 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 110.125 -0.324 . . . . 72.31 110.125 -173.797 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 121' ' ' ALA . . . . . 0.527 ' HA ' ' HA ' ' B' ' 185' ' ' VAL . . . -111.43 137.15 49.59 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.388 0.675 . . . . 63.21 111.231 -177.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 122' ' ' GLU . . . . . 0.816 ' HB2' ' HA ' ' B' ' 186' ' ' THR . 5.6 tp10 -92.66 90.15 6.97 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 107.665 -1.235 . . . . 73.22 107.665 170.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 123' ' ' LEU . . . . . 0.712 ' HB3' ' HA ' ' B' ' 183' ' ' ALA . 1.1 pt? -105.36 114.28 63.49 Favored Pre-proline 0 N--CA 1.49 1.539 0 CA-C-N 118.474 0.579 . . . . 73.3 112.116 -174.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . 0.544 ' HA ' ' O ' ' C' ' 179' ' ' ARG . 36.2 Cg_exo -64.64 112.35 1.94 Allowed 'Trans proline' 0 C--N 1.386 2.528 0 C-N-CA 122.606 2.204 . . . . 72.51 110.489 164.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 125' ' ' LEU . . . . . 0.408 HD23 HG21 ' C' ' 153' ' ' VAL . 51.3 tp -131.79 147.3 52.48 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 122.552 0.341 . . . . 74.03 110.828 -169.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 126' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -92.08 151.47 20.42 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.302 0.641 . . . . 61.53 109.946 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 127' ' ' LEU . . . . . 0.42 ' CD2' HD13 ' C' ' 180' ' ' LEU . 25.2 mt -65.82 -50.99 62.66 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.425 1.09 . . . . 62.25 110.311 -177.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -53.69 -42.87 68.44 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 113.165 -1.834 . . . . 75.24 109.896 176.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 129' ' ' GLU . . . . . 0.508 ' HA ' ' HB2' ' C' ' 132' ' ' HIS . 15.1 mm-40 -82.33 -16.93 47.5 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.737 0.815 . . . . 73.53 111.821 -175.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -71.93 -31.53 66.44 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 109.014 -0.735 . . . . 64.34 109.014 172.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 131' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -73.11 -51.12 19.16 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 115.471 -0.786 . . . . 75.55 110.659 164.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 132' ' ' HIS . . . . . 0.508 ' HB2' ' HA ' ' C' ' 129' ' ' GLU . 38.3 m80 -76.32 3.82 10.16 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.005 0.522 . . . . 60.22 112.234 -171.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -58.83 88.26 0.02 OUTLIER Glycine 0 CA--C 1.539 1.544 0 N-CA-C 114.578 0.591 . . . . 65.31 114.578 171.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . -88.03 -143.9 9.12 Favored Glycine 0 C--N 1.355 1.631 0 N-CA-C 111.34 -0.704 . . . . 53.24 111.34 170.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 26.1 mp0 -70.48 93.83 0.92 Allowed 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 107.971 -1.122 . . . . 71.2 107.971 171.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 136' ' ' ARG . . . . . 0.582 ' HB3' ' HB2' ' B' ' 181' ' ' LEU . 78.7 mtt180 -115.58 138.19 51.31 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.024 0.529 . . . . 72.12 110.081 -173.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 137' ' ' VAL . . . . . 0.507 ' HA ' ' HA ' ' C' ' 146' ' ' SER . 21.5 t -76.7 103.57 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-N 116.099 -0.501 . . . . 71.12 109.877 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 138' ' ' VAL . . . . . 0.508 ' HB ' HD23 ' B' ' 181' ' ' LEU . 4.6 p -80.43 123.69 37.45 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 123.659 0.784 . . . . 72.14 109.22 174.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 139' ' ' GLU . . . . . 0.642 ' HG2' ' HG3' ' C' ' 144' ' ' ARG . 28.3 mt-10 -118.97 92.01 3.7 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.77 0.828 . . . . 74.31 109.175 -165.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 140' ' ' VAL . . . . . 0.438 ' HB ' ' HB1' ' B' ' 183' ' ' ALA . 7.1 p -143.53 147.39 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 C-N-CA 123.282 0.633 . . . . 63.22 111.435 -168.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 64.53 17.29 10.78 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 125.045 1.338 . . . . 15.23 111.908 -174.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 142' ' ' GLY . . . . . 0.517 ' H ' ' HB2' ' B' ' 44' ' ' ALA . . . 87.37 -8.64 76.29 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-N 115.568 -0.742 . . . . 45.25 112.947 -175.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 143' ' ' ARG . . . . . 0.432 ' HD3' ' HA ' ' C' ' 143' ' ' ARG . 6.7 mmt180 -101.47 139.94 36.45 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.446 0.641 . . . . 73.04 111.474 -177.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 144' ' ' ARG . . . . . 0.642 ' HG3' ' HG2' ' C' ' 139' ' ' GLU . 59.7 ttt180 -115.45 93.22 4.19 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-N 114.652 -1.158 . . . . 71.51 110.178 -165.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 145' ' ' VAL . . . . . . . . . . . . . 30.3 m -118.79 142.5 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 123.179 0.591 . . . . 75.03 112.001 -172.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 146' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' C' ' 137' ' ' VAL . 20.3 m -95.0 128.97 42.23 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.266 1.026 . . . . 54.21 111.054 -177.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 14.4 p -162.75 148.1 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 123.042 0.537 . . . . 72.53 110.663 175.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 29.8 ttm-85 -84.28 117.22 23.41 Favored 'General case' 0 C--N 1.349 0.571 0 N-CA-C 108.994 -0.743 . . . . 74.22 108.994 166.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 149' ' ' ILE . . . . . 0.452 HD13 HD21 ' B' ' 181' ' ' LEU . 42.2 pt -88.36 150.12 46.12 Favored Pre-proline 0 CA--C 1.548 0.878 0 N-CA-C 108.642 -0.873 . . . . 71.41 108.642 172.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -50.02 112.29 0.69 Allowed 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 123.183 2.589 . . . . 61.44 113.236 179.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -61.5 106.35 0.41 Allowed 'Trans proline' 0 C--N 1.383 2.376 0 C-N-CA 122.958 2.439 . . . . 73.2 112.117 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 152' ' ' GLY . . . . . . . . . . . . . . . 129.19 101.53 1.0 Allowed Glycine 0 C--N 1.343 0.922 0 CA-C-N 115.214 -0.903 . . . . 54.32 111.37 -171.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 153' ' ' VAL . . . . . 0.408 HG21 HD23 ' C' ' 125' ' ' LEU . 1.0 OUTLIER -122.77 159.84 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 CA-C-N 117.145 0.472 . . . . 71.13 110.398 -179.042 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 154' ' ' ARG . . . . . 0.624 ' HB2' ' HB2' ' C' ' 157' ' ' SER . 38.6 mtp180 -119.05 121.77 40.61 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.245 1.018 . . . . 75.32 109.105 -171.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 155' ' ' GLU . . . . . 0.712 ' HB3' ' HG2' ' C' ' 187' ' ' ARG . 9.4 tp10 -45.3 122.94 3.73 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.909 0.883 . . . . 74.51 112.45 174.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 87.52 -21.25 22.86 Favored Glycine 0 C--N 1.351 1.403 0 O-C-N 124.425 1.078 . . . . 64.51 113.276 176.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 157' ' ' SER . . . . . 0.624 ' HB2' ' HB2' ' C' ' 154' ' ' ARG . 33.8 m -88.97 -177.92 5.59 Favored 'General case' 0 C--O 1.247 0.962 0 CA-C-O 121.445 0.641 . . . . 75.43 110.733 -172.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 7.2 p -128.11 127.53 67.78 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 CA-C-N 115.48 -0.782 . . . . 64.44 111.587 -173.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 159' ' ' ILE . . . . . 0.597 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 47.9 mt -73.63 139.04 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.673 1.189 . . . . 52.25 109.194 168.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 160' ' ' ARG . . . . . 0.492 HH11 ' HD2' ' B' ' 314' ' ' ARG . 30.1 ttt85 -117.38 111.02 18.76 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 109.098 -0.705 . . . . 72.21 109.098 175.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 161' ' ' VAL . . . . . 0.619 HG13 ' HB3' ' C' ' 174' ' ' LEU . 1.6 p -106.03 98.93 20.31 Favored Pre-proline 0 CA--C 1.555 1.166 0 N-CA-C 108.295 -1.002 . . . . 75.24 108.295 168.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -76.54 140.17 21.14 Favored 'Trans proline' 0 C--N 1.384 2.433 0 C-N-CA 123.07 2.513 . . . . 63.42 112.141 178.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 110.14 -7.84 30.99 Favored Glycine 0 C--N 1.347 1.157 0 CA-C-O 119.817 -0.435 . . . . 53.31 112.455 178.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 164' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -158.13 124.17 4.65 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.959 0.904 . . . . 73.35 109.383 172.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . -125.68 -116.33 2.1 Favored Glycine 0 C--N 1.346 1.123 0 C-N-CA 123.854 0.74 . . . . 64.24 112.474 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 166' ' ' GLY . . . . . 0.576 ' HA3' HD12 ' C' ' 119' ' ' LEU . . . -169.87 -61.52 0.04 OUTLIER Glycine 0 C--N 1.346 1.103 0 C-N-CA 120.21 -0.995 . . . . 75.44 114.653 175.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 167' ' ' GLN . . . . . 0.693 ' HB2' ' HB2' ' C' ' 117' ' ' ARG . 14.1 mm100 -66.69 98.58 0.53 Allowed 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 117.09 0.445 . . . . 64.31 110.692 -165.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 168' ' ' GLY . . . . . 0.548 ' HA2' ' HA2' ' C' ' 107' ' ' GLY . . . 110.34 -144.25 17.01 Favored Glycine 0 C--O 1.213 -1.173 0 CA-C-O 118.352 -1.249 . . . . 13.44 111.72 -165.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 169' ' ' ASN . . . . . 0.444 ' HB3' ' HD3' ' C' ' 170' ' ' PRO . 17.9 t-20 -150.21 -51.39 0.02 OUTLIER Pre-proline 0 CA--C 1.594 2.659 0 CA-C-N 119.723 1.762 . . . . 62.44 113.291 -177.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 170' ' ' PRO . . . . . 0.444 ' HD3' ' HB3' ' C' ' 169' ' ' ASN . 49.5 Cg_exo -48.59 177.03 0.02 OUTLIER 'Trans proline' 0 N--CA 1.522 3.188 0 C-N-CA 124.359 3.373 . . . . 51.41 116.765 168.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 171' ' ' PRO . . . . . 0.572 ' HA ' ' HA2' ' C' ' 87' ' ' GLY . 1.1 Cg_exo -31.55 119.25 0.08 OUTLIER 'Trans proline' 0 C--N 1.404 3.483 1 C-N-CA 125.417 4.078 . . . . 74.02 117.272 172.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -160.56 -172.24 27.56 Favored Glycine 0 C--N 1.356 1.668 0 C-N-CA 124.276 0.941 . . . . 74.42 111.333 177.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 173' ' ' ASP . . . . . 0.484 ' O ' ' HA ' ' C' ' 118' ' ' ASP . 5.8 p-10 -140.79 147.68 39.44 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.718 0.771 . . . . 74.51 111.209 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 174' ' ' LEU . . . . . 0.619 ' HB3' HG13 ' C' ' 161' ' ' VAL . 43.9 tp -97.83 112.63 24.47 Favored 'General case' 0 C--O 1.245 0.849 0 N-CA-C 109.147 -0.686 . . . . 75.22 109.147 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 175' ' ' LEU . . . . . 0.689 HD21 ' HG3' ' B' ' 314' ' ' ARG . 55.7 mt -87.18 112.25 21.78 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.245 -1.343 . . . . 71.32 109.664 174.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 176' ' ' LEU . . . . . 0.597 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 57.7 mt -100.41 97.26 8.02 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 109.355 -0.609 . . . . 43.02 109.355 174.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 177' ' ' VAL . . . . . . . . . . . . . 17.1 t -83.61 103.36 10.78 Favored 'Isoleucine or valine' 0 C--O 1.253 1.238 0 N-CA-C 107.904 -1.147 . . . . 74.43 107.904 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 178' ' ' VAL . . . . . . . . . . . . . 6.1 m -84.95 117.43 30.19 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 CA-C-N 114.397 -1.274 . . . . 74.01 112.086 -172.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 179' ' ' ARG . . . . . 0.544 ' O ' ' HA ' ' C' ' 124' ' ' PRO . 6.2 mmm180 -105.36 107.77 18.94 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 106.142 -1.799 . . . . 72.33 106.142 166.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 180' ' ' LEU . . . . . 0.618 HD12 ' HB2' ' C' ' 155' ' ' GLU . 58.4 mt -70.12 148.23 48.99 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 122.35 -0.219 . . . . 70.51 110.583 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 181' ' ' LEU . . . . . . . . . . . . . 67.5 mt -54.28 167.03 0.6 Allowed Pre-proline 0 N--CA 1.494 1.75 0 C-N-CA 125.261 1.425 . . . . 74.2 112.434 -176.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -56.64 71.43 0.04 OUTLIER 'Trans proline' 0 C--N 1.387 2.554 0 C-N-CA 123.029 2.486 . . . . 64.12 111.217 163.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 183' ' ' HIS . . . . . 0.41 ' N ' ' HD3' ' C' ' 184' ' ' PRO . 81.2 t60 -179.2 51.91 0.05 OUTLIER Pre-proline 0 CA--C 1.557 1.249 0 C-N-CA 126.768 2.027 . . . . 62.13 106.237 -164.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 184' ' ' PRO . . . . . 0.41 ' HD3' ' N ' ' C' ' 183' ' ' HIS . 61.5 Cg_endo -92.18 65.19 0.87 Allowed 'Trans proline' 0 C--N 1.386 2.537 0 C-N-CA 123.046 2.498 . . . . 71.54 110.662 -170.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 185' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 12.4 t -93.37 -33.86 5.52 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.41 0 CA-C-N 115.284 -0.871 . . . . 72.23 109.035 -171.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 186' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -127.79 106.0 8.83 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 118.809 0.732 . . . . 61.44 111.93 -175.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 187' ' ' ARG . . . . . 0.712 ' HG2' ' HB3' ' C' ' 155' ' ' GLU . 1.6 tmt_? -95.26 116.59 28.95 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 107.352 -1.351 . . . . 75.14 107.352 169.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 188' ' ' LEU . . . . . 0.482 HD13 ' HD2' ' C' ' 240' ' ' PHE . 65.3 tp -80.74 138.89 36.32 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 122.917 0.487 . . . . 74.14 111.762 -178.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -142.6 113.09 7.28 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 106.548 -1.649 . . . . 71.33 106.548 169.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 73.92 -109.44 2.8 Favored Glycine 0 N--CA 1.474 1.177 0 N-CA-C 111.413 -0.675 . . . . 74.2 111.413 -170.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 191' ' ' GLN . . . . . 0.455 ' HA ' HD11 ' C' ' 188' ' ' LEU . 28.1 mt-30 -123.85 7.0 8.7 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 123.564 0.745 . . . . 60.21 109.085 167.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 192' ' ' ASP . . . . . 0.481 ' HB3' ' HE1' ' C' ' 250' ' ' TYR . 3.8 m-20 -95.63 142.74 27.59 Favored 'General case' 0 C--N 1.344 0.351 0 C-N-CA 125.176 1.391 . . . . 65.13 109.188 -172.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 193' ' ' LEU . . . . . 0.472 HD21 ' CD2' ' C' ' 240' ' ' PHE . 86.7 mt -112.45 142.34 45.11 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.587 0.355 . . . . 52.2 110.777 -178.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 194' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -108.97 128.05 54.6 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 108.17 -1.048 . . . . 75.43 108.17 165.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 195' ' ' ALA . . . . . 0.584 ' HB3' ' HG ' ' C' ' 251' ' ' LEU . . . -127.03 -178.19 4.32 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.404 0.682 . . . . 65.11 110.768 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 33.0 m -135.54 111.03 9.14 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 107.675 -1.231 . . . . 51.32 107.675 169.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 197' ' ' LEU . . . . . 0.462 HD13 ' HB2' ' C' ' 212' ' ' ALA . 42.2 tp -88.92 136.89 32.77 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 123.436 0.694 . . . . 73.5 110.055 176.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -92.4 117.32 29.8 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 108.616 -0.883 . . . . 44.52 108.616 173.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 199' ' ' VAL . . . . . 0.581 ' HA ' HG11 ' C' ' 210' ' ' VAL . 21.4 t -125.6 106.57 26.7 Favored Pre-proline 0 CA--C 1.544 0.728 0 N-CA-C 108.09 -1.078 . . . . 61.21 108.09 176.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 200' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -67.76 141.69 55.29 Favored 'Trans proline' 0 C--N 1.369 1.613 0 C-N-CA 121.737 1.625 . . . . 71.34 111.33 176.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 201' ' ' ALA . . . . . . . . . . . . . . . -42.65 -49.16 13.3 Favored Pre-proline 0 CA--C 1.559 1.313 0 C-N-CA 125.498 1.519 . . . . 74.35 114.507 -176.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 202' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -55.34 -52.04 8.65 Favored 'Trans proline' 0 C--N 1.388 2.611 0 C-N-CA 121.558 1.505 . . . . 63.15 112.95 175.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 203' ' ' ILE . . . . . 0.483 ' HA ' HG12 ' C' ' 206' ' ' VAL . 53.0 mt -63.45 -34.57 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 122.885 0.474 . . . . 63.4 111.022 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -62.7 -43.27 99.24 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.79 0.836 . . . . 75.02 111.522 178.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 205' ' ' VAL . . . . . 0.48 ' HA ' ' H ' ' C' ' 226' ' ' ARG . 88.5 t -79.29 -34.12 16.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 115.842 -0.617 . . . . 63.41 112.097 -176.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 206' ' ' VAL . . . . . 0.659 HG23 ' HG3' ' A' ' 270' ' ' LYS . 9.9 p -80.24 -32.05 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 122.183 0.193 . . . . 52.12 111.04 -177.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 79.48 56.32 3.42 Favored Glycine 0 C--N 1.336 0.582 0 N-CA-C 111.366 -0.694 . . . . 63.21 111.366 -171.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -92.84 -124.21 3.53 Favored Glycine 0 C--N 1.34 0.786 0 N-CA-C 111.104 -0.798 . . . . 51.32 111.104 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 209' ' ' LYS . . . . . 0.554 ' HB3' ' HG2' ' C' ' 220' ' ' GLU . 40.5 mtmt -148.0 149.35 31.99 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.399 0.679 . . . . 72.12 111.074 176.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 210' ' ' VAL . . . . . 0.581 HG11 ' HA ' ' C' ' 199' ' ' VAL . 15.8 m -137.76 141.68 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-N 114.546 -1.206 . . . . 62.05 108.753 174.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 211' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.73 110.54 19.4 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.264 0.626 . . . . 72.44 111.013 -176.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 212' ' ' ALA . . . . . 0.462 ' HB2' HD13 ' C' ' 197' ' ' LEU . . . -90.46 113.56 25.54 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 107.742 -1.207 . . . . 74.43 107.742 165.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 213' ' ' MET . . . . . . . . . . . . . 6.8 tmm? -71.62 132.45 44.64 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 107.79 -1.189 . . . . 63.12 107.79 176.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 214' ' ' THR . . . . . 0.444 ' OG1' HG12 ' C' ' 219' ' ' VAL . 0.2 OUTLIER -127.19 175.18 8.34 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.008 0.523 . . . . 54.24 110.68 -176.93 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 215' ' ' LEU . . . . . . . . . . . . . 20.3 mt -68.17 -23.31 64.85 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.12 0.968 . . . . 44.41 112.074 -172.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -87.36 -26.83 23.16 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 114.684 -1.144 . . . . 71.0 109.735 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 141.47 179.44 18.64 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 109.403 -1.479 . . . . 64.11 109.403 -168.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -75.15 119.11 5.47 Favored 'Trans proline' 0 CA--C 1.559 1.735 0 C-N-CA 122.561 2.174 . . . . 52.13 113.481 -175.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 219' ' ' VAL . . . . . 0.456 HG23 HG22 ' B' ' 238' ' ' THR . 8.6 p -91.66 125.32 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 N-CA-C 108.253 -1.018 . . . . 52.53 108.253 169.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 220' ' ' GLU . . . . . 0.554 ' HG2' ' HB3' ' C' ' 209' ' ' LYS . 15.6 tt0 -90.53 106.33 18.43 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.874 0.845 . . . . 72.32 108.757 177.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 221' ' ' VAL . . . . . . . . . . . . . 71.0 t -72.64 126.39 33.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 113.807 -1.542 . . . . 74.03 111.972 -174.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -72.6 117.33 14.15 Favored 'General case' 0 CA--C 1.549 0.919 0 O-C-N 124.314 1.009 . . . . 73.3 110.306 169.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 90.9 t -91.35 140.93 25.68 Favored Pre-proline 0 CA--C 1.555 1.157 0 C-N-CA 124.514 1.125 . . . . 73.11 109.794 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 224' ' ' PRO . . . . . 0.543 ' HG3' HH22 ' C' ' 231' ' ' ARG . 87.3 Cg_endo -81.03 147.54 16.66 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 123.172 2.581 . . . . 54.33 112.089 167.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 225' ' ' PRO . . . . . 0.487 ' HG2' HG23 ' B' ' 246' ' ' THR . 86.7 Cg_exo -52.45 132.45 44.95 Favored 'Trans proline' 0 C--N 1.372 1.793 0 C-N-CA 122.417 2.078 . . . . 74.0 112.793 169.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 226' ' ' ARG . . . . . 0.79 HH22 HD13 ' B' ' 97' ' ' ILE . 0.0 OUTLIER 51.31 85.6 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 126.279 1.832 . . . . 70.15 112.583 -171.703 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 227' ' ' THR . . . . . 0.531 HG22 HG11 ' C' ' 253' ' ' VAL . 90.4 m -101.11 130.79 47.21 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 114.406 -1.27 . . . . 70.3 109.854 174.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 228' ' ' GLN . . . . . 0.757 HE21 ' HG2' ' A' ' 259' ' ' GLU . 25.2 mp0 -95.4 147.39 23.57 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.499 1.12 . . . . 74.32 111.978 -176.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -72.76 124.25 24.96 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 114.989 -1.005 . . . . 62.12 109.209 173.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 108.32 -9.76 36.03 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-O 119.641 -0.533 . . . . 62.04 112.526 -172.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 231' ' ' ARG . . . . . 0.543 HH22 ' HG3' ' C' ' 224' ' ' PRO . 34.3 mtp180 -64.35 169.92 4.27 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 117.616 0.708 . . . . 74.12 110.465 169.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 232' ' ' LYS . . . . . 0.45 ' HA ' ' O ' ' C' ' 251' ' ' LEU . 33.6 ttmt -142.92 136.96 29.11 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.226 0.536 . . . . 71.45 110.552 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 233' ' ' LEU . . . . . 0.739 HD13 ' HB2' ' C' ' 251' ' ' LEU . 4.0 mp -98.01 145.92 26.02 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 114.478 -1.237 . . . . 74.21 109.759 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 11.5 ptp85 -110.02 90.9 3.45 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 124.628 1.205 . . . . 72.34 108.183 163.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 235' ' ' LEU . . . . . 0.438 HD12 HD23 ' C' ' 249' ' ' LEU . 24.8 mt -78.25 95.95 5.12 Favored 'General case' 0 C--N 1.352 0.686 0 N-CA-C 107.407 -1.331 . . . . 73.43 107.407 169.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -70.75 125.71 27.57 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 114.516 -1.22 . . . . 71.55 111.594 -171.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 75.72 29.23 59.73 Favored Glycine 0 C--N 1.348 1.22 0 O-C-N 123.867 0.73 . . . . 71.42 112.423 -176.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -124.34 17.02 9.04 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.279 0.631 . . . . 72.03 110.535 176.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -77.53 -165.44 24.88 Favored Glycine 0 C--N 1.359 1.811 0 N-CA-C 110.893 -0.883 . . . . 31.21 110.893 167.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 240' ' ' PHE . . . . . 0.482 ' HD2' HD13 ' C' ' 188' ' ' LEU . 1.2 m-85 -70.67 127.29 92.05 Favored Pre-proline 0 C--O 1.257 1.472 0 CA-C-N 118.061 0.93 . . . . 75.14 108.959 176.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 241' ' ' PRO . . . . . 0.444 ' HA ' ' HB3' ' C' ' 246' ' ' ARG . 32.0 Cg_exo -61.47 94.94 0.12 Allowed 'Trans proline' 0 C--N 1.385 2.459 0 C-N-CA 123.553 2.836 . . . . 70.21 113.171 177.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 242' ' ' GLY . . . . . 0.517 ' H ' ' HA ' ' C' ' 246' ' ' ARG . . . -77.56 137.94 20.96 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-N 113.838 -1.528 . . . . 70.14 112.126 -179.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 243' ' ' PRO . . . . . 0.553 ' HG2' ' HA ' ' B' ' 304' ' ' PRO . 57.9 Cg_endo -68.47 -9.32 25.66 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 123.152 2.568 . . . . 71.42 113.804 -176.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -120.78 23.09 10.91 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.393 0.677 . . . . 71.42 110.576 176.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 115.31 143.85 8.14 Favored Glycine 0 C--N 1.341 0.83 0 N-CA-C 109.951 -1.26 . . . . 51.32 109.951 -171.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 246' ' ' ARG . . . . . 0.517 ' HA ' ' H ' ' C' ' 242' ' ' GLY . 15.3 ptp180 -99.42 170.84 8.34 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 118.01 0.905 . . . . 61.31 112.395 -171.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -92.38 -164.92 38.51 Favored Glycine 0 C--N 1.35 1.356 0 CA-C-N 114.932 -1.031 . . . . 63.23 113.581 177.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -130.35 148.11 52.14 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.08 0.952 . . . . 73.54 109.055 -172.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 249' ' ' LEU . . . . . 0.438 HD23 HD12 ' C' ' 235' ' ' LEU . 22.8 tp -101.24 137.16 39.95 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.903 0.881 . . . . 74.23 110.611 -175.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 250' ' ' TYR . . . . . 0.589 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 59.3 m-85 -127.46 101.56 6.49 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.443 1.097 . . . . 71.43 109.265 -176.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 251' ' ' LEU . . . . . 0.739 ' HB2' HD13 ' C' ' 233' ' ' LEU . 1.2 mp -101.33 139.13 37.42 Favored 'General case' 0 N--CA 1.508 2.442 0 CA-C-N 118.138 0.426 . . . . 64.53 110.923 -175.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -80.09 138.99 37.06 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 108.953 -0.758 . . . . 73.41 108.953 168.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 253' ' ' VAL . . . . . 0.531 HG11 HG22 ' C' ' 227' ' ' THR . 99.0 t -87.29 128.14 40.12 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 CA-C-O 121.079 0.466 . . . . 73.5 111.214 176.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 254' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 -110.18 111.67 23.16 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.465 1.106 . . . . 74.13 108.828 167.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 255' ' ' ILE . . . . . 0.502 ' O ' ' HB ' ' A' ' 255' ' ' ILE . 33.8 mm -80.84 120.51 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 N-CA-C 108.294 -1.002 . . . . 75.24 108.294 171.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 256' ' ' THR . . . . . 0.537 HG22 ' HB3' ' A' ' 229' ' ' ALA . 46.4 p -120.34 -172.78 2.43 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.672 0.789 . . . . 53.32 111.257 -173.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 2.7 pp -141.45 148.79 52.02 Favored Pre-proline 0 N--CA 1.489 1.477 0 C-N-CA 123.39 0.676 . . . . 64.54 110.196 178.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -61.26 -7.69 8.86 Favored 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 123.372 2.715 . . . . 73.21 114.684 -174.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 57.12 -78.35 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.908 1.283 . . . . 72.3 110.846 -166.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 22.5 ptt-85 -60.35 136.58 58.08 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 124.23 1.012 . . . . 73.41 110.26 177.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 261' ' ' LEU . . . . . 0.494 HD22 ' HB3' ' C' ' 265' ' ' GLU . 94.8 mt -143.34 148.21 35.91 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.58 0.752 . . . . 71.21 109.65 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 262' ' ' THR . . . . . 0.467 ' OG1' ' HG2' ' C' ' 265' ' ' GLU . 36.4 p -84.31 162.42 51.39 Favored Pre-proline 0 CA--C 1.548 0.898 0 N-CA-C 108.417 -0.957 . . . . 61.23 108.417 167.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -53.4 -35.84 76.94 Favored 'Trans proline' 0 C--N 1.374 1.881 0 C-N-CA 122.267 1.978 . . . . 74.2 114.202 175.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -66.43 -48.11 71.07 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 122.381 0.272 . . . . 71.04 110.514 178.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 265' ' ' GLU . . . . . 0.494 ' HB3' HD22 ' C' ' 261' ' ' LEU . 33.2 mm-40 -52.57 -51.33 60.27 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 123.612 0.57 . . . . 65.11 109.633 175.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 266' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -54.43 -41.57 69.54 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 114.354 -1.294 . . . . 64.21 110.627 -177.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 267' ' ' ALA . . . . . 0.447 ' O ' ' HG3' ' C' ' 271' ' ' LYS . . . -62.13 -46.0 90.95 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.731 -0.668 . . . . 70.32 111.573 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 268' ' ' LEU . . . . . 0.443 ' HB2' HD21 ' A' ' 272' ' ' LEU . 10.4 mp -66.33 -41.94 88.91 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 111.591 0.219 . . . . 52.44 111.591 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -63.48 -33.11 74.86 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 122.988 0.515 . . . . 61.11 111.141 176.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 270' ' ' LYS . . . . . 0.456 ' O ' ' HG2' ' C' ' 274' ' ' GLU . 4.2 mmmp? -61.04 -48.92 79.52 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.631 0.772 . . . . 75.43 110.076 173.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 271' ' ' LYS . . . . . 0.447 ' HG3' ' O ' ' C' ' 267' ' ' ALA . 63.2 mttm -58.55 -43.76 89.41 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.72 0.808 . . . . 75.33 111.568 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 91.2 mt -61.63 -40.36 94.59 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.368 -0.833 . . . . 74.33 110.404 176.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -64.38 -34.69 78.75 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 115.522 -0.763 . . . . 34.13 110.822 177.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 274' ' ' GLU . . . . . 0.456 ' HG2' ' O ' ' C' ' 270' ' ' LYS . 13.5 mm-40 -67.58 -40.3 84.85 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.127 0.571 . . . . 63.21 109.702 177.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -61.71 -30.84 71.02 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.457 0.703 . . . . 70.04 110.662 174.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 276' ' ' TYR . . . . . 0.551 ' HA ' ' HD3' ' C' ' 279' ' ' ARG . 9.6 m-85 -77.27 -31.6 55.0 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.069 -0.968 . . . . 75.52 112.733 172.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -76.3 -19.13 58.56 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 118.526 0.603 . . . . 44.24 110.198 175.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -69.13 -16.58 63.69 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.331 0.652 . . . . 55.2 110.538 169.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 279' ' ' ARG . . . . . 0.551 ' HD3' ' HA ' ' C' ' 276' ' ' TYR . 16.3 mtp-105 -83.52 -14.81 51.46 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.155 0.582 . . . . 71.52 110.978 173.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.085 -0.96 . . . . 75.14 110.338 -179.233 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 79.8 mtp . . . . . 0 N--CA 1.476 0.844 0 N-CA-C 111.152 0.056 . . . . 64.12 111.152 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.47 42.99 8.26 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.956 0.902 . . . . 51.4 112.285 170.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -70.54 75.83 0.57 Allowed 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.559 0.744 . . . . 74.04 110.493 177.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.9 ttmp? -38.91 110.02 0.12 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 126.064 1.746 . . . . 62.43 114.472 -174.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -100.26 114.49 27.98 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 123.546 0.739 . . . . 74.32 109.071 164.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.502 ' HA ' ' OH ' ' A' ' 66' ' ' TYR . 23.9 t70 -82.46 102.94 11.65 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 107.729 -1.211 . . . . 61.41 107.729 168.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.434 ' HD1' HD12 ' A' ' 10' ' ' ILE . 32.4 m-85 -64.08 -30.44 71.51 Favored 'General case' 0 C--O 1.244 0.811 0 CA-C-N 115.576 -0.738 . . . . 73.34 112.131 -171.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.428 ' CD1' HD11 ' A' ' 22' ' ' ILE . 64.9 m-85 -62.04 -44.34 96.89 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 122.851 0.46 . . . . 73.33 110.394 174.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.94 -41.84 97.49 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.285 0.634 . . . . 60.32 111.229 178.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.434 HD12 ' HD1' ' A' ' 7' ' ' TYR . 65.1 mt -55.77 -43.28 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 123.469 0.707 . . . . 74.23 110.976 176.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.6 mt -79.62 -14.12 59.03 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 112.936 0.717 . . . . 51.33 112.936 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.39 36.65 59.25 Favored Glycine 0 C--N 1.351 1.378 0 O-C-N 123.026 0.204 . . . . 53.33 113.485 -176.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.3 m -119.93 157.33 52.96 Favored Pre-proline 0 N--CA 1.482 1.175 0 C-N-CA 124.764 1.226 . . . . 71.43 109.164 175.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.502 ' HG2' ' HB2' ' A' ' 17' ' ' ALA . 12.2 Cg_endo -55.93 153.1 33.05 Favored 'Trans proline' 0 C--N 1.388 2.645 0 C-N-CA 122.771 2.314 . . . . 50.12 112.508 177.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 72.3 mtp180 -81.63 59.53 4.19 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.113 0.965 . . . . 75.43 111.411 -170.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 176.37 -27.96 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.643 1.177 . . . . 64.11 109.273 -168.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.502 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . . . -37.64 138.01 0.4 Allowed 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 126.864 2.065 . . . . 64.31 114.897 -171.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.9 p -61.67 162.26 8.76 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 124.6 1.16 . . . . 71.11 112.455 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -56.05 -35.93 67.47 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.118 0.967 . . . . 64.21 112.279 -175.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.51 -29.49 61.43 Favored 'General case' 0 C--O 1.209 -1.058 0 CA-C-O 118.939 -0.553 . . . . 72.43 110.654 -177.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -69.67 -39.0 77.27 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 118.516 0.598 . . . . 64.03 110.005 173.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.428 HD11 ' CD1' ' A' ' 8' ' ' TYR . 1.6 mp -61.86 -40.91 88.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 C-N-CA 124.199 1.0 . . . . 73.31 110.345 172.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.677 ' HE2' ' HA ' ' B' ' 95' ' ' LYS . 3.8 ttpm? -80.32 -25.76 39.15 Favored 'General case' 0 C--O 1.213 -0.844 0 CA-C-N 114.491 -1.231 . . . . 71.24 110.197 -174.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.454 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 73.5 mtp180 -78.07 -34.85 50.1 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.484 0.714 . . . . 54.12 109.918 173.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.78 -34.36 73.65 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 123.893 0.746 . . . . 64.0 109.982 173.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -63.96 -60.23 3.51 Favored 'General case' 0 C--O 1.209 -1.068 0 CA-C-N 115.672 -0.695 . . . . 73.1 109.533 172.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.454 ' HE3' ' HA ' ' A' ' 24' ' ' ARG . 51.6 mtmt -53.87 -38.2 64.48 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 124.31 1.044 . . . . 74.22 110.686 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.2 ttt180 -59.37 -57.91 10.93 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.521 1.128 . . . . 71.15 110.956 176.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.602 ' HB3' HD13 ' A' ' 50' ' ' ILE . 84.7 mt -76.81 -11.69 59.87 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.702 0.801 . . . . 74.11 111.18 -177.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.06 -20.44 24.36 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.909 0.884 . . . . 63.3 110.535 178.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 75.4 mtm180 -95.68 -31.9 13.02 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.052 0.541 . . . . 72.33 110.673 171.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -77.03 -55.0 5.83 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 108.981 -0.748 . . . . 63.33 108.981 -178.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.629 ' HA ' HD22 ' A' ' 38' ' ' ASN . 39.2 m-85 -93.47 33.55 1.24 Allowed 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 115.879 -0.601 . . . . 63.25 110.531 173.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 7.9 t-80 -61.28 107.75 1.23 Allowed Pre-proline 0 C--N 1.357 0.912 0 N-CA-C 108.564 -0.902 . . . . 63.41 108.564 177.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -57.87 -19.32 38.84 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 122.976 2.451 . . . . 74.13 113.086 -169.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -63.42 -42.69 98.73 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.685 1.194 . . . . 72.45 112.704 178.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.5 t -105.09 -37.46 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 123.173 0.589 . . . . 65.53 109.984 -177.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.629 HD22 ' HA ' ' A' ' 33' ' ' TYR . 63.1 t30 -98.09 68.13 1.95 Allowed 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 122.634 1.207 . . . . 61.35 108.51 178.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt -79.6 75.88 6.24 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 113.827 -1.533 . . . . 73.11 109.282 -178.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.8 m -135.55 108.29 10.12 Favored Pre-proline 0 N--CA 1.467 0.422 0 CA-C-O 118.124 -0.941 . . . . 54.41 108.622 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -39.31 -45.31 3.03 Favored 'Trans proline' 0 C--N 1.387 2.569 0 C-N-CA 124.23 3.287 . . . . 72.23 114.248 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -56.22 -46.93 79.33 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.408 0.683 . . . . 64.43 111.343 178.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.5 -16.96 61.78 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.527 0.731 . . . . 72.14 111.623 -178.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -92.07 -30.72 15.87 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.532 0.733 . . . . 62.01 110.428 -176.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -72.23 -36.62 69.16 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 109.417 -0.586 . . . . 62.44 109.417 168.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -62.84 -41.28 99.27 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 116.058 -0.519 . . . . 74.03 109.834 170.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.625 ' HA ' HD12 ' A' ' 50' ' ' ILE . 52.1 t80 -63.64 -31.56 72.77 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.583 0.753 . . . . 73.24 110.716 176.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -63.64 -45.14 91.56 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 122.567 0.347 . . . . 75.14 110.975 171.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -65.63 -25.87 67.57 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 111.821 0.304 . . . . 71.44 111.821 178.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.625 HD12 ' HA ' ' A' ' 47' ' ' PHE . 66.1 mt -74.78 -39.28 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 123.847 0.859 . . . . 70.53 110.103 172.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.438 ' HB3' ' HD1' ' A' ' 88' ' ' PHE . 94.4 m-20 -71.07 -23.56 62.16 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.684 0.793 . . . . 73.43 110.911 176.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -76.05 -53.35 8.49 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.593 1.557 . . . . 63.42 109.626 177.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.06 -47.19 78.4 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 113.928 -1.487 . . . . 65.45 110.417 176.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -68.87 -37.05 78.82 Favored 'General case' 0 C--O 1.207 -1.14 0 CA-C-N 114.64 -1.164 . . . . 72.32 110.928 176.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -51.93 -53.81 36.78 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 118.658 0.663 . . . . 53.01 110.462 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.477 HG13 ' HZ ' ' A' ' 101' ' ' PHE . 47.0 t -64.1 -55.93 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 113.866 -1.515 . . . . 74.52 110.273 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 78.1 mt -81.61 2.03 31.2 Favored 'General case' 0 CA--C 1.556 1.183 0 N-CA-C 113.745 1.017 . . . . 62.04 113.745 -169.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.0 t -80.19 -75.14 0.27 Allowed 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 109.215 -0.661 . . . . 74.34 109.215 174.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -68.86 116.95 46.5 Favored Pre-proline 0 C--O 1.239 0.549 0 CA-C-O 118.651 -0.69 . . . . 74.34 109.392 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -49.88 -28.0 17.27 Favored 'Trans proline' 0 C--N 1.388 2.621 0 C-N-CA 124.069 3.179 . . . . 72.41 114.294 -175.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -60.34 -62.73 1.65 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.704 0.802 . . . . 72.3 110.735 175.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.448 ' HA ' HD12 ' A' ' 65' ' ' ILE . 29.6 mtmm -64.28 -33.12 75.09 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.176 0.591 . . . . 74.54 110.737 -177.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 22.3 ttt85 -61.83 -45.76 92.45 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.065 -0.971 . . . . 74.11 110.703 176.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -70.65 -28.25 64.65 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 119.279 -0.391 . . . . 74.25 111.262 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.448 HD12 ' HA ' ' A' ' 62' ' ' LYS . 73.2 mt -53.24 -52.8 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 N-CA-C 108.86 -0.793 . . . . 64.42 108.86 168.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.502 ' OH ' ' HA ' ' A' ' 6' ' ' ASP . 55.9 t80 -61.97 -52.01 65.76 Favored 'General case' 0 CA--C 1.556 1.179 0 CA-C-N 114.561 -1.2 . . . . 75.4 112.004 178.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -56.37 -40.54 74.73 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.135 0.974 . . . . 64.04 111.848 -175.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 58.6 p -80.35 -22.55 41.31 Favored 'General case' 0 C--O 1.215 -0.728 0 CA-C-N 115.498 -0.774 . . . . 75.13 111.07 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -66.45 109.23 2.66 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 118.909 0.777 . . . . 63.45 108.934 176.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 113.18 13.29 10.98 Favored Glycine 0 CA--C 1.537 1.429 0 CA-C-N 115.337 -0.847 . . . . 52.54 111.565 -166.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 50.7 m -148.4 -61.08 0.25 Allowed 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 103.986 -2.598 . . . . 71.23 103.986 176.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 61.8 m -75.83 139.87 41.97 Favored 'General case' 0 C--O 1.248 1.005 0 N-CA-C 104.549 -2.389 . . . . 74.23 104.549 155.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.14 -25.8 7.94 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 122.792 0.437 . . . . 74.04 111.179 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.08 132.51 90.18 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 123.851 0.86 . . . . 75.1 110.597 176.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -55.51 141.95 81.88 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 122.74 2.294 . . . . 75.41 111.252 168.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -57.72 149.93 65.27 Favored 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 123.501 2.801 . . . . 74.25 113.009 -173.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -66.2 170.81 11.25 Favored 'Trans proline' 0 C--N 1.383 2.393 0 C-N-CA 124.095 3.197 . . . . 62.44 113.742 -173.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -33.71 127.58 0.16 Allowed 'Trans proline' 0 C--N 1.401 3.304 0 C-N-CA 124.818 3.679 . . . . 43.51 114.404 174.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.569 ' HG3' ' HA3' ' A' ' 104' ' ' GLY . 42.2 Cg_endo -77.92 119.8 4.84 Favored 'Trans proline' 0 CA--C 1.559 1.73 0 C-N-CA 123.277 2.651 . . . . 71.05 113.049 -165.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.423 ' HB2' ' HB2' ' B' ' 84' ' ' ARG . 72.0 Cg_endo -73.09 76.23 2.63 Favored 'Trans proline' 0 CA--C 1.554 1.511 0 C-N-CA 122.592 2.195 . . . . 51.35 112.746 -178.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 115.22 0.96 22.25 Favored Glycine 0 C--N 1.347 1.152 0 CA-C-N 115.075 -0.966 . . . . 62.41 112.002 -176.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.74 147.14 12.31 Favored Glycine 0 C--N 1.352 1.436 0 N-CA-C 110.713 -0.955 . . . . 53.03 110.713 -167.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -65.53 100.62 0.52 Allowed 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 118.349 1.074 . . . . 74.41 109.029 172.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -54.1 139.75 34.14 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.496 1.118 . . . . 71.31 112.519 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.486 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 65.2 m-85 -143.48 72.85 1.37 Allowed 'General case' 0 N--CA 1.47 0.55 0 O-C-N 124.136 0.897 . . . . 70.22 109.682 171.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 18.2 m -52.7 86.7 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 125.509 1.524 . . . . 74.44 112.68 -179.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.781 ' H ' ' HA3' ' A' ' 163' ' ' GLY . . . 80.7 1.39 89.2 Favored Glycine 0 C--N 1.34 0.767 0 CA-C-N 115.858 -0.61 . . . . 70.11 112.853 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.486 ' HB2' ' HB3' ' A' ' 85' ' ' PHE . 17.4 m-85 -97.24 114.29 26.01 Favored 'General case' 0 C--N 1.344 0.365 0 N-CA-C 107.727 -1.212 . . . . 72.34 107.727 -176.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -80.22 80.92 6.58 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.245 0.545 . . . . 71.44 110.191 -174.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.63 HG21 HD22 ' A' ' 105' ' ' LEU . 1.6 p -42.31 -39.42 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 125.413 1.485 . . . . 75.21 112.936 174.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -57.23 -33.36 67.47 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.008 0.923 . . . . 75.33 112.714 -176.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -105.32 11.6 32.66 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.236 0.541 . . . . 45.35 111.69 -178.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 17.2 m-30 -90.33 173.84 7.9 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 121.967 -0.458 . . . . 71.01 109.881 174.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 86.0 p -65.72 157.89 28.96 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 113.631 0.974 . . . . 74.5 113.631 -167.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.45 -42.77 96.82 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.345 1.058 . . . . 74.31 111.633 176.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -55.63 -49.93 71.52 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.092 0.957 . . . . 75.03 111.2 177.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.526 ' HE2' HG23 ' A' ' 90' ' ' VAL . 37.7 t80 -60.01 -42.84 95.17 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.443 -1.253 . . . . 63.23 110.584 176.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -78.27 -4.35 47.42 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.325 -0.852 . . . . 73.05 112.415 -178.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -102.34 -34.05 9.34 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.038 0.535 . . . . 70.02 111.286 169.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 41.6 tp -65.81 -52.13 53.25 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.223 0.609 . . . . 55.03 109.56 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.477 ' HZ ' HG13 ' A' ' 56' ' ' VAL . 88.8 m-85 -92.86 -0.49 57.23 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.529 -0.76 . . . . 72.11 110.745 174.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.402 ' N ' ' HD2' ' A' ' 103' ' ' PRO . . . -42.78 -56.65 4.27 Favored Glycine 0 C--N 1.353 1.509 0 CA-C-O 118.213 -1.326 . . . . 72.43 115.188 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.402 ' HD2' ' N ' ' A' ' 102' ' ' GLY . 4.8 Cg_exo -34.76 -32.49 0.07 OUTLIER 'Trans proline' 0 C--N 1.395 3.024 1 C-N-CA 125.697 4.264 . . . . 23.1 115.263 177.17 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.569 ' HA3' ' HG3' ' A' ' 79' ' ' PRO . . . -152.94 49.21 0.52 Allowed Glycine 0 C--N 1.351 1.4 0 C-N-CA 120.547 -0.835 . . . . 44.4 113.786 179.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.63 HD22 HG21 ' A' ' 90' ' ' VAL . 29.7 mt -58.22 79.61 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 112.444 0.535 . . . . 74.25 112.444 171.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.51 ' HD1' ' H ' ' A' ' 108' ' ' GLY . 0.1 OUTLIER 42.27 -110.29 0.14 Allowed 'General case' 0 CA--C 1.559 1.326 0 C-N-CA 126.514 1.925 . . . . 72.25 112.819 -179.751 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 70.24 -0.66 23.01 Favored Glycine 0 C--N 1.362 2.011 0 CA-C-N 118.27 0.486 . . . . 44.0 113.663 -172.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.51 ' H ' ' HD1' ' A' ' 106' ' ' PHE . . . 62.63 -109.56 2.73 Favored Glycine 0 C--N 1.352 1.417 0 N-CA-C 112.26 -0.336 . . . . 71.34 112.26 -172.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -126.83 15.67 7.45 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.905 0.882 . . . . 64.11 109.725 176.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -89.34 -23.83 33.12 Favored Glycine 0 C--N 1.346 1.091 0 CA-C-N 115.77 -0.65 . . . . 55.25 112.853 179.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 17.1 tpp180 70.47 -22.59 0.17 Allowed 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 125.55 1.54 . . . . 71.44 113.238 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.13 -12.15 60.79 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.859 0.864 . . . . 73.25 112.156 -173.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 59.6 m 66.34 67.52 0.45 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.436 1.095 . . . . 74.21 110.209 -173.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -73.82 159.53 32.75 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 114.669 -1.151 . . . . 74.52 110.823 -178.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.524 ' HA ' ' HD2' ' A' ' 170' ' ' PRO . 8.0 tmtm? -87.36 123.63 32.52 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 107.226 -1.398 . . . . 72.15 107.226 168.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -73.71 148.71 40.51 Favored Glycine 0 CA--C 1.531 1.086 0 O-C-N 123.373 0.421 . . . . 55.22 113.335 -175.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.417 ' H ' ' HA3' ' A' ' 166' ' ' GLY . 8.0 tmm_? -114.79 155.6 26.43 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 124.081 0.952 . . . . 71.34 110.349 -175.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -58.37 131.42 50.64 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 123.731 0.813 . . . . 74.23 111.694 -178.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.2 tt -145.63 164.77 30.69 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 108.566 -0.901 . . . . 70.23 108.566 -172.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.483 ' NH2' HH21 ' A' ' 179' ' ' ARG . 60.1 ttt180 -129.54 139.22 51.59 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.62 -0.881 . . . . 74.51 108.62 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -135.61 151.51 50.33 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.642 0.777 . . . . 41.51 108.994 177.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.525 ' H ' ' HB3' ' B' ' 9' ' ' ALA . 13.0 mm-40 -102.18 133.78 46.5 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 107.119 -1.437 . . . . 61.0 107.119 -177.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.456 ' HA ' HD12 ' B' ' 8' ' ' LEU . 39.7 tp -102.54 95.15 5.74 Favored Pre-proline 0 CA--C 1.544 0.743 0 N-CA-C 107.991 -1.114 . . . . 54.05 107.991 179.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.536 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 52.6 Cg_endo -72.39 112.73 3.52 Favored 'Trans proline' 0 C--N 1.384 2.42 0 C-N-CA 121.532 1.488 . . . . 75.33 109.085 174.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.669 ' HA ' HG21 ' B' ' 6' ' ' ILE . 42.0 tp -123.79 137.49 54.67 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.243 0.544 . . . . 64.01 110.862 -166.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 17.3 m -75.78 133.85 40.58 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 114.984 -1.007 . . . . 71.34 109.72 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 49.5 mt -49.69 -44.01 47.76 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 124.656 1.183 . . . . 70.54 112.103 -169.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -57.58 -54.07 50.97 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.009 -0.996 . . . . 75.32 110.518 -176.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -57.8 -40.29 79.55 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 115.719 -0.673 . . . . 64.33 110.788 177.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -58.76 -48.85 79.79 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 124.291 0.994 . . . . 41.43 112.246 -176.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -74.15 -41.02 62.19 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 123.274 0.359 . . . . 74.51 111.717 -177.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -68.53 -43.54 76.51 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 120.79 0.328 . . . . 75.25 110.87 -178.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.423 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 76.21 177.57 43.44 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-N 115.418 -0.81 . . . . 71.54 113.802 178.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 109.48 -152.41 17.14 Favored Glycine 0 C--N 1.34 0.783 0 C-N-CA 123.48 0.562 . . . . 70.42 112.178 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -77.31 111.52 13.05 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.653 0.781 . . . . 73.14 111.115 -178.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 4.4 tpm_? -101.09 124.12 46.31 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 123.919 0.888 . . . . 74.4 109.81 176.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.0 t -84.33 109.5 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 123.959 0.904 . . . . 71.24 109.308 177.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.9 p -129.56 131.07 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.335 1.054 . . . . 73.14 108.881 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 144' ' ' ARG . 39.3 tt0 -113.93 142.45 46.11 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.035 0.445 . . . . 71.3 110.911 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.7 p -155.31 127.83 1.06 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.59 0 C-N-CA 124.4 1.08 . . . . 75.1 108.622 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 58.81 18.38 6.01 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.025 0.93 . . . . 74.24 112.536 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 103.12 -32.36 7.68 Favored Glycine 0 C--N 1.352 1.453 0 C-N-CA 122.903 0.287 . . . . 31.1 112.463 -176.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.35 105.26 4.02 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 108.898 -0.778 . . . . 72.12 108.898 178.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.494 ' HB3' ' O ' ' B' ' 87' ' ' ALA . 16.1 ttm180 -94.9 98.81 10.98 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.755 0.822 . . . . 74.41 109.51 173.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 6.8 p -95.8 140.75 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.777 0.831 . . . . 73.53 111.303 -177.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 28.7 t -92.62 84.36 5.04 Favored 'General case' 0 C--O 1.243 0.742 0 N-CA-C 108.67 -0.863 . . . . 31.45 108.67 174.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 31.5 m -82.64 122.99 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 N-CA-C 110.257 -0.275 . . . . 73.42 110.257 -177.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -73.73 103.27 4.23 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.565 0.698 . . . . 74.14 109.525 174.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.423 HG13 ' HA2' ' A' ' 133' ' ' GLY . 18.1 pt -82.43 133.7 49.63 Favored Pre-proline 0 CA--C 1.554 1.112 0 CA-C-N 114.565 -1.198 . . . . 74.13 108.206 167.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.588 ' HB2' HG23 ' B' ' 103' ' ' THR . 26.5 Cg_endo -62.78 143.17 91.44 Favored 'Trans proline' 0 C--N 1.371 1.742 0 C-N-CA 121.939 1.759 . . . . 60.34 112.163 175.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -57.47 92.14 0.05 OUTLIER 'Trans proline' 0 C--N 1.389 2.695 0 C-N-CA 123.22 2.614 . . . . 74.15 112.563 176.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.687 ' HA3' ' HD2' ' A' ' 241' ' ' PRO . . . 98.65 56.87 1.01 Allowed Glycine 0 C--N 1.335 0.474 0 CA-C-N 114.812 -1.085 . . . . 75.51 111.214 -169.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.449 HG22 HG11 ' A' ' 178' ' ' VAL . 5.4 p -78.38 131.29 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-O 121.73 0.776 . . . . 75.43 109.288 178.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.676 ' HA ' HD21 ' A' ' 188' ' ' LEU . 21.8 mtt85 -100.75 149.67 23.58 Favored 'General case' 0 C--O 1.21 -0.98 0 CA-C-N 114.587 -1.188 . . . . 73.23 110.873 -163.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -58.77 118.65 5.95 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.795 0.838 . . . . 72.32 110.916 -178.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 91.66 12.33 59.56 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-N 115.214 -0.903 . . . . 14.21 113.414 -176.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 24.0 t -70.94 113.97 8.53 Favored 'General case' 0 C--N 1.356 0.874 0 N-CA-C 108.319 -0.993 . . . . 74.23 108.319 173.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.488 HG22 HG22 ' A' ' 177' ' ' VAL . 47.2 t -85.57 90.33 2.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 C-N-CA 123.565 0.746 . . . . 72.34 109.09 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 61.6 mt -71.86 93.0 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 107.779 -1.193 . . . . 75.24 107.779 171.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -81.19 109.02 15.33 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.795 -0.639 . . . . 61.32 110.416 -174.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 3.7 p -114.63 108.17 49.73 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 123.606 0.763 . . . . 61.33 109.506 177.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.612 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 52.6 Cg_endo -68.33 155.37 69.49 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 121.95 1.766 . . . . 74.53 110.894 172.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.781 ' HA3' ' H ' ' A' ' 87' ' ' GLY . . . 75.81 27.64 62.39 Favored Glycine 0 C--N 1.345 1.063 0 C-N-CA 121.44 -0.409 . . . . 70.43 114.022 176.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 36.6 tpp -134.65 -22.78 1.65 Allowed 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.031 0.532 . . . . 64.15 111.385 -178.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.6 ' HA2' HD13 ' A' ' 174' ' ' LEU . . . -68.65 -99.93 0.03 OUTLIER Glycine 0 C--N 1.354 1.54 0 N-CA-C 114.993 0.757 . . . . 73.33 114.993 -172.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.417 ' HA3' ' H ' ' A' ' 117' ' ' ARG . . . -63.69 121.51 23.88 Favored Glycine 0 C--N 1.347 1.182 0 N-CA-C 111.888 -0.485 . . . . 74.5 111.888 178.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.573 HE21 ' HA ' ' A' ' 167' ' ' GLN . 0.0 OUTLIER -67.96 104.84 1.83 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.506 0.722 . . . . 75.42 110.596 -174.726 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -165.32 170.52 40.29 Favored Glycine 0 C--N 1.339 0.733 0 CA-C-O 118.785 -1.008 . . . . 64.21 111.242 -178.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . 0.51 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . 24.4 t-20 -49.52 -65.88 0.74 Allowed Pre-proline 0 CA--C 1.561 1.399 0 CA-C-O 117.247 -1.359 . . . . 63.11 110.858 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.524 ' HD2' ' HA ' ' A' ' 115' ' ' LYS . 71.1 Cg_endo -93.83 94.06 0.13 Allowed 'Trans proline' 0 C--N 1.393 2.869 0 CA-C-N 122.645 1.98 . . . . 71.13 108.881 165.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -69.73 158.26 57.62 Favored 'Trans proline' 0 C--N 1.373 1.848 0 C-N-CA 122.475 2.117 . . . . 71.25 111.765 -164.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -70.1 171.74 42.04 Favored Glycine 0 C--N 1.34 0.802 0 CA-C-N 116.143 -0.48 . . . . 72.4 113.598 -174.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.612 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 31.0 t70 -67.63 142.75 56.31 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 109.329 -0.619 . . . . 71.14 109.329 172.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.6 HD13 ' HA2' ' A' ' 165' ' ' GLY . 23.4 tp -124.57 131.85 53.46 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 120.859 0.362 . . . . 64.32 110.291 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 47.1 mt -102.53 98.37 8.45 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.676 0.791 . . . . 72.12 109.271 176.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.642 HD22 HD11 ' B' ' 8' ' ' LEU . 80.2 mt -83.09 93.98 7.72 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 118.051 0.387 . . . . 70.05 110.577 178.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.488 HG22 HG22 ' A' ' 158' ' ' VAL . 24.2 t -85.47 107.43 16.18 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 N-CA-C 107.965 -1.124 . . . . 61.43 107.965 177.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.449 HG11 HG22 ' A' ' 153' ' ' VAL . 7.5 p -69.4 127.7 31.68 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 CA-C-O 121.386 0.613 . . . . 70.33 111.233 -174.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.536 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 37.0 mmt180 -116.77 101.7 8.78 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 125.193 1.397 . . . . 53.32 108.278 176.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 4.9 mt -69.92 143.14 52.81 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 118.559 0.618 . . . . 72.4 110.246 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 83.4 mt -61.32 155.47 57.21 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 123.995 0.918 . . . . 73.14 111.755 -175.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -76.95 53.59 4.23 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 122.892 2.395 . . . . 71.42 109.858 163.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 27.8 t-80 -79.19 131.3 66.49 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 125.014 1.326 . . . . 73.35 108.572 -171.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -9.06 -53.6 0.0 OUTLIER 'Trans proline' 0 C--N 1.383 2.379 1 C-N-CA 127.692 5.595 . . . . 61.24 119.748 -163.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 44.2 t -99.76 -59.32 3.35 Favored 'Isoleucine or valine' 0 C--N 1.356 0.855 0 CA-C-N 119.322 0.965 . . . . 64.21 109.993 -168.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . 0.631 ' HB3' HD22 ' A' ' 193' ' ' LEU . 51.8 m-85 -101.4 138.78 37.96 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 112.863 0.69 . . . . 72.31 112.863 -165.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 27.2 ttp-105 -116.58 98.51 6.58 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 106.02 -1.844 . . . . 75.51 106.02 164.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.676 HD21 ' HA ' ' A' ' 154' ' ' ARG . 56.0 tp -68.98 144.16 54.2 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.616 -0.513 . . . . 74.21 109.616 176.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -149.15 115.67 5.87 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 107.788 -1.19 . . . . 70.31 107.788 -176.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.432 ' O ' ' HB3' ' A' ' 154' ' ' ARG . . . 73.29 -75.9 0.95 Allowed Glycine 0 C--N 1.349 1.29 0 CA-C-O 119.889 -0.395 . . . . 65.41 113.587 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -153.15 -2.98 0.22 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.976 0.911 . . . . 72.32 110.959 176.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -125.21 148.15 48.75 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.961 0.904 . . . . 72.32 110.446 -172.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.631 HD22 ' HB3' ' A' ' 186' ' ' PHE . 81.7 mt -90.83 149.88 21.78 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.856 0.862 . . . . 63.44 111.162 -171.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -128.58 99.59 5.43 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.312 1.045 . . . . 73.14 108.456 171.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.564 ' HB3' HD23 ' A' ' 251' ' ' LEU . . . -110.78 110.86 21.67 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.537 1.135 . . . . 74.34 111.055 -171.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 77.4 m -64.59 121.84 15.4 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 109.299 -0.63 . . . . 70.21 109.299 178.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 54.0 tp -122.62 105.73 10.36 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 123.722 0.809 . . . . 72.21 108.978 -166.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -70.35 126.2 28.96 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.144 0.497 . . . . 61.43 109.917 173.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 7.1 p -142.79 136.96 14.7 Favored Pre-proline 0 CA--C 1.548 0.894 0 N-CA-C 107.179 -1.415 . . . . 64.4 107.179 179.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.64 154.56 34.99 Favored 'Trans proline' 0 C--N 1.361 1.19 0 C-N-CA 121.55 1.5 . . . . 64.51 111.718 172.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -53.72 -47.25 97.28 Favored Pre-proline 0 CA--C 1.565 1.52 0 N-CA-C 114.718 1.377 . . . . 71.34 114.718 -174.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -59.11 -39.74 76.69 Favored 'Trans proline' 0 C--N 1.383 2.376 0 C-N-CA 122.088 1.859 . . . . 63.54 114.325 176.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 45.7 mt -75.43 -26.79 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 122.517 0.327 . . . . 64.32 110.609 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.09 -43.68 74.03 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.196 0.598 . . . . 71.51 111.158 173.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 11.1 t -69.23 -52.64 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 123.957 0.903 . . . . 63.23 112.017 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 85.3 t -85.28 -31.7 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 123.231 0.612 . . . . 74.41 111.262 -171.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 83.4 94.66 0.61 Allowed Glycine 0 CA--C 1.53 0.989 0 CA-C-N 116.308 -0.405 . . . . 72.35 113.035 -178.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -123.54 -178.15 15.34 Favored Glycine 0 N--CA 1.476 1.33 0 N-CA-C 111.487 -0.645 . . . . 55.24 111.487 174.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -81.28 134.15 35.55 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 117.963 0.882 . . . . 45.21 110.409 177.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 33.2 m -123.54 143.8 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 106.537 -1.653 . . . . 63.11 106.537 164.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . 0.428 ' HE ' ' HG2' ' A' ' 220' ' ' GLU . 29.8 ttm180 -92.87 113.65 25.98 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 121.622 -0.674 . . . . 71.41 109.809 -176.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.03 128.8 46.07 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.265 1.026 . . . . 62.04 109.22 -177.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . 0.409 ' HA ' ' HA ' ' A' ' 218' ' ' PRO . 1.6 mpt? -82.65 124.06 29.84 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.118 -0.697 . . . . 71.23 109.118 -177.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 77.2 p -109.3 -179.61 3.89 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 123.228 0.611 . . . . 74.1 109.784 178.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 49.3 mt -75.83 1.0 16.12 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.388 1.075 . . . . 63.31 111.987 -171.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -133.75 5.17 3.64 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 124.317 1.047 . . . . 64.44 111.592 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 137.49 170.6 11.93 Favored Glycine 0 N--CA 1.482 1.709 0 CA-C-O 119.802 -0.443 . . . . 33.0 113.545 176.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . 0.409 ' HA ' ' HA ' ' A' ' 213' ' ' MET . 85.2 Cg_endo -80.49 115.86 3.2 Favored 'Trans proline' 0 C--N 1.372 1.778 0 C-N-CA 122.955 2.437 . . . . 70.23 112.609 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 35.8 m -114.35 147.54 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.637 0.775 . . . . 73.4 109.834 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.428 ' HG2' ' HE ' ' A' ' 211' ' ' ARG . 42.0 mt-10 -73.85 147.18 43.54 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 109.566 -0.531 . . . . 75.04 109.566 175.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 10.1 p -137.24 116.52 15.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-O 121.544 0.688 . . . . 74.13 109.574 175.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -77.39 101.09 6.2 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 123.954 0.902 . . . . 60.25 109.522 -177.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.422 ' HA ' HD12 ' B' ' 441' ' ' ILE . 91.3 t -66.98 131.92 93.83 Favored Pre-proline 0 CA--C 1.556 1.205 0 CA-C-N 114.989 -1.005 . . . . 63.14 109.46 178.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.58 165.99 30.96 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.688 2.258 . . . . 75.51 110.922 175.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -69.47 158.62 56.66 Favored 'Trans proline' 0 C--N 1.37 1.695 0 C-N-CA 121.766 1.644 . . . . 72.53 111.857 175.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 15.3 mmt180 69.26 15.62 8.53 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 125.277 1.431 . . . . 74.04 112.046 175.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.429 HG23 HD21 ' A' ' 233' ' ' LEU . 4.0 m -59.89 104.65 0.31 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.188 0.995 . . . . 64.32 111.065 -179.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -92.11 139.55 30.52 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 114.418 -1.264 . . . . 75.32 111.671 -173.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . 0.635 ' HB1' HD21 ' B' ' 265' ' ' LEU . . . -54.11 153.19 5.27 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.496 1.518 . . . . 62.31 112.337 174.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 79.36 -49.15 3.53 Favored Glycine 0 C--N 1.345 1.069 0 N-CA-C 112.269 -0.332 . . . . 73.32 112.269 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -63.73 163.44 11.55 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 124.276 1.03 . . . . 74.0 111.363 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.534 ' HG3' ' HG2' ' A' ' 252' ' ' GLU . 2.9 mppt? -112.12 129.5 56.21 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 114.838 -1.074 . . . . 72.22 110.355 -175.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.585 ' HB3' HG21 ' B' ' 441' ' ' ILE . 79.6 mt -77.59 104.3 8.04 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 108.323 -0.992 . . . . 71.4 108.323 170.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 42.1 ttm105 -82.25 109.3 16.4 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 122.643 0.377 . . . . 64.14 110.247 177.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.519 ' HB3' ' HA ' ' B' ' 441' ' ' ILE . 0.4 OUTLIER -120.83 106.31 11.54 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 108.055 -1.091 . . . . 61.12 108.055 169.866 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -74.56 159.87 31.62 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.069 0.948 . . . . 64.43 112.666 -169.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 73.35 9.51 77.51 Favored Glycine 0 C--N 1.349 1.294 0 CA-C-N 115.496 -0.774 . . . . 74.2 113.369 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.518 ' HD2' HD11 ' B' ' 439' ' ' LEU . 0.0 OUTLIER -108.38 -11.63 15.15 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.295 0.638 . . . . 73.01 111.187 -176.49 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -79.53 -154.34 8.72 Favored Glycine 0 C--N 1.348 1.218 0 N-CA-C 112.515 -0.234 . . . . 74.43 112.515 177.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -92.41 137.69 24.47 Favored Pre-proline 0 N--CA 1.48 1.063 0 CA-C-O 118.918 -0.563 . . . . 73.13 110.132 -175.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.687 ' HD2' ' HA3' ' A' ' 152' ' ' GLY . 89.7 Cg_exo -46.78 107.99 0.14 Allowed 'Trans proline' 0 C--N 1.388 2.61 0 C-N-CA 123.973 3.115 . . . . 73.33 113.83 -178.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -134.56 -145.35 5.21 Favored Glycine 0 C--N 1.35 1.317 0 CA-C-O 119.073 -0.848 . . . . 73.52 112.585 -171.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . 0.479 ' HD3' ' HB3' ' B' ' 109' ' ' TYR . 89.3 Cg_endo -72.78 -26.93 15.37 Favored 'Trans proline' 0 C--N 1.385 2.475 0 C-N-CA 123.052 2.501 . . . . 70.45 112.655 -173.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -94.2 22.89 5.47 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.19 0.996 . . . . 70.11 111.066 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 90.13 -68.97 2.42 Favored Glycine 0 C--N 1.345 1.077 0 N-CA-C 109.579 -1.408 . . . . 62.24 109.579 -171.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.604 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 75.8 mtp180 -127.23 168.39 14.79 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.53 1.132 . . . . 75.41 109.306 166.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -84.95 -166.2 41.29 Favored Glycine 0 C--N 1.346 1.094 0 CA-C-N 116.171 -0.468 . . . . 42.24 111.973 172.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . 0.438 ' HB2' ' CE1' ' A' ' 250' ' ' TYR . 26.6 m-20 -104.39 158.99 16.09 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.371 0.669 . . . . 75.44 109.831 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.426 ' HB3' ' HG ' ' A' ' 235' ' ' LEU . 40.6 tp -106.57 122.74 46.91 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 107.619 -1.252 . . . . 70.31 107.619 167.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.438 ' CE1' ' HB2' ' A' ' 248' ' ' ASP . 42.4 m-85 -108.27 105.69 15.52 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.096 -1.076 . . . . 52.51 108.096 176.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.58 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 69.1 mt -84.41 102.83 13.06 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 108.75 -0.833 . . . . 72.24 108.75 176.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.534 ' HG2' ' HG3' ' A' ' 232' ' ' LYS . 27.7 mt-10 -74.96 96.34 3.15 Favored 'General case' 0 C--N 1.356 0.855 0 C-N-CA 123.57 0.748 . . . . 75.41 109.091 -176.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 46.3 t -55.73 133.74 19.55 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 125.571 1.548 . . . . 24.43 112.222 -172.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . 0.518 ' HA ' HD22 ' B' ' 265' ' ' LEU . 3.9 tmm_? -133.93 94.42 3.26 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 107.733 -1.21 . . . . 73.14 107.733 -179.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.451 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 77.6 mt -79.59 133.9 28.81 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-N 115.961 -0.563 . . . . 74.34 111.144 -176.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 31.1 p -129.87 176.22 8.22 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.548 1.139 . . . . 73.43 109.519 172.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.7 pp -133.23 153.03 80.51 Favored Pre-proline 0 CA--C 1.569 1.703 0 C-N-CA 123.803 0.841 . . . . 73.4 111.116 -174.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . 0.422 ' HG2' HD21 ' A' ' 261' ' ' LEU . 23.5 Cg_endo -59.18 -9.68 8.77 Favored 'Trans proline' 0 C--N 1.387 2.597 0 C-N-CA 123.999 3.133 . . . . 74.45 116.278 -166.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.499 ' HA ' ' HB3' ' C' ' 226' ' ' ARG . 36.3 mt-10 56.67 -67.52 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.075 0 C-N-CA 125.415 1.486 . . . . 63.24 113.89 -174.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.03 132.59 39.02 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.55 -0.718 . . . . 75.12 109.66 172.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.613 HD22 ' HB2' ' A' ' 265' ' ' GLU . 56.2 mt -123.73 148.92 46.15 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.414 0.686 . . . . 55.32 110.453 173.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 21.7 p -127.9 155.09 78.12 Favored Pre-proline 0 CA--C 1.558 1.259 0 C-N-CA 125.06 1.344 . . . . 44.34 108.054 172.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -17.96 -52.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.403 3.44 1 C-N-CA 126.867 5.045 . . . . 74.33 117.989 -170.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . 0.442 ' O ' HD13 ' A' ' 268' ' ' LEU . 63.3 mm-40 -55.71 -74.68 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.012 0.525 . . . . 71.44 111.285 177.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . 0.613 ' HB2' HD22 ' A' ' 261' ' ' LEU . 1.5 mp0 -64.07 -30.31 71.39 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 122.858 0.463 . . . . 64.2 109.964 -172.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' GLU . . . . . 0.529 ' HA ' HD13 ' A' ' 261' ' ' LEU . 7.6 tp10 -55.51 -62.73 1.49 Allowed 'General case' 0 C--O 1.248 1.01 0 O-C-N 123.79 0.681 . . . . 73.45 109.69 176.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -60.63 -38.86 86.16 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 115.238 -0.892 . . . . 64.12 111.354 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . 0.442 HD13 ' O ' ' A' ' 264' ' ' GLU . 2.2 mp -63.46 -48.09 79.13 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.007 0.923 . . . . 73.14 111.921 -176.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 77.9 m95 -68.79 -33.44 73.87 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.315 0.646 . . . . 75.0 111.398 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . 0.433 ' HG2' ' O ' ' A' ' 266' ' ' GLU . 29.8 mmtp -70.43 -39.95 74.07 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 122.405 0.282 . . . . 62.43 111.504 175.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -73.44 -30.24 63.08 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.016 0.526 . . . . 70.22 110.574 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 24.0 mt -59.67 -54.4 46.84 Favored 'General case' 0 C--O 1.205 -1.252 0 N-CA-C 108.541 -0.911 . . . . 63.4 108.541 167.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -51.28 -48.57 62.22 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 124.107 0.879 . . . . 64.51 111.948 -177.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.492 ' HG2' ' NE2' ' B' ' 252' ' ' GLN . 25.8 mt-10 -62.72 -56.96 12.87 Favored 'General case' 0 CA--C 1.551 0.989 0 O-C-N 123.371 0.419 . . . . 74.35 110.389 178.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -57.71 -65.85 0.57 Allowed 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.726 0.81 . . . . 71.44 111.761 -177.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . 0.516 ' HE2' ' HG3' ' C' ' 258' ' ' PRO . 81.9 t80 -45.61 -59.09 2.94 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.703 1.601 . . . . 75.02 112.826 178.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' TYR . . . . . 0.572 ' HA ' ' HB2' ' A' ' 280' ' ' ALA . 2.3 t80 -66.86 -35.01 79.07 Favored 'General case' 0 N--CA 1.482 1.132 0 O-C-N 123.59 0.556 . . . . 70.12 110.691 -170.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -61.38 -20.1 62.64 Favored 'General case' 0 CA--C 1.554 1.102 0 N-CA-C 112.761 0.652 . . . . 75.41 112.761 176.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.4 16.29 7.69 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-O 118.437 -0.792 . . . . 74.13 111.479 176.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . 0.572 ' HB2' ' HA ' ' A' ' 277' ' ' TYR . . . . . . . . 0 N--CA 1.495 1.802 0 N-CA-C 113.135 0.791 . . . . 72.21 113.135 -166.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.479 1.002 0 N-CA-C 109.167 -0.679 . . . . 71.44 109.167 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.4 ' HE3' ' O ' ' B' ' 4' ' ' SER . 58.0 tptt -63.43 108.25 1.3 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.491 0.716 . . . . 54.1 109.645 175.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 61.3 tp60 -82.7 73.92 9.7 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 109.126 -0.694 . . . . 74.04 109.126 177.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . 0.4 ' O ' ' HE3' ' B' ' 2' ' ' LYS . 61.4 p 45.65 -88.06 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 126.012 1.725 . . . . 52.14 114.062 172.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 59.4 m 56.95 133.5 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 126.18 1.792 . . . . 70.11 114.044 -178.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.669 HG21 ' HA ' ' A' ' 125' ' ' LEU . 37.5 pt -137.54 172.43 14.6 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 C-N-CA 122.991 0.517 . . . . 64.44 111.971 -175.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -124.97 -167.6 1.7 Allowed 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.616 1.167 . . . . 72.01 108.991 175.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.642 HD11 HD22 ' A' ' 176' ' ' LEU . 11.0 tp -130.69 167.1 19.35 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 109.428 -0.582 . . . . 75.22 109.428 177.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . 0.525 ' HB3' ' H ' ' A' ' 122' ' ' GLU . . . -87.68 -67.11 0.85 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 122.804 0.441 . . . . 62.4 110.864 173.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 3.8 tt 64.05 94.27 0.05 Allowed 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.556 1.142 . . . . 74.1 108.834 -169.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 57.2 mt -79.11 114.69 46.69 Favored Pre-proline 0 CA--C 1.553 1.08 0 CA-C-O 118.751 -0.642 . . . . 45.35 109.434 -176.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -58.86 110.36 0.66 Allowed 'Trans proline' 0 C--N 1.384 2.418 0 C-N-CA 123.628 2.885 . . . . 61.33 112.94 -172.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 4.2 pp 50.86 25.47 2.18 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 126.236 1.815 . . . . 75.01 113.863 -178.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' B' ' 14' ' ' LEU . 62.5 mt 73.46 40.34 0.52 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.815 1.246 . . . . 64.54 112.193 -176.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' PHE . . . . . 0.486 ' O ' ' HD3' ' B' ' 17' ' ' PRO . 16.8 m-85 -75.8 85.91 2.79 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 106.385 -1.709 . . . . 60.01 106.385 157.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 35.6 p -85.66 104.36 5.02 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 123.741 0.816 . . . . 51.11 111.697 -174.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' PRO . . . . . 0.486 ' HD3' ' O ' ' B' ' 15' ' ' PHE . 18.2 Cg_endo -96.1 8.92 1.6 Allowed 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 123.257 2.638 . . . . 62.42 112.167 176.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.453 HG23 ' HD2' ' B' ' 17' ' ' PRO . 3.8 t -91.64 -1.38 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 C-N-CA 123.42 0.688 . . . . 61.41 110.519 -174.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 9.6 t -57.13 -39.28 74.84 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.419 0.688 . . . . 71.22 109.647 170.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' LYS . . . . . 0.463 ' NZ ' ' SG ' ' B' ' 190' ' ' CYS . 58.3 mttp -150.63 119.82 6.78 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 105.567 -2.012 . . . . 62.34 105.567 167.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -46.24 106.11 0.07 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 124.413 1.07 . . . . 75.34 111.497 -174.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . 0.583 HH21 ' HA3' ' B' ' 209' ' ' GLY . 0.2 OUTLIER -64.75 -78.03 0.05 Allowed 'General case' 0 C--N 1.357 0.898 0 O-C-N 124.289 0.993 . . . . 73.31 109.936 -175.322 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' THR . . . . . 0.458 HG22 ' HB2' ' B' ' 25' ' ' GLU . 21.1 m 51.19 90.79 0.08 OUTLIER Pre-proline 0 CA--C 1.556 1.19 0 C-N-CA 124.586 1.155 . . . . 72.45 111.333 -176.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . 0.429 ' HB3' HD13 ' B' ' 68' ' ' ILE . 11.9 Cg_exo -67.8 76.09 0.6 Allowed 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 122.739 2.293 . . . . 74.55 110.3 172.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . 0.458 ' HB2' HG22 ' B' ' 23' ' ' THR . 34.1 tt0 -91.42 -4.5 55.57 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 114.508 -1.223 . . . . 74.53 110.947 -172.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . 0.627 ' HB3' ' HB1' ' B' ' 204' ' ' ALA . 99.4 mmm -133.04 154.7 81.44 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 124.324 1.049 . . . . 75.13 109.524 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.82 -46.78 15.13 Favored 'Trans proline' 0 C--N 1.386 2.522 0 C-N-CA 123.285 2.656 . . . . 71.1 114.722 -175.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 43.7 t 69.25 141.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 C-N-CA 124.804 1.241 . . . . 73.51 110.362 -170.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 4.4 mm? 65.72 41.93 3.76 Favored 'General case' 0 N--CA 1.5 2.053 0 C-N-CA 124.519 1.128 . . . . 62.2 110.702 -172.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -91.38 -61.25 1.69 Allowed 'General case' 0 CA--C 1.563 1.442 0 C-N-CA 124.819 1.248 . . . . 70.24 111.778 -174.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 174.02 -50.72 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.507 1.123 . . . . 74.34 111.068 -177.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' ARG . . . . . 0.516 ' HD2' ' HB2' ' B' ' 37' ' ' ASP . 3.8 tmt_? -171.99 -32.34 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 124.247 1.019 . . . . 72.22 108.466 -168.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . 81.44 -69.13 0.08 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 126.138 1.775 . . . . 73.31 112.846 172.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -57.53 131.97 51.78 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.85 0.86 . . . . 53.33 112.13 -172.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . 0.462 ' HB3' ' OH ' ' C' ' 250' ' ' TYR . 9.3 pt20 51.97 9.63 0.09 Allowed 'General case' 0 N--CA 1.502 2.171 0 C-N-CA 126.749 2.02 . . . . 73.13 113.773 -174.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . 0.506 ' HA3' ' O ' ' B' ' 56' ' ' ARG . . . 75.67 -18.83 2.81 Favored Glycine 0 CA--C 1.539 1.549 0 CA-C-O 119.592 -0.56 . . . . 74.33 113.752 -171.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . 0.516 ' HB2' ' HD2' ' B' ' 32' ' ' ARG . 38.3 t70 66.83 109.08 0.04 OUTLIER 'General case' 0 C--N 1.365 1.255 0 C-N-CA 126.359 1.864 . . . . 61.44 111.486 -178.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . 0.612 HG12 ' HB2' ' B' ' 56' ' ' ARG . 33.3 mt -75.08 89.02 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 N-CA-C 109.809 -0.441 . . . . 75.44 109.809 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 88.8 m -131.74 106.07 7.89 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.839 -1.171 . . . . 64.25 107.839 171.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . 53.61 93.65 0.05 OUTLIER Pre-proline 0 CA--C 1.555 1.135 0 C-N-CA 124.925 1.29 . . . . 64.0 112.241 -176.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . 0.453 ' HB3' ' HD3' ' B' ' 56' ' ' ARG . 15.4 Cg_exo -70.66 -14.8 33.53 Favored 'Trans proline' 0 C--N 1.377 2.038 0 C-N-CA 123.034 2.489 . . . . 72.44 112.983 -179.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.81 -71.29 2.75 Favored Glycine 0 C--N 1.347 1.188 0 N-CA-C 109.941 -1.263 . . . . 45.24 109.941 -171.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -115.54 145.63 18.71 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 114.634 -0.783 . . . . 42.15 111.247 171.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -157.75 109.17 2.28 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 108.453 -0.943 . . . . 63.2 108.453 175.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 21.0 tpp180 -59.86 -61.91 2.26 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.227 0.611 . . . . 74.21 110.993 -177.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 32.7 ttm180 73.6 -52.89 0.7 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 125.286 1.434 . . . . 75.02 111.45 -173.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 64.35 -81.75 0.03 OUTLIER 'General case' 0 C--N 1.358 0.976 0 C-N-CA 125.313 1.445 . . . . 53.22 107.615 -170.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 8.2 m -142.62 -62.93 0.43 Allowed 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 109.09 -0.707 . . . . 51.22 109.09 172.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -93.91 46.88 2.26 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 115.378 -0.828 . . . . 74.15 113.143 -175.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 10.1 t70 72.42 -54.8 0.68 Allowed 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 125.653 1.581 . . . . 64.2 112.947 176.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 62.19 33.09 17.04 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 124.415 1.086 . . . . 75.3 111.309 178.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 2.1 m 65.72 33.93 7.92 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.851 1.261 . . . . 73.31 110.586 175.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -85.43 -14.62 45.62 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 115.139 -0.937 . . . . 73.24 111.659 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.426 ' HB2' HG13 ' B' ' 329' ' ' ILE . . . -65.54 -84.07 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 122.779 0.432 . . . . 75.51 110.541 176.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 92.5 mt 33.67 -89.41 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 125.575 1.55 . . . . 72.35 114.109 -177.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . 0.612 ' HB2' HG12 ' B' ' 38' ' ' ILE . 0.0 OUTLIER 58.61 14.01 2.87 Favored 'General case' 0 C--N 1.366 1.295 0 C-N-CA 124.813 1.245 . . . . 73.2 111.977 -167.177 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -71.61 91.87 1.11 Allowed 'General case' 0 C--N 1.353 0.76 0 C-N-CA 124.217 1.007 . . . . 75.31 108.941 -176.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 44.1 p -161.45 169.55 21.67 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 114.936 -1.029 . . . . 62.01 109.707 -172.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . 0.444 HD23 ' H ' ' B' ' 59' ' ' LEU . 1.5 pt? -131.66 128.23 38.62 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 109.078 -0.712 . . . . 72.44 109.078 -179.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 16.1 m -65.6 122.84 18.15 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.38 0.672 . . . . 63.51 109.98 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -70.29 78.7 0.53 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.726 0.81 . . . . 71.45 110.734 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -143.94 78.89 13.69 Favored Pre-proline 0 N--CA 1.468 0.446 0 N-CA-C 106.58 -1.637 . . . . 72.3 106.58 173.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.18 84.71 1.09 Allowed 'Trans proline' 0 C--N 1.374 1.904 0 C-N-CA 121.784 1.656 . . . . 72.24 110.88 177.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 23.55 -82.3 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 127.294 2.238 . . . . 72.04 114.182 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -145.82 88.49 1.83 Allowed 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 105.896 -1.89 . . . . 65.32 105.896 167.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 68.26 -169.07 0.19 Allowed 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 124.717 1.207 . . . . 72.41 108.779 -169.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 12.0 tt -76.97 67.13 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.576 1.959 0 CA-C-O 122.646 1.212 . . . . 72.03 110.661 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . 0.429 HD13 ' HB3' ' B' ' 24' ' ' PRO . 2.9 mp 45.12 -81.06 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.559 1.319 0 C-N-CA 128.159 2.583 . . . . 73.4 113.128 -178.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -87.37 4.65 42.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.934 -0.479 . . . . 73.12 111.911 -178.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 7.9 mp 64.72 21.22 12.34 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 124.505 1.122 . . . . 44.44 110.705 -173.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . 0.655 HG23 ' HA ' ' B' ' 75' ' ' MET . 38.2 mm -103.07 108.49 24.46 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 C-N-CA 123.944 0.898 . . . . 74.32 109.658 -176.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.66 -163.49 36.6 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 111.435 -0.666 . . . . 62.21 111.435 171.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -70.61 111.43 6.1 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 122.772 0.429 . . . . 63.44 109.957 178.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.68 34.42 31.45 Favored Glycine 0 C--N 1.344 0.992 0 CA-C-N 116.229 -0.442 . . . . 64.42 112.13 -174.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 75' ' ' MET . . . . . 0.655 ' HA ' HG23 ' B' ' 71' ' ' ILE . 0.0 OUTLIER 70.31 -69.46 0.17 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.741 1.616 . . . . 74.01 111.46 178.821 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . -146.97 9.01 1.3 Allowed Glycine 0 C--N 1.342 0.886 0 CA-C-O 119.698 -0.501 . . . . 71.13 112.884 176.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 32.4 t70 61.46 -81.45 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 125.265 1.426 . . . . 73.03 111.167 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . 0.417 ' H ' ' H ' ' B' ' 79' ' ' GLU . 71.6 p -166.73 -15.32 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.536 1.134 . . . . 51.1 109.764 178.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . 0.417 ' H ' ' H ' ' B' ' 78' ' ' SER . 50.9 mt-10 -73.11 -15.82 61.48 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.384 0.674 . . . . 74.44 111.667 176.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 15.2 tt -58.57 -39.34 75.31 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.136 0 C-N-CA 123.537 0.735 . . . . 72.52 111.087 175.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 74.1 m -153.29 120.16 5.7 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 107.917 -1.142 . . . . 71.34 107.917 177.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.84 91.73 0.07 Allowed 'General case' 0 N--CA 1.473 0.723 0 O-C-N 123.705 0.628 . . . . 61.11 110.381 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -92.81 -58.41 2.35 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 114.905 -1.043 . . . . 71.35 110.489 -176.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 84' ' ' ARG . . . . . 0.455 ' HG2' ' HB2' ' B' ' 87' ' ' ALA . 6.5 tpm_? -168.4 -51.45 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.184 -0.462 . . . . 73.0 110.097 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 75.89 0.34 3.32 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 125.421 1.488 . . . . 72.23 112.189 -177.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -175.11 91.12 0.06 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.338 1.055 . . . . 63.12 109.251 176.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . 0.494 ' O ' ' HB3' ' A' ' 144' ' ' ARG . . . -118.38 107.77 14.26 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 108.69 -0.856 . . . . 52.24 108.69 174.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -83.92 48.15 1.41 Allowed 'General case' 0 CA--C 1.563 1.464 0 CA-C-O 121.839 0.828 . . . . 74.14 111.591 -172.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -90.72 59.32 3.28 Favored Glycine 0 C--N 1.351 1.373 0 N-CA-C 110.981 -0.848 . . . . 54.33 110.981 169.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -144.1 -64.11 0.37 Allowed 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.672 -0.862 . . . . 62.33 108.672 -174.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 81.03 -60.17 4.7 Favored Glycine 0 C--N 1.352 1.457 0 CA-C-N 115.776 -0.647 . . . . 70.11 112.868 178.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.29 39.19 4.31 Favored Glycine 0 C--N 1.346 1.136 0 N-CA-C 112.101 -0.4 . . . . 23.53 112.101 -177.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -94.62 131.61 40.21 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.617 0.767 . . . . 74.22 110.311 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -60.95 131.52 50.91 Favored 'General case' 0 N--CA 1.479 1.018 0 O-C-N 124.124 0.89 . . . . 71.21 111.962 -175.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . 0.677 ' HA ' ' HE2' ' A' ' 23' ' ' LYS . 82.9 tttt -76.78 -13.25 60.04 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 116.258 -0.428 . . . . 74.14 110.882 172.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.36 -165.87 31.58 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-N 115.922 -0.581 . . . . 72.31 113.115 175.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 21.6 pt -130.61 26.83 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 124.35 1.06 . . . . 72.22 109.281 -176.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -67.48 -55.89 11.74 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.132 1.373 . . . . 75.21 110.593 -171.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . 0.463 ' H ' HD12 ' B' ' 100' ' ' LEU . . . -128.1 21.67 6.25 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 114.972 -1.013 . . . . 61.12 109.649 176.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . 0.491 HD21 ' HD3' ' B' ' 95' ' ' LYS . 4.8 mp -111.48 111.15 55.12 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 123.909 0.884 . . . . 74.2 109.479 -174.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -66.69 146.42 78.86 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 122.966 2.444 . . . . 72.21 112.277 173.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 87.3 mt -70.98 86.79 0.72 Allowed 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.282 0.633 . . . . 73.12 109.857 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 103' ' ' THR . . . . . 0.588 HG23 ' HB2' ' A' ' 150' ' ' PRO . 2.6 m 66.82 10.43 7.56 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 124.67 1.188 . . . . 75.52 111.499 -178.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.13 73.45 2.58 Favored Glycine 0 C--N 1.348 1.22 0 CA-C-N 116.34 -0.391 . . . . 51.35 112.748 -174.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -73.52 88.12 1.63 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.305 0.642 . . . . 75.22 109.648 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 48.1 t80 70.73 -78.03 0.05 Allowed 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 125.054 1.341 . . . . 74.44 111.09 176.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 26.2 p -116.02 45.84 1.67 Allowed 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 124.211 1.004 . . . . 63.32 109.507 177.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 74.0 m80 70.42 -65.54 0.32 Allowed 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 125.399 1.48 . . . . 71.44 109.276 -165.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.479 ' HB3' ' HD3' ' A' ' 243' ' ' PRO . 36.0 t80 -150.65 134.84 16.95 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 124.224 1.009 . . . . 53.33 108.932 174.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.22 90.53 0.91 Allowed 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 107.832 -1.173 . . . . 71.24 107.832 165.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . 0.479 ' HB3' ' HG3' ' A' ' 243' ' ' PRO . 0.9 OUTLIER -54.76 145.55 19.23 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.433 1.093 . . . . 64.15 112.789 -173.988 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -71.67 -47.75 52.13 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.524 0.73 . . . . 73.2 110.39 -176.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 113' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -123.06 179.68 4.59 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.393 1.077 . . . . 75.13 109.242 177.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -56.2 -44.34 79.37 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.695 0.798 . . . . 74.01 112.474 -175.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 3.9 m -101.41 31.9 3.54 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 123.411 0.684 . . . . 73.23 109.679 178.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . 0.474 ' HA2' ' HB2' ' B' ' 111' ' ' LEU . . . 75.96 -69.84 2.12 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 111.507 -0.637 . . . . 55.33 111.507 -175.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 10.1 tptp -158.41 97.78 1.78 Allowed Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 124.601 1.16 . . . . 70.25 108.236 170.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 118' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -96.22 -154.37 0.04 OUTLIER 'Trans proline' 0 C--N 1.363 1.326 0 C-N-CA 123.404 2.736 . . . . 60.53 111.142 169.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 119' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -77.51 155.85 31.38 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 108.009 -1.108 . . . . 75.33 108.009 165.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 120' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -78.91 83.98 4.98 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-O 121.743 0.782 . . . . 70.1 109.798 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 4.2 t -117.17 29.42 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.234 0 N-CA-C 108.039 -1.097 . . . . 74.32 108.039 176.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 25.9 m -63.97 -37.95 89.3 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.258 1.023 . . . . 75.24 111.178 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -74.53 -10.78 59.88 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.699 0.8 . . . . 64.3 112.053 176.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 80.6 p 59.24 19.47 7.56 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 126.012 1.725 . . . . 43.31 112.532 -175.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -108.3 2.21 22.47 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.967 0.907 . . . . 73.02 110.162 174.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . 62.31 13.13 5.73 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 125.172 1.389 . . . . 74.13 112.54 -176.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 42.2 m 58.5 24.69 12.16 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.673 1.189 . . . . 70.01 112.163 -173.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.6 -47.65 74.97 Favored 'General case' 0 C--N 1.355 0.808 0 C-N-CA 123.918 0.887 . . . . 72.01 111.174 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 21.7 m 78.03 -50.27 0.49 Allowed 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 125.34 1.456 . . . . 54.34 112.994 172.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . 79.21 -40.25 0.24 Allowed 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 126.124 1.77 . . . . 44.22 111.433 -176.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 131' ' ' TRP . . . . . 0.403 ' O ' HD21 ' B' ' 173' ' ' LEU . 24.4 m-90 71.21 -61.85 0.47 Allowed 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 125.857 1.663 . . . . 73.51 111.464 178.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 21.5 p -74.83 56.37 0.73 Allowed 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 125.017 1.327 . . . . 51.4 110.865 176.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 12.1 t -140.37 -171.15 3.14 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 125.395 1.478 . . . . 62.25 108.316 -175.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 134' ' ' GLY . . . . . 0.452 ' H ' ' HA ' ' B' ' 137' ' ' THR . . . 99.84 -59.64 0.76 Allowed Glycine 0 N--CA 1.474 1.229 0 N-CA-C 111.71 -0.556 . . . . 55.15 111.71 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 135' ' ' VAL . . . . . . . . . . . . . 2.3 p -67.2 93.35 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.059 0 N-CA-C 108.95 -0.759 . . . . 73.24 108.95 171.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt 85.69 -24.18 0.14 Allowed 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 126.369 1.868 . . . . 52.43 111.136 -173.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 137' ' ' THR . . . . . 0.452 ' HA ' ' H ' ' B' ' 134' ' ' GLY . 5.9 m 61.79 27.43 16.76 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.868 1.267 . . . . 75.31 111.391 178.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -95.82 -34.93 11.69 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.355 -0.839 . . . . 75.52 110.246 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 65.09 174.96 0.21 Allowed 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 125.182 1.393 . . . . 73.24 109.703 -171.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -53.41 -56.69 18.46 Favored Glycine 0 C--N 1.353 1.518 0 N-CA-C 110.827 -0.909 . . . . 65.04 110.827 171.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . 49.36 32.06 4.27 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 125.696 1.598 . . . . 75.34 114.13 164.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 2.3 pp 48.49 19.24 0.22 Allowed 'General case' 0 N--CA 1.502 2.157 0 C-N-CA 125.759 1.624 . . . . 70.15 114.394 -177.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -90.72 27.29 8.99 Favored Glycine 0 C--N 1.342 0.873 0 N-CA-C 115.668 1.027 . . . . 61.25 115.668 -165.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.26 -56.45 12.58 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.282 0 CA-C-N 117.913 0.856 . . . . 75.31 109.374 172.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 4.3 t70 167.27 156.63 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 126.523 1.929 . . . . 64.3 107.94 176.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 21.3 mt 62.88 11.63 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 C-N-CA 124.699 1.2 . . . . 72.52 111.948 177.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 44.8 p-80 43.9 90.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 125.168 1.387 . . . . 72.43 111.708 -166.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . 0.404 ' HG3' ' N ' ' B' ' 149' ' ' LYS . 15.6 pt-20 -56.35 -53.46 57.07 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 123.398 0.679 . . . . 73.05 111.64 -175.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 149' ' ' LYS . . . . . 0.576 ' HG2' ' HB3' ' B' ' 163' ' ' LEU . 0.3 OUTLIER -65.55 144.97 56.65 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.213 1.005 . . . . 72.23 109.54 -169.533 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 150' ' ' ASP . . . . . 0.433 ' N ' ' HD2' ' B' ' 149' ' ' LYS . 16.8 t70 95.38 -27.39 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 126.891 2.077 . . . . 74.11 110.695 -178.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 13.6 p-80 -167.72 65.34 0.73 Allowed Pre-proline 0 N--CA 1.492 1.665 0 C-N-CA 123.403 0.681 . . . . 74.43 111.468 175.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -84.44 -9.87 9.03 Favored 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 122.914 2.409 . . . . 42.51 113.462 -176.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 2.4 m 64.55 28.23 13.35 Favored 'General case' 0 CA--C 1.564 1.487 0 C-N-CA 124.319 1.048 . . . . 74.2 110.219 -174.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 9.6 tt -154.54 132.82 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.939 0.896 . . . . 74.25 109.304 176.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 155' ' ' LEU . . . . . 0.506 HD23 HD12 ' B' ' 163' ' ' LEU . 46.8 tp 74.65 -62.43 0.46 Allowed 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 125.615 1.566 . . . . 72.1 111.815 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 156' ' ' GLU . . . . . 0.737 ' HB3' ' HA ' ' B' ' 159' ' ' LYS . 46.9 mt-10 -73.23 99.28 2.82 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.415 0.686 . . . . 72.23 110.163 176.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 157' ' ' MET . . . . . . . . . . . . . 14.7 tmm? -58.11 -55.46 34.63 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 124.282 1.033 . . . . 53.54 111.095 -178.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 158' ' ' ALA . . . . . . . . . . . . . . . -100.02 -76.12 0.56 Allowed 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 106.934 -1.506 . . . . 34.04 106.934 166.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . 0.737 ' HA ' ' HB3' ' B' ' 156' ' ' GLU . 64.1 pttt -174.52 147.35 1.1 Allowed 'General case' 0 C--N 1.354 0.794 0 O-C-N 124.432 1.083 . . . . 55.45 109.853 163.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -102.63 -8.35 21.01 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.074 -0.966 . . . . 70.22 109.843 171.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . 60.44 24.42 14.0 Favored 'General case' 0 C--N 1.362 1.143 0 C-N-CA 124.463 1.105 . . . . 71.1 110.928 -175.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . -133.21 -59.22 0.08 OUTLIER Glycine 0 C--N 1.352 1.462 0 CA-C-N 115.697 -0.683 . . . . 73.4 112.157 -174.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . 0.576 ' HB3' ' HG2' ' B' ' 149' ' ' LYS . 50.6 tp 55.44 -86.58 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 125.063 1.345 . . . . 65.02 112.366 -179.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 164' ' ' ALA . . . . . . . . . . . . . . . -177.57 149.85 0.65 Allowed 'General case' 0 C--O 1.243 0.728 0 C-N-CA 124.942 1.297 . . . . 75.34 108.676 -171.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 8.8 t -166.71 7.74 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.805 0.842 . . . . 64.15 110.285 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . 130.03 107.29 1.22 Allowed Glycine 0 C--N 1.342 0.897 0 N-CA-C 109.727 -1.349 . . . . 71.15 109.727 -170.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 167' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -63.94 -31.52 72.73 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.582 0.753 . . . . 72.31 111.908 -176.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 8.0 p 46.64 39.18 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 C-N-CA 125.689 1.596 . . . . 74.13 112.693 178.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 32.5 t -70.52 110.9 5.66 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 113.822 -1.535 . . . . 54.35 109.922 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 170' ' ' THR . . . . . 0.591 ' HA ' ' SD ' ' C' ' 213' ' ' MET . 4.9 m 63.15 33.58 14.29 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.861 1.264 . . . . 63.1 110.19 -177.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . 76.63 -45.39 0.5 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 126.164 1.785 . . . . 53.32 111.831 -174.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 172' ' ' GLU . . . . . 0.557 ' HG3' ' H ' ' B' ' 173' ' ' LEU 0.265 10.5 pt-20 45.73 -92.74 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.454 0 C-N-CA 126.094 1.758 . . . . 73.22 114.039 -175.94 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 173' ' ' LEU . . . . . 0.557 ' H ' ' HG3' ' B' ' 172' ' ' GLU . 4.5 mm? 52.34 -91.19 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.925 0.89 . . . . 74.23 110.17 -166.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 174' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 174.74 -64.92 0.01 OUTLIER 'General case' 0 C--N 1.351 0.668 0 C-N-CA 125.374 1.47 . . . . 74.45 107.912 177.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 175' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -100.4 154.79 18.22 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.103 -0.953 . . . . 74.1 110.631 -177.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -162.58 122.87 2.41 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.476 1.11 . . . . 74.11 108.49 174.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 177' ' ' THR . . . . . 0.452 ' HA ' ' HD3' ' B' ' 178' ' ' PRO . 45.5 p -67.14 114.31 17.79 Favored Pre-proline 0 CA--C 1.555 1.166 0 C-N-CA 123.526 0.73 . . . . 64.31 110.131 179.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 178' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' B' ' 177' ' ' THR . 4.5 Cg_exo -78.84 67.12 8.6 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 123.391 2.727 . . . . 74.53 112.912 -173.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -85.26 -69.36 0.66 Allowed 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 108.276 -1.009 . . . . 61.34 108.276 173.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . 60.79 -74.69 0.03 OUTLIER 'General case' 0 C--N 1.358 0.963 0 O-C-N 125.111 1.507 . . . . 74.4 113.407 169.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 181' ' ' LEU . . . . . 0.439 ' HG ' ' HB ' ' C' ' 138' ' ' VAL . 30.3 tp -63.06 -30.14 71.36 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.146 1.378 . . . . 62.04 112.176 -177.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 182' ' ' VAL . . . . . 0.58 HG21 ' HB3' ' C' ' 139' ' ' GLU . 2.8 p -99.11 133.93 39.97 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 CA-C-N 116.189 -0.459 . . . . 71.31 110.982 174.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 183' ' ' ALA . . . . . 0.433 ' HB3' ' HA ' ' C' ' 123' ' ' LEU . . . -159.11 39.47 0.21 Allowed 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 114.806 -1.088 . . . . 65.24 108.453 163.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 42.5 p-80 54.49 171.44 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 127.216 2.207 . . . . 74.15 114.731 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 185' ' ' VAL . . . . . 0.478 HG21 HD11 ' C' ' 119' ' ' LEU . 6.9 p -78.65 134.92 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-N 115.638 -0.71 . . . . 71.33 110.469 177.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 186' ' ' THR . . . . . 0.505 HG21 ' HG3' ' C' ' 122' ' ' GLU . 8.8 t -79.6 163.89 24.26 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.395 0.678 . . . . 51.31 111.406 -177.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 187' ' ' SER . . . . . . . . . . . . . 11.6 m -81.58 -29.08 33.5 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.418 1.087 . . . . 62.14 111.005 177.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 21.7 mtm180 -88.24 115.71 25.92 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.725 0.81 . . . . 71.52 109.84 -176.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -74.33 85.7 1.96 Allowed 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.454 0.702 . . . . 72.52 109.995 -177.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 190' ' ' CYS . . . . . 0.529 ' HB2' HG21 ' C' ' 177' ' ' VAL . 36.7 m -85.81 90.14 7.96 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 114.735 -1.12 . . . . 70.33 109.64 -179.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -64.18 145.47 55.9 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 114.975 -1.011 . . . . 74.04 110.352 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -113.38 158.02 14.56 Favored Glycine 0 N--CA 1.468 0.804 0 CA-C-O 119.508 -0.606 . . . . 64.22 112.532 -178.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 193' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -95.09 -162.95 0.09 OUTLIER 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 123.273 2.649 . . . . 64.32 111.547 175.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 194' ' ' SER . . . . . . . . . . . . . 47.1 m -84.38 155.11 22.47 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 109.807 -0.442 . . . . 24.51 109.807 171.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 195' ' ' ALA . . . . . . . . . . . . . . . -138.35 145.48 41.16 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.544 0.737 . . . . 74.32 110.383 -178.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 196' ' ' THR . . . . . 0.431 ' HB ' ' O ' ' B' ' 202' ' ' GLY . 8.0 m -63.21 -66.98 0.46 Allowed 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 108.767 -0.827 . . . . 73.32 108.767 172.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 47.6 m 50.92 28.99 4.09 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.866 1.266 . . . . 75.11 113.03 174.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 198' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.07 89.32 3.01 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 108.749 -0.834 . . . . 51.12 108.749 -174.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 45.9 tttp 71.18 -8.19 1.03 Allowed 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 125.308 1.443 . . . . 74.4 112.595 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 200' ' ' CYS . . . . . . . . . . . . . 34.8 m -138.93 168.89 13.95 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 124.057 0.943 . . . . 73.31 109.897 -167.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 201' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -73.11 3.37 4.62 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 122.107 1.871 . . . . 71.34 112.458 165.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 202' ' ' GLY . . . . . 0.67 ' HA2' ' HA2' ' C' ' 190' ' ' GLY . . . -58.12 117.18 9.66 Favored Glycine 0 C--N 1.359 1.849 0 C-N-CA 123.728 0.68 . . . . 63.04 113.498 175.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 27.3 t30 -170.28 122.68 0.67 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.59 1.156 . . . . 71.33 109.027 -178.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 204' ' ' ALA . . . . . 0.627 ' HB1' ' HB3' ' B' ' 26' ' ' MET . . . -71.68 88.87 0.99 Allowed 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.207 -0.664 . . . . 74.01 109.207 174.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 205' ' ' LEU . . . . . . . . . . . . . 19.4 tp -106.57 -52.74 2.73 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.068 -0.969 . . . . 51.03 108.603 -176.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 58.01 -74.26 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.833 1.653 . . . . 62.32 110.467 -173.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 207' ' ' LYS . . . . . 0.418 ' HD2' ' HB ' ' B' ' 23' ' ' THR . 4.1 ttmp? -103.81 -78.11 0.56 Allowed 'General case' 0 C--O 1.243 0.72 0 N-CA-C 107.349 -1.352 . . . . 74.32 107.349 174.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 52.21 34.06 39.52 Favored Glycine 0 C--N 1.356 1.676 0 O-C-N 124.005 0.816 . . . . 71.52 114.527 173.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 209' ' ' GLY . . . . . 0.583 ' HA3' HH21 ' B' ' 22' ' ' ARG . . . 93.71 75.95 1.31 Allowed Glycine 0 C--N 1.341 0.807 0 N-CA-C 111.316 -0.714 . . . . 42.21 111.316 -174.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 210' ' ' LYS . . . . . 0.515 ' HD3' ' O ' ' C' ' 155' ' ' GLU . 4.8 ttpm? -163.97 -34.22 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.001 0.52 . . . . 74.51 111.394 -178.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . -69.38 66.95 0.55 Allowed Glycine 0 C--N 1.362 1.998 0 O-C-N 123.792 0.683 . . . . 74.43 114.067 -171.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 65.4 m -165.77 -44.04 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.641 1.576 . . . . 74.04 107.579 -172.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 49.3 mt 55.67 80.61 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.362 1.14 0 C-N-CA 125.86 1.664 . . . . 64.4 111.047 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 74.0 p -78.15 77.94 4.64 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-O 122.507 1.146 . . . . 75.43 109.443 178.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 215' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -128.06 -52.99 1.31 Allowed 'General case' 0 C--O 1.237 0.408 0 CA-C-N 113.697 -1.592 . . . . 73.31 108.16 -176.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 77.81 -20.63 0.37 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 124.824 1.328 . . . . 61.42 112.401 175.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 5.7 tt -77.21 -64.0 1.24 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.878 0.871 . . . . 75.4 110.253 -169.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . 0.541 ' HB3' ' HA ' ' B' ' 222' ' ' ALA . 51.8 mt -80.97 -36.92 30.18 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 110.139 -0.319 . . . . 71.43 110.139 173.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 70.28 103.94 0.06 Allowed 'General case' 0 C--N 1.359 1.014 0 O-C-N 124.771 1.294 . . . . 71.24 112.419 172.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . 64.81 -75.16 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 125.384 1.474 . . . . 61.1 113.42 167.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 221' ' ' ARG . . . . . . . . . . . . . 18.0 tpp180 -60.22 -40.65 90.91 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.47 1.108 . . . . 73.55 111.446 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . 0.541 ' HA ' ' HB3' ' B' ' 218' ' ' LEU . . . 60.53 49.55 6.54 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 124.216 0.948 . . . . 42.52 111.327 177.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -46.75 -64.78 0.68 Allowed 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 125.696 1.598 . . . . 61.02 112.774 -172.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 54.6 t -41.53 -62.6 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 125.558 1.543 . . . . 74.2 112.736 -167.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 225' ' ' THR . . . . . 0.575 HG22 ' HD2' ' C' ' 184' ' ' PRO . 60.2 p 50.69 -70.36 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 125.771 1.628 . . . . 54.34 113.726 -175.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 2.7 tm? 72.7 96.05 0.07 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.679 1.192 . . . . 74.43 109.282 175.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . 155.81 -22.16 0.53 Allowed Glycine 0 C--N 1.347 1.14 0 CA-C-O 119.433 -0.648 . . . . 51.31 113.313 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . -56.12 -55.38 29.64 Favored Glycine 0 CA--C 1.536 1.388 0 N-CA-C 114.299 0.48 . . . . 72.41 114.299 -173.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -118.64 50.93 0.78 Allowed Glycine 0 C--N 1.345 1.051 0 N-CA-C 111.037 -0.825 . . . . 70.24 111.037 176.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -58.33 130.99 49.3 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.054 0.942 . . . . 70.23 111.725 -174.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 231' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -68.27 130.64 43.51 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 123.814 0.696 . . . . 73.24 112.116 -169.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 232' ' ' THR . . . . . 0.419 ' H ' HD21 ' B' ' 258' ' ' LEU . 14.7 t -154.95 -178.6 7.35 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.571 1.148 . . . . 74.24 108.859 177.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -132.77 94.08 3.33 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 107.795 -1.187 . . . . 70.41 107.795 172.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -148.08 173.39 12.98 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.338 0.655 . . . . 72.31 110.857 -176.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . 0.478 ' HA ' ' HZ3' ' C' ' 209' ' ' LYS . 38.1 tt0 -158.87 77.01 0.74 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.3 0.64 . . . . 54.41 110.502 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 236' ' ' THR . . . . . . . . . . . . . 85.6 m -150.77 128.18 11.39 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.761 0.824 . . . . 73.34 109.565 172.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -76.62 85.06 3.28 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.108 0.563 . . . . 71.12 109.58 172.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 4.4 m -93.67 17.29 12.06 Favored 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 123.818 0.847 . . . . 71.31 110.753 -175.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 239' ' ' ALA . . . . . 0.426 ' HA ' HD22 ' C' ' 235' ' ' LEU . . . -83.29 153.29 24.72 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.678 0.791 . . . . 74.42 111.345 -176.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 240' ' ' GLY . . . . . 0.424 ' O ' ' HE3' ' B' ' 245' ' ' LYS . . . -86.86 -60.62 1.67 Allowed Glycine 0 C--N 1.349 1.288 0 CA-C-N 116.008 -0.542 . . . . 71.23 113.708 -164.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 241' ' ' GLU . . . . . 0.422 ' HG2' ' H ' ' C' ' 234' ' ' ARG . 15.4 pt-20 -112.18 -167.41 1.18 Allowed 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 117.49 0.645 . . . . 71.21 110.685 178.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 242' ' ' TRP . . . . . 0.416 ' CH2' HG21 ' C' ' 253' ' ' VAL 0.259 0.0 OUTLIER 59.53 166.33 0.06 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 127.647 2.379 . . . . 70.32 114.567 177.496 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' B' B ' 243' ' ' GLN . . . . . 0.466 ' HG3' ' H ' ' B' ' 245' ' ' LYS . 1.9 pt20 51.99 -166.95 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 126.519 1.928 . . . . 74.22 114.584 170.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -78.98 -43.81 10.58 Favored Glycine 0 C--N 1.362 2.007 0 CA-C-N 115.773 -0.649 . . . . 63.11 112.246 173.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 245' ' ' LYS . . . . . 0.466 ' H ' ' HG3' ' B' ' 243' ' ' GLN . 22.9 pttm 44.74 40.77 4.46 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 126.324 1.85 . . . . 75.34 112.734 -178.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 15.3 t -145.45 174.14 11.4 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.63 0.772 . . . . 71.02 110.316 -175.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 247' ' ' LEU . . . . . . . . . . . . . 87.8 mt 64.95 -83.36 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.834 1.254 . . . . 72.51 110.834 -177.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 248' ' ' ARG . . . . . . . . . . . . . 7.4 tpp180 -164.54 11.19 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.155 0.982 . . . . 75.15 109.097 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 51.61 -145.3 0.53 Allowed 'General case' 0 C--N 1.354 0.77 0 C-N-CA 124.794 1.238 . . . . 71.33 112.239 -169.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 250' ' ' GLN . . . . . 0.482 ' HG3' ' HD3' ' C' ' 225' ' ' PRO . 46.5 mm-40 -96.59 51.88 1.19 Allowed 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 111.905 0.335 . . . . 65.4 111.905 -156.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 251' ' ' ALA . . . . . . . . . . . . . . . 75.05 -58.0 0.59 Allowed 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 125.778 1.631 . . . . 61.03 113.149 174.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . 0.492 ' NE2' ' HG2' ' A' ' 274' ' ' GLU . 88.9 mm-40 -86.51 53.26 2.75 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.475 0.71 . . . . 72.3 111.751 -177.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 253' ' ' ALA . . . . . 0.667 ' HB1' ' HE3' ' C' ' 209' ' ' LYS . . . -102.43 40.45 1.35 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.76 0.824 . . . . 51.41 109.356 175.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 42.1 ttp-105 -168.28 -64.83 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.277 0.631 . . . . 72.51 109.957 -178.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . 58.68 -100.85 0.18 Allowed Glycine 0 C--N 1.362 2.024 0 O-C-N 123.568 0.543 . . . . 54.22 111.877 -177.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 256' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -148.04 -57.9 0.24 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.291 1.037 . . . . 52.52 108.7 168.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 25.9 pt20 -143.3 174.97 10.26 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.586 0.755 . . . . 74.31 110.474 -173.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 258' ' ' LEU . . . . . 0.43 ' HB3' ' HE1' ' A' ' 277' ' ' TYR . 2.3 pt? -148.82 148.36 29.83 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.404 0.682 . . . . 75.13 109.745 178.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 15.1 m -119.24 163.56 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.745 0.818 . . . . 63.02 110.163 173.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 260' ' ' SER . . . . . . . . . . . . . 21.3 t -121.13 142.54 49.77 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.855 0.862 . . . . 73.11 108.734 177.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -101.0 -69.26 0.78 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 122.74 0.416 . . . . 52.21 110.873 178.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 262' ' ' ALA . . . . . . . . . . . . . . . -166.67 -149.92 0.11 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.528 0.731 . . . . 43.43 109.258 -169.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 263' ' ' ALA . . . . . 0.447 ' HB3' HG21 ' B' ' 225' ' ' THR . . . -161.64 -167.8 1.81 Allowed 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 118.024 0.375 . . . . 70.44 111.919 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 264' ' ' SER . . . . . 0.769 ' H ' HG21 ' C' ' 196' ' ' THR . 36.1 t 68.31 94.89 0.07 Allowed 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 126.284 1.834 . . . . 51.14 112.553 175.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 265' ' ' LEU . . . . . 0.635 HD21 ' HB1' ' A' ' 229' ' ' ALA . 27.8 mt -130.07 -74.63 0.54 Allowed 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 124.098 0.959 . . . . 64.12 109.923 171.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 266' ' ' ASN . . . . . 0.583 HD21 ' HB3' ' B' ' 270' ' ' GLU . 8.5 t-20 69.0 158.72 0.16 Allowed 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 125.345 1.458 . . . . 71.52 110.934 -173.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 75.9 p -72.91 -56.72 4.77 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 109.487 -0.56 . . . . 73.13 109.487 175.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 6.2 p 177.37 -40.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.661 1.584 . . . . 74.44 107.532 175.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 269' ' ' THR . . . . . . . . . . . . . 20.0 p -140.27 35.04 1.89 Allowed 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.82 1.248 . . . . 74.31 108.739 177.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 270' ' ' GLU . . . . . 0.583 ' HB3' HD21 ' B' ' 266' ' ' ASN . 8.6 pt-20 46.76 -72.52 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.052 0 C-N-CA 127.363 2.265 . . . . 72.41 114.966 -177.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 271' ' ' ALA . . . . . . . . . . . . . . . -70.2 79.37 0.52 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.934 0.893 . . . . 75.3 111.195 -178.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 272' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -125.62 -63.9 1.1 Allowed 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 107.802 -1.184 . . . . 54.14 107.802 177.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 46.6 mm-40 47.98 -86.05 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 126.542 1.937 . . . . 61.32 114.319 170.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 67.3 126.01 0.02 OUTLIER 'General case' 0 C--N 1.363 1.18 0 C-N-CA 125.265 1.426 . . . . 71.44 111.171 -176.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 275' ' ' LYS . . . . . 0.406 ' HB3' ' NZ ' ' B' ' 275' ' ' LYS . 0.0 OUTLIER 64.84 93.63 0.06 OUTLIER Pre-proline 0 CA--C 1.567 1.618 0 C-N-CA 123.896 0.879 . . . . 71.33 110.294 177.194 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -83.98 3.04 7.88 Favored 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 122.642 2.228 . . . . 62.35 113.245 175.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 277' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -72.74 116.12 12.85 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 122.997 0.519 . . . . 63.32 110.084 -179.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -54.5 -50.98 66.51 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 124.081 0.953 . . . . 62.0 112.104 176.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . 139.28 -99.67 0.27 Allowed Glycine 0 C--N 1.342 0.883 0 N-CA-C 110.92 -0.872 . . . . 75.43 110.92 -171.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.81 -37.38 0.37 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 122.9 0.48 . . . . 53.23 111.542 -178.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 281' ' ' PHE . . . . . 0.4 ' CE1' ' HB3' ' B' ' 250' ' ' GLN . 76.0 t80 63.19 -87.07 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.359 1.064 . . . . 75.31 109.978 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . 60.01 27.65 17.09 Favored 'General case' 0 CA--C 1.565 1.556 0 N-CA-C 115.401 1.63 . . . . 65.41 115.401 168.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -86.02 -52.04 5.96 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.997 -0.439 . . . . 72.33 111.619 -177.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . -78.5 71.98 2.43 Favored Glycine 0 C--N 1.35 1.329 0 CA-C-N 115.571 -0.74 . . . . 61.45 112.85 -173.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 7.0 t30 57.88 91.19 0.04 OUTLIER 'General case' 0 C--N 1.358 0.978 0 C-N-CA 125.058 1.343 . . . . 72.41 111.545 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 286' ' ' MET . . . . . 0.564 ' HG3' ' HD3' ' B' ' 289' ' ' ARG . 44.8 tpp -157.05 68.36 4.3 Favored Pre-proline 0 CA--C 1.555 1.162 0 N-CA-C 109.2 -0.667 . . . . 64.1 109.2 -178.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 287' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -76.87 -68.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.385 2.451 0 C-N-CA 122.549 2.166 . . . . 73.33 112.322 -176.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 288' ' ' VAL . . . . . . . . . . . . . 27.0 m -88.75 20.93 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 123.65 0.78 . . . . 74.32 111.07 176.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 289' ' ' ARG . . . . . 0.564 ' HD3' ' HG3' ' B' ' 286' ' ' MET . 25.2 mmt85 59.6 84.34 0.12 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.155 1.382 . . . . 72.14 111.343 173.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 290' ' ' TRP . . . . . . . . . . . . . 64.6 m95 72.02 118.44 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 125.85 1.66 . . . . 75.34 110.5 -177.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 291' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -153.38 126.79 8.62 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 109.868 -0.419 . . . . 64.34 109.868 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . 63.69 -151.6 48.9 Favored Glycine 0 C--N 1.35 1.308 0 O-C-N 124.091 0.87 . . . . 62.12 113.649 174.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -92.52 15.47 1.52 Allowed 'Trans proline' 0 CA--C 1.556 1.577 0 C-N-CA 123.281 2.654 . . . . 51.12 113.272 177.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 63.0 tttp 70.31 -74.83 0.08 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.911 1.284 . . . . 41.23 112.685 177.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -61.45 -39.28 90.29 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 112.911 0.708 . . . . 34.32 112.911 -172.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 6.2 t 47.57 -178.97 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 126.446 1.898 . . . . 65.42 113.266 -176.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 20.6 t80 41.06 84.43 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 125.778 1.631 . . . . 64.12 113.447 165.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 77.38 -57.2 0.51 Allowed 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 125.731 1.612 . . . . 71.5 111.991 -178.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . -62.99 -30.36 77.18 Favored Glycine 0 C--N 1.354 1.549 0 O-C-N 123.282 0.364 . . . . 63.41 112.854 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 66.07 -74.3 0.06 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.741 1.616 . . . . 72.23 111.902 177.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 301' ' ' ILE . . . . . 0.431 HG23 ' HB2' ' B' ' 303' ' ' LYS . 17.0 tt -145.77 145.21 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 123.124 0.57 . . . . 72.24 110.857 -177.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -79.91 56.21 2.28 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.823 0.849 . . . . 63.41 109.047 171.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 303' ' ' LYS . . . . . 0.431 ' HB2' HG23 ' B' ' 301' ' ' ILE . 11.4 tmtt? -80.19 108.1 8.61 Favored Pre-proline 0 CA--C 1.549 0.916 0 N-CA-C 108.733 -0.84 . . . . 74.11 108.733 -175.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 304' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -87.66 -162.82 0.15 Allowed 'Trans proline' 0 C--N 1.375 1.929 0 C-N-CA 122.681 2.254 . . . . 75.12 111.311 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -63.94 -36.95 85.63 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 122.808 0.443 . . . . 42.33 110.518 172.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 61.8 t 62.71 -76.16 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 125.554 1.542 . . . . 72.33 110.493 -176.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 38.4 m -78.13 103.68 8.23 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.983 0.913 . . . . 74.23 109.462 177.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 308' ' ' CYS . . . . . . . . . . . . . 48.4 t -82.46 -6.63 59.42 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.286 0.634 . . . . 74.22 110.47 175.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 19.6 m -68.12 118.61 60.48 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 124.242 1.017 . . . . 72.2 109.936 173.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -60.51 -46.33 17.99 Favored 'Trans proline' 0 C--N 1.382 2.327 0 C-N-CA 122.573 2.182 . . . . 63.14 111.841 177.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 311' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -163.31 150.86 11.02 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 124.073 0.949 . . . . 73.13 109.538 177.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 312' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -77.51 148.58 26.42 Favored 'Trans proline' 0 C--N 1.377 2.054 0 C-N-CA 122.414 2.076 . . . . 70.14 111.689 175.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 313' ' ' GLN . . . . . . . . . . . . . 26.7 mp0 -79.18 120.11 23.22 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 122.982 0.513 . . . . 75.13 110.252 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 314' ' ' ARG . . . . . . . . . . . . . 2.6 ppt_? -73.98 84.72 1.76 Allowed 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 122.978 0.511 . . . . 72.01 110.823 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 315' ' ' ASN . . . . . . . . . . . . . 7.2 t30 70.33 -74.53 0.08 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.864 1.266 . . . . 72.12 110.22 -175.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 316' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -95.1 -166.77 1.51 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.922 0.889 . . . . 74.4 110.546 -178.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 4.5 m -90.42 -68.28 0.79 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.526 0.731 . . . . 75.41 111.695 -177.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 318' ' ' VAL . . . . . 0.417 ' H ' ' HD2' ' B' ' 319' ' ' PRO . 62.4 t -130.52 -62.87 0.02 OUTLIER Pre-proline 0 CA--C 1.567 1.629 0 CA-C-O 118.414 -0.803 . . . . 73.13 112.664 -164.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 319' ' ' PRO . . . . . 0.417 ' HD2' ' H ' ' B' ' 318' ' ' VAL . 76.4 Cg_endo -70.7 -12.0 30.45 Favored 'Trans proline' 0 C--N 1.386 2.528 0 C-N-CA 121.802 1.668 . . . . 65.1 114.514 -165.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 320' ' ' THR . . . . . . . . . . . . . 7.9 m 62.91 76.34 0.37 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.599 1.16 . . . . 53.31 109.73 -175.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 321' ' ' LEU . . . . . . . . . . . . . 28.0 tp -140.77 76.56 1.56 Allowed 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 116.007 -0.542 . . . . 65.14 110.925 -170.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 322' ' ' ALA . . . . . . . . . . . . . . . 63.29 -75.56 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 125.775 1.63 . . . . 64.54 114.743 166.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 323' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -96.99 178.32 5.32 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.677 0.791 . . . . 74.02 110.488 -175.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 324' ' ' MET . . . . . 0.423 ' SD ' ' N ' ' B' ' 324' ' ' MET . 1.4 mpt? -71.51 90.85 1.02 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 109.256 -0.646 . . . . 71.32 109.256 177.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 325' ' ' THR . . . . . . . . . . . . . 50.2 p -55.78 -35.87 66.73 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.155 0.982 . . . . 72.33 113.058 -172.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 326' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -161.36 -94.64 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.52 0.328 . . . . 72.01 110.336 176.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -82.91 101.3 10.93 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.774 -0.578 . . . . 54.34 110.197 -177.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 328' ' ' ALA . . . . . . . . . . . . . . . -82.72 -26.37 32.05 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 115.596 -0.729 . . . . 72.03 109.975 169.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 329' ' ' ILE . . . . . 0.426 HG13 ' HB2' ' B' ' 54' ' ' ALA . 0.2 OUTLIER -136.91 161.04 36.52 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 C-N-CA 124.834 1.254 . . . . 73.5 109.083 -179.618 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 330' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -82.03 -43.35 18.06 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.903 -0.589 . . . . 63.42 110.885 174.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 331' ' ' LEU . . . . . 0.439 HD11 ' HD2' ' C' ' 234' ' ' ARG . 19.5 tp -168.54 172.03 8.47 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.32 0.648 . . . . 63.34 109.897 -167.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -65.17 114.13 4.45 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 123.989 0.916 . . . . 74.41 110.089 173.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 333' ' ' SER . . . . . . . . . . . . . 35.6 t -100.12 176.62 5.34 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.546 0.738 . . . . 65.04 110.274 175.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 334' ' ' LYS . . . . . 0.411 ' HZ2' ' HB3' ' B' ' 334' ' ' LYS . 0.0 OUTLIER -137.16 -14.66 1.53 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.54 0.736 . . . . 63.11 110.088 -173.619 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 335' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -83.82 59.51 5.25 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.657 0.783 . . . . 73.25 112.1 -168.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -174.52 -72.68 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.339 1.456 . . . . 61.02 107.201 171.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 337' ' ' LYS . . . . . . . . . . . . . 85.8 tttt 56.1 -81.69 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 125.392 1.477 . . . . 62.43 112.472 175.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 338' ' ' GLY . . . . . . . . . . . . . . . -178.54 -163.13 29.35 Favored Glycine 0 C--O 1.243 0.712 0 N-CA-C 109.817 -1.313 . . . . 72.34 109.817 -176.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 339' ' ' PHE . . . . . . . . . . . . . 40.0 t80 58.05 38.42 26.64 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.603 0.716 . . . . 74.33 109.69 176.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 340' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 63.02 -78.77 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 125.43 1.492 . . . . 75.24 110.304 -169.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 341' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -166.96 -79.15 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 105.339 -2.097 . . . . 75.34 105.339 170.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 342' ' ' GLN . . . . . 0.401 ' HA ' ' HB3' ' B' ' 347' ' ' SER . 49.6 mt-30 58.97 179.98 0.08 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 125.201 1.401 . . . . 64.25 112.829 175.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 343' ' ' VAL . . . . . 0.448 HG13 ' H ' ' B' ' 344' ' ' GLU 0.255 6.9 p 47.94 -70.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.467 0 C-N-CA 126.705 2.002 . . . . 64.24 114.215 -179.905 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 344' ' ' GLU . . . . . 0.448 ' H ' HG13 ' B' ' 343' ' ' VAL . 36.6 tt0 -64.37 -40.0 94.97 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.039 0.936 . . . . 73.03 110.25 173.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 345' ' ' GLY . . . . . . . . . . . . . . . -90.13 153.51 22.96 Favored Glycine 0 C--N 1.346 1.096 0 N-CA-C 111.1 -0.8 . . . . 62.31 111.1 174.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 346' ' ' ALA . . . . . . . . . . . . . . . -74.77 86.44 2.2 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.245 0.545 . . . . 72.22 110.622 -178.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 347' ' ' SER . . . . . 0.401 ' HB3' ' HA ' ' B' ' 342' ' ' GLN . 11.1 p -87.19 29.1 0.87 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.139 0.976 . . . . 72.21 112.079 -178.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 2.3 mp 60.91 -76.56 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.098 0 C-N-CA 125.332 1.453 . . . . 73.42 109.543 -174.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 349' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -75.46 140.47 42.89 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 120.982 0.42 . . . . 71.13 110.107 172.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 350' ' ' LYS . . . . . 0.425 ' HE3' ' HB2' ' B' ' 350' ' ' LYS . 30.2 mtmt -110.49 105.05 13.87 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 124.557 1.143 . . . . 74.52 108.571 -173.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -70.73 81.44 0.62 Allowed 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.232 0.613 . . . . 71.32 110.336 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -175.71 37.38 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.585 1.154 . . . . 74.35 108.29 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 353' ' ' HIS . . . . . . . . . . . . . 4.9 p80 63.58 -17.45 0.06 Allowed 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 127.499 2.32 . . . . 74.33 115.156 178.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 354' ' ' ALA . . . . . . . . . . . . . . . 52.41 -90.77 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.468 1.107 . . . . 70.11 111.909 -174.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 355' ' ' ALA . . . . . . . . . . . . . . . -116.42 -80.26 0.6 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.543 0.737 . . . . 75.44 109.152 177.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 356' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -164.91 61.58 0.83 Allowed Pre-proline 0 N--CA 1.485 1.315 0 C-N-CA 123.113 0.565 . . . . 74.32 111.347 178.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 357' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.4 -31.43 11.4 Favored 'Trans proline' 0 C--N 1.38 2.222 0 C-N-CA 122.476 2.117 . . . . 55.22 112.97 -177.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 358' ' ' CYS . . . . . . . . . . . . . 67.8 m -78.17 130.62 36.56 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 109.566 -0.531 . . . . 73.32 109.566 177.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 359' ' ' GLY . . . . . . . . . . . . . . . -82.44 55.04 4.96 Favored Glycine 0 C--N 1.347 1.18 0 O-C-N 123.585 0.553 . . . . 62.01 112.555 -179.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 360' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -81.13 128.04 33.31 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.727 0.811 . . . . 53.34 109.159 -179.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 361' ' ' ILE . . . . . . . . . . . . . 58.0 mt -69.66 91.3 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 N-CA-C 107.769 -1.197 . . . . 61.31 107.769 171.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 362' ' ' GLY . . . . . . . . . . . . . . . 73.34 -157.6 52.16 Favored Glycine 0 C--N 1.348 1.205 0 CA-C-N 115.6 -0.727 . . . . 72.35 111.29 -167.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 363' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 62.57 15.41 7.9 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 125.081 1.352 . . . . 73.13 111.433 174.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 364' ' ' THR . . . . . 0.431 HG21 HD12 ' B' ' 367' ' ' LEU . 1.3 m -82.51 10.5 7.15 Favored 'General case' 0 CA--C 1.562 1.424 0 C-N-CA 123.44 0.696 . . . . 74.04 111.064 -174.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 49.1 t 70.44 -75.01 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.361 1.069 0 C-N-CA 126.431 1.892 . . . . 74.01 110.845 173.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -73.65 -42.14 61.78 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.752 0.821 . . . . 50.12 111.611 -177.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 367' ' ' LEU . . . . . 0.431 HD12 HG21 ' B' ' 364' ' ' THR . 64.0 mt -74.52 -77.95 0.11 Allowed 'General case' 0 CA--C 1.546 0.8 0 O-C-N 123.307 0.379 . . . . 75.05 110.441 -176.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 368' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -142.25 158.79 43.33 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.151 0.58 . . . . 71.23 111.006 -173.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 369' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -99.1 -80.52 0.46 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.372 1.069 . . . . 70.1 110.298 175.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 370' ' ' ALA . . . . . . . . . . . . . . . -179.19 -60.71 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 108.611 -0.885 . . . . 74.25 108.611 -177.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 371' ' ' VAL . . . . . . . . . . . . . 65.6 t -102.24 -58.44 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 115.119 -0.946 . . . . 74.11 109.291 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 372' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 71.15 -16.23 0.37 Allowed 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 125.299 1.44 . . . . 63.2 114.329 176.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 373' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -74.0 86.31 1.81 Allowed 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 108.695 -0.854 . . . . 72.05 108.695 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . 61.63 18.08 9.22 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.661 0.784 . . . . 71.45 112.628 -178.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 375' ' ' LEU . . . . . . . . . . . . . 46.9 tp 69.51 150.17 0.08 Allowed 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 125.799 1.64 . . . . 62.01 111.659 -172.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -84.18 135.33 34.41 Favored 'General case' 0 CA--C 1.559 1.31 0 C-N-CA 124.232 1.013 . . . . 73.13 109.254 175.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 377' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -132.79 68.62 1.5 Allowed 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.684 0.794 . . . . 73.31 109.741 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 378' ' ' ALA . . . . . 0.429 ' HB3' ' HA ' ' B' ' 383' ' ' ASN . . . 56.54 -74.76 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 125.512 1.525 . . . . 61.1 113.407 177.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . 0.484 ' HA ' ' HB3' ' B' ' 400' ' ' ALA . 0.2 OUTLIER -84.57 4.57 31.51 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 124.011 0.924 . . . . 72.01 110.632 171.681 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 380' ' ' LYS . . . . . . . . . . . . . 26.2 tptp 73.88 -63.03 0.44 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.226 1.81 . . . . 53.14 111.567 -172.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 381' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -65.54 -36.76 84.73 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.969 0.908 . . . . 74.34 112.279 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 382' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' B' ' 379' ' ' LYS . . . -155.29 122.89 1.27 Allowed Glycine 0 C--N 1.346 1.115 0 N-CA-C 110.926 -0.87 . . . . 73.1 110.926 -178.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 383' ' ' ASN . . . . . 0.429 ' HA ' ' HB3' ' B' ' 378' ' ' ALA . 2.4 p-10 -57.65 -66.82 0.4 Allowed 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.577 0.751 . . . . 73.1 112.502 -175.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 384' ' ' THR . . . . . 0.407 ' HB ' ' H ' ' B' ' 385' ' ' LEU . 1.8 p -160.53 -162.85 1.0 Allowed 'General case' 0 C--O 1.246 0.879 0 C-N-CA 125.359 1.464 . . . . 63.41 107.692 -174.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 385' ' ' LEU . . . . . 0.454 ' HB3' ' OE1' ' B' ' 432' ' ' GLN . 4.0 mm? 67.28 -173.19 0.19 Allowed 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 124.443 1.097 . . . . 75.12 111.549 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 386' ' ' VAL . . . . . 0.684 HG22 ' HB3' ' B' ' 391' ' ' ASP . 25.1 t -76.78 88.5 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 123.16 0.584 . . . . 62.42 110.159 -177.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 387' ' ' ILE . . . . . . . . . . . . . 8.6 tp -78.4 125.15 37.74 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 N-CA-C 109.557 -0.535 . . . . 74.12 109.557 178.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 388' ' ' VAL . . . . . . . . . . . . . 61.2 t 64.79 -73.84 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 125.653 1.581 . . . . 54.33 111.34 -174.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 389' ' ' THR . . . . . . . . . . . . . 14.5 t -155.74 9.7 0.27 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 122.713 0.405 . . . . 71.25 111.516 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . -144.83 126.8 15.47 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 122.816 0.446 . . . . 70.34 110.522 -176.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 391' ' ' ASP . . . . . 0.684 ' HB3' HG22 ' B' ' 386' ' ' VAL . 5.1 p-10 -85.49 -29.85 23.94 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.617 0.767 . . . . 64.12 110.746 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 392' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 65.25 -82.15 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.067 1.347 . . . . 72.42 112.005 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -158.55 -158.53 0.71 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.941 0.896 . . . . 61.53 109.008 -172.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -57.53 -59.82 4.59 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 109.663 -0.495 . . . . 73.31 109.663 172.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . -69.94 90.72 0.63 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 107.543 -1.28 . . . . 71.44 107.543 166.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 23.9 t -56.44 -29.79 62.07 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.502 1.121 . . . . 75.55 111.565 -175.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 397' ' ' GLN . . . . . 0.599 HE22 ' HB ' ' B' ' 399' ' ' VAL . 0.6 OUTLIER -131.04 144.17 51.25 Favored 'General case' 0 CA--C 1.556 1.175 0 N-CA-C 105.706 -1.961 . . . . 71.41 105.706 169.482 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 8.4 tp -65.9 -42.77 92.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 112.587 0.588 . . . . 75.44 112.587 -167.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 399' ' ' VAL . . . . . 0.599 ' HB ' HE22 ' B' ' 397' ' ' GLN . 79.4 t -64.08 145.53 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 123.449 0.7 . . . . 73.32 110.945 -178.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 400' ' ' ALA . . . . . 0.484 ' HB3' ' HA ' ' B' ' 379' ' ' LYS . . . 72.41 113.66 0.03 OUTLIER Pre-proline 0 C--N 1.357 0.905 0 O-C-N 124.967 1.417 . . . . 51.41 110.47 -178.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 401' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' B' ' 400' ' ' ALA . 11.1 Cg_exo -73.1 35.39 0.35 Allowed 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 123.494 2.796 . . . . 71.04 114.42 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 402' ' ' ASP . . . . . 0.575 ' HB3' ' HB3' ' B' ' 405' ' ' ALA . 2.3 m-20 80.36 -10.86 1.21 Allowed 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 125.898 1.679 . . . . 74.34 113.57 169.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 403' ' ' THR . . . . . 0.677 HG22 ' HG3' ' B' ' 404' ' ' LYS . 20.1 m 58.23 -81.16 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.261 0 C-N-CA 124.999 1.32 . . . . 51.3 111.992 -177.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 404' ' ' LYS . . . . . 0.677 ' HG3' HG22 ' B' ' 403' ' ' THR . 66.1 mttm -123.58 17.44 9.61 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.044 0.938 . . . . 70.03 111.285 -175.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 405' ' ' ALA . . . . . 0.575 ' HB3' ' HB3' ' B' ' 402' ' ' ASP . . . -107.92 93.84 11.48 Favored Pre-proline 0 N--CA 1.484 1.245 0 C-N-CA 122.932 0.493 . . . . 71.24 110.768 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 406' ' ' PRO . . . . . 0.419 ' HD3' ' O ' ' B' ' 404' ' ' LYS . 8.7 Cg_exo -74.54 -27.27 11.1 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 122.939 2.426 . . . . 44.44 111.302 172.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . -134.74 -119.07 1.91 Allowed Glycine 0 C--N 1.345 1.064 0 N-CA-C 111.153 -0.779 . . . . 55.33 111.153 175.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 408' ' ' LEU . . . . . . . . . . . . . 83.0 mt 70.04 5.3 5.21 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 125.053 1.341 . . . . 72.03 111.642 -175.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 11.0 t -77.71 -172.68 2.7 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 123.52 0.728 . . . . 73.52 111.716 -171.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 410' ' ' GLN . . . . . 0.488 ' NE2' ' HB2' ' B' ' 391' ' ' ASP . 0.9 OUTLIER -78.55 80.3 4.93 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 124.274 1.03 . . . . 51.32 109.467 -175.019 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . -71.77 146.63 47.96 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.187 -0.915 . . . . 63.14 109.962 177.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 73.2 mt -76.73 72.3 3.35 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.147 0.579 . . . . 60.41 109.724 -177.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 169.17 -44.8 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 126.237 1.815 . . . . 71.14 107.355 -173.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 414' ' ' THR . . . . . . . . . . . . . 55.8 m -64.01 137.06 57.82 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 114.655 -1.157 . . . . 73.24 111.265 178.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 415' ' ' LYS . . . . . 0.499 ' HE3' ' NE2' ' B' ' 432' ' ' GLN . 15.8 tptp 65.41 41.92 4.06 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.964 1.306 . . . . 73.42 110.593 176.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -74.6 84.78 2.07 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 114.994 -1.003 . . . . 75.33 110.82 -177.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 417' ' ' GLY . . . . . . . . . . . . . . . 50.4 67.8 1.72 Allowed Glycine 0 C--N 1.355 1.611 0 C-N-CA 124.232 0.92 . . . . 43.15 115.079 168.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 418' ' ' ALA . . . . . . . . . . . . . . . -66.82 -40.42 88.02 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.092 0.557 . . . . 70.25 110.626 177.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 419' ' ' VAL . . . . . . . . . . . . . 8.9 p -121.57 -27.04 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 C-N-CA 124.142 0.977 . . . . 62.03 109.657 173.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 420' ' ' MET . . . . . . . . . . . . . 16.6 tpt 79.62 -40.75 0.22 Allowed 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 125.968 1.707 . . . . 73.12 112.89 173.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 421' ' ' VAL . . . . . 0.458 ' HB ' ' HB3' ' B' ' 426' ' ' ASN . 4.1 t 59.0 67.47 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.097 0 C-N-CA 124.516 1.126 . . . . 72.42 109.761 -175.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 422' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -83.64 2.44 37.49 Favored 'General case' 0 N--CA 1.486 1.325 0 CA-C-N 115.002 -0.999 . . . . 74.1 111.619 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 423' ' ' SER . . . . . . . . . . . . . 6.7 m -55.6 -36.22 66.7 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.163 1.385 . . . . 62.22 112.512 -176.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 424' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -145.78 18.14 1.46 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.67 0.788 . . . . 72.42 110.453 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . 64.7 70.67 1.02 Allowed Glycine 0 C--N 1.351 1.393 0 CA-C-N 116.11 -0.495 . . . . 75.12 112.087 -176.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 426' ' ' ASN . . . . . 0.458 ' HB3' ' HB ' ' B' ' 421' ' ' VAL . 28.1 t-20 -101.91 -32.13 10.36 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.682 0.793 . . . . 75.43 111.137 -177.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 427' ' ' SER . . . . . . . . . . . . . 27.4 m 65.73 29.05 10.89 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.485 1.114 . . . . 75.14 111.997 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 428' ' ' GLU . . . . . 0.407 ' HG3' ' HA ' ' B' ' 432' ' ' GLN . 30.1 tt0 66.47 86.7 0.13 Allowed 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 124.779 1.232 . . . . 73.23 111.128 175.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 429' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -157.41 -35.31 0.08 Allowed 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 114.187 -1.37 . . . . 63.42 110.086 -172.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -49.81 -45.81 50.36 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.697 1.199 . . . . 55.41 111.835 -177.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 18.0 p -164.74 20.98 0.06 Allowed 'General case' 0 C--O 1.237 0.427 0 CA-C-N 114.694 -1.139 . . . . 73.31 109.392 176.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 432' ' ' GLN . . . . . 0.499 ' NE2' ' HE3' ' B' ' 415' ' ' LYS . 27.8 mt-30 58.31 -79.92 0.02 OUTLIER 'General case' 0 C--N 1.362 1.15 0 C-N-CA 124.422 1.089 . . . . 71.1 110.044 -165.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 433' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -84.3 71.92 10.61 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.046 0.938 . . . . 73.43 108.696 -178.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 434' ' ' HIS . . . . . . . . . . . . . 55.0 t60 -63.84 96.84 0.14 Allowed 'General case' 0 C--N 1.35 0.616 0 N-CA-C 108.109 -1.071 . . . . 65.13 108.109 176.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 435' ' ' THR . . . . . . . . . . . . . 29.4 m -74.19 82.04 1.82 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 122.04 0.924 . . . . 73.42 109.49 -178.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . -133.85 11.04 4.85 Favored Glycine 0 C--N 1.339 0.747 0 CA-C-N 113.799 -1.546 . . . . 43.54 111.008 176.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 46.8 t -107.42 -52.68 2.73 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.922 0.889 . . . . 54.14 109.288 179.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 438' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 37.03 -77.1 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.323 0 C-N-CA 126.686 1.995 . . . . 71.55 114.406 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 439' ' ' LEU . . . . . 0.518 HD11 ' HD2' ' A' ' 238' ' ' LYS . 49.0 tp 70.4 101.84 0.06 Allowed 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.571 1.148 . . . . 74.24 111.684 173.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 440' ' ' ARG . . . . . 0.454 ' N ' ' HD2' ' B' ' 440' ' ' ARG . 5.8 mpt_? -84.6 121.59 27.84 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 109.047 -0.723 . . . . 70.1 109.047 -176.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 441' ' ' ILE . . . . . 0.585 HG21 ' HB3' ' A' ' 233' ' ' LEU . 62.3 mt -76.26 -52.64 17.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 123.346 0.658 . . . . 74.15 109.981 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 442' ' ' ALA . . . . . . . . . . . . . . . 61.5 23.58 13.83 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.649 1.18 . . . . 71.41 112.42 177.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . -70.72 -46.77 62.45 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.244 0.618 . . . . 74.21 110.667 176.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -95.43 104.69 16.6 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.284 -0.871 . . . . 65.34 110.111 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . 174.94 54.4 0.05 OUTLIER Glycine 0 CA--C 1.531 1.057 0 CA-C-N 115.286 -0.87 . . . . 74.34 111.159 170.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 446' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -69.86 -50.1 0.49 Allowed 'Trans proline' 0 C--N 1.386 2.55 0 C-N-CA 122.719 2.28 . . . . 63.02 112.406 -168.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 447' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -163.42 124.16 2.3 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 108.089 -1.078 . . . . 60.0 108.089 178.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . -108.26 73.44 0.88 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.46 0.704 . . . . 74.31 109.849 -179.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 449' ' ' ALA . . . . . . . . . . . . . . . 57.93 -166.83 0.14 Allowed 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.417 1.087 . . . . 61.52 112.275 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 450' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -128.74 149.72 50.58 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 108.814 -0.81 . . . . 61.12 108.814 175.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 11.9 p -76.28 -0.05 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.589 0 C-N-CA 124.742 1.217 . . . . 63.1 111.834 -176.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 452' ' ' VAL . . . . . . . . . . . . . 29.6 m -74.04 82.49 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.22 0 CA-C-O 122.713 1.244 . . . . 60.45 111.656 176.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . -140.65 -86.59 0.11 Allowed Glycine 0 C--N 1.339 0.718 0 CA-C-N 114.695 -1.139 . . . . 73.44 110.97 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 454' ' ' LEU . . . . . . . . . . . . . 83.5 mt 58.84 90.68 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.727 1.211 . . . . 72.5 110.186 -177.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 74.3 p -78.68 18.16 0.62 Allowed 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 124.042 0.937 . . . . 61.41 112.951 -170.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -106.85 139.07 41.85 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.04 0.936 . . . . 74.3 109.165 171.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 457' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 62.28 13.98 6.38 Favored 'General case' 0 CA--C 1.567 1.615 0 C-N-CA 124.76 1.224 . . . . 42.14 111.24 -176.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 9.9 t -71.19 -16.13 62.5 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 124.707 1.203 . . . . 72.13 111.518 -176.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 459' ' ' ASP . . . . . . . . . . . . . 26.2 t70 71.69 -64.84 0.37 Allowed 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 126.046 1.739 . . . . 73.31 111.137 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 460' ' ' LEU . . . . . 0.581 HD23 ' HA ' ' B' ' 464' ' ' MET . 33.9 tp -62.12 154.49 26.95 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.747 0.819 . . . . 65.42 110.629 175.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -57.39 95.46 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 124.502 1.121 . . . . 62.31 111.569 -175.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 35.7 t80 67.61 -79.04 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 125.412 1.485 . . . . 72.53 111.886 175.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 10.0 t -119.74 162.36 19.19 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.216 0.606 . . . . 61.35 110.843 -178.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 464' ' ' MET . . . . . 0.581 ' HA ' HD23 ' B' ' 460' ' ' LEU . 0.0 OUTLIER -86.66 173.89 9.22 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 108.871 -0.788 . . . . 75.31 108.871 175.377 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 465' ' ' LYS . . . . . 0.543 ' N ' ' SD ' ' B' ' 464' ' ' MET . 68.3 mttm -56.55 93.46 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.709 0.804 . . . . 72.15 110.719 173.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -135.53 -38.34 0.74 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.157 0.983 . . . . 62.32 108.66 175.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . -131.67 20.75 4.66 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.101 -0.954 . . . . 75.3 109.755 173.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 94.5 mt -127.11 122.85 35.4 Favored 'General case' 0 C--O 1.246 0.91 0 C-N-CA 124.055 0.942 . . . . 45.51 109.579 -177.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 469' ' ' GLY . . . . . . . . . . . . . . . -133.14 -131.54 3.18 Favored Glycine 0 C--N 1.345 1.044 0 N-CA-C 110.866 -0.894 . . . . 50.44 110.866 173.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 470' ' ' LEU . . . . . . . . . . . . . 53.1 tp -165.67 142.22 5.37 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.692 1.197 . . . . 73.2 108.34 175.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 471' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.555 1.144 0 N-CA-C 107.017 -1.475 . . . . 74.2 107.017 175.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 85.7 mtp . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 119.559 -0.257 . . . . 55.23 111.302 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.13 41.91 19.71 Favored 'General case' 0 C--N 1.355 0.823 0 C-N-CA 124.474 1.11 . . . . 65.31 110.899 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.74 -5.02 0.51 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 114.673 1.36 . . . . 52.01 114.673 -171.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 4.4 ttmp? 46.36 78.46 0.07 Allowed 'General case' 0 C--O 1.244 0.773 0 C-N-CA 125.93 1.692 . . . . 70.52 113.385 178.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -78.42 111.1 14.08 Favored 'General case' 0 C--O 1.246 0.882 0 N-CA-C 107.614 -1.254 . . . . 63.2 107.614 165.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 6' ' ' ASP . . . . . 0.49 ' HA ' ' OH ' ' C' ' 66' ' ' TYR . 13.9 t70 -64.73 113.35 3.72 Favored 'General case' 0 C--N 1.345 0.41 0 O-C-N 123.679 0.612 . . . . 63.22 109.837 177.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 7' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -63.83 -31.6 72.84 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 114.893 -1.049 . . . . 73.43 111.535 -176.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -64.76 -39.71 94.08 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 116.322 -0.399 . . . . 72.53 110.462 174.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.93 -41.5 86.94 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.25 0.62 . . . . 52.31 111.166 176.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 61.3 mt -58.57 -40.15 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 122.988 0.515 . . . . 63.34 110.433 178.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 94.0 mt -83.8 -12.62 55.39 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 112.606 0.595 . . . . 45.45 112.606 177.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.36 22.67 78.8 Favored Glycine 0 CA--C 1.535 1.33 0 N-CA-C 114.196 0.438 . . . . 64.33 114.196 -178.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 14.1 m -104.47 152.76 39.39 Favored Pre-proline 0 N--CA 1.482 1.136 0 C-N-CA 123.916 0.886 . . . . 64.04 110.337 177.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -64.0 157.95 50.24 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.542 2.162 . . . . 74.43 112.436 173.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 71.0 mtt180 -77.47 22.3 0.24 Allowed 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 123.508 0.723 . . . . 71.52 112.262 -179.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -120.9 8.79 10.53 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.965 1.306 . . . . 71.24 108.333 173.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.41 133.92 50.47 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 123.671 0.788 . . . . 71.14 111.328 -178.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 53.0 p -104.24 -176.11 2.99 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.564 1.146 . . . . 74.41 109.993 -178.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -48.41 -52.3 22.64 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 124.623 1.169 . . . . 74.45 112.184 -171.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.79 -48.4 63.73 Favored 'General case' 0 C--O 1.212 -0.912 0 O-C-N 123.746 0.654 . . . . 64.05 109.943 -172.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -63.93 -38.98 93.07 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.003 0.921 . . . . 73.42 111.562 -174.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 22' ' ' ILE . . . . . 0.816 HD13 ' HB3' ' C' ' 57' ' ' LEU . 78.3 mt -67.9 -50.3 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 123.977 0.911 . . . . 61.32 110.325 175.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -66.3 -22.31 66.29 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.195 -0.912 . . . . 74.13 110.017 -178.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 -74.05 -48.4 30.19 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.088 1.355 . . . . 73.52 110.035 176.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.39 -38.35 80.28 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 123.925 0.765 . . . . 75.32 110.678 175.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 26' ' ' TYR . . . . . 0.479 ' HE1' ' ND2' ' C' ' 51' ' ' ASN . 54.4 t80 -58.96 -62.52 1.82 Allowed 'General case' 0 C--O 1.208 -1.098 0 CA-C-N 115.097 -0.956 . . . . 72.31 109.857 173.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -50.33 -38.59 42.74 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 124.089 0.868 . . . . 74.1 111.582 -177.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 28' ' ' ARG . . . . . 0.405 ' HA ' ' NH2' ' C' ' 31' ' ' ARG . 59.5 ttt180 -57.95 -59.84 4.64 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.138 0.975 . . . . 71.15 110.957 176.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . 0.57 HD22 ' HE2' ' C' ' 33' ' ' TYR . 75.9 mt -76.98 -11.9 59.87 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 114.982 -1.008 . . . . 60.22 110.933 -176.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -88.83 -24.56 22.55 Favored 'General case' 0 C--O 1.213 -0.858 0 C-N-CA 124.131 0.973 . . . . 75.32 110.219 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . 0.405 ' NH2' ' HA ' ' C' ' 28' ' ' ARG . 45.3 mtm105 -85.12 -39.07 18.34 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.208 0.603 . . . . 73.5 110.204 171.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.72 -56.62 5.45 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 122.871 0.468 . . . . 71.12 110.196 -177.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 33' ' ' TYR . . . . . 0.57 ' HE2' HD22 ' C' ' 29' ' ' LEU . 50.1 m-85 -90.48 23.22 3.07 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 122.986 0.514 . . . . 70.15 111.438 -176.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 34' ' ' HIS . . . . . 0.404 ' HD2' ' HB3' ' C' ' 36' ' ' ASP . 20.6 t60 -68.99 109.1 3.72 Favored Pre-proline 0 N--CA 1.477 0.915 0 CA-C-O 118.265 -0.874 . . . . 72.34 110.114 -178.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 35' ' ' PRO . . . . . 0.505 ' HG3' ' HG2' ' C' ' 44' ' ' GLU . 76.9 Cg_exo -53.12 -25.38 29.04 Favored 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 123.663 2.909 . . . . 71.32 114.932 -173.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 36' ' ' ASP . . . . . 0.404 ' HB3' ' HD2' ' C' ' 34' ' ' HIS . 30.4 t70 -74.49 -35.74 63.25 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.508 0.723 . . . . 60.34 111.687 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 58.0 t -92.29 -56.01 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 109.336 -0.616 . . . . 75.33 109.336 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -100.62 92.17 4.99 Favored 'General case' 0 C--O 1.244 0.795 0 C-N-CA 125.098 1.359 . . . . 54.22 109.616 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.84 76.13 6.53 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.109 0.564 . . . . 62.24 109.722 -178.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . 0.463 ' O ' ' HG3' ' C' ' 44' ' ' GLU . 69.8 m -131.23 111.42 15.45 Favored Pre-proline 0 N--CA 1.475 0.777 0 CA-C-O 118.256 -0.878 . . . . 74.14 110.221 179.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -45.1 -40.88 16.1 Favored 'Trans proline' 0 C--N 1.383 2.388 0 C-N-CA 123.718 2.946 . . . . 63.44 113.397 174.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -53.41 -48.83 68.37 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.996 0.919 . . . . 65.44 110.229 175.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 43' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' C' ' 47' ' ' PHE . . . -72.01 -18.72 61.95 Favored 'General case' 0 C--O 1.212 -0.913 0 CA-C-N 113.655 -1.611 . . . . 62.05 111.393 -177.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 44' ' ' GLU . . . . . 0.505 ' HG2' ' HG3' ' C' ' 35' ' ' PRO . 44.1 mt-10 -88.43 -40.61 13.36 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.805 0.842 . . . . 74.04 111.139 -174.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -69.93 -40.85 75.27 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 109.974 -0.38 . . . . 42.53 109.974 173.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 46' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -66.43 -35.12 79.51 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.916 -0.584 . . . . 72.32 110.774 173.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 47' ' ' PHE . . . . . 0.468 ' HB2' ' O ' ' C' ' 43' ' ' ALA . 77.3 t80 -57.73 -44.63 86.13 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.364 0.666 . . . . 62.23 109.271 173.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -58.87 -46.46 87.76 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 122.878 0.471 . . . . 72.04 111.311 176.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -64.37 -32.27 73.81 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 120.719 0.295 . . . . 72.33 111.756 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 50' ' ' ILE . . . . . 0.536 HD13 ' HB3' ' C' ' 29' ' ' LEU . 80.5 mt -74.03 -31.81 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 124.148 0.979 . . . . 75.43 110.136 175.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 51' ' ' ASN . . . . . 0.479 ' ND2' ' HE1' ' C' ' 26' ' ' TYR . 0.9 OUTLIER -82.81 -14.65 54.0 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.04 0.936 . . . . 74.04 110.811 176.805 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -81.48 -50.32 9.55 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.288 1.435 . . . . 63.42 108.429 173.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.95 -40.35 76.26 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 113.276 -1.783 . . . . 63.1 110.567 174.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 54' ' ' TYR . . . . . 0.408 ' O ' ' HB2' ' C' ' 58' ' ' SER . 78.7 t80 -77.61 -33.97 53.57 Favored 'General case' 0 C--O 1.215 -0.72 0 CA-C-N 115.544 -0.753 . . . . 75.01 111.356 174.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 55' ' ' ALA . . . . . 0.713 ' HB1' ' HB3' ' C' ' 85' ' ' PHE . . . -51.01 -46.49 61.54 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.916 0.865 . . . . 60.54 110.266 178.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 47.2 t -76.71 -58.6 4.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-N 113.453 -1.703 . . . . 72.43 110.605 177.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 57' ' ' LEU . . . . . 0.816 ' HB3' HD13 ' C' ' 22' ' ' ILE . 69.6 mt -82.03 1.95 33.28 Favored 'General case' 0 CA--C 1.563 1.45 0 N-CA-C 114.465 1.283 . . . . 75.02 114.465 -166.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 58' ' ' SER . . . . . 0.408 ' HB2' ' O ' ' C' ' 54' ' ' TYR . 48.4 t -50.79 -56.45 12.05 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 124.262 1.025 . . . . 62.42 113.393 -173.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -123.79 150.42 62.05 Favored Pre-proline 0 C--O 1.252 1.207 0 CA-C-N 114.359 -1.291 . . . . 72.03 108.387 -171.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 60' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -47.19 -45.7 21.22 Favored 'Trans proline' 0 C--N 1.384 2.41 0 C-N-CA 123.761 2.974 . . . . 33.23 114.389 -169.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -58.15 -53.38 58.87 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.154 0.582 . . . . 62.13 112.365 -174.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -69.96 -37.24 75.76 Favored 'General case' 0 C--O 1.247 0.948 0 CA-C-N 115.602 -0.726 . . . . 75.23 110.821 -176.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 1.1 ppt_? -64.76 -35.85 82.4 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 115.847 -0.615 . . . . 64.42 109.601 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -73.82 -29.71 62.3 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.107 0.963 . . . . 74.15 111.198 177.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 82.6 mt -62.11 -43.68 98.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 109.57 -0.53 . . . . 62.34 109.57 172.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 66' ' ' TYR . . . . . 0.49 ' OH ' ' HA ' ' C' ' 6' ' ' ASP . 22.2 t80 -57.71 -50.82 71.93 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 116.145 -0.479 . . . . 74.22 110.094 173.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -58.45 -40.89 83.86 Favored 'General case' 0 N--CA 1.48 1.074 0 O-C-N 123.813 0.696 . . . . 73.14 112.182 -178.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 40.3 p -69.13 -22.27 63.96 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 119.604 -0.236 . . . . 63.2 110.722 178.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -81.69 142.17 32.94 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 108.678 -0.86 . . . . 75.22 108.678 166.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.72 22.05 62.62 Favored Glycine 0 C--N 1.345 1.071 0 N-CA-C 110.817 -0.913 . . . . 62.51 110.817 -174.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 61.5 m -145.54 -54.72 0.29 Allowed 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 103.045 -2.946 . . . . 72.34 103.045 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 47.3 m -83.41 142.26 31.12 Favored 'General case' 0 C--O 1.26 1.646 0 N-CA-C 105.214 -2.143 . . . . 73.35 105.214 157.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.32 -33.59 28.9 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.72 0.808 . . . . 73.23 111.022 177.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.16 152.89 71.63 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 123.741 0.817 . . . . 53.23 110.521 177.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -58.95 125.77 19.17 Favored 'Trans proline' 0 C--N 1.38 2.211 0 C-N-CA 122.638 2.226 . . . . 75.14 111.162 171.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -58.03 151.02 60.91 Favored 'Trans proline' 0 C--N 1.384 2.429 0 C-N-CA 123.323 2.682 . . . . 63.14 112.215 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -49.28 111.35 0.47 Allowed 'Trans proline' 0 C--N 1.387 2.556 0 C-N-CA 123.492 2.795 . . . . 51.51 113.347 -177.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 78' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.0 133.1 45.37 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.769 2.312 . . . . 74.44 112.493 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 79' ' ' PRO . . . . . 0.413 ' HA ' ' HD3' ' C' ' 80' ' ' PRO . 81.2 Cg_exo -50.16 124.45 12.88 Favored 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 122.399 2.066 . . . . 61.04 110.244 167.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 80' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' C' ' 79' ' ' PRO . 32.0 Cg_exo -65.68 37.81 0.13 Allowed 'Trans proline' 0 C--N 1.383 2.385 0 C-N-CA 124.741 3.627 . . . . 51.5 116.746 -172.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -163.24 -10.46 0.03 OUTLIER Glycine 0 CA--C 1.524 0.619 0 C-N-CA 123.51 0.576 . . . . 75.2 112.265 168.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 144.99 168.93 13.11 Favored Glycine 0 C--N 1.35 1.345 0 N-CA-C 114.384 0.513 . . . . 74.45 114.384 173.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -98.5 135.03 40.64 Favored 'General case' 0 C--O 1.219 -0.545 0 N-CA-C 106.744 -1.576 . . . . 70.14 106.744 171.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 84' ' ' ASP . . . . . 0.442 ' HB2' ' NE ' ' C' ' 143' ' ' ARG . 14.2 t70 -72.49 137.18 46.19 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 118.8 0.727 . . . . 63.13 112.333 -178.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 85' ' ' PHE . . . . . 0.713 ' HB3' ' HB1' ' C' ' 55' ' ' ALA . 6.8 p90 -164.49 48.46 0.11 Allowed 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.413 1.485 . . . . 74.41 109.09 170.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 86' ' ' SER . . . . . 0.67 ' HA ' ' HG2' ' C' ' 171' ' ' PRO . 68.2 m -63.38 122.89 17.32 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 115.223 -0.898 . . . . 45.43 112.056 -176.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.01 4.52 88.42 Favored Glycine 0 C--N 1.351 1.385 0 CA-C-N 115.29 -0.868 . . . . 74.33 113.401 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 88' ' ' PHE . . . . . 0.496 ' HB3' ' HZ ' ' C' ' 93' ' ' PHE . 11.7 m-85 -108.17 137.67 45.75 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 117.481 0.641 . . . . 74.44 109.579 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -79.92 78.75 6.52 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.52 0.676 . . . . 72.23 111.376 -173.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 90' ' ' VAL . . . . . . . . . . . . . 3.4 p -49.21 -34.83 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 125.478 1.511 . . . . 54.41 113.952 176.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.21 -19.99 64.8 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 123.152 0.581 . . . . 74.21 110.529 -174.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -110.91 16.05 21.46 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-O 121.01 0.433 . . . . 75.53 111.469 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 93' ' ' PHE . . . . . 0.496 ' HZ ' ' HB3' ' C' ' 88' ' ' PHE . 16.7 m-30 -89.13 166.29 13.94 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 109.797 -0.445 . . . . 72.45 109.797 172.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 80.6 p -65.53 164.62 13.71 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.683 0.793 . . . . 45.51 112.91 -170.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.14 -36.81 78.34 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 114.951 -1.022 . . . . 55.43 110.831 170.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -58.71 -45.67 89.01 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.189 0.996 . . . . 65.02 110.466 177.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 97' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -62.2 -45.63 92.5 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.936 -0.575 . . . . 64.25 109.661 176.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -81.05 -0.3 39.19 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 115.747 -0.66 . . . . 51.52 112.716 -175.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -101.55 -63.85 1.11 Allowed 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.357 0.663 . . . . 74.43 110.786 168.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 51.3 tp -55.1 -45.08 75.43 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.551 0.74 . . . . 73.23 111.265 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -98.5 -6.1 30.95 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.572 -0.74 . . . . 73.25 111.271 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -45.28 -61.42 3.6 Favored Glycine 0 C--N 1.356 1.647 0 N-CA-C 115.793 1.077 . . . . 54.11 115.793 -176.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -55.37 -27.68 59.37 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 123.097 2.531 . . . . 62.02 112.826 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -115.45 28.2 8.0 Favored Glycine 0 C--N 1.359 1.843 0 CA-C-O 118.937 -0.924 . . . . 43.23 112.815 -177.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 72.2 mt -75.14 47.84 0.38 Allowed 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 119.594 1.697 . . . . 73.03 110.528 170.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 106' ' ' PHE . . . . . 0.637 ' HB3' ' H ' ' C' ' 168' ' ' GLY . 52.6 m-85 52.03 -174.0 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 124.662 1.185 . . . . 64.24 110.396 -169.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . 3.29 -44.63 0.0 OUTLIER Glycine 0 N--CA 1.5 2.951 0 N-CA-C 118.469 2.148 . . . . 51.05 118.469 155.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 108' ' ' GLY . . . . . 0.465 ' O ' ' HG3' ' C' ' 114' ' ' ARG . . . 64.1 -145.63 49.81 Favored Glycine 0 C--N 1.356 1.673 0 CA-C-N 114.186 -1.007 . . . . 74.41 110.893 -179.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 109' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -108.34 27.31 9.47 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 107.256 -1.387 . . . . 74.45 107.256 164.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 110' ' ' GLY . . . . . . . . . . . . . . . -92.49 11.72 71.44 Favored Glycine 0 C--N 1.361 1.946 0 CA-C-N 115.246 -0.888 . . . . 54.22 114.608 -169.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? 66.11 0.56 1.67 Allowed 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 124.148 0.979 . . . . 75.25 112.357 -176.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 112' ' ' ARG . . . . . . . . . . . . . 54.4 ttp180 -80.17 45.25 0.73 Allowed 'General case' 0 CA--C 1.563 1.47 0 C-N-CA 126.608 1.963 . . . . 74.1 110.449 173.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 113' ' ' SER . . . . . 0.413 ' HB2' ' HB2' ' C' ' 167' ' ' GLN . 19.0 m 70.27 78.59 0.19 Allowed 'General case' 0 C--N 1.36 1.059 0 C-N-CA 123.682 0.793 . . . . 72.53 111.35 -177.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 114' ' ' ARG . . . . . 0.62 ' HG2' ' H ' ' C' ' 115' ' ' LYS . 49.4 ttp180 -66.58 -171.65 0.14 Allowed 'General case' 0 CA--C 1.579 2.076 0 C-N-CA 124.059 0.944 . . . . 74.05 109.768 176.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 115' ' ' LYS . . . . . 0.681 ' HA ' ' HD2' ' C' ' 170' ' ' PRO . 60.8 tttm -5.73 112.78 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.653 0 C-N-CA 127.563 2.345 . . . . 54.14 116.771 -159.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -67.18 140.91 38.44 Favored Glycine 0 C--N 1.355 1.585 0 CA-C-N 114.403 -1.271 . . . . 45.25 115.233 -171.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.04 -175.38 2.78 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.147 1.379 . . . . 64.44 110.18 -177.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -72.44 131.84 43.11 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 109.281 -0.637 . . . . 75.42 109.281 167.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 119' ' ' LEU . . . . . 0.478 HD11 HG21 ' B' ' 185' ' ' VAL . 36.1 tp -110.73 142.21 42.99 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.246 1.018 . . . . 75.21 108.617 -175.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -117.73 104.45 11.0 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 108.719 -0.845 . . . . 72.31 108.719 -169.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 121' ' ' ALA . . . . . 0.446 ' HB3' HD23 ' C' ' 176' ' ' LEU . . . -113.41 116.2 29.26 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.077 -0.712 . . . . 63.21 109.077 176.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 122' ' ' GLU . . . . . 0.505 ' HG3' HG21 ' B' ' 186' ' ' THR . 44.5 mt-10 -89.03 110.95 21.58 Favored 'General case' 0 C--N 1.347 0.462 0 N-CA-C 108.26 -1.015 . . . . 73.22 108.26 172.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 123' ' ' LEU . . . . . 0.6 HD23 ' H ' ' C' ' 123' ' ' LEU . 1.1 pt? -106.31 113.71 63.03 Favored Pre-proline 0 C--O 1.248 0.976 0 O-C-N 123.781 0.676 . . . . 73.3 109.39 -177.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -58.33 114.45 1.98 Allowed 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 122.205 1.937 . . . . 72.51 110.2 162.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 125' ' ' LEU . . . . . 0.547 ' O ' ' HA ' ' C' ' 180' ' ' LEU . 53.7 tp -142.94 154.94 44.57 Favored 'General case' 0 C--O 1.219 -0.547 0 N-CA-C 106.967 -1.494 . . . . 74.03 106.967 -171.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 126' ' ' THR . . . . . 0.452 ' HB ' HD12 ' C' ' 181' ' ' LEU . 11.1 t -119.3 171.62 8.18 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 119.735 1.152 . . . . 61.53 110.795 177.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 127' ' ' LEU . . . . . 0.505 HD11 ' H ' ' C' ' 185' ' ' VAL . 10.0 mt -62.86 -47.48 83.19 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 113.724 -1.58 . . . . 62.25 110.72 -171.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -58.32 -44.58 88.69 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 114.219 -1.355 . . . . 75.24 109.896 -177.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -75.25 -24.37 57.64 Favored 'General case' 0 C--O 1.216 -0.703 0 CA-C-N 114.975 -1.011 . . . . 73.53 111.445 178.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 130' ' ' ALA . . . . . 0.422 ' HB1' ' H ' ' C' ' 153' ' ' VAL . . . -71.76 -31.58 66.79 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 109.611 -0.514 . . . . 64.34 109.611 175.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 131' ' ' PHE . . . . . 0.551 ' HB2' HD13 ' C' ' 215' ' ' LEU . 75.5 t80 -70.35 -41.88 72.59 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.207 1.003 . . . . 75.55 109.855 172.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 132' ' ' HIS . . . . . . . . . . . . . 24.9 m170 -76.62 -8.23 56.83 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 115.19 -0.914 . . . . 60.22 110.99 176.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -54.02 134.1 44.52 Favored Glycine 0 C--N 1.356 1.661 0 O-C-N 123.973 0.796 . . . . 65.31 113.233 176.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . 173.17 -128.37 1.51 Allowed Glycine 0 C--O 1.24 0.526 0 N-CA-C 108.969 -1.652 . . . . 53.24 108.969 -177.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -72.0 95.54 1.61 Allowed 'General case' 0 C--N 1.35 0.587 0 N-CA-C 108.357 -0.979 . . . . 71.2 108.357 175.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 136' ' ' ARG . . . . . . . . . . . . . 19.5 mmt180 -126.1 162.48 25.24 Favored 'General case' 0 C--O 1.243 0.724 0 C-N-CA 123.522 0.729 . . . . 72.12 109.837 -178.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 137' ' ' VAL . . . . . . . . . . . . . 8.6 p -78.85 123.81 36.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 CA-C-N 115.374 -0.83 . . . . 71.12 110.119 177.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 138' ' ' VAL . . . . . 0.439 ' HB ' ' HG ' ' B' ' 181' ' ' LEU . 8.8 p -115.87 131.28 68.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 108.247 -1.02 . . . . 72.14 108.247 169.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 139' ' ' GLU . . . . . 0.58 ' HB3' HG21 ' B' ' 182' ' ' VAL . 9.9 tp10 -124.32 83.31 2.13 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 107.075 -1.454 . . . . 74.31 107.075 174.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 140' ' ' VAL . . . . . . . . . . . . . 54.6 t -140.9 148.67 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 107.214 -1.402 . . . . 63.22 107.214 178.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 68.67 23.39 7.13 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 124.14 0.976 . . . . 15.23 111.524 -177.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 67.14 40.62 92.74 Favored Glycine 0 C--N 1.347 1.167 0 O-C-N 123.931 0.769 . . . . 45.25 112.94 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 143' ' ' ARG . . . . . 0.587 ' NH2' ' HA ' ' C' ' 164' ' ' MET . 25.3 ttp-105 -153.07 124.18 7.49 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-O 120.82 0.343 . . . . 73.04 110.883 179.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 62.9 ttt-85 -88.34 124.0 33.48 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.239 -0.891 . . . . 71.51 109.269 167.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 145' ' ' VAL . . . . . . . . . . . . . 8.0 p -151.52 142.38 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.083 0.553 . . . . 75.03 109.587 173.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 52.9 p -84.33 105.36 15.1 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 109.196 -0.668 . . . . 54.21 109.196 174.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 14.5 p -123.2 146.73 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 N-CA-C 109.663 -0.495 . . . . 72.53 109.663 -178.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -91.16 114.93 27.59 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 122.933 0.493 . . . . 74.22 110.465 174.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 149' ' ' ILE . . . . . . . . . . . . . 31.5 pt -93.24 153.63 41.57 Favored Pre-proline 0 CA--C 1.55 0.953 0 N-CA-C 107.955 -1.128 . . . . 71.41 107.955 164.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -47.52 122.02 6.25 Favored 'Trans proline' 0 C--N 1.384 2.404 0 C-N-CA 123.029 2.486 . . . . 61.44 112.018 177.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -61.25 109.35 0.71 Allowed 'Trans proline' 0 C--N 1.385 2.498 0 C-N-CA 123.043 2.495 . . . . 73.2 111.536 -178.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 152' ' ' GLY . . . . . . . . . . . . . . . 110.58 109.78 3.19 Favored Glycine 0 C--N 1.338 0.673 0 CA-C-N 115.456 -0.793 . . . . 54.32 111.973 -170.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 153' ' ' VAL . . . . . 0.522 ' HB ' HG21 ' C' ' 178' ' ' VAL . 2.1 m -105.27 168.75 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 123.063 0.545 . . . . 71.13 109.647 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 154' ' ' ARG . . . . . 0.44 ' O ' HG23 ' C' ' 178' ' ' VAL . 18.2 mtp180 -115.78 116.26 27.73 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 122.905 0.482 . . . . 75.32 111.258 -174.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 155' ' ' GLU . . . . . 0.547 ' HG2' ' HE ' ' C' ' 187' ' ' ARG . 2.9 tp10 -22.7 115.95 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 126.733 2.013 . . . . 74.51 114.234 168.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 57.76 10.29 6.23 Favored Glycine 0 C--N 1.351 1.406 0 O-C-N 123.827 0.704 . . . . 64.51 114.752 171.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 157' ' ' SER . . . . . 0.425 ' HB2' ' HB2' ' C' ' 154' ' ' ARG . 49.5 m -106.74 167.28 9.98 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 121.572 0.701 . . . . 75.43 110.466 -173.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 18.4 t -103.31 104.75 17.13 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 CA-C-N 114.774 -1.103 . . . . 64.44 110.439 -169.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 159' ' ' ILE . . . . . 0.44 HD11 ' HB ' ' C' ' 153' ' ' VAL . 19.1 mt -72.23 145.87 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 109.287 -0.634 . . . . 52.25 109.287 167.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -109.82 108.4 18.71 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 109.148 -0.686 . . . . 72.21 109.148 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 161' ' ' VAL . . . . . 0.576 HG21 HD12 ' C' ' 176' ' ' LEU . 49.4 t -125.87 95.23 40.27 Favored Pre-proline 0 N--CA 1.485 1.283 0 C-N-CA 123.734 0.814 . . . . 75.24 110.967 -171.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -64.53 146.57 89.48 Favored 'Trans proline' 0 C--N 1.363 1.327 0 C-N-CA 121.805 1.67 . . . . 63.42 109.736 165.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 129.78 -16.87 5.54 Favored Glycine 0 N--CA 1.475 1.296 0 C-N-CA 121.715 -0.279 . . . . 53.31 113.569 -176.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 164' ' ' MET . . . . . 0.587 ' HA ' ' NH2' ' C' ' 143' ' ' ARG . 2.9 mpp? -121.58 -79.5 0.61 Allowed 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 109.434 -0.58 . . . . 73.35 109.434 170.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 165' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' C' ' 173' ' ' ASP . . . 68.9 174.18 9.37 Favored Glycine 0 C--N 1.349 1.28 0 N-CA-C 114.436 0.535 . . . . 64.24 114.436 -178.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . -71.11 165.14 53.43 Favored Glycine 0 C--N 1.343 0.934 0 N-CA-C 111.988 -0.445 . . . . 75.44 111.988 172.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 167' ' ' GLN . . . . . 0.514 HE21 ' HA ' ' C' ' 167' ' ' GLN . 0.0 OUTLIER -67.27 144.28 56.01 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 109.828 -0.434 . . . . 64.31 109.828 -179.655 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 168' ' ' GLY . . . . . 0.637 ' H ' ' HB3' ' C' ' 106' ' ' PHE . . . 144.68 130.85 2.33 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-O 119.084 -0.842 . . . . 13.44 111.37 -174.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 169' ' ' ASN . . . . . 0.569 ' HB3' ' HD3' ' C' ' 170' ' ' PRO . 8.5 t30 -49.88 -49.82 71.74 Favored Pre-proline 0 CA--C 1.557 1.224 0 C-N-CA 124.468 1.107 . . . . 62.44 112.46 -172.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 170' ' ' PRO . . . . . 0.681 ' HD2' ' HA ' ' C' ' 115' ' ' LYS . 1.5 Cg_endo -86.87 104.71 0.64 Allowed 'Trans proline' 0 C--N 1.383 2.345 0 CA-C-N 121.522 1.579 . . . . 51.41 110.061 162.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 171' ' ' PRO . . . . . 0.67 ' HG2' ' HA ' ' C' ' 86' ' ' SER . 72.4 Cg_endo -72.83 173.09 14.05 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.906 2.404 . . . . 74.02 112.648 -175.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -117.21 -94.76 1.79 Allowed Glycine 0 C--N 1.346 1.09 0 CA-C-N 115.772 -0.649 . . . . 74.42 112.895 -177.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 173' ' ' ASP . . . . . 0.44 ' O ' ' HA2' ' C' ' 165' ' ' GLY . 6.8 t70 -166.26 151.32 8.21 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.906 0.882 . . . . 74.51 109.626 -164.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 174' ' ' LEU . . . . . . . . . . . . . 30.1 tp -117.84 105.15 11.64 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.554 0.741 . . . . 75.22 109.207 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 77.2 mt -74.81 96.18 3.04 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-N 114.523 -1.217 . . . . 71.32 109.744 172.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 176' ' ' LEU . . . . . 0.576 HD12 HG21 ' C' ' 161' ' ' VAL . 41.7 mt -85.77 96.87 9.88 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-N 115.313 -0.858 . . . . 43.02 109.945 178.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 177' ' ' VAL . . . . . 0.529 HG21 ' HB2' ' B' ' 190' ' ' CYS . 22.0 t -84.57 101.24 8.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 107.906 -1.146 . . . . 74.43 107.906 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 178' ' ' VAL . . . . . 0.522 HG21 ' HB ' ' C' ' 153' ' ' VAL . 0.8 OUTLIER -84.74 102.66 11.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.059 -0.973 . . . . 74.01 110.632 -171.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 179' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -87.95 104.08 16.28 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.291 -1.374 . . . . 72.33 107.291 175.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 180' ' ' LEU . . . . . 0.547 ' HA ' ' O ' ' C' ' 125' ' ' LEU . 96.5 mt -68.83 138.29 54.63 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 109.99 -0.374 . . . . 70.51 109.99 177.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 181' ' ' LEU . . . . . 0.452 HD12 ' HB ' ' C' ' 126' ' ' THR . 51.8 mt -56.87 167.6 1.02 Allowed Pre-proline 0 N--CA 1.493 1.679 0 C-N-CA 125.539 1.536 . . . . 74.2 112.045 -173.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 182' ' ' PRO . . . . . 0.465 ' HB3' HD21 ' B' ' 218' ' ' LEU . 87.1 Cg_exo -54.62 68.38 0.03 OUTLIER 'Trans proline' 0 C--N 1.388 2.654 0 C-N-CA 123.842 3.028 . . . . 64.12 112.58 164.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 183' ' ' HIS . . . . . 0.508 ' HA ' ' O ' ' B' ' 225' ' ' THR . 84.3 t60 177.39 48.16 0.03 OUTLIER Pre-proline 0 CA--C 1.567 1.615 0 C-N-CA 128.466 2.707 . . . . 62.13 106.444 -169.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 184' ' ' PRO . . . . . 0.575 ' HD2' HG22 ' B' ' 225' ' ' THR . 4.3 Cg_endo -87.95 65.66 3.57 Favored 'Trans proline' 0 C--N 1.398 3.141 0 C-N-CA 123.318 2.679 . . . . 71.54 110.236 -175.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 185' ' ' VAL . . . . . 0.505 ' H ' HD11 ' C' ' 127' ' ' LEU . 11.1 t -94.63 -24.77 4.79 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.076 0 CA-C-N 115.0 -1.0 . . . . 72.23 109.938 -170.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 186' ' ' PHE . . . . . 0.426 ' CD1' HD13 ' C' ' 127' ' ' LEU . 32.4 m-85 -124.58 105.51 9.42 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.398 0.618 . . . . 61.44 110.759 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 187' ' ' ARG . . . . . 0.547 ' HE ' ' HG2' ' C' ' 155' ' ' GLU . 35.4 ttm105 -108.3 104.41 13.79 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.708 1.203 . . . . 75.14 108.9 -174.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 188' ' ' LEU . . . . . . . . . . . . . 58.7 tp -77.91 134.89 37.82 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.202 0.815 . . . . 74.14 113.202 -167.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -132.55 119.07 20.03 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 126.008 1.723 . . . . 71.33 107.277 164.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 190' ' ' GLY . . . . . 0.67 ' HA2' ' HA2' ' B' ' 202' ' ' GLY . . . 64.44 -99.21 0.32 Allowed Glycine 0 C--N 1.343 0.954 0 CA-C-N 116.07 -0.514 . . . . 74.2 112.614 -175.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 191' ' ' GLN . . . . . 0.47 ' HB2' ' NH2' ' B' ' 32' ' ' ARG . 50.4 mt-30 -127.3 -12.94 5.63 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.106 0.962 . . . . 60.21 109.336 173.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -86.74 148.49 25.4 Favored 'General case' 0 C--N 1.362 1.111 0 C-N-CA 123.509 0.724 . . . . 65.13 109.516 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 193' ' ' LEU . . . . . 0.458 HD21 ' CD2' ' C' ' 240' ' ' PHE . 90.1 mt -103.48 161.84 13.53 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.325 0.65 . . . . 52.2 110.681 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 194' ' ' TYR . . . . . 0.413 ' HB3' ' HB3' ' C' ' 187' ' ' ARG . 10.5 t80 -125.29 106.73 10.07 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.707 -1.22 . . . . 75.43 107.707 170.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 195' ' ' ALA . . . . . 0.496 ' HB2' HD11 ' C' ' 249' ' ' LEU . . . -105.76 -176.81 3.18 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.211 1.004 . . . . 65.11 110.268 177.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 196' ' ' THR . . . . . 0.769 HG21 ' H ' ' B' ' 264' ' ' SER . 87.0 m -139.07 120.95 15.48 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 114.953 -1.021 . . . . 51.32 108.836 166.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 197' ' ' LEU . . . . . 0.424 HD13 HD22 ' C' ' 251' ' ' LEU . 27.3 tp -90.69 115.48 27.82 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.886 0.874 . . . . 73.5 110.628 -175.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -78.15 104.06 8.49 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.826 0.85 . . . . 44.52 109.76 -178.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 199' ' ' VAL . . . . . 0.535 HG22 HG21 ' C' ' 210' ' ' VAL . 39.4 t -120.35 115.64 32.63 Favored Pre-proline 0 N--CA 1.482 1.145 0 C-N-CA 124.388 1.075 . . . . 61.21 109.481 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 200' ' ' PRO . . . . . 0.4 ' HG2' HD12 ' C' ' 203' ' ' ILE . 38.1 Cg_endo -69.28 149.75 70.33 Favored 'Trans proline' 0 C--N 1.367 1.529 0 C-N-CA 121.71 1.606 . . . . 71.34 111.988 175.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 201' ' ' ALA . . . . . 0.427 ' O ' HG23 ' C' ' 205' ' ' VAL . . . -54.73 -47.6 97.68 Favored Pre-proline 0 CA--C 1.562 1.42 0 N-CA-C 114.263 1.209 . . . . 74.35 114.263 -170.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 202' ' ' PRO . . . . . 0.436 ' O ' HG12 ' C' ' 206' ' ' VAL . 78.2 Cg_exo -53.3 -45.74 38.85 Favored 'Trans proline' 0 C--N 1.388 2.646 0 C-N-CA 121.763 1.642 . . . . 63.15 112.728 175.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 203' ' ' ILE . . . . . 0.4 HD12 ' HG2' ' C' ' 200' ' ' PRO . 38.7 mt -67.88 -33.86 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 124.048 0.939 . . . . 63.4 111.167 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 204' ' ' ALA . . . . . 0.411 ' HA ' HG11 ' C' ' 223' ' ' VAL . . . -68.73 -34.07 74.98 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.485 0.714 . . . . 75.02 111.654 178.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 205' ' ' VAL . . . . . 0.55 HG13 ' HG3' ' C' ' 226' ' ' ARG . 95.1 t -85.26 -40.42 14.82 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 N-CA-C 112.775 0.658 . . . . 63.41 112.775 -175.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 206' ' ' VAL . . . . . 0.436 HG12 ' O ' ' C' ' 202' ' ' PRO . 6.4 p -81.36 -39.35 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-N 118.959 0.799 . . . . 52.12 110.472 176.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 207' ' ' GLY . . . . . 0.423 ' O ' ' HB2' ' B' ' 250' ' ' GLN . . . 97.27 92.49 1.89 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.387 -0.685 . . . . 63.21 111.387 -166.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -113.98 -141.36 7.76 Favored Glycine 0 C--N 1.338 0.694 0 N-CA-C 111.734 -0.546 . . . . 51.32 111.734 176.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 209' ' ' LYS . . . . . 0.667 ' HE3' ' HB1' ' B' ' 253' ' ' ALA . 8.7 mtmp? -140.21 141.28 35.94 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.126 0.571 . . . . 72.12 110.557 171.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 210' ' ' VAL . . . . . 0.535 HG21 HG22 ' C' ' 199' ' ' VAL . 15.1 m -133.59 135.34 55.84 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 C-N-CA 124.912 1.285 . . . . 62.05 107.597 169.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 211' ' ' ARG . . . . . 0.498 ' HA ' ' HA ' ' C' ' 220' ' ' GLU . 0.5 OUTLIER -89.43 122.11 32.32 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 122.279 0.232 . . . . 72.44 110.761 -174.371 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 212' ' ' ALA . . . . . 0.477 ' HB3' HG13 ' C' ' 219' ' ' VAL . . . -81.16 116.35 21.02 Favored 'General case' 0 C--O 1.248 1.023 0 N-CA-C 107.678 -1.23 . . . . 74.43 107.678 173.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 213' ' ' MET . . . . . 0.591 ' SD ' ' HA ' ' B' ' 170' ' ' THR . 4.8 tmm? -70.36 117.25 11.67 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 108.002 -1.11 . . . . 63.12 108.002 174.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 214' ' ' THR . . . . . 0.526 HG21 ' HD2' ' C' ' 238' ' ' LYS . 1.0 OUTLIER -115.57 168.12 10.3 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 122.043 0.925 . . . . 54.24 112.406 -176.954 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 215' ' ' LEU . . . . . 0.551 HD13 ' HB2' ' C' ' 131' ' ' PHE . 81.4 mt -65.98 -37.17 85.29 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 114.438 -1.256 . . . . 44.41 113.003 -169.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 216' ' ' GLU . . . . . 0.46 ' HG2' HH11 ' C' ' 246' ' ' ARG . 0.0 OUTLIER -105.23 9.84 33.89 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 114.492 -1.231 . . . . 71.0 110.951 -174.936 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 148.41 -144.81 12.74 Favored Glycine 0 C--N 1.353 1.484 0 CA-C-O 119.925 -0.375 . . . . 64.11 112.4 178.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -105.6 165.14 0.15 Allowed 'Trans proline' 0 CA--C 1.548 1.221 0 C-N-CA 123.61 2.873 . . . . 52.13 113.716 168.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 219' ' ' VAL . . . . . 0.477 HG13 ' HB3' ' C' ' 212' ' ' ALA . 4.5 p -145.7 116.54 1.83 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 107.154 -1.424 . . . . 52.53 107.154 163.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 220' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' C' ' 211' ' ' ARG . 28.2 tt0 -82.78 110.74 18.07 Favored 'General case' 0 C--O 1.247 0.971 0 N-CA-C 108.893 -0.78 . . . . 72.32 108.893 -179.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 221' ' ' VAL . . . . . . . . . . . . . 62.1 t -88.38 126.12 41.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 CA-C-N 115.16 -0.927 . . . . 74.03 109.515 -176.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 222' ' ' ALA . . . . . 0.595 ' HA ' ' HG2' ' C' ' 209' ' ' LYS . . . -87.24 143.72 27.15 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.666 -0.697 . . . . 73.3 110.378 176.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . 0.411 HG11 ' HA ' ' C' ' 204' ' ' ALA . 56.0 t -112.22 139.41 22.46 Favored Pre-proline 0 CA--C 1.558 1.254 0 C-N-CA 125.155 1.382 . . . . 73.11 108.537 -174.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 224' ' ' PRO . . . . . 0.415 ' HD3' ' CZ2' ' B' ' 242' ' ' TRP . 55.1 Cg_endo -87.76 168.34 6.98 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 123.213 2.609 . . . . 54.33 112.627 175.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 225' ' ' PRO . . . . . 0.482 ' HD3' ' HG3' ' B' ' 250' ' ' GLN . 27.6 Cg_endo -65.77 119.4 6.42 Favored 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 122.197 1.931 . . . . 74.0 112.358 174.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 226' ' ' ARG . . . . . 0.55 ' HG3' HG13 ' C' ' 205' ' ' VAL . 0.0 OUTLIER 66.48 89.81 0.1 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.211 1.804 . . . . 70.15 111.679 179.763 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 227' ' ' THR . . . . . . . . . . . . . 40.6 m -112.95 124.91 53.7 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 113.56 -1.654 . . . . 70.3 110.612 -174.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 228' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -90.52 152.02 21.1 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.946 0.898 . . . . 74.32 111.63 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 229' ' ' ALA . . . . . 0.442 ' HA ' ' O ' ' C' ' 253' ' ' VAL . . . -76.16 135.59 39.77 Favored 'General case' 0 C--O 1.243 0.745 0 CA-C-N 115.31 -0.859 . . . . 62.12 109.673 175.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 98.06 -2.38 59.75 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 115.774 -0.648 . . . . 62.04 113.339 -169.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 231' ' ' ARG . . . . . . . . . . . . . 68.8 mtt180 -66.35 172.06 4.31 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 117.75 0.775 . . . . 74.12 110.736 167.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 232' ' ' LYS . . . . . 0.559 ' HA ' ' O ' ' C' ' 251' ' ' LEU . 37.7 ttmt -154.32 143.89 21.53 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.243 0.831 . . . . 71.45 113.243 -173.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 233' ' ' LEU . . . . . 0.558 ' O ' ' HA ' ' C' ' 250' ' ' TYR . 3.4 mp -123.88 144.23 49.88 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 115.03 -0.987 . . . . 74.21 109.936 170.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 234' ' ' ARG . . . . . 0.439 ' HD2' HD11 ' B' ' 331' ' ' LEU . 16.1 ptp180 -101.66 115.85 31.45 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 108.366 -0.976 . . . . 72.34 108.366 162.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 235' ' ' LEU . . . . . 0.426 HD22 ' HA ' ' B' ' 239' ' ' ALA . 33.7 mt -98.2 119.37 36.74 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 107.913 -1.143 . . . . 73.43 107.913 176.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -67.93 128.78 37.76 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.739 0.815 . . . . 71.55 112.087 -172.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 78.8 3.69 87.63 Favored Glycine 0 C--N 1.352 1.448 0 CA-C-N 115.731 -0.668 . . . . 71.42 113.342 176.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 238' ' ' LYS . . . . . 0.526 ' HD2' HG21 ' C' ' 214' ' ' THR . 67.0 mmtt -96.17 8.34 44.07 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.161 0.584 . . . . 72.03 111.518 -177.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -87.42 -170.09 46.17 Favored Glycine 0 C--N 1.352 1.464 0 O-C-N 123.373 0.421 . . . . 31.21 112.802 174.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 240' ' ' PHE . . . . . 0.458 ' CD2' HD21 ' C' ' 193' ' ' LEU . 2.0 m-85 -81.47 150.47 67.09 Favored Pre-proline 0 N--CA 1.48 1.073 0 N-CA-C 110.001 -0.37 . . . . 75.14 110.001 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 241' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -62.08 139.79 80.54 Favored 'Trans proline' 0 C--N 1.385 2.494 0 C-N-CA 123.26 2.64 . . . . 70.21 113.92 -174.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 242' ' ' GLY . . . . . 0.462 ' HA3' HE21 ' C' ' 191' ' ' GLN . . . -132.07 177.28 18.81 Favored Glycine 0 CA--C 1.522 0.485 0 CA-C-N 114.852 -1.067 . . . . 70.14 111.501 177.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.97 -11.25 27.21 Favored 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 122.792 2.328 . . . . 71.42 112.716 -175.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -110.34 -4.83 15.43 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.655 0.782 . . . . 71.42 111.858 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 147.65 -104.86 0.3 Allowed Glycine 0 C--N 1.35 1.342 0 N-CA-C 111.814 -0.514 . . . . 51.32 111.814 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 246' ' ' ARG . . . . . 0.46 HH11 ' HG2' ' C' ' 216' ' ' GLU . 85.0 mtm180 -146.05 167.71 22.71 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 124.78 1.232 . . . . 61.31 109.248 176.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -87.67 -156.8 30.64 Favored Glycine 0 C--N 1.346 1.136 0 N-CA-C 112.21 -0.356 . . . . 63.23 112.21 172.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -115.51 170.01 8.74 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.177 0.591 . . . . 73.54 109.585 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 249' ' ' LEU . . . . . 0.496 HD11 ' HB2' ' C' ' 195' ' ' ALA . 28.4 tp -116.02 115.06 25.46 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.406 0.682 . . . . 74.23 110.857 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 250' ' ' TYR . . . . . 0.558 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 2.1 m-30 -100.83 98.15 8.69 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.231 0.612 . . . . 71.43 109.696 -178.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 251' ' ' LEU . . . . . 0.559 ' O ' ' HA ' ' C' ' 232' ' ' LYS . 1.8 mp -94.53 126.29 39.73 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 119.448 -0.31 . . . . 64.53 110.222 -177.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -80.29 113.16 18.26 Favored 'General case' 0 C--O 1.217 -0.619 0 O-C-N 124.887 1.367 . . . . 73.41 108.579 170.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 253' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' C' ' 229' ' ' ALA . 40.5 t -72.36 133.12 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 123.15 0.58 . . . . 73.5 110.335 -174.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 254' ' ' ARG . . . . . 0.445 ' HG2' ' HG ' ' B' ' 265' ' ' LEU . 2.3 tmt_? -122.84 114.82 21.01 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.545 1.138 . . . . 74.13 108.918 -165.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 255' ' ' ILE . . . . . 0.429 HG12 ' HB2' ' C' ' 229' ' ' ALA . 20.8 mm -88.61 115.67 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 109.19 -0.67 . . . . 75.24 109.19 -179.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 256' ' ' THR . . . . . . . . . . . . . 1.4 t -124.09 151.43 43.88 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.973 0.909 . . . . 53.32 111.394 -174.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 2.4 pp -121.55 120.49 28.78 Favored Pre-proline 0 N--CA 1.482 1.173 0 N-CA-C 107.55 -1.278 . . . . 64.54 107.55 170.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 258' ' ' PRO . . . . . 0.516 ' HG3' ' HE2' ' A' ' 276' ' ' TYR . 26.6 Cg_endo -78.98 11.68 2.5 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 C-N-CA 122.845 2.364 . . . . 73.21 113.946 -161.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 69.21 -62.24 0.41 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.592 1.557 . . . . 72.3 111.025 -173.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.51 130.43 31.75 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.24 1.016 . . . . 73.41 111.098 176.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 261' ' ' LEU . . . . . . . . . . . . . 88.0 mt -156.68 143.78 18.8 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.188 1.395 . . . . 71.21 107.702 177.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 71.8 p -83.41 152.01 63.41 Favored Pre-proline 0 CA--C 1.549 0.936 0 CA-C-O 118.105 -0.95 . . . . 61.23 108.457 172.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_exo -45.6 -33.36 9.66 Favored 'Trans proline' 0 C--N 1.384 2.432 0 C-N-CA 123.486 2.79 . . . . 74.2 114.647 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -63.07 -62.01 2.0 Allowed 'General case' 0 C--O 1.251 1.148 0 C-N-CA 124.258 1.023 . . . . 71.04 110.695 175.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -50.55 -52.0 42.83 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 115.196 -0.911 . . . . 65.11 109.798 178.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 266' ' ' GLU . . . . . 0.467 ' O ' ' HG2' ' C' ' 270' ' ' LYS . 30.6 tt0 -57.75 -38.44 75.37 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.103 1.361 . . . . 64.21 111.249 -178.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -59.65 -42.92 93.89 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.386 0.674 . . . . 70.32 110.958 177.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 268' ' ' LEU . . . . . . . . . . . . . 8.2 mp -65.02 -39.13 92.95 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 115.744 -0.662 . . . . 52.44 110.791 175.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -64.19 -29.81 70.9 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 122.582 0.353 . . . . 61.11 111.822 174.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 270' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' C' ' 266' ' ' GLU . 33.9 mmtp -68.91 -44.12 73.82 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 122.967 0.507 . . . . 75.43 109.927 176.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 11.0 mmmm -57.27 -45.98 83.52 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 123.92 0.762 . . . . 75.33 111.077 176.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 85.0 mt -62.52 -42.7 99.69 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 114.791 -1.095 . . . . 74.33 110.577 176.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -62.44 -39.16 92.44 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.491 0.716 . . . . 34.13 110.998 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -62.5 -47.82 82.28 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.542 0.737 . . . . 63.21 110.038 176.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -58.91 -30.85 68.13 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 115.319 -0.855 . . . . 70.04 111.368 176.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 276' ' ' TYR . . . . . 0.459 ' HD1' HH11 ' C' ' 279' ' ' ARG . 9.2 m-85 -80.55 -33.32 36.32 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.517 0.727 . . . . 75.52 112.662 178.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -73.36 -23.45 60.21 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 118.392 0.542 . . . . 44.24 109.822 177.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -66.79 -11.97 57.13 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 123.754 0.821 . . . . 55.2 112.289 171.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 279' ' ' ARG . . . . . 0.459 HH11 ' HD1' ' C' ' 276' ' ' TYR . 50.8 mtp180 -79.56 -12.8 59.84 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 122.845 0.458 . . . . 71.52 111.055 174.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.904 -0.57 . . . . 75.14 109.971 178.107 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.478 0.961 0 N-CA-C 109.525 -0.546 . . . . 64.12 109.525 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.61 26.01 10.63 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.224 1.409 . . . . 51.4 112.446 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -87.88 60.64 5.99 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.633 0.773 . . . . 74.04 109.99 -175.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -37.59 103.78 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.316 1.446 . . . . 62.43 113.76 -176.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.427 ' HG2' ' HB3' ' A' ' 96' ' ' PHE . 14.5 mmmm -79.7 94.58 5.75 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 107.544 -1.28 . . . . 74.32 107.544 168.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.428 ' O ' HG13 ' A' ' 10' ' ' ILE . 11.8 t70 -70.55 92.71 0.86 Allowed 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.154 -1.054 . . . . 61.41 108.154 177.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -58.84 -35.35 72.77 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.765 0.826 . . . . 73.34 112.89 -167.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.407 ' CE1' HD11 ' A' ' 22' ' ' ILE . 88.7 m-85 -63.78 -45.22 90.73 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 116.501 -0.318 . . . . 73.33 110.515 176.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.34 -39.42 90.52 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 123.597 0.561 . . . . 60.32 110.964 178.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 6' ' ' ASP . 37.7 mt -65.46 -37.06 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 123.01 0.524 . . . . 74.23 110.55 179.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.509 ' HB2' HG22 ' A' ' 13' ' ' VAL . 81.5 mt -73.25 -16.17 61.4 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.114 0.566 . . . . 51.33 111.737 174.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.71 18.0 79.36 Favored Glycine 0 C--N 1.351 1.365 0 O-C-N 123.412 0.445 . . . . 53.33 112.782 -176.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.509 HG22 ' HB2' ' A' ' 11' ' ' LEU . 27.5 m -107.58 158.18 33.95 Favored Pre-proline 0 N--CA 1.479 0.991 0 C-N-CA 124.399 1.08 . . . . 71.43 109.57 179.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -64.09 158.15 49.54 Favored 'Trans proline' 0 C--N 1.378 2.117 0 C-N-CA 122.23 1.954 . . . . 50.12 111.998 178.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -72.61 11.78 0.58 Allowed 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 113.418 0.896 . . . . 75.43 113.418 -176.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -135.75 23.34 3.36 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.768 1.227 . . . . 64.11 108.017 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.55 134.22 49.7 Favored 'General case' 0 C--N 1.348 0.518 0 CA-C-N 115.233 -0.894 . . . . 64.31 110.03 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.6 p -68.84 155.93 39.32 Favored 'General case' 0 C--O 1.241 0.646 0 O-C-N 124.053 0.846 . . . . 71.11 109.362 173.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.439 ' HA ' ' HB ' ' A' ' 22' ' ' ILE . 52.1 tt0 -62.68 -19.34 63.77 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 123.026 0.53 . . . . 64.21 110.769 177.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -62.14 -53.55 53.7 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 125.019 1.328 . . . . 72.43 109.773 171.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -64.65 -32.97 74.88 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.846 0.858 . . . . 64.03 111.58 177.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.449 HD13 ' HB3' ' A' ' 57' ' ' LEU . 78.6 mt -69.68 -33.03 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.555 1.142 . . . . 73.31 110.846 177.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -72.99 -35.43 66.85 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.494 0.718 . . . . 71.24 110.263 175.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 52.8 mtp180 -66.55 -40.78 89.21 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.383 0.673 . . . . 54.12 110.649 173.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.81 -36.33 82.12 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.508 0.723 . . . . 64.0 110.47 178.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -59.98 -63.18 1.39 Allowed 'General case' 0 C--O 1.21 -0.985 0 CA-C-N 114.847 -1.07 . . . . 73.1 109.918 173.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -52.03 -48.37 64.56 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.066 0.547 . . . . 74.22 111.404 -177.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 50.5 ttt180 -56.38 -68.05 0.25 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.083 0.553 . . . . 71.15 111.784 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.44 ' HB3' HD13 ' A' ' 50' ' ' ILE . 93.8 mt -78.73 -43.38 25.89 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-N 115.74 -0.664 . . . . 74.11 111.753 -168.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.73 -25.35 63.8 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 118.015 -0.993 . . . . 63.3 112.814 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.56 ' HA ' ' HB2' ' A' ' 34' ' ' HIS . 81.7 mtp180 -85.02 -31.57 23.39 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 120.3 1.409 . . . . 72.33 110.969 171.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 48.0 tp60 -66.84 -32.57 73.93 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.607 0.363 . . . . 63.33 111.282 174.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.428 ' HB3' ' HB2' ' A' ' 47' ' ' PHE . 23.8 m-85 -111.24 16.53 20.92 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.553 0.741 . . . . 63.25 110.493 -178.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.56 ' HB2' ' HA ' ' A' ' 31' ' ' ARG . 2.7 t-80 -67.86 116.65 40.49 Favored Pre-proline 0 C--N 1.354 0.781 0 CA-C-O 118.181 -0.914 . . . . 63.41 109.743 -175.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_exo -47.57 -31.94 14.94 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 123.317 2.678 . . . . 74.13 113.534 -178.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -59.91 -53.05 62.41 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.885 0.874 . . . . 72.45 111.493 176.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.6 t -90.44 -56.87 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 122.969 0.508 . . . . 65.53 109.737 -173.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -97.7 84.81 3.44 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 121.808 0.813 . . . . 61.35 108.816 -178.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -79.54 69.23 5.78 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 114.45 -1.25 . . . . 73.11 109.475 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.9 m -134.53 107.68 10.99 Favored Pre-proline 0 N--CA 1.473 0.703 0 CA-C-O 118.386 -0.816 . . . . 54.41 109.475 -177.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.443 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 24.5 Cg_exo -36.81 -56.11 0.78 Allowed 'Trans proline' 0 C--N 1.388 2.62 0 C-N-CA 124.713 3.609 . . . . 72.23 114.597 -177.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.476 ' HG2' ' HE3' ' A' ' 46' ' ' LYS . 28.3 tt0 -54.39 -43.48 71.47 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.088 0.955 . . . . 64.43 111.348 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.99 -31.48 69.19 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.023 -0.99 . . . . 72.14 110.375 -178.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.444 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 51.5 mt-10 -78.9 -23.13 44.98 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.224 0.61 . . . . 62.01 109.674 -178.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 41' ' ' PRO . 23.6 mm-40 -71.5 -47.9 52.43 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.366 0.666 . . . . 62.44 109.527 172.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.476 ' HE3' ' HG2' ' A' ' 42' ' ' GLU . 97.0 mttt -60.32 -37.02 79.3 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 115.0 -1.0 . . . . 74.03 110.251 175.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.428 ' HB2' ' HB3' ' A' ' 33' ' ' TYR . 85.1 t80 -57.72 -53.88 53.21 Favored 'General case' 0 C--O 1.215 -0.713 0 C-N-CA 124.115 0.966 . . . . 73.24 109.307 173.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 44' ' ' GLU . 91.2 mttt -52.41 -45.86 66.09 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.468 0.707 . . . . 75.14 111.582 -179.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -62.47 -51.76 66.17 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 123.575 0.547 . . . . 71.44 111.885 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.44 HD13 ' HB3' ' A' ' 29' ' ' LEU . 86.5 mt -64.13 -31.4 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 124.216 1.006 . . . . 70.53 110.712 -178.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -95.67 -7.78 36.54 Favored 'General case' 0 C--O 1.215 -0.735 0 C-N-CA 123.679 0.792 . . . . 73.43 111.731 -176.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -72.35 -50.25 28.12 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 106.616 -1.624 . . . . 63.42 106.616 163.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.13 -49.8 68.38 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 112.756 -2.02 . . . . 65.45 111.477 175.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -67.31 -43.93 80.44 Favored 'General case' 0 C--O 1.212 -0.883 0 CA-C-N 115.357 -0.838 . . . . 72.32 110.795 177.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.451 ' HB2' ' CD2' ' A' ' 88' ' ' PHE . . . -56.54 -33.1 65.78 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 112.446 0.536 . . . . 53.01 112.446 -176.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 95.4 t -74.06 -53.92 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 CA-C-N 115.809 -0.632 . . . . 74.52 109.894 171.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.449 ' HB3' HD13 ' A' ' 22' ' ' ILE . 82.4 mt -83.99 7.12 19.46 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 113.912 1.079 . . . . 62.04 113.912 -169.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.0 t -87.83 -41.25 13.38 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.104 0.961 . . . . 74.34 110.517 178.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -104.27 107.57 57.83 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 108.593 -0.892 . . . . 74.34 108.593 -174.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -33.75 -32.86 0.06 OUTLIER 'Trans proline' 0 C--N 1.388 2.655 1 C-N-CA 125.613 4.208 . . . . 72.41 116.953 -179.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.458 ' HB2' ' HB2' ' A' ' 144' ' ' ARG . 16.3 tp10 -63.61 -65.01 0.74 Allowed 'General case' 0 N--CA 1.485 1.316 0 CA-C-O 121.197 0.522 . . . . 72.3 110.596 179.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -65.67 -31.99 73.3 Favored 'General case' 0 C--O 1.247 0.929 0 CA-C-N 114.805 -1.089 . . . . 74.54 110.955 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.496 HH11 ' HG2' ' A' ' 63' ' ' ARG . 26.4 ttt-85 -58.27 -54.59 45.27 Favored 'General case' 0 C--N 1.344 0.345 0 CA-C-N 115.316 -0.856 . . . . 74.11 109.917 176.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -71.07 -21.26 62.26 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.527 -0.76 . . . . 74.25 111.787 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.461 HG23 ' HG2' ' A' ' 76' ' ' PRO . 50.9 mt -58.88 -50.13 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 N-CA-C 109.327 -0.62 . . . . 64.42 109.327 168.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.422 ' OH ' ' HA ' ' A' ' 6' ' ' ASP . 34.1 t80 -59.68 -49.98 75.63 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 123.68 0.613 . . . . 75.4 110.534 175.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -57.72 -34.93 69.99 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.457 0.703 . . . . 64.04 112.062 -178.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 69.7 p -89.81 -16.31 30.44 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 119.203 -0.427 . . . . 75.13 111.457 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -74.4 131.34 41.01 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 109.268 -0.642 . . . . 63.45 109.268 178.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 98.34 14.66 37.78 Favored Glycine 0 CA--C 1.53 0.982 0 N-CA-C 110.884 -0.886 . . . . 52.54 110.884 -164.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 37.6 m -146.97 -53.25 0.22 Allowed 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 103.622 -2.733 . . . . 71.23 103.622 177.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.5 m -75.45 135.58 40.71 Favored 'General case' 0 C--O 1.253 1.258 0 N-CA-C 104.408 -2.442 . . . . 74.23 104.408 155.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.23 -34.19 5.99 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.775 0.83 . . . . 74.04 110.917 -173.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -84.71 150.65 56.77 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 123.662 0.785 . . . . 75.1 109.625 176.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.419 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 34.6 Cg_exo -60.28 133.12 47.62 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 122.393 2.062 . . . . 75.41 111.259 175.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.461 ' HG2' HG23 ' A' ' 65' ' ' ILE . 39.3 Cg_exo -60.43 153.86 57.48 Favored 'Trans proline' 0 C--N 1.375 1.934 0 C-N-CA 123.27 2.646 . . . . 74.25 113.174 -173.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.29 128.16 15.16 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.498 2.132 . . . . 62.44 111.415 175.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -62.92 116.02 3.3 Favored 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 123.043 2.495 . . . . 43.51 112.214 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -65.33 169.33 12.59 Favored 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 123.087 2.524 . . . . 71.05 111.979 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.83 86.23 0.03 OUTLIER 'Trans proline' 0 C--N 1.386 2.543 0 C-N-CA 123.394 2.729 . . . . 51.35 112.905 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.429 ' HA3' ' HA ' ' A' ' 141' ' ' ALA . . . 141.99 -37.44 1.58 Allowed Glycine 0 C--N 1.347 1.184 0 CA-C-N 115.021 -0.99 . . . . 62.41 111.411 178.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 114.14 -149.6 18.71 Favored Glycine 0 C--N 1.352 1.436 0 N-CA-C 112.274 -0.33 . . . . 53.03 112.274 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -110.98 73.62 0.83 Allowed 'General case' 0 C--O 1.242 0.66 0 C-N-CA 124.25 1.02 . . . . 74.41 108.283 175.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -57.38 125.11 21.34 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 115.511 -0.768 . . . . 71.31 110.914 177.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -121.92 24.28 9.67 Favored 'General case' 0 C--O 1.248 0.975 0 C-N-CA 123.737 0.815 . . . . 70.22 110.703 -175.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.412 ' OG ' ' HA2' ' A' ' 166' ' ' GLY . 74.0 m -50.61 124.9 11.75 Favored 'General case' 0 C--N 1.355 0.815 0 O-C-N 124.116 0.885 . . . . 74.44 111.814 176.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 129.0 -40.95 1.62 Allowed Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 109.012 -1.635 . . . . 70.11 109.012 -174.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.451 ' CD2' ' HB2' ' A' ' 55' ' ' ALA . 28.5 m-85 -137.18 143.31 42.32 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.78 0.432 . . . . 72.34 110.041 -170.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -75.37 89.37 2.62 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-O 121.515 0.674 . . . . 71.44 110.445 -177.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.557 HG21 ' ND2' ' A' ' 169' ' ' ASN . 2.8 p -38.01 -44.58 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 126.303 1.841 . . . . 75.21 114.068 172.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -70.28 -19.53 63.1 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.477 0.711 . . . . 75.33 111.789 -168.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -80.27 -24.8 39.83 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.102 0.561 . . . . 45.35 110.709 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -73.79 173.2 10.2 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 113.572 0.953 . . . . 71.01 113.572 -166.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.401 ' OG ' ' HG3' ' A' ' 5' ' ' LYS . 81.2 p -81.88 178.12 8.48 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 114.564 1.32 . . . . 74.5 114.564 -164.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -62.67 -52.52 62.99 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 113.181 -1.827 . . . . 74.31 112.307 -170.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.427 ' HB3' ' HG2' ' A' ' 5' ' ' LYS . 78.0 t80 -54.28 -41.97 69.47 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 123.501 0.72 . . . . 75.03 111.533 -178.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.511 ' CE2' HG23 ' A' ' 90' ' ' VAL . 36.9 t80 -64.9 -46.2 82.72 Favored 'General case' 0 CA--C 1.555 1.157 0 CA-C-N 114.763 -1.108 . . . . 63.23 110.513 176.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -67.05 -12.89 61.18 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.323 0.649 . . . . 73.05 112.371 178.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -89.82 -53.43 4.5 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.289 0.636 . . . . 70.02 111.36 173.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.2 tp -66.66 -52.78 41.02 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.059 0.944 . . . . 55.03 111.269 -171.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -96.21 -3.04 44.99 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.161 0.584 . . . . 72.11 111.174 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.419 ' N ' ' HD2' ' A' ' 103' ' ' PRO . . . -44.34 -55.83 5.72 Favored Glycine 0 C--N 1.354 1.551 0 CA-C-O 118.724 -1.042 . . . . 72.43 115.366 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.419 ' HD2' ' N ' ' A' ' 102' ' ' GLY . 9.5 Cg_endo -47.69 -28.11 8.93 Favored 'Trans proline' 0 C--N 1.388 2.655 0 C-N-CA 124.211 3.274 . . . . 23.1 114.941 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -134.69 35.08 2.25 Favored Glycine 0 C--N 1.346 1.134 0 CA-C-O 119.487 -0.618 . . . . 44.4 112.888 -176.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.422 ' HB3' ' OG ' ' A' ' 113' ' ' SER . 17.6 mt -67.53 26.2 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 114.683 1.364 . . . . 74.25 114.683 176.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER 58.6 -107.39 0.35 Allowed 'General case' 0 CA--C 1.562 1.437 0 C-N-CA 124.46 1.104 . . . . 72.25 110.884 163.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.661 ' H ' ' HB2' ' A' ' 169' ' ' ASN . . . 74.92 8.64 82.92 Favored Glycine 0 C--N 1.354 1.539 0 C-N-CA 123.18 0.419 . . . . 44.0 112.709 -177.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 59.34 -135.7 51.3 Favored Glycine 0 C--N 1.353 1.481 0 N-CA-C 111.854 -0.499 . . . . 71.34 111.854 -170.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -79.9 -4.66 53.28 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.125 0.57 . . . . 64.11 111.278 170.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -80.02 -35.95 26.14 Favored Glycine 0 C--N 1.348 1.242 0 N-CA-C 111.728 -0.549 . . . . 55.25 111.728 177.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 75.04 -26.02 0.2 Allowed 'General case' 0 CA--C 1.566 1.579 0 C-N-CA 125.106 1.362 . . . . 71.44 112.681 174.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 18.8 ttt180 -65.58 -8.23 18.94 Favored 'General case' 0 CA--C 1.563 1.474 0 C-N-CA 125.342 1.457 . . . . 73.25 113.148 -175.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.422 ' OG ' ' HB3' ' A' ' 105' ' ' LEU . 16.4 m 75.05 46.01 0.13 Allowed 'General case' 0 C--N 1.366 1.295 0 C-N-CA 125.018 1.327 . . . . 74.21 108.621 -171.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.423 ' NE ' ' H ' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -103.21 160.09 14.97 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.127 -0.942 . . . . 74.52 111.249 -171.055 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.423 ' H ' ' NE ' ' A' ' 114' ' ' ARG . 27.9 tptp -35.66 137.61 0.19 Allowed 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 127.896 2.478 . . . . 72.15 115.557 -163.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.453 ' HA2' ' HA3' ' A' ' 168' ' ' GLY . . . -84.4 167.88 43.57 Favored Glycine 0 C--N 1.343 0.935 0 N-CA-C 115.587 0.995 . . . . 55.22 115.587 -176.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.519 ' HB3' ' HB2' ' A' ' 167' ' ' GLN . 12.5 ttm180 -115.65 144.32 44.09 Favored 'General case' 0 C--O 1.26 1.628 0 C-N-CA 124.17 0.988 . . . . 71.34 111.31 -174.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.467 ' HA ' ' H ' ' A' ' 173' ' ' ASP . 9.3 p-10 -64.6 134.9 55.29 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 114.719 -1.128 . . . . 74.23 109.978 169.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.505 HD11 ' HB2' ' B' ' 11' ' ' LEU . 7.9 tp -144.12 143.67 31.23 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.08 -0.341 . . . . 70.23 110.08 -174.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.424 ' HD2' HG21 ' B' ' 19' ' ' THR . 45.8 ttm180 -97.53 111.13 23.52 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.715 -0.846 . . . . 74.51 108.715 166.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -112.56 167.13 10.71 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 107.957 -1.127 . . . . 41.51 107.957 172.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.497 ' HG2' ' HB ' ' A' ' 177' ' ' VAL . 38.2 mt-10 -127.82 118.55 23.91 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 118.786 0.721 . . . . 61.0 109.648 -172.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.442 HD22 HD13 ' A' ' 176' ' ' LEU . 57.1 tp -100.13 104.62 30.5 Favored Pre-proline 0 N--CA 1.478 0.974 0 C-N-CA 123.985 0.914 . . . . 54.05 111.372 -164.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.653 ' HA ' ' HB2' ' A' ' 179' ' ' ARG . 24.6 Cg_exo -61.68 141.04 89.47 Favored 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 122.428 2.085 . . . . 75.33 110.511 176.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 13.4 tp -148.41 149.34 31.57 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.268 0.556 . . . . 64.01 111.975 177.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 97.8 m -85.5 140.26 30.82 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.708 1.203 . . . . 71.34 109.393 175.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.576 ' HB3' HD22 ' A' ' 215' ' ' LEU . 34.0 mt -54.79 -59.88 4.12 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 124.364 1.066 . . . . 70.54 113.359 -171.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -58.82 -39.1 80.18 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 114.961 -1.018 . . . . 75.32 110.644 -178.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -72.6 -21.83 61.06 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.06 0.944 . . . . 64.33 111.591 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.593 ' HB1' ' O ' ' A' ' 153' ' ' VAL . . . -74.87 -43.5 54.07 Favored 'General case' 0 C--O 1.247 0.947 0 C-N-CA 123.795 0.838 . . . . 41.43 110.915 178.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -72.05 -32.12 66.8 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 116.128 -0.487 . . . . 74.51 110.479 173.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 52.0 m170 -59.69 -48.13 82.88 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 123.4 0.438 . . . . 75.25 110.671 175.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.42 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 81.07 -136.08 15.65 Favored Glycine 0 CA--C 1.526 0.755 0 O-C-N 123.822 0.701 . . . . 71.54 111.583 -176.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 85.34 -172.04 46.6 Favored Glycine 0 C--N 1.344 0.983 0 O-C-N 123.632 0.254 . . . . 70.42 112.75 178.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.487 ' HB3' ' HB3' ' A' ' 146' ' ' SER . 1.8 mp0 -87.96 108.42 19.19 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 108.15 -1.056 . . . . 73.14 108.15 173.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 13.8 tpp180 -93.53 122.3 35.82 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 122.85 0.46 . . . . 74.4 110.003 -173.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 95.9 t -78.68 124.36 36.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 123.582 0.753 . . . . 71.24 109.782 -178.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.3 p -151.03 133.04 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 C-N-CA 123.82 0.848 . . . . 73.14 109.873 -174.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -84.93 135.25 34.13 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.196 0.998 . . . . 71.3 110.927 -176.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.66 HG23 ' HB2' ' B' ' 10' ' ' LEU . 2.6 p -166.4 111.56 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.201 0 C-N-CA 123.544 0.738 . . . . 75.1 111.168 -178.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.429 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . 60.25 37.71 20.33 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 113.796 1.035 . . . . 74.24 113.796 168.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 77.34 11.87 85.1 Favored Glycine 0 N--CA 1.475 1.298 0 CA-C-N 116.208 -0.451 . . . . 31.1 113.125 -178.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 26.6 ttm-85 -116.78 119.86 36.75 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.775 1.23 . . . . 72.12 108.197 174.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.458 ' HB2' ' HB2' ' A' ' 61' ' ' GLU . 14.1 tpp180 -93.34 89.62 6.44 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 106.707 -1.59 . . . . 74.41 106.707 170.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 11.6 p -89.53 140.16 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-O 121.368 0.604 . . . . 73.53 110.569 -170.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.487 ' HB3' ' HB3' ' A' ' 135' ' ' GLU . 25.2 m -106.01 90.14 3.28 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 107.768 -1.197 . . . . 31.45 107.768 174.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 3.3 p -77.35 112.56 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-O 121.335 0.588 . . . . 73.42 109.44 -174.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 5.8 tpm_? -67.06 92.12 0.24 Allowed 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 108.454 -0.943 . . . . 74.14 108.454 175.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.56 HG22 HD13 ' A' ' 159' ' ' ILE . 33.3 pt -93.44 131.74 31.88 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-N 115.203 -0.908 . . . . 74.13 109.089 -179.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -63.25 139.4 71.79 Favored 'Trans proline' 0 C--N 1.37 1.667 0 C-N-CA 122.414 2.076 . . . . 60.34 111.502 175.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -59.23 114.13 1.89 Allowed 'Trans proline' 0 C--N 1.383 2.393 0 C-N-CA 123.068 2.512 . . . . 74.15 111.855 -178.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 98.87 76.43 1.26 Allowed Glycine 0 C--N 1.345 1.066 0 N-CA-C 110.068 -1.213 . . . . 75.51 110.068 -175.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.593 ' O ' ' HB1' ' A' ' 130' ' ' ALA . 4.7 p -126.23 132.02 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 124.315 1.046 . . . . 75.43 108.453 172.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.65 ' HD2' HD12 ' A' ' 215' ' ' LEU . 0.0 OUTLIER -134.71 156.86 48.06 Favored 'General case' 0 N--CA 1.483 1.176 0 O-C-N 121.715 -0.616 . . . . 73.23 110.915 -169.92 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -51.66 117.09 2.45 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 125.222 1.409 . . . . 72.32 112.223 -172.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 114.55 -9.63 21.9 Favored Glycine 0 C--N 1.339 0.748 0 CA-C-N 115.596 -0.729 . . . . 14.21 112.708 -176.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 27.5 t -76.01 144.01 41.14 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.459 -0.941 . . . . 74.23 108.459 171.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 18.6 t -113.75 102.44 13.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 N-CA-C 108.357 -0.979 . . . . 72.34 108.357 174.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.632 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 50.9 mt -70.65 84.48 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.831 0 N-CA-C 107.45 -1.315 . . . . 75.24 107.45 172.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 70.9 ttt-85 -75.56 100.63 4.63 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.076 -1.083 . . . . 61.32 108.076 176.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.516 HG13 ' HB3' ' A' ' 174' ' ' LEU . 2.4 p -105.9 102.78 40.99 Favored Pre-proline 0 CA--C 1.546 0.825 0 N-CA-C 108.175 -1.046 . . . . 61.33 108.175 175.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -61.97 140.84 86.92 Favored 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 122.613 2.208 . . . . 74.53 110.582 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.409 ' HA2' ' HB2' ' A' ' 171' ' ' PRO . . . 83.33 26.11 44.96 Favored Glycine 0 CA--C 1.523 0.544 0 CA-C-O 118.984 -0.898 . . . . 70.43 114.557 178.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.435 ' C ' ' HB2' ' A' ' 174' ' ' LEU . 44.0 ttm -139.06 -6.06 1.44 Allowed 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 118.768 1.284 . . . . 64.15 113.423 -177.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.477 ' HA2' HD13 ' A' ' 174' ' ' LEU . . . -49.25 -59.58 6.9 Favored Glycine 0 N--CA 1.499 2.87 0 CA-C-O 122.406 1.003 . . . . 73.33 111.111 -177.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.509 ' H ' ' HA3' ' A' ' 172' ' ' GLY . . . 132.74 -86.66 0.28 Allowed Glycine 0 CA--C 1.48 -2.1 0 CA-C-N 112.227 -1.987 . . . . 74.5 109.554 158.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.519 ' HB2' ' HB3' ' A' ' 117' ' ' ARG . 19.0 mm-40 -23.36 105.32 0.02 OUTLIER 'General case' 0 C--N 1.364 1.207 0 O-C-N 129.193 3.525 . . . . 75.42 115.947 -160.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.453 ' HA3' ' HA2' ' A' ' 116' ' ' GLY . . . 137.86 -118.74 1.71 Allowed Glycine 0 N--CA 1.44 -1.071 0 N-CA-C 105.668 -2.973 . . . . 64.21 105.668 -164.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . 0.661 ' HB2' ' H ' ' A' ' 107' ' ' GLY . 57.7 t30 -165.37 -43.12 0.0 OUTLIER Pre-proline 0 N--CA 1.481 1.101 0 CA-C-N 117.769 0.784 . . . . 63.11 110.912 165.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -61.21 165.32 12.89 Favored 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 121.872 1.715 . . . . 71.13 109.647 160.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.409 ' HB2' ' HA2' ' A' ' 163' ' ' GLY . 18.6 Cg_endo -56.28 113.75 1.59 Allowed 'Trans proline' 0 CA--C 1.548 1.186 0 C-N-CA 122.811 2.34 . . . . 71.25 116.58 -168.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.509 ' HA3' ' H ' ' A' ' 166' ' ' GLY . . . -67.46 -142.06 0.07 OUTLIER Glycine 0 C--N 1.371 2.479 0 C-N-CA 118.593 -1.765 . . . . 72.4 113.534 153.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.467 ' H ' ' HA ' ' A' ' 118' ' ' ASP . 45.1 m-20 -152.27 108.53 3.41 Favored 'General case' 0 N--CA 1.51 2.569 0 CA-C-N 118.49 1.145 . . . . 71.14 108.916 176.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.516 ' HB3' HG13 ' A' ' 161' ' ' VAL . 7.8 tp -91.55 135.13 34.08 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 118.478 0.581 . . . . 64.32 112.019 -167.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 6.2 mt -115.99 93.94 4.46 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 106.029 -1.841 . . . . 72.12 106.029 177.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.632 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 82.2 mt -88.36 101.89 14.33 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.171 0.588 . . . . 70.05 111.519 -175.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.514 HG21 ' HB3' ' B' ' 392' ' ' HIS . 61.4 t -82.53 97.85 4.41 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 N-CA-C 107.378 -1.341 . . . . 61.43 107.378 174.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.507 HG11 HG22 ' A' ' 153' ' ' VAL . 10.5 p -64.84 124.01 18.84 Favored 'Isoleucine or valine' 0 C--O 1.251 1.158 0 CA-C-N 115.469 -0.787 . . . . 70.33 110.585 -174.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.653 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 8.4 mmt85 -87.94 148.17 24.71 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.03 -1.441 . . . . 53.32 108.526 167.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.488 HD11 ' HA ' ' A' ' 154' ' ' ARG . 29.2 mt -118.54 152.39 36.07 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.878 -0.786 . . . . 72.4 108.878 165.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 85.9 mt -53.09 153.87 5.97 Favored Pre-proline 0 CA--C 1.558 1.264 0 O-C-N 124.389 1.056 . . . . 73.14 111.111 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.28 11.66 0.1 Allowed 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 123.456 2.771 . . . . 71.42 115.372 -174.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.57 ' HB3' HD11 ' A' ' 127' ' ' LEU . 4.0 t-80 -61.35 104.54 0.47 Allowed Pre-proline 0 CA--C 1.565 1.529 0 C-N-CA 125.166 1.386 . . . . 73.35 108.17 169.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -80.11 29.28 0.51 Allowed 'Trans proline' 0 C--N 1.368 1.571 0 C-N-CA 124.53 3.486 . . . . 61.24 117.229 -159.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.582 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 23.8 t -89.41 -51.39 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 120.379 1.445 . . . . 64.21 108.703 -172.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . 0.428 ' CZ ' ' HA ' ' A' ' 214' ' ' THR . 65.1 m-85 -114.2 129.38 56.63 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 112.267 0.469 . . . . 72.31 112.267 -169.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.571 HH22 ' HB2' ' A' ' 189' ' ' GLU . 28.4 ttp85 -127.86 123.91 36.22 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.048 -1.093 . . . . 75.51 108.048 164.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 9.1 tp -93.0 148.05 22.32 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 123.15 0.58 . . . . 74.21 110.475 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.571 ' HB2' HH22 ' A' ' 187' ' ' ARG . 10.0 tp10 -123.5 90.58 3.31 Favored 'General case' 0 C--O 1.246 0.911 0 N-CA-C 107.583 -1.266 . . . . 70.31 107.583 163.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.515 ' HA3' ' HA ' ' B' ' 415' ' ' LYS . . . 64.83 -82.2 0.06 OUTLIER Glycine 0 C--N 1.353 1.506 0 CA-C-N 114.373 -1.285 . . . . 65.41 113.494 176.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 5.3 pm0 -93.18 -45.4 7.89 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.447 0.699 . . . . 72.32 111.362 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -111.09 144.85 39.56 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.38 -0.825 . . . . 72.32 113.009 -163.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.428 ' HB2' ' HA ' ' A' ' 249' ' ' LEU . 86.7 mt -91.46 157.41 17.07 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.491 1.116 . . . . 63.44 110.971 -177.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -131.1 105.22 7.56 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 107.777 -1.194 . . . . 73.14 107.777 170.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.582 ' HA ' ' O ' ' A' ' 185' ' ' VAL . . . -104.7 -175.77 2.89 Favored 'General case' 0 C--O 1.218 -0.567 0 C-N-CA 124.393 1.077 . . . . 74.34 110.67 178.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 34.7 m -125.18 128.66 48.71 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.672 -0.862 . . . . 70.21 108.672 173.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.423 HD22 HD13 ' A' ' 251' ' ' LEU . 48.3 tp -129.55 121.17 26.62 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 109.835 -0.432 . . . . 72.21 109.835 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -85.92 122.12 29.52 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 108.886 -0.783 . . . . 61.43 108.886 169.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 7.1 p -133.19 133.24 22.77 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 107.866 -1.161 . . . . 64.4 107.866 178.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.5 152.19 59.78 Favored 'Trans proline' 0 C--N 1.364 1.372 0 C-N-CA 121.378 1.385 . . . . 64.51 111.192 175.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.64 ' HB3' ' HH2' ' A' ' 269' ' ' TRP . . . -53.92 -44.5 98.29 Favored Pre-proline 0 CA--C 1.557 1.223 0 N-CA-C 114.782 1.401 . . . . 71.34 114.782 -175.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -64.2 -37.28 42.13 Favored 'Trans proline' 0 C--N 1.381 2.266 0 CA-C-N 121.677 1.635 . . . . 63.54 112.994 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 38.0 mt -73.59 -31.52 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.021 0.529 . . . . 64.32 110.21 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.15 -44.71 79.1 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.495 0.718 . . . . 71.51 110.999 177.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 69.5 t -68.32 -63.62 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 123.208 0.603 . . . . 63.23 110.273 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 96.4 t -72.56 -40.12 62.43 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 CA-C-N 115.466 -0.788 . . . . 74.41 111.899 -168.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 96.89 108.32 2.53 Favored Glycine 0 C--N 1.339 0.726 0 N-CA-C 111.1 -0.8 . . . . 72.35 111.1 -173.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -144.33 -157.44 7.2 Favored Glycine 0 C--N 1.342 0.871 0 CA-C-O 120.137 -0.257 . . . . 55.24 112.551 -177.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -117.18 130.41 56.58 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 117.17 0.485 . . . . 45.21 110.897 -176.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 29.8 m -132.94 -172.39 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 N-CA-C 107.591 -1.263 . . . . 63.11 107.591 167.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . 0.497 ' HD3' ' HB2' ' A' ' 218' ' ' PRO . 25.7 ttm180 -113.55 126.49 55.35 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 121.897 -0.502 . . . . 71.41 110.663 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -104.57 116.74 32.59 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.868 0.867 . . . . 62.04 109.009 175.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . 0.421 ' SD ' ' N ' ' A' ' 213' ' ' MET . 3.3 mpp? -82.75 104.72 13.21 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.836 -0.802 . . . . 71.23 108.836 178.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . 0.428 ' HA ' ' CZ ' ' A' ' 186' ' ' PHE . 82.1 p -116.49 174.09 6.26 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 123.314 0.646 . . . . 74.1 110.364 -178.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.65 HD12 ' HD2' ' A' ' 154' ' ' ARG . 14.6 mt -75.76 -17.64 59.82 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.131 0.573 . . . . 63.31 110.053 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.406 ' HG2' ' OG1' ' A' ' 214' ' ' THR . 1.5 pm0 -88.41 -5.21 58.41 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.772 1.229 . . . . 64.44 110.755 174.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 125.21 162.46 11.35 Favored Glycine 0 C--N 1.35 1.323 0 C-N-CA 123.579 0.609 . . . . 33.0 113.274 172.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . 0.497 ' HB2' ' HD3' ' A' ' 211' ' ' ARG . 60.5 Cg_endo -72.06 99.61 1.01 Allowed 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 122.463 2.109 . . . . 70.23 110.143 174.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 35.2 m -102.39 161.26 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.666 0.786 . . . . 73.4 111.466 -172.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -83.04 107.4 15.6 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 108.95 -0.759 . . . . 75.04 108.95 171.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 7.6 p -96.5 116.41 38.45 Favored 'Isoleucine or valine' 0 C--O 1.246 0.907 0 N-CA-C 109.161 -0.681 . . . . 74.13 109.161 178.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -81.97 97.32 8.04 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.646 -0.872 . . . . 60.25 108.646 175.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 97.5 t -58.22 121.82 54.44 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 124.454 1.101 . . . . 63.14 109.308 176.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.67 159.83 51.99 Favored 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 122.416 2.077 . . . . 75.51 111.453 176.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -65.04 156.35 63.19 Favored 'Trans proline' 0 C--N 1.365 1.417 0 C-N-CA 121.91 1.74 . . . . 72.53 111.711 171.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . 0.775 HH11 ' HA ' ' C' ' 260' ' ' ARG . 3.2 mmp_? 73.97 11.15 4.47 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.638 1.575 . . . . 74.04 111.89 176.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 13.2 m -59.69 120.78 10.14 Favored 'General case' 0 C--N 1.356 0.861 0 C-N-CA 124.002 0.921 . . . . 64.32 110.588 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . 0.523 ' HA ' HD11 ' A' ' 255' ' ' ILE . 48.0 tt0 -128.17 142.49 51.17 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.316 -0.402 . . . . 75.32 111.033 -166.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -60.95 133.85 56.51 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 124.1 0.875 . . . . 62.31 111.079 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 98.89 -38.67 3.01 Favored Glycine 0 C--N 1.34 0.792 0 O-C-N 123.553 0.533 . . . . 73.32 111.92 -177.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 28.5 mtm-85 -70.38 170.04 12.69 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-O 121.214 0.531 . . . . 74.0 111.053 173.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.667 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 2.9 mptp? -124.39 129.52 50.83 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.45 -0.795 . . . . 72.22 109.553 -176.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.452 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 54.7 mt -79.63 99.72 7.49 Favored 'General case' 0 C--N 1.346 0.455 0 N-CA-C 109.012 -0.736 . . . . 71.4 109.012 173.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . 0.424 ' HB3' ' HA ' ' B' ' 443' ' ' ALA . 32.8 ttp180 -72.09 100.51 2.54 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.042 0.937 . . . . 64.14 110.014 178.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.54 HD22 HG12 ' B' ' 441' ' ' ILE . 5.0 mt -87.75 102.2 14.43 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 107.64 -1.245 . . . . 61.12 107.64 176.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -51.69 126.51 17.92 Favored 'General case' 0 CA--C 1.549 0.932 0 O-C-N 124.148 0.905 . . . . 64.43 113.219 -173.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 75.3 10.22 84.37 Favored Glycine 0 C--N 1.347 1.194 0 CA-C-N 115.051 -0.977 . . . . 74.2 115.47 168.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? -84.37 -11.17 56.78 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 117.615 0.707 . . . . 73.01 110.865 175.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -98.91 -164.94 30.17 Favored Glycine 0 C--N 1.348 1.215 0 N-CA-C 111.206 -0.758 . . . . 74.43 111.206 168.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . 0.403 ' N ' ' CD1' ' A' ' 240' ' ' PHE . 2.4 m-30 -96.06 131.6 28.58 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 123.895 0.878 . . . . 73.13 110.326 -168.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.13 153.91 62.35 Favored 'Trans proline' 0 CA--C 1.547 1.139 0 C-N-CA 122.742 2.295 . . . . 73.33 112.564 177.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -148.78 -178.14 23.6 Favored Glycine 0 C--N 1.347 1.149 0 CA-C-O 119.396 -0.669 . . . . 73.52 112.876 177.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -52.75 -53.36 6.96 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 123.63 2.886 . . . . 70.45 113.315 175.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -120.46 -28.26 5.01 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 122.963 0.505 . . . . 70.11 111.575 178.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -97.67 99.64 2.27 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 111.837 -0.505 . . . . 62.24 111.837 -176.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -86.03 121.83 29.2 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 108.959 -0.756 . . . . 75.41 108.959 173.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.63 130.1 10.03 Favored Glycine 0 C--O 1.246 0.852 0 N-CA-C 114.851 0.7 . . . . 42.24 114.851 -173.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -123.12 165.38 16.94 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.933 0.893 . . . . 75.44 108.961 176.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.464 HD23 HD12 ' A' ' 235' ' ' LEU . 38.0 tp -99.33 101.68 13.04 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 109.086 -0.709 . . . . 70.31 109.086 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.667 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 14.0 m-85 -87.04 103.58 15.51 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 109.155 -0.683 . . . . 52.51 109.155 -177.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.576 HD23 ' HB3' ' A' ' 195' ' ' ALA . 87.4 mt -83.22 108.63 16.59 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 108.777 -0.823 . . . . 72.24 108.777 177.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.516 ' HG2' ' HG3' ' A' ' 232' ' ' LYS . 40.6 mt-10 -75.11 110.9 9.81 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 108.394 -0.965 . . . . 75.41 108.394 -175.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 59.5 t -67.16 125.57 24.91 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 CA-C-N 114.0 -1.454 . . . . 24.43 111.832 -170.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 3.3 mmm-85 -118.13 94.2 4.41 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 125.066 1.346 . . . . 73.14 107.626 170.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.523 HD11 ' HA ' ' A' ' 228' ' ' GLN . 57.5 mt -70.35 128.81 34.15 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 N-CA-C 109.02 -0.733 . . . . 74.34 109.02 174.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 51.9 p -122.59 146.66 47.23 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 124.434 1.094 . . . . 73.43 108.904 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.556 HD11 HE21 ' C' ' 228' ' ' GLN . 2.7 pp -109.75 147.37 36.0 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 123.32 0.648 . . . . 73.4 109.458 175.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -50.49 -18.8 4.08 Favored 'Trans proline' 0 N--CA 1.505 2.16 0 C-N-CA 124.658 3.572 . . . . 74.45 115.906 -168.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 58.51 -80.33 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.761 1.225 . . . . 63.24 110.644 -168.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 12.1 ptm85 -73.93 139.43 44.91 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 109.227 -0.657 . . . . 75.12 109.227 173.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.641 ' HB3' ' HB2' ' A' ' 266' ' ' GLU . 9.3 mt -145.04 138.13 26.51 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.228 0.611 . . . . 55.32 111.403 -169.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 27.0 p -83.04 153.41 66.7 Favored Pre-proline 0 CA--C 1.555 1.15 0 C-N-CA 124.647 1.179 . . . . 44.34 109.572 175.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -39.14 -65.3 0.17 Allowed 'Trans proline' 0 C--N 1.384 2.396 0 C-N-CA 124.878 3.719 . . . . 74.33 116.798 -171.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -68.79 -40.69 79.51 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.016 0.526 . . . . 71.44 111.816 -172.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -68.13 -37.73 81.41 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.063 0.545 . . . . 64.2 110.974 -178.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' GLU . . . . . 0.641 ' HB2' ' HB3' ' A' ' 261' ' ' LEU . 41.3 tt0 -64.2 -48.07 77.29 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 121.487 0.661 . . . . 73.45 109.306 176.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . 0.427 ' HB1' ' HE3' ' A' ' 271' ' ' LYS . . . -54.66 -41.94 70.73 Favored 'General case' 0 C--O 1.208 -1.123 0 CA-C-N 113.8 -1.545 . . . . 64.12 109.81 175.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 12.4 tp -64.81 -46.47 81.87 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.234 1.014 . . . . 73.14 110.885 -175.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' TRP . . . . . 0.64 ' HH2' ' HB3' ' A' ' 201' ' ' ALA . 73.5 m95 -55.59 -44.94 77.4 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 115.232 -0.894 . . . . 75.0 111.331 173.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . 0.615 ' HE3' ' HA ' ' C' ' 206' ' ' VAL . 53.6 mtpt -90.27 -9.31 48.42 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 115.359 -0.837 . . . . 62.43 112.267 -171.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . 0.427 ' HE3' ' HB1' ' A' ' 267' ' ' ALA . 90.1 mttt -76.05 -45.09 36.0 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.55 -1.278 . . . . 70.22 107.55 166.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' LEU . . . . . 0.622 HD21 ' HB2' ' C' ' 268' ' ' LEU . 46.1 mt -55.57 -47.23 76.73 Favored 'General case' 0 C--O 1.213 -0.831 0 CA-C-N 114.4 -1.273 . . . . 63.4 110.185 169.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . 0.532 ' HB3' ' HA ' ' A' ' 270' ' ' LYS . . . -63.75 -47.27 81.7 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 124.258 0.974 . . . . 64.51 112.758 -174.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -65.8 -44.2 86.38 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 123.226 0.329 . . . . 74.35 110.909 177.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -67.27 -27.52 67.26 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 122.885 0.474 . . . . 71.44 111.598 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . 0.514 ' HE2' ' HG3' ' C' ' 258' ' ' PRO . 24.0 t80 -75.1 -74.95 0.18 Allowed 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 107.974 -1.121 . . . . 75.02 107.974 177.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -49.69 -60.5 2.83 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.307 1.843 . . . . 70.12 112.315 -175.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -70.23 -8.24 48.49 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 112.926 0.713 . . . . 75.41 112.926 -172.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . 0.467 ' HE ' ' HA ' ' A' ' 279' ' ' ARG . 1.0 OUTLIER -121.64 1.65 10.04 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-O 118.906 -0.569 . . . . 74.13 111.391 -178.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.416 0 O-C-N 124.392 1.058 . . . . 72.21 111.185 -172.514 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mpp? . . . . . 0 N--CA 1.482 1.154 0 N-CA-C 109.302 -0.629 . . . . 71.44 109.302 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -67.33 116.88 8.59 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 108.999 -0.741 . . . . 54.1 108.999 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -86.15 68.9 10.42 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 122.344 1.068 . . . . 74.04 108.91 175.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 18.7 m -104.97 113.28 26.78 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-N 113.881 -1.509 . . . . 52.14 108.415 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.95 174.67 7.79 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 121.094 0.473 . . . . 70.11 110.524 -178.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 25.0 pt -138.93 160.13 29.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 123.357 0.663 . . . . 64.44 111.665 -163.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . 0.485 ' HB3' ' HG3' ' B' ' 75' ' ' MET . . . -136.17 143.43 44.44 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 107.09 -1.448 . . . . 72.01 107.09 166.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 35.4 tp -71.41 -89.01 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.579 0.752 . . . . 75.22 110.656 -170.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . 159.16 -61.36 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 126.188 1.795 . . . . 62.4 106.761 -175.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . 0.66 ' HB2' HG23 ' A' ' 140' ' ' VAL . 3.1 tt 53.49 115.65 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 113.561 -1.654 . . . . 74.1 110.024 -162.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.505 ' HB2' HD11 ' A' ' 119' ' ' LEU . 51.9 mt -73.03 106.28 2.15 Favored Pre-proline 0 CA--C 1.546 0.819 0 N-CA-C 108.874 -0.787 . . . . 45.35 108.874 179.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' B' ' 11' ' ' LEU . 16.9 Cg_exo -66.43 151.71 82.52 Favored 'Trans proline' 0 C--N 1.376 1.997 0 C-N-CA 123.198 2.599 . . . . 61.33 114.068 -161.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -50.43 -34.99 26.57 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.395 1.478 . . . . 75.01 111.715 168.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 38.8 tp -62.75 136.06 57.67 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.885 0.874 . . . . 64.54 109.539 175.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 43.7 t80 72.38 -82.38 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.006 1.322 . . . . 60.01 108.923 -172.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 33.4 m -159.37 122.74 2.01 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 123.767 0.827 . . . . 51.11 109.439 176.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.01 76.33 4.21 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 122.892 2.395 . . . . 62.42 112.168 172.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.453 HG22 ' H ' ' B' ' 19' ' ' THR . 4.0 p -159.94 176.65 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.019 0 N-CA-C 107.592 -1.262 . . . . 61.41 107.592 174.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . 0.453 ' H ' HG22 ' B' ' 18' ' ' VAL . 24.2 p -66.54 87.46 0.12 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.366 0.666 . . . . 71.22 111.938 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -128.71 12.06 6.26 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.573 1.149 . . . . 62.34 110.445 171.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.88 -10.1 59.4 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.314 0.645 . . . . 75.34 111.369 176.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . 0.495 ' NH1' HD13 ' B' ' 69' ' ' LEU . 25.0 tpt180 -139.33 47.68 1.88 Allowed 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 122.136 0.969 . . . . 73.31 108.782 176.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' THR . . . . . . . . . . . . . 75.5 p -119.01 86.91 32.79 Favored Pre-proline 0 CA--C 1.55 0.969 0 CA-C-N 114.752 -1.113 . . . . 72.45 109.265 176.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -80.03 148.53 19.51 Favored 'Trans proline' 0 C--N 1.374 1.878 0 C-N-CA 122.82 2.347 . . . . 74.55 112.846 -174.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -158.39 101.03 1.69 Allowed 'General case' 0 C--O 1.243 0.75 0 N-CA-C 107.751 -1.203 . . . . 74.53 107.751 177.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . 0.47 ' H ' HG12 ' B' ' 371' ' ' VAL . 0.0 OUTLIER -164.07 150.75 9.93 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 123.848 0.859 . . . . 75.13 109.096 -174.846 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -89.56 11.64 2.83 Favored 'Trans proline' 0 C--N 1.365 1.395 0 C-N-CA 122.48 2.12 . . . . 71.1 111.79 170.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.539 HG11 ' HB3' ' B' ' 33' ' ' ALA . 13.5 m 48.17 20.31 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 C-N-CA 127.11 2.164 . . . . 73.51 113.861 -174.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 63.13 14.45 7.68 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 125.261 1.424 . . . . 62.2 113.042 178.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -165.88 151.96 9.27 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.334 1.054 . . . . 70.24 109.093 176.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -71.11 97.2 1.45 Allowed 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 108.324 -0.991 . . . . 74.34 108.324 176.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -157.02 -57.56 0.08 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.757 0.823 . . . . 72.22 109.061 -169.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . 0.539 ' HB3' HG11 ' B' ' 28' ' ' VAL . . . -134.87 61.23 1.68 Allowed 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.287 -0.869 . . . . 73.31 108.917 178.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -119.02 -112.22 0.34 Allowed 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 114.59 -1.186 . . . . 53.33 108.722 176.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . 0.455 ' HB2' HE22 ' B' ' 372' ' ' GLN . 51.4 mt-30 62.92 107.78 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 124.28 1.032 . . . . 73.13 110.576 -171.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . 0.522 ' HA2' ' HB3' ' B' ' 312' ' ' PRO . . . 165.58 38.48 0.02 OUTLIER Glycine 0 C--N 1.338 0.646 0 CA-C-O 119.386 -0.674 . . . . 74.33 112.715 -179.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 1.7 p30 41.73 -80.41 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 125.948 1.699 . . . . 61.44 114.303 -174.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 10.3 tt -151.27 -34.21 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.671 0 C-N-CA 124.597 1.159 . . . . 75.44 109.518 -173.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 12.7 t -149.35 -8.72 0.33 Allowed 'General case' 0 C--O 1.215 -0.737 0 CA-C-O 118.64 -0.695 . . . . 64.25 111.812 -177.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.445 ' HB3' ' HD3' ' B' ' 373' ' ' ARG . . . 51.47 92.14 0.06 OUTLIER Pre-proline 0 N--CA 1.483 1.199 0 C-N-CA 124.549 1.14 . . . . 64.0 112.005 -177.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . 0.601 ' HG2' ' HG2' ' B' ' 313' ' ' GLN . 74.3 Cg_endo -72.18 172.86 13.95 Favored 'Trans proline' 0 C--N 1.371 1.757 0 C-N-CA 122.663 2.242 . . . . 72.44 112.861 -178.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . 0.417 ' HA2' ' HB2' ' B' ' 51' ' ' GLN . . . -79.92 79.49 1.69 Allowed Glycine 0 C--N 1.337 0.595 0 CA-C-N 115.888 -0.596 . . . . 45.24 112.101 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . 0.465 ' HA2' ' NE2' ' B' ' 313' ' ' GLN . . . -65.35 -70.55 1.06 Allowed Glycine 0 C--N 1.349 1.289 0 N-CA-C 111.704 -0.558 . . . . 42.15 111.704 176.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -96.69 97.23 9.19 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 106.34 -1.726 . . . . 63.2 106.34 167.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.0 105.95 0.05 Allowed 'General case' 0 N--CA 1.484 1.239 0 O-C-N 125.037 1.461 . . . . 74.21 111.825 -174.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 18.3 tpt180 -77.31 83.85 3.75 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 114.258 -1.337 . . . . 75.02 108.137 -177.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.408 ' HB2' ' HE1' ' B' ' 377' ' ' PHE . 41.3 tp 65.39 -78.63 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.927 1.291 . . . . 53.22 110.224 -169.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 11.6 t -167.99 165.08 13.75 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.855 0.862 . . . . 51.22 110.405 -176.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.53 29.43 13.97 Favored Glycine 0 C--N 1.351 1.406 0 CA-C-N 115.866 -0.606 . . . . 74.15 112.869 175.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 29.0 t70 52.85 74.59 0.28 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.939 1.296 . . . . 64.2 110.274 -173.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' GLN . . . . . 0.417 ' HB2' ' HA2' ' B' ' 42' ' ' GLY . 10.3 tt0 67.69 -82.71 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 125.097 1.359 . . . . 75.3 111.323 -173.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . 0.55 ' HB ' ' HB3' ' B' ' 55' ' ' LEU . 32.5 p -78.72 108.48 12.17 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 122.896 0.478 . . . . 73.31 110.895 -174.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.06 87.52 0.57 Allowed 'General case' 0 C--O 1.244 0.805 0 C-N-CA 123.806 0.842 . . . . 73.24 109.853 176.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . 58.08 72.58 0.51 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.738 1.215 . . . . 75.51 111.219 -178.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.55 ' HB3' ' HB ' ' B' ' 52' ' ' THR . 48.5 tp -157.71 131.5 7.98 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.076 -0.713 . . . . 72.35 109.076 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 6.4 ttp180 -164.25 124.25 2.04 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 108.907 -0.775 . . . . 73.2 108.907 170.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 35.7 t70 54.25 92.66 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.41 1.484 . . . . 75.31 111.513 178.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 50.0 m -143.2 -73.86 0.28 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 122.559 0.343 . . . . 62.01 110.705 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . 0.435 HD11 HD11 ' B' ' 69' ' ' LEU . 21.9 tp -104.63 168.46 9.06 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.716 0.406 . . . . 72.44 110.756 -171.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . 0.439 ' HA ' ' SD ' ' B' ' 26' ' ' MET . 23.6 p -135.18 179.36 6.37 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.589 1.155 . . . . 63.51 110.67 178.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 14.6 t70 71.5 141.79 0.05 Allowed 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 125.137 1.375 . . . . 71.45 112.789 177.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' LYS . . . . . 0.409 ' HE2' ' HG ' ' B' ' 375' ' ' LEU . 4.9 mmmp? -119.2 -55.82 0.04 OUTLIER Pre-proline 0 CA--C 1.56 1.364 0 C-N-CA 124.396 1.078 . . . . 72.3 112.505 176.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . 0.634 ' HG2' ' HB2' ' B' ' 65' ' ' LYS . 48.3 Cg_endo -86.2 8.35 4.53 Favored 'Trans proline' 0 C--N 1.385 2.486 0 C-N-CA 121.63 1.553 . . . . 72.24 114.75 -172.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.29 39.75 15.18 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.99 0.916 . . . . 72.04 110.135 -176.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.634 ' HB2' ' HG2' ' B' ' 63' ' ' PRO . 23.6 tptp -71.97 -25.61 61.93 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-N 114.886 -1.052 . . . . 65.32 111.533 -170.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -88.2 52.68 2.52 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 123.374 0.67 . . . . 72.41 110.1 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 60.7 mt 64.69 -76.9 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 125.217 1.407 . . . . 72.03 109.627 -172.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 19.3 pt -137.02 172.36 15.11 Favored 'Isoleucine or valine' 0 C--O 1.245 0.862 0 C-N-CA 125.405 1.482 . . . . 73.4 108.46 177.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.571 ' HB3' ' HB2' ' B' ' 73' ' ' ASP . 60.2 tp -63.46 110.92 2.11 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.111 0.565 . . . . 73.12 111.514 -173.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 58.7 32.51 22.26 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.911 1.284 . . . . 44.44 110.065 177.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 28.9 pt 44.47 26.58 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 C-N-CA 126.271 1.828 . . . . 74.32 113.823 -174.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -125.79 -84.99 0.57 Allowed Glycine 0 C--N 1.353 1.495 0 N-CA-C 110.176 -1.17 . . . . 62.21 110.176 177.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . 0.571 ' HB2' ' HB3' ' B' ' 69' ' ' LEU . 20.4 t70 54.93 -87.33 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.634 1.173 . . . . 63.44 112.033 176.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -89.69 79.13 1.55 Allowed Glycine 0 C--N 1.349 1.262 0 N-CA-C 110.807 -0.917 . . . . 64.42 110.807 177.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 75' ' ' MET . . . . . 0.485 ' HG3' ' HB3' ' B' ' 7' ' ' ALA . 21.6 ptt? -68.67 172.01 6.92 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.327 0.651 . . . . 74.01 111.928 -177.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 137.46 -150.92 20.96 Favored Glycine 0 C--N 1.336 0.579 0 CA-C-N 115.554 -0.748 . . . . 71.13 111.583 -178.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -159.55 138.66 11.06 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 108.502 -0.925 . . . . 73.03 108.502 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 24.9 t -82.77 42.69 0.79 Allowed 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 123.889 0.876 . . . . 51.1 110.818 -176.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . 0.4 ' HB3' ' HA ' ' B' ' 84' ' ' ARG . 15.2 tp10 66.18 137.5 0.02 OUTLIER 'General case' 0 C--N 1.362 1.142 0 C-N-CA 125.435 1.494 . . . . 74.44 110.85 -172.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 61.4 mt -69.52 -56.29 12.14 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 123.276 0.631 . . . . 72.52 111.067 -177.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 9.3 t -151.56 -31.85 0.16 Allowed 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 113.307 0.854 . . . . 71.34 113.307 -172.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.8 -27.14 67.81 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 112.641 0.608 . . . . 61.11 112.641 -170.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -167.94 38.24 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.448 1.099 . . . . 71.35 109.335 -176.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 84' ' ' ARG . . . . . 0.4 ' HA ' ' HB3' ' B' ' 79' ' ' GLU . 2.1 ptm180 -58.37 93.26 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.192 0.597 . . . . 73.0 112.325 -170.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 4.1 t30 59.83 16.96 6.05 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 124.922 1.289 . . . . 72.23 111.78 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -70.59 117.35 12.01 Favored 'General case' 0 C--N 1.352 0.692 0 CA-C-O 120.961 0.41 . . . . 63.12 110.67 -173.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -123.73 78.7 1.63 Allowed 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.631 1.173 . . . . 52.24 108.4 178.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -141.12 140.07 34.06 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.84 0.856 . . . . 74.14 108.719 -175.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -158.94 59.18 0.33 Allowed Glycine 0 C--N 1.346 1.139 0 N-CA-C 111.546 -0.622 . . . . 54.33 111.546 178.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.84 103.12 1.37 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.599 0.76 . . . . 62.33 110.321 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 75.49 24.22 71.09 Favored Glycine 0 C--N 1.345 1.039 0 CA-C-N 116.046 -0.525 . . . . 70.11 112.48 -175.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -162.72 28.27 0.25 Allowed Glycine 0 C--N 1.346 1.119 0 N-CA-C 112.207 -0.357 . . . . 23.53 112.207 -177.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -81.45 104.74 12.1 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 109.045 -0.724 . . . . 74.22 109.045 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -130.18 145.07 51.69 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.12 0.968 . . . . 71.21 109.706 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -75.23 -30.67 60.62 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.092 0.557 . . . . 74.14 109.647 169.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 112.8 7.46 21.88 Favored Glycine 0 C--N 1.353 1.476 0 CA-C-N 115.947 -0.569 . . . . 72.31 112.562 -179.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 32.5 pt -134.03 21.86 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 C-N-CA 123.96 0.904 . . . . 72.22 109.793 177.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -75.53 97.52 3.74 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.153 0.981 . . . . 75.21 110.753 -169.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -146.8 81.01 1.55 Allowed 'General case' 0 C--O 1.235 0.315 0 N-CA-C 106.548 -1.649 . . . . 61.12 106.548 174.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -79.66 111.27 19.88 Favored Pre-proline 0 N--CA 1.471 0.614 0 C-N-CA 124.069 0.948 . . . . 74.2 110.494 -169.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -90.56 157.29 4.35 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.836 2.357 . . . . 72.21 111.17 172.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -81.91 -2.96 53.07 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 116.541 -0.299 . . . . 73.12 110.464 174.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 13.5 t 52.27 24.83 3.03 Favored 'General case' 0 C--N 1.369 1.435 0 C-N-CA 126.84 2.056 . . . . 75.52 113.76 170.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 137.04 -27.16 2.93 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-O 119.688 -0.506 . . . . 51.35 112.422 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 23.6 tp60 77.7 -45.33 0.44 Allowed 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 126.104 1.762 . . . . 75.22 112.438 177.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -64.08 -17.45 63.42 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.522 1.129 . . . . 74.44 112.089 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 4.2 t -66.72 92.78 0.23 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.808 0.843 . . . . 63.32 110.058 174.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -67.62 -42.3 82.58 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 114.96 -1.018 . . . . 71.44 110.344 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -145.47 -69.62 0.28 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.832 0.853 . . . . 53.33 108.808 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -171.19 173.11 5.07 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.602 1.161 . . . . 71.24 109.721 -177.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . 0.412 HD23 ' H ' ' B' ' 111' ' ' LEU . 2.6 pt? -73.96 116.72 14.91 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-O 121.291 0.567 . . . . 64.15 109.997 176.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -81.34 145.5 30.83 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.828 -0.804 . . . . 73.2 108.828 175.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 113' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -168.33 -37.43 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.672 0.789 . . . . 75.13 109.747 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 96.3 mttt 63.78 -72.94 0.05 Allowed 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 125.301 1.441 . . . . 74.01 111.256 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 26.2 p -73.02 153.46 40.89 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.663 0.785 . . . . 73.23 110.124 168.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -111.22 13.88 28.41 Favored Glycine 0 C--N 1.339 0.697 0 CA-C-O 119.683 -0.51 . . . . 55.33 112.078 175.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt 64.91 134.05 0.04 OUTLIER Pre-proline 0 N--CA 1.485 1.293 0 C-N-CA 125.298 1.439 . . . . 70.25 111.633 -173.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 118' ' ' PRO . . . . . 0.544 ' HB2' ' HA ' ' B' ' 121' ' ' VAL . 71.1 Cg_endo -70.72 84.77 0.79 Allowed 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.317 2.011 . . . . 60.53 111.441 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 119' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -58.6 -56.02 27.56 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.894 1.277 . . . . 75.33 110.658 -177.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 120' ' ' TYR . . . . . 0.462 ' CD1' ' HB2' ' B' ' 123' ' ' ASP . 0.1 OUTLIER -80.9 -7.68 59.54 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 114.937 -1.029 . . . . 70.1 112.18 177.857 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 121' ' ' VAL . . . . . 0.544 ' HA ' ' HB2' ' B' ' 118' ' ' PRO . 49.3 t 58.42 -82.71 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.251 0 C-N-CA 125.894 1.678 . . . . 74.32 112.06 -179.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 68.2 p -85.29 -31.93 22.8 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.261 0.624 . . . . 75.24 111.531 -176.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . 0.466 ' HB3' ' NH1' ' C' ' 260' ' ' ARG . 38.4 t70 61.01 77.82 0.31 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.814 1.246 . . . . 64.3 110.878 -178.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 17.6 m 65.99 -78.87 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.985 1.314 . . . . 43.31 111.625 177.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -154.64 163.16 40.64 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.483 0.713 . . . . 73.02 111.061 -177.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -84.25 -20.8 31.62 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 115.124 -0.944 . . . . 74.13 111.234 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 42.1 t -142.02 159.43 42.23 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.075 0.95 . . . . 70.01 108.951 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -138.01 -73.76 0.41 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.921 0.489 . . . . 72.01 110.861 -176.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 12.1 t -74.12 -5.9 44.43 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.605 0.762 . . . . 54.34 112.771 -170.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . 62.06 -156.07 0.34 Allowed 'General case' 0 C--N 1.366 1.293 0 C-N-CA 124.056 0.942 . . . . 44.22 109.537 -173.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 80.4 t90 76.93 -49.07 0.55 Allowed 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 124.911 1.284 . . . . 73.51 111.533 178.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 47.5 p -59.87 149.85 30.29 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.837 1.255 . . . . 51.4 111.28 174.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 5.5 m -66.02 -22.73 66.46 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 124.22 1.008 . . . . 62.25 111.466 -177.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 124.09 50.18 0.21 Allowed Glycine 0 C--N 1.342 0.913 0 CA-C-O 119.349 -0.695 . . . . 55.15 112.27 171.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 135' ' ' VAL . . . . . 0.628 HG13 ' HB2' ' B' ' 468' ' ' LEU . 70.2 t 72.63 -65.09 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 125.333 1.453 . . . . 73.24 111.35 174.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 136' ' ' LYS . . . . . 0.456 ' HA ' ' HB3' ' A' ' 279' ' ' ARG . 35.6 mmtm -126.6 34.9 4.72 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.908 1.283 . . . . 52.43 109.638 174.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 137' ' ' THR . . . . . 0.709 ' HB ' ' HB2' ' B' ' 141' ' ' ALA . 91.5 m 65.78 87.65 0.12 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.231 1.013 . . . . 75.31 110.449 -177.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 63.48 -82.12 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.467 1.507 . . . . 75.52 112.924 174.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -107.81 -15.43 14.56 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.792 0.837 . . . . 73.24 112.518 -170.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . 136.07 -0.66 3.31 Favored Glycine 0 C--N 1.347 1.16 0 CA-C-O 119.342 -0.699 . . . . 65.04 112.882 -175.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 141' ' ' ALA . . . . . 0.709 ' HB2' ' HB ' ' B' ' 137' ' ' THR . . . 59.21 42.37 18.68 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.237 1.015 . . . . 75.34 111.332 177.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 tt -79.82 94.41 5.8 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 108.866 -0.79 . . . . 70.15 108.866 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 178.17 -154.98 15.88 Favored Glycine 0 C--N 1.341 0.858 0 CA-C-N 115.021 -0.99 . . . . 61.25 111.841 178.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 19.8 m -120.68 -57.71 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 CA-C-N 117.298 0.549 . . . . 75.31 110.961 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 145' ' ' ASP . . . . . 0.546 ' O ' ' HG2' ' B' ' 148' ' ' GLU . 14.2 t70 -85.1 -52.65 5.8 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.373 0.669 . . . . 64.3 109.605 -176.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . 0.515 HD13 ' HB1' ' B' ' 141' ' ' ALA . 20.2 mt 60.87 -86.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 124.91 1.284 . . . . 72.52 110.893 174.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -134.06 -81.97 0.45 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.333 1.453 . . . . 72.43 107.126 177.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . 0.579 ' HB3' ' HE2' ' B' ' 275' ' ' LYS . 3.4 mm-40 52.84 -80.39 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 126.377 1.871 . . . . 73.05 112.07 -175.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 149' ' ' LYS . . . . . 0.657 ' HA ' ' HB2' ' B' ' 273' ' ' GLN . 2.3 ptpt -73.64 -43.06 60.51 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 124.109 0.964 . . . . 72.23 109.483 176.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 150' ' ' ASP . . . . . 0.647 ' HB3' ' HA ' ' B' ' 232' ' ' THR . 5.9 t70 53.24 34.69 18.22 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 125.301 1.441 . . . . 74.11 109.394 -174.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 151' ' ' HIS . . . . . 0.428 ' H ' ' HG3' ' B' ' 149' ' ' LYS . 24.5 m170 65.58 133.38 0.04 OUTLIER Pre-proline 0 CA--C 1.561 1.377 0 C-N-CA 125.279 1.431 . . . . 74.43 109.865 -167.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 152' ' ' PRO . . . . . 0.504 ' HB3' ' HB1' ' B' ' 271' ' ' ALA . 12.0 Cg_endo -54.42 -32.48 73.04 Favored 'Trans proline' 0 C--N 1.382 2.301 0 C-N-CA 123.196 2.597 . . . . 42.51 113.541 -173.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 10.3 m 50.99 75.89 0.17 Allowed 'General case' 0 C--O 1.246 0.916 0 C-N-CA 125.605 1.562 . . . . 74.2 111.489 177.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 18.8 pt -87.69 169.98 1.33 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.632 0 CA-C-N 115.51 -0.768 . . . . 74.25 109.437 177.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 75.1 mt 69.98 8.82 6.86 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.797 1.239 . . . . 72.1 111.871 -176.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.81 158.5 28.17 Favored 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 124.396 1.079 . . . . 72.23 109.457 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 157' ' ' MET . . . . . . . . . . . . . 22.2 mmt -53.75 -59.42 4.64 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 124.894 1.278 . . . . 53.54 114.028 -166.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 158' ' ' ALA . . . . . . . . . . . . . . . -137.08 0.42 2.36 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 122.771 0.429 . . . . 34.04 111.705 -177.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . 0.548 ' HE3' ' HA ' ' B' ' 159' ' ' LYS . 0.4 OUTLIER 63.21 -80.78 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.486 1.515 . . . . 55.45 111.564 177.697 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -69.37 -55.48 10.26 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.245 0.618 . . . . 70.22 110.273 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -81.19 3.9 22.09 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 122.755 0.422 . . . . 71.1 111.503 175.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . -93.69 -40.78 4.6 Favored Glycine 0 C--N 1.35 1.318 0 O-C-N 123.398 0.436 . . . . 73.4 112.091 177.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . 0.507 HD21 ' HA ' ' B' ' 231' ' ' LYS . 3.1 tm? -94.29 -48.27 6.24 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.454 0.701 . . . . 65.02 110.382 -178.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 164' ' ' ALA . . . . . . . . . . . . . . . -70.44 -16.69 62.96 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 112.223 0.453 . . . . 75.34 112.223 -175.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 13.3 t -165.84 -177.95 4.53 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.194 0.997 . . . . 64.15 108.797 175.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . -118.39 54.93 0.6 Allowed Glycine 0 C--N 1.342 0.885 0 N-CA-C 109.62 -1.392 . . . . 71.15 109.62 172.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 167' ' ' ASN . . . . . . . . . . . . . 53.3 t30 65.13 -76.99 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 125.319 1.448 . . . . 72.31 109.988 -169.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 12.9 m -118.0 123.53 71.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 124.95 1.3 . . . . 74.13 107.949 174.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 43.9 m -134.68 111.21 9.8 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.368 0.667 . . . . 54.35 109.446 -175.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 26.1 m 65.57 85.38 0.14 Allowed 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.884 1.274 . . . . 63.1 111.393 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -154.53 -166.49 2.35 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-N 115.033 -0.985 . . . . 53.32 109.15 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 172' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -80.66 44.36 0.72 Allowed 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 112.649 0.611 . . . . 73.22 112.649 -177.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 173' ' ' LEU . . . . . . . . . . . . . 7.1 mp -73.26 -46.58 49.14 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 107.516 -1.29 . . . . 74.23 107.516 165.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 174' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -97.61 69.12 2.16 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 106.854 -1.536 . . . . 74.45 106.854 169.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 175' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -61.5 96.82 0.06 Allowed 'General case' 0 N--CA 1.48 1.04 0 CA-C-O 122.119 0.961 . . . . 74.1 110.844 -173.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -105.47 -20.35 13.51 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 114.806 -1.088 . . . . 74.11 110.676 -177.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 17.1 m -74.8 -43.2 4.93 Favored Pre-proline 0 CA--C 1.568 1.636 0 C-N-CA 123.893 0.877 . . . . 64.31 112.931 -177.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 178' ' ' PRO . . . . . 0.527 ' HG3' ' HG3' ' C' ' 129' ' ' GLU . 12.4 Cg_exo -69.65 127.32 14.52 Favored 'Trans proline' 0 C--N 1.39 2.745 0 C-N-CA 121.698 1.599 . . . . 74.53 111.257 175.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -61.4 -44.41 97.19 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-O 121.671 0.748 . . . . 61.34 110.822 176.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 180' ' ' ALA . . . . . 0.401 ' HB1' HG23 ' C' ' 137' ' ' VAL . . . -174.38 -43.15 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.561 1.544 . . . . 74.4 107.385 -177.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 181' ' ' LEU . . . . . 0.738 HD23 ' HB ' ' C' ' 138' ' ' VAL . 41.8 tp -177.25 -63.87 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 126.48 1.912 . . . . 62.04 106.878 169.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 182' ' ' VAL . . . . . . . . . . . . . 15.0 p -107.2 149.18 10.83 Favored 'Isoleucine or valine' 0 C--O 1.244 0.787 0 CA-C-N 114.461 -1.245 . . . . 71.31 108.556 175.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -76.33 -62.72 1.52 Allowed 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 109.088 -0.708 . . . . 65.24 109.088 172.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 26.1 t-80 -171.42 -95.06 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.72 0 O-C-N 124.335 1.022 . . . . 74.15 108.437 173.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 185' ' ' VAL . . . . . 0.575 ' HA ' ' HB1' ' C' ' 121' ' ' ALA . 58.5 t -140.0 113.66 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 CA-C-N 118.844 0.747 . . . . 71.33 110.305 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 186' ' ' THR . . . . . 0.517 ' HA ' ' HG2' ' C' ' 122' ' ' GLU . 58.6 p 62.12 4.6 1.25 Allowed 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 116.583 2.068 . . . . 51.31 116.583 162.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 187' ' ' SER . . . . . . . . . . . . . 49.0 m -147.16 107.48 4.06 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 119.378 0.99 . . . . 62.14 111.775 -174.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 18.8 tpt180 -173.02 150.44 1.99 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.468 0.707 . . . . 71.52 110.646 175.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -118.36 139.47 51.31 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.886 0.875 . . . . 72.52 108.992 166.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 190' ' ' CYS . . . . . 0.513 ' HB2' HD21 ' C' ' 181' ' ' LEU . 76.9 m -143.04 -174.39 4.17 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.895 0.878 . . . . 70.33 109.648 176.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 28.7 t80 77.13 147.01 0.09 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 125.501 1.52 . . . . 74.04 111.668 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -136.16 101.74 0.38 Allowed Glycine 0 C--N 1.34 0.752 0 N-CA-C 110.718 -0.953 . . . . 64.22 110.718 176.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 193' ' ' PRO . . . . . 0.455 ' HB3' HD22 ' B' ' 454' ' ' LEU . 94.0 Cg_endo -75.72 -10.87 20.18 Favored 'Trans proline' 0 C--N 1.372 1.789 0 C-N-CA 122.307 2.005 . . . . 64.32 113.596 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 194' ' ' SER . . . . . . . . . . . . . 23.0 t 69.05 176.59 0.27 Allowed 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 125.182 1.393 . . . . 24.51 111.142 -178.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 195' ' ' ALA . . . . . . . . . . . . . . . -123.71 29.96 6.37 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.339 1.056 . . . . 74.32 109.993 -179.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 91.3 m 67.84 -69.21 0.15 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.18 1.392 . . . . 73.32 109.898 -169.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 24.7 p -122.24 -81.43 0.64 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.242 1.017 . . . . 75.11 108.543 171.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 198' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -178.75 -40.45 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.583 1.153 . . . . 51.12 108.961 -174.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -163.61 131.58 3.61 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 106.898 -1.519 . . . . 74.4 106.898 177.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 200' ' ' CYS . . . . . . . . . . . . . 52.4 t 61.1 105.74 0.03 OUTLIER Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 124.783 1.233 . . . . 73.31 111.235 -177.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 201' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -75.51 66.82 6.43 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.857 2.371 . . . . 71.34 110.929 175.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . -76.95 119.54 5.43 Favored Glycine 0 C--N 1.346 1.112 0 CA-C-N 115.227 -0.897 . . . . 63.04 112.075 -174.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -159.76 -42.0 0.05 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.961 0.904 . . . . 71.33 108.814 176.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -157.57 119.86 3.81 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 124.046 0.938 . . . . 74.01 109.473 175.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 205' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -136.73 94.28 2.97 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 107.701 -1.222 . . . . 51.03 107.701 175.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 61.7 34.29 17.55 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 124.355 1.062 . . . . 62.32 110.915 175.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 9.1 tmtt? -70.17 112.49 6.56 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 108.978 -0.749 . . . . 74.32 108.978 -179.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 78.54 22.8 66.36 Favored Glycine 0 C--N 1.343 0.94 0 O-C-N 124.102 0.876 . . . . 71.52 112.524 -177.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . -67.83 81.55 0.17 Allowed Glycine 0 C--N 1.352 1.463 0 N-CA-C 111.787 -0.525 . . . . 42.21 111.787 177.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 18.0 tptm -83.12 136.15 34.56 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 123.543 0.737 . . . . 74.51 110.886 -171.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . -167.16 169.13 40.8 Favored Glycine 0 C--N 1.338 0.662 0 O-C-N 123.942 0.776 . . . . 74.43 111.597 174.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 22.9 t 67.84 -75.95 0.06 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.172 1.389 . . . . 74.04 111.356 176.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 46.1 mm -71.81 137.11 24.32 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 123.798 0.839 . . . . 64.4 109.558 178.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 214' ' ' THR . . . . . 0.423 ' O ' ' HA ' ' B' ' 218' ' ' LEU . 10.4 t -88.67 -36.63 16.11 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.528 0.331 . . . . 75.43 110.218 178.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 215' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -66.41 158.91 28.16 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.25 1.02 . . . . 73.31 110.553 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 68.28 90.08 0.1 Allowed 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 124.53 1.132 . . . . 61.42 108.28 -167.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 75.6 mt 62.14 85.1 0.13 Allowed 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 108.328 -0.99 . . . . 75.4 108.328 -166.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . 0.423 ' HA ' ' O ' ' B' ' 214' ' ' THR . 36.7 tp -62.36 137.07 58.19 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 114.951 -1.022 . . . . 71.43 111.745 -168.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 66.22 13.47 9.18 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.793 1.237 . . . . 71.24 111.637 -177.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . 61.13 16.06 6.84 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.453 1.101 . . . . 61.1 111.493 -171.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 221' ' ' ARG . . . . . 0.538 ' HD2' HG13 ' B' ' 224' ' ' VAL . 0.0 OUTLIER -82.61 77.45 9.37 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 106.24 -1.763 . . . . 73.55 106.24 -179.175 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -66.93 -33.14 74.94 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 114.579 -1.191 . . . . 42.52 112.619 -167.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 223' ' ' ASP . . . . . 0.513 ' HA ' ' HB2' ' B' ' 226' ' ' LEU . 9.1 p-10 -81.47 13.92 2.77 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 113.24 0.83 . . . . 61.02 113.24 -169.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . 0.538 HG13 ' HD2' ' B' ' 221' ' ' ARG . 12.8 m -57.56 -39.53 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 CA-C-O 121.131 0.491 . . . . 74.2 110.528 169.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 25.3 p -89.45 -23.51 22.1 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.256 1.022 . . . . 54.34 111.194 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . 0.513 ' HB2' ' HA ' ' B' ' 223' ' ' ASP . 3.7 mm? -83.71 -173.65 4.84 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.351 0.66 . . . . 74.43 111.008 178.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . 158.66 48.66 0.01 OUTLIER Glycine 0 C--N 1.332 0.328 0 N-CA-C 107.572 -2.211 . . . . 51.31 107.572 -177.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 228' ' ' GLY . . . . . 0.415 ' HA2' ' HA ' ' B' ' 150' ' ' ASP . . . 118.58 -159.38 14.39 Favored Glycine 0 C--O 1.243 0.707 0 CA-C-N 113.703 -1.248 . . . . 72.41 110.449 -162.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -177.59 -57.25 0.07 OUTLIER Glycine 0 C--N 1.341 0.823 0 N-CA-C 112.317 -0.313 . . . . 70.24 112.317 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -175.92 -41.12 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.955 0.902 . . . . 70.23 110.866 -175.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 231' ' ' LYS . . . . . 0.507 ' HA ' HD21 ' B' ' 163' ' ' LEU . 99.6 mttt -88.42 83.09 6.87 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.3 0.64 . . . . 73.24 111.178 -172.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 232' ' ' THR . . . . . 0.647 ' HA ' ' HB3' ' B' ' 150' ' ' ASP . 5.0 t -67.21 86.96 0.16 Allowed 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.873 0.844 . . . . 74.24 109.333 172.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 233' ' ' PHE . . . . . 0.43 ' HB2' ' HB2' ' B' ' 274' ' ' GLN . 81.6 m-85 -59.28 101.75 0.11 Allowed 'General case' 0 C--N 1.349 0.561 0 CA-C-N 114.341 -1.3 . . . . 70.41 112.038 -168.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -123.36 105.35 9.76 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 107.705 -1.22 . . . . 72.31 107.705 174.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . 0.691 ' HB3' ' HZ3' ' C' ' 209' ' ' LYS . 56.4 mt-10 -80.08 138.75 37.03 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-N 115.788 -0.642 . . . . 54.41 109.601 -176.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 236' ' ' THR . . . . . . . . . . . . . 31.7 p -73.86 96.61 2.62 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.082 0.553 . . . . 73.34 109.91 -178.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -72.13 77.0 0.96 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.708 0.803 . . . . 71.12 110.87 -177.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 30.7 m -152.32 149.69 28.93 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.827 1.251 . . . . 71.31 108.16 -177.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -168.05 -89.65 0.01 OUTLIER 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.059 0.944 . . . . 74.42 109.899 164.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . 159.11 -169.73 35.37 Favored Glycine 0 C--N 1.338 0.692 0 N-CA-C 111.404 -0.678 . . . . 71.23 111.404 -167.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 241' ' ' GLU . . . . . 0.473 ' HG3' ' HG3' ' C' ' 234' ' ' ARG . 9.7 pt-20 -93.04 -13.86 28.09 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 113.376 0.88 . . . . 71.21 113.376 -166.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 11.3 m95 55.9 -88.12 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 124.242 1.017 . . . . 70.32 111.706 -177.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 243' ' ' GLN . . . . . 0.509 ' HA ' ' NH2' ' C' ' 234' ' ' ARG . 9.9 pt20 173.67 -37.77 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 126.438 1.895 . . . . 74.22 108.059 -166.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -175.94 128.0 1.32 Allowed Glycine 0 C--N 1.348 1.247 0 N-CA-C 110.033 -1.227 . . . . 63.11 110.033 177.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 245' ' ' LYS . . . . . 0.649 ' HA ' ' HB3' ' C' ' 224' ' ' PRO . 0.0 OUTLIER -158.91 124.96 4.48 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.582 0.753 . . . . 75.34 110.128 -172.336 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 14.9 t -129.5 -166.69 1.69 Allowed 'General case' 0 CA--C 1.563 1.447 0 C-N-CA 123.54 0.736 . . . . 71.02 111.187 -170.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 247' ' ' LEU . . . . . . . . . . . . . 4.7 tt -42.0 126.64 3.26 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 126.738 2.015 . . . . 72.51 114.08 -176.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 248' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.43 116.63 32.77 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.675 0.79 . . . . 75.15 108.965 170.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -169.94 158.98 7.52 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 106.092 -1.818 . . . . 71.33 106.092 178.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 250' ' ' GLN . . . . . 0.494 HE21 ' HA ' ' B' ' 253' ' ' ALA . 18.7 tt0 -60.22 -28.88 68.36 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 118.909 0.777 . . . . 65.4 110.749 176.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 251' ' ' ALA . . . . . . . . . . . . . . . 71.85 -64.14 0.4 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.836 1.654 . . . . 61.03 111.491 171.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . 0.635 HE21 ' HA ' ' B' ' 252' ' ' GLN . 0.0 OUTLIER -88.85 72.26 8.54 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 108.884 -0.784 . . . . 72.3 108.884 170.613 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 253' ' ' ALA . . . . . 0.541 ' HB1' ' HB3' ' B' ' 256' ' ' TYR . . . -97.04 -48.53 5.36 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.274 -0.875 . . . . 51.41 109.822 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? 61.77 -83.12 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.628 1.571 . . . . 72.51 112.265 176.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -90.91 -38.88 5.94 Favored Glycine 0 C--N 1.345 1.047 0 N-CA-C 111.539 -0.624 . . . . 54.22 111.539 178.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 256' ' ' TYR . . . . . 0.541 ' HB3' ' HB1' ' B' ' 253' ' ' ALA . 33.1 p90 40.7 47.49 2.44 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 125.615 1.566 . . . . 52.52 112.069 -177.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -60.75 118.04 6.13 Favored 'General case' 0 C--N 1.35 0.59 0 CA-C-N 114.659 -1.155 . . . . 74.31 110.731 -173.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 258' ' ' LEU . . . . . 0.576 ' HA ' ' HB3' ' B' ' 263' ' ' ALA . 4.7 tt 74.8 -71.61 0.13 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.769 1.628 . . . . 75.13 109.862 178.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . 0.536 HG23 ' H ' ' B' ' 260' ' ' SER 0.272 19.6 m 44.25 -76.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 C-N-CA 126.805 2.042 . . . . 63.02 113.849 -176.609 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 260' ' ' SER . . . . . 0.536 ' H ' HG23 ' B' ' 259' ' ' VAL . 61.5 p -163.14 144.72 9.81 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.812 1.245 . . . . 73.11 108.49 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 73.01 -66.43 0.31 Allowed 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.899 1.279 . . . . 52.21 113.719 168.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 262' ' ' ALA . . . . . . . . . . . . . . . -44.58 -59.92 2.23 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.909 1.283 . . . . 43.43 113.121 -176.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 263' ' ' ALA . . . . . 0.576 ' HB3' ' HA ' ' B' ' 258' ' ' LEU . . . -101.02 -4.74 26.89 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 122.623 0.369 . . . . 70.44 111.61 178.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 264' ' ' SER . . . . . 0.451 ' HB2' HD12 ' B' ' 265' ' ' LEU . 12.4 m -85.82 -67.99 0.77 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 122.836 0.455 . . . . 51.14 110.302 -178.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 265' ' ' LEU . . . . . 0.451 HD12 ' HB2' ' B' ' 264' ' ' SER . 5.4 mp -95.12 -28.73 14.93 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.332 0.653 . . . . 64.12 111.401 -175.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 266' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 66.15 -72.29 0.08 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 125.12 1.368 . . . . 71.52 109.735 -166.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 24.6 p -75.82 89.18 2.87 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 108.057 -1.09 . . . . 73.13 108.057 167.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . 0.506 HG22 ' HB3' ' B' ' 270' ' ' GLU . 4.3 p -53.85 -45.12 62.35 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 124.333 1.053 . . . . 74.44 112.003 -175.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 269' ' ' THR . . . . . . . . . . . . . 30.1 p 44.11 39.44 2.85 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 125.427 1.491 . . . . 74.31 112.259 177.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 270' ' ' GLU . . . . . 0.506 ' HB3' HG22 ' B' ' 268' ' ' VAL . 0.0 OUTLIER -60.35 -19.66 56.42 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.781 1.232 . . . . 72.41 113.254 -169.531 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 271' ' ' ALA . . . . . 0.504 ' HB1' ' HB3' ' B' ' 152' ' ' PRO . . . 63.73 21.8 12.83 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 124.468 1.107 . . . . 75.3 111.753 177.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 272' ' ' ASN . . . . . 0.46 ' H ' ' HG2' ' B' ' 270' ' ' GLU . 0.2 OUTLIER 57.85 33.7 23.51 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.924 1.289 . . . . 54.14 110.569 -175.774 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 273' ' ' GLN . . . . . 0.657 ' HB2' ' HA ' ' B' ' 149' ' ' LYS . 27.3 mm-40 -118.85 136.15 54.18 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.47 0.708 . . . . 61.32 109.896 178.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 274' ' ' GLN . . . . . 0.43 ' HB2' ' HB2' ' B' ' 233' ' ' PHE . 17.6 tt0 76.45 -58.85 0.52 Allowed 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 126.449 1.9 . . . . 71.44 113.298 175.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 275' ' ' LYS . . . . . 0.579 ' HE2' ' HB3' ' B' ' 148' ' ' GLU . 74.6 mmtt -54.78 109.48 1.6 Allowed Pre-proline 0 N--CA 1.478 0.938 0 C-N-CA 124.448 1.099 . . . . 71.33 112.566 -164.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -67.02 115.33 3.56 Favored 'Trans proline' 0 C--N 1.383 2.389 0 C-N-CA 122.32 2.013 . . . . 62.35 110.25 176.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 277' ' ' LEU . . . . . . . . . . . . . 96.3 mt -58.36 133.49 55.77 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.608 0.763 . . . . 63.32 111.422 -177.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 1.2 pp -86.2 13.95 7.16 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.894 0.878 . . . . 62.0 112.823 -173.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . -75.13 -110.71 0.1 OUTLIER Glycine 0 C--N 1.351 1.365 0 O-C-N 123.312 0.382 . . . . 75.43 112.432 -178.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 2.6 tt -142.56 -80.88 0.21 Allowed 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 107.117 -1.438 . . . . 53.23 107.117 176.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 68.67 -62.12 0.39 Allowed 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 125.778 1.631 . . . . 75.31 112.791 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 282' ' ' ALA . . . . . 0.5 ' HB1' ' HG3' ' B' ' 245' ' ' LYS . . . 74.68 -74.05 0.09 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.873 1.669 . . . . 65.41 109.0 -174.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -151.24 118.54 5.98 Favored 'General case' 0 C--O 1.245 0.865 0 N-CA-C 107.618 -1.253 . . . . 72.33 107.618 174.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . 61.74 -96.17 0.12 Allowed Glycine 0 C--N 1.351 1.377 0 O-C-N 123.935 0.772 . . . . 61.45 111.297 -174.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -146.88 86.12 1.64 Allowed 'General case' 0 C--O 1.244 0.766 0 N-CA-C 107.897 -1.149 . . . . 72.41 107.897 173.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 286' ' ' MET . . . . . . . . . . . . . 6.3 mmt 68.96 163.81 0.14 Allowed Pre-proline 0 CA--C 1.558 1.256 0 C-N-CA 124.674 1.189 . . . . 64.1 113.099 173.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 287' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -71.04 -2.72 11.52 Favored 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 122.647 2.231 . . . . 73.33 112.761 167.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 288' ' ' VAL . . . . . 0.404 HG12 ' HG3' ' B' ' 289' ' ' ARG . 94.6 t 71.57 -73.35 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.366 1.291 0 C-N-CA 125.591 1.556 . . . . 74.32 110.878 176.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 289' ' ' ARG . . . . . 0.404 ' HG3' HG12 ' B' ' 288' ' ' VAL . 98.3 mtt180 -135.19 -53.63 0.79 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.577 0.751 . . . . 72.14 109.839 178.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 290' ' ' TRP . . . . . . . . . . . . . 47.4 p90 -66.94 146.06 54.78 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.403 -0.817 . . . . 75.34 111.864 -174.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 291' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -111.15 -52.97 2.75 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 108.516 -0.92 . . . . 64.34 108.516 175.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . -143.71 69.79 0.41 Allowed Glycine 0 C--N 1.348 1.199 0 CA-C-N 115.573 -0.74 . . . . 62.12 112.669 -178.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -80.64 -36.21 0.47 Allowed 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 122.461 2.108 . . . . 51.12 112.956 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 5.4 tmtp? -91.31 85.81 5.94 Favored 'General case' 0 C--N 1.356 0.881 0 N-CA-C 108.329 -0.989 . . . . 41.23 108.329 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -157.13 124.04 5.11 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 114.65 -1.159 . . . . 34.32 108.787 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 14.8 t -151.39 169.86 20.96 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 123.562 0.745 . . . . 65.42 109.906 179.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -125.61 -159.21 0.89 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.285 1.034 . . . . 64.12 109.557 -175.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 42.2 m80 73.96 -76.69 0.06 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.219 1.407 . . . . 71.5 110.477 178.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . 98.06 156.99 29.99 Favored Glycine 0 C--N 1.349 1.263 0 N-CA-C 111.606 -0.597 . . . . 63.41 111.606 -175.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -85.04 -57.48 3.08 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 109.681 -0.488 . . . . 72.23 109.681 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 301' ' ' ILE . . . . . . . . . . . . . 35.1 pt -134.63 -172.66 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 123.838 0.855 . . . . 72.24 110.025 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 26.5 t70 70.33 8.15 6.51 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 125.026 1.33 . . . . 63.41 112.967 174.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 303' ' ' LYS . . . . . 0.464 ' N ' ' HD2' ' B' ' 304' ' ' PRO . 39.7 mtmt -72.52 -29.31 1.17 Allowed Pre-proline 0 CA--C 1.562 1.404 0 C-N-CA 124.581 1.153 . . . . 74.11 112.735 173.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 304' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' B' ' 33' ' ' ALA . 43.7 Cg_endo -67.59 -8.72 23.12 Favored 'Trans proline' 0 C--N 1.397 3.119 0 CA-C-N 121.345 1.516 . . . . 75.12 112.697 164.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . 67.49 26.22 8.27 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 125.07 1.348 . . . . 42.33 111.94 176.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . 0.632 HG13 ' H ' ' B' ' 307' ' ' THR . 2.2 p -129.2 -84.77 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 CA-C-N 115.746 -0.661 . . . . 72.33 109.925 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . 0.632 ' H ' HG13 ' B' ' 306' ' ' VAL . 3.0 m 70.61 -23.91 0.17 Allowed 'General case' 0 CA--C 1.566 1.567 0 C-N-CA 125.786 1.635 . . . . 74.23 113.549 178.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 308' ' ' CYS . . . . . 0.499 ' SG ' HG11 ' C' ' 177' ' ' VAL . 39.7 t -76.79 -115.84 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 124.19 0.996 . . . . 74.22 109.399 177.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . 0.466 HG22 ' HD3' ' B' ' 312' ' ' PRO . 88.9 m 52.55 98.83 0.04 OUTLIER Pre-proline 0 CA--C 1.561 1.375 0 C-N-CA 124.442 1.097 . . . . 72.2 111.881 -177.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -77.39 56.84 5.68 Favored 'Trans proline' 0 CA--C 1.557 1.648 0 C-N-CA 122.591 2.194 . . . . 63.14 112.628 178.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 311' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -133.67 -52.6 0.03 OUTLIER Pre-proline 0 CA--C 1.567 1.615 0 CA-C-O 117.609 -1.186 . . . . 73.13 112.971 -175.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 312' ' ' PRO . . . . . 0.522 ' HB3' ' HA2' ' B' ' 36' ' ' GLY . 32.4 Cg_exo -58.13 116.03 2.95 Favored 'Trans proline' 0 C--N 1.399 3.216 0 C-N-CA 122.014 1.809 . . . . 70.14 111.954 177.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 313' ' ' GLN . . . . . 0.601 ' HG2' ' HG2' ' B' ' 41' ' ' PRO . 26.3 pt20 -165.21 17.12 0.04 OUTLIER 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 113.718 1.006 . . . . 75.13 113.718 -171.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 314' ' ' ARG . . . . . 0.584 ' HG2' ' HD3' ' B' ' 41' ' ' PRO . 18.0 mmt85 -61.78 -68.76 0.29 Allowed 'General case' 0 N--CA 1.501 2.108 0 CA-C-N 120.412 1.46 . . . . 72.01 109.887 176.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 315' ' ' ASN . . . . . 0.42 ' HB2' ' NZ ' ' C' ' 115' ' ' LYS . 6.0 t30 -173.04 126.3 0.45 Allowed 'General case' 0 N--CA 1.473 0.677 0 O-C-N 124.025 0.828 . . . . 72.12 109.265 170.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 316' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -79.57 -75.35 0.25 Allowed 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 109.059 -0.719 . . . . 74.4 109.059 169.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 68.6 m -156.41 177.1 11.84 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.52 0.728 . . . . 75.41 110.987 -176.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 318' ' ' VAL . . . . . . . . . . . . . 34.7 m -110.77 146.63 34.8 Favored Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 123.802 0.841 . . . . 73.13 109.356 172.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 319' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -78.7 159.14 28.26 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.593 2.195 . . . . 65.1 112.551 175.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 320' ' ' THR . . . . . . . . . . . . . 22.5 p -138.36 10.63 2.75 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.236 1.014 . . . . 53.31 110.65 178.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 321' ' ' LEU . . . . . . . . . . . . . 58.6 tp -96.81 143.32 27.83 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.393 0.677 . . . . 65.14 111.15 -175.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 322' ' ' ALA . . . . . . . . . . . . . . . -88.87 116.29 27.04 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 107.775 -1.194 . . . . 64.54 107.775 165.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 323' ' ' GLN . . . . . 0.664 ' HG3' ' SD ' ' B' ' 324' ' ' MET . 10.8 pt20 -60.98 -37.79 83.7 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 113.097 0.777 . . . . 74.02 113.097 -170.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 324' ' ' MET . . . . . 0.664 ' SD ' ' HG3' ' B' ' 323' ' ' GLN . 0.1 OUTLIER -162.62 168.8 21.18 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 112.083 0.401 . . . . 71.32 112.083 173.884 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 325' ' ' THR . . . . . 0.714 HG23 HD13 ' B' ' 348' ' ' ILE . 41.9 p -84.75 -107.51 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 124.155 0.982 . . . . 72.33 111.767 -174.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 326' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -174.4 154.27 2.09 Favored 'General case' 0 C--N 1.362 1.13 0 C-N-CA 124.275 1.03 . . . . 72.01 109.436 -175.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 81.8 tttt 176.71 41.84 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.315 0 C-N-CA 125.747 1.619 . . . . 54.34 108.733 170.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 328' ' ' ALA . . . . . . . . . . . . . . . 73.6 91.34 0.09 Allowed 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 125.303 1.441 . . . . 72.03 111.83 177.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 329' ' ' ILE . . . . . 0.419 HG23 ' HG3' ' B' ' 330' ' ' GLU . 10.7 tt -145.09 166.69 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.447 1.099 . . . . 73.5 109.127 173.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 330' ' ' GLU . . . . . 0.419 ' HG3' HG23 ' B' ' 329' ' ' ILE . 44.6 mt-10 71.42 99.22 0.07 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.06 1.344 . . . . 63.42 113.279 170.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 331' ' ' LEU . . . . . 0.43 ' HG ' ' H ' ' B' ' 332' ' ' LEU . 1.2 pt? 41.28 -73.76 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 117.465 2.394 . . . . 63.34 117.465 167.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 332' ' ' LEU . . . . . 0.434 HD23 HG23 ' C' ' 18' ' ' THR . 3.2 tm? 76.63 -66.07 0.27 Allowed 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 125.827 1.651 . . . . 74.41 108.663 -163.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 333' ' ' SER . . . . . . . . . . . . . 27.8 p -111.65 -61.14 1.75 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.634 0.773 . . . . 65.04 110.053 -176.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 334' ' ' LYS . . . . . 0.575 ' HA ' ' HE2' ' B' ' 334' ' ' LYS . 9.9 mmpt? -120.93 132.12 54.75 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.169 0.987 . . . . 63.11 110.387 -176.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 335' ' ' ASN . . . . . 0.504 ' HB2' HD11 ' B' ' 341' ' ' LEU . 2.8 p-10 -92.34 -12.16 33.14 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.877 0.871 . . . . 73.25 111.109 -178.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -80.73 -5.77 57.54 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.069 0.947 . . . . 61.02 110.774 -177.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 337' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -58.9 128.77 38.9 Favored 'General case' 0 C--N 1.36 1.061 0 C-N-CA 123.86 0.864 . . . . 62.43 111.274 -177.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 338' ' ' GLY . . . . . . . . . . . . . . . 79.01 -67.07 3.31 Favored Glycine 0 C--N 1.346 1.116 0 N-CA-C 110.767 -0.933 . . . . 72.34 110.767 -170.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 339' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -166.05 -47.52 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.542 1.137 . . . . 74.33 108.894 172.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 340' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -169.78 91.65 0.21 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.405 -0.961 . . . . 75.24 108.405 -177.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 341' ' ' LEU . . . . . 0.504 HD11 ' HB2' ' B' ' 335' ' ' ASN . 5.1 mp 48.17 52.94 12.51 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.967 1.307 . . . . 75.34 112.962 174.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 342' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -73.56 -13.96 61.12 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 111.575 0.213 . . . . 64.25 111.575 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 343' ' ' VAL . . . . . . . . . . . . . 7.4 p -62.14 142.0 17.04 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 123.257 0.623 . . . . 64.24 109.448 171.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -130.69 144.19 51.26 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.437 1.095 . . . . 73.03 109.106 -178.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 345' ' ' GLY . . . . . . . . . . . . . . . -169.73 -78.74 0.04 OUTLIER Glycine 0 C--N 1.346 1.111 0 CA-C-O 119.845 -0.42 . . . . 62.31 112.927 -176.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 346' ' ' ALA . . . . . 0.408 ' HB1' ' HG2' ' B' ' 324' ' ' MET . . . -57.64 115.69 2.94 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.525 0.73 . . . . 72.22 111.054 177.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 347' ' ' SER . . . . . 0.533 ' HB2' ' H ' ' B' ' 352' ' ' ASP . 61.3 p -166.75 21.85 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 113.373 0.879 . . . . 72.21 113.373 -172.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 348' ' ' ILE . . . . . 0.714 HD13 HG23 ' B' ' 325' ' ' THR . 14.9 mm 59.54 43.59 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 CA-C-O 122.346 1.069 . . . . 73.42 108.979 -173.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 349' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 60.93 15.06 5.73 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 114.812 -1.085 . . . . 71.13 112.765 173.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 350' ' ' LYS . . . . . . . . . . . . . 4.6 ttmp? -141.65 112.08 7.02 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 107.59 -1.263 . . . . 74.52 107.59 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -62.51 91.76 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.836 0 O-C-N 124.063 0.852 . . . . 71.32 112.392 -163.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 352' ' ' ASP . . . . . 0.533 ' H ' ' HB2' ' B' ' 347' ' ' SER . 21.6 t70 -164.74 -79.2 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.257 1.423 . . . . 74.35 107.238 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 353' ' ' HIS . . . . . . . . . . . . . 4.9 t60 165.47 -39.7 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 125.798 1.639 . . . . 74.33 107.53 -178.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 354' ' ' ALA . . . . . . . . . . . . . . . 67.59 -95.9 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 126.106 1.762 . . . . 70.11 110.749 -175.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 355' ' ' ALA . . . . . . . . . . . . . . . 54.53 25.07 5.85 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 124.248 1.019 . . . . 75.44 112.618 -176.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 356' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -68.31 -46.15 38.5 Favored Pre-proline 0 CA--C 1.562 1.417 0 N-CA-C 113.804 1.038 . . . . 74.32 113.804 -175.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 357' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -72.72 77.82 2.18 Favored 'Trans proline' 0 C--N 1.395 3.004 0 C-N-CA 122.027 1.818 . . . . 55.22 113.175 -175.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 358' ' ' CYS . . . . . . . . . . . . . 85.3 m -103.85 160.16 15.03 Favored 'General case' 0 C--O 1.246 0.886 0 C-N-CA 123.402 0.681 . . . . 73.32 109.64 176.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 359' ' ' GLY . . . . . . . . . . . . . . . -73.12 82.88 0.63 Allowed Glycine 0 C--N 1.347 1.162 0 N-CA-C 110.899 -0.88 . . . . 62.01 110.899 173.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 360' ' ' GLN . . . . . 0.463 ' NE2' ' H ' ' B' ' 360' ' ' GLN . 0.3 OUTLIER -48.07 -51.49 24.18 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 124.707 1.203 . . . . 53.34 112.58 -176.921 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 361' ' ' ILE . . . . . . . . . . . . . 3.6 mp -109.52 78.93 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 N-CA-C 107.011 -1.477 . . . . 61.31 107.011 167.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 362' ' ' GLY . . . . . . . . . . . . . . . -174.06 -73.53 0.05 OUTLIER Glycine 0 C--N 1.344 0.974 0 CA-C-N 115.234 -0.894 . . . . 72.35 111.831 177.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 363' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -82.17 -0.73 46.32 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.954 0.901 . . . . 73.13 112.371 -171.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 364' ' ' THR . . . . . . . . . . . . . 3.0 t -160.84 77.58 0.59 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.703 0.801 . . . . 74.04 110.553 -178.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 31.4 t -125.71 -18.53 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 C-N-CA 123.195 0.598 . . . . 74.01 111.181 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 35.2 t0 68.55 28.37 5.89 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 124.712 1.205 . . . . 50.12 108.372 -167.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 367' ' ' LEU . . . . . . . . . . . . . 2.2 tt 55.74 -105.74 0.29 Allowed 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 126.228 1.811 . . . . 75.05 109.94 -178.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 368' ' ' ASP . . . . . . . . . . . . . 4.6 t70 179.24 -145.16 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.607 -0.886 . . . . 71.23 108.607 -170.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 369' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 73.34 -73.53 0.1 Allowed 'General case' 0 C--N 1.36 1.054 0 C-N-CA 126.174 1.79 . . . . 70.1 111.875 170.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 370' ' ' ALA . . . . . . . . . . . . . . . -94.03 172.38 8.26 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.337 0.655 . . . . 74.25 110.51 177.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 371' ' ' VAL . . . . . 0.47 HG12 ' H ' ' B' ' 26' ' ' MET . 6.1 p -132.12 77.43 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 C-N-CA 122.953 0.501 . . . . 74.11 109.844 177.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 372' ' ' GLN . . . . . 0.455 HE22 ' HB2' ' B' ' 35' ' ' GLN . 2.8 mp0 69.73 -63.37 0.39 Allowed 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 125.173 1.389 . . . . 63.2 112.265 176.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 373' ' ' ARG . . . . . 0.445 ' HD3' ' HB3' ' B' ' 40' ' ' ALA . 55.9 mtp180 83.82 -4.14 1.13 Allowed 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 126.53 1.932 . . . . 72.05 112.758 169.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 374' ' ' ALA . . . . . 0.445 ' HB2' HG23 ' B' ' 309' ' ' THR . . . -74.82 -8.6 56.93 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.131 0.491 . . . . 71.45 111.023 171.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 375' ' ' LEU . . . . . 0.409 ' HG ' ' HE2' ' B' ' 62' ' ' LYS . 2.9 mm? -70.92 -6.17 36.41 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.775 1.23 . . . . 62.01 110.957 173.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.23 -24.11 67.25 Favored 'General case' 0 C--N 1.355 0.84 0 C-N-CA 123.432 0.693 . . . . 73.13 110.437 170.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 377' ' ' PHE . . . . . 0.408 ' HE1' ' HB2' ' B' ' 47' ' ' LEU . 3.4 t80 -94.12 57.64 2.41 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.717 0.807 . . . . 73.31 109.868 -179.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 378' ' ' ALA . . . . . . . . . . . . . . . -73.41 1.65 9.28 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 115.017 -0.992 . . . . 61.1 110.256 165.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . 0.456 ' O ' ' HG3' ' B' ' 380' ' ' LYS . 29.0 mttt -70.66 -9.71 57.68 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 126.424 1.89 . . . . 72.01 110.714 169.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 380' ' ' LYS . . . . . 0.709 ' HD2' ' HB2' ' B' ' 408' ' ' LEU 0.287 0.0 OUTLIER 54.88 140.42 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 127.82 2.448 . . . . 53.14 114.352 -175.783 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' B' B ' 381' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -75.6 165.22 25.41 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.711 0.804 . . . . 74.34 112.607 -175.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . 80.67 -69.82 3.13 Favored Glycine 0 C--N 1.351 1.408 0 CA-C-N 115.501 -0.772 . . . . 73.1 111.478 -176.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 383' ' ' ASN . . . . . . . . . . . . . 7.2 t30 63.4 68.9 0.58 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.895 1.278 . . . . 73.1 111.081 174.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 384' ' ' THR . . . . . 0.573 ' HA ' HG12 ' B' ' 388' ' ' VAL . 3.5 m -150.43 0.31 0.43 Allowed 'General case' 0 CA--C 1.558 1.278 0 CA-C-N 114.913 -1.04 . . . . 63.41 110.109 177.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 385' ' ' LEU . . . . . 0.509 HD23 ' HE3' ' B' ' 380' ' ' LYS . 3.3 mm? -51.6 -53.33 39.46 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 126.094 1.758 . . . . 75.12 111.846 -172.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 386' ' ' VAL . . . . . 0.677 ' HB ' ' HB3' ' B' ' 390' ' ' ALA . 18.4 t -125.43 77.76 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 N-CA-C 108.739 -0.838 . . . . 62.42 108.739 176.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 387' ' ' ILE . . . . . . . . . . . . . 20.8 mm 58.48 27.41 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 C-N-CA 124.678 1.191 . . . . 74.12 110.753 173.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 388' ' ' VAL . . . . . 0.573 HG12 ' HA ' ' B' ' 384' ' ' THR . 1.5 m 63.41 -0.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 C-N-CA 126.494 1.917 . . . . 54.33 113.404 -177.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 389' ' ' THR . . . . . . . . . . . . . 9.3 t -128.1 37.64 4.13 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.755 -0.59 . . . . 71.25 111.481 -166.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 390' ' ' ALA . . . . . 0.677 ' HB3' ' HB ' ' B' ' 386' ' ' VAL . . . -153.63 -79.25 0.1 Allowed 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 108.492 -0.929 . . . . 70.34 108.492 170.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 391' ' ' ASP . . . . . 0.402 ' O ' ' HB2' ' B' ' 392' ' ' HIS . 1.4 m-20 54.27 78.25 0.17 Allowed 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 116.188 1.921 . . . . 64.12 116.188 155.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 392' ' ' HIS . . . . . 0.514 ' HB3' HG21 ' A' ' 177' ' ' VAL . 11.1 t-80 179.32 142.57 0.13 Allowed 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 122.993 0.517 . . . . 72.42 111.059 160.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 393' ' ' ALA . . . . . 0.472 ' HB2' ' HZ3' ' B' ' 415' ' ' LYS . . . -118.06 145.01 45.13 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 107.582 -1.266 . . . . 61.53 107.582 166.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 394' ' ' HIS . . . . . 0.408 ' NE2' ' HB3' ' B' ' 397' ' ' GLN . 30.9 t60 -108.21 -26.74 10.43 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 118.047 0.385 . . . . 73.31 111.423 -175.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . 64.75 31.87 11.51 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.818 1.247 . . . . 71.44 113.104 171.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 23.9 t 62.37 31.19 17.39 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.634 1.174 . . . . 75.55 110.051 177.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 397' ' ' GLN . . . . . 0.408 ' HB3' ' NE2' ' B' ' 394' ' ' HIS . 16.2 pm0 44.25 29.69 0.39 Allowed 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 126.663 1.985 . . . . 71.41 113.987 -174.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 66.9 mt -70.61 93.38 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 107.395 -1.335 . . . . 75.44 107.395 173.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 399' ' ' VAL . . . . . 0.605 ' HA ' ' HA ' ' B' ' 63' ' ' PRO . 73.6 t 65.16 -82.04 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.209 0 C-N-CA 124.848 1.259 . . . . 73.32 109.556 -170.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 400' ' ' ALA . . . . . 0.44 ' HB3' ' HB ' ' B' ' 403' ' ' THR . . . 167.65 145.83 0.06 OUTLIER Pre-proline 0 N--CA 1.484 1.242 0 C-N-CA 126.278 1.831 . . . . 51.41 108.554 175.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 401' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -67.54 -43.94 5.11 Favored 'Trans proline' 0 C--N 1.373 1.84 0 C-N-CA 122.576 2.184 . . . . 71.04 110.844 170.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -86.95 22.82 1.9 Allowed 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.072 1.349 . . . . 74.34 111.55 -177.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 403' ' ' THR . . . . . 0.48 ' O ' ' HB ' ' B' ' 306' ' ' VAL . 15.1 t -64.79 -26.29 68.28 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 112.913 0.709 . . . . 51.3 112.913 -170.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 404' ' ' LYS . . . . . 0.4 ' HD3' ' HA ' ' B' ' 306' ' ' VAL . 46.5 mmtm -86.05 -64.11 1.21 Allowed 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 108.712 -0.847 . . . . 70.03 108.712 172.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 405' ' ' ALA . . . . . 0.52 ' HB3' ' HD3' ' B' ' 406' ' ' PRO . . . -176.03 -56.42 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.342 0 C-N-CA 124.702 1.201 . . . . 71.24 109.966 177.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 406' ' ' PRO . . . . . 0.52 ' HD3' ' HB3' ' B' ' 405' ' ' ALA . 59.1 Cg_endo -97.47 98.72 0.07 OUTLIER 'Trans proline' 0 C--N 1.394 2.94 0 C-N-CA 122.464 2.11 . . . . 44.44 111.818 176.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . -73.82 -57.89 4.7 Favored Glycine 0 C--N 1.341 0.86 0 N-CA-C 111.329 -0.708 . . . . 55.33 111.329 175.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 408' ' ' LEU . . . . . 0.709 ' HB2' ' HD2' ' B' ' 380' ' ' LYS . 4.2 mp -110.83 137.64 48.23 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 108.553 -0.906 . . . . 72.03 108.553 178.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 90.0 m -146.76 141.73 27.03 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.601 0.761 . . . . 73.52 109.578 -174.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 410' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 73.44 153.67 0.14 Allowed 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 125.054 1.342 . . . . 51.32 112.09 173.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . -113.08 161.99 16.44 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.415 0.686 . . . . 63.14 111.242 -178.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 68.35 125.64 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 125.341 1.456 . . . . 60.41 111.435 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 413' ' ' ASN . . . . . 0.459 ' N ' HD22 ' B' ' 413' ' ' ASN . 0.7 OUTLIER 69.85 9.29 7.08 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 125.221 1.408 . . . . 71.14 111.405 -173.518 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 414' ' ' THR . . . . . . . . . . . . . 41.5 p -113.66 -49.61 2.88 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.671 0.788 . . . . 73.24 111.347 -169.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 415' ' ' LYS . . . . . 0.515 ' HA ' ' HA3' ' A' ' 190' ' ' GLY . 35.2 tttp -150.58 36.83 0.65 Allowed 'General case' 0 N--CA 1.485 1.295 0 CA-C-O 121.975 0.893 . . . . 73.42 110.757 -176.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.1 -15.85 62.54 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 114.482 -1.236 . . . . 75.33 112.755 -176.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 417' ' ' GLY . . . . . . . . . . . . . . . -54.62 102.47 0.14 Allowed Glycine 0 C--N 1.352 1.472 0 O-C-N 123.982 0.801 . . . . 43.15 114.541 -173.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 418' ' ' ALA . . . . . . . . . . . . . . . -90.22 18.6 5.82 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.849 1.26 . . . . 70.25 111.354 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 419' ' ' VAL . . . . . 0.554 HG12 ' H ' ' B' ' 420' ' ' MET . 3.4 t 67.63 179.38 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.57 1.718 0 C-N-CA 125.492 1.517 . . . . 62.03 110.231 175.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 420' ' ' MET . . . . . 0.554 ' H ' HG12 ' B' ' 419' ' ' VAL . 42.2 ttp 77.2 89.98 0.07 Allowed 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.644 1.178 . . . . 73.12 111.285 171.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 421' ' ' VAL . . . . . . . . . . . . . 41.2 t -80.89 -19.98 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 C-N-CA 123.744 0.818 . . . . 72.42 111.519 -174.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 422' ' ' MET . . . . . . . . . . . . . 18.2 ptm -63.0 90.78 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.421 0.688 . . . . 74.1 112.48 -173.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 423' ' ' SER . . . . . . . . . . . . . 32.6 t 56.33 -91.16 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.27 1.428 . . . . 62.22 112.202 175.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 424' ' ' TYR . . . . . 0.481 ' HD1' ' HA ' ' B' ' 428' ' ' GLU . 87.1 m-85 -92.0 117.55 29.93 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.963 -0.754 . . . . 72.42 108.963 -178.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . -137.89 144.81 16.23 Favored Glycine 0 C--O 1.241 0.567 0 N-CA-C 110.207 -1.157 . . . . 75.12 110.207 176.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 426' ' ' ASN . . . . . . . . . . . . . 10.4 t30 66.68 -73.21 0.08 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.603 1.161 . . . . 75.43 110.175 -175.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 427' ' ' SER . . . . . . . . . . . . . 22.8 t -161.96 103.14 1.15 Allowed 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 107.805 -1.183 . . . . 75.14 107.805 173.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 428' ' ' GLU . . . . . 0.481 ' HA ' ' HD1' ' B' ' 424' ' ' TYR . 3.4 mp0 59.23 -97.98 0.08 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.59 1.156 . . . . 73.23 111.193 -177.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 429' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 56.67 23.39 7.75 Favored 'General case' 0 C--N 1.362 1.117 0 C-N-CA 124.651 1.181 . . . . 63.42 112.984 -177.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -123.46 78.37 1.58 Allowed 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.554 0.692 . . . . 55.41 109.558 -172.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 19.3 m -88.56 -57.75 2.8 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.574 1.15 . . . . 73.31 111.464 177.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 432' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.92 11.25 1.06 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 122.671 0.388 . . . . 71.1 110.824 177.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 433' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -132.7 -171.24 2.61 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.203 0.601 . . . . 73.43 111.014 -170.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 434' ' ' HIS . . . . . . . . . . . . . 41.8 m80 74.84 -102.43 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.327 1.451 . . . . 65.13 111.547 -176.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 435' ' ' THR . . . . . 0.525 ' HB ' ' HB2' ' B' ' 438' ' ' GLN . 28.1 m 48.19 -81.02 0.0 OUTLIER 'General case' 0 CA--C 1.569 1.673 0 C-N-CA 125.234 1.414 . . . . 73.42 112.886 -174.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . -166.73 -80.41 0.04 OUTLIER Glycine 0 C--N 1.348 1.22 0 N-CA-C 109.704 -1.358 . . . . 43.54 109.704 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 44.5 t -78.99 -74.58 0.28 Allowed 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 107.993 -1.114 . . . . 54.14 107.993 170.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 438' ' ' GLN . . . . . 0.525 ' HB2' ' HB ' ' B' ' 435' ' ' THR . 53.7 tp60 61.75 -72.31 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 125.686 1.594 . . . . 71.55 114.409 165.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 439' ' ' LEU . . . . . . . . . . . . 0.313 0.3 OUTLIER 46.66 -92.26 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 126.751 2.02 . . . . 74.24 113.311 -174.304 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 440' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 71.61 -36.11 0.35 Allowed 'General case' 0 N--CA 1.505 2.294 0 C-N-CA 125.453 1.501 . . . . 70.1 112.439 -171.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 441' ' ' ILE . . . . . 0.54 HG12 HD22 ' A' ' 235' ' ' LEU . 67.7 mt 78.2 -81.6 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.347 0.492 0 C-N-CA 125.411 1.484 . . . . 74.15 111.486 165.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 442' ' ' ALA . . . . . . . . . . . . . . . 62.38 -70.3 0.05 Allowed 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 124.554 1.142 . . . . 71.41 110.09 -169.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 443' ' ' ALA . . . . . 0.424 ' HA ' ' HB3' ' A' ' 234' ' ' ARG . . . 73.41 -71.5 0.13 Allowed 'General case' 0 C--N 1.357 0.894 0 C-N-CA 125.979 1.712 . . . . 74.21 112.258 170.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -87.49 170.64 11.16 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.762 0.825 . . . . 65.34 111.194 -176.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . -144.57 166.47 27.3 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 110.365 -1.094 . . . . 74.34 110.365 173.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 446' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.81 78.87 0.53 Allowed 'Trans proline' 0 C--N 1.369 1.653 0 C-N-CA 123.305 2.67 . . . . 63.02 111.934 178.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 447' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -175.4 -23.06 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.78 1.232 . . . . 60.0 110.245 -177.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . -56.52 101.45 0.06 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.612 0.765 . . . . 74.31 111.221 -178.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 449' ' ' ALA . . . . . . . . . . . . . . . -144.7 125.37 14.14 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 124.804 1.242 . . . . 61.52 108.539 177.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 450' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -134.82 -64.5 0.66 Allowed 'General case' 0 C--O 1.243 0.714 0 C-N-CA 123.745 0.818 . . . . 61.12 110.186 -174.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 99.5 t -80.16 75.85 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 122.411 1.1 . . . . 63.1 108.842 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 452' ' ' VAL . . . . . . . . . . . . . 98.8 t -141.0 -43.18 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 CA-C-N 113.674 -1.603 . . . . 60.45 107.497 177.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . -160.11 158.88 30.23 Favored Glycine 0 C--N 1.35 1.33 0 CA-C-N 114.911 -1.04 . . . . 73.44 112.1 177.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 454' ' ' LEU . . . . . 0.455 HD22 ' HB3' ' B' ' 193' ' ' PRO . 39.6 tp 59.96 -118.47 0.86 Allowed 'General case' 0 CA--C 1.565 1.554 0 C-N-CA 124.829 1.252 . . . . 72.5 110.939 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 62.0 m -167.08 134.29 2.42 Favored 'General case' 0 C--O 1.243 0.72 0 N-CA-C 106.773 -1.565 . . . . 61.41 106.773 -173.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -94.22 171.53 8.78 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 122.044 0.926 . . . . 74.3 112.499 -176.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 457' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -161.32 -155.66 0.41 Allowed 'General case' 0 CA--C 1.555 1.167 0 CA-C-N 113.432 -1.713 . . . . 42.14 108.302 -176.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 25.1 p -55.19 -63.13 1.25 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.079 0.952 . . . . 72.13 113.091 -174.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 459' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -157.51 161.79 38.84 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.62 0.768 . . . . 73.31 109.64 -175.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 7.6 mp 76.58 165.2 0.25 Allowed 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 125.506 1.522 . . . . 65.42 109.747 -167.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 69.34 8.69 6.93 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 124.902 1.281 . . . . 62.31 112.642 176.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -73.04 101.11 3.17 Favored 'General case' 0 C--N 1.359 0.991 0 N-CA-C 108.564 -0.902 . . . . 72.53 108.564 171.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 14.7 t -101.66 -155.26 0.51 Allowed 'General case' 0 CA--C 1.559 1.295 0 CA-C-N 115.265 -0.88 . . . . 61.35 110.823 -167.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 464' ' ' MET . . . . . . . . . . . . . 23.2 mmt -63.92 159.74 19.18 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.414 1.086 . . . . 75.31 111.84 179.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.08 170.09 8.12 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.518 0.727 . . . . 72.15 110.859 -177.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -150.18 148.1 28.52 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 114.95 -1.023 . . . . 62.32 109.022 173.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 467' ' ' ALA . . . . . 0.492 ' HB3' HG21 ' B' ' 135' ' ' VAL . . . -65.03 -19.2 65.88 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.854 0.861 . . . . 75.3 112.201 -178.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 468' ' ' LEU . . . . . 0.628 ' HB2' HG13 ' B' ' 135' ' ' VAL . 8.2 tt -143.41 98.66 3.29 Favored 'General case' 0 C--O 1.245 0.847 0 N-CA-C 106.648 -1.612 . . . . 45.51 106.648 168.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 469' ' ' GLY . . . . . . . . . . . . . . . -79.43 84.58 1.27 Allowed Glycine 0 C--N 1.342 0.896 0 N-CA-C 111.217 -0.753 . . . . 50.44 111.217 175.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 470' ' ' LEU . . . . . 0.493 HD23 ' H ' ' B' ' 470' ' ' LEU . 2.4 pt? -75.76 -38.3 58.49 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.33 0.652 . . . . 73.2 110.299 174.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 471' ' ' LYS . . . . . 0.564 ' HB3' ' HZ3' ' B' ' 471' ' ' LYS . 0.8 OUTLIER . . . . . 0 C--O 1.26 1.646 0 C-N-CA 124.677 1.191 . . . . 74.2 109.885 -177.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 73.3 mtm . . . . . 0 N--CA 1.476 0.856 0 CA-C-O 119.856 -0.116 . . . . 55.23 110.866 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 55.76 25.56 8.49 Favored 'General case' 0 C--N 1.358 0.941 0 C-N-CA 124.692 1.197 . . . . 65.31 112.152 -177.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.92 78.14 4.42 Favored 'General case' 0 C--N 1.35 0.62 0 N-CA-C 108.885 -0.783 . . . . 52.01 108.885 -178.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -36.55 94.54 0.01 OUTLIER 'General case' 0 C--N 1.365 1.241 0 C-N-CA 125.232 1.413 . . . . 70.52 113.371 -175.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 5' ' ' LYS . . . . . 0.433 ' HB3' HD11 ' C' ' 10' ' ' ILE . 29.7 mmtp -65.76 95.84 0.26 Allowed 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.485 -1.234 . . . . 63.2 108.625 169.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 6' ' ' ASP . . . . . 0.478 ' HA ' ' OH ' ' C' ' 66' ' ' TYR . 16.2 t70 -73.14 97.25 2.35 Favored 'General case' 0 C--N 1.343 0.321 0 N-CA-C 106.975 -1.491 . . . . 63.22 106.975 169.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 7' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -63.6 -30.23 71.37 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 114.811 -1.086 . . . . 73.43 112.389 -169.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -61.56 -44.47 96.97 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.593 0.357 . . . . 72.53 110.16 172.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.47 -42.95 98.59 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.177 0.591 . . . . 52.31 110.934 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 10' ' ' ILE . . . . . 0.433 HD11 ' HB3' ' C' ' 5' ' ' LYS . 56.2 mt -59.98 -39.09 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 C-N-CA 123.407 0.683 . . . . 63.34 110.762 178.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 93.0 mt -76.98 -20.84 55.58 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 116.081 -0.509 . . . . 45.45 112.272 175.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.55 39.48 56.18 Favored Glycine 0 C--N 1.346 1.128 0 O-C-N 123.189 0.306 . . . . 64.33 112.549 -176.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 27.2 m -120.32 157.28 53.96 Favored Pre-proline 0 N--CA 1.479 0.976 0 C-N-CA 124.915 1.286 . . . . 64.04 109.097 176.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -51.16 145.76 25.19 Favored 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 122.849 2.366 . . . . 74.43 113.105 177.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 79.2 mtt180 -74.21 18.13 0.16 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 114.105 1.15 . . . . 71.52 114.105 -175.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -148.76 21.1 1.02 Allowed 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 124.985 1.314 . . . . 71.24 108.176 177.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.47 156.41 32.53 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.314 1.046 . . . . 71.14 112.883 -170.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . 0.434 HG23 HD23 ' B' ' 332' ' ' LEU . 70.3 p -65.18 148.39 51.77 Favored 'General case' 0 C--N 1.348 0.534 0 CA-C-N 115.365 -0.834 . . . . 74.41 108.75 170.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 19' ' ' GLN . . . . . 0.447 ' OE1' ' HD2' ' C' ' 63' ' ' ARG . 1.2 mp0 -63.29 -20.01 65.09 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 122.954 0.502 . . . . 74.45 110.477 175.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 20' ' ' GLU . . . . . 0.401 ' HG3' ' HB2' ' B' ' 346' ' ' ALA . 29.1 tt0 -65.4 -44.7 86.64 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.261 -0.881 . . . . 64.05 111.408 168.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -63.71 -35.3 80.12 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.114 0.565 . . . . 73.42 110.657 176.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 22' ' ' ILE . . . . . 0.652 HG12 ' HB3' ' C' ' 57' ' ' LEU . 1.7 mp -59.72 -41.33 85.01 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 CA-C-N 115.664 -0.698 . . . . 61.32 109.833 170.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 23' ' ' LYS . . . . . 0.468 ' HA ' ' HB3' ' C' ' 26' ' ' TYR . 36.0 mtmm -77.94 -14.96 59.35 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.217 0.607 . . . . 74.13 112.631 175.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -75.18 -37.39 61.24 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 108.622 -0.881 . . . . 73.52 108.622 170.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -76.94 -25.21 52.6 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.246 -0.888 . . . . 75.32 110.936 175.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 26' ' ' TYR . . . . . 0.528 ' O ' ' HB3' ' C' ' 30' ' ' ALA . 87.5 t80 -66.73 -47.43 72.32 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 109.315 -0.624 . . . . 72.31 109.315 169.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . 0.521 ' HD3' ' HA ' ' B' ' 325' ' ' THR . 45.0 mtmt -59.04 -53.69 55.52 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 109.29 -0.633 . . . . 74.1 109.29 173.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 18.5 ttm180 -50.5 -69.34 0.12 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.9 1.28 . . . . 71.15 110.589 -175.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . 0.406 ' HB3' HD13 ' C' ' 50' ' ' ILE . 94.3 mt -82.17 -35.59 28.23 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 114.799 -1.092 . . . . 60.22 112.862 -169.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' C' ' 26' ' ' TYR . . . -87.21 -5.78 58.84 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 118.345 0.521 . . . . 75.32 112.222 -176.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . 0.506 ' HA ' ' HB2' ' C' ' 34' ' ' HIS . 99.4 mtt180 -96.68 -37.37 10.35 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 118.323 0.51 . . . . 73.5 109.902 163.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -62.02 -43.17 99.4 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.344 0.658 . . . . 71.12 111.148 177.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 33' ' ' TYR . . . . . 0.523 ' HD2' HD11 ' C' ' 50' ' ' ILE . 19.3 m-85 -109.42 26.05 11.09 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.36 1.064 . . . . 70.15 110.044 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 34' ' ' HIS . . . . . 0.506 ' HB2' ' HA ' ' C' ' 31' ' ' ARG . 37.8 t60 -63.68 112.76 7.9 Favored Pre-proline 0 N--CA 1.475 0.79 0 CA-C-O 118.505 -0.76 . . . . 72.34 109.189 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.41 -18.81 15.62 Favored 'Trans proline' 0 N--CA 1.501 1.966 0 C-N-CA 123.392 2.728 . . . . 71.32 114.834 -170.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 36' ' ' ASP . . . . . 0.417 ' HB3' ' HD2' ' C' ' 34' ' ' HIS . 13.0 t70 -80.04 -46.72 16.07 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.041 0.936 . . . . 60.34 110.804 176.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 71.0 t -84.15 -54.49 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 123.361 0.664 . . . . 75.33 109.818 -175.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -98.45 83.83 3.09 Favored 'General case' 0 C--O 1.244 0.787 0 N-CA-C 107.991 -1.115 . . . . 54.22 107.991 176.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -79.03 78.09 5.48 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.011 -0.995 . . . . 62.24 109.895 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 71.0 m -139.37 118.55 9.09 Favored Pre-proline 0 CA--C 1.542 0.673 0 C-N-CA 123.882 0.873 . . . . 74.14 108.743 174.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_exo -47.05 -38.74 24.82 Favored 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 123.606 2.871 . . . . 63.44 113.207 176.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -58.05 -44.23 87.3 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.839 0.856 . . . . 65.44 110.211 177.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.47 -21.29 61.96 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.23 -0.896 . . . . 62.05 110.603 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 44' ' ' GLU . . . . . 0.407 ' O ' ' HG2' ' C' ' 48' ' ' LYS . 0.4 OUTLIER -81.54 -33.2 31.9 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.14 0.976 . . . . 74.04 109.2 -178.776 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -68.21 -45.39 73.49 Favored 'General case' 0 C--O 1.261 1.695 0 C-N-CA 124.013 0.925 . . . . 42.53 109.475 174.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 46' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -61.05 -38.61 86.78 Favored 'General case' 0 C--N 1.348 0.518 0 CA-C-N 114.588 -1.187 . . . . 72.32 110.33 172.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 47' ' ' PHE . . . . . 0.676 ' HA ' HD12 ' C' ' 50' ' ' ILE . 65.3 t80 -57.77 -41.13 81.35 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.177 0.991 . . . . 62.23 110.299 176.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 48' ' ' LYS . . . . . 0.407 ' HG2' ' O ' ' C' ' 44' ' ' GLU . 72.3 mmtt -59.01 -49.94 75.97 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 122.383 0.273 . . . . 72.04 110.59 175.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -58.93 -39.43 81.55 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 124.23 0.956 . . . . 72.33 112.097 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 50' ' ' ILE . . . . . 0.676 HD12 ' HA ' ' C' ' 47' ' ' PHE . 55.2 mt -62.76 -47.89 90.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 124.254 1.022 . . . . 75.43 109.628 177.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 51' ' ' ASN . . . . . 0.561 ' HA ' ' HB3' ' C' ' 54' ' ' TYR . 64.2 m-80 -79.85 -5.91 56.36 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 115.522 -0.763 . . . . 74.04 112.176 -178.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 52' ' ' GLU . . . . . 0.444 ' HA ' ' CE2' ' C' ' 93' ' ' PHE . 32.0 tt0 -75.3 -56.23 4.92 Favored 'General case' 0 C--O 1.249 1.027 0 CA-C-O 122.166 0.984 . . . . 63.42 108.844 167.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.86 -37.31 73.7 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 113.485 -1.689 . . . . 63.1 111.442 174.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 54' ' ' TYR . . . . . 0.561 ' HB3' ' HA ' ' C' ' 51' ' ' ASN . 70.0 t80 -75.84 -34.32 60.07 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.263 -0.88 . . . . 75.01 110.5 178.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.57 -40.71 75.68 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.099 0.476 . . . . 60.54 110.508 175.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 44.4 t -79.95 -37.23 17.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 114.737 -1.12 . . . . 72.43 112.578 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 57' ' ' LEU . . . . . 0.652 ' HB3' HG12 ' C' ' 22' ' ' ILE . 94.6 mt -111.14 12.38 21.89 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 114.033 1.123 . . . . 75.02 114.033 -170.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 47.4 t -57.94 -58.97 6.05 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.239 0.616 . . . . 62.42 111.073 178.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -99.73 150.93 37.26 Favored Pre-proline 0 N--CA 1.47 0.558 0 CA-C-N 114.786 -1.097 . . . . 72.03 110.236 -178.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 60' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -54.31 -34.63 80.94 Favored 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 123.659 2.906 . . . . 33.23 112.513 171.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -66.19 -47.17 74.79 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.912 0.885 . . . . 62.13 110.645 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -66.05 -33.59 76.15 Favored 'General case' 0 C--O 1.249 1.042 0 CA-C-N 115.093 -0.958 . . . . 75.23 111.049 178.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 63' ' ' ARG . . . . . 0.447 ' HD2' ' OE1' ' C' ' 19' ' ' GLN . 13.6 ttt180 -60.94 -47.27 87.21 Favored 'General case' 0 C--O 1.218 -0.585 0 CA-C-N 115.718 -0.674 . . . . 64.42 109.901 173.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -61.83 -34.42 75.92 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 123.603 0.564 . . . . 74.15 111.285 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 72.6 mt -54.2 -57.55 5.73 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.95 0 N-CA-C 108.522 -0.918 . . . . 62.34 108.522 169.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 66' ' ' TYR . . . . . 0.478 ' OH ' ' HA ' ' C' ' 6' ' ' ASP . 10.0 t80 -52.37 -51.52 58.47 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.253 0.621 . . . . 74.22 112.025 176.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -55.22 -36.33 65.87 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.899 0.88 . . . . 73.14 111.257 -174.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 68' ' ' THR . . . . . 0.402 ' O ' ' HB ' ' C' ' 72' ' ' THR . 54.8 p -102.37 -14.29 16.96 Favored 'General case' 0 CA--C 1.556 1.189 0 N-CA-C 112.782 0.66 . . . . 63.2 112.782 -178.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -122.05 125.02 45.32 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.023 0.529 . . . . 75.22 109.663 -173.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 74.61 18.93 80.02 Favored Glycine 0 N--CA 1.473 1.155 0 CA-C-O 121.539 0.522 . . . . 62.51 111.937 -175.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 47.8 m -141.31 -50.33 0.42 Allowed 'General case' 0 C--O 1.239 0.505 0 N-CA-C 103.898 -2.63 . . . . 72.34 103.898 178.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . 0.402 ' HB ' ' O ' ' C' ' 68' ' ' THR . 19.2 m -106.62 163.61 12.76 Favored 'General case' 0 C--O 1.253 1.244 0 N-CA-C 105.192 -2.151 . . . . 73.35 105.192 156.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.09 13.06 27.84 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.511 1.124 . . . . 73.23 111.115 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.42 -152.25 0.0 OUTLIER Pre-proline 0 CA--C 1.607 3.15 0 CA-C-O 115.936 -1.983 . . . . 53.23 113.066 -175.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 75' ' ' PRO . . . . . 0.481 ' HA ' ' HD2' ' C' ' 76' ' ' PRO . 0.8 OUTLIER 0.75 118.32 0.0 OUTLIER 'Trans proline' 1 C--N 1.427 4.684 1 C-N-CA 125.92 4.413 . . . . 75.14 119.796 -158.671 . . . . . . . . 5 4 . 1 . 010 nuclear nobuild full ' C' C ' 76' ' ' PRO . . . . . 0.481 ' HD2' ' HA ' ' C' ' 75' ' ' PRO . 55.7 Cg_endo -63.39 178.22 1.3 Allowed 'Trans proline' 0 N--CA 1.51 2.472 0 C-N-CA 123.864 3.043 . . . . 63.14 112.745 176.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 77' ' ' PRO . . . . . 0.523 ' HA ' ' HD3' ' C' ' 78' ' ' PRO . 0.7 OUTLIER -26.41 116.96 0.03 OUTLIER 'Trans proline' 0 C--N 1.401 3.318 0 C-N-CA 124.929 3.753 . . . . 51.51 115.437 173.631 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 78' ' ' PRO . . . . . 0.523 ' HD3' ' HA ' ' C' ' 77' ' ' PRO . 25.3 Cg_exo -65.68 167.92 16.19 Favored 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 124.111 3.207 . . . . 74.44 114.17 -171.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -54.16 132.91 52.88 Favored 'Trans proline' 0 C--N 1.39 2.712 0 C-N-CA 123.104 2.536 . . . . 61.04 113.227 175.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -58.47 83.76 0.05 OUTLIER 'Trans proline' 0 C--N 1.39 2.726 0 C-N-CA 123.65 2.9 . . . . 51.5 111.879 176.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . 0.627 ' HA2' ' HA2' ' C' ' 108' ' ' GLY . . . -175.41 -34.08 0.04 OUTLIER Glycine 0 C--O 1.225 -0.442 0 N-CA-C 109.329 -1.508 . . . . 75.2 109.329 -176.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.561 ' HA3' ' HA ' ' C' ' 106' ' ' PHE . . . 95.09 165.15 35.29 Favored Glycine 0 C--N 1.35 1.339 0 N-CA-C 116.607 1.403 . . . . 74.45 116.607 166.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -69.58 135.84 50.51 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 124.258 1.023 . . . . 70.14 108.318 168.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 84' ' ' ASP . . . . . 0.402 ' HB2' ' HB2' ' C' ' 143' ' ' ARG . 35.6 t70 -66.94 129.22 39.18 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 118.273 0.488 . . . . 63.13 109.728 175.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 85' ' ' PHE . . . . . 0.524 ' HB3' ' HG3' ' C' ' 171' ' ' PRO . 23.5 t80 -116.68 34.77 4.89 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.688 0.795 . . . . 74.41 109.857 -165.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 52.8 m -5.74 78.99 0.0 OUTLIER 'General case' 0 CA--C 1.569 1.691 0 N-CA-C 116.836 2.161 . . . . 45.43 116.836 -170.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 53.06 31.71 41.04 Favored Glycine 0 CA--C 1.545 1.959 0 N-CA-C 116.399 1.32 . . . . 74.33 116.399 175.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 88' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -101.67 155.34 18.16 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 119.134 1.467 . . . . 74.44 113.643 -173.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -85.13 79.04 9.72 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.337 0.655 . . . . 72.23 111.128 -178.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 90' ' ' VAL . . . . . . . . . . . . . 2.0 p -42.17 -37.45 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 114.4 1.259 . . . . 54.41 114.4 177.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.11 -14.64 7.21 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 114.19 1.182 . . . . 74.21 114.19 -176.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -113.32 -3.49 13.81 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 112.757 0.651 . . . . 75.53 112.757 -175.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 93' ' ' PHE . . . . . 0.444 ' CE2' ' HA ' ' C' ' 52' ' ' GLU . 2.3 m-85 -77.13 153.33 34.33 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 122.741 0.417 . . . . 72.45 110.937 -176.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 97.0 p -82.94 -178.81 7.25 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.768 0.827 . . . . 45.51 113.013 -166.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.38 -61.81 2.33 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 114.552 -1.204 . . . . 55.43 112.911 -175.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 96' ' ' PHE . . . . . 0.413 ' HB3' ' HG2' ' C' ' 5' ' ' LYS . 84.4 t80 -58.07 -38.98 77.38 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 118.753 0.706 . . . . 65.02 110.743 -171.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 97' ' ' PHE . . . . . 0.446 ' CE2' ' HE2' ' C' ' 85' ' ' PHE . 83.4 t80 -60.31 -54.75 41.94 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 114.43 -1.259 . . . . 64.25 110.009 175.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -81.69 5.18 19.19 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 112.478 0.547 . . . . 51.52 112.478 -177.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -100.05 -39.11 8.28 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.836 0.855 . . . . 74.43 109.942 170.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 45.6 tp -78.5 -52.51 8.41 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.892 0.853 . . . . 73.23 109.502 -178.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 101' ' ' PHE . . . . . 0.446 ' HB3' HD13 ' C' ' 105' ' ' LEU . 96.5 m-85 -86.31 -20.72 27.96 Favored 'General case' 0 C--O 1.214 -0.77 0 CA-C-N 113.952 -1.477 . . . . 73.25 111.347 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -49.26 -50.81 27.96 Favored Glycine 0 CA--C 1.549 2.217 0 CA-C-O 118.558 -1.135 . . . . 54.11 115.754 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -49.34 -25.33 9.89 Favored 'Trans proline' 0 C--N 1.387 2.596 0 C-N-CA 124.139 3.226 . . . . 62.02 115.09 175.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 104' ' ' GLY . . . . . 0.438 ' O ' ' HA2' ' C' ' 82' ' ' GLY . . . -137.72 31.68 2.46 Favored Glycine 0 C--N 1.353 1.485 0 CA-C-O 119.401 -0.666 . . . . 43.23 112.188 174.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 105' ' ' LEU . . . . . 0.446 HD13 ' HB3' ' C' ' 101' ' ' PHE . 13.1 tp -78.14 74.51 4.69 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 118.103 0.951 . . . . 73.03 109.128 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 106' ' ' PHE . . . . . 0.561 ' HA ' ' HA3' ' C' ' 82' ' ' GLY . 1.2 m-85 58.96 -148.83 0.47 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.826 1.25 . . . . 64.24 113.586 174.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 107' ' ' GLY . . . . . 0.504 ' HA3' ' HA ' ' C' ' 113' ' ' SER . . . 70.55 42.82 62.67 Favored Glycine 0 C--N 1.359 1.811 0 N-CA-C 111.368 -0.693 . . . . 51.05 111.368 -163.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 108' ' ' GLY . . . . . 0.627 ' HA2' ' HA2' ' C' ' 81' ' ' GLY . . . -13.66 -71.7 0.01 OUTLIER Glycine 0 C--N 1.364 2.108 0 C-N-CA 125.784 1.659 . . . . 74.41 115.791 168.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 109' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -92.75 76.68 4.9 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 108.183 -1.043 . . . . 74.45 108.183 168.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 110' ' ' GLY . . . . . . . . . . . . . . . -8.56 -60.31 0.01 OUTLIER Glycine 0 C--N 1.366 2.201 0 C-N-CA 126.471 1.986 . . . . 54.22 116.564 171.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . 0.633 ' NE ' ' H ' ' C' ' 111' ' ' ARG . 0.0 OUTLIER -4.62 -43.15 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.366 0 C-N-CA 127.673 2.389 . . . . 75.25 116.394 160.942 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 112' ' ' ARG . . . . . 0.476 ' HG3' ' HB3' ' C' ' 114' ' ' ARG . 14.7 tpt180 -120.14 -38.05 2.98 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.788 0.835 . . . . 74.1 110.972 -173.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 113' ' ' SER . . . . . 0.504 ' HA ' ' HA3' ' C' ' 107' ' ' GLY . 29.1 m 47.04 22.12 0.19 Allowed 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 125.122 1.369 . . . . 72.53 113.562 -175.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 114' ' ' ARG . . . . . 0.476 ' HB3' ' HG3' ' C' ' 112' ' ' ARG . 2.6 tpm_? -115.03 -116.28 0.33 Allowed 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 117.686 -1.149 . . . . 74.05 111.476 -169.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 115' ' ' LYS . . . . . 0.42 ' NZ ' ' HB2' ' B' ' 315' ' ' ASN . 45.8 tttm -66.19 133.28 50.32 Favored 'General case' 0 C--N 1.361 1.068 0 CA-C-N 119.62 1.1 . . . . 54.14 111.808 -164.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 116' ' ' GLY . . . . . 0.551 ' HA3' ' HA ' ' C' ' 171' ' ' PRO . . . -74.88 109.52 2.81 Favored Glycine 0 CA--C 1.486 -1.734 0 N-CA-C 109.768 -1.333 . . . . 45.25 109.768 169.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 117' ' ' ARG . . . . . 0.425 ' HB2' ' O ' ' B' ' 313' ' ' GLN . 37.0 ptt180 -90.5 161.42 15.51 Favored 'General case' 0 C--O 1.264 1.835 0 N-CA-C 108.076 -1.083 . . . . 64.44 108.076 172.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -62.6 155.35 26.3 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 115.031 -0.986 . . . . 75.42 109.416 168.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 119' ' ' LEU . . . . . 0.478 HD13 ' HA ' ' C' ' 174' ' ' LEU . 0.0 OUTLIER -119.64 144.57 47.08 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 108.247 -1.02 . . . . 75.21 108.247 171.562 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.439 ' HA ' ' O ' ' C' ' 175' ' ' LEU . 19.6 ttt180 -138.9 106.77 5.66 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 109.612 -0.514 . . . . 72.31 109.612 -162.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 121' ' ' ALA . . . . . 0.575 ' HB1' ' HA ' ' B' ' 185' ' ' VAL . . . -134.83 127.67 31.24 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 115.492 -0.776 . . . . 63.21 109.835 -172.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 122' ' ' GLU . . . . . 0.517 ' HG2' ' HA ' ' B' ' 186' ' ' THR . 13.2 pt-20 -85.54 141.16 30.07 Favored 'General case' 0 C--O 1.244 0.77 0 N-CA-C 110.13 -0.322 . . . . 73.22 110.13 176.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -142.71 144.28 29.31 Favored Pre-proline 0 N--CA 1.481 1.102 0 CA-C-N 116.182 -0.463 . . . . 73.3 110.937 -170.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -75.44 121.69 6.56 Favored 'Trans proline' 0 C--N 1.368 1.603 0 C-N-CA 123.147 2.565 . . . . 72.51 111.278 173.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 125' ' ' LEU . . . . . 0.521 ' HB3' HG23 ' C' ' 178' ' ' VAL . 55.7 tp -137.37 147.11 45.25 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.279 0.631 . . . . 74.03 110.058 -177.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.73 155.21 18.44 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 123.449 0.7 . . . . 61.53 110.308 -178.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 127' ' ' LEU . . . . . 0.508 HD13 ' HD2' ' C' ' 186' ' ' PHE . 96.2 mt -66.3 -44.74 82.62 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.373 1.069 . . . . 62.25 111.234 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 18.4 mp0 -65.09 -33.33 75.77 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.729 1.212 . . . . 75.24 109.733 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 129' ' ' GLU . . . . . 0.527 ' HG3' ' HG3' ' B' ' 178' ' ' PRO . 53.3 mm-40 -77.83 -25.38 48.75 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.712 0.805 . . . . 73.53 112.116 177.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -74.3 -32.75 62.99 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 109.142 -0.688 . . . . 64.34 109.142 173.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 131' ' ' PHE . . . . . 0.423 ' HB2' HD13 ' C' ' 215' ' ' LEU . 70.7 t80 -67.46 -44.89 77.51 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.407 1.083 . . . . 75.55 111.088 173.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 132' ' ' HIS . . . . . . . . . . . . . 54.2 m170 -70.72 -49.46 46.7 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 116.261 -0.427 . . . . 60.22 110.685 -176.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 68.39 -90.65 0.23 Allowed Glycine 0 C--N 1.345 1.069 0 N-CA-C 110.664 -0.974 . . . . 65.31 110.664 -170.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.28 161.83 5.7 Favored Glycine 0 C--N 1.353 1.509 0 O-C-N 123.876 0.398 . . . . 53.24 114.008 174.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -71.44 94.69 1.28 Allowed 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 109.105 -0.702 . . . . 71.2 109.105 174.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 136' ' ' ARG . . . . . 0.641 ' HB3' ' HB2' ' B' ' 181' ' ' LEU . 2.7 mpt_? -105.15 158.77 16.35 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.669 1.187 . . . . 72.12 109.051 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 137' ' ' VAL . . . . . 0.401 HG23 ' HB1' ' B' ' 180' ' ' ALA . 23.0 m -104.62 127.77 58.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 109.798 -0.445 . . . . 71.12 109.798 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 138' ' ' VAL . . . . . 0.738 ' HB ' HD23 ' B' ' 181' ' ' LEU . 6.1 p -113.12 114.61 47.44 Favored 'Isoleucine or valine' 0 C--O 1.248 0.986 0 C-N-CA 123.531 0.733 . . . . 72.14 110.052 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 139' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -120.68 93.15 3.94 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 124.829 1.252 . . . . 74.31 108.067 178.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 140' ' ' VAL . . . . . . . . . . . . . 12.7 p -147.61 149.04 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 108.877 -0.786 . . . . 63.22 108.877 -177.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 141' ' ' ALA . . . . . 0.425 ' HB1' ' NE2' ' C' ' 167' ' ' GLN . . . 65.2 19.47 11.74 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 124.75 1.22 . . . . 15.23 112.1 177.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 84.39 -4.03 84.92 Favored Glycine 0 C--N 1.344 0.991 0 CA-C-N 115.675 -0.693 . . . . 45.25 113.553 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 143' ' ' ARG . . . . . 0.526 ' NH2' ' HB3' ' C' ' 164' ' ' MET . 0.0 OUTLIER -111.41 124.37 52.12 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.41 0.684 . . . . 73.04 109.658 -176.722 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 12.9 ttt180 -114.3 121.61 44.18 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.656 1.182 . . . . 71.51 110.859 -171.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 145' ' ' VAL . . . . . 0.549 HG21 ' SD ' ' C' ' 164' ' ' MET . 21.9 m -143.25 177.1 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 C-N-CA 123.922 0.889 . . . . 75.03 110.581 172.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 23.0 t -119.36 129.79 55.01 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.761 0.825 . . . . 54.21 108.78 171.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 11.4 p -149.01 154.47 9.6 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 C-N-CA 123.489 0.716 . . . . 72.53 111.003 -178.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 22.0 ttm180 -96.06 116.19 28.58 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 108.082 -1.081 . . . . 74.22 108.082 164.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 149' ' ' ILE . . . . . 0.457 HD13 HD11 ' B' ' 181' ' ' LEU . 31.9 pt -73.22 147.41 87.86 Favored Pre-proline 0 CA--C 1.551 1.001 0 CA-C-O 118.597 -0.716 . . . . 71.41 109.302 172.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -43.07 115.07 0.51 Allowed 'Trans proline' 0 C--N 1.385 2.45 0 C-N-CA 123.698 2.932 . . . . 61.44 113.594 178.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -62.18 95.96 0.15 Allowed 'Trans proline' 0 C--N 1.386 2.533 0 C-N-CA 123.046 2.497 . . . . 73.2 111.636 178.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 152' ' ' GLY . . . . . . . . . . . . . . . 131.28 108.23 1.19 Allowed Glycine 0 C--N 1.343 0.943 0 CA-C-N 114.98 -1.009 . . . . 54.32 112.44 -174.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 153' ' ' VAL . . . . . 0.705 HG21 HG21 ' C' ' 178' ' ' VAL . 1.8 m -131.1 163.53 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 CA-C-N 117.121 0.46 . . . . 71.13 111.067 -179.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 154' ' ' ARG . . . . . 0.416 ' HE ' ' HA ' ' C' ' 189' ' ' GLU . 29.6 mtt85 -118.49 144.27 46.14 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.823 0.849 . . . . 75.32 109.443 -178.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 155' ' ' GLU . . . . . 0.497 ' HB2' HD12 ' C' ' 180' ' ' LEU . 4.6 tp10 -56.22 128.32 35.09 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.267 0.627 . . . . 74.51 111.974 173.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 68.29 14.66 66.79 Favored Glycine 0 C--N 1.344 1.024 0 O-C-N 123.882 0.739 . . . . 64.51 113.68 176.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 157' ' ' SER . . . . . . . . . . . . . 34.0 t -104.05 164.53 11.64 Favored 'General case' 0 C--N 1.349 0.566 0 C-N-CA 123.201 0.6 . . . . 75.43 109.534 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 8.8 p -112.48 108.01 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.136 0 CA-C-O 121.738 0.78 . . . . 64.44 111.007 -170.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 159' ' ' ILE . . . . . . . . . . . . . 14.6 mt -71.38 117.2 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.588 1.155 . . . . 52.25 108.91 172.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 48.1 ttt-85 -95.44 119.73 34.45 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 118.532 0.605 . . . . 72.21 109.676 171.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 161' ' ' VAL . . . . . 0.611 ' HB ' ' HB3' ' C' ' 174' ' ' LEU . 92.9 t -99.0 99.02 7.1 Favored Pre-proline 0 C--O 1.246 0.892 0 N-CA-C 107.9 -1.148 . . . . 75.24 107.9 171.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -80.83 153.19 19.58 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.638 2.225 . . . . 63.42 112.002 -178.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 89.92 28.7 17.52 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-O 119.42 -0.656 . . . . 53.31 113.647 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 164' ' ' MET . . . . . 0.549 ' SD ' HG21 ' C' ' 145' ' ' VAL . 20.7 mtm -130.67 -88.14 0.49 Allowed 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 117.888 0.844 . . . . 73.35 111.717 178.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 165' ' ' GLY . . . . . 0.421 ' HA3' ' HB3' ' C' ' 171' ' ' PRO . . . 131.91 147.93 6.02 Favored Glycine 0 N--CA 1.482 1.737 0 CA-C-N 118.686 0.676 . . . . 64.24 114.501 -172.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . -108.16 -105.95 3.04 Favored Glycine 0 C--N 1.371 2.494 0 N-CA-C 112.279 -0.328 . . . . 75.44 112.279 172.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 167' ' ' GLN . . . . . 0.425 ' NE2' ' HB1' ' C' ' 141' ' ' ALA . 22.7 mm-40 -105.38 107.0 17.76 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.515 0.726 . . . . 64.31 111.642 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . 129.9 159.54 9.81 Favored Glycine 0 C--N 1.357 1.702 0 CA-C-N 117.762 0.256 . . . . 13.44 113.108 171.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 169' ' ' ASN . . . . . 0.471 ' HB2' ' HD3' ' C' ' 170' ' ' PRO . 1.3 m-20 -61.72 -63.18 4.57 Favored Pre-proline 0 CA--C 1.572 1.795 0 C-N-CA 125.008 1.323 . . . . 62.44 114.01 -168.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 170' ' ' PRO . . . . . 0.471 ' HD3' ' HB2' ' C' ' 169' ' ' ASN . 73.2 Cg_endo -79.03 98.7 1.2 Allowed 'Trans proline' 0 C--N 1.406 3.569 0 CA-C-N 122.309 1.86 . . . . 51.41 110.335 173.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 171' ' ' PRO . . . . . 0.551 ' HA ' ' HA3' ' C' ' 116' ' ' GLY . 10.2 Cg_exo -69.74 142.47 48.13 Favored 'Trans proline' 0 C--N 1.369 1.658 0 C-N-CA 123.704 2.936 . . . . 74.02 116.557 -159.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 172' ' ' GLY . . . . . 0.4 ' O ' ' HA2' ' C' ' 165' ' ' GLY . . . -109.01 141.51 15.95 Favored Glycine 0 C--O 1.213 -1.208 0 N-CA-C 106.549 -2.62 . . . . 74.42 106.549 163.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 173' ' ' ASP . . . . . 0.444 ' HB3' ' O ' ' C' ' 161' ' ' VAL . 64.8 m-20 -81.12 -161.51 0.41 Allowed 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 115.349 1.611 . . . . 74.51 115.349 -159.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 174' ' ' LEU . . . . . 0.611 ' HB3' ' HB ' ' C' ' 161' ' ' VAL . 40.7 tp -94.34 141.95 27.98 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 121.504 -0.747 . . . . 75.22 110.896 -176.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 175' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' C' ' 120' ' ' ARG . 76.2 mt -130.06 84.78 2.23 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.416 1.486 . . . . 71.32 109.435 176.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 176' ' ' LEU . . . . . . . . . . . . . 69.5 mt -80.2 107.45 13.0 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.424 0.69 . . . . 43.02 109.644 175.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 177' ' ' VAL . . . . . 0.499 HG11 ' SG ' ' B' ' 308' ' ' CYS . 58.2 t -83.06 95.48 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 107.553 -1.277 . . . . 74.43 107.553 175.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 178' ' ' VAL . . . . . 0.705 HG21 HG21 ' C' ' 153' ' ' VAL . 3.0 p -71.25 122.65 23.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.875 0.845 . . . . 74.01 111.334 -174.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 179' ' ' ARG . . . . . . . . . . . . . 17.1 mmm-85 -105.62 111.74 24.55 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 107.277 -1.379 . . . . 72.33 107.277 169.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 180' ' ' LEU . . . . . 0.502 HD13 HD21 ' C' ' 127' ' ' LEU . 97.3 mt -72.12 136.85 46.67 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.35 0.595 . . . . 70.51 111.101 -177.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 181' ' ' LEU . . . . . 0.513 HD21 ' HB2' ' B' ' 190' ' ' CYS . 60.3 mt -62.98 167.14 6.51 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 126.016 1.726 . . . . 74.2 113.857 -173.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -52.04 71.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.396 3.068 0 C-N-CA 124.208 3.272 . . . . 64.12 113.165 167.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 183' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -178.15 49.0 0.05 OUTLIER Pre-proline 0 CA--C 1.549 0.933 0 N-CA-C 105.153 -2.165 . . . . 62.13 105.153 -171.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 184' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -90.2 65.29 1.88 Allowed 'Trans proline' 0 C--N 1.387 2.586 0 C-N-CA 123.229 2.619 . . . . 71.54 111.655 -163.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 185' ' ' VAL . . . . . 0.566 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 21.2 t -95.73 -59.68 3.02 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.443 0 N-CA-C 108.223 -1.029 . . . . 72.23 108.223 -174.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 186' ' ' PHE . . . . . 0.508 ' HD2' HD13 ' C' ' 127' ' ' LEU . 53.8 m-85 -100.11 125.32 46.2 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.725 0.81 . . . . 61.44 110.787 -168.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 187' ' ' ARG . . . . . 0.414 ' HG2' ' HB3' ' C' ' 155' ' ' GLU . 0.0 OUTLIER -126.23 109.35 12.21 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 107.256 -1.387 . . . . 75.14 107.256 178.906 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 188' ' ' LEU . . . . . 0.468 HD13 ' HD2' ' C' ' 240' ' ' PHE . 52.3 tp -77.48 154.13 32.83 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.617 0.969 . . . . 74.14 113.617 -169.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 189' ' ' GLU . . . . . 0.416 ' HA ' ' HE ' ' C' ' 154' ' ' ARG . 7.9 tp10 -142.25 103.47 4.29 Favored 'General case' 0 C--O 1.248 1.01 0 N-CA-C 107.06 -1.459 . . . . 71.33 107.06 158.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 75.13 -88.39 0.79 Allowed Glycine 0 C--N 1.349 1.253 0 CA-C-N 115.471 -0.786 . . . . 74.2 112.526 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 191' ' ' GLN . . . . . 0.517 ' HB3' ' HA3' ' C' ' 247' ' ' GLY . 48.3 mt-30 -123.83 -23.05 4.75 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.659 1.184 . . . . 60.21 110.303 176.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -93.23 127.26 38.74 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 123.756 0.822 . . . . 65.13 110.79 -171.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 193' ' ' LEU . . . . . . . . . . . . . 84.3 mt -86.64 165.72 15.92 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.849 0.86 . . . . 52.2 111.316 -177.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 194' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -126.96 103.69 7.61 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.56 -1.274 . . . . 75.43 107.56 165.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 195' ' ' ALA . . . . . 0.566 ' HA ' ' O ' ' C' ' 185' ' ' VAL . . . -98.41 -177.08 3.58 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 124.024 0.93 . . . . 65.11 109.843 172.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 88.6 m -132.41 106.67 8.02 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 107.9 -1.148 . . . . 51.32 107.9 168.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 197' ' ' LEU . . . . . . . . . . . . . 43.3 tp -78.12 122.22 25.34 Favored 'General case' 0 C--N 1.35 0.596 0 N-CA-C 109.327 -0.62 . . . . 73.5 109.327 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -96.18 100.44 12.08 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 108.396 -0.965 . . . . 44.52 108.396 -177.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 199' ' ' VAL . . . . . . . . . . . . . 25.6 t -108.25 124.58 34.18 Favored Pre-proline 0 N--CA 1.481 1.11 0 C-N-CA 123.285 0.634 . . . . 61.21 109.649 -176.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 200' ' ' PRO . . . . . 0.556 ' HG2' HD12 ' C' ' 203' ' ' ILE . 4.5 Cg_exo -63.31 145.92 93.26 Favored 'Trans proline' 0 C--N 1.37 1.673 0 C-N-CA 121.961 1.774 . . . . 71.34 110.834 170.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 201' ' ' ALA . . . . . . . . . . . . . . . -53.37 -47.4 96.33 Favored Pre-proline 0 CA--C 1.558 1.262 0 N-CA-C 113.834 1.05 . . . . 74.35 113.834 -179.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 202' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -63.77 -41.88 22.44 Favored 'Trans proline' 0 C--N 1.384 2.444 0 C-N-CA 121.509 1.473 . . . . 63.15 112.523 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 203' ' ' ILE . . . . . 0.556 HD12 ' HG2' ' C' ' 200' ' ' PRO . 39.5 mt -65.73 -36.04 76.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.009 0.524 . . . . 63.4 110.324 179.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 204' ' ' ALA . . . . . 0.454 ' HA ' HG11 ' C' ' 223' ' ' VAL . . . -62.05 -43.01 99.75 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.33 0.652 . . . . 75.02 110.897 176.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 205' ' ' VAL . . . . . . . . . . . . . 70.0 t -67.97 -45.35 83.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.659 0.784 . . . . 63.41 112.529 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 206' ' ' VAL . . . . . 0.615 ' HA ' ' HE3' ' A' ' 270' ' ' LYS . 14.8 p -78.9 -31.15 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 CA-C-O 121.021 0.438 . . . . 52.12 110.98 -176.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 82.12 52.06 4.2 Favored Glycine 0 C--N 1.336 0.546 0 CA-C-N 115.345 -0.843 . . . . 63.21 111.701 -172.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -84.22 -135.83 3.08 Favored Glycine 0 C--N 1.346 1.099 0 N-CA-C 111.868 -0.493 . . . . 51.32 111.868 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 209' ' ' LYS . . . . . 0.691 ' HZ3' ' HB3' ' B' ' 235' ' ' GLU . 9.7 mtmp? -137.01 139.84 41.69 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 117.509 0.654 . . . . 72.12 111.397 175.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 210' ' ' VAL . . . . . 0.486 HG13 HG21 ' C' ' 203' ' ' ILE . 22.3 m -128.33 135.59 62.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.399 1.08 . . . . 62.05 109.216 175.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 211' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -84.62 112.51 20.51 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 120.852 0.358 . . . . 72.44 110.833 -176.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -81.69 114.58 20.46 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.07 0.948 . . . . 74.43 108.607 170.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 213' ' ' MET . . . . . . . . . . . . . 4.1 tmm? -74.87 116.08 15.19 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 107.311 -1.366 . . . . 63.12 107.311 178.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 214' ' ' THR . . . . . 0.443 ' OG1' HG12 ' C' ' 219' ' ' VAL . 0.2 OUTLIER -116.96 174.4 6.11 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.286 0.565 . . . . 54.24 110.478 -174.167 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 215' ' ' LEU . . . . . 0.423 HD13 ' HB2' ' C' ' 131' ' ' PHE . 27.1 mt -64.47 -29.89 70.93 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.107 1.363 . . . . 44.41 112.067 -177.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -91.65 1.4 57.18 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 114.78 -1.1 . . . . 71.0 110.826 -177.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 110.77 -170.06 13.72 Favored Glycine 0 C--N 1.341 0.843 0 N-CA-C 110.693 -0.963 . . . . 64.11 110.693 -169.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -80.5 119.12 3.67 Favored 'Trans proline' 0 CA--C 1.554 1.524 0 C-N-CA 122.566 2.178 . . . . 52.13 113.506 -173.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 219' ' ' VAL . . . . . 0.443 HG12 ' OG1' ' C' ' 214' ' ' THR . 14.8 p -97.82 148.05 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 N-CA-C 107.728 -1.212 . . . . 52.53 107.728 165.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 220' ' ' GLU . . . . . 0.484 ' HG2' ' HB3' ' C' ' 209' ' ' LYS . 13.3 tt0 -96.93 155.94 16.56 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 108.574 -0.899 . . . . 72.32 108.574 175.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 221' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' C' ' 209' ' ' LYS . 41.9 t -122.5 116.88 50.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 124.094 0.958 . . . . 74.03 110.154 -178.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 222' ' ' ALA . . . . . 0.519 ' HA ' ' HG2' ' C' ' 209' ' ' LYS . . . -78.74 102.64 8.2 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 108.965 -0.754 . . . . 73.3 108.965 171.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . 0.454 HG11 ' HA ' ' C' ' 204' ' ' ALA . 58.2 t -76.43 142.81 71.57 Favored Pre-proline 0 CA--C 1.566 1.574 0 C-N-CA 124.643 1.177 . . . . 73.11 110.372 -177.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 224' ' ' PRO . . . . . 0.649 ' HB3' ' HA ' ' B' ' 245' ' ' LYS . 71.7 Cg_endo -78.69 154.49 26.93 Favored 'Trans proline' 0 C--N 1.38 2.186 0 C-N-CA 122.957 2.438 . . . . 54.33 113.073 168.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -58.89 119.59 6.94 Favored 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 123.496 2.797 . . . . 74.0 112.674 175.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 226' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.0 82.92 0.13 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.275 1.43 . . . . 70.15 110.795 -175.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 227' ' ' THR . . . . . 0.414 HG22 HG11 ' C' ' 253' ' ' VAL . 97.8 m -93.31 133.08 36.92 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 114.295 -1.32 . . . . 70.3 109.482 174.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 228' ' ' GLN . . . . . 0.556 HE21 HD11 ' A' ' 257' ' ' ILE . 1.6 mp0 -100.09 147.75 25.32 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 121.24 0.543 . . . . 74.32 110.65 176.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 229' ' ' ALA . . . . . 0.41 ' HB2' ' H ' ' C' ' 255' ' ' ILE . . . -67.83 140.44 56.59 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 114.967 -1.015 . . . . 62.12 109.521 173.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 105.83 -18.37 40.45 Favored Glycine 0 C--N 1.333 0.37 0 N-CA-C 111.471 -0.652 . . . . 62.04 111.471 -171.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 231' ' ' ARG . . . . . . . . . . . . . 36.1 mtt85 -62.69 168.35 3.84 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 117.105 0.452 . . . . 74.12 111.697 169.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 232' ' ' LYS . . . . . 0.644 ' HD3' ' HB3' ' C' ' 250' ' ' TYR . 3.9 ttmp? -150.18 131.76 14.86 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.33 0.586 . . . . 71.45 111.117 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 233' ' ' LEU . . . . . 0.595 HD13 ' HB2' ' C' ' 251' ' ' LEU . 4.7 mp -88.03 158.44 18.61 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.65 1.18 . . . . 74.21 110.214 178.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 234' ' ' ARG . . . . . 0.509 ' NH2' ' HA ' ' B' ' 243' ' ' GLN . 3.1 ptt85 -128.17 87.89 2.67 Favored 'General case' 0 CA--C 1.55 0.96 0 O-C-N 125.171 1.544 . . . . 72.34 108.19 164.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 54.4 mt -77.29 120.46 22.36 Favored 'General case' 0 C--N 1.361 1.071 0 CA-C-N 115.468 -0.787 . . . . 73.43 109.008 174.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -80.94 127.28 32.39 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.686 0.795 . . . . 71.55 111.48 -172.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 72.95 36.17 57.49 Favored Glycine 0 C--N 1.347 1.154 0 O-C-N 123.853 0.721 . . . . 71.42 113.028 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 24.0 mmtm -129.01 21.52 5.8 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.561 0.745 . . . . 72.03 110.987 176.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -92.78 -164.08 37.74 Favored Glycine 0 C--N 1.353 1.505 0 O-C-N 123.559 0.537 . . . . 31.21 112.975 175.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 240' ' ' PHE . . . . . 0.468 ' HD2' HD13 ' C' ' 188' ' ' LEU . 2.5 m-85 -80.89 157.58 71.43 Favored Pre-proline 0 CA--C 1.557 1.244 0 CA-C-O 119.352 -0.356 . . . . 75.14 110.065 177.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 241' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -59.26 114.52 2.06 Favored 'Trans proline' 0 C--N 1.387 2.565 0 C-N-CA 123.415 2.744 . . . . 70.21 112.786 -177.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 242' ' ' GLY . . . . . 0.458 ' HA3' ' NE2' ' C' ' 191' ' ' GLN . . . -99.53 168.3 21.65 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-N 115.217 -0.901 . . . . 70.14 112.812 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -67.46 -23.0 44.32 Favored 'Trans proline' 0 C--N 1.374 1.89 0 C-N-CA 123.116 2.544 . . . . 71.42 112.302 176.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -95.33 -4.18 45.93 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.837 0.855 . . . . 71.42 111.3 177.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 141.55 -85.55 0.2 Allowed Glycine 0 C--N 1.349 1.274 0 N-CA-C 111.311 -0.716 . . . . 51.32 111.311 -178.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 246' ' ' ARG . . . . . . . . . . . . . 85.6 mtm180 -138.61 175.26 9.71 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.657 1.183 . . . . 61.31 110.119 178.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 247' ' ' GLY . . . . . 0.517 ' HA3' ' HB3' ' C' ' 191' ' ' GLN . . . -104.08 -158.46 24.25 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 115.201 -0.909 . . . . 63.23 111.926 165.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -118.79 174.66 6.15 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.295 0.638 . . . . 73.54 109.492 -178.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 249' ' ' LEU . . . . . 0.463 ' HG ' HD11 ' C' ' 251' ' ' LEU . 20.6 tp -126.93 118.03 23.71 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.576 0.751 . . . . 74.23 110.841 -173.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 250' ' ' TYR . . . . . 0.644 ' HB3' ' HD3' ' C' ' 232' ' ' LYS . 22.3 m-30 -100.89 106.47 17.83 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.47 0.708 . . . . 71.43 110.715 178.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 251' ' ' LEU . . . . . 0.595 ' HB2' HD13 ' C' ' 233' ' ' LEU . 2.9 mp -105.3 124.32 49.34 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-N 118.836 0.744 . . . . 64.53 111.2 -174.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -76.7 120.2 21.55 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 109.068 -0.716 . . . . 73.41 109.068 174.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 253' ' ' VAL . . . . . 0.414 HG11 HG22 ' C' ' 227' ' ' THR . 72.1 t -77.16 128.16 38.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 C-N-CA 123.235 0.614 . . . . 73.5 111.289 -176.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 254' ' ' ARG . . . . . . . . . . . . . 28.2 mtm180 -107.04 137.22 45.52 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.391 -0.966 . . . . 74.13 108.391 164.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 255' ' ' ILE . . . . . 0.485 ' O ' ' HB ' ' A' ' 255' ' ' ILE . 30.2 mm -98.64 109.61 24.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 105.843 -1.91 . . . . 75.24 105.843 165.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 256' ' ' THR . . . . . . . . . . . . . 7.5 t -131.15 176.87 7.9 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 124.09 0.956 . . . . 53.32 109.793 -170.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 49.6 pt -126.81 155.65 75.01 Favored Pre-proline 0 CA--C 1.557 1.226 0 C-N-CA 123.356 0.662 . . . . 64.54 110.254 -177.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 258' ' ' PRO . . . . . 0.514 ' HG3' ' HE2' ' A' ' 276' ' ' TYR . 49.6 Cg_endo -80.86 41.4 1.14 Allowed 'Trans proline' 0 C--N 1.377 2.051 0 C-N-CA 123.625 2.883 . . . . 73.21 113.945 -175.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 259' ' ' GLU . . . . . 0.404 ' O ' ' HD3' ' A' ' 226' ' ' ARG . 60.8 mm-40 60.51 -93.63 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.882 1.273 . . . . 72.3 110.015 -171.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 260' ' ' ARG . . . . . 0.775 ' HA ' HH11 ' A' ' 226' ' ' ARG . 0.0 OUTLIER -115.03 164.1 14.66 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.514 1.126 . . . . 73.41 110.197 -178.16 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 261' ' ' LEU . . . . . . . . . . . . . 45.6 mt -126.96 173.15 9.85 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.023 0.929 . . . . 71.21 111.398 -171.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 73.4 p -84.27 148.6 53.32 Favored Pre-proline 0 CA--C 1.552 1.051 0 CA-C-N 114.942 -1.026 . . . . 61.23 108.801 168.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -43.34 -36.78 6.75 Favored 'Trans proline' 0 C--N 1.382 2.324 0 C-N-CA 124.478 3.452 . . . . 74.2 115.114 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -64.23 -60.94 2.6 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.251 0.62 . . . . 71.04 110.905 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -53.32 -51.1 63.44 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.448 -0.796 . . . . 65.11 109.874 178.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 266' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -55.99 -36.17 67.6 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 114.547 -1.206 . . . . 64.21 111.706 -178.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -63.76 -48.89 75.13 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.2 0.6 . . . . 70.32 111.259 176.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 268' ' ' LEU . . . . . 0.622 ' HB2' HD21 ' A' ' 272' ' ' LEU . 8.0 mp -63.94 -38.17 90.09 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 123.033 0.208 . . . . 52.44 111.379 178.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 77.1 m95 -64.78 -33.36 75.79 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.054 0.542 . . . . 61.11 111.017 175.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -70.87 -31.78 68.56 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.109 0.564 . . . . 75.43 111.74 175.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -69.76 -38.79 76.88 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 120.567 0.223 . . . . 75.33 110.903 175.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 92.9 mt -60.63 -44.91 95.81 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 115.723 -0.671 . . . . 74.33 109.581 170.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -62.12 -41.69 98.48 Favored 'General case' 0 C--O 1.216 -0.709 0 CA-C-N 115.42 -0.809 . . . . 34.13 111.401 -178.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -69.54 -33.71 73.19 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.386 0.675 . . . . 63.21 111.021 178.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -60.55 -33.77 73.16 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 121.243 0.544 . . . . 70.04 110.398 171.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 276' ' ' TYR . . . . . 0.706 ' HA ' ' HD3' ' C' ' 279' ' ' ARG . 16.4 m-85 -80.91 -31.39 35.13 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.251 -0.886 . . . . 75.52 112.839 174.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 18.6 m-30 -73.17 -22.2 60.53 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 118.391 0.541 . . . . 44.24 109.886 178.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -64.94 -23.43 67.22 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.474 0.71 . . . . 55.2 111.109 171.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 279' ' ' ARG . . . . . 0.706 ' HD3' ' HA ' ' C' ' 276' ' ' TYR . 17.2 mtp-105 -78.63 -21.37 48.51 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.498 0.719 . . . . 71.52 110.515 174.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.137 0 C-N-CA 123.507 0.723 . . . . 75.14 109.231 -178.857 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.2 mtp . . . . . 0 N--CA 1.473 0.677 0 N-CA-C 109.794 -0.447 . . . . 64.12 109.794 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 60.52 21.83 11.55 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 124.664 1.186 . . . . 51.4 113.98 173.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -88.29 53.89 2.89 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 122.858 0.463 . . . . 74.04 110.744 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.8 ttpp -38.96 105.65 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 125.337 1.455 . . . . 62.43 114.103 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -77.57 131.18 37.71 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.205 1.002 . . . . 74.32 110.427 177.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -83.76 86.84 7.08 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 107.022 -1.474 . . . . 61.41 107.022 166.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.453 ' CD1' ' HA ' ' A' ' 53' ' ' ALA . 66.6 m-85 -61.2 -31.11 70.87 Favored 'General case' 0 C--O 1.249 1.063 0 CA-C-N 115.094 -0.957 . . . . 73.34 112.144 -174.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -57.37 -55.38 35.51 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.241 0.617 . . . . 73.33 109.494 172.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.73 -33.66 74.43 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.816 0.847 . . . . 60.32 111.764 -177.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 78.1 mt -62.89 -40.14 87.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.287 0.635 . . . . 74.23 110.477 175.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 93.3 mt -80.03 -2.81 45.82 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 112.49 0.552 . . . . 51.33 112.49 173.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.26 18.03 72.63 Favored Glycine 0 C--N 1.351 1.394 0 O-C-N 123.3 0.375 . . . . 53.33 113.67 177.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.607 HG21 HG12 ' A' ' 22' ' ' ILE . 22.8 m -111.55 142.06 25.79 Favored Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 123.209 0.604 . . . . 71.43 110.185 177.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -82.94 169.78 12.89 Favored 'Trans proline' 0 C--N 1.366 1.453 0 C-N-CA 122.255 1.97 . . . . 50.12 112.048 174.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.6 mmt85 -67.92 80.43 0.21 Allowed 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 114.969 -1.014 . . . . 75.43 110.422 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -174.96 -32.75 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.166 1.387 . . . . 64.11 108.399 -177.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.28 122.07 17.08 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.831 -0.622 . . . . 64.31 110.56 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 72.8 p -76.58 175.13 9.57 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.14 0.976 . . . . 71.11 110.236 178.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -50.41 -38.63 43.99 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 124.424 1.09 . . . . 64.21 112.484 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.455 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 1.8 tm-20 -74.05 -41.76 61.26 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.397 1.079 . . . . 72.43 110.265 -175.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -67.86 -37.51 81.92 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 123.871 0.869 . . . . 64.03 110.623 177.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.666 HD13 HD13 ' A' ' 57' ' ' LEU . 45.0 mt -68.06 -33.06 58.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 C-N-CA 125.342 1.457 . . . . 73.31 110.612 175.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.2 ttmm -69.76 -38.99 76.98 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.733 0.813 . . . . 71.24 109.63 177.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.455 ' HG3' ' O ' ' A' ' 20' ' ' GLU . 48.9 mtt180 -61.36 -45.67 93.41 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 123.582 0.551 . . . . 54.12 109.97 174.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.72 -46.02 84.98 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 124.262 0.976 . . . . 64.0 111.302 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -60.6 -49.81 76.02 Favored 'General case' 0 C--N 1.348 0.534 0 O-C-N 123.693 0.621 . . . . 73.1 111.02 177.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -61.43 -35.95 78.99 Favored 'General case' 0 N--CA 1.484 1.229 0 O-C-N 124.078 0.861 . . . . 74.22 111.601 -178.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.8 ttt180 -58.52 -51.11 71.27 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.642 1.177 . . . . 71.15 110.355 174.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.704 ' HB3' HD13 ' A' ' 50' ' ' ILE . 54.2 mt -73.94 -21.07 60.17 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 114.843 -1.071 . . . . 74.11 110.708 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -88.4 -9.57 52.17 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.361 1.064 . . . . 63.3 111.392 179.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 48.4 mtm105 -93.5 -46.68 7.2 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.08 0.552 . . . . 72.33 109.967 166.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -69.75 -60.12 2.51 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.451 0.7 . . . . 63.33 111.423 -174.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.428 ' HE2' HD22 ' A' ' 29' ' ' LEU . 26.4 m-85 -92.97 19.52 7.68 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.371 0.668 . . . . 63.25 111.541 -174.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 -57.52 102.91 0.33 Allowed Pre-proline 0 N--CA 1.48 1.025 0 C-N-CA 125.147 1.379 . . . . 63.41 111.323 -172.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -62.17 -25.08 76.81 Favored 'Trans proline' 0 C--N 1.375 1.935 0 C-N-CA 123.164 2.576 . . . . 74.13 113.367 -177.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -59.66 -31.11 69.25 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.446 0.698 . . . . 72.45 111.416 175.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.9 t -102.2 -63.18 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 N-CA-C 109.254 -0.647 . . . . 65.53 109.254 176.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -97.95 86.07 3.65 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.397 1.079 . . . . 61.35 109.869 -174.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -77.13 71.46 3.63 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 115.382 -0.826 . . . . 73.11 109.707 174.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 43.7 m -118.19 117.57 34.9 Favored Pre-proline 0 N--CA 1.471 0.606 0 N-CA-C 108.287 -1.005 . . . . 54.41 108.287 178.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -41.22 -50.47 4.37 Favored 'Trans proline' 0 C--N 1.388 2.637 0 C-N-CA 124.291 3.327 . . . . 72.23 113.955 -171.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -53.98 -48.51 70.29 Favored 'General case' 0 CA--C 1.549 0.922 0 O-C-N 124.583 1.177 . . . . 64.43 111.323 -179.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.3 -28.74 67.44 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.384 -0.826 . . . . 72.14 111.237 -178.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.458 ' O ' ' HD3' ' A' ' 48' ' ' LYS . 49.2 mt-10 -84.84 -36.74 21.39 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.334 0.654 . . . . 62.01 110.321 -172.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -70.29 -42.68 71.73 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.842 0.857 . . . . 62.44 109.336 177.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -57.73 -41.48 81.91 Favored 'General case' 0 C--N 1.35 0.593 0 CA-C-N 114.857 -1.065 . . . . 74.03 109.689 169.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.426 ' HA ' HD12 ' A' ' 50' ' ' ILE . 35.1 t80 -70.47 -23.2 62.65 Favored 'General case' 0 CA--C 1.547 0.845 0 O-C-N 123.468 0.48 . . . . 73.24 111.836 179.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.458 ' HD3' ' O ' ' A' ' 44' ' ' GLU . 1.9 mptm? -68.98 -41.22 78.16 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 109.702 -0.481 . . . . 75.14 109.702 171.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -65.25 -37.37 87.01 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 123.629 0.58 . . . . 71.44 110.537 176.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.704 HD13 ' HB3' ' A' ' 29' ' ' LEU . 79.9 mt -69.14 -39.43 79.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.783 1.233 . . . . 70.53 110.565 177.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -67.95 -36.14 79.61 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.606 -0.724 . . . . 73.43 110.396 175.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.443 ' O ' HG23 ' A' ' 56' ' ' VAL . 32.4 tt0 -63.78 -53.39 51.57 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.551 1.141 . . . . 63.42 110.138 179.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.453 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . . . -60.41 -44.15 96.02 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 113.372 -1.74 . . . . 65.45 112.063 -177.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -82.54 -18.28 42.02 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 115.994 -0.548 . . . . 72.32 111.629 177.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.431 ' HB1' ' CD2' ' A' ' 85' ' ' PHE . . . -61.55 -36.62 81.1 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.8 0.809 . . . . 53.01 109.663 172.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.474 HG22 ' CE1' ' A' ' 101' ' ' PHE . 38.0 t -69.77 -61.73 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 CA-C-N 113.439 -1.709 . . . . 74.52 110.433 170.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.666 HD13 HD13 ' A' ' 22' ' ' ILE . 52.8 mt -86.45 12.78 9.52 Favored 'General case' 0 CA--C 1.559 1.322 0 CA-C-N 114.864 -1.062 . . . . 62.04 113.166 -165.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.6 t -67.88 -56.24 9.86 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.774 0.83 . . . . 74.34 110.664 174.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -95.04 148.05 34.04 Favored Pre-proline 0 N--CA 1.47 0.547 0 CA-C-N 115.095 -0.957 . . . . 74.34 110.286 -177.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.75 -41.15 57.65 Favored 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 123.266 2.644 . . . . 72.41 111.207 169.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -60.57 -54.69 42.35 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 123.97 0.908 . . . . 72.3 111.527 -178.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.436 ' HA ' HD12 ' A' ' 65' ' ' ILE . 37.6 mtpt -73.39 -32.04 64.24 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.625 0.77 . . . . 74.54 112.386 -174.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.462 HH21 HD12 ' A' ' 22' ' ' ILE . 7.6 ptm180 -67.31 -38.94 85.78 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.636 -0.505 . . . . 74.11 109.636 175.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -65.05 -35.91 82.68 Favored 'General case' 0 C--N 1.362 1.134 0 O-C-N 123.593 0.558 . . . . 74.25 110.904 174.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.436 HD12 ' HA ' ' A' ' 62' ' ' LYS . 83.4 mt -55.58 -47.14 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 C-N-CA 123.366 0.666 . . . . 64.42 110.469 174.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -58.04 -55.61 32.68 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 115.578 -0.737 . . . . 75.4 111.274 170.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -58.75 -31.8 68.67 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.467 0.707 . . . . 64.04 112.135 -173.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 67.8 p -86.98 -18.3 31.02 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.301 0.64 . . . . 75.13 111.338 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -72.47 134.64 45.42 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 106.839 -1.541 . . . . 63.45 106.839 164.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.63 26.77 49.52 Favored Glycine 0 N--CA 1.471 1.0 0 N-CA-C 111.201 -0.76 . . . . 52.54 111.201 -171.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 52.8 m -144.42 -56.45 0.36 Allowed 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 102.587 -3.116 . . . . 71.23 102.587 172.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.5 m -84.2 140.95 31.37 Favored 'General case' 0 C--O 1.25 1.098 0 N-CA-C 104.782 -2.303 . . . . 74.23 104.782 157.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.23 -41.84 63.27 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.08 0.552 . . . . 74.04 110.539 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.78 151.8 53.04 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 123.731 0.812 . . . . 75.1 110.134 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -63.0 133.8 43.11 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.214 1.943 . . . . 75.41 110.58 172.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.404 ' HG2' ' HA ' ' A' ' 65' ' ' ILE . 67.8 Cg_exo -47.26 150.44 3.3 Favored 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 124.373 3.382 . . . . 74.25 115.207 -178.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -55.82 113.35 1.39 Allowed 'Trans proline' 0 C--N 1.389 2.662 0 C-N-CA 123.302 2.668 . . . . 62.44 112.46 -178.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -62.58 146.45 95.39 Favored 'Trans proline' 0 C--N 1.382 2.297 0 C-N-CA 123.397 2.731 . . . . 43.51 113.283 -178.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -66.21 150.24 84.98 Favored 'Trans proline' 0 C--N 1.373 1.844 0 C-N-CA 122.819 2.346 . . . . 71.05 111.566 174.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.478 ' HD2' ' HA3' ' A' ' 142' ' ' GLY . 74.1 Cg_endo -72.75 64.89 3.94 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 123.576 2.851 . . . . 51.35 112.124 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -178.51 -31.98 0.05 OUTLIER Glycine 0 CA--C 1.522 0.484 0 CA-C-N 114.502 -1.227 . . . . 62.41 110.047 -170.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.77 -169.03 18.8 Favored Glycine 0 C--N 1.356 1.674 0 C-N-CA 122.993 0.33 . . . . 53.03 113.115 176.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -108.0 111.76 24.0 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.326 1.05 . . . . 74.41 110.165 -178.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -67.76 155.5 39.14 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.76 1.224 . . . . 71.31 110.944 172.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.523 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 64.8 m-85 -144.39 77.64 1.55 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.894 0.878 . . . . 70.22 110.517 -177.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.462 ' HB3' ' HG2' ' A' ' 162' ' ' PRO . 6.0 m -49.42 85.06 0.0 OUTLIER 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 125.446 1.499 . . . . 74.44 113.667 -179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.33 20.71 79.96 Favored Glycine 0 CA--C 1.535 1.299 0 CA-C-N 116.118 -0.492 . . . . 70.11 113.772 -179.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.523 ' HB2' ' HB3' ' A' ' 85' ' ' PHE . 24.2 m-85 -114.09 106.86 14.89 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 117.41 0.605 . . . . 72.34 109.502 -176.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -83.73 80.52 9.11 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 121.686 0.755 . . . . 71.44 109.907 -177.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.439 ' HA ' ' CD2' ' A' ' 93' ' ' PHE . 3.4 p -39.94 -32.94 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 C-N-CA 126.635 1.974 . . . . 75.21 114.688 174.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.478 ' HB2' ' NH2' ' A' ' 114' ' ' ARG . 10.5 tp10 -53.47 -38.55 63.73 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.557 1.143 . . . . 75.33 111.783 -176.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -97.18 0.68 48.74 Favored 'General case' 0 CA--C 1.554 1.126 0 CA-C-N 115.332 -0.849 . . . . 45.35 111.495 -173.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.439 ' CD2' ' HA ' ' A' ' 90' ' ' VAL . 10.3 m-30 -88.68 -178.12 5.72 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.588 0.755 . . . . 71.01 110.555 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 89.6 p -77.47 163.74 26.07 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 113.595 0.961 . . . . 74.5 113.595 -168.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.413 ' O ' ' HG3' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -61.57 -40.34 94.38 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 114.312 -1.313 . . . . 74.31 112.123 175.889 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -63.33 -39.31 94.2 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 110.085 -0.339 . . . . 75.03 110.085 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -62.14 -40.33 95.61 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.529 -0.759 . . . . 63.23 109.654 176.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -81.16 -1.61 45.24 Favored 'General case' 0 CA--C 1.558 1.272 0 CA-C-N 114.801 -1.091 . . . . 73.05 112.288 177.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 95' ' ' GLU . 51.8 mt-10 -96.6 -46.46 6.31 Favored 'General case' 0 N--CA 1.503 2.224 0 C-N-CA 123.278 0.631 . . . . 70.02 111.62 167.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 33.5 tp -65.41 -45.55 83.5 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.678 1.191 . . . . 55.03 110.215 -177.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.474 ' CE1' HG22 ' A' ' 56' ' ' VAL . 97.5 m-85 -95.71 -7.97 35.89 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.544 -0.753 . . . . 72.11 111.033 176.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -45.16 -58.58 4.98 Favored Glycine 0 CA--C 1.541 1.67 0 CA-C-O 118.656 -1.08 . . . . 72.43 115.625 -177.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -62.3 -8.21 12.01 Favored 'Trans proline' 0 C--N 1.386 2.512 0 C-N-CA 123.169 2.58 . . . . 23.1 113.86 -175.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -142.01 33.49 1.93 Allowed Glycine 0 C--N 1.357 1.731 0 CA-C-O 119.551 -0.583 . . . . 44.4 112.771 175.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.5 mt -66.79 20.92 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.305 0 N-CA-C 114.864 1.431 . . . . 74.25 114.864 -178.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.571 ' HD1' ' H ' ' A' ' 108' ' ' GLY . 0.2 OUTLIER 57.06 -107.26 0.37 Allowed 'General case' 0 CA--C 1.564 1.486 0 C-N-CA 124.182 0.993 . . . . 72.25 110.541 165.123 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 66.22 15.36 63.11 Favored Glycine 0 C--N 1.362 1.975 0 CA-C-N 118.044 0.384 . . . . 44.0 113.414 -176.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.571 ' H ' ' HD1' ' A' ' 106' ' ' PHE . . . 59.22 -113.77 5.48 Favored Glycine 0 C--N 1.353 1.5 0 N-CA-C 111.482 -0.647 . . . . 71.34 111.482 -170.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -109.34 -5.61 15.79 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.544 0.737 . . . . 64.11 110.197 169.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -66.96 -27.17 73.31 Favored Glycine 0 C--N 1.351 1.41 0 C-N-CA 123.099 0.381 . . . . 55.25 112.846 177.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 61.8 mtt180 77.01 -40.02 0.35 Allowed 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 126.011 1.724 . . . . 71.44 114.308 169.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 40.3 ttt180 -86.23 46.88 1.38 Allowed 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 118.599 0.636 . . . . 73.25 110.046 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.406 ' HB3' HG11 ' A' ' 90' ' ' VAL . 45.1 m 46.52 52.32 11.03 Favored 'General case' 0 C--N 1.36 1.052 0 C-N-CA 124.712 1.205 . . . . 74.21 112.351 167.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.478 ' NH2' ' HB2' ' A' ' 91' ' ' GLU . 0.3 OUTLIER -110.71 160.8 16.38 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 112.508 0.559 . . . . 74.52 112.508 -166.56 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 170' ' ' PRO . 39.2 ttmt -68.79 135.52 51.34 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.729 0.812 . . . . 72.15 112.365 -170.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -97.18 -168.21 33.07 Favored Glycine 0 CA--C 1.549 2.196 0 CA-C-N 115.643 -0.708 . . . . 55.22 113.29 179.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.548 HH22 ' HB3' ' B' ' 13' ' ' LEU . 7.1 tmm_? -112.95 139.06 48.92 Favored 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 124.374 1.07 . . . . 71.34 109.766 177.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -50.61 113.92 1.02 Allowed 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.962 0.887 . . . . 74.23 112.724 -176.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.455 HD11 ' HA ' ' B' ' 12' ' ' PRO . 5.4 tt -105.81 148.65 27.28 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 114.652 -1.158 . . . . 70.23 108.795 -168.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.447 ' HD2' ' HB2' ' A' ' 175' ' ' LEU . 14.8 tpt180 -98.21 143.13 29.04 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 108.586 -0.894 . . . . 74.51 108.586 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.557 ' HB2' HD11 ' A' ' 174' ' ' LEU . . . -138.93 166.19 25.12 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 118.768 0.713 . . . . 41.51 111.45 -178.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.544 ' HB2' ' HB3' ' B' ' 9' ' ' ALA . 18.0 mm-40 -116.61 98.4 6.52 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 106.874 -1.528 . . . . 61.0 106.874 179.024 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.496 ' HB2' HD22 ' A' ' 176' ' ' LEU . 11.7 tp -98.25 103.57 18.65 Favored Pre-proline 0 C--O 1.213 -0.86 0 N-CA-C 107.392 -1.336 . . . . 54.05 107.392 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.489 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 55.2 Cg_endo -66.81 151.22 82.83 Favored 'Trans proline' 0 C--N 1.362 1.276 0 C-N-CA 121.253 1.302 . . . . 75.33 108.847 169.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.649 ' HA ' HG21 ' B' ' 6' ' ' ILE . 17.9 tp -150.91 148.2 28.14 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 119.283 0.947 . . . . 64.01 112.016 177.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 33.8 m -76.21 127.05 32.13 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 114.436 -1.256 . . . . 71.34 109.341 175.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.578 ' HB3' HD22 ' A' ' 215' ' ' LEU . 3.5 mm? -44.61 -57.73 3.46 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 125.516 1.526 . . . . 70.54 112.452 -178.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 17.5 mp0 -59.13 -44.56 92.05 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 114.33 -1.304 . . . . 75.32 109.632 -176.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -76.63 -12.28 59.99 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 115.185 -0.916 . . . . 64.33 111.856 -178.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.603 ' HB1' ' O ' ' A' ' 153' ' ' VAL . . . -79.45 -38.5 34.48 Favored 'General case' 0 C--O 1.252 1.223 0 CA-C-O 121.772 0.796 . . . . 41.43 109.206 176.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.461 ' HB2' HH21 ' A' ' 154' ' ' ARG . 89.2 t80 -70.57 -41.87 71.85 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 114.564 -1.198 . . . . 74.51 110.762 171.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 33.6 m170 -77.22 -36.46 54.68 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.149 0.579 . . . . 75.25 112.065 -172.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.513 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 70.21 -150.35 48.58 Favored Glycine 0 CA--C 1.531 1.087 0 O-C-N 123.411 0.444 . . . . 71.54 114.009 -179.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 91.57 -174.29 37.87 Favored Glycine 0 C--N 1.352 1.461 0 C-N-CA 123.483 0.563 . . . . 70.42 112.571 178.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 21.5 mp0 -67.95 113.16 5.42 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.823 0.849 . . . . 73.14 109.231 179.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 13.1 tpp180 -108.67 122.77 47.81 Favored 'General case' 0 C--O 1.244 0.806 0 C-N-CA 123.626 0.771 . . . . 74.4 109.626 -175.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 48.7 t -73.45 114.86 13.57 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 O-C-N 124.01 0.819 . . . . 71.24 109.156 175.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.466 HG13 HG13 ' A' ' 145' ' ' VAL . 5.5 p -142.39 134.64 26.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 124.65 1.18 . . . . 73.14 107.889 177.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -123.43 144.38 49.54 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 121.973 -0.454 . . . . 71.3 110.732 -175.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.518 ' HB ' ' HB3' ' B' ' 8' ' ' LEU . 11.9 p -159.32 141.09 4.69 Favored 'Isoleucine or valine' 0 C--O 1.243 0.715 0 C-N-CA 124.646 1.178 . . . . 75.1 108.111 173.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 58.92 31.71 21.57 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.911 0.885 . . . . 74.24 110.795 -177.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.478 ' HA3' ' HD2' ' A' ' 80' ' ' PRO . . . 73.05 0.15 50.09 Favored Glycine 0 C--N 1.355 1.598 0 CA-C-N 115.399 -0.818 . . . . 31.1 114.282 -178.378 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.75 99.08 10.41 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.317 1.047 . . . . 72.12 108.311 -174.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 27.1 ttt-85 -74.82 92.38 2.51 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.464 1.106 . . . . 74.41 109.702 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.466 HG13 HG13 ' A' ' 138' ' ' VAL . 7.5 p -95.62 136.76 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 123.217 0.607 . . . . 73.53 110.899 -177.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 40.3 t -102.02 85.2 2.64 Favored 'General case' 0 C--O 1.243 0.718 0 N-CA-C 108.523 -0.917 . . . . 31.45 108.523 177.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 89.0 t -81.16 113.17 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 108.598 -0.89 . . . . 73.42 108.598 -176.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 40.4 ttt85 -68.79 93.04 0.51 Allowed 'General case' 0 C--O 1.242 0.692 0 N-CA-C 108.552 -0.907 . . . . 74.14 108.552 173.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.513 HG13 ' HA2' ' A' ' 133' ' ' GLY . 41.2 pt -72.91 133.16 82.24 Favored Pre-proline 0 CA--C 1.553 1.084 0 CA-C-N 114.481 -1.236 . . . . 74.13 108.832 177.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -59.87 128.52 27.03 Favored 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 122.527 2.152 . . . . 60.34 111.701 177.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.09 92.78 0.09 OUTLIER 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 122.5 2.134 . . . . 74.15 110.519 172.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 126.29 60.59 0.15 Allowed Glycine 0 C--N 1.339 0.698 0 CA-C-O 121.721 0.623 . . . . 75.51 111.709 -168.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.603 ' O ' ' HB1' ' A' ' 130' ' ' ALA . 7.5 p -137.46 138.02 45.26 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.754 0 N-CA-C 107.068 -1.456 . . . . 75.43 107.068 169.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.622 HH21 HD12 ' A' ' 215' ' ' LEU . 57.6 mtt180 -151.13 175.12 12.44 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.627 0.771 . . . . 73.23 109.102 173.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.561 ' HB3' ' H ' ' A' ' 188' ' ' LEU . 17.3 tp10 -34.7 128.16 0.47 Allowed 'General case' 0 N--CA 1.502 2.162 0 C-N-CA 126.442 1.897 . . . . 72.32 114.852 -166.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.72 -9.98 66.51 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 114.823 0.689 . . . . 14.21 114.823 175.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 15.3 t -73.18 153.56 40.65 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 117.329 0.564 . . . . 74.23 109.562 174.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 85.6 t -119.94 108.16 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.749 0.82 . . . . 72.34 109.846 -175.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.568 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 59.5 mt -86.7 113.85 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 N-CA-C 108.718 -0.845 . . . . 75.24 108.718 174.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -76.27 107.08 8.27 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 108.691 -0.855 . . . . 61.32 108.691 171.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 15.0 p -117.14 114.9 38.62 Favored Pre-proline 0 CA--C 1.554 1.106 0 N-CA-C 109.281 -0.637 . . . . 61.33 109.281 174.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.462 ' HG2' ' HB3' ' A' ' 86' ' ' SER . 50.4 Cg_endo -69.22 140.83 45.72 Favored 'Trans proline' 0 C--N 1.369 1.633 0 C-N-CA 122.368 2.045 . . . . 74.53 112.62 178.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.533 ' N ' ' HB3' ' A' ' 171' ' ' PRO . . . 116.2 -26.52 8.66 Favored Glycine 0 N--CA 1.477 1.409 0 C-N-CA 123.519 0.58 . . . . 70.43 113.355 166.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.538 ' HB2' HD22 ' A' ' 174' ' ' LEU . 1.0 OUTLIER -102.37 -33.25 9.63 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.213 0.605 . . . . 64.15 110.245 -174.798 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.471 ' N ' ' HB2' ' A' ' 174' ' ' LEU . . . -89.86 151.97 22.06 Favored Glycine 0 CA--C 1.493 -1.343 0 N-CA-C 108.801 -1.72 . . . . 73.33 108.801 170.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.701 ' HA3' ' HA3' ' A' ' 172' ' ' GLY . . . 53.13 79.16 0.09 OUTLIER Glycine 0 CA--C 1.48 -2.129 0 CA-C-O 118.67 -1.072 . . . . 74.5 112.335 -161.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.544 HE21 ' HA ' ' A' ' 167' ' ' GLN . 0.0 OUTLIER -55.59 104.09 0.12 Allowed 'General case' 0 C--N 1.353 0.725 0 O-C-N 128.275 2.986 . . . . 75.42 109.27 -177.4 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -174.46 -135.95 2.15 Favored Glycine 0 N--CA 1.435 -1.414 0 N-CA-C 109.32 -1.512 . . . . 64.21 109.32 -172.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . 0.547 ' ND2' ' HB3' ' A' ' 106' ' ' PHE . 0.5 OUTLIER -134.31 -57.01 0.02 OUTLIER Pre-proline 0 CA--C 1.552 1.039 0 CA-C-O 118.518 -0.753 . . . . 63.11 109.204 176.344 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.462 ' O ' ' HA ' ' A' ' 115' ' ' LYS . 17.2 Cg_exo -67.98 124.1 11.43 Favored 'Trans proline' 0 C--N 1.39 2.751 0 N-CA-C 106.461 -2.169 . . . . 71.13 106.461 160.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.533 ' HB3' ' N ' ' A' ' 163' ' ' GLY . 57.2 Cg_endo -67.46 143.08 61.85 Favored 'Trans proline' 0 C--O 1.244 0.777 0 C-N-CA 122.067 1.845 . . . . 71.25 114.612 -164.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.701 ' HA3' ' HA3' ' A' ' 166' ' ' GLY . . . -74.68 -29.54 61.24 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 119.597 -1.287 . . . . 72.4 110.872 158.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 92.58 138.79 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 127.975 2.51 . . . . 71.14 109.635 -177.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.557 HD11 ' HB2' ' A' ' 121' ' ' ALA . 26.4 tp -109.05 141.02 41.8 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 122.678 0.391 . . . . 64.32 110.343 -173.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.447 ' HB2' ' HD2' ' A' ' 120' ' ' ARG . 65.8 mt -107.98 83.2 1.75 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.332 1.053 . . . . 72.12 108.686 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.568 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 92.1 mt -66.62 101.33 0.77 Allowed 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.174 -0.921 . . . . 70.05 110.283 179.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 64.0 t -84.29 102.81 10.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 N-CA-C 107.677 -1.231 . . . . 61.43 107.677 173.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 7.3 p -66.88 128.43 30.05 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 CA-C-N 115.358 -0.837 . . . . 70.33 110.592 -177.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.489 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 33.3 mmt180 -124.09 91.82 3.54 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.255 1.422 . . . . 53.32 107.272 -174.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.569 HD13 HD13 ' A' ' 127' ' ' LEU . 27.9 mt -70.17 147.52 49.77 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.597 -0.729 . . . . 72.4 112.181 -171.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 61.9 mt -58.95 149.14 67.33 Favored Pre-proline 0 N--CA 1.479 1.024 0 C-N-CA 124.362 1.065 . . . . 73.14 110.814 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -58.86 79.42 0.05 OUTLIER 'Trans proline' 0 C--N 1.383 2.381 0 C-N-CA 123.413 2.742 . . . . 71.42 112.703 176.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 66.5 t-80 -129.39 103.5 18.01 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 105.917 -1.882 . . . . 73.35 105.917 -175.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -73.58 25.39 0.32 Allowed 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 123.638 2.892 . . . . 61.24 116.227 -163.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 71.5 t -97.57 -61.21 2.32 Favored 'Isoleucine or valine' 0 C--N 1.351 0.669 0 CA-C-N 118.425 0.557 . . . . 64.21 110.465 -177.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 15.5 m-30 -124.34 147.92 47.85 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-O 121.829 0.823 . . . . 72.31 112.714 -171.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -144.8 150.28 36.89 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.328 1.851 . . . . 75.51 106.665 172.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.632 HD12 ' HA ' ' A' ' 193' ' ' LEU . 6.3 tp -121.17 173.43 7.31 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 107.177 -1.416 . . . . 74.21 107.177 178.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -159.56 128.98 5.34 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 109.076 -0.713 . . . . 70.31 109.076 165.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 68.6 -74.55 0.31 Allowed Glycine 0 C--N 1.347 1.169 0 N-CA-C 110.979 -0.848 . . . . 65.41 110.979 -170.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.446 ' N ' HD21 ' B' ' 300' ' ' ASN . 3.4 tp-100 -164.17 -0.68 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 123.758 0.823 . . . . 72.32 111.547 172.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -95.89 146.49 24.54 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.914 -0.491 . . . . 72.32 109.685 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.632 ' HA ' HD12 ' A' ' 188' ' ' LEU . 0.8 OUTLIER -89.69 157.2 18.1 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.473 1.109 . . . . 63.44 111.486 -165.765 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -142.96 154.9 44.51 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.648 1.579 . . . . 73.14 107.631 175.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.439 ' HB3' HD23 ' A' ' 251' ' ' LEU . . . -158.84 127.16 5.21 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.902 0.881 . . . . 74.34 109.122 -176.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 31.1 m -75.66 127.23 32.62 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 118.163 0.438 . . . . 70.21 110.128 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 38.5 tp -130.7 104.32 7.12 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.522 0.729 . . . . 72.21 110.032 -175.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -89.85 124.59 34.82 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 109.261 -0.644 . . . . 61.43 109.261 171.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 8.9 p -138.06 137.62 21.53 Favored Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 123.874 0.869 . . . . 64.4 109.16 -174.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.85 155.16 53.69 Favored 'Trans proline' 0 C--N 1.378 2.086 0 C-N-CA 121.765 1.643 . . . . 64.51 111.327 174.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -52.2 -49.66 83.5 Favored Pre-proline 0 CA--C 1.552 1.043 0 N-CA-C 114.633 1.346 . . . . 71.34 114.633 -172.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.443 ' HG2' ' HE1' ' C' ' 276' ' ' TYR . 54.3 Cg_exo -58.75 -41.28 64.83 Favored 'Trans proline' 0 C--N 1.386 2.541 0 C-N-CA 121.912 1.741 . . . . 63.54 113.997 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.485 HD11 ' HB3' ' C' ' 276' ' ' TYR . 44.0 mt -68.29 -35.57 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 109.907 -0.405 . . . . 64.32 109.907 178.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.16 -45.82 79.59 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.46 0.704 . . . . 71.51 111.751 176.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 53.0 t -68.26 -48.75 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 124.194 0.998 . . . . 63.23 111.522 -176.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 54.7 t -83.13 -37.59 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.042 0.937 . . . . 74.41 111.613 -172.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 92.22 70.61 1.17 Allowed Glycine 0 C--O 1.24 0.48 0 CA-C-N 115.765 -0.652 . . . . 72.35 111.493 -174.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -92.18 -154.23 30.7 Favored Glycine 0 C--N 1.34 0.793 0 CA-C-N 115.055 -0.572 . . . . 55.24 113.312 -177.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 36.3 mtmt -130.02 132.84 46.39 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.327 -0.62 . . . . 45.21 109.327 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 29.0 m -132.52 160.37 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 N-CA-C 108.678 -0.86 . . . . 63.11 108.678 172.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -97.68 115.36 27.8 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.358 -0.979 . . . . 71.41 108.358 177.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -100.89 165.65 11.24 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.936 0.894 . . . . 62.04 110.326 -174.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . 0.456 ' SD ' ' N ' ' A' ' 213' ' ' MET . 0.0 OUTLIER -98.98 137.04 38.08 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.241 -0.89 . . . . 71.23 109.211 -174.941 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 67.6 p -124.53 177.51 5.89 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 107.934 -1.135 . . . . 74.1 107.934 163.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.622 HD12 HH21 ' A' ' 154' ' ' ARG . 33.0 mt -78.26 -23.14 47.42 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.81 -0.632 . . . . 63.31 110.395 -177.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -83.62 -12.84 55.49 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.148 0.979 . . . . 64.44 111.175 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 138.28 -164.62 25.6 Favored Glycine 0 C--N 1.346 1.137 0 N-CA-C 111.564 -0.614 . . . . 33.0 111.564 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . 0.487 ' HB3' HG21 ' B' ' 384' ' ' THR . 65.0 Cg_endo -79.09 134.8 11.87 Favored 'Trans proline' 0 C--N 1.363 1.303 0 C-N-CA 122.262 1.974 . . . . 70.23 111.693 175.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 34.8 m -130.89 168.14 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 107.681 -1.229 . . . . 73.4 107.681 171.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -106.54 152.84 23.17 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 121.856 -0.528 . . . . 75.04 111.894 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 10.2 p -142.63 141.65 27.41 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 CA-C-N 114.868 -1.06 . . . . 74.13 109.319 -173.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.476 ' HB3' ' HA ' ' B' ' 440' ' ' ARG . . . -106.83 104.77 14.53 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 109.608 -0.515 . . . . 60.25 109.608 -179.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.563 ' HA ' HD12 ' B' ' 441' ' ' ILE . 66.7 t -58.53 142.78 82.27 Favored Pre-proline 0 CA--C 1.569 1.68 0 C-N-CA 125.262 1.425 . . . . 63.14 110.472 -179.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -84.31 167.36 12.13 Favored 'Trans proline' 0 C--N 1.386 2.515 0 C-N-CA 122.863 2.375 . . . . 75.51 111.195 175.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.12 145.91 28.26 Favored 'Trans proline' 0 C--N 1.367 1.546 0 C-N-CA 121.495 1.463 . . . . 72.53 112.681 174.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 71.9 mtt85 65.76 34.18 7.66 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 125.341 1.456 . . . . 74.04 111.642 175.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.503 HG22 HG11 ' A' ' 253' ' ' VAL . 89.3 m -63.15 108.67 1.31 Allowed 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 113.657 -1.611 . . . . 64.32 110.705 174.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -98.71 150.89 21.34 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.597 0.759 . . . . 75.32 110.824 -169.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -63.86 128.04 34.05 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.896 0.879 . . . . 62.31 110.742 177.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 97.0 -26.18 23.71 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-N 116.377 -0.374 . . . . 73.32 112.53 -178.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 55.8 mtt180 -74.36 135.3 42.47 Favored 'General case' 0 C--N 1.36 1.057 0 CA-C-O 121.623 0.725 . . . . 74.0 111.094 -178.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.634 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 33.6 mttm -102.71 112.37 25.12 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 114.219 -1.355 . . . . 72.22 109.03 -178.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.548 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 45.6 mt -75.33 99.5 4.12 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.031 0.932 . . . . 71.4 109.755 -172.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 58.9 ttt180 -73.64 123.89 24.91 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.59 1.156 . . . . 64.14 110.958 -173.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.494 HD21 HG23 ' B' ' 441' ' ' ILE . 67.3 mt -116.64 109.41 17.16 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.964 0.905 . . . . 61.12 109.889 -179.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -62.5 125.31 23.5 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 123.668 0.787 . . . . 64.43 112.767 -173.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 73.08 30.65 62.79 Favored Glycine 0 C--N 1.352 1.43 0 O-C-N 124.036 0.835 . . . . 74.2 113.881 174.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -115.77 -12.38 11.49 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.333 0.653 . . . . 73.01 111.65 -178.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -87.17 -168.77 45.14 Favored Glycine 0 C--N 1.348 1.205 0 O-C-N 123.311 0.382 . . . . 74.43 112.323 171.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . 0.494 ' HE2' ' HG3' ' A' ' 154' ' ' ARG . 13.2 m-30 -95.0 154.29 39.69 Favored Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 123.039 0.536 . . . . 73.13 111.903 -169.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.521 ' HA ' ' HA ' ' A' ' 246' ' ' ARG . 59.5 Cg_endo -70.16 120.54 7.25 Favored 'Trans proline' 0 C--N 1.386 2.544 0 C-N-CA 123.339 2.692 . . . . 73.33 113.62 -176.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -157.05 -138.78 2.58 Favored Glycine 0 C--N 1.35 1.327 0 CA-C-O 119.208 -0.773 . . . . 73.52 112.645 -178.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -70.57 -16.31 34.12 Favored 'Trans proline' 0 C--N 1.385 2.493 0 C-N-CA 123.24 2.627 . . . . 70.45 113.549 -173.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -100.18 20.43 14.62 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.737 0.815 . . . . 70.11 110.643 177.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 79.09 -80.19 1.53 Allowed Glycine 0 C--N 1.351 1.398 0 N-CA-C 109.503 -1.439 . . . . 62.24 109.503 -171.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.521 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 44.8 mtm180 -125.6 159.36 32.33 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.476 1.11 . . . . 75.41 108.514 164.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -87.64 -176.81 48.3 Favored Glycine 0 C--N 1.339 0.696 0 CA-C-N 116.14 -0.482 . . . . 42.24 112.285 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -123.2 151.6 42.07 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.027 0.931 . . . . 75.44 109.648 178.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.491 HD23 HD12 ' A' ' 235' ' ' LEU . 53.8 tp -96.84 111.31 23.55 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 109.434 -0.58 . . . . 70.31 109.434 -178.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.634 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 18.7 m-85 -96.82 105.91 18.12 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.323 1.049 . . . . 52.51 109.539 -179.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.548 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 12.1 mt -81.63 97.4 7.86 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.949 0.5 . . . . 72.24 109.739 176.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -77.47 105.74 8.79 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.988 0.915 . . . . 75.41 108.726 -174.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.503 HG11 HG22 ' A' ' 227' ' ' THR . 55.0 t -88.79 144.35 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 N-CA-C 114.192 1.182 . . . . 24.43 114.192 -165.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -128.65 111.47 13.23 Favored 'General case' 0 C--N 1.351 0.666 0 C-N-CA 125.838 1.655 . . . . 73.14 108.01 168.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 58.2 mt -76.8 138.6 20.28 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 122.955 0.502 . . . . 74.34 109.769 178.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 48.2 p -122.87 173.48 7.75 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.588 1.155 . . . . 73.43 109.307 176.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.455 HG13 ' H ' ' A' ' 259' ' ' GLU . 27.3 pt -117.82 162.18 30.42 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 123.301 0.64 . . . . 73.4 109.68 175.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . 0.411 ' HA ' ' HB3' ' B' ' 376' ' ' GLU . 47.9 Cg_endo -66.65 5.98 0.65 Allowed 'Trans proline' 0 N--CA 1.502 1.979 0 C-N-CA 123.263 2.642 . . . . 74.45 115.609 176.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.477 ' HG3' ' NE2' ' C' ' 228' ' ' GLN . 2.4 mp0 48.52 -97.68 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.692 0.797 . . . . 63.24 109.659 -161.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' ARG . . . . . 0.653 ' HG2' ' HB3' ' B' ' 373' ' ' ARG . 0.0 OUTLIER -87.7 160.95 17.9 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.062 0.945 . . . . 75.12 111.003 -172.598 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 79.7 mt -138.51 157.38 46.29 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.673 0.789 . . . . 55.32 110.446 -175.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 78.4 p -102.67 151.19 38.24 Favored Pre-proline 0 CA--C 1.554 1.133 0 N-CA-C 108.394 -0.965 . . . . 44.34 108.394 169.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -25.79 -46.29 0.06 OUTLIER 'Trans proline' 0 C--N 1.394 2.958 1 C-N-CA 126.58 4.854 . . . . 74.33 117.932 -170.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -66.64 -62.73 1.3 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 122.935 0.494 . . . . 71.44 111.445 -176.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -66.12 -25.81 67.16 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 122.509 0.324 . . . . 64.2 110.5 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' GLU . . . . . 0.404 ' O ' ' HD3' ' A' ' 270' ' ' LYS . 7.8 tp10 -56.75 -52.12 66.22 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 124.179 0.924 . . . . 73.45 109.455 173.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -62.39 -42.42 99.41 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.698 -1.137 . . . . 64.12 111.653 176.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 10.4 mp -58.04 -55.46 34.63 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 122.971 0.508 . . . . 73.14 111.955 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 66.4 m95 -60.12 -39.79 87.46 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.487 0.715 . . . . 75.0 111.647 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . 0.569 ' HE2' HG23 ' C' ' 206' ' ' VAL . 1.1 mptm? -64.34 -44.03 92.78 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 123.62 0.575 . . . . 62.43 111.585 177.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -63.72 -43.02 97.78 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 122.993 0.517 . . . . 70.22 110.608 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 272' ' ' LEU . . . . . 0.492 ' O ' ' HB2' ' A' ' 276' ' ' TYR . 75.6 mt -56.53 -46.01 80.83 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 124.422 1.076 . . . . 63.4 110.57 174.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . 0.583 ' HB1' HE22 ' B' ' 250' ' ' GLN . . . -74.69 -37.99 62.49 Favored 'General case' 0 C--O 1.244 0.797 0 O-C-N 124.468 1.105 . . . . 64.51 113.63 -171.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -77.3 -39.11 49.1 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.072 0.549 . . . . 74.35 109.566 -179.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . 0.445 ' HB1' ' NH2' ' A' ' 279' ' ' ARG . . . -74.19 -20.49 60.18 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.162 0.585 . . . . 71.44 111.034 174.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . 0.492 ' HB2' ' O ' ' A' ' 272' ' ' LEU . 14.7 t80 -65.16 -63.63 1.06 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.079 0.951 . . . . 75.02 108.762 172.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -64.94 -38.64 91.64 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 114.987 -1.006 . . . . 70.12 110.406 -173.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . 0.495 ' HA ' HD23 ' B' ' 278' ' ' LEU . . . -62.85 -26.15 68.62 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.236 0.614 . . . . 75.41 112.093 176.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . 0.445 ' NH2' ' HB1' ' A' ' 275' ' ' ALA . 27.5 mtm180 -117.4 31.2 6.86 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.477 0.711 . . . . 74.13 109.938 179.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.393 0 N-CA-C 109.087 -0.708 . . . . 72.21 109.087 171.984 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.481 1.081 0 N-CA-C 109.872 -0.418 . . . . 71.44 109.872 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 57.6 tttp 70.97 135.11 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.931 1.292 . . . . 54.1 113.594 176.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 63.08 30.14 16.21 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 125.62 1.568 . . . . 74.04 112.168 171.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 11.9 m -66.63 -34.96 79.04 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.769 0.428 . . . . 52.14 110.448 175.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 1.8 m 69.14 152.03 0.09 Allowed 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 125.593 1.557 . . . . 70.11 112.167 177.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.649 HG21 ' HA ' ' A' ' 125' ' ' LEU . 31.4 pt -136.83 171.2 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 N-CA-C 113.044 0.757 . . . . 64.44 113.044 -158.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -146.05 123.58 11.75 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.169 0.988 . . . . 72.01 110.187 -178.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.538 HD11 ' HB1' ' A' ' 121' ' ' ALA . 36.3 tp -77.75 145.37 36.53 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.119 0.968 . . . . 75.22 110.908 -173.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . 0.544 ' HB3' ' HB2' ' A' ' 122' ' ' GLU . . . -88.79 -50.39 6.26 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.052 0.541 . . . . 62.4 111.828 178.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 86.9 mt 68.0 122.57 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 124.872 1.269 . . . . 74.1 111.283 -166.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.423 HD22 ' HD2' ' B' ' 15' ' ' PHE . 68.2 mt -111.11 100.84 48.42 Favored Pre-proline 0 N--CA 1.481 1.078 0 N-CA-C 108.046 -1.094 . . . . 45.35 108.046 171.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.455 ' HA ' HD11 ' A' ' 119' ' ' LEU . 13.6 Cg_endo -51.95 -65.77 0.13 Allowed 'Trans proline' 0 C--N 1.384 2.429 0 C-N-CA 123.462 2.775 . . . . 61.33 112.65 -174.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . 0.548 ' HB3' HH22 ' A' ' 117' ' ' ARG . 2.5 pt? -170.07 147.76 3.28 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.201 1.001 . . . . 75.01 108.87 175.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 94.8 mt 70.7 -23.84 0.17 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 125.146 1.378 . . . . 64.54 114.45 174.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 15' ' ' PHE . . . . . 0.423 ' HD2' HD22 ' B' ' 11' ' ' LEU . 69.6 t80 -76.43 96.78 4.12 Favored 'General case' 0 C--N 1.349 0.583 0 CA-C-O 121.447 0.641 . . . . 60.01 109.38 -178.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . 0.402 HG22 HG23 ' B' ' 18' ' ' VAL . 41.4 m -139.57 126.69 12.74 Favored Pre-proline 0 CA--C 1.546 0.811 0 N-CA-C 107.487 -1.301 . . . . 51.11 107.487 178.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -66.92 73.85 0.45 Allowed 'Trans proline' 0 C--N 1.379 2.15 0 C-N-CA 123.086 2.524 . . . . 62.42 113.741 -177.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.402 HG23 HG22 ' B' ' 16' ' ' THR . 57.5 t -135.47 90.19 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.092 0.957 . . . . 61.41 109.173 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 4.4 m 64.24 10.14 5.34 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 124.335 1.054 . . . . 71.22 113.199 165.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -159.01 -72.24 0.08 Allowed 'General case' 0 N--CA 1.479 1.006 0 O-C-N 121.333 -0.854 . . . . 62.34 111.624 -175.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.98 77.44 5.45 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.354 0.661 . . . . 75.34 111.213 -170.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? 54.43 91.35 0.03 OUTLIER 'General case' 0 C--N 1.356 0.869 0 C-N-CA 125.377 1.471 . . . . 73.31 110.972 -177.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 23' ' ' THR . . . . . . . . . . . . . 23.4 m -101.63 107.59 52.16 Favored Pre-proline 0 CA--C 1.554 1.11 0 N-CA-C 108.906 -0.776 . . . . 72.45 108.906 178.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.02 -21.57 68.29 Favored 'Trans proline' 0 C--N 1.381 2.242 0 C-N-CA 123.441 2.761 . . . . 74.55 112.955 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -93.55 97.97 10.86 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 108.369 -0.974 . . . . 74.53 108.369 178.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . 0.509 ' H ' ' HD2' ' B' ' 27' ' ' PRO . 28.0 ttt -171.26 -38.77 0.0 OUTLIER Pre-proline 0 CA--C 1.567 1.61 0 C-N-CA 124.402 1.081 . . . . 75.13 111.716 -172.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 27' ' ' PRO . . . . . 0.509 ' HD2' ' H ' ' B' ' 26' ' ' MET . 30.1 Cg_endo -62.9 168.63 10.13 Favored 'Trans proline' 0 C--N 1.394 2.949 0 C-N-CA 122.167 1.912 . . . . 71.1 112.68 167.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 64.9 t 78.2 -28.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 C-N-CA 126.08 1.752 . . . . 73.51 111.132 -172.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 80.3 mt -68.65 175.88 3.27 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.306 1.042 . . . . 62.2 112.03 173.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 63.42 34.39 12.93 Favored 'General case' 0 C--N 1.357 0.903 0 C-N-CA 124.539 1.136 . . . . 70.24 110.258 -174.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 52.0 t-20 -64.36 93.59 0.1 Allowed 'General case' 0 C--N 1.365 1.281 0 N-CA-C 108.752 -0.833 . . . . 74.34 108.752 176.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 18.5 ttp180 -108.48 11.72 26.68 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 124.99 1.316 . . . . 72.22 109.609 -172.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.56 -51.92 4.89 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.344 1.058 . . . . 73.31 108.923 172.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -119.06 107.88 14.04 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 124.275 1.03 . . . . 53.33 108.69 178.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -166.37 71.21 0.13 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.138 0.975 . . . . 73.13 108.517 -178.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . 0.427 ' HA2' ' HA2' ' C' ' 247' ' ' GLY . . . 55.93 -107.78 0.92 Allowed Glycine 0 C--N 1.342 0.866 0 CA-C-N 114.635 -1.166 . . . . 74.33 114.472 178.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -65.57 -26.02 67.67 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 114.16 1.17 . . . . 61.44 114.16 -172.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 13.3 tt -74.33 -20.21 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-N 117.816 0.28 . . . . 75.44 111.544 -176.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 10.3 t -107.52 -32.38 7.73 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.021 0.528 . . . . 64.25 110.766 176.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -166.51 103.86 0.67 Allowed Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 123.954 0.902 . . . . 64.0 109.38 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -68.9 72.54 1.04 Allowed 'Trans proline' 0 C--N 1.383 2.386 0 C-N-CA 123.25 2.633 . . . . 72.44 112.563 176.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 60.26 -89.72 0.04 OUTLIER Glycine 0 C--N 1.351 1.413 0 CA-C-N 115.863 -0.608 . . . . 45.24 112.4 -175.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -168.77 18.12 0.07 OUTLIER Glycine 0 CA--C 1.528 0.86 0 CA-C-O 119.599 -0.556 . . . . 42.15 112.291 174.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . 62.61 -75.68 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.654 1.182 . . . . 63.2 109.873 -170.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -65.81 138.75 58.12 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.564 0.746 . . . . 74.21 109.546 166.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -79.01 -27.61 43.27 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 108.22 -1.03 . . . . 75.02 108.22 171.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 44.0 tp 78.56 -36.63 0.2 Allowed 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 126.278 1.831 . . . . 53.22 112.894 171.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 11.8 m 75.13 -3.98 2.48 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 124.918 1.287 . . . . 51.22 111.36 -177.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.62 19.57 61.6 Favored Glycine 0 C--N 1.348 1.215 0 N-CA-C 111.359 -0.696 . . . . 74.15 111.359 -169.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -80.8 151.02 28.96 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 123.569 0.748 . . . . 64.2 110.597 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -134.95 -0.92 2.73 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.388 1.075 . . . . 75.3 110.579 -178.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 4.1 m 60.25 41.05 17.15 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 124.364 1.066 . . . . 73.31 110.621 -177.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.17 95.87 0.6 Allowed 'General case' 0 C--N 1.354 0.799 0 CA-C-N 115.223 -0.899 . . . . 73.24 109.355 177.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.687 ' HB1' HH11 ' B' ' 56' ' ' ARG . . . 65.23 10.1 6.16 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.758 1.223 . . . . 75.51 112.299 -175.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 24.0 tp 58.01 23.56 10.11 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 124.972 1.309 . . . . 72.35 110.893 -172.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . 0.687 HH11 ' HB1' ' B' ' 54' ' ' ALA . 79.1 mtt85 -120.59 -167.93 1.55 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.519 1.128 . . . . 73.2 110.043 -175.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -82.47 15.73 2.4 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 123.354 0.662 . . . . 75.31 111.601 177.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 31.1 t -64.83 -22.66 67.03 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.478 1.111 . . . . 62.01 112.395 -178.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -66.26 -27.94 68.33 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.988 0.515 . . . . 72.44 110.772 174.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 33.0 t -94.85 95.29 8.58 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.315 1.046 . . . . 63.51 109.168 178.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -66.94 145.14 55.75 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.178 0.591 . . . . 71.45 110.415 176.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 62' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm 62.77 82.01 0.22 Allowed Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 125.056 1.342 . . . . 72.3 111.721 -176.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -68.11 -13.18 37.38 Favored 'Trans proline' 0 C--N 1.382 2.295 0 C-N-CA 123.211 2.607 . . . . 72.24 112.578 170.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . 0.517 ' HB1' ' HB1' ' B' ' 262' ' ' ALA . . . 68.25 -78.53 0.04 OUTLIER 'General case' 0 C--N 1.361 1.098 0 C-N-CA 125.577 1.551 . . . . 72.04 111.085 -177.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -107.78 -11.61 15.36 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.255 0.622 . . . . 65.32 111.126 178.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 70.5 145.93 0.06 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.697 1.199 . . . . 72.41 112.684 177.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 13.7 tt 41.0 60.34 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 C-N-CA 126.65 1.98 . . . . 72.03 112.606 176.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 31.6 pt -77.34 77.09 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 CA-C-N 114.607 -1.179 . . . . 73.4 110.783 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.31 99.24 0.9 Allowed 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 114.428 -1.26 . . . . 73.12 109.51 179.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 8.6 mp 68.16 -75.93 0.06 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.84 1.256 . . . . 44.44 110.004 -177.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . 0.445 HG12 ' H ' ' B' ' 73' ' ' ASP . 17.7 tt -135.52 123.28 37.03 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 C-N-CA 123.698 0.799 . . . . 74.32 109.256 174.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -106.79 26.36 19.76 Favored Glycine 0 N--CA 1.476 1.342 0 N-CA-C 111.296 -0.722 . . . . 62.21 111.296 177.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . 0.445 ' H ' HG12 ' B' ' 71' ' ' ILE . 2.7 m-20 -111.5 -40.29 4.4 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.61 1.164 . . . . 63.44 109.805 -172.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 172.45 118.07 0.47 Allowed Glycine 0 C--N 1.337 0.604 0 N-CA-C 109.478 -1.449 . . . . 64.42 109.478 -178.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 75' ' ' MET . . . . . 0.48 ' N ' ' SD ' ' B' ' 75' ' ' MET . 0.7 OUTLIER -74.95 88.04 2.34 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 122.001 0.905 . . . . 74.01 109.29 -174.362 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 161.74 61.04 0.02 OUTLIER Glycine 0 C--N 1.333 0.371 0 N-CA-C 108.3 -1.92 . . . . 71.13 108.3 -173.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -53.07 -49.68 65.89 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 125.064 1.346 . . . . 73.03 111.052 -173.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 95.9 p 60.41 -65.45 0.05 Allowed 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 126.93 2.092 . . . . 51.1 111.745 -178.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . 0.587 ' HG3' HG12 ' B' ' 80' ' ' ILE . 10.3 tp10 74.14 -81.6 0.03 OUTLIER 'General case' 0 C--N 1.352 0.702 0 C-N-CA 125.353 1.461 . . . . 74.44 110.37 171.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.587 HG12 ' HG3' ' B' ' 79' ' ' GLU . 11.2 pt -144.77 -165.62 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 125.174 1.39 . . . . 72.52 107.896 -178.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 23.1 m -69.79 155.81 39.97 Favored 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 108.343 -0.984 . . . . 71.34 108.343 168.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -49.05 95.31 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.751 1.221 . . . . 61.11 112.269 -171.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -161.08 -57.39 0.05 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.469 1.108 . . . . 71.35 108.879 -176.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -102.65 96.15 6.69 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 109.029 -0.73 . . . . 73.0 109.029 174.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -131.58 -68.81 0.64 Allowed 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 107.612 -1.255 . . . . 72.23 107.612 175.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 60.6 t80 65.74 145.49 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 125.461 1.504 . . . . 63.12 112.286 175.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . 58.28 -135.88 0.96 Allowed 'General case' 0 N--CA 1.481 1.123 0 CA-C-O 118.433 -0.794 . . . . 52.24 109.515 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 69.13 -77.11 0.05 Allowed 'General case' 0 C--N 1.364 1.21 0 C-N-CA 124.704 1.202 . . . . 74.14 110.564 168.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 170.6 -32.58 0.15 Allowed Glycine 0 C--N 1.339 0.735 0 N-CA-C 110.564 -1.015 . . . . 54.33 110.564 179.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.7 -36.31 83.42 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.262 1.025 . . . . 62.33 112.311 178.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -163.49 88.68 0.1 Allowed Glycine 0 C--N 1.343 0.969 0 N-CA-C 111.256 -0.737 . . . . 70.11 111.256 -179.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.96 -42.83 99.87 Favored Glycine 0 C--N 1.356 1.683 0 N-CA-C 111.936 -0.465 . . . . 23.53 111.936 177.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 23.8 t80 63.26 82.69 0.18 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.219 1.408 . . . . 74.22 111.071 176.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -82.64 -4.42 57.71 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 114.544 -1.207 . . . . 71.21 111.176 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . 0.612 ' HB2' HG22 ' B' ' 97' ' ' ILE . 42.1 mttp 73.74 -19.49 0.34 Allowed 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 125.592 1.557 . . . . 74.14 114.064 167.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.3 8.78 85.73 Favored Glycine 0 C--N 1.349 1.265 0 CA-C-O 120.035 -0.314 . . . . 72.31 113.609 -176.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 97' ' ' ILE . . . . . 0.612 HG22 ' HB2' ' B' ' 95' ' ' LYS . 9.3 tt -89.48 75.06 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.166 0 CA-C-O 122.599 1.19 . . . . 72.22 109.559 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -157.29 140.18 15.16 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.008 -0.996 . . . . 75.21 109.104 -178.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . 72.03 -11.31 0.79 Allowed 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 125.906 1.683 . . . . 61.12 113.408 -177.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 76.2 mt -76.57 -41.22 2.82 Favored Pre-proline 0 CA--C 1.558 1.257 0 C-N-CA 124.392 1.077 . . . . 74.2 112.089 176.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -60.23 109.78 0.68 Allowed 'Trans proline' 0 C--N 1.405 3.523 0 C-N-CA 121.945 1.764 . . . . 72.21 111.751 172.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 55.1 tp -64.2 126.78 28.85 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.68 0.792 . . . . 73.12 110.217 -178.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 27.5 m -76.03 80.99 2.88 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-O 121.769 0.795 . . . . 75.52 109.684 178.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.86 151.48 30.53 Favored Glycine 0 C--N 1.343 0.965 0 CA-C-N 114.592 -1.186 . . . . 51.35 111.743 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 26.3 mp0 -74.72 -17.74 60.61 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.052 0.941 . . . . 75.22 110.829 178.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 59.9 t80 80.83 -43.87 0.21 Allowed 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 125.245 1.418 . . . . 74.44 112.6 170.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 58.8 p -74.9 95.26 2.93 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.91 0.884 . . . . 63.32 112.183 -173.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 32.9 m80 71.49 116.31 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 125.284 1.434 . . . . 71.44 113.115 167.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -136.51 93.6 2.9 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.472 1.109 . . . . 53.33 108.139 174.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -133.56 118.02 17.78 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.435 0.694 . . . . 71.24 110.607 -172.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 3.9 pp -90.03 156.65 18.25 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.446 0.698 . . . . 64.15 109.98 173.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 112' ' ' ASN . . . . . 0.434 ' ND2' ' HB ' ' B' ' 115' ' ' THR . 27.0 t-20 68.62 -73.1 0.09 Allowed 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 124.961 1.304 . . . . 73.2 112.603 174.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 113' ' ' LYS . . . . . 0.69 ' HG2' ' HB2' ' C' ' 36' ' ' ASP . 15.7 tppt? 75.08 -69.31 0.18 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 126.232 1.813 . . . . 75.13 111.945 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.64 61.75 1.38 Allowed 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 121.765 0.793 . . . . 74.01 111.8 -173.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . 0.434 ' HB ' ' ND2' ' B' ' 112' ' ' ASN . 69.7 m -137.47 120.84 17.0 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 108.723 -0.843 . . . . 73.23 108.723 174.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . 0.462 ' O ' ' HD3' ' B' ' 118' ' ' PRO . . . 63.12 -111.72 4.35 Favored Glycine 0 C--N 1.357 1.742 0 N-CA-C 110.019 -1.232 . . . . 55.33 110.019 -171.038 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . 0.272 4.2 tppp? 99.91 -81.18 0.0 OUTLIER Pre-proline 0 CA--C 1.574 1.877 0 C-N-CA 127.215 2.206 . . . . 70.25 115.102 164.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 118' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' B' ' 116' ' ' GLY . 10.8 Cg_endo -84.11 -74.32 0.01 OUTLIER 'Trans proline' 0 C--N 1.4 3.237 0 CA-C-N 122.4 1.893 . . . . 60.53 114.788 -160.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 119' ' ' ASP . . . . . . . . . . . . . 38.3 t70 65.24 -74.85 0.05 Allowed 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 125.071 1.348 . . . . 75.33 110.545 -167.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 120' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 57.3 75.97 0.34 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 124.458 1.103 . . . . 70.1 112.406 177.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 27.9 m -97.54 -20.43 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-N 115.301 -0.863 . . . . 74.32 110.452 170.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 35.6 m 56.29 85.71 0.07 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.657 1.183 . . . . 75.24 110.552 -172.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -73.53 177.33 5.4 Favored 'General case' 0 CA--C 1.56 1.333 0 CA-C-N 115.601 -0.727 . . . . 64.3 110.878 -174.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 39.2 p -17.35 -90.94 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 127.75 2.42 . . . . 43.31 115.58 -172.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . 177.48 -74.46 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 124.564 1.146 . . . . 73.02 110.007 176.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -171.01 -166.1 0.46 Allowed 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 114.393 -1.276 . . . . 74.13 109.379 -172.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 63.7 m -104.54 -69.08 0.82 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.64 1.176 . . . . 70.01 110.4 -179.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -131.9 88.48 2.56 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 124.991 1.316 . . . . 72.01 108.63 175.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 15.3 t -67.32 131.43 45.71 Favored 'General case' 0 CA--C 1.559 1.312 0 CA-C-N 116.015 -0.539 . . . . 54.34 110.511 -174.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . 78.44 128.0 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 126.213 1.805 . . . . 44.22 110.976 -169.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 16.9 t90 71.17 -62.23 0.46 Allowed 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 126.054 1.742 . . . . 73.51 111.586 -179.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 20.8 m 79.46 -63.04 0.27 Allowed 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 125.442 1.497 . . . . 51.4 113.099 167.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 26.1 m -69.32 92.83 0.6 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.197 0.999 . . . . 62.25 110.827 -175.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 118.65 -19.99 10.29 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 116.188 -0.46 . . . . 55.15 112.717 -178.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 135' ' ' VAL . . . . . . . . . . . . . 62.1 t 66.83 -78.52 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 125.509 1.524 . . . . 73.24 112.439 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm 55.87 48.43 18.07 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.741 1.216 . . . . 52.43 111.288 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 71.3 p 62.89 -4.06 0.28 Allowed 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 126.127 1.771 . . . . 75.31 115.145 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 31.0 p90 37.15 -65.24 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.638 0 C-N-CA 127.896 2.478 . . . . 75.52 116.917 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 14.9 m120 68.08 22.16 8.48 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 125.074 1.35 . . . . 73.24 112.105 176.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . 86.44 -55.87 4.72 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-O 119.57 -0.572 . . . . 65.04 113.657 173.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . 66.81 103.51 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.714 1.206 . . . . 75.34 110.51 -173.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -151.3 -169.65 3.44 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.809 0.844 . . . . 70.15 109.511 -175.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 162.48 -20.49 0.18 Allowed Glycine 0 C--N 1.353 1.496 0 CA-C-O 119.607 -0.551 . . . . 61.25 113.919 175.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 58.3 t 71.76 -65.84 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 125.589 1.556 . . . . 75.31 111.417 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -83.14 -29.51 28.59 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.082 0.953 . . . . 64.3 110.678 176.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 2.9 pp -125.52 -177.38 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 123.841 0.856 . . . . 72.52 110.027 175.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 43.2 p-80 -143.07 144.23 32.17 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.069 0.548 . . . . 72.43 110.247 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 61.98 -79.63 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 125.221 1.408 . . . . 73.05 112.878 171.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 149' ' ' LYS . . . . . . . . . . . . . 55.6 tttm 69.42 -83.84 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 125.704 1.602 . . . . 72.23 113.259 173.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -100.01 -48.23 4.73 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 113.208 0.818 . . . . 74.11 113.208 -166.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -79.95 -62.94 0.38 Allowed Pre-proline 0 CA--C 1.566 1.561 0 N-CA-C 114.012 1.116 . . . . 74.43 114.012 -168.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.8 91.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.394 2.954 0 C-N-CA 123.352 2.701 . . . . 42.51 115.235 -161.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . 0.448 ' HB ' ' HA ' ' B' ' 159' ' ' LYS . 4.2 m 60.27 22.96 12.38 Favored 'General case' 0 CA--C 1.56 1.36 0 C-N-CA 125.465 1.506 . . . . 74.2 113.073 168.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 154' ' ' ILE . . . . . 0.409 HD13 ' HG3' ' B' ' 159' ' ' LYS . 35.8 mm -66.44 -40.26 86.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 123.486 0.714 . . . . 74.25 109.523 175.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 3.9 tt -86.97 68.09 9.98 Favored 'General case' 0 CA--C 1.555 1.159 0 N-CA-C 108.557 -0.905 . . . . 72.1 108.557 174.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -173.89 -106.67 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.303 0 C-N-CA 124.046 0.938 . . . . 72.23 109.606 171.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 157' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -176.04 -33.96 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.915 0.886 . . . . 53.54 110.664 -174.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 158' ' ' ALA . . . . . . . . . . . . . . . -88.91 34.41 0.78 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.454 0.702 . . . . 34.04 111.125 -176.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . 0.448 ' HA ' ' HB ' ' B' ' 153' ' ' THR . 11.4 tmtt? -60.03 -72.15 0.11 Allowed 'General case' 0 C--N 1.354 0.77 0 C-N-CA 124.444 1.098 . . . . 55.45 108.953 177.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 160' ' ' ALA . . . . . 0.427 ' HB3' ' HG2' ' C' ' 182' ' ' PRO . . . 173.49 86.37 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.505 1.522 . . . . 70.22 108.193 175.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -163.34 80.28 0.45 Allowed 'General case' 0 C--O 1.24 0.564 0 C-N-CA 124.01 0.924 . . . . 71.1 108.74 178.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . -80.29 -58.28 2.79 Favored Glycine 0 C--N 1.341 0.854 0 N-CA-C 110.194 -1.162 . . . . 73.4 110.194 171.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 49.4 tp 56.59 -85.16 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 125.302 1.441 . . . . 65.02 111.377 175.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 164' ' ' ALA . . . . . . . . . . . . . . . -68.18 -34.48 76.36 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.737 0.815 . . . . 75.34 111.171 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 14.9 t -99.59 38.82 1.38 Allowed 'General case' 0 CA--C 1.558 1.263 0 CA-C-O 121.845 0.831 . . . . 64.15 109.607 173.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . -73.25 89.34 0.6 Allowed Glycine 0 C--N 1.348 1.203 0 CA-C-N 115.466 -0.788 . . . . 71.15 112.375 177.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 167' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -64.34 118.86 9.3 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.567 0.747 . . . . 72.31 109.497 177.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 71.0 t 68.36 -73.82 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.156 0 C-N-CA 125.183 1.393 . . . . 74.13 111.311 -178.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 46.9 t 63.95 -81.37 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.264 1.426 . . . . 54.35 111.313 178.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 2.7 m 59.97 24.13 13.26 Favored 'General case' 0 CA--C 1.565 1.534 0 C-N-CA 124.697 1.199 . . . . 63.1 111.174 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . 0.451 ' HB2' ' HG2' ' C' ' 128' ' ' GLU . . . -134.81 -176.03 4.1 Favored 'General case' 0 C--O 1.244 0.779 0 C-N-CA 124.581 1.153 . . . . 53.32 108.925 179.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 172' ' ' GLU . . . . . 0.613 ' HB3' ' HG2' ' C' ' 213' ' ' MET . 13.1 tp10 -78.13 80.73 4.54 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 109.749 -0.463 . . . . 73.22 109.749 177.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 173' ' ' LEU . . . . . . . . . . . . . 80.1 mt 65.5 9.48 5.84 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 124.896 1.279 . . . . 74.23 112.907 176.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 174' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -92.35 99.74 12.45 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.278 0.631 . . . . 74.45 109.732 -175.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 175' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -85.4 153.99 22.15 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.717 0.807 . . . . 74.1 111.249 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -159.18 125.57 4.52 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.023 0.929 . . . . 74.11 109.651 178.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 35.8 p -121.05 93.28 48.84 Favored Pre-proline 0 CA--C 1.554 1.126 0 C-N-CA 123.696 0.798 . . . . 64.31 110.347 176.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 178' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -83.99 -177.33 3.02 Favored 'Trans proline' 0 C--N 1.377 2.064 0 C-N-CA 122.646 2.231 . . . . 74.53 111.551 170.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -67.32 -53.0 33.61 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 108.97 -0.752 . . . . 61.34 108.97 172.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . -162.14 -28.84 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 115.127 -0.942 . . . . 74.4 110.292 175.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 181' ' ' LEU . . . . . 0.573 HD22 ' HB2' ' C' ' 136' ' ' ARG . 29.3 tp -153.45 -68.7 0.15 Allowed 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 107.636 -1.246 . . . . 62.04 107.636 168.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 182' ' ' VAL . . . . . . . . . . . . . 62.6 t -76.43 131.81 34.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 108.123 -1.066 . . . . 71.31 108.123 168.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.1 -48.79 74.77 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 123.726 0.641 . . . . 65.24 110.695 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 179.9 -170.44 0.14 Allowed 'General case' 0 N--CA 1.485 1.301 0 O-C-N 124.2 0.938 . . . . 74.15 110.738 173.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 185' ' ' VAL . . . . . 0.507 HG23 ' HA ' ' C' ' 121' ' ' ALA . 1.8 p -142.24 116.67 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 106.557 -1.645 . . . . 71.33 106.557 160.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 25.6 p 56.54 -160.71 0.21 Allowed 'General case' 0 CA--C 1.567 1.622 0 C-N-CA 123.87 0.868 . . . . 51.31 112.342 172.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 187' ' ' SER . . . . . 0.599 ' HB3' ' HA ' ' B' ' 328' ' ' ALA . 16.8 p -74.15 87.24 1.91 Allowed 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 123.414 0.686 . . . . 62.14 111.662 -178.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 188' ' ' ARG . . . . . 0.431 ' HG2' ' O ' ' B' ' 185' ' ' VAL . 7.1 mmt180 -130.73 169.16 16.05 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.648 0.779 . . . . 71.52 109.95 175.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -95.85 162.65 13.5 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.97 0.908 . . . . 72.52 110.086 176.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 190' ' ' CYS . . . . . 0.459 ' SG ' ' NZ ' ' B' ' 337' ' ' LYS . 41.9 t -127.83 150.71 49.71 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.579 0.751 . . . . 70.33 110.402 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -133.84 162.75 31.15 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.66 0.784 . . . . 74.04 110.051 -174.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -68.88 163.53 50.28 Favored Glycine 0 CA--C 1.54 1.6 0 CA-C-O 119.169 -0.795 . . . . 64.22 113.339 177.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 193' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -64.23 135.54 47.31 Favored 'Trans proline' 0 C--N 1.372 1.802 0 C-N-CA 123.25 2.633 . . . . 64.32 112.961 -171.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 194' ' ' SER . . . . . . . . . . . . . 37.9 m -145.72 103.82 3.82 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 123.522 0.729 . . . . 24.51 109.8 -178.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 195' ' ' ALA . . . . . . . . . . . . . . . -158.23 171.17 20.68 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.501 1.12 . . . . 74.32 109.338 177.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 86.6 m -103.89 -65.57 1.01 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 122.967 0.507 . . . . 73.32 110.108 176.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 73.1 m -156.95 -47.2 0.07 Allowed 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.009 -1.108 . . . . 75.11 108.009 -177.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 198' ' ' GLU . . . . . 0.458 ' HG3' ' HB2' ' C' ' 146' ' ' SER . 1.9 mm-40 62.19 -76.91 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 126.184 1.794 . . . . 51.12 109.889 178.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 73.83 -29.67 0.2 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 115.179 1.548 . . . . 74.4 115.179 163.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 200' ' ' CYS . . . . . . . . . . . . . 86.3 m -62.04 104.09 0.44 Allowed Pre-proline 0 CA--C 1.557 1.242 0 C-N-CA 124.367 1.067 . . . . 73.31 112.986 -169.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 201' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -105.84 18.74 0.13 Allowed 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 123.736 2.958 . . . . 71.34 112.863 -178.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . -74.27 -8.99 80.64 Favored Glycine 0 C--N 1.354 1.536 0 CA-C-O 118.915 -0.936 . . . . 63.04 114.629 -170.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 58.9 t30 70.5 161.81 0.23 Allowed 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 124.643 1.177 . . . . 71.33 111.862 172.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -56.74 -54.01 51.16 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 123.302 0.641 . . . . 74.01 110.065 171.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 205' ' ' LEU . . . . . . . . . . . . . 3.2 tt 48.08 82.53 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 125.365 1.466 . . . . 51.03 111.249 171.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.94 -56.39 22.26 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 123.052 0.541 . . . . 62.32 110.764 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 207' ' ' LYS . . . . . 0.418 ' HD3' ' HA ' ' B' ' 207' ' ' LYS . 36.1 mmtm -156.01 -49.81 0.08 Allowed 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 125.136 1.374 . . . . 74.32 109.244 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . -90.76 -46.29 4.0 Favored Glycine 0 C--N 1.352 1.418 0 CA-C-N 116.365 -0.379 . . . . 71.52 113.311 -172.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 134.26 -47.38 1.0 Allowed Glycine 0 N--CA 1.469 0.862 0 N-CA-C 110.789 -0.924 . . . . 42.21 110.789 -176.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 66.6 tttm -140.48 109.63 6.15 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 108.109 -1.071 . . . . 74.51 108.109 175.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . -154.04 144.84 11.7 Favored Glycine 0 C--N 1.341 0.832 0 N-CA-C 110.811 -0.916 . . . . 74.43 110.811 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 47.9 t 62.2 87.9 0.1 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.577 1.151 . . . . 74.04 110.582 -177.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 10.8 tp -70.21 -33.38 54.34 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 CA-C-N 115.874 -0.603 . . . . 64.4 111.029 -176.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 26.6 m 60.83 -80.89 0.02 OUTLIER 'General case' 0 C--N 1.36 1.029 0 C-N-CA 125.705 1.602 . . . . 75.43 112.273 176.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 215' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -151.24 0.92 0.39 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.576 0.75 . . . . 73.31 111.355 -175.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -72.65 140.76 48.15 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.658 0.783 . . . . 61.42 109.876 177.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . 0.497 HD12 ' H ' ' B' ' 218' ' ' LEU 0.329 4.2 pp 54.29 -68.57 0.01 OUTLIER 'General case' 0 CA--C 1.569 1.711 0 C-N-CA 127.043 2.137 . . . . 75.4 114.24 -179.579 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . 0.497 ' H ' HD12 ' B' ' 217' ' ' LEU . 82.8 mt 57.59 -81.35 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 125.71 1.604 . . . . 71.43 112.265 -178.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 32.1 t-20 -160.21 153.56 22.11 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.342 -0.985 . . . . 71.24 108.342 178.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -144.48 174.65 10.76 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.923 0.889 . . . . 61.1 110.669 -176.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 221' ' ' ARG . . . . . 0.406 ' HD2' ' H ' ' B' ' 221' ' ' ARG . 2.4 mpt_? -58.09 -67.22 0.37 Allowed 'General case' 0 N--CA 1.476 0.848 0 O-C-N 124.23 0.956 . . . . 73.55 109.096 -178.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . 0.48 ' HB3' ' HE ' ' C' ' 187' ' ' ARG . . . 36.77 61.09 0.89 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 125.101 1.501 . . . . 42.52 112.013 176.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -85.09 -160.08 0.47 Allowed 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 114.277 -1.329 . . . . 61.02 112.52 -162.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 22.2 m -58.05 -34.98 50.51 Favored 'Isoleucine or valine' 0 C--N 1.361 1.096 0 C-N-CA 123.314 0.646 . . . . 74.2 111.697 -178.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 225' ' ' THR . . . . . 0.624 HG21 HG22 ' C' ' 185' ' ' VAL . 99.3 m 72.02 -59.06 0.57 Allowed 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 126.147 1.779 . . . . 54.34 113.236 179.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 1.4 tm? 70.49 85.02 0.14 Allowed 'General case' 0 C--N 1.355 0.811 0 C-N-CA 125.441 1.496 . . . . 74.43 107.736 -170.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . -161.06 25.54 0.26 Allowed Glycine 0 C--N 1.345 1.047 0 CA-C-N 115.882 -0.599 . . . . 51.31 112.558 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . -89.14 -106.6 1.1 Allowed Glycine 0 C--N 1.352 1.458 0 N-CA-C 111.479 -0.648 . . . . 72.41 111.479 175.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . 65.51 -125.74 29.26 Favored Glycine 0 C--N 1.353 1.527 0 CA-C-O 119.549 -0.584 . . . . 70.24 113.404 175.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -157.3 152.01 25.5 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.076 0.95 . . . . 70.23 109.597 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 231' ' ' LYS . . . . . 0.414 ' HA ' ' HB2' ' B' ' 282' ' ' ALA . 27.7 tptp -167.69 165.76 14.15 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.582 0.753 . . . . 73.24 109.655 -172.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 232' ' ' THR . . . . . 0.501 HG22 ' HA ' ' B' ' 280' ' ' LEU . 52.7 p -51.68 102.18 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.127 1.371 . . . . 74.24 112.783 -178.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 233' ' ' PHE . . . . . 0.78 ' HB2' HH22 ' C' ' 211' ' ' ARG . 33.3 t80 -160.17 -51.91 0.05 Allowed 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.313 0.645 . . . . 70.41 109.668 174.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . 79.33 -33.25 0.14 Allowed 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 125.433 1.493 . . . . 72.31 112.59 178.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . 0.553 ' HB2' ' HB3' ' C' ' 220' ' ' GLU . 4.1 tm-20 69.94 139.42 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 125.374 1.47 . . . . 54.41 111.778 176.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 236' ' ' THR . . . . . 0.448 ' HB ' ' O ' ' B' ' 348' ' ' ILE . 42.3 m -141.97 84.65 1.89 Allowed 'General case' 0 C--O 1.249 1.04 0 N-CA-C 107.483 -1.303 . . . . 73.34 107.483 171.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . 0.424 ' HB1' ' H ' ' B' ' 355' ' ' ALA . . . 61.96 66.61 0.81 Allowed 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 114.374 -1.284 . . . . 71.12 111.099 175.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 238' ' ' THR . . . . . 0.475 HG22 HG23 ' C' ' 219' ' ' VAL . 6.2 m -150.33 98.92 2.73 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.141 0.576 . . . . 71.31 109.946 -178.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -165.63 -98.84 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 123.337 0.655 . . . . 74.42 110.44 171.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . 173.32 -148.52 10.36 Favored Glycine 0 C--N 1.35 1.334 0 N-CA-C 111.615 -0.594 . . . . 71.23 111.615 -176.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -86.38 -167.96 2.06 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.516 0.726 . . . . 71.21 111.144 -176.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 242' ' ' TRP . . . . . 0.59 ' HZ3' ' HD3' ' C' ' 231' ' ' ARG . 0.0 OUTLIER 86.59 -26.82 0.08 Allowed 'General case' 0 N--CA 1.504 2.231 0 C-N-CA 127.191 2.197 . . . . 70.32 111.66 175.872 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 243' ' ' GLN . . . . . 0.409 ' H ' ' HG2' ' B' ' 243' ' ' GLN . 0.6 OUTLIER -102.24 120.69 40.89 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 124.054 0.942 . . . . 74.22 110.676 -168.461 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -60.35 -40.73 97.91 Favored Glycine 0 C--N 1.353 1.49 0 N-CA-C 110.458 -1.057 . . . . 63.11 110.458 165.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 245' ' ' LYS . . . . . 0.43 ' HE3' ' HB3' ' B' ' 357' ' ' PRO . 5.5 ttpp 63.2 13.74 7.16 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.148 1.379 . . . . 75.34 112.755 162.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 22.1 p -126.8 7.56 6.77 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.964 0.905 . . . . 71.02 110.849 -175.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 247' ' ' LEU . . . . . 0.754 HD13 ' HG2' ' C' ' 225' ' ' PRO . 5.5 tt -101.39 100.0 10.42 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 108.266 -1.012 . . . . 72.51 108.266 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 248' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 71.47 -75.41 0.08 Allowed 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 125.841 1.656 . . . . 75.15 112.642 172.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 63.33 33.35 14.05 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.183 0.993 . . . . 71.33 110.509 -173.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 250' ' ' GLN . . . . . 0.583 HE22 ' HB1' ' A' ' 273' ' ' ALA . 8.0 mm-40 69.95 156.02 0.14 Allowed 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 126.391 1.876 . . . . 65.4 113.082 178.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 251' ' ' ALA . . . . . . . . . . . . . . . -68.82 123.11 20.05 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.87 -0.789 . . . . 61.03 108.87 169.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -71.06 88.76 0.79 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.588 0.755 . . . . 72.3 109.616 -178.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -62.31 142.47 57.75 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.605 0.762 . . . . 51.41 110.509 179.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 30.0 ttt180 70.09 81.94 0.16 Allowed 'General case' 0 N--CA 1.48 1.051 0 O-C-N 124.805 1.315 . . . . 72.51 108.764 -172.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 255' ' ' GLY . . . . . 0.548 ' HA2' ' HA ' ' B' ' 259' ' ' VAL . . . -147.05 48.18 0.66 Allowed Glycine 0 C--N 1.349 1.258 0 CA-C-N 115.252 -0.886 . . . . 54.22 113.126 -172.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 256' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -69.82 102.28 1.91 Allowed 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 109.726 -0.472 . . . . 52.52 109.726 173.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 13.9 tm0? 64.57 -73.84 0.05 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.748 1.619 . . . . 74.31 109.957 177.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 258' ' ' LEU . . . . . . . . . . . . . 4.6 tt -131.55 80.89 1.95 Allowed 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 106.888 -1.523 . . . . 75.13 106.888 170.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . 0.548 ' HA ' ' HA2' ' B' ' 255' ' ' GLY . 58.6 t 66.81 -71.1 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 C-N-CA 125.87 1.668 . . . . 63.02 111.835 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 260' ' ' SER . . . . . . . . . . . . . 31.2 p -178.57 -38.38 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 126.404 1.882 . . . . 73.11 106.754 175.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -151.45 145.21 25.06 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-N 114.25 -1.341 . . . . 52.21 108.023 175.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 262' ' ' ALA . . . . . 0.517 ' HB1' ' HB1' ' B' ' 64' ' ' ALA . . . -76.78 -61.61 1.91 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.792 0.837 . . . . 43.43 110.17 173.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -170.11 94.39 0.24 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.713 1.205 . . . . 70.44 108.726 175.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 13.9 m 64.68 21.46 12.4 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 124.936 1.294 . . . . 51.14 113.011 175.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 265' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -63.22 -50.86 68.57 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.456 1.102 . . . . 64.12 110.108 -175.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 266' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -75.87 -20.74 57.85 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 116.322 -0.399 . . . . 71.52 110.461 179.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 52.3 m 78.35 -38.93 0.25 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 125.931 1.693 . . . . 73.13 113.252 173.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 59.2 t -68.49 -52.47 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 122.922 0.489 . . . . 74.44 110.008 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 269' ' ' THR . . . . . . . . . . . . . 62.5 m 51.46 90.11 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.052 1.341 . . . . 74.31 111.584 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 270' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -65.86 -29.72 70.22 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.265 1.026 . . . . 72.41 111.509 -177.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 271' ' ' ALA . . . . . . . . . . . . . . . 56.4 36.02 26.85 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 124.292 0.995 . . . . 75.3 111.127 -177.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 272' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -65.58 146.51 54.74 Favored 'General case' 0 C--O 1.247 0.964 0 CA-C-N 114.692 -1.14 . . . . 54.14 110.599 -177.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -67.01 100.49 0.75 Allowed 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.588 -0.733 . . . . 61.32 109.294 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -142.5 87.35 2.0 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 107.88 -1.156 . . . . 71.44 107.88 174.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 275' ' ' LYS . . . . . . . . . . . . . 11.7 mptt 50.34 53.37 13.99 Favored Pre-proline 0 CA--C 1.56 1.33 0 CA-C-N 114.331 -1.304 . . . . 71.33 111.911 -178.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 276' ' ' PRO . . . . . 0.415 ' HD2' HD12 ' B' ' 277' ' ' LEU . 51.2 Cg_endo -83.84 14.45 2.4 Favored 'Trans proline' 0 C--N 1.391 2.776 0 C-N-CA 122.435 2.09 . . . . 62.35 112.498 -177.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 277' ' ' LEU . . . . . 0.429 HD22 ' HA ' ' A' ' 279' ' ' ARG . 5.2 mp -83.78 -99.36 0.05 Allowed 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 108.468 -0.938 . . . . 63.32 108.468 175.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 278' ' ' LEU . . . . . 0.495 HD23 ' HA ' ' A' ' 278' ' ' ALA . 80.9 mt 60.68 20.4 10.39 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-N 118.848 0.749 . . . . 62.0 112.555 177.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . 112.26 -18.72 23.13 Favored Glycine 0 N--CA 1.479 1.514 0 C-N-CA 123.168 0.413 . . . . 75.43 112.992 -175.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 280' ' ' LEU . . . . . 0.501 ' HA ' HG22 ' B' ' 232' ' ' THR . 2.9 tm? -62.92 -48.13 80.27 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.022 0.929 . . . . 53.23 109.778 178.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -73.53 -47.74 38.54 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 109.727 -0.471 . . . . 75.31 109.727 175.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 282' ' ' ALA . . . . . 0.414 ' HB2' ' HA ' ' B' ' 231' ' ' LYS . . . 76.95 -33.46 0.2 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 125.901 1.68 . . . . 65.41 113.123 176.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 24.2 t70 65.34 -75.32 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 125.609 1.564 . . . . 72.33 111.883 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . -81.44 68.31 3.48 Favored Glycine 0 C--N 1.342 0.914 0 N-CA-C 111.548 -0.621 . . . . 61.45 111.548 175.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -76.02 92.18 3.14 Favored 'General case' 0 C--O 1.244 0.814 0 C-N-CA 124.138 0.975 . . . . 72.41 108.548 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 286' ' ' MET . . . . . 0.431 ' HB3' ' HD2' ' B' ' 287' ' ' PRO . 64.0 mtm 71.7 168.11 0.12 Allowed Pre-proline 0 CA--C 1.564 1.504 0 C-N-CA 124.73 1.212 . . . . 64.1 110.957 -176.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 287' ' ' PRO . . . . . 0.431 ' HD2' ' HB3' ' B' ' 286' ' ' MET . 30.7 Cg_endo -62.0 -3.15 3.51 Favored 'Trans proline' 0 C--N 1.388 2.626 0 C-N-CA 122.611 2.207 . . . . 73.33 114.012 174.12 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 288' ' ' VAL . . . . . . . . . . . . . 21.5 t -78.18 74.39 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 CA-C-O 121.702 0.763 . . . . 74.32 109.438 174.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 289' ' ' ARG . . . . . . . . . . . . . 49.4 ttt180 -101.82 -15.36 16.94 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.212 1.005 . . . . 72.14 110.319 -179.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 290' ' ' TRP . . . . . . . . . . . . . 71.9 t-105 73.29 119.63 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 125.528 1.531 . . . . 75.34 109.889 -170.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 291' ' ' LEU . . . . . 0.421 HD22 HG23 ' B' ' 452' ' ' VAL . 35.4 tp 71.91 144.36 0.06 Allowed 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 125.676 1.59 . . . . 64.34 111.36 -172.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . 151.47 -64.42 0.38 Allowed Glycine 0 C--N 1.35 1.353 0 CA-C-O 119.552 -0.582 . . . . 62.12 112.261 -179.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -82.66 42.87 1.38 Allowed 'Trans proline' 0 C--N 1.383 2.382 0 C-N-CA 123.587 2.858 . . . . 51.12 113.078 -179.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -82.95 130.08 35.1 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.536 1.134 . . . . 41.23 110.936 -174.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -163.86 -51.69 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.554 1.142 . . . . 34.32 109.133 168.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 18.0 m 70.81 139.1 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 125.84 1.656 . . . . 65.42 112.384 177.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 57.5 t80 68.92 -82.21 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 125.086 1.354 . . . . 64.12 111.376 172.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 29.1 p80 39.21 82.49 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 126.176 1.79 . . . . 71.5 113.788 -175.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . -79.45 65.66 3.61 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-N 115.913 -0.585 . . . . 63.41 113.015 178.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 300' ' ' ASN . . . . . 0.446 HD21 ' N ' ' A' ' 191' ' ' GLN . 39.6 t30 -172.56 -135.65 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 106.736 -1.579 . . . . 72.23 106.736 -177.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 301' ' ' ILE . . . . . . . . . . . . . 8.0 mm 64.57 13.98 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.576 1.945 0 C-N-CA 124.134 0.973 . . . . 72.24 111.561 172.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -140.15 154.53 47.0 Favored 'General case' 0 N--CA 1.485 1.281 0 O-C-N 121.096 -1.003 . . . . 63.41 111.33 -170.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 303' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.86 -47.65 15.45 Favored Pre-proline 0 CA--C 1.568 1.668 0 C-N-CA 124.377 1.071 . . . . 74.11 113.865 -168.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 304' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -57.57 -27.51 77.12 Favored 'Trans proline' 0 C--N 1.39 2.741 0 C-N-CA 122.233 1.955 . . . . 75.12 113.443 170.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . 68.92 -72.36 0.1 Allowed 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 125.257 1.423 . . . . 42.33 110.717 -177.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 7.4 p -104.84 144.38 14.79 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 N-CA-C 108.936 -0.764 . . . . 72.33 108.936 170.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 7.8 m -62.02 -26.76 68.43 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 124.307 1.043 . . . . 74.23 112.367 -172.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 308' ' ' CYS . . . . . . . . . . . . . 29.2 p -72.45 -11.61 60.75 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.574 0.75 . . . . 74.22 112.329 -176.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 52.9 p -119.09 85.5 29.74 Favored Pre-proline 0 CA--C 1.557 1.232 0 C-N-CA 123.403 0.681 . . . . 72.2 110.568 179.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -83.16 168.77 13.24 Favored 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 122.857 2.371 . . . . 63.14 112.582 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 311' ' ' ASN . . . . . 0.445 ' HB3' ' HD3' ' B' ' 312' ' ' PRO . 4.4 t30 -92.93 -50.24 0.28 Allowed Pre-proline 0 CA--C 1.566 1.583 0 CA-C-O 118.866 -0.587 . . . . 73.13 111.423 177.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 312' ' ' PRO . . . . . 0.445 ' HD3' ' HB3' ' B' ' 311' ' ' ASN . 41.0 Cg_endo -95.97 -152.85 0.03 OUTLIER 'Trans proline' 0 C--N 1.391 2.785 0 C-N-CA 122.545 2.163 . . . . 70.14 110.715 170.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 313' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -91.98 17.1 9.79 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.717 0.407 . . . . 75.13 111.135 174.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 314' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 69.33 -78.2 0.05 OUTLIER 'General case' 0 C--N 1.353 0.723 0 C-N-CA 125.329 1.452 . . . . 72.01 110.662 -177.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 315' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 57.35 -85.1 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.855 1.262 . . . . 72.12 111.097 -173.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 316' ' ' ASP . . . . . . . . . . . . . 35.6 t70 58.08 -80.53 0.02 OUTLIER 'General case' 0 C--N 1.355 0.837 0 C-N-CA 125.75 1.62 . . . . 74.4 112.556 177.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 317' ' ' SER . . . . . 0.499 ' HA ' HG22 ' B' ' 325' ' ' THR . 19.6 m -78.89 -25.48 43.86 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.721 0.809 . . . . 75.41 111.334 -176.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 318' ' ' VAL . . . . . 0.5 HG12 ' HA ' ' B' ' 322' ' ' ALA . 20.2 m -114.66 96.68 44.69 Favored Pre-proline 0 CA--C 1.563 1.466 0 C-N-CA 124.228 1.011 . . . . 73.13 110.166 -177.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 319' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -62.97 -49.61 4.84 Favored 'Trans proline' 0 C--N 1.382 2.326 0 C-N-CA 122.75 2.3 . . . . 65.1 112.379 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 320' ' ' THR . . . . . . . . . . . . . 24.7 m -132.55 -52.9 0.94 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.637 0.775 . . . . 53.31 109.41 -179.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 321' ' ' LEU . . . . . . . . . . . . . 96.2 mt -114.89 -179.38 3.61 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.195 0.998 . . . . 65.14 109.668 178.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 322' ' ' ALA . . . . . 0.5 ' HA ' HG12 ' B' ' 318' ' ' VAL . . . -83.29 40.48 0.71 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.799 0.84 . . . . 64.54 111.779 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 323' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -62.77 -38.35 90.25 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.481 0.713 . . . . 74.02 110.246 178.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 324' ' ' MET . . . . . 0.483 ' SD ' ' HB3' ' B' ' 317' ' ' SER . 46.6 tpp 69.18 110.58 0.05 Allowed 'General case' 0 N--CA 1.478 0.938 0 O-C-N 125.047 1.467 . . . . 71.32 113.055 169.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 325' ' ' THR . . . . . 0.499 HG22 ' HA ' ' B' ' 317' ' ' SER . 10.0 t -77.15 118.3 19.54 Favored 'General case' 0 C--O 1.246 0.88 0 N-CA-C 108.04 -1.096 . . . . 72.33 108.04 164.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 326' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -67.28 145.49 55.11 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.304 0.642 . . . . 72.01 109.593 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . 0.439 ' HD2' ' N ' ' B' ' 327' ' ' LYS . 2.3 mptp? -80.78 12.6 3.09 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.318 0.647 . . . . 54.34 112.109 -174.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 328' ' ' ALA . . . . . 0.599 ' HA ' ' HB3' ' B' ' 187' ' ' SER . . . 67.92 178.68 0.24 Allowed 'General case' 0 C--N 1.354 0.777 0 C-N-CA 125.096 1.358 . . . . 72.03 113.253 168.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 329' ' ' ILE . . . . . . . . . . . . . 20.4 tt -147.62 173.0 2.3 Favored 'Isoleucine or valine' 0 C--O 1.251 1.158 0 N-CA-C 106.378 -1.712 . . . . 73.5 106.378 173.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 330' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -55.04 -69.4 0.13 Allowed 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 109.278 -0.638 . . . . 63.42 109.278 171.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 331' ' ' LEU . . . . . . . . . . . . . 57.3 tp 45.11 -98.35 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.995 1.318 . . . . 63.34 111.174 -178.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 99.1 mt 34.18 -90.82 0.01 OUTLIER 'General case' 0 C--N 1.361 1.105 0 C-N-CA 126.25 1.82 . . . . 74.41 113.657 -178.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 333' ' ' SER . . . . . . . . . . . . . 15.6 p -167.95 -66.34 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 107.941 -1.133 . . . . 65.04 107.941 -177.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt 74.33 -41.59 0.48 Allowed 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 125.965 1.706 . . . . 63.11 113.126 172.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 335' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -67.31 93.94 0.35 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.322 1.049 . . . . 73.25 111.189 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 58.06 93.9 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.836 1.255 . . . . 61.02 113.796 168.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 337' ' ' LYS . . . . . 0.459 ' NZ ' ' SG ' ' B' ' 190' ' ' CYS . 35.3 mtpt -131.52 15.0 4.97 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.226 0.61 . . . . 62.43 110.994 171.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 338' ' ' GLY . . . . . . . . . . . . . . . -156.14 158.98 29.04 Favored Glycine 0 C--N 1.346 1.124 0 N-CA-C 111.495 -0.642 . . . . 72.34 111.495 -179.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 339' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -141.59 165.57 27.14 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.869 0.868 . . . . 74.33 109.773 -177.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 340' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -69.59 153.49 43.38 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.237 0.615 . . . . 75.24 110.933 -178.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 341' ' ' LEU . . . . . . . . . . . . . 5.0 tt -121.46 106.75 11.71 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 107.348 -1.353 . . . . 75.34 107.348 174.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 342' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -82.42 71.25 9.49 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-O 121.894 0.854 . . . . 64.25 111.067 -176.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 343' ' ' VAL . . . . . . . . . . . . . 7.3 p -75.51 -39.0 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-N 115.602 -0.727 . . . . 64.24 109.755 175.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 62.8 -78.79 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.848 1.659 . . . . 73.03 112.243 174.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 345' ' ' GLY . . . . . . . . . . . . . . . -95.47 166.61 25.5 Favored Glycine 0 C--N 1.347 1.163 0 C-N-CA 122.782 0.229 . . . . 62.31 112.765 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 346' ' ' ALA . . . . . . . . . . . . . . . -111.92 174.77 5.72 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.334 1.054 . . . . 72.22 109.907 177.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 41.6 t -63.61 -55.3 24.72 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 122.789 0.436 . . . . 72.21 110.08 178.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 348' ' ' ILE . . . . . 0.448 ' O ' ' HB ' ' B' ' 236' ' ' THR . 62.8 mt 64.01 -70.33 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 125.928 1.691 . . . . 73.42 111.185 -177.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 349' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -48.34 100.74 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 125.425 1.49 . . . . 71.13 112.547 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 350' ' ' LYS . . . . . . . . . . . . . 5.9 ttpm? 51.61 67.84 0.89 Allowed 'General case' 0 N--CA 1.483 1.192 0 O-C-N 124.49 1.118 . . . . 74.52 111.68 163.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 351' ' ' GLN . . . . . 0.566 HE22 ' HZ ' ' B' ' 233' ' ' PHE . 25.1 mt-30 -85.52 157.05 20.52 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.267 -0.878 . . . . 71.32 112.225 -172.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 7.9 t0 65.66 -92.02 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 125.317 1.447 . . . . 74.35 111.378 172.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 353' ' ' HIS . . . . . . . . . . . . . 49.5 p-80 -143.96 12.41 1.63 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.949 0.9 . . . . 74.33 109.401 -176.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 354' ' ' ALA . . . . . . . . . . . . . . . 74.81 -178.57 0.17 Allowed 'General case' 0 N--CA 1.484 1.27 0 O-C-N 125.133 1.52 . . . . 70.11 110.115 -158.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 355' ' ' ALA . . . . . 0.424 ' H ' ' HB1' ' B' ' 237' ' ' ALA . . . -86.24 -178.08 6.4 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 122.87 0.468 . . . . 75.44 110.027 178.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 356' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -116.22 86.79 18.01 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 123.585 0.754 . . . . 74.32 109.036 173.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 357' ' ' PRO . . . . . 0.43 ' HB3' ' HE3' ' B' ' 245' ' ' LYS . 68.1 Cg_endo -81.9 -8.19 12.2 Favored 'Trans proline' 0 C--N 1.384 2.396 0 C-N-CA 122.781 2.321 . . . . 55.22 112.245 175.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 358' ' ' CYS . . . . . 0.408 ' HA ' ' CG2' ' B' ' 365' ' ' VAL . 30.4 p -156.21 141.57 17.56 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 124.364 1.066 . . . . 73.32 108.862 178.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 359' ' ' GLY . . . . . . . . . . . . . . . -81.36 68.39 3.46 Favored Glycine 0 C--N 1.34 0.804 0 N-CA-C 109.677 -1.369 . . . . 62.01 109.677 169.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 360' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 64.84 -68.91 0.1 Allowed 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 125.862 1.665 . . . . 53.34 109.213 -167.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 361' ' ' ILE . . . . . 0.466 HG22 ' H ' ' B' ' 363' ' ' GLU . 73.5 mt -79.69 141.98 14.59 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 C-N-CA 124.186 0.994 . . . . 61.31 109.211 170.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 362' ' ' GLY . . . . . . . . . . . . . . . -70.01 -29.49 70.67 Favored Glycine 0 C--N 1.347 1.158 0 C-N-CA 122.93 0.3 . . . . 72.35 113.78 -177.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 363' ' ' GLU . . . . . 0.466 ' H ' HG22 ' B' ' 361' ' ' ILE . 1.7 mp0 -72.55 -20.39 61.34 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.51 0.724 . . . . 73.13 111.699 -179.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 364' ' ' THR . . . . . . . . . . . . . 16.6 m -61.76 -27.46 68.75 Favored 'General case' 0 CA--C 1.557 1.22 0 C-N-CA 123.749 0.819 . . . . 74.04 111.44 179.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 365' ' ' VAL . . . . . 0.708 HG23 ' H ' ' B' ' 366' ' ' ASP . 5.6 m -110.35 -82.78 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.416 0 CA-C-O 118.758 -0.639 . . . . 74.01 111.155 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 366' ' ' ASP . . . . . 0.708 ' H ' HG23 ' B' ' 365' ' ' VAL . 24.6 t70 47.84 -96.49 0.03 OUTLIER 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 124.743 1.217 . . . . 50.12 111.654 -171.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 367' ' ' LEU . . . . . 0.449 HD21 ' HB2' ' C' ' 225' ' ' PRO . 7.1 mp -136.31 130.06 32.36 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 107.048 -1.464 . . . . 75.05 107.048 170.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 368' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -84.93 179.82 7.22 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 122.746 0.419 . . . . 71.23 110.462 176.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 369' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 71.23 -72.2 0.12 Allowed 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 125.231 1.412 . . . . 70.1 111.142 -170.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 370' ' ' ALA . . . . . . . . . . . . . . . 68.99 -68.87 0.17 Allowed 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 125.311 1.444 . . . . 74.25 111.527 -177.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 371' ' ' VAL . . . . . . . . . . . . . 43.4 t 65.33 -87.21 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 125.137 1.375 . . . . 74.11 109.881 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 372' ' ' GLN . . . . . . . . . . . . . 20.6 tp60 -172.29 25.83 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.557 1.543 . . . . 63.2 107.082 174.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 373' ' ' ARG . . . . . 0.653 ' HB3' ' HG2' ' A' ' 260' ' ' ARG . 99.4 mtt180 59.46 90.59 0.05 Allowed 'General case' 0 C--N 1.364 1.235 0 C-N-CA 124.787 1.235 . . . . 72.05 109.326 -165.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -61.73 116.5 4.85 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.644 -0.707 . . . . 71.45 111.267 -172.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 375' ' ' LEU . . . . . . . . . . . . . 54.7 tp -73.1 118.17 15.73 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 115.468 -0.787 . . . . 62.01 108.88 174.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 376' ' ' GLU . . . . . 0.411 ' HB3' ' HA ' ' A' ' 258' ' ' PRO . 0.0 OUTLIER -61.16 -29.29 69.7 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.069 0.947 . . . . 73.13 112.885 -178.057 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 377' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -57.77 -34.3 69.43 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.154 0.982 . . . . 73.31 111.016 178.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 378' ' ' ALA . . . . . . . . . . . . . . . -64.63 -38.8 92.26 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 115.551 -0.75 . . . . 61.1 110.427 176.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? 78.06 -24.72 0.21 Allowed 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 125.678 1.591 . . . . 72.01 112.37 170.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 380' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt 72.69 -78.95 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 125.48 1.512 . . . . 53.14 112.188 172.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 381' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -99.89 106.76 18.63 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 122.958 0.503 . . . . 74.34 110.562 -170.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . 69.56 53.92 14.75 Favored Glycine 0 C--N 1.348 1.238 0 CA-C-N 115.225 -0.898 . . . . 73.1 113.085 178.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 383' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -76.49 -59.73 2.65 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 109.575 -0.528 . . . . 73.1 109.575 176.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 384' ' ' THR . . . . . 0.487 HG21 ' HB3' ' A' ' 218' ' ' PRO . 18.5 m 61.87 -82.69 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.163 0 CA-C-N 113.883 -1.508 . . . . 63.41 111.515 -176.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 83.8 mt 59.87 -82.73 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.627 1.171 . . . . 75.12 109.681 -169.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 386' ' ' VAL . . . . . 0.559 ' HA ' ' HA3' ' B' ' 417' ' ' GLY . 9.2 t -121.53 41.23 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 108.037 -1.097 . . . . 62.42 108.037 174.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 387' ' ' ILE . . . . . . . . . . . . . 2.1 mp 70.49 -59.81 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 C-N-CA 125.773 1.629 . . . . 74.12 108.804 -168.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 388' ' ' VAL . . . . . 0.507 HG23 ' HB2' ' B' ' 391' ' ' ASP . 35.3 m -87.74 148.11 4.81 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.146 0 C-N-CA 123.93 0.892 . . . . 54.33 109.878 167.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 389' ' ' THR . . . . . . . . . . . . . 14.6 t -86.88 -29.38 22.2 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 122.924 0.49 . . . . 71.25 112.049 -175.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . -70.66 -13.08 61.94 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.429 0.691 . . . . 70.34 112.586 -174.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 391' ' ' ASP . . . . . 0.507 ' HB2' HG23 ' B' ' 388' ' ' VAL . 3.9 t70 -76.3 176.24 8.32 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.158 0.983 . . . . 64.12 110.374 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 392' ' ' HIS . . . . . . . . . . . . . 58.7 t60 67.69 21.21 9.35 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.513 1.125 . . . . 72.42 109.508 -175.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . 55.3 39.7 31.35 Favored 'General case' 0 C--N 1.36 1.037 0 C-N-CA 125.156 1.382 . . . . 61.53 111.845 -174.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 26.6 m170 -71.89 74.52 0.88 Allowed 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 122.162 0.982 . . . . 73.31 110.373 177.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . -153.16 113.8 4.06 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 105.989 -1.856 . . . . 71.44 105.989 -177.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 31.1 p -76.33 -8.05 56.27 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.988 0.915 . . . . 75.55 112.002 -174.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 397' ' ' GLN . . . . . . . . . . . . . 76.9 mm-40 -75.3 83.09 2.43 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.964 0.906 . . . . 71.41 110.273 -177.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 398' ' ' ILE . . . . . 0.404 HD12 HG21 ' B' ' 409' ' ' THR . 8.9 tt -97.71 114.54 35.22 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 C-N-CA 124.318 1.047 . . . . 75.44 109.143 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 399' ' ' VAL . . . . . . . . . . . . . 60.0 t -73.19 -75.51 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 123.159 0.584 . . . . 73.32 110.632 -173.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 400' ' ' ALA . . . . . . . . . . . . . . . -173.36 85.75 0.39 Allowed Pre-proline 0 N--CA 1.48 1.032 0 C-N-CA 123.769 0.828 . . . . 51.41 110.755 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 401' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -86.68 57.59 3.7 Favored 'Trans proline' 0 C--N 1.374 1.888 0 C-N-CA 123.512 2.808 . . . . 71.04 110.385 168.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -69.67 -56.29 7.65 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.654 1.182 . . . . 74.34 109.628 -176.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 403' ' ' THR . . . . . . . . . . . . . 3.9 t -101.75 138.79 38.26 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 115.288 -0.869 . . . . 51.3 109.026 170.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 404' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? 53.0 91.76 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.114 1.365 . . . . 70.03 110.44 -175.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 405' ' ' ALA . . . . . . . . . . . . . . . -106.86 93.42 8.86 Favored Pre-proline 0 N--CA 1.478 0.935 0 C-N-CA 122.744 0.418 . . . . 71.24 110.916 -177.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 406' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -90.98 22.47 0.72 Allowed 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 122.735 2.29 . . . . 44.44 112.647 176.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . 67.57 -99.02 0.5 Allowed Glycine 0 C--N 1.349 1.255 0 N-CA-C 111.15 -0.78 . . . . 55.33 111.15 -171.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 408' ' ' LEU . . . . . . . . . . . . . 78.6 mt 59.42 13.54 3.27 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 125.356 1.463 . . . . 72.03 113.299 -178.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 409' ' ' THR . . . . . 0.404 HG21 HD12 ' B' ' 398' ' ' ILE . 10.1 t -137.48 149.53 46.89 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 124.542 1.137 . . . . 73.52 108.821 -177.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 410' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 55.47 -66.41 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 127.381 2.273 . . . . 51.32 114.756 176.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . -123.61 -65.53 1.07 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.484 0.713 . . . . 63.14 112.435 -176.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 58.4 tp -62.42 104.56 0.52 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.353 0.661 . . . . 60.41 110.859 -173.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -170.4 -79.32 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.858 0.863 . . . . 71.14 109.138 178.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 414' ' ' THR . . . . . . . . . . . . . 77.7 p -116.62 157.71 24.91 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.742 0.817 . . . . 73.24 109.692 -178.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 415' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -119.88 -6.71 10.05 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.787 0.835 . . . . 73.42 111.901 -168.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -76.79 176.55 8.39 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.977 0.911 . . . . 75.33 111.989 -172.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 417' ' ' GLY . . . . . 0.559 ' HA3' ' HA ' ' B' ' 386' ' ' VAL . . . 99.04 14.31 36.8 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 115.213 -0.903 . . . . 43.15 113.561 177.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 418' ' ' ALA . . . . . 0.573 ' HB3' ' HB ' ' B' ' 421' ' ' VAL . . . -158.67 135.55 9.68 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 122.855 0.462 . . . . 70.25 110.885 173.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 419' ' ' VAL . . . . . . . . . . . . . 85.3 t -61.58 -43.13 96.46 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 C-N-CA 124.505 1.122 . . . . 62.03 109.965 171.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 420' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -130.01 124.37 32.78 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 107.217 -1.401 . . . . 73.12 107.217 175.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 421' ' ' VAL . . . . . 0.573 ' HB ' ' HB3' ' B' ' 418' ' ' ALA . 6.8 p -134.98 112.79 15.22 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.133 0 CA-C-O 121.426 0.631 . . . . 72.42 110.697 -174.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 422' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.35 -3.61 28.49 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.078 0.951 . . . . 74.1 110.655 177.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 423' ' ' SER . . . . . . . . . . . . . 15.5 m -102.77 24.16 11.02 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.293 1.037 . . . . 62.22 109.305 171.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 424' ' ' TYR . . . . . 0.45 ' CD1' ' HG2' ' B' ' 429' ' ' GLU . 21.6 t80 -53.59 -37.41 62.94 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 125.986 1.714 . . . . 72.42 110.779 175.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . -124.95 47.6 1.01 Allowed Glycine 0 C--N 1.349 1.263 0 N-CA-C 110.785 -0.926 . . . . 75.12 110.785 172.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 426' ' ' ASN . . . . . 0.579 HD22 ' HB3' ' C' ' 280' ' ' ALA . 16.6 m120 65.69 -82.65 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 125.367 1.467 . . . . 75.43 112.042 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 427' ' ' SER . . . . . . . . . . . . . 20.4 m -102.49 101.65 11.87 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.65 0.78 . . . . 75.14 110.61 -170.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 49.7 79.43 0.08 Allowed 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 125.792 1.637 . . . . 73.23 112.418 171.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 429' ' ' GLU . . . . . 0.45 ' HG2' ' CD1' ' B' ' 424' ' ' TYR . 13.6 tp10 -88.7 162.24 16.38 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 116.467 -0.333 . . . . 63.42 110.923 -177.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -40.91 -39.31 1.12 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 126.419 1.888 . . . . 55.41 112.662 169.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 26.1 m -67.12 81.05 0.13 Allowed 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 124.023 0.929 . . . . 73.31 110.844 -179.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 432' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -119.01 31.34 6.69 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.997 1.319 . . . . 71.1 108.514 174.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 433' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -63.93 131.04 46.48 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 114.62 -1.173 . . . . 73.43 110.429 -178.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 434' ' ' HIS . . . . . . . . . . . . . 76.0 t60 67.27 33.81 5.23 Favored 'General case' 0 CA--C 1.561 1.381 0 C-N-CA 124.529 1.132 . . . . 65.13 110.894 178.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 435' ' ' THR . . . . . . . . . . . . . 15.1 t -73.74 -6.87 49.57 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 122.887 0.475 . . . . 73.42 111.56 176.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . -60.14 -30.91 71.59 Favored Glycine 0 C--N 1.359 1.835 0 C-N-CA 123.084 0.373 . . . . 43.54 112.227 170.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 30.0 m -89.39 81.33 6.62 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 107.479 -1.304 . . . . 54.14 107.479 164.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 438' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -67.55 98.01 0.64 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.241 -0.89 . . . . 71.55 111.211 -173.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 439' ' ' LEU . . . . . . . . . . . . . 80.0 mt -80.64 -4.05 52.8 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 115.017 -0.992 . . . . 74.24 110.747 171.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 440' ' ' ARG . . . . . 0.476 ' HA ' ' HB3' ' A' ' 222' ' ' ALA . 40.0 mtp85 -76.58 112.5 13.2 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 107.626 -1.25 . . . . 70.1 107.626 173.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 441' ' ' ILE . . . . . 0.563 HD12 ' HA ' ' A' ' 223' ' ' VAL . 63.9 mt -70.97 112.5 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 C-N-CA 123.202 0.601 . . . . 74.15 111.896 -167.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 442' ' ' ALA . . . . . . . . . . . . . . . -102.63 27.1 7.2 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.303 1.041 . . . . 71.41 110.39 177.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 443' ' ' ALA . . . . . 0.404 ' H ' HG22 ' B' ' 441' ' ' ILE . . . -70.2 165.64 21.7 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.404 0.682 . . . . 74.21 111.661 178.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 17.2 m-30 77.43 -18.69 0.48 Allowed 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 125.7 1.6 . . . . 65.34 111.818 -173.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . 61.32 71.58 0.77 Allowed Glycine 0 C--N 1.353 1.494 0 CA-C-O 118.489 -1.173 . . . . 74.34 110.913 -169.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 446' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -45.29 100.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.38 2.211 0 C-N-CA 124.32 3.347 . . . . 63.02 114.662 -168.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 447' ' ' HIS . . . . . . . . . . . . . 10.3 p-80 -131.4 135.19 46.98 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.103 0.961 . . . . 60.0 109.526 175.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . -141.95 -164.38 1.78 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.961 0.904 . . . . 74.31 109.895 -178.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 449' ' ' ALA . . . . . . . . . . . . . . . 67.04 30.84 7.24 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 124.424 1.089 . . . . 61.52 110.992 -175.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 450' ' ' ASN . . . . . . . . . . . . . 9.9 t30 70.49 2.3 4.01 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 125.466 1.506 . . . . 61.12 112.474 -178.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 76.6 t -71.01 89.1 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 N-CA-C 108.82 -0.807 . . . . 63.1 108.82 176.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 452' ' ' VAL . . . . . 0.421 HG23 HD22 ' B' ' 291' ' ' LEU . 7.4 p -90.43 -33.59 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.429 1.091 . . . . 60.45 110.894 -173.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . -77.95 74.61 1.98 Allowed Glycine 0 C--N 1.35 1.309 0 CA-C-N 115.542 -0.754 . . . . 73.44 112.052 -178.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 454' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -158.93 129.84 6.13 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 106.561 -1.644 . . . . 72.5 106.561 -177.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 86.1 m -83.22 -82.65 0.15 Allowed 'General case' 0 CA--C 1.553 1.059 0 N-CA-C 109.613 -0.514 . . . . 61.41 109.613 177.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -140.03 152.67 46.42 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.653 0.781 . . . . 74.3 108.931 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 457' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 63.8 99.07 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.912 1.285 . . . . 42.14 110.642 -172.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 5.8 m -95.3 8.67 42.42 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 123.605 0.762 . . . . 72.13 110.346 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 459' ' ' ASP . . . . . . . . . . . . . 12.4 t70 68.62 110.7 0.05 OUTLIER 'General case' 0 C--N 1.362 1.131 0 C-N-CA 124.99 1.316 . . . . 73.31 109.518 -169.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 1.5 tt 69.02 109.88 0.05 Allowed 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 125.138 1.375 . . . . 65.42 109.205 178.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -78.46 67.21 4.19 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-O 121.831 0.825 . . . . 62.31 111.305 -177.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -150.54 10.68 0.66 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.955 1.302 . . . . 72.53 108.723 176.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 28.3 p -84.02 54.61 2.98 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.679 1.192 . . . . 61.35 110.398 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 464' ' ' MET . . . . . . . . . . . . . 24.4 ptt? -99.42 36.99 1.64 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.018 1.327 . . . . 75.31 109.33 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 465' ' ' LYS . . . . . 0.562 ' HE3' ' HA ' ' B' ' 465' ' ' LYS . 0.7 OUTLIER -69.46 81.61 0.39 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.07 0.948 . . . . 72.15 110.891 -173.835 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -106.26 -170.56 1.75 Allowed 'General case' 0 C--O 1.239 0.539 0 C-N-CA 124.156 0.982 . . . . 62.32 109.453 -177.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . -82.39 22.97 0.79 Allowed 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 123.726 0.81 . . . . 75.3 111.322 175.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 3.2 pp -57.03 150.53 16.82 Favored 'General case' 0 C--N 1.361 1.076 0 C-N-CA 124.193 0.997 . . . . 45.51 111.172 178.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 469' ' ' GLY . . . . . . . . . . . . . . . 70.38 -91.17 0.38 Allowed Glycine 0 C--N 1.342 0.916 0 N-CA-C 110.833 -0.907 . . . . 50.44 110.833 -171.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 470' ' ' LEU . . . . . . . . . . . . . 40.4 tp -163.48 -41.94 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.03 0.932 . . . . 73.2 109.923 177.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 471' ' ' LYS . . . . . . . . . . . . . 6.9 tmtm? . . . . . 0 CA--C 1.559 1.318 0 C-N-CA 125.137 1.375 . . . . 74.2 108.661 -172.244 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 N--CA 1.479 1.003 0 N-CA-C 109.346 -0.613 . . . . 55.23 109.346 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.94 24.38 10.92 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.772 1.229 . . . . 65.31 112.41 178.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -90.91 43.87 1.17 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.971 0.908 . . . . 52.01 111.055 -169.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -37.47 95.1 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 125.693 1.597 . . . . 70.52 114.197 -176.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -67.19 107.73 2.44 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 108.288 -1.004 . . . . 63.2 108.288 166.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -77.74 92.73 4.2 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 106.739 -1.578 . . . . 63.22 106.739 171.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 7' ' ' TYR . . . . . 0.438 ' CD1' ' HA ' ' C' ' 53' ' ' ALA . 75.8 m-85 -62.73 -25.9 68.42 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 114.51 -1.223 . . . . 73.43 112.128 -172.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -64.91 -46.49 81.46 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.382 0.673 . . . . 72.53 110.408 174.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.64 -39.44 94.36 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.266 0.626 . . . . 52.31 111.011 178.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 66.7 mt -59.75 -41.1 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 123.797 0.686 . . . . 63.34 110.475 175.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 98.0 mt -85.57 -3.55 58.9 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 112.265 0.469 . . . . 45.45 112.265 176.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 61.27 44.6 97.89 Favored Glycine 0 C--N 1.354 1.54 0 N-CA-C 114.063 0.385 . . . . 64.33 114.063 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 11.0 m -133.13 148.56 69.71 Favored Pre-proline 0 N--CA 1.487 1.423 0 C-N-CA 124.795 1.238 . . . . 64.04 109.823 177.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -75.29 161.36 38.03 Favored 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 122.721 2.281 . . . . 74.43 111.844 170.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 -77.07 20.17 0.27 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.806 0.842 . . . . 71.52 112.518 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -119.0 -15.39 9.29 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.243 1.017 . . . . 71.24 109.079 177.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.08 131.98 51.36 Favored 'General case' 0 C--N 1.355 0.828 0 C-N-CA 123.246 0.618 . . . . 71.14 109.595 175.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 59.8 p -65.59 161.8 19.57 Favored 'General case' 0 C--O 1.246 0.872 0 C-N-CA 123.047 0.539 . . . . 74.41 109.866 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 19' ' ' GLN . . . . . 0.525 ' HG2' ' HD3' ' C' ' 60' ' ' PRO . 25.1 tp60 -54.26 -38.82 66.25 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.586 0.754 . . . . 74.45 111.978 -173.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 20' ' ' GLU . . . . . 0.443 ' O ' ' HG3' ' C' ' 24' ' ' ARG . 0.4 OUTLIER -68.72 -35.6 77.35 Favored 'General case' 0 C--O 1.211 -0.933 0 CA-C-O 119.182 -0.437 . . . . 64.05 111.128 -179.058 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . 0.747 ' HG2' HH21 ' C' ' 24' ' ' ARG . 37.4 mt-10 -68.92 -38.11 79.32 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-O 121.006 0.431 . . . . 73.42 110.76 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 66.6 mt -66.15 -38.58 82.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 124.188 0.995 . . . . 61.32 109.889 174.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 23' ' ' LYS . . . . . 0.438 ' O ' ' HD3' ' C' ' 27' ' ' LYS . 6.6 ttpt -71.4 -33.85 69.85 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 114.68 -1.145 . . . . 74.13 109.972 178.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 24' ' ' ARG . . . . . 0.747 HH21 ' HG2' ' C' ' 21' ' ' GLU . 40.8 mtm180 -75.84 -24.21 55.8 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.305 0.642 . . . . 73.52 110.478 176.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.67 -43.96 87.73 Favored 'General case' 0 C--N 1.345 0.41 0 O-C-N 123.711 0.632 . . . . 75.32 109.636 170.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 26' ' ' TYR . . . . . 0.466 ' HD1' HG22 ' C' ' 50' ' ' ILE . 81.6 t80 -58.01 -52.42 65.58 Favored 'General case' 0 C--N 1.36 1.04 0 O-C-N 123.624 0.578 . . . . 72.31 110.865 171.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . 0.441 ' HE2' ' HA ' ' C' ' 24' ' ' ARG . 4.8 mppt? -61.0 -31.8 71.41 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 122.878 0.471 . . . . 74.1 111.487 -177.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 28' ' ' ARG . . . . . 0.493 HH21 HD21 ' C' ' 29' ' ' LEU . 38.9 ttp180 -62.28 -48.19 81.01 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.908 0.883 . . . . 71.15 109.602 174.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . 0.721 HD13 HD12 ' C' ' 50' ' ' ILE . 49.9 mt -74.55 -19.09 60.47 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 114.738 -1.119 . . . . 60.22 111.487 178.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.11 -22.49 33.37 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.409 0.684 . . . . 75.32 110.197 178.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' C' ' 27' ' ' LYS . 58.6 mtm180 -86.85 -31.78 20.61 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.252 0.621 . . . . 73.5 110.318 170.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -70.27 -60.58 2.19 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.827 0.851 . . . . 71.12 109.493 -178.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -90.61 24.52 2.63 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.028 0.931 . . . . 70.15 110.934 -177.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 34' ' ' HIS . . . . . 0.474 ' NE2' ' HB3' ' C' ' 36' ' ' ASP . 55.0 t60 -55.12 96.42 0.09 OUTLIER Pre-proline 0 N--CA 1.486 1.345 0 C-N-CA 124.963 1.305 . . . . 72.34 112.84 -164.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 35' ' ' PRO . . . . . 0.518 ' O ' ' HG2' ' C' ' 39' ' ' LYS . 57.9 Cg_endo -76.55 -2.24 12.42 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 123.429 2.753 . . . . 71.32 112.758 -167.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 36' ' ' ASP . . . . . 0.69 ' HB2' ' HG2' ' B' ' 113' ' ' LYS . 32.7 t70 -75.88 -38.03 58.28 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.949 0.899 . . . . 60.34 110.81 173.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 59.6 t -117.32 -52.69 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 122.89 0.476 . . . . 75.33 109.835 -174.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -97.51 79.29 2.73 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.701 0.762 . . . . 54.22 108.945 178.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 39' ' ' LYS . . . . . 0.518 ' HG2' ' O ' ' C' ' 35' ' ' PRO . 9.8 mtmp? -81.14 69.37 7.73 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 115.189 -0.914 . . . . 62.24 109.815 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . 0.551 ' HB2' ' HB3' ' C' ' 43' ' ' ALA . 49.6 m -92.5 111.66 51.77 Favored Pre-proline 0 CA--C 1.546 0.81 0 CA-C-O 118.317 -0.849 . . . . 74.14 108.99 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -38.93 -61.09 0.42 Allowed 'Trans proline' 0 C--N 1.387 2.596 0 C-N-CA 124.571 3.514 . . . . 63.44 114.905 -174.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -61.18 -33.94 74.27 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.857 0.863 . . . . 65.44 111.397 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 43' ' ' ALA . . . . . 0.551 ' HB3' ' HB2' ' C' ' 40' ' ' SER . . . -77.35 -20.52 54.7 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.248 0.619 . . . . 62.05 110.659 -178.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -84.06 -28.44 27.6 Favored 'General case' 0 C--N 1.351 0.659 0 N-CA-C 109.127 -0.694 . . . . 74.04 109.127 176.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -70.62 -42.19 71.24 Favored 'General case' 0 C--O 1.25 1.125 0 C-N-CA 123.676 0.79 . . . . 42.53 109.602 173.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 46' ' ' LYS . . . . . 0.523 ' O ' HG12 ' C' ' 50' ' ' ILE . 63.5 mttp -58.12 -45.65 86.96 Favored 'General case' 0 C--N 1.355 0.832 0 CA-C-N 114.789 -1.096 . . . . 72.32 109.429 168.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -62.66 -30.31 71.29 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.926 0.89 . . . . 62.23 110.963 -178.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 2.7 mptm? -63.54 -50.37 69.82 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 109.07 -0.715 . . . . 72.04 109.07 171.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -67.57 -17.34 64.6 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 112.791 0.663 . . . . 72.33 112.791 176.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 50' ' ' ILE . . . . . 0.721 HD12 HD13 ' C' ' 29' ' ' LEU . 28.2 mm -78.36 -38.03 22.51 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 N-CA-C 108.832 -0.803 . . . . 75.43 108.832 173.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 51' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -78.85 -11.87 60.01 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.799 0.84 . . . . 74.04 111.399 174.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 52' ' ' GLU . . . . . 0.448 ' O ' HG23 ' C' ' 56' ' ' VAL . 30.0 tt0 -77.83 -53.07 7.92 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 108.064 -1.088 . . . . 63.42 108.064 169.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . 0.438 ' HA ' ' CD1' ' C' ' 7' ' ' TYR . . . -57.8 -34.14 69.31 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 114.432 -1.258 . . . . 63.1 111.399 175.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 54' ' ' TYR . . . . . 0.467 ' O ' ' HB2' ' C' ' 58' ' ' SER . 22.9 t80 -82.9 -32.45 27.28 Favored 'General case' 0 C--O 1.216 -0.68 0 C-N-CA 123.79 0.836 . . . . 75.01 110.378 177.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.39 -31.66 66.03 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 118.277 0.489 . . . . 60.54 110.537 173.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 56' ' ' VAL . . . . . 0.465 HG12 ' HB2' ' C' ' 66' ' ' TYR . 10.1 t -100.06 -21.3 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.245 0 CA-C-N 115.129 -0.941 . . . . 72.43 112.598 -179.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 57' ' ' LEU . . . . . 0.547 HD22 ' HG3' ' C' ' 63' ' ' ARG . 71.0 mt -127.4 29.3 5.56 Favored 'General case' 0 N--CA 1.501 2.122 0 CA-C-N 119.424 1.011 . . . . 75.02 112.655 -179.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 58' ' ' SER . . . . . 0.467 ' HB2' ' O ' ' C' ' 54' ' ' TYR . 21.4 t -68.62 -60.81 2.15 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.297 0.57 . . . . 62.42 112.221 177.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -125.9 158.98 63.8 Favored Pre-proline 0 N--CA 1.481 1.097 0 C-N-CA 124.393 1.077 . . . . 72.03 109.117 -171.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 60' ' ' PRO . . . . . 0.525 ' HD3' ' HG2' ' C' ' 19' ' ' GLN . 10.3 Cg_endo -48.89 -30.46 17.53 Favored 'Trans proline' 0 C--N 1.388 2.631 0 C-N-CA 123.162 2.574 . . . . 33.23 113.299 178.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . 0.441 ' O ' HG12 ' C' ' 65' ' ' ILE . 18.4 tt0 -50.79 -69.34 0.11 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.306 1.042 . . . . 62.13 110.625 170.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -60.22 -44.81 94.86 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-N 114.724 -1.125 . . . . 75.23 111.357 -174.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 63' ' ' ARG . . . . . 0.547 ' HG3' HD22 ' C' ' 57' ' ' LEU . 31.7 ttp-105 -62.77 -46.14 89.41 Favored 'General case' 0 C--N 1.349 0.544 0 CA-C-N 114.865 -1.062 . . . . 64.42 110.595 -174.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -72.57 -25.95 61.54 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 123.744 0.652 . . . . 74.15 111.552 -178.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 65' ' ' ILE . . . . . 0.441 HG12 ' O ' ' C' ' 61' ' ' GLU . 46.1 mm -60.13 -46.61 94.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 109.351 -0.611 . . . . 62.34 109.351 168.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 66' ' ' TYR . . . . . 0.465 ' HB2' HG12 ' C' ' 56' ' ' VAL . 18.3 t80 -63.63 -46.26 86.51 Favored 'General case' 0 C--N 1.353 0.723 0 CA-C-N 115.664 -0.698 . . . . 74.22 110.677 176.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -62.44 -33.67 75.28 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.219 0.607 . . . . 73.14 111.461 -176.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 44.5 p -78.14 -20.27 52.41 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.362 -0.381 . . . . 63.2 111.001 175.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -75.02 133.65 41.6 Favored 'General case' 0 CA--C 1.556 1.181 0 N-CA-C 108.415 -0.957 . . . . 75.22 108.415 165.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 91.28 15.6 55.25 Favored Glycine 0 N--CA 1.476 1.345 0 N-CA-C 111.225 -0.75 . . . . 62.51 111.225 -167.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 99.9 m -141.27 -60.34 0.49 Allowed 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 103.601 -2.74 . . . . 72.34 103.601 175.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 91.0 m -78.15 139.09 39.0 Favored 'General case' 0 C--O 1.251 1.155 0 N-CA-C 104.268 -2.493 . . . . 73.35 104.268 155.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.38 -45.93 4.34 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.62 0.768 . . . . 73.23 109.659 -172.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -73.87 144.32 82.5 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 123.435 0.694 . . . . 53.23 109.979 178.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.82 120.78 8.69 Favored 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 122.738 2.292 . . . . 75.14 110.989 173.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -54.27 159.59 7.79 Favored 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 123.685 2.924 . . . . 63.14 114.444 -176.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.57 127.75 14.37 Favored 'Trans proline' 0 C--N 1.381 2.242 0 C-N-CA 122.249 1.966 . . . . 51.51 110.839 172.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 78' ' ' PRO . . . . . 0.46 ' HB3' ' HA3' ' C' ' 104' ' ' GLY . 18.1 Cg_endo -59.02 129.91 34.06 Favored 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 122.609 2.206 . . . . 74.44 112.75 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.07 156.02 66.43 Favored 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 122.749 2.299 . . . . 61.04 111.45 174.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_exo -53.78 87.47 0.03 OUTLIER 'Trans proline' 0 C--N 1.385 2.494 0 C-N-CA 123.314 2.676 . . . . 51.5 112.707 176.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 159.55 -45.45 0.43 Allowed Glycine 0 C--N 1.342 0.894 0 CA-C-N 114.673 -1.149 . . . . 75.2 111.179 178.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 109.45 167.87 20.27 Favored Glycine 0 C--N 1.352 1.433 0 C-N-CA 123.669 0.652 . . . . 74.45 111.987 -175.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -78.03 112.15 14.65 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 109.293 -0.632 . . . . 70.14 109.293 176.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 84' ' ' ASP . . . . . 0.42 ' HA ' ' CE2' ' C' ' 106' ' ' PHE . 3.1 t70 -63.56 146.22 54.13 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.808 0.843 . . . . 63.13 112.801 -178.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 85' ' ' PHE . . . . . 0.47 ' O ' ' HB3' ' C' ' 171' ' ' PRO . 75.9 m-85 -138.62 71.33 1.39 Allowed 'General case' 0 C--N 1.356 0.878 0 C-N-CA 124.299 1.039 . . . . 74.41 110.207 171.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 37.0 m -51.0 86.75 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 125.05 1.34 . . . . 45.43 112.744 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 75.68 -5.54 37.66 Favored Glycine 0 CA--C 1.535 1.294 0 CA-C-N 116.067 -0.515 . . . . 74.33 113.493 -176.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 88' ' ' PHE . . . . . 0.451 ' HB2' ' HB3' ' C' ' 85' ' ' PHE . 12.8 m-85 -81.19 118.52 22.64 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.829 -0.804 . . . . 74.44 108.829 -171.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -76.86 81.4 3.44 Favored 'General case' 0 C--O 1.243 0.745 0 CA-C-O 121.204 0.526 . . . . 72.23 110.483 -173.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 90' ' ' VAL . . . . . 0.746 HG21 HD21 ' C' ' 169' ' ' ASN . 1.5 p -44.41 -40.96 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 125.46 1.504 . . . . 54.41 111.852 175.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -48.12 -40.0 22.2 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.716 1.606 . . . . 74.21 112.961 -178.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -85.1 -29.37 24.91 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.583 0.753 . . . . 75.53 112.165 -173.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 17.1 m-30 -68.98 170.39 9.9 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 113.143 0.794 . . . . 72.45 113.143 -164.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 81.0 p -71.95 172.77 9.37 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 124.77 1.228 . . . . 45.51 113.779 -164.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 95' ' ' GLU . . . . . 0.49 ' O ' ' HG3' ' C' ' 99' ' ' GLU . 4.7 mp0 -71.6 -34.0 69.5 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 115.275 -0.875 . . . . 55.43 110.953 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -61.19 -44.2 97.67 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-O 121.494 0.664 . . . . 65.02 110.33 174.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 97' ' ' PHE . . . . . 0.652 ' HE2' HG23 ' C' ' 90' ' ' VAL . 47.9 t80 -56.93 -43.77 81.8 Favored 'General case' 0 CA--C 1.554 1.103 0 CA-C-N 114.148 -1.387 . . . . 64.25 109.884 172.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -70.6 -18.97 62.88 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.055 0.542 . . . . 51.52 112.459 177.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . 0.49 ' HG3' ' O ' ' C' ' 95' ' ' GLU . 43.2 mt-10 -74.27 -55.35 6.13 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.127 0.489 . . . . 74.43 110.015 173.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 27.3 tp -74.91 -45.22 44.17 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.819 -1.082 . . . . 73.23 111.643 -170.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -97.24 -19.1 18.82 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.599 0.76 . . . . 73.25 112.257 -175.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -47.42 -57.96 6.93 Favored Glycine 0 CA--C 1.545 1.913 0 CA-C-O 118.947 -0.918 . . . . 54.11 115.119 -178.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -59.07 -9.41 7.97 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 123.788 2.992 . . . . 62.02 114.621 -179.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 104' ' ' GLY . . . . . 0.46 ' HA3' ' HB3' ' C' ' 78' ' ' PRO . . . -136.8 34.29 2.23 Favored Glycine 0 C--N 1.351 1.414 0 CA-C-O 119.985 -0.342 . . . . 43.23 113.116 178.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 105' ' ' LEU . . . . . 0.555 ' HB3' ' ND2' ' C' ' 169' ' ' ASN . 43.1 mt -73.18 68.97 1.03 Allowed 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.314 0.645 . . . . 73.03 111.474 172.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 106' ' ' PHE . . . . . 0.504 ' HB3' ' H ' ' C' ' 168' ' ' GLY . 23.2 m-85 48.56 -115.4 0.73 Allowed 'General case' 0 CA--C 1.564 1.482 0 C-N-CA 125.383 1.473 . . . . 64.24 114.36 176.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . 69.07 3.54 37.4 Favored Glycine 0 C--N 1.369 2.4 0 CA-C-O 119.89 -0.394 . . . . 51.05 113.388 -163.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 55.88 -128.13 44.51 Favored Glycine 0 C--N 1.364 2.097 0 N-CA-C 111.83 -0.508 . . . . 74.41 111.83 -171.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 109' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -109.05 9.25 26.36 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.786 0.834 . . . . 74.45 109.633 169.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 110' ' ' GLY . . . . . . . . . . . . . . . -92.0 -13.28 57.94 Favored Glycine 0 C--N 1.349 1.276 0 CA-C-N 115.976 -0.556 . . . . 54.22 112.643 -177.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? 59.16 6.88 0.77 Allowed 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 114.123 1.157 . . . . 75.25 114.123 178.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 112' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -53.54 -35.4 60.7 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.186 1.394 . . . . 74.1 111.572 169.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 113' ' ' SER . . . . . . . . . . . . . 25.0 m 52.79 30.37 8.89 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 125.002 1.321 . . . . 72.53 112.724 176.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 114' ' ' ARG . . . . . 0.482 ' HG3' ' H ' ' C' ' 115' ' ' LYS . 7.7 tpt180 -139.3 -164.66 1.71 Allowed 'General case' 0 CA--C 1.554 1.117 0 CA-C-O 117.713 -1.137 . . . . 74.05 109.646 -177.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 115' ' ' LYS . . . . . 0.482 ' H ' ' HG3' ' C' ' 114' ' ' ARG . 14.8 ttpp -14.41 121.9 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.244 0 C-N-CA 127.236 2.214 . . . . 54.14 116.48 -163.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 116' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' C' ' 170' ' ' PRO . . . -67.2 141.21 38.96 Favored Glycine 0 C--N 1.348 1.219 0 CA-C-N 115.024 -0.989 . . . . 45.25 113.102 179.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 117' ' ' ARG . . . . . 0.557 HH21 ' HB3' ' C' ' 167' ' ' GLN . 69.4 mtm180 -110.41 163.86 13.26 Favored 'General case' 0 C--O 1.265 1.891 0 CA-C-O 122.154 0.978 . . . . 64.44 110.534 -177.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.09 117.74 5.06 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 112.589 -2.096 . . . . 75.42 108.353 165.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 119' ' ' LEU . . . . . 0.505 ' HG ' ' HG2' ' C' ' 167' ' ' GLN . 3.3 tt -92.23 116.18 28.73 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 104.59 -2.374 . . . . 75.21 104.59 178.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.423 ' HA ' ' O ' ' C' ' 175' ' ' LEU . 63.0 ttt180 -117.98 118.84 33.04 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.35 -0.982 . . . . 72.31 108.35 -164.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 121' ' ' ALA . . . . . 0.507 ' HA ' HG23 ' B' ' 185' ' ' VAL . . . -108.58 170.03 8.28 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 113.847 1.055 . . . . 63.21 113.847 -164.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -127.79 108.14 10.47 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 114.16 -1.382 . . . . 73.22 110.288 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -139.12 111.68 7.94 Favored Pre-proline 0 N--CA 1.487 1.42 0 CA-C-N 118.535 0.607 . . . . 73.3 112.431 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -65.74 121.59 9.0 Favored 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 122.037 1.824 . . . . 72.51 109.692 162.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 125' ' ' LEU . . . . . 0.484 ' O ' ' HA ' ' C' ' 180' ' ' LEU . 12.7 tp -145.56 167.93 21.85 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 107.585 -1.265 . . . . 74.03 107.585 -169.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 126' ' ' THR . . . . . . . . . . . . . 14.5 t -128.26 176.99 7.25 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 119.366 0.985 . . . . 61.53 110.911 173.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 127' ' ' LEU . . . . . 0.469 HD11 ' H ' ' C' ' 185' ' ' VAL . 6.3 mt -60.73 -43.54 97.76 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.485 1.514 . . . . 62.25 109.696 -177.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 128' ' ' GLU . . . . . 0.451 ' HG2' ' HB2' ' B' ' 171' ' ' ALA . 1.9 mp0 -60.96 -39.67 90.43 Favored 'General case' 0 C--O 1.213 -0.836 0 CA-C-N 114.133 -1.394 . . . . 75.24 110.031 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 129' ' ' GLU . . . . . 0.532 ' HA ' ' HB2' ' C' ' 132' ' ' HIS . 50.3 mm-40 -77.2 -22.85 51.74 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.783 0.833 . . . . 73.53 111.225 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 130' ' ' ALA . . . . . 0.487 ' HB1' ' HA2' ' C' ' 152' ' ' GLY . . . -72.26 -35.26 68.73 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 109.297 -0.631 . . . . 64.34 109.297 175.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 131' ' ' PHE . . . . . 0.546 ' HB2' HD13 ' C' ' 215' ' ' LEU . 10.5 t80 -71.09 -43.56 67.47 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 114.131 -1.395 . . . . 75.55 110.855 168.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 132' ' ' HIS . . . . . 0.532 ' HB2' ' HA ' ' C' ' 129' ' ' GLU . 32.4 m170 -75.32 -6.82 51.88 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.854 0.461 . . . . 60.22 110.378 -178.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -59.57 77.81 0.01 OUTLIER Glycine 0 C--N 1.356 1.648 0 C-N-CA 123.815 0.721 . . . . 65.31 112.904 168.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . -113.94 -152.61 10.78 Favored Glycine 0 C--N 1.342 0.884 0 N-CA-C 109.417 -1.473 . . . . 53.24 109.417 174.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -71.55 92.99 1.17 Allowed 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 108.409 -0.96 . . . . 71.2 108.409 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 136' ' ' ARG . . . . . 0.573 ' HB2' HD22 ' B' ' 181' ' ' LEU . 78.3 mtp180 -139.55 159.48 42.06 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.116 0.966 . . . . 72.12 109.589 -173.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 137' ' ' VAL . . . . . . . . . . . . . 93.5 t -70.78 98.87 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.887 0 CA-C-O 121.978 0.894 . . . . 71.12 110.664 -175.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 138' ' ' VAL . . . . . . . . . . . . . 72.9 t -79.17 112.16 16.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 CA-C-N 113.853 -1.521 . . . . 72.14 107.831 169.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 139' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -115.69 82.22 1.72 Allowed 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 108.092 -1.077 . . . . 74.31 108.092 -170.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 140' ' ' VAL . . . . . 0.503 HG11 HD11 ' C' ' 174' ' ' LEU . 67.4 t -122.86 104.65 14.82 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 C-N-CA 124.292 1.037 . . . . 63.22 110.833 -169.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 69.21 15.01 8.64 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 125.145 1.378 . . . . 15.23 113.388 168.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 116.8 -30.15 6.51 Favored Glycine 0 C--N 1.339 0.746 0 N-CA-C 110.987 -0.845 . . . . 45.25 110.987 -175.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 143' ' ' ARG . . . . . 0.489 ' CZ ' ' HB ' ' C' ' 145' ' ' VAL . 13.0 tpt180 -70.73 114.32 8.7 Favored 'General case' 0 C--N 1.361 1.092 0 N-CA-C 109.055 -0.72 . . . . 73.04 109.055 177.005 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 7.5 ttt-85 -114.27 99.26 7.47 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 115.339 -0.846 . . . . 71.51 108.95 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 145' ' ' VAL . . . . . 0.551 HG22 ' HB ' ' C' ' 147' ' ' VAL . 3.1 p -124.85 124.41 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.473 1.109 . . . . 75.03 110.028 -178.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 146' ' ' SER . . . . . 0.458 ' HB2' ' HG3' ' B' ' 198' ' ' GLU . 29.2 m -87.13 86.41 7.29 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 108.906 -0.775 . . . . 54.21 108.906 177.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 147' ' ' VAL . . . . . 0.551 ' HB ' HG22 ' C' ' 145' ' ' VAL . 7.3 p -134.81 160.56 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 124.114 0.966 . . . . 72.53 110.59 -169.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 28.5 ttm-85 -90.18 104.89 17.41 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 108.11 -1.071 . . . . 74.22 108.11 168.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 149' ' ' ILE . . . . . . . . . . . . . 29.6 pt -69.34 150.73 97.09 Favored Pre-proline 0 CA--C 1.548 0.872 0 CA-C-O 117.755 -1.117 . . . . 71.41 108.438 165.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 150' ' ' PRO . . . . . 0.564 ' HD2' HG22 ' C' ' 161' ' ' VAL . 28.4 Cg_exo -38.68 107.97 0.07 OUTLIER 'Trans proline' 0 C--N 1.393 2.88 0 C-N-CA 123.415 2.743 . . . . 61.44 113.124 178.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -69.71 130.66 19.79 Favored 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 122.671 2.247 . . . . 73.2 111.541 -171.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 152' ' ' GLY . . . . . 0.538 ' HA3' HD23 ' C' ' 188' ' ' LEU . . . 91.71 112.01 1.8 Allowed Glycine 0 C--N 1.342 0.905 0 CA-C-N 115.645 -0.707 . . . . 54.32 113.091 -177.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 153' ' ' VAL . . . . . 0.71 HG21 HG21 ' C' ' 178' ' ' VAL . 3.0 m -123.64 177.66 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 C-N-CA 123.745 0.818 . . . . 71.13 109.595 -173.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 154' ' ' ARG . . . . . 0.456 ' HD2' ' HB2' ' B' ' 217' ' ' LEU . 97.0 mtt180 -135.03 155.48 50.69 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 123.429 0.692 . . . . 75.32 110.775 -178.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 155' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -67.88 102.53 1.27 Allowed 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.911 1.284 . . . . 74.51 112.036 -176.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 97.36 3.5 58.66 Favored Glycine 0 C--N 1.348 1.236 0 CA-C-N 115.354 -0.839 . . . . 64.51 113.009 179.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 157' ' ' SER . . . . . 0.422 ' HB3' ' HA ' ' B' ' 217' ' ' LEU . 52.0 m -95.75 169.82 9.74 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 117.205 0.502 . . . . 75.43 111.394 -175.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 158' ' ' VAL . . . . . 0.435 HG12 HG22 ' C' ' 177' ' ' VAL . 27.6 m -105.68 127.87 60.27 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 CA-C-O 121.604 0.716 . . . . 64.44 111.038 178.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 159' ' ' ILE . . . . . 0.594 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 15.2 mt -78.07 98.21 2.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 107.995 -1.113 . . . . 52.25 107.995 168.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 36.5 ttp180 -78.74 99.64 6.74 Favored 'General case' 0 C--O 1.239 0.51 0 O-C-N 123.794 0.684 . . . . 72.21 109.683 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 161' ' ' VAL . . . . . 0.613 ' HB ' ' HB3' ' C' ' 174' ' ' LEU . 19.3 t -95.99 113.11 61.52 Favored Pre-proline 0 C--O 1.251 1.15 0 N-CA-C 108.223 -1.028 . . . . 75.24 108.223 175.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -53.31 106.95 0.17 Allowed 'Trans proline' 0 C--N 1.381 2.277 0 C-N-CA 123.848 3.032 . . . . 63.42 114.476 -174.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 71.44 16.4 75.61 Favored Glycine 0 C--N 1.347 1.189 0 N-CA-C 115.694 1.038 . . . . 53.31 115.694 168.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 164' ' ' MET . . . . . 0.435 ' SD ' HG11 ' C' ' 145' ' ' VAL . 37.5 ttp -105.28 21.76 16.58 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 118.143 0.972 . . . . 73.35 110.939 -178.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . -78.12 -121.81 0.26 Allowed Glycine 0 C--N 1.35 1.345 0 CA-C-O 119.42 -0.656 . . . . 64.24 112.311 174.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . 150.98 -80.1 0.2 Allowed Glycine 0 C--N 1.356 1.639 0 C-N-CA 118.909 -1.615 . . . . 75.44 114.442 170.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 167' ' ' GLN . . . . . 0.557 ' HB3' HH21 ' C' ' 117' ' ' ARG . 31.6 mm-40 -14.91 101.18 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.491 0 C-N-CA 126.244 1.818 . . . . 64.31 114.043 -161.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 168' ' ' GLY . . . . . 0.504 ' H ' ' HB3' ' C' ' 106' ' ' PHE . . . 115.1 143.57 8.11 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 109.078 -1.609 . . . . 13.44 109.078 -162.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 169' ' ' ASN . . . . . 0.746 HD21 HG21 ' C' ' 90' ' ' VAL . 2.7 t-20 -54.76 -57.61 18.36 Favored Pre-proline 0 CA--C 1.572 1.812 0 N-CA-C 114.597 1.332 . . . . 62.44 114.597 -164.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 170' ' ' PRO . . . . . 0.455 ' HD3' ' HB3' ' C' ' 169' ' ' ASN . 33.1 Cg_exo -62.18 154.16 64.72 Favored 'Trans proline' 0 C--N 1.393 2.905 0 CA-C-N 121.93 1.725 . . . . 51.41 112.208 172.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 171' ' ' PRO . . . . . 0.47 ' HB3' ' O ' ' C' ' 85' ' ' PHE . 22.7 Cg_endo -62.08 129.88 28.75 Favored 'Trans proline' 0 C--N 1.368 1.553 0 C-N-CA 122.234 1.956 . . . . 74.02 112.828 175.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -99.39 -175.23 31.37 Favored Glycine 0 N--CA 1.474 1.174 0 N-CA-C 110.51 -1.036 . . . . 74.42 110.51 166.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 173' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -98.91 152.97 19.19 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 117.993 0.896 . . . . 74.51 109.302 178.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 174' ' ' LEU . . . . . 0.613 ' HB3' ' HB ' ' C' ' 161' ' ' VAL . 26.5 tp -99.25 121.74 41.47 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 121.946 -0.472 . . . . 75.22 110.585 -176.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 175' ' ' LEU . . . . . 0.423 ' O ' ' HA ' ' C' ' 120' ' ' ARG . 81.3 mt -117.74 87.71 2.77 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.281 0.632 . . . . 71.32 109.9 176.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 176' ' ' LEU . . . . . 0.594 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 48.6 mt -76.22 108.46 9.17 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 116.232 -0.44 . . . . 43.02 109.949 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 177' ' ' VAL . . . . . 0.435 HG22 HG12 ' C' ' 158' ' ' VAL . 61.5 t -81.82 106.46 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 N-CA-C 108.256 -1.016 . . . . 74.43 108.256 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 178' ' ' VAL . . . . . 0.71 HG21 HG21 ' C' ' 153' ' ' VAL . 4.0 p -95.64 138.83 20.24 Favored 'Isoleucine or valine' 0 C--O 1.242 0.69 0 CA-C-N 114.344 -1.298 . . . . 74.01 110.344 -177.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 179' ' ' ARG . . . . . . . . . . . . . 52.4 mmm-85 -121.68 109.9 15.31 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 107.73 -1.211 . . . . 72.33 107.73 175.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 180' ' ' LEU . . . . . 0.484 ' HA ' ' O ' ' C' ' 125' ' ' LEU . 87.6 mt -71.11 147.87 48.02 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.199 0.6 . . . . 70.51 111.843 -176.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 181' ' ' LEU . . . . . . . . . . . . . 30.5 mt -62.01 167.83 4.42 Favored Pre-proline 0 CA--C 1.559 1.316 0 C-N-CA 124.892 1.277 . . . . 74.2 112.106 -179.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 182' ' ' PRO . . . . . 0.427 ' HG2' ' HB3' ' B' ' 160' ' ' ALA . 29.3 Cg_exo -42.43 -1.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.398 3.157 1 C-N-CA 125.364 4.043 . . . . 64.12 118.557 175.458 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 183' ' ' HIS . . . . . 0.428 ' HA ' HG23 ' B' ' 225' ' ' THR . 0.9 OUTLIER -127.2 81.2 70.42 Favored Pre-proline 0 CA--C 1.562 1.438 0 CA-C-N 118.971 0.805 . . . . 62.13 109.792 166.017 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 184' ' ' PRO . . . . . 0.437 ' O ' ' HA ' ' B' ' 222' ' ' ALA . 88.3 Cg_endo -85.51 69.6 5.23 Favored 'Trans proline' 0 C--N 1.371 1.713 0 C-N-CA 123.628 2.886 . . . . 71.54 110.485 174.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 185' ' ' VAL . . . . . 0.624 HG22 HG21 ' B' ' 225' ' ' THR . 3.9 t -89.89 -42.37 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 109.843 -0.429 . . . . 72.23 109.843 -165.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 186' ' ' PHE . . . . . 0.598 ' HB3' HD22 ' C' ' 193' ' ' LEU . 20.9 m-85 -99.38 116.05 30.65 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.369 0.604 . . . . 61.44 112.425 -170.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 187' ' ' ARG . . . . . 0.48 ' HE ' ' HB3' ' B' ' 222' ' ' ALA . 37.2 ttm180 -102.51 101.77 11.99 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.312 1.445 . . . . 75.14 107.339 171.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 188' ' ' LEU . . . . . 0.538 HD23 ' HA3' ' C' ' 152' ' ' GLY . 57.8 tp -92.55 141.16 28.8 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 113.301 0.852 . . . . 74.14 113.301 -169.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -125.23 101.25 6.9 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 107.857 -1.164 . . . . 71.33 107.857 160.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 72.2 -81.12 0.59 Allowed Glycine 0 C--N 1.353 1.504 0 CA-C-N 115.18 -0.918 . . . . 74.2 113.51 176.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 191' ' ' GLN . . . . . 0.584 ' HA ' ' HB2' ' C' ' 240' ' ' PHE . 19.4 mt-30 -132.64 -9.94 3.16 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.318 0.647 . . . . 60.21 111.746 178.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -105.49 115.38 30.16 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 121.23 0.538 . . . . 65.13 110.587 -176.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 193' ' ' LEU . . . . . 0.598 HD22 ' HB3' ' C' ' 186' ' ' PHE . 72.2 mt -86.0 152.27 23.06 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.932 1.293 . . . . 52.2 111.132 -178.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 194' ' ' TYR . . . . . 0.47 ' O ' ' HA ' ' C' ' 186' ' ' PHE . 49.7 t80 -111.98 148.96 32.68 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 107.25 -1.389 . . . . 75.43 107.25 162.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 195' ' ' ALA . . . . . 0.42 ' HA ' ' O ' ' C' ' 185' ' ' VAL . . . -154.42 -176.95 6.14 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.078 0.551 . . . . 65.11 111.177 -177.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 40.2 m -128.36 139.05 52.59 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.049 -0.978 . . . . 51.32 108.893 168.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 197' ' ' LEU . . . . . 0.431 HD13 HD22 ' C' ' 251' ' ' LEU . 35.9 tp -115.53 143.46 45.28 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.522 1.129 . . . . 73.5 108.473 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -113.04 102.1 10.09 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.388 -0.597 . . . . 44.52 109.388 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 199' ' ' VAL . . . . . 0.605 ' HA ' HG11 ' C' ' 210' ' ' VAL . 95.2 t -108.08 119.36 50.17 Favored Pre-proline 0 N--CA 1.473 0.698 0 C-N-CA 123.901 0.88 . . . . 61.21 109.005 176.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 200' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.94 149.54 65.91 Favored 'Trans proline' 0 C--N 1.371 1.751 0 C-N-CA 121.858 1.705 . . . . 71.34 110.934 175.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 201' ' ' ALA . . . . . . . . . . . . . . . -56.02 -43.44 99.23 Favored Pre-proline 0 CA--C 1.553 1.093 0 N-CA-C 114.093 1.145 . . . . 74.35 114.093 -174.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 202' ' ' PRO . . . . . 0.427 ' O ' HG12 ' C' ' 206' ' ' VAL . 77.0 Cg_exo -54.18 -53.44 6.31 Favored 'Trans proline' 0 C--N 1.398 3.156 0 C-N-CA 121.752 1.635 . . . . 63.15 112.286 175.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 203' ' ' ILE . . . . . . . . . . . . . 41.0 mt -62.73 -32.99 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 124.554 1.142 . . . . 63.4 111.209 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.96 -43.9 81.92 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.756 0.822 . . . . 75.02 112.013 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 205' ' ' VAL . . . . . . . . . . . . . 87.9 t -71.7 -47.95 54.38 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 123.256 0.622 . . . . 63.41 111.199 -179.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 206' ' ' VAL . . . . . 0.569 HG23 ' HE2' ' A' ' 270' ' ' LYS . 14.7 p -80.1 -34.74 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 112.761 0.652 . . . . 52.12 112.761 -171.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 90.57 104.5 1.25 Allowed Glycine 0 C--N 1.343 0.92 0 N-CA-C 111.069 -0.812 . . . . 63.21 111.069 -167.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -143.44 -126.71 2.03 Favored Glycine 0 C--N 1.343 0.927 0 N-CA-C 111.679 -0.568 . . . . 51.32 111.679 -176.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 209' ' ' LYS . . . . . 0.478 ' HG2' ' HG2' ' C' ' 220' ' ' GLU . 34.1 ttmt -157.21 137.18 12.53 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 117.633 0.717 . . . . 72.12 110.85 -176.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 210' ' ' VAL . . . . . 0.605 HG11 ' HA ' ' C' ' 199' ' ' VAL . 23.4 m -129.95 177.03 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 125.501 1.52 . . . . 62.05 109.526 174.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 211' ' ' ARG . . . . . 0.78 HH22 ' HB2' ' B' ' 233' ' ' PHE . 0.1 OUTLIER -109.46 149.99 28.76 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 118.436 0.562 . . . . 72.44 111.204 -179.845 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -129.5 118.55 22.26 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 107.45 -1.315 . . . . 74.43 107.45 166.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 213' ' ' MET . . . . . 0.613 ' HG2' ' HB3' ' B' ' 172' ' ' GLU . 1.4 tmm? -73.82 117.79 16.02 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.344 -0.984 . . . . 63.12 108.344 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 214' ' ' THR . . . . . 0.429 ' OG1' HG12 ' C' ' 219' ' ' VAL . 0.2 OUTLIER -122.8 175.76 6.36 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 119.014 0.824 . . . . 54.24 112.095 -173.521 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 215' ' ' LEU . . . . . 0.546 HD13 ' HB2' ' C' ' 131' ' ' PHE . 41.7 mt -75.82 -29.8 58.78 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.459 1.503 . . . . 44.41 112.012 -171.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -87.11 3.28 46.86 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 114.803 -1.09 . . . . 71.0 110.272 176.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 118.26 -178.22 16.75 Favored Glycine 0 C--N 1.348 1.208 0 N-CA-C 110.433 -1.067 . . . . 64.11 110.433 -172.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -75.26 125.2 9.0 Favored 'Trans proline' 0 CA--C 1.554 1.477 0 C-N-CA 121.954 1.769 . . . . 52.13 111.97 178.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 219' ' ' VAL . . . . . 0.475 HG23 HG22 ' B' ' 238' ' ' THR . 14.0 p -100.56 157.51 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 N-CA-C 106.865 -1.531 . . . . 52.53 106.865 171.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 220' ' ' GLU . . . . . 0.553 ' HB3' ' HB2' ' B' ' 235' ' ' GLU . 16.5 tt0 -126.63 108.33 11.01 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.859 -0.793 . . . . 72.32 108.859 -177.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 221' ' ' VAL . . . . . 0.423 HG22 HD21 ' C' ' 235' ' ' LEU . 32.1 t -68.9 123.99 23.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 125.858 1.663 . . . . 74.03 111.2 -174.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -84.67 108.49 17.42 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 109.413 -0.588 . . . . 73.3 109.413 172.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 61.1 t -84.25 127.64 65.54 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 123.744 0.818 . . . . 73.11 110.508 -176.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 224' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -79.76 161.83 24.33 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 123.233 2.622 . . . . 54.33 111.082 168.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 225' ' ' PRO . . . . . 0.754 ' HG2' HD13 ' B' ' 247' ' ' LEU . 39.4 Cg_exo -63.12 159.05 40.7 Favored 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 122.427 2.084 . . . . 74.0 113.483 177.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 226' ' ' ARG . . . . . 0.444 ' HD2' ' O ' ' A' ' 259' ' ' GLU . 9.5 mmt180 55.3 63.0 2.24 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.514 1.526 . . . . 70.15 111.894 177.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 227' ' ' THR . . . . . . . . . . . . . 52.4 m -96.92 128.93 44.36 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 123.815 0.846 . . . . 70.3 110.97 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 228' ' ' GLN . . . . . 0.477 ' NE2' ' HG3' ' A' ' 259' ' ' GLU . 27.8 mp0 -105.23 147.67 27.8 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 124.545 1.138 . . . . 74.32 111.893 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -73.28 123.4 23.65 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 115.43 -0.805 . . . . 62.12 109.264 177.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 116.12 -7.41 18.99 Favored Glycine 0 C--N 1.337 0.599 0 O-C-N 123.522 0.514 . . . . 62.04 112.064 -176.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 231' ' ' ARG . . . . . 0.59 ' HD3' ' HZ3' ' B' ' 242' ' ' TRP . 36.0 mtt180 -63.02 169.57 3.27 Favored 'General case' 0 C--N 1.354 0.79 0 CA-C-N 116.846 0.323 . . . . 74.12 110.925 171.072 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 232' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' C' ' 251' ' ' LEU . 3.7 ttmp? -139.29 147.06 41.13 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.567 -0.531 . . . . 71.45 109.567 176.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 233' ' ' LEU . . . . . 0.468 ' O ' ' HA ' ' C' ' 250' ' ' TYR . 1.7 tt -133.01 125.01 28.77 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.693 0.797 . . . . 74.21 109.308 -166.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -93.19 104.22 16.43 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-O 121.065 0.459 . . . . 72.34 110.614 170.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 235' ' ' LEU . . . . . 0.423 HD21 HG22 ' C' ' 221' ' ' VAL . 75.8 mt -85.11 123.88 31.14 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.391 -0.966 . . . . 73.43 108.391 166.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -85.32 131.75 34.36 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 123.349 0.66 . . . . 71.55 111.541 -171.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 80.83 -1.28 84.45 Favored Glycine 0 C--N 1.351 1.402 0 O-C-N 124.033 0.833 . . . . 71.42 113.687 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 238' ' ' LYS . . . . . 0.405 ' HG3' ' HB3' ' C' ' 235' ' ' LEU . 14.0 mmtm -95.11 9.05 41.03 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.19 0.996 . . . . 72.03 112.019 -172.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -86.29 -133.01 3.27 Favored Glycine 0 C--N 1.346 1.085 0 N-CA-C 111.723 -0.551 . . . . 31.21 111.723 172.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 240' ' ' PHE . . . . . 0.584 ' HB2' ' HA ' ' C' ' 191' ' ' GLN . 1.9 m-85 -103.37 128.45 27.48 Favored Pre-proline 0 N--CA 1.47 0.558 0 C-N-CA 123.105 0.562 . . . . 75.14 110.132 177.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 241' ' ' PRO . . . . . 0.454 ' HA ' ' HG2' ' C' ' 246' ' ' ARG . 31.4 Cg_exo -61.98 105.21 0.37 Allowed 'Trans proline' 0 C--N 1.37 1.688 0 C-N-CA 123.405 2.736 . . . . 70.21 112.916 173.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -75.67 173.16 53.58 Favored Glycine 0 CA--C 1.531 1.081 0 CA-C-N 115.195 -0.911 . . . . 70.14 112.798 174.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -64.86 -17.17 58.69 Favored 'Trans proline' 0 C--N 1.367 1.545 0 C-N-CA 123.184 2.589 . . . . 71.42 113.955 -170.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -130.84 1.07 4.34 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.631 0.773 . . . . 71.42 111.907 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . -173.19 -136.66 2.22 Favored Glycine 0 C--N 1.35 1.349 0 CA-C-O 119.648 -0.529 . . . . 51.32 113.09 -178.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 246' ' ' ARG . . . . . 0.454 ' HG2' ' HA ' ' C' ' 241' ' ' PRO . 77.8 mtm180 -150.04 165.06 33.89 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.826 0.851 . . . . 61.31 110.891 -176.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 247' ' ' GLY . . . . . 0.427 ' HA2' ' HA2' ' B' ' 36' ' ' GLY . . . -102.35 -166.66 26.63 Favored Glycine 0 C--N 1.35 1.322 0 CA-C-N 114.801 -1.091 . . . . 63.23 111.951 174.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -129.44 164.12 24.36 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 121.114 0.483 . . . . 73.54 110.359 -171.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 249' ' ' LEU . . . . . 0.413 HD23 HD12 ' C' ' 235' ' ' LEU . 17.7 tp -120.18 127.62 52.63 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.167 0.987 . . . . 74.23 109.401 -174.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 250' ' ' TYR . . . . . 0.468 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 79.0 m-85 -117.24 100.78 7.93 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.704 0.802 . . . . 71.43 110.323 -177.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 251' ' ' LEU . . . . . 0.447 ' O ' ' HA ' ' C' ' 232' ' ' LYS . 0.6 OUTLIER -100.97 134.29 44.19 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 109.932 -0.395 . . . . 64.53 109.932 -176.133 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -76.68 107.73 9.19 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.145 -1.057 . . . . 73.41 108.145 168.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 253' ' ' VAL . . . . . . . . . . . . . 46.2 t -75.07 113.78 14.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 115.199 -0.91 . . . . 73.5 110.2 -176.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 254' ' ' ARG . . . . . . . . . . . . . 39.1 mtm180 -97.13 155.46 16.81 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.297 0.639 . . . . 74.13 110.882 177.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 255' ' ' ILE . . . . . . . . . . . . . 36.9 mm -101.56 124.88 55.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 114.764 -1.107 . . . . 75.24 108.052 166.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 256' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.07 175.97 8.46 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.138 1.375 . . . . 53.32 108.536 -178.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 35.4 pt -131.16 147.88 67.99 Favored Pre-proline 0 N--CA 1.484 1.243 0 C-N-CA 123.491 0.716 . . . . 64.54 110.047 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -62.56 -12.89 30.3 Favored 'Trans proline' 0 C--N 1.377 2.07 0 C-N-CA 122.862 2.375 . . . . 73.21 113.858 -172.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 54.24 -67.58 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 125.481 1.512 . . . . 72.3 112.194 -164.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 8.0 ppt_? -60.07 132.7 54.76 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.264 0.626 . . . . 73.41 110.433 174.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 261' ' ' LEU . . . . . . . . . . . . . 92.4 mt -139.9 147.86 41.2 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.728 0.811 . . . . 71.21 109.978 -174.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 74.4 p -81.89 160.45 63.56 Favored Pre-proline 0 CA--C 1.553 1.084 0 N-CA-C 107.97 -1.122 . . . . 61.23 107.97 168.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -45.84 -44.08 18.67 Favored 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 122.782 2.322 . . . . 74.2 112.538 172.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -60.97 -54.18 48.14 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-N 114.18 -1.373 . . . . 71.04 111.514 176.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -50.02 -58.45 5.46 Favored 'General case' 0 C--N 1.359 0.994 0 O-C-N 124.284 0.99 . . . . 65.11 109.992 -177.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 266' ' ' GLU . . . . . 0.468 ' O ' ' HG2' ' C' ' 270' ' ' LYS . 26.8 tt0 -61.34 -38.21 86.09 Favored 'General case' 0 C--N 1.349 0.574 0 CA-C-N 114.719 -1.128 . . . . 64.21 111.336 -175.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -57.28 -46.43 83.11 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.201 0.6 . . . . 70.32 112.351 177.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 268' ' ' LEU . . . . . 0.477 ' HB2' HD21 ' A' ' 272' ' ' LEU . 10.4 mp -66.15 -39.97 90.21 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 116.407 -0.36 . . . . 52.44 110.89 177.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -60.44 -36.0 77.17 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 123.266 0.354 . . . . 61.11 111.277 174.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 270' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' C' ' 266' ' ' GLU . 34.2 mmtp -64.08 -45.94 86.49 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.397 0.679 . . . . 75.43 110.439 178.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -56.29 -47.42 78.69 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 124.036 0.835 . . . . 75.33 111.577 176.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 91.3 mt -61.42 -42.09 98.19 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 114.834 -1.075 . . . . 74.33 110.803 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -61.47 -40.4 94.39 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.373 0.669 . . . . 34.13 111.046 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -68.16 -34.06 75.62 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.715 0.806 . . . . 63.21 111.634 177.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -62.67 -31.43 72.32 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 115.838 -0.619 . . . . 70.04 110.331 172.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 276' ' ' TYR . . . . . 0.485 ' HB3' HD11 ' A' ' 203' ' ' ILE . 53.6 m-85 -79.82 -30.99 40.61 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.084 0.554 . . . . 75.52 112.437 171.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 19.0 m-30 -68.11 -24.23 65.0 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 118.517 0.599 . . . . 44.24 110.205 178.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -61.32 -8.3 3.74 Favored 'General case' 0 CA--C 1.559 1.326 0 C-N-CA 124.193 0.997 . . . . 55.2 113.425 172.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 279' ' ' ARG . . . . . . . . . . . . . 81.3 mtt180 -73.59 -24.07 60.01 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 122.739 0.416 . . . . 71.52 112.005 174.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 280' ' ' ALA . . . . . 0.579 ' HB3' HD22 ' B' ' 426' ' ' ASN . . . . . . . . 0 CA--C 1.556 1.186 0 O-C-N 124.417 1.073 . . . . 75.14 112.781 -167.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.48 1.065 0 CA-C-O 121.17 0.509 . . . . 64.12 109.806 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.43 27.04 16.07 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 125.212 1.405 . . . . 51.4 113.208 176.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.24 71.26 9.29 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.508 0.723 . . . . 74.04 110.635 -176.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -40.43 100.99 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 125.716 1.606 . . . . 62.43 113.789 176.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.417 ' HB3' HD11 ' A' ' 10' ' ' ILE . 51.3 mtmt -87.96 128.18 35.38 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 108.565 -0.902 . . . . 74.32 108.565 169.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.492 ' HA ' ' OH ' ' A' ' 66' ' ' TYR . 10.7 t70 -76.48 105.81 7.75 Favored 'General case' 0 C--N 1.347 0.491 0 N-CA-C 109.187 -0.672 . . . . 61.41 109.187 -177.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -68.44 -33.31 73.98 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.692 0.797 . . . . 73.34 112.531 -170.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -64.12 -45.62 87.77 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 109.634 -0.506 . . . . 73.33 109.634 174.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.48 -42.1 95.59 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.632 -0.713 . . . . 60.32 111.375 178.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.417 HD11 ' HB3' ' A' ' 5' ' ' LYS . 81.4 mt -58.79 -42.22 84.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 123.676 0.79 . . . . 74.23 110.231 176.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.2 mt -76.14 -11.81 60.0 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 112.912 0.708 . . . . 51.33 112.912 178.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.56 35.09 56.12 Favored Glycine 0 C--N 1.351 1.385 0 O-C-N 122.972 0.17 . . . . 53.33 112.709 -178.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.5 m -127.1 154.5 76.67 Favored Pre-proline 0 CA--C 1.552 1.028 0 C-N-CA 124.916 1.286 . . . . 71.43 109.608 178.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -74.57 168.56 24.52 Favored 'Trans proline' 0 C--N 1.374 1.914 0 C-N-CA 122.282 1.988 . . . . 50.12 112.25 177.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 83.7 mtt180 -75.12 17.36 0.24 Allowed 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 113.142 0.793 . . . . 75.43 113.142 -178.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -124.78 15.42 8.67 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.101 0.96 . . . . 64.11 108.974 173.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.11 112.08 2.84 Favored 'General case' 0 C--N 1.349 0.566 0 CA-C-N 115.069 -0.969 . . . . 64.31 110.437 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 62.1 p -72.31 169.76 15.57 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.59 0.756 . . . . 71.11 109.708 176.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -54.03 -41.06 67.62 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.954 0.902 . . . . 64.21 112.07 -177.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -65.69 -41.28 92.6 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.187 0.595 . . . . 72.43 110.598 -177.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -69.29 -40.81 77.51 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.36 0.664 . . . . 64.03 111.014 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.554 HD13 ' HB3' ' A' ' 57' ' ' LEU . 60.9 mt -68.68 -32.86 56.74 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 C-N-CA 124.271 1.028 . . . . 73.31 110.721 178.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp -73.49 -37.88 65.57 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.177 0.991 . . . . 71.24 110.341 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -75.72 -29.25 58.86 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.044 0.538 . . . . 54.12 110.909 175.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.87 -33.85 71.01 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.351 0.66 . . . . 64.0 110.073 174.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -64.96 -53.05 52.36 Favored 'General case' 0 C--O 1.201 -1.466 0 CA-C-N 114.916 -1.038 . . . . 73.1 109.369 173.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -54.08 -40.14 66.96 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.643 0.777 . . . . 74.22 111.703 178.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.419 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 61.0 ttt180 -55.08 -68.19 0.21 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.174 1.39 . . . . 71.15 110.79 177.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.745 ' HB3' HD13 ' A' ' 50' ' ' ILE . 96.2 mt -74.43 -16.71 60.86 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.411 -0.813 . . . . 74.11 111.745 -174.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.21 -56.71 8.75 Favored 'General case' 0 C--O 1.204 -1.306 0 N-CA-C 108.177 -1.046 . . . . 63.3 108.177 174.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 69.2 mtp180 -55.22 -51.88 65.17 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 124.127 0.892 . . . . 72.33 110.768 177.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.419 ' HG2' ' O ' ' A' ' 28' ' ' ARG . 14.5 mm100 -54.28 -47.13 72.68 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 124.303 1.002 . . . . 63.33 111.728 -178.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.404 ' HE2' HD22 ' A' ' 29' ' ' LEU . 27.7 m-85 -117.82 29.54 7.77 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.36 0.664 . . . . 63.25 111.775 -168.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -75.84 111.79 16.56 Favored Pre-proline 0 N--CA 1.485 1.281 0 CA-C-O 117.795 -1.098 . . . . 63.41 109.705 -179.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.4 -26.86 83.71 Favored 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 122.516 2.144 . . . . 74.13 111.759 176.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -59.81 -37.39 79.04 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.126 1.37 . . . . 72.45 111.572 175.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 73.5 t -101.97 -58.66 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 CA-C-O 121.478 0.656 . . . . 65.53 109.74 -178.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -97.0 98.96 10.51 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.122 1.369 . . . . 61.35 109.739 -177.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -74.36 82.76 1.91 Allowed 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.953 -0.758 . . . . 73.11 108.953 177.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.412 ' O ' ' HG3' ' A' ' 44' ' ' GLU . 53.7 m -139.64 113.52 7.87 Favored Pre-proline 0 N--CA 1.474 0.753 0 CA-C-O 118.492 -0.765 . . . . 54.41 109.281 177.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -48.19 -40.95 34.97 Favored 'Trans proline' 0 C--N 1.385 2.48 0 C-N-CA 123.606 2.87 . . . . 72.23 113.437 178.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -55.15 -47.03 75.68 Favored 'General case' 0 C--O 1.248 0.999 0 C-N-CA 124.578 1.151 . . . . 64.43 110.696 175.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.64 -23.04 63.43 Favored 'General case' 0 C--N 1.354 0.787 0 CA-C-N 115.077 -0.965 . . . . 72.14 110.782 -178.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.526 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 33.5 mt-10 -76.31 -49.11 17.8 Favored 'General case' 0 C--N 1.358 0.957 0 O-C-N 123.511 0.507 . . . . 62.01 109.781 -176.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -67.95 -39.68 83.38 Favored 'General case' 0 C--O 1.251 1.166 0 O-C-N 123.801 0.688 . . . . 62.44 110.927 -179.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 42.8 mttp -56.94 -48.95 77.1 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 116.168 -0.469 . . . . 74.03 110.177 170.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -59.71 -32.91 70.97 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.101 0.96 . . . . 73.24 110.84 179.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.526 ' HG2' ' O ' ' A' ' 44' ' ' GLU . 33.5 mmtp -66.66 -43.41 84.63 Favored 'General case' 0 C--N 1.349 0.548 0 CA-C-O 119.245 -0.407 . . . . 75.14 110.662 177.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -68.17 -26.56 65.81 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 123.706 0.629 . . . . 71.44 112.278 176.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.745 HD13 ' HB3' ' A' ' 29' ' ' LEU . 59.5 mt -76.76 -35.2 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 124.106 0.962 . . . . 70.53 110.242 175.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -79.3 -21.61 45.73 Favored 'General case' 0 C--O 1.212 -0.891 0 C-N-CA 123.889 0.875 . . . . 73.43 110.621 175.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -77.27 -45.64 25.71 Favored 'General case' 0 C--O 1.247 0.924 0 C-N-CA 124.977 1.311 . . . . 63.42 108.726 176.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.78 -47.45 82.51 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-N 113.672 -1.604 . . . . 65.45 110.184 174.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.488 ' HD2' ' HZ ' ' A' ' 88' ' ' PHE . 16.6 t80 -76.48 -23.27 53.8 Favored 'General case' 0 C--O 1.207 -1.166 0 CA-C-N 115.435 -0.802 . . . . 72.32 110.713 177.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.408 ' HB1' ' HD2' ' A' ' 85' ' ' PHE . . . -60.97 -36.16 78.69 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 118.833 0.742 . . . . 53.01 110.875 175.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.532 HG11 ' HB2' ' A' ' 66' ' ' TYR . 19.2 t -76.04 -57.66 5.79 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 CA-C-N 115.363 -0.835 . . . . 74.52 110.099 171.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.554 ' HB3' HD13 ' A' ' 22' ' ' ILE . 49.2 mt -87.31 12.0 12.99 Favored 'General case' 0 CA--C 1.561 1.397 0 CA-C-N 115.003 -0.999 . . . . 62.04 112.964 -164.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.463 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 26.0 t -69.06 -38.61 79.17 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 123.933 0.893 . . . . 74.34 111.228 176.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.481 ' HB2' ' HD3' ' A' ' 62' ' ' LYS . 8.8 m-20 -124.6 142.07 39.57 Favored Pre-proline 0 N--CA 1.475 0.813 0 N-CA-C 108.96 -0.755 . . . . 74.34 108.96 -177.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.423 ' O ' ' HG2' ' A' ' 64' ' ' ARG . 40.0 Cg_exo -58.04 -27.45 79.57 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 122.972 2.448 . . . . 72.41 113.115 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -59.43 -58.72 7.39 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.012 0.925 . . . . 72.3 110.817 176.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.481 ' HD3' ' HB2' ' A' ' 59' ' ' ASP . 20.8 mtpt -73.07 -29.56 63.04 Favored 'General case' 0 C--O 1.249 1.078 0 CA-C-N 114.53 -1.214 . . . . 74.54 111.029 -175.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.432 ' HG3' HD22 ' A' ' 57' ' ' LEU . 61.6 ttt-85 -60.05 -43.92 95.05 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.204 -0.907 . . . . 74.11 109.462 172.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.423 ' HG2' ' O ' ' A' ' 60' ' ' PRO . 22.8 mmt180 -68.93 -31.34 70.17 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 123.736 0.648 . . . . 74.25 112.029 177.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.448 HD12 ' HA ' ' A' ' 62' ' ' LYS . 87.3 mt -54.38 -46.5 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 CA-C-O 121.255 0.55 . . . . 64.42 109.653 169.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.532 ' HB2' HG11 ' A' ' 56' ' ' VAL . 7.7 t80 -63.82 -49.99 70.7 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 115.532 -0.758 . . . . 75.4 111.377 175.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -57.68 -36.07 71.43 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.997 0.919 . . . . 64.04 111.323 -176.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 60.8 p -79.31 -28.08 42.18 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 119.054 -0.498 . . . . 75.13 110.922 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -67.88 102.78 1.32 Allowed 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 109.455 -0.572 . . . . 63.45 109.455 176.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 119.68 17.63 4.64 Favored Glycine 0 N--CA 1.473 1.124 0 C-N-CA 124.053 0.835 . . . . 52.54 111.346 -170.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 67.8 m -150.61 -55.75 0.16 Allowed 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 104.208 -2.516 . . . . 71.23 104.208 177.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 34.0 m -78.98 138.45 38.06 Favored 'General case' 0 C--O 1.251 1.146 0 N-CA-C 104.466 -2.42 . . . . 74.23 104.466 156.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.75 -31.58 12.17 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.015 0.526 . . . . 74.04 110.122 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.72 152.15 87.04 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 123.923 0.889 . . . . 75.1 110.314 175.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -62.32 116.58 3.59 Favored 'Trans proline' 0 C--N 1.375 1.934 0 C-N-CA 122.262 1.975 . . . . 75.41 109.952 168.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -51.02 144.99 26.33 Favored 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 123.653 2.902 . . . . 74.25 114.07 -177.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.438 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 11.0 Cg_endo -50.54 124.46 13.36 Favored 'Trans proline' 0 C--N 1.389 2.705 0 C-N-CA 123.828 3.019 . . . . 62.44 113.279 -174.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 77' ' ' PRO . 25.4 Cg_exo -63.87 135.33 47.59 Favored 'Trans proline' 0 C--N 1.379 2.152 0 C-N-CA 122.627 2.218 . . . . 43.51 112.227 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.402 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 85.3 Cg_exo -51.16 149.91 15.07 Favored 'Trans proline' 0 C--N 1.378 2.091 0 C-N-CA 122.932 2.422 . . . . 71.05 112.281 168.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 79' ' ' PRO . 38.9 Cg_exo -61.3 85.23 0.09 OUTLIER 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 123.183 2.589 . . . . 51.35 113.266 -175.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 150.03 -34.29 1.02 Allowed Glycine 0 N--CA 1.466 0.674 0 N-CA-C 109.963 -1.255 . . . . 62.41 109.963 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 140.76 -152.73 23.27 Favored Glycine 0 C--N 1.35 1.32 0 C-N-CA 124.151 0.882 . . . . 53.03 110.955 175.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -99.01 113.22 25.29 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.152 0.981 . . . . 74.41 108.897 175.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -55.1 141.76 33.32 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.638 1.175 . . . . 71.31 111.47 174.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.429 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 55.8 m-85 -140.58 77.99 1.63 Allowed 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 124.429 1.092 . . . . 70.22 110.215 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.592 ' HA ' ' HA3' ' A' ' 163' ' ' GLY . 1.7 m -45.62 82.86 0.0 OUTLIER 'General case' 0 CA--C 1.561 1.392 0 C-N-CA 125.892 1.677 . . . . 74.44 113.225 -177.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 62.4 28.48 71.15 Favored Glycine 0 C--N 1.349 1.282 0 CA-C-N 116.044 -0.525 . . . . 70.11 114.306 -176.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.488 ' HZ ' ' HD2' ' A' ' 54' ' ' TYR . 30.1 m-85 -112.23 117.66 33.16 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.034 0.534 . . . . 72.34 110.031 -176.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.494 ' HA ' ' HB3' ' A' ' 170' ' ' PRO . 5.7 m-20 -82.89 74.75 9.83 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 122.405 1.097 . . . . 71.44 110.225 178.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.512 HG21 HD22 ' A' ' 105' ' ' LEU . 1.6 p -50.13 -30.0 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 126.613 1.965 . . . . 75.21 113.11 171.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -63.59 -4.99 3.33 Favored 'General case' 0 CA--C 1.566 1.595 0 C-N-CA 124.651 1.18 . . . . 75.33 111.989 177.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -119.03 -15.49 9.27 Favored 'General case' 0 CA--C 1.562 1.433 0 C-N-CA 124.652 1.181 . . . . 45.35 111.559 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 18.7 m-30 -74.94 -170.06 1.03 Allowed 'General case' 0 N--CA 1.503 2.212 0 C-N-CA 123.75 0.82 . . . . 71.01 112.625 -173.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 82.5 p -77.76 167.3 21.77 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 113.693 0.997 . . . . 74.5 113.693 -169.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.02 -49.02 77.72 Favored 'General case' 0 C--N 1.365 1.276 0 CA-C-N 115.455 -0.793 . . . . 74.31 111.665 179.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -56.35 -40.87 75.2 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.592 0.757 . . . . 75.03 110.258 -177.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -65.27 -45.88 82.74 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 114.606 -1.179 . . . . 63.23 110.228 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.503 ' HA ' HD11 ' A' ' 105' ' ' LEU . 41.1 mt-30 -80.82 1.73 29.35 Favored 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 114.994 -1.003 . . . . 73.05 111.868 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -99.64 -51.09 3.85 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 124.074 0.95 . . . . 70.02 111.748 170.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 43.0 tp -66.61 -46.92 74.31 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.548 0.739 . . . . 55.03 110.382 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -90.76 -5.05 56.19 Favored 'General case' 0 CA--C 1.55 0.981 0 CA-C-N 115.766 -0.652 . . . . 72.11 110.694 176.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -44.99 -59.39 4.47 Favored Glycine 0 CA--C 1.541 1.681 0 CA-C-O 118.651 -1.083 . . . . 72.43 114.975 178.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -59.6 -1.72 1.18 Allowed 'Trans proline' 0 C--N 1.387 2.564 0 C-N-CA 123.711 2.941 . . . . 23.1 115.126 -177.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -149.49 36.32 1.01 Allowed Glycine 0 C--N 1.354 1.574 0 CA-C-N 118.549 0.613 . . . . 44.4 112.82 173.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.512 HD22 HG21 ' A' ' 90' ' ' VAL . 18.3 mt -71.94 62.51 0.45 Allowed 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 117.705 0.753 . . . . 74.25 112.348 172.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 35.47 -112.07 0.07 Allowed 'General case' 0 CA--C 1.561 1.378 0 C-N-CA 126.403 1.881 . . . . 72.25 114.214 173.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 56.86 18.88 27.24 Favored Glycine 0 C--N 1.369 2.397 0 N-CA-C 111.77 -0.532 . . . . 44.0 111.77 -163.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 55.58 -114.13 4.51 Favored Glycine 0 C--N 1.361 1.972 0 O-C-N 124.604 0.826 . . . . 71.34 111.96 -166.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -125.16 16.76 8.43 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.128 0.971 . . . . 64.11 109.554 173.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -91.04 -22.23 33.42 Favored Glycine 0 C--N 1.343 0.926 0 CA-C-N 115.783 -0.644 . . . . 55.25 111.821 172.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.34 9.3 1.38 Allowed 'General case' 0 CA--C 1.565 1.539 0 C-N-CA 125.143 1.377 . . . . 71.44 113.326 174.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 42.7 tpt85 -57.24 -35.29 69.52 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.641 0.377 . . . . 73.25 110.068 164.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 59.4 m 59.99 63.87 1.37 Allowed 'General case' 0 CA--C 1.546 0.806 0 O-C-N 124.295 0.997 . . . . 74.21 110.375 -176.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -125.19 164.68 19.75 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 115.134 -0.939 . . . . 74.52 109.956 177.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.532 ' HA ' ' HD2' ' A' ' 170' ' ' PRO . 37.4 tttp -54.11 128.86 32.53 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 125.26 1.424 . . . . 72.15 112.637 -175.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -80.47 165.75 48.64 Favored Glycine 0 C--N 1.348 1.239 0 O-C-N 124.108 0.88 . . . . 55.22 115.094 -168.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.594 ' HA ' ' HA ' ' B' ' 401' ' ' PRO . 24.3 ttt180 -59.99 143.93 50.54 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.819 1.248 . . . . 71.34 111.495 176.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.624 ' HB3' ' HE3' ' B' ' 404' ' ' LYS . 3.1 p-10 -78.68 126.92 31.38 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 108.733 -0.84 . . . . 74.23 108.733 166.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 53.9 tp -119.25 132.56 55.94 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 109.386 -0.598 . . . . 70.23 109.386 -176.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 67.9 ttp85 -90.8 110.97 22.17 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 108.36 -0.978 . . . . 74.51 108.36 171.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -114.72 150.97 34.47 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.637 0.775 . . . . 41.51 109.131 178.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -106.95 118.63 37.21 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 107.134 -1.432 . . . . 61.0 107.134 -170.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.41 HD11 ' HE ' ' A' ' 136' ' ' ARG . 13.2 tp -99.79 100.14 10.48 Favored Pre-proline 0 N--CA 1.472 0.67 0 N-CA-C 108.892 -0.781 . . . . 54.05 108.892 -176.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.643 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 50.8 Cg_endo -71.75 111.05 3.05 Favored 'Trans proline' 0 C--N 1.374 1.891 0 N-CA-C 108.544 -1.368 . . . . 75.33 108.544 172.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.474 ' HB3' HD23 ' A' ' 180' ' ' LEU . 60.6 tp -115.78 140.22 49.43 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.438 0.637 . . . . 64.01 110.263 -171.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 93.3 m -74.87 134.4 41.66 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 114.068 -1.423 . . . . 71.34 111.078 179.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.429 HD13 ' HB2' ' A' ' 186' ' ' PHE . 91.0 mt -57.96 -38.36 75.87 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.939 0.895 . . . . 70.54 111.134 -177.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -56.2 -42.6 77.44 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 114.492 -1.231 . . . . 75.32 110.045 176.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -73.26 -34.61 65.91 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.583 0.753 . . . . 64.33 111.412 178.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -67.23 -25.94 66.35 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 121.128 0.49 . . . . 41.43 110.326 178.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -78.49 -42.75 28.78 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 114.657 -1.156 . . . . 74.51 110.538 173.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 36.6 m170 -68.32 -66.69 0.54 Allowed 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.14 0.576 . . . . 75.25 111.055 -177.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.588 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 81.97 56.48 2.89 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-N 116.068 -0.515 . . . . 71.54 112.789 177.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -126.42 -170.11 12.89 Favored Glycine 0 N--CA 1.471 1.017 0 N-CA-C 111.584 -0.606 . . . . 70.42 111.584 178.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 30.1 mp0 -71.37 104.71 3.27 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.447 0.699 . . . . 73.14 109.69 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.738 HH22 HD12 ' A' ' 159' ' ' ILE . 0.0 OUTLIER -90.93 147.08 23.37 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.298 -1.001 . . . . 74.4 108.298 174.843 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 62.3 t -102.68 132.44 48.78 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 N-CA-C 107.923 -1.139 . . . . 71.24 107.923 171.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.492 HG13 HG13 ' A' ' 145' ' ' VAL . 2.2 p -139.08 113.0 6.98 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 124.362 1.065 . . . . 73.14 108.389 -177.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -95.97 142.6 28.0 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 115.599 -0.728 . . . . 71.3 109.76 -176.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.2 p -168.97 138.59 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 123.617 0.767 . . . . 75.1 109.939 173.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 57.2 32.07 21.11 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 124.404 1.082 . . . . 74.24 112.548 175.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 78.41 0.37 78.27 Favored Glycine 0 C--N 1.35 1.349 0 CA-C-N 116.538 -0.301 . . . . 31.1 113.333 -178.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.92 104.39 14.36 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 124.266 1.026 . . . . 72.12 108.233 178.153 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 27.9 ttp-105 -92.67 104.4 16.68 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 125.135 1.374 . . . . 74.41 108.775 175.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.492 HG13 HG13 ' A' ' 138' ' ' VAL . 3.4 p -107.23 131.69 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 CA-C-O 120.935 0.398 . . . . 73.53 112.045 -175.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 37.6 t -100.4 110.55 22.76 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 108.249 -1.019 . . . . 31.45 108.249 170.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -136.37 140.53 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.8 1.24 . . . . 73.42 108.593 -178.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.488 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 52.7 ttt85 -83.41 144.55 29.54 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.354 0.662 . . . . 74.14 110.9 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.588 HG13 ' HA2' ' A' ' 133' ' ' GLY . 6.3 pt -106.56 145.62 31.41 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 124.609 1.164 . . . . 74.13 108.359 167.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -70.95 143.12 44.27 Favored 'Trans proline' 0 C--N 1.369 1.647 0 C-N-CA 122.272 1.981 . . . . 60.34 111.428 170.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.4 97.5 0.12 Allowed 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 122.606 2.204 . . . . 74.15 110.485 170.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 106.03 66.21 0.66 Allowed Glycine 0 C--N 1.339 0.74 0 CA-C-N 115.675 -0.693 . . . . 75.51 111.837 -168.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.432 HG22 HG11 ' A' ' 178' ' ' VAL . 2.1 p -111.89 110.91 33.94 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 N-CA-C 107.999 -1.112 . . . . 75.43 107.999 175.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.51 ' HG3' ' HG ' ' A' ' 188' ' ' LEU . 0.0 OUTLIER -93.87 159.5 15.16 Favored 'General case' 0 C--O 1.205 -1.278 0 C-N-CA 124.09 0.956 . . . . 73.23 110.704 -165.633 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -50.89 119.01 3.52 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.934 1.294 . . . . 72.32 110.357 175.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 93.46 1.19 66.56 Favored Glycine 0 CA--C 1.534 1.252 0 CA-C-O 119.296 -0.725 . . . . 14.21 113.875 -179.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 12.7 t -72.19 126.53 30.02 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 108.458 -0.941 . . . . 74.23 108.458 178.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.572 HG22 HG22 ' A' ' 177' ' ' VAL . 48.4 t -102.38 105.46 18.14 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 C-N-CA 123.552 0.741 . . . . 72.34 110.416 -172.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.738 HD12 HH22 ' A' ' 136' ' ' ARG . 57.2 mt -76.3 102.23 3.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 107.777 -1.194 . . . . 75.24 107.777 166.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 58.1 ttt180 -74.42 101.06 3.99 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 107.798 -1.186 . . . . 61.32 107.798 172.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 6.2 p -124.41 95.57 42.98 Favored Pre-proline 0 CA--C 1.547 0.856 0 N-CA-C 109.448 -0.575 . . . . 61.33 109.448 177.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.507 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 28.9 Cg_endo -63.91 152.55 80.27 Favored 'Trans proline' 0 C--N 1.369 1.616 0 C-N-CA 121.963 1.776 . . . . 74.53 111.667 172.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.592 ' HA3' ' HA ' ' A' ' 86' ' ' SER . . . 105.12 -25.9 23.73 Favored Glycine 0 C--N 1.335 0.514 0 CA-C-N 116.043 -0.526 . . . . 70.43 113.628 176.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -103.61 0.05 30.28 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 117.331 0.566 . . . . 64.15 110.949 178.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.576 ' HA2' HD13 ' A' ' 174' ' ' LEU . . . -82.71 -129.65 1.36 Allowed Glycine 0 C--N 1.35 1.315 0 O-C-N 123.286 0.366 . . . . 73.33 113.904 -174.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -73.95 158.27 52.0 Favored Glycine 0 C--N 1.338 0.683 0 CA-C-N 115.507 -0.346 . . . . 74.5 113.089 -176.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -71.7 111.53 7.06 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.955 1.302 . . . . 75.42 112.09 -169.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -174.7 159.56 28.34 Favored Glycine 0 C--O 1.221 -0.661 0 CA-C-O 118.327 -1.263 . . . . 64.21 110.723 176.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . 0.597 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . 55.3 t30 -55.35 -56.64 26.69 Favored Pre-proline 0 N--CA 1.496 1.872 0 CA-C-N 118.262 1.031 . . . . 63.11 111.36 -169.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.597 ' HD3' ' HB3' ' A' ' 169' ' ' ASN . 3.3 Cg_endo -88.55 94.4 0.38 Allowed 'Trans proline' 0 C--N 1.386 2.545 0 N-CA-C 107.403 -1.807 . . . . 71.13 107.403 157.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -65.45 154.5 73.39 Favored 'Trans proline' 0 C--N 1.378 2.086 0 C-N-CA 122.111 1.874 . . . . 71.25 111.805 -167.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.436 ' HA3' ' O ' ' A' ' 117' ' ' ARG . . . -74.28 -179.55 41.08 Favored Glycine 0 C--O 1.241 0.559 0 N-CA-C 115.372 0.909 . . . . 72.4 115.372 -164.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.507 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 7.0 m-20 -74.59 108.58 7.44 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.105 0.962 . . . . 71.14 110.425 -173.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.576 HD13 ' HA2' ' A' ' 165' ' ' GLY . 21.9 tp -82.9 99.84 10.01 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 108.759 -0.83 . . . . 64.32 108.759 176.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 77.0 mt -74.77 89.15 2.28 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.206 -0.906 . . . . 72.12 109.188 174.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.473 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 65.9 mt -75.46 90.17 2.7 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.474 -0.784 . . . . 70.05 110.025 177.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.572 HG22 HG22 ' A' ' 158' ' ' VAL . 46.3 t -84.33 103.71 11.83 Favored 'Isoleucine or valine' 0 C--O 1.244 0.809 0 N-CA-C 107.234 -1.395 . . . . 61.43 107.234 175.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.432 HG11 HG22 ' A' ' 153' ' ' VAL . 11.6 p -70.27 118.63 15.06 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 CA-C-N 115.136 -0.938 . . . . 70.33 111.396 -173.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.643 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 35.4 mmt180 -98.94 104.52 16.57 Favored 'General case' 0 C--O 1.216 -0.706 0 N-CA-C 108.263 -1.014 . . . . 53.32 108.263 170.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.474 HD23 ' HB3' ' A' ' 125' ' ' LEU . 77.1 mt -69.23 142.48 54.19 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 118.7 0.682 . . . . 72.4 109.534 178.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 82.9 mt -54.17 161.56 1.86 Allowed Pre-proline 0 N--CA 1.486 1.348 0 C-N-CA 124.19 0.996 . . . . 73.14 112.939 -170.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -76.34 30.72 0.4 Allowed 'Trans proline' 0 C--N 1.383 2.382 0 C-N-CA 122.791 2.327 . . . . 71.42 111.982 164.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -64.59 115.49 20.73 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 125.976 1.71 . . . . 73.35 107.283 175.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -76.5 24.73 0.45 Allowed 'Trans proline' 0 N--CA 1.497 1.709 0 C-N-CA 123.474 2.783 . . . . 61.24 115.832 -161.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.419 HG12 ' CD1' ' A' ' 186' ' ' PHE . 51.0 t -106.99 -61.01 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 122.841 0.457 . . . . 64.21 110.446 -176.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . 0.552 ' HE2' HD13 ' A' ' 193' ' ' LEU . 2.9 m-30 -131.42 165.78 22.75 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.939 0.895 . . . . 72.31 110.792 -172.051 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 22.8 ttp85 -150.4 87.73 1.46 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 114.362 -1.29 . . . . 75.51 108.338 169.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.51 ' HG ' ' HG3' ' A' ' 154' ' ' ARG . 51.5 tp -62.23 104.81 0.52 Allowed 'General case' 0 C--O 1.207 -1.157 0 CA-C-N 115.141 -0.936 . . . . 74.21 108.776 174.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -136.44 132.93 36.08 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.068 1.347 . . . . 70.31 109.02 -171.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 82.72 -84.81 1.52 Allowed Glycine 0 C--N 1.35 1.32 0 N-CA-C 110.757 -0.937 . . . . 65.41 110.757 -177.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.61 ' HG2' ' HD2' ' A' ' 243' ' ' PRO . 0.9 OUTLIER -153.89 3.73 0.27 Allowed 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 125.158 1.383 . . . . 72.32 109.962 165.917 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.413 ' HB3' ' H ' ' A' ' 248' ' ' ASP . 2.5 p-10 -118.74 175.29 5.81 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.246 1.419 . . . . 72.32 109.809 -169.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.552 HD13 ' HE2' ' A' ' 186' ' ' PHE . 41.3 mt -114.75 126.16 54.53 Favored 'General case' 0 C--O 1.215 -0.762 0 C-N-CA 123.276 0.63 . . . . 63.44 110.544 -171.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -105.21 102.23 11.73 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.469 0.707 . . . . 73.14 109.437 174.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.58 ' HB3' HD23 ' A' ' 251' ' ' LEU . . . -108.28 156.46 19.35 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.946 -0.761 . . . . 74.34 108.946 172.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 57.0 m -93.6 123.57 37.01 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 109.036 -0.727 . . . . 70.21 109.036 178.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.514 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 32.5 tp -113.09 94.62 4.98 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 108.662 -0.866 . . . . 72.21 108.662 178.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -79.5 122.09 26.02 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 107.026 -1.472 . . . . 61.43 107.026 169.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 9.2 p -133.48 137.47 29.06 Favored Pre-proline 0 CA--C 1.545 0.765 0 N-CA-C 108.156 -1.053 . . . . 64.4 108.156 -177.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.75 159.51 48.34 Favored 'Trans proline' 0 C--N 1.36 1.183 0 C-N-CA 121.796 1.664 . . . . 64.51 111.5 173.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -56.32 -52.94 69.08 Favored Pre-proline 0 CA--C 1.555 1.146 0 CA-C-O 117.715 -1.136 . . . . 71.34 113.242 -172.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -59.3 -40.97 63.34 Favored 'Trans proline' 0 C--N 1.391 2.804 0 C-N-CA 122.03 1.82 . . . . 63.54 113.417 -179.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.534 HD11 ' HB3' ' C' ' 276' ' ' TYR . 36.0 mt -71.93 -31.42 40.65 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.962 0 C-N-CA 122.782 0.433 . . . . 64.32 110.368 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.71 -40.73 84.26 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-O 121.155 0.502 . . . . 71.51 110.606 174.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.521 HG13 HD11 ' C' ' 261' ' ' LEU . 48.4 t -71.21 -46.92 63.45 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 C-N-CA 124.189 0.995 . . . . 63.23 112.167 -176.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.503 HG21 ' HA ' ' C' ' 270' ' ' LYS . 94.6 t -98.92 -26.38 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 123.698 0.799 . . . . 74.41 111.574 -170.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 99.03 160.29 29.46 Favored Glycine 0 C--O 1.241 0.554 0 N-CA-C 110.941 -0.864 . . . . 72.35 110.941 -170.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.469 ' O ' HG12 ' A' ' 223' ' ' VAL . . . 162.18 168.37 23.99 Favored Glycine 0 N--CA 1.467 0.73 0 N-CA-C 111.84 -0.504 . . . . 55.24 111.84 177.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -99.62 117.65 34.46 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 117.068 0.434 . . . . 45.21 110.519 -175.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 35.9 m -121.71 162.46 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 124.136 0.974 . . . . 63.11 109.055 177.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -70.39 115.29 9.41 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 120.635 0.255 . . . . 71.41 110.96 -177.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -103.12 112.54 25.44 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 108.176 -1.046 . . . . 62.04 108.176 168.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -76.48 116.57 17.29 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 107.382 -1.34 . . . . 71.23 107.382 173.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . 0.408 ' HA ' ' CE1' ' A' ' 186' ' ' PHE . 72.8 p -118.79 167.92 11.24 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.804 0.442 . . . . 74.1 110.354 178.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 72.1 mt -66.2 -20.77 66.23 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.278 0.631 . . . . 63.31 111.595 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -91.29 -18.31 24.55 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 123.555 0.742 . . . . 64.44 111.562 177.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 147.34 170.63 15.73 Favored Glycine 0 C--N 1.36 1.909 0 CA-C-O 119.97 -0.35 . . . . 33.0 113.594 174.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.79 103.98 1.67 Allowed 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 122.482 2.122 . . . . 70.23 111.404 176.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 33.6 m -106.9 179.83 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 124.25 1.02 . . . . 73.4 110.444 -177.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -110.99 119.54 39.4 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.357 0.663 . . . . 75.04 109.248 173.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 7.2 p -96.85 121.0 46.91 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 N-CA-C 108.979 -0.749 . . . . 74.13 108.979 175.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -80.09 96.68 6.57 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.662 -0.866 . . . . 60.25 108.662 172.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.469 HG12 ' O ' ' A' ' 208' ' ' GLY . 10.7 p -68.35 132.72 91.4 Favored Pre-proline 0 CA--C 1.554 1.102 0 N-CA-C 108.916 -0.772 . . . . 63.14 108.916 178.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . 0.505 ' HG3' ' HB3' ' B' ' 443' ' ' ALA . 37.0 Cg_endo -64.39 163.55 26.3 Favored 'Trans proline' 0 C--N 1.374 1.875 0 C-N-CA 122.483 2.122 . . . . 75.51 112.455 174.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -64.77 163.9 26.21 Favored 'Trans proline' 0 C--N 1.37 1.664 0 C-N-CA 121.993 1.795 . . . . 72.53 112.95 169.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . 0.429 ' HD2' ' HB3' ' B' ' 446' ' ' PRO . 0.0 OUTLIER 41.25 67.78 0.5 Allowed 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 126.057 1.743 . . . . 74.04 112.824 -173.207 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.532 HG23 HD21 ' A' ' 233' ' ' LEU . 95.0 m -101.68 103.01 13.77 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 114.407 -1.27 . . . . 64.32 109.224 177.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . 0.813 ' HB3' ' HD3' ' A' ' 231' ' ' ARG . 5.5 tp-100 -87.18 145.96 26.2 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.166 0.986 . . . . 75.32 111.784 -172.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -73.15 143.42 47.29 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.975 0.91 . . . . 62.31 111.267 179.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 85.26 -0.59 88.73 Favored Glycine 0 C--N 1.348 1.233 0 CA-C-N 115.787 -0.642 . . . . 73.32 113.103 -178.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.813 ' HD3' ' HB3' ' A' ' 228' ' ' GLN . 78.7 mtp180 -112.03 162.49 15.33 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.536 1.134 . . . . 74.0 108.949 176.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.414 ' HB3' ' HG2' ' A' ' 252' ' ' GLU . 49.6 pttt -129.63 136.31 49.6 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 122.902 0.481 . . . . 72.22 110.389 -171.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.532 HD21 HG23 ' A' ' 227' ' ' THR . 26.3 mt -86.72 110.97 20.26 Favored 'General case' 0 C--O 1.212 -0.882 0 CA-C-N 115.281 -0.872 . . . . 71.4 110.133 -172.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -77.22 106.94 9.26 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.01 0.524 . . . . 64.14 110.25 175.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.706 HD22 ' HA ' ' B' ' 441' ' ' ILE . 8.5 mt -101.68 93.54 5.39 Favored 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 108.454 -0.943 . . . . 61.12 108.454 172.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.512 ' HG3' ' HB2' ' B' ' 457' ' ' GLN . 4.5 tmtm? -73.67 117.97 16.06 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.437 0.695 . . . . 64.43 111.939 -164.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 101.45 32.16 5.27 Favored Glycine 0 C--N 1.347 1.157 0 CA-C-N 115.813 -0.63 . . . . 74.2 112.614 175.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 2.8 mmmt -117.26 -28.19 6.23 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.941 0.896 . . . . 73.01 111.229 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -79.0 -166.87 32.04 Favored Glycine 0 C--N 1.342 0.915 0 O-C-N 123.663 0.602 . . . . 74.43 113.256 174.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -97.59 158.97 32.15 Favored Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 123.565 0.746 . . . . 73.13 110.333 -173.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.535 ' HD3' ' HA ' ' B' ' 421' ' ' VAL . 32.0 Cg_endo -58.64 151.92 59.57 Favored 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 122.656 2.237 . . . . 73.33 113.322 -173.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -173.88 -163.42 27.32 Favored Glycine 0 C--N 1.341 0.816 0 CA-C-N 115.65 -0.705 . . . . 73.52 113.761 177.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . 0.61 ' HD2' ' HG2' ' A' ' 191' ' ' GLN . 73.4 Cg_endo -70.8 -5.86 17.81 Favored 'Trans proline' 0 C--N 1.373 1.862 0 C-N-CA 123.708 2.939 . . . . 70.45 113.613 -179.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -103.94 23.12 13.38 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.74 0.816 . . . . 70.11 109.954 171.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 82.37 -84.44 1.51 Allowed Glycine 0 C--N 1.351 1.4 0 N-CA-C 110.78 -0.928 . . . . 62.24 110.78 -177.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 50.2 mtm180 -125.68 144.64 50.51 Favored 'General case' 0 C--O 1.246 0.871 0 N-CA-C 108.348 -0.982 . . . . 75.41 108.348 171.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -65.79 166.82 35.11 Favored Glycine 0 N--CA 1.448 -0.552 0 O-C-N 123.979 0.799 . . . . 42.24 113.457 176.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . 0.413 ' H ' ' HB3' ' A' ' 192' ' ' ASP . 4.1 m-20 -110.91 -178.31 3.44 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 123.776 0.831 . . . . 75.44 108.89 -179.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.497 HD23 HD12 ' A' ' 235' ' ' LEU . 31.1 tp -118.63 96.53 5.32 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 107.875 -1.157 . . . . 70.31 107.875 169.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -79.69 109.52 14.17 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.285 1.034 . . . . 52.51 109.79 175.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.58 HD23 ' HB3' ' A' ' 195' ' ' ALA . 89.7 mt -97.88 97.86 9.31 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.5 -0.773 . . . . 72.24 109.483 177.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.414 ' HG2' ' HB3' ' A' ' 232' ' ' LYS . 28.7 mt-10 -75.61 115.97 15.84 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.374 0.67 . . . . 75.41 109.611 -176.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 91.7 t -86.43 132.89 31.11 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 C-N-CA 125.468 1.507 . . . . 24.43 113.06 -163.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -130.07 107.04 9.03 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.19 1.396 . . . . 73.14 108.565 173.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.538 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 73.4 mt -84.01 130.74 35.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 123.257 0.623 . . . . 74.34 111.016 -176.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 20.3 p -119.1 174.15 6.49 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.497 1.119 . . . . 73.43 109.844 173.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.418 ' HB ' ' HD2' ' A' ' 258' ' ' PRO . 2.9 pp -136.13 154.91 77.72 Favored Pre-proline 0 CA--C 1.566 1.576 0 C-N-CA 123.696 0.798 . . . . 73.4 109.938 -179.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . 0.418 ' HD2' ' HB ' ' A' ' 257' ' ' ILE . 49.1 Cg_endo -64.67 -5.56 10.53 Favored 'Trans proline' 0 C--N 1.385 2.493 0 C-N-CA 123.457 2.771 . . . . 74.45 116.1 -163.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.503 ' HG2' ' NE2' ' C' ' 228' ' ' GLN . 31.4 mt-10 52.42 -87.37 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.422 0 C-N-CA 124.122 0.969 . . . . 63.24 112.728 -170.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.27 132.84 47.83 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 109.935 -0.394 . . . . 75.12 109.935 -177.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.401 HD21 ' HG2' ' A' ' 258' ' ' PRO . 97.5 mt -130.93 134.62 46.91 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.702 0.801 . . . . 55.32 110.575 -177.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 19.1 p -84.16 146.26 47.87 Favored Pre-proline 0 CA--C 1.545 0.788 0 CA-C-O 117.874 -1.06 . . . . 44.34 108.841 169.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -30.94 -42.98 0.11 Allowed 'Trans proline' 0 C--N 1.39 2.731 1 C-N-CA 126.062 4.508 . . . . 74.33 116.569 -172.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -64.59 -64.3 0.91 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.25 0.62 . . . . 71.44 110.99 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -61.48 -32.49 72.5 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.086 0.954 . . . . 64.2 110.866 -178.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -53.48 -52.95 57.89 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.779 1.231 . . . . 73.45 109.847 174.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . 0.406 ' O ' ' HG3' ' A' ' 271' ' ' LYS . . . -65.69 -41.72 92.07 Favored 'General case' 0 C--O 1.214 -0.795 0 CA-C-N 114.923 -1.035 . . . . 64.12 111.585 178.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 10.9 mp -57.24 -47.0 82.47 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 123.071 0.548 . . . . 73.14 111.544 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -64.89 -40.76 95.6 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 123.755 0.659 . . . . 75.0 111.091 178.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . 0.469 ' HE2' ' HA ' ' C' ' 206' ' ' VAL . 1.5 mptm? -71.68 -25.33 62.06 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.093 0.557 . . . . 62.43 111.98 178.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . 0.406 ' HG3' ' O ' ' A' ' 267' ' ' ALA . 97.1 mttt -73.75 -48.82 28.99 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.873 -0.788 . . . . 70.22 108.873 176.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 72.6 mt -55.28 -40.96 71.62 Favored 'General case' 0 C--O 1.198 -1.641 0 O-C-N 124.774 1.296 . . . . 63.4 109.992 172.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -65.79 -55.51 16.8 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.056 0.942 . . . . 64.51 113.105 -174.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -66.57 -43.75 84.16 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 123.787 0.679 . . . . 74.35 110.76 -176.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -62.59 -47.95 81.59 Favored 'General case' 0 C--N 1.355 0.82 0 O-C-N 123.944 0.778 . . . . 71.44 110.285 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -62.75 -45.77 91.14 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.729 0.812 . . . . 75.02 110.945 -177.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -66.82 -40.04 87.89 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 123.519 0.512 . . . . 70.12 110.103 -176.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -66.62 -17.86 65.06 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 115.824 -0.625 . . . . 75.41 111.579 174.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . 0.459 ' HG2' ' HA ' ' B' ' 278' ' ' LEU . 82.6 mtt180 -117.76 20.05 13.56 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.134 0.974 . . . . 74.13 109.733 178.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.845 0 N-CA-C 109.173 -0.677 . . . . 72.21 109.173 179.193 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 63.7 mtt . . . . . 0 N--CA 1.483 1.182 0 N-CA-C 109.104 -0.702 . . . . 71.44 109.104 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -82.06 126.65 32.25 Favored 'General case' 0 C--N 1.353 0.733 0 N-CA-C 108.649 -0.871 . . . . 54.1 108.649 172.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -106.34 37.49 2.28 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.137 0.575 . . . . 74.04 110.095 -176.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 55.2 m -53.89 -3.51 0.04 OUTLIER 'General case' 0 CA--C 1.565 1.535 0 N-CA-C 117.31 2.337 . . . . 52.14 117.31 -162.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 16.9 m -132.27 147.6 52.41 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 119.316 0.962 . . . . 70.11 110.291 171.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 15.1 pt -138.23 169.59 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 123.85 0.86 . . . . 64.44 112.384 -164.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -131.51 147.68 52.56 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 124.21 1.004 . . . . 72.01 109.672 176.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 15.2 tp -85.51 157.0 20.54 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.863 0.865 . . . . 75.22 110.918 -172.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.44 -59.52 2.67 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.322 0.649 . . . . 62.4 111.81 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 66.1 mt 61.12 18.1 8.72 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.863 1.265 . . . . 74.1 111.911 -165.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 64.5 mt 58.69 79.53 0.31 Allowed Pre-proline 0 N--CA 1.485 1.309 0 C-N-CA 124.771 1.228 . . . . 45.35 112.116 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -89.05 -84.17 0.0 OUTLIER 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 122.964 2.443 . . . . 61.33 112.422 176.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 41.8 mt -131.59 -165.26 1.55 Allowed 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 124.406 1.083 . . . . 75.01 109.946 178.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 10.4 tp -95.85 -177.67 4.11 Favored 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 123.763 0.825 . . . . 64.54 109.66 179.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -91.32 170.81 9.68 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.611 0.764 . . . . 60.01 111.585 -173.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 61.6 p -85.92 135.65 37.35 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 124.006 0.922 . . . . 51.11 110.132 176.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 17' ' ' PRO . . . . . 0.651 ' HG3' ' HA ' ' B' ' 366' ' ' ASP . 60.4 Cg_endo -66.93 97.36 0.4 Allowed 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 123.26 2.64 . . . . 62.42 113.08 -175.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 47.7 t -77.66 -35.75 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 124.17 0.988 . . . . 61.41 109.713 177.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 50.0 p -70.77 -23.37 62.39 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.865 0.866 . . . . 71.22 111.097 173.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 20' ' ' LYS . . . . . 0.59 ' HA ' ' HE3' ' B' ' 20' ' ' LYS . 0.4 OUTLIER 75.43 -64.04 0.39 Allowed 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 126.411 1.884 . . . . 62.34 111.828 179.551 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 66.34 99.56 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.919 1.288 . . . . 75.34 112.361 175.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 84.0 mmt-85 -131.29 162.48 29.96 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.254 1.022 . . . . 73.31 109.219 173.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 23' ' ' THR . . . . . 0.466 ' HA ' ' HD3' ' B' ' 24' ' ' PRO . 26.1 m -66.52 107.48 1.65 Allowed Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 123.592 0.757 . . . . 72.45 109.394 176.052 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' B' ' 23' ' ' THR . 5.9 Cg_exo -76.55 -71.47 0.01 OUTLIER 'Trans proline' 0 C--N 1.371 1.756 0 C-N-CA 122.907 2.404 . . . . 74.55 113.886 -166.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -85.79 160.09 19.58 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-O 121.27 0.557 . . . . 74.53 110.835 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 13.3 tpt -93.5 116.67 66.79 Favored Pre-proline 0 C--O 1.242 0.681 0 N-CA-C 108.203 -1.036 . . . . 75.13 108.203 169.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -61.73 84.47 0.09 OUTLIER 'Trans proline' 0 C--N 1.374 1.904 0 C-N-CA 123.48 2.787 . . . . 71.1 113.053 178.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 34.0 m -101.81 -13.63 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 124.281 1.032 . . . . 73.51 110.633 176.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 3.5 tt 64.78 -107.06 0.15 Allowed 'General case' 0 CA--C 1.562 1.437 0 C-N-CA 124.718 1.207 . . . . 62.2 108.453 -172.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 58.36 168.63 0.05 Allowed 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 125.039 1.336 . . . . 70.24 112.048 -177.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 31' ' ' ASN . . . . . 0.43 ' ND2' ' HB2' ' C' ' 236' ' ' LYS . 68.4 m-20 80.3 -49.78 0.34 Allowed 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 126.194 1.798 . . . . 74.34 111.174 177.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 71.81 -52.79 0.69 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 126.736 2.015 . . . . 72.22 110.524 -172.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . 0.668 ' HB3' ' HE2' ' C' ' 238' ' ' LYS . . . 72.74 105.93 0.07 Allowed 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 125.217 1.407 . . . . 73.31 110.323 170.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . 76.99 -52.15 0.57 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 126.502 1.921 . . . . 53.33 110.279 -164.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 68.52 -6.16 0.85 Allowed 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 125.286 1.435 . . . . 73.13 112.674 174.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -172.65 157.58 27.1 Favored Glycine 0 C--N 1.34 0.804 0 O-C-N 122.067 -0.396 . . . . 74.33 112.349 -174.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . 0.436 ' HB2' HG23 ' B' ' 165' ' ' THR . 36.7 t0 -76.24 157.9 32.14 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 124.584 1.154 . . . . 61.44 109.946 177.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 16.8 tt -64.87 -23.46 33.47 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.299 0 C-N-CA 124.432 1.093 . . . . 75.44 111.328 174.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . 0.669 ' HB ' HD21 ' B' ' 167' ' ' ASN . 53.4 m -141.33 -51.89 0.44 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.477 0.711 . . . . 64.25 110.97 -178.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . 0.321 . . 99.57 -72.73 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.678 0 C-N-CA 127.524 2.33 . . . . 64.0 112.6 -176.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.06 114.84 4.03 Favored 'Trans proline' 0 C--N 1.398 3.156 0 CA-C-N 122.793 2.033 . . . . 72.44 112.417 178.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 179.3 -42.17 0.08 OUTLIER Glycine 0 C--N 1.349 1.271 0 CA-C-N 115.876 -0.602 . . . . 45.24 112.43 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.7 -172.02 32.33 Favored Glycine 0 C--N 1.348 1.244 0 C-N-CA 122.754 0.216 . . . . 42.15 113.319 176.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.68 -13.73 59.82 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.306 1.043 . . . . 63.2 112.254 -177.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.741 ' HG2' ' HG3' ' B' ' 46' ' ' ARG . 56.2 ttp180 75.92 -74.06 0.08 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.461 1.504 . . . . 74.21 111.764 176.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 46' ' ' ARG . . . . . 0.741 ' HG3' ' HG2' ' B' ' 45' ' ' ARG . 82.3 mtp180 -127.86 -176.55 3.81 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 123.726 0.81 . . . . 75.02 110.501 -177.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -159.74 157.77 30.05 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.473 0.709 . . . . 53.22 110.681 -178.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.455 ' OG1' ' HA ' ' B' ' 193' ' ' PRO . 1.4 t -163.25 -64.4 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.731 0.812 . . . . 51.22 110.8 178.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . 0.432 ' H ' HG23 ' B' ' 48' ' ' THR . . . 73.98 -77.33 0.98 Allowed Glycine 0 C--N 1.349 1.263 0 CA-C-N 116.607 -0.27 . . . . 74.15 113.186 -176.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -85.24 160.68 19.82 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.017 0.927 . . . . 64.2 111.173 -174.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -99.24 -26.34 14.21 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 114.711 -1.131 . . . . 75.3 109.812 167.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 12.6 t -174.85 170.17 3.35 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.02 0.928 . . . . 73.31 110.319 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . 0.582 ' HB3' ' HB2' ' B' ' 190' ' ' CYS . . . -166.56 139.03 3.71 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.5 1.12 . . . . 73.24 108.793 174.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -136.05 -88.6 0.32 Allowed 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 123.558 0.743 . . . . 75.51 111.848 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 1.1 tt -93.58 64.83 3.64 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.423 0.689 . . . . 72.35 110.104 -171.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . 0.473 ' HA ' ' HG3' ' B' ' 188' ' ' ARG . 66.0 mtt-85 73.95 -40.1 0.45 Allowed 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 125.655 1.582 . . . . 73.2 113.614 175.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 63.53 9.3 4.12 Favored 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 124.914 1.286 . . . . 75.31 112.537 169.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . 0.631 ' HB2' ' HB3' ' C' ' 122' ' ' GLU . 24.0 p -104.87 85.28 2.27 Favored 'General case' 0 C--O 1.243 0.731 0 C-N-CA 125.123 1.369 . . . . 62.01 109.723 -170.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -123.8 -49.52 1.86 Allowed 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 115.261 -0.881 . . . . 72.44 109.819 -177.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 67.6 m 62.5 -175.49 0.14 Allowed 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 124.473 1.109 . . . . 63.51 111.383 -166.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.19 -10.65 27.59 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.891 0.876 . . . . 71.45 110.487 -178.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 62' ' ' LYS . . . . . 0.581 ' HB3' ' HE2' ' B' ' 303' ' ' LYS . 1.2 tmtp? -164.57 142.78 5.54 Favored Pre-proline 0 CA--C 1.555 1.147 0 N-CA-C 106.944 -1.502 . . . . 72.3 106.944 -175.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -66.99 27.32 0.11 Allowed 'Trans proline' 0 C--N 1.39 2.735 0 C-N-CA 123.463 2.775 . . . . 72.24 115.736 175.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . 0.657 ' HB1' ' HB ' ' C' ' 158' ' ' VAL . . . 68.89 -86.01 0.03 OUTLIER 'General case' 0 C--N 1.355 0.836 0 C-N-CA 125.718 1.607 . . . . 72.04 112.342 176.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? 52.15 -99.97 0.09 Allowed 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 117.844 -1.074 . . . . 65.32 110.465 -171.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 49.0 -74.08 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 126.144 1.778 . . . . 72.41 115.521 173.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . 0.564 HG13 HG12 ' B' ' 68' ' ' ILE . 7.7 pt 61.31 172.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 127.171 2.188 . . . . 72.03 112.413 -174.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . 0.564 HG12 HG13 ' B' ' 67' ' ' ILE . 49.7 mm 73.77 148.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 C-N-CA 124.73 1.212 . . . . 73.4 111.287 -178.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.479 ' HB3' ' HA2' ' C' ' 190' ' ' GLY . 87.5 mt 65.65 75.33 0.35 Allowed 'General case' 0 C--N 1.359 0.979 0 C-N-CA 124.999 1.32 . . . . 73.12 110.925 -178.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . 0.412 HD23 HE22 ' B' ' 360' ' ' GLN . 46.3 tp -163.46 -62.76 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 114.937 -1.029 . . . . 44.44 108.623 -179.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . 0.502 HD12 ' HB3' ' C' ' 243' ' ' PRO 0.264 0.0 OUTLIER 39.86 -70.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 C-N-CA 127.737 2.415 . . . . 74.32 115.755 177.09 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 162.18 -162.53 34.32 Favored Glycine 0 C--N 1.341 0.846 0 N-CA-C 111.246 -0.742 . . . . 62.21 111.246 -175.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -124.77 158.59 32.94 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.787 0.835 . . . . 63.44 109.992 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.37 -6.22 61.23 Favored Glycine 0 C--N 1.35 1.331 0 O-C-N 123.848 0.717 . . . . 64.42 113.163 172.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 65.5 mtt 78.01 -56.53 0.49 Allowed 'General case' 0 C--N 1.366 1.291 0 C-N-CA 126.689 1.996 . . . . 74.01 111.452 176.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 86.99 0.23 85.72 Favored Glycine 0 C--N 1.346 1.12 0 CA-C-O 119.738 -0.479 . . . . 71.13 112.85 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 4.7 t70 63.35 -157.84 0.32 Allowed 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 124.759 1.224 . . . . 73.03 109.518 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 17.2 t 67.69 78.17 0.24 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.099 1.36 . . . . 51.1 110.947 176.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.77 167.01 20.83 Favored 'General case' 0 CA--C 1.553 1.096 0 CA-C-N 114.576 -1.193 . . . . 74.44 109.622 177.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.617 HG22 HG22 ' B' ' 81' ' ' THR . 3.4 mp 66.27 -81.28 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.563 1.452 0 C-N-CA 124.842 1.257 . . . . 72.52 110.036 -175.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . 0.617 HG22 HG22 ' B' ' 80' ' ' ILE . 12.6 t -166.41 175.39 8.19 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.174 0.989 . . . . 71.34 109.697 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -147.75 17.03 1.13 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.124 0.97 . . . . 61.11 110.515 175.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -95.24 178.3 5.57 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.498 0.719 . . . . 71.35 111.479 -175.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 68.2 -78.98 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.796 1.639 . . . . 73.0 111.691 178.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 59.45 -80.91 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 125.045 1.338 . . . . 72.23 111.327 -178.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -142.63 95.03 2.72 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 107.441 -1.318 . . . . 63.12 107.441 -174.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . 0.477 ' HA ' HD21 ' B' ' 155' ' ' LEU . . . -143.96 35.45 1.25 Allowed 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.08 0.466 . . . . 52.24 111.231 -171.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -155.33 139.67 16.71 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 115.662 -0.699 . . . . 74.14 109.954 -177.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -88.88 -52.24 2.83 Favored Glycine 0 C--N 1.348 1.238 0 CA-C-N 116.225 -0.443 . . . . 54.33 112.101 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . 70.54 -67.04 0.26 Allowed 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 125.233 1.413 . . . . 62.33 112.43 175.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -67.34 -4.26 29.35 Favored Glycine 0 N--CA 1.48 1.623 0 N-CA-C 114.561 0.584 . . . . 70.11 114.561 177.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -63.16 -28.0 71.47 Favored Glycine 0 C--N 1.353 1.516 0 C-N-CA 123.071 0.367 . . . . 23.53 112.72 176.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -66.29 -45.66 79.63 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.892 0.477 . . . . 74.22 110.351 177.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -67.19 -39.05 86.3 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.582 -0.735 . . . . 71.21 110.759 -178.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -79.97 6.06 12.32 Favored 'General case' 0 CA--C 1.565 1.528 0 C-N-CA 123.829 0.852 . . . . 74.14 110.87 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . -81.41 24.13 4.39 Favored Glycine 0 C--N 1.357 1.713 0 N-CA-C 114.685 0.634 . . . . 72.31 114.685 177.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 39.4 mm -116.72 -33.99 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 124.217 1.007 . . . . 72.22 109.512 175.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -132.85 138.69 47.14 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.732 0.813 . . . . 75.21 110.229 -175.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -103.71 -4.17 24.06 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.027 0.931 . . . . 61.12 111.35 177.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 59.74 69.83 1.18 Allowed Pre-proline 0 CA--C 1.557 1.24 0 C-N-CA 125.777 1.631 . . . . 74.2 110.152 -169.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -91.54 -172.95 0.48 Allowed 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 123.494 2.796 . . . . 72.21 111.071 170.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -66.53 135.44 54.2 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 108.732 -0.84 . . . . 73.12 108.732 173.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 19.7 p -72.11 108.62 5.4 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.741 0.817 . . . . 75.52 110.301 177.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 113.56 -3.12 24.81 Favored Glycine 0 N--CA 1.469 0.851 0 CA-C-N 115.871 -0.604 . . . . 51.35 111.703 -170.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 105' ' ' GLN . . . . . 0.482 HE21 ' HG ' ' B' ' 111' ' ' LEU . 52.8 tt0 -107.76 -82.7 0.55 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.063 0.945 . . . . 75.22 109.121 178.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 47.98 -93.1 0.02 OUTLIER 'General case' 0 C--N 1.367 1.354 0 C-N-CA 124.305 1.042 . . . . 74.44 111.534 -172.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 30.4 p -123.86 119.33 29.33 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.444 -1.317 . . . . 63.32 107.444 171.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -156.71 88.22 1.04 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 122.513 0.325 . . . . 71.44 110.803 -176.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.751 ' HA ' ' HA ' ' B' ' 114' ' ' LYS . 75.8 m-85 47.2 -79.51 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 126.777 2.031 . . . . 53.33 115.501 168.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.0 -29.61 70.75 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.145 0.978 . . . . 71.24 112.38 -174.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . 0.482 ' HG ' HE21 ' B' ' 105' ' ' GLN . 3.0 mm? -84.84 -5.69 59.34 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.469 0.707 . . . . 64.15 111.595 -178.013 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -135.99 -164.36 1.54 Allowed 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.274 1.03 . . . . 73.2 110.0 -174.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 113' ' ' LYS . . . . . 0.537 ' HE3' ' HA ' ' B' ' 113' ' ' LYS . 0.7 OUTLIER -91.94 36.79 0.97 Allowed 'General case' 0 CA--C 1.555 1.17 0 CA-C-O 121.721 0.772 . . . . 75.13 109.354 170.302 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 114' ' ' LYS . . . . . 0.751 ' HA ' ' HA ' ' B' ' 109' ' ' TYR . 96.6 mttt 58.93 15.06 3.66 Favored 'General case' 0 C--N 1.364 1.201 0 C-N-CA 125.093 1.357 . . . . 74.01 112.745 -177.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 16.3 m 65.48 -8.49 0.28 Allowed 'General case' 0 CA--C 1.566 1.592 0 C-N-CA 125.351 1.46 . . . . 73.23 113.066 -176.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -73.89 -20.79 79.73 Favored Glycine 0 C--N 1.358 1.794 0 O-C-N 122.043 -0.41 . . . . 55.33 112.985 -174.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 4.9 ttmp? -149.13 79.56 8.28 Favored Pre-proline 0 CA--C 1.548 0.901 0 N-CA-C 108.799 -0.815 . . . . 70.25 108.799 176.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 118' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -66.62 -32.46 38.51 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.319 2.013 . . . . 60.53 111.977 179.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 119' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -168.04 162.95 13.48 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.618 0.767 . . . . 75.33 110.228 177.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 120' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -130.7 117.37 19.35 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 106.989 -1.486 . . . . 70.1 106.989 169.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 7.4 p -57.34 -36.17 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 113.727 1.01 . . . . 74.32 113.727 -167.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 14.1 m -73.97 -36.57 64.57 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.871 0.468 . . . . 75.24 111.3 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -105.71 18.61 21.89 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.263 1.025 . . . . 64.3 111.61 -175.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 63.8 p -65.51 116.51 6.86 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.265 0.626 . . . . 43.31 110.045 178.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . 0.401 ' HB2' HG22 ' B' ' 259' ' ' VAL . . . -77.59 71.38 4.07 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-O 121.942 0.877 . . . . 73.02 110.285 -178.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -160.95 -68.32 0.06 Allowed 'General case' 0 C--O 1.24 0.569 0 CA-C-N 114.596 -1.184 . . . . 74.13 108.358 -174.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 20.0 m 59.62 -76.28 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.519 1.528 . . . . 70.01 111.425 -176.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -124.1 119.01 28.24 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 124.696 1.198 . . . . 72.01 108.078 173.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 25.1 p -105.71 82.7 1.83 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.602 0.761 . . . . 54.34 111.195 -176.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . 63.03 -168.24 0.2 Allowed 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 124.08 0.952 . . . . 44.22 112.86 175.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 16.8 m-90 -125.14 138.64 54.15 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.574 1.149 . . . . 73.51 108.325 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 59.1 p 53.81 -78.0 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 125.622 1.569 . . . . 51.4 113.796 177.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 5.8 m 70.98 7.18 6.13 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.921 1.288 . . . . 62.25 112.836 171.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 70.68 35.93 67.1 Favored Glycine 0 C--N 1.355 1.607 0 N-CA-C 111.705 -0.558 . . . . 55.15 111.705 -177.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 135' ' ' VAL . . . . . . . . . . . . . 36.6 t 62.24 112.86 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.466 1.506 . . . . 73.24 110.409 -165.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -60.68 -59.1 5.93 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.244 1.018 . . . . 52.43 110.934 -173.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 4.7 m 62.39 -77.38 0.03 OUTLIER 'General case' 0 CA--C 1.56 1.332 0 C-N-CA 125.134 1.374 . . . . 75.31 111.133 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -165.52 26.41 0.05 Allowed 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 124.86 1.264 . . . . 75.52 110.134 174.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -60.59 -38.87 86.06 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.858 0.863 . . . . 73.24 112.646 -168.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -91.91 -1.32 70.51 Favored Glycine 0 C--N 1.347 1.158 0 CA-C-O 119.897 -0.391 . . . . 65.04 113.076 178.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -92.74 -47.29 7.15 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.726 0.81 . . . . 75.34 110.522 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 84.1 mt -100.61 -55.7 2.52 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.263 0.625 . . . . 70.15 110.28 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 67.56 -108.73 2.56 Favored Glycine 0 C--N 1.347 1.15 0 N-CA-C 111.374 -0.69 . . . . 61.25 111.374 -175.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 21.0 m 43.4 33.71 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 C-N-CA 126.778 2.031 . . . . 75.31 113.927 176.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 75.15 -34.93 0.27 Allowed 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 126.023 1.729 . . . . 64.3 112.442 -176.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . 0.532 HG13 ' H ' ' B' ' 147' ' ' HIS . 3.5 tp 55.09 -170.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.562 1.405 0 C-N-CA 126.607 1.963 . . . . 72.52 111.982 -177.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 147' ' ' HIS . . . . . 0.532 ' H ' HG13 ' B' ' 146' ' ' ILE . 0.2 OUTLIER 83.03 -17.27 0.52 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.084 1.354 . . . . 72.43 112.02 172.81 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 64.83 -84.77 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 125.055 1.342 . . . . 73.05 112.806 168.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 149' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -74.56 -42.77 58.2 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.585 0.754 . . . . 72.23 110.436 -174.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -67.34 -64.1 0.93 Allowed 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.007 -0.997 . . . . 74.11 108.843 174.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 151' ' ' HIS . . . . . 0.416 ' H ' ' HB3' ' B' ' 147' ' ' HIS . 55.6 t-80 51.65 89.73 0.09 OUTLIER Pre-proline 0 CA--C 1.551 1.016 0 O-C-N 124.982 1.426 . . . . 74.43 112.185 178.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -88.0 -163.44 0.16 Allowed 'Trans proline' 0 C--N 1.363 1.318 0 C-N-CA 122.295 1.997 . . . . 42.51 109.928 171.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 14.4 m -91.09 153.11 20.32 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 107.639 -1.245 . . . . 74.2 107.639 164.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 23.3 pt -46.77 118.26 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 123.818 0.847 . . . . 74.25 110.957 178.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 155' ' ' LEU . . . . . 0.477 HD21 ' HA ' ' B' ' 87' ' ' ALA . 45.6 tp -63.66 98.7 0.19 Allowed 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.465 -0.789 . . . . 72.1 111.408 -166.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -117.7 161.22 20.04 Favored 'General case' 0 C--O 1.245 0.816 0 CA-C-N 114.816 -1.084 . . . . 72.23 108.713 175.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 157' ' ' MET . . . . . 0.453 ' N ' ' SD ' ' B' ' 157' ' ' MET . 1.4 mpt? -75.92 87.88 2.9 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.884 0.874 . . . . 53.54 109.912 -173.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 158' ' ' ALA . . . . . . . . . . . . . . . -125.54 -77.61 0.59 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.476 0.71 . . . . 34.04 109.715 178.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -98.46 -2.38 39.12 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.021 0.928 . . . . 55.45 110.806 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -129.24 172.2 11.69 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.254 0.621 . . . . 70.22 111.753 -169.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . 69.2 -69.68 0.16 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.929 1.692 . . . . 71.1 111.785 -176.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 81.78 151.38 8.83 Favored Glycine 0 CA--C 1.534 1.254 0 N-CA-C 113.939 0.336 . . . . 73.4 113.939 174.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 91.1 mt -80.08 -168.63 1.71 Allowed 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.686 0.794 . . . . 65.02 110.496 174.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 164' ' ' ALA . . . . . . . . . . . . . . . 68.82 26.43 5.97 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.448 1.099 . . . . 75.34 111.065 -173.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 165' ' ' THR . . . . . 0.436 HG23 ' HB2' ' B' ' 37' ' ' ASP . 9.8 t -172.83 171.62 4.3 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.592 1.157 . . . . 64.15 109.828 -177.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . 174.66 52.26 0.05 OUTLIER Glycine 0 C--N 1.343 0.949 0 N-CA-C 110.653 -0.979 . . . . 71.15 110.653 -177.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 167' ' ' ASN . . . . . 0.669 HD21 ' HB ' ' B' ' 39' ' ' THR . 0.1 OUTLIER -54.54 132.97 45.99 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.516 1.126 . . . . 72.31 112.84 -165.238 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 39.4 t 73.94 -38.79 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 C-N-CA 126.406 1.883 . . . . 74.13 112.16 -178.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 37.1 m -78.54 -1.84 35.88 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 124.144 0.977 . . . . 54.35 111.169 173.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 8.5 p -67.37 157.63 33.62 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 123.698 0.799 . . . . 63.1 111.453 172.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -123.17 102.21 7.83 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 107.244 -1.391 . . . . 53.32 107.244 171.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 172' ' ' GLU . . . . . 0.413 ' HA ' ' OE1' ' B' ' 174' ' ' GLN . 2.5 mp0 -71.85 89.76 1.08 Allowed 'General case' 0 N--CA 1.472 0.672 0 O-C-N 123.958 0.786 . . . . 73.22 112.575 -169.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 173' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -113.17 8.63 18.29 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 114.4 -1.273 . . . . 74.23 108.459 162.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 174' ' ' GLN . . . . . 0.413 ' OE1' ' HA ' ' B' ' 172' ' ' GLU . 22.7 mp0 -94.95 156.88 16.15 Favored 'General case' 0 C--N 1.352 0.708 0 C-N-CA 125.203 1.401 . . . . 74.45 109.516 -177.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 175' ' ' ASP . . . . . 0.58 ' H ' HG21 ' C' ' 126' ' ' THR . 11.5 t70 179.06 105.6 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.418 1.087 . . . . 74.1 109.302 -175.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -97.67 25.98 5.4 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.153 0.581 . . . . 74.11 110.96 178.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 177' ' ' THR . . . . . 0.499 ' N ' ' HD2' ' B' ' 178' ' ' PRO . 9.2 m -78.94 -30.8 0.68 Allowed Pre-proline 0 CA--C 1.573 1.838 0 CA-C-O 116.534 -1.698 . . . . 64.31 115.061 -176.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 178' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' B' ' 177' ' ' THR . 10.3 Cg_endo -50.57 -42.17 50.44 Favored 'Trans proline' 1 C--N 1.417 4.147 0 CA-C-N 123.023 2.115 . . . . 74.53 112.271 -178.539 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -176.23 -172.22 0.47 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.119 1.368 . . . . 61.34 108.843 173.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . -66.11 -35.22 79.91 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 109.368 -0.604 . . . . 74.4 109.368 166.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 181' ' ' LEU . . . . . 0.527 ' HB2' ' HB3' ' C' ' 136' ' ' ARG . 58.0 tp -159.79 -69.95 0.08 Allowed 'General case' 0 C--N 1.353 0.726 0 CA-C-N 115.816 -0.629 . . . . 62.04 111.186 -176.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 182' ' ' VAL . . . . . 0.523 HG11 ' H ' ' C' ' 139' ' ' GLU . 8.2 p -79.93 150.43 4.96 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 CA-C-N 115.355 -0.839 . . . . 71.31 112.711 -163.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -119.67 38.17 3.98 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.909 0.883 . . . . 65.24 109.278 171.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 184' ' ' HIS . . . . . 0.401 ' H ' HG22 ' B' ' 182' ' ' VAL . 35.7 m80 56.85 -87.11 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.723 1.209 . . . . 74.15 110.589 -171.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 185' ' ' VAL . . . . . 0.559 HG23 ' HA ' ' C' ' 121' ' ' ALA . 1.5 p -161.11 121.36 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 124.382 1.073 . . . . 71.33 108.71 173.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 81.9 p 55.04 85.38 0.06 Allowed 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 125.404 1.481 . . . . 51.31 112.795 175.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 187' ' ' SER . . . . . . . . . . . . . 90.1 p -163.38 -170.63 2.31 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.156 0.582 . . . . 62.14 110.534 178.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 188' ' ' ARG . . . . . 0.564 ' HA ' ' HG2' ' C' ' 124' ' ' PRO . 0.0 OUTLIER -145.83 -173.47 4.15 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 113.07 0.767 . . . . 71.52 113.07 -173.863 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 2.4 ttpt -146.7 143.37 28.69 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.449 1.499 . . . . 72.52 107.587 168.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 190' ' ' CYS . . . . . 0.582 ' HB2' ' HB3' ' B' ' 53' ' ' ALA . 35.2 t -126.87 103.59 7.58 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.215 0.531 . . . . 70.33 110.061 175.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -95.88 -37.25 10.79 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.567 1.147 . . . . 74.04 108.776 173.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 96.63 153.26 29.53 Favored Glycine 0 C--N 1.348 1.195 0 CA-C-N 115.315 -0.857 . . . . 64.22 112.829 178.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 193' ' ' PRO . . . . . 0.455 ' HA ' ' OG1' ' B' ' 48' ' ' THR . 29.6 Cg_endo -88.71 50.11 1.51 Allowed 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 124.026 3.15 . . . . 64.32 112.548 -173.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 194' ' ' SER . . . . . . . . . . . . . 38.2 m -73.96 14.54 0.39 Allowed 'General case' 0 CA--C 1.555 1.139 0 N-CA-C 114.181 1.178 . . . . 24.51 114.181 -172.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 195' ' ' ALA . . . . . . . . . . . . . . . -56.99 -52.85 63.61 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.073 0.949 . . . . 74.32 111.185 177.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 25.2 m 51.59 109.94 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 125.74 1.616 . . . . 73.32 114.955 168.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 19.4 m -66.29 91.7 0.17 Allowed 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.19 0.596 . . . . 75.11 109.539 171.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 198' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -81.76 111.89 18.41 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.012 0.925 . . . . 51.12 111.334 -170.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt 51.02 83.73 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.844 1.258 . . . . 74.4 112.755 164.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 200' ' ' CYS . . . . . 0.412 ' HB2' ' HD3' ' B' ' 201' ' ' PRO . 81.2 m -139.59 -49.3 0.02 OUTLIER Pre-proline 0 CA--C 1.562 1.411 0 CA-C-O 118.135 -0.936 . . . . 73.31 112.131 -176.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 201' ' ' PRO . . . . . 0.412 ' HD3' ' HB2' ' B' ' 200' ' ' CYS . 23.9 Cg_exo -65.51 95.8 0.28 Allowed 'Trans proline' 0 C--N 1.398 3.152 0 C-N-CA 121.622 1.548 . . . . 71.34 111.847 172.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . -80.86 68.11 3.46 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-N 115.739 -0.664 . . . . 63.04 111.673 176.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 203' ' ' ASN . . . . . 0.424 ' ND2' ' HA ' ' B' ' 283' ' ' ASP . 42.2 p30 -138.66 26.13 2.56 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.991 0.916 . . . . 71.33 111.412 -176.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -71.96 83.37 0.95 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.265 0.626 . . . . 74.01 111.694 -171.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 205' ' ' LEU . . . . . . . . . . . . . 53.5 tp 56.75 -79.17 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 126.314 1.846 . . . . 51.03 112.935 174.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -56.53 -68.8 0.18 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.134 1.374 . . . . 62.32 111.079 -178.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -93.99 75.6 4.14 Favored 'General case' 0 C--N 1.344 0.344 0 N-CA-C 108.821 -0.807 . . . . 74.32 108.821 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 208' ' ' GLY . . . . . 0.4 ' HA2' ' HA ' ' B' ' 203' ' ' ASN . . . -147.4 34.75 1.26 Allowed Glycine 0 C--N 1.337 0.636 0 CA-C-N 114.389 -1.278 . . . . 71.52 111.476 177.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 82.89 -62.93 4.56 Favored Glycine 0 C--N 1.346 1.108 0 CA-C-N 115.42 -0.39 . . . . 42.21 112.306 -177.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt 67.75 -77.33 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 125.328 1.451 . . . . 74.51 110.169 -177.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . -88.54 -33.06 10.59 Favored Glycine 0 C--N 1.349 1.294 0 N-CA-C 110.863 -0.895 . . . . 74.43 110.863 171.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 36.2 m 63.7 -164.28 0.25 Allowed 'General case' 0 C--N 1.36 1.053 0 C-N-CA 124.568 1.147 . . . . 74.04 110.957 178.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 68.3 mt 75.36 -64.34 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 C-N-CA 125.291 1.437 . . . . 64.4 110.833 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 32.2 m 74.86 -27.63 0.19 Allowed 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 125.527 1.531 . . . . 75.43 112.723 176.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 215' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 75.61 -68.66 0.19 Allowed 'General case' 0 C--N 1.359 1.002 0 C-N-CA 126.378 1.871 . . . . 73.31 111.766 173.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -146.61 -81.09 0.15 Allowed 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 119.657 -0.211 . . . . 61.42 111.061 -176.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . 0.594 ' HB2' HE22 ' B' ' 274' ' ' GLN . 10.1 mp 60.18 -157.11 0.34 Allowed 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.987 0.915 . . . . 75.4 110.275 -166.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . 0.406 HD23 ' H ' ' B' ' 218' ' ' LEU . 2.6 pt? -133.21 17.41 4.08 Favored 'General case' 0 N--CA 1.483 1.204 0 O-C-N 121.701 -0.624 . . . . 71.43 112.451 -170.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 57.3 -142.23 0.74 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.255 -0.646 . . . . 71.24 109.255 -176.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . 84.72 -36.32 0.05 Allowed 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 125.149 1.38 . . . . 61.1 112.316 163.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 221' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.21 133.8 1.15 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.314 1.046 . . . . 73.55 108.342 170.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -120.5 118.78 31.15 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 108.949 -0.76 . . . . 42.52 108.949 177.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -65.39 -35.03 79.71 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.646 0.778 . . . . 61.02 109.556 178.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 2.0 p -103.53 101.68 12.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 107.281 -1.377 . . . . 74.2 107.281 166.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 5.7 t -72.12 -52.71 15.44 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 122.647 0.379 . . . . 54.34 111.085 -175.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . 0.431 HD11 ' HA ' ' B' ' 281' ' ' PHE . 8.4 tt 65.24 150.81 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 125.032 1.333 . . . . 74.43 111.628 -179.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . -163.72 137.64 4.87 Favored Glycine 0 C--N 1.341 0.814 0 N-CA-C 111.205 -0.758 . . . . 51.31 111.205 178.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . -120.92 165.73 14.03 Favored Glycine 0 N--CA 1.469 0.848 0 N-CA-C 111.273 -0.731 . . . . 72.41 111.273 177.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . 91.0 119.1 2.18 Favored Glycine 0 C--N 1.341 0.834 0 CA-C-N 116.904 0.352 . . . . 70.24 113.107 177.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -75.22 -14.57 60.54 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.512 0.725 . . . . 70.23 110.114 171.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 231' ' ' LYS . . . . . 0.43 ' HG3' HD22 ' B' ' 265' ' ' LEU . 53.9 tttp 79.38 94.09 0.06 Allowed 'General case' 0 C--N 1.358 0.958 0 C-N-CA 125.81 1.644 . . . . 73.24 110.877 169.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 10.0 t -116.66 125.76 52.22 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.955 0.902 . . . . 74.24 111.397 179.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 233' ' ' PHE . . . . . 0.427 ' HE1' ' HE3' ' B' ' 231' ' ' LYS . 34.4 p90 -176.25 132.46 0.23 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.296 1.438 . . . . 70.41 108.403 170.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -136.74 -63.03 0.63 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.276 0.63 . . . . 72.31 110.155 177.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . 0.521 ' HG3' ' H ' ' B' ' 237' ' ' ALA . 13.5 tp10 -157.23 146.57 20.2 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.237 0.615 . . . . 54.41 110.031 -174.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 236' ' ' THR . . . . . . . . . . . . . 13.4 m -66.82 -24.43 66.16 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.191 1.396 . . . . 73.34 112.302 -176.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . 0.521 ' H ' ' HG3' ' B' ' 235' ' ' GLU . . . -113.28 -75.34 0.6 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.344 0.658 . . . . 71.12 110.324 175.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 238' ' ' THR . . . . . 0.479 HG21 ' H ' ' C' ' 220' ' ' GLU . 0.2 OUTLIER 64.79 -9.57 0.18 Allowed 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 125.945 1.698 . . . . 71.31 113.599 -177.871 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -163.81 174.38 11.64 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.803 0.729 . . . . 74.42 111.113 -165.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . -79.51 -106.29 0.24 Allowed Glycine 0 C--N 1.345 1.051 0 CA-C-N 115.409 -0.814 . . . . 71.23 111.804 174.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.29 -179.52 5.62 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.41 0.684 . . . . 71.21 111.132 -178.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 242' ' ' TRP . . . . . 0.485 ' CZ3' HG21 ' C' ' 253' ' ' VAL . 7.8 m0 -94.18 -60.54 1.71 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.198 0.999 . . . . 70.32 109.375 -175.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -172.25 -33.16 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 113.472 -1.694 . . . . 74.22 109.097 -167.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -162.15 101.7 0.2 Allowed Glycine 0 C--N 1.347 1.185 0 N-CA-C 111.375 -0.69 . . . . 63.11 111.375 174.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 39.1 tptt -120.56 110.28 16.27 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.13 0.972 . . . . 75.34 109.976 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 1.9 p -148.16 101.99 3.32 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.859 1.264 . . . . 71.02 108.322 174.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 247' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' C' ' 206' ' ' VAL . 2.5 tm? -165.64 133.0 2.88 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 108.829 -0.804 . . . . 72.51 108.829 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 248' ' ' ARG . . . . . . . . . . . . . 31.9 mtp-105 -68.44 96.72 0.7 Allowed 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.538 0.735 . . . . 75.15 110.07 176.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -81.33 78.3 8.12 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 121.361 0.6 . . . . 71.33 110.403 -176.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -158.58 139.8 13.2 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 115.013 -0.994 . . . . 65.4 109.384 -177.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 251' ' ' ALA . . . . . . . . . . . . . . . -73.1 107.04 5.22 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 108.849 -0.797 . . . . 61.03 108.849 175.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 25.9 tp60 -67.68 -26.0 65.97 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.032 0.933 . . . . 72.3 110.844 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -73.34 77.71 1.36 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.26 0.624 . . . . 51.41 109.487 173.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -71.39 -48.18 51.55 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 115.572 -0.74 . . . . 72.51 111.155 -171.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . 62.62 -84.46 0.04 OUTLIER Glycine 0 C--N 1.352 1.444 0 O-C-N 124.571 1.169 . . . . 54.22 114.006 175.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 256' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 72.61 -61.82 0.49 Allowed 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 126.329 1.852 . . . . 52.52 111.605 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -61.46 126.79 28.61 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 124.22 1.008 . . . . 74.31 110.613 176.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 258' ' ' LEU . . . . . . . . . . . . . 26.5 tp 67.59 10.21 7.6 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 125.263 1.425 . . . . 75.13 111.852 -178.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . 0.401 HG22 ' HB2' ' B' ' 125' ' ' ALA . 24.7 t 65.0 148.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 C-N-CA 125.508 1.523 . . . . 63.02 110.941 -173.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 260' ' ' SER . . . . . 0.466 ' HA ' HD22 ' B' ' 277' ' ' LEU . 66.7 p -147.5 -179.2 6.69 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 121.593 -0.692 . . . . 73.11 111.123 -175.242 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -79.63 74.34 6.3 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.969 0.907 . . . . 52.21 109.55 175.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 262' ' ' ALA . . . . . . . . . . . . . . . -173.84 -53.06 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.259 1.424 . . . . 43.43 107.915 -178.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -86.79 155.96 20.1 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 114.724 -1.125 . . . . 70.44 110.357 178.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 10.5 m 73.68 -69.29 0.19 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 126.027 1.731 . . . . 51.14 112.649 175.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 265' ' ' LEU . . . . . 0.43 HD22 ' HG3' ' B' ' 231' ' ' LYS . 1.6 tt 72.34 134.26 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 125.46 1.504 . . . . 64.12 109.602 -175.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 266' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 77.82 -67.38 0.19 Allowed 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 125.736 1.614 . . . . 71.52 110.907 -176.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 49.7 m 48.13 59.68 4.1 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.42 1.088 . . . . 73.13 112.943 175.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 6.7 p -75.13 73.58 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.287 0 CA-C-O 122.69 1.233 . . . . 74.44 109.832 175.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 269' ' ' THR . . . . . . . . . . . . . 2.7 t -164.54 100.44 0.81 Allowed 'General case' 0 C--O 1.242 0.698 0 CA-C-N 114.356 -1.293 . . . . 74.31 108.574 -177.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 270' ' ' GLU . . . . . 0.409 ' HG2' ' HB2' ' B' ' 274' ' ' GLN . 30.7 tt0 65.41 27.21 11.89 Favored 'General case' 0 CA--C 1.558 1.261 0 C-N-CA 124.036 0.934 . . . . 72.41 111.096 172.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 271' ' ' ALA . . . . . 0.487 ' HB1' ' HA3' ' B' ' 279' ' ' GLY . . . -82.58 4.85 23.01 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.192 0.997 . . . . 75.3 112.751 -175.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 272' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -80.72 71.46 7.62 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.387 0.675 . . . . 54.14 109.769 175.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 62.89 -6.76 0.16 Allowed 'General case' 0 CA--C 1.565 1.529 0 C-N-CA 125.797 1.639 . . . . 61.32 114.907 175.094 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 274' ' ' GLN . . . . . 0.594 HE22 ' HB2' ' B' ' 217' ' ' LEU . 26.8 mm-40 -74.44 -50.7 17.36 Favored 'General case' 0 C--N 1.357 0.931 0 N-CA-C 107.534 -1.284 . . . . 71.44 107.534 171.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 275' ' ' LYS . . . . . . . . . . . . . 53.6 mttp -106.89 92.27 7.33 Favored Pre-proline 0 CA--C 1.541 0.611 0 N-CA-C 106.778 -1.564 . . . . 71.33 106.778 162.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -84.23 36.67 0.59 Allowed 'Trans proline' 0 C--N 1.372 1.784 0 C-N-CA 122.974 2.449 . . . . 62.35 111.499 -178.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 277' ' ' LEU . . . . . 0.466 HD22 ' HA ' ' B' ' 260' ' ' SER . 26.1 mt -89.71 -97.7 0.1 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.661 1.184 . . . . 63.32 109.072 -173.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 278' ' ' LEU . . . . . 0.459 ' HA ' ' HG2' ' A' ' 279' ' ' ARG . 2.4 mm? -89.8 22.78 2.96 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 122.957 0.503 . . . . 62.0 111.781 -172.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 279' ' ' GLY . . . . . 0.487 ' HA3' ' HB1' ' B' ' 271' ' ' ALA . . . -127.76 -83.89 0.43 Allowed Glycine 0 C--N 1.348 1.231 0 CA-C-O 119.945 -0.364 . . . . 75.43 112.674 -177.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 86.1 mt 66.75 -76.36 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 125.334 1.454 . . . . 53.23 111.264 -173.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 281' ' ' PHE . . . . . 0.431 ' HA ' HD11 ' B' ' 226' ' ' LEU . 77.3 t80 -140.68 127.17 20.06 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.713 0.805 . . . . 75.31 109.485 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -92.12 123.66 35.63 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.793 0.837 . . . . 65.41 109.908 178.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 283' ' ' ASP . . . . . 0.424 ' HA ' ' ND2' ' B' ' 203' ' ' ASN . 38.1 t0 -166.05 149.48 7.58 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.467 0.707 . . . . 72.33 109.948 174.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . -136.45 -54.98 0.06 OUTLIER Glycine 0 C--N 1.342 0.876 0 CA-C-N 115.893 -0.594 . . . . 61.45 111.986 -178.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 73.54 -57.46 0.63 Allowed 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 125.535 1.534 . . . . 72.41 112.21 -175.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 286' ' ' MET . . . . . 0.429 ' HA ' ' O ' ' B' ' 290' ' ' TRP . 69.3 mtm 63.34 66.57 1.14 Allowed Pre-proline 0 CA--C 1.554 1.105 0 C-N-CA 124.866 1.266 . . . . 64.1 110.655 -173.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 287' ' ' PRO . . . . . 0.504 ' HD2' ' HA ' ' B' ' 291' ' ' LEU . 19.9 Cg_exo -68.42 112.31 2.78 Favored 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 123.248 2.632 . . . . 73.33 112.345 -177.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 288' ' ' VAL . . . . . 0.572 HG12 ' HG2' ' B' ' 289' ' ' ARG . 41.7 t 59.18 -80.43 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.242 0 C-N-CA 125.101 1.36 . . . . 74.32 111.965 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 289' ' ' ARG . . . . . 0.572 ' HG2' HG12 ' B' ' 288' ' ' VAL . 59.5 mmt-85 -124.68 102.66 7.7 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.647 0.779 . . . . 72.14 110.019 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 290' ' ' TRP . . . . . 0.429 ' O ' ' HA ' ' B' ' 286' ' ' MET . 8.0 m-90 65.82 -83.32 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 125.317 1.447 . . . . 75.34 112.264 176.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 291' ' ' LEU . . . . . 0.504 ' HA ' ' HD2' ' B' ' 287' ' ' PRO . 5.9 mp -134.11 49.3 2.27 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.406 -0.961 . . . . 64.34 108.406 177.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . 87.21 153.61 24.88 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-O 118.318 -1.268 . . . . 62.12 111.317 -170.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -38.4 92.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 124.125 3.217 . . . . 51.12 114.624 172.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 294' ' ' LYS . . . . . 0.451 ' HE2' ' HA ' ' B' ' 294' ' ' LYS . 11.4 mmpt? -70.97 -30.49 66.77 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 114.495 -1.229 . . . . 41.23 110.248 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 295' ' ' ALA . . . . . 0.537 ' HB3' ' HB2' ' C' ' 184' ' ' PRO . . . -153.56 163.76 39.41 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 124.944 1.297 . . . . 34.32 108.42 171.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 29.1 m -94.31 143.02 26.75 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.206 0.603 . . . . 65.42 109.828 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -61.83 97.13 0.07 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.768 0.827 . . . . 64.12 109.88 178.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 298' ' ' HIS . . . . . 0.491 ' HB3' HD11 ' B' ' 375' ' ' LEU . 36.8 t-80 60.82 23.15 13.15 Favored 'General case' 0 CA--C 1.563 1.475 0 C-N-CA 124.724 1.21 . . . . 71.5 111.442 177.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . -85.21 8.41 70.97 Favored Glycine 0 C--N 1.354 1.581 0 CA-C-N 115.928 -0.578 . . . . 63.41 113.151 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -86.83 53.01 2.67 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.698 1.199 . . . . 72.23 109.518 176.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 301' ' ' ILE . . . . . 0.609 HG13 ' H ' ' B' ' 302' ' ' ASP 0.275 21.2 pt 37.82 -82.79 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.564 1.484 0 C-N-CA 127.152 2.181 . . . . 72.24 114.407 -167.942 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 302' ' ' ASP . . . . . 0.609 ' H ' HG13 ' B' ' 301' ' ' ILE . 14.0 t70 65.66 100.55 0.04 OUTLIER 'General case' 0 C--O 1.242 0.701 0 C-N-CA 124.784 1.234 . . . . 63.41 113.076 -177.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 303' ' ' LYS . . . . . 0.581 ' HE2' ' HB3' ' B' ' 62' ' ' LYS . 0.1 OUTLIER 155.09 -56.84 0.0 OUTLIER Pre-proline 0 N--CA 1.486 1.354 0 C-N-CA 126.913 2.085 . . . . 74.11 109.445 158.305 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 304' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -78.38 104.9 1.9 Allowed 'Trans proline' 0 C--N 1.391 2.799 0 C-N-CA 121.849 1.699 . . . . 75.12 112.55 -177.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -166.61 -55.79 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.606 0.762 . . . . 42.33 111.384 175.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 6.3 p -77.63 -36.16 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 113.16 0.8 . . . . 72.33 113.16 -176.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . 0.446 HG21 HD12 ' B' ' 367' ' ' LEU . 63.2 m 59.12 -87.06 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 124.163 0.985 . . . . 74.23 110.241 -158.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 308' ' ' CYS . . . . . . . . . . . . . 37.6 t 171.07 119.75 0.01 OUTLIER 'General case' 0 C--N 1.359 1.007 0 C-N-CA 125.325 1.45 . . . . 74.22 108.657 -173.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . 0.482 ' H ' HG13 ' B' ' 68' ' ' ILE . 23.6 m -90.72 120.14 68.88 Favored Pre-proline 0 N--CA 1.475 0.777 0 C-N-CA 123.298 0.639 . . . . 72.2 109.501 176.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -65.48 -35.6 38.22 Favored 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 122.544 2.162 . . . . 63.14 112.556 -176.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 311' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -99.16 146.33 31.53 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 123.565 0.746 . . . . 73.13 110.422 -177.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 312' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -66.58 123.61 11.31 Favored 'Trans proline' 0 C--N 1.367 1.534 0 C-N-CA 122.306 2.004 . . . . 70.14 111.512 167.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 313' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -77.8 109.88 12.19 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.538 -0.912 . . . . 75.13 108.538 170.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 314' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? -65.2 131.18 45.83 Favored 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 109.466 -0.568 . . . . 72.01 109.466 -176.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 315' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -109.66 -55.44 2.43 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 108.585 -0.894 . . . . 72.12 108.585 174.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 316' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -158.69 156.53 30.09 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 115.066 -0.97 . . . . 74.4 108.518 -177.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 78.6 p -69.45 -40.37 77.2 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 122.946 0.498 . . . . 75.41 110.879 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 318' ' ' VAL . . . . . . . . . . . . . 7.6 p -141.1 77.93 19.83 Favored Pre-proline 0 CA--C 1.561 1.371 0 N-CA-C 108.406 -0.961 . . . . 73.13 108.406 176.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 319' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.98 -24.12 39.81 Favored 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 122.89 2.393 . . . . 65.1 112.423 -175.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 320' ' ' THR . . . . . . . . . . . . . 19.0 p -84.1 -9.98 58.17 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 123.956 0.902 . . . . 53.31 111.644 175.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 321' ' ' LEU . . . . . . . . . . . . . 2.8 tt 49.43 -94.17 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 126.138 1.775 . . . . 65.14 112.908 167.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 322' ' ' ALA . . . . . . . . . . . . . . . -142.8 26.74 1.7 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.046 0.938 . . . . 64.54 110.176 -177.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 323' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -84.91 99.15 10.76 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.723 0.809 . . . . 74.02 109.404 177.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 324' ' ' MET . . . . . . . . . . . . . 51.7 ttm -165.81 -22.35 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.175 0.99 . . . . 71.32 110.57 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 325' ' ' THR . . . . . . . . . . . . . 80.6 m 70.76 -83.24 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.363 1.465 . . . . 72.33 110.252 -173.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 326' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -172.31 -80.57 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.43 0.692 . . . . 72.01 109.254 -178.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . 0.556 ' HB3' ' NH2' ' C' ' 24' ' ' ARG . 0.1 OUTLIER -146.5 -32.98 0.32 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.547 0.739 . . . . 54.34 109.852 175.612 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 328' ' ' ALA . . . . . . . . . . . . . . . 50.75 -93.97 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 124.93 1.292 . . . . 72.03 112.444 173.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 329' ' ' ILE . . . . . . . . . . . . . 9.6 tp -148.73 -43.64 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.121 0 C-N-CA 122.432 0.293 . . . . 73.5 111.717 178.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 330' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -71.19 -23.2 61.99 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 112.495 0.554 . . . . 63.42 112.495 -173.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 331' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -67.65 148.66 51.07 Favored 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 108.833 -0.803 . . . . 63.34 108.833 176.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 332' ' ' LEU . . . . . 0.476 ' HG ' ' NE2' ' C' ' 19' ' ' GLN . 2.7 mm? -78.19 69.02 4.34 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 124.168 0.987 . . . . 74.41 112.95 -159.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 333' ' ' SER . . . . . . . . . . . . . 48.8 m -140.25 -76.77 0.32 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.085 0.954 . . . . 65.04 108.802 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 85.9 mttt 65.95 -66.44 0.16 Allowed 'General case' 0 C--N 1.362 1.117 0 C-N-CA 125.943 1.697 . . . . 63.11 113.319 168.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 335' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -70.63 92.45 0.86 Allowed 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 109.495 -0.558 . . . . 73.25 109.495 175.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -81.2 98.02 7.88 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.672 -0.862 . . . . 61.02 108.672 177.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 337' ' ' LYS . . . . . 0.531 ' HD2' ' ND2' ' C' ' 16' ' ' ASN . 0.3 OUTLIER -105.94 99.45 9.04 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.589 0.756 . . . . 62.43 110.848 -176.318 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 338' ' ' GLY . . . . . . . . . . . . . . . 47.63 -92.6 0.01 OUTLIER Glycine 0 C--N 1.356 1.661 0 C-N-CA 124.341 0.972 . . . . 72.34 114.087 174.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 339' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -87.03 70.93 10.3 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.938 0.895 . . . . 74.33 108.668 173.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 340' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -69.3 -23.21 63.78 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 115.48 -0.782 . . . . 75.24 110.172 171.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 341' ' ' LEU . . . . . . . . . . . . . 2.7 tm? 77.18 -64.2 0.33 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 126.352 1.861 . . . . 75.34 111.107 174.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 342' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -45.24 90.84 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 125.547 1.539 . . . . 64.25 113.332 -175.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 343' ' ' VAL . . . . . 0.447 HG22 ' H ' ' B' ' 344' ' ' GLU . 9.8 p -85.51 179.61 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 CA-C-N 114.278 -1.328 . . . . 64.24 109.265 179.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 344' ' ' GLU . . . . . 0.447 ' H ' HG22 ' B' ' 343' ' ' VAL . 9.2 tp10 -42.13 109.84 0.15 Allowed 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.521 1.128 . . . . 73.03 111.332 171.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 345' ' ' GLY . . . . . . . . . . . . . . . 151.13 99.15 0.19 Allowed Glycine 0 C--N 1.336 0.536 0 N-CA-C 109.808 -1.317 . . . . 62.31 109.808 -172.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 346' ' ' ALA . . . . . . . . . . . . . . . -62.8 -66.81 0.49 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.58 0.752 . . . . 72.22 111.255 -174.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 69.7 m -154.66 13.19 0.41 Allowed 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.921 0.888 . . . . 72.21 110.262 175.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 348' ' ' ILE . . . . . 0.423 ' HB ' ' NH2' ' C' ' 31' ' ' ARG . 21.9 mm 55.79 52.25 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.162 0 CA-C-O 123.584 1.659 . . . . 73.42 107.406 -160.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 349' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -79.4 -14.06 59.19 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 112.203 -2.271 . . . . 71.13 113.039 -165.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 350' ' ' LYS . . . . . . . . . . . . . 42.9 mttp -74.77 -19.04 60.37 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.212 0.605 . . . . 74.52 110.96 -177.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 -104.03 116.21 31.83 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 107.813 -1.18 . . . . 71.32 107.813 169.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 18.6 t70 73.89 -56.11 0.65 Allowed 'General case' 0 N--CA 1.503 2.175 0 C-N-CA 125.516 1.526 . . . . 74.35 112.863 173.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 353' ' ' HIS . . . . . . . . . . . . . 6.1 t60 91.48 -34.56 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 126.772 2.029 . . . . 74.33 112.793 167.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 354' ' ' ALA . . . . . . . . . . . . . . . -133.49 -76.64 0.48 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.608 0.363 . . . . 70.11 110.892 -171.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 355' ' ' ALA . . . . . . . . . . . . . . . 174.67 -39.02 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.034 1.334 . . . . 75.44 108.145 -172.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 356' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 54.52 58.94 11.66 Favored Pre-proline 0 CA--C 1.561 1.396 0 CA-C-N 114.249 -1.341 . . . . 74.32 111.874 177.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 357' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -77.92 -44.26 0.18 Allowed 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 122.584 2.189 . . . . 55.22 113.033 -173.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 358' ' ' CYS . . . . . . . . . . . . . 66.9 m -147.32 107.74 4.09 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.092 0.957 . . . . 73.32 108.709 -178.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 359' ' ' GLY . . . . . . . . . . . . . . . -77.79 80.16 1.36 Allowed Glycine 0 C--N 1.344 1.021 0 N-CA-C 111.0 -0.84 . . . . 62.01 111.0 175.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 360' ' ' GLN . . . . . 0.412 HE22 HD23 ' B' ' 70' ' ' LEU . 6.2 pt20 -72.03 80.54 0.94 Allowed 'General case' 0 CA--C 1.553 1.082 0 CA-C-O 121.763 0.792 . . . . 53.34 111.429 -178.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 361' ' ' ILE . . . . . . . . . . . . . 1.4 pt -156.07 153.69 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 125.564 1.546 . . . . 61.31 108.68 178.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 362' ' ' GLY . . . . . . . . . . . . . . . 155.67 -163.52 31.73 Favored Glycine 0 C--N 1.341 0.815 0 CA-C-N 115.952 -0.567 . . . . 72.35 112.533 -178.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 363' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -157.68 107.81 2.18 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.689 0.796 . . . . 73.13 108.901 179.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 364' ' ' THR . . . . . . . . . . . . . 77.8 m -104.41 -68.95 0.83 Allowed 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.143 -0.688 . . . . 74.04 109.143 175.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 365' ' ' VAL . . . . . 0.592 HG12 ' H ' ' B' ' 366' ' ' ASP . 3.0 t 60.16 -178.93 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.57 1.734 0 C-N-CA 124.737 1.215 . . . . 74.01 111.238 -178.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 366' ' ' ASP . . . . . 0.651 ' HA ' ' HG3' ' B' ' 17' ' ' PRO . 3.7 m-20 82.65 -12.0 0.94 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 125.488 1.515 . . . . 50.12 112.776 166.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 367' ' ' LEU . . . . . 0.446 HD12 HG21 ' B' ' 307' ' ' THR . 69.5 mt -102.38 25.76 8.6 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 108.51 -0.922 . . . . 75.05 108.51 169.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 368' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -116.16 -156.76 0.63 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.432 1.493 . . . . 71.23 109.667 -174.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 369' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 72.98 107.51 0.07 Allowed 'General case' 0 C--N 1.357 0.918 0 C-N-CA 125.452 1.501 . . . . 70.1 110.757 176.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 370' ' ' ALA . . . . . . . . . . . . . . . -151.52 166.97 29.49 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.735 0.814 . . . . 74.25 110.37 -177.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 371' ' ' VAL . . . . . . . . . . . . . 57.3 t -72.08 125.38 30.62 Favored 'Isoleucine or valine' 0 C--O 1.245 0.828 0 N-CA-C 107.505 -1.294 . . . . 74.11 107.505 166.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 372' ' ' GLN . . . . . . . . . . . . . 50.9 tp60 -61.86 133.82 55.92 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 123.842 0.714 . . . . 63.2 110.632 -175.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 373' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -68.24 -27.4 66.32 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.356 -0.838 . . . . 72.05 111.183 -175.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . 73.36 173.47 0.29 Allowed 'General case' 0 C--O 1.247 0.923 0 C-N-CA 124.909 1.284 . . . . 71.45 111.329 -177.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 375' ' ' LEU . . . . . 0.491 HD11 ' HB3' ' B' ' 298' ' ' HIS . 2.9 mm? -62.26 133.43 55.15 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 114.906 -1.043 . . . . 62.01 111.095 -171.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 64.5 20.46 12.16 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.401 1.08 . . . . 73.13 112.455 173.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 377' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 68.2 100.91 0.05 Allowed 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.979 1.311 . . . . 73.31 111.689 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 378' ' ' ALA . . . . . . . . . . . . . . . 85.38 2.76 0.65 Allowed 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 125.866 1.666 . . . . 61.1 114.228 167.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -81.9 79.23 8.49 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 121.878 0.847 . . . . 72.01 110.267 175.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 380' ' ' LYS . . . . . 0.486 ' HE2' ' HA ' ' B' ' 380' ' ' LYS . 0.6 OUTLIER -134.89 57.28 1.81 Allowed 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 106.424 -1.695 . . . . 53.14 106.424 172.203 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 381' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 57.37 -83.5 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 114.026 -1.443 . . . . 74.34 110.756 -172.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . 73.27 -79.21 0.78 Allowed Glycine 0 C--N 1.351 1.366 0 CA-C-O 121.332 0.406 . . . . 73.1 112.099 178.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 383' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -129.92 119.77 23.79 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 106.064 -1.828 . . . . 73.1 106.064 167.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 384' ' ' THR . . . . . . . . . . . . . 23.6 p -82.08 45.55 0.94 Allowed 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.409 0.684 . . . . 63.41 110.888 -178.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 37.9 tp -150.85 -55.0 0.15 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.132 0.973 . . . . 75.12 108.87 -175.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 386' ' ' VAL . . . . . . . . . . . . . 20.8 m -134.9 155.65 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 C-N-CA 124.09 0.956 . . . . 62.42 109.93 177.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 387' ' ' ILE . . . . . 0.444 HG13 HG23 ' B' ' 388' ' ' VAL . 10.9 tp -112.22 146.51 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 123.049 0.539 . . . . 74.12 109.976 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 388' ' ' VAL . . . . . 0.444 HG23 HG13 ' B' ' 387' ' ' ILE . 49.1 t 61.03 -91.34 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 C-N-CA 125.18 1.392 . . . . 54.33 111.049 -178.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 389' ' ' THR . . . . . . . . . . . . . 62.3 m -158.73 -64.93 0.08 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.89 0.876 . . . . 71.25 108.694 -177.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . -171.02 -177.19 2.14 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.357 1.063 . . . . 70.34 110.038 -174.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 391' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -63.74 -52.92 58.29 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.377 0.671 . . . . 64.12 110.664 173.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 392' ' ' HIS . . . . . . . . . . . . . 28.1 t-80 63.5 -76.94 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.618 1.167 . . . . 72.42 111.214 -175.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -153.86 74.33 0.98 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.534 0.733 . . . . 61.53 109.273 179.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 62.24 35.58 15.31 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 124.275 1.03 . . . . 73.31 110.164 -178.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . 63.19 9.57 4.03 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.978 1.311 . . . . 71.44 112.976 -177.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 43.5 t -96.46 135.97 37.6 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 123.971 0.909 . . . . 75.55 109.472 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 397' ' ' GLN . . . . . . . . . . . . . 20.4 tp60 -66.49 -48.37 70.03 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.037 0.935 . . . . 71.41 110.793 176.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 398' ' ' ILE . . . . . 0.515 HG12 HG22 ' B' ' 399' ' ' VAL 0.264 7.6 tt 36.61 -95.86 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.571 1.787 0 C-N-CA 125.93 1.692 . . . . 75.44 111.968 -171.048 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 399' ' ' VAL . . . . . 0.515 HG22 HG12 ' B' ' 398' ' ' ILE . 1.4 m -148.49 -61.8 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 124.921 1.288 . . . . 73.32 108.698 171.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 400' ' ' ALA . . . . . 0.548 ' HB1' ' HB ' ' B' ' 403' ' ' THR . . . 46.21 53.27 12.73 Favored Pre-proline 0 CA--C 1.567 1.61 0 C-N-CA 125.515 1.526 . . . . 51.41 113.175 -179.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 401' ' ' PRO . . . . . 0.594 ' HA ' ' HA ' ' A' ' 117' ' ' ARG . 26.1 Cg_exo -61.95 -58.61 0.36 Allowed 'Trans proline' 0 C--N 1.388 2.606 0 C-N-CA 123.021 2.481 . . . . 71.04 113.491 -169.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -95.6 26.29 4.04 Favored 'General case' 0 CA--C 1.554 1.124 0 CA-C-O 121.643 0.735 . . . . 74.34 110.499 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 403' ' ' THR . . . . . 0.548 ' HB ' ' HB1' ' B' ' 400' ' ' ALA . 9.1 m -107.56 87.4 2.49 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 108.579 -0.897 . . . . 51.3 108.579 176.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 404' ' ' LYS . . . . . 0.624 ' HE3' ' HB3' ' A' ' 118' ' ' ASP . 43.0 mmtm -129.41 143.53 50.88 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.819 0.848 . . . . 70.03 109.909 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 405' ' ' ALA . . . . . 0.456 ' H ' ' HD2' ' B' ' 406' ' ' PRO . . . -170.38 -41.78 0.0 OUTLIER Pre-proline 0 CA--C 1.563 1.455 0 CA-C-O 118.108 -0.948 . . . . 71.24 112.152 -169.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 406' ' ' PRO . . . . . 0.456 ' HD2' ' H ' ' B' ' 405' ' ' ALA . 72.3 Cg_exo -46.74 144.06 8.3 Favored 'Trans proline' 0 C--N 1.406 3.571 0 C-N-CA 122.872 2.381 . . . . 44.44 113.732 171.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . 95.56 -64.22 1.31 Allowed Glycine 0 C--N 1.342 0.916 0 N-CA-C 111.061 -0.815 . . . . 55.33 111.061 -176.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 408' ' ' LEU . . . . . . . . . . . . . 44.9 tp 57.78 -80.15 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 125.392 1.477 . . . . 72.03 112.43 175.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 21.6 m -110.56 68.13 0.66 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.654 0.781 . . . . 73.52 109.977 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 410' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 62.86 21.19 12.68 Favored 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 124.982 1.313 . . . . 51.32 113.503 170.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . -71.53 151.69 43.64 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 121.744 -0.598 . . . . 63.14 110.171 175.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 24.8 tp 71.89 10.88 6.23 Favored 'General case' 0 CA--C 1.566 1.595 0 C-N-CA 125.573 1.549 . . . . 60.41 111.817 -179.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -66.03 -37.69 86.51 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.06 0.544 . . . . 71.14 110.311 173.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 414' ' ' THR . . . . . . . . . . . . . 49.8 m 78.6 -42.61 0.33 Allowed 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 126.195 1.798 . . . . 73.24 112.191 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 415' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt 69.82 -81.79 0.03 OUTLIER 'General case' 0 C--N 1.352 0.693 0 C-N-CA 125.766 1.626 . . . . 73.42 111.17 -178.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -133.41 -175.11 3.7 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.796 0.838 . . . . 75.33 111.234 -168.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 417' ' ' GLY . . . . . 0.442 ' O ' ' HG3' ' A' ' 241' ' ' PRO . . . 155.99 -21.32 0.51 Allowed Glycine 0 C--N 1.35 1.341 0 CA-C-N 115.58 -0.737 . . . . 43.15 111.695 -177.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 418' ' ' ALA . . . . . . . . . . . . . . . -59.59 -31.48 69.5 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.076 0.95 . . . . 70.25 112.035 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 419' ' ' VAL . . . . . 0.467 HG23 ' HG2' ' B' ' 420' ' ' MET . 30.4 m -74.23 -24.1 18.87 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 C-N-CA 123.646 0.779 . . . . 62.03 112.241 178.138 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 420' ' ' MET . . . . . 0.467 ' HG2' HG23 ' B' ' 419' ' ' VAL . 26.6 mmt -99.95 23.64 9.56 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.834 0.854 . . . . 73.12 111.662 -172.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 421' ' ' VAL . . . . . 0.535 ' HA ' ' HD3' ' A' ' 241' ' ' PRO . 18.6 m -69.05 -156.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 C-N-CA 123.793 0.837 . . . . 72.42 111.789 178.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 422' ' ' MET . . . . . . . . . . . . . 20.8 ptt? -67.39 67.25 0.08 Allowed 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 122.62 1.2 . . . . 74.1 111.092 173.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 423' ' ' SER . . . . . . . . . . . . . 12.0 t -173.78 -166.66 0.32 Allowed 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 127.142 2.177 . . . . 62.22 106.405 -170.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 424' ' ' TYR . . . . . . . . . . . . . 92.9 t80 67.21 -77.02 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 124.378 1.071 . . . . 72.42 111.857 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . -73.12 165.92 54.69 Favored Glycine 0 C--N 1.35 1.323 0 CA-C-O 119.845 -0.419 . . . . 75.12 112.796 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 426' ' ' ASN . . . . . 0.517 ' HB3' ' HB ' ' B' ' 435' ' ' THR . 3.0 t30 48.6 61.17 3.2 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 125.107 1.363 . . . . 75.43 111.132 -177.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 427' ' ' SER . . . . . . . . . . . . . 16.2 t 60.7 23.55 13.41 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 124.833 1.253 . . . . 75.14 113.112 175.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 50.64 -68.56 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 127.613 2.365 . . . . 73.23 115.339 175.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 429' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -78.03 -60.05 2.53 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 107.872 -1.158 . . . . 63.42 107.872 173.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 11.9 t70 53.4 97.21 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.732 1.613 . . . . 55.41 111.794 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 14.7 m 76.53 -39.7 0.36 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.671 1.588 . . . . 73.31 111.77 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 432' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -169.47 -66.89 0.02 OUTLIER 'General case' 0 C--N 1.35 0.622 0 C-N-CA 123.774 0.829 . . . . 71.1 109.383 -172.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 433' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -166.98 166.21 15.45 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.538 0.735 . . . . 73.43 109.887 -166.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 434' ' ' HIS . . . . . . . . . . . . . 38.9 m80 66.19 18.03 10.87 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 124.652 1.181 . . . . 65.13 111.936 175.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 435' ' ' THR . . . . . 0.517 ' HB ' ' HB3' ' B' ' 426' ' ' ASN . 29.4 p 57.08 34.22 24.55 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.542 1.537 . . . . 73.42 112.381 -176.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . 166.83 27.84 0.02 OUTLIER Glycine 0 C--N 1.348 1.241 0 CA-C-O 119.322 -0.71 . . . . 43.54 113.886 175.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 39.3 t 59.28 -77.55 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.827 1.251 . . . . 54.14 110.918 -169.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 438' ' ' GLN . . . . . 0.418 ' NE2' ' HA2' ' B' ' 453' ' ' GLY . 3.6 pp0? -67.63 -174.94 0.47 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.079 1.352 . . . . 71.55 112.56 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 439' ' ' LEU . . . . . . . . . . . . . 94.9 mt -80.82 26.84 0.4 Allowed 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 113.805 1.039 . . . . 74.24 113.805 -169.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 440' ' ' ARG . . . . . . . . . . . . . 30.6 mmm180 60.81 34.93 19.6 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 123.743 0.817 . . . . 70.1 112.219 174.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 441' ' ' ILE . . . . . 0.706 ' HA ' HD22 ' A' ' 235' ' ' LEU . 39.2 mt -67.34 98.4 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 CA-C-N 115.263 -0.88 . . . . 74.15 112.359 -169.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 442' ' ' ALA . . . . . . . . . . . . . . . -92.25 -88.13 0.21 Allowed 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 114.956 -1.02 . . . . 71.41 108.711 171.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 443' ' ' ALA . . . . . 0.505 ' HB3' ' HG3' ' A' ' 224' ' ' PRO . . . 66.24 -72.16 0.08 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 125.355 1.462 . . . . 74.21 114.013 168.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 444' ' ' TYR . . . . . 0.429 ' CE2' ' HA ' ' A' ' 227' ' ' THR . 88.6 m-85 -134.61 158.0 45.14 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.308 1.043 . . . . 65.34 108.512 175.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . -123.78 62.54 0.57 Allowed Glycine 0 CA--C 1.537 1.463 0 CA-C-O 119.196 -0.78 . . . . 74.34 113.086 176.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 446' ' ' PRO . . . . . 0.429 ' HB3' ' HD2' ' A' ' 226' ' ' ARG . 4.0 Cg_exo -84.44 121.19 2.58 Favored 'Trans proline' 0 C--N 1.384 2.396 0 C-N-CA 123.065 2.51 . . . . 63.02 110.316 174.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 447' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 71.87 -58.77 0.57 Allowed 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 125.959 1.704 . . . . 60.0 110.547 -171.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . 75.46 -67.21 0.25 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 125.665 1.586 . . . . 74.31 113.196 168.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 449' ' ' ALA . . . . . . . . . . . . . . . -75.55 75.59 2.58 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.851 0.86 . . . . 61.52 111.92 -173.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 450' ' ' ASN . . . . . . . . . . . . . 65.3 t30 168.73 -35.72 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 126.366 1.867 . . . . 61.12 107.976 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 42.3 t -78.81 125.85 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.268 1.027 . . . . 63.1 109.785 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 452' ' ' VAL . . . . . . . . . . . . . 30.2 m -71.97 159.24 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 123.239 0.615 . . . . 60.45 111.021 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 453' ' ' GLY . . . . . 0.418 ' HA2' ' NE2' ' B' ' 438' ' ' GLN . . . 97.87 -58.64 1.06 Allowed Glycine 0 C--N 1.341 0.813 0 N-CA-C 111.518 -0.633 . . . . 73.44 111.518 -177.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 454' ' ' LEU . . . . . . . . . . . . . 97.1 mt 68.05 159.41 0.16 Allowed 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 125.121 1.368 . . . . 72.5 113.171 176.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 12.5 p -77.67 94.73 4.46 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 114.928 -1.033 . . . . 61.41 109.59 172.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -64.58 -52.97 54.84 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.518 -0.764 . . . . 74.3 110.938 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 457' ' ' GLN . . . . . 0.512 ' HB2' ' HG3' ' A' ' 236' ' ' LYS . 0.5 OUTLIER -81.86 96.39 7.62 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.056 -1.09 . . . . 42.14 108.056 179.424 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 43.6 p 51.18 -165.82 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 125.626 1.571 . . . . 72.13 112.802 -176.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 459' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -86.73 -48.7 8.04 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 121.986 -0.446 . . . . 73.31 111.859 -170.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 9.4 mp 49.64 49.52 19.86 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 123.787 0.835 . . . . 65.42 110.344 -171.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -63.33 119.53 9.84 Favored 'General case' 0 CA--C 1.552 1.04 0 CA-C-N 114.231 -1.35 . . . . 62.31 112.069 -171.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -125.93 29.88 5.8 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.702 1.201 . . . . 72.53 108.626 169.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 5.7 t -99.73 90.75 4.57 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 114.872 -1.058 . . . . 61.35 110.142 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 464' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -98.41 29.46 3.61 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.788 0.835 . . . . 75.31 109.065 170.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? 67.27 8.02 5.93 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 125.63 1.572 . . . . 72.15 111.006 -166.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . 54.99 -157.69 0.21 Allowed 'General case' 0 C--N 1.364 1.217 0 C-N-CA 124.735 1.214 . . . . 62.32 110.982 -172.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 467' ' ' ALA . . . . . 0.401 ' HB1' ' HA ' ' C' ' 263' ' ' PRO . . . -96.11 -27.47 15.05 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.181 0.592 . . . . 75.3 110.215 172.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 3.3 pp -162.13 -30.13 0.05 OUTLIER 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.598 1.559 . . . . 45.51 109.85 177.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 469' ' ' GLY . . . . . . . . . . . . . . . 72.21 -91.04 0.53 Allowed Glycine 0 C--N 1.35 1.336 0 C-N-CA 123.913 0.768 . . . . 50.44 112.859 177.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 470' ' ' LEU . . . . . . . . . . . . . 16.6 tp 68.08 6.98 5.54 Favored 'General case' 0 CA--C 1.562 1.418 0 C-N-CA 125.774 1.629 . . . . 73.2 112.122 -178.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 471' ' ' LYS . . . . . . . . . . . . . 64.4 tttp . . . . . 0 C--O 1.252 1.215 0 N-CA-C 107.866 -1.161 . . . . 74.2 107.866 176.632 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 77.2 mtm . . . . . 0 N--CA 1.476 0.826 0 CA-C-O 119.745 -0.169 . . . . 55.23 111.108 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.69 41.22 18.87 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.417 1.087 . . . . 65.31 111.63 177.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -72.48 77.6 1.05 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.763 0.825 . . . . 52.01 110.534 178.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -36.89 117.52 0.52 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.891 1.676 . . . . 70.52 114.288 -176.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 5' ' ' LYS . . . . . 0.462 ' HB3' HD11 ' C' ' 10' ' ' ILE . 14.1 mmmm -93.93 108.59 20.37 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 108.355 -0.98 . . . . 63.2 108.355 167.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -71.94 93.97 1.41 Allowed 'General case' 0 C--O 1.238 0.487 0 N-CA-C 107.583 -1.265 . . . . 63.22 107.583 175.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 7' ' ' TYR . . . . . 0.483 ' HA ' HD12 ' C' ' 10' ' ' ILE . 30.9 m-85 -60.41 -30.36 69.56 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 115.004 -0.998 . . . . 73.43 112.158 -171.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -66.76 -45.04 79.78 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.572 -0.74 . . . . 72.53 110.521 177.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.9 -42.58 99.25 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.088 0.555 . . . . 52.31 110.685 177.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 10' ' ' ILE . . . . . 0.483 HD12 ' HA ' ' C' ' 7' ' ' TYR . 69.5 mt -55.3 -50.95 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 123.72 0.808 . . . . 63.34 111.144 178.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 83.4 mt -74.48 -12.0 60.37 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.528 -0.76 . . . . 45.45 112.371 -179.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 69.99 33.82 70.35 Favored Glycine 0 C--N 1.351 1.384 0 O-C-N 123.045 0.216 . . . . 64.33 112.754 -176.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 13' ' ' VAL . . . . . 0.447 ' HB ' ' HD2' ' C' ' 14' ' ' PRO . 11.6 m -108.46 164.39 14.86 Favored Pre-proline 0 N--CA 1.479 1.021 0 C-N-CA 124.46 1.104 . . . . 64.04 109.615 174.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 14' ' ' PRO . . . . . 0.447 ' HD2' ' HB ' ' C' ' 13' ' ' VAL . 35.5 Cg_endo -60.12 162.79 15.76 Favored 'Trans proline' 0 C--N 1.384 2.4 0 C-N-CA 122.095 1.863 . . . . 74.43 112.596 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 8.8 mmm180 -77.18 14.31 0.94 Allowed 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.042 0.937 . . . . 71.52 112.413 -170.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 16' ' ' ASN . . . . . 0.531 ' ND2' ' HD2' ' B' ' 337' ' ' LYS . 6.6 t30 -148.99 14.75 0.92 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.692 1.197 . . . . 71.24 108.716 -176.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.04 137.5 56.81 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 123.923 0.889 . . . . 71.14 112.914 -170.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 78.8 p -70.77 161.87 30.13 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.798 0.839 . . . . 74.41 110.649 178.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 19' ' ' GLN . . . . . 0.476 ' NE2' ' HG ' ' B' ' 332' ' ' LEU . 0.2 OUTLIER -57.52 -29.34 64.26 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.519 0.728 . . . . 74.45 111.541 -177.204 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -65.68 -47.92 73.84 Favored 'General case' 0 C--O 1.215 -0.733 0 CA-C-O 119.33 -0.367 . . . . 64.05 110.486 176.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -61.24 -35.62 77.73 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 123.711 0.632 . . . . 73.42 110.821 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.46 -44.04 97.85 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.928 0 C-N-CA 123.671 0.788 . . . . 61.32 110.756 173.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 23' ' ' LYS . . . . . 0.481 ' HB3' ' HZ3' ' C' ' 23' ' ' LYS . 6.5 ttpm? -73.02 -31.43 64.46 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.539 0.736 . . . . 74.13 111.304 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 24' ' ' ARG . . . . . 0.556 ' NH2' ' HB3' ' B' ' 327' ' ' LYS . 40.0 mtt180 -69.08 -45.47 70.21 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.124 0.97 . . . . 73.52 110.083 178.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -71.77 -31.81 67.01 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 124.522 1.139 . . . . 75.32 111.183 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 26' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -58.0 -60.3 3.94 Favored 'General case' 0 C--O 1.21 -0.995 0 O-C-N 124.191 0.932 . . . . 72.31 109.323 171.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . 0.423 ' O ' ' HG3' ' C' ' 31' ' ' ARG . 53.4 mtmt -63.07 -35.08 79.04 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 124.366 1.041 . . . . 74.1 111.336 -178.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 28' ' ' ARG . . . . . 0.613 ' HA ' HH21 ' C' ' 31' ' ' ARG . 63.7 ttt180 -58.11 -51.88 67.86 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.071 0.948 . . . . 71.15 110.244 177.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . 0.517 ' HA ' ' HB3' ' C' ' 32' ' ' GLN . 83.2 mt -90.62 -0.02 57.54 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 113.983 -1.462 . . . . 60.22 111.195 -177.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.15 -10.96 29.05 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.778 0.831 . . . . 75.32 110.003 169.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . 0.613 HH21 ' HA ' ' C' ' 28' ' ' ARG . 32.7 mtm105 -93.66 -35.81 12.66 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.261 0.624 . . . . 73.5 109.454 165.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 32' ' ' GLN . . . . . 0.517 ' HB3' ' HA ' ' C' ' 29' ' ' LEU . 8.3 tt0 -67.69 -60.55 2.45 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 122.489 0.316 . . . . 71.12 110.386 176.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -92.38 31.71 1.28 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.287 0.635 . . . . 70.15 109.781 178.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 34' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -58.91 106.46 0.72 Allowed Pre-proline 0 N--CA 1.481 1.078 0 C-N-CA 124.184 0.993 . . . . 72.34 109.059 -179.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -58.37 -29.45 88.25 Favored 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 123.041 2.494 . . . . 71.32 113.146 -165.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -72.28 -33.15 67.22 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.042 0.937 . . . . 60.34 112.442 178.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 61.8 t -97.73 -23.15 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 123.457 0.703 . . . . 75.33 110.689 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -128.86 83.61 2.17 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.74 0.816 . . . . 54.22 109.504 -168.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -81.85 36.05 0.44 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.134 0.973 . . . . 62.24 111.374 178.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . 0.47 ' HB2' ' HB3' ' C' ' 43' ' ' ALA . 20.0 m -93.02 107.71 26.97 Favored Pre-proline 0 CA--C 1.544 0.742 0 N-CA-C 108.63 -0.878 . . . . 74.14 108.63 -178.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -43.39 -54.67 3.4 Favored 'Trans proline' 0 C--N 1.386 2.507 0 C-N-CA 124.437 3.425 . . . . 63.44 114.439 -171.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -67.29 -31.14 71.25 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.974 0.91 . . . . 65.44 110.777 -176.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 43' ' ' ALA . . . . . 0.47 ' HB3' ' HB2' ' C' ' 40' ' ' SER . . . -77.31 -19.13 56.84 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.021 0.528 . . . . 62.05 110.68 177.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -82.9 -28.06 30.23 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.11 0.564 . . . . 74.04 109.504 176.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -75.63 -32.74 60.36 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.542 0.737 . . . . 42.53 109.832 173.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 46' ' ' LYS . . . . . . . . . . . . . 41.1 mmtm -65.17 -44.02 89.87 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.73 -0.668 . . . . 72.32 109.992 168.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -56.71 -37.01 70.32 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.529 0.732 . . . . 62.23 110.171 174.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -62.41 -44.33 96.71 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 123.745 0.653 . . . . 72.04 111.72 174.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -66.35 -33.87 76.69 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 122.334 0.253 . . . . 72.33 111.628 176.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 50' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.56 -39.44 85.05 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 C-N-CA 123.77 0.828 . . . . 75.43 109.751 173.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 51' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -72.08 -29.29 63.97 Favored 'General case' 0 C--O 1.212 -0.88 0 C-N-CA 124.034 0.934 . . . . 74.04 110.785 177.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -67.51 -57.53 6.33 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.566 1.146 . . . . 63.42 109.966 177.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.57 -47.12 85.32 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-N 113.158 -1.837 . . . . 63.1 111.629 -176.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -60.22 -57.76 11.4 Favored 'General case' 0 C--O 1.203 -1.362 0 CA-C-N 115.051 -0.977 . . . . 75.01 110.567 174.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.97 -30.77 64.38 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 113.174 0.805 . . . . 60.54 113.174 -170.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 94.3 t -73.78 -60.06 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 N-CA-C 109.843 -0.429 . . . . 72.43 109.843 170.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 57' ' ' LEU . . . . . 0.432 HD11 ' HB2' ' C' ' 7' ' ' TYR . 79.7 mt -81.64 4.6 21.06 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 113.454 0.909 . . . . 75.02 113.454 -169.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 41.8 t -74.62 -36.53 62.92 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.447 1.099 . . . . 62.42 109.717 177.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -82.96 127.78 68.16 Favored Pre-proline 0 C--N 1.331 -0.206 0 N-CA-C 108.399 -0.963 . . . . 72.03 108.399 174.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 60' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -54.71 -32.91 78.05 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.571 2.181 . . . . 33.23 111.073 165.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -55.4 -64.64 0.78 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.957 1.303 . . . . 62.13 110.864 174.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 36.8 mtpt -76.45 -16.0 59.78 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.13 0.972 . . . . 75.23 112.197 -173.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -71.37 -45.15 63.57 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 107.816 -1.179 . . . . 64.42 107.816 171.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -72.13 -24.06 61.41 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.199 0.599 . . . . 74.15 111.861 175.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 90.3 mt -66.06 -42.93 92.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 N-CA-C 109.204 -0.665 . . . . 62.34 109.204 171.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -60.58 -48.89 79.77 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 115.486 -0.779 . . . . 74.22 109.5 174.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -57.39 -42.73 82.76 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.801 0.84 . . . . 73.14 112.112 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 35.8 p -74.13 -23.18 59.25 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.659 0.384 . . . . 63.2 111.431 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -74.11 142.93 45.56 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 109.133 -0.692 . . . . 75.22 109.133 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.64 11.99 65.18 Favored Glycine 0 N--CA 1.476 1.351 0 N-CA-C 112.072 -0.411 . . . . 62.51 112.072 -171.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 36.2 m -144.75 -54.26 0.32 Allowed 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 104.259 -2.497 . . . . 72.34 104.259 175.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 55.0 m -88.73 151.98 22.08 Favored 'General case' 0 C--O 1.246 0.88 0 N-CA-C 104.949 -2.241 . . . . 73.35 104.949 156.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.56 -17.33 2.27 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.872 0.869 . . . . 73.23 110.29 -176.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.88 132.55 77.28 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 123.572 0.749 . . . . 53.23 110.466 174.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -61.46 156.87 44.17 Favored 'Trans proline' 0 C--N 1.377 2.071 0 C-N-CA 123.413 2.742 . . . . 75.14 112.48 175.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -63.21 169.08 9.87 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 123.421 2.748 . . . . 63.14 112.81 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.85 122.58 5.92 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 121.86 1.707 . . . . 51.51 111.305 171.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 78' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.81 122.8 7.53 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 122.51 2.14 . . . . 74.44 112.043 175.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -82.72 159.55 16.4 Favored 'Trans proline' 0 CA--C 1.557 1.672 0 C-N-CA 122.72 2.28 . . . . 61.04 112.109 173.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.27 84.77 0.04 OUTLIER 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 123.123 2.549 . . . . 51.5 112.18 169.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . 0.564 ' HA3' ' HB1' ' C' ' 141' ' ' ALA . . . 160.21 -30.18 0.37 Allowed Glycine 0 C--O 1.239 0.43 0 CA-C-N 114.559 -1.2 . . . . 75.2 110.316 -178.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 92.14 178.86 41.58 Favored Glycine 0 C--N 1.35 1.311 0 CA-C-N 115.196 -0.502 . . . . 74.45 112.314 173.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -80.68 102.16 9.71 Favored 'General case' 0 C--O 1.243 0.761 0 N-CA-C 106.927 -1.508 . . . . 70.14 106.927 168.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -53.73 132.69 41.56 Favored 'General case' 0 C--O 1.248 0.978 0 O-C-N 124.769 1.293 . . . . 63.13 111.42 -174.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 85' ' ' PHE . . . . . 0.495 ' CD1' ' HB ' ' C' ' 90' ' ' VAL . 2.1 t80 -156.18 24.02 0.36 Allowed 'General case' 0 C--O 1.243 0.761 0 CA-C-N 114.624 -1.171 . . . . 74.41 110.697 -173.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 52.3 m -58.45 128.38 36.85 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.274 -0.876 . . . . 45.43 111.01 -176.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 91.47 -30.31 6.55 Favored Glycine 0 C--N 1.342 0.906 0 CA-C-O 119.591 -0.561 . . . . 74.33 113.175 -179.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 88' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -94.44 137.74 33.22 Favored 'General case' 0 C--N 1.355 0.823 0 N-CA-C 108.443 -0.947 . . . . 74.44 108.443 -177.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -86.64 70.45 10.41 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.244 0.618 . . . . 72.23 111.142 -169.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 90' ' ' VAL . . . . . 0.495 ' HB ' ' CD1' ' C' ' 85' ' ' PHE . 1.3 p -39.59 -47.13 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 C-N-CA 125.138 1.375 . . . . 54.41 113.446 178.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -69.93 -23.38 63.2 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 114.695 -1.139 . . . . 74.21 111.753 -167.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -100.77 -7.18 23.96 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.293 0.637 . . . . 75.53 111.1 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 8.1 m-30 -78.73 -172.12 2.85 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 109.869 -0.419 . . . . 72.45 109.869 176.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 88.0 p -68.27 148.81 50.26 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 112.332 0.493 . . . . 45.51 112.332 -170.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.63 -38.26 89.55 Favored 'General case' 0 CA--C 1.551 1.009 0 CA-C-N 114.871 -1.059 . . . . 55.43 110.869 175.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -49.05 -52.45 25.38 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.658 1.183 . . . . 65.02 111.375 171.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 97' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -62.37 -43.68 98.25 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 114.409 -1.268 . . . . 64.25 110.626 178.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -73.3 -5.06 37.15 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.428 0.691 . . . . 51.52 112.341 -178.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -100.08 -41.96 6.93 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.267 0.627 . . . . 74.43 111.712 167.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 26.6 tp -67.24 -42.86 83.28 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.329 0.652 . . . . 73.23 111.573 -173.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -109.91 5.13 22.18 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-O 121.062 0.458 . . . . 73.25 109.875 173.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -44.96 -52.56 7.87 Favored Glycine 0 CA--C 1.538 1.514 0 CA-C-O 118.416 -1.213 . . . . 54.11 115.153 -177.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -35.03 -29.05 0.05 OUTLIER 'Trans proline' 0 C--N 1.389 2.658 0 C-N-CA 125.045 3.83 . . . . 62.02 117.142 175.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -145.73 21.79 1.82 Allowed Glycine 0 C--N 1.36 1.91 0 CA-C-N 118.552 0.615 . . . . 43.23 113.891 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 6.9 mt -75.05 76.54 2.24 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 113.284 0.846 . . . . 73.03 113.284 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 106' ' ' PHE . . . . . 0.505 ' HB3' ' O ' ' C' ' 168' ' ' GLY . 3.7 m-30 45.29 -105.73 0.1 Allowed 'General case' 0 CA--C 1.563 1.451 0 O-C-N 124.622 1.202 . . . . 64.24 112.913 162.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . 111.04 28.33 3.92 Favored Glycine 0 C--N 1.36 1.879 0 N-CA-C 116.182 1.233 . . . . 51.05 116.182 164.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 108' ' ' GLY . . . . . 0.705 ' HA2' ' HA ' ' C' ' 114' ' ' ARG . . . -11.14 -89.79 0.01 OUTLIER Glycine 0 N--CA 1.477 1.38 0 N-CA-C 118.165 2.026 . . . . 74.41 118.165 169.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 109' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -75.72 -8.06 55.89 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 117.034 0.417 . . . . 74.45 111.352 -170.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 110' ' ' GLY . . . . . . . . . . . . . . . -90.56 3.57 81.67 Favored Glycine 0 C--N 1.348 1.248 0 N-CA-C 111.206 -0.758 . . . . 54.22 111.206 173.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 64.5 mtm180 57.97 8.92 0.81 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 125.55 1.54 . . . . 75.25 113.21 175.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 112' ' ' ARG . . . . . . . . . . . . . 53.1 ttt180 -81.94 47.48 1.11 Allowed 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 125.694 1.597 . . . . 74.1 109.657 176.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 113' ' ' SER . . . . . 0.437 ' HB3' ' HB3' ' C' ' 167' ' ' GLN . 28.5 m 90.3 75.97 0.01 OUTLIER 'General case' 0 C--N 1.365 1.252 0 C-N-CA 126.17 1.788 . . . . 72.53 110.963 -166.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 114' ' ' ARG . . . . . 0.726 ' HG2' ' H ' ' C' ' 115' ' ' LYS . 18.1 ttm180 -74.48 -163.35 0.2 Allowed 'General case' 0 CA--C 1.581 2.172 0 C-N-CA 123.948 0.899 . . . . 74.05 110.107 170.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 115' ' ' LYS . . . . . 0.726 ' H ' ' HG2' ' C' ' 114' ' ' ARG . 24.3 ttpp -8.0 111.25 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.303 0 C-N-CA 128.058 2.543 . . . . 54.14 116.121 -164.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -63.09 112.83 5.31 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-N 114.626 -1.17 . . . . 45.25 113.573 -171.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 16.2 mtm180 -58.21 124.53 19.73 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.43 0.692 . . . . 64.44 109.25 174.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -57.92 135.22 56.87 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 123.836 0.71 . . . . 75.42 109.249 176.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 119' ' ' LEU . . . . . . . . . . . . . 4.9 tt -95.28 121.34 36.83 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 107.57 -1.27 . . . . 75.21 107.57 -172.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.76 94.78 5.26 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 107.668 -1.234 . . . . 72.31 107.668 -168.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 121' ' ' ALA . . . . . 0.559 ' HA ' HG23 ' B' ' 185' ' ' VAL . . . -108.58 113.0 25.65 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 108.308 -0.997 . . . . 63.21 108.308 -176.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 122' ' ' GLU . . . . . 0.631 ' HB3' ' HB2' ' B' ' 58' ' ' SER . 0.0 OUTLIER -94.15 110.52 22.23 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 106.959 -1.497 . . . . 73.22 106.959 -178.649 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 123' ' ' LEU . . . . . 0.432 HD23 ' H ' ' C' ' 123' ' ' LEU . 2.4 pt? -129.82 133.32 24.89 Favored Pre-proline 0 N--CA 1.48 1.031 0 C-N-CA 122.481 0.313 . . . . 73.3 111.801 -165.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . 0.564 ' HG2' ' HA ' ' B' ' 188' ' ' ARG . 10.7 Cg_exo -73.53 119.57 6.01 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 123.077 2.518 . . . . 72.51 111.172 170.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 125' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' C' ' 180' ' ' LEU . 47.1 tp -128.97 165.32 21.34 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.187 0.995 . . . . 74.03 108.631 -177.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 126' ' ' THR . . . . . 0.58 HG21 ' H ' ' B' ' 175' ' ' ASP . 0.2 OUTLIER -105.61 170.9 7.62 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 121.541 0.686 . . . . 61.53 111.686 179.405 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 127' ' ' LEU . . . . . 0.478 HD22 ' CD2' ' C' ' 183' ' ' HIS . 2.4 mt -81.46 -56.69 3.87 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 114.583 -1.189 . . . . 62.25 109.698 -162.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -49.07 -47.13 45.27 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 112.756 -2.02 . . . . 75.24 110.33 170.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -67.88 -33.0 73.88 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 115.707 -0.679 . . . . 73.53 111.456 -177.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 130' ' ' ALA . . . . . 0.477 ' HB1' HG22 ' C' ' 153' ' ' VAL . . . -68.17 -31.95 71.87 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 123.698 0.623 . . . . 64.34 110.721 173.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 131' ' ' PHE . . . . . 0.405 ' HB2' HD13 ' C' ' 215' ' ' LEU . 74.0 t80 -75.28 -31.85 60.85 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 124.029 0.932 . . . . 75.55 111.37 174.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 132' ' ' HIS . . . . . . . . . . . . . 34.6 m170 -79.62 -55.64 4.88 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 112.335 0.495 . . . . 60.22 112.335 -173.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.07 -111.41 3.34 Favored Glycine 0 C--N 1.345 1.068 0 N-CA-C 110.253 -1.139 . . . . 65.31 110.253 -167.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.41 168.2 35.53 Favored Glycine 0 C--N 1.356 1.645 0 CA-C-N 117.426 0.613 . . . . 53.24 113.511 177.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -71.05 93.65 1.04 Allowed 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 108.932 -0.766 . . . . 71.2 108.932 175.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 136' ' ' ARG . . . . . 0.527 ' HB3' ' HB2' ' B' ' 181' ' ' LEU . 9.6 mpt_? -117.47 133.5 55.9 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.452 1.101 . . . . 72.12 109.493 -174.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 137' ' ' VAL . . . . . . . . . . . . . 27.8 m -71.91 131.12 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-O 121.346 0.593 . . . . 71.12 111.616 -176.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 138' ' ' VAL . . . . . 0.523 HG11 ' SD ' ' C' ' 164' ' ' MET . 13.2 p -115.3 130.12 70.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 C-N-CA 124.684 1.194 . . . . 72.14 107.808 170.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 139' ' ' GLU . . . . . 0.523 ' H ' HG11 ' B' ' 182' ' ' VAL . 42.4 mt-10 -126.61 86.52 2.52 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 108.117 -1.068 . . . . 74.31 108.117 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 140' ' ' VAL . . . . . . . . . . . . . 11.0 m -125.39 107.59 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 123.25 0.62 . . . . 63.22 111.319 -175.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 141' ' ' ALA . . . . . 0.564 ' HB1' ' HA3' ' C' ' 81' ' ' GLY . . . 56.31 28.74 13.84 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.812 1.245 . . . . 15.23 113.27 173.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 119.49 -24.3 8.13 Favored Glycine 0 C--N 1.353 1.475 0 CA-C-N 116.5 -0.318 . . . . 45.25 113.663 177.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 143' ' ' ARG . . . . . 0.563 ' HG2' ' HG3' ' C' ' 164' ' ' MET . 0.3 OUTLIER -76.44 97.63 4.35 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.511 0.724 . . . . 73.04 109.059 178.838 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 40.9 ttp180 -113.42 95.45 5.37 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 109.17 -0.678 . . . . 71.51 109.17 176.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 145' ' ' VAL . . . . . . . . . . . . . 7.6 p -142.31 141.62 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 123.438 0.695 . . . . 75.03 111.254 -176.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 28.0 t -80.4 101.4 8.99 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 108.754 -0.832 . . . . 54.21 108.754 170.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 12.4 p -122.79 152.58 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.102 0.961 . . . . 72.53 110.014 -176.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -99.98 98.86 9.57 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 107.488 -1.301 . . . . 74.22 107.488 171.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 149' ' ' ILE . . . . . 0.653 HD12 HG21 ' C' ' 159' ' ' ILE . 45.9 pt -68.72 151.39 97.27 Favored Pre-proline 0 CA--C 1.55 0.961 0 N-CA-C 108.873 -0.788 . . . . 71.41 108.873 173.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -43.09 110.53 0.17 Allowed 'Trans proline' 0 C--N 1.387 2.604 0 C-N-CA 123.451 2.767 . . . . 61.44 113.543 -178.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -62.3 131.3 33.61 Favored 'Trans proline' 0 C--N 1.386 2.53 0 C-N-CA 122.786 2.324 . . . . 73.2 110.992 178.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 152' ' ' GLY . . . . . . . . . . . . . . . 102.13 61.57 0.74 Allowed Glycine 0 C--N 1.334 0.422 0 N-CA-C 110.396 -1.082 . . . . 54.32 110.396 -171.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 153' ' ' VAL . . . . . 0.501 ' HB ' HG12 ' C' ' 159' ' ' ILE . 0.9 OUTLIER -77.98 158.64 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 108.679 -0.86 . . . . 71.13 108.679 -179.691 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 154' ' ' ARG . . . . . 0.752 ' HG2' HD23 ' C' ' 188' ' ' LEU . 33.8 mtp180 -110.52 111.69 23.1 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 118.757 -0.639 . . . . 75.32 110.179 -170.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 155' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -43.29 120.29 1.84 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.735 1.214 . . . . 74.51 112.853 173.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.12 -7.8 20.47 Favored Glycine 0 C--N 1.354 1.551 0 C-N-CA 124.395 0.997 . . . . 64.51 114.182 177.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 157' ' ' SER . . . . . 0.522 ' HB2' ' HB2' ' C' ' 154' ' ' ARG . 69.4 m -109.91 -172.78 2.11 Favored 'General case' 0 C--O 1.246 0.905 0 C-N-CA 124.461 1.105 . . . . 75.43 110.735 -175.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 158' ' ' VAL . . . . . 0.657 ' HB ' ' HB1' ' B' ' 64' ' ' ALA . 12.1 p -88.25 138.99 18.07 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 CA-C-N 114.346 -1.297 . . . . 64.44 112.894 -170.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 159' ' ' ILE . . . . . 0.678 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 8.7 mt -108.31 93.25 2.41 Favored 'Isoleucine or valine' 0 C--O 1.245 0.819 0 N-CA-C 105.428 -2.064 . . . . 52.25 105.428 161.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 160' ' ' ARG . . . . . 0.545 ' HD2' ' HB ' ' B' ' 67' ' ' ILE . 6.1 ptm180 -82.27 123.65 29.24 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 108.951 -0.759 . . . . 72.21 108.951 178.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 161' ' ' VAL . . . . . 0.653 HG13 ' HB3' ' C' ' 174' ' ' LEU . 2.0 p -126.47 95.9 37.22 Favored Pre-proline 0 C--O 1.247 0.966 0 N-CA-C 107.694 -1.225 . . . . 75.24 107.694 170.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.26 147.75 88.12 Favored 'Trans proline' 0 C--N 1.381 2.268 0 C-N-CA 122.499 2.133 . . . . 63.42 110.836 175.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 87.64 25.73 31.88 Favored Glycine 0 C--N 1.338 0.686 0 CA-C-O 119.372 -0.682 . . . . 53.31 112.039 -171.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 164' ' ' MET . . . . . 0.563 ' HG3' ' HG2' ' C' ' 143' ' ' ARG . 34.4 ttm -156.44 23.26 0.35 Allowed 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 117.373 0.586 . . . . 73.35 112.144 -177.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . -86.77 -160.94 35.46 Favored Glycine 0 N--CA 1.48 1.604 0 N-CA-C 114.36 0.504 . . . . 64.24 114.36 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . -96.63 -175.46 35.45 Favored Glycine 0 C--N 1.357 1.733 0 C-N-CA 123.02 0.343 . . . . 75.44 113.514 -177.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 167' ' ' GLN . . . . . 0.437 ' HB3' ' HB3' ' C' ' 113' ' ' SER . 0.0 OUTLIER -43.42 122.01 2.46 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 126.036 1.734 . . . . 64.31 113.334 -176.941 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 168' ' ' GLY . . . . . 0.505 ' O ' ' HB3' ' C' ' 106' ' ' PHE . . . 177.07 -126.46 1.11 Allowed Glycine 0 C--N 1.349 1.288 0 CA-C-O 118.889 -0.951 . . . . 13.44 112.003 -175.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 169' ' ' ASN . . . . . 0.55 ' HB3' ' HD3' ' C' ' 170' ' ' PRO . 2.2 t-20 -174.53 -66.57 0.0 OUTLIER Pre-proline 0 CA--C 1.565 1.532 0 CA-C-O 117.759 -1.115 . . . . 62.44 110.731 163.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 170' ' ' PRO . . . . . 0.55 ' HD3' ' HB3' ' C' ' 169' ' ' ASN . 6.9 Cg_exo -69.31 -70.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.403 3.439 0 CA-C-N 122.015 1.755 . . . . 51.41 113.685 -177.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 171' ' ' PRO . . . . . 0.52 ' HG2' ' HG3' ' C' ' 115' ' ' LYS . 85.0 Cg_endo -93.85 126.08 0.53 Allowed 'Trans proline' 0 C--N 1.405 3.542 0 CA-C-N 123.901 2.429 . . . . 74.02 111.521 178.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -154.43 107.79 0.34 Allowed Glycine 0 C--N 1.331 0.25 0 N-CA-C 109.293 -1.523 . . . . 74.42 109.293 176.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 173' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -126.06 121.99 34.53 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 123.447 0.699 . . . . 74.51 109.473 -166.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 174' ' ' LEU . . . . . 0.653 ' HB3' HG13 ' C' ' 161' ' ' VAL . 61.8 tp -81.96 107.3 14.57 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 109.467 -0.568 . . . . 75.22 109.467 177.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 175' ' ' LEU . . . . . 0.448 HD22 HG21 ' C' ' 158' ' ' VAL . 11.4 mt -89.76 87.91 7.16 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 115.632 -0.713 . . . . 71.32 109.641 174.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 176' ' ' LEU . . . . . 0.678 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 98.5 mt -73.8 98.12 2.89 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 108.431 -0.951 . . . . 43.02 108.431 171.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 177' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' C' ' 122' ' ' GLU . 23.7 t -81.24 97.96 3.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 106.585 -1.635 . . . . 74.43 106.585 178.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 178' ' ' VAL . . . . . 0.432 HG21 HG21 ' C' ' 153' ' ' VAL . 3.5 p -87.86 129.95 38.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.012 -0.994 . . . . 74.01 110.756 -169.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 179' ' ' ARG . . . . . 0.434 ' O ' ' HA ' ' C' ' 124' ' ' PRO . 7.4 mmm180 -115.26 107.05 14.76 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 106.216 -1.772 . . . . 72.33 106.216 169.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 180' ' ' LEU . . . . . 0.413 ' HA ' ' O ' ' C' ' 125' ' ' LEU . 80.8 mt -68.38 138.51 55.42 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 109.147 -0.686 . . . . 70.51 109.147 175.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 181' ' ' LEU . . . . . . . . . . . . . 86.7 mt -50.55 129.76 26.36 Favored Pre-proline 0 N--CA 1.495 1.817 0 CA-C-O 117.848 -1.072 . . . . 74.2 108.672 -173.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER 11.42 -67.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.39 2.723 1 C-N-CA 126.135 4.557 . . . . 64.12 116.329 -153.024 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 183' ' ' HIS . . . . . 0.478 ' CD2' HD22 ' C' ' 127' ' ' LEU . 37.7 t-80 57.29 73.33 0.79 Allowed Pre-proline 0 N--CA 1.479 0.992 0 C-N-CA 124.18 0.992 . . . . 62.13 111.964 168.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 184' ' ' PRO . . . . . 0.537 ' HB2' ' HB3' ' B' ' 295' ' ' ALA . 63.8 Cg_endo -93.22 59.22 0.44 Allowed 'Trans proline' 0 C--N 1.358 1.042 0 N-CA-C 107.678 -1.701 . . . . 71.54 107.678 163.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 185' ' ' VAL . . . . . 0.626 HG11 ' SD ' ' C' ' 213' ' ' MET . 2.2 t -119.5 -59.01 2.95 Favored 'Isoleucine or valine' 0 C--N 1.362 1.133 0 N-CA-C 108.652 -0.87 . . . . 72.23 108.652 178.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 186' ' ' PHE . . . . . 0.495 ' HZ ' ' HA ' ' C' ' 214' ' ' THR . 40.8 m-85 -128.82 173.02 10.73 Favored 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 113.564 0.95 . . . . 61.44 113.564 -172.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 187' ' ' ARG . . . . . 0.442 ' NH1' ' HB2' ' C' ' 189' ' ' GLU . 2.1 tmt_? -152.61 120.92 6.3 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.983 1.313 . . . . 75.14 108.138 167.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 188' ' ' LEU . . . . . 0.752 HD23 ' HG2' ' C' ' 154' ' ' ARG . 48.7 tp -85.59 129.9 34.7 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 118.765 0.711 . . . . 74.14 112.797 -175.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 189' ' ' GLU . . . . . 0.442 ' HB2' ' NH1' ' C' ' 187' ' ' ARG . 14.6 tp10 -133.8 122.41 23.24 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 107.618 -1.253 . . . . 71.33 107.618 165.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 190' ' ' GLY . . . . . 0.479 ' HA2' ' HB3' ' B' ' 69' ' ' LEU . . . 67.27 -107.98 2.25 Favored Glycine 0 C--N 1.344 1.025 0 N-CA-C 111.473 -0.651 . . . . 74.2 111.473 -172.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 191' ' ' GLN . . . . . 0.442 ' NE2' ' HA3' ' C' ' 242' ' ' GLY . 24.7 mt-30 -122.93 -16.93 6.92 Favored 'General case' 0 C--O 1.258 1.513 0 C-N-CA 124.506 1.123 . . . . 60.21 109.446 174.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -81.37 135.8 35.69 Favored 'General case' 0 C--N 1.355 0.816 0 C-N-CA 124.76 1.224 . . . . 65.13 110.295 -178.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 193' ' ' LEU . . . . . 0.523 HD21 ' CD2' ' C' ' 240' ' ' PHE . 95.4 mt -92.9 154.04 18.44 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.771 0.428 . . . . 52.2 110.67 177.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 194' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -116.64 105.75 12.77 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.076 -1.453 . . . . 75.43 107.076 167.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 195' ' ' ALA . . . . . 0.527 ' HB3' ' HG ' ' C' ' 251' ' ' LEU . . . -103.07 -177.5 3.39 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 124.017 0.927 . . . . 65.11 110.536 177.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 46.7 m -134.64 110.83 9.55 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 108.702 -0.851 . . . . 51.32 108.702 168.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 197' ' ' LEU . . . . . 0.446 HD22 HD12 ' C' ' 233' ' ' LEU . 47.9 tp -85.22 146.13 27.23 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 109.139 -0.689 . . . . 73.5 109.139 174.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 198' ' ' ASP . . . . . 0.508 ' HA ' ' HB2' ' C' ' 254' ' ' ARG . 28.4 t70 -117.89 105.88 12.39 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 108.661 -0.866 . . . . 44.52 108.661 -179.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 199' ' ' VAL . . . . . 0.428 HG22 HG21 ' C' ' 210' ' ' VAL . 44.7 t -115.05 122.12 33.99 Favored Pre-proline 0 N--CA 1.48 1.046 0 C-N-CA 124.095 0.958 . . . . 61.21 109.435 -176.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 200' ' ' PRO . . . . . 0.451 ' HA ' ' O ' ' C' ' 256' ' ' THR . 55.3 Cg_endo -70.36 148.91 62.24 Favored 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 122.021 1.814 . . . . 71.34 111.341 175.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 201' ' ' ALA . . . . . . . . . . . . . . . -53.9 -45.41 98.92 Favored Pre-proline 0 CA--C 1.559 1.318 0 C-N-CA 124.844 1.258 . . . . 74.35 113.763 -172.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 202' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -55.49 -49.27 16.63 Favored 'Trans proline' 0 C--N 1.396 3.064 0 C-N-CA 121.879 1.719 . . . . 63.15 112.847 175.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 203' ' ' ILE . . . . . . . . . . . . . 58.0 mt -68.12 -33.14 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.721 0.808 . . . . 63.4 110.869 -178.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 204' ' ' ALA . . . . . 0.401 ' HA ' HG11 ' C' ' 223' ' ' VAL . . . -64.25 -44.07 92.93 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.653 0.781 . . . . 75.02 110.856 178.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 205' ' ' VAL . . . . . 0.503 ' HA ' ' HA ' ' C' ' 226' ' ' ARG . 87.0 t -75.4 -39.16 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 115.508 -0.769 . . . . 63.41 112.131 -176.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 206' ' ' VAL . . . . . 0.469 ' HA ' ' HE2' ' A' ' 270' ' ' LYS . 14.6 p -77.34 -37.04 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 CA-C-N 118.078 0.399 . . . . 52.12 110.635 -178.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 86.57 57.68 2.05 Favored Glycine 0 C--N 1.337 0.631 0 N-CA-C 111.384 -0.687 . . . . 63.21 111.384 -168.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -89.49 -131.61 4.36 Favored Glycine 0 C--N 1.345 1.075 0 N-CA-C 110.915 -0.874 . . . . 51.32 110.915 177.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 209' ' ' LYS . . . . . 0.513 ' HG2' ' HG2' ' C' ' 220' ' ' GLU . 4.6 ttmp? -150.44 143.35 24.72 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.345 0.658 . . . . 72.12 110.123 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 210' ' ' VAL . . . . . 0.428 HG21 HG22 ' C' ' 199' ' ' VAL . 30.4 m -134.34 167.98 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 C-N-CA 124.824 1.25 . . . . 62.05 109.486 177.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 211' ' ' ARG . . . . . 0.452 ' HA ' ' HA ' ' C' ' 220' ' ' GLU . 36.2 ttm180 -92.24 127.77 37.85 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 122.608 0.363 . . . . 72.44 111.027 179.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 212' ' ' ALA . . . . . . . . . . . . . . . -102.47 122.99 45.41 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 107.817 -1.179 . . . . 74.43 107.817 164.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 213' ' ' MET . . . . . 0.626 ' SD ' HG11 ' C' ' 185' ' ' VAL . 1.3 tmt? -77.63 136.63 38.26 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.757 -0.831 . . . . 63.12 108.757 175.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 214' ' ' THR . . . . . 0.495 ' HA ' ' HZ ' ' C' ' 186' ' ' PHE . 0.1 OUTLIER -134.32 166.8 21.98 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.014 0.526 . . . . 54.24 110.932 178.15 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 215' ' ' LEU . . . . . 0.405 HD13 ' HB2' ' C' ' 131' ' ' PHE . 52.1 mt -60.12 -38.77 84.03 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.752 1.221 . . . . 44.41 112.851 -171.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.41 14.64 22.55 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.044 0.938 . . . . 71.0 111.844 -174.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 148.77 169.2 15.28 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-O 119.645 -0.531 . . . . 64.11 112.735 176.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -91.73 118.3 0.49 Allowed 'Trans proline' 0 CA--C 1.56 1.815 0 C-N-CA 122.829 2.353 . . . . 52.13 113.004 176.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 219' ' ' VAL . . . . . 0.491 HG12 ' OG1' ' C' ' 214' ' ' THR . 2.9 p -100.01 115.26 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.13 0.572 . . . . 52.53 110.174 178.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 220' ' ' GLU . . . . . 0.513 ' HG2' ' HG2' ' C' ' 209' ' ' LYS . 24.8 tt0 -82.93 103.79 12.66 Favored 'General case' 0 CA--C 1.556 1.173 0 N-CA-C 108.015 -1.106 . . . . 72.32 108.015 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 221' ' ' VAL . . . . . 0.469 HG21 HD11 ' C' ' 233' ' ' LEU . 7.6 p -101.79 138.87 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.648 0.779 . . . . 74.03 112.513 -168.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -81.45 117.58 21.99 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.839 1.256 . . . . 73.3 112.424 -173.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . 0.401 HG11 ' HA ' ' C' ' 204' ' ' ALA . 59.7 t -77.7 142.09 65.39 Favored Pre-proline 0 CA--C 1.564 1.491 0 C-N-CA 125.801 1.64 . . . . 73.11 110.423 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 224' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -84.47 155.26 12.26 Favored 'Trans proline' 0 C--N 1.384 2.444 0 C-N-CA 123.408 2.739 . . . . 54.33 113.188 174.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.88 117.67 4.33 Favored 'Trans proline' 0 C--N 1.382 2.306 0 C-N-CA 123.49 2.793 . . . . 74.0 113.3 176.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 226' ' ' ARG . . . . . 0.503 ' HA ' ' HA ' ' C' ' 205' ' ' VAL . 0.0 OUTLIER 65.35 88.69 0.1 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.652 1.581 . . . . 70.15 112.224 -177.917 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 227' ' ' THR . . . . . . . . . . . . . 58.4 m -106.5 131.57 53.53 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 114.337 -1.301 . . . . 70.3 110.345 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 228' ' ' GLN . . . . . 0.503 ' NE2' ' HG2' ' A' ' 259' ' ' GLU . 22.8 mp0 -103.81 152.68 21.61 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.833 0.853 . . . . 74.32 110.816 177.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -69.27 140.71 54.46 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.032 -0.985 . . . . 62.12 109.523 177.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 93.28 -3.88 73.14 Favored Glycine 0 C--N 1.338 0.654 0 CA-C-O 119.639 -0.534 . . . . 62.04 112.942 -174.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 231' ' ' ARG . . . . . 0.439 ' HD2' ' H ' ' C' ' 228' ' ' GLN . 54.3 mtt180 -64.81 174.51 1.82 Allowed 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 117.564 0.682 . . . . 74.12 111.376 168.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 232' ' ' LYS . . . . . 0.467 ' HA ' ' O ' ' C' ' 251' ' ' LEU . 2.6 ttmp? -143.29 151.43 40.51 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.641 0.734 . . . . 71.45 111.064 179.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 233' ' ' LEU . . . . . 0.553 HD13 HD13 ' C' ' 251' ' ' LEU . 1.9 tt -127.97 142.35 51.27 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.049 1.74 . . . . 74.21 107.873 -169.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 234' ' ' ARG . . . . . 0.424 ' HA ' ' O ' ' C' ' 249' ' ' LEU . 36.3 ptt180 -115.22 116.78 28.91 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 121.577 0.703 . . . . 72.34 111.379 173.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 235' ' ' LEU . . . . . 0.456 ' HB2' ' HB3' ' C' ' 249' ' ' LEU . 67.9 mt -109.63 99.42 8.61 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 108.839 -0.8 . . . . 73.43 108.839 171.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 236' ' ' LYS . . . . . 0.43 ' HB2' ' ND2' ' B' ' 31' ' ' ASN . 30.6 mmmt -69.4 126.19 28.99 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 114.335 -1.302 . . . . 71.55 110.949 -172.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 87.56 7.06 76.2 Favored Glycine 0 C--N 1.349 1.269 0 O-C-N 123.749 0.656 . . . . 71.42 113.956 -177.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 238' ' ' LYS . . . . . 0.668 ' HE2' ' HB3' ' B' ' 33' ' ' ALA . 74.5 mmtt -109.91 17.16 21.43 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.469 0.708 . . . . 72.03 111.412 -178.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 239' ' ' GLY . . . . . 0.423 ' HA2' ' HG ' ' C' ' 193' ' ' LEU . . . -86.78 -166.11 42.06 Favored Glycine 0 C--N 1.348 1.239 0 N-CA-C 112.081 -0.408 . . . . 31.21 112.081 174.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 240' ' ' PHE . . . . . 0.523 ' CD2' HD21 ' C' ' 193' ' ' LEU . 2.2 m-85 -86.79 152.61 54.23 Favored Pre-proline 0 CA--C 1.558 1.261 0 N-CA-C 108.845 -0.798 . . . . 75.14 108.845 175.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 241' ' ' PRO . . . . . 0.43 ' HA ' ' HG2' ' C' ' 246' ' ' ARG . 31.5 Cg_exo -43.34 141.07 3.49 Favored 'Trans proline' 0 C--N 1.382 2.309 0 C-N-CA 124.622 3.548 . . . . 70.21 115.674 178.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 242' ' ' GLY . . . . . 0.442 ' HA3' ' NE2' ' C' ' 191' ' ' GLN . . . -133.88 148.95 19.61 Favored Glycine 0 C--N 1.348 1.217 0 CA-C-O 119.097 -0.835 . . . . 70.14 112.422 -176.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 243' ' ' PRO . . . . . 0.502 ' HB3' HD12 ' B' ' 71' ' ' ILE . 36.3 Cg_endo -60.09 -40.36 61.48 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 123.729 2.953 . . . . 71.42 113.462 -169.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -118.45 19.46 13.34 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.865 0.866 . . . . 71.42 110.787 -175.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 142.16 136.3 3.21 Favored Glycine 0 C--N 1.344 1.022 0 N-CA-C 110.063 -1.215 . . . . 51.32 110.063 -175.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 246' ' ' ARG . . . . . 0.43 ' HG2' ' HA ' ' C' ' 241' ' ' PRO . 90.5 mtt180 -78.25 150.72 33.37 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 117.349 0.575 . . . . 61.31 110.918 -172.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -72.76 -170.47 17.03 Favored Glycine 0 C--N 1.35 1.311 0 O-C-N 124.29 0.993 . . . . 63.23 114.831 -171.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -129.9 155.1 46.59 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.761 0.824 . . . . 73.54 109.017 -170.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 249' ' ' LEU . . . . . 0.486 HD11 ' HB2' ' C' ' 195' ' ' ALA . 24.0 tp -100.27 133.37 44.77 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.934 0.894 . . . . 74.23 110.89 -171.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 250' ' ' TYR . . . . . 0.488 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 1.0 OUTLIER -122.7 100.56 6.98 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.236 1.014 . . . . 71.43 111.084 178.662 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 251' ' ' LEU . . . . . 0.553 HD13 HD13 ' C' ' 233' ' ' LEU . 1.6 mp -97.0 125.69 41.6 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 118.9 -0.572 . . . . 64.53 110.586 -176.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -82.6 136.22 34.86 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 108.852 -0.795 . . . . 73.41 108.852 167.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 253' ' ' VAL . . . . . 0.485 HG21 ' CZ3' ' B' ' 242' ' ' TRP . 47.0 t -92.71 138.03 20.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 123.887 0.875 . . . . 73.5 112.82 -168.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 254' ' ' ARG . . . . . 0.508 ' HB2' ' HA ' ' C' ' 198' ' ' ASP . 20.6 mmt85 -102.65 136.07 43.15 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.2 1.4 . . . . 74.13 108.49 168.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 255' ' ' ILE . . . . . . . . . . . . . 32.7 mm -102.14 104.45 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 107.188 -1.412 . . . . 75.24 107.188 163.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 256' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' C' ' 200' ' ' PRO . 1.7 t -107.82 148.25 29.79 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.365 1.066 . . . . 53.32 109.902 -175.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 2.9 pp -111.9 145.73 33.31 Favored Pre-proline 0 N--CA 1.476 0.853 0 N-CA-C 109.393 -0.595 . . . . 64.54 109.393 176.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -60.4 -8.41 8.66 Favored 'Trans proline' 0 N--CA 1.507 2.268 0 C-N-CA 123.036 2.49 . . . . 73.21 115.36 -169.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 58.61 -68.5 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.572 1.549 . . . . 72.3 112.38 -168.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.17 149.68 44.75 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.771 0.829 . . . . 73.41 109.377 170.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 261' ' ' LEU . . . . . 0.521 HD11 HG13 ' A' ' 205' ' ' VAL . 77.6 mt -141.41 148.39 39.52 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.077 0.465 . . . . 71.21 111.089 -178.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 69.2 p -94.28 154.66 40.38 Favored Pre-proline 0 CA--C 1.554 1.129 0 N-CA-C 108.544 -0.91 . . . . 61.23 108.544 168.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 263' ' ' PRO . . . . . 0.401 ' HA ' ' HB1' ' B' ' 467' ' ' ALA . 86.0 Cg_exo -45.27 -45.06 15.52 Favored 'Trans proline' 0 C--N 1.391 2.798 0 C-N-CA 123.553 2.836 . . . . 74.2 114.188 -176.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -61.37 -52.59 64.01 Favored 'General case' 0 C--O 1.249 1.045 0 CA-C-N 115.1 -0.955 . . . . 71.04 110.856 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -52.06 -60.32 3.33 Favored 'General case' 0 C--N 1.362 1.129 0 O-C-N 124.537 1.148 . . . . 65.11 110.373 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 266' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -61.43 -33.82 74.35 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 124.179 0.924 . . . . 64.21 111.732 -172.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -59.63 -51.52 69.44 Favored 'General case' 0 CA--C 1.552 1.042 0 O-C-N 123.273 0.358 . . . . 70.32 111.359 173.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 268' ' ' LEU . . . . . . . . . . . . . 11.1 mp -66.61 -41.74 87.92 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 119.327 -0.368 . . . . 52.44 111.766 179.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -58.76 -38.57 78.74 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.654 0.782 . . . . 61.11 110.716 177.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 270' ' ' LYS . . . . . 0.503 ' HA ' HG21 ' A' ' 206' ' ' VAL . 9.6 mtpm? -66.51 -46.38 76.4 Favored 'General case' 0 C--N 1.361 1.091 0 C-N-CA 122.997 0.519 . . . . 75.43 111.139 176.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.83 -37.59 74.11 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 123.66 0.6 . . . . 75.33 111.405 178.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 82.5 mt -68.35 -42.48 79.16 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.537 -0.756 . . . . 74.33 110.356 174.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -67.58 -25.6 65.86 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.408 0.683 . . . . 34.13 111.369 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -81.31 -36.34 29.91 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.252 1.021 . . . . 63.21 109.879 176.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -61.02 -28.36 68.99 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.522 -0.763 . . . . 70.04 110.327 168.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 276' ' ' TYR . . . . . 0.534 ' HB3' HD11 ' A' ' 203' ' ' ILE . 7.9 m-85 -82.08 -32.4 30.32 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.419 1.088 . . . . 75.52 111.863 175.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 23.0 m-30 -64.68 -30.16 71.17 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 109.483 -0.562 . . . . 44.24 109.483 172.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -66.38 -15.48 63.32 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 123.784 0.834 . . . . 55.2 112.41 175.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 279' ' ' ARG . . . . . . . . . . . . . 26.3 mtp-105 -82.47 -15.67 51.66 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.1 0.56 . . . . 71.52 111.091 175.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.065 0 C-N-CA 122.938 0.495 . . . . 75.14 109.718 178.317 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 80.5 mtp . . . . . 0 N--CA 1.48 1.035 0 N-CA-C 110.586 -0.153 . . . . 64.12 110.586 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.29 40.77 11.04 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.574 1.149 . . . . 51.4 112.059 177.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -74.66 77.56 2.03 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.523 0.729 . . . . 74.04 110.229 177.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -35.82 110.79 0.11 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 125.489 1.515 . . . . 62.43 114.312 -177.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -87.9 102.77 15.04 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 107.479 -1.304 . . . . 74.32 107.479 163.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.485 ' HA ' ' OH ' ' A' ' 66' ' ' TYR . 7.3 t0 -71.37 92.7 1.08 Allowed 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 108.455 -0.943 . . . . 61.41 108.455 178.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -62.93 -36.28 82.89 Favored 'General case' 0 C--O 1.244 0.796 0 C-N-CA 123.613 0.765 . . . . 73.34 111.979 -171.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.419 ' CE1' HD11 ' A' ' 22' ' ' ILE . 77.7 m-85 -62.98 -44.49 95.9 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.595 -0.73 . . . . 73.33 110.674 175.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.91 -36.91 83.33 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.965 0.506 . . . . 60.32 111.431 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 6' ' ' ASP . 76.3 mt -61.61 -41.69 91.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.134 0.574 . . . . 74.23 110.086 176.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.1 mt -75.28 -14.12 60.48 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-N 116.145 -0.48 . . . . 51.33 111.955 175.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.49 24.13 76.77 Favored Glycine 0 C--N 1.353 1.476 0 CA-C-N 116.745 -0.207 . . . . 53.33 113.256 -177.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.5 m -108.48 152.38 42.04 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 124.128 0.971 . . . . 71.43 110.008 178.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -58.87 152.51 57.08 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.904 2.402 . . . . 50.12 112.602 174.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -69.49 7.34 0.84 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 112.664 0.616 . . . . 75.43 112.664 178.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -128.44 28.5 5.44 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.025 1.33 . . . . 64.11 107.786 177.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.6 168.7 2.75 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.96 0.904 . . . . 64.31 111.436 176.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 67.2 p -114.08 172.91 6.71 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.275 0.63 . . . . 71.11 109.642 175.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -58.02 -36.53 72.82 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.327 0.651 . . . . 64.21 110.393 176.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -66.59 -43.96 83.48 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.474 0.709 . . . . 72.43 111.433 177.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -67.42 -40.2 85.54 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.204 0.602 . . . . 64.03 111.743 -178.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.601 HD13 ' HB3' ' A' ' 57' ' ' LEU . 69.0 mt -71.59 -38.78 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.135 0.974 . . . . 73.31 110.748 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -65.25 -50.94 63.85 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.198 -0.91 . . . . 71.24 110.295 177.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 31.9 mtm180 -67.52 -33.12 74.42 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.352 0.661 . . . . 54.12 111.565 -178.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.32 -49.91 73.74 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 123.902 0.751 . . . . 64.0 109.588 174.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -60.58 -44.02 96.68 Favored 'General case' 0 C--O 1.206 -1.19 0 O-C-N 124.088 0.868 . . . . 73.1 110.589 178.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -58.69 -46.74 86.58 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.846 0.859 . . . . 74.22 110.833 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 47.4 ttt180 -57.14 -53.85 53.42 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.134 0.974 . . . . 71.15 110.671 177.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.643 ' HB3' HD13 ' A' ' 50' ' ' ILE . 73.6 mt -77.35 -21.66 53.01 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 115.274 -0.875 . . . . 74.11 111.368 -172.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -80.29 -32.09 38.17 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.443 0.697 . . . . 63.3 110.785 178.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 78.3 mtp180 -81.08 -39.99 24.83 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 122.938 0.495 . . . . 72.33 110.245 174.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.558 HE21 ' HA ' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -70.12 -50.13 43.75 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.297 0.639 . . . . 63.33 111.34 -175.288 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.51 ' HE2' HD22 ' A' ' 29' ' ' LEU . 15.6 m-85 -100.21 30.19 3.94 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.153 0.581 . . . . 63.25 109.628 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -65.71 111.44 6.32 Favored Pre-proline 0 C--N 1.354 0.763 0 N-CA-C 108.59 -0.893 . . . . 63.41 108.59 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -53.87 -38.37 85.79 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 123.186 2.591 . . . . 74.13 113.778 -168.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -70.24 -28.94 65.65 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.055 0.942 . . . . 72.45 112.3 -179.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 46.9 t -88.51 -61.58 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 N-CA-C 109.122 -0.696 . . . . 65.53 109.122 177.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -100.13 90.26 4.31 Favored 'General case' 0 C--O 1.243 0.759 0 C-N-CA 124.384 1.074 . . . . 61.35 108.881 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -81.04 69.93 7.75 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 108.67 -0.863 . . . . 73.11 108.67 178.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.2 m -125.03 106.04 28.8 Favored Pre-proline 0 C--O 1.237 0.4 0 N-CA-C 107.883 -1.154 . . . . 54.41 107.883 178.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_exo -43.89 -44.7 11.78 Favored 'Trans proline' 0 C--N 1.388 2.626 0 C-N-CA 123.749 2.966 . . . . 72.23 112.979 -177.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -50.81 -52.43 41.24 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.395 1.078 . . . . 64.43 111.31 176.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.7 -28.45 69.08 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 114.434 -1.257 . . . . 72.14 110.426 -177.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -82.19 -33.6 29.37 Favored 'General case' 0 C--O 1.219 -0.55 0 O-C-N 123.936 0.772 . . . . 62.01 110.293 -175.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.651 ' HA ' ' HD3' ' A' ' 48' ' ' LYS . 44.0 mt-10 -66.89 -46.35 75.19 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.961 0.905 . . . . 62.44 109.983 176.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -62.22 -42.64 99.49 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 114.224 -1.353 . . . . 74.03 109.875 174.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -56.99 -40.53 76.73 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.302 1.041 . . . . 73.24 110.725 176.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.651 ' HD3' ' HA ' ' A' ' 45' ' ' GLU . 24.0 mtpp -60.68 -48.75 80.38 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.703 0.801 . . . . 75.14 109.982 177.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -65.57 -26.5 67.89 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 123.38 0.425 . . . . 71.44 111.848 177.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.643 HD13 ' HB3' ' A' ' 29' ' ' LEU . 72.7 mt -74.5 -29.49 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 124.241 1.016 . . . . 70.53 110.058 175.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -73.27 -35.08 66.12 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.126 0.57 . . . . 73.43 110.444 172.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -67.86 -45.31 74.93 Favored 'General case' 0 C--O 1.256 1.443 0 C-N-CA 124.76 1.224 . . . . 63.42 110.302 175.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.13 -51.31 70.15 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 113.762 -1.563 . . . . 65.45 110.186 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 92.5 t80 -63.26 -35.26 79.75 Favored 'General case' 0 C--O 1.205 -1.267 0 CA-C-N 114.7 -1.136 . . . . 72.32 110.691 174.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.04 -51.34 66.61 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.298 0.639 . . . . 53.01 111.838 -177.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 94.4 t -75.39 -38.78 40.7 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 CA-C-N 115.121 -0.945 . . . . 74.52 110.893 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.601 ' HB3' HD13 ' A' ' 22' ' ' ILE . 73.1 mt -89.02 3.97 49.88 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 113.43 0.9 . . . . 62.04 113.43 -174.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.2 t -68.18 -73.12 0.15 Allowed 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.751 0.821 . . . . 74.34 110.497 -179.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -83.41 120.54 75.75 Favored Pre-proline 0 C--O 1.25 1.095 0 N-CA-C 108.346 -0.983 . . . . 74.34 108.346 178.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.553 ' O ' ' HG3' ' A' ' 64' ' ' ARG . 9.5 Cg_endo -53.82 -19.76 15.76 Favored 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 123.582 2.855 . . . . 72.41 115.187 -172.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -72.63 -53.14 12.63 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 119.397 0.999 . . . . 72.3 111.183 178.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -56.25 -41.16 75.32 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 122.417 1.103 . . . . 74.54 110.112 173.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.477 ' HB3' ' HA ' ' A' ' 60' ' ' PRO . 32.6 ttt180 -60.12 -43.09 95.91 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 113.273 -1.785 . . . . 74.11 111.142 175.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.553 ' HG3' ' O ' ' A' ' 60' ' ' PRO . 42.1 mtm180 -62.04 -37.23 84.16 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-O 118.974 -0.536 . . . . 74.25 110.314 177.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 84.9 mt -57.65 -44.55 85.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 O-C-N 123.982 0.801 . . . . 64.42 109.655 176.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.485 ' OH ' ' HA ' ' A' ' 6' ' ' ASP . 35.1 t80 -61.13 -50.51 72.89 Favored 'General case' 0 CA--C 1.558 1.25 0 CA-C-N 115.912 -0.585 . . . . 75.4 111.163 175.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -65.26 -23.85 67.16 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.857 0.863 . . . . 64.04 112.425 -179.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 81.5 p -97.0 -7.3 33.32 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 122.855 0.462 . . . . 75.13 110.601 176.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -73.28 103.76 4.09 Favored 'General case' 0 C--N 1.353 0.737 0 N-CA-C 106.997 -1.483 . . . . 63.45 106.997 168.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 110.15 23.95 5.9 Favored Glycine 0 CA--C 1.531 1.055 0 N-CA-C 110.947 -0.861 . . . . 52.54 110.947 -164.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 94.3 m -145.69 -56.33 0.3 Allowed 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 104.633 -2.358 . . . . 71.23 104.633 172.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 85.8 m -89.85 148.22 23.31 Favored 'General case' 0 C--O 1.252 1.235 0 N-CA-C 105.23 -2.137 . . . . 74.23 105.23 157.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.78 -42.32 4.53 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 123.405 0.682 . . . . 74.04 110.895 -178.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.25 134.98 51.13 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 123.346 0.658 . . . . 75.1 109.315 177.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.414 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 75.0 Cg_exo -52.28 126.16 19.7 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.718 2.279 . . . . 75.41 111.749 175.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 75' ' ' PRO . 43.4 Cg_exo -57.51 160.99 12.76 Favored 'Trans proline' 0 C--N 1.375 1.974 0 C-N-CA 123.305 2.67 . . . . 74.25 113.562 -177.088 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -64.48 121.25 8.78 Favored 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 122.195 1.93 . . . . 62.44 111.523 173.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.479 ' HG3' ' HA3' ' A' ' 104' ' ' GLY . 35.9 Cg_endo -63.25 136.43 55.63 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 122.871 2.38 . . . . 43.51 111.702 177.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.567 ' HB3' HD11 ' B' ' 29' ' ' LEU . 51.8 Cg_exo -57.89 157.07 25.61 Favored 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 123.183 2.589 . . . . 71.05 112.626 175.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -60.37 84.46 0.07 OUTLIER 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 122.801 2.334 . . . . 51.35 111.411 172.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.21 -32.3 0.32 Allowed Glycine 0 CA--C 1.525 0.672 0 CA-C-N 114.312 -1.313 . . . . 62.41 109.824 -176.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.92 156.32 31.37 Favored Glycine 0 C--N 1.351 1.366 0 C-N-CA 123.413 0.53 . . . . 53.03 113.072 171.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -63.06 94.47 0.07 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.809 0.843 . . . . 74.41 110.169 170.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -76.78 157.89 31.28 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 109.002 -0.74 . . . . 71.31 109.002 169.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.521 ' HE2' ' HD2' ' A' ' 93' ' ' PHE . 16.1 t80 -127.49 50.46 2.01 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.567 0.699 . . . . 70.22 109.563 -178.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.428 ' HB3' HH22 ' B' ' 22' ' ' ARG . 57.8 m -0.41 83.69 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.484 0 C-N-CA 127.288 2.235 . . . . 74.44 116.475 -174.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.86 -13.94 2.94 Favored Glycine 0 N--CA 1.482 1.748 0 N-CA-C 116.655 1.422 . . . . 70.11 116.655 168.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.502 ' HB3' ' HE2' ' A' ' 93' ' ' PHE . 63.5 m-85 -90.34 136.98 32.72 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 118.158 0.979 . . . . 72.34 110.179 -174.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -66.17 92.51 0.18 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.091 0.556 . . . . 71.44 110.695 -170.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.568 HG13 ' HG3' ' A' ' 91' ' ' GLU . 2.3 p -40.9 -51.49 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 125.12 1.368 . . . . 75.21 113.0 171.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.568 ' HG3' HG13 ' A' ' 90' ' ' VAL . 40.3 mt-10 -71.87 -12.1 61.11 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.614 0.766 . . . . 75.33 111.528 -173.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -87.09 -34.35 19.17 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.518 0.727 . . . . 45.35 110.632 174.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.521 ' HD2' ' HE2' ' A' ' 85' ' ' PHE . 26.5 m-85 -91.49 174.14 7.53 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.158 0.799 . . . . 71.01 113.158 -168.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 88.5 p -58.76 151.39 21.32 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 115.395 1.628 . . . . 74.5 115.395 -162.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.91 -42.87 80.72 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.028 -1.442 . . . . 74.31 110.877 170.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -50.61 -50.99 52.76 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.185 0.994 . . . . 75.03 111.042 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.478 ' HE2' HG23 ' A' ' 90' ' ' VAL . 1.4 t80 -59.69 -50.56 73.35 Favored 'General case' 0 CA--C 1.555 1.172 0 O-C-N 124.226 0.954 . . . . 63.23 109.829 174.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -66.56 -6.6 15.71 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.207 0.603 . . . . 73.05 112.249 -176.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -103.0 -30.95 10.47 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.168 0.987 . . . . 70.02 111.831 170.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 26.3 tp -73.59 -56.19 5.33 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.341 0.657 . . . . 55.03 110.842 -177.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -93.51 -6.55 46.54 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.115 0.566 . . . . 72.11 110.662 174.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -47.48 -55.75 8.93 Favored Glycine 0 C--N 1.351 1.394 0 CA-C-O 118.767 -1.018 . . . . 72.43 115.579 -177.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -46.4 -13.83 0.11 Allowed 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 124.792 3.661 . . . . 23.1 116.746 176.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.479 ' HA3' ' HG3' ' A' ' 78' ' ' PRO . . . -149.93 29.03 1.14 Allowed Glycine 0 C--N 1.355 1.585 0 CA-C-O 118.599 -1.112 . . . . 44.4 114.215 174.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.526 HD13 HD21 ' A' ' 169' ' ' ASN . 15.1 mt -60.99 79.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 113.005 0.743 . . . . 74.25 113.005 177.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.77 ' HB3' ' HA ' ' A' ' 169' ' ' ASN . 0.5 OUTLIER 24.72 -100.9 0.01 OUTLIER 'General case' 0 CA--C 1.569 1.7 0 C-N-CA 127.249 2.219 . . . . 72.25 113.956 170.175 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 80.06 6.28 89.23 Favored Glycine 0 C--N 1.363 2.046 0 CA-C-N 117.896 0.317 . . . . 44.0 113.431 -176.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 59.61 -129.51 48.74 Favored Glycine 0 C--N 1.348 1.231 0 N-CA-C 111.317 -0.713 . . . . 71.34 111.317 -172.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -97.82 -2.13 41.64 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.35 0.66 . . . . 64.11 110.294 169.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -81.09 -26.96 51.43 Favored Glycine 0 C--N 1.355 1.597 0 N-CA-C 111.896 -0.482 . . . . 55.25 111.896 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? 60.15 3.65 0.55 Allowed 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 115.248 1.573 . . . . 71.44 115.248 170.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.86 -15.67 60.18 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 122.795 0.438 . . . . 73.25 109.994 174.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.421 ' HB3' HD22 ' A' ' 169' ' ' ASN . 40.4 m 70.23 46.4 0.61 Allowed 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.622 1.169 . . . . 74.21 110.518 -177.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -86.17 159.22 19.57 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 114.948 -1.024 . . . . 74.52 112.369 -174.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -59.11 146.1 39.9 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 124.826 1.251 . . . . 72.15 111.756 174.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -88.65 169.98 37.87 Favored Glycine 0 C--N 1.353 1.478 0 CA-C-N 116.337 -0.392 . . . . 55.22 112.961 178.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.418 ' HD3' ' H ' ' A' ' 117' ' ' ARG . 0.0 OUTLIER -113.95 -178.25 3.33 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.523 0.729 . . . . 71.34 110.353 -179.839 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -77.07 142.54 39.77 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 109.04 -0.726 . . . . 74.23 109.04 170.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.472 HD11 ' HB3' ' B' ' 10' ' ' LEU . 7.7 tt -144.18 125.75 14.98 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 107.658 -1.238 . . . . 70.23 107.658 -175.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.5 ' NH2' ' HB ' ' A' ' 177' ' ' VAL . 0.0 OUTLIER -97.58 126.44 42.88 Favored 'General case' 0 C--O 1.217 -0.625 0 N-CA-C 107.293 -1.373 . . . . 74.51 107.293 175.903 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.475 ' HB3' HD23 ' A' ' 176' ' ' LEU . . . -120.42 155.7 32.93 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-N 118.39 0.541 . . . . 41.51 111.534 -177.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.549 ' HB2' ' HB3' ' B' ' 9' ' ' ALA . 1.2 mm-40 -92.8 111.7 23.41 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 106.244 -1.761 . . . . 61.0 106.244 175.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.487 ' HB3' ' HA ' ' A' ' 178' ' ' VAL . 61.1 tp -101.35 96.17 5.79 Favored Pre-proline 0 N--CA 1.476 0.854 0 N-CA-C 108.29 -1.004 . . . . 54.05 108.29 177.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.645 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 58.5 Cg_endo -73.23 112.37 3.51 Favored 'Trans proline' 0 C--N 1.376 2.016 0 C-N-CA 121.406 1.404 . . . . 75.33 110.001 178.198 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.5 ' HB3' HD23 ' A' ' 180' ' ' LEU . 52.8 tp -116.73 138.9 51.13 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.413 0.625 . . . . 64.01 111.536 -168.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.633 ' HB ' ' HG2' ' A' ' 129' ' ' GLU . 93.3 m -72.3 125.73 28.06 Favored 'General case' 0 CA--C 1.553 1.072 0 CA-C-N 113.856 -1.52 . . . . 71.34 109.369 174.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.449 ' HB3' HD22 ' A' ' 215' ' ' LEU . 48.9 mt -53.4 -39.7 64.48 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 124.032 0.933 . . . . 70.54 112.249 -171.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -69.03 -33.85 74.28 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 115.465 -0.789 . . . . 75.32 110.628 -177.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.633 ' HG2' ' HB ' ' A' ' 126' ' ' THR . 12.2 mm-40 -72.99 -26.42 61.33 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 109.949 -0.389 . . . . 64.33 109.949 175.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.433 ' HB1' ' O ' ' A' ' 153' ' ' VAL . . . -66.7 -37.62 85.08 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 123.393 0.433 . . . . 41.43 110.54 174.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -65.38 -50.52 65.22 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 115.025 -0.989 . . . . 74.51 111.287 173.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 30.9 m170 -70.74 -45.19 65.29 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.183 0.593 . . . . 75.25 111.624 -171.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.07 -163.27 54.11 Favored Glycine 0 C--N 1.339 0.742 0 O-C-N 123.465 0.478 . . . . 71.54 112.834 -175.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 96.93 -173.84 29.64 Favored Glycine 0 C--N 1.345 1.051 0 N-CA-C 112.554 -0.219 . . . . 70.42 112.554 179.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 2.0 mp0 -78.88 109.53 13.24 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 122.655 -0.321 . . . . 73.14 110.357 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -90.97 126.46 36.08 Favored 'General case' 0 C--O 1.248 1.022 0 N-CA-C 109.317 -0.623 . . . . 74.4 109.317 173.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.412 HG13 ' HG3' ' A' ' 144' ' ' ARG . 76.3 t -80.31 116.31 24.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 114.742 -1.117 . . . . 71.24 108.483 168.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.638 ' HB ' HG13 ' A' ' 145' ' ' VAL . 62.2 t -124.75 129.21 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.08 0.952 . . . . 73.14 109.042 -175.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.429 ' HG2' ' HB3' ' B' ' 30' ' ' GLU . 14.7 tp10 -98.03 142.92 29.15 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 122.996 0.518 . . . . 71.3 110.941 -177.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.549 ' HB ' ' HB3' ' B' ' 8' ' ' LEU . 8.1 p -160.67 121.86 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 C-N-CA 123.515 0.726 . . . . 75.1 111.023 174.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 65.51 14.3 9.4 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.471 1.108 . . . . 74.24 113.911 169.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 84.6 28.04 33.69 Favored Glycine 0 N--CA 1.479 1.518 0 N-CA-C 111.9 -0.48 . . . . 31.1 111.9 -174.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 17.9 tpt85 -152.62 97.31 2.23 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 107.737 -1.208 . . . . 72.12 107.737 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.611 ' HB3' ' HA ' ' B' ' 28' ' ' VAL . 0.0 OUTLIER -64.54 129.96 41.86 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 114.908 -1.042 . . . . 74.41 111.424 179.375 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.638 HG13 ' HB ' ' A' ' 138' ' ' VAL . 1.4 p -91.79 130.09 41.46 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 C-N-CA 124.346 1.058 . . . . 73.53 109.223 165.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.549 ' HB2' ' NH1' ' A' ' 144' ' ' ARG . 47.5 t -92.96 132.03 37.43 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 108.317 -0.994 . . . . 31.45 108.317 167.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 2.1 p -139.81 118.01 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 O-C-N 123.65 0.594 . . . . 73.42 109.919 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.443 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 47.8 ttt85 -74.37 93.41 2.41 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 107.864 -1.162 . . . . 74.14 107.864 167.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.554 ' HB ' HG11 ' A' ' 153' ' ' VAL . 34.2 pt -71.75 125.23 91.7 Favored Pre-proline 0 CA--C 1.55 0.956 0 N-CA-C 108.408 -0.96 . . . . 74.13 108.408 175.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -59.39 138.28 83.3 Favored 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 122.371 2.048 . . . . 60.34 111.951 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -62.84 93.02 0.14 Allowed 'Trans proline' 0 C--N 1.374 1.877 0 C-N-CA 121.996 1.797 . . . . 74.15 110.116 171.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.503 ' HA2' ' CD2' ' A' ' 240' ' ' PHE . . . 125.02 24.21 1.69 Allowed Glycine 0 C--N 1.345 1.046 0 CA-C-N 115.1 -0.954 . . . . 75.51 113.084 -173.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.581 HG21 HD11 ' A' ' 159' ' ' ILE . 2.6 p -75.38 149.67 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 123.626 0.77 . . . . 75.43 110.366 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.467 ' O ' HG13 ' A' ' 178' ' ' VAL . 0.1 OUTLIER -119.24 -165.35 1.14 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.507 0.723 . . . . 73.23 112.099 -161.043 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.549 ' HB3' ' O ' ' A' ' 188' ' ' LEU . 3.0 tp10 -86.6 141.36 29.06 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 105.481 -2.044 . . . . 72.32 105.481 160.252 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 65.71 9.03 43.46 Favored Glycine 0 CA--C 1.535 1.311 0 N-CA-C 115.322 0.889 . . . . 14.21 115.322 177.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.501 ' O ' HG12 ' A' ' 178' ' ' VAL . 23.2 t -74.64 117.89 16.98 Favored 'General case' 0 C--N 1.355 0.833 0 N-CA-C 107.949 -1.13 . . . . 74.23 107.949 175.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.521 HG22 HG22 ' A' ' 177' ' ' VAL . 41.7 t -84.84 88.63 2.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.577 -0.898 . . . . 72.34 108.577 -178.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.581 HD11 HG21 ' A' ' 153' ' ' VAL . 30.0 mt -72.3 98.82 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 107.704 -1.221 . . . . 75.24 107.704 174.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -79.61 98.19 6.81 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 114.581 -1.19 . . . . 61.32 108.687 -176.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 3.4 p -123.51 94.92 45.81 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 123.649 0.78 . . . . 61.33 109.473 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.628 ' HG2' ' HG2' ' B' ' 20' ' ' LYS . 10.8 Cg_endo -56.65 143.67 88.47 Favored 'Trans proline' 0 C--N 1.363 1.336 0 C-N-CA 123.025 2.483 . . . . 74.53 112.874 167.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 95.51 20.37 27.27 Favored Glycine 0 N--CA 1.445 -0.764 0 CA-C-N 114.658 -1.155 . . . . 70.43 115.056 172.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.458 ' HG3' HG23 ' A' ' 145' ' ' VAL . 24.9 mmt -143.99 7.96 1.43 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.16 0.584 . . . . 64.15 110.433 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.563 ' HA2' HD13 ' A' ' 174' ' ' LEU . . . -90.55 -121.13 2.31 Favored Glycine 0 C--N 1.346 1.115 0 CA-C-N 115.672 -0.694 . . . . 73.33 114.436 -168.129 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.492 ' O ' ' HA ' ' A' ' 171' ' ' PRO . . . -60.94 115.71 8.25 Favored Glycine 0 C--N 1.362 2.007 0 CA-C-O 119.493 -0.615 . . . . 74.5 113.494 -169.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -59.59 146.25 41.5 Favored 'General case' 0 C--N 1.35 0.615 0 O-C-N 125.087 1.11 . . . . 75.42 111.034 -175.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 169.18 -125.25 1.24 Allowed Glycine 0 CA--C 1.495 -1.197 0 N-CA-C 106.816 -2.514 . . . . 64.21 106.816 -174.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . 0.77 ' HA ' ' HB3' ' A' ' 106' ' ' PHE . 43.4 t-20 -98.31 -57.09 0.17 Allowed Pre-proline 0 CA--C 1.55 0.981 0 N-CA-C 107.415 -1.328 . . . . 63.11 107.415 170.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.668 ' HD3' ' HB3' ' A' ' 169' ' ' ASN . 59.5 Cg_endo -95.03 109.18 0.13 Allowed 'Trans proline' 0 C--N 1.382 2.341 0 C-N-CA 122.033 1.822 . . . . 71.13 110.937 165.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.492 ' HA ' ' O ' ' A' ' 166' ' ' GLY . 29.6 Cg_endo -61.59 113.58 1.87 Allowed 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 121.74 1.627 . . . . 71.25 108.936 174.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -63.94 -142.06 0.02 OUTLIER Glycine 0 N--CA 1.484 1.841 0 N-CA-C 116.096 1.198 . . . . 72.4 116.096 -166.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.613 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 38.9 t70 -80.85 124.71 29.32 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 122.177 -0.602 . . . . 71.14 109.427 -177.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.563 HD13 ' HA2' ' A' ' 165' ' ' GLY . 26.9 tp -106.88 118.36 36.48 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.148 0.499 . . . . 64.32 110.5 -174.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.65 HD11 ' HB2' ' B' ' 15' ' ' PHE . 47.5 mt -94.58 85.53 4.54 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 124.061 0.944 . . . . 72.12 108.764 176.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.538 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 43.1 mt -72.73 84.37 1.19 Allowed 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.025 -0.534 . . . . 70.05 109.852 178.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.521 HG22 HG22 ' A' ' 158' ' ' VAL . 46.6 t -82.9 98.71 5.13 Favored 'Isoleucine or valine' 0 C--O 1.248 1.026 0 N-CA-C 104.917 -2.253 . . . . 61.43 104.917 176.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.501 HG12 ' O ' ' A' ' 157' ' ' SER . 10.0 p -76.27 113.29 15.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 112.108 -2.315 . . . . 70.33 111.001 -166.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.645 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 30.8 mmm-85 -90.16 106.45 18.49 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-N 115.499 -0.773 . . . . 53.32 108.989 178.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.5 HD23 ' HB3' ' A' ' 125' ' ' LEU . 23.3 mt -68.66 147.36 51.98 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 118.76 0.709 . . . . 72.4 110.29 177.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 125' ' ' LEU . 83.9 mt -55.37 159.1 4.8 Favored Pre-proline 0 N--CA 1.484 1.261 0 C-N-CA 124.17 0.988 . . . . 73.14 112.289 -176.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -74.87 24.01 0.39 Allowed 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 122.991 2.46 . . . . 71.42 112.689 170.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.418 ' ND1' HD12 ' A' ' 127' ' ' LEU . 65.5 t-80 -61.62 116.09 18.67 Favored Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 125.231 1.412 . . . . 73.35 108.327 174.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -75.51 24.89 0.4 Allowed 'Trans proline' 0 C--N 1.371 1.727 0 C-N-CA 124.146 3.23 . . . . 61.24 116.902 -160.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 97.0 t -97.24 -57.82 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 119.168 0.895 . . . . 64.21 109.695 -179.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . 0.501 ' CE1' ' HB2' ' A' ' 195' ' ' ALA . 19.1 m-85 -132.87 143.61 49.63 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 112.551 0.574 . . . . 72.31 112.551 -171.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.736 HH22 ' HB2' ' B' ' 411' ' ' ALA . 0.0 OUTLIER -114.12 83.33 1.85 Allowed 'General case' 0 C--O 1.239 0.508 0 N-CA-C 106.735 -1.58 . . . . 75.51 106.735 163.389 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.549 ' O ' ' HB3' ' A' ' 155' ' ' GLU . 48.1 tp -75.07 131.1 40.32 Favored 'General case' 0 C--O 1.202 -1.395 0 CA-C-N 114.465 -1.243 . . . . 74.21 109.367 177.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.404 ' HG3' ' HA ' ' B' ' 410' ' ' GLN . 0.4 OUTLIER -147.2 129.89 16.05 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.089 -1.078 . . . . 70.31 108.089 171.94 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 66.26 -81.86 0.1 Allowed Glycine 0 C--N 1.344 0.98 0 O-C-N 124.352 1.032 . . . . 65.41 112.564 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.5 ' HB2' ' HA2' ' A' ' 247' ' ' GLY . 0.7 OUTLIER -129.97 -32.63 1.83 Allowed 'General case' 0 C--O 1.249 1.071 0 C-N-CA 123.834 0.853 . . . . 72.32 109.867 179.268 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -88.26 149.38 23.85 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.625 -0.716 . . . . 72.32 111.776 -166.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.478 HD23 ' HB2' ' A' ' 188' ' ' LEU . 88.6 mt -103.25 158.99 15.94 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.532 1.133 . . . . 63.44 108.97 173.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.686 ' HB2' ' HB3' ' A' ' 187' ' ' ARG . 28.5 m-85 -131.35 101.33 5.5 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 108.707 -0.849 . . . . 73.14 108.707 168.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.501 ' HB2' ' CE1' ' A' ' 186' ' ' PHE . . . -105.4 131.48 52.78 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 109.145 -0.687 . . . . 74.34 109.145 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . 0.586 ' HA ' ' HB2' ' A' ' 252' ' ' GLU . 30.4 m -71.72 110.75 6.47 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 109.308 -0.627 . . . . 70.21 109.308 177.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.568 HD22 HD13 ' A' ' 251' ' ' LEU . 50.1 tp -103.15 101.14 11.09 Favored 'General case' 0 C--N 1.347 0.487 0 N-CA-C 110.111 -0.329 . . . . 72.21 110.111 -178.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -73.6 127.7 33.47 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.562 -1.273 . . . . 61.43 107.562 164.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.581 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 7.1 p -142.18 135.35 14.14 Favored Pre-proline 0 CA--C 1.539 0.545 0 N-CA-C 107.889 -1.152 . . . . 64.4 107.889 178.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.3 158.72 37.0 Favored 'Trans proline' 0 C--N 1.361 1.222 0 C-N-CA 121.475 1.45 . . . . 64.51 112.196 172.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.411 ' HB3' ' HD3' ' A' ' 202' ' ' PRO . . . -56.83 -49.66 92.57 Favored Pre-proline 0 N--CA 1.481 1.109 0 N-CA-C 113.233 0.827 . . . . 71.34 113.233 -178.08 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.411 ' HD3' ' HB3' ' A' ' 201' ' ' ALA . 57.1 Cg_exo -57.28 -45.42 35.14 Favored 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 121.953 1.768 . . . . 63.54 113.802 178.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 55.4 mt -71.39 -29.69 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 122.953 0.501 . . . . 64.32 110.86 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.89 -42.2 85.92 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.715 0.406 . . . . 71.51 110.391 175.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 46.0 t -68.85 -55.66 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.593 0.757 . . . . 63.23 111.292 -178.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.653 HG21 ' HA ' ' C' ' 270' ' ' LYS . 61.4 t -83.06 -41.69 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-O 120.872 0.367 . . . . 74.41 111.173 -172.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 88.96 168.89 44.27 Favored Glycine 0 C--N 1.338 0.692 0 CA-C-N 115.968 -0.56 . . . . 72.35 111.973 -174.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 161.32 -125.34 1.43 Allowed Glycine 0 C--O 1.224 -0.495 0 N-CA-C 110.149 -1.18 . . . . 55.24 110.149 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -137.97 135.74 36.29 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 118.099 0.95 . . . . 45.21 110.882 175.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 28.4 m -129.34 -176.71 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 124.181 0.993 . . . . 63.11 109.276 170.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -80.86 133.24 35.55 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.32 0.648 . . . . 71.41 110.765 176.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -119.92 111.94 18.57 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.542 -1.281 . . . . 62.04 107.542 165.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -71.81 129.16 37.96 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.055 -0.72 . . . . 71.23 109.055 177.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 43.4 p -109.27 179.82 4.05 Favored 'General case' 0 C--O 1.243 0.763 0 N-CA-C 107.744 -1.206 . . . . 74.1 107.744 171.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.449 HD22 ' HB3' ' A' ' 127' ' ' LEU . 72.2 mt -61.21 -22.11 64.46 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 114.021 1.119 . . . . 63.31 114.021 -170.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -142.64 28.7 1.6 Allowed 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 112.705 0.632 . . . . 64.44 112.705 -177.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 155.89 159.67 9.51 Favored Glycine 0 N--CA 1.477 1.419 0 N-CA-C 114.28 0.472 . . . . 33.0 114.28 173.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -87.69 130.39 2.7 Favored 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 123.199 2.599 . . . . 70.23 113.305 178.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 30.9 m -110.99 175.59 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 123.749 0.82 . . . . 73.4 110.262 175.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -101.82 111.22 23.4 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.803 0.841 . . . . 75.04 109.355 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 14.7 p -100.15 133.81 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 123.156 0.582 . . . . 74.13 109.584 177.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -86.64 104.47 16.08 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 122.955 0.502 . . . . 60.25 110.49 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 60.2 t -71.24 128.74 89.95 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 123.914 0.886 . . . . 63.14 109.857 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . 0.558 ' HD3' HD12 ' B' ' 441' ' ' ILE . 79.0 Cg_endo -74.62 167.02 28.07 Favored 'Trans proline' 0 C--N 1.373 1.835 0 C-N-CA 122.743 2.295 . . . . 75.51 111.636 172.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . 0.466 ' HB2' ' HE ' ' A' ' 226' ' ' ARG . 58.8 Cg_endo -70.35 159.99 51.07 Favored 'Trans proline' 0 C--N 1.365 1.418 0 C-N-CA 122.712 2.274 . . . . 72.53 113.441 171.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . 0.466 ' HE ' ' HB2' ' A' ' 225' ' ' PRO 0.266 0.0 OUTLIER 38.03 55.96 1.64 Allowed 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 126.428 1.891 . . . . 74.04 113.378 -175.913 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.522 HG23 HD21 ' A' ' 233' ' ' LEU . 64.2 m -84.2 90.44 7.51 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 113.06 -1.882 . . . . 64.32 108.953 173.198 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -86.15 146.45 26.58 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.766 0.826 . . . . 75.32 111.545 -171.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -64.8 148.45 51.23 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.846 0.858 . . . . 62.31 112.333 -176.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . 0.405 ' HA3' ' NH2' ' C' ' 254' ' ' ARG . . . 90.78 -21.16 34.71 Favored Glycine 0 C--N 1.345 1.041 0 CA-C-N 115.434 -0.803 . . . . 73.32 113.311 -178.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.53 ' HD3' ' OH ' ' B' ' 444' ' ' TYR . 99.8 mtt180 -81.2 170.81 15.64 Favored 'General case' 0 C--O 1.245 0.821 0 C-N-CA 123.757 0.823 . . . . 74.0 110.993 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.444 ' HG3' ' HB3' ' A' ' 250' ' ' TYR . 0.3 OUTLIER -129.02 117.28 20.65 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 114.601 -1.181 . . . . 72.22 109.03 -178.892 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.522 HD21 HG23 ' A' ' 227' ' ' THR . 58.2 mt -78.33 110.86 13.73 Favored 'General case' 0 C--O 1.218 -0.558 0 N-CA-C 108.034 -1.098 . . . . 71.4 108.034 175.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -80.99 106.51 13.05 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.974 0.909 . . . . 64.14 109.974 175.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.672 ' HB3' ' HA ' ' B' ' 441' ' ' ILE . 0.2 OUTLIER -118.68 107.22 13.43 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.229 0.537 . . . . 61.12 109.757 171.912 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 248' ' ' ASP . 25.6 mtpp -76.52 159.75 30.08 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.36 1.064 . . . . 64.43 111.079 -177.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 66.37 18.56 67.63 Favored Glycine 0 C--N 1.348 1.207 0 CA-C-N 115.688 -0.687 . . . . 74.2 113.279 -176.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.598 ' HG3' HD12 ' A' ' 235' ' ' LEU . 45.5 mmtm -114.32 -29.93 6.76 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.229 1.011 . . . . 73.01 109.805 -179.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -79.04 -154.98 8.56 Favored Glycine 0 C--N 1.343 0.95 0 CA-C-N 115.001 -1.0 . . . . 74.43 111.107 169.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . 0.503 ' CD2' ' HA2' ' A' ' 152' ' ' GLY . 35.3 m-85 -95.35 123.44 56.72 Favored Pre-proline 0 C--O 1.239 0.504 0 N-CA-C 109.519 -0.548 . . . . 73.13 109.519 -173.383 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.728 ' HA ' ' HA ' ' A' ' 246' ' ' ARG . 73.8 Cg_endo -73.24 132.16 17.52 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 122.721 2.281 . . . . 73.33 113.116 -170.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -101.65 -167.48 27.44 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 110.757 -0.937 . . . . 73.52 110.757 167.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -60.07 -62.54 0.15 Allowed 'Trans proline' 0 C--N 1.377 2.037 0 C-N-CA 122.915 2.41 . . . . 70.45 111.649 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -106.34 -25.31 11.98 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.449 0.7 . . . . 70.11 110.104 170.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -89.84 67.42 2.7 Favored Glycine 0 C--N 1.352 1.447 0 CA-C-N 115.759 -0.655 . . . . 62.24 112.457 -175.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.728 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 52.3 mtm-85 -69.92 118.24 12.51 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 123.529 0.732 . . . . 75.41 109.853 175.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.5 ' HA2' ' HB2' ' A' ' 191' ' ' GLN . . . -52.85 149.86 10.4 Favored Glycine 0 C--N 1.351 1.376 0 N-CA-C 117.346 1.698 . . . . 42.24 117.346 -167.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . 0.488 ' HA ' ' HA ' ' A' ' 236' ' ' LYS . 0.8 OUTLIER -98.46 172.87 7.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 113.858 -1.171 . . . . 75.44 109.173 -179.228 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.503 ' HB3' ' HG ' ' A' ' 235' ' ' LEU . 17.5 tp -137.06 101.78 4.65 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 106.21 -1.774 . . . . 70.31 106.21 170.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.444 ' HB3' ' HG3' ' A' ' 232' ' ' LYS . 84.6 m-85 -85.98 112.14 20.93 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 123.553 0.741 . . . . 52.51 109.219 174.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.568 HD13 HD22 ' A' ' 197' ' ' LEU . 94.0 mt -88.92 121.12 30.96 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.152 -0.931 . . . . 72.24 110.065 178.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.586 ' HB2' ' HA ' ' A' ' 196' ' ' THR . 45.9 mm-40 -75.15 91.49 2.6 Favored 'General case' 0 C--N 1.352 0.711 0 N-CA-C 108.132 -1.062 . . . . 75.41 108.132 177.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 42.0 t -65.41 115.59 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 O-C-N 123.705 0.628 . . . . 24.43 110.239 -178.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . 0.478 ' HA ' ' HD3' ' A' ' 254' ' ' ARG . 7.2 mmt180 -129.23 102.22 6.36 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.703 0.801 . . . . 73.14 108.921 172.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.581 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 60.9 mt -77.38 134.04 29.4 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-N 114.174 -1.375 . . . . 74.34 110.706 -179.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 28.4 p -127.7 174.5 9.05 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.638 1.175 . . . . 73.43 109.503 173.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.9 pp -134.98 152.89 78.08 Favored Pre-proline 0 CA--C 1.567 1.625 0 C-N-CA 123.583 0.753 . . . . 73.4 110.768 -177.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -65.95 -6.77 15.06 Favored 'Trans proline' 0 N--CA 1.51 2.448 0 C-N-CA 123.854 3.036 . . . . 74.45 115.58 -166.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.446 ' O ' ' HG2' ' C' ' 226' ' ' ARG . 39.1 mt-10 48.16 -83.62 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.751 1.221 . . . . 63.24 112.368 -164.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 7.1 ppt_? -61.02 137.86 58.21 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.388 0.675 . . . . 75.12 110.115 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.473 HD13 ' HA ' ' A' ' 266' ' ' GLU . 74.1 mt -137.86 140.92 40.68 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.321 0.581 . . . . 55.32 111.1 -172.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 37.0 p -83.4 138.74 41.57 Favored Pre-proline 0 CA--C 1.554 1.097 0 CA-C-O 117.683 -1.151 . . . . 44.34 108.745 175.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' PRO . . . . . 0.403 ' O ' ' HB3' ' A' ' 266' ' ' GLU . 24.6 Cg_exo -24.79 -56.02 0.07 OUTLIER 'Trans proline' 0 C--N 1.386 2.55 1 C-N-CA 126.309 4.673 . . . . 74.33 117.382 -169.481 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -80.94 -33.22 34.14 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 112.481 0.548 . . . . 71.44 112.481 -173.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -69.95 -35.61 74.64 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 122.833 0.453 . . . . 64.2 110.066 174.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' GLU . . . . . 0.473 ' HA ' HD13 ' A' ' 261' ' ' LEU . 8.1 tp10 -54.36 -52.98 59.9 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 124.119 0.968 . . . . 73.45 109.091 169.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . 0.538 ' O ' ' HG3' ' A' ' 271' ' ' LYS . . . -57.42 -43.96 84.24 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 114.291 -1.322 . . . . 64.12 111.486 177.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 4.7 mp -59.55 -53.23 60.53 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 123.983 0.913 . . . . 73.14 111.286 -176.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -53.88 -48.15 70.35 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 124.198 0.937 . . . . 75.0 110.608 175.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . 0.533 ' HG3' HG23 ' C' ' 206' ' ' VAL . 1.0 OUTLIER -62.76 -34.82 78.03 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 123.875 0.735 . . . . 62.43 112.715 -179.327 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . 0.538 ' HG3' ' O ' ' A' ' 267' ' ' ALA . 64.2 mttm -62.33 -59.03 5.58 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.814 -0.81 . . . . 70.22 108.814 177.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 272' ' ' LEU . . . . . 0.534 ' O ' ' HB2' ' A' ' 276' ' ' TYR . 82.2 mt -49.2 -46.19 45.35 Favored 'General case' 0 C--N 1.358 0.963 0 O-C-N 125.564 1.79 . . . . 63.4 110.366 178.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . 0.488 ' HA ' ' HB2' ' C' ' 202' ' ' PRO . . . -79.12 -47.73 15.57 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 114.556 1.317 . . . . 64.51 114.556 -165.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -74.48 -31.4 62.2 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 110.123 -0.325 . . . . 74.35 110.123 -178.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . 0.449 ' O ' ' HG3' ' A' ' 279' ' ' ARG . . . -68.19 -42.04 80.51 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 109.756 -0.461 . . . . 71.44 109.756 169.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . 0.534 ' HB2' ' O ' ' A' ' 272' ' ' LEU . 32.7 t80 -56.26 -49.99 72.64 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 124.906 1.283 . . . . 75.02 110.683 178.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -64.18 -41.57 97.05 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 114.556 -1.202 . . . . 70.12 109.54 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -68.99 -10.42 57.39 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 123.432 0.693 . . . . 75.41 112.599 176.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . 0.585 ' HA ' HD22 ' B' ' 278' ' ' LEU . 74.4 mtt180 -89.51 -11.28 43.34 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.377 0.671 . . . . 74.13 111.23 175.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.302 0 N-CA-C 109.206 -0.664 . . . . 72.21 109.206 177.851 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.41 ' HB2' ' HB2' ' B' ' 4' ' ' SER . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.407 0 N-CA-C 108.683 -0.858 . . . . 71.44 108.683 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -81.16 -46.96 14.11 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 108.352 -0.981 . . . . 54.1 108.352 170.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 20.6 mm-40 -138.43 91.38 2.54 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.395 1.478 . . . . 74.04 108.531 173.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . 0.41 ' HB2' ' HB2' ' B' ' 1' ' ' MET . 47.6 t -108.35 151.69 25.66 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 123.991 0.916 . . . . 52.14 108.774 174.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 4.5 m -123.87 156.19 36.68 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 123.121 0.568 . . . . 70.11 110.813 -172.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.444 HG21 ' HA ' ' A' ' 125' ' ' LEU . 25.8 pt -139.32 174.21 9.81 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 C-N-CA 124.325 1.05 . . . . 64.44 111.449 -165.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -115.15 -163.31 0.87 Allowed 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.113 0.965 . . . . 72.01 110.295 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.57 HD22 HG11 ' A' ' 145' ' ' VAL . 14.9 tp -148.09 178.89 8.16 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.129 0.571 . . . . 75.22 110.66 -178.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . 0.549 ' HB3' ' HB2' ' A' ' 122' ' ' GLU . . . -156.91 105.51 2.18 Favored 'General case' 0 C--N 1.358 0.937 0 C-N-CA 124.576 1.15 . . . . 62.4 108.389 178.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . 0.472 ' HB3' HD11 ' A' ' 119' ' ' LEU . 93.6 mt -79.59 121.27 25.05 Favored 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 123.997 0.919 . . . . 74.1 111.522 -173.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.539 HD22 ' HA ' ' B' ' 370' ' ' ALA . 2.9 mt -126.82 168.03 15.77 Favored Pre-proline 0 N--CA 1.506 2.357 0 C-N-CA 124.679 1.191 . . . . 45.35 109.195 -178.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -74.84 -137.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.394 2.968 0 C-N-CA 123.222 2.615 . . . . 61.33 113.513 -174.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 90.4 mt 89.88 179.22 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.49 0 C-N-CA 126.138 1.775 . . . . 75.01 113.249 172.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 63.1 tp -134.15 148.52 50.95 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 124.338 1.055 . . . . 64.54 111.623 -165.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 15' ' ' PHE . . . . . 0.65 ' HB2' HD11 ' A' ' 175' ' ' LEU . 0.5 OUTLIER -170.59 -151.85 0.08 Allowed 'General case' 0 CA--C 1.569 1.697 0 C-N-CA 124.133 0.973 . . . . 60.01 110.153 174.733 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . 0.419 ' HA ' ' HD3' ' B' ' 17' ' ' PRO . 97.9 m -146.48 135.2 11.05 Favored Pre-proline 0 CA--C 1.567 1.605 0 C-N-CA 124.317 1.047 . . . . 51.11 110.119 -175.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 17' ' ' PRO . . . . . 0.569 ' HB3' ' HB3' ' A' ' 162' ' ' PRO . 17.9 Cg_exo -70.09 129.4 17.19 Favored 'Trans proline' 0 C--N 1.384 2.42 0 C-N-CA 123.473 2.782 . . . . 62.42 114.076 -179.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 88.0 t -136.53 -81.68 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 C-N-CA 123.362 0.665 . . . . 61.41 112.171 174.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . 0.448 ' O ' ' HD2' ' A' ' 162' ' ' PRO . 56.4 m -84.96 120.99 27.13 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.468 0.707 . . . . 71.22 112.884 -163.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 20' ' ' LYS . . . . . 0.628 ' HG2' ' HG2' ' A' ' 162' ' ' PRO . 52.5 mttp -124.88 119.83 29.92 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.499 0.72 . . . . 62.34 110.524 -173.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -160.91 119.61 2.53 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.775 0.83 . . . . 75.34 109.914 176.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . 0.428 HH22 ' HB3' ' A' ' 86' ' ' SER . 2.5 mpt_? -123.68 -178.28 3.98 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.836 0.826 . . . . 73.31 112.054 -176.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 23' ' ' THR . . . . . . . . . . . . . 2.2 t -135.47 160.49 67.68 Favored Pre-proline 0 CA--C 1.563 1.458 0 C-N-CA 125.472 1.509 . . . . 72.45 107.973 175.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . 0.465 ' HA ' ' HG2' ' A' ' 60' ' ' PRO . 11.5 Cg_exo -36.4 119.27 0.21 Allowed 'Trans proline' 0 C--N 1.387 2.557 0 C-N-CA 124.156 3.237 . . . . 74.55 115.66 171.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -90.97 45.88 1.28 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.842 0.857 . . . . 74.53 111.17 174.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 14.2 tmm? -69.36 -44.39 26.03 Favored Pre-proline 0 CA--C 1.568 1.639 0 CA-C-N 115.723 -0.671 . . . . 75.13 110.069 167.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -87.38 49.97 1.95 Allowed 'Trans proline' 0 C--N 1.397 3.118 0 C-N-CA 122.314 2.009 . . . . 71.1 111.945 171.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.627 HG13 ' HG ' ' B' ' 29' ' ' LEU . 11.5 p -80.32 -17.41 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 C-N-CA 123.27 0.628 . . . . 73.51 112.241 -175.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.627 ' HG ' HG13 ' B' ' 28' ' ' VAL . 60.2 mt -121.92 111.26 16.86 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.531 0.732 . . . . 62.2 110.352 -175.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.429 ' HB3' ' HG2' ' A' ' 139' ' ' GLU . 13.0 tp10 -147.13 146.62 29.97 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.492 0.717 . . . . 70.24 109.252 171.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -106.35 -24.83 12.15 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.612 0.765 . . . . 74.34 110.416 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 11.8 tpp180 -73.52 99.82 3.12 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 121.538 0.685 . . . . 72.22 110.459 178.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -103.71 132.01 50.35 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 114.291 -1.322 . . . . 73.31 107.796 168.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -160.68 -174.13 4.29 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.39 0.676 . . . . 53.33 110.581 -176.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 73.18 -74.3 0.09 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.968 1.707 . . . . 73.13 111.371 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . 0.402 ' HA3' ' HB2' ' A' ' 124' ' ' PRO . . . -99.35 161.78 19.83 Favored Glycine 0 C--N 1.341 0.837 0 CA-C-N 116.163 -0.471 . . . . 74.33 113.221 -174.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -155.75 178.51 10.17 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 123.683 0.793 . . . . 61.44 108.996 -178.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . 0.562 HD13 ' HA ' ' B' ' 367' ' ' LEU . 2.3 mp -60.75 -22.99 27.71 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.404 0 C-N-CA 125.594 1.558 . . . . 75.44 111.263 170.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 8.3 m 76.72 32.2 0.53 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 125.342 1.457 . . . . 64.25 108.189 -162.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.716 ' HB1' HG21 ' B' ' 309' ' ' THR . . . -64.99 -36.34 15.77 Favored Pre-proline 0 CA--C 1.561 1.404 0 CA-C-N 113.645 -1.616 . . . . 64.0 111.834 171.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . 0.672 ' HB3' ' HB ' ' B' ' 361' ' ' ILE . 44.0 Cg_exo -47.4 -32.87 15.81 Favored 'Trans proline' 0 C--N 1.397 3.099 0 C-N-CA 122.872 2.381 . . . . 72.44 114.62 164.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -77.28 -7.38 86.9 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-O 119.616 -0.546 . . . . 45.24 113.99 -176.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -133.14 177.3 19.04 Favored Glycine 0 C--N 1.353 1.484 0 CA-C-N 117.552 0.676 . . . . 42.15 113.544 -175.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -162.57 120.87 2.13 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.647 1.179 . . . . 63.2 109.045 174.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' B' ' 45' ' ' ARG . 2.1 mpt_? 45.46 -88.59 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 126.272 1.829 . . . . 74.21 111.232 -170.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.33 67.05 0.71 Allowed 'General case' 0 C--O 1.24 0.554 0 N-CA-C 105.173 -2.158 . . . . 75.02 105.173 177.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 35.2 tp 78.12 152.9 0.13 Allowed 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 126.053 1.741 . . . . 53.22 109.866 -169.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 33.1 p -80.59 50.99 1.4 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.042 0.937 . . . . 51.22 112.401 -176.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -82.31 63.96 4.34 Favored Glycine 0 C--N 1.343 0.967 0 N-CA-C 109.285 -1.526 . . . . 74.15 109.285 165.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . 0.47 ' O ' HD21 ' B' ' 111' ' ' LEU . 15.3 t70 -89.16 -64.44 1.14 Allowed 'General case' 0 C--N 1.351 0.643 0 C-N-CA 124.245 1.018 . . . . 64.2 109.027 -177.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 59.27 -83.46 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 125.105 1.362 . . . . 75.3 110.578 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 9.5 m 50.85 77.4 0.13 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 125.352 1.461 . . . . 73.31 112.404 176.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -157.8 -53.2 0.07 Allowed 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 121.117 0.484 . . . . 73.24 109.951 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -158.37 -179.23 7.91 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.426 -0.806 . . . . 75.51 110.809 -175.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 2.8 pp -121.81 25.6 9.12 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.177 0.991 . . . . 72.35 109.619 175.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 78.29 -47.15 0.44 Allowed 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 125.936 1.694 . . . . 73.2 112.425 -179.021 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 22.8 t70 78.74 -49.88 0.45 Allowed 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 125.766 1.627 . . . . 75.31 111.967 177.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 42.3 m -72.11 74.93 0.95 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 123.842 0.857 . . . . 62.01 111.047 -178.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . 0.604 HD13 HG21 ' B' ' 196' ' ' THR . 60.4 mt -91.45 71.24 6.0 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 124.028 0.931 . . . . 72.44 108.736 -177.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 31.0 m -139.56 -31.63 0.67 Allowed 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 114.814 -1.084 . . . . 63.51 110.169 -177.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 63.46 77.28 0.33 Allowed 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 125.065 1.346 . . . . 71.45 109.631 175.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 62' ' ' LYS . . . . . . . . . . . . . 41.6 mtpt -90.66 124.62 61.9 Favored Pre-proline 0 N--CA 1.472 0.673 0 CA-C-N 115.538 -0.755 . . . . 72.3 111.172 -169.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -76.55 -11.41 18.74 Favored 'Trans proline' 0 C--N 1.38 2.214 0 C-N-CA 122.85 2.366 . . . . 72.24 113.031 176.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 69.85 -70.24 0.15 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 125.388 1.475 . . . . 72.04 110.482 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.521 ' HG2' ' H ' ' B' ' 66' ' ' ASN . 75.2 tttt -76.41 177.35 7.42 Favored 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 124.449 1.1 . . . . 65.32 108.835 170.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 66' ' ' ASN . . . . . 0.521 ' H ' ' HG2' ' B' ' 65' ' ' LYS . 4.1 m-20 72.97 13.72 4.89 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.79 1.236 . . . . 72.41 112.967 173.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . 0.459 ' H ' HD13 ' B' ' 67' ' ' ILE . 0.2 OUTLIER -80.74 -23.96 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 122.999 0.52 . . . . 72.03 110.997 176.778 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 22.8 pt -95.97 -39.66 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 123.663 0.785 . . . . 73.4 110.775 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 95.7 mt -127.99 126.98 42.41 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 107.3 -1.37 . . . . 73.12 107.3 177.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 82.2 mt -49.76 -43.78 48.3 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.384 1.074 . . . . 44.44 113.005 -171.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . 0.458 HG13 ' HB3' ' B' ' 73' ' ' ASP . 38.3 pt -111.82 2.84 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 123.109 0.564 . . . . 74.32 111.957 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 64.0 33.12 86.39 Favored Glycine 0 C--N 1.357 1.723 0 CA-C-O 121.047 0.248 . . . . 62.21 112.614 178.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . 0.458 ' HB3' HG13 ' B' ' 71' ' ' ILE . 17.1 p-10 -74.03 -61.1 1.97 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.655 1.182 . . . . 63.44 112.925 -170.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.23 45.62 85.21 Favored Glycine 0 CA--C 1.535 1.291 0 N-CA-C 111.825 -0.51 . . . . 64.42 111.825 -168.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -62.64 123.83 19.42 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.845 0.858 . . . . 74.01 110.337 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . -150.31 56.76 0.46 Allowed Glycine 0 C--N 1.338 0.664 0 N-CA-C 110.024 -1.23 . . . . 71.13 110.024 175.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . 0.564 ' HA ' ' HB2' ' B' ' 88' ' ' GLU . 11.5 t70 -75.55 136.71 40.55 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 122.655 0.382 . . . . 73.03 110.882 -174.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . 0.641 ' HA ' ' HB3' ' B' ' 84' ' ' ARG . 48.9 m 70.69 37.17 1.44 Allowed 'General case' 0 N--CA 1.477 0.907 0 O-C-N 124.723 1.264 . . . . 51.1 111.207 -176.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . 0.415 ' HG2' HG12 ' B' ' 80' ' ' ILE . 40.0 tt0 -116.41 121.68 42.61 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.215 -0.902 . . . . 74.44 110.069 177.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.415 HG12 ' HG2' ' B' ' 79' ' ' GLU . 31.2 mm 53.63 -91.69 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.56 1.331 0 C-N-CA 125.778 1.631 . . . . 72.52 112.417 173.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 20.5 p 21.32 -86.53 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 127.201 2.2 . . . . 71.34 115.124 -178.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -152.78 56.99 0.8 Allowed 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 106.293 -1.743 . . . . 61.11 106.293 174.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . 73.63 -61.15 0.51 Allowed 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 125.329 1.452 . . . . 71.35 107.475 -157.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 84' ' ' ARG . . . . . 0.641 ' HB3' ' HA ' ' B' ' 78' ' ' SER . 7.8 ptm180 -153.34 -174.6 5.0 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.602 1.161 . . . . 73.0 108.951 163.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -133.14 -83.51 0.47 Allowed 'General case' 0 N--CA 1.479 1.025 0 CA-C-O 119.108 -0.472 . . . . 72.23 109.87 -178.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -149.4 -55.57 0.18 Allowed 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 112.884 0.698 . . . . 63.12 112.884 -176.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -122.53 29.1 7.06 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 113.07 0.767 . . . . 52.24 113.07 -162.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 88' ' ' GLU . . . . . 0.564 ' HB2' ' HA ' ' B' ' 77' ' ' ASP . 5.3 mp0 -74.36 -21.51 59.64 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.156 0.583 . . . . 74.14 109.995 -178.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -62.05 -15.56 50.34 Favored Glycine 0 C--N 1.356 1.66 0 CA-C-O 119.205 -0.775 . . . . 54.33 113.493 173.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . 74.84 -66.07 0.31 Allowed 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.545 1.538 . . . . 62.33 112.993 167.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -71.29 -105.12 0.05 OUTLIER Glycine 0 C--N 1.351 1.381 0 O-C-N 123.639 0.587 . . . . 70.11 112.431 179.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 107.05 -175.48 20.61 Favored Glycine 0 C--N 1.344 1.016 0 CA-C-N 116.978 0.389 . . . . 23.53 112.631 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -60.12 99.71 0.08 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.659 1.184 . . . . 74.22 111.11 -176.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 66.17 -71.53 0.09 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 125.536 1.534 . . . . 71.21 112.376 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? 61.15 103.52 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.738 1.215 . . . . 74.14 111.55 173.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . -81.94 46.74 3.55 Favored Glycine 0 N--CA 1.475 1.28 0 CA-C-O 120.947 0.193 . . . . 72.31 112.876 178.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 49.9 mm -121.04 -35.86 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 124.85 1.26 . . . . 72.22 108.832 177.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -145.02 159.93 42.17 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.899 0.88 . . . . 75.21 109.649 -176.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . 77.08 -50.52 0.55 Allowed 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 125.912 1.685 . . . . 61.12 112.844 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . 0.498 ' HB2' ' HD3' ' B' ' 101' ' ' PRO . 5.5 mp -84.25 -57.45 0.4 Allowed Pre-proline 0 CA--C 1.566 1.595 0 C-N-CA 123.802 0.841 . . . . 74.2 110.76 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 101' ' ' PRO . . . . . 0.498 ' HD3' ' HB2' ' B' ' 100' ' ' LEU . 76.2 Cg_endo -91.4 96.35 0.22 Allowed 'Trans proline' 0 C--N 1.393 2.879 0 C-N-CA 121.793 1.662 . . . . 72.21 113.42 -177.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 8.5 mp -90.33 160.98 15.84 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 108.549 -0.908 . . . . 73.12 108.549 168.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 34.9 p -50.56 -68.4 0.17 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.28 1.032 . . . . 75.52 112.165 -174.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . -159.67 150.72 21.23 Favored Glycine 0 C--N 1.343 0.971 0 N-CA-C 111.845 -0.502 . . . . 51.35 111.845 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -151.65 139.57 19.99 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 123.68 0.792 . . . . 75.22 109.455 -178.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 106' ' ' TYR . . . . . 0.501 ' O ' ' HD3' ' C' ' 148' ' ' ARG . 6.5 p90 -159.77 -54.17 0.06 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.886 0.874 . . . . 74.44 110.15 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 1.4 m 64.41 -1.99 0.68 Allowed 'General case' 0 N--CA 1.509 2.514 0 C-N-CA 125.304 1.442 . . . . 63.32 112.911 -176.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 71.9 t60 -164.99 97.03 0.73 Allowed 'General case' 0 C--O 1.243 0.742 0 N-CA-C 107.249 -1.389 . . . . 71.44 107.249 -171.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -76.88 103.01 6.59 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 107.718 -1.215 . . . . 53.33 107.718 173.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -81.7 15.8 2.02 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.82 0.848 . . . . 71.24 111.996 -176.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . 0.47 HD21 ' O ' ' B' ' 50' ' ' ASP . 4.8 tt 73.67 -64.24 0.4 Allowed 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.897 1.679 . . . . 64.15 111.077 174.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -74.65 83.73 2.08 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.695 0.76 . . . . 73.2 110.016 176.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 113' ' ' LYS . . . . . 0.4 ' HD3' ' HB2' ' C' ' 150' ' ' PRO . 52.9 tptt -144.75 30.42 1.2 Allowed 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 107.452 -1.314 . . . . 75.13 107.452 177.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.63 142.98 29.57 Favored 'General case' 0 C--N 1.349 0.545 0 CA-C-N 114.895 -1.048 . . . . 74.01 110.578 -176.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 4.1 m 64.58 154.82 0.07 Allowed 'General case' 0 CA--C 1.563 1.452 0 C-N-CA 125.449 1.499 . . . . 73.23 113.605 170.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . 0.464 ' O ' ' HD3' ' B' ' 118' ' ' PRO . . . 116.04 67.11 0.4 Allowed Glycine 0 C--N 1.347 1.162 0 CA-C-N 115.783 -0.644 . . . . 55.33 112.174 174.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -90.06 105.8 12.48 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 123.431 0.692 . . . . 70.25 110.439 172.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 118' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' B' ' 116' ' ' GLY . 1.8 Cg_endo -85.02 94.71 0.66 Allowed 'Trans proline' 0 C--N 1.366 1.453 0 C-N-CA 122.403 2.068 . . . . 60.53 108.281 165.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 119' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -77.52 -97.35 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 115.662 -0.699 . . . . 75.33 110.54 -174.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 120' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -130.61 97.53 4.4 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 109.129 -0.693 . . . . 70.1 109.129 -178.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 3.3 t -118.11 39.47 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.037 0 N-CA-C 107.947 -1.131 . . . . 74.32 107.947 176.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 47.6 p 55.58 58.48 4.51 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 125.369 1.467 . . . . 75.24 111.264 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . 0.464 ' HB3' ' H ' ' B' ' 405' ' ' ALA . 6.9 m-20 -88.06 48.74 1.68 Allowed 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 114.85 -1.068 . . . . 64.3 111.126 -173.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 20.4 t -104.06 112.73 25.85 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 107.496 -1.298 . . . . 43.31 107.496 175.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . 0.683 ' HB1' ' H ' ' B' ' 299' ' ' GLY . . . -155.77 31.02 0.36 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.22 0.608 . . . . 73.02 110.595 -177.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . 50.94 72.32 0.36 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.647 1.179 . . . . 74.13 112.249 -177.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 38.5 t -77.32 -26.96 52.67 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 115.543 -0.753 . . . . 70.01 110.627 177.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . 0.598 ' HB1' ' HB2' ' B' ' 131' ' ' TRP . . . -145.26 110.7 5.31 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.879 0.871 . . . . 72.01 109.353 -179.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 23.1 p -98.91 -62.06 1.29 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.738 0.815 . . . . 54.34 110.98 -178.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . -78.25 -22.95 47.58 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.27 0.628 . . . . 44.22 111.416 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 131' ' ' TRP . . . . . 0.598 ' HB2' ' HB1' ' B' ' 128' ' ' ALA . 22.8 m-90 -76.43 92.45 3.39 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.032 0.933 . . . . 73.51 109.296 -177.021 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 28.7 p -139.04 -66.39 0.47 Allowed 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 115.446 -0.797 . . . . 51.4 110.826 -175.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 43.1 p -88.44 48.05 1.58 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.963 0.905 . . . . 62.25 111.38 -173.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 64.24 -116.16 8.76 Favored Glycine 0 C--N 1.348 1.238 0 N-CA-C 111.739 -0.544 . . . . 55.15 111.739 -179.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 135' ' ' VAL . . . . . . . . . . . . . 21.6 t -95.43 58.97 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.055 0 N-CA-C 108.707 -0.849 . . . . 73.24 108.707 177.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 85.0 tttt 53.7 57.6 5.93 Favored 'General case' 0 CA--C 1.561 1.379 0 C-N-CA 124.749 1.219 . . . . 52.43 111.724 177.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 36.8 m -81.66 89.08 6.22 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.249 0.547 . . . . 75.31 110.2 -177.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -143.82 143.21 31.23 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 115.108 -0.951 . . . . 75.52 108.787 173.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 69.72 -74.88 0.08 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.181 1.392 . . . . 73.24 111.364 -176.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . 67.38 -100.67 0.61 Allowed Glycine 0 C--N 1.346 1.129 0 O-C-N 123.211 0.319 . . . . 65.04 112.649 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 141' ' ' ALA . . . . . 0.489 ' HB1' ' HB3' ' B' ' 145' ' ' ASP . . . -111.7 -10.42 14.07 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.808 0.843 . . . . 75.34 111.128 177.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 64.31 -76.62 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 125.493 1.517 . . . . 70.15 110.229 -175.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 177.54 32.03 0.05 OUTLIER Glycine 0 C--N 1.338 0.66 0 N-CA-C 110.027 -1.229 . . . . 61.25 110.027 175.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 16.0 m -133.99 22.99 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.089 1.356 . . . . 75.31 109.965 -176.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 145' ' ' ASP . . . . . 0.489 ' HB3' ' HB1' ' B' ' 141' ' ' ALA . 10.0 p-10 -51.9 -42.48 62.77 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.448 1.099 . . . . 64.3 110.79 178.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . 0.481 HG23 ' HG3' ' B' ' 148' ' ' GLU . 15.6 tt 157.97 -10.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 C-N-CA 127.644 2.377 . . . . 72.52 107.792 -175.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 51.3 m170 82.23 25.12 0.19 Allowed 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 126.328 1.851 . . . . 72.43 112.334 177.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . 0.481 ' HG3' HG23 ' B' ' 146' ' ' ILE . 55.9 mt-10 -76.64 -41.83 44.32 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 109.009 -0.737 . . . . 73.05 109.009 165.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 149' ' ' LYS . . . . . . . . . . . . . 18.0 mmtp -100.52 -53.75 3.02 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.675 -0.861 . . . . 72.23 108.675 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 29.8 t70 62.22 -86.14 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.344 1.458 . . . . 74.11 111.16 177.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 151' ' ' HIS . . . . . 0.643 ' H ' ' HD2' ' B' ' 152' ' ' PRO . 42.4 m80 -149.88 -48.15 0.02 OUTLIER Pre-proline 0 CA--C 1.565 1.552 0 C-N-CA 124.817 1.247 . . . . 74.43 112.261 -172.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 152' ' ' PRO . . . . . 0.643 ' HD2' ' H ' ' B' ' 151' ' ' HIS . 55.2 Cg_endo -66.09 85.5 0.25 Allowed 'Trans proline' 0 C--N 1.402 3.368 0 CA-C-N 121.972 1.74 . . . . 42.51 112.638 178.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 60.7 m -86.85 92.97 9.17 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 107.863 -1.162 . . . . 74.2 107.863 174.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 154' ' ' ILE . . . . . 0.438 HG22 ' O ' ' B' ' 262' ' ' ALA . 2.3 pp -102.81 128.73 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 115.286 -0.87 . . . . 74.25 110.401 -170.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 155' ' ' LEU . . . . . 0.507 ' HG ' ' H ' ' B' ' 156' ' ' GLU . 20.7 tp 59.67 -170.93 0.13 Allowed 'General case' 0 CA--C 1.571 1.765 0 C-N-CA 124.621 1.168 . . . . 72.1 111.593 170.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 156' ' ' GLU . . . . . 0.507 ' H ' ' HG ' ' B' ' 155' ' ' LEU . 56.6 mm-40 -57.99 -36.96 73.37 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.503 0.721 . . . . 72.23 110.34 166.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 157' ' ' MET . . . . . . . . . . . . . 1.5 tmt? 75.21 -14.64 0.74 Allowed 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 125.728 1.611 . . . . 53.54 111.813 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 158' ' ' ALA . . . . . . . . . . . . . . . 76.45 -60.16 0.48 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 126.371 1.868 . . . . 34.04 111.816 179.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -76.12 -37.12 58.44 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.833 0.853 . . . . 55.45 110.746 -175.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -61.76 -49.96 74.27 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.767 -0.651 . . . . 70.22 109.502 175.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -64.49 -29.46 70.5 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.144 0.978 . . . . 71.1 111.952 177.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . -66.99 -36.9 91.66 Favored Glycine 0 C--N 1.352 1.448 0 O-C-N 123.49 0.494 . . . . 73.4 112.919 179.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 67.2 tp -77.91 -51.41 10.46 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.338 0.655 . . . . 65.02 109.578 175.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 164' ' ' ALA . . . . . . . . . . . . . . . -158.29 117.4 3.14 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 114.902 -1.045 . . . . 75.34 108.428 -173.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 9.7 t -57.43 -35.35 69.96 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 123.282 0.633 . . . . 64.15 111.794 -177.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . 61.71 29.41 72.04 Favored Glycine 0 C--N 1.355 1.62 0 O-C-N 123.652 0.595 . . . . 71.15 112.524 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 167' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -76.94 142.41 40.06 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.014 0.926 . . . . 72.31 110.351 -173.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 9.3 p -67.04 135.19 29.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 122.512 0.325 . . . . 74.13 110.217 -178.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 94.3 p 55.86 33.15 21.03 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.259 1.424 . . . . 54.35 112.4 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 15.3 t -68.35 -19.87 64.68 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.759 0.424 . . . . 63.1 111.115 174.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . 70.51 -73.82 0.09 Allowed 'General case' 0 C--N 1.361 1.069 0 C-N-CA 126.034 1.734 . . . . 53.32 111.483 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 172' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 65.31 102.07 0.04 OUTLIER 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 125.196 1.398 . . . . 73.22 109.216 -176.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 173' ' ' LEU . . . . . 0.502 HD21 ' HG2' ' C' ' 128' ' ' GLU . 3.4 mm? -73.65 -39.94 64.09 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.686 0.795 . . . . 74.23 111.18 -172.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 174' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 69.96 -67.83 0.22 Allowed 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 125.343 1.457 . . . . 74.45 110.69 -176.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 175' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -106.25 139.83 40.14 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.038 0.935 . . . . 74.1 108.779 171.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -115.31 70.06 0.74 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.509 0.723 . . . . 74.11 109.721 -178.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 39.3 m -158.65 111.78 1.64 Allowed Pre-proline 0 CA--C 1.553 1.082 0 C-N-CA 124.197 0.999 . . . . 64.31 108.423 175.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 178' ' ' PRO . . . . . 0.562 ' HD3' ' HG3' ' C' ' 129' ' ' GLU . 90.6 Cg_endo -83.7 -42.51 0.08 OUTLIER 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 122.752 2.301 . . . . 74.53 113.25 179.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -167.79 27.37 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.405 1.082 . . . . 61.34 109.618 -174.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 180' ' ' ALA . . . . . 0.514 ' HB1' ' HB ' ' C' ' 137' ' ' VAL . . . 61.5 -79.19 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 124.461 1.104 . . . . 74.4 109.881 -165.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 181' ' ' LEU . . . . . 0.578 HD22 ' HB2' ' C' ' 136' ' ' ARG . 15.4 tp -168.29 21.48 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.315 0 C-N-CA 123.587 0.755 . . . . 62.04 110.364 172.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 182' ' ' VAL . . . . . . . . . . . . . 26.2 t -136.16 148.98 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.403 -0.81 . . . . 71.31 110.701 -173.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -149.07 -72.38 0.19 Allowed 'General case' 0 C--N 1.359 0.999 0 C-N-CA 123.376 0.67 . . . . 65.24 110.933 169.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 56.0 p-80 -150.52 161.37 42.67 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 122.402 0.281 . . . . 74.15 111.548 -174.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 185' ' ' VAL . . . . . . . . . . . . . 21.3 t -98.73 161.38 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.379 0 C-N-CA 124.389 1.076 . . . . 71.33 109.065 175.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 11.1 t -153.12 -171.25 3.86 Favored 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 123.871 0.868 . . . . 51.31 110.098 -176.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 187' ' ' SER . . . . . . . . . . . . . 45.8 m -92.89 130.94 38.32 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.28 1.032 . . . . 62.14 110.24 178.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 188' ' ' ARG . . . . . 0.506 ' HG2' ' H ' ' B' ' 189' ' ' LYS . 21.5 ttm180 178.55 -163.96 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 124.69 1.196 . . . . 71.52 108.335 -176.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 189' ' ' LYS . . . . . 0.506 ' H ' ' HG2' ' B' ' 188' ' ' ARG . 15.0 ptpt -147.63 152.22 37.51 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.673 1.189 . . . . 72.52 108.52 170.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 190' ' ' CYS . . . . . . . . . . . . . 51.2 m -140.27 137.82 34.52 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.308 0.643 . . . . 70.33 111.211 -173.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -166.88 143.71 4.66 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.265 1.026 . . . . 74.04 109.896 173.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 148.2 66.92 0.01 OUTLIER Glycine 0 C--N 1.352 1.462 0 CA-C-O 119.298 -0.723 . . . . 64.22 112.34 173.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 193' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -70.75 134.69 26.43 Favored 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 123.455 2.77 . . . . 64.32 113.889 -174.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 194' ' ' SER . . . . . 0.534 ' H ' ' HB2' ' C' ' 162' ' ' PRO . 52.2 p -162.35 171.83 16.58 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.861 1.264 . . . . 24.51 109.121 172.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 195' ' ' ALA . . . . . . . . . . . . . . . -136.39 -165.42 1.72 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.188 0.595 . . . . 74.32 111.227 -174.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 196' ' ' THR . . . . . 0.604 HG21 HD13 ' B' ' 59' ' ' LEU . 81.2 m 76.84 129.54 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 125.836 1.654 . . . . 73.32 111.645 -179.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 70.5 p -163.08 -175.85 4.55 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 124.172 0.989 . . . . 75.11 109.367 178.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 198' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 74.56 135.23 0.05 Allowed 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 125.299 1.439 . . . . 51.12 112.016 168.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 199' ' ' LYS . . . . . 0.439 ' HB3' HH22 ' C' ' 148' ' ' ARG . 52.8 tttp -161.23 90.86 0.83 Allowed 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 115.301 -0.863 . . . . 74.4 108.997 -176.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 200' ' ' CYS . . . . . . . . . . . . . 66.1 m -60.38 -46.71 97.57 Favored Pre-proline 0 CA--C 1.563 1.454 0 N-CA-C 113.289 0.848 . . . . 73.31 113.289 -178.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 201' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -75.06 3.16 5.9 Favored 'Trans proline' 0 C--N 1.39 2.747 0 C-N-CA 121.974 1.783 . . . . 71.34 113.23 178.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . -86.47 46.95 3.66 Favored Glycine 0 C--N 1.351 1.362 0 C-N-CA 122.804 0.24 . . . . 63.04 112.694 178.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -141.12 136.97 32.44 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.769 1.227 . . . . 71.33 108.64 -178.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -74.51 127.79 33.94 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.556 0.743 . . . . 74.01 109.813 177.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 205' ' ' LEU . . . . . . . . . . . . . 56.0 tp -62.81 -67.89 0.38 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.062 0.945 . . . . 51.03 110.932 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -156.42 -89.07 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 106.541 -1.651 . . . . 62.32 106.541 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 4.2 tmtm? 179.69 -75.84 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 107.785 -1.191 . . . . 74.32 107.785 178.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 121.59 51.29 0.24 Allowed Glycine 0 C--N 1.343 0.957 0 N-CA-C 109.143 -1.583 . . . . 71.52 109.143 -163.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . -66.98 -33.93 85.4 Favored Glycine 0 C--N 1.35 1.337 0 CA-C-N 114.769 -0.716 . . . . 42.21 114.109 -171.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -90.68 143.11 27.07 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.436 0.694 . . . . 74.51 110.096 177.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . 179.19 -65.19 0.08 OUTLIER Glycine 0 C--N 1.339 0.746 0 N-CA-C 109.898 -1.281 . . . . 74.43 109.898 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 46.5 m -82.77 95.64 7.94 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 123.93 0.892 . . . . 74.04 109.771 174.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . 0.558 ' HB ' HD23 ' B' ' 218' ' ' LEU . 61.0 mt -72.61 131.48 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 N-CA-C 108.746 -0.835 . . . . 64.4 108.746 175.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 214' ' ' THR . . . . . 0.669 ' HA ' ' HB2' ' B' ' 219' ' ' ASN . 11.1 t -127.22 151.64 48.43 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 123.685 0.794 . . . . 75.43 109.937 -179.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 215' ' ' GLU . . . . . 0.474 ' O ' ' HA ' ' B' ' 220' ' ' ALA . 36.8 tt0 72.8 -68.31 0.23 Allowed 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.794 1.638 . . . . 73.31 112.676 177.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -76.54 109.05 9.96 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.375 0.67 . . . . 61.42 110.175 -173.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 86.6 mt 67.68 -73.65 0.08 Allowed 'General case' 0 N--CA 1.478 0.974 0 O-C-N 124.896 1.372 . . . . 75.4 111.182 -179.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . 0.558 HD23 ' HB ' ' B' ' 213' ' ' ILE . 26.8 tp -78.8 133.57 37.05 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.692 0.797 . . . . 71.43 109.361 177.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 219' ' ' ASN . . . . . 0.669 ' HB2' ' HA ' ' B' ' 214' ' ' THR . 93.6 m-20 58.51 49.08 11.07 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.924 0.89 . . . . 71.24 109.94 -172.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' B' ' 215' ' ' GLU . . . -52.36 103.22 0.06 Allowed 'General case' 0 C--N 1.353 0.749 0 C-N-CA 124.567 1.147 . . . . 61.1 112.569 -168.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 221' ' ' ARG . . . . . . . . . . . . . 65.1 mtm180 64.9 -78.31 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 125.412 1.485 . . . . 73.55 110.287 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -166.98 134.01 2.41 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 125.115 1.366 . . . . 42.52 107.706 172.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -67.91 -34.16 76.09 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.456 0.702 . . . . 61.02 111.301 -179.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 12.9 t -83.76 -8.63 11.33 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.175 0 CA-C-N 115.797 -0.638 . . . . 74.2 110.14 176.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 16.5 m 71.9 108.01 0.07 Allowed 'General case' 0 C--N 1.361 1.083 0 C-N-CA 125.564 1.546 . . . . 54.34 110.006 -178.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 63.2 mt 69.77 166.87 0.28 Allowed 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.953 1.301 . . . . 74.43 111.117 -172.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . -84.34 62.25 4.6 Favored Glycine 0 CA--C 1.532 1.127 0 CA-C-N 116.242 -0.435 . . . . 51.31 112.573 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . -126.26 7.21 7.61 Favored Glycine 0 N--CA 1.476 1.348 0 C-N-CA 123.124 0.392 . . . . 72.41 112.534 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -87.63 -173.02 47.98 Favored Glycine 0 C--N 1.344 1.015 0 C-N-CA 122.836 0.255 . . . . 70.24 112.881 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . 74.54 -53.84 0.67 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.704 1.602 . . . . 70.23 111.179 -173.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 231' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? 65.14 19.19 11.72 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 124.943 1.297 . . . . 73.24 111.188 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 9.8 t -143.3 137.83 29.11 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.709 1.203 . . . . 74.24 109.122 -179.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -130.01 72.64 1.49 Allowed 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 108.645 -0.872 . . . . 70.41 108.645 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -149.62 122.2 8.57 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.045 -0.979 . . . . 72.31 108.963 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -120.47 -168.86 1.71 Allowed 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.822 0.849 . . . . 54.41 110.436 -176.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 236' ' ' THR . . . . . . . . . . . . . 8.0 m -64.43 -26.55 68.5 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.963 0.905 . . . . 73.34 111.549 177.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . 70.21 121.33 0.03 OUTLIER 'General case' 0 C--N 1.361 1.085 0 C-N-CA 125.423 1.489 . . . . 71.12 110.748 -174.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 20.8 m -69.27 -24.66 64.0 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 123.529 0.732 . . . . 71.31 111.206 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -75.86 145.57 40.46 Favored 'General case' 0 C--N 1.348 0.532 0 C-N-CA 123.833 0.853 . . . . 74.42 112.262 -177.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 240' ' ' GLY . . . . . 0.508 ' H ' HD22 ' C' ' 235' ' ' LEU . . . -74.93 -138.78 0.59 Allowed Glycine 0 CA--C 1.533 1.158 0 CA-C-N 114.656 -1.157 . . . . 71.23 111.984 168.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -158.93 172.65 17.82 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.068 0.547 . . . . 71.21 111.221 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 242' ' ' TRP . . . . . 0.543 ' HH2' HG21 ' C' ' 227' ' ' THR . 0.0 OUTLIER -157.2 -46.65 0.07 Allowed 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.247 1.419 . . . . 70.32 108.514 -172.147 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 243' ' ' GLN . . . . . 0.593 ' HB2' ' HG2' ' C' ' 224' ' ' PRO . 35.8 mt-30 -117.76 -170.06 1.8 Allowed 'General case' 0 C--O 1.247 0.928 0 N-CA-C 107.71 -1.218 . . . . 74.22 107.71 166.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -78.37 89.4 1.11 Allowed Glycine 0 C--N 1.345 1.036 0 N-CA-C 111.147 -0.781 . . . . 63.11 111.147 171.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 1.7 pptp? -77.11 141.74 40.07 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.05 0.54 . . . . 75.34 111.513 -177.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 72.8 m -151.02 140.2 21.21 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.059 0.944 . . . . 71.02 109.446 -178.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 247' ' ' LEU . . . . . . . . . . . . . 74.9 mt -84.46 130.05 34.8 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.449 0.7 . . . . 72.51 109.53 176.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 248' ' ' ARG . . . . . 0.625 ' HG3' HG22 ' C' ' 206' ' ' VAL . 25.0 mmm180 -85.14 -173.47 4.72 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.69 0.796 . . . . 75.15 111.187 177.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -109.99 153.98 23.8 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.728 0.811 . . . . 71.33 109.757 -176.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -76.49 89.75 3.27 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 107.09 -1.448 . . . . 65.4 107.09 166.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 251' ' ' ALA . . . . . . . . . . . . . . . -72.38 74.25 1.01 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.506 0.723 . . . . 61.03 109.605 -177.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 59.71 110.16 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 125.546 1.538 . . . . 72.3 110.5 -164.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -70.69 -20.15 62.7 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.553 0.741 . . . . 51.41 111.231 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 66.1 mtp180 72.06 81.01 0.15 Allowed 'General case' 0 C--N 1.359 1.01 0 C-N-CA 125.263 1.425 . . . . 72.51 111.742 170.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -174.14 -102.9 0.16 Allowed Glycine 0 C--N 1.346 1.112 0 CA-C-N 114.937 -1.029 . . . . 54.22 111.908 178.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 256' ' ' TYR . . . . . . . . . . . . . 41.2 t80 55.12 41.22 31.84 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.845 1.307 . . . . 52.52 109.759 -172.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -156.67 -53.48 0.08 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 114.527 -1.215 . . . . 74.31 108.999 -174.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 258' ' ' LEU . . . . . . . . . . . . . 29.8 tp -166.83 -37.78 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 115.499 -0.773 . . . . 75.13 110.795 -175.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 39.1 t -65.67 -65.89 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.711 0.804 . . . . 63.02 112.208 -164.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 260' ' ' SER . . . . . 0.457 ' HA ' HD21 ' B' ' 278' ' ' LEU . 32.6 p -102.27 33.97 2.91 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 121.948 0.88 . . . . 73.11 110.884 -178.045 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -103.08 59.65 0.77 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-N 114.613 -1.176 . . . . 52.21 108.35 -177.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 262' ' ' ALA . . . . . 0.438 ' O ' HG22 ' B' ' 154' ' ' ILE . . . 58.74 72.78 0.51 Allowed 'General case' 0 C--N 1.356 0.863 0 CA-C-N 114.274 -1.33 . . . . 43.43 110.001 -174.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . 59.69 -92.29 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.632 1.173 . . . . 70.44 111.271 -175.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 45.6 m 51.47 33.07 9.63 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.419 1.088 . . . . 51.14 113.882 177.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 265' ' ' LEU . . . . . 0.406 HD11 ' HA ' ' B' ' 278' ' ' LEU . 10.6 mp -61.24 160.0 11.23 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.271 0.628 . . . . 64.12 111.333 175.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 266' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -68.56 89.04 0.36 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.297 0.639 . . . . 71.52 110.152 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 26.2 m 59.68 -84.41 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 125.251 1.421 . . . . 73.13 111.918 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 49.0 t 67.16 131.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 C-N-CA 125.245 1.418 . . . . 74.44 111.221 -177.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 269' ' ' THR . . . . . 0.402 HG22 ' H ' ' B' ' 270' ' ' GLU . 1.3 m -92.37 -144.8 0.21 Allowed 'General case' 0 CA--C 1.563 1.448 0 N-CA-C 108.124 -1.065 . . . . 74.31 108.124 -178.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 270' ' ' GLU . . . . . 0.402 ' H ' HG22 ' B' ' 269' ' ' THR . 35.0 tt0 68.14 33.88 4.23 Favored 'General case' 0 CA--C 1.563 1.452 0 C-N-CA 123.806 0.842 . . . . 72.41 111.087 168.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 271' ' ' ALA . . . . . 0.443 ' O ' ' HE3' ' B' ' 275' ' ' LYS . . . 66.46 -79.17 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.861 1.265 . . . . 75.3 112.0 178.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 272' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -167.58 32.22 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.801 0.84 . . . . 54.14 109.573 -177.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.82 -62.95 1.49 Allowed 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 109.308 -0.627 . . . . 61.32 109.308 -177.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -94.5 -4.08 48.75 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 116.321 -0.4 . . . . 71.44 111.965 -177.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 275' ' ' LYS . . . . . 0.443 ' HE3' ' O ' ' B' ' 271' ' ' ALA . 6.8 mtmp? -61.34 -44.83 94.24 Favored Pre-proline 0 CA--C 1.562 1.411 0 CA-C-O 118.535 -0.745 . . . . 71.33 112.468 178.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -88.0 6.32 5.01 Favored 'Trans proline' 0 C--N 1.389 2.689 0 C-N-CA 122.342 2.028 . . . . 62.35 113.472 176.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 277' ' ' LEU . . . . . . . . . . . . . 67.0 tp -113.0 108.36 17.23 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 108.829 -0.804 . . . . 63.32 108.829 178.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 278' ' ' LEU . . . . . 0.585 HD22 ' HA ' ' A' ' 279' ' ' ARG . 5.1 mp -59.24 -65.67 0.63 Allowed 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.741 0.816 . . . . 62.0 110.263 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . 58.85 18.91 41.58 Favored Glycine 0 C--N 1.356 1.664 0 CA-C-N 115.045 -0.98 . . . . 75.43 113.122 -174.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 280' ' ' LEU . . . . . 0.625 ' HB3' HG21 ' C' ' 262' ' ' THR . 6.5 tt 75.19 -40.7 0.44 Allowed 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 126.337 1.855 . . . . 53.23 110.126 -169.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 80.0 t80 74.04 105.68 0.07 Allowed 'General case' 0 C--N 1.36 1.044 0 C-N-CA 125.672 1.589 . . . . 75.31 110.744 176.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -163.73 -83.42 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.713 0.805 . . . . 65.41 109.061 177.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -101.93 31.98 3.65 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-O 121.663 0.745 . . . . 72.33 109.638 176.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 284' ' ' GLY . . . . . 0.719 ' HA2' ' HG3' ' C' ' 260' ' ' ARG . . . -84.9 69.11 3.37 Favored Glycine 0 C--N 1.351 1.363 0 CA-C-N 114.944 -1.025 . . . . 61.45 110.838 173.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -155.97 176.61 12.42 Favored 'General case' 0 C--O 1.244 0.786 0 C-N-CA 123.604 0.762 . . . . 72.41 110.348 -177.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 286' ' ' MET . . . . . . . . . . . . . 12.7 tmm? 64.21 84.63 0.18 Allowed Pre-proline 0 CA--C 1.553 1.089 0 C-N-CA 124.961 1.304 . . . . 64.1 110.825 178.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 287' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -91.65 118.55 0.51 Allowed 'Trans proline' 0 C--N 1.368 1.602 0 C-N-CA 123.07 2.513 . . . . 73.33 111.215 166.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 288' ' ' VAL . . . . . . . . . . . . . 44.3 t -70.14 91.51 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 108.429 -0.952 . . . . 74.32 108.429 177.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 289' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -115.68 146.06 42.19 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.153 0.981 . . . . 72.14 109.408 -172.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 290' ' ' TRP . . . . . . . . . . . . . 6.3 m0 75.18 -49.41 0.64 Allowed 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 125.618 1.567 . . . . 75.34 112.27 178.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 291' ' ' LEU . . . . . . . . . . . . . 58.4 tp -52.89 -51.09 62.43 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.456 1.103 . . . . 64.34 111.355 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . -94.54 -69.41 1.07 Allowed Glycine 0 CA--C 1.535 1.288 0 CA-C-N 115.441 -0.799 . . . . 62.12 111.35 174.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.05 88.21 0.83 Allowed 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 123.26 2.64 . . . . 51.12 112.645 -178.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 4.9 ttpm? 179.06 -26.34 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 125.175 1.39 . . . . 41.23 109.391 179.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -79.84 36.02 0.32 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.137 0.975 . . . . 34.32 112.766 -175.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 9.8 t -167.74 150.36 5.82 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.053 0.941 . . . . 65.42 110.795 178.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -179.11 118.5 0.07 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 126.046 1.738 . . . . 64.12 106.81 174.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 56.5 t60 67.6 107.65 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.083 0.953 . . . . 71.5 111.094 -178.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 299' ' ' GLY . . . . . 0.683 ' H ' ' HB1' ' B' ' 125' ' ' ALA . . . -87.91 176.59 45.91 Favored Glycine 0 N--CA 1.469 0.869 0 N-CA-C 110.99 -0.844 . . . . 63.41 110.99 166.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 54.7 t30 70.17 156.44 0.15 Allowed 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 124.354 1.062 . . . . 72.23 111.784 178.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 301' ' ' ILE . . . . . . . . . . . . . 18.3 pt -60.92 -33.91 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.252 0.621 . . . . 72.24 111.285 175.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -161.23 -106.17 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.924 0 CA-C-O 119.094 -0.479 . . . . 63.41 110.505 174.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 303' ' ' LYS . . . . . 0.413 ' H ' ' HD2' ' B' ' 304' ' ' PRO . 7.6 mtmp? -157.22 -42.96 0.0 OUTLIER Pre-proline 0 CA--C 1.578 2.023 0 CA-C-O 117.382 -1.294 . . . . 74.11 114.174 -164.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 304' ' ' PRO . . . . . 0.413 ' HD2' ' H ' ' B' ' 303' ' ' LYS . 82.1 Cg_exo -49.19 141.42 23.62 Favored 'Trans proline' 0 C--N 1.402 3.346 0 C-N-CA 122.838 2.359 . . . . 75.12 114.766 177.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -133.33 160.24 37.92 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.117 0.967 . . . . 42.33 110.133 -178.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . 0.469 ' HB ' ' HD3' ' B' ' 373' ' ' ARG . 2.8 p -61.63 111.07 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.916 0.887 . . . . 72.33 112.307 -175.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -161.36 99.66 1.18 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.42 1.088 . . . . 74.23 109.105 176.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 308' ' ' CYS . . . . . 0.543 ' HB3' ' HG2' ' B' ' 369' ' ' GLU . 51.6 t -164.83 -30.98 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.44 0.696 . . . . 74.22 110.728 175.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . 0.716 HG21 ' HB1' ' B' ' 40' ' ' ALA . 97.9 m -56.71 130.04 77.39 Favored Pre-proline 0 N--CA 1.481 1.093 0 CA-C-O 117.928 -1.034 . . . . 72.2 111.55 176.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -53.32 -67.12 0.09 OUTLIER 'Trans proline' 0 C--N 1.393 2.898 0 C-N-CA 123.708 2.939 . . . . 63.14 112.799 -176.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 311' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -175.06 147.96 1.07 Allowed Pre-proline 0 N--CA 1.479 0.986 0 C-N-CA 123.31 0.644 . . . . 73.13 110.328 175.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 312' ' ' PRO . . . . . 0.594 ' HG3' ' HA ' ' B' ' 41' ' ' PRO . 21.4 Cg_endo -92.4 -147.22 0.03 OUTLIER 'Trans proline' 0 C--N 1.365 1.433 0 C-N-CA 123.351 2.701 . . . . 70.14 110.636 170.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 313' ' ' GLN . . . . . 0.624 HE22 ' HB2' ' B' ' 316' ' ' ASP . 0.5 OUTLIER -64.92 105.17 0.97 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.332 0.653 . . . . 75.13 109.439 175.544 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 314' ' ' ARG . . . . . . . . . . . . . 35.1 mmt180 -124.69 79.3 1.76 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.588 1.155 . . . . 72.01 108.564 177.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 315' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -156.26 -57.76 0.09 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.524 0.73 . . . . 72.12 109.316 -177.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 316' ' ' ASP . . . . . 0.624 ' HB2' HE22 ' B' ' 313' ' ' GLN . 2.8 m-20 -81.93 69.81 8.71 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.893 0.877 . . . . 74.4 108.664 176.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 25.6 t -117.85 87.64 2.76 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.149 -0.932 . . . . 75.41 109.096 -176.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 318' ' ' VAL . . . . . . . . . . . . . 34.1 m 39.59 62.08 5.49 Favored Pre-proline 0 CA--C 1.57 1.743 0 C-N-CA 126.597 1.959 . . . . 73.13 114.112 -178.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 319' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -86.34 -179.13 3.0 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 122.587 2.191 . . . . 65.1 112.627 -178.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 320' ' ' THR . . . . . . . . . . . . . 57.8 m 74.02 -56.7 0.64 Allowed 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 126.404 1.882 . . . . 53.31 111.936 -173.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 321' ' ' LEU . . . . . . . . . . . . . 34.9 tp -83.32 64.67 7.91 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 124.122 0.969 . . . . 65.14 110.125 -177.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 322' ' ' ALA . . . . . . . . . . . . . . . -89.6 -59.42 2.21 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.497 -0.774 . . . . 64.54 110.431 -178.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 323' ' ' GLN . . . . . 0.477 ' NE2' ' HG3' ' B' ' 342' ' ' GLN . 9.6 tt0 58.38 76.55 0.33 Allowed 'General case' 0 CA--C 1.553 1.096 0 CA-C-O 121.816 0.817 . . . . 74.02 109.658 -178.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 324' ' ' MET . . . . . . . . . . . . . 41.9 ttp 59.61 -105.9 0.26 Allowed 'General case' 0 CA--C 1.561 1.403 0 CA-C-N 113.783 -1.553 . . . . 71.32 109.426 -168.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 325' ' ' THR . . . . . . . . . . . . . 31.5 m 63.5 -63.41 0.13 Allowed 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 125.81 1.644 . . . . 72.33 113.838 178.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 326' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -48.96 132.51 18.61 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 125.097 1.359 . . . . 72.01 112.812 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 1.7 tmmt? 64.6 -77.25 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.881 0 O-C-N 125.451 1.72 . . . . 54.34 110.59 176.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 328' ' ' ALA . . . . . . . . . . . . . . . 64.55 -72.18 0.07 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 125.69 1.596 . . . . 72.03 111.244 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 329' ' ' ILE . . . . . . . . . . . . . 17.4 pt 53.0 125.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 C-N-CA 127.652 2.381 . . . . 73.5 113.624 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 330' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 50.72 16.49 0.32 Allowed 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 125.975 1.71 . . . . 63.42 113.669 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 331' ' ' LEU . . . . . . . . . . . . . 6.9 mp -107.93 179.29 4.27 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.072 1.349 . . . . 63.34 108.681 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 67.62 -72.9 0.09 Allowed 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 125.127 1.371 . . . . 74.41 110.729 -176.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 333' ' ' SER . . . . . 0.465 ' HB3' ' HB2' ' B' ' 336' ' ' GLU . 18.8 m 74.63 -10.27 1.2 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 125.948 1.699 . . . . 65.04 112.147 -177.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 61.3 mttm 63.84 -77.12 0.03 OUTLIER 'General case' 0 C--N 1.365 1.267 0 C-N-CA 125.263 1.425 . . . . 63.11 112.025 178.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 335' ' ' ASN . . . . . 0.401 ' HB2' ' CA ' ' C' ' 237' ' ' GLY . 8.0 t30 -76.75 -48.92 17.24 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 122.871 0.468 . . . . 73.25 111.517 -178.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 336' ' ' GLU . . . . . 0.465 ' HB2' ' HB3' ' B' ' 333' ' ' SER . 4.0 mp0 -66.19 86.82 0.1 Allowed 'General case' 0 C--N 1.353 0.718 0 O-C-N 124.236 0.96 . . . . 61.02 109.374 -177.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 337' ' ' LYS . . . . . . . . . . . . . 44.8 tttp 64.72 -77.01 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 126.549 1.939 . . . . 62.43 111.434 -171.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 338' ' ' GLY . . . . . . . . . . . . . . . 135.17 -36.81 2.01 Favored Glycine 0 C--N 1.343 0.936 0 N-CA-C 110.813 -0.915 . . . . 72.34 110.813 -174.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 339' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 60.45 -80.76 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.567 1.547 . . . . 74.33 112.175 176.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 340' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -88.76 102.64 15.2 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 108.563 -0.903 . . . . 75.24 108.563 174.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 341' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -101.74 130.24 48.09 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 108.655 -0.868 . . . . 75.34 108.655 172.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 342' ' ' GLN . . . . . 0.477 ' HG3' ' NE2' ' B' ' 323' ' ' GLN . 10.2 tt0 -63.34 94.23 0.08 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.612 0.765 . . . . 64.25 109.447 178.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 343' ' ' VAL . . . . . . . . . . . . . 14.5 p -63.16 -33.85 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.242 1.017 . . . . 64.24 112.233 -170.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -97.26 119.53 35.96 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.258 0.623 . . . . 73.03 110.305 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 345' ' ' GLY . . . . . . . . . . . . . . . 78.28 -75.35 1.94 Allowed Glycine 0 C--N 1.344 1.016 0 O-C-N 124.189 0.931 . . . . 62.31 113.567 173.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 346' ' ' ALA . . . . . . . . . . . . . . . 64.22 16.93 10.4 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.813 1.245 . . . . 72.22 111.82 -177.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 28.2 t -92.39 27.66 2.18 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.279 1.031 . . . . 72.21 110.731 -175.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 348' ' ' ILE . . . . . 0.482 HG22 ' HB2' ' B' ' 351' ' ' GLN . 10.9 mt 55.03 47.02 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 107.633 -1.247 . . . . 73.42 107.633 -171.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 349' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -59.75 -36.8 77.35 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 113.163 -1.835 . . . . 71.13 113.066 -160.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 350' ' ' LYS . . . . . 0.644 ' HD2' ' H ' ' B' ' 350' ' ' LYS . 0.0 OUTLIER -74.38 -25.45 59.5 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.312 -0.858 . . . . 74.52 111.866 -175.349 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 351' ' ' GLN . . . . . 0.482 ' HB2' HG22 ' B' ' 348' ' ' ILE . 21.0 tp60 -63.58 167.21 5.89 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.551 0.74 . . . . 71.32 110.271 -179.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -47.5 105.96 0.08 Allowed 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 125.332 1.453 . . . . 74.35 111.737 -171.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 353' ' ' HIS . . . . . . . . . . . . . 44.6 p-80 -141.18 173.37 11.55 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.56 0.744 . . . . 74.33 110.768 -171.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 354' ' ' ALA . . . . . . . . . . . . . . . 57.92 43.13 21.87 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.959 1.304 . . . . 70.11 111.911 176.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 355' ' ' ALA . . . . . . . . . . . . . . . 65.09 19.12 11.73 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.499 1.12 . . . . 75.44 112.744 173.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 356' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -133.73 140.64 37.26 Favored Pre-proline 0 N--CA 1.479 1.024 0 C-N-CA 123.009 0.524 . . . . 74.32 110.509 177.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 357' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -89.27 42.66 0.6 Allowed 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 123.564 2.843 . . . . 55.22 111.304 173.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 358' ' ' CYS . . . . . . . . . . . . . 47.9 t 69.82 -0.96 2.49 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 124.679 1.192 . . . . 73.32 111.984 -177.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 359' ' ' GLY . . . . . . . . . . . . . . . 66.98 -95.53 0.28 Allowed Glycine 0 C--N 1.353 1.507 0 N-CA-C 109.892 -1.283 . . . . 62.01 109.892 -166.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 360' ' ' GLN . . . . . 0.407 ' HA ' ' NE2' ' B' ' 313' ' ' GLN . 8.6 tt0 55.64 -80.16 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 126.322 1.849 . . . . 53.34 113.239 167.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 361' ' ' ILE . . . . . 0.672 ' HB ' ' HB3' ' B' ' 41' ' ' PRO . 2.8 pp -72.22 -20.56 20.04 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 125.107 1.363 . . . . 61.31 111.905 -175.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 362' ' ' GLY . . . . . . . . . . . . . . . -70.72 -17.21 74.82 Favored Glycine 0 C--N 1.354 1.562 0 O-C-N 123.76 0.663 . . . . 72.35 113.224 178.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 363' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -81.98 -16.25 51.02 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.551 0.74 . . . . 73.13 111.439 -178.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 364' ' ' THR . . . . . . . . . . . . . 17.3 p -126.17 118.31 24.94 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.847 0.859 . . . . 74.04 111.181 -177.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 3.0 m -123.54 84.22 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 N-CA-C 107.598 -1.26 . . . . 74.01 107.598 168.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -76.46 -37.11 57.42 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 115.285 -0.871 . . . . 50.12 112.499 -162.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 367' ' ' LEU . . . . . 0.562 ' HA ' HD13 ' B' ' 38' ' ' ILE . 3.1 tt 61.85 73.51 0.47 Allowed 'General case' 0 CA--C 1.553 1.08 0 N-CA-C 108.343 -0.984 . . . . 75.05 108.343 -171.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 368' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -107.69 -72.18 0.73 Allowed 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 116.085 -0.507 . . . . 71.23 111.975 -171.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 369' ' ' GLU . . . . . 0.543 ' HG2' ' HB3' ' B' ' 308' ' ' CYS . 0.3 OUTLIER -55.97 134.87 52.55 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.684 1.194 . . . . 70.1 111.241 -164.497 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 370' ' ' ALA . . . . . 0.539 ' HA ' HD22 ' B' ' 11' ' ' LEU . . . -153.3 40.61 0.53 Allowed 'General case' 0 CA--C 1.557 1.231 0 N-CA-C 113.11 0.782 . . . . 74.25 113.11 -170.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 371' ' ' VAL . . . . . . . . . . . . . 9.9 p -144.79 -25.83 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.575 -0.703 . . . . 74.11 112.889 175.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 372' ' ' GLN . . . . . 0.403 ' HG2' ' N ' ' B' ' 373' ' ' ARG . 55.7 tt0 -112.21 175.55 5.39 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.174 0.99 . . . . 63.2 110.176 -173.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 373' ' ' ARG . . . . . 0.469 ' HD3' ' HB ' ' B' ' 306' ' ' VAL . 33.2 mtm180 89.15 122.09 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 126.525 1.93 . . . . 72.05 112.278 170.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 374' ' ' ALA . . . . . 0.471 ' HB1' HG11 ' A' ' 177' ' ' VAL . . . 61.2 121.43 0.01 OUTLIER 'General case' 0 C--N 1.359 1.007 0 C-N-CA 126.088 1.755 . . . . 71.45 113.71 163.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 375' ' ' LEU . . . . . 0.462 ' HA ' ' HA ' ' B' ' 378' ' ' ALA . 85.5 mt 70.43 15.07 7.34 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.891 1.276 . . . . 62.01 112.338 -178.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.84 -29.77 66.0 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.246 0.618 . . . . 73.13 109.605 171.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 377' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -103.92 -25.91 12.86 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.22 1.008 . . . . 73.31 110.579 167.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 378' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' B' ' 375' ' ' LEU . . . 74.95 -166.01 0.08 Allowed 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 124.972 1.309 . . . . 61.1 112.688 172.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? 71.39 109.28 0.06 Allowed 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 125.469 1.508 . . . . 72.01 111.191 -173.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 380' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -157.04 -56.34 0.08 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.013 0.925 . . . . 53.14 108.815 176.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 381' ' ' GLU . . . . . 0.404 ' HG3' ' HG2' ' B' ' 415' ' ' LYS . 14.8 tt0 -74.64 113.85 12.38 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.624 -0.716 . . . . 74.34 109.639 176.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -74.27 -46.21 21.8 Favored Glycine 0 C--N 1.342 0.906 0 N-CA-C 110.637 -0.985 . . . . 73.1 110.637 168.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 383' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -168.18 -179.07 3.9 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.817 1.247 . . . . 73.1 108.696 176.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 384' ' ' THR . . . . . . . . . . . . . 14.4 t -119.61 11.66 12.08 Favored 'General case' 0 CA--C 1.558 1.269 0 C-N-CA 123.313 0.645 . . . . 63.41 111.296 -175.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 5.0 mp -101.25 -73.4 0.65 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.588 0.755 . . . . 75.12 109.096 -178.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 386' ' ' VAL . . . . . . . . . . . . . 2.5 m -139.41 116.77 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.023 1.329 . . . . 62.42 108.037 175.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 387' ' ' ILE . . . . . 0.666 HG21 ' HA ' ' B' ' 414' ' ' THR . 8.6 tp -83.21 -155.55 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.572 1.805 0 C-N-CA 123.783 0.833 . . . . 74.12 110.622 -174.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 388' ' ' VAL . . . . . 0.621 ' H ' HG13 ' B' ' 387' ' ' ILE . 19.2 t 72.26 2.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 C-N-CA 125.507 1.523 . . . . 54.33 110.502 -174.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 389' ' ' THR . . . . . . . . . . . . . 8.1 m -66.6 -36.41 82.55 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.648 1.179 . . . . 71.25 110.421 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . -84.55 114.86 22.27 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 124.117 0.967 . . . . 70.34 110.018 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 391' ' ' ASP . . . . . . . . . . . . . 32.0 t70 65.29 -102.6 0.09 Allowed 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 124.71 1.204 . . . . 64.12 111.943 173.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 392' ' ' HIS . . . . . 0.455 ' H ' ' H ' ' B' ' 393' ' ' ALA . 48.3 p-80 171.56 10.36 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 125.852 1.661 . . . . 72.42 109.624 -173.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 393' ' ' ALA . . . . . 0.455 ' H ' ' H ' ' B' ' 392' ' ' HIS . . . 65.15 78.73 0.27 Allowed 'General case' 0 C--N 1.363 1.155 0 C-N-CA 124.98 1.312 . . . . 61.53 111.33 -174.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -135.89 170.14 16.47 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.218 -1.031 . . . . 73.31 108.218 168.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . 65.57 15.31 9.98 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.812 0.845 . . . . 71.44 111.827 -178.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 29.8 t -78.51 85.0 4.61 Favored 'General case' 0 C--N 1.348 0.529 0 N-CA-C 107.2 -1.407 . . . . 75.55 107.2 171.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 397' ' ' GLN . . . . . 0.44 ' HB2' ' OH ' ' A' ' 194' ' ' TYR . 2.7 mp0 57.62 -148.88 0.47 Allowed 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 124.297 1.039 . . . . 71.41 110.778 178.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 398' ' ' ILE . . . . . 0.408 ' H ' ' HB3' ' B' ' 397' ' ' GLN . 2.9 pt 68.72 155.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 C-N-CA 126.767 2.027 . . . . 75.44 114.0 168.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 399' ' ' VAL . . . . . . . . . . . . . 53.6 t 68.43 155.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 C-N-CA 125.177 1.391 . . . . 73.32 111.778 177.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 400' ' ' ALA . . . . . . . . . . . . . . . 74.62 172.29 0.1 OUTLIER Pre-proline 0 N--CA 1.48 1.027 0 C-N-CA 125.326 1.451 . . . . 51.41 110.348 -177.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 401' ' ' PRO . . . . . 0.479 ' HG2' ' HG2' ' C' ' 184' ' ' PRO . 41.2 Cg_exo -44.19 119.98 2.33 Favored 'Trans proline' 0 C--N 1.384 2.405 0 C-N-CA 122.472 2.114 . . . . 71.04 112.673 167.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 22.5 p-10 -82.16 11.35 5.38 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.824 1.25 . . . . 74.34 111.561 -178.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 403' ' ' THR . . . . . . . . . . . . . 34.0 p -115.98 2.58 13.51 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.734 1.614 . . . . 51.3 111.099 -172.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 404' ' ' LYS . . . . . . . . . . . . . 52.6 tttm -168.86 103.71 0.4 Allowed 'General case' 0 C--N 1.355 0.821 0 C-N-CA 122.904 0.481 . . . . 70.03 110.387 176.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 405' ' ' ALA . . . . . 0.464 ' H ' ' HB3' ' B' ' 123' ' ' ASP . . . -177.17 124.18 0.28 Allowed Pre-proline 0 N--CA 1.476 0.829 0 C-N-CA 124.954 1.302 . . . . 71.24 108.529 171.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 406' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -65.74 86.49 0.22 Allowed 'Trans proline' 0 C--N 1.383 2.376 0 C-N-CA 122.719 2.279 . . . . 44.44 112.241 177.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . -124.75 -93.95 1.01 Allowed Glycine 0 C--N 1.348 1.208 0 N-CA-C 109.41 -1.476 . . . . 55.33 109.41 174.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 408' ' ' LEU . . . . . . . . . . . . . 5.8 mp 61.47 -90.12 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.6 1.16 . . . . 72.03 111.067 174.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 77.9 m -83.65 151.93 25.04 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.761 0.824 . . . . 73.52 109.173 178.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 410' ' ' GLN . . . . . 0.404 ' HA ' ' HG3' ' A' ' 189' ' ' GLU . 10.1 mm100 70.72 153.69 0.12 Allowed 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 125.049 1.34 . . . . 51.32 112.361 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 411' ' ' ALA . . . . . 0.736 ' HB2' HH22 ' A' ' 187' ' ' ARG . . . -141.3 -87.58 0.17 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.189 -0.914 . . . . 63.14 108.774 178.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 43.0 tp 174.68 139.75 0.05 OUTLIER 'General case' 0 C--N 1.359 1.0 0 C-N-CA 124.57 1.148 . . . . 60.41 109.736 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 17.2 t30 72.88 164.17 0.28 Allowed 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.735 1.214 . . . . 71.14 113.944 163.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 414' ' ' THR . . . . . 0.666 ' HA ' HG21 ' B' ' 387' ' ' ILE . 11.8 m 82.91 124.32 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 126.956 2.102 . . . . 73.24 112.865 172.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 415' ' ' LYS . . . . . 0.443 ' HE3' ' O ' ' A' ' 158' ' ' VAL . 22.1 tptm -130.68 -54.12 1.07 Allowed 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.208 1.403 . . . . 73.42 108.762 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -88.16 -178.13 5.87 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.754 0.822 . . . . 75.33 109.971 174.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 417' ' ' GLY . . . . . . . . . . . . . . . -151.84 174.11 30.96 Favored Glycine 0 C--N 1.346 1.084 0 C-N-CA 121.899 -0.191 . . . . 43.15 113.063 -176.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 418' ' ' ALA . . . . . . . . . . . . . . . -97.6 175.46 6.19 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.448 1.099 . . . . 70.25 110.462 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 419' ' ' VAL . . . . . . . . . . . . . 68.9 t -77.5 108.86 11.36 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 C-N-CA 123.322 0.649 . . . . 62.03 109.846 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 420' ' ' MET . . . . . 0.543 ' HG3' ' H ' ' B' ' 421' ' ' VAL . 23.2 ptm 46.31 -79.11 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 127.267 2.227 . . . . 73.12 114.678 177.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 421' ' ' VAL . . . . . 0.543 ' H ' ' HG3' ' B' ' 420' ' ' MET . 27.2 m -119.36 -38.02 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 123.702 0.801 . . . . 72.42 110.9 -176.269 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 422' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER 61.89 -72.64 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 125.682 1.593 . . . . 74.1 111.708 -174.383 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 423' ' ' SER . . . . . . . . . . . . . 38.0 m -82.48 111.35 18.42 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.871 0.868 . . . . 62.22 110.876 -178.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 424' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 62.07 -161.48 0.29 Allowed 'General case' 0 N--CA 1.477 0.878 0 O-C-N 124.36 1.038 . . . . 72.42 112.525 170.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . 157.1 -84.94 0.13 Allowed Glycine 0 C--N 1.338 0.684 0 N-CA-C 109.593 -1.403 . . . . 75.12 109.593 173.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 426' ' ' ASN . . . . . 0.835 ' HB2' ' HB2' ' B' ' 432' ' ' GLN . 0.0 OUTLIER -173.28 102.57 0.12 Allowed 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 107.819 -1.178 . . . . 75.43 107.819 -179.89 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 427' ' ' SER . . . . . . . . . . . . . 44.0 m 62.54 20.05 11.68 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 124.237 1.015 . . . . 75.14 110.552 -167.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 50.93 25.99 2.46 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 125.024 1.33 . . . . 73.23 112.061 -168.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 429' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -149.57 -90.39 0.07 Allowed 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 109.082 -0.71 . . . . 63.42 109.082 -176.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -168.82 -171.22 1.32 Allowed 'General case' 0 CA--C 1.555 1.155 0 N-CA-C 109.141 -0.689 . . . . 55.41 109.141 -171.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 28.4 t 80.95 -1.83 1.79 Allowed 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 125.37 1.468 . . . . 73.31 113.249 168.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 432' ' ' GLN . . . . . 0.835 ' HB2' ' HB2' ' B' ' 426' ' ' ASN . 14.7 mm100 -101.89 -47.84 4.46 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 118.418 0.554 . . . . 71.1 110.033 173.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 433' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 64.79 -80.25 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.681 1.192 . . . . 73.43 110.116 -176.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 434' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -78.26 81.43 4.62 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 107.733 -1.21 . . . . 65.13 107.733 167.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 435' ' ' THR . . . . . . . . . . . . . 3.1 t -68.41 -48.82 63.67 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.02 -0.991 . . . . 73.42 109.652 175.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . 56.9 16.61 18.55 Favored Glycine 0 C--N 1.356 1.671 0 N-CA-C 114.503 0.561 . . . . 43.54 114.503 175.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 37.5 p -71.65 -44.01 65.08 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 123.987 0.915 . . . . 54.14 110.396 -176.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 438' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -152.71 -81.46 0.09 Allowed 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.916 -1.038 . . . . 71.55 109.554 -174.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 439' ' ' LEU . . . . . . . . . . . . . 5.9 mp 53.62 -85.27 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.955 0.902 . . . . 74.24 109.121 -164.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 440' ' ' ARG . . . . . . . . . . . . . 18.4 mmt180 65.73 171.66 0.22 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 124.967 1.307 . . . . 70.1 113.148 172.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 441' ' ' ILE . . . . . 0.672 ' HA ' ' HB3' ' A' ' 235' ' ' LEU . 27.5 mt -114.72 121.96 67.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 114.842 -1.072 . . . . 74.15 109.802 179.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 442' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' B' ' 458' ' ' THR . . . -60.9 -39.6 89.94 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.746 0.818 . . . . 71.41 110.7 178.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . -73.54 142.16 46.69 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.378 0.671 . . . . 74.21 110.7 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 444' ' ' TYR . . . . . 0.565 ' HB3' ' ND2' ' B' ' 450' ' ' ASN . 84.0 m-85 64.43 -86.11 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.311 1.044 . . . . 65.34 110.97 175.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . 64.23 -136.26 39.99 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-O 119.462 -0.632 . . . . 74.34 112.671 -176.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 446' ' ' PRO . . . . . 0.54 ' HD3' ' HA ' ' B' ' 459' ' ' ASP . 71.9 Cg_endo -99.71 47.94 0.06 OUTLIER 'Trans proline' 0 CA--C 1.555 1.554 0 C-N-CA 123.309 2.673 . . . . 63.02 112.089 168.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 447' ' ' HIS . . . . . . . . . . . . . 70.5 t60 -77.49 76.76 4.02 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.522 0.729 . . . . 60.0 111.13 -175.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . 65.33 -77.59 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.085 1.354 . . . . 74.31 112.009 177.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 449' ' ' ALA . . . . . . . . . . . . . . . -142.83 7.43 1.65 Allowed 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.729 0.812 . . . . 61.52 111.422 178.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 450' ' ' ASN . . . . . 0.565 ' ND2' ' HB3' ' B' ' 444' ' ' TYR . 5.4 m-20 55.5 17.07 2.08 Favored 'General case' 0 N--CA 1.502 2.125 0 C-N-CA 125.331 1.453 . . . . 61.12 114.5 173.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 65.0 t -69.37 96.05 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 122.934 0.494 . . . . 63.1 109.943 -174.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 452' ' ' VAL . . . . . . . . . . . . . 7.1 t 62.32 25.71 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.564 1.482 0 C-N-CA 125.2 1.4 . . . . 60.45 109.942 -177.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . -91.13 68.54 2.21 Favored Glycine 0 C--N 1.35 1.327 0 CA-C-N 115.456 -0.793 . . . . 73.44 113.348 -170.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 454' ' ' LEU . . . . . . . . . . . . . 2.2 tt -78.15 70.82 4.57 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.068 -1.086 . . . . 72.5 108.068 175.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 55.8 p -127.47 144.26 51.09 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 124.508 1.123 . . . . 61.41 109.917 -171.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -77.49 82.94 3.91 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.632 0.773 . . . . 74.3 110.07 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 457' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -101.78 -29.57 11.8 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.07 1.348 . . . . 42.14 110.957 -179.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 458' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' B' ' 442' ' ' ALA . 62.2 m 71.64 120.98 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.675 1.59 . . . . 72.13 110.837 -174.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 459' ' ' ASP . . . . . 0.54 ' HA ' ' HD3' ' B' ' 446' ' ' PRO . 34.7 t70 -68.97 138.66 54.75 Favored 'General case' 0 C--N 1.352 0.704 0 C-N-CA 123.189 0.595 . . . . 73.31 111.321 -175.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 30.6 tp -123.71 -12.01 7.67 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.387 1.075 . . . . 65.42 108.73 176.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 72.5 t80 55.04 88.57 0.04 OUTLIER 'General case' 0 C--N 1.36 1.063 0 C-N-CA 125.227 1.411 . . . . 62.31 111.102 -172.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -110.68 -14.48 14.03 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 115.313 -0.858 . . . . 72.53 110.397 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 26.0 m -78.26 92.81 4.54 Favored 'General case' 0 C--N 1.35 0.621 0 CA-C-O 121.676 0.75 . . . . 61.35 110.5 -175.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 464' ' ' MET . . . . . . . . . . . . . 19.2 ptp -147.02 20.71 1.25 Allowed 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 114.33 -1.304 . . . . 75.31 109.308 177.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -149.4 146.59 27.55 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 124.597 1.159 . . . . 72.15 109.589 -174.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -90.31 1.61 56.36 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.77 0.828 . . . . 62.32 110.663 173.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . 67.74 -76.61 0.05 Allowed 'General case' 0 C--N 1.368 1.374 0 C-N-CA 125.709 1.604 . . . . 75.3 111.399 176.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 5.0 tt -78.08 -26.74 48.33 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 124.119 0.967 . . . . 45.51 109.494 178.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 469' ' ' GLY . . . . . 0.404 ' N ' ' HB3' ' C' ' 263' ' ' PRO . . . -85.55 66.65 3.74 Favored Glycine 0 C--N 1.349 1.274 0 CA-C-N 116.086 -0.506 . . . . 50.44 113.449 -176.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 470' ' ' LEU . . . . . . . . . . . . . 3.2 pp -131.29 -6.58 3.8 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.433 0.693 . . . . 73.2 111.249 175.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 471' ' ' LYS . . . . . . . . . . . . . 61.5 tttp . . . . . 0 C--O 1.252 1.186 0 N-CA-C 108.907 -0.775 . . . . 74.2 108.907 -175.643 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 67.2 mtt . . . . . 0 N--CA 1.479 1.001 0 N-CA-C 109.315 -0.624 . . . . 55.23 109.315 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.03 24.08 12.3 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.368 1.467 . . . . 65.31 112.885 178.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.0 76.56 3.55 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.262 0.625 . . . . 52.01 110.257 -178.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 5.0 ttmp? -38.33 99.43 0.02 OUTLIER 'General case' 0 C--N 1.364 1.2 0 C-N-CA 124.691 1.196 . . . . 70.52 113.536 -176.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 5' ' ' LYS . . . . . 0.453 ' HG3' ' OG ' ' C' ' 94' ' ' SER . 1.3 mmmp? -67.64 96.87 0.57 Allowed 'General case' 0 C--O 1.241 0.651 0 N-CA-C 107.319 -1.363 . . . . 63.2 107.319 165.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 6' ' ' ASP . . . . . 0.481 ' HA ' ' OH ' ' C' ' 66' ' ' TYR . 38.4 t70 -70.42 96.56 1.16 Allowed 'General case' 0 C--N 1.348 0.539 0 N-CA-C 108.453 -0.943 . . . . 63.22 108.453 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 7' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -58.36 -34.32 70.54 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 113.835 -1.53 . . . . 73.43 111.737 -173.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -62.0 -47.22 85.76 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 115.777 -0.647 . . . . 72.53 110.42 175.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.99 -40.32 93.0 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.252 0.621 . . . . 52.31 111.288 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 10' ' ' ILE . . . . . 0.411 HG22 HD13 ' C' ' 50' ' ' ILE . 58.6 mt -60.93 -39.59 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.079 0.552 . . . . 63.34 110.227 176.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 11' ' ' LEU . . . . . 0.417 ' HB2' HG22 ' C' ' 13' ' ' VAL . 87.0 mt -80.26 -6.97 58.77 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 112.785 0.661 . . . . 45.45 112.785 177.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 69.2 31.39 71.85 Favored Glycine 0 C--N 1.353 1.5 0 O-C-N 123.055 0.222 . . . . 64.33 113.189 -178.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 13' ' ' VAL . . . . . 0.417 HG22 ' HB2' ' C' ' 11' ' ' LEU . 26.9 m -126.34 154.67 74.78 Favored Pre-proline 0 N--CA 1.481 1.107 0 C-N-CA 124.932 1.293 . . . . 64.04 109.268 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -80.36 167.56 19.23 Favored 'Trans proline' 0 C--N 1.371 1.743 0 C-N-CA 122.401 2.067 . . . . 74.43 112.754 178.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -72.85 74.29 1.14 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.12 0.968 . . . . 71.52 109.652 173.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -178.3 -19.3 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.164 1.386 . . . . 71.24 108.538 -176.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -49.42 112.04 0.58 Allowed 'General case' 0 C--N 1.354 0.782 0 C-N-CA 125.176 1.391 . . . . 71.14 112.345 175.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 77.9 p -73.62 -177.94 2.91 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.011 0.925 . . . . 74.41 111.429 -178.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -51.74 -52.25 50.06 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.307 0.643 . . . . 74.45 111.846 -176.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -67.18 -32.01 72.81 Favored 'General case' 0 C--O 1.206 -1.227 0 CA-C-O 118.679 -0.677 . . . . 64.05 112.107 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -68.92 -40.77 78.87 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 119.014 0.824 . . . . 73.42 110.767 -179.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 22' ' ' ILE . . . . . 0.884 HD13 ' HB3' ' C' ' 57' ' ' LEU . 96.6 mt -69.62 -37.77 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.553 1.141 . . . . 61.32 110.199 174.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 23' ' ' LYS . . . . . 0.475 ' O ' ' HG3' ' C' ' 27' ' ' LYS . 10.4 tppt? -65.41 -42.86 92.08 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 114.942 -1.026 . . . . 74.13 109.636 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 24' ' ' ARG . . . . . 0.438 ' HA ' ' HD2' ' C' ' 27' ' ' LYS . 97.3 mtt180 -77.71 -28.23 50.84 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 124.607 1.163 . . . . 73.52 110.669 -177.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.72 -43.65 95.9 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 123.895 0.747 . . . . 75.32 109.065 172.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 26' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -65.08 -45.36 85.55 Favored 'General case' 0 C--O 1.213 -0.818 0 CA-C-N 114.939 -1.028 . . . . 72.31 110.886 176.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . 0.491 ' HE2' ' HA ' ' B' ' 196' ' ' THR . 83.9 mttt -55.57 -46.19 77.22 Favored 'General case' 0 N--CA 1.502 2.14 0 C-N-CA 123.824 0.85 . . . . 74.1 110.143 178.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 25.0 ttm180 -56.07 -56.58 19.1 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 114.338 -1.301 . . . . 71.15 110.203 178.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . 0.622 HD13 HD12 ' C' ' 50' ' ' ILE . 66.1 mt -80.46 -9.61 59.76 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 114.543 -1.208 . . . . 60.22 111.636 -172.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.77 -27.52 26.83 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.702 0.801 . . . . 75.32 110.248 173.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 81.9 mtm180 -90.9 -21.71 21.26 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 123.56 0.537 . . . . 73.5 111.107 171.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -82.55 -55.67 4.33 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.363 0.665 . . . . 71.12 110.187 -178.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -89.63 17.08 6.8 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.221 0.609 . . . . 70.15 110.984 178.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 34' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -47.14 94.8 0.08 OUTLIER Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 125.151 1.38 . . . . 72.34 112.365 -169.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -75.35 -8.87 20.02 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 123.313 2.675 . . . . 71.32 112.817 -164.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -65.05 -41.32 95.26 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.62 1.168 . . . . 60.34 110.107 171.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 88.5 t -97.06 -48.11 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 115.683 -0.69 . . . . 75.33 109.868 -178.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -97.0 75.02 2.62 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 108.152 -1.055 . . . . 54.22 108.152 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 10.5 mtmp? -75.8 75.83 2.75 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 114.377 -1.283 . . . . 62.24 109.247 177.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 49.7 m -139.42 132.72 15.59 Favored Pre-proline 0 C--O 1.245 0.831 0 CA-C-N 115.027 -0.988 . . . . 74.14 109.847 -176.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . 0.548 ' HA ' ' HB2' ' C' ' 44' ' ' GLU . 81.7 Cg_exo -47.37 -33.16 16.22 Favored 'Trans proline' 0 C--N 1.389 2.709 0 C-N-CA 124.049 3.166 . . . . 63.44 113.059 174.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -45.17 -59.62 2.54 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.418 1.087 . . . . 65.44 110.494 171.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.6 -7.93 59.65 Favored 'General case' 0 C--O 1.211 -0.923 0 CA-C-N 114.339 -1.301 . . . . 62.05 110.646 -177.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 44' ' ' GLU . . . . . 0.548 ' HB2' ' HA ' ' C' ' 41' ' ' PRO . 22.0 mm-40 -78.26 -60.57 2.32 Favored 'General case' 0 C--O 1.213 -0.825 0 N-CA-C 108.422 -0.955 . . . . 74.04 108.422 175.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -53.28 -47.89 68.79 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.147 0.979 . . . . 42.53 110.925 176.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 46' ' ' LYS . . . . . 0.509 ' O ' HG12 ' C' ' 50' ' ' ILE . 49.4 mttp -65.48 -52.28 53.99 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.301 -0.863 . . . . 72.32 112.32 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -68.98 -23.1 64.08 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 118.511 0.596 . . . . 62.23 111.624 -178.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 48' ' ' LYS . . . . . 0.436 ' HD3' ' O ' ' C' ' 44' ' ' GLU . 13.1 mptt -75.85 -35.89 59.78 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 122.59 0.356 . . . . 72.04 110.27 177.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -67.28 -33.23 74.87 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 117.763 0.256 . . . . 72.33 110.351 170.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 50' ' ' ILE . . . . . 0.622 HD12 HD13 ' C' ' 29' ' ' LEU . 22.8 mm -66.34 -38.88 82.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 N-CA-C 109.538 -0.542 . . . . 75.43 109.538 173.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 51' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -65.3 -42.29 93.2 Favored 'General case' 0 C--O 1.204 -1.335 0 C-N-CA 123.637 0.775 . . . . 74.04 110.08 178.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -61.82 -52.73 62.97 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.329 1.052 . . . . 63.42 110.097 177.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.13 -56.56 19.41 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-N 113.582 -1.644 . . . . 63.1 111.571 -176.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -64.51 -35.82 82.2 Favored 'General case' 0 C--O 1.204 -1.318 0 CA-C-N 114.19 -1.368 . . . . 75.01 111.226 177.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.78 -39.72 92.66 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 118.779 0.718 . . . . 60.54 111.747 -176.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 78.8 t -72.94 -50.34 33.27 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 O-C-N 123.597 0.56 . . . . 72.43 109.715 174.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 57' ' ' LEU . . . . . 0.884 ' HB3' HD13 ' C' ' 22' ' ' ILE . 60.9 mt -88.12 1.43 54.36 Favored 'General case' 0 CA--C 1.56 1.362 0 N-CA-C 114.582 1.327 . . . . 75.02 114.582 -168.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 41.5 t -55.8 -38.08 69.47 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 124.599 1.16 . . . . 62.42 112.719 -173.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -121.41 137.91 27.54 Favored Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 107.409 -1.33 . . . . 72.03 107.409 -168.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 60' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -48.9 -36.64 34.75 Favored 'Trans proline' 0 C--N 1.381 2.261 0 C-N-CA 123.839 3.026 . . . . 33.23 113.441 -177.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -58.12 -66.76 0.43 Allowed 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 114.261 -1.336 . . . . 62.13 111.398 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 1.8 mtpm? -72.4 -23.31 61.08 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.54 0.736 . . . . 75.23 111.7 -174.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 -57.24 -50.13 73.85 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.276 -0.874 . . . . 64.42 109.153 169.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 64' ' ' ARG . . . . . 0.514 ' HA ' ' HB2' ' C' ' 67' ' ' ASP . 27.4 mmt180 -72.7 -21.81 60.99 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.636 -0.711 . . . . 74.15 112.117 178.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 1.6 mp -58.86 -46.92 90.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-N 118.556 0.616 . . . . 62.34 109.417 167.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 66' ' ' TYR . . . . . 0.481 ' OH ' ' HA ' ' C' ' 6' ' ' ASP . 37.0 t80 -62.41 -51.41 67.65 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 115.78 -0.646 . . . . 74.22 110.52 174.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 67' ' ' ASP . . . . . 0.514 ' HB2' ' HA ' ' C' ' 64' ' ' ARG . 27.4 m-20 -59.83 -31.14 69.46 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.704 0.802 . . . . 73.14 112.021 -176.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 39.9 p -81.31 -26.93 35.26 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 119.269 -0.396 . . . . 63.2 110.986 176.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 69' ' ' TYR . . . . . 0.402 ' HE2' ' HE1' ' C' ' 96' ' ' PHE . 71.2 t80 -72.6 133.52 44.73 Favored 'General case' 0 C--N 1.359 1.019 0 N-CA-C 108.518 -0.919 . . . . 75.22 108.518 173.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.46 16.94 41.11 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.286 -0.726 . . . . 62.51 111.286 -164.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 63.1 m -146.76 -61.42 0.3 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 103.497 -2.779 . . . . 72.34 103.497 172.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 28.3 m -76.5 142.08 41.04 Favored 'General case' 0 C--O 1.25 1.099 0 N-CA-C 104.997 -2.223 . . . . 73.35 104.997 157.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.46 -10.74 8.39 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.342 0.657 . . . . 73.23 110.82 177.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -77.5 138.61 63.26 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 123.242 0.617 . . . . 53.23 109.529 171.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -63.16 136.66 57.2 Favored 'Trans proline' 0 C--N 1.373 1.836 0 C-N-CA 122.602 2.201 . . . . 75.14 111.808 174.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.04 159.37 53.31 Favored 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 123.323 2.682 . . . . 63.14 112.229 -178.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -59.51 116.38 3.25 Favored 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 122.693 2.262 . . . . 51.51 112.637 174.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 78' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -68.48 136.5 36.8 Favored 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 122.675 2.25 . . . . 74.44 111.82 175.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 79' ' ' PRO . . . . . 0.621 ' HB3' ' HA3' ' C' ' 142' ' ' GLY . 38.5 Cg_exo -45.77 159.46 0.21 Allowed 'Trans proline' 0 CA--C 1.567 2.134 0 C-N-CA 123.955 3.103 . . . . 61.04 114.303 166.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -66.02 84.21 0.25 Allowed 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 123.075 2.516 . . . . 51.5 111.892 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 146.67 -28.19 1.62 Allowed Glycine 0 C--N 1.336 0.567 0 CA-C-N 114.668 -1.151 . . . . 75.2 110.799 -178.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 146.93 173.77 18.43 Favored Glycine 0 C--N 1.344 1.026 0 C-N-CA 123.857 0.741 . . . . 74.45 112.004 172.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 83' ' ' TYR . . . . . 0.478 ' HA ' ' HD2' ' C' ' 79' ' ' PRO . 76.5 m-85 -52.05 120.34 5.29 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.009 0.924 . . . . 70.14 110.591 176.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 84' ' ' ASP . . . . . 0.604 ' HB2' ' HG2' ' C' ' 79' ' ' PRO . 44.3 t0 -60.65 124.83 21.55 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 124.502 1.126 . . . . 63.13 110.385 -176.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 85' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -169.34 17.94 0.02 OUTLIER 'General case' 0 C--O 1.257 1.492 0 CA-C-N 114.185 -1.37 . . . . 74.41 107.493 -167.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 19.6 m -59.08 116.44 3.84 Favored 'General case' 0 C--N 1.361 1.09 0 CA-C-N 113.755 -1.566 . . . . 45.43 110.781 -166.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 87' ' ' GLY . . . . . 0.504 ' HA2' ' HA ' ' C' ' 171' ' ' PRO . . . 124.1 -20.57 7.1 Favored Glycine 0 C--N 1.342 0.867 0 O-C-N 123.732 0.645 . . . . 74.33 112.936 179.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 88' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -123.32 131.96 53.84 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 117.599 0.7 . . . . 74.44 111.804 -169.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -75.42 86.16 2.56 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.553 0.741 . . . . 72.23 111.154 -171.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 90' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -39.8 -43.72 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 C-N-CA 125.901 1.68 . . . . 54.41 114.74 174.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -65.07 -18.52 65.37 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.327 0.651 . . . . 74.21 112.149 -174.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -79.3 -30.44 42.89 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 122.848 0.459 . . . . 75.53 110.693 177.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -85.47 174.64 9.36 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.484 0.714 . . . . 72.45 112.908 -164.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 94' ' ' SER . . . . . 0.453 ' OG ' ' HG3' ' C' ' 5' ' ' LYS . 93.7 p -78.88 178.24 8.11 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 114.363 1.246 . . . . 45.51 114.363 -163.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -62.61 -54.02 45.91 Favored 'General case' 0 C--N 1.355 0.818 0 CA-C-N 113.888 -1.505 . . . . 55.43 111.2 -176.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 96' ' ' PHE . . . . . 0.402 ' HE1' ' HE2' ' C' ' 69' ' ' TYR . 48.6 t80 -48.44 -50.19 32.28 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 123.629 0.772 . . . . 65.02 111.626 -176.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 97' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -60.14 -52.01 67.14 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 114.592 -1.186 . . . . 64.25 110.116 175.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 98' ' ' GLN . . . . . 0.632 ' HA ' HD11 ' C' ' 105' ' ' LEU . 22.2 mt-30 -73.13 3.78 5.18 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 112.753 0.649 . . . . 51.52 112.753 -178.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -100.47 -54.5 2.83 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.879 0.872 . . . . 74.43 111.796 168.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 28.9 tp -63.84 -44.76 92.19 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.215 0.606 . . . . 73.23 110.809 -176.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 101' ' ' PHE . . . . . 0.458 ' O ' ' HG ' ' C' ' 105' ' ' LEU . 42.3 m-85 -94.78 -5.76 44.53 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.387 -0.824 . . . . 73.25 110.152 177.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -42.61 -60.97 2.67 Favored Glycine 0 CA--C 1.541 1.669 0 CA-C-O 118.553 -1.137 . . . . 54.11 115.076 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -41.42 -24.49 0.23 Allowed 'Trans proline' 0 C--N 1.391 2.785 0 C-N-CA 125.05 3.833 . . . . 62.02 116.584 -179.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -149.29 38.92 0.94 Allowed Glycine 0 C--N 1.35 1.352 0 CA-C-O 119.226 -0.763 . . . . 43.23 112.706 -176.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 105' ' ' LEU . . . . . 0.632 HD11 ' HA ' ' C' ' 98' ' ' GLN . 38.5 mt -64.2 80.66 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 114.647 1.351 . . . . 73.03 114.647 176.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 106' ' ' PHE . . . . . 0.46 ' HB3' ' H ' ' C' ' 107' ' ' GLY . 0.6 OUTLIER 48.23 -150.79 0.14 Allowed 'General case' 0 CA--C 1.556 1.202 0 N-CA-C 117.158 2.281 . . . . 64.24 117.158 162.893 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 107' ' ' GLY . . . . . 0.46 ' H ' ' HB3' ' C' ' 106' ' ' PHE . . . 93.15 -1.19 69.83 Favored Glycine 0 C--N 1.353 1.494 0 N-CA-C 111.766 -0.534 . . . . 51.05 111.766 -165.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 108' ' ' GLY . . . . . 0.408 ' HA2' ' HB3' ' C' ' 167' ' ' GLN . . . 61.76 -136.65 46.61 Favored Glycine 0 C--N 1.35 1.353 0 N-CA-C 111.776 -0.53 . . . . 74.41 111.776 -175.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 109' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -86.62 -0.9 57.11 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.162 0.585 . . . . 74.45 110.61 176.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 110' ' ' GLY . . . . . . . . . . . . . . . -93.98 -28.41 11.02 Favored Glycine 0 C--N 1.356 1.663 0 CA-C-N 116.417 -0.356 . . . . 54.22 112.768 178.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 13.7 mmm180 67.76 -11.49 0.33 Allowed 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 114.477 1.288 . . . . 75.25 114.477 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 112' ' ' ARG . . . . . . . . . . . . . 39.1 ttp180 -78.6 12.96 1.79 Allowed 'General case' 0 CA--C 1.565 1.547 0 C-N-CA 123.988 0.915 . . . . 74.1 112.423 -178.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 113' ' ' SER . . . . . . . . . . . . . 66.4 m 66.6 36.97 4.61 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.743 1.217 . . . . 72.53 112.113 175.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 114' ' ' ARG . . . . . 0.504 ' HG2' ' H ' ' C' ' 115' ' ' LYS . 2.1 ttp180 -70.3 174.35 5.72 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 115.55 -0.75 . . . . 74.05 111.608 -174.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 115' ' ' LYS . . . . . 0.635 ' HA ' ' HD2' ' C' ' 170' ' ' PRO . 61.8 tttp -47.1 143.25 3.21 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.336 1.054 . . . . 54.14 110.441 168.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 116' ' ' GLY . . . . . 0.412 ' HA2' ' HA3' ' C' ' 168' ' ' GLY . . . -44.01 124.51 5.23 Favored Glycine 0 C--N 1.359 1.809 0 CA-C-O 118.822 -0.988 . . . . 45.25 110.653 169.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 37.8 ttp180 -57.24 101.99 0.08 Allowed 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.401 -0.963 . . . . 64.44 108.401 -177.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -47.05 100.55 0.02 OUTLIER 'General case' 0 C--N 1.351 0.653 0 O-C-N 124.739 1.274 . . . . 75.42 107.734 172.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 119' ' ' LEU . . . . . . . . . . . . . 23.3 tp -91.15 119.21 31.07 Favored 'General case' 0 C--N 1.338 0.095 0 CA-C-N 114.466 -1.243 . . . . 75.21 109.441 -161.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.439 ' HD3' ' N ' ' B' ' 188' ' ' ARG . 10.6 mtt180 -112.22 88.56 2.84 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 114.312 -1.313 . . . . 72.31 107.734 -169.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 121' ' ' ALA . . . . . 0.484 ' HB3' HD23 ' C' ' 176' ' ' LEU . . . -109.46 142.38 40.55 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 109.363 -0.606 . . . . 63.21 109.363 -174.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -126.97 127.81 45.4 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 107.152 -1.425 . . . . 73.22 107.152 178.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -138.51 147.32 54.6 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 123.249 0.62 . . . . 73.3 110.992 -167.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' C' ' 179' ' ' ARG . 6.1 Cg_exo -80.78 122.73 4.47 Favored 'Trans proline' 0 C--N 1.368 1.576 0 C-N-CA 123.184 2.59 . . . . 72.51 110.445 166.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 125' ' ' LEU . . . . . 0.463 ' HB3' HG13 ' C' ' 178' ' ' VAL . 18.1 tp -132.23 151.97 51.56 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 108.995 -0.743 . . . . 74.03 108.995 -177.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 126' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -95.04 152.61 18.18 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-O 120.734 0.302 . . . . 61.53 110.47 -178.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 127' ' ' LEU . . . . . 0.548 HD13 ' HD2' ' C' ' 186' ' ' PHE . 89.4 mt -60.51 -49.16 78.67 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.272 1.029 . . . . 62.25 111.029 177.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 128' ' ' GLU . . . . . 0.502 ' HG2' HD21 ' B' ' 173' ' ' LEU . 22.1 mp0 -66.32 -33.45 75.76 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 115.564 -0.743 . . . . 75.24 110.564 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 129' ' ' GLU . . . . . 0.562 ' HG3' ' HD3' ' B' ' 178' ' ' PRO . 13.5 mm-40 -68.83 -29.09 67.35 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.423 0.689 . . . . 73.53 111.363 176.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -75.18 -40.95 59.01 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 109.256 -0.646 . . . . 64.34 109.256 176.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 131' ' ' PHE . . . . . 0.596 ' HB2' HD13 ' C' ' 215' ' ' LEU . 84.6 t80 -55.06 -40.12 69.95 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.044 0.937 . . . . 75.55 110.744 174.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 132' ' ' HIS . . . . . . . . . . . . . 35.4 m170 -64.75 -59.52 4.14 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 115.545 -0.752 . . . . 60.22 109.676 174.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 62.77 -132.59 43.82 Favored Glycine 0 C--N 1.352 1.434 0 CA-C-N 115.719 -0.673 . . . . 65.31 111.925 -176.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 134' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' C' ' 148' ' ' ARG . . . 63.52 -151.65 48.52 Favored Glycine 0 C--N 1.351 1.41 0 O-C-N 123.956 0.445 . . . . 53.24 112.905 175.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -70.82 107.96 4.25 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.268 0.627 . . . . 71.2 109.784 178.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 136' ' ' ARG . . . . . 0.578 ' HB2' HD22 ' B' ' 181' ' ' LEU . 5.6 mmp_? -106.48 145.51 31.72 Favored 'General case' 0 C--O 1.249 1.029 0 C-N-CA 123.942 0.897 . . . . 72.12 109.185 171.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 137' ' ' VAL . . . . . 0.514 ' HB ' ' HB1' ' B' ' 180' ' ' ALA . 82.9 t -72.07 106.57 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.175 0.99 . . . . 71.12 110.412 -178.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 138' ' ' VAL . . . . . 0.56 ' HB ' HD23 ' B' ' 181' ' ' LEU . 12.1 p -119.54 111.73 34.26 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 CA-C-O 121.534 0.683 . . . . 72.14 110.173 176.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 139' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' C' ' 143' ' ' ARG . 1.4 tm-20 -119.32 99.85 6.95 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 106.882 -1.525 . . . . 74.31 106.882 169.289 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 140' ' ' VAL . . . . . . . . . . . . . 7.3 p -139.03 134.83 42.15 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 109.128 -0.693 . . . . 63.22 109.128 -179.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 141' ' ' ALA . . . . . 0.589 ' HB1' ' HG2' ' C' ' 167' ' ' GLN . . . 68.7 6.81 5.72 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.759 1.223 . . . . 15.23 112.713 -179.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 142' ' ' GLY . . . . . 0.621 ' HA3' ' HB3' ' C' ' 79' ' ' PRO . . . 105.49 -8.1 43.64 Favored Glycine 0 C--N 1.349 1.304 0 N-CA-C 112.611 -0.196 . . . . 45.25 112.611 -176.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 143' ' ' ARG . . . . . 0.459 ' O ' ' HA ' ' C' ' 139' ' ' GLU . 23.9 ttt85 -86.42 104.21 15.7 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.403 0.681 . . . . 73.04 110.615 179.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 39.8 ttt180 -98.18 107.76 20.31 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.684 0.794 . . . . 71.51 109.9 177.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 145' ' ' VAL . . . . . . . . . . . . . 7.2 p -150.94 157.14 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 123.914 0.886 . . . . 75.03 109.787 177.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 41.3 m -100.83 105.1 16.37 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.106 -1.072 . . . . 54.21 108.106 168.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 147' ' ' VAL . . . . . 0.477 HG21 HG13 ' C' ' 161' ' ' VAL . 7.6 p -104.67 146.26 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 N-CA-C 110.311 -0.255 . . . . 72.53 110.311 -173.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 148' ' ' ARG . . . . . 0.501 ' HD3' ' O ' ' B' ' 106' ' ' TYR . 12.6 ttm180 -85.78 109.73 18.86 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 116.224 -0.444 . . . . 74.22 110.318 177.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 149' ' ' ILE . . . . . . . . . . . . . 31.3 pt -91.99 150.08 39.94 Favored Pre-proline 0 C--O 1.245 0.846 0 CA-C-N 114.971 -1.013 . . . . 71.41 108.334 169.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 150' ' ' PRO . . . . . 0.513 ' HD2' HG23 ' C' ' 159' ' ' ILE . 19.3 Cg_endo -56.04 125.76 20.13 Favored 'Trans proline' 0 C--N 1.383 2.359 0 C-N-CA 122.744 2.296 . . . . 61.44 110.974 178.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 151' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' C' ' 150' ' ' PRO . 46.8 Cg_exo -57.07 93.77 0.05 OUTLIER 'Trans proline' 0 C--N 1.383 2.346 0 C-N-CA 123.187 2.592 . . . . 73.2 111.971 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 152' ' ' GLY . . . . . . . . . . . . . . . 114.25 131.44 5.21 Favored Glycine 0 C--N 1.342 0.9 0 CA-C-N 115.259 -0.882 . . . . 54.32 112.633 -174.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 p -145.66 158.95 12.5 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.11 0 C-N-CA 123.694 0.797 . . . . 71.13 110.664 -177.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 154' ' ' ARG . . . . . . . . . . . . . 16.7 mtt85 -101.98 153.19 20.11 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 124.399 1.08 . . . . 75.32 110.335 -173.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 155' ' ' GLU . . . . . 0.432 ' HB2' HD12 ' C' ' 180' ' ' LEU . 12.7 tp10 -65.59 127.25 31.14 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.891 0.877 . . . . 74.51 110.372 169.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 76.18 6.08 82.4 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-N 115.576 -0.738 . . . . 64.51 114.566 178.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 157' ' ' SER . . . . . . . . . . . . . 26.7 t -107.38 156.41 18.96 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 117.337 0.569 . . . . 75.43 111.229 -175.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 158' ' ' VAL . . . . . 0.406 ' HB ' ' HB3' ' C' ' 175' ' ' LEU . 18.4 m -93.31 134.25 31.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-N 114.83 -1.077 . . . . 64.44 111.772 -176.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 159' ' ' ILE . . . . . 0.564 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 80.9 mt -86.88 132.04 33.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 C-N-CA 124.187 0.995 . . . . 52.25 108.53 166.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 160' ' ' ARG . . . . . 0.454 ' NH1' HD13 ' B' ' 111' ' ' LEU . 21.3 ttm180 -82.49 99.97 9.8 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 109.084 -0.71 . . . . 72.21 109.084 171.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 161' ' ' VAL . . . . . 0.477 HG13 HG21 ' C' ' 147' ' ' VAL . 63.5 t -96.24 95.37 1.96 Allowed Pre-proline 0 CA--C 1.548 0.866 0 N-CA-C 106.432 -1.692 . . . . 75.24 106.432 169.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 162' ' ' PRO . . . . . 0.534 ' HB2' ' H ' ' B' ' 194' ' ' SER . 26.9 Cg_endo -94.86 165.68 1.7 Allowed 'Trans proline' 0 C--N 1.361 1.232 0 C-N-CA 123.05 2.5 . . . . 63.42 115.226 -162.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 65.83 13.41 59.18 Favored Glycine 0 C--N 1.345 1.044 0 CA-C-N 114.114 -1.403 . . . . 53.31 114.829 172.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 164' ' ' MET . . . . . 0.432 ' SD ' ' NH2' ' C' ' 143' ' ' ARG . 35.1 mtm -136.81 -88.68 0.29 Allowed 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 117.468 0.634 . . . . 73.35 110.067 -175.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . 79.85 -152.56 35.24 Favored Glycine 0 C--N 1.351 1.412 0 CA-C-N 116.762 -0.199 . . . . 64.24 113.369 -172.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . -98.77 -159.64 29.68 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-N 115.307 -0.447 . . . . 75.44 112.819 -178.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 167' ' ' GLN . . . . . 0.589 ' HG2' ' HB1' ' C' ' 141' ' ' ALA . 27.4 mm-40 -70.66 118.91 14.05 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.899 0.88 . . . . 64.31 111.533 -174.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 168' ' ' GLY . . . . . 0.412 ' HA3' ' HA2' ' C' ' 116' ' ' GLY . . . 161.77 162.48 13.13 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 109.929 -1.269 . . . . 13.44 109.929 178.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 169' ' ' ASN . . . . . 0.723 ' HB2' ' HD3' ' C' ' 170' ' ' PRO . 1.7 m-20 -73.57 -68.41 0.36 Allowed Pre-proline 0 CA--C 1.578 2.051 0 CA-C-O 117.846 -1.073 . . . . 62.44 112.97 -166.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 170' ' ' PRO . . . . . 0.723 ' HD3' ' HB2' ' C' ' 169' ' ' ASN . 34.1 Cg_exo -63.73 176.17 2.48 Favored 'Trans proline' 0 C--N 1.401 3.298 0 C-N-CA 122.475 2.117 . . . . 51.41 113.281 172.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 171' ' ' PRO . . . . . 0.504 ' HA ' ' HA2' ' C' ' 87' ' ' GLY . 29.7 Cg_endo -62.28 139.23 76.35 Favored 'Trans proline' 0 C--N 1.389 2.666 0 C-N-CA 122.551 2.167 . . . . 74.02 111.76 172.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -116.18 -34.03 1.41 Allowed Glycine 0 C--N 1.336 0.574 0 CA-C-N 116.089 -0.505 . . . . 74.42 112.56 177.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 173' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 71.04 147.97 0.08 Allowed 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 125.089 1.355 . . . . 74.51 111.273 -179.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 174' ' ' LEU . . . . . . . . . . . . . 11.0 tp -121.97 128.55 51.61 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.904 0.882 . . . . 75.22 108.853 -174.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 175' ' ' LEU . . . . . 0.478 ' HB2' HH11 ' B' ' 188' ' ' ARG . 71.8 mt -110.49 130.58 55.53 Favored 'General case' 0 C--O 1.243 0.721 0 C-N-CA 123.597 0.759 . . . . 71.32 109.23 172.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 176' ' ' LEU . . . . . 0.564 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 95.7 mt -108.33 107.97 18.77 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.373 0.669 . . . . 43.02 110.884 178.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 177' ' ' VAL . . . . . . . . . . . . . 56.0 t -81.53 101.12 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 107.147 -1.427 . . . . 74.43 107.147 173.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 178' ' ' VAL . . . . . 0.463 HG13 ' HB3' ' C' ' 125' ' ' LEU . 39.7 t -76.65 128.87 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 114.599 -1.182 . . . . 74.01 110.755 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 179' ' ' ARG . . . . . 0.466 ' O ' ' HA ' ' C' ' 124' ' ' PRO . 36.6 mmt180 -111.94 101.03 9.36 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 105.325 -2.102 . . . . 72.33 105.325 171.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 180' ' ' LEU . . . . . 0.454 ' HA ' ' O ' ' C' ' 125' ' ' LEU . 28.9 mt -68.93 133.03 47.65 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 108.922 -0.77 . . . . 70.51 108.922 -176.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 181' ' ' LEU . . . . . . . . . . . . . 85.0 mt -54.05 163.01 1.29 Allowed Pre-proline 0 N--CA 1.493 1.717 0 C-N-CA 125.31 1.444 . . . . 74.2 113.317 -167.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -51.52 77.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.391 2.813 0 C-N-CA 123.744 2.963 . . . . 64.12 111.982 164.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 183' ' ' HIS . . . . . . . . . . . . . 75.3 t60 -174.08 53.92 0.15 Allowed Pre-proline 0 CA--C 1.553 1.059 0 N-CA-C 104.112 -2.551 . . . . 62.13 104.112 -170.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 184' ' ' PRO . . . . . 0.479 ' HG2' ' HG2' ' B' ' 401' ' ' PRO . 92.1 Cg_endo -86.67 65.79 4.68 Favored 'Trans proline' 0 C--N 1.388 2.65 0 C-N-CA 123.535 2.823 . . . . 71.54 112.079 -164.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 185' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 11.7 t -95.89 -50.24 11.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 108.047 -1.094 . . . . 72.23 108.047 -178.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 186' ' ' PHE . . . . . 0.548 ' HD2' HD13 ' C' ' 127' ' ' LEU . 34.0 m-85 -117.67 156.39 28.28 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.488 0.715 . . . . 61.44 111.956 -174.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 187' ' ' ARG . . . . . 0.49 ' O ' ' HB3' ' C' ' 194' ' ' TYR . 33.8 ttp180 -153.64 112.11 3.64 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.476 1.51 . . . . 75.14 107.742 177.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 188' ' ' LEU . . . . . 0.431 HD21 ' O ' ' C' ' 190' ' ' GLY . 47.9 tp -80.73 153.1 28.02 Favored 'General case' 0 CA--C 1.558 1.263 0 N-CA-C 115.392 1.627 . . . . 74.14 115.392 -163.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -126.92 99.59 5.8 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.889 1.675 . . . . 71.33 107.182 159.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 190' ' ' GLY . . . . . 0.431 ' O ' HD21 ' C' ' 188' ' ' LEU . . . 63.61 -80.09 0.04 OUTLIER Glycine 0 CA--C 1.539 1.575 0 N-CA-C 114.194 0.438 . . . . 74.2 114.194 175.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 191' ' ' GLN . . . . . 0.456 HE21 ' HA3' ' C' ' 242' ' ' GLY . 42.8 mt-30 -122.42 -34.86 3.2 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.877 1.271 . . . . 60.21 109.635 177.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -83.63 125.12 31.5 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.189 0.995 . . . . 65.13 110.983 -174.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 193' ' ' LEU . . . . . 0.439 ' HG ' ' HA2' ' C' ' 239' ' ' GLY . 91.7 mt -80.65 159.09 25.44 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.253 0.621 . . . . 52.2 112.017 -179.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 194' ' ' TYR . . . . . 0.49 ' HB3' ' O ' ' C' ' 187' ' ' ARG . 43.7 t80 -119.12 106.94 12.88 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 108.112 -1.07 . . . . 75.43 108.112 165.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 195' ' ' ALA . . . . . 0.549 ' HB2' HD11 ' C' ' 249' ' ' LEU . . . -108.2 -174.9 2.63 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.553 0.741 . . . . 65.11 110.099 175.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 29.3 m -138.47 119.06 13.93 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.586 -0.733 . . . . 51.32 109.604 174.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 197' ' ' LEU . . . . . 0.491 HD13 ' HB2' ' C' ' 212' ' ' ALA . 53.5 tp -98.78 118.21 35.01 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.292 0.637 . . . . 73.5 109.375 -179.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 198' ' ' ASP . . . . . 0.584 ' HA ' ' HB2' ' C' ' 254' ' ' ARG . 26.4 t70 -85.69 99.97 11.67 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.501 0.721 . . . . 44.52 109.087 -178.102 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 199' ' ' VAL . . . . . 0.482 HG22 HG21 ' C' ' 210' ' ' VAL . 21.4 t -110.59 123.6 35.26 Favored Pre-proline 0 N--CA 1.479 0.989 0 N-CA-C 108.661 -0.866 . . . . 61.21 108.661 -178.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 200' ' ' PRO . . . . . 0.439 ' HD2' HG11 ' C' ' 210' ' ' VAL . 46.2 Cg_endo -69.09 147.22 66.72 Favored 'Trans proline' 0 C--N 1.367 1.546 0 C-N-CA 121.565 1.51 . . . . 71.34 110.553 173.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 201' ' ' ALA . . . . . 0.476 ' HB3' ' HH2' ' C' ' 269' ' ' TRP . . . -52.59 -45.46 96.06 Favored Pre-proline 0 CA--C 1.555 1.158 0 C-N-CA 124.638 1.175 . . . . 74.35 113.467 -176.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 202' ' ' PRO . . . . . 0.488 ' HB2' ' HA ' ' A' ' 273' ' ' ALA . 23.7 Cg_endo -57.99 -49.71 12.09 Favored 'Trans proline' 0 C--N 1.391 2.774 0 C-N-CA 121.384 1.389 . . . . 63.15 112.304 177.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 203' ' ' ILE . . . . . . . . . . . . . 29.2 mt -64.42 -32.34 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 123.218 0.607 . . . . 63.4 111.145 178.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.8 -37.6 84.87 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.134 0.574 . . . . 75.02 111.512 179.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 205' ' ' VAL . . . . . 0.425 ' HA ' ' HA ' ' C' ' 226' ' ' ARG . 91.2 t -82.09 -37.24 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 123.233 0.613 . . . . 63.41 111.972 -178.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 206' ' ' VAL . . . . . 0.625 HG22 ' HG3' ' B' ' 248' ' ' ARG . 8.3 p -87.61 -33.58 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 N-CA-C 111.975 0.361 . . . . 52.12 111.975 -175.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 90.33 126.44 3.22 Favored Glycine 0 C--N 1.344 0.98 0 N-CA-C 111.076 -0.81 . . . . 63.21 111.076 -167.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -159.93 -137.3 2.2 Favored Glycine 0 C--N 1.336 0.57 0 CA-C-N 117.81 0.805 . . . . 51.32 111.466 179.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 209' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' C' ' 221' ' ' VAL . 7.6 mtmp? -139.26 134.75 33.06 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 123.43 0.692 . . . . 72.12 110.603 171.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 210' ' ' VAL . . . . . 0.482 HG21 HG22 ' C' ' 199' ' ' VAL . 27.7 m -134.3 140.57 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 107.754 -1.202 . . . . 62.05 107.754 169.021 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 211' ' ' ARG . . . . . 0.53 ' HA ' ' HA ' ' C' ' 220' ' ' GLU . 32.4 ttm105 -80.5 133.12 35.78 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 122.975 0.51 . . . . 72.44 111.66 -175.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 212' ' ' ALA . . . . . 0.491 ' HB2' HD13 ' C' ' 197' ' ' LEU . . . -104.18 130.36 51.94 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.785 1.234 . . . . 74.43 107.704 164.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 213' ' ' MET . . . . . 0.407 ' HG2' ' N ' ' C' ' 214' ' ' THR . 6.6 ttt -70.39 149.49 47.24 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 109.264 -0.643 . . . . 63.12 109.264 168.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 214' ' ' THR . . . . . 0.528 HG21 ' HD2' ' C' ' 238' ' ' LYS . 0.1 OUTLIER -139.92 169.14 18.26 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.173 0.511 . . . . 54.24 110.415 168.101 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 215' ' ' LEU . . . . . 0.596 HD13 ' HB2' ' C' ' 131' ' ' PHE . 54.4 mt -61.82 -36.05 80.02 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.144 1.378 . . . . 44.41 112.667 -172.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.78 -2.67 27.63 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.396 0.679 . . . . 71.0 112.11 -177.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 155.69 171.41 22.14 Favored Glycine 0 C--O 1.212 -1.274 0 CA-C-O 119.556 -0.58 . . . . 64.11 112.492 -178.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -88.26 126.01 1.91 Allowed 'Trans proline' 0 CA--C 1.556 1.618 0 C-N-CA 122.998 2.465 . . . . 52.13 112.748 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 219' ' ' VAL . . . . . 0.44 HG13 ' HB3' ' C' ' 212' ' ' ALA . 3.3 p -103.2 115.12 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 123.925 0.89 . . . . 52.53 109.696 177.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 220' ' ' GLU . . . . . 0.53 ' HA ' ' HA ' ' C' ' 211' ' ' ARG . 23.6 tt0 -84.43 109.38 17.83 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 109.491 -0.559 . . . . 72.32 109.491 -179.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 221' ' ' VAL . . . . . 0.458 HG11 HD21 ' C' ' 233' ' ' LEU . 47.7 t -74.13 127.88 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 124.491 1.116 . . . . 74.03 111.957 -174.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 222' ' ' ALA . . . . . 0.421 ' HA ' ' HG2' ' C' ' 209' ' ' LYS . . . -80.97 103.52 10.85 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 124.199 0.937 . . . . 73.3 109.05 167.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 62.1 t -79.04 129.47 72.91 Favored Pre-proline 0 CA--C 1.553 1.079 0 C-N-CA 123.744 0.818 . . . . 73.11 109.721 176.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 224' ' ' PRO . . . . . 0.593 ' HG2' ' HB2' ' B' ' 243' ' ' GLN . 3.1 Cg_exo -78.68 160.64 28.01 Favored 'Trans proline' 0 C--N 1.371 1.722 0 C-N-CA 123.925 3.084 . . . . 54.33 112.103 169.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.51 143.49 98.02 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 122.944 2.429 . . . . 74.0 112.93 176.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 226' ' ' ARG . . . . . 0.446 ' HG2' ' O ' ' A' ' 259' ' ' GLU . 0.6 OUTLIER 55.18 86.02 0.06 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.468 1.907 . . . . 70.15 113.79 173.748 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 227' ' ' THR . . . . . 0.543 HG21 ' HH2' ' B' ' 242' ' ' TRP . 82.1 m -123.93 133.36 53.74 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 114.828 -1.078 . . . . 70.3 111.143 -178.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 228' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -104.77 155.71 18.65 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.712 0.768 . . . . 74.32 110.702 176.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -72.23 145.59 47.86 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.328 -0.851 . . . . 62.12 109.936 176.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 95.42 -9.34 69.36 Favored Glycine 0 N--CA 1.464 0.561 0 CA-C-N 115.746 -0.661 . . . . 62.04 112.118 -171.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 231' ' ' ARG . . . . . 0.404 ' NH1' ' HA ' ' C' ' 227' ' ' THR . 81.8 mtt180 -69.55 178.34 2.54 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 117.339 0.569 . . . . 74.12 110.761 167.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 232' ' ' LYS . . . . . 0.571 ' HD3' ' HB3' ' C' ' 250' ' ' TYR . 1.9 ttmp? -153.93 126.86 8.29 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 112.258 0.466 . . . . 71.45 112.258 -174.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 233' ' ' LEU . . . . . 0.615 ' O ' ' HA ' ' C' ' 250' ' ' TYR . 5.1 mp -86.39 158.66 19.57 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.488 1.115 . . . . 74.21 110.437 175.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 19.1 ptt-85 -128.92 88.46 2.72 Favored 'General case' 0 CA--C 1.556 1.204 0 O-C-N 124.712 1.257 . . . . 72.34 109.513 170.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 235' ' ' LEU . . . . . 0.508 HD22 ' H ' ' B' ' 240' ' ' GLY . 56.9 mt -86.55 105.99 17.22 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 108.213 -1.032 . . . . 73.43 108.213 174.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -67.71 132.75 48.05 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.36 0.664 . . . . 71.55 111.639 -168.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 237' ' ' GLY . . . . . 0.401 ' CA ' ' HB2' ' B' ' 335' ' ' ASN . . . 80.95 1.38 89.79 Favored Glycine 0 C--N 1.349 1.254 0 N-CA-C 115.018 0.767 . . . . 71.42 115.018 174.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 238' ' ' LYS . . . . . 0.528 ' HD2' HG21 ' C' ' 214' ' ' THR . 73.8 mmtt -92.8 13.18 21.09 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 123.588 0.755 . . . . 72.03 111.116 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 239' ' ' GLY . . . . . 0.439 ' HA2' ' HG ' ' C' ' 193' ' ' LEU . . . -95.17 -169.6 36.3 Favored Glycine 0 C--N 1.358 1.772 0 C-N-CA 122.977 0.322 . . . . 31.21 113.205 177.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 240' ' ' PHE . . . . . 0.41 ' HD2' HD13 ' C' ' 188' ' ' LEU . 3.8 m-85 -78.73 148.28 72.49 Favored Pre-proline 0 N--CA 1.481 1.102 0 C-N-CA 123.027 0.531 . . . . 75.14 110.397 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 241' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -63.64 137.31 58.5 Favored 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 123.43 2.753 . . . . 70.21 112.103 -178.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 242' ' ' GLY . . . . . 0.456 ' HA3' HE21 ' C' ' 191' ' ' GLN . . . -131.71 168.6 22.26 Favored Glycine 0 C--N 1.342 0.911 0 CA-C-O 120.169 -0.24 . . . . 70.14 113.678 -175.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -73.91 -2.38 12.17 Favored 'Trans proline' 0 C--N 1.38 2.206 0 C-N-CA 123.642 2.894 . . . . 71.42 114.553 -173.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -137.62 11.8 2.95 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.655 0.782 . . . . 71.42 111.118 178.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 137.43 167.79 11.17 Favored Glycine 0 C--N 1.348 1.214 0 N-CA-C 111.111 -0.795 . . . . 51.32 111.111 -176.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 246' ' ' ARG . . . . . . . . . . . . . 26.8 mtm-85 -81.85 151.32 27.38 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-N 117.275 0.537 . . . . 61.31 109.914 176.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -78.13 -169.93 35.31 Favored Glycine 0 C--N 1.34 0.798 0 O-C-N 123.872 0.733 . . . . 63.23 113.48 -178.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -123.79 142.66 50.89 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.122 -1.066 . . . . 73.54 108.122 -173.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 249' ' ' LEU . . . . . 0.549 HD11 ' HB2' ' C' ' 195' ' ' ALA . 25.6 tp -83.89 109.52 17.65 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.95 -0.568 . . . . 74.23 109.797 -179.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 250' ' ' TYR . . . . . 0.615 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 22.0 m-30 -101.02 100.53 11.15 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 109.498 -0.556 . . . . 71.43 109.498 179.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 251' ' ' LEU . . . . . 0.578 ' HB2' HD13 ' C' ' 233' ' ' LEU . 2.2 mp -100.39 121.91 42.29 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 119.166 -0.445 . . . . 64.53 110.338 -172.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 252' ' ' GLU . . . . . 0.454 ' HB2' ' HE1' ' C' ' 194' ' ' TYR . 25.3 tt0 -75.07 129.7 38.04 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-O 121.129 0.49 . . . . 73.41 109.681 170.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 253' ' ' VAL . . . . . 0.52 HG11 HG22 ' C' ' 227' ' ' THR . 60.4 t -76.23 135.19 27.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 115.166 -0.925 . . . . 73.5 111.012 -175.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 254' ' ' ARG . . . . . 0.584 ' HB2' ' HA ' ' C' ' 198' ' ' ASP . 11.4 mmt85 -103.8 135.19 45.8 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.321 1.448 . . . . 74.13 108.32 165.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 255' ' ' ILE . . . . . . . . . . . . . 33.0 mm -106.94 105.34 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 107.028 -1.471 . . . . 75.24 107.028 165.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 256' ' ' THR . . . . . . . . . . . . . 3.5 t -115.76 171.72 7.58 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.037 0.935 . . . . 53.32 110.067 -173.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 10.7 pt -134.95 152.93 78.18 Favored Pre-proline 0 CA--C 1.552 1.037 0 C-N-CA 123.987 0.915 . . . . 64.54 109.876 -173.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -80.79 20.98 0.91 Allowed 'Trans proline' 0 C--N 1.381 2.274 0 C-N-CA 123.372 2.715 . . . . 73.21 113.737 -168.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 57.3 -89.81 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.778 1.231 . . . . 72.3 111.18 -174.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 260' ' ' ARG . . . . . 0.719 ' HG3' ' HA2' ' B' ' 284' ' ' GLY . 0.0 OUTLIER -80.39 145.86 31.78 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 123.214 0.606 . . . . 73.41 109.473 -179.317 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 261' ' ' LEU . . . . . . . . . . . . . 96.4 mt -128.73 154.69 46.1 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.89 0.876 . . . . 71.21 109.566 176.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 262' ' ' THR . . . . . 0.625 HG21 ' HB3' ' B' ' 280' ' ' LEU . 45.1 p -84.92 155.72 61.11 Favored Pre-proline 0 CA--C 1.555 1.142 0 N-CA-C 109.252 -0.647 . . . . 61.23 109.252 170.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 263' ' ' PRO . . . . . 0.404 ' HB3' ' N ' ' B' ' 469' ' ' GLY . 3.8 Cg_exo -34.35 -51.81 0.62 Allowed 'Trans proline' 0 C--N 1.382 2.302 1 C-N-CA 125.684 4.256 . . . . 74.2 115.836 -178.606 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -62.94 -55.05 29.33 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.954 0.501 . . . . 71.04 110.259 -177.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -49.31 -55.14 13.77 Favored 'General case' 0 C--N 1.356 0.866 0 O-C-N 124.451 1.094 . . . . 65.11 109.675 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 266' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' C' ' 270' ' ' LYS . 15.4 tp10 -54.62 -43.27 72.09 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 124.655 1.222 . . . . 64.21 110.997 -177.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -60.6 -45.42 94.07 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.508 0.723 . . . . 70.32 112.217 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 268' ' ' LEU . . . . . 0.511 ' HB2' HD21 ' A' ' 272' ' ' LEU . 10.3 mp -66.35 -50.99 61.69 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 116.729 -0.214 . . . . 52.44 110.93 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 269' ' ' TRP . . . . . 0.476 ' HH2' ' HB3' ' C' ' 201' ' ' ALA . 92.5 m95 -56.95 -32.41 65.99 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.292 0.637 . . . . 61.11 111.039 177.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 270' ' ' LYS . . . . . 0.653 ' HA ' HG21 ' A' ' 206' ' ' VAL . 10.2 tmtt? -67.76 -46.46 72.02 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.987 0.915 . . . . 75.43 110.336 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -63.2 -37.21 86.32 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 122.73 0.412 . . . . 75.33 111.486 177.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 272' ' ' LEU . . . . . 0.416 HD12 ' HA ' ' C' ' 269' ' ' TRP . 75.1 mt -64.9 -37.11 86.54 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.295 0.638 . . . . 74.33 110.125 176.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -63.43 -45.39 91.16 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.438 0.695 . . . . 34.13 111.055 177.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -65.72 -36.71 84.38 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.289 0.636 . . . . 63.21 111.036 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -62.7 -33.07 74.33 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 115.596 -0.729 . . . . 70.04 110.584 174.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 276' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -73.46 -42.34 62.06 Favored 'General case' 0 CA--C 1.554 1.114 0 CA-C-N 115.36 -0.836 . . . . 75.52 111.939 174.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -68.05 -22.61 64.94 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.949 -0.469 . . . . 44.24 111.403 178.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -59.77 -22.53 62.26 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.504 0.722 . . . . 55.2 112.131 174.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 279' ' ' ARG . . . . . . . . . . . . . 39.0 mtm180 -72.66 -29.84 63.77 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 122.743 0.417 . . . . 71.52 110.738 178.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.044 0 C-N-CA 123.7 0.8 . . . . 75.14 109.378 -173.402 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.47 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.1 mpt? . . . . . 0 N--CA 1.475 0.786 0 N-CA-C 109.87 -0.418 . . . . 64.12 109.87 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.76 16.06 7.54 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 125.333 1.453 . . . . 51.4 113.649 175.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -80.72 76.76 7.6 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.256 0.622 . . . . 74.04 110.224 -174.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -37.28 105.22 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 126.722 2.009 . . . . 62.43 113.039 -178.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -77.68 109.34 11.57 Favored 'General case' 0 C--O 1.245 0.863 0 C-N-CA 124.031 0.932 . . . . 74.32 109.413 171.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -82.34 94.53 7.39 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 108.459 -0.941 . . . . 61.41 108.459 177.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -60.54 -37.46 81.3 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.191 0.997 . . . . 73.34 111.672 -174.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.497 ' HB3' ' O ' ' A' ' 13' ' ' VAL . 95.1 m-85 -67.28 -35.74 80.12 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 114.609 -1.178 . . . . 73.33 111.324 178.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.86 -40.13 72.51 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 122.897 0.479 . . . . 60.32 111.014 177.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 77.0 mt -56.0 -42.75 72.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 123.613 0.765 . . . . 74.23 109.455 174.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 87.7 mt -81.06 -17.47 50.0 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 115.212 -0.903 . . . . 51.33 112.392 176.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.09 18.74 78.06 Favored Glycine 0 CA--C 1.536 1.398 0 N-CA-C 114.71 0.644 . . . . 53.33 114.71 -178.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.497 ' O ' ' HB3' ' A' ' 8' ' ' TYR . 19.6 m -103.89 144.07 27.94 Favored Pre-proline 0 N--CA 1.484 1.228 0 C-N-CA 123.666 0.787 . . . . 71.43 109.252 173.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -54.58 151.01 32.81 Favored 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 122.889 2.393 . . . . 50.12 113.282 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.33 69.48 1.61 Allowed 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.692 0.797 . . . . 75.43 110.561 179.253 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 170.92 -24.36 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.805 1.242 . . . . 64.11 109.422 -173.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.09 138.85 19.12 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.283 1.033 . . . . 64.31 111.761 -177.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 67.2 p -63.49 166.08 7.1 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.17 0.988 . . . . 71.11 111.033 -175.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -56.64 -33.37 66.25 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.985 0.914 . . . . 64.21 111.384 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -69.72 -36.1 75.6 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 122.89 0.476 . . . . 72.43 111.062 -178.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -72.02 -42.06 66.83 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.629 0.772 . . . . 64.03 110.664 177.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 73.7 mt -58.59 -39.53 76.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 124.558 1.143 . . . . 73.31 110.241 173.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.734 ' HG2' ' HE3' ' A' ' 27' ' ' LYS . 33.9 ttmt -71.67 -37.94 70.71 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 114.555 -1.202 . . . . 71.24 110.259 -177.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 49.1 mtp180 -57.36 -52.46 65.25 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.503 0.721 . . . . 54.12 110.319 173.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.33 -38.47 91.14 Favored 'General case' 0 C--O 1.246 0.899 0 CA-C-N 114.435 -1.257 . . . . 64.0 111.653 -177.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -61.87 -60.75 3.18 Favored 'General case' 0 C--O 1.209 -1.067 0 CA-C-N 115.433 -0.803 . . . . 73.1 109.487 177.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.734 ' HE3' ' HG2' ' A' ' 23' ' ' LYS . 10.1 mtmp? -58.71 -33.58 70.36 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 124.266 0.979 . . . . 74.22 111.913 -177.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 14.6 ttt180 -52.74 -58.72 5.94 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.299 1.04 . . . . 71.15 109.856 171.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.662 ' HB3' HD13 ' A' ' 50' ' ' ILE . 88.1 mt -81.21 -10.28 59.64 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 115.172 -0.922 . . . . 74.11 111.991 -178.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.489 ' HB3' ' HA ' ' A' ' 27' ' ' LYS . . . -94.53 -14.59 24.92 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.772 0.829 . . . . 63.3 111.34 -178.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.4 mtm105 -97.96 -38.09 9.53 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.957 -0.757 . . . . 72.33 108.957 168.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -65.43 -47.36 76.48 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.26 0.624 . . . . 63.33 111.092 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -107.4 29.21 7.37 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.515 0.726 . . . . 63.25 110.734 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -68.23 101.51 0.31 Allowed Pre-proline 0 N--CA 1.483 1.204 0 C-N-CA 123.979 0.911 . . . . 63.41 110.547 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.528 ' O ' ' HG3' ' A' ' 39' ' ' LYS . 46.6 Cg_exo -55.07 -39.82 89.0 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 123.073 2.516 . . . . 74.13 113.306 -169.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -46.89 -36.94 8.11 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.799 1.239 . . . . 72.45 112.786 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 48.7 t -101.79 -49.25 10.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 C-N-CA 123.657 0.783 . . . . 65.53 109.28 178.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -107.27 75.26 1.01 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 125.121 1.368 . . . . 61.35 110.665 -176.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.528 ' HG3' ' O ' ' A' ' 35' ' ' PRO . 9.0 mtmp? -78.02 72.47 4.56 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 109.636 -0.505 . . . . 73.11 109.636 172.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 70.4 m -116.9 113.31 39.85 Favored Pre-proline 0 N--CA 1.471 0.621 0 N-CA-C 107.906 -1.146 . . . . 54.41 107.906 176.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -42.8 -53.29 4.01 Favored 'Trans proline' 0 C--N 1.387 2.591 0 C-N-CA 124.58 3.52 . . . . 72.23 114.191 -170.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -52.12 -46.82 65.49 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.221 1.009 . . . . 64.43 111.817 176.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.82 -29.16 69.01 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.597 0.759 . . . . 72.14 110.982 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.503 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 46.1 mt-10 -84.47 -29.7 25.83 Favored 'General case' 0 C--N 1.352 0.707 0 C-N-CA 123.423 0.689 . . . . 62.01 110.461 -175.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -72.31 -43.45 64.16 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.929 0.892 . . . . 62.44 109.791 176.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.422 ' HD3' ' HA ' ' A' ' 46' ' ' LYS . 40.2 mmtm -62.65 -39.7 94.72 Favored 'General case' 0 C--N 1.345 0.405 0 CA-C-N 115.038 -0.983 . . . . 74.03 109.631 171.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.485 ' HE1' ' HA ' ' A' ' 30' ' ' ALA . 60.0 t80 -63.08 -30.14 71.36 Favored 'General case' 0 C--N 1.356 0.866 0 O-C-N 123.867 0.729 . . . . 73.24 110.656 176.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.503 ' HG2' ' O ' ' A' ' 44' ' ' GLU . 34.3 mmtp -62.98 -47.36 83.49 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 109.893 -0.41 . . . . 75.14 109.893 171.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -67.95 -25.88 65.67 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 112.384 0.513 . . . . 71.44 112.384 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.662 HD13 ' HB3' ' A' ' 29' ' ' LEU . 63.0 mt -79.47 -33.46 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 C-N-CA 124.515 1.126 . . . . 70.53 110.102 176.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -70.22 -39.14 75.29 Favored 'General case' 0 C--O 1.208 -1.08 0 CA-C-N 115.265 -0.879 . . . . 73.43 109.81 173.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -61.01 -48.75 80.37 Favored 'General case' 0 C--O 1.247 0.952 0 C-N-CA 124.986 1.314 . . . . 63.42 109.541 176.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.32 -60.42 3.36 Favored 'General case' 0 C--N 1.352 0.69 0 CA-C-N 113.52 -1.673 . . . . 65.45 111.188 177.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -63.92 -35.73 81.62 Favored 'General case' 0 C--O 1.214 -0.771 0 CA-C-N 115.686 -0.688 . . . . 72.32 111.412 -179.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.14 -53.34 58.29 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.579 0.752 . . . . 53.01 110.831 -177.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 66.4 t -62.84 -50.86 78.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 114.533 -1.212 . . . . 74.52 110.352 177.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 67.2 mt -76.07 -8.3 56.67 Favored 'General case' 0 CA--C 1.557 1.242 0 N-CA-C 113.152 0.797 . . . . 62.04 113.152 -172.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.2 t -65.42 -58.46 5.8 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.405 1.082 . . . . 74.34 111.853 -176.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.491 ' HB2' ' HD3' ' A' ' 62' ' ' LYS . 13.4 m-20 -99.31 142.33 24.41 Favored Pre-proline 0 C--O 1.244 0.778 0 C-N-CA 123.419 0.688 . . . . 74.34 109.432 -174.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.515 ' O ' ' HG2' ' A' ' 64' ' ' ARG . 48.7 Cg_exo -54.55 -47.23 27.92 Favored 'Trans proline' 0 C--N 1.385 2.447 0 C-N-CA 123.167 2.578 . . . . 72.41 112.941 -172.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.485 ' O ' HG12 ' A' ' 65' ' ' ILE . 3.1 mp0 -58.78 -58.2 9.64 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.505 0.722 . . . . 72.3 111.213 -174.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.491 ' HD3' ' HB2' ' A' ' 59' ' ' ASP . 37.9 mtpt -58.28 -43.52 88.05 Favored 'General case' 0 C--O 1.257 1.492 0 C-N-CA 124.29 1.036 . . . . 74.54 111.135 -178.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -59.04 -46.81 87.3 Favored 'General case' 0 C--N 1.349 0.581 0 CA-C-N 114.667 -1.152 . . . . 74.11 110.793 178.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.515 ' HG2' ' O ' ' A' ' 60' ' ' PRO . 30.2 mmm180 -77.6 -18.66 56.61 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 123.677 0.61 . . . . 74.25 111.305 -175.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.485 HG12 ' O ' ' A' ' 61' ' ' GLU . 28.3 mm -62.29 -50.93 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 N-CA-C 108.081 -1.081 . . . . 64.42 108.081 168.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -60.35 -52.25 66.07 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 114.908 -1.042 . . . . 75.4 111.001 175.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -63.31 -31.22 72.31 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.457 0.703 . . . . 64.04 112.059 -172.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.3 p -76.65 -31.55 57.41 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 119.166 -0.445 . . . . 75.13 110.773 173.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -64.06 115.12 4.63 Favored 'General case' 0 CA--C 1.556 1.2 0 N-CA-C 109.492 -0.559 . . . . 63.45 109.492 178.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 115.38 5.66 18.82 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 123.562 0.601 . . . . 52.54 111.969 -169.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 86.2 m -147.59 -56.62 0.24 Allowed 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 104.823 -2.288 . . . . 71.23 104.823 178.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.4 m -82.79 141.92 31.95 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 104.446 -2.427 . . . . 74.23 104.446 156.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.79 -35.08 10.25 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 118.617 0.644 . . . . 74.04 111.145 -179.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -93.24 134.18 27.41 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 123.393 0.677 . . . . 75.1 109.412 179.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.92 116.93 3.61 Favored 'Trans proline' 0 C--N 1.373 1.833 0 C-N-CA 122.299 1.999 . . . . 75.41 110.532 171.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -52.14 142.32 45.58 Favored 'Trans proline' 0 C--N 1.38 2.19 0 C-N-CA 123.035 2.49 . . . . 74.25 112.611 177.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -43.4 129.86 6.58 Favored 'Trans proline' 0 C--N 1.388 2.642 0 C-N-CA 123.969 3.113 . . . . 62.44 113.424 -174.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.421 ' HG3' ' HA3' ' A' ' 104' ' ' GLY . 28.2 Cg_endo -58.41 144.02 96.98 Favored 'Trans proline' 0 C--N 1.387 2.579 0 C-N-CA 122.84 2.36 . . . . 43.51 112.705 -171.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.404 ' HB2' HH21 ' A' ' 143' ' ' ARG . 58.9 Cg_endo -65.89 167.49 17.59 Favored 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 122.876 2.384 . . . . 71.05 112.59 -177.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.84 88.45 0.07 OUTLIER 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 122.665 2.244 . . . . 51.35 111.694 176.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 149.91 -40.88 0.84 Allowed Glycine 0 CA--C 1.524 0.611 0 CA-C-N 113.728 -1.578 . . . . 62.41 109.525 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 110.63 -169.51 13.46 Favored Glycine 0 C--N 1.351 1.383 0 C-N-CA 123.594 0.616 . . . . 53.03 111.686 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -84.72 88.36 7.37 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 123.431 0.692 . . . . 74.41 109.867 176.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -58.11 157.96 7.49 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 114.407 -1.269 . . . . 71.31 111.828 175.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -154.56 72.44 0.86 Allowed 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 108.597 -0.89 . . . . 70.22 108.597 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.4 m -43.58 84.99 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 126.134 1.774 . . . . 74.44 115.218 -165.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.451 ' N ' ' HA3' ' A' ' 163' ' ' GLY . . . 67.78 10.81 59.23 Favored Glycine 0 C--N 1.352 1.449 0 CA-C-N 115.815 -0.629 . . . . 70.11 114.008 175.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -93.23 122.95 36.15 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.231 -1.396 . . . . 72.34 107.231 178.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -69.74 90.39 0.59 Allowed 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 110.177 -0.305 . . . . 71.44 110.177 -173.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.491 HG23 ' HE2' ' A' ' 97' ' ' PHE . 2.4 p -34.81 -50.31 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 125.578 1.551 . . . . 75.21 114.084 175.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -59.84 -34.22 72.81 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.255 1.022 . . . . 75.33 111.297 -173.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -78.08 -30.84 49.87 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.218 1.007 . . . . 45.35 111.753 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -82.14 172.19 13.48 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 122.746 0.419 . . . . 71.01 110.161 -173.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 83.8 p -57.56 150.06 19.94 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 114.093 1.145 . . . . 74.5 114.093 -164.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.96 -41.8 71.58 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 114.568 -1.196 . . . . 74.31 110.881 170.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -59.76 -43.06 94.5 Favored 'General case' 0 C--N 1.354 0.769 0 C-N-CA 123.226 0.61 . . . . 75.03 110.755 -177.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.491 ' HE2' HG23 ' A' ' 90' ' ' VAL . 26.5 t80 -58.58 -49.99 75.42 Favored 'General case' 0 CA--C 1.548 0.895 0 O-C-N 123.761 0.663 . . . . 63.23 109.242 173.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.524 ' HA ' HD11 ' A' ' 105' ' ' LEU . 46.4 mt-30 -71.97 -5.6 36.04 Favored 'General case' 0 CA--C 1.557 1.237 0 CA-C-N 115.347 -0.842 . . . . 73.05 112.291 -178.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -97.65 -47.61 5.55 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 124.239 1.015 . . . . 70.02 111.903 173.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 37.2 tp -70.86 -52.75 18.34 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.655 0.782 . . . . 55.03 109.739 -176.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -86.16 -11.64 52.01 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 115.718 -0.674 . . . . 72.11 110.745 178.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -39.27 -58.82 1.94 Allowed Glycine 0 CA--C 1.543 1.792 0 CA-C-O 118.623 -1.098 . . . . 72.43 114.742 177.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -35.02 -36.92 0.13 Allowed 'Trans proline' 0 C--N 1.394 2.937 0 C-N-CA 125.289 3.993 . . . . 23.1 116.362 176.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.421 ' HA3' ' HG3' ' A' ' 78' ' ' PRO . . . -145.77 42.38 0.97 Allowed Glycine 0 C--N 1.354 1.53 0 CA-C-O 119.224 -0.764 . . . . 44.4 112.117 -178.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.524 HD11 ' HA ' ' A' ' 98' ' ' GLN . 8.1 mt -63.2 71.73 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.071 0.948 . . . . 74.25 112.867 177.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.72 ' HB3' ' HA ' ' A' ' 169' ' ' ASN . 1.5 t80 32.4 -105.13 0.02 OUTLIER 'General case' 0 CA--C 1.562 1.413 0 C-N-CA 126.3 1.84 . . . . 72.25 111.738 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 80.48 -40.03 2.38 Favored Glycine 0 C--N 1.359 1.844 0 CA-C-O 119.213 -0.77 . . . . 44.0 113.204 179.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.686 ' HA3' ' HB3' ' A' ' 167' ' ' GLN . . . 51.06 -121.21 10.73 Favored Glycine 0 C--N 1.359 1.839 0 C-N-CA 123.514 0.578 . . . . 71.34 113.519 179.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -84.37 -8.53 58.96 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.468 0.707 . . . . 64.11 111.313 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -77.54 -35.74 35.81 Favored Glycine 0 C--N 1.35 1.308 0 N-CA-C 110.639 -0.984 . . . . 55.25 110.639 168.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 20.1 tpp180 73.51 -40.79 0.47 Allowed 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 126.707 2.003 . . . . 71.44 114.203 171.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.01 21.54 1.94 Allowed 'General case' 0 CA--C 1.565 1.548 0 C-N-CA 125.182 1.393 . . . . 73.25 110.859 -168.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 48.1 m 60.28 41.94 15.76 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-O 122.175 0.988 . . . . 74.21 109.013 -167.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 17.2 ttp180 -80.48 162.42 24.39 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 114.006 -1.452 . . . . 74.52 110.836 -173.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.586 ' HA ' ' HD2' ' A' ' 170' ' ' PRO . 21.9 ttmm -70.52 149.69 46.9 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.223 0.609 . . . . 72.15 109.842 174.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -89.36 161.18 29.86 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-N 116.65 -0.25 . . . . 55.22 113.7 -177.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -100.97 145.59 28.47 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.797 1.239 . . . . 71.34 108.174 175.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -58.6 144.95 41.25 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 118.717 0.69 . . . . 74.23 112.014 -175.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.416 ' O ' HD12 ' A' ' 174' ' ' LEU . 7.8 tt -144.5 137.13 26.68 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 109.049 -0.723 . . . . 70.23 109.049 -173.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -93.19 130.56 38.83 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.306 0.642 . . . . 74.51 109.364 174.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.619 ' HB1' HD11 ' B' ' 8' ' ' LEU . . . -141.31 140.86 33.9 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.415 -0.957 . . . . 41.51 108.415 176.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.461 ' HG3' HD11 ' B' ' 11' ' ' LEU . 42.6 mt-10 -123.11 109.27 13.83 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 108.704 -0.85 . . . . 61.0 108.704 -166.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.797 HD23 HD22 ' A' ' 176' ' ' LEU . 3.8 pp -101.27 114.84 65.71 Favored Pre-proline 0 N--CA 1.484 1.252 0 N-CA-C 110.293 -0.262 . . . . 54.05 110.293 -169.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.659 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 40.4 Cg_endo -67.24 109.56 1.79 Allowed 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 120.7 0.933 . . . . 75.33 110.309 173.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.722 ' HA ' HG21 ' B' ' 6' ' ' ILE . 57.7 tp -110.25 144.25 39.21 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 123.555 0.742 . . . . 64.01 110.829 -171.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 40.5 m -71.43 136.71 47.8 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 114.908 -1.042 . . . . 71.34 110.892 178.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.875 ' HB3' HD22 ' A' ' 215' ' ' LEU . 59.4 mt -54.37 -49.5 69.68 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.109 0.963 . . . . 70.54 111.688 -177.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -54.99 -46.51 75.14 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 114.646 -1.161 . . . . 75.32 111.452 175.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -65.66 -29.43 69.99 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 122.743 0.417 . . . . 64.33 111.451 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -66.75 -47.54 71.91 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.878 0.471 . . . . 41.43 110.503 178.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -63.96 -44.51 92.55 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 114.762 -1.108 . . . . 74.51 111.518 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 30.8 m170 -76.64 -45.58 29.39 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 115.709 -0.678 . . . . 75.25 111.404 -174.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.487 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 74.49 -153.25 45.85 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 123.54 0.525 . . . . 71.54 112.689 -177.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 81.72 -153.12 32.66 Favored Glycine 0 C--N 1.348 1.245 0 C-N-CA 123.223 0.439 . . . . 70.42 112.935 178.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -72.22 97.4 1.97 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.286 0.635 . . . . 73.14 110.09 -177.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.668 HH11 HD13 ' A' ' 125' ' ' LEU . 5.2 tmm_? -96.05 120.4 36.28 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 107.365 -1.346 . . . . 74.4 107.365 173.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 59.6 t -85.75 134.61 26.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 108.945 -0.761 . . . . 71.24 108.945 178.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.504 ' HB ' HG13 ' A' ' 145' ' ' VAL . 85.9 t -116.41 133.44 62.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 C-N-CA 124.007 0.923 . . . . 73.14 108.627 176.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -106.81 114.16 28.09 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 107.719 -1.215 . . . . 71.3 107.719 171.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.554 ' HB ' ' HB3' ' B' ' 8' ' ' LEU . 3.1 p -147.09 108.44 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 122.81 0.444 . . . . 75.1 111.845 -170.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 62.5 20.67 12.1 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.31 1.044 . . . . 74.24 112.198 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 92.64 4.87 65.31 Favored Glycine 0 C--N 1.352 1.428 0 CA-C-N 116.257 -0.429 . . . . 31.1 112.782 -175.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.468 ' HA ' ' NE ' ' A' ' 143' ' ' ARG . 3.7 tpm_? -98.59 106.67 18.97 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.567 0.747 . . . . 72.12 109.998 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 49.5 ttp180 -85.32 98.75 10.71 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.716 0.806 . . . . 74.41 109.252 174.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.504 HG13 ' HB ' ' A' ' 138' ' ' VAL . 2.5 p -110.8 131.93 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 123.458 0.703 . . . . 73.53 110.906 -177.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 48.3 t -89.35 93.28 9.48 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.705 0.802 . . . . 31.45 109.501 177.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 43.4 t -93.95 111.17 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 109.353 -0.61 . . . . 73.42 109.353 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 58.9 ttt85 -77.84 105.18 8.86 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 109.432 -0.581 . . . . 74.14 109.432 175.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.487 HG13 ' HA2' ' A' ' 133' ' ' GLY . 33.2 pt -90.71 149.17 40.04 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 123.766 0.826 . . . . 74.13 110.409 177.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -63.73 132.14 33.97 Favored 'Trans proline' 0 C--N 1.379 2.158 0 C-N-CA 122.843 2.362 . . . . 60.34 111.794 175.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.24 95.54 0.06 OUTLIER 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 123.155 2.57 . . . . 74.15 112.184 171.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 107.81 47.32 0.97 Allowed Glycine 0 C--N 1.341 0.828 0 N-CA-C 111.255 -0.738 . . . . 75.51 111.255 -172.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 5.2 p -86.25 141.39 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 108.219 -1.03 . . . . 75.43 108.219 175.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.529 ' HG2' ' HA ' ' A' ' 191' ' ' GLN . 0.0 OUTLIER -118.97 135.76 54.44 Favored 'General case' 0 C--O 1.198 -1.62 0 CA-C-O 117.116 -1.421 . . . . 73.23 110.146 -160.839 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.469 ' HB3' ' HB3' ' A' ' 188' ' ' LEU . 5.0 tp10 -43.62 129.94 5.35 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 119.386 0.994 . . . . 72.32 111.381 174.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 88.3 -7.47 81.49 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-O 119.062 -0.855 . . . . 14.21 113.594 -175.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.423 ' O ' HG12 ' A' ' 178' ' ' VAL . 8.2 t -66.26 113.53 4.65 Favored 'General case' 0 C--N 1.362 1.129 0 N-CA-C 107.247 -1.39 . . . . 74.23 107.247 176.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 58.9 t -85.12 91.27 3.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 107.696 -1.224 . . . . 72.34 107.696 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.599 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 32.8 mt -70.71 82.82 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 107.3 -1.37 . . . . 75.24 107.3 174.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 63.2 ttt-85 -74.57 97.93 3.26 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 107.804 -1.184 . . . . 61.32 107.804 179.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.401 ' HA ' ' HD2' ' A' ' 162' ' ' PRO . 2.5 p -106.82 104.71 52.67 Favored Pre-proline 0 C--O 1.242 0.707 0 N-CA-C 108.834 -0.802 . . . . 61.33 108.834 -178.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 161' ' ' VAL . 29.0 Cg_endo -62.03 104.16 0.32 Allowed 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 122.055 1.836 . . . . 74.53 109.956 173.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.451 ' HA3' ' N ' ' A' ' 87' ' ' GLY . . . 124.56 26.82 1.38 Allowed Glycine 0 C--N 1.341 0.843 0 N-CA-C 115.759 1.063 . . . . 70.43 115.759 174.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 22.5 mmt -138.63 1.75 2.15 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 117.999 0.899 . . . . 64.15 111.33 172.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.639 ' HA2' HD13 ' A' ' 174' ' ' LEU . . . -84.01 -123.09 0.98 Allowed Glycine 0 C--N 1.351 1.38 0 N-CA-C 114.252 0.461 . . . . 73.33 114.252 -171.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -58.54 143.95 43.96 Favored Glycine 0 C--N 1.351 1.37 0 O-C-N 124.122 0.542 . . . . 74.5 111.864 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.686 ' HB3' ' HA3' ' A' ' 108' ' ' GLY . 27.1 mm-40 -68.47 103.98 1.8 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.956 0.902 . . . . 75.42 111.937 -164.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -156.05 168.62 33.52 Favored Glycine 0 C--N 1.338 0.69 0 N-CA-C 109.759 -1.337 . . . . 64.21 109.759 177.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . 0.72 ' HA ' ' HB3' ' A' ' 106' ' ' PHE . 0.3 OUTLIER -62.14 -53.62 57.32 Favored Pre-proline 0 N--CA 1.485 1.289 0 CA-C-N 118.401 1.1 . . . . 63.11 110.032 -179.198 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.659 ' HD3' ' HB3' ' A' ' 169' ' ' ASN . 24.4 Cg_endo -95.99 90.79 0.09 OUTLIER 'Trans proline' 0 C--N 1.387 2.558 0 C-N-CA 122.089 1.86 . . . . 71.13 108.079 159.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.428 ' HD3' ' O ' ' A' ' 169' ' ' ASN . 25.3 Cg_exo -60.58 174.82 1.42 Allowed 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 122.786 2.324 . . . . 71.25 113.857 -171.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -66.35 175.15 21.01 Favored Glycine 0 N--CA 1.472 1.052 0 N-CA-C 115.397 0.919 . . . . 72.4 115.397 -175.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -69.79 97.43 1.09 Allowed 'General case' 0 C--O 1.242 0.693 0 N-CA-C 108.225 -1.028 . . . . 71.14 108.225 172.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.639 HD13 ' HA2' ' A' ' 165' ' ' GLY . 21.4 tp -78.47 104.0 8.78 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 109.518 -0.549 . . . . 64.32 109.518 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 68.4 mt -71.67 81.58 0.85 Allowed 'General case' 0 C--O 1.242 0.67 0 C-N-CA 124.1 0.96 . . . . 72.12 109.07 173.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.797 HD22 HD23 ' A' ' 123' ' ' LEU . 34.8 mt -76.02 90.06 3.01 Favored 'General case' 0 C--N 1.35 0.627 0 CA-C-N 115.978 -0.556 . . . . 70.05 110.133 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.446 ' HB ' ' HG2' ' A' ' 122' ' ' GLU . 17.4 t -82.22 105.04 11.65 Favored 'Isoleucine or valine' 0 C--O 1.246 0.886 0 N-CA-C 106.954 -1.498 . . . . 61.43 106.954 179.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.423 HG12 ' O ' ' A' ' 157' ' ' SER . 7.1 p -71.21 106.42 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.037 0 CA-C-N 114.924 -1.034 . . . . 70.33 110.963 -174.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.659 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 33.7 mmt180 -91.89 94.46 9.32 Favored 'General case' 0 C--O 1.208 -1.089 0 C-N-CA 123.233 0.613 . . . . 53.32 110.215 179.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.536 HD23 ' HB3' ' A' ' 125' ' ' LEU . 17.6 mt -67.12 143.73 56.48 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 121.379 -0.826 . . . . 72.4 110.564 -177.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.41 ' HA ' ' HD3' ' A' ' 182' ' ' PRO . 82.5 mt -54.37 144.62 41.01 Favored Pre-proline 0 N--CA 1.476 0.835 0 O-C-N 124.367 1.042 . . . . 73.14 111.329 -172.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 181' ' ' LEU . 8.0 Cg_exo -75.17 36.52 0.45 Allowed 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 123.041 2.494 . . . . 71.42 113.073 176.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.488 ' HB3' HD11 ' A' ' 127' ' ' LEU . 24.1 t-80 -61.45 126.26 86.16 Favored Pre-proline 0 CA--C 1.549 0.929 0 N-CA-C 107.636 -1.246 . . . . 73.35 107.636 171.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 183' ' ' HIS . 21.2 Cg_exo -66.16 24.06 0.1 OUTLIER 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 124.078 3.185 . . . . 61.24 118.689 -160.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 16.2 t -102.93 -59.99 3.1 Favored 'Isoleucine or valine' 0 C--N 1.367 1.366 0 CA-C-N 121.23 1.832 . . . . 64.21 109.362 175.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . 0.543 ' CD1' ' HB2' ' A' ' 195' ' ' ALA . 49.0 m-85 -120.09 140.6 50.8 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.006 0.743 . . . . 72.31 113.006 -168.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -117.49 92.18 3.78 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 104.604 -2.369 . . . . 75.51 104.604 162.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.579 ' HA ' ' HA ' ' A' ' 193' ' ' LEU . 13.9 tp -73.33 162.14 29.68 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.468 1.107 . . . . 74.21 109.897 -177.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.466 ' H ' HD12 ' A' ' 188' ' ' LEU . 11.4 tp10 -163.99 129.53 2.95 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.766 0.827 . . . . 70.31 109.464 171.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 75.25 -77.99 1.15 Allowed Glycine 0 C--N 1.348 1.237 0 O-C-N 123.388 0.43 . . . . 65.41 112.986 175.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.529 ' HA ' ' HG2' ' A' ' 154' ' ' ARG . 0.5 OUTLIER -153.26 -0.8 0.24 Allowed 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 124.708 1.203 . . . . 72.32 110.364 170.28 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.47 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 6.4 p-10 -117.95 133.19 56.16 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.998 1.319 . . . . 72.32 111.566 -172.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.579 ' HA ' ' HA ' ' A' ' 188' ' ' LEU . 18.2 mt -88.43 155.11 19.86 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.611 1.165 . . . . 63.44 110.126 -171.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -126.2 99.13 5.75 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 108.489 -0.93 . . . . 73.14 108.489 167.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.544 ' HB3' HD23 ' A' ' 251' ' ' LEU . . . -103.02 173.19 6.42 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.021 0.929 . . . . 74.34 109.325 175.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . 0.538 HG21 ' HD3' ' B' ' 293' ' ' PRO . 30.7 m -110.88 149.06 31.15 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 108.457 -0.942 . . . . 70.21 108.457 171.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.424 HD22 HD13 ' A' ' 251' ' ' LEU . 49.5 tp -142.44 109.53 5.55 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 109.248 -0.649 . . . . 72.21 109.248 -176.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -86.35 121.93 29.61 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 108.296 -1.002 . . . . 61.43 108.296 173.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 7.5 p -140.36 133.25 14.8 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 123.987 0.915 . . . . 64.4 108.588 -176.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.69 156.55 48.93 Favored 'Trans proline' 0 C--N 1.369 1.645 0 C-N-CA 121.858 1.705 . . . . 64.51 111.911 175.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -57.51 -46.64 99.77 Favored Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 124.725 1.21 . . . . 71.34 114.038 -170.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -57.86 -45.04 35.28 Favored 'Trans proline' 0 C--N 1.39 2.75 0 C-N-CA 121.643 1.562 . . . . 63.54 113.082 175.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.471 HD11 ' HB3' ' C' ' 276' ' ' TYR . 33.8 mt -71.33 -27.19 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.087 0.555 . . . . 64.32 110.273 -179.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -71.52 -47.33 55.93 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.359 0.663 . . . . 71.51 111.08 177.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 53.0 t -65.71 -49.94 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 123.629 0.772 . . . . 63.23 111.309 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 59.0 t -88.74 -43.47 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.588 0.755 . . . . 74.41 111.509 -170.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 96.19 121.75 3.98 Favored Glycine 0 C--N 1.338 0.666 0 CA-C-N 115.947 -0.569 . . . . 72.35 112.683 -174.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.451 ' H ' ' HB ' ' A' ' 223' ' ' VAL . . . -141.98 -137.2 3.34 Favored Glycine 0 C--N 1.341 0.827 0 N-CA-C 111.095 -0.802 . . . . 55.24 111.095 178.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -136.24 137.71 41.07 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 118.006 0.903 . . . . 45.21 109.739 174.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 26.9 m -133.74 149.47 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 N-CA-C 108.59 -0.893 . . . . 63.11 108.59 172.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . 0.417 ' HD2' ' O ' ' B' ' 408' ' ' LEU . 21.3 ttm105 -75.36 107.58 7.57 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 121.101 0.477 . . . . 71.41 110.12 177.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -105.78 144.81 31.99 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.348 1.059 . . . . 62.04 109.181 175.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . 0.514 ' SD ' ' N ' ' A' ' 213' ' ' MET . 0.5 OUTLIER -87.02 151.82 22.92 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 123.07 0.548 . . . . 71.23 109.898 -177.998 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 81.3 p -122.05 -162.67 1.01 Allowed 'General case' 0 C--O 1.243 0.732 0 N-CA-C 108.36 -0.978 . . . . 74.1 108.36 170.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.875 HD22 ' HB3' ' A' ' 127' ' ' LEU . 34.1 mt -65.36 -42.63 92.57 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.159 0.584 . . . . 63.31 110.781 177.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -129.3 30.35 5.0 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 115.331 -0.85 . . . . 64.44 112.351 -165.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 155.45 158.2 8.65 Favored Glycine 0 C--N 1.352 1.457 0 CA-C-O 119.75 -0.472 . . . . 33.0 113.888 173.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -94.25 101.67 0.13 Allowed 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 123.277 2.651 . . . . 70.23 112.716 178.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 29.7 m -90.63 173.67 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 123.822 0.849 . . . . 73.4 109.771 -176.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.551 ' HG3' ' HA ' ' B' ' 438' ' ' GLN . 25.9 pt-20 -100.74 124.01 45.76 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 108.47 -0.937 . . . . 75.04 108.47 169.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 14.4 p -100.22 129.21 51.29 Favored 'Isoleucine or valine' 0 C--O 1.245 0.867 0 N-CA-C 108.493 -0.928 . . . . 74.13 108.493 173.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.509 ' HB3' ' HA ' ' B' ' 440' ' ' ARG . . . -84.43 101.24 11.87 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 109.379 -0.6 . . . . 60.25 109.379 178.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.451 ' HB ' ' H ' ' A' ' 208' ' ' GLY . 62.4 t -58.33 136.49 85.16 Favored Pre-proline 0 CA--C 1.553 1.067 0 CA-C-N 113.677 -1.601 . . . . 63.14 110.064 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . 0.594 ' HG3' HD11 ' B' ' 441' ' ' ILE . 32.0 Cg_endo -81.8 176.32 8.5 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 122.987 2.458 . . . . 75.51 110.716 177.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -71.53 159.09 52.27 Favored 'Trans proline' 0 C--N 1.359 1.131 0 C-N-CA 120.607 0.871 . . . . 72.53 110.844 165.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . 0.572 ' HD2' ' O ' ' C' ' 259' ' ' GLU . 11.1 mmt180 65.81 26.95 11.16 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 124.56 1.144 . . . . 74.04 113.195 168.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.529 HG23 HD21 ' A' ' 233' ' ' LEU . 31.4 m -65.1 84.43 0.05 OUTLIER 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 124.969 1.308 . . . . 64.32 109.568 175.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -86.39 138.89 31.44 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.291 1.036 . . . . 75.32 110.713 -171.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -50.11 127.26 16.42 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.39 1.476 . . . . 62.31 112.112 -176.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . 0.459 ' HA3' ' HB3' ' B' ' 290' ' ' TRP . . . 88.29 -25.06 9.6 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-N 115.543 -0.753 . . . . 73.32 114.462 172.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.432 ' O ' HG23 ' A' ' 253' ' ' VAL . 70.8 mtt180 -67.5 156.01 37.69 Favored 'General case' 0 C--N 1.345 0.408 0 N-CA-C 109.323 -0.621 . . . . 74.0 109.323 172.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? -110.46 123.29 49.63 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.558 -0.904 . . . . 72.22 108.558 -176.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.529 HD21 HG23 ' A' ' 227' ' ' THR . 80.7 mt -72.42 111.53 7.69 Favored 'General case' 0 C--O 1.217 -0.645 0 N-CA-C 107.525 -1.287 . . . . 71.4 107.525 179.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -95.21 100.28 12.11 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 123.462 0.476 . . . . 64.14 110.185 -178.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.731 ' HB3' ' HB ' ' B' ' 441' ' ' ILE . 0.2 OUTLIER -107.31 107.02 17.74 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.547 0.739 . . . . 61.12 109.455 -179.659 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.609 ' HA ' ' HB3' ' A' ' 248' ' ' ASP . 14.2 mmmm -67.54 148.91 50.84 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.702 0.801 . . . . 64.43 111.73 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.475 ' HA2' ' HB2' ' A' ' 246' ' ' ARG . . . 73.55 23.79 76.2 Favored Glycine 0 C--N 1.352 1.45 0 CA-C-N 116.164 -0.471 . . . . 74.2 113.566 177.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.568 ' HG3' HD12 ' A' ' 235' ' ' LEU . 46.6 mmtm -123.05 -26.23 4.4 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.873 0.869 . . . . 73.01 110.985 -174.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -80.19 -155.19 10.58 Favored Glycine 0 C--N 1.345 1.079 0 CA-C-N 115.948 -0.569 . . . . 74.43 113.009 171.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . 0.5 ' HZ ' HD11 ' A' ' 215' ' ' LEU . 3.9 m-85 -94.92 139.03 21.98 Favored Pre-proline 0 N--CA 1.478 0.95 0 CA-C-O 118.893 -0.575 . . . . 73.13 111.175 -168.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.597 ' HA ' ' HA ' ' A' ' 246' ' ' ARG . 59.6 Cg_exo -42.4 129.04 4.75 Favored 'Trans proline' 0 C--N 1.391 2.79 0 C-N-CA 124.437 3.425 . . . . 73.33 114.585 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -165.23 -147.15 5.04 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-O 119.334 -0.703 . . . . 73.52 112.586 -176.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . 0.465 ' HD2' ' HG2' ' A' ' 191' ' ' GLN . 28.1 Cg_exo -62.71 -28.42 76.51 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 123.761 2.974 . . . . 70.45 113.138 -177.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -90.82 21.28 4.2 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.964 0.906 . . . . 70.11 111.524 -179.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 78.28 -70.11 2.65 Favored Glycine 0 C--N 1.35 1.346 0 N-CA-C 109.762 -1.335 . . . . 62.24 109.762 -170.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.597 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 64.0 mtm180 -122.65 144.82 48.88 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 107.154 -1.425 . . . . 75.41 107.154 164.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -69.55 -165.81 4.81 Favored Glycine 0 C--N 1.335 0.514 0 CA-C-O 121.435 0.464 . . . . 42.24 113.919 172.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . 0.609 ' HB3' ' HA ' ' A' ' 236' ' ' LYS . 0.9 OUTLIER -121.0 173.53 7.2 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.589 0.755 . . . . 75.44 111.492 -174.049 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.467 HD23 HD11 ' A' ' 235' ' ' LEU . 16.2 tp -126.56 136.25 52.32 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.297 -1.001 . . . . 70.31 108.297 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.443 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 56.5 m-85 -111.78 113.94 26.61 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.352 1.061 . . . . 52.51 109.112 176.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.544 HD23 ' HB3' ' A' ' 195' ' ' ALA . 78.2 mt -102.39 106.85 17.67 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 109.262 -0.644 . . . . 72.24 109.262 178.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -76.79 117.94 18.9 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 109.435 -0.58 . . . . 75.41 109.435 -178.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 231' ' ' ARG . 49.2 t -71.61 134.19 30.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-N 114.477 -1.238 . . . . 24.43 111.31 -171.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -130.94 91.23 3.02 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 106.82 -1.548 . . . . 73.14 106.82 177.113 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.492 HD13 HG23 ' C' ' 257' ' ' ILE . 62.0 mt -77.52 127.88 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 122.767 0.427 . . . . 74.34 111.243 -173.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 25.6 p -116.11 165.16 13.46 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.738 1.215 . . . . 73.43 110.263 175.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.486 ' HB ' ' HD2' ' A' ' 258' ' ' PRO . 2.9 pp -134.17 154.54 80.13 Favored Pre-proline 0 N--CA 1.486 1.363 0 C-N-CA 123.519 0.728 . . . . 73.4 109.079 174.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . 0.486 ' HD2' ' HB ' ' A' ' 257' ' ' ILE . 18.4 Cg_endo -54.28 -17.84 12.89 Favored 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 123.705 2.937 . . . . 74.45 116.336 -164.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.413 ' H ' HD12 ' A' ' 257' ' ' ILE . 7.7 mm-40 59.18 -64.49 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 125.234 1.414 . . . . 63.24 113.119 -167.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -79.24 129.68 34.7 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.792 -0.568 . . . . 75.12 111.013 178.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.413 HD12 ' HD2' ' C' ' 226' ' ' ARG . 67.4 mt -143.29 154.59 43.94 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.412 1.085 . . . . 55.32 109.852 177.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . 0.445 ' HB ' ' HD2' ' A' ' 263' ' ' PRO . 18.0 p -132.33 159.3 72.84 Favored Pre-proline 0 CA--C 1.564 1.515 0 C-N-CA 124.791 1.236 . . . . 44.34 108.787 174.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' PRO . . . . . 0.445 ' HD2' ' HB ' ' A' ' 262' ' ' THR . 39.2 Cg_exo -17.21 -58.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.398 3.155 1 C-N-CA 127.317 5.344 . . . . 74.33 119.167 -170.921 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -70.9 -47.51 58.76 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 118.056 0.389 . . . . 71.44 111.861 -173.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . 0.4 ' HB3' HD22 ' A' ' 261' ' ' LEU . 5.5 mp0 -66.05 -36.97 84.67 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 109.506 -0.553 . . . . 64.2 109.506 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' GLU . . . . . 0.461 ' O ' ' HG3' ' A' ' 270' ' ' LYS . 4.2 tp10 -52.55 -48.97 65.81 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 124.509 1.131 . . . . 73.45 109.238 172.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -58.65 -51.16 71.11 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.697 1.199 . . . . 64.12 112.835 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 11.0 mp -59.94 -46.62 88.81 Favored 'General case' 0 N--CA 1.483 1.223 0 O-C-N 123.717 0.636 . . . . 73.14 110.689 -178.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -65.61 -34.93 79.37 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 123.58 0.752 . . . . 75.0 112.385 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' A' ' 266' ' ' GLU . 9.1 mtpm? -63.06 -55.31 26.6 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 122.961 0.504 . . . . 62.43 110.793 176.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 30.7 mmtm -62.98 -27.99 69.78 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 124.085 0.865 . . . . 70.22 111.634 -178.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 272' ' ' LEU . . . . . 0.434 ' O ' ' HB2' ' A' ' 276' ' ' TYR . 40.9 mt -60.12 -55.42 34.05 Favored 'General case' 0 C--O 1.207 -1.158 0 O-C-N 123.836 0.71 . . . . 63.4 109.887 167.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -63.34 -33.42 75.48 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.874 0.87 . . . . 64.51 113.184 -176.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.439 ' HA ' ' HB3' ' B' ' 250' ' ' GLN . 43.9 mt-10 -69.57 -55.34 10.39 Favored 'General case' 0 C--O 1.252 1.203 0 C-N-CA 123.957 0.903 . . . . 74.35 109.736 179.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -77.26 -2.86 36.86 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-N 115.032 -0.985 . . . . 71.44 111.668 178.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . 0.434 ' HB2' ' O ' ' A' ' 272' ' ' LEU . 33.4 t80 -79.53 -61.79 1.89 Allowed 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.236 -1.024 . . . . 75.02 108.236 171.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 277' ' ' TYR . . . . . 0.472 ' HA ' ' HB2' ' A' ' 280' ' ' ALA . 2.6 t80 -58.03 -38.76 76.84 Favored 'General case' 0 C--N 1.356 0.877 0 O-C-N 124.988 1.43 . . . . 70.12 109.53 -175.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -48.03 -38.05 16.31 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.67 1.188 . . . . 75.41 113.7 175.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . 0.536 ' HA ' HD21 ' B' ' 277' ' ' LEU . 0.1 OUTLIER -132.55 37.85 3.47 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 109.319 -0.623 . . . . 74.13 109.319 179.139 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . 0.472 ' HB2' ' HA ' ' A' ' 277' ' ' TYR . . . . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 118.89 -0.576 . . . . 72.21 112.102 -175.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 61.1 mtm . . . . . 0 N--CA 1.483 1.18 0 N-CA-C 109.488 -0.56 . . . . 71.44 109.488 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt 67.09 -77.42 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 125.335 1.454 . . . . 54.1 111.552 177.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 36.6 tp60 -154.51 128.01 8.57 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 107.258 -1.386 . . . . 74.04 107.258 -177.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 39.4 m -141.75 100.65 3.8 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 108.763 -0.828 . . . . 52.14 108.763 -178.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 8.6 m -64.09 153.34 37.86 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.353 0.661 . . . . 70.11 112.428 -168.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.722 HG21 ' HA ' ' A' ' 125' ' ' LEU . 19.1 pt -117.55 -177.64 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 N-CA-C 113.12 0.785 . . . . 64.44 113.12 -167.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -135.76 143.66 45.39 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 114.572 -1.194 . . . . 72.01 110.322 177.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.619 HD11 ' HB1' ' A' ' 121' ' ' ALA . 36.9 tp -115.76 157.72 23.91 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.842 1.257 . . . . 75.22 108.494 173.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -103.73 -35.66 8.14 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.016 0.526 . . . . 62.4 111.926 178.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . 0.424 ' HG ' HG21 ' A' ' 140' ' ' VAL . 88.4 mt 76.68 2.58 3.4 Favored 'General case' 0 N--CA 1.502 2.145 0 C-N-CA 125.556 1.543 . . . . 74.1 110.726 -162.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.461 HD11 ' HG3' ' A' ' 122' ' ' GLU . 65.0 mt 64.43 36.32 0.2 Allowed Pre-proline 0 CA--C 1.578 2.043 0 N-CA-C 116.383 1.994 . . . . 45.35 116.383 177.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.77 -23.87 13.9 Favored 'Trans proline' 0 C--N 1.402 3.344 0 CA-C-N 122.511 1.933 . . . . 61.33 109.661 160.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 2.2 pp -136.31 153.43 51.16 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 126.027 1.731 . . . . 75.01 107.218 169.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -148.02 145.72 28.61 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 122.436 0.294 . . . . 64.54 110.509 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -119.37 103.56 9.58 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.013 0.925 . . . . 60.01 108.712 176.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 40.2 p -82.46 157.48 67.54 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 123.573 0.749 . . . . 51.11 109.181 172.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -59.37 95.85 0.09 OUTLIER 'Trans proline' 0 C--N 1.384 2.404 0 C-N-CA 122.379 2.053 . . . . 62.42 111.464 176.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 6.3 p -69.35 91.14 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.139 0 CA-C-O 122.203 1.001 . . . . 61.41 110.721 -178.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 10.1 t -160.84 159.51 29.93 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 114.789 -1.096 . . . . 71.22 109.325 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 45.7 tptt -153.69 -45.33 0.09 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.167 0.587 . . . . 62.34 109.827 -178.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -147.19 -29.98 0.35 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.215 0.606 . . . . 75.34 111.153 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 68.33 -73.5 0.08 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 125.02 1.328 . . . . 73.31 110.135 -172.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 23' ' ' THR . . . . . . . . . . . . . 29.0 m -123.33 96.2 44.42 Favored Pre-proline 0 CA--C 1.546 0.789 0 N-CA-C 107.634 -1.247 . . . . 72.45 107.634 173.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.87 84.0 0.86 Allowed 'Trans proline' 0 C--N 1.38 2.227 0 C-N-CA 122.618 2.212 . . . . 74.55 110.825 176.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -73.98 90.86 1.98 Allowed 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 114.803 -1.089 . . . . 74.53 109.598 178.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 52.5 mtp -155.47 -49.04 0.01 OUTLIER Pre-proline 0 N--CA 1.499 2.02 0 C-N-CA 124.641 1.177 . . . . 75.13 111.67 175.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -80.17 42.4 1.31 Allowed 'Trans proline' 0 C--N 1.402 3.391 0 C-N-CA 122.772 2.314 . . . . 71.1 112.527 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 34.9 m -107.6 -2.7 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 123.948 0.899 . . . . 73.51 111.607 -176.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 30.6 tp -53.25 -53.86 44.7 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 125.221 1.408 . . . . 62.2 112.464 -173.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' B' ' 371' ' ' VAL . 0.0 OUTLIER -105.52 2.98 28.91 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 114.143 -1.39 . . . . 70.24 111.376 -169.631 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -74.64 -20.42 59.9 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 123.068 0.547 . . . . 74.34 110.501 -178.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 32' ' ' ARG . . . . . 0.561 ' HB3' ' HA ' ' B' ' 375' ' ' LEU . 4.9 tpm_? -146.93 -60.05 0.29 Allowed 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 122.83 0.452 . . . . 72.22 111.337 175.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . 0.56 ' HA ' ' HB3' ' B' ' 373' ' ' ARG . . . 56.03 80.02 0.15 Allowed 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.675 1.19 . . . . 73.31 111.59 -167.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.48 12.21 2.11 Favored 'General case' 0 CA--C 1.555 1.173 0 N-CA-C 113.168 0.803 . . . . 53.33 113.168 -175.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . 0.488 ' HA ' HE21 ' B' ' 35' ' ' GLN . 0.1 OUTLIER -157.99 -63.8 0.09 Allowed 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 118.499 0.591 . . . . 73.13 111.363 174.705 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 122.87 -71.9 0.41 Allowed Glycine 0 C--N 1.339 0.732 0 N-CA-C 110.563 -1.015 . . . . 74.33 110.563 -175.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . 0.433 ' HB2' HH22 ' C' ' 234' ' ' ARG . 11.9 m-20 58.55 94.29 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 125.288 1.435 . . . . 61.44 111.124 -179.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 45.7 pt -127.67 13.96 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.981 0 C-N-CA 123.955 0.902 . . . . 75.44 112.262 -172.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 7.6 m -52.46 107.12 0.19 Allowed 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 123.607 0.763 . . . . 64.25 111.171 -170.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -48.31 107.04 0.68 Allowed Pre-proline 0 N--CA 1.482 1.128 0 O-C-N 125.267 1.605 . . . . 64.0 113.779 -166.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -78.19 -46.4 0.12 Allowed 'Trans proline' 0 C--N 1.37 1.671 0 C-N-CA 122.346 2.031 . . . . 72.44 109.654 167.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.6 113.87 0.25 Allowed Glycine 0 C--N 1.351 1.396 0 CA-C-N 114.901 -1.045 . . . . 45.24 112.466 176.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.67 103.15 0.92 Allowed Glycine 0 CA--C 1.532 1.108 0 CA-C-O 119.692 -0.504 . . . . 42.15 111.854 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . 62.89 96.4 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 125.223 1.409 . . . . 63.2 111.269 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.56 ' HG2' HG23 ' B' ' 236' ' ' THR . 4.9 mmp_? -82.37 98.92 9.09 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 122.677 0.391 . . . . 74.21 110.851 -174.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.24 23.57 1.23 Allowed 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 126.609 1.964 . . . . 75.02 113.797 178.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 68.6 tp -58.15 -42.75 86.58 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.515 1.126 . . . . 53.22 111.556 -174.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 29.1 m 70.36 -64.1 0.38 Allowed 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 125.933 1.693 . . . . 51.22 111.29 -178.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -166.32 -90.54 0.08 OUTLIER Glycine 0 C--N 1.339 0.711 0 N-CA-C 110.517 -1.033 . . . . 74.15 110.517 173.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -105.79 91.54 3.79 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 107.548 -1.279 . . . . 64.2 107.548 172.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 9.7 pm0 -64.38 -28.58 69.79 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.036 0.935 . . . . 75.3 111.485 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 3.3 m -104.49 150.03 24.93 Favored 'General case' 0 CA--C 1.554 1.127 0 N-CA-C 108.303 -0.999 . . . . 73.31 108.303 177.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.22 145.32 55.33 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 112.888 0.699 . . . . 73.24 112.888 -165.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.507 ' HA ' ' HA3' ' B' ' 162' ' ' GLY . . . -80.92 170.94 15.63 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.493 1.117 . . . . 75.51 110.844 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.417 HD22 ' N ' ' B' ' 56' ' ' ARG . 0.0 OUTLIER -51.15 -37.6 47.24 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.722 1.209 . . . . 72.35 112.983 -175.451 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . 0.56 ' HD3' ' SD ' ' B' ' 157' ' ' MET . 44.3 ttt180 52.15 -82.73 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 125.231 1.412 . . . . 73.2 113.374 175.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -78.9 -84.75 0.08 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.472 0.709 . . . . 75.31 110.371 -174.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 22.3 t 63.75 26.29 14.41 Favored 'General case' 0 CA--C 1.565 1.547 0 C-N-CA 124.404 1.082 . . . . 62.01 112.498 176.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -81.78 137.69 35.28 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.481 0.712 . . . . 72.44 110.209 172.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 79.9 p -85.9 2.65 45.19 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.792 0.837 . . . . 63.51 111.649 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -77.14 -11.17 59.78 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 124.092 0.957 . . . . 71.45 111.922 178.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 62' ' ' LYS . . . . . 0.414 ' HB3' HD11 ' B' ' 155' ' ' LEU . 27.8 mmtp -78.03 154.52 80.17 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 123.934 0.894 . . . . 72.3 110.84 -174.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -47.87 -33.09 18.88 Favored 'Trans proline' 0 C--N 1.391 2.768 0 C-N-CA 124.511 3.474 . . . . 72.24 113.953 -174.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 57.25 -89.56 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.096 1.359 . . . . 72.04 111.503 174.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -91.04 -49.23 6.52 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.704 0.801 . . . . 65.32 110.509 -176.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -79.6 96.7 6.24 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.181 -0.674 . . . . 72.41 109.181 -178.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . 0.594 HG13 ' H ' ' B' ' 69' ' ' LEU . 7.0 tp -161.55 143.3 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.103 0.961 . . . . 72.03 108.476 -174.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 43.6 pt -61.4 -20.57 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 123.322 0.649 . . . . 73.4 112.55 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.594 ' H ' HG13 ' B' ' 67' ' ' ILE . 1.4 tt 55.47 -103.11 0.17 Allowed 'General case' 0 CA--C 1.559 1.293 0 C-N-CA 124.775 1.23 . . . . 73.12 109.788 176.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . 0.419 ' H ' ' HB3' ' B' ' 69' ' ' LEU . 95.2 mt -147.88 26.56 1.0 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.428 1.491 . . . . 44.44 107.6 176.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 50.9 mm -64.99 121.74 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 124.865 1.266 . . . . 74.32 111.121 -171.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 142.73 61.41 0.03 OUTLIER Glycine 0 C--N 1.341 0.819 0 N-CA-C 110.114 -1.194 . . . . 62.21 110.114 -176.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 65.7 -76.86 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 125.437 1.495 . . . . 63.44 110.221 -172.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -156.35 53.04 0.42 Allowed Glycine 0 C--N 1.342 0.878 0 N-CA-C 110.445 -1.062 . . . . 64.42 110.445 177.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 7.8 tpt -74.15 93.82 2.35 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 109.15 -0.685 . . . . 74.01 109.15 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 123.4 -41.18 1.82 Allowed Glycine 0 N--CA 1.47 0.952 0 N-CA-C 111.351 -0.699 . . . . 71.13 111.351 -175.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -76.15 -62.49 1.59 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.833 0.853 . . . . 73.03 109.9 178.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 19.7 t 61.39 24.15 14.3 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 125.034 1.333 . . . . 51.1 111.405 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . 0.644 ' HG3' HG23 ' B' ' 80' ' ' ILE . 11.2 tp10 -97.52 153.82 17.91 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 124.452 1.101 . . . . 74.44 110.12 -177.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.644 HG23 ' HG3' ' B' ' 79' ' ' GLU . 22.6 pt 50.5 21.53 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 C-N-CA 126.813 2.045 . . . . 72.52 114.5 176.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . 0.486 HG23 ' H ' ' B' ' 82' ' ' ALA . 0.6 OUTLIER -108.11 -68.5 0.9 Allowed 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.438 0.695 . . . . 71.34 109.685 173.87 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . 0.486 ' H ' HG23 ' B' ' 81' ' ' THR . . . 62.5 6.43 1.98 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.632 1.173 . . . . 61.11 113.39 -178.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . 65.07 -69.27 0.1 Allowed 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.881 1.273 . . . . 71.35 111.607 -171.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? 69.28 -84.97 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 125.26 1.424 . . . . 73.0 109.596 176.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 50.98 -87.45 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 125.633 1.573 . . . . 72.23 111.642 -177.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -111.91 88.23 2.75 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.137 -1.06 . . . . 63.12 108.137 177.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.83 -174.98 4.68 Favored 'General case' 0 C--O 1.247 0.925 0 C-N-CA 124.904 1.282 . . . . 52.24 108.967 -178.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 63.37 28.26 15.52 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 124.039 0.936 . . . . 74.14 110.897 175.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -87.18 -125.93 2.1 Favored Glycine 0 C--N 1.344 1.016 0 CA-C-O 119.33 -0.706 . . . . 54.33 111.338 179.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . 65.63 -71.47 0.08 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 125.196 1.398 . . . . 62.33 111.737 178.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.68 -8.63 78.78 Favored Glycine 0 C--N 1.347 1.192 0 CA-C-O 119.66 -0.522 . . . . 70.11 113.193 175.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -84.84 45.61 3.54 Favored Glycine 0 C--N 1.356 1.643 0 CA-C-N 116.977 0.388 . . . . 23.53 112.385 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -161.59 119.18 2.26 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.632 1.173 . . . . 74.22 108.67 178.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -89.48 63.14 6.23 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 121.561 0.696 . . . . 71.21 109.301 177.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -110.55 153.24 25.41 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.537 -0.756 . . . . 74.14 110.315 -178.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 69.67 -92.85 0.36 Allowed Glycine 0 C--N 1.345 1.072 0 O-C-N 123.979 0.8 . . . . 72.31 111.682 -176.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 97' ' ' ILE . . . . . 0.421 HG12 ' HB3' ' B' ' 100' ' ' LEU . 0.7 OUTLIER 74.78 -29.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 C-N-CA 126.319 1.848 . . . . 72.22 112.79 178.386 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 69.33 -78.7 0.04 OUTLIER 'General case' 0 C--N 1.361 1.079 0 C-N-CA 125.84 1.656 . . . . 75.21 111.79 171.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -157.64 30.85 0.27 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.66 0.784 . . . . 61.12 110.142 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . 0.512 ' HB3' ' HD3' ' B' ' 101' ' ' PRO . 2.8 tm? -59.83 -56.53 34.75 Favored Pre-proline 0 CA--C 1.566 1.561 0 C-N-CA 124.189 0.996 . . . . 74.2 111.038 -178.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 101' ' ' PRO . . . . . 0.512 ' HD3' ' HB3' ' B' ' 100' ' ' LEU . 40.7 Cg_endo -96.18 22.23 0.4 Allowed 'Trans proline' 0 C--N 1.392 2.839 0 C-N-CA 122.144 1.896 . . . . 72.21 112.73 -179.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 63.6 tp -80.14 -51.39 9.04 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 109.707 -0.479 . . . . 73.12 109.707 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 103' ' ' THR . . . . . 0.627 HG22 ' H ' ' B' ' 105' ' ' GLN . 18.1 m 68.68 151.99 0.09 Allowed 'General case' 0 N--CA 1.483 1.215 0 O-C-N 124.92 1.387 . . . . 75.52 111.222 -173.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . -63.75 -34.06 88.91 Favored Glycine 0 C--N 1.352 1.422 0 N-CA-C 111.846 -0.502 . . . . 51.35 111.846 173.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 105' ' ' GLN . . . . . 0.627 ' H ' HG22 ' B' ' 103' ' ' THR . 87.8 mt-30 68.7 99.08 0.06 Allowed 'General case' 0 C--N 1.36 1.058 0 C-N-CA 125.523 1.529 . . . . 75.22 110.473 176.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 69.93 166.95 0.29 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.126 1.37 . . . . 74.44 111.624 -179.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 66.8 p -79.17 102.24 8.39 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 109.053 -0.721 . . . . 63.32 109.053 178.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 25.8 m170 -68.8 106.5 2.7 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 109.436 -0.579 . . . . 71.44 109.436 177.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -60.96 -25.51 66.88 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.206 -0.906 . . . . 53.33 111.114 176.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . 66.79 -163.8 0.23 Allowed 'General case' 0 C--O 1.247 0.928 0 C-N-CA 124.594 1.158 . . . . 71.24 110.356 -177.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 2.9 mm? 61.67 34.88 17.32 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 124.119 0.967 . . . . 64.15 109.914 -177.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -73.02 101.21 3.18 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.621 0.769 . . . . 73.2 110.004 -175.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 113' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt 58.78 37.71 24.91 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.427 1.091 . . . . 75.13 109.747 -179.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 40.7 tptt -66.83 95.04 0.34 Allowed 'General case' 0 C--O 1.246 0.905 0 CA-C-N 114.249 -1.341 . . . . 74.01 111.509 -168.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 47.9 p 45.72 64.78 1.32 Allowed 'General case' 0 C--O 1.242 0.665 0 O-C-N 124.623 1.202 . . . . 73.23 111.617 -175.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -56.87 -41.71 91.62 Favored Glycine 0 C--N 1.353 1.505 0 N-CA-C 109.785 -1.326 . . . . 55.33 109.785 168.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . 0.495 ' HG3' ' HG2' ' B' ' 464' ' ' MET . 24.6 mmtp -136.04 156.36 77.08 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-N 113.269 -1.466 . . . . 70.25 107.826 161.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 118' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.5 -15.19 48.56 Favored 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 122.695 2.263 . . . . 60.53 111.839 170.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 119' ' ' ASP . . . . . . . . . . . . . 23.6 t0 77.0 155.14 0.16 Allowed 'General case' 0 C--N 1.359 0.982 0 C-N-CA 126.369 1.867 . . . . 75.33 111.024 174.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 120' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -78.54 134.87 37.21 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.006 0.922 . . . . 70.1 109.636 177.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 14.0 p -82.5 1.89 3.41 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.493 0 C-N-CA 123.874 0.869 . . . . 74.32 110.237 174.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 82.8 p -71.41 85.19 0.82 Allowed 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 124.864 1.266 . . . . 75.24 112.268 -171.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.03 -52.98 3.66 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.052 1.341 . . . . 64.3 108.955 178.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 9.4 t 61.18 21.18 11.66 Favored 'General case' 0 CA--C 1.56 1.328 0 C-N-CA 125.529 1.532 . . . . 43.31 113.463 170.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -70.46 103.06 2.35 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.169 0.588 . . . . 73.02 109.486 175.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -156.27 -63.82 0.11 Allowed 'General case' 0 C--O 1.24 0.605 0 C-N-CA 123.768 0.827 . . . . 74.13 109.432 -176.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 41.2 m 56.86 -157.06 0.28 Allowed 'General case' 0 CA--C 1.563 1.472 0 C-N-CA 124.205 1.002 . . . . 70.01 110.998 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -81.06 -11.17 59.57 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 118.668 0.667 . . . . 72.01 110.884 174.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 16.3 m -63.85 -23.97 67.56 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.561 0.744 . . . . 54.34 110.505 171.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 130' ' ' ALA . . . . . 0.557 ' HB1' HG12 ' B' ' 135' ' ' VAL . . . -56.33 -29.49 61.37 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.453 1.101 . . . . 44.22 113.031 177.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 18.6 m95 -88.68 -4.92 58.43 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.192 0.597 . . . . 73.51 111.841 -175.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 132' ' ' SER . . . . . 0.534 ' HA ' ' HB2' ' B' ' 167' ' ' ASN . 48.1 t -76.38 99.35 4.81 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 108.423 -0.954 . . . . 51.4 108.423 172.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 8.7 m 78.84 -40.05 0.25 Allowed 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 125.768 1.627 . . . . 62.25 112.11 -176.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 136.69 168.94 11.57 Favored Glycine 0 C--N 1.351 1.376 0 N-CA-C 112.123 -0.391 . . . . 55.15 112.123 176.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 135' ' ' VAL . . . . . 0.593 HG22 ' SG ' ' B' ' 200' ' ' CYS . 27.0 m -86.57 21.01 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 C-N-CA 123.642 0.777 . . . . 73.24 111.837 -176.084 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 136' ' ' LYS . . . . . 0.541 ' HB2' HD13 ' B' ' 205' ' ' LEU . 2.5 pptp? -132.96 175.13 9.64 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.497 0.719 . . . . 52.43 111.656 -168.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 13.2 t -137.9 -170.25 2.73 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.145 0.978 . . . . 75.31 108.431 175.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -145.4 111.93 5.81 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.046 0.538 . . . . 75.52 110.47 175.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 4.4 m120 63.06 -87.13 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.934 1.694 . . . . 73.24 112.474 167.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -151.13 50.76 0.53 Allowed Glycine 0 C--N 1.346 1.115 0 N-CA-C 111.013 -0.835 . . . . 65.04 111.013 -175.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.03 76.49 1.71 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.847 0.859 . . . . 75.34 109.7 177.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 87.2 mt -122.79 1.27 9.36 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.064 0.945 . . . . 70.15 111.745 -171.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 143' ' ' GLY . . . . . 0.432 ' HA2' ' HA ' ' B' ' 147' ' ' HIS . . . -79.09 81.33 1.43 Allowed Glycine 0 C--N 1.347 1.176 0 O-C-N 123.145 0.278 . . . . 61.25 113.34 -176.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 20.3 t -89.81 -58.42 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 N-CA-C 108.868 -0.79 . . . . 75.31 108.868 175.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 145' ' ' ASP . . . . . 0.524 ' HB3' ' HA ' ' B' ' 350' ' ' LYS . 8.7 p-10 -132.59 -41.9 0.95 Allowed 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 108.28 -1.007 . . . . 64.3 108.28 169.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 11.2 tt -85.27 105.24 13.99 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 N-CA-C 107.295 -1.372 . . . . 72.52 107.295 171.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 147' ' ' HIS . . . . . 0.432 ' HA ' ' HA2' ' B' ' 143' ' ' GLY . 5.8 p80 -80.34 142.72 34.2 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.841 -0.618 . . . . 72.43 110.436 -171.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . 0.433 ' HB3' ' HA ' ' B' ' 212' ' ' SER . 12.3 tp10 -82.46 138.62 34.32 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 107.226 -1.398 . . . . 73.05 107.226 163.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 149' ' ' LYS . . . . . . . . . . . . . 42.1 pttt -89.28 -27.46 20.55 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.177 0.591 . . . . 72.23 110.243 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 27.8 t70 61.56 -81.62 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 125.557 1.543 . . . . 74.11 112.006 169.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 68.5 m80 -149.67 -62.64 0.02 OUTLIER Pre-proline 0 CA--C 1.562 1.425 0 C-N-CA 124.492 1.117 . . . . 74.43 111.347 -177.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 152' ' ' PRO . . . . . 0.604 ' HB2' ' HB2' ' B' ' 155' ' ' LEU . 65.5 Cg_endo -75.66 2.56 6.81 Favored 'Trans proline' 0 C--N 1.395 3.007 0 C-N-CA 121.698 1.599 . . . . 42.51 114.923 -162.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 24.4 m 67.11 -77.8 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 125.384 1.474 . . . . 74.2 111.537 177.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 45.1 pt -123.45 -35.41 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.942 0.897 . . . . 74.25 110.681 178.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 155' ' ' LEU . . . . . 0.604 ' HB2' ' HB2' ' B' ' 152' ' ' PRO . 13.0 tp 49.71 -148.99 0.26 Allowed 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 124.514 1.125 . . . . 72.1 109.957 -175.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 156' ' ' GLU . . . . . 0.501 ' H ' ' HG ' ' B' ' 155' ' ' LEU . 16.9 mp0 -67.39 -58.13 5.33 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 107.108 -1.442 . . . . 72.23 107.108 158.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 157' ' ' MET . . . . . 0.56 ' SD ' ' HD3' ' B' ' 56' ' ' ARG . 1.9 mpp? -130.51 129.3 42.71 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 106.153 -1.795 . . . . 53.54 106.153 165.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 158' ' ' ALA . . . . . 0.642 ' HB3' ' HB ' ' B' ' 214' ' ' THR . . . -70.06 77.19 0.5 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 108.784 -0.821 . . . . 34.04 108.784 172.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' B' ' 210' ' ' LYS . 8.9 tmtt? 56.72 110.29 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 126.354 1.862 . . . . 55.45 111.443 -168.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -80.37 138.93 36.74 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 123.362 0.665 . . . . 70.22 110.512 177.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -69.23 -21.46 63.93 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.608 0.763 . . . . 71.1 111.783 -178.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 162' ' ' GLY . . . . . 0.507 ' HA3' ' HA ' ' B' ' 54' ' ' ALA . . . -82.38 56.56 5.0 Favored Glycine 0 C--N 1.351 1.397 0 O-C-N 123.369 0.418 . . . . 73.4 112.067 173.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 4.4 tt -158.26 77.89 0.8 Allowed 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 106.219 -1.771 . . . . 65.02 106.219 -176.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 164' ' ' ALA . . . . . . . . . . . . . . . -161.46 161.08 29.99 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.072 0.949 . . . . 75.34 109.477 -177.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 49.6 p -88.35 -50.33 6.4 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 123.57 0.748 . . . . 64.15 110.373 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . 74.32 -152.51 45.1 Favored Glycine 0 C--N 1.349 1.28 0 CA-C-N 116.031 -0.531 . . . . 71.15 112.158 -177.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 167' ' ' ASN . . . . . 0.534 ' HB2' ' HA ' ' B' ' 132' ' ' SER . 28.3 t-20 -126.38 -69.9 0.75 Allowed 'General case' 0 C--O 1.243 0.718 0 N-CA-C 108.697 -0.853 . . . . 72.31 108.697 176.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 88.4 t 68.13 -65.58 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 C-N-CA 125.491 1.516 . . . . 74.13 111.624 -177.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 169' ' ' SER . . . . . 0.605 ' HB3' ' HA ' ' B' ' 173' ' ' LEU . 43.4 m -71.28 79.18 0.72 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.981 0.912 . . . . 54.35 110.966 176.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 9.6 m -90.9 -45.15 8.94 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.156 0.982 . . . . 63.1 110.212 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -110.95 -55.63 2.47 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.929 0.892 . . . . 53.32 109.278 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 172' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -81.95 95.81 7.5 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.212 1.005 . . . . 73.22 109.473 175.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 173' ' ' LEU . . . . . 0.605 ' HA ' ' HB3' ' B' ' 169' ' ' SER . 11.1 mp -83.14 -67.95 0.75 Allowed 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 122.675 0.39 . . . . 74.23 111.109 -178.14 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 174' ' ' GLN . . . . . 0.45 ' HB3' ' HG3' ' B' ' 193' ' ' PRO . 7.4 tp-100 -168.73 141.82 2.91 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 107.934 -1.136 . . . . 74.45 107.934 -175.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 175' ' ' ASP . . . . . . . . . . . . . 13.0 t70 73.37 107.73 0.07 Allowed 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 125.264 1.425 . . . . 74.1 109.476 -173.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -113.79 21.93 14.49 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.07 0.948 . . . . 74.11 108.964 173.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 19.0 p -123.08 92.66 48.95 Favored Pre-proline 0 C--O 1.244 0.764 0 C-N-CA 124.063 0.945 . . . . 64.31 110.456 -169.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 178' ' ' PRO . . . . . 0.746 ' HA ' ' HD2' ' B' ' 189' ' ' LYS . 19.2 Cg_exo -68.78 -48.33 1.02 Allowed 'Trans proline' 0 C--N 1.371 1.759 0 C-N-CA 122.089 1.859 . . . . 74.53 111.414 170.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -163.34 -42.88 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.905 0.882 . . . . 61.34 109.042 172.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 180' ' ' ALA . . . . . 0.635 ' HB1' HG23 ' C' ' 137' ' ' VAL . . . -161.77 -69.81 0.06 Allowed 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 108.505 -0.924 . . . . 74.4 108.505 172.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 20.1 tp -88.35 -68.72 0.75 Allowed 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 107.171 -1.418 . . . . 62.04 107.171 160.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 182' ' ' VAL . . . . . 0.495 ' HA ' ' HB2' ' B' ' 178' ' ' PRO . 78.4 t -135.64 -70.95 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.705 0.802 . . . . 71.31 109.644 175.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -171.64 -89.44 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.257 0.623 . . . . 65.24 110.537 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 26.7 p-80 -168.01 -167.58 0.85 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.481 0.712 . . . . 74.15 110.869 -173.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 185' ' ' VAL . . . . . . . . . . . . . 89.6 t -56.6 113.81 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 124.1 0.96 . . . . 71.33 111.011 -179.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 186' ' ' THR . . . . . 0.411 HG22 ' HG2' ' C' ' 122' ' ' GLU . 75.3 p 47.04 69.52 0.49 Allowed 'General case' 0 C--N 1.358 0.951 0 C-N-CA 125.688 1.595 . . . . 51.31 112.114 -178.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 187' ' ' SER . . . . . . . . . . . . . 47.3 t -145.46 145.27 31.03 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.201 1.0 . . . . 62.14 109.508 -177.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 188' ' ' ARG . . . . . 0.477 ' HB2' ' HG2' ' C' ' 124' ' ' PRO . 0.0 OUTLIER -128.64 146.91 50.73 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.8 0.44 . . . . 71.52 111.731 -173.271 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 189' ' ' LYS . . . . . 0.746 ' HD2' ' HA ' ' B' ' 178' ' ' PRO . 10.2 tmtt? -163.98 96.85 0.82 Allowed 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 107.432 -1.322 . . . . 72.52 107.432 171.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 190' ' ' CYS . . . . . . . . . . . . . 27.7 p -94.93 -179.75 4.95 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 123.687 0.795 . . . . 70.33 109.159 173.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 48.3 p90 -125.53 153.67 43.27 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 120.77 0.319 . . . . 74.04 110.596 175.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -167.11 77.53 0.12 Allowed Glycine 0 C--N 1.338 0.683 0 N-CA-C 110.615 -0.994 . . . . 64.22 110.615 178.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 193' ' ' PRO . . . . . 0.45 ' HG3' ' HB3' ' B' ' 174' ' ' GLN . 92.0 Cg_endo -75.44 -7.61 18.9 Favored 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 123.13 2.553 . . . . 64.32 114.131 -170.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 194' ' ' SER . . . . . . . . . . . . . 41.3 t 75.79 -61.33 0.47 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.481 1.513 . . . . 24.51 111.698 -175.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 195' ' ' ALA . . . . . . . . . . . . . . . 67.98 11.49 8.39 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.813 1.245 . . . . 74.32 112.3 -177.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 2.2 t 53.1 8.12 0.1 Allowed 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 127.017 2.127 . . . . 73.32 115.246 177.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 36.9 m 53.77 24.69 4.56 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.576 1.151 . . . . 75.11 112.702 -177.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 198' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 68.35 145.26 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 125.361 1.464 . . . . 51.12 112.063 -173.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -90.89 88.5 7.06 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 107.624 -1.251 . . . . 74.4 107.624 166.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 200' ' ' CYS . . . . . 0.593 ' SG ' HG22 ' B' ' 135' ' ' VAL . 67.1 m -59.73 -43.62 95.6 Favored Pre-proline 0 CA--C 1.565 1.54 0 N-CA-C 115.032 1.493 . . . . 73.31 115.032 -168.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 201' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -76.64 64.49 7.45 Favored 'Trans proline' 0 C--N 1.397 3.089 0 CA-C-N 121.589 1.603 . . . . 71.34 111.758 173.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . -126.7 143.42 14.32 Favored Glycine 0 C--N 1.346 1.136 0 CA-C-N 115.507 -0.77 . . . . 63.04 112.012 -177.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 66.06 -78.72 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 125.651 1.58 . . . . 71.33 111.882 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -139.86 158.21 44.46 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.88 0.872 . . . . 74.01 110.212 -177.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 205' ' ' LEU . . . . . 0.541 HD13 ' HB2' ' B' ' 136' ' ' LYS . 21.1 tp -161.11 -63.84 0.06 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.224 0.61 . . . . 51.03 109.789 -177.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -111.34 -56.35 2.39 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.503 -0.925 . . . . 62.32 108.503 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 207' ' ' LYS . . . . . 0.442 ' HD3' ' N ' ' B' ' 208' ' ' GLY . 1.1 tmtp? -78.4 139.81 38.74 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 108.432 -0.951 . . . . 74.32 108.432 175.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 208' ' ' GLY . . . . . 0.442 ' N ' ' HD3' ' B' ' 207' ' ' LYS . . . 174.68 -99.19 0.13 Allowed Glycine 0 C--N 1.343 0.932 0 N-CA-C 111.748 -0.541 . . . . 71.52 111.748 173.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 124.05 33.72 0.77 Allowed Glycine 0 C--N 1.343 0.959 0 N-CA-C 111.17 -0.772 . . . . 42.21 111.17 -173.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 210' ' ' LYS . . . . . 0.46 ' O ' ' HG3' ' B' ' 159' ' ' LYS . 0.0 OUTLIER -149.9 45.17 0.92 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.889 0.876 . . . . 74.51 109.763 -179.574 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . -78.58 -89.96 0.39 Allowed Glycine 0 C--N 1.343 0.972 0 N-CA-C 110.793 -0.923 . . . . 74.43 110.793 175.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 212' ' ' SER . . . . . 0.433 ' HA ' ' HB3' ' B' ' 148' ' ' GLU . 13.3 p 41.31 -86.26 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.22 0 C-N-CA 126.536 1.934 . . . . 74.04 115.589 172.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . 0.406 ' H ' ' HB3' ' B' ' 159' ' ' LYS . 50.9 mt 59.19 87.85 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 125.148 1.379 . . . . 64.4 108.947 -163.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 214' ' ' THR . . . . . 0.642 ' HB ' ' HB3' ' B' ' 158' ' ' ALA . 88.0 m -141.49 -56.86 0.48 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.833 0.853 . . . . 75.43 109.022 -174.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 215' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 71.32 -65.58 0.34 Allowed 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 125.744 1.617 . . . . 73.31 110.922 -173.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.4 136.69 43.5 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.463 1.105 . . . . 61.42 109.126 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 3.3 pp -117.94 152.29 35.74 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.813 0.445 . . . . 75.4 110.635 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . 0.552 HD23 ' H ' ' B' ' 218' ' ' LEU . 2.2 pt? -124.14 22.59 8.65 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.986 0.914 . . . . 71.43 109.684 -177.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -72.78 -10.48 59.84 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 124.551 1.141 . . . . 71.24 112.378 -175.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -65.29 -35.06 79.87 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.258 0.623 . . . . 61.1 110.112 171.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 221' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 71.49 -60.84 0.5 Allowed 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 126.573 1.949 . . . . 73.55 111.462 176.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -53.7 -32.55 52.27 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.37 0.668 . . . . 42.52 110.732 168.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -114.44 138.74 50.2 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 108.507 -0.923 . . . . 61.02 108.507 165.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 3.2 p -134.69 134.19 54.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 124.097 0.959 . . . . 74.2 108.757 -176.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 35.7 p -92.19 -166.41 1.54 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.062 0.545 . . . . 54.34 110.396 175.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 76.87 -48.6 0.54 Allowed 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 126.028 1.731 . . . . 74.43 111.502 -176.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . 83.12 5.09 89.46 Favored Glycine 0 C--N 1.346 1.099 0 CA-C-N 116.423 -0.353 . . . . 51.31 113.115 179.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 87.89 -24.23 11.48 Favored Glycine 0 C--N 1.355 1.59 0 CA-C-O 119.552 -0.582 . . . . 72.41 113.866 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -71.25 -61.25 4.02 Favored Glycine 0 C--N 1.356 1.654 0 CA-C-N 117.367 0.584 . . . . 70.24 111.835 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -73.01 103.11 3.68 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.157 0.583 . . . . 70.23 110.24 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 231' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -123.59 132.89 54.0 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.142 0.977 . . . . 73.24 109.285 177.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 30.2 p -74.04 104.13 4.76 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.487 0.715 . . . . 74.24 109.616 176.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -71.97 160.02 33.24 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 109.84 -0.43 . . . . 70.41 109.84 174.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -69.44 165.76 20.19 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.151 0.58 . . . . 72.31 110.845 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -58.78 118.48 5.76 Favored 'General case' 0 N--CA 1.48 1.066 0 O-C-N 123.499 0.5 . . . . 54.41 109.908 178.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 236' ' ' THR . . . . . 0.56 HG23 ' HG2' ' B' ' 45' ' ' ARG . 98.5 m -61.83 116.14 4.59 Favored 'General case' 0 C--O 1.242 0.694 0 O-C-N 124.433 1.083 . . . . 73.34 109.989 177.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -63.8 94.17 0.09 Allowed 'General case' 0 C--N 1.348 0.527 0 O-C-N 124.076 0.86 . . . . 71.12 108.946 173.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 33.0 m -71.02 -25.02 62.49 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.047 -0.979 . . . . 71.31 110.016 175.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 239' ' ' ALA . . . . . 0.417 ' HA ' HD22 ' C' ' 235' ' ' LEU . . . -68.96 137.96 54.18 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 114.671 -1.15 . . . . 74.42 111.16 172.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . -70.34 -101.57 0.04 OUTLIER Glycine 0 C--N 1.355 1.586 0 N-CA-C 110.923 -0.871 . . . . 71.23 110.923 172.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 241' ' ' GLU . . . . . 0.496 ' HB3' ' HG3' ' B' ' 245' ' ' LYS . 24.0 pt-20 -175.31 171.58 2.87 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.847 0.859 . . . . 71.21 111.462 169.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 242' ' ' TRP . . . . . 0.424 ' CZ3' HG21 ' C' ' 253' ' ' VAL . 0.7 OUTLIER -98.27 -66.11 0.92 Allowed 'General case' 0 C--O 1.237 0.408 0 N-CA-C 107.094 -1.447 . . . . 70.32 107.094 -175.773 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 243' ' ' GLN . . . . . 0.684 ' HG2' HH22 ' B' ' 373' ' ' ARG . 44.9 mt-30 -141.72 19.49 2.17 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 112.586 -2.097 . . . . 74.22 106.974 -175.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 114.41 164.88 15.09 Favored Glycine 0 CA--C 1.535 1.341 0 N-CA-C 109.75 -1.34 . . . . 63.11 109.75 -156.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 245' ' ' LYS . . . . . 0.496 ' HG3' ' HB3' ' B' ' 241' ' ' GLU . 0.2 OUTLIER -150.05 164.64 35.03 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.727 0.811 . . . . 75.34 111.019 177.223 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 34.0 m -138.8 134.99 34.15 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.488 0.715 . . . . 71.02 110.397 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 247' ' ' LEU . . . . . . . . . . . . . 95.9 mt -118.29 109.61 16.53 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.313 1.045 . . . . 72.51 108.885 175.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 248' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -129.57 140.73 51.13 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.813 0.845 . . . . 75.15 109.328 177.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -67.3 135.02 52.67 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.993 0.917 . . . . 71.33 110.544 178.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 250' ' ' GLN . . . . . 0.439 ' HB3' ' HA ' ' A' ' 274' ' ' GLU . 8.8 mp0 -102.17 -77.8 0.55 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.606 0.762 . . . . 65.4 110.207 -172.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 251' ' ' ALA . . . . . . . . . . . . . . . -84.54 4.86 30.06 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.425 0.69 . . . . 61.03 112.421 -172.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . 0.626 HE21 ' HB2' ' B' ' 349' ' ' ASP . 1.7 mp0 -72.21 145.28 48.1 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.485 1.114 . . . . 72.3 111.805 -171.173 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 253' ' ' ALA . . . . . 0.448 ' H ' ' HA ' ' B' ' 348' ' ' ILE . . . 67.85 -75.76 0.06 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.843 1.657 . . . . 51.41 111.833 -177.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . 0.401 ' HB2' HG23 ' B' ' 320' ' ' THR . 11.9 tpt180 -137.08 6.14 2.83 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.263 0.625 . . . . 72.51 111.098 -176.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -67.84 -23.43 74.18 Favored Glycine 0 C--N 1.355 1.621 0 O-C-N 122.389 -0.194 . . . . 54.22 112.644 178.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 256' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -64.16 -40.59 96.46 Favored 'General case' 0 C--N 1.357 0.917 0 C-N-CA 123.264 0.626 . . . . 52.52 110.442 172.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 257' ' ' GLN . . . . . 0.597 ' HB2' HG21 ' B' ' 325' ' ' THR . 12.5 pt20 41.95 103.57 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 126.549 1.94 . . . . 74.31 113.289 -177.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 258' ' ' LEU . . . . . . . . . . . . . 86.6 mt -33.38 112.92 0.14 Allowed 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 126.192 1.797 . . . . 75.13 113.922 -169.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 9.0 p -133.87 158.91 42.6 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 124.041 0.937 . . . . 63.02 109.925 -174.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 260' ' ' SER . . . . . . . . . . . . . 22.5 p -95.68 16.7 16.63 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.552 0.741 . . . . 73.11 110.351 174.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 27.5 t70 62.5 178.3 0.14 Allowed 'General case' 0 C--N 1.37 1.492 0 C-N-CA 124.846 1.258 . . . . 52.21 110.391 179.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 262' ' ' ALA . . . . . . . . . . . . . . . -60.47 -39.15 86.59 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.959 0.504 . . . . 43.43 110.795 171.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -143.13 -51.93 0.36 Allowed 'General case' 0 C--N 1.349 0.545 0 C-N-CA 123.125 0.57 . . . . 70.44 111.878 -176.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 66.1 m 72.21 -57.36 0.62 Allowed 'General case' 0 N--CA 1.504 2.259 0 C-N-CA 125.595 1.558 . . . . 51.14 111.669 -172.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 265' ' ' LEU . . . . . . . . . . . . . 19.7 tp -58.97 -17.25 23.05 Favored 'General case' 0 CA--C 1.56 1.331 0 C-N-CA 125.762 1.625 . . . . 64.12 112.258 178.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 266' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -79.5 79.61 5.95 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.734 0.814 . . . . 71.52 109.554 175.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 33.5 p -167.03 178.66 5.61 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.053 0.941 . . . . 73.13 110.369 -178.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 57.7 t -66.15 -70.07 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 124.009 0.923 . . . . 74.44 111.553 -173.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 269' ' ' THR . . . . . . . . . . . . . 6.9 m -73.28 -24.28 60.41 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.167 0.587 . . . . 74.31 110.011 178.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 270' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 57.53 16.39 3.29 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 126.547 1.939 . . . . 72.41 114.352 173.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 271' ' ' ALA . . . . . . . . . . . . . . . -65.5 -50.22 66.08 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.788 0.835 . . . . 75.3 111.121 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 272' ' ' ASN . . . . . 0.641 HD21 ' HB ' ' B' ' 343' ' ' VAL . 22.3 p-10 -156.38 -52.37 0.08 Allowed 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 111.969 0.359 . . . . 54.14 111.969 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -157.42 76.97 0.84 Allowed 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 121.657 0.741 . . . . 61.32 110.032 -170.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -114.5 18.45 16.78 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.946 0.898 . . . . 71.44 109.266 173.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 275' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -68.18 150.5 97.71 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 123.73 0.812 . . . . 71.33 111.805 -175.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -81.15 58.27 6.89 Favored 'Trans proline' 0 C--N 1.372 1.783 0 C-N-CA 123.054 2.502 . . . . 62.35 109.737 163.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 277' ' ' LEU . . . . . 0.536 HD21 ' HA ' ' A' ' 279' ' ' ARG . 22.9 tp -83.0 159.15 22.26 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.421 1.089 . . . . 63.32 109.668 -174.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 278' ' ' LEU . . . . . 0.42 HD22 ' HA ' ' B' ' 278' ' ' LEU . 1.0 OUTLIER 70.28 86.97 0.12 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.495 1.518 . . . . 62.0 109.105 -173.941 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . -159.13 -172.57 26.41 Favored Glycine 0 C--N 1.347 1.171 0 CA-C-N 115.86 -0.609 . . . . 75.43 113.348 -178.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 280' ' ' LEU . . . . . 0.482 HD11 ' HB3' ' C' ' 198' ' ' ASP . 17.1 tp -97.17 136.52 37.57 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 108.999 -0.741 . . . . 53.23 108.999 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -80.19 -60.39 2.35 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.491 0.716 . . . . 75.31 112.166 -165.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -73.25 -35.58 66.25 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 109.55 -0.537 . . . . 65.41 109.55 174.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 283' ' ' ASP . . . . . 0.426 ' HA ' HD23 ' B' ' 280' ' ' LEU . 6.1 t0 70.2 -71.62 0.12 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 126.064 1.746 . . . . 72.33 112.209 169.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . -81.51 39.98 2.56 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 123.489 0.566 . . . . 61.45 112.971 177.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -79.28 85.93 5.08 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 107.484 -1.302 . . . . 72.41 107.484 173.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 286' ' ' MET . . . . . 0.592 ' H ' ' HD2' ' B' ' 287' ' ' PRO . 47.6 mtm -131.6 -53.97 0.03 OUTLIER Pre-proline 0 CA--C 1.561 1.394 0 CA-C-N 115.395 -0.821 . . . . 64.1 112.261 -168.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 287' ' ' PRO . . . . . 0.592 ' HD2' ' H ' ' B' ' 286' ' ' MET . 62.8 Cg_endo -70.04 161.22 46.8 Favored 'Trans proline' 0 C--N 1.403 3.425 0 C-N-CA 121.778 1.652 . . . . 73.33 112.75 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 288' ' ' VAL . . . . . . . . . . . . . 4.9 p -76.33 81.66 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.301 0 CA-C-O 123.01 1.386 . . . . 74.32 109.89 177.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 289' ' ' ARG . . . . . 0.459 ' NE ' ' H ' ' B' ' 290' ' ' TRP . 1.2 tpm_? -151.47 174.32 13.53 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 113.959 -1.473 . . . . 72.14 107.207 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 290' ' ' TRP . . . . . 0.46 ' HB3' HH11 ' C' ' 254' ' ' ARG . 5.2 m-90 79.94 -5.01 1.89 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.764 1.225 . . . . 75.34 112.39 171.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 291' ' ' LEU . . . . . . . . . . . . . 5.2 mp -123.4 95.76 4.72 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 107.993 -1.114 . . . . 64.34 107.993 172.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . -53.63 -60.48 8.23 Favored Glycine 0 CA--C 1.539 1.54 0 O-C-N 123.879 0.737 . . . . 62.12 114.755 179.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 293' ' ' PRO . . . . . 0.538 ' HD3' HG21 ' A' ' 196' ' ' THR . 43.6 Cg_endo -86.76 32.91 0.44 Allowed 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 123.13 2.553 . . . . 51.12 113.087 -177.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 30.0 tttm 64.42 -85.88 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.69 1.196 . . . . 41.23 111.122 -177.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . 176.03 42.79 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.299 1.04 . . . . 34.32 108.666 -169.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 2.9 t 51.49 -169.82 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 125.718 1.607 . . . . 65.42 111.828 -172.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -128.43 91.34 3.22 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 108.087 -1.079 . . . . 64.12 108.087 170.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -87.24 -24.29 24.44 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.086 -0.961 . . . . 71.5 110.997 -176.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . 100.26 -11.9 60.16 Favored Glycine 0 C--N 1.345 1.057 0 O-C-N 123.466 0.479 . . . . 63.41 112.548 -173.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 300' ' ' ASN . . . . . 0.53 ' HB2' ' HB1' ' B' ' 374' ' ' ALA . 3.7 p-10 -165.1 26.79 0.06 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.843 0.857 . . . . 72.23 110.315 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 301' ' ' ILE . . . . . 0.584 HG12 ' HZ3' ' C' ' 232' ' ' LYS . 0.3 OUTLIER 49.44 -78.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 C-N-CA 127.099 2.16 . . . . 72.24 113.277 -174.73 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -62.04 158.12 17.27 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 125.51 1.524 . . . . 63.41 111.99 -171.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 303' ' ' LYS . . . . . 0.508 ' N ' ' HD3' ' B' ' 304' ' ' PRO . 8.2 tmtt? 66.39 57.67 1.01 Allowed Pre-proline 0 CA--C 1.567 1.623 0 C-N-CA 125.967 1.707 . . . . 74.11 111.386 -169.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 304' ' ' PRO . . . . . 0.508 ' HD3' ' N ' ' B' ' 303' ' ' LYS . 1.7 Cg_endo -87.38 95.58 0.46 Allowed 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 123.119 2.546 . . . . 75.12 110.518 169.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . 73.7 -68.92 0.2 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.803 1.641 . . . . 42.33 110.265 -177.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . 0.456 HG21 ' HA ' ' B' ' 303' ' ' LYS . 62.5 t 64.38 90.77 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 125.281 1.432 . . . . 72.33 111.789 176.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . 0.702 HG22 ' HB2' ' C' ' 226' ' ' ARG . 39.3 p 68.3 -24.3 0.13 Allowed 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 126.535 1.934 . . . . 74.23 114.105 177.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 308' ' ' CYS . . . . . . . . . . . . . 59.3 m 56.93 -74.8 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 124.903 1.281 . . . . 74.22 110.256 -170.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 54.6 p -84.64 118.38 70.91 Favored Pre-proline 0 CA--C 1.55 0.978 0 N-CA-C 107.799 -1.186 . . . . 72.2 107.799 163.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -59.49 152.94 58.03 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 122.625 2.216 . . . . 63.14 112.137 -177.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 311' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -58.65 109.59 1.97 Allowed Pre-proline 0 N--CA 1.479 1.004 0 C-N-CA 123.855 0.862 . . . . 73.13 110.75 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 312' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -85.46 -17.01 4.53 Favored 'Trans proline' 0 C--N 1.373 1.818 0 C-N-CA 121.867 1.712 . . . . 70.14 112.706 176.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 313' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 53.34 167.34 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 C-N-CA 127.127 2.171 . . . . 75.13 114.278 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 314' ' ' ARG . . . . . 0.581 ' NH1' ' HA ' ' B' ' 316' ' ' ASP . 0.0 OUTLIER -167.19 150.4 6.4 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.285 0.634 . . . . 72.01 110.609 178.805 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 315' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -86.26 144.06 27.61 Favored 'General case' 0 C--O 1.245 0.845 0 N-CA-C 107.953 -1.129 . . . . 72.12 107.953 170.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 316' ' ' ASP . . . . . 0.581 ' HA ' ' NH1' ' B' ' 314' ' ' ARG . 10.7 m-20 -86.99 68.28 10.02 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 122.975 0.51 . . . . 74.4 110.955 -172.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 24.8 m 54.19 -82.89 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 125.778 1.631 . . . . 75.41 112.414 -178.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 318' ' ' VAL . . . . . . . . . . . . . 7.4 m -101.6 106.62 47.37 Favored Pre-proline 0 CA--C 1.558 1.258 0 C-N-CA 124.411 1.084 . . . . 73.13 110.402 -176.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 319' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.58 94.77 0.85 Allowed 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 122.736 2.291 . . . . 65.1 111.501 176.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 320' ' ' THR . . . . . 0.401 HG23 ' HB2' ' B' ' 254' ' ' ARG . 26.1 m 65.44 86.8 0.12 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.672 1.189 . . . . 53.31 110.683 -179.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 321' ' ' LEU . . . . . . . . . . . . . 45.0 tp -101.85 -23.82 14.12 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.919 0.887 . . . . 65.14 110.166 176.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 322' ' ' ALA . . . . . . . . . . . . . . . 67.19 -169.74 0.2 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.783 1.233 . . . . 64.54 110.986 -173.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 323' ' ' GLN . . . . . 0.548 ' HG2' ' H ' ' B' ' 324' ' ' MET . 26.1 tt0 66.07 -170.46 0.19 Allowed 'General case' 0 CA--C 1.57 1.745 0 C-N-CA 124.461 1.104 . . . . 74.02 110.253 178.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 324' ' ' MET . . . . . 0.548 ' H ' ' HG2' ' B' ' 323' ' ' GLN . 50.3 ttm 79.59 -56.35 0.4 Allowed 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 125.44 1.496 . . . . 71.32 112.113 174.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 325' ' ' THR . . . . . 0.597 HG21 ' HB2' ' B' ' 257' ' ' GLN . 47.3 p -80.7 70.55 7.48 Favored 'General case' 0 CA--C 1.553 1.078 0 CA-C-O 121.718 0.771 . . . . 72.33 110.463 178.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 326' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -75.73 -63.64 1.25 Allowed 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.246 1.018 . . . . 72.01 110.187 -178.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 39.51 40.33 0.59 Allowed 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 126.31 1.844 . . . . 54.34 113.796 -178.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 328' ' ' ALA . . . . . . . . . . . . . . . -64.16 -51.31 64.43 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.166 0.587 . . . . 72.03 111.097 -178.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 329' ' ' ILE . . . . . . . . . . . . . 33.4 pt -137.24 -175.54 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 123.797 0.839 . . . . 73.5 111.03 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 330' ' ' GLU . . . . . 0.417 ' O ' ' HB2' ' B' ' 331' ' ' LEU . 8.0 tp10 64.8 99.56 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 125.736 1.615 . . . . 63.42 113.331 176.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 331' ' ' LEU . . . . . 0.471 ' HG ' ' H ' ' B' ' 332' ' ' LEU . 13.3 tp 175.2 -145.22 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 125.52 1.528 . . . . 63.34 107.344 168.21 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 332' ' ' LEU . . . . . 0.471 ' H ' ' HG ' ' B' ' 331' ' ' LEU . 7.1 mp -80.81 -176.1 5.67 Favored 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 124.117 0.967 . . . . 74.41 109.87 170.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 333' ' ' SER . . . . . . . . . . . . . 41.7 t -61.58 -30.17 70.5 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.312 1.045 . . . . 65.04 112.225 -177.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -79.78 4.84 15.17 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.479 0.712 . . . . 63.11 112.667 -176.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 335' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -116.94 -170.47 1.84 Allowed 'General case' 0 CA--C 1.553 1.07 0 N-CA-C 107.371 -1.344 . . . . 73.25 107.371 167.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 77.47 -3.33 2.45 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 125.01 1.324 . . . . 61.02 112.62 168.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 337' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -75.52 -8.26 56.3 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.573 0.749 . . . . 62.43 109.966 162.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 338' ' ' GLY . . . . . . . . . . . . . . . 107.83 -146.66 16.33 Favored Glycine 0 C--N 1.353 1.507 0 N-CA-C 111.282 -0.727 . . . . 72.34 111.282 -179.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 339' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -114.89 158.1 22.43 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.049 1.34 . . . . 74.33 108.804 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 340' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -79.42 85.66 5.2 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 121.22 0.533 . . . . 75.24 110.858 -172.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 341' ' ' LEU . . . . . . . . . . . . . 51.3 mt -128.92 5.48 5.43 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.17 0.988 . . . . 75.34 110.03 169.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 342' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -92.33 106.6 18.57 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 107.774 -1.195 . . . . 64.25 107.774 176.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 343' ' ' VAL . . . . . 0.641 ' HB ' HD21 ' B' ' 272' ' ' ASN . 39.2 t 53.65 84.37 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 C-N-CA 124.686 1.195 . . . . 64.24 109.363 -167.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 344' ' ' GLU . . . . . 0.624 ' HG2' ' H ' ' B' ' 345' ' ' GLY . 0.1 OUTLIER -94.86 -103.8 0.15 Allowed 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 123.926 0.89 . . . . 73.03 110.912 -166.703 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 345' ' ' GLY . . . . . 0.624 ' H ' ' HG2' ' B' ' 344' ' ' GLU . . . 79.52 -61.75 4.19 Favored Glycine 0 C--N 1.357 1.695 0 CA-C-N 119.601 1.091 . . . . 62.31 112.905 -177.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 346' ' ' ALA . . . . . . . . . . . . . . . -67.65 92.74 0.34 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.244 1.018 . . . . 72.22 110.643 178.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 32.3 t -170.94 -49.45 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.936 1.294 . . . . 72.21 108.996 178.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 348' ' ' ILE . . . . . 0.448 ' HA ' ' H ' ' B' ' 253' ' ' ALA . 30.7 mm -94.85 -58.39 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 123.158 0.583 . . . . 73.42 109.683 -175.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 349' ' ' ASP . . . . . 0.626 ' HB2' HE21 ' B' ' 252' ' ' GLN . 11.1 m-20 48.0 74.92 0.15 Allowed 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 125.5 1.52 . . . . 71.13 113.367 171.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 350' ' ' LYS . . . . . 0.524 ' HA ' ' HB3' ' B' ' 145' ' ' ASP . 28.3 ttpt 75.59 -61.91 0.46 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 125.563 1.545 . . . . 74.52 111.132 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 351' ' ' GLN . . . . . 0.612 HE21 ' HA ' ' B' ' 351' ' ' GLN . 0.0 OUTLIER 67.26 -171.48 0.19 Allowed 'General case' 0 CA--C 1.561 1.376 0 C-N-CA 123.689 0.795 . . . . 71.32 109.305 -178.733 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 352' ' ' ASP . . . . . 0.455 ' N ' ' HG3' ' B' ' 351' ' ' GLN . 4.5 m-20 -73.37 43.79 0.14 Allowed 'General case' 0 CA--C 1.562 1.408 0 C-N-CA 124.344 1.058 . . . . 74.35 110.926 166.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 353' ' ' HIS . . . . . . . . . . . . . 19.8 t-80 -141.26 92.79 2.51 Favored 'General case' 0 C--N 1.355 0.834 0 C-N-CA 125.294 1.438 . . . . 74.33 108.567 -171.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 354' ' ' ALA . . . . . . . . . . . . . . . -170.36 -67.82 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.925 0.89 . . . . 70.11 109.404 -178.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 355' ' ' ALA . . . . . 0.451 ' HB1' ' HD2' ' B' ' 357' ' ' PRO . . . -170.76 169.6 6.92 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.293 1.037 . . . . 75.44 109.641 -178.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 356' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -83.24 -49.37 0.73 Allowed Pre-proline 0 CA--C 1.56 1.346 0 CA-C-O 118.162 -0.923 . . . . 74.32 112.336 177.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 357' ' ' PRO . . . . . 0.451 ' HD2' ' HB1' ' B' ' 355' ' ' ALA . 74.0 Cg_endo -72.05 93.49 0.72 Allowed 'Trans proline' 0 C--N 1.404 3.477 0 C-N-CA 121.709 1.606 . . . . 55.22 112.993 -172.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 358' ' ' CYS . . . . . . . . . . . . . 57.7 m -74.54 -50.64 17.29 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 107.82 -1.178 . . . . 73.32 107.82 168.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 359' ' ' GLY . . . . . . . . . . . . . . . -107.59 87.38 0.49 Allowed Glycine 0 C--N 1.345 1.054 0 N-CA-C 109.817 -1.313 . . . . 62.01 109.817 171.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 360' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 -50.85 132.91 26.93 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.318 1.047 . . . . 53.34 110.599 175.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 361' ' ' ILE . . . . . 0.523 HG22 ' H ' ' B' ' 363' ' ' GLU . 71.2 mt 74.39 -59.79 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 C-N-CA 125.657 1.583 . . . . 61.31 110.35 -172.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 362' ' ' GLY . . . . . . . . . . . . . . . 82.81 -12.15 49.75 Favored Glycine 0 C--N 1.348 1.238 0 C-N-CA 122.788 0.232 . . . . 72.35 113.668 175.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 363' ' ' GLU . . . . . 0.523 ' H ' HG22 ' B' ' 361' ' ' ILE . 36.9 mt-10 -101.43 8.43 42.15 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.26 1.024 . . . . 73.13 110.207 176.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 364' ' ' THR . . . . . . . . . . . . . 24.1 p -83.68 60.32 5.66 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.207 1.003 . . . . 74.04 109.978 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 35.8 m -89.24 156.41 3.07 Favored 'Isoleucine or valine' 0 C--O 1.245 0.838 0 CA-C-N 114.625 -1.17 . . . . 74.01 110.073 -178.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -80.75 85.09 6.15 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 109.172 -0.677 . . . . 50.12 109.172 177.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 367' ' ' LEU . . . . . . . . . . . . . 56.9 mt 62.51 -166.34 0.22 Allowed 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 124.511 1.125 . . . . 75.05 111.236 177.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 368' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -70.93 -47.23 60.18 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.782 -0.822 . . . . 71.23 108.782 172.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 369' ' ' GLU . . . . . 0.668 ' HG2' ' H ' ' B' ' 371' ' ' VAL . 0.0 OUTLIER -170.79 -33.54 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 114.34 -1.3 . . . . 70.1 109.282 170.218 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 370' ' ' ALA . . . . . 0.553 ' HB3' HE21 ' B' ' 372' ' ' GLN . . . 56.77 31.36 19.32 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 125.022 1.329 . . . . 74.25 111.56 -175.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 371' ' ' VAL . . . . . 0.668 ' H ' ' HG2' ' B' ' 369' ' ' GLU . 4.6 t 53.39 38.16 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.786 0 C-N-CA 124.839 1.255 . . . . 74.11 110.907 -175.173 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 372' ' ' GLN . . . . . 0.553 HE21 ' HB3' ' B' ' 370' ' ' ALA . 43.4 mt-30 -102.74 100.23 10.24 Favored 'General case' 0 N--CA 1.483 1.217 0 O-C-N 121.181 -0.95 . . . . 63.2 110.402 178.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 373' ' ' ARG . . . . . 0.684 HH22 ' HG2' ' B' ' 243' ' ' GLN . 0.2 OUTLIER -157.75 -82.17 0.06 Allowed 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 109.133 -0.691 . . . . 72.05 109.133 171.758 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 374' ' ' ALA . . . . . 0.53 ' HB1' ' HB2' ' B' ' 300' ' ' ASN . . . 170.39 179.4 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 125.606 1.562 . . . . 71.45 108.693 -171.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 375' ' ' LEU . . . . . 0.561 ' HA ' ' HB3' ' B' ' 32' ' ' ARG . 79.9 mt -68.78 -175.38 0.69 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 122.565 0.346 . . . . 62.01 111.236 170.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -60.88 97.02 0.05 Allowed 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 121.446 0.641 . . . . 73.13 110.74 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 377' ' ' PHE . . . . . 0.406 ' HB2' ' HB3' ' B' ' 303' ' ' LYS . 42.0 p90 -79.69 7.09 9.12 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.462 1.105 . . . . 73.31 112.515 -177.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 378' ' ' ALA . . . . . . . . . . . . . . . -77.57 23.28 0.23 Allowed 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 124.243 1.017 . . . . 61.1 112.056 178.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -99.57 164.12 12.21 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 124.775 1.23 . . . . 72.01 109.401 177.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 380' ' ' LYS . . . . . 0.438 ' NZ ' HD12 ' B' ' 385' ' ' LEU . 25.2 tttt -70.31 -88.47 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.097 0 O-C-N 123.76 0.662 . . . . 53.14 110.416 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 381' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 179.37 -75.88 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 106.593 -1.632 . . . . 74.34 106.593 -166.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 382' ' ' GLY . . . . . 0.421 ' HA3' ' HG ' ' B' ' 385' ' ' LEU . . . -99.74 75.22 0.47 Allowed Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 108.679 -1.768 . . . . 73.1 108.679 172.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 383' ' ' ASN . . . . . . . . . . . . . 49.7 m-20 -64.2 -27.33 68.99 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 113.868 -1.166 . . . . 73.1 111.036 -175.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 384' ' ' THR . . . . . . . . . . . . . 14.7 t -121.9 28.72 7.44 Favored 'General case' 0 CA--C 1.56 1.349 0 C-N-CA 123.574 0.749 . . . . 63.41 111.585 -174.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 385' ' ' LEU . . . . . 0.603 HD13 ' H ' ' B' ' 418' ' ' ALA . 70.3 mt -63.17 135.71 57.31 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 122.4 0.28 . . . . 75.12 111.107 177.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 386' ' ' VAL . . . . . . . . . . . . . 42.3 t 66.04 -75.59 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 125.343 1.457 . . . . 62.42 110.457 -172.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 387' ' ' ILE . . . . . . . . . . . . . 35.9 pt -119.7 162.85 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.365 1.066 . . . . 74.12 109.574 178.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 388' ' ' VAL . . . . . . . . . . . . . 11.8 p -70.9 109.66 3.34 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 CA-C-O 121.602 0.715 . . . . 54.33 109.681 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 389' ' ' THR . . . . . . . . . . . . . 9.1 m -136.18 28.85 3.1 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.121 0.969 . . . . 71.25 109.002 -173.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . -83.82 -91.68 0.08 Allowed 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 115.59 -0.732 . . . . 70.34 111.771 -171.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 391' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 53.94 -88.36 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 125.077 1.351 . . . . 64.12 112.266 -175.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 392' ' ' HIS . . . . . . . . . . . . . 32.0 m-70 -114.51 95.28 5.18 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 107.272 -1.381 . . . . 72.42 107.272 178.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . 65.39 -86.37 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.023 1.329 . . . . 61.53 110.782 -174.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -163.05 127.52 3.0 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 107.058 -1.46 . . . . 73.31 107.058 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . -62.14 98.97 0.12 Allowed 'General case' 0 CA--C 1.542 0.657 0 O-C-N 123.792 0.682 . . . . 71.44 110.196 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 45.7 t -123.84 -49.88 1.85 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.499 1.12 . . . . 75.55 108.833 178.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 397' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 66.31 65.07 0.5 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.999 1.32 . . . . 71.41 110.3 177.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 1.7 mp 77.45 -33.63 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 124.889 1.276 . . . . 75.44 112.874 171.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 399' ' ' VAL . . . . . . . . . . . . . 15.5 m -59.24 -42.29 86.59 Favored 'Isoleucine or valine' 0 C--N 1.36 1.043 0 C-N-CA 122.962 0.505 . . . . 73.32 111.64 -170.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 400' ' ' ALA . . . . . . . . . . . . . . . 55.79 103.53 0.03 OUTLIER Pre-proline 0 N--CA 1.483 1.179 0 C-N-CA 125.09 1.356 . . . . 51.41 112.131 175.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 401' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -49.8 98.44 0.04 OUTLIER 'Trans proline' 0 C--N 1.386 2.516 0 C-N-CA 123.261 2.641 . . . . 71.04 112.969 -178.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -76.06 -62.47 1.59 Allowed 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 114.5 -1.227 . . . . 74.34 109.702 -173.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 403' ' ' THR . . . . . . . . . . . . . 15.1 t -160.45 -155.03 0.41 Allowed 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 124.301 1.04 . . . . 51.3 108.3 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 404' ' ' LYS . . . . . . . . . . . . . 64.7 mttp 76.32 -62.74 0.41 Allowed 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 125.288 1.435 . . . . 70.03 111.74 176.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 405' ' ' ALA . . . . . . . . . . . . . . . -114.41 89.28 17.49 Favored Pre-proline 0 N--CA 1.477 0.902 0 C-N-CA 123.552 0.741 . . . . 71.24 111.003 178.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 406' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -83.33 10.27 3.74 Favored 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 122.566 2.177 . . . . 44.44 112.495 164.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 407' ' ' GLY . . . . . 0.627 ' HA3' ' HA3' ' B' ' 417' ' ' GLY . . . 91.03 -42.77 2.85 Favored Glycine 0 C--N 1.358 1.794 0 C-N-CA 122.954 0.311 . . . . 55.33 113.639 172.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 408' ' ' LEU . . . . . 0.417 ' O ' ' HD2' ' A' ' 211' ' ' ARG . 3.3 pp -68.74 -18.0 64.15 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.486 0.714 . . . . 72.03 111.691 177.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 53.3 m -65.14 140.27 58.77 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.655 1.182 . . . . 73.52 111.771 178.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 410' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -63.96 128.75 37.18 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.923 0.889 . . . . 51.32 109.305 173.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . 74.74 -60.04 0.53 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 125.493 1.517 . . . . 63.14 112.208 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -74.68 88.96 2.23 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 122.084 0.945 . . . . 60.41 109.82 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 27.3 p30 -151.57 -161.53 1.34 Allowed 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 114.108 -1.406 . . . . 71.14 109.663 -174.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 414' ' ' THR . . . . . . . . . . . . . 4.0 m 69.49 165.66 0.27 Allowed 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 124.968 1.307 . . . . 73.24 110.583 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 415' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 77.77 -46.59 0.46 Allowed 'General case' 0 N--CA 1.505 2.307 0 C-N-CA 125.748 1.619 . . . . 73.42 111.561 -178.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -160.12 -170.69 2.93 Favored 'General case' 0 CA--C 1.557 1.239 0 N-CA-C 107.707 -1.22 . . . . 75.33 107.707 -179.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 417' ' ' GLY . . . . . 0.627 ' HA3' ' HA3' ' B' ' 407' ' ' GLY . . . 104.18 52.31 0.89 Allowed Glycine 0 N--CA 1.468 0.823 0 C-N-CA 122.715 0.198 . . . . 43.15 112.877 174.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 418' ' ' ALA . . . . . 0.603 ' H ' HD13 ' B' ' 385' ' ' LEU . . . 60.6 -88.7 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.171 1.388 . . . . 70.25 111.997 178.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 419' ' ' VAL . . . . . 0.424 HG12 ' HB2' ' B' ' 423' ' ' SER . 31.5 m -136.72 -17.26 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 C-N-CA 123.868 0.867 . . . . 62.03 110.806 -176.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 420' ' ' MET . . . . . 0.421 ' HB3' ' HE2' ' B' ' 420' ' ' MET . 23.4 mtp 69.02 -67.64 0.21 Allowed 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 125.525 1.53 . . . . 73.12 111.178 -173.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 421' ' ' VAL . . . . . 0.543 HG22 ' HG2' ' B' ' 422' ' ' MET . 1.4 p -147.83 -53.89 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 125.731 1.612 . . . . 72.42 107.527 175.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 422' ' ' MET . . . . . 0.543 ' HG2' HG22 ' B' ' 421' ' ' VAL . 25.6 mmt -132.34 129.65 39.74 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 106.997 -1.482 . . . . 74.1 106.997 176.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 423' ' ' SER . . . . . 0.424 ' HB2' HG12 ' B' ' 419' ' ' VAL . 13.6 t -85.88 46.95 1.37 Allowed 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 123.583 0.753 . . . . 62.22 110.923 -178.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 424' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -157.42 101.26 1.86 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.205 1.002 . . . . 72.42 108.828 -178.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . 55.03 39.42 69.15 Favored Glycine 0 C--N 1.354 1.537 0 O-C-N 124.113 0.883 . . . . 75.12 113.982 175.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 426' ' ' ASN . . . . . . . . . . . . . 10.3 m120 69.46 -73.44 0.09 Allowed 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 125.137 1.375 . . . . 75.43 111.015 -178.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 427' ' ' SER . . . . . 0.506 ' HB2' ' HB2' ' B' ' 422' ' ' MET . 40.3 m 57.6 30.79 19.36 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 125.12 1.368 . . . . 75.14 111.669 -177.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 428' ' ' GLU . . . . . 0.43 ' HA ' HG11 ' B' ' 421' ' ' VAL . 8.6 pt-20 -78.48 79.99 4.89 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.283 1.033 . . . . 73.23 109.848 179.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 429' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -58.44 136.54 57.5 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 114.324 -1.307 . . . . 63.42 111.789 -176.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 18.9 t70 63.32 -82.37 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.87 1.268 . . . . 55.41 112.005 175.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 18.8 t -161.37 19.91 0.12 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.174 0.59 . . . . 73.31 110.535 -175.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 432' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 42.42 47.16 4.25 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 125.757 1.623 . . . . 71.1 112.739 -178.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 433' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -53.08 141.87 21.6 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.555 1.142 . . . . 73.43 113.498 -170.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 434' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -82.38 52.17 1.99 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.48 1.112 . . . . 65.13 109.88 177.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 435' ' ' THR . . . . . . . . . . . . . 15.3 t -88.59 -166.23 1.54 Allowed 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 123.701 0.8 . . . . 73.42 110.259 -170.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . 92.27 11.27 59.97 Favored Glycine 0 C--N 1.347 1.169 0 CA-C-O 119.75 -0.472 . . . . 43.54 112.977 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 49.5 m 58.57 30.75 20.24 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.255 1.022 . . . . 54.14 111.029 -178.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 438' ' ' GLN . . . . . 0.551 ' HA ' ' HG3' ' A' ' 220' ' ' GLU . 2.0 pt20 58.41 9.29 1.02 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 126.887 2.075 . . . . 71.55 113.741 -175.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 439' ' ' LEU . . . . . 0.415 HD12 ' HD2' ' A' ' 238' ' ' LYS . 4.0 mm? 60.12 -78.52 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 125.021 1.328 . . . . 74.24 111.714 -175.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 440' ' ' ARG . . . . . 0.509 ' HA ' ' HB3' ' A' ' 222' ' ' ALA . 27.2 tpt180 59.25 95.86 0.03 OUTLIER 'General case' 0 C--N 1.355 0.836 0 C-N-CA 125.457 1.503 . . . . 70.1 108.839 -168.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 441' ' ' ILE . . . . . 0.731 ' HB ' ' HB3' ' A' ' 235' ' ' LEU . 6.1 pt -75.24 -41.29 43.96 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 N-CA-C 114.422 1.268 . . . . 74.15 114.422 -151.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 442' ' ' ALA . . . . . 0.432 ' N ' HG13 ' B' ' 441' ' ' ILE . . . 56.1 82.29 0.11 Allowed 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 124.441 1.096 . . . . 71.41 112.075 -168.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . -130.66 -57.68 1.05 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.317 1.047 . . . . 74.21 108.375 173.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -81.55 78.37 8.31 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 114.829 -1.078 . . . . 65.34 108.639 169.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 445' ' ' GLY . . . . . 0.406 ' O ' ' HE3' ' B' ' 465' ' ' LYS . . . -61.18 -55.84 27.12 Favored Glycine 0 C--N 1.349 1.268 0 CA-C-N 114.559 -1.2 . . . . 74.34 112.271 172.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 446' ' ' PRO . . . . . 0.604 ' HG2' ' HB2' ' B' ' 471' ' ' LYS . 39.4 Cg_exo -60.25 145.34 98.77 Favored 'Trans proline' 0 C--N 1.381 2.251 0 C-N-CA 122.373 2.049 . . . . 63.02 112.276 175.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 447' ' ' HIS . . . . . . . . . . . . . 31.3 t-80 -65.98 -42.81 89.36 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.581 0.752 . . . . 60.0 111.828 -175.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 448' ' ' ALA . . . . . 0.49 ' HB1' ' HB3' ' C' ' 260' ' ' ARG . . . -93.23 -25.74 17.67 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 122.993 0.517 . . . . 74.31 111.179 178.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 449' ' ' ALA . . . . . 0.511 ' O ' ' HA ' ' B' ' 470' ' ' LEU . . . 61.48 -77.41 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.158 1.383 . . . . 61.52 112.482 177.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 450' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 65.6 -60.4 0.27 Allowed 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 125.261 1.425 . . . . 61.12 111.898 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 451' ' ' VAL . . . . . 0.551 HG22 ' HE3' ' B' ' 471' ' ' LYS . 62.0 t 83.02 139.52 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 125.789 1.636 . . . . 63.1 111.493 166.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 452' ' ' VAL . . . . . 0.451 ' O ' HG12 ' B' ' 451' ' ' VAL . 8.5 p -62.72 165.3 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.545 0 C-N-CA 124.559 1.144 . . . . 60.45 110.126 172.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . -62.88 87.48 0.05 OUTLIER Glycine 0 CA--C 1.538 1.469 0 O-C-N 122.282 -0.261 . . . . 73.44 112.917 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 454' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.85 107.76 5.16 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.08 0.952 . . . . 72.5 108.861 -177.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 8.5 t -75.89 -40.92 53.46 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.628 0.771 . . . . 61.41 112.192 -173.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -85.67 -11.43 53.8 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 112.398 0.518 . . . . 74.3 112.398 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 457' ' ' GLN . . . . . 0.437 HE22 ' HZ1' ' B' ' 471' ' ' LYS . 16.9 tp60 54.62 43.54 30.04 Favored 'General case' 0 CA--C 1.558 1.271 0 CA-C-O 122.266 1.032 . . . . 42.14 111.374 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 5.2 t -84.46 59.09 5.23 Favored 'General case' 0 CA--C 1.553 1.092 0 CA-C-O 122.47 1.129 . . . . 72.13 110.138 175.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 459' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -169.3 150.42 4.31 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 114.446 -1.252 . . . . 73.31 109.242 -173.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 460' ' ' LEU . . . . . 0.701 ' HA ' ' HD2' ' B' ' 471' ' ' LYS . 2.5 pt? -156.74 139.72 15.35 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.831 0.852 . . . . 65.42 109.949 173.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -129.32 146.93 51.12 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.877 0.871 . . . . 62.31 109.488 176.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -110.02 78.1 1.1 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.621 1.168 . . . . 72.53 109.32 -178.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 81.2 p -92.55 -177.23 4.53 Favored 'General case' 0 C--O 1.247 0.929 0 CA-C-N 116.045 -0.525 . . . . 61.35 109.775 174.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 464' ' ' MET . . . . . 0.495 ' HG2' ' HG3' ' B' ' 117' ' ' LYS . 1.3 tpt -71.08 138.12 49.5 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 123.215 0.606 . . . . 75.31 110.467 177.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 465' ' ' LYS . . . . . 0.406 ' HE3' ' O ' ' B' ' 445' ' ' GLY . 11.5 mptt -87.41 65.56 8.72 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.058 0.943 . . . . 72.15 108.62 177.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -82.94 -146.97 0.08 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.143 0.977 . . . . 62.32 109.973 -178.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . -80.35 -32.13 37.81 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 118.91 0.777 . . . . 75.3 110.067 175.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 11.1 mp -117.17 -124.35 0.29 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 124.407 1.083 . . . . 45.51 109.767 176.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 469' ' ' GLY . . . . . . . . . . . . . . . 100.86 121.13 4.72 Favored Glycine 0 C--N 1.354 1.557 0 N-CA-C 111.393 -0.683 . . . . 50.44 111.393 -171.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 470' ' ' LEU . . . . . 0.511 ' HA ' ' O ' ' B' ' 449' ' ' ALA . 6.8 tt -114.65 147.74 39.15 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.058 0.943 . . . . 73.2 109.376 175.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 471' ' ' LYS . . . . . 0.701 ' HD2' ' HA ' ' B' ' 460' ' ' LEU . 9.3 ttpp . . . . . 0 CA--C 1.561 1.4 0 C-N-CA 123.179 0.592 . . . . 74.2 110.538 -177.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 61.9 mtm . . . . . 0 N--CA 1.485 1.282 0 CA-C-O 119.651 -0.214 . . . . 55.23 111.094 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.56 40.89 32.03 Favored 'General case' 0 C--N 1.359 0.985 0 C-N-CA 124.286 1.034 . . . . 65.31 111.437 -176.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -73.99 77.79 1.68 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.163 0.585 . . . . 52.01 110.308 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? -37.64 96.2 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 125.616 1.566 . . . . 70.52 113.179 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 5' ' ' LYS . . . . . 0.484 ' HB3' HD11 ' C' ' 10' ' ' ILE . 97.4 mttt -96.86 106.93 19.34 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.72 0.808 . . . . 63.2 109.561 174.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -73.83 97.62 2.79 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 107.076 -1.453 . . . . 63.22 107.076 166.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 7' ' ' TYR . . . . . 0.41 ' HA ' HD12 ' C' ' 10' ' ' ILE . 61.1 m-85 -61.16 -26.04 67.42 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 114.451 -1.249 . . . . 73.43 112.257 -172.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -68.67 -46.77 68.22 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.851 0.461 . . . . 72.53 109.792 176.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.3 -42.88 92.35 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.366 0.666 . . . . 52.31 110.678 178.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 10' ' ' ILE . . . . . 0.484 HD11 ' HB3' ' C' ' 5' ' ' LYS . 83.3 mt -54.17 -47.39 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 C-N-CA 124.023 0.929 . . . . 63.34 110.615 174.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 11' ' ' LEU . . . . . 0.4 ' HB2' HG22 ' C' ' 13' ' ' VAL . 85.8 mt -75.79 -13.6 60.29 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 115.397 -0.82 . . . . 45.45 112.787 179.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.66 21.29 75.06 Favored Glycine 0 C--N 1.351 1.393 0 CA-C-N 117.903 0.32 . . . . 64.33 113.655 -177.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 13' ' ' VAL . . . . . 0.4 HG22 ' HB2' ' C' ' 11' ' ' LEU . 12.5 m -106.19 160.58 25.7 Favored Pre-proline 0 N--CA 1.483 1.187 0 C-N-CA 124.291 1.036 . . . . 64.04 110.271 176.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -56.82 153.37 37.47 Favored 'Trans proline' 0 C--N 1.388 2.65 0 C-N-CA 122.714 2.276 . . . . 74.43 112.152 177.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 63.6 mtp180 -70.67 7.21 1.16 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 113.661 0.985 . . . . 71.52 113.661 -174.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -135.93 21.94 3.29 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.276 1.031 . . . . 71.24 108.594 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.04 128.07 34.99 Favored 'General case' 0 C--N 1.35 0.608 0 CA-C-N 114.684 -1.144 . . . . 71.14 111.089 -176.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 70.8 p -71.44 169.22 15.84 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 123.662 0.785 . . . . 74.41 110.252 177.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -50.98 -38.59 51.89 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.052 0.941 . . . . 74.45 111.615 -178.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 20' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' C' ' 24' ' ' ARG . 0.3 OUTLIER -69.68 -45.56 68.04 Favored 'General case' 0 CA--C 1.553 1.061 0 O-C-N 123.952 0.783 . . . . 64.05 110.539 -176.14 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -63.47 -43.41 97.42 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.724 0.773 . . . . 73.42 110.741 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 22' ' ' ILE . . . . . 0.755 HD13 ' HB3' ' C' ' 57' ' ' LEU . 89.8 mt -63.13 -34.3 65.88 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 CA-C-N 114.044 -1.435 . . . . 61.32 110.75 175.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -72.67 -29.95 63.86 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.928 0.891 . . . . 74.13 111.223 176.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 24' ' ' ARG . . . . . 0.431 ' HG3' ' O ' ' C' ' 20' ' ' GLU . 94.6 mtt180 -64.81 -53.05 52.94 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.142 0.577 . . . . 73.52 109.541 175.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.93 -40.96 97.32 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 114.704 -1.135 . . . . 75.32 111.24 178.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 26' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -52.48 -64.43 0.82 Allowed 'General case' 0 C--O 1.212 -0.877 0 O-C-N 124.789 1.306 . . . . 72.31 110.309 176.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -59.01 -38.73 79.9 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 124.339 1.025 . . . . 74.1 111.45 -174.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 -55.03 -53.68 52.67 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 123.715 0.634 . . . . 71.15 110.588 177.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . 0.526 ' HB3' HD13 ' C' ' 50' ' ' ILE . 72.4 mt -82.65 -17.14 45.66 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 115.009 -0.996 . . . . 60.22 111.941 -176.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -85.84 -16.6 38.17 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.738 0.815 . . . . 75.32 110.472 179.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -95.19 -37.7 10.92 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.525 0.73 . . . . 73.5 109.954 170.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 25.8 tp60 -65.07 -47.76 76.17 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.393 0.677 . . . . 71.12 111.187 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -108.69 22.7 15.57 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.333 0.653 . . . . 70.15 111.069 -175.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 34' ' ' HIS . . . . . 0.527 ' CD2' ' HB3' ' C' ' 36' ' ' ASP . 54.3 t60 -60.51 99.39 0.18 Allowed Pre-proline 0 N--CA 1.487 1.412 0 C-N-CA 124.913 1.285 . . . . 72.34 111.547 -174.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -61.97 -22.37 74.15 Favored 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 123.51 2.806 . . . . 71.32 113.916 -167.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 36' ' ' ASP . . . . . 0.527 ' HB3' ' CD2' ' C' ' 34' ' ' HIS . 9.4 t70 -56.44 -43.88 79.91 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.38 1.072 . . . . 60.34 111.603 174.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . 0.432 HG23 ' HD2' ' C' ' 34' ' ' HIS . 51.7 t -99.94 -46.24 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-O 121.762 0.791 . . . . 75.33 109.754 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -100.93 84.5 2.7 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.391 1.476 . . . . 54.22 109.921 -175.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -83.37 54.88 2.96 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.402 0.681 . . . . 62.24 110.663 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 44.3 m -104.37 108.33 60.14 Favored Pre-proline 0 N--CA 1.475 0.791 0 CA-C-O 118.572 -0.728 . . . . 74.14 109.136 -178.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -40.75 -52.12 3.34 Favored 'Trans proline' 0 C--N 1.387 2.6 0 C-N-CA 124.655 3.57 . . . . 63.44 114.707 -174.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 42' ' ' GLU . . . . . 0.404 ' O ' ' HD3' ' C' ' 46' ' ' LYS . 41.8 tt0 -56.81 -47.39 80.35 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 124.043 0.839 . . . . 65.44 110.813 178.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.05 -20.87 66.32 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 115.966 -0.561 . . . . 62.05 110.901 -178.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 44' ' ' GLU . . . . . 0.406 ' O ' ' HD3' ' C' ' 48' ' ' LYS . 45.7 mt-10 -86.29 -28.87 23.47 Favored 'General case' 0 C--N 1.355 0.814 0 C-N-CA 123.21 0.604 . . . . 74.04 109.995 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -60.85 -50.26 74.17 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.753 -0.832 . . . . 42.53 108.753 171.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 46' ' ' LYS . . . . . 0.404 ' HD3' ' O ' ' C' ' 42' ' ' GLU . 12.3 mptt -62.5 -48.79 78.04 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 113.811 -1.541 . . . . 72.32 110.07 179.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -56.25 -39.19 72.18 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.809 0.844 . . . . 62.23 110.79 178.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 48' ' ' LYS . . . . . 0.406 ' HD3' ' O ' ' C' ' 44' ' ' GLU . 1.2 mptm? -62.02 -49.19 77.01 Favored 'General case' 0 C--O 1.214 -0.794 0 O-C-N 123.841 0.713 . . . . 72.04 109.97 179.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -70.68 -22.02 62.53 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 112.557 0.577 . . . . 72.33 112.557 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 50' ' ' ILE . . . . . 0.526 HD13 ' HB3' ' C' ' 29' ' ' LEU . 73.2 mt -80.11 -36.78 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 124.423 1.089 . . . . 75.43 110.69 176.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 51' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -89.63 -8.64 52.07 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.031 0.932 . . . . 74.04 110.521 177.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 52' ' ' GLU . . . . . 0.413 ' O ' HG23 ' C' ' 56' ' ' VAL . 29.4 tt0 -79.0 -47.19 16.71 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.93 1.292 . . . . 63.42 107.928 166.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.42 -44.34 80.29 Favored 'General case' 0 C--N 1.346 0.431 0 CA-C-N 114.243 -1.344 . . . . 63.1 110.684 173.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -80.93 -22.84 39.31 Favored 'General case' 0 CA--C 1.553 1.06 0 CA-C-N 115.501 -0.772 . . . . 75.01 111.125 178.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.85 -38.24 78.28 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 118.839 0.745 . . . . 60.54 110.22 171.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 56' ' ' VAL . . . . . 0.413 HG23 ' O ' ' C' ' 52' ' ' GLU . 26.1 t -77.34 -47.69 26.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-N 114.891 -1.049 . . . . 72.43 110.501 174.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 57' ' ' LEU . . . . . 0.755 ' HB3' HD13 ' C' ' 22' ' ' ILE . 85.1 mt -103.72 20.8 17.36 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 113.569 0.952 . . . . 75.02 113.569 -166.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 33.6 t -55.89 -43.1 76.92 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 124.161 0.984 . . . . 62.42 113.275 177.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -140.71 156.91 68.82 Favored Pre-proline 0 N--CA 1.472 0.664 0 C-N-CA 124.379 1.072 . . . . 72.03 109.559 -170.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 60' ' ' PRO . . . . . 0.472 ' O ' ' HG2' ' C' ' 64' ' ' ARG . 19.6 Cg_endo -54.62 -29.21 59.8 Favored 'Trans proline' 0 C--N 1.394 2.959 0 C-N-CA 123.408 2.739 . . . . 33.23 112.454 179.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -54.04 -63.16 1.24 Allowed 'General case' 0 C--O 1.252 1.199 0 C-N-CA 124.823 1.249 . . . . 62.13 111.801 177.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 44.0 mtpt -81.55 -24.64 36.45 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 113.94 -1.482 . . . . 75.23 110.152 -171.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -54.3 -50.13 68.05 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.763 1.225 . . . . 64.42 109.595 166.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 64' ' ' ARG . . . . . 0.472 ' HG2' ' O ' ' C' ' 60' ' ' PRO . 20.9 mmt180 -71.11 -29.02 64.74 Favored 'General case' 0 C--N 1.358 0.967 0 CA-C-O 119.13 -0.462 . . . . 74.15 111.801 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 65' ' ' ILE . . . . . 0.401 HG23 ' HG2' ' C' ' 76' ' ' PRO . 69.4 mt -56.86 -44.92 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-O 121.296 0.57 . . . . 62.34 110.317 168.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -63.19 -48.15 79.6 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.994 -0.548 . . . . 74.22 110.969 176.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -58.84 -41.4 86.86 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 123.581 0.551 . . . . 73.14 111.725 -177.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 64.9 p -67.8 -28.99 68.06 Favored 'General case' 0 C--N 1.349 0.574 0 O-C-N 123.341 0.4 . . . . 63.2 110.671 176.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -77.26 142.71 39.36 Favored 'General case' 0 C--N 1.359 0.989 0 N-CA-C 109.052 -0.721 . . . . 75.22 109.052 171.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.69 13.3 82.6 Favored Glycine 0 C--N 1.346 1.102 0 N-CA-C 112.009 -0.436 . . . . 62.51 112.009 -177.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 28.8 m -136.93 -54.5 0.71 Allowed 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 103.749 -2.686 . . . . 72.34 103.749 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 82.2 m -97.51 150.17 21.37 Favored 'General case' 0 C--O 1.255 1.354 0 N-CA-C 104.532 -2.395 . . . . 73.35 104.532 156.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.12 -34.16 11.8 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.844 0.858 . . . . 73.23 110.258 -178.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -70.64 128.1 91.31 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 123.742 0.817 . . . . 53.23 110.732 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -67.13 150.38 82.12 Favored 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 122.647 2.231 . . . . 75.14 111.176 172.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 76' ' ' PRO . . . . . 0.401 ' HG2' HG23 ' C' ' 65' ' ' ILE . 48.1 Cg_exo -58.75 147.39 88.44 Favored 'Trans proline' 0 C--N 1.373 1.856 0 C-N-CA 122.645 2.23 . . . . 63.14 112.123 173.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 77' ' ' PRO . . . . . 0.401 ' HA ' ' HD3' ' C' ' 78' ' ' PRO . 50.5 Cg_exo -56.43 147.42 68.55 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 122.388 2.059 . . . . 51.51 112.113 171.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 78' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' C' ' 77' ' ' PRO . 43.3 Cg_exo -59.05 123.05 12.63 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.975 2.45 . . . . 74.44 112.618 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -71.91 170.68 18.25 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 122.872 2.382 . . . . 61.04 112.178 178.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 80' ' ' PRO . . . . . 0.49 ' HB2' ' HB1' ' C' ' 141' ' ' ALA . 82.4 Cg_exo -48.8 89.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.393 2.911 0 C-N-CA 123.468 2.779 . . . . 51.5 113.607 178.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 118.29 -40.1 2.4 Favored Glycine 0 C--O 1.225 -0.464 0 CA-C-N 114.651 -1.158 . . . . 75.2 110.255 177.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.508 ' HA3' ' HA ' ' C' ' 106' ' ' PHE . . . 126.5 -176.04 17.68 Favored Glycine 0 C--N 1.347 1.18 0 N-CA-C 111.249 -0.741 . . . . 74.45 111.249 -172.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -73.98 124.13 25.63 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.839 0.856 . . . . 70.14 111.152 -176.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 84' ' ' ASP . . . . . 0.662 ' HB3' HH21 ' C' ' 143' ' ' ARG . 6.9 p-10 -70.77 149.15 47.18 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.616 0.766 . . . . 63.13 110.506 177.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 85' ' ' PHE . . . . . 0.543 ' HB3' ' HB2' ' C' ' 88' ' ' PHE . 53.6 m-85 -148.37 74.86 1.3 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.641 0.777 . . . . 74.41 110.056 -179.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 16.5 m -54.98 86.57 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 125.131 1.373 . . . . 45.43 113.645 -175.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 85.49 13.45 70.45 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-N 115.686 -0.688 . . . . 74.33 112.829 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 88' ' ' PHE . . . . . 0.543 ' HB2' ' HB3' ' C' ' 85' ' ' PHE . 18.5 m-85 -115.34 108.15 16.16 Favored 'General case' 0 C--N 1.355 0.815 0 C-N-CA 123.135 0.574 . . . . 74.44 109.641 -174.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -74.46 88.13 2.1 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 108.042 -1.095 . . . . 72.23 108.042 177.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 90' ' ' VAL . . . . . 0.715 HG21 HD22 ' C' ' 105' ' ' LEU . 2.1 p -47.35 -40.65 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 CA-C-N 114.317 -1.311 . . . . 54.41 113.151 176.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 91' ' ' GLU . . . . . 0.443 ' HB2' ' ND2' ' C' ' 169' ' ' ASN . 33.7 tt0 -65.99 -21.3 66.4 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.863 0.865 . . . . 74.21 111.43 -175.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -86.42 -21.59 27.03 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 123.728 0.811 . . . . 75.53 111.239 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -77.24 -177.72 4.72 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.339 0.656 . . . . 72.45 112.338 -175.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 92.4 p -78.14 173.31 12.38 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 113.307 0.854 . . . . 45.51 113.307 -168.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.21 -51.07 71.59 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 114.333 -1.303 . . . . 55.43 111.557 178.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -56.17 -40.51 74.0 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.984 0.914 . . . . 65.02 111.087 -175.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 97' ' ' PHE . . . . . 0.427 ' HE2' HG23 ' C' ' 90' ' ' VAL . 60.1 t80 -64.72 -50.36 67.22 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 114.519 -1.219 . . . . 64.25 110.04 177.113 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -80.06 2.69 22.89 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 115.213 -0.903 . . . . 51.52 112.56 -177.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -100.07 -45.12 5.77 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.568 0.747 . . . . 74.43 110.507 170.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 13.2 tp -62.74 -58.29 7.96 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.242 0.617 . . . . 73.23 110.127 176.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -81.87 -11.36 58.97 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 115.71 -0.677 . . . . 73.25 111.408 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -37.38 -63.18 0.84 Allowed Glycine 0 C--N 1.358 1.767 0 C-N-CA 124.807 1.194 . . . . 54.11 115.679 -177.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_exo -46.21 -34.13 13.08 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 123.841 3.028 . . . . 62.02 115.282 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -119.05 27.88 6.87 Favored Glycine 0 C--N 1.356 1.647 0 CA-C-O 119.318 -0.712 . . . . 43.23 113.823 -175.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 105' ' ' LEU . . . . . 0.715 HD22 HG21 ' C' ' 90' ' ' VAL . 29.0 mt -68.67 81.79 0.28 Allowed 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 117.761 0.78 . . . . 73.03 112.706 176.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 106' ' ' PHE . . . . . 0.539 ' HB2' ' HA ' ' C' ' 169' ' ' ASN . 0.2 OUTLIER 36.61 -113.84 0.1 Allowed 'General case' 0 CA--C 1.558 1.269 0 C-N-CA 126.864 2.066 . . . . 64.24 115.464 174.928 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . 68.48 2.2 26.31 Favored Glycine 0 C--N 1.359 1.861 0 N-CA-C 112.219 -0.353 . . . . 51.05 112.219 -162.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 108' ' ' GLY . . . . . 0.629 ' HA3' ' HA ' ' C' ' 167' ' ' GLN . . . 55.56 -142.59 36.82 Favored Glycine 0 C--N 1.36 1.898 0 N-CA-C 111.389 -0.684 . . . . 74.41 111.389 -168.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 109' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -85.05 -0.58 54.95 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 122.797 0.439 . . . . 74.45 109.988 170.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 110' ' ' GLY . . . . . . . . . . . . . . . -90.1 -15.41 57.61 Favored Glycine 0 C--N 1.361 1.95 0 CA-C-O 119.832 -0.427 . . . . 54.22 112.36 -178.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 52.8 15.22 0.51 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 114.694 1.368 . . . . 75.25 114.694 174.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 112' ' ' ARG . . . . . . . . . . . . . 38.2 ttp-105 -56.93 -32.59 66.12 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.147 0.979 . . . . 74.1 111.366 169.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 113' ' ' SER . . . . . . . . . . . . . 31.7 m 58.12 32.28 21.81 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.714 1.206 . . . . 72.53 111.246 -176.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 18.2 mtp85 -135.38 -178.69 5.22 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.791 0.836 . . . . 74.05 110.782 177.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 115' ' ' LYS . . . . . 0.543 ' HA ' ' HD2' ' C' ' 170' ' ' PRO . 56.6 tttp -28.73 129.02 0.08 Allowed 'General case' 0 N--CA 1.503 2.18 0 C-N-CA 126.207 1.803 . . . . 54.14 115.378 -163.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 116' ' ' GLY . . . . . 0.514 ' HA2' ' HA3' ' C' ' 168' ' ' GLY . . . -89.72 144.91 18.02 Favored Glycine 0 C--N 1.344 1.004 0 O-C-N 123.986 0.804 . . . . 45.25 113.902 -174.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.09 -176.82 2.99 Favored 'General case' 0 C--O 1.26 1.621 0 C-N-CA 124.301 1.041 . . . . 64.44 108.907 168.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 118' ' ' ASP . . . . . 0.471 ' HA ' ' O ' ' C' ' 173' ' ' ASP . 4.8 p-10 -60.62 152.99 24.9 Favored 'General case' 0 C--O 1.244 0.764 0 CA-C-N 115.127 -0.942 . . . . 75.42 112.828 -171.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 119' ' ' LEU . . . . . 0.469 ' O ' HD12 ' C' ' 174' ' ' LEU . 20.0 tp -110.85 118.28 35.71 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 106.57 -1.641 . . . . 75.21 106.57 173.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 21.8 ttm180 -112.37 106.03 14.45 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 121.207 0.527 . . . . 72.31 110.761 -167.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 121' ' ' ALA . . . . . . . . . . . . . . . -124.13 117.28 24.3 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.445 -0.798 . . . . 63.21 109.314 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 122' ' ' GLU . . . . . 0.411 ' HG2' HG22 ' B' ' 186' ' ' THR . 9.1 pt-20 -82.14 125.44 30.89 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 108.478 -0.934 . . . . 73.22 108.478 170.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 123' ' ' LEU . . . . . 0.434 HD13 HD22 ' C' ' 176' ' ' LEU . 2.2 pt? -130.33 115.3 17.34 Favored Pre-proline 0 CA--C 1.554 1.134 0 C-N-CA 123.03 0.532 . . . . 73.3 110.461 -171.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . 0.477 ' HG2' ' HB2' ' B' ' 188' ' ' ARG . 53.6 Cg_exo -62.78 115.69 3.08 Favored 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 123.301 2.667 . . . . 72.51 113.707 170.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 125' ' ' LEU . . . . . 0.592 HD23 HG11 ' C' ' 153' ' ' VAL . 19.0 tp -131.32 166.52 21.05 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 106.308 -1.738 . . . . 74.03 106.308 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 126' ' ' THR . . . . . 0.443 ' H ' ' HB2' ' C' ' 129' ' ' GLU . 11.7 t -129.54 176.03 8.31 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 120.833 1.651 . . . . 61.53 112.1 175.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 127' ' ' LEU . . . . . 0.483 HD23 HD13 ' C' ' 180' ' ' LEU . 7.4 mt -60.79 -41.67 96.07 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.003 1.721 . . . . 62.25 110.069 -177.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -65.02 -43.63 91.83 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 113.867 -1.515 . . . . 75.24 110.716 176.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 129' ' ' GLU . . . . . 0.443 ' HB2' ' H ' ' C' ' 126' ' ' THR . 38.8 mm-40 -72.59 -21.17 61.17 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-N 115.47 -0.786 . . . . 73.53 111.224 -179.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 130' ' ' ALA . . . . . 0.555 ' HB2' HG12 ' C' ' 153' ' ' VAL . . . -78.57 -46.25 19.84 Favored 'General case' 0 C--O 1.22 -0.456 0 O-C-N 124.139 0.899 . . . . 64.34 109.194 174.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 131' ' ' PHE . . . . . 0.623 ' HB2' HD13 ' C' ' 215' ' ' LEU . 88.1 t80 -50.68 -42.99 57.42 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.709 1.204 . . . . 75.55 110.796 173.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 132' ' ' HIS . . . . . . . . . . . . . 28.0 m170 -67.44 -67.43 0.46 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.187 -0.915 . . . . 60.22 108.754 175.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 50.51 -139.28 22.04 Favored Glycine 0 C--N 1.358 1.791 0 O-C-N 124.198 0.936 . . . . 65.31 113.662 175.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.86 -152.97 37.58 Favored Glycine 0 C--N 1.342 0.913 0 O-C-N 123.958 0.446 . . . . 53.24 113.27 177.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -79.15 94.4 5.37 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 108.554 -0.906 . . . . 71.2 108.554 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 136' ' ' ARG . . . . . . . . . . . . . 28.1 mmm-85 -103.39 125.35 49.95 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.778 0.831 . . . . 72.12 109.382 -177.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 137' ' ' VAL . . . . . 0.635 HG23 ' HB1' ' B' ' 180' ' ' ALA . 31.6 m -77.43 135.96 25.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 N-CA-C 109.361 -0.607 . . . . 71.12 109.361 174.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 138' ' ' VAL . . . . . . . . . . . . . 7.3 p -136.28 126.42 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.607 0.763 . . . . 72.14 109.35 -176.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 139' ' ' GLU . . . . . 0.496 ' HG3' ' HB2' ' C' ' 144' ' ' ARG . 1.6 mp0 -86.72 75.81 9.6 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.543 -0.539 . . . . 74.31 109.543 -176.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 140' ' ' VAL . . . . . . . . . . . . . 87.0 t -86.04 113.02 23.41 Favored 'Isoleucine or valine' 0 C--O 1.246 0.891 0 N-CA-C 108.396 -0.964 . . . . 63.22 108.396 -178.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 141' ' ' ALA . . . . . 0.49 ' HB1' ' HB2' ' C' ' 80' ' ' PRO . . . 62.78 37.01 12.75 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 124.565 1.165 . . . . 15.23 110.914 176.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 101.55 -34.81 5.36 Favored Glycine 0 C--N 1.351 1.363 0 CA-C-N 114.856 -1.065 . . . . 45.25 112.803 177.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 143' ' ' ARG . . . . . 0.662 HH21 ' HB3' ' C' ' 84' ' ' ASP . 0.2 OUTLIER -92.4 118.96 31.47 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 117.179 0.489 . . . . 73.04 111.324 -171.508 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 144' ' ' ARG . . . . . 0.523 ' HG3' ' HB ' ' C' ' 137' ' ' VAL . 35.4 ttm180 -73.92 115.95 13.97 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.194 -0.912 . . . . 71.51 109.638 171.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 145' ' ' VAL . . . . . . . . . . . . . 4.2 p -131.51 128.87 61.46 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 C-N-CA 124.049 0.94 . . . . 75.03 109.775 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 36.1 t -75.45 93.02 2.9 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 123.977 0.911 . . . . 54.21 110.582 -177.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 8.8 p -88.15 119.12 35.04 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 N-CA-C 109.241 -0.652 . . . . 72.53 109.241 175.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -75.53 104.33 6.04 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 109.513 -0.551 . . . . 74.22 109.513 174.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 149' ' ' ILE . . . . . 0.422 HG21 HG21 ' C' ' 159' ' ' ILE . 36.0 pt -120.29 95.46 49.07 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 107.133 -1.432 . . . . 71.41 107.133 165.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -49.78 161.14 0.96 Allowed 'Trans proline' 0 C--N 1.395 2.994 0 C-N-CA 124.271 3.314 . . . . 61.44 114.205 -174.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -43.56 94.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.389 2.7 0 C-N-CA 123.345 2.697 . . . . 73.2 112.247 174.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 152' ' ' GLY . . . . . 0.449 ' HA2' ' CD2' ' C' ' 240' ' ' PHE . . . 151.44 132.76 1.93 Allowed Glycine 0 C--N 1.348 1.222 0 CA-C-N 115.073 -0.967 . . . . 54.32 113.637 -174.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 153' ' ' VAL . . . . . 0.612 HG22 HG11 ' C' ' 178' ' ' VAL . 0.6 OUTLIER -153.59 160.23 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.028 0 CA-C-N 116.745 0.273 . . . . 71.13 110.948 169.696 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 154' ' ' ARG . . . . . 0.457 ' HG2' ' HB3' ' C' ' 188' ' ' LEU . 22.1 mtp180 -121.36 123.49 42.26 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.206 1.002 . . . . 75.32 110.447 -170.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 155' ' ' GLU . . . . . 0.47 ' HB2' HD12 ' C' ' 180' ' ' LEU . 13.3 tp10 -51.18 124.74 12.26 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.439 0.696 . . . . 74.51 112.241 171.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 76.28 12.39 84.23 Favored Glycine 0 C--N 1.348 1.241 0 O-C-N 124.394 1.059 . . . . 64.51 114.008 170.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 157' ' ' SER . . . . . . . . . . . . . 55.4 m -101.94 156.1 17.74 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.202 0.525 . . . . 75.43 110.829 -178.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 158' ' ' VAL . . . . . 0.643 HG12 HG22 ' C' ' 177' ' ' VAL . 27.1 m -96.56 111.71 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 CA-C-N 115.103 -0.953 . . . . 64.44 109.161 175.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 159' ' ' ILE . . . . . 0.714 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 57.1 mt -71.39 94.95 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 107.903 -1.147 . . . . 52.25 107.903 170.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 12.1 ttp180 -86.87 100.75 12.78 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 109.336 -0.616 . . . . 72.21 109.336 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 161' ' ' VAL . . . . . 0.601 HG13 ' HB3' ' C' ' 174' ' ' LEU . 2.1 p -101.03 102.46 20.19 Favored Pre-proline 0 CA--C 1.553 1.076 0 N-CA-C 108.866 -0.79 . . . . 75.24 108.866 172.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -63.76 136.34 53.07 Favored 'Trans proline' 0 C--N 1.386 2.52 0 C-N-CA 122.921 2.414 . . . . 63.42 112.855 -175.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 163' ' ' GLY . . . . . 0.418 ' O ' ' HB2' ' C' ' 171' ' ' PRO . . . 98.29 -6.82 61.69 Favored Glycine 0 C--N 1.341 0.847 0 CA-C-N 115.317 -0.856 . . . . 53.31 113.512 177.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 164' ' ' MET . . . . . . . . . . . . . 82.7 mtp -103.26 30.68 4.74 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 118.016 0.908 . . . . 73.35 110.883 178.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 165' ' ' GLY . . . . . 0.499 ' HA2' ' O ' ' C' ' 173' ' ' ASP . . . -57.34 162.8 7.73 Favored Glycine 0 C--N 1.351 1.393 0 CA-C-N 114.932 -1.031 . . . . 64.24 114.82 177.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . -117.85 -59.55 0.29 Allowed Glycine 0 C--N 1.346 1.101 0 C-N-CA 121.532 -0.366 . . . . 75.44 112.764 -170.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 167' ' ' GLN . . . . . 0.629 ' HA ' ' HA3' ' C' ' 108' ' ' GLY . 29.9 mm-40 -88.46 99.07 12.0 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 110.164 -0.31 . . . . 64.31 110.164 -173.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 168' ' ' GLY . . . . . 0.514 ' HA3' ' HA2' ' C' ' 116' ' ' GLY . . . 123.04 147.96 7.5 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-O 119.564 -0.575 . . . . 13.44 112.9 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 169' ' ' ASN . . . . . 0.539 ' HA ' ' HB2' ' C' ' 106' ' ' PHE . 7.3 t30 -61.04 -59.41 13.91 Favored Pre-proline 0 N--CA 1.491 1.607 0 CA-C-O 117.621 -1.18 . . . . 62.44 113.781 -169.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 170' ' ' PRO . . . . . 0.543 ' HD2' ' HA ' ' C' ' 115' ' ' LYS . 6.6 Cg_exo -75.12 106.08 2.21 Favored 'Trans proline' 0 C--N 1.39 2.76 0 C-N-CA 122.01 1.807 . . . . 51.41 109.792 170.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 171' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' C' ' 170' ' ' PRO . 17.0 Cg_exo -66.58 126.02 14.79 Favored 'Trans proline' 0 C--N 1.372 1.798 0 C-N-CA 122.75 2.3 . . . . 74.02 113.229 -167.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -71.37 -74.94 0.68 Allowed Glycine 0 C--N 1.355 1.619 0 O-C-N 123.797 0.686 . . . . 74.42 113.464 -177.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 173' ' ' ASP . . . . . 0.499 ' O ' ' HA2' ' C' ' 165' ' ' GLY . 4.6 p-10 -164.05 166.64 21.21 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.04 0.936 . . . . 74.51 109.746 175.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 174' ' ' LEU . . . . . 0.601 ' HB3' HG13 ' C' ' 161' ' ' VAL . 31.6 tp -113.48 113.76 25.6 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.901 -0.778 . . . . 75.22 108.901 176.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 175' ' ' LEU . . . . . 0.469 HD22 ' HB ' ' C' ' 158' ' ' VAL . 70.4 mt -87.72 93.54 9.47 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 123.882 0.873 . . . . 71.32 109.879 170.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 176' ' ' LEU . . . . . 0.714 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 82.3 mt -82.92 100.44 10.4 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 108.989 -0.745 . . . . 43.02 108.989 170.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 177' ' ' VAL . . . . . 0.643 HG22 HG12 ' C' ' 158' ' ' VAL . 41.4 t -81.49 93.35 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 108.49 -0.93 . . . . 74.43 108.49 -178.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 178' ' ' VAL . . . . . 0.612 HG11 HG22 ' C' ' 153' ' ' VAL . 2.1 p -76.77 125.29 36.43 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 CA-C-N 115.329 -0.85 . . . . 74.01 110.996 -172.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 179' ' ' ARG . . . . . 0.461 ' O ' ' HA ' ' C' ' 124' ' ' PRO . 34.8 mmt180 -120.29 112.9 19.62 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 114.355 -1.293 . . . . 72.33 108.308 178.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 180' ' ' LEU . . . . . 0.545 ' HA ' ' O ' ' C' ' 125' ' ' LEU . 80.5 mt -69.48 143.32 53.54 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 116.561 -0.291 . . . . 70.51 111.579 -178.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 181' ' ' LEU . . . . . . . . . . . . . 36.6 mt -60.94 156.49 47.07 Favored Pre-proline 0 N--CA 1.482 1.17 0 CA-C-O 117.731 -1.128 . . . . 74.2 109.92 -179.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -49.02 79.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.395 2.987 0 C-N-CA 124.205 3.27 . . . . 64.12 115.516 -174.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 183' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 171.87 76.78 0.04 OUTLIER Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 128.456 2.702 . . . . 62.13 106.82 172.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 184' ' ' PRO . . . . . 0.532 ' HG2' ' HB3' ' B' ' 287' ' ' PRO . 71.9 Cg_endo -74.22 68.86 4.99 Favored 'Trans proline' 0 C--N 1.38 2.19 0 C-N-CA 123.686 2.924 . . . . 71.54 111.533 178.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 185' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 13.1 t -90.48 -41.16 13.32 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.702 0 N-CA-C 109.326 -0.62 . . . . 72.23 109.326 -168.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 186' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -122.25 111.03 16.44 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 120.9 0.381 . . . . 61.44 111.718 -172.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 187' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -95.98 112.9 24.51 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 106.562 -1.644 . . . . 75.14 106.562 170.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 188' ' ' LEU . . . . . 0.457 ' HB3' ' HG2' ' C' ' 154' ' ' ARG . 62.0 tp -80.75 144.8 31.88 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-O 121.272 0.558 . . . . 74.14 112.465 -175.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -136.9 101.52 4.6 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.634 1.574 . . . . 71.33 107.124 169.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 72.41 -97.27 0.77 Allowed Glycine 0 C--N 1.349 1.263 0 N-CA-C 112.084 -0.406 . . . . 74.2 112.084 -175.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 191' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -119.86 -18.57 8.21 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 124.323 1.049 . . . . 60.21 110.321 175.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -94.53 140.94 29.18 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.168 0.987 . . . . 65.13 110.467 -172.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 193' ' ' LEU . . . . . 0.55 HD21 ' CE2' ' C' ' 240' ' ' PHE . 88.5 mt -100.25 170.18 8.62 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 113.119 0.785 . . . . 52.2 113.119 -169.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 194' ' ' TYR . . . . . 0.423 ' HA ' ' O ' ' C' ' 250' ' ' TYR . 52.1 t80 -127.97 108.42 10.66 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.787 0.835 . . . . 75.43 110.197 167.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 195' ' ' ALA . . . . . 0.522 ' HA ' ' O ' ' C' ' 185' ' ' VAL . . . -110.68 -175.85 2.82 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.823 0.849 . . . . 65.11 109.125 168.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 17.9 m -121.8 132.15 54.44 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 108.432 -0.951 . . . . 51.32 108.432 167.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 197' ' ' LEU . . . . . 0.476 HD22 HD12 ' C' ' 233' ' ' LEU . 53.7 tp -102.1 145.68 29.01 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.459 0.704 . . . . 73.5 110.444 -177.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 198' ' ' ASP . . . . . 0.482 ' HB3' HD11 ' B' ' 280' ' ' LEU . 6.0 t70 -116.61 101.61 8.75 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.274 -1.01 . . . . 44.52 108.274 -179.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 199' ' ' VAL . . . . . . . . . . . . . 39.5 t -115.13 126.29 27.98 Favored Pre-proline 0 N--CA 1.476 0.872 0 N-CA-C 108.826 -0.805 . . . . 61.21 108.826 177.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 200' ' ' PRO . . . . . 0.635 ' HG2' HD12 ' C' ' 203' ' ' ILE . 24.0 Cg_exo -60.73 150.01 84.81 Favored 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 122.588 2.192 . . . . 71.34 112.204 168.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 201' ' ' ALA . . . . . 0.454 ' O ' HG23 ' C' ' 205' ' ' VAL . . . -51.84 -57.92 13.02 Favored Pre-proline 0 CA--C 1.56 1.358 0 C-N-CA 124.756 1.222 . . . . 74.35 113.409 177.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 202' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -71.46 -30.68 14.9 Favored 'Trans proline' 0 C--N 1.389 2.71 0 CA-C-N 121.585 1.602 . . . . 63.15 112.544 -174.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 203' ' ' ILE . . . . . 0.635 HD12 ' HG2' ' C' ' 200' ' ' PRO . 20.4 mt -64.43 -40.48 89.21 Favored 'Isoleucine or valine' 0 C--N 1.361 1.085 0 N-CA-C 109.307 -0.627 . . . . 63.4 109.307 172.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 204' ' ' ALA . . . . . 0.534 ' HB1' ' HB ' ' C' ' 227' ' ' THR . . . -62.06 -39.06 91.1 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.24 -0.891 . . . . 75.02 110.816 176.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 205' ' ' VAL . . . . . 0.454 HG23 ' O ' ' C' ' 201' ' ' ALA . 53.4 t -74.06 -48.86 36.27 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 N-CA-C 114.027 1.121 . . . . 63.41 114.027 -173.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 206' ' ' VAL . . . . . . . . . . . . . 9.0 p -92.73 -33.55 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 CA-C-N 119.551 1.069 . . . . 52.12 111.453 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 105.58 121.69 4.9 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.399 -0.68 . . . . 63.21 111.399 -173.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 208' ' ' GLY . . . . . 0.405 ' H ' ' HB ' ' C' ' 223' ' ' VAL . . . -145.41 -136.22 2.95 Favored Glycine 0 C--N 1.339 0.709 0 N-CA-C 110.833 -0.907 . . . . 51.32 110.833 178.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 209' ' ' LYS . . . . . 0.425 ' HA ' ' O ' ' C' ' 221' ' ' VAL . 20.2 ttpp -151.7 118.48 5.78 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 117.523 0.661 . . . . 72.12 109.903 175.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 210' ' ' VAL . . . . . . . . . . . . . 19.1 m -111.35 170.0 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 124.829 1.252 . . . . 62.05 109.671 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 211' ' ' ARG . . . . . . . . . . . . . 8.1 tmm_? -103.25 125.35 49.87 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 120.922 0.391 . . . . 72.44 110.909 -179.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 212' ' ' ALA . . . . . 0.463 ' HB3' HG13 ' C' ' 219' ' ' VAL . . . -105.72 152.36 23.27 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.849 1.26 . . . . 74.43 109.728 168.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 213' ' ' MET . . . . . . . . . . . . . 17.8 mmm -85.15 142.06 29.74 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.439 0.695 . . . . 63.12 110.017 174.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 214' ' ' THR . . . . . 0.523 HG21 ' HD3' ' C' ' 238' ' ' LYS . 0.2 OUTLIER -141.23 175.05 9.96 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.114 0.566 . . . . 54.24 111.204 172.619 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 215' ' ' LEU . . . . . 0.623 HD13 ' HB2' ' C' ' 131' ' ' PHE . 23.9 mt -61.92 -48.46 80.33 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.246 1.018 . . . . 44.41 111.394 -173.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -91.21 13.62 16.61 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 114.399 -1.273 . . . . 71.0 111.416 -176.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 124.39 -171.21 16.56 Favored Glycine 0 C--N 1.351 1.392 0 N-CA-C 111.824 -0.51 . . . . 64.11 111.824 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -81.7 129.55 6.44 Favored 'Trans proline' 0 CA--C 1.558 1.719 0 C-N-CA 122.675 2.25 . . . . 52.13 113.848 -178.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 219' ' ' VAL . . . . . 0.463 HG13 ' HB3' ' C' ' 212' ' ' ALA . 5.1 p -97.5 140.32 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 N-CA-C 108.361 -0.978 . . . . 52.53 108.361 172.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 220' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -98.44 107.98 20.56 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 118.583 0.629 . . . . 72.32 109.651 179.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 221' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' C' ' 209' ' ' LYS . 37.9 t -69.8 116.04 10.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 126.058 1.743 . . . . 74.03 112.708 -179.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -76.01 113.67 13.78 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.493 0.717 . . . . 73.3 109.146 168.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . 0.405 ' HB ' ' H ' ' C' ' 208' ' ' GLY . 47.0 t -92.17 138.08 24.61 Favored Pre-proline 0 CA--C 1.561 1.371 0 C-N-CA 124.136 0.975 . . . . 73.11 110.646 -174.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 224' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -86.22 164.19 9.86 Favored 'Trans proline' 0 C--N 1.387 2.6 0 C-N-CA 123.377 2.718 . . . . 54.33 112.103 173.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.07 128.48 21.87 Favored 'Trans proline' 0 C--N 1.377 2.079 0 C-N-CA 122.751 2.3 . . . . 74.0 113.705 177.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 226' ' ' ARG . . . . . 0.702 ' HB2' HG22 ' B' ' 307' ' ' THR . 0.0 OUTLIER 59.43 89.09 0.07 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.814 2.045 . . . . 70.15 110.988 179.886 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 227' ' ' THR . . . . . 0.534 ' HB ' ' HB1' ' C' ' 204' ' ' ALA . 24.7 m -106.63 135.68 47.73 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 113.789 -1.551 . . . . 70.3 110.221 178.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 228' ' ' GLN . . . . . 0.44 ' H ' ' NE ' ' C' ' 231' ' ' ARG . 3.9 tp-100 -110.35 142.83 41.47 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 124.291 1.036 . . . . 74.32 110.479 -175.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -71.23 137.46 48.67 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.677 -0.86 . . . . 62.12 108.677 174.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 100.99 0.68 54.97 Favored Glycine 0 CA--C 1.521 0.411 0 CA-C-N 116.08 -0.509 . . . . 62.04 112.286 -170.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 231' ' ' ARG . . . . . 0.509 ' HD2' HG23 ' C' ' 227' ' ' THR . 86.2 mtt180 -76.08 172.4 12.85 Favored 'General case' 0 C--N 1.359 1.018 0 CA-C-N 117.115 0.458 . . . . 74.12 110.142 164.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 232' ' ' LYS . . . . . 0.65 ' HD3' ' HB3' ' C' ' 250' ' ' TYR . 4.0 ttmp? -148.07 109.4 4.35 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.394 0.616 . . . . 71.45 110.164 175.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 233' ' ' LEU . . . . . 0.607 ' O ' ' HA ' ' C' ' 250' ' ' TYR . 0.5 OUTLIER -72.14 144.75 48.5 Favored 'General case' 0 C--O 1.209 -1.075 0 C-N-CA 125.781 1.632 . . . . 74.21 109.429 -178.02 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 234' ' ' ARG . . . . . 0.433 HH22 ' HB2' ' B' ' 37' ' ' ASP . 10.1 ptt180 -118.37 90.48 3.34 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 124.912 1.285 . . . . 72.34 110.108 173.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 235' ' ' LEU . . . . . 0.55 ' HB2' ' HB3' ' C' ' 249' ' ' LEU . 66.4 mt -77.79 116.41 18.29 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.509 0.723 . . . . 73.43 111.057 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -63.02 117.03 5.88 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.089 0.956 . . . . 71.55 112.65 -176.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 77.78 11.79 85.08 Favored Glycine 0 C--N 1.351 1.399 0 CA-C-N 115.223 -0.899 . . . . 71.42 114.688 175.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 238' ' ' LYS . . . . . 0.527 ' HA ' ' NZ ' ' C' ' 238' ' ' LYS . 0.1 OUTLIER -99.96 8.53 43.99 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.008 0.523 . . . . 72.03 111.053 178.447 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -86.44 -151.25 18.26 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 110.852 -0.899 . . . . 31.21 110.852 164.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 240' ' ' PHE . . . . . 0.55 ' CE2' HD21 ' C' ' 193' ' ' LEU . 48.3 m-85 -90.57 137.02 27.46 Favored Pre-proline 0 N--CA 1.476 0.856 0 CA-C-N 117.036 0.418 . . . . 75.14 110.65 175.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 241' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -57.39 120.98 9.25 Favored 'Trans proline' 0 C--N 1.383 2.382 0 C-N-CA 123.254 2.636 . . . . 70.21 111.353 175.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 242' ' ' GLY . . . . . 0.407 ' H ' ' HA ' ' C' ' 246' ' ' ARG . . . -100.28 157.77 19.48 Favored Glycine 0 C--N 1.348 1.246 0 CA-C-O 119.612 -0.549 . . . . 70.14 113.096 -173.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -65.62 -21.98 58.61 Favored 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 123.036 2.491 . . . . 71.42 113.61 -176.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -132.06 25.56 4.58 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.778 0.831 . . . . 71.42 110.57 178.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 164.25 -137.78 4.92 Favored Glycine 0 C--N 1.346 1.124 0 N-CA-C 111.549 -0.62 . . . . 51.32 111.549 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 246' ' ' ARG . . . . . 0.407 ' HA ' ' H ' ' C' ' 242' ' ' GLY . 0.0 OUTLIER -157.12 163.07 39.33 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.037 0.935 . . . . 61.31 109.664 173.546 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -86.87 170.53 41.84 Favored Glycine 0 C--O 1.242 0.613 0 CA-C-N 116.088 -0.506 . . . . 63.23 111.986 178.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -124.32 136.42 54.09 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 107.763 -1.199 . . . . 73.54 107.763 -178.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 249' ' ' LEU . . . . . 0.55 ' HB3' ' HB2' ' C' ' 235' ' ' LEU . 19.4 tp -81.57 117.86 22.3 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.18 0.592 . . . . 74.23 109.877 -176.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 250' ' ' TYR . . . . . 0.65 ' HB3' ' HD3' ' C' ' 232' ' ' LYS . 19.4 m-30 -99.68 101.76 13.05 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 122.799 0.439 . . . . 71.43 109.915 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 251' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' C' ' 232' ' ' LYS . 2.0 mp -101.44 124.4 47.05 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 119.375 -0.345 . . . . 64.53 110.303 -175.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -70.97 109.31 5.0 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.544 -0.91 . . . . 73.41 108.544 173.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 253' ' ' VAL . . . . . 0.424 HG21 ' CZ3' ' B' ' 242' ' ' TRP . 57.0 t -77.52 128.96 37.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 123.427 0.691 . . . . 73.5 111.655 -169.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 254' ' ' ARG . . . . . 0.46 HH11 ' HB3' ' B' ' 290' ' ' TRP . 20.9 mtm180 -108.64 147.26 32.13 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.125 0.97 . . . . 74.13 109.568 170.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 255' ' ' ILE . . . . . 0.471 HD11 HG22 ' C' ' 227' ' ' THR . 36.5 mm -107.05 125.56 63.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 C-N-CA 124.452 1.101 . . . . 75.24 108.065 171.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 256' ' ' THR . . . . . . . . . . . . . 60.2 p -122.94 -175.59 3.21 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.855 0.862 . . . . 53.32 111.69 -171.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 257' ' ' ILE . . . . . 0.544 ' HB ' ' HD2' ' C' ' 258' ' ' PRO . 44.9 pt -135.48 161.58 62.32 Favored Pre-proline 0 CA--C 1.571 1.756 0 C-N-CA 123.53 0.732 . . . . 64.54 111.233 -179.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 258' ' ' PRO . . . . . 0.544 ' HD2' ' HB ' ' C' ' 257' ' ' ILE . 61.3 Cg_endo -69.43 11.26 0.37 Allowed 'Trans proline' 0 C--N 1.395 3.021 0 C-N-CA 123.733 2.956 . . . . 73.21 116.696 -170.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 259' ' ' GLU . . . . . 0.572 ' O ' ' HD2' ' A' ' 226' ' ' ARG . 5.5 mm-40 60.85 -84.29 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.607 0.763 . . . . 72.3 109.775 -170.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 260' ' ' ARG . . . . . 0.49 ' HB3' ' HB1' ' B' ' 448' ' ' ALA . 0.1 OUTLIER -92.47 172.02 8.66 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.45 0.7 . . . . 73.41 110.771 175.333 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 261' ' ' LEU . . . . . 0.47 ' HB2' HH12 ' A' ' 226' ' ' ARG . 11.3 mt -149.47 163.33 38.08 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 121.604 0.716 . . . . 71.21 111.919 176.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 1.2 p -104.36 147.62 34.66 Favored Pre-proline 0 CA--C 1.562 1.404 0 CA-C-N 113.494 -1.685 . . . . 61.23 108.997 171.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -45.51 -48.8 11.37 Favored 'Trans proline' 0 C--N 1.39 2.758 0 C-N-CA 125.038 3.825 . . . . 74.2 115.868 -166.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -64.62 -51.2 63.91 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-O 121.303 0.573 . . . . 71.04 111.242 -173.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 11.4 mp0 -60.98 -45.53 94.4 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 114.502 -1.226 . . . . 65.11 109.44 -177.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 266' ' ' GLU . . . . . 0.433 ' HG2' ' HE3' ' C' ' 270' ' ' LYS . 42.4 tt0 -61.42 -37.44 83.5 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 114.934 -1.03 . . . . 64.21 111.076 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -63.71 -38.55 91.54 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.591 0.756 . . . . 70.32 111.52 177.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 268' ' ' LEU . . . . . . . . . . . . . 11.1 mp -62.23 -43.38 98.96 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 123.242 0.339 . . . . 52.44 110.72 172.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 92.9 m95 -58.34 -36.11 72.94 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 122.904 0.482 . . . . 61.11 111.104 174.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 270' ' ' LYS . . . . . 0.433 ' HE3' ' HG2' ' C' ' 266' ' ' GLU . 99.5 mttt -70.75 -39.35 73.32 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.543 0.737 . . . . 75.43 111.442 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.64 -38.35 89.11 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.954 0.502 . . . . 75.33 110.611 178.009 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 88.8 mt -73.49 -31.31 63.68 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.618 0.767 . . . . 74.33 110.891 176.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -66.24 -40.93 90.57 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.295 0.638 . . . . 34.13 110.021 175.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -69.3 -37.84 77.99 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.13 0.972 . . . . 63.21 110.97 178.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -62.85 -30.76 71.75 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.298 0.639 . . . . 70.04 110.43 172.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 276' ' ' TYR . . . . . 0.471 ' HB3' HD11 ' A' ' 203' ' ' ILE . 1.6 m-85 -75.25 -38.04 60.73 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.705 0.802 . . . . 75.52 111.492 173.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -69.56 -24.26 63.68 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 122.456 0.302 . . . . 44.24 110.254 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -63.45 -20.1 65.28 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.922 0.889 . . . . 55.2 112.176 173.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 279' ' ' ARG . . . . . 0.459 ' HD3' ' HA ' ' C' ' 276' ' ' TYR . 14.9 mtp-105 -75.22 -9.64 58.74 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.251 0.62 . . . . 71.52 111.8 176.098 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.151 0 CA-C-O 118.252 -0.88 . . . . 75.14 108.673 174.149 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.3 mtm . . . . . 0 C--O 1.234 0.282 0 N-CA-C 108.934 -0.765 . . . . 64.12 108.934 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.15 22.28 13.02 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 114.417 -1.265 . . . . 51.4 113.892 169.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -86.96 44.83 1.2 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.926 0.491 . . . . 74.04 110.485 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -37.81 97.12 0.01 OUTLIER 'General case' 0 C--N 1.364 1.229 0 C-N-CA 125.786 1.634 . . . . 62.43 113.357 -176.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.527 ' HB3' HD11 ' A' ' 10' ' ' ILE . 14.3 mmmm -63.4 110.86 2.07 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.29 -1.004 . . . . 74.32 108.29 170.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -73.39 93.64 1.97 Allowed 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 107.638 -1.245 . . . . 61.41 107.638 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.42 ' CD1' ' HA ' ' A' ' 53' ' ' ALA . 62.4 m-85 -63.82 -30.13 71.26 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 114.88 -1.055 . . . . 73.34 112.291 -168.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -66.4 -44.47 82.92 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 116.215 -0.448 . . . . 73.33 109.961 173.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.47 -37.58 87.85 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.943 0.497 . . . . 60.32 111.421 178.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.527 HD11 ' HB3' ' A' ' 5' ' ' LYS . 72.9 mt -64.13 -36.22 76.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 123.452 0.701 . . . . 74.23 110.462 176.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.0 mt -81.05 -10.36 59.7 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 112.331 0.493 . . . . 51.33 112.331 173.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.02 32.4 60.71 Favored Glycine 0 C--N 1.35 1.352 0 N-CA-C 113.888 0.315 . . . . 53.33 113.888 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.4 m -126.07 155.21 73.77 Favored Pre-proline 0 N--CA 1.482 1.148 0 C-N-CA 124.346 1.058 . . . . 71.43 110.377 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.2 158.98 55.16 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 122.491 2.128 . . . . 50.12 112.335 173.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 35.3 mtm180 -82.02 64.37 6.67 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.068 0.947 . . . . 75.43 110.347 -177.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -179.7 -14.81 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.257 1.423 . . . . 64.11 109.032 -175.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.52 131.15 29.1 Favored 'General case' 0 C--N 1.36 1.061 0 C-N-CA 123.604 0.762 . . . . 64.31 111.325 176.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 58.1 p -63.37 164.6 8.85 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 123.867 0.729 . . . . 71.11 111.148 -175.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 47.6 tp60 -61.32 -27.39 68.45 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.376 0.671 . . . . 64.21 111.538 -176.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -67.97 -46.29 71.78 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.47 -0.786 . . . . 72.43 109.771 175.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -67.24 -35.96 80.65 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.209 0.604 . . . . 64.03 111.012 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.449 HG21 ' HB3' ' A' ' 57' ' ' LEU . 70.9 mt -66.06 -47.13 86.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.361 1.064 . . . . 73.31 110.586 178.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 51.4 tttt -55.65 -48.43 75.02 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.597 1.159 . . . . 71.24 110.533 173.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 63.9 mtt180 -75.94 -15.97 60.08 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 115.805 -0.634 . . . . 54.12 111.763 -177.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -77.26 -40.13 45.8 Favored 'General case' 0 C--O 1.251 1.17 0 C-N-CA 123.356 0.663 . . . . 64.0 110.262 173.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.546 ' HD1' HG22 ' A' ' 50' ' ' ILE . 64.6 t80 -55.45 -56.79 16.09 Favored 'General case' 0 C--N 1.352 0.702 0 CA-C-N 114.83 -1.077 . . . . 73.1 108.984 169.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.425 ' O ' ' HG3' ' A' ' 31' ' ' ARG . 55.5 mtpt -60.7 -38.98 86.84 Favored 'General case' 0 N--CA 1.483 1.208 0 O-C-N 124.248 0.967 . . . . 74.22 111.701 -177.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 45.6 ttt180 -52.04 -60.23 3.44 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 125.122 1.369 . . . . 71.15 110.913 175.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 95.9 mt -79.22 -13.5 59.65 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 114.876 -1.056 . . . . 74.11 111.314 -178.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.89 -14.72 46.93 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.309 0.643 . . . . 63.3 110.934 175.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.425 ' HG3' ' O ' ' A' ' 27' ' ' LYS . 82.7 mtm180 -89.63 -39.55 13.16 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.248 0.619 . . . . 72.33 109.734 168.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -67.28 -59.73 3.18 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.272 0.558 . . . . 63.33 111.447 178.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.689 ' HD2' HD11 ' A' ' 50' ' ' ILE . 21.3 m-85 -91.0 25.83 2.31 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.958 0.903 . . . . 63.25 110.718 -178.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 40.1 t60 -62.61 108.57 1.73 Allowed Pre-proline 0 C--N 1.358 0.955 0 CA-C-O 118.439 -0.791 . . . . 63.41 110.215 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.466 ' HB3' ' HG2' ' A' ' 44' ' ' GLU . 16.5 Cg_endo -53.64 -40.17 80.41 Favored 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 123.281 2.654 . . . . 74.13 113.447 -167.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -60.65 -40.7 93.01 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.553 0.741 . . . . 72.45 112.551 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 64.8 t -89.8 -30.08 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 CA-C-O 121.184 0.516 . . . . 65.53 110.28 -175.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 53.6 t-20 -108.44 97.29 6.98 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 124.397 1.079 . . . . 61.35 108.845 -172.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -81.1 71.11 8.07 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.618 0.767 . . . . 73.11 109.795 -177.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 62.2 m -152.07 112.55 2.88 Favored Pre-proline 0 N--CA 1.476 0.86 0 C-N-CA 123.88 0.872 . . . . 54.41 109.156 178.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -51.31 -36.02 55.76 Favored 'Trans proline' 0 C--N 1.388 2.633 0 C-N-CA 123.347 2.698 . . . . 72.23 111.662 176.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -47.34 -51.15 20.3 Favored 'General case' 0 C--N 1.35 0.596 0 C-N-CA 124.993 1.317 . . . . 64.43 111.339 174.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.79 -20.05 61.23 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.004 -0.998 . . . . 72.14 111.307 -175.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.466 ' HG2' ' HB3' ' A' ' 35' ' ' PRO . 40.4 mt-10 -86.03 -33.34 21.05 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.594 0.758 . . . . 62.01 110.777 -177.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -70.62 -42.7 70.57 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.831 -0.803 . . . . 62.44 108.831 174.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.528 ' O ' HG13 ' A' ' 50' ' ' ILE . 13.2 mptt -65.55 -32.87 74.7 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 114.76 -1.109 . . . . 74.03 110.685 171.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.686 ' HA ' HD12 ' A' ' 50' ' ' ILE . 86.9 t80 -62.86 -40.3 97.06 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.402 0.681 . . . . 73.24 110.453 175.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.473 ' HB3' ' HE1' ' A' ' 93' ' ' PHE . 48.2 mtmt -69.11 -33.43 73.48 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.929 -0.578 . . . . 75.14 110.799 176.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -65.37 -30.79 71.66 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-N 117.734 0.243 . . . . 71.44 111.577 172.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.689 HD11 ' HD2' ' A' ' 33' ' ' TYR . 31.1 mt -65.18 -43.48 95.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 109.012 -0.736 . . . . 70.53 109.012 172.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.429 ' HB3' ' HD1' ' A' ' 88' ' ' PHE . 43.7 m-80 -69.11 -21.53 64.03 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 115.282 -0.872 . . . . 73.43 111.716 175.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -73.37 -51.79 16.11 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-O 122.244 1.021 . . . . 63.42 108.974 175.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.42 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . . . -57.24 -41.75 80.15 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 113.35 -1.75 . . . . 65.45 111.032 175.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.441 ' O ' ' HB2' ' A' ' 58' ' ' SER . 13.0 t80 -79.15 -22.93 44.38 Favored 'General case' 0 C--O 1.212 -0.887 0 CA-C-N 114.887 -1.051 . . . . 72.32 110.279 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.93 -26.54 65.13 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.815 -0.553 . . . . 53.01 110.789 173.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.57 HG22 ' HE1' ' A' ' 101' ' ' PHE . 20.6 t -95.68 -23.12 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 115.8 -0.636 . . . . 74.52 111.778 173.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.498 HD22 ' HG2' ' A' ' 63' ' ' ARG . 62.3 mt -123.72 26.07 7.86 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.575 -0.703 . . . . 62.04 112.292 -174.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.441 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 16.5 t -66.24 -48.24 71.17 Favored 'General case' 0 N--CA 1.502 2.16 0 CA-C-O 121.45 0.643 . . . . 74.34 111.801 176.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -110.28 154.32 42.94 Favored Pre-proline 0 N--CA 1.475 0.798 0 CA-C-N 114.697 -1.138 . . . . 74.34 109.109 -176.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.12 -28.26 83.07 Favored 'Trans proline' 0 C--N 1.382 2.333 0 C-N-CA 122.637 2.225 . . . . 72.41 111.818 173.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -70.68 -53.73 14.59 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.269 1.028 . . . . 72.3 111.534 -179.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -58.48 -40.15 81.93 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 121.692 0.758 . . . . 74.54 110.475 175.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.498 ' HG2' HD22 ' A' ' 57' ' ' LEU . 4.5 tmt_? -58.39 -42.19 86.55 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 113.92 -1.491 . . . . 74.11 109.762 178.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -72.19 -27.28 62.46 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 118.601 -0.714 . . . . 74.25 112.721 175.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 78.9 mt -62.66 -45.97 97.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 CA-C-N 118.754 0.706 . . . . 64.42 109.456 174.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -64.87 -45.39 86.22 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 115.688 -0.687 . . . . 75.4 110.503 176.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -54.61 -42.8 71.58 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 122.892 0.477 . . . . 64.04 111.194 176.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 80.8 p -82.28 -12.68 57.88 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 118.889 -0.577 . . . . 75.13 111.58 -178.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -65.72 120.46 13.03 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 108.305 -0.998 . . . . 63.45 108.305 172.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 109.14 8.3 27.58 Favored Glycine 0 C--N 1.344 1.021 0 CA-C-N 115.948 -0.569 . . . . 52.54 111.929 -164.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 85.9 m -147.27 -57.94 0.26 Allowed 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 103.862 -2.644 . . . . 71.23 103.862 176.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 27.1 m -71.37 123.83 23.2 Favored 'General case' 0 C--O 1.246 0.874 0 N-CA-C 103.402 -2.814 . . . . 74.23 103.402 154.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.32 -35.0 6.19 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 117.934 0.334 . . . . 74.04 110.628 -178.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.35 138.91 74.88 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 123.232 0.613 . . . . 75.1 109.832 173.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -57.0 149.9 59.27 Favored 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 122.769 2.312 . . . . 75.41 110.994 171.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.46 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 22.7 Cg_endo -57.3 136.18 74.7 Favored 'Trans proline' 0 CA--C 1.564 1.984 0 C-N-CA 122.695 2.263 . . . . 74.25 112.249 -176.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 76' ' ' PRO . 50.0 Cg_exo -55.43 123.24 13.32 Favored 'Trans proline' 0 C--N 1.386 2.538 0 C-N-CA 123.668 2.912 . . . . 62.44 113.916 -173.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -67.39 120.15 7.19 Favored 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 122.766 2.311 . . . . 43.51 112.842 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.534 ' HG3' HG21 ' B' ' 18' ' ' VAL . 84.7 Cg_endo -78.97 167.12 22.46 Favored 'Trans proline' 0 C--N 1.378 2.108 0 C-N-CA 122.826 2.351 . . . . 71.05 111.621 173.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.24 82.89 0.05 OUTLIER 'Trans proline' 0 C--N 1.388 2.605 0 C-N-CA 123.415 2.743 . . . . 51.35 112.131 175.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 147.37 -44.8 0.79 Allowed Glycine 0 C--N 1.337 0.637 0 CA-C-N 114.74 -1.118 . . . . 62.41 110.331 -176.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 104.39 -160.52 15.73 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 116.478 0.139 . . . . 53.03 113.134 -176.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -106.77 128.68 54.44 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.993 0.917 . . . . 74.41 111.486 -175.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.412 ' HA ' ' HD2' ' A' ' 106' ' ' PHE . 13.2 t70 -70.14 144.58 51.98 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.017 1.327 . . . . 71.31 112.811 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.594 ' HB3' ' HB2' ' A' ' 88' ' ' PHE . 54.0 m-85 -136.54 72.18 1.43 Allowed 'General case' 0 C--N 1.358 0.977 0 CA-C-O 121.998 0.904 . . . . 70.22 111.453 -178.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.438 ' O ' HG21 ' B' ' 23' ' ' THR . 51.3 m -52.93 105.59 0.13 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 113.398 -1.728 . . . . 74.44 113.314 177.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.667 ' H ' ' HA3' ' A' ' 163' ' ' GLY . . . 67.9 2.3 23.02 Favored Glycine 0 C--N 1.343 0.938 0 C-N-CA 123.187 0.423 . . . . 70.11 113.976 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.594 ' HB2' ' HB3' ' A' ' 85' ' ' PHE . 19.0 m-85 -95.78 121.77 37.86 Favored 'General case' 0 C--N 1.349 0.569 0 N-CA-C 108.948 -0.76 . . . . 72.34 108.948 -174.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -82.85 60.06 5.16 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 122.119 0.962 . . . . 71.44 109.899 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.499 ' HA ' ' CD2' ' A' ' 93' ' ' PHE . 1.3 p -47.97 -38.69 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 126.532 1.933 . . . . 75.21 113.531 -179.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -55.61 -31.66 62.45 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 124.048 0.939 . . . . 75.33 112.236 -178.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -108.7 0.64 20.66 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.39 0.676 . . . . 45.35 112.111 -176.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.499 ' CD2' ' HA ' ' A' ' 90' ' ' VAL . 20.9 m-30 -72.05 178.97 3.48 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.907 -0.495 . . . . 71.01 110.697 177.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 77.5 p -58.94 155.72 12.84 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.637 0.775 . . . . 74.5 113.007 -173.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.464 ' O ' ' HG3' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -58.85 -41.67 87.52 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.165 -0.925 . . . . 74.31 110.631 173.381 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -57.92 -44.18 86.68 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.79 0.436 . . . . 75.03 111.286 175.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.43 ' HE2' HG23 ' A' ' 90' ' ' VAL . 47.2 t80 -59.92 -44.39 94.34 Favored 'General case' 0 C--O 1.244 0.805 0 CA-C-O 121.424 0.631 . . . . 63.23 109.814 177.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -75.44 -2.6 29.45 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 114.314 -1.312 . . . . 73.05 111.753 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.464 ' HG3' ' O ' ' A' ' 95' ' ' GLU . 48.8 mt-10 -93.88 -47.61 6.66 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 123.011 0.525 . . . . 70.02 110.949 163.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 48.8 tp -63.45 -32.16 73.52 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.54 1.136 . . . . 55.03 111.679 -171.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.57 ' HE1' HG22 ' A' ' 56' ' ' VAL . 93.7 m-85 -120.13 9.24 11.08 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.979 0.512 . . . . 72.11 110.477 173.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.41 ' HA2' ' HG ' ' A' ' 105' ' ' LEU . . . -48.47 -62.2 4.56 Favored Glycine 0 C--N 1.352 1.458 0 C-N-CA 124.702 1.144 . . . . 72.43 115.894 -172.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -56.63 -17.34 22.14 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 123.366 2.711 . . . . 23.1 113.474 178.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -129.57 43.22 1.33 Allowed Glycine 0 C--N 1.35 1.329 0 CA-C-O 119.679 -0.512 . . . . 44.4 112.287 178.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.496 HD22 HG21 ' A' ' 90' ' ' VAL . 33.7 mt -78.95 56.98 2.06 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 117.855 0.827 . . . . 74.25 111.065 170.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.686 ' HD1' ' H ' ' A' ' 108' ' ' GLY . 0.2 OUTLIER 35.05 -108.55 0.04 OUTLIER 'General case' 0 CA--C 1.568 1.651 0 C-N-CA 126.29 1.836 . . . . 72.25 112.565 178.215 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 72.06 12.2 75.34 Favored Glycine 0 C--N 1.357 1.701 0 CA-C-N 118.485 0.584 . . . . 44.0 112.722 -173.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.686 ' H ' ' HD1' ' A' ' 106' ' ' PHE . . . 64.38 -112.65 5.18 Favored Glycine 0 C--N 1.342 0.865 0 C-N-CA 124.058 0.837 . . . . 71.34 113.446 -178.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -114.33 -5.32 12.94 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.912 0.885 . . . . 64.11 109.636 173.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -80.84 -29.32 42.98 Favored Glycine 0 C--N 1.357 1.71 0 N-CA-C 111.547 -0.621 . . . . 55.25 111.547 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.8 tpp180 63.39 2.18 1.12 Allowed 'General case' 0 CA--C 1.566 1.566 0 C-N-CA 125.39 1.476 . . . . 71.44 113.503 171.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 75.2 ttt180 -65.78 -23.89 66.81 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.16 0.984 . . . . 73.25 111.463 171.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.403 ' HA ' ' HB2' ' A' ' 169' ' ' ASN . 69.5 m 74.02 46.97 0.16 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.777 1.231 . . . . 74.21 111.227 -178.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -111.09 160.53 16.8 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 115.089 -0.96 . . . . 74.52 109.265 174.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.451 ' HG3' ' O ' ' A' ' 170' ' ' PRO . 87.1 tttt -57.57 148.69 23.32 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 125.047 1.339 . . . . 72.15 112.789 -175.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -81.31 171.94 53.55 Favored Glycine 0 C--N 1.345 1.05 0 CA-C-N 115.438 -0.801 . . . . 55.22 113.371 174.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.8 tmm_? -87.19 140.43 29.55 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 108.568 -0.901 . . . . 71.34 108.568 176.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -53.68 116.9 2.74 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.949 0.9 . . . . 74.23 111.383 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.0 tt -109.86 140.99 43.18 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 121.833 -0.542 . . . . 70.23 109.953 -167.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 29.6 ttt-85 -99.01 107.52 19.97 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.992 0.917 . . . . 74.51 108.755 -178.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.441 ' HB2' HD11 ' A' ' 174' ' ' LEU . . . -111.14 165.14 12.15 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.275 0.63 . . . . 41.51 109.425 178.065 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.455 ' O ' ' HD3' ' A' ' 124' ' ' PRO . 19.4 mm-40 -123.78 111.41 16.1 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 107.49 -1.3 . . . . 61.0 107.49 -174.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.406 ' O ' ' HA ' ' A' ' 178' ' ' VAL . 60.0 tp -99.71 96.66 4.85 Favored Pre-proline 0 N--CA 1.487 1.398 0 CA-C-N 118.869 0.759 . . . . 54.05 109.55 -172.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.46 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 39.3 Cg_endo -74.92 112.19 3.5 Favored 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 121.189 1.259 . . . . 75.33 110.067 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.616 ' HA ' HG21 ' B' ' 6' ' ' ILE . 38.2 tp -117.26 141.71 47.96 Favored 'General case' 0 C--N 1.338 0.08 0 C-N-CA 123.856 0.863 . . . . 64.01 110.113 -169.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.415 ' HB ' ' HG2' ' A' ' 129' ' ' GLU . 27.0 m -74.78 130.17 38.98 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.177 0.991 . . . . 71.34 110.199 178.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.4 HD23 HD22 ' A' ' 180' ' ' LEU . 64.9 mt -53.84 -52.87 58.99 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.225 1.01 . . . . 70.54 111.852 -177.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.448 ' HA ' ' HB3' ' A' ' 215' ' ' LEU . 5.7 mp0 -58.83 -38.17 78.06 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.938 0.895 . . . . 75.32 110.377 -176.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.415 ' HG2' ' HB ' ' A' ' 126' ' ' THR . 16.0 mm-40 -74.95 -28.4 60.56 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 114.925 -1.034 . . . . 64.33 110.837 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -68.79 -35.64 77.29 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.969 0.508 . . . . 41.43 111.182 176.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.431 ' HB2' HD12 ' A' ' 215' ' ' LEU . 77.6 t80 -67.19 -49.56 64.18 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 123.481 0.488 . . . . 74.51 110.815 173.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 34.6 m170 -70.35 -36.49 74.23 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 123.526 0.516 . . . . 75.25 111.789 -175.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.437 ' HA3' ' HG3' ' A' ' 151' ' ' PRO . . . 72.7 -171.37 50.13 Favored Glycine 0 CA--C 1.528 0.889 0 O-C-N 123.451 0.469 . . . . 71.54 113.574 -176.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.15 172.95 25.25 Favored Glycine 0 N--CA 1.476 1.347 0 C-N-CA 122.704 0.193 . . . . 70.42 112.788 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.769 ' HG2' HH21 ' B' ' 22' ' ' ARG . 1.8 mp0 -71.68 108.82 5.21 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.362 0.665 . . . . 73.14 111.112 -174.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.415 ' CZ ' ' HB3' ' A' ' 129' ' ' GLU . 6.5 tpp180 -92.84 122.11 34.89 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 108.628 -0.878 . . . . 74.4 108.628 -177.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 94.6 t -78.39 96.71 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 109.237 -0.653 . . . . 71.24 109.237 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.579 ' HB ' HG13 ' B' ' 6' ' ' ILE . 0.2 OUTLIER -112.27 118.37 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 108.294 -1.002 . . . . 73.14 108.294 176.388 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 144' ' ' ARG . 30.5 mt-10 -101.29 133.99 45.04 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.092 0.557 . . . . 71.3 111.152 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.585 HG11 HD23 ' B' ' 8' ' ' LEU . 15.0 p -170.64 139.08 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.039 0 O-C-N 123.628 0.58 . . . . 75.1 111.613 -178.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.644 ' HA ' ' HA ' ' B' ' 15' ' ' PHE . . . 55.43 26.28 8.67 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 115.696 1.739 . . . . 74.24 115.696 163.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 98.22 10.15 52.08 Favored Glycine 0 N--CA 1.476 1.301 0 C-N-CA 121.694 -0.289 . . . . 31.1 113.02 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.425 ' HA ' ' HA ' ' B' ' 20' ' ' LYS . 34.0 ttm105 -144.07 106.58 4.42 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 123.343 0.657 . . . . 72.12 110.958 -171.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.507 ' H ' ' HA ' ' B' ' 20' ' ' LYS . 32.4 ttm180 -78.48 93.57 4.79 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 107.173 -1.418 . . . . 74.41 107.173 162.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.452 ' O ' HG13 ' A' ' 138' ' ' VAL . 1.5 p -84.83 107.82 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 108.306 -0.998 . . . . 73.53 108.306 175.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.42 ' HB3' ' HG2' ' B' ' 22' ' ' ARG . 26.9 t -84.53 83.03 8.15 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 107.586 -1.265 . . . . 31.45 107.586 172.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.6 p -87.86 109.65 19.87 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 CA-C-O 121.422 0.629 . . . . 73.42 110.343 -173.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.422 ' HB2' ' HG3' ' A' ' 135' ' ' GLU . 20.3 ttm180 -57.47 93.42 0.01 OUTLIER 'General case' 0 C--O 1.24 0.565 0 CA-C-N 115.232 -0.895 . . . . 74.14 108.924 166.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.623 ' HB ' HG11 ' A' ' 153' ' ' VAL . 28.8 pt -72.88 118.64 70.01 Favored Pre-proline 0 CA--C 1.547 0.85 0 CA-C-N 114.068 -1.424 . . . . 74.13 108.192 173.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.556 ' HB3' ' HG3' ' B' ' 314' ' ' ARG . 31.8 Cg_exo -63.52 128.69 23.02 Favored 'Trans proline' 0 C--N 1.368 1.578 0 C-N-CA 122.248 1.965 . . . . 60.34 110.723 177.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.741 ' HB2' ' HB2' ' B' ' 315' ' ' ASN . 52.1 Cg_exo -53.36 100.37 0.06 OUTLIER 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 122.579 2.186 . . . . 74.15 111.272 177.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.444 ' HA2' ' CD2' ' A' ' 240' ' ' PHE . . . 116.75 36.44 1.06 Allowed Glycine 0 C--N 1.342 0.914 0 CA-C-N 115.532 -0.758 . . . . 75.51 112.647 -173.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.623 HG11 ' HB ' ' A' ' 149' ' ' ILE . 2.1 p -91.66 132.8 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 123.843 0.857 . . . . 75.43 108.737 176.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.401 ' HB3' ' HA ' ' A' ' 189' ' ' GLU . 0.1 OUTLIER -101.97 168.1 9.62 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.983 0.913 . . . . 73.23 113.047 -161.09 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.579 ' HB3' ' O ' ' A' ' 188' ' ' LEU . 9.0 tp10 -68.37 127.1 31.75 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 108.747 -0.835 . . . . 72.32 108.747 167.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 73.07 14.59 78.81 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-N 115.378 -0.828 . . . . 14.21 113.362 -174.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 46.5 t -66.34 109.76 2.82 Favored 'General case' 0 C--N 1.359 0.999 0 N-CA-C 107.721 -1.214 . . . . 74.23 107.721 171.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.524 HG21 ' H ' ' B' ' 34' ' ' ALA . 58.6 t -84.86 87.13 2.37 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 N-CA-C 108.59 -0.893 . . . . 72.34 108.59 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.66 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 54.6 mt -74.01 91.89 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.642 0 N-CA-C 107.763 -1.199 . . . . 75.24 107.763 174.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.444 ' HB2' ' HB2' ' B' ' 31' ' ' ASN . 70.1 ttt180 -74.87 105.25 5.82 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 115.566 -0.743 . . . . 61.32 109.528 179.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 4.3 p -115.05 110.36 45.97 Favored Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 123.68 0.792 . . . . 61.33 108.94 173.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.467 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 46.5 Cg_endo -66.61 153.8 76.69 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 122.698 2.265 . . . . 74.53 111.684 177.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.667 ' HA3' ' H ' ' A' ' 87' ' ' GLY . . . 76.93 15.9 81.25 Favored Glycine 0 C--N 1.34 0.756 0 CA-C-N 115.827 -0.624 . . . . 70.43 113.892 178.241 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 49.2 mtt -125.46 -3.13 7.37 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 117.954 0.877 . . . . 64.15 111.465 177.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.488 ' HA2' HD13 ' A' ' 174' ' ' LEU . . . -85.15 -124.12 1.29 Allowed Glycine 0 C--N 1.343 0.956 0 N-CA-C 113.739 0.256 . . . . 73.33 113.739 -168.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -65.13 164.54 36.36 Favored Glycine 0 C--N 1.348 1.225 0 O-C-N 123.97 0.453 . . . . 74.5 113.422 -176.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.417 ' HB3' ' CA ' ' A' ' 108' ' ' GLY . 29.3 mm-40 -65.47 105.65 1.23 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.47 1.108 . . . . 75.42 111.581 -171.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -169.96 167.21 40.34 Favored Glycine 0 C--N 1.354 1.563 0 CA-C-O 118.96 -0.911 . . . . 64.21 112.124 -178.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . 0.639 ' HA ' ' HB3' ' A' ' 106' ' ' PHE . 48.3 t30 -63.74 -59.04 12.57 Favored Pre-proline 0 N--CA 1.493 1.694 0 CA-C-N 118.077 0.938 . . . . 63.11 110.752 -173.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.556 ' HD3' ' HB3' ' A' ' 169' ' ' ASN . 27.1 Cg_endo -94.64 95.13 0.11 Allowed 'Trans proline' 0 C--N 1.381 2.247 0 N-CA-C 106.181 -2.276 . . . . 71.13 106.181 156.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_exo -51.9 175.73 0.06 OUTLIER 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 123.391 2.727 . . . . 71.25 115.205 -170.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -62.72 -178.6 4.01 Favored Glycine 0 N--CA 1.474 1.229 0 CA-C-O 121.844 0.691 . . . . 72.4 114.499 -176.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.467 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 3.5 m-20 -79.9 104.76 10.7 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.441 -0.948 . . . . 71.14 108.441 171.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.488 HD13 ' HA2' ' A' ' 165' ' ' GLY . 18.2 tp -78.95 124.64 28.44 Favored 'General case' 0 C--N 1.346 0.421 0 N-CA-C 109.29 -0.633 . . . . 64.32 109.29 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.45 ' HB3' HG13 ' A' ' 158' ' ' VAL . 42.8 mt -101.28 88.88 3.59 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 106.661 -1.607 . . . . 72.12 106.661 -177.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.66 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 91.2 mt -72.66 83.18 1.15 Allowed 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 109.357 -0.608 . . . . 70.05 109.357 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.442 HG22 HG22 ' A' ' 158' ' ' VAL . 23.3 t -84.36 98.89 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 107.97 -1.122 . . . . 61.43 107.97 -176.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 98.6 t -56.58 140.46 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 N-CA-C 113.046 0.758 . . . . 70.33 113.046 -172.318 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.46 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 62.5 mmt-85 -114.52 89.92 3.21 Favored 'General case' 0 C--N 1.343 0.296 0 N-CA-C 107.463 -1.31 . . . . 53.32 107.463 163.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.4 HD22 HD23 ' A' ' 127' ' ' LEU . 10.7 mt -66.63 125.01 24.43 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 107.675 -1.232 . . . . 72.4 107.675 178.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 44.4 mt -51.85 152.9 4.82 Favored Pre-proline 0 N--CA 1.485 1.279 0 O-C-N 124.639 1.212 . . . . 73.14 113.628 -162.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -72.36 23.41 0.27 Allowed 'Trans proline' 0 C--N 1.382 2.321 0 C-N-CA 123.311 2.674 . . . . 71.42 113.366 178.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.467 ' HA ' ' HD3' ' A' ' 184' ' ' PRO . 59.7 t-80 -59.84 105.49 0.57 Allowed Pre-proline 0 CA--C 1.556 1.179 0 N-CA-C 106.399 -1.704 . . . . 73.35 106.399 164.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 183' ' ' HIS . 13.7 Cg_exo -69.2 25.31 0.16 Allowed 'Trans proline' 0 C--N 1.375 1.921 0 C-N-CA 124.049 3.166 . . . . 61.24 117.534 -161.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 87.5 t -97.02 -58.92 3.49 Favored 'Isoleucine or valine' 0 C--N 1.35 0.623 0 CA-C-N 119.524 1.056 . . . . 64.21 110.422 -175.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -121.51 121.4 37.41 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 118.373 0.533 . . . . 72.31 112.22 -174.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.57 92.15 4.99 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 107.215 -1.402 . . . . 75.51 107.215 165.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.579 ' O ' ' HB3' ' A' ' 155' ' ' GLU . 53.7 tp -87.91 139.97 29.97 Favored 'General case' 0 C--O 1.207 -1.157 0 C-N-CA 123.769 0.828 . . . . 74.21 109.855 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.418 ' HG2' ' HA ' ' B' ' 307' ' ' THR . 40.0 tt0 -162.22 125.47 3.0 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 118.482 0.583 . . . . 70.31 110.003 177.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 73.59 -65.37 1.74 Allowed Glycine 0 C--N 1.356 1.691 0 O-C-N 123.586 0.554 . . . . 65.41 112.223 -173.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.556 ' NE2' ' HB2' ' B' ' 304' ' ' PRO . 4.3 pm0 -164.45 -19.42 0.03 OUTLIER 'General case' 0 C--O 1.249 1.037 0 C-N-CA 125.694 1.598 . . . . 72.32 109.104 177.073 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.422 ' H ' ' H ' ' A' ' 191' ' ' GLN . 2.0 p30 -94.65 134.81 36.83 Favored 'General case' 0 C--N 1.358 0.968 0 C-N-CA 123.908 0.883 . . . . 72.32 112.005 -169.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.555 ' HB2' ' HA ' ' A' ' 249' ' ' LEU . 66.8 mt -95.91 150.12 20.79 Favored 'General case' 0 C--O 1.22 -0.463 0 C-N-CA 125.788 1.635 . . . . 63.44 110.368 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -133.74 105.27 6.72 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 106.944 -1.502 . . . . 73.14 106.944 169.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.502 ' HB3' HD23 ' A' ' 251' ' ' LEU . . . -118.6 119.33 34.16 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.658 1.183 . . . . 74.34 109.906 -172.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 31.8 m -69.83 129.41 39.47 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 123.358 0.411 . . . . 70.21 109.912 -175.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 54.6 tp -128.79 99.99 5.53 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 109.001 -0.74 . . . . 72.21 109.001 -170.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -80.21 121.43 25.6 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.955 -0.757 . . . . 61.43 108.955 176.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 6.3 p -138.68 135.58 18.02 Favored Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 124.714 1.206 . . . . 64.4 108.374 -175.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -74.12 152.73 45.86 Favored 'Trans proline' 0 C--N 1.368 1.553 0 C-N-CA 121.923 1.748 . . . . 64.51 111.081 173.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -53.35 -50.57 82.0 Favored Pre-proline 0 CA--C 1.553 1.07 0 N-CA-C 113.93 1.085 . . . . 71.34 113.93 -173.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -55.52 -46.25 33.58 Favored 'Trans proline' 0 C--N 1.38 2.19 0 C-N-CA 121.902 1.735 . . . . 63.54 113.581 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 19.6 mt -70.32 -32.32 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 CA-C-N 116.141 -0.481 . . . . 64.32 110.927 -176.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.89 -42.4 85.58 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.004 0.522 . . . . 71.51 111.301 175.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.419 ' CG1' HD11 ' C' ' 261' ' ' LEU . 53.9 t -73.17 -40.85 58.43 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.037 0 C-N-CA 124.082 0.953 . . . . 63.23 112.577 -174.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 65.0 t -95.58 -34.77 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 122.614 0.366 . . . . 74.41 111.694 -175.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 93.42 108.84 1.94 Allowed Glycine 0 C--N 1.335 0.508 0 CA-C-N 116.354 -0.384 . . . . 72.35 112.166 -178.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -141.45 -161.94 8.93 Favored Glycine 0 N--CA 1.469 0.841 0 N-CA-C 110.741 -0.943 . . . . 55.24 110.741 177.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 44.5 mtmt -100.43 124.11 45.52 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 118.426 1.113 . . . . 45.21 110.814 176.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 31.4 m -108.89 166.07 4.75 Favored 'Isoleucine or valine' 0 C--O 1.247 0.924 0 C-N-CA 125.014 1.326 . . . . 63.11 108.973 170.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . 0.656 ' HG2' HG21 ' B' ' 421' ' ' VAL . 0.0 OUTLIER -95.16 117.41 30.18 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.022 -0.733 . . . . 71.41 109.022 174.501 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -119.71 130.97 55.27 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 107.481 -1.303 . . . . 62.04 107.481 172.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . 0.546 ' HA ' ' HA ' ' A' ' 218' ' ' PRO . 0.8 OUTLIER -80.27 148.62 30.69 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 122.46 0.304 . . . . 71.23 110.505 -176.497 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 71.5 p -117.67 -177.81 3.33 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 108.808 -0.812 . . . . 74.1 108.808 168.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.448 ' HB3' ' HA ' ' A' ' 128' ' ' GLU . 86.0 mt -76.89 -1.98 31.23 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.642 -0.708 . . . . 63.31 112.098 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -126.89 -2.17 6.56 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.145 0.578 . . . . 64.44 111.805 177.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 149.17 167.31 13.82 Favored Glycine 0 N--CA 1.481 1.635 0 N-CA-C 114.626 0.61 . . . . 33.0 114.626 173.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . 0.546 ' HA ' ' HA ' ' A' ' 213' ' ' MET . 2.7 Cg_exo -76.19 116.59 4.4 Favored 'Trans proline' 0 C--N 1.374 1.888 0 C-N-CA 123.662 2.908 . . . . 70.23 111.968 -177.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.655 HG12 HG22 ' B' ' 435' ' ' THR . 34.7 m -106.42 162.29 5.32 Favored 'Isoleucine or valine' 0 C--O 1.254 1.317 0 C-N-CA 123.98 0.912 . . . . 73.4 112.03 -172.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.651 ' HA ' HH21 ' A' ' 211' ' ' ARG . 29.4 mt-10 -86.49 103.12 14.72 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 114.213 -1.358 . . . . 75.04 109.889 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.479 HG13 HD11 ' B' ' 441' ' ' ILE . 39.7 t -106.93 116.9 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.172 0.589 . . . . 74.13 109.48 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.451 ' O ' HG13 ' B' ' 441' ' ' ILE . . . -77.88 99.36 5.95 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 109.255 -0.646 . . . . 60.25 109.255 174.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 14.3 p -64.9 134.0 95.93 Favored Pre-proline 0 CA--C 1.559 1.326 0 N-CA-C 109.491 -0.559 . . . . 63.14 109.491 177.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -61.44 168.71 7.64 Favored 'Trans proline' 0 C--N 1.38 2.227 0 C-N-CA 122.735 2.29 . . . . 75.51 112.654 176.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.77 150.96 31.34 Favored 'Trans proline' 0 C--N 1.374 1.904 0 C-N-CA 121.624 1.549 . . . . 72.53 112.474 172.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 45.3 mtt-85 66.29 27.34 10.17 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 125.692 1.597 . . . . 74.04 110.963 169.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.651 HG23 HD21 ' A' ' 233' ' ' LEU . 80.6 m -63.59 104.87 0.7 Allowed 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 113.06 -1.882 . . . . 64.32 110.843 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -85.14 139.83 31.4 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 123.945 0.898 . . . . 75.32 110.647 -176.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -62.24 157.4 19.59 Favored 'General case' 0 C--N 1.356 0.863 0 C-N-CA 124.152 0.981 . . . . 62.31 111.082 177.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 81.1 -38.74 2.41 Favored Glycine 0 C--N 1.346 1.088 0 CA-C-N 116.637 -0.256 . . . . 73.32 112.606 177.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -69.07 166.94 17.06 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 123.686 0.794 . . . . 74.0 110.26 173.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.705 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 2.7 mptp? -124.85 131.87 53.39 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 115.13 -0.941 . . . . 72.22 108.772 -178.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.651 HD21 HG23 ' A' ' 227' ' ' THR . 59.4 mt -76.62 97.54 4.44 Favored 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 107.903 -1.147 . . . . 71.4 107.903 176.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . 0.419 ' HG3' ' HB3' ' A' ' 248' ' ' ASP . 40.7 ttp180 -78.73 103.52 8.73 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 123.599 0.562 . . . . 64.14 109.737 -176.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.46 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 10.7 mt -100.04 89.33 4.0 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.217 -1.031 . . . . 61.12 108.217 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -71.0 139.08 50.42 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.751 0.42 . . . . 64.43 110.977 -173.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 79.32 2.6 87.76 Favored Glycine 0 CA--C 1.536 1.346 0 O-C-N 123.533 0.521 . . . . 74.2 113.271 -174.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.493 ' HE3' ' HA ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -105.83 -16.45 14.66 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 117.47 0.635 . . . . 73.01 111.73 -179.395 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -72.32 -163.29 6.63 Favored Glycine 0 CA--C 1.534 1.238 0 O-C-N 123.412 0.445 . . . . 74.43 112.87 173.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . 0.444 ' CD2' ' HA2' ' A' ' 152' ' ' GLY . 58.6 m-85 -95.01 166.26 15.29 Favored Pre-proline 0 N--CA 1.485 1.284 0 CA-C-O 118.282 -0.866 . . . . 73.13 109.869 -177.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.466 ' HD3' HD21 ' B' ' 315' ' ' ASN . 10.2 Cg_endo -49.69 146.26 15.86 Favored 'Trans proline' 0 C--N 1.392 2.868 0 C-N-CA 123.399 2.733 . . . . 73.33 113.943 -177.062 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.428 ' HA3' ' HB3' ' A' ' 191' ' ' GLN . . . -168.65 -158.68 12.91 Favored Glycine 0 C--N 1.338 0.657 0 CA-C-N 114.928 -1.033 . . . . 73.52 112.002 -178.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -78.46 -5.52 14.95 Favored 'Trans proline' 0 C--N 1.369 1.626 0 C-N-CA 123.284 2.656 . . . . 70.45 112.749 -173.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -113.51 22.0 14.57 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.003 0.921 . . . . 70.11 110.309 177.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 90.84 -75.28 1.63 Allowed Glycine 0 C--N 1.345 1.031 0 N-CA-C 109.996 -1.241 . . . . 62.24 109.996 -174.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 73.9 mtp180 -119.94 175.29 5.98 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.994 0.918 . . . . 75.41 109.279 168.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -105.58 -161.03 23.14 Favored Glycine 0 C--N 1.341 0.85 0 CA-C-N 115.988 -0.551 . . . . 42.24 114.306 -177.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . 0.419 ' HB3' ' HG3' ' A' ' 234' ' ' ARG . 19.3 m-20 -110.7 134.75 52.18 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 124.032 0.933 . . . . 75.44 108.813 -174.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.555 ' HA ' ' HB2' ' A' ' 193' ' ' LEU . 12.3 tp -98.95 95.51 7.21 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.0 -1.111 . . . . 70.31 108.0 176.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.705 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 84.4 m-85 -82.27 108.28 15.6 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 109.523 -0.547 . . . . 52.51 109.523 178.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.512 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 86.7 mt -86.8 105.7 17.19 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 109.298 -0.63 . . . . 72.24 109.298 172.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -76.54 106.99 8.5 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.358 0.663 . . . . 75.41 109.504 -174.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.454 HG11 HG22 ' A' ' 227' ' ' THR . 23.9 t -69.27 127.93 31.91 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 124.252 1.021 . . . . 24.43 112.089 -170.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -127.5 93.93 3.85 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 107.365 -1.346 . . . . 73.14 107.365 178.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.409 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 69.6 mt -83.25 136.11 23.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 C-N-CA 122.641 0.377 . . . . 74.34 110.762 -177.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 22.5 p -124.93 169.57 11.95 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.594 1.157 . . . . 73.43 109.497 172.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.554 HD12 ' H ' ' A' ' 259' ' ' GLU . 2.3 pp -109.58 141.18 23.07 Favored Pre-proline 0 N--CA 1.484 1.25 0 C-N-CA 122.928 0.491 . . . . 73.4 109.92 178.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . 0.539 ' HB3' ' HE1' ' C' ' 276' ' ' TYR . 12.7 Cg_endo -52.53 -20.95 13.03 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 124.598 3.532 . . . . 74.45 115.615 -170.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.554 ' H ' HD12 ' A' ' 257' ' ' ILE . 23.2 mt-10 50.85 -78.93 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.561 1.144 . . . . 63.24 110.576 -160.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' ARG . . . . . 0.415 ' HG3' ' HG3' ' B' ' 381' ' ' GLU . 0.0 OUTLIER -48.59 129.34 16.26 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.271 1.029 . . . . 75.12 111.713 176.973 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.43 HD22 ' HB3' ' A' ' 265' ' ' GLU . 89.1 mt -154.99 144.85 21.6 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.555 1.142 . . . . 55.32 109.096 -179.073 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 64.2 p -93.86 156.72 39.06 Favored Pre-proline 0 CA--C 1.555 1.151 0 CA-C-O 118.06 -0.971 . . . . 44.34 109.101 171.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' PRO . . . . . 0.477 ' HG2' HD12 ' B' ' 375' ' ' LEU . 11.3 Cg_exo -34.98 -48.07 0.69 Allowed 'Trans proline' 0 C--N 1.388 2.639 0 C-N-CA 124.843 3.695 . . . . 74.33 116.532 -177.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -68.46 -49.47 59.6 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.05 0.54 . . . . 71.44 111.406 -178.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . 0.43 ' HB3' HD22 ' A' ' 261' ' ' LEU . 49.9 mt-10 -56.95 -43.77 81.91 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.077 0.551 . . . . 64.2 110.344 178.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -57.12 -45.81 83.18 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 114.483 -1.235 . . . . 73.45 110.513 177.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -60.93 -41.67 96.65 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.162 -0.926 . . . . 64.12 111.685 178.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . 0.406 ' HG ' ' HG ' ' C' ' 268' ' ' LEU . 9.7 mp -64.78 -48.53 74.17 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.296 0.638 . . . . 73.14 111.193 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 68.5 m95 -57.86 -45.58 86.08 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.142 0.577 . . . . 75.0 111.583 178.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . 0.619 ' HE3' HG23 ' C' ' 206' ' ' VAL . 44.9 mttp -65.16 -42.95 93.22 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-N 115.536 -0.756 . . . . 62.43 111.547 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 34.4 mmtm -63.31 -42.94 99.05 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 122.88 0.472 . . . . 70.22 111.789 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 272' ' ' LEU . . . . . 0.44 ' O ' ' HB2' ' A' ' 276' ' ' TYR . 67.5 mt -54.93 -49.28 71.69 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 124.251 0.97 . . . . 63.4 109.435 172.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -70.06 -33.22 71.66 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.076 1.139 . . . . 64.51 114.076 -175.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.428 ' HG3' ' O ' ' A' ' 270' ' ' LYS . 40.6 mt-10 -65.08 -53.94 37.81 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.373 -0.973 . . . . 74.35 108.373 176.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -69.87 -20.83 63.38 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 113.567 -1.651 . . . . 71.44 112.161 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . 0.554 ' HE2' ' HB3' ' C' ' 258' ' ' PRO . 23.8 t80 -75.49 -64.07 1.15 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.188 0.995 . . . . 75.02 109.4 178.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -72.09 -23.06 61.28 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 114.799 -1.091 . . . . 70.12 111.848 -170.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -59.24 -26.99 65.37 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 112.762 0.653 . . . . 75.41 112.762 172.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -77.58 -15.14 59.42 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 116.429 -0.351 . . . . 74.13 110.497 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.131 0 C-N-CA 123.857 0.863 . . . . 72.21 109.042 175.507 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 14.6 tpt . . . . . 0 N--CA 1.479 0.979 0 N-CA-C 109.391 -0.596 . . . . 71.44 109.391 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt 59.86 33.94 21.69 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 124.568 1.147 . . . . 54.1 112.126 175.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 59.22 72.94 0.5 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.736 1.214 . . . . 74.04 109.814 -173.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 11.1 p -82.87 -17.51 43.57 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 115.029 -0.987 . . . . 52.14 111.864 -176.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 4.5 m 68.94 158.72 0.16 Allowed 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 125.234 1.413 . . . . 70.11 113.252 174.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.616 HG21 ' HA ' ' A' ' 125' ' ' LEU . 14.5 pt -138.57 175.08 8.93 Favored 'Isoleucine or valine' 0 C--N 1.364 1.199 0 C-N-CA 123.316 0.646 . . . . 64.44 111.117 -172.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -150.38 141.81 23.39 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.074 0.95 . . . . 72.01 109.017 172.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.585 HD23 HG11 ' A' ' 140' ' ' VAL . 52.7 tp -75.76 143.03 42.22 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.263 1.025 . . . . 75.22 109.91 -174.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.93 -68.1 0.35 Allowed 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 109.513 -0.551 . . . . 62.4 109.513 172.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 6.6 tt 53.39 101.23 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 125.365 1.466 . . . . 74.1 110.527 -176.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 31.0 mt -49.68 120.9 11.52 Favored Pre-proline 0 CA--C 1.556 1.209 0 C-N-CA 124.732 1.213 . . . . 45.35 110.769 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -54.21 136.4 68.07 Favored 'Trans proline' 0 C--N 1.383 2.348 0 C-N-CA 124.139 3.226 . . . . 61.33 114.634 -155.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 41.4 mt -150.0 -47.62 0.13 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.415 1.486 . . . . 75.01 108.801 177.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -155.84 162.9 40.38 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.717 0.807 . . . . 64.54 109.766 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 15' ' ' PHE . . . . . 0.644 ' HA ' ' HA ' ' A' ' 141' ' ' ALA . 62.6 t80 -154.26 117.31 4.48 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.307 0.643 . . . . 60.01 109.83 173.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 1.3 p -146.88 169.84 8.77 Favored Pre-proline 0 CA--C 1.558 1.26 0 C-N-CA 125.649 1.58 . . . . 51.11 108.283 174.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -105.06 23.57 0.1 Allowed 'Trans proline' 0 CA--C 1.557 1.663 0 C-N-CA 122.934 2.423 . . . . 62.42 112.656 164.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.534 HG21 ' HG3' ' A' ' 79' ' ' PRO . 4.8 p -66.57 -66.67 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 N-CA-C 114.941 1.46 . . . . 61.41 114.941 -163.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 25.4 m -87.8 -53.6 4.68 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 122.523 0.329 . . . . 71.22 111.55 -163.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 20' ' ' LYS . . . . . 0.507 ' HA ' ' H ' ' A' ' 144' ' ' ARG . 92.4 mttt 70.56 178.89 0.25 Allowed 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 124.771 1.228 . . . . 62.34 110.367 -171.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -179.79 151.63 0.45 Allowed 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.539 0.685 . . . . 75.34 112.494 178.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . 0.769 HH21 ' HG2' ' A' ' 135' ' ' GLU . 26.0 mtp-105 -141.86 104.51 4.52 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.491 1.116 . . . . 73.31 108.766 172.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 23' ' ' THR . . . . . 0.438 HG21 ' O ' ' A' ' 86' ' ' SER . 17.8 p -139.43 52.86 4.3 Favored Pre-proline 0 N--CA 1.497 1.915 0 CA-C-N 118.806 0.73 . . . . 72.45 112.583 168.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . 0.44 ' HD2' ' HG2' ' B' ' 25' ' ' GLU . 8.7 Cg_endo -101.15 0.19 0.57 Allowed 'Trans proline' 0 C--N 1.371 1.745 0 C-N-CA 122.444 2.096 . . . . 74.55 113.859 176.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . 0.44 ' HG2' ' HD2' ' B' ' 24' ' ' PRO . 69.8 mm-40 -75.22 -20.32 59.31 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.573 0.749 . . . . 74.53 112.634 -167.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . 0.493 ' H ' ' HD2' ' B' ' 27' ' ' PRO . 51.2 ttm -170.89 -50.35 0.0 OUTLIER Pre-proline 0 CA--C 1.567 1.611 0 CA-C-O 118.264 -0.874 . . . . 75.13 112.542 -171.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 27' ' ' PRO . . . . . 0.493 ' HD2' ' H ' ' B' ' 26' ' ' MET . 72.7 Cg_endo -71.07 10.51 0.66 Allowed 'Trans proline' 0 C--N 1.399 3.214 0 C-N-CA 122.212 1.941 . . . . 71.1 115.355 -172.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 29.0 m -70.51 142.77 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 N-CA-C 109.146 -0.687 . . . . 73.51 109.146 166.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 32.0 tp -141.93 166.94 23.34 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.119 0.568 . . . . 62.2 110.64 -171.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -76.29 155.27 34.43 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.093 0.957 . . . . 70.24 110.104 173.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 31' ' ' ASN . . . . . 0.444 ' HB2' ' HB2' ' A' ' 160' ' ' ARG . 28.7 t-20 -129.41 168.5 16.21 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.992 0.917 . . . . 74.34 109.738 -175.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 21.5 ptt-85 -65.68 -0.63 2.2 Favored 'General case' 0 CA--C 1.561 1.392 0 C-N-CA 125.02 1.328 . . . . 72.22 113.372 173.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . 0.404 ' O ' ' HG3' ' B' ' 35' ' ' GLN . . . 75.41 118.15 0.05 Allowed 'General case' 0 C--N 1.365 1.242 0 C-N-CA 126.535 1.934 . . . . 73.31 108.482 -166.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . 0.524 ' H ' HG21 ' A' ' 158' ' ' VAL . . . -64.53 99.01 0.28 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.211 0.529 . . . . 53.33 110.082 178.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . 0.404 ' HG3' ' O ' ' B' ' 33' ' ' ALA . 65.3 mt-30 -87.28 170.75 11.17 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.081 0.952 . . . . 73.13 110.673 -178.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -132.33 178.42 18.03 Favored Glycine 0 C--N 1.34 0.792 0 CA-C-N 116.004 -0.544 . . . . 74.33 112.148 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -76.01 -53.7 7.98 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.601 0.76 . . . . 61.44 110.235 179.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 48.7 mm 76.03 -59.8 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 C-N-CA 125.483 1.513 . . . . 75.44 113.277 168.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 54.6 m -59.11 -67.18 0.4 Allowed 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.054 0.942 . . . . 64.25 112.642 -173.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.478 ' HB3' ' HD3' ' B' ' 41' ' ' PRO . . . -112.2 -54.37 0.05 OUTLIER Pre-proline 0 N--CA 1.489 1.511 0 CA-C-O 118.286 -0.864 . . . . 64.0 112.13 -174.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . 0.478 ' HD3' ' HB3' ' B' ' 40' ' ' ALA . 15.1 Cg_exo -71.81 107.98 2.33 Favored 'Trans proline' 0 C--N 1.388 2.642 0 CA-C-N 121.795 1.677 . . . . 72.44 111.662 172.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -167.84 -125.18 0.76 Allowed Glycine 0 C--N 1.344 1.016 0 N-CA-C 110.974 -0.85 . . . . 45.24 110.974 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -159.99 -152.82 6.66 Favored Glycine 0 C--N 1.344 1.025 0 N-CA-C 111.852 -0.499 . . . . 42.15 111.852 179.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . 59.31 87.07 0.08 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.817 1.247 . . . . 63.2 109.837 -172.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 20.2 mtp180 64.86 -142.68 0.24 Allowed 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 124.128 0.971 . . . . 74.21 109.172 -171.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 82.9 mtt180 70.82 103.34 0.06 Allowed 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.485 1.114 . . . . 75.02 111.026 176.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 79.4 mt 62.06 23.42 13.81 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.989 0.915 . . . . 53.22 112.004 172.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 28.1 m -80.27 -41.48 24.93 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 114.762 -1.108 . . . . 51.22 109.58 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -161.95 31.25 0.31 Allowed Glycine 0 C--N 1.338 0.649 0 CA-C-N 114.58 -1.191 . . . . 74.15 110.375 175.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . 0.403 ' HB3' ' HD3' ' C' ' 160' ' ' ARG . 2.1 m-20 -85.71 -2.27 58.03 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.513 1.125 . . . . 64.2 112.447 -167.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -116.41 -63.29 1.47 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 122.94 0.496 . . . . 75.3 111.86 -175.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 41.2 p -109.51 -45.89 3.62 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.108 0.563 . . . . 73.31 111.761 -173.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.7 -55.36 35.83 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.693 0.797 . . . . 73.24 112.138 -170.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -99.53 4.46 45.95 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.232 0.613 . . . . 75.51 110.642 175.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 94.0 mt 65.52 -167.38 0.22 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 125.194 1.398 . . . . 72.35 110.644 -170.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 92.4 mtt-85 -113.14 107.71 16.3 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.283 0.633 . . . . 73.2 109.575 176.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 9.3 t70 66.38 -176.4 0.19 Allowed 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 124.39 1.076 . . . . 75.31 110.467 175.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 51.1 m -143.1 39.6 1.46 Allowed 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.743 -0.598 . . . . 62.01 110.228 177.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 45.9 tp -60.35 102.6 0.18 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.423 0.689 . . . . 72.44 110.641 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 29.4 m -91.61 84.07 5.43 Favored 'General case' 0 C--O 1.244 0.779 0 C-N-CA 123.853 0.861 . . . . 63.51 109.882 -177.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 14.3 t70 62.57 -94.75 0.04 OUTLIER 'General case' 0 CA--C 1.563 1.462 0 O-C-N 124.309 1.006 . . . . 71.45 111.267 169.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 62' ' ' LYS . . . . . . . . . . . . . 87.9 tttt 162.21 91.09 0.01 OUTLIER Pre-proline 0 C--N 1.359 0.981 0 C-N-CA 126.854 2.061 . . . . 72.3 106.64 -176.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -68.75 -36.4 14.06 Favored 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 122.557 2.172 . . . . 72.24 113.055 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -97.97 105.31 17.44 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.703 0.801 . . . . 72.04 111.029 -173.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.402 ' HE2' ' HD3' ' C' ' 24' ' ' ARG . 7.6 tmtt? -92.32 69.88 5.14 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 106.996 -1.483 . . . . 65.32 106.996 170.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -127.57 155.14 44.3 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.247 0.619 . . . . 72.41 110.135 -177.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 16.1 tt -124.88 140.79 46.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 124.051 0.941 . . . . 72.03 108.742 176.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 8.3 tt -64.13 102.04 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.118 0 CA-C-O 121.398 0.618 . . . . 73.4 109.812 177.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 57.1 tp -67.85 -59.7 3.09 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.767 -0.651 . . . . 73.12 110.099 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 57.8 tp -162.54 147.43 12.17 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.176 0.59 . . . . 44.44 109.935 -177.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 29.4 pt -72.04 134.15 30.43 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 C-N-CA 123.462 0.705 . . . . 74.32 110.613 173.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -82.13 135.0 13.61 Favored Glycine 0 C--N 1.344 1.024 0 CA-C-O 119.327 -0.707 . . . . 62.21 112.318 -178.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 4.1 t70 69.98 175.73 0.28 Allowed 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 125.224 1.409 . . . . 63.44 110.825 177.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -125.51 -103.03 1.38 Allowed Glycine 0 C--N 1.352 1.432 0 O-C-N 121.864 -0.522 . . . . 64.42 112.625 178.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 75' ' ' MET . . . . . 0.487 ' HA ' ' HB2' ' B' ' 79' ' ' GLU . 1.0 OUTLIER 62.41 -84.31 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 125.276 1.43 . . . . 74.01 110.169 -172.272 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 59.01 -85.47 0.01 OUTLIER Glycine 0 C--N 1.355 1.6 0 N-CA-C 114.55 0.58 . . . . 71.13 114.55 175.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -88.53 21.64 2.86 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.784 1.234 . . . . 73.03 111.767 -176.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 17.0 m 76.71 -0.72 2.97 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 125.796 1.638 . . . . 51.1 111.411 -168.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . 0.487 ' HB2' ' HA ' ' B' ' 75' ' ' MET . 32.3 tt0 54.01 44.95 28.59 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 125.149 1.38 . . . . 74.44 111.49 176.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 2.2 pp 48.29 16.03 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 C-N-CA 126.41 1.884 . . . . 72.52 114.638 -177.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 20.4 m -75.79 -26.85 57.69 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.716 0.806 . . . . 71.34 110.414 -178.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.13 -29.93 65.85 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 115.423 -0.808 . . . . 61.11 110.494 172.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -77.42 119.35 20.91 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.156 0.583 . . . . 71.35 110.311 177.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 61.1 mtp85 -92.57 35.42 1.02 Allowed 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.871 0.868 . . . . 73.0 111.427 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 9.1 t30 61.05 -79.72 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.936 1.294 . . . . 72.23 111.232 -174.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -61.24 -72.19 0.12 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.673 0.789 . . . . 63.12 110.963 -177.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . 175.26 -72.47 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.897 1.279 . . . . 52.24 107.976 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -102.45 -78.44 0.54 Allowed 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 114.743 -1.117 . . . . 74.14 108.487 -177.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 145.89 -92.32 0.16 Allowed Glycine 0 C--N 1.349 1.261 0 N-CA-C 112.303 -0.319 . . . . 54.33 112.303 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -162.12 30.11 0.12 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.578 0.751 . . . . 62.33 110.305 -174.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.18 -78.93 0.78 Allowed Glycine 0 C--N 1.344 1.022 0 CA-C-N 115.769 -0.651 . . . . 70.11 112.199 -175.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . 0.498 ' HA2' ' HA ' ' B' ' 210' ' ' LYS . . . -175.66 -152.54 9.53 Favored Glycine 0 C--N 1.339 0.709 0 N-CA-C 111.615 -0.594 . . . . 23.53 111.615 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -93.34 -18.62 22.2 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.286 0.635 . . . . 74.22 111.346 178.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -56.33 -62.67 1.56 Allowed 'General case' 0 N--CA 1.479 1.02 0 CA-C-O 119.115 -0.469 . . . . 71.21 110.817 -178.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 6.8 tmtm? 60.53 -77.85 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 O-C-N 124.33 1.019 . . . . 74.14 108.906 -174.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . -171.04 42.82 0.19 Allowed Glycine 0 C--N 1.346 1.121 0 N-CA-C 110.199 -1.16 . . . . 72.31 110.199 172.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 13.7 pt -70.13 -31.56 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 123.58 0.752 . . . . 72.22 112.051 -173.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -147.7 -153.68 0.51 Allowed 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 109.327 -0.62 . . . . 75.21 109.327 -172.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . 69.59 24.89 5.43 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.156 1.383 . . . . 61.12 112.346 -175.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 5.9 mp -58.91 -46.36 99.54 Favored Pre-proline 0 N--CA 1.484 1.255 0 CA-C-O 118.511 -0.757 . . . . 74.2 110.809 167.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -67.19 -5.83 14.7 Favored 'Trans proline' 0 C--N 1.4 3.262 0 C-N-CA 121.896 1.731 . . . . 72.21 113.268 177.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . 0.535 ' HB3' ' H ' ' B' ' 114' ' ' LYS . 69.3 mt 71.05 -69.54 0.18 Allowed 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 125.902 1.681 . . . . 73.12 111.156 173.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 3.6 t -88.04 -46.32 9.44 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.472 1.109 . . . . 75.52 110.445 171.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 71.96 12.05 74.82 Favored Glycine 0 C--N 1.35 1.345 0 CA-C-O 119.512 -0.605 . . . . 51.35 114.539 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -162.38 -63.81 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 117.553 0.677 . . . . 75.22 111.253 -175.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -93.59 107.09 19.0 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.076 0.551 . . . . 74.44 110.931 -171.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 83.8 m -137.14 -63.46 0.6 Allowed 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.217 -1.031 . . . . 63.32 108.217 176.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 57.72 -77.15 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 126.024 1.73 . . . . 71.44 113.107 173.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -129.61 -63.98 0.9 Allowed 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 108.893 -0.781 . . . . 53.33 108.893 173.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -136.6 121.58 18.87 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.159 0.984 . . . . 71.24 109.666 179.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . 0.436 HD13 ' N ' ' B' ' 112' ' ' ASN . 1.5 tm? -150.92 151.54 32.32 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.637 -0.875 . . . . 64.15 108.637 -178.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 112' ' ' ASN . . . . . 0.436 ' N ' HD13 ' B' ' 111' ' ' LEU . 19.7 m120 -74.79 113.14 11.74 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.041 0.537 . . . . 73.2 109.978 178.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 113' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.72 -165.08 0.33 Allowed 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 123.657 0.783 . . . . 75.13 110.357 176.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 114' ' ' LYS . . . . . 0.535 ' H ' ' HB3' ' B' ' 102' ' ' LEU . 1.4 tpmt? -58.22 -35.55 71.83 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.358 0.663 . . . . 74.01 111.378 -177.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 11.9 m 65.6 -76.06 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.86 1.664 . . . . 73.23 110.269 -176.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -161.42 174.7 38.0 Favored Glycine 0 C--O 1.242 0.65 0 N-CA-C 109.961 -1.256 . . . . 55.33 109.961 172.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . 0.433 ' N ' ' HE3' ' B' ' 117' ' ' LYS . 0.8 OUTLIER 68.4 136.96 0.05 OUTLIER Pre-proline 0 CA--C 1.57 1.744 0 C-N-CA 124.538 1.135 . . . . 70.25 111.01 -175.928 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 118' ' ' PRO . . . . . 0.646 ' HD2' ' HB ' ' B' ' 121' ' ' VAL . 19.4 Cg_exo -67.62 72.67 0.65 Allowed 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 123.196 2.597 . . . . 60.53 111.21 169.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 119' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 56.19 -92.01 0.03 OUTLIER 'General case' 0 C--N 1.352 0.711 0 C-N-CA 125.609 1.564 . . . . 75.33 110.955 -170.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 120' ' ' TYR . . . . . 0.676 ' HB2' ' HG ' ' B' ' 280' ' ' LEU . 41.4 t80 -104.61 -19.85 13.85 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.402 0.681 . . . . 70.1 110.874 -175.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 121' ' ' VAL . . . . . 0.646 ' HB ' ' HD2' ' B' ' 118' ' ' PRO 0.288 8.3 p 52.05 -68.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 C-N-CA 127.385 2.274 . . . . 74.32 114.336 -174.433 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 32.5 m -55.55 95.67 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 124.44 1.096 . . . . 75.24 112.538 -174.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -98.21 4.84 48.88 Favored 'General case' 0 CA--C 1.553 1.07 0 CA-C-N 115.345 -0.843 . . . . 64.3 109.904 172.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 44.5 t 60.98 -100.74 0.1 Allowed 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 125.646 1.579 . . . . 43.31 112.265 171.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . 0.558 ' HA ' ' HE2' ' B' ' 210' ' ' LYS . . . -163.96 -58.4 0.04 OUTLIER 'General case' 0 C--N 1.36 1.023 0 CA-C-N 118.852 0.751 . . . . 73.02 112.872 -172.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -71.65 163.41 27.82 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 122.745 0.418 . . . . 74.13 111.893 -172.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 35.5 m 65.1 -175.37 0.18 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.68 1.192 . . . . 70.01 112.541 177.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . 66.38 -68.68 0.13 Allowed 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 125.127 1.371 . . . . 72.01 111.669 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 129' ' ' THR . . . . . 0.634 HG23 ' HA2' ' B' ' 209' ' ' GLY . 34.1 p -67.81 -40.09 83.88 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.178 0.591 . . . . 54.34 109.533 166.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . -79.93 -164.34 0.66 Allowed 'General case' 0 CA--C 1.553 1.065 0 CA-C-N 115.334 -0.848 . . . . 44.22 109.526 169.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 131' ' ' TRP . . . . . 0.521 ' HH2' HD23 ' B' ' 205' ' ' LEU . 25.1 m0 69.7 27.0 4.8 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 124.249 1.02 . . . . 73.51 110.375 -166.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 132' ' ' SER . . . . . 0.587 ' HB2' ' HD2' ' B' ' 231' ' ' LYS . 12.8 p -155.37 -83.97 0.06 Allowed 'General case' 0 CA--C 1.541 0.635 0 N-CA-C 106.558 -1.645 . . . . 51.4 106.558 172.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 31.9 m -154.0 -84.46 0.07 Allowed 'General case' 0 CA--C 1.551 0.983 0 N-CA-C 108.249 -1.019 . . . . 62.25 108.249 170.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . -151.02 37.74 0.86 Allowed Glycine 0 C--N 1.35 1.347 0 N-CA-C 110.266 -1.133 . . . . 55.15 110.266 178.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 135' ' ' VAL . . . . . . . . . . . . . 8.3 p -158.78 160.21 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.32 1.048 . . . . 73.24 108.51 -173.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 136' ' ' LYS . . . . . 0.458 ' HG3' ' H ' ' B' ' 137' ' ' THR . 0.5 OUTLIER -131.41 176.73 8.05 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 122.736 0.414 . . . . 52.43 110.325 -179.846 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 137' ' ' THR . . . . . 0.458 ' H ' ' HG3' ' B' ' 136' ' ' LYS . 5.5 t -55.34 92.88 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 125.171 1.388 . . . . 75.31 112.889 -176.143 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 58.9 t80 73.68 -74.41 0.09 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.797 1.639 . . . . 75.52 112.295 172.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . 0.437 ' OD1' ' HA ' ' B' ' 212' ' ' SER . 12.7 t30 70.05 154.29 0.12 Allowed 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 125.242 1.417 . . . . 73.24 112.609 -177.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . 91.15 -3.88 80.56 Favored Glycine 0 C--N 1.348 1.229 0 CA-C-N 115.559 -0.746 . . . . 65.04 112.272 -176.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -91.51 -0.3 57.59 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.007 0.923 . . . . 75.34 111.447 -178.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -79.6 109.33 13.89 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.115 -1.069 . . . . 70.15 108.115 176.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -108.68 -34.46 2.63 Favored Glycine 0 C--N 1.342 0.91 0 O-C-N 123.61 0.569 . . . . 61.25 111.907 174.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 5.0 p -104.53 131.34 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.886 0.874 . . . . 75.31 110.175 -179.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -95.52 -36.97 11.09 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.702 0.801 . . . . 64.3 110.47 176.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 44.0 mm -62.74 127.57 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 123.753 0.821 . . . . 72.52 111.334 -178.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 61.57 4.27 0.98 Allowed 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 125.832 1.653 . . . . 72.43 113.561 175.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -92.88 163.82 13.56 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.444 0.698 . . . . 73.05 110.9 -171.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 149' ' ' LYS . . . . . 0.441 ' HE2' ' HA ' ' B' ' 260' ' ' SER . 20.5 tptp -75.47 97.48 3.69 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 123.327 0.651 . . . . 72.23 112.19 -172.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -85.15 142.95 29.12 Favored 'General case' 0 CA--C 1.553 1.072 0 CA-C-N 115.362 -0.836 . . . . 74.11 109.553 165.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 58.2 m80 66.26 116.1 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.593 0 C-N-CA 125.569 1.548 . . . . 74.43 112.619 -175.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 152' ' ' PRO . . . . . 0.459 ' HD2' ' HA3' ' B' ' 209' ' ' GLY . 57.9 Cg_endo -72.08 166.78 28.62 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.094 1.863 . . . . 42.51 110.723 163.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 12.7 t -160.43 -31.74 0.06 Allowed 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 112.429 0.529 . . . . 74.2 112.429 -174.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 9.8 tt -94.41 76.25 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 CA-C-O 121.859 0.838 . . . . 74.25 110.615 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 7.3 mp 51.28 -86.13 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 125.82 1.648 . . . . 72.1 113.397 174.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -159.73 -79.25 0.06 Allowed 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 107.505 -1.294 . . . . 72.23 107.505 -177.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 157' ' ' MET . . . . . 0.544 ' HB3' HD21 ' B' ' 218' ' ' LEU . 26.8 ptm 167.34 164.61 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 126.292 1.837 . . . . 53.54 108.511 179.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 158' ' ' ALA . . . . . . . . . . . . . . . -163.32 -171.34 2.56 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.278 1.031 . . . . 34.04 108.473 174.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 54.6 tptt -102.67 -15.0 16.47 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 123.148 0.579 . . . . 55.45 109.558 169.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -151.98 -75.09 0.14 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.734 0.814 . . . . 70.22 110.398 177.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -156.71 -82.87 0.06 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.433 0.693 . . . . 71.1 109.976 178.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 162' ' ' GLY . . . . . 0.683 ' HA2' ' HB2' ' B' ' 235' ' ' GLU . . . 76.81 -71.38 2.16 Favored Glycine 0 C--N 1.352 1.432 0 C-N-CA 122.71 0.195 . . . . 73.4 113.077 -178.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 71.5 mt 67.33 23.9 9.13 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.93 1.292 . . . . 65.02 112.48 173.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 164' ' ' ALA . . . . . . . . . . . . . . . -90.63 -100.77 0.1 Allowed 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 122.868 0.467 . . . . 75.34 111.06 178.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 87.0 m 63.22 -69.96 0.07 Allowed 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 124.721 1.209 . . . . 64.15 111.441 -167.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . -87.82 -167.79 43.82 Favored Glycine 0 C--N 1.346 1.132 0 N-CA-C 112.129 -0.388 . . . . 71.15 112.129 174.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 167' ' ' ASN . . . . . 0.456 HD21 ' HB3' ' B' ' 75' ' ' MET . 38.0 p30 -70.3 -26.56 63.85 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 117.375 0.588 . . . . 72.31 110.694 175.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 26.9 m 39.86 42.27 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 126.616 1.966 . . . . 74.13 113.574 176.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 169' ' ' SER . . . . . 0.711 ' HB2' ' HB3' ' B' ' 172' ' ' GLU . 55.7 p -63.51 -32.67 74.2 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-N 115.177 -0.919 . . . . 54.35 111.62 -177.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 32.4 m 58.31 88.92 0.06 Allowed 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.817 1.247 . . . . 63.1 111.834 170.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . 77.4 -19.62 0.42 Allowed 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 125.342 1.457 . . . . 53.32 112.299 -178.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 172' ' ' GLU . . . . . 0.711 ' HB3' ' HB2' ' B' ' 169' ' ' SER . 3.0 tm-20 -74.75 103.36 4.99 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 108.823 -0.806 . . . . 73.22 108.823 173.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 173' ' ' LEU . . . . . 0.584 ' HG ' ' HG2' ' B' ' 174' ' ' GLN . 2.4 pt? -168.34 -41.08 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 107.594 -1.262 . . . . 74.23 107.594 166.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 174' ' ' GLN . . . . . 0.584 ' HG2' ' HG ' ' B' ' 173' ' ' LEU . 27.0 pt20 -172.95 -175.23 1.2 Allowed 'General case' 0 C--O 1.244 0.77 0 C-N-CA 125.251 1.421 . . . . 74.45 108.377 177.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 175' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -70.86 -82.21 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 116.021 -0.536 . . . . 74.1 110.21 169.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . 171.91 -42.26 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.123 1.369 . . . . 74.11 108.006 -171.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 16.1 p -139.58 73.46 35.3 Favored Pre-proline 0 CA--C 1.557 1.233 0 C-N-CA 125.141 1.376 . . . . 64.31 108.576 172.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 178' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.85 169.27 22.49 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 122.665 2.244 . . . . 74.53 112.778 -175.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -119.08 21.32 12.4 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.836 0.854 . . . . 61.34 109.57 176.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . 58.37 -79.24 0.02 OUTLIER 'General case' 0 C--N 1.359 1.0 0 C-N-CA 124.953 1.301 . . . . 74.4 110.472 -164.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 181' ' ' LEU . . . . . 0.503 HD22 ' HB3' ' C' ' 136' ' ' ARG . 12.8 tp -162.94 26.61 0.09 Allowed 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.699 0.762 . . . . 62.04 109.505 174.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 182' ' ' VAL . . . . . 0.464 HG13 ' HB3' ' C' ' 139' ' ' GLU . 76.7 t -83.44 147.45 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.505 1.122 . . . . 71.31 110.761 -174.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 183' ' ' ALA . . . . . 0.457 ' HB2' HD13 ' C' ' 123' ' ' LEU . . . -134.05 -13.69 2.43 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.54 0.736 . . . . 65.24 112.222 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 55.53 -138.77 1.02 Allowed 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.995 0.918 . . . . 74.15 108.836 -174.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 185' ' ' VAL . . . . . . . . . . . . . 61.0 t -114.76 102.17 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 106.997 -1.483 . . . . 71.33 106.997 158.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 66.6 p 55.79 84.97 0.07 Allowed 'General case' 0 CA--C 1.56 1.364 0 C-N-CA 125.456 1.503 . . . . 51.31 112.798 177.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 187' ' ' SER . . . . . . . . . . . . . 64.5 p -116.95 172.48 7.23 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.7 1.2 . . . . 62.14 111.036 -178.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -136.34 152.15 50.35 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.52 0.728 . . . . 71.52 111.358 -179.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 189' ' ' LYS . . . . . 0.557 ' H ' ' HG2' ' C' ' 124' ' ' PRO . 55.1 tttp -115.81 116.63 28.36 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.796 1.238 . . . . 72.52 109.633 -174.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 190' ' ' CYS . . . . . . . . . . . . . 8.1 p -99.91 151.39 21.37 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.634 0.774 . . . . 70.33 109.994 174.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -153.85 136.8 15.44 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.225 0.61 . . . . 74.04 110.195 -176.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -93.85 105.62 3.31 Favored Glycine 0 C--N 1.348 1.239 0 CA-C-O 118.79 -1.006 . . . . 64.22 111.201 173.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 193' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -69.17 157.43 61.56 Favored 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 122.593 2.195 . . . . 64.32 112.611 178.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 194' ' ' SER . . . . . . . . . . . . . 32.7 t -73.87 151.48 40.46 Favored 'General case' 0 C--O 1.244 0.802 0 C-N-CA 123.457 0.703 . . . . 24.51 111.132 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 195' ' ' ALA . . . . . . . . . . . . . . . -64.18 105.04 0.82 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.634 0.773 . . . . 74.32 110.889 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 88.4 m -102.11 116.03 31.8 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.91 0.884 . . . . 73.32 109.907 -179.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 30.4 t -108.63 128.59 54.98 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.999 -0.741 . . . . 75.11 108.999 176.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 198' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 55.68 -94.11 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.725 1.21 . . . . 51.12 111.358 176.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 4.3 mmmp? -140.47 -63.25 0.48 Allowed 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 106.79 -1.559 . . . . 74.4 106.79 171.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 200' ' ' CYS . . . . . . . . . . . . . 97.5 m -161.1 73.55 2.63 Favored Pre-proline 0 CA--C 1.562 1.442 0 C-N-CA 125.388 1.475 . . . . 73.31 108.984 173.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 201' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -78.41 -23.49 8.6 Favored 'Trans proline' 0 C--N 1.374 1.891 0 C-N-CA 122.452 2.101 . . . . 71.34 113.039 -175.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . -85.39 93.52 1.84 Allowed Glycine 0 C--N 1.346 1.093 0 CA-C-N 115.88 -0.6 . . . . 63.04 111.701 -178.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 203' ' ' ASN . . . . . 0.702 HD21 ' H ' ' B' ' 207' ' ' LYS . 65.8 t30 70.36 7.77 6.35 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 124.922 1.289 . . . . 71.33 112.414 174.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . 59.25 -84.98 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 125.744 1.618 . . . . 74.01 113.389 174.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 205' ' ' LEU . . . . . 0.56 ' H ' HD13 ' B' ' 205' ' ' LEU . 0.0 OUTLIER -110.39 8.83 23.42 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.532 0.733 . . . . 51.03 111.88 -174.488 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 206' ' ' GLU . . . . . 0.479 ' HA ' ' ND2' ' B' ' 203' ' ' ASN . 36.4 mm-40 67.14 118.52 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.396 1.078 . . . . 62.32 111.192 -173.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 207' ' ' LYS . . . . . 0.702 ' H ' HD21 ' B' ' 203' ' ' ASN . 9.6 mtpm? -123.79 34.25 5.12 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.796 1.239 . . . . 74.32 110.493 -174.011 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . -67.94 80.67 0.19 Allowed Glycine 0 C--N 1.357 1.707 0 O-C-N 123.385 0.428 . . . . 71.52 114.167 -174.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 209' ' ' GLY . . . . . 0.634 ' HA2' HG23 ' B' ' 129' ' ' THR . . . -120.7 68.98 0.4 Allowed Glycine 0 C--N 1.342 0.886 0 N-CA-C 112.006 -0.437 . . . . 42.21 112.006 -175.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 210' ' ' LYS . . . . . 0.558 ' HE2' ' HA ' ' B' ' 125' ' ' ALA . 3.4 mptp? -72.83 -28.3 62.46 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.768 0.827 . . . . 74.51 110.937 -174.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . -153.43 -168.48 17.27 Favored Glycine 0 C--O 1.248 0.982 0 N-CA-C 110.136 -1.186 . . . . 74.43 110.136 175.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 212' ' ' SER . . . . . 0.437 ' HA ' ' OD1' ' B' ' 139' ' ' ASN . 67.5 m 58.18 31.74 21.14 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.47 0.708 . . . . 74.04 111.902 -179.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 24.8 pt -68.57 -36.26 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 CA-C-N 115.984 -0.553 . . . . 64.4 110.475 -179.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 214' ' ' THR . . . . . 0.511 HG22 ' HG3' ' B' ' 215' ' ' GLU . 6.8 m 57.56 -77.46 0.02 OUTLIER 'General case' 0 C--N 1.36 1.056 0 C-N-CA 126.194 1.798 . . . . 75.43 111.702 -176.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 215' ' ' GLU . . . . . 0.511 ' HG3' HG22 ' B' ' 214' ' ' THR . 0.0 OUTLIER -174.22 -25.26 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 126.029 1.732 . . . . 73.31 109.044 178.393 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 216' ' ' GLN . . . . . 0.416 HE21 ' HG2' ' B' ' 149' ' ' LYS . 8.9 tt0 62.68 79.65 0.25 Allowed 'General case' 0 C--N 1.359 1.018 0 C-N-CA 125.685 1.594 . . . . 61.42 110.824 177.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . 0.535 ' HA ' ' HB2' ' B' ' 221' ' ' ARG . 0.0 OUTLIER -59.54 -29.3 67.81 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 115.007 -0.997 . . . . 75.4 113.664 -176.557 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . 0.544 HD21 ' HB3' ' B' ' 157' ' ' MET . 2.6 mm? -62.73 -38.97 92.59 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.525 0.33 . . . . 71.43 110.821 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -103.78 86.77 2.66 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.181 0.592 . . . . 71.24 110.456 -173.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . 72.05 7.99 5.87 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.94 1.296 . . . . 61.1 114.382 168.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 221' ' ' ARG . . . . . 0.535 ' HB2' ' HA ' ' B' ' 217' ' ' LEU . 7.8 mpt_? -110.46 6.03 21.8 Favored 'General case' 0 N--CA 1.499 2.002 0 CA-C-N 118.472 0.578 . . . . 73.55 111.241 173.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -162.81 -47.54 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.431 1.092 . . . . 42.52 109.111 175.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 70.4 -53.09 0.65 Allowed 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 126.968 2.107 . . . . 61.02 114.2 170.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 11.4 p -64.95 -16.02 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 124.681 1.192 . . . . 74.2 112.336 177.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 225' ' ' THR . . . . . 0.426 HG21 HD23 ' B' ' 217' ' ' LEU . 23.8 p -66.53 87.55 0.12 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.725 0.81 . . . . 54.34 111.443 177.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 8.5 tt -81.71 105.75 13.1 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-N 115.119 -0.946 . . . . 74.43 108.501 176.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . -173.54 64.6 0.12 Allowed Glycine 0 C--N 1.342 0.869 0 CA-C-N 115.775 -0.648 . . . . 51.31 111.545 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . -76.88 90.57 0.98 Allowed Glycine 0 C--N 1.342 0.897 0 N-CA-C 111.491 -0.643 . . . . 72.41 111.491 177.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -155.5 169.2 33.33 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-O 121.044 0.247 . . . . 70.24 113.624 -176.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -99.63 69.12 1.6 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.039 0.936 . . . . 70.23 110.288 -176.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 231' ' ' LYS . . . . . 0.587 ' HD2' ' HB2' ' B' ' 132' ' ' SER . 31.5 tttp 67.72 9.58 7.18 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 125.387 1.475 . . . . 73.24 113.015 173.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -93.31 169.91 10.02 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.009 0.524 . . . . 74.24 110.274 -172.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -69.26 -91.45 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.496 0.718 . . . . 70.41 112.52 -168.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -150.19 21.27 0.86 Allowed 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 118.723 0.692 . . . . 72.31 112.557 -168.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . 0.683 ' HB2' ' HA2' ' B' ' 162' ' ' GLY . 12.8 mp0 -74.21 127.85 34.03 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.23 0.612 . . . . 54.41 109.869 -173.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 236' ' ' THR . . . . . . . . . . . . . 26.2 m -114.61 -79.69 0.59 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.311 0.644 . . . . 73.34 109.529 -178.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -83.72 89.56 7.17 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.08 0.552 . . . . 71.12 111.125 -172.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 238' ' ' THR . . . . . 0.461 HG22 HG23 ' C' ' 219' ' ' VAL . 6.9 m -75.62 -16.56 60.2 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-N 115.594 -0.73 . . . . 71.31 110.197 172.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 239' ' ' ALA . . . . . 0.658 ' HB2' ' HA ' ' C' ' 221' ' ' VAL . . . -60.79 -177.09 0.07 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.032 1.333 . . . . 74.42 114.117 -178.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . -103.21 -95.48 2.33 Favored Glycine 0 C--N 1.341 0.837 0 N-CA-C 110.32 -1.112 . . . . 71.23 110.32 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -166.07 157.12 13.29 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.506 0.723 . . . . 71.21 110.789 -179.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -170.58 -69.37 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.17 0.988 . . . . 70.32 109.971 174.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -136.74 -6.97 1.91 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.389 1.076 . . . . 74.22 110.505 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 142.74 -163.79 27.21 Favored Glycine 0 C--N 1.352 1.468 0 N-CA-C 113.472 0.149 . . . . 63.11 113.472 174.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -167.48 131.33 1.79 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.322 1.049 . . . . 75.34 109.526 -174.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . 0.537 ' HB ' ' HG ' ' B' ' 247' ' ' LEU . 0.6 OUTLIER -163.15 151.39 13.82 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 112.848 0.684 . . . . 71.02 112.848 -179.626 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 247' ' ' LEU . . . . . 0.537 ' HG ' ' HB ' ' B' ' 246' ' ' THR . 85.2 mt 75.44 154.02 0.15 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 126.585 1.954 . . . . 72.51 115.374 159.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 248' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.98 60.84 0.13 Allowed 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 106.082 -1.821 . . . . 75.15 106.082 -177.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -77.22 163.93 26.08 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 113.638 0.977 . . . . 71.33 113.638 -163.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -115.45 175.71 5.4 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 114.58 -1.191 . . . . 65.4 112.491 -167.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 251' ' ' ALA . . . . . 0.555 ' HB1' ' HB3' ' B' ' 254' ' ' ARG . . . -138.11 94.04 2.83 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.59 1.156 . . . . 61.03 108.217 175.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.01 -32.19 67.69 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 114.068 1.136 . . . . 72.3 114.068 -170.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -154.08 7.26 0.33 Allowed 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.261 0.624 . . . . 51.41 110.772 175.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . 0.555 ' HB3' ' HB1' ' B' ' 251' ' ' ALA . 0.0 OUTLIER -80.14 102.37 9.34 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 109.013 -0.736 . . . . 72.51 109.013 -173.114 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . 90.51 71.54 1.23 Allowed Glycine 0 C--N 1.35 1.345 0 O-C-N 123.823 0.702 . . . . 54.22 111.408 -177.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 256' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -155.25 -48.48 0.08 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.28 0.632 . . . . 52.52 110.114 -175.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 257' ' ' GLN . . . . . 0.567 ' HG3' ' HG ' ' B' ' 258' ' ' LEU . 8.7 tp-100 63.86 -83.29 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.923 1.289 . . . . 74.31 109.702 -171.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 258' ' ' LEU . . . . . 0.567 ' HG ' ' HG3' ' B' ' 257' ' ' GLN . 3.3 pp -159.67 -8.15 0.06 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.531 1.132 . . . . 75.13 110.636 175.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . 0.554 HG23 ' H ' ' B' ' 260' ' ' SER . 5.6 m -87.62 -70.41 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 C-N-CA 123.452 0.701 . . . . 63.02 111.772 -174.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 260' ' ' SER . . . . . 0.554 ' H ' HG23 ' B' ' 259' ' ' VAL . 74.9 m -167.38 -56.0 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.355 1.062 . . . . 73.11 109.748 -174.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -144.78 -71.54 0.27 Allowed 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 114.58 -1.191 . . . . 52.21 108.839 -167.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 262' ' ' ALA . . . . . 0.428 ' HB1' ' H ' ' B' ' 280' ' ' LEU . . . 64.87 7.36 3.88 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.754 1.222 . . . . 43.43 113.392 178.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -109.76 -30.6 7.79 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.788 0.835 . . . . 70.44 112.036 -171.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 78.7 p -58.64 -50.34 74.22 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.124 0.97 . . . . 51.14 113.384 -167.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 265' ' ' LEU . . . . . 0.437 HD12 ' HB3' ' B' ' 280' ' ' LEU . 95.9 mt -59.94 -38.21 81.78 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.196 0.598 . . . . 64.12 112.006 -176.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 266' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -66.19 -29.52 69.81 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 115.749 -0.66 . . . . 71.52 110.581 176.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 267' ' ' SER . . . . . 0.481 ' HA ' ' HG3' ' C' ' 260' ' ' ARG . 49.5 m -89.44 -26.88 20.73 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.111 0.964 . . . . 73.13 112.642 -177.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . 0.503 HG12 HG23 ' B' ' 269' ' ' THR . 41.0 t -77.48 -48.75 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 123.576 0.75 . . . . 74.44 110.257 -178.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 269' ' ' THR . . . . . 0.503 HG23 HG12 ' B' ' 268' ' ' VAL . 36.7 p -119.69 -172.9 2.42 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.667 0.787 . . . . 74.31 110.703 -176.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 270' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 79.28 -53.97 0.43 Allowed 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 126.216 1.806 . . . . 72.41 112.949 172.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 271' ' ' ALA . . . . . . . . . . . . . . . 75.55 -13.41 0.87 Allowed 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 125.173 1.389 . . . . 75.3 114.158 175.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 272' ' ' ASN . . . . . 0.691 HD21 ' HG3' ' B' ' 293' ' ' PRO . 8.9 p30 -172.53 -168.68 0.54 Allowed 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 118.446 0.566 . . . . 54.14 111.415 -179.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 72.31 43.53 0.49 Allowed 'General case' 0 C--N 1.364 1.206 0 C-N-CA 125.662 1.585 . . . . 61.32 109.502 -177.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 62.84 -79.4 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 125.216 1.407 . . . . 71.44 111.064 -177.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 275' ' ' LYS . . . . . . . . . . . . . 25.3 mmtp 58.39 73.54 0.72 Allowed Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 124.312 1.045 . . . . 71.33 109.634 -176.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.53 157.31 51.76 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 123.103 2.536 . . . . 62.35 113.36 -178.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 277' ' ' LEU . . . . . . . . . . . . . 1.5 pp -86.38 35.98 0.68 Allowed 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 115.126 -0.943 . . . . 63.32 110.965 177.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 61.7 tp -65.35 -52.43 53.79 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.137 1.375 . . . . 62.0 110.875 -173.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . -171.46 72.43 0.11 Allowed Glycine 0 C--N 1.339 0.721 0 CA-C-N 114.77 -1.105 . . . . 75.43 110.465 -177.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 280' ' ' LEU . . . . . 0.676 ' HG ' ' HB2' ' B' ' 120' ' ' TYR . 3.7 mm? 72.45 -66.99 0.28 Allowed 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 125.697 1.599 . . . . 53.23 110.97 178.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 281' ' ' PHE . . . . . 0.4 ' HA ' ' HB2' ' B' ' 286' ' ' MET . 14.3 t80 58.91 -164.67 0.2 Allowed 'General case' 0 CA--C 1.566 1.59 0 C-N-CA 124.712 1.205 . . . . 75.31 111.804 170.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . 76.48 -74.07 0.08 Allowed 'General case' 0 C--N 1.361 1.074 0 C-N-CA 125.304 1.441 . . . . 65.41 111.522 167.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -146.01 -15.42 0.46 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.626 0.77 . . . . 72.33 110.666 -175.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . -73.83 -91.66 0.14 Allowed Glycine 0 C--N 1.356 1.647 0 C-N-CA 123.108 0.385 . . . . 61.45 113.937 -172.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -86.17 -35.51 20.07 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 117.095 0.448 . . . . 72.41 110.8 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 286' ' ' MET . . . . . 0.4 ' HB2' ' HA ' ' B' ' 281' ' ' PHE . 89.7 mtp -110.83 97.6 34.34 Favored Pre-proline 0 N--CA 1.475 0.807 0 C-N-CA 123.92 0.888 . . . . 64.1 108.769 177.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 287' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -76.44 82.88 2.15 Favored 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 122.475 2.117 . . . . 73.33 111.265 174.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 288' ' ' VAL . . . . . . . . . . . . . 11.5 p -76.19 157.49 5.64 Favored 'Isoleucine or valine' 0 C--O 1.243 0.719 0 CA-C-N 115.441 -0.799 . . . . 74.32 109.001 173.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 289' ' ' ARG . . . . . . . . . . . . . 63.1 mtp180 -63.71 132.98 52.72 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 109.974 -0.38 . . . . 72.14 109.974 176.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 290' ' ' TRP . . . . . . . . . . . . . 2.6 m-90 -86.69 4.1 42.04 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 115.356 -0.838 . . . . 75.34 112.441 -166.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 291' ' ' LEU . . . . . . . . . . . . . 28.9 tp 71.21 -71.56 0.13 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.975 1.71 . . . . 64.34 111.044 -176.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . -167.55 -62.26 0.03 OUTLIER Glycine 0 CA--C 1.534 1.244 0 CA-C-O 119.06 -0.856 . . . . 62.12 113.075 -174.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 293' ' ' PRO . . . . . 0.691 ' HG3' HD21 ' B' ' 272' ' ' ASN . 18.1 Cg_endo -55.95 -47.88 22.67 Favored 'Trans proline' 0 C--N 1.383 2.392 0 C-N-CA 123.624 2.883 . . . . 51.12 113.697 -175.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 6.0 tmtm? 57.44 -80.92 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 125.656 1.583 . . . . 41.23 111.16 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -81.25 12.95 3.14 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.735 0.814 . . . . 34.32 112.272 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 11.3 m 78.75 34.39 0.24 Allowed 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 125.697 1.599 . . . . 65.42 111.314 175.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 82.8 t80 60.37 99.33 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 124.356 1.062 . . . . 64.12 112.693 169.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 67.8 m-70 -125.88 114.81 19.03 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.774 0.83 . . . . 71.5 108.855 176.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . -163.4 21.56 0.17 Allowed Glycine 0 C--N 1.341 0.847 0 CA-C-O 119.768 -0.462 . . . . 63.41 113.379 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -64.87 -24.46 67.54 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.341 0.656 . . . . 72.23 111.188 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 301' ' ' ILE . . . . . . . . . . . . . 48.6 mm 68.93 -75.42 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.207 0 C-N-CA 125.608 1.563 . . . . 72.24 109.601 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -173.87 -47.77 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.648 1.179 . . . . 63.41 107.952 170.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 303' ' ' LYS . . . . . . . . . . . . . 24.3 tptp -177.32 115.49 0.25 Allowed Pre-proline 0 CA--C 1.547 0.828 0 N-CA-C 107.442 -1.318 . . . . 74.11 107.442 -176.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 304' ' ' PRO . . . . . 0.556 ' HB2' ' NE2' ' A' ' 191' ' ' GLN . 42.4 Cg_exo -56.33 -34.33 93.75 Favored 'Trans proline' 0 C--N 1.386 2.514 0 C-N-CA 122.881 2.388 . . . . 75.12 112.579 -177.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 305' ' ' ALA . . . . . 0.598 ' HB1' ' HB ' ' B' ' 309' ' ' THR . . . -153.87 136.13 14.88 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.065 -1.087 . . . . 42.33 108.065 168.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 58.1 t -54.43 -70.57 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 124.314 1.046 . . . . 72.33 111.731 -170.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . 0.418 ' HA ' ' HG2' ' A' ' 189' ' ' GLU . 39.1 m -148.73 -60.98 0.24 Allowed 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 120.987 0.422 . . . . 74.23 110.447 -175.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 308' ' ' CYS . . . . . . . . . . . . . 42.1 t -127.06 36.73 4.39 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.682 0.793 . . . . 74.22 109.146 176.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . 0.598 ' HB ' ' HB1' ' B' ' 305' ' ' ALA . 9.0 m -65.86 -44.85 64.0 Favored Pre-proline 0 CA--C 1.571 1.767 0 CA-C-N 115.003 -0.999 . . . . 72.2 111.723 177.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 310' ' ' PRO . . . . . 0.475 ' HD3' ' HB1' ' B' ' 305' ' ' ALA . 48.6 Cg_endo -92.72 160.38 2.83 Favored 'Trans proline' 0 C--N 1.391 2.814 0 C-N-CA 121.87 1.713 . . . . 63.14 112.282 171.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 311' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -81.81 157.91 68.64 Favored Pre-proline 0 CA--C 1.549 0.911 0 N-CA-C 107.891 -1.152 . . . . 73.13 107.891 167.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 312' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -71.6 125.91 11.62 Favored 'Trans proline' 0 C--N 1.363 1.327 0 C-N-CA 121.759 1.639 . . . . 70.14 111.476 173.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 313' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -85.75 4.23 37.75 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.468 0.707 . . . . 75.13 111.031 179.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 314' ' ' ARG . . . . . 0.556 ' HG3' ' HB3' ' A' ' 150' ' ' PRO . 9.4 mpt_? 61.8 -164.48 0.24 Allowed 'General case' 0 C--N 1.373 1.606 0 C-N-CA 124.763 1.225 . . . . 72.01 109.91 -176.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 315' ' ' ASN . . . . . 0.741 ' HB2' ' HB2' ' A' ' 151' ' ' PRO . 3.8 m-80 -146.07 151.81 38.32 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.411 0.684 . . . . 72.12 109.309 165.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 316' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -127.85 172.6 10.71 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 107.223 -1.399 . . . . 74.4 107.223 175.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 100.0 p 54.98 52.34 12.03 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.532 1.133 . . . . 75.41 110.947 -174.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 318' ' ' VAL . . . . . 0.468 ' N ' ' HD2' ' B' ' 319' ' ' PRO . 25.4 m -69.78 -22.55 0.65 Allowed Pre-proline 0 CA--C 1.568 1.64 0 N-CA-C 115.207 1.558 . . . . 73.13 115.207 -173.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 319' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' B' ' 318' ' ' VAL . 10.7 Cg_endo -55.53 -33.11 85.39 Favored 'Trans proline' 0 C--N 1.403 3.412 0 CA-C-N 122.784 2.03 . . . . 65.1 112.375 166.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 320' ' ' THR . . . . . . . . . . . . . 41.3 m 62.21 -79.34 0.03 OUTLIER 'General case' 0 C--N 1.359 0.985 0 C-N-CA 124.892 1.277 . . . . 53.31 111.25 179.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 321' ' ' LEU . . . . . . . . . . . . . 49.7 tp -103.58 83.86 2.21 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 108.324 -0.991 . . . . 65.14 108.324 175.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 322' ' ' ALA . . . . . . . . . . . . . . . -82.33 -30.24 30.55 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 115.778 -0.646 . . . . 64.54 110.484 177.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 323' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -119.23 101.01 7.68 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.251 1.02 . . . . 74.02 110.529 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 324' ' ' MET . . . . . . . . . . . . . 23.7 ptp -105.96 15.98 25.75 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.944 0.898 . . . . 71.32 109.884 171.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 325' ' ' THR . . . . . . . . . . . . . 3.5 m 62.07 28.81 17.4 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.711 1.204 . . . . 72.33 110.251 -174.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 326' ' ' ASP . . . . . . . . . . . . . 36.7 t70 64.1 -73.01 0.05 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.308 1.443 . . . . 72.01 109.788 -171.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -87.62 133.4 33.82 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 107.899 -1.149 . . . . 54.34 107.899 168.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 328' ' ' ALA . . . . . . . . . . . . . . . -64.42 -57.6 8.83 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.854 0.462 . . . . 72.03 110.746 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 329' ' ' ILE . . . . . 0.604 ' HB ' ' HB3' ' B' ' 431' ' ' SER . 4.0 mp -123.93 -68.35 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 107.985 -1.117 . . . . 73.5 107.985 172.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 330' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 72.45 -38.02 0.41 Allowed 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 125.807 1.643 . . . . 63.42 113.047 -175.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 331' ' ' LEU . . . . . . . . . . . . . 33.6 tp -55.84 -38.94 70.73 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.443 1.097 . . . . 63.34 112.305 -178.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 332' ' ' LEU . . . . . 0.503 ' HG ' HG21 ' B' ' 329' ' ' ILE . 96.9 mt -72.71 -10.87 60.3 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 113.196 0.813 . . . . 74.41 113.196 -178.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 333' ' ' SER . . . . . . . . . . . . . 10.4 t -67.28 112.48 4.55 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 122.992 0.517 . . . . 65.04 109.84 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -166.46 -155.29 0.2 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.725 1.21 . . . . 63.11 108.203 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 335' ' ' ASN . . . . . 0.563 HD22 ' HB2' ' B' ' 339' ' ' PHE . 5.0 t-20 86.38 -47.21 0.05 Allowed 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 125.366 1.466 . . . . 73.25 111.439 176.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.29 -23.3 62.3 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 124.153 0.981 . . . . 61.02 112.702 -175.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 337' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -59.56 -39.18 83.19 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.58 1.152 . . . . 62.43 110.836 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 338' ' ' GLY . . . . . . . . . . . . . . . 150.17 33.77 0.04 OUTLIER Glycine 0 C--N 1.348 1.237 0 C-N-CA 121.645 -0.312 . . . . 72.34 113.548 176.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 339' ' ' PHE . . . . . 0.563 ' HB2' HD22 ' B' ' 335' ' ' ASN . 86.0 m-85 -91.77 89.29 7.02 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 122.935 0.494 . . . . 74.33 109.852 -178.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 340' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -88.76 174.63 7.89 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.524 0.73 . . . . 75.24 111.304 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 341' ' ' LEU . . . . . . . . . . . . . 54.9 tp -71.84 105.73 3.91 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 124.308 1.043 . . . . 75.34 110.792 -175.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 342' ' ' GLN . . . . . . . . . . . . . 48.1 tp60 -95.98 -40.08 9.45 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.121 0.968 . . . . 64.25 111.534 -178.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 343' ' ' VAL . . . . . . . . . . . . . 59.6 t -64.09 -24.23 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 123.443 0.697 . . . . 64.24 111.469 -175.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -134.98 143.47 46.85 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 108.682 -0.858 . . . . 73.03 108.682 178.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 345' ' ' GLY . . . . . . . . . . . . . . . -166.25 106.15 0.26 Allowed Glycine 0 C--N 1.353 1.515 0 CA-C-O 119.395 -0.67 . . . . 62.31 111.686 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 346' ' ' ALA . . . . . . . . . . . . . . . 65.98 11.29 7.62 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 124.785 1.234 . . . . 72.22 113.164 175.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 14.0 m -99.06 0.81 44.47 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.274 1.029 . . . . 72.21 110.844 -178.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 70.2 mt 67.91 -77.35 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 125.964 1.706 . . . . 73.42 110.801 -177.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 349' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -72.01 -83.31 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.21 0.604 . . . . 71.13 110.41 -176.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 350' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -139.36 146.53 40.34 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.97 0.908 . . . . 74.52 108.803 177.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -97.5 136.5 37.84 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 108.0 -1.111 . . . . 71.32 108.0 170.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 26.6 t70 76.2 -59.43 0.51 Allowed 'General case' 0 CA--C 1.55 0.967 0 O-C-N 124.713 1.258 . . . . 74.35 111.106 179.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 353' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -86.03 164.69 17.2 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.473 0.709 . . . . 74.33 111.64 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 354' ' ' ALA . . . . . . . . . . . . . . . 64.95 8.5 4.71 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 124.546 1.139 . . . . 70.11 112.871 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 355' ' ' ALA . . . . . . . . . . . . . . . -92.76 5.95 49.31 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.039 0.935 . . . . 75.44 110.759 174.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 356' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -63.94 -45.04 80.48 Favored Pre-proline 0 CA--C 1.554 1.099 0 C-N-CA 125.049 1.34 . . . . 74.32 112.667 -178.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 357' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -68.08 -17.09 45.74 Favored 'Trans proline' 0 C--N 1.388 2.609 0 C-N-CA 121.899 1.733 . . . . 55.22 112.714 171.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 358' ' ' CYS . . . . . . . . . . . . . 56.9 m 65.5 18.39 11.26 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.721 1.209 . . . . 73.32 111.698 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 359' ' ' GLY . . . . . . . . . . . . . . . 65.02 -86.78 0.08 OUTLIER Glycine 0 C--N 1.353 1.474 0 N-CA-C 111.302 -0.719 . . . . 62.01 111.302 -172.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 360' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -79.49 93.97 5.51 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 108.966 -0.753 . . . . 53.34 108.966 174.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 361' ' ' ILE . . . . . 0.41 HG23 ' H ' ' B' ' 363' ' ' GLU . 7.9 tp -86.54 -20.56 7.74 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.227 0 C-N-CA 124.1 0.96 . . . . 61.31 110.264 177.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 362' ' ' GLY . . . . . . . . . . . . . . . 118.29 -10.78 13.04 Favored Glycine 0 C--N 1.347 1.192 0 CA-C-N 116.089 -0.505 . . . . 72.35 112.52 -178.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 363' ' ' GLU . . . . . 0.41 ' H ' HG23 ' B' ' 361' ' ' ILE . 20.3 mm-40 -81.25 97.48 7.66 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.333 0.653 . . . . 73.13 109.466 179.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 364' ' ' THR . . . . . . . . . . . . . 26.7 p -103.81 93.73 5.05 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.25 1.02 . . . . 74.04 110.758 -176.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 97.9 t -101.26 -56.67 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 N-CA-C 108.457 -0.942 . . . . 74.01 108.457 175.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -128.64 158.3 38.91 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 107.931 -1.137 . . . . 50.12 107.931 177.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 367' ' ' LEU . . . . . . . . . . . . . 81.4 mt -112.93 22.05 14.82 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.114 0.966 . . . . 75.05 110.607 178.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 368' ' ' ASP . . . . . 0.561 ' HA ' HG12 ' B' ' 371' ' ' VAL . 11.0 p-10 -69.0 -10.11 55.86 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 113.932 1.086 . . . . 71.23 113.932 -175.01 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 369' ' ' GLU . . . . . 0.466 ' HA ' ' NH1' ' B' ' 373' ' ' ARG . 16.9 tp10 -97.66 12.23 34.33 Favored 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 123.587 0.755 . . . . 70.1 110.542 177.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 370' ' ' ALA . . . . . . . . . . . . . . . -147.84 -23.84 0.36 Allowed 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 112.751 0.649 . . . . 74.25 112.751 178.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 371' ' ' VAL . . . . . 0.561 HG12 ' HA ' ' B' ' 368' ' ' ASP . 7.3 p -60.78 -66.55 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.333 0 N-CA-C 112.967 0.729 . . . . 74.11 112.967 -167.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 372' ' ' GLN . . . . . 0.434 ' H ' HG13 ' B' ' 371' ' ' VAL . 0.3 OUTLIER -175.6 107.32 0.09 Allowed 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 108.67 -0.863 . . . . 63.2 108.67 -174.117 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 373' ' ' ARG . . . . . 0.466 ' NH1' ' HA ' ' B' ' 369' ' ' GLU . 1.9 mpp_? -119.99 -11.37 9.3 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 123.219 0.608 . . . . 72.05 111.32 174.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . 73.85 -55.59 0.66 Allowed 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 125.883 1.673 . . . . 71.45 112.223 -175.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 375' ' ' LEU . . . . . 0.477 HD12 ' HG2' ' A' ' 263' ' ' PRO . 8.4 tt 75.77 -7.18 1.85 Allowed 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 125.228 1.411 . . . . 62.01 111.395 178.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -69.89 81.18 0.47 Allowed 'General case' 0 C--N 1.357 0.897 0 CA-C-O 121.969 0.89 . . . . 73.13 109.579 173.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 377' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -163.37 -44.35 0.03 OUTLIER 'General case' 0 C--O 1.224 -0.272 0 CA-C-N 113.92 -1.491 . . . . 73.31 107.933 -175.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 378' ' ' ALA . . . . . 0.484 ' HA ' ' HB3' ' B' ' 381' ' ' GLU . . . -55.51 -24.48 31.89 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 124.741 1.216 . . . . 61.1 113.249 -178.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -65.37 -51.57 59.58 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.882 0.873 . . . . 72.01 110.36 175.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 380' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -84.84 -15.28 45.3 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.66 0.784 . . . . 53.14 110.86 -178.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 381' ' ' GLU . . . . . 0.484 ' HB3' ' HA ' ' B' ' 378' ' ' ALA . 23.9 tt0 -72.06 -34.47 68.76 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.399 1.08 . . . . 74.34 109.999 175.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 382' ' ' GLY . . . . . 0.443 ' HA2' HG23 ' B' ' 403' ' ' THR . . . -73.82 66.39 1.75 Allowed Glycine 0 C--N 1.345 1.079 0 N-CA-C 111.666 -0.574 . . . . 73.1 111.666 176.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 383' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -73.87 -46.14 46.61 Favored 'General case' 0 C--N 1.351 0.633 0 C-N-CA 123.988 0.915 . . . . 73.1 109.368 -176.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 384' ' ' THR . . . . . . . . . . . . . 5.2 m 69.63 1.13 3.24 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 124.442 1.097 . . . . 63.41 112.473 173.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 1.3 pp -100.99 165.04 11.53 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.692 0.797 . . . . 75.12 111.728 -177.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 386' ' ' VAL . . . . . . . . . . . . . 10.0 p -94.74 27.41 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 C-N-CA 124.352 1.061 . . . . 62.42 109.884 -179.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 387' ' ' ILE . . . . . . . . . . . . . 48.8 mm 72.49 -66.34 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 126.418 1.887 . . . . 74.12 110.767 -171.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 388' ' ' VAL . . . . . . . . . . . . . 90.4 t 75.31 -49.56 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 C-N-CA 125.564 1.546 . . . . 54.33 111.464 -178.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 389' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 78.58 -12.09 1.13 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 126.914 2.086 . . . . 71.25 113.193 173.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . 53.11 73.74 0.34 Allowed 'General case' 0 C--N 1.363 1.164 0 C-N-CA 124.406 1.082 . . . . 70.34 111.352 176.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 391' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 68.48 -76.3 0.06 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.153 1.381 . . . . 64.12 110.628 -172.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 392' ' ' HIS . . . . . . . . . . . . . 30.1 p-80 -157.1 16.77 0.28 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.013 0.925 . . . . 72.42 110.859 -177.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -68.17 -55.98 10.41 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.552 0.741 . . . . 61.53 110.837 -175.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 44.0 t-80 68.41 -71.47 0.11 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 126.126 1.77 . . . . 73.31 111.579 179.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . 54.42 -100.57 0.11 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.315 1.046 . . . . 71.44 109.308 -169.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 16.5 m 63.71 -17.79 0.07 Allowed 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 124.947 1.299 . . . . 75.55 114.344 177.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 397' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 62.2 -68.83 0.06 Allowed 'General case' 0 C--N 1.356 0.852 0 C-N-CA 126.591 1.956 . . . . 71.41 111.226 -171.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 20.9 pt -85.59 155.17 3.46 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.209 0 C-N-CA 124.213 1.005 . . . . 75.44 110.639 172.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 399' ' ' VAL . . . . . . . . . . . . . 11.5 p -78.65 -25.62 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 122.553 0.341 . . . . 73.32 110.86 -175.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 400' ' ' ALA . . . . . . . . . . . . . . . -123.31 83.3 52.19 Favored Pre-proline 0 CA--C 1.557 1.219 0 C-N-CA 124.017 0.927 . . . . 51.41 110.247 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 401' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -69.78 -52.82 0.3 Allowed 'Trans proline' 0 C--N 1.386 2.552 0 C-N-CA 122.818 2.345 . . . . 71.04 111.868 176.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 402' ' ' ASP . . . . . 0.409 ' HB3' ' HD3' ' A' ' 260' ' ' ARG . 6.6 t70 59.15 -179.64 0.08 Allowed 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 125.128 1.371 . . . . 74.34 112.478 174.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 403' ' ' THR . . . . . 0.443 HG23 ' HA2' ' B' ' 382' ' ' GLY . 85.8 m -147.61 106.22 3.8 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.992 0.917 . . . . 51.3 108.968 172.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 404' ' ' LYS . . . . . 0.421 ' HE2' ' HB1' ' C' ' 275' ' ' ALA . 24.6 tptp -84.89 -29.81 24.93 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 122.699 0.4 . . . . 70.03 109.997 177.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 405' ' ' ALA . . . . . . . . . . . . . . . -50.3 105.6 0.54 Allowed Pre-proline 0 CA--C 1.558 1.262 0 C-N-CA 124.727 1.211 . . . . 71.24 112.286 -177.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 406' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -72.1 1.33 6.07 Favored 'Trans proline' 0 C--N 1.384 2.413 0 C-N-CA 123.281 2.654 . . . . 44.44 114.224 -174.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . -74.36 -24.9 71.94 Favored Glycine 0 C--N 1.344 1.016 0 N-CA-C 111.957 -0.457 . . . . 55.33 111.957 169.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 408' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -105.94 26.78 9.25 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.283 1.033 . . . . 72.03 109.993 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 9.5 t -64.41 -25.32 67.96 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 124.195 0.998 . . . . 73.52 112.827 -178.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 410' ' ' GLN . . . . . . . . . . . . . 71.0 mm-40 67.33 -77.27 0.05 OUTLIER 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.609 1.564 . . . . 51.32 110.362 -174.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . 60.45 -76.84 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 125.3 1.44 . . . . 63.14 112.435 174.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 5.8 mp -64.5 -37.58 88.04 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.195 0.998 . . . . 60.41 110.09 178.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -76.99 85.2 3.51 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.103 -0.953 . . . . 71.14 109.012 175.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 414' ' ' THR . . . . . . . . . . . . . 12.9 p -98.52 82.15 2.82 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.067 0.947 . . . . 73.24 108.879 174.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 415' ' ' LYS . . . . . . . . . . . . . 5.0 ttmp? -133.25 -44.01 0.85 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.521 0.728 . . . . 73.42 109.867 -175.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 70.43 138.28 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.968 1.707 . . . . 75.33 111.5 -177.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 417' ' ' GLY . . . . . . . . . . . . . . . -65.82 -36.53 92.32 Favored Glycine 0 C--N 1.346 1.126 0 N-CA-C 110.663 -0.975 . . . . 43.15 110.663 169.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 418' ' ' ALA . . . . . . . . . . . . . . . -139.27 114.5 9.64 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.091 0.957 . . . . 70.25 108.481 171.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 419' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.5 140.89 18.96 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 C-N-CA 123.668 0.787 . . . . 62.03 109.487 175.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 420' ' ' MET . . . . . 0.476 ' SD ' ' N ' ' B' ' 421' ' ' VAL . 9.5 tmm? 72.66 153.97 0.14 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 124.813 1.245 . . . . 73.12 109.111 -169.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 421' ' ' VAL . . . . . 0.656 HG21 ' HG2' ' A' ' 211' ' ' ARG . 15.9 m -67.96 91.2 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.331 0 CA-C-O 122.115 0.96 . . . . 72.42 112.63 -174.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 422' ' ' MET . . . . . . . . . . . . . 13.6 tpt -63.6 -48.99 75.11 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 115.175 -0.921 . . . . 74.1 108.67 166.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 423' ' ' SER . . . . . . . . . . . . . 46.2 m -148.8 -57.02 0.21 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 107.282 -1.377 . . . . 62.22 107.282 170.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 424' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -140.51 107.63 5.47 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.49 1.116 . . . . 72.42 108.407 172.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . -171.12 152.36 18.08 Favored Glycine 0 C--N 1.344 0.987 0 N-CA-C 110.787 -0.925 . . . . 75.12 110.787 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 426' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 64.53 87.77 0.11 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.717 1.207 . . . . 75.43 111.012 -177.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 427' ' ' SER . . . . . . . . . . . . . 34.6 p -74.09 86.88 1.87 Allowed 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 115.213 -0.903 . . . . 75.14 110.925 -176.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 58.56 28.0 16.45 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 125.197 1.399 . . . . 73.23 112.385 175.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 429' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 62.39 -89.76 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 124.718 1.207 . . . . 63.42 110.738 -172.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 18.5 t70 177.12 -86.93 0.0 OUTLIER 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.176 1.39 . . . . 55.41 108.102 -174.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 431' ' ' SER . . . . . 0.604 ' HB3' ' HB ' ' B' ' 329' ' ' ILE . 51.4 m -167.68 10.88 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 124.452 1.101 . . . . 73.31 111.564 -174.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 432' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -71.9 -49.34 38.72 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.387 0.675 . . . . 71.1 110.882 -173.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 433' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -135.51 -40.92 0.71 Allowed 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.245 -0.889 . . . . 73.43 109.758 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 434' ' ' HIS . . . . . . . . . . . . . 59.6 t-80 66.89 102.54 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.284 1.034 . . . . 65.13 110.68 177.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 435' ' ' THR . . . . . 0.655 HG22 HG12 ' A' ' 219' ' ' VAL . 1.7 m -69.1 -25.47 64.43 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.65 0.78 . . . . 73.42 112.649 -167.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . -66.01 94.72 0.22 Allowed Glycine 0 C--N 1.349 1.283 0 N-CA-C 111.49 -0.644 . . . . 43.54 111.49 174.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 24.9 p -79.93 -85.98 0.08 Allowed 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 123.319 0.648 . . . . 54.14 111.74 -172.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 438' ' ' GLN . . . . . . . . . . . . . 13.9 tm0? -107.74 -76.39 0.61 Allowed 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 108.05 -1.092 . . . . 71.55 108.05 -177.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 439' ' ' LEU . . . . . . . . . . . . . 1.7 pp 34.79 45.58 0.16 Allowed 'General case' 0 N--CA 1.502 2.138 0 C-N-CA 126.347 1.859 . . . . 74.24 114.96 169.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 440' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -75.1 -4.1 36.63 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 115.964 -0.562 . . . . 70.1 112.327 -169.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 441' ' ' ILE . . . . . 0.616 HG22 ' H ' ' B' ' 443' ' ' ALA . 46.2 mm 76.42 -83.87 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 125.355 1.462 . . . . 74.15 111.673 170.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 442' ' ' ALA . . . . . . . . . . . . . . . 67.63 2.34 2.95 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 124.654 1.182 . . . . 71.41 114.176 -177.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 443' ' ' ALA . . . . . 0.616 ' H ' HG22 ' B' ' 441' ' ' ILE . . . -89.23 154.6 19.99 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.641 0.776 . . . . 74.21 110.709 178.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 65.08 -80.26 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.865 1.266 . . . . 65.34 110.787 -174.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . 168.28 78.72 0.04 OUTLIER Glycine 0 C--N 1.341 0.816 0 N-CA-C 110.717 -0.953 . . . . 74.34 110.717 -177.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 446' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -79.58 0.11 10.28 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 122.544 2.163 . . . . 63.02 111.536 175.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 447' ' ' HIS . . . . . 0.467 ' HB3' HD21 ' B' ' 450' ' ' ASN . 26.9 m80 -123.32 87.8 2.81 Favored 'General case' 0 C--N 1.35 0.623 0 C-N-CA 124.407 1.083 . . . . 60.0 108.453 178.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . -124.72 117.05 23.35 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.963 1.305 . . . . 74.31 109.238 -177.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 449' ' ' ALA . . . . . . . . . . . . . . . 57.82 67.22 0.99 Allowed 'General case' 0 CA--C 1.549 0.906 0 O-C-N 124.207 0.942 . . . . 61.52 110.467 -174.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 450' ' ' ASN . . . . . 0.467 HD21 ' HB3' ' B' ' 447' ' ' HIS . 14.9 m120 -64.11 -68.68 0.33 Allowed 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 114.774 -1.103 . . . . 61.12 111.354 -174.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 46.8 t 62.16 -74.07 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 C-N-CA 125.038 1.335 . . . . 63.1 111.365 -178.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 452' ' ' VAL . . . . . . . . . . . . . 29.8 m -85.49 172.59 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 123.585 0.754 . . . . 60.45 109.786 171.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . -148.18 44.05 0.79 Allowed Glycine 0 N--CA 1.466 0.687 0 N-CA-C 110.924 -0.87 . . . . 73.44 110.924 175.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 454' ' ' LEU . . . . . . . . . . . . . 42.4 tp -146.7 120.39 9.2 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.32 0.648 . . . . 72.5 109.664 -176.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 11.1 t -154.54 13.49 0.42 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.115 0.966 . . . . 61.41 109.753 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -82.22 -19.59 39.41 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.327 1.051 . . . . 74.3 112.65 -165.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 457' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -65.6 154.72 37.95 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.348 0.659 . . . . 42.14 111.114 -179.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 46.8 p -57.76 -26.56 62.04 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.443 1.097 . . . . 72.13 112.855 -178.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 459' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -62.15 -37.76 86.43 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.772 0.829 . . . . 73.31 110.602 174.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 94.1 mt 66.87 99.12 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.497 1.519 . . . . 65.42 110.672 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -76.13 -176.32 3.48 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.675 0.79 . . . . 62.31 110.578 178.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 462' ' ' TYR . . . . . 0.472 ' HB3' ' HA3' ' B' ' 469' ' ' GLY . 39.7 m-85 -74.96 107.48 7.06 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 109.247 -0.649 . . . . 72.53 109.247 174.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 463' ' ' THR . . . . . 0.595 HG22 ' HA ' ' B' ' 470' ' ' LEU . 12.5 t -68.96 -179.35 1.46 Allowed 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 122.95 0.5 . . . . 61.35 111.104 -179.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 464' ' ' MET . . . . . . . . . . . . . 21.7 mmt -76.98 20.37 0.26 Allowed 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 123.933 0.893 . . . . 75.31 113.203 -168.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt -80.28 140.26 36.28 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 109.37 -0.604 . . . . 72.15 109.37 169.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -73.79 147.27 43.57 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 122.791 0.436 . . . . 62.32 109.911 170.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . 72.38 111.96 0.06 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.299 1.439 . . . . 75.3 111.825 -178.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 39.3 tp 66.04 -73.37 0.07 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 125.4 1.48 . . . . 45.51 110.724 -177.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 469' ' ' GLY . . . . . 0.472 ' HA3' ' HB3' ' B' ' 462' ' ' TYR . . . 142.73 -96.13 0.19 Allowed Glycine 0 C--N 1.345 1.058 0 N-CA-C 112.202 -0.359 . . . . 50.44 112.202 172.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 470' ' ' LEU . . . . . 0.595 ' HA ' HG22 ' B' ' 463' ' ' THR . 46.5 tp -62.58 -55.09 30.44 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.421 0.688 . . . . 73.2 111.157 -175.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 471' ' ' LYS . . . . . . . . . . . . . 5.3 mtpm? . . . . . 0 CA--C 1.55 0.966 0 CA-C-N 115.04 -0.982 . . . . 74.2 108.772 179.697 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 68.3 mtm . . . . . 0 N--CA 1.481 1.082 0 N-CA-C 110.426 -0.213 . . . . 55.23 110.426 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.39 29.4 18.96 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.932 1.293 . . . . 65.31 112.69 175.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -74.68 76.9 2.04 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.382 0.673 . . . . 52.01 109.693 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -37.72 101.63 0.02 OUTLIER 'General case' 0 C--N 1.354 0.773 0 C-N-CA 125.765 1.626 . . . . 70.52 113.756 -176.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 5' ' ' LYS . . . . . 0.477 ' HE2' HD11 ' C' ' 10' ' ' ILE . 14.6 mmmm -73.32 98.94 2.78 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.46 -1.311 . . . . 63.2 107.46 164.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -71.15 92.78 1.01 Allowed 'General case' 0 C--O 1.234 0.258 0 N-CA-C 107.759 -1.2 . . . . 63.22 107.759 177.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 7' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -58.64 -29.96 66.94 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 114.668 -1.151 . . . . 73.43 112.17 -170.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -67.33 -48.75 66.63 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.112 -0.949 . . . . 72.53 110.002 176.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.12 -38.52 86.66 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.978 0.511 . . . . 52.31 110.941 178.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 10' ' ' ILE . . . . . 0.477 HD11 ' HE2' ' C' ' 5' ' ' LYS . 59.5 mt -61.79 -39.36 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.335 0.654 . . . . 63.34 110.185 176.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 96.0 mt -80.44 -7.47 59.16 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 112.586 0.587 . . . . 45.45 112.586 176.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.37 35.84 51.41 Favored Glycine 0 C--N 1.352 1.454 0 CA-C-N 117.917 0.326 . . . . 64.33 113.636 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 6.3 m -133.55 155.89 80.15 Favored Pre-proline 0 N--CA 1.483 1.206 0 C-N-CA 125.109 1.364 . . . . 64.04 109.576 177.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -81.98 155.42 17.49 Favored 'Trans proline' 0 C--N 1.371 1.714 0 C-N-CA 122.195 1.93 . . . . 74.43 112.306 174.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 90.1 mtm-85 -67.35 75.98 0.16 Allowed 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.747 0.819 . . . . 71.52 110.311 174.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -177.48 -31.63 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.572 1.149 . . . . 71.24 108.779 -175.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.68 134.22 56.52 Favored 'General case' 0 C--N 1.353 0.748 0 CA-C-N 115.578 -0.737 . . . . 71.14 110.401 177.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 75.0 p -71.36 173.46 7.8 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.319 0.648 . . . . 74.41 111.671 -175.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 19' ' ' GLN . . . . . 0.464 HE22 ' HE2' ' C' ' 23' ' ' LYS . 0.1 OUTLIER -60.24 -39.55 87.09 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.347 1.059 . . . . 74.45 110.376 -176.005 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 20' ' ' GLU . . . . . 0.42 ' O ' ' HG3' ' C' ' 24' ' ' ARG . 7.8 tm-20 -66.64 -34.94 78.98 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 123.148 0.579 . . . . 64.05 110.015 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -70.97 -36.95 72.73 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 122.734 0.414 . . . . 73.42 110.773 176.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 1.4 mp -63.87 -34.52 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.333 1.053 . . . . 61.32 110.078 173.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 23' ' ' LYS . . . . . 0.534 ' O ' ' HG3' ' C' ' 27' ' ' LYS . 13.7 tppt? -66.55 -45.18 80.22 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.295 0.638 . . . . 74.13 109.305 178.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 24' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' C' ' 20' ' ' GLU . 63.1 mtm-85 -63.49 -41.99 98.55 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 123.459 0.475 . . . . 73.52 110.839 178.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.95 -38.45 86.14 Favored 'General case' 0 C--O 1.253 1.251 0 CA-C-N 115.257 -0.883 . . . . 75.32 110.987 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 26' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -57.14 -55.78 30.25 Favored 'General case' 0 C--O 1.216 -0.685 0 CA-C-N 114.541 -1.208 . . . . 72.31 109.13 173.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . 0.534 ' HG3' ' O ' ' C' ' 23' ' ' LYS . 33.2 mtmt -57.39 -41.56 80.47 Favored 'General case' 0 N--CA 1.483 1.186 0 O-C-N 124.424 1.078 . . . . 74.1 110.824 -177.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -55.32 -51.45 66.69 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.004 0.921 . . . . 71.15 110.961 178.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 82.3 mt -86.07 -6.02 59.1 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.724 -0.671 . . . . 60.22 111.498 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.41 -0.09 49.75 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.934 0.893 . . . . 75.32 110.011 171.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . 0.402 ' HG3' ' O ' ' C' ' 27' ' ' LYS . 95.7 mtt180 -100.94 -41.89 6.64 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.26 1.024 . . . . 73.5 109.208 165.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.33 -50.16 49.07 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 115.637 -0.71 . . . . 71.12 109.629 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 33' ' ' TYR . . . . . 0.422 ' HB3' ' O ' ' C' ' 43' ' ' ALA . 37.2 m-85 -95.4 14.94 20.9 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.924 0.49 . . . . 70.15 111.52 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 34' ' ' HIS . . . . . 0.422 ' CD2' HG23 ' C' ' 37' ' ' VAL . 12.4 t60 -61.4 107.82 1.27 Allowed Pre-proline 0 N--CA 1.489 1.48 0 C-N-CA 124.36 1.064 . . . . 72.34 110.792 -177.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -61.74 -21.31 71.87 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 123.018 2.479 . . . . 71.32 114.16 -172.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.05 -26.31 36.44 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.951 0.9 . . . . 60.34 111.668 178.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . 0.422 HG23 ' CD2' ' C' ' 34' ' ' HIS . 90.2 t -97.39 -58.33 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 109.046 -0.724 . . . . 75.33 109.046 176.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -98.12 84.21 3.24 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 114.801 -1.09 . . . . 54.22 108.907 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.26 79.21 0.99 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 114.866 -1.061 . . . . 62.24 108.635 175.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 67.1 m -140.38 114.9 7.53 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-O 118.301 -0.857 . . . . 74.14 109.387 -178.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -52.12 -41.85 62.61 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 123.326 2.684 . . . . 63.44 112.774 -176.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -48.62 -50.62 31.94 Favored 'General case' 0 N--CA 1.483 1.18 0 O-C-N 124.078 0.861 . . . . 65.44 110.85 173.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 43' ' ' ALA . . . . . 0.422 ' O ' ' HB3' ' C' ' 33' ' ' TYR . . . -71.55 -23.55 61.78 Favored 'General case' 0 C--O 1.216 -0.679 0 CA-C-N 114.768 -1.105 . . . . 62.05 110.931 -176.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 44' ' ' GLU . . . . . 0.469 ' O ' ' HG3' ' C' ' 48' ' ' LYS . 47.9 mt-10 -80.72 -33.48 35.22 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 122.992 0.517 . . . . 74.04 110.672 -176.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 45' ' ' GLU . . . . . 0.418 ' HA ' ' HD2' ' C' ' 48' ' ' LYS . 40.3 mt-10 -76.36 -39.4 53.95 Favored 'General case' 0 C--O 1.244 0.763 0 C-N-CA 123.316 0.647 . . . . 42.53 109.643 178.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 46' ' ' LYS . . . . . 0.535 ' O ' HG12 ' C' ' 50' ' ' ILE . 99.6 mttt -64.26 -34.7 78.71 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.008 -0.997 . . . . 72.32 110.131 170.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -66.34 -35.87 81.45 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.919 0.888 . . . . 62.23 110.297 175.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 48' ' ' LYS . . . . . 0.469 ' HG3' ' O ' ' C' ' 44' ' ' GLU . 95.1 mttt -60.67 -42.32 96.83 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 109.773 -0.454 . . . . 72.04 109.773 173.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -66.67 -33.8 76.45 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 123.653 0.596 . . . . 72.33 111.578 174.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 50' ' ' ILE . . . . . 0.535 HG12 ' O ' ' C' ' 46' ' ' LYS . 32.8 mm -65.72 -33.93 66.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 109.005 -0.739 . . . . 75.43 109.005 175.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 51' ' ' ASN . . . . . 0.555 ' HA ' ' HB3' ' C' ' 54' ' ' TYR . 36.3 m-80 -93.0 -3.98 53.46 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.123 0.969 . . . . 74.04 112.333 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -81.53 -51.45 8.25 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 107.243 -1.391 . . . . 63.42 107.243 165.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.14 -37.29 71.82 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 112.503 -2.135 . . . . 63.1 111.304 173.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 54' ' ' TYR . . . . . 0.555 ' HB3' ' HA ' ' C' ' 51' ' ' ASN . 58.1 t80 -78.18 -39.21 41.51 Favored 'General case' 0 C--O 1.215 -0.724 0 CA-C-N 115.5 -0.773 . . . . 75.01 110.411 174.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.52 -28.32 44.46 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 118.751 0.705 . . . . 60.54 111.56 177.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 56' ' ' VAL . . . . . 0.462 ' O ' ' HB2' ' C' ' 62' ' ' LYS . 47.3 t -83.28 -67.09 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 CA-C-O 121.288 0.566 . . . . 72.43 110.443 169.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 57' ' ' LEU . . . . . . . . . . . . . 52.1 mt -84.47 15.5 3.67 Favored 'General case' 0 CA--C 1.565 1.538 0 N-CA-C 113.066 0.765 . . . . 75.02 113.066 -164.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 45.5 t -61.2 -45.8 93.09 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 124.188 0.995 . . . . 62.42 112.291 -178.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -123.31 149.83 58.82 Favored Pre-proline 0 C--O 1.242 0.69 0 CA-C-N 114.897 -1.047 . . . . 72.03 108.639 -173.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 60' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -51.43 -26.97 22.9 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 123.299 2.666 . . . . 33.23 113.088 174.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -62.56 -70.28 0.21 Allowed 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.439 -0.8 . . . . 62.13 111.272 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 62' ' ' LYS . . . . . 0.486 ' HD3' ' H ' ' C' ' 62' ' ' LYS . 0.0 OUTLIER -70.64 -20.66 62.71 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 122.117 0.167 . . . . 75.23 110.857 -175.568 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -53.59 -62.11 1.87 Allowed 'General case' 0 C--N 1.354 0.776 0 O-C-N 124.002 0.814 . . . . 64.42 109.864 168.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -70.1 -27.56 64.69 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 112.249 0.463 . . . . 74.15 112.249 -176.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 88.5 mt -57.71 -50.27 78.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 109.68 -0.489 . . . . 62.34 109.68 172.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -61.74 -47.61 84.45 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.112 0.565 . . . . 74.22 111.691 174.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -53.94 -32.16 52.75 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.119 0.568 . . . . 73.14 111.979 -178.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 68' ' ' THR . . . . . 0.446 ' O ' ' HB ' ' C' ' 72' ' ' THR . 40.1 p -97.02 -24.09 15.96 Favored 'General case' 0 CA--C 1.553 1.069 0 N-CA-C 112.512 0.56 . . . . 63.2 112.512 176.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 69' ' ' TYR . . . . . 0.444 ' HE2' ' HD3' ' C' ' 78' ' ' PRO . 3.4 t80 -118.25 120.29 37.22 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.31 -0.869 . . . . 75.22 110.763 -172.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.94 23.58 66.25 Favored Glycine 0 C--N 1.346 1.136 0 N-CA-C 111.616 -0.594 . . . . 62.51 111.616 -173.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 54.8 m -142.18 -53.58 0.42 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 103.745 -2.687 . . . . 72.34 103.745 175.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . 0.446 ' HB ' ' O ' ' C' ' 68' ' ' THR . 21.1 m -105.25 173.3 6.36 Favored 'General case' 0 CA--C 1.564 1.498 0 N-CA-C 104.969 -2.234 . . . . 73.35 104.969 158.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -90.85 11.41 22.67 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 118.999 0.818 . . . . 73.23 111.081 173.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 74' ' ' ALA . . . . . 0.45 ' HB1' ' HD2' ' C' ' 75' ' ' PRO . . . -62.12 -163.35 0.0 OUTLIER Pre-proline 0 CA--C 1.594 2.646 0 C-N-CA 125.728 1.611 . . . . 53.23 112.305 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 75' ' ' PRO . . . . . 0.523 ' HA ' ' HD2' ' C' ' 76' ' ' PRO . 0.2 OUTLIER 8.2 109.24 0.0 OUTLIER 'Trans proline' 1 C--N 1.419 4.25 0 C-N-CA 125.153 3.902 . . . . 75.14 118.512 -156.134 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' C' C ' 76' ' ' PRO . . . . . 0.523 ' HD2' ' HA ' ' C' ' 75' ' ' PRO . 42.5 Cg_endo -62.12 165.96 13.59 Favored 'Trans proline' 0 C--N 1.387 2.556 0 C-N-CA 123.52 2.813 . . . . 63.14 113.321 -179.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -21.39 106.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.405 3.517 1 C-N-CA 126.157 4.572 . . . . 51.51 116.029 178.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 78' ' ' PRO . . . . . 0.624 ' HG2' ' HA ' ' C' ' 101' ' ' PHE . 1.3 Cg_exo -37.59 146.45 0.11 Allowed 'Trans proline' 0 C--N 1.379 2.133 1 C-N-CA 126.277 4.651 . . . . 74.44 117.639 -171.781 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -58.87 119.43 6.68 Favored 'Trans proline' 0 C--N 1.391 2.813 0 C-N-CA 123.555 2.837 . . . . 61.04 113.411 -178.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -62.12 75.49 0.1 OUTLIER 'Trans proline' 0 C--N 1.391 2.811 0 C-N-CA 123.56 2.84 . . . . 51.5 110.321 169.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -167.48 -24.89 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 113.704 -1.589 . . . . 75.2 110.281 -166.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.41 ' HA2' ' O ' ' C' ' 104' ' ' GLY . . . 118.21 141.73 6.81 Favored Glycine 0 C--N 1.361 1.969 0 N-CA-C 116.377 1.311 . . . . 74.45 116.377 163.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 83' ' ' TYR . . . . . 0.505 ' CE1' ' HB3' ' C' ' 78' ' ' PRO . 22.7 m-85 -110.03 92.93 4.24 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 107.311 -1.366 . . . . 70.14 107.311 165.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -27.67 135.29 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 127.471 2.308 . . . . 63.13 116.157 -175.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 85' ' ' PHE . . . . . 0.564 ' HZ ' HD22 ' C' ' 105' ' ' LEU . 16.0 m-85 -135.49 74.21 1.5 Allowed 'General case' 0 C--N 1.346 0.451 0 CA-C-N 115.167 -0.924 . . . . 74.41 110.999 -177.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 86' ' ' SER . . . . . 0.521 ' OG ' ' HA2' ' C' ' 163' ' ' GLY . 1.4 m -55.82 83.21 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 123.715 0.806 . . . . 45.43 110.523 177.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 62.65 16.0 54.92 Favored Glycine 0 CA--C 1.54 1.637 0 CA-C-O 119.007 -0.885 . . . . 74.33 114.624 -170.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 88' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -86.46 120.81 28.19 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 118.536 1.168 . . . . 74.44 109.772 -174.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -76.56 88.67 3.28 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 120.856 0.36 . . . . 72.23 110.604 -174.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 90' ' ' VAL . . . . . . . . . . . . . 6.0 p -45.43 -43.96 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 124.333 1.053 . . . . 54.41 113.06 175.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -61.48 -31.2 71.17 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.745 0.818 . . . . 74.21 111.381 -176.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -79.08 -24.89 43.18 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.275 -0.875 . . . . 75.53 111.083 -176.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 19.1 m-30 -73.83 165.51 24.98 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 122.637 0.375 . . . . 72.45 110.787 -175.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 86.3 p -67.62 163.45 21.33 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 113.509 0.929 . . . . 45.51 113.509 -167.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.11 -42.91 95.72 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.027 -0.988 . . . . 55.43 110.645 172.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -58.44 -43.53 88.82 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.161 0.584 . . . . 65.02 110.653 178.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 97' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -61.51 -43.67 98.45 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.203 -0.908 . . . . 64.25 109.691 177.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 98' ' ' GLN . . . . . 0.541 ' HA ' HD12 ' C' ' 105' ' ' LEU . 48.6 mt-30 -82.58 -5.21 58.65 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 115.091 -0.958 . . . . 51.52 113.306 -177.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -101.4 -35.95 9.03 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.412 0.685 . . . . 74.43 110.947 172.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 46.3 tp -74.2 -61.4 1.87 Allowed 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 109.067 -0.716 . . . . 73.23 109.067 -178.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 101' ' ' PHE . . . . . 0.624 ' HA ' ' HG2' ' C' ' 78' ' ' PRO . 65.6 m-85 -92.08 8.72 36.54 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 115.389 -0.823 . . . . 73.25 111.55 -177.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -46.52 -58.28 6.05 Favored Glycine 0 CA--C 1.544 1.895 0 N-CA-C 117.629 1.811 . . . . 54.11 117.629 -169.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . 0.433 ' HD2' ' HD2' ' C' ' 78' ' ' PRO . 52.9 Cg_exo -58.49 -18.55 39.84 Favored 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 123.359 2.706 . . . . 62.02 114.41 179.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 104' ' ' GLY . . . . . 0.41 ' O ' ' HA2' ' C' ' 82' ' ' GLY . . . -105.35 -1.71 41.05 Favored Glycine 0 C--N 1.348 1.197 0 CA-C-O 119.501 -0.61 . . . . 43.23 113.814 179.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 105' ' ' LEU . . . . . 0.564 HD22 ' HZ ' ' C' ' 85' ' ' PHE . 15.3 mt -83.56 32.97 0.46 Allowed 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 119.284 1.542 . . . . 73.03 113.595 -175.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 106' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 53.03 -117.64 1.22 Allowed 'General case' 0 CA--C 1.557 1.216 0 N-CA-C 107.846 -1.168 . . . . 64.24 107.846 -177.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.48 54.68 1.22 Allowed Glycine 0 C--N 1.368 2.344 0 N-CA-C 120.815 3.086 . . . . 51.05 120.815 155.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 61.82 -77.1 0.02 OUTLIER Glycine 0 CA--C 1.554 2.483 0 N-CA-C 115.95 1.14 . . . . 74.41 115.95 162.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 109' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -77.0 -7.54 55.81 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 124.757 1.223 . . . . 74.45 111.049 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 110' ' ' GLY . . . . . . . . . . . . . . . -65.91 13.45 0.33 Allowed Glycine 0 CA--C 1.556 2.656 0 N-CA-C 116.574 1.389 . . . . 54.22 116.574 176.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 47.8 ttp180 87.79 -42.03 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 125.745 1.618 . . . . 75.25 113.399 167.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 112' ' ' ARG . . . . . . . . . . . . . 7.5 tpm_? -114.7 -44.55 3.06 Favored 'General case' 0 N--CA 1.503 2.192 0 CA-C-N 119.104 0.866 . . . . 74.1 108.895 168.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 113' ' ' SER . . . . . . . . . . . . . 22.9 m -4.28 80.23 0.0 OUTLIER 'General case' 0 C--O 1.205 -1.278 0 C-N-CA 127.271 2.228 . . . . 72.53 115.821 154.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 114' ' ' ARG . . . . . 0.444 ' HA ' ' HD3' ' C' ' 114' ' ' ARG . 18.4 mmt180 -133.12 -131.4 0.18 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.75 -1.219 . . . . 74.05 111.524 176.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 115' ' ' LYS . . . . . 0.4 ' H ' ' HB3' ' C' ' 114' ' ' ARG . 7.6 tmtt? -82.25 106.05 13.83 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 103.441 -2.8 . . . . 54.14 103.441 161.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 116' ' ' GLY . . . . . 0.431 ' HA3' ' HB3' ' C' ' 171' ' ' PRO . . . -63.28 132.06 42.06 Favored Glycine 0 C--N 1.344 1.022 0 O-C-N 123.858 0.724 . . . . 45.25 111.965 -171.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 60.4 mtt180 -80.26 174.91 11.13 Favored 'General case' 0 C--O 1.247 0.947 0 N-CA-C 108.963 -0.755 . . . . 64.44 108.963 175.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.39 130.91 43.19 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-O 120.865 0.364 . . . . 75.42 110.293 174.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 119' ' ' LEU . . . . . . . . . . . . . 5.1 tt -90.47 137.35 32.43 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 105.15 -2.167 . . . . 75.21 105.15 -179.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.443 ' H ' ' HD2' ' C' ' 120' ' ' ARG . 0.0 OUTLIER -127.48 148.88 50.31 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 110.14 -0.318 . . . . 72.31 110.14 -172.765 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.27 118.56 6.84 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.525 -0.761 . . . . 63.21 109.45 177.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 122' ' ' GLU . . . . . 0.417 ' HA ' ' O ' ' C' ' 177' ' ' VAL . 38.5 tt0 -83.93 132.54 34.76 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 109.772 -0.455 . . . . 73.22 109.772 178.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 123' ' ' LEU . . . . . 0.457 HD13 ' HB2' ' B' ' 183' ' ' ALA . 2.6 pt? -144.69 129.88 9.38 Favored Pre-proline 0 N--CA 1.481 1.1 0 C-N-CA 122.646 0.378 . . . . 73.3 110.185 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . 0.557 ' HG2' ' H ' ' B' ' 189' ' ' LYS . 17.3 Cg_exo -72.14 124.83 10.33 Favored 'Trans proline' 0 C--N 1.366 1.452 0 C-N-CA 122.218 1.945 . . . . 72.51 111.281 165.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 125' ' ' LEU . . . . . . . . . . . . . 38.0 tp -142.64 155.05 44.89 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.199 1.0 . . . . 74.03 109.015 -170.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 126' ' ' THR . . . . . 0.587 ' HB ' ' HG2' ' C' ' 129' ' ' GLU . 1.8 m -101.45 158.04 16.36 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 122.965 0.506 . . . . 61.53 110.289 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 127' ' ' LEU . . . . . 0.565 HD21 HD13 ' C' ' 180' ' ' LEU . 56.1 mt -64.45 -44.69 90.33 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.581 1.153 . . . . 62.25 110.92 178.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -59.93 -36.98 78.19 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 114.954 -1.021 . . . . 75.24 110.505 175.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 129' ' ' GLU . . . . . 0.587 ' HG2' ' HB ' ' C' ' 126' ' ' THR . 6.8 mm-40 -78.54 -22.08 47.81 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.105 0.562 . . . . 73.53 111.401 -179.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -73.79 -31.68 63.39 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 121.118 0.485 . . . . 64.34 109.935 174.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 131' ' ' PHE . . . . . 0.421 ' CZ ' ' HB3' ' C' ' 216' ' ' GLU . 49.4 t80 -69.19 -46.84 66.5 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 114.575 -1.193 . . . . 75.55 110.186 167.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 132' ' ' HIS . . . . . . . . . . . . . 28.1 m170 -78.03 -6.32 54.17 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.152 0.581 . . . . 60.22 111.608 -176.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -55.45 -94.29 0.01 OUTLIER Glycine 0 C--N 1.355 1.631 0 O-C-N 123.977 0.798 . . . . 65.31 113.259 175.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . 55.06 -137.0 45.1 Favored Glycine 0 C--N 1.355 1.636 0 CA-C-N 117.306 0.553 . . . . 53.24 112.799 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 135' ' ' GLU . . . . . 0.499 ' HG3' ' HB2' ' C' ' 148' ' ' ARG . 2.5 mp0 -76.29 96.4 3.96 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 108.839 -0.8 . . . . 71.2 108.839 172.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 136' ' ' ARG . . . . . 0.515 ' HA ' ' HE ' ' C' ' 136' ' ' ARG . 2.4 tpm_? -140.43 160.2 40.52 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-O 120.842 0.353 . . . . 72.12 110.296 -175.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 137' ' ' VAL . . . . . . . . . . . . . 19.9 m -74.73 96.19 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.191 0 CA-C-O 122.249 1.023 . . . . 71.12 111.741 -177.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 138' ' ' VAL . . . . . . . . . . . . . 42.8 t -90.36 136.54 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 114.621 -1.172 . . . . 72.14 108.758 172.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 139' ' ' GLU . . . . . 0.487 ' HA ' ' O ' ' C' ' 143' ' ' ARG . 1.4 tm-20 -124.09 115.89 21.89 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 108.165 -1.05 . . . . 74.31 108.165 174.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 140' ' ' VAL . . . . . . . . . . . . . 66.8 t -137.64 109.13 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 124.187 0.995 . . . . 63.22 109.148 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 63.59 25.75 14.45 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.265 1.026 . . . . 15.23 113.186 173.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 108.68 -8.24 34.29 Favored Glycine 0 N--CA 1.473 1.153 0 CA-C-N 116.666 -0.243 . . . . 45.25 113.006 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 143' ' ' ARG . . . . . 0.705 HH12 ' HA ' ' C' ' 164' ' ' MET . 27.4 mmm-85 -87.85 95.98 10.3 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.135 0.574 . . . . 73.04 110.718 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 47.1 ttp180 -96.9 98.84 10.44 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 108.631 -0.878 . . . . 71.51 108.631 175.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 145' ' ' VAL . . . . . 0.536 HG21 ' NH2' ' C' ' 143' ' ' ARG . 69.8 t -132.38 133.09 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.061 0.944 . . . . 75.03 110.525 -169.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 15.7 m -85.59 85.03 7.44 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 108.455 -0.943 . . . . 54.21 108.455 170.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 147' ' ' VAL . . . . . 0.404 ' HB ' HG12 ' C' ' 145' ' ' VAL . 10.4 p -118.54 145.35 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 123.232 0.613 . . . . 72.53 110.428 -171.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 148' ' ' ARG . . . . . 0.499 ' HB2' ' HG3' ' C' ' 135' ' ' GLU . 42.3 ttm180 -78.25 105.76 9.7 Favored 'General case' 0 C--N 1.348 0.518 0 N-CA-C 108.468 -0.938 . . . . 74.22 108.468 169.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 149' ' ' ILE . . . . . 0.633 HD12 HG21 ' C' ' 159' ' ' ILE . 6.9 pt -80.82 152.71 72.33 Favored Pre-proline 0 C--O 1.246 0.869 0 N-CA-C 107.299 -1.371 . . . . 71.41 107.299 165.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -39.79 108.91 0.08 OUTLIER 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 122.828 2.352 . . . . 61.44 112.12 168.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -63.98 107.91 0.85 Allowed 'Trans proline' 0 C--N 1.382 2.32 0 C-N-CA 122.928 2.419 . . . . 73.2 110.662 -176.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 152' ' ' GLY . . . . . . . . . . . . . . . 105.11 137.61 9.11 Favored Glycine 0 C--N 1.34 0.803 0 CA-C-N 115.837 -0.62 . . . . 54.32 113.955 -170.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 153' ' ' VAL . . . . . 0.704 HG21 HG21 ' C' ' 178' ' ' VAL . 1.9 m -134.57 171.84 17.13 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.192 0 C-N-CA 123.029 0.532 . . . . 71.13 110.922 -175.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 154' ' ' ARG . . . . . . . . . . . . . 8.7 mtp180 -135.34 145.06 47.03 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.176 0.99 . . . . 75.32 108.906 -174.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 155' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -56.17 126.07 24.51 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 118.601 0.637 . . . . 74.51 111.766 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 60.84 24.04 62.01 Favored Glycine 0 C--N 1.351 1.364 0 CA-C-N 115.305 -0.861 . . . . 64.51 114.01 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 157' ' ' SER . . . . . . . . . . . . . 37.7 m -107.91 163.59 13.0 Favored 'General case' 0 C--O 1.246 0.87 0 CA-C-O 121.209 0.528 . . . . 75.43 110.275 178.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 20.7 m -102.67 110.42 29.3 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 CA-C-N 114.997 -1.001 . . . . 64.44 110.528 -174.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 159' ' ' ILE . . . . . 0.633 HG21 HD12 ' C' ' 149' ' ' ILE . 7.4 mt -71.51 97.9 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.791 0 N-CA-C 108.251 -1.018 . . . . 52.25 108.251 172.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 160' ' ' ARG . . . . . 0.456 ' HA ' ' O ' ' C' ' 174' ' ' LEU . 15.3 ttp180 -79.62 102.63 9.02 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.591 -0.732 . . . . 72.21 110.572 -177.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 161' ' ' VAL . . . . . 0.645 HG22 ' HB3' ' C' ' 174' ' ' LEU . 0.7 OUTLIER -109.2 130.34 22.86 Favored Pre-proline 0 CA--C 1.548 0.892 0 N-CA-C 108.221 -1.029 . . . . 75.24 108.221 178.05 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -76.67 147.35 27.81 Favored 'Trans proline' 0 C--N 1.369 1.617 0 C-N-CA 122.528 2.152 . . . . 63.42 111.014 169.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 163' ' ' GLY . . . . . 0.521 ' HA2' ' OG ' ' C' ' 86' ' ' SER . . . 112.53 24.88 4.84 Favored Glycine 0 N--CA 1.47 0.917 0 CA-C-O 119.38 -0.678 . . . . 53.31 114.015 174.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 164' ' ' MET . . . . . 0.705 ' HA ' HH12 ' C' ' 143' ' ' ARG . 26.4 mmt -130.2 -79.75 0.54 Allowed 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 118.002 0.901 . . . . 73.35 110.769 -179.005 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 165' ' ' GLY . . . . . 0.611 ' H ' ' HA ' ' C' ' 173' ' ' ASP . . . 84.13 139.36 4.12 Favored Glycine 0 C--N 1.349 1.3 0 N-CA-C 114.033 0.373 . . . . 64.24 114.033 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . -76.37 -170.93 31.9 Favored Glycine 0 C--N 1.363 2.045 0 CA-C-N 117.213 0.507 . . . . 75.44 112.5 167.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 167' ' ' GLN . . . . . 0.607 HE21 ' HA ' ' C' ' 167' ' ' GLN . 0.0 OUTLIER -77.08 105.78 8.38 Favored 'General case' 0 N--CA 1.479 0.982 0 O-C-N 122.18 -0.6 . . . . 64.31 111.841 -174.192 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . 149.85 171.38 18.25 Favored Glycine 0 C--N 1.346 1.138 0 CA-C-O 121.492 0.496 . . . . 13.44 113.713 177.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 169' ' ' ASN . . . . . 0.503 ' HB3' ' HD2' ' C' ' 170' ' ' PRO . 1.0 OUTLIER -60.2 158.98 24.33 Favored Pre-proline 0 CA--C 1.559 1.317 0 C-N-CA 126.642 1.977 . . . . 62.44 109.498 175.537 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 170' ' ' PRO . . . . . 0.503 ' HD2' ' HB3' ' C' ' 169' ' ' ASN . 6.5 Cg_exo -0.05 75.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.403 3.415 1 C-N-CA 126.326 4.684 . . . . 51.41 115.511 -162.054 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 171' ' ' PRO . . . . . 0.522 ' HD2' ' O ' ' C' ' 85' ' ' PHE . 93.9 Cg_endo -81.97 176.54 8.18 Favored 'Trans proline' 0 C--N 1.37 1.708 0 C-N-CA 123.065 2.51 . . . . 74.02 114.965 -165.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 172' ' ' GLY . . . . . 0.436 ' O ' ' HA2' ' C' ' 165' ' ' GLY . . . -95.49 127.82 9.29 Favored Glycine 0 C--N 1.342 0.882 0 CA-C-N 114.247 -1.342 . . . . 74.42 110.118 -178.038 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 173' ' ' ASP . . . . . 0.611 ' HA ' ' H ' ' C' ' 165' ' ' GLY . 50.0 m-20 -72.85 -162.05 0.1 Allowed 'General case' 0 CA--C 1.555 1.15 0 N-CA-C 114.038 1.125 . . . . 74.51 114.038 -169.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 174' ' ' LEU . . . . . 0.645 ' HB3' HG22 ' C' ' 161' ' ' VAL . 38.2 tp -87.99 142.29 27.91 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 112.621 0.6 . . . . 75.22 112.621 -164.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 49.8 mt -129.21 95.23 3.99 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.681 1.592 . . . . 71.32 107.95 177.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 176' ' ' LEU . . . . . 0.582 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 95.4 mt -82.24 109.04 16.16 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 110.037 -0.357 . . . . 43.02 110.037 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 177' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' C' ' 122' ' ' GLU . 57.8 t -83.52 95.63 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 107.657 -1.238 . . . . 74.43 107.657 -179.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 178' ' ' VAL . . . . . 0.704 HG21 HG21 ' C' ' 153' ' ' VAL . 3.3 p -87.26 140.19 16.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 121.342 0.591 . . . . 74.01 112.117 -172.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 179' ' ' ARG . . . . . 0.478 ' O ' ' HA ' ' C' ' 124' ' ' PRO . 36.7 mmt180 -117.65 105.5 12.1 Favored 'General case' 0 C--N 1.342 0.276 0 C-N-CA 124.939 1.296 . . . . 72.33 107.872 177.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 180' ' ' LEU . . . . . 0.565 HD13 HD21 ' C' ' 127' ' ' LEU . 96.2 mt -73.45 143.02 46.84 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 122.547 0.339 . . . . 70.51 111.47 -175.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 181' ' ' LEU . . . . . . . . . . . . . 16.8 mt -61.19 166.86 4.47 Favored Pre-proline 0 CA--C 1.56 1.359 0 C-N-CA 124.66 1.184 . . . . 74.2 112.27 -178.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 99.4 Cg_exo -52.71 12.59 0.02 OUTLIER 'Trans proline' 0 C--N 1.39 2.755 0 C-N-CA 124.305 3.337 . . . . 64.12 118.361 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 183' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -129.38 74.24 81.08 Favored Pre-proline 0 CA--C 1.564 1.51 0 CA-C-N 119.069 0.85 . . . . 62.13 108.779 163.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 184' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -86.43 66.08 4.9 Favored 'Trans proline' 0 C--N 1.378 2.091 0 C-N-CA 123.099 2.532 . . . . 71.54 110.484 178.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 185' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 26.2 t -91.47 -45.25 14.53 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.552 0 CA-C-N 115.623 -0.717 . . . . 72.23 109.331 -166.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 186' ' ' PHE . . . . . 0.491 ' HB3' HD13 ' C' ' 193' ' ' LEU . 42.8 m-85 -103.95 101.45 11.23 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.534 0.734 . . . . 61.44 110.058 -173.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 187' ' ' ARG . . . . . . . . . . . . . 18.1 ttt180 -103.61 129.51 50.89 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.403 0.681 . . . . 75.14 109.298 -177.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 188' ' ' LEU . . . . . 0.557 HD13 ' HD2' ' C' ' 240' ' ' PHE . 53.7 tp -79.93 144.73 33.1 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 112.421 0.526 . . . . 74.14 112.421 -173.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -143.75 116.75 8.86 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 107.176 -1.416 . . . . 71.33 107.176 163.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 63.1 -97.08 0.18 Allowed Glycine 0 C--N 1.345 1.075 0 N-CA-C 111.436 -0.666 . . . . 74.2 111.436 -172.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 191' ' ' GLN . . . . . 0.421 ' HA ' HD11 ' C' ' 188' ' ' LEU . 45.8 mt-30 -129.01 -10.34 4.82 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.992 0.917 . . . . 60.21 110.675 171.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 192' ' ' ASP . . . . . 0.413 ' O ' HD12 ' C' ' 188' ' ' LEU . 22.2 m-20 -82.86 161.91 21.77 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.706 0.802 . . . . 65.13 110.448 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 193' ' ' LEU . . . . . 0.619 HD21 ' CD2' ' C' ' 240' ' ' PHE . 79.6 mt -123.03 161.33 24.5 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 122.885 0.474 . . . . 52.2 111.901 -176.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 194' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -124.27 128.99 49.98 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 107.824 -1.176 . . . . 75.43 107.824 168.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 195' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' C' ' 185' ' ' VAL . . . -136.33 -176.65 4.4 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.576 1.15 . . . . 65.11 109.305 -177.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 87.9 m -137.98 119.93 15.42 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 108.594 -0.891 . . . . 51.32 108.594 171.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 197' ' ' LEU . . . . . . . . . . . . . 55.8 tp -96.66 124.1 40.55 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.066 0.546 . . . . 73.5 110.606 -175.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -77.75 104.59 8.39 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.42 1.088 . . . . 44.52 109.64 179.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 199' ' ' VAL . . . . . 0.577 HG22 HG21 ' C' ' 210' ' ' VAL . 41.1 t -121.53 120.4 28.84 Favored Pre-proline 0 N--CA 1.481 1.105 0 C-N-CA 124.413 1.085 . . . . 61.21 109.196 -178.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 200' ' ' PRO . . . . . 0.504 ' HG2' HD12 ' C' ' 203' ' ' ILE . 12.9 Cg_exo -66.3 150.53 84.6 Favored 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 122.534 2.156 . . . . 71.34 112.12 173.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 201' ' ' ALA . . . . . . . . . . . . . . . -57.09 -48.42 97.44 Favored Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 123.746 0.819 . . . . 74.35 113.068 178.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 202' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -57.13 -49.34 14.42 Favored 'Trans proline' 0 C--N 1.383 2.369 0 C-N-CA 121.631 1.554 . . . . 63.15 112.856 175.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 203' ' ' ILE . . . . . 0.504 HD12 ' HG2' ' C' ' 200' ' ' PRO . 27.2 mt -63.11 -29.53 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 123.276 0.631 . . . . 63.4 111.055 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -74.45 -36.59 63.36 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.612 0.765 . . . . 75.02 112.217 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 205' ' ' VAL . . . . . . . . . . . . . 69.1 t -76.73 -41.15 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 122.909 0.483 . . . . 63.41 111.984 -179.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 206' ' ' VAL . . . . . 0.619 HG23 ' HE3' ' A' ' 270' ' ' LYS . 12.4 p -90.88 -34.61 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 112.218 0.451 . . . . 52.12 112.218 -176.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 94.03 127.65 4.86 Favored Glycine 0 C--N 1.344 0.999 0 N-CA-C 111.644 -0.582 . . . . 63.21 111.644 -167.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -156.81 -131.18 1.32 Allowed Glycine 0 C--N 1.346 1.108 0 N-CA-C 111.042 -0.823 . . . . 51.32 111.042 177.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 209' ' ' LYS . . . . . 0.492 ' HG2' ' HA ' ' C' ' 222' ' ' ALA . 8.2 mtmp? -147.07 140.77 25.71 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.486 0.714 . . . . 72.12 111.072 173.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 210' ' ' VAL . . . . . 0.577 HG21 HG22 ' C' ' 199' ' ' VAL . 17.8 m -136.6 138.92 45.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 125.216 1.406 . . . . 62.05 108.32 172.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 211' ' ' ARG . . . . . . . . . . . . . 36.0 ttm180 -86.82 126.82 34.88 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.376 0.51 . . . . 72.44 112.376 -173.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 212' ' ' ALA . . . . . 0.503 ' HB3' HG13 ' C' ' 219' ' ' VAL . . . -92.56 114.84 27.5 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 123.97 0.908 . . . . 74.43 108.568 164.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 213' ' ' MET . . . . . . . . . . . . . 5.4 tmm? -77.31 105.8 8.65 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 107.895 -1.15 . . . . 63.12 107.895 175.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 214' ' ' THR . . . . . 0.526 ' OG1' HG12 ' C' ' 219' ' ' VAL . 0.2 OUTLIER -100.75 173.09 6.68 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.49 0.662 . . . . 54.24 110.594 -176.269 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 215' ' ' LEU . . . . . 0.408 HD13 ' CE1' ' C' ' 240' ' ' PHE . 25.9 mt -69.91 -26.72 64.29 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 114.488 -1.233 . . . . 44.41 112.836 -169.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 216' ' ' GLU . . . . . 0.421 ' HB3' ' CZ ' ' C' ' 131' ' ' PHE . 0.0 OUTLIER -111.52 8.69 21.13 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.206 1.002 . . . . 71.0 111.614 -178.985 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 137.92 172.67 12.63 Favored Glycine 0 C--N 1.341 0.833 0 CA-C-O 119.803 -0.443 . . . . 64.11 112.607 179.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -87.62 119.48 1.36 Allowed 'Trans proline' 0 CA--C 1.555 1.562 0 C-N-CA 123.178 2.586 . . . . 52.13 113.099 -174.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 219' ' ' VAL . . . . . 0.526 HG12 ' OG1' ' C' ' 214' ' ' THR . 3.8 p -98.71 115.4 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 108.961 -0.755 . . . . 52.53 108.961 173.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 220' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -80.99 106.6 13.12 Favored 'General case' 0 C--O 1.244 0.77 0 N-CA-C 108.716 -0.846 . . . . 72.32 108.716 178.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 221' ' ' VAL . . . . . 0.658 ' HA ' ' HB2' ' B' ' 239' ' ' ALA . 88.3 t -77.85 127.34 38.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 114.786 -1.097 . . . . 74.03 110.589 -176.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 222' ' ' ALA . . . . . 0.492 ' HA ' ' HG2' ' C' ' 209' ' ' LYS . . . -95.58 130.51 42.41 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.585 0.754 . . . . 73.3 111.099 177.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 94.8 t -108.35 140.31 21.62 Favored Pre-proline 0 CA--C 1.558 1.28 0 C-N-CA 125.328 1.451 . . . . 73.11 110.065 -173.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 224' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -89.47 168.59 5.0 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 123.556 2.838 . . . . 54.33 111.958 169.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -58.35 142.66 97.82 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.386 2.057 . . . . 74.0 112.428 170.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 226' ' ' ARG . . . . . . . . . . . . . 30.8 mmt-85 66.44 95.12 0.06 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.531 1.533 . . . . 70.15 111.073 -176.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 227' ' ' THR . . . . . 0.435 HG22 HG11 ' C' ' 253' ' ' VAL . 25.7 m -137.29 116.78 12.84 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.637 0.775 . . . . 70.3 111.32 173.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 228' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -101.8 155.88 17.86 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.842 0.857 . . . . 74.32 111.17 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 229' ' ' ALA . . . . . 0.484 ' HB2' ' H ' ' C' ' 255' ' ' ILE . . . -70.37 144.0 51.75 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 115.197 -0.91 . . . . 62.12 109.986 175.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 97.02 -11.85 65.75 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-O 119.2 -0.778 . . . . 62.04 113.024 -172.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 231' ' ' ARG . . . . . . . . . . . . . 54.9 mtt180 -69.37 174.34 4.93 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 118.348 1.074 . . . . 74.12 111.04 170.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 232' ' ' LYS . . . . . 0.425 ' HD3' ' HB3' ' C' ' 250' ' ' TYR . 28.0 ttmt -147.75 141.95 26.15 Favored 'General case' 0 C--N 1.355 0.819 0 CA-C-O 121.371 0.605 . . . . 71.45 112.222 -176.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 233' ' ' LEU . . . . . 0.539 ' O ' ' HA ' ' C' ' 250' ' ' TYR . 3.3 mp -114.63 154.53 28.21 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.945 1.298 . . . . 74.21 109.519 -179.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -122.95 120.72 34.23 Favored 'General case' 0 C--O 1.243 0.744 0 N-CA-C 109.19 -0.67 . . . . 72.34 109.19 167.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 44.5 mt -107.54 125.35 51.19 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.418 -0.956 . . . . 73.43 108.418 177.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -74.3 130.11 39.08 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.848 0.859 . . . . 71.55 112.192 -171.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 77.87 -0.69 71.03 Favored Glycine 0 C--N 1.35 1.336 0 CA-C-N 115.16 -0.927 . . . . 71.42 114.013 178.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -92.11 8.6 37.11 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.361 0.664 . . . . 72.03 112.06 -173.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -81.63 -168.29 40.5 Favored Glycine 0 C--N 1.349 1.303 0 N-CA-C 111.367 -0.693 . . . . 31.21 111.367 167.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 240' ' ' PHE . . . . . 0.619 ' CD2' HD21 ' C' ' 193' ' ' LEU . 18.4 m-85 -78.86 149.59 74.16 Favored Pre-proline 0 CA--C 1.558 1.287 0 CA-C-N 117.105 0.452 . . . . 75.14 110.249 178.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 241' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -82.65 142.18 11.38 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 123.492 2.794 . . . . 70.21 112.501 -173.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -132.63 165.06 23.91 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-O 119.422 -0.654 . . . . 70.14 112.69 -178.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -67.79 -1.81 7.48 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 123.527 2.818 . . . . 71.42 113.768 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -121.82 -15.45 7.88 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.657 0.783 . . . . 71.42 111.299 174.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 154.7 174.7 24.99 Favored Glycine 0 C--N 1.357 1.703 0 CA-C-O 120.16 -0.244 . . . . 51.32 113.474 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 246' ' ' ARG . . . . . . . . . . . . . 59.3 mtm180 -91.94 157.32 16.89 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 123.983 0.913 . . . . 61.31 111.049 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -85.38 -161.19 34.14 Favored Glycine 0 C--N 1.353 1.493 0 CA-C-O 120.137 -0.257 . . . . 63.23 113.705 176.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -127.41 136.47 51.89 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 117.458 0.629 . . . . 73.54 109.906 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 249' ' ' LEU . . . . . 0.447 HD11 ' HB2' ' C' ' 195' ' ' ALA . 31.0 tp -86.22 119.87 26.97 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.6 0.76 . . . . 74.23 110.59 -177.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 250' ' ' TYR . . . . . 0.539 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 14.3 m-85 -100.84 102.79 13.93 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 109.372 -0.603 . . . . 71.43 109.372 176.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 251' ' ' LEU . . . . . 0.435 ' HB2' HD13 ' C' ' 233' ' ' LEU . 1.3 mp -97.52 135.93 38.66 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.58 -0.896 . . . . 64.53 108.58 -178.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -98.17 121.07 39.64 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 108.906 -0.776 . . . . 73.41 108.906 175.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 253' ' ' VAL . . . . . 0.435 HG11 HG22 ' C' ' 227' ' ' THR . 92.0 t -58.48 138.32 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 124.403 1.081 . . . . 73.5 111.897 -176.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 254' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -131.72 109.06 9.9 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.22 1.008 . . . . 74.13 108.295 -178.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 255' ' ' ILE . . . . . 0.484 ' H ' ' HB2' ' C' ' 229' ' ' ALA . 41.4 mm -81.34 123.05 37.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 122.759 0.423 . . . . 75.24 110.186 179.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 256' ' ' THR . . . . . 0.431 ' O ' ' HA ' ' C' ' 200' ' ' PRO . 0.0 OUTLIER -125.79 151.78 46.29 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.157 1.383 . . . . 53.32 109.177 -179.565 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 2.8 pp -114.77 153.14 46.9 Favored Pre-proline 0 N--CA 1.49 1.532 0 C-N-CA 122.883 0.473 . . . . 64.54 111.137 -176.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 258' ' ' PRO . . . . . 0.554 ' HB3' ' HE2' ' A' ' 276' ' ' TYR . 37.7 Cg_endo -62.01 -2.9 3.28 Favored 'Trans proline' 0 C--N 1.385 2.46 0 C-N-CA 123.451 2.767 . . . . 73.21 115.119 -173.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 58.38 -83.33 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.111 1.364 . . . . 72.3 111.567 -173.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 260' ' ' ARG . . . . . 0.481 ' HG3' ' HA ' ' B' ' 267' ' ' SER . 0.0 OUTLIER -66.41 158.09 30.24 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 122.878 0.471 . . . . 73.41 110.631 -177.178 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 261' ' ' LEU . . . . . 0.653 HD13 ' HA ' ' C' ' 266' ' ' GLU . 95.7 mt -145.96 130.86 18.15 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.542 -0.54 . . . . 71.21 109.542 175.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 58.3 p -82.84 154.69 67.97 Favored Pre-proline 0 N--CA 1.479 0.988 0 CA-C-O 117.264 -1.351 . . . . 61.23 107.729 170.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -34.66 -40.59 0.23 Allowed 'Trans proline' 0 N--CA 1.508 2.353 0 C-N-CA 124.314 3.343 . . . . 74.2 116.52 -175.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -76.58 -54.95 5.99 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.83 0.452 . . . . 71.04 110.963 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 265' ' ' GLU . . . . . 0.469 ' HB3' HD22 ' C' ' 261' ' ' LEU . 16.0 mm-40 -44.56 -51.88 8.55 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 124.1 0.875 . . . . 65.11 109.84 173.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 266' ' ' GLU . . . . . 0.653 ' HA ' HD13 ' C' ' 261' ' ' LEU . 7.9 tp10 -48.82 -60.29 2.86 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 112.856 -1.974 . . . . 64.21 111.007 176.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -53.23 -43.43 67.29 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 124.131 0.894 . . . . 70.32 112.92 -175.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 268' ' ' LEU . . . . . 0.418 ' O ' ' HG ' ' C' ' 272' ' ' LEU . 10.5 mp -65.13 -54.12 34.63 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 116.564 -0.289 . . . . 52.44 111.123 179.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 93.3 m95 -60.36 -31.51 70.41 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 111.76 0.281 . . . . 61.11 111.76 178.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 270' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' C' ' 266' ' ' GLU . 4.5 mmmp? -61.4 -52.63 63.81 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.483 0.713 . . . . 75.43 109.801 176.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 42.3 mtpt -59.8 -38.9 83.25 Favored 'General case' 0 N--CA 1.481 1.102 0 O-C-N 123.858 0.724 . . . . 75.33 111.848 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 272' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' C' ' 268' ' ' LEU . 78.1 mt -63.0 -41.88 99.7 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 123.823 0.702 . . . . 74.33 111.174 178.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -71.81 -41.13 68.61 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 115.599 -0.728 . . . . 34.13 112.257 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -67.84 -34.07 76.0 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.263 0.625 . . . . 63.21 110.084 179.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 275' ' ' ALA . . . . . 0.421 ' HB1' ' HE2' ' B' ' 404' ' ' LYS . . . -62.87 -37.53 87.24 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 114.974 -1.012 . . . . 70.04 110.451 172.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 276' ' ' TYR . . . . . 0.539 ' HE1' ' HB3' ' A' ' 258' ' ' PRO . 0.2 OUTLIER -66.72 -44.84 80.54 Favored 'General case' 0 CA--C 1.554 1.107 0 CA-C-N 115.184 -0.916 . . . . 75.52 111.612 173.903 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -69.04 -22.61 64.04 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 122.707 0.403 . . . . 44.24 110.15 -178.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -69.49 0.34 5.4 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.982 0.913 . . . . 55.2 113.012 175.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 279' ' ' ARG . . . . . . . . . . . . . 73.3 mtm180 -82.24 -31.25 30.31 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 117.945 0.339 . . . . 71.52 110.335 168.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.98 0 C-N-CA 123.763 0.825 . . . . 75.14 109.246 -177.252 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.3 mtm . . . . . 0 N--CA 1.479 1.015 0 CA-C-O 119.532 -0.27 . . . . 64.12 111.433 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.43 36.84 24.15 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.362 1.065 . . . . 51.4 111.331 -178.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.61 79.14 4.11 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 114.646 -1.161 . . . . 74.04 111.066 -171.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.416 ' HE2' ' HD2' ' A' ' 69' ' ' TYR . 40.9 ttmt -36.89 103.0 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.351 1.06 . . . . 62.43 113.255 176.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.411 ' HE2' HD11 ' A' ' 10' ' ' ILE . 49.5 mtpt -80.93 120.17 24.4 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 108.061 -1.088 . . . . 74.32 108.061 168.089 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -71.22 94.92 1.21 Allowed 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 108.23 -1.026 . . . . 61.41 108.23 178.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -63.39 -28.7 70.17 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 114.513 -1.221 . . . . 73.34 112.016 -172.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -67.01 -43.48 82.79 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 122.888 0.475 . . . . 73.33 110.14 176.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.05 -43.66 98.0 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 123.65 0.594 . . . . 60.32 110.467 177.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.411 HD11 ' HE2' ' A' ' 5' ' ' LYS . 65.8 mt -57.4 -40.62 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 123.917 0.761 . . . . 74.23 110.662 176.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 87.2 mt -79.4 -21.09 46.11 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 112.448 0.536 . . . . 51.33 112.448 177.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.62 49.59 8.91 Favored Glycine 0 CA--C 1.539 1.56 0 CA-C-N 117.688 0.222 . . . . 53.33 113.35 -175.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.547 HG13 ' HB2' ' A' ' 25' ' ' ALA . 3.4 m -134.25 161.45 63.64 Favored Pre-proline 0 N--CA 1.491 1.602 0 C-N-CA 125.226 1.41 . . . . 71.43 109.581 175.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -46.73 147.76 4.31 Favored 'Trans proline' 0 C--N 1.392 2.862 0 C-N-CA 123.104 2.536 . . . . 50.12 113.032 173.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 61.7 mtp180 -80.88 27.32 0.39 Allowed 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 113.359 0.874 . . . . 75.43 113.359 -166.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -161.08 20.74 0.13 Allowed 'General case' 0 CA--C 1.559 1.319 0 C-N-CA 124.894 1.278 . . . . 64.11 108.646 172.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.58 147.25 51.95 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.762 1.225 . . . . 64.31 112.731 -171.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.2 p -79.89 176.95 9.27 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.806 0.843 . . . . 71.11 112.658 -175.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -52.2 -47.09 65.79 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.492 1.517 . . . . 64.21 113.09 -172.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.453 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 17.2 tp10 -75.42 -28.16 59.27 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 111.656 0.243 . . . . 72.43 111.656 -174.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -65.81 -46.78 77.36 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 121.031 0.443 . . . . 64.03 109.973 174.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.628 HG12 ' HB3' ' A' ' 57' ' ' LEU . 1.7 mp -61.33 -36.39 72.57 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 CA-C-N 114.632 -1.167 . . . . 73.31 110.912 174.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.494 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 1.6 tppp? -63.12 -47.98 80.48 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.937 0.895 . . . . 71.24 109.639 179.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 20' ' ' GLU . 52.8 mtm180 -67.76 -38.22 83.16 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.166 0.987 . . . . 54.12 111.424 -177.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.547 ' HB2' HG13 ' A' ' 13' ' ' VAL . . . -61.72 -43.88 98.01 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.725 0.81 . . . . 64.0 110.49 176.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -59.07 -49.24 78.65 Favored 'General case' 0 C--O 1.202 -1.404 0 CA-C-N 114.335 -1.302 . . . . 73.1 110.238 174.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 88.2 mttt -52.63 -50.33 63.35 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.732 0.813 . . . . 74.22 110.854 -178.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 54.1 ttp180 -55.8 -55.88 27.11 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 114.501 -1.227 . . . . 71.15 111.571 178.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.614 ' HB3' HD13 ' A' ' 50' ' ' ILE . 96.8 mt -76.64 -18.97 58.28 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.476 0.711 . . . . 74.11 112.527 -174.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -86.33 -29.16 23.21 Favored 'General case' 0 C--O 1.211 -0.93 0 C-N-CA 123.134 0.574 . . . . 63.3 110.153 -178.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 45.7 mtp180 -83.94 -35.01 24.33 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 122.446 0.298 . . . . 72.33 110.397 173.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -71.79 -45.49 61.42 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.332 0.653 . . . . 63.33 110.72 -179.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.482 ' HA ' HD22 ' A' ' 38' ' ' ASN . 22.4 m-85 -107.56 35.98 2.89 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.516 0.726 . . . . 63.25 109.829 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -66.11 114.72 17.88 Favored Pre-proline 0 N--CA 1.476 0.866 0 N-CA-C 108.63 -0.878 . . . . 63.41 108.63 178.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.404 ' O ' ' HG2' ' A' ' 39' ' ' LYS . 32.1 Cg_exo -58.04 -15.2 21.64 Favored 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 123.249 2.633 . . . . 74.13 114.564 -168.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -94.66 -32.1 13.54 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.814 0.846 . . . . 72.45 111.882 177.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 99.3 t -85.46 -59.97 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 CA-C-O 121.679 0.752 . . . . 65.53 109.084 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.482 HD22 ' HA ' ' A' ' 33' ' ' TYR . 37.4 t30 -98.7 75.64 2.15 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 114.507 -1.224 . . . . 61.35 108.745 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.404 ' HG2' ' O ' ' A' ' 35' ' ' PRO . 45.4 mtmt -78.04 79.6 4.49 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 114.538 -1.21 . . . . 73.11 108.891 177.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.2 m -131.59 125.62 20.66 Favored Pre-proline 0 N--CA 1.471 0.623 0 N-CA-C 108.812 -0.811 . . . . 54.41 108.812 176.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -43.09 -45.73 9.33 Favored 'Trans proline' 0 C--N 1.383 2.392 0 C-N-CA 123.498 2.798 . . . . 72.23 113.281 171.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -51.27 -47.53 62.47 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.893 1.277 . . . . 64.43 111.194 174.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.23 -23.67 62.05 Favored 'General case' 0 C--N 1.35 0.623 0 CA-C-N 114.498 -1.228 . . . . 72.14 111.13 -177.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.457 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 46.9 mt-10 -78.82 -41.27 30.64 Favored 'General case' 0 C--N 1.359 0.989 0 O-C-N 123.623 0.577 . . . . 62.01 109.651 -178.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -64.58 -46.89 80.79 Favored 'General case' 0 C--O 1.251 1.174 0 C-N-CA 124.25 1.02 . . . . 62.44 110.622 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -61.9 -44.0 97.69 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 114.951 -1.022 . . . . 74.03 110.087 173.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -61.56 -31.36 71.39 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.717 0.807 . . . . 73.24 110.867 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' A' ' 44' ' ' GLU . 33.0 mmtp -65.16 -50.64 65.18 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.072 0.549 . . . . 75.14 109.993 175.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -64.51 -29.88 70.91 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 123.247 0.342 . . . . 71.44 111.56 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.614 HD13 ' HB3' ' A' ' 29' ' ' LEU . 84.6 mt -74.1 -31.89 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.577 1.151 . . . . 70.53 110.208 175.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -72.59 -36.64 68.19 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.579 0.752 . . . . 73.43 110.522 175.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -66.88 -49.46 65.58 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.286 1.034 . . . . 63.42 109.976 176.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.1 -52.06 66.98 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 114.558 -1.201 . . . . 65.45 111.138 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -63.52 -33.65 76.04 Favored 'General case' 0 C--O 1.209 -1.026 0 CA-C-N 115.166 -0.924 . . . . 72.32 110.615 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.54 -56.46 20.99 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.798 0.439 . . . . 53.01 110.861 177.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.415 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 48.5 t -66.28 -33.42 63.43 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 CA-C-N 114.595 -1.184 . . . . 74.52 111.303 -176.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.628 ' HB3' HG12 ' A' ' 22' ' ' ILE . 75.4 mt -102.38 -5.02 24.63 Favored 'General case' 0 CA--C 1.555 1.163 0 N-CA-C 114.416 1.265 . . . . 62.04 114.416 -172.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 34.8 t -75.03 -56.82 4.36 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 118.497 0.59 . . . . 74.34 109.916 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.5 ' HB2' ' HE3' ' A' ' 62' ' ' LYS . 12.9 m-20 -80.62 127.38 75.67 Favored Pre-proline 0 C--O 1.255 1.35 0 CA-C-N 115.372 -0.831 . . . . 74.34 110.041 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.464 ' O ' ' HG2' ' A' ' 64' ' ' ARG . 64.6 Cg_exo -53.11 -26.43 32.93 Favored 'Trans proline' 0 C--N 1.387 2.575 0 C-N-CA 123.57 2.847 . . . . 72.41 113.02 177.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -54.13 -65.72 0.52 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.006 1.322 . . . . 72.3 111.688 174.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.58 ' HE2' ' HB3' ' A' ' 84' ' ' ASP . 21.9 mttt -72.08 -26.14 62.04 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 115.667 -0.697 . . . . 74.54 110.117 -173.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.6 tpt180 -55.34 -51.34 67.1 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 124.015 0.822 . . . . 74.11 109.802 168.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.464 ' HG2' ' O ' ' A' ' 60' ' ' PRO . 1.7 mmp_? -63.67 -36.56 84.24 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.889 0.476 . . . . 74.25 111.392 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.622 HD11 ' HG3' ' A' ' 79' ' ' PRO . 79.5 mt -60.73 -40.19 84.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 123.753 0.658 . . . . 64.42 110.535 175.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -69.18 -41.83 76.66 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.827 -0.624 . . . . 75.4 109.462 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -61.36 -43.09 99.46 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.222 0.609 . . . . 64.04 110.899 177.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 50.9 p -72.07 -20.44 61.66 Favored 'General case' 0 C--N 1.348 0.537 0 CA-C-N 115.701 -0.682 . . . . 75.13 110.653 177.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.416 ' HD2' ' HE2' ' A' ' 4' ' ' LYS . 46.2 t80 -86.01 101.18 12.69 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 108.243 -1.021 . . . . 63.45 108.243 173.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 115.2 17.63 6.63 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.894 -0.882 . . . . 52.54 110.894 -166.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 90.6 m -142.17 -61.39 0.45 Allowed 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 103.822 -2.659 . . . . 71.23 103.822 173.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 50.9 m -79.92 146.35 32.17 Favored 'General case' 0 C--O 1.251 1.178 0 N-CA-C 105.032 -2.211 . . . . 74.23 105.032 157.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.36 -39.85 10.26 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.025 0.53 . . . . 74.04 111.375 -177.163 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.47 155.9 56.65 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 123.633 0.773 . . . . 75.1 110.528 -176.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -57.08 119.71 7.14 Favored 'Trans proline' 0 C--N 1.384 2.4 0 C-N-CA 122.673 2.249 . . . . 75.41 111.266 175.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.45 155.99 23.53 Favored 'Trans proline' 0 C--N 1.384 2.431 0 C-N-CA 122.909 2.406 . . . . 74.25 112.841 178.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -56.12 135.45 69.93 Favored 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 122.512 2.141 . . . . 62.44 111.123 174.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -42.61 118.69 1.2 Allowed 'Trans proline' 0 C--N 1.383 2.36 0 C-N-CA 123.687 2.925 . . . . 43.51 113.821 177.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.622 ' HG3' HD11 ' A' ' 65' ' ' ILE . 52.2 Cg_endo -62.31 166.58 12.7 Favored 'Trans proline' 0 C--N 1.383 2.391 0 C-N-CA 123.723 2.949 . . . . 71.05 112.342 -176.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -49.45 83.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.398 3.155 0 C-N-CA 124.095 3.197 . . . . 51.35 114.007 -175.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.541 ' HA2' ' HG2' ' A' ' 111' ' ' ARG . . . 136.26 -61.81 0.61 Allowed Glycine 0 N--CA 1.445 -0.701 0 CA-C-N 113.905 -1.498 . . . . 62.41 109.551 -176.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.407 ' O ' ' HG2' ' A' ' 79' ' ' PRO . . . 144.86 -157.75 27.39 Favored Glycine 0 N--CA 1.468 0.812 0 N-CA-C 110.579 -1.008 . . . . 53.03 110.579 -169.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.407 ' HE1' HD13 ' A' ' 65' ' ' ILE . 96.3 m-85 -105.1 106.54 17.08 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.489 0.716 . . . . 74.41 109.884 -177.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.58 ' HB3' ' HE2' ' A' ' 62' ' ' LYS . 5.0 t70 -78.98 138.59 38.12 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.298 1.039 . . . . 71.31 112.313 -177.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -136.59 68.98 1.42 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.802 0.841 . . . . 70.22 109.812 170.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 59.0 m -53.32 94.71 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 125.104 1.362 . . . . 74.44 113.766 -176.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.654 ' H ' ' NH2' ' A' ' 114' ' ' ARG . . . 70.34 9.14 63.76 Favored Glycine 0 C--N 1.352 1.436 0 CA-C-N 115.901 -0.591 . . . . 70.11 114.144 178.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -96.23 130.59 43.27 Favored 'General case' 0 C--O 1.241 0.63 0 N-CA-C 107.71 -1.218 . . . . 72.34 107.71 -179.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -75.32 81.56 2.42 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 121.668 0.747 . . . . 71.44 111.134 -171.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.568 HG23 ' HZ ' ' A' ' 97' ' ' PHE . 0.9 OUTLIER -40.02 -41.19 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 126.633 1.973 . . . . 75.21 112.4 171.66 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -69.51 -5.85 26.84 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.328 1.051 . . . . 75.33 113.167 -172.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -115.45 -12.08 11.74 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.997 0.519 . . . . 45.35 111.753 -177.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 20.8 m-30 -85.53 168.57 14.39 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 112.919 0.711 . . . . 71.01 112.919 -167.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 98.7 p -65.69 168.51 7.59 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 124.919 1.288 . . . . 74.5 114.233 -164.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.24 -35.9 82.34 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 115.308 -0.86 . . . . 74.31 111.148 174.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -58.29 -47.08 84.79 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.96 0.904 . . . . 75.03 109.901 177.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.568 ' HZ ' HG23 ' A' ' 90' ' ' VAL . 5.3 t80 -56.94 -52.28 65.83 Favored 'General case' 0 CA--C 1.554 1.126 0 O-C-N 124.348 1.03 . . . . 63.23 110.114 172.226 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -65.59 -17.23 64.43 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 112.81 0.67 . . . . 73.05 112.81 -173.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -99.9 -36.5 9.38 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 112.93 0.715 . . . . 70.02 112.93 178.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 50.6 tp -78.23 -41.91 32.82 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-O 121.392 0.615 . . . . 55.03 110.355 -179.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -97.18 -24.88 15.51 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.213 1.005 . . . . 72.11 111.278 -175.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -44.17 -56.13 5.47 Favored Glycine 0 CA--C 1.545 1.958 0 CA-C-O 118.807 -0.996 . . . . 72.43 115.193 -178.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_exo -47.32 -25.8 5.13 Favored 'Trans proline' 0 C--N 1.391 2.769 0 C-N-CA 124.039 3.16 . . . . 23.1 115.53 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -133.11 28.96 3.27 Favored Glycine 0 C--N 1.354 1.581 0 CA-C-O 119.53 -0.594 . . . . 44.4 113.427 -177.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 44.6 mt -72.19 72.25 0.9 Allowed 'General case' 0 CA--C 1.563 1.477 0 CA-C-N 117.316 0.558 . . . . 74.25 112.151 170.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.727 ' HB3' ' HB3' ' A' ' 112' ' ' ARG . 11.8 p90 32.4 -130.76 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 127.27 2.228 . . . . 72.25 116.199 163.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.443 ' HA2' ' H ' ' A' ' 169' ' ' ASN . . . 92.2 36.36 6.32 Favored Glycine 0 C--N 1.354 1.541 0 N-CA-C 111.49 -0.644 . . . . 44.0 111.49 -165.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 71.39 -74.29 0.71 Allowed Glycine 0 C--N 1.359 1.838 0 CA-C-O 121.434 0.463 . . . . 71.34 112.847 167.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -73.47 -8.01 54.15 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.4 1.08 . . . . 64.11 109.601 169.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -77.32 8.39 32.97 Favored Glycine 0 CA--C 1.544 1.884 0 CA-C-N 115.774 -0.648 . . . . 55.25 113.788 164.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.541 ' HG2' ' HA2' ' A' ' 81' ' ' GLY . 31.3 ttp180 83.86 -38.14 0.07 Allowed 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 125.539 1.536 . . . . 71.44 114.224 163.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.727 ' HB3' ' HB3' ' A' ' 106' ' ' PHE . 16.3 tpp85 -78.29 -35.77 47.46 Favored 'General case' 0 N--CA 1.506 2.325 0 CA-C-N 119.286 0.948 . . . . 73.25 111.994 178.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.519 ' HB3' ' HA ' ' A' ' 167' ' ' GLN . 69.0 m 58.14 67.54 0.94 Allowed 'General case' 0 CA--C 1.557 1.213 0 O-C-N 124.116 0.885 . . . . 74.21 112.277 177.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.654 ' NH2' ' H ' ' A' ' 87' ' ' GLY . 0.6 OUTLIER -110.49 -118.32 0.29 Allowed 'General case' 0 C--O 1.19 -2.064 0 N-CA-C 116.443 2.016 . . . . 74.52 116.443 -167.618 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 48.6 tptt -70.33 81.57 0.54 Allowed 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 115.85 1.796 . . . . 72.15 115.85 -159.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.714 ' H ' ' HA3' ' A' ' 172' ' ' GLY . . . -121.29 -155.56 9.53 Favored Glycine 0 CA--C 1.548 2.152 0 C-N-CA 127.317 2.389 . . . . 55.22 112.76 162.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.437 ' H ' ' HA ' ' A' ' 171' ' ' PRO . 0.0 OUTLIER -67.06 143.46 56.7 Favored 'General case' 0 C--O 1.285 2.97 0 N-CA-C 116.361 1.985 . . . . 71.34 116.361 178.926 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.598 ' HA ' ' O ' ' A' ' 173' ' ' ASP . 14.8 p-10 -76.16 104.57 6.75 Favored 'General case' 0 CA--C 1.552 1.052 0 CA-C-N 112.175 -2.284 . . . . 74.23 113.151 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.462 ' O ' HD12 ' A' ' 174' ' ' LEU . 6.4 tt -93.37 165.36 12.82 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.1 1.36 . . . . 70.23 107.556 174.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 30.4 ttp85 -112.66 130.82 55.91 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 118.503 0.592 . . . . 74.51 110.127 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.641 ' HB3' HD11 ' A' ' 174' ' ' LEU . . . -146.33 176.54 9.69 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.998 0.919 . . . . 41.51 110.886 -175.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -107.89 139.88 41.83 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-N 114.533 -1.212 . . . . 61.0 109.197 -171.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.587 ' HB2' HD13 ' A' ' 176' ' ' LEU . 45.7 tp -100.18 96.97 5.55 Favored Pre-proline 0 N--CA 1.473 0.71 0 N-CA-C 107.368 -1.345 . . . . 54.05 107.368 170.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.512 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 53.0 Cg_endo -75.54 107.31 2.44 Favored 'Trans proline' 0 C--N 1.37 1.704 0 N-CA-C 106.923 -1.991 . . . . 75.33 106.923 171.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.524 ' HB3' HD23 ' A' ' 180' ' ' LEU . 59.5 tp -116.54 127.47 54.55 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 109.241 -0.651 . . . . 64.01 109.241 -167.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.634 HG21 ' HB2' ' B' ' 4' ' ' SER . 50.6 m -57.03 130.55 46.58 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 124.66 1.225 . . . . 71.34 110.965 -178.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 35.4 mt -47.62 -47.22 29.01 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.358 1.063 . . . . 70.54 111.232 -178.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -56.23 -49.53 73.87 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 114.391 -1.277 . . . . 75.32 110.695 178.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -64.26 -33.71 76.45 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.298 0.639 . . . . 64.33 111.7 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.474 ' HB2' HD22 ' A' ' 180' ' ' LEU . . . -62.46 -38.68 90.76 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.459 0.704 . . . . 41.43 110.825 177.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -66.33 -46.02 78.26 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 114.874 -1.057 . . . . 74.51 111.071 173.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.499 ' HE1' ' HA ' ' B' ' 2' ' ' LYS . 24.0 m170 -66.55 -65.52 0.67 Allowed 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.282 0.633 . . . . 75.25 111.378 -173.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.509 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 90.82 179.76 43.15 Favored Glycine 0 C--N 1.346 1.117 0 CA-C-N 116.14 -0.482 . . . . 71.54 112.421 -177.029 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.59 -157.45 27.67 Favored Glycine 0 C--N 1.345 1.038 0 C-N-CA 123.298 0.475 . . . . 70.42 112.313 179.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 13.7 mp0 -70.98 98.77 1.67 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.929 0.892 . . . . 73.14 111.091 -176.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 7.1 tpp180 -94.01 119.95 33.59 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.872 0.869 . . . . 74.4 109.295 172.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.489 ' O ' HG23 ' B' ' 5' ' ' THR . 76.2 t -79.44 106.01 9.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 114.749 -1.114 . . . . 71.24 109.218 172.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.441 HG23 HG13 ' B' ' 6' ' ' ILE . 3.6 p -111.32 125.1 68.63 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 N-CA-C 108.86 -0.793 . . . . 73.14 108.86 172.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.553 ' HB3' ' HG3' ' A' ' 144' ' ' ARG . 6.4 pt-20 -124.97 116.46 22.19 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.547 0.739 . . . . 71.3 111.426 -166.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.476 HG11 ' HB2' ' B' ' 8' ' ' LEU . 9.2 p -159.92 155.19 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.166 0.986 . . . . 75.1 108.963 177.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 61.63 22.68 13.13 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 124.274 1.03 . . . . 74.24 112.757 174.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 87.42 -13.05 61.15 Favored Glycine 0 C--N 1.353 1.486 0 CA-C-N 116.369 -0.378 . . . . 31.1 113.285 -177.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 22.7 tpt180 -95.81 115.09 26.92 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.395 0.678 . . . . 72.12 110.251 178.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.553 ' HG3' ' HB3' ' A' ' 139' ' ' GLU . 13.1 ttt180 -100.55 88.22 3.57 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.081 0.952 . . . . 74.41 108.726 173.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 11.2 p -94.88 144.99 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 123.083 0.553 . . . . 73.53 110.909 -173.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 22.9 t -107.64 86.97 2.39 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 109.226 -0.657 . . . . 31.45 109.226 176.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.7 p -85.02 124.17 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 123.305 0.642 . . . . 73.42 110.003 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 61.6 ttt85 -75.88 95.74 3.58 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.311 0.577 . . . . 74.14 109.652 177.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.509 HG13 ' HA2' ' A' ' 133' ' ' GLY . 33.6 pt -77.37 140.2 64.76 Favored Pre-proline 0 CA--C 1.557 1.225 0 CA-C-N 115.255 -0.884 . . . . 74.13 109.977 175.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -61.86 130.83 32.54 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.547 2.164 . . . . 60.34 112.301 174.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -61.96 112.11 1.42 Allowed 'Trans proline' 0 C--N 1.377 2.065 0 C-N-CA 122.389 2.059 . . . . 74.15 111.45 170.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 84.37 46.3 5.87 Favored Glycine 0 C--N 1.343 0.951 0 N-CA-C 111.128 -0.789 . . . . 75.51 111.128 -171.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -80.36 153.1 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 N-CA-C 109.525 -0.546 . . . . 75.43 109.525 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.542 ' HG2' ' HA ' ' A' ' 191' ' ' GLN . 0.0 OUTLIER -124.91 159.46 31.09 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 123.448 0.699 . . . . 73.23 110.926 -174.629 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.437 ' HB2' ' HB3' ' A' ' 188' ' ' LEU . 10.4 tp10 -57.73 126.29 26.71 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.222 1.409 . . . . 72.32 110.998 -179.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 103.52 -10.32 53.46 Favored Glycine 0 C--N 1.347 1.148 0 CA-C-O 119.175 -0.792 . . . . 14.21 113.993 178.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 33.6 t -63.63 112.18 2.71 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 117.693 0.746 . . . . 74.23 109.962 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.471 HG22 HG22 ' A' ' 177' ' ' VAL . 41.8 t -89.51 115.96 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.156 0.582 . . . . 72.34 110.672 -176.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 55.2 mt -108.22 108.14 24.54 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 123.967 0.907 . . . . 75.24 108.684 175.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -75.39 101.17 4.67 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 108.68 -0.859 . . . . 61.32 108.68 174.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.438 HG11 HD12 ' A' ' 176' ' ' LEU . 7.6 p -124.15 113.58 27.99 Favored Pre-proline 0 CA--C 1.541 0.62 0 N-CA-C 108.26 -1.015 . . . . 61.33 108.26 -173.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.414 ' HA ' ' H ' ' A' ' 174' ' ' LEU . 10.1 Cg_exo -71.66 146.43 48.94 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 121.106 1.204 . . . . 74.53 111.839 178.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.538 ' H ' ' HA ' ' A' ' 173' ' ' ASP . . . 131.36 -23.91 4.24 Favored Glycine 0 C--N 1.344 0.977 0 N-CA-C 116.646 1.418 . . . . 70.43 116.646 170.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -124.47 -3.8 7.84 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 113.498 0.925 . . . . 64.15 113.498 -165.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.691 ' HA2' HD13 ' A' ' 174' ' ' LEU . . . -74.7 -100.23 0.1 OUTLIER Glycine 0 N--CA 1.474 1.202 0 CA-C-O 118.653 -1.082 . . . . 73.33 113.836 -174.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.659 ' HA3' ' HB2' ' A' ' 171' ' ' PRO . . . -70.04 167.17 49.19 Favored Glycine 0 C--N 1.377 2.808 0 C-N-CA 118.079 -2.01 . . . . 74.5 111.333 172.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.526 HE21 ' HA ' ' A' ' 167' ' ' GLN . 0.0 OUTLIER -104.32 102.85 12.52 Favored 'General case' 0 CA--C 1.56 1.359 0 CA-C-N 118.675 1.238 . . . . 75.42 114.095 -177.434 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 122.1 -161.64 16.17 Favored Glycine 0 C--N 1.369 2.392 0 N-CA-C 115.653 1.021 . . . . 64.21 115.653 164.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . 0.443 ' H ' ' HA2' ' A' ' 107' ' ' GLY . 20.4 m120 -63.88 -45.91 81.27 Favored Pre-proline 0 CA--C 1.576 1.953 0 CA-C-O 118.494 -0.765 . . . . 63.11 111.023 174.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.472 ' HB2' ' HD3' ' A' ' 171' ' ' PRO . 12.6 Cg_exo -72.67 -56.7 0.09 OUTLIER 'Trans proline' 0 CA--C 1.593 3.451 0 CA-C-N 121.973 1.74 . . . . 71.13 116.001 175.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.659 ' HB2' ' HA3' ' A' ' 166' ' ' GLY . 18.8 Cg_endo -98.75 155.27 0.7 Allowed 'Trans proline' 0 C--N 1.399 3.189 0 C-N-CA 122.647 2.231 . . . . 71.25 111.24 167.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.714 ' HA3' ' H ' ' A' ' 116' ' ' GLY . . . -170.13 -80.04 0.05 OUTLIER Glycine 0 C--N 1.379 2.951 0 N-CA-C 120.489 2.956 . . . . 72.4 120.489 -164.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.598 ' O ' ' HA ' ' A' ' 118' ' ' ASP . 59.0 m-20 -63.08 162.96 10.71 Favored 'General case' 0 N--CA 1.509 2.476 0 CA-C-N 118.054 0.927 . . . . 71.14 112.179 -168.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.691 HD13 ' HA2' ' A' ' 165' ' ' GLY . 20.1 tp -128.42 147.85 50.68 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 120.132 1.333 . . . . 64.32 113.608 -177.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 8.4 mt -111.09 92.75 4.17 Favored 'General case' 0 CA--C 1.555 1.145 0 N-CA-C 106.774 -1.565 . . . . 72.12 106.774 168.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.587 HD13 ' HB2' ' A' ' 123' ' ' LEU . 15.0 mt -76.19 138.51 40.71 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 118.132 0.424 . . . . 70.05 111.607 178.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.471 HG22 HG22 ' A' ' 158' ' ' VAL . 47.4 t -119.71 116.0 49.25 Favored 'Isoleucine or valine' 0 C--O 1.242 0.677 0 N-CA-C 106.017 -1.846 . . . . 61.43 106.017 164.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.449 ' HA ' ' HB3' ' A' ' 123' ' ' LEU . 10.1 p -72.12 120.32 20.3 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 CA-C-O 121.848 0.832 . . . . 70.33 111.314 -171.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.512 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 32.3 mmt180 -106.82 99.53 9.09 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 107.849 -1.167 . . . . 53.32 107.849 172.109 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.794 HD12 ' HG ' ' A' ' 188' ' ' LEU . 80.4 mt -70.12 131.22 43.96 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 109.162 -0.681 . . . . 72.4 109.162 179.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.486 HD12 ' HA ' ' A' ' 126' ' ' THR . 54.7 mt -53.38 150.5 11.92 Favored Pre-proline 0 N--CA 1.481 1.084 0 O-C-N 124.606 1.191 . . . . 73.14 113.666 -163.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -83.21 49.1 2.9 Favored 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 122.796 2.331 . . . . 71.42 108.488 160.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 26.6 t-80 -69.97 131.5 89.08 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 107.254 -1.387 . . . . 73.35 107.254 178.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_exo -16.84 -34.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.386 2.522 1 C-N-CA 127.977 5.784 . . . . 61.24 120.623 -164.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 4.8 t -95.06 -59.57 3.05 Favored 'Isoleucine or valine' 0 C--N 1.353 0.744 0 CA-C-N 120.011 1.278 . . . . 64.21 108.728 -172.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . 0.487 ' CD1' ' HB2' ' A' ' 195' ' ' ALA . 49.2 m-85 -115.76 154.62 29.28 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 121.177 0.513 . . . . 72.31 111.333 -169.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 26.6 ttp180 -138.6 129.57 26.77 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 107.032 -1.47 . . . . 75.51 107.032 165.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.794 ' HG ' HD12 ' A' ' 180' ' ' LEU . 4.5 mm? -79.51 166.16 22.24 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.96 0.886 . . . . 74.21 112.3 -176.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -163.83 96.86 0.83 Allowed 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 105.663 -1.976 . . . . 70.31 105.663 174.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 62.02 -122.6 29.11 Favored Glycine 0 CA--C 1.531 1.075 0 N-CA-C 111.413 -0.675 . . . . 65.41 111.413 -168.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.542 ' HA ' ' HG2' ' A' ' 154' ' ' ARG . 2.2 mp0 -86.39 -13.89 45.0 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.793 0.837 . . . . 72.32 111.512 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -107.98 156.57 19.08 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 121.718 0.771 . . . . 72.32 112.684 -168.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.536 HD21 ' HE1' ' A' ' 240' ' ' PHE . 59.5 mt -103.61 155.7 18.35 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.781 1.633 . . . . 63.44 111.06 -170.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -132.04 100.13 4.95 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 107.845 -1.168 . . . . 73.14 107.845 169.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.571 ' HB3' HD23 ' A' ' 251' ' ' LEU . . . -105.32 116.0 31.2 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.429 1.091 . . . . 74.34 110.656 -176.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 38.3 m -71.4 102.62 2.68 Favored 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 109.409 -0.589 . . . . 70.21 109.409 176.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.582 HD22 HD13 ' A' ' 251' ' ' LEU . 33.2 tp -101.26 104.42 15.45 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 108.727 -0.842 . . . . 72.21 108.727 -174.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -84.4 108.68 17.35 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.891 -0.781 . . . . 61.43 108.891 175.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.53 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 6.2 p -120.76 137.27 26.2 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 124.71 1.204 . . . . 64.4 108.316 -177.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.29 156.84 33.28 Favored 'Trans proline' 0 C--N 1.363 1.327 0 C-N-CA 121.485 1.457 . . . . 64.51 111.605 173.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.411 ' HB3' ' HH2' ' A' ' 269' ' ' TRP . . . -56.46 -48.82 96.35 Favored Pre-proline 0 CA--C 1.557 1.227 0 N-CA-C 114.701 1.371 . . . . 71.34 114.701 -168.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -57.5 -42.71 58.25 Favored 'Trans proline' 0 C--N 1.395 2.995 0 CA-C-N 121.526 1.581 . . . . 63.54 112.079 178.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.438 HG12 ' HE1' ' C' ' 277' ' ' TYR . 20.2 mt -73.21 -28.74 26.51 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 CA-C-N 115.262 -0.881 . . . . 64.32 110.634 -176.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -72.05 -48.64 42.89 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.348 0.659 . . . . 71.51 111.371 178.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.479 HG11 HD11 ' C' ' 261' ' ' LEU . 95.6 t -72.03 -41.54 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.469 0.708 . . . . 63.23 111.747 -175.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 70.3 t -87.32 -41.9 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 116.07 -0.513 . . . . 74.41 111.384 -176.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 91.73 83.81 1.46 Allowed Glycine 0 CA--C 1.525 0.711 0 CA-C-N 116.097 -0.501 . . . . 72.35 112.83 -177.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -126.22 -172.42 13.35 Favored Glycine 0 N--CA 1.473 1.149 0 N-CA-C 111.363 -0.695 . . . . 55.24 111.363 173.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 221' ' ' VAL . 50.2 mtmt -85.06 133.16 34.24 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 117.75 0.775 . . . . 45.21 112.522 -174.281 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 34.8 m -121.55 170.55 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 124.253 1.021 . . . . 63.11 108.726 166.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 22.2 ttm180 -82.43 109.36 16.6 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 109.473 -0.566 . . . . 71.41 109.473 172.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -103.18 132.32 49.52 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 108.426 -0.953 . . . . 62.04 108.426 173.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . 0.444 ' SD ' ' N ' ' A' ' 213' ' ' MET . 1.5 mpt? -92.38 135.75 33.77 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.494 -0.558 . . . . 71.23 109.494 -175.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 55.8 p -111.79 -176.45 2.94 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.379 0.672 . . . . 74.1 109.517 174.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 58.5 mt -80.41 -4.17 52.59 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.658 0.783 . . . . 63.31 111.949 -177.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.428 ' HA ' ' HE2' ' B' ' 2' ' ' LYS . 56.3 mm-40 -115.65 -17.93 10.99 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.356 0.662 . . . . 64.44 111.507 176.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 156.16 175.35 27.04 Favored Glycine 0 C--N 1.354 1.536 0 C-N-CA 121.465 -0.398 . . . . 33.0 114.012 176.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -77.93 124.41 6.76 Favored 'Trans proline' 0 C--N 1.372 1.795 0 C-N-CA 122.934 2.423 . . . . 70.23 112.349 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 30.9 m -121.11 179.92 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 124.451 1.1 . . . . 73.4 109.429 177.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -102.58 150.27 23.58 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.356 0.662 . . . . 75.04 109.584 172.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 209' ' ' LYS . 2.8 p -145.98 141.36 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 N-CA-C 108.972 -0.751 . . . . 74.13 108.972 176.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -86.45 100.81 12.62 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.045 0.538 . . . . 60.25 110.47 -178.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 91.8 t -53.9 143.29 41.88 Favored Pre-proline 0 N--CA 1.494 1.734 0 C-N-CA 125.204 1.402 . . . . 63.14 111.136 -179.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . 0.416 ' HG3' ' O ' ' B' ' 441' ' ' ILE . 32.7 Cg_exo -62.11 162.83 21.59 Favored 'Trans proline' 0 C--N 1.386 2.534 0 C-N-CA 122.627 2.218 . . . . 75.51 112.406 172.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.54 155.47 35.92 Favored 'Trans proline' 0 C--N 1.367 1.521 0 C-N-CA 121.408 1.405 . . . . 72.53 111.134 166.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . 0.404 ' HD2' ' O ' ' C' ' 259' ' ' GLU . 21.1 mmt180 65.33 20.59 11.87 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 125.305 1.442 . . . . 74.04 112.244 173.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.437 HG23 HD21 ' A' ' 233' ' ' LEU . 96.5 m -59.19 104.52 0.25 Allowed 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 124.715 1.206 . . . . 64.32 111.202 -176.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 5.3 tp60 -98.11 133.97 41.83 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.689 1.196 . . . . 75.32 111.994 -168.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -62.48 140.32 58.6 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.833 1.253 . . . . 62.31 112.892 -173.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 92.37 -35.69 3.94 Favored Glycine 0 C--N 1.349 1.291 0 O-C-N 123.877 0.736 . . . . 73.32 112.005 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -74.04 161.76 29.71 Favored 'General case' 0 C--N 1.349 0.555 0 C-N-CA 123.867 0.867 . . . . 74.0 111.352 -177.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.723 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 3.4 mptp? -113.34 118.46 34.65 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.909 0.884 . . . . 72.22 109.065 -175.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.486 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 39.0 mt -76.79 100.25 5.41 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.764 -0.828 . . . . 71.4 108.764 178.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 54.3 ttm-85 -71.86 105.86 3.97 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 110.245 -0.279 . . . . 64.14 110.245 179.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.637 HD22 ' HA ' ' B' ' 441' ' ' ILE . 9.1 mt -95.31 104.06 15.94 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 107.508 -1.293 . . . . 61.12 107.508 173.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 18.0 tptp -71.47 118.82 14.76 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.353 0.661 . . . . 64.43 111.181 -172.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 85.47 32.21 19.92 Favored Glycine 0 C--N 1.35 1.347 0 O-C-N 123.418 0.449 . . . . 74.2 113.251 177.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -125.62 5.69 7.52 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.68 0.792 . . . . 73.01 112.443 -175.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -93.86 -157.5 33.15 Favored Glycine 0 N--CA 1.469 0.868 0 C-N-CA 123.378 0.513 . . . . 74.43 112.451 171.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . 0.536 ' HE1' HD21 ' A' ' 193' ' ' LEU . 27.2 m-85 -83.38 140.44 41.9 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 122.954 0.502 . . . . 73.13 111.136 -175.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 240' ' ' PHE . 3.6 Cg_exo -77.41 138.09 17.26 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 123.558 2.839 . . . . 73.33 112.587 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 178.19 -138.52 3.75 Favored Glycine 0 CA--C 1.534 1.275 0 CA-C-O 119.056 -0.858 . . . . 73.52 112.449 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -67.69 -12.52 35.8 Favored 'Trans proline' 0 C--N 1.382 2.337 0 C-N-CA 123.844 3.03 . . . . 70.45 114.086 -177.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -103.96 21.77 15.78 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.744 0.418 . . . . 70.11 110.37 175.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 71.88 -93.74 0.58 Allowed Glycine 0 C--N 1.353 1.483 0 N-CA-C 110.329 -1.108 . . . . 62.24 110.329 -173.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 -126.18 131.46 52.0 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 107.626 -1.25 . . . . 75.41 107.626 167.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -70.35 -168.0 7.0 Favored Glycine 0 C--N 1.352 1.419 0 O-C-N 123.266 0.354 . . . . 42.24 112.871 178.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -111.55 173.34 6.4 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 117.513 0.656 . . . . 75.44 111.112 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.531 HD23 HD12 ' A' ' 235' ' ' LEU . 23.5 tp -128.9 104.07 7.39 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.556 -0.905 . . . . 70.31 108.556 176.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.723 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 0.4 OUTLIER -89.81 105.65 17.94 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.701 -0.852 . . . . 52.51 108.701 -178.881 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.582 HD13 HD22 ' A' ' 197' ' ' LEU . 66.3 mt -84.93 101.95 12.75 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.906 -0.775 . . . . 72.24 108.906 177.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.588 ' HG2' ' HG3' ' A' ' 232' ' ' LYS . 26.0 mt-10 -76.36 104.47 6.89 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.025 0.93 . . . . 75.41 108.743 -177.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 40.6 t -67.11 127.68 29.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 114.316 -1.311 . . . . 24.43 112.145 -167.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.49 91.93 3.4 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 107.516 -1.291 . . . . 73.14 107.516 175.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.53 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 66.7 mt -79.4 133.55 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 109.777 -0.453 . . . . 74.34 109.777 -178.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 19.6 p -130.52 175.26 9.13 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.144 0.978 . . . . 73.43 110.481 174.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.513 HD12 ' H ' ' A' ' 259' ' ' GLU . 2.7 pp -132.38 152.45 80.09 Favored Pre-proline 0 CA--C 1.558 1.26 0 C-N-CA 123.843 0.857 . . . . 73.4 109.557 -178.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -76.55 8.63 2.91 Favored 'Trans proline' 0 N--CA 1.507 2.301 0 C-N-CA 123.157 2.571 . . . . 74.45 115.03 -165.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.579 ' HG2' ' NE2' ' C' ' 228' ' ' GLN . 33.3 mt-10 53.11 -85.53 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.616 1.166 . . . . 63.24 111.219 -163.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.83 158.93 5.86 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.163 0.985 . . . . 75.12 111.878 179.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.619 HD22 ' HB3' ' A' ' 265' ' ' GLU . 74.7 mt -143.39 151.22 40.15 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.416 0.686 . . . . 55.32 110.558 178.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 58.3 p -83.67 161.57 55.74 Favored Pre-proline 0 CA--C 1.559 1.303 0 N-CA-C 108.689 -0.856 . . . . 44.34 108.689 166.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -42.06 -47.03 6.95 Favored 'Trans proline' 0 C--N 1.385 2.45 0 C-N-CA 123.779 2.986 . . . . 74.33 115.217 177.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -67.14 -47.42 71.15 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.017 0.527 . . . . 71.44 109.856 -179.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . 0.619 ' HB3' HD22 ' A' ' 261' ' ' LEU . 43.6 mt-10 -56.83 -42.46 79.67 Favored 'General case' 0 C--N 1.352 0.693 0 O-C-N 123.873 0.733 . . . . 64.2 110.866 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -62.58 -50.13 72.53 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 123.195 0.31 . . . . 73.45 110.292 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -54.97 -51.61 65.65 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 124.158 0.912 . . . . 64.12 111.569 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . 0.478 ' HB2' HD21 ' C' ' 272' ' ' LEU . 10.1 mp -73.67 -43.62 58.89 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.291 0.637 . . . . 73.14 111.935 -173.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 269' ' ' TRP . . . . . 0.411 ' HH2' ' HB3' ' A' ' 201' ' ' ALA . 62.5 m95 -58.68 -45.79 88.66 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 123.358 0.663 . . . . 75.0 111.086 177.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . 0.417 ' NZ ' ' HB3' ' A' ' 270' ' ' LYS . 8.7 mtpm? -63.34 -50.06 71.48 Favored 'General case' 0 C--N 1.352 0.693 0 CA-C-N 115.842 -0.617 . . . . 62.43 111.012 178.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -64.38 -29.66 70.72 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.045 0.538 . . . . 70.22 111.979 -179.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 272' ' ' LEU . . . . . 0.424 ' O ' ' HB2' ' A' ' 276' ' ' TYR . 31.5 mt -61.62 -52.41 64.48 Favored 'General case' 0 C--O 1.211 -0.943 0 N-CA-C 109.377 -0.601 . . . . 63.4 109.377 172.238 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -64.68 -37.04 86.23 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 123.904 0.752 . . . . 64.51 112.824 -178.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -67.18 -47.65 70.3 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.823 0.849 . . . . 74.35 110.485 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . 0.514 ' O ' ' HG2' ' A' ' 279' ' ' ARG . . . -59.68 -60.13 4.34 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.546 0.738 . . . . 71.44 109.767 175.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . 0.424 ' HB2' ' O ' ' A' ' 272' ' ' LEU . 24.5 t80 -39.24 -58.96 1.1 Allowed 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 127.45 2.3 . . . . 75.02 111.939 178.072 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -62.45 -46.02 90.44 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 114.572 -1.195 . . . . 70.12 109.963 -176.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -69.81 -8.9 52.24 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.005 0.742 . . . . 75.41 113.005 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . 0.514 ' HG2' ' O ' ' A' ' 275' ' ' ALA . 8.7 mmm180 -93.26 -7.45 45.02 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 117.902 0.319 . . . . 74.13 111.63 177.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . 0.555 ' HA ' HD21 ' B' ' 59' ' ' LEU . . . . . . . . 0 CA--C 1.555 1.163 0 CA-C-O 118.309 -0.853 . . . . 72.21 109.811 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.2 mmt . . . . . 0 N--CA 1.475 0.796 0 N-CA-C 110.135 -0.321 . . . . 71.44 110.135 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.499 ' HA ' ' HE1' ' A' ' 132' ' ' HIS . 0.2 OUTLIER -78.68 1.45 22.86 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.934 0.894 . . . . 54.1 113.286 -165.996 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.62 10.04 4.71 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.811 0.845 . . . . 74.04 111.118 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . 0.634 ' HB2' HG21 ' A' ' 126' ' ' THR . 60.8 m -70.81 101.11 2.04 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-O 121.599 0.714 . . . . 52.14 110.703 -176.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 0.489 HG23 ' O ' ' A' ' 137' ' ' VAL . 92.9 m -85.85 154.78 21.3 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 114.337 -1.301 . . . . 70.11 110.986 -179.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.493 HD13 ' HA ' ' A' ' 125' ' ' LEU . 21.9 pt -126.61 178.44 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 C-N-CA 124.509 1.124 . . . . 64.44 111.487 -167.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -147.19 134.5 20.66 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.805 1.242 . . . . 72.01 108.448 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.502 HD12 ' HA ' ' A' ' 123' ' ' LEU . 1.5 mm? -63.59 150.9 43.04 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 118.575 0.625 . . . . 75.22 111.569 -178.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.04 -43.17 79.33 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 114.787 -1.097 . . . . 62.4 110.054 173.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 29.9 mt 74.34 -40.76 0.46 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 126.477 1.911 . . . . 74.1 113.525 -179.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.426 ' N ' ' HD3' ' B' ' 12' ' ' PRO . 53.1 mt 55.53 53.26 8.5 Favored Pre-proline 0 CA--C 1.565 1.533 0 C-N-CA 124.566 1.146 . . . . 45.35 110.714 -173.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.742 ' HD2' ' HB3' ' B' ' 15' ' ' PHE . 11.2 Cg_exo -68.59 122.55 9.52 Favored 'Trans proline' 0 C--N 1.392 2.818 0 C-N-CA 122.571 2.181 . . . . 61.33 111.068 -175.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 45.43 -76.16 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 126.47 1.908 . . . . 75.01 113.775 -173.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 18.6 tp -145.76 29.59 1.11 Allowed 'General case' 0 N--CA 1.484 1.255 0 CA-C-O 121.569 0.699 . . . . 64.54 110.201 -175.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 15' ' ' PHE . . . . . 0.742 ' HB3' ' HD2' ' B' ' 12' ' ' PRO . 87.3 t80 -92.04 101.94 14.49 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.147 0.579 . . . . 60.01 109.454 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 3.1 t -167.21 150.29 5.95 Favored Pre-proline 0 N--CA 1.478 0.971 0 C-N-CA 125.171 1.388 . . . . 51.11 108.521 -178.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -58.87 -18.34 41.55 Favored 'Trans proline' 0 C--N 1.375 1.964 0 C-N-CA 122.478 2.119 . . . . 62.42 113.722 171.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 5.2 t -96.63 14.34 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.494 0 C-N-CA 123.826 0.85 . . . . 61.41 110.327 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . 0.537 HG23 ' HD2' ' B' ' 20' ' ' LYS . 9.8 t -59.67 -39.09 83.33 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.49 0.716 . . . . 71.22 111.654 -178.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 20' ' ' LYS . . . . . 0.537 ' HD2' HG23 ' B' ' 19' ' ' THR . 2.6 mptp? -140.11 161.95 36.4 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.483 1.113 . . . . 62.34 108.711 172.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.85 80.18 5.22 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 109.119 -0.697 . . . . 75.34 109.119 174.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 34.7 mtm180 -80.43 -50.96 9.39 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.183 -0.917 . . . . 73.31 110.184 -176.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 23' ' ' THR . . . . . . . . . . . . . 10.6 m 57.34 87.82 0.13 Allowed Pre-proline 0 CA--C 1.556 1.201 0 O-C-N 124.746 1.279 . . . . 72.45 110.225 -170.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -81.67 42.46 1.33 Allowed 'Trans proline' 0 C--N 1.372 1.787 0 C-N-CA 123.163 2.575 . . . . 74.55 112.617 -179.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -62.5 -54.62 37.27 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.254 1.021 . . . . 74.53 110.59 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . 0.529 ' HB3' HG21 ' B' ' 296' ' ' THR . 65.9 mtt -119.04 164.8 19.25 Favored Pre-proline 0 CA--C 1.544 0.722 0 CA-C-N 114.847 -1.07 . . . . 75.13 110.091 -174.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 27' ' ' PRO . . . . . 0.403 ' HD2' HG21 ' B' ' 296' ' ' THR . 61.7 Cg_exo -47.54 -31.49 13.93 Favored 'Trans proline' 0 C--N 1.382 2.305 0 C-N-CA 123.385 2.723 . . . . 71.1 114.198 165.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 84.0 t 71.73 -70.49 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 C-N-CA 125.317 1.447 . . . . 73.51 111.212 176.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -109.97 104.3 13.18 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 108.616 -0.883 . . . . 62.2 108.616 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -96.64 -19.96 18.64 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.549 0.74 . . . . 70.24 109.577 170.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 70.15 -80.07 0.04 OUTLIER 'General case' 0 C--N 1.357 0.902 0 C-N-CA 126.234 1.813 . . . . 74.34 111.229 175.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -80.59 85.31 6.01 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.262 0.553 . . . . 72.22 110.406 -173.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -129.68 84.81 2.24 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.436 -0.949 . . . . 73.31 108.436 174.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -127.52 92.94 3.59 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.18 0.992 . . . . 53.33 109.333 -178.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 67.19 91.48 0.09 Allowed 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.654 1.182 . . . . 73.13 110.609 -179.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.72 89.96 0.1 Allowed Glycine 0 C--N 1.343 0.97 0 N-CA-C 110.846 -0.902 . . . . 74.33 110.846 -178.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 61.99 95.46 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.297 1.439 . . . . 61.44 111.262 -173.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 2.8 mp -67.26 106.98 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 N-CA-C 107.343 -1.354 . . . . 75.44 107.343 172.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 14.7 t -68.3 -22.26 64.73 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 123.571 0.749 . . . . 64.25 112.473 -173.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . 58.3 78.13 0.37 Allowed Pre-proline 0 N--CA 1.48 1.042 0 C-N-CA 124.521 1.128 . . . . 64.0 110.577 -174.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.94 -158.27 0.09 OUTLIER 'Trans proline' 0 C--N 1.372 1.811 0 C-N-CA 122.895 2.397 . . . . 72.44 112.039 -177.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . 0.579 ' HA3' ' HB2' ' C' ' 246' ' ' ARG . . . -82.7 76.01 2.29 Favored Glycine 0 C--N 1.344 1.026 0 N-CA-C 114.074 0.39 . . . . 45.24 114.074 -174.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -93.52 -114.77 2.41 Favored Glycine 0 C--N 1.342 0.891 0 N-CA-C 111.141 -0.784 . . . . 42.15 111.141 171.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.81 124.36 24.66 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.587 0.755 . . . . 63.2 110.461 178.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.441 ' NE ' ' HB ' ' B' ' 232' ' ' THR . 14.1 mtp180 -86.22 -176.34 5.88 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.805 0.842 . . . . 74.21 110.645 -178.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 16.3 tpt180 -113.7 141.11 47.64 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.674 0.789 . . . . 75.02 109.168 176.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -137.68 67.4 1.43 Allowed 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.872 0.844 . . . . 53.22 109.335 175.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 9.8 m -56.75 -33.39 66.53 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 114.769 -1.105 . . . . 51.22 111.842 -178.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 159.53 61.2 0.01 OUTLIER Glycine 0 C--N 1.341 0.851 0 N-CA-C 109.762 -1.335 . . . . 74.15 109.762 177.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 28.9 t70 68.49 -97.41 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.785 1.234 . . . . 64.2 109.203 -165.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 51' ' ' GLN . . . . . 0.479 ' HG3' ' HB2' ' B' ' 53' ' ' ALA . 36.4 tp60 175.38 -30.66 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.929 1.292 . . . . 75.3 110.222 177.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 6.9 m 59.32 40.27 21.39 Favored 'General case' 0 CA--C 1.557 1.213 0 CA-C-O 122.187 0.994 . . . . 73.31 109.326 -174.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . 0.479 ' HB2' ' HG3' ' B' ' 51' ' ' GLN . . . -80.06 66.3 5.51 Favored 'General case' 0 C--N 1.354 0.786 0 CA-C-N 114.715 -1.13 . . . . 73.24 109.766 179.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.449 ' HB1' ' O ' ' B' ' 161' ' ' ALA . . . -97.56 166.86 11.31 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-N 114.533 -1.212 . . . . 75.51 109.952 -176.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.489 ' HB3' ' HB3' ' B' ' 58' ' ' SER . 8.1 mp 75.49 -36.57 0.3 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 125.555 1.542 . . . . 72.35 112.063 -173.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 54.3 ttp85 73.4 -74.9 0.08 Allowed 'General case' 0 C--N 1.365 1.243 0 C-N-CA 125.411 1.484 . . . . 73.2 110.07 179.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -131.26 -14.89 3.32 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.947 0.899 . . . . 75.31 110.951 172.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . 0.489 ' HB3' ' HB3' ' B' ' 55' ' ' LEU . 89.8 p 59.6 12.91 3.06 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 125.944 1.698 . . . . 62.01 113.659 -177.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . 0.555 HD21 ' HA ' ' A' ' 280' ' ' ALA . 97.8 mt -90.06 125.34 35.38 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 123.898 0.879 . . . . 72.44 109.147 176.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . 0.406 ' HB3' ' HG ' ' B' ' 142' ' ' LEU . 73.9 p -75.49 168.13 20.59 Favored 'General case' 0 C--O 1.24 0.588 0 O-C-N 123.722 0.638 . . . . 63.51 110.866 174.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -69.88 155.04 41.16 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 114.853 -1.067 . . . . 71.45 110.603 174.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 62' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -140.48 93.54 8.75 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 124.462 1.105 . . . . 72.3 108.115 171.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -72.46 -16.03 27.59 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 122.593 2.195 . . . . 72.24 112.435 176.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 70.41 -70.7 0.14 Allowed 'General case' 0 C--N 1.365 1.259 0 C-N-CA 125.955 1.702 . . . . 72.04 111.734 179.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 56.1 pttt -124.5 -1.08 8.08 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.984 0.914 . . . . 65.32 111.27 178.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 60.1 t30 73.98 -63.11 0.44 Allowed 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 125.761 1.624 . . . . 72.41 111.227 -176.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 1.8 pp -78.42 68.86 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.278 0 C-N-CA 124.221 1.008 . . . . 72.03 111.913 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 10.3 tt -48.28 -40.75 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 C-N-CA 125.205 1.402 . . . . 73.4 113.834 -173.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 44.5 tp -125.17 -10.96 7.04 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.16 0.584 . . . . 73.12 111.263 -176.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 2.9 tt 61.59 87.26 0.1 Allowed 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 108.003 -1.11 . . . . 44.44 108.003 -166.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 15.1 tt -92.62 142.31 13.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 C-N-CA 123.798 0.839 . . . . 74.32 109.749 -178.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -83.5 179.93 52.39 Favored Glycine 0 C--N 1.347 1.161 0 N-CA-C 112.266 -0.334 . . . . 62.21 112.266 176.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -72.27 118.91 15.74 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.122 0.569 . . . . 63.44 109.531 177.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.55 24.83 73.94 Favored Glycine 0 C--N 1.353 1.519 0 O-C-N 123.682 0.614 . . . . 64.42 112.111 -172.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 75' ' ' MET . . . . . 0.6 ' HG3' ' HB2' ' B' ' 193' ' ' PRO . 0.6 OUTLIER 69.33 -67.48 0.22 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 126.01 1.724 . . . . 74.01 110.936 -171.796 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 107.08 67.06 0.64 Allowed Glycine 0 C--N 1.343 0.928 0 N-CA-C 110.616 -0.994 . . . . 71.13 110.616 -176.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . 0.404 ' HB2' ' SD ' ' B' ' 75' ' ' MET . 25.0 t70 -140.96 156.67 46.02 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.532 0.733 . . . . 73.03 109.826 -174.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 92.7 p 58.39 -78.86 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 127.036 2.135 . . . . 51.1 112.706 179.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 68.16 -73.08 0.09 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.375 1.47 . . . . 74.44 110.661 -174.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 14.8 pt -136.33 30.33 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 124.885 1.274 . . . . 72.52 108.494 174.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 56.4 m 74.49 -48.48 0.65 Allowed 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 126.411 1.884 . . . . 71.34 110.369 -170.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.56 127.79 32.91 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 109.047 -0.723 . . . . 61.11 109.047 164.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -177.04 -47.99 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.305 1.442 . . . . 71.35 107.424 -176.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -81.21 -168.47 1.84 Allowed 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 114.144 -1.389 . . . . 73.0 109.504 176.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -75.08 81.33 2.25 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 108.538 -0.912 . . . . 72.23 108.538 176.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 66.55 170.63 0.24 Allowed 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 125.631 1.572 . . . . 63.12 112.25 -179.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.38 137.57 9.3 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.263 0.625 . . . . 52.24 110.013 -177.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -79.97 104.5 10.59 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.812 0.845 . . . . 74.14 109.443 178.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.49 91.66 0.28 Allowed Glycine 0 C--N 1.345 1.053 0 O-C-N 123.454 0.471 . . . . 54.33 111.939 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.8 -30.57 70.03 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.539 0.736 . . . . 62.33 111.748 -178.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.63 -78.97 0.59 Allowed Glycine 0 C--N 1.348 1.208 0 CA-C-N 116.06 -0.518 . . . . 70.11 111.906 -177.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 68.86 -88.4 0.22 Allowed Glycine 0 C--N 1.351 1.41 0 N-CA-C 111.298 -0.721 . . . . 23.53 111.298 -178.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -161.19 48.88 0.22 Allowed 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 107.508 -1.293 . . . . 74.22 107.508 174.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -58.37 -42.11 86.25 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 115.666 -0.697 . . . . 71.21 110.237 178.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . 0.468 ' HB3' ' HB2' ' B' ' 98' ' ' ASP . 14.5 mmmm -132.75 -44.4 0.89 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.85 0.86 . . . . 74.14 110.235 176.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.16 -98.87 2.26 Favored Glycine 0 C--N 1.348 1.234 0 N-CA-C 111.552 -0.619 . . . . 72.31 111.552 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 3.2 mp -92.24 -66.94 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 108.391 -0.966 . . . . 72.22 108.391 175.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . 0.468 ' HB2' ' HB3' ' B' ' 95' ' ' LYS . 26.7 t70 61.06 -82.26 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 125.127 1.371 . . . . 75.21 112.409 174.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -159.97 92.76 1.03 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 106.652 -1.61 . . . . 61.12 106.652 179.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 6.5 tt -64.54 114.64 15.15 Favored Pre-proline 0 CA--C 1.55 0.957 0 C-N-CA 123.966 0.906 . . . . 74.2 110.218 -175.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -56.29 121.3 9.77 Favored 'Trans proline' 0 C--N 1.386 2.504 0 C-N-CA 122.715 2.276 . . . . 72.21 110.871 172.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . 0.599 HD13 ' HB2' ' C' ' 118' ' ' ASP . 62.3 mt -76.75 10.4 2.24 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.191 0.996 . . . . 73.12 113.083 -166.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 26.7 m -72.49 -43.3 63.83 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.905 0.882 . . . . 75.52 110.458 170.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . -151.85 -167.67 15.33 Favored Glycine 0 C--N 1.346 1.089 0 CA-C-N 115.508 -0.769 . . . . 51.35 112.339 -175.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 105' ' ' GLN . . . . . 0.564 ' HB3' ' HA ' ' B' ' 110' ' ' ALA . 21.8 tt0 -77.74 80.17 4.2 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 108.888 -0.782 . . . . 75.22 108.888 175.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 32.7 t80 77.11 -55.62 0.54 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 126.081 1.752 . . . . 74.44 112.312 177.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 15.0 p -129.54 103.31 6.8 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.188 0.595 . . . . 63.32 110.574 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 61.9 m80 66.1 -77.46 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 125.283 1.433 . . . . 71.44 113.289 171.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -128.34 167.59 16.74 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.954 1.301 . . . . 53.33 108.329 -175.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . 0.564 ' HA ' ' HB3' ' B' ' 105' ' ' GLN . . . -64.04 149.46 47.43 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.369 0.604 . . . . 71.24 111.394 175.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . 0.519 HD13 HE21 ' B' ' 105' ' ' GLN . 8.3 mp -74.73 -8.3 55.98 Favored 'General case' 0 CA--C 1.554 1.099 0 CA-C-N 115.537 -0.756 . . . . 64.15 110.139 172.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 112' ' ' ASN . . . . . 0.404 ' N ' HD22 ' B' ' 112' ' ' ASN . 0.8 OUTLIER -70.37 84.47 0.58 Allowed 'General case' 0 C--N 1.362 1.128 0 C-N-CA 124.15 0.98 . . . . 73.2 109.641 170.975 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 113' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -166.12 -168.66 1.29 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.176 1.39 . . . . 75.13 108.049 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -81.07 13.32 2.82 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 113.072 0.767 . . . . 74.01 113.072 -174.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 10.9 t -165.49 153.29 10.98 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.896 0.879 . . . . 73.23 109.741 168.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 107.19 -41.74 2.11 Favored Glycine 0 N--CA 1.472 1.051 0 CA-C-O 119.95 -0.361 . . . . 55.33 112.713 176.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -141.45 94.48 7.53 Favored Pre-proline 0 N--CA 1.48 1.052 0 C-N-CA 123.267 0.627 . . . . 70.25 109.965 176.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 118' ' ' PRO . . . . . 0.524 ' HA ' ' HD2' ' B' ' 193' ' ' PRO . 91.5 Cg_endo -82.99 162.34 15.76 Favored 'Trans proline' 0 C--N 1.367 1.549 0 C-N-CA 122.564 2.176 . . . . 60.53 111.206 165.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 119' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -150.03 -179.27 7.03 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 108.704 -0.851 . . . . 75.33 108.704 178.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 120' ' ' TYR . . . . . . . . . . . . . 29.7 p90 -143.47 177.48 8.43 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.034 0.934 . . . . 70.1 109.674 -171.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 121' ' ' VAL . . . . . 0.557 HG13 ' H ' ' B' ' 122' ' ' THR . 2.1 p -164.02 -68.74 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 N-CA-C 107.902 -1.147 . . . . 74.32 107.902 166.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . 0.557 ' H ' HG13 ' B' ' 121' ' ' VAL . 39.8 p 47.72 14.7 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 115.69 1.737 . . . . 75.24 115.69 171.027 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -177.99 143.51 0.31 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.271 1.029 . . . . 64.3 108.813 -175.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 46.8 m 58.99 24.95 13.22 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.244 1.018 . . . . 43.31 111.94 178.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -68.28 -15.08 63.43 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.672 1.189 . . . . 73.02 112.35 -176.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . 63.63 -167.69 0.21 Allowed 'General case' 0 C--N 1.365 1.26 0 C-N-CA 124.535 1.134 . . . . 74.13 109.638 -171.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 127' ' ' SER . . . . . 0.645 ' H ' HD23 ' B' ' 218' ' ' LEU . 16.0 m 59.99 -156.02 0.35 Allowed 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 123.299 0.64 . . . . 70.01 110.771 177.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -170.13 93.37 0.23 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.297 1.039 . . . . 72.01 108.475 165.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 73.8 p 49.86 -93.48 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.249 0 C-N-CA 125.644 1.578 . . . . 54.34 112.747 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 130' ' ' ALA . . . . . 0.411 ' HA ' ' HB2' ' B' ' 222' ' ' ALA . . . 173.77 81.98 0.0 OUTLIER 'General case' 0 C--O 1.238 0.481 0 N-CA-C 105.451 -2.055 . . . . 44.22 105.451 -178.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 131' ' ' TRP . . . . . 0.593 ' HE1' ' HB3' ' B' ' 164' ' ' ALA . 87.1 t90 80.09 -37.48 0.16 Allowed 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 125.424 1.49 . . . . 73.51 112.527 -174.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 32.0 t -70.0 78.85 0.49 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.626 1.17 . . . . 51.4 113.229 -166.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 12.0 t 177.91 172.96 0.61 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 125.179 1.391 . . . . 62.25 109.216 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 134' ' ' GLY . . . . . 0.496 ' HA3' HG21 ' B' ' 165' ' ' THR . . . 80.39 -73.82 2.44 Favored Glycine 0 C--N 1.349 1.273 0 N-CA-C 110.999 -0.841 . . . . 55.15 110.999 -178.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 135' ' ' VAL . . . . . 0.587 HG11 HD21 ' B' ' 155' ' ' LEU . 11.8 m -73.74 123.83 29.71 Favored 'Isoleucine or valine' 0 C--O 1.242 0.662 0 N-CA-C 108.342 -0.984 . . . . 73.24 108.342 169.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? 76.18 -10.59 1.27 Allowed 'General case' 0 CA--C 1.559 1.318 0 C-N-CA 125.737 1.615 . . . . 52.43 111.731 -174.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 26.8 m 69.7 -67.54 0.22 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 125.891 1.677 . . . . 75.31 112.157 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -68.26 -55.31 12.62 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.739 1.216 . . . . 75.52 112.17 -172.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -152.86 125.38 8.22 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 108.788 -0.819 . . . . 73.24 108.788 -172.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -68.73 -81.17 0.21 Allowed Glycine 0 C--N 1.35 1.311 0 O-C-N 123.544 0.528 . . . . 65.04 112.726 -179.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . 64.14 -1.49 0.69 Allowed 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 125.326 1.451 . . . . 75.34 114.628 175.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . 0.516 ' HB3' HG12 ' B' ' 144' ' ' VAL . 32.4 mt 52.96 94.66 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.854 1.262 . . . . 70.15 111.855 -170.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -79.32 58.86 4.38 Favored Glycine 0 C--N 1.351 1.415 0 N-CA-C 112.052 -0.419 . . . . 61.25 112.052 174.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 144' ' ' VAL . . . . . 0.516 HG12 ' HB3' ' B' ' 142' ' ' LEU . 11.4 p -143.7 158.28 16.49 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 C-N-CA 124.274 1.03 . . . . 75.31 108.874 -174.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -69.75 84.69 0.47 Allowed 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 124.311 1.045 . . . . 64.3 111.955 -175.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . 0.418 HG22 HH21 ' A' ' 279' ' ' ARG . 3.7 mp 60.32 9.92 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.586 2.36 0 C-N-CA 125.427 1.491 . . . . 72.52 112.157 174.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 49.5 p-80 46.8 88.11 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 126.148 1.779 . . . . 72.43 113.061 -174.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -95.55 -44.78 7.35 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.46 -0.775 . . . . 73.05 112.821 -172.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 149' ' ' LYS . . . . . 0.489 ' HB2' HG23 ' B' ' 153' ' ' THR . 0.8 OUTLIER -80.94 123.61 28.45 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 122.793 0.437 . . . . 72.23 110.352 -174.439 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 24.6 t70 57.34 -92.67 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.696 1.198 . . . . 74.11 110.222 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 151' ' ' HIS . . . . . 0.475 ' HB2' ' HD3' ' B' ' 152' ' ' PRO . 91.2 m-70 -144.97 -61.7 0.02 OUTLIER Pre-proline 0 CA--C 1.561 1.383 0 CA-C-O 118.044 -0.979 . . . . 74.43 110.309 176.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 152' ' ' PRO . . . . . 0.475 ' HD3' ' HB2' ' B' ' 151' ' ' HIS . 43.5 Cg_endo -85.97 -0.89 8.64 Favored 'Trans proline' 0 C--N 1.399 3.205 0 CA-C-N 122.3 1.857 . . . . 42.51 113.139 178.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . 0.489 HG23 ' HB2' ' B' ' 149' ' ' LYS . 72.9 m 62.28 79.63 0.25 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 125.291 1.436 . . . . 74.2 111.876 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 9.5 tt 48.97 24.42 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 C-N-CA 126.698 1.999 . . . . 74.25 113.087 175.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 155' ' ' LEU . . . . . 0.587 HD21 HG11 ' B' ' 135' ' ' VAL . 4.8 tt -66.21 -49.97 65.44 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 107.704 -1.221 . . . . 72.1 107.704 178.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -98.69 111.01 23.52 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 108.2 -1.037 . . . . 72.23 108.2 165.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 157' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -68.54 -45.82 71.14 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 108.31 -0.996 . . . . 53.54 108.31 173.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 158' ' ' ALA . . . . . . . . . . . . . . . -74.15 96.38 2.73 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 108.52 -0.918 . . . . 34.04 108.52 167.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -72.87 87.93 1.32 Allowed 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 108.752 -0.833 . . . . 55.45 108.752 177.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -97.97 2.12 48.65 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 114.882 -1.054 . . . . 70.22 110.15 176.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . 0.449 ' O ' ' HB1' ' B' ' 54' ' ' ALA . . . 67.68 16.55 9.82 Favored 'General case' 0 C--N 1.359 1.009 0 C-N-CA 124.896 1.279 . . . . 71.1 112.449 176.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . -70.82 -29.35 69.42 Favored Glycine 0 C--N 1.347 1.163 0 CA-C-O 120.053 -0.304 . . . . 73.4 112.555 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 35.4 tp 73.63 84.27 0.11 Allowed 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.652 1.581 . . . . 65.02 109.379 -172.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 164' ' ' ALA . . . . . 0.593 ' HB3' ' HE1' ' B' ' 131' ' ' TRP . . . 63.07 -78.95 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 126.142 1.777 . . . . 75.34 112.972 176.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 165' ' ' THR . . . . . 0.508 HG23 HG13 ' B' ' 135' ' ' VAL . 10.9 p -112.03 14.96 20.81 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.214 1.005 . . . . 64.15 112.042 -175.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . 78.31 67.76 1.58 Allowed Glycine 0 C--N 1.344 0.997 0 N-CA-C 111.559 -0.617 . . . . 71.15 111.559 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 167' ' ' ASN . . . . . 0.418 ' HB2' ' HD1' ' B' ' 131' ' ' TRP . 2.9 t-20 -54.77 -50.17 69.12 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.613 0.765 . . . . 72.31 110.294 176.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 20.1 m 43.74 22.7 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 C-N-CA 126.398 1.879 . . . . 74.13 114.76 174.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 169' ' ' SER . . . . . 0.474 ' HB3' HD13 ' B' ' 226' ' ' LEU . 50.6 m -70.27 113.82 7.81 Favored 'General case' 0 C--N 1.352 0.676 0 N-CA-C 108.303 -0.999 . . . . 54.35 108.303 176.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 170' ' ' THR . . . . . 0.514 ' O ' ' HD2' ' B' ' 231' ' ' LYS . 24.5 m 82.17 -50.05 0.21 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 126.472 1.909 . . . . 63.1 110.479 -171.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -50.4 -36.9 34.88 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.844 1.258 . . . . 53.32 113.702 -177.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 172' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -65.52 -45.05 84.99 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.89 0.876 . . . . 73.22 111.444 -178.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 173' ' ' LEU . . . . . 0.532 HD13 ' HB3' ' B' ' 231' ' ' LYS . 33.3 tp 77.4 -17.17 0.58 Allowed 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 125.224 1.41 . . . . 74.23 112.715 176.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 174' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -98.52 101.17 12.53 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 121.811 -0.556 . . . . 74.45 111.963 -170.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 175' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 70.8 172.79 0.31 Allowed 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 114.236 1.199 . . . . 74.1 114.236 163.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -164.65 -175.31 3.77 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-N 113.501 -1.681 . . . . 74.11 107.85 176.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 60.5 m -108.14 95.25 14.86 Favored Pre-proline 0 N--CA 1.479 0.979 0 N-CA-C 108.533 -0.914 . . . . 64.31 108.533 166.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 178' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -87.64 -176.75 1.82 Allowed 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 123.05 2.5 . . . . 74.53 112.362 175.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -84.02 -177.76 6.77 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.68 0.792 . . . . 61.34 110.726 175.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 180' ' ' ALA . . . . . 0.495 ' HB1' HG23 ' C' ' 137' ' ' VAL . . . -63.71 -63.68 1.1 Allowed 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 109.16 -0.681 . . . . 74.4 109.16 170.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 181' ' ' LEU . . . . . 0.574 HD13 ' HB2' ' C' ' 136' ' ' ARG . 45.1 tp -143.85 -67.28 0.34 Allowed 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 106.727 -1.582 . . . . 62.04 106.727 167.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 182' ' ' VAL . . . . . 0.559 HG23 ' HB2' ' C' ' 125' ' ' LEU . 14.7 p -151.4 153.78 9.34 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 N-CA-C 107.185 -1.413 . . . . 71.31 107.185 -177.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -83.08 63.97 7.41 Favored 'General case' 0 CA--C 1.562 1.438 0 N-CA-C 115.266 1.58 . . . . 65.24 115.266 -158.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 12.3 m170 60.79 -176.16 0.11 Allowed 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 114.379 1.252 . . . . 74.15 114.379 161.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 185' ' ' VAL . . . . . . . . . . . . . 2.6 p -99.72 112.6 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 122.816 0.446 . . . . 71.33 110.509 173.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 72.6 p 62.56 -67.8 0.07 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 126.76 2.024 . . . . 51.31 114.467 168.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 187' ' ' SER . . . . . . . . . . . . . 16.2 m -53.69 96.23 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.584 1.154 . . . . 62.14 111.353 177.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 19.1 mmm180 -138.66 139.76 38.6 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.538 0.735 . . . . 71.52 111.077 -177.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -115.35 80.61 1.45 Allowed 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.068 -1.086 . . . . 72.52 108.068 170.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 190' ' ' CYS . . . . . . . . . . . . . 25.6 p -169.45 149.54 4.02 Favored 'General case' 0 C--O 1.245 0.832 0 CA-C-N 115.012 -0.995 . . . . 70.33 109.194 178.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 43.9 t80 69.68 160.78 0.2 Allowed 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 124.876 1.27 . . . . 74.04 112.154 174.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 157.07 -161.18 30.97 Favored Glycine 0 C--N 1.347 1.152 0 CA-C-O 119.258 -0.745 . . . . 64.22 113.227 174.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 193' ' ' PRO . . . . . 0.6 ' HB2' ' HG3' ' B' ' 75' ' ' MET . 58.0 Cg_exo -48.36 100.95 0.04 OUTLIER 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 124.155 3.237 . . . . 64.32 112.878 171.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 194' ' ' SER . . . . . . . . . . . . . 33.0 m -107.63 149.58 27.91 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.374 -0.83 . . . . 24.51 109.579 178.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 195' ' ' ALA . . . . . . . . . . . . . . . -83.69 1.78 40.86 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.654 0.782 . . . . 74.32 111.72 179.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 196' ' ' THR . . . . . 0.654 HG21 ' HA2' ' B' ' 202' ' ' GLY . 35.7 m 80.88 -52.24 0.31 Allowed 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 126.451 1.9 . . . . 73.32 112.165 179.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 24.4 m 72.15 10.07 5.99 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 125.005 1.322 . . . . 75.11 112.906 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 198' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -96.01 81.61 3.41 Favored 'General case' 0 CA--C 1.551 0.983 0 N-CA-C 107.744 -1.206 . . . . 51.12 107.744 176.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 25.9 pttm 47.45 -69.4 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.152 0 C-N-CA 127.409 2.284 . . . . 74.4 115.724 179.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 200' ' ' CYS . . . . . 0.419 ' H ' ' HD2' ' B' ' 201' ' ' PRO . 83.2 m -140.66 -54.84 0.02 OUTLIER Pre-proline 0 CA--C 1.569 1.711 0 C-N-CA 124.511 1.124 . . . . 73.31 111.686 -178.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 201' ' ' PRO . . . . . 0.419 ' HD2' ' H ' ' B' ' 200' ' ' CYS . 56.2 Cg_endo -82.7 -179.16 4.34 Favored 'Trans proline' 0 C--N 1.403 3.412 0 CA-C-N 121.747 1.66 . . . . 71.34 113.751 -177.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 202' ' ' GLY . . . . . 0.654 ' HA2' HG21 ' B' ' 196' ' ' THR . . . -97.34 46.56 1.66 Allowed Glycine 0 C--N 1.351 1.375 0 CA-C-N 115.068 -0.969 . . . . 63.04 111.976 178.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -87.13 73.75 9.74 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.82 0.848 . . . . 71.33 109.393 -176.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . 65.6 158.55 0.11 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.819 1.248 . . . . 74.01 111.483 -175.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 205' ' ' LEU . . . . . 0.523 ' HB3' HG23 ' B' ' 196' ' ' THR . 2.2 pt? -155.14 165.04 37.93 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.081 0.467 . . . . 51.03 111.241 -173.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -95.01 -13.4 25.27 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 124.329 1.052 . . . . 62.32 110.226 173.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 207' ' ' LYS . . . . . 0.623 ' HB2' ' HG3' ' C' ' 182' ' ' PRO . 4.5 tmtm? 85.4 -36.96 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 126.612 1.965 . . . . 74.32 110.172 -166.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 98.56 69.38 0.94 Allowed Glycine 0 C--N 1.344 1.02 0 N-CA-C 111.517 -0.633 . . . . 71.52 111.517 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . -102.47 -57.84 0.79 Allowed Glycine 0 C--N 1.344 1.025 0 N-CA-C 110.963 -0.855 . . . . 42.21 110.963 174.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -105.01 -22.56 13.1 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.014 0.925 . . . . 74.51 111.275 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . -72.62 148.24 41.56 Favored Glycine 0 C--N 1.347 1.193 0 O-C-N 123.586 0.554 . . . . 74.43 112.265 -177.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 34.5 t 75.05 -56.8 0.62 Allowed 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 125.992 1.717 . . . . 74.04 111.078 -174.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 6.5 tt -67.19 112.37 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 C-N-CA 123.454 0.701 . . . . 64.4 111.366 177.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 85.0 m -79.39 84.43 5.29 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 108.233 -1.025 . . . . 75.43 108.233 167.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 215' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -63.08 -30.06 71.3 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 114.649 -1.16 . . . . 73.31 110.913 -178.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 64.08 83.36 0.17 Allowed 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.72 1.208 . . . . 61.42 109.5 176.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 23.7 tp -160.44 -77.76 0.06 Allowed 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 109.242 -0.651 . . . . 75.4 109.242 176.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . 0.645 HD23 ' H ' ' B' ' 127' ' ' SER . 2.7 mm? -86.56 67.18 9.8 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 107.44 -1.318 . . . . 71.43 107.44 172.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -62.41 122.53 15.94 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 114.697 -1.138 . . . . 71.24 111.331 -171.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . 78.09 -42.49 0.35 Allowed 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 125.641 1.576 . . . . 61.1 112.968 177.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 221' ' ' ARG . . . . . . . . . . . . . 45.3 ttt180 -48.05 -43.69 30.61 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.272 1.429 . . . . 73.55 111.911 176.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . 0.411 ' HB2' ' HA ' ' B' ' 130' ' ' ALA . . . 70.53 7.74 6.33 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 125.133 1.373 . . . . 42.52 112.017 -175.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 19.6 t70 67.29 -68.25 0.16 Allowed 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 126.188 1.795 . . . . 61.02 113.817 174.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 11.3 p -50.2 -34.63 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 125.14 1.376 . . . . 74.2 112.828 -178.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 225' ' ' THR . . . . . 0.433 ' HB ' ' H ' ' B' ' 170' ' ' THR . 69.5 p 50.37 27.41 2.73 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 125.335 1.454 . . . . 54.34 113.631 177.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . 0.474 HD13 ' HB3' ' B' ' 169' ' ' SER . 6.8 mp 51.19 79.24 0.1 Allowed 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.762 1.225 . . . . 74.43 111.799 173.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . 96.32 -45.75 1.88 Allowed Glycine 0 C--N 1.346 1.133 0 CA-C-N 116.033 -0.531 . . . . 51.31 111.973 -177.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 64.95 -99.3 0.35 Allowed Glycine 0 C--N 1.354 1.54 0 C-N-CA 123.402 0.525 . . . . 72.41 112.638 178.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -83.78 71.0 3.07 Favored Glycine 0 C--N 1.346 1.096 0 N-CA-C 111.405 -0.678 . . . . 70.24 111.405 178.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -163.33 -30.69 0.04 OUTLIER 'General case' 0 C--O 1.244 0.769 0 C-N-CA 124.054 0.942 . . . . 70.23 110.115 -176.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 231' ' ' LYS . . . . . 0.532 ' HB3' HD13 ' B' ' 173' ' ' LEU . 34.1 tttt -54.54 107.32 0.27 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.121 0.969 . . . . 73.24 111.25 177.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 232' ' ' THR . . . . . 0.441 ' HB ' ' NE ' ' B' ' 45' ' ' ARG . 5.4 m -143.67 148.1 35.27 Favored 'General case' 0 C--O 1.244 0.789 0 N-CA-C 107.374 -1.343 . . . . 74.24 107.374 170.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -68.93 141.74 54.91 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 108.876 -0.787 . . . . 70.41 108.876 -179.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -73.77 166.55 23.1 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 112.919 0.711 . . . . 72.31 112.919 -165.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -65.5 -48.41 72.66 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 113.964 -1.471 . . . . 54.41 109.685 -171.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 236' ' ' THR . . . . . . . . . . . . . 25.4 p -72.07 -69.83 0.37 Allowed 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.198 -0.91 . . . . 73.34 109.631 172.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -160.14 -76.86 0.06 Allowed 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 107.824 -1.176 . . . . 71.12 107.824 175.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 238' ' ' THR . . . . . 0.571 HG22 HG23 ' C' ' 219' ' ' VAL . 3.0 m -132.36 -66.75 0.68 Allowed 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 107.527 -1.286 . . . . 71.31 107.527 171.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -84.09 169.13 15.21 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.746 -0.661 . . . . 74.42 110.204 175.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 240' ' ' GLY . . . . . 0.515 ' H ' HD22 ' C' ' 235' ' ' LEU . . . -109.91 -93.08 2.22 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 110.778 -0.929 . . . . 71.23 110.778 -173.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 241' ' ' GLU . . . . . 0.413 ' HG3' ' HG3' ' C' ' 234' ' ' ARG . 8.5 pt-20 -165.34 161.2 18.89 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.7 0.8 . . . . 71.21 110.097 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 13.8 m95 -108.19 -82.08 0.56 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.655 0.782 . . . . 70.32 108.944 177.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -153.12 -162.21 1.44 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.765 1.626 . . . . 74.22 107.772 -171.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -73.7 79.53 0.83 Allowed Glycine 0 C--N 1.349 1.274 0 N-CA-C 111.199 -0.76 . . . . 63.11 111.199 170.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 2.1 pptp? -74.72 155.0 38.16 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.946 0.898 . . . . 75.34 111.55 -174.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 9.7 t -165.03 158.69 17.15 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.413 0.685 . . . . 71.02 110.434 -175.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 247' ' ' LEU . . . . . . . . . . . . . 34.2 tp -101.56 127.5 48.24 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.077 0.951 . . . . 72.51 109.43 -179.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 248' ' ' ARG . . . . . 0.49 ' HG3' ' HG2' ' C' ' 226' ' ' ARG . 9.9 ptp180 -133.15 71.52 1.47 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 122.319 1.057 . . . . 75.15 109.17 -178.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -86.65 -43.74 12.39 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 113.62 -1.627 . . . . 71.33 112.52 -170.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -66.35 -57.5 7.32 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 123.555 0.534 . . . . 65.4 112.307 -164.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 251' ' ' ALA . . . . . 0.527 ' H ' ' HG ' ' B' ' 280' ' ' LEU . . . 54.7 -78.88 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 125.058 1.343 . . . . 61.03 112.163 -175.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -84.49 64.21 8.29 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 124.493 1.117 . . . . 72.3 108.09 172.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -69.95 -31.77 69.68 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.378 -0.828 . . . . 51.41 110.336 178.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -142.44 -72.18 0.32 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 107.657 -1.238 . . . . 72.51 107.657 177.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . 70.08 -76.6 0.45 Allowed Glycine 0 C--N 1.357 1.747 0 O-C-N 123.766 0.666 . . . . 54.22 113.676 172.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 256' ' ' TYR . . . . . 0.702 ' HA ' ' HA ' ' B' ' 266' ' ' ASN . 92.3 m-85 -75.74 -0.6 21.47 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.448 1.099 . . . . 52.52 112.73 -178.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 64.44 -88.65 0.03 OUTLIER 'General case' 0 C--N 1.356 0.866 0 C-N-CA 125.38 1.472 . . . . 74.31 109.586 -176.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 258' ' ' LEU . . . . . . . . . . . . . 53.9 tp -176.21 -69.71 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.32 1.048 . . . . 75.13 108.724 169.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 13.0 m -139.14 135.04 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.196 0.998 . . . . 63.02 108.963 178.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 260' ' ' SER . . . . . . . . . . . . . 58.1 m -151.82 80.64 1.27 Allowed 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 106.79 -1.559 . . . . 73.11 106.79 173.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 66.4 -69.43 0.12 Allowed 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 125.009 1.324 . . . . 52.21 109.99 -166.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 262' ' ' ALA . . . . . . . . . . . . . . . -82.17 145.53 30.04 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.478 0.711 . . . . 43.43 110.55 171.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -74.11 131.79 41.65 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.127 0.571 . . . . 70.44 109.726 175.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 80.1 p 49.92 46.07 24.57 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.631 1.572 . . . . 51.14 111.35 -175.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 265' ' ' LEU . . . . . . . . . . . . . 61.1 tp -59.39 -31.19 69.01 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.929 0.892 . . . . 64.12 111.425 -179.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 266' ' ' ASN . . . . . 0.702 ' HA ' ' HA ' ' B' ' 256' ' ' TYR . 64.6 t30 81.6 -70.49 0.07 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.154 1.382 . . . . 71.52 111.458 170.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 21.8 m 65.13 -76.16 0.04 OUTLIER 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 125.019 1.328 . . . . 73.13 112.959 173.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 10.2 p -59.32 -32.72 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.668 0.787 . . . . 74.44 112.485 -173.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 269' ' ' THR . . . . . 0.458 ' HB ' ' ND2' ' B' ' 266' ' ' ASN . 16.4 m -84.47 -11.83 55.44 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 123.259 0.624 . . . . 74.31 112.345 -176.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 270' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -139.51 -60.01 0.56 Allowed 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.486 -0.759 . . . . 72.41 112.585 -177.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 271' ' ' ALA . . . . . . . . . . . . . . . -70.54 112.14 6.58 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.75 0.82 . . . . 75.3 110.911 -174.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 272' ' ' ASN . . . . . . . . . . . . . 8.9 t30 70.91 -74.82 0.08 Allowed 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 126.103 1.761 . . . . 54.14 112.021 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 17.3 mp0 -60.41 -48.13 83.08 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.406 0.682 . . . . 61.32 111.072 -175.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 57.29 22.94 8.24 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.823 1.249 . . . . 71.44 112.272 178.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 275' ' ' LYS . . . . . 0.52 ' HD2' HD12 ' B' ' 278' ' ' LEU . 37.1 ttpt -157.78 99.2 1.85 Allowed Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 123.699 0.8 . . . . 71.33 109.797 -169.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 276' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' B' ' 269' ' ' THR . 85.5 Cg_endo -85.22 -59.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 122.541 2.161 . . . . 62.35 112.742 173.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 277' ' ' LEU . . . . . . . . . . . . . 97.9 mt -137.74 94.77 2.95 Favored 'General case' 0 C--N 1.356 0.87 0 C-N-CA 124.573 1.149 . . . . 63.32 109.536 -170.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 278' ' ' LEU . . . . . 0.52 HD12 ' HD2' ' B' ' 275' ' ' LYS . 0.7 OUTLIER -86.05 -13.19 48.12 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 124.287 1.035 . . . . 62.0 109.871 178.648 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . -64.06 -20.91 65.3 Favored Glycine 0 N--CA 1.478 1.466 0 N-CA-C 114.165 0.426 . . . . 75.43 114.165 -178.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 280' ' ' LEU . . . . . 0.527 ' HG ' ' H ' ' B' ' 251' ' ' ALA . 2.4 mm? -90.7 11.79 21.11 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.773 0.829 . . . . 53.23 111.318 178.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -147.87 111.19 4.92 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.935 0.894 . . . . 75.31 108.613 -176.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -83.99 33.21 0.48 Allowed 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 124.178 0.991 . . . . 65.41 112.422 -176.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 16.3 t70 64.57 26.86 13.33 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.56 1.144 . . . . 72.33 110.366 -179.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . 82.71 53.95 3.4 Favored Glycine 0 C--N 1.35 1.346 0 N-CA-C 111.245 -0.742 . . . . 61.45 111.245 -174.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 9.1 t30 68.36 110.32 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 125.034 1.333 . . . . 72.41 110.885 -172.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 286' ' ' MET . . . . . . . . . . . . . 47.8 tpp -74.22 119.68 77.58 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 123.651 0.78 . . . . 64.1 110.212 -179.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 287' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -67.67 112.5 2.66 Favored 'Trans proline' 0 C--N 1.377 2.071 0 C-N-CA 122.77 2.313 . . . . 73.33 111.18 178.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 288' ' ' VAL . . . . . . . . . . . . . 33.8 m -111.99 158.19 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.385 0.674 . . . . 74.32 109.785 177.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 289' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -107.47 171.44 7.38 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.103 0.961 . . . . 72.14 109.531 179.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 290' ' ' TRP . . . . . . . . . . . . . 60.6 m95 56.73 27.49 12.8 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 124.715 1.206 . . . . 75.34 111.275 -178.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 291' ' ' LEU . . . . . 0.505 HD23 ' H ' ' B' ' 291' ' ' LEU . 2.7 pt? -90.23 1.08 56.85 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.1 0.96 . . . . 64.34 112.703 -169.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . -168.46 -102.41 0.16 Allowed Glycine 0 C--N 1.344 1.008 0 CA-C-O 119.008 -0.885 . . . . 62.12 111.609 178.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 293' ' ' PRO . . . . . 0.581 ' HB2' HG22 ' B' ' 296' ' ' THR . 96.5 Cg_endo -77.39 80.79 2.81 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.789 2.326 . . . . 51.12 112.403 -176.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -83.24 -27.19 30.08 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 115.681 -0.691 . . . . 41.23 110.703 177.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -128.21 89.85 2.98 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 107.763 -1.199 . . . . 34.32 107.763 173.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 296' ' ' THR . . . . . 0.581 HG22 ' HB2' ' B' ' 293' ' ' PRO . 29.0 p -74.37 90.55 2.16 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 124.017 0.927 . . . . 65.42 110.195 -173.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 297' ' ' TYR . . . . . 0.548 ' HD2' ' HA ' ' B' ' 300' ' ' ASN . 77.7 t80 66.73 1.79 2.35 Favored 'General case' 0 CA--C 1.562 1.426 0 C-N-CA 124.824 1.25 . . . . 64.12 111.264 -173.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 3.6 t60 53.01 84.8 0.05 Allowed 'General case' 0 C--N 1.361 1.086 0 C-N-CA 125.029 1.332 . . . . 71.5 110.64 -167.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . 71.01 63.16 3.24 Favored Glycine 0 C--N 1.344 0.98 0 CA-C-N 114.912 -1.04 . . . . 63.41 111.751 -178.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 300' ' ' ASN . . . . . 0.548 ' HA ' ' HD2' ' B' ' 297' ' ' TYR . 53.8 t30 -58.02 89.83 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.572 1.149 . . . . 72.23 110.902 -177.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 301' ' ' ILE . . . . . . . . . . . . . 50.2 mm 74.89 -34.15 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.559 1.32 0 C-N-CA 125.77 1.628 . . . . 72.24 112.751 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 31.6 t70 57.54 87.28 0.07 Allowed 'General case' 0 C--N 1.361 1.069 0 C-N-CA 124.353 1.061 . . . . 63.41 109.162 -172.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 303' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -154.38 130.88 5.7 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 109.287 -0.634 . . . . 74.11 109.287 -169.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 304' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -69.82 -163.56 0.11 Allowed 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 122.842 2.361 . . . . 75.12 110.899 166.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -81.58 60.96 4.79 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 122.827 0.451 . . . . 42.33 110.276 174.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 78.4 t 66.89 -54.34 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 C-N-CA 126.399 1.88 . . . . 72.33 113.145 -178.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 51.3 m 83.77 -53.58 0.14 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 126.518 1.927 . . . . 74.23 111.143 173.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 308' ' ' CYS . . . . . . . . . . . . . 24.6 p -81.13 20.01 0.86 Allowed 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.697 0.799 . . . . 74.22 113.082 -172.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 18.4 p -120.79 82.5 35.01 Favored Pre-proline 0 CA--C 1.556 1.209 0 C-N-CA 123.201 0.601 . . . . 72.2 110.258 171.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -84.59 -168.43 0.53 Allowed 'Trans proline' 0 C--N 1.375 1.925 0 C-N-CA 122.536 2.157 . . . . 63.14 112.199 170.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 311' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -136.03 101.14 10.49 Favored Pre-proline 0 N--CA 1.48 1.028 0 C-N-CA 123.957 0.903 . . . . 73.13 108.877 173.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 312' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -76.73 102.28 1.6 Allowed 'Trans proline' 0 C--N 1.374 1.88 0 C-N-CA 121.975 1.783 . . . . 70.14 111.481 170.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 313' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -95.83 156.33 16.37 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.899 0.48 . . . . 75.13 109.796 175.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 314' ' ' ARG . . . . . 0.462 ' NH1' ' H ' ' B' ' 322' ' ' ALA . 13.3 ptp180 -123.42 72.72 1.14 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.128 0.971 . . . . 72.01 109.023 -178.09 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 315' ' ' ASN . . . . . . . . . . . . . 7.9 t30 71.22 -61.4 0.48 Allowed 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 125.507 1.523 . . . . 72.12 109.759 -167.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 316' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -87.51 148.43 24.92 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.491 1.116 . . . . 74.4 109.685 172.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 31.3 p -83.07 -70.97 0.52 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.101 0.56 . . . . 75.41 109.925 175.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 318' ' ' VAL . . . . . . . . . . . . . 41.7 t -81.31 -47.66 1.08 Allowed Pre-proline 0 CA--C 1.568 1.647 0 CA-C-O 118.453 -0.784 . . . . 73.13 111.38 -179.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 319' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -65.38 157.71 56.5 Favored 'Trans proline' 0 C--N 1.398 3.147 0 C-N-CA 121.936 1.757 . . . . 65.1 112.404 173.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 320' ' ' THR . . . . . 0.571 ' HA ' ' HA ' ' B' ' 325' ' ' THR . 6.7 m 69.67 -11.53 0.51 Allowed 'General case' 0 CA--C 1.566 1.572 0 C-N-CA 125.595 1.558 . . . . 53.31 113.16 178.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 321' ' ' LEU . . . . . . . . . . . . . 56.1 tp -70.42 98.14 1.38 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.813 0.845 . . . . 65.14 111.054 -172.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 322' ' ' ALA . . . . . 0.462 ' H ' ' NH1' ' B' ' 314' ' ' ARG . . . 76.63 -34.77 0.23 Allowed 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 126.267 1.827 . . . . 64.54 112.961 178.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 323' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -161.82 -171.66 2.99 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 125.861 1.664 . . . . 74.02 107.68 178.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 324' ' ' MET . . . . . . . . . . . . . 18.6 ptp 44.44 79.99 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 125.642 1.577 . . . . 71.32 112.642 177.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 325' ' ' THR . . . . . 0.571 ' HA ' ' HA ' ' B' ' 320' ' ' THR . 35.3 p -60.45 -58.04 10.17 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 115.243 -0.889 . . . . 72.33 112.995 -171.017 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 326' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -109.37 -63.77 1.32 Allowed 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 122.91 0.484 . . . . 72.01 109.996 178.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -160.04 98.14 1.3 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.938 0.895 . . . . 54.34 108.908 -171.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 328' ' ' ALA . . . . . . . . . . . . . . . -114.98 89.92 3.21 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 108.658 -0.867 . . . . 72.03 108.658 177.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 329' ' ' ILE . . . . . . . . . . . . . 48.2 pt -121.74 175.46 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.077 0.951 . . . . 73.5 111.373 -171.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 330' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -94.04 144.4 25.51 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.898 0.879 . . . . 63.42 108.739 169.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 331' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -66.89 -49.9 64.14 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.793 0.837 . . . . 63.34 110.212 176.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 5.4 tt -165.92 109.83 0.81 Allowed 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 109.231 -0.655 . . . . 74.41 109.231 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 333' ' ' SER . . . . . . . . . . . . . 17.2 m -86.79 125.45 33.95 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 108.335 -0.987 . . . . 65.04 108.335 169.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 23.4 mtpp -81.93 71.69 8.97 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-O 121.671 0.748 . . . . 63.11 111.246 177.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 335' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -74.34 -34.8 63.53 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 114.542 -1.208 . . . . 73.25 110.935 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.19 -20.43 60.2 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.769 0.828 . . . . 61.02 111.182 176.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 337' ' ' LYS . . . . . . . . . . . . . 23.3 tptm 76.91 -23.84 0.24 Allowed 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 125.862 1.665 . . . . 62.43 112.592 174.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 338' ' ' GLY . . . . . . . . . . . . . . . 68.26 47.86 55.9 Favored Glycine 0 C--N 1.345 1.058 0 N-CA-C 110.931 -0.868 . . . . 72.34 110.931 -170.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 339' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -72.93 82.13 1.2 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.618 0.767 . . . . 74.33 110.29 -177.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 340' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 56.85 16.39 2.72 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 125.585 1.554 . . . . 75.24 112.959 178.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 341' ' ' LEU . . . . . . . . . . . . . 72.2 mt 57.29 46.79 17.93 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.63 1.172 . . . . 75.34 110.968 -173.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 342' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -111.74 153.7 26.1 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.595 0.758 . . . . 64.25 111.273 -178.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 343' ' ' VAL . . . . . . . . . . . . . 6.7 t 63.72 3.46 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.576 1.947 0 C-N-CA 126.18 1.792 . . . . 64.24 112.717 175.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.53 -15.66 30.29 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.447 0.699 . . . . 73.03 112.269 -175.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 345' ' ' GLY . . . . . . . . . . . . . . . 140.5 -44.01 1.08 Allowed Glycine 0 C--N 1.348 1.247 0 CA-C-N 117.624 0.193 . . . . 62.31 112.628 174.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 346' ' ' ALA . . . . . . . . . . . . . . . -103.28 29.29 5.68 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.709 0.804 . . . . 72.22 111.2 -175.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 9.6 m -62.66 93.05 0.05 Allowed 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.392 1.077 . . . . 72.21 112.404 -172.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 2.7 mp 69.97 -61.53 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 C-N-CA 125.848 1.659 . . . . 73.42 111.373 -179.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 349' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -70.5 166.92 19.47 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.972 0.909 . . . . 71.13 112.495 177.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 350' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -158.44 156.19 29.92 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 114.466 -1.243 . . . . 74.52 108.106 -178.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -63.43 150.69 43.02 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.634 0.373 . . . . 71.32 110.649 177.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -118.24 108.43 15.13 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 122.8 0.44 . . . . 74.35 110.812 -177.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 353' ' ' HIS . . . . . . . . . . . . . 51.9 m80 54.08 39.24 30.43 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.735 1.214 . . . . 74.33 111.988 174.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 354' ' ' ALA . . . . . . . . . . . . . . . 69.04 -72.21 0.11 Allowed 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 125.109 1.364 . . . . 70.11 110.068 -168.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 355' ' ' ALA . . . . . . . . . . . . . . . -148.8 -64.98 0.24 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.4 0.68 . . . . 75.44 109.685 179.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 356' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -163.1 127.27 1.91 Allowed Pre-proline 0 N--CA 1.477 0.888 0 N-CA-C 108.079 -1.082 . . . . 74.32 108.079 178.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 357' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -54.85 -51.62 9.92 Favored 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 123.09 2.527 . . . . 55.22 113.381 -176.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 358' ' ' CYS . . . . . . . . . . . . . 67.3 m -70.41 -24.33 62.91 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.04 0.536 . . . . 73.32 111.457 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 359' ' ' GLY . . . . . . . . . . . . . . . -74.1 -31.96 59.05 Favored Glycine 0 C--N 1.347 1.174 0 CA-C-N 116.256 -0.429 . . . . 62.01 112.7 178.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 360' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -96.14 38.9 1.16 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.181 0.592 . . . . 53.34 111.217 -176.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 361' ' ' ILE . . . . . . . . . . . . . 2.7 pp -70.64 -7.83 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 C-N-CA 123.4 0.68 . . . . 61.31 112.177 174.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 362' ' ' GLY . . . . . . . . . . . . . . . -145.48 -168.72 13.23 Favored Glycine 0 C--N 1.342 0.89 0 N-CA-C 111.196 -0.762 . . . . 72.35 111.196 172.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 363' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 63.22 -80.84 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 125.413 1.485 . . . . 73.13 112.189 176.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 364' ' ' THR . . . . . . . . . . . . . 66.6 p -96.38 27.37 3.8 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.76 0.824 . . . . 74.04 111.849 -173.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 8.1 m -65.76 -29.76 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 123.492 0.717 . . . . 74.01 111.784 173.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -84.0 -10.47 57.87 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.276 0.63 . . . . 50.12 111.191 174.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 367' ' ' LEU . . . . . . . . . . . . . 9.2 mp 64.98 169.47 0.19 Allowed 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 124.787 1.235 . . . . 75.05 112.449 178.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 368' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -84.89 86.25 7.38 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 122.203 1.002 . . . . 71.23 108.549 170.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 369' ' ' GLU . . . . . 0.446 ' HB3' ' HB3' ' B' ' 372' ' ' GLN . 50.7 mt-10 -75.03 -64.35 1.07 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 114.412 -1.267 . . . . 70.1 111.084 -176.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 370' ' ' ALA . . . . . . . . . . . . . . . 66.13 -73.36 0.07 Allowed 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.307 1.443 . . . . 74.25 111.452 -175.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 371' ' ' VAL . . . . . . . . . . . . . 9.2 p -74.81 -30.0 23.64 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.085 0 C-N-CA 124.472 1.109 . . . . 74.11 112.582 -177.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 372' ' ' GLN . . . . . 0.446 ' HB3' ' HB3' ' B' ' 369' ' ' GLU . 0.2 OUTLIER -66.28 -61.73 1.86 Allowed 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.19 0.596 . . . . 63.2 110.881 -170.381 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 373' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -111.75 148.31 33.77 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 122.961 0.504 . . . . 72.05 111.014 178.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . 65.76 -82.84 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 125.47 1.508 . . . . 71.45 112.177 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 375' ' ' LEU . . . . . . . . . . . . . 44.4 tp 50.16 -102.18 0.1 Allowed 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.882 1.273 . . . . 62.01 111.356 -175.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -127.43 -7.67 5.78 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.004 0.921 . . . . 73.13 110.345 176.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 377' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -59.47 -65.41 0.68 Allowed 'General case' 0 C--N 1.355 0.832 0 O-C-N 124.098 0.874 . . . . 73.31 109.217 -177.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 378' ' ' ALA . . . . . . . . . . . . . . . 60.54 -1.38 0.22 Allowed 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 114.741 1.385 . . . . 61.1 114.741 171.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -77.14 86.56 3.61 Favored 'General case' 0 C--N 1.351 0.639 0 N-CA-C 108.751 -0.833 . . . . 72.01 108.751 -176.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 380' ' ' LYS . . . . . . . . . . . . . 88.8 tttt 48.8 91.42 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.402 1.481 . . . . 53.14 112.752 177.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 381' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -61.66 -45.52 93.68 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 108.52 -0.918 . . . . 74.34 108.52 171.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -166.29 -162.42 17.7 Favored Glycine 0 C--N 1.34 0.798 0 CA-C-N 114.118 -1.401 . . . . 73.1 109.624 171.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 383' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -74.82 169.41 17.95 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 109.289 -0.634 . . . . 73.1 109.289 170.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 384' ' ' THR . . . . . . . . . . . . . 48.3 p -80.94 76.04 7.9 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-O 121.898 0.856 . . . . 63.41 111.627 -173.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -159.67 109.04 1.83 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.901 1.28 . . . . 75.12 107.943 171.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 386' ' ' VAL . . . . . . . . . . . . . 4.4 m -86.79 67.19 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.694 0.798 . . . . 62.42 110.572 -175.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 387' ' ' ILE . . . . . 0.503 HG12 HG23 ' B' ' 388' ' ' VAL . 9.8 tt -65.49 129.09 29.39 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.094 0 CA-C-N 115.317 -0.856 . . . . 74.12 109.824 177.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 388' ' ' VAL . . . . . 0.503 HG23 HG12 ' B' ' 387' ' ' ILE . 65.9 t 77.02 -51.91 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 C-N-CA 125.882 1.673 . . . . 54.33 111.997 -178.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 389' ' ' THR . . . . . . . . . . . . . 35.2 p -85.02 16.92 3.14 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 123.652 0.781 . . . . 71.25 112.713 -176.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . -66.36 -66.42 0.55 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.635 0.774 . . . . 70.34 111.317 177.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 391' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -145.25 -87.78 0.11 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.468 0.707 . . . . 64.12 109.876 -173.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 392' ' ' HIS . . . . . . . . . . . . . 40.0 m80 52.46 83.16 0.06 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.331 1.052 . . . . 72.42 111.218 -168.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -76.17 69.17 2.69 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.203 0.601 . . . . 61.53 109.762 173.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 33.1 m80 56.2 -84.88 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 126.176 1.79 . . . . 73.31 112.361 -178.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . -153.51 -0.9 0.22 Allowed 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 112.884 0.698 . . . . 71.44 112.884 -174.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 66.3 m -96.75 19.62 12.21 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 112.118 0.414 . . . . 75.55 112.118 -177.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 397' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 67.8 -73.99 0.08 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.84 1.256 . . . . 71.41 109.679 -174.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 12.6 tt -157.87 135.26 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 C-N-CA 124.261 1.024 . . . . 75.44 108.567 176.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 399' ' ' VAL . . . . . 0.597 HG23 ' H ' ' B' ' 400' ' ' ALA 0.26 29.8 m 44.6 -79.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 C-N-CA 126.699 2.0 . . . . 73.32 114.599 -178.919 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 400' ' ' ALA . . . . . 0.597 ' H ' HG23 ' B' ' 399' ' ' VAL . . . -113.3 129.38 24.64 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 123.802 0.841 . . . . 51.41 108.843 -177.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 401' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -70.63 81.58 1.02 Allowed 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 122.745 2.297 . . . . 71.04 112.126 -179.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 25.8 t70 65.35 107.71 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.859 1.264 . . . . 74.34 111.162 -178.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 403' ' ' THR . . . . . 0.49 ' H ' ' HG3' ' B' ' 406' ' ' PRO . 89.0 m -140.94 101.16 3.99 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 122.909 0.484 . . . . 51.3 110.575 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 404' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp 63.3 -75.57 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.551 1.54 . . . . 70.03 113.195 169.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 405' ' ' ALA . . . . . . . . . . . . . . . -125.56 76.5 69.57 Favored Pre-proline 0 CA--C 1.555 1.135 0 C-N-CA 123.656 0.782 . . . . 71.24 110.832 179.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 406' ' ' PRO . . . . . 0.49 ' HG3' ' H ' ' B' ' 403' ' ' THR . 9.8 Cg_endo -94.1 115.58 0.24 Allowed 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 123.25 2.633 . . . . 44.44 110.586 169.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . -64.99 137.94 38.98 Favored Glycine 0 CA--C 1.535 1.324 0 CA-C-N 116.741 -0.208 . . . . 55.33 113.114 -177.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 408' ' ' LEU . . . . . . . . . . . . . 3.9 tt -139.62 99.73 3.79 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 107.573 -1.269 . . . . 72.03 107.573 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 93.4 m 73.86 -66.25 0.31 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 125.236 1.414 . . . . 73.52 112.187 176.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 410' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -111.94 104.7 12.99 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.942 0.897 . . . . 51.32 109.692 -179.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . -148.87 -83.65 0.1 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.677 0.791 . . . . 63.14 109.023 174.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 96.2 mt -142.33 -60.78 0.45 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.879 0.871 . . . . 60.41 109.881 -177.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -118.6 5.16 11.64 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.953 0.901 . . . . 71.14 110.62 -174.092 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 414' ' ' THR . . . . . . . . . . . . . 11.8 p -75.52 118.38 18.31 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.661 0.784 . . . . 73.24 110.538 -177.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 415' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt 67.09 -72.47 0.09 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.856 1.262 . . . . 73.42 111.46 -176.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -68.94 129.03 38.79 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.639 0.776 . . . . 75.33 109.422 173.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 417' ' ' GLY . . . . . . . . . . . . . . . 97.24 -28.66 13.05 Favored Glycine 0 C--N 1.346 1.086 0 N-CA-C 111.899 -0.48 . . . . 43.15 111.899 -174.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 418' ' ' ALA . . . . . . . . . . . . . . . -80.78 70.76 7.62 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 108.858 -0.793 . . . . 70.25 108.858 173.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 419' ' ' VAL . . . . . . . . . . . . . 29.3 m -77.18 160.74 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 114.693 -1.139 . . . . 62.03 110.441 -177.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 420' ' ' MET . . . . . . . . . . . . . 14.9 tpt 75.82 -20.62 0.34 Allowed 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 125.707 1.603 . . . . 73.12 111.924 -175.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 421' ' ' VAL . . . . . . . . . . . . . 26.3 t -78.27 73.57 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.073 0 C-N-CA 123.966 0.906 . . . . 72.42 109.274 176.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 422' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -175.7 -72.63 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 107.1 -1.445 . . . . 74.1 107.1 -178.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 423' ' ' SER . . . . . . . . . . . . . 28.3 t 61.77 -79.43 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.348 0 C-N-CA 125.629 1.572 . . . . 62.22 112.214 -179.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 424' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -138.49 21.82 2.73 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 123.588 0.755 . . . . 72.42 110.766 176.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . -168.88 -145.08 4.45 Favored Glycine 0 C--N 1.336 0.549 0 N-CA-C 110.87 -0.892 . . . . 75.12 110.87 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 426' ' ' ASN . . . . . 0.437 ' H ' ' H ' ' B' ' 427' ' ' SER . 8.3 t30 -166.26 -1.57 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.548 0.739 . . . . 75.43 109.875 175.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 427' ' ' SER . . . . . 0.437 ' H ' ' H ' ' B' ' 426' ' ' ASN . 16.3 m 70.1 11.58 7.63 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 125.198 1.399 . . . . 75.14 111.015 -171.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 163.85 96.47 0.0 OUTLIER 'General case' 0 C--N 1.359 1.018 0 C-N-CA 127.553 2.341 . . . . 73.23 105.814 -179.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 429' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -87.42 31.28 0.75 Allowed 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.273 0.629 . . . . 63.42 111.68 -169.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -76.95 90.34 3.54 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 108.365 -0.976 . . . . 55.41 108.365 176.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 52.9 m 63.19 17.49 10.24 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.868 1.267 . . . . 73.31 112.121 -172.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 432' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 51.57 40.31 26.79 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 124.628 1.171 . . . . 71.1 111.255 -172.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 433' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -77.87 87.56 4.08 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 115.36 -0.836 . . . . 73.43 110.302 -175.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 434' ' ' HIS . . . . . . . . . . . . . 39.3 p-80 -98.81 73.61 2.01 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.579 -0.897 . . . . 65.13 108.579 172.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 435' ' ' THR . . . . . . . . . . . . . 55.0 m -44.64 -46.61 10.26 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 125.473 1.509 . . . . 73.42 113.133 -173.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . -108.3 154.55 16.49 Favored Glycine 0 C--N 1.344 0.997 0 N-CA-C 111.423 -0.671 . . . . 43.54 111.423 174.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 58.6 p -74.25 -29.73 61.82 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.392 0.677 . . . . 54.14 110.261 173.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 438' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 62.36 22.9 13.53 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 125.37 1.468 . . . . 71.55 112.066 178.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 439' ' ' LEU . . . . . . . . . . . . . 88.5 mt -75.29 93.49 2.88 Favored 'General case' 0 C--N 1.352 0.678 0 N-CA-C 109.197 -0.668 . . . . 74.24 109.197 175.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 440' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -56.44 110.72 0.82 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.492 0.717 . . . . 70.1 110.73 177.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 441' ' ' ILE . . . . . 0.637 ' HA ' HD22 ' A' ' 235' ' ' LEU . 18.0 tt -134.11 19.58 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 CA-C-O 122.514 1.15 . . . . 74.15 109.904 175.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 442' ' ' ALA . . . . . . . . . . . . . . . -80.78 79.07 7.49 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.509 -0.768 . . . . 71.41 109.754 175.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . -93.31 -56.8 2.81 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.837 0.855 . . . . 74.21 109.463 176.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 3.1 m-30 -89.95 86.65 6.67 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.41 -0.814 . . . . 65.34 109.257 176.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . -79.24 115.01 4.01 Favored Glycine 0 C--N 1.342 0.883 0 N-CA-C 109.976 -1.25 . . . . 74.34 109.976 169.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 446' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -66.9 83.31 0.32 Allowed 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 122.66 2.24 . . . . 63.02 112.124 -178.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 447' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -82.21 85.34 6.83 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.089 -0.96 . . . . 60.0 109.988 -178.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . -106.86 -153.66 0.5 Allowed 'General case' 0 C--O 1.245 0.82 0 CA-C-N 114.634 -1.166 . . . . 74.31 108.39 172.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 449' ' ' ALA . . . . . 0.514 ' O ' ' HA ' ' B' ' 461' ' ' PHE . . . 67.6 -81.23 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.31 1.044 . . . . 61.52 111.372 175.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 450' ' ' ASN . . . . . 0.417 ' HB3' HG13 ' B' ' 452' ' ' VAL . 7.5 m120 -155.33 166.15 34.42 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.018 0.927 . . . . 61.12 110.871 -178.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 7.4 p -100.21 20.76 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 123.926 0.89 . . . . 63.1 110.689 175.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 452' ' ' VAL . . . . . 0.417 HG13 ' HB3' ' B' ' 450' ' ' ASN . 15.8 m -57.58 116.86 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 C-N-CA 124.296 1.038 . . . . 60.45 111.682 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 100.09 -31.79 8.04 Favored Glycine 0 C--N 1.343 0.968 0 CA-C-N 115.691 -0.686 . . . . 73.44 113.282 179.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 454' ' ' LEU . . . . . 0.478 HD22 ' HB2' ' B' ' 456' ' ' ASP . 0.5 OUTLIER -78.81 -40.95 31.55 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.237 0.615 . . . . 72.5 110.588 -175.035 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 9.4 m 69.5 0.9 3.11 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 124.529 1.131 . . . . 61.41 112.658 179.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 456' ' ' ASP . . . . . 0.478 ' HB2' HD22 ' B' ' 454' ' ' LEU . 30.6 t70 -73.81 -16.66 61.14 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.869 0.868 . . . . 74.3 111.86 -175.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 457' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 69.18 15.52 8.62 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 125.185 1.394 . . . . 42.14 112.742 -176.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 7.4 t -77.99 63.25 2.94 Favored 'General case' 0 CA--C 1.556 1.207 0 CA-C-O 122.703 1.24 . . . . 72.13 109.495 171.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 459' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -102.02 128.37 48.49 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.216 -0.902 . . . . 73.31 110.192 -171.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 95.9 mt -128.02 82.34 2.08 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 106.996 -1.483 . . . . 65.42 106.996 166.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 461' ' ' PHE . . . . . 0.514 ' HA ' ' O ' ' B' ' 449' ' ' ALA . 44.8 p90 -61.93 -36.77 82.36 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 115.205 -0.907 . . . . 62.31 111.788 -178.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 462' ' ' TYR . . . . . 0.473 ' HD2' ' H ' ' B' ' 465' ' ' LYS . 39.2 p90 -81.24 -14.33 57.59 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.193 0.997 . . . . 72.53 111.566 176.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 94.3 m 65.08 -77.8 0.04 OUTLIER 'General case' 0 C--N 1.36 1.047 0 C-N-CA 125.215 1.406 . . . . 61.35 110.432 -172.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 464' ' ' MET . . . . . 0.584 ' HB3' HD21 ' B' ' 468' ' ' LEU . 6.3 tpt -151.48 92.07 1.73 Allowed 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 107.519 -1.289 . . . . 75.31 107.519 171.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 465' ' ' LYS . . . . . 0.473 ' H ' ' HD2' ' B' ' 462' ' ' TYR . 83.4 tttt 63.65 -80.01 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 125.119 1.367 . . . . 72.15 110.665 -170.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -177.1 149.33 0.68 Allowed 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.105 0.962 . . . . 62.32 110.197 178.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . 56.23 88.61 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.283 1.433 . . . . 75.3 113.338 170.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 468' ' ' LEU . . . . . 0.584 HD21 ' HB3' ' B' ' 464' ' ' MET . 6.0 mp -115.7 17.57 16.12 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.303 0.641 . . . . 45.51 110.538 175.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 469' ' ' GLY . . . . . . . . . . . . . . . 80.32 -1.12 82.56 Favored Glycine 0 C--N 1.347 1.19 0 CA-C-N 116.827 -0.17 . . . . 50.44 113.44 -176.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 470' ' ' LEU . . . . . . . . . . . . . 1.3 pp -124.18 -164.99 1.3 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.947 1.299 . . . . 73.2 108.976 178.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 471' ' ' LYS . . . . . 0.45 ' HE2' ' HA ' ' B' ' 471' ' ' LYS . 0.6 OUTLIER . . . . . 0 CA--C 1.56 1.359 0 C-N-CA 123.202 0.601 . . . . 74.2 109.604 178.012 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 62.9 mtm . . . . . 0 N--CA 1.481 1.107 0 N-CA-C 109.309 -0.626 . . . . 55.23 109.309 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 74.72 -33.56 0.25 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 126.081 1.752 . . . . 65.31 113.575 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -74.64 79.41 2.01 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.206 1.002 . . . . 52.01 111.304 -177.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -36.86 117.51 0.51 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.974 1.71 . . . . 70.52 114.133 173.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -76.07 102.58 5.75 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.849 -0.796 . . . . 63.2 108.849 165.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 6' ' ' ASP . . . . . 0.432 ' HA ' ' OH ' ' C' ' 66' ' ' TYR . 8.6 t70 -75.01 94.24 2.83 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.184 -1.043 . . . . 63.22 108.184 176.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 7' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -61.44 -35.51 77.78 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-N 115.264 -0.88 . . . . 73.43 112.361 -171.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -60.12 -50.24 74.49 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 116.121 -0.49 . . . . 72.53 110.179 175.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.7 -39.16 93.62 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.899 -0.591 . . . . 52.31 111.506 -178.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 81.5 mt -58.14 -42.13 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 C-N-CA 123.665 0.786 . . . . 63.34 110.163 176.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 95.9 mt -74.35 -24.01 59.11 Favored 'General case' 0 N--CA 1.48 1.075 0 CA-C-N 116.19 -0.459 . . . . 45.45 112.025 175.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.99 38.31 10.44 Favored Glycine 0 C--N 1.345 1.079 0 CA-C-N 116.93 -0.123 . . . . 64.33 113.187 -176.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 6.0 m -125.78 157.14 69.87 Favored Pre-proline 0 N--CA 1.481 1.116 0 C-N-CA 124.786 1.235 . . . . 64.04 110.226 176.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -67.77 165.38 27.95 Favored 'Trans proline' 0 C--N 1.383 2.386 0 C-N-CA 122.782 2.321 . . . . 74.43 112.423 177.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -77.54 16.38 0.66 Allowed 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 123.18 0.592 . . . . 71.52 111.982 -179.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -119.18 -0.15 11.1 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.786 1.635 . . . . 71.24 108.406 178.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.46 133.01 47.99 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.406 0.682 . . . . 71.14 111.94 -171.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 68.4 p -87.69 175.47 7.86 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.452 1.101 . . . . 74.41 110.862 -178.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -51.5 -39.14 57.01 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.183 0.993 . . . . 74.45 111.527 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -62.59 -47.46 83.72 Favored 'General case' 0 C--N 1.349 0.584 0 O-C-N 123.811 0.694 . . . . 64.05 111.258 178.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -66.77 -37.99 85.69 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.659 0.784 . . . . 73.42 111.322 -177.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 22' ' ' ILE . . . . . 0.629 HG12 ' HB3' ' C' ' 57' ' ' LEU . 1.7 mp -62.28 -42.56 95.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.323 1.049 . . . . 61.32 110.439 175.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -69.24 -39.65 78.37 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 114.853 -1.067 . . . . 74.13 110.891 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -70.27 -33.63 71.81 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.737 0.815 . . . . 73.52 110.572 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -74.65 -36.26 62.85 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.777 0.831 . . . . 75.32 110.624 177.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 26' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -60.03 -48.28 82.35 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 115.447 -0.797 . . . . 72.31 108.988 172.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -60.1 -44.76 94.6 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.317 1.047 . . . . 74.1 111.203 178.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 22.6 ttt180 -51.25 -52.16 47.38 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.744 1.217 . . . . 71.15 110.963 177.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . 0.454 ' HB3' HD13 ' C' ' 50' ' ' ILE . 83.3 mt -83.6 -12.47 56.02 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 114.585 -1.189 . . . . 60.22 111.506 -178.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.19 -2.65 55.01 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.684 0.793 . . . . 75.32 110.41 173.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 76.6 mtp180 -95.89 -45.35 6.99 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.6 0.76 . . . . 73.5 109.045 166.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -68.31 -52.84 29.08 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 115.343 -0.844 . . . . 71.12 111.188 -178.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 33' ' ' TYR . . . . . 0.448 ' HE2' HD22 ' C' ' 29' ' ' LEU . 37.3 m-85 -100.97 26.26 7.16 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.577 0.751 . . . . 70.15 110.464 -178.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 34' ' ' HIS . . . . . . . . . . . . . 13.0 t60 -55.12 99.16 0.19 Allowed Pre-proline 0 N--CA 1.488 1.46 0 C-N-CA 124.765 1.226 . . . . 72.34 110.738 -177.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -59.58 -27.88 86.05 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 123.088 2.525 . . . . 71.32 113.97 -167.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -72.1 -25.86 61.92 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.357 0.663 . . . . 60.34 111.929 -177.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 67.2 t -113.22 -25.59 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 CA-C-O 121.352 0.596 . . . . 75.33 110.783 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -105.43 83.98 2.03 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 106.807 -1.553 . . . . 54.22 106.807 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.96 76.5 7.9 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.89 -0.782 . . . . 62.24 108.89 -178.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 67.4 m -143.08 108.43 5.37 Favored Pre-proline 0 C--O 1.235 0.329 0 N-CA-C 107.004 -1.48 . . . . 74.14 107.004 172.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . 0.44 ' O ' ' HG2' ' C' ' 45' ' ' GLU . 76.9 Cg_exo -46.79 -30.59 9.53 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 123.548 2.832 . . . . 63.44 114.161 175.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -57.14 -45.53 83.48 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.752 0.821 . . . . 65.44 111.216 175.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.54 -19.19 62.91 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.508 -0.769 . . . . 62.05 110.84 178.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 44' ' ' GLU . . . . . 0.411 ' O ' ' HG3' ' C' ' 48' ' ' LYS . 36.5 mt-10 -87.6 -30.36 20.54 Favored 'General case' 0 C--N 1.358 0.95 0 C-N-CA 123.184 0.594 . . . . 74.04 110.409 -178.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 45' ' ' GLU . . . . . 0.44 ' HG2' ' O ' ' C' ' 41' ' ' PRO . 11.8 mm-40 -72.39 -40.09 67.51 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 108.895 -0.78 . . . . 42.53 108.895 174.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 46' ' ' LYS . . . . . 0.41 ' O ' HG13 ' C' ' 50' ' ' ILE . 48.4 mttp -63.25 -38.11 89.88 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-N 114.587 -1.188 . . . . 72.32 110.413 170.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 47' ' ' PHE . . . . . 0.813 ' HA ' HD12 ' C' ' 50' ' ' ILE . 26.8 t80 -62.45 -35.28 78.81 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 123.526 0.516 . . . . 62.23 110.387 175.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 48' ' ' LYS . . . . . 0.428 ' HB3' ' CE1' ' C' ' 93' ' ' PHE . 98.3 mttt -63.16 -44.74 94.64 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.099 0.56 . . . . 72.04 111.009 174.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -61.13 -36.38 79.6 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 120.997 0.427 . . . . 72.33 111.407 177.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 50' ' ' ILE . . . . . 0.813 HD12 ' HA ' ' C' ' 47' ' ' PHE . 52.5 mt -65.89 -40.28 87.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 124.051 0.94 . . . . 75.43 109.887 174.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 51' ' ' ASN . . . . . 0.413 ' HB3' ' CD1' ' C' ' 88' ' ' PHE . 28.5 m-80 -75.93 -16.68 59.98 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.067 0.947 . . . . 74.04 111.757 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -73.18 -53.39 11.08 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 108.939 -0.763 . . . . 63.42 108.939 170.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.29 -42.88 82.57 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 113.852 -1.522 . . . . 63.1 111.051 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -68.44 -40.67 81.06 Favored 'General case' 0 C--O 1.204 -1.307 0 CA-C-N 114.655 -1.157 . . . . 75.01 110.129 175.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.55 -35.04 73.46 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 112.373 0.508 . . . . 60.54 112.373 -179.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 56' ' ' VAL . . . . . 0.414 HG13 ' HZ ' ' C' ' 101' ' ' PHE . 15.6 t -96.39 -16.48 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 O-C-N 123.47 0.482 . . . . 72.43 111.882 -177.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 57' ' ' LEU . . . . . 0.629 ' HB3' HG12 ' C' ' 22' ' ' ILE . 92.9 mt -118.81 11.01 12.52 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.086 -1.009 . . . . 75.02 113.153 177.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 58' ' ' SER . . . . . 0.474 ' HB3' ' HD2' ' C' ' 62' ' ' LYS . 43.1 t -52.7 -34.21 51.2 Favored 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 124.749 1.219 . . . . 62.42 113.315 -176.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -134.28 155.93 79.45 Favored Pre-proline 0 N--CA 1.474 0.763 0 C-N-CA 124.803 1.241 . . . . 72.03 108.891 -174.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 60' ' ' PRO . . . . . 0.407 ' O ' ' HG2' ' C' ' 64' ' ' ARG . 50.3 Cg_exo -55.5 -29.73 70.61 Favored 'Trans proline' 0 C--N 1.383 2.347 0 C-N-CA 122.79 2.327 . . . . 33.23 112.354 169.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -56.8 -61.84 2.15 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.738 0.815 . . . . 62.13 110.278 174.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 62' ' ' LYS . . . . . 0.474 ' HD2' ' HB3' ' C' ' 58' ' ' SER . 56.1 mttp -64.31 -37.79 88.75 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 114.527 -1.215 . . . . 75.23 110.785 -176.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -56.28 -49.61 73.75 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 114.072 -1.422 . . . . 64.42 110.389 178.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 64' ' ' ARG . . . . . 0.407 ' HG2' ' O ' ' C' ' 60' ' ' PRO . 29.9 mmt180 -73.1 -27.54 61.77 Favored 'General case' 0 C--N 1.35 0.595 0 CA-C-O 118.591 -0.718 . . . . 74.15 111.755 -177.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 81.3 mt -58.73 -47.29 89.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-O 121.215 0.531 . . . . 62.34 109.585 170.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 66' ' ' TYR . . . . . 0.432 ' OH ' ' HA ' ' C' ' 6' ' ' ASP . 25.2 t80 -60.17 -52.75 63.98 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.028 -0.987 . . . . 74.22 110.323 175.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -62.05 -34.38 76.15 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.356 0.662 . . . . 73.14 111.831 -175.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 72.0 p -77.24 -24.97 51.12 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 119.223 -0.418 . . . . 63.2 110.634 176.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -66.7 128.95 38.23 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 108.816 -0.809 . . . . 75.22 108.816 173.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 93.79 15.55 48.91 Favored Glycine 0 C--N 1.344 1.021 0 N-CA-C 111.498 -0.641 . . . . 62.51 111.498 -168.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 86.3 m -143.95 -62.46 0.39 Allowed 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 102.959 -2.978 . . . . 72.34 102.959 174.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 27.1 m -70.41 132.93 46.35 Favored 'General case' 0 C--O 1.25 1.115 0 N-CA-C 104.615 -2.365 . . . . 73.35 104.615 155.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.16 -43.83 6.18 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 122.853 0.461 . . . . 73.23 111.316 -173.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -90.89 136.95 27.05 Favored Pre-proline 0 N--CA 1.477 0.886 0 C-N-CA 123.653 0.781 . . . . 53.23 109.834 -179.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.33 138.43 86.19 Favored 'Trans proline' 0 C--N 1.376 2.02 0 C-N-CA 122.761 2.308 . . . . 75.14 111.856 171.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -59.73 152.63 61.78 Favored 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 122.604 2.202 . . . . 63.14 112.417 176.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -51.67 136.77 50.3 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 122.98 2.454 . . . . 51.51 111.848 178.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 78' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.87 124.03 15.28 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 123.052 2.501 . . . . 74.44 112.565 -176.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.87 173.91 2.02 Favored 'Trans proline' 0 N--CA 1.51 2.46 0 C-N-CA 123.727 2.951 . . . . 61.04 114.447 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -57.11 88.62 0.04 OUTLIER 'Trans proline' 0 C--N 1.392 2.856 0 C-N-CA 122.857 2.372 . . . . 51.5 112.628 171.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 130.34 -23.93 4.51 Favored Glycine 0 N--CA 1.467 0.738 0 CA-C-N 114.442 -1.254 . . . . 75.2 110.729 178.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.641 ' HA3' ' HA ' ' C' ' 106' ' ' PHE . . . 107.75 -171.1 15.92 Favored Glycine 0 C--N 1.349 1.289 0 C-N-CA 124.852 1.215 . . . . 74.45 111.006 176.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -65.0 90.18 0.08 Allowed 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.59 -0.893 . . . . 70.14 108.59 165.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 84' ' ' ASP . . . . . 0.602 ' HB3' ' HG3' ' C' ' 143' ' ' ARG . 18.4 t0 -62.36 139.79 58.54 Favored 'General case' 0 C--O 1.241 0.652 0 O-C-N 124.1 0.875 . . . . 63.13 109.624 178.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 85' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -153.74 6.49 0.33 Allowed 'General case' 0 C--O 1.243 0.73 0 CA-C-N 115.447 -0.797 . . . . 74.41 110.273 -175.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 86' ' ' SER . . . . . 0.488 ' HB3' ' O ' ' C' ' 163' ' ' GLY . 74.8 m -64.41 146.75 53.99 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.315 -0.857 . . . . 45.43 110.859 -177.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 97.9 -28.03 16.35 Favored Glycine 0 C--N 1.339 0.719 0 N-CA-C 110.765 -0.934 . . . . 74.33 110.765 -165.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 88' ' ' PHE . . . . . 0.413 ' CD1' ' HB3' ' C' ' 51' ' ' ASN . 23.2 m-85 -116.07 138.03 51.59 Favored 'General case' 0 C--N 1.356 0.882 0 N-CA-C 108.684 -0.858 . . . . 74.44 108.684 -178.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -74.73 81.85 2.08 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.638 0.775 . . . . 72.23 110.589 -174.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 90' ' ' VAL . . . . . 0.438 HG13 ' HG2' ' C' ' 91' ' ' GLU . 6.5 p -41.54 -43.69 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 C-N-CA 125.119 1.368 . . . . 54.41 112.845 177.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 91' ' ' GLU . . . . . 0.438 ' HG2' HG13 ' C' ' 90' ' ' VAL . 51.5 mm-40 -74.97 8.09 2.76 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.653 1.181 . . . . 74.21 113.288 -172.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -120.38 -27.35 5.23 Favored 'General case' 0 C--O 1.243 0.753 0 C-N-CA 123.811 0.844 . . . . 75.53 110.929 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 93' ' ' PHE . . . . . 0.428 ' CE1' ' HB3' ' C' ' 48' ' ' LYS . 2.3 m-30 -77.73 170.95 15.7 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 120.864 0.364 . . . . 72.45 111.726 -165.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 87.1 p -63.02 164.21 8.65 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 114.964 1.468 . . . . 45.51 114.964 -162.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 95' ' ' GLU . . . . . 0.458 ' O ' ' HG3' ' C' ' 99' ' ' GLU . 0.0 OUTLIER -66.59 -33.02 74.74 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 113.749 -1.568 . . . . 55.43 111.401 173.767 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -66.61 -40.08 88.67 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 120.938 0.399 . . . . 65.02 110.469 176.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 97' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -58.85 -44.13 90.92 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 115.415 -0.811 . . . . 64.25 109.73 170.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 98' ' ' GLN . . . . . 0.426 ' O ' ' HA3' ' C' ' 102' ' ' GLY . 69.4 mt-30 -66.78 -18.62 65.46 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 123.463 0.705 . . . . 51.52 112.05 177.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' C' ' 95' ' ' GLU . 47.5 mt-10 -81.14 -48.15 12.52 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.156 0.583 . . . . 74.43 112.123 171.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 19.3 tp -82.14 -49.42 10.17 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 116.149 -0.478 . . . . 73.23 111.517 -168.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 101' ' ' PHE . . . . . 0.414 ' HZ ' HG13 ' C' ' 56' ' ' VAL . 93.2 m-85 -100.12 -25.11 14.4 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.117 0.567 . . . . 73.25 111.474 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 102' ' ' GLY . . . . . 0.426 ' HA3' ' O ' ' C' ' 98' ' ' GLN . . . -43.08 -58.27 3.83 Favored Glycine 0 CA--C 1.546 2.02 0 CA-C-O 118.961 -0.911 . . . . 54.11 115.325 -178.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -54.68 -22.35 28.5 Favored 'Trans proline' 0 C--N 1.387 2.583 0 C-N-CA 123.843 3.029 . . . . 62.02 113.957 -177.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -126.29 16.17 6.74 Favored Glycine 0 C--N 1.356 1.658 0 CA-C-O 118.756 -1.024 . . . . 43.23 113.95 -177.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 34.4 mt -57.76 89.15 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 117.829 0.814 . . . . 73.03 111.607 176.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 106' ' ' PHE . . . . . 0.641 ' HA ' ' HA3' ' C' ' 82' ' ' GLY . 50.7 m-85 60.05 -108.2 0.36 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.138 1.375 . . . . 64.24 113.142 175.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 107' ' ' GLY . . . . . 0.449 ' HA2' ' HA ' ' C' ' 113' ' ' SER . . . 73.61 5.79 69.44 Favored Glycine 0 CA--C 1.549 2.209 0 N-CA-C 110.846 -0.902 . . . . 51.05 110.846 -160.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . -13.11 -74.77 0.01 OUTLIER Glycine 0 C--N 1.387 3.371 0 C-N-CA 127.302 2.382 . . . . 74.41 115.953 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 109' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -100.76 75.65 1.73 Allowed 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 108.349 -0.982 . . . . 74.45 108.349 172.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 110' ' ' GLY . . . . . . . . . . . . . . . -10.04 -69.99 0.01 OUTLIER Glycine 0 N--CA 1.493 2.469 0 C-N-CA 126.126 1.822 . . . . 54.22 115.407 171.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -5.76 -41.4 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.885 0 C-N-CA 126.927 2.091 . . . . 75.25 116.607 161.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 112' ' ' ARG . . . . . 0.401 ' HA ' ' NE ' ' C' ' 112' ' ' ARG . 1.0 OUTLIER -122.65 -38.26 2.67 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.009 1.324 . . . . 74.1 109.638 179.062 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 113' ' ' SER . . . . . 0.449 ' HA ' ' HA2' ' C' ' 107' ' ' GLY . 67.6 m 55.19 14.56 1.05 Allowed 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 125.198 1.399 . . . . 72.53 112.728 -173.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 26.9 tpt180 -144.96 -112.61 0.1 Allowed 'General case' 0 C--O 1.194 -1.816 0 CA-C-O 117.297 -1.335 . . . . 74.05 110.412 -163.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 115' ' ' LYS . . . . . . . . . . . . . 25.3 tptp -38.15 111.88 0.19 Allowed 'General case' 0 N--CA 1.507 2.395 0 CA-C-N 121.248 1.84 . . . . 54.14 114.193 -167.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -67.59 121.86 15.97 Favored Glycine 0 C--N 1.362 1.99 0 O-C-N 124.257 0.973 . . . . 45.25 112.473 -174.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 74.9 mtt85 -89.86 173.17 8.39 Favored 'General case' 0 C--O 1.253 1.261 0 C-N-CA 123.422 0.689 . . . . 64.44 111.51 -178.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 118' ' ' ASP . . . . . 0.599 ' HB2' HD13 ' B' ' 102' ' ' LEU . 4.0 m-20 -66.93 133.93 50.99 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 107.69 -1.226 . . . . 75.42 107.69 169.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 119' ' ' LEU . . . . . 0.435 HD11 ' HB2' ' C' ' 141' ' ' ALA . 3.9 tt -93.61 137.49 32.82 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 106.607 -1.627 . . . . 75.21 106.607 -177.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.405 ' N ' HD23 ' C' ' 119' ' ' LEU . 6.0 mmm-85 -128.0 104.02 7.56 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.194 0.521 . . . . 72.31 109.682 -172.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 121' ' ' ALA . . . . . 0.468 ' HB3' HD23 ' C' ' 176' ' ' LEU . . . -109.29 115.52 30.15 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.206 -1.405 . . . . 63.21 107.206 172.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 122' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -104.42 88.93 3.08 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 105.174 -2.158 . . . . 73.22 105.174 174.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 123' ' ' LEU . . . . . 0.438 HD23 ' H ' ' C' ' 123' ' ' LEU . 1.7 pt? -125.52 136.21 27.98 Favored Pre-proline 0 N--CA 1.485 1.294 0 N-CA-C 114.252 1.204 . . . . 73.3 114.252 -158.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . 0.527 ' HA ' ' O ' ' C' ' 179' ' ' ARG . 53.2 Cg_exo -57.42 140.41 93.06 Favored 'Trans proline' 0 C--N 1.39 2.753 0 C-N-CA 123.816 3.01 . . . . 72.51 114.519 175.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 125' ' ' LEU . . . . . 0.559 ' HB2' HG23 ' B' ' 182' ' ' VAL . 54.3 tp -158.38 155.56 28.9 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.071 0.948 . . . . 74.03 109.791 176.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 126' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -102.49 153.7 19.8 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.122 0.569 . . . . 61.53 110.427 178.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 127' ' ' LEU . . . . . 0.67 HD13 ' HD2' ' C' ' 186' ' ' PHE . 98.0 mt -63.15 -44.46 95.46 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.237 1.015 . . . . 62.25 111.353 176.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 12.2 mp0 -62.04 -37.27 84.29 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 114.729 -1.123 . . . . 75.24 110.553 177.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 129' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -67.95 -37.82 82.06 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.68 0.792 . . . . 73.53 111.283 177.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -68.27 -33.58 74.62 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 123.748 0.655 . . . . 64.34 109.972 178.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 131' ' ' PHE . . . . . 0.442 ' HB2' HD13 ' C' ' 215' ' ' LEU . 83.0 t80 -67.21 -42.46 84.05 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.412 1.085 . . . . 75.55 111.007 174.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 132' ' ' HIS . . . . . . . . . . . . . 35.3 m170 -61.89 -40.96 97.23 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 123.585 0.553 . . . . 60.22 110.076 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . 64.09 -108.37 2.22 Favored Glycine 0 C--N 1.355 1.588 0 N-CA-C 111.04 -0.824 . . . . 65.31 111.04 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . 70.49 147.09 0.37 Allowed Glycine 0 C--N 1.354 1.568 0 O-C-N 124.23 0.606 . . . . 53.24 114.535 173.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -80.19 92.94 5.76 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 107.359 -1.349 . . . . 71.2 107.359 176.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 136' ' ' ARG . . . . . 0.574 ' HB2' HD13 ' B' ' 181' ' ' LEU . 72.7 mtp180 -123.82 155.89 37.16 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 124.08 0.952 . . . . 72.12 109.501 -168.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 137' ' ' VAL . . . . . 0.495 HG23 ' HB1' ' B' ' 180' ' ' ALA . 31.3 m -78.97 122.52 34.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 CA-C-O 121.242 0.544 . . . . 71.12 111.893 -172.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 138' ' ' VAL . . . . . 0.533 ' HB ' HD23 ' B' ' 181' ' ' LEU . 12.9 p -111.56 140.8 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 107.681 -1.229 . . . . 72.14 107.681 169.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 139' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -109.83 100.77 9.7 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 108.131 -1.063 . . . . 74.31 108.131 179.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 140' ' ' VAL . . . . . . . . . . . . . 11.7 p -143.62 134.88 22.65 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.111 0 C-N-CA 123.484 0.714 . . . . 63.22 109.579 -173.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 141' ' ' ALA . . . . . 0.435 ' HB2' HD11 ' C' ' 119' ' ' LEU . . . 67.26 -1.67 1.43 Allowed 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 125.301 1.44 . . . . 15.23 114.173 178.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 119.55 -2.13 13.86 Favored Glycine 0 C--N 1.348 1.238 0 CA-C-O 119.23 -0.761 . . . . 45.25 114.231 179.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 143' ' ' ARG . . . . . 0.602 ' HG3' ' HB3' ' C' ' 84' ' ' ASP . 64.2 mtm180 -119.41 130.7 55.42 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 118.367 1.083 . . . . 73.04 111.744 175.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -83.76 103.61 13.19 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 107.709 -1.219 . . . . 71.51 107.709 164.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 145' ' ' VAL . . . . . . . . . . . . . 7.3 p -125.18 130.41 73.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.162 0.585 . . . . 75.03 111.733 -174.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 46.2 m -74.5 95.94 2.84 Favored 'General case' 0 C--N 1.353 0.736 0 C-N-CA 123.602 0.761 . . . . 54.21 110.369 176.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 35.1 m -123.42 152.29 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.538 0.735 . . . . 72.53 109.564 177.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 45.5 ttp180 -107.1 105.7 15.84 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 107.594 -1.262 . . . . 74.22 107.594 170.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 149' ' ' ILE . . . . . . . . . . . . . 31.6 pt -69.52 147.43 96.76 Favored Pre-proline 0 CA--C 1.55 0.946 0 CA-C-O 118.235 -0.888 . . . . 71.41 108.647 170.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -35.9 115.75 0.12 Allowed 'Trans proline' 0 C--N 1.394 2.925 0 C-N-CA 124.185 3.256 . . . . 61.44 113.578 -178.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -57.21 95.58 0.06 OUTLIER 'Trans proline' 0 C--N 1.39 2.715 0 C-N-CA 123.052 2.501 . . . . 73.2 111.886 -176.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 152' ' ' GLY . . . . . . . . . . . . . . . 109.64 136.11 7.4 Favored Glycine 0 C--N 1.345 1.08 0 CA-C-N 114.785 -1.098 . . . . 54.32 114.873 -174.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 153' ' ' VAL . . . . . 0.442 HG11 HD11 ' C' ' 159' ' ' ILE . 7.0 m -146.61 174.47 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 124.613 1.165 . . . . 71.13 111.077 172.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 154' ' ' ARG . . . . . 0.543 ' HB3' ' H ' ' C' ' 188' ' ' LEU . 11.7 ptt180 -124.72 168.74 12.77 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.495 1.118 . . . . 75.32 109.11 174.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 155' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -60.03 119.88 8.62 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.319 0.648 . . . . 74.51 111.104 176.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 82.27 15.05 75.26 Favored Glycine 0 C--N 1.351 1.368 0 CA-C-N 115.649 -0.705 . . . . 64.51 113.476 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 157' ' ' SER . . . . . . . . . . . . . 34.1 t -75.63 125.59 29.34 Favored 'General case' 0 C--N 1.353 0.736 0 N-CA-C 109.162 -0.681 . . . . 75.43 109.162 176.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 6.0 p -98.5 97.06 5.62 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 CA-C-O 121.844 0.83 . . . . 64.44 109.714 -177.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 159' ' ' ILE . . . . . 0.666 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 58.0 mt -70.71 113.17 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-N 115.179 -0.919 . . . . 52.25 109.678 175.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 160' ' ' ARG . . . . . 0.417 ' HA ' ' O ' ' C' ' 174' ' ' LEU . 61.8 ttt180 -99.22 101.25 12.51 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 109.696 -0.483 . . . . 72.21 109.696 179.006 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 161' ' ' VAL . . . . . 0.682 ' HB ' ' HB3' ' C' ' 174' ' ' LEU . 97.7 t -82.95 119.7 74.79 Favored Pre-proline 0 C--O 1.25 1.116 0 N-CA-C 108.455 -0.943 . . . . 75.24 108.455 174.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -60.64 106.04 0.34 Allowed 'Trans proline' 0 C--N 1.384 2.42 0 C-N-CA 123.335 2.69 . . . . 63.42 113.163 -173.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 163' ' ' GLY . . . . . 0.488 ' O ' ' HB3' ' C' ' 86' ' ' SER . . . 91.06 -25.34 14.5 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 118.581 -1.122 . . . . 53.31 114.927 169.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 164' ' ' MET . . . . . 0.433 ' O ' ' HB2' ' C' ' 174' ' ' LEU . 39.6 ttp -87.39 50.66 2.05 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 118.536 1.168 . . . . 73.35 112.783 -165.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . -125.69 -96.11 1.03 Allowed Glycine 0 N--CA 1.472 1.041 0 N-CA-C 110.665 -0.974 . . . . 64.24 110.665 171.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . 61.98 40.29 98.69 Favored Glycine 0 C--N 1.353 1.475 0 N-CA-C 115.61 1.004 . . . . 75.44 115.61 162.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 167' ' ' GLN . . . . . 0.675 HE21 ' HA ' ' C' ' 167' ' ' GLN . 0.0 OUTLIER -64.96 105.26 0.99 Allowed 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 117.155 0.477 . . . . 64.31 110.126 177.689 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . 159.0 -67.91 0.27 Allowed Glycine 0 C--O 1.219 -0.827 0 N-CA-C 110.867 -0.893 . . . . 13.44 110.867 -178.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 169' ' ' ASN . . . . . 0.604 ' HB3' ' HD3' ' C' ' 170' ' ' PRO . 26.6 t-20 -173.7 -62.21 0.0 OUTLIER Pre-proline 0 CA--C 1.575 1.916 0 C-N-CA 124.172 0.989 . . . . 62.44 111.569 172.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 170' ' ' PRO . . . . . 0.604 ' HD3' ' HB3' ' C' ' 169' ' ' ASN . 13.4 Cg_exo -72.63 160.34 46.7 Favored 'Trans proline' 0 C--N 1.4 3.259 0 C-N-CA 121.802 1.668 . . . . 51.41 111.618 172.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 171' ' ' PRO . . . . . 0.403 ' HB3' ' HA ' ' C' ' 86' ' ' SER . 30.7 Cg_endo -62.79 152.47 78.4 Favored 'Trans proline' 0 C--N 1.374 1.875 0 C-N-CA 122.163 1.909 . . . . 74.02 113.073 177.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -130.96 -103.48 0.97 Allowed Glycine 0 C--N 1.341 0.855 0 N-CA-C 109.29 -1.524 . . . . 74.42 109.29 174.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 173' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -170.68 162.91 7.98 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 124.72 1.208 . . . . 74.51 109.474 165.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 174' ' ' LEU . . . . . 0.682 ' HB3' ' HB ' ' C' ' 161' ' ' VAL . 28.3 tp -104.86 137.47 42.58 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.425 0.69 . . . . 75.22 110.523 -175.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 96.8 mt -124.08 92.02 3.58 Favored 'General case' 0 C--O 1.246 0.88 0 C-N-CA 124.62 1.168 . . . . 71.32 109.538 177.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 176' ' ' LEU . . . . . 0.666 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 74.3 mt -83.21 92.38 7.45 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 108.817 -0.808 . . . . 43.02 108.817 173.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 177' ' ' VAL . . . . . . . . . . . . . 96.0 t -83.45 102.24 9.16 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 N-CA-C 107.642 -1.244 . . . . 74.43 107.642 174.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 178' ' ' VAL . . . . . . . . . . . . . 5.9 p -74.83 132.14 33.84 Favored 'Isoleucine or valine' 0 C--O 1.249 1.039 0 CA-C-N 114.433 -1.258 . . . . 74.01 111.693 -173.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 179' ' ' ARG . . . . . 0.527 ' O ' ' HA ' ' C' ' 124' ' ' PRO . 23.0 mmt180 -110.74 103.27 11.79 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 106.844 -1.539 . . . . 72.33 106.844 170.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 180' ' ' LEU . . . . . 0.609 HD13 HD21 ' C' ' 127' ' ' LEU . 83.9 mt -69.92 148.33 49.11 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 116.006 -0.543 . . . . 70.51 111.059 -179.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 181' ' ' LEU . . . . . . . . . . . . . 63.5 mt -66.83 166.91 15.77 Favored Pre-proline 0 CA--C 1.552 1.045 0 CA-C-N 115.083 -0.962 . . . . 74.2 111.299 -175.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 182' ' ' PRO . . . . . 0.623 ' HG3' ' HB2' ' B' ' 207' ' ' LYS . 18.1 Cg_endo -57.33 78.1 0.04 OUTLIER 'Trans proline' 0 C--N 1.394 2.936 0 C-N-CA 122.99 2.46 . . . . 64.12 111.815 170.186 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 183' ' ' HIS . . . . . 0.413 ' N ' ' HD3' ' C' ' 184' ' ' PRO . 62.6 t60 176.68 51.65 0.03 OUTLIER Pre-proline 0 CA--C 1.556 1.202 0 C-N-CA 127.772 2.429 . . . . 62.13 105.591 -173.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 184' ' ' PRO . . . . . 0.413 ' HD3' ' N ' ' C' ' 183' ' ' HIS . 79.8 Cg_endo -94.47 65.12 0.31 Allowed 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 122.919 2.413 . . . . 71.54 110.903 -169.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 185' ' ' VAL . . . . . 0.605 HG12 ' HB1' ' C' ' 195' ' ' ALA . 6.7 t -94.09 -52.64 9.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 108.951 -0.759 . . . . 72.23 108.951 -167.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 186' ' ' PHE . . . . . 0.67 ' HD2' HD13 ' C' ' 127' ' ' LEU . 67.1 m-85 -99.79 121.35 41.15 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.437 0.695 . . . . 61.44 110.288 -169.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 187' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -114.99 107.59 15.58 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.066 0.946 . . . . 75.14 108.699 179.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 188' ' ' LEU . . . . . 0.543 ' H ' ' HB3' ' C' ' 154' ' ' ARG . 58.8 tp -77.12 140.69 40.31 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.479 1.112 . . . . 74.14 112.964 -171.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -142.0 123.58 15.02 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 106.925 -1.509 . . . . 71.33 106.925 163.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 68.02 -111.54 4.1 Favored Glycine 0 CA--C 1.536 1.377 0 N-CA-C 111.526 -0.629 . . . . 74.2 111.526 -172.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 191' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -113.89 -10.95 12.89 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 124.086 0.954 . . . . 60.21 110.057 172.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -95.96 147.45 23.68 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.029 0.932 . . . . 65.13 109.98 -168.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 193' ' ' LEU . . . . . 0.504 HD21 ' CD2' ' C' ' 240' ' ' PHE . 84.6 mt -104.21 158.25 16.57 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.018 0.527 . . . . 52.2 111.115 -176.15 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 194' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -131.46 106.67 8.38 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 108.119 -1.067 . . . . 75.43 108.119 165.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 195' ' ' ALA . . . . . 0.605 ' HB1' HG12 ' C' ' 185' ' ' VAL . . . -116.15 -177.75 3.24 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.159 0.984 . . . . 65.11 109.549 176.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 25.2 m -128.73 111.42 13.13 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 109.32 -0.622 . . . . 51.32 109.32 178.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 197' ' ' LEU . . . . . 0.504 HD13 ' HB2' ' C' ' 212' ' ' ALA . 55.2 tp -85.18 130.88 34.52 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.289 1.036 . . . . 73.5 110.497 -179.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -89.8 112.14 23.37 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.359 0.663 . . . . 44.52 109.386 174.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 199' ' ' VAL . . . . . 0.55 ' HA ' HG11 ' C' ' 210' ' ' VAL . 59.3 t -117.77 113.55 38.04 Favored Pre-proline 0 N--CA 1.471 0.612 0 C-N-CA 124.347 1.059 . . . . 61.21 108.621 177.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 200' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' C' ' 256' ' ' THR . 39.7 Cg_endo -68.3 146.25 68.57 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 121.788 1.659 . . . . 71.34 110.907 176.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 201' ' ' ALA . . . . . . . . . . . . . . . -53.23 -46.18 97.98 Favored Pre-proline 0 CA--C 1.56 1.357 0 C-N-CA 124.917 1.287 . . . . 74.35 114.271 -172.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 202' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -59.3 -45.51 26.63 Favored 'Trans proline' 0 C--N 1.397 3.09 0 CA-C-N 121.212 1.469 . . . . 63.15 111.977 178.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 203' ' ' ILE . . . . . . . . . . . . . 42.4 mt -66.1 -30.54 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 123.84 0.856 . . . . 63.4 110.675 178.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.32 -42.69 79.01 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.332 0.653 . . . . 75.02 111.799 178.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 205' ' ' VAL . . . . . 0.515 HG11 HD11 ' A' ' 261' ' ' LEU . 57.5 t -75.71 -46.84 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 116.016 -0.538 . . . . 63.41 111.942 -176.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 206' ' ' VAL . . . . . . . . . . . . . 14.1 p -81.14 -28.9 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 CA-C-O 120.743 0.306 . . . . 52.12 111.118 -179.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 80.12 83.13 0.71 Allowed Glycine 0 C--N 1.337 0.624 0 N-CA-C 111.431 -0.668 . . . . 63.21 111.431 -174.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -105.92 -127.83 5.98 Favored Glycine 0 C--N 1.34 0.78 0 N-CA-C 110.365 -1.094 . . . . 51.32 110.365 176.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 209' ' ' LYS . . . . . 0.493 ' HG2' ' HA ' ' C' ' 222' ' ' ALA . 8.2 mtmp? -139.19 145.32 39.17 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.494 0.664 . . . . 72.12 110.545 172.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 210' ' ' VAL . . . . . 0.55 HG11 ' HA ' ' C' ' 199' ' ' VAL . 34.1 m -126.87 178.6 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.299 1.44 . . . . 62.05 107.671 173.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 211' ' ' ARG . . . . . 0.497 ' HD3' ' HB2' ' C' ' 218' ' ' PRO . 33.6 ttm-85 -128.65 124.01 34.65 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 118.522 0.601 . . . . 72.44 112.167 -178.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 212' ' ' ALA . . . . . 0.504 ' HB2' HD13 ' C' ' 197' ' ' LEU . . . -97.81 114.24 26.23 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 107.756 -1.202 . . . . 74.43 107.756 166.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 213' ' ' MET . . . . . . . . . . . . . 2.3 tmm? -77.06 98.53 5.03 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 107.112 -1.44 . . . . 63.12 107.112 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 214' ' ' THR . . . . . 0.485 ' OG1' HG12 ' C' ' 219' ' ' VAL . 1.0 OUTLIER -100.98 170.67 8.13 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.359 0.599 . . . . 54.24 109.746 -172.991 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 215' ' ' LEU . . . . . 0.442 HD13 ' HB2' ' C' ' 131' ' ' PHE . 8.4 mt -61.94 -43.55 98.61 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.24 1.416 . . . . 44.41 110.956 -173.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -93.35 17.83 10.65 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 113.824 -1.535 . . . . 71.0 111.627 -177.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 125.44 152.86 8.32 Favored Glycine 0 C--N 1.344 0.982 0 CA-C-N 116.006 -0.543 . . . . 64.11 111.744 178.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 218' ' ' PRO . . . . . 0.497 ' HB2' ' HD3' ' C' ' 211' ' ' ARG . 68.8 Cg_endo -74.98 103.29 1.7 Allowed 'Trans proline' 0 CA--C 1.554 1.507 0 C-N-CA 122.377 2.051 . . . . 52.13 112.517 175.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 219' ' ' VAL . . . . . 0.571 HG23 HG22 ' B' ' 238' ' ' THR . 1.5 p -75.43 127.4 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 122.938 0.495 . . . . 52.53 109.667 178.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 220' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -87.0 104.62 16.48 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 107.383 -1.339 . . . . 72.32 107.383 171.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 221' ' ' VAL . . . . . . . . . . . . . 47.6 t -71.22 125.96 30.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 125.733 1.613 . . . . 74.03 111.631 -177.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 222' ' ' ALA . . . . . 0.493 ' HA ' ' HG2' ' C' ' 209' ' ' LYS . . . -78.55 106.94 10.85 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.174 0.59 . . . . 73.3 109.821 171.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . 0.407 ' HA ' ' HD3' ' C' ' 224' ' ' PRO . 60.4 t -83.05 132.69 49.95 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 123.906 0.882 . . . . 73.11 109.179 178.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 224' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' C' ' 223' ' ' VAL . 2.2 Cg_endo -83.13 156.76 15.0 Favored 'Trans proline' 0 C--N 1.379 2.179 0 C-N-CA 123.271 2.647 . . . . 54.33 110.979 172.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -57.64 134.52 63.63 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 122.309 2.006 . . . . 74.0 112.012 174.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 226' ' ' ARG . . . . . 0.49 ' HG2' ' HG3' ' B' ' 248' ' ' ARG . 9.8 mpt_? 70.97 82.16 0.15 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.617 1.167 . . . . 70.15 110.374 177.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 227' ' ' THR . . . . . . . . . . . . . 53.2 m -115.91 123.23 47.58 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.775 0.83 . . . . 70.3 110.612 179.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 228' ' ' GLN . . . . . 0.579 ' NE2' ' HG2' ' A' ' 259' ' ' GLU . 24.7 mp0 -102.33 150.8 22.96 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.307 1.043 . . . . 74.32 111.197 -179.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -72.47 134.11 45.16 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 114.559 -1.2 . . . . 62.12 109.563 176.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 102.88 -6.45 51.75 Favored Glycine 0 C--N 1.339 0.712 0 O-C-N 123.681 0.613 . . . . 62.04 112.375 -173.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 231' ' ' ARG . . . . . 0.411 ' HD2' ' H ' ' C' ' 228' ' ' GLN . 59.6 mtt180 -65.38 171.97 3.54 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 117.266 0.533 . . . . 74.12 110.85 167.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 232' ' ' LYS . . . . . 0.45 ' HA ' ' O ' ' C' ' 251' ' ' LEU . 37.1 ttmt -148.51 124.74 10.83 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.2 -0.455 . . . . 71.45 110.849 -177.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 233' ' ' LEU . . . . . 0.582 ' O ' ' HA ' ' C' ' 250' ' ' TYR . 6.3 mp -84.66 156.9 21.3 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.444 1.098 . . . . 74.21 110.254 174.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 234' ' ' ARG . . . . . 0.413 ' HG3' ' HG3' ' B' ' 241' ' ' GLU . 18.2 ptt-85 -128.0 85.2 2.32 Favored 'General case' 0 CA--C 1.553 1.08 0 O-C-N 124.966 1.416 . . . . 72.34 108.527 166.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 235' ' ' LEU . . . . . 0.515 HD22 ' H ' ' B' ' 240' ' ' GLY . 49.8 mt -79.0 116.02 19.04 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.434 -0.803 . . . . 73.43 108.849 176.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -77.28 129.62 36.12 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 123.219 0.607 . . . . 71.55 111.835 -169.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 76.18 14.74 82.0 Favored Glycine 0 C--N 1.346 1.088 0 O-C-N 124.451 1.095 . . . . 71.42 114.731 177.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 14.2 mmtm -98.87 9.65 43.0 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.386 0.674 . . . . 72.03 111.493 -179.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 239' ' ' GLY . . . . . 0.417 ' HA2' ' HG ' ' C' ' 193' ' ' LEU . . . -86.88 -169.55 46.0 Favored Glycine 0 C--N 1.346 1.113 0 O-C-N 123.447 0.467 . . . . 31.21 112.763 177.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 240' ' ' PHE . . . . . 0.504 ' CD2' HD21 ' C' ' 193' ' ' LEU . 12.8 m-85 -81.35 150.7 67.99 Favored Pre-proline 0 C--O 1.247 0.968 0 CA-C-O 119.167 -0.444 . . . . 75.14 110.005 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 241' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_exo -71.44 96.14 0.72 Allowed 'Trans proline' 0 C--N 1.388 2.647 0 C-N-CA 123.418 2.745 . . . . 70.21 112.341 -175.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -83.03 177.52 53.2 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 115.255 -0.884 . . . . 70.14 113.278 178.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -69.82 -18.93 36.46 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 123.134 2.556 . . . . 71.42 112.602 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -111.21 15.51 21.46 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.052 0.941 . . . . 71.42 110.563 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 109.42 177.26 21.33 Favored Glycine 0 C--N 1.354 1.534 0 N-CA-C 111.712 -0.555 . . . . 51.32 111.712 -175.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 246' ' ' ARG . . . . . 0.579 ' HB2' ' HA3' ' B' ' 42' ' ' GLY . 34.2 mtm180 -71.72 147.81 47.02 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.124 0.569 . . . . 61.31 111.393 -179.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -78.64 -159.0 12.97 Favored Glycine 0 N--CA 1.48 1.59 0 O-C-N 123.43 0.456 . . . . 63.23 113.329 176.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -124.47 135.96 53.64 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 108.944 -0.761 . . . . 73.54 108.944 -175.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 249' ' ' LEU . . . . . 0.5 HD23 HD12 ' C' ' 235' ' ' LEU . 18.7 tp -83.89 121.9 27.98 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.0 0.92 . . . . 74.23 110.397 -179.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 250' ' ' TYR . . . . . 0.582 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 23.1 m-85 -101.64 109.94 21.83 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.221 -0.659 . . . . 71.43 109.221 175.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 251' ' ' LEU . . . . . 0.558 HD23 ' HB3' ' C' ' 195' ' ' ALA . 68.5 mt -102.64 112.85 25.8 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 116.402 -0.363 . . . . 64.53 110.917 -175.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -70.4 128.46 36.27 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 108.537 -0.912 . . . . 73.41 108.537 168.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 253' ' ' VAL . . . . . . . . . . . . . 84.6 t -82.01 122.53 36.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.014 -0.539 . . . . 73.5 110.944 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 254' ' ' ARG . . . . . . . . . . . . . 13.8 mmt180 -102.1 114.42 28.54 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 107.853 -1.166 . . . . 74.13 107.853 164.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 255' ' ' ILE . . . . . 0.513 ' O ' ' HB ' ' A' ' 255' ' ' ILE . 34.2 mm -76.7 119.16 24.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 106.455 -1.683 . . . . 75.24 106.455 164.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 256' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' C' ' 200' ' ' PRO . 2.3 t -134.4 172.32 13.06 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.594 1.158 . . . . 53.32 109.416 -171.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 257' ' ' ILE . . . . . 0.434 HD12 ' H ' ' C' ' 259' ' ' GLU . 2.9 pp -135.2 156.11 78.38 Favored Pre-proline 0 N--CA 1.482 1.137 0 C-N-CA 123.273 0.629 . . . . 64.54 109.793 -176.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -77.43 22.31 0.59 Allowed 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 122.835 2.357 . . . . 73.21 114.952 -170.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 259' ' ' GLU . . . . . 0.434 ' H ' HD12 ' C' ' 257' ' ' ILE . 43.5 mt-10 61.55 -78.49 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.98 1.312 . . . . 72.3 111.098 -174.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.11 178.23 8.2 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.389 0.675 . . . . 73.41 110.026 179.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 261' ' ' LEU . . . . . 0.552 HD22 ' HB3' ' C' ' 265' ' ' GLU . 85.6 mt -142.57 151.36 41.48 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.888 0.875 . . . . 71.21 109.504 169.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 66.2 p -82.76 155.36 68.21 Favored Pre-proline 0 N--CA 1.479 0.981 0 N-CA-C 107.689 -1.226 . . . . 61.23 107.689 166.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -39.21 -44.27 2.71 Favored 'Trans proline' 0 C--N 1.381 2.285 0 C-N-CA 123.814 3.009 . . . . 74.2 115.592 178.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -67.43 -50.4 59.55 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.298 0.639 . . . . 71.04 110.826 -178.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 265' ' ' GLU . . . . . 0.552 ' HB3' HD22 ' C' ' 261' ' ' LEU . 47.8 mt-10 -55.31 -52.08 64.64 Favored 'General case' 0 C--N 1.358 0.968 0 O-C-N 123.927 0.767 . . . . 65.11 109.943 176.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 266' ' ' GLU . . . . . 0.444 ' O ' ' HG2' ' C' ' 270' ' ' LYS . 3.7 tp10 -43.98 -56.08 4.2 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.596 1.558 . . . . 64.21 111.209 176.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -59.97 -48.85 80.01 Favored 'General case' 0 CA--C 1.549 0.93 0 O-C-N 124.217 0.948 . . . . 70.32 112.503 -176.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 268' ' ' LEU . . . . . . . . . . . . . 11.1 mp -65.37 -44.19 88.41 Favored 'General case' 0 N--CA 1.481 1.12 0 O-C-N 123.392 0.433 . . . . 52.44 111.319 -178.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 78.3 m95 -61.26 -37.68 83.99 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.558 0.743 . . . . 61.11 111.221 177.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 270' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' C' ' 266' ' ' GLU . 31.1 mmtp -64.73 -47.23 79.03 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.142 0.577 . . . . 75.43 110.695 178.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -64.15 -41.46 97.16 Favored 'General case' 0 N--CA 1.484 1.234 0 O-C-N 123.534 0.521 . . . . 75.33 111.486 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 272' ' ' LEU . . . . . 0.478 HD21 ' HB2' ' A' ' 268' ' ' LEU . 69.2 mt -57.92 -45.85 85.88 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 123.92 0.763 . . . . 74.33 110.146 174.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -60.67 -44.2 96.74 Favored 'General case' 0 C--O 1.209 -1.063 0 O-C-N 124.4 1.062 . . . . 34.13 111.718 -176.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -63.13 -49.92 72.48 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-O 121.437 0.637 . . . . 63.21 110.428 178.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -61.17 -23.25 65.43 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 114.493 -1.231 . . . . 70.04 111.342 176.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 276' ' ' TYR . . . . . 0.457 ' HB2' ' O ' ' C' ' 272' ' ' LEU . 6.7 t80 -89.46 -31.69 17.57 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.416 1.086 . . . . 75.52 110.665 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 277' ' ' TYR . . . . . 0.438 ' HE1' HG12 ' A' ' 203' ' ' ILE . 22.7 m-85 -68.24 -25.61 65.27 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 109.176 -0.676 . . . . 44.24 109.176 176.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -53.48 -26.61 21.25 Favored 'General case' 0 CA--C 1.554 1.13 0 O-C-N 124.331 1.019 . . . . 55.2 112.954 171.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 279' ' ' ARG . . . . . . . . . . . . . 26.4 mtm180 -73.5 -16.45 61.28 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 117.898 0.317 . . . . 71.52 111.726 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.087 0 C-N-CA 123.289 0.636 . . . . 75.14 109.764 -177.231 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.6 mtm . . . . . 0 N--CA 1.474 0.742 0 N-CA-C 109.59 -0.522 . . . . 64.12 109.59 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.511 ' HA ' ' HD1' ' A' ' 96' ' ' PHE . . . 63.11 34.37 13.74 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.692 1.197 . . . . 51.4 113.68 173.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -86.78 49.68 1.86 Allowed 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.109 0.564 . . . . 74.04 111.079 -179.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -37.0 113.27 0.24 Allowed 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 125.398 1.479 . . . . 62.43 114.869 -174.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.54 ' HB3' HD11 ' A' ' 10' ' ' ILE . 99.5 mttt -81.21 123.23 28.29 Favored 'General case' 0 C--O 1.245 0.85 0 N-CA-C 108.924 -0.769 . . . . 74.32 108.924 167.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.459 ' HA ' ' OH ' ' A' ' 66' ' ' TYR . 37.2 t70 -75.53 103.97 5.89 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 107.58 -1.267 . . . . 61.41 107.58 167.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.404 ' HB2' HD11 ' A' ' 57' ' ' LEU . 38.4 m-85 -61.83 -27.57 68.86 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 114.876 -1.056 . . . . 73.34 111.873 -173.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.548 ' HE1' HD11 ' A' ' 22' ' ' ILE . 30.7 m-85 -68.12 -42.26 80.5 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 116.355 -0.384 . . . . 73.33 110.038 175.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.21 -45.58 92.69 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.13 0.572 . . . . 60.32 110.403 177.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.54 HD11 ' HB3' ' A' ' 5' ' ' LYS . 64.0 mt -52.91 -47.78 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 123.236 0.614 . . . . 74.23 110.41 175.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.465 ' HB3' ' HB1' ' A' ' 25' ' ' ALA . 88.6 mt -81.16 -9.47 59.79 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 115.159 -0.928 . . . . 51.33 113.16 -178.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.71 27.7 68.66 Favored Glycine 0 CA--C 1.543 1.824 0 N-CA-C 114.412 0.525 . . . . 53.33 114.412 179.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.407 HG13 ' HB2' ' A' ' 25' ' ' ALA . 5.9 m -114.49 162.08 25.28 Favored Pre-proline 0 N--CA 1.486 1.345 0 C-N-CA 124.507 1.123 . . . . 71.43 110.087 176.359 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -64.3 163.72 25.43 Favored 'Trans proline' 0 C--N 1.389 2.688 0 C-N-CA 122.38 2.053 . . . . 50.12 112.769 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 41.1 mtp180 -83.23 41.43 0.76 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.065 0.946 . . . . 75.43 112.135 -170.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.44 ' H ' ' H ' ' A' ' 17' ' ' ALA . 24.7 t-20 -172.86 -5.24 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.053 1.341 . . . . 64.11 109.355 -171.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.44 ' H ' ' H ' ' A' ' 16' ' ' ASN . . . -40.8 131.43 2.42 Favored 'General case' 0 C--N 1.364 1.229 0 C-N-CA 125.879 1.672 . . . . 64.31 112.674 178.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 63.2 p -78.29 -178.94 5.96 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.2 0.6 . . . . 71.11 112.249 -174.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -46.44 -58.72 3.49 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 124.915 1.286 . . . . 64.21 112.778 -177.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -71.1 -33.36 70.1 Favored 'General case' 0 C--O 1.211 -0.966 0 CA-C-O 119.111 -0.471 . . . . 72.43 111.114 -174.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -62.12 -49.29 76.48 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.137 0.494 . . . . 64.03 110.959 179.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.548 HD11 ' HE1' ' A' ' 8' ' ' TYR . 71.9 mt -61.76 -42.41 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.123 0.969 . . . . 73.31 110.518 177.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -70.85 -28.17 64.38 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.121 -0.945 . . . . 71.24 111.624 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -73.06 -36.94 66.97 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.331 0.653 . . . . 54.12 110.12 175.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.465 ' HB1' ' HB3' ' A' ' 11' ' ' LEU . . . -66.95 -39.95 87.42 Favored 'General case' 0 C--O 1.246 0.909 0 O-C-N 124.028 0.83 . . . . 64.0 110.874 175.006 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.472 ' HD1' HG22 ' A' ' 50' ' ' ILE . 48.8 t80 -57.03 -66.87 0.38 Allowed 'General case' 0 C--O 1.203 -1.391 0 CA-C-N 114.398 -1.273 . . . . 73.1 109.08 172.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -50.74 -40.93 55.88 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.567 1.147 . . . . 74.22 111.888 -178.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.8 ttt180 -57.5 -67.54 0.32 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.247 0.619 . . . . 71.15 110.59 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 83.9 mt -71.72 -22.79 61.58 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.499 -0.773 . . . . 74.11 111.577 -173.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.9 -26.14 29.62 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.466 0.707 . . . . 63.3 110.782 -178.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 85.0 mtt180 -83.82 -26.48 29.5 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 122.951 0.501 . . . . 72.33 110.551 172.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -70.58 -52.18 23.32 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 121.004 0.431 . . . . 63.33 110.393 173.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.465 ' HD2' HD11 ' A' ' 50' ' ' ILE . 14.4 m-85 -97.97 35.51 1.71 Allowed 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.988 0.915 . . . . 63.25 109.843 -177.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.488 ' CD2' ' HB3' ' A' ' 36' ' ' ASP . 18.3 t60 -76.63 109.91 10.07 Favored Pre-proline 0 N--CA 1.473 0.695 0 C-N-CA 124.763 1.225 . . . . 63.41 110.156 -172.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -52.21 -37.22 69.73 Favored 'Trans proline' 0 C--N 1.379 2.148 0 C-N-CA 123.584 2.856 . . . . 74.13 113.274 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.488 ' HB3' ' CD2' ' A' ' 34' ' ' HIS . 15.9 t70 -64.28 -31.49 72.71 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.93 0.892 . . . . 72.45 111.778 178.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 85.3 t -84.79 -54.25 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 122.868 0.467 . . . . 65.53 109.876 176.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -133.9 110.05 9.46 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.319 1.048 . . . . 61.35 109.762 -174.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -85.97 63.7 8.18 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.376 0.671 . . . . 73.11 109.983 -178.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 66.9 m -99.8 112.56 64.0 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-O 117.654 -1.165 . . . . 54.41 108.459 174.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -38.61 -53.54 1.79 Allowed 'Trans proline' 0 C--N 1.39 2.732 0 C-N-CA 124.411 3.408 . . . . 72.23 114.044 -177.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -63.12 -35.04 78.96 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.671 0.788 . . . . 64.43 111.816 -178.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.451 ' O ' ' HB3' ' A' ' 33' ' ' TYR . . . -71.2 -29.78 65.58 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 122.829 0.452 . . . . 72.14 110.157 176.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -82.54 -26.74 32.16 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 109.422 -0.585 . . . . 62.01 109.422 -178.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -69.01 -41.83 77.25 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.913 0.885 . . . . 62.44 109.653 172.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 9.7 mptt -64.66 -41.02 96.39 Favored 'General case' 0 C--O 1.212 -0.903 0 CA-C-N 115.315 -0.857 . . . . 74.03 110.271 174.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.491 ' HA ' HD12 ' A' ' 50' ' ' ILE . 90.7 t80 -55.78 -45.42 78.18 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.794 0.838 . . . . 73.24 109.684 174.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.466 ' HB3' ' HE1' ' A' ' 93' ' ' PHE . 52.4 mtpt -60.25 -41.26 92.84 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.866 0.866 . . . . 75.14 111.435 176.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -67.61 -34.47 77.07 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.479 0.712 . . . . 71.44 111.717 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.491 HD12 ' HA ' ' A' ' 47' ' ' PHE . 53.8 mt -69.33 -35.93 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.496 1.118 . . . . 70.53 109.499 174.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -83.43 -13.55 54.54 Favored 'General case' 0 C--O 1.206 -1.222 0 C-N-CA 124.224 1.01 . . . . 73.43 111.401 178.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -74.27 -56.8 4.47 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 107.646 -1.242 . . . . 63.42 107.646 169.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -52.94 -50.64 63.6 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-N 113.152 -1.84 . . . . 65.45 110.515 177.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -66.35 -41.91 88.86 Favored 'General case' 0 C--O 1.205 -1.247 0 CA-C-N 115.296 -0.865 . . . . 72.32 110.857 178.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.62 -39.65 65.11 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 118.76 0.709 . . . . 53.01 111.986 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 61.1 t -70.8 -51.06 39.31 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 CA-C-N 115.794 -0.639 . . . . 74.52 110.748 174.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.454 HD13 HD13 ' A' ' 22' ' ' ILE . 48.6 mt -89.81 -0.1 57.34 Favored 'General case' 0 CA--C 1.568 1.657 0 N-CA-C 113.806 1.039 . . . . 62.04 113.806 -167.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 48.0 t -71.07 -51.15 26.89 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 124.091 0.956 . . . . 74.34 111.411 -173.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -86.59 125.19 68.07 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 114.613 -1.176 . . . . 74.34 107.87 177.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -53.21 -26.01 32.21 Favored 'Trans proline' 0 C--N 1.374 1.921 0 C-N-CA 123.322 2.681 . . . . 72.41 113.335 178.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -70.93 -56.26 6.61 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.957 0.903 . . . . 72.3 110.911 177.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.496 ' HA ' HD12 ' A' ' 65' ' ' ILE . 46.4 mtpt -66.96 -27.7 67.67 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 123.829 0.852 . . . . 74.54 111.477 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -60.92 -55.5 32.17 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 114.48 -1.236 . . . . 74.11 109.713 171.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -54.21 -40.61 67.78 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 124.165 0.916 . . . . 74.25 111.159 177.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.665 HD13 ' HE1' ' A' ' 83' ' ' TYR . 77.3 mt -51.92 -63.78 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.025 0 O-C-N 124.404 1.065 . . . . 64.42 109.265 174.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.459 ' OH ' ' HA ' ' A' ' 6' ' ' ASP . 32.6 t80 -50.19 -54.66 19.41 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 119.024 -0.512 . . . . 75.4 112.071 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -43.27 -55.22 4.13 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 124.433 1.083 . . . . 64.04 110.585 -178.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.425 ' HB ' ' HB3' ' A' ' 74' ' ' ALA . 69.1 p -98.47 -2.53 38.73 Favored 'General case' 0 CA--C 1.551 1.019 0 CA-C-N 115.071 -0.968 . . . . 75.13 113.258 -171.271 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -117.78 118.72 32.82 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 118.754 0.706 . . . . 63.45 109.428 -178.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.08 21.81 72.81 Favored Glycine 0 C--N 1.344 0.991 0 CA-C-O 121.6 0.556 . . . . 52.54 112.781 177.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 90.6 m -146.67 -51.81 0.22 Allowed 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 103.969 -2.604 . . . . 71.23 103.969 178.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 60.6 m -102.2 161.43 13.7 Favored 'General case' 0 C--O 1.258 1.533 0 CA-C-N 112.198 -2.273 . . . . 74.23 105.165 158.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.89 12.3 17.77 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.409 0.683 . . . . 74.04 112.203 179.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.425 ' HB3' ' HB ' ' A' ' 68' ' ' THR . . . -70.3 -152.05 0.0 OUTLIER Pre-proline 0 CA--C 1.589 2.456 0 CA-C-O 116.775 -1.583 . . . . 75.1 111.333 176.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.427 ' HA ' ' HD2' ' A' ' 76' ' ' PRO . 6.2 Cg_exo 7.76 107.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.412 3.909 0 C-N-CA 124.384 3.39 . . . . 75.41 117.835 -153.026 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 75' ' ' PRO . 28.9 Cg_endo -57.98 -177.44 0.09 OUTLIER 'Trans proline' 0 N--CA 1.518 2.961 0 C-N-CA 124.519 3.48 . . . . 74.25 113.217 174.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -39.11 131.49 1.36 Allowed 'Trans proline' 0 C--N 1.402 3.351 0 C-N-CA 123.111 2.54 . . . . 62.44 114.056 173.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.473 ' HG3' ' HE2' ' A' ' 83' ' ' TYR . 0.5 OUTLIER -29.03 123.31 0.05 OUTLIER 'Trans proline' 0 C--N 1.382 2.324 1 C-N-CA 126.105 4.537 . . . . 43.51 117.314 -172.433 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -78.39 156.45 28.96 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 123.137 2.558 . . . . 71.05 114.07 -176.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -56.35 80.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.393 2.915 0 C-N-CA 124.384 3.389 . . . . 51.35 113.191 175.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -178.15 -34.85 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 N-CA-C 109.903 -1.279 . . . . 62.41 109.903 -177.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 75.63 168.82 25.41 Favored Glycine 0 C--N 1.353 1.52 0 N-CA-C 115.194 0.838 . . . . 53.03 115.194 171.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.665 ' HE1' HD13 ' A' ' 65' ' ' ILE . 27.0 m-85 -111.06 102.25 10.72 Favored 'General case' 0 C--O 1.243 0.731 0 C-N-CA 124.789 1.236 . . . . 74.41 109.406 178.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -89.49 152.79 21.26 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.148 0.579 . . . . 71.31 110.819 175.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -127.65 77.89 1.78 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.386 1.074 . . . . 70.22 108.367 175.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 9.0 m -38.37 86.67 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 126.982 2.113 . . . . 74.44 115.505 -172.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 76.03 -7.27 29.8 Favored Glycine 0 C--N 1.35 1.32 0 CA-C-N 116.041 -0.527 . . . . 70.11 113.789 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -89.71 125.29 35.22 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.609 1.164 . . . . 72.34 108.208 -178.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -71.71 88.68 0.99 Allowed 'General case' 0 N--CA 1.482 1.139 0 CA-C-O 121.52 0.676 . . . . 71.44 110.082 -175.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -47.13 -43.05 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 126.112 1.765 . . . . 75.21 111.949 177.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -73.88 -6.5 47.55 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 115.214 -0.903 . . . . 75.33 111.889 -173.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -91.64 -27.93 17.81 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.976 0.911 . . . . 45.35 110.787 172.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.466 ' HE1' ' HB3' ' A' ' 48' ' ' LYS . 23.8 m-85 -76.78 -176.2 3.76 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 112.802 0.667 . . . . 71.01 112.802 -170.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 67.8 p -56.86 145.28 30.22 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.194 0.998 . . . . 74.5 112.944 -167.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.63 -41.26 85.55 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.0 -1.0 . . . . 74.31 111.428 177.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.511 ' HD1' ' HA ' ' A' ' 2' ' ' ALA . 74.2 t80 -58.91 -44.3 91.25 Favored 'General case' 0 C--N 1.355 0.812 0 C-N-CA 123.038 0.535 . . . . 75.03 110.145 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -58.08 -49.64 76.21 Favored 'General case' 0 CA--C 1.555 1.16 0 CA-C-N 116.077 -0.51 . . . . 63.23 109.963 174.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -73.98 -3.92 32.08 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 112.428 0.529 . . . . 73.05 112.428 -178.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -95.73 -60.15 1.71 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.427 0.691 . . . . 70.02 110.398 171.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.4 HD23 ' CE2' ' A' ' 101' ' ' PHE . 24.2 tp -58.5 -56.77 17.9 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.916 1.286 . . . . 55.03 110.785 -177.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.4 ' CE2' HD23 ' A' ' 100' ' ' LEU . 92.2 m-85 -84.25 -8.13 59.13 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 114.251 -1.341 . . . . 72.11 111.043 178.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -40.65 -66.28 0.88 Allowed Glycine 0 C--N 1.351 1.376 0 N-CA-C 116.114 1.206 . . . . 72.43 116.114 -174.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.452 ' HB2' ' HG2' ' A' ' 78' ' ' PRO . 23.7 Cg_exo -62.6 -14.86 42.43 Favored 'Trans proline' 0 C--N 1.373 1.864 0 C-N-CA 122.749 2.299 . . . . 23.1 114.06 -175.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -103.36 -2.23 47.58 Favored Glycine 0 C--N 1.358 1.773 0 CA-C-O 118.91 -0.939 . . . . 44.4 113.825 -177.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.43 ' HB3' ' OD1' ' A' ' 169' ' ' ASN . 86.6 mt -63.32 77.11 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 124.065 0.946 . . . . 74.25 113.007 -177.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 19.65 -105.14 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.256 0 C-N-CA 127.9 2.48 . . . . 72.25 116.36 174.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 71.85 2.88 53.59 Favored Glycine 0 C--N 1.35 1.353 0 CA-C-O 119.576 -0.569 . . . . 44.0 112.664 -164.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 53.9 -125.73 33.7 Favored Glycine 0 C--N 1.355 1.584 0 O-C-N 123.923 0.425 . . . . 71.34 112.763 -172.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -88.21 -6.96 57.53 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.125 0.97 . . . . 64.11 111.194 177.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -80.51 -38.85 16.08 Favored Glycine 0 C--N 1.345 1.058 0 CA-C-N 116.387 -0.37 . . . . 55.25 112.651 179.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? 65.68 -7.46 0.35 Allowed 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 114.572 1.323 . . . . 71.44 114.572 176.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.57 -20.24 66.13 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.321 1.049 . . . . 73.25 110.632 171.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 46.2 m 71.83 70.61 0.16 Allowed 'General case' 0 C--N 1.351 0.671 0 C-N-CA 124.529 1.132 . . . . 74.21 110.673 177.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.412 ' HG3' ' H ' ' A' ' 115' ' ' LYS . 2.2 tpm_? -135.28 172.75 12.56 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.515 0.726 . . . . 74.52 110.453 178.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.412 ' H ' ' HG3' ' A' ' 114' ' ' ARG . 51.7 tttm -60.87 142.87 55.87 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.396 1.078 . . . . 72.15 112.906 -177.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -85.99 -178.3 50.0 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 115.7 -0.682 . . . . 55.22 113.646 177.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.437 ' O ' ' HA3' ' A' ' 172' ' ' GLY . 13.4 ptt180 -96.05 173.43 7.43 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.796 0.838 . . . . 71.34 111.061 179.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -78.82 138.76 38.33 Favored 'General case' 0 CA--C 1.549 0.941 0 N-CA-C 109.267 -0.642 . . . . 74.23 109.267 166.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 9.3 tt -144.95 139.33 27.48 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 107.966 -1.124 . . . . 70.23 107.966 -173.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.543 ' HA ' ' HB2' ' A' ' 175' ' ' LEU . 2.8 tmm_? -100.26 119.04 37.78 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 108.891 -0.781 . . . . 74.51 108.891 175.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.488 ' HB2' HD11 ' A' ' 174' ' ' LEU . . . -111.73 169.87 8.53 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-O 121.7 0.762 . . . . 41.51 110.41 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.413 ' HB2' ' HB3' ' B' ' 9' ' ' ALA . 7.4 mm-40 -120.26 113.42 20.39 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 106.497 -1.668 . . . . 61.0 106.497 -176.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 51.1 tp -98.64 98.02 5.53 Favored Pre-proline 0 N--CA 1.473 0.682 0 N-CA-C 108.194 -1.039 . . . . 54.05 108.194 -178.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.647 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 73.4 Cg_endo -77.05 114.24 3.77 Favored 'Trans proline' 0 C--N 1.372 1.789 0 C-N-CA 121.32 1.347 . . . . 75.33 108.958 177.194 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.524 ' HA ' HG21 ' B' ' 6' ' ' ILE . 61.6 tp -123.06 139.56 53.95 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.075 0.55 . . . . 64.01 110.687 -169.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 27.2 m -68.56 128.86 38.14 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.861 0.864 . . . . 71.34 109.99 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.526 HD23 ' HB3' ' A' ' 180' ' ' LEU . 75.7 mt -50.93 -49.88 58.8 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 124.187 0.995 . . . . 70.54 111.21 -174.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -55.93 -49.4 73.59 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.239 -1.346 . . . . 75.32 109.911 -178.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -75.06 -19.84 59.82 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 114.631 -1.168 . . . . 64.33 111.677 -176.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -68.86 -43.69 74.88 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.334 0.653 . . . . 41.43 109.723 174.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -70.8 -35.51 72.57 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 115.126 -0.943 . . . . 74.51 111.364 176.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -73.65 -39.95 64.09 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 116.202 -0.453 . . . . 75.25 111.885 -178.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.581 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 77.29 -166.44 53.67 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-N 116.513 -0.312 . . . . 71.54 113.42 -176.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 100.08 179.04 30.32 Favored Glycine 0 C--N 1.35 1.311 0 C-N-CA 122.828 0.251 . . . . 70.42 113.161 176.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.432 ' HB3' ' OG ' ' A' ' 146' ' ' SER . 2.1 mp0 -74.75 100.63 4.07 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 122.96 0.504 . . . . 73.14 110.2 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -90.57 123.99 34.67 Favored 'General case' 0 C--O 1.244 0.8 0 N-CA-C 109.307 -0.627 . . . . 74.4 109.307 -177.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 98.3 t -72.39 108.41 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 N-CA-C 109.043 -0.725 . . . . 71.24 109.043 173.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.557 HG13 HG13 ' A' ' 145' ' ' VAL . 3.1 p -121.57 133.16 68.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 124.752 1.221 . . . . 73.14 108.312 175.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -122.42 146.59 47.22 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.037 0.535 . . . . 71.3 110.243 -170.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 10.7 p -163.89 135.03 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 123.26 0.624 . . . . 75.1 110.06 175.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 61.9 19.89 11.05 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.727 1.211 . . . . 74.24 112.871 176.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 96.87 -19.91 52.84 Favored Glycine 0 C--N 1.348 1.226 0 CA-C-N 116.386 -0.37 . . . . 31.1 112.844 -176.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -80.31 115.8 20.04 Favored 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 108.58 -0.896 . . . . 72.12 108.58 -179.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 42.2 ttt180 -98.38 99.53 10.73 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.187 0.995 . . . . 74.41 109.781 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.557 HG13 HG13 ' A' ' 138' ' ' VAL . 6.7 p -104.37 153.01 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 C-N-CA 123.231 0.612 . . . . 73.53 110.446 -177.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.432 ' OG ' ' HB3' ' A' ' 135' ' ' GLU . 32.0 t -124.61 103.99 8.44 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.599 0.759 . . . . 31.45 109.6 -179.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 4.8 p -101.38 121.99 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 123.169 0.588 . . . . 73.42 110.646 -175.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -73.84 99.36 3.19 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.422 0.629 . . . . 74.14 109.969 173.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.581 HG13 ' HA2' ' A' ' 133' ' ' GLY . 24.1 pt -80.96 142.89 52.48 Favored Pre-proline 0 CA--C 1.558 1.25 0 CA-C-N 114.608 -1.178 . . . . 74.13 109.622 173.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -66.43 136.28 42.63 Favored 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 122.538 2.159 . . . . 60.34 113.24 174.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -56.36 96.9 0.06 OUTLIER 'Trans proline' 0 C--N 1.385 2.45 0 C-N-CA 123.084 2.523 . . . . 74.15 112.409 168.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 104.57 39.63 2.35 Favored Glycine 0 C--N 1.339 0.713 0 CA-C-N 115.298 -0.865 . . . . 75.51 111.675 -174.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 11.6 p -78.56 140.94 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 N-CA-C 109.158 -0.682 . . . . 75.43 109.158 177.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.414 ' NH1' ' HD3' ' A' ' 243' ' ' PRO . 9.5 mtm105 -115.23 147.15 40.7 Favored 'General case' 0 C--O 1.205 -1.264 0 CA-C-N 115.937 -0.574 . . . . 73.23 111.77 -164.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -53.77 120.01 5.7 Favored 'General case' 0 CA--C 1.551 0.984 0 O-C-N 124.266 0.979 . . . . 72.32 110.355 175.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 105.09 -8.34 45.23 Favored Glycine 0 C--N 1.347 1.14 0 CA-C-N 115.536 -0.757 . . . . 14.21 113.425 -176.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 44.1 m -68.32 105.09 2.03 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 117.447 0.623 . . . . 74.23 110.253 177.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.444 HG22 HG22 ' A' ' 177' ' ' VAL . 41.5 t -85.17 90.81 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-N 115.117 -0.947 . . . . 72.34 109.31 -178.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.599 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 56.9 mt -70.44 91.64 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 108.404 -0.961 . . . . 75.24 108.404 175.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 67.9 ttt-85 -78.38 100.05 6.62 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.778 -0.647 . . . . 61.32 109.273 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.6 p -106.6 105.39 54.56 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 123.662 0.785 . . . . 61.33 109.266 177.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.478 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 23.8 Cg_exo -65.25 104.18 0.59 Allowed 'Trans proline' 0 C--N 1.377 2.058 0 C-N-CA 122.551 2.168 . . . . 74.53 111.283 175.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' A' ' 171' ' ' PRO . . . 126.99 25.77 1.18 Allowed Glycine 0 C--N 1.342 0.873 0 N-CA-C 115.801 1.081 . . . . 70.43 115.801 175.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 24.7 mmt -137.57 0.44 2.26 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 119.013 1.406 . . . . 64.15 112.057 177.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.695 ' HA2' HD13 ' A' ' 174' ' ' LEU . . . -75.85 -108.22 0.12 Allowed Glycine 0 N--CA 1.477 1.404 0 C-N-CA 123.685 0.66 . . . . 73.33 114.274 -170.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -58.22 119.05 15.25 Favored Glycine 0 C--N 1.344 0.992 0 N-CA-C 110.051 -1.22 . . . . 74.5 110.051 168.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -64.45 109.09 1.83 Allowed 'General case' 0 CA--C 1.538 0.503 0 O-C-N 124.67 0.865 . . . . 75.42 110.056 -175.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -146.77 174.14 26.71 Favored Glycine 0 C--N 1.339 0.739 0 N-CA-C 110.1 -1.2 . . . . 64.21 110.1 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . 0.447 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . 50.4 t30 -59.61 -61.05 8.66 Favored Pre-proline 0 CA--C 1.565 1.525 0 CA-C-O 118.629 -0.7 . . . . 63.11 109.742 -176.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.447 ' HD3' ' HB3' ' A' ' 169' ' ' ASN . 19.6 Cg_endo -94.81 96.16 0.11 Allowed 'Trans proline' 0 C--N 1.382 2.314 0 CA-C-N 121.44 1.55 . . . . 71.13 108.16 154.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.44 ' O ' ' HA2' ' A' ' 163' ' ' GLY . 18.1 Cg_exo -61.59 167.41 9.95 Favored 'Trans proline' 0 C--N 1.385 2.473 0 C-N-CA 122.361 2.041 . . . . 71.25 112.638 -169.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.437 ' HA3' ' O ' ' A' ' 117' ' ' ARG . . . -85.81 -168.83 45.25 Favored Glycine 0 C--O 1.216 -0.989 0 C-N-CA 121.172 -0.537 . . . . 72.4 113.247 -177.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.478 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 13.6 m-20 -72.59 138.69 46.99 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 122.94 0.496 . . . . 71.14 110.467 -176.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.695 HD13 ' HA2' ' A' ' 165' ' ' GLY . 25.6 tp -119.21 132.05 55.9 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 110.0 -0.37 . . . . 64.32 110.0 177.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.543 ' HB2' ' HA ' ' A' ' 120' ' ' ARG . 44.6 mt -102.09 85.74 2.73 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 107.999 -1.112 . . . . 72.12 107.999 176.083 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.599 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 79.8 mt -71.72 85.83 0.92 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 109.543 -0.539 . . . . 70.05 109.543 176.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.444 HG22 HG22 ' A' ' 158' ' ' VAL . 18.9 t -82.64 102.22 8.33 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 N-CA-C 106.787 -1.56 . . . . 61.43 106.787 178.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 8.2 p -67.92 107.7 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.961 0 CA-C-O 122.516 1.151 . . . . 70.33 110.705 -171.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.647 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 36.0 mmt180 -95.18 100.08 11.95 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.116 -1.402 . . . . 53.32 108.953 175.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.526 ' HB3' HD23 ' A' ' 127' ' ' LEU . 26.3 mt -68.98 142.91 54.53 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 109.753 -0.462 . . . . 72.4 109.753 -179.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 55.2 mt -53.97 159.06 3.02 Favored Pre-proline 0 N--CA 1.486 1.336 0 C-N-CA 124.281 1.032 . . . . 73.14 113.142 -168.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -74.8 28.72 0.35 Allowed 'Trans proline' 0 C--N 1.38 2.215 0 C-N-CA 123.488 2.792 . . . . 71.42 112.485 167.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 64.8 t-80 -60.1 104.83 0.48 Allowed Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 125.722 1.609 . . . . 73.35 106.881 169.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -70.03 24.53 0.18 Allowed 'Trans proline' 0 C--N 1.382 2.34 0 C-N-CA 124.513 3.475 . . . . 61.24 116.801 -160.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 49.1 t -98.92 -50.94 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 118.721 0.691 . . . . 64.21 109.349 178.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . 0.485 ' HB3' HD22 ' A' ' 193' ' ' LEU . 82.9 m-85 -127.74 124.8 38.65 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.045 0.538 . . . . 72.31 110.864 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 52.1 ttp85 -103.5 87.96 2.98 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 107.007 -1.479 . . . . 75.51 107.007 164.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.459 ' HA ' ' HA ' ' A' ' 193' ' ' LEU . 16.3 tp -66.9 155.84 37.37 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.29 0.636 . . . . 74.21 109.601 177.089 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.404 ' H ' HD12 ' A' ' 188' ' ' LEU . 44.7 tt0 -163.92 121.07 1.73 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.236 0.614 . . . . 70.31 109.384 178.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 74.62 -79.23 0.97 Allowed Glycine 0 C--N 1.348 1.238 0 N-CA-C 112.239 -0.344 . . . . 65.41 112.239 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.538 ' HB3' ' HD2' ' A' ' 243' ' ' PRO . 3.8 pm0 -146.25 -13.3 0.46 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.567 1.147 . . . . 72.32 110.251 173.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -112.03 140.31 46.81 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.285 1.034 . . . . 72.32 111.503 -169.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.485 HD22 ' HB3' ' A' ' 186' ' ' PHE . 35.5 mt -90.2 153.88 20.17 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.312 1.445 . . . . 63.44 111.027 -172.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -128.2 98.89 5.24 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 107.738 -1.208 . . . . 73.14 107.738 170.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.459 ' HB3' HD23 ' A' ' 251' ' ' LEU . . . -113.08 130.1 56.28 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.755 0.822 . . . . 74.34 109.932 -176.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 41.2 m -77.25 131.43 38.18 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 109.579 -0.526 . . . . 70.21 109.579 -176.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.422 HD22 HD13 ' A' ' 251' ' ' LEU . 57.1 tp -124.91 108.03 11.47 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 123.216 0.606 . . . . 72.21 109.704 -170.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -80.72 107.74 13.79 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 108.513 -0.921 . . . . 61.43 108.513 173.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 6.7 p -126.51 130.59 23.85 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 124.055 0.942 . . . . 64.4 108.58 -179.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.401 ' HB2' ' HE1' ' C' ' 276' ' ' TYR . 72.9 Cg_endo -75.45 157.44 40.88 Favored 'Trans proline' 0 C--N 1.365 1.409 0 C-N-CA 121.627 1.551 . . . . 64.51 111.96 173.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.425 ' HB3' ' HD3' ' A' ' 202' ' ' PRO . . . -54.09 -53.29 60.21 Favored Pre-proline 0 CA--C 1.559 1.295 0 N-CA-C 114.177 1.177 . . . . 71.34 114.177 -169.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.425 ' HD3' ' HB3' ' A' ' 201' ' ' ALA . 50.4 Cg_exo -58.5 -35.63 98.43 Favored 'Trans proline' 0 C--N 1.382 2.292 0 C-N-CA 122.02 1.813 . . . . 63.54 113.682 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 46.2 mt -74.51 -33.89 34.03 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 N-CA-C 109.966 -0.383 . . . . 64.32 109.966 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.508 ' HA ' HG11 ' A' ' 223' ' ' VAL . . . -67.92 -41.32 82.78 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.303 0.641 . . . . 71.51 111.275 175.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.534 HG13 HD11 ' C' ' 261' ' ' LEU . 55.1 t -78.94 -42.16 24.02 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 C-N-CA 123.865 0.866 . . . . 63.23 112.466 -172.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 84.6 t -84.17 -33.0 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 122.793 0.437 . . . . 74.41 110.288 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 88.04 48.5 4.08 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-N 115.551 -0.749 . . . . 72.35 111.796 -177.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -76.93 173.86 54.62 Favored Glycine 0 C--N 1.341 0.853 0 N-CA-C 111.334 -0.706 . . . . 55.24 111.334 173.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.528 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 46.8 mtmt -84.76 129.92 34.76 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 117.694 0.747 . . . . 45.21 111.915 -178.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.42 HG21 HD11 ' A' ' 197' ' ' LEU . 30.2 m -111.56 -172.12 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.961 0 N-CA-C 106.237 -1.764 . . . . 63.11 106.237 161.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . 0.508 ' HD3' ' HB2' ' A' ' 218' ' ' PRO . 15.5 ttm180 -127.39 132.16 50.2 Favored 'General case' 0 C--O 1.237 0.432 0 O-C-N 121.954 -0.466 . . . . 71.41 110.353 177.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -99.51 111.75 24.05 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 108.29 -1.004 . . . . 62.04 108.29 174.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . 0.5 ' HA ' ' HA ' ' A' ' 218' ' ' PRO . 3.5 mpp? -71.93 123.78 23.46 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 108.602 -0.888 . . . . 71.23 108.602 173.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . 0.453 ' HA ' ' HE1' ' A' ' 186' ' ' PHE . 24.5 p -108.81 -177.74 3.4 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 109.405 -0.591 . . . . 74.1 109.405 179.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.437 HD11 ' HZ ' ' A' ' 240' ' ' PHE . 61.5 mt -58.82 -27.21 64.88 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.661 1.184 . . . . 63.31 113.141 -171.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -142.34 28.84 1.64 Allowed 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 116.323 -0.399 . . . . 64.44 111.222 -175.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 155.72 146.59 4.48 Favored Glycine 0 C--N 1.35 1.346 0 O-C-N 121.513 -0.742 . . . . 33.0 114.612 171.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . 0.508 ' HB2' ' HD3' ' A' ' 211' ' ' ARG . 72.9 Cg_endo -85.94 108.82 0.98 Allowed 'Trans proline' 0 C--N 1.369 1.613 0 C-N-CA 122.962 2.441 . . . . 70.23 112.567 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 30.1 m -103.05 150.28 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 123.592 0.757 . . . . 73.4 109.648 -178.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -79.36 142.32 36.14 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 117.802 0.273 . . . . 75.04 110.613 -177.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 3.9 m -134.1 110.87 14.34 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 C-N-CA 124.163 0.985 . . . . 74.13 108.578 174.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.528 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -72.61 114.53 10.85 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 109.145 -0.687 . . . . 60.25 109.145 174.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.609 ' HA ' HD12 ' B' ' 441' ' ' ILE . 50.5 t -59.53 146.63 79.46 Favored Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 124.357 1.063 . . . . 63.14 109.425 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . 0.599 ' HD3' ' HB ' ' B' ' 441' ' ' ILE . 60.4 Cg_endo -70.75 158.9 54.36 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 121.592 1.528 . . . . 75.51 109.316 169.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . 0.411 ' HG2' ' HD3' ' B' ' 446' ' ' PRO . 33.2 Cg_endo -72.34 151.46 54.14 Favored 'Trans proline' 0 CA--C 1.549 1.25 0 CA-C-N 119.925 1.009 . . . . 72.53 111.969 171.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 46.1 mtt180 64.82 39.26 6.22 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 125.331 1.452 . . . . 74.04 110.894 169.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.604 HG23 HD21 ' A' ' 233' ' ' LEU . 53.2 m -74.42 109.58 8.01 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 112.989 -1.914 . . . . 64.32 111.716 -177.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . 0.401 ' HB3' ' HD2' ' A' ' 231' ' ' ARG . 5.8 tp60 -84.86 140.96 30.78 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.618 1.167 . . . . 75.32 111.521 -177.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -63.31 145.56 55.29 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.061 0.944 . . . . 62.31 112.184 -179.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 86.29 -24.89 7.58 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-N 116.334 -0.394 . . . . 73.32 113.355 178.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.401 ' HD2' ' HB3' ' A' ' 228' ' ' GLN . 93.7 mtt180 -69.15 160.83 30.37 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-O 121.46 0.648 . . . . 74.0 110.905 176.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.623 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 2.8 mppt? -115.16 114.87 25.85 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.112 -1.07 . . . . 72.22 108.112 178.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.604 HD21 HG23 ' A' ' 227' ' ' THR . 87.9 mt -76.16 103.44 6.2 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 115.46 -0.791 . . . . 71.4 109.905 -175.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -76.14 105.09 6.99 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 123.712 0.632 . . . . 64.14 109.982 177.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.577 ' HB3' ' HA ' ' B' ' 441' ' ' ILE . 0.4 OUTLIER -108.45 115.45 30.13 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.006 -1.109 . . . . 61.12 108.006 167.772 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -69.73 141.44 53.46 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 114.651 -1.159 . . . . 64.43 111.978 -167.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 69.98 17.42 73.58 Favored Glycine 0 C--N 1.348 1.221 0 O-C-N 123.936 0.773 . . . . 74.2 113.922 174.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.451 ' HG3' HD12 ' A' ' 235' ' ' LEU . 33.7 mmtp -107.62 5.15 26.65 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.225 0.61 . . . . 73.01 111.086 -176.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -101.74 -156.3 26.42 Favored Glycine 0 C--N 1.347 1.19 0 C-N-CA 123.194 0.426 . . . . 74.43 112.659 173.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . 0.437 ' HZ ' HD11 ' A' ' 215' ' ' LEU . 3.4 m-85 -94.23 145.18 29.28 Favored Pre-proline 0 N--CA 1.481 1.079 0 C-N-CA 123.136 0.575 . . . . 73.13 111.065 -172.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' A' ' 246' ' ' ARG . 37.4 Cg_exo -60.56 119.09 6.07 Favored 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 123.52 2.813 . . . . 73.33 112.85 178.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -156.42 -148.19 4.99 Favored Glycine 0 C--N 1.35 1.323 0 CA-C-O 118.548 -1.14 . . . . 73.52 113.746 -173.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . 0.538 ' HD2' ' HB3' ' A' ' 191' ' ' GLN . 74.2 Cg_exo -51.92 -38.52 68.82 Favored 'Trans proline' 0 C--N 1.39 2.747 0 C-N-CA 124.138 3.225 . . . . 70.45 113.84 -176.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -82.98 15.33 2.8 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.821 0.848 . . . . 70.11 112.207 -178.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 81.16 -71.57 2.89 Favored Glycine 0 C--N 1.345 1.048 0 N-CA-C 109.814 -1.314 . . . . 62.24 109.814 -169.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.41 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 23.1 mtp180 -122.12 147.49 46.08 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.491 1.117 . . . . 75.41 108.723 168.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -86.14 -177.44 49.89 Favored Glycine 0 C--N 1.339 0.706 0 CA-C-N 116.303 -0.408 . . . . 42.24 112.346 175.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -111.45 170.93 7.79 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.29 0.636 . . . . 75.44 110.072 -179.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.5 ' HB3' ' HG ' ' A' ' 235' ' ' LEU . 34.0 tp -114.91 134.39 55.19 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.361 -1.348 . . . . 70.31 107.361 170.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.623 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 62.0 m-85 -116.38 106.28 13.45 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 107.945 -1.131 . . . . 52.51 107.945 175.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.459 HD23 ' HB3' ' A' ' 195' ' ' ALA . 49.5 mt -90.23 108.2 19.61 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 109.51 -0.552 . . . . 72.24 109.51 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.516 ' HG2' ' HG3' ' A' ' 232' ' ' LYS . 30.6 mt-10 -76.33 111.5 11.84 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.663 1.185 . . . . 75.41 109.068 -172.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 27.5 t -69.81 119.24 15.49 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 C-N-CA 123.827 0.851 . . . . 24.43 111.902 -168.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.28 91.67 3.59 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 107.433 -1.321 . . . . 73.14 107.433 174.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.475 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 62.4 mt -78.61 129.68 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 O-C-N 123.204 0.315 . . . . 74.34 110.305 -177.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 51.9 p -113.94 166.46 11.57 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.939 0.895 . . . . 73.43 109.703 173.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.632 HG23 HG21 ' C' ' 255' ' ' ILE . 2.6 pp -118.17 157.52 48.67 Favored Pre-proline 0 CA--C 1.56 1.329 0 C-N-CA 123.735 0.814 . . . . 73.4 110.378 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . 0.503 ' HD2' ' HB ' ' A' ' 257' ' ' ILE . 25.7 Cg_endo -56.23 -17.2 19.65 Favored 'Trans proline' 0 N--CA 1.513 2.631 0 C-N-CA 124.42 3.413 . . . . 74.45 115.165 -168.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.727 ' HG2' HE21 ' C' ' 228' ' ' GLN . 40.5 mt-10 50.01 -81.61 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 124.859 1.264 . . . . 63.24 111.659 -166.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.6 161.49 29.52 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 120.114 1.325 . . . . 75.12 109.806 173.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.697 HD22 ' HB3' ' A' ' 265' ' ' GLU . 54.6 mt -147.47 146.5 29.55 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.37 0.668 . . . . 55.32 109.936 173.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 72.5 p -83.97 161.35 55.67 Favored Pre-proline 0 CA--C 1.551 1.011 0 N-CA-C 107.958 -1.127 . . . . 44.34 107.958 165.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' PRO . . . . . 0.425 ' HG3' ' HA ' ' B' ' 376' ' ' GLU . 10.4 Cg_endo -50.24 -40.25 52.08 Favored 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 123.279 2.653 . . . . 74.33 113.562 -179.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -63.1 -56.99 12.16 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.745 -0.661 . . . . 71.44 110.53 177.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . 0.697 ' HB3' HD22 ' A' ' 261' ' ' LEU . 53.0 mt-10 -57.38 -35.97 70.66 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 123.626 0.579 . . . . 64.2 111.102 -179.032 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' GLU . . . . . 0.54 ' HA ' HD13 ' A' ' 261' ' ' LEU . 7.3 tp10 -59.69 -50.41 73.96 Favored 'General case' 0 C--O 1.248 0.984 0 C-N-CA 123.985 0.914 . . . . 73.45 109.519 178.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -60.71 -41.54 95.45 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 114.627 -1.169 . . . . 64.12 111.814 177.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 10.1 mp -69.85 -45.28 68.11 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.42 0.688 . . . . 73.14 111.786 -176.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 63.1 m95 -66.68 -35.38 80.02 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.563 0.745 . . . . 75.0 111.62 -179.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . 0.455 ' HE2' HG23 ' C' ' 206' ' ' VAL . 96.2 mttt -85.22 -16.79 39.09 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 116.216 -0.447 . . . . 62.43 112.142 177.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 4.0 mmmp? -74.47 -32.79 62.69 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 110.029 -0.36 . . . . 70.22 110.029 166.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 91.6 mt -61.87 -58.24 8.7 Favored 'General case' 0 C--O 1.212 -0.892 0 N-CA-C 108.338 -0.986 . . . . 63.4 108.338 170.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -57.5 -32.59 67.16 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.52 1.128 . . . . 64.51 112.793 -177.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -65.17 -62.68 1.4 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.443 0.697 . . . . 74.35 109.35 172.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -70.6 -6.35 36.02 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.276 0.631 . . . . 71.44 112.564 -175.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -93.64 -80.51 0.39 Allowed 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 107.612 -1.255 . . . . 75.02 107.612 174.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -73.27 -38.1 66.06 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.33 -0.85 . . . . 70.12 112.005 -166.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -73.37 -4.54 34.05 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 122.345 -0.222 . . . . 75.41 111.1 178.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -120.96 10.74 10.88 Favored 'General case' 0 C--N 1.358 0.961 0 C-N-CA 123.451 0.7 . . . . 74.13 110.059 176.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.142 0 C-N-CA 123.603 0.761 . . . . 72.21 111.314 -178.502 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.435 ' HB3' ' HB3' ' B' ' 4' ' ' SER . 1.5 mpt? . . . . . 0 N--CA 1.477 0.898 0 N-CA-C 110.238 -0.282 . . . . 71.44 110.238 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -79.77 -49.43 12.04 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.189 0.596 . . . . 54.1 110.608 176.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -93.88 19.89 8.37 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.312 0.645 . . . . 74.04 112.3 -171.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . 0.435 ' HB3' ' HB3' ' B' ' 1' ' ' MET . 13.9 p -65.97 -56.31 12.33 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-O 120.945 0.403 . . . . 52.14 110.156 178.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 4.1 m 67.78 151.8 0.08 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.501 1.52 . . . . 70.11 112.328 174.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.524 HG21 ' HA ' ' A' ' 125' ' ' LEU . 46.2 pt -130.93 159.99 42.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 123.019 0.527 . . . . 64.44 111.645 -162.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -131.93 134.74 45.99 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.828 0.851 . . . . 72.01 110.104 178.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 32.7 tp -73.15 144.69 46.81 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.429 0.691 . . . . 75.22 110.378 -176.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . 0.413 ' HB3' ' HB2' ' A' ' 122' ' ' GLU . . . -80.39 -50.03 10.67 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 122.477 0.311 . . . . 62.4 111.345 178.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 31.4 mt 71.22 -25.09 0.17 Allowed 'General case' 0 N--CA 1.504 2.251 0 C-N-CA 125.295 1.438 . . . . 74.1 113.282 -172.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 61.0 mt 56.56 69.47 1.76 Allowed Pre-proline 0 CA--C 1.558 1.278 0 C-N-CA 124.468 1.107 . . . . 45.35 109.649 -168.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -91.03 -151.01 0.04 OUTLIER 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 123.17 2.58 . . . . 61.33 112.368 -176.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -59.21 -30.53 68.29 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.071 0.948 . . . . 75.01 112.676 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 3.2 pp -135.37 153.98 51.65 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.405 0.682 . . . . 64.54 110.183 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -156.82 132.0 9.11 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 108.767 -0.827 . . . . 60.01 108.767 177.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 36.6 p -110.94 98.62 39.35 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 123.659 0.784 . . . . 51.11 110.065 178.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -91.61 -163.01 0.11 Allowed 'Trans proline' 0 C--N 1.373 1.86 0 C-N-CA 123.015 2.476 . . . . 62.42 112.119 174.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 34.6 m -71.48 -6.85 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 C-N-CA 123.81 0.844 . . . . 61.41 112.7 179.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 11.8 m -58.1 -44.05 87.44 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.618 0.767 . . . . 71.22 110.678 175.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -76.82 -73.94 0.26 Allowed 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 115.751 -0.659 . . . . 62.34 110.317 178.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.87 88.78 7.13 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.358 -0.608 . . . . 75.34 109.358 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 37.5 mtp85 -65.64 -60.5 2.85 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 114.573 -1.194 . . . . 73.31 109.093 -178.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 23' ' ' THR . . . . . 0.424 ' HB ' ' HD3' ' B' ' 24' ' ' PRO 0.276 18.0 m 98.05 -84.22 0.0 OUTLIER Pre-proline 0 CA--C 1.57 1.748 0 C-N-CA 127.219 2.208 . . . . 72.45 114.85 164.626 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . 0.424 ' HD3' ' HB ' ' B' ' 23' ' ' THR . 27.5 Cg_endo -85.41 26.13 0.66 Allowed 'Trans proline' 0 C--N 1.392 2.844 0 CA-C-N 122.47 1.918 . . . . 74.55 114.935 -154.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -79.95 83.22 5.9 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 122.889 0.476 . . . . 74.53 110.215 179.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 59.0 mtm -75.61 -44.01 4.15 Favored Pre-proline 0 CA--C 1.561 1.393 0 CA-C-N 115.083 -0.962 . . . . 75.13 111.662 174.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -59.22 108.11 0.41 Allowed 'Trans proline' 0 C--N 1.397 3.095 0 C-N-CA 121.982 1.788 . . . . 71.1 112.689 176.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 5.8 m -73.67 99.73 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 CA-C-N 115.38 -0.827 . . . . 73.51 109.781 176.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 66.4 mt 71.19 -72.41 0.11 Allowed 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 125.949 1.7 . . . . 62.2 111.096 -178.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.96 -4.16 3.57 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.27 1.028 . . . . 70.24 110.522 178.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 7.2 t30 64.28 65.62 0.66 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.492 1.517 . . . . 74.34 109.654 -172.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 32' ' ' ARG . . . . . 0.563 ' HG3' ' H ' ' B' ' 33' ' ' ALA . 14.9 ptp180 -63.99 -73.82 0.11 Allowed 'General case' 0 CA--C 1.558 1.286 0 CA-C-N 113.944 -1.48 . . . . 72.22 113.175 -175.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . 0.563 ' H ' ' HG3' ' B' ' 32' ' ' ARG . . . 165.78 -61.05 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 126.11 1.764 . . . . 73.31 108.548 -174.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -157.28 -73.76 0.09 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.81 0.844 . . . . 53.33 111.215 -177.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -77.83 -69.26 0.56 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.257 0.623 . . . . 73.13 110.423 -172.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . 0.401 ' HA2' ' HD3' ' B' ' 32' ' ' ARG . . . -170.65 140.98 6.25 Favored Glycine 0 C--N 1.342 0.889 0 CA-C-O 118.718 -1.045 . . . . 74.33 111.292 -175.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 20.4 t70 69.28 156.46 0.14 Allowed 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 124.342 1.057 . . . . 61.44 111.478 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 50.5 mm -60.92 -59.47 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 123.528 0.731 . . . . 75.44 112.043 -172.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 9.7 t -163.14 179.41 7.49 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.123 0.569 . . . . 64.25 109.959 -177.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.8 114.17 8.98 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 123.576 0.75 . . . . 64.0 110.571 177.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -68.6 102.59 0.87 Allowed 'Trans proline' 0 C--N 1.382 2.32 0 C-N-CA 122.741 2.294 . . . . 72.44 111.605 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -73.2 -64.44 2.52 Favored Glycine 0 C--N 1.34 0.79 0 CA-C-N 115.62 -0.718 . . . . 45.24 112.812 -177.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 62.13 41.72 99.71 Favored Glycine 0 C--N 1.349 1.293 0 N-CA-C 111.134 -0.787 . . . . 42.15 111.134 -172.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -84.84 -173.87 4.96 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.218 1.007 . . . . 63.2 111.356 -175.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.59 32.59 7.08 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.591 1.156 . . . . 74.21 110.353 -179.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 46' ' ' ARG . . . . . 0.52 ' HG3' ' HA ' ' B' ' 236' ' ' THR . 19.6 ttm180 -91.59 45.37 1.23 Allowed 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.857 0.863 . . . . 75.02 110.706 -174.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -86.04 96.71 9.95 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 107.986 -1.116 . . . . 53.22 107.986 177.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 22.6 m 79.65 -45.89 0.33 Allowed 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 125.981 1.713 . . . . 51.22 111.578 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.5 -60.81 4.67 Favored Glycine 0 C--N 1.343 0.943 0 N-CA-C 111.11 -0.796 . . . . 74.15 111.11 -175.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 18.9 t70 61.08 -87.72 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.243 1.417 . . . . 64.2 110.576 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 62.41 16.61 8.76 Favored 'General case' 0 CA--C 1.559 1.324 0 C-N-CA 124.684 1.194 . . . . 75.3 111.782 173.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . 0.455 ' HB ' ' HB1' ' B' ' 158' ' ' ALA . 22.2 p -134.95 -13.35 2.16 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 112.784 0.661 . . . . 73.31 112.784 -171.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.98 81.92 4.36 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 122.907 0.483 . . . . 73.24 111.337 -178.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . 52.42 53.59 12.08 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.962 1.305 . . . . 75.51 112.768 174.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 44.7 tp -75.18 109.41 8.65 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 109.037 -0.727 . . . . 72.35 109.037 175.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . 0.53 HH21 ' HB3' ' B' ' 64' ' ' ALA . 0.3 OUTLIER -64.47 121.03 13.42 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.637 0.775 . . . . 73.2 110.833 -179.839 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -168.25 -79.34 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.467 1.107 . . . . 75.31 108.411 170.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 21.3 m -81.9 89.52 6.37 Favored 'General case' 0 C--N 1.347 0.47 0 N-CA-C 108.599 -0.889 . . . . 62.01 108.599 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . 0.575 ' HA ' ' HB3' ' B' ' 63' ' ' PRO . 57.7 mt 64.5 -78.38 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.053 0 O-C-N 124.646 1.216 . . . . 72.44 111.451 175.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 14.4 m 72.41 -67.65 0.25 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.93 1.692 . . . . 63.51 111.89 172.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . 0.575 ' HB3' ' HB2' ' B' ' 272' ' ' ASN . 10.0 t0 -151.4 -68.61 0.18 Allowed 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 107.974 -1.121 . . . . 71.45 107.974 176.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 62' ' ' LYS . . . . . 0.414 ' HB2' ' HB3' ' B' ' 273' ' ' GLN . 11.3 mptt -118.53 118.24 33.82 Favored Pre-proline 0 N--CA 1.481 1.082 0 N-CA-C 107.645 -1.243 . . . . 72.3 107.645 162.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . 0.575 ' HB3' ' HA ' ' B' ' 59' ' ' LEU . 65.9 Cg_endo -82.24 28.19 0.57 Allowed 'Trans proline' 0 C--N 1.38 2.205 0 C-N-CA 123.277 2.651 . . . . 72.24 113.165 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . 0.611 ' HA ' ' HG2' ' B' ' 273' ' ' GLN . . . 70.92 -15.94 0.37 Allowed 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 125.435 1.494 . . . . 72.04 113.894 -177.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 85.0 tttt 56.31 63.74 1.9 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.964 1.306 . . . . 65.32 110.394 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -85.46 12.41 8.5 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 114.567 -1.197 . . . . 72.41 111.573 -177.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 9.4 tt -69.78 86.53 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.342 0 CA-C-O 121.695 0.759 . . . . 72.03 110.311 178.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 2.2 mp 61.63 -83.77 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.181 0 C-N-CA 125.567 1.547 . . . . 73.4 110.784 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 56.2 tp -178.93 148.35 0.39 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.937 1.295 . . . . 73.12 108.894 -177.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 7.4 mp -69.1 95.1 0.71 Allowed 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 108.614 -0.884 . . . . 44.44 108.614 170.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 2.8 pp -73.05 -23.7 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.747 0.819 . . . . 74.32 111.883 -177.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 131.89 99.05 0.76 Allowed Glycine 0 C--N 1.348 1.243 0 N-CA-C 111.912 -0.475 . . . . 62.21 111.912 178.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -101.21 158.68 15.85 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.149 0.58 . . . . 63.44 109.734 175.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -158.39 61.73 0.32 Allowed Glycine 0 C--N 1.333 0.412 0 N-CA-C 109.774 -1.33 . . . . 64.42 109.774 174.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 24.8 ttt 63.31 36.18 11.89 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-O 122.496 1.141 . . . . 74.01 109.08 -174.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . -91.11 62.86 2.85 Favored Glycine 0 C--N 1.348 1.222 0 CA-C-N 114.699 -1.137 . . . . 71.13 111.973 -175.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -70.62 -33.81 71.42 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.074 0.55 . . . . 73.03 109.74 177.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 92.6 p 50.84 38.35 19.61 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 125.933 1.693 . . . . 51.1 113.172 174.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . 0.51 ' HG3' ' HA ' ' B' ' 111' ' ' LEU . 9.0 tp10 -130.3 90.19 2.9 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 108.732 -0.84 . . . . 74.44 108.732 177.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 33.4 mm 56.01 67.28 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 125.326 1.45 . . . . 72.52 110.581 -177.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . 0.517 ' HA ' ' CE1' ' B' ' 108' ' ' HIS . 41.2 p -71.74 -29.43 64.52 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 115.744 -0.662 . . . . 71.34 112.161 -176.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 60.9 15.61 6.18 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.559 1.143 . . . . 61.11 112.151 -177.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -104.83 115.17 29.85 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 123.591 0.757 . . . . 71.35 110.225 -172.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 41.4 mmt180 -94.63 132.05 39.76 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.558 0.743 . . . . 73.0 110.482 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . 0.491 HD22 ' HA ' ' B' ' 99' ' ' ALA . 49.4 t-20 -74.25 -83.61 0.05 Allowed 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 107.754 -1.202 . . . . 72.23 107.754 169.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 4.7 t80 60.5 -174.86 0.12 Allowed 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.824 0.849 . . . . 63.12 112.07 169.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.03 -15.91 52.0 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 122.827 0.451 . . . . 52.24 110.496 168.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -74.07 -63.79 1.15 Allowed 'General case' 0 C--N 1.351 0.636 0 C-N-CA 123.78 0.832 . . . . 74.14 110.38 177.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -70.61 -42.48 62.89 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 115.773 -0.649 . . . . 54.33 112.441 -177.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . 56.21 19.26 3.75 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.77 1.228 . . . . 62.33 113.075 176.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -89.78 61.25 3.46 Favored Glycine 0 C--N 1.35 1.325 0 N-CA-C 112.134 -0.386 . . . . 70.11 112.134 -176.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -160.86 -169.82 24.63 Favored Glycine 0 C--N 1.34 0.759 0 N-CA-C 111.953 -0.459 . . . . 23.53 111.953 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -105.64 9.12 33.33 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.406 1.082 . . . . 74.22 111.984 -174.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 54.9 t80 66.91 6.11 4.45 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 124.827 1.251 . . . . 71.21 112.756 174.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -69.87 -12.69 61.81 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 124.376 1.071 . . . . 74.14 113.714 -172.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 94.08 -34.12 4.86 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 112.563 -0.215 . . . . 72.31 112.563 -176.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 14.3 tt -105.76 -0.54 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 123.643 0.777 . . . . 72.22 110.17 178.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -78.18 1.58 20.93 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 125.181 1.392 . . . . 75.21 112.617 -176.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . 0.491 ' HA ' HD22 ' B' ' 85' ' ' ASN . . . -81.03 31.49 0.32 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.015 0.926 . . . . 61.12 111.894 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 91.9 mt -73.15 154.73 90.47 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 124.838 1.255 . . . . 74.2 110.798 -177.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -67.05 83.37 0.34 Allowed 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 122.837 2.358 . . . . 72.21 111.718 173.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 38.4 tp -95.29 -11.22 28.24 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.101 -0.954 . . . . 73.12 109.867 176.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 13.6 t -156.07 170.66 21.66 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.315 0.646 . . . . 75.52 110.399 -176.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . -152.52 146.55 15.25 Favored Glycine 0 C--N 1.344 0.973 0 N-CA-C 111.192 -0.763 . . . . 51.35 111.192 177.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -75.87 89.9 2.92 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.326 0.65 . . . . 75.22 110.084 -178.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 44.1 t80 61.76 -177.24 0.12 Allowed 'General case' 0 CA--C 1.568 1.662 0 C-N-CA 124.348 1.059 . . . . 74.44 111.654 177.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 40.1 m -49.82 121.02 4.77 Favored 'General case' 0 C--N 1.355 0.831 0 C-N-CA 123.847 0.859 . . . . 63.32 110.428 170.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 108' ' ' HIS . . . . . 0.517 ' CE1' ' HA ' ' B' ' 81' ' ' THR . 2.8 m-70 -79.44 98.37 6.76 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 107.069 -1.456 . . . . 71.44 107.069 -176.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -77.61 -30.13 52.2 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 122.455 0.302 . . . . 53.33 110.972 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.35 -69.07 0.24 Allowed 'General case' 0 N--CA 1.477 0.911 0 O-C-N 123.776 0.673 . . . . 71.24 111.11 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . 0.51 ' HA ' ' HG3' ' B' ' 79' ' ' GLU . 94.5 mt 48.67 -87.59 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.955 1.302 . . . . 64.15 111.818 -179.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -169.18 114.72 0.57 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.159 1.384 . . . . 73.2 107.721 177.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 113' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp 70.65 7.34 6.18 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 124.749 1.22 . . . . 75.13 112.207 -175.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt 62.42 -76.96 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.501 1.521 . . . . 74.01 112.514 -178.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 14.2 t -129.6 12.26 5.85 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.402 0.681 . . . . 73.23 110.498 -177.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -91.17 13.44 66.31 Favored Glycine 0 C--N 1.35 1.312 0 CA-C-N 116.616 -0.266 . . . . 55.33 113.087 177.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . 0.534 ' HB3' ' HD3' ' B' ' 118' ' ' PRO . 6.6 tmtm? -164.03 -52.12 0.01 OUTLIER Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 124.55 1.14 . . . . 70.25 108.118 -178.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 118' ' ' PRO . . . . . 0.534 ' HD3' ' HB3' ' B' ' 117' ' ' LYS . 12.1 Cg_endo -94.08 66.83 0.38 Allowed 'Trans proline' 0 C--N 1.385 2.464 0 C-N-CA 122.265 1.977 . . . . 60.53 109.368 169.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 119' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -56.62 99.41 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 113.957 -1.474 . . . . 75.33 112.265 -167.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 120' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -90.33 -43.3 10.44 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.561 0.745 . . . . 70.1 110.498 -176.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 7.9 p -63.16 -42.37 96.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 123.003 0.521 . . . . 74.32 111.297 -176.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 81.7 p -88.63 94.33 9.86 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 108.976 -0.749 . . . . 75.24 108.976 173.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 54.56 -85.81 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 125.542 1.537 . . . . 64.3 112.815 178.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 57.1 p -172.85 28.64 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.1 0.96 . . . . 43.31 109.993 -172.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . 63.54 30.52 15.12 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.741 1.217 . . . . 73.02 110.955 -173.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -82.11 143.37 31.53 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.956 0.902 . . . . 74.13 111.52 -177.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 50.2 m -139.03 143.16 38.31 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.816 0.846 . . . . 70.01 109.956 176.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -139.39 179.15 6.71 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.791 0.836 . . . . 72.01 111.102 -172.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 20.2 m 76.63 -51.75 0.58 Allowed 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 126.027 1.731 . . . . 54.34 112.106 -178.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . -55.94 142.29 36.23 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.3 1.04 . . . . 44.22 112.078 177.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 66.4 p-90 -63.57 -22.86 67.13 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.48 0.712 . . . . 73.51 112.286 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 50.1 p -77.76 -54.18 6.65 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.034 0.934 . . . . 51.4 112.326 -175.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 73.7 p -104.67 -24.84 12.9 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.434 0.694 . . . . 62.25 112.0 -173.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . -72.96 -0.77 53.43 Favored Glycine 0 N--CA 1.476 1.309 0 CA-C-N 115.921 -0.581 . . . . 55.15 114.281 -177.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 135' ' ' VAL . . . . . 0.414 HG23 ' HB2' ' B' ' 59' ' ' LEU . 16.8 m -97.14 21.02 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.118 0 C-N-CA 124.214 1.006 . . . . 73.24 110.286 170.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 136' ' ' LYS . . . . . 0.471 ' O ' ' HB3' ' B' ' 59' ' ' LEU . 87.1 tttt 67.98 108.99 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 125.448 1.499 . . . . 52.43 111.683 177.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 137' ' ' THR . . . . . 0.508 ' HA ' HD13 ' B' ' 59' ' ' LEU . 11.0 p -80.04 50.84 1.27 Allowed 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.119 0.968 . . . . 75.31 112.245 -179.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 62.2 t80 62.98 -76.3 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.442 1.497 . . . . 75.52 110.306 -175.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 59.18 -82.82 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 125.111 1.364 . . . . 73.24 113.321 171.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . 98.07 -149.18 19.12 Favored Glycine 0 C--N 1.351 1.406 0 N-CA-C 111.049 -0.82 . . . . 65.04 111.049 -170.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -80.43 85.92 5.83 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 122.961 0.504 . . . . 75.34 109.887 178.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . 0.472 HD11 HD12 ' B' ' 146' ' ' ILE . 0.7 OUTLIER -86.64 20.57 2.47 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.868 0.867 . . . . 70.15 112.468 -174.153 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 101.71 -46.79 1.23 Allowed Glycine 0 C--N 1.346 1.098 0 N-CA-C 111.576 -0.61 . . . . 61.25 111.576 -178.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 3.6 t -92.8 34.57 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 CA-C-O 121.817 0.818 . . . . 75.31 109.479 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 60.61 -98.4 0.08 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.271 1.428 . . . . 64.3 111.427 -178.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . 0.472 HD12 HD11 ' B' ' 142' ' ' LEU . 34.1 mt 50.91 52.39 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 CA-C-O 122.51 1.148 . . . . 72.52 109.702 -175.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -67.94 -80.5 0.04 OUTLIER 'General case' 0 C--N 1.358 0.965 0 CA-C-N 114.116 -1.402 . . . . 72.43 110.769 -176.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -176.74 121.39 0.14 Allowed 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 107.491 -1.3 . . . . 73.05 107.491 -174.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 149' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm 54.99 31.21 15.59 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 123.692 0.797 . . . . 72.23 110.307 -163.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -130.6 129.55 42.87 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.633 1.173 . . . . 74.11 108.635 -173.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 39.1 m80 69.38 165.22 0.13 Allowed Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 124.452 1.095 . . . . 74.43 111.267 -170.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -58.88 -171.82 0.05 OUTLIER 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 122.55 2.167 . . . . 42.51 112.767 166.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 1.4 t 56.45 -159.55 0.23 Allowed 'General case' 0 CA--C 1.568 1.637 0 C-N-CA 124.698 1.199 . . . . 74.2 110.916 -176.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 154' ' ' ILE . . . . . 0.457 ' HA ' ' HB2' ' B' ' 136' ' ' LYS . 64.5 mt 74.76 -75.55 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 C-N-CA 124.747 1.219 . . . . 74.25 110.157 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 155' ' ' LEU . . . . . 0.675 HD23 ' H ' ' B' ' 155' ' ' LEU . 2.1 pt? -90.54 -27.52 19.11 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 108.765 -0.828 . . . . 72.1 108.765 172.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 64.84 28.79 12.76 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 125.084 1.353 . . . . 72.23 111.63 168.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 157' ' ' MET . . . . . . . . . . . . . 84.9 mtp 58.62 24.05 11.62 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 124.19 0.996 . . . . 53.54 111.21 -176.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 158' ' ' ALA . . . . . 0.455 ' HB1' ' HB ' ' B' ' 52' ' ' THR . . . 68.43 -69.92 0.14 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.003 1.721 . . . . 34.04 113.268 179.136 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 12.0 mptt 66.1 -166.51 0.22 Allowed 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 124.681 1.192 . . . . 55.45 110.047 -166.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 160' ' ' ALA . . . . . 0.676 ' HA ' ' HA ' ' B' ' 230' ' ' ALA . . . 65.84 -156.98 0.27 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.912 0.885 . . . . 70.22 111.588 176.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . 78.35 -60.99 0.39 Allowed 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 125.333 1.453 . . . . 71.1 112.503 176.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . -74.78 -5.81 75.74 Favored Glycine 0 CA--C 1.535 1.309 0 N-CA-C 114.902 0.721 . . . . 73.4 114.902 -175.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . 0.537 ' HG ' HD13 ' B' ' 226' ' ' LEU . 2.7 tm? -167.13 155.67 9.88 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 108.981 -0.748 . . . . 65.02 108.981 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 164' ' ' ALA . . . . . . . . . . . . . . . -131.68 133.54 44.98 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.112 0.965 . . . . 75.34 109.82 -178.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 20.1 p -119.79 -66.31 1.08 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.015 0.526 . . . . 64.15 111.084 176.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.35 -178.59 53.83 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-O 119.775 -0.458 . . . . 71.15 112.826 -174.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 167' ' ' ASN . . . . . . . . . . . . . 7.5 t30 57.05 95.47 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 125.361 1.464 . . . . 72.31 112.062 -178.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . 0.58 HG22 ' H ' ' B' ' 174' ' ' GLN . 7.5 t 59.62 50.17 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 C-N-CA 124.991 1.316 . . . . 74.13 109.507 -177.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 31.3 t -142.95 -45.38 0.3 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.456 -0.793 . . . . 54.35 111.9 -172.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 170' ' ' THR . . . . . 0.641 ' HB ' ' HB3' ' B' ' 231' ' ' LYS . 9.4 t -110.13 -43.43 3.95 Favored 'General case' 0 N--CA 1.478 0.969 0 O-C-N 122.163 -0.336 . . . . 63.1 111.848 -175.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -164.29 -42.57 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 122.425 0.29 . . . . 53.32 111.382 -173.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 172' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.34 120.95 12.0 Favored 'General case' 0 CA--C 1.555 1.142 0 O-C-N 123.69 0.619 . . . . 73.22 110.614 -178.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 173' ' ' LEU . . . . . . . . . . . . . 4.6 tt -107.67 102.51 11.74 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 108.492 -0.929 . . . . 74.23 108.492 -173.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 174' ' ' GLN . . . . . 0.58 ' H ' HG22 ' B' ' 168' ' ' VAL . 0.9 OUTLIER -102.29 99.03 9.08 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 107.584 -1.265 . . . . 74.45 107.584 177.415 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 175' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -122.67 18.12 10.34 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.688 0.795 . . . . 74.1 109.723 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . 57.94 87.05 0.07 Allowed 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.665 1.186 . . . . 74.11 110.715 -172.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 177' ' ' THR . . . . . 0.416 HG22 ' HG3' ' C' ' 129' ' ' GLU . 15.2 t -71.8 -31.9 1.94 Allowed Pre-proline 0 CA--C 1.574 1.889 0 CA-C-O 117.287 -1.339 . . . . 64.31 113.923 -178.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 178' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -86.29 -163.81 0.19 Allowed 'Trans proline' 0 C--N 1.402 3.373 0 CA-C-N 122.875 2.062 . . . . 74.53 111.957 174.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -52.24 -51.61 57.33 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.465 0.706 . . . . 61.34 109.979 171.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . -176.92 -57.57 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 105.869 -1.9 . . . . 74.4 105.869 170.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 46.1 tp -142.75 123.18 13.95 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 106.35 -1.722 . . . . 62.04 106.35 163.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 182' ' ' VAL . . . . . 0.7 ' HB ' ' HB2' ' C' ' 123' ' ' LEU . 69.5 t -68.67 131.94 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.064 0.546 . . . . 71.31 110.817 -172.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -119.54 16.78 12.91 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.767 0.827 . . . . 65.24 112.264 -172.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 184' ' ' HIS . . . . . . . . . . . . . 28.5 m-70 -62.18 100.39 0.17 Allowed 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 122.789 0.436 . . . . 74.15 111.138 -178.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 185' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' C' ' 121' ' ' ALA . 60.6 t -68.04 151.63 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.826 0.851 . . . . 71.33 110.102 177.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 186' ' ' THR . . . . . 0.452 ' HB ' ' HG2' ' C' ' 122' ' ' GLU . 15.0 t -125.87 172.25 10.04 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.889 0.875 . . . . 51.31 110.576 -177.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 187' ' ' SER . . . . . . . . . . . . . 20.7 m -83.93 134.35 34.67 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.824 0.85 . . . . 62.14 112.437 -170.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 188' ' ' ARG . . . . . 0.451 ' HD3' ' HD2' ' C' ' 120' ' ' ARG . 59.8 ttt85 -173.61 160.95 3.87 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.828 1.251 . . . . 71.52 108.739 177.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -141.31 112.9 7.61 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 108.726 -0.842 . . . . 72.52 108.726 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 190' ' ' CYS . . . . . . . . . . . . . 6.8 p -177.35 -176.89 0.66 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.806 1.242 . . . . 70.33 109.878 173.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -163.79 168.97 18.96 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.654 1.182 . . . . 74.04 109.511 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . 0.665 ' HA3' HD21 ' B' ' 203' ' ' ASN . . . -80.79 147.67 28.11 Favored Glycine 0 CA--C 1.54 1.624 0 CA-C-O 118.835 -0.981 . . . . 64.22 113.025 -179.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 193' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -52.63 -44.55 46.69 Favored 'Trans proline' 0 C--N 1.382 2.34 0 C-N-CA 124.609 3.539 . . . . 64.32 115.491 -173.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 194' ' ' SER . . . . . . . . . . . . . 9.0 m 78.33 88.16 0.07 Allowed 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 125.382 1.473 . . . . 24.51 112.509 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 195' ' ' ALA . . . . . . . . . . . . . . . -162.05 106.19 1.2 Allowed 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 123.606 0.762 . . . . 74.32 110.613 178.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 196' ' ' THR . . . . . 0.602 HG22 ' H ' ' B' ' 197' ' ' SER . 2.2 m 60.86 -150.06 0.41 Allowed 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 124.821 1.248 . . . . 73.32 110.793 174.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 197' ' ' SER . . . . . 0.602 ' H ' HG22 ' B' ' 196' ' ' THR . 37.3 m -58.0 104.6 0.21 Allowed 'General case' 0 C--N 1.363 1.186 0 CA-C-N 119.245 0.93 . . . . 75.11 109.676 172.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 198' ' ' GLU . . . . . 0.558 ' HG3' ' HD3' ' B' ' 201' ' ' PRO . 35.8 tp10 -69.8 -24.45 63.49 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 113.714 1.005 . . . . 51.12 113.714 -163.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt 69.43 2.64 3.81 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 124.265 1.026 . . . . 74.4 112.925 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 200' ' ' CYS . . . . . 0.456 ' HB3' ' HA2' ' C' ' 172' ' ' GLY . 69.8 m 60.71 79.36 0.29 Allowed Pre-proline 0 CA--C 1.566 1.59 0 C-N-CA 124.261 1.024 . . . . 73.31 112.453 177.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 201' ' ' PRO . . . . . 0.558 ' HD3' ' HG3' ' B' ' 198' ' ' GLU . 29.1 Cg_endo -97.88 16.96 0.56 Allowed 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 123.788 2.992 . . . . 71.34 112.963 177.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 116.95 79.59 0.74 Allowed Glycine 0 C--N 1.338 0.672 0 N-CA-C 110.745 -0.942 . . . . 63.04 110.745 -173.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 203' ' ' ASN . . . . . 0.665 HD21 ' HA3' ' B' ' 192' ' ' GLY . 18.8 m120 -144.41 -138.52 0.1 Allowed 'General case' 0 CA--C 1.572 1.822 0 C-N-CA 123.942 0.897 . . . . 71.33 109.441 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 204' ' ' ALA . . . . . 0.954 ' HA ' ' HA3' ' C' ' 166' ' ' GLY . . . -74.34 -172.13 1.36 Allowed 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 115.585 1.698 . . . . 74.01 115.585 -169.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 205' ' ' LEU . . . . . 0.551 ' HG ' ' NH1' ' C' ' 143' ' ' ARG . 0.5 OUTLIER -83.76 -92.73 0.07 Allowed 'General case' 0 CA--C 1.578 2.021 0 C-N-CA 124.962 1.305 . . . . 51.03 112.047 -165.182 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 206' ' ' GLU . . . . . 0.407 ' HG2' ' HZ ' ' C' ' 88' ' ' PHE . 6.0 tp10 2.47 93.32 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 128.346 2.658 . . . . 62.32 117.193 -157.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm 52.3 -176.87 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 125.574 1.55 . . . . 74.32 114.613 165.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . -115.99 -59.53 0.33 Allowed Glycine 0 C--N 1.339 0.697 0 N-CA-C 110.258 -1.137 . . . . 71.52 110.258 169.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 124.73 -168.41 16.85 Favored Glycine 0 C--N 1.341 0.842 0 CA-C-O 119.372 -0.682 . . . . 42.21 111.582 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp 69.07 -64.28 0.34 Allowed 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 125.492 1.517 . . . . 74.51 113.113 176.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . -53.92 103.64 0.18 Allowed Glycine 0 C--N 1.356 1.662 0 O-C-N 123.409 0.443 . . . . 74.43 112.62 177.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 48.9 m -110.76 -2.87 16.02 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.788 1.235 . . . . 74.04 111.635 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 21.8 pt -82.05 116.98 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-O 121.219 0.533 . . . . 64.4 110.661 179.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 37.0 p -143.05 -38.79 0.34 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.624 1.17 . . . . 75.43 109.085 174.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 215' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -58.98 -48.69 80.64 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.709 0.804 . . . . 73.31 110.45 179.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 46.32 29.84 0.92 Allowed 'General case' 0 N--CA 1.5 2.044 0 C-N-CA 126.238 1.815 . . . . 61.42 113.588 172.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 64.3 tp -71.57 88.89 0.95 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.541 0.736 . . . . 75.4 111.029 -173.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . 0.476 HD22 ' N ' ' B' ' 221' ' ' ARG . 1.8 tt 75.58 -48.76 0.61 Allowed 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 126.336 1.854 . . . . 71.43 111.086 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 39.4 t30 76.92 -66.3 0.25 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 126.2 1.8 . . . . 71.24 110.164 178.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -60.06 -23.93 64.15 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.884 0.874 . . . . 61.1 112.473 177.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 221' ' ' ARG . . . . . 0.476 ' N ' HD22 ' B' ' 218' ' ' LEU . 26.1 mmt180 67.62 6.34 4.94 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 124.69 1.196 . . . . 73.55 112.819 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -172.71 165.85 5.39 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.72 1.208 . . . . 42.52 109.999 -178.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 71.15 -69.02 0.19 Allowed 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 125.737 1.615 . . . . 61.02 112.485 173.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 41.0 t 70.07 -73.45 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 125.777 1.631 . . . . 74.2 110.217 -175.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 8.8 t -144.81 13.85 1.51 Allowed 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.936 0.895 . . . . 54.34 110.043 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . 0.537 HD13 ' HG ' ' B' ' 163' ' ' LEU . 8.4 mp 67.83 -74.97 0.07 Allowed 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 125.647 1.579 . . . . 74.43 110.56 -177.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . -133.35 -5.14 3.03 Favored Glycine 0 N--CA 1.476 1.303 0 C-N-CA 122.946 0.308 . . . . 51.31 113.249 177.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 90.64 165.93 40.66 Favored Glycine 0 C--N 1.345 1.063 0 CA-C-N 116.562 0.181 . . . . 72.41 112.998 -179.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . 61.9 60.63 7.75 Favored Glycine 0 C--N 1.347 1.175 0 O-C-N 123.881 0.401 . . . . 70.24 112.489 -178.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . 0.676 ' HA ' ' HA ' ' B' ' 160' ' ' ALA . . . -147.05 104.62 3.7 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.261 0.625 . . . . 70.23 109.555 -172.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 231' ' ' LYS . . . . . 0.641 ' HB3' ' HB ' ' B' ' 170' ' ' THR . 0.0 OUTLIER -120.37 -51.38 2.19 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.247 0.619 . . . . 73.24 112.466 -165.039 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 72.9 p -66.62 129.14 38.86 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.312 0.645 . . . . 74.24 112.2 -168.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -77.28 129.72 36.24 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.87 0.868 . . . . 70.41 109.431 178.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -110.29 81.86 1.5 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.131 0.572 . . . . 72.31 112.517 -171.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -134.79 76.96 1.66 Allowed 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 106.779 -1.563 . . . . 54.41 106.779 165.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 236' ' ' THR . . . . . 0.52 ' HA ' ' HG3' ' B' ' 46' ' ' ARG . 63.5 m 71.04 -67.14 0.26 Allowed 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 124.837 1.255 . . . . 73.34 109.014 -164.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -133.07 -163.73 1.39 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.849 1.26 . . . . 71.12 107.628 170.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 90.8 m -75.14 -16.24 60.54 Favored 'General case' 0 CA--C 1.56 1.348 0 C-N-CA 123.185 0.594 . . . . 71.31 110.148 170.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -88.95 168.1 12.66 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 113.88 1.067 . . . . 74.42 113.88 -176.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 240' ' ' GLY . . . . . 0.567 ' H ' HD22 ' C' ' 235' ' ' LEU . . . -102.44 -118.79 4.48 Favored Glycine 0 C--N 1.34 0.766 0 CA-C-N 112.94 -1.936 . . . . 71.23 110.543 176.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -161.11 -179.49 7.53 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-O 121.705 0.764 . . . . 71.21 110.334 174.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 242' ' ' TRP . . . . . 0.438 ' CZ3' HG21 ' C' ' 253' ' ' VAL . 2.6 m0 -106.17 -52.57 2.78 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 106.468 -1.678 . . . . 70.32 106.468 174.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 243' ' ' GLN . . . . . 0.403 ' CD ' HH21 ' C' ' 231' ' ' ARG . 5.1 pt20 179.76 -152.13 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.139 0 CA-C-N 112.987 -1.915 . . . . 74.22 107.802 -167.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -62.02 116.31 9.18 Favored Glycine 0 CA--C 1.542 1.751 0 CA-C-N 117.785 0.266 . . . . 63.11 113.629 175.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? -105.8 105.59 15.69 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.052 0.941 . . . . 75.34 108.886 179.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 21.8 m -76.71 143.71 39.81 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 109.116 -0.698 . . . . 71.02 109.116 171.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 247' ' ' LEU . . . . . . . . . . . . . 3.9 pp -116.41 137.24 52.32 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 119.464 1.029 . . . . 72.51 111.861 178.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 248' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 177.12 94.73 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 126.433 1.893 . . . . 75.15 107.236 172.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.77 -39.22 90.89 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.563 1.145 . . . . 71.33 112.66 -179.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 172.29 -76.95 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.519 1.128 . . . . 65.4 109.913 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 251' ' ' ALA . . . . . . . . . . . . . . . -168.46 49.71 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.437 1.095 . . . . 61.03 108.766 -170.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . 0.595 HE21 ' HB3' ' B' ' 367' ' ' LEU . 22.9 tt0 -68.45 -10.92 58.57 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 114.636 -1.165 . . . . 72.3 111.582 -178.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 253' ' ' ALA . . . . . 0.541 ' HA ' HD13 ' B' ' 367' ' ' LEU . . . -56.56 -33.51 66.21 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.405 0.682 . . . . 51.41 110.709 172.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 28.6 tpt180 -84.97 141.93 29.99 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 123.031 0.532 . . . . 72.51 110.489 173.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . 141.05 -86.94 0.19 Allowed Glycine 0 C--N 1.351 1.374 0 N-CA-C 111.465 -0.654 . . . . 54.22 111.465 177.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 256' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 63.12 -78.02 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 125.569 1.548 . . . . 52.52 112.36 177.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -68.2 -27.22 66.2 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.644 0.778 . . . . 74.31 110.545 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 258' ' ' LEU . . . . . . . . . . . . . 6.0 tt 68.55 -77.92 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 125.67 1.588 . . . . 75.13 108.37 -175.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . 0.522 ' HA ' ' HG3' ' B' ' 357' ' ' PRO . 8.3 p -88.85 155.3 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 C-N-CA 123.55 0.74 . . . . 63.02 110.016 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 260' ' ' SER . . . . . . . . . . . . . 48.0 m -73.91 85.65 1.75 Allowed 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 122.665 0.386 . . . . 73.11 110.633 176.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 26.7 t70 59.46 -86.52 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 125.306 1.442 . . . . 52.21 112.502 176.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 262' ' ' ALA . . . . . . . . . . . . . . . -118.82 131.1 56.08 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.903 0.881 . . . . 43.43 110.659 -174.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 263' ' ' ALA . . . . . 0.424 ' HB3' HG21 ' B' ' 259' ' ' VAL . . . -162.24 -32.19 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.79 0.836 . . . . 70.44 110.486 179.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 20.6 t 74.88 -69.62 0.17 Allowed 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 125.41 1.484 . . . . 51.14 111.327 174.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 265' ' ' LEU . . . . . . . . . . . . . 2.9 pp -122.19 5.34 9.75 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.977 0.911 . . . . 64.12 110.444 173.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 266' ' ' ASN . . . . . 0.451 ' ND2' ' H ' ' B' ' 267' ' ' SER 0.255 2.1 p-10 47.35 -76.87 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 126.634 1.974 . . . . 71.52 113.374 -166.092 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 267' ' ' SER . . . . . 0.451 ' H ' ' ND2' ' B' ' 266' ' ' ASN . 36.8 p -164.41 22.39 0.06 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.651 0.78 . . . . 73.13 109.71 -173.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 28.7 m -140.36 162.94 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.684 0.794 . . . . 74.44 110.106 -174.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 269' ' ' THR . . . . . . . . . . . . . 12.1 p -140.84 22.61 2.28 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.838 0.855 . . . . 74.31 109.744 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 270' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -102.76 101.38 11.46 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.404 0.681 . . . . 72.41 111.306 -175.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 271' ' ' ALA . . . . . . . . . . . . . . . -78.29 -35.14 48.34 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.312 0.645 . . . . 75.3 110.432 169.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 272' ' ' ASN . . . . . 0.575 ' HB2' ' HB3' ' B' ' 61' ' ' ASP . 41.3 m-80 -127.47 137.64 52.73 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.775 0.83 . . . . 54.14 109.722 178.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 273' ' ' GLN . . . . . 0.611 ' HG2' ' HA ' ' B' ' 64' ' ' ALA . 7.3 tp-100 63.82 138.13 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 125.533 1.533 . . . . 61.32 112.413 -173.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 72.7 -61.83 0.49 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.439 1.496 . . . . 71.44 109.997 -176.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 275' ' ' LYS . . . . . 0.43 ' HE3' ' HA ' ' B' ' 272' ' ' ASN . 92.4 mttt 45.79 47.66 4.32 Favored Pre-proline 0 N--CA 1.486 1.326 0 C-N-CA 125.264 1.426 . . . . 71.33 111.471 175.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 276' ' ' PRO . . . . . 0.406 ' O ' ' HB2' ' B' ' 355' ' ' ALA . 4.8 Cg_exo -74.09 90.53 0.97 Allowed 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 122.357 2.038 . . . . 62.35 111.106 -166.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 277' ' ' LEU . . . . . . . . . . . . . 75.3 mt -106.29 7.9 31.58 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 114.719 -1.128 . . . . 63.32 109.311 175.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 90.8 mt -98.87 131.7 44.77 Favored 'General case' 0 C--N 1.351 0.634 0 C-N-CA 123.962 0.905 . . . . 62.0 109.655 177.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . -129.44 38.12 2.06 Favored Glycine 0 C--N 1.332 0.343 0 N-CA-C 109.276 -1.53 . . . . 75.43 109.276 176.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 88.5 mt -55.8 -40.72 73.08 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.622 1.169 . . . . 53.23 110.523 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -136.38 144.27 44.46 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 108.365 -0.976 . . . . 75.31 108.365 172.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -126.24 167.48 15.39 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.505 0.722 . . . . 65.41 111.258 -176.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 70.01 -72.99 0.1 Allowed 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 125.6 1.56 . . . . 72.33 111.726 175.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . -78.38 74.27 2.1 Favored Glycine 0 C--N 1.351 1.38 0 C-N-CA 122.546 0.117 . . . . 61.45 113.35 -177.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -135.16 -71.02 0.48 Allowed 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.765 -0.828 . . . . 72.41 108.765 178.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 286' ' ' MET . . . . . . . . . . . . . 96.5 mmm -92.61 -45.48 0.33 Allowed Pre-proline 0 N--CA 1.486 1.342 0 CA-C-O 118.788 -0.625 . . . . 64.1 110.647 175.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 287' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -87.06 -170.05 0.57 Allowed 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 121.673 1.582 . . . . 73.33 112.012 165.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 288' ' ' VAL . . . . . . . . . . . . . 38.6 t 62.05 -84.53 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 125.198 1.399 . . . . 74.32 110.096 -174.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 289' ' ' ARG . . . . . . . . . . . . . 52.5 ttp180 53.81 87.14 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.085 1.354 . . . . 72.14 111.735 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 290' ' ' TRP . . . . . . . . . . . . . 42.9 p90 -76.81 159.0 30.45 Favored 'General case' 0 C--O 1.246 0.878 0 C-N-CA 122.779 0.432 . . . . 75.34 110.006 175.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 291' ' ' LEU . . . . . . . . . . . . . 9.2 mp -77.86 -47.72 18.13 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.967 0.507 . . . . 64.34 109.852 -178.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . 121.46 -73.33 0.36 Allowed Glycine 0 CA--C 1.533 1.17 0 CA-C-O 119.42 -0.656 . . . . 62.12 111.994 -176.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 293' ' ' PRO . . . . . 0.48 ' HG3' ' SD ' ' B' ' 464' ' ' MET . 6.2 Cg_exo -75.78 108.45 2.69 Favored 'Trans proline' 0 C--N 1.383 2.381 0 C-N-CA 122.405 2.07 . . . . 51.12 111.247 179.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -61.64 -41.13 97.07 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 109.109 -0.701 . . . . 41.23 109.109 173.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -129.26 113.41 14.98 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.24 -0.891 . . . . 34.32 108.605 168.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 75.2 m -73.51 83.78 1.51 Allowed 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 109.11 -0.7 . . . . 65.42 109.11 175.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -158.13 140.7 14.55 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 114.825 -1.08 . . . . 64.12 108.734 -179.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 22.3 m170 -135.93 -172.24 3.06 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.741 1.216 . . . . 71.5 109.456 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . 72.37 34.36 60.76 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.074 -0.81 . . . . 63.41 111.074 -168.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -149.72 -42.48 0.14 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.076 0.55 . . . . 72.23 111.954 -175.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 301' ' ' ILE . . . . . . . . . . . . . 14.9 tt -128.61 16.55 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-O 121.974 0.892 . . . . 72.24 110.833 -170.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -81.27 -24.88 37.0 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.805 0.842 . . . . 63.41 111.737 -172.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 303' ' ' LYS . . . . . . . . . . . . . 4.7 ttmp? 62.13 83.34 0.21 Allowed Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 124.791 1.237 . . . . 74.11 110.49 -175.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 304' ' ' PRO . . . . . 0.741 ' HA ' ' HB ' ' B' ' 307' ' ' THR . 33.5 Cg_exo -61.37 -10.44 15.96 Favored 'Trans proline' 0 C--N 1.383 2.367 0 C-N-CA 123.533 2.822 . . . . 75.12 113.939 178.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -62.05 -40.07 94.5 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.586 0.755 . . . . 42.33 111.24 172.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 34.7 m -121.67 33.02 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 123.619 0.768 . . . . 72.33 110.054 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . 0.741 ' HB ' ' HA ' ' B' ' 304' ' ' PRO . 8.9 t -58.01 -31.68 67.2 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.512 1.125 . . . . 74.23 113.424 -176.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 308' ' ' CYS . . . . . . . . . . . . . 49.7 t -86.84 -28.7 22.74 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.185 0.594 . . . . 74.22 110.562 177.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . 0.454 ' HB ' ' HD3' ' B' ' 310' ' ' PRO 0.261 36.5 m 105.1 -62.93 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.867 0 C-N-CA 128.19 2.596 . . . . 72.2 111.825 -174.405 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 310' ' ' PRO . . . . . 0.454 ' HD3' ' HB ' ' B' ' 309' ' ' THR . 37.5 Cg_exo -60.98 114.97 2.4 Favored 'Trans proline' 0 C--N 1.393 2.908 0 CA-C-N 122.232 1.833 . . . . 63.14 113.612 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 311' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -78.7 -34.02 0.95 Allowed Pre-proline 0 CA--C 1.57 1.742 0 CA-C-O 116.949 -1.5 . . . . 73.13 114.644 176.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 312' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -75.78 75.57 3.99 Favored 'Trans proline' 0 C--N 1.404 3.474 0 CA-C-N 123.186 2.173 . . . . 70.14 112.465 -175.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 313' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -50.15 -46.87 54.35 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.892 1.677 . . . . 75.13 112.049 -171.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 314' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 -70.56 82.54 0.59 Allowed 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.159 0.984 . . . . 72.01 112.18 -176.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 315' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -161.86 43.96 0.15 Allowed 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 122.593 1.187 . . . . 72.12 107.858 178.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 316' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -148.53 -42.79 0.15 Allowed 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 114.439 -1.255 . . . . 74.4 112.087 -164.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 51.1 m 56.99 33.88 24.04 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 124.144 0.978 . . . . 75.41 111.446 -176.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 318' ' ' VAL . . . . . . . . . . . . 0.253 7.4 p 36.83 87.21 0.12 Allowed Pre-proline 0 CA--C 1.564 1.493 0 C-N-CA 126.706 2.002 . . . . 73.13 112.281 -167.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 319' ' ' PRO . . . . . 0.415 ' HG2' ' H ' ' B' ' 423' ' ' SER . 24.3 Cg_exo -64.77 -26.1 60.5 Favored 'Trans proline' 0 C--N 1.388 2.655 0 C-N-CA 123.274 2.649 . . . . 65.1 113.293 -173.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 320' ' ' THR . . . . . . . . . . . . . 19.3 m 59.74 80.76 0.19 Allowed 'General case' 0 C--N 1.354 0.768 0 O-C-N 124.612 1.195 . . . . 53.31 109.363 -173.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 321' ' ' LEU . . . . . . . . . . . . . 60.4 mt -64.25 -55.8 19.0 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 114.858 -1.065 . . . . 65.14 110.213 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 322' ' ' ALA . . . . . . . . . . . . . . . 56.75 22.66 7.13 Favored 'General case' 0 CA--C 1.553 1.091 0 CA-C-N 114.677 -1.147 . . . . 64.54 110.933 -172.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 323' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -77.45 76.46 3.99 Favored 'General case' 0 C--N 1.359 0.991 0 C-N-CA 123.834 0.854 . . . . 74.02 109.554 -178.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 324' ' ' MET . . . . . . . . . . . . . 21.9 ptp -103.54 -21.94 13.69 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.147 0.979 . . . . 71.32 110.366 -178.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 325' ' ' THR . . . . . . . . . . . . . 31.9 m -75.98 97.06 3.9 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.137 0.575 . . . . 72.33 110.224 178.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 326' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -67.34 136.09 54.28 Favored 'General case' 0 C--N 1.351 0.649 0 C-N-CA 123.272 0.629 . . . . 72.01 110.091 175.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -134.43 17.48 3.67 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.062 0.945 . . . . 54.34 109.541 178.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 328' ' ' ALA . . . . . 0.409 ' HB2' HD23 ' B' ' 439' ' ' LEU . . . -99.95 -44.43 6.04 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.405 -0.816 . . . . 72.03 111.173 -175.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 329' ' ' ILE . . . . . . . . . . . . . 35.5 mm 61.73 81.8 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 C-N-CA 124.776 1.23 . . . . 73.5 109.348 -175.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 330' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 71.41 137.81 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 126.189 1.796 . . . . 63.42 111.211 -176.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 331' ' ' LEU . . . . . 0.494 HD13 ' HA ' ' B' ' 438' ' ' GLN . 50.3 tp -70.0 -58.68 3.55 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.564 -0.744 . . . . 63.34 110.227 -179.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 332' ' ' LEU . . . . . 0.443 HD22 ' HG ' ' B' ' 331' ' ' LEU . 4.1 mm? -106.86 -147.47 0.41 Allowed 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 108.348 -0.982 . . . . 74.41 108.348 171.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 333' ' ' SER . . . . . 0.433 ' HB2' ' OE1' ' B' ' 457' ' ' GLN . 8.7 t 82.92 24.84 0.14 Allowed 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 125.361 1.464 . . . . 65.04 110.867 174.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -97.43 24.96 6.04 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.045 0.938 . . . . 63.11 110.419 178.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 335' ' ' ASN . . . . . . . . . . . . . 60.7 t30 57.19 69.58 0.73 Allowed 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.853 0.861 . . . . 73.25 109.726 179.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 17.0 mp0 -57.56 -68.1 0.27 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.595 1.158 . . . . 61.02 110.884 -170.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 337' ' ' LYS . . . . . 0.43 ' HG2' ' H ' ' B' ' 339' ' ' PHE . 22.3 ttmm 174.0 141.13 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 125.352 1.461 . . . . 62.43 108.798 167.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 338' ' ' GLY . . . . . . . . . . . . . . . -79.38 5.98 58.65 Favored Glycine 0 CA--C 1.536 1.355 0 CA-C-O 119.234 -0.759 . . . . 72.34 114.96 -177.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 339' ' ' PHE . . . . . 0.43 ' H ' ' HG2' ' B' ' 337' ' ' LYS . 49.1 p90 -156.28 147.22 22.07 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 118.289 1.044 . . . . 74.33 111.019 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 340' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -131.56 -71.22 0.56 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.156 0.582 . . . . 75.24 111.091 -175.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 341' ' ' LEU . . . . . . . . . . . . . 1.7 pp -64.58 -25.8 68.13 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 112.473 0.545 . . . . 75.34 112.473 -171.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 342' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 74.2 -15.48 0.6 Allowed 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 125.565 1.546 . . . . 64.25 112.171 172.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 343' ' ' VAL . . . . . . . . . . . . . 13.3 t 60.46 32.92 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.42 0 C-N-CA 124.444 1.098 . . . . 64.24 108.394 -167.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -62.66 130.68 46.08 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.312 1.045 . . . . 73.03 110.786 -176.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 345' ' ' GLY . . . . . . . . . . . . . . . -147.55 -21.03 0.09 OUTLIER Glycine 0 C--N 1.345 1.043 0 O-C-N 123.406 0.441 . . . . 62.31 113.161 -175.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 346' ' ' ALA . . . . . . . . . . . . . . . -73.77 151.94 40.48 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 117.362 0.581 . . . . 72.22 111.784 -177.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 19.9 t 77.29 -43.88 0.43 Allowed 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 126.068 1.747 . . . . 72.21 112.239 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 61.1 mt -85.2 -42.73 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.829 0.852 . . . . 73.42 110.312 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 349' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 64.67 -82.51 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.676 1.59 . . . . 71.13 110.881 -173.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 350' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -129.23 -87.41 0.53 Allowed 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.001 -0.74 . . . . 74.52 109.001 178.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 48.26 85.16 0.03 OUTLIER 'General case' 0 C--N 1.362 1.151 0 C-N-CA 124.452 1.101 . . . . 71.32 110.526 -171.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -53.74 -25.68 19.85 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.186 0.995 . . . . 74.35 113.352 -171.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 353' ' ' HIS . . . . . . . . . . . . . 49.8 m80 76.41 -35.35 0.24 Allowed 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 125.416 1.486 . . . . 74.33 111.568 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 354' ' ' ALA . . . . . . . . . . . . . . . -62.87 97.05 0.1 Allowed 'General case' 0 C--O 1.242 0.686 0 C-N-CA 124.149 0.98 . . . . 70.11 110.26 168.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 355' ' ' ALA . . . . . 0.406 ' HB2' ' O ' ' B' ' 276' ' ' PRO . . . -72.42 -77.85 0.09 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.523 -0.762 . . . . 75.44 110.825 -179.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 356' ' ' ASN . . . . . 0.506 ' HB3' ' HD3' ' B' ' 357' ' ' PRO . 27.4 t-20 173.78 -58.76 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.336 0 C-N-CA 125.045 1.338 . . . . 74.32 109.31 -176.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 357' ' ' PRO . . . . . 0.522 ' HG3' ' HA ' ' B' ' 259' ' ' VAL . 4.5 Cg_endo -102.07 -174.22 0.1 Allowed 'Trans proline' 0 C--N 1.393 2.92 0 C-N-CA 122.678 2.252 . . . . 55.22 113.5 -175.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 358' ' ' CYS . . . . . . . . . . . . . 60.3 m -99.82 60.81 1.11 Allowed 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 108.978 -0.749 . . . . 73.32 108.978 170.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 359' ' ' GLY . . . . . . . . . . . . . . . -76.71 77.71 1.42 Allowed Glycine 0 C--N 1.349 1.254 0 CA-C-N 114.813 -1.085 . . . . 62.01 112.968 -176.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 360' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -117.93 149.68 40.49 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.43 0.692 . . . . 53.34 110.58 -178.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 361' ' ' ILE . . . . . . . . . . . . . 16.4 tt -159.16 155.26 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.931 0.892 . . . . 61.31 108.629 -178.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 362' ' ' GLY . . . . . . . . . . . . . . . -127.26 -106.12 1.38 Allowed Glycine 0 C--N 1.348 1.23 0 C-N-CA 121.6 -0.333 . . . . 72.35 113.296 -178.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 363' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -75.07 -19.78 59.82 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.831 0.852 . . . . 73.13 112.327 -171.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 364' ' ' THR . . . . . 0.52 HG23 HG23 ' B' ' 365' ' ' VAL . 3.8 t 55.34 168.28 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 126.484 1.914 . . . . 74.04 113.862 -173.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 365' ' ' VAL . . . . . 0.52 HG23 HG23 ' B' ' 364' ' ' THR . 58.6 t 70.05 140.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 125.475 1.51 . . . . 74.01 111.896 -178.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 2.3 p30 32.78 53.34 0.35 Allowed 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 126.47 1.908 . . . . 50.12 114.428 178.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 367' ' ' LEU . . . . . 0.595 ' HB3' HE21 ' B' ' 252' ' ' GLN . 3.1 pp -57.08 -16.7 8.02 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 124.0 0.92 . . . . 75.05 113.367 179.049 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 368' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -58.2 -60.92 3.0 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.982 1.713 . . . . 71.23 111.397 178.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 369' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 52.62 -100.7 0.1 Allowed 'General case' 0 CA--C 1.564 1.49 0 C-N-CA 124.988 1.315 . . . . 70.1 109.34 -168.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 370' ' ' ALA . . . . . . . . . . . . . . . 176.43 -70.65 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 124.668 1.187 . . . . 74.25 110.551 176.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 371' ' ' VAL . . . . . . . . . . . . . 29.5 t -110.71 -18.25 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 C-N-CA 123.519 0.728 . . . . 74.11 112.266 -167.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 372' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -71.96 86.31 1.0 Allowed 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 120.959 0.409 . . . . 63.2 111.751 -176.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 373' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -162.37 157.71 23.0 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.499 1.12 . . . . 72.05 108.715 170.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -78.16 156.74 29.7 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.312 0.645 . . . . 71.45 112.554 -170.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 375' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -144.81 160.01 41.95 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.65 1.18 . . . . 62.01 108.932 -177.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 376' ' ' GLU . . . . . 0.425 ' HA ' ' HG3' ' A' ' 263' ' ' PRO . 2.9 mp0 -64.07 -32.39 73.93 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.371 0.669 . . . . 73.13 111.218 -174.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 377' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -65.26 100.65 0.48 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.829 0.852 . . . . 73.31 110.067 177.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 378' ' ' ALA . . . . . . . . . . . . . . . -87.53 0.75 55.13 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 115.353 -0.839 . . . . 61.1 111.602 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt 75.34 -57.65 0.59 Allowed 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 125.831 1.652 . . . . 72.01 111.095 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 380' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.21 157.37 29.36 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 108.974 -0.75 . . . . 53.14 108.974 170.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 381' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -84.18 22.24 1.25 Allowed 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 123.702 0.801 . . . . 74.34 110.908 -176.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . 71.81 3.58 55.69 Favored Glycine 0 C--N 1.352 1.467 0 C-N-CA 122.84 0.257 . . . . 73.1 112.741 -171.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 383' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -93.69 99.1 11.58 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.015 0.926 . . . . 73.1 110.487 -173.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 384' ' ' THR . . . . . . . . . . . . . 35.8 p -108.12 -56.48 2.24 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.522 -0.918 . . . . 63.41 108.522 174.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 62.59 150.35 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 126.029 1.731 . . . . 75.12 113.589 178.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 386' ' ' VAL . . . . . 0.654 HG21 ' HD2' ' B' ' 415' ' ' LYS . 7.7 p 47.05 23.78 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.606 0 C-N-CA 126.774 2.03 . . . . 62.42 113.609 178.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 387' ' ' ILE . . . . . . . . . . . . . 34.8 mm 57.37 -74.35 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 125.21 1.404 . . . . 74.12 110.867 -172.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 388' ' ' VAL . . . . . 0.52 HG13 HG13 ' B' ' 386' ' ' VAL 0.285 4.3 m 46.47 -102.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 125.856 1.662 . . . . 54.33 111.979 -171.371 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 389' ' ' THR . . . . . 0.452 ' H ' HG23 ' B' ' 388' ' ' VAL . 45.2 p -94.89 -34.87 12.26 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 109.348 -0.612 . . . . 71.25 109.348 173.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . 57.51 69.69 0.72 Allowed 'General case' 0 C--O 1.245 0.825 0 C-N-CA 125.418 1.487 . . . . 70.34 109.794 -174.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 391' ' ' ASP . . . . . . . . . . . . . 14.4 t70 74.08 -66.01 0.32 Allowed 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 113.35 -1.75 . . . . 64.12 109.319 -170.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 392' ' ' HIS . . . . . 0.526 ' HD2' ' HB3' ' B' ' 404' ' ' LYS . 16.2 t-80 -157.21 -21.72 0.09 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.19 0.596 . . . . 72.42 110.478 174.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -69.44 76.12 0.39 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.302 1.041 . . . . 61.53 113.502 -167.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 81.5 t60 173.08 126.14 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 126.287 1.835 . . . . 73.31 107.5 177.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . 54.97 60.88 3.21 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 124.085 0.866 . . . . 71.44 110.096 -174.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 78.5 p -70.21 83.47 0.54 Allowed 'General case' 0 CA--C 1.555 1.152 0 CA-C-N 114.089 -1.414 . . . . 75.55 112.128 -169.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 397' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -174.62 -28.93 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 125.024 1.33 . . . . 71.41 108.425 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 9.1 tt -42.57 -46.41 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 C-N-CA 125.085 1.354 . . . . 75.44 113.089 -174.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 399' ' ' VAL . . . . . . . . . . . . . 13.9 t -132.29 72.56 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 N-CA-C 107.888 -1.152 . . . . 73.32 107.888 170.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 400' ' ' ALA . . . . . . . . . . . . . . . -71.0 -43.41 13.4 Favored Pre-proline 0 CA--C 1.563 1.455 0 N-CA-C 114.103 1.149 . . . . 51.41 114.103 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 401' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -52.31 114.01 1.46 Allowed 'Trans proline' 0 C--N 1.397 3.083 0 C-N-CA 122.335 2.023 . . . . 71.04 113.254 179.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 12.9 t70 66.89 -85.15 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 125.058 1.343 . . . . 74.34 110.775 -179.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 403' ' ' THR . . . . . . . . . . . . . 34.4 p -150.25 -156.98 0.77 Allowed 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 125.601 1.56 . . . . 51.3 107.73 178.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 404' ' ' LYS . . . . . 0.526 ' HB3' ' HD2' ' B' ' 392' ' ' HIS . 0.0 OUTLIER -84.09 -9.37 58.66 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.53 0.332 . . . . 70.03 111.733 168.697 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 405' ' ' ALA . . . . . . . . . . . . . . . -60.81 -32.31 10.86 Favored Pre-proline 0 CA--C 1.563 1.472 0 N-CA-C 114.237 1.199 . . . . 71.24 114.237 -177.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 406' ' ' PRO . . . . . . . . . . . . . 0.7 OUTLIER -33.85 -39.41 0.14 Allowed 'Trans proline' 0 C--N 1.393 2.883 0 C-N-CA 123.734 2.956 . . . . 44.44 115.472 163.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . 130.67 142.22 5.06 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-N 116.495 -0.32 . . . . 55.33 112.912 172.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 408' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -156.08 136.82 13.38 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 124.299 1.039 . . . . 72.03 108.539 177.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 9.7 t -134.8 -29.35 1.16 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.469 0.708 . . . . 73.52 110.881 -178.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 410' ' ' GLN . . . . . . . . . . . . . 65.2 tp60 -121.74 81.76 1.86 Allowed 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.217 0.607 . . . . 51.32 110.371 -175.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . -95.4 -82.93 0.37 Allowed 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 106.985 -1.487 . . . . 63.14 106.985 164.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 54.9 tp 54.73 -78.41 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.357 1.463 . . . . 60.41 112.642 176.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 17.8 m120 60.91 -161.26 0.29 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 125.176 1.39 . . . . 71.14 110.591 -177.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 414' ' ' THR . . . . . . . . . . . . . 52.6 p -84.22 38.21 0.65 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.645 0.778 . . . . 73.24 109.93 171.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 415' ' ' LYS . . . . . 0.654 ' HD2' HG21 ' B' ' 386' ' ' VAL . 55.3 mtmt 52.47 46.2 27.13 Favored 'General case' 0 C--N 1.356 0.856 0 C-N-CA 124.846 1.259 . . . . 73.42 110.792 -164.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 31.5 t70 58.22 -97.98 0.08 Allowed 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 112.781 -2.009 . . . . 75.33 110.686 -178.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 417' ' ' GLY . . . . . 0.43 ' O ' ' HD2' ' A' ' 211' ' ' ARG . . . -105.85 34.46 5.74 Favored Glycine 0 C--N 1.345 1.03 0 N-CA-C 111.894 -0.482 . . . . 43.15 111.894 179.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 418' ' ' ALA . . . . . . . . . . . . . . . 72.68 -66.74 0.29 Allowed 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 125.535 1.534 . . . . 70.25 110.926 -175.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 419' ' ' VAL . . . . . . . . . . . . . 57.4 t 64.45 -71.86 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 C-N-CA 125.652 1.581 . . . . 62.03 112.32 176.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 420' ' ' MET . . . . . 0.552 ' HB2' HG23 ' B' ' 386' ' ' VAL . 27.2 ttt -46.21 -26.62 0.82 Allowed 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 125.823 1.649 . . . . 73.12 113.175 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 421' ' ' VAL . . . . . . . . . . . . . 21.2 t -77.26 63.13 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.347 0 CA-C-O 121.906 0.86 . . . . 72.42 109.777 175.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 422' ' ' MET . . . . . 0.46 ' HB3' ' NH2' ' A' ' 211' ' ' ARG . 19.6 ptp -141.97 -4.22 1.06 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.087 1.355 . . . . 74.1 109.795 176.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 423' ' ' SER . . . . . 0.44 ' HB3' ' HB3' ' B' ' 426' ' ' ASN . 16.3 m 76.46 -24.99 0.21 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 125.919 1.688 . . . . 62.22 112.559 -176.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 424' ' ' TYR . . . . . . . . . . . . . 31.0 t80 73.16 -71.65 0.13 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.948 1.299 . . . . 72.42 109.948 173.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . -150.91 16.67 0.93 Allowed Glycine 0 CA--C 1.532 1.115 0 CA-C-N 116.265 -0.425 . . . . 75.12 112.358 172.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 426' ' ' ASN . . . . . 0.44 ' HB3' ' HB3' ' B' ' 423' ' ' SER . 29.2 t-20 -66.15 -45.13 82.06 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.275 1.03 . . . . 75.43 112.263 -172.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 427' ' ' SER . . . . . 0.666 ' HB3' ' HA ' ' B' ' 431' ' ' SER . 26.8 t -71.7 121.68 19.29 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 109.003 -0.74 . . . . 75.14 109.003 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -55.26 -61.13 2.53 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.228 1.411 . . . . 73.23 113.889 -161.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 429' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -84.0 79.45 9.49 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.056 0.542 . . . . 63.42 110.658 -174.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 38.7 t70 54.94 37.93 29.6 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 124.068 0.947 . . . . 55.41 111.457 171.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 431' ' ' SER . . . . . 0.666 ' HA ' ' HB3' ' B' ' 427' ' ' SER . 29.7 t 66.63 -79.18 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.379 1.072 . . . . 73.31 110.27 -166.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 432' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 64.67 7.68 3.96 Favored 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 124.018 0.927 . . . . 71.1 111.995 179.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 433' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -69.67 -22.73 63.42 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.687 0.795 . . . . 73.43 111.47 -177.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 434' ' ' HIS . . . . . . . . . . . . . 61.3 t-80 72.13 168.71 0.31 Allowed 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 124.953 1.301 . . . . 65.13 112.113 171.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 435' ' ' THR . . . . . 0.507 ' O ' ' HG ' ' B' ' 439' ' ' LEU . 53.2 m 82.38 -54.54 0.21 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.344 1.858 . . . . 73.42 111.861 174.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . -53.54 -67.41 2.15 Favored Glycine 0 N--CA 1.481 1.695 0 CA-C-N 118.519 0.599 . . . . 43.54 113.994 -174.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 23.9 m -64.84 -23.33 67.2 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.279 0.632 . . . . 54.14 111.82 177.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 438' ' ' GLN . . . . . 0.494 ' HA ' HD13 ' B' ' 331' ' ' LEU . 22.8 mp0 -79.7 -23.3 42.48 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.2 1.0 . . . . 71.55 111.248 -172.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 439' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' B' ' 435' ' ' THR . 93.8 mt -79.85 35.83 0.32 Allowed 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.651 0.781 . . . . 74.24 111.205 177.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 440' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -67.7 169.7 9.07 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 123.643 0.777 . . . . 70.1 112.108 -174.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 441' ' ' ILE . . . . . 0.609 HD12 ' HA ' ' A' ' 223' ' ' VAL . 47.2 mt -95.02 140.33 17.0 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 CA-C-N 114.748 -1.115 . . . . 74.15 109.731 177.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 442' ' ' ALA . . . . . . . . . . . . . . . -83.76 -80.99 0.18 Allowed 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 108.751 -0.833 . . . . 71.41 108.751 172.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 443' ' ' ALA . . . . . 0.498 ' HB3' ' HG3' ' A' ' 224' ' ' PRO . . . 56.73 -85.08 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 125.464 1.506 . . . . 74.21 113.173 173.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 31.4 p90 -167.49 -160.78 0.37 Allowed 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.959 0.904 . . . . 65.34 110.32 -177.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . 137.72 -89.05 0.21 Allowed Glycine 0 C--N 1.347 1.163 0 CA-C-O 119.75 -0.472 . . . . 74.34 111.972 174.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 446' ' ' PRO . . . . . 0.411 ' HD3' ' HG2' ' A' ' 225' ' ' PRO . 48.6 Cg_endo -97.77 -163.34 0.07 OUTLIER 'Trans proline' 0 C--N 1.368 1.578 0 C-N-CA 123.151 2.567 . . . . 63.02 110.616 168.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 447' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -144.92 51.17 1.24 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 122.274 1.035 . . . . 60.0 108.997 170.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . 176.24 142.61 0.07 Allowed 'General case' 0 C--O 1.24 0.569 0 CA-C-N 112.416 -2.174 . . . . 74.31 106.822 172.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 449' ' ' ALA . . . . . . . . . . . . . . . -169.63 -58.16 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 122.078 0.942 . . . . 61.52 108.721 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 450' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -120.32 172.11 8.04 Favored 'General case' 0 CA--C 1.552 1.042 0 CA-C-N 113.681 -1.599 . . . . 61.12 108.228 178.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 67.4 t 78.45 -57.58 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 C-N-CA 125.598 1.559 . . . . 63.1 110.771 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 452' ' ' VAL . . . . . . . . . . . . . 28.3 m -62.88 -26.89 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 123.853 0.861 . . . . 60.45 112.168 175.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . -69.74 -27.48 73.21 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-O 119.905 -0.386 . . . . 73.44 113.074 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 454' ' ' LEU . . . . . . . . . . . . . 87.2 mt 61.85 21.39 12.22 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 124.499 1.119 . . . . 72.5 110.691 -175.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . 0.417 ' HB ' HD23 ' B' ' 460' ' ' LEU . 38.5 p -100.14 151.8 20.99 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 124.288 1.035 . . . . 61.41 110.566 -176.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -70.32 146.59 50.43 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.372 0.669 . . . . 74.3 109.982 -177.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 457' ' ' GLN . . . . . 0.433 ' OE1' ' HB2' ' B' ' 333' ' ' SER . 47.8 mt-30 -100.44 4.14 43.56 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.274 0.842 . . . . 42.14 113.274 -166.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 36.2 p -66.3 -56.02 13.21 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 118.445 0.566 . . . . 72.13 109.563 177.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 459' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -161.28 82.05 0.62 Allowed 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.21 -0.905 . . . . 73.31 109.921 178.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 460' ' ' LEU . . . . . 0.417 HD23 ' HB ' ' B' ' 455' ' ' THR . 23.9 tp -163.98 -86.71 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.49 -0.777 . . . . 65.42 109.535 175.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 65.94 -63.9 0.22 Allowed 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 125.08 1.352 . . . . 62.31 111.899 -175.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 20.8 t80 66.09 54.51 0.98 Allowed 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 125.465 1.506 . . . . 72.53 110.728 174.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 62.1 m -74.42 86.15 2.01 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 115.147 -0.933 . . . . 61.35 110.199 174.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 464' ' ' MET . . . . . 0.48 ' SD ' ' HG3' ' B' ' 293' ' ' PRO . 24.9 ttt -120.76 144.05 48.48 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 107.974 -1.121 . . . . 75.31 107.974 178.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? 77.12 -38.87 0.31 Allowed 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 125.342 1.457 . . . . 72.15 112.525 -177.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -67.82 -20.31 65.16 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.726 0.81 . . . . 62.32 112.248 178.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . -84.62 0.87 48.6 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 123.883 0.873 . . . . 75.3 111.613 175.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 468' ' ' LEU . . . . . 0.616 ' HA ' ' HG2' ' C' ' 266' ' ' GLU . 67.5 tp -113.19 112.07 23.14 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.619 1.168 . . . . 45.51 108.761 179.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 469' ' ' GLY . . . . . . . . . . . . . . . 74.3 144.38 0.89 Allowed Glycine 0 C--N 1.351 1.394 0 O-C-N 123.311 0.382 . . . . 50.44 112.887 -176.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 470' ' ' LEU . . . . . . . . . . . . . 6.6 tt -85.98 -48.25 8.85 Favored 'General case' 0 N--CA 1.485 1.275 0 O-C-N 121.868 -0.783 . . . . 73.2 109.081 176.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 471' ' ' LYS . . . . . . . . . . . . . 11.1 tmtt? . . . . . 0 CA--C 1.557 1.218 0 N-CA-C 107.119 -1.437 . . . . 74.2 107.119 -165.295 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 70.8 mtm . . . . . 0 N--CA 1.477 0.882 0 N-CA-C 110.738 -0.097 . . . . 55.23 110.738 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . 0.451 ' HA ' ' HD1' ' C' ' 96' ' ' PHE . . . 65.33 41.32 4.38 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.714 1.206 . . . . 65.31 112.039 174.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -75.79 72.83 2.72 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.554 0.741 . . . . 52.01 109.798 175.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -37.91 123.8 1.1 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.237 1.815 . . . . 70.52 114.951 -174.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 22.3 mmtp -93.53 122.68 36.22 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.6 -0.727 . . . . 63.2 109.591 166.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -82.65 86.18 6.89 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 107.48 -1.304 . . . . 63.22 107.48 170.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 7' ' ' TYR . . . . . 0.437 ' HB3' ' HA ' ' C' ' 53' ' ' ALA . 73.9 m-85 -61.61 -35.12 76.95 Favored 'General case' 0 C--O 1.244 0.764 0 CA-C-N 114.341 -1.299 . . . . 73.43 111.198 -176.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -60.26 -46.86 88.34 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.584 -0.735 . . . . 72.53 110.113 175.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.55 -39.19 92.83 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.888 0.475 . . . . 52.31 111.27 179.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 69.0 mt -57.86 -39.79 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 122.984 0.513 . . . . 63.34 110.704 174.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 11' ' ' LEU . . . . . 0.509 HD13 HG23 ' C' ' 22' ' ' ILE . 67.9 mt -79.92 -17.13 53.85 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 122.898 0.479 . . . . 45.45 112.068 176.059 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.66 26.7 45.22 Favored Glycine 0 CA--C 1.537 1.445 0 N-CA-C 113.887 0.315 . . . . 64.33 113.887 -178.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 12.3 m -120.0 156.83 54.11 Favored Pre-proline 0 CA--C 1.555 1.167 0 C-N-CA 124.76 1.224 . . . . 64.04 110.069 178.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.62 164.03 36.79 Favored 'Trans proline' 0 C--N 1.383 2.357 0 C-N-CA 122.85 2.366 . . . . 74.43 112.283 177.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -70.03 8.06 0.82 Allowed 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 114.068 1.136 . . . . 71.52 114.068 -174.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -128.01 16.13 6.79 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.508 0.723 . . . . 71.24 109.432 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.5 123.44 19.23 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.354 1.062 . . . . 71.14 110.788 178.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 76.0 p -74.0 177.18 5.83 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.303 0.641 . . . . 74.41 111.003 -177.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.46 -55.44 21.92 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 124.269 1.028 . . . . 74.45 111.191 -171.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -67.9 -29.11 68.12 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.393 0.677 . . . . 64.05 112.008 -174.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -71.16 -47.37 58.14 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-O 121.12 0.486 . . . . 73.42 110.682 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 22' ' ' ILE . . . . . 0.767 HD13 ' HB3' ' C' ' 57' ' ' LEU . 82.3 mt -57.89 -44.01 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 124.447 1.099 . . . . 61.32 110.27 172.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 23' ' ' LYS . . . . . 0.446 ' HG2' ' HE2' ' C' ' 27' ' ' LYS . 79.1 tttt -66.35 -35.86 81.43 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 113.723 -1.58 . . . . 74.13 111.257 -176.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 27.2 mtm180 -78.95 -33.84 44.96 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 123.323 0.649 . . . . 73.52 111.463 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.98 -44.61 95.56 Favored 'General case' 0 C--O 1.257 1.482 0 CA-C-O 121.812 0.815 . . . . 75.32 110.032 173.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 26' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -60.95 -57.89 10.72 Favored 'General case' 0 C--O 1.201 -1.48 0 CA-C-N 113.797 -1.547 . . . . 72.31 110.125 175.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . 0.446 ' HE2' ' HG2' ' C' ' 23' ' ' LYS . 49.9 mtmt -54.8 -35.55 64.0 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 123.698 0.799 . . . . 74.1 111.142 -176.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 39.7 ttp180 -57.13 -57.77 11.14 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.026 0.531 . . . . 71.15 109.75 172.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . 0.623 ' HB3' HD13 ' C' ' 50' ' ' ILE . 95.5 mt -74.71 -14.84 60.78 Favored 'General case' 0 CA--C 1.557 1.229 0 CA-C-N 115.686 -0.688 . . . . 60.22 112.586 -177.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.32 -23.46 19.26 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.376 1.07 . . . . 75.32 111.129 -176.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -88.86 -35.98 16.25 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 109.041 -0.726 . . . . 73.5 109.041 171.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.45 -50.1 55.01 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 122.996 0.518 . . . . 71.12 109.759 -178.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 33' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -97.43 25.8 5.39 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.886 0.474 . . . . 70.15 111.178 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 34' ' ' HIS . . . . . . . . . . . . . 13.2 t-160 -59.92 106.87 0.83 Allowed Pre-proline 0 N--CA 1.487 1.406 0 CA-C-O 118.708 -0.663 . . . . 72.34 111.324 -173.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.06 -22.49 69.7 Favored 'Trans proline' 0 C--N 1.383 2.355 0 C-N-CA 123.351 2.701 . . . . 71.32 113.233 -172.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -70.08 -36.48 74.95 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.782 0.833 . . . . 60.34 111.094 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 62.1 t -98.81 -57.54 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 CA-C-O 121.676 0.75 . . . . 75.33 109.266 -179.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -94.0 79.49 4.1 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 124.836 1.254 . . . . 54.22 107.979 -178.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -75.59 78.85 2.59 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-N 113.738 -1.574 . . . . 62.24 109.196 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 26.7 m -132.54 107.09 13.1 Favored Pre-proline 0 C--O 1.236 0.352 0 N-CA-C 108.35 -0.981 . . . . 74.14 108.35 178.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . 0.431 ' O ' ' HG2' ' C' ' 45' ' ' GLU . 48.0 Cg_exo -42.02 -45.7 7.13 Favored 'Trans proline' 0 C--N 1.386 2.512 0 C-N-CA 123.814 3.009 . . . . 63.44 113.308 178.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -59.92 -41.16 91.14 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.672 0.789 . . . . 65.44 111.481 -179.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.89 -27.34 65.7 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 115.678 -0.692 . . . . 62.05 109.956 178.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 44' ' ' GLU . . . . . 0.473 ' O ' ' HG3' ' C' ' 48' ' ' LYS . 38.5 mt-10 -79.2 -27.72 42.58 Favored 'General case' 0 C--O 1.215 -0.759 0 O-C-N 123.827 0.704 . . . . 74.04 109.508 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 45' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' C' ' 41' ' ' PRO . 29.6 mm-40 -70.78 -48.08 56.16 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.636 0.774 . . . . 42.53 110.344 177.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 46' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -57.89 -42.77 85.32 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 114.8 -1.091 . . . . 72.32 109.484 172.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -65.62 -30.15 70.82 Favored 'General case' 0 C--O 1.213 -0.834 0 CA-C-N 115.04 -0.982 . . . . 62.23 111.202 178.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 48' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' C' ' 44' ' ' GLU . 92.8 mttt -64.89 -43.42 92.94 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.057 0.543 . . . . 72.04 110.384 174.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -61.9 -39.69 92.86 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.595 0.712 . . . . 72.33 111.221 177.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 50' ' ' ILE . . . . . 0.623 HD13 ' HB3' ' C' ' 29' ' ' LEU . 79.0 mt -67.35 -34.1 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 CA-C-N 115.018 -0.992 . . . . 75.43 110.468 173.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 51' ' ' ASN . . . . . 0.515 ' HB3' ' CD1' ' C' ' 88' ' ' PHE . 70.8 m-20 -76.92 -17.06 59.17 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.586 1.154 . . . . 74.04 111.408 177.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -75.48 -51.27 13.39 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 108.103 -1.073 . . . . 63.42 108.103 171.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . 0.437 ' HA ' ' HB3' ' C' ' 7' ' ' TYR . . . -55.3 -38.15 68.29 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 113.752 -1.567 . . . . 63.1 111.518 174.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -80.9 -29.87 35.55 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.132 0.973 . . . . 75.01 110.454 178.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.56 -28.21 66.93 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 123.17 0.588 . . . . 60.54 110.559 174.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 21.1 t -92.02 -45.31 14.34 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.166 0 CA-C-N 115.285 -0.871 . . . . 72.43 112.023 175.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 57' ' ' LEU . . . . . 0.767 ' HB3' HD13 ' C' ' 22' ' ' ILE . 87.3 mt -104.52 4.58 33.19 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 115.584 1.698 . . . . 75.02 115.584 -163.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 38.6 t -66.71 -74.55 0.11 Allowed 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 118.56 0.618 . . . . 62.42 112.414 -177.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -66.6 140.97 96.72 Favored Pre-proline 0 C--N 1.349 0.571 0 N-CA-C 108.7 -0.852 . . . . 72.03 108.7 176.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 60' ' ' PRO . . . . . 0.46 ' O ' ' HG2' ' C' ' 64' ' ' ARG . 18.1 Cg_endo -58.29 -27.75 82.05 Favored 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 122.067 1.845 . . . . 33.23 111.013 174.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -65.01 -52.23 57.24 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.541 0.736 . . . . 62.13 111.418 175.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 62' ' ' LYS . . . . . 0.557 ' HD3' ' HB3' ' C' ' 84' ' ' ASP . 46.4 mtmt -66.06 -36.49 83.35 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 121.163 0.506 . . . . 75.23 110.72 -178.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 45.0 ttt-85 -57.44 -46.06 84.0 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.14 -0.936 . . . . 64.42 108.74 175.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 64' ' ' ARG . . . . . 0.46 ' HG2' ' O ' ' C' ' 60' ' ' PRO . 24.0 mmt180 -68.75 -24.65 64.47 Favored 'General case' 0 C--O 1.213 -0.823 0 CA-C-N 115.442 -0.799 . . . . 74.15 111.999 177.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 65' ' ' ILE . . . . . 0.543 HG12 ' HG2' ' C' ' 76' ' ' PRO . 78.4 mt -60.89 -45.28 98.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 108.906 -0.776 . . . . 62.34 108.906 171.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -60.86 -51.38 69.57 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 115.146 -0.933 . . . . 74.22 109.95 174.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -58.01 -40.0 79.69 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.605 0.762 . . . . 73.14 111.862 -177.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 63.5 p -74.64 -24.83 58.89 Favored 'General case' 0 C--O 1.217 -0.615 0 CA-C-O 119.288 -0.387 . . . . 63.2 110.339 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -75.28 120.12 20.32 Favored 'General case' 0 C--N 1.356 0.868 0 N-CA-C 108.653 -0.869 . . . . 75.22 108.653 174.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.55 24.87 22.59 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.293 -0.723 . . . . 62.51 111.293 -169.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 56.8 m -145.62 -62.49 0.33 Allowed 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 103.269 -2.863 . . . . 72.34 103.269 171.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 23.6 m -85.1 148.67 26.02 Favored 'General case' 0 C--O 1.254 1.29 0 N-CA-C 105.458 -2.052 . . . . 73.35 105.458 157.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.94 -28.56 15.11 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.273 0.629 . . . . 73.23 110.703 176.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -87.56 136.97 32.43 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 123.594 0.757 . . . . 53.23 110.253 178.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -68.51 127.59 15.85 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.435 2.09 . . . . 75.14 110.495 175.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 76' ' ' PRO . . . . . 0.543 ' HG2' HG12 ' C' ' 65' ' ' ILE . 9.8 Cg_endo -51.87 132.87 43.8 Favored 'Trans proline' 0 C--N 1.387 2.602 0 C-N-CA 123.058 2.505 . . . . 63.14 111.741 177.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -48.08 128.54 16.94 Favored 'Trans proline' 0 C--N 1.387 2.585 0 C-N-CA 123.877 3.051 . . . . 51.51 114.101 -169.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 78' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -67.95 154.72 72.08 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 122.383 2.055 . . . . 74.44 111.574 178.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.97 156.39 39.14 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.398 2.065 . . . . 61.04 111.439 170.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -54.75 85.56 0.03 OUTLIER 'Trans proline' 0 C--N 1.388 2.645 0 C-N-CA 123.367 2.712 . . . . 51.5 113.13 177.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 153.17 -42.11 0.66 Allowed Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 114.032 -1.44 . . . . 75.2 110.492 -179.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 137.54 169.44 11.63 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-N 115.151 -0.525 . . . . 74.45 112.1 178.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -57.93 148.81 24.52 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.008 0.923 . . . . 70.14 110.36 172.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 84' ' ' ASP . . . . . 0.557 ' HB3' ' HD3' ' C' ' 62' ' ' LYS . 18.0 t0 -57.32 130.82 47.95 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 123.739 0.649 . . . . 63.13 111.88 -179.114 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 85' ' ' PHE . . . . . 0.497 ' CD1' ' HB2' ' C' ' 88' ' ' PHE . 0.3 OUTLIER -148.91 32.97 0.76 Allowed 'General case' 0 C--O 1.241 0.624 0 O-C-N 123.625 0.578 . . . . 74.41 111.543 -170.808 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 86' ' ' SER . . . . . 0.592 ' HA ' ' O ' ' C' ' 169' ' ' ASN . 18.3 m -70.89 93.75 1.0 Allowed 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.286 -0.87 . . . . 45.43 112.721 -169.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 86.62 10.02 74.01 Favored Glycine 0 C--N 1.346 1.112 0 CA-C-N 114.796 -1.093 . . . . 74.33 113.306 177.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 88' ' ' PHE . . . . . 0.525 ' HB3' ' HE2' ' C' ' 93' ' ' PHE . 10.2 m-85 -92.62 138.18 31.72 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 108.384 -0.969 . . . . 74.44 108.384 -176.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -84.32 76.63 10.1 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 122.029 -0.42 . . . . 72.23 110.799 -168.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 90' ' ' VAL . . . . . 0.414 HG23 HD22 ' C' ' 105' ' ' LEU . 4.2 p -43.46 -55.53 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 C-N-CA 125.177 1.391 . . . . 54.41 114.594 -176.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -70.76 -19.71 62.69 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.52 0.328 . . . . 74.21 111.813 -173.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -87.64 -23.0 24.38 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 110.221 -0.289 . . . . 75.53 110.221 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 93' ' ' PHE . . . . . 0.525 ' HE2' ' HB3' ' C' ' 88' ' ' PHE . 11.9 m-30 -72.35 171.86 11.42 Favored 'General case' 0 C--N 1.352 0.683 0 N-CA-C 113.314 0.857 . . . . 72.45 113.314 -168.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 49.7 m -60.24 150.51 29.93 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 114.288 -1.324 . . . . 45.51 112.463 -172.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 95' ' ' GLU . . . . . 0.425 ' O ' ' HG3' ' C' ' 99' ' ' GLU . 0.0 OUTLIER -66.38 -45.05 81.37 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.448 0.699 . . . . 55.43 110.854 -178.542 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 96' ' ' PHE . . . . . 0.451 ' HD1' ' HA ' ' C' ' 2' ' ' ALA . 33.2 t80 -52.09 -44.41 64.38 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.556 1.142 . . . . 65.02 110.946 172.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 97' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -66.56 -39.7 88.65 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 114.118 -1.401 . . . . 64.25 110.605 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -76.66 -9.7 58.85 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.644 0.778 . . . . 51.52 112.037 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . 0.425 ' HG3' ' O ' ' C' ' 95' ' ' GLU . 51.1 mt-10 -90.28 -47.02 8.03 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.916 0.486 . . . . 74.43 111.102 169.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 25.6 tp -66.6 -50.0 64.48 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.844 0.858 . . . . 73.23 110.808 -176.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -92.54 -1.23 57.09 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.664 -0.698 . . . . 73.25 111.257 177.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -45.47 -61.42 3.69 Favored Glycine 0 C--N 1.356 1.68 0 CA-C-O 118.769 -1.017 . . . . 54.11 114.704 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -46.66 -18.8 0.57 Allowed 'Trans proline' 0 C--N 1.391 2.808 0 C-N-CA 124.511 3.474 . . . . 62.02 114.735 179.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -150.62 53.32 0.5 Allowed Glycine 0 C--N 1.347 1.163 0 CA-C-O 119.894 -0.392 . . . . 43.23 112.728 177.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 105' ' ' LEU . . . . . 0.414 HD22 HG23 ' C' ' 90' ' ' VAL . 32.6 mt -67.4 20.74 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.268 0 N-CA-C 113.94 1.089 . . . . 73.03 113.94 172.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 69.99 -167.03 0.17 Allowed 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 126.687 1.995 . . . . 64.24 113.132 169.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . 106.54 -6.18 38.39 Favored Glycine 0 C--N 1.346 1.098 0 CA-C-N 115.958 -0.565 . . . . 51.05 111.775 -163.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 67.58 -125.86 23.81 Favored Glycine 0 C--N 1.347 1.17 0 N-CA-C 112.035 -0.426 . . . . 74.41 112.035 177.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 109' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -82.12 -8.2 59.65 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 122.88 0.472 . . . . 74.45 110.981 175.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 110' ' ' GLY . . . . . . . . . . . . . . . -89.95 -32.02 10.39 Favored Glycine 0 C--N 1.345 1.061 0 N-CA-C 111.929 -0.468 . . . . 54.22 111.929 177.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . 0.427 ' HD3' ' O ' ' C' ' 111' ' ' ARG . 0.5 OUTLIER 69.7 -18.03 0.22 Allowed 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 125.404 1.482 . . . . 75.25 112.908 176.749 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 112' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -78.98 18.19 0.66 Allowed 'General case' 0 CA--C 1.563 1.46 0 C-N-CA 123.985 0.914 . . . . 74.1 111.65 -174.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 113' ' ' SER . . . . . . . . . . . . . 53.5 m 50.32 38.04 16.73 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.514 0.725 . . . . 72.53 111.685 -177.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.03 -168.39 2.21 Favored 'General case' 0 C--O 1.21 -1.004 0 CA-C-N 115.491 -0.777 . . . . 74.05 110.816 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 115' ' ' LYS . . . . . 0.496 ' HA ' ' HD2' ' C' ' 170' ' ' PRO . 15.4 tptm -53.81 141.86 25.73 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.231 1.012 . . . . 54.14 112.892 -170.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 116' ' ' GLY . . . . . 0.429 ' HA3' ' N ' ' B' ' 204' ' ' ALA . . . -55.45 128.89 45.54 Favored Glycine 0 C--N 1.367 2.258 0 N-CA-C 110.197 -1.161 . . . . 45.25 110.197 167.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 117' ' ' ARG . . . . . 0.438 ' O ' ' HA2' ' C' ' 166' ' ' GLY . 49.8 ttp180 -88.19 116.62 26.52 Favored 'General case' 0 C--O 1.253 1.246 0 N-CA-C 108.96 -0.755 . . . . 64.44 108.96 177.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -40.8 120.58 1.32 Allowed 'General case' 0 N--CA 1.483 1.189 0 O-C-N 124.465 1.103 . . . . 75.42 109.908 175.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 119' ' ' LEU . . . . . . . . . . . . . 13.5 tp -94.81 154.36 17.3 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 118.687 -1.205 . . . . 75.21 108.289 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.451 ' HD2' ' HD3' ' B' ' 188' ' ' ARG . 0.0 OUTLIER -143.49 112.71 6.77 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 105.823 -1.917 . . . . 72.31 105.823 -175.403 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 121' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' B' ' 185' ' ' VAL . . . -132.38 116.52 16.95 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 109.002 -0.74 . . . . 63.21 109.002 -177.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 122' ' ' GLU . . . . . 0.504 ' HA ' ' O ' ' C' ' 177' ' ' VAL . 13.8 pt-20 -88.91 131.44 35.13 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 109.357 -0.609 . . . . 73.22 109.357 178.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 123' ' ' LEU . . . . . 0.7 ' HB2' ' HB ' ' B' ' 182' ' ' VAL . 2.6 pt? -134.86 124.37 16.63 Favored Pre-proline 0 N--CA 1.478 0.964 0 N-CA-C 111.89 0.33 . . . . 73.3 111.89 -170.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . 0.451 ' HD2' HG11 ' B' ' 182' ' ' VAL . 16.2 Cg_exo -68.95 117.84 5.29 Favored 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 122.924 2.416 . . . . 72.51 110.314 170.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 125' ' ' LEU . . . . . 0.487 HD23 HG11 ' C' ' 153' ' ' VAL . 42.9 tp -143.68 146.77 33.46 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 122.896 0.479 . . . . 74.03 109.785 -169.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 126' ' ' THR . . . . . 0.486 HG23 HD12 ' C' ' 181' ' ' LEU . 34.0 p -93.93 166.75 12.02 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.753 0.787 . . . . 61.53 110.379 171.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 127' ' ' LEU . . . . . 0.549 HD21 HD13 ' C' ' 180' ' ' LEU . 15.2 mt -71.25 -37.7 71.94 Favored 'General case' 0 C--O 1.249 1.065 0 CA-C-N 114.04 -1.436 . . . . 62.25 109.358 178.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 11.2 mp0 -61.36 -49.87 75.19 Favored 'General case' 0 C--O 1.216 -0.696 0 CA-C-N 113.085 -1.871 . . . . 75.24 109.134 178.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 129' ' ' GLU . . . . . 0.691 ' HA ' ' HB2' ' C' ' 132' ' ' HIS . 28.7 mm-40 -81.52 -7.48 59.59 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 123.848 0.717 . . . . 73.53 111.562 178.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -68.6 -46.34 69.58 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 109.478 -0.564 . . . . 64.34 109.478 166.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 131' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -67.11 -51.27 56.31 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 115.719 -0.673 . . . . 75.55 110.426 169.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 132' ' ' HIS . . . . . 0.691 ' HB2' ' HA ' ' C' ' 129' ' ' GLU . 30.6 m170 -74.06 -1.17 18.95 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.694 0.798 . . . . 60.22 111.604 -174.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -63.3 -101.37 0.01 OUTLIER Glycine 0 C--N 1.352 1.453 0 N-CA-C 111.365 -0.694 . . . . 65.31 111.365 165.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 134' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' C' ' 148' ' ' ARG . . . 53.74 -108.49 0.83 Allowed Glycine 0 C--N 1.349 1.253 0 N-CA-C 111.61 -0.596 . . . . 53.24 111.61 -177.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -77.13 95.99 4.38 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.173 -1.047 . . . . 71.2 108.173 174.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 136' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.29 138.53 47.88 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 123.755 0.822 . . . . 72.12 109.291 -174.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 137' ' ' VAL . . . . . . . . . . . . . 34.0 m -86.61 131.54 34.51 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 N-CA-C 109.181 -0.674 . . . . 71.12 109.181 174.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 138' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' C' ' 144' ' ' ARG . 7.6 p -133.96 143.74 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.22 1.008 . . . . 72.14 108.464 -176.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 139' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -123.47 82.99 2.07 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.237 0.541 . . . . 74.31 109.813 176.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 140' ' ' VAL . . . . . 0.563 HG11 ' HG2' ' C' ' 164' ' ' MET . 6.9 p -96.34 137.21 24.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 115.299 -0.864 . . . . 63.22 109.226 176.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 55.93 28.27 12.37 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 123.978 0.911 . . . . 15.23 111.701 -177.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 72.2 31.19 64.12 Favored Glycine 0 C--N 1.35 1.338 0 CA-C-N 116.343 -0.39 . . . . 45.25 113.394 -179.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 143' ' ' ARG . . . . . 0.551 ' NH1' ' HG ' ' B' ' 205' ' ' LEU . 55.5 ttt180 -128.03 104.3 7.71 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.561 0.744 . . . . 73.04 109.632 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 144' ' ' ARG . . . . . 0.419 ' HA ' ' O ' ' C' ' 138' ' ' VAL . 49.1 ttt180 -85.35 107.42 17.34 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.618 0.767 . . . . 71.51 110.845 -178.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 145' ' ' VAL . . . . . . . . . . . . . 22.7 t -123.05 140.98 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.534 0.734 . . . . 75.03 110.187 178.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 20.0 m -83.13 96.0 8.26 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 108.88 -0.785 . . . . 54.21 108.88 168.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 29.4 m -98.73 157.93 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 123.528 0.731 . . . . 72.53 109.839 -178.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 148' ' ' ARG . . . . . 0.461 HH22 ' HB3' ' C' ' 243' ' ' PRO . 62.8 ttt180 -116.73 94.5 4.63 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 108.638 -0.875 . . . . 74.22 108.638 167.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 149' ' ' ILE . . . . . . . . . . . . . 19.4 pt -79.03 150.94 75.54 Favored Pre-proline 0 N--CA 1.476 0.863 0 N-CA-C 107.818 -1.179 . . . . 71.41 107.818 170.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -53.82 120.85 8.56 Favored 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 122.092 1.861 . . . . 61.44 110.875 176.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -60.04 98.39 0.12 Allowed 'Trans proline' 0 C--N 1.386 2.515 0 C-N-CA 122.509 2.139 . . . . 73.2 110.204 177.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 152' ' ' GLY . . . . . 0.433 ' HA2' ' CZ ' ' C' ' 240' ' ' PHE . . . 147.63 145.34 4.16 Favored Glycine 0 C--N 1.347 1.18 0 CA-C-N 115.943 -0.572 . . . . 54.32 113.35 -172.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 153' ' ' VAL . . . . . 0.487 HG11 HD23 ' C' ' 125' ' ' LEU . 2.9 p -159.99 155.07 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.314 0 N-CA-C 112.708 0.633 . . . . 71.13 112.708 172.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 154' ' ' ARG . . . . . . . . . . . . . 16.7 ttm180 -120.72 132.07 54.87 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.626 1.57 . . . . 75.32 109.089 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 155' ' ' GLU . . . . . 0.579 ' HB2' HD12 ' C' ' 180' ' ' LEU . 8.3 tp10 -41.61 127.65 3.14 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 124.779 1.232 . . . . 74.51 112.887 175.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 74.04 0.76 57.6 Favored Glycine 0 C--N 1.352 1.429 0 N-CA-C 114.44 0.536 . . . . 64.51 114.44 173.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 157' ' ' SER . . . . . . . . . . . . . 36.1 t -92.71 155.52 17.65 Favored 'General case' 0 C--O 1.255 1.365 0 CA-C-O 121.519 0.676 . . . . 75.43 109.877 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 158' ' ' VAL . . . . . 0.578 HG12 HG22 ' C' ' 177' ' ' VAL . 29.7 m -99.54 122.0 50.84 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 CA-C-N 114.209 -1.36 . . . . 64.44 110.086 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 159' ' ' ILE . . . . . 0.664 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 31.7 mt -80.22 105.14 9.46 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 N-CA-C 107.198 -1.408 . . . . 52.25 107.198 170.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 62.0 ttm-85 -74.33 99.25 3.43 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 107.658 -1.238 . . . . 72.21 107.658 173.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 161' ' ' VAL . . . . . . . . . . . . . 2.4 p -117.48 101.97 52.28 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 124.301 1.041 . . . . 75.24 109.736 -178.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.69 145.46 81.41 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.106 1.87 . . . . 63.42 110.144 168.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 99.36 4.05 56.34 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-O 119.468 -0.629 . . . . 53.31 113.857 -176.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 164' ' ' MET . . . . . 0.588 ' SD ' HD23 ' C' ' 174' ' ' LEU . 19.1 ttm -144.42 5.75 1.25 Allowed 'General case' 0 CA--C 1.559 1.293 0 CA-C-N 117.668 0.734 . . . . 73.35 112.698 -174.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . -129.43 177.56 17.93 Favored Glycine 0 N--CA 1.488 2.143 0 CA-C-O 118.421 -1.211 . . . . 64.24 113.203 177.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 166' ' ' GLY . . . . . 0.954 ' HA3' ' HA ' ' B' ' 204' ' ' ALA . . . 98.28 106.11 2.54 Favored Glycine 0 C--N 1.364 2.087 0 CA-C-N 119.636 1.718 . . . . 75.44 116.366 176.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 167' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -99.98 100.18 11.04 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 105.87 -1.9 . . . . 64.31 105.87 160.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . 163.12 -139.11 5.7 Favored Glycine 0 C--O 1.208 -1.521 0 CA-C-O 119.188 -0.784 . . . . 13.44 112.521 -169.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 169' ' ' ASN . . . . . 0.623 ' HB3' ' HD3' ' C' ' 170' ' ' PRO . 2.1 t30 -145.3 -66.05 0.02 OUTLIER Pre-proline 0 CA--C 1.574 1.87 0 CA-C-O 116.846 -1.55 . . . . 62.44 111.254 -176.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 170' ' ' PRO . . . . . 0.623 ' HD3' ' HB3' ' C' ' 169' ' ' ASN . 73.9 Cg_exo -54.12 142.45 66.43 Favored 'Trans proline' 0 C--N 1.405 3.528 0 CA-C-N 124.046 2.481 . . . . 51.41 112.897 174.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 171' ' ' PRO . . . . . 0.541 ' HA ' ' HB3' ' B' ' 204' ' ' ALA . 60.9 Cg_endo -85.18 150.55 10.7 Favored 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 123.424 2.749 . . . . 74.02 115.22 -161.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 172' ' ' GLY . . . . . 0.556 ' HA3' ' H ' ' B' ' 203' ' ' ASN . . . -160.96 -109.3 0.24 Allowed Glycine 0 C--N 1.357 1.71 0 CA-C-O 118.629 -1.095 . . . . 74.42 113.495 177.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 173' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -173.56 171.94 3.76 Favored 'General case' 0 C--O 1.263 1.785 0 CA-C-O 123.782 1.753 . . . . 74.51 115.19 -168.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 174' ' ' LEU . . . . . 0.588 HD23 ' SD ' ' C' ' 164' ' ' MET . 9.9 tp -110.89 143.25 41.81 Favored 'General case' 0 C--N 1.353 0.723 0 CA-C-N 112.008 -2.36 . . . . 75.22 108.934 170.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 175' ' ' LEU . . . . . 0.439 ' HB3' ' HB ' ' C' ' 158' ' ' VAL . 72.1 mt -106.97 95.68 5.89 Favored 'General case' 0 C--O 1.249 1.036 0 N-CA-C 108.054 -1.091 . . . . 71.32 108.054 171.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 176' ' ' LEU . . . . . 0.664 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 67.5 mt -72.61 101.14 2.95 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.767 -0.651 . . . . 43.02 109.913 175.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 177' ' ' VAL . . . . . 0.578 HG22 HG12 ' C' ' 158' ' ' VAL . 25.3 t -82.67 96.94 3.95 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 N-CA-C 107.701 -1.222 . . . . 74.43 107.701 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 178' ' ' VAL . . . . . 0.475 HG21 HG11 ' C' ' 153' ' ' VAL . 8.5 p -72.99 135.45 27.68 Favored 'Isoleucine or valine' 0 C--O 1.248 1.003 0 CA-C-O 121.938 0.875 . . . . 74.01 111.62 -172.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 179' ' ' ARG . . . . . 0.416 ' O ' ' HA ' ' C' ' 124' ' ' PRO . 35.3 mmt180 -110.57 94.55 5.06 Favored 'General case' 0 C--O 1.243 0.717 0 N-CA-C 106.596 -1.631 . . . . 72.33 106.596 171.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 180' ' ' LEU . . . . . 0.579 HD12 ' HB2' ' C' ' 155' ' ' GLU . 80.0 mt -69.17 136.5 52.2 Favored 'General case' 0 C--N 1.351 0.631 0 CA-C-O 120.981 0.419 . . . . 70.51 110.462 178.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 181' ' ' LEU . . . . . 0.486 HD12 HG23 ' C' ' 126' ' ' THR . 98.7 mt -72.88 165.21 54.51 Favored Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 123.806 0.842 . . . . 74.2 111.234 -173.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -53.84 80.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.391 2.78 0 C-N-CA 123.154 2.569 . . . . 64.12 112.478 169.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 183' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -172.93 60.72 0.26 Allowed Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 126.165 1.786 . . . . 62.13 106.373 -175.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 184' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -82.51 65.38 8.21 Favored 'Trans proline' 0 C--N 1.384 2.397 0 C-N-CA 123.066 2.511 . . . . 71.54 111.293 -176.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 185' ' ' VAL . . . . . . . . . . . . . 17.8 t -95.45 -36.75 6.94 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.593 0 CA-C-N 115.705 -0.68 . . . . 72.23 109.248 -177.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 186' ' ' PHE . . . . . 0.408 ' HD1' ' HB2' ' C' ' 195' ' ' ALA . 38.0 m-85 -133.38 157.39 45.66 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.287 1.035 . . . . 61.44 110.825 -178.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 187' ' ' ARG . . . . . 0.434 ' HE ' ' HB3' ' C' ' 155' ' ' GLU . 35.8 ttt180 -150.73 131.82 14.37 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 108.967 -0.753 . . . . 75.14 108.967 168.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 188' ' ' LEU . . . . . 0.594 HD13 ' HD2' ' C' ' 240' ' ' PHE . 39.5 tp -79.93 146.83 31.9 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 114.266 1.21 . . . . 74.14 114.266 -168.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -139.79 100.6 3.99 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 126.157 1.783 . . . . 71.33 106.907 165.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 70.88 -95.9 0.57 Allowed Glycine 0 N--CA 1.477 1.375 0 CA-C-N 116.495 -0.32 . . . . 74.2 112.597 -176.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 191' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -124.4 -14.08 6.99 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.423 1.089 . . . . 60.21 109.805 169.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -84.38 153.53 23.39 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.397 0.679 . . . . 65.13 109.456 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 193' ' ' LEU . . . . . 0.524 HD21 ' CE2' ' C' ' 240' ' ' PHE . 89.1 mt -117.32 156.27 28.11 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.26 0.553 . . . . 52.2 111.636 -173.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 194' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -121.44 109.45 14.87 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 107.199 -1.408 . . . . 75.43 107.199 168.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 195' ' ' ALA . . . . . 0.633 ' HB3' ' HG ' ' C' ' 251' ' ' LEU . . . -111.42 -177.56 3.23 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 123.576 0.75 . . . . 65.11 111.578 -175.142 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 38.8 m -136.05 118.48 15.77 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.293 -0.867 . . . . 51.32 109.572 170.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 197' ' ' LEU . . . . . 0.431 HD13 ' HB2' ' C' ' 212' ' ' ALA . 51.4 tp -98.25 136.38 38.53 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.428 0.691 . . . . 73.5 109.758 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 198' ' ' ASP . . . . . 0.463 ' HB3' HG21 ' C' ' 256' ' ' THR . 66.9 m-20 -101.83 102.0 12.54 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 109.122 -0.696 . . . . 44.52 109.122 179.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 199' ' ' VAL . . . . . 0.401 HG22 HG21 ' C' ' 210' ' ' VAL . 21.4 t -107.05 117.15 57.17 Favored Pre-proline 0 N--CA 1.473 0.72 0 N-CA-C 108.41 -0.959 . . . . 61.21 108.41 178.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 200' ' ' PRO . . . . . 0.495 ' HD2' HG11 ' C' ' 210' ' ' VAL . 45.4 Cg_endo -69.49 151.76 70.66 Favored 'Trans proline' 0 C--N 1.371 1.718 0 C-N-CA 122.001 1.801 . . . . 71.34 111.81 175.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 201' ' ' ALA . . . . . . . . . . . . . . . -54.65 -47.16 98.74 Favored Pre-proline 0 CA--C 1.564 1.489 0 N-CA-C 114.425 1.268 . . . . 74.35 114.425 -171.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 202' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -54.49 -51.37 10.65 Favored 'Trans proline' 0 C--N 1.384 2.41 0 C-N-CA 121.813 1.675 . . . . 63.15 112.916 175.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 203' ' ' ILE . . . . . 0.459 HG21 HG13 ' C' ' 210' ' ' VAL . 53.9 mt -64.92 -32.86 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.303 0.641 . . . . 63.4 111.032 -178.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -63.72 -48.07 78.55 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.737 0.815 . . . . 75.02 111.187 178.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 205' ' ' VAL . . . . . . . . . . . . . 79.5 t -69.35 -43.26 81.19 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 CA-C-N 115.125 -0.943 . . . . 63.41 112.315 -176.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 206' ' ' VAL . . . . . 0.455 HG23 ' HE2' ' A' ' 270' ' ' LYS . 9.1 p -79.26 -36.19 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 123.248 0.343 . . . . 52.12 111.715 -176.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 82.21 71.77 1.29 Allowed Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.773 -0.649 . . . . 63.21 111.912 -168.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -100.81 -128.32 6.33 Favored Glycine 0 C--N 1.342 0.907 0 N-CA-C 111.249 -0.74 . . . . 51.32 111.249 176.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 209' ' ' LYS . . . . . 0.484 ' HG2' ' HA ' ' C' ' 222' ' ' ALA . 8.5 mtmp? -140.7 143.62 35.15 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.207 0.603 . . . . 72.12 110.424 174.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 210' ' ' VAL . . . . . 0.495 HG11 ' HD2' ' C' ' 200' ' ' PRO . 30.4 m -135.18 149.93 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 124.453 1.101 . . . . 62.05 108.207 172.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 211' ' ' ARG . . . . . 0.406 HH11 ' HB2' ' C' ' 218' ' ' PRO . 8.1 tmm_? -94.94 126.63 40.41 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 122.74 0.416 . . . . 72.44 111.033 -175.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 212' ' ' ALA . . . . . 0.431 ' HB2' HD13 ' C' ' 197' ' ' LEU . . . -96.92 118.73 33.98 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 107.201 -1.407 . . . . 74.43 107.201 167.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 213' ' ' MET . . . . . . . . . . . . . 4.3 tmm? -76.68 104.96 7.46 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 108.445 -0.946 . . . . 63.12 108.445 -178.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.49 168.74 10.0 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.857 0.837 . . . . 54.24 110.561 -176.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 215' ' ' LEU . . . . . . . . . . . . . 14.6 mt -71.53 -32.34 68.05 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 113.636 -1.62 . . . . 44.41 111.66 -168.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.28 17.75 19.93 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 114.813 -1.085 . . . . 71.0 111.366 -177.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 144.92 164.51 10.65 Favored Glycine 0 C--N 1.355 1.587 0 CA-C-O 119.685 -0.509 . . . . 64.11 112.521 176.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 218' ' ' PRO . . . . . 0.406 ' HB2' HH11 ' C' ' 211' ' ' ARG . 94.6 Cg_endo -84.12 113.37 1.8 Allowed 'Trans proline' 0 CA--C 1.552 1.397 0 C-N-CA 122.633 2.222 . . . . 52.13 112.027 177.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 219' ' ' VAL . . . . . . . . . . . . . 12.1 p -93.62 130.65 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 109.941 -0.392 . . . . 52.53 109.941 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 220' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -98.33 105.74 17.93 Favored 'General case' 0 C--N 1.349 0.559 0 N-CA-C 109.184 -0.673 . . . . 72.32 109.184 176.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 221' ' ' VAL . . . . . 0.511 HG11 HD21 ' C' ' 233' ' ' LEU . 70.7 t -73.14 131.74 34.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 125.236 1.414 . . . . 74.03 112.35 -177.033 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 222' ' ' ALA . . . . . 0.484 ' HA ' ' HG2' ' C' ' 209' ' ' LYS . . . -81.19 108.1 14.55 Favored 'General case' 0 CA--C 1.548 0.887 0 O-C-N 123.91 0.756 . . . . 73.3 110.247 169.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 83.7 t -81.85 136.19 48.0 Favored Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 124.87 1.268 . . . . 73.11 109.697 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 224' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -83.81 160.2 14.09 Favored 'Trans proline' 0 C--N 1.383 2.366 0 C-N-CA 123.019 2.479 . . . . 54.33 111.8 172.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -62.09 140.3 83.29 Favored 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 122.292 1.995 . . . . 74.0 111.4 174.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 226' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? 63.31 68.14 0.62 Allowed 'General case' 0 N--CA 1.477 0.883 0 O-C-N 124.243 0.964 . . . . 70.15 110.635 -178.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 227' ' ' THR . . . . . 0.442 ' O ' HG12 ' A' ' 257' ' ' ILE . 16.8 m -93.44 115.17 27.7 Favored 'General case' 0 C--O 1.219 -0.521 0 C-N-CA 123.051 0.54 . . . . 70.3 109.729 176.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 228' ' ' GLN . . . . . 0.727 HE21 ' HG2' ' A' ' 259' ' ' GLU . 27.4 mp0 -89.57 151.36 21.97 Favored 'General case' 0 C--O 1.246 0.895 0 C-N-CA 124.521 1.128 . . . . 74.32 111.94 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -72.17 108.42 5.34 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 113.914 -1.494 . . . . 62.12 109.016 174.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 121.0 1.22 11.53 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 119.215 -0.77 . . . . 62.04 113.569 -176.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 231' ' ' ARG . . . . . 0.546 ' HD2' ' H ' ' C' ' 228' ' ' GLN . 19.3 mtp180 -71.53 -179.78 2.68 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 118.107 0.953 . . . . 74.12 110.872 172.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 232' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' C' ' 251' ' ' LEU . 31.7 ttmt -143.27 144.88 32.31 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.38 0.609 . . . . 71.45 111.76 -176.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 233' ' ' LEU . . . . . 0.683 HD13 ' HB2' ' C' ' 251' ' ' LEU . 5.3 mp -114.05 156.98 23.14 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.198 1.399 . . . . 74.21 109.986 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 20.9 ptt180 -129.92 86.11 2.37 Favored 'General case' 0 CA--C 1.553 1.081 0 O-C-N 124.948 1.405 . . . . 72.34 109.19 170.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 235' ' ' LEU . . . . . 0.567 HD22 ' H ' ' B' ' 240' ' ' GLY . 59.6 mt -83.36 98.62 9.56 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 108.464 -0.939 . . . . 73.43 108.464 173.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -65.71 133.38 50.94 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.805 0.842 . . . . 71.55 111.273 -175.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 237' ' ' GLY . . . . . 0.405 ' O ' ' HD3' ' C' ' 246' ' ' ARG . . . 77.24 7.29 86.85 Favored Glycine 0 C--N 1.348 1.207 0 O-C-N 123.444 0.465 . . . . 71.42 114.058 179.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -105.95 16.3 25.31 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.279 0.632 . . . . 72.03 111.603 -177.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -78.6 -135.06 0.95 Allowed Glycine 0 C--N 1.348 1.214 0 N-CA-C 111.285 -0.726 . . . . 31.21 111.285 170.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 240' ' ' PHE . . . . . 0.594 ' HD2' HD13 ' C' ' 188' ' ' LEU . 48.2 m-85 -97.59 116.53 65.82 Favored Pre-proline 0 C--O 1.247 0.964 0 N-CA-C 109.201 -0.666 . . . . 75.14 109.201 168.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 241' ' ' PRO . . . . . 0.432 ' HA ' ' HG2' ' C' ' 246' ' ' ARG . 48.9 Cg_exo -59.13 99.99 0.12 Allowed 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 123.446 2.764 . . . . 70.21 113.071 169.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -82.82 159.32 37.87 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-N 114.428 -1.26 . . . . 70.14 111.927 175.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 243' ' ' PRO . . . . . 0.461 ' HB3' HH22 ' C' ' 148' ' ' ARG . 59.4 Cg_endo -70.16 -1.71 9.25 Favored 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 122.89 2.394 . . . . 71.42 113.688 -179.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -119.47 -10.98 9.56 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.549 0.74 . . . . 71.42 111.425 176.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 158.22 157.86 8.69 Favored Glycine 0 C--N 1.346 1.116 0 N-CA-C 112.147 -0.381 . . . . 51.32 112.147 -178.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 246' ' ' ARG . . . . . 0.432 ' HG2' ' HA ' ' C' ' 241' ' ' PRO . 41.8 mtt180 -85.89 146.47 26.7 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.733 0.813 . . . . 61.31 111.576 -179.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -82.78 -172.23 48.1 Favored Glycine 0 C--N 1.35 1.349 0 N-CA-C 111.573 -0.611 . . . . 63.23 111.573 165.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -115.7 164.54 14.21 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 117.567 0.683 . . . . 73.54 109.886 -176.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 249' ' ' LEU . . . . . 0.551 HD23 HD12 ' C' ' 235' ' ' LEU . 34.2 tp -113.12 109.19 18.39 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 123.734 0.814 . . . . 74.23 109.08 177.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 250' ' ' TYR . . . . . 0.548 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 39.1 m-85 -102.0 103.14 13.74 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 108.97 -0.752 . . . . 71.43 108.97 177.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 251' ' ' LEU . . . . . 0.683 ' HB2' HD13 ' C' ' 233' ' ' LEU . 2.8 mp -96.78 147.56 23.8 Favored 'General case' 0 N--CA 1.505 2.275 0 N-CA-C 109.903 -0.406 . . . . 64.53 109.903 -173.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -107.53 137.67 45.14 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 108.883 -0.784 . . . . 73.41 108.883 169.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 253' ' ' VAL . . . . . 0.438 HG21 ' CZ3' ' B' ' 242' ' ' TRP . 45.8 t -89.68 142.59 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 113.377 0.88 . . . . 73.5 113.377 -169.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 254' ' ' ARG . . . . . . . . . . . . . 42.8 mtm180 -119.78 145.27 46.75 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.405 1.082 . . . . 74.13 108.255 163.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 255' ' ' ILE . . . . . 0.632 HG21 HG23 ' A' ' 257' ' ' ILE . 29.6 mm -98.32 123.46 50.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 107.958 -1.127 . . . . 75.24 107.958 169.199 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 256' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' C' ' 200' ' ' PRO . 0.5 OUTLIER -127.3 172.71 10.37 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.524 1.13 . . . . 53.32 109.215 -173.569 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 257' ' ' ILE . . . . . 0.448 HD12 ' H ' ' C' ' 259' ' ' GLU . 2.8 pp -136.91 157.53 74.6 Favored Pre-proline 0 CA--C 1.567 1.621 0 C-N-CA 124.124 0.969 . . . . 64.54 109.529 177.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -80.98 17.01 1.51 Allowed 'Trans proline' 0 C--N 1.384 2.404 0 C-N-CA 122.775 2.317 . . . . 73.21 114.209 -167.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 259' ' ' GLU . . . . . 0.448 ' H ' HD12 ' C' ' 257' ' ' ILE . 31.8 mt-10 55.32 -83.45 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.507 1.123 . . . . 72.3 110.547 -164.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 260' ' ' ARG . . . . . 0.416 ' HG2' ' H ' ' C' ' 260' ' ' ARG . 2.4 ptp85 -78.68 134.75 37.09 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 124.312 1.045 . . . . 73.41 110.812 -174.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 261' ' ' LEU . . . . . 0.534 HD11 HG13 ' A' ' 205' ' ' VAL . 65.3 mt -113.54 154.17 27.56 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 115.065 -0.971 . . . . 71.21 111.347 -170.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 52.7 p -83.74 164.05 46.38 Favored Pre-proline 0 CA--C 1.555 1.14 0 N-CA-C 108.31 -0.996 . . . . 61.23 108.31 169.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -51.05 -42.31 53.36 Favored 'Trans proline' 0 C--N 1.382 2.298 0 C-N-CA 122.417 2.078 . . . . 74.2 112.933 173.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -57.82 -58.14 9.68 Favored 'General case' 0 C--O 1.252 1.213 0 C-N-CA 124.058 0.943 . . . . 71.04 110.316 178.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -48.01 -67.22 0.29 Allowed 'General case' 0 C--N 1.357 0.91 0 O-C-N 125.056 1.473 . . . . 65.11 109.999 177.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 266' ' ' GLU . . . . . 0.616 ' HG2' ' HA ' ' B' ' 468' ' ' LEU . 8.3 tp10 -49.18 -51.33 33.29 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.2 1.4 . . . . 64.21 111.838 -171.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -60.7 -49.11 78.84 Favored 'General case' 0 C--O 1.257 1.479 0 CA-C-N 115.582 -0.736 . . . . 70.32 112.012 -177.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 268' ' ' LEU . . . . . 0.412 ' O ' ' HG ' ' C' ' 272' ' ' LEU . 7.6 mp -65.39 -38.3 89.58 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.428 -0.806 . . . . 52.44 110.906 -178.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 73.1 m95 -58.41 -41.72 85.58 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.103 0.561 . . . . 61.11 110.693 175.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 270' ' ' LYS . . . . . 0.524 ' HE2' ' HG3' ' C' ' 266' ' ' GLU . 68.3 mmtt -56.08 -51.53 67.53 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 123.327 0.392 . . . . 75.43 110.134 176.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -56.45 -43.63 79.69 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 114.872 -1.058 . . . . 75.33 111.541 -178.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 272' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' C' ' 268' ' ' LEU . 82.8 mt -65.83 -41.1 92.2 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.14 -0.937 . . . . 74.33 110.656 -179.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -59.17 -42.68 91.37 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.758 0.423 . . . . 34.13 110.431 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -63.26 -38.99 93.32 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.23 0.612 . . . . 63.21 111.28 176.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -61.69 -30.04 70.49 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.037 0.535 . . . . 70.04 111.366 174.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 276' ' ' TYR . . . . . 0.401 ' HE1' ' HB2' ' A' ' 200' ' ' PRO . 2.6 m-85 -78.68 -33.86 46.63 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.04 0.536 . . . . 75.52 112.042 176.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -63.14 -32.53 73.94 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 120.993 0.425 . . . . 44.24 109.955 170.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -68.48 -14.21 62.85 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 123.587 0.755 . . . . 55.2 112.066 175.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 279' ' ' ARG . . . . . . . . . . . . . 42.4 mtm180 -83.86 -16.26 45.11 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 122.749 0.419 . . . . 71.52 110.394 174.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.628 0 N-CA-C 108.268 -1.012 . . . . 75.14 108.268 173.582 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.0 mmt . . . . . 0 N--CA 1.478 0.971 0 N-CA-C 108.594 -0.891 . . . . 64.12 108.594 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.66 33.04 21.84 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.707 1.203 . . . . 51.4 111.603 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -86.14 57.23 4.37 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.272 0.629 . . . . 74.04 111.0 -176.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -36.48 100.74 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 125.6 1.56 . . . . 62.43 114.135 -175.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.472 ' HG2' ' HB3' ' A' ' 96' ' ' PHE . 70.5 mmtt -93.44 94.32 8.63 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 107.907 -1.145 . . . . 74.32 107.907 171.158 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.41 ' O ' HG13 ' A' ' 10' ' ' ILE . 49.3 t0 -69.37 95.71 0.82 Allowed 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 107.305 -1.368 . . . . 61.41 107.305 173.09 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -61.82 -35.32 77.89 Favored 'General case' 0 C--O 1.244 0.803 0 O-C-N 124.121 0.888 . . . . 73.34 112.252 -171.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -65.04 -45.91 83.47 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.079 -0.51 . . . . 73.33 110.045 177.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.01 -37.86 84.02 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 123.435 0.459 . . . . 60.32 111.119 179.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.41 HG13 ' O ' ' A' ' 6' ' ' ASP . 68.3 mt -61.7 -39.58 83.73 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 C-N-CA 123.367 0.667 . . . . 74.23 110.318 175.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 92.9 mt -80.3 -5.52 56.42 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 112.543 0.572 . . . . 51.33 112.543 176.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.23 34.24 58.23 Favored Glycine 0 C--N 1.354 1.577 0 O-C-N 123.146 0.279 . . . . 53.33 113.396 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 23.8 m -133.23 158.77 74.91 Favored Pre-proline 0 CA--C 1.559 1.295 0 C-N-CA 124.853 1.261 . . . . 71.43 109.622 -177.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -75.3 166.55 28.63 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 122.417 2.078 . . . . 50.12 112.145 176.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -70.49 9.84 0.57 Allowed 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 113.706 1.002 . . . . 75.43 113.706 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -116.86 -1.19 12.07 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.493 1.117 . . . . 64.11 108.897 -177.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.63 121.73 14.62 Favored 'General case' 0 C--N 1.347 0.492 0 C-N-CA 124.477 1.111 . . . . 64.31 110.133 176.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.7 p -75.07 173.0 11.35 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.543 0.737 . . . . 71.11 110.931 -176.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -58.02 -33.11 68.61 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.796 0.839 . . . . 64.21 110.801 178.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.448 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 16.9 tp10 -58.0 -49.57 76.37 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.149 0.98 . . . . 72.43 110.567 171.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -70.68 -30.01 66.47 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.477 0.711 . . . . 64.03 111.85 -176.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.4 mp -69.25 -39.93 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 123.718 0.807 . . . . 73.31 109.213 174.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -64.0 -42.52 97.13 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 124.122 0.889 . . . . 71.24 110.357 178.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.52 ' HA ' ' HD3' ' A' ' 27' ' ' LYS . 66.2 mtm180 -68.69 -44.72 73.38 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.087 0.555 . . . . 54.12 110.849 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.2 -40.31 89.6 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.434 -0.803 . . . . 64.0 110.243 177.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -64.92 -47.73 76.67 Favored 'General case' 0 C--O 1.201 -1.486 0 CA-C-N 115.164 -0.926 . . . . 73.1 110.6 177.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.52 ' HD3' ' HA ' ' A' ' 24' ' ' ARG . 25.4 mtpp -50.07 -47.74 53.47 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 123.674 0.789 . . . . 74.22 110.428 178.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.436 ' HA ' ' NH2' ' A' ' 31' ' ' ARG . 8.1 tpt180 -56.52 -56.19 24.39 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 114.326 -1.306 . . . . 71.15 111.285 176.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.621 HD22 ' HE2' ' A' ' 33' ' ' TYR . 64.5 mt -82.62 -12.06 57.94 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.594 0.758 . . . . 74.11 112.297 -171.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 34' ' ' HIS . . . -93.37 -18.79 21.99 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.733 0.813 . . . . 63.3 110.015 179.106 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.436 ' NH2' ' HA ' ' A' ' 28' ' ' ARG . 48.8 mtm180 -84.96 -44.98 12.62 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 123.311 0.382 . . . . 72.33 110.204 165.088 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -67.5 -48.29 67.51 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.43 0.692 . . . . 63.33 111.03 -174.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.621 ' HE2' HD22 ' A' ' 29' ' ' LEU . 60.6 m-85 -102.9 24.82 10.11 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.169 0.588 . . . . 63.25 111.308 -176.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.486 ' CD2' ' HB3' ' A' ' 36' ' ' ASP . 48.8 t60 -71.09 102.05 0.44 Allowed Pre-proline 0 N--CA 1.482 1.141 0 C-N-CA 124.362 1.065 . . . . 63.41 110.726 -177.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.507 ' HB3' ' HG2' ' A' ' 44' ' ' GLU . 23.6 Cg_exo -62.06 -25.8 77.78 Favored 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 123.066 2.511 . . . . 74.13 113.29 -168.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.486 ' HB3' ' CD2' ' A' ' 34' ' ' HIS . 8.0 t70 -62.92 -40.18 96.83 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.117 1.367 . . . . 72.45 112.208 179.109 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 98.5 t -103.83 -44.7 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-O 121.431 0.634 . . . . 65.53 109.684 -177.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -98.44 83.1 2.97 Favored 'General case' 0 C--O 1.243 0.721 0 C-N-CA 124.344 1.057 . . . . 61.35 108.333 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -78.26 79.22 4.71 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.146 -0.934 . . . . 73.11 108.616 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 74.3 m -138.71 115.62 8.9 Favored Pre-proline 0 CA--C 1.542 0.671 0 CA-C-N 115.297 -0.865 . . . . 54.41 108.985 178.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_exo -46.15 -42.83 21.34 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 124.213 3.275 . . . . 72.23 114.353 -178.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -51.33 -49.82 60.64 Favored 'General case' 0 N--CA 1.482 1.161 0 O-C-N 124.245 0.966 . . . . 64.43 110.49 175.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.26 -26.85 67.54 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-N 114.676 -1.147 . . . . 72.14 111.602 -177.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.507 ' HG2' ' HB3' ' A' ' 35' ' ' PRO . 39.8 mt-10 -81.68 -34.48 30.67 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 122.86 0.464 . . . . 62.01 110.964 -173.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -82.3 -32.44 29.48 Favored 'General case' 0 C--O 1.246 0.897 0 N-CA-C 110.305 -0.257 . . . . 62.44 110.305 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 36.5 mmtm -62.54 -40.63 97.4 Favored 'General case' 0 C--N 1.348 0.502 0 CA-C-N 115.715 -0.675 . . . . 74.03 109.369 167.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -60.16 -38.63 83.74 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.555 0.742 . . . . 73.24 110.489 175.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -56.74 -57.49 12.2 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 120.793 0.33 . . . . 75.14 110.341 174.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -58.61 -41.43 85.85 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 115.151 -0.931 . . . . 71.44 111.786 -176.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.457 HD13 ' HB3' ' A' ' 29' ' ' LEU . 77.3 mt -74.33 -33.1 32.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.777 1.231 . . . . 70.53 111.217 -176.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -88.31 -10.58 49.04 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 119.237 -0.411 . . . . 73.43 111.28 179.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -75.89 -49.19 18.59 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 108.06 -1.089 . . . . 63.42 108.06 166.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -53.5 -46.9 70.21 Favored 'General case' 0 C--N 1.35 0.623 0 CA-C-N 113.625 -1.625 . . . . 65.45 111.307 174.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -69.05 -44.66 72.21 Favored 'General case' 0 C--O 1.216 -0.662 0 CA-C-N 115.026 -0.988 . . . . 72.32 110.618 177.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.409 ' HB2' ' CD2' ' A' ' 88' ' ' PHE . . . -50.1 -37.74 35.32 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.41 0.684 . . . . 53.01 112.224 -179.003 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 88.3 t -76.86 -57.74 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.971 0 CA-C-N 115.267 -0.878 . . . . 74.52 110.943 175.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 65.9 mt -87.22 6.04 35.12 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 113.619 0.97 . . . . 62.04 113.619 -166.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 37.2 t -73.03 -42.15 63.46 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 124.154 0.981 . . . . 74.34 111.349 -178.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -116.25 138.22 24.09 Favored Pre-proline 0 N--CA 1.471 0.579 0 CA-C-N 115.112 -0.949 . . . . 74.34 108.483 -171.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -58.61 -20.95 52.81 Favored 'Trans proline' 0 C--N 1.383 2.375 0 C-N-CA 123.844 3.029 . . . . 72.41 113.416 -172.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -66.6 -70.01 0.27 Allowed 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.622 0.769 . . . . 72.3 110.867 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt -67.22 -25.28 66.03 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.698 0.799 . . . . 74.54 110.894 -178.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -54.97 -56.92 14.34 Favored 'General case' 0 C--N 1.35 0.614 0 CA-C-N 114.791 -1.095 . . . . 74.11 109.702 169.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -58.13 -37.91 75.5 Favored 'General case' 0 C--N 1.364 1.236 0 O-C-N 123.784 0.677 . . . . 74.25 111.362 178.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.564 HG23 ' HG2' ' A' ' 76' ' ' PRO . 1.7 mp -54.31 -48.64 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 123.521 0.513 . . . . 64.42 110.997 175.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -69.72 -43.13 73.0 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 119.43 -0.319 . . . . 75.4 110.88 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -57.68 -39.95 78.3 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.156 0.582 . . . . 64.04 111.344 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 63.1 p -74.17 -25.5 59.76 Favored 'General case' 0 C--N 1.347 0.495 0 CA-C-N 115.617 -0.72 . . . . 75.13 110.6 177.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -72.86 136.41 45.32 Favored 'General case' 0 CA--C 1.551 0.983 0 N-CA-C 108.752 -0.833 . . . . 63.45 108.752 169.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.95 18.0 56.88 Favored Glycine 0 N--CA 1.471 1.007 0 N-CA-C 111.513 -0.635 . . . . 52.54 111.513 -171.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 34.9 m -144.33 -58.81 0.38 Allowed 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 103.415 -2.809 . . . . 71.23 103.415 176.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 51.3 m -80.93 142.82 33.14 Favored 'General case' 0 C--O 1.25 1.127 0 N-CA-C 105.411 -2.07 . . . . 74.23 105.411 156.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.67 -25.22 13.23 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.66 0.784 . . . . 74.04 110.637 178.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.98 143.19 77.29 Favored Pre-proline 0 C--O 1.245 0.843 0 C-N-CA 123.71 0.804 . . . . 75.1 110.094 175.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.416 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 34.0 Cg_endo -62.55 143.56 93.06 Favored 'Trans proline' 0 C--N 1.371 1.761 0 C-N-CA 122.224 1.95 . . . . 75.41 109.921 170.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.564 ' HG2' HG23 ' A' ' 65' ' ' ILE . 31.6 Cg_exo -59.98 144.37 99.47 Favored 'Trans proline' 0 C--N 1.371 1.741 0 C-N-CA 122.831 2.354 . . . . 74.25 112.293 -179.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.53 119.21 6.27 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 122.647 2.231 . . . . 62.44 111.421 176.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -65.74 134.35 37.45 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 122.76 2.307 . . . . 43.51 112.78 -173.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -72.92 145.49 40.34 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.387 2.058 . . . . 71.05 111.201 174.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -59.88 87.01 0.07 OUTLIER 'Trans proline' 0 C--N 1.384 2.402 0 C-N-CA 122.924 2.416 . . . . 51.35 111.605 178.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 155.26 -46.67 0.52 Allowed Glycine 0 C--N 1.332 0.308 0 N-CA-C 109.141 -1.584 . . . . 62.41 109.141 -176.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.489 ' HA3' ' HA ' ' A' ' 106' ' ' PHE . . . 117.01 -174.01 14.99 Favored Glycine 0 C--N 1.346 1.102 0 CA-C-N 115.575 -0.313 . . . . 53.03 113.55 174.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -92.78 130.45 38.39 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.825 0.85 . . . . 74.41 110.655 -178.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.65 158.19 30.63 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 124.464 1.103 . . . . 71.31 110.432 174.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -153.35 75.33 1.06 Allowed 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 107.93 -1.137 . . . . 70.22 107.93 177.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.511 ' HA ' ' HE3' ' A' ' 164' ' ' MET . 12.9 m -38.4 84.87 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 127.229 2.212 . . . . 74.44 116.536 -164.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 71.69 20.17 78.42 Favored Glycine 0 C--N 1.342 0.88 0 N-CA-C 114.791 0.676 . . . . 70.11 114.791 174.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.421 ' HB3' ' CE2' ' A' ' 93' ' ' PHE . 35.0 m-85 -122.04 135.87 54.87 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 123.62 0.768 . . . . 72.34 109.454 -174.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -74.9 88.47 2.32 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 115.842 -0.617 . . . . 71.44 111.22 -171.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.6 p -33.11 -47.9 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.562 1.426 0 C-N-CA 126.34 1.856 . . . . 75.21 113.529 169.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -64.76 -22.85 67.07 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.048 0.939 . . . . 75.33 111.984 -170.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -89.38 -27.74 20.24 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.216 0.606 . . . . 45.35 112.437 -178.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.421 ' CE2' ' HB3' ' A' ' 88' ' ' PHE . 40.1 m-85 -75.7 173.93 10.45 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 113.288 0.847 . . . . 71.01 113.288 -166.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 53.2 p -71.56 175.43 5.58 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 114.655 1.354 . . . . 74.5 114.655 -161.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -67.23 -50.64 59.95 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 113.562 -1.654 . . . . 74.31 110.374 -174.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.472 ' HB3' ' HG2' ' A' ' 5' ' ' LYS . 72.5 t80 -54.01 -41.06 67.55 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 124.48 1.113 . . . . 75.03 111.729 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -60.46 -51.97 67.2 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 115.384 -0.825 . . . . 63.23 110.121 172.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.527 ' HA ' HD11 ' A' ' 105' ' ' LEU . 46.8 mt-30 -70.04 -3.14 14.99 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.609 0.763 . . . . 73.05 112.281 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -98.29 -47.98 5.24 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.191 0.996 . . . . 70.02 111.684 170.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 52.8 tp -73.4 -50.77 20.05 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.394 0.678 . . . . 55.03 110.531 -172.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -90.11 -7.44 53.75 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.363 -0.835 . . . . 72.11 110.067 175.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.418 ' HA2' ' HG ' ' A' ' 105' ' ' LEU . . . -44.64 -59.1 4.42 Favored Glycine 0 C--N 1.364 2.096 0 CA-C-O 118.058 -1.412 . . . . 72.43 115.078 -178.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -40.56 -25.8 0.2 Allowed 'Trans proline' 0 C--N 1.391 2.809 0 C-N-CA 124.687 3.591 . . . . 23.1 115.739 178.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -149.11 54.79 0.5 Allowed Glycine 0 C--N 1.348 1.216 0 N-CA-C 111.461 -0.656 . . . . 44.4 111.461 177.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.527 HD11 ' HA ' ' A' ' 98' ' ' GLN . 13.4 mt -69.0 73.3 0.27 Allowed 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 117.468 0.634 . . . . 74.25 110.998 171.142 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.613 ' CG ' ' HA3' ' A' ' 168' ' ' GLY . 0.1 OUTLIER 43.97 -115.02 0.39 Allowed 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 125.639 1.576 . . . . 72.25 113.152 177.769 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.459 ' H ' ' HB3' ' A' ' 106' ' ' PHE . . . 60.8 20.86 57.65 Favored Glycine 0 C--N 1.36 1.863 0 CA-C-O 119.712 -0.493 . . . . 44.0 112.965 -168.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 57.19 -133.66 52.6 Favored Glycine 0 C--N 1.36 1.903 0 N-CA-C 111.577 -0.609 . . . . 71.34 111.577 -171.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -83.25 -7.51 59.59 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.715 0.406 . . . . 64.11 110.469 174.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -92.24 -10.99 60.34 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-O 119.018 -0.879 . . . . 55.25 114.17 -177.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 45.1 tpt85 58.76 5.55 0.5 Allowed 'General case' 0 N--CA 1.506 2.361 0 CA-C-N 118.137 0.968 . . . . 71.44 113.439 174.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -61.21 -21.42 63.83 Favored 'General case' 0 CA--C 1.562 1.429 0 C-N-CA 124.498 1.119 . . . . 73.25 113.721 -176.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 35.3 m 58.46 46.46 15.05 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.324 1.05 . . . . 74.21 110.546 -174.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.416 ' HD2' ' H ' ' A' ' 115' ' ' LYS . 2.0 tmm_? -92.63 156.37 17.14 Favored 'General case' 0 CA--C 1.553 1.072 0 CA-C-N 115.517 -0.765 . . . . 74.52 109.338 -173.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.416 ' H ' ' HD2' ' A' ' 114' ' ' ARG . 22.5 tptm -96.11 148.6 22.51 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.547 0.739 . . . . 72.15 110.953 -174.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.602 ' HA2' ' HA ' ' A' ' 170' ' ' PRO . . . -106.37 177.42 22.19 Favored Glycine 0 CA--C 1.5 -0.886 0 N-CA-C 122.751 3.86 . . . . 55.22 122.751 -162.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -120.97 150.18 41.51 Favored 'General case' 0 C--O 1.266 1.926 0 CA-C-N 111.197 -2.501 . . . . 71.34 110.034 175.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -66.21 149.95 49.54 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.837 1.255 . . . . 74.23 112.466 -174.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 10.0 tt -149.32 147.05 27.87 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.881 -0.785 . . . . 70.23 108.881 178.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.497 HH21 HG21 ' A' ' 177' ' ' VAL . 33.8 mtp-105 -94.26 122.76 37.13 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.011 0.524 . . . . 74.51 109.961 176.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.466 ' HB2' HD11 ' A' ' 174' ' ' LEU . . . -113.57 166.63 11.33 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.549 -0.908 . . . . 41.51 108.549 171.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -127.59 118.9 24.79 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.666 -1.235 . . . . 61.0 107.666 -174.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 25.4 tp -99.92 99.76 9.84 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 108.611 -0.885 . . . . 54.05 108.611 -169.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.493 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 56.3 Cg_endo -73.61 113.55 3.81 Favored 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 121.69 1.594 . . . . 75.33 108.637 176.04 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.553 ' HA ' HG21 ' B' ' 6' ' ' ILE . 28.0 tp -120.82 138.43 54.05 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 123.44 0.696 . . . . 64.01 109.848 -169.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.437 HG21 ' H ' ' B' ' 4' ' ' SER . 96.6 m -67.79 128.85 38.01 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 114.408 -1.269 . . . . 71.34 110.062 176.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.898 ' HB3' HD22 ' A' ' 215' ' ' LEU . 8.2 mt -54.8 -47.63 73.78 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 122.264 1.031 . . . . 70.54 111.914 -173.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.459 ' HG2' ' HA2' ' B' ' 96' ' ' GLY . 16.7 mp0 -62.28 -44.04 97.45 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 113.292 -1.776 . . . . 75.32 109.997 -177.019 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -76.57 -20.09 57.2 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 115.577 -0.738 . . . . 64.33 111.798 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.515 ' HB1' ' O ' ' A' ' 153' ' ' VAL . . . -69.26 -39.98 78.1 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.523 0.729 . . . . 41.43 109.636 175.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -75.78 -38.91 57.86 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 115.06 -0.973 . . . . 74.51 111.564 176.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 54.4 m170 -71.25 -35.51 71.45 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 122.565 0.346 . . . . 75.25 111.188 -178.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.94 -141.15 26.83 Favored Glycine 0 C--N 1.344 1.012 0 CA-C-N 116.069 -0.514 . . . . 71.54 113.039 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 84.09 -175.48 51.5 Favored Glycine 0 C--N 1.348 1.249 0 C-N-CA 123.254 0.454 . . . . 70.42 113.036 178.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.445 ' HB3' ' OG ' ' A' ' 146' ' ' SER . 1.2 mp0 -72.29 111.87 7.87 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.249 0.62 . . . . 73.14 109.588 174.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 8.3 tpp180 -93.65 119.32 32.52 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.246 0.618 . . . . 74.4 109.611 -178.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 74.9 t -81.65 105.37 11.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 108.326 -0.99 . . . . 71.24 108.326 175.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.0 p -124.99 123.33 65.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 C-N-CA 124.396 1.078 . . . . 73.14 108.44 176.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -121.2 146.63 46.58 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.119 0.568 . . . . 71.3 109.971 -177.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 11.0 p -160.4 131.66 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-N 115.5 -0.773 . . . . 75.1 109.509 -177.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 59.93 24.64 13.75 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 124.319 1.048 . . . . 74.24 112.007 -177.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 92.85 -24.65 23.17 Favored Glycine 0 C--N 1.355 1.627 0 CA-C-N 116.13 -0.486 . . . . 31.1 112.387 -176.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 66.1 ttp85 -74.52 99.81 3.7 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.772 0.829 . . . . 72.12 110.489 -177.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -89.97 116.13 27.79 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 123.674 0.79 . . . . 74.41 109.977 178.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.3 p -121.5 148.39 24.93 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 C-N-CA 123.993 0.917 . . . . 73.53 109.506 177.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.445 ' OG ' ' HB3' ' A' ' 135' ' ' GLU . 34.6 t -113.48 87.56 2.64 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.109 0.963 . . . . 31.45 109.035 179.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 29.6 m -83.83 112.51 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-N 116.093 -0.503 . . . . 73.42 109.729 -176.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.442 ' HA ' ' HA ' ' A' ' 135' ' ' GLU . 57.4 ttt85 -68.46 95.01 0.59 Allowed 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.329 0.585 . . . . 74.14 109.461 177.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.607 ' HB ' HG11 ' A' ' 153' ' ' VAL . 44.6 pt -81.45 138.13 48.16 Favored Pre-proline 0 CA--C 1.554 1.108 0 CA-C-N 114.896 -1.047 . . . . 74.13 109.506 178.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.401 ' HA ' ' HD3' ' A' ' 151' ' ' PRO . 56.2 Cg_endo -69.48 140.38 43.59 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 122.282 1.988 . . . . 60.34 111.525 177.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 150' ' ' PRO . 31.7 Cg_exo -61.07 93.53 0.11 Allowed 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 123.076 2.518 . . . . 74.15 111.913 174.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 138.59 -5.74 3.19 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-O 118.946 -0.919 . . . . 75.51 113.22 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.607 HG11 ' HB ' ' A' ' 149' ' ' ILE . 7.5 p -58.8 123.22 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 C-N-CA 123.767 0.827 . . . . 75.43 110.969 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.775 ' HD3' HD21 ' A' ' 193' ' ' LEU . 95.4 mtt180 -140.67 167.97 20.91 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 121.704 -0.622 . . . . 73.23 111.271 -173.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.514 ' HB3' ' H ' ' A' ' 188' ' ' LEU . 10.3 tp10 -35.62 118.46 0.48 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 126.977 2.111 . . . . 72.32 114.119 -172.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 107.95 -27.25 15.0 Favored Glycine 0 C--N 1.342 0.867 0 CA-C-O 119.398 -0.668 . . . . 14.21 112.92 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 30.7 t -59.6 112.51 1.82 Allowed 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.533 0.733 . . . . 74.23 110.133 -178.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 48.4 t -86.67 96.88 5.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 115.633 -0.712 . . . . 72.34 109.266 -179.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.593 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 65.8 mt -72.91 102.5 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 N-CA-C 108.409 -0.96 . . . . 75.24 108.409 171.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 51.9 ttt-85 -85.53 103.36 14.32 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.929 -0.578 . . . . 61.32 109.991 -175.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.473 HG13 ' HB3' ' A' ' 174' ' ' LEU . 4.4 p -120.64 116.81 31.64 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 122.895 0.478 . . . . 61.33 109.999 178.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.576 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 48.3 Cg_endo -68.86 175.77 6.92 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.573 2.182 . . . . 74.53 112.809 178.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 65.05 6.37 25.03 Favored Glycine 0 C--N 1.351 1.404 0 N-CA-C 115.787 1.075 . . . . 70.43 115.787 173.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.511 ' HE3' ' HA ' ' A' ' 86' ' ' SER . 64.1 mtt -131.44 -1.7 3.91 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 117.776 0.788 . . . . 64.15 112.796 -173.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -54.63 -89.11 0.01 OUTLIER Glycine 0 N--CA 1.487 2.091 0 N-CA-C 110.54 -1.024 . . . . 73.33 110.54 -176.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.588 ' O ' ' HA ' ' A' ' 171' ' ' PRO . . . -74.89 161.49 53.43 Favored Glycine 0 CA--C 1.541 1.689 0 N-CA-C 106.185 -2.766 . . . . 74.5 106.185 155.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.498 HE21 ' HA ' ' A' ' 167' ' ' GLN . 0.0 OUTLIER -102.7 99.67 9.67 Favored 'General case' 0 CA--C 1.56 1.339 0 CA-C-N 120.153 1.977 . . . . 75.42 113.61 -174.162 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.613 ' HA3' ' CG ' ' A' ' 106' ' ' PHE . . . 75.06 -19.68 2.13 Favored Glycine 0 C--N 1.363 2.076 0 N-CA-C 119.471 2.548 . . . . 64.21 119.471 158.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . 0.552 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . 10.8 t30 -107.8 -43.88 0.12 Allowed Pre-proline 0 C--N 1.319 -0.757 0 N-CA-C 105.111 -2.181 . . . . 63.11 105.111 164.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.602 ' HA ' ' HA2' ' A' ' 116' ' ' GLY . 97.2 Cg_endo -106.64 52.28 0.02 OUTLIER 'Trans proline' 0 CA--C 1.587 3.126 0 C-N-CA 122.361 2.041 . . . . 71.13 114.687 158.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.588 ' HA ' ' O ' ' A' ' 166' ' ' GLY . 59.0 Cg_endo -63.89 102.61 0.37 Allowed 'Trans proline' 1 C--N 1.43 4.855 0 C-N-CA 122.746 2.297 . . . . 71.25 110.997 -177.771 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -116.75 -169.63 15.24 Favored Glycine 0 N--CA 1.482 1.761 0 C-N-CA 120.665 -0.779 . . . . 72.4 114.677 -169.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.576 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 33.5 m-20 -79.33 105.84 10.93 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 108.725 -0.842 . . . . 71.14 108.725 169.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.473 ' HB3' HG13 ' A' ' 161' ' ' VAL . 20.8 tp -82.73 108.67 16.26 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.416 -0.811 . . . . 64.32 110.004 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 82.4 mt -85.93 93.68 9.0 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.764 -0.828 . . . . 72.12 108.764 175.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.593 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 92.2 mt -78.02 93.88 4.55 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-N 115.794 -0.639 . . . . 70.05 109.958 178.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.497 HG21 HH21 ' A' ' 120' ' ' ARG . 41.9 t -81.99 98.21 4.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 106.137 -1.801 . . . . 61.43 106.137 174.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 12.8 p -65.39 110.77 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-O 121.797 0.808 . . . . 70.33 110.101 -174.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.493 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 11.9 mmm-85 -91.32 127.45 36.75 Favored 'General case' 0 C--O 1.219 -0.509 0 N-CA-C 107.636 -1.246 . . . . 53.32 107.636 173.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.408 HD13 HD22 ' A' ' 127' ' ' LEU . 15.5 mt -91.16 147.33 23.13 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.806 -0.442 . . . . 72.4 109.806 176.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 89.3 mt -55.88 162.77 2.49 Favored Pre-proline 0 N--CA 1.487 1.395 0 C-N-CA 124.979 1.312 . . . . 73.14 113.841 -169.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.23 14.55 0.29 Allowed 'Trans proline' 0 C--N 1.395 2.987 0 C-N-CA 123.052 2.501 . . . . 71.42 113.696 173.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.414 ' HA ' ' HD3' ' A' ' 184' ' ' PRO . 66.2 t-80 -60.85 105.36 0.57 Allowed Pre-proline 0 CA--C 1.563 1.47 0 N-CA-C 106.317 -1.734 . . . . 73.35 106.317 165.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 183' ' ' HIS . 6.6 Cg_exo -72.13 28.24 0.26 Allowed 'Trans proline' 0 N--CA 1.506 2.222 0 C-N-CA 124.764 3.643 . . . . 61.24 118.161 -158.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 21.6 t -93.97 -57.95 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-N 119.583 1.083 . . . . 64.21 110.303 -172.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . 0.538 ' HB3' HD22 ' A' ' 193' ' ' LEU . 26.8 m-85 -124.81 155.82 38.79 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 112.815 0.672 . . . . 72.31 112.815 -169.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -147.39 99.18 3.1 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 106.076 -1.824 . . . . 75.51 106.076 171.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.514 ' H ' ' HB3' ' A' ' 155' ' ' GLU . 0.7 OUTLIER -78.83 158.03 28.25 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 122.736 0.415 . . . . 74.21 111.429 -175.356 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.441 ' HG2' ' HA ' ' B' ' 120' ' ' TYR . 26.6 tt0 -148.61 128.64 13.58 Favored 'General case' 0 C--O 1.247 0.937 0 N-CA-C 107.439 -1.319 . . . . 70.31 107.439 166.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.452 ' HA3' ' HB3' ' B' ' 120' ' ' TYR . . . 70.85 -82.38 0.41 Allowed Glycine 0 C--N 1.349 1.267 0 O-C-N 123.653 0.596 . . . . 65.41 112.716 -178.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.403 ' OE1' ' HD2' ' A' ' 243' ' ' PRO . 0.1 OUTLIER -147.63 -5.8 0.47 Allowed 'General case' 0 C--O 1.252 1.222 0 C-N-CA 123.19 0.596 . . . . 72.32 111.776 179.856 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -111.23 147.84 34.13 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 122.886 0.474 . . . . 72.32 111.262 -175.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.775 HD21 ' HD3' ' A' ' 154' ' ' ARG . 83.8 mt -93.54 137.25 33.01 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.191 0.996 . . . . 63.44 111.035 -177.149 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -105.74 103.37 12.86 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 108.063 -1.088 . . . . 73.14 108.063 165.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.495 ' HB3' HD23 ' A' ' 251' ' ' LEU . . . -103.15 172.55 6.75 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.285 1.034 . . . . 74.34 110.759 179.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 91.1 m -119.81 131.84 55.43 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.625 0.77 . . . . 70.21 108.956 171.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.436 ' HB2' HD22 ' A' ' 251' ' ' LEU . 38.2 tp -113.86 129.05 56.63 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.358 0.663 . . . . 72.21 110.793 -176.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -88.15 120.64 29.69 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 107.411 -1.329 . . . . 61.43 107.411 167.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 4.2 p -142.88 120.65 7.11 Favored Pre-proline 0 CA--C 1.544 0.747 0 N-CA-C 109.404 -0.591 . . . . 64.4 109.404 179.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.72 151.22 74.69 Favored 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 121.763 1.642 . . . . 64.51 111.038 174.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -51.05 -45.54 88.34 Favored Pre-proline 0 CA--C 1.552 1.021 0 N-CA-C 114.756 1.391 . . . . 71.34 114.756 -173.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -55.96 -45.79 35.99 Favored 'Trans proline' 0 C--N 1.388 2.616 0 C-N-CA 122.013 1.809 . . . . 63.54 113.584 175.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.566 HD11 ' HB3' ' C' ' 276' ' ' TYR . 27.8 mt -71.4 -28.27 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 123.082 0.553 . . . . 64.32 110.645 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.95 -41.86 77.47 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.043 0.537 . . . . 71.51 110.761 177.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 34.1 t -71.18 -48.19 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.602 0.761 . . . . 63.23 111.828 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 86.8 t -94.26 -35.5 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.059 0.544 . . . . 74.41 112.1 -169.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 88.68 111.7 1.17 Allowed Glycine 0 CA--C 1.53 0.977 0 CA-C-N 116.366 -0.379 . . . . 72.35 113.569 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -173.62 -158.7 18.54 Favored Glycine 0 C--N 1.351 1.402 0 CA-C-O 120.174 -0.237 . . . . 55.24 112.763 177.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -80.31 119.2 22.73 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.343 0.868 . . . . 45.21 113.343 -167.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.426 HG21 HD11 ' A' ' 197' ' ' LEU . 29.2 m -110.84 -172.74 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 114.158 -1.383 . . . . 63.11 107.665 162.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . 0.457 ' HD2' ' HB2' ' A' ' 218' ' ' PRO . 60.2 ttp180 -126.4 115.93 20.38 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 109.823 -0.436 . . . . 71.41 109.823 172.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -105.68 160.06 15.5 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.94 -0.763 . . . . 62.04 108.94 172.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 54.1 ttm -97.09 147.86 23.62 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 109.164 -0.68 . . . . 71.23 109.164 176.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 81.4 p -124.86 -173.3 2.77 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 108.455 -0.943 . . . . 74.1 108.455 169.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.898 HD22 ' HB3' ' A' ' 127' ' ' LEU . 22.5 mt -72.64 -19.78 61.38 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.044 0.538 . . . . 63.31 110.699 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -110.6 25.95 11.22 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.978 0.911 . . . . 64.44 110.506 178.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 98.94 -175.26 28.53 Favored Glycine 0 C--N 1.351 1.373 0 N-CA-C 114.839 0.696 . . . . 33.0 114.839 173.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . 0.457 ' HB2' ' HD2' ' A' ' 211' ' ' ARG . 83.8 Cg_endo -76.58 132.07 13.05 Favored 'Trans proline' 0 CA--C 1.557 1.671 0 C-N-CA 123.399 2.733 . . . . 70.23 113.719 -174.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.407 ' HA ' HG21 ' B' ' 384' ' ' THR . 27.2 m -125.7 153.93 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 124.891 1.276 . . . . 73.4 110.257 177.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -79.79 130.08 35.02 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.947 -0.39 . . . . 75.04 109.947 173.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 88.9 t -119.96 121.73 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 123.6 0.76 . . . . 74.13 110.269 -176.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -81.33 103.5 11.14 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.184 0.593 . . . . 60.25 109.812 177.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.601 ' HA ' HD12 ' B' ' 441' ' ' ILE . 92.9 t -67.64 146.58 98.58 Favored Pre-proline 0 CA--C 1.56 1.328 0 C-N-CA 125.497 1.519 . . . . 63.14 110.609 177.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -83.04 161.82 15.66 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 122.434 2.09 . . . . 75.51 111.268 172.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . 0.564 ' HD2' ' HD3' ' B' ' 446' ' ' PRO . 11.3 Cg_exo -70.47 148.4 60.37 Favored 'Trans proline' 0 C--N 1.365 1.44 0 C-N-CA 122.23 1.953 . . . . 72.53 112.647 176.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 57.6 mtt-85 69.32 28.41 4.82 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.578 1.551 . . . . 74.04 111.575 171.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.459 HG23 HD21 ' A' ' 233' ' ' LEU . 19.6 m -69.27 104.45 2.23 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.665 1.586 . . . . 64.32 110.512 174.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . 0.476 HE21 ' HG3' ' C' ' 259' ' ' GLU . 6.0 tt0 -101.21 151.61 21.65 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.712 0.805 . . . . 75.32 110.475 -177.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . 0.45 ' HA ' ' HB ' ' A' ' 253' ' ' VAL . . . -75.01 152.01 38.74 Favored 'General case' 0 C--N 1.355 0.847 0 N-CA-C 113.19 0.811 . . . . 62.31 113.19 -169.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 85.73 -3.34 87.28 Favored Glycine 0 C--N 1.348 1.209 0 CA-C-N 114.719 -1.128 . . . . 73.32 112.988 -176.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -98.02 156.74 16.5 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.671 0.788 . . . . 74.0 110.563 -178.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -104.82 112.39 25.48 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.936 0.895 . . . . 72.22 108.683 176.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.459 HD21 HG23 ' A' ' 227' ' ' THR . 65.9 mt -75.8 99.83 4.56 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 107.906 -1.146 . . . . 71.4 107.906 174.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -83.58 100.46 10.82 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 109.578 -0.527 . . . . 64.14 109.578 176.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.511 ' H ' HD23 ' A' ' 235' ' ' LEU . 0.3 OUTLIER -95.94 115.48 27.49 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 107.838 -1.171 . . . . 61.12 107.838 172.118 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -68.09 136.66 54.1 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 114.577 -1.192 . . . . 64.43 112.203 -171.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 84.99 35.82 12.08 Favored Glycine 0 C--N 1.349 1.282 0 O-C-N 123.807 0.692 . . . . 74.2 114.375 169.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.407 ' HE3' HD12 ' A' ' 235' ' ' LEU . 74.5 mmtt -116.04 -23.2 8.62 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.787 0.435 . . . . 73.01 111.68 -177.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -89.06 -173.64 46.47 Favored Glycine 0 C--N 1.348 1.211 0 N-CA-C 111.063 -0.815 . . . . 74.43 111.063 171.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -96.27 164.24 18.89 Favored Pre-proline 0 N--CA 1.49 1.563 0 CA-C-N 117.794 0.797 . . . . 73.13 111.398 -173.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.516 ' HA ' ' HA ' ' A' ' 246' ' ' ARG . 96.4 Cg_exo -48.75 135.57 28.03 Favored 'Trans proline' 0 C--N 1.388 2.655 0 C-N-CA 123.356 2.704 . . . . 73.33 114.949 175.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.413 ' HA2' ' HE3' ' B' ' 117' ' ' LYS . . . -161.42 -162.42 12.87 Favored Glycine 0 C--N 1.347 1.144 0 CA-C-O 119.253 -0.749 . . . . 73.52 112.601 179.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . 0.51 ' HB2' ' HE1' ' B' ' 120' ' ' TYR . 32.0 Cg_exo -58.15 -23.65 62.6 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 123.399 2.733 . . . . 70.45 113.164 177.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -88.09 19.06 3.84 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.777 0.831 . . . . 70.11 111.716 176.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 81.44 -82.41 1.57 Allowed Glycine 0 C--N 1.349 1.26 0 N-CA-C 110.269 -1.132 . . . . 62.24 110.269 -174.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.516 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 70.2 mtm180 -126.51 151.86 47.27 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.709 1.203 . . . . 75.41 108.032 169.149 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -83.74 175.96 52.13 Favored Glycine 0 C--N 1.347 1.185 0 N-CA-C 114.192 0.437 . . . . 42.24 114.192 -174.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -122.83 -175.68 3.22 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.113 0.965 . . . . 75.44 110.906 -174.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.487 ' HB3' ' HG ' ' A' ' 235' ' ' LEU . 50.9 tp -127.58 130.44 49.07 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.048 -1.093 . . . . 70.31 108.048 169.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -113.24 105.33 13.29 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 107.429 -1.323 . . . . 52.51 107.429 178.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.495 HD23 ' HB3' ' A' ' 195' ' ' ALA . 36.8 mt -93.6 110.92 22.5 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.129 0.571 . . . . 72.24 110.016 -176.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -77.69 109.72 11.92 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.256 0.623 . . . . 75.41 109.491 -177.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.45 ' HB ' ' HA ' ' A' ' 229' ' ' ALA . 31.9 t -68.99 111.25 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 CA-C-N 114.669 -1.151 . . . . 24.43 111.691 -170.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -110.8 99.93 8.76 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 107.803 -1.184 . . . . 73.14 107.803 167.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.559 HD12 ' HA ' ' C' ' 256' ' ' THR . 72.4 mt -76.9 122.18 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 114.853 -1.067 . . . . 74.34 109.985 179.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 61.8 p -107.46 165.36 11.46 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 124.164 0.986 . . . . 73.43 109.667 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.773 HD11 HE21 ' C' ' 228' ' ' GLN . 2.8 pp -130.86 152.24 80.26 Favored Pre-proline 0 CA--C 1.557 1.231 0 C-N-CA 123.517 0.727 . . . . 73.4 110.285 -176.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_exo -53.44 -16.4 7.43 Favored 'Trans proline' 0 C--N 1.383 2.344 0 C-N-CA 123.891 3.061 . . . . 74.45 116.744 -169.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.437 ' HA ' ' HB3' ' C' ' 226' ' ' ARG . 64.8 mt-10 50.54 -74.22 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 124.581 1.152 . . . . 63.24 112.947 -167.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.51 139.71 42.35 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 109.814 -0.439 . . . . 75.12 109.814 174.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.633 HD22 ' HB2' ' A' ' 265' ' ' GLU . 83.4 mt -134.99 152.25 51.56 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.436 0.694 . . . . 55.32 109.949 174.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.0 155.6 39.74 Favored Pre-proline 0 CA--C 1.552 1.039 0 N-CA-C 106.513 -1.662 . . . . 44.34 106.513 164.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -42.95 -27.92 1.06 Allowed 'Trans proline' 0 C--N 1.39 2.74 0 C-N-CA 124.325 3.35 . . . . 74.33 115.515 -174.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -60.51 -71.49 0.13 Allowed 'General case' 0 C--O 1.252 1.194 0 C-N-CA 124.28 1.032 . . . . 71.44 111.842 178.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . 0.633 ' HB2' HD22 ' A' ' 261' ' ' LEU . 2.1 mp0 -65.83 -30.92 71.62 Favored 'General case' 0 C--N 1.356 0.871 0 N-CA-C 109.265 -0.643 . . . . 64.2 109.265 -177.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' GLU . . . . . 0.568 ' HA ' HD13 ' A' ' 261' ' ' LEU . 4.7 tp10 -51.58 -54.77 24.08 Favored 'General case' 0 C--N 1.355 0.815 0 O-C-N 124.294 0.996 . . . . 73.45 109.678 174.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -65.71 -37.41 86.36 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.214 0.606 . . . . 64.12 112.108 -177.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . 0.445 HD21 ' HE3' ' C' ' 271' ' ' LYS . 9.3 mp -59.47 -60.33 4.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 123.452 0.47 . . . . 73.14 110.982 175.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -55.65 -38.43 69.54 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.359 1.064 . . . . 75.0 112.465 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . 0.676 ' HG3' HG23 ' C' ' 206' ' ' VAL . 0.0 OUTLIER -65.47 -50.17 66.33 Favored 'General case' 0 N--CA 1.478 0.969 0 O-C-N 123.52 0.512 . . . . 62.43 110.181 -179.784 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 3.2 tmpt? -57.64 -48.9 78.18 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 123.68 0.612 . . . . 70.22 109.89 179.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 272' ' ' LEU . . . . . 0.502 ' O ' ' HB2' ' A' ' 276' ' ' TYR . 83.9 mt -52.43 -50.5 62.43 Favored 'General case' 0 C--N 1.357 0.916 0 O-C-N 124.413 1.07 . . . . 63.4 110.586 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -72.33 -43.49 64.05 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.019 1.118 . . . . 64.51 114.019 -171.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -75.39 -36.16 60.92 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.038 0.535 . . . . 74.35 110.13 -175.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -72.33 -32.91 66.92 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 116.293 -0.412 . . . . 71.44 110.414 171.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . 0.518 ' HE2' ' HG3' ' C' ' 258' ' ' PRO . 51.4 t80 -55.93 -53.01 62.08 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.344 1.058 . . . . 75.02 109.37 176.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 277' ' ' TYR . . . . . 0.413 ' HA ' ' HB3' ' A' ' 280' ' ' ALA . 0.2 OUTLIER -69.37 -34.75 75.02 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 115.401 -0.818 . . . . 70.12 110.391 -179.236 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . 0.417 ' HA ' HG23 ' B' ' 232' ' ' THR . . . -63.0 -10.54 14.23 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 112.757 0.651 . . . . 75.41 112.757 173.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . 0.46 HH22 ' CD ' ' C' ' 265' ' ' GLU . 49.7 mtm180 -122.95 3.65 9.39 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.777 0.831 . . . . 74.13 111.033 174.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . 0.413 ' HB3' ' HA ' ' A' ' 277' ' ' TYR . . . . . . . . 0 C--O 1.257 1.465 0 C-N-CA 123.576 0.75 . . . . 72.21 109.775 176.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.297 0 N-CA-C 111.394 0.146 . . . . 71.44 111.394 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.516 ' HB3' ' HB2' ' B' ' 94' ' ' PHE . 74.8 tttt -89.62 120.22 30.72 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.727 0.811 . . . . 54.1 110.056 -179.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -82.05 -10.94 59.05 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.743 -0.598 . . . . 74.04 112.154 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . 0.437 ' H ' HG21 ' A' ' 126' ' ' THR . 19.5 m 58.97 -84.11 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 125.384 1.474 . . . . 52.14 112.838 177.015 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 11.8 m -95.49 150.8 19.92 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.277 0.631 . . . . 70.11 110.139 -175.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.553 HG21 ' HA ' ' A' ' 125' ' ' LEU . 38.2 pt -134.13 169.92 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 123.388 0.675 . . . . 64.44 112.329 -163.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -139.44 134.38 32.27 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.314 1.046 . . . . 72.01 109.582 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 52.9 tp -74.32 147.87 41.88 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.213 1.005 . . . . 75.22 111.705 -171.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.35 -57.73 3.96 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.075 0.55 . . . . 62.4 111.559 178.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 21.8 mt 67.43 -13.31 0.23 Allowed 'General case' 0 N--CA 1.506 2.367 0 C-N-CA 124.961 1.304 . . . . 74.1 113.449 -169.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 83.9 mt 58.68 71.83 0.93 Allowed Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 125.155 1.382 . . . . 45.35 112.305 -176.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -71.38 -55.7 0.13 Allowed 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 122.84 2.36 . . . . 61.33 110.059 173.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -148.82 129.69 14.28 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 108.051 -1.092 . . . . 75.01 108.051 169.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -151.0 107.92 3.55 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 107.388 -1.338 . . . . 64.54 107.388 -176.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -133.6 88.67 2.5 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 108.032 -1.099 . . . . 60.01 108.032 176.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 23.8 p -71.36 141.43 85.77 Favored Pre-proline 0 CA--C 1.547 0.861 0 CA-C-N 115.822 -0.626 . . . . 51.11 109.472 172.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.18 86.33 0.79 Allowed 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 122.273 1.982 . . . . 62.42 111.105 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 35.5 m -85.53 -27.81 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 CA-C-N 115.043 -0.981 . . . . 61.41 110.011 176.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 32.5 p -69.84 -33.46 72.32 Favored 'General case' 0 C--N 1.348 0.538 0 CA-C-N 115.089 -0.96 . . . . 71.22 109.682 169.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 23.6 mtpp 62.04 -79.43 0.03 OUTLIER 'General case' 0 C--N 1.357 0.905 0 C-N-CA 126.0 1.72 . . . . 62.34 111.332 -179.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -153.44 -95.17 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 108.031 -1.1 . . . . 75.34 108.031 177.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . 0.628 ' HB3' HH11 ' C' ' 154' ' ' ARG . 5.0 ppt_? 42.31 27.4 0.08 Allowed 'General case' 0 N--CA 1.508 2.425 0 C-N-CA 126.032 1.733 . . . . 73.31 114.966 176.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 23' ' ' THR . . . . . . . . . . . . . 70.6 p -81.14 154.8 72.47 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 123.59 0.756 . . . . 72.45 109.529 177.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -59.34 106.28 0.3 Allowed 'Trans proline' 0 C--N 1.37 1.69 0 C-N-CA 122.322 2.015 . . . . 74.55 110.606 171.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -61.46 -48.17 82.33 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.333 0.587 . . . . 74.53 110.033 178.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . 0.442 ' SD ' ' HB3' ' B' ' 29' ' ' LEU . 43.0 ttm -132.85 128.95 20.98 Favored Pre-proline 0 CA--C 1.544 0.714 0 N-CA-C 107.512 -1.292 . . . . 75.13 107.512 172.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 27' ' ' PRO . . . . . 0.571 ' HG2' ' HB3' ' B' ' 315' ' ' ASN . 83.7 Cg_exo -48.08 -42.19 32.73 Favored 'Trans proline' 0 C--N 1.384 2.437 0 C-N-CA 123.966 3.111 . . . . 71.1 113.5 -179.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.518 HG13 ' HD2' ' B' ' 319' ' ' PRO . 4.9 p -171.31 138.29 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 C-N-CA 124.569 1.147 . . . . 73.51 109.048 174.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.442 ' HB3' ' SD ' ' B' ' 26' ' ' MET . 0.4 OUTLIER -127.27 134.23 50.08 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.602 1.161 . . . . 62.2 108.789 174.969 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 70.6 151.76 0.1 Allowed 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 125.153 1.381 . . . . 70.24 110.495 -174.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 31' ' ' ASN . . . . . 0.494 ' H ' HD22 ' B' ' 31' ' ' ASN . 0.1 OUTLIER -106.64 -38.72 6.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.939 -0.476 . . . . 74.34 111.623 179.256 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -159.36 104.27 1.64 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 122.606 0.363 . . . . 72.22 110.6 178.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -94.08 103.1 15.18 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 106.474 -1.676 . . . . 73.31 106.474 164.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.85 -63.1 1.29 Allowed 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.097 0.959 . . . . 53.33 112.298 -166.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 57.72 -162.5 0.21 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.816 0.847 . . . . 73.13 111.063 179.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 59.96 63.08 5.39 Favored Glycine 0 C--N 1.355 1.625 0 CA-C-O 119.653 -0.526 . . . . 74.33 112.806 172.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 24.8 t70 65.33 -88.54 0.03 OUTLIER 'General case' 0 C--N 1.355 0.828 0 C-N-CA 124.355 1.062 . . . . 61.44 109.738 -173.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 13.3 tt 171.54 -29.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 124.679 1.192 . . . . 75.44 109.261 -177.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 8.9 t -57.14 -54.49 46.19 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.44 1.096 . . . . 64.25 112.891 -168.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.545 ' HB1' ' HB2' ' B' ' 328' ' ' ALA . . . -178.4 82.22 0.22 Allowed Pre-proline 0 C--N 1.36 1.052 0 C-N-CA 123.324 0.649 . . . . 64.0 111.863 -177.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -88.83 -174.71 1.07 Allowed 'Trans proline' 0 C--N 1.365 1.416 0 C-N-CA 122.635 2.223 . . . . 72.44 111.211 162.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 151.98 -72.81 0.27 Allowed Glycine 0 C--N 1.345 1.071 0 C-N-CA 121.844 -0.217 . . . . 45.24 113.146 170.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -152.82 137.22 5.74 Favored Glycine 0 C--N 1.335 0.493 0 N-CA-C 111.356 -0.698 . . . . 42.15 111.356 -176.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . 0.436 ' HA ' ' HB2' ' B' ' 336' ' ' GLU . . . -75.62 2.6 11.44 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.409 0.684 . . . . 63.2 112.675 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.57 ' HB2' ' HD2' ' B' ' 337' ' ' LYS . 22.0 mmt180 66.81 -68.86 0.14 Allowed 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 126.114 1.766 . . . . 74.21 112.274 176.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 46' ' ' ARG . . . . . 0.47 HH12 ' HB3' ' C' ' 139' ' ' GLU . 10.0 ttm180 73.22 -86.93 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 125.325 1.45 . . . . 75.02 110.728 177.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.424 ' HG ' ' H ' ' B' ' 48' ' ' THR . 18.4 tp 164.52 -176.17 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 126.187 1.795 . . . . 53.22 106.445 -169.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.54 ' HA ' ' HD3' ' C' ' 144' ' ' ARG . 88.5 m -56.52 -55.72 30.26 Favored 'General case' 0 C--N 1.352 0.704 0 CA-C-N 118.431 0.559 . . . . 51.22 109.73 168.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.37 -1.02 78.44 Favored Glycine 0 C--N 1.347 1.148 0 CA-C-O 119.812 -0.438 . . . . 74.15 113.122 177.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . 0.502 ' HA ' ' ND1' ' B' ' 184' ' ' HIS . 13.3 t70 -79.11 -75.97 0.22 Allowed 'General case' 0 C--N 1.356 0.86 0 N-CA-C 107.053 -1.462 . . . . 64.2 107.053 172.061 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 51' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 59.93 11.37 2.56 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 125.103 1.361 . . . . 75.3 112.816 174.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 44.7 p -134.46 -162.84 1.29 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.231 1.012 . . . . 73.31 109.719 -169.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -127.44 82.12 2.07 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.846 -0.798 . . . . 73.24 108.846 171.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.425 ' HB2' ' HD2' ' B' ' 184' ' ' HIS . . . -77.8 113.6 15.83 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 108.989 -0.745 . . . . 75.51 108.989 174.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 88.5 mt -103.53 -14.26 16.26 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.413 0.685 . . . . 72.35 110.842 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . 0.591 ' HG3' HD12 ' B' ' 59' ' ' LEU . 0.0 OUTLIER 68.87 106.74 0.05 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.476 1.51 . . . . 73.2 110.585 -176.117 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -63.15 -71.57 0.16 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.62 1.168 . . . . 75.31 110.799 -177.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 27.2 t -90.1 74.48 7.17 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 121.846 0.832 . . . . 62.01 110.298 178.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . 0.591 HD12 ' HG3' ' B' ' 56' ' ' ARG . 0.5 OUTLIER -146.95 3.97 0.83 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 113.907 -1.497 . . . . 72.44 108.216 164.079 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 18.7 t -169.88 176.14 4.9 Favored 'General case' 0 C--O 1.248 1.016 0 C-N-CA 125.75 1.62 . . . . 63.51 107.32 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 15.6 t70 66.74 -74.72 0.06 Allowed 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 124.158 0.983 . . . . 71.45 110.893 -177.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 62' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -123.03 85.97 50.99 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 124.366 1.066 . . . . 72.3 109.228 175.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -87.08 123.45 1.97 Allowed 'Trans proline' 0 C--N 1.371 1.713 0 C-N-CA 122.555 2.17 . . . . 72.24 109.699 167.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -79.18 -24.97 42.86 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.303 0.641 . . . . 72.04 111.608 -176.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 64.66 -78.42 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.786 1.234 . . . . 65.32 110.102 -173.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 66' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 68.75 -66.32 0.25 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 125.403 1.481 . . . . 72.41 111.432 -177.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . 0.485 HD11 HD12 ' B' ' 69' ' ' LEU . 16.7 tt 51.34 112.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 C-N-CA 126.948 2.099 . . . . 72.03 113.298 172.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 34.1 mt -70.17 -5.32 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.598 0 C-N-CA 124.007 0.923 . . . . 73.4 112.051 -171.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.631 HD11 ' HG3' ' B' ' 312' ' ' PRO . 63.7 mt -79.92 60.19 3.42 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 124.25 1.02 . . . . 73.12 111.345 177.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -143.84 21.88 1.78 Allowed 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 108.088 -1.078 . . . . 44.44 108.088 169.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 61.8 mt 61.38 64.19 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 C-N-CA 124.847 1.259 . . . . 74.32 108.443 -168.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -113.0 4.58 25.61 Favored Glycine 0 C--N 1.349 1.272 0 CA-C-N 113.898 -1.501 . . . . 62.21 112.863 -177.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -106.49 151.52 24.86 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.229 1.012 . . . . 63.44 109.807 -178.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 56.4 -97.56 0.06 OUTLIER Glycine 0 C--N 1.356 1.666 0 O-C-N 123.561 0.538 . . . . 64.42 111.859 -175.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.7 93.95 9.74 Favored 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 108.063 -1.088 . . . . 74.01 108.063 168.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . -98.23 95.17 1.59 Allowed Glycine 0 C--N 1.343 0.961 0 CA-C-O 119.023 -0.876 . . . . 71.13 112.238 -176.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 29.5 t70 51.75 -88.91 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 125.423 1.489 . . . . 73.03 111.979 179.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 45.4 m -85.91 66.36 9.57 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.08 0.952 . . . . 51.1 109.525 177.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . 0.549 ' HG3' HG22 ' B' ' 80' ' ' ILE . 11.1 pt-20 -64.51 -34.11 77.46 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 114.712 -1.131 . . . . 74.44 111.912 178.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.549 HG22 ' HG3' ' B' ' 79' ' ' GLU . 15.9 tt -169.3 -32.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.802 1.241 . . . . 72.52 108.653 -178.098 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 14.3 m 62.41 73.9 0.45 Allowed 'General case' 0 C--N 1.36 1.046 0 C-N-CA 124.858 1.263 . . . . 71.34 110.433 174.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 61.52 -78.53 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 125.112 1.365 . . . . 61.11 112.073 -175.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . 69.23 109.21 0.05 Allowed 'General case' 0 C--N 1.36 1.024 0 C-N-CA 125.462 1.505 . . . . 71.35 110.47 -174.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -69.4 87.13 0.44 Allowed 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 108.381 -0.97 . . . . 73.0 108.381 -179.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 75.03 -19.5 0.38 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 125.458 1.503 . . . . 72.23 113.304 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 75.3 t80 66.98 -75.82 0.06 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.978 1.311 . . . . 63.12 111.885 178.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.01 -166.67 2.61 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.884 0.873 . . . . 52.24 110.305 -177.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 60.18 -91.5 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.996 1.318 . . . . 74.14 112.002 175.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . -94.8 64.46 1.48 Allowed Glycine 0 C--N 1.348 1.21 0 N-CA-C 111.16 -0.776 . . . . 54.33 111.16 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.26 -45.74 86.8 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.067 0.547 . . . . 62.33 109.966 176.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.3 173.36 36.1 Favored Glycine 0 C--N 1.347 1.173 0 CA-C-N 115.402 -0.817 . . . . 70.11 114.019 171.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.26 -27.49 5.08 Favored Glycine 0 C--N 1.343 0.966 0 CA-C-O 119.064 -0.853 . . . . 23.53 114.576 173.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 34.7 t80 67.6 -71.98 0.1 Allowed 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 125.25 1.42 . . . . 74.22 110.635 -175.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 94' ' ' PHE . . . . . 0.516 ' HB2' ' HB3' ' B' ' 2' ' ' LYS . 81.7 m-85 67.75 40.24 2.49 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 125.403 1.481 . . . . 71.21 111.55 175.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 51.7 mttp 66.73 -82.08 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.965 1.306 . . . . 74.14 111.605 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 96' ' ' GLY . . . . . 0.459 ' HA2' ' HG2' ' A' ' 128' ' ' GLU . . . 90.93 -52.82 3.27 Favored Glycine 0 C--N 1.35 1.331 0 N-CA-C 111.04 -0.824 . . . . 72.31 111.04 -171.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 1.2 pp -94.24 75.36 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 124.395 1.078 . . . . 72.22 110.19 176.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -84.25 73.81 10.4 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 109.011 -0.737 . . . . 75.21 109.011 178.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -81.38 99.48 8.72 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 114.75 -1.114 . . . . 61.12 109.769 -175.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . 0.553 ' HG ' ' HD3' ' B' ' 101' ' ' PRO . 4.1 pp -164.79 -36.39 0.0 OUTLIER Pre-proline 0 CA--C 1.572 1.813 0 C-N-CA 124.616 1.166 . . . . 74.2 112.911 176.165 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 101' ' ' PRO . . . . . 0.553 ' HD3' ' HG ' ' B' ' 100' ' ' LEU . 42.4 Cg_endo -91.98 6.8 3.35 Favored 'Trans proline' 0 C--N 1.406 3.592 0 CA-C-N 122.735 2.012 . . . . 72.21 113.569 177.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . 0.403 HD23 ' H ' ' B' ' 102' ' ' LEU . 2.3 pt? -78.42 83.58 4.63 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 122.191 0.996 . . . . 73.12 109.982 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 9.9 t -166.61 151.49 7.75 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-N 114.81 -1.086 . . . . 75.52 109.563 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 149.12 130.64 1.9 Allowed Glycine 0 C--N 1.337 0.635 0 N-CA-C 110.32 -1.112 . . . . 51.35 110.32 -178.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 -73.35 81.99 1.4 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.637 0.775 . . . . 75.22 110.083 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 106' ' ' TYR . . . . . 0.578 ' HB3' HD12 ' B' ' 412' ' ' LEU . 18.4 m-85 62.02 10.47 3.66 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.456 1.502 . . . . 74.44 113.943 171.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 22.7 m -88.71 92.42 9.19 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.635 0.731 . . . . 63.32 110.635 -175.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 23.4 p-80 -114.57 55.41 0.75 Allowed 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 108.078 -1.082 . . . . 71.44 108.078 172.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -73.22 94.85 2.03 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 114.486 -1.234 . . . . 53.33 109.848 -176.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -81.88 -6.39 59.06 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.896 0.879 . . . . 71.24 111.708 178.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 53.6 tp 71.17 -73.85 0.09 Allowed 'General case' 0 C--N 1.362 1.124 0 C-N-CA 125.274 1.429 . . . . 64.15 110.647 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 9.9 t30 61.48 40.04 14.25 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 124.371 1.068 . . . . 73.2 110.365 178.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 113' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -69.59 123.58 21.7 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.12 -0.945 . . . . 75.13 108.745 178.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 52.7 tttm 62.75 23.31 13.89 Favored 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 124.355 1.062 . . . . 74.01 110.032 -177.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 20.2 m 65.18 -77.42 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 125.288 1.435 . . . . 73.23 110.57 -171.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 64.23 30.75 78.67 Favored Glycine 0 C--N 1.359 1.848 0 O-C-N 123.221 0.325 . . . . 55.33 113.676 175.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . 0.493 ' HE2' ' HD3' ' A' ' 243' ' ' PRO . 6.1 ttpm? -129.1 135.2 27.24 Favored Pre-proline 0 CA--C 1.553 1.075 0 C-N-CA 124.151 0.98 . . . . 70.25 109.317 -172.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 118' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -73.88 176.35 9.57 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 123.136 2.558 . . . . 60.53 114.775 -170.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 119' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -90.64 169.62 10.84 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 114.288 -1.324 . . . . 75.33 110.487 177.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 120' ' ' TYR . . . . . 0.51 ' HE1' ' HB2' ' A' ' 243' ' ' PRO . 29.6 p90 -133.65 150.2 51.57 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.43 1.092 . . . . 70.1 109.551 -177.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 10.3 t 50.38 46.87 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-O 122.833 1.301 . . . . 74.32 109.507 -178.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 3.1 m -97.82 30.68 2.9 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 114.549 -1.205 . . . . 75.24 110.347 -171.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 4.2 p30 46.12 30.74 1.01 Allowed 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 125.368 1.467 . . . . 64.3 112.335 -173.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 46.2 t -71.33 106.19 3.78 Favored 'General case' 0 C--N 1.354 0.765 0 N-CA-C 108.157 -1.053 . . . . 43.31 108.157 178.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . 61.63 31.39 18.72 Favored 'General case' 0 CA--C 1.55 0.96 0 O-C-N 124.446 1.091 . . . . 73.02 110.477 -171.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . 62.91 69.23 0.6 Allowed 'General case' 0 C--N 1.358 0.978 0 C-N-CA 125.192 1.397 . . . . 74.13 111.277 -178.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 27.2 p -90.17 106.24 18.35 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.281 0.632 . . . . 70.01 110.561 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . 64.0 37.6 9.18 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 124.642 1.177 . . . . 72.01 112.53 174.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 41.2 p -108.2 0.72 21.64 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.995 0.918 . . . . 54.34 112.257 -178.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . -82.27 155.98 24.56 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 121.074 0.464 . . . . 44.22 111.781 -177.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 24.1 m-90 -104.52 164.61 11.63 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.613 1.165 . . . . 73.51 109.416 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 36.7 p -154.65 138.7 16.43 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.111 0.564 . . . . 51.4 110.707 -176.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 49.8 m 71.55 -71.14 0.14 Allowed 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 125.409 1.484 . . . . 62.25 111.037 -178.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . -141.45 -53.89 0.04 OUTLIER Glycine 0 C--N 1.349 1.283 0 N-CA-C 112.118 -0.393 . . . . 55.15 112.118 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 135' ' ' VAL . . . . . . . . . . . . . 18.5 m -113.18 -167.56 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 N-CA-C 108.7 -0.852 . . . . 73.24 108.7 179.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 3.2 tmtp? -71.2 -55.63 7.73 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 108.302 -0.999 . . . . 52.43 108.302 177.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 19.6 m -87.08 69.79 10.2 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-N 115.537 -0.756 . . . . 75.31 110.012 -178.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 61.08 -89.86 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.27 0 C-N-CA 125.123 1.369 . . . . 75.52 112.065 177.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -135.6 -2.33 2.44 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.188 0.995 . . . . 73.24 110.255 -175.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . -64.18 84.44 0.06 OUTLIER Glycine 0 C--N 1.353 1.473 0 C-N-CA 123.142 0.401 . . . . 65.04 112.875 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.43 -49.47 48.5 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.024 0.93 . . . . 75.34 110.086 -177.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 35.9 tp -92.73 -16.64 25.21 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 115.319 -0.855 . . . . 70.15 109.885 172.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . 83.84 -58.39 5.02 Favored Glycine 0 C--N 1.353 1.479 0 N-CA-C 111.819 -0.512 . . . . 61.25 111.819 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 144' ' ' VAL . . . . . 0.669 HG21 ' HB2' ' B' ' 151' ' ' HIS . 58.5 t -76.86 -40.77 31.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 124.665 1.186 . . . . 75.31 109.745 174.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 145' ' ' ASP . . . . . 0.419 ' HA ' ' HG ' ' B' ' 218' ' ' LEU . 1.0 OUTLIER 68.47 -79.55 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.131 1.373 . . . . 64.3 113.084 173.904 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 17.1 tt -132.86 -8.17 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 C-N-CA 123.135 0.574 . . . . 72.52 111.236 -175.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 -59.79 -45.13 93.26 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.847 0.859 . . . . 72.43 111.619 -177.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -140.24 163.91 31.5 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.121 1.368 . . . . 73.05 108.154 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 149' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -92.14 -9.58 41.93 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.049 0.54 . . . . 72.23 109.985 170.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -96.61 169.51 9.84 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.375 1.07 . . . . 74.11 109.979 -178.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 151' ' ' HIS . . . . . 0.669 ' HB2' HG21 ' B' ' 144' ' ' VAL . 34.1 m-70 65.73 85.62 0.15 Allowed Pre-proline 0 N--CA 1.485 1.305 0 C-N-CA 125.155 1.382 . . . . 74.43 109.446 -178.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.45 -16.14 24.55 Favored 'Trans proline' 0 C--N 1.374 1.891 0 C-N-CA 122.566 2.178 . . . . 42.51 113.02 -176.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 28.3 m 69.18 -68.55 0.18 Allowed 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 125.455 1.502 . . . . 74.2 110.482 -177.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 8.1 tp -88.3 134.51 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 N-CA-C 108.504 -0.924 . . . . 74.25 108.504 168.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 155' ' ' LEU . . . . . 0.641 HD23 ' H ' ' B' ' 155' ' ' LEU . 2.2 pt? -111.86 -4.41 14.6 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.441 0.696 . . . . 72.1 111.504 -173.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -88.72 -68.61 0.76 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.258 0.623 . . . . 72.23 110.026 -176.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 157' ' ' MET . . . . . . . . . . . . . 19.8 mmt -145.24 174.48 11.05 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.777 1.231 . . . . 53.54 108.691 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 158' ' ' ALA . . . . . . . . . . . . . . . -164.89 94.57 0.67 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.244 0.617 . . . . 34.04 109.543 175.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -152.14 80.51 1.25 Allowed 'General case' 0 C--O 1.242 0.679 0 C-N-CA 122.841 0.456 . . . . 55.45 109.973 175.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -172.85 133.46 0.56 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.262 1.025 . . . . 70.22 109.407 173.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.56 -34.27 62.88 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.422 0.689 . . . . 71.1 110.671 177.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 71.57 -155.68 52.35 Favored Glycine 0 C--N 1.352 1.463 0 CA-C-O 119.443 -0.643 . . . . 73.4 112.18 -178.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 9.4 tt 67.32 123.54 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 125.025 1.33 . . . . 65.02 111.889 177.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 164' ' ' ALA . . . . . . . . . . . . . . . -139.8 170.56 15.65 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.607 0.763 . . . . 75.34 109.614 175.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 3.2 t -73.59 75.36 1.49 Allowed 'General case' 0 CA--C 1.553 1.079 0 CA-C-O 121.925 0.869 . . . . 64.15 110.045 176.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . 84.16 -56.14 5.03 Favored Glycine 0 C--N 1.349 1.273 0 CA-C-N 114.988 -1.005 . . . . 71.15 111.98 -176.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 167' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -145.54 153.9 41.6 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 124.101 0.96 . . . . 72.31 109.582 -178.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . 0.62 HG21 ' HG3' ' B' ' 193' ' ' PRO . 88.4 t -61.14 104.97 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.952 1.301 . . . . 74.13 111.135 -176.007 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 25.2 m -88.64 -178.62 5.85 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.17 0.988 . . . . 54.35 110.567 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 72.6 p -63.5 -58.06 8.22 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.475 0.71 . . . . 63.1 110.288 178.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . 59.44 -81.21 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 125.389 1.476 . . . . 53.32 113.517 170.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 172' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -83.3 73.33 10.14 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.55 0.74 . . . . 73.22 110.786 -171.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 173' ' ' LEU . . . . . . . . . . . . . 21.7 tp 61.41 22.78 13.13 Favored 'General case' 0 CA--C 1.562 1.419 0 C-N-CA 124.876 1.271 . . . . 74.23 112.128 173.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 174' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 73.51 -8.64 1.32 Allowed 'General case' 0 N--CA 1.505 2.324 0 C-N-CA 124.629 1.172 . . . . 74.45 111.456 -173.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 175' ' ' ASP . . . . . . . . . . . . . 28.2 t70 71.56 135.05 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 127.159 2.184 . . . . 74.1 112.44 -177.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -96.34 -8.03 33.68 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.964 0.905 . . . . 74.11 112.154 -175.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 16.7 m -64.23 -40.77 55.59 Favored Pre-proline 0 CA--C 1.568 1.647 0 CA-C-O 118.377 -0.821 . . . . 64.31 112.843 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 178' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -58.56 156.31 32.33 Favored 'Trans proline' 0 C--N 1.399 3.231 0 C-N-CA 121.858 1.705 . . . . 74.53 112.568 172.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 179' ' ' ALA . . . . . 0.415 ' HB1' ' NE ' ' B' ' 46' ' ' ARG . . . -88.9 24.93 1.92 Allowed 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.997 0.919 . . . . 61.34 112.669 -170.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . 68.3 -67.26 0.2 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.329 1.452 . . . . 74.4 110.541 -169.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 35.1 tp -154.63 114.86 3.86 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 109.109 -0.7 . . . . 62.04 109.109 -178.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 182' ' ' VAL . . . . . . . . . . . . . 14.4 p 44.53 111.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 C-N-CA 127.033 2.133 . . . . 71.31 116.196 178.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -103.61 84.61 2.31 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 107.579 -1.267 . . . . 65.24 107.579 167.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 184' ' ' HIS . . . . . 0.509 ' NE2' ' HB3' ' B' ' 187' ' ' SER . 23.7 p-80 64.85 165.3 0.16 Allowed 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 126.871 2.068 . . . . 74.15 113.841 174.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 185' ' ' VAL . . . . . 0.619 HG23 ' HA ' ' C' ' 121' ' ' ALA . 7.7 p -84.94 116.18 28.05 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.969 0 CA-C-N 115.02 -0.991 . . . . 71.33 111.875 -170.094 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 80.4 p 48.45 79.72 0.07 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 125.868 1.667 . . . . 51.31 114.09 166.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 187' ' ' SER . . . . . 0.509 ' HB3' ' NE2' ' B' ' 184' ' ' HIS . 29.9 t -179.16 -33.19 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.359 0.663 . . . . 62.14 110.556 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.01 -78.17 0.12 Allowed 'General case' 0 CA--C 1.542 0.671 0 O-C-N 123.564 0.54 . . . . 71.52 109.687 -174.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 189' ' ' LYS . . . . . 0.542 ' HZ1' ' CD ' ' C' ' 122' ' ' GLU . 4.5 ttmp? 54.08 91.5 0.03 OUTLIER 'General case' 0 CA--C 1.56 1.364 0 C-N-CA 124.204 1.002 . . . . 72.52 111.906 -175.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 190' ' ' CYS . . . . . 0.866 ' HA ' ' HA ' ' B' ' 294' ' ' LYS . 54.0 t -142.58 92.71 2.44 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.054 0.541 . . . . 70.33 110.338 178.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 191' ' ' TYR . . . . . 0.623 ' HB2' HD22 ' C' ' 181' ' ' LEU . 49.7 p90 -157.79 149.71 22.05 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 111.991 0.367 . . . . 74.04 111.991 -174.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 63.04 174.12 2.41 Favored Glycine 0 C--N 1.35 1.34 0 O-C-N 124.387 1.054 . . . . 64.22 114.73 172.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 193' ' ' PRO . . . . . 0.62 ' HG3' HG21 ' B' ' 168' ' ' VAL . 73.0 Cg_endo -71.07 162.6 42.09 Favored 'Trans proline' 0 C--N 1.366 1.465 0 C-N-CA 122.531 2.154 . . . . 64.32 111.833 178.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 194' ' ' SER . . . . . . . . . . . . . 46.6 m -87.07 41.91 1.0 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.371 0.668 . . . . 24.51 111.174 178.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.05 -23.08 64.0 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.754 0.822 . . . . 74.32 110.805 175.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 196' ' ' THR . . . . . 0.47 HG23 ' HB ' ' B' ' 296' ' ' THR . 5.2 t -89.63 23.28 2.7 Favored 'General case' 0 CA--C 1.561 1.39 0 C-N-CA 124.698 1.199 . . . . 73.32 110.946 174.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 22.7 m 71.55 103.07 0.07 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.327 1.451 . . . . 75.11 112.599 169.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 198' ' ' GLU . . . . . 0.713 ' HB2' ' HA ' ' B' ' 296' ' ' THR . 6.5 tm-20 -160.31 -79.34 0.05 Allowed 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 107.267 -1.383 . . . . 51.12 107.267 172.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.59 -34.79 40.47 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.892 -0.781 . . . . 74.4 108.892 171.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 200' ' ' CYS . . . . . . . . . . . . . 55.3 m 68.93 154.19 0.14 Allowed Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 125.74 1.616 . . . . 73.31 113.2 168.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 201' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -83.5 164.28 14.47 Favored 'Trans proline' 0 C--N 1.369 1.617 0 C-N-CA 122.393 2.062 . . . . 71.34 111.789 170.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 150.86 -121.33 1.21 Allowed Glycine 0 C--N 1.335 0.48 0 N-CA-C 110.29 -1.124 . . . . 63.04 110.29 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -91.88 -162.23 0.9 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.3 0.64 . . . . 71.33 109.372 174.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 204' ' ' ALA . . . . . 0.491 ' H ' HD21 ' B' ' 217' ' ' LEU . . . -96.14 28.24 3.29 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.204 0.602 . . . . 74.01 110.846 177.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 205' ' ' LEU . . . . . . . . . . . . . 41.2 tp 64.36 -75.15 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.352 1.461 . . . . 51.03 110.126 -171.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 206' ' ' GLU . . . . . 0.509 ' HG2' ' HA2' ' B' ' 211' ' ' GLY . 0.5 OUTLIER -131.73 125.91 33.19 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 106.871 -1.529 . . . . 62.32 106.871 176.692 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 207' ' ' LYS . . . . . 0.447 ' HA ' ' HE2' ' B' ' 207' ' ' LYS . 0.6 OUTLIER -64.49 -37.86 89.01 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.881 0.873 . . . . 74.32 112.139 -173.197 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 137.09 10.85 1.1 Allowed Glycine 0 N--CA 1.469 0.897 0 CA-C-N 116.016 -0.538 . . . . 71.52 111.944 -174.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . -170.94 132.01 2.36 Favored Glycine 0 C--N 1.342 0.915 0 N-CA-C 110.723 -0.951 . . . . 42.21 110.723 -177.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 77.5 tttt 70.59 -78.01 0.05 Allowed 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 125.049 1.34 . . . . 74.51 111.393 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 211' ' ' GLY . . . . . 0.509 ' HA2' ' HG2' ' B' ' 206' ' ' GLU . . . 166.63 53.89 0.03 OUTLIER Glycine 0 C--N 1.335 0.492 0 N-CA-C 107.55 -2.22 . . . . 74.43 107.55 -169.036 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 50.3 m 65.58 88.38 0.11 Allowed 'General case' 0 C--N 1.354 0.78 0 C-N-CA 125.257 1.423 . . . . 74.04 108.738 -162.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 8.7 tp -68.54 -21.43 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 124.065 0.946 . . . . 64.4 111.413 -179.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 51.1 p -81.64 -1.49 46.84 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.332 0.653 . . . . 75.43 110.817 173.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 215' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 68.66 -69.45 0.15 Allowed 'General case' 0 C--N 1.366 1.285 0 C-N-CA 126.179 1.791 . . . . 73.31 109.916 -178.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -112.8 168.55 9.59 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.139 0.976 . . . . 61.42 109.133 169.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . 0.491 HD21 ' H ' ' B' ' 204' ' ' ALA . 3.5 pp -145.15 21.66 1.56 Allowed 'General case' 0 N--CA 1.484 1.229 0 CA-C-O 121.674 0.75 . . . . 75.4 109.639 173.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . 0.419 ' HG ' ' HA ' ' B' ' 145' ' ' ASP . 3.7 mm? -79.91 179.26 7.67 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 114.628 -1.169 . . . . 71.43 110.136 -177.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 12.2 t30 61.71 32.5 18.33 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 122.587 1.184 . . . . 71.24 108.809 -171.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -64.04 -24.49 67.72 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 114.332 -1.303 . . . . 61.1 112.484 -174.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 221' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -90.29 44.33 1.2 Allowed 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.861 0.864 . . . . 73.55 110.053 178.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -87.55 147.83 25.15 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 123.34 0.656 . . . . 42.52 109.419 175.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 223' ' ' ASP . . . . . 0.571 ' HA ' HG21 ' B' ' 269' ' ' THR . 28.7 t70 66.74 -82.82 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.692 1.197 . . . . 61.02 110.88 -177.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 45.2 t -84.41 84.11 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 108.194 -1.039 . . . . 74.2 108.194 173.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 15.0 m -74.84 -11.28 60.1 Favored 'General case' 0 CA--C 1.553 1.095 0 CA-C-N 114.902 -1.044 . . . . 54.34 111.255 -179.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 31.5 mt 73.2 108.65 0.07 Allowed 'General case' 0 C--N 1.366 1.302 0 C-N-CA 125.451 1.5 . . . . 74.43 109.765 178.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . -67.59 -18.37 69.92 Favored Glycine 0 C--N 1.351 1.397 0 O-C-N 123.461 0.476 . . . . 51.31 112.822 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 80.32 29.94 43.15 Favored Glycine 0 C--N 1.35 1.349 0 O-C-N 124.045 0.497 . . . . 72.41 112.002 177.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -166.01 -146.56 4.87 Favored Glycine 0 C--N 1.342 0.915 0 O-C-N 123.564 0.214 . . . . 70.24 112.753 -176.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -159.22 16.13 0.17 Allowed 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.761 0.824 . . . . 70.23 111.393 -171.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 231' ' ' LYS . . . . . . . . . . . . . 5.3 mptt 65.9 95.61 0.06 Allowed 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.484 1.114 . . . . 73.24 111.82 171.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 232' ' ' THR . . . . . 0.417 HG23 ' HA ' ' A' ' 278' ' ' ALA . 70.8 p 77.52 -41.4 0.36 Allowed 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 127.693 2.397 . . . . 74.24 112.709 177.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 65.19 -174.93 0.18 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.215 1.006 . . . . 70.41 110.323 -170.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -140.71 48.17 1.73 Allowed 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.084 0.469 . . . . 72.31 110.12 -173.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -101.92 126.2 48.77 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 108.335 -0.987 . . . . 54.41 108.335 178.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 236' ' ' THR . . . . . . . . . . . . . 45.1 m -80.65 -63.42 1.41 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.838 0.855 . . . . 73.34 111.3 -176.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -166.95 90.31 0.38 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.452 0.701 . . . . 71.12 110.4 -175.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 238' ' ' THR . . . . . 0.604 HG22 HG23 ' C' ' 219' ' ' VAL . 59.3 m -132.58 109.18 9.57 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 107.072 -1.455 . . . . 71.31 107.072 169.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 239' ' ' ALA . . . . . 0.418 ' H ' ' HA3' ' B' ' 359' ' ' GLY . . . -162.78 -88.56 0.02 OUTLIER 'General case' 0 C--O 1.236 0.387 0 N-CA-C 109.42 -0.585 . . . . 74.42 109.42 179.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 240' ' ' GLY . . . . . 0.577 ' HA3' ' HA ' ' C' ' 235' ' ' LEU . . . 162.55 -128.9 1.95 Allowed Glycine 0 C--N 1.339 0.705 0 N-CA-C 110.628 -0.989 . . . . 71.23 110.628 -169.04 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 241' ' ' GLU . . . . . 0.676 ' HG3' ' HG3' ' C' ' 234' ' ' ARG . 6.4 pt-20 -150.24 138.08 20.05 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.412 0.685 . . . . 71.21 109.784 -175.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 242' ' ' TRP . . . . . 0.408 ' CD2' ' HG ' ' C' ' 233' ' ' LEU . 1.0 OUTLIER -173.16 117.24 0.29 Allowed 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 107.155 -1.424 . . . . 70.32 107.155 170.628 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 243' ' ' GLN . . . . . 0.512 ' HA ' ' HB2' ' B' ' 367' ' ' LEU . 30.6 mt-30 59.69 -82.56 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 124.104 0.962 . . . . 74.22 109.081 -168.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 179.83 88.22 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 107.362 -2.295 . . . . 63.11 107.362 177.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 245' ' ' LYS . . . . . 0.427 ' HD3' ' HB3' ' C' ' 222' ' ' ALA . 0.0 OUTLIER -64.29 155.64 31.45 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 112.337 0.495 . . . . 75.34 112.337 -172.721 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 12.3 t -147.53 157.49 43.59 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.137 0.575 . . . . 71.02 111.075 -179.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 247' ' ' LEU . . . . . 0.481 HD13 ' HE3' ' C' ' 209' ' ' LYS . 40.7 tp -113.72 95.64 5.44 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 107.537 -1.282 . . . . 72.51 107.537 171.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 248' ' ' ARG . . . . . 0.512 ' HB3' HG22 ' C' ' 206' ' ' VAL . 0.9 OUTLIER -87.99 120.15 29.04 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 107.856 -1.164 . . . . 75.15 107.856 179.436 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -160.25 114.21 2.18 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 107.832 -1.173 . . . . 71.33 107.832 -170.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -123.7 85.94 2.5 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.41 0.684 . . . . 65.4 109.827 -174.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 251' ' ' ALA . . . . . . . . . . . . . . . 62.13 -86.94 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.13 1.372 . . . . 61.03 112.065 178.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . 0.564 ' NE2' ' HB2' ' B' ' 278' ' ' LEU . 59.6 tt0 172.24 -179.41 0.07 Allowed 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.98 0.912 . . . . 72.3 109.183 -168.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -58.17 159.5 5.85 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.993 0.917 . . . . 51.41 110.387 162.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 4.1 ppt_? -62.46 -22.04 65.92 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 112.956 0.725 . . . . 72.51 112.956 -170.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 255' ' ' GLY . . . . . 0.534 ' HA3' HD22 ' B' ' 277' ' ' LEU . . . -62.87 -25.0 67.26 Favored Glycine 0 C--N 1.357 1.746 0 O-C-N 123.43 0.456 . . . . 54.22 113.042 178.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 256' ' ' TYR . . . . . 0.458 ' HD2' HD23 ' B' ' 258' ' ' LEU . 36.1 t80 62.54 16.25 8.59 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.797 1.239 . . . . 52.52 112.895 166.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 257' ' ' GLN . . . . . 0.491 ' HG3' HD23 ' B' ' 278' ' ' LEU . 24.5 tm0? 67.01 3.27 3.05 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 124.747 1.219 . . . . 74.31 111.994 178.128 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 258' ' ' LEU . . . . . 0.458 HD23 ' HD2' ' B' ' 256' ' ' TYR . 2.5 pp -83.43 24.91 0.79 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.258 -0.901 . . . . 75.13 112.039 -177.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 30.1 m -63.56 -15.91 17.27 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 C-N-CA 124.765 1.226 . . . . 63.02 112.372 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 260' ' ' SER . . . . . . . . . . . . . 49.2 m 65.37 33.2 9.16 Favored 'General case' 0 C--N 1.366 1.299 0 C-N-CA 124.615 1.166 . . . . 73.11 111.816 172.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 30.6 t70 71.47 147.78 0.08 Allowed 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 125.431 1.492 . . . . 52.21 111.385 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 262' ' ' ALA . . . . . . . . . . . . . . . 75.95 -49.23 0.6 Allowed 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 125.651 1.581 . . . . 43.43 111.487 -175.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . 73.64 -69.83 0.18 Allowed 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 125.326 1.45 . . . . 70.44 110.967 177.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 47.3 t -137.33 -22.89 1.13 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.047 0.939 . . . . 51.14 110.027 176.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 265' ' ' LEU . . . . . . . . . . . . . 56.9 tp 57.29 94.99 0.02 OUTLIER 'General case' 0 C--N 1.357 0.911 0 C-N-CA 125.294 1.438 . . . . 64.12 111.569 178.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 266' ' ' ASN . . . . . 0.685 ' HB3' ' HD2' ' B' ' 275' ' ' LYS . 45.9 t30 -130.7 119.5 22.48 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 107.621 -1.251 . . . . 71.52 107.621 176.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 30.9 m -63.68 -33.65 76.1 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.877 0.871 . . . . 73.13 112.571 -168.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 8.5 p -72.66 128.7 35.72 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 N-CA-C 109.545 -0.539 . . . . 74.44 109.545 176.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 269' ' ' THR . . . . . 0.571 HG21 ' HA ' ' B' ' 223' ' ' ASP . 8.3 t -62.73 -42.6 99.74 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.27 0.628 . . . . 74.31 110.532 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 270' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' B' ' 269' ' ' THR . 4.7 pt-20 64.55 -11.32 0.13 Allowed 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 127.62 2.368 . . . . 72.41 115.716 168.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 271' ' ' ALA . . . . . . . . . . . . . . . 66.39 -9.32 0.32 Allowed 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 125.392 1.477 . . . . 75.3 114.785 174.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 272' ' ' ASN . . . . . 0.437 ' HA ' HG22 ' C' ' 262' ' ' THR . 96.8 m-20 -99.67 31.86 3.06 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.479 0.711 . . . . 54.14 111.116 -174.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 15.4 tm0? 62.4 -84.0 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.404 1.082 . . . . 61.32 109.901 -178.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 274' ' ' GLN . . . . . 0.44 ' HB3' ' HD3' ' B' ' 275' ' ' LYS . 7.2 tp60 65.63 -72.28 0.08 Allowed 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 126.144 1.778 . . . . 71.44 113.497 178.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 275' ' ' LYS . . . . . 0.685 ' HD2' ' HB3' ' B' ' 266' ' ' ASN . 2.2 mppt? -81.16 -60.96 0.41 Allowed Pre-proline 0 CA--C 1.562 1.436 0 CA-C-O 118.705 -0.664 . . . . 71.33 111.727 -172.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 276' ' ' PRO . . . . . 0.482 ' HD3' ' HB2' ' B' ' 275' ' ' LYS . 89.4 Cg_endo -88.66 103.93 0.43 Allowed 'Trans proline' 0 C--N 1.393 2.887 0 C-N-CA 121.949 1.766 . . . . 62.35 112.621 -172.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 277' ' ' LEU . . . . . 0.534 HD22 ' HA3' ' B' ' 255' ' ' GLY . 6.5 mp -74.95 -7.65 54.21 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 122.819 0.448 . . . . 63.32 111.388 175.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 278' ' ' LEU . . . . . 0.564 ' HB2' ' NE2' ' B' ' 252' ' ' GLN . 37.3 tp -162.32 -57.33 0.04 OUTLIER 'General case' 0 C--O 1.234 0.27 0 N-CA-C 107.525 -1.287 . . . . 62.0 107.525 172.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . 75.47 -77.67 1.21 Allowed Glycine 0 C--N 1.347 1.178 0 CA-C-N 115.082 -0.963 . . . . 75.43 111.651 -176.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 63.79 72.05 0.48 Allowed 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.132 1.373 . . . . 53.23 109.728 178.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -160.91 -47.32 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.78 -0.646 . . . . 75.31 110.06 178.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -156.93 148.13 22.05 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.726 0.81 . . . . 65.41 110.042 -178.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -170.9 -59.8 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.799 1.24 . . . . 72.33 108.324 -179.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . 96.28 137.35 9.3 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-N 114.503 -1.226 . . . . 61.45 112.958 176.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -93.54 -159.01 0.66 Allowed 'General case' 0 CA--C 1.551 0.995 0 N-CA-C 107.948 -1.13 . . . . 72.41 107.948 172.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 286' ' ' MET . . . . . . . . . . . . . 57.8 mtt -124.94 74.93 66.43 Favored Pre-proline 0 N--CA 1.488 1.463 0 CA-C-N 118.731 0.696 . . . . 64.1 111.715 -175.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 287' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -86.95 -33.13 0.17 Allowed 'Trans proline' 0 C--N 1.384 2.441 0 C-N-CA 122.732 2.288 . . . . 73.33 113.485 170.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 288' ' ' VAL . . . . . . . . . . . . . 29.3 t 53.22 -89.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 125.614 1.566 . . . . 74.32 111.717 -176.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 289' ' ' ARG . . . . . 0.541 ' NH1' ' HB3' ' B' ' 291' ' ' LEU . 0.4 OUTLIER 169.74 89.14 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 104.755 -2.313 . . . . 72.14 104.755 179.504 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 290' ' ' TRP . . . . . . . . . . . . . 70.0 m95 -93.81 143.71 26.09 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.247 0.546 . . . . 75.34 111.117 -177.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 291' ' ' LEU . . . . . 0.541 ' HB3' ' NH1' ' B' ' 289' ' ' ARG . 2.3 pt? -153.45 174.06 14.87 Favored 'General case' 0 C--O 1.243 0.714 0 CA-C-N 114.633 -1.167 . . . . 64.34 109.893 -179.279 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . -113.9 83.65 0.34 Allowed Glycine 0 C--N 1.344 0.977 0 CA-C-O 118.965 -0.908 . . . . 62.12 112.703 177.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -83.13 65.06 7.9 Favored 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 123.099 2.533 . . . . 51.12 111.31 174.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 294' ' ' LYS . . . . . 0.866 ' HA ' ' HA ' ' B' ' 190' ' ' CYS . 15.0 ptpt 55.4 8.36 0.28 Allowed 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 127.042 2.137 . . . . 41.23 115.709 174.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 295' ' ' ALA . . . . . 0.414 ' HB2' ' O ' ' B' ' 191' ' ' TYR . . . 61.63 -75.0 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.986 1.314 . . . . 34.32 111.593 -175.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 296' ' ' THR . . . . . 0.713 ' HA ' ' HB2' ' B' ' 198' ' ' GLU . 9.5 t -150.14 -15.25 0.25 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.084 0.953 . . . . 65.42 111.014 -179.007 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 20.5 t80 64.73 20.44 12.13 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 125.23 1.412 . . . . 64.12 111.915 -178.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 298' ' ' HIS . . . . . 0.534 ' H ' HG23 ' B' ' 296' ' ' THR . 65.0 m170 -72.49 85.58 1.14 Allowed 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 108.804 -0.813 . . . . 71.5 108.804 171.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . -60.91 -37.84 94.42 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-N 115.441 -0.799 . . . . 63.41 113.559 -171.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -67.68 -34.58 77.21 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.037 0.935 . . . . 72.23 111.232 176.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 301' ' ' ILE . . . . . . . . . . . . . 16.1 tt 37.32 90.28 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.366 1.315 0 C-N-CA 126.467 1.907 . . . . 72.24 112.09 -172.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 302' ' ' ASP . . . . . 0.452 ' O ' ' HG2' ' B' ' 303' ' ' LYS . 18.3 t70 -75.25 81.66 2.37 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.41 -0.814 . . . . 63.41 111.389 -170.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 303' ' ' LYS . . . . . 0.687 ' HE3' ' HA ' ' B' ' 303' ' ' LYS . 0.0 OUTLIER -172.0 -61.22 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.36 0 C-N-CA 126.891 2.076 . . . . 74.11 107.758 162.717 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 304' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -92.66 -28.37 0.14 Allowed 'Trans proline' 0 C--N 1.395 3.007 0 C-N-CA 121.863 1.709 . . . . 75.12 114.561 176.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . 50.55 -95.11 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.969 1.308 . . . . 42.33 111.826 -172.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . 0.523 HG21 HH12 ' B' ' 56' ' ' ARG . 26.4 m -142.06 156.58 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 125.176 1.391 . . . . 72.33 108.144 170.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 8.7 t -91.66 111.35 22.83 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 108.172 -1.048 . . . . 74.23 108.172 171.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 308' ' ' CYS . . . . . . . . . . . . . 44.3 t -88.76 21.21 3.12 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.025 0.93 . . . . 74.22 111.374 -173.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 42.2 p -77.28 112.63 24.76 Favored Pre-proline 0 CA--C 1.553 1.082 0 C-N-CA 124.166 0.986 . . . . 72.2 110.733 -177.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -74.86 107.66 2.53 Favored 'Trans proline' 0 C--N 1.377 2.037 0 C-N-CA 122.226 1.951 . . . . 63.14 110.673 174.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 311' ' ' ASN . . . . . 0.627 HD22 ' HD2' ' C' ' 160' ' ' ARG . 3.7 t30 -72.63 136.83 80.47 Favored Pre-proline 0 CA--C 1.552 1.052 0 N-CA-C 109.245 -0.65 . . . . 73.13 109.245 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 312' ' ' PRO . . . . . 0.631 ' HG3' HD11 ' B' ' 69' ' ' LEU . 52.8 Cg_exo -57.1 166.65 3.96 Favored 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 123.076 2.518 . . . . 70.14 113.823 178.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 313' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -85.58 45.7 1.22 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.866 0.867 . . . . 75.13 110.48 -178.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 314' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -70.18 106.01 3.14 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.009 0.923 . . . . 72.01 108.817 -177.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 315' ' ' ASN . . . . . 0.571 ' HB3' ' HG2' ' B' ' 27' ' ' PRO . 51.8 t30 72.22 125.19 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.471 1.509 . . . . 72.12 112.037 178.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 316' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -102.53 -16.97 15.95 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.876 0.87 . . . . 74.4 110.964 176.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 15.2 m -91.63 106.36 18.42 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.706 0.802 . . . . 75.41 111.009 -170.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 318' ' ' VAL . . . . . 0.408 HG23 HG11 ' B' ' 28' ' ' VAL . 2.9 p -75.54 117.42 63.23 Favored Pre-proline 0 CA--C 1.556 1.188 0 C-N-CA 123.366 0.666 . . . . 73.13 109.576 171.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 319' ' ' PRO . . . . . 0.518 ' HD2' HG13 ' B' ' 28' ' ' VAL . 73.4 Cg_exo -54.55 107.5 0.23 Allowed 'Trans proline' 0 C--N 1.382 2.324 0 C-N-CA 123.07 2.513 . . . . 65.1 112.176 175.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 320' ' ' THR . . . . . . . . . . . . . 14.4 t -162.44 170.28 19.01 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.427 0.691 . . . . 53.31 110.328 -178.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 321' ' ' LEU . . . . . . . . . . . . . 50.4 tp -108.36 -90.93 0.44 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 122.887 0.475 . . . . 65.14 110.04 -178.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 322' ' ' ALA . . . . . 0.555 ' HA ' ' HB2' ' C' ' 27' ' ' LYS . . . -156.07 -62.35 0.11 Allowed 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 107.203 -1.406 . . . . 64.54 107.203 -179.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 323' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -82.2 101.37 10.43 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 114.97 -1.014 . . . . 74.02 108.43 169.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 324' ' ' MET . . . . . 0.514 ' HB2' ' HE2' ' C' ' 27' ' ' LYS . 17.1 tmm? -73.7 -49.14 27.17 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 106.59 -1.633 . . . . 71.32 106.59 169.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 325' ' ' THR . . . . . 0.42 ' HA ' ' NH2' ' C' ' 24' ' ' ARG . 91.7 m 75.16 -55.95 0.63 Allowed 'General case' 0 C--N 1.356 0.869 0 C-N-CA 126.46 1.904 . . . . 72.33 113.358 168.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 326' ' ' ASP . . . . . 0.653 ' HB3' HD12 ' B' ' 329' ' ' ILE . 1.4 t70 58.99 -92.1 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.814 0 O-C-N 124.203 0.94 . . . . 72.01 109.216 -170.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . 0.409 ' HA ' ' HD2' ' B' ' 327' ' ' LYS . 20.2 tptp 174.64 -38.86 0.01 OUTLIER 'General case' 0 C--N 1.36 1.053 0 C-N-CA 124.127 0.971 . . . . 54.34 110.376 -178.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 328' ' ' ALA . . . . . 0.545 ' HB2' ' HB1' ' B' ' 40' ' ' ALA . . . -138.64 -12.56 1.32 Allowed 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 115.874 1.805 . . . . 72.03 115.874 -165.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 329' ' ' ILE . . . . . 0.653 HD12 ' HB3' ' B' ' 326' ' ' ASP . 0.2 OUTLIER -58.2 -27.06 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.757 0 CA-C-N 120.922 1.692 . . . . 73.5 113.039 -177.197 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 330' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -106.78 -11.73 15.7 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.867 0.867 . . . . 63.42 112.426 -172.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 331' ' ' LEU . . . . . . . . . . . . . 3.4 pp -149.58 -157.33 0.81 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.611 0.764 . . . . 63.34 110.034 -177.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 332' ' ' LEU . . . . . 0.435 HD12 ' HB3' ' B' ' 335' ' ' ASN . 2.0 tm? 81.13 -41.35 0.16 Allowed 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 125.566 1.546 . . . . 74.41 111.973 174.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 333' ' ' SER . . . . . . . . . . . . . 19.9 m 78.76 120.91 0.05 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.917 1.687 . . . . 65.04 110.819 -173.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm 65.39 -83.06 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.488 1.515 . . . . 63.11 111.638 -175.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 335' ' ' ASN . . . . . 0.435 ' HB3' HD12 ' B' ' 332' ' ' LEU . 2.0 p-10 50.53 120.81 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 126.013 1.725 . . . . 73.25 112.421 -168.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 336' ' ' GLU . . . . . 0.436 ' HB2' ' HA ' ' B' ' 44' ' ' ALA . 46.8 mt-10 74.84 -51.35 0.67 Allowed 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 125.654 1.582 . . . . 61.02 113.024 -179.096 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 337' ' ' LYS . . . . . 0.57 ' HD2' ' HB2' ' B' ' 45' ' ' ARG . 61.9 tttm -52.07 -41.44 62.36 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.709 1.204 . . . . 62.43 113.049 -174.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 338' ' ' GLY . . . . . . . . . . . . . . . -147.03 13.06 1.46 Allowed Glycine 0 C--N 1.34 0.761 0 CA-C-N 116.133 -0.485 . . . . 72.34 112.891 177.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 339' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -146.4 125.58 12.96 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.405 0.682 . . . . 74.33 110.174 -177.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 340' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -78.2 -23.24 47.63 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 108.951 -0.759 . . . . 75.24 108.951 165.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 341' ' ' LEU . . . . . . . . . . . . . 31.4 tp 67.63 -78.01 0.04 OUTLIER 'General case' 0 C--N 1.357 0.909 0 C-N-CA 125.734 1.614 . . . . 75.34 110.62 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 342' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -161.32 27.5 0.13 Allowed 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 123.037 0.535 . . . . 64.25 109.81 -176.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 343' ' ' VAL . . . . . . . . . . . . . 7.6 p -71.51 82.45 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.236 0 CA-C-O 122.211 1.005 . . . . 64.24 110.531 -177.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 61.75 10.0 3.18 Favored 'General case' 0 C--N 1.36 1.064 0 CA-C-N 114.221 -1.354 . . . . 73.03 112.679 -177.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 345' ' ' GLY . . . . . . . . . . . . . . . 77.54 -63.18 3.41 Favored Glycine 0 C--N 1.351 1.393 0 N-CA-C 111.305 -0.718 . . . . 62.31 111.305 -170.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 346' ' ' ALA . . . . . . . . . . . . . . . -122.19 119.7 32.02 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.246 1.018 . . . . 72.22 109.59 172.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 18.5 m -80.03 89.5 5.36 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.624 0.769 . . . . 72.21 108.949 174.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 14.9 tt -155.56 30.95 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.108 0 C-N-CA 123.994 0.917 . . . . 73.42 109.006 -173.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 349' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 61.0 69.05 0.7 Allowed 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.64 1.176 . . . . 71.13 108.924 -172.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 350' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.37 84.58 6.62 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.041 -0.981 . . . . 74.52 108.697 -172.155 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 55.85 19.89 3.8 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 125.131 1.372 . . . . 71.32 113.647 171.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -80.55 157.06 26.19 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 122.634 0.374 . . . . 74.35 110.458 -173.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 353' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -55.33 -40.92 71.75 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.026 0.931 . . . . 74.33 111.29 175.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 354' ' ' ALA . . . . . . . . . . . . . . . 76.46 -61.9 0.43 Allowed 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 125.543 1.537 . . . . 70.11 113.738 168.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 355' ' ' ALA . . . . . . . . . . . . . . . 74.2 4.83 4.61 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 125.259 1.424 . . . . 75.44 111.312 -167.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 356' ' ' ASN . . . . . 0.412 ' N ' ' HD2' ' B' ' 357' ' ' PRO . 1.8 m-20 -76.08 -43.77 3.67 Favored Pre-proline 0 CA--C 1.557 1.223 0 C-N-CA 124.574 1.15 . . . . 74.32 111.269 175.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 357' ' ' PRO . . . . . 0.412 ' HD2' ' N ' ' B' ' 356' ' ' ASN . 58.1 Cg_endo -67.8 172.18 11.04 Favored 'Trans proline' 0 C--N 1.403 3.412 0 C-N-CA 121.877 1.718 . . . . 55.22 113.472 177.156 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 358' ' ' CYS . . . . . . . . . . . . . 48.3 t 79.34 158.11 0.17 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 126.012 1.725 . . . . 73.32 111.741 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 359' ' ' GLY . . . . . 0.418 ' HA3' ' H ' ' B' ' 239' ' ' ALA . . . -167.8 78.3 0.11 Allowed Glycine 0 C--N 1.342 0.869 0 CA-C-N 115.301 -0.863 . . . . 62.01 111.635 178.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 360' ' ' GLN . . . . . 0.556 HE21 ' HG3' ' C' ' 236' ' ' LYS . 12.3 mm-40 59.99 -153.63 0.38 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.792 1.237 . . . . 53.34 112.398 175.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 361' ' ' ILE . . . . . . . . . . . . . 34.2 mm -53.71 152.22 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 124.609 1.164 . . . . 61.31 111.365 178.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 362' ' ' GLY . . . . . . . . . . . . . . . -65.72 -156.39 0.32 Allowed Glycine 0 C--N 1.352 1.449 0 C-N-CA 123.287 0.47 . . . . 72.35 114.245 178.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 363' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -81.0 82.11 7.06 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 108.753 -0.832 . . . . 73.13 108.753 -175.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 364' ' ' THR . . . . . . . . . . . . . 5.5 t -92.52 -42.7 9.56 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 114.974 -1.012 . . . . 74.04 112.978 -165.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 50.2 t 58.89 105.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 124.37 1.068 . . . . 74.01 110.816 -167.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -153.28 167.61 28.77 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.675 0.79 . . . . 50.12 109.238 -174.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 367' ' ' LEU . . . . . 0.512 ' HB2' ' HA ' ' B' ' 243' ' ' GLN . 96.3 mt 58.97 100.06 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.697 1.199 . . . . 75.05 112.527 175.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 368' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -62.48 126.6 27.89 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.466 0.706 . . . . 71.23 110.738 178.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 369' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -137.29 128.63 28.11 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.385 0.674 . . . . 70.1 109.313 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 370' ' ' ALA . . . . . . . . . . . . . . . -162.24 105.29 1.14 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.958 0.903 . . . . 74.25 108.896 -173.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 371' ' ' VAL . . . . . . . . . . . . . 11.7 m -127.29 -48.12 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 112.905 0.706 . . . . 74.11 112.905 -168.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 372' ' ' GLN . . . . . 0.457 ' HB3' ' HG2' ' C' ' 228' ' ' GLN . 49.9 tp60 -95.43 -79.62 0.43 Allowed 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 119.237 -0.411 . . . . 63.2 110.716 -163.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 373' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 44.73 16.87 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.417 0 C-N-CA 127.083 2.153 . . . . 72.05 116.067 -179.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 374' ' ' ALA . . . . . 0.477 ' HB3' HH22 ' C' ' 279' ' ' ARG . . . 61.58 12.1 4.28 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.253 1.021 . . . . 71.45 112.165 -170.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 375' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 64.58 -77.28 0.04 OUTLIER 'General case' 0 C--N 1.356 0.875 0 C-N-CA 126.615 1.966 . . . . 62.01 110.487 -174.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -91.37 124.6 35.68 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.868 0.867 . . . . 73.13 110.803 -175.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 377' ' ' PHE . . . . . 0.441 ' O ' ' HG2' ' C' ' 279' ' ' ARG . 83.3 m-85 -86.95 -16.05 37.0 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.561 0.744 . . . . 73.31 110.469 169.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 378' ' ' ALA . . . . . . . . . . . . . . . -87.39 -63.78 1.25 Allowed 'General case' 0 C--N 1.344 0.352 0 C-N-CA 123.267 0.627 . . . . 61.1 110.936 -178.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . 0.517 ' HE2' ' HG2' ' B' ' 381' ' ' GLU 0.263 8.2 ptmm? 48.48 -77.53 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 125.915 1.686 . . . . 72.01 112.504 -164.562 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 380' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? 57.27 79.8 0.18 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.903 0.881 . . . . 53.14 111.563 -176.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 381' ' ' GLU . . . . . 0.517 ' HG2' ' HE2' ' B' ' 379' ' ' LYS . 40.9 mm-40 -90.08 -30.2 17.85 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.236 -0.438 . . . . 74.34 110.006 178.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . 64.58 58.14 10.96 Favored Glycine 0 C--N 1.351 1.39 0 N-CA-C 111.284 -0.727 . . . . 73.1 111.284 -174.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 383' ' ' ASN . . . . . . . . . . . . 0.271 10.7 p30 72.5 -16.25 0.45 Allowed 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 126.994 2.118 . . . . 73.1 114.676 176.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 384' ' ' THR . . . . . 0.407 HG21 ' HA ' ' A' ' 219' ' ' VAL . 3.1 m 58.6 44.52 17.48 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 124.747 1.219 . . . . 63.41 110.796 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 96.4 mt 61.77 22.97 13.4 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 124.273 1.029 . . . . 75.12 111.268 -175.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 386' ' ' VAL . . . . . 0.444 ' O ' HG22 ' B' ' 387' ' ' ILE . 3.1 t 53.05 23.19 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 C-N-CA 125.722 1.609 . . . . 62.42 111.121 -173.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 387' ' ' ILE . . . . . 0.475 HG23 ' H ' ' B' ' 389' ' ' THR 0.262 6.3 tt 67.33 -41.74 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 C-N-CA 128.031 2.532 . . . . 74.12 114.789 -177.253 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 388' ' ' VAL . . . . . . . . . . . . . 4.8 p 55.61 20.09 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 C-N-CA 126.185 1.794 . . . . 54.33 113.34 175.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 389' ' ' THR . . . . . 0.475 ' H ' HG23 ' B' ' 387' ' ' ILE . 56.0 m -156.02 157.5 36.24 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.162 0.985 . . . . 71.25 109.169 -176.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . 68.94 36.19 2.62 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 124.464 1.106 . . . . 70.34 110.695 177.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 391' ' ' ASP . . . . . 0.536 ' HB3' ' HA2' ' B' ' 436' ' ' GLY . 5.0 p-10 -75.48 -163.99 0.3 Allowed 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 114.588 -1.187 . . . . 64.12 111.123 176.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 392' ' ' HIS . . . . . . . . . . . . . 57.4 t60 -63.36 -48.23 78.78 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.144 0.978 . . . . 72.42 111.287 -176.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -99.71 5.37 45.71 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.522 0.729 . . . . 61.53 111.514 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 11.6 m170 66.46 16.91 10.56 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 124.903 1.281 . . . . 73.31 112.002 172.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . -163.11 -56.44 0.04 OUTLIER 'General case' 0 C--O 1.238 0.454 0 C-N-CA 123.633 0.773 . . . . 71.44 109.586 -172.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 77.4 p 51.73 -173.32 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 125.853 1.661 . . . . 75.55 113.572 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 397' ' ' GLN . . . . . 0.545 ' HB2' ' HB3' ' B' ' 401' ' ' PRO . 2.3 mp0 -72.24 116.67 12.95 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.549 -0.908 . . . . 71.41 108.549 170.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 398' ' ' ILE . . . . . 0.604 HG21 ' HD2' ' B' ' 415' ' ' LYS . 14.1 tt -57.71 144.69 9.85 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 O-C-N 123.826 0.704 . . . . 75.44 110.706 176.021 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 399' ' ' VAL . . . . . . . . . . . . . 58.3 t 74.68 -83.93 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 C-N-CA 125.43 1.492 . . . . 73.32 110.661 -176.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 400' ' ' ALA . . . . . . . . . . . . . . . -128.05 91.41 44.77 Favored Pre-proline 0 N--CA 1.492 1.631 0 N-CA-C 113.309 0.855 . . . . 51.41 113.309 -168.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 401' ' ' PRO . . . . . 0.545 ' HB3' ' HB2' ' B' ' 397' ' ' GLN . 68.5 Cg_endo -96.36 -171.67 0.19 Allowed 'Trans proline' 0 C--N 1.371 1.715 0 C-N-CA 123.559 2.839 . . . . 71.04 111.186 160.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -166.02 94.21 0.56 Allowed 'General case' 0 N--CA 1.482 1.172 0 CA-C-O 120.922 0.391 . . . . 74.34 110.799 -178.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 403' ' ' THR . . . . . 0.554 ' H ' ' HB2' ' B' ' 433' ' ' GLU . 7.5 m 61.14 12.24 3.95 Favored 'General case' 0 CA--C 1.569 1.695 0 C-N-CA 124.817 1.247 . . . . 51.3 111.897 174.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 404' ' ' LYS . . . . . . . . . . . . . 9.3 mtmp? -148.46 86.89 1.55 Allowed 'General case' 0 C--O 1.243 0.724 0 C-N-CA 125.363 1.465 . . . . 70.03 107.259 -171.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 405' ' ' ALA . . . . . . . . . . . . . . . -66.04 -43.66 57.71 Favored Pre-proline 0 CA--C 1.56 1.339 0 CA-C-N 115.261 -0.881 . . . . 71.24 111.944 179.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 406' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -94.02 50.41 0.31 Allowed 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 122.291 1.994 . . . . 44.44 111.386 165.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . -70.22 -71.61 0.99 Allowed Glycine 0 C--N 1.344 1.017 0 CA-C-N 115.867 -0.606 . . . . 55.33 113.741 -176.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 408' ' ' LEU . . . . . 0.458 HD13 ' N ' ' B' ' 409' ' ' THR . 0.8 OUTLIER -148.99 151.7 35.01 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 109.0 -0.741 . . . . 72.03 109.0 -170.75 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 409' ' ' THR . . . . . 0.458 ' N ' HD13 ' B' ' 408' ' ' LEU . 52.8 p 56.06 24.32 7.73 Favored 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 125.591 1.556 . . . . 73.52 111.811 -174.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 410' ' ' GLN . . . . . 0.502 ' HA ' ' OG1' ' B' ' 414' ' ' THR . 0.1 OUTLIER -81.06 81.34 7.32 Favored 'General case' 0 C--N 1.35 0.624 0 N-CA-C 108.073 -1.084 . . . . 51.32 108.073 178.616 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . -77.26 -62.14 1.75 Allowed 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 114.753 -1.112 . . . . 63.14 109.523 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 412' ' ' LEU . . . . . 0.578 HD12 ' HB3' ' B' ' 106' ' ' TYR . 1.7 tm? -158.95 93.72 1.18 Allowed 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 106.258 -1.756 . . . . 60.41 106.258 -178.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 78.33 -43.04 0.35 Allowed 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 125.605 1.562 . . . . 71.14 112.791 -179.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 414' ' ' THR . . . . . 0.502 ' OG1' ' HA ' ' B' ' 410' ' ' GLN . 1.7 m 66.03 37.16 5.41 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.86 1.264 . . . . 73.24 109.833 -176.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 415' ' ' LYS . . . . . 0.604 ' HD2' HG21 ' B' ' 398' ' ' ILE . 92.6 mttt 72.42 118.0 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 125.355 1.462 . . . . 73.42 110.313 -178.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -70.96 84.06 0.68 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.293 1.037 . . . . 75.33 111.067 -175.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 417' ' ' GLY . . . . . . . . . . . . . . . 78.26 154.02 7.01 Favored Glycine 0 C--N 1.345 1.053 0 CA-C-N 115.418 -0.81 . . . . 43.15 113.395 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 418' ' ' ALA . . . . . . . . . . . . . . . -85.87 73.26 10.38 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.101 -1.074 . . . . 70.25 108.101 170.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 419' ' ' VAL . . . . . . . . . . . . . 31.5 m -60.54 131.15 25.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 CA-C-N 114.117 -1.401 . . . . 62.03 112.635 -168.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 420' ' ' MET . . . . . . . . . . . . . 70.6 mtm 72.11 -59.95 0.54 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 126.082 1.753 . . . . 73.12 112.572 177.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 421' ' ' VAL . . . . . . . . . . . . . 19.9 m -58.53 -52.25 61.87 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 C-N-CA 124.235 1.014 . . . . 72.42 112.679 -177.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 422' ' ' MET . . . . . 0.486 ' HG3' ' H ' ' B' ' 424' ' ' TYR . 8.4 tpt 60.99 139.99 0.01 OUTLIER 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 124.65 1.18 . . . . 74.1 112.567 -176.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 423' ' ' SER . . . . . . . . . . . . . 34.5 t -81.0 -14.17 58.19 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.445 0.698 . . . . 62.22 111.821 -178.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 424' ' ' TYR . . . . . 0.486 ' H ' ' HG3' ' B' ' 422' ' ' MET . 8.5 m-85 64.87 -153.92 0.29 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.836 1.254 . . . . 72.42 110.83 -178.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . 107.14 74.16 0.87 Allowed Glycine 0 C--N 1.345 1.073 0 N-CA-C 109.956 -1.258 . . . . 75.12 109.956 -174.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 426' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -62.11 -35.56 79.07 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.545 0.738 . . . . 75.43 112.236 -174.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 427' ' ' SER . . . . . . . . . . . . . 27.8 t -108.14 36.9 2.62 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.376 0.67 . . . . 75.14 109.354 177.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 69.73 -74.75 0.08 Allowed 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 125.974 1.71 . . . . 73.23 111.046 -177.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 429' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 34.03 -74.45 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 127.846 2.458 . . . . 63.42 117.008 167.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 430' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -71.84 -68.05 0.49 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.396 0.678 . . . . 55.41 111.257 -170.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 11.8 p -98.34 -12.03 21.91 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-O 119.124 -0.465 . . . . 73.31 112.052 -175.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 432' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 59.48 -74.24 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 125.288 1.435 . . . . 71.1 113.988 170.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 433' ' ' GLU . . . . . 0.554 ' HB2' ' H ' ' B' ' 403' ' ' THR . 55.2 tt0 -80.76 -16.3 54.19 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.488 0.715 . . . . 73.43 110.585 175.227 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 434' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 67.91 13.42 9.16 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.677 1.191 . . . . 65.13 113.895 166.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 435' ' ' THR . . . . . . . . . . . . . 4.8 m 61.67 26.35 16.04 Favored 'General case' 0 CA--C 1.563 1.463 0 CA-C-O 122.495 1.141 . . . . 73.42 109.371 -174.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 436' ' ' GLY . . . . . 0.536 ' HA2' ' HB3' ' B' ' 391' ' ' ASP . . . 141.54 90.31 0.16 Allowed Glycine 0 C--N 1.348 1.195 0 N-CA-C 109.075 -1.61 . . . . 43.54 109.075 -168.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 37.1 p -85.43 70.22 10.77 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.663 0.785 . . . . 54.14 110.22 -177.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 438' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 58.65 169.66 0.06 Allowed 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 126.43 1.892 . . . . 71.55 112.935 -176.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 439' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -85.96 83.12 7.88 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 107.628 -1.249 . . . . 74.24 107.628 177.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 440' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -95.98 146.82 24.3 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.14 0.576 . . . . 70.1 110.789 -179.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 441' ' ' ILE . . . . . 0.601 HD12 ' HA ' ' A' ' 223' ' ' VAL . 58.7 mt -97.99 138.08 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.861 0.864 . . . . 74.15 110.58 -179.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 442' ' ' ALA . . . . . . . . . . . . . . . -132.87 98.91 4.43 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 107.758 -1.201 . . . . 71.41 107.758 170.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . -133.92 -67.86 0.58 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.551 0.741 . . . . 74.21 110.054 -174.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -151.6 153.12 33.86 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.838 0.855 . . . . 65.34 109.639 174.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . 125.3 -82.99 0.35 Allowed Glycine 0 CA--C 1.53 0.974 0 CA-C-O 119.229 -0.762 . . . . 74.34 111.229 -177.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 446' ' ' PRO . . . . . 0.564 ' HD3' ' HD2' ' A' ' 225' ' ' PRO . 94.5 Cg_endo -80.54 135.5 10.49 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 122.726 2.284 . . . . 63.02 112.379 -176.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 447' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -139.06 152.28 47.43 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.966 0.907 . . . . 60.0 108.998 178.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . -68.11 134.65 50.91 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.103 0.561 . . . . 74.31 109.969 175.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 449' ' ' ALA . . . . . . . . . . . . . . . -109.43 113.16 25.73 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.766 0.826 . . . . 61.52 108.916 177.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 450' ' ' ASN . . . . . 0.541 HD22 ' HG ' ' B' ' 454' ' ' LEU . 28.2 p-10 -72.51 -27.47 62.28 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.341 0.657 . . . . 61.12 111.065 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 451' ' ' VAL . . . . . 0.544 HG12 ' HA ' ' B' ' 464' ' ' MET 0.283 35.1 m 49.52 -76.77 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 C-N-CA 127.26 2.224 . . . . 63.1 114.131 177.72 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 452' ' ' VAL . . . . . 0.514 ' H ' HG23 ' B' ' 451' ' ' VAL . 62.0 t -68.64 -40.72 82.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 123.278 0.631 . . . . 60.45 109.814 -179.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 155.4 -163.86 31.76 Favored Glycine 0 C--N 1.338 0.68 0 CA-C-N 115.22 -0.9 . . . . 73.44 111.157 -178.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 454' ' ' LEU . . . . . 0.541 ' HG ' HD22 ' B' ' 450' ' ' ASN . 0.4 OUTLIER -156.92 152.01 26.19 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.085 0.554 . . . . 72.5 111.094 -179.421 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 56.8 p -92.6 3.39 55.65 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.318 1.047 . . . . 61.41 111.07 177.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -70.53 -65.8 0.68 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.965 0.906 . . . . 74.3 110.577 -178.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 457' ' ' GLN . . . . . 0.406 HE22 ' HB2' ' B' ' 459' ' ' ASP . 1.1 tm0? -170.97 134.0 0.94 Allowed 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 106.912 -1.514 . . . . 42.14 106.912 179.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 30.6 p -50.7 95.99 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.166 0.986 . . . . 72.13 111.653 -177.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 459' ' ' ASP . . . . . 0.406 ' HB2' HE22 ' B' ' 457' ' ' GLN . 32.3 t70 -166.79 166.03 15.94 Favored 'General case' 0 C--O 1.243 0.741 0 C-N-CA 124.515 1.126 . . . . 73.31 108.313 -178.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 78.6 mt 62.89 33.12 15.34 Favored 'General case' 0 C--N 1.359 0.984 0 CA-C-O 122.09 0.947 . . . . 65.42 109.9 -175.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -64.67 125.55 25.11 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 114.346 -1.297 . . . . 62.31 109.832 178.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 68.9 t80 68.5 14.0 9.04 Favored 'General case' 0 CA--C 1.567 1.598 0 C-N-CA 124.498 1.119 . . . . 72.53 111.786 -179.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 84.0 m -73.9 83.56 1.7 Allowed 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 122.223 1.011 . . . . 61.35 109.086 172.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 464' ' ' MET . . . . . 0.544 ' HA ' HG12 ' B' ' 451' ' ' VAL . 54.3 mtt -128.05 137.03 52.01 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 113.986 -1.461 . . . . 75.31 108.209 -175.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -75.87 93.49 3.2 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 108.315 -0.995 . . . . 72.15 108.315 172.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -71.61 -172.24 0.76 Allowed 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.14 -0.936 . . . . 62.32 110.685 176.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . -60.91 -45.53 94.28 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 109.414 -0.588 . . . . 75.3 109.414 170.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 5.0 mp -109.67 -161.46 0.76 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.056 0.943 . . . . 45.51 108.786 173.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 469' ' ' GLY . . . . . . . . . . . . . . . -84.54 177.62 51.45 Favored Glycine 0 C--N 1.35 1.308 0 N-CA-C 112.334 -0.307 . . . . 50.44 112.334 171.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 470' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.47 121.96 14.13 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 122.929 0.492 . . . . 73.2 110.667 -178.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 471' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.258 1.537 0 C-N-CA 124.978 1.311 . . . . 74.2 110.394 175.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 64.6 mtm . . . . . 0 N--CA 1.471 0.621 0 N-CA-C 109.481 -0.563 . . . . 55.23 109.481 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.7 21.15 7.03 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.662 1.185 . . . . 65.31 113.026 177.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -86.91 45.28 1.25 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.418 0.687 . . . . 52.01 110.588 -178.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -39.42 100.76 0.02 OUTLIER 'General case' 0 C--N 1.351 0.674 0 C-N-CA 125.301 1.44 . . . . 70.52 112.996 171.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -76.42 123.18 25.6 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 106.445 -1.687 . . . . 63.2 106.445 166.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -72.4 96.0 1.83 Allowed 'General case' 0 C--O 1.245 0.818 0 N-CA-C 108.705 -0.85 . . . . 63.22 108.705 -176.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 7' ' ' TYR . . . . . 0.432 ' CE2' HG21 ' C' ' 56' ' ' VAL . 50.2 m-85 -66.89 -24.2 66.08 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 113.893 -1.503 . . . . 73.43 112.083 -169.099 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -66.36 -49.11 68.0 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.803 -0.443 . . . . 72.53 109.803 174.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.09 -41.87 97.47 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 123.635 0.584 . . . . 52.31 110.986 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 58.3 mt -59.05 -41.83 84.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 123.645 0.591 . . . . 63.34 110.715 176.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 11' ' ' LEU . . . . . 0.429 ' HB2' HG22 ' C' ' 13' ' ' VAL . 78.4 mt -69.97 -26.24 64.0 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 115.994 -0.548 . . . . 45.45 111.869 174.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.95 22.31 55.52 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-N 116.694 -0.23 . . . . 64.33 112.953 -173.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 13' ' ' VAL . . . . . 0.429 HG22 ' HB2' ' C' ' 11' ' ' LEU . 19.0 m -107.23 150.5 40.02 Favored Pre-proline 0 N--CA 1.481 1.077 0 C-N-CA 124.184 0.994 . . . . 64.04 109.588 174.156 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -66.38 163.15 33.33 Favored 'Trans proline' 0 C--N 1.371 1.738 0 C-N-CA 122.455 2.103 . . . . 74.43 111.809 178.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -77.27 21.59 0.24 Allowed 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 123.175 0.59 . . . . 71.52 112.326 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -131.49 18.3 4.81 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.1 1.36 . . . . 71.24 107.691 173.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.23 123.72 18.07 Favored 'General case' 0 C--N 1.353 0.74 0 C-N-CA 124.166 0.986 . . . . 71.14 111.322 -178.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 44.0 p -66.72 170.29 6.65 Favored 'General case' 0 C--O 1.251 1.168 0 N-CA-C 109.059 -0.719 . . . . 74.41 109.059 170.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 59.4 tp60 -61.43 -36.42 80.31 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.538 -0.301 . . . . 74.45 111.081 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 20' ' ' GLU . . . . . 0.448 ' HB3' ' NH1' ' C' ' 24' ' ' ARG . 0.1 OUTLIER -73.27 -36.59 66.38 Favored 'General case' 0 C--O 1.212 -0.91 0 CA-C-O 118.869 -0.586 . . . . 64.05 110.171 179.773 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -55.93 -48.79 75.07 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.383 0.611 . . . . 73.42 111.188 174.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 22' ' ' ILE . . . . . 0.544 HD13 ' HB3' ' C' ' 57' ' ' LEU . 71.7 mt -61.6 -43.05 96.36 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-N 114.743 -1.117 . . . . 61.32 110.964 176.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 23' ' ' LYS . . . . . 0.542 ' O ' ' HG3' ' C' ' 27' ' ' LYS . 13.1 tppt? -68.76 -25.45 64.73 Favored 'General case' 0 CA--C 1.558 1.287 0 CA-C-N 115.34 -0.845 . . . . 74.13 110.158 179.214 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 24' ' ' ARG . . . . . 0.448 ' NH1' ' HB3' ' C' ' 20' ' ' GLU . 68.5 mtt85 -71.94 -50.95 24.66 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.775 0.83 . . . . 73.52 110.283 178.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.87 -37.73 74.45 Favored 'General case' 0 C--O 1.246 0.917 0 O-C-N 124.296 0.997 . . . . 75.32 110.293 177.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 26' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -56.31 -71.37 0.09 Allowed 'General case' 0 C--N 1.358 0.968 0 CA-C-O 117.642 -1.171 . . . . 72.31 110.487 172.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . 0.555 ' HB2' ' HA ' ' B' ' 322' ' ' ALA . 39.0 mttp -50.24 -39.59 45.17 Favored 'General case' 0 N--CA 1.504 2.237 0 C-N-CA 123.633 0.773 . . . . 74.1 112.259 -173.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -54.75 -62.7 1.49 Allowed 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.691 1.197 . . . . 71.15 110.852 176.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . 0.514 HD13 HD13 ' C' ' 50' ' ' ILE . 42.3 mt -81.66 -8.81 59.75 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 115.25 -0.886 . . . . 60.22 111.256 -175.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . 0.463 ' HA ' ' HE1' ' C' ' 47' ' ' PHE . . . -93.36 -14.51 26.79 Favored 'General case' 0 C--O 1.215 -0.763 0 C-N-CA 124.23 1.012 . . . . 75.32 110.579 179.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 54.1 mtm180 -92.4 -41.67 10.19 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 109.245 -0.65 . . . . 73.5 109.245 164.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 23.9 tp60 -63.78 -50.61 68.35 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.764 0.826 . . . . 71.12 111.564 -175.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 33' ' ' TYR . . . . . 0.428 ' HE2' HD22 ' C' ' 29' ' ' LEU . 32.6 m-85 -104.26 20.16 18.87 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.235 0.614 . . . . 70.15 110.846 -177.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 34' ' ' HIS . . . . . 0.429 ' CD2' ' HB3' ' C' ' 36' ' ' ASP . 5.8 t60 -62.57 114.48 12.17 Favored Pre-proline 0 N--CA 1.475 0.819 0 CA-C-O 118.405 -0.807 . . . . 72.34 109.461 -179.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -51.15 -33.47 44.09 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 123.345 2.696 . . . . 71.32 114.414 -173.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 36' ' ' ASP . . . . . 0.429 ' HB3' ' CD2' ' C' ' 34' ' ' HIS . 15.7 t70 -68.51 -44.13 75.32 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.745 0.818 . . . . 60.34 111.639 177.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 61.5 t -80.51 -51.14 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 CA-C-O 121.495 0.664 . . . . 75.33 110.05 -173.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -112.67 96.79 6.17 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 114.809 -1.087 . . . . 54.22 108.939 177.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -84.08 67.03 9.53 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.899 0.479 . . . . 62.24 109.961 178.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 49.4 m -124.41 109.77 28.73 Favored Pre-proline 0 N--CA 1.477 0.878 0 C-N-CA 123.645 0.778 . . . . 74.14 108.933 177.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -43.82 -47.21 10.09 Favored 'Trans proline' 0 C--N 1.386 2.547 0 C-N-CA 124.197 3.265 . . . . 63.44 113.775 -177.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -55.25 -42.36 73.4 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.913 0.885 . . . . 65.44 111.299 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.68 -27.37 61.19 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 114.972 -1.013 . . . . 62.05 110.754 -178.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 44' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -81.51 -24.69 36.51 Favored 'General case' 0 C--N 1.352 0.689 0 O-C-N 123.774 0.671 . . . . 74.04 109.955 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -73.32 -45.07 57.5 Favored 'General case' 0 C--O 1.244 0.774 0 C-N-CA 123.709 0.804 . . . . 42.53 109.688 173.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 46' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -60.83 -41.03 94.99 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 115.605 -0.725 . . . . 72.32 110.36 171.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 47' ' ' PHE . . . . . 0.463 ' HE1' ' HA ' ' C' ' 30' ' ' ALA . 84.6 t80 -57.09 -45.99 82.92 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 124.149 0.906 . . . . 62.23 109.933 176.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 48' ' ' LYS . . . . . 0.484 ' HE3' ' HB3' ' C' ' 89' ' ' ASP . 48.5 mtpt -58.98 -46.26 88.54 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 123.965 0.791 . . . . 72.04 111.555 178.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -60.56 -43.15 97.56 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.303 0.573 . . . . 72.33 112.099 178.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 50' ' ' ILE . . . . . 0.514 HD13 HD13 ' C' ' 29' ' ' LEU . 82.8 mt -70.56 -29.35 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 124.187 0.995 . . . . 75.43 110.526 178.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 51' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -90.21 -5.58 56.23 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.802 0.841 . . . . 74.04 111.212 178.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -78.0 -48.49 16.06 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 107.319 -1.363 . . . . 63.42 107.319 164.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . 0.428 ' HA ' ' CD1' ' C' ' 7' ' ' TYR . . . -53.87 -43.6 69.7 Favored 'General case' 0 C--N 1.344 0.331 0 CA-C-N 113.236 -1.802 . . . . 63.1 111.29 174.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -79.32 -30.37 42.75 Favored 'General case' 0 C--O 1.214 -0.8 0 CA-C-N 114.934 -1.03 . . . . 75.01 111.111 176.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.82 -36.92 68.01 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 119.01 0.823 . . . . 60.54 111.172 176.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 56' ' ' VAL . . . . . 0.436 HG13 ' HZ ' ' C' ' 101' ' ' PHE . 35.3 t -78.78 -55.02 10.82 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 CA-C-N 114.894 -1.048 . . . . 72.43 110.445 174.024 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 57' ' ' LEU . . . . . 0.544 ' HB3' HD13 ' C' ' 22' ' ' ILE . 79.4 mt -92.56 19.18 7.59 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 113.021 0.749 . . . . 75.02 113.021 -168.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 29.9 t -51.31 -61.48 2.21 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.852 1.261 . . . . 62.42 113.657 -177.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -133.03 151.59 78.2 Favored Pre-proline 0 N--CA 1.476 0.846 0 N-CA-C 108.422 -0.955 . . . . 72.03 108.422 -172.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 60' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -41.01 -31.53 0.77 Allowed 'Trans proline' 0 C--N 1.386 2.528 0 C-N-CA 124.997 3.798 . . . . 33.23 116.417 -175.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -70.13 -58.97 3.2 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 118.078 0.399 . . . . 62.13 111.242 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -65.23 -28.63 69.5 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.028 0.442 . . . . 75.23 111.544 179.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 45.0 tpt85 -54.71 -53.46 54.68 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.371 1.069 . . . . 64.42 110.001 168.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -73.11 -19.16 61.2 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 115.806 -0.634 . . . . 74.15 112.386 -179.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 68.0 mt -65.34 -44.46 94.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 N-CA-C 108.869 -0.789 . . . . 62.34 108.869 170.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -60.54 -47.76 84.77 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.725 -0.67 . . . . 74.22 110.334 173.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -56.62 -45.79 81.3 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.312 0.645 . . . . 73.14 111.814 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 67.2 p -71.62 -25.48 62.18 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.197 -0.456 . . . . 63.2 110.829 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 69' ' ' TYR . . . . . 0.425 ' CD1' HD13 ' C' ' 100' ' ' LEU . 5.6 t80 -79.68 137.07 36.95 Favored 'General case' 0 C--N 1.358 0.953 0 N-CA-C 109.728 -0.471 . . . . 75.22 109.728 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.48 17.89 53.82 Favored Glycine 0 N--CA 1.473 1.144 0 N-CA-C 111.339 -0.704 . . . . 62.51 111.339 -170.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 87.7 m -147.32 -58.98 0.27 Allowed 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 103.615 -2.735 . . . . 72.34 103.615 176.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 34.7 m -84.48 148.96 26.26 Favored 'General case' 0 C--O 1.249 1.048 0 N-CA-C 105.403 -2.073 . . . . 73.35 105.403 156.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.96 -16.13 7.65 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.929 0.892 . . . . 73.23 110.202 -176.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.92 125.88 87.64 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 123.086 0.554 . . . . 53.23 109.781 174.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -61.57 148.49 92.89 Favored 'Trans proline' 0 C--N 1.372 1.804 0 C-N-CA 122.684 2.256 . . . . 75.14 111.373 169.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -65.83 165.24 24.13 Favored 'Trans proline' 0 CA--C 1.56 1.806 0 C-N-CA 122.735 2.29 . . . . 63.14 112.725 -179.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -67.37 158.54 56.56 Favored 'Trans proline' 0 C--N 1.374 1.918 0 C-N-CA 122.868 2.379 . . . . 51.51 111.427 167.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 78' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.27 116.83 3.5 Favored 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 122.498 2.132 . . . . 74.44 111.758 175.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -66.7 155.67 69.37 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 122.469 2.112 . . . . 61.04 110.087 177.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_exo -46.52 76.27 0.01 OUTLIER 'Trans proline' 0 N--CA 1.509 2.428 0 C-N-CA 124.819 3.68 . . . . 51.5 116.309 -172.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 137.51 -47.06 0.97 Allowed Glycine 0 CA--C 1.53 1.01 0 CA-C-N 115.879 -0.6 . . . . 75.2 112.266 -178.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.406 ' HA3' ' CE1' ' C' ' 106' ' ' PHE . . . 141.25 164.61 10.03 Favored Glycine 0 N--CA 1.473 1.151 0 N-CA-C 109.799 -1.32 . . . . 74.45 109.799 -174.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -70.18 115.15 9.05 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 122.945 0.498 . . . . 70.14 110.028 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -52.09 121.99 7.74 Favored 'General case' 0 C--O 1.242 0.662 0 O-C-N 124.698 1.249 . . . . 63.13 111.661 176.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 85' ' ' PHE . . . . . 0.518 ' HA ' ' HD2' ' C' ' 88' ' ' PHE . 56.3 m-85 -135.39 59.23 1.73 Allowed 'General case' 0 N--CA 1.475 0.789 0 O-C-N 124.074 0.859 . . . . 74.41 110.444 169.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 25.0 m -61.0 89.59 0.02 OUTLIER 'General case' 0 C--N 1.354 0.783 0 CA-C-N 114.311 -1.313 . . . . 45.43 113.326 179.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 79.74 13.45 82.35 Favored Glycine 0 C--N 1.35 1.36 0 CA-C-N 115.271 -0.877 . . . . 74.33 112.967 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 88' ' ' PHE . . . . . 0.518 ' HD2' ' HA ' ' C' ' 85' ' ' PHE . 5.7 m-85 -100.8 119.77 39.13 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 107.657 -1.238 . . . . 74.44 107.657 -178.05 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 89' ' ' ASP . . . . . 0.484 ' HB3' ' HE3' ' C' ' 48' ' ' LYS . 62.7 t0 -80.19 72.21 6.99 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-O 121.647 0.737 . . . . 72.23 110.622 -176.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 90' ' ' VAL . . . . . 0.579 HG23 ' HE2' ' C' ' 97' ' ' PHE . 5.3 p -49.91 -42.53 18.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 125.416 1.486 . . . . 54.41 113.261 -176.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -66.39 -23.07 66.26 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.512 0.725 . . . . 74.21 111.575 -173.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -90.38 -19.54 23.86 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.429 0.691 . . . . 75.53 111.112 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 20.1 m-30 -77.81 178.02 7.72 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.138 0.575 . . . . 72.45 111.778 -174.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 94' ' ' SER . . . . . 0.419 ' O ' ' HB3' ' C' ' 97' ' ' PHE . 78.4 p -62.16 153.87 28.94 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.607 0.763 . . . . 45.51 112.323 -171.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 95' ' ' GLU . . . . . 0.455 ' O ' ' HG3' ' C' ' 99' ' ' GLU . 0.0 OUTLIER -68.49 -32.14 71.9 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.723 -0.671 . . . . 55.43 111.199 178.582 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -51.38 -53.1 39.84 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.131 0.972 . . . . 65.02 110.556 169.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 97' ' ' PHE . . . . . 0.579 ' HE2' HG23 ' C' ' 90' ' ' VAL . 48.6 t80 -56.6 -47.51 79.46 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-N 113.775 -1.557 . . . . 64.25 110.327 178.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 98' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -76.58 -9.21 58.49 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 114.753 -1.112 . . . . 51.52 112.988 -176.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . 0.455 ' HG3' ' O ' ' C' ' 95' ' ' GLU . 61.7 mt-10 -82.61 -51.31 7.87 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.211 0.604 . . . . 74.43 109.563 166.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 100' ' ' LEU . . . . . 0.425 HD13 ' CD1' ' C' ' 69' ' ' TYR . 18.7 tp -59.35 -44.84 92.62 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 114.438 -1.256 . . . . 73.23 111.911 -171.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 101' ' ' PHE . . . . . 0.436 ' HZ ' HG13 ' C' ' 56' ' ' VAL . 48.2 m-85 -105.38 11.47 32.69 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.375 0.27 . . . . 73.25 111.03 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -42.23 -64.63 1.48 Allowed Glycine 0 C--N 1.357 1.745 0 C-N-CA 124.823 1.201 . . . . 54.11 114.538 -171.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -29.93 -31.44 0.02 OUTLIER 'Trans proline' 0 C--N 1.389 2.69 1 C-N-CA 126.299 4.666 . . . . 62.02 117.266 176.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -156.83 52.67 0.41 Allowed Glycine 0 C--N 1.354 1.538 0 C-N-CA 120.934 -0.651 . . . . 43.23 113.024 179.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 105' ' ' LEU . . . . . 0.532 ' HB3' HG21 ' C' ' 90' ' ' VAL . 92.7 mt -55.88 13.86 0.0 OUTLIER 'General case' 0 CA--C 1.579 2.065 0 N-CA-C 117.218 2.303 . . . . 73.03 117.218 177.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 106' ' ' PHE . . . . . 0.788 ' HA ' ' HB3' ' C' ' 114' ' ' ARG 0.302 2.2 m-30 46.51 -98.98 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 121.008 1.731 . . . . 64.24 113.444 178.484 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . 112.71 47.83 0.66 Allowed Glycine 0 C--O 1.229 -0.212 0 N-CA-C 115.55 0.98 . . . . 51.05 115.55 170.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . -15.75 -70.76 0.01 OUTLIER Glycine 0 N--CA 1.49 2.296 0 C-N-CA 125.026 1.298 . . . . 74.41 115.115 161.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 109' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -97.38 -4.27 38.69 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.075 0.95 . . . . 74.45 111.704 178.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 110' ' ' GLY . . . . . . . . . . . . . . . -73.65 -16.8 79.04 Favored Glycine 0 C--N 1.357 1.706 0 N-CA-C 111.521 -0.632 . . . . 54.22 111.521 175.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 88.0 mtt-85 79.68 -40.52 0.22 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.896 2.078 . . . . 75.25 113.856 166.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 112' ' ' ARG . . . . . . . . . . . . . 3.3 tpp180 -126.75 -39.54 1.97 Allowed 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 119.47 1.032 . . . . 74.1 112.626 174.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 113' ' ' SER . . . . . . . . . . . . . 15.3 m -7.31 -36.23 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.696 0 N-CA-C 120.066 3.358 . . . . 72.53 120.066 -176.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 114' ' ' ARG . . . . . 0.788 ' HB3' ' HA ' ' C' ' 106' ' ' PHE . 1.6 tpm_? -164.17 170.93 15.71 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 125.548 1.539 . . . . 74.05 107.983 169.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 115' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -78.14 114.12 16.72 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 118.59 -0.719 . . . . 54.14 110.469 175.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -61.85 109.35 2.49 Favored Glycine 0 C--N 1.359 1.831 0 N-CA-C 109.813 -1.315 . . . . 45.25 109.813 166.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 117' ' ' ARG . . . . . 0.511 ' HD3' HD13 ' B' ' 59' ' ' LEU . 67.0 mtt180 -97.49 113.13 24.76 Favored 'General case' 0 C--O 1.257 1.463 0 CA-C-O 122.304 1.049 . . . . 64.44 110.903 -172.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 118' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -74.36 109.28 7.72 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 111.612 -2.54 . . . . 75.42 105.647 162.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 119' ' ' LEU . . . . . 0.629 HD12 ' HA2' ' C' ' 165' ' ' GLY . 70.0 mt -91.01 106.84 18.8 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.341 -0.391 . . . . 75.21 110.445 -162.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -90.01 94.45 9.8 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 106.604 -1.628 . . . . 72.31 106.604 -178.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 121' ' ' ALA . . . . . 0.619 ' HA ' HG23 ' B' ' 185' ' ' VAL . . . -105.44 113.8 27.6 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 109.104 -0.702 . . . . 63.21 109.104 -171.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 122' ' ' GLU . . . . . 0.542 ' CD ' ' HZ1' ' B' ' 189' ' ' LYS . 5.2 tm-20 -73.31 107.74 5.79 Favored 'General case' 0 C--O 1.244 0.775 0 N-CA-C 106.981 -1.489 . . . . 73.22 106.981 171.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 123' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -116.13 137.27 23.31 Favored Pre-proline 0 N--CA 1.474 0.756 0 CA-C-O 120.48 0.181 . . . . 73.3 111.465 -179.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.13 116.84 4.54 Favored 'Trans proline' 0 C--N 1.371 1.734 0 C-N-CA 122.984 2.456 . . . . 72.51 110.802 168.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 125' ' ' LEU . . . . . 0.484 ' HB3' HG13 ' C' ' 178' ' ' VAL . 13.6 tp -152.63 161.28 42.78 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 109.479 -0.563 . . . . 74.03 109.479 -178.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 126' ' ' THR . . . . . 0.462 ' HB ' ' HG ' ' C' ' 181' ' ' LEU . 6.2 t -125.98 175.25 7.84 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.56 0.695 . . . . 61.53 109.96 171.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 127' ' ' LEU . . . . . 0.516 HD21 HD13 ' C' ' 180' ' ' LEU . 13.6 mt -60.4 -48.52 81.41 Favored 'General case' 0 C--O 1.245 0.821 0 C-N-CA 125.55 1.54 . . . . 62.25 110.303 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 128' ' ' GLU . . . . . 0.521 ' HG3' ' HA ' ' C' ' 215' ' ' LEU . 8.5 mp0 -63.55 -33.06 74.75 Favored 'General case' 0 C--O 1.215 -0.723 0 CA-C-N 114.009 -1.45 . . . . 75.24 110.748 178.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 129' ' ' GLU . . . . . 0.413 ' HA ' ' HB2' ' C' ' 132' ' ' HIS . 19.4 mm-40 -84.65 -13.65 50.89 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.779 0.832 . . . . 73.53 111.771 178.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 130' ' ' ALA . . . . . 0.516 ' HB2' HG12 ' C' ' 153' ' ' VAL . . . -76.33 -34.61 59.0 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.876 -0.787 . . . . 64.34 108.876 170.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 131' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -70.54 -46.28 63.89 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 113.993 -1.458 . . . . 75.55 111.512 168.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 132' ' ' HIS . . . . . 0.413 ' HB2' ' HA ' ' C' ' 129' ' ' GLU . 35.8 m170 -80.65 -9.71 59.77 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 123.365 0.666 . . . . 60.22 111.02 -178.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -66.44 -120.16 0.01 OUTLIER Glycine 0 C--N 1.354 1.528 0 O-C-N 123.921 0.763 . . . . 65.31 113.371 177.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . 64.85 -103.69 0.81 Allowed Glycine 0 C--N 1.342 0.91 0 N-CA-C 110.852 -0.899 . . . . 53.24 110.852 -173.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 135' ' ' GLU . . . . . 0.71 ' HG3' ' HB2' ' C' ' 148' ' ' ARG . 2.7 mp0 -87.94 94.06 9.66 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.03 0.932 . . . . 71.2 109.277 -177.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 136' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -142.41 166.95 23.28 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.502 0.721 . . . . 72.12 110.263 -177.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 137' ' ' VAL . . . . . . . . . . . . . 17.7 m -73.89 88.66 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.1 0 CA-C-N 115.251 -0.886 . . . . 71.12 111.202 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 138' ' ' VAL . . . . . 0.53 ' O ' ' HA ' ' C' ' 144' ' ' ARG . 37.4 t -80.21 129.76 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.912 0.885 . . . . 72.14 109.819 175.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 139' ' ' GLU . . . . . 0.47 ' HB3' HH12 ' B' ' 46' ' ' ARG . 8.3 tp10 -124.95 113.73 18.21 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 108.3 -1.0 . . . . 74.31 108.3 169.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 140' ' ' VAL . . . . . 0.617 HG13 ' HB ' ' B' ' 185' ' ' VAL . 30.7 t -150.02 126.88 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.215 1.006 . . . . 63.22 108.341 167.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 65.04 32.4 10.43 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.172 0.989 . . . . 15.23 112.895 172.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 73.03 26.94 69.64 Favored Glycine 0 C--N 1.344 0.991 0 N-CA-C 111.722 -0.551 . . . . 45.25 111.722 -178.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 143' ' ' ARG . . . . . . . . . . . . . 45.2 mtp180 -115.74 96.27 5.53 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 107.539 -1.282 . . . . 73.04 107.539 171.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 144' ' ' ARG . . . . . 0.54 ' HD3' ' HA ' ' B' ' 48' ' ' THR . 29.2 ttp-105 -114.25 104.22 11.87 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 123.491 0.716 . . . . 71.51 109.539 -178.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 145' ' ' VAL . . . . . . . . . . . . . 7.7 p -150.47 146.21 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.34 0.656 . . . . 75.03 110.639 -175.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 24.7 m -77.62 88.29 3.92 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 108.601 -0.889 . . . . 54.21 108.601 171.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 11.2 p -117.18 154.44 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.656 0.782 . . . . 72.53 109.91 -173.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 148' ' ' ARG . . . . . 0.71 ' HB2' ' HG3' ' C' ' 135' ' ' GLU . 31.5 ttt85 -92.54 114.27 26.77 Favored 'General case' 0 C--O 1.242 0.669 0 O-C-N 123.801 0.688 . . . . 74.22 111.02 177.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 149' ' ' ILE . . . . . 0.449 HD12 HD13 ' C' ' 159' ' ' ILE . 26.2 pt -94.47 154.26 40.24 Favored Pre-proline 0 CA--C 1.552 1.028 0 N-CA-C 107.493 -1.299 . . . . 71.41 107.493 163.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -51.15 115.6 2.15 Favored 'Trans proline' 0 CA--C 1.565 2.038 0 C-N-CA 122.311 2.007 . . . . 61.44 111.378 174.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -61.36 113.45 1.78 Allowed 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 123.359 2.706 . . . . 73.2 111.169 -178.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 152' ' ' GLY . . . . . . . . . . . . . . . 129.28 142.15 5.24 Favored Glycine 0 C--N 1.34 0.779 0 O-C-N 123.449 0.468 . . . . 54.32 114.13 -172.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 153' ' ' VAL . . . . . 0.516 HG12 ' HB2' ' C' ' 130' ' ' ALA . 3.0 p -164.69 168.36 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.39 0 N-CA-C 112.524 0.564 . . . . 71.13 112.524 174.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 154' ' ' ARG . . . . . 0.628 HH11 ' HB3' ' B' ' 22' ' ' ARG . 0.8 OUTLIER -125.81 169.48 12.57 Favored 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 125.806 1.642 . . . . 75.32 108.563 176.96 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 155' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -65.06 128.45 35.83 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.158 0.583 . . . . 74.51 110.289 169.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 71.82 12.0 74.19 Favored Glycine 0 C--N 1.348 1.215 0 O-C-N 123.891 0.744 . . . . 64.51 113.478 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 157' ' ' SER . . . . . 0.471 ' HB2' ' HB3' ' C' ' 154' ' ' ARG . 43.6 t -78.82 140.98 38.1 Favored 'General case' 0 C--O 1.252 1.206 0 C-N-CA 123.117 0.567 . . . . 75.43 109.903 -179.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 158' ' ' VAL . . . . . 0.477 HG23 ' HB3' ' C' ' 175' ' ' LEU . 5.4 p -108.78 96.94 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 O-C-N 125.077 1.485 . . . . 64.44 108.956 -174.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 159' ' ' ILE . . . . . 0.616 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 56.4 mt -78.41 111.45 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 108.687 -0.857 . . . . 52.25 108.687 178.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 160' ' ' ARG . . . . . 0.627 ' HD2' HD22 ' B' ' 311' ' ' ASN . 26.4 ttt180 -85.58 107.94 17.73 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 108.826 -0.805 . . . . 72.21 108.826 173.134 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 161' ' ' VAL . . . . . . . . . . . . . 2.2 t -98.17 105.66 30.0 Favored Pre-proline 0 CA--C 1.557 1.228 0 N-CA-C 106.219 -1.771 . . . . 75.24 106.219 171.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 162' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -64.68 132.02 31.43 Favored 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 123.512 2.808 . . . . 63.42 113.042 -171.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 64.83 19.57 65.52 Favored Glycine 0 C--N 1.347 1.194 0 O-C-N 124.01 0.819 . . . . 53.31 113.348 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 164' ' ' MET . . . . . . . . . . . . . 31.8 mmm -110.08 -2.48 16.96 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.583 0.753 . . . . 73.35 111.753 -178.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 165' ' ' GLY . . . . . 0.629 ' HA2' HD12 ' C' ' 119' ' ' LEU . . . -89.5 -111.87 1.33 Allowed Glycine 0 C--N 1.347 1.162 0 N-CA-C 108.293 -1.923 . . . . 64.24 108.293 164.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . -156.78 118.11 0.82 Allowed Glycine 0 C--N 1.335 0.498 0 C-N-CA 120.692 -0.766 . . . . 75.44 111.831 161.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 167' ' ' GLN . . . . . 0.556 ' HA ' ' HA ' ' C' ' 171' ' ' PRO . 15.0 mm-40 -71.23 101.9 2.42 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 107.792 -1.188 . . . . 64.31 107.792 175.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . -115.77 -125.5 3.88 Favored Glycine 0 N--CA 1.467 0.758 0 N-CA-C 110.275 -1.13 . . . . 13.44 110.275 178.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 169' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -61.41 -67.19 1.15 Allowed Pre-proline 0 CA--C 1.574 1.865 0 CA-C-N 117.956 0.878 . . . . 62.44 110.562 175.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 170' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -93.94 113.82 0.22 Allowed 'Trans proline' 0 C--N 1.393 2.878 0 CA-C-N 122.107 1.788 . . . . 51.41 109.143 163.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 171' ' ' PRO . . . . . 0.556 ' HA ' ' HA ' ' C' ' 167' ' ' GLN . 6.5 Cg_exo -33.87 131.78 0.15 Allowed 'Trans proline' 0 C--N 1.372 1.763 0 C-N-CA 124.609 3.54 . . . . 74.02 115.514 -178.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 172' ' ' GLY . . . . . 0.549 ' H ' ' HA ' ' C' ' 167' ' ' GLN . . . -120.85 115.93 3.04 Favored Glycine 0 C--N 1.341 0.828 0 N-CA-C 110.968 -0.853 . . . . 74.42 110.968 -171.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 173' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -107.75 158.9 16.91 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 108.512 -0.921 . . . . 74.51 108.512 175.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 174' ' ' LEU . . . . . 0.442 HD11 HG21 ' C' ' 140' ' ' VAL . 9.8 tp -81.41 107.56 14.29 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 109.739 -0.467 . . . . 75.22 109.739 -177.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 175' ' ' LEU . . . . . 0.477 ' HB3' HG23 ' C' ' 158' ' ' VAL . 78.6 mt -95.12 82.22 3.75 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.43 1.092 . . . . 71.32 110.084 179.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 176' ' ' LEU . . . . . 0.616 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 75.7 mt -68.4 100.76 1.12 Allowed 'General case' 0 CA--C 1.546 0.804 0 CA-C-O 121.022 0.439 . . . . 43.02 110.86 178.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 177' ' ' VAL . . . . . . . . . . . . . 61.0 t -85.53 101.57 10.11 Favored 'Isoleucine or valine' 0 C--O 1.244 0.784 0 C-N-CA 124.147 0.979 . . . . 74.43 108.398 176.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 178' ' ' VAL . . . . . 0.484 HG13 ' HB3' ' C' ' 125' ' ' LEU . 52.1 t -84.93 135.82 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 N-CA-C 112.538 0.57 . . . . 74.01 112.538 -174.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 179' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -110.76 113.27 25.73 Favored 'General case' 0 C--O 1.254 1.33 0 C-N-CA 124.981 1.312 . . . . 72.33 108.436 169.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 180' ' ' LEU . . . . . 0.516 HD13 HD21 ' C' ' 127' ' ' LEU . 91.8 mt -76.53 153.76 35.15 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 124.572 1.149 . . . . 70.51 111.445 178.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 181' ' ' LEU . . . . . 0.623 HD22 ' HB2' ' B' ' 191' ' ' TYR . 8.2 mt -65.73 168.4 8.75 Favored Pre-proline 0 N--CA 1.49 1.553 0 C-N-CA 123.105 0.562 . . . . 74.2 110.892 -179.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -60.45 70.07 0.07 OUTLIER 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 122.482 2.121 . . . . 64.12 110.793 160.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 183' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -160.44 62.39 1.73 Allowed Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 106.753 -1.573 . . . . 62.13 106.753 -167.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 184' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -85.34 64.53 5.97 Favored 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 123.03 2.486 . . . . 71.54 111.217 -170.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 185' ' ' VAL . . . . . 0.618 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 18.1 t -95.55 -56.42 5.22 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.905 0 N-CA-C 107.826 -1.176 . . . . 72.23 107.826 -173.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 186' ' ' PHE . . . . . 0.478 ' HD1' ' HB2' ' C' ' 195' ' ' ALA . 33.9 m-85 -114.8 153.66 29.99 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.56 0.744 . . . . 61.44 110.832 -174.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 187' ' ' ARG . . . . . . . . . . . . . 7.5 mtm180 -143.42 115.74 8.5 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.569 1.148 . . . . 75.14 108.772 175.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 188' ' ' LEU . . . . . 0.536 HD13 ' HD2' ' C' ' 240' ' ' PHE . 55.6 tp -77.48 143.27 38.63 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.973 0.731 . . . . 74.14 112.973 -171.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 189' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -141.76 105.22 4.67 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 107.14 -1.429 . . . . 71.33 107.14 166.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 74.32 -101.06 1.21 Allowed Glycine 0 CA--C 1.536 1.37 0 N-CA-C 111.885 -0.486 . . . . 74.2 111.885 -175.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 191' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -123.14 -5.13 8.41 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 124.246 1.018 . . . . 60.21 110.744 172.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -101.92 140.14 36.61 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.299 0.64 . . . . 65.13 110.088 -174.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 193' ' ' LEU . . . . . 0.434 HD21 ' CE2' ' C' ' 240' ' ' PHE . 82.0 mt -99.39 153.24 19.14 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.558 0.743 . . . . 52.2 111.273 -174.134 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 194' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -113.73 107.27 15.52 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 107.418 -1.327 . . . . 75.43 107.418 168.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 195' ' ' ALA . . . . . 0.618 ' HA ' ' O ' ' C' ' 185' ' ' VAL . . . -105.09 -178.59 3.7 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.164 0.586 . . . . 65.11 110.119 175.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 26.0 m -142.35 99.33 3.48 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 107.457 -1.312 . . . . 51.32 107.457 171.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 197' ' ' LEU . . . . . 0.446 HD13 ' HB2' ' C' ' 212' ' ' ALA . 25.7 tp -80.44 121.31 25.58 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.773 -0.649 . . . . 73.5 111.013 -171.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -74.51 100.1 3.78 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 108.166 -1.05 . . . . 44.52 108.166 175.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 199' ' ' VAL . . . . . . . . . . . . . 58.5 t -111.32 117.69 48.97 Favored Pre-proline 0 N--CA 1.474 0.731 0 N-CA-C 108.23 -1.026 . . . . 61.21 108.23 178.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 200' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -72.17 143.96 40.95 Favored 'Trans proline' 0 C--N 1.369 1.625 0 C-N-CA 121.727 1.618 . . . . 71.34 109.81 174.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 201' ' ' ALA . . . . . 0.43 ' N ' ' HD2' ' C' ' 202' ' ' PRO . . . -55.0 -44.28 99.52 Favored Pre-proline 0 CA--C 1.552 1.058 0 N-CA-C 114.119 1.155 . . . . 74.35 114.119 -173.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 202' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' C' ' 201' ' ' ALA . 17.3 Cg_endo -55.29 -46.99 28.51 Favored 'Trans proline' 0 C--N 1.393 2.906 0 C-N-CA 121.883 1.722 . . . . 63.15 112.67 176.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 203' ' ' ILE . . . . . 0.471 ' HA ' HG12 ' C' ' 206' ' ' VAL . 48.0 mt -68.18 -37.52 78.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.14 0.576 . . . . 63.4 110.871 -178.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 204' ' ' ALA . . . . . 0.434 ' HA ' HG11 ' C' ' 223' ' ' VAL . . . -58.53 -44.13 89.44 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.477 0.711 . . . . 75.02 111.338 176.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 205' ' ' VAL . . . . . 0.503 ' HA ' ' HA ' ' C' ' 226' ' ' ARG . 81.7 t -72.74 -42.65 61.87 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 115.156 -0.929 . . . . 63.41 111.786 -177.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 206' ' ' VAL . . . . . 0.676 HG23 ' HG3' ' A' ' 270' ' ' LYS . 11.3 p -77.05 -29.38 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 CA-C-O 120.676 0.274 . . . . 52.12 110.74 -174.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 77.18 51.91 5.93 Favored Glycine 0 C--N 1.341 0.826 0 N-CA-C 110.634 -0.987 . . . . 63.21 110.634 -171.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -91.78 -120.37 2.55 Favored Glycine 0 C--N 1.344 1.026 0 N-CA-C 111.246 -0.741 . . . . 51.32 111.246 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 209' ' ' LYS . . . . . 0.58 ' HG2' ' HG2' ' C' ' 220' ' ' GLU . 34.6 ttmt -151.72 133.17 14.64 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.619 0.723 . . . . 72.12 111.208 -178.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 210' ' ' VAL . . . . . . . . . . . . . 26.8 m -115.16 -175.28 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 126.596 1.958 . . . . 62.05 108.091 174.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 211' ' ' ARG . . . . . 0.473 ' HD3' ' HB2' ' C' ' 218' ' ' PRO . 36.9 ttm105 -142.85 127.99 18.61 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 118.236 0.471 . . . . 72.44 111.908 -178.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 212' ' ' ALA . . . . . 0.446 ' HB2' HD13 ' C' ' 197' ' ' LEU . . . -101.68 113.49 26.7 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 108.039 -1.097 . . . . 74.43 108.039 168.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 213' ' ' MET . . . . . 0.468 ' HA ' ' HA ' ' C' ' 218' ' ' PRO . 2.9 ttp -69.73 105.87 2.89 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 107.86 -1.163 . . . . 63.12 107.86 174.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 214' ' ' THR . . . . . 0.549 ' OG1' HG12 ' C' ' 219' ' ' VAL . 0.2 OUTLIER -101.02 175.63 5.53 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.506 0.669 . . . . 54.24 110.243 -173.144 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 215' ' ' LEU . . . . . 0.521 ' HA ' ' HG3' ' C' ' 128' ' ' GLU . 9.2 mt -63.0 -41.14 99.5 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.711 1.604 . . . . 44.41 111.326 -175.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -92.77 0.33 57.4 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 114.32 -1.309 . . . . 71.0 111.15 -177.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 134.36 162.65 9.98 Favored Glycine 0 C--N 1.343 0.931 0 N-CA-C 111.669 -0.572 . . . . 64.11 111.669 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 218' ' ' PRO . . . . . 0.473 ' HB2' ' HD3' ' C' ' 211' ' ' ARG . 59.9 Cg_endo -70.04 107.88 2.01 Favored 'Trans proline' 0 CA--C 1.555 1.575 0 C-N-CA 122.708 2.272 . . . . 52.13 112.952 -178.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 219' ' ' VAL . . . . . 0.604 HG23 HG22 ' B' ' 238' ' ' THR . 7.3 p -80.71 120.85 33.12 Favored 'Isoleucine or valine' 0 C--N 1.355 0.832 0 N-CA-C 107.664 -1.236 . . . . 52.53 107.664 174.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 220' ' ' GLU . . . . . 0.58 ' HG2' ' HG2' ' C' ' 209' ' ' LYS . 16.3 tt0 -92.75 103.79 16.12 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 107.583 -1.266 . . . . 72.32 107.583 -179.059 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 221' ' ' VAL . . . . . . . . . . . . . 60.8 t -85.88 123.29 39.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 113.534 -1.666 . . . . 74.03 112.319 -165.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 222' ' ' ALA . . . . . 0.427 ' HB3' ' HD3' ' B' ' 245' ' ' LYS . . . -74.84 143.56 43.85 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.311 0.644 . . . . 73.3 110.508 173.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . 0.434 HG11 ' HA ' ' C' ' 204' ' ' ALA . 98.0 t -116.62 138.11 24.22 Favored Pre-proline 0 N--CA 1.485 1.299 0 C-N-CA 124.316 1.047 . . . . 73.11 109.512 -174.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 224' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -78.74 156.02 27.43 Favored 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 123.279 2.653 . . . . 54.33 111.488 170.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.48 124.46 16.31 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 123.346 2.697 . . . . 74.0 113.137 -175.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 226' ' ' ARG . . . . . 0.503 ' HA ' ' HA ' ' C' ' 205' ' ' VAL . 0.0 OUTLIER 58.53 90.87 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.62 1.568 . . . . 70.15 112.378 -179.495 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 227' ' ' THR . . . . . 0.548 HG22 HG11 ' C' ' 253' ' ' VAL . 21.6 m -110.03 127.96 55.13 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 114.817 -1.083 . . . . 70.3 111.378 179.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 228' ' ' GLN . . . . . 0.773 HE21 HD11 ' A' ' 257' ' ' ILE . 0.8 OUTLIER -96.54 153.52 17.8 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.11 0.964 . . . . 74.32 111.859 -179.596 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 229' ' ' ALA . . . . . 0.49 ' HB2' ' H ' ' C' ' 255' ' ' ILE . . . -70.45 134.01 47.38 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 114.681 -1.145 . . . . 62.12 109.69 173.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 110.45 -19.28 26.77 Favored Glycine 0 C--N 1.339 0.702 0 O-C-N 123.613 0.571 . . . . 62.04 112.088 -173.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 231' ' ' ARG . . . . . 0.543 ' NH1' ' HA ' ' C' ' 227' ' ' THR . 71.3 mtt180 -65.78 174.9 2.13 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 117.138 0.469 . . . . 74.12 111.46 173.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 232' ' ' LYS . . . . . 0.444 ' HA ' ' O ' ' C' ' 251' ' ' LEU . 30.2 ttmt -142.85 145.71 33.42 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 121.206 0.527 . . . . 71.45 111.525 -178.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 233' ' ' LEU . . . . . 0.728 HD13 ' HB2' ' C' ' 251' ' ' LEU . 1.7 mp -113.26 145.33 41.2 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.815 1.246 . . . . 74.21 108.412 178.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 234' ' ' ARG . . . . . 0.676 ' HG3' ' HG3' ' B' ' 241' ' ' GLU . 9.2 ptp85 -120.29 95.06 4.59 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 121.957 0.884 . . . . 72.34 109.432 169.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 235' ' ' LEU . . . . . 0.577 ' HA ' ' HA3' ' B' ' 240' ' ' GLY . 26.0 mt -84.67 107.66 16.99 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.611 -0.722 . . . . 73.43 109.324 178.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 236' ' ' LYS . . . . . 0.556 ' HG3' HE21 ' B' ' 360' ' ' GLN . 71.1 mmtt -69.07 122.99 19.85 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 123.627 0.771 . . . . 71.55 111.483 -174.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 76.54 32.56 50.6 Favored Glycine 0 C--N 1.344 0.994 0 O-C-N 124.199 0.937 . . . . 71.42 113.192 178.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 33.5 mmtm -123.83 14.99 9.34 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.821 0.848 . . . . 72.03 111.209 175.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -91.62 -147.39 20.02 Favored Glycine 0 C--N 1.353 1.477 0 N-CA-C 111.178 -0.769 . . . . 31.21 111.178 170.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 240' ' ' PHE . . . . . 0.536 ' HD2' HD13 ' C' ' 188' ' ' LEU . 39.9 m-85 -94.56 142.12 24.36 Favored Pre-proline 0 N--CA 1.482 1.141 0 CA-C-N 117.572 0.686 . . . . 75.14 111.302 178.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 241' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' C' ' 240' ' ' PHE . 3.3 Cg_exo -76.65 113.99 3.76 Favored 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 123.837 3.025 . . . . 70.21 113.69 -172.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -96.78 159.96 21.65 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-O 119.015 -0.88 . . . . 70.14 111.396 170.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.58 -13.43 37.27 Favored 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 122.781 2.32 . . . . 71.42 112.857 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -103.25 -16.71 15.6 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.515 0.726 . . . . 71.42 110.935 174.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 157.88 158.41 8.96 Favored Glycine 0 C--N 1.356 1.641 0 O-C-N 123.119 0.262 . . . . 51.32 113.702 177.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 246' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -73.65 152.62 40.44 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.804 0.842 . . . . 61.31 110.22 174.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -77.44 -164.69 22.9 Favored Glycine 0 C--N 1.346 1.112 0 O-C-N 123.702 0.626 . . . . 63.23 112.004 173.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -119.72 154.48 34.06 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 108.877 -0.786 . . . . 73.54 108.877 -178.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 249' ' ' LEU . . . . . 0.561 HD23 HD12 ' C' ' 235' ' ' LEU . 19.0 tp -99.61 109.24 21.76 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.637 -0.71 . . . . 74.23 109.284 175.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 250' ' ' TYR . . . . . 0.593 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 20.2 m-85 -99.44 100.36 11.39 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 109.236 -0.653 . . . . 71.43 109.236 178.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 251' ' ' LEU . . . . . 0.728 ' HB2' HD13 ' C' ' 233' ' ' LEU . 0.8 OUTLIER -100.4 140.37 34.74 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.232 -0.655 . . . . 64.53 109.232 -176.716 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -89.54 128.43 36.01 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 108.225 -1.028 . . . . 73.41 108.225 168.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 253' ' ' VAL . . . . . 0.548 HG11 HG22 ' C' ' 227' ' ' THR . 80.0 t -67.97 131.97 32.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 123.641 0.776 . . . . 73.5 110.25 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 254' ' ' ARG . . . . . 0.416 ' HB3' HH11 ' C' ' 254' ' ' ARG . 0.0 OUTLIER -126.72 93.06 3.67 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.354 -1.351 . . . . 74.13 107.354 179.226 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 255' ' ' ILE . . . . . 0.49 ' H ' ' HB2' ' C' ' 229' ' ' ALA . 49.8 mm -73.11 127.49 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 O-C-N 123.853 0.721 . . . . 75.24 109.788 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 256' ' ' THR . . . . . 0.559 ' HA ' HD12 ' A' ' 255' ' ' ILE . 1.7 t -144.73 171.04 14.97 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 124.412 1.07 . . . . 53.32 110.396 -171.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 257' ' ' ILE . . . . . 0.467 HD12 ' H ' ' C' ' 259' ' ' GLU . 2.7 pp -132.59 148.31 69.06 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 123.735 0.814 . . . . 64.54 109.398 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 258' ' ' PRO . . . . . 0.518 ' HG3' ' HE2' ' A' ' 276' ' ' TYR . 98.5 Cg_endo -74.53 11.14 1.37 Allowed 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 123.323 2.682 . . . . 73.21 114.277 -172.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 259' ' ' GLU . . . . . 0.476 ' HG3' HE21 ' A' ' 228' ' ' GLN . 18.0 mt-10 62.1 -80.64 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 125.194 1.398 . . . . 72.3 111.101 -171.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 2.8 ptp85 -77.87 143.89 37.41 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.518 1.527 . . . . 73.41 110.928 -173.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 261' ' ' LEU . . . . . . . . . . . . . 75.3 mt -141.7 169.98 16.58 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.046 0.938 . . . . 71.21 110.107 -177.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 262' ' ' THR . . . . . 0.437 HG22 ' HA ' ' B' ' 272' ' ' ASN . 23.9 p -84.04 152.02 61.37 Favored Pre-proline 0 CA--C 1.552 1.024 0 N-CA-C 107.765 -1.198 . . . . 61.23 107.765 169.019 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -48.12 -34.64 24.24 Favored 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 123.173 2.582 . . . . 74.2 113.9 176.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.52 -56.14 9.36 Favored 'General case' 0 C--O 1.268 2.037 0 C-N-CA 124.249 1.019 . . . . 71.04 110.624 -178.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 265' ' ' GLU . . . . . 0.46 ' CD ' HH22 ' A' ' 279' ' ' ARG . 40.7 mm-40 -51.16 -55.09 19.66 Favored 'General case' 0 C--N 1.359 1.002 0 CA-C-N 114.953 -1.021 . . . . 65.11 110.359 175.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 266' ' ' GLU . . . . . 0.483 ' O ' ' HG2' ' C' ' 270' ' ' LYS . 30.8 tt0 -61.15 -31.46 71.18 Favored 'General case' 0 C--O 1.217 -0.652 0 CA-C-N 114.186 -1.37 . . . . 64.21 111.39 -175.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -60.76 -45.15 95.46 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 123.461 0.475 . . . . 70.32 110.866 174.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 268' ' ' LEU . . . . . 0.536 ' HA ' ' HE2' ' C' ' 271' ' ' LYS . 11.2 mp -64.18 -42.32 96.74 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 116.202 -0.454 . . . . 52.44 111.465 174.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -65.12 -25.36 67.73 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 122.797 0.439 . . . . 61.11 111.296 175.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 270' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' C' ' 266' ' ' GLU . 13.2 mmmm -67.93 -49.66 60.53 Favored 'General case' 0 C--N 1.363 1.175 0 C-N-CA 122.837 0.455 . . . . 75.43 109.867 175.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 271' ' ' LYS . . . . . 0.536 ' HE2' ' HA ' ' C' ' 268' ' ' LEU . 52.7 mtmt -57.62 -44.72 85.72 Favored 'General case' 0 N--CA 1.484 1.243 0 O-C-N 123.688 0.618 . . . . 75.33 111.294 178.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 88.3 mt -62.08 -41.41 98.16 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.237 0.615 . . . . 74.33 111.189 175.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -64.83 -45.35 86.56 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 115.573 -0.74 . . . . 34.13 111.545 -177.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -70.26 -32.42 70.24 Favored 'General case' 0 C--O 1.242 0.667 0 O-C-N 124.142 0.901 . . . . 63.21 110.62 -178.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -61.82 -34.13 75.39 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.684 -0.689 . . . . 70.04 110.678 170.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 276' ' ' TYR . . . . . 0.566 ' HB3' HD11 ' A' ' 203' ' ' ILE . 10.0 m-85 -83.49 -25.48 31.07 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 113.047 0.758 . . . . 75.52 113.047 174.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 20.3 m-30 -72.81 -21.23 61.01 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 118.524 0.602 . . . . 44.24 109.933 176.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -61.81 -3.6 1.2 Allowed 'General case' 0 CA--C 1.558 1.266 0 CA-C-N 115.02 -0.991 . . . . 55.2 112.821 169.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 279' ' ' ARG . . . . . 0.477 HH22 ' HB3' ' B' ' 374' ' ' ALA . 81.7 mtt180 -72.7 -14.12 61.5 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.255 0.622 . . . . 71.52 112.441 171.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.257 0 C-N-CA 124.452 1.101 . . . . 75.14 112.683 -175.924 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.5 mtm . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 119.508 -0.282 . . . . 64.12 111.511 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 49.91 34.22 7.61 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.929 1.292 . . . . 51.4 112.333 -175.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.5 71.57 9.58 Favored 'General case' 0 C--N 1.349 0.559 0 C-N-CA 123.308 0.643 . . . . 74.04 109.957 -176.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -38.91 106.53 0.05 Allowed 'General case' 0 C--N 1.353 0.723 0 C-N-CA 124.533 1.133 . . . . 62.43 113.072 176.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.48 ' HE3' ' HB3' ' A' ' 94' ' ' SER . 94.6 mttt -70.84 133.08 46.19 Favored 'General case' 0 C--O 1.244 0.766 0 N-CA-C 108.917 -0.772 . . . . 74.32 108.917 166.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -75.44 86.74 2.58 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 106.388 -1.708 . . . . 61.41 106.388 168.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -60.62 -34.67 74.59 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-N 115.002 -0.999 . . . . 73.34 111.231 -173.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.418 ' HE1' HD11 ' A' ' 22' ' ' ILE . 88.9 m-85 -62.56 -45.02 94.87 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.517 -0.765 . . . . 73.33 110.713 175.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.81 -42.84 99.52 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.871 0.468 . . . . 60.32 111.254 178.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.407 HD11 ' HB3' ' A' ' 5' ' ' LYS . 71.3 mt -55.88 -45.13 79.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 C-N-CA 123.508 0.723 . . . . 74.23 110.311 177.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.662 HD13 HG23 ' A' ' 22' ' ' ILE . 83.1 mt -69.43 -29.87 67.68 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 115.898 -0.592 . . . . 51.33 111.674 175.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.3 46.54 5.24 Favored Glycine 0 C--N 1.344 0.995 0 CA-C-O 120.946 0.192 . . . . 53.33 112.737 -173.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.528 HG13 ' HB2' ' A' ' 25' ' ' ALA . 3.1 m -141.5 154.76 67.06 Favored Pre-proline 0 N--CA 1.483 1.204 0 C-N-CA 125.166 1.387 . . . . 71.43 109.615 178.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -69.07 165.7 29.26 Favored 'Trans proline' 0 N--CA 1.502 1.994 0 C-N-CA 123.239 2.626 . . . . 50.12 113.328 178.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -73.68 14.23 0.39 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 113.855 1.057 . . . . 75.43 113.855 -172.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -135.74 19.97 3.3 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 108.954 -0.758 . . . . 64.11 108.954 175.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.36 121.96 15.56 Favored 'General case' 0 C--N 1.343 0.291 0 CA-C-N 115.095 -0.957 . . . . 64.31 110.137 178.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 39.9 p -76.88 171.13 15.25 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.554 -0.748 . . . . 71.11 110.166 175.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 15.9 mp0 -53.54 -28.98 34.57 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 124.399 1.08 . . . . 64.21 112.359 -177.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -71.95 -48.0 48.37 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.017 0.927 . . . . 72.43 110.869 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -63.88 -41.97 97.6 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 121.742 0.782 . . . . 64.03 110.493 178.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.662 HG23 HD13 ' A' ' 11' ' ' LEU . 74.9 mt -68.07 -32.07 54.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 114.093 -1.412 . . . . 73.31 111.174 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -70.53 -35.97 73.46 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.463 0.705 . . . . 71.24 110.907 175.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 45.9 mtm105 -61.94 -50.85 70.48 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 109.68 -0.489 . . . . 54.12 109.68 173.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.528 ' HB2' HG13 ' A' ' 13' ' ' VAL . . . -62.08 -37.66 85.88 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 114.891 -1.05 . . . . 64.0 111.764 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -60.26 -64.21 1.03 Allowed 'General case' 0 C--O 1.207 -1.142 0 CA-C-N 114.831 -1.077 . . . . 73.1 109.362 176.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -55.15 -30.5 59.97 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 124.167 0.917 . . . . 74.22 112.021 -177.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.47 ' O ' ' HG2' ' A' ' 32' ' ' GLN . 50.2 ttp180 -59.46 -67.98 0.32 Allowed 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.567 -0.531 . . . . 71.15 109.567 172.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.633 ' HB3' HD13 ' A' ' 50' ' ' ILE . 91.8 mt -70.9 -14.34 62.35 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.171 0.588 . . . . 74.11 112.171 -175.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.638 ' HA ' ' HE1' ' A' ' 47' ' ' PHE . . . -82.96 -38.66 22.43 Favored 'General case' 0 C--O 1.206 -1.229 0 C-N-CA 123.695 0.798 . . . . 63.3 109.864 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.0 mtm180 -78.98 -33.41 45.11 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 122.497 0.319 . . . . 72.33 110.692 176.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.47 ' HG2' ' O ' ' A' ' 28' ' ' ARG . 15.1 mm100 -67.46 -62.44 1.42 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 122.962 0.505 . . . . 63.33 110.44 177.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.452 ' HE2' HD22 ' A' ' 29' ' ' LEU . 21.7 m-85 -94.83 31.39 1.84 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.288 0.635 . . . . 63.25 110.941 -176.027 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -61.5 105.65 0.65 Allowed Pre-proline 0 N--CA 1.482 1.16 0 C-N-CA 123.877 0.871 . . . . 63.41 109.983 -178.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.65 -14.53 36.56 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.423 2.082 . . . . 74.13 111.444 -172.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -62.65 -37.48 86.53 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.399 1.08 . . . . 72.45 111.065 173.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 46.7 t -104.58 -51.64 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 CA-C-O 121.356 0.598 . . . . 65.53 109.862 -178.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -99.12 86.13 3.38 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.552 1.141 . . . . 61.35 110.72 -177.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.4 mtmp? -85.78 61.06 6.61 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.352 0.596 . . . . 73.11 110.402 176.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 66.4 m -107.13 110.58 63.46 Favored Pre-proline 0 N--CA 1.476 0.845 0 CA-C-O 118.176 -0.916 . . . . 54.41 109.202 176.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.421 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 2.8 Cg_endo -38.07 -53.62 1.57 Allowed 'Trans proline' 0 C--N 1.393 2.911 0 C-N-CA 124.941 3.761 . . . . 72.23 114.151 -172.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -47.43 -52.9 15.54 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 124.657 1.183 . . . . 64.43 112.005 177.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.58 -24.89 63.75 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 114.599 -1.182 . . . . 72.14 111.244 -176.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -85.03 -36.46 21.24 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.753 0.821 . . . . 62.01 110.84 -175.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 41' ' ' PRO . 28.0 mm-40 -68.74 -47.73 65.53 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 108.854 -0.795 . . . . 62.44 108.854 177.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 49.4 mttp -65.87 -33.15 75.18 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 114.856 -1.065 . . . . 74.03 111.38 175.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.638 ' HE1' ' HA ' ' A' ' 30' ' ' ALA . 88.2 t80 -58.6 -44.64 89.94 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.051 0.54 . . . . 73.24 110.292 173.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.534 ' HB3' ' HE1' ' A' ' 93' ' ' PHE . 48.5 mtmt -62.45 -39.54 93.7 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.258 -0.428 . . . . 75.14 111.055 177.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -65.4 -28.7 69.44 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.044 0.45 . . . . 71.44 111.926 176.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.633 HD13 ' HB3' ' A' ' 29' ' ' LEU . 68.2 mt -73.86 -32.9 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.516 0.726 . . . . 70.53 109.834 173.088 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.413 ' O ' ' HB2' ' A' ' 55' ' ' ALA . 25.9 m-80 -81.19 -14.7 57.3 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.541 0.736 . . . . 73.43 111.3 174.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -73.68 -55.56 6.11 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.82 1.248 . . . . 63.42 108.484 170.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.76 -51.47 65.6 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 113.448 -1.705 . . . . 65.45 110.707 175.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -60.82 -45.91 92.59 Favored 'General case' 0 C--O 1.21 -0.984 0 CA-C-N 114.936 -1.029 . . . . 72.32 110.649 177.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 51' ' ' ASN . . . -52.64 -52.58 54.93 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.355 0.662 . . . . 53.01 112.246 -177.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 97.3 t -61.11 -49.44 84.64 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 O-C-N 124.201 0.938 . . . . 74.52 109.782 178.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.538 ' HB3' HD13 ' A' ' 22' ' ' ILE . 69.5 mt -87.75 -6.82 58.0 Favored 'General case' 0 CA--C 1.56 1.335 0 N-CA-C 114.6 1.333 . . . . 62.04 114.6 -168.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.2 t -79.83 -32.63 40.65 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 123.268 0.627 . . . . 74.34 110.694 -177.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -100.55 129.43 27.78 Favored Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 108.296 -1.002 . . . . 74.34 108.296 -176.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.82 -40.18 86.33 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 123.297 2.665 . . . . 72.41 113.499 -172.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.422 ' O ' HG13 ' A' ' 65' ' ' ILE . 13.0 mp0 -64.77 -56.09 15.71 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.055 0.942 . . . . 72.3 110.067 -178.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.463 ' HA ' HD12 ' A' ' 65' ' ' ILE . 44.3 mtpt -65.11 -36.49 84.44 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.838 0.855 . . . . 74.54 111.65 -176.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 54.2 ttt180 -56.91 -49.98 73.93 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 124.051 0.844 . . . . 74.11 108.967 174.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -69.73 -25.27 63.76 Favored 'General case' 0 C--O 1.214 -0.814 0 CA-C-N 115.091 -0.959 . . . . 74.25 112.354 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.555 HG12 ' HG2' ' A' ' 76' ' ' PRO . 85.1 mt -61.14 -48.08 90.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 108.763 -0.828 . . . . 64.42 108.763 172.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -58.03 -58.26 9.22 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 115.414 -0.812 . . . . 75.4 110.774 173.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -58.13 -38.47 76.6 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.415 1.086 . . . . 64.04 112.381 -172.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 73.1 p -76.14 -33.1 59.4 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 118.935 -0.555 . . . . 75.13 110.459 178.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -63.46 120.71 12.2 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-N 118.535 0.607 . . . . 63.45 109.915 -176.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 107.61 5.61 33.79 Favored Glycine 0 CA--C 1.54 1.597 0 C-N-CA 123.443 0.544 . . . . 52.54 112.034 -166.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 91.4 m -146.53 -57.7 0.28 Allowed 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 104.583 -2.377 . . . . 71.23 104.583 175.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 96.4 m -79.14 149.14 32.11 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 105.277 -2.12 . . . . 74.23 105.277 155.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.58 -17.77 3.23 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 122.863 0.465 . . . . 74.04 111.942 -171.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -101.98 140.96 21.63 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 123.42 0.688 . . . . 75.1 109.666 177.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.13 126.85 13.53 Favored 'Trans proline' 0 C--N 1.374 1.884 0 C-N-CA 122.803 2.335 . . . . 75.41 112.322 177.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.555 ' HG2' HG12 ' A' ' 65' ' ' ILE . 71.4 Cg_exo -53.7 149.28 32.92 Favored 'Trans proline' 0 C--N 1.385 2.495 0 C-N-CA 123.751 2.967 . . . . 74.25 113.419 177.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -55.36 136.83 75.42 Favored 'Trans proline' 0 C--N 1.383 2.39 0 C-N-CA 122.941 2.427 . . . . 62.44 112.181 -176.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -61.27 126.02 18.34 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.907 2.404 . . . . 43.51 112.796 -178.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -58.09 157.95 23.41 Favored 'Trans proline' 0 C--N 1.382 2.328 0 C-N-CA 123.415 2.743 . . . . 71.05 113.038 173.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.548 ' HD2' ' HA3' ' A' ' 142' ' ' GLY . 79.8 Cg_exo -48.78 82.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.388 2.64 0 C-N-CA 124.648 3.565 . . . . 51.35 115.42 178.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 136.84 -39.55 1.62 Allowed Glycine 0 N--CA 1.467 0.766 0 N-CA-C 109.881 -1.287 . . . . 62.41 109.881 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 144.61 -176.89 23.5 Favored Glycine 0 C--N 1.344 0.982 0 C-N-CA 124.237 0.922 . . . . 53.03 110.969 176.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -58.79 98.47 0.04 OUTLIER 'General case' 0 C--O 1.243 0.738 0 N-CA-C 107.604 -1.258 . . . . 74.41 107.604 164.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -64.8 110.68 2.49 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.51 0.671 . . . . 71.31 109.307 -173.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.417 ' H ' ' HE2' ' A' ' 106' ' ' PHE . 23.0 t80 -133.05 23.9 4.2 Favored 'General case' 0 C--O 1.259 1.567 0 C-N-CA 124.862 1.265 . . . . 70.22 108.664 -168.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.457 ' HA ' ' CG ' ' A' ' 171' ' ' PRO . 73.4 m -58.5 146.28 36.0 Favored 'General case' 0 C--N 1.349 0.559 0 CA-C-N 113.986 -1.461 . . . . 74.44 112.279 -171.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.456 ' H ' ' HG2' ' A' ' 171' ' ' PRO . . . 79.73 -9.08 45.97 Favored Glycine 0 CA--C 1.536 1.382 0 CA-C-O 118.803 -0.998 . . . . 70.11 114.629 -176.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.429 ' HB3' ' HE2' ' A' ' 93' ' ' PHE . 51.8 m-85 -112.74 142.63 45.13 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 119.383 1.591 . . . . 72.34 112.575 -176.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -82.42 75.89 9.31 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 124.149 0.98 . . . . 71.44 111.126 -172.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.601 HG23 ' HE2' ' A' ' 97' ' ' PHE . 2.5 p -39.4 -48.55 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.62 0 C-N-CA 125.787 1.635 . . . . 75.21 113.904 176.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.17 -36.52 70.88 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 124.157 0.983 . . . . 75.33 112.195 -176.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -72.69 -31.7 65.23 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.949 -0.568 . . . . 45.35 110.902 -175.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.534 ' HE1' ' HB3' ' A' ' 48' ' ' LYS . 15.4 m-30 -80.05 174.71 11.32 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.905 -0.589 . . . . 71.01 111.939 -164.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.48 ' HB3' ' HE3' ' A' ' 5' ' ' LYS . 78.7 p -57.1 149.41 19.47 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.808 0.843 . . . . 74.5 113.129 -168.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.16 -39.61 72.59 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 114.839 -1.073 . . . . 74.31 110.084 168.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -54.49 -47.25 73.26 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.384 1.074 . . . . 75.03 110.896 176.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.601 ' HE2' HG23 ' A' ' 90' ' ' VAL . 44.3 t80 -59.42 -50.07 75.35 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 115.338 -0.847 . . . . 63.23 110.092 175.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -76.31 -2.18 30.36 Favored 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 112.403 0.52 . . . . 73.05 112.403 -175.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -93.94 -59.3 2.01 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.652 0.781 . . . . 70.02 110.191 169.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 33.4 tp -62.46 -46.18 89.68 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.979 0.912 . . . . 55.03 111.24 -176.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.407 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 82.4 m-85 -92.75 -3.65 54.44 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.104 0.562 . . . . 72.11 111.477 177.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -46.35 -57.73 6.28 Favored Glycine 0 CA--C 1.544 1.87 0 CA-C-O 118.988 -0.895 . . . . 72.43 115.195 177.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -68.21 11.51 0.26 Allowed 'Trans proline' 0 C--N 1.382 2.317 0 C-N-CA 123.637 2.891 . . . . 23.1 114.635 -178.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -147.05 16.5 1.54 Allowed Glycine 0 C--N 1.348 1.228 0 CA-C-O 119.078 -0.845 . . . . 44.4 113.077 171.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 101' ' ' PHE . 35.5 mt -66.65 79.81 0.11 Allowed 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 118.01 0.905 . . . . 74.25 111.61 174.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.417 ' HE2' ' H ' ' A' ' 85' ' ' PHE . 2.7 m-85 38.55 -113.27 0.12 Allowed 'General case' 0 CA--C 1.56 1.34 0 C-N-CA 126.632 1.973 . . . . 72.25 115.813 172.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 70.31 0.49 29.96 Favored Glycine 0 C--N 1.368 2.311 0 N-CA-C 112.29 -0.324 . . . . 44.0 112.29 -162.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 55.46 -122.84 28.1 Favored Glycine 0 C--N 1.355 1.604 0 C-N-CA 123.198 0.428 . . . . 71.34 113.284 -171.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -105.78 -0.05 25.71 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.875 0.87 . . . . 64.11 110.077 175.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -93.56 -25.47 18.22 Favored Glycine 0 C--N 1.353 1.478 0 CA-C-O 119.599 -0.556 . . . . 55.25 113.553 -178.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.6 tpm_? 67.45 -11.01 0.32 Allowed 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 124.972 1.309 . . . . 71.44 112.986 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.42 12.25 0.49 Allowed 'General case' 0 CA--C 1.562 1.424 0 O-C-N 121.184 -0.947 . . . . 73.25 111.636 178.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 51.8 m 53.39 37.92 26.65 Favored 'General case' 0 C--N 1.367 1.338 0 C-N-CA 124.308 1.043 . . . . 74.21 111.141 176.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 21.2 tpt180 -76.68 158.05 31.32 Favored 'General case' 0 C--N 1.344 0.359 0 CA-C-N 114.221 -1.354 . . . . 74.52 111.935 -169.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -60.7 129.49 41.8 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.061 0.944 . . . . 72.15 109.181 175.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.429 ' HA2' HH11 ' A' ' 117' ' ' ARG . . . -64.53 160.52 40.4 Favored Glycine 0 C--N 1.343 0.954 0 CA-C-O 121.664 0.591 . . . . 55.22 113.471 178.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.527 ' H ' ' HA3' ' A' ' 166' ' ' GLY . 2.7 mpt_? -102.87 165.43 11.05 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.424 1.09 . . . . 71.34 110.923 -168.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -76.44 115.75 16.48 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 106.698 -1.593 . . . . 74.23 106.698 163.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.524 HD12 ' HA2' ' A' ' 166' ' ' GLY . 3.6 tt -114.99 136.85 52.67 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 107.756 -1.201 . . . . 70.23 107.756 -174.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 29.8 ttt-85 -117.02 135.94 53.33 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 108.554 -0.906 . . . . 74.51 108.554 174.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.97 168.7 23.06 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 121.192 0.52 . . . . 41.51 111.407 -177.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -111.66 112.77 24.7 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.324 1.05 . . . . 61.0 109.439 -169.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 37.5 tp -100.92 96.2 5.39 Favored Pre-proline 0 CA--C 1.549 0.909 0 N-CA-C 108.796 -0.816 . . . . 54.05 108.796 -178.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.426 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 1.1 Cg_endo -83.53 114.27 2.07 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 122.695 2.263 . . . . 75.33 110.61 -173.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.521 ' HB3' HD23 ' A' ' 180' ' ' LEU . 46.3 tp -117.41 141.55 48.19 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.152 0.501 . . . . 64.01 111.134 -169.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 24.0 m -69.41 142.05 53.96 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 114.908 -1.042 . . . . 71.34 110.277 173.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.586 HD13 ' HB2' ' A' ' 186' ' ' PHE . 84.5 mt -57.65 -46.53 84.1 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.245 0.618 . . . . 70.54 110.389 179.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -62.67 -37.51 86.7 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 115.071 -0.968 . . . . 75.32 110.519 -177.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -76.6 -21.4 55.63 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.256 0.622 . . . . 64.33 111.574 178.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -71.71 -40.9 69.18 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.023 0.529 . . . . 41.43 110.166 171.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -65.02 -42.43 94.38 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.477 1.111 . . . . 74.51 110.547 177.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 41.7 m170 -69.16 -48.3 62.66 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.384 -0.826 . . . . 75.25 111.273 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.46 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 71.3 -141.96 33.36 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 115.941 -0.572 . . . . 71.54 112.496 -175.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 71.97 -161.2 54.25 Favored Glycine 0 C--N 1.349 1.297 0 C-N-CA 122.987 0.327 . . . . 70.42 113.141 178.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.671 ' HB3' ' HB2' ' A' ' 146' ' ' SER . 26.2 mp0 -69.54 118.46 12.44 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 122.949 0.5 . . . . 73.14 110.146 178.354 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 11.1 tpp180 -101.21 118.91 37.92 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.794 -0.817 . . . . 74.4 108.794 176.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.581 ' HB ' HG21 ' B' ' 5' ' ' THR . 97.2 t -81.74 96.0 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 121.413 0.625 . . . . 71.24 109.465 -178.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.1 p -115.47 124.11 71.65 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-N 114.985 -1.007 . . . . 73.14 108.435 173.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -85.13 115.11 22.73 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 114.792 -1.095 . . . . 71.3 110.246 178.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 33.9 m -122.58 127.65 75.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 124.226 1.011 . . . . 75.1 110.684 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 63.17 21.26 12.76 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.105 0.962 . . . . 74.24 112.575 177.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.548 ' HA3' ' HD2' ' A' ' 80' ' ' PRO . . . 90.2 -17.95 51.04 Favored Glycine 0 C--N 1.35 1.33 0 C-N-CA 122.689 0.185 . . . . 31.1 113.075 -175.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -87.83 118.64 27.49 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.201 1.001 . . . . 72.12 108.831 176.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 45.4 ttm105 -82.4 115.46 21.44 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.592 0.757 . . . . 74.41 109.05 178.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 14.7 p -125.47 149.54 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-O 121.4 0.619 . . . . 73.53 110.607 -177.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.671 ' HB2' ' HB3' ' A' ' 135' ' ' GLU . 35.9 p -107.55 93.27 4.45 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 124.382 1.073 . . . . 31.45 110.45 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 3.4 p -80.57 112.68 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 123.108 0.563 . . . . 73.42 109.564 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -67.02 95.28 0.38 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.658 0.742 . . . . 74.14 110.378 176.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.46 HG13 ' HA2' ' A' ' 133' ' ' GLY . 44.5 pt -78.15 140.58 61.63 Favored Pre-proline 0 CA--C 1.556 1.186 0 CA-C-N 114.42 -1.264 . . . . 74.13 108.713 170.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -66.31 138.48 51.19 Favored 'Trans proline' 0 C--N 1.373 1.833 0 C-N-CA 121.995 1.797 . . . . 60.34 112.187 176.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -63.82 92.63 0.17 Allowed 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 122.424 2.083 . . . . 74.15 110.749 171.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 123.4 27.35 1.49 Allowed Glycine 0 CA--C 1.526 0.736 0 CA-C-N 114.756 -1.111 . . . . 75.51 110.993 -171.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 5.7 p -73.67 137.45 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 123.294 0.637 . . . . 75.43 109.552 179.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.56 HH21 ' HG2' ' A' ' 241' ' ' PRO . 0.0 OUTLIER -112.36 154.61 25.47 Favored 'General case' 0 C--O 1.211 -0.941 0 CA-C-N 116.372 -0.376 . . . . 73.23 111.816 -163.704 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -54.0 124.26 15.02 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 124.049 0.843 . . . . 72.32 110.248 171.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.46 4.88 70.13 Favored Glycine 0 C--N 1.342 0.9 0 CA-C-O 119.159 -0.8 . . . . 14.21 113.747 -178.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 58.3 m -67.78 102.09 1.17 Allowed 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 118.157 0.979 . . . . 74.23 108.857 170.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 53.9 t -83.94 91.4 2.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 107.34 -1.356 . . . . 72.34 107.34 177.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.653 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 53.0 mt -71.99 85.12 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.801 0 N-CA-C 107.618 -1.253 . . . . 75.24 107.618 174.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -74.17 99.52 3.42 Favored 'General case' 0 C--N 1.353 0.76 0 N-CA-C 107.378 -1.342 . . . . 61.32 107.378 175.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.0 p -110.13 118.75 48.87 Favored Pre-proline 0 CA--C 1.548 0.903 0 CA-C-N 115.076 -0.966 . . . . 61.33 110.872 -169.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -79.06 125.3 6.45 Favored 'Trans proline' 0 C--N 1.369 1.626 0 C-N-CA 122.386 2.057 . . . . 74.53 106.841 160.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.421 ' HA2' ' O ' ' A' ' 86' ' ' SER . . . 130.0 -23.75 4.63 Favored Glycine 0 N--CA 1.469 0.9 0 N-CA-C 111.303 -0.719 . . . . 70.43 111.303 -165.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -134.22 144.55 48.5 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 106.152 -1.795 . . . . 64.15 106.152 163.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -175.85 -160.95 24.27 Favored Glycine 0 CA--C 1.498 -0.993 0 N-CA-C 114.596 0.598 . . . . 73.33 114.596 171.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.527 ' HA3' ' H ' ' A' ' 117' ' ' ARG . . . -57.79 135.64 51.56 Favored Glycine 0 C--N 1.356 1.691 0 O-C-N 124.476 0.75 . . . . 74.5 112.322 175.059 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -70.38 105.11 2.91 Favored 'General case' 0 CA--C 1.548 0.899 0 O-C-N 125.686 1.462 . . . . 75.42 110.105 -172.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -170.39 155.7 25.51 Favored Glycine 0 C--N 1.339 0.727 0 CA-C-O 118.887 -0.952 . . . . 64.21 111.253 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . 0.495 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . 7.3 t30 -64.74 -56.26 22.99 Favored Pre-proline 0 N--CA 1.488 1.438 0 CA-C-O 117.826 -1.083 . . . . 63.11 111.41 -170.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.495 ' HD3' ' HB3' ' A' ' 169' ' ' ASN . 1.7 Cg_endo -82.68 91.74 0.96 Allowed 'Trans proline' 0 C--N 1.388 2.649 0 N-CA-C 106.965 -1.975 . . . . 71.13 106.965 162.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.457 ' CG ' ' HA ' ' A' ' 86' ' ' SER . 56.0 Cg_endo -76.6 174.58 12.61 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 123.479 2.786 . . . . 71.25 117.232 -156.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -95.48 -158.86 32.73 Favored Glycine 0 C--N 1.363 2.05 0 CA-C-N 114.724 -1.125 . . . . 72.4 114.736 -177.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -133.52 146.08 50.73 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 125.386 1.474 . . . . 71.14 108.147 -177.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 41.8 tp -118.26 141.63 48.31 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 120.966 0.412 . . . . 64.32 112.015 -172.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 68.9 mt -97.2 91.67 5.65 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 124.268 1.027 . . . . 72.12 108.284 171.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.653 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 85.4 mt -74.28 85.61 1.93 Allowed 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.392 -0.966 . . . . 70.05 108.392 170.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 46.5 t -83.34 97.82 4.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 107.037 -1.468 . . . . 61.43 107.037 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 8.9 p -68.41 125.88 27.1 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 CA-C-N 115.558 -0.746 . . . . 70.33 110.144 -173.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.426 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 40.4 mmm-85 -116.94 97.61 6.04 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.497 1.119 . . . . 53.32 108.215 -176.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.521 HD23 ' HB3' ' A' ' 125' ' ' LEU . 45.3 mt -69.34 141.11 54.31 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 110.067 -0.346 . . . . 72.4 110.067 -179.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 79.6 mt -57.52 148.2 56.51 Favored Pre-proline 0 CA--C 1.549 0.929 0 O-C-N 124.066 0.854 . . . . 73.14 111.202 -177.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -77.43 48.19 2.49 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 123.084 2.523 . . . . 71.42 110.441 167.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.431 ' HA ' ' HD3' ' A' ' 184' ' ' PRO . 53.2 t-80 -70.28 136.94 86.54 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 125.27 1.428 . . . . 73.35 109.051 -172.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 183' ' ' HIS . 53.1 Cg_exo -58.32 12.09 0.04 OUTLIER 'Trans proline' 0 C--N 1.381 2.253 0 C-N-CA 124.202 3.268 . . . . 61.24 118.127 -168.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 40.2 t -106.63 -55.2 5.61 Favored 'Isoleucine or valine' 0 C--N 1.352 0.702 0 CA-C-N 119.43 1.014 . . . . 64.21 109.181 172.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . 0.586 ' HB2' HD13 ' A' ' 127' ' ' LEU . 23.1 m-85 -134.49 147.11 50.3 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 115.061 -0.972 . . . . 72.31 111.681 -168.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -133.79 90.96 2.77 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 106.177 -1.786 . . . . 75.51 106.177 165.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.49 HD13 ' HG ' ' A' ' 193' ' ' LEU . 60.0 tp -71.47 161.33 31.21 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 124.48 1.112 . . . . 74.21 111.652 -177.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -154.28 107.54 2.89 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 122.905 0.482 . . . . 70.31 110.59 174.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 82.22 -53.37 4.76 Favored Glycine 0 C--N 1.36 1.861 0 C-N-CA 123.375 0.512 . . . . 65.41 114.216 174.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -178.97 -21.43 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 126.917 2.087 . . . . 72.32 107.789 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -85.31 120.37 26.72 Favored 'General case' 0 C--N 1.357 0.923 0 CA-C-N 114.405 -1.271 . . . . 72.32 109.509 -178.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.566 HD13 HD13 ' A' ' 249' ' ' LEU . 0.6 OUTLIER -89.97 142.7 27.46 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.06 0.944 . . . . 63.44 110.112 -170.23 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -119.3 145.18 46.35 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 107.878 -1.156 . . . . 73.14 107.878 166.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.441 ' HB3' HD23 ' A' ' 251' ' ' LEU . . . -144.63 175.84 9.85 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.609 1.164 . . . . 74.34 109.485 -171.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . 0.446 ' OG1' ' HA ' ' B' ' 120' ' ' TYR . 2.9 m -118.41 139.84 50.77 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.643 -0.873 . . . . 70.21 108.643 172.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.628 HD22 HD13 ' A' ' 251' ' ' LEU . 34.5 tp -145.61 105.87 4.05 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 110.127 -0.323 . . . . 72.21 110.127 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -73.62 133.38 43.46 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 109.285 -0.635 . . . . 61.43 109.285 167.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 7.3 p -143.59 133.03 11.63 Favored Pre-proline 0 CA--C 1.548 0.879 0 N-CA-C 107.781 -1.192 . . . . 64.4 107.781 178.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.28 146.15 35.46 Favored 'Trans proline' 0 C--N 1.368 1.586 0 C-N-CA 121.313 1.342 . . . . 64.51 110.404 169.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.477 ' HB3' ' HH2' ' A' ' 269' ' ' TRP . . . -44.13 -52.0 17.16 Favored Pre-proline 0 CA--C 1.568 1.669 0 N-CA-C 115.644 1.72 . . . . 71.34 115.644 -173.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.408 ' HD3' ' HB3' ' A' ' 201' ' ' ALA . 50.5 Cg_exo -60.07 -38.55 76.86 Favored 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 121.809 1.673 . . . . 63.54 113.845 -179.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 46.3 mt -70.17 -29.4 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 110.016 -0.364 . . . . 64.32 110.016 179.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.18 -48.83 61.1 Favored 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 123.069 0.548 . . . . 71.51 111.941 172.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 201' ' ' ALA . 93.4 t -65.54 -43.04 94.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 C-N-CA 123.837 0.855 . . . . 63.23 111.859 -175.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.472 HG21 ' HB2' ' C' ' 273' ' ' ALA . 70.4 t -92.55 -34.68 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.594 0.757 . . . . 74.41 111.458 -173.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 88.09 89.21 1.12 Allowed Glycine 0 C--N 1.341 0.845 0 N-CA-C 111.319 -0.712 . . . . 72.35 111.319 -175.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -107.4 -139.28 9.1 Favored Glycine 0 C--N 1.34 0.798 0 CA-C-O 120.277 -0.18 . . . . 55.24 112.67 -177.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -130.85 128.21 40.16 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.175 0.99 . . . . 45.21 108.917 177.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 29.3 m -129.83 159.24 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 109.038 -0.727 . . . . 63.11 109.038 175.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 55.2 ttm-85 -93.93 107.24 19.16 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 109.494 -0.558 . . . . 71.41 109.494 178.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -102.25 124.35 47.69 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 124.111 0.964 . . . . 62.04 109.436 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . 0.413 ' SD ' ' N ' ' A' ' 213' ' ' MET . 1.0 OUTLIER -75.08 126.08 30.27 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.202 0.601 . . . . 71.23 109.747 175.922 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 72.7 p -116.1 -178.01 3.3 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 123.876 0.87 . . . . 74.1 108.726 173.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.424 ' HG ' ' HE2' ' A' ' 186' ' ' PHE . 63.8 mt -77.01 -7.6 55.93 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 122.778 0.431 . . . . 63.31 110.727 174.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -99.98 -19.66 16.46 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.225 1.01 . . . . 64.44 110.553 176.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 139.53 172.84 12.86 Favored Glycine 0 C--N 1.353 1.504 0 CA-C-O 119.858 -0.412 . . . . 33.0 113.451 175.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -75.9 99.32 1.27 Allowed 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 122.93 2.42 . . . . 70.23 111.285 178.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 32.5 m -103.2 159.34 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.208 1.003 . . . . 73.4 110.619 -174.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.646 ' HB2' ' HB2' ' B' ' 428' ' ' GLU . 36.8 mt-10 -93.8 105.07 17.12 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.152 -0.684 . . . . 75.04 109.152 179.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 8.7 p -101.64 137.52 29.09 Favored 'Isoleucine or valine' 0 C--O 1.253 1.273 0 C-N-CA 123.832 0.853 . . . . 74.13 110.021 -174.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -86.42 102.75 14.34 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.784 0.834 . . . . 60.25 110.744 -178.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.452 ' HA ' HD12 ' B' ' 441' ' ' ILE . 48.8 t -63.48 137.76 97.17 Favored Pre-proline 0 CA--C 1.56 1.353 0 C-N-CA 124.458 1.103 . . . . 63.14 110.304 179.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . 0.616 ' HB2' ' HB2' ' B' ' 444' ' ' TYR . 65.0 Cg_endo -79.98 164.01 22.76 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 122.673 2.249 . . . . 75.51 110.612 174.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.99 152.4 46.11 Favored 'Trans proline' 0 C--N 1.369 1.63 0 C-N-CA 121.786 1.657 . . . . 72.53 112.814 178.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . 0.571 HH12 ' HG ' ' C' ' 261' ' ' LEU . 63.5 mtt-85 67.54 26.06 8.22 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 125.533 1.533 . . . . 74.04 111.873 172.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.504 HG23 HD21 ' A' ' 233' ' ' LEU . 10.5 m -61.17 104.01 0.34 Allowed 'General case' 0 CA--C 1.559 1.323 0 C-N-CA 125.699 1.6 . . . . 64.32 111.026 175.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . 0.562 ' HB3' ' HD2' ' A' ' 231' ' ' ARG . 4.8 tp-100 -97.38 143.89 27.67 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.085 0.954 . . . . 75.32 111.263 -173.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -63.57 150.91 42.94 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.588 0.755 . . . . 62.31 112.462 -177.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 83.71 -28.27 4.03 Favored Glycine 0 C--N 1.349 1.271 0 O-C-N 123.684 0.615 . . . . 73.32 112.523 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.562 ' HD2' ' HB3' ' A' ' 228' ' ' GLN . 76.6 mtt180 -77.63 167.11 22.12 Favored 'General case' 0 C--N 1.347 0.492 0 C-N-CA 123.971 0.908 . . . . 74.0 110.469 178.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.443 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 12.5 mptt -121.82 120.55 34.89 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 115.067 -0.97 . . . . 72.22 108.571 -178.078 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.504 HD21 HG23 ' A' ' 227' ' ' THR . 81.8 mt -74.59 110.3 8.77 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 108.595 -0.891 . . . . 71.4 108.595 177.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . 0.563 ' HG3' ' HB3' ' A' ' 248' ' ' ASP . 39.9 ttp180 -87.63 100.77 13.05 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 122.622 0.369 . . . . 64.14 110.121 178.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.504 HD13 HG12 ' B' ' 441' ' ' ILE . 0.2 OUTLIER -100.84 106.84 18.25 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 106.466 -1.679 . . . . 61.12 106.466 170.662 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -76.18 143.95 40.81 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 115.045 -0.979 . . . . 64.43 111.708 -169.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 71.35 32.62 64.97 Favored Glycine 0 C--N 1.348 1.2 0 O-C-N 123.704 0.627 . . . . 74.2 112.536 -178.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.491 ' HG3' HD12 ' A' ' 235' ' ' LEU . 43.9 mmtm -125.32 -17.18 5.71 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.985 0.914 . . . . 73.01 110.453 178.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . 0.515 ' HA2' HD12 ' A' ' 193' ' ' LEU . . . -79.6 -151.86 6.85 Favored Glycine 0 C--N 1.353 1.474 0 CA-C-N 116.298 -0.41 . . . . 74.43 112.655 176.354 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -96.72 146.06 30.65 Favored Pre-proline 0 N--CA 1.482 1.169 0 C-N-CA 122.882 0.473 . . . . 73.13 109.857 -179.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.728 ' HA ' ' HA ' ' A' ' 246' ' ' ARG . 33.1 Cg_endo -61.27 167.26 9.66 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 123.203 2.602 . . . . 73.33 114.195 -175.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -175.2 -176.35 43.4 Favored Glycine 0 CA--C 1.535 1.335 0 CA-C-N 115.213 -0.903 . . . . 73.52 112.18 177.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -62.44 -19.31 67.05 Favored 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 123.68 2.92 . . . . 70.45 113.961 -175.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -102.53 22.52 13.4 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 124.027 0.931 . . . . 70.11 110.855 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 90.18 -164.38 30.9 Favored Glycine 0 C--N 1.35 1.338 0 N-CA-C 111.471 -0.651 . . . . 62.24 111.471 -174.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.728 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 25.1 ttm180 -73.08 139.37 46.45 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 117.664 0.732 . . . . 75.41 110.383 177.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -70.06 179.11 28.58 Favored Glycine 0 C--N 1.34 0.775 0 CA-C-N 115.709 -0.678 . . . . 42.24 113.379 -176.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . 0.563 ' HB3' ' HG3' ' A' ' 234' ' ' ARG . 55.7 m-20 -106.12 140.57 38.89 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.52 0.728 . . . . 75.44 109.493 -173.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.566 HD13 HD13 ' A' ' 193' ' ' LEU . 34.4 tp -97.61 120.0 37.19 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.349 -0.982 . . . . 70.31 108.349 178.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.443 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 2.9 m-85 -100.93 106.18 17.49 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.363 1.065 . . . . 52.51 108.66 177.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.628 HD13 HD22 ' A' ' 197' ' ' LEU . 47.1 mt -87.03 121.45 29.51 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.392 0.677 . . . . 72.24 109.659 177.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.427 ' HB2' ' O ' ' A' ' 195' ' ' ALA . 2.8 tm-20 -74.38 107.3 6.45 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 107.45 -1.315 . . . . 75.41 107.45 -178.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.497 HG12 HG13 ' A' ' 255' ' ' ILE . 42.6 t -67.36 99.67 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.687 0 O-C-N 124.117 0.886 . . . . 24.43 110.223 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.25 92.16 4.39 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 107.181 -1.414 . . . . 73.14 107.181 177.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.497 HG13 HG12 ' A' ' 253' ' ' VAL . 70.2 mt -83.8 130.95 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-O 120.779 0.323 . . . . 74.34 110.583 -177.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 51.8 p -128.99 169.38 14.75 Favored 'General case' 0 C--O 1.253 1.265 0 C-N-CA 123.942 0.897 . . . . 73.43 109.585 172.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.551 HD13 HG22 ' C' ' 205' ' ' VAL . 2.1 pp -119.14 155.95 52.91 Favored Pre-proline 0 CA--C 1.564 1.513 0 N-CA-C 108.121 -1.066 . . . . 73.4 108.121 173.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -76.27 9.21 2.56 Favored 'Trans proline' 0 N--CA 1.512 2.564 0 C-N-CA 123.027 2.485 . . . . 74.45 115.328 -162.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.48 ' H ' HD12 ' A' ' 257' ' ' ILE . 5.6 mm-40 56.72 -90.72 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 123.858 0.863 . . . . 63.24 109.925 -164.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' ARG . . . . . 0.464 HH22 HG23 ' A' ' 262' ' ' THR . 0.0 OUTLIER -74.33 144.32 44.53 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.589 0.756 . . . . 75.12 111.521 -175.029 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.435 HD11 HG11 ' C' ' 205' ' ' VAL . 49.5 mt -123.41 178.67 5.05 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.046 0.938 . . . . 55.32 111.165 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . 0.464 HG23 HH22 ' A' ' 260' ' ' ARG . 1.2 p -128.16 143.88 49.61 Favored Pre-proline 0 CA--C 1.556 1.181 0 CA-C-N 114.007 -1.451 . . . . 44.34 108.43 176.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -28.26 -53.91 0.14 Allowed 'Trans proline' 0 C--N 1.39 2.757 1 C-N-CA 126.166 4.577 . . . . 74.33 117.734 -167.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . 0.406 ' O ' HD13 ' A' ' 268' ' ' LEU . 16.9 tp10 -70.25 -47.52 60.98 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 122.589 0.356 . . . . 71.44 110.68 -174.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -64.51 -29.22 70.26 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.284 1.034 . . . . 64.2 110.319 178.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 266' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -62.76 -50.53 70.69 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.736 0.814 . . . . 73.45 109.047 175.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -62.76 -37.13 85.4 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 114.991 -1.004 . . . . 64.12 112.097 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . 0.5 HD21 ' HB3' ' C' ' 271' ' ' LYS . 6.7 mp -64.73 -56.05 16.08 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.704 0.802 . . . . 73.14 111.396 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 269' ' ' TRP . . . . . 0.477 ' HH2' ' HB3' ' A' ' 201' ' ' ALA . 68.1 m95 -58.62 -41.73 86.57 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.431 0.693 . . . . 75.0 111.279 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -60.25 -58.54 8.07 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 123.828 0.705 . . . . 62.43 111.516 178.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 30.8 mmtm -66.34 -33.64 76.18 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 112.418 0.525 . . . . 70.22 112.418 -175.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 13.7 mt -54.25 -53.54 52.3 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 109.224 -0.658 . . . . 63.4 109.224 169.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . 0.443 ' HA ' ' HB2' ' C' ' 202' ' ' PRO . . . -67.41 -37.84 83.68 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.671 1.188 . . . . 64.51 113.664 -172.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.466 ' HB3' ' HA ' ' B' ' 250' ' ' GLN . 37.6 mt-10 -67.81 -53.81 24.08 Favored 'General case' 0 C--O 1.243 0.733 0 C-N-CA 123.956 0.902 . . . . 74.35 109.398 -179.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -66.29 -30.41 70.82 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 115.538 -0.755 . . . . 71.44 111.145 178.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -68.57 -44.65 74.0 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.474 0.71 . . . . 75.02 109.945 178.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 277' ' ' TYR . . . . . 0.465 ' HA ' ' HB3' ' A' ' 280' ' ' ALA . 70.3 t80 -65.12 -37.53 87.75 Favored 'General case' 0 C--O 1.242 0.674 0 O-C-N 124.06 0.85 . . . . 70.12 110.245 -178.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -57.79 -23.83 54.3 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 115.571 -0.74 . . . . 75.41 111.683 173.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 67.7 mtm-85 -102.89 -15.76 16.08 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 124.026 0.93 . . . . 74.13 111.398 176.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . 0.465 ' HB3' ' HA ' ' A' ' 277' ' ' TYR . . . . . . . . 0 C--O 1.259 1.561 0 C-N-CA 123.851 0.86 . . . . 72.21 110.275 -176.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 62.9 mtm . . . . . 0 N--CA 1.482 1.148 0 N-CA-C 109.25 -0.648 . . . . 71.44 109.25 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 61.93 -158.23 0.33 Allowed 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.766 0.826 . . . . 54.1 109.777 -177.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -90.47 67.5 6.58 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 108.108 -1.071 . . . . 74.04 108.108 169.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 21.8 p -69.94 97.57 1.15 Allowed 'General case' 0 C--O 1.244 0.776 0 CA-C-N 115.53 -0.759 . . . . 52.14 110.543 -177.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 0.581 HG21 ' HB ' ' A' ' 137' ' ' VAL . 0.0 OUTLIER -97.07 166.17 11.72 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.475 -0.784 . . . . 70.11 111.71 -174.59 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 19.7 pt -133.78 166.57 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 115.248 -0.887 . . . . 64.44 112.385 -157.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -128.59 155.31 45.15 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.878 1.271 . . . . 72.01 108.625 173.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 45.7 tp -89.36 -98.55 0.1 Allowed 'General case' 0 CA--C 1.55 0.961 0 CA-C-O 119.131 -0.461 . . . . 75.22 110.574 -173.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . 166.31 -55.0 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 125.126 1.371 . . . . 62.4 109.065 -173.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 93.0 mt 57.95 91.29 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.983 1.313 . . . . 74.1 110.459 -168.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 78.7 mt -100.82 100.85 13.68 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 123.526 0.73 . . . . 45.35 109.434 -177.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -75.86 72.15 5.27 Favored 'Trans proline' 0 C--N 1.381 2.281 0 C-N-CA 122.974 2.449 . . . . 61.33 111.349 -177.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 7.4 mp 59.75 31.31 20.76 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.637 1.175 . . . . 75.01 110.635 -175.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 29.0 tp -79.48 14.91 1.42 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 124.726 1.211 . . . . 64.54 111.994 -172.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -82.57 69.22 9.29 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.105 0.962 . . . . 60.01 109.742 179.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 2.5 t -142.84 68.55 18.83 Favored Pre-proline 0 CA--C 1.56 1.344 0 CA-C-N 115.225 -0.898 . . . . 51.11 110.351 -179.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 17' ' ' PRO . . . . . 0.501 ' HB3' ' HB3' ' B' ' 21' ' ' ALA . 39.6 Cg_exo -64.7 96.39 0.25 Allowed 'Trans proline' 0 C--N 1.385 2.483 0 C-N-CA 122.895 2.397 . . . . 62.42 112.319 172.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 12.8 m -76.19 86.3 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.344 0 C-N-CA 123.395 0.678 . . . . 61.41 111.144 -179.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 20.6 m 76.04 -48.16 0.58 Allowed 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 126.202 1.801 . . . . 71.22 112.525 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -69.56 112.15 5.87 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 107.841 -1.17 . . . . 62.34 107.841 170.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . 0.501 ' HB3' ' HB3' ' B' ' 17' ' ' PRO . . . 74.28 169.31 0.3 Allowed 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 125.267 1.427 . . . . 75.34 110.68 -164.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 72.67 -65.57 0.35 Allowed 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 124.966 1.306 . . . . 73.31 109.823 -165.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 23' ' ' THR . . . . . . . . . . . . . 31.0 m -128.3 88.46 52.55 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 124.036 0.934 . . . . 72.45 108.562 176.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -57.06 112.35 1.08 Allowed 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 123.28 2.654 . . . . 74.55 112.796 -179.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -95.6 111.99 23.8 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.049 0.54 . . . . 74.53 109.721 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . 0.411 ' SD ' ' N ' ' B' ' 26' ' ' MET . 1.5 mpt? -79.06 158.83 74.29 Favored Pre-proline 0 CA--C 1.557 1.214 0 C-N-CA 123.798 0.839 . . . . 75.13 109.995 176.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -66.87 84.85 0.31 Allowed 'Trans proline' 0 C--N 1.384 2.441 0 C-N-CA 122.373 2.049 . . . . 71.1 110.625 172.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.534 HG13 ' H ' ' B' ' 29' ' ' LEU 0.276 5.1 p 39.53 -80.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 C-N-CA 126.42 1.888 . . . . 73.51 113.747 -168.233 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.534 ' H ' HG13 ' B' ' 28' ' ' VAL . 81.8 mt 72.92 -38.59 0.42 Allowed 'General case' 0 N--CA 1.499 2.0 0 C-N-CA 126.387 1.875 . . . . 62.2 113.663 -179.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -72.47 84.1 1.11 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.789 0.836 . . . . 70.24 110.817 -174.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -99.13 -20.09 16.84 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.258 0.623 . . . . 74.34 110.994 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -84.24 76.02 10.14 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.543 0.737 . . . . 72.22 110.469 -174.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -91.44 -24.65 19.64 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 115.067 -0.97 . . . . 73.31 111.062 177.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . 76.03 -43.51 0.48 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 126.173 1.789 . . . . 53.33 112.535 178.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 69.74 -73.67 0.09 Allowed 'General case' 0 C--N 1.361 1.074 0 C-N-CA 125.714 1.606 . . . . 73.13 110.955 176.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 161.85 45.14 0.02 OUTLIER Glycine 0 C--N 1.341 0.842 0 N-CA-C 110.253 -1.139 . . . . 74.33 110.253 177.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -68.95 119.89 13.98 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.651 0.78 . . . . 61.44 110.963 -175.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 38.5 mm 57.4 -88.24 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.166 0 C-N-CA 125.407 1.483 . . . . 75.44 110.25 -170.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 15.5 p -155.69 12.34 0.32 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 124.759 1.223 . . . . 64.25 109.948 178.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . 51.82 64.87 7.11 Favored Pre-proline 0 CA--C 1.562 1.406 0 C-N-CA 124.078 0.951 . . . . 64.0 111.117 -166.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -75.35 6.6 3.44 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 123.545 2.83 . . . . 72.44 114.185 -176.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -79.75 61.77 4.24 Favored Glycine 0 C--N 1.35 1.324 0 C-N-CA 122.92 0.295 . . . . 45.24 112.735 176.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -172.0 14.49 0.05 OUTLIER Glycine 0 C--N 1.345 1.079 0 C-N-CA 123.502 0.573 . . . . 42.15 112.198 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . 66.64 -73.5 0.07 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.668 1.587 . . . . 63.2 111.345 -177.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 20.1 tpp180 -156.54 -60.35 0.1 Allowed 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 106.563 -1.643 . . . . 74.21 106.563 175.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 71.6 mtt180 -131.39 -173.05 3.01 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 114.98 -1.009 . . . . 75.02 109.518 171.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 1.8 pp -83.1 -171.57 3.65 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.278 0.631 . . . . 53.22 111.247 178.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 31.1 m 69.13 80.08 0.19 Allowed 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.101 1.36 . . . . 51.22 109.993 -175.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.28 111.04 3.28 Favored Glycine 0 C--N 1.35 1.336 0 CA-C-N 114.904 -1.043 . . . . 74.15 112.804 -176.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -64.36 -45.46 87.66 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.055 0.942 . . . . 64.2 110.26 175.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 51' ' ' GLN . . . . . 0.668 ' HB2' HD21 ' B' ' 55' ' ' LEU . 73.6 mt-30 65.22 -75.86 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 125.399 1.479 . . . . 75.3 111.512 -179.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 32.2 m -117.2 -60.44 1.83 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.489 0.715 . . . . 73.31 109.392 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -176.56 -58.68 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.446 1.099 . . . . 73.24 109.385 177.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -147.49 103.52 3.55 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.654 0.782 . . . . 75.51 109.419 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.668 HD21 ' HB2' ' B' ' 51' ' ' GLN . 2.8 mm? -87.23 109.2 19.32 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.751 0.82 . . . . 72.35 108.861 -178.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . 0.404 ' HA ' ' H ' ' B' ' 233' ' ' PHE . 0.1 OUTLIER 79.17 -16.45 0.67 Allowed 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 125.235 1.414 . . . . 73.2 113.021 176.763 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 48.9 t0 74.3 142.52 0.07 Allowed 'General case' 0 C--N 1.372 1.555 0 C-N-CA 124.887 1.275 . . . . 75.31 109.902 -175.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 23.6 m -107.7 170.52 7.93 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.489 0.716 . . . . 62.01 112.153 -169.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 4.5 mm? 77.53 79.45 0.08 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 125.957 1.703 . . . . 72.44 112.47 -178.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 68.1 m -143.98 23.19 1.72 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.862 1.265 . . . . 63.51 109.134 171.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . 0.572 ' HB2' ' HD2' ' B' ' 63' ' ' PRO . 2.2 m-20 -85.68 -59.63 2.25 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.162 0.985 . . . . 71.45 110.082 -168.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 62' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -175.4 -48.32 0.0 OUTLIER Pre-proline 0 CA--C 1.555 1.142 0 C-N-CA 125.424 1.49 . . . . 72.3 108.362 -175.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . 0.572 ' HD2' ' HB2' ' B' ' 61' ' ' ASP . 73.2 Cg_endo -71.37 -165.18 0.18 Allowed 'Trans proline' 0 C--N 1.406 3.597 0 C-N-CA 122.08 1.853 . . . . 72.24 113.671 174.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 78.66 100.28 0.06 Allowed 'General case' 0 C--N 1.361 1.087 0 C-N-CA 126.0 1.72 . . . . 72.04 109.758 -170.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.431 ' NZ ' HG22 ' B' ' 68' ' ' ILE . 57.0 tttm 84.16 -64.42 0.08 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 126.063 1.745 . . . . 65.32 110.904 175.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 66' ' ' ASN . . . . . 0.446 HD21 ' HA ' ' B' ' 63' ' ' PRO . 20.5 m120 57.69 -88.7 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 124.449 1.099 . . . . 72.41 113.055 175.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 60.9 mt -76.76 98.07 1.79 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.69 0 C-N-CA 123.313 0.645 . . . . 72.03 109.31 -175.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . 0.541 HD13 ' HG2' ' B' ' 221' ' ' ARG . 2.9 pp -66.08 142.78 16.34 Favored 'Isoleucine or valine' 0 C--O 1.246 0.906 0 CA-C-N 114.995 -1.002 . . . . 73.4 108.462 168.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.61 132.05 44.86 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 107.013 -1.477 . . . . 73.12 107.013 176.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 7.6 mp -55.54 -34.11 64.41 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.151 0.98 . . . . 44.44 111.73 -173.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . . . . . . . . . 31.6 pt -136.56 157.25 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 124.906 1.283 . . . . 74.32 108.973 173.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.75 -29.32 3.75 Favored Glycine 0 N--CA 1.478 1.481 0 CA-C-O 119.56 -0.578 . . . . 62.21 114.104 174.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . 0.477 ' HB3' ' HG3' ' B' ' 221' ' ' ARG . 15.7 t70 -53.35 -43.61 67.85 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 124.966 1.306 . . . . 63.44 110.499 178.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -132.71 124.77 3.92 Favored Glycine 0 C--N 1.334 0.47 0 N-CA-C 108.396 -1.882 . . . . 64.42 108.396 163.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 14.2 tpt -79.69 86.36 5.3 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 117.583 0.691 . . . . 74.01 109.778 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 70.7 -176.24 36.25 Favored Glycine 0 CA--C 1.534 1.252 0 CA-C-N 115.292 -0.867 . . . . 71.13 113.379 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . 0.702 ' HA ' HG11 ' B' ' 224' ' ' VAL . 5.8 p-10 -95.91 148.38 22.69 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.826 0.85 . . . . 73.03 109.768 173.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . 0.413 ' H ' HG21 ' B' ' 224' ' ' VAL . 17.9 m -73.18 85.71 1.38 Allowed 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 121.638 0.732 . . . . 51.1 111.239 -174.304 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -75.55 -16.4 60.27 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 114.629 -1.169 . . . . 74.44 111.391 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 6.6 tp -50.08 -39.99 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 124.611 1.165 . . . . 72.52 111.131 175.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 26.7 m -116.4 -81.24 0.61 Allowed 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 108.448 -0.945 . . . . 71.34 108.448 170.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . 58.9 169.47 0.06 Allowed 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 124.585 1.154 . . . . 61.11 112.976 -173.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . 70.08 -67.3 0.24 Allowed 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 125.058 1.343 . . . . 71.35 113.101 176.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 30.5 tpt180 65.58 103.74 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.682 1.193 . . . . 73.0 109.124 -175.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . 0.458 ' HB2' ' HA2' ' B' ' 89' ' ' GLY . 6.2 m-20 69.18 87.32 0.12 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.045 0.938 . . . . 72.23 108.797 -164.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -76.71 -18.32 58.58 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.553 0.741 . . . . 63.12 111.453 -174.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -81.19 -80.74 0.14 Allowed 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 109.201 -0.666 . . . . 52.24 109.201 172.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -112.79 98.24 7.07 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.683 0.793 . . . . 74.14 109.481 177.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . 0.458 ' HA2' ' HB2' ' B' ' 85' ' ' ASN . . . -81.78 14.57 30.49 Favored Glycine 0 C--N 1.351 1.397 0 CA-C-N 115.726 -0.67 . . . . 54.33 113.544 178.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -87.89 158.98 18.55 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.644 0.778 . . . . 62.33 110.284 176.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -93.83 -32.51 7.54 Favored Glycine 0 C--N 1.341 0.824 0 CA-C-N 115.894 -0.594 . . . . 70.11 111.822 171.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -90.36 126.51 8.37 Favored Glycine 0 C--N 1.343 0.957 0 N-CA-C 111.881 -0.488 . . . . 23.53 111.881 177.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . 0.479 ' CE2' ' HA ' ' B' ' 304' ' ' PRO . 93.7 m-85 -122.86 138.68 54.58 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.834 0.853 . . . . 74.22 109.646 -178.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 63.66 118.08 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 125.244 1.418 . . . . 71.21 110.891 -175.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -83.63 56.94 3.82 Favored 'General case' 0 CA--C 1.561 1.402 0 CA-C-O 123.122 1.439 . . . . 74.14 109.834 -178.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . -166.21 141.6 7.08 Favored Glycine 0 C--N 1.332 0.309 0 CA-C-N 114.431 -1.259 . . . . 72.31 110.37 -176.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 97' ' ' ILE . . . . . . . . . . . . . 2.1 pp -120.12 164.44 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-O 121.432 0.634 . . . . 72.22 111.551 -174.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -111.66 24.96 12.14 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.694 1.198 . . . . 75.21 109.549 173.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.76 105.48 0.66 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.768 0.827 . . . . 61.12 111.269 -174.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 3.5 pp -58.54 149.98 58.61 Favored Pre-proline 0 CA--C 1.558 1.258 0 C-N-CA 124.956 1.303 . . . . 74.2 112.503 -178.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -61.77 93.09 0.12 Allowed 'Trans proline' 0 C--N 1.384 2.414 0 C-N-CA 123.27 2.647 . . . . 72.21 112.739 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . 0.43 HD23 ' H ' ' B' ' 102' ' ' LEU . 2.3 pt? -113.1 -173.73 2.31 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.02 0.928 . . . . 73.12 110.249 179.079 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 6.2 t 57.62 14.87 2.55 Favored 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 126.718 2.007 . . . . 75.52 114.824 172.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.53 -82.18 1.09 Allowed Glycine 0 C--N 1.347 1.185 0 N-CA-C 111.179 -0.769 . . . . 51.35 111.179 172.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -141.16 153.41 45.34 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 124.478 1.111 . . . . 75.22 108.748 173.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 106' ' ' TYR . . . . . 0.438 ' HA ' ' HA2' ' B' ' 382' ' ' GLY . 60.1 t80 73.21 -13.35 0.71 Allowed 'General case' 0 N--CA 1.501 2.097 0 C-N-CA 124.639 1.176 . . . . 74.44 112.899 174.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 49.8 p -107.39 2.13 24.15 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.642 1.177 . . . . 63.32 111.291 -177.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -163.96 151.33 12.23 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.559 0.743 . . . . 71.44 109.69 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -92.82 147.34 22.94 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.903 -0.777 . . . . 53.33 108.903 171.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . 68.08 118.26 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.991 1.316 . . . . 71.24 113.027 173.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 48.3 tp -129.19 85.26 2.3 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.951 0.9 . . . . 64.15 108.742 177.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 57.41 -162.62 0.2 Allowed 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 125.017 1.327 . . . . 73.2 111.69 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 113' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? 69.36 -78.25 0.05 OUTLIER 'General case' 0 C--N 1.357 0.932 0 C-N-CA 125.988 1.715 . . . . 75.13 111.014 173.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -66.82 86.46 0.13 Allowed 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 121.645 0.736 . . . . 74.01 111.442 -173.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 29.5 p -100.02 -91.51 0.3 Allowed 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 108.067 -1.086 . . . . 73.23 108.067 171.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 52.85 -101.23 0.07 OUTLIER Glycine 0 C--N 1.359 1.86 0 N-CA-C 114.681 0.633 . . . . 55.33 114.681 175.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . 0.426 ' HE3' ' HD2' ' B' ' 118' ' ' PRO . 32.5 mmmt 70.21 164.79 0.14 Allowed Pre-proline 0 N--CA 1.49 1.555 0 C-N-CA 125.578 1.551 . . . . 70.25 112.079 -177.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 118' ' ' PRO . . . . . 0.426 ' HD2' ' HE3' ' B' ' 117' ' ' LYS . 80.2 Cg_endo -73.77 -150.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.389 2.684 0 C-N-CA 122.287 1.992 . . . . 60.53 111.458 171.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 119' ' ' ASP . . . . . 0.455 ' HB3' ' HB2' ' B' ' 126' ' ' ALA . 1.8 m-20 80.92 -59.81 0.26 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.245 1.418 . . . . 75.33 111.159 175.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 120' ' ' TYR . . . . . 0.446 ' HA ' ' OG1' ' A' ' 196' ' ' THR . 52.9 m-85 64.78 -74.69 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.802 1.241 . . . . 70.1 113.311 168.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 7.3 p -155.98 -30.83 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.559 1.313 0 C-N-CA 123.167 0.587 . . . . 74.32 111.536 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 20.8 m -144.79 7.07 1.23 Allowed 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 123.722 0.809 . . . . 75.24 111.313 -173.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . 0.402 ' O ' ' HA ' ' B' ' 119' ' ' ASP . 12.9 t70 -103.88 157.11 17.31 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 124.0 0.92 . . . . 64.3 110.582 -176.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 16.2 m 57.6 -82.93 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 125.397 1.479 . . . . 43.31 112.872 176.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . 0.414 ' HB2' ' HG2' ' C' ' 252' ' ' GLU . . . -155.01 29.92 0.41 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.822 0.849 . . . . 73.02 110.492 -178.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . 0.455 ' HB2' ' HB3' ' B' ' 119' ' ' ASP . . . -69.13 138.49 54.27 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 122.962 0.505 . . . . 74.13 110.436 177.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 10.9 m 73.1 1.43 4.01 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.729 1.212 . . . . 70.01 112.296 -177.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -95.05 114.66 26.5 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.434 0.694 . . . . 72.01 110.533 -177.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 129' ' ' THR . . . . . 0.562 ' HB ' ' HA ' ' B' ' 133' ' ' THR . 6.7 m -147.02 172.44 13.73 Favored 'General case' 0 CA--C 1.557 1.235 0 N-CA-C 107.94 -1.133 . . . . 54.34 107.94 179.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . -61.74 130.76 47.34 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.187 0.595 . . . . 44.22 110.842 175.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 131' ' ' TRP . . . . . 0.501 ' HA ' ' OD1' ' B' ' 167' ' ' ASN . 5.7 m-90 57.9 44.68 19.5 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.566 1.146 . . . . 73.51 110.698 -177.099 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 38.0 t 71.62 -59.94 0.53 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 126.291 1.836 . . . . 51.4 110.696 -173.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 133' ' ' THR . . . . . 0.562 ' HA ' ' HB ' ' B' ' 129' ' ' THR . 10.7 t -159.66 22.16 0.18 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.566 0.746 . . . . 62.25 110.048 178.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.08 23.47 61.34 Favored Glycine 0 C--N 1.348 1.242 0 CA-C-N 115.708 -0.678 . . . . 55.15 111.821 -170.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 135' ' ' VAL . . . . . . . . . . . . . 60.2 t 61.11 -80.39 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.559 1.309 0 C-N-CA 125.912 1.685 . . . . 73.24 112.331 -177.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 136' ' ' LYS . . . . . . . . . . . . . 8.2 mtpm? -69.47 84.29 0.41 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.02 0.528 . . . . 52.43 112.042 -172.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 55.1 m -162.16 -33.96 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.489 1.516 . . . . 75.31 108.97 179.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -52.96 91.94 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.423 0 C-N-CA 124.629 1.171 . . . . 75.52 111.719 -177.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 56.9 t30 67.47 -67.13 0.18 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 125.464 1.506 . . . . 73.24 110.846 -170.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . 159.65 131.43 1.24 Allowed Glycine 0 C--N 1.341 0.83 0 N-CA-C 111.192 -0.763 . . . . 65.04 111.192 174.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -90.44 -4.9 56.68 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.461 0.705 . . . . 75.34 111.704 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 6.3 tt 79.05 -60.17 0.38 Allowed 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 126.352 1.861 . . . . 70.15 110.088 179.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -72.7 86.4 0.54 Allowed Glycine 0 CA--C 1.533 1.202 0 CA-C-O 119.981 -0.344 . . . . 61.25 113.526 -177.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 144' ' ' VAL . . . . . 0.471 HG22 ' HB2' ' B' ' 148' ' ' GLU . 54.9 t 64.47 80.25 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 125.228 1.411 . . . . 75.31 112.215 171.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -106.79 -47.27 3.77 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.496 0.718 . . . . 64.3 110.403 174.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 26.2 pt -101.25 -42.42 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 122.746 0.418 . . . . 72.52 110.809 177.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -163.65 -75.32 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 122.753 0.421 . . . . 72.43 110.276 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . 0.471 ' HB2' HG22 ' B' ' 144' ' ' VAL . 10.0 mm-40 54.41 -170.91 0.06 Allowed 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.842 1.257 . . . . 73.05 111.864 -170.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 149' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -160.4 96.85 1.2 Allowed 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.046 0.45 . . . . 72.23 110.734 173.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -96.04 -83.92 0.36 Allowed 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 107.172 -1.418 . . . . 74.11 107.172 167.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 151' ' ' HIS . . . . . 0.733 ' HB2' ' HG3' ' B' ' 206' ' ' GLU . 43.2 t60 -176.18 -57.68 0.0 OUTLIER Pre-proline 0 N--CA 1.486 1.336 0 CA-C-O 118.539 -0.743 . . . . 74.43 111.922 175.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -83.0 161.82 15.75 Favored 'Trans proline' 0 C--N 1.388 2.65 0 C-N-CA 121.533 1.488 . . . . 42.51 112.406 -171.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 67.4 p -72.29 -28.09 62.88 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.191 -0.913 . . . . 74.2 111.055 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 154' ' ' ILE . . . . . 0.541 HG22 ' HG ' ' B' ' 155' ' ' LEU . 41.1 mm 67.25 -71.18 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 125.358 1.463 . . . . 74.25 110.004 -176.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 155' ' ' LEU . . . . . 0.541 ' HG ' HG22 ' B' ' 154' ' ' ILE . 74.8 mt -122.04 -43.57 2.33 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.813 0.845 . . . . 72.1 110.011 176.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 156' ' ' GLU . . . . . 0.473 ' HG3' ' H ' ' B' ' 158' ' ' ALA . 8.4 tp10 -148.5 147.55 29.22 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.041 0.937 . . . . 72.23 109.657 178.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 157' ' ' MET . . . . . . . . . . . . . 53.6 ttm -57.25 -30.73 64.88 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 124.849 1.26 . . . . 53.54 112.274 -177.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 158' ' ' ALA . . . . . 0.473 ' H ' ' HG3' ' B' ' 156' ' ' GLU . . . -109.65 107.65 17.78 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.426 0.69 . . . . 34.04 110.751 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 82.8 tttt 67.66 11.38 8.35 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 124.666 1.186 . . . . 55.45 112.993 168.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . 71.63 -54.16 0.68 Allowed 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 125.446 1.498 . . . . 70.22 111.833 -175.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . 75.01 -40.86 0.45 Allowed 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 115.629 1.714 . . . . 71.1 115.629 164.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . -76.58 13.64 8.02 Favored Glycine 0 CA--C 1.538 1.487 0 N-CA-C 114.35 0.5 . . . . 73.4 114.35 -171.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -76.12 -11.73 59.99 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.2 1.0 . . . . 65.02 109.968 175.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 164' ' ' ALA . . . . . . . . . . . . . . . -50.58 -32.05 17.59 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 125.051 1.34 . . . . 75.34 112.162 173.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 26.4 m -54.86 107.3 0.28 Allowed 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.591 1.156 . . . . 64.15 111.199 175.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . 152.91 -47.81 0.55 Allowed Glycine 0 C--N 1.346 1.132 0 N-CA-C 111.259 -0.736 . . . . 71.15 111.259 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 167' ' ' ASN . . . . . 0.501 ' OD1' ' HA ' ' B' ' 131' ' ' TRP . 9.3 p30 -110.1 22.3 15.74 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.473 0.709 . . . . 72.31 110.624 -179.112 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 30.3 m -78.24 -173.4 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.179 0 C-N-CA 123.556 0.742 . . . . 74.13 111.726 -178.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 18.9 m -57.53 103.82 0.15 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.419 1.088 . . . . 54.35 111.058 179.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 25.6 m 64.77 -77.99 0.03 OUTLIER 'General case' 0 C--N 1.36 1.026 0 C-N-CA 124.884 1.274 . . . . 63.1 110.591 -172.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . 177.64 175.04 0.48 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.907 1.283 . . . . 53.32 108.992 178.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 172' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.76 147.61 28.31 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 106.429 -1.693 . . . . 73.22 106.429 163.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 173' ' ' LEU . . . . . 0.659 ' HB2' ' HB3' ' B' ' 335' ' ' ASN . 6.7 mp -71.21 -0.05 8.97 Favored 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 123.191 0.596 . . . . 74.23 112.168 -173.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 174' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -61.96 78.97 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.946 0.898 . . . . 74.45 110.64 172.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 175' ' ' ASP . . . . . . . . . . . . . 39.2 t70 63.04 148.04 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 125.655 1.582 . . . . 74.1 112.268 -168.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -138.98 34.01 2.15 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.579 0.752 . . . . 74.11 110.139 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 10.7 m -116.98 93.38 41.82 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 123.609 0.763 . . . . 64.31 109.598 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 178' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -81.28 -23.17 5.34 Favored 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 122.524 2.149 . . . . 74.53 112.602 175.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -175.3 -71.78 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.919 1.287 . . . . 61.34 108.46 175.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 180' ' ' ALA . . . . . 0.565 ' HB1' HG23 ' C' ' 137' ' ' VAL . . . -170.03 -76.97 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.197 1.399 . . . . 74.4 107.553 177.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 181' ' ' LEU . . . . . 0.672 HD22 ' HB2' ' C' ' 136' ' ' ARG . 33.9 tp -132.46 -58.01 0.94 Allowed 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 107.518 -1.289 . . . . 62.04 107.518 163.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 182' ' ' VAL . . . . . 0.494 HG13 ' H ' ' B' ' 184' ' ' HIS . 11.5 p -74.04 160.51 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-N 114.883 -1.053 . . . . 71.31 110.812 178.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -90.33 22.75 3.21 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.888 0.875 . . . . 65.24 111.305 173.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 184' ' ' HIS . . . . . 0.494 ' H ' HG13 ' B' ' 182' ' ' VAL . 77.1 t60 64.98 -83.65 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.138 1.375 . . . . 74.15 107.885 -166.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 185' ' ' VAL . . . . . 0.439 HG23 ' HA ' ' C' ' 121' ' ' ALA . 1.7 p -165.56 122.33 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 123.921 0.888 . . . . 71.33 109.002 168.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 66.7 p 51.95 -74.74 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.283 0 O-C-N 125.52 1.762 . . . . 51.31 113.005 174.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 187' ' ' SER . . . . . . . . . . . . . 21.7 m -59.48 119.13 6.93 Favored 'General case' 0 C--N 1.352 0.717 0 C-N-CA 123.877 0.871 . . . . 62.14 110.396 171.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 188' ' ' ARG . . . . . 0.689 ' HD3' ' SG ' ' B' ' 190' ' ' CYS . 34.6 ttt180 -134.18 149.6 51.04 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.774 -0.824 . . . . 71.52 108.774 178.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -83.91 7.74 17.23 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 123.176 0.59 . . . . 72.52 112.312 -176.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 190' ' ' CYS . . . . . 0.689 ' SG ' ' HD3' ' B' ' 188' ' ' ARG . 28.1 p -80.82 75.32 7.76 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 123.077 0.551 . . . . 70.33 110.51 179.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 191' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -157.98 -178.9 7.65 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.433 0.693 . . . . 74.04 109.917 177.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 114.96 85.4 1.28 Allowed Glycine 0 C--N 1.348 1.217 0 N-CA-C 110.988 -0.845 . . . . 64.22 110.988 -176.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 193' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -56.67 -23.5 49.54 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 123.524 2.816 . . . . 64.32 113.643 175.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 194' ' ' SER . . . . . . . . . . . . . 95.5 p 55.5 26.98 9.61 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 125.611 1.565 . . . . 24.51 112.684 176.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 195' ' ' ALA . . . . . . . . . . . . . . . -147.97 109.99 4.53 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.73 0.812 . . . . 74.32 109.567 -177.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 30.5 p -73.02 -61.0 1.97 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.955 0.902 . . . . 73.32 109.872 177.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 71.8 m -149.79 -177.74 6.06 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.136 1.374 . . . . 75.11 108.003 168.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 198' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -65.01 85.47 0.05 OUTLIER 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 123.446 0.698 . . . . 51.12 110.482 177.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 12.6 mptt 67.11 -73.85 0.07 Allowed 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 126.072 1.749 . . . . 74.4 111.44 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 200' ' ' CYS . . . . . 0.638 ' H ' ' HD2' ' B' ' 201' ' ' PRO . 86.3 m -147.55 -54.57 0.02 OUTLIER Pre-proline 0 CA--C 1.561 1.384 0 C-N-CA 124.385 1.074 . . . . 73.31 111.713 175.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 201' ' ' PRO . . . . . 0.638 ' HD2' ' H ' ' B' ' 200' ' ' CYS . 61.7 Cg_endo -67.94 -29.01 35.05 Favored 'Trans proline' 0 C--N 1.395 3.021 0 C-N-CA 122.04 1.827 . . . . 71.34 113.218 -173.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 81.57 -59.3 4.84 Favored Glycine 0 C--N 1.35 1.359 0 N-CA-C 111.985 -0.446 . . . . 63.04 111.985 -177.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 203' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -70.38 161.93 29.56 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.452 1.101 . . . . 71.33 110.29 173.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -57.14 112.76 1.46 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.928 0.891 . . . . 74.01 112.094 -178.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 205' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -98.47 -33.07 11.16 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.322 1.049 . . . . 51.03 110.513 -178.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 206' ' ' GLU . . . . . 0.733 ' HG3' ' HB2' ' B' ' 151' ' ' HIS . 34.9 tt0 77.52 96.33 0.06 Allowed 'General case' 0 N--CA 1.479 0.989 0 O-C-N 125.1 1.5 . . . . 62.32 110.093 -172.19 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 21.6 pttm -125.1 163.96 21.25 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.848 1.259 . . . . 74.32 109.693 -179.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 82.53 21.0 60.86 Favored Glycine 0 N--CA 1.471 0.995 0 N-CA-C 111.908 -0.477 . . . . 71.52 111.908 -175.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . -74.87 -177.32 39.08 Favored Glycine 0 C--N 1.345 1.047 0 CA-C-N 115.194 -0.503 . . . . 42.21 113.193 175.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 210' ' ' LYS . . . . . 0.501 ' HE3' ' HA ' ' B' ' 210' ' ' LYS . 0.3 OUTLIER 73.03 -62.49 0.47 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.403 1.481 . . . . 74.51 110.171 -173.164 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . -64.78 87.23 0.08 OUTLIER Glycine 0 C--N 1.352 1.453 0 O-C-N 123.164 0.29 . . . . 74.43 112.662 177.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 35.3 t -72.41 92.99 1.49 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.795 0.838 . . . . 74.04 111.113 -173.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . 0.516 HG13 ' H ' ' B' ' 214' ' ' THR 0.259 18.7 pt 40.42 -74.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 C-N-CA 127.407 2.283 . . . . 64.4 115.026 -176.406 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 214' ' ' THR . . . . . 0.516 ' H ' HG13 ' B' ' 213' ' ' ILE . 8.6 t -171.22 -26.25 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.143 0.977 . . . . 75.43 110.093 178.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 215' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 71.24 170.21 0.32 Allowed 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 125.275 1.43 . . . . 73.31 112.121 -176.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 66.24 28.53 9.97 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.054 1.342 . . . . 61.42 112.157 -177.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -82.79 73.93 9.79 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 107.989 -1.115 . . . . 75.4 107.989 168.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 22.1 tp -127.24 30.17 5.45 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 108.253 -1.017 . . . . 71.43 108.253 -178.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 56.95 -153.38 0.37 Allowed 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 114.027 -1.442 . . . . 71.24 111.479 -174.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . 73.68 10.47 4.79 Favored 'General case' 0 C--N 1.36 1.043 0 C-N-CA 124.165 0.986 . . . . 61.1 112.25 174.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 221' ' ' ARG . . . . . 0.541 ' HG2' HD13 ' B' ' 68' ' ' ILE . 0.0 OUTLIER -105.59 -71.36 0.75 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.48 0.712 . . . . 73.55 111.328 -177.415 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -141.54 27.2 1.89 Allowed 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.874 0.87 . . . . 42.52 110.883 -170.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -98.0 -52.3 3.75 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 125.617 1.567 . . . . 61.02 109.465 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . 0.702 HG11 ' HA ' ' B' ' 77' ' ' ASP . 14.5 p -85.96 -31.79 6.68 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 CA-C-N 114.611 -1.177 . . . . 74.2 110.21 175.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 3.8 m -83.8 -43.18 15.68 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.707 0.803 . . . . 54.34 110.602 -172.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 7.4 mp -118.33 166.37 12.72 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.816 0.846 . . . . 74.43 109.69 176.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . -177.24 -44.7 0.06 OUTLIER Glycine 0 C--N 1.342 0.9 0 N-CA-C 110.729 -0.949 . . . . 51.31 110.729 178.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . -94.05 -126.6 4.54 Favored Glycine 0 C--N 1.346 1.116 0 CA-C-N 114.863 -0.669 . . . . 72.41 112.052 172.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . 72.6 20.37 79.52 Favored Glycine 0 C--N 1.345 1.07 0 N-CA-C 111.732 -0.547 . . . . 70.24 111.732 -171.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -80.68 136.22 36.15 Favored 'General case' 0 C--N 1.351 0.656 0 C-N-CA 124.385 1.074 . . . . 70.23 110.101 -174.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 231' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -75.45 120.36 20.78 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.259 1.024 . . . . 73.24 109.709 -175.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 3.1 t -170.47 100.1 0.26 Allowed 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 124.166 0.986 . . . . 74.24 110.297 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 233' ' ' PHE . . . . . 0.404 ' H ' ' HA ' ' B' ' 56' ' ' ARG . 19.4 t80 -163.27 73.75 0.33 Allowed 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.865 0.866 . . . . 70.41 109.921 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . 0.474 ' H ' ' HA ' ' B' ' 363' ' ' GLU . . . -161.82 134.55 6.0 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 116.513 -0.312 . . . . 72.31 111.091 175.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.38 94.72 5.84 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 106.589 -1.634 . . . . 54.41 106.589 171.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 236' ' ' THR . . . . . 0.594 ' H ' HD21 ' B' ' 247' ' ' LEU . 33.4 m 76.86 -30.52 0.18 Allowed 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 125.06 1.344 . . . . 73.34 111.961 178.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . 72.19 -72.53 0.11 Allowed 'General case' 0 C--N 1.361 1.085 0 C-N-CA 126.305 1.842 . . . . 71.12 112.066 170.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 238' ' ' THR . . . . . 0.455 ' HB ' ' HA ' ' C' ' 219' ' ' VAL . 6.3 m -140.83 -8.46 1.06 Allowed 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 123.357 0.663 . . . . 71.31 110.826 -175.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 239' ' ' ALA . . . . . 0.511 ' HB2' ' HA ' ' C' ' 221' ' ' VAL . . . -77.14 172.95 12.42 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.867 1.062 . . . . 74.42 113.867 -167.125 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 240' ' ' GLY . . . . . 0.439 ' H ' HD22 ' C' ' 235' ' ' LEU . . . -113.05 -101.3 2.5 Favored Glycine 0 C--N 1.339 0.723 0 CA-C-N 114.015 -1.448 . . . . 71.23 109.634 177.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -157.51 162.16 38.84 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.588 0.709 . . . . 71.21 111.562 -175.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 242' ' ' TRP . . . . . 0.592 ' HH2' HG21 ' C' ' 199' ' ' VAL . 5.4 m95 -107.04 -47.36 3.71 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 114.106 -1.406 . . . . 70.32 107.478 172.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 177.69 -35.78 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 111.532 -2.576 . . . . 74.22 105.504 -166.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -156.5 -176.0 28.1 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 113.487 -1.688 . . . . 63.11 109.459 166.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -170.16 153.59 4.63 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.661 0.784 . . . . 75.34 110.303 175.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . 0.538 HG22 ' HD3' ' C' ' 225' ' ' PRO . 11.2 t -167.31 174.43 8.08 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.426 0.691 . . . . 71.02 109.898 168.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 247' ' ' LEU . . . . . 0.647 HD13 ' HB3' ' B' ' 363' ' ' GLU . 2.2 pp -159.87 160.17 33.33 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 124.472 1.109 . . . . 72.51 108.868 178.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 248' ' ' ARG . . . . . 0.405 ' HD3' ' O ' ' B' ' 249' ' ' GLU . 0.0 OUTLIER -157.63 174.88 14.68 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.353 0.596 . . . . 75.15 111.221 -179.594 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 249' ' ' GLU . . . . . 0.693 ' HG2' ' HA3' ' B' ' 362' ' ' GLY . 2.5 tm-20 -86.9 163.11 17.34 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 114.751 -1.113 . . . . 71.33 109.943 -171.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 250' ' ' GLN . . . . . 0.466 ' HA ' ' HB3' ' A' ' 274' ' ' GLU . 1.9 mp0 -76.91 11.26 1.82 Allowed 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 124.494 1.118 . . . . 65.4 112.641 -176.298 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 251' ' ' ALA . . . . . . . . . . . . . . . 61.33 28.02 17.58 Favored 'General case' 0 C--N 1.361 1.072 0 C-N-CA 124.953 1.301 . . . . 61.03 110.688 -171.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 69.41 -87.17 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.681 1.992 . . . . 72.3 112.474 173.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . 57.69 -84.91 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 124.096 0.958 . . . . 51.41 111.072 -170.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 12.0 ttp180 174.76 -60.28 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.998 1.719 . . . . 72.51 106.652 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . 177.69 -170.86 43.39 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-N 114.371 -1.286 . . . . 54.22 110.934 -178.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 256' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -94.78 39.55 1.1 Allowed 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 117.492 0.646 . . . . 52.52 110.757 -175.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 69.22 -152.08 0.14 Allowed 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.306 1.043 . . . . 74.31 110.828 -177.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 258' ' ' LEU . . . . . 0.528 HD23 ' HA ' ' B' ' 266' ' ' ASN . 41.9 tp -49.83 134.13 21.17 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.263 1.025 . . . . 75.13 112.684 -178.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 2.4 p -124.8 85.83 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 N-CA-C 107.902 -1.147 . . . . 63.02 107.902 172.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 260' ' ' SER . . . . . 0.591 ' HB3' ' HB2' ' B' ' 265' ' ' LEU . 44.6 t -87.8 93.6 9.5 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.192 -0.913 . . . . 73.11 109.971 178.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 22.4 t70 65.74 -79.41 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.985 1.314 . . . . 52.21 112.392 174.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 262' ' ' ALA . . . . . . . . . . . . . . . -76.79 -76.13 0.18 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.909 0.884 . . . . 43.43 111.341 -176.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -165.82 130.82 2.38 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 123.526 0.73 . . . . 70.44 109.408 -177.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 264' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' B' ' 258' ' ' LEU . 88.0 p 52.33 -93.71 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 125.504 1.522 . . . . 51.14 112.81 -178.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 265' ' ' LEU . . . . . 0.591 ' HB2' ' HB3' ' B' ' 260' ' ' SER . 84.3 mt 52.81 43.6 31.29 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.665 1.186 . . . . 64.12 111.623 -173.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 266' ' ' ASN . . . . . 0.528 ' HA ' HD23 ' B' ' 258' ' ' LEU . 13.5 m120 -65.35 150.45 48.26 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 115.243 -0.89 . . . . 71.52 110.535 178.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 33.0 t -72.82 86.56 1.26 Allowed 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 123.107 0.563 . . . . 73.13 110.699 -175.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 60.2 t 64.36 -79.84 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 C-N-CA 125.904 1.682 . . . . 74.44 110.211 -175.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 269' ' ' THR . . . . . . . . . . . . . 40.8 p -91.42 -54.87 3.73 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.238 -1.023 . . . . 74.31 108.238 169.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 270' ' ' GLU . . . . . 0.561 ' HB2' HD22 ' B' ' 277' ' ' LEU . 9.0 tp10 -178.02 -35.08 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.325 1.45 . . . . 72.41 109.277 178.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 271' ' ' ALA . . . . . . . . . . . . . . . 79.56 -51.37 0.4 Allowed 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 126.066 1.747 . . . . 75.3 110.248 -169.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 272' ' ' ASN . . . . . 0.447 ' HB2' ' HG3' ' B' ' 270' ' ' GLU . 3.6 m-20 -62.07 144.26 55.49 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 109.415 -0.587 . . . . 54.14 109.415 169.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 65.36 27.26 11.96 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.075 0.95 . . . . 61.32 110.734 -172.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 60.96 -91.37 0.03 OUTLIER 'General case' 0 C--N 1.355 0.827 0 C-N-CA 125.83 1.652 . . . . 71.44 111.735 179.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 275' ' ' LYS . . . . . 0.448 ' HB2' ' HD3' ' B' ' 276' ' ' PRO . 7.8 mtpm? -128.88 -57.87 0.03 OUTLIER Pre-proline 0 CA--C 1.557 1.25 0 CA-C-O 118.243 -0.884 . . . . 71.33 112.013 -169.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 276' ' ' PRO . . . . . 0.448 ' HD3' ' HB2' ' B' ' 275' ' ' LYS . 91.1 Cg_endo -78.73 81.5 2.76 Favored 'Trans proline' 0 C--N 1.395 2.991 0 C-N-CA 121.488 1.459 . . . . 62.35 112.898 -172.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 277' ' ' LEU . . . . . 0.561 HD22 ' HB2' ' B' ' 270' ' ' GLU . 47.2 tp -74.95 94.08 2.78 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.439 -0.8 . . . . 63.32 109.082 175.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 1.6 tm? 77.23 -57.68 0.51 Allowed 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 125.667 1.587 . . . . 62.0 110.845 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . -158.71 -164.06 13.79 Favored Glycine 0 C--N 1.344 1.022 0 O-C-N 122.396 -0.19 . . . . 75.43 112.892 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 280' ' ' LEU . . . . . 0.553 HD11 ' HB2' ' B' ' 456' ' ' ASP . 3.0 tm? -98.17 148.08 23.94 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.286 1.035 . . . . 53.23 109.522 -176.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -150.66 -52.72 0.14 Allowed 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 108.645 -0.872 . . . . 75.31 108.645 171.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 282' ' ' ALA . . . . . 0.569 ' HB1' HD21 ' B' ' 454' ' ' LEU . . . -155.22 30.03 0.4 Allowed 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 115.18 -0.918 . . . . 65.41 110.02 -176.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -99.36 -18.6 17.44 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.703 0.801 . . . . 72.33 111.49 -172.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 284' ' ' GLY . . . . . 0.532 ' HA3' ' HA ' ' B' ' 456' ' ' ASP . . . -65.83 -48.77 63.68 Favored Glycine 0 CA--C 1.534 1.228 0 CA-C-O 119.707 -0.496 . . . . 61.45 114.077 -176.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 60.25 61.41 1.81 Allowed 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 122.002 0.906 . . . . 72.41 111.74 173.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 286' ' ' MET . . . . . . . . . . . . . 44.5 mtt -152.57 173.55 4.44 Favored Pre-proline 0 N--CA 1.489 1.487 0 C-N-CA 124.396 1.078 . . . . 64.1 109.43 -177.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 287' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -45.1 115.18 0.82 Allowed 'Trans proline' 0 C--N 1.388 2.65 0 C-N-CA 122.858 2.372 . . . . 73.33 112.045 166.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 288' ' ' VAL . . . . . 0.423 HG13 ' HB ' ' B' ' 455' ' ' THR . 43.0 t -63.28 86.24 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.17 0 C-N-CA 124.432 1.093 . . . . 74.32 113.315 -160.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 289' ' ' ARG . . . . . 0.45 ' H ' ' HA ' ' B' ' 457' ' ' GLN . 19.9 ptt180 36.56 -154.43 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 127.979 2.511 . . . . 72.14 116.481 163.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 290' ' ' TRP . . . . . 0.454 ' HA ' ' HG ' ' B' ' 460' ' ' LEU . 6.0 m0 66.06 22.85 11.13 Favored 'General case' 0 C--N 1.363 1.179 0 C-N-CA 124.684 1.194 . . . . 75.34 111.332 176.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 291' ' ' LEU . . . . . . . . . . . . . 2.3 pp -146.09 -16.67 0.45 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.392 1.077 . . . . 64.34 110.598 176.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . -79.2 155.53 40.36 Favored Glycine 0 C--N 1.355 1.599 0 CA-C-O 119.448 -0.64 . . . . 62.12 113.284 -174.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -82.7 174.18 9.82 Favored 'Trans proline' 0 C--N 1.373 1.837 0 C-N-CA 123.32 2.68 . . . . 51.12 112.796 -177.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -78.4 -15.46 58.65 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.924 -0.58 . . . . 41.23 111.822 -179.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . 53.64 41.51 32.06 Favored 'General case' 0 C--N 1.36 1.053 0 C-N-CA 124.387 1.075 . . . . 34.32 111.416 172.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 31.4 p -79.64 72.41 6.32 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 114.936 -1.029 . . . . 65.42 110.837 -175.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -101.0 6.84 43.66 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.154 -0.93 . . . . 64.12 110.625 178.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 69.79 -60.86 0.46 Allowed 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 126.423 1.889 . . . . 71.5 111.852 -176.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . 84.47 -158.5 34.12 Favored Glycine 0 C--N 1.347 1.167 0 N-CA-C 110.865 -0.894 . . . . 63.41 110.865 -177.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -87.31 -33.39 19.23 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.913 -0.773 . . . . 72.23 108.913 172.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 301' ' ' ILE . . . . . . . . . . . . . 76.1 mt 66.19 -64.88 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.059 0 C-N-CA 125.989 1.716 . . . . 72.24 109.271 -165.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 37.3 t70 66.2 76.85 0.3 Allowed 'General case' 0 C--N 1.352 0.702 0 C-N-CA 124.327 1.051 . . . . 63.41 110.39 168.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 303' ' ' LYS . . . . . 0.652 ' HB3' ' HA ' ' B' ' 306' ' ' VAL . 0.1 OUTLIER 57.48 95.73 0.05 OUTLIER Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 125.543 1.537 . . . . 74.11 110.641 -175.698 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 304' ' ' PRO . . . . . 0.479 ' HA ' ' CE2' ' B' ' 93' ' ' PHE . 41.4 Cg_exo -55.65 94.52 0.05 OUTLIER 'Trans proline' 0 C--N 1.383 2.391 0 C-N-CA 123.428 2.752 . . . . 75.12 113.076 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . 59.15 25.91 14.53 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 124.304 1.042 . . . . 42.33 111.21 -174.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . 0.652 ' HA ' ' HB3' ' B' ' 303' ' ' LYS . 40.2 t 65.17 -68.37 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.135 0 C-N-CA 126.443 1.897 . . . . 72.33 111.179 -171.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 85.6 m 69.36 -70.54 0.14 Allowed 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 125.428 1.491 . . . . 74.23 111.585 178.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 308' ' ' CYS . . . . . . . . . . . . . 52.3 t -65.68 94.64 0.21 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.51 0.724 . . . . 74.22 110.273 177.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 17.2 p -126.44 137.67 30.82 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 124.3 1.04 . . . . 72.2 109.746 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -78.41 -144.66 0.03 OUTLIER 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.66 2.24 . . . . 63.14 110.106 169.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 311' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -111.58 86.58 7.06 Favored Pre-proline 0 N--CA 1.478 0.953 0 N-CA-C 108.534 -0.913 . . . . 73.13 108.534 169.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 312' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -94.68 19.56 0.68 Allowed 'Trans proline' 0 C--N 1.377 2.043 0 C-N-CA 122.868 2.379 . . . . 70.14 113.408 -176.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 313' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -54.01 -67.44 0.26 Allowed 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.95 0.9 . . . . 75.13 111.11 -177.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 314' ' ' ARG . . . . . . . . . . . . . 46.9 mtp180 63.21 -84.81 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.86 1.264 . . . . 72.01 110.385 -176.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 315' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -97.46 -28.81 13.82 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.702 0.801 . . . . 72.12 109.894 175.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 316' ' ' ASP . . . . . . . . . . . . . 26.6 t70 68.35 -77.58 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.215 1.806 . . . . 74.4 110.604 -174.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 70.4 m -145.19 -58.89 0.34 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.183 0.593 . . . . 75.41 110.506 -174.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 318' ' ' VAL . . . . . 0.584 HG11 HD22 ' B' ' 356' ' ' ASN . 30.8 m -85.71 142.09 36.71 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 123.189 0.596 . . . . 73.13 110.418 -177.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 319' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -49.84 -48.1 20.7 Favored 'Trans proline' 0 C--N 1.384 2.423 0 C-N-CA 123.541 2.827 . . . . 65.1 114.572 -176.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 320' ' ' THR . . . . . 0.545 HG23 ' HA ' ' B' ' 357' ' ' PRO . 28.6 m 59.51 81.78 0.16 Allowed 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.81 0.844 . . . . 53.31 111.131 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 321' ' ' LEU . . . . . 0.486 ' HB3' ' HA ' ' B' ' 354' ' ' ALA . 58.8 tp -83.72 -43.59 15.34 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.45 -0.796 . . . . 65.14 110.255 -179.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 322' ' ' ALA . . . . . . . . . . . . . . . -159.76 -162.92 1.07 Allowed 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 116.129 -0.487 . . . . 64.54 111.7 -170.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 323' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -134.47 170.89 15.08 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 124.779 1.232 . . . . 74.02 107.867 169.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 324' ' ' MET . . . . . . . . . . . . . 43.8 mtm 78.05 113.82 0.07 Allowed 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 125.687 1.595 . . . . 71.32 109.451 -174.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 325' ' ' THR . . . . . . . . . . . . . 69.4 p 50.93 60.13 4.1 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 125.245 1.418 . . . . 72.33 109.9 -170.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 326' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -135.12 -3.29 2.48 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 112.841 -1.981 . . . . 72.01 111.899 -158.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 33.1 mtmm -110.38 -2.99 16.37 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.757 0.823 . . . . 54.34 111.021 -178.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 328' ' ' ALA . . . . . . . . . . . . . . . 72.17 159.4 0.21 Allowed 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 125.69 1.596 . . . . 72.03 112.727 -175.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 329' ' ' ILE . . . . . . . . . . . . . 19.7 pt 47.63 30.3 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 C-N-CA 126.5 1.92 . . . . 73.5 114.788 178.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 330' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -83.58 56.14 3.49 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 123.683 0.793 . . . . 63.42 111.107 179.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 331' ' ' LEU . . . . . . . . . . . . . 2.4 tt -176.31 135.78 0.26 Allowed 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 105.777 -1.934 . . . . 63.34 105.777 -178.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 2.7 pp -66.72 145.35 55.64 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 118.555 0.616 . . . . 74.41 111.086 178.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 333' ' ' SER . . . . . . . . . . . . . 16.2 t -103.02 66.66 0.92 Allowed 'General case' 0 C--O 1.242 0.709 0 C-N-CA 123.498 0.719 . . . . 65.04 109.56 -176.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 334' ' ' LYS . . . . . 0.494 ' HE2' ' HB3' ' B' ' 337' ' ' LYS . 19.1 tptm 70.15 -71.49 0.13 Allowed 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 125.397 1.479 . . . . 63.11 110.185 -178.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 335' ' ' ASN . . . . . 0.659 ' HB3' ' HB2' ' B' ' 173' ' ' LEU . 20.7 m120 58.95 -86.23 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 125.89 1.676 . . . . 73.25 113.269 172.121 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -83.51 -9.96 58.63 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 123.188 0.595 . . . . 61.02 112.127 -175.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 337' ' ' LYS . . . . . 0.494 ' HB3' ' HE2' ' B' ' 334' ' ' LYS . 45.1 mmtm -95.5 18.52 12.55 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.255 0.622 . . . . 62.43 110.385 169.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 338' ' ' GLY . . . . . . . . . . . . . . . -165.37 -157.28 9.73 Favored Glycine 0 C--N 1.344 1.02 0 N-CA-C 111.561 -0.615 . . . . 72.34 111.561 178.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 339' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -108.49 -5.0 16.78 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.699 0.8 . . . . 74.33 110.691 178.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 340' ' ' PHE . . . . . . . . . . . . . 46.3 t80 55.87 62.36 2.43 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 124.966 1.307 . . . . 75.24 110.149 -174.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 341' ' ' LEU . . . . . . . . . . . . . 6.6 tt -72.38 -49.08 36.6 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 114.286 -1.325 . . . . 75.34 109.623 -175.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 342' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -92.9 95.75 9.69 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.871 -0.604 . . . . 64.25 111.002 -176.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 343' ' ' VAL . . . . . . . . . . . . . 42.1 t -76.35 -32.43 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.923 0.889 . . . . 64.24 109.535 175.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -61.27 -34.82 75.81 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.488 0.715 . . . . 73.03 111.075 175.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 345' ' ' GLY . . . . . . . . . . . . . . . -101.37 43.2 1.76 Allowed Glycine 0 C--N 1.349 1.279 0 CA-C-N 115.909 -0.587 . . . . 62.31 111.731 177.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 346' ' ' ALA . . . . . . . . . . . . . . . -78.78 85.07 4.81 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.107 0.563 . . . . 72.22 109.699 176.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 347' ' ' SER . . . . . . . . . . . . . 21.2 t 65.7 -162.04 0.26 Allowed 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 124.781 1.232 . . . . 72.21 111.084 177.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 42.9 mm -81.27 79.12 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 C-N-CA 123.633 0.773 . . . . 73.42 110.187 -178.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 349' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -88.55 141.11 28.79 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.07 -0.968 . . . . 71.13 109.679 175.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 350' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? 74.84 -42.86 0.5 Allowed 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 125.586 1.554 . . . . 74.52 113.168 175.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -59.82 -77.35 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.469 0.708 . . . . 71.32 110.187 177.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 30.2 t70 58.33 -179.26 0.07 Allowed 'General case' 0 CA--C 1.567 1.609 0 C-N-CA 124.156 0.982 . . . . 74.35 111.924 178.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 353' ' ' HIS . . . . . . . . . . . . . 49.0 m80 -108.73 -28.61 9.13 Favored 'General case' 0 N--CA 1.479 1.018 0 O-C-N 121.148 -0.97 . . . . 74.33 112.11 178.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 354' ' ' ALA . . . . . 0.486 ' HA ' ' HB3' ' B' ' 321' ' ' LEU . . . -111.95 -21.89 11.34 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 112.883 0.697 . . . . 70.11 112.883 -175.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 355' ' ' ALA . . . . . . . . . . . . . . . 62.56 52.86 2.78 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.242 1.017 . . . . 75.44 109.966 -171.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 356' ' ' ASN . . . . . 0.584 HD22 HG11 ' B' ' 318' ' ' VAL . 33.0 t30 71.07 126.93 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.631 0 C-N-CA 125.114 1.366 . . . . 74.32 111.358 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 357' ' ' PRO . . . . . 0.545 ' HA ' HG23 ' B' ' 320' ' ' THR . 45.0 Cg_endo -79.61 51.99 4.11 Favored 'Trans proline' 0 C--N 1.381 2.242 0 C-N-CA 123.369 2.713 . . . . 55.22 112.664 178.048 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 358' ' ' CYS . . . . . . . . . . . . . 90.3 m 65.08 -73.05 0.06 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 125.165 1.386 . . . . 73.32 111.687 -171.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 359' ' ' GLY . . . . . . . . . . . . . . . 86.56 -12.23 61.71 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 123.168 0.413 . . . . 62.01 112.168 -172.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 360' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -88.39 45.79 1.32 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.393 1.477 . . . . 53.34 111.764 -170.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 361' ' ' ILE . . . . . . . . . . . . . 19.3 mm -85.4 -29.38 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 108.523 -0.918 . . . . 61.31 108.523 174.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 362' ' ' GLY . . . . . 0.693 ' HA3' ' HG2' ' B' ' 249' ' ' GLU . . . 72.25 58.37 5.14 Favored Glycine 0 C--N 1.344 0.979 0 CA-C-N 115.151 -0.931 . . . . 72.35 112.82 176.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 363' ' ' GLU . . . . . 0.647 ' HB3' HD13 ' B' ' 247' ' ' LEU . 6.9 mm-40 66.81 -80.92 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.05 1.34 . . . . 73.13 110.615 178.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 364' ' ' THR . . . . . 0.424 ' H ' ' H ' ' B' ' 365' ' ' VAL . 58.0 m -155.33 -23.98 0.11 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.218 1.407 . . . . 74.04 109.287 -177.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 365' ' ' VAL . . . . . 0.563 HG22 ' HG3' ' B' ' 249' ' ' GLU . 7.2 t 66.62 168.38 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.568 1.661 0 C-N-CA 124.922 1.289 . . . . 74.01 109.523 -172.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 29.5 t70 75.47 -7.77 1.72 Allowed 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 114.045 1.128 . . . . 50.12 114.045 161.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 367' ' ' LEU . . . . . . . . . . . . . 96.5 mt -90.51 -1.87 57.9 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 113.305 0.854 . . . . 75.05 113.305 -174.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 368' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -75.38 -159.27 0.1 Allowed 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 122.784 0.434 . . . . 71.23 110.55 174.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 369' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 54.12 52.26 13.05 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.783 0.833 . . . . 70.1 109.403 -167.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 370' ' ' ALA . . . . . . . . . . . . . . . -63.19 -177.01 0.16 Allowed 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 114.407 -1.27 . . . . 74.25 112.65 -176.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 371' ' ' VAL . . . . . . . . . . . . . 8.1 t -69.41 1.09 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.573 1.848 0 C-N-CA 123.176 0.591 . . . . 74.11 110.997 178.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 372' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 83.62 -18.48 0.43 Allowed 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 126.444 1.898 . . . . 63.2 111.966 169.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 373' ' ' ARG . . . . . . . . . . . . . 13.2 tpt180 74.77 -53.61 0.67 Allowed 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 125.811 1.644 . . . . 72.05 110.456 -175.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -67.98 -21.47 65.06 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.129 0.972 . . . . 71.45 112.61 178.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 375' ' ' LEU . . . . . . . . . . . . . 91.4 mt 69.89 -70.36 0.15 Allowed 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 125.423 1.489 . . . . 62.01 110.471 -175.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -119.45 -179.59 3.91 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.399 1.08 . . . . 73.13 108.937 174.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 377' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -118.87 67.44 0.78 Allowed 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.666 -0.864 . . . . 73.31 108.666 175.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 378' ' ' ALA . . . . . . . . . . . . . . . -79.29 -3.45 46.09 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 115.481 -0.781 . . . . 61.1 111.96 -178.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.21 74.13 0.43 Allowed 'General case' 0 C--N 1.357 0.894 0 C-N-CA 125.09 1.356 . . . . 72.01 109.931 -174.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 380' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -84.29 -9.82 58.16 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 114.693 -1.14 . . . . 53.14 110.253 179.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 381' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -85.21 179.82 7.15 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.493 1.517 . . . . 74.34 111.251 178.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 382' ' ' GLY . . . . . 0.438 ' HA2' ' HA ' ' B' ' 106' ' ' TYR . . . -175.78 -96.99 0.1 Allowed Glycine 0 C--N 1.346 1.089 0 CA-C-N 115.62 -0.718 . . . . 73.1 111.378 179.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 383' ' ' ASN . . . . . . . . . . . . . 58.6 t-20 -163.24 138.81 6.71 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 107.647 -1.242 . . . . 73.1 107.647 178.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 384' ' ' THR . . . . . . . . . . . . . 41.6 p -99.29 76.44 2.06 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.115 0.566 . . . . 63.41 109.945 -177.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 5.8 mp -67.63 87.22 0.21 Allowed 'General case' 0 C--N 1.358 0.966 0 N-CA-C 108.356 -0.979 . . . . 75.12 108.356 174.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 386' ' ' VAL . . . . . . . . . . . . . 58.4 t 76.75 -54.94 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 126.574 1.949 . . . . 62.42 110.305 -175.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 387' ' ' ILE . . . . . 0.464 HG21 ' HB2' ' B' ' 395' ' ' ALA . 5.0 tp -149.75 -62.86 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.169 0 C-N-CA 123.558 0.743 . . . . 74.12 110.407 179.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 388' ' ' VAL . . . . . 0.444 ' H ' HG23 ' B' ' 387' ' ' ILE . 91.0 t 61.39 123.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 125.62 1.568 . . . . 54.33 112.13 -174.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 389' ' ' THR . . . . . . . . . . . . . 42.8 m -150.09 112.52 4.7 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.968 0.907 . . . . 71.25 108.662 176.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . 68.9 112.28 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.08 1.352 . . . . 70.34 112.194 177.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 391' ' ' ASP . . . . . . . . . . . . . 18.2 t70 67.15 -92.1 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.373 1.069 . . . . 64.12 110.632 176.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 392' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -144.94 1.89 1.01 Allowed 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 124.554 1.142 . . . . 72.42 109.746 178.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -64.83 122.92 18.07 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 123.94 0.896 . . . . 61.53 110.311 -174.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -67.05 88.89 0.16 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.478 0.711 . . . . 73.31 109.386 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 395' ' ' ALA . . . . . 0.464 ' HB2' HG21 ' B' ' 387' ' ' ILE . . . 64.72 5.67 2.89 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 125.122 1.369 . . . . 71.44 113.09 -176.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 37.6 m 54.6 87.66 0.04 OUTLIER 'General case' 0 C--N 1.361 1.095 0 C-N-CA 124.436 1.094 . . . . 75.55 110.995 -172.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 397' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -90.12 24.09 2.61 Favored 'General case' 0 CA--C 1.569 1.686 0 C-N-CA 123.932 0.893 . . . . 71.41 111.041 -170.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . 0.26 12.0 tt 46.88 107.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 C-N-CA 126.565 1.946 . . . . 75.44 113.675 -173.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 399' ' ' VAL . . . . . . . . . . . . . 55.9 t 64.75 -97.72 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 C-N-CA 125.244 1.418 . . . . 73.32 110.697 -178.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 400' ' ' ALA . . . . . . . . . . . . . . . -174.55 63.91 0.26 Allowed Pre-proline 0 CA--C 1.561 1.381 0 C-N-CA 123.003 0.521 . . . . 51.41 111.524 -174.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 401' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -89.66 111.1 0.48 Allowed 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 122.822 2.348 . . . . 71.04 112.822 -178.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 17.8 t70 66.93 11.6 8.44 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 125.613 1.565 . . . . 74.34 112.172 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 403' ' ' THR . . . . . . . . . . . . . 81.0 p -82.21 9.74 8.17 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.391 0.676 . . . . 51.3 110.967 176.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 404' ' ' LYS . . . . . . . . . . . . . 53.4 mmtt 64.16 -93.38 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.285 1.834 . . . . 70.03 109.652 178.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 405' ' ' ALA . . . . . 0.458 ' HB3' ' HD3' ' B' ' 406' ' ' PRO . . . 175.19 -59.81 0.0 OUTLIER Pre-proline 0 CA--C 1.557 1.238 0 C-N-CA 125.376 1.471 . . . . 71.24 109.739 175.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 406' ' ' PRO . . . . . 0.458 ' HD3' ' HB3' ' B' ' 405' ' ' ALA . 71.4 Cg_endo -77.0 97.01 1.12 Allowed 'Trans proline' 0 C--N 1.396 3.042 0 C-N-CA 121.874 1.716 . . . . 44.44 112.7 -176.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . 63.53 33.79 88.19 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 115.014 -0.994 . . . . 55.33 114.495 170.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 408' ' ' LEU . . . . . . . . . . . . . 73.1 mt 61.19 -79.26 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 125.117 1.367 . . . . 72.03 110.983 -176.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 24.6 m 66.56 -63.69 0.25 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.989 1.716 . . . . 73.52 112.559 175.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 410' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 83.27 -25.1 0.15 Allowed 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 126.398 1.879 . . . . 51.32 113.047 172.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . 74.68 -56.62 0.63 Allowed 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 125.877 1.671 . . . . 63.14 112.719 177.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 412' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -59.56 172.34 0.7 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 125.191 1.396 . . . . 60.41 112.612 -176.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -68.02 82.14 0.22 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.208 1.003 . . . . 71.14 110.458 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 414' ' ' THR . . . . . . . . . . . . . 6.5 t -170.43 -51.01 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.722 1.209 . . . . 73.24 108.635 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 415' ' ' LYS . . . . . 0.611 ' HD3' ' SD ' ' B' ' 420' ' ' MET . 3.8 mptp? 65.83 -65.55 0.18 Allowed 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 125.502 1.521 . . . . 73.42 111.032 -177.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 37.6 t70 80.06 -56.52 0.36 Allowed 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 125.867 1.667 . . . . 75.33 112.702 166.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 417' ' ' GLY . . . . . . . . . . . . . . . -71.72 72.04 0.86 Allowed Glycine 0 C--N 1.347 1.17 0 N-CA-C 111.487 -0.645 . . . . 43.15 111.487 174.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 418' ' ' ALA . . . . . . . . . . . . . . . 65.69 -166.27 0.22 Allowed 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 125.244 1.418 . . . . 70.25 111.583 -172.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 419' ' ' VAL . . . . . . . . . . . . . 76.6 t 70.02 -80.93 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 125.637 1.575 . . . . 62.03 109.597 -175.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 420' ' ' MET . . . . . 0.611 ' SD ' ' HD3' ' B' ' 415' ' ' LYS . 87.1 mtp -97.82 176.43 5.8 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.404 0.681 . . . . 73.12 109.945 175.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 421' ' ' VAL . . . . . . . . . . . . . 60.9 t 74.41 -62.31 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 C-N-CA 125.465 1.506 . . . . 72.42 110.615 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 422' ' ' MET . . . . . . . . . . . . . 91.8 mmm -66.0 -39.33 90.2 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.831 0.852 . . . . 74.1 111.425 172.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 423' ' ' SER . . . . . . . . . . . . . 68.5 m -151.79 -155.13 0.59 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.859 1.263 . . . . 62.22 108.176 -178.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 424' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -157.3 -38.9 0.07 Allowed 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 107.884 -1.154 . . . . 72.42 107.884 162.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . -121.19 -164.03 12.2 Favored Glycine 0 C--N 1.346 1.136 0 N-CA-C 110.664 -0.974 . . . . 75.12 110.664 166.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 426' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -65.29 -44.07 89.13 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.45 0.643 . . . . 75.43 109.411 175.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 427' ' ' SER . . . . . 0.707 ' HB3' ' HB2' ' B' ' 430' ' ' ASP . 36.1 t -156.74 176.46 12.71 Favored 'General case' 0 C--O 1.245 0.834 0 N-CA-C 107.896 -1.15 . . . . 75.14 107.896 170.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 428' ' ' GLU . . . . . 0.646 ' HB2' ' HB2' ' A' ' 220' ' ' GLU . 0.4 OUTLIER -71.83 -76.4 0.11 Allowed 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 108.51 -0.922 . . . . 73.23 108.51 179.435 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 429' ' ' GLU . . . . . 0.501 ' HA ' ' HA ' ' B' ' 433' ' ' GLU . 0.0 OUTLIER -85.74 49.88 1.86 Allowed 'General case' 0 N--CA 1.481 1.078 0 CA-C-O 121.897 0.856 . . . . 63.42 109.857 -179.24 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 430' ' ' ASP . . . . . 0.707 ' HB2' ' HB3' ' B' ' 427' ' ' SER . 32.6 t70 -84.6 78.73 9.79 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 125.21 1.404 . . . . 55.41 108.429 178.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 19.9 t 78.37 -51.14 0.48 Allowed 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 126.431 1.892 . . . . 73.31 113.373 174.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 432' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -110.54 -2.23 16.56 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 118.837 0.744 . . . . 71.1 112.825 -174.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 433' ' ' GLU . . . . . 0.501 ' HA ' ' HA ' ' B' ' 429' ' ' GLU . 2.1 mp0 58.4 95.06 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 124.05 0.94 . . . . 73.43 109.917 -170.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 434' ' ' HIS . . . . . 0.454 ' NE2' ' HB3' ' B' ' 430' ' ' ASP . 22.1 m-70 -65.99 -39.96 90.77 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.952 0.901 . . . . 65.13 112.056 -168.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 435' ' ' THR . . . . . . . . . . . . . 96.7 m -144.65 -69.65 0.3 Allowed 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 111.992 0.367 . . . . 73.42 111.992 177.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . -55.82 -49.05 68.28 Favored Glycine 0 C--N 1.351 1.373 0 O-C-N 123.761 0.663 . . . . 43.54 114.398 -166.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 15.8 m 73.2 -55.64 0.67 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.988 1.715 . . . . 54.14 112.589 176.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 438' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.84 -104.89 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 124.576 1.15 . . . . 71.55 109.545 176.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 439' ' ' LEU . . . . . 0.542 HD12 ' HG3' ' B' ' 428' ' ' GLU . 65.7 mt 54.42 16.17 1.2 Allowed 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 125.168 1.387 . . . . 74.24 113.878 176.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 440' ' ' ARG . . . . . . . . . . . . . 76.2 mtp180 -92.75 112.5 24.48 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 108.618 -0.882 . . . . 70.1 108.618 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 441' ' ' ILE . . . . . 0.504 HG12 HD13 ' A' ' 235' ' ' LEU . 53.9 mt -76.24 101.79 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 CA-C-O 120.84 0.352 . . . . 74.15 110.456 -178.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 442' ' ' ALA . . . . . . . . . . . . . . . -87.88 84.32 7.02 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 108.743 -0.836 . . . . 71.41 108.743 172.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . -131.07 -54.37 1.04 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.747 0.819 . . . . 74.21 109.822 -175.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 444' ' ' TYR . . . . . 0.616 ' HB2' ' HB2' ' A' ' 224' ' ' PRO . 6.4 m-85 -106.6 28.16 8.13 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.913 0.885 . . . . 65.34 109.619 177.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . 100.87 -167.3 19.63 Favored Glycine 0 C--N 1.344 0.98 0 CA-C-N 115.539 -0.755 . . . . 74.34 111.629 -175.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 446' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -79.43 164.65 23.76 Favored 'Trans proline' 0 C--N 1.368 1.579 0 C-N-CA 122.617 2.212 . . . . 63.02 112.45 177.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 447' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -83.22 0.32 45.98 Favored 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 123.587 0.755 . . . . 60.0 110.164 176.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . -63.86 91.47 0.06 Allowed 'General case' 0 C--N 1.359 1.003 0 C-N-CA 124.391 1.076 . . . . 74.31 110.37 174.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 449' ' ' ALA . . . . . . . . . . . . . . . -82.49 -5.08 58.49 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.743 0.817 . . . . 61.52 111.7 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 450' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 67.11 94.24 0.07 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.42 1.488 . . . . 61.12 110.479 177.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 451' ' ' VAL . . . . . 0.742 HG13 ' H ' ' B' ' 464' ' ' MET . 84.2 t -73.15 -45.63 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.684 0.794 . . . . 63.1 111.21 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 452' ' ' VAL . . . . . 0.556 HG13 ' H ' ' B' ' 453' ' ' GLY . 2.5 p -64.23 -75.13 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 O-C-N 123.877 0.736 . . . . 60.45 112.334 -175.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 453' ' ' GLY . . . . . 0.556 ' H ' HG13 ' B' ' 452' ' ' VAL . . . 55.91 -102.7 0.19 Allowed Glycine 0 C--N 1.346 1.1 0 CA-C-O 121.025 0.236 . . . . 73.44 112.555 -171.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 454' ' ' LEU . . . . . 0.569 HD21 ' HB1' ' B' ' 282' ' ' ALA . 1.9 pt? -161.14 -41.84 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 107.694 -1.224 . . . . 72.5 107.694 -176.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . 0.423 ' HB ' HG13 ' B' ' 288' ' ' VAL . 4.9 m 49.88 -85.63 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 126.57 1.948 . . . . 61.41 114.166 171.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 456' ' ' ASP . . . . . 0.553 ' HB2' HD11 ' B' ' 280' ' ' LEU . 7.1 t70 -171.19 -162.52 0.25 Allowed 'General case' 0 CA--C 1.554 1.132 0 N-CA-C 107.747 -1.205 . . . . 74.3 107.747 -172.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 457' ' ' GLN . . . . . 0.45 ' HA ' ' H ' ' B' ' 289' ' ' ARG . 54.6 tt0 -146.51 -32.03 0.34 Allowed 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 118.704 0.684 . . . . 42.14 111.205 174.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 33.3 p -87.1 -12.21 47.83 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.966 1.098 . . . . 72.13 113.966 -168.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 459' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -95.95 173.93 7.19 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 119.534 1.061 . . . . 73.31 111.466 174.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 460' ' ' LEU . . . . . 0.454 ' HG ' ' HA ' ' B' ' 290' ' ' TRP . 5.8 tt -160.15 104.08 1.48 Allowed 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 107.564 -1.273 . . . . 65.42 107.564 -176.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -132.94 -87.62 0.43 Allowed 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.576 0.75 . . . . 62.31 110.379 177.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -149.58 162.76 39.54 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.001 -1.111 . . . . 72.53 108.001 -173.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 41.8 p -63.7 168.66 4.67 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 122.98 0.512 . . . . 61.35 111.587 176.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 464' ' ' MET . . . . . 0.742 ' H ' HG13 ' B' ' 451' ' ' VAL . 1.8 tpt 75.2 131.69 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.865 1.266 . . . . 75.31 110.791 -178.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 36.1 mtmm -69.88 85.98 0.51 Allowed 'General case' 0 C--N 1.355 0.826 0 N-CA-C 108.884 -0.784 . . . . 72.15 108.884 173.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -164.48 -52.5 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.353 -1.294 . . . . 62.32 108.608 -174.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 467' ' ' ALA . . . . . 0.456 ' HA ' ' HZ1' ' C' ' 271' ' ' LYS . . . -90.41 69.55 6.94 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.131 -0.94 . . . . 75.3 110.844 179.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -91.64 -172.47 3.23 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 123.019 0.527 . . . . 45.51 111.185 -178.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 469' ' ' GLY . . . . . . . . . . . . . . . -115.51 -82.6 1.02 Allowed Glycine 0 C--N 1.356 1.645 0 N-CA-C 112.19 -0.364 . . . . 50.44 112.19 174.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 470' ' ' LEU . . . . . 0.409 HD12 ' N ' ' B' ' 471' ' ' LYS . 3.8 pp -170.67 -38.98 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.636 1.175 . . . . 73.2 108.486 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 471' ' ' LYS . . . . . 0.409 ' N ' HD12 ' B' ' 470' ' ' LEU . 5.2 tmtm? . . . . . 0 C--O 1.252 1.19 0 N-CA-C 104.167 -2.531 . . . . 74.2 104.167 172.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 59.0 mtm . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 119.613 -0.232 . . . . 55.23 110.48 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 52.68 39.82 29.12 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.152 0.981 . . . . 65.31 111.957 -177.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -84.46 64.18 8.26 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 109.56 -0.533 . . . . 52.01 109.56 178.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -40.5 95.67 0.01 OUTLIER 'General case' 0 C--N 1.359 0.99 0 C-N-CA 125.564 1.546 . . . . 70.52 114.045 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 5' ' ' LYS . . . . . 0.416 ' HB3' HD11 ' C' ' 10' ' ' ILE . 48.6 mtmt -87.72 124.52 33.67 Favored 'General case' 0 C--O 1.247 0.942 0 N-CA-C 108.899 -0.778 . . . . 63.2 108.899 170.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -75.84 112.88 12.7 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.629 -0.878 . . . . 63.22 108.629 175.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 7' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -64.47 -26.16 68.32 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.713 0.805 . . . . 73.43 112.711 -171.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -70.89 -45.07 65.0 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 109.319 -0.623 . . . . 72.53 109.319 178.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.57 -36.91 84.16 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.973 -1.012 . . . . 52.31 110.762 176.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 10' ' ' ILE . . . . . 0.416 HD11 ' HB3' ' C' ' 5' ' ' LYS . 56.6 mt -59.46 -46.57 92.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 122.908 0.483 . . . . 63.34 110.06 174.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 11' ' ' LEU . . . . . 0.622 ' HB3' ' HB1' ' C' ' 25' ' ' ALA . 56.6 mt -71.39 -6.73 42.36 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 112.639 0.607 . . . . 45.45 112.639 176.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.84 21.09 79.66 Favored Glycine 0 C--N 1.355 1.629 0 C-N-CA 122.812 0.244 . . . . 64.33 113.62 178.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 13' ' ' VAL . . . . . 0.421 HG11 ' HB2' ' C' ' 25' ' ' ALA . 31.3 m -113.98 161.51 27.57 Favored Pre-proline 0 N--CA 1.477 0.885 0 C-N-CA 124.111 0.964 . . . . 64.04 110.259 -177.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -54.89 148.52 46.32 Favored 'Trans proline' 0 C--N 1.382 2.294 0 C-N-CA 122.617 2.211 . . . . 74.43 113.05 174.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 68.4 mtm180 -76.94 19.9 0.28 Allowed 'General case' 0 CA--C 1.559 1.296 0 C-N-CA 123.757 0.823 . . . . 71.52 112.969 -172.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -136.97 8.17 2.97 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 125.076 1.35 . . . . 71.24 109.344 179.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.07 141.13 58.84 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.851 0.86 . . . . 71.14 112.242 -174.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 47.7 p -93.24 176.44 6.4 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.276 1.03 . . . . 74.41 112.335 -174.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -53.41 -36.34 61.39 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 125.288 1.435 . . . . 74.45 112.585 -175.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -57.95 -47.98 81.31 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.55 1.14 . . . . 64.05 111.405 175.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -76.89 -29.98 56.0 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.042 -1.436 . . . . 73.42 111.194 -174.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 22' ' ' ILE . . . . . 0.452 HG12 ' HB3' ' C' ' 57' ' ' LEU . 1.7 mp -72.28 -34.11 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 C-N-CA 124.119 0.968 . . . . 61.32 110.058 175.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 23' ' ' LYS . . . . . 0.534 ' HD3' ' NH2' ' C' ' 148' ' ' ARG . 34.1 ttpt -61.5 -50.64 71.9 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.694 0.798 . . . . 74.13 109.973 173.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 24' ' ' ARG . . . . . . . . . . . . . 50.1 mtm180 -75.5 -20.23 58.89 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 115.582 -0.736 . . . . 73.52 112.423 -178.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . 0.622 ' HB1' ' HB3' ' C' ' 11' ' ' LEU . . . -74.23 -38.75 63.45 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.098 0.559 . . . . 75.32 110.238 172.364 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 26' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -63.8 -43.69 95.57 Favored 'General case' 0 C--O 1.216 -0.7 0 CA-C-N 114.846 -1.07 . . . . 72.31 109.524 174.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -55.48 -55.14 35.21 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.886 0.474 . . . . 74.1 109.994 175.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -46.5 -62.39 1.39 Allowed 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.047 1.339 . . . . 71.15 111.956 -179.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 62.7 mt -74.46 -38.83 62.85 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.385 -0.825 . . . . 60.22 112.168 -173.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.01 2.96 32.25 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 122.573 0.349 . . . . 75.32 111.742 -178.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -95.94 -44.99 7.12 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 108.944 -0.761 . . . . 73.5 108.944 163.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 21.3 tp60 -67.65 -55.86 11.63 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 123.501 0.5 . . . . 71.12 112.216 -176.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 33' ' ' TYR . . . . . 0.472 ' HD2' HD11 ' C' ' 50' ' ' ILE . 11.1 m-85 -95.66 25.5 4.54 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.699 0.8 . . . . 70.15 110.942 -178.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 34' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 -64.9 114.86 16.44 Favored Pre-proline 0 CA--C 1.546 0.813 0 CA-C-O 118.251 -0.881 . . . . 72.34 109.691 -177.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -55.62 -16.14 14.02 Favored 'Trans proline' 0 C--N 1.38 2.211 0 C-N-CA 123.216 2.611 . . . . 71.32 114.314 -177.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -67.75 -53.26 28.79 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.486 0.714 . . . . 60.34 110.391 169.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 77.1 t -77.07 -50.67 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.801 0.84 . . . . 75.33 110.508 -173.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -114.26 86.58 2.45 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.775 1.23 . . . . 54.22 109.011 -178.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -75.96 77.21 2.84 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 116.056 -0.52 . . . . 62.24 109.786 178.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 22.5 m -135.37 121.06 14.01 Favored Pre-proline 0 N--CA 1.471 0.608 0 CA-C-O 118.284 -0.865 . . . . 74.14 109.278 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -47.99 -37.16 29.22 Favored 'Trans proline' 0 C--N 1.384 2.443 0 C-N-CA 123.346 2.697 . . . . 63.44 112.694 174.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -59.94 -41.84 92.69 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.16 0.984 . . . . 65.44 110.246 177.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.7 -17.98 61.06 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 116.2 -0.455 . . . . 62.05 110.521 177.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 44' ' ' GLU . . . . . 0.526 ' HA ' ' HB3' ' C' ' 47' ' ' PHE . 50.1 mt-10 -86.22 -14.88 42.6 Favored 'General case' 0 C--N 1.358 0.953 0 C-N-CA 123.045 0.538 . . . . 74.04 110.371 177.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 45' ' ' GLU . . . . . 0.425 ' O ' ' HB2' ' C' ' 48' ' ' LYS . 32.6 mt-10 -82.72 -38.29 23.52 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.924 -0.769 . . . . 42.53 108.924 169.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 46' ' ' LYS . . . . . 0.502 ' O ' HG13 ' C' ' 50' ' ' ILE . 59.0 mttp -64.13 -32.04 73.46 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.597 -0.729 . . . . 72.32 110.115 166.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 47' ' ' PHE . . . . . 0.526 ' HB3' ' HA ' ' C' ' 44' ' ' GLU . 46.3 t80 -78.29 -21.98 48.91 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.582 0.753 . . . . 62.23 110.533 177.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 48' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' C' ' 45' ' ' GLU . 50.6 mttp -60.35 -53.13 61.29 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 107.961 -1.125 . . . . 72.04 107.961 164.033 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -56.81 -40.19 75.53 Favored 'General case' 0 CA--C 1.55 0.954 0 O-C-N 124.447 1.092 . . . . 72.33 112.132 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 50' ' ' ILE . . . . . 0.502 HG13 ' O ' ' C' ' 46' ' ' LYS . 69.9 mt -62.75 -55.13 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 C-N-CA 123.312 0.645 . . . . 75.43 110.082 176.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 51' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -71.67 -20.91 61.87 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 114.823 -1.08 . . . . 74.04 112.174 -173.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -79.52 -54.29 6.05 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.279 1.032 . . . . 63.42 108.548 178.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.71 -33.74 72.0 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 114.125 -1.398 . . . . 63.1 111.732 176.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 54' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -81.66 -33.74 31.13 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 119.138 -0.458 . . . . 75.01 110.452 177.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 55' ' ' ALA . . . . . 0.417 ' HB1' ' HD2' ' C' ' 85' ' ' PHE . . . -56.6 -35.33 68.12 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 118.023 0.374 . . . . 60.54 110.535 174.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 56' ' ' VAL . . . . . 0.459 ' O ' ' HB2' ' C' ' 62' ' ' LYS . 46.2 t -81.02 -62.2 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 CA-C-N 115.559 -0.746 . . . . 72.43 110.986 176.087 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 57' ' ' LEU . . . . . 0.452 ' HB3' HG12 ' C' ' 22' ' ' ILE . 39.4 mt -79.84 -7.88 58.96 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 114.169 1.174 . . . . 75.02 114.169 -164.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 32.6 t -59.92 -51.9 67.69 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.335 0.588 . . . . 62.42 110.433 178.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.86 126.39 80.14 Favored Pre-proline 0 C--O 1.246 0.891 0 CA-C-N 114.787 -1.097 . . . . 72.03 108.805 172.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 60' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -59.12 -23.77 70.61 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.095 1.863 . . . . 33.23 111.231 168.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -64.8 -54.74 26.49 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 124.568 1.147 . . . . 62.13 110.905 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 62' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' C' ' 56' ' ' VAL . 70.3 mttt -69.77 -30.85 68.51 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 115.873 -0.603 . . . . 75.23 110.804 178.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 1.3 ttp180 -57.91 -43.6 86.3 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.62 -0.882 . . . . 64.42 108.62 175.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 64' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -72.13 -28.4 63.24 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 115.053 -0.976 . . . . 74.15 112.32 177.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 65' ' ' ILE . . . . . 0.475 HD13 ' HE1' ' C' ' 83' ' ' TYR . 78.6 mt -59.82 -44.54 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 109.878 -0.416 . . . . 62.34 109.878 170.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -67.58 -42.65 82.2 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 116.169 -0.469 . . . . 74.22 110.207 176.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -58.91 -39.96 83.06 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.329 0.652 . . . . 73.14 111.423 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 71.6 p -77.1 -19.33 57.13 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 122.948 0.499 . . . . 63.2 110.983 177.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -74.08 114.29 12.23 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 108.517 -0.92 . . . . 75.22 108.517 170.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 112.26 11.92 14.69 Favored Glycine 0 N--CA 1.472 1.084 0 N-CA-C 111.699 -0.561 . . . . 62.51 111.699 -166.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 95.2 m -144.38 -50.39 0.29 Allowed 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 105.05 -2.204 . . . . 72.34 105.05 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 33.1 m -93.8 137.3 33.19 Favored 'General case' 0 C--O 1.249 1.078 0 N-CA-C 103.527 -2.768 . . . . 73.35 103.527 156.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.06 -31.75 13.44 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 118.384 0.538 . . . . 73.23 110.687 177.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.94 140.91 74.39 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 123.582 0.753 . . . . 53.23 109.968 176.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 75' ' ' PRO . . . . . 0.41 ' HB3' ' O ' ' C' ' 100' ' ' LEU . 10.2 Cg_endo -53.03 115.87 2.56 Favored 'Trans proline' 0 C--N 1.376 2.016 0 C-N-CA 123.173 2.582 . . . . 75.14 112.306 176.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -53.44 148.9 32.18 Favored 'Trans proline' 0 C--N 1.391 2.772 0 C-N-CA 123.911 3.074 . . . . 63.14 113.276 -178.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 77' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -50.87 118.62 4.37 Favored 'Trans proline' 0 C--N 1.389 2.663 0 C-N-CA 123.24 2.627 . . . . 51.51 113.521 -178.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 78' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.11 139.48 80.31 Favored 'Trans proline' 0 C--N 1.386 2.511 0 C-N-CA 123.343 2.695 . . . . 74.44 112.943 -178.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.58 158.02 17.31 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 123.078 2.519 . . . . 61.04 112.591 177.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -74.91 42.48 0.84 Allowed 'Trans proline' 0 C--N 1.382 2.312 0 C-N-CA 123.678 2.918 . . . . 51.5 112.735 174.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -159.46 16.86 0.23 Allowed Glycine 0 CA--C 1.529 0.951 0 N-CA-C 108.585 -1.806 . . . . 75.2 108.585 177.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 67.6 -171.93 32.86 Favored Glycine 0 C--N 1.365 2.179 0 C-N-CA 124.439 1.019 . . . . 74.45 111.959 -175.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 83' ' ' TYR . . . . . 0.475 ' HE1' HD13 ' C' ' 65' ' ' ILE . 58.8 m-85 -83.58 98.15 9.44 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 105.991 -1.855 . . . . 70.14 105.991 162.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 84' ' ' ASP . . . . . 0.492 ' OD1' ' HA3' ' C' ' 163' ' ' GLY . 0.3 OUTLIER -56.32 137.18 52.88 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 112.015 0.376 . . . . 63.13 112.015 -175.114 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 85' ' ' PHE . . . . . 0.459 ' HB3' ' HB2' ' C' ' 88' ' ' PHE . 30.7 m-85 -133.06 73.1 1.5 Allowed 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.523 1.129 . . . . 74.41 108.325 177.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 86' ' ' SER . . . . . 0.411 ' HA ' ' HB2' ' C' ' 162' ' ' PRO . 50.4 m -51.64 85.72 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 124.308 1.043 . . . . 45.43 112.345 178.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 65.61 19.11 66.7 Favored Glycine 0 CA--C 1.534 1.273 0 CA-C-N 115.566 -0.743 . . . . 74.33 113.672 -175.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 88' ' ' PHE . . . . . 0.459 ' HB2' ' HB3' ' C' ' 85' ' ' PHE . 23.0 m-85 -101.81 118.55 37.16 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 109.411 -0.588 . . . . 74.44 109.411 -176.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -75.74 90.23 2.86 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.216 0.531 . . . . 72.23 109.686 -178.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 90' ' ' VAL . . . . . 0.432 HG23 HD22 ' C' ' 105' ' ' LEU . 1.6 p -41.12 -47.99 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 CA-C-N 113.96 -1.473 . . . . 54.41 113.326 171.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 91' ' ' GLU . . . . . 0.509 ' HB2' ' HG3' ' C' ' 112' ' ' ARG . 45.5 tt0 -68.78 -19.32 64.31 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.275 0.63 . . . . 74.21 111.635 -175.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -93.06 -2.89 55.16 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.354 0.662 . . . . 75.53 111.583 -178.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -95.21 174.77 6.89 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 122.714 0.405 . . . . 72.45 111.803 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 90.0 p -66.23 167.15 10.71 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 114.643 1.349 . . . . 45.51 114.643 -168.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 95' ' ' GLU . . . . . 0.403 ' O ' ' HG3' ' C' ' 99' ' ' GLU . 0.0 OUTLIER -59.49 -50.89 72.19 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 114.962 -1.017 . . . . 55.43 112.026 178.744 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -57.13 -46.44 82.66 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.608 0.763 . . . . 65.02 110.502 -176.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 97' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -54.64 -52.29 62.77 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 114.756 -1.111 . . . . 64.25 110.634 175.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 98' ' ' GLN . . . . . 0.576 ' HA ' HD21 ' C' ' 105' ' ' LEU . 98.0 mt-30 -69.0 -18.29 64.03 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.617 -0.719 . . . . 51.52 112.558 -175.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' C' ' 95' ' ' GLU . 44.3 mt-10 -86.65 -52.42 5.55 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.729 0.411 . . . . 74.43 111.087 176.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 100' ' ' LEU . . . . . 0.41 ' O ' ' HB3' ' C' ' 75' ' ' PRO . 54.5 tp -62.09 -39.58 92.94 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.528 0.731 . . . . 73.23 111.012 -178.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 101' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -96.57 7.49 46.41 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.987 -0.551 . . . . 73.25 110.839 178.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 102' ' ' GLY . . . . . 0.481 ' HA2' ' HG ' ' C' ' 105' ' ' LEU . . . -43.38 -62.34 2.49 Favored Glycine 0 C--N 1.356 1.672 0 C-N-CA 124.906 1.241 . . . . 54.11 114.916 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -49.6 -21.22 5.07 Favored 'Trans proline' 0 C--N 1.384 2.431 0 C-N-CA 123.985 3.123 . . . . 62.02 115.105 -177.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -146.97 41.26 0.97 Allowed Glycine 0 C--N 1.36 1.909 0 CA-C-O 119.576 -0.569 . . . . 43.23 112.823 178.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 105' ' ' LEU . . . . . 0.576 HD21 ' HA ' ' C' ' 98' ' ' GLN . 13.2 mt -56.77 13.36 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.59 0 N-CA-C 115.717 1.747 . . . . 73.03 115.717 177.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 106' ' ' PHE . . . . . 0.545 ' HA ' ' HB2' ' C' ' 169' ' ' ASN . 0.2 OUTLIER 72.35 -104.44 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.044 0.937 . . . . 64.24 111.821 166.077 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 107' ' ' GLY . . . . . 0.472 ' HA2' ' HB2' ' C' ' 112' ' ' ARG . . . 109.56 24.84 5.71 Favored Glycine 0 N--CA 1.466 0.668 0 N-CA-C 111.376 -0.69 . . . . 51.05 111.376 -161.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . -15.48 -67.7 0.01 OUTLIER Glycine 0 C--N 1.364 2.111 0 C-N-CA 124.882 1.229 . . . . 74.41 113.343 160.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 109' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -91.01 78.51 5.94 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 107.631 -1.248 . . . . 74.45 107.631 167.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 110' ' ' GLY . . . . . . . . . . . . . . . 0.51 -69.16 0.0 OUTLIER Glycine 0 N--CA 1.498 2.779 0 C-N-CA 127.308 2.385 . . . . 54.22 116.86 -179.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 17.9 mtp180 -7.04 -40.31 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.914 0 C-N-CA 126.432 1.893 . . . . 75.25 116.031 158.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 112' ' ' ARG . . . . . 0.509 ' HG3' ' HB2' ' C' ' 91' ' ' GLU . 5.5 mpt_? -85.96 47.09 1.4 Allowed 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 126.347 1.859 . . . . 74.1 110.213 -174.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 113' ' ' SER . . . . . . . . . . . . . 44.4 m 84.76 -0.2 0.87 Allowed 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 117.179 2.289 . . . . 72.53 117.179 162.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 114' ' ' ARG . . . . . 0.701 ' HB3' ' HA ' ' C' ' 169' ' ' ASN . 0.1 OUTLIER -154.75 158.85 40.14 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 120.725 1.602 . . . . 74.05 112.376 174.23 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 115' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -103.47 131.43 50.58 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.762 1.023 . . . . 54.14 113.762 -177.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -109.56 165.88 12.49 Favored Glycine 0 CA--C 1.542 1.732 0 O-C-N 123.456 0.473 . . . . 45.25 112.901 163.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 4.6 ppt_? -116.51 137.25 52.32 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.714 -0.847 . . . . 64.44 108.714 167.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 118' ' ' ASP . . . . . 0.894 ' HA ' ' HA2' ' C' ' 166' ' ' GLY . 8.7 p-10 -61.3 134.85 57.41 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 123.851 0.861 . . . . 75.42 111.517 -172.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 119' ' ' LEU . . . . . 0.563 ' HB2' ' O ' ' C' ' 165' ' ' GLY . 0.2 OUTLIER -92.81 143.62 26.1 Favored 'General case' 0 N--CA 1.504 2.252 0 C-N-CA 119.293 -0.963 . . . . 75.21 109.697 -176.979 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -128.87 95.44 4.09 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 107.947 -1.131 . . . . 72.31 107.947 175.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 121' ' ' ALA . . . . . 0.453 ' HB3' HD23 ' C' ' 176' ' ' LEU . . . -108.33 114.1 27.7 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 108.542 -0.911 . . . . 63.21 108.542 -177.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 122' ' ' GLU . . . . . 0.484 ' HA ' ' O ' ' C' ' 177' ' ' VAL . 37.4 mt-10 -95.27 101.44 13.17 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 107.114 -1.439 . . . . 73.22 107.114 172.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 123' ' ' LEU . . . . . 0.63 HD23 ' H ' ' C' ' 123' ' ' LEU . 1.7 pt? -105.57 115.52 61.63 Favored Pre-proline 0 N--CA 1.478 0.942 0 CA-C-N 115.702 -0.681 . . . . 73.3 110.896 -168.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . 0.535 ' HA ' ' O ' ' C' ' 179' ' ' ARG . 85.8 Cg_exo -52.76 113.46 1.26 Allowed 'Trans proline' 0 C--N 1.384 2.426 0 C-N-CA 122.506 2.138 . . . . 72.51 111.121 164.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 125' ' ' LEU . . . . . 0.566 HD23 HG11 ' C' ' 153' ' ' VAL . 37.8 tp -129.99 143.84 51.01 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.648 0.379 . . . . 74.03 110.106 -175.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 126' ' ' THR . . . . . . . . . . . . . 2.5 m -85.37 149.49 25.4 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 116.033 -0.531 . . . . 61.53 110.917 -177.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 127' ' ' LEU . . . . . 0.476 HD11 ' H ' ' C' ' 185' ' ' VAL . 9.8 mt -70.61 -52.14 23.47 Favored 'General case' 0 C--O 1.247 0.962 0 C-N-CA 124.198 0.999 . . . . 62.25 109.038 -178.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 128' ' ' GLU . . . . . 0.551 ' HG3' ' HA ' ' C' ' 215' ' ' LEU . 1.7 mp0 -59.49 -34.72 72.93 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 113.88 -1.509 . . . . 75.24 111.227 178.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 129' ' ' GLU . . . . . 0.518 ' HA ' ' HB2' ' C' ' 132' ' ' HIS . 17.7 mm-40 -84.47 -19.55 33.18 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.616 0.366 . . . . 73.53 111.544 -179.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 130' ' ' ALA . . . . . . . . . . . . . . . -70.5 -33.68 71.49 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 108.882 -0.785 . . . . 64.34 108.882 171.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 131' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -65.46 -49.06 70.53 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 115.482 -0.781 . . . . 75.55 109.91 167.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 132' ' ' HIS . . . . . 0.518 ' HB2' ' HA ' ' C' ' 129' ' ' GLU . 32.8 m170 -72.18 -3.82 25.62 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 112.704 0.631 . . . . 60.22 112.704 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -54.41 165.13 2.83 Favored Glycine 0 CA--C 1.547 2.047 0 N-CA-C 115.715 1.046 . . . . 65.31 115.715 174.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . 158.52 -130.44 2.53 Favored Glycine 0 C--N 1.348 1.218 0 N-CA-C 110.269 -1.133 . . . . 53.24 110.269 -174.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 17.0 mp0 -81.2 95.53 6.95 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 108.263 -1.014 . . . . 71.2 108.263 169.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 136' ' ' ARG . . . . . 0.672 ' HB2' HD22 ' B' ' 181' ' ' LEU . 26.9 mmt180 -121.83 147.04 46.48 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 122.897 0.479 . . . . 72.12 110.662 -172.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 137' ' ' VAL . . . . . 0.565 HG23 ' HB1' ' B' ' 180' ' ' ALA . 8.0 m -74.42 132.55 33.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 121.69 0.757 . . . . 71.12 110.72 -175.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 138' ' ' VAL . . . . . 0.412 HG13 HG11 ' B' ' 182' ' ' VAL . 2.3 t -139.02 133.31 40.64 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 C-N-CA 124.656 1.183 . . . . 72.14 109.269 -175.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 139' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -125.28 109.17 12.49 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 107.898 -1.149 . . . . 74.31 107.898 171.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 140' ' ' VAL . . . . . . . . . . . . . 3.2 p -143.32 134.03 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.022 0.929 . . . . 63.22 109.174 178.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 141' ' ' ALA . . . . . . . . . . . . . . . 64.42 8.17 4.1 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.613 1.165 . . . . 15.23 113.329 177.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 105.29 1.46 41.17 Favored Glycine 0 C--N 1.351 1.37 0 CA-C-O 119.63 -0.539 . . . . 45.25 113.817 -178.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 143' ' ' ARG . . . . . 0.425 HH11 ' HG2' ' C' ' 164' ' ' MET . 77.2 ttt180 -100.14 124.98 46.17 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 118.037 0.918 . . . . 73.04 110.708 -179.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 49.2 ttt-85 -96.22 116.57 29.22 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.163 0.985 . . . . 71.51 108.944 170.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 145' ' ' VAL . . . . . 0.437 HG11 ' SD ' ' C' ' 164' ' ' MET . 7.7 p -151.74 147.4 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 122.714 0.405 . . . . 75.03 111.104 -177.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 50.8 m -85.39 93.47 8.74 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 108.044 -1.095 . . . . 54.21 108.044 166.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 6.2 p -81.33 154.41 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-O 120.853 0.359 . . . . 72.53 110.414 -175.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 148' ' ' ARG . . . . . 0.534 ' NH2' ' HD3' ' C' ' 23' ' ' LYS . 53.5 ttm-85 -113.77 95.79 5.51 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 108.275 -1.009 . . . . 74.22 108.275 172.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 149' ' ' ILE . . . . . . . . . . . . . 34.8 pt -106.91 150.99 40.45 Favored Pre-proline 0 CA--C 1.548 0.898 0 N-CA-C 108.49 -0.93 . . . . 71.41 108.49 171.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -40.24 111.73 0.15 Allowed 'Trans proline' 0 C--N 1.384 2.409 0 C-N-CA 124.311 3.341 . . . . 61.44 115.042 -179.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -64.09 93.78 0.19 Allowed 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.996 2.464 . . . . 73.2 109.856 166.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 152' ' ' GLY . . . . . . . . . . . . . . . 113.17 90.6 1.87 Allowed Glycine 0 C--N 1.341 0.816 0 N-CA-C 110.004 -1.238 . . . . 54.32 110.004 -165.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 153' ' ' VAL . . . . . 0.566 HG11 HD23 ' C' ' 125' ' ' LEU . 2.0 p -115.51 156.74 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 C-N-CA 123.051 0.54 . . . . 71.13 110.152 -174.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 154' ' ' ARG . . . . . 0.517 ' HB2' ' HB3' ' C' ' 157' ' ' SER . 56.7 mtp180 -107.54 135.26 49.3 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.68 0.792 . . . . 75.32 110.675 -174.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 155' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -47.04 120.91 3.33 Favored 'General case' 0 CA--C 1.553 1.059 0 CA-C-N 118.663 0.665 . . . . 74.51 111.588 166.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.59 -0.49 88.23 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-O 119.263 -0.743 . . . . 64.51 114.496 176.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 157' ' ' SER . . . . . 0.517 ' HB3' ' HB2' ' C' ' 154' ' ' ARG . 91.5 p -77.83 147.96 34.93 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 118.183 0.991 . . . . 75.43 109.93 177.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 6.1 p -119.63 109.58 26.69 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 CA-C-O 121.668 0.746 . . . . 64.44 109.902 -173.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 159' ' ' ILE . . . . . 0.586 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 17.3 mt -88.24 116.01 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.613 1.165 . . . . 52.25 109.078 -178.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 160' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -91.01 111.84 23.48 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.521 -0.548 . . . . 72.21 109.521 177.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 161' ' ' VAL . . . . . 0.454 HG11 ' HE2' ' C' ' 164' ' ' MET . 1.9 p -122.21 96.4 46.39 Favored Pre-proline 0 CA--C 1.558 1.286 0 C-N-CA 124.254 1.022 . . . . 75.24 108.964 177.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 162' ' ' PRO . . . . . 0.83 ' HA ' ' HA ' ' C' ' 173' ' ' ASP . 10.6 Cg_endo -57.05 128.03 28.18 Favored 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 122.847 2.364 . . . . 63.42 113.329 176.023 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 163' ' ' GLY . . . . . 0.492 ' HA3' ' OD1' ' C' ' 84' ' ' ASP . . . 107.31 13.03 22.12 Favored Glycine 0 C--N 1.348 1.209 0 N-CA-C 115.179 0.832 . . . . 53.31 115.179 172.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 164' ' ' MET . . . . . 0.454 ' HE2' HG11 ' C' ' 161' ' ' VAL . 5.7 mtm -126.67 32.0 5.23 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 117.991 0.896 . . . . 73.35 112.216 -176.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 165' ' ' GLY . . . . . 0.673 ' H ' ' HA2' ' C' ' 172' ' ' GLY . . . 112.35 122.49 4.07 Favored Glycine 0 C--O 1.192 -2.483 0 CA-C-O 115.526 -2.819 . . . . 64.24 107.48 -176.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 166' ' ' GLY . . . . . 0.894 ' HA2' ' HA ' ' C' ' 118' ' ' ASP . . . 144.5 -143.57 12.23 Favored Glycine 0 C--O 1.199 -2.035 0 CA-C-N 122.379 3.089 . . . . 75.44 113.239 -161.18 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 167' ' ' GLN . . . . . 0.52 ' H ' ' HB3' ' C' ' 173' ' ' ASP . 22.2 mm-40 -90.07 114.33 26.21 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 118.968 1.384 . . . . 64.31 110.539 177.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . -167.59 -150.97 6.74 Favored Glycine 0 N--CA 1.479 1.502 0 CA-C-O 119.654 -0.526 . . . . 13.44 113.118 -175.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 169' ' ' ASN . . . . . 0.701 ' HA ' ' HB3' ' C' ' 114' ' ' ARG . 25.1 t-20 -72.33 -56.23 4.31 Favored Pre-proline 0 C--N 1.358 0.973 0 N-CA-C 108.354 -0.98 . . . . 62.44 108.354 168.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 170' ' ' PRO . . . . . 0.598 ' HD3' ' HB3' ' C' ' 169' ' ' ASN . 57.7 Cg_endo -98.83 -160.11 0.05 OUTLIER 'Trans proline' 0 C--N 1.365 1.409 0 N-CA-C 105.292 -2.619 . . . . 51.41 105.292 159.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 171' ' ' PRO . . . . . 0.508 ' HA ' ' O ' ' C' ' 166' ' ' GLY . 22.3 Cg_exo -47.17 119.47 3.52 Favored 'Trans proline' 0 CA--C 1.587 3.13 0 CA-C-N 121.543 1.587 . . . . 74.02 114.733 160.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 172' ' ' GLY . . . . . 0.673 ' HA2' ' H ' ' C' ' 165' ' ' GLY . . . -150.96 84.45 0.16 Allowed Glycine 1 CA--C 1.587 4.575 0 N-CA-C 117.169 1.628 . . . . 74.42 117.169 168.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 173' ' ' ASP . . . . . 0.83 ' HA ' ' HA ' ' C' ' 162' ' ' PRO . 29.0 t70 163.05 93.21 0.0 OUTLIER 'General case' 0 N--CA 1.535 3.817 0 C-N-CA 127.58 2.352 . . . . 74.51 108.231 -178.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 174' ' ' LEU . . . . . . . . . . . . . 15.1 tp -104.45 139.79 38.87 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 114.724 -1.125 . . . . 75.22 113.035 -162.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 66.9 mt -110.26 92.26 3.98 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.462 1.105 . . . . 71.32 109.398 172.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 176' ' ' LEU . . . . . 0.586 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 68.1 mt -75.29 93.6 2.89 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-N 114.796 -1.093 . . . . 43.02 110.953 175.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 177' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' C' ' 122' ' ' GLU . 59.4 t -84.53 101.33 8.91 Favored 'Isoleucine or valine' 0 C--O 1.244 0.777 0 N-CA-C 107.28 -1.378 . . . . 74.43 107.28 172.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 178' ' ' VAL . . . . . . . . . . . . . 28.9 m -76.92 122.05 30.58 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 CA-C-O 121.927 0.87 . . . . 74.01 110.18 -176.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 179' ' ' ARG . . . . . 0.535 ' O ' ' HA ' ' C' ' 124' ' ' PRO . 9.9 mmm180 -113.71 111.87 22.52 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 106.376 -1.713 . . . . 72.33 106.376 174.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 180' ' ' LEU . . . . . . . . . . . . . 53.2 mt -67.8 148.19 51.56 Favored 'General case' 0 CA--C 1.558 1.253 0 CA-C-N 117.619 0.191 . . . . 70.51 111.026 -176.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 181' ' ' LEU . . . . . . . . . . . . . 41.1 mt -53.23 167.75 0.41 Allowed Pre-proline 0 N--CA 1.5 2.068 0 C-N-CA 125.671 1.588 . . . . 74.2 113.827 -171.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -61.66 68.7 0.1 Allowed 'Trans proline' 0 C--N 1.393 2.9 0 C-N-CA 122.861 2.374 . . . . 64.12 110.252 161.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 183' ' ' HIS . . . . . 0.407 ' N ' ' HD3' ' C' ' 184' ' ' PRO . 81.6 t60 172.85 47.52 0.01 OUTLIER Pre-proline 0 CA--C 1.562 1.404 0 C-N-CA 129.031 2.932 . . . . 62.13 104.503 -167.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 184' ' ' PRO . . . . . 0.407 ' HD3' ' N ' ' C' ' 183' ' ' HIS . 85.8 Cg_endo -95.05 63.89 0.23 Allowed 'Trans proline' 0 C--N 1.387 2.573 0 C-N-CA 122.395 2.064 . . . . 71.54 109.713 -167.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 185' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 9.8 t -92.85 -23.02 5.66 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.476 0 CA-C-N 114.748 -1.114 . . . . 72.23 109.271 -168.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 186' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -130.68 101.03 5.51 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 118.746 0.703 . . . . 61.44 110.945 -175.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 187' ' ' ARG . . . . . . . . . . . . . 40.7 ttt85 -94.57 117.27 29.86 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 114.494 -1.23 . . . . 75.14 108.066 171.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 188' ' ' LEU . . . . . 0.515 HD13 ' HD2' ' C' ' 240' ' ' PHE . 61.5 tp -82.03 145.95 29.95 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 121.489 0.661 . . . . 74.14 111.824 -179.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 189' ' ' GLU . . . . . 0.427 ' HA ' ' NE ' ' C' ' 154' ' ' ARG . 31.2 tt0 -143.71 111.98 6.32 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 107.064 -1.458 . . . . 71.33 107.064 164.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 67.49 -100.51 0.61 Allowed Glycine 0 C--N 1.35 1.316 0 N-CA-C 111.271 -0.732 . . . . 74.2 111.271 -171.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 191' ' ' GLN . . . . . 0.482 ' HA ' HD11 ' C' ' 188' ' ' LEU . 48.9 mt-30 -125.61 -6.27 6.93 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.531 0.732 . . . . 60.21 111.136 171.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -84.8 138.99 32.26 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 122.892 0.477 . . . . 65.13 110.475 179.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 193' ' ' LEU . . . . . 0.494 HD21 ' CD2' ' C' ' 240' ' ' PHE . 90.4 mt -101.49 163.61 12.18 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.408 0.623 . . . . 52.2 111.142 178.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 194' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -129.82 115.4 17.19 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 114.59 -1.186 . . . . 75.43 108.915 172.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 195' ' ' ALA . . . . . 0.531 ' HA ' ' O ' ' C' ' 185' ' ' VAL . . . -114.59 -178.32 3.34 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.73 0.812 . . . . 65.11 111.242 176.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 196' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' C' ' 252' ' ' GLU . 78.1 m -136.32 114.53 11.57 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 108.27 -1.011 . . . . 51.32 108.27 164.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 197' ' ' LEU . . . . . . . . . . . . . 45.7 tp -88.85 132.57 34.6 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 123.814 0.846 . . . . 73.5 110.542 -176.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -88.22 105.32 17.46 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 108.551 -0.907 . . . . 44.52 108.551 175.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 199' ' ' VAL . . . . . 0.592 HG21 ' HH2' ' B' ' 242' ' ' TRP . 51.2 t -115.22 118.5 39.92 Favored Pre-proline 0 N--CA 1.469 0.504 0 N-CA-C 108.019 -1.104 . . . . 61.21 108.019 177.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 200' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.69 138.36 31.8 Favored 'Trans proline' 0 C--N 1.372 1.785 0 C-N-CA 121.76 1.64 . . . . 71.34 110.612 175.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 201' ' ' ALA . . . . . 0.404 ' O ' HG23 ' C' ' 205' ' ' VAL . . . -41.47 -48.14 9.19 Favored Pre-proline 0 CA--C 1.562 1.411 0 N-CA-C 115.363 1.616 . . . . 74.35 115.363 178.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 202' ' ' PRO . . . . . 0.443 ' HB2' ' HA ' ' A' ' 273' ' ' ALA . 11.9 Cg_endo -53.36 -54.46 4.92 Favored 'Trans proline' 0 C--N 1.386 2.548 0 CA-C-N 121.281 1.493 . . . . 63.15 112.638 176.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 203' ' ' ILE . . . . . . . . . . . . . 63.9 mt -63.74 -29.88 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 123.197 0.599 . . . . 63.4 110.703 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.96 -35.79 78.98 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.995 0.918 . . . . 75.02 112.377 179.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 205' ' ' VAL . . . . . 0.551 HG22 HD13 ' A' ' 257' ' ' ILE . 46.3 t -80.04 -42.8 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 CA-C-O 119.355 -0.355 . . . . 63.41 111.675 179.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 206' ' ' VAL . . . . . . . . . . . . . 10.9 p -80.18 -36.84 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 112.558 0.577 . . . . 52.12 112.558 -172.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 83.31 89.45 0.73 Allowed Glycine 0 C--N 1.344 1.024 0 N-CA-C 111.755 -0.538 . . . . 63.21 111.755 -166.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 208' ' ' GLY . . . . . . . . . . . . . . . -127.8 -129.55 3.23 Favored Glycine 0 C--N 1.344 1.006 0 N-CA-C 111.03 -0.828 . . . . 51.32 111.03 177.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 209' ' ' LYS . . . . . 0.581 ' HG2' ' HA ' ' C' ' 222' ' ' ALA . 5.9 mtmp? -136.3 146.95 47.19 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 117.711 0.756 . . . . 72.12 111.71 170.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 210' ' ' VAL . . . . . 0.429 HG21 HG22 ' C' ' 199' ' ' VAL . 33.4 m -128.67 168.22 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 125.225 1.41 . . . . 62.05 107.678 169.075 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 211' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -106.19 136.43 45.91 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 118.117 0.417 . . . . 72.44 111.391 -177.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 212' ' ' ALA . . . . . 0.532 ' HB3' HG13 ' C' ' 219' ' ' VAL . . . -120.56 120.72 36.64 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 107.6 -1.259 . . . . 74.43 107.6 171.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 213' ' ' MET . . . . . 0.426 ' SD ' ' N ' ' C' ' 214' ' ' THR . 8.7 tmm? -71.98 146.38 47.77 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.431 -0.951 . . . . 63.12 108.431 173.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 214' ' ' THR . . . . . 0.561 HG21 ' HD2' ' C' ' 238' ' ' LYS . 0.1 OUTLIER -141.79 168.85 18.78 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 119.035 0.834 . . . . 54.24 112.333 178.165 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 215' ' ' LEU . . . . . 0.551 ' HA ' ' HG3' ' C' ' 128' ' ' GLU . 30.8 mt -62.8 -35.78 80.99 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 124.566 1.146 . . . . 44.41 113.444 -166.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.48 -2.21 15.61 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 114.546 -1.207 . . . . 71.0 111.495 -171.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 164.37 -168.16 38.61 Favored Glycine 0 C--O 1.21 -1.363 0 CA-C-O 119.6 -0.556 . . . . 64.11 111.786 -174.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -94.41 165.42 1.91 Allowed 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 122.302 2.001 . . . . 52.13 112.554 171.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 219' ' ' VAL . . . . . 0.631 ' HB ' ' HE3' ' C' ' 238' ' ' LYS . 2.2 p -142.96 112.9 2.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 108.073 -1.084 . . . . 52.53 108.073 168.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 220' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -90.78 108.12 19.62 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 108.277 -1.009 . . . . 72.32 108.277 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 221' ' ' VAL . . . . . 0.511 ' HA ' ' HB2' ' B' ' 239' ' ' ALA . 39.4 t -71.33 127.15 32.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 114.012 -1.449 . . . . 74.03 112.767 -171.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 222' ' ' ALA . . . . . 0.581 ' HA ' ' HG2' ' C' ' 209' ' ' LYS . . . -81.41 109.09 15.57 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 123.713 0.633 . . . . 73.3 109.346 169.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 58.1 t -82.02 139.6 46.13 Favored Pre-proline 0 CA--C 1.558 1.263 0 C-N-CA 124.282 1.033 . . . . 73.11 110.116 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 224' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -84.93 160.81 11.86 Favored 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 122.929 2.419 . . . . 54.33 111.938 170.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 225' ' ' PRO . . . . . 0.538 ' HD3' HG22 ' B' ' 246' ' ' THR . 25.7 Cg_exo -63.36 140.57 77.33 Favored 'Trans proline' 0 C--N 1.372 1.779 0 C-N-CA 122.247 1.965 . . . . 74.0 110.828 169.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 226' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? 70.0 83.62 0.15 Allowed 'General case' 0 N--CA 1.483 1.189 0 O-C-N 124.403 1.065 . . . . 70.15 111.174 177.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 227' ' ' THR . . . . . 0.604 HG22 HD11 ' C' ' 255' ' ' ILE . 52.7 m -128.1 122.05 31.11 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.874 -0.603 . . . . 70.3 112.404 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 228' ' ' GLN . . . . . 0.452 HE21 HG13 ' A' ' 257' ' ' ILE . 26.1 mp0 -108.89 162.28 14.35 Favored 'General case' 0 C--O 1.253 1.259 0 CA-C-O 122.615 1.197 . . . . 74.32 111.152 168.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 229' ' ' ALA . . . . . 0.432 ' HB2' ' H ' ' C' ' 255' ' ' ILE . . . -65.64 138.29 57.91 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 112.934 -1.939 . . . . 62.12 109.32 175.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 101.56 -4.79 54.21 Favored Glycine 0 CA--C 1.523 0.574 0 CA-C-O 119.616 -0.547 . . . . 62.04 113.012 -174.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 231' ' ' ARG . . . . . . . . . . . . . 43.1 mtt85 -70.19 171.3 9.97 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 108.567 -0.901 . . . . 74.12 108.567 162.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 232' ' ' LYS . . . . . 0.505 ' HA ' ' O ' ' C' ' 251' ' ' LEU . 32.6 ttmt -155.48 126.18 6.92 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.274 0.559 . . . . 71.45 111.744 -178.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 233' ' ' LEU . . . . . 0.631 HD13 ' HB2' ' C' ' 251' ' ' LEU . 4.5 mp -84.92 155.03 21.84 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 114.762 -1.108 . . . . 74.21 110.712 -178.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 234' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -122.78 100.62 7.0 Favored 'General case' 0 CA--C 1.55 0.953 0 O-C-N 125.099 1.5 . . . . 72.34 108.941 165.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 235' ' ' LEU . . . . . 0.448 HD13 HG21 ' C' ' 219' ' ' VAL . 61.3 mt -95.22 114.88 26.72 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.495 0.718 . . . . 73.43 109.165 176.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -71.83 130.82 42.0 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.795 0.838 . . . . 71.55 111.899 -174.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 85.01 -12.81 57.0 Favored Glycine 0 C--N 1.352 1.426 0 CA-C-N 116.029 -0.532 . . . . 71.42 113.123 178.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 238' ' ' LYS . . . . . 0.631 ' HE3' ' HB ' ' C' ' 219' ' ' VAL . 68.5 mmtt -92.25 13.13 20.1 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.743 0.817 . . . . 72.03 112.279 -172.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 239' ' ' GLY . . . . . . . . . . . . . . . -80.16 -163.25 27.77 Favored Glycine 0 C--N 1.352 1.462 0 N-CA-C 110.992 -0.843 . . . . 31.21 110.992 164.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 240' ' ' PHE . . . . . 0.515 ' HD2' HD13 ' C' ' 188' ' ' LEU . 1.9 m-85 -73.21 124.23 90.36 Favored Pre-proline 0 C--O 1.249 1.036 0 CA-C-N 118.167 0.983 . . . . 75.14 109.141 175.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 241' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' C' ' 240' ' ' PHE . 39.4 Cg_exo -63.51 107.28 0.69 Allowed 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 123.353 2.702 . . . . 70.21 114.381 178.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . -79.41 158.3 43.44 Favored Glycine 0 C--N 1.341 0.834 0 CA-C-O 118.904 -0.942 . . . . 70.14 111.371 168.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -57.31 -30.1 86.43 Favored 'Trans proline' 0 C--N 1.374 1.89 0 C-N-CA 123.53 2.82 . . . . 71.42 113.826 -170.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -134.27 17.55 3.72 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.023 0.529 . . . . 71.42 111.439 -177.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 175.77 115.29 0.41 Allowed Glycine 0 C--N 1.346 1.116 0 N-CA-C 111.761 -0.535 . . . . 51.32 111.761 -178.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 246' ' ' ARG . . . . . . . . . . . . . 52.4 mtm180 -82.21 156.33 24.46 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.508 0.723 . . . . 61.31 110.264 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -82.24 -160.93 28.17 Favored Glycine 0 N--CA 1.479 1.509 0 N-CA-C 113.825 0.29 . . . . 63.23 113.825 178.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -133.41 133.31 42.2 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 121.539 0.685 . . . . 73.54 110.647 -175.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 249' ' ' LEU . . . . . 0.439 HD23 HD12 ' C' ' 235' ' ' LEU . 19.2 tp -88.96 129.5 35.62 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.108 0.963 . . . . 74.23 110.85 -175.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 250' ' ' TYR . . . . . 0.588 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 26.8 m-85 -112.38 101.62 9.81 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.856 0.863 . . . . 71.43 110.092 177.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 251' ' ' LEU . . . . . 0.631 ' HB2' HD13 ' C' ' 233' ' ' LEU . 3.3 mp -96.94 117.1 30.4 Favored 'General case' 0 N--CA 1.504 2.249 0 C-N-CA 120.845 -0.342 . . . . 64.53 110.59 -175.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 252' ' ' GLU . . . . . 0.424 ' O ' ' HA ' ' C' ' 196' ' ' THR . 6.3 tp10 -70.55 128.94 37.86 Favored 'General case' 0 C--O 1.218 -0.578 0 N-CA-C 108.522 -0.918 . . . . 73.41 108.522 170.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 253' ' ' VAL . . . . . . . . . . . . . 78.1 t -85.41 140.27 16.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 O-C-N 121.815 -0.553 . . . . 73.5 111.306 -174.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 254' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 -128.81 121.57 28.59 Favored 'General case' 0 C--N 1.346 0.456 0 C-N-CA 124.337 1.055 . . . . 74.13 108.899 169.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 255' ' ' ILE . . . . . 0.604 HD11 HG22 ' C' ' 227' ' ' THR . 38.7 mm -87.7 125.97 41.28 Favored 'Isoleucine or valine' 0 C--N 1.344 0.328 0 CA-C-N 115.854 -0.612 . . . . 75.24 109.775 178.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 256' ' ' THR . . . . . . . . . . . . . 43.9 p -121.61 -174.8 2.94 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.024 0.93 . . . . 53.32 111.027 -173.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 257' ' ' ILE . . . . . 0.466 HD12 ' H ' ' C' ' 259' ' ' GLU . 2.8 pp -140.0 156.45 70.43 Favored Pre-proline 0 CA--C 1.561 1.381 0 C-N-CA 123.408 0.683 . . . . 64.54 110.815 -176.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -56.5 -10.86 5.56 Favored 'Trans proline' 0 C--N 1.387 2.576 0 C-N-CA 124.046 3.164 . . . . 73.21 115.795 -174.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 259' ' ' GLU . . . . . 0.466 ' H ' HD12 ' C' ' 257' ' ' ILE . 50.6 mt-10 53.87 -84.62 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 124.772 1.229 . . . . 72.3 110.006 -163.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 260' ' ' ARG . . . . . 0.406 ' H ' ' HG3' ' C' ' 260' ' ' ARG . 0.0 OUTLIER -73.28 155.68 39.24 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.012 0.925 . . . . 73.41 110.827 176.765 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 261' ' ' LEU . . . . . 0.571 ' HG ' HH12 ' A' ' 226' ' ' ARG . 85.2 mt -130.97 141.36 50.25 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.297 0.639 . . . . 71.21 110.161 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 80.6 p -84.65 164.66 41.57 Favored Pre-proline 0 CA--C 1.558 1.279 0 N-CA-C 107.812 -1.181 . . . . 61.23 107.812 166.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -45.61 -41.87 18.82 Favored 'Trans proline' 0 C--N 1.387 2.574 0 C-N-CA 122.783 2.322 . . . . 74.2 113.776 176.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -55.25 -63.37 1.18 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.037 1.335 . . . . 71.04 111.056 175.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -58.4 -41.46 84.95 Favored 'General case' 0 C--N 1.348 0.525 0 CA-C-N 114.442 -1.253 . . . . 65.11 110.719 -176.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 266' ' ' GLU . . . . . 0.568 ' HA ' HD13 ' C' ' 261' ' ' LEU . 11.0 tp10 -56.31 -51.64 67.47 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.908 0.883 . . . . 64.21 110.43 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -59.44 -49.99 75.68 Favored 'General case' 0 CA--C 1.553 1.085 0 CA-C-N 115.747 -0.66 . . . . 70.32 112.114 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 268' ' ' LEU . . . . . . . . . . . . . 10.3 mp -71.4 -38.31 71.47 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 112.536 0.569 . . . . 52.44 112.536 -174.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 269' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -70.98 -30.21 66.41 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 122.629 0.371 . . . . 61.11 111.09 177.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 26.8 mmtp -68.14 -40.45 82.44 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 122.913 0.485 . . . . 75.43 111.172 173.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 271' ' ' LYS . . . . . 0.5 ' HB3' HD21 ' A' ' 268' ' ' LEU . 3.4 mmtm -64.14 -41.3 97.25 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 121.048 0.451 . . . . 75.33 111.256 175.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 72.7 mt -61.41 -42.31 98.54 Favored 'General case' 0 C--O 1.217 -0.649 0 CA-C-N 115.728 -0.669 . . . . 74.33 110.177 172.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 273' ' ' ALA . . . . . 0.472 ' HB2' HG21 ' A' ' 206' ' ' VAL . . . -56.51 -43.09 79.41 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.07 0.548 . . . . 34.13 110.899 -179.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -58.66 -52.15 66.9 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.177 0.991 . . . . 63.21 110.845 174.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -57.88 -28.92 64.62 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 115.05 -0.977 . . . . 70.04 112.09 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 276' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -95.87 -17.23 21.27 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.532 0.733 . . . . 75.52 111.943 -179.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 277' ' ' TYR . . . . . . . . . . . . . 19.5 m-30 -67.41 -33.88 76.1 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.544 -0.91 . . . . 44.24 108.544 168.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 278' ' ' ALA . . . . . . . . . . . . . . . -71.66 -1.05 12.37 Favored 'General case' 0 CA--C 1.557 1.228 0 CA-C-N 114.671 -1.15 . . . . 55.2 112.737 173.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 279' ' ' ARG . . . . . . . . . . . . . 30.2 mtp-105 -99.63 -1.71 37.37 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.403 0.681 . . . . 71.52 110.973 171.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.051 0 CA-C-O 118.551 -0.738 . . . . 75.14 109.722 175.671 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.6 mtp . . . . . 0 N--CA 1.476 0.837 0 N-CA-C 109.197 -0.668 . . . . 64.12 109.197 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.8 23.92 14.26 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.465 1.106 . . . . 51.4 111.957 178.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -83.57 65.44 8.45 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.433 0.693 . . . . 74.04 110.672 -174.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -38.46 98.36 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.599 1.56 . . . . 62.43 114.288 -175.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.442 ' HZ2' ' HB3' ' A' ' 94' ' ' SER . 29.3 mmtp -73.18 97.66 2.46 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 107.766 -1.198 . . . . 74.32 107.766 164.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.515 ' HA ' ' OH ' ' A' ' 66' ' ' TYR . 14.3 t70 -74.06 90.55 2.01 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.562 -1.273 . . . . 61.41 107.562 174.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.416 ' HB2' HD11 ' A' ' 57' ' ' LEU . 48.9 m-85 -58.16 -31.69 67.49 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 113.919 -1.491 . . . . 73.34 112.264 -170.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -66.22 -44.56 83.48 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 122.822 0.449 . . . . 73.33 110.736 177.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.73 -41.83 99.36 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 122.992 0.517 . . . . 60.32 110.828 178.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.423 HD11 ' HD2' ' A' ' 5' ' ' LYS . 65.6 mt -58.73 -41.19 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 O-C-N 124.071 0.857 . . . . 74.23 110.683 177.096 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 87.6 mt -80.11 -12.21 59.69 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 112.681 0.622 . . . . 51.33 112.681 177.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.86 17.85 78.61 Favored Glycine 0 C--N 1.349 1.267 0 O-C-N 122.958 0.161 . . . . 53.33 113.403 -176.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.9 m -101.34 154.4 37.24 Favored Pre-proline 0 N--CA 1.482 1.144 0 C-N-CA 124.075 0.95 . . . . 71.43 109.623 174.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -58.5 154.56 41.21 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 122.695 2.263 . . . . 50.12 113.534 176.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 79.0 mtt180 -77.02 66.7 2.89 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.184 0.994 . . . . 75.43 109.797 177.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -178.86 -25.24 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 114.629 -1.169 . . . . 64.11 109.088 -168.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.21 133.32 39.48 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 125.098 1.359 . . . . 64.31 113.338 -174.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.439 ' O ' HD13 ' A' ' 22' ' ' ILE . 51.1 p -78.44 172.98 12.85 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.768 0.827 . . . . 71.11 111.16 179.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 22.7 tm0? -50.4 -37.26 36.69 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.814 1.246 . . . . 64.21 111.016 176.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.446 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 0.3 OUTLIER -61.47 -47.56 85.09 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 124.502 1.121 . . . . 72.43 110.217 -179.522 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -70.32 -34.52 72.78 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.308 1.043 . . . . 64.03 111.211 -178.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.439 HD13 ' O ' ' A' ' 18' ' ' THR . 1.5 mp -64.6 -36.96 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.375 1.07 . . . . 73.31 110.04 174.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -73.42 -30.47 63.26 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.766 0.826 . . . . 71.24 110.42 179.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.446 ' HG3' ' O ' ' A' ' 20' ' ' GLU . 95.3 mtt180 -62.02 -54.67 38.24 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.296 0.57 . . . . 54.12 110.031 172.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.8 -34.29 72.84 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 114.541 -1.208 . . . . 64.0 111.61 178.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -62.82 -49.95 72.92 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.957 0.903 . . . . 73.1 111.12 176.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.438 ' HE2' ' HA ' ' A' ' 24' ' ' ARG . 49.5 mtmt -57.57 -55.15 38.55 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 109.799 -0.445 . . . . 74.22 109.799 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.7 ttp-105 -52.57 -65.89 0.48 Allowed 'General case' 0 N--CA 1.479 1.022 0 O-C-N 123.825 0.703 . . . . 71.15 111.523 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.732 ' HB3' HD13 ' A' ' 50' ' ' ILE . 95.4 mt -72.23 -48.7 40.85 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.186 -0.915 . . . . 74.11 112.434 -170.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.75 -15.54 59.73 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 112.872 0.693 . . . . 63.3 112.872 -173.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -81.3 -40.24 23.96 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 119.187 0.903 . . . . 72.33 109.57 165.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -63.43 -33.94 76.65 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 115.46 -0.791 . . . . 63.33 111.84 -179.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.439 ' HB3' ' O ' ' A' ' 43' ' ' ALA . 21.7 m-85 -111.6 15.97 20.85 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.89 0.876 . . . . 63.25 110.474 -175.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -69.8 119.35 70.72 Favored Pre-proline 0 C--N 1.352 0.685 0 C-N-CA 123.492 0.717 . . . . 63.41 109.332 -176.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.453 ' HG3' ' HG2' ' A' ' 44' ' ' GLU . 32.6 Cg_exo -60.51 -8.66 9.34 Favored 'Trans proline' 0 C--N 1.373 1.829 0 C-N-CA 123.12 2.547 . . . . 74.13 114.369 -178.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -73.56 -43.74 59.1 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.965 0.506 . . . . 72.45 110.601 170.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 52.3 t -95.75 -63.66 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 123.286 0.634 . . . . 65.53 110.168 -177.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -98.28 80.58 2.67 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 122.303 1.049 . . . . 61.35 109.223 -173.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -76.43 81.45 3.15 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 114.205 -1.361 . . . . 73.11 109.638 178.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 69.8 m -140.43 113.94 7.38 Favored Pre-proline 0 N--CA 1.475 0.78 0 C-N-CA 124.152 0.981 . . . . 54.41 108.439 174.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -40.82 -46.17 4.86 Favored 'Trans proline' 0 C--N 1.387 2.568 0 C-N-CA 124.31 3.34 . . . . 72.23 114.05 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.401 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 6.4 tm-20 -54.37 -50.43 67.52 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.679 1.192 . . . . 64.43 109.924 177.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.439 ' O ' ' HB3' ' A' ' 33' ' ' TYR . . . -62.55 -31.86 72.73 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 115.121 -0.945 . . . . 72.14 110.691 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.639 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 47.9 mt-10 -77.4 -34.4 54.82 Favored 'General case' 0 C--O 1.217 -0.626 0 O-C-N 123.75 0.656 . . . . 62.01 109.945 -173.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -65.59 -44.22 87.32 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.533 0.733 . . . . 62.44 109.932 174.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 42' ' ' GLU . 13.3 mmmm -58.13 -44.94 88.07 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 123.772 0.67 . . . . 74.03 109.869 174.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -58.96 -38.97 80.29 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.085 1.354 . . . . 73.24 110.968 178.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.639 ' HG2' ' O ' ' A' ' 44' ' ' GLU . 32.9 mmtp -66.55 -43.45 85.04 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 122.688 0.395 . . . . 75.14 110.925 179.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -58.59 -42.54 88.3 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 123.855 0.722 . . . . 71.44 111.184 175.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.732 HD13 ' HB3' ' A' ' 29' ' ' LEU . 62.3 mt -76.1 -28.68 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 124.935 1.294 . . . . 70.53 111.321 -176.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.422 ' HA ' ' HB3' ' A' ' 54' ' ' TYR . 13.7 m-80 -93.61 -5.65 48.31 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.587 0.755 . . . . 73.43 111.421 175.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -77.01 -53.47 7.77 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 107.49 -1.3 . . . . 63.42 107.49 164.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.18 -37.09 76.53 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 112.962 -1.927 . . . . 65.45 111.133 176.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.422 ' HB3' ' HA ' ' A' ' 51' ' ' ASN . 61.4 t80 -73.43 -47.27 43.04 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-O 118.811 -0.614 . . . . 72.32 110.537 173.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -50.27 -36.18 30.31 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 123.231 0.613 . . . . 53.01 112.368 -178.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.527 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 61.3 t -78.74 -67.48 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 CA-C-N 114.697 -1.138 . . . . 74.52 110.025 175.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.466 HD22 ' HG2' ' A' ' 63' ' ' ARG . 46.3 mt -80.09 4.59 16.74 Favored 'General case' 0 CA--C 1.564 1.483 0 N-CA-C 113.484 0.92 . . . . 62.04 113.484 -165.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.5 t -76.24 -25.0 54.57 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 123.875 0.87 . . . . 74.34 110.275 174.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -109.99 117.47 51.87 Favored Pre-proline 0 N--CA 1.449 -0.524 0 N-CA-C 107.142 -1.429 . . . . 74.34 107.142 176.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.447 ' O ' ' HG2' ' A' ' 64' ' ' ARG . 84.0 Cg_exo -46.96 -26.47 4.89 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 123.147 2.565 . . . . 72.41 113.318 171.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -63.62 -61.21 2.47 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 122.962 0.505 . . . . 72.3 111.274 175.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.527 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 34.8 mttp -66.79 -26.72 67.09 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 122.375 0.27 . . . . 74.54 111.029 -178.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.466 ' HG2' HD22 ' A' ' 57' ' ' LEU . 4.2 tmt_? -61.58 -48.17 82.2 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.845 1.258 . . . . 74.11 108.826 176.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.447 ' HG2' ' O ' ' A' ' 60' ' ' PRO . 19.7 mmm180 -67.1 -33.84 76.33 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.516 -0.765 . . . . 74.25 111.717 176.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.436 HD12 ' HA ' ' A' ' 62' ' ' LYS . 84.5 mt -60.49 -42.87 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 C-N-CA 123.077 0.551 . . . . 64.42 110.169 176.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.515 ' OH ' ' HA ' ' A' ' 6' ' ' ASP . 32.5 t80 -62.76 -51.92 65.23 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.623 -0.717 . . . . 75.4 110.068 175.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -54.17 -41.48 68.57 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 123.826 0.704 . . . . 64.04 111.271 -178.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 68.7 p -79.07 -22.39 45.37 Favored 'General case' 0 C--N 1.348 0.506 0 CA-C-N 115.637 -0.711 . . . . 75.13 111.931 -178.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -70.9 112.46 7.1 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 109.186 -0.672 . . . . 63.45 109.186 177.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 111.34 9.34 21.95 Favored Glycine 0 N--CA 1.473 1.109 0 CA-C-N 115.832 -0.622 . . . . 52.54 111.638 -170.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.8 m -141.44 -59.4 0.48 Allowed 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 104.177 -2.527 . . . . 71.23 104.177 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.5 m -76.64 141.81 40.87 Favored 'General case' 0 C--O 1.252 1.232 0 N-CA-C 104.472 -2.418 . . . . 74.23 104.472 155.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.66 -49.38 6.32 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.243 0.617 . . . . 74.04 111.219 -178.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -97.08 142.49 24.61 Favored Pre-proline 0 N--CA 1.477 0.893 0 C-N-CA 123.037 0.535 . . . . 75.1 110.441 -174.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.421 ' HB2' ' HG3' ' A' ' 103' ' ' PRO . 37.2 Cg_exo -59.34 151.85 65.03 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 123.114 2.543 . . . . 75.41 112.697 174.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.05 158.86 45.52 Favored 'Trans proline' 0 C--N 1.377 2.053 0 C-N-CA 123.216 2.611 . . . . 74.25 114.36 -175.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.96 120.26 7.96 Favored 'Trans proline' 0 C--N 1.386 2.54 0 C-N-CA 123.221 2.614 . . . . 62.44 112.198 171.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.45 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 60.3 Cg_endo -69.18 118.31 5.6 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 122.859 2.372 . . . . 43.51 112.087 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.588 ' HB2' ' HA3' ' A' ' 142' ' ' GLY . 6.5 Cg_exo -74.16 165.62 31.52 Favored 'Trans proline' 0 CA--C 1.566 2.115 0 C-N-CA 122.868 2.378 . . . . 71.05 111.726 178.151 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_exo -51.91 85.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.393 2.913 0 C-N-CA 123.921 3.081 . . . . 51.35 114.428 -176.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 141.29 -44.89 0.99 Allowed Glycine 0 C--N 1.338 0.69 0 N-CA-C 109.767 -1.333 . . . . 62.41 109.767 178.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.42 -168.19 33.27 Favored Glycine 0 C--N 1.351 1.399 0 C-N-CA 123.38 0.514 . . . . 53.03 113.535 176.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -70.14 100.48 1.66 Allowed 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.476 1.11 . . . . 74.41 110.215 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.472 ' HB3' ' NE ' ' A' ' 143' ' ' ARG . 32.6 t0 -60.84 115.82 3.97 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.84 0.856 . . . . 71.31 109.783 173.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -112.9 70.24 0.71 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.458 1.103 . . . . 70.22 108.374 -174.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 16.1 m -44.57 86.56 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 126.232 1.813 . . . . 74.44 115.479 -164.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 65.44 23.39 70.21 Favored Glycine 0 C--N 1.353 1.489 0 CA-C-N 115.496 -0.774 . . . . 70.11 114.741 173.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -102.4 136.25 42.56 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 109.617 -0.512 . . . . 72.34 109.617 -178.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -77.37 91.16 3.83 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 122.111 -0.368 . . . . 71.44 110.033 -175.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.4 p -34.69 -56.65 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 115.019 1.488 . . . . 75.21 115.019 175.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -64.4 -26.32 68.41 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 118.363 0.529 . . . . 75.33 112.369 -178.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -79.85 -21.04 44.6 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.614 0.765 . . . . 45.35 111.006 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -94.82 170.33 9.51 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 107.974 -1.121 . . . . 71.01 107.974 177.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.442 ' HB3' ' HZ2' ' A' ' 5' ' ' LYS . 80.4 p -60.3 149.65 32.84 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 113.826 1.047 . . . . 74.5 113.826 -165.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.42 ' O ' ' HG3' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -61.06 -30.16 70.16 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 114.893 -1.049 . . . . 74.31 110.486 168.127 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -57.83 -45.07 86.7 Favored 'General case' 0 C--N 1.355 0.812 0 C-N-CA 124.002 0.921 . . . . 75.03 110.838 172.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -63.5 -44.54 94.02 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 115.311 -0.859 . . . . 63.23 109.729 175.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.414 ' HA ' HD11 ' A' ' 105' ' ' LEU . 51.1 mt-30 -68.47 -9.8 51.26 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 115.963 -0.562 . . . . 73.05 111.917 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.42 ' HG3' ' O ' ' A' ' 95' ' ' GLU . 38.7 mt-10 -88.78 -59.29 2.27 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 124.119 0.968 . . . . 70.02 111.208 165.099 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 33.8 tp -60.83 -35.67 77.13 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.943 1.297 . . . . 55.03 112.474 -167.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -116.14 6.43 13.95 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.117 0.567 . . . . 72.11 110.67 176.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -42.84 -57.99 3.81 Favored Glycine 0 C--N 1.357 1.721 0 C-N-CA 124.629 1.109 . . . . 72.43 115.131 177.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.421 ' HG3' ' HB2' ' A' ' 75' ' ' PRO . 28.3 Cg_endo -56.88 -19.08 30.17 Favored 'Trans proline' 0 C--N 1.39 2.752 0 C-N-CA 123.264 2.643 . . . . 23.1 113.377 -173.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -142.1 39.89 1.34 Allowed Glycine 0 C--N 1.354 1.563 0 CA-C-O 119.718 -0.49 . . . . 44.4 112.426 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.466 ' HB3' ' ND2' ' A' ' 169' ' ' ASN . 48.6 mt -61.72 72.61 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 123.026 0.53 . . . . 74.25 111.487 169.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.612 ' HB3' ' HA ' ' A' ' 169' ' ' ASN . 2.2 t80 21.09 -106.12 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.432 0 C-N-CA 127.109 2.163 . . . . 72.25 112.774 -170.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 58.99 41.41 96.37 Favored Glycine 0 C--N 1.364 2.11 0 CA-C-O 119.744 -0.475 . . . . 44.0 112.644 178.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.846 ' HA3' ' HB3' ' A' ' 167' ' ' GLN . . . -14.11 -70.57 0.01 OUTLIER Glycine 0 C--N 1.367 2.269 0 C-N-CA 124.896 1.236 . . . . 71.34 114.887 165.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -86.42 72.46 10.3 Favored 'General case' 0 C--O 1.251 1.153 0 N-CA-C 108.783 -0.821 . . . . 64.11 108.783 169.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -13.39 -67.84 0.01 OUTLIER Glycine 0 C--N 1.368 2.319 0 C-N-CA 126.03 1.776 . . . . 55.25 115.324 170.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -4.88 -44.08 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.527 0 C-N-CA 127.447 2.299 . . . . 71.44 116.496 162.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.507 ' HG2' ' HB2' ' A' ' 114' ' ' ARG . 59.5 ttt180 -113.77 -35.28 5.21 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.427 0.691 . . . . 73.25 110.755 -172.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 33.0 m 54.51 31.46 14.88 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 124.17 0.988 . . . . 74.21 111.443 -176.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.507 ' HB2' ' HG2' ' A' ' 112' ' ' ARG . 7.6 mmt180 -148.11 -175.28 4.83 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.465 0.706 . . . . 74.52 110.922 -173.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -44.4 143.94 1.16 Allowed 'General case' 0 N--CA 1.479 1.008 0 O-C-N 125.45 1.719 . . . . 72.15 114.907 -163.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -90.22 -173.47 44.89 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-N 115.129 -0.941 . . . . 55.22 113.601 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -93.86 164.07 13.26 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 124.926 1.29 . . . . 71.34 109.572 -177.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -74.25 99.67 3.51 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 121.216 -0.927 . . . . 74.23 109.887 174.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 38.3 tp -95.5 141.19 29.32 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 121.039 0.447 . . . . 70.23 111.484 -167.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -93.0 122.18 35.09 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 107.184 -1.413 . . . . 74.51 107.184 169.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -129.9 168.99 15.77 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.399 -0.593 . . . . 41.51 109.399 176.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -128.91 115.4 17.8 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.482 -0.933 . . . . 61.0 108.482 -175.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 65.3 tp -99.59 100.39 10.71 Favored Pre-proline 0 N--CA 1.472 0.659 0 N-CA-C 108.432 -0.951 . . . . 54.05 108.432 -173.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.555 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 46.4 Cg_endo -67.41 135.86 37.96 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 121.587 1.525 . . . . 75.33 109.535 178.047 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.627 ' HA ' HG21 ' B' ' 6' ' ' ILE . 57.1 tp -146.66 154.93 42.03 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 118.467 0.576 . . . . 64.01 110.311 -176.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 48.5 m -84.67 145.24 28.07 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 124.536 1.134 . . . . 71.34 110.337 178.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.736 ' HB3' HD22 ' A' ' 215' ' ' LEU . 18.7 mt -55.83 -60.55 3.3 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.927 0.891 . . . . 70.54 112.233 -175.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -51.33 -46.37 62.6 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 114.447 -1.252 . . . . 75.32 110.836 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -70.48 -23.94 62.77 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.138 0.975 . . . . 64.33 111.997 -177.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -67.91 -48.01 67.17 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 123.198 0.599 . . . . 41.43 109.596 176.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.419 ' HA ' ' HA2' ' A' ' 152' ' ' GLY . 61.0 t80 -71.85 -28.92 63.88 Favored 'General case' 0 CA--C 1.556 1.199 0 O-C-N 124.015 0.822 . . . . 74.51 111.702 178.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 49.6 m170 -69.61 -53.43 18.85 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 122.663 0.385 . . . . 75.25 111.039 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.563 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 81.19 -167.7 49.65 Favored Glycine 0 CA--C 1.538 1.474 0 CA-C-N 116.266 -0.425 . . . . 71.54 113.199 -178.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.82 -175.75 23.46 Favored Glycine 0 N--CA 1.477 1.41 0 C-N-CA 123.563 0.601 . . . . 70.42 112.205 -179.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.467 ' HB3' ' HB3' ' A' ' 146' ' ' SER . 2.5 mp0 -72.16 108.8 5.53 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.696 -0.853 . . . . 73.14 108.696 176.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 17.8 tpt180 -91.47 127.05 36.76 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.625 -0.88 . . . . 74.4 108.625 -177.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.44 ' HB ' HG21 ' B' ' 5' ' ' THR . 61.6 t -72.7 118.04 17.2 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 N-CA-C 108.779 -0.822 . . . . 71.24 108.779 176.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.512 ' HB ' HG13 ' A' ' 145' ' ' VAL . 59.2 t -132.23 115.8 27.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 124.056 0.942 . . . . 73.14 109.236 -175.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -79.62 124.73 28.8 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 109.04 -0.726 . . . . 71.3 109.04 170.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.532 HG21 HD23 ' B' ' 8' ' ' LEU . 12.2 p -167.68 138.13 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 122.899 0.48 . . . . 75.1 110.57 172.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 64.66 12.3 7.45 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.933 1.293 . . . . 74.24 112.205 -178.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.588 ' HA3' ' HB2' ' A' ' 79' ' ' PRO . . . 76.05 20.41 77.6 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-N 116.562 -0.29 . . . . 31.1 113.132 -172.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.472 ' NE ' ' HB3' ' A' ' 84' ' ' ASP . 1.0 OUTLIER -123.85 114.32 19.71 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 107.926 -1.138 . . . . 72.12 107.926 175.866 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 55.0 ttt-85 -73.16 87.57 1.43 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.3 1.04 . . . . 74.41 109.357 176.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.512 HG13 ' HB ' ' A' ' 138' ' ' VAL . 5.7 p -86.06 134.48 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 123.572 0.749 . . . . 73.53 111.136 -176.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.467 ' HB3' ' HB3' ' A' ' 135' ' ' GLU . 15.2 m -94.41 84.86 4.43 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 114.879 -1.055 . . . . 31.45 108.515 174.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 90.0 t -79.92 108.84 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 N-CA-C 108.207 -1.034 . . . . 73.42 108.207 -177.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 50.5 ttt180 -76.23 92.87 3.32 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 109.116 -0.698 . . . . 74.14 109.116 -177.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.633 ' HB ' HG11 ' A' ' 153' ' ' VAL . 42.2 pt -80.1 137.96 53.04 Favored Pre-proline 0 CA--C 1.555 1.163 0 CA-C-N 114.481 -1.236 . . . . 74.13 109.266 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -62.56 141.58 86.74 Favored 'Trans proline' 0 C--N 1.374 1.888 0 C-N-CA 122.519 2.146 . . . . 60.34 112.245 176.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -58.88 93.79 0.08 OUTLIER 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 122.659 2.24 . . . . 74.15 111.045 170.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . 104.85 77.19 1.13 Allowed Glycine 0 C--N 1.335 0.524 0 CA-C-N 115.032 -0.986 . . . . 75.51 110.85 -172.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.633 HG11 ' HB ' ' A' ' 149' ' ' ILE . 5.8 p -135.01 103.37 4.3 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.239 0 C-N-CA 123.899 0.88 . . . . 75.43 109.248 174.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.618 ' HD2' HD11 ' A' ' 193' ' ' LEU . 60.5 mtt180 -113.32 173.74 6.25 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 113.3 0.852 . . . . 73.23 113.3 -166.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.53 ' HB2' ' HB2' ' A' ' 180' ' ' LEU . 8.6 tp10 -47.65 94.06 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 127.222 2.209 . . . . 72.32 113.965 -167.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 121.49 8.57 7.59 Favored Glycine 0 N--CA 1.478 1.471 0 CA-C-O 119.82 -0.433 . . . . 14.21 114.065 178.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 21.8 t -80.9 147.76 30.18 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 109.048 -0.723 . . . . 74.23 109.048 171.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 61.2 t -114.49 94.15 2.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 C-N-CA 123.584 0.754 . . . . 72.34 109.072 -178.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.594 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 51.7 mt -74.95 95.13 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 N-CA-C 108.212 -1.033 . . . . 75.24 108.212 173.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -79.94 118.01 21.3 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.395 -0.366 . . . . 61.32 110.127 179.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.5 p -118.08 108.89 41.6 Favored Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 123.653 0.781 . . . . 61.33 109.594 175.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -76.37 115.3 4.07 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 123.103 2.536 . . . . 74.53 111.141 175.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 125.56 -28.07 5.08 Favored Glycine 0 CA--C 1.507 -0.458 0 N-CA-C 111.205 -0.758 . . . . 70.43 111.205 176.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 87.9 mtp -94.77 144.21 25.82 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 105.229 -2.137 . . . . 64.15 105.229 162.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 171.4 -124.79 1.14 Allowed Glycine 0 CA--C 1.498 -0.995 0 C-N-CA 121.724 -0.274 . . . . 73.33 112.434 175.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -68.93 160.98 52.11 Favored Glycine 0 C--O 1.245 0.787 0 O-C-N 124.508 0.769 . . . . 74.5 111.967 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.846 ' HB3' ' HA3' ' A' ' 108' ' ' GLY . 31.9 mm-40 -68.87 104.58 2.09 Favored 'General case' 0 CA--C 1.55 0.972 0 O-C-N 125.142 1.143 . . . . 75.42 111.706 -169.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -171.33 162.57 35.24 Favored Glycine 0 C--N 1.344 1.016 0 CA-C-O 118.762 -1.021 . . . . 64.21 112.182 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . 0.622 ' HB3' ' HD3' ' A' ' 170' ' ' PRO . 49.5 t-20 -56.54 -58.69 15.43 Favored Pre-proline 0 N--CA 1.503 2.214 0 CA-C-O 118.288 -0.863 . . . . 63.11 110.571 -171.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.622 ' HD3' ' HB3' ' A' ' 169' ' ' ASN . 12.8 Cg_endo -91.6 97.21 0.21 Allowed 'Trans proline' 0 C--N 1.383 2.376 0 N-CA-C 107.779 -1.662 . . . . 71.13 107.779 157.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.43 165.3 3.32 Favored 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 122.502 2.134 . . . . 71.25 113.861 -170.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -69.0 -118.34 0.03 OUTLIER Glycine 0 N--CA 1.484 1.881 0 N-CA-C 115.401 0.92 . . . . 72.4 115.401 -170.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -135.7 118.89 16.56 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 107.667 -1.234 . . . . 71.14 107.667 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 11.2 tp -105.58 132.46 51.71 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.082 0.467 . . . . 64.32 111.303 -166.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 58.9 mt -108.37 94.69 5.2 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 114.915 -1.039 . . . . 72.12 108.445 176.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.594 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 72.2 mt -78.5 93.84 4.85 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.564 -0.744 . . . . 70.05 109.732 -179.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.0 t -83.4 96.76 4.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 107.498 -1.297 . . . . 61.43 107.498 176.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 12.8 p -65.76 110.37 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.083 0 CA-C-N 115.009 -0.996 . . . . 70.33 111.032 -172.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.555 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 38.8 mmm-85 -96.88 96.14 8.33 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 114.817 -1.083 . . . . 53.32 109.677 179.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.53 ' HB2' ' HB2' ' A' ' 155' ' ' GLU . 29.3 mt -69.59 151.21 46.23 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 122.423 -0.173 . . . . 72.4 110.895 178.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 99.3 mt -51.63 143.08 21.64 Favored Pre-proline 0 N--CA 1.481 1.076 0 C-N-CA 124.173 0.989 . . . . 73.14 111.489 -175.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.2 86.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.387 2.582 0 C-N-CA 123.475 2.784 . . . . 71.42 112.407 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.506 ' HA ' ' HD3' ' A' ' 184' ' ' PRO . 16.3 t-80 -136.96 112.69 9.64 Favored Pre-proline 0 CA--C 1.546 0.823 0 N-CA-C 107.0 -1.482 . . . . 73.35 107.0 -178.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.506 ' HD3' ' HA ' ' A' ' 183' ' ' HIS . 14.2 Cg_exo -70.35 27.05 0.19 Allowed 'Trans proline' 0 CA--C 1.556 1.611 0 C-N-CA 124.42 3.413 . . . . 61.24 117.916 -162.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 14.5 t -94.66 -60.08 2.76 Favored 'Isoleucine or valine' 0 C--N 1.364 1.225 0 CA-C-N 121.102 1.774 . . . . 64.21 109.13 177.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . 0.434 ' HB3' HD21 ' A' ' 193' ' ' LEU . 48.7 m-85 -109.29 140.92 42.33 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 114.765 1.394 . . . . 72.31 114.765 -164.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 7.9 tpp180 -145.13 94.38 2.52 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 126.592 1.957 . . . . 75.51 106.839 172.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.519 ' HA ' ' HA ' ' A' ' 193' ' ' LEU . 22.5 tp -75.0 150.24 39.03 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.056 0.942 . . . . 74.21 110.556 173.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -131.25 100.15 5.09 Favored 'General case' 0 C--O 1.244 0.805 0 N-CA-C 107.879 -1.156 . . . . 70.31 107.879 167.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 65.92 -87.51 0.11 Allowed Glycine 0 C--N 1.352 1.448 0 CA-C-N 115.522 -0.763 . . . . 65.41 113.412 176.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.588 HE21 ' HA3' ' A' ' 242' ' ' GLY . 33.3 tt0 -107.04 -35.13 6.96 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.078 0.951 . . . . 72.32 110.931 -175.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.448 ' HB2' ' HE1' ' A' ' 250' ' ' TYR . 10.6 p-10 -108.02 125.13 51.19 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-O 121.699 0.762 . . . . 72.32 110.598 -168.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.618 HD11 ' HD2' ' A' ' 154' ' ' ARG . 0.4 OUTLIER -91.9 125.7 36.7 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.12 -0.946 . . . . 63.44 108.628 -169.985 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.452 ' HA ' ' HB2' ' A' ' 250' ' ' TYR . 39.3 m-85 -95.97 158.25 15.53 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.837 -0.801 . . . . 73.14 108.837 170.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.466 ' HB2' HD11 ' A' ' 249' ' ' LEU . . . -156.05 176.17 13.01 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 123.155 0.582 . . . . 74.34 109.581 -173.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 35.6 m -130.51 142.08 50.48 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.824 0.849 . . . . 70.21 108.792 172.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 47.6 tp -135.47 125.21 25.41 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 123.796 0.838 . . . . 72.21 109.526 -174.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -82.99 126.2 32.26 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 109.186 -0.672 . . . . 61.43 109.186 170.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 7.5 p -141.19 134.08 14.34 Favored Pre-proline 0 CA--C 1.542 0.662 0 N-CA-C 107.508 -1.293 . . . . 64.4 107.508 175.031 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -78.65 161.22 27.91 Favored 'Trans proline' 0 CA--C 1.545 1.047 0 C-N-CA 121.537 1.491 . . . . 64.51 111.377 169.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.524 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -55.55 -53.89 57.35 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 124.621 1.169 . . . . 71.34 113.899 -171.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -67.53 -28.98 37.78 Favored 'Trans proline' 0 C--N 1.384 2.421 0 CA-C-N 120.769 1.31 . . . . 63.54 112.032 -173.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 17.8 mt -73.74 -34.06 39.75 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 C-N-CA 123.632 0.773 . . . . 64.32 110.318 176.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.79 -38.61 80.12 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 122.858 0.463 . . . . 71.51 111.389 176.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 201' ' ' ALA . 39.9 t -78.43 -42.93 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 123.096 0.558 . . . . 63.23 111.941 -175.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.421 HG11 ' HD2' ' C' ' 270' ' ' LYS . 56.0 t -89.38 -37.81 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 122.507 0.323 . . . . 74.41 111.45 -177.006 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 101.0 105.45 2.8 Favored Glycine 0 C--N 1.337 0.604 0 CA-C-N 116.413 -0.358 . . . . 72.35 112.421 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.434 ' HA3' ' CE1' ' C' ' 277' ' ' TYR . . . -158.69 178.46 34.88 Favored Glycine 0 C--N 1.347 1.152 0 CA-C-N 116.631 0.215 . . . . 55.24 113.163 -178.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.428 ' HE3' ' HB2' ' A' ' 209' ' ' LYS . 38.1 mtmt -79.98 137.38 36.83 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.945 0.498 . . . . 45.21 111.63 -172.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.462 HG11 ' HA ' ' A' ' 199' ' ' VAL . 27.5 m -130.45 151.74 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.83 1.252 . . . . 63.11 108.0 167.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 43.3 ttp180 -84.18 115.13 22.26 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 110.054 -0.35 . . . . 71.41 110.054 -179.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.29 132.09 47.0 Favored 'General case' 0 C--O 1.245 0.832 0 C-N-CA 123.502 0.721 . . . . 62.04 109.415 174.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . 0.509 ' SD ' ' N ' ' A' ' 213' ' ' MET . 1.0 OUTLIER -86.37 101.79 13.43 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 107.64 -1.244 . . . . 71.23 107.64 178.931 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 60.2 p -111.23 168.99 9.09 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 108.896 -0.779 . . . . 74.1 108.896 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.736 HD22 ' HB3' ' A' ' 127' ' ' LEU . 7.2 mt -79.14 -6.76 57.28 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 120.865 0.364 . . . . 63.31 111.183 -172.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -100.31 -4.36 29.39 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.697 1.199 . . . . 64.44 110.92 173.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 132.67 -175.36 20.02 Favored Glycine 0 C--N 1.351 1.37 0 CA-C-O 120.038 -0.312 . . . . 33.0 113.312 174.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -83.68 101.36 0.92 Allowed 'Trans proline' 0 C--N 1.369 1.628 0 C-N-CA 122.754 2.302 . . . . 70.23 111.155 175.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 34.9 m -101.37 162.2 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 123.151 0.58 . . . . 73.4 109.836 -177.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -100.82 112.63 25.09 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 109.397 -0.594 . . . . 75.04 109.397 176.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.495 HG13 HD11 ' B' ' 441' ' ' ILE . 76.6 t -93.84 106.3 17.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 107.985 -1.117 . . . . 74.13 107.985 177.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -71.91 99.65 2.27 Favored 'General case' 0 C--N 1.347 0.495 0 N-CA-C 107.923 -1.14 . . . . 60.25 107.923 172.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 90.6 t -62.77 133.33 95.04 Favored Pre-proline 0 CA--C 1.543 0.705 0 CA-C-N 114.015 -1.448 . . . . 63.14 109.569 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -58.03 155.63 32.89 Favored 'Trans proline' 0 C--N 1.376 1.986 0 C-N-CA 122.493 2.129 . . . . 75.51 112.614 171.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.33 156.77 64.81 Favored 'Trans proline' 0 C--N 1.372 1.771 0 C-N-CA 121.798 1.665 . . . . 72.53 112.33 172.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . 0.435 HH21 ' HG ' ' C' ' 261' ' ' LEU . 1.5 ptp85 43.53 48.45 6.3 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 126.484 1.914 . . . . 74.04 113.047 -178.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 20.1 m -86.63 115.68 24.25 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 113.053 -1.885 . . . . 64.32 109.815 175.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -87.13 147.3 25.7 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.652 0.781 . . . . 75.32 111.291 -175.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -63.65 132.92 52.61 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.884 0.874 . . . . 62.31 110.9 175.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 99.29 -19.82 52.39 Favored Glycine 0 C--N 1.343 0.924 0 CA-C-O 119.612 -0.549 . . . . 73.32 112.902 177.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 30.1 mtm-85 -77.35 158.93 29.87 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 117.289 0.544 . . . . 74.0 110.424 175.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -108.97 123.46 49.15 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.122 0.969 . . . . 72.22 109.883 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.45 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 57.5 mt -77.9 108.3 11.05 Favored 'General case' 0 C--N 1.348 0.542 0 N-CA-C 108.489 -0.93 . . . . 71.4 108.489 173.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -88.07 109.37 19.8 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 122.96 0.504 . . . . 64.14 110.927 -178.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.525 ' HG ' ' HB3' ' A' ' 249' ' ' LEU . 0.6 OUTLIER -121.85 111.79 17.55 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.15 0.58 . . . . 61.12 111.577 -179.194 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.456 ' HE3' ' HB3' ' A' ' 248' ' ' ASP . 4.2 mmpt? -52.87 147.92 8.36 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.862 1.265 . . . . 64.43 113.096 174.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 101.56 -17.32 55.36 Favored Glycine 0 C--N 1.351 1.377 0 CA-C-N 115.562 -0.745 . . . . 74.2 114.315 173.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.407 ' HB2' ' HB2' ' A' ' 249' ' ' LEU . 73.0 mmtt -104.91 5.75 33.12 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 112.567 0.58 . . . . 73.01 112.567 -175.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -100.23 174.81 26.59 Favored Glycine 0 C--N 1.349 1.27 0 N-CA-C 112.383 -0.287 . . . . 74.43 112.383 166.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -100.53 163.92 17.24 Favored Pre-proline 0 N--CA 1.48 1.074 0 C-N-CA 125.155 1.382 . . . . 73.13 112.584 -163.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -46.94 140.63 13.07 Favored 'Trans proline' 0 C--N 1.394 2.952 0 C-N-CA 124.23 3.286 . . . . 73.33 114.563 174.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.588 ' HA3' HE21 ' A' ' 191' ' ' GLN . . . 175.75 -167.48 39.33 Favored Glycine 0 CA--C 1.534 1.271 0 CA-C-N 115.422 -0.808 . . . . 73.52 112.122 179.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -56.32 -28.81 73.96 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 123.733 2.956 . . . . 70.45 114.439 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -92.83 22.43 4.85 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.562 0.745 . . . . 70.11 111.843 -178.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 78.18 -93.1 1.19 Allowed Glycine 0 C--N 1.348 1.233 0 N-CA-C 109.762 -1.335 . . . . 62.24 109.762 -172.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 30.3 mtp180 -127.19 148.09 50.19 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.88 0.872 . . . . 75.41 108.904 166.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -78.32 -157.03 9.64 Favored Glycine 0 CA--C 1.535 1.33 0 CA-C-O 121.637 0.576 . . . . 42.24 113.902 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . 0.456 ' HB3' ' HE3' ' A' ' 236' ' ' LYS . 0.4 OUTLIER -134.49 165.0 26.2 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.404 1.081 . . . . 75.44 111.223 -174.96 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.55 HD13 HD13 ' A' ' 193' ' ' LEU . 61.6 tp -100.39 153.31 19.44 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.493 1.117 . . . . 70.31 109.756 178.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.452 ' HB2' ' HA ' ' A' ' 194' ' ' TYR . 62.9 m-85 -128.65 103.6 7.18 Favored 'General case' 0 C--O 1.219 -0.536 0 N-CA-C 108.873 -0.788 . . . . 52.51 108.873 177.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.45 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 32.8 mt -90.09 104.16 16.76 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.122 -0.696 . . . . 72.24 109.122 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -77.36 125.27 29.07 Favored 'General case' 0 C--N 1.362 1.141 0 CA-C-O 121.64 0.734 . . . . 75.41 109.933 -176.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 61.1 t -78.76 117.61 24.6 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-N 114.271 -1.331 . . . . 24.43 111.701 -169.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 15.8 mmm-85 -114.49 96.17 5.63 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.126 -1.064 . . . . 73.14 108.126 170.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.501 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 69.8 mt -75.44 133.95 30.27 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 CA-C-N 114.86 -1.064 . . . . 74.34 110.12 178.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 22.6 p -126.09 -177.95 4.13 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.865 1.266 . . . . 73.43 110.144 178.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . 0.538 HG23 HG21 ' C' ' 255' ' ' ILE . 2.4 pp -139.01 159.66 65.93 Favored Pre-proline 0 N--CA 1.491 1.589 0 C-N-CA 123.803 0.841 . . . . 73.4 110.655 -177.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -60.96 -9.44 12.06 Favored 'Trans proline' 0 C--N 1.393 2.903 0 C-N-CA 123.112 2.541 . . . . 74.45 115.519 -167.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.826 ' HG2' HE21 ' C' ' 228' ' ' GLN . 42.4 mt-10 57.0 -64.92 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 125.824 1.649 . . . . 63.24 114.288 -174.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' ARG . . . . . 0.54 ' HB2' ' HG3' ' B' ' 376' ' ' GLU . 0.0 OUTLIER -92.15 157.16 16.87 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 109.326 -0.62 . . . . 75.12 109.326 168.157 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.594 HD13 ' HA ' ' A' ' 266' ' ' GLU . 64.2 mt -141.9 131.47 23.95 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 118.287 0.494 . . . . 55.32 111.237 -178.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.46 148.35 52.1 Favored Pre-proline 0 CA--C 1.555 1.143 0 N-CA-C 107.702 -1.222 . . . . 44.34 107.702 167.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' PRO . . . . . 0.521 ' HG3' HD22 ' B' ' 375' ' ' LEU . 56.0 Cg_exo -40.8 -31.82 0.76 Allowed 'Trans proline' 0 C--N 1.392 2.838 0 C-N-CA 124.939 3.76 . . . . 74.33 116.58 -167.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -61.38 -68.08 0.35 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.448 0.699 . . . . 71.44 110.758 176.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . 0.543 ' HB2' HD22 ' A' ' 261' ' ' LEU . 1.7 mp0 -67.17 -28.28 67.98 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 123.487 0.492 . . . . 64.2 110.28 -175.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 266' ' ' GLU . . . . . 0.594 ' HA ' HD13 ' A' ' 261' ' ' LEU . 8.3 tp10 -50.38 -58.46 5.65 Favored 'General case' 0 C--O 1.253 1.249 0 C-N-CA 124.258 1.023 . . . . 73.45 109.459 171.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . 0.447 ' O ' ' HG2' ' A' ' 271' ' ' LYS . . . -59.13 -58.43 8.67 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 114.702 -1.135 . . . . 64.12 111.15 177.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 10.2 mp -57.6 -45.92 84.69 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 123.852 0.861 . . . . 73.14 112.854 -170.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 269' ' ' TRP . . . . . . . . . . . . . 63.3 m95 -60.23 -46.92 88.1 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 123.749 0.655 . . . . 75.0 110.805 175.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . 0.625 ' HE2' ' HA ' ' C' ' 206' ' ' VAL . 2.2 mptm? -63.05 -34.33 77.35 Favored 'General case' 0 CA--C 1.548 0.874 0 O-C-N 123.727 0.642 . . . . 62.43 112.03 178.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' A' ' 267' ' ' ALA . 26.4 mmmt -73.96 -40.31 63.12 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 118.084 0.402 . . . . 70.22 110.366 -177.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 39.5 mt -57.72 -39.38 77.11 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 123.467 0.707 . . . . 63.4 110.204 170.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -65.97 -45.1 82.92 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 124.129 0.893 . . . . 64.51 112.644 -177.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -67.35 -42.85 82.83 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.811 0.844 . . . . 74.35 110.763 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 275' ' ' ALA . . . . . . . . . . . . . . . -62.53 -44.13 97.1 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.38 -0.827 . . . . 71.44 110.231 177.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -63.69 -44.25 94.25 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.415 1.086 . . . . 75.02 109.909 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -62.71 -43.6 98.4 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.82 1.248 . . . . 70.12 109.492 -177.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -75.02 -5.03 41.83 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 115.236 -0.893 . . . . 75.41 112.563 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 43.7 mtm180 -115.38 -0.88 13.01 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.808 0.843 . . . . 74.13 110.08 173.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.1 0 N-CA-C 108.546 -0.909 . . . . 72.21 108.546 178.975 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.476 0.874 0 N-CA-C 109.627 -0.509 . . . . 71.44 109.627 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.408 ' HG2' ' HG3' ' B' ' 3' ' ' GLN . 85.1 tttt 65.43 143.89 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 125.483 1.513 . . . . 54.1 111.906 -176.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . 0.408 ' HG3' ' HG2' ' B' ' 2' ' ' LYS . 25.1 mt-30 64.64 1.66 1.43 Allowed 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 125.164 1.386 . . . . 74.04 113.479 -178.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 43.3 m -72.57 95.28 1.8 Allowed 'General case' 0 C--N 1.354 0.797 0 C-N-CA 123.468 0.707 . . . . 52.14 109.111 -179.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 0.44 HG21 ' HB ' ' A' ' 137' ' ' VAL . 0.1 OUTLIER -83.39 160.85 21.53 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.418 -0.81 . . . . 70.11 111.102 -171.879 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.627 HG21 ' HA ' ' A' ' 125' ' ' LEU . 38.5 pt -130.34 168.89 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 112.943 0.72 . . . . 64.44 112.943 -154.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -145.25 124.78 13.17 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.82 0.848 . . . . 72.01 108.975 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.532 HD23 HG21 ' A' ' 140' ' ' VAL . 60.7 tp -63.53 138.3 58.46 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.066 0.946 . . . . 75.22 110.894 -174.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.52 -48.63 80.9 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 124.183 0.927 . . . . 62.4 111.074 177.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 6.1 tt 53.67 89.79 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.155 0 O-C-N 124.53 1.144 . . . . 74.1 108.957 -172.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 91.7 mt -66.44 112.06 8.36 Favored Pre-proline 0 CA--C 1.547 0.833 0 N-CA-C 110.045 -0.354 . . . . 45.35 110.045 -176.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -83.85 -152.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.373 1.826 0 C-N-CA 122.839 2.36 . . . . 61.33 111.969 -173.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . 0.611 HD23 ' H ' ' B' ' 13' ' ' LEU . 2.6 pt? -87.78 19.86 3.29 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 123.044 0.538 . . . . 75.01 111.079 175.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 6.0 tt -153.15 100.09 2.44 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 107.62 -1.252 . . . . 64.54 107.62 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -159.88 17.16 0.15 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.353 0.661 . . . . 60.01 111.122 175.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . 0.549 HG23 HG22 ' B' ' 18' ' ' VAL . 9.5 t -70.93 140.48 86.13 Favored Pre-proline 0 CA--C 1.561 1.397 0 C-N-CA 123.28 0.632 . . . . 51.11 111.437 -175.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 17' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -80.12 24.54 0.64 Allowed 'Trans proline' 0 C--N 1.386 2.531 0 C-N-CA 123.428 2.752 . . . . 62.42 114.234 -175.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.549 HG22 HG23 ' B' ' 16' ' ' THR . 32.7 m -68.01 -14.4 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 123.494 0.718 . . . . 61.41 111.998 176.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 9.9 t -63.63 -21.02 66.14 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.841 0.856 . . . . 71.22 111.814 174.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 20' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -111.44 46.21 1.13 Allowed 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 124.155 0.982 . . . . 62.34 108.555 175.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.1 -34.46 77.68 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 115.738 -0.665 . . . . 75.34 111.304 177.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.52 75.98 5.86 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 121.616 0.722 . . . . 73.31 109.292 177.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 23' ' ' THR . . . . . 0.469 ' HB ' ' HD3' ' B' ' 24' ' ' PRO . 73.7 m -88.86 -47.25 0.43 Allowed Pre-proline 0 CA--C 1.556 1.199 0 N-CA-C 108.605 -0.887 . . . . 72.45 108.605 162.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . 0.518 ' HA ' ' NH1' ' C' ' 154' ' ' ARG . 84.4 Cg_endo -92.84 101.43 0.16 Allowed 'Trans proline' 0 C--N 1.391 2.814 0 C-N-CA 121.803 1.669 . . . . 74.55 111.578 167.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -76.13 -72.76 0.31 Allowed 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.072 -0.714 . . . . 74.53 109.072 175.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . 0.414 ' HB2' ' NH2' ' C' ' 154' ' ' ARG . 15.4 tmm? 58.92 88.87 0.12 Allowed Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 125.036 1.334 . . . . 75.13 110.844 -178.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_exo -47.55 115.61 1.48 Allowed 'Trans proline' 0 C--N 1.372 1.809 0 C-N-CA 122.568 2.179 . . . . 71.1 111.107 164.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 7.7 p -70.95 76.19 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.392 0 CA-C-O 123.221 1.486 . . . . 73.51 111.588 -172.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -121.69 90.32 3.29 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 113.968 -1.469 . . . . 62.2 107.489 177.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -134.71 -74.76 0.47 Allowed 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 107.455 -1.313 . . . . 70.24 107.455 177.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 43.7 t30 56.19 -84.33 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 124.576 1.15 . . . . 74.34 111.447 -178.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 32' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -137.9 85.94 2.14 Favored 'General case' 0 C--N 1.351 0.636 0 C-N-CA 124.989 1.316 . . . . 72.22 108.157 177.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.42 79.57 8.83 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 109.08 -0.711 . . . . 73.31 109.08 175.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -93.16 -3.3 54.2 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.861 0.865 . . . . 53.33 112.043 -175.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -79.35 83.0 5.43 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-O 122.162 0.982 . . . . 73.13 111.121 179.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -148.98 -128.78 1.72 Allowed Glycine 0 C--N 1.338 0.666 0 N-CA-C 108.407 -1.877 . . . . 74.33 108.407 172.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 29.8 t70 64.16 -70.81 0.07 Allowed 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 125.068 1.347 . . . . 61.44 113.026 168.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 36.1 mm -67.56 -26.66 36.07 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.968 0 C-N-CA 124.066 0.946 . . . . 75.44 110.902 176.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 42.9 p -62.25 89.76 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 123.588 0.755 . . . . 64.25 112.328 -176.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -164.02 98.46 0.94 Allowed Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 124.537 1.135 . . . . 64.0 108.041 -178.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -72.44 85.09 1.11 Allowed 'Trans proline' 0 C--N 1.372 1.783 0 C-N-CA 123.058 2.505 . . . . 72.44 112.566 -178.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -78.29 140.12 23.34 Favored Glycine 0 C--N 1.347 1.161 0 CA-C-N 115.641 -0.709 . . . . 45.24 111.904 177.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.27 -24.63 29.42 Favored Glycine 0 C--N 1.346 1.105 0 CA-C-O 119.765 -0.464 . . . . 42.15 112.363 -175.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . 65.45 4.2 2.65 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 124.931 1.293 . . . . 63.2 113.507 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 31.0 tpt180 61.4 -74.22 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 125.392 1.477 . . . . 74.21 111.598 -170.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 46' ' ' ARG . . . . . 0.469 ' HG2' ' HB1' ' B' ' 234' ' ' ALA . 17.3 tpp180 -142.9 -81.81 0.19 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.61 0.764 . . . . 75.02 109.628 -171.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 8.9 mp 54.8 -88.0 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 123.716 0.806 . . . . 53.22 110.991 -167.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 92.9 m 71.42 -47.0 0.65 Allowed 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 125.632 1.573 . . . . 51.22 112.812 -176.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.94 64.15 3.73 Favored Glycine 0 C--N 1.347 1.175 0 C-N-CA 123.243 0.449 . . . . 74.15 113.542 178.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -136.69 -11.18 1.81 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.618 1.167 . . . . 64.2 109.797 176.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 51' ' ' GLN . . . . . 0.412 HE22 HG21 ' B' ' 122' ' ' THR . 57.0 tp60 67.13 80.38 0.22 Allowed 'General case' 0 C--N 1.362 1.11 0 C-N-CA 124.97 1.308 . . . . 75.3 109.93 -175.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 18.3 m -83.23 78.15 9.66 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.399 0.68 . . . . 73.31 110.083 -178.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . 58.41 -82.52 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 125.204 1.402 . . . . 73.24 111.7 -178.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . 55.64 -88.0 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.233 1.413 . . . . 75.51 112.605 174.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.546 ' HB3' ' HG3' ' B' ' 350' ' ' LYS . 0.6 OUTLIER 72.14 -49.58 0.69 Allowed 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 126.071 1.748 . . . . 72.35 111.412 -177.404 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 56' ' ' ARG . . . . . . . . . . . . . 36.1 ttm180 77.2 144.56 0.08 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 125.18 1.392 . . . . 73.2 110.889 172.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 26.2 t70 66.43 -99.53 0.06 Allowed 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 124.6 1.16 . . . . 75.31 110.745 -174.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 26.2 p -179.39 -79.41 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.226 1.011 . . . . 62.01 109.768 -174.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 92.6 mt -142.68 -77.51 0.25 Allowed 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 107.911 -1.144 . . . . 72.44 107.911 -174.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 49.2 m 51.32 -79.18 0.01 OUTLIER 'General case' 0 C--N 1.366 1.283 0 C-N-CA 125.665 1.586 . . . . 63.51 113.466 -177.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -84.4 170.81 13.19 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.875 0.87 . . . . 71.45 112.243 -171.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 79.5 65.36 0.18 Allowed Pre-proline 0 C--N 1.351 0.668 0 C-N-CA 126.844 2.058 . . . . 72.3 108.578 -178.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . 0.587 ' HB2' ' HB1' ' B' ' 295' ' ' ALA . 35.6 Cg_endo -86.01 41.2 0.82 Allowed 'Trans proline' 0 C--N 1.378 2.079 0 C-N-CA 123.739 2.959 . . . . 72.24 111.543 -173.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . -138.94 -24.96 0.89 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.537 1.135 . . . . 72.04 110.769 -172.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.5 ' HG3' ' H ' ' B' ' 66' ' ' ASN 0.257 21.3 ptmt 46.79 -77.48 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.316 0 C-N-CA 125.829 1.652 . . . . 65.32 113.109 -169.211 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 66' ' ' ASN . . . . . 0.5 ' H ' ' HG3' ' B' ' 65' ' ' LYS . 45.6 t30 -80.11 -65.4 1.01 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.638 0.775 . . . . 72.41 109.263 175.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 4.0 tt -175.11 34.87 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.563 1.47 0 N-CA-C 107.621 -1.251 . . . . 72.03 107.621 -173.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 68' ' ' ILE . . . . . . . . . . . . . 78.4 mt 72.56 -58.36 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 C-N-CA 126.01 1.724 . . . . 73.4 109.994 -168.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 67.7 mt -74.02 148.79 41.67 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.287 1.035 . . . . 73.12 110.509 175.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . . . . . . . . . 3.2 tt -166.83 90.8 0.4 Allowed 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 109.434 -0.58 . . . . 44.44 109.434 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . 0.638 HG23 ' H ' ' B' ' 73' ' ' ASP . 9.0 tp 175.17 -25.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 C-N-CA 125.535 1.534 . . . . 74.32 108.884 169.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.89 -36.32 3.26 Favored Glycine 0 C--N 1.341 0.819 0 N-CA-C 108.981 -1.648 . . . . 62.21 108.981 -172.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . 0.638 ' H ' HG23 ' B' ' 71' ' ' ILE . 5.0 m-20 72.6 23.96 2.93 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.587 1.555 . . . . 63.44 113.608 161.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -80.36 55.3 4.62 Favored Glycine 0 C--N 1.349 1.27 0 N-CA-C 110.758 -0.937 . . . . 64.42 110.758 164.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 14.4 tpt -162.42 18.24 0.09 Allowed 'General case' 0 CA--C 1.559 1.318 0 C-N-CA 124.796 1.239 . . . . 74.01 108.657 -170.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . -62.68 -40.56 99.33 Favored Glycine 0 C--N 1.361 1.964 0 CA-C-N 116.055 -0.52 . . . . 71.13 112.493 -177.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 77' ' ' ASP . . . . . . . . . . . . . 32.0 t70 69.65 -73.05 0.1 Allowed 'General case' 0 C--N 1.357 0.894 0 C-N-CA 125.448 1.499 . . . . 73.03 113.085 167.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 34.1 m -90.53 -78.85 0.37 Allowed 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.353 0.661 . . . . 51.1 111.745 -174.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . 0.423 ' HA ' ' HB3' ' B' ' 82' ' ' ALA . 0.0 OUTLIER -148.22 -159.02 0.97 Allowed 'General case' 0 N--CA 1.485 1.324 0 CA-C-O 118.704 -0.665 . . . . 74.44 109.712 -174.664 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . 0.533 HG13 ' H ' ' B' ' 81' ' ' THR 0.296 49.7 pt 54.14 -69.47 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 C-N-CA 127.372 2.269 . . . . 72.52 114.028 179.987 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . 0.533 ' H ' HG13 ' B' ' 80' ' ' ILE . 32.7 m -66.43 -36.3 82.46 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.251 0.62 . . . . 71.34 109.63 171.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . 0.423 ' HB3' ' HA ' ' B' ' 79' ' ' GLU . . . -67.08 -36.46 82.03 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.094 0.957 . . . . 61.11 111.337 174.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.64 -25.66 64.04 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.543 0.737 . . . . 71.35 111.066 176.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 84' ' ' ARG . . . . . . . . . . . . . 56.7 ttt180 68.48 -79.22 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.214 1.406 . . . . 73.0 111.766 173.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -158.42 19.7 0.23 Allowed 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.227 0.611 . . . . 72.23 110.573 -179.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 61.2 t80 69.96 -70.96 0.13 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.829 1.252 . . . . 63.12 110.443 -169.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . 66.65 -77.9 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.78 1.232 . . . . 52.24 110.987 -179.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -125.5 149.36 48.34 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.901 0.881 . . . . 74.14 109.416 178.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 89' ' ' GLY . . . . . . . . . . . . . . . 167.72 -0.42 0.04 OUTLIER Glycine 0 C--N 1.342 0.897 0 CA-C-O 119.242 -0.754 . . . . 54.33 113.423 177.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . 74.94 -60.13 0.53 Allowed 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 125.386 1.474 . . . . 62.33 112.355 177.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . 0.471 ' HA2' ' HE1' ' B' ' 94' ' ' PHE . . . -82.23 66.53 3.86 Favored Glycine 0 C--N 1.351 1.368 0 C-N-CA 123.206 0.431 . . . . 70.11 113.516 -178.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . -98.96 51.36 1.16 Allowed Glycine 0 C--N 1.342 0.916 0 CA-C-O 119.885 -0.397 . . . . 23.53 112.198 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 66.8 125.59 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 125.277 1.431 . . . . 74.22 112.231 -177.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 94' ' ' PHE . . . . . 0.471 ' HE1' ' HA2' ' B' ' 91' ' ' GLY . 71.3 m-85 -125.98 -170.34 2.17 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.052 0.941 . . . . 71.21 110.278 -178.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt 67.92 -82.45 0.03 OUTLIER 'General case' 0 C--N 1.363 1.158 0 C-N-CA 125.395 1.478 . . . . 74.14 110.561 -178.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 96' ' ' GLY . . . . . . . . . . . . . . . 173.58 65.18 0.05 OUTLIER Glycine 0 C--N 1.332 0.36 0 N-CA-C 109.299 -1.521 . . . . 72.31 109.299 -175.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 97' ' ' ILE . . . . . 0.409 HG13 ' H ' ' B' ' 99' ' ' ALA . 10.8 tp -62.72 146.18 12.87 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 C-N-CA 123.706 0.802 . . . . 72.22 110.802 -177.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -77.37 3.52 12.99 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.334 1.053 . . . . 75.21 112.361 -179.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 99' ' ' ALA . . . . . 0.409 ' H ' HG13 ' B' ' 97' ' ' ILE . . . -114.39 95.12 5.11 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.022 0.929 . . . . 61.12 109.484 177.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 93.9 mt -77.19 126.24 85.47 Favored Pre-proline 0 N--CA 1.48 1.027 0 C-N-CA 123.261 0.625 . . . . 74.2 109.759 176.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -63.77 133.18 37.99 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 122.749 2.299 . . . . 72.21 111.639 175.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . 0.558 HD13 ' HE2' ' B' ' 106' ' ' TYR 0.267 0.1 OUTLIER 38.55 -92.08 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.353 0 C-N-CA 126.568 1.947 . . . . 73.12 113.803 -175.22 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 7.2 m 58.71 -80.97 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 125.046 1.339 . . . . 75.52 112.446 -178.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . -75.28 -18.61 79.97 Favored Glycine 0 C--N 1.356 1.647 0 CA-C-O 120.117 -0.268 . . . . 51.35 112.86 -179.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -69.31 -5.33 22.48 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.4 0.68 . . . . 75.22 112.149 177.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 106' ' ' TYR . . . . . 0.558 ' HE2' HD13 ' B' ' 102' ' ' LEU . 76.6 m-85 -81.86 -53.01 6.52 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 123.586 0.754 . . . . 74.44 110.154 169.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 50.6 m 69.9 -34.69 0.29 Allowed 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 125.369 1.468 . . . . 63.32 114.002 176.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 108' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -61.85 93.44 0.04 OUTLIER 'General case' 0 C--N 1.361 1.081 0 C-N-CA 124.958 1.303 . . . . 71.44 109.804 178.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.404 ' H ' ' H ' ' B' ' 110' ' ' ALA . 65.8 t80 176.8 -15.95 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.093 1.757 . . . . 53.33 108.547 -170.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . 0.581 ' HB2' ' HB2' ' B' ' 282' ' ' ALA . . . -58.21 -49.92 75.37 Favored 'General case' 0 C--N 1.353 0.718 0 C-N-CA 124.44 1.096 . . . . 71.24 111.187 179.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -99.38 78.41 2.2 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 107.258 -1.386 . . . . 64.15 107.258 169.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -153.72 71.45 0.87 Allowed 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 108.221 -1.029 . . . . 73.2 108.221 173.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 113' ' ' LYS . . . . . 0.432 ' HG2' ' O ' ' B' ' 256' ' ' TYR . 16.5 tppt? -164.62 -82.96 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 114.576 -1.193 . . . . 75.13 109.221 174.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 114' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -168.19 110.53 0.58 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.128 0.571 . . . . 74.01 109.508 -170.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 8.9 m 63.55 155.69 0.06 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 124.648 1.179 . . . . 73.23 112.424 177.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 125.93 -168.97 17.92 Favored Glycine 0 C--N 1.346 1.088 0 N-CA-C 111.522 -0.631 . . . . 55.33 111.522 179.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . 0.575 ' HE2' ' HE2' ' B' ' 120' ' ' TYR . 13.8 mmmm -135.82 -56.57 0.02 OUTLIER Pre-proline 0 CA--C 1.566 1.594 0 N-CA-C 114.079 1.14 . . . . 70.25 114.079 -178.152 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 118' ' ' PRO . . . . . 0.708 ' HB2' ' HA ' ' B' ' 281' ' ' PHE . 71.1 Cg_endo -65.26 128.59 20.77 Favored 'Trans proline' 0 C--N 1.389 2.664 0 C-N-CA 122.195 1.93 . . . . 60.53 112.654 -161.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 119' ' ' ASP . . . . . . . . . . . . . 20.7 t70 169.47 -41.04 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 125.258 1.423 . . . . 75.33 109.16 -176.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 120' ' ' TYR . . . . . 0.575 ' HE2' ' HE2' ' B' ' 117' ' ' LYS . 0.2 OUTLIER -76.33 -153.72 0.05 OUTLIER 'General case' 0 CA--C 1.558 1.251 0 CA-C-N 113.654 -1.612 . . . . 70.1 112.455 -175.729 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 121' ' ' VAL . . . . . 0.485 ' HB ' ' H ' ' B' ' 221' ' ' ARG . 7.6 p -135.89 114.3 15.4 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.162 0 C-N-CA 124.075 0.95 . . . . 74.32 109.463 165.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . 0.412 HG21 HE22 ' B' ' 51' ' ' GLN . 1.4 m 64.96 24.57 12.67 Favored 'General case' 0 CA--C 1.566 1.567 0 C-N-CA 124.915 1.286 . . . . 75.24 113.454 168.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 67.63 -79.36 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 C-N-CA 124.647 1.179 . . . . 64.3 111.828 174.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 124' ' ' SER . . . . . . . . . . . . . 41.4 t -70.04 -55.34 9.79 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 125.087 1.355 . . . . 43.31 110.642 -175.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . 68.85 -64.26 0.33 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 125.381 1.473 . . . . 73.02 112.366 178.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -129.94 13.92 5.78 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.772 0.829 . . . . 74.13 111.177 177.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 127' ' ' SER . . . . . . . . . . . . . 30.8 t 62.94 86.78 0.11 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.408 1.083 . . . . 70.01 111.357 -179.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . 68.69 -73.36 0.09 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 125.247 1.419 . . . . 72.01 111.387 -175.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 12.6 t -156.67 5.33 0.16 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.219 1.008 . . . . 54.34 110.29 176.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 130' ' ' ALA . . . . . . . . . . . . . . . 55.88 -87.29 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.177 1.391 . . . . 44.22 111.327 -168.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 3.6 p90 -164.43 164.38 22.03 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.944 1.297 . . . . 73.51 109.245 -175.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 15.0 m -86.4 92.46 8.84 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.082 0.553 . . . . 51.4 110.083 -179.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 133' ' ' THR . . . . . . . . . . . . . 12.9 m 70.79 97.02 0.07 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.915 1.286 . . . . 62.25 111.561 175.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . -167.49 159.54 32.89 Favored Glycine 0 C--N 1.346 1.114 0 CA-C-O 119.763 -0.465 . . . . 55.15 112.788 176.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 135' ' ' VAL . . . . . . . . . . . . . 61.9 t 61.65 -81.46 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 125.113 1.365 . . . . 73.24 111.413 -178.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 136' ' ' LYS . . . . . 0.434 ' HB3' ' HD2' ' B' ' 138' ' ' TYR . 60.8 tttp -79.96 -21.26 43.96 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.064 0.546 . . . . 52.43 110.648 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 137' ' ' THR . . . . . . . . . . . . . 19.3 m 77.5 -44.5 0.43 Allowed 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 125.021 1.329 . . . . 75.31 111.09 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 138' ' ' TYR . . . . . 0.434 ' HD2' ' HB3' ' B' ' 136' ' ' LYS 0.25 3.6 p90 47.78 -80.24 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 127.043 2.137 . . . . 75.52 114.756 170.577 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -69.46 -24.44 63.79 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 122.97 0.508 . . . . 73.24 111.272 -176.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 140' ' ' GLY . . . . . . . . . . . . . . . 98.51 -77.32 0.56 Allowed Glycine 0 C--N 1.351 1.362 0 O-C-N 123.974 0.796 . . . . 65.04 112.334 176.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . 64.9 -76.62 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 125.082 1.353 . . . . 75.34 112.009 -178.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 2.0 pp -108.26 -10.07 15.42 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.712 0.805 . . . . 70.15 111.529 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 143' ' ' GLY . . . . . . . . . . . . . . . -124.51 167.23 16.87 Favored Glycine 0 C--N 1.353 1.487 0 C-N-CA 123.658 0.647 . . . . 61.25 112.09 178.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 7.8 p 39.6 43.26 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 C-N-CA 126.126 1.77 . . . . 75.31 112.417 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -66.91 104.39 1.35 Allowed 'General case' 0 C--O 1.244 0.782 0 CA-C-N 114.899 -1.046 . . . . 64.3 108.364 -178.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 73.3 mt 72.63 -63.16 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 125.337 1.455 . . . . 72.52 110.794 -174.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 147' ' ' HIS . . . . . . . . . . . . . 25.7 t-80 -159.39 -61.57 0.07 Allowed 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 121.051 0.453 . . . . 72.43 110.134 -178.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . 0.417 ' HA ' ' HB3' ' B' ' 151' ' ' HIS . 40.6 mm-40 -110.59 -117.18 0.3 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.758 0.823 . . . . 73.05 109.424 -175.19 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 149' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt 69.01 -69.31 0.16 Allowed 'General case' 0 C--N 1.369 1.435 0 C-N-CA 125.517 1.527 . . . . 72.23 111.879 175.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 150' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -86.08 -37.35 18.93 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.455 0.702 . . . . 74.11 110.94 174.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 151' ' ' HIS . . . . . 0.417 ' HB3' ' HA ' ' B' ' 148' ' ' GLU . 30.9 t-80 -64.78 105.72 0.8 Allowed Pre-proline 0 CA--C 1.557 1.224 0 C-N-CA 124.636 1.174 . . . . 74.43 111.52 -174.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -93.7 -31.2 0.07 OUTLIER 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 122.992 2.461 . . . . 42.51 114.452 -175.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 21.7 p -103.82 99.18 8.95 Favored 'General case' 0 C--N 1.349 0.546 0 C-N-CA 123.77 0.828 . . . . 74.2 110.493 -170.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 154' ' ' ILE . . . . . . . . . . . . . 3.1 mp -90.62 -29.86 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-N 115.294 -0.866 . . . . 74.25 109.51 174.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 93.8 mt -65.32 85.09 0.06 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.5 0.72 . . . . 72.1 111.617 -176.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 60.35 103.18 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.774 1.63 . . . . 72.23 112.423 176.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 157' ' ' MET . . . . . 0.446 ' HB3' ' HG2' ' B' ' 207' ' ' LYS . 1.9 mpt? -71.36 -21.69 62.0 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.626 0.77 . . . . 53.54 110.766 176.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 158' ' ' ALA . . . . . . . . . . . . . . . -69.52 -20.59 63.7 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.067 0.947 . . . . 34.04 111.967 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 33.7 mmtm -53.89 -35.83 62.02 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.941 0.896 . . . . 55.45 111.595 174.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 160' ' ' ALA . . . . . . . . . . . . . . . -79.03 74.41 5.56 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.447 0.699 . . . . 70.22 110.285 176.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 161' ' ' ALA . . . . . . . . . . . . . . . -87.61 81.92 7.58 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.628 -0.714 . . . . 71.1 109.947 179.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . 83.96 -72.11 2.87 Favored Glycine 0 C--N 1.347 1.144 0 CA-C-N 115.772 -0.649 . . . . 73.4 112.716 178.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . . . . . . . . 0.274 2.4 pp 59.96 -64.53 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 127.813 2.445 . . . . 65.02 114.082 177.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 164' ' ' ALA . . . . . . . . . . . . . . . -90.76 -6.36 54.48 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.25 0.62 . . . . 75.34 111.825 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 165' ' ' THR . . . . . . . . . . . . . 50.3 p -72.23 86.55 1.09 Allowed 'General case' 0 CA--C 1.548 0.88 0 CA-C-O 121.706 0.765 . . . . 64.15 111.193 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . -153.53 101.62 0.21 Allowed Glycine 0 C--N 1.337 0.609 0 N-CA-C 110.548 -1.021 . . . . 71.15 110.548 179.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 167' ' ' ASN . . . . . 0.705 HD22 ' HG2' ' C' ' 129' ' ' GLU . 52.9 t30 58.36 27.28 15.14 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.856 1.263 . . . . 72.31 111.864 -178.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 168' ' ' VAL . . . . . . . . . . . . . 9.9 m -72.15 93.69 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-N 115.454 -0.794 . . . . 74.13 109.299 176.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 169' ' ' SER . . . . . . . . . . . . . 48.7 m 70.85 11.09 7.1 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.114 1.366 . . . . 54.35 111.907 -174.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 22.6 m 62.22 144.41 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 125.497 1.519 . . . . 63.1 112.591 -176.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -63.72 -56.84 12.55 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.877 0.471 . . . . 53.32 110.133 175.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 172' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.61 -36.18 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.706 0.802 . . . . 73.22 109.601 173.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 173' ' ' LEU . . . . . . . . . . . . . 28.9 tp -159.3 144.94 16.1 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.808 0.843 . . . . 74.23 109.571 179.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 174' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 65.62 -82.41 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.487 1.515 . . . . 74.45 112.907 176.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 175' ' ' ASP . . . . . . . . . . . . . 10.4 t70 57.23 -83.1 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 124.387 1.075 . . . . 74.1 108.853 -164.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . 57.95 19.61 6.01 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 124.952 1.301 . . . . 74.11 113.548 171.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 8.7 m -78.95 -54.79 1.01 Allowed Pre-proline 0 CA--C 1.564 1.509 0 C-N-CA 123.428 0.691 . . . . 64.31 112.648 -172.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 178' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -82.23 174.18 10.19 Favored 'Trans proline' 0 C--N 1.387 2.574 0 C-N-CA 122.097 1.864 . . . . 74.53 114.023 -166.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . 76.66 -39.65 0.35 Allowed 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 126.197 1.799 . . . . 61.34 114.308 169.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . 54.54 48.45 20.41 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.838 0.828 . . . . 74.4 109.088 -168.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 31.2 tp 62.25 -77.56 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.28 0 CA-C-N 113.277 -1.783 . . . . 62.04 111.584 -166.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 182' ' ' VAL . . . . . 0.667 ' HA ' ' HB3' ' C' ' 123' ' ' LEU . 91.3 t -96.5 141.3 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 123.839 0.856 . . . . 71.31 111.364 -175.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -134.8 8.05 3.52 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.5 0.72 . . . . 65.24 112.708 -176.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 184' ' ' HIS . . . . . 0.438 ' HD2' ' HB3' ' C' ' 122' ' ' GLU . 80.0 t60 -145.44 152.33 39.64 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 118.104 0.411 . . . . 74.15 110.371 179.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 185' ' ' VAL . . . . . . . . . . . . . 71.4 t 76.44 -50.48 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 C-N-CA 126.124 1.77 . . . . 71.33 110.439 -170.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 1.9 t -156.21 123.68 5.47 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.191 0.996 . . . . 51.31 110.529 -174.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 187' ' ' SER . . . . . . . . . . . . . 22.5 t 174.05 166.26 0.21 Allowed 'General case' 0 C--O 1.244 0.77 0 C-N-CA 125.197 1.399 . . . . 62.14 108.539 174.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 52.3 ttt180 -83.33 77.86 9.73 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 107.691 -1.226 . . . . 71.52 107.691 171.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -155.2 137.31 14.7 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 106.743 -1.577 . . . . 72.52 106.743 -170.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 190' ' ' CYS . . . . . . . . . . . . . 66.6 m -72.39 94.0 1.59 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 122.982 0.513 . . . . 70.33 110.651 -177.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 191' ' ' TYR . . . . . 0.567 ' HA ' ' HA ' ' B' ' 197' ' ' SER . 7.8 p90 -129.47 164.89 22.72 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.078 0.951 . . . . 74.04 109.958 -175.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . 58.06 -103.16 0.3 Allowed Glycine 0 C--N 1.351 1.368 0 O-C-N 124.481 1.113 . . . . 64.22 114.391 165.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 193' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -55.97 -23.37 42.91 Favored 'Trans proline' 0 C--N 1.388 2.636 0 C-N-CA 123.572 2.848 . . . . 64.32 113.082 176.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 194' ' ' SER . . . . . . . . . . . . . 50.5 m -86.55 72.29 10.28 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 109.228 -0.656 . . . . 24.51 109.228 171.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 195' ' ' ALA . . . . . . . . . . . . . . . 61.45 -80.63 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 125.22 1.408 . . . . 74.32 113.157 175.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 97.3 m -127.51 146.54 50.47 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.884 1.274 . . . . 73.32 109.527 -176.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 197' ' ' SER . . . . . 0.567 ' HA ' ' HA ' ' B' ' 191' ' ' TYR . 11.1 t -84.72 -83.12 0.16 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 122.907 0.483 . . . . 75.11 110.99 -178.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 198' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -101.3 175.09 5.7 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 122.882 0.473 . . . . 51.12 109.966 -178.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp 72.04 -65.74 0.34 Allowed 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 125.354 1.462 . . . . 74.4 112.902 174.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 200' ' ' CYS . . . . . 0.433 ' SG ' ' HB3' ' B' ' 203' ' ' ASN . 42.4 t 58.91 62.07 4.45 Favored Pre-proline 0 CA--C 1.556 1.205 0 C-N-CA 124.469 1.108 . . . . 73.31 109.911 -174.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 201' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.45 -26.18 24.6 Favored 'Trans proline' 0 C--N 1.383 2.342 0 C-N-CA 123.082 2.522 . . . . 71.34 113.29 -166.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . -71.65 -31.0 65.61 Favored Glycine 0 C--N 1.352 1.428 0 O-C-N 123.386 0.429 . . . . 63.04 112.296 178.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 203' ' ' ASN . . . . . 0.433 ' HB3' ' SG ' ' B' ' 200' ' ' CYS . 44.6 t-20 -94.39 64.37 3.13 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 108.417 -0.957 . . . . 71.33 108.417 175.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -92.43 86.23 5.6 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 108.431 -0.951 . . . . 74.01 108.431 175.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 205' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -86.97 65.8 9.14 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.949 0.881 . . . . 51.03 109.982 -174.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -83.49 136.35 34.32 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 114.24 -1.345 . . . . 62.32 109.611 175.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 207' ' ' LYS . . . . . 0.535 ' HB2' ' HA ' ' B' ' 210' ' ' LYS . 82.8 mttt -91.74 7.26 42.59 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.795 0.838 . . . . 74.32 110.753 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 72.75 -100.03 0.97 Allowed Glycine 0 C--N 1.352 1.441 0 O-C-N 123.385 0.428 . . . . 71.52 112.041 -177.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . -81.08 5.1 67.7 Favored Glycine 0 C--N 1.351 1.39 0 CA-C-O 119.545 -0.586 . . . . 42.21 113.034 177.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 210' ' ' LYS . . . . . 0.535 ' HA ' ' HB2' ' B' ' 207' ' ' LYS . 29.2 mmtp 51.98 75.1 0.23 Allowed 'General case' 0 C--N 1.364 1.203 0 C-N-CA 125.741 1.616 . . . . 74.51 110.904 174.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . 68.0 63.19 3.77 Favored Glycine 0 C--N 1.354 1.546 0 N-CA-C 110.787 -0.925 . . . . 74.43 110.787 -172.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 39.5 p -56.38 -72.15 0.08 Allowed 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 124.106 0.962 . . . . 74.04 112.636 -167.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . 0.462 ' HA ' HD23 ' B' ' 217' ' ' LEU . 0.2 OUTLIER -137.87 157.04 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 C-N-CA 123.528 0.731 . . . . 64.4 110.531 178.487 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 40.7 p -123.88 -61.35 1.38 Allowed 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 107.573 -1.269 . . . . 75.43 107.573 172.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 215' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -105.13 -61.85 1.42 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.064 0.946 . . . . 73.31 108.565 166.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 216' ' ' GLN . . . . . 0.423 ' HB3' ' HA ' ' B' ' 65' ' ' LYS . 13.0 pt20 -155.31 -45.56 0.08 Allowed 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.055 -0.975 . . . . 61.42 110.945 -173.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . 0.462 HD23 ' HA ' ' B' ' 213' ' ' ILE . 3.8 mm? 60.67 -179.5 0.1 Allowed 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.254 1.022 . . . . 75.4 110.756 -166.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 63.7 tp 77.1 -40.79 0.37 Allowed 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 125.132 1.373 . . . . 71.43 112.208 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 219' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 69.18 -74.49 0.08 Allowed 'General case' 0 C--N 1.359 0.996 0 C-N-CA 125.329 1.452 . . . . 71.24 110.359 -173.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . 65.36 113.86 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.319 1.447 . . . . 61.1 111.508 176.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 221' ' ' ARG . . . . . 0.485 ' H ' ' HB ' ' B' ' 121' ' ' VAL . 44.7 mtm180 65.7 -167.41 0.21 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 124.797 1.239 . . . . 73.55 110.052 -174.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . 72.69 -17.6 0.39 Allowed 'General case' 0 N--CA 1.505 2.291 0 C-N-CA 124.801 1.24 . . . . 42.52 113.75 175.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -60.23 -39.12 85.55 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.424 0.689 . . . . 61.02 109.58 177.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 18.7 m 48.67 -154.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 C-N-CA 125.765 1.626 . . . . 74.2 112.257 174.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 19.3 m 83.37 -66.15 0.08 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.166 1.386 . . . . 54.34 111.669 166.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 28.8 mt -73.52 156.86 37.72 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 122.643 0.377 . . . . 74.43 111.823 -170.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 227' ' ' GLY . . . . . 0.451 ' HA2' ' HD3' ' B' ' 118' ' ' PRO . . . -144.02 -71.69 0.02 OUTLIER Glycine 0 C--N 1.341 0.823 0 CA-C-N 115.493 -0.776 . . . . 51.31 111.21 -179.098 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . -103.67 23.27 33.18 Favored Glycine 0 C--N 1.347 1.158 0 CA-C-O 119.846 -0.419 . . . . 72.41 112.48 176.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -79.05 64.88 3.65 Favored Glycine 0 C--N 1.356 1.691 0 C-N-CA 123.108 0.385 . . . . 70.24 112.256 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . 0.482 ' HB2' ' HD3' ' B' ' 117' ' ' LYS . . . -122.1 -152.9 0.53 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.893 1.277 . . . . 70.23 108.071 -175.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 231' ' ' LYS . . . . . 0.47 ' HD2' ' HB3' ' B' ' 230' ' ' ALA . 0.1 OUTLIER 57.31 46.53 18.32 Favored 'General case' 0 C--N 1.361 1.102 0 C-N-CA 124.143 0.977 . . . . 73.24 110.06 175.025 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 232' ' ' THR . . . . . 0.584 ' HA ' ' SG ' ' B' ' 358' ' ' CYS . 26.4 p -66.23 85.44 0.1 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.144 0.978 . . . . 74.24 112.158 -170.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -91.93 126.1 36.88 Favored 'General case' 0 C--N 1.351 0.631 0 N-CA-C 108.313 -0.995 . . . . 70.41 108.313 175.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . 0.469 ' HB1' ' HG2' ' B' ' 46' ' ' ARG . . . -177.05 119.84 0.12 Allowed 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 108.547 -0.908 . . . . 72.31 108.547 -176.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . 0.716 ' HA ' ' HE2' ' C' ' 209' ' ' LYS . 43.4 mt-10 -132.77 169.18 17.08 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 121.475 0.655 . . . . 54.41 112.66 -177.102 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 236' ' ' THR . . . . . . . . . . . . . 5.0 t -167.18 115.89 0.82 Allowed 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 113.831 -1.531 . . . . 73.34 108.116 175.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -89.14 52.68 2.45 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 121.732 0.777 . . . . 71.12 111.02 -177.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 8.9 m -78.69 -17.7 55.51 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-N 115.047 -0.979 . . . . 71.31 109.562 172.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 239' ' ' ALA . . . . . 0.518 ' HB2' ' HA ' ' C' ' 221' ' ' VAL . . . -67.91 -179.36 1.17 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.345 1.058 . . . . 74.42 111.964 176.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 240' ' ' GLY . . . . . 0.469 ' HA3' ' O ' ' C' ' 234' ' ' ARG . . . -103.38 -114.09 3.89 Favored Glycine 0 C--N 1.343 0.956 0 CA-C-O 119.718 -0.49 . . . . 71.23 111.903 -176.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -149.99 142.55 24.47 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.217 0.607 . . . . 71.21 111.087 -178.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -179.63 117.25 0.06 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 125.279 1.432 . . . . 70.32 108.971 173.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 243' ' ' GLN . . . . . 0.618 HE21 ' HG2' ' C' ' 224' ' ' PRO . 26.2 mt-30 65.36 -79.48 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 125.068 1.347 . . . . 74.22 113.004 176.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 152.63 100.13 0.19 Allowed Glycine 0 C--N 1.347 1.177 0 N-CA-C 111.699 -0.561 . . . . 63.11 111.699 -177.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.53 110.79 2.43 Favored 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 123.835 0.854 . . . . 75.34 111.48 -178.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 6.9 p -145.04 79.83 1.6 Allowed 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 122.885 0.474 . . . . 71.02 111.083 -176.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 247' ' ' LEU . . . . . 0.499 HD23 ' HA2' ' C' ' 208' ' ' GLY . 2.8 pp -68.87 146.12 53.11 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 116.299 -0.41 . . . . 72.51 110.141 169.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 248' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -154.91 109.32 2.97 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.784 -0.45 . . . . 75.15 109.784 177.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 177.59 173.07 0.55 Allowed 'General case' 0 N--CA 1.484 1.23 0 O-C-N 125.411 1.695 . . . . 71.33 109.136 161.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 250' ' ' GLN . . . . . 0.459 HE22 ' HA ' ' B' ' 363' ' ' GLU . 63.7 tt0 -160.93 114.69 2.04 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.027 0.531 . . . . 65.4 109.973 -174.042 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 251' ' ' ALA . . . . . . . . . . . . . . . -100.05 94.4 6.24 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.936 0.895 . . . . 61.03 110.11 175.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 6.0 pm0 -138.28 0.96 2.16 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.219 1.008 . . . . 72.3 109.575 174.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -75.8 89.21 2.86 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.617 0.767 . . . . 51.41 110.827 -170.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 28.6 tpt180 70.72 124.98 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 125.624 1.57 . . . . 72.51 111.928 175.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -117.38 108.92 1.78 Allowed Glycine 0 C--N 1.355 1.626 0 CA-C-O 119.635 -0.536 . . . . 54.22 113.127 -173.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 256' ' ' TYR . . . . . 0.432 ' O ' ' HG2' ' B' ' 113' ' ' LYS . 56.3 t80 73.91 -26.69 0.19 Allowed 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 125.828 1.651 . . . . 52.52 113.848 173.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 9.5 mp0 60.76 79.02 0.26 Allowed 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 108.798 -0.816 . . . . 74.31 108.798 -169.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 258' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -50.31 131.59 24.18 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.492 1.117 . . . . 75.13 112.445 -175.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 10.9 m 54.26 9.04 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.408 0 C-N-CA 126.775 2.03 . . . . 63.02 114.702 179.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 260' ' ' SER . . . . . . . . . . . . . 33.5 t -93.86 -4.29 50.32 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.693 0.797 . . . . 73.11 110.734 -178.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -64.2 -49.84 70.42 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 123.441 0.697 . . . . 52.21 110.684 178.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 262' ' ' ALA . . . . . . . . . . . . . . . 50.6 27.36 2.88 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 124.995 1.318 . . . . 43.43 112.032 -175.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -114.18 -24.95 8.7 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.073 0.949 . . . . 70.44 111.743 -168.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 34.1 t -153.46 126.75 8.55 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 108.947 -0.76 . . . . 51.14 108.947 -179.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 265' ' ' LEU . . . . . 0.471 ' HA ' ' HG3' ' B' ' 270' ' ' GLU . 3.4 tm? 67.14 127.44 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 124.681 1.192 . . . . 64.12 109.811 -174.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 266' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 63.75 45.15 4.62 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 124.473 1.109 . . . . 71.52 108.975 -171.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 44.4 t -158.29 173.62 16.41 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 114.682 -1.145 . . . . 73.13 109.756 -171.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 53.8 t -62.55 -29.12 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 124.54 1.136 . . . . 74.44 110.68 178.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 269' ' ' THR . . . . . . . . . . . . . 21.5 p -109.31 55.31 0.64 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.309 1.044 . . . . 74.31 110.287 176.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 270' ' ' GLU . . . . . 0.471 ' HG3' ' HA ' ' B' ' 265' ' ' LEU . 34.4 tt0 -79.31 -23.78 43.27 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 114.969 -1.014 . . . . 72.41 110.731 174.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 271' ' ' ALA . . . . . . . . . . . . . . . -70.68 1.92 4.74 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.871 0.868 . . . . 75.3 111.818 176.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 272' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -57.96 -28.61 64.5 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.254 1.422 . . . . 54.14 110.917 167.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 76.79 -20.14 0.39 Allowed 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 125.814 1.645 . . . . 61.32 112.188 175.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 274' ' ' GLN . . . . . 0.482 ' HB3' ' O ' ' B' ' 282' ' ' ALA . 47.3 mt-30 -116.91 168.65 10.05 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 125.582 1.553 . . . . 71.44 109.205 -174.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 275' ' ' LYS . . . . . . . . . . . . . 55.4 tttp -154.28 130.61 5.6 Favored Pre-proline 0 N--CA 1.475 0.785 0 N-CA-C 109.477 -0.564 . . . . 71.33 109.477 175.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 276' ' ' PRO . . . . . 0.417 ' HB3' ' HA ' ' B' ' 110' ' ' ALA . 59.2 Cg_endo -68.63 154.92 70.52 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 122.43 2.087 . . . . 62.35 110.944 169.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 277' ' ' LEU . . . . . 0.629 HD21 ' HB3' ' B' ' 280' ' ' LEU . 2.2 pt? -165.62 171.49 13.03 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.911 0.484 . . . . 63.32 111.27 175.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 2.2 pp -72.32 -6.38 42.87 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.937 0.895 . . . . 62.0 112.695 -177.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . -132.87 -160.01 9.39 Favored Glycine 0 C--N 1.348 1.215 0 N-CA-C 110.774 -0.931 . . . . 75.43 110.774 173.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 280' ' ' LEU . . . . . 0.629 ' HB3' HD21 ' B' ' 277' ' ' LEU . 27.1 tp 54.39 -90.11 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.778 1.231 . . . . 53.23 111.166 176.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 281' ' ' PHE . . . . . 0.708 ' HA ' ' HB2' ' B' ' 118' ' ' PRO . 58.5 t80 177.42 -89.87 0.0 OUTLIER 'General case' 0 C--N 1.36 1.052 0 C-N-CA 125.203 1.401 . . . . 75.31 107.784 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 282' ' ' ALA . . . . . 0.581 ' HB2' ' HB2' ' B' ' 110' ' ' ALA . . . 179.75 14.53 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.145 1.378 . . . . 65.41 109.644 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 283' ' ' ASP . . . . . 0.428 ' HA ' HE21 ' B' ' 274' ' ' GLN . 7.6 p-10 -89.64 161.94 15.87 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.949 0.9 . . . . 72.33 110.357 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . -106.91 123.45 7.32 Favored Glycine 0 C--N 1.349 1.275 0 N-CA-C 111.674 -0.57 . . . . 61.45 111.674 -178.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 33.0 p-10 -73.02 -21.33 60.83 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.367 0.667 . . . . 72.41 111.776 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 286' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -91.62 114.05 60.64 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 123.526 0.73 . . . . 64.1 109.497 177.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 287' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -79.72 152.48 22.54 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.684 2.256 . . . . 73.33 111.444 170.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 288' ' ' VAL . . . . . . . . . . . . . 35.1 m -66.65 -19.57 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 122.696 0.398 . . . . 74.32 112.008 179.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 289' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 72.69 150.07 0.1 Allowed 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 124.912 1.285 . . . . 72.14 110.673 -177.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 290' ' ' TRP . . . . . . . . . . . . . 49.7 t90 79.47 -24.54 0.21 Allowed 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 125.389 1.476 . . . . 75.34 112.272 -179.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 291' ' ' LEU . . . . . . . . . . . . . 8.1 mp 70.96 -72.82 0.11 Allowed 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 125.035 1.334 . . . . 64.34 111.078 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . 85.93 -100.15 2.46 Favored Glycine 0 C--N 1.351 1.414 0 CA-C-O 119.013 -0.881 . . . . 62.12 111.333 -177.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -57.71 130.91 41.02 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.314 2.01 . . . . 51.12 110.433 164.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -70.64 -61.43 1.77 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 122.57 0.348 . . . . 41.23 110.379 -175.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 295' ' ' ALA . . . . . 0.587 ' HB1' ' HB2' ' B' ' 63' ' ' PRO . . . 63.51 6.9 2.73 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.928 1.291 . . . . 34.32 113.294 -179.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 22.6 p -75.82 98.01 4.05 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.315 0.646 . . . . 65.42 109.621 -179.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -73.83 147.29 43.47 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 115.884 -0.598 . . . . 64.12 110.351 -178.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 24.5 p-80 -163.48 155.3 17.35 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.189 0.596 . . . . 71.5 110.848 -169.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . -93.29 -35.29 6.33 Favored Glycine 0 C--N 1.339 0.7 0 CA-C-N 116.248 -0.433 . . . . 63.41 112.374 172.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 58.3 t30 -106.4 149.98 26.48 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.923 0.889 . . . . 72.23 110.896 -175.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 301' ' ' ILE . . . . . . . . . . . . 0.262 2.6 pp 48.39 -178.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 C-N-CA 127.267 2.227 . . . . 72.24 114.983 178.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 33.0 t70 54.73 48.61 19.83 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 125.009 1.324 . . . . 63.41 111.925 173.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 303' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -110.65 135.09 20.74 Favored Pre-proline 0 N--CA 1.481 1.114 0 C-N-CA 123.894 0.878 . . . . 74.11 110.513 -177.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 304' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -70.72 -21.13 29.43 Favored 'Trans proline' 0 C--N 1.379 2.157 0 C-N-CA 122.902 2.401 . . . . 75.12 112.401 171.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -107.96 164.22 12.46 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.536 0.734 . . . . 42.33 111.219 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 20.6 m -126.3 31.5 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 C-N-CA 124.156 0.982 . . . . 72.33 110.69 -176.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 89.0 m 66.61 -74.56 0.06 Allowed 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 125.165 1.386 . . . . 74.23 111.194 -178.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 308' ' ' CYS . . . . . . . . . . . . . 16.5 p -115.49 137.57 51.93 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 124.386 1.075 . . . . 74.22 108.884 176.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 6.6 m -61.34 -47.18 94.64 Favored Pre-proline 0 CA--C 1.563 1.468 0 CA-C-O 118.88 -0.581 . . . . 72.2 111.65 -178.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.35 107.01 2.23 Favored 'Trans proline' 0 C--N 1.386 2.529 0 C-N-CA 121.435 1.424 . . . . 63.14 110.279 163.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 311' ' ' ASN . . . . . 0.426 ' N ' ' HD2' ' B' ' 312' ' ' PRO . 17.8 m120 -85.0 -48.24 0.62 Allowed Pre-proline 0 CA--C 1.561 1.394 0 CA-C-O 118.148 -0.93 . . . . 73.13 111.646 176.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 312' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' B' ' 311' ' ' ASN . 19.8 Cg_endo -57.66 -62.96 0.17 Allowed 'Trans proline' 0 C--N 1.402 3.35 0 C-N-CA 122.545 2.163 . . . . 70.14 112.482 178.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 313' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 73.52 -45.76 0.62 Allowed 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 125.914 1.686 . . . . 75.13 114.238 172.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 314' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 177.52 -31.28 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.313 1.045 . . . . 72.01 108.983 -165.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 315' ' ' ASN . . . . . 0.42 ' O ' ' HG3' ' B' ' 324' ' ' MET . 29.0 m-80 -73.68 -2.73 24.42 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.354 1.062 . . . . 72.12 111.947 -176.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 316' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -90.73 -38.34 13.11 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.806 0.842 . . . . 74.4 111.46 -179.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 18.1 t -159.51 -159.07 0.71 Allowed 'General case' 0 CA--C 1.553 1.06 0 N-CA-C 109.624 -0.51 . . . . 75.41 109.624 -168.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 318' ' ' VAL . . . . . . . . . . . . . 5.5 m 63.67 143.93 0.07 OUTLIER Pre-proline 0 N--CA 1.497 1.894 0 C-N-CA 127.603 2.361 . . . . 73.13 113.748 176.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 319' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -61.48 140.42 87.28 Favored 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 122.498 2.132 . . . . 65.1 110.905 174.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 320' ' ' THR . . . . . . . . . . . . . 2.7 m 67.17 83.67 0.16 Allowed 'General case' 0 CA--C 1.557 1.25 0 C-N-CA 124.526 1.13 . . . . 53.31 109.151 -173.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 321' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -91.66 8.27 37.65 Favored 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 124.294 1.037 . . . . 65.14 113.012 -169.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 322' ' ' ALA . . . . . . . . . . . . . . . 70.49 -101.67 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.225 1.41 . . . . 64.54 112.298 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 323' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -134.75 28.42 3.57 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.694 0.798 . . . . 74.02 110.901 -171.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 324' ' ' MET . . . . . 0.42 ' HG3' ' O ' ' B' ' 315' ' ' ASN . 1.3 tmt? -63.96 -58.18 7.5 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 109.017 -0.734 . . . . 71.32 109.017 171.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 325' ' ' THR . . . . . . . . . . . . . 13.9 p -70.22 103.94 2.5 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 109.059 -0.719 . . . . 72.33 109.059 169.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 326' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -172.01 -48.65 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.867 0.867 . . . . 72.01 109.255 -175.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt 64.63 45.18 3.6 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.633 1.173 . . . . 54.34 111.617 176.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 328' ' ' ALA . . . . . . . . . . . . . . . 64.25 25.35 13.54 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.411 1.084 . . . . 72.03 113.12 167.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 329' ' ' ILE . . . . . . . . . . . . . 3.0 mp 51.85 39.79 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.734 0 CA-C-O 122.6 1.191 . . . . 73.5 110.752 -175.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 330' ' ' GLU . . . . . 0.567 ' HB3' ' HA ' ' B' ' 333' ' ' SER . 46.7 mt-10 -93.29 -67.09 0.88 Allowed 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.522 -0.763 . . . . 63.42 110.054 176.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 331' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 54.52 93.59 0.02 OUTLIER 'General case' 0 C--N 1.365 1.252 0 C-N-CA 125.215 1.406 . . . . 63.34 111.202 178.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 332' ' ' LEU . . . . . . . . . . . . . 68.0 mt 73.65 0.91 3.78 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 124.977 1.311 . . . . 74.41 111.366 -168.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 333' ' ' SER . . . . . 0.567 ' HA ' ' HB3' ' B' ' 330' ' ' GLU . 19.7 t 54.26 78.8 0.15 Allowed 'General case' 0 C--N 1.356 0.856 0 C-N-CA 125.231 1.412 . . . . 65.04 112.183 -177.03 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.97 16.0 3.05 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 116.289 -0.414 . . . . 63.11 110.519 172.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 335' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -57.69 -61.62 2.38 Favored 'General case' 0 C--N 1.361 1.08 0 C-N-CA 123.861 0.865 . . . . 73.25 110.063 173.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 336' ' ' GLU . . . . . 0.561 ' HG2' ' H ' ' B' ' 338' ' ' GLY . 38.9 tt0 -166.78 146.85 5.72 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 124.352 1.061 . . . . 61.02 108.471 174.249 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 337' ' ' LYS . . . . . 0.597 ' HE3' ' HA ' ' B' ' 337' ' ' LYS . 0.6 OUTLIER -81.47 -36.17 29.63 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.312 0.645 . . . . 62.43 110.365 177.084 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 338' ' ' GLY . . . . . 0.561 ' H ' ' HG2' ' B' ' 336' ' ' GLU . . . 72.57 44.92 38.68 Favored Glycine 0 C--N 1.35 1.334 0 N-CA-C 111.161 -0.776 . . . . 72.34 111.161 -174.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 339' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -80.87 85.32 6.2 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.265 1.026 . . . . 74.33 109.2 -171.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 340' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -78.46 -40.93 34.15 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 115.689 -0.687 . . . . 75.24 112.063 -173.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 341' ' ' LEU . . . . . . . . . . . . . 98.3 mt 55.21 34.51 22.87 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 124.199 1.0 . . . . 75.34 111.616 -177.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 342' ' ' GLN . . . . . 0.545 HE22 ' HB2' ' B' ' 349' ' ' ASP . 6.7 tp-100 -70.47 87.57 0.65 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.186 0.994 . . . . 64.25 110.534 -176.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 343' ' ' VAL . . . . . . . . . . . . . 27.2 m -73.64 162.05 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 122.957 0.503 . . . . 64.24 110.578 176.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 344' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -111.61 177.96 4.48 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.985 0.914 . . . . 73.03 110.919 -174.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 345' ' ' GLY . . . . . . . . . . . . . . . 79.3 -85.97 1.22 Allowed Glycine 0 C--N 1.355 1.604 0 O-C-N 123.389 0.43 . . . . 62.31 112.061 179.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 346' ' ' ALA . . . . . . . . . . . . . . . -76.87 -39.38 51.27 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.212 -0.662 . . . . 72.22 109.212 171.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 347' ' ' SER . . . . . 0.419 ' HB2' ' HB2' ' B' ' 350' ' ' LYS . 19.6 m 66.9 124.36 0.02 OUTLIER 'General case' 0 C--N 1.361 1.104 0 C-N-CA 125.807 1.643 . . . . 72.21 112.48 174.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 11.7 tt -59.53 -33.85 52.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 C-N-CA 123.422 0.689 . . . . 73.42 111.18 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 349' ' ' ASP . . . . . 0.545 ' HB2' HE22 ' B' ' 342' ' ' GLN . 25.9 t70 -68.09 -36.78 80.36 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.87 0.868 . . . . 71.13 110.971 177.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 350' ' ' LYS . . . . . 0.546 ' HG3' ' HB3' ' B' ' 55' ' ' LEU . 11.0 mptt -92.48 -77.65 0.43 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.276 0.631 . . . . 74.52 110.704 -175.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 54.68 25.73 6.74 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.713 1.205 . . . . 71.32 112.438 -175.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 352' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -65.62 145.57 55.9 Favored 'General case' 0 C--N 1.351 0.666 0 CA-C-O 121.348 0.594 . . . . 74.35 110.755 -178.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 353' ' ' HIS . . . . . . . . . . . . . 11.2 p80 -143.44 -3.74 0.91 Allowed 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 114.856 -1.065 . . . . 74.33 110.356 -175.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 354' ' ' ALA . . . . . . . . . . . . . . . 69.22 -60.13 0.47 Allowed 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 125.47 1.508 . . . . 70.11 112.764 -177.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 355' ' ' ALA . . . . . . . . . . . . . . . 83.25 130.81 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 126.459 1.904 . . . . 75.44 110.673 178.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 356' ' ' ASN . . . . . . . . . . . . . 11.5 m120 68.48 129.05 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.482 0 C-N-CA 125.328 1.451 . . . . 74.32 110.736 -173.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 357' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -61.36 -28.21 83.91 Favored 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 122.228 1.952 . . . . 55.22 111.514 171.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 358' ' ' CYS . . . . . 0.584 ' SG ' ' HA ' ' B' ' 232' ' ' THR . 24.2 t 60.78 38.8 17.89 Favored 'General case' 0 C--N 1.361 1.07 0 C-N-CA 124.924 1.289 . . . . 73.32 111.303 173.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 359' ' ' GLY . . . . . . . . . . . . . . . -84.84 55.01 4.97 Favored Glycine 0 C--N 1.348 1.225 0 CA-C-N 115.206 -0.906 . . . . 62.01 113.257 -177.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 360' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 54.27 7.13 0.12 Allowed 'General case' 0 N--CA 1.502 2.154 0 C-N-CA 127.255 2.222 . . . . 53.34 116.351 170.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 361' ' ' ILE . . . . . 0.416 HG23 ' H ' ' B' ' 362' ' ' GLY 0.292 16.3 tt 45.55 -70.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 C-N-CA 126.521 1.928 . . . . 61.31 113.373 -166.547 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 362' ' ' GLY . . . . . 0.416 ' H ' HG23 ' B' ' 361' ' ' ILE . . . -122.26 179.48 16.19 Favored Glycine 0 C--N 1.35 1.325 0 N-CA-C 111.956 -0.458 . . . . 72.35 111.956 175.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 363' ' ' GLU . . . . . 0.459 ' HA ' HE22 ' B' ' 250' ' ' GLN . 7.7 tp10 -89.27 54.26 2.9 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.986 0.914 . . . . 73.13 109.5 -178.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 364' ' ' THR . . . . . . . . . . . . . 32.3 m 52.71 -101.45 0.11 Allowed 'General case' 0 CA--C 1.561 1.392 0 C-N-CA 125.042 1.337 . . . . 74.04 110.624 -169.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 365' ' ' VAL . . . . . . . . . . . . . 74.2 t -143.27 -69.56 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 N-CA-C 107.484 -1.302 . . . . 74.01 107.484 174.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 366' ' ' ASP . . . . . . . . . . . . . 36.6 t70 54.3 85.7 0.05 Allowed 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.148 1.379 . . . . 50.12 112.276 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 367' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -167.91 84.51 0.2 Allowed 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 105.797 -1.927 . . . . 75.05 105.797 176.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 368' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 57.41 40.27 27.53 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 124.111 0.964 . . . . 71.23 109.866 -169.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 369' ' ' GLU . . . . . . . . . . . . . 8.8 tm-20 -137.79 -21.93 1.1 Allowed 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 114.384 -1.28 . . . . 70.1 110.409 -164.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 370' ' ' ALA . . . . . . . . . . . . . . . -54.46 95.57 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.28 1.032 . . . . 74.25 111.935 -176.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 371' ' ' VAL . . . . . 0.493 HG13 HD21 ' B' ' 375' ' ' LEU . 2.4 p 56.31 6.57 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 C-N-CA 126.706 2.002 . . . . 74.11 113.255 -177.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 372' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -86.06 75.73 9.89 Favored 'General case' 0 C--N 1.352 0.693 0 N-CA-C 107.863 -1.162 . . . . 63.2 107.863 -175.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 373' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 -127.85 -48.37 1.37 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 114.228 -1.351 . . . . 72.05 109.055 -175.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -126.77 -84.54 0.61 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.365 0.666 . . . . 71.45 109.491 177.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 375' ' ' LEU . . . . . 0.521 HD22 ' HG3' ' A' ' 263' ' ' PRO . 79.1 mt 72.27 -43.31 0.56 Allowed 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 125.381 1.472 . . . . 62.01 113.225 178.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 376' ' ' GLU . . . . . 0.54 ' HG3' ' HB2' ' A' ' 260' ' ' ARG . 12.4 mm-40 73.45 -60.59 0.53 Allowed 'General case' 0 N--CA 1.5 2.028 0 C-N-CA 125.92 1.688 . . . . 73.13 113.444 171.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 377' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 71.2 -80.22 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.396 1.478 . . . . 73.31 111.302 177.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 378' ' ' ALA . . . . . . . . . . . . . . . -92.34 25.0 3.13 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.663 0.785 . . . . 61.1 111.637 -173.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . 0.503 ' HE3' ' HG2' ' A' ' 260' ' ' ARG . 63.2 tttp -139.55 102.24 4.41 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.846 0.858 . . . . 72.01 109.104 -177.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 380' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -99.99 -50.43 4.0 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.584 0.754 . . . . 53.14 109.392 174.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 381' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 60.52 38.26 19.11 Favored 'General case' 0 CA--C 1.555 1.163 0 CA-C-O 122.221 1.01 . . . . 74.34 111.07 172.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -147.58 67.38 0.39 Allowed Glycine 0 C--N 1.343 0.919 0 CA-C-N 114.903 -1.044 . . . . 73.1 110.493 -178.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 383' ' ' ASN . . . . . 0.43 HD22 HG22 ' B' ' 387' ' ' ILE . 15.4 m120 -137.46 105.69 5.74 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.677 1.191 . . . . 73.1 107.924 -178.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 384' ' ' THR . . . . . 0.402 ' HB ' ' HA ' ' C' ' 280' ' ' ALA . 35.8 m -113.44 -63.05 1.5 Allowed 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 111.977 0.362 . . . . 63.41 111.977 -171.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 86.3 mt -108.56 -86.91 0.51 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.502 0.721 . . . . 75.12 111.615 -171.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 386' ' ' VAL . . . . . 0.519 HG13 HD12 ' B' ' 387' ' ' ILE . 14.3 p -97.22 -26.15 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 122.619 0.368 . . . . 62.42 111.548 -169.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 387' ' ' ILE . . . . . 0.527 HG23 ' HB3' ' B' ' 391' ' ' ASP . 2.3 mp -72.51 86.99 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.074 0 CA-C-O 122.414 1.102 . . . . 74.12 109.233 173.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 388' ' ' VAL . . . . . . . . . . . . . 2.7 m -157.67 -42.26 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 127.579 2.352 . . . . 54.33 105.994 174.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 389' ' ' THR . . . . . . . . . . . . . 41.5 m -100.69 -35.43 9.48 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 114.361 -1.29 . . . . 71.25 108.584 168.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 390' ' ' ALA . . . . . . . . . . . . . . . -77.72 142.21 38.88 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 108.864 -0.791 . . . . 70.34 108.864 167.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 391' ' ' ASP . . . . . 0.527 ' HB3' HG23 ' B' ' 387' ' ' ILE . 30.1 t70 57.03 27.98 14.14 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 122.163 0.983 . . . . 64.12 110.678 -179.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 392' ' ' HIS . . . . . . . . . . . . . 29.1 t60 -68.62 94.04 0.55 Allowed 'General case' 0 C--N 1.351 0.641 0 CA-C-N 114.701 -1.136 . . . . 72.42 109.817 -177.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -154.63 117.23 4.34 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 123.828 0.851 . . . . 61.53 109.029 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 394' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -71.95 -23.02 61.38 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.096 0.558 . . . . 73.31 111.137 175.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 395' ' ' ALA . . . . . . . . . . . . . . . 64.54 -74.44 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.651 1.58 . . . . 71.44 111.645 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 396' ' ' SER . . . . . . . . . . . . . 36.9 t -66.84 120.84 14.23 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.082 0.953 . . . . 75.55 110.614 177.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 397' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -70.38 -10.37 58.87 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 112.416 0.524 . . . . 71.41 112.416 -177.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 86.6 mt -49.19 -50.45 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 124.244 1.017 . . . . 75.44 110.655 174.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 399' ' ' VAL . . . . . . . . . . . . . 15.3 m -88.74 112.41 23.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-N 115.536 -0.756 . . . . 73.32 110.069 176.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 400' ' ' ALA . . . . . . . . . . . . . . . -77.6 -41.44 2.27 Favored Pre-proline 0 CA--C 1.563 1.443 0 CA-C-O 118.03 -0.986 . . . . 51.41 112.18 176.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 401' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -61.47 88.3 0.1 OUTLIER 'Trans proline' 0 C--N 1.397 3.082 0 C-N-CA 122.075 1.85 . . . . 71.04 113.377 174.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 402' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -108.4 -70.88 0.78 Allowed 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 107.866 -1.161 . . . . 74.34 107.866 174.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 403' ' ' THR . . . . . . . . . . . . . 20.1 m -72.95 -30.45 63.86 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.529 0.732 . . . . 51.3 109.94 176.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 404' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -93.15 72.18 4.6 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.984 0.914 . . . . 70.03 109.692 -179.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 405' ' ' ALA . . . . . 0.462 ' HB3' ' HD3' ' B' ' 406' ' ' PRO . . . -170.19 -52.2 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.341 0 C-N-CA 124.018 0.927 . . . . 71.24 111.058 177.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 406' ' ' PRO . . . . . 0.462 ' HD3' ' HB3' ' B' ' 405' ' ' ALA . 42.0 Cg_endo -107.85 20.07 0.09 OUTLIER 'Trans proline' 0 C--N 1.387 2.567 0 C-N-CA 123.057 2.505 . . . . 44.44 113.835 176.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 407' ' ' GLY . . . . . . . . . . . . . . . -75.3 79.5 1.05 Allowed Glycine 0 C--N 1.354 1.548 0 N-CA-C 114.096 0.398 . . . . 55.33 114.096 -171.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 408' ' ' LEU . . . . . 0.553 HD11 HD21 ' B' ' 412' ' ' LEU . 14.7 tp 64.1 41.68 6.16 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 125.074 1.349 . . . . 72.03 110.939 178.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 409' ' ' THR . . . . . . . . . . . . . 30.5 p -67.72 -36.17 80.11 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.336 -0.847 . . . . 73.52 111.965 178.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 410' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -73.92 155.78 38.33 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.745 0.818 . . . . 51.32 111.225 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . -85.29 -3.88 58.97 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.558 0.743 . . . . 63.14 112.233 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 412' ' ' LEU . . . . . 0.553 HD21 HD11 ' B' ' 408' ' ' LEU . 3.3 mm? 69.29 -68.93 0.17 Allowed 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 125.62 1.568 . . . . 60.41 110.877 -175.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 413' ' ' ASN . . . . . . . . . . . . . 18.4 m120 67.22 173.72 0.26 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.126 1.37 . . . . 71.14 111.219 -178.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 414' ' ' THR . . . . . . . . . . . . . 30.2 p -67.01 -54.56 20.51 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.028 -1.101 . . . . 73.24 108.028 167.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 415' ' ' LYS . . . . . 0.489 ' HG2' ' HB3' ' B' ' 418' ' ' ALA . 35.6 ttmt 59.72 18.61 7.38 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 124.536 1.134 . . . . 73.42 111.483 171.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 416' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -58.85 -49.18 78.72 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.948 1.299 . . . . 75.33 111.308 -171.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 417' ' ' GLY . . . . . . . . . . . . . . . -61.98 -28.78 70.97 Favored Glycine 0 C--N 1.347 1.179 0 O-C-N 123.857 0.723 . . . . 43.15 113.251 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 418' ' ' ALA . . . . . 0.489 ' HB3' ' HG2' ' B' ' 415' ' ' LYS . . . -80.95 -40.34 24.63 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.423 0.689 . . . . 70.25 110.971 178.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 419' ' ' VAL . . . . . . . . . . . . . 32.8 m -92.51 32.6 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 123.245 0.618 . . . . 62.03 110.812 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 420' ' ' MET . . . . . . . . . . . . . 26.4 ptm -68.54 -7.6 33.94 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.737 0.815 . . . . 73.12 112.065 176.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 421' ' ' VAL . . . . . . . . . . . . . 34.1 m -76.58 -27.96 17.42 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 C-N-CA 122.752 0.421 . . . . 72.42 110.604 172.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 422' ' ' MET . . . . . 0.441 ' HA ' ' HB ' ' B' ' 435' ' ' THR . 1.7 tmt? -95.04 134.07 38.13 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.374 1.07 . . . . 74.1 109.556 179.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 423' ' ' SER . . . . . . . . . . . . . 22.8 t 64.08 -73.88 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 125.503 1.521 . . . . 62.22 112.358 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 424' ' ' TYR . . . . . . . . . . . . 0.259 50.1 p90 50.91 -74.16 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 126.815 2.046 . . . . 72.42 113.993 -178.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 425' ' ' GLY . . . . . . . . . . . . . . . -163.39 28.97 0.24 Allowed Glycine 0 N--CA 1.468 0.774 0 N-CA-C 111.17 -0.772 . . . . 75.12 111.17 -177.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 426' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -69.34 -43.23 74.08 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.683 1.193 . . . . 75.43 111.835 -173.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 427' ' ' SER . . . . . . . . . . . . . 22.4 t 78.43 -42.43 0.33 Allowed 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 125.328 1.451 . . . . 75.14 112.054 -178.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -57.4 -39.31 75.83 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.167 0.587 . . . . 73.23 109.952 172.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 429' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 71.12 111.41 0.06 Allowed 'General case' 0 CA--C 1.546 0.794 0 O-C-N 124.862 1.351 . . . . 63.42 110.873 165.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 430' ' ' ASP . . . . . 0.563 ' HB2' ' HB3' ' B' ' 433' ' ' GLU . 6.7 p-10 -69.24 -26.67 64.91 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.353 1.061 . . . . 55.41 112.959 -171.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 431' ' ' SER . . . . . . . . . . . . . 15.3 m 63.11 44.3 5.88 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.349 1.06 . . . . 73.31 110.792 179.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 432' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 70.67 54.46 0.27 Allowed 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 124.668 1.187 . . . . 71.1 109.859 -179.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 433' ' ' GLU . . . . . 0.563 ' HB3' ' HB2' ' B' ' 430' ' ' ASP . 33.1 tt0 -109.85 22.29 15.83 Favored 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 124.273 1.029 . . . . 73.43 109.153 173.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 434' ' ' HIS . . . . . . . . . . . . . 16.4 t60 76.24 -64.35 0.35 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 125.589 1.556 . . . . 65.13 111.569 176.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 435' ' ' THR . . . . . 0.441 ' HB ' ' HA ' ' B' ' 422' ' ' MET . 2.4 m 70.01 146.65 0.06 Allowed 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 125.423 1.489 . . . . 73.42 111.971 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 436' ' ' GLY . . . . . . . . . . . . . . . 95.54 -0.05 63.06 Favored Glycine 0 C--N 1.341 0.811 0 N-CA-C 110.712 -0.955 . . . . 43.54 110.712 -163.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 437' ' ' SER . . . . . . . . . . . . . 16.4 m -90.68 121.02 32.22 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.023 1.329 . . . . 54.14 109.16 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 438' ' ' GLN . . . . . . . . . . . . . 47.1 tp60 60.54 90.57 0.06 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.361 1.064 . . . . 71.55 110.024 -172.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 439' ' ' LEU . . . . . 0.443 HD23 ' H ' ' B' ' 439' ' ' LEU . 2.0 pt? -89.49 33.08 0.83 Allowed 'General case' 0 CA--C 1.555 1.16 0 CA-C-N 115.035 -0.984 . . . . 74.24 111.518 -173.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 440' ' ' ARG . . . . . . . . . . . . . 52.1 ttp180 70.07 100.81 0.06 Allowed 'General case' 0 C--N 1.367 1.337 0 C-N-CA 124.731 1.212 . . . . 70.1 110.89 178.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 441' ' ' ILE . . . . . 0.495 HD11 HG13 ' A' ' 221' ' ' VAL . 55.1 mt -127.58 116.48 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 124.037 0.935 . . . . 74.15 109.945 -176.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 442' ' ' ALA . . . . . . . . . . . . . . . -105.77 37.62 2.2 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.84 0.856 . . . . 71.41 110.235 177.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 443' ' ' ALA . . . . . . . . . . . . . . . -77.78 -65.09 1.01 Allowed 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.538 -0.755 . . . . 74.21 111.193 -177.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 444' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -98.33 154.3 17.92 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.414 0.686 . . . . 65.34 109.78 -176.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 445' ' ' GLY . . . . . . . . . . . . . . . -153.01 -161.59 10.41 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-O 119.244 -0.753 . . . . 74.34 111.407 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 446' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -78.08 144.18 20.93 Favored 'Trans proline' 0 C--N 1.37 1.678 0 C-N-CA 122.669 2.246 . . . . 63.02 111.983 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 447' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -73.78 131.15 41.26 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 108.664 -0.865 . . . . 60.0 108.664 179.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 448' ' ' ALA . . . . . . . . . . . . . . . -67.93 84.62 0.22 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 123.552 0.741 . . . . 74.31 109.547 175.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 449' ' ' ALA . . . . . . . . . . . . . . . -139.23 129.28 25.14 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 124.859 1.264 . . . . 61.52 108.214 -176.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 450' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 46.02 -163.6 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 125.269 1.428 . . . . 61.12 112.681 -176.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 59.2 t 63.28 -79.31 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 124.568 1.147 . . . . 63.1 110.583 -174.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 452' ' ' VAL . . . . . 0.464 HG13 ' H ' ' B' ' 453' ' ' GLY 0.279 2.7 p 40.29 -82.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.371 1.54 0 C-N-CA 126.792 2.037 . . . . 60.45 113.575 179.998 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 453' ' ' GLY . . . . . 0.464 ' H ' HG13 ' B' ' 452' ' ' VAL . . . 176.14 -75.11 0.08 OUTLIER Glycine 0 C--N 1.339 0.709 0 CA-C-N 118.42 0.554 . . . . 73.44 112.534 176.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 454' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 60.55 -78.41 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.949 1.3 . . . . 72.5 110.423 -171.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 30.8 m 66.37 -79.82 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.342 1.457 . . . . 61.41 111.435 179.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 456' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -116.24 -25.01 7.73 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.437 1.095 . . . . 74.3 109.91 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 457' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -71.53 127.56 32.98 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.851 0.86 . . . . 42.14 108.818 175.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 458' ' ' THR . . . . . . . . . . . . . 18.8 p -108.69 87.78 2.57 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.557 0.743 . . . . 72.13 111.274 -176.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 459' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -115.96 155.41 28.07 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.072 -1.085 . . . . 73.31 108.072 172.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 460' ' ' LEU . . . . . . . . . . . . . 2.0 pp -73.12 -0.37 13.9 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 113.691 0.997 . . . . 65.42 113.691 -176.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 461' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -68.76 0.2 4.59 Favored 'General case' 0 CA--C 1.563 1.476 0 N-CA-C 113.516 0.932 . . . . 62.31 113.516 -175.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 462' ' ' TYR . . . . . . . . . . . . . 20.4 p90 -78.65 23.35 0.32 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.217 -0.927 . . . . 72.53 111.94 172.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 4.6 m -71.16 77.16 0.7 Allowed 'General case' 0 CA--C 1.56 1.332 0 C-N-CA 125.158 1.383 . . . . 61.35 110.59 173.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 464' ' ' MET . . . . . . . . . . . . . 18.9 ptm -96.93 92.67 6.22 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-O 121.733 0.778 . . . . 75.31 110.212 177.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 465' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -123.98 85.39 2.41 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 108.27 -1.011 . . . . 72.15 108.27 170.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -91.43 -173.41 3.58 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 114.974 -1.012 . . . . 62.32 110.189 177.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 467' ' ' ALA . . . . . . . . . . . . . . . 71.93 -69.25 0.19 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 125.438 1.495 . . . . 75.3 111.539 178.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 468' ' ' LEU . . . . . 0.4 ' H ' ' HG ' ' B' ' 468' ' ' LEU . 2.2 pp -82.97 -12.04 57.63 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.558 0.743 . . . . 45.51 111.281 173.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 469' ' ' GLY . . . . . . . . . . . . . . . -143.05 -173.65 14.81 Favored Glycine 0 C--N 1.353 1.504 0 C-N-CA 123.436 0.541 . . . . 50.44 111.889 177.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 470' ' ' LEU . . . . . . . . . . . . . 58.5 tp -163.71 139.91 6.7 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.084 0.954 . . . . 73.2 109.666 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 471' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.546 0.805 0 N-CA-C 107.007 -1.479 . . . . 74.2 107.007 173.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . 0.502 ' SD ' ' N ' ' C' ' 1' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.474 0.775 0 N-CA-C 109.197 -0.668 . . . . 55.23 109.197 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.59 25.91 12.19 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 125.908 1.683 . . . . 65.31 113.543 176.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 3' ' ' ALA . . . . . . . . . . . . . . . -85.38 66.67 9.81 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.006 0.522 . . . . 52.01 110.008 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 4' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -38.72 104.96 0.04 OUTLIER 'General case' 0 C--N 1.358 0.939 0 C-N-CA 125.504 1.522 . . . . 70.52 112.779 178.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 5' ' ' LYS . . . . . 0.47 ' HE2' HD11 ' C' ' 10' ' ' ILE . 47.6 mtpt -97.34 112.37 24.22 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.625 -0.88 . . . . 63.2 108.625 173.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -71.07 105.01 3.19 Favored 'General case' 0 C--O 1.244 0.788 0 N-CA-C 108.806 -0.813 . . . . 63.22 108.806 174.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 7' ' ' TYR . . . . . 0.421 ' HA ' HD12 ' C' ' 10' ' ' ILE . 75.5 m-85 -63.42 -26.54 68.78 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 114.544 -1.207 . . . . 73.43 112.074 -173.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 8' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -63.58 -48.23 78.25 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 109.578 -0.527 . . . . 72.53 109.578 173.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.95 -37.84 83.77 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.102 0.561 . . . . 52.31 111.544 179.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 10' ' ' ILE . . . . . 0.47 HD11 ' HE2' ' C' ' 5' ' ' LYS . 63.8 mt -58.78 -43.9 89.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 C-N-CA 123.225 0.61 . . . . 63.34 110.465 174.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 73.4 mt -76.32 -11.83 59.97 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 115.77 -0.65 . . . . 45.45 112.698 177.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.32 40.22 55.7 Favored Glycine 0 C--N 1.35 1.353 0 N-CA-C 112.821 -0.112 . . . . 64.33 112.821 -176.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 13' ' ' VAL . . . . . . . . . . . . . 14.6 m -131.78 156.66 79.83 Favored Pre-proline 0 N--CA 1.485 1.295 0 C-N-CA 124.927 1.291 . . . . 64.04 109.826 178.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -80.97 177.16 8.23 Favored 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 122.452 2.101 . . . . 74.43 112.421 176.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 90.5 mtt180 -83.78 36.99 0.57 Allowed 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 122.485 1.136 . . . . 71.52 111.297 176.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -117.34 -15.59 10.35 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.702 2.001 . . . . 71.24 107.417 172.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.79 104.69 0.56 Allowed 'General case' 0 C--N 1.35 0.621 0 CA-C-N 114.383 -1.28 . . . . 71.14 112.834 -169.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 76.7 p -71.28 -170.13 0.46 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.894 1.278 . . . . 74.41 110.841 174.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.83 -42.89 90.34 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 124.276 1.03 . . . . 74.45 110.152 177.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 20' ' ' GLU . . . . . 0.493 ' O ' ' HG3' ' C' ' 24' ' ' ARG . 0.9 OUTLIER -75.58 -35.74 60.52 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 116.235 -0.438 . . . . 64.05 110.326 -175.582 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -68.52 -38.85 81.26 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-O 121.223 0.535 . . . . 73.42 110.55 178.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 22' ' ' ILE . . . . . . . . . . . . . 1.1 mp -60.14 -39.53 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.397 1.079 . . . . 61.32 109.796 169.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 23' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -70.01 -31.39 69.04 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.297 -0.865 . . . . 74.13 110.812 178.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 24' ' ' ARG . . . . . 0.493 ' HG3' ' O ' ' C' ' 20' ' ' GLU . 89.0 mtt180 -65.81 -44.87 84.35 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 109.398 -0.593 . . . . 73.52 109.398 177.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.09 -34.9 79.11 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 114.57 -1.196 . . . . 75.32 111.562 176.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 26' ' ' TYR . . . . . 0.418 ' O ' ' HB3' ' C' ' 30' ' ' ALA . 86.6 t80 -67.9 -48.15 66.8 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 123.816 0.698 . . . . 72.31 110.631 177.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -59.37 -56.11 26.18 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.381 -0.6 . . . . 74.1 109.381 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 28' ' ' ARG . . . . . . . . . . . . . 32.3 ttt180 -50.49 -70.76 0.08 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.947 0.899 . . . . 71.15 111.489 177.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 29' ' ' LEU . . . . . . . . . . . . . 86.7 mt -75.0 -50.31 16.98 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.42 -0.809 . . . . 60.22 112.04 -168.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' C' ' 26' ' ' TYR . . . -67.57 -28.52 67.85 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-O 117.714 -1.136 . . . . 75.32 112.239 -176.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . 0.462 ' HA ' ' HB2' ' C' ' 34' ' ' HIS . 74.5 mtm180 -80.9 -28.24 35.95 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 120.051 1.296 . . . . 73.5 110.842 173.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -65.34 -31.33 72.4 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.212 0.605 . . . . 71.12 110.367 171.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 33' ' ' TYR . . . . . 0.453 ' HB3' ' O ' ' C' ' 43' ' ' ALA . 21.7 m-85 -111.02 8.13 21.8 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.884 0.873 . . . . 70.15 112.056 -174.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 34' ' ' HIS . . . . . 0.462 ' HB2' ' HA ' ' C' ' 31' ' ' ARG . 9.4 t-160 -75.43 114.33 34.79 Favored Pre-proline 0 N--CA 1.479 1.003 0 CA-C-O 118.26 -0.876 . . . . 72.34 110.152 -174.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 35' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.52 -20.53 49.9 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 122.423 2.082 . . . . 71.32 112.882 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 36' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -53.5 -43.69 68.45 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.773 1.229 . . . . 60.34 112.181 173.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 86.5 t -107.53 -52.49 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 123.109 0.564 . . . . 75.33 109.955 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -98.37 90.68 4.88 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.128 0.971 . . . . 54.22 109.898 -176.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 39' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -74.84 81.4 2.12 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 109.113 -0.699 . . . . 62.24 109.113 176.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 70.8 m -137.37 117.02 10.31 Favored Pre-proline 0 N--CA 1.48 1.037 0 C-N-CA 123.459 0.704 . . . . 74.14 109.756 176.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -50.52 -43.33 45.52 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 123.882 3.055 . . . . 63.44 114.005 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -58.06 -40.3 80.66 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.406 0.682 . . . . 65.44 110.549 175.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 43' ' ' ALA . . . . . 0.453 ' O ' ' HB3' ' C' ' 33' ' ' TYR . . . -73.41 -17.93 61.21 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 115.661 -0.7 . . . . 62.05 110.259 -178.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 44' ' ' GLU . . . . . 0.457 ' O ' ' HD3' ' C' ' 48' ' ' LYS . 44.1 mt-10 -74.87 -43.9 51.9 Favored 'General case' 0 C--N 1.358 0.947 0 N-CA-C 109.217 -0.66 . . . . 74.04 109.217 175.01 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -57.69 -46.03 84.87 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 121.672 0.748 . . . . 42.53 110.048 175.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 46' ' ' LYS . . . . . 0.557 ' O ' HG12 ' C' ' 50' ' ' ILE . 99.9 mttt -63.6 -39.56 94.67 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 114.237 -1.347 . . . . 72.32 110.802 176.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -62.94 -32.53 73.86 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.869 0.868 . . . . 62.23 110.476 177.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 48' ' ' LYS . . . . . 0.457 ' HD3' ' O ' ' C' ' 44' ' ' GLU . 2.5 mptm? -65.81 -47.32 75.48 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 122.959 0.504 . . . . 72.04 109.702 173.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -58.57 -44.59 89.81 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.13 0.572 . . . . 72.33 111.304 178.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 50' ' ' ILE . . . . . 0.557 HG12 ' O ' ' C' ' 46' ' ' LYS . 20.3 mm -63.21 -49.31 83.7 Favored 'Isoleucine or valine' 0 C--N 1.361 1.078 0 CA-C-N 115.686 -0.688 . . . . 75.43 109.733 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 51' ' ' ASN . . . . . 0.51 ' HA ' ' HB3' ' C' ' 54' ' ' TYR . 22.0 m-80 -79.9 -9.18 59.65 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.703 0.801 . . . . 74.04 112.169 -176.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 52' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -71.26 -61.37 1.79 Allowed 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 107.842 -1.17 . . . . 63.42 107.842 167.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.65 -41.72 86.71 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 113.626 -1.624 . . . . 63.1 112.216 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 54' ' ' TYR . . . . . 0.51 ' HB3' ' HA ' ' C' ' 51' ' ' ASN . 67.2 t80 -65.1 -52.68 54.04 Favored 'General case' 0 C--O 1.213 -0.837 0 CA-C-N 115.148 -0.933 . . . . 75.01 109.884 177.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.68 -38.2 63.95 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 112.199 0.444 . . . . 60.54 112.199 -177.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 56' ' ' VAL . . . . . . . . . . . . . 98.2 t -64.61 -55.61 20.39 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 O-C-N 123.99 0.807 . . . . 72.43 110.887 173.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 57' ' ' LEU . . . . . . . . . . . . . 68.0 mt -94.27 7.58 44.86 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 113.616 0.969 . . . . 75.02 113.616 -168.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 43.8 t -69.65 -81.03 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.719 0.807 . . . . 62.42 110.919 -175.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -83.8 145.4 47.0 Favored Pre-proline 0 C--O 1.248 1.021 0 N-CA-C 109.37 -0.604 . . . . 72.03 109.37 -174.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 60' ' ' PRO . . . . . 0.402 ' O ' ' HG2' ' C' ' 64' ' ' ARG . 9.8 Cg_endo -47.13 -33.92 16.4 Favored 'Trans proline' 0 C--N 1.387 2.588 0 C-N-CA 124.546 3.497 . . . . 33.23 113.634 -176.02 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -56.11 -71.03 0.1 Allowed 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 124.492 1.117 . . . . 62.13 111.62 178.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 33.8 mtmt -66.01 -29.08 69.39 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.74 0.816 . . . . 75.23 111.185 -174.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 63' ' ' ARG . . . . . . . . . . . . . 23.8 tpt85 -54.19 -52.47 61.1 Favored 'General case' 0 C--N 1.356 0.876 0 O-C-N 124.277 0.986 . . . . 64.42 109.583 170.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 64' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' C' ' 60' ' ' PRO . 1.7 mmp_? -63.33 -35.99 82.21 Favored 'General case' 0 C--N 1.357 0.896 0 CA-C-O 118.613 -0.708 . . . . 74.15 111.915 178.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 1.5 mp -55.98 -45.31 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-N 118.281 0.492 . . . . 62.34 110.363 175.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 66' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -61.59 -55.17 33.7 Favored 'General case' 0 C--N 1.358 0.957 0 N-CA-C 109.937 -0.394 . . . . 74.22 109.937 176.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 67' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -56.48 -36.48 69.15 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.646 0.778 . . . . 73.14 112.586 -176.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 68' ' ' THR . . . . . . . . . . . . . 45.5 p -77.35 -30.65 54.0 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 119.085 -0.484 . . . . 63.2 110.92 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 69' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -66.82 128.39 36.13 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 118.425 0.557 . . . . 75.22 110.471 -179.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.19 14.85 55.4 Favored Glycine 0 C--N 1.345 1.059 0 N-CA-C 111.582 -0.607 . . . . 62.51 111.582 -176.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 71' ' ' THR . . . . . . . . . . . . . 29.8 m -142.48 -57.44 0.44 Allowed 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 103.942 -2.614 . . . . 72.34 103.942 177.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 49.5 m -79.73 141.15 36.61 Favored 'General case' 0 C--O 1.257 1.494 0 N-CA-C 104.871 -2.27 . . . . 73.35 104.871 154.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.4 -40.07 10.12 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.486 0.714 . . . . 73.23 109.833 178.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -77.88 128.28 79.56 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 123.886 0.874 . . . . 53.23 110.619 -175.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 75' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -62.48 121.28 9.18 Favored 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 122.642 2.228 . . . . 75.14 110.746 174.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 76' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -52.23 131.19 38.67 Favored 'Trans proline' 0 C--N 1.38 2.193 0 C-N-CA 123.328 2.685 . . . . 63.14 113.001 -179.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 77' ' ' PRO . . . . . 0.503 ' HA ' ' HD3' ' C' ' 78' ' ' PRO . 12.2 Cg_endo -53.03 126.79 22.62 Favored 'Trans proline' 0 C--N 1.39 2.743 0 C-N-CA 123.392 2.728 . . . . 51.51 112.232 -175.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 78' ' ' PRO . . . . . 0.503 ' HD3' ' HA ' ' C' ' 77' ' ' PRO . 19.7 Cg_exo -64.09 148.53 91.39 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 122.738 2.292 . . . . 74.44 112.317 -172.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 79' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -57.34 158.1 19.81 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 122.512 2.141 . . . . 61.04 111.251 171.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -53.42 80.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.386 2.52 0 C-N-CA 124.069 3.179 . . . . 51.5 115.259 -171.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . 149.75 -41.91 0.81 Allowed Glycine 0 C--N 1.341 0.826 0 N-CA-C 110.773 -0.931 . . . . 75.2 110.773 -178.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 145.86 174.86 18.42 Favored Glycine 0 C--N 1.343 0.921 0 C-N-CA 123.472 0.558 . . . . 74.45 111.881 177.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -53.56 124.32 14.64 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.209 1.004 . . . . 70.14 109.799 169.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 84' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -58.1 110.85 1.01 Allowed 'General case' 0 N--CA 1.479 0.984 0 O-C-N 123.88 0.737 . . . . 63.13 111.179 175.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 85' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -142.86 31.62 1.42 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.371 1.469 . . . . 74.41 108.736 170.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 86' ' ' SER . . . . . 0.462 ' OG ' ' HD2' ' C' ' 143' ' ' ARG . 7.4 m -71.04 106.88 3.86 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 114.216 -1.356 . . . . 45.43 110.191 -173.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 87' ' ' GLY . . . . . . . . . . . . . . . 100.84 -21.8 42.21 Favored Glycine 0 C--N 1.337 0.626 0 CA-C-N 116.107 -0.497 . . . . 74.33 112.811 -176.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 88' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -88.0 130.65 34.9 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 108.203 -1.036 . . . . 74.44 108.203 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 89' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -75.68 69.55 2.39 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.964 0.905 . . . . 72.23 110.664 -170.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 90' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -48.34 -43.27 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 125.679 1.592 . . . . 54.41 112.114 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -62.76 -30.78 71.7 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.267 0.627 . . . . 74.21 111.91 -176.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -81.53 -26.02 35.43 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.511 0.324 . . . . 75.53 110.607 177.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 15.1 m-30 -68.95 166.75 17.24 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.499 0.319 . . . . 72.45 110.855 -174.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 94' ' ' SER . . . . . . . . . . . . . 65.1 p -63.68 162.2 13.6 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 114.3 1.222 . . . . 45.51 114.3 -165.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 95' ' ' GLU . . . . . 0.421 ' O ' ' HG3' ' C' ' 99' ' ' GLU . 0.0 OUTLIER -63.39 -44.17 95.47 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 114.988 -1.006 . . . . 55.43 111.931 178.245 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 96' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -55.79 -46.95 77.85 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.313 0.645 . . . . 65.02 110.545 177.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 97' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -56.58 -46.85 80.59 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 113.77 -1.559 . . . . 64.25 110.271 175.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 98' ' ' GLN . . . . . 0.489 ' HA ' ' CD1' ' C' ' 105' ' ' LEU . 93.1 mt-30 -73.89 -12.71 60.75 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.183 0.808 . . . . 51.52 113.183 -176.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . 0.421 ' HG3' ' O ' ' C' ' 95' ' ' GLU . 46.8 mt-10 -87.1 -48.43 8.08 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.19 0.596 . . . . 74.43 111.211 172.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 100' ' ' LEU . . . . . . . . . . . . . 13.3 tp -66.6 -60.1 3.01 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.588 0.755 . . . . 73.23 111.313 -175.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 101' ' ' PHE . . . . . 0.402 ' C ' ' HG ' ' C' ' 105' ' ' LEU . 64.4 m-85 -85.23 -8.98 58.29 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 116.205 -0.452 . . . . 73.25 110.994 -177.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . -39.0 -55.24 2.34 Favored Glycine 0 C--N 1.365 2.157 0 CA-C-O 118.407 -1.218 . . . . 54.11 114.943 -176.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -29.24 -37.47 0.04 OUTLIER 'Trans proline' 0 C--N 1.391 2.782 1 C-N-CA 125.731 4.287 . . . . 62.02 116.888 173.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 104' ' ' GLY . . . . . . . . . . . . . . . -147.52 36.45 1.17 Allowed Glycine 0 C--N 1.352 1.454 0 C-N-CA 121.559 -0.353 . . . . 43.23 112.982 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 105' ' ' LEU . . . . . 0.489 ' CD1' ' HA ' ' C' ' 98' ' ' GLN . 4.1 mt -68.61 14.2 0.08 Allowed 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 115.629 1.714 . . . . 73.03 115.629 -174.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 106' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 54.92 -160.13 0.17 Allowed 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 119.21 0.914 . . . . 64.24 110.088 -170.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 107' ' ' GLY . . . . . . . . . . . . . . . 85.73 64.25 1.5 Allowed Glycine 0 C--N 1.36 1.877 0 C-N-CA 118.566 -1.778 . . . . 51.05 117.459 162.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 64.7 -81.57 0.06 OUTLIER Glycine 0 N--CA 1.48 1.606 0 N-CA-C 114.896 0.719 . . . . 74.41 114.896 162.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 109' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -73.07 -5.34 38.31 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.217 1.007 . . . . 74.45 112.093 -177.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 110' ' ' GLY . . . . . . . . . . . . . . . -71.03 9.99 3.53 Favored Glycine 0 CA--C 1.56 2.872 0 N-CA-C 115.879 1.112 . . . . 54.22 115.879 172.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 82.06 -40.9 0.12 Allowed 'General case' 0 N--CA 1.503 2.222 0 C-N-CA 125.753 1.621 . . . . 75.25 114.705 170.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 112' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -105.75 -46.2 4.2 Favored 'General case' 0 N--CA 1.503 2.189 0 CA-C-N 119.776 1.171 . . . . 74.1 107.991 169.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 113' ' ' SER . . . . . . . . . . . . . 31.3 m -1.09 79.64 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 128.142 2.577 . . . . 72.53 115.662 153.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 114' ' ' ARG . . . . . 0.569 ' HG3' ' H ' ' C' ' 115' ' ' LYS . 0.3 OUTLIER -99.13 -161.87 0.91 Allowed 'General case' 0 CA--C 1.557 1.213 0 O-C-N 121.453 -0.78 . . . . 74.05 111.263 177.696 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 115' ' ' LYS . . . . . 0.777 ' HG3' ' HB2' ' C' ' 170' ' ' PRO . 84.8 tttt -83.68 140.15 32.33 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 106.467 -1.679 . . . . 54.14 106.467 160.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -57.56 109.13 1.61 Allowed Glycine 0 C--N 1.347 1.174 0 N-CA-C 111.252 -0.739 . . . . 45.25 111.252 176.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 117' ' ' ARG . . . . . . . . . . . . . 67.7 mtp180 -93.91 163.55 13.45 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.545 0.738 . . . . 64.44 109.977 177.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 118' ' ' ASP . . . . . 0.403 ' HA ' ' O ' ' C' ' 173' ' ' ASP . 9.6 p-10 -73.33 93.52 1.92 Allowed 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 108.57 -0.9 . . . . 75.42 108.57 174.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 119' ' ' LEU . . . . . 0.462 HD13 ' HA ' ' C' ' 174' ' ' LEU . 0.0 OUTLIER -95.33 157.08 16.05 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 108.233 -1.025 . . . . 75.21 108.233 -178.544 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.64 126.41 48.97 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.94 -0.392 . . . . 72.31 109.94 -174.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 121' ' ' ALA . . . . . . . . . . . . . . . -125.19 118.71 26.65 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 108.747 -0.834 . . . . 63.21 108.747 -178.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 122' ' ' GLU . . . . . 0.438 ' HB3' ' HD2' ' B' ' 184' ' ' HIS . 37.2 tt0 -94.88 148.16 22.6 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 122.676 0.39 . . . . 73.22 110.839 -171.116 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 123' ' ' LEU . . . . . 0.667 ' HB3' ' HA ' ' B' ' 182' ' ' VAL . 1.0 OUTLIER -144.61 114.82 5.19 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 122.862 0.465 . . . . 73.3 111.137 -177.318 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' C' ' 179' ' ' ARG . 33.1 Cg_endo -66.18 114.45 3.03 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 121.862 1.708 . . . . 72.51 108.964 162.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 125' ' ' LEU . . . . . 0.583 HD23 HG11 ' C' ' 153' ' ' VAL . 18.4 tp -138.15 155.52 48.64 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.579 0.351 . . . . 74.03 110.846 -164.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 126' ' ' THR . . . . . . . . . . . . . 15.0 p -100.09 160.6 14.19 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-O 121.871 0.843 . . . . 61.53 111.218 173.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 127' ' ' LEU . . . . . 0.486 HD21 HD13 ' C' ' 180' ' ' LEU . 8.4 mt -67.13 -35.46 79.77 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 113.46 -1.7 . . . . 62.25 108.479 174.127 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -62.88 -47.23 84.2 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 113.145 -1.843 . . . . 75.24 109.605 176.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 129' ' ' GLU . . . . . 0.705 ' HG2' HD22 ' B' ' 167' ' ' ASN . 12.1 mm-40 -66.46 -28.82 68.89 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 122.854 0.462 . . . . 73.53 111.732 176.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 130' ' ' ALA . . . . . 0.416 ' HB2' HG12 ' C' ' 153' ' ' VAL . . . -63.85 -41.23 97.85 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 123.463 0.477 . . . . 64.34 110.51 175.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 131' ' ' PHE . . . . . 0.439 ' HB2' HD13 ' C' ' 215' ' ' LEU . 52.3 t80 -65.31 -43.0 92.46 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.965 0.906 . . . . 75.55 110.292 172.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 132' ' ' HIS . . . . . 0.472 ' O ' ' HD3' ' C' ' 136' ' ' ARG . 23.5 m170 -80.01 -1.8 41.35 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.206 -0.906 . . . . 60.22 110.781 -176.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 133' ' ' GLY . . . . . . . . . . . . . . . -69.15 65.47 0.52 Allowed Glycine 0 C--N 1.358 1.8 0 C-N-CA 123.977 0.799 . . . . 65.31 114.447 174.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 134' ' ' GLY . . . . . . . . . . . . . . . -93.47 -126.23 4.25 Favored Glycine 0 C--N 1.343 0.936 0 N-CA-C 109.442 -1.463 . . . . 53.24 109.442 165.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 135' ' ' GLU . . . . . . . . . . . . . 13.8 mp0 -71.97 94.79 1.5 Allowed 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 117.667 0.734 . . . . 71.2 109.119 175.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 136' ' ' ARG . . . . . 0.472 ' HD3' ' O ' ' C' ' 132' ' ' HIS . 17.9 mmm180 -110.82 147.64 34.07 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.45 0.7 . . . . 72.12 110.313 -175.081 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 137' ' ' VAL . . . . . . . . . . . . . 35.8 m -91.73 144.19 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 108.823 -0.806 . . . . 71.12 108.823 178.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 138' ' ' VAL . . . . . 0.432 HG22 HG23 ' C' ' 140' ' ' VAL . 14.7 p -160.64 151.0 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 O-C-N 123.211 0.32 . . . . 72.14 110.936 -177.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 139' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -120.1 113.27 20.22 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 107.561 -1.274 . . . . 74.31 107.561 171.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 140' ' ' VAL . . . . . 0.512 HG11 HD13 ' C' ' 174' ' ' LEU . 90.0 t -130.14 101.61 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 123.759 0.824 . . . . 63.22 110.794 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 141' ' ' ALA . . . . . 0.652 ' HB3' HH21 ' C' ' 143' ' ' ARG . . . 55.45 44.65 26.69 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.576 1.551 . . . . 15.23 112.562 168.04 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 142' ' ' GLY . . . . . . . . . . . . . . . 103.08 6.26 45.72 Favored Glycine 0 C--N 1.347 1.175 0 CA-C-N 115.46 -0.791 . . . . 45.25 113.183 178.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 143' ' ' ARG . . . . . 0.652 HH21 ' HB3' ' C' ' 141' ' ' ALA . 0.0 OUTLIER -120.82 95.39 4.69 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 117.452 0.626 . . . . 73.04 110.19 -176.95 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 144' ' ' ARG . . . . . . . . . . . . . 52.9 ttt180 -90.49 87.25 6.69 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 107.767 -1.197 . . . . 71.51 107.767 168.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 145' ' ' VAL . . . . . . . . . . . . . 27.4 m -119.66 148.77 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 115.4 -0.818 . . . . 75.03 111.574 -176.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 146' ' ' SER . . . . . . . . . . . . . 16.0 p -99.11 96.9 8.1 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 124.492 1.117 . . . . 54.21 108.433 168.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 147' ' ' VAL . . . . . . . . . . . . . 14.8 p -124.83 151.52 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.753 0.821 . . . . 72.53 110.471 -173.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 148' ' ' ARG . . . . . . . . . . . . . 24.2 ttm180 -98.24 110.15 22.78 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 109.952 -0.388 . . . . 74.22 109.952 169.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 149' ' ' ILE . . . . . 0.429 HD12 HD13 ' C' ' 159' ' ' ILE . 39.8 pt -78.82 153.88 78.04 Favored Pre-proline 0 CA--C 1.552 1.038 0 N-CA-C 108.085 -1.08 . . . . 71.41 108.085 164.297 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 150' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -43.03 111.73 0.24 Allowed 'Trans proline' 0 C--N 1.385 2.45 0 C-N-CA 122.989 2.459 . . . . 61.44 112.879 175.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 151' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.95 102.6 0.13 Allowed 'Trans proline' 0 C--N 1.389 2.708 0 C-N-CA 123.507 2.805 . . . . 73.2 111.257 -178.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 152' ' ' GLY . . . . . 0.48 ' HA3' HD22 ' C' ' 188' ' ' LEU . . . 132.06 140.33 4.49 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 116.025 -0.534 . . . . 54.32 112.635 -171.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 153' ' ' VAL . . . . . 0.657 HG22 HG11 ' C' ' 178' ' ' VAL . 0.3 OUTLIER -152.59 167.26 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 N-CA-C 112.267 0.469 . . . . 71.13 112.267 -174.899 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 154' ' ' ARG . . . . . 0.518 ' NH1' ' HA ' ' B' ' 24' ' ' PRO . 19.2 mtt180 -138.61 162.89 33.47 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.529 1.131 . . . . 75.32 109.28 -173.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 155' ' ' GLU . . . . . 0.43 ' HB2' HD12 ' C' ' 180' ' ' LEU . 10.2 tp10 -72.76 132.65 43.89 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 123.98 0.912 . . . . 74.51 111.953 178.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 65.17 19.73 66.41 Favored Glycine 0 C--N 1.359 1.839 0 O-C-N 123.745 0.653 . . . . 64.51 113.601 173.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 157' ' ' SER . . . . . 0.459 ' OG ' ' HB2' ' C' ' 154' ' ' ARG . 53.4 m -98.18 172.19 7.75 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.241 0.616 . . . . 75.43 111.018 -172.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 158' ' ' VAL . . . . . . . . . . . . . 7.7 p -127.13 118.55 50.46 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.987 0 CA-C-N 115.173 -0.921 . . . . 64.44 110.062 -173.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 159' ' ' ILE . . . . . 0.69 ' HB ' ' HB2' ' C' ' 176' ' ' LEU . 25.4 mt -94.58 103.56 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 108.281 -1.007 . . . . 52.25 108.281 178.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 160' ' ' ARG . . . . . 0.479 HH12 ' HB3' ' C' ' 162' ' ' PRO . 64.4 ttp85 -83.55 100.92 11.09 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 109.819 -0.437 . . . . 72.21 109.819 -179.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 161' ' ' VAL . . . . . 0.609 ' HB ' ' HB3' ' C' ' 174' ' ' LEU . 58.2 t -94.59 103.37 11.02 Favored Pre-proline 0 CA--C 1.554 1.13 0 N-CA-C 108.404 -0.961 . . . . 75.24 108.404 175.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 162' ' ' PRO . . . . . 0.479 ' HB3' HH12 ' C' ' 160' ' ' ARG . 90.9 Cg_endo -73.87 164.19 35.2 Favored 'Trans proline' 0 C--N 1.373 1.843 0 C-N-CA 122.924 2.416 . . . . 63.42 113.879 -172.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.46 -25.14 6.58 Favored Glycine 0 C--N 1.345 1.055 0 CA-C-N 114.886 -1.052 . . . . 53.31 114.294 172.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 164' ' ' MET . . . . . 0.413 ' SD ' ' HG2' ' C' ' 143' ' ' ARG . 23.9 ttp -83.5 -77.7 0.24 Allowed 'General case' 0 C--N 1.356 0.853 0 CA-C-N 117.779 0.789 . . . . 73.35 110.071 -172.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 165' ' ' GLY . . . . . . . . . . . . . . . 87.21 -173.27 44.32 Favored Glycine 0 C--N 1.342 0.887 0 CA-C-O 120.116 -0.269 . . . . 64.24 113.664 179.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . -83.2 -125.53 1.03 Allowed Glycine 0 C--N 1.345 1.048 0 CA-C-O 119.98 -0.344 . . . . 75.44 112.826 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 167' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -79.64 146.64 32.39 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 117.037 0.419 . . . . 64.31 110.851 -177.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 168' ' ' GLY . . . . . 0.553 ' HA3' ' O ' ' C' ' 114' ' ' ARG . . . 78.11 -166.48 52.8 Favored Glycine 0 C--N 1.348 1.216 0 O-C-N 123.876 0.735 . . . . 13.44 112.934 -175.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 169' ' ' ASN . . . . . 0.402 ' HB3' ' HD3' ' C' ' 170' ' ' PRO . 23.0 t30 -104.6 -64.35 0.04 OUTLIER Pre-proline 0 CA--C 1.558 1.275 0 CA-C-O 117.214 -1.374 . . . . 62.44 114.421 -164.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 170' ' ' PRO . . . . . 0.777 ' HB2' ' HG3' ' C' ' 115' ' ' LYS . 95.6 Cg_exo -42.67 117.4 0.86 Allowed 'Trans proline' 0 C--N 1.408 3.679 0 C-N-CA 123.3 2.667 . . . . 51.41 114.216 -162.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 171' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -36.27 115.72 0.13 Allowed 'Trans proline' 0 C--N 1.397 3.099 1 C-N-CA 125.614 4.21 . . . . 74.02 115.876 -163.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -118.87 -150.51 8.8 Favored Glycine 0 C--N 1.345 1.03 0 CA-C-N 115.863 -0.608 . . . . 74.42 112.358 178.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 173' ' ' ASP . . . . . 0.403 ' O ' ' HA ' ' C' ' 118' ' ' ASP . 11.6 m-20 -136.43 147.12 47.09 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-O 121.794 0.807 . . . . 74.51 111.189 -178.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 174' ' ' LEU . . . . . 0.609 ' HB3' ' HB ' ' C' ' 161' ' ' VAL . 19.0 tp -103.06 136.72 42.34 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 114.194 -1.366 . . . . 75.22 107.71 168.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 66.5 mt -123.44 85.87 2.49 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.321 1.049 . . . . 71.32 108.97 -178.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 176' ' ' LEU . . . . . 0.69 ' HB2' ' HB ' ' C' ' 159' ' ' ILE . 82.0 mt -71.43 108.15 4.71 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.156 -0.475 . . . . 43.02 110.352 179.384 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 177' ' ' VAL . . . . . . . . . . . . . 25.1 t -84.96 93.46 3.57 Favored 'Isoleucine or valine' 0 C--N 1.347 0.472 0 N-CA-C 108.253 -1.017 . . . . 74.43 108.253 178.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 178' ' ' VAL . . . . . 0.657 HG11 HG22 ' C' ' 153' ' ' VAL . 2.4 p -84.11 117.15 29.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.292 -0.867 . . . . 74.01 110.525 -175.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 179' ' ' ARG . . . . . 0.404 ' O ' ' HA ' ' C' ' 124' ' ' PRO . 6.1 mmm180 -108.2 116.0 31.16 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 107.8 -1.185 . . . . 72.33 107.8 172.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 180' ' ' LEU . . . . . 0.486 HD13 HD21 ' C' ' 127' ' ' LEU . 92.9 mt -74.59 148.33 40.89 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 120.854 0.359 . . . . 70.51 110.499 178.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 181' ' ' LEU . . . . . . . . . . . . . 80.9 mt -70.14 166.09 37.12 Favored Pre-proline 0 CA--C 1.552 1.049 0 CA-C-O 118.236 -0.888 . . . . 74.2 109.348 177.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 182' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -54.2 76.15 0.03 OUTLIER 'Trans proline' 0 C--N 1.393 2.869 0 C-N-CA 123.224 2.616 . . . . 64.12 112.58 170.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 183' ' ' HIS . . . . . 0.432 ' N ' ' HD3' ' C' ' 184' ' ' PRO . 74.5 t60 174.88 54.48 0.03 OUTLIER Pre-proline 0 CA--C 1.561 1.384 0 C-N-CA 126.895 2.078 . . . . 62.13 106.384 -167.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 184' ' ' PRO . . . . . 0.432 ' HD3' ' N ' ' C' ' 183' ' ' HIS . 66.3 Cg_endo -93.83 65.1 0.41 Allowed 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.409 2.739 . . . . 71.54 110.628 -174.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 185' ' ' VAL . . . . . 0.527 ' O ' ' HA ' ' C' ' 195' ' ' ALA . 16.4 t -93.28 -58.04 3.93 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.559 0 N-CA-C 108.946 -0.761 . . . . 72.23 108.946 -167.249 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 186' ' ' PHE . . . . . 0.405 ' H ' HD13 ' C' ' 127' ' ' LEU . 48.2 m-85 -101.23 104.31 15.35 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 121.201 0.524 . . . . 61.44 111.052 -169.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 187' ' ' ARG . . . . . 0.428 ' NH1' ' HB2' ' C' ' 189' ' ' GLU . 4.0 tmt_? -95.63 122.37 38.32 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 107.79 -1.189 . . . . 75.14 107.79 174.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 188' ' ' LEU . . . . . 0.577 HD13 ' HD2' ' C' ' 240' ' ' PHE . 59.2 tp -80.34 147.94 30.87 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.689 0.396 . . . . 74.14 111.861 -177.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 189' ' ' GLU . . . . . 0.428 ' HB2' ' NH1' ' C' ' 187' ' ' ARG . 8.8 tp10 -144.93 110.54 5.33 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 107.756 -1.202 . . . . 71.33 107.756 161.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 190' ' ' GLY . . . . . . . . . . . . . . . 67.88 -93.12 0.26 Allowed Glycine 0 C--N 1.35 1.345 0 N-CA-C 111.58 -0.608 . . . . 74.2 111.58 -172.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 191' ' ' GLN . . . . . 0.517 ' NE2' ' HA3' ' C' ' 242' ' ' GLY . 51.0 mt-30 -128.37 -16.39 4.42 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.383 1.073 . . . . 60.21 110.553 173.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 192' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -91.63 134.86 34.33 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.09 0.956 . . . . 65.13 110.249 -173.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 193' ' ' LEU . . . . . 0.63 ' HG ' ' HA2' ' C' ' 239' ' ' GLY . 17.4 mt -98.27 173.13 7.15 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 122.878 0.471 . . . . 52.2 112.043 -171.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 194' ' ' TYR . . . . . 0.512 ' HA ' ' O ' ' C' ' 250' ' ' TYR . 35.4 t80 -139.05 107.04 5.69 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 114.824 -1.08 . . . . 75.43 108.843 171.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 195' ' ' ALA . . . . . 0.527 ' HA ' ' O ' ' C' ' 185' ' ' VAL . . . -106.72 -176.16 3.0 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.322 1.049 . . . . 65.11 109.871 175.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 41.0 m -132.31 110.66 10.75 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 108.909 -0.774 . . . . 51.32 108.909 167.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 197' ' ' LEU . . . . . 0.473 ' HB2' HD22 ' C' ' 251' ' ' LEU . 35.6 tp -97.7 109.38 22.14 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.835 0.854 . . . . 73.5 109.169 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -88.94 104.5 17.01 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-O 121.917 0.865 . . . . 44.52 110.071 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 199' ' ' VAL . . . . . 0.405 ' HA ' HG11 ' C' ' 210' ' ' VAL . 42.3 t -92.35 123.22 62.92 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 124.958 1.303 . . . . 61.21 109.148 179.215 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 200' ' ' PRO . . . . . 0.431 ' HA ' ' O ' ' C' ' 256' ' ' THR . 55.6 Cg_endo -69.48 149.44 68.66 Favored 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 121.95 1.767 . . . . 71.34 110.826 176.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 201' ' ' ALA . . . . . 0.41 ' HB3' ' HH2' ' C' ' 269' ' ' TRP . . . -54.89 -46.84 99.47 Favored Pre-proline 0 CA--C 1.553 1.061 0 CA-C-O 117.579 -1.2 . . . . 74.35 113.909 -169.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 202' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -54.08 -47.16 28.57 Favored 'Trans proline' 0 C--N 1.395 3.006 0 C-N-CA 121.926 1.751 . . . . 63.15 112.625 176.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 203' ' ' ILE . . . . . . . . . . . . . 48.6 mt -69.77 -37.75 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.152 0.981 . . . . 63.4 111.156 -177.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 204' ' ' ALA . . . . . . . . . . . . . . . -61.71 -43.95 97.87 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.507 0.723 . . . . 75.02 110.87 178.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 205' ' ' VAL . . . . . . . . . . . . . 78.7 t -74.16 -40.99 51.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 115.024 -0.989 . . . . 63.41 112.378 -176.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 206' ' ' VAL . . . . . 0.625 ' HA ' ' HE2' ' A' ' 270' ' ' LYS . 11.1 p -78.15 -33.99 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 CA-C-N 118.047 0.385 . . . . 52.12 110.839 -177.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 207' ' ' GLY . . . . . . . . . . . . . . . 85.13 52.64 3.37 Favored Glycine 0 C--N 1.338 0.652 0 CA-C-N 115.779 -0.646 . . . . 63.21 111.518 -170.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 208' ' ' GLY . . . . . 0.499 ' HA2' HD23 ' B' ' 247' ' ' LEU . . . -90.13 -123.49 2.56 Favored Glycine 0 C--N 1.345 1.055 0 CA-C-N 115.104 -0.548 . . . . 51.32 111.778 -177.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 209' ' ' LYS . . . . . 0.716 ' HE2' ' HA ' ' B' ' 235' ' ' GLU . 6.5 mtmp? -147.2 144.13 28.7 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.53 0.681 . . . . 72.12 111.103 175.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 210' ' ' VAL . . . . . 0.405 HG11 ' HA ' ' C' ' 199' ' ' VAL . 16.2 m -122.67 178.66 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 113.6 -1.637 . . . . 62.05 107.468 167.073 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 211' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -132.3 130.29 40.64 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.922 0.392 . . . . 72.44 110.542 -178.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 212' ' ' ALA . . . . . 0.566 ' HB3' HG13 ' C' ' 219' ' ' VAL . . . -104.85 113.98 27.91 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 107.171 -1.418 . . . . 74.43 107.171 173.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 213' ' ' MET . . . . . . . . . . . . . 5.4 tmm? -67.38 135.51 53.31 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 107.84 -1.17 . . . . 63.12 107.84 171.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 214' ' ' THR . . . . . 0.536 HG21 ' HD2' ' C' ' 238' ' ' LYS . 0.1 OUTLIER -134.46 171.42 14.33 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-O 122.088 0.947 . . . . 54.24 111.962 -174.896 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 215' ' ' LEU . . . . . 0.439 HD13 ' HB2' ' C' ' 131' ' ' PHE . 27.4 mt -73.24 -31.16 63.96 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 114.151 -1.386 . . . . 44.41 113.08 -163.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.92 8.04 21.97 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.956 -1.02 . . . . 71.0 111.362 -178.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 217' ' ' GLY . . . . . . . . . . . . . . . 149.37 -163.11 29.18 Favored Glycine 0 C--N 1.351 1.381 0 CA-C-O 119.479 -0.623 . . . . 64.11 111.938 -177.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 218' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -96.44 163.89 1.19 Allowed 'Trans proline' 0 C--N 1.362 1.269 0 C-N-CA 122.984 2.456 . . . . 52.13 113.415 173.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 219' ' ' VAL . . . . . 0.744 ' HB ' ' HE3' ' C' ' 238' ' ' LYS . 1.7 p -142.44 114.64 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.099 0 N-CA-C 108.154 -1.054 . . . . 52.53 108.154 166.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 220' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -90.84 107.74 19.38 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.081 -1.081 . . . . 72.32 108.081 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 221' ' ' VAL . . . . . 0.518 ' HA ' ' HB2' ' B' ' 239' ' ' ALA . 56.0 t -76.07 129.77 36.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 125.124 1.37 . . . . 74.03 111.798 -172.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 222' ' ' ALA . . . . . 0.516 ' HA ' ' HG2' ' C' ' 209' ' ' LYS . . . -90.99 123.77 34.72 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.59 0.756 . . . . 73.3 109.848 173.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 58.4 t -99.17 142.0 23.84 Favored Pre-proline 0 CA--C 1.561 1.389 0 C-N-CA 125.149 1.38 . . . . 73.11 110.168 -172.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 224' ' ' PRO . . . . . 0.618 ' HG2' HE21 ' B' ' 243' ' ' GLN . 5.1 Cg_exo -85.6 158.9 10.73 Favored 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 123.958 3.105 . . . . 54.33 112.923 168.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 225' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -55.95 128.52 30.59 Favored 'Trans proline' 0 C--N 1.385 2.497 0 C-N-CA 123.462 2.775 . . . . 74.0 113.448 178.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 226' ' ' ARG . . . . . 0.554 HH11 HD12 ' A' ' 261' ' ' LEU . 0.0 OUTLIER 52.45 81.14 0.09 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.756 1.622 . . . . 70.15 112.141 -178.82 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 227' ' ' THR . . . . . 0.561 HG22 HG11 ' C' ' 253' ' ' VAL . 54.7 m -93.64 142.27 27.54 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 114.869 -1.06 . . . . 70.3 110.204 176.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 228' ' ' GLN . . . . . 0.826 HE21 ' HG2' ' A' ' 259' ' ' GLU . 27.3 mp0 -101.94 146.56 27.69 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.733 0.813 . . . . 74.32 112.271 -173.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 229' ' ' ALA . . . . . . . . . . . . . . . -69.56 118.14 12.05 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 114.647 -1.16 . . . . 62.12 108.519 169.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 230' ' ' GLY . . . . . . . . . . . . . . . 113.12 -2.3 25.47 Favored Glycine 0 C--N 1.339 0.717 0 CA-C-O 119.6 -0.556 . . . . 62.04 112.205 -175.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 231' ' ' ARG . . . . . . . . . . . . . 60.0 mtp85 -73.79 -179.49 3.68 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 117.126 0.463 . . . . 74.12 111.273 171.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 232' ' ' LYS . . . . . 0.575 ' HD3' ' HB3' ' C' ' 250' ' ' TYR . 34.4 ttmt -148.61 146.43 28.22 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.891 -0.595 . . . . 71.45 111.225 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 233' ' ' LEU . . . . . 0.649 HD13 ' HB2' ' C' ' 251' ' ' LEU . 0.9 OUTLIER -117.26 155.61 29.17 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.998 1.319 . . . . 74.21 108.495 177.349 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 234' ' ' ARG . . . . . 0.469 ' O ' ' HA3' ' B' ' 240' ' ' GLY . 16.8 ptt180 -127.07 109.6 12.05 Favored 'General case' 0 N--CA 1.475 0.775 0 O-C-N 123.702 0.626 . . . . 72.34 109.583 166.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 235' ' ' LEU . . . . . 0.481 HD12 HD23 ' C' ' 249' ' ' LEU . 26.8 mt -95.82 128.08 42.39 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.614 0.765 . . . . 73.43 109.185 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 236' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -79.87 125.76 30.13 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.25 0.62 . . . . 71.55 112.284 -168.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . 77.77 13.71 83.16 Favored Glycine 0 C--N 1.353 1.481 0 O-C-N 124.124 0.89 . . . . 71.42 113.458 178.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 238' ' ' LYS . . . . . 0.744 ' HE3' ' HB ' ' C' ' 219' ' ' VAL . 69.6 mmtt -105.05 19.85 19.88 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.592 0.757 . . . . 72.03 111.446 -178.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 239' ' ' GLY . . . . . 0.63 ' HA2' ' HG ' ' C' ' 193' ' ' LEU . . . -92.53 -171.08 40.86 Favored Glycine 0 C--N 1.345 1.071 0 CA-C-N 116.217 -0.447 . . . . 31.21 112.749 171.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 240' ' ' PHE . . . . . 0.577 ' HD2' HD13 ' C' ' 188' ' ' LEU . 11.9 m-85 -79.04 154.68 77.61 Favored Pre-proline 0 CA--C 1.563 1.447 0 C-N-CA 122.965 0.506 . . . . 75.14 110.221 177.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 241' ' ' PRO . . . . . 0.584 ' HA ' ' HG2' ' C' ' 246' ' ' ARG . 18.6 Cg_exo -67.55 136.73 40.4 Favored 'Trans proline' 0 C--N 1.396 3.05 0 C-N-CA 124.183 3.255 . . . . 70.21 114.355 -172.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 242' ' ' GLY . . . . . 0.517 ' HA3' ' NE2' ' C' ' 191' ' ' GLN . . . -134.2 171.96 21.97 Favored Glycine 0 C--N 1.35 1.344 0 CA-C-N 115.514 -0.767 . . . . 70.14 113.041 178.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.01 -25.06 38.53 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 123.764 2.976 . . . . 71.42 113.321 -177.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 244' ' ' ALA . . . . . . . . . . . . . . . -112.7 14.52 20.02 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.894 0.878 . . . . 71.42 111.008 178.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 245' ' ' GLY . . . . . . . . . . . . . . . 119.45 177.09 16.3 Favored Glycine 0 C--N 1.349 1.299 0 N-CA-C 112.078 -0.409 . . . . 51.32 112.078 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 246' ' ' ARG . . . . . 0.584 ' HG2' ' HA ' ' C' ' 241' ' ' PRO . 72.4 mtm-85 -85.09 158.77 20.33 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.856 0.862 . . . . 61.31 111.005 -177.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.82 -155.03 6.18 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 114.045 0.378 . . . . 63.23 114.045 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 248' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -124.96 139.11 54.12 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.363 0.665 . . . . 73.54 109.578 -179.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 249' ' ' LEU . . . . . 0.481 HD23 HD12 ' C' ' 235' ' ' LEU . 28.8 tp -85.2 115.27 22.88 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.927 0.891 . . . . 74.23 110.836 -177.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 250' ' ' TYR . . . . . 0.587 ' HA ' ' O ' ' C' ' 233' ' ' LEU . 16.0 m-30 -99.91 101.7 12.89 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 110.022 -0.362 . . . . 71.43 110.022 179.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 251' ' ' LEU . . . . . 0.649 ' HB2' HD13 ' C' ' 233' ' ' LEU . 0.8 OUTLIER -100.62 138.41 37.72 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.632 -0.668 . . . . 64.53 109.802 -175.716 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 252' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -87.57 125.44 34.35 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.895 -0.78 . . . . 73.41 108.895 171.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 253' ' ' VAL . . . . . 0.561 HG11 HG22 ' C' ' 227' ' ' THR . 59.3 t -74.5 136.84 24.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 123.213 0.605 . . . . 73.5 110.899 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 254' ' ' ARG . . . . . . . . . . . . . 40.8 mtm180 -116.12 147.11 41.67 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 107.63 -1.248 . . . . 74.13 107.63 163.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 255' ' ' ILE . . . . . 0.538 HG21 HG23 ' A' ' 257' ' ' ILE . 33.4 mm -97.89 119.07 45.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 106.757 -1.571 . . . . 75.24 106.757 164.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 256' ' ' THR . . . . . 0.431 ' O ' ' HA ' ' C' ' 200' ' ' PRO . 0.0 OUTLIER -123.4 173.59 7.89 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.031 1.333 . . . . 53.32 108.461 -178.947 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 257' ' ' ILE . . . . . . . . . . . . . 2.3 pp -144.12 153.27 56.36 Favored Pre-proline 0 N--CA 1.477 0.888 0 C-N-CA 123.181 0.592 . . . . 64.54 110.569 -174.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 258' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.51 6.1 1.35 Allowed 'Trans proline' 0 C--N 1.385 2.495 0 C-N-CA 122.812 2.341 . . . . 73.21 114.278 -175.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 259' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 52.43 -84.29 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.858 1.663 . . . . 72.3 112.825 -174.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 260' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.14 140.1 58.83 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.908 0.883 . . . . 73.41 110.718 -177.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 261' ' ' LEU . . . . . 0.508 HD22 ' HB3' ' C' ' 265' ' ' GLU . 65.1 mt -124.7 152.97 43.04 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.363 0.665 . . . . 71.21 111.101 -176.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 262' ' ' THR . . . . . . . . . . . . . 67.6 p -85.05 168.35 21.15 Favored Pre-proline 0 CA--C 1.556 1.202 0 N-CA-C 107.572 -1.27 . . . . 61.23 107.572 164.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 263' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -51.16 -37.44 58.61 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 122.799 2.333 . . . . 74.2 112.863 171.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 264' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -58.71 -64.08 1.06 Allowed 'General case' 0 C--O 1.251 1.138 0 C-N-CA 124.762 1.225 . . . . 71.04 110.845 175.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 265' ' ' GLU . . . . . 0.508 ' HB3' HD22 ' C' ' 261' ' ' LEU . 32.1 mm-40 -53.21 -44.06 67.72 Favored 'General case' 0 C--N 1.352 0.704 0 O-C-N 124.375 1.047 . . . . 65.11 110.493 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 266' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -58.72 -43.02 90.01 Favored 'General case' 0 C--O 1.214 -0.791 0 C-N-CA 123.462 0.705 . . . . 64.21 110.374 -178.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 267' ' ' ALA . . . . . . . . . . . . . . . -62.22 -51.84 66.17 Favored 'General case' 0 CA--C 1.555 1.157 0 O-C-N 123.726 0.641 . . . . 70.32 111.764 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 268' ' ' LEU . . . . . . . . . . . . . 8.7 mp -66.75 -48.69 68.33 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 116.498 -0.319 . . . . 52.44 111.238 -176.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 269' ' ' TRP . . . . . 0.41 ' HH2' ' HB3' ' C' ' 201' ' ' ALA . 94.6 m95 -61.22 -32.53 72.31 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.511 0.724 . . . . 61.11 111.281 176.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 270' ' ' LYS . . . . . 0.421 ' HD2' HG11 ' A' ' 206' ' ' VAL . 1.2 mmmm -61.35 -52.34 65.07 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 123.433 0.693 . . . . 75.43 110.872 176.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 271' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -63.48 -37.57 87.82 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 123.686 0.616 . . . . 75.33 111.233 -178.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 272' ' ' LEU . . . . . . . . . . . . . 95.5 mt -67.14 -35.1 79.0 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 122.744 0.418 . . . . 74.33 111.586 173.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 273' ' ' ALA . . . . . . . . . . . . . . . -64.3 -45.53 87.55 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.35 0.66 . . . . 34.13 110.479 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 274' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -69.27 -38.72 78.53 Favored 'General case' 0 C--O 1.245 0.845 0 O-C-N 124.38 1.05 . . . . 63.21 110.931 -179.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 275' ' ' ALA . . . . . . . . . . . . . . . -60.91 -30.7 70.34 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.768 -0.651 . . . . 70.04 110.554 172.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 276' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -94.05 -13.73 26.58 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 122.984 0.514 . . . . 75.52 112.304 177.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 277' ' ' TYR . . . . . 0.434 ' CE1' ' HA3' ' A' ' 208' ' ' GLY . 22.6 m-30 -70.3 -30.65 67.7 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.001 -1.111 . . . . 44.24 108.001 169.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 278' ' ' ALA . . . . . 0.451 ' HA ' HG12 ' B' ' 387' ' ' ILE . . . -63.79 2.61 0.46 Allowed 'General case' 0 CA--C 1.557 1.249 0 CA-C-N 114.177 -1.374 . . . . 55.2 113.07 169.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 279' ' ' ARG . . . . . . . . . . . . . 51.9 ttt180 -73.91 -33.54 64.01 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.043 0.537 . . . . 71.52 110.882 171.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 280' ' ' ALA . . . . . 0.402 ' HA ' ' HB ' ' B' ' 384' ' ' THR . . . . . . . . 0 CA--C 1.555 1.168 0 O-C-N 123.333 0.396 . . . . 75.14 110.725 -169.499 . . . . . . . . 1 1 . 1 stop_ save_